=LDR  01055cz  a2200193n  4500
=001  9880363732202441
=005  20141212192313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008457
=035  \\$aCBA1706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x500.$x500
=150  \\$aMeasles
=450  \\$aRubeola
=550  \\$wg$aMorbillivirus Infections
=550  \\$wh$aSubacute Sclerosing Panencephalitis
=667  \\$acaused by a morbillivirus; do not confuse X ref RUBEOLA with RUBELLA (German measles); French for measles = rougeole (not rubéole which = RUBELLA), Ital for measles = rosolia (not rubeola which = RUBELLA); Span for measles = sarampi (not rubeola which = RUBELLA)
=680  \\$iA highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.
=750  \0$aMeasles$5IEN$0(DLC)sh 85082696

=LDR  00711cz  a2200229n  4500
=001  9880363732302441
=005  20141212203256.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008456
=035  \\$aCBA1705M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x500
=072  \\$aD2.$x241.$x511.$x316.$x682.$x224
=150  \\$a2-Methyl-4-chlorophenoxyacetic Acid
=450  \\$wnnna$a2 Methyl 4 chlorophenoxyacetic Acid
=450  \\$wnnna$aAgroxone
=450  \\$aMCPA
=450  \\$wnnna$aMethoxone
=550  \\$wg$aPhenoxyacetates
=680  \\$iA powerful herbicide used as a selective weed killer.
=688  \\$a2001(1975)
=750  \0$aMCPA (Herbicide)$5IEN-M$0(DLC)sh 85082644

=LDR  01543cz  a2200325n  4500
=001  9880363732402441
=005  20141212203255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008452
=035  \\$aCBA1701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x210
=072  \\$aN6.$x850.$x460.$x350.$x600.$x615
=150  \\$aMaximum Allowable Concentration
=450  \\$wnnna$aAllowable Concentration, Maximum
=450  \\$wnnna$aAllowable Concentrations, Maximum
=450  \\$wnnna$aConcentration, Maximum Allowable
=450  \\$wnnna$aConcentrations, Maximum Allowable
=450  \\$wnnna$aMaximum Allowable Concentrations
=450  \\$wnnna$aMaximum Permissible Exposure Concentration
=450  \\$aMaximum Permissible Exposure Level
=450  \\$wnnna$aMPEL
=450  \\$wnnna$aMPELs
=550  \\$wg$aEnvironmental Exposure
=550  \\$wg$aOccupational Exposure
=550  \\$aThreshold Limit Values
=667  \\$aNIM; no qualif; coord NIM with specific drug or substance (IM without qualif); DF: MPEL
=680  \\$iThe maximum exposure to a biologically active physical or chemical agent that is allowed during an 8-hour period (a workday) in a population of workers, or during a 24-hour period in the general population, which does not appear to cause appreciable harm, whether immediate or delayed for any period, in the target population. (From Lewis Dictionary of Toxicology, 1st ed)
=688  \\$a2000(1991)
=750  \0$aThreshold limit values (Industrial toxicology)$5IEN-M$0(DLC)sh 85135047

=LDR  01352cz  a2200289n  4500
=001  9880363732502441
=005  20141212203253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008447
=035  \\$aCBA1696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x510
=150  \\$aMaxillofacial Prosthesis
=450  \\$wnnna$aMaxillary Prostheses
=450  \\$aMaxillary Prosthesis
=450  \\$wnnna$aMaxillofacial Prostheses
=450  \\$wnnna$aProstheses, Maxillary
=450  \\$wnnna$aProstheses, Maxillofacial
=450  \\$wnnna$aProsthesis, Maxillary
=450  \\$wnnna$aProsthesis, Maxillofacial
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aMandibular Prosthesis
=550  \\$aMaxillofacial Prosthesis Implantation
=667  \\$amaxillo- here may be either jaw but MANDIBULAR PROSTHESIS is also available; not for outer ear replacements ( = EAR, EXTERNAL (IM) + PROSTHESES AND IMPLANTS (IM) ) or nose replacements ( = NOSE (IM) + PROSTHESES AND IMPLANTS (IM) )
=680  \\$iA prosthetic appliance for the replacement of areas of the maxilla, mandible, and face, missing as a result of deformity, disease, injury, or surgery. When the prosthesis replaces portions of the mandible only, it is referred to as MANDIBULAR PROSTHESIS.
=688  \\$a67(66)
=750  \0$aMaxillofacial prosthesis$5IEN$0(DLC)sh 85082361

=LDR  00974cz  a2200265n  4500
=001  9880363732602441
=005  20141212203253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008445
=035  \\$aCBA1694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625.$x100.$x478
=072  \\$aG11.$x427.$x590.$x560.$x100.$x478
=150  \\$aMaxillofacial Development
=450  \\$wnnna$aDevelopment, Maxillofacial
=450  \\$wnnna$aDevelopments, Maxillofacial
=450  \\$aFace$xgrowth & development
=450  \\$aJaw$xgrowth & development
=450  \\$wnnna$aMaxillofacial Developments
=550  \\$wg$aBone Development
=550  \\$aMaxilla
=667  \\$along face syndrome does not go here: index under FACIAL BONES /abnorm (IM) + MALOCCLUSION or specific type (IM) + SYNDROME (NIM)
=680  \\$iThe process of growth and differentiation of the jaws and face.
=688  \\$a65
=750  \0$aFace$xGrowth$5IEN$0(DLC)sh2009124053

=LDR  01377cz  a2200361n  4500
=001  9880363732702441
=005  20141212203252.0
=008  830531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008444
=035  \\$aCBA1693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x650.$x693.$x575
=072  \\$aC8.$x460.$x669.$x693.$x575
=072  \\$aC8.$x460.$x692.$x503.$x503
=072  \\$aC8.$x785.$x600.$x693.$x575
=072  \\$aC9.$x603.$x669.$x693.$x575
=072  \\$aC9.$x603.$x692.$x503.$x503
=072  \\$aC9.$x647.$x685.$x693.$x575
=150  \\$aMaxillary Sinus Neoplasms
=450  \\$wnnna$aCancer, Maxillary Sinus
=450  \\$aCancer of Maxillary Sinus
=450  \\$wnnna$aCancers, Maxillary Sinus
=450  \\$wnnna$aMaxillary Sinus Cancer
=450  \\$wnnna$aMaxillary Sinus Cancers
=450  \\$wnnna$aMaxillary Sinus Neoplasm
=450  \\$wnnna$aNeoplasm, Maxillary Sinus
=450  \\$wnnna$aNeoplasms, Maxillary Sinus
=550  \\$wg$aParanasal Sinus Neoplasms
=667  \\$acoordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms.
=688  \\$a91(84); was see under PARANASAL SINUS NEOPLASMS 1984-90
=750  \0$aMaxillary sinus$xTumors$5IEN-M$0(DLC)sh 85082360
=750  \0$aMaxillary sinus$xCancer$5IEN-HS$0(DLC)sh 85082357

=LDR  00986cz  a2200253n  4500
=001  9880363732802441
=005  20141212203252.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008443
=035  \\$aCBA1692HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x621.$x578
=150  \\$aMaxillary Sinus
=450  \\$wnnna$aAntrum, Maxillary
=450  \\$aAntrum of Highmore
=450  \\$wnnna$aAntrums, Maxillary
=450  \\$wnnna$aHighmore Antrum
=450  \\$aMaxillary Antrum
=450  \\$wnnna$aMaxillary Antrums
=450  \\$wnnna$aSinus, Maxillary
=550  \\$wg$aParanasal Sinuses
=667  \\$ainflammation or sinusitis = MAXILLARY SINUSITIS; fractures: coordinate MAXILLARY SINUS /inj (IM) + MAXILLARY FRACTURES (IM)
=680  \\$iThe air space located in the body of the MAXILLARY BONE near each cheek. Each maxillary sinus communicates with the middle passage (meatus) of the NASAL CAVITY on the same side.
=750  \0$aMaxillary sinus$5IEN$0(DLC)sh 85082355

=LDR  00999cz  a2200277n  4500
=001  9880363732902441
=005  20141212203251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008441
=035  \\$aCBA1690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721.$x450.$x601
=072  \\$aC5.$x116.$x231.$x754.$x450.$x601
=072  \\$aC5.$x500.$x499.$x601
=072  \\$aC5.$x500.$x693.$x528
=072  \\$aC7.$x320.$x515.$x601
=072  \\$aC7.$x320.$x660.$x601
=150  \\$aMaxillary Neoplasms
=450  \\$wnnna$aMaxillary Neoplasm
=450  \\$wnnna$aNeoplasm, Maxillary
=450  \\$wnnna$aNeoplasms, Maxillary
=550  \\$wg$aJaw Neoplasms
=550  \\$wg$aMaxillary Diseases
=667  \\$amust be of the MAXILLA, not for "jaws" ( = JAW NEOPLASMS); /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iCancer or tumors of the MAXILLA or upper jaw.
=750  \0$aMaxilla$xCancer$5IEN-M$0(DLC)sh2010009740

=LDR  00709cz  a2200229n  4500
=001  9880363733002441
=005  20141212203251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008440
=035  \\$aCBA1689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x400.$x510
=072  \\$aC26.$x404.$x750.$x467.$x611
=150  \\$aMaxillary Fractures
=450  \\$wnnna$aFracture, Maxillary
=450  \\$wnnna$aFractures, Maxillary
=450  \\$wnnna$aMaxillary Fracture
=550  \\$wg$aJaw Fractures
=667  \\$amust be of the MAXILLA, not for "jaws" ( = JAW FRACTURES)
=680  \\$iFractures of the upper jaw.
=688  \\$a66
=750  \0$aMaxilla$xFractures$5IEN$0(DLC)sh 85082352

=LDR  00662cz  a2200229n  4500
=001  9880363733102441
=005  20141212203251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008439
=035  \\$aCBA1688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x693
=072  \\$aC7.$x320.$x660
=150  \\$aMaxillary Diseases
=450  \\$wnnna$aDisease, Maxillary
=450  \\$wnnna$aDiseases, Maxillary
=450  \\$wnnna$aMaxillary Disease
=550  \\$wg$aJaw Diseases
=550  \\$wh$aMaxillary Neoplasms
=667  \\$amust be of the MAXILLA, not for "jaws" ( = JAW DISEASES)
=688  \\$a67
=750  \0$aMaxilla$xDiseases$5IEN-M$0(IEN)369102

=LDR  01135cz  a2200253n  4500
=001  9880363733202441
=005  20141212203250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008437
=035  \\$aCBA1686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x645
=072  \\$aA14.$x521.$x645
=150  \\$aMaxilla
=450  \\$wnnna$aBone, Maxillary
=450  \\$wnnna$aBones, Maxillary
=450  \\$wnnna$aMaxillae
=450  \\$wnnna$aMaxillary Bone
=450  \\$wnnna$aMaxillary Bones
=450  \\$wnnna$aMaxillas
=550  \\$wg$aJaw
=667  \\$athe upper jaw bone (jawbone) only; check text for loose use of "maxillary" to mean "jaw", not precisely MAXILLA; /blood supply: consider also MAXILLARY ARTERY; /growth: consider also MAXILLOFACIAL DEVELOPMENT; /inj: consider also MAXILLOFACIAL INJURIES; /innerv: consider also MAXILLARY NERVE
=680  \\$iOne of a pair of irregularly shaped bones that form the upper jaw. A maxillary bone provides tooth sockets for the superior teeth, forms part of the ORBIT, and contains the MAXILLARY SINUS.
=750  \0$aMaxilla$5IEN$0(DLC)sh 85082351

=LDR  00794cz  a2200229n  4500
=001  9880363733302441
=005  20141212203249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008434
=035  \\$aCBA1683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186.$x501.$x630
=072  \\$aE7.$x222.$x501.$x630
=150  \\$aMatrix Bands
=450  \\$wnnna$aBand, Matrix
=450  \\$wnnna$aBands, Matrix
=450  \\$aDental Matrices$5IEN
=450  \\$wnnna$aMatrix Band
=550  \\$wg$aDental Instruments
=680  \\$iDevices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity.
=688  \\$a91(80); was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79
=750  \0$aDental matrices$5IEN$0(DLC)sh 85036906

=LDR  00950cz  a2200241n  4500
=001  9880363733402441
=005  20141212203249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008433
=035  \\$aCBA1682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x548
=150  \\$aMathematics
=450  \\$wnnna$aMathematic
=450  \\$aMathematicians$5IEN
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aGame Theory
=550  \\$wh$aNonlinear Dynamics
=550  \\$wh$aStatistics as Topic
=667  \\$athe discipline (education, history, etc) only; use MATHEMATICAL CONCEPTS or specifics treed under it for numeric concepts including concepts in arithmetic, geometry and calculus
=680  \\$iThe deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aMathematics$5IEN-M$0(DLC)sh 85082139
=750  \0$aMathematicians$5IEN-HS$0(DLC)sh 85082138

=LDR  01159cz  a2200325n  4500
=001  9880363733502441
=005  20141212203249.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008432
=035  \\$aCBA1681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x680
=150  \\$aMathematical Computing
=450  \\$wnnna$aComputing, Mathematic
=450  \\$wnnna$aComputing, Mathematical
=450  \\$wnnna$aComputing, Statistical
=450  \\$wnnna$aComputings, Mathematic
=450  \\$wnnna$aComputings, Mathematical
=450  \\$wnnna$aComputings, Statistical
=450  \\$wnnna$aMathematic Computing
=450  \\$wnnna$aMathematic Computings
=450  \\$wnnna$aMathematical Computings
=450  \\$aStatistical Computing
=450  \\$wnnna$aStatistical Computings
=450  \\$wnnna$aStatistical Programs, Computer Based
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aNumerical Analysis, Computer-Assisted
=680  \\$iComputer-assisted interpretation and analysis of various mathematical functions related to a particular problem.
=688  \\$a87
=750  \0$aMathematics$xData processing$5IEN$0(DLC)sh 85082146

=LDR  01052cz  a2200265n  4500
=001  9880363733602441
=005  20141212203248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008431
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x455
=150  \\$aMaternal-Fetal Exchange
=450  \\$wnnna$aExchange, Maternal-Fetal
=450  \\$wnnna$aExposure, Transplacental
=450  \\$wnnna$aMaternal Fetal Exchange
=450  \\$aTransplacental Exposure
=550  \\$wg$aPregnancy
=550  \\$aBiological Transport
=550  \\$aFetus
=550  \\$aMaternal Exposure
=550  \\$aMaternal-Fetal Relations
=550  \\$aPlacenta
=667  \\$acheck the tags FEMALE & PREGNANCY; note that FETOMATERNAL TRANSFUSION (Cat C) & IMMUNITY, MATERNALLY-ACQUIRED (Cat G) exist
=680  \\$iExchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.
=750  \0$aMaternal-fetal exchange$5IEN$0(DLC)sh 85082101

=LDR  00654cz  a2200205n  4500
=001  9880363733702441
=005  20161116115306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008429
=035  \\$aCBA1678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x678
=150  \\$aMaternal Welfare
=450  \\$wnnna$aHealth, Maternal
=450  \\$wnnna$aWelfare, Maternal
=550  \\$wg$aSocial Welfare
=550  \\$aMaternal Health
=667  \\$aspecify geog
=680  \\$iOrganized efforts by communities or organizations to improve the health and well-being of the mother.
=750  \0$aMaternal and infant welfare$5IEN$0(DLC)sh 85082098

=LDR  01005cz  a2200253n  4500
=001  9880363733802441
=005  20141212203247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008428
=035  \\$aCBA1677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x500
=072  \\$aL1.$x280.$x975.$x550.$x500
=072  \\$aN1.$x224.$x935.$x698.$x653
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x500
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x500
=150  \\$aMaternal Mortality
=450  \\$wnnna$aMaternal Mortalities
=450  \\$wnnna$aMortalities, Maternal
=450  \\$wnnna$aMortality, Maternal
=550  \\$wg$aMortality
=667  \\$aa statistical concept; do not confuse with MATERNAL DEATH; IM general only; coordinate NIM with disease / mortal (IM); specify geographic term if pertinent
=680  \\$iMaternal deaths resulting from complications of pregnancy and childbirth in a given population.
=750  \0$aMothers$xMortality$5IEN$0(DLC)sh 85087530

=LDR  01104cz  a2200313n  4500
=001  9880363733902441
=005  20161117092429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x620
=072  \\$aN2.$x421.$x800.$x500
=150  \\$aMaternal Health Services
=450  \\$wnnna$aHealth Service, Maternal
=450  \\$wnnna$aHealth Services, Maternal
=450  \\$wnnna$aMaternal Health Service
=450  \\$wnnna$aService, Maternal Health
=450  \\$wnnna$aServices, Maternal Health
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aReproductive Health Services
=550  \\$wh$aMaternal-Child Health Services
=550  \\$wh$aPerinatal Care
=550  \\$wh$aPreconception Care
=550  \\$wh$aPrenatal Care
=550  \\$aMaternal Welfare
=667  \\$aspecify geog; check also tags HUMAN; FEMALE & PREGNANCY; DF: MATERNAL HEALTH SERV
=680  \\$iOrganized services to provide health care to expectant and nursing mothers.
=688  \\$a68
=750  \0$aMaternal health services$5IEN$0(DLC)sh 85082102

=LDR  00659cz  a2200217n  4500
=001  9880363734002441
=005  20141212203247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008426
=035  \\$aCBA1675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x240
=150  \\$aMaternal Deprivation
=450  \\$wnnna$aDeprivation, Maternal
=450  \\$wnnna$aDeprivations, Maternal
=450  \\$wnnna$aMaternal Deprivations
=550  \\$wg$aFamily Relations
=667  \\$ahuman & animal
=680  \\$iProlonged separation of the offspring from the mother.
=688  \\$a69(66)
=750  \0$aMaternal deprivation$5IEN$0(DLC)sh 85082100

=LDR  00801cz  a2200265n  4500
=001  9880363734102441
=005  20141212203246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008423
=035  \\$aCBA1672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x560
=072  \\$aN5.$x715.$x350.$x75.$x550
=072  \\$aN6.$x850.$x490.$x250.$x550
=150  \\$aMaternal Age
=450  \\$wnnna$aAge, Maternal
=450  \\$wnnna$aAges, Maternal
=450  \\$wnnoa$aMaternal Age 35 and over$5IEN-M
=450  \\$wnnna$aMaternal Ages
=550  \\$wg$aAge Factors
=550  \\$wg$aReproductive Physiological Phenomena
=667  \\$arelation to PREGNANCY: Manual 28.16.4
=680  \\$iThe age of the mother in PREGNANCY.
=688  \\$a67(65)
=750  \0$aMaternal age$5IEN$0(DLC)sh 85082097

=LDR  01436cz  a2200361n  4500
=001  9880363734202441
=005  20141212203246.0
=008  860620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008422
=035  \\$aCBA1671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x570
=150  \\$aMaterials Testing
=450  \\$aBiocompatibility Testing
=450  \\$aBiocompatible Materials Testing
=450  \\$aHemocompatibility Testing
=450  \\$wnnna$aHemocompatibility Testings
=450  \\$wnnna$aHemocompatible Materials Testing
=450  \\$wnnna$aMaterials Testing, Biocompatible
=450  \\$wnnna$aMaterials Testing, Hemocompatible
=450  \\$wnnna$aTesting, Biocompatibility
=450  \\$aTesting, Biocompatible Materials
=450  \\$wnnna$aTesting, Hemocompatibility
=450  \\$wnnna$aTesting, Hemocompatible Materials
=450  \\$wnnna$aTesting, Materials
=450  \\$wnnna$aTestings, Biocompatibility
=450  \\$wnnna$aTestings, Hemocompatibility
=550  \\$wg$aInvestigative Techniques
=550  \\$aBiocompatible Materials
=667  \\$ado not confuse HEMOCOMPATIBILITY TESTING with HISTOCOMPATIBILITY TESTING
=680  \\$iThe testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility.
=688  \\$a87
=750  \0$aMaterials$xTesting$5IEN$0(DLC)sh 85082086

=LDR  01327cz  a2200325n  4500
=001  9880363734302441
=005  20141212203245.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008421
=035  \\$aCBA1670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x650
=072  \\$aN4.$x452.$x442.$x650
=150  \\$aMaterials Management, Hospital
=450  \\$aEquipment and Supplies, Hospital$xorganization & administration
=450  \\$wnnna$aHospital Material Management
=450  \\$wnnna$aHospital Material Managements
=450  \\$aHospital Materials Management
=450  \\$wnnna$aManagement, Hospital Material
=450  \\$wnnna$aManagement, Hospital Materials
=450  \\$wnnna$aManagements, Hospital Material
=450  \\$wnnna$aMaterial Management, Hospital
=450  \\$wnnna$aMaterial Managements, Hospital
=450  \\$aStoreroom
=450  \\$aStorerooms
=550  \\$wg$aHospital Administration
=550  \\$wh$aInventories, Hospital
=680  \\$iThe management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc.
=688  \\$a78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77
=750  \0$aHospitals$xMaterials management$5IEN$0(DLC)sh 85062340

=LDR  01664cz  a2200541n  4500
=001  9880363734402441
=005  20200629171024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008420
=035  \\$aCBA1669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637
=150  \\$aManufactured Materials
=450  \\$wnnna$aManufactured Material
=450  \\$wnnna$aMaterial, Manufactured
=450  \\$wnnna$aMaterials, Manufactured
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aAdhesives
=550  \\$wh$aBiomedical and Dental Materials
=550  \\$wh$aBiomimetic Materials
=550  \\$wh$aCellophane
=550  \\$wh$aCeramics
=550  \\$wh$aClothing
=550  \\$wh$aConstruction Materials
=550  \\$wh$aCooking and Eating Utensils
=550  \\$wh$aElastomers
=550  \\$wh$aGlass
=550  \\$wh$aIndustrial Oils
=550  \\$wh$aInk
=550  \\$wh$aJewelry
=550  \\$wh$aLiquid Crystals
=550  \\$wh$aMagnets
=550  \\$wh$aMicro-Electrical-Mechanical Systems
=550  \\$wh$aNanostructures
=550  \\$wh$aNylons
=550  \\$wh$aPaint
=550  \\$wh$aPaper
=550  \\$wh$aProtective Devices
=550  \\$wh$aSmoking Devices
=550  \\$wh$aSports Equipment
=550  \\$wh$aTobacco Products
=550  \\$wh$aTobacco Use Cessation Products
=550  \\$wh$aWeapons
=550  \\$wh$aWool
=667  \\$aGEN or unspecified; prefer specifics; TN 124
=680  \\$iSubstances and materials manufactured for use in various technologies and industries and for domestic use.
=688  \\$a98; use explode 1967-97
=750  \0$aMaterials$5IEN-M$0(DLC)sh 85082065

=LDR  01246cz  a2200241n  4500
=001  9880363734502441
=005  20141212203244.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008419
=035  \\$aCBA1668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x526
=150  \\$aMateria Medica
=450  \\$aHomeopathic Remedies
=450  \\$wnnna$aMedica, Materia
=450  \\$aNosodes
=450  \\$wnnna$aRemedies, Homeopathic
=550  \\$wg$aPharmaceutical Preparations
=550  \\$aMedicine, Traditional
=667  \\$aprefer the more specific PHYTOTHERAPY or HOMEOPATHY; coord IM with specific substance IM; for use in therapy coord /ther use (IM) with substance /ther use (IM) if permitted + disease /*drug ther (IM); do not capitalize Chinese names of various substances in titles or translations
=680  \\$iMaterials or substances used in the composition of traditional medical remedies. The use of this term in MeSH was formerly restricted to historical articles or those concerned with traditional medicine, but it can also refer to homeopathic remedies. Nosodes are specific types of homeopathic remedies prepared from causal agents or disease products.
=688  \\$a88
=750  \0$aMateria medica$5IEN$0(DLC)sh 85082055

=LDR  00510cz  a2200181n  4500
=001  9880363734602441
=005  20141212203244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008418
=035  \\$aCBA1667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x526
=150  \\$aMasturbation
=450  \\$wnnna$aMasturbations
=550  \\$wg$aSexual Behavior
=667  \\$ahuman & animal
=680  \\$iSexual stimulation or gratification of the self.
=750  \0$aMasturbation$5IEN$0(DLC)sh 85082015

=LDR  00692cz  a2200205n  4500
=001  9880363734702441
=005  20141212203244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008417
=035  \\$aCBA1666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x160.$x495.$x500
=072  \\$aC5.$x116.$x165.$x495.$x249
=072  \\$aC9.$x218.$x705.$x663.$x652
=150  \\$aMastoiditis
=450  \\$wnnna$aMastoiditides
=550  \\$wg$aOsteomyelitis
=550  \\$wg$aOtitis Media
=680  \\$iInflammation of the honeycomb-like MASTOID BONE in the skull just behind the ear. It is usually a complication of OTITIS MEDIA.
=750  \0$aMastoid process$xDiseases$5IEN$0(DLC)sh 85082010

=LDR  00923cz  a2200277n  4500
=001  9880363734802441
=005  20141212203244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008416
=035  \\$aCBA1665HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x885.$x444
=150  \\$aMastoid
=450  \\$wnnna$aBone, Mastoid
=450  \\$wnnna$aBones, Mastoid
=450  \\$wnnna$aMastoid Bone
=450  \\$wnnna$aMastoid Bones
=450  \\$wnnna$aMastoid Process
=450  \\$wnnna$aMastoid Processes
=450  \\$wnnna$aMastoids
=450  \\$wnnna$aProcess, Mastoid
=450  \\$wnnna$aProcesses, Mastoid
=550  \\$wg$aTemporal Bone
=667  \\$ainflammation = MASTOIDITIS; fractures: coordinate MASTOID /inj (IM) + SKULL FRACTURES (IM)
=680  \\$iThe posterior part of the temporal bone. It is a projection of the petrous bone.
=750  \0$aMastoid process$5IEN$0(DLC)sh 85082009

=LDR  01200cz  a2200313n  4500
=001  9880363734902441
=005  20141212203243.0
=008  860407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008415
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x465
=072  \\$aC17.$x800.$x508
=150  \\$aMastocytosis
=450  \\$wnnna$aDisease, Mast-Cell
=450  \\$wnnna$aDiseases, Mast-Cell
=450  \\$wnnna$aMast Cell Disease
=450  \\$aMast-Cell Disease
=450  \\$wnnna$aMast-Cell Diseases
=450  \\$wnnna$aMastocytoses
=550  \\$wg$aNeoplasms, Connective Tissue
=550  \\$wg$aSkin Diseases
=550  \\$wh$aMast-Cell Sarcoma
=550  \\$wh$aMastocytoma
=550  \\$wh$aMastocytosis, Cutaneous
=550  \\$wh$aMastocytosis, Systemic
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
=688  \\$a87; was see URTICARIA PIGMENTOSA 1975-86
=750  \0$aMast cell disease$5IEN$0(DLC)sh 85081981

=LDR  00697cz  a2200217n  4500
=001  9880363735002441
=005  20141212203243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008413
=035  \\$aCBA1662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x844.$x603
=072  \\$aC17.$x800.$x90.$x968
=150  \\$aMastitis
=550  \\$wg$aBreast Diseases
=550  \\$wg$aPuerperal Disorders
=550  \\$wh$aGranulomatous Mastitis
=667  \\$aCHRONIC CYSTIC MASTITIS see FIBROCYSTIC BREAST DISEASE is also available; MASTITIS, BOVINE is also available
=680  \\$iINFLAMMATION of the BREAST, or MAMMARY GLAND.
=688  \\$a1966
=750  \0$aMastitis$5IEN$0(DLC)sh 85082006

=LDR  01011cz  a2200265n  4500
=001  9880363735102441
=005  20141212203242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008410
=035  \\$aCBA1659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x600
=072  \\$aA14.$x530
=150  \\$aMasticatory Muscles
=450  \\$wnnna$aMasticatory Muscle
=450  \\$wnnna$aMuscle, Masticatory
=450  \\$wnnna$aMuscles, Masticatory
=550  \\$wg$aMuscle, Skeletal
=550  \\$wg$aStomatognathic System
=550  \\$wh$aMasseter Muscle
=550  \\$wh$aPterygoid Muscles
=550  \\$wh$aTemporal Muscle
=667  \\$aGEN: prefer specific; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iMuscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. (From Stedman, 25th ed)
=750  \0$aMasticatory Muscles$5IEN-M$0(DLC)sh 91002842

=LDR  00585cz  a2200205n  4500
=001  9880363735202441
=005  20141212203242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008409
=035  \\$aCBA1658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x593.$x260.$x500
=072  \\$aG7.$x700.$x620.$x260.$x500
=072  \\$aG10.$x261.$x326.$x240.$x500
=150  \\$aMastication
=450  \\$aChewing
=550  \\$wg$aEating
=550  \\$aTooth
=680  \\$iThe act and process of chewing and grinding food in the mouth.
=750  \0$aMastication$5IEN$0(DLC)sh 85081999

=LDR  01831cz  a2200505n  4500
=001  9880363735302441
=005  20141212211031.0
=008  880607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015412
=035  \\$aCBA1655M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x466.$x701
=150  \\$aMastectomy, Segmental
=450  \\$wnnna$aBreast-Conserving Surgeries
=450  \\$aBreast-Conserving Surgery
=450  \\$wnnna$aBreast Conserving Surgery
=450  \\$wnnna$aExcision Mastectomies, Local
=450  \\$wnnna$aExcision Mastectomy, Local
=450  \\$wnnna$aLimited Resection Mastectomies
=450  \\$wnnna$aLimited Resection Mastectomy
=450  \\$wnnna$aLocal Excision Mastectomies
=450  \\$wnnna$aLocal Excision Mastectomy
=450  \\$aLumpectomy
=450  \\$wnnna$aMastectomies, Limited Resection
=450  \\$wnnna$aMastectomies, Local Excision
=450  \\$wnnna$aMastectomies, Partial
=450  \\$wnnna$aMastectomies, Segmental
=450  \\$wnnna$aMastectomy, Limited Resection
=450  \\$wnnna$aMastectomy, Local Excision
=450  \\$wnnna$aMastectomy, Partial
=450  \\$wnnna$aPartial Mastectomies
=450  \\$aPartial Mastectomy
=450  \\$wnnna$aResection Mastectomies, Limited
=450  \\$wnnna$aResection Mastectomy, Limited
=450  \\$wnnna$aSegmental Mastectomies
=450  \\$wnnna$aSegmental Mastectomy
=450  \\$wnnna$aSegmentectomies
=450  \\$wnnna$aSegmentectomy
=450  \\$wnnna$aSurgeries, Breast-Conserving
=450  \\$wnnna$aSurgery, Breast-Conserving
=450  \\$wnnna$aSurgery, Breast Conserving
=550  \\$wg$aMastectomy
=680  \\$iRemoval of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.
=688  \\$a89
=750  \0$aLumpectomy$5IEN-M$0(DLC)sh2003001251

=LDR  00805cz  a2200265n  4500
=001  9880363735402441
=005  20181126161630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008408
=035  \\$aCBA1651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x466
=150  \\$aMastectomy
=450  \\$wnnna$aMammectomies
=450  \\$wnnna$aMammectomy
=450  \\$wnnna$aMastectomies
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aMastectomy, Radical
=550  \\$wh$aMastectomy, Segmental
=550  \\$wh$aMastectomy, Simple
=550  \\$wh$aMastectomy, Subcutaneous
=550  \\$wh$aProphylactic Mastectomy
=550  \\$aBreast
=667  \\$aGEN or unspecified; prefer specifics; do not use /util except by MeSH definition
=750  \0$aMastectomy$5IEN$0(DLC)sh 85081984

=LDR  01126cz  a2200265n  4500
=001  9880363735502441
=005  20141212203241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x427
=072  \\$aA15.$x382.$x652
=150  \\$aMast Cells
=450  \\$wnnna$aBasophil, Tissue
=450  \\$aBasophils, Tissue
=450  \\$wnnna$aCell, Mast
=450  \\$wnnna$aCells, Mast
=450  \\$wnnna$aMast Cell
=450  \\$wnnna$aTissue Basophil
=450  \\$wnnna$aTissue Basophils
=550  \\$wg$aConnective Tissue Cells
=550  \\$wg$aImmune System
=667  \\$aMAST-CELL DISEASE see MASTOCYTOSIS is available
=680  \\$iGranulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR.
=750  \0$aMast cells$5IEN$0(DLC)sh 85081982

=LDR  00790cz  a2200229n  4500
=001  9880363735602441
=005  20141212203241.0
=008  790312\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008406
=035  \\$aCBA1649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x600.$x500
=072  \\$aA14.$x530.$x630
=150  \\$aMasseter Muscle
=450  \\$wnnna$aMasseter Muscles
=450  \\$wnnna$aMuscle, Masseter
=450  \\$wnnna$aMuscles, Masseter
=550  \\$wg$aMasticatory Muscles
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iA masticatory muscle whose action is closing the jaws.
=688  \\$a91(80); was see under MASTICATORY MUSCLES 1980-90
=750  \0$aMasseter muscle$5IEN$0(DLC)sh 85081971

=LDR  01332cz  a2200373n  4500
=001  9880363735702441
=005  20200526114728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008405
=035  \\$aCBA1648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x599.$x750.$x750
=072  \\$aE2.$x779.$x867.$x880.$x750
=072  \\$aE2.$x831.$x535.$x867.$x880.$x750
=150  \\$aMassage
=450  \\$wnnna$aBodywork
=450  \\$wnnna$aBodyworks
=450  \\$wnnna$aCraniosacral Massage
=450  \\$wnnna$aMassage, Craniosacral
=450  \\$wnnna$aMassage Therapies
=450  \\$wnnna$aMassage Therapy
=450  \\$aReflexology
=450  \\$wnnna$aRolfing
=450  \\$wnnna$aTherapies, Massage
=450  \\$wnnna$aTherapies, Zone
=450  \\$wnnna$aTherapy, Massage
=450  \\$wnnna$aTherapy, Zone
=450  \\$wnnna$aZone Therapies
=450  \\$aZone Therapy
=550  \\$wg$aTherapy, Soft Tissue
=550  \\$wh$aManual Lymphatic Drainage
=667  \\$ado not confuse entry term REFLEXOLOGY with REFLEXOTHERAPY; do not confuse with THERAPEUTIC TOUCH
=680  \\$iThe systematic and methodical manipulations of body tissues best performed with the hands for the purpose of affecting the nervous and muscular systems and the general circulation.
=750  \0$aMassage$5IEN$0(DLC)sh 85081957

=LDR  01513cz  a2200445n  4500
=001  9880363735802441
=005  20141212203240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008403
=035  \\$aCBA1646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x500
=072  \\$aE5.$x318.$x308.$x250.$x580
=072  \\$aN2.$x421.$x143.$x827.$x233.$x443
=072  \\$aN2.$x421.$x726.$x233.$x443
=072  \\$aN5.$x715.$x360.$x300.$x375.$x500
=072  \\$aN6.$x850.$x520.$x308.$x250.$x580
=072  \\$aN6.$x850.$x780.$x500
=150  \\$aMass Screening
=450  \\$wnnna$aMass Screenings
=450  \\$aMedical Screening$5IEN
=450  \\$wnnna$aScreening
=450  \\$wnnna$aScreening, Mass
=450  \\$wnnna$aScreenings
=450  \\$wnnna$aScreenings, Mass
=550  \\$wg$aDiagnostic Services
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aHealth Surveys
=550  \\$wg$aPublic Health Practice
=550  \\$wh$aAnonymous Testing
=550  \\$wh$aMandatory Testing
=550  \\$wh$aMass Chest X-Ray
=550  \\$wh$aMultiphasic Screening
=550  \\$wh$aNeonatal Screening
=550  \\$wh$aSubstance Abuse Detection
=550  \\$wh$aVision Screening
=667  \\$acoord with disease/diag or /epidemiol or /prev
=680  \\$iOrganized periodic procedures performed on large groups of people for the purpose of detecting disease.
=688  \\$a68; was MASS SCREENING TECHNICS 1963-67
=750  \0$aMedical screening$5IEN$0(DLC)sh 85083024

=LDR  01158cz  a2200301n  4500
=001  9880363735902441
=005  20141212203240.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008402
=035  \\$aCBA1645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x590
=150  \\$aMass Media
=450  \\$wnnna$aBroadcast Media
=450  \\$wnnna$aFolk Media
=450  \\$wnnna$aMedia, Broadcast
=450  \\$wnnna$aMedia, Folk
=450  \\$wnnna$aMedia, Mass
=450  \\$wnnna$aMedia, Printed
=450  \\$wnnna$aPrinted Media
=550  \\$wg$aCommunications Media
=550  \\$wh$aMotion Pictures as Topic
=550  \\$wh$aRadio
=550  \\$wh$aTelevision
=667  \\$aIM with general reference to NEWSPAPERS; PERIODICALS; RADIO; TELEVISION; MOTION PICTURES; etc., as mass media; do not use as routine coord with the specific: coord only when specific is discussed as a mass medium, as "magazines as mass media"
=680  \\$iInstruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc.
=688  \\$a80
=750  \0$aMass media$5IEN$0(DLC)sh 85081863

=LDR  00745cz  a2200229n  4500
=001  9880363736002441
=005  20141212203238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008399
=035  \\$aCBA1642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x527
=150  \\$aMass Behavior
=450  \\$wnnna$aBehavior, Mass
=450  \\$wnnna$aBehaviors, Mass
=450  \\$aCollective Behavior$5IEN
=450  \\$wnnna$aMass Behaviors
=550  \\$wg$aSocial Behavior
=667  \\$adifferentiate from GROUP PROCESSES
=680  \\$iCollective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.
=688  \\$a74
=750  \0$aCollective behavior$5IEN$0(DLC)sh 85028094

=LDR  00720cz  a2200217n  4500
=001  9880363736102441
=005  20160609131029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008398
=035  \\$aCBA1641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x500
=150  \\$aMasochism
=450  \\$wnnna$aMasochism, Sexual
=450  \\$wnnna$aMasochisms
=450  \\$wnnna$aMasochisms, Sexual
=450  \\$aSexual Masochism
=450  \\$wnnna$aSexual Masochisms
=550  \\$wg$aParaphilic Disorders
=680  \\$iPleasure derived from being physically or psychologically abused, whether inflicted by oneself or by others. Masochism includes sexual masochism.
=750  \0$aMasochism$5IEN$0(DLC)sh 85081828

=LDR  00820cz  a2200241n  4500
=001  9880363736202441
=005  20141212203238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008397
=035  \\$aCBA1640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x877.$x500
=072  \\$aE7.$x700.$x500
=072  \\$aE7.$x858.$x594.$x750
=072  \\$aJ1.$x637.$x708.$x500
=150  \\$aMasks
=450  \\$wnnna$aMask
=550  \\$wg$aProtective Devices
=550  \\$wg$aSurgical Attire
=550  \\$wh$aLaryngeal Masks
=667  \\$aincludes surgical masks; GAS MASKS see RESPIRATORY PROTECTIVE DEVICES is available
=680  \\$iDevices that cover the nose and mouth to maintain aseptic conditions or to administer inhaled anesthetics or other gases. (UMDNS, 1999)
=750  \0$aMasks$5IEN$0(DLC)sh 85081817

=LDR  00878cz  a2200253n  4500
=001  9880363736302441
=005  20141212203237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008394
=035  \\$aCBA1637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573
=150  \\$aMarsupialia
=450  \\$wnnna$aMarsupial
=450  \\$wnnna$aMarsupials
=450  \\$aMetatheria
=550  \\$wg$aMammals
=550  \\$wh$aMacropodidae
=550  \\$wh$aOpossums
=550  \\$wh$aPhalangeridae
=550  \\$wh$aPhascolarctidae
=550  \\$wh$aPotoroidae
=680  \\$iAn infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch (marsupium). In contrast to Eutheria (placentals), marsupials have an incomplete PLACENTA.
=750  \0$aMarsupials$5IEN$0(DLC)sh 85081610

=LDR  00895cz  a2200241n  4500
=001  9880363736502441
=005  20141212203237.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008392
=035  \\$aCBA1635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x750.$x460
=150  \\$aMarmota
=450  \\$wnnna$aMarmot
=450  \\$wnnna$aMarmotas
=450  \\$wnnna$aMarmots
=450  \\$wnnna$aWoodchuck
=450  \\$aWoodchucks
=550  \\$wg$aSciuridae
=667  \\$aa genus of marmots or woodchucks: do not confuse with MARMOSETS see CALLITHRIX, a genus of monkey; IM; qualif permitted
=680  \\$iA genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.
=688  \\$a91(82); was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81
=750  \0$aMarmots$5IEN$0(DLC)sh 85081390

=LDR  01261cz  a2200349n  4500
=001  9880363736602441
=005  20141212203236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008390
=035  \\$aCBA1633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x500
=072  \\$aE5.$x318.$x740.$x996.$x500
=072  \\$aG17.$x830.$x500
=072  \\$aN5.$x715.$x360.$x750.$x625.$x500
=072  \\$aN5.$x715.$x360.$x750.$x770.$x500
=072  \\$aN6.$x850.$x520.$x830.$x600.$x500
=072  \\$aN6.$x850.$x520.$x830.$x996.$x500
=150  \\$aMarkov Chains
=450  \\$wnnna$aChain, Markov
=450  \\$wnnna$aChains, Markov
=450  \\$wnnna$aMarkov Chain
=450  \\$aMarkov Process
=450  \\$wnnna$aMarkov Processes
=450  \\$wnnna$aProcess, Markov
=450  \\$wnnna$aProcesses, Markov
=550  \\$wg$aProbability
=550  \\$wg$aStochastic Processes
=667  \\$ano qualif
=680  \\$iA stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.
=688  \\$a91(75); was see under PROBABILITY 1975-90
=750  \0$aMarkov processes$5IEN$0(DLC)sh 85081369

=LDR  01155cz  a2200325n  4500
=001  9880363736702441
=005  20141212203236.0
=008  780509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008389
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x687.$x550
=072  \\$aN3.$x219.$x463.$x548
=072  \\$aN5.$x300.$x430.$x500
=150  \\$aMarketing of Health Services
=450  \\$wnnna$aHealth Marketing Service
=450  \\$wnnna$aHealth Marketing Services
=450  \\$aHealth Services Marketing
=450  \\$wnnna$aMarketing, Health Services
=450  \\$wnnna$aMarketing Service, Health
=450  \\$wnnna$aMarketing Services, Health
=450  \\$wnnna$aServices, Health Marketing
=550  \\$wg$aFinancial Management
=550  \\$wg$aHealth Services Accessibility
=550  \\$wg$aMarketing
=550  \\$wh$aSocial Marketing
=550  \\$aHealth Care Sector
=667  \\$aDF: MARKETING HEALTH SERV
=680  \\$iApplication of marketing principles and techniques to maximize the use of health care resources.
=688  \\$a80(79); was see under HEALTH RESOURCES 1979
=750  \0$aMedical care$xMarketing$5IEN$0(DLC)sh2008107622

=LDR  00981cz  a2200289n  4500
=001  9880363736802441
=005  20141212203236.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008388
=035  \\$aCBA1631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x581.$x550
=150  \\$aMarital Therapy
=450  \\$aMarital Psychotherapy$5IEN
=450  \\$wnnna$aMarital Therapies
=450  \\$wnnna$aMarriage Therapies
=450  \\$aMarriage Therapy
=450  \\$wnnna$aTherapies, Marital
=450  \\$wnnna$aTherapies, Marriage
=450  \\$wnnna$aTherapy, Marital
=450  \\$wnnna$aTherapy, Marriage
=550  \\$wg$aPsychotherapy, Group
=550  \\$aCouples Therapy
=667  \\$aa psychother technique; DF: MARITAL THER
=680  \\$iA form of psychotherapy involving the husband and wife and directed to improving the marital relationship.
=688  \\$a76; was MARRIAGE THERAPY 1973-75
=750  \0$aMarital psychotherapy$5IEN$0(DLC)sh 85081303

=LDR  01096cz  a2200289n  4500
=001  9880363736902441
=005  20141212203235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008387
=035  \\$aCBA1630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946.$x580
=150  \\$aMarine Toxins
=450  \\$wnnna$aToxins, Marine
=550  \\$wg$aToxins, Biological
=550  \\$wh$aCiguatoxins
=550  \\$wh$aCnidarian Venoms
=550  \\$wh$aFish Venoms
=550  \\$wh$aHolothurin
=550  \\$wh$aLyngbya Toxins
=550  \\$wh$aMollusk Venoms
=550  \\$wh$aSaxitoxin
=550  \\$wh$aTetrodotoxin
=667  \\$a/antag permitted but consider also ANTITOXINS; coordinate IM with specific source (IM with no qualifiers); does not include venoms of sea snakes ( = SEA SNAKE VENOMS)
=680  \\$iToxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES.
=688  \\$a74
=750  \0$aMarine toxins$5IEN$0(DLC)sh 85081276

=LDR  01064cz  a2200301n  4500
=001  9880363737002441
=005  20141212203235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008386
=035  \\$aCBA1629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x750.$x500
=072  \\$aH1.$x277.$x249.$x750.$x500
=072  \\$aH1.$x277.$x750.$x500
=150  \\$aMarine Biology
=450  \\$wnnna$aBiology, Marine
=450  \\$wnnna$aEcology, Marine
=450  \\$wnnna$aHydrobiology, Marine
=450  \\$aMarine Biologists$5IEN
=450  \\$wnnna$aMarine Ecology
=450  \\$wnnna$aMarine Hydrobiology
=550  \\$wg$aHydrobiology
=550  \\$wg$aOceanography
=550  \\$aAquatic Organisms
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the origin, structure, development, growth, function, genetics, and reproduction of organisms which inhabit the OCEANS AND SEAS.
=750  \0$aMarine biologists$5IEN-M$0(DLC)sh 85081137
=750  \0$aMarine biology$5IEN-HS$0(DLC)sh 85081138

=LDR  00746cz  a2200205n  4500
=001  9880363737102441
=005  20141212203235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008383
=035  \\$aCBA1626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x651
=072  \\$aJ2.$x500.$x350.$x500
=072  \\$aJ2.$x500.$x375.$x650
=150  \\$aMargarine
=550  \\$wg$aDairy Products
=550  \\$wg$aDietary Fats
=667  \\$aa butter substitute
=680  \\$iA butterlike product made of refined vegetable oils, sometimes blended with animal fats, and emulsified usually with water or milk. It is used as a butter substitute. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aMargarine$5IEN$0(DLC)sh 85081045

=LDR  01689cz  a2200385n  4500
=001  9880363737202441
=005  20141212203234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008382
=035  \\$aCBA1625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x674
=072  \\$aC14.$x240.$x400.$x725
=072  \\$aC14.$x280.$x400.$x725
=072  \\$aC16.$x131.$x77.$x550
=072  \\$aC16.$x131.$x240.$x400.$x720
=072  \\$aC16.$x320.$x540
=072  \\$aC17.$x300.$x500
=150  \\$aMarfan Syndrome
=450  \\$wnnna$aMarfan Syndrome, Type I
=450  \\$wnnna$aMarfan's Syndrome
=450  \\$wnnna$aMarfans Syndrome
=450  \\$wnnna$aSyndrome, Marfan
=450  \\$wnnna$aSyndrome, Marfan's
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aHeart Defects, Congenital
=550  \\$aLoeys-Dietz Syndrome
=550  \\$aWeill-Marchesani Syndrome
=680  \\$iAn autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome is associated with mutations in the gene encoding fibrillin, a major element of extracellular microfibrils of connective tissue.
=688  \\$a1985; use ARACHNODACTYLY 1963-1984
=688  \\$a85; was ARACHNODACTYLY 1963-84
=750  \0$aMarfan syndrome$0(DLC) sh 87000793$5IEN

=LDR  01442cz  a2200385n  4500
=001  9880363737302441
=005  20141212203234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008380
=035  \\$aCBA1623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x650
=072  \\$aC2.$x928.$x489
=072  \\$aC4.$x619.$x935.$x489
=072  \\$aC4.$x925.$x489
=072  \\$aC15.$x604.$x515.$x700
=072  \\$aC20.$x683.$x515.$x840
=072  \\$aC22.$x131.$x546
=150  \\$aMarek Disease
=450  \\$wnnna$aFowl Paralyses
=450  \\$aFowl Paralysis
=450  \\$aMarek's Disease
=450  \\$wnnna$aMareks Disease
=450  \\$wnnna$aNeurolymphomatoses
=450  \\$aNeurolymphomatosis
=450  \\$wnnna$aParalyses, Fowl
=450  \\$wnnna$aParalysis, Fowl
=550  \\$wg$aBird Diseases
=550  \\$wg$aHerpesviridae Infections
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wg$aTumor Virus Infections
=667  \\$adon't forget also BIRDS or POULTRY (NIM) or specific bird or fowl (IM); check tag ANIMALS
=680  \\$iA transmissible viral disease of birds caused by avian herpesvirus 2 (HERPESVIRUS 2, GALLID) and other MARDIVIRUS. There is lymphoid cell infiltration or lymphomatous tumor formation in the peripheral nerves and gonads, but may also involve visceral organs, skin, muscle, and the eye.
=688  \\$a73(72)
=750  \0$aMarek's disease$0(DLC) sh 85081032$5IEN

=LDR  00929cz  a2200289n  4500
=001  9880363737402441
=005  20141212203233.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008379
=035  \\$aCBA1622HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x417.$x560
=072  \\$aC2.$x782.$x580.$x250.$x500
=072  \\$aC22.$x735.$x500.$x500
=150  \\$aMarburg Virus Disease
=450  \\$wnnna$aDisease, Marburg
=450  \\$wnnna$aFever, Marburg Hemorrhagic
=450  \\$wnnna$aHemorrhagic Fever, Marburg
=450  \\$wnnna$aMarburg Disease
=450  \\$wnnna$aMarburg Hemorrhagic Fever
=550  \\$wg$aFiloviridae Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=550  \\$wg$aMonkey Diseases
=680  \\$iAn RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.
=688  \\$a1975
=688  \\$a75
=750  \0$aMarburg virus disease$0(DLC) sh 85080962$5IEN

=LDR  00826cz  a2200229n  4500
=001  9880363737502441
=005  20141212203233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008377
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x426
=072  \\$aL1.$x178.$x820.$x90.$x426
=150  \\$aMaps as Topic
=450  \\$wnnna$aMaps as Topics
=550  \\$wg$aAudiovisual Aids
=550  \\$aGeographic Mapping
=550  \\$aGeography
=667  \\$ado not confuse with Publication Type MAPS
=680  \\$iRepresentations, normally to scale and on a flat medium, of a selection of material or abstract features on the surface of the earth, the heavens, or celestial bodies.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Maps
=750  \0$aMaps$0(DLC) sh 85080858$5IEN

=LDR  01246cz   2200217n  4500
=001  9880363737702441
=005  20230901090843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008373
=035  \\$aCBA1616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x608
=150  \\$aManuscripts as Topic
=550  \\$wg$aPublications
=550  \\$wh$aManuscripts, Medical as Topic
=667  \\$aIM; includes books prepared by hand before invention of printing; also handwritten or typescript drafts of pre-print papers, correspondence, diaries, notebooks, memoranda, etc.; check century tag if appropriate; do not confuse with the Publication Type MANUSCRIPTS
=680  \\$iCompositions written by hand, as one written before the invention or adoption of printing. A manuscript may also refer to a handwritten copy of an ancient author. A manuscript may be handwritten or typewritten as distinguished from a printed copy, especially the copy of a writer's work from which printed copies are made. (Webster, 3d ed)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Manuscripts
=750  \0$aManuscripts$5IEN$0(DLC)sh 85080672
=750  \0$iNarrower mapping$aManuscripts, Sui$0(DLC)sh2022006997$4NM$5IEN-M

=LDR  00627cz  a2200193n  4500
=001  9880363737802441
=005  20141212203231.0
=008  771206\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008372
=035  \\$aCBA1615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x601
=150  \\$aManure
=550  \\$wg$aComplex Mixtures
=550  \\$aFeces
=667  \\$aincludes slurry
=680  \\$iAccumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. Its chief application is as a fertilizer. (From Webster's 3d ed)
=688  \\$a79
=750  \0$aManures$5IEN$0(DLC)sh 85080667

=LDR  00727cz  a2200229n  4500
=001  9880363737902441
=005  20141212203228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008365
=035  \\$aCBA1608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x559
=150  \\$aManometry
=450  \\$wnnna$aManometries
=450  \\$aTonometry
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aRhinomanometry
=550  \\$aPressure
=667  \\$afor measurement of intraocular pressure use TONOMETRY, OCULAR; NIM
=680  \\$iMeasurement of the pressure or tension of liquids or gases with a manometer.
=688  \\$a1963; for TONOMETRY use TONOMETRY 1963-2003
=750  \0$aManometers$5IEN-M$0(DLC)sh 85080609

=LDR  00802cz  a2200217n  4500
=001  9880363738002441
=005  20141212203227.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008361
=035  \\$aCBA1604M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x625
=150  \\$aMannosidases
=550  \\$wg$aGlycoside Hydrolases
=550  \\$wh$aalpha-Mannosidase
=550  \\$wh$abeta-Mannosidase
=550  \\$aMannosidase Deficiency Diseases
=667  \\$aALPHA-MANNOSIDASE and BETA-MANNOSIDASE are also available; /defic: consider also MANNOSIDASE DEFICIENCY DISEASES
=680  \\$iGlycoside hydrolases that catalyze the hydrolysis of alpha or beta linked MANNOSE.
=688  \\$a78(75); was see under DISACCHARIDASES 1975-77
=750  \0$aMannosidases$5IEN-M$0(DLC)sh 95006939

=LDR  00725cz  a2200205n  4500
=001  9880363738102441
=005  20141212203226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008358
=035  \\$aCBA1601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x359.$x588
=150  \\$aMannose
=450  \\$wnnna$aD-Mannose
=450  \\$wnnna$aD Mannose
=450  \\$wnnna$aMannopyranose
=450  \\$wnnna$aMannopyranoside
=550  \\$wg$aHexoses
=680  \\$iA hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant & Hackh's Chemical Dictionary, 5th ed & Random House Unabridged Dictionary, 2d ed)
=750  \0$aMannose$5IEN$0(DLC)sh 85080602

=LDR  01058cz  a2200229n  4500
=001  9880363738202441
=005  20141212203225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008353
=035  \\$aCBA1596M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x609
=072  \\$aD9.$x853.$x609
=150  \\$aMannitol
=450  \\$wnnna$a(L)-Mannitol
=450  \\$wnnna$aOsmitrol
=450  \\$wnnna$aOsmofundin
=550  \\$wg$aSugar Alcohols
=550  \\$wh$aMannitol Phosphates
=550  \\$wh$aMitobronitol
=680  \\$iA diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.
=750  \0$aMannitol$0(DLC) sh2008008250$5IEN-M

=LDR  00838cz  a2200217n  4500
=001  9880363738302441
=005  20141212203225.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008352
=035  \\$aCBA1595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x650
=072  \\$aD2.$x522.$x650
=150  \\$aMannich Bases
=450  \\$wnnna$aBases, Mannich
=550  \\$wg$aAmines
=550  \\$wg$aKetones
=667  \\$aIM general only
=680  \\$iKetonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols.
=688  \\$a91(77); was see under AMINES 1977-90
=750  \0$aMannich bases$5IEN-M$0(DLC)sh 94002475

=LDR  01017cz  a2200205n  4500
=001  9880363738402441
=005  20141212203223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008345
=035  \\$aCBA1588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x484
=072  \\$aD1.$x268.$x956.$x374
=072  \\$aD1.$x552.$x544.$x484
=150  \\$aManganese
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aMn-55; Mn-50-54, 56-58 = MANGANESE (IM) + RADIOISOTOPES (IM)
=680  \\$iA trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
=750  \0$aManganese$5IEN-M$0(DLC)sh 85080479

=LDR  00762cz  a2200205n  4500
=001  9880363738502441
=005  20141212203223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008344
=035  \\$aCBA1587M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x869.$x265.$x441
=072  \\$aD2.$x691.$x600
=072  \\$aD2.$x886.$x706.$x250.$x500
=150  \\$aManeb
=550  \\$wg$aEthylenebis(dithiocarbamates)
=550  \\$wg$aOrganometallic Compounds
=680  \\$iManganese derivative of ethylenebisdithiocarbamate. It is used in agriculture as a fungicide and has been shown to cause irritation to the eyes, nose, skin, and throat.
=688  \\$a91(72); was see under THIOCARBAMATES 1972-90
=750  \0$aManeb$0(DLC)sh2008020248$5IEN-M

=LDR  00956cz  a2200241n  4500
=001  9880363738602441
=005  20141212203222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008341
=035  \\$aCBA1584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x510.$x500
=150  \\$aMandibular Prosthesis
=450  \\$wnnna$aMandibular Prostheses
=450  \\$wnnna$aProstheses, Mandibular
=450  \\$wnnna$aProsthesis, Mandibular
=550  \\$wg$aMaxillofacial Prosthesis
=550  \\$aMandibular Prosthesis Implantation
=550  \\$aMaxillofacial Prosthesis
=667  \\$ato replace missing part of mandible: do not use for prosthetic replacement of teeth in mandible ( = DENTAL PROSTHESIS + MANDIBLE)
=680  \\$iA prosthetic appliance for the replacement of areas of the mandible missing or defective as a result of deformity, disease, injury, or surgery.
=688  \\$a67
=750  \0$aMandibular prosthesis$5IEN$0(DLC)sh 85080439

=LDR  00605cz  a2200205n  4500
=001  9880363738702441
=005  20141212203221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008338
=035  \\$aCBA1581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x500
=150  \\$aMandibular Injuries
=450  \\$wnnna$aInjuries, Mandibular
=450  \\$wnnna$aInjury, Mandibular
=450  \\$aMandible$xinjuries
=450  \\$wnnna$aMandibular Injury
=550  \\$wg$aMaxillofacial Injuries
=680  \\$iInjuries to the lower jaw bone.
=750  \0$aMandible$xWounds and injuries$5IEN

=LDR  00637cz  a2200217n  4500
=001  9880363738802441
=005  20141212203221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008337
=035  \\$aCBA1580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x400.$x255
=072  \\$aC26.$x404.$x750.$x467.$x441
=150  \\$aMandibular Fractures
=450  \\$wnnna$aFracture, Mandibular
=450  \\$wnnna$aFractures, Mandibular
=450  \\$wnnna$aMandibular Fracture
=550  \\$wg$aJaw Fractures
=680  \\$iFractures of the lower jaw.
=688  \\$a66
=750  \0$aMandible$xFractures$5IEN-M$0(IEN)369064

=LDR  00762cz  a2200217n  4500
=001  9880363738902441
=005  20141212203221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008335
=035  \\$aCBA1578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x632.$x600
=072  \\$aA14.$x521.$x632.$x600
=150  \\$aMandibular Condyle
=450  \\$wnnna$aCondyle, Mandibular
=450  \\$wnnna$aCondyles, Mandibular
=450  \\$wnnna$aMandibular Condyles
=550  \\$wg$aMandible
=680  \\$iThe posterior process on the ramus of the mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck.
=688  \\$a65
=750  \0$aMandibular condyle$5IEN$0(DLC)sh 85080438

=LDR  01040cz  a2200313n  4500
=001  9880363739002441
=005  20141212203221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008334
=035  \\$aCBA1577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x632
=072  \\$aA14.$x521.$x632
=150  \\$aMandible
=450  \\$wnnna$aGroove, Mylohyoid
=450  \\$wnnna$aGrooves, Mylohyoid
=450  \\$wnnna$aMandibles
=450  \\$wnnna$aMylohyoid Groove
=450  \\$wnnna$aMylohyoid Grooves
=450  \\$wnnna$aMylohyoid Ridge
=450  \\$wnnna$aMylohyoid Ridges
=450  \\$wnnna$aRidge, Mylohyoid
=450  \\$wnnna$aRidges, Mylohyoid
=550  \\$wg$aJaw
=550  \\$wh$aChin
=550  \\$wh$aMandibular Condyle
=667  \\$a/growth: consider also MAXILLOFACIAL DEVELOPMENT; /innerv: consider also MANDIBULAR NERVE
=680  \\$iThe largest and strongest bone of the FACE constituting the lower jaw. It supports the lower teeth.
=750  \0$aMandible$5IEN$0(DLC)sh 85080435

=LDR  01099cz  a2200289n  4500
=001  9880363739102441
=005  20141212203220.0
=008  840411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008332
=035  \\$aCBA1575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x420
=150  \\$aManagement Quality Circles
=450  \\$wnnna$aCircle, Management Quality
=450  \\$wnnna$aCircle, Quality
=450  \\$wnnna$aCircles, Management Quality
=450  \\$wnnna$aCircles, Quality
=450  \\$wnnna$aManagement Quality Circle
=450  \\$wnnna$aQuality Circle
=450  \\$wnnna$aQuality Circle, Management
=450  \\$aQuality Circles
=450  \\$wnnna$aQuality Circles, Management
=550  \\$wg$aPersonnel Management
=667  \\$apersonnel & management as a labor-management team
=680  \\$iParticipation of employees with management as a labor-management team, in decisions pertaining to the operational activities of the organization or industry.
=688  \\$a91(85); was see under PERSONNEL MANAGEMENT 1985-90
=750  \0$aQuality circles$5IEN$0(DLC)sh 85109439

=LDR  01668cz  a2200385n  4500
=001  9880363739202441
=005  20141212203220.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008331
=035  \\$aCBA1574HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300.$x680
=072  \\$aN4.$x452.$x515
=150  \\$aManagement Information Systems
=450  \\$wnnna$aInformation System, Management
=450  \\$wnnna$aInformation Systems, Management
=450  \\$wnnna$aManagement Information System
=450  \\$wnnna$aSystem, Management Information
=450  \\$wnnna$aSystems, Management Information
=550  \\$wg$aInformation Systems
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aAmbulatory Care Information Systems
=550  \\$wh$aClinical Laboratory Information Systems
=550  \\$wh$aClinical Pharmacy Information Systems
=550  \\$wh$aDatabase Management Systems
=550  \\$wh$aDecision Support Systems, Management
=550  \\$wh$aHealthcare Common Procedure Coding System
=550  \\$wh$aHospital Information Systems
=550  \\$wh$aOffice Automation
=550  \\$wh$aPersonnel Staffing and Scheduling Information Systems
=550  \\$wh$aRadiology Information Systems
=667  \\$afor automated systems do not coord with AUTOMATIC DATA PROCESSING
=680  \\$iSystems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.
=688  \\$a87(83); was see under INFORMATION SYSTEMS 1983-86
=750  \0$aManagement information systems$5IEN$0(DLC)sh 85080359

=LDR  01055cz  a2200277n  4500
=001  9880363739302441
=005  20141212203219.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008330
=035  \\$aCBA1573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x500
=150  \\$aManagement Audit
=450  \\$wnnna$aAudit, Management
=450  \\$wnnna$aAudit, Operational
=450  \\$wnnna$aAudits, Management
=450  \\$wnnna$aAudits, Operational
=450  \\$wnnna$aManagement Audits
=450  \\$aOperational Audit
=450  \\$wnnna$aOperational Audits
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aBenchmarking
=667  \\$ado not use /util except by MeSH definition
=680  \\$iManagement review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals.
=688  \\$a91(82); was see under ORGANIZATION AND ADMINISTRATION 1982-90
=750  \0$aManagement audit$5IEN$0(DLC)sh 85080350

=LDR  02085cz  a2200421n  4500
=001  9880363739402441
=005  20141212203219.0
=008  870502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008329
=035  \\$aCBA1572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x800
=072  \\$aN4.$x590.$x374.$x410
=150  \\$aManaged Care Programs
=450  \\$wnnna$aCare, Managed
=450  \\$aCase Management, Insurance
=450  \\$aInsurance Case Management
=450  \\$wnnna$aManaged Care
=450  \\$wnnna$aManaged Care Program
=450  \\$aManaged Health Care Insurance Plans
=450  \\$wnnna$aManagement, Insurance Case
=450  \\$wnnna$aProgram, Managed Care
=450  \\$wnnna$aPrograms, Managed Care
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aInsurance, Health
=550  \\$wh$aCompetitive Medical Plans
=550  \\$wh$aHealth Maintenance Organizations
=550  \\$wh$aIndependent Practice Associations
=550  \\$wh$aPatient Freedom of Choice Laws
=550  \\$wh$aPreferred Provider Organizations
=550  \\$wh$aProvider-Sponsored Organizations
=550  \\$aCase Management
=550  \\$aCost Sharing
=550  \\$aRisk Sharing, Financial
=667  \\$aspecify geog
=680  \\$iHealth insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.
=688  \\$a90(88); was see under DELIVERY OF HEALTH CARE 1988-89
=750  \0$aManaged care plans (Medical care)$5IEN-M$0(DLC)sh 87004126

=LDR  00909cz  a2200265n  4500
=001  9880363739502441
=005  20141212203218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008328
=035  \\$aCBA1571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x412.$x575
=072  \\$aJ1.$x293.$x556.$x441
=072  \\$aJ1.$x897.$x441
=150  \\$aMan-Machine Systems
=450  \\$wnnna$aMan-Machine System
=450  \\$wnnna$aMan Machine Systems
=450  \\$wnnna$aSystem, Man-Machine
=450  \\$wnnna$aSystems, Man-Machine
=550  \\$wg$aHuman Engineering
=550  \\$wg$aTechnology
=667  \\$ano qualif; with computers, USER-COMPUTER INTERFACE is also available
=680  \\$iA system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.
=688  \\$a70(66)
=750  \0$aHuman-machine systems$5IEN$0(DLC)sh 85080326

=LDR  00623cz  a2200229n  4500
=001  9880363739602441
=005  20141212203218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008327
=035  \\$aCBA1570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x500
=150  \\$aMammography
=450  \\$aBreast$xradiography
=450  \\$wnnna$aMammographies
=550  \\$wg$aRadiography
=550  \\$wh$aXeromammography
=550  \\$aBreast
=667  \\$aDF: MAMMOGR
=680  \\$iRadiographic examination of the breast.
=688  \\$a66(64)
=750  \0$aBreast$xradiography$5IEN$0(DLC)sh 85016687

=LDR  01053cz  a2200253n  4500
=001  9880363739702441
=005  20141212203217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008324
=035  \\$aCBA1567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x124.$x500
=072  \\$aB4.$x909.$x574.$x807.$x124.$x500
=072  \\$aB4.$x909.$x777.$x731.$x124.$x500
=150  \\$aMammary Tumor Virus, Mouse
=450  \\$aBittner Virus
=450  \\$aMammary Cancer Virus
=450  \\$wnnna$aMammary Tumor Viruses, Mouse
=450  \\$aMouse mammary tumor virus
=550  \\$wg$aBetaretrovirus
=667  \\$ainfection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + (if pertinent) MAMMARY NEOPLASMS, EXPERIMENTAL (IM)
=680  \\$iThe type species of BETARETROVIRUS commonly latent in mice. It causes mammary adenocarcinoma in a genetically susceptible strain of mice when the appropriate hormonal influences operate.
=688  \\$a2002 (1966)
=750  \0$aMouse mammary tumor virus$5IEN$0(DLC)sh 89005903

=LDR  00741cz  a2200241n  4500
=001  9880363739802441
=005  20200508134937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008322
=035  \\$aCBA1565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649
=150  \\$aMammals
=450  \\$wnnna$aMammal
=450  \\$aMammalia
=550  \\$wg$aVertebrates
=550  \\$wh$aEutheria
=550  \\$wh$aMarsupialia
=550  \\$wh$aMonotremata
=550  \\$wh$aProboscidea Mammal
=667  \\$aavoid: too general: prefer specifics
=680  \\$iWarm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young.
=750  \0$aMammals$5IEN$0(DLC)sh 85080259

=LDR  00961cz  a2200289n  4500
=001  9880363739902441
=005  20141212203216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008321
=035  \\$aCBA1564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x336.$x482
=072  \\$aA13.$x589
=150  \\$aMammary Glands, Animal
=450  \\$wnnna$aAnimal Mammary Gland
=450  \\$wnnna$aAnimal Mammary Glands
=450  \\$aMammae
=450  \\$wnnna$aMammary Gland, Animal
=450  \\$aUdder
=450  \\$wnnna$aUdders
=550  \\$wg$aAnimal Structures
=550  \\$wg$aExocrine Glands
=550  \\$aBreast
=667  \\$aanimal only; inflammation = MASTITIS or MASTITIS, BOVINE; for neoplasms use MAMMARY NEOPLASMS: see note there; MAMMARY NEOPLASMS, EXPERIMENTAL is also available; Manual 24.5+, 24.6+
=680  \\$iMAMMARY GLANDS in the non-human MAMMALS.
=688  \\$a2004 (1966)
=750  \0$aMammary glands$5IEN-M$0(DLC)sh 85080275

=LDR  00655cz  a2200193n  4500
=001  9880363740002441
=005  20141212203216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008320
=035  \\$aCBA1563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x365.$x450
=072  \\$aD9.$x698.$x629.$x305.$x523
=150  \\$aMaltose
=550  \\$wg$aDisaccharides
=550  \\$wg$aGlucans
=667  \\$aISOMALTOSE is available
=680  \\$iA dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aMaltose$5IEN$0(DLC)sh 85080226

=LDR  01021cz  a2200265n  4500
=001  9880363740102441
=005  20141212203215.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008318
=035  \\$aCBA1561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x524
=072  \\$aN3.$x706.$x535.$x606
=150  \\$aMalpractice
=450  \\$wnnna$aNegligence
=450  \\$wnnna$aNegligence, Professional
=550  \\$wg$aJurisprudence
=550  \\$wh$aDefensive Medicine
=550  \\$wh$aProfessional Impairment
=550  \\$aLiability, Legal
=550  \\$aMedical Errors
=550  \\$aProfessional Misconduct
=667  \\$anot restricted to med malpractice; coord IM with specialty (IM)
=680  \\$iFailure of a professional person, a physician or lawyer, to render proper services through reprehensible ignorance or negligence or through criminal intent, especially when injury or loss follows. (Random House Unabridged Dictionary, 2d ed)
=750  \0$aMalpractice$5IEN-M$0(DLC)sh 85080191

=LDR  00763cz  a2200253n  4500
=001  9880363740202441
=005  20141212203214.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008315
=035  \\$aCBA1558M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x700
=150  \\$aMalondialdehyde
=450  \\$aMalonaldehyde
=450  \\$wnnna$aMalondialdehyde, Sodium
=450  \\$wnnna$aMalonylaldehyde
=450  \\$wnnna$aMalonyldialdehyde
=450  \\$aPropanedial
=450  \\$wnnna$aSodium Malondialdehyde
=550  \\$wg$aAldehydes
=550  \\$wh$aThiobarbituric Acid Reactive Substances
=680  \\$iThe dialdehyde of malonic acid.
=688  \\$a91(75); was see under MALONATES 1975-90
=750  \0$aMalondialdehyde$5IEN-M$0(DLC)sh 00007059

=LDR  01819cz  a2200469n  4500
=001  9880363740302441
=005  20141212203213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008310
=035  \\$aCBA1553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x494
=150  \\$aMalocclusion
=450  \\$wnnna$aAngle Classification
=450  \\$aAngle's Classification
=450  \\$wnnna$aAngles Classification
=450  \\$wnnna$aBite, Cross
=450  \\$wnnna$aBites, Cross
=450  \\$wnnna$aClassification, Angle's
=450  \\$wnnna$aCross Bite
=450  \\$wnnna$aCross Bites
=450  \\$aCrossbite
=450  \\$wnnna$aCrossbites
=450  \\$wnnna$aCrowding, Tooth
=450  \\$wnnna$aCrowdings, Tooth
=450  \\$wnnna$aMalocclusions
=450  \\$aTooth Crowding
=550  \\$wg$aTooth Diseases
=550  \\$wh$aDental Occlusion, Traumatic
=550  \\$wh$aDiastema
=550  \\$wh$aMalocclusion, Angle Class I
=550  \\$wh$aMalocclusion, Angle Class II
=550  \\$wh$aMalocclusion, Angle Class III
=550  \\$wh$aOpen Bite
=550  \\$aDental Occlusion
=550  \\$aMandibular Advancement
=550  \\$aOrthodontics, Corrective
=550  \\$aPrognathism
=550  \\$aRetrognathia
=667  \\$aentry term ANGLE'S CLASSIFICATION: Angle's classes MALOCCLUSION, ANGLE CLASS I & MALOCCLUSION, ANGLE CLASS II & MALOCCLUSION, ANGLE CLASS III are also available but index Angle's classification in general or unspecified as MALOCCLUSION /class
=680  \\$iSuch malposition and contact of the maxillary and mandibular teeth as to interfere with the highest efficiency during the excursive movements of the jaw that are essential for mastication. (Jablonski, Illustrated Dictionary of Dentistry, 1982)
=750  \0$aMalocclusion$5IEN$0(DLC)sh 85080183

=LDR  00544cz  a2200157n  4500
=001  9880363740402441
=005  20141212203212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008306
=035  \\$aCBA1549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x925
=150  \\$aMalingering
=550  \\$wg$aBehavioral Symptoms
=680  \\$iSimulation of symptoms of illness or injury with intent to deceive in order to obtain a goal, e.g., a claim of physical illness to avoid jury duty.
=750  \0$aMalingering$5IEN$0(DLC)sh 85080158

=LDR  01388cz  a2200385n  4500
=001  9880363740502441
=005  20141212203212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008305
=035  \\$aCBA1548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x505.$x700
=072  \\$aC23.$x550.$x767.$x600
=150  \\$aMalignant Hyperthermia
=450  \\$wnnna$aAnesthesia Hyperthermia
=450  \\$wnnna$aAnesthesia Hyperthermias
=450  \\$wnnna$aAnesthesia Related Hyperthermia
=450  \\$wnnna$aAnesthesia Related Hyperthermias
=450  \\$aHyperpyrexia, Malignant
=450  \\$wnnna$aHyperpyrexias, Malignant
=450  \\$wnnna$aHyperthermia, Anesthesia Related
=450  \\$aHyperthermia, Malignant
=450  \\$wnnna$aHyperthermia of Anesthesia
=450  \\$wnnna$aHyperthermias, Anesthesia Related
=450  \\$aMalignant Hyperpyrexia
=450  \\$wnnna$aMalignant Hyperpyrexias
=450  \\$wnnna$aMalignant Hyperthermias
=450  \\$wnnna$aRelated Hyperthermia, Anesthesia
=450  \\$wnnna$aRelated Hyperthermias, Anesthesia
=550  \\$wg$aIntraoperative Complications
=550  \\$wg$aPostoperative Complications
=550  \\$aFever
=680  \\$iRapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia.
=688  \\$a73
=750  \0$aMalignant hyperthermia$5IEN$0(DLC)sh 85080155

=LDR  01300cz  a2200313n  4500
=001  9880363740602441
=005  20141212192306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008304
=035  \\$aCBA1547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x606
=072  \\$aC22.$x196.$x540
=150  \\$aMalignant Catarrh
=450  \\$wnnna$aCatarrh, Malignant
=450  \\$wnnna$aCatarrhal Fever, Malignant
=450  \\$wnnna$aCatarrhal Fevers, Malignant
=450  \\$wnnna$aCatarrhs, Malignant
=450  \\$wnnna$aFever, Malignant Catarrhal
=450  \\$wnnna$aFevers, Malignant Catarrhal
=450  \\$wnnna$aMalignant Catarrhal Fever
=450  \\$wnnna$aMalignant Catarrhal Fevers
=450  \\$wnnna$aMalignant Catarrhs
=550  \\$wg$aCattle Diseases
=550  \\$wg$aHerpesviridae Infections
=667  \\$acaused by a herpesvirus; usually animal; check tag ANIMALS; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES
=680  \\$iA herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte.
=688  \\$a71
=750  \0$aMalignant catarrhal fever$5IEN-M$0(DLC)sh 92005297

=LDR  01501cz  a2200265n  4500
=001  9880363740702441
=005  20141212203211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008303
=035  \\$aCBA1546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x200.$x500
=072  \\$aC4.$x557.$x470.$x200.$x25.$x200.$x500
=072  \\$aC4.$x557.$x580.$x625.$x650.$x200.$x500
=150  \\$aMalignant Carcinoid Syndrome
=450  \\$wnnna$aCarcinoid Syndrome, Malignant
=450  \\$wnnna$aCarcinoid Syndromes, Malignant
=450  \\$wnnna$aMalignant Carcinoid Syndromes
=450  \\$wnnna$aSyndrome, Malignant Carcinoid
=450  \\$wnnna$aSyndromes, Malignant Carcinoid
=550  \\$wg$aCarcinoid Tumor
=550  \\$wh$aCarcinoid Heart Disease
=667  \\$ado not use /blood supply /chem /second /secret /ultrastruct; for cardiac manifest use CARCINOID HEART DISEASE
=680  \\$iA symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)
=750  \0$aMalignant carcinoid syndrome$5IEN$0(DLC)sh 85080154

=LDR  00835cz  a2200217n  4500
=001  9880363740802441
=005  20141212203210.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008300
=035  \\$aCBA1543M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x710.$x400
=150  \\$aMaleic Hydrazide
=450  \\$wnnna$aAcid Hydrazide, Maleic
=450  \\$wnnna$aHydrazide, Maleic
=450  \\$wnnna$aHydrazide, Maleic Acid
=450  \\$aMaleic Acid Hydrazide
=550  \\$wg$aPyridazines
=680  \\$i1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage.
=688  \\$a91(77); was see under PYRIDAZINES 1977-90
=750  \0$aMaleic hydrazide$0(DLC)sh2007003957$5IEN-M

=LDR  00935cz  a2200253n  4500
=001  9880363740902441
=005  20141212203210.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008299
=035  \\$aCBA1542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x113.$x450
=072  \\$aD3.$x383.$x312.$x520
=150  \\$aMaleic Anhydrides
=450  \\$a2,5-Furandiones
=450  \\$wnnna$a2,5 Furandiones
=450  \\$wnnna$aAnhydride, Maleic
=450  \\$wnnna$aAnhydrides, Maleic
=450  \\$wnnna$aMaleic Anhydride
=550  \\$wg$aAnhydrides
=550  \\$wg$aFurans
=680  \\$iUsed in copolymerization reactions, in the Diels-Alder(diene)synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns.
=688  \\$a91(79); was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78
=750  \0$aMaleic anhydride$5IEN$0(DLC)sh 85080133

=LDR  01171cz  a2200289n  4500
=001  9880363741002441
=005  20141212203209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008294
=035  \\$aCBA1537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x500
=072  \\$aD2.$x705.$x539.$x345.$x500
=072  \\$aD2.$x886.$x300.$x692.$x500
=150  \\$aMalathion
=450  \\$wnnna$aCarbafos
=450  \\$wnnna$aCarbofos
=450  \\$wnnna$aCarbophos
=450  \\$wnnna$aCythion
=450  \\$wnnna$aKarbofos
=450  \\$wnnna$aPrioderm
=450  \\$wnnna$aSadophos
=550  \\$wg$aOrganothiophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iA wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes.
=688  \\$a72
=750  \0$aMalathion$5IEN$0(DLC)sh 91004490

=LDR  00900cz  a2200241n  4500
=001  9880363741102441
=005  20141212203208.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008291
=035  \\$aCBA1534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x820.$x496
=150  \\$aMalate Dehydrogenase
=450  \\$wnnna$aDehydrogenase, Malate
=450  \\$wnnna$aDehydrogenase, Malic
=450  \\$wnnna$aDehydrogenase, NAD-Malate
=450  \\$wnnna$aMalic Dehydrogenase
=450  \\$wnnna$aNAD-Malate Dehydrogenase
=450  \\$wnnna$aNAD Malate Dehydrogenase
=550  \\$wg$aNAD (+) and NADP (+) Dependent Alcohol Oxidoreductases
=680  \\$iAn enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.
=688  \\$aMALIC ENZYME was see MALATE DEHYDROGENASE 1983-93
=750  \0$aMalate dehydrogenase$0(DLC) sh 85080044$5IEN

=LDR  00870cz  a2200229n  4500
=001  9880363741202441
=005  20141212203207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008289
=035  \\$aCBA1532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x530.$x606
=072  \\$aC22.$x131.$x498
=150  \\$aMalaria, Avian
=450  \\$wnnna$aAvian Malaria
=450  \\$wnnna$aAvian Malarias
=450  \\$wnnna$aMalarias, Avian
=550  \\$wg$aBird Diseases
=550  \\$wg$aMalaria
=667  \\$acoord with BIRDS (NIM) or specific bird or fowl (IM)
=680  \\$iAny of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.
=750  \0$aAvian malaria$5IEN$0(DLC)sh 85010533

=LDR  01825cz  a2200337n  4500
=001  9880363741302441
=005  20141212203207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008288
=035  \\$aCBA1531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x530
=150  \\$aMalaria
=450  \\$wnnna$aFever, Marsh
=450  \\$wnnna$aFever, Remittent
=450  \\$wnnna$aInfection, Plasmodium
=450  \\$wnnna$aInfections, Plasmodium
=450  \\$aMarsh Fever
=450  \\$wnnna$aPaludism
=450  \\$wnnna$aPlasmodium Infection
=450  \\$aPlasmodium Infections
=450  \\$aRemittent Fever
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aMalaria, Avian
=550  \\$wh$aMalaria, Cerebral
=550  \\$wh$aMalaria, Falciparum
=550  \\$wh$aMalaria, Vivax
=667  \\$aGEN or unspecified; specify Plasmodium species IM if possible but note P. falciparum malaria = MALARIA, FALCIPARUM; P. vivax malaria = MALARIA, VIVAX; tertian malaria = MALARIA, VIVAX, quartan malaria: coord IM with PLASMODIUM MALARIAE (IM); malariotherapy = HYPERTHERMIA, INDUCED: do not confuse with MALARIA /ther; /drug ther: consider also ANTIMALARIALS
=680  \\$iA protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
=688  \\$aMALARIA CONTROL was heading 1963-66
=750  \0$aMalaria$5IEN$0(DLC)sh 85080038

=LDR  01242cz  a2200349n  4500
=001  9880363741402441
=005  20141212203206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008286
=035  \\$aCBA1529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637
=072  \\$aC18.$x452.$x603
=150  \\$aMalabsorption Syndromes
=450  \\$wnnna$aMalabsorption Syndrome
=450  \\$wnnna$aSyndrome, Malabsorption
=450  \\$wnnna$aSyndromes, Malabsorption
=550  \\$wg$aIntestinal Diseases
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aBlind Loop Syndrome
=550  \\$wh$aCeliac Disease
=550  \\$wh$aCollagenous Sprue
=550  \\$wh$aHyperhomocysteinemia
=550  \\$wh$aLactose Intolerance
=550  \\$wh$aShort Bowel Syndrome
=550  \\$wh$aSprue, Tropical
=550  \\$wh$aSteatorrhea
=550  \\$wh$aWhipple Disease
=550  \\$aIntestinal Absorption
=680  \\$iGeneral term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
=688  \\$a65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64
=750  \0$aMalabsorption syndromes$5IEN$0(DLC)sh 85080011

=LDR  01631cz  a2200349n  4500
=001  9880363741502441
=005  20141212203206.0
=008  780320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x610
=072  \\$aG5.$x360.$x340.$x24.$x380.$x500
=072  \\$aG12.$x500.$x500
=150  \\$aMajor Histocompatibility Complex
=450  \\$wnnna$aComplex, Histocompatibility
=450  \\$wnnna$aComplex, Major Histocompatibility
=450  \\$wnnna$aComplices, Histocompatibility
=450  \\$wnnna$aComplices, Major Histocompatibility
=450  \\$aHistocompatibility Complex
=450  \\$wnnna$aHistocompatibility Complex, Major
=450  \\$wnnna$aHistocompatibility Complices
=450  \\$wnnna$aHistocompatibility Complices, Major
=450  \\$wnnna$aMajor Histocompatibility Complices
=550  \\$wg$aGenes
=550  \\$wg$aGenetic Loci
=550  \\$wg$aImmunogenetic Phenomena
=550  \\$wh$aGenes, MHC Class I
=550  \\$wh$aGenes, MHC Class II
=667  \\$aDF: MHC
=680  \\$iThe genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.
=688  \\$a79
=750  \0$aMajor histocompatibility complex$5IEN$0(DLC)sh 86004408

=LDR  01298cz  a2200325n  4500
=001  9880363741602441
=005  20141212203205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008284
=035  \\$aCBA1527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x450
=072  \\$aN2.$x628.$x472
=072  \\$aN4.$x452.$x442.$x422.$x450
=150  \\$aMaintenance and Engineering, Hospital
=450  \\$aEngineering, Hospital
=450  \\$wnnna$aGroundskeeping, Hospital
=450  \\$aHospital Engineering
=450  \\$aHospital Groundskeeping
=450  \\$wnnna$aHospital Landscaping
=450  \\$aHospital Maintenance
=450  \\$wnnna$aHospital Maintenance and Engineering
=450  \\$aLandscaping, Hospital
=450  \\$wnnna$aMaintenance, Hospital
=550  \\$wg$aHospital Departments
=550  \\$wg$aMaintenance
=667  \\$aDF: MAINTENANCE HOSP or MAINTENANCE HOSPITAL
=680  \\$iHospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise.
=688  \\$a80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77
=750  \0$aHospital buildings$xMaintenance and repair$5IEN$0(DLC)sh 85062339

=LDR  00614cz  a2200205n  4500
=001  9880363741702441
=005  20141212203205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008283
=035  \\$aCBA1526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x628
=150  \\$aMaintenance
=450  \\$wnnna$aMaintenances
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=550  \\$wh$aMaintenance and Engineering, Hospital
=667  \\$a"upkeep of property or equipment"; NIM
=680  \\$iThe upkeep of property or equipment.
=688  \\$a73
=750  \0$aMaintenance$5IEN$0(DLC)sh 85079931

=LDR  01342cz  a2200313n  4500
=001  9880363741802441
=005  20141212211033.0
=008  880607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015416
=035  \\$aCBA1523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x149.$x465.$x500
=072  \\$aG2.$x607.$x750.$x500
=150  \\$aMaillard Reaction
=450  \\$wnnna$aBrowning, Food
=450  \\$aBrowning Reaction
=450  \\$wnnna$aBrowning Reactions
=450  \\$wnnna$aBrownings, Food
=450  \\$aFood Browning
=450  \\$wnnna$aFood Brownings
=450  \\$wnnna$aReaction, Browning
=450  \\$wnnna$aReaction, Maillard
=450  \\$wnnna$aReactions, Browning
=550  \\$wg$aOrganic Chemistry Processes
=550  \\$aFood Handling
=550  \\$aFood Preservation
=680  \\$iOne of a group of nonenzymatic reactions in which aldehydes, ketones, or reducing sugars react with amino acids, peptides, or proteins. Food browning reactions, such as those that occur with cooking of meats, and also food deterioration reactions, resulting in decreased nutritional value and color changes, are attributed to this reaction type. The Maillard reaction is studied by scientists in the agriculture, food, nutrition, and carbohydrate chemistry fields.
=688  \\$a89
=750  \0$aMaillard reaction$5IEN$0(DLC)sh 85079891

=LDR  01213cz  a2200241n  4500
=001  9880363741902441
=005  20141212210924.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015225
=035  \\$aCBA1522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x500
=072  \\$aE1.$x370.$x405.$x440
=072  \\$aE5.$x540.$x500
=150  \\$aMagnetoencephalography
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aMagnetometry
=550  \\$aTranscranial Magnetic Stimulation
=667  \\$aDF: MAGNETOENCEPHALOGR
=680  \\$iThe measurement of magnetic fields over the head generated by electric currents in the brain. As in any electrical conductor, electric fields in the brain are accompanied by orthogonal magnetic fields. The measurement of these fields provides information about the localization of brain activity which is complementary to that provided by ELECTROENCEPHALOGRAPHY. Magnetoencephalography may be used alone or together with electroencephalography, for measurement of spontaneous or evoked activity, and for research or clinical purposes.
=688  \\$a89
=750  \0$aMagnetoencephalography$5IEN$0(DLC)sh 89006236

=LDR  00664cz  a2200205n  4500
=001  9880363742002441
=005  20141212203204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008280
=035  \\$aCBA1521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x493
=150  \\$aMagnetics
=450  \\$wnnna$aMagnetic
=550  \\$wg$aPhysics
=550  \\$aMagnetic Phenomena
=550  \\$aMagnets
=667  \\$athe discipline (education, history, etc) only; use MAGNETIC PHENOMENA for characteristics of magnetic substances; MAGNETIC FIELDS is also available
=680  \\$iThe study of MAGNETIC PHENOMENA.
=750  \0$aMagnetics$0(DLC) sh 85079758$5IEN-M

=LDR  02555cz  a2200613n  4500
=001  9880363742102441
=005  20141212192306.0
=008  870508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008279
=035  \\$aCBA1520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x825.$x500
=150  \\$aMagnetic Resonance Imaging
=450  \\$aChemical Shift Imaging
=450  \\$wnnna$aChemical Shift Imagings
=450  \\$afMRI
=450  \\$wnnna$aFunctional Magnetic Resonance Imaging
=450  \\$wnnna$aFunctional MRI
=450  \\$wnnna$aFunctional MRIs
=450  \\$wnnna$aImaging, Chemical Shift
=450  \\$wnnna$aImaging, Magnetic Resonance
=450  \\$wnnna$aImaging, NMR
=450  \\$wnnna$aImagings, Chemical Shift
=450  \\$aMagnetic Resonance Imaging, Functional
=450  \\$aMagnetization Transfer Contrast Imaging
=450  \\$aMR Tomography
=450  \\$aMRI, Functional
=450  \\$wnnna$aMRI Scan
=450  \\$aMRI Scans
=450  \\$wnnna$aMRIs, Functional
=450  \\$aNMR Imaging
=450  \\$aNMR Tomography
=450  \\$wnnna$aProton Spin Tomography
=450  \\$wnnna$aScan, MRI
=450  \\$wnnna$aScans, MRI
=450  \\$wnnna$aShift Imaging, Chemical
=450  \\$wnnna$aShift Imagings, Chemical
=450  \\$wnnna$aTomography, MR
=450  \\$aTomography, NMR
=450  \\$aTomography, Proton Spin
=450  \\$wnnna$aZeugmatography
=550  \\$wg$aTomography
=550  \\$wh$aCholangiopancreatography, Magnetic Resonance
=550  \\$wh$aDiffusion Magnetic Resonance Imaging
=550  \\$wh$aEcho-Planar Imaging
=550  \\$wh$aFluorine-19 Magnetic Resonance Imaging
=550  \\$wh$aMagnetic Resonance Angiography
=550  \\$wh$aMagnetic Resonance Imaging, Cine
=550  \\$aAnatomy, Cross-Sectional
=550  \\$aMagnetic Resonance Spectroscopy
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with MAGNETIC RESONANCE SPECTROSCOPY: check text
=680  \\$iNon-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
=688  \\$a1988; for NMR TOMOGRAPHY & TOMOGRAPHY, NMR & TOMOGRAPHY, PROTON SPIN use MAGNETIC RESONANCE SPECTROSCOPY 1985-1987; for CHEMICAL SHIFT IMAGING use MAGNETIC RESONANCE SPECTROSCOPY 1995-2000
=750  \0$aMagnetic resonance imaging$0(DLC) sh 85079741$5IEN

=LDR  00825cz  a2200253n  4500
=001  9880363742202441
=005  20141212203204.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008276
=035  \\$aCBA1517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x550
=072  \\$aD1.$x524.$x485
=150  \\$aMagnesium Hydroxide
=450  \\$aBrucite
=450  \\$wnnna$aHydrate, Magnesium
=450  \\$wnnna$aHydroxide, Magnesium
=450  \\$wnnna$aMagnesium Hydrate
=450  \\$wnnna$aMagnesium Hydroxide (Mg(OH)4)
=550  \\$wg$aHydroxides
=550  \\$wg$aMagnesium Compounds
=680  \\$iAn inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.
=688  \\$a91(77); was see under MAGNESIUM 1977-90
=750  \0$aBrucite$5IEN$0(DLC)sh 85017297

=LDR  00575cz  a2200205n  4500
=001  9880363762302441
=005  20141212202609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007452
=035  \\$aCBA0654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x480
=072  \\$aD1.$x475.$x400
=150  \\$aIodates
=550  \\$wg$aAnions
=550  \\$wg$aIodine Compounds
=667  \\$asalts of iodic acid
=680  \\$iInorganic salts of iodic acid (HIO3).
=688  \\$a91(71); was see under IODINE 1971-90
=750  \0$aIodates$5IEN$0(DLC)sh 85067767

=LDR  00501cz  a2200181n  4500
=001  9880363762402441
=005  20141212202609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007449
=035  \\$aCBA0651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x702
=150  \\$aInvestments
=450  \\$wnnna$aInvestment
=550  \\$wg$aEconomics
=680  \\$iUse for articles on the investing of funds for income or profit.
=688  \\$a68(64)
=750  \0$aInvestments$5IEN$0(DLC)sh 85067715

=LDR  01115cz  a2200397n  4500
=001  9880363762502441
=005  20141212202609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007448
=035  \\$aCBA0650HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500
=150  \\$aInvertebrates
=450  \\$aBrachiopoda
=450  \\$wnnna$aBrachiopodas
=450  \\$wnnna$aInvertebrate
=450  \\$aMesozoa
=450  \\$wnnna$aMesozoas
=550  \\$wg$aAnimals
=550  \\$wh$aAnnelida
=550  \\$wh$aArthropods
=550  \\$wh$aBryozoa
=550  \\$wh$aChordata, Nonvertebrate
=550  \\$wh$aCnidaria
=550  \\$wh$aCtenophora
=550  \\$wh$aEchinodermata
=550  \\$wh$aHelminths
=550  \\$wh$aMollusca
=550  \\$wh$aParasites
=550  \\$wh$aPlacozoa
=550  \\$wh$aPorifera
=550  \\$wh$aTardigrada
=667  \\$ageneral; prefer specific classes, orders, families, & genera
=680  \\$iAnimals that have no spinal column.
=688  \\$aBRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85
=750  \0$aInvertebrates$5IEN$0(DLC)sh 85067691

=LDR  00692cz  a2200217n  4500
=001  9880363762602441
=005  20141212202608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007447
=035  \\$aCBA0649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x445
=150  \\$aInvertebrate Hormones
=450  \\$aHormones, Invertebrate
=550  \\$wg$aHormones
=550  \\$wh$aInsect Hormones
=667  \\$acoord IM with specific invertebrate (IM)
=680  \\$iHormones produced by invertebrates, usually insects, mollusks, annelids, and helminths.
=688  \\$a67
=750  \0$81$wb$aHormones$5IEN$0(DLC)sh 85061980
=750  \0$81$wb$aInvertebrates$5IEN-HS$0(DLC)sh 85067691

=LDR  01303cz  a2200325n  4500
=001  9880363762702441
=005  20141212202608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x190
=072  \\$aG5.$x355.$x600.$x805.$x500
=072  \\$aG5.$x365.$x590.$x175.$x190
=072  \\$aG5.$x365.$x590.$x770.$x500
=150  \\$aChromosome Inversion
=450  \\$wnnna$aChromosomal Inversion
=450  \\$wnnna$aChromosomal Inversions
=450  \\$wnnna$aChromosome Inversions
=450  \\$wnnna$aInversion, Chromosomal
=450  \\$aInversion, Chromosome
=450  \\$wnnoa$aInversion (Genetics)$5IEN-HS
=450  \\$wnnna$aInversions, Chromosomal
=450  \\$wnnna$aInversions, Chromosome
=550  \\$wg$aChromosome Aberrations
=550  \\$wg$aSequence Inversion
=680  \\$iAn aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome.
=688  \\$a2010 (1969)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Inversion, Chromosome
=688  \\$a2005(1969)
=750  \0$aChromosome inversions$0(DLC) sh 92001069$5IEN

=LDR  00806cz  a2200205n  4500
=001  9880363762802441
=005  20141212202608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007444
=035  \\$aCBA0646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x855.$x750
=072  \\$aD9.$x698.$x350.$x500
=072  \\$aD9.$x698.$x365.$x855.$x750
=150  \\$aInulin
=550  \\$wg$aFructans
=550  \\$wg$aStarch
=667  \\$ausually /diag use in KIDNEY FUNCTION TESTS; do not confuse with INSULIN
=680  \\$iA starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.
=750  \0$aInulin$5IEN$0(DLC)sh 85067660

=LDR  01541cz  a2200253n  4500
=001  9880363762902441
=005  20141212202607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007443
=035  \\$aCBA0645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x531.$x577
=150  \\$aIntussusception
=450  \\$wnnna$aIntestinal Invagination
=450  \\$wnnna$aIntestinal Invaginations
=450  \\$wnnna$aIntussusceptions
=450  \\$wnnna$aIntususception
=450  \\$wnnna$aIntususceptions
=450  \\$aInvagination, Intestinal
=450  \\$wnnna$aInvaginations, Intestinal
=550  \\$wg$aIntestinal Obstruction
=667  \\$acoord IM with specific precoord intestinal dis term; ileocolic intussusception = ILEAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES; ileocecal intussusception = ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (NIM) but not also CECAL DISEASES; cecocolic intussusception = CECAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES
=680  \\$iA form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.
=750  \0$aIntestines$xIntussusception$5IEN$0(DLC)sh 85067594

=LDR  00980cz  a2200301n  4500
=001  9880363763002441
=005  20141212202607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007442
=035  \\$aCBA0644HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x500
=072  \\$aE2.$x585.$x578
=072  \\$aE5.$x497.$x578
=150  \\$aIntubation, Intratracheal
=450  \\$wnnna$aEndotracheal Intubation
=450  \\$wnnna$aEndotracheal Intubations
=450  \\$wnnna$aIntratracheal Intubation
=450  \\$wnnna$aIntratracheal Intubations
=450  \\$aIntubation, Endotracheal
=450  \\$wnnna$aIntubations, Endotracheal
=450  \\$wnnna$aIntubations, Intratracheal
=550  \\$wg$aAirway Management
=550  \\$wg$aIntubation
=550  \\$wh$aLaryngeal Masks
=550  \\$aTrachea
=667  \\$ado not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg
=750  \0$aTrachea$xIntubation$5IEN$0(DLC)sh 85136404

=LDR  01210cz  a2200289n  4500
=001  9880363763102441
=005  20141212202607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007441
=035  \\$aCBA0643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x585.$x412
=072  \\$aE5.$x497.$x412
=150  \\$aIntubation, Gastrointestinal
=450  \\$wnnna$aGastrointestinal Intubation
=450  \\$wnnna$aGastrointestinal Intubations
=450  \\$aIntubation, Nasogastric
=450  \\$wnnna$aIntubations, Gastrointestinal
=450  \\$wnnna$aIntubations, Nasogastric
=450  \\$wnnna$aNasogastric Intubation
=450  \\$wnnna$aNasogastric Intubations
=550  \\$wg$aIntubation
=550  \\$aEnteral Nutrition
=667  \\$ado not use /util except by MeSH definition; for intub in dis, coord with dis /ther, not /surg; esophageal intub & esophageal obturator airway do not go here: see note on INTUBATION
=680  \\$iThe insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc.
=688  \\$a66; DUODENAL INTUBATION was heading 1963-65
=750  \0$aStomach$xIntubation$5IEN-M$0(DLC)sh 85128267

=LDR  00711cz  a2200229n  4500
=001  9880363763202441
=005  20141212202606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007439
=035  \\$aCBA0641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x511
=072  \\$aF2.$x739.$x794.$x438
=150  \\$aIntroversion (Psychology)
=450  \\$wnnna$aIntroversion
=450  \\$wnnna$aIntroversions (Psychology)
=550  \\$wg$aPersonality Development
=550  \\$wg$aPsychoanalytic Theory
=667  \\$ano qualif; DF: INTROVERSION
=680  \\$iA state in which attention is largely directed inward upon one's self.
=688  \\$a68
=750  \0$aIntroversion$5IEN$0(DLC)sh 85067649

=LDR  00972cz  a2200241n  4500
=001  9880363763302441
=005  20141212202606.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007438
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x220.$x400
=072  \\$aG5.$x360.$x340.$x24.$x340.$x137.$x515
=150  \\$aIntrons
=450  \\$wnnna$aIntervening Sequence
=450  \\$aIntervening Sequences
=450  \\$wnnna$aIntron
=450  \\$wnnna$aSequence, Intervening
=450  \\$wnnna$aSequences, Intervening
=550  \\$wg$aDNA, Intergenic
=550  \\$wg$aGene Components
=680  \\$iSequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes.
=688  \\$a87; INTERVENING SEQUENCES & INTRONS were see BASE SEQUENCE 1981-86
=750  \0$aIntrons$5IEN$0(DLC)sh 90004139

=LDR  00718cz  a2200181n  4500
=001  9880363763402441
=005  20141212202605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007437
=035  \\$aCBA0639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x560.$x494
=150  \\$aIntrinsic Factor
=450  \\$wnnna$aFactor, Intrinsic
=550  \\$wg$aMucoproteins
=550  \\$aParietal Cells, Gastric
=680  \\$iA glycoprotein secreted by the cells of the GASTRIC GLANDS that is required for the absorption of VITAMIN B 12 (cyanocobalamin). Deficiency of intrinsic factor leads to VITAMIN B 12 DEFICIENCY and ANEMIA, PERNICIOUS.
=750  \0$aIntrinsic factor (Physiology)$5IEN-M$0(DLC)sh 85067641

=LDR  02226cz  a2200493n  4500
=001  9880363763502441
=005  20141212202605.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007436
=035  \\$aCBA0638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x250.$x520.$x520
=150  \\$aIntrauterine Devices, Medicated
=450  \\$wnnna$aDevice, Hormone-Releasing Intrauterine
=450  \\$wnnna$aDevice, Medicated Intrauterine
=450  \\$wnnna$aDevice, Progesterone-Releasing Intrauterine
=450  \\$wnnna$aDevices, Hormone-Releasing Intrauterine
=450  \\$wnnna$aDevices, Medicated Intrauterine
=450  \\$wnnna$aDevices, Progesterone-Releasing Intrauterine
=450  \\$wnnna$aHormone-Releasing Intrauterine Device
=450  \\$wnnna$aHormone-Releasing Intrauterine Devices
=450  \\$wnnna$aHormone Releasing IUD
=450  \\$wnnna$aHormone-Releasing IUD
=450  \\$wnnna$aHormone-Releasing IUDs
=450  \\$wnnna$aIntrauterine Device, Hormone-Releasing
=450  \\$wnnna$aIntrauterine Device, Medicated
=450  \\$wnnna$aIntrauterine Device, Progesterone-Releasing
=450  \\$wnnna$aIntrauterine Devices, Hormone-Releasing
=450  \\$wnnna$aIntrauterine Devices, Hormone Releasing
=450  \\$wnnna$aIntrauterine Devices, Progesterone-Releasing
=450  \\$wnnna$aIntrauterine Devices, Progesterone Releasing
=450  \\$wnnna$aIUD, Hormone Releasing
=450  \\$wnnna$aIUD, Hormone-Releasing
=450  \\$wnnna$aIUDs, Hormone-Releasing
=450  \\$wnnna$aMedicated Intrauterine Device
=450  \\$wnnna$aMedicated Intrauterine Devices
=450  \\$wnnna$aProgesterone-Releasing Intrauterine Device
=450  \\$wnnna$aProgesterone-Releasing Intrauterine Devices
=550  \\$wg$aIntrauterine Devices
=550  \\$wh$aIntrauterine Devices, Copper
=667  \\$a"IUDs that release contraceptive agents"; coord IM with specific contraceptive agent (IM); pregn despite use: see note on INTRAUTERINE DEVICES; DF: IUD MEDICATED
=680  \\$iIntrauterine devices that release contraceptive agents.
=688  \\$a79(75); was see under INTRAUTERINE DEVICES 1975-78
=750  \0$aIntrauterine contraceptives, Medicated$5IEN$0(DLC)sh 85067628

=LDR  01723cz  a2200445n  4500
=001  9880363763602441
=005  20141212202604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007434
=035  \\$aCBA0636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x250.$x520
=150  \\$aIntrauterine Devices
=450  \\$wnnna$aContraceptive Device, Intrauterine
=450  \\$aContraceptive Devices, Intrauterine
=450  \\$wnnna$aContraceptive IUD
=450  \\$wnnna$aContraceptive IUDs
=450  \\$aContraceptives, Intrauterine$5IEN-M
=450  \\$wnnna$aDevice, Intrauterine
=450  \\$wnnna$aDevice, Intrauterine Contraceptive
=450  \\$wnnna$aDevices, Intrauterine
=450  \\$wnnna$aDevices, Intrauterine Contraceptive
=450  \\$aDevices, Unmedicated Intrauterine$5IEN-M
=450  \\$wnnna$aIntrauterine Contraceptive Device
=450  \\$wnnna$aIntrauterine Contraceptive Devices
=450  \\$aIntrauterine Contraceptives$5IEN
=450  \\$wnnna$aIntrauterine Device
=450  \\$aIntrauterine Devices, Unmedicated$5IEN-M
=450  \\$wnnna$aIUD, Contraceptive
=450  \\$wnnna$aIUD, Unmedicated
=450  \\$wnnna$aIUDs, Contraceptive
=450  \\$aUnmedicated Intrauterine Devices$5IEN-M
=450  \\$wnnna$aUnmedicated IUD
=450  \\$wnnna$aUnmedicated IUDs
=550  \\$wg$aContraceptive Devices, Female
=550  \\$wh$aIntrauterine Devices, Medicated
=667  \\$acoordinate IM with material of which device is made (NIM); pregnancy despite use of IUD = IUD with no qualifiers, not IUD / adv eff
=680  \\$iContraceptive devices placed high in the uterine fundus.
=688  \\$a67
=750  \0$aIntrauterine contraceptives$5IEN$0(DLC)sh 85067626

=LDR  01592cz  a2200361n  4500
=001  9880363763702441
=005  20141212202603.0
=008  790312\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007431
=035  \\$aCBA0633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x505
=150  \\$aIntraoperative Complications
=450  \\$wnnna$aComplication, Intraoperative
=450  \\$wnnna$aComplication, Peroperative
=450  \\$wnnna$aComplications, Intraoperative
=450  \\$wnnna$aComplications, Peroperative
=450  \\$wnnna$aInjuries, Surgical
=450  \\$wnnna$aInjury, Surgical
=450  \\$wnnna$aIntraoperative Complication
=450  \\$wnnna$aPeroperative Complication
=450  \\$aPeroperative Complications
=450  \\$aSurgical Injuries
=450  \\$wnnna$aSurgical Injury
=550  \\$wg$aPathologic Processes
=550  \\$wh$aBlood Loss, Surgical
=550  \\$wh$aIntraoperative Awareness
=550  \\$wh$aMalignant Hyperthermia
=550  \\$aSurgical Procedures, Operative
=667  \\$afew qualif apply; IM; coord with Cat E4 term (IM) if pertinent with or without /adv eff depending on its relation to the intraop compl: for policy apply principles of POSTOPERATIVE COMPLICATIONS, Manual 23.18+; for iatrogenic compl (as X ref SURGICAL INJURIES) or other: TN 179; DF: INTRAOP COMPL
=680  \\$iComplications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.
=688  \\$a80
=750  \0$aSurgery$xComplications$5IEN$0(DLC)sh 85130768

=LDR  00828cz  a2200265n  4500
=001  9880363763802441
=005  20141212202602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007429
=035  \\$aCBA0631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x440
=150  \\$aIntraocular Pressure
=450  \\$wnnna$aIntraocular Pressures
=450  \\$aOcular Tension
=450  \\$wnnna$aOcular Tensions
=450  \\$wnnna$aPressure, Intraocular
=450  \\$wnnna$aPressures, Intraocular
=450  \\$wnnna$aTension, Ocular
=450  \\$wnnna$aTensions, Ocular
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$aEye
=667  \\$aOCULAR HYPERTENSION & OCULAR HYPOTENSION are also available
=680  \\$iThe pressure of the fluids in the eye.
=750  \0$aIntraocular pressure$5IEN$0(DLC)sh 85067624

=LDR  01195cz  a2200325n  4500
=001  9880363763902441
=005  20141212202601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007427
=035  \\$aCBA0629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x170.$x505
=150  \\$aIntracranial Pressure
=450  \\$aIntracerebral Pressure
=450  \\$wnnna$aIntracerebral Pressures
=450  \\$wnnna$aIntracranial Pressures
=450  \\$wnnna$aPressure, Intracerebral
=450  \\$wnnna$aPressure, Intracranial
=450  \\$wnnna$aPressure, Subarachnoid
=450  \\$wnnna$aPressures, Intracerebral
=450  \\$wnnna$aPressures, Intracranial
=450  \\$wnnna$aPressures, Subarachnoid
=450  \\$aSubarachnoid Pressure
=450  \\$wnnna$aSubarachnoid Pressures
=550  \\$wg$aCerebrospinal Fluid Pressure
=550  \\$aCerebrospinal Fluid Pressure
=550  \\$aSkull
=667  \\$aINTRACRANIAL HYPOTENSION & INTRACRANIAL HYPERTENSION are also available
=680  \\$iPressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity.
=750  \0$aIntracranial pressure$5IEN$0(DLC)sh 85067615

=LDR  01385cz  a2200277n  4500
=001  9880363764002441
=005  20141212202600.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007423
=035  \\$aCBA0625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x50.$x215.$x400
=150  \\$aIntra-Aortic Balloon Pumping
=450  \\$wnnna$aBalloon Pumping, Intra-Aortic
=450  \\$wnnna$aBalloon Pumping, Intraaortic
=450  \\$aIntra-Aortic Balloon Counterpulsation$5IEN
=450  \\$wnnna$aIntra Aortic Balloon Pumping
=450  \\$wnnna$aIntraaortic Balloon Pumping
=450  \\$aPumping, Intra-Aortic Balloon
=450  \\$wnnna$aPumping, Intra Aortic Balloon
=450  \\$wnnna$aPumping, Intraaortic Balloon
=550  \\$wg$aCounterpulsation
=667  \\$aDF: IABP
=680  \\$iCounterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.
=688  \\$a86(77); was see under ASSISTED CIRCULATION 1977-85
=750  \0$aIntra-aortic balloon counterpulsation$5IEN$0(DLC)sh 85067607

=LDR  01050cz  a2200241n  4500
=001  9880363764102441
=005  20141212202559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007422
=035  \\$aCBA0624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124
=150  \\$aIntestines
=360  \\$iconsider also terms at$aENTER-
=450  \\$wnnna$aIntestine
=550  \\$wg$aGastrointestinal Tract
=550  \\$wh$aIntestinal Mucosa
=550  \\$wh$aIntestine, Large
=550  \\$wh$aIntestine, Small
=667  \\$aGEN; /secret = INTESTINAL MUCOSA /secret or INTESTINAL SECRETIONS; invagination = INTUSSUSCEPTION; /surg: consider also ENTEROSTOMY & GASTROENTEROSTOMY; inflammation or inflamm dis: see note on INTESTINAL DISEASES; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS
=680  \\$iThe section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.
=688  \\$a/microbiology was INTESTINAL MICROORGANISMS 1963-67
=750  \0$aIntestines$5IEN$0(DLC)sh 85067581

=LDR  00960cz  a2200253n  4500
=001  9880363764202441
=005  20141212202559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007421
=035  \\$aCBA0623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x684
=150  \\$aIntestine, Small
=450  \\$wnnna$aIntestines, Small
=450  \\$wnnna$aSmall Intestine
=450  \\$wnnna$aSmall Intestines
=550  \\$wg$aIntestines
=550  \\$wh$aDuodenum
=550  \\$wh$aIleum
=550  \\$wh$aJejunum
=667  \\$aGEN; inflammation = ENTERITIS but ENTEROCOLITIS; DUODENITIS & ILEITIS are available
=680  \\$iThe portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.
=688  \\$aINTESTINAL MICROORGANISMS was heading 1963-67
=750  \0$aIntestine, Small$5IEN$0(DLC)sh 85067575

=LDR  00874cz  a2200265n  4500
=001  9880363764302441
=005  20141212202559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007420
=035  \\$aCBA0622HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526
=072  \\$aA3.$x556.$x249.$x249
=150  \\$aIntestine, Large
=450  \\$wnnna$aLarge Intestine
=550  \\$wg$aIntestines
=550  \\$wg$aLower Gastrointestinal Tract
=550  \\$wh$aAnal Canal
=550  \\$wh$aCecum
=550  \\$wh$aColon
=550  \\$wh$aRectum
=667  \\$aGEN: prefer specifics; inflammation: coord IM with GASTROENTERITIS (IM)
=680  \\$iA segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.
=688  \\$aINTESTINAL MICROORGANISMS was heading 1963-67
=750  \0$aIntestine, Large$5IEN$0(DLC)sh 85067571

=LDR  00560cz  a2200193n  4500
=001  9880363764402441
=005  20141212202558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007419
=035  \\$aCBA0621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x390
=150  \\$aIntestinal Secretions
=450  \\$wnnna$aIntestinal Secretion
=450  \\$wnnna$aSecretion, Intestinal
=450  \\$wnnna$aSecretions, Intestinal
=550  \\$wg$aBodily Secretions
=550  \\$aIntestinal Mucosa
=750  \0$aIntestines$xSecretions$5IEN$0(DLC)sh 85067599

=LDR  00797cz  a2200229n  4500
=001  9880363764502441
=005  20141212202557.0
=008  771206\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007417
=035  \\$aCBA0619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x825.$x411
=150  \\$aIntestinal Polyps
=450  \\$wnnna$aIntestinal Polyp
=450  \\$wnnna$aPolyp, Intestinal
=450  \\$wnnna$aPolyps, Intestinal
=550  \\$wg$aPolyps
=550  \\$wh$aColonic Polyps
=667  \\$aINTESTINAL POLYPOSIS is also available
=680  \\$iDiscrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.
=688  \\$a68
=750  \0$aIntestinal polyps$5IEN$0(DLC)sh 85067570

=LDR  00980cz  a2200277n  4500
=001  9880363764602441
=005  20200526145526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007415
=035  \\$aCBA0617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x531
=150  \\$aIntestinal Obstruction
=450  \\$wnnna$aIntestinal Obstructions
=450  \\$wnnna$aObstruction, Intestinal
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aAfferent Loop Syndrome
=550  \\$wh$aDuodenal Obstruction
=550  \\$wh$aFecal Impaction
=550  \\$wh$aIleus
=550  \\$wh$aIntestinal Volvulus
=550  \\$wh$aIntussusception
=550  \\$wh$aMeconium Ileus
=667  \\$acoord IM with specific precoord intestinal dis (IM); INTESTINAL PSEUDO-OBSTRUCTION is also available
=680  \\$iAny impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.
=750  \0$aIntestines$xObstructions$5IEN$0(DLC)sh 85067596

=LDR  01717cz  a2200505n  4500
=001  9880363764702441
=005  20141212202556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007414
=035  \\$aCBA0616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411
=072  \\$aC6.$x301.$x371.$x411
=072  \\$aC6.$x405.$x249.$x411
=072  \\$aC6.$x405.$x469.$x491
=150  \\$aIntestinal Neoplasms
=450  \\$wnnna$aCancer, Intestinal
=450  \\$wnnna$aCancer, Intestines
=450  \\$aCancer of Intestines
=450  \\$wnnna$aCancer of the Intestines
=450  \\$wnnna$aCancers, Intestinal
=450  \\$wnnna$aCancers, Intestines
=450  \\$aIntestinal Cancer
=450  \\$wnnna$aIntestinal Cancers
=450  \\$wnnna$aIntestinal Neoplasm
=450  \\$wnnna$aIntestines Cancer
=450  \\$wnnna$aIntestines Cancers
=450  \\$wnnna$aIntestines Neoplasm
=450  \\$wnnna$aIntestines Neoplasms
=450  \\$wnnna$aNeoplasm, Intestinal
=450  \\$wnnna$aNeoplasm, Intestines
=450  \\$wnnna$aNeoplasms, Intestinal
=450  \\$wnnna$aNeoplasms, Intestines
=550  \\$wg$aGastrointestinal Neoplasms
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aCecal Neoplasms
=550  \\$wh$aColorectal Neoplasms
=550  \\$wh$aDuodenal Neoplasms
=550  \\$wh$aIleal Neoplasms
=550  \\$wh$aImmunoproliferative Small Intestinal Disease
=550  \\$wh$aJejunal Neoplasms
=667  \\$aGEN: prefer specific precoord; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the INTESTINES.
=750  \0$aIntestines$xTumors$5IEN-M$0(DLC)sh 95000179
=750  \0$aIntestines$xCancer$5IEN-HS$0(DLC)sh 85067585

=LDR  01321cz  a2200325n  4500
=001  9880363764802441
=005  20141212202556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007413
=035  \\$aCBA0615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x369
=072  \\$aA10.$x615.$x550.$x444
=150  \\$aIntestinal Mucosa
=450  \\$wnnna$aEpithelium, Intestinal
=450  \\$wnnna$aGland, Intestinal
=450  \\$wnnna$aGlands, Intestinal
=450  \\$aIntestinal Epithelium
=450  \\$wnnna$aIntestinal Gland
=450  \\$wnnna$aIntestinal Glands
=450  \\$wnnna$aMucosa, Intestinal
=550  \\$wg$aIntestines
=550  \\$wg$aMucous Membrane
=550  \\$wh$aEnterocytes
=550  \\$wh$aGoblet Cells
=550  \\$wh$aPaneth Cells
=667  \\$a/cytol: consider also specific cell types available in MeSH; for X ref INTESTINAL EPITHELIUM, do not routinely coordinate with EPITHELIUM unless it is specifically discussed
=680  \\$iLining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI.
=688  \\$a67(65)
=750  \0$aIntestinal mucosa$5IEN$0(DLC)sh 88005282

=LDR  01673cz  a2200301n  4500
=001  9880363764902441
=005  20141212202555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007412
=035  \\$aCBA0614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x550
=072  \\$aC6.$x405.$x469.$x471
=072  \\$aC23.$x300.$x575.$x185.$x550
=150  \\$aIntestinal Fistula
=450  \\$wnnna$aCholecystoduodenal Fistula
=450  \\$wnnna$aColovesical Fistula
=450  \\$wnnna$aEnterocutaneous Fistula
=450  \\$wnnna$aFistula, Cholecystoduodenal
=450  \\$wnnna$aFistula, Colovesical
=450  \\$wnnna$aFistula, Enterocutaneous
=450  \\$wnnna$aFistula, Intestinal
=550  \\$wg$aDigestive System Fistula
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aRectal Fistula
=667  \\$afistula policy: Manual 23.19+; RECTAL FISTULA & RECTOVAGINAL FISTULA are also available; pathological artificial anus in historical literature is indexed here or under its specifics; surgically created artificial anus is indexed under COLOSTOMY
=680  \\$iAn abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN (enterocutaneous fistula). Internal intestinal fistula can be connected to a number of organs, such as STOMACH (gastrocolic fistula), the BILIARY TRACT (cholecystoduodenal fistula), or the URINARY BLADDER of the URINARY TRACT (colovesical fistula). Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures (MEDICAL ERRORS).
=750  \0$aFistula, Intestinal$5IEN$0(DLC)sh 85048898

=LDR  01902cz  a2200505n  4500
=001  9880363765002441
=005  20141212202555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007410
=035  \\$aCBA0612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469
=150  \\$aIntestinal Diseases
=450  \\$wnnna$aDisease, Intestinal
=450  \\$wnnna$aDiseases, Intestinal
=450  \\$wnnna$aIntestinal Disease
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wh$aCecal Diseases
=550  \\$wh$aColonic Diseases
=550  \\$wh$aDuodenal Diseases
=550  \\$wh$aDysentery
=550  \\$wh$aEnteritis
=550  \\$wh$aEnterocolitis
=550  \\$wh$aHIV Enteropathy
=550  \\$wh$aIleal Diseases
=550  \\$wh$aInflammatory Bowel Diseases
=550  \\$wh$aIntestinal Atresia
=550  \\$wh$aIntestinal Diseases, Parasitic
=550  \\$wh$aIntestinal Fistula
=550  \\$wh$aIntestinal Neoplasms
=550  \\$wh$aIntestinal Obstruction
=550  \\$wh$aIntestinal Perforation
=550  \\$wh$aIntestinal Polyposis
=550  \\$wh$aJejunal Diseases
=550  \\$wh$aMalabsorption Syndromes
=550  \\$wh$aMesenteric Ischemia
=550  \\$wh$aMesenteric Vascular Occlusion
=550  \\$wh$aPneumatosis Cystoides Intestinalis
=550  \\$wh$aProtein-Losing Enteropathies
=550  \\$wh$aRectal Diseases
=550  \\$wh$aZollinger-Ellison Syndrome
=667  \\$aGEN: prefer specifics; inflamm dis = GASTROENTERITIS or specifics; consider also INFLAMMATORY BOWEL DISEASE; gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS
=680  \\$iPathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
=688  \\$aINTESTINAL MICROORGANISMS was heading 1963-67; general or unspecified inflamm dis was indexed under ENTERITIS or INTESTINAL DISEASES 1966-79
=750  \0$aIntestines$xDiseases$5IEN$0(DLC)sh 85067586

=LDR  00887cz  a2200277n  4500
=001  9880363765102441
=005  20141212192253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007408
=035  \\$aCBA0610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x23.$x500.$x374.$x500
=072  \\$aG3.$x787.$x24.$x500.$x374.$x500
=072  \\$aG7.$x610.$x593.$x345.$x500
=072  \\$aG7.$x690.$x725.$x15.$x500.$x374.$x500
=072  \\$aG7.$x700.$x620.$x431
=072  \\$aG10.$x261.$x326.$x305.$x500
=150  \\$aIntestinal Absorption
=450  \\$aAbsorption, Intestinal
=550  \\$wg$aGastrointestinal Absorption
=550  \\$wg$aNutrition Processes
=550  \\$wh$aIntestinal Reabsorption
=550  \\$aAbsorption
=680  \\$iUptake of substances through the lining of the INTESTINES.
=688  \\$a65
=750  \0$aIntestinal absorption$5IEN$0(DLC)sh 85067569

=LDR  01545cz  a2200397n  4500
=001  9880363765202441
=005  20141212202553.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007407
=035  \\$aCBA0609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x420
=072  \\$aL1.$x280.$x520
=072  \\$aN5.$x715.$x360.$x300.$x400
=072  \\$aN6.$x850.$x520.$x308.$x420
=150  \\$aInterviews as Topic
=450  \\$wnnna$aGroup Interview
=450  \\$wnnna$aGroup Interviews
=450  \\$wnnna$aInterview, Group
=450  \\$wnnna$aInterview, Telephone
=450  \\$wnnna$aInterviewer
=450  \\$wnnna$aInterviewers
=450  \\$aInterviewing$5IEN
=450  \\$wnnna$aInterviews, Group
=450  \\$wnnna$aInterviews, Telephone
=450  \\$wnnna$aOral History as Topic
=450  \\$wnnna$aTelephone Interview
=450  \\$wnnna$aTelephone Interviews
=550  \\$wg$aData Collection
=667  \\$afor articles on how to conduct interviews, their value, behavior of participants, etc.: do not confuse with the Publication Type INTERVIEW
=680  \\$iConversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.
=688  \\$a2008(1980)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Interviews
=688  \\$a80
=750  \0$aInterviewing$0(DLC) sh 85067550$5IEN
=750  \0$aInterviews$0(DLC) sh 85067568$5IEN-M

=LDR  00956cz  a2200253n  4500
=001  9880363765302441
=005  20141212202553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007406
=035  \\$aCBA0608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x669.$x599
=150  \\$aInterview, Psychological
=450  \\$wnnna$aInterview, Psychologic
=450  \\$wnnna$aInterviews, Psychologic
=450  \\$wnnna$aInterviews, Psychological
=450  \\$wnnna$aPsychologic Interview
=450  \\$wnnna$aPsychologic Interviews
=450  \\$wnnna$aPsychological Interview
=450  \\$wnnna$aPsychological Interviews
=550  \\$wg$aPsychological Techniques
=680  \\$iA directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist.
=688  \\$a68(65)
=750  \0$aInterviewing in mental health$5IEN$0(DLC)sh 85067561

=LDR  02596cz  a2200685n  4500
=001  9880363765402441
=005  20141212202553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007405
=035  \\$aCBA0607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x307
=072  \\$aC23.$x300.$x707.$x952
=150  \\$aIntervertebral Disc Displacement
=450  \\$wnnna$aDisc Displacement, Intervertebral
=450  \\$wnnna$aDisc Displacements, Intervertebral
=450  \\$aDisc, Herniated
=450  \\$wnnna$aDisc, Prolapsed
=450  \\$wnnna$aDisc, Slipped
=450  \\$wnnna$aDiscs, Herniated
=450  \\$wnnna$aDiscs, Prolapsed
=450  \\$wnnna$aDiscs, Slipped
=450  \\$wnnna$aDisk Displacement, Intervertebral
=450  \\$wnnna$aDisk Displacements, Intervertebral
=450  \\$aDisk, Herniated
=450  \\$wnnna$aDisk Prolapse
=450  \\$wnnna$aDisk, Prolapsed
=450  \\$wnnna$aDisk Prolapses
=450  \\$wnnna$aDisk, Slipped
=450  \\$wnnna$aDisks, Herniated
=450  \\$wnnna$aDisks, Prolapsed
=450  \\$wnnna$aDisks, Slipped
=450  \\$wnnna$aDisplacement, Intervertebral Disc
=450  \\$wnnna$aDisplacement, Intervertebral Disk
=450  \\$wnnna$aDisplacements, Intervertebral Disc
=450  \\$wnnna$aDisplacements, Intervertebral Disk
=450  \\$wnnna$aHerniated Disc
=450  \\$wnnna$aHerniated Discs
=450  \\$wnnna$aHerniated Disk
=450  \\$wnnna$aHerniated Disks
=450  \\$wnnna$aIntervertebral Disc Displacements
=450  \\$aIntervertebral Disk Displacement
=450  \\$wnnna$aIntervertebral Disk Displacements
=450  \\$wnnna$aProlapse, Disk
=450  \\$wnnna$aProlapsed Disc
=450  \\$wnnna$aProlapsed Discs
=450  \\$aProlapsed Disk
=450  \\$wnnna$aProlapsed Disks
=450  \\$wnnna$aProlapses, Disk
=450  \\$wnnna$aSlipped Disc
=450  \\$wnnna$aSlipped Discs
=450  \\$aSlipped Disk
=450  \\$wnnna$aSlipped Disks
=550  \\$wg$aHernia
=550  \\$wg$aSpinal Diseases
=550  \\$aSciatica
=667  \\$acoordinate IM with specific vertebrae (IM); therapy by chemonucleolysis = INTERVERTEBRAL DISC CHEMOLYSIS: see note there; INTERVERTEBRAL DISC DEGENERATION is also available
=680  \\$iAn INTERVERTEBRAL DISC in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region.
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Intervertebral Disk Displacement
=750  \0$aIntervertebral disk displacement$0(DLC) sh 85067549$5IEN

=LDR  02348cz  a2200553n  4500
=001  9880363765502441
=005  20141212202552.0
=008  860620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007404
=035  \\$aCBA0606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x718.$x500
=150  \\$aIntervertebral Disc Chemolysis
=450  \\$wnnna$aChemolyses, Intervertebral Disc
=450  \\$wnnna$aChemolyses, Intervertebral Disk
=450  \\$wnnna$aChemolysis, Intervertebral Disc
=450  \\$aChemolysis, Intervertebral Disk
=450  \\$wnnna$aChemonucleolyses
=450  \\$aChemonucleolysis
=450  \\$wnnna$aDisc Chemolyses, Intervertebral
=450  \\$wnnna$aDisc Chemolysis, Intervertebral
=450  \\$wnnna$aDisc Nucleolyses, Intervertebral
=450  \\$wnnna$aDisc Nucleolysis, Intervertebral
=450  \\$wnnna$aDiscolyses
=450  \\$aDiscolysis
=450  \\$wnnna$aDisk Chemolyses, Intervertebral
=450  \\$wnnna$aDisk Chemolysis, Intervertebral
=450  \\$wnnna$aDisk Nucleolyses, Intervertebral
=450  \\$wnnna$aDisk Nucleolysis, Intervertebral
=450  \\$wnnna$aIntervertebral Disc Chemolyses
=450  \\$wnnna$aIntervertebral Disc Nucleolyses
=450  \\$wnnna$aIntervertebral Disc Nucleolysis
=450  \\$wnnna$aIntervertebral Disk Chemolyses
=450  \\$aIntervertebral Disk Chemolysis
=450  \\$wnnna$aIntervertebral Disk Nucleolyses
=450  \\$wnnna$aIntervertebral Disk Nucleolysis
=450  \\$wnnna$aNucleolyses, Intervertebral Disc
=450  \\$wnnna$aNucleolyses, Intervertebral Disk
=450  \\$wnnna$aNucleolysis, Intervertebral Disc
=450  \\$aNucleolysis, Intervertebral Disk
=550  \\$wg$aOrthopedic Procedures
=550  \\$aIntervertebral Disc Degeneration
=550  \\$aIntervertebral Disc Displacement
=667  \\$acoordinate IM with specific substance /ther use (usually CHYMOPAPAIN) if particularly discussed
=680  \\$iThe dissolving of the nucleus pulposus, the semi-gelatinous tissue of a displaced INTERVERTEBRAL DISC. It is usually achieved by the direct injection of a proteolytic enzyme, especially CHYMOPAPAIN, into the herniated disc.
=688  \\$a2012 (1987)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Intervertebral Disk Chemolysis
=688  \\$a87
=750  \0$aChemonucleolysis$0(DLC) sh 88000962$5IEN

=LDR  01353cz  a2200337n  4500
=001  9880363765602441
=005  20180212124128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007403
=035  \\$aCBA0605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x165.$x308.$x410
=072  \\$aA2.$x835.$x232.$x834.$x432
=072  \\$aA10.$x165.$x382.$x350.$x50
=150  \\$aIntervertebral Disc
=450  \\$wnnna$aDisc, Intervertebral
=450  \\$wnnna$aDiscs, Intervertebral
=450  \\$aDisk, Intervertebral
=450  \\$wnnna$aDisks, Intervertebral
=450  \\$wnnna$aIntervertebral Discs
=450  \\$aIntervertebral Disk
=450  \\$wnnna$aIntervertebral Disks
=550  \\$wg$aFibrocartilage
=550  \\$wg$aSpine
=550  \\$wh$aAnnulus Fibrosus
=550  \\$wh$aNucleus Pulposus
=667  \\$acoordinate IM with specific vertebrae (IM); diseases: probably DISCITIS, INTERVERTEBRAL DISC DISPLACEMENT, or INTERVERTEBRAL DISC DEGENERATION but if not, index as INTERVERTEBRAL DISC (IM) + SPINAL DISEASES (IM); chemonucleolysis = INTERVERTEBRAL DISC CHEMOLYSIS
=680  \\$iAny of the 23 plates of fibrocartilage found between the bodies of adjacent VERTEBRAE.
=688  \\$a2012 (1963)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Intervertebral Disk
=750  \0$aIntervertebral disk$0(DLC) sh 85067544$5IEN

=LDR  00773cz  a2200217n  4500
=001  9880363765702441
=005  20141212202550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007401
=035  \\$aCBA0603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x530
=150  \\$aInterrenal Gland
=450  \\$wnnna$aGland, Interrenal
=450  \\$wnnna$aGlands, Interrenal
=450  \\$wnnna$aInterrenal Glands
=550  \\$wg$aAnimal Structures
=667  \\$aalso called interrenal body; in fish
=680  \\$iStructures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney.
=688  \\$a89(75); was see under ADRENAL GLANDS 1969-88
=750  \0$aInterrenal gland$5IEN$0(DLC)sh 85067500

=LDR  00888cz  a2200241n  4500
=001  9880363765802441
=005  20141212202550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007400
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x205
=150  \\$aInterprofessional Relations
=450  \\$wnnna$aEtiquette, Medical
=450  \\$wnnna$aMedical Etiquette
=450  \\$wnnna$aRelations, Interprofessional
=550  \\$wg$aInterpersonal Relations
=550  \\$wh$aInterdisciplinary Communication
=550  \\$wh$aPhysician-Nurse Relations
=550  \\$aInterdisciplinary Communication
=667  \\$acoord IM with med or other spec (IM) if pertinent; INTERDISCIPLINARY COMMUNICATION is also available
=680  \\$iThe reciprocal interaction of two or more professional individuals.
=688  \\$a65
=750  \0$aInterprofessional relations$5IEN-M$0(DLC)sh 95002729

=LDR  02024cz  a2200613n  4500
=001  9880363765902441
=005  20141212202549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007398
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401
=150  \\$aInterpersonal Relations
=450  \\$wnnna$aCommunication, Husband-Wife
=450  \\$wnnna$aCommunication, Partner
=450  \\$wnnna$aCommunications, Husband-Wife
=450  \\$wnnna$aCommunications, Partner
=450  \\$wnnna$aGender Issue
=450  \\$wnnna$aGender Issues
=450  \\$wnnna$aGender Relation
=450  \\$aGender Relations
=450  \\$wnnna$aHusband-Wife Communication
=450  \\$wnnna$aHusband Wife Communication
=450  \\$wnnna$aHusband-Wife Communications
=450  \\$wnnna$aInteraction, Social
=450  \\$wnnna$aInteractions, Social
=450  \\$wnnna$aInterpersonal Relation
=450  \\$wnnna$aIssue, Gender
=450  \\$wnnna$aIssues, Gender
=450  \\$wnnna$aPartner Communication
=450  \\$wnnna$aPartner Communications
=450  \\$wnnna$aRelation, Gender
=450  \\$wnnna$aRelation, Interpersonal
=450  \\$wnnna$aRelations, Gender
=450  \\$wnnna$aRelations, Interpersonal
=450  \\$aSocial Interaction
=450  \\$wnnna$aSocial Interactions
=550  \\$wg$aPsychology, Social
=550  \\$wh$aDisclosure
=550  \\$wh$aDissent and Disputes
=550  \\$wh$aFamily Conflict
=550  \\$wh$aForgiveness
=550  \\$wh$aIntergenerational Relations
=550  \\$wh$aInterprofessional Relations
=550  \\$wh$aNegotiating
=550  \\$wh$aProfessional-Family Relations
=550  \\$wh$aProfessional-Patient Relations
=550  \\$wh$aSocial Skills
=550  \\$wh$aTrust
=550  \\$aEmotional Intelligence
=550  \\$aFriends
=680  \\$iThe reciprocal interaction of two or more persons.
=688  \\$a64
=750  \0$aSocial interaction$5IEN-M$0(DLC)sh 85123965
=750  \0$aInterpersonal relations$5IEN-HS$0(DLC)sh 85067484

=LDR  01620cz  a2200445n  4500
=001  9880363766002441
=005  20141212202549.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007397
=035  \\$aCBA0599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x750
=150  \\$aInternship, Nonmedical
=450  \\$wnnna$aInternship, Non-Medical
=450  \\$wnnna$aInternship, Non Medical
=450  \\$wnnna$aInternships, Non-Medical
=450  \\$wnnna$aInternships, Non Medical
=450  \\$wnnna$aInternships, Nonmedical
=450  \\$wnnna$aNon-Medical Internship
=450  \\$wnnna$aNon Medical Internship
=450  \\$wnnna$aNon-Medical Internships
=450  \\$wnnna$aNon Medical Internships
=450  \\$wnnna$aNon-Medical Residencies
=450  \\$wnnna$aNon-Medical Residency
=450  \\$wnnna$aNonmedical Internship
=450  \\$wnnna$aNonmedical Internships
=450  \\$wnnna$aNonmedical Residencies
=450  \\$wnnna$aNonmedical Residency
=450  \\$wnnna$aResidencies, Non-Medical
=450  \\$wnnna$aResidencies, Non Medical
=450  \\$wnnna$aResidencies, Nonmedical
=450  \\$wnnna$aResidency, Non-Medical
=450  \\$wnnna$aResidency, Non Medical
=450  \\$aResidency, Nonmedical
=550  \\$wg$aEducation, Professional
=550  \\$wh$aPharmacy Residencies
=667  \\$aDF: INTERNSHIP NONMED
=680  \\$iAdvanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc.
=688  \\$a78
=750  \0$aInternship programs$5IEN$0(DLC)sh 86001851

=LDR  01626cz  a2200445n  4500
=001  9880363766102441
=005  20141212202548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007396
=035  \\$aCBA0598HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x399.$x644
=150  \\$aInternship and Residency
=450  \\$wnnna$aDental Internship
=450  \\$wnnna$aDental Internships
=450  \\$wnnna$aDental Residencies
=450  \\$wnnna$aDental Residency
=450  \\$aHouse Staff
=450  \\$wnnna$aHouse Staffs
=450  \\$wnnna$aInternship
=450  \\$aInternship, Dental
=450  \\$wnnna$aInternships
=450  \\$wnnna$aInternships, Dental
=450  \\$wnnna$aMedical Residencies
=450  \\$wnnna$aMedical Residency
=450  \\$wnnna$aResidencies
=450  \\$wnnna$aResidencies, Dental
=450  \\$wnnna$aResidencies, Medical
=450  \\$wnnna$aResidency
=450  \\$wnnna$aResidency and Internship
=450  \\$aResidency, Dental
=450  \\$aResidency, Medical
=450  \\$wnnna$aStaff, House
=450  \\$wnnna$aStaffs, House
=550  \\$wg$aEducation, Medical
=550  \\$wh$aTeaching Rounds
=667  \\$amed & dent only; "junior physicians" are not interns: index under MEDICAL STAFF, HOSPITAL; DF: INTERNSHIP
=680  \\$iPrograms of training in medicine and medical specialties offered by hospitals for graduates of medicine to meet the requirements established by accrediting authorities.
=750  \0$aMedicine$xStudy and teaching (Internship)$5IEN-M$0(IEN)368914
=750  \0$aMedicine$xStudy and teaching (Residency)$5IEN-M$0(IEN)368916

=LDR  01025cz  a2200289n  4500
=001  9880363766202441
=005  20150312104622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007395
=035  \\$aCBA0597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x358
=072  \\$aA11.$x671.$x358
=150  \\$aInterneurons
=450  \\$wnnna$aIntercalated Neuron
=450  \\$aIntercalated Neurons
=450  \\$wnnna$aInterneuron
=450  \\$wnnna$aNeuron, Intercalated
=450  \\$wnnna$aNeurons, Intercalated
=550  \\$wg$aNeurons
=550  \\$wh$aAmacrine Cells
=550  \\$wh$aCommissural Interneurons
=550  \\$wh$aRenshaw Cells
=550  \\$wh$aRetinal Bipolar Cells
=680  \\$iMost generally any NEURONS which are not motor or sensory. Interneurons may also refer to neurons whose AXONS remain within a particular brain region as contrasted with projection neurons which have axons projecting to other brain regions.
=688  \\$a68
=750  \0$aInterneurons$0(DLC)sh 90004630$5IEN-M

=LDR  00989cz  a2200265n  4500
=001  9880363766302441
=005  20141212202547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007391
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x615.$x500
=150  \\$aInternational Cooperation
=450  \\$wnnna$aAid, Foreign
=450  \\$wnnna$aCooperation, International
=450  \\$aForeign Aid
=450  \\$wnnna$aTreaties
=450  \\$wnnna$aTreaty
=550  \\$wg$aInternationality
=550  \\$wh$aDeveloped Countries
=550  \\$wh$aDeveloping Countries
=550  \\$wh$aInternational Educational Exchange
=550  \\$wh$aMedical Missions, Official
=667  \\$aspecify geog for cooperating nations; do not index here for "international congresses": CONGRESSES is adequate
=680  \\$iThe interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest.
=750  \0$aInternational cooperation$5IEN$0(DLC)sh 85067385

=LDR  00656cz  a2200205n  4500
=001  9880363766402441
=005  20161123110249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007390
=035  \\$aCBA0592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x514
=150  \\$aInternational Agencies
=450  \\$wnnna$aAgencies, International
=450  \\$wnnna$aAgency, International
=450  \\$wnnna$aInternational Agency
=550  \\$wg$aOrganizations
=667  \\$aspecify geog
=680  \\$iInternational organizations which provide health-related or other cooperative services.
=750  \0$aInternational agencies$5IEN$0(DLC)sh 85067357

=LDR  00918cz  a2200253n  4500
=001  9880363766502441
=005  20141212202547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007389
=035  \\$aCBA0591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x379
=150  \\$aInternal-External Control
=450  \\$wnnna$aControl, Internal-External
=450  \\$wnnna$aControl Locus
=450  \\$wnnna$aControls, Internal-External
=450  \\$wnnna$aInternal External Control
=450  \\$wnnna$aInternal-External Controls
=450  \\$aLocus of Control
=550  \\$wg$aPsychology, Social
=667  \\$ano qualif
=680  \\$iPersonality construct referring to an individual's perception of the locus of events as determined internally by his or her own behavior versus fate, luck, or external forces. (ERIC Thesaurus, 1996).
=688  \\$a72
=750  \0$aLocus of control$5IEN$0(DLC)sh 90004038

=LDR  01010cz  a2200301n  4500
=001  9880363766602441
=005  20141212202546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007388
=035  \\$aCBA0590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429
=150  \\$aInternal Medicine
=450  \\$wnnna$aMedicine, Internal
=550  \\$wg$aMedicine
=550  \\$wh$aCardiology
=550  \\$wh$aEndocrinology
=550  \\$wh$aGastroenterology
=550  \\$wh$aHematology
=550  \\$wh$aInfectious Disease Medicine
=550  \\$wh$aMedical Oncology
=550  \\$wh$aNephrology
=550  \\$wh$aPulmonary Medicine
=550  \\$wh$aRheumatology
=550  \\$wh$aSleep Medicine Specialty
=667  \\$aSPEC: SPEC qualif; when permitted for "internal diseases": Manual 28.10; DF: INTERNAL MED
=680  \\$iA medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults.
=750  \0$aInternal medicine$5IEN$0(DLC)sh 85067347

=LDR  01533cz  a2200301n  4500
=001  9880363766702441
=005  20141212202545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007384
=035  \\$aCBA0586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x625.$x790.$x520
=072  \\$aE2.$x880.$x820.$x790.$x520
=150  \\$aIntermittent Positive-Pressure Breathing
=450  \\$wnnna$aBreathing, Inspiratory Positive-Pressure
=450  \\$wnnna$aBreathing, Intermittent Positive-Pressure
=450  \\$aInspiratory Positive-Pressure Breathing
=450  \\$wnnna$aInspiratory Positive Pressure Breathing
=450  \\$wnnna$aIntermittent Positive Pressure Breathing
=450  \\$wnnna$aIntermittent Positive Pressure Breathing (IPPB)
=450  \\$aIPPB
=450  \\$wnnna$aPositive-Pressure Breathing, Inspiratory
=450  \\$wnnna$aPositive-Pressure Breathing, Intermittent
=550  \\$wg$aPositive-Pressure Respiration
=667  \\$ado not use /util except by MeSH definition; do not confuse with INTERMITTENT POSITIVE-PRESSURE VENTILATION: IPPB is spontaneous, IPPV is on a ventilator; DF: note short X ref
=680  \\$iApplication of positive pressure to the inspiratory phase of spontaneous respiration.
=688  \\$a91(79); was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING (IPPB) see under POSITIVE PRESSURE RESPIRATION 1969-78
=750  \0$aIntermittent positive pressure breathing$5IEN$0(DLC)sh 85067311

=LDR  00844cz  a2200193n  4500
=001  9880363766802441
=005  20141212202545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007383
=035  \\$aCBA0585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137.$x126.$x669
=072  \\$aC23.$x888.$x531
=150  \\$aIntermittent Claudication
=450  \\$wnnna$aClaudication, Intermittent
=550  \\$wg$aArteriosclerosis
=550  \\$wg$aSigns and Symptoms
=680  \\$iA symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
=750  \0$aIntermittent claudication$5IEN$0(DLC)sh 85067309

=LDR  01248cz  a2200337n  4500
=001  9880363766902441
=005  20141212202545.0
=008  820511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007381
=035  \\$aCBA0583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x593
=072  \\$aD12.$x776.$x220.$x475
=150  \\$aIntermediate Filament Proteins
=450  \\$aFibroblast Intermediate Filament Proteins
=450  \\$wnnna$aFilament Proteins, Intermediate
=450  \\$aProfilaggrin$5IEN-M
=450  \\$wnnna$aProteins, Intermediate Filament
=550  \\$wg$aBiopolymers
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wh$aDesmin
=550  \\$wh$aGlial Fibrillary Acidic Protein
=550  \\$wh$aKeratins
=550  \\$wh$aNestin
=550  \\$wh$aNeurofilament Proteins
=550  \\$wh$aPeripherins
=550  \\$wh$aVimentin
=667  \\$a/biosyn /drug eff /physiol permitted
=680  \\$iFilaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.
=688  \\$a83
=750  \0$aIntermediate filament proteins$0(DLC) sh 85067297$5IEN

=LDR  00551cz  a2200193n  4500
=001  9880363767002441
=005  20141212202544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007379
=035  \\$aCBA0581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x639.$x493
=072  \\$aL1.$x583.$x464.$x493
=150  \\$aInterlibrary Loans
=450  \\$wnnna$aInterlibrary Loan
=450  \\$wnnna$aLoan, Interlibrary
=450  \\$wnnna$aLoans, Interlibrary
=550  \\$wg$aLibrary Services
=750  \0$aInterlibrary loans$5IEN$0(DLC)sh 85067196

=LDR  01615cz  a2200457n  4500
=001  9880363767102441
=005  20170405160840.0
=008  870509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007378
=035  \\$aCBA0580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465
=072  \\$aD12.$x776.$x467.$x374.$x465
=072  \\$aD23.$x529.$x374.$x465
=150  \\$aInterleukins
=450  \\$wnnna$aInterleukin
=550  \\$wg$aCytokines
=550  \\$wh$aInterleukin-1
=550  \\$wh$aInterleukin-10
=550  \\$wh$aInterleukin-11
=550  \\$wh$aInterleukin-12
=550  \\$wh$aInterleukin-13
=550  \\$wh$aInterleukin-15
=550  \\$wh$aInterleukin-16
=550  \\$wh$aInterleukin-17
=550  \\$wh$aInterleukin-18
=550  \\$wh$aInterleukin-2
=550  \\$wh$aInterleukin-23
=550  \\$wh$aInterleukin-27
=550  \\$wh$aInterleukin-3
=550  \\$wh$aInterleukin-33
=550  \\$wh$aInterleukin-4
=550  \\$wh$aInterleukin-5
=550  \\$wh$aInterleukin-6
=550  \\$wh$aInterleukin-7
=550  \\$wh$aInterleukin-8
=550  \\$wh$aInterleukin-9
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iSoluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli.
=688  \\$a1988; for MITOGENIC FACTORS, LYMPHOCYTE use INTERLEUKIN-2 1983-2001, LYMPHOKINES 1978-1982
=750  \0$aInterleukins$0(DLC) sh 85067285$5IEN

=LDR  02150cz  a2200505n  4500
=001  9880363767202441
=005  20141212202543.0
=008  860408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007377
=035  \\$aCBA0579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x400
=072  \\$aD12.$x644.$x276.$x374.$x465.$x503
=072  \\$aD12.$x776.$x395.$x240.$x400
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x400
=072  \\$aD12.$x776.$x467.$x374.$x465.$x503
=072  \\$aD23.$x529.$x374.$x410.$x240.$x400
=072  \\$aD23.$x529.$x374.$x465.$x503
=150  \\$aInterleukin-3
=450  \\$aBurst-Promoting Factor, Erythrocyte
=450  \\$wnnna$aBurst Promoting Factor, Erythrocyte
=450  \\$aColony-Stimulating Factor 2 Alpha
=450  \\$aColony-Stimulating Factor, Mast-Cell
=450  \\$wnnna$aColony Stimulating Factor, Mast Cell
=450  \\$aColony-Stimulating Factor, Multipotential
=450  \\$wnnna$aColony Stimulating Factor, Multipotential
=450  \\$wnnna$aEosinophil-Mast Cell Growth-Factor
=450  \\$wnnna$aEosinophil Mast Cell Growth Factor
=450  \\$aErythrocyte Burst-Promoting Factor
=450  \\$wnnna$aErythrocyte Burst Promoting Factor
=450  \\$wnnna$aHematopoietin-2
=450  \\$wnnna$aHematopoietin 2
=450  \\$aIL-3
=450  \\$wnnna$aInterleukin 3
=450  \\$aMast-Cell Colony-Stimulating Factor
=450  \\$aMultipotential Colony-Stimulating Factor
=450  \\$wnnna$aMultipotential Colony Stimulating Factor
=450  \\$aP-Cell Stimulating Factor
=450  \\$wnnna$aP Cell Stimulating Factor
=550  \\$wg$aColony-Stimulating Factors
=550  \\$wg$aInterleukins
=680  \\$iA multilineage cell growth factor secreted by LYMPHOCYTES; EPITHELIAL CELLS; and ASTROCYTES which stimulates clonal proliferation and differentiation of various types of blood and tissue cells.
=688  \\$a1987; for HEMATOPOIETIN-2 use HEMATOPOIETIC CELL GROWTH FACTORS 1990-2006
=688  \\$a90; was INTERLEUKIN 3 1987-89; GROWTH FACTOR, MAST-CELL was see INTERLEUKIN-3 1987-94
=750  \0$aInterleukin-3$0(DLC) sh 92005138$5IEN

=LDR  01854cz  a2200541n  4500
=001  9880363767302441
=005  20141212202542.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007376
=035  \\$aCBA0578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x502
=072  \\$aD12.$x644.$x276.$x374.$x480.$x372
=072  \\$aD12.$x776.$x467.$x374.$x465.$x502
=072  \\$aD12.$x776.$x467.$x374.$x480.$x372
=072  \\$aD23.$x529.$x374.$x465.$x502
=072  \\$aD23.$x529.$x374.$x480.$x372
=150  \\$aInterleukin-2
=450  \\$aIL-2
=450  \\$wnnna$aIL2
=450  \\$wnnna$aInterleukin 2
=450  \\$wnnna$aInterleukin II
=450  \\$wnnna$aInterleukine 2
=450  \\$aLymphocyte Mitogenic Factor
=450  \\$wnnna$aMitogenic Factor, Lymphocyte
=450  \\$wnnna$aRo-23-6019
=450  \\$wnnna$aRo 23 6019
=450  \\$wnnna$aRo-236019
=450  \\$wnnna$aRo 236019
=450  \\$wnnna$aRo236019
=450  \\$wnnna$aRU 49637
=450  \\$wnnna$aRU-49637
=450  \\$wnnna$aRU49637
=450  \\$aT-Cell Growth Factor
=450  \\$wnnna$aT Cell Growth Factor
=450  \\$wnnna$aT-Cell Stimulating Factor
=450  \\$wnnna$aT Cell Stimulating Factor
=450  \\$aTCGF
=450  \\$wnnna$aThymocyte Stimulating Factor
=550  \\$wg$aInterleukins
=550  \\$wg$aLymphokines
=550  \\$aKiller Cells, Lymphokine-Activated
=550  \\$aT-Lymphocytes, Helper-Inducer
=667  \\$aDF: IL 2 or IL2
=680  \\$iA soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.
=688  \\$a1990(1978)
=688  \\$a90; was INTERLEUKIN 2 1987-89; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82
=750  \0$aInterleukin-2$5IEN$0(DLC)sh 87006638

=LDR  01682cz  a2200409n  4500
=001  9880363767402441
=005  20141212202542.0
=008  820429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007375
=035  \\$aCBA0577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x501
=072  \\$aD12.$x644.$x276.$x374.$x500.$x400
=072  \\$aD12.$x776.$x467.$x374.$x465.$x501
=072  \\$aD12.$x776.$x467.$x374.$x500.$x400
=072  \\$aD23.$x529.$x374.$x465.$x501
=072  \\$aD23.$x529.$x374.$x500.$x400
=150  \\$aInterleukin-1
=450  \\$wnnna$aEpidermal Cell Derived Thymocyte-Activating Factor
=450  \\$wnnna$aEpidermal Cell Derived Thymocyte Activating Factor
=450  \\$aIL-1
=450  \\$wnnna$aInterleukin 1
=450  \\$wnnna$aInterleukin I
=450  \\$aLymphocyte-Activating Factor
=450  \\$wnnna$aLymphocyte Activating Factor
=450  \\$wnnna$aMacrophage Cell Factor
=450  \\$wnnna$aT Helper Factor
=550  \\$wg$aInterleukins
=550  \\$wg$aMonokines
=550  \\$wh$aInterleukin-1alpha
=550  \\$wh$aInterleukin-1beta
=550  \\$aCaspase 1
=667  \\$aDF: IL 1 or IL1
=680  \\$iA soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation.
=688  \\$a1990(1983)
=688  \\$a90; was INTERLEUKIN 1 1983-89
=750  \0$aInterleukin-1$5IEN$0(DLC)sh 89004301

=LDR  01129cz  a2200313n  4500
=001  9880363767502441
=005  20141212202541.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007374
=035  \\$aCBA0576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x290
=150  \\$aInterior Design and Furnishings
=450  \\$wnnna$aDesign, Interior
=450  \\$wnnna$aDesigns, Interior
=450  \\$wnnna$aFurnishing, Interior
=450  \\$wnnna$aFurnishings, Interior
=450  \\$aFurniture
=450  \\$aInterior Decoration$5IEN
=450  \\$wnnna$aInterior Design
=450  \\$wnnna$aInterior Designs
=450  \\$wnnna$aInterior Furnishing
=450  \\$aInterior Furnishings
=550  \\$wg$aFacility Design and Construction
=667  \\$afor houses, commerc estab, hosp, institutions, etc.; DF: INTERIOR DESIGN
=680  \\$iThe planning of the furnishings and decorations of an architectural interior.
=688  \\$a91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
=750  \0$aInterior decoration$5IEN-M$0(DLC)sh 85067272
=750  \0$aFurniture$5IEN-HS$0(DLC)sh 85052522

=LDR  00977cz  a2200265n  4500
=001  9880363767602441
=005  20141212202541.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007373
=035  \\$aCBA0575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x822.$x400
=150  \\$aInterinstitutional Relations
=450  \\$wnnna$aInteragency Relation
=450  \\$aInteragency Relations
=450  \\$wnnna$aInterinstitutional Relation
=450  \\$wnnna$aRelation, Interagency
=450  \\$wnnna$aRelation, Interinstitutional
=450  \\$wnnna$aRelations, Interagency
=450  \\$wnnna$aRelations, Interinstitutional
=550  \\$wg$aPublic Relations
=667  \\$ano qualif; coord IM with specific institution, agency or organization (IM); DF: INTERINSTITUTIONAL RELAT
=680  \\$iThe interactions between representatives of institutions, agencies, or organizations.
=688  \\$a80
=750  \0$aInterorganizational relations$5IEN$0(DLC)sh 85067477

=LDR  01248cz  a2200289n  4500
=001  9880363767702441
=005  20141212202541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007372
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x440
=072  \\$aD12.$x644.$x276.$x718
=072  \\$aD12.$x776.$x467.$x374.$x440
=072  \\$aD12.$x776.$x467.$x718
=072  \\$aD23.$x529.$x374.$x440
=072  \\$aD23.$x529.$x718
=150  \\$aInterferons
=450  \\$wnnna$aInterferon
=550  \\$wg$aCytokines
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aInterferon-gamma
=550  \\$wh$aInterferon Type I
=550  \\$aViral Interference
=667  \\$a"stimulators" or "inducers" = INTERFERON INDUCERS
=680  \\$iProteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions.
=688  \\$a83; was INTERFERON 1963-82
=750  \0$aInterferon$5IEN$0(DLC)sh 85067260

=LDR  00749cz  a2200193n  4500
=001  9880363767802441
=005  20141212202539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007369
=035  \\$aCBA0571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x828
=150  \\$aInterferon Inducers
=450  \\$wnnna$aInducers, Interferon
=550  \\$wg$aImmunologic Factors
=667  \\$aDF: INTERFERON IND
=680  \\$iAgents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons.
=688  \\$a73
=750  \0$aInterferon inducers$5IEN$0(DLC)sh 85067261

=LDR  00781cz  a2200217n  4500
=001  9880363767902441
=005  20141212202539.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007368
=035  \\$aCBA0566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x490
=150  \\$aInterferometry
=450  \\$wnnna$aInterferometries
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aMicroscopy, Interference
=550  \\$wh$aMoire Topography
=667  \\$aNIM; coord with LIGHT (NIM) or SOUND (NIM) if specified
=680  \\$iMeasurement of distances or movements by means of the phenomena caused by the interference of two rays of light (optical interferometry) or of sound (acoustic interferometry).
=688  \\$a77
=750  \0$aInterferometry$5IEN$0(DLC)sh 85067258

=LDR  00844cz  a2200205n  4500
=001  9880363768002441
=005  20141212202539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007366
=035  \\$aCBA0563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x900.$x500
=150  \\$aIntercostal Muscles
=450  \\$wnnna$aIntercostal Muscle
=450  \\$wnnna$aMuscle, Intercostal
=450  \\$wnnna$aMuscles, Intercostal
=550  \\$wg$aRespiratory Muscles
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iRespiratory muscles that arise from the lower border of one rib and insert into the upper border of the adjoining rib, and contract during inspiration or respiration. (From Stedman, 25th ed)
=750  \0$aIntercostal muscles$5IEN$0(DLC)sh 85067219

=LDR  01508cz  a2200361n  4500
=001  9880363768102441
=005  20141212202538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007365
=035  \\$aCBA0562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x420
=150  \\$aIntercellular Junctions
=450  \\$wnnna$aCell Junction
=450  \\$aCell Junctions
=450  \\$wnnna$aIntercellular Junction
=450  \\$wnnna$aJunction, Cell
=450  \\$wnnna$aJunction, Intercellular
=450  \\$wnnna$aJunctions, Cell
=450  \\$wnnna$aJunctions, Intercellular
=550  \\$wg$aCell Membrane Structures
=550  \\$wh$aAdherens Junctions
=550  \\$wh$aDesmosomes
=550  \\$wh$aGap Junctions
=550  \\$wh$aImmunological Synapses
=550  \\$wh$aPlasmodesmata
=550  \\$wh$aSynapses
=550  \\$wh$aTight Junctions
=550  \\$aCell Communication
=667  \\$aA 11 qualif except /cytol /transpl; /genet permitted
=680  \\$iDirect contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p792)
=688  \\$a72(70)
=750  \0$aCell junctions$5IEN$0(DLC)sh 85021650

=LDR  00926cz  a2200289n  4500
=001  9880363768202441
=005  20141212202538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007362
=035  \\$aCBA0558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x493
=150  \\$aIntensive Care Units
=450  \\$wnnna$aCare Unit, Intensive
=450  \\$wnnna$aCare Units, Intensive
=450  \\$wnnna$aIntensive Care Unit
=450  \\$wnnna$aUnit, Intensive Care
=450  \\$wnnna$aUnits, Intensive Care
=550  \\$wg$aHospital Units
=550  \\$wh$aBurn Units
=550  \\$wh$aCoronary Care Units
=550  \\$wh$aIntensive Care Units, Pediatric
=550  \\$wh$aRecovery Room
=550  \\$wh$aRespiratory Care Units
=680  \\$iHospital units providing continuous surveillance and care to acutely ill patients.
=688  \\$a66(63)
=750  \0$aIntensive care units$5IEN$0(DLC)sh 85067186

=LDR  00838cz  a2200265n  4500
=001  9880363768302441
=005  20141212202537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007361
=035  \\$aCBA0557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x141.$x493
=150  \\$aIntelligence Tests
=450  \\$wnnna$aIntelligence Test
=450  \\$wnnna$aMental Test
=450  \\$aMental Tests
=450  \\$wnnna$aTest, Intelligence
=450  \\$wnnna$aTest, Mental
=450  \\$wnnna$aTests, Intelligence
=450  \\$wnnna$aTests, Mental
=550  \\$wg$aAptitude Tests
=550  \\$wh$aStanford-Binet Test
=550  \\$wh$aWechsler Scales
=680  \\$iStandardized tests that measure the present general ability or aptitude for intellectual performance.
=750  \0$aIntelligence tests$5IEN$0(DLC)sh 85067180

=LDR  00704cz  a2200217n  4500
=001  9880363768402441
=005  20141212202537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007360
=035  \\$aCBA0556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x543
=150  \\$aIntelligence
=450  \\$aIntellect$5IEN
=450  \\$aIntelligence Levels$5IEN
=550  \\$wg$aPersonality
=550  \\$wh$aEmotional Intelligence
=667  \\$a/genet permitted
=680  \\$iThe ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.
=750  \0$aIntellect$5IEN-M$0(DLC)sh 85067157
=750  \0$aIntelligence levels$5IEN-HS$0(DLC)sh 85067173

=LDR  00745cz  a2200229n  4500
=001  9880363768502441
=005  20141212202536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007358
=035  \\$aCBA0554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x658
=150  \\$aInsurance, Psychiatric
=450  \\$aInsurance, Mental Health$5IEN
=450  \\$wnnna$aInsurances, Psychiatric
=450  \\$wnnna$aPsychiatric Insurance
=450  \\$wnnna$aPsychiatric Insurances
=550  \\$wg$aInsurance, Health
=667  \\$aspecify geog if possible
=680  \\$iInsurance providing benefits to cover part or all of the psychiatric care.
=688  \\$a68
=750  \0$aMental health insurance$5IEN$0(DLC)sh 85066999

=LDR  01350cz  a2200325n  4500
=001  9880363768602441
=005  20141212202536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007357
=035  \\$aCBA0553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x616
=150  \\$aInsurance, Physician Services
=450  \\$wnnna$aInsurance Physician Service
=450  \\$wnnna$aInsurance Physician Services
=450  \\$wnnna$aInsurances, Physician Services
=450  \\$wnnna$aPhysician Service, Insurance
=450  \\$wnnna$aPhysician Services, Insurance
=450  \\$wnnna$aPhysician Services Insurance
=450  \\$wnnna$aPhysician Services Insurances
=450  \\$wnnna$aService, Insurance Physician
=450  \\$wnnna$aServices Insurance, Physician
=450  \\$wnnna$aServices, Insurance Physician
=450  \\$wnnna$aServices Insurances, Physician
=550  \\$wg$aInsurance, Health
=550  \\$wh$aMedicare Assignment
=667  \\$aspecify geog if possible; DF: INSURANCE PHYSICIAN SERV
=680  \\$iInsurance providing benefits for the costs of care by a physician which can be comprehensive or limited to surgical expenses or for care provided only in the hospital. It is frequently called "regular medical expense" or "surgical expense".
=688  \\$a68
=750  \0$aInsurance, Health$5IEN

=LDR  01333cz  a2200361n  4500
=001  9880363768702441
=005  20141212202536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007356
=035  \\$aCBA0552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x575
=150  \\$aInsurance, Pharmaceutical Services
=450  \\$wnnna$aDrug Benefit Plan
=450  \\$aDrug Benefit Plans
=450  \\$aDrug Insurance
=450  \\$wnnna$aInsurance, Drug
=450  \\$wnnna$aInsurance, Pharmaceutic Services
=450  \\$wnnna$aInsurance, Pharmacy Services
=450  \\$wnnna$aInsurance, Prescription
=450  \\$wnnna$aPharmaceutic Services Insurance
=450  \\$wnnna$aPharmaceutical Services Insurance
=450  \\$wnnna$aPharmacy Services Insurance
=450  \\$wnnna$aPlan, Drug Benefit
=450  \\$wnnna$aPlans, Drug Benefit
=450  \\$aPrescription Insurance
=550  \\$wg$aInsurance, Health
=550  \\$wh$aMedicare Part D
=550  \\$aPharmacy Administration
=667  \\$aspecify geog if possible; DF: INSURANCE PHARM SERV
=680  \\$iInsurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
=688  \\$a68
=750  \0$aPharmaceutical services insurance$5IEN$0(DLC)sh 85067012

=LDR  01589cz  a2200373n  4500
=001  9880363768802441
=005  20141212202535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007354
=035  \\$aCBA0550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x533
=150  \\$aInsurance, Major Medical
=450  \\$aCatastrophic Health Insurance
=450  \\$wnnna$aCatastrophic Health Insurances
=450  \\$aComprehensive Health Insurance
=450  \\$wnnna$aComprehensive Health Insurances
=450  \\$wnnna$aHealth Insurance, Catastrophic
=450  \\$wnnna$aHealth Insurance, Comprehensive
=450  \\$wnnna$aHealth Insurances, Catastrophic
=450  \\$wnnna$aHealth Insurances, Comprehensive
=450  \\$wnnna$aInsurance, Catastrophic Health
=450  \\$wnnna$aInsurance, Comprehensive Health
=450  \\$aInsurance, Health, Catastrophic
=450  \\$wnnna$aInsurances, Catastrophic Health
=450  \\$wnnna$aInsurances, Comprehensive Health
=450  \\$wnnna$aMajor Medical Insurance
=450  \\$wnnna$aMedical Insurance, Major
=550  \\$wg$aInsurance, Health
=550  \\$aCatastrophic Illness
=667  \\$aspecify geog if possible; DF: INSURANCE MAJOR MED
=680  \\$iInsurance providing a broad range of medical services and supplies, when prescribed by a physician, whether or not the patient is hospitalized. It frequently is an extension of a basic policy and benefits will not begin until the basic policy is exhausted.
=688  \\$a68
=750  \0$aCatastrophic health insurance$5IEN$0(DLC)sh 88004138

=LDR  01203cz  a2200325n  4500
=001  9880363768902441
=005  20141212202508.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007262
=035  \\$aCBA0456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x82.$x500
=072  \\$aE2.$x319.$x267.$x510.$x590
=150  \\$aInfusions, Intravenous
=450  \\$wnnna$aDrip Infusion
=450  \\$aDrip Infusions
=450  \\$wnnna$aDrip, Intravenous
=450  \\$wnnna$aInfusion, Drip
=450  \\$wnnna$aInfusion, Intravenous
=450  \\$wnnna$aInfusions, Drip
=450  \\$aIntravenous Drip
=450  \\$wnnna$aIntravenous Infusion
=450  \\$aIntravenous Infusions
=550  \\$wg$aAdministration, Intravenous
=550  \\$wg$aInfusions, Parenteral
=550  \\$aPhlebotomy
=667  \\$aNIM; do not use /util except by MeSH definition; do not confuse with INJECTIONS, INTRAVENOUS
=680  \\$iThe long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.
=688  \\$a87; was see INFUSIONS, PARENTERAL 1975-86
=750  \0$aIntravenous therapy$5IEN$0(DLC)sh 85067634

=LDR  01987cz  a2200493n  4500
=001  9880363769002441
=005  20141212202507.0
=008  860604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007260
=035  \\$aCBA0454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x505
=072  \\$aE7.$x858.$x82.$x505
=150  \\$aInfusion Pumps
=450  \\$wnnna$aDrug Infusion System
=450  \\$aDrug Infusion Systems
=450  \\$wnnna$aExternal Infusion Pump
=450  \\$wnnna$aExternal Infusion Pumps
=450  \\$wnnna$aInfusion Pump
=450  \\$wnnna$aInfusion Pump, External
=450  \\$aInfusion Pumps, External
=450  \\$wnnna$aInfusion System, Drug
=450  \\$wnnna$aInfusion Systems, Drug
=450  \\$wnnna$aInfusor
=450  \\$aInfusors
=450  \\$aIntravenous Drug Delivery Systems
=450  \\$wnnna$aPerfusion Pump
=450  \\$aPerfusion Pumps
=450  \\$wnnna$aPump, External Infusion
=450  \\$wnnna$aPump, Infusion
=450  \\$wnnna$aPump, Perfusion
=450  \\$wnnna$aPumps, External Infusion
=450  \\$aPumps, Infusion
=450  \\$wnnna$aPumps, Perfusion
=450  \\$wnnna$aSystem, Drug Infusion
=450  \\$wnnna$aSystems, Drug Infusion
=550  \\$wg$aArtificial Organs
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aInfusion Pumps, Implantable
=550  \\$wh$aInsulin Infusion Systems
=667  \\$a/psychol permitted; coord IM with drug /admin (IM); INFUSION PUMPS, IMPLANTABLE is also available
=680  \\$iFluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders.
=688  \\$a87
=750  \0$aDrug infusion pumps$5IEN$0(DLC)sh 87004794

=LDR  01412cz  a2200349n  4500
=001  9880363769102441
=005  20141212202506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007259
=035  \\$aCBA0452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650.$x552
=072  \\$aG1.$x590.$x540.$x552
=072  \\$aG1.$x750.$x250.$x650.$x552
=072  \\$aG1.$x750.$x770.$x578.$x552
=072  \\$aG16.$x500.$x275.$x63.$x725.$x525.$x400
=072  \\$aG16.$x500.$x750.$x775.$x525.$x400
=072  \\$aN6.$x230.$x300.$x100.$x725.$x525.$x400
=150  \\$aInfrared Rays
=450  \\$wnnna$aHeat Wave
=450  \\$aHeat Waves
=450  \\$aInfrared Radiation$5IEN
=450  \\$wnnna$aInfrared Ray
=450  \\$wnnna$aRay, Infrared
=450  \\$wnnna$aRays, Infrared
=450  \\$wnnna$aWave, Heat
=450  \\$wnnna$aWaves, Heat
=550  \\$wg$aLight
=550  \\$wg$aSunlight
=667  \\$anon-ionizing; radiation policy: Manual 28.11+; black light goes here or under ULTRAVIOLET RAYS depending on text but unspecified index under ULTRAVIOLET RAYS
=680  \\$iThat portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants.
=750  \0$aInfrared radiation$0(DLC) sh 85066322$5IEN

=LDR  01146cz  a2200313n  4500
=001  9880363769202441
=005  20141212202506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007258
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x650.$x718
=072  \\$aI1.$x880.$x604.$x583.$x427
=072  \\$aN3.$x706.$x437.$x650.$x312
=072  \\$aN3.$x706.$x535.$x489
=150  \\$aInformed Consent
=450  \\$wnnna$aConsent, Informed
=550  \\$wg$aJurisprudence
=550  \\$wg$aPatient Rights
=550  \\$wh$aConsent Forms
=550  \\$wh$aInformed Consent By Minors
=550  \\$wh$aThird-Party Consent
=550  \\$aDisclosure
=550  \\$aMental Competency
=550  \\$aTherapeutic Misconception
=550  \\$aTreatment Refusal
=667  \\$acompetency to consent: coordinate IM with MENTAL COMPETENCY (IM)
=680  \\$iVoluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment.
=688  \\$a73(71)
=750  \0$aInformed consent (Medical law)$5IEN$0(DLC)sh 85066306

=LDR  00903cz  a2200217n  4500
=001  9880363769302441
=005  20141212202505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007257
=035  \\$aCBA0450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x488
=150  \\$aInformation Theory
=450  \\$wnnna$aInformation Theories
=450  \\$wnnna$aTheories, Information
=450  \\$wnnna$aTheory, Information
=550  \\$wg$aInformation Science
=550  \\$aOperations Research
=680  \\$iAn interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content. It overlaps considerably with communication theory and CYBERNETICS.
=688  \\$a65(64)
=750  \0$aInformation theory$5IEN$0(DLC)sh 85066289

=LDR  02374cz  a2200577n  4500
=001  9880363769402441
=005  20141212202505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007256
=035  \\$aCBA0449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300
=150  \\$aInformation Systems
=450  \\$wnnna$aAncillary Information System
=450  \\$aAncillary Information Systems
=450  \\$wnnna$aData System
=450  \\$aData Systems
=450  \\$aEmergency Care Information Systems
=450  \\$wnnna$aInformation Retrieval System
=450  \\$aInformation Retrieval Systems
=450  \\$wnnna$aInformation System
=450  \\$wnnna$aInformation System, Ancillary
=450  \\$wnnna$aInformation Systems, Ancillary
=450  \\$wnnna$aSystem, Ancillary Information
=450  \\$wnnna$aSystem, Data
=450  \\$wnnna$aSystem, Information
=450  \\$wnnna$aSystem, Information Retrieval
=450  \\$wnnna$aSystems, Ancillary Information
=450  \\$wnnna$aSystems, Data
=450  \\$wnnna$aSystems, Information
=450  \\$wnnna$aSystems, Information Retrieval
=550  \\$wg$aMedical Informatics Applications
=550  \\$wh$aClinical Laboratory Information Systems
=550  \\$wh$aCommunity Networks
=550  \\$wh$aDatabases as Topic
=550  \\$wh$aDecision Support Systems, Clinical
=550  \\$wh$aGeographic Information Systems
=550  \\$wh$aHealth Information Systems
=550  \\$wh$aHospital Information Systems
=550  \\$wh$aIntegrated Advanced Information Management Systems
=550  \\$wh$aKnowledge Bases
=550  \\$wh$aManagement Information Systems
=550  \\$wh$aMedical Records Systems, Computerized
=550  \\$wh$aMEDLARS
=550  \\$wh$aOnline Systems
=550  \\$wh$aRadiology Information Systems
=550  \\$wh$aReminder Systems
=667  \\$afor automated systems do not coord with AUTOMATIC DATA PROCESSING; for medical information systems do not coord with MEDICINE
=680  \\$iIntegrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information.
=688  \\$a82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91
=750  \0$aInformation storage and retrieval systems$5IEN$0(DLC)sh 85066163

=LDR  01515cz  a2200409n  4500
=001  9880363769502441
=005  20141212202504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007255
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453
=150  \\$aInformation Services
=450  \\$wnnna$aInformation Network
=450  \\$wnnna$aInformation Networks
=450  \\$wnnna$aInformation Service
=450  \\$wnnna$aInformation Specialist
=450  \\$wnnna$aInformation Specialists
=450  \\$wnnna$aNetwork, Information
=450  \\$wnnna$aNetworks, Information
=450  \\$wnnna$aService, Information
=450  \\$wnnna$aServices, Information
=450  \\$wnnna$aSpecialist, Information
=450  \\$wnnna$aSpecialists, Information
=550  \\$wg$aInformation Science
=550  \\$wh$aBibliography as Topic
=550  \\$wh$aBook Selection
=550  \\$wh$aDocumentation
=550  \\$wh$aDrug Information Services
=550  \\$wh$aHuman Genome Project
=550  \\$wh$aLibrary Services
=550  \\$wh$aLibrary Technical Services
=550  \\$aInformation Dissemination
=550  \\$aResearch
=667  \\$amed inform serv: do not coord with MEDICINE; DRUG INFORMATION SERVICES is available; DF: INFORMATION SERV
=680  \\$iOrganized services to provide information on any questions an individual might have using databases and other sources. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a66
=750  \0$aInformation services$5IEN-HS$0(DLC)sh 85066157

=LDR  01855cz  a2200517n  4500
=001  9880363769602441
=005  20200517150757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007254
=035  \\$aCBA0447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1
=150  \\$aInformation Science
=450  \\$wnnna$aInformation Sciences
=450  \\$wnnna$aScience, Information
=450  \\$wnnna$aSciences, Information
=550  \\$wh$aBook Collecting
=550  \\$wh$aCalendars as Topic
=550  \\$wh$aChronology as Topic
=550  \\$wh$aClassification
=550  \\$wh$aCommunication
=550  \\$wh$aCommunications Media
=550  \\$wh$aComputer Security
=550  \\$wh$aComputing Methodologies
=550  \\$wh$aCopying Processes
=550  \\$wh$aData Collection
=550  \\$wh$aData Display
=550  \\$wh$aInformatics
=550  \\$wh$aInformation Centers
=550  \\$wh$aInformation Management
=550  \\$wh$aInformation Services
=550  \\$wh$aInformation Storage and Retrieval
=550  \\$wh$aInformation Technology
=550  \\$wh$aInformation Theory
=550  \\$wh$aKnowledge
=550  \\$wh$aLibrary Science
=550  \\$wh$aMedical Informatics
=550  \\$wh$aMetadata
=550  \\$wh$aPattern Recognition, Automated
=550  \\$wh$aPostcards as Topic
=550  \\$wh$aPublishing
=550  \\$wh$aSystems Analysis
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe field of knowledge, theory, and technology dealing with the collection of facts and figures, and the processes and methods involved in their manipulation, storage, dissemination, publication, and retrieval. It includes the fields of COMMUNICATION; PUBLISHING; LIBRARY SCIENCE; and informatics.
=688  \\$a93; was INFORMATION SCIENCE (NON MESH) 1974-92
=750  \0$aInformation science$5IEN-M$0(DLC)sh 85066150

=LDR  01790cz  a2200373n  4500
=001  9880363769702441
=005  20141212202503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007252
=035  \\$aCBA0445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x302
=150  \\$aInfluenza Vaccines
=450  \\$wnnna$aCAIV-T vaccine
=450  \\$wnnna$aFlu Vaccines
=450  \\$wnnna$aFluMist
=450  \\$wnnna$aInfluenza Vaccine
=450  \\$wnnna$aInfluenza Virus Vaccines
=450  \\$wnnna$aInfluenzavirus Vaccines
=450  \\$wnnna$aLAIV vaccine
=450  \\$wnnna$aMedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine
=450  \\$wnnna$aTrivalent Live Attenuated Influenza Vaccine
=450  \\$wnnna$aVaccine, Influenza
=450  \\$wnnna$avaccine, LAIV
=450  \\$wnnna$aVaccines, Flu
=450  \\$wnnna$aVaccines, Influenza
=450  \\$wnnna$aVaccines, Influenza Virus
=450  \\$wnnna$aVaccines, Influenzavirus
=450  \\$wnnna$aVirus Vaccines, Influenza
=550  \\$wg$aViral Vaccines
=667  \\$acoordinate IM with specific influenza virus or virus subtype /immunol (IM); SCR records for several specific influenza vaccines are also available; not for Haemophilus influenzae vaccines ( = HAEMOPHILUS VACCINES)
=680  \\$iVaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.
=688  \\$a2005 (1963)
=750  \0$aInfluenza vaccines$0(DLC) sh 85066132$5IEN

=LDR  01358cz  a2200361n  4500
=001  9880363769802441
=005  20141212202502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007251
=035  \\$aCBA0444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x620.$x365
=072  \\$aC8.$x730.$x310
=150  \\$aInfluenza, Human
=450  \\$wnnna$aFlu, Human
=450  \\$aGrippe
=450  \\$aHuman Flu
=450  \\$aHuman Influenza
=450  \\$wnnna$aHuman Influenzas
=450  \\$wnnna$aInfluenza
=450  \\$wnnna$aInfluenza in Human
=450  \\$aInfluenza in Humans
=450  \\$wnnna$aInfluenzas
=450  \\$wnnna$aInfluenzas, Human
=550  \\$wg$aOrthomyxoviridae Infections
=550  \\$wg$aRespiratory Tract Infections
=550  \\$aInfluenza Pandemic, 1918-1919
=667  \\$acoordinate IM with specific influenza virus (IM) if pertinent; note specific subtypes of INFLUENZA A VIRUS are available
=680  \\$iAn acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Influenza
=688  \\$aINFLUENZA, ASIAN was heading 1963-80
=750  \0$aInfluenza$0(DLC) sh 85066127$5IEN

=LDR  00856cz  a2200241n  4500
=001  9880363769902441
=005  20141212210918.0
=008  880504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015212
=035  \\$aCBA0442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x731
=072  \\$aC6.$x405.$x469.$x432
=150  \\$aInflammatory Bowel Diseases
=450  \\$wnnna$aBowel Diseases, Inflammatory
=450  \\$wnnna$aInflammatory Bowel Disease
=550  \\$wg$aGastroenteritis
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aColitis, Ulcerative
=550  \\$wh$aCrohn Disease
=680  \\$iChronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
=688  \\$a89
=750  \0$aInflammatory bowel diseases$5IEN$0(DLC)sh 90000009

=LDR  01271cz  a2200265n  4500
=001  9880363770002441
=005  20141212202502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007249
=035  \\$aCBA0441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x470
=150  \\$aInflammation
=450  \\$wnnna$aInflammations
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAcute-Phase Reaction
=550  \\$wh$aForeign-Body Reaction
=550  \\$wh$aNeurogenic Inflammation
=550  \\$wh$aSeroma
=550  \\$wh$aSerositis
=550  \\$wh$aSuppuration
=550  \\$wh$aSystemic Inflammatory Response Syndrome
=667  \\$aIM general inflammatory process; look for specific inflamm dis in MeSH as -ITIS; NIM as coord for organ /dis not in MeSH as -ITIS; /drug ther: consider also ANTI-INFLAMMATORY AGENTS & its specifics; ACUTE PHASE REACTION (an early local inflammatory reaction to inj: see MeSH definition) is available; Manual 23.13+; DF: INFLAMM
=680  \\$iA pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
=750  \0$aInflammation$5IEN$0(DLC)sh 85066108

=LDR  01254cz  a2200361n  4500
=001  9880363770102441
=005  20190128110116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007248
=035  \\$aCBA0440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x365.$x700
=150  \\$aInfertility, Male
=450  \\$wnnna$aMale Infertility
=450  \\$wnnna$aMale Sterility
=450  \\$wnnna$aMale Sub-Fertility
=450  \\$wnnna$aMale Subfertility
=450  \\$aSterility, Male
=450  \\$wnnna$aSub-Fertility, Male
=450  \\$wnnna$aSub Fertility, Male
=450  \\$wnnna$aSubfertility, Male
=550  \\$wg$aInfertility
=550  \\$wh$aAspermia
=550  \\$wh$aAsthenozoospermia
=550  \\$wh$aAzoospermia
=550  \\$wh$aOligospermia
=550  \\$wh$aSertoli Cell-Only Syndrome
=550  \\$wh$aTeratozoospermia
=550  \\$aSperm Injections, Intracytoplasmic
=667  \\$a/chem ind permitted but not for testing of contraceptives
=680  \\$iThe inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility.
=688  \\$a83; was STERILITY, MALE 1963-82
=750  \0$aInfertility, Male$0(DLC) sh 85066092$5IEN

=LDR  01016cz  a2200301n  4500
=001  9880363770202441
=005  20141212202501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007247
=035  \\$aCBA0439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x365.$x700
=150  \\$aInfertility, Female
=450  \\$wnnna$aFemale Infertility
=450  \\$wnnna$aFemale Sterility
=450  \\$wnnna$aFemale Sub-Fertility
=450  \\$wnnna$aFemale Subfertility
=450  \\$wnnna$aPostpartum Sterility
=450  \\$aSterility, Female
=450  \\$wnnna$aSterility, Postpartum
=450  \\$wnnna$aSub-Fertility, Female
=450  \\$wnnna$aSub Fertility, Female
=450  \\$wnnna$aSubfertility, Female
=550  \\$wg$aInfertility
=667  \\$a/chem ind permitted but not for testing of contraceptives
=680  \\$iDiminished or absent ability of a female to achieve conception.
=688  \\$a83; was STERILITY, FEMALE 1963-82
=750  \0$aInfertility, Female$5IEN$0(DLC)sh 85066091

=LDR  01044cz  a2200301n  4500
=001  9880363770302441
=005  20141212202500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007246
=035  \\$aCBA0438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x365
=072  \\$aC13.$x351.$x500.$x365
=150  \\$aInfertility
=450  \\$wnnna$aReproductive Sterility
=450  \\$aSterility
=450  \\$wnnna$aSterility, Reproductive
=450  \\$wnnna$aSub-Fertility
=450  \\$wnnna$aSubfertility
=550  \\$wg$aGenital Diseases, Female
=550  \\$wg$aGenital Diseases, Male
=550  \\$wh$aInfertility, Female
=550  \\$wh$aInfertility, Male
=550  \\$aFertility
=667  \\$ageneral or unspecified as male or female; prefer the specifics; PLANT INFERTILITY is available
=680  \\$iInability to reproduce after a specified period of unprotected intercourse. Reproductive sterility is permanent infertility.
=688  \\$a83; was STERILITY 1963-82
=750  \0$aInfertility$5IEN$0(DLC)sh 85066087

=LDR  01279cz  a2200361n  4500
=001  9880363770402441
=005  20141212192249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007245
=035  \\$aCBA0437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x800.$x407
=072  \\$aA8.$x186.$x211.$x653.$x727.$x249
=150  \\$aInferior Colliculi
=450  \\$wnnna$aBrachial Nucleus of the Inferior Colliculus
=450  \\$wnnna$aCaudal Colliculus
=450  \\$wnnna$aColliculi, Inferior
=450  \\$wnnna$aColliculus, Caudal
=450  \\$wnnna$aColliculus Inferior
=450  \\$aColliculus, Inferior
=450  \\$wnnna$aColliculus Inferiors
=450  \\$wnnna$aColliculus, Posterior
=450  \\$wnnna$aInferior Colliculus
=450  \\$wnnna$aInferior, Colliculus
=450  \\$wnnna$aInferiors, Colliculus
=450  \\$wnnna$aPosterior Colliculus
=550  \\$wg$aTectum Mesencephali
=680  \\$iThe posterior pair of the quadrigeminal bodies which contain centers for auditory function.
=688  \\$a2008; use INFERIOR COLLICULUS 1971-2007
=688  \\$a2008 (1971)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Inferior Colliculus
=688  \\$a71
=750  \0$aInferior colliculus$0(DLC) sh 85066084$5IEN

=LDR  01127cz  a2200265n  4500
=001  9880363770502441
=005  20141212202500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007244
=035  \\$aCBA0436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x313.$x400
=072  \\$aC15.$x378.$x553.$x381
=072  \\$aC15.$x604.$x515.$x516
=072  \\$aC20.$x683.$x515.$x515
=150  \\$aInfectious Mononucleosis
=450  \\$wnnna$aFever, Glandular
=450  \\$aGlandular Fever
=450  \\$wnnna$aMononucleosis, Infectious
=550  \\$wg$aEpstein-Barr Virus Infections
=550  \\$wg$aLeukocyte Disorders
=550  \\$wg$aLymphoproliferative Disorders
=667  \\$aif not caused by Epstein-Barr Virus (HERPESVIRUS 4, HUMAN) coord IM with specific infection (IM)
=680  \\$iA common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.
=750  \0$aMononucleosis$5IEN$0(DLC)sh 85086955

=LDR  01082cz  a2200265n  4500
=001  9880363770602441
=005  20141212202459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007241
=035  \\$aCBA0433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x488
=072  \\$aC22.$x196.$x429
=150  \\$aInfectious Bovine Rhinotracheitis
=450  \\$wnnna$aBovine Rhinotracheitides, Infectious
=450  \\$wnnna$aBovine Rhinotracheitis, Infectious
=450  \\$wnnna$aInfectious Bovine Rhinotracheitides
=450  \\$wnnna$aRhinotracheitides, Infectious Bovine
=450  \\$wnnna$aRhinotracheitis, Infectious Bovine
=550  \\$wg$aCattle Diseases
=550  \\$wg$aHerpesviridae Infections
=667  \\$acheck the tags ANIMALS and CATTLE; DF: INFECT BOVINE RHINOTRACHEITIS
=680  \\$iA herpesvirus infection of CATTLE characterized by INFLAMMATION and NECROSIS of the mucous membranes of the upper RESPIRATORY TRACT.
=688  \\$a78(73); was see under CATTLE DISEASES 1975-77
=750  \0$aInfectious bovine rhinotracheitis$5IEN$0(DLC)sh 85066080

=LDR  01009cz  a2200265n  4500
=001  9880363770802441
=005  20141212202457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007238
=035  \\$aCBA0430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x513.$x355
=072  \\$aC23.$x550.$x717.$x489
=150  \\$aInfarction
=450  \\$wnnna$aInfarctions
=550  \\$wg$aIschemia
=550  \\$wg$aNecrosis
=550  \\$aBrain Infarction
=550  \\$aBrain Stem Infarctions
=550  \\$aInfarction, Anterior Cerebral Artery
=550  \\$aInfarction, Middle Cerebral Artery
=550  \\$aInfarction, Posterior Cerebral Artery
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with organ /blood supply (IM): Manual 23.14.2; DF: INFARCT
=680  \\$iFormation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.
=750  \0$aInfarction$5IEN$0(DLC)sh 85066075

=LDR  00713cz  a2200193n  4500
=001  9880363770902441
=005  20141212202457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007237
=035  \\$aCBA0429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x470.$x572
=150  \\$aInfanticide
=450  \\$wnnna$aInfanticides
=550  \\$wg$aHomicide
=550  \\$aDeath
=667  \\$arestrict to humans: do not use for the killing of young of other primates or other animals in scientific exper; do not use for killing of newborn or young animals by their parents ( = BEHAVIOR, ANIMAL)
=680  \\$iThe killing of infants at birth or soon after.
=750  \0$aInfanticide$5IEN$0(DLC)sh 85066012

=LDR  00666cz  a2200205n  4500
=001  9880363771002441
=005  20141212202457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007235
=035  \\$aCBA0427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x521
=150  \\$aInfant, Premature, Diseases
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wh$aBronchopulmonary Dysplasia
=550  \\$wh$aLeukomalacia, Periventricular
=550  \\$wh$aRespiratory Distress Syndrome, Newborn
=550  \\$wh$aRetinopathy of Prematurity
=667  \\$aadd INFANT, PREMATURE: Manual 23.21.4
=750  \0$aPremature infants$xDiseases$5IEN$0(DLC)sh 85066066

=LDR  00992cz  a2200313n  4500
=001  9880363771102441
=005  20141212202456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007234
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x703.$x520.$x520
=150  \\$aInfant, Premature
=450  \\$wnnna$aInfant, Preterm
=450  \\$wnnna$aInfants, Premature
=450  \\$wnnna$aInfants, Preterm
=450  \\$wnnna$aNeonatal Prematurity
=450  \\$wnnna$aPremature Infant
=450  \\$wnnna$aPremature Infants
=450  \\$wnnna$aPrematurity, Neonatal
=450  \\$wnnna$aPreterm Infant
=450  \\$wnnna$aPreterm Infants
=550  \\$wg$aInfant, Newborn
=550  \\$wh$aInfant, Extremely Premature
=550  \\$aGestational Age
=550  \\$aObstetric Labor, Premature
=550  \\$aPremature Birth
=667  \\$acheck the tag INFANT, NEWBORN
=680  \\$iA human infant born before 37 weeks of GESTATION.
=750  \0$aPremature infants$5IEN$0(DLC)sh 85066065

=LDR  02346cz  a2200529n  4500
=001  9880363771202441
=005  20141212202456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007232
=035  \\$aCBA0424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614
=150  \\$aInfant, Newborn, Diseases
=550  \\$wg$aCongenital, Hereditary, and Neonatal Diseases and Abnormalities
=550  \\$wh$aAmniotic Band Syndrome
=550  \\$wh$aAnemia, Neonatal
=550  \\$wh$aAsphyxia Neonatorum
=550  \\$wh$aBirth Injuries
=550  \\$wh$aCongenital Hyperinsulinism
=550  \\$wh$aCystic Fibrosis
=550  \\$wh$aEpilepsy, Benign Neonatal
=550  \\$wh$aErythroblastosis, Fetal
=550  \\$wh$aHernia, Umbilical
=550  \\$wh$aHydrophthalmos
=550  \\$wh$aHyperbilirubinemia, Neonatal
=550  \\$wh$aHyperostosis, Cortical, Congenital
=550  \\$wh$aIchthyosis
=550  \\$wh$aInfant, Premature, Diseases
=550  \\$wh$aMeconium Aspiration Syndrome
=550  \\$wh$aMobius Syndrome
=550  \\$wh$aNeonatal Abstinence Syndrome
=550  \\$wh$aNystagmus, Congenital
=550  \\$wh$aOphthalmia Neonatorum
=550  \\$wh$aPersistent Fetal Circulation Syndrome
=550  \\$wh$aRothmund-Thomson Syndrome
=550  \\$wh$aSclerema Neonatorum
=550  \\$wh$aSevere Combined Immunodeficiency
=550  \\$wh$aSyphilis, Congenital
=550  \\$wh$aThanatophoric Dysplasia
=550  \\$wh$aThrombocytopenia, Neonatal Alloimmune
=550  \\$wh$aToxoplasmosis, Congenital
=550  \\$wh$aVitamin K Deficiency Bleeding
=550  \\$wh$aWolman Disease
=550  \\$aPerinatology
=667  \\$aIM GEN only; for specific dis in newborn inf use specific dis (IM) + check tag INFANT, NEWBORN; do not use /compl /congen; check the tag INFANT, NEWBORN: Manual 18.5.10; relation to /congen: Manual 19.8.18, 23.21+; TN 109: relation to other Cat C16 terms
=680  \\$iDiseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
=750  \0$aNewborn infants$xDiseases$5IEN$0(DLC)sh 85066052

=LDR  00917cz  a2200289n  4500
=001  9880363771302441
=005  20141212192248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007231
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x703.$x520
=150  \\$aInfant, Newborn
=450  \\$wnnna$aInfants, Newborn
=450  \\$aNeonate
=450  \\$wnnna$aNeonates
=450  \\$wnnna$aNewborn
=450  \\$wnnna$aNewborn Infant
=450  \\$wnnna$aNewborn Infants
=450  \\$wnnna$aNewborns
=550  \\$wg$aInfant
=550  \\$wh$aInfant, Low Birth Weight
=550  \\$wh$aInfant, Postmature
=550  \\$wh$aInfant, Premature
=550  \\$aNeonatology
=667  \\$ausually check tag: NIM no qualifiers; IM when a healthy neonate is the point of the article; see Manual Chapter 9
=680  \\$iAn infant during the first month after birth.
=750  \0$aNewborn infants$5IEN$0(DLC)sh 85066048

=LDR  01300cz  a2200313n  4500
=001  9880363771402441
=005  20141212202455.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007230
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x703.$x520.$x460
=150  \\$aInfant, Low Birth Weight
=450  \\$wnnna$aBirth Weight, Low
=450  \\$wnnna$aBirth Weights, Low
=450  \\$wnnna$aInfant, Low-Birth-Weight
=450  \\$wnnna$aInfants, Low-Birth-Weight
=450  \\$wnnna$aLow Birth Weight
=450  \\$wnnna$aLow-Birth-Weight Infant
=450  \\$wnnna$aLow Birth Weight Infant
=450  \\$wnnna$aLow-Birth-Weight Infants
=450  \\$wnnna$aLow Birth Weights
=550  \\$wg$aInfant, Newborn
=550  \\$wh$aInfant, Small for Gestational Age
=550  \\$wh$aInfant, Very Low Birth Weight
=550  \\$aBirth Weight
=667  \\$aborn weighing 2500 gms (5.5 lbs) or less; qualif permitted as for INFANT, NEWBORN; check tag INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT is also available; DF: INFANT LBW
=680  \\$iAn infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.
=688  \\$a77
=750  \0$aBirth weight, Low$5IEN$0(DLC)sh 85014390

=LDR  00741cz  a2200217n  4500
=001  9880363771502441
=005  20141212202455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007229
=035  \\$aCBA0421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x539
=150  \\$aInfant Welfare
=450  \\$wnnna$aHealth, Infant
=450  \\$aInfant Health
=450  \\$wnnna$aWelfare, Infant
=550  \\$wg$aSocial Welfare
=667  \\$aspecify geog if pertinent; check the tag INFANT
=680  \\$iOrganized efforts by communities or organizations to improve the health and well-being of the infant.
=688  \\$a91(75); was see under CHILD WELFARE 1975-90
=750  \0$aMaternal and infant welfare$5IEN$0(DLC)sh 85082098

=LDR  01198cz  a2200325n  4500
=001  9880363771602441
=005  20141212202454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007228
=035  \\$aCBA0420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x422
=150  \\$aInfant Nutrition Disorders
=450  \\$aInfant Malnutrition
=450  \\$wnnna$aInfant Nutrition Disorder
=450  \\$wnnna$aInfant Overnutrition
=450  \\$wnnna$aInfantile Malnutrition
=450  \\$wnnna$aMalnutrition in Infant
=450  \\$wnnna$aMalnutrition in Infants
=450  \\$aMalnutrition, Infant
=450  \\$wnnna$aMalnutrition, Infantile
=450  \\$wnnna$aNutrition Disorder, Infant
=450  \\$aNutrition Disorders, Infant
=450  \\$wnnna$aOvernutrition, Infant
=550  \\$wg$aNutrition Disorders
=550  \\$wh$aVitamin K Deficiency Bleeding
=550  \\$aChild Nutrition Disorders
=667  \\$aGEN only; prefer specific dis with infant check tag
=680  \\$iDisorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in infants ages 1 month to 24 months.
=750  \0$aNutrition disorders in infants$5IEN$0(DLC)sh 85093471

=LDR  01664cz  a2200445n  4500
=001  9880363771702441
=005  20141212202454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007227
=035  \\$aCBA0419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x220.$x500
=150  \\$aInfant Nutritional Physiological Phenomena
=450  \\$wnnna$aComplementary Feeding
=450  \\$wnnna$aComplementary Feedings
=450  \\$wnnna$aFeeding, Complementary
=450  \\$wnnna$aFeeding, Supplementary
=450  \\$wnnna$aFeedings, Complementary
=450  \\$wnnna$aFeedings, Supplementary
=450  \\$wnno$aInfant Nutrition$5IEN-M
=450  \\$aInfant Nutrition Physiology
=450  \\$wnnna$aInfant Nutritional Physiological Phenomenon
=450  \\$wnnna$aInfant Nutritional Physiology
=450  \\$aNutrition Physiology, Infant
=450  \\$wnnna$aNutritional Physiology, Infant
=450  \\$wnnna$aPhysiology, Infant Nutrition
=450  \\$wnnna$aPhysiology, Infant Nutritional
=450  \\$wnnna$aSupplementary Feeding
=450  \\$wnnna$aSupplementary Feedings
=550  \\$wg$aChild Nutritional Physiological Phenomena
=550  \\$wh$aBreast Feeding
=550  \\$wh$aWeaning
=550  \\$aChild Nutritional Physiological Phenomena
=667  \\$acheck the tag INFANT
=680  \\$iNutritional physiology of children from birth to 2 years of age.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Infant Nutrition Physiology
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Infant Nutrition
=750  \0$aInfants$xNutrition$0(DLC) sh 85066038$5IEN

=LDR  01674cz  a2200373n  4500
=001  9880363771802441
=005  20141212192248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007226
=035  \\$aCBA0418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x475
=072  \\$aL1.$x280.$x975.$x550.$x475
=072  \\$aN1.$x224.$x935.$x698.$x489
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x475
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x475
=150  \\$aInfant Mortality
=450  \\$wnnna$aInfant Mortalities
=450  \\$wnnna$aMortalities, Infant
=450  \\$wnnna$aMortalities, Neonatal
=450  \\$wnnna$aMortalities, Postneonatal
=450  \\$wnnna$aMortality, Infant
=450  \\$wnnna$aMortality, Neonatal
=450  \\$wnnna$aMortality, Postneonatal
=450  \\$wnnna$aNeonatal Mortalities
=450  \\$aNeonatal Mortality
=450  \\$wnnna$aPostneonatal Mortalities
=450  \\$wnnna$aPostneonatal Mortality
=550  \\$wg$aMortality
=550  \\$aInfant Death
=550  \\$aPerinatal Mortality
=667  \\$aa statistical concept & not a substitute for / mortal with INFANT, NEWBORN, DISEASES or with specific diseases in infants; do not confuse with INFANT DEATH;  add geographic term if pertinent; PERINATAL MORTALITY is also available
=680  \\$iPostnatal deaths from BIRTH to 365 days after birth in a given population. Postneonatal mortality represents deaths between 28 days and 365 days after birth (as defined by National Center for Health Statistics). Neonatal mortality represents deaths from birth to 27 days after birth.
=750  \0$aInfants$xMortality$5IEN$0(DLC)sh 85066037

=LDR  00743cz  a2200241n  4500
=001  9880363771902441
=005  20141212202453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007225
=035  \\$aCBA0417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x525.$x500
=150  \\$aInfant Food
=450  \\$aBaby Foods$5IEN
=450  \\$aFood, Infant
=450  \\$wnnna$aFoods, Infant
=450  \\$wnnna$aInfant Foods
=550  \\$wg$aFoods, Specialized
=550  \\$wh$aInfant Formula
=550  \\$aInfant Formula
=680  \\$iFood processed and manufactured for the nutritional health of children in their first year of life.
=688  \\$a73; was INFANT FOODS 1970-72 (Prov)
=750  \0$aBaby foods$5IEN$0(DLC)sh 85010753

=LDR  00764cz  a2200241n  4500
=001  9880363772002441
=005  20141212202453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007224
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x88.$x120
=150  \\$aInfant Care
=550  \\$wg$aChild Care
=550  \\$wh$aFacilitated Tucking
=550  \\$wh$aIntensive Care, Neonatal
=550  \\$wh$aKangaroo-Mother Care Method
=550  \\$wh$aPerinatal Care
=550  \\$wh$aRooming-in Care
=550  \\$aChild Care
=667  \\$ahumans only; check the tags HUMAN and INFANT or INFANT, NEWBORN
=680  \\$iCare of infants in the home or institution.
=688  \\$aDIAPERS was see INFANT CARE 1989-91
=750  \0$aInfants$xCare$5IEN$0(DLC)sh 85066027

=LDR  00531cz  a2200181n  4500
=001  9880363772102441
=005  20141212192247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x703
=150  \\$aInfant
=450  \\$wnnna$aInfants
=550  \\$wg$aAge Groups
=550  \\$wh$aInfant, Newborn
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9
=680  \\$iA child between 1 and 23 months of age.
=750  \0$aInfants$5IEN$0(DLC)sh 85066022

=LDR  01178cz  a2200349n  4500
=001  9880363772202441
=005  20141212202453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007222
=035  \\$aCBA0413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC24.$x426
=072  \\$aC25.$x723.$x455.$x571
=150  \\$aInert Gas Narcosis
=450  \\$aDepth Intoxication
=450  \\$wnnna$aDepth Intoxications
=450  \\$wnnna$aInert Gas Narcoses
=450  \\$wnnna$aIntoxication, Depth
=450  \\$wnnna$aIntoxications, Depth
=450  \\$wnnna$aNarcoses, Inert Gas
=450  \\$wnnna$aNarcoses, Nitrogen
=450  \\$wnnna$aNarcosis, Inert Gas
=450  \\$wnnna$aNarcosis, Nitrogen
=450  \\$wnnna$aNitrogen Narcoses
=450  \\$aNitrogen Narcosis
=550  \\$wg$aGas Poisoning
=550  \\$wg$aOccupational Diseases
=550  \\$aDiving
=667  \\$aIM; specify gas (IM)
=680  \\$iProgressive mental disturbances and unconsciousness due to breathing mixtures of oxygen and inert gases (argon, helium, xenon, krypton, and atmospheric nitrogen) at high pressure.
=688  \\$a70(68)
=750  \0$aInert gas narcosis$5IEN$0(DLC)sh 85065986

=LDR  01279cz  a2200361n  4500
=001  9880363772302441
=005  20161116093512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576
=150  \\$aIndustry
=450  \\$wnnna$aIndustries
=450  \\$wnnna$aSector, Tertiary
=450  \\$wnnna$aSectors, Tertiary
=450  \\$wnnna$aTertiary Sector
=450  \\$wnnna$aTertiary Sectors
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aBarbering
=550  \\$wh$aBeauty Culture
=550  \\$wh$aFood Industry
=550  \\$wh$aForestry
=550  \\$wh$aHealth Care Sector
=550  \\$wh$aIndustrial Development
=550  \\$wh$aLaundering
=550  \\$wh$aManufacturing Industry
=550  \\$wh$aProduct Packaging
=550  \\$wh$aTanning
=550  \\$aCommerce
=550  \\$aEthics, Business
=680  \\$iAny enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries.
=688  \\$a73
=750  \0$aIndustries$5IEN-M$0(DLC)sh 85065960

=LDR  01475cz  a2200337n  4500
=001  9880363893002441
=005  20141212205930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013373
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x812.$x900.$x866
=072  \\$aD12.$x644.$x400.$x800.$x750
=072  \\$aD12.$x644.$x456.$x800.$x866
=072  \\$aD12.$x776.$x467.$x812.$x900.$x866
=072  \\$aD12.$x776.$x641.$x650.$x800.$x750
=072  \\$aD23.$x469.$x50.$x375.$x850.$x890
=072  \\$aD23.$x529.$x812.$x900.$x866
=150  \\$aSubstance P
=450  \\$wnnna$aEuler-Gaddum Substance P
=450  \\$wnnna$aEuler Gaddum Substance P
=450  \\$wnnna$aHypothalamic Substance P
=450  \\$wnnna$aP, Euler-Gaddum Substance
=450  \\$wnnna$aP, Hypothalamic Substance
=450  \\$wnnna$aP, Substance
=450  \\$wnnna$aSP(1-11)
=450  \\$wnnna$aSubstance P, Euler-Gaddum
=450  \\$wnnna$aSubstance P, Hypothalamic
=550  \\$wg$aTachykinins
=680  \\$iAn eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.
=688  \\$a73(65); was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92
=750  \0$aSubstance P$5IEN$0(DLC)sh 85129540

=LDR  01142cz  a2200289n  4500
=001  9880363893102441
=005  20141212205929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013369
=035  \\$aCBA6694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x463.$x600.$x500
=072  \\$aC1.$x539.$x830.$x25.$x20.$x810
=072  \\$aC6.$x844.$x640.$x500
=150  \\$aSubphrenic Abscess
=450  \\$aAbscess, Subdiaphragmatic
=450  \\$aAbscess, Subphrenic
=450  \\$wnnna$aAbscesses, Subdiaphragmatic
=450  \\$wnnna$aAbscesses, Subphrenic
=450  \\$aSubdiaphragmatic Abscess
=450  \\$wnnna$aSubdiaphragmatic Abscesses
=450  \\$wnnna$aSubphrenic Abscesses
=550  \\$wg$aAbdominal Abscess
=550  \\$wg$aPeritonitis
=667  \\$acoordinate IM with specific organism/infection term (IM) but not with BACTERIAL INFECTIONS for unspecified bacterial abscess
=680  \\$iAccumulation of purulent EXUDATES beneath the DIAPHRAGM, also known as upper abdominal abscess. It is usually associated with PERITONITIS or postoperative infections.
=750  \0$aSubphrenic abscess$5IEN$0(DLC)sh 85129523

=LDR  00737cz  a2200193n  4500
=001  9880363893202441
=005  20141212205928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013366
=035  \\$aCBA6691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x560.$x508
=150  \\$aSubmarine Medicine
=450  \\$wnnna$aMedicine, Submarine
=550  \\$wg$aNaval Medicine
=550  \\$aOceanography
=667  \\$aSPEC: SPEC qualif; for med & physiol aspects of activities of submarine personnel; Manual 28.8; DIVING is also available; DF: SUBMARINE MED
=680  \\$iThe field of medicine concerned with conditions affecting the health of people in submarines or sealabs.
=750  \0$aSubmarine medicine$5IEN$0(DLC)sh 85129496

=LDR  01099cz  a2200265n  4500
=001  9880363893302441
=005  20141212205928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013363
=035  \\$aCBA6688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x760.$x812
=072  \\$aA10.$x336.$x779.$x812
=072  \\$aA14.$x549.$x760.$x812
=150  \\$aSubmandibular Gland
=450  \\$wnnna$aGland, Submandibular
=450  \\$wnnna$aGland, Submaxillary
=450  \\$wnnna$aGlands, Submandibular
=450  \\$wnnna$aGlands, Submaxillary
=450  \\$wnnna$aSubmandibular Glands
=450  \\$aSubmaxillary Gland
=450  \\$wnnna$aSubmaxillary Glands
=550  \\$wg$aSalivary Glands
=680  \\$iOne of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed)
=750  \0$aSubmandibular gland$5IEN$0(DLC)sh 85129482

=LDR  00659cz  a2200217n  4500
=001  9880363893402441
=005  20141212205927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013361
=035  \\$aCBA6686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x760.$x687
=072  \\$aA10.$x336.$x779.$x687
=072  \\$aA14.$x549.$x760.$x687
=150  \\$aSublingual Gland
=450  \\$wnnna$aGland, Sublingual
=450  \\$wnnna$aGlands, Sublingual
=450  \\$wnnna$aSublingual Glands
=550  \\$wg$aSalivary Glands
=667  \\$adiseases: coord IM with SALIVARY GLAND DISEASES (NIM)
=750  \0$aSublingual gland$5IEN$0(DLC)sh 85129479

=LDR  00940cz  a2200265n  4500
=001  9880363893502441
=005  20141212205927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013360
=035  \\$aCBA6685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x710.$x750
=150  \\$aSubliminal Stimulation
=450  \\$wnnna$aPerception, Subliminal
=450  \\$wnnna$aPerceptions, Subliminal
=450  \\$wnnna$aStimulation, Subliminal
=450  \\$wnnna$aStimulations, Subliminal
=450  \\$aSubliminal Perception
=450  \\$wnnna$aSubliminal Perceptions
=450  \\$wnnna$aSubliminal Stimulations
=550  \\$wg$aSensory Thresholds
=667  \\$ano qualif
=680  \\$iStimulation at an intensity below that where a differentiated response can be elicited.
=688  \\$a69(64); SUBLIMINAL PERCEPTION was see under SUBLIMINAL STIMULATION 1969-78
=750  \0$aSubliminal perception$5IEN$0(DLC)sh 85129477

=LDR  01602cz  a2200361n  4500
=001  9880363893802441
=005  20141212205926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013357
=035  \\$aCBA6682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x874
=150  \\$aSubgingival Curettage
=450  \\$wnnna$aCurettage, Gingival
=450  \\$wnnna$aCurettage, Subgingival
=450  \\$wnnna$aCurettages, Gingival
=450  \\$wnnna$aCurettages, Subgingival
=450  \\$wnnna$aDebridement, Periodontal Epithelial
=450  \\$wnnna$aDebridements, Periodontal Epithelial
=450  \\$wnnna$aEpithelial Debridement, Periodontal
=450  \\$wnnna$aEpithelial Debridements, Periodontal
=450  \\$aGingival Curettage
=450  \\$wnnna$aGingival Curettages
=450  \\$aPeriodontal Epithelial Debridement
=450  \\$wnnna$aPeriodontal Epithelial Debridements
=450  \\$wnnna$aSubgingival Curettages
=550  \\$wg$aPeriodontics
=550  \\$wh$aRoot Planing
=550  \\$aPeriodontal Debridement
=550  \\$aPeriodontitis
=680  \\$iRemoval of degenerated and necrotic epithelium and underlying connective tissue of a periodontal pocket in an effort to convert a chronic ulcerated wound to an acute surgical wound, thereby insuring wound healing and attachment or epithelial adhesion, and shrinkage of the marginal gingiva. The term is sometimes used in connection with smoothing of a root surface or ROOT PLANING. (Jablonski; Illustrated Dictionary of Dentistry, 1982)
=688  \\$a65
=750  \0$aSubgingival curettage$5IEN$0(DLC)sh 85129421

=LDR  01682cz  a2200325n  4500
=001  9880363893902441
=005  20141212205925.0
=008  830421\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013354
=035  \\$aCBA6679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x200
=072  \\$aC1.$x395.$x750
=072  \\$aC1.$x539.$x830.$x305.$x330
=072  \\$aC10.$x228.$x228.$x180.$x350
=072  \\$aC10.$x228.$x228.$x227
=072  \\$aC10.$x228.$x228.$x709.$x300
=150  \\$aEmpyema, Subdural
=450  \\$aAbscess, Intracranial, Subdural
=450  \\$aSubdural Empyema
=450  \\$wnnna$aSubdural Empyemas
=550  \\$wg$aCentral Nervous System Bacterial Infections
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aEmpyema
=550  \\$wg$aPerimeningeal Infections
=550  \\$aBrain Abscess
=667  \\$acoord IM with specific infection (IM) and specific CNS infection term (IM)
=680  \\$iAn intracranial or rarely intraspinal suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID. Bacteria and other pathogenic organisms may gain entrance to the subdural space from the FRONTAL SINUS; ETHMOID SINUS; middle ear (EAR, MIDDLE); MASTOID; or as the result of CRANIOCEREBRAL TRAUMA or NEUROSURGICAL PROCEDURES. This condition may be associated with intracranial sinus thrombosis (SINUS THROMBOSIS, INTRACRANIAL). Circumscribed collections of purulent material in the subdural space are referred to as subdural abscesses. (From Adams et al., Principles of Neurology, 6th ed, p709)
=688  \\$a1995(1984)
=750  \0$aDura mater$xAbscess$5IEN$0(DLC)sh 85040018

=LDR  00933cz  a2200253n  4500
=001  9880363894002441
=005  20141212192542.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013351
=035  \\$aCBA6676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x688.$x178.$x937
=072  \\$aA8.$x186.$x211.$x132.$x659.$x800.$x713
=072  \\$aA8.$x186.$x211.$x653.$x727.$x437
=072  \\$aA8.$x713.$x49.$x937
=150  \\$aSubcommissural Organ
=450  \\$wnnna$aOrgan, Subcommissural
=450  \\$wnnna$aOrgans, Subcommissural
=450  \\$wnnna$aSubcommissural Organs
=550  \\$wg$aCircumventricular Organs
=550  \\$wg$aTectum Mesencephali
=680  \\$iEpendymal derivative located at the junction of the THIRD VENTRICLE and the CEREBRAL AQUEDUCT; and the SOMATOSTATIN SECRETING CELLS.
=688  \\$a91(77); was see under NEUROSECRETORY SYSTEMS 1977-90
=750  \0$aSubcommissural organ$5IEN$0(DLC)sh 85129413

=LDR  02592cz  a2200529n  4500
=001  9880363894102441
=005  20141212205924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013349
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x150.$x956.$x700
=072  \\$aC14.$x907.$x253.$x92.$x956.$x700
=072  \\$aC14.$x907.$x253.$x956.$x700
=150  \\$aSubclavian Steal Syndrome
=450  \\$wnnna$aArtery Stenoses, Subclavian
=450  \\$wnnna$aArtery Stenosis, Subclavian
=450  \\$aBasilar Steal Syndrome
=450  \\$wnnna$aBasilar Steal Syndromes
=450  \\$aBrachial-Basilar Insufficiency Syndrome
=450  \\$wnnna$aBrachial Basilar Insufficiency Syndrome
=450  \\$wnnna$aBrachial-Basilar Insufficiency Syndromes
=450  \\$wnnna$aInsufficiency Syndrome, Brachial-Basilar
=450  \\$wnnna$aInsufficiency Syndromes, Brachial-Basilar
=450  \\$wnnna$aPhenomenon, Subclavian Steal
=450  \\$wnnna$aSteal Phenomenon, Subclavian
=450  \\$wnnna$aSteal, Subclavian
=450  \\$wnnna$aSteal Syndrome, Basilar
=450  \\$wnnna$aSteal Syndrome, Subclavian
=450  \\$wnnna$aSteal Syndromes, Basilar
=450  \\$wnnna$aSteal Syndromes, Subclavian
=450  \\$wnnna$aStenoses, Subclavian Artery
=450  \\$wnnna$aStenosis, Subclavian Artery
=450  \\$wnnna$aSubclavian Artery Stenoses
=450  \\$aSubclavian Artery Stenosis
=450  \\$wnnna$aSubclavian-Carotid Artery Steal Syndrome
=450  \\$wnnna$aSubclavian Carotid Artery Steal Syndrome
=450  \\$wnnna$aSubclavian Steal
=450  \\$wnnna$aSubclavian Steal Phenomenon
=450  \\$wnnna$aSubclavian Steal Syndromes
=450  \\$wnnna$aSyndrome, Brachial-Basilar Insufficiency
=450  \\$wnnna$aSyndromes, Brachial-Basilar Insufficiency
=550  \\$wg$aVertebrobasilar Insufficiency
=550  \\$aCoronary-Subclavian Steal Syndrome
=667  \\$ado not confuse with CORONARY-SUBCLAVIAN STEAL SYNDROME
=680  \\$iA clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM (i.e., VERTEBROBASILAR INSUFFICIENCY) resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. (From J Cardiovasc Surg 1994;35(1):11-4; Acta Neurol Scand 1994;90(3):174-8)
=688  \\$a1965(1964)
=750  \0$aSubclavian steal syndrome$5IEN$0(DLC)sh 85129412

=LDR  00725cz  a2200193n  4500
=001  9880363894202441
=005  20141212205923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013348
=035  \\$aCBA6673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x839
=150  \\$aSubclavian Artery
=450  \\$wnnna$aArteries, Subclavian
=450  \\$wnnna$aArtery, Subclavian
=450  \\$wnnna$aSubclavian Arteries
=550  \\$wg$aArteries
=680  \\$iArtery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb.
=750  \0$aSubclavian artery$5IEN$0(DLC)sh 85129410

=LDR  00611cz  a2200205n  4500
=001  9880363894302441
=005  20141212205923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013346
=035  \\$aCBA6671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x566.$x166.$x686
=150  \\$aSubarachnoid Space
=450  \\$wnnna$aSpace, Subarachnoid
=450  \\$wnnna$aSpaces, Subarachnoid
=450  \\$wnnna$aSubarachnoid Spaces
=550  \\$wg$aArachnoid
=550  \\$wh$aCisterna Magna
=667  \\$aNIM: usually locational so few qualif apply
=750  \0$aSubarachnoid space$5IEN$0(DLC)sh 85129405

=LDR  02528cz  a2200541n  4500
=001  9880363894402441
=005  20141212205922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013345
=035  \\$aCBA6670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x535.$x800
=072  \\$aC14.$x907.$x253.$x573.$x800
=072  \\$aC23.$x550.$x414.$x913.$x850
=150  \\$aSubarachnoid Hemorrhage
=450  \\$wnnna$aAneurysmal Subarachnoid Hemorrhage
=450  \\$wnnna$aAneurysmal Subarachnoid Hemorrhages
=450  \\$wnnna$aHemorrhage, Aneurysmal Subarachnoid
=450  \\$wnnna$aHemorrhage, Intracranial Subarachnoid
=450  \\$wnnna$aHemorrhage, Perinatal Subarachnoid
=450  \\$wnnna$aHemorrhage, Spontaneous Subarachnoid
=450  \\$aHemorrhage, Subarachnoid
=450  \\$wnnna$aHemorrhages, Aneurysmal Subarachnoid
=450  \\$wnnna$aHemorrhages, Intracranial Subarachnoid
=450  \\$wnnna$aHemorrhages, Perinatal Subarachnoid
=450  \\$wnnna$aHemorrhages, Spontaneous Subarachnoid
=450  \\$wnnna$aHemorrhages, Subarachnoid
=450  \\$wnnna$aIntracranial Subarachnoid Hemorrhage
=450  \\$wnnna$aIntracranial Subarachnoid Hemorrhages
=450  \\$aPerinatal Subarachnoid Hemorrhage
=450  \\$wnnna$aPerinatal Subarachnoid Hemorrhages
=450  \\$wnnna$aSAH (Subarachnoid Hemorrhage)
=450  \\$wnnna$aSAHs (Subarachnoid Hemorrhage)
=450  \\$wnnna$aSpontaneous Subarachnoid Hemorrhage
=450  \\$wnnna$aSpontaneous Subarachnoid Hemorrhages
=450  \\$aSubarachnoid Hemorrhage, Aneurysmal
=450  \\$wnnna$aSubarachnoid Hemorrhage, Intracranial
=450  \\$wnnna$aSubarachnoid Hemorrhage, Perinatal
=450  \\$aSubarachnoid Hemorrhage, Spontaneous
=450  \\$wnnna$aSubarachnoid Hemorrhages
=450  \\$wnnna$aSubarachnoid Hemorrhages, Aneurysmal
=450  \\$wnnna$aSubarachnoid Hemorrhages, Intracranial
=450  \\$wnnna$aSubarachnoid Hemorrhages, Perinatal
=450  \\$wnnna$aSubarachnoid Hemorrhages, Spontaneous
=550  \\$wg$aIntracranial Hemorrhages
=550  \\$wh$aSubarachnoid Hemorrhage, Traumatic
=680  \\$iBleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
=750  \0$aSubarachnoid hemorrhage$5IEN$0(DLC)sh 85129404

=LDR  02798cz  a2200517n  4500
=001  9880363894502441
=005  20141212205922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013344
=035  \\$aCBA6669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182.$x500.$x300.$x600
=072  \\$aC2.$x290.$x700
=072  \\$aC2.$x782.$x580.$x600.$x500.$x500.$x800
=072  \\$aC2.$x839.$x862
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x600
=072  \\$aC10.$x228.$x228.$x245.$x340.$x700
=150  \\$aSubacute Sclerosing Panencephalitis
=450  \\$wnnna$aEncephaltis, Inclusion Body, Measles
=450  \\$wnnna$aInclusion Body Encephalitis, Measles
=450  \\$wnnna$aLeukoencephalitides, Subacute Sclerosing
=450  \\$aLeukoencephalitis, Subacute Sclerosing
=450  \\$wnnna$aLeukoencephalitis, Van Bogaert
=450  \\$wnnna$aLeukoencephalitis, Van Bogaert's
=450  \\$wnnna$aLeukoencephalitis, Van Bogaerts
=450  \\$aMeasles Inclusion Body Encephalitis
=450  \\$wnnna$aPanencephalitides, Subacute Sclerosing
=450  \\$aPanencephalitis, Subacute Sclerosing
=450  \\$wnnna$aSclerosing Leukoencephalitides, Subacute
=450  \\$wnnna$aSclerosing Leukoencephalitis, Subacute
=450  \\$wnnna$aSclerosing Panencephalitides, Subacute
=450  \\$wnnna$aSclerosing Panencephalitis, Subacute
=450  \\$aSSPE
=450  \\$wnnna$aSubacute Sclerosing Leukoencephalitides
=450  \\$wnnna$aSubacute Sclerosing Leukoencephalitis
=450  \\$wnnna$aSubacute Sclerosing Panencephalitides
=450  \\$wnnna$aVan Bogaert Leukoencephalitis
=450  \\$aVan Bogaert's Leukoencephalitis
=450  \\$wnnna$aVan Bogaerts Leukoencephalitis
=550  \\$wg$aEncephalitis, Viral
=550  \\$wg$aMeasles
=550  \\$wg$aSlow Virus Diseases
=550  \\$aMeasles virus
=680  \\$iA rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8)
=688  \\$a71; VAN BOGAERT'S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70
=750  \0$aSubacute sclerosing panencephalitis$5IEN$0(DLC)sh 86002656

=LDR  01537cz  a2200289n  4500
=001  9880363894602441
=005  20141212205920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013342
=035  \\$aCBA6667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x750
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x750
=150  \\$aStuttering
=450  \\$wnnna$aAcquired Stuttering
=450  \\$wnnna$aAdult Stuttering
=450  \\$wnnna$aChildhood Stuttering
=450  \\$wnnna$aDevelopmental Stuttering
=450  \\$aStammering
=450  \\$wnnna$aStuttering, Acquired
=450  \\$wnnna$aStuttering, Adult
=450  \\$wnnna$aStuttering, Childhood
=450  \\$wnnna$aStuttering, Developmental
=450  \\$wnnna$aStuttering, Familial Persistent 1
=550  \\$wg$aSpeech Disorders
=680  \\$iA disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)
=750  \0$aStuttering$5IEN$0(DLC)sh 85129370

=LDR  02605cz  a2200601n  4500
=001  9880363894702441
=005  20141212205920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013341
=035  \\$aCBA6666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x645.$x375.$x850
=072  \\$aC10.$x562.$x800
=072  \\$aC14.$x907.$x77.$x850
=150  \\$aSturge-Weber Syndrome
=450  \\$wnnna$aAngiomatosis, Meningo-Oculo-Facial
=450  \\$wnnna$aAngiomatosis Oculoorbital-Thalamic Syndrome
=450  \\$wnnna$aEncephalofacial Hemangiomatosis Syndrome
=450  \\$wnnna$aHemangiomatosis Syndrome, Encephalofacial
=450  \\$wnnna$aMeningo-Oculo-Facial Angiomatosis
=450  \\$wnnna$aMeningo Oculo Facial Angiomatosis
=450  \\$wnnna$aMeningofacial Angiomatosis-Cerebral Calcification Syndrome
=450  \\$aNeuroretinoangiomatosis
=450  \\$wnnna$aParkes Weber Syndrome
=450  \\$wnnna$aParkes-Weber Syndrome
=450  \\$aPhakomatosis, Sturge-Weber
=450  \\$wnnna$aPhakomatosis, Sturge Weber
=450  \\$wnnna$aSturge Disease
=450  \\$wnnna$aSturge-Kalischer-Weber Syndrome
=450  \\$wnnna$aSturge Kalischer Weber Syndrome
=450  \\$wnnna$aSturge Syndrome
=450  \\$wnnna$aSturge-Weber-Dimitri Syndrome
=450  \\$wnnna$aSturge Weber Dimitri Syndrome
=450  \\$wnnna$aSturge-Weber-Krabbe Syndrome
=450  \\$wnnna$aSturge Weber Krabbe Syndrome
=450  \\$wnnna$aSturge-Weber Phakomatosis
=450  \\$wnnna$aSturge Weber Syndrome
=450  \\$wnnna$aSturge's Syndrome
=450  \\$wnnna$aSyndrome, Encephalofacial Hemangiomatosis
=450  \\$wnnna$aSyndrome, Parkes Weber
=450  \\$wnnna$aSyndrome, Parkes-Weber
=450  \\$wnnna$aSyndrome, Sturge
=450  \\$wnnna$aSyndrome, Sturge-Kalischer-Weber
=450  \\$wnnna$aSyndrome, Sturge-Weber
=450  \\$wnnna$aSyndrome, Sturge-Weber-Dimitri
=450  \\$wnnna$aSyndrome, Sturge-Weber-Krabbe
=450  \\$wnnna$aSyndrome, Sturge's
=550  \\$wg$aAngiomatosis
=550  \\$wg$aHemangioma
=550  \\$wg$aNeurocutaneous Syndromes
=680  \\$iA non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.
=688  \\$a91(75); was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93
=750  \0$aSturge-Weber syndrome$5IEN$0(DLC)sh 85129350

=LDR  00787cz  a2200229n  4500
=001  9880363894802441
=005  20141212205919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013339
=035  \\$aCBA6663M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x851.$x686.$x768
=072  \\$aM1.$x848.$x769.$x768
=150  \\$aStudents, Pharmacy
=450  \\$wnnna$aPharmacy Student
=450  \\$wnnna$aPharmacy Students
=450  \\$wnnna$aStudent, Pharmacy
=550  \\$wg$aStudents, Health Occupations
=667  \\$a/educ = EDUCATION, PHARMACY or its specifics; DF: STUDENTS PHARM
=680  \\$iIndividuals enrolled in a school of pharmacy or a formal educational program leading to a degree in pharmacy.
=688  \\$a68
=750  \0$aPharmacy students$0(DLC)sh2009007390$5IEN-M

=LDR  00903cz  a2200277n  4500
=001  9880363894902441
=005  20141212205919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013338
=035  \\$aCBA6662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x851.$x686.$x685
=072  \\$aM1.$x848.$x769.$x685
=150  \\$aStudents, Nursing
=450  \\$wnnna$aNurse, Pupil
=450  \\$aNurses, Pupil
=450  \\$wnnna$aNursing Student
=450  \\$wnnna$aNursing Students
=450  \\$wnnna$aPupil Nurse
=450  \\$aPupil Nurses
=450  \\$wnnna$aStudent, Nursing
=550  \\$wg$aStudents, Health Occupations
=667  \\$a/educ = EDUCATION, NURSING or its specifics; DF: STUDENTS NURS
=680  \\$iIndividuals enrolled in a school of nursing or a formal educational program leading to a degree in nursing.
=688  \\$a66
=750  \0$aNursing students$5IEN$0(DLC)sh 85093434

=LDR  00756cz  a2200229n  4500
=001  9880363895002441
=005  20141212205918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013337
=035  \\$aCBA6661NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x851.$x686.$x602
=072  \\$aM1.$x848.$x769.$x602
=150  \\$aStudents, Medical
=450  \\$wnnna$aMedical Student
=450  \\$wnnna$aMedical Students
=450  \\$wnnna$aStudent, Medical
=550  \\$wg$aStudents, Health Occupations
=667  \\$a/educ = EDUCATION, MEDICAL or its specifics; DF: STUDENTS MED
=680  \\$iIndividuals enrolled in a school of medicine or a formal educational program in medicine.
=688  \\$a66
=750  \0$aMedical students$5IEN$0(DLC)sh 85083034

=LDR  01109cz  a2200325n  4500
=001  9880363895102441
=005  20141212205918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013336
=035  \\$aCBA6660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x851.$x686
=072  \\$aM1.$x848.$x769
=150  \\$aStudents, Health Occupations
=450  \\$wnnna$aHealth Occupations Student
=450  \\$wnnna$aHealth Occupations Students
=450  \\$wnnna$aOccupations Student, Health
=450  \\$wnnna$aOccupations Students, Health
=450  \\$wnnna$aStudent, Health Occupations
=550  \\$wg$aStudents
=550  \\$wh$aStudents, Dental
=550  \\$wh$aStudents, Medical
=550  \\$wh$aStudents, Nursing
=550  \\$wh$aStudents, Pharmacy
=550  \\$wh$aStudents, Premedical
=550  \\$wh$aStudents, Public Health
=667  \\$a/educ = HEALTH OCCUPATIONS /educ; DF: STUDENTS HEALTH OCCUP
=680  \\$iIndividuals enrolled in a school or formal educational program in the health occupations.
=688  \\$a68
=750  \0$aHealth occupations students$5IEN$0(DLC)sh 85059580

=LDR  00773cz  a2200229n  4500
=001  9880363895202441
=005  20141212205918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013335
=035  \\$aCBA6659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x851.$x686.$x519
=072  \\$aM1.$x848.$x769.$x519
=150  \\$aStudents, Dental
=450  \\$wnnna$aDental Student
=450  \\$wnnna$aDental Students
=450  \\$wnnna$aStudent, Dental
=550  \\$wg$aStudents, Health Occupations
=667  \\$a/educ = EDUCATION, DENTAL or its specifics; DF: STUDENTS DENT
=680  \\$iIndividuals enrolled a school of dentistry or a formal educational program in leading to a degree in dentistry.
=688  \\$a66
=750  \0$aDental students$5IEN$0(DLC)sh 85036935

=LDR  00960cz  a2200277n  4500
=001  9880363895302441
=005  20181214144125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013334
=035  \\$aCBA6658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x848
=150  \\$aStudents
=450  \\$wnnna$aEnrollment, School
=450  \\$wnnna$aEnrollments, School
=450  \\$wnnna$aSchool Enrollment
=450  \\$wnnna$aSchool Enrollments
=450  \\$wnnna$aStudent
=550  \\$wg$aPersons
=550  \\$wh$aStudent Dropouts
=550  \\$wh$aStudents, Health Occupations
=550  \\$aCollege Fraternities and Sororities
=550  \\$aEducation
=667  \\$a/psychol: consider also PSYCHOLOGY, EDUCATIONAL; as persons: Manual 30.7.3; as children: Manual 34.16; relation to EDUCATION: Manual 34.16; /educ = EDUCATION
=680  \\$iIndividuals enrolled in a school or formal educational program.
=750  \0$aStudents$5IEN$0(DLC)sh 85129296

=LDR  01256cz  a2200313n  4500
=001  9880363895402441
=005  20141212205918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013333
=035  \\$aCBA6657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x897
=150  \\$aStudent Health Services
=450  \\$wnnna$aHealth Service, Student
=450  \\$wnnna$aHealth Service, University
=450  \\$wnnna$aHealth Services, Student
=450  \\$wnnna$aHealth Services, University
=450  \\$wnnna$aService, Student Health
=450  \\$wnnna$aService, University Health
=450  \\$wnnna$aServices, Student Health
=450  \\$wnnna$aServices, University Health
=450  \\$wnnna$aStudent Health Service
=450  \\$wnnna$aUniversity Health Service
=450  \\$aUniversity Health Services
=550  \\$wg$aHealth Services
=667  \\$ado not confuse with SCHOOL HEALTH SERVICES for high school & under; specify geog; DF: STUDENT HEALTH SERV
=680  \\$iHealth services for college and university students usually provided by the educational institution.
=688  \\$aUNIVERSITY HEALTH SERVICES was see under STUDENT HEALTH SERVICES 1963-78
=750  \0$aCollege students$xHealth and hygiene$5IEN$0(DLC)sh2008101196

=LDR  00926cz  a2200301n  4500
=001  9880363895502441
=005  20141212205917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013332
=035  \\$aCBA6656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x796
=072  \\$aI2.$x233.$x748.$x686
=072  \\$aM1.$x848.$x602
=150  \\$aStudent Dropouts
=450  \\$wnnna$aDropout, School
=450  \\$wnnna$aDropout, Student
=450  \\$wnnna$aDropouts, School
=450  \\$wnnna$aDropouts, Student
=450  \\$wnnna$aSchool Dropout
=450  \\$aSchool Dropouts
=450  \\$wnnna$aStudent Dropout
=550  \\$wg$aPsychology, Educational
=550  \\$wg$aStudents
=550  \\$aSocial Problems
=680  \\$iIndividuals who leave school, secondary or college, prior to completion of specified curriculum requirements.
=688  \\$a67(64)
=750  \0$aDropouts$5IEN$0(DLC)sh 85039629

=LDR  00816cz  a2200193n  4500
=001  9880363895602441
=005  20141212205917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013331
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x722
=072  \\$aD3.$x438.$x473.$x402.$x681.$x722
=150  \\$aStrychnine
=450  \\$wnnna$aNitrate, Strychnine
=450  \\$wnnna$aStrychnine Nitrate
=550  \\$wg$aSecologanin Tryptamine Alkaloids
=680  \\$iAn alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison.
=688  \\$aNUX VOMICA was heading 1963-78
=750  \0$aStrychnine$5IEN$0(DLC)sh 85129226

=LDR  01202cz  a2200265n  4500
=001  9880363895702441
=005  20170609090724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013329
=035  \\$aCBA6653HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x830
=072  \\$aG7.$x690.$x773.$x997
=150  \\$aStructure-Activity Relationship
=450  \\$wnnna$aRelationship, Structure-Activity
=450  \\$wnnna$aRelationships, Structure-Activity
=450  \\$wnnna$aStructure Activity Relationship
=450  \\$wnnna$aStructure-Activity Relationships
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aPharmacological Phenomena
=550  \\$wh$aQuantitative Structure-Activity Relationship
=667  \\$acoordinate NIM with specific drug IM; DF: STRUCT ACTIV RELAT
=680  \\$iThe relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
=688  \\$a72
=750  \0$aStructure-activity relationships (Biochemistry)$5IEN$0(DLC)sh 85129212

=LDR  00710cz  a2200205n  4500
=001  9880363895802441
=005  20141212205915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013325
=035  \\$aCBA6649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x840
=150  \\$aStrontium Isotopes
=450  \\$wnnna$aIsotopes, Strontium
=550  \\$wg$aIsotopes
=550  \\$wh$aStrontium Radioisotopes
=550  \\$aStrontium
=667  \\$aSr-84,86,87; NIM
=680  \\$iStable strontium atoms that have the same atomic number as the element strontium, but differ in the atomic weight. Sr-84, 86, 87, and 88 are the stable strontium isotopes.
=750  \0$aStrontium$xIsotopes$5IEN$0(DLC)sh 85129179

=LDR  00814cz  a2200241n  4500
=001  9880363895902441
=005  20141212205915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013324
=035  \\$aCBA6648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552.$x850
=072  \\$aD1.$x268.$x556.$x825
=072  \\$aD1.$x552.$x539.$x861
=072  \\$aD1.$x552.$x544.$x825
=150  \\$aStrontium
=450  \\$aStrontium Compounds$5IEN
=550  \\$wg$aMetals, Alkaline Earth
=550  \\$wg$aMetals, Heavy
=667  \\$aan alkaline earth metal; Sr-88
=680  \\$iAn element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.
=750  \0$aStrontium$5IEN-M$0(DLC)sh 85129178
=750  \0$aStrontium compounds$5IEN-HS$0(DLC)sh 85129183

=LDR  00794cz  a2200205n  4500
=001  9880363896002441
=005  20141212205914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013322
=035  \\$aCBA6646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x700.$x799
=150  \\$aStrongyloidiasis
=450  \\$wnnna$aAnguilluliases
=450  \\$aAnguilluliasis
=450  \\$wnnna$aStrongyloidiases
=550  \\$wg$aRhabditida Infections
=667  \\$anematode infect caused by STRONGYLOIDES, not STRONGYLOIDEA
=680  \\$iInfection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.
=750  \0$aStrongyloidiasis$5IEN$0(DLC)sh 89001284

=LDR  00867cz  a2200277n  4500
=001  9880363896102441
=005  20141212205913.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013317
=035  \\$aCBA6641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x571.$x608
=072  \\$aN4.$x452.$x677.$x842
=150  \\$aStrikes, Employee
=450  \\$wnnna$aEmployee Strike
=450  \\$aEmployee Strikes
=450  \\$wnnna$aStrike
=450  \\$wnnna$aStrike, Employee
=450  \\$wnnna$aStrikes
=550  \\$wg$aLabor Unions
=550  \\$wg$aPersonnel Management
=550  \\$aLabor Unions
=667  \\$aDF: STRIKES
=680  \\$iWork-related situations in which the employees as a group refuse to work until certain conditions of employment are granted by the employer.
=688  \\$a80
=750  \0$aStrikes and lockouts$5IEN$0(DLC)sh 85128731

=LDR  01557cz  a2200409n  4500
=001  9880363896202441
=005  20200609120756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013315
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x990
=072  \\$aF2.$x830.$x900
=150  \\$aStress, Psychological
=450  \\$aAnguish
=450  \\$aEmotional Stress
=450  \\$aLife Stress
=450  \\$wnnna$aLife Stresses
=450  \\$aMental Suffering
=450  \\$wnnna$aPsychologic Stress
=450  \\$wnnna$aPsychological Stress
=450  \\$wnnna$aPsychological Stresses
=450  \\$wnnna$aStress, Emotional
=450  \\$wnnna$aStress, Life
=450  \\$wnnna$aStress, Psychologic
=450  \\$wnnna$aStresses, Life
=450  \\$wnnna$aStresses, Psychological
=450  \\$wnnna$aSuffering
=450  \\$wnnna$aSuffering, Mental
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aPsychophysiology
=550  \\$wh$aBurnout, Professional
=550  \\$wh$aCompassion Fatigue
=550  \\$wh$aOccupational Stress
=667  \\$ahuman & animal; coord IM with type of stress if relevant (IM or NIM); "stressful events" is indexed under LIFE CHANGE EVENTS (restrict to humans) but note LIFE STRESS goes here; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS, PSYCHOLOGICAL or STRESS, PHYSIOLOGICAL (IM or NIM); DF: STRESS PSYCHOL
=680  \\$iStress wherein emotional factors predominate.
=688  \\$a73; was STRESS, PSYCHOLOGIC 1969-72
=750  \0$aStress (Psychology)$5IEN$0(DLC)sh 85128705

=LDR  00949cz  a2200229n  4500
=001  9880363896302441
=005  20141212205912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013314
=035  \\$aCBA6638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x676.$x830
=072  \\$aG1.$x595.$x540.$x830
=150  \\$aStress, Mechanical
=450  \\$wnnna$aMechanical Stress
=450  \\$wnnna$aMechanical Stresses
=450  \\$wnnna$aStresses, Mechanical
=550  \\$wg$aMechanical Processes
=667  \\$anote category: does not refer to stress response to mechanical stimuli such as vibration (= STRESS, PHYSIOLOGICAL + VIBRATION)
=680  \\$iA purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.
=688  \\$a73(71)
=750  \0$aStrains and stresses$5IEN$0(DLC)sh 85128457

=LDR  02114cz  a2200529n  4500
=001  9880363896502441
=005  20170609110627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013312
=035  \\$aCBA6636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x775
=150  \\$aStress, Physiological
=450  \\$wnnna$aBiological Stress
=450  \\$wnnna$aBiological Stresses
=450  \\$aMetabolic Stress
=450  \\$wnnna$aMetabolic Stress Response
=450  \\$wnnna$aMetabolic Stress Responses
=450  \\$wnnna$aMetabolic Stresses
=450  \\$aPhysiological Stress
=450  \\$wnnna$aPhysiological Stress Reaction
=450  \\$wnnna$aPhysiological Stress Reactions
=450  \\$wnnna$aPhysiological Stress Reactivity
=450  \\$wnnna$aPhysiological Stress Response
=450  \\$wnnna$aPhysiological Stress Responses
=450  \\$wnnna$aPhysiological Stresses
=450  \\$wnnna$aResponse, Metabolic Stress
=450  \\$wnnna$aResponses, Metabolic Stress
=450  \\$wnnna$aStress, Biological
=450  \\$wnnna$aStress, Metabolic
=450  \\$wnnna$aStress Reaction, Physiological
=450  \\$wnnna$aStress Reactions, Physiological
=450  \\$wnnna$aStress Response, Metabolic
=450  \\$wnnna$aStress Response, Physiological
=450  \\$wnnna$aStress Responses, Metabolic
=450  \\$wnnna$aStresses, Biological
=450  \\$wnnna$aStresses, Metabolic
=450  \\$wnnna$aStresses, Physiological
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aCold-Shock Response
=550  \\$wh$aHeat-Shock Response
=550  \\$wh$aOxidative Stress
=667  \\$anote category: may be used with microorganisms, plants and invertebrates
=680  \\$iThe unfavorable effect of environmental factors (stressors) on the physiological functions of an organism. Prolonged unresolved physiological stress can affect HOMEOSTASIS of the organism, and may lead to damaging or pathological conditions.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Stress
=750  \0$aStress (Physiology)$0(DLC) sh 85128702$5IEN

=LDR  01032cz  a2200277n  4500
=001  9880363896602441
=005  20141212205910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013311
=035  \\$aCBA6635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x654.$x692.$x768
=072  \\$aD2.$x948.$x594.$x768
=072  \\$aD9.$x408.$x51.$x900
=150  \\$aStreptozocin
=450  \\$wnnna$a2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose
=450  \\$wnnna$aStreptozocin Teva Brand
=450  \\$aStreptozotocin
=450  \\$wnnna$aStreptozotocine
=450  \\$wnnna$aTeva Brand of Streptozocin
=450  \\$wnnna$aZanosar
=550  \\$wg$aAminoglycosides
=550  \\$wg$aNitrosourea Compounds
=680  \\$iAn antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
=688  \\$a93; was STREPTOZOTOCIN 1972-92 (Prov 1972); STREPTOZOCIN was see STREPTOZOTOCIN 1977-92
=750  \0$aStreptozotocin$5IEN$0(DLC)sh 85128700

=LDR  00941cz  a2200205n  4500
=001  9880363896702441
=005  20141212205909.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013309
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x892
=150  \\$aStreptothricins
=450  \\$wnnna$aNourseothricin
=450  \\$aRacemomycins
=450  \\$wnnna$aStreptothricin
=450  \\$aYazumycins
=550  \\$wg$aAminoglycosides
=680  \\$iA group of antibiotic aminoglycosides differing only in the number of repeating residues in the peptide side chain. They are produced by Streptomyces and Actinomyces and may have broad spectrum antimicrobial and some antiviral properties.
=688  \\$a1991(1978); use ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN use ANTIBIOTICS 1975-1977; NOURSEOTHRICIN was (NM) 1975-1993; for RACEMOMYCINS use RACEMOMYCIN (NM) 2000-2003
=750  \0$aStreptothricin$5IEN$0(DLC)sh 85128698

=LDR  01662cz  a2200421n  4500
=001  9880363896802441
=005  20141212192541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013307
=035  \\$aCBA6631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x885
=150  \\$aStreptomycin
=450  \\$wnnna$aCEPA Brand of Streptomycin Sulfate
=450  \\$wnnna$aClariana Brand of Streptomycin Sulfate
=450  \\$wnnna$aEstreptomicina CEPA
=450  \\$wnnna$aEstreptomicina Clariana
=450  \\$wnnna$aEstreptomicina Normon
=450  \\$wnnna$aFatol Brand of Streptomycin Sulfate
=450  \\$wnnna$aGrünenthal Brand of Streptomycin Sulfate
=450  \\$wnnna$aNormon Brand of Streptomycin Sulfate
=450  \\$wnnna$aPanpharma Brand of Streptomycin Sulfate
=450  \\$wnnna$aSanavita Brand of Streptomycin Sulfate
=450  \\$wnnna$aStrepto-Fatol
=450  \\$wnnna$aStrepto Fatol
=450  \\$wnnna$aStrepto-Hefa
=450  \\$wnnna$aStrepto Hefa
=450  \\$wnnna$aStreptomycin Grünenthal
=450  \\$wnnna$aStreptomycin Sulfate
=450  \\$wnnna$aStreptomycin Sulfate (2:3) Salt
=450  \\$wnnna$aStreptomycin Sulphate
=450  \\$wnnna$aStreptomycine Panpharma
=450  \\$wnnna$aWernigerode Brand of Streptomycin Sulfate
=550  \\$wg$aAminoglycosides
=550  \\$wh$aDihydrostreptomycin Sulfate
=680  \\$iAn antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.
=688  \\$a/adv eff-pois-tox was STREPTOMYCIN TOXICOLOGY 1963-65
=750  \0$aStreptomycin$5IEN$0(DLC)sh 85128696

=LDR  00714cz  a2200229n  4500
=001  9880363896902441
=005  20141212205909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x810
=072  \\$aB3.$x510.$x24.$x49.$x775
=072  \\$aB3.$x510.$x415.$x400.$x810
=072  \\$aB3.$x510.$x460.$x410.$x810
=150  \\$aStreptomycetaceae
=550  \\$wg$aActinomycetales
=550  \\$wg$aGram-Positive Endospore-Forming Rods
=550  \\$wh$aStreptomyces
=667  \\$asoil bacteria
=680  \\$iA family of soil bacteria. It also includes some parasitic forms.
=688  \\$a75
=750  \0$aStreptomycetaceae$5IEN$0(DLC)sh 85128695

=LDR  00738cz  a2200205n  4500
=001  9880363897002441
=005  20141212205909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013305
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x810.$x768.$x375
=072  \\$aB3.$x510.$x24.$x49.$x775.$x775.$x375
=072  \\$aB3.$x510.$x415.$x400.$x810.$x768.$x375
=072  \\$aB3.$x510.$x460.$x410.$x810.$x768.$x375
=150  \\$aStreptomyces griseus
=550  \\$wg$aStreptomyces
=667  \\$ayields streptomycin, candicidin & grisein
=680  \\$iAn actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained.
=688  \\$a74(72)
=750  \0$aStreptomyces griseus$5IEN$0(DLC)sh 88023345

=LDR  00709cz  a2200205n  4500
=001  9880363897102441
=005  20141212205908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x810.$x768.$x125
=072  \\$aB3.$x510.$x24.$x49.$x775.$x775.$x125
=072  \\$aB3.$x510.$x415.$x400.$x810.$x768.$x125
=072  \\$aB3.$x510.$x460.$x410.$x810.$x768.$x125
=150  \\$aStreptomyces aureofaciens
=550  \\$wg$aStreptomyces
=667  \\$ayields chlortetracycline
=680  \\$iAn actinomycete from which the antibiotic CHLORTETRACYCLINE is obtained.
=688  \\$a74(72)
=750  \0$aStreptomyces aureofaciens$5IEN$0(DLC)sh 88023343

=LDR  01067cz  a2200265n  4500
=001  9880363897202441
=005  20141212205908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x810.$x768
=072  \\$aB3.$x510.$x24.$x49.$x775.$x775
=072  \\$aB3.$x510.$x415.$x400.$x810.$x768
=072  \\$aB3.$x510.$x460.$x410.$x810.$x768
=150  \\$aStreptomyces
=550  \\$wg$aStreptomycetaceae
=550  \\$wh$aStreptomyces antibioticus
=550  \\$wh$aStreptomyces aureofaciens
=550  \\$wh$aStreptomyces coelicolor
=550  \\$wh$aStreptomyces griseus
=550  \\$wh$aStreptomyces lividans
=550  \\$wh$aStreptomyces rimosus
=667  \\$athe bacterium that produces many antibiotics
=680  \\$iA genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
=750  \0$aStreptomyces$5IEN$0(DLC)sh 85128692

=LDR  00879cz  a2200253n  4500
=001  9880363897302441
=005  20141212205908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013301
=035  \\$aCBA6625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x695.$x937
=072  \\$aD23.$x946.$x123.$x868
=072  \\$aD23.$x946.$x350.$x750
=150  \\$aStreptolysins
=450  \\$wnnna$aStreptolysin
=550  \\$wg$aBacterial Toxins
=550  \\$wg$aExotoxins
=550  \\$wg$aPore Forming Cytotoxic Proteins
=550  \\$aStreptococcus pyogenes
=667  \\$a/antag permitted but consider also ANTISTREPTOLYSIN
=680  \\$iExotoxins produced by certain strains of streptococci, particularly those of group A (STREPTOCOCCUS PYOGENES), that cause HEMOLYSIS.
=688  \\$a78; was STREPTOLYSIN 1963-77
=750  \0$aStreptolysin$5IEN$0(DLC)sh 85128691

=LDR  01211cz  a2200325n  4500
=001  9880363897402441
=005  20141212205907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013300
=035  \\$aCBA6624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x775
=072  \\$aD12.$x776.$x124.$x125.$x662.$x537
=150  \\$aStreptokinase
=450  \\$wnnna$aAvelizin
=450  \\$wnnna$aAwelysin
=450  \\$wnnna$aCeliase
=450  \\$wnnna$aDistreptase
=450  \\$wnnna$aKabikinase
=450  \\$wnnna$aKabivitrum
=450  \\$wnnna$aStreptase
=450  \\$wnnna$aStreptodecase
=550  \\$wg$aEndopeptidases
=550  \\$wg$aPlasminogen Activators
=550  \\$wh$aAnistreplase
=550  \\$wh$aStreptodornase and Streptokinase
=667  \\$aan enzyme; see note on STREPTODORNASE AND STREPTOKINASE
=680  \\$iStreptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-.
=688  \\$a66
=750  \0$aStreptokinase$5IEN$0(DLC)sh 85128689

=LDR  01030cz  a2200229n  4500
=001  9880363897502441
=005  20141212205906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013297
=035  \\$aCBA6621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x575
=072  \\$aB3.$x510.$x550.$x737.$x872.$x575
=150  \\$aStreptococcus pyogenes
=450  \\$wnnna$aBacteria, Flesh-Eating
=450  \\$aFlesh-Eating Bacteria
=450  \\$aStreptococcus Group A
=550  \\$wg$aStreptococcus
=550  \\$aPicibanil
=667  \\$ainfection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM); note entry term BACTERIA, FLESH-EATING: consider also FASCIITIS, NECROTIZING; DF: STREP PYOGENES
=680  \\$iA species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.
=750  \0$aStreptococcus pyogenes$5IEN$0(DLC)sh 85128686

=LDR  00932cz  a2200217n  4500
=001  9880363897602441
=005  20141212205906.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013296
=035  \\$aCBA6620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x550
=072  \\$aB3.$x510.$x550.$x737.$x872.$x550
=150  \\$aStreptococcus pneumoniae
=450  \\$aDiplococcus pneumoniae
=450  \\$aPneumococcus
=550  \\$wg$aStreptococcus
=667  \\$ainfection = PNEUMOCOCCAL INFECTIONS & do not coord with STREPTOCOCCUS PNEUMONIAE; consider also PNEUMONIA, PNEUMOCOCCAL; DF: STREP PNEUMONIAE
=680  \\$iA gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
=688  \\$a76; was DIPLOCOCCUS PNEUMONIAE 1963-75
=750  \0$aStreptococcus pneumoniae$5IEN$0(DLC)sh 85128685

=LDR  00667cz  a2200181n  4500
=001  9880363897702441
=005  20141212205906.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013295
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x875.$x520
=072  \\$aB3.$x510.$x550.$x737.$x872.$x875.$x520
=150  \\$aStreptococcus mutans
=550  \\$wg$aViridans Streptococci
=667  \\$afound in dental plaque; DF: STREP MUTANS
=680  \\$iA polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
=688  \\$a78(76); was see under STREPTOCOCCUS 1976-77
=750  \0$aStreptococcus mutans$5IEN$0(DLC)sh 85128684

=LDR  00768cz  a2200205n  4500
=001  9880363897802441
=005  20141212205906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013294
=035  \\$aCBA6618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x500.$x400
=072  \\$aB3.$x510.$x550.$x737.$x500.$x400
=150  \\$aLactococcus lactis
=450  \\$wnnna$aLactococcus lactis subsp. lactis
=450  \\$aStreptococcus lactis
=550  \\$wg$aLactococcus
=680  \\$iA non-pathogenic species of LACTOCOCCUS found in DAIRY PRODUCTS and responsible for the souring of MILK and the production of LACTIC ACID.
=688  \\$a92(72); was STREPTOCOCCUS LACTIS 1972-91 (Prov 1972-73)
=750  \0$aLactococcus lactis$5IEN-M$0(DLC)sh 85128683

=LDR  00802cz  a2200193n  4500
=001  9880363897902441
=005  20141212205905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013293
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x550.$x250.$x250.$x280
=150  \\$aEnterococcus faecalis
=450  \\$aStreptococcus faecalis
=450  \\$aStreptococcus Group D
=550  \\$wg$aEnterococcus
=667  \\$ainfection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM); do not confuse with ENTEROCOCCUS FAECIUM
=680  \\$iA species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.
=688  \\$a92; was STREPTOCOCCUS FAECALIS 1963-91
=750  \0$aEnterococcus faecalis$5IEN-M$0(DLC)sh 85128682

=LDR  00700cz  a2200205n  4500
=001  9880363898002441
=005  20141212205905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013292
=035  \\$aCBA6616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x100
=072  \\$aB3.$x510.$x550.$x737.$x872.$x100
=150  \\$aStreptococcus agalactiae
=450  \\$aStreptococcus Group B
=550  \\$wg$aStreptococcus
=667  \\$ainfection: coord IM with STREPTOCOCCAL INFECTIONS (IM); DF: STREP AGALACTIAE
=680  \\$iA bacterium which causes mastitis in cattle and occasionally in man.
=688  \\$a74(72)
=750  \0$aStreptococcus agalactiae$5IEN$0(DLC)sh 85128679

=LDR  01723cz  a2200337n  4500
=001  9880363898102441
=005  20190102114027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013291
=035  \\$aCBA6615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x353.$x750.$x737.$x872
=072  \\$aB3.$x510.$x400.$x800.$x872
=072  \\$aB3.$x510.$x550.$x737.$x872
=150  \\$aStreptococcus
=550  \\$wg$aStreptococcaceae
=550  \\$wh$aStreptococcus agalactiae
=550  \\$wh$aStreptococcus bovis
=550  \\$wh$aStreptococcus equi
=550  \\$wh$aStreptococcus gallolyticus
=550  \\$wh$aStreptococcus gordonii
=550  \\$wh$aStreptococcus iniae
=550  \\$wh$aStreptococcus pneumoniae
=550  \\$wh$aStreptococcus pyogenes
=550  \\$wh$aStreptococcus salivarius
=550  \\$wh$aStreptococcus suis
=550  \\$wh$aStreptococcus thermophilus
=550  \\$wh$aViridans Streptococci
=667  \\$aGEN or unspecified; prefer specifics; hemolytic streptococci = STREPTOCOCCUS unless specified in text as S. pyogenes, S. agalactiae, etc.; group A = STREPTOCOCCUS PYOGENES; B = STREPTOCOCCUS AGALACTIAE; D = ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS BOVIS; S. equinus (index under STREPTOCOCCUS); N = LACTOCOCCUS LACTIS; groups E, L, M, O, R, S go under STREPTOCOCCUS; infection = STREPTOCOCCAL INFECTIONS; DF: STREP
=680  \\$iA genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
=750  \0$aStreptococcus$5IEN-M$0(DLC)sh 85128678

=LDR  00962cz  a2200289n  4500
=001  9880363898202441
=005  20141212205904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013290
=035  \\$aCBA6614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890
=150  \\$aStreptococcal Infections
=450  \\$wnnna$aInfection, Streptococcal
=450  \\$wnnna$aInfections, Streptococcal
=450  \\$wnnna$aStreptococcal Infection
=550  \\$wg$aGram-Positive Bacterial Infections
=550  \\$wh$aEcthyma
=550  \\$wh$aEndocarditis, Subacute Bacterial
=550  \\$wh$aErysipelas
=550  \\$wh$aImpetigo
=550  \\$wh$aPneumococcal Infections
=550  \\$wh$aRheumatic Fever
=550  \\$wh$aScarlet Fever
=667  \\$agram-pos bact infect; coord IM with species (IM); DF: STREP INFECT
=680  \\$iInfections with bacteria of the genus STREPTOCOCCUS.
=750  \0$aStreptococcal infections$5IEN$0(DLC)sh 85128677

=LDR  00767cz  a2200229n  4500
=001  9880363898302441
=005  20141212205904.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013289
=035  \\$aCBA6613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800
=072  \\$aB3.$x510.$x550.$x737
=150  \\$aStreptococcaceae
=450  \\$aGaffkya homari
=550  \\$wg$aGram-Positive Cocci
=550  \\$wg$aLactobacillales
=550  \\$wh$aLactococcus
=550  \\$wh$aStreptococcus
=680  \\$iA family of gram-positive non-sporing bacteria including many parasitic, pathogenic, and saprophytic forms.
=688  \\$a76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75
=750  \0$aStreptococcaceae$5IEN$0(DLC)sh 85128676

=LDR  00856cz  a2200193n  4500
=001  9880363898402441
=005  20141212205904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013288
=035  \\$aCBA6612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x370.$x700
=072  \\$aB3.$x440.$x450.$x700
=150  \\$aStreptobacillus
=550  \\$wg$aFusobacteria
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=667  \\$ainfection: coord IM with FUSOBACTERIUM INFECTIONS (IM) or RAT-BITE FEVER (IM) (see MeSH definition)
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that require SERUM; ASCITIC FLUID; or BLOOD for growth. Its organisms inhabit the THROAT; and NASOPHARYNX of wild and laboratory rats and cause one form of RAT-BITE FEVER in man.
=750  \0$aStreptobacillus$5IEN$0(DLC)sh 88023341

=LDR  01289cz  a2200337n  4500
=001  9880363898602441
=005  20190304141939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013286
=035  \\$aCBA6610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x188.$x800
=150  \\$aDatura stramonium
=450  \\$wnnna$aDatura stramoniums
=450  \\$wnnna$aJimson Weed
=450  \\$wnnna$aJimson Weeds
=450  \\$aJimsonweed
=450  \\$wnnna$aJimsonweeds
=450  \\$aStramonium
=450  \\$wnnna$astramonium, Datura
=450  \\$wnnna$aStramoniums
=450  \\$wnnna$astramoniums, Datura
=450  \\$aThornapple
=450  \\$wnnna$aThornapples
=450  \\$wnnna$aWeed, Jimson
=450  \\$wnnna$aWeeds, Jimson
=550  \\$wg$aDatura
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus DATURA, family SOLANACEAE, that contains TROPANES and other SOLANACEOUS ALKALOIDS.
=688  \\$a2003(1963)
=750  \0$aDatura stramonium$0(DLC)sh 85035895$5IEN

=LDR  01414cz  a2200373n  4500
=001  9880363898702441
=005  20141212205903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013285
=035  \\$aCBA6609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x562.$x887
=072  \\$aC11.$x590.$x810
=150  \\$aStrabismus
=450  \\$wnnna$aComitant Strabismus
=450  \\$wnnna$aComitant Strabismus, Convergent
=450  \\$wnnna$aConvergent Comitant Strabismus
=450  \\$aHypertropia
=450  \\$wnnna$aHypertropias
=450  \\$wnnna$aMechanical Strabismus
=450  \\$wnnna$aNoncomitant Strabismus
=450  \\$wnnna$aPhoria
=450  \\$aPhorias
=450  \\$aSquint
=450  \\$aStrabismus, Comitant
=450  \\$wnnna$aStrabismus, Convergent Comitant
=450  \\$wnnna$aStrabismus, Mechanical
=450  \\$aStrabismus, Noncomitant
=550  \\$wg$aOcular Motility Disorders
=550  \\$wh$aEsotropia
=550  \\$wh$aExotropia
=550  \\$aOrthoptics
=680  \\$iMisalignment of the visual axes of the eyes. In comitant strabismus the degree of ocular misalignment does not vary with the direction of gaze. In noncomitant strabismus the degree of misalignment varies depending on direction of gaze or which eye is fixating on the target. (Miller, Walsh & Hoyt's Clinical Neuro-Ophthalmology, 4th ed, p641)
=750  \0$aStrabismus$5IEN$0(DLC)sh 85128443

=LDR  00985cz  a2200313n  4500
=001  9880363898802441
=005  20141212205901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013280
=035  \\$aCBA6603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x864
=150  \\$aStomatitis
=450  \\$wnnna$aMucositides, Oral
=450  \\$wnnna$aMucositis, Oral
=450  \\$wnnna$aOral Mucositides
=450  \\$aOral Mucositis
=450  \\$wnnna$aOromucositides
=450  \\$wnnna$aOromucositis
=450  \\$wnnna$aStomatitides
=550  \\$wg$aMouth Diseases
=550  \\$wh$aStevens-Johnson Syndrome
=550  \\$wh$aStomatitis, Aphthous
=550  \\$wh$aStomatitis, Denture
=550  \\$wh$aStomatitis, Herpetic
=550  \\$wh$aVesicular Stomatitis
=667  \\$amycotic stomatitis = CANDIDIASIS, ORAL
=680  \\$iINFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
=750  \0$aStomatitis$5IEN$0(DLC)sh 85128278

=LDR  01105cz  a2200265n  4500
=001  9880363898902441
=005  20141212205900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013276
=035  \\$aCBA6599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x608.$x849
=072  \\$aC6.$x405.$x748.$x586.$x849
=150  \\$aStomach Ulcer
=450  \\$aGastric Ulcer
=450  \\$wnnna$aGastric Ulcers
=450  \\$wnnna$aStomach Ulcers
=450  \\$wnnna$aUlcer, Gastric
=450  \\$wnnna$aUlcer, Stomach
=450  \\$wnnna$aUlcers, Gastric
=450  \\$wnnna$aUlcers, Stomach
=550  \\$wg$aPeptic Ulcer
=667  \\$aperforated = STOMACH ULCER /compl (IM) + PEPTIC ULCER PERFORATION (IM); hemorrhage = STOMACH ULCER /compl (IM) + PEPTIC ULCER HEMORRHAGE (IM); "gastroduodenal ulcer" = GASTRODUODENAL ULCER see PEPTIC ULCER
=680  \\$iUlceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
=750  \0$aStomach$xUlcers$5IEN$0(DLC)sh 85128275

=LDR  01563cz  a2200445n  4500
=001  9880363899002441
=005  20141212205859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013274
=035  \\$aCBA6597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x767
=072  \\$aC6.$x301.$x371.$x767
=072  \\$aC6.$x405.$x249.$x767
=072  \\$aC6.$x405.$x748.$x789
=150  \\$aStomach Neoplasms
=450  \\$wnnna$aCancer, Gastric
=450  \\$aCancer of Stomach
=450  \\$wnnna$aCancer of the Stomach
=450  \\$wnnna$aCancer, Stomach
=450  \\$wnnna$aCancers, Gastric
=450  \\$wnnna$aCancers, Stomach
=450  \\$aGastric Cancer
=450  \\$wnnna$aGastric Cancer, Familial Diffuse
=450  \\$wnnna$aGastric Cancers
=450  \\$wnnna$aGastric Neoplasm
=450  \\$aGastric Neoplasms
=450  \\$wnnna$aNeoplasm, Gastric
=450  \\$wnnna$aNeoplasm, Stomach
=450  \\$wnnna$aNeoplasms, Gastric
=450  \\$wnnna$aNeoplasms, Stomach
=450  \\$aStomach Cancer
=450  \\$wnnna$aStomach Cancers
=450  \\$wnnna$aStomach Neoplasm
=550  \\$wg$aGastrointestinal Neoplasms
=550  \\$wg$aStomach Diseases
=667  \\$acoord IM with histol type of neopl (IM); neopl of ruminant stomach or its parts: coord STOMACH, RUMINANT or indention (IM) with STOMACH NEOPLASMS /vet (IM) + histol type of neopl /vet (IM)
=680  \\$iTumors or cancer of the STOMACH.
=750  \0$aStomach$xTumors$5IEN-M$0(DLC)sh 85128274
=750  \0$aStomach$xCancer$5IEN-HS$0(DLC)sh 85128258

=LDR  01410cz  a2200433n  4500
=001  9880363899102441
=005  20141212205858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013272
=035  \\$aCBA6595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748
=150  \\$aStomach Diseases
=450  \\$wnnna$aDisease, Gastric
=450  \\$wnnna$aDisease, Stomach
=450  \\$wnnna$aDiseases, Gastric
=450  \\$wnnna$aDiseases, Stomach
=450  \\$wnnna$aGastric Disease
=450  \\$wnnna$aGastric Diseases
=450  \\$wnnna$aStomach Disease
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wh$aAchlorhydria
=550  \\$wh$aDiverticulosis, Stomach
=550  \\$wh$aDuodenogastric Reflux
=550  \\$wh$aGastric Antral Vascular Ectasia
=550  \\$wh$aGastric Dilatation
=550  \\$wh$aGastric Outlet Obstruction
=550  \\$wh$aGastritis
=550  \\$wh$aGastroparesis
=550  \\$wh$aPeptic Ulcer
=550  \\$wh$aPostgastrectomy Syndromes
=550  \\$wh$aStomach Neoplasms
=550  \\$wh$aStomach Rupture
=550  \\$wh$aStomach Volvulus
=550  \\$wh$aZollinger-Ellison Syndrome
=667  \\$aGEN; inflamm dis = GASTRITIS; gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there
=680  \\$iPathological processes involving the STOMACH.
=688  \\$a66
=750  \0$aStomach$xDiseases$5IEN$0(DLC)sh 85128261

=LDR  00924cz  a2200253n  4500
=001  9880363899202441
=005  20141212205858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013271
=035  \\$aCBA6594M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x300
=150  \\$aGastric Dilatation
=450  \\$wnnna$aDilatation, Gastric
=450  \\$wnnna$aDilatation, Stomach
=450  \\$wnnna$aDilation, Gastric
=450  \\$wnnna$aDilation, Stomach
=450  \\$wnnna$aGastric Dilation
=450  \\$aStomach Dilatation
=450  \\$wnnna$aStomach Dilation
=550  \\$wg$aStomach Diseases
=680  \\$iAbnormal distention of the STOMACH due to accumulation of gastric contents that may reach 10 to 15 liters. Gastric dilatation may be the result of GASTRIC OUTLET OBSTRUCTION; ILEUS; GASTROPARESIS; or denervation.
=688  \\$a2005 (1966)
=750  \0$aStomach$xDilatation$0(IEN)7213724$5IEN-M

=LDR  01510cz  a2200277n  4500
=001  9880363899302441
=005  20141212205857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013270
=035  \\$aCBA6593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x875
=150  \\$aStomach
=360  \\$iconsider also terms at$aGASTR-
=450  \\$wnnna$aStomachs
=550  \\$wg$aUpper Gastrointestinal Tract
=550  \\$wh$aCardia
=550  \\$wh$aEsophagogastric Junction
=550  \\$wh$aGastric Fundus
=550  \\$wh$aGastric Mucosa
=550  \\$wh$aGastric Stump
=550  \\$wh$aPyloric Antrum
=550  \\$wh$aPylorus
=667  \\$a/blood supply: gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there; perforation = STOMACH /inj, not STOMACH RUPTURE; gastric secretion = GASTRIC JUICE /secret or GASTRIC MUCOSA /secret, not STOMACH /secret; stomach secretes GASTRIN; HYDROCHLORIC ACID, GASTRIC (see GASTRIC ACID); INTRINSIC FACTOR & PEPSINOGENS; /surg: consider also GASTRECTOMY; GASTROENTEROSTOMY & GASTROSTOMY; inflammation = GASTRITIS; Heidenhain pouch: index STOMACH /physiol; gastric hyperacidity: index under GASTRIC ACID /secret; mucosal prolapse = GASTRIC MUCOSA (IM) + STOMACH DISEASES (NIM) + PROLAPSE; many parts of STOMACH are available
=680  \\$iAn organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
=750  \0$aStomach$5IEN$0(DLC)sh 85128254

=LDR  01031cz  a2200277n  4500
=001  9880363899402441
=005  20141212205857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013269
=035  \\$aCBA6592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x996
=072  \\$aG17.$x830
=072  \\$aN5.$x715.$x360.$x750.$x770
=072  \\$aN6.$x850.$x520.$x830.$x996
=150  \\$aStochastic Processes
=450  \\$wnnna$aProcess, Stochastic
=450  \\$wnnna$aProcesses, Stochastic
=450  \\$wnnna$aStochastic Process
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aMarkov Chains
=667  \\$aIM general only; coordinate NIM with specific disease or other concept (IM)
=680  \\$iProcesses that incorporate some element of randomness, used particularly to refer to a time series of random variables.
=688  \\$a91(75); was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89
=750  \0$aStochastic processes$5IEN$0(DLC)sh 85128181

=LDR  00829cz  a2200253n  4500
=001  9880363899502441
=005  20141212205856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013267
=035  \\$aCBA6590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x700
=150  \\$aStilbenes
=550  \\$wg$aBenzylidene Compounds
=550  \\$wh$a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
=550  \\$wh$a4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
=550  \\$wh$aBibenzyls
=550  \\$wh$aChlorotrianisene
=550  \\$wh$aClomiphene
=550  \\$wh$aDiethylstilbestrol
=550  \\$wh$aStilbamidines
=550  \\$wh$aTamoxifen
=680  \\$iOrganic compounds that contain 1,2-diphenylethylene as a functional group.
=750  \0$aStilbene$5IEN-M$0(DLC)sh 93009136

=LDR  03049cz  a2200649n  4500
=001  9880363899602441
=005  20141212205856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013262
=035  \\$aCBA6585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x864.$x500
=072  \\$aC17.$x800.$x174.$x600.$x900
=072  \\$aC17.$x800.$x229.$x400.$x683
=072  \\$aC17.$x800.$x865.$x475.$x683
=072  \\$aC20.$x543.$x206.$x380.$x900
=072  \\$aC25.$x100.$x468.$x380.$x900
=150  \\$aStevens-Johnson Syndrome
=450  \\$wnnna$aDrug-Induced Stevens Johnson Syndrome
=450  \\$wnnna$aDrug-Induced Stevens-Johnson Syndrome
=450  \\$wnnna$aDrug Induced Stevens Johnson Syndrome
=450  \\$wnnna$aDrug-Induced Stevens-Johnson Syndromes
=450  \\$wnnna$aEpidermal Necrolyses, Toxic
=450  \\$wnnna$aEpidermal Necrolysis, Toxic
=450  \\$wnnna$aLyell Syndrome
=450  \\$wnnna$aLyell's Syndrome
=450  \\$wnnna$aLyell's Syndromes
=450  \\$wnnna$aMycoplasma-Induced Stevens Johnson Syndrome
=450  \\$wnnna$aMycoplasma-Induced Stevens-Johnson Syndrome
=450  \\$wnnna$aMycoplasma Induced Stevens Johnson Syndrome
=450  \\$wnnna$aNecrolyses, Toxic Epidermal
=450  \\$wnnna$aNecrolysis, Toxic Epidermal
=450  \\$wnnna$aNonstaphylococcal Scalded Skin Syndrome
=450  \\$wnnna$aScalded Skin Syndrome, Nonstaphylococcal
=450  \\$wnnna$aStevens Johnson Syndrome
=450  \\$wnnna$aStevens-Johnson Syndrome, Drug-Induced
=450  \\$wnnna$aStevens-Johnson Syndrome, Mycoplasma-Induced
=450  \\$wnnna$aStevens Johnson Syndrome Toxic Epidermal Necrolysis
=450  \\$wnnna$aStevens-Johnson Syndrome Toxic Epidermal Necrolysis
=450  \\$wnnna$aStevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
=450  \\$wnnna$aStevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
=450  \\$wnnna$aStevens-Johnson Syndromes, Drug-Induced
=450  \\$wnnna$aSyndrome, Lyell's
=450  \\$wnnna$aSyndrome, Mycoplasma-Induced Stevens-Johnson
=450  \\$wnnna$aSyndromes, Lyell's
=450  \\$wnnna$aToxic Epidermal Necrolyses
=450  \\$wnnna$aToxic Epidermal Necrolysis
=450  \\$wnnna$aToxic Epidermal Necrolysis Stevens Johnson Syndrome
=450  \\$wnnna$aToxic Epidermal Necrolysis Stevens-Johnson Syndrome
=450  \\$wnnna$aToxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum
=450  \\$wnnna$aToxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum
=550  \\$wg$aDrug Eruptions
=550  \\$wg$aErythema Multiforme
=550  \\$wg$aStomatitis
=550  \\$aErythema Multiforme
=680  \\$iRare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
=750  \0$aToxic epidermal necrolysis$0(DLC)sh 85136322$5IEM-M

=LDR  00961cz  a2200313n  4500
=001  9880363899702441
=005  20141212205855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013261
=035  \\$aCBA6584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x808
=072  \\$aD10.$x570.$x938
=072  \\$aD10.$x851
=150  \\$aSterols
=550  \\$wg$aCholestanes
=550  \\$wg$aLipids
=550  \\$wg$aMembrane Lipids
=550  \\$wh$aAdosterol
=550  \\$wh$aCholecalciferol
=550  \\$wh$aCholesterol
=550  \\$wh$aDihydrotachysterol
=550  \\$wh$aErgocalciferols
=550  \\$wh$aFusidic Acid
=550  \\$wh$aLanosterol
=550  \\$wh$aPhytosterols
=550  \\$wh$aSolanine
=680  \\$iSteroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987)
=750  \0$aSterols$0(DLC) sh 85128059$5IEN

=LDR  01796cz  a2200433n  4500
=001  9880363899802441
=005  20180710123224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013256
=035  \\$aCBA6579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x210.$x500
=150  \\$aSteroids
=450  \\$wnnna$aCatatoxic Steroids
=450  \\$wnnna$aSteroids, Catatoxic
=550  \\$wg$aFused-Ring Compounds
=550  \\$wh$aAndrostanes
=550  \\$wh$aBile Acids and Salts
=550  \\$wh$aCardanolides
=550  \\$wh$aCholanes
=550  \\$wh$aCholestanes
=550  \\$wh$aCyclosteroids
=550  \\$wh$aEstranes
=550  \\$wh$aGonanes
=550  \\$wh$aHomosteroids
=550  \\$wh$aHydroxysteroids
=550  \\$wh$aKetosteroids
=550  \\$wh$aNorsteroids
=550  \\$wh$aPregnanes
=550  \\$wh$aSapogenins
=550  \\$wh$aSecosteroids
=550  \\$wh$aSteroids, Brominated
=550  \\$wh$aSteroids, Chlorinated
=550  \\$wh$aSteroids, Fluorinated
=550  \\$wh$aSteroids, Heterocyclic
=667  \\$aGEN; avoid: too general; prefer more specific steroid groups or specific steroids; PLANT STEROIDS see PHYTOSTEROLS is also available.
=680  \\$iA group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=688  \\$a63; CATATOXIC STEROIDS was heading 1974-95
=750  \0$aSteroids$5IEN$0(DLC)sh 85128057

=LDR  00459cz  a2200181n  4500
=001  9880363899902441
=005  20181210101011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013249
=035  \\$aCBA6572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x570.$x750
=150  \\$aSternum
=450  \\$wnnna$aSternums
=550  \\$wg$aRib Cage
=550  \\$wh$aManubrium
=550  \\$wh$aXiphoid Bone
=750  \0$aSternum$5IEN$0(DLC)sh 85128047

=LDR  02353cz  a2200673n  4500
=001  9880363900002441
=005  20141212205849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013246
=035  \\$aCBA6568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x300.$x766
=072  \\$aE4.$x950.$x599.$x683
=150  \\$aSterilization, Tubal
=450  \\$wnnna$aAldridge Procedure
=450  \\$wnnna$aChemical Tubal Occlusion
=450  \\$wnnna$aChemical Tubal Occlusions
=450  \\$wnnna$aCoagulations, Cornual
=450  \\$wnnna$aCooke Method
=450  \\$wnnna$aCornual Coagulation
=450  \\$wnnna$aCornual Coagulations
=450  \\$wnnna$aFimbriectomies
=450  \\$wnnna$aFimbriectomy
=450  \\$wnnna$aFimbriectomy, Kroener
=450  \\$wnnna$aIrving Method
=450  \\$wnnna$aKroener Fimbriectomy
=450  \\$wnnna$aKroener Method
=450  \\$aLigation, Tubal
=450  \\$wnnna$aLigations, Tubal
=450  \\$wnnna$aMadlener Method
=450  \\$wnnna$aNonchemical Tubal Occlusion
=450  \\$wnnna$aNonchemical Tubal Occlusions
=450  \\$wnnna$aOcclusion, Chemical Tubal
=450  \\$wnnna$aOcclusion, Nonchemical Tubal
=450  \\$wnnna$aPomeroy Method
=450  \\$wnnna$aPomeroy Sterilization
=450  \\$wnnna$aRing, Tubal
=450  \\$wnnna$aRings, Tubal
=450  \\$wnnna$aSterilization, Pomeroy
=450  \\$wnnna$aSterilizations, Tubal
=450  \\$aTubal Ligation
=450  \\$wnnna$aTubal Ligations
=450  \\$wnnna$aTubal Occlusion
=450  \\$wnnna$aTubal Occlusion, Chemical
=450  \\$wnnna$aTubal Occlusion, Nonchemical
=450  \\$wnnna$aTubal Occlusions
=450  \\$wnnna$aTubal Occlusions, Chemical
=450  \\$wnnna$aTubal Occlusions, Nonchemical
=450  \\$wnnna$aTubal Ring
=450  \\$wnnna$aTubal Rings
=450  \\$wnnna$aTubal Sterilization
=450  \\$wnnna$aTubal Sterilizations
=450  \\$wnnna$aUchida Method
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$wg$aSterilization, Reproductive
=550  \\$aFallopian Tubes
=680  \\$iProcedures that render the female sterile by interrupting the flow in the FALLOPIAN TUBE. These procedures generally are surgical, and may also use chemicals or physical means.
=688  \\$a1973
=750  \0$aTubal sterilization$5IEN$0(DLC)sh 85138390

=LDR  02254cz  a2200553n  4500
=001  9880363900102441
=005  20141212205848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013245
=035  \\$aCBA6567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x194.$x910
=072  \\$aE4.$x950.$x599
=150  \\$aSterilization, Reproductive
=450  \\$wnnna$aFemale Sterilization
=450  \\$wnnna$aFemale Sterilization, Voluntary
=450  \\$wnnna$aFemale Sterilizations
=450  \\$wnnna$aFemale Sterilizations, Voluntary
=450  \\$wnnna$aMale Sterilization
=450  \\$wnnna$aMale Sterilization, Voluntary
=450  \\$wnnna$aMale Sterilizations
=450  \\$wnnna$aMale Sterilizations, Voluntary
=450  \\$aReproductive Sterilization
=450  \\$wnnna$aReproductive Sterilizations
=450  \\$wnnna$aSterilization, Female
=450  \\$wnnna$aSterilization, Male
=450  \\$wnno$aSterilization, Sexual$5IEN-M
=450  \\$wnnna$aSterilization, Voluntary
=450  \\$wnnna$aSterilizations, Female
=450  \\$wnnna$aSterilizations, Male
=450  \\$wnnna$aSterilizations, Reproductive
=450  \\$wnnna$aSterilizations, Voluntary
=450  \\$wnnna$aVoluntary Female Sterilization
=450  \\$wnnna$aVoluntary Female Sterilizations
=450  \\$wnnna$aVoluntary Male Sterilization
=450  \\$wnnna$aVoluntary Male Sterilizations
=450  \\$aVoluntary Sterilization
=450  \\$wnnna$aVoluntary Sterilizations
=550  \\$wg$aContraception
=550  \\$wg$aUrogenital Surgical Procedures
=550  \\$wh$aSterilization, Involuntary
=550  \\$wh$aSterilization Reversal
=550  \\$wh$aSterilization, Tubal
=550  \\$wh$aVasectomy
=550  \\$aPopulation Control
=667  \\$arestrict to humans and vertebrates; for invertebrates, consider PEST CONTROL, BIOLOGICAL
=680  \\$iProcedures to block or remove all or part of the genital tract for the purpose of rendering individuals sterile, incapable of reproduction. Surgical sterilization procedures are the most commonly used. There are also sterilization procedures involving chemical or physical means.
=688  \\$a2004 (1963)
=750  \0$aSterilization (Birth control)$5IEN$0(DLC)sh 85128029

=LDR  01393cz  a2200373n  4500
=001  9880363900202441
=005  20141212205847.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013243
=035  \\$aCBA6565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x599.$x500
=150  \\$aSterilization Reversal
=450  \\$wnnna$aFallopian Tube Reanastomoses
=450  \\$wnnna$aFallopian Tube Reanastomosis
=450  \\$wnnna$aReanastomoses, Fallopian Tube
=450  \\$wnnna$aReanastomoses, Tubal
=450  \\$wnnna$aReanastomoses, Vas Deferens
=450  \\$wnnna$aReanastomosis, Fallopian Tube
=450  \\$wnnna$aReanastomosis, Tubal
=450  \\$wnnna$aReanastomosis, Vas Deferens
=450  \\$wnnna$aSterilization Reversals
=450  \\$wnnna$aTubal Reanastomoses
=450  \\$wnnna$aTubal Reanastomosis
=450  \\$wnnna$aVas Deferens Reanastomoses
=450  \\$wnnna$aVas Deferens Reanastomosis
=450  \\$wnnna$aVas Reanastomosis
=550  \\$wg$aSterilization, Reproductive
=550  \\$wh$aVasovasostomy
=550  \\$aSterilization, Tubal
=550  \\$aVasectomy
=680  \\$iProcedures to reverse the effect of REPRODUCTIVE STERILIZATION and to regain fertility. Reversal procedures include those used to restore the flow in the FALLOPIAN TUBE or the VAS DEFERENS.
=688  \\$a1975
=750  \0$aSterilization reversal$5IEN$0(DLC)sh 85128036

=LDR  00775cz  a2200193n  4500
=001  9880363900302441
=005  20141212205847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013242
=035  \\$aCBA6564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x450.$x850
=150  \\$aSterilization
=550  \\$wg$aInfection Control
=550  \\$wh$aDisinfection
=550  \\$aPasteurization
=667  \\$aof the environment, not sexual; differentiate from DISINFECTION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text
=680  \\$iThe destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.
=750  \0$aSterilization$5IEN$0(DLC)sh 85128026

=LDR  00805cz  a2200229n  4500
=001  9880363900502441
=005  20141212205846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013239
=035  \\$aCBA6561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x896
=150  \\$aStereotyped Behavior
=450  \\$wnnna$aBehavior, Stereotyped
=450  \\$wnnna$aBehaviors, Stereotyped
=450  \\$wnnna$aStereotyped Behaviors
=550  \\$wg$aBehavior
=550  \\$aStereotypic Movement Disorder
=667  \\$ahuman & animal
=680  \\$iRelatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive.
=688  \\$a81(73); was see under BEHAVIOR 1975-80
=750  \0$aStereotyped behavior (Psychiatry)$5IEN-M$0(DLC)sh 89004346

=LDR  01231cz  a2200349n  4500
=001  9880363900602441
=005  20141212205846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013238
=035  \\$aCBA6560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x800
=072  \\$aE5.$x873
=150  \\$aStereotaxic Techniques
=450  \\$wnnna$aStereotactic Technique
=450  \\$wnnna$aStereotactic Techniques
=450  \\$wnnna$aStereotaxic Technic
=450  \\$wnnna$aStereotaxic Technics
=450  \\$wnnna$aStereotaxic Technique
=450  \\$wnnna$aTechnic, Stereotaxic
=450  \\$wnnna$aTechnics, Stereotaxic
=450  \\$wnnna$aTechnique, Stereotactic
=450  \\$wnnna$aTechnique, Stereotaxic
=450  \\$wnnna$aTechniques, Stereotactic
=450  \\$wnnna$aTechniques, Stereotaxic
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wh$aNeuronavigation
=550  \\$wh$aRadiosurgery
=680  \\$iTechniques used mostly during brain surgery which use a system of three-dimensional coordinates to locate the site to be operated on.
=688  \\$a91; was STEREOTAXIC TECHNICS 1965-90
=750  \0$aStereotaxic techniques$5IEN$0(DLC)sh 88005696

=LDR  01083cz  a2200265n  4500
=001  9880363900702441
=005  20141212205845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013237
=035  \\$aCBA6559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x607.$x500.$x682
=150  \\$aStereoisomerism
=450  \\$aMolecular Stereochemistry
=450  \\$aStereochemistry$5IEN
=450  \\$wnnna$aStereochemistry, Molecular
=450  \\$wnnna$aStereoisomer
=450  \\$aStereoisomers
=550  \\$wg$aIsomerism
=667  \\$aNIM; policy: Manual 25.5.5.1
=680  \\$iThe phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=688  \\$a1997 (1968); for MOLECULAR STEREOCHEMISTRY use MOLECULAR CONFORMATION 1993-2008
=688  \\$a97; was STEREOISOMERS 1974-96 (Prov 1968-73)
=750  \0$aStereochemistry$5IEN-M$0(DLC)sh 85128002
=750  \0$aStereoisomers$5IEN-HS$0(DLC)sh 85128005

=LDR  01733cz  a2200529n  4500
=001  9880363900802441
=005  20180928103429.0
=008  830224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013234
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x872
=150  \\$aStem Cells
=450  \\$wnnna$aCell, Mother
=450  \\$wnnna$aCell, Progenitor
=450  \\$wnnna$aCell, Stem
=450  \\$wnnna$aCells, Mother
=450  \\$wnnna$aCells, Progenitor
=450  \\$wnnna$aCells, Stem
=450  \\$wnnna$aColony-Forming Unit
=450  \\$wnnna$aColony Forming Unit
=450  \\$aColony-Forming Units
=450  \\$wnnna$aColony Forming Units
=450  \\$wnnna$aMother Cell
=450  \\$aMother Cells
=450  \\$wnnna$aProgenitor Cell
=450  \\$aProgenitor Cells
=450  \\$wnnna$aStem Cell
=450  \\$wnnna$aUnit, Colony-Forming
=450  \\$wnnna$aUnits, Colony-Forming
=550  \\$wg$aCells
=550  \\$wh$aAdult Stem Cells
=550  \\$wh$aEmbryonic Stem Cells
=550  \\$wh$aEndothelial Progenitor Cells
=550  \\$wh$aFetal Stem Cells
=550  \\$wh$aHematopoietic Stem Cells
=550  \\$wh$aMultipotent Stem Cells
=550  \\$wh$aMyoblasts
=550  \\$wh$aNeoplastic Stem Cells
=550  \\$wh$aNeural Stem Cells
=550  \\$wh$aOogonial Stem Cells
=550  \\$wh$aPluripotent Stem Cells
=550  \\$wh$aSide-Population Cells
=550  \\$wh$aTotipotent Stem Cells
=550  \\$aStem Cell Research
=680  \\$iRelatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells.
=688  \\$a84
=750  \0$aStem cells$0(DLC) sh 85127923$5IEN

=LDR  00870cz  a2200253n  4500
=001  9880363900902441
=005  20141212205844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013232
=035  \\$aCBA6554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x490.$x800
=072  \\$aD1.$x552.$x33.$x847
=072  \\$aD25.$x58.$x807
=072  \\$aJ1.$x637.$x51.$x58.$x807
=150  \\$aSteel
=450  \\$wnnna$aSteels
=550  \\$wg$aAlloys
=550  \\$wg$aIron Compounds
=550  \\$wh$aStainless Steel
=667  \\$aD25-26 qualif
=680  \\$iA tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation.
=688  \\$a91(75); was see under ALLOYS 1968-90; was see under METALS 1963-67
=750  \0$aSteel$5IEN$0(DLC)sh 85127749

=LDR  00962cz  a2200265n  4500
=001  9880363901002441
=005  20141212205843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013229
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x882
=150  \\$aStearic Acids
=450  \\$wnnna$aAcids, Dihydrooleic
=450  \\$wnnna$aAcids, Octadecanoic
=450  \\$wnnna$aAcids, Stearic
=450  \\$wnnna$aAcids, Tetrahydrolinoleic
=450  \\$aDihydrooleic Acids
=450  \\$aOctadecanoic Acids
=450  \\$aTetrahydrolinoleic Acids
=550  \\$wg$aFatty Acids
=550  \\$wh$aStearates
=667  \\$ado not confuse X ref OCTADECANOIC ACIDS with OCTADECENOIC ACIDS see OLEIC ACIDS
=680  \\$iA group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. (Stedman, 25th ed)
=688  \\$a75; was STEARIC ACID 1963-74
=750  \0$aStearic acid$5IEN$0(DLC)sh 85127739

=LDR  00533cz  a2200169n  4500
=001  9880363901102441
=005  20141212205843.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013228
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x882.$x800
=150  \\$aStearates
=450  \\$aOctadecanoates
=550  \\$wg$aStearic Acids
=680  \\$iSalts and esters of the 18-carbon saturated, monocarboxylic acid--stearic acid.
=688  \\$a91(75); was see under STEARIC ACIDS 1975-90
=750  \0$aStearates$0(DLC) sh 85127738$5IEN

=LDR  00856cz  a2200289n  4500
=001  9880363901202441
=005  20141212205842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013227
=035  \\$aCBA6549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x900.$x800
=072  \\$aD1.$x650.$x550.$x925.$x800
=072  \\$aG16.$x500.$x887
=072  \\$aN6.$x230.$x650
=150  \\$aSteam
=450  \\$wnnna$aSteams
=450  \\$wnnna$aVapor, Water
=450  \\$wnnna$aVapors, Water
=450  \\$wnnna$aWater Vapor
=450  \\$wnnna$aWater Vapors
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aEnvironment
=550  \\$wg$aWater
=550  \\$aWater
=680  \\$iWater in its gaseous state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aSteam$5IEN$0(DLC)sh 85127636

=LDR  04302cz  a2201141n  4500
=001  9880363901302441
=005  20141212205841.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013223
=035  \\$aCBA6545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740
=072  \\$aH1.$x548.$x832
=072  \\$aN5.$x715.$x360.$x750
=072  \\$aN6.$x850.$x520.$x830
=150  \\$aStatistics as Topic
=450  \\$wnnna$aAnalyses, Area
=450  \\$wnnna$aAnalyses, Data
=450  \\$wnnna$aAnalyses, Multiple Classification
=450  \\$wnnna$aAnalysis, Area
=450  \\$wnnna$aAnalysis, Data
=450  \\$wnnna$aAnalysis, Multiple Classification
=450  \\$wnnna$aArea Analyses
=450  \\$wnnna$aArea Analysis
=450  \\$wnnna$aClassification Analyses, Multiple
=450  \\$wnnna$aClassification Analysis, Multiple
=450  \\$wnnna$aCorrelation of Data
=450  \\$wnnna$aCorrelation Studies
=450  \\$wnnna$aCorrelation Study
=450  \\$wnnna$aData Analyses
=450  \\$wnnna$aData Analysis
=450  \\$wnnna$aData Correlation
=450  \\$wnnna$aData Correlations
=450  \\$wnnna$aEstimation Technic
=450  \\$wnnna$aEstimation Technic, Indirect
=450  \\$wnnna$aEstimation Technics
=450  \\$wnnna$aEstimation Technics, Indirect
=450  \\$wnnna$aEstimation Technique
=450  \\$wnnna$aEstimation Technique, Indirect
=450  \\$wnnna$aEstimation Techniques
=450  \\$wnnna$aEstimation Techniques, Indirect
=450  \\$wnnna$aIndirect Estimation Technic
=450  \\$wnnna$aIndirect Estimation Technics
=450  \\$wnnna$aIndirect Estimation Technique
=450  \\$wnnna$aIndirect Estimation Techniques
=450  \\$aMedical Statistics$5IEN
=450  \\$wnnna$aMultiple Classification Analyses
=450  \\$wnnna$aMultiple Classification Analysis
=450  \\$wnnna$aService Statistics
=450  \\$wnnna$aStatistical Studies
=450  \\$wnnna$aStatistical Study
=450  \\$aStatisticians$5IEN
=450  \\$wnnna$aStatistics, Service
=450  \\$wnnna$aStudies, Correlation
=450  \\$wnnna$aStudies, Statistical
=450  \\$wnnna$aStudy, Correlation
=450  \\$wnnna$aStudy, Statistical
=450  \\$wnnna$aTables and Charts as Topic
=450  \\$wnnna$aTechnic, Estimation
=450  \\$wnnna$aTechnic, Indirect Estimation
=450  \\$wnnna$aTechnics, Estimation
=450  \\$wnnna$aTechnics, Indirect Estimation
=450  \\$wnnna$aTechnique, Estimation
=450  \\$wnnna$aTechnique, Indirect Estimation
=450  \\$wnnna$aTechniques, Estimation
=450  \\$wnnna$aTechniques, Indirect Estimation
=550  \\$wg$aEpidemiologic Methods
=550  \\$wg$aHealth Care Evaluation Mechanisms
=550  \\$wg$aMathematics
=550  \\$wh$aActuarial Analysis
=550  \\$wh$aAnalysis of Variance
=550  \\$wh$aArea Under Curve
=550  \\$wh$aBiometry
=550  \\$wh$aBiostatistics
=550  \\$wh$aCluster Analysis
=550  \\$wh$aConfidence Intervals
=550  \\$wh$aData Interpretation, Statistical
=550  \\$wh$aDiscriminant Analysis
=550  \\$wh$aFactor Analysis, Statistical
=550  \\$wh$aMatched-Pair Analysis
=550  \\$wh$aModels, Statistical
=550  \\$wh$aMonte Carlo Method
=550  \\$wh$aMultilevel Analysis
=550  \\$wh$aPrincipal Component Analysis
=550  \\$wh$aProbability
=550  \\$wh$aRegression Analysis
=550  \\$wh$aSensitivity and Specificity
=550  \\$wh$aSpatial Analysis
=550  \\$wh$aStatistical Distributions
=550  \\$wh$aStatistics, Nonparametric
=550  \\$wh$aStochastic Processes
=550  \\$wh$aSurvival Analysis
=667  \\$aprefer the qualifier /statist with non-disease terms; statistics on a disease = /epidemiol; do not confuse with MATHEMATICS; do not confuse with the Publication Type STATISTICS
=680  \\$iThe science and art of collecting, summarizing, and analyzing data that are subject to random variation. The term is also applied to the data themselves and to the summarization of the data.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Statistics
=750  \0$aStatistics$0(DLC) sh 85127580$5IEN-HS
=750  \0$aStatisticians$0(DLC) sh 85127579$5IEN-HS

=LDR  01327cz  a2200277n  4500
=001  9880363901402441
=005  20141212205839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013222
=035  \\$aCBA6544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x550.$x902
=072  \\$aN3.$x858
=150  \\$aState Medicine
=450  \\$wnnna$aBritish Health Service, National
=450  \\$wnnna$aBritish National Health Service
=450  \\$wnnna$aMedicine, Socialized
=450  \\$wnnna$aMedicine, State
=450  \\$aNational Health Service, British
=450  \\$wnnna$aService, British National Health
=450  \\$aSocialized Medicine
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wg$aNational Health Programs
=667  \\$anot for medical programs of individual states; compulsory system of personal medical care under control of a national government paying physicians out of public funds; compulsory: do not confuse with NATIONAL HEALTH PROGRAMS; specify country, even GREAT BRITAIN despite entry term NATIONAL HEALTH SERVICE, BRITISH
=680  \\$iA system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.
=750  \0$aNational health services$5IEN$0(DLC)sh 85083180

=LDR  00872cz  a2200253n  4500
=001  9880363901502441
=005  20141212205838.0
=008  830620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013219
=035  \\$aCBA6541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x409.$x775
=072  \\$aN3.$x540.$x348.$x875
=150  \\$aState Government
=450  \\$wnnna$aGovernment, Provincial
=450  \\$aGovernment, State
=450  \\$wnnna$aGovernments, State
=450  \\$aProvincial Government
=450  \\$wnnna$aState Governments
=550  \\$wg$aGovernment
=667  \\$anot restricted to the U.S.; no qualif; specify state or province
=680  \\$iThe level of governmental organization and function below that of the national or country-wide government.
=688  \\$a90(84); was see under GOVERNMENT 1984-89
=750  \0$aState governments$5IEN$0(DLC)sh 85127498

=LDR  00962cz  a2200265n  4500
=001  9880363901602441
=005  20141212205838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013218
=035  \\$aCBA6540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x787
=150  \\$aState Dentistry
=450  \\$wnnna$aDentistries, Socialized
=450  \\$wnnna$aDentistries, State
=450  \\$wnnna$aDentistry, Socialized
=450  \\$wnnna$aDentistry, State
=450  \\$wnnna$aSocialized Dentistries
=450  \\$aSocialized Dentistry
=450  \\$wnnna$aState Dentistries
=550  \\$wg$aHealth Care Economics and Organizations
=667  \\$anot for dent programs of individual states ( = specific dent program + specific state); specify country; DF: STATE DENT
=680  \\$iControl, direction and financing of the total dental care of the population by a national government.
=688  \\$a65
=750  \0$aDentistry, State$5IEN$0(DLC)sh 85036971

=LDR  00726cz  a2200229n  4500
=001  9880363901702441
=005  20141212205838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013217
=035  \\$aCBA6539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x750
=150  \\$aStarvation
=450  \\$wnnna$aFamine
=450  \\$wnnna$aFamines
=450  \\$wnnna$aStarvations
=550  \\$wg$aMalnutrition
=550  \\$aFasting
=550  \\$aFood Deprivation
=667  \\$aTN 80: definition & relation to FASTING; refeeding after starvation: index refeeding under FOOD if pertinent
=680  \\$iLengthy and continuous deprivation of food. (Stedman, 25th ed)
=750  \0$aStarvation$5IEN$0(DLC)sh 85127471

=LDR  01576cz  a2200421n  4500
=001  9880363901802441
=005  20141212192540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013216
=035  \\$aCBA6538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x550.$x650.$x800
=072  \\$aE1.$x370.$x600.$x550.$x650.$x800
=072  \\$aF2.$x830.$x702.$x807
=072  \\$aG11.$x561.$x600.$x765.$x869
=150  \\$aReflex, Startle
=450  \\$wnnna$aAcoustic Startle Reflex
=450  \\$wnnna$aMoro Reflex
=450  \\$wnnna$aReaction, Startle
=450  \\$wnnna$aReactions, Startle
=450  \\$wnnna$aReflex, Acoustic Startle
=450  \\$wnnna$aReflex, Moro
=450  \\$wnnna$aResponse, Startle
=450  \\$wnnna$aResponses, Startle
=450  \\$aStartle Reaction
=450  \\$wnnna$aStartle Reactions
=450  \\$wnnna$aStartle Reflex
=450  \\$wnnna$aStartle Reflex, Acoustic
=450  \\$wnnna$aStartle Response
=450  \\$wnnna$aStartle Responses
=550  \\$wg$aReflex
=550  \\$aPrepulse Inhibition
=667  \\$ahuman & animal
=680  \\$iA complex involuntary response to an unexpected strong stimulus. The reaction involves physical movement away from the stimulus, MUSCLE CONTRACTION and limb flexion, BLINKING, and changes in HEART RATE, BLOOD PRESSURE, and RESPIRATION.
=688  \\$a2015(1954); use STARTLE REACTION 1966-2014, use REFLEX 1954-1965
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Startle Reaction
=688  \\$a69(65)
=750  \0$aStartle reaction$5IEN$0(DLC)sh 85127470

=LDR  00620cz  a2200217n  4500
=001  9880363901902441
=005  20141212205838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013215
=035  \\$aCBA6537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x765
=150  \\$aStarfish
=450  \\$wnnna$aStarfishs
=550  \\$wg$aEchinodermata
=550  \\$wh$aAsterias
=550  \\$wh$aAsterina
=667  \\$anote specifics
=680  \\$iEchinoderms having bodies of usually five radially disposed arms coalescing at the center.
=688  \\$a72
=750  \0$aStarfishes$5IEN$0(DLC)sh 85127400

=LDR  01006cz  a2200301n  4500
=001  9880363902002441
=005  20141212205837.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013213
=035  \\$aCBA6535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x855
=072  \\$aD9.$x698.$x365.$x855
=150  \\$aStarch
=450  \\$wnnna$aAmylomaize Starch
=450  \\$wnnna$aAmylum
=450  \\$wnnna$aCornstarch
=450  \\$wnnna$aKeoflo
=450  \\$wnnna$aStarch, Amylomaize
=550  \\$wg$aGlucans
=550  \\$wh$aAmylopectin
=550  \\$wh$aAmylose
=550  \\$wh$aDextrins
=550  \\$wh$aHydroxyethyl Starch Derivatives
=550  \\$wh$aInulin
=550  \\$aEndosperm
=680  \\$iAny of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants.
=750  \0$aStarch$5IEN$0(DLC)sh 85127386

=LDR  01034cz  a2200205n  4500
=001  9880363902102441
=005  20141212205836.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013211
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x800.$x750.$x100
=072  \\$aB3.$x510.$x100.$x750.$x750.$x100
=072  \\$aB3.$x510.$x400.$x790.$x750.$x100
=150  \\$aStaphylococcus aureus
=550  \\$wg$aStaphylococcus
=550  \\$wh$aMethicillin-Resistant Staphylococcus aureus
=667  \\$ainfection = STAPHYLOCOCCAL INFECTIONS & do not bother to coord with S. aureus unless particularly discussed (index IM); DF: STAPH AUREUS
=680  \\$iPotentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
=688  \\$a76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91
=750  \0$aStaphylococcus aureus$5IEN$0(DLC)sh 85127365

=LDR  01356cz  a2200289n  4500
=001  9880363902202441
=005  20200706140515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013210
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x800.$x750
=072  \\$aB3.$x510.$x100.$x750.$x750
=072  \\$aB3.$x510.$x400.$x790.$x750
=150  \\$aStaphylococcus
=550  \\$wg$aStaphylococcaceae
=550  \\$wh$aStaphylococcus aureus
=550  \\$wh$aStaphylococcus capitis
=550  \\$wh$aStaphylococcus epidermidis
=550  \\$wh$aStaphylococcus haemolyticus
=550  \\$wh$aStaphylococcus hominis
=550  \\$wh$aStaphylococcus hyicus
=550  \\$wh$aStaphylococcus intermedius
=550  \\$wh$aStaphylococcus lugdunensis
=550  \\$wh$aStaphylococcus saprophyticus
=667  \\$ainfection = STAPHYLOCOCCAL INFECTIONS on data form; staphylococcal clumping factor = COAGULASE (see X refs there); DF: STAPH
=680  \\$iA genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
=750  \0$aStaphylococcus$5IEN$0(DLC)sh 85127364

=LDR  01119cz  a2200253n  4500
=001  9880363902302441
=005  20141212205834.0
=008  770524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013205
=035  \\$aCBA6527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97.$x820
=072  \\$aD23.$x50.$x161.$x821
=150  \\$aStaphylococcal Protein A
=450  \\$wnnna$aA, Protein
=450  \\$wnnna$aA, Staphylococcal Protein
=450  \\$aProtein A
=450  \\$wnnna$aProtein A, Staphylococcal
=550  \\$wg$aAntigens, Bacterial
=550  \\$wg$aBacterial Proteins
=667  \\$a/drug eff /ultrastruct permitted; DF: STAPH PROTEIN A
=680  \\$iA protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function.
=688  \\$a78
=750  \0$aStaphylococcal protein A$5IEN$0(DLC)sh 85127363

=LDR  01008cz  a2200253n  4500
=001  9880363902402441
=005  20141212205834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013203
=035  \\$aCBA6525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x868
=150  \\$aStaphylococcal Infections
=450  \\$wnnna$aInfection, Staphylococcal
=450  \\$wnnna$aInfections, Staphylococcal
=450  \\$wnnna$aStaphylococcal Infection
=550  \\$wg$aGram-Positive Bacterial Infections
=550  \\$wh$aPneumonia, Staphylococcal
=550  \\$wh$aStaphylococcal Food Poisoning
=550  \\$wh$aStaphylococcal Skin Infections
=667  \\$agram-pos bact infect; STAPHYLOCOCCAL FOOD POISONING is also available; DF: STAPH INFECT
=680  \\$iInfections with bacteria of the genus STAPHYLOCOCCUS.
=688  \\$aSTAPHYLOCOCCAL INFECTIONS, GASTROINTESTINAL & STAPHYLOCOCCAL INFECTIONS, RESPIRATORY were headings 1963-67
=750  \0$aStaphylococcal infections$5IEN$0(DLC)sh 85127362

=LDR  00796cz  a2200265n  4500
=001  9880363902502441
=005  20141212205833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013201
=035  \\$aCBA6523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x450.$x731
=150  \\$aStapes Surgery
=450  \\$wnnna$aStapedectomies
=450  \\$aStapedectomy
=450  \\$wnnna$aStapes Surgeries
=450  \\$aStapes$xsurgery
=450  \\$wnnna$aSurgeries, Stapes
=450  \\$wnnna$aSurgery, Stapes
=550  \\$wg$aOtologic Surgical Procedures
=550  \\$wh$aStapes Mobilization
=550  \\$aEar Ossicles
=667  \\$ado not use /util except by MeSH definition; STAPES MOBILIZATION is also available
=688  \\$a64
=750  \0$aStapes$xSurgery$5IEN$0(DLC)sh 85127360

=LDR  00585cz  a2200169n  4500
=001  9880363902602441
=005  20141212205832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013199
=035  \\$aCBA6521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x397.$x247.$x806
=150  \\$aStapes
=550  \\$wg$aEar Ossicles
=680  \\$iOne of the three ossicles of the middle ear. It transmits sound vibrations from the INCUS to the internal ear (Ear, Internal see LABYRINTH).
=688  \\$a91(75); was see under EAR OSSICLES 1975-90
=750  \0$aStapes$5IEN$0(DLC)sh 85127359

=LDR  00861cz  a2200229n  4500
=001  9880363902702441
=005  20141212205831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013195
=035  \\$aCBA6517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x141.$x493.$x225
=150  \\$aStanford-Binet Test
=450  \\$aBinet Test
=450  \\$wnnna$aStanford Binet Test
=450  \\$wnnna$aSTANFTAN
=450  \\$wnnna$aTest, Binet
=450  \\$wnnna$aTest, Stanford-Binet
=550  \\$wg$aIntelligence Tests
=680  \\$iAn individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands.
=688  \\$a91(79); was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78
=750  \0$aStanford-Binet Test$5IEN$0(DLC)sh 85127326

=LDR  00655cz  a2200205n  4500
=001  9880363902802441
=005  20141212205809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013115
=035  \\$aCBA6437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x803
=150  \\$aSpinal Canal
=450  \\$wnnna$aCanal, Spinal
=450  \\$wnnna$aCanals, Spinal
=450  \\$wnnna$aSpinal Canals
=550  \\$wg$aSpine
=550  \\$wh$aEpidural Space
=667  \\$acoord IM with specific vertebrae (NIM) to locate level of spinal canal; "narrowing of the spinal canal" = SPINAL STENOSIS
=750  \0$aSpinal canal$5IEN$0(DLC)sh 85126664

=LDR  00770cz  a2200205n  4500
=001  9880363902902441
=005  20141212205809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013113
=035  \\$aCBA6435HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x389.$x678
=150  \\$aSpin Labels
=450  \\$wnnna$aLabels, Spin
=550  \\$wg$aFree Radicals
=550  \\$wh$aTriacetoneamine-N-Oxyl
=667  \\$a/chem syn permitted
=680  \\$iMolecules which contain an atom or a group of atoms exhibiting an unpaired electron spin that can be detected by electron spin resonance spectroscopy and can be bonded to another molecule. (McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed)
=688  \\$a74
=750  \0$aSpin labels$5IEN$0(DLC)sh 85126654

=LDR  01112cz  a2200205n  4500
=001  9880363903002441
=005  20141212205808.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013112
=035  \\$aCBA6434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x803
=150  \\$aSpiders
=450  \\$wnnna$aSpider
=550  \\$wg$aArachnida
=550  \\$wh$aBlack Widow Spider
=550  \\$wh$aBrown Recluse Spider
=667  \\$aSPIDER BITES is available; venomous genera include: Latrodectus (BLACK WIDOW SPIDER), Loxosceles (BROWN RECLUSE SPIDER), Tarantula
=680  \\$iArthropods of the class ARACHNIDA, order Araneae. Except for mites and ticks, spiders constitute the largest order of arachnids, with approximately 37,000 species having been described. The majority of spiders are harmless, although some species can be regarded as moderately harmful since their bites can lead to quite severe local symptoms. (From Barnes, Invertebrate Zoology, 5th ed, p508; Smith, Insects and Other Arthropods of Medical Importance, 1973, pp424-430)
=750  \0$aSpiders$5IEN$0(DLC)sh 85126625

=LDR  01318cz  a2200373n  4500
=001  9880363903102441
=005  20141212205808.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013111
=035  \\$aCBA6433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65.$x870
=072  \\$aD23.$x946.$x833.$x65.$x870
=150  \\$aSpider Venoms
=450  \\$wnnna$aArachnid Venom
=450  \\$aArachnid Venoms
=450  \\$wnnna$aAraneid Venom
=450  \\$aAraneid Venoms
=450  \\$wnnna$aSpider Venom
=450  \\$wnnna$aTarantula Venoms
=450  \\$wnnna$aVenom, Arachnid
=450  \\$wnnna$aVenom, Araneid
=450  \\$wnnna$aVenom, Spider
=450  \\$wnnna$aVenoms, Arachnid
=450  \\$wnnna$aVenoms, Araneid
=450  \\$wnnna$aVenoms, Spider
=450  \\$wnnna$aVenoms, Tarantula
=550  \\$wg$aArthropod Venoms
=550  \\$wh$aAgatoxins
=550  \\$aSpider Bites
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted
=680  \\$iVenoms of arthropods of the order Araneida of the ARACHNIDA. The venoms usually contain several protein fractions, including ENZYMES, hemolytic, neurolytic, and other TOXINS, BIOLOGICAL.
=688  \\$a91(78); was see under ARTHROPOD VENOMS 1978-90
=750  \0$aPoisonous spiders$xVenom$5IEN-M$0(DLC)sh 85126627

=LDR  01076cz  a2200313n  4500
=001  9880364004202441
=005  20141212211710.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x806.$x400.$x249.$x350
=072  \\$aD3.$x383.$x97.$x500.$x350
=072  \\$aD3.$x438.$x473.$x412.$x249.$x350
=150  \\$aMitomycin
=450  \\$wnnna$aAmetycine
=450  \\$wnnna$aMitocin-C
=450  \\$wnnna$aMitocin C
=450  \\$wnnna$aMitocinC
=450  \\$wnnna$aMitomycin-C
=450  \\$aMitomycin C
=450  \\$wnnna$aMutamycin
=450  \\$wnnna$aNSC-26980
=450  \\$wnnna$aNSC 26980
=450  \\$wnnna$aNSC26980
=550  \\$wg$aMitomycins
=667  \\$aMITOMYCINS is also available
=680  \\$iAn antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
=688  \\$a2000(1992); for MITOMYCIN use MITOMYCIN (NM) 1981-1991
=750  \0$aMitomycin C$5IEN-M$0(DLC)sh 85086286

=LDR  00853cz  a2200265n  4500
=001  9880364004302441
=005  20141212211710.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016683
=035  \\$aCBM5579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x695.$x625
=150  \\$aSupine Position
=450  \\$aDorsal Position
=450  \\$wnnna$aDorsal Positions
=450  \\$wnnna$aPosition, Dorsal
=450  \\$wnnna$aPosition, Supine
=450  \\$wnnna$aPositions, Dorsal
=450  \\$wnnna$aPositions, Supine
=450  \\$wnnna$aSupine Positions
=550  \\$wg$aPosture
=667  \\$aalmost never IM; do not confuse with SUPINATION, a movement of the foot or forearm
=680  \\$iThe posture of an individual lying face up.
=688  \\$a92; was see SUPINATION 1988-91
=750  \0$aSupine position$5IEN-M$0(DLC)sh 85130681

=LDR  00765cz  a2200241n  4500
=001  9880364004402441
=005  20141212211709.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016680
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x358.$x207
=150  \\$aGenome, Bacterial
=450  \\$aBacterial Genome
=450  \\$wnnna$aBacterial Genomes
=450  \\$wnnna$aGenomes, Bacterial
=550  \\$wg$aGenome, Microbial
=550  \\$wh$aGenes, Bacterial
=550  \\$wh$aOperon
=550  \\$aGenes, Bacterial
=667  \\$acoordinate IM with specific bacterium /genet (IM); DF: GENOME BACT
=680  \\$iThe genetic complement of a BACTERIA as represented in its DNA.
=688  \\$a92
=750  \0$aBacterial genomes$0(DLC) sh2003008346$5IEN-M

=LDR  00778cz  a2200229n  4500
=001  9880364004502441
=005  20141212211708.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016679
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x358.$x840
=150  \\$aGenome, Viral
=450  \\$wnnna$aGenomes, Viral
=450  \\$aViral Genome
=450  \\$wnnna$aViral Genomes
=550  \\$wg$aGenome, Microbial
=550  \\$wh$aGenes, Viral
=550  \\$aGenes, Viral
=667  \\$acoordinate IM with specific virus /genet (IM)
=680  \\$iThe complete genetic complement contained in a DNA or RNA molecule in a virus.
=688  \\$a92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91
=750  \0$aViral genomes$0(DLC) sh2003001451$5IEN-M

=LDR  01170cz  a2200361n  4500
=001  9880364004602441
=005  20141212211708.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016678
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340
=150  \\$aGenome
=450  \\$wnnna$aGenomes
=550  \\$wg$aGenetic Structures
=550  \\$wh$aExome
=550  \\$wh$aGenome Components
=550  \\$wh$aGenome, Helminth
=550  \\$wh$aGenome, Human
=550  \\$wh$aGenome, Insect
=550  \\$wh$aGenome, Microbial
=550  \\$wh$aGenome, Mitochondrial
=550  \\$wh$aGenome, Plant
=550  \\$wh$aGenome, Plastid
=550  \\$wh$aGenome, Protozoan
=550  \\$wh$aGenome Size
=550  \\$wh$aGenomic Library
=550  \\$wh$aMetagenome
=550  \\$aGenes
=550  \\$aProteome
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with animal /genet (IM) or organism /genet (IM)
=680  \\$iThe genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA.
=688  \\$a92; was see GENOMIC LIBRARY 1990-91
=750  \0$aGenomes$5IEN-M$0(DLC)sh 85053924

=LDR  00732cz  a2200193n  4500
=001  9880364004702441
=005  20141212211707.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016674
=035  \\$aCBM5570M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x420
=150  \\$aHylobatidae
=550  \\$wg$aCatarrhini
=550  \\$wh$aHylobates
=667  \\$aa family with only one genus (HYLOBATES): gibbon, not monkey & not ape; IM; qualif permitted; diseases: coord IM with specific dis /vet (IM)
=680  \\$iA family of the suborder HAPLORHINI comprising only one genus, HYLOBATES (also called Nomascus or Symphalangus).
=688  \\$a92
=750  \0$aGibbons$0(DLC)sh 85054854$5IEN-M

=LDR  02650cz  a2200637n  4500
=001  9880364004802441
=005  20141212211706.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016672
=035  \\$aCBM5568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x415.$x625.$x900
=150  \\$aZenker Diverticulum
=450  \\$wnnna$aDiverticula, Esophago-Pharyngeal
=450  \\$wnnna$aDiverticula, Pharyngeal
=450  \\$wnnna$aDiverticula, Pharyngo-Esophageal
=450  \\$wnnna$aDiverticula, Pharyngoesophageal
=450  \\$wnnna$aDiverticula, Pharyngoesophageal Pulsion
=450  \\$wnnna$aDiverticula, Zenker's
=450  \\$wnnna$aDiverticulum, Esophago-Pharyngeal
=450  \\$wnnna$aDiverticulum, Esophagopharyngeal
=450  \\$wnnna$aDiverticulum, Pharyngeal
=450  \\$wnnna$aDiverticulum, Pharyngo-Esophageal
=450  \\$wnnna$aDiverticulum, Pharyngoesophageal
=450  \\$wnnna$aDiverticulum, Pharyngoesophageal Pulsion
=450  \\$wnnna$aDiverticulum, Zenker
=450  \\$wnnna$aDiverticulum, Zenker's
=450  \\$wnnna$aDiverticulums, Esophagopharyngeal
=450  \\$wnnna$aEsophago-Pharyngeal Diverticula
=450  \\$wnnna$aEsophago Pharyngeal Diverticula
=450  \\$wnnna$aEsophago-Pharyngeal Diverticulum
=450  \\$wnnna$aEsophago Pharyngeal Diverticulum
=450  \\$aEsophagopharyngeal Diverticulum
=450  \\$wnnna$aEsophagopharyngeal Diverticulums
=450  \\$wnnna$aPharyngeal Diverticula
=450  \\$aPharyngeal Diverticulum
=450  \\$wnnna$aPharyngo-Esophageal Diverticula
=450  \\$wnnna$aPharyngo Esophageal Diverticula
=450  \\$wnnna$aPharyngo-Esophageal Diverticulum
=450  \\$wnnna$aPharyngo Esophageal Diverticulum
=450  \\$wnnna$aPharyngoesophageal Diverticula
=450  \\$aPharyngoesophageal Diverticulum
=450  \\$wnnna$aPharyngoesophageal Pulsion Diverticula
=450  \\$wnnna$aPharyngoesophageal Pulsion Diverticulum
=450  \\$wnnna$aPulsion Diverticula, Pharyngoesophageal
=450  \\$wnnna$aPulsion Diverticulum, Pharyngoesophageal
=450  \\$wnnna$aZenker Diverticula
=450  \\$wnnna$aZenker's Diverticula
=450  \\$wnnna$aZenkers Diverticula
=450  \\$aZenker's Diverticulum
=450  \\$wnnna$aZenkers Diverticulum
=550  \\$wg$aDiverticulum, Esophageal
=667  \\$ainflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (IM)
=680  \\$iA DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus.
=688  \\$a2000(1992)
=750  \0$aHypopharynx$xDiverticula$5IEN-M$0(DLC)sh 85063803

=LDR  01279cz  a2200301n  4500
=001  9880364004902441
=005  20141212211705.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016671
=035  \\$aCBM5567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x730
=150  \\$aTheropithecus
=450  \\$aBaboon, Gelada
=450  \\$wnnna$aBaboons, Gelada
=450  \\$wnnna$aGelada
=450  \\$aGelada Baboon
=450  \\$wnnna$aGelada Baboons
=450  \\$wnnna$agelada, Theropithecus
=450  \\$wnnna$aGeladas
=450  \\$wnnna$ageladas, Theropithecus
=450  \\$aTheropithecus gelada
=450  \\$wnnna$aTheropithecus geladas
=550  \\$wg$aCercopithecinae
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of Old World monkeys of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, that inhabits the mountainous regions of Ethiopia. The genus consists of only one species, Theropithecus gelada.
=688  \\$a92; THEROPITHECUS GELADA was heading 1981-96 (see under CERCOPITHECIDAE 1981-90); was GELADA see under MONKEYS 1975-80
=750  \0$aTheropithecus$5IEN-M$0(DLC)sh 85134826

=LDR  00827cz  a2200193n  4500
=001  9880364005002441
=005  20141212211705.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016669
=035  \\$aCBM5565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x260
=150  \\$aErythrocebus
=550  \\$wg$aCercopithecinae
=550  \\$wh$aErythrocebus patas
=667  \\$aOld World monkey; NIM when exper animal; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$ia genus of Old World monkeys of the family CERCOPITHECINAE that inhabit the forests and savannas of Africa. It contains only one species, ERYTHROCEBUS PATAS, also known as the patas monkey or red monkey.
=688  \\$a92
=750  \0$aErythrocebus$5IEN-M$0(DLC)sh 87003816

=LDR  00817cz  a2200229n  4500
=001  9880364005102441
=005  20141212211704.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016664
=035  \\$aCBM5561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x120
=150  \\$aCercocebus
=450  \\$aLophocebus
=450  \\$wnnna$aMangabey
=450  \\$aMangabeys
=550  \\$wg$aCercopithecinae
=550  \\$wh$aCercocebus atys
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the subfamily CERCOPITHECINAE inhabiting the African forests. They are also known as mangabeys.
=688  \\$a92
=750  \0$aMangabeys$5IEN-M$0(DLC)sh 85080474

=LDR  01919cz  a2200493n  4500
=001  9880364005202441
=005  20141212211701.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016656
=035  \\$aCBM5553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x200
=072  \\$aI1.$x880.$x604.$x825.$x608.$x200
=072  \\$aN3.$x623.$x500.$x608.$x214
=150  \\$aFamily Planning Policy
=450  \\$wnnna$aAntinatalist Policies
=450  \\$wnnna$aAntinatalist Policy
=450  \\$wnnna$aFamily Planning Policies
=450  \\$wnnna$aFamily Policies
=450  \\$wnnna$aFamily Policy
=450  \\$wnnna$aOne Child Policies
=450  \\$wnnna$aOne-Child Policies
=450  \\$wnnna$aOne Child Policy
=450  \\$wnnna$aOne-Child Policy
=450  \\$wnnna$aPolicies, Antinatalist
=450  \\$wnnna$aPolicies, Family
=450  \\$wnnna$aPolicies, Family Planning
=450  \\$wnnna$aPolicies, One Child
=450  \\$wnnna$aPolicies, One-Child
=450  \\$wnnna$aPolicies, Pronatalist
=450  \\$wnnna$aPolicy, Antinatalist
=450  \\$wnnna$aPolicy, Family
=450  \\$wnnna$aPolicy, Family Planning
=450  \\$wnnna$aPolicy, One Child
=450  \\$wnnna$aPolicy, One-Child
=450  \\$wnnna$aPolicy, Pronatalist
=450  \\$wnnna$aPronatalist Policies
=450  \\$wnnna$aPronatalist Policy
=550  \\$wg$aPublic Policy
=550  \\$aPopulation Control
=667  \\$aby government: for planning on family or personal level index under FAMILY PLANNING; specify state or country
=680  \\$iA course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family.
=688  \\$a92
=750  \0$aBirth control$xGovernment policy$5IEN-M

=LDR  02067cz  a2200421n  4500
=001  9880364005302441
=005  20141212211659.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x630.$x750
=072  \\$aC19.$x391.$x630.$x750
=150  \\$aPrimary Ovarian Insufficiency
=450  \\$wnnna$aFMR1-Related Primary Ovarian Insufficiency
=450  \\$wnnna$aFMR1 Related Primary Ovarian Insufficiency
=450  \\$wnnna$aFragile X-Associated Primary Ovarian Insufficiency
=450  \\$wnnna$aFragile X Associated Primary Ovarian Insufficiency
=450  \\$aGonadotropin-Resistant Ovary Syndrome
=450  \\$wnnna$aGonadotropin Resistant Ovary Syndrome
=450  \\$wnnna$aHypergonadotropic Ovarian Failure, X-Linked
=450  \\$wnnna$aHypergonadotropic Ovarian Failure, X Linked
=450  \\$wnnna$aInsufficiency, Primary Ovarian
=450  \\$aOvarian Failure, Premature
=450  \\$wnnna$aOvarian Insufficiency, Primary
=450  \\$wnnna$aPremature Ovarian Failure
=450  \\$wnnna$aPremature Ovarian Failure 1
=450  \\$wnnna$aPremature Ovarian Failure, X-Linked
=450  \\$wnnna$aPremature Ovarian Failure, X Linked
=450  \\$aResistant Ovary Syndrome
=450  \\$wnnna$aX-Linked Hypergonadotropic Ovarian Failure
=450  \\$wnnna$aX Linked Hypergonadotropic Ovarian Failure
=550  \\$wg$aOvarian Diseases
=550  \\$aMenopause, Premature
=680  \\$iCessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.
=688  \\$a2011(1992)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Ovarian Failure, Premature
=688  \\$a1992
=750  \0$aPremature ovarian failure$0(DLC) sh 94009026$5IEN-M

=LDR  01257cz  a2200325n  4500
=001  9880364005402441
=005  20141212211658.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016647
=035  \\$aCBM5546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x150.$x105
=150  \\$aCallimico
=450  \\$wnnna$aCallimiconinae
=450  \\$wnnna$aCallimicos
=450  \\$wnnna$aGoeldi Monkey
=450  \\$wnnna$aGoeldi's Marmosets
=450  \\$aGoeldi's Monkey
=450  \\$wnnna$aGoeldis Monkey
=450  \\$wnnna$aMarmosets, Goeldi
=450  \\$aMarmosets, Goeldi's
=450  \\$wnnna$aMarmosets, Goeldis
=450  \\$wnnna$aMonkey, Goeldi's
=550  \\$wg$aCallitrichinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA genus in the subfamily CALLITRICHINAE, comprising a single species with the common name Goeldi's monkey.
=688  \\$a2006 (1975); see CALLITHRICIDAE 1981-1991
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Callimiconinae
=688  \\$a92; CALLIMICO was see CALLITHRICIDAE 1981-91; was see under MONKEYS 1975-80
=750  \0$aCallimico$0(DLC) sh 86003011$5IEN-M

=LDR  01578cz  a2200337n  4500
=001  9880364005502441
=005  20141212211658.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016645
=035  \\$aCBM5544M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x37
=150  \\$aAotidae
=450  \\$wnnna$aAotinae
=450  \\$aDouroucouli
=450  \\$aMonkey, Night
=450  \\$aMonkey, Owl
=450  \\$wnnna$aMonkeys, Night
=450  \\$wnnna$aMonkeys, Owl
=450  \\$aNight Monkey
=450  \\$wnnna$aNight Monkeys
=450  \\$aOwl Monkey
=450  \\$wnnna$aOwl Monkeys
=550  \\$wg$aPlatyrrhini
=550  \\$wh$aAotus trivirgatus
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA family of the New World monkeys inhabiting the forests of South and Central America. There is a single genus and several species occurring in this family, including AOTUS TRIVIRGATUS (Northern night monkeys).
=688  \\$a2007 (1992); for DOUROUCOULI use AOTUS TRIVIRGATUS 1981-1991; for MONKEY, NIGHT use AOTUS TRIVIRGATUS 1981-1991, use MONKEYS 1975-1980; for MONKEY, OWL use AOTUS TRIVIRGATUS 1981-1991
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Aotinae
=688  \\$a92; DOUROUCOULI was see AOTUS TRIVIRGATUS 1981-91; MONKEY, NIGHT was see AOTUS TRIVIRGATUS 1981-91, was NIGHT MONKEYS see under MONKEYS 1975-80; MONKEY, OWL was see AOTUS TRIVIRGATUS 1981-91
=750  \2$aNyctipithecidae$0(DLC)sh2006001560$5IEN-M

=LDR  01059cz  a2200277n  4500
=001  9880364005602441
=005  20141212211657.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016644
=035  \\$aCBM5543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x868.$x249
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x887.$x249
=072  \\$aD2.$x455.$x849.$x131.$x868.$x249
=072  \\$aD23.$x767.$x261.$x887.$x249
=150  \\$aCanthaxanthin
=450  \\$wnnna$aC.I. 40850
=450  \\$wnnna$aCanthaxanthine
=450  \\$wnnna$aCarophyll Red
=450  \\$wnnna$aFood Orange 8
=450  \\$wnnna$aOrobronze
=450  \\$wnnna$aRoxanthin Red 10
=550  \\$wg$aXanthophylls
=680  \\$iA trans-carotenoid pigment widely distributed in nature. The compound is used as an oral suntanning agent and as a food and drug coloring agent. Oral ingestion of the compound causes canthaxanthin retinopathy.
=688  \\$a92; was CANTHAXANTHIN (NM) 1978-91
=750  \0$aCanthaxanthin$5IEN-M$0(DLC)sh 85019808

=LDR  01695cz  a2200313n  4500
=001  9880364005702441
=005  20141212211657.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016643
=035  \\$aCBM5542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800.$x260
=072  \\$aC10.$x574.$x843.$x300
=072  \\$aC22.$x196.$x250
=150  \\$aEncephalopathy, Bovine Spongiform
=450  \\$wnnna$aBovine Spongiform Encephalitis
=450  \\$aBovine Spongiform Encephalopathy
=450  \\$wnnna$aBSE (Bovine Spongiform Encephalopathy)
=450  \\$wnnna$aBSEs (Bovine Spongiform Encephalopathy)
=450  \\$wnnna$aEncephalitis, Bovine Spongiform
=450  \\$aMad Cow Disease
=450  \\$wnnna$aMad Cow Diseases
=450  \\$aSpongiform Encephalopathy, Bovine
=550  \\$wg$aCattle Diseases
=550  \\$wg$aPrion Diseases
=667  \\$aif transmitted to man, coord IM (with probably /transm) with specific brain or other neurol dis in text (IM); if transmitted to another species of animal, coord IM (with probably /transm) with animal/dis precoord (IM) + specific animal IM or NIM; DF ENCEPH BOVINE SPONGIFORM
=680  \\$iA transmissible spongiform encephalopathy of cattle associated with abnormal prion proteins in the brain. Affected animals develop excitability and salivation followed by ATAXIA. This disorder has been associated with consumption of SCRAPIE infected ruminant derived protein. This condition may be transmitted to humans, where it is referred to as variant or new variant CREUTZFELDT-JAKOB SYNDROME. (Vet Rec 1998 Jul 25;143(41):101-5)
=688  \\$a1992
=750  \0$aBovine Spongiform Encephalopathy$5IEN-M$0(DLC)sh 91004265

=LDR  00822cz  a2200229n  4500
=001  9880364005802441
=005  20141212211655.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016638
=035  \\$aCBM5538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x625
=150  \\$aCritical Illness
=450  \\$wnnna$aCritical Illnesses
=450  \\$wnnna$aCritically Ill
=450  \\$wnnna$aIllness, Critical
=450  \\$wnnna$aIllnesses, Critical
=550  \\$wg$aDisease Attributes
=667  \\$aIM GEN only; do not index with specific dis of critically ill patient unless particularly discussed & then NIM with no qualif; /ther: consider also CRITICAL CARE
=680  \\$iA disease or state in which death is possible or imminent.
=688  \\$a92
=750  \0$aCritically ill$5IEN-M$0(DLC)sh 85034145

=LDR  02726cz  a2200565n  4500
=001  9880364005902441
=005  20141212211654.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016634
=035  \\$aCBM5535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x530
=072  \\$aE4.$x525.$x800.$x650
=072  \\$aE5.$x873.$x500
=150  \\$aRadiosurgery
=450  \\$wnnna$aBody Radiotherapies, Stereotactic
=450  \\$wnnna$aBody Radiotherapy, Stereotactic
=450  \\$wnnna$aCyberKnife Radiosurgeries
=450  \\$wnnna$aCyberKnife Radiosurgery
=450  \\$wnnna$aGamma Knife Radiosurgeries
=450  \\$aGamma Knife Radiosurgery
=450  \\$wnnna$aLINAC Radiosurgery
=450  \\$wnnna$aLinear Accelerator Radiosurgeries
=450  \\$aLinear Accelerator Radiosurgery
=450  \\$wnnna$aRadiosurgeries
=450  \\$wnnna$aRadiosurgeries, CyberKnife
=450  \\$wnnna$aRadiosurgeries, Gamma Knife
=450  \\$wnnna$aRadiosurgeries, LINAC
=450  \\$wnnna$aRadiosurgeries, Linac
=450  \\$wnnna$aRadiosurgeries, Linear Accelerator
=450  \\$wnnna$aRadiosurgeries, Stereotactic
=450  \\$wnnna$aRadiosurgery, CyberKnife
=450  \\$wnnna$aRadiosurgery, Gamma Knife
=450  \\$wnnna$aRadiosurgery, Linac
=450  \\$wnnna$aRadiosurgery, Linear Accelerator
=450  \\$wnnna$aRadiosurgery, Stereotactic
=450  \\$wnnna$aRadiotherapies, Stereotactic Body
=450  \\$wnnna$aRadiotherapy, Stereotactic Body
=450  \\$wnnna$aStereotactic Body Radiotherapies
=450  \\$aStereotactic Body Radiotherapy
=450  \\$wnnna$aStereotactic Radiosurgeries
=450  \\$aStereotactic Radiosurgery
=550  \\$wg$aRadiotherapy
=550  \\$wg$aStereotaxic Techniques
=550  \\$aParticle Accelerators
=550  \\$aRadiotherapy, Conformal
=667  \\$aa specific type of surgery; do not confuse with COMBINED MODALITY THERAPY using surgery + radiotherapy; coordinate IM with disease /surg (IM), not /radiother; gamma knife, CyberKnife & linear accelerator: index under RADIOSURGERY /instrum & do not coordinate with GAMMA RAYS or PARTICLE ACCELERATORS unless particularly discussed
=680  \\$iA radiological stereotactic technique developed for cutting or destroying tissue by high doses of radiation in place of surgical incisions. It was originally developed for neurosurgery on structures in the brain and its use gradually spread to radiation surgery on extracranial structures as well. The usual rigid needles or probes of stereotactic surgery are replaced with beams of ionizing radiation directed toward a target so as to achieve local tissue destruction.
=688  \\$a92
=750  \0$aRadiosurgery$5IEN-M$0(DLC)sh 91004318

=LDR  00660cz  a2200205n  4500
=001  9880364006002441
=005  20141212211652.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016629
=035  \\$aCBM5530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x346
=150  \\$aEsophagectomy
=450  \\$wnnna$aEsophagectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aEsophagus
=667  \\$aincludes partial & total; do not use /util except by MeSH definition
=680  \\$iExcision of part (partial) or all (total) of the esophagus. (Dorland, 28th ed)
=688  \\$a92
=750  \0$aEsophagectomy$5IEN-M$0(DLC)sh 85044849

=LDR  01081cz  a2200217n  4500
=001  9880364006102441
=005  20141212211651.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016624
=035  \\$aCBM5526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670.$x520
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670.$x520
=072  \\$aE5.$x200.$x500.$x620.$x670.$x520
=072  \\$aE5.$x200.$x750.$x600.$x670.$x520
=150  \\$aNegative Staining
=450  \\$wnnna$aStaining, Negative
=550  \\$wg$aStaining and Labeling
=680  \\$iThe technique of washing tissue specimens with a concentrated solution of a heavy metal salt and letting it dry. The specimen will be covered with a very thin layer of the metal salt, being excluded in areas where an adsorbed macromolecule is present. The macromolecules allow electrons from the beam of an electron microscope to pass much more readily than the heavy metal; thus, a reversed or negative image of the molecule is created.
=688  \\$a92
=750  \0$aNegative staining$5IEN-M$0(DLC)sh 89003755

=LDR  01024cz  a2200325n  4500
=001  9880364006202441
=005  20141212211650.0
=008  910613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016623
=035  \\$aCBM5525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x450
=072  \\$aD12.$x776.$x543.$x585.$x450
=150  \\$aIon Pumps
=450  \\$wnnna$aIon Pump
=450  \\$wnnna$aPump, Ion
=450  \\$wnnna$aPumps, Ion
=550  \\$wg$aMembrane Transport Proteins
=550  \\$wh$aAnion Transport Proteins
=550  \\$wh$aAntiporters
=550  \\$wh$aCation Transport Proteins
=550  \\$wh$aSLC4A Proteins
=550  \\$wh$aSymporters
=550  \\$aBiological Transport, Active
=550  \\$aIon Channels
=550  \\$aIon Transport
=667  \\$aGEN: prefer specifics
=680  \\$iA general class of integral membrane proteins that transport ions across a membrane against an electrochemical gradient.
=688  \\$a1994(1992);
=750  \0$aIon pumps$5IEN-M$0(DLC)sh 85067805

=LDR  01077cz  a2200277n  4500
=001  9880364006302441
=005  20141212211650.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016622
=035  \\$aCBM5524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670.$x780
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670.$x780
=072  \\$aE5.$x200.$x500.$x620.$x670.$x780
=072  \\$aE5.$x200.$x750.$x600.$x670.$x780
=150  \\$aSilver Staining
=450  \\$wnnna$aNitrate Staining, Silver
=450  \\$aSilver Nitrate Staining
=450  \\$wnnna$aStaining, Silver
=450  \\$wnnna$aStaining, Silver Nitrate
=550  \\$wg$aStaining and Labeling
=667  \\$ausually silver nitrate is the reagent in the staining so do not coord with SILVER NITRATE
=680  \\$iThe use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens.
=688  \\$a92
=750  \0$81$wb$aSilver nitrate$5IEN-M$0(DLC)sh 85122640
=750  \0$81$wb$aStains and staining (Microscopy)$5IEN-HS$0(DLC)sh 85127263

=LDR  00817cz  a2200193n  4500
=001  9880364006402441
=005  20141212211649.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x845
=072  \\$aG5.$x360.$x160.$x845
=150  \\$aTelomere
=450  \\$wnnna$aTelomeres
=550  \\$wg$aChromosome Structures
=667  \\$aterminal section of a chromosome involved in chromosomal replication & stability; A 11 qualif except /cytol; /genet permitted
=680  \\$iA terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.
=688  \\$a92
=750  \0$aTelomere$5IEN-M$0(DLC)sh 94005630

=LDR  00920cz  a2200229n  4500
=001  9880364006502441
=005  20141212211649.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016613
=035  \\$aCBM5518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x720.$x640
=072  \\$aE1.$x370.$x225.$x750.$x600.$x720.$x640
=072  \\$aE5.$x200.$x500.$x620.$x720.$x640
=072  \\$aE5.$x200.$x750.$x600.$x720.$x640
=150  \\$aPlastic Embedding
=450  \\$wnnna$aEmbedding, Plastic
=550  \\$wg$aTissue Embedding
=667  \\$acoord IM with embedding material (IM or NIM with no qualif)
=680  \\$iThe infiltrating of histological specimens with plastics, including acrylic resins, epoxy resins and polyethylene glycol, for support of the tissues in preparation for sectioning with a microtome.
=688  \\$a92
=750  \0$aTissues$xPlastic embedment$5IEN-M$0(DLC)sh 85135597

=LDR  01922cz  a2200349n  4500
=001  9880364006602441
=005  20141212211645.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016603
=035  \\$aCBM5510HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x290
=072  \\$aC10.$x668.$x491.$x387
=072  \\$aC15.$x378.$x553.$x231.$x335
=150  \\$aEosinophilia-Myalgia Syndrome
=450  \\$wnnna$aEosinophilia Myalgia Syndrome
=450  \\$wnnna$aEosinophilia-Myalgia Syndrome, L-Tryptophan-Related
=450  \\$wnnna$aEosinophilia-Myalgia Syndromes
=450  \\$wnnna$aEosinophilia-Myalgia Syndromes, L-Tryptophan-Related
=450  \\$wnnna$aL-Tryptophan-Related Eosinophilia-Myalgia Syndrome
=450  \\$wnnna$aL-Tryptophan-Related Eosinophilia-Myalgia Syndromes
=450  \\$wnnna$aSyndrome, Eosinophilia-Myalgia
=450  \\$wnnna$aSyndrome, Eosinophilia-Myalgia, L-Tryptophan-Related
=450  \\$wnnna$aSyndrome, L-Tryptophan-Related Eosinophilia-Myalgia
=450  \\$wnnna$aSyndromes, Eosinophilia-Myalgia
=450  \\$wnnna$aSyndromes, L-Tryptophan-Related Eosinophilia-Myalgia
=550  \\$wg$aEosinophilia
=550  \\$wg$aMuscular Diseases
=550  \\$aTryptophan
=680  \\$iA complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
=688  \\$a92
=750  \0$aEosinophilia-myalgia syndrome$5IEN-M$0(DLC)sh 94003464

=LDR  01327cz  a2200385n  4500
=001  9880364006702441
=005  20141212211644.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016602
=035  \\$aCBM5509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x986.$x950.$x500
=150  \\$aNeedlestick Injuries
=450  \\$wnnna$aInjuries, Needle-Stick
=450  \\$wnnna$aInjuries, Needlestick
=450  \\$wnnna$aInjuries, Sharps
=450  \\$wnnna$aInjury, Needle-Stick
=450  \\$wnnna$aInjury, Needlestick
=450  \\$wnnna$aInjury, Sharps
=450  \\$wnnna$aNeedle-Stick
=450  \\$wnnna$aNeedle-Stick Injuries
=450  \\$wnnna$aNeedle Stick Injuries
=450  \\$wnnna$aNeedle-Stick Injury
=450  \\$wnnna$aNeedle-Sticks
=450  \\$wnnna$aNeedle Sticks
=450  \\$wnnna$aNeedlestick
=450  \\$wnnna$aNeedlestick Injury
=450  \\$wnnna$aNeedlesticks
=450  \\$aSharps Injuries
=450  \\$wnnna$aSharps Injury
=550  \\$wg$aWounds, Stab
=667  \\$aIM; coord with organ/inj or precoord inj term (IM)
=680  \\$iPenetrating stab wounds caused by needles. They are of special concern to health care workers since such injuries put them at risk for developing infectious disease.
=688  \\$a92
=750  \0$aNeedlestick injuries$5IEN-M$0(DLC)sh 93008199

=LDR  00963cz  a2200241n  4500
=001  9880364006802441
=005  20141212211643.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016596
=035  \\$aCBM5506M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x220.$x990
=150  \\$aVinculin
=450  \\$aalpha-Vinculin
=450  \\$wnnna$aalpha Vinculin
=450  \\$abeta-Vinculin
=450  \\$wnnna$abeta Vinculin
=450  \\$wnnna$aIsovinculin
=550  \\$wg$aCytoskeletal Proteins
=667  \\$aa cytoskeletal protein in cell-cell & cell-matrix interactions; /drug eff /ultrastruct permitted
=680  \\$iA cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10.
=688  \\$a92; was VINCULIN (NM) 1980-91
=750  \0$aVinculin$0(DLC)sh2011005727$5IEN-M

=LDR  03190cz  a2200925n  4500
=001  9880364006902441
=005  20141212211640.0
=008  910124\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016589
=035  \\$aCBM5501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x103.$x105
=150  \\$aAstemizole
=450  \\$wnnna$aAlacan Brand of Astemizole
=450  \\$wnnna$aAlermizol
=450  \\$wnnna$aAlonga, Astemizol
=450  \\$wnnna$aAlonga Brand of Astemizole
=450  \\$wnnna$aAstemina
=450  \\$wnnna$aAstemizol Alonga
=450  \\$wnnna$aAstemizol ratiopharm
=450  \\$wnnna$aAstemizole Alacan Brand
=450  \\$wnnna$aAstemizole Alonga Brand
=450  \\$wnnna$aAstemizole Byk Brand
=450  \\$wnnna$aAstemizole Diba Brand
=450  \\$wnnna$aAstemizole Elfar Brand
=450  \\$wnnna$aAstemizole Esteve Brand
=450  \\$wnnna$aAstemizole Fustery Brand
=450  \\$wnnna$aAstemizole ICN Brand
=450  \\$wnnna$aAstemizole Janssen Brand
=450  \\$wnnna$aAstemizole Lesvi Brand
=450  \\$wnnna$aAstemizole McNeil Brand
=450  \\$wnnna$aAstemizole Medinsa Brand
=450  \\$wnnna$aAstemizole Merck Brand
=450  \\$wnnna$aAstemizole ratiopharm Brand
=450  \\$wnnna$aAstemizole Senosiain Brand
=450  \\$wnnna$aAstemizole Septa Brand
=450  \\$wnnna$aAstemizole Smaller Brand
=450  \\$wnnna$aAstemizole Urbion Brand
=450  \\$wnnna$aAstemizole Vita Brand
=450  \\$wnnna$aAstesen
=450  \\$wnnna$aByk Brand of Astemizole
=450  \\$wnnna$aDiba Brand of Astemizole
=450  \\$wnnna$aElfar Brand of Astemizole
=450  \\$wnnna$aEmdar
=450  \\$wnnna$aEsmacen
=450  \\$wnnna$aEsteve Brand of Astemizole
=450  \\$wnnna$aFustermizol
=450  \\$wnnna$aFustery Brand of Astemizole
=450  \\$wnnna$aHismanal
=450  \\$wnnna$aHistaminos
=450  \\$wnnna$aHubermizol
=450  \\$wnnna$aICN Brand of Astemizole
=450  \\$wnnna$aJanssen Brand of Astemizole
=450  \\$wnnna$aLaridal
=450  \\$wnnna$aLesvi Brand of Astemizole
=450  \\$wnnna$aMcNeil Brand of Astemizole
=450  \\$wnnna$aMedinsa Brand of Astemizole
=450  \\$wnnna$aMerck Brand of Astemizole
=450  \\$wnnna$aParalergin
=450  \\$wnnna$aR-43-512
=450  \\$wnnna$aR 43 512
=450  \\$wnnna$aR43512
=450  \\$wnnna$aratiopharm, Astemizol
=450  \\$wnnna$aratiopharm Brand of Astemizole
=450  \\$wnnna$aReig Jofre Brand of Astemizole
=450  \\$wnnna$aRetolen
=450  \\$wnnna$aRifedot
=450  \\$wnnna$aRimbol
=450  \\$wnnna$aRomadin
=450  \\$wnnna$aSenosiain Brand of Astemizole
=450  \\$wnnna$aSepta Brand of Astemizole
=450  \\$wnnna$aSimprox
=450  \\$wnnna$aSmaller Brand of Astemizole
=450  \\$wnnna$aUrbion Brand of Astemizole
=450  \\$wnnna$aUrdrim
=450  \\$wnnna$aVita Brand of Astemizole
=550  \\$wg$aBenzimidazoles
=680  \\$iAntihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
=688  \\$a92; was ASTEMIZOLE (NM) 1981-91
=750  \0$aAstemizole$5IEN-M$0(DLC)sh 90001170

=LDR  01329cz  a2200313n  4500
=001  9880364007002441
=005  20141212211637.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016585
=035  \\$aCBM5497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x954
=072  \\$aC13.$x351.$x500.$x894.$x906.$x800
=150  \\$aVaginosis, Bacterial
=450  \\$wnnna$aBacterial Vaginitides
=450  \\$wnnna$aBacterial Vaginitis
=450  \\$wnnna$aBacterial Vaginoses
=450  \\$aBacterial Vaginosis
=450  \\$wnnna$aNonspecific Vaginitis
=450  \\$wnnna$aVaginitides, Bacterial
=450  \\$aVaginitis, Bacterial
=450  \\$aVaginitis, Nonspecific
=450  \\$wnnna$aVaginoses, Bacterial
=550  \\$wg$aBacterial Infections
=550  \\$wg$aVaginitis
=667  \\$acoord IM with specific bacterium/infections heading (IM) or specific bacterium (IM) if no precoord bact/infect term exists; DF: VAGINOSIS BACT
=680  \\$iPolymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
=688  \\$a92
=750  \0$aBacterial vaginitis$5IEN-M$0(DLC)sh 87005114

=LDR  01494cz  a2200265n  4500
=001  9880364007102441
=005  20141212211636.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016584
=035  \\$aCBM5496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x700
=150  \\$aPanic Disorder
=450  \\$wnnna$aAttack, Panic
=450  \\$wnnna$aAttacks, Panic
=450  \\$wnnna$aDisorder, Panic
=450  \\$wnnna$aDisorders, Panic
=450  \\$wnnna$aPanic Attack
=450  \\$aPanic Attacks
=450  \\$wnnna$aPanic Disorders
=550  \\$wg$aAnxiety Disorders
=667  \\$anote category: do not confuse with PANIC (Cat F1)
=680  \\$iA type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
=688  \\$a92
=750  \0$aPanic disorders$0(DLC) sh 86006745$5IEN-M

=LDR  01927cz  a2200493n  4500
=001  9880364007202441
=005  20141212211636.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016583
=035  \\$aCBM5495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x200.$x260
=072  \\$aC4.$x557.$x337.$x100
=072  \\$aC20.$x673.$x483.$x260
=072  \\$aC22.$x196.$x260
=150  \\$aEnzootic Bovine Leukosis
=450  \\$aBovine Leukemia
=450  \\$wnnna$aBovine Leukemias
=450  \\$wnnna$aBovine Leukoses
=450  \\$wnnna$aBovine Leukoses, Enzootic
=450  \\$aBovine Leukosis
=450  \\$wnnna$aBovine Leukosis, Enzootic
=450  \\$aBovine Lymphoma
=450  \\$wnnna$aBovine Lymphomas
=450  \\$aBovine Lymphosarcoma
=450  \\$wnnna$aBovine Lymphosarcomas
=450  \\$wnnna$aEnzootic Bovine Leukoses
=450  \\$aLeukemia, Bovine
=450  \\$wnnna$aLeukemias, Bovine
=450  \\$wnnna$aLeukoses, Bovine
=450  \\$wnnna$aLeukoses, Enzootic Bovine
=450  \\$aLeukosis, Bovine
=450  \\$wnnna$aLeukosis, Enzootic Bovine
=450  \\$aLymphoma, Bovine
=450  \\$wnnna$aLymphomas, Bovine
=450  \\$aLymphosarcoma, Bovine
=450  \\$wnnna$aLymphosarcomas, Bovine
=550  \\$wg$aCattle Diseases
=550  \\$wg$aDeltaretrovirus Infections
=550  \\$wg$aLeukemia
=667  \\$aa specific dis caused by BOVINE LEUKEMIA VIRUS (see LEUKEMIA VIRUS, BOVINE): do not confuse with the general group BLV INFECTIONS see DELTARETROVIRUS INFECTIONS; don't forget also CATTLE (NIM) & check tag ANIMALS
=680  \\$iA lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. Enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding.
=688  \\$a92
=750  \0$aBovine Leukosis$5IEN-M$0(DLC)sh 85016141

=LDR  00848cz  a2200265n  4500
=001  9880364007302441
=005  20141212211635.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016582
=035  \\$aCBM5494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x622
=072  \\$aC4.$x557.$x337.$x385
=072  \\$aC22.$x180.$x500
=150  \\$aLeukemia, Feline
=450  \\$aFeline Leukemia
=450  \\$wnnna$aFeline Leukemias
=450  \\$wnnna$aLeukemias, Feline
=550  \\$wg$aCat Diseases
=550  \\$wg$aLeukemia
=550  \\$wg$aRetroviridae Infections
=667  \\$acaused by a retrovirus; don't forget also CATS (NIM) & check tag ANIMALS
=680  \\$iA neoplastic disease of cats frequently associated with feline leukemia virus infection.
=688  \\$a92
=750  \0$aFeline leukemia$5IEN-M$0(DLC)sh 85047699

=LDR  01175cz  a2200253n  4500
=001  9880364007402441
=005  20201209104624.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016578
=035  \\$aCBM5493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x74.$x722.$x388.$x250
=072  \\$aD3.$x132.$x889.$x354.$x250
=072  \\$aD3.$x605.$x869.$x388.$x250
=072  \\$aD4.$x75.$x80.$x875.$x99.$x722.$x388.$x250
=072  \\$aD26.$x878.$x250
=150  \\$aCrack Cocaine
=450  \\$wnnna$aCocaine, Crack
=550  \\$wg$aCocaine
=550  \\$wg$aIllicit Drugs
=667  \\$aaddiction to crack cocaine = CRACK COCAINE (IM) + COCAINE-RELATED DISORDERS (IM)
=680  \\$iThe purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. The slang term "crack" was derived from the crackling sound made upon igniting of this form of cocaine for smoking.
=688  \\$a92
=750  \0$aCrack (Drug)$5IEN-M$0(DLC)sh 87000392

=LDR  00869cz  a2200241n  4500
=001  9880364007502441
=005  20141212211635.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016577
=035  \\$aCBM5492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x760
=150  \\$aPancreaticoduodenectomy
=450  \\$wnnna$aDuodenopancreatectomies
=450  \\$aDuodenopancreatectomy
=450  \\$wnnna$aPancreaticoduodenectomies
=450  \\$wnnna$aPancreatoduodenectomies
=450  \\$aPancreatoduodenectomy
=550  \\$wg$aDigestive System Surgical Procedures
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
=688  \\$a95; was PANCREATODUODENECTOMY 1992-94
=750  \0$aPancreaticoduodenectomy$5IEN-M$0(DLC)sh 97003730

=LDR  01377cz  a2200325n  4500
=001  9880364007602441
=005  20141212211634.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016575
=035  \\$aCBM5490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x946.$x315
=150  \\$aHidradenitis
=450  \\$wnnna$aEccrine Hidradenitides, Neutrophilic
=450  \\$wnnna$aEccrine Hidradenitis, Neutrophilic
=450  \\$wnnna$aHidradenitides
=450  \\$wnnna$aHidradenitides, Neutrophilic Eccrine
=450  \\$wnnna$aHidradenitis, Neutrophilic Eccrine
=450  \\$wnnna$aHidrosadenitides
=450  \\$aHidrosadenitis
=450  \\$wnnna$aHydradenitides
=450  \\$wnnna$aHydradenitis
=450  \\$wnnna$aNeutrophilic Eccrine Hidradenitides
=450  \\$aNeutrophilic Eccrine Hidradenitis
=550  \\$wg$aSweat Gland Diseases
=550  \\$wh$aHidradenitis Suppurativa
=667  \\$ainflamm of a sweat gland
=680  \\$iThe inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions.
=688  \\$a92
=750  \0$aSweat glands$xInflammation$5IEN-M

=LDR  01458cz  a2200313n  4500
=001  9880364007702441
=005  20141212211634.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016574
=035  \\$aCBM5489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x600.$x300.$x700
=150  \\$aSeasonal Affective Disorder
=450  \\$wnnna$aAffective Disorder, Seasonal
=450  \\$wnnna$aAffective Disorders, Seasonal
=450  \\$wnnna$aDisorder, Seasonal Affective
=450  \\$wnnna$aDisorder, Seasonal Mood
=450  \\$wnnna$aDisorders, Seasonal Affective
=450  \\$wnnna$aDisorders, Seasonal Mood
=450  \\$wnnna$aMood Disorder, Seasonal
=450  \\$wnnna$aMood Disorders, Seasonal
=450  \\$wnnna$aSeasonal Affective Disorders
=450  \\$aSeasonal Mood Disorder
=450  \\$wnnna$aSeasonal Mood Disorders
=550  \\$wg$aDepressive Disorder
=667  \\$a"seasonal" refers usually to winter; DF: SAD
=680  \\$iA syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. SAD (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence.
=688  \\$a92
=750  \0$aSeasonal affective disorder$5IEN-M$0(DLC)sh 88004706

=LDR  00795cz  a2200241n  4500
=001  9880364007802441
=005  20141212211634.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016573
=035  \\$aCBM5488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31
=150  \\$aAgrochemicals
=450  \\$wnnna$aAgrichemicals
=450  \\$aAgricultural Chemicals
=450  \\$wnnna$aChemicals, Agricultural
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aFertilizers
=550  \\$wh$aPesticides
=667  \\$aD25-26 qualif; DF: AGROCHEM
=680  \\$iChemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc.
=688  \\$a92
=750  \0$aAgricultural Chemicals$5IEN-M$0(DLC)sh 85002279

=LDR  01362cz  a2200385n  4500
=001  9880364007902441
=005  20141212192707.0
=008  910108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016572
=035  \\$aCBM5487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x235.$x300
=072  \\$aD12.$x644.$x641.$x235.$x300
=150  \\$aCyclosporine
=450  \\$wnnna$aCiclosporin
=450  \\$wnnna$aCsA-Neoral
=450  \\$wnnna$aCsA Neoral
=450  \\$wnnna$aCsANeoral
=450  \\$wnnna$aCyA-NOF
=450  \\$wnnna$aCyA NOF
=450  \\$wnnna$aCyclosporin
=450  \\$aCyclosporin A
=450  \\$wnnna$aCyclosporine A
=450  \\$wnnna$aNeoral
=450  \\$wnnna$aOL 27-400
=450  \\$wnnna$aOL 27 400
=450  \\$wnnna$aOL 27400
=450  \\$wnnna$aSandimmun
=450  \\$wnnna$aSandimmun Neoral
=450  \\$wnnna$aSandimmune
=550  \\$wg$aCyclosporins
=667  \\$aa specific drug: do not confuse with CYCLOSPORINS
=680  \\$iA cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).
=688  \\$a92; for CYCLOSPORIN A use CYCLOSPORINS 1982-91
=750  \0$aCyclosporine$5IEN-M$0(DLC)sh 85035108

=LDR  00744cz  a2200217n  4500
=001  9880364008102441
=005  20141212211632.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016568
=035  \\$aCBM5483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x360
=150  \\$aDrugs, Generic
=450  \\$aDrugs, Nonproprietary
=450  \\$aGeneric Drugs
=450  \\$wnnna$aNonproprietary Drugs
=550  \\$wg$aPharmaceutical Preparations
=667  \\$aGEN only or unspecified; D25-26 qualif; for specific drug as a generic, coord IM with drug (IM)
=680  \\$iDrugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
=688  \\$a92
=750  \0$aGeneric drugs$5IEN-M$0(DLC)sh 89000501

=LDR  00665cz  a2200217n  4500
=001  9880364008202441
=005  20141212211632.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016566
=035  \\$aCBM5481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x712
=150  \\$aOrganoselenium Compounds
=450  \\$wnnna$aCompounds, Organoselenium
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aSelenocysteine
=550  \\$wh$aSelenomethionine
=667  \\$aDF: ORGANOSELENIUM CPDS
=680  \\$iOrganic compounds which contain selenium as an integral part of the molecule.
=688  \\$a92
=750  \0$aOrganoselenium compounds$5IEN-M$0(DLC)sh 85095573

=LDR  01230cz  a2200337n  4500
=001  9880364008302441
=005  20141212211631.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016565
=035  \\$aCBM5480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x700.$x200
=150  \\$aCheirogaleidae
=450  \\$aAllocebus
=450  \\$aCheirogaleus
=450  \\$wnnna$aDwarf Lemur
=450  \\$wnnna$aDwarf Lemurs
=450  \\$aLemur, Dwarf
=450  \\$aLemur, Mouse
=450  \\$wnnna$aLemurs, Dwarf
=450  \\$wnnna$aLemurs, Mouse
=450  \\$aMicrocebus
=450  \\$aMirza
=450  \\$wnnna$aMouse Lemur
=450  \\$wnnna$aMouse Lemurs
=450  \\$aPhaner
=550  \\$wg$aStrepsirhini
=667  \\$aprosimians; do not confuse X refs with genus LEMUR; IM; qualif permitted
=680  \\$iA family of the order PRIMATES, suborder Strepsirhini (PROSIMII), containing five genera. All inhabitants of Madagascar, the genera are: Allocebus, Cheirogaleus (dwarf lemurs), Microcebus (mouse lemurs), Mirza, and Phaner.
=688  \\$a92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91
=750  \0$aCheirogaleidae$5IEN-M$0(DLC)sh 85022863

=LDR  01260cz  a2200349n  4500
=001  9880364008402441
=005  20141212211630.0
=008  910424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016559
=035  \\$aCBM5475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x810
=150  \\$aTacrolimus
=450  \\$wnnna$aAnhydrous Tacrolimus
=450  \\$wnnna$aAnhydrous, Tacrolimus
=450  \\$wnnna$aCilag Brand of Tacrolimus
=450  \\$wnnna$aFK-506
=450  \\$wnnna$aFK 506
=450  \\$wnnna$aFK506
=450  \\$wnnna$aFR-900506
=450  \\$wnnna$aFR 900506
=450  \\$wnnna$aFR900506
=450  \\$wnnna$aFujisawa Brand of Tacrolimus
=450  \\$wnnna$aJanssen Brand of Tacrolimus
=450  \\$wnnna$aPrograf
=450  \\$wnnna$aPrograft
=450  \\$wnnna$aTacrolimus Anhydrous
=450  \\$wnnna$aTacrolimus, Anhydrous
=550  \\$wg$aMacrolides
=680  \\$iA macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.
=688  \\$a96; was FK-506 1992-95, was FK 506 (NM) 1987-91
=750  \0$aFK-506 (Drug)$5IEN-M$0(DLC)sh 94005977

=LDR  01485cz  a2200361n  4500
=001  9880364008502441
=005  20141212211629.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016555
=035  \\$aCBM5471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x475
=072  \\$aE5.$x318.$x780.$x485
=072  \\$aN5.$x715.$x360.$x750.$x500
=072  \\$aN5.$x715.$x360.$x780.$x500
=072  \\$aN6.$x850.$x520.$x445.$x485
=072  \\$aN6.$x850.$x520.$x830.$x475
=150  \\$aMatched-Pair Analysis
=450  \\$wnnna$aAnalyses, Matched-Pair
=450  \\$wnnna$aAnalysis, Matched-Pair
=450  \\$wnnna$aAnalysis, Matched Pair
=450  \\$wnnna$aComparison, Paired
=450  \\$wnnna$aComparisons, Paired
=450  \\$wnnna$aMatched-Pair Analyses
=450  \\$wnnna$aMatched Pair Analysis
=450  \\$wnnna$aPaired Comparison
=450  \\$wnnna$aPaired Comparisons
=550  \\$wg$aEpidemiologic Research Design
=550  \\$wg$aStatistics as Topic
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM) + matched parameter (e.g. age, sex, physiol state) (IM or NIM); no qualif
=680  \\$iA type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects (e.g., age-matched controls).
=688  \\$a92
=750  \0$aPaired comparisons (Statistics)$5IEN-M$0(DLC)sh 85096859

=LDR  00733cz  a2200217n  4500
=001  9880364008602441
=005  20141212211627.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016548
=035  \\$aCBM5465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730
=150  \\$aProsencephalon
=450  \\$aForebrain
=450  \\$wnnna$aForebrains
=550  \\$wg$aBrain
=550  \\$wh$aDiencephalon
=550  \\$wh$aTelencephalon
=680  \\$iThe anterior of the three primitive cerebral vesicles of the embryonic brain arising from the NEURAL TUBE. It subdivides to form DIENCEPHALON and TELENCEPHALON. (Stedmans Medical Dictionary, 27th ed)
=688  \\$a92
=750  \0$aProsencephalon$5IEN-M$0(DLC)sh 85107580

=LDR  01360nz  a2200349n  4500
=001  9882116471602441
=005  20230127145440.0
=008  910712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D016547
=035  \\$a(DNLM)D016547
=035  \\$a(NLM)98196843330000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25.$x193.$x500
=072  \\$aD12.$x776.$x220.$x600.$x450.$x450
=072  \\$aD12.$x776.$x631.$x560.$x450
=150  \\$aKinesins
=450  \\$aKinesin
=450  \\$aKinesin Heavy-Chain Protein
=450  \\$aKinesin Light-Chain Protein
=450  \\$aKinesin Light-Chain Proteins
=450  \\$aKinesin Superfamily
=450  \\$wnnna$aHeavy-Chain Protein, Kinesin
=450  \\$wnnna$aLight-Chain Protein, Kinesin
=450  \\$wnnna$aLight-Chain Proteins, Kinesin
=450  \\$wnnna$aProtein, Kinesin Heavy-Chain
=450  \\$wnnna$aProtein, Kinesin Heavy-Chain
=450  \\$wnnna$aProtein, Kinesin Light-Chain
=450  \\$wnnna$aProteins, Kinesin Light-Chain
=450  \\$wnnna$aSuperfamily, Kinesin
=667  \\$aa microtubule-associated protein
=680  \\$iA family of microtubule-associated mechanical adenosine triphosphatases, that uses the energy of ATP hydrolysis to move organelles along microtubules including mitosis, meiosis, and axonal transport.
=688  \\$a92; was KINESIN (NM) 1985-91
=750  \0$aKinesin$5IEN-M$0(DLC)sh 88004415

=LDR  01606cz  a2200313n  4500
=001  9880364008802441
=005  20141212211626.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016545
=035  \\$aCBM5463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195.$x205.$x200
=072  \\$aC10.$x228.$x140.$x211.$x280.$x300
=072  \\$aC10.$x551.$x240.$x250.$x200.$x200
=150  \\$aChoroid Plexus Neoplasms
=450  \\$wnnna$aChoroid Plexus Neoplasm
=450  \\$wnnna$aChoroid Plexus Neoplasms, Primary
=450  \\$wnnna$aChoroid Plexus Tumor
=450  \\$aChoroid Plexus Tumors
=450  \\$wnnna$aNeoplasm, Choroid Plexus
=450  \\$wnnna$aNeoplasms, Choroid Plexus
=450  \\$wnnna$aPrimary Choroid Plexus Neoplasms
=550  \\$wg$aCerebral Ventricle Neoplasms
=550  \\$wh$aPapilloma, Choroid Plexus
=667  \\$ain the brain: do not confuse with CHOROID NEOPLASMS (in the eye); coord IM with histol type of neopl (IM)
=680  \\$iBenign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. Papillomas (see PAPILLOMA, CHOROID PLEXUS) and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. Clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated HYDROCEPHALUS. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072; J Neurosurg 1998 Mar;88(3):521-8)
=688  \\$a1992
=750  \0$aChoroid plexus$xTumors$5IEN-M
=750  \0$aChoroid plexus$xCancer$5IEN-HS

=LDR  01182cz  a2200301n  4500
=001  9880364008902441
=005  20141212211535.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016372
=035  \\$aCBG6702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x150.$x650
=072  \\$aD13.$x444.$x600.$x150.$x760
=072  \\$aD13.$x444.$x735.$x150
=072  \\$aD27.$x720.$x470.$x530.$x600.$x150.$x760
=150  \\$aRNA, Antisense
=450  \\$wnnna$aAnti-Sense RNA
=450  \\$wnnna$aAnti Sense RNA
=450  \\$aAntisense RNA
=450  \\$wnnna$aRNA, Anti-Sense
=550  \\$wg$aAntisense Elements (Genetics)
=550  \\$wg$aRNA
=550  \\$wh$aMicroRNAs
=550  \\$wh$aOligoribonucleotides, Antisense
=550  \\$wh$aRNA, Small Interfering
=680  \\$iRNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
=688  \\$a91
=750  \0$aAntisense RNA$5IEN$0(DLC)sh 89003559

=LDR  01079cz  a2200277n  4500
=001  9880364009002441
=005  20201216175032.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016367
=035  \\$aCBG6698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x65
=072  \\$aB4.$x525.$x100
=150  \\$aBaculoviridae
=450  \\$wnnna$aBaculovirus
=450  \\$wnnna$aBaculoviruses
=450  \\$wnnna$aOryctes Virus
=450  \\$aOryctes Viruses
=550  \\$wg$aDNA Viruses
=550  \\$wg$aInsect Viruses
=550  \\$wh$aGranulovirus
=550  \\$wh$aNucleopolyhedroviruses
=667  \\$acoord IM with specific insect /virol
=680  \\$iFamily of INSECT VIRUSES containing two subfamilies: Eubaculovirinae (occluded baculoviruses) and Nudibaculovirinae (nonoccluded baculoviruses). The Eubaculovirinae, which contain polyhedron-shaped inclusion bodies, have two genera: NUCLEOPOLYHEDROVIRUS and GRANULOVIRUS. Baculovirus vectors are used for expression of foreign genes in insects.
=688  \\$a91
=750  \0$aBaculoviruses$5IEN$0(DLC)sh 85010884

=LDR  01588cz  a2200433n  4500
=001  9880364009102441
=005  20141212211532.0
=008  900802\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x490
=072  \\$aN3.$x706.$x535.$x547
=150  \\$aLiability, Legal
=450  \\$wnnna$aInstitutional Liabilities
=450  \\$aInstitutional Liability
=450  \\$wnnna$aLegal Liabilities
=450  \\$wnnna$aLegal Liability
=450  \\$wnnna$aLiabilities, Institutional
=450  \\$wnnna$aLiabilities, Legal
=450  \\$wnnna$aLiabilities, Medical
=450  \\$wnnna$aLiabilities, Personal
=450  \\$wnnna$aLiabilities, Professional
=450  \\$wnnna$aLiability, Institutional
=450  \\$wnnna$aLiability, Medical
=450  \\$wnnna$aLiability, Personal
=450  \\$wnnna$aLiability, Professional
=450  \\$wnnna$aMedical Liabilities
=450  \\$wnnna$aMedical Liability
=450  \\$wnnna$aPersonal Liabilities
=450  \\$aPersonal Liability
=450  \\$wnnna$aProfessional Liabilities
=450  \\$aProfessional Liability
=450  \\$wnnna$aTort
=450  \\$wnnna$aTorts
=550  \\$wg$aJurisprudence
=667  \\$astatement of responsibility: do not confuse with MALPRACTICE, the commission of a harmful act; coord IM with specialty (IM) if relevant or area of responsibility (IM) if relevant
=680  \\$iAccountability and responsibility to another, enforceable by civil or criminal sanctions.
=688  \\$a91
=750  \0$aLiability (Law)$5IEN$0(DLC)sh 85076398

=LDR  01074cz  a2200325n  4500
=001  9880364009202441
=005  20141212211531.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016363
=035  \\$aCBG6694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x100
=150  \\$aAntitrust Laws
=450  \\$wnnna$aAct, Sherman Antitrust
=450  \\$wnnna$aAntitrust Act, Sherman
=450  \\$wnnna$aAntitrust Law
=450  \\$wnnna$aAntitrust Liabilities
=450  \\$aAntitrust Liability
=450  \\$wnnna$aLaw, Antitrust
=450  \\$wnnna$aLaws, Antitrust
=450  \\$wnnna$aLiabilities, Antitrust
=450  \\$wnnna$aLiability, Antitrust
=450  \\$aSherman Antitrust Act
=550  \\$wg$aLegislation as Topic
=550  \\$aCommerce
=550  \\$aEconomic Competition
=667  \\$aspecify geog
=680  \\$iThose federal and state laws, and their enforcement, that protect trade and commerce from unlawful restraints and monopolies or unfair business practices.
=688  \\$a91
=750  \0$aAntitrust law$5IEN$0(DLC)sh 85005782

=LDR  00742cz  a2200229n  4500
=001  9880364009302441
=005  20141212211531.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016361
=035  \\$aCBG6692HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x45
=150  \\$aBankruptcy
=450  \\$wnnna$aBankruptcies
=450  \\$wnnna$aFinancial Insolvencies
=450  \\$aFinancial Insolvency
=450  \\$wnnna$aInsolvencies, Financial
=450  \\$wnnna$aInsolvency, Financial
=550  \\$wg$aFinancial Management
=680  \\$iThe state of legal insolvency with assets taken over by judicial process so that they may be distributed among creditors.
=688  \\$a91
=750  \0$aBankruptcy$5IEN$0(DLC)sh 85011601

=LDR  01033nz  a2200205n  4500
=001  9881821065502441
=005  20220302164157.0
=008  900525\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D016360
=035  \\$a(DNLM)D016360
=035  \\$a(NLM)98199770720000041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 127.5.C5
=072  \\$aB3.$x353.$x625.$x657.$x500
=150  \\$aClostridioides difficile
=450  \\$aClostridium difficile
=667  \\$ainfection: coordinate with probably ENTEROCOLITIS, PSEUDOMEMBRANOUS; otherwise coordinate with CLOSTRIDIOIDES DIFFICILE INFECTIONS see CLOSTRIDIUM INFECTIONS
=680  \\$iA common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy.
=688  \\$a2021(1991)
=750  \0$aClostridium difficile$0(DLC) sh 85027144$5IEN-M

=LDR  01028cz  a2200277n  4500
=001  9880364009502441
=005  20141212211528.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016353
=035  \\$aCBG6684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x750
=072  \\$aF1.$x145.$x488.$x700
=150  \\$aSelf-Examination
=450  \\$wnnna$aExamination, Self
=450  \\$wnnna$aExaminations, Self
=450  \\$wnnna$aSelf Examination
=450  \\$wnnna$aSelf Examinations
=450  \\$wnnna$aSelf-Examinations
=550  \\$wg$aHealth Behavior
=550  \\$wg$aPhysical Examination
=550  \\$wh$aBreast Self-Examination
=667  \\$acoord IM with organ with no qualif (IM) + disease term /diag (IM) if discussed; BREAST SELF-EXAMINATION is also available; DF: SELF EXAM
=680  \\$iThe inspection of one's own body, usually for signs of disease (e.g., BREAST SELF-EXAMINATION, testicular self-examination).
=688  \\$a91
=750  \0$aSelf-examination, Medical$5IEN$0(DLC)sh 85119745

=LDR  00910cz  a2200217n  4500
=001  9880364009602441
=005  20141212211527.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016352
=035  \\$aCBG6683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x375
=150  \\$aGroup Homes
=450  \\$wnnna$aGroup Home
=450  \\$wnnna$aHome, Group
=450  \\$wnnna$aHomes, Group
=550  \\$wg$aResidential Facilities
=667  \\$ain med & non-med contexts
=680  \\$iHousing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family.
=688  \\$a91; was see RESIDENTIAL FACILITIES 1990
=750  \0$aGroup homes$5IEN$0(DLC)sh 85057478

=LDR  01052cz  a2200229n  4500
=001  9880364009702441
=005  20141212211527.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016350
=035  \\$aCBG6682M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x790.$x709.$x600.$x40.$x520
=150  \\$aLeucine Zippers
=450  \\$wnnna$aLeucine Zipper
=450  \\$wnnna$aZipper, Leucine
=450  \\$wnnna$aZippers, Leucine
=550  \\$wg$aAmino Acid Motifs
=550  \\$aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors
=550  \\$aDNA-Binding Proteins
=680  \\$iDNA-binding motifs formed from two alpha-helixes which intertwine for about eight turns into a coiled coil and then bifurcate to form Y shaped structures. Leucines occurring in heptad repeats end up on the same sides of the helixes and are adjacent to each other in the stem of the Y (the "zipper" region). The DNA-binding residues are located in the bifurcated region of the Y.
=688  \\$a91
=750  \0$aLeucine zippers$5IEN-M$0(DLC)sh 97006172

=LDR  00858cz  a2200193n  4500
=001  9880364009802441
=005  20141212211527.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016348
=035  \\$aCBG6681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x195.$x140.$x570
=072  \\$aG16.$x100.$x856.$x150.$x150.$x570
=150  \\$aOsseointegration
=550  \\$wg$aBone Regeneration
=667  \\$anote category & MeSH definition: must involve bone growth in relation to surg implanted material; do not confuse with OSSIFICATION, HETEROTOPIC, a Cat C term
=680  \\$iThe growth action of bone tissue, as it assimilates surgically implanted devices or prostheses to be used as either replacement parts (e.g., hip) or as anchors (e.g., endosseous dental implants).
=688  \\$a91
=750  \0$aOsseointegration$5IEN-M$0(DLC)sh 96011577

=LDR  02300cz  a2200565n  4500
=001  9880364009902441
=005  20170329110247.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016347
=035  \\$aCBG6680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x968.$x625
=072  \\$aL1.$x280.$x900.$x968.$x775
=072  \\$aL1.$x700.$x508.$x300.$x695
=072  \\$aN4.$x452.$x859.$x564.$x650
=072  \\$aN5.$x715.$x360.$x300.$x715.$x500.$x530
=072  \\$aN6.$x850.$x520.$x308.$x940.$x968.$x625
=150  \\$aMedical Records Systems, Computerized
=450  \\$wnnna$aAutomated Medical Record System
=450  \\$wnnna$aAutomated Medical Record Systems
=450  \\$wnnna$aAutomated Medical Records System
=450  \\$aAutomated Medical Records Systems
=450  \\$wnnna$aComputerized Medical Record
=450  \\$wnnna$aComputerized Medical Record System
=450  \\$wnnna$aComputerized Medical Record Systems
=450  \\$wnnna$aComputerized Medical Records
=450  \\$wnnna$aComputerized Medical Records System
=450  \\$aComputerized Medical Records Systems
=450  \\$wnnna$aComputerized Patient Medical Records
=450  \\$wnnna$aMedical Record, Computerized
=450  \\$wnnna$aMedical Record System, Automated
=450  \\$wnnna$aMedical Record System, Computerized
=450  \\$wnnna$aMedical Record Systems, Automated
=450  \\$wnnna$aMedical Record Systems, Computerized
=450  \\$wnnna$aMedical Records, Computerized
=450  \\$wnnna$aMedical Records System, Automated
=450  \\$wnnna$aMedical Records System, Computerized
=450  \\$wnnna$aMedical Records Systems, Automated
=450  \\$wnnna$aRecord, Computerized Medical
=450  \\$wnnna$aRecords, Computerized Medical
=550  \\$wg$aInformation Systems
=550  \\$wg$aMedical Records
=550  \\$wh$aElectronic Health Records
=550  \\$wh$aHealth Smart Cards
=550  \\$wh$aMedical Order Entry Systems
=550  \\$aForms and Records Control
=667  \\$aDF: AUTOMATED MED RECORDS
=680  \\$iComputer-based systems for input, storage, display, retrieval, and printing of information contained in a patient's medical record.
=688  \\$a91
=750  \0$aMedical records$xData processing$5IEN$0(DLC)sh 85083013

=LDR  00847cz  a2200241n  4500
=001  9880364010002441
=005  20141212211525.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016343
=035  \\$aCBG6676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x510
=072  \\$aE4.$x510
=150  \\$aMonitoring, Intraoperative
=450  \\$aIntraoperative Monitoring
=550  \\$wg$aMonitoring, Physiologic
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aIntraoperative Neurophysiological Monitoring
=550  \\$aConsciousness Monitors
=667  \\$aDF: MONITORING INTRAOP
=680  \\$iThe constant checking on the state or condition of a patient during the course of a surgical operation (e.g., checking of vital signs).
=688  \\$a98(91)
=750  \0$aIntraoperative monitoring$5IEN$0(DLC)sh 91000054

=LDR  01491cz  a2200301n  4500
=001  9880364010102441
=005  20141212192657.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016342
=035  \\$aCBG6675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x50.$x75
=072  \\$aE2.$x594.$x60
=072  \\$aE4.$x14.$x520.$x60
=072  \\$aE4.$x100.$x814.$x529.$x124.$x75
=072  \\$aE4.$x502.$x382.$x124.$x75
=150  \\$aAngioplasty, Laser
=450  \\$wnnna$aAngioplasties, Laser
=450  \\$wnnna$aLaser Angioplasties
=450  \\$aLaser Angioplasty
=550  \\$wg$aAngioplasty
=550  \\$wg$aLaser Therapy
=550  \\$wh$aAngioplasty, Balloon, Laser-Assisted
=550  \\$aCatheter Ablation
=667  \\$acoordinate IM with disease / ther (IM); ANGIOPLASTY, BALLOON, LASER-ASSISTED is also available
=680  \\$iA technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an EXCIMER LASER which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (ANGIOPLASTY, BALLOON, LASER-ASSISTED).
=688  \\$a91
=750  \0$aLaser angioplasty$5IEN$0(DLC)sh 88007921

=LDR  01009cz  a2200241n  4500
=001  9880364010202441
=005  20141212211523.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016337
=035  \\$aCBG6670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x797
=072  \\$aD13.$x444.$x735.$x790.$x199
=150  \\$aRNA, Catalytic
=450  \\$aCatalytic RNA
=450  \\$aRibozymes
=550  \\$wg$aEnzymes
=550  \\$wg$aRNA, Untranslated
=550  \\$wh$aRibonuclease P
=550  \\$wh$aRNA, Ribosomal, Self-Splicing
=680  \\$iRNA that has catalytic activity. The catalytic RNA sequence folds to form a complex surface that can function as an enzyme in reactions with itself and other molecules. It may function even in the absence of protein. There are numerous examples of RNA species that are acted upon by catalytic RNA, however the scope of this enzyme class is not limited to a particular type of substrate.
=688  \\$a91
=750  \0$aCatalytic RNA$5IEN$0(DLC)sh 89006601

=LDR  01413cz  a2200313n  4500
=001  9880364010302441
=005  20180404101706.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016335
=035  \\$aCBG6668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x820.$x709.$x275.$x500.$x985
=150  \\$aZinc Fingers
=450  \\$wnnna$aFinger, Zinc
=450  \\$wnnna$aFingers, Zinc
=450  \\$wnnna$aMotif, Zinc Finger
=450  \\$wnnna$aMotifs, Zinc Finger
=450  \\$wnnna$aZinc Finger
=450  \\$wnnna$aZinc Finger Motif
=450  \\$wnnna$aZinc Finger Motifs
=550  \\$wg$aAmino Acid Motifs
=550  \\$wh$aCYS2-HIS2 Zinc Fingers
=550  \\$wh$aMYND Domains
=550  \\$wh$aPHD Zinc Fingers
=550  \\$wh$aRING Finger Domains
=550  \\$aDNA-Binding Proteins
=680  \\$iMotifs in DNA- and RNA-binding proteins whose amino acids are folded into a single structural unit around a zinc atom. In the classic zinc finger, one zinc atom is bound to two cysteines and two histidines. In between the cysteines and histidines are 12 residues which form a DNA binding fingertip. By variations in the composition of the sequences in the fingertip and the number and spacing of tandem repeats of the motif, zinc fingers can form a large number of different sequence specific binding sites.
=688  \\$a91
=750  \0$aZinc-finger proteins$0(DLC) sh 93002533$5IEN-M

=LDR  01769cz  a2200397n  4500
=001  9880364010402441
=005  20141212211522.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016332
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x580.$x300
=150  \\$aFetal Tissue Transplantation
=450  \\$wnnna$aDonation, Fetal Tissue
=450  \\$wnnna$aDonations, Fetal Tissue
=450  \\$wnnna$aFetal Tissue Donation
=450  \\$wnnna$aFetal Tissue Donations
=450  \\$wnnna$aFetal Tissue Grafting
=450  \\$wnnna$aFetal Tissue Graftings
=450  \\$wnnna$aFetal Tissue Transplantations
=450  \\$aFetus$xtransplantation
=450  \\$aGrafting, Fetal Tissue
=450  \\$wnnna$aGraftings, Fetal Tissue
=450  \\$wnnna$aTissue Donation, Fetal
=450  \\$wnnna$aTissue Donations, Fetal
=450  \\$wnnna$aTissue Grafting, Fetal
=450  \\$wnnna$aTissue Graftings, Fetal
=450  \\$wnnna$aTissue Transplantation, Fetal
=450  \\$wnnna$aTissue Transplantations, Fetal
=450  \\$aTransplantation, Fetal Tissue
=450  \\$wnnna$aTransplantations, Fetal Tissue
=550  \\$wg$aTissue Transplantation
=550  \\$aFetal Research
=667  \\$afetal or embryonic; coordinate IM with specific embryonic tissue / transpl or specific organ / embryol + / transpl; do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transplantation of fetal brain tissue: coordinate IM with BRAIN TISSUE TRANSPLANTATION (IM) + specific brain tissue / transpl + / embryol if pertinent
=680  \\$iTransference of fetal tissue between individuals of the same species or between individuals of different species.
=688  \\$a91
=750  \0$aFetal tissues$xTransplantation$5IEN$0(DLC)sh 94002037

=LDR  01167cz   2200349n  4500
=001  9880364010502441
=005  20240216145006.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016330
=035  \\$aCBG6663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x116.$x100.$x540
=150  \\$aFrail Elderly
=450  \\$wnnna$aAdult, Frail Older
=450  \\$wnnna$aAdults, Frail Older
=450  \\$wnnna$aElder, Frail
=450  \\$aElderly, Frail
=450  \\$wnnna$aElderly, Functionally-Impaired
=450  \\$wnnna$aElders, Frail
=450  \\$wnnna$aFrail Elder
=450  \\$wnnna$aFrail Elders
=450  \\$wnnna$aFrail Older Adult
=450  \\$aFrail Older Adults
=450  \\$aFunctionally-Impaired Elderly
=450  \\$wnnna$aFunctionally Impaired Elderly
=450  \\$wnnna$aOlder Adult, Frail
=450  \\$wnnna$aOlder Adults, Frail
=550  \\$wg$aAged
=667  \\$acheck the tags AGED or AGED, 80 AND OVER
=680  \\$iOlder adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity.
=688  \\$a91
=750  \0$aFrail older people$5IEN$0(DLC)sh 89004704

=LDR  01757cz  a2200481n  4500
=001  9880364010602441
=005  20141212211520.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016328
=035  \\$aCBG6661M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x600
=072  \\$aD12.$x776.$x660.$x600
=072  \\$aD12.$x776.$x930.$x600
=150  \\$aNF-kappa B
=450  \\$wnnna$aEnhancer-Binding Protein, Immunoglobulin
=450  \\$wnnna$aFactor NF-kB, Transcription
=450  \\$wnnna$aIg-EBP-1
=450  \\$wnnna$aIg EBP 1
=450  \\$aImmunoglobulin Enhancer-Binding Protein
=450  \\$wnnna$aImmunoglobulin Enhancer Binding Protein
=450  \\$akappa B Enhancer Binding Protein
=450  \\$wnnna$aNF-kappaB
=450  \\$wnnna$aNF kappaB
=450  \\$wnnna$aNF-kB
=450  \\$wnnna$aNF kB
=450  \\$wnnna$aNF-kB, Transcription Factor
=450  \\$aNuclear Factor kappa B
=450  \\$aTranscription Factor NF-kB
=450  \\$wnnna$aTranscription Factor NF kB
=550  \\$wg$aDNA-Binding Proteins
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aTranscription Factors
=550  \\$wh$aNF-kappa B p50 Subunit
=550  \\$wh$aNF-kappa B p52 Subunit
=550  \\$wh$aTranscription Factor RelA
=550  \\$wh$aTranscription Factor RelB
=550  \\$aHIV Enhancer
=550  \\$aI-kappa B Proteins
=667  \\$aDF: NFKB
=680  \\$iUbiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.
=688  \\$a91
=750  \0$aNF-kappa B (DNA-binding protein)$0(DLC) sh 00001784$5IEN-M

=LDR  01912cz  a2200433n  4500
=001  9880364010702441
=005  20200605172227.0
=008  900617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016326
=035  \\$aCBG6660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x860.$x300
=150  \\$aExtracellular Matrix Proteins
=450  \\$wnnna$aMatrix Proteins, Extracellular
=450  \\$wnnna$aProteins, Extracellular Matrix
=550  \\$wg$aScleroproteins
=550  \\$wh$aActivated-Leukocyte Cell Adhesion Molecule
=550  \\$wh$aADAMTS Proteins
=550  \\$wh$aAggrecans
=550  \\$wh$aCartilage Oligomeric Matrix Protein
=550  \\$wh$aCCN Intercellular Signaling Proteins
=550  \\$wh$aCollagen
=550  \\$wh$aElastin
=550  \\$wh$aFibrillins
=550  \\$wh$aFibronectins
=550  \\$wh$aIntegrin-Binding Sialoprotein
=550  \\$wh$aLaminin
=550  \\$wh$aMatrilin Proteins
=550  \\$wh$aNetrins
=550  \\$wh$aOsteopontin
=550  \\$wh$aSmall Leucine-Rich Proteoglycans
=550  \\$wh$aTenascin
=550  \\$wh$aVersicans
=550  \\$wh$aVitronectin
=550  \\$aExtracellular Traps
=667  \\$a/drug eff /ultrastruct permitted
=680  \\$iMacromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
=688  \\$a91
=750  \0$aExtracellular matrix proteins$5IEN-M$0(DLC)sh 93000875

=LDR  00951cz  a2200241n  4500
=001  9880364010802441
=005  20141212211518.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016321
=035  \\$aCBG6655HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x170.$x100
=072  \\$aN2.$x421.$x240.$x190.$x210
=150  \\$aDental Care for Aged
=450  \\$wnnna$aAged, Dentistry for
=450  \\$wnnna$aDental Care for Elderly
=450  \\$aDentistry for Aged
=550  \\$wg$aDental Care
=550  \\$aGeriatric Dentistry
=667  \\$a= professional care by a professional; do not confuse with GERIATRIC DENTISTRY, the specialty; check tag AGED; DF: DENT CARE AGED
=680  \\$iThe giving of attention to the special dental needs of the elderly for proper maintenance or treatment. The dental care may include the services provided by dental specialists.
=688  \\$a91
=750  \0$aOlder people$xDental care$5IEN-M$0(DLC)sh 85002094

=LDR  01560cz  a2200385n  4500
=001  9880364010902441
=005  20141212211517.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016320
=035  \\$aCBG6654M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x128.$x800
=072  \\$aN2.$x278.$x808.$x930
=150  \\$aSubstance Abuse Treatment Centers
=450  \\$wnnna$aCenter, Drug Rehabilitation
=450  \\$wnnna$aCenter, Drug Treatment
=450  \\$wnnna$aCenters, Drug Rehabilitation
=450  \\$wnnna$aCenters, Drug Treatment
=450  \\$aDrug Abuse Treatment Centers
=450  \\$wnnna$aDrug Rehabilitation Center
=450  \\$wnnna$aDrug Rehabilitation Centers
=450  \\$wnnna$aDrug Treatment Center
=450  \\$aDrug Treatment Centers
=450  \\$wnnna$aRehabilitation Center, Drug
=450  \\$aRehabilitation Centers, Drug
=450  \\$wnnna$aTreatment Center, Drug
=450  \\$wnnna$aTreatment Centers, Drug
=450  \\$wnnna$aTreatment Centers, Drug Abuse
=450  \\$wnnna$aTreatment Centers, Substance Abuse
=550  \\$wg$aCommunity Health Centers
=550  \\$wg$aRehabilitation Centers
=550  \\$aNeedle-Exchange Programs
=680  \\$iHealth facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included.
=688  \\$a94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93
=750  \0$aSubstance abuse treatment facilities$0(DLC) sh2005001304$5IEN-M

=LDR  01651cz  a2200457n  4500
=001  9880364011002441
=005  20141212211511.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016301
=035  \\$aCBG6639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x264.$x150
=072  \\$aC7.$x465.$x714.$x354.$x500
=150  \\$aAlveolar Bone Loss
=450  \\$wnnna$aAlveolar Bone Atrophies
=450  \\$wnnna$aAlveolar Bone Atrophy
=450  \\$wnnna$aAlveolar Bone Losses
=450  \\$wnnna$aAlveolar Process Atrophies
=450  \\$wnnna$aAlveolar Process Atrophy
=450  \\$aAlveolar Resorption
=450  \\$wnnna$aAlveolar Resorptions
=450  \\$wnnna$aBone Atrophies, Alveolar
=450  \\$wnnna$aBone Atrophy, Alveolar
=450  \\$aBone Loss, Alveolar
=450  \\$aBone Loss, Periodontal
=450  \\$wnnna$aBone Losses, Periodontal
=450  \\$aPeriodontal Bone Loss
=450  \\$wnnna$aPeriodontal Bone Losses
=450  \\$aPeriodontal Resorption
=450  \\$wnnna$aPeriodontal Resorptions
=450  \\$wnnna$aResorption, Alveolar
=450  \\$wnnna$aResorption, Periodontal
=450  \\$wnnna$aResorptions, Alveolar
=550  \\$wg$aBone Resorption
=550  \\$wg$aPeriodontal Atrophy
=550  \\$aBone Resorption
=667  \\$acoordinate IM with MANDIBULAR DISEASES or MAXILLARY DISEASES (IM or NIM)
=680  \\$iResorption or wasting of the tooth-supporting bone (ALVEOLAR PROCESS) in the MAXILLA or MANDIBLE.
=688  \\$a91; was see BONE RESORPTION 1987-90
=750  \0$81$wb$aBone resorption$5IEN$0(DLC)sh 85015529
=750  \0$81$wb$aAlveolar process$5IEN-HS$0(DLC)sh 85004064

=LDR  01540cz  a2200397n  4500
=001  9880364011102441
=005  20141212211510.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016297
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x420.$x601.$x575
=150  \\$aMutagenesis, Site-Directed
=450  \\$wnnna$aMutageneses, Oligonucleotide-Directed
=450  \\$wnnna$aMutageneses, Site-Directed
=450  \\$wnnna$aMutageneses, Site-Specific
=450  \\$aMutagenesis, Oligonucleotide-Directed
=450  \\$wnnna$aMutagenesis, Oligonucleotide Directed
=450  \\$wnnna$aMutagenesis, Site Directed
=450  \\$aMutagenesis, Site-Specific
=450  \\$wnnna$aMutagenesis, Site Specific
=450  \\$wnnna$aOligonucleotide-Directed Mutageneses
=450  \\$aOligonucleotide-Directed Mutagenesis
=450  \\$wnnna$aOligonucleotide Directed Mutagenesis
=450  \\$wnnna$aSite-Directed Mutageneses
=450  \\$aSite-Directed Mutagenesis
=450  \\$wnnna$aSite Directed Mutagenesis
=450  \\$wnnna$aSite-Specific Mutageneses
=450  \\$aSite-Specific Mutagenesis
=450  \\$wnnna$aSite Specific Mutagenesis
=550  \\$wg$aProtein Engineering
=550  \\$wh$aTargeted Gene Repair
=550  \\$aAmino Acid Substitution
=550  \\$aProtein Engineering
=680  \\$iGenetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.
=688  \\$a91
=750  \0$aSite-specific mutagenesis$5IEN$0(DLC)sh 90004417

=LDR  01125cz  a2200361n  4500
=001  9880364011202441
=005  20141212211509.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016296
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x600
=150  \\$aMutagenesis
=450  \\$wnnna$aMutageneses
=550  \\$wg$aGenetic Processes
=550  \\$wh$aAmino Acid Substitution
=550  \\$wh$aChromosome Duplication
=550  \\$wh$aDNA Repeat Expansion
=550  \\$wh$aGene Amplification
=550  \\$wh$aGene Duplication
=550  \\$wh$aINDEL Mutation
=550  \\$wh$aMutagenesis, Insertional
=550  \\$wh$aNondisjunction, Genetic
=550  \\$wh$aSequence Deletion
=550  \\$wh$aSequence Inversion
=550  \\$wh$aSomatic Hypermutation, Immunoglobulin
=550  \\$wh$aSuppression, Genetic
=550  \\$wh$aTranslocation, Genetic
=550  \\$aMutagens
=550  \\$aMutation
=550  \\$aTeratogenesis
=680  \\$iProcess of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS.
=688  \\$a91
=750  \0$aMutagenesis$5IEN$0(DLC)sh 85089125

=LDR  01160cz  a2200313n  4500
=001  9880364011302441
=005  20141212211509.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016294
=035  \\$aCBG6633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x645
=150  \\$aModels, Nursing
=450  \\$wnnna$aModel, Nursing
=450  \\$wnnna$aModel, Orem Self-Care
=450  \\$wnnna$aModels, Orem Self-Care
=450  \\$wnnna$aNursing Model
=450  \\$aNursing Models
=450  \\$wnnna$aOrem Self-Care Model
=450  \\$wnnna$aOrem Self Care Model
=450  \\$wnnna$aOrem Self-Care Models
=450  \\$wnnna$aSelf-Care Model, Orem
=450  \\$wnnna$aSelf-Care Models, Orem
=550  \\$wg$aModels, Theoretical
=550  \\$aNursing Theory
=667  \\$ano qualif
=680  \\$iTheoretical models simulating behavior or activities in nursing, including nursing care, management and economics, theory, assessment, research, and education. Some examples of these models include Orem Self-Care Model, Roy Adaptation Model, and Rogers Life Process Model.
=688  \\$a91
=750  \0$aNursing models$5IEN-M$0(DLC)sh 94000104

=LDR  01101cz  a2200277n  4500
=001  9880364011402441
=005  20141212211508.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016288
=035  \\$aCBG6629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x115.$x500
=150  \\$aComputer Terminals
=450  \\$wnnna$aComputer Terminal
=450  \\$wnnna$aDisplay Terminal, Video
=450  \\$wnnna$aDisplay Terminals, Video
=450  \\$wnnna$aTerminal, Computer
=450  \\$wnnna$aTerminal, Video Display
=450  \\$aTerminals, Computer
=450  \\$wnnna$aTerminals, Video Display
=450  \\$wnnna$aVideo Display Terminal
=450  \\$aVideo Display Terminals
=550  \\$wg$aComputer Peripherals
=680  \\$iInput/output devices designed to receive data in an environment associated with the job to be performed, and capable of transmitting entries to, and obtaining output from, the system of which it is a part. (Computer Dictionary, 4th ed.)
=688  \\$a91; was see COMPUTER SYSTEMS 1987-90
=750  \0$aComputer terminals$5IEN$0(DLC)sh 85029543

=LDR  01669cz  a2200385n  4500
=001  9880364011502441
=005  20141212211507.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016287
=035  \\$aCBG6628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x115
=150  \\$aComputer Peripherals
=450  \\$wnnna$aComputer Peripheral
=450  \\$wnnna$aComputer Peripheral Device
=450  \\$wnnna$aComputer Peripheral Devices
=450  \\$wnnna$aComputer Peripheral Equipment
=450  \\$wnnna$aComputer Peripheral Equipments
=450  \\$wnnna$aDevice, Computer Peripheral
=450  \\$wnnna$aDevices, Computer Peripheral
=450  \\$wnnna$aEquipment, Computer Peripheral
=450  \\$wnnna$aEquipments, Computer Peripheral
=450  \\$wnnna$aPeripheral, Computer
=450  \\$wnnna$aPeripheral Device, Computer
=450  \\$wnnna$aPeripheral Devices, Computer
=450  \\$aPeripheral Equipment, Computer
=450  \\$wnnna$aPeripheral Equipments, Computer
=450  \\$wnnna$aPeripherals, Computer
=550  \\$wg$aComputers
=550  \\$wh$aComputer Storage Devices
=550  \\$wh$aComputer Terminals
=550  \\$wh$aModems
=680  \\$iVarious units or machines that operate in combination or in conjunction with a computer but are not physically part of it. Peripheral devices typically display computer data, store data from the computer and return the data to the computer on demand, prepare data for human use, or acquire data from a source and convert it to a form usable by a computer. (Computer Dictionary, 4th ed.)
=688  \\$a91
=750  \0$aComputer peripherals$5IEN-M$0(DLC)sh 94001703

=LDR  00945cz  a2200241n  4500
=001  9880364011602441
=005  20141212211507.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x550.$x700.$x125
=072  \\$aD23.$x469.$x700.$x275
=150  \\$aIloprost
=450  \\$aCiloprost
=450  \\$wnnna$aCoTherix Brand of Iloprost
=450  \\$wnnna$aVentavis
=450  \\$wnnna$aZK-36374
=450  \\$wnnna$aZK 36374
=450  \\$wnnna$aZK36374
=550  \\$wg$aProstaglandins, Synthetic
=680  \\$iAn eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.
=688  \\$a91
=750  \0$aIloprost$5IEN$0(DLC)sh 87001839

=LDR  00774cz  a2200229n  4500
=001  9880364011702441
=005  20141212211504.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016278
=035  \\$aCBG6620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x962.$x900
=150  \\$aVentricular Function, Right
=450  \\$wnnna$aFunction, Right Ventricular
=450  \\$wnnna$aFunctions, Right Ventricular
=450  \\$aRight Ventricular Function
=450  \\$wnnna$aRight Ventricular Functions
=450  \\$wnnna$aVentricular Functions, Right
=550  \\$wg$aVentricular Function
=680  \\$iThe hemodynamic and electrophysiological action of the right HEART VENTRICLE.
=688  \\$a91
=750  \0$aHeart$xRight ventricle$5IEN-M$0(DLC)sh 87005966

=LDR  00928cz  a2200229n  4500
=001  9880364011802441
=005  20141212211504.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016277
=035  \\$aCBG6619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x962.$x800
=150  \\$aVentricular Function, Left
=450  \\$wnnna$aFunction, Left Ventricular
=450  \\$wnnna$aFunctions, Left Ventricular
=450  \\$aLeft Ventricular Function
=450  \\$wnnna$aLeft Ventricular Functions
=450  \\$wnnna$aVentricular Functions, Left
=550  \\$wg$aVentricular Function
=680  \\$iThe hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
=688  \\$a91
=750  \0$aHeart$xLeft ventricle$5IEN-HS$0(DLC)sh 87005967

=LDR  01380cz  a2200373n  4500
=001  9880364011902441
=005  20141212211503.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016274
=035  \\$aCBG6616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x630
=072  \\$aD12.$x776.$x624.$x664.$x520.$x750.$x750
=072  \\$aD12.$x776.$x660.$x700
=072  \\$aD12.$x776.$x964.$x700.$x750.$x750
=072  \\$aD12.$x776.$x964.$x775.$x750.$x750
=150  \\$aOncogene Protein p55(v-myc)
=450  \\$wnnna$amyc Oncogene Product p55
=450  \\$amyc Oncogene Protein p55
=450  \\$wnnna$aOncogene Product p55(v-myc)
=450  \\$wnnna$ap55 v-myc
=450  \\$ap55(v-myc)
=450  \\$wnnna$ap55 v myc
=450  \\$wnnna$aProtein p55, v-myc
=450  \\$av-myc Protein p55
=450  \\$wnnna$av myc Protein p55
=550  \\$wg$aDNA-Binding Proteins
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aRetroviridae Proteins, Oncogenic
=550  \\$aGenes, myc
=667  \\$aIM; coord with specific virus (IM); /drug eff /ultrastruct permitted; DF: note short X ref
=680  \\$iTransforming protein coded by myc oncogenes. The v-myc protein has been found in several replication-defective avian retrovirus isolates which induce a broad spectrum of malignancies.
=688  \\$a91
=750  \0$aMyc proteins$5IEN-M$0(DLC)sh 95009183

=LDR  01010cz  a2200265n  4500
=001  9880364012002441
=005  20171219114254.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016273
=035  \\$aCBG6615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x600
=150  \\$aOccupational Exposure
=450  \\$wnnna$aExposure, Occupational
=450  \\$wnnna$aExposures, Occupational
=450  \\$wnnna$aOccupational Exposures
=550  \\$wg$aEnvironmental Exposure
=550  \\$wh$aMaximum Allowable Concentration
=550  \\$wh$aThreshold Limit Values
=550  \\$wh$aWar Exposure
=550  \\$aEnvironmental Exposure
=667  \\$acoord IM with specific occup dis (IM) or specific occupation (IM); DF: OCCUP EXPOSURE
=680  \\$iThe exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation.
=688  \\$a91; was see ENVIRONMENTAL EXPOSURE 1989-90
=750  \0$aIndustrial toxicology$5IEN-M$0(DLC)sh 85065953

=LDR  01197cz  a2200289n  4500
=001  9880364012102441
=005  20141212211502.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016272
=035  \\$aCBG6614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x525
=150  \\$aOccupational Health
=450  \\$aEmployee Health
=450  \\$wnnna$aHealth, Employee
=450  \\$wnnna$aHealth, Industrial
=450  \\$wnnna$aHealth, Occupational
=450  \\$wnnna$aHygiene, Industrial
=450  \\$aIndustrial Health
=450  \\$aIndustrial Hygiene
=450  \\$aOccupational Safety
=450  \\$wnnna$aSafety, Occupational
=550  \\$wg$aHealth
=667  \\$a"promotion & maintenance of physical & mental health in the work environment": do not confuse with OCCUPATIONAL MEDICINE (the specialty) or OCCUPATIONAL HEALTH SERVICES; note X ref OCCUPATIONAL SAFETY which is GEN only: do not use as coord for safety in an industrial milieu ( = SAFETY + specific indust or occup heading); DF: OCCUP HEALTH
=680  \\$iThe promotion and maintenance of physical and mental health in the work environment.
=688  \\$a91
=750  \0$aIndustrial hygiene$5IEN$0(DLC)sh 85065884

=LDR  01873cz  a2200493n  4500
=001  9880364012202441
=005  20141212211501.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016271
=035  \\$aCBG6613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x676
=072  \\$aD12.$x776.$x624.$x664.$x700.$x189
=072  \\$aD12.$x776.$x660.$x765
=150  \\$aProto-Oncogene Proteins c-myc
=450  \\$ac-myc Proteins
=450  \\$wnnna$ac myc Proteins
=450  \\$aL-myc Proteins
=450  \\$wnnna$aL myc Proteins
=450  \\$wnnna$amyc Proto-Oncogene Product p62
=450  \\$wnnna$amyc Proto Oncogene Product p62
=450  \\$amyc Proto-Oncogene Proteins
=450  \\$wnnna$amyc Proto Oncogene Proteins
=450  \\$wnnna$amyc, Proto-Oncogene Proteins
=450  \\$aN-myc Proteins
=450  \\$wnnna$aN myc Proteins
=450  \\$wnnna$ap62 c-myc
=450  \\$ap62(c-myc)
=450  \\$wnnna$ap62 c myc
=450  \\$wnnna$aProteins myc, Proto-Oncogene
=450  \\$wnnna$aProto-Oncogene Products c-myc
=450  \\$wnnna$aProto Oncogene Products c myc
=450  \\$wnnna$aProto Oncogene Proteins c myc
=450  \\$wnnna$aProto-Oncogene Proteins myc
=450  \\$wnnna$aProto Oncogene Proteins myc
=450  \\$wnnna$aProto-Oncogene Proteins, myc
=550  \\$wg$aDNA-Binding Proteins
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aProto-Oncogene Proteins
=550  \\$aGenes, myc
=667  \\$a/drug eff /ultrastruct permitted; DF: note short X refs
=680  \\$iCellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis.
=688  \\$a91
=750  \0$aMyc proteins$0(DLC) sh 95009183$5IEN-M

=LDR  01373cz  a2200349n  4500
=001  9880364012302441
=005  20141212192655.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016267
=035  \\$aCBG6609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x660.$x430
=072  \\$aE7.$x858.$x690.$x725.$x430
=150  \\$aExternal Fixators
=450  \\$wnnna$aDevice, External Fixation
=450  \\$wnnna$aDevices, External Fixation
=450  \\$wnnna$aExternal Fixation Device
=450  \\$wnnna$aExternal Fixation Devices
=450  \\$wnnna$aExternal Fixator
=450  \\$wnnna$aFixation Device, External
=450  \\$aFixation Devices, External
=450  \\$wnnna$aFixator, External
=450  \\$wnnna$aFixators, External
=550  \\$wg$aOrthopedic Fixation Devices
=550  \\$wh$aCasts, Surgical
=550  \\$wh$aSplints
=550  \\$aFracture Fixation
=550  \\$aOsteogenesis, Distraction
=667  \\$afor fracture fixation
=680  \\$iExternal devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved.
=688  \\$a91
=750  \0$aExternal skeletal fixation (Surgery)$5IEN$0(DLC)sh 85046562

=LDR  01050cz  a2200253n  4500
=001  9880364012402441
=005  20141212211500.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016265
=035  \\$aCBG6607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x130
=072  \\$aN5.$x350.$x225
=150  \\$aConflict of Interest
=450  \\$aConflict of Interests$5IEN
=450  \\$wnnna$aInterest Conflict
=450  \\$wnnna$aInterest Conflicts
=550  \\$wg$aEthics
=550  \\$wh$aPhysician Self-Referral
=550  \\$aMorals
=550  \\$aProfessional Misconduct
=680  \\$iA situation in which an individual might benefit personally from official or professional actions. It includes a conflict between a person's private interests and official responsibilities in a position of trust. The term is not restricted to government officials. The concept refers both to actual conflict of interest and the appearance or perception of conflict.
=688  \\$a1991
=750  \0$aConflict of interests$5IEN$0(DLC)sh 85030963

=LDR  02693cz  a2200733n  4500
=001  9880364012502441
=005  20141212211457.0
=008  900628\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016259
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791.$x420
=150  \\$aGenes, myc
=450  \\$wnnna$ac-myc Gene
=450  \\$ac-myc Genes
=450  \\$wnnna$ac myc Genes
=450  \\$wnnna$ac-myc Proto-Oncogene
=450  \\$wnnna$ac-myc Proto-Oncogenes
=450  \\$wnnna$ac myc Proto Oncogenes
=450  \\$wnnna$aGene, c-myc
=450  \\$wnnna$aGene, L-myc
=450  \\$wnnna$aGene, myc
=450  \\$wnnna$aGene, N-myc
=450  \\$wnnna$aGene, v-myc
=450  \\$wnnna$aGenes, c-myc
=450  \\$wnnna$aGenes, L-myc
=450  \\$wnnna$aGenes, N-myc
=450  \\$wnnna$aGenes, v-myc
=450  \\$wnnna$aL-myc Gene
=450  \\$aL-myc Genes
=450  \\$wnnna$aL myc Genes
=450  \\$wnnna$aL-myc Proto-Oncogene
=450  \\$wnnna$aL-myc Proto-Oncogenes
=450  \\$wnnna$aL myc Proto Oncogenes
=450  \\$wnnna$amyc Gene
=450  \\$amyc Genes
=450  \\$wnnna$amyc Oncogene
=450  \\$wnnna$amyc Oncogenes
=450  \\$wnnna$aN-myc Gene
=450  \\$aN-myc Genes
=450  \\$wnnna$aN myc Genes
=450  \\$wnnna$aN-myc Proto-Oncogene
=450  \\$wnnna$aN-myc Proto-Oncogenes
=450  \\$wnnna$aN myc Proto Oncogenes
=450  \\$wnnna$aOncogene, myc
=450  \\$wnnna$aOncogene, v-myc
=450  \\$wnnna$aOncogenes, myc
=450  \\$wnnna$aOncogenes, v-myc
=450  \\$wnnna$aProto-Oncogene, c-myc
=450  \\$wnnna$aProto-Oncogene, L-myc
=450  \\$wnnna$aProto-Oncogene, N-myc
=450  \\$wnnna$aProto-Oncogenes, c-myc
=450  \\$wnnna$aProto-Oncogenes, L-myc
=450  \\$wnnna$aProto-Oncogenes, N-myc
=450  \\$wnnna$av-myc Gene
=450  \\$av-myc Genes
=450  \\$wnnna$av myc Genes
=450  \\$wnnna$av-myc Oncogene
=450  \\$wnnna$av-myc Oncogenes
=450  \\$wnnna$av myc Oncogenes
=550  \\$wg$aProto-Oncogenes
=667  \\$amyc stands for "MYeloCytomatosis"
=680  \\$iFamily of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.
=688  \\$a91; was MYC GENES see ONCOGENES 1985-90
=750  \0$aMyc oncogenes$5IEN-M$0(DLC)sh 95009180

=LDR  01538cz  a2200325n  4500
=001  9880364012602441
=005  20141212211453.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016252
=035  \\$aCBG6596HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x666.$x500
=072  \\$aE5.$x595.$x666.$x500
=150  \\$aMicroscopy, Scanning Tunneling
=450  \\$wnnna$aMicroscopies, Scanning Tunneling
=450  \\$wnnna$aMicroscopies, Scanning Tunnelling
=450  \\$wnnna$aMicroscopy, Scanning Tunnelling
=450  \\$wnnna$aScanning Tunneling Microscopies
=450  \\$aScanning Tunneling Microscopy
=450  \\$wnnna$aScanning Tunnelling Microscopies
=450  \\$wnnna$aScanning Tunnelling Microscopy
=450  \\$wnnna$aTunneling Microscopies, Scanning
=450  \\$wnnna$aTunneling Microscopy, Scanning
=450  \\$wnnna$aTunnelling Microscopies, Scanning
=450  \\$wnnna$aTunnelling Microscopy, Scanning
=550  \\$wg$aMicroscopy, Scanning Probe
=550  \\$aMicroscopy, Atomic Force
=680  \\$iA type of scanning probe microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured, and from this are produced three-dimensional topographs. Due to the poor electron conductivity of most biological samples, thin metal coatings are deposited on the sample.
=688  \\$a91
=750  \0$aScanning tunneling microscopy$5IEN$0(DLC)sh 88004761

=LDR  01228cz  a2200289n  4500
=001  9880364012702441
=005  20141212211453.0
=008  900611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016251
=035  \\$aCBG6595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x668.$x800.$x250.$x200
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x800.$x250.$x200
=072  \\$aL1.$x178.$x590.$x875.$x800.$x250.$x200
=072  \\$aL1.$x178.$x820.$x90.$x668.$x800.$x250.$x200
=072  \\$aL1.$x178.$x820.$x90.$x898.$x800.$x250.$x200
=072  \\$aL1.$x224.$x230.$x260.$x115.$x475.$x600.$x325.$x750
=072  \\$aL1.$x240.$x960.$x800.$x250.$x200
=150  \\$aCD-ROM
=450  \\$wnnna$aCDROM
=450  \\$aCompact Disk Read-Only Memory
=450  \\$wnnna$aCompact Disk Read Only Memory
=550  \\$wg$aCompact Disks
=667  \\$aa type of compact disk; X ref explains acronym; do not use /util except by MeSH definition
=680  \\$iAn optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use.
=688  \\$a91
=750  \0$aCD-ROM$5IEN$0(DLC)n  88506221

=LDR  01293cz  a2200373n  4500
=001  9880364012802441
=005  20141212211452.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016250
=035  \\$aCBG6594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x668.$x800.$x250
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x800.$x250
=072  \\$aL1.$x178.$x590.$x875.$x800.$x250
=072  \\$aL1.$x178.$x820.$x90.$x668.$x800.$x250
=072  \\$aL1.$x178.$x820.$x90.$x898.$x800.$x250
=072  \\$aL1.$x224.$x230.$x260.$x115.$x475.$x600.$x325
=072  \\$aL1.$x240.$x960.$x800.$x250
=150  \\$aCompact Disks
=450  \\$wnnna$aCompact Disc
=450  \\$wnnna$aCompact Discs
=450  \\$wnnna$aCompact Disk
=450  \\$wnnna$aDisc, Compact
=450  \\$wnnna$aDiscs, Compact
=450  \\$wnnna$aDisk, Compact
=450  \\$wnnna$aDisks, Compact
=550  \\$wg$aOptical Storage Devices
=550  \\$wg$aVideodisc Recording
=550  \\$wh$aCD-I
=550  \\$wh$aCD-ROM
=667  \\$ado not use /util except by MeSH definition
=680  \\$iComputer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage.
=688  \\$a91
=750  \0$aCompact discs$5IEN$0(DLC)sh 86000125

=LDR  01319cz  a2200349n  4500
=001  9880364012902441
=005  20141212211452.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016249
=035  \\$aCBG6593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x668
=072  \\$aL1.$x178.$x820.$x90.$x668
=072  \\$aL1.$x224.$x230.$x260.$x115.$x475.$x600
=150  \\$aOptical Storage Devices
=450  \\$wnnna$aDevice, Optical Storage
=450  \\$wnnna$aDevices, Optical Storage
=450  \\$wnnna$aDisk, WORM
=450  \\$wnnna$aDisks, WORM
=450  \\$wnnna$aOptical Storage Device
=450  \\$wnnna$aStorage Device, Optical
=450  \\$wnnna$aStorage Devices, Optical
=450  \\$wnnna$aWORM Disk
=450  \\$aWORM Disks
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aComputer Storage Devices
=550  \\$wh$aCompact Disks
=550  \\$wh$aVideodisc Recording
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase.
=688  \\$a91
=750  \0$aOptical storage devices$5IEN$0(DLC)sh 85095172

=LDR  01266cz  a2200349n  4500
=001  9880364013002441
=005  20141212211451.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016248
=035  \\$aCBG6592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x115.$x475
=150  \\$aComputer Storage Devices
=450  \\$wnnna$aComputer Memory System
=450  \\$wnnna$aComputer Memory Systems
=450  \\$wnnna$aComputer Storage Device
=450  \\$wnnna$aDevice, Computer Storage
=450  \\$wnnna$aDevice, Mass Storage
=450  \\$wnnna$aDevices, Computer Storage
=450  \\$wnnna$aDevices, Mass Storage
=450  \\$wnnna$aMass Storage Device
=450  \\$aMass Storage Devices
=450  \\$wnnna$aMemory System, Computer
=450  \\$wnnna$aMemory Systems, Computer
=450  \\$wnnna$aSystem, Computer Memory
=450  \\$wnnna$aSystems, Computer Memory
=550  \\$wg$aComputer Peripherals
=550  \\$wh$aOptical Storage Devices
=667  \\$ado not use /util except by MeSH definition
=680  \\$iDevices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.
=688  \\$a91
=750  \0$aComputer storage devices$5IEN$0(DLC)sh 85029541

=LDR  00823cz  a2200193n  4500
=001  9880364013102441
=005  20141212211450.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016245
=035  \\$aCBG6590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x555
=150  \\$aLibrarians
=450  \\$wnnna$aLibrarian
=550  \\$wg$aOccupational Groups
=667  \\$aIM; coord with area of specialism of the librarian (IM)
=680  \\$iSpecialists in the management of a library or the services rendered by a library, bringing professional skills to administration, organization of material and personnel, interpretation of bibliothecal rules, the development and maintenance of the library's collection, and the provision of information services.
=688  \\$a91
=750  \0$aLibrarians$5IEN$0(DLC)sh 85076491

=LDR  01166cz  a2200253n  4500
=001  9880364013202441
=005  20141212211450.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016243
=035  \\$aCBG6588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583.$x410
=150  \\$aLibrary Collection Development
=450  \\$aCollection Development (Libraries)
=450  \\$wnnna$aCollection Development, Library
=450  \\$wnnna$aCollection Developments (Libraries)
=450  \\$wnnna$aDevelopment, Collection (Libraries)
=450  \\$wnnna$aDevelopment, Library Collection
=450  \\$wnnna$aDevelopments, Collection (Libraries)
=550  \\$wg$aLibrary Science
=667  \\$aDF: COLLECTION DEVELOPMENT
=680  \\$iDevelopment of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting.
=688  \\$a91
=750  \0$aCollection Development (Libraries)$5IEN$0(DLC)sh 85027992

=LDR  00660cz  a2200181n  4500
=001  9880364013302441
=005  20141212211449.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016242
=035  \\$aCBG6587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583.$x400
=150  \\$aLibrary Automation
=450  \\$wnnna$aAutomation, Library
=550  \\$wg$aLibrary Science
=680  \\$iThe use of automatic machines or processing devices in libraries. The automation may be applied to library administrative activities, office procedures, and delivery of library services to users.
=688  \\$a91
=750  \0$aLibraries$xAutomation$5IEN$0(DLC)sh 85076504

=LDR  01150cz  a2200277n  4500
=001  9880364013402441
=005  20141212211449.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x106
=150  \\$aChild of Impaired Parents
=450  \\$wnnna$aChildren, Impaired Parents'
=450  \\$aChildren of Impaired Parents
=450  \\$wnnna$aImpaired Parents' Children
=450  \\$wnnna$aImpaired Parents Offspring
=450  \\$wnnna$aImpaired Parents Offsprings
=450  \\$aOffspring of Impaired Parents
=450  \\$wnnna$aParents Offspring, Impaired
=450  \\$wnnna$aParents Offsprings, Impaired
=550  \\$wg$aPersons
=550  \\$aParents
=667  \\$acoord IM with parental dis (IM with no qualif); restrict to impaired parents: for child with impaired siblings; index CHILD (IM) + disease of sibling (IM) + SIBLINGS (IM); interpret "child" as "offspring" & check appropriate age check tags
=680  \\$iChild with one or more parents afflicted by a physical or mental disorder.
=688  \\$a91
=750  \0$aChildren of parents with disabilities$5IEN$0(DLC)sh 85023549

=LDR  01137cz  a2200277n  4500
=001  9880364013502441
=005  20141212192654.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016239
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x500.$x650.$x500
=072  \\$aL1.$x700.$x508.$x280.$x710.$x500
=072  \\$aL1.$x700.$x508.$x280.$x750.$x500
=072  \\$aL1.$x700.$x508.$x300.$x188.$x300.$x650.$x500
=072  \\$aL1.$x700.$x508.$x300.$x710.$x500
=072  \\$aL1.$x700.$x508.$x300.$x742.$x650.$x500
=150  \\$aMEDLINE
=450  \\$aIndex Medicus
=550  \\$wg$aMEDLARS
=550  \\$wg$aPubMed
=550  \\$aMedical Subject Headings
=550  \\$aPubMed
=667  \\$aCATALOG: use NAF entry
=680  \\$iThe premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE® (MEDLARS Online) is the primary subset of PUBMED and can be searched on NLM's Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS (MeSH).
=688  \\$a1991; use MEDLARS 1978-1990; for INDEX MEDICUS use MEDLINE 1979-2004
=750  \0$aMEDLINE$5IEN$0(DLC)sh 85083240

=LDR  01316cz  a2200265n  4500
=001  9880364013602441
=005  20141212211446.0
=008  900628\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016232
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x400
=072  \\$aD12.$x776.$x467.$x400
=072  \\$aD23.$x529.$x400
=150  \\$aEndothelins
=450  \\$wnnna$aEndothelin
=450  \\$aEndothelium-Derived Vasoconstrictor Factors
=450  \\$wnnna$aVasoconstrictor Factors, Endothelium-Derived
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aEndothelin-1
=550  \\$wh$aEndothelin-2
=550  \\$wh$aEndothelin-3
=667  \\$aGEN or unspecified; prefer specifics; /drug eff permitted
=680  \\$i21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides.
=688  \\$a91
=750  \0$aEndothelins$5IEN$0(DLC)sh 90000772

=LDR  02247cz  a2200577n  4500
=001  9880364013702441
=005  20141212211445.0
=008  900617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016229
=035  \\$aCBG6575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x24
=072  \\$aD12.$x776.$x49.$x407.$x249.$x500
=072  \\$aD12.$x776.$x543.$x39.$x500
=150  \\$aAmyloid beta-Peptides
=450  \\$wnnna$aABP, Alzheimer's
=450  \\$wnnna$aAD-AP, Amyloid
=450  \\$wnnna$aAlzheimer ABP
=450  \\$aAlzheimer beta-Protein
=450  \\$wnnna$aAlzheimer beta Protein
=450  \\$wnnna$aAlzheimer's ABP
=450  \\$wnnna$aAlzheimers ABP
=450  \\$wnnna$aAlzheimer's Amyloid Fibril Protein
=450  \\$wnnna$aAmyloid AD-AP
=450  \\$wnnna$aAmyloid AD AP
=450  \\$aAmyloid beta-Peptide
=450  \\$wnnna$aAmyloid beta Peptide
=450  \\$wnnna$aAmyloid beta Peptides
=450  \\$aAmyloid beta-Protein
=450  \\$wnnna$aAmyloid beta Protein
=450  \\$wnnna$aAmyloid beta-Proteins
=450  \\$wnnna$aAmyloid beta Proteins
=450  \\$wnnna$aAmyloid Fibril Protein, Alzheimer's
=450  \\$aAmyloid Protein A4
=450  \\$abeta-Amyloid Protein
=450  \\$wnnna$abeta Amyloid Protein
=450  \\$wnnna$abeta-Peptide, Amyloid
=450  \\$wnnna$abeta-Peptides, Amyloid
=450  \\$wnnna$abeta-Protein, Alzheimer
=450  \\$wnnna$abeta-Protein, Amyloid
=450  \\$wnnna$abeta-Proteins, Amyloid
=450  \\$wnnna$aProtein A4, Amyloid
=450  \\$wnnna$aProtein, beta-Amyloid
=550  \\$wg$aAmyloid beta-Protein Precursor
=550  \\$wg$aPeptides
=550  \\$aAlzheimer Disease
=550  \\$aNeurofibrils
=680  \\$iPeptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
=688  \\$a91
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Amyloid beta-Protein
=750  \0$aAmyloid beta-protein$0(DLC) sh 92004712$5IEN

=LDR  00998cz  a2200193n  4500
=001  9880364013802441
=005  20141212211444.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016226
=035  \\$aCBG6572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x695.$x635
=150  \\$aPhosphorus, Dietary
=450  \\$aDietary Phosphorus
=550  \\$wg$aPhosphorus Compounds
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther
=680  \\$iPhosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis.
=688  \\$a91
=750  \0$aFood$xPhosphorus content$5IEN$0(DLC)sh 90004798

=LDR  01581cz  a2200421n  4500
=001  9880364013902441
=005  20141212211443.0
=008  900601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x20
=072  \\$aN3.$x706.$x535.$x20
=072  \\$aN4.$x590.$x233.$x624.$x124.$x50
=150  \\$aAdvance Directives
=450  \\$wnnna$aAdvance Directive
=450  \\$wnnna$aAttorney Healthcare Power
=450  \\$wnnna$aAttorney Medical Power
=450  \\$wnnna$aContract, Ulysses
=450  \\$wnnna$aContracts, Ulysses
=450  \\$wnnna$aDirective, Advance
=450  \\$wnnna$aDirectives, Advance
=450  \\$aHealth Care Power of Attorney
=450  \\$wnnna$aHealthcare Power of Attorney
=450  \\$aMedical Power of Attorney
=450  \\$wnnna$aPsychiatric Will
=450  \\$wnnna$aPsychiatric Wills
=450  \\$wnnna$aUlysses Contract
=450  \\$wnnna$aUlysses Contracts
=450  \\$wnnna$aWill, Psychiatric
=450  \\$wnnna$aWills, Psychiatric
=550  \\$wg$aAdvance Care Planning
=550  \\$wg$aJurisprudence
=550  \\$wh$aLiving Wills
=550  \\$aAdvance Directive Adherence
=550  \\$aPatient Self-Determination Act
=680  \\$iDeclarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. (Bioethics Thesaurus)
=688  \\$a1991
=750  \0$aAdvance directives (Medical care)$5IEN-M$0(DLC)sh 98000411

=LDR  01219cz  a2200349n  4500
=001  9880364014002441
=005  20141212211439.0
=008  900617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016213
=035  \\$aCBG6563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x360.$x262
=072  \\$aD12.$x776.$x167.$x218
=072  \\$aD12.$x776.$x476.$x262
=150  \\$aCyclins
=450  \\$wnnna$aCyclin
=550  \\$wg$aCell Cycle Proteins
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wh$aCyclin A
=550  \\$wh$aCyclin B
=550  \\$wh$aCyclin C
=550  \\$wh$aCyclin D
=550  \\$wh$aCyclin E
=550  \\$wh$aCyclin G
=550  \\$wh$aCyclin H
=550  \\$wh$aCyclin I
=550  \\$wh$aCyclin T
=550  \\$aMaturation-Promoting Factor
=667  \\$anote specifics
=680  \\$iA large family of regulatory proteins that function as accessory subunits to a variety of CYCLIN-DEPENDENT KINASES. They generally function as ENZYME ACTIVATORS that drive the CELL CYCLE through transitions between phases. A subset of cyclins may also function as transcriptional regulators.
=688  \\$a93; was CYCLIN 1991-2
=750  \0$aCyclins$0(DLC) sh 97004869$5IEN-M

=LDR  02014cz  a2200397n  4500
=001  9880364014102441
=005  20141212211438.0
=008  900629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x687
=072  \\$aD12.$x644.$x276.$x954.$x800.$x720
=072  \\$aD12.$x644.$x276.$x963.$x720
=072  \\$aD12.$x776.$x467.$x374.$x687
=072  \\$aD12.$x776.$x467.$x942.$x800.$x720
=072  \\$aD12.$x776.$x467.$x960.$x720
=072  \\$aD23.$x529.$x374.$x687
=072  \\$aD23.$x529.$x942.$x800.$x720
=072  \\$aD23.$x529.$x960.$x720
=150  \\$aTransforming Growth Factor beta
=450  \\$aBone-Derived Transforming Growth Factor
=450  \\$wnnna$aBone Derived Transforming Growth Factor
=450  \\$wnnna$aFactor, Milk Growth
=450  \\$wnnna$aGrowth Factor, Milk
=450  \\$wnnna$aMilk Growth Factor
=450  \\$aPlatelet Transforming Growth Factor
=450  \\$aTGF-beta
=450  \\$wnnna$aTGFbeta
=550  \\$wg$aCytokines
=550  \\$wg$aTransforming Growth Factors
=550  \\$wh$aTransforming Growth Factor beta1
=550  \\$wh$aTransforming Growth Factor beta2
=550  \\$wh$aTransforming Growth Factor beta3
=680  \\$iA factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins.
=688  \\$a91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90
=750  \0$aTransforming growth factors beta$5IEN$0(DLC)sh 90001874

=LDR  02852cz  a2200685n  4500
=001  9880364014202441
=005  20141212211437.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016209
=035  \\$aCBG6559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x200.$x120.$x800
=072  \\$aD12.$x644.$x276.$x374.$x465.$x508
=072  \\$aD12.$x776.$x467.$x374.$x200.$x120.$x800
=072  \\$aD12.$x776.$x467.$x374.$x465.$x508
=072  \\$aD23.$x125.$x300.$x120.$x800
=072  \\$aD23.$x469.$x200.$x120.$x800
=072  \\$aD23.$x529.$x374.$x200.$x120.$x800
=072  \\$aD23.$x529.$x374.$x465.$x508
=150  \\$aInterleukin-8
=450  \\$wnnna$aAlveolar Macrophage Chemotactic Factor-I
=450  \\$wnnna$aAlveolar Macrophage Chemotactic Factor I
=450  \\$wnnna$aAMCF-I
=450  \\$wnnna$aAnionic Neutrophil-Activating Peptide
=450  \\$wnnna$aAnionic Neutrophil Activating Peptide
=450  \\$aChemokine CXCL8
=450  \\$wnnna$aChemokine, CXCL8
=450  \\$wnnna$aChemokines, CXCL8
=450  \\$aChemotactic Factor, Macrophage-Derived
=450  \\$wnnna$aChemotactic Factor, Macrophage Derived
=450  \\$wnnna$aChemotactic Factor, Neutrophil
=450  \\$aChemotactic Factor, Neutrophil, Monocyte-Derived
=450  \\$wnnna$aChemotactic Peptide-Interleukin-8, Granulocyte
=450  \\$aCXCL8 Chemokine
=450  \\$wnnna$aCXCL8, Chemokine
=450  \\$wnnna$aCXCL8 Chemokines
=450  \\$wnnna$aGranulocyte Chemotactic Peptide-Interleukin-8
=450  \\$wnnna$aGranulocyte Chemotactic Peptide Interleukin 8
=450  \\$aIL-8
=450  \\$wnnna$aIL8
=450  \\$wnnna$aInterleukin 8
=450  \\$wnnna$aLymphocyte-Derived Neutrophil-Activating Peptide
=450  \\$wnnna$aMacrophage-Derived Chemotactic Factor
=450  \\$wnnna$aMonocyte-Derived Neutrophil-Activating Peptide
=450  \\$wnnna$aMonocyte-Derived Neutrophil Chemotactic Factor
=450  \\$wnnna$aNeutrophil-Activating Peptide, Anionic
=450  \\$aNeutrophil-Activating Peptide, Lymphocyte-Derived
=450  \\$wnnna$aNeutrophil Activating Peptide, Lymphocyte Derived
=450  \\$aNeutrophil-Activating Peptide, Monocyte-Derived
=450  \\$wnnna$aNeutrophil Activating Peptide, Monocyte Derived
=450  \\$wnnna$aNeutrophil Activation Factor
=450  \\$wnnna$aNeutrophil Chemotactic Factor
=450  \\$wnnna$aPeptide, Anionic Neutrophil-Activating
=550  \\$wg$aChemokines, CXC
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 8
=680  \\$iA member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.
=688  \\$a1991
=688  \\$a91
=750  \0$aInterleukin-8$0(DLC) sh 91003712$5IEN

=LDR  01215cz  a2200301n  4500
=001  9880363802402441
=005  20141212205459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012494
=035  \\$aCBA5803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x875
=072  \\$aN5.$x715.$x360.$x775.$x700
=072  \\$aN6.$x850.$x520.$x450.$x875
=150  \\$aSampling Studies
=450  \\$wnnna$aProbability Sample
=450  \\$wnnna$aProbability Samples
=450  \\$wnnna$aSample, Probability
=450  \\$wnnna$aSamples, Probability
=450  \\$wnnna$aSampling Study
=450  \\$wnnna$aStudies, Sampling
=450  \\$wnnna$aStudy, Sampling
=550  \\$wg$aEpidemiologic Study Characteristics as Topic
=550  \\$wh$aLot Quality Assurance Sampling
=667  \\$aNIM with specific study IM; no qualif; epidemiological & statist only: not for blood samples, soil samples, water samples, air samples, etc.
=680  \\$iStudies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
=688  \\$a67(65)
=750  \0$aSampling (Statistics)$5IEN$0(DLC)sh 85117056

=LDR  00849cz  a2200193n  4500
=001  9880363802502441
=005  20141212205459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012493
=035  \\$aCBA5802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x937
=072  \\$aD1.$x268.$x558.$x362.$x937
=072  \\$aD1.$x552.$x550.$x399.$x937
=150  \\$aSamarium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Sm-152; Sm-144, 150, 154 = SAMARIUM (IM) + ISOTOPES (NIM); Sm-142, 143, 145-149, 151, 153, 155-157 = SAMARIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iSamarium. An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors.
=750  \0$aSamarium$5IEN$0(DLC)sh 85117001

=LDR  00714cz  a2200169n  4500
=001  9880363802602441
=005  20141212205458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012492
=035  \\$aCBA5801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x786
=150  \\$aSalts
=550  \\$wg$aInorganic Chemicals
=667  \\$anote plural: not for "salt" referring to common salt (SODIUM CHLORIDE) or TABLE SALT see SODIUM CHLORIDE, DIETARY; GEN; NIM; Manual 25.5.5.2
=680  \\$iSubstances produced from the reaction between acids and bases; compounds consisting of a metal (positive) and nonmetal (negative) radical. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aSalts$5IEN$0(DLC)sh 85116900

=LDR  01270cz  a2200265n  4500
=001  9880363802702441
=005  20141212205458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012491
=035  \\$aCBA5800HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x811
=150  \\$aSalt Gland
=450  \\$wnnna$aGland, Rectal
=450  \\$wnnna$aGland, Salt
=450  \\$wnnna$aGlands, Rectal
=450  \\$wnnna$aGlands, Salt
=450  \\$aRectal Gland
=450  \\$wnnna$aRectal Glands
=450  \\$wnnna$aSalt Glands
=550  \\$wg$aAnimal Structures
=667  \\$ain marine animals & birds only; X ref RECTAL GLAND is found in sharks, rays & skates & is used often in marine electrolyte studies
=680  \\$iA compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance. The Pekin duck serves as a common research animal in salt gland studies. A rectal gland or rectal salt gland in the dogfish shark is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. (Storer, Usinger, Stebbins & Nybakken: General Zoology, 6th ed, p658)
=688  \\$a70(64)
=750  \0$aSalt gland$5IEN$0(DLC)sh 85116869

=LDR  00808cz  a2200181n  4500
=001  9880363802802441
=005  20141212205457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x390.$x890
=072  \\$aC13.$x351.$x500.$x56.$x750.$x875
=150  \\$aSalpingitis
=450  \\$wnnna$aSalpingitides
=550  \\$wg$aFallopian Tube Diseases
=550  \\$wg$aPelvic Inflammatory Disease
=680  \\$iInflammation of the uterine salpinx, the trumpet-shaped FALLOPIAN TUBES, usually caused by ascending infections of organisms from the lower reproductive tract. Salpingitis can lead to tubal scarring, hydrosalpinx, tubal occlusion, INFERTILITY, and ectopic pregnancy (PREGNANCY, ECTOPIC)
=750  \0$aSalpingitis$0(DLC)sh2005006501$5IEN-M

=LDR  01055cz  a2200277n  4500
=001  9880363802902441
=005  20141212205457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012487
=035  \\$aCBA5796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750
=150  \\$aSalmonidae
=450  \\$wnnna$aGrayling
=450  \\$aGraylings
=450  \\$wnnna$aSalmonid
=450  \\$wnnna$aSalmonids
=450  \\$aThymallus
=450  \\$aWhitefish
=550  \\$wg$aSalmoniformes
=550  \\$wh$aSalmon
=550  \\$wh$aTrout
=667  \\$aGEN or unspecified; prefer SALMON & TROUT but check text for genera Oncorhynchus & Salmo: some are salmon, some are trout
=680  \\$iA family of anadromous fish comprising SALMON; TROUT; whitefish; and graylings. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. (Nelson: Fishes of the World, 1976, p97)
=688  \\$a1968
=750  \0$aSalmonidae$5IEN$0(DLC)sh 85116835

=LDR  00788cz  a2200193n  4500
=001  9880363803002441
=005  20141212205457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012486
=035  \\$aCBA5795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x800.$x200.$x825
=072  \\$aB3.$x660.$x250.$x150.$x710.$x160.$x760
=150  \\$aSalmonella typhimurium
=450  \\$aSalmonella typhimurium LT2
=550  \\$wg$aSalmonella enterica
=667  \\$ainfection: coordinate IM with SALMONELLA INFECTIONS (IM) or SALMONELLA FOOD POISONING (IM) if pertinent
=680  \\$iA serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.
=750  \0$aSalmonella typhimurium$5IEN$0(DLC)sh 87000829

=LDR  00724cz  a2200205n  4500
=001  9880363803102441
=005  20141212205456.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012485
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x800.$x200.$x800
=072  \\$aB3.$x660.$x250.$x150.$x710.$x160.$x750
=150  \\$aSalmonella typhi
=450  \\$wnnna$aSalmonella enterica serovar Typhi
=450  \\$wnnna$aSalmonella typhosa
=550  \\$wg$aSalmonella enterica
=667  \\$ainfection = TYPHOID FEVER
=680  \\$iA serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.
=688  \\$a76; was SALMONELLA TYPHOSA 1963-75
=750  \0$aSalmonella typhi$5IEN$0(DLC)sh 88023330

=LDR  00940cz  a2200265n  4500
=001  9880363803202441
=005  20141212205455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012481
=035  \\$aCBA5790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x821.$x706
=072  \\$aC22.$x812
=150  \\$aSalmonella Infections, Animal
=450  \\$wnnna$aAnimal Salmonella Infection
=450  \\$wnnna$aAnimal Salmonella Infections
=450  \\$wnnna$aInfection, Animal Salmonella
=450  \\$wnnna$aInfections, Animal Salmonella
=450  \\$wnnna$aSalmonella Infection, Animal
=450  \\$aSalmonella Infections$xveterinary
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aSalmonella Infections
=667  \\$aexper or vet; don't forget to check tag ANIMALS
=680  \\$iInfections in animals with bacteria of the genus SALMONELLA.
=750  \0$aSalmonella infections in animals$5IEN$0(DLC)sh 92000930

=LDR  01014cz  a2200277n  4500
=001  9880363803302441
=005  20141212205455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012480
=035  \\$aCBA5789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x821
=150  \\$aSalmonella Infections
=450  \\$wnnna$aInfection, Salmonella
=450  \\$wnnna$aInfections, Salmonella
=450  \\$wnnna$aSalmonella Infection
=450  \\$wnnna$aSalmonelloses
=450  \\$aSalmonellosis
=550  \\$wg$aEnterobacteriaceae Infections
=550  \\$wh$aParatyphoid Fever
=550  \\$wh$aSalmonella Food Poisoning
=550  \\$wh$aSalmonella Infections, Animal
=550  \\$wh$aTyphoid Fever
=667  \\$agram-neg bact infect; GEN or unspecified; see notes on specific species terms; SALMONELLA INFECTIONS, ANIMAL & SALMONELLA FOOD POISONING are available
=680  \\$iInfections with bacteria of the genus SALMONELLA.
=750  \0$aSalmonella infections$0(DLC)sh2006006099$5IEN-M

=LDR  00979cz  a2200241n  4500
=001  9880363803402441
=005  20141212205455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012478
=035  \\$aCBA5787M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x821.$x606
=072  \\$aC25.$x723.$x415.$x738
=150  \\$aSalmonella Food Poisoning
=450  \\$wnnna$aFood Poisoning, Salmonella
=450  \\$wnnna$aFood Poisonings, Salmonella
=450  \\$wnnna$aPoisoning, Salmonella Food
=450  \\$wnnna$aPoisonings, Salmonella Food
=450  \\$wnnna$aSalmonella Food Poisonings
=550  \\$wg$aFoodborne Diseases
=550  \\$wg$aSalmonella Infections
=680  \\$iPoisoning caused by ingestion of food harboring species of SALMONELLA. Conditions of raising, shipping, slaughtering, and marketing of domestic animals contribute to the spread of this bacterium in the food supply.
=750  \0$aSalmonella food poisoning$0(DLC)sh2006006098$5IEN-M

=LDR  00751cz  a2200205n  4500
=001  9880363803502441
=005  20141212205454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012477
=035  \\$aCBA5786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x800.$x200.$x300
=072  \\$aB3.$x660.$x250.$x150.$x710.$x160.$x160
=150  \\$aSalmonella enteritidis
=450  \\$wnnna$aSalmonella enterica serovar enteritidis
=550  \\$wg$aSalmonella enterica
=667  \\$ainfection: coord IM with SALMONELLA INFECTIONS (IM)
=680  \\$iA serotype of Salmonella enterica which is an etiologic agent of gastroenteritis in man and other animals.
=688  \\$a74(72)
=750  \0$aSalmonella enteritidis$5IEN$0(DLC)sh 88023325

=LDR  01087cz  a2200205n  4500
=001  9880363803602441
=005  20141212205454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012475
=035  \\$aCBA5784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x800
=072  \\$aB3.$x660.$x250.$x150.$x710
=150  \\$aSalmonella
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aSalmonella arizonae
=550  \\$wh$aSalmonella enterica
=667  \\$aGEN or unspecified; prefer specifics; infection = SALMONELLA INFECTIONS or its specifics: see notes on species terms for various infections
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.
=750  \0$aSalmonella$0(DLC) sh 86004896$5IEN

=LDR  01258cz  a2200325n  4500
=001  9880363803702441
=005  20141212205453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012474
=035  \\$aCBA5783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x705
=150  \\$aSalmon
=450  \\$wnnna$aChinook Salmon
=450  \\$aOncorhynchus gorbuscha
=450  \\$aOncorhynchus nerka
=450  \\$aOncorhynchus tshawytscha
=450  \\$wnnna$aPink Salmon
=450  \\$aSalmo salmo
=450  \\$aSalmon, Chinook
=450  \\$aSalmon, Pink
=450  \\$aSalmon, Sockeye
=450  \\$wnnna$aSockeye Salmon
=550  \\$wg$aSalmonidae
=550  \\$wh$aOncorhynchus
=550  \\$wh$aSalmo salar
=667  \\$agenera Oncorhynchus and Salmo may be either salmon or trout; check text; canned salmon = SALMON (IM) + FOOD PRESERVATION (IM)
=680  \\$iFish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed).
=688  \\$a72
=750  \0$aSalmon$5IEN$0(DLC)sh 85116821

=LDR  01357cz  a2200373n  4500
=001  9880363803802441
=005  20141212205453.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012471
=035  \\$aCBA5780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x848
=072  \\$aD12.$x776.$x850
=150  \\$aSalivary Proteins and Peptides
=450  \\$wnnoa$aParotin$5IEN-M
=450  \\$aSalivary Gland Proteins
=450  \\$wnnna$aSalivary Peptides
=450  \\$aSalivary Proteins
=550  \\$wg$aPeptides
=550  \\$wg$aProteins
=550  \\$wh$aGlue Proteins, Drosophila
=550  \\$wh$aHistatins
=550  \\$wh$aLipocalin 1
=550  \\$wh$aMucin-5B
=550  \\$wh$aSalivary alpha-Amylases
=550  \\$wh$aSalivary Cystatins
=550  \\$wh$aSalivary Proline-Rich Proteins
=550  \\$aDental Pellicle
=667  \\$ageneral or unspecified; prefer specifics; do not confuse entry term SALIVARY PROTEINS with SIALOPROTEINS, a type of glycoprotein
=680  \\$iProteins and peptides found in SALIVA and the SALIVARY GLANDS. Some salivary proteins such as ALPHA-AMYLASES are enzymes, but their composition varies in different individuals.
=688  \\$a2009(1977)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Salivary Proteins
=688  \\$a77
=750  \0$aSalivary proteins$0(DLC) sh 90004424$5IEN

=LDR  00636cz  a2200181n  4500
=001  9880363803902441
=005  20141212205425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012375
=035  \\$aCBA5683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650.$x700
=150  \\$aRodent Control
=450  \\$wnnna$aControl, Rodent
=550  \\$wg$aPest Control
=667  \\$acoord IM with specific rodent (IM)
=680  \\$iThe reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.
=750  \0$aRodents$xControl$5IEN$0(DLC)sh 85114804

=LDR  01147cz  a2200229n  4500
=001  9880363804002441
=005  20141212192505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012373
=035  \\$aCBA5681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x790.$x700
=072  \\$aC1.$x252.$x400.$x825.$x775
=150  \\$aRocky Mountain Spotted Fever
=450  \\$aSao Paulo Typhus
=450  \\$aTyphus, Sao Paulo
=550  \\$wg$aRickettsia Infections
=550  \\$wg$aTick-Borne Diseases
=667  \\$acaused by Rickettsia rickettsii; for X ref, in titles & translations use diacrit: São Paulo
=680  \\$iAn acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.
=688  \\$aSAO PAULO TYPHUS was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-76
=750  \0$aRocky Mountain spotted fever$5IEN$0(DLC)sh 85114788

=LDR  01137cz  a2200289n  4500
=001  9880363804102441
=005  20141212192505.0
=008  860408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012371
=035  \\$aCBA5679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x293.$x643
=072  \\$aJ1.$x897.$x104.$x834
=072  \\$aL1.$x224.$x65.$x630
=150  \\$aRobotics
=450  \\$wnnna$aOperation, Remote (Robotics)
=450  \\$wnnna$aOperations, Remote (Robotics)
=450  \\$wnnna$aRemote Operation (Robotics)
=450  \\$aRemote Operations (Robotics)
=450  \\$aTelerobotics
=550  \\$wg$aArtificial Intelligence
=550  \\$wg$aAutomation
=550  \\$wg$aElectronics
=550  \\$aRobotic Surgical Procedures
=680  \\$iThe application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses.
=688  \\$a87; was see AUTOMATION 1963-86
=750  \0$aRobotics$5IEN$0(DLC)sh 85114628

=LDR  01149cz  a2200313n  4500
=001  9880363804202441
=005  20141212205417.0
=008  770520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012346
=035  \\$aCBA5654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x780
=072  \\$aD13.$x444.$x735.$x757.$x715
=150  \\$aRNA, Transfer, Amino Acyl
=450  \\$wnnna$aAcyl tRNA, Amino
=450  \\$wnnna$aAcyl, tRNA-Amino
=450  \\$wnnna$aAmino Acyl T RNA
=450  \\$aAmino Acyl tRNA
=450  \\$aAminoacyl tRNA$5IEN
=450  \\$aTransfer RNA, Amino Acyl
=450  \\$atRNA-Amino Acyl
=450  \\$wnnna$atRNA Amino Acyl
=450  \\$wnnna$atRNA, Amino Acyl
=550  \\$wg$aAmino Acids
=550  \\$wg$aRNA, Transfer
=667  \\$aIM; /drug eff /ultrastruct permitted; DF: TRNA AMINO ACYL
=680  \\$iIntermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process.
=688  \\$a88; was AMINO ACYL T RNA 1978-87
=750  \0$aAminoacyl tRNA$5IEN$0(DLC)sh 85004497

=LDR  01370cz  a2200289n  4500
=001  9880363804302441
=005  20141212205416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012343
=035  \\$aCBA5651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x757
=150  \\$aRNA, Transfer
=450  \\$wnnna$aRNA, Suppressor Transfer
=450  \\$wnnna$aRNA, Transfer, Suppressor
=450  \\$aSuppressor Transfer RNA
=450  \\$aTransfer RNA
=450  \\$wnnna$aTransfer RNA, Suppressor
=450  \\$atRNA
=550  \\$wg$aRNA
=550  \\$wh$aAnticodon
=550  \\$wh$aRNA, Transfer, Amino Acid-Specific
=550  \\$wh$aRNA, Transfer, Amino Acyl
=667  \\$aGEN; prefer specifics; for suppressor transfer RNA coord with GENES, SUPPRESSOR or SUPPRESSION, GENETIC
=680  \\$iThe small RNA molecules, 73-80 nucleotides long, that function during translation (TRANSLATION, GENETIC) to align AMINO ACIDS at the RIBOSOMES in a sequence determined by the mRNA (RNA, MESSENGER). There are about 30 different transfer RNAs. Each recognizes a specific CODON set on the mRNA through its own ANTICODON and as aminoacyl tRNAs (RNA, TRANSFER, AMINO ACYL), each carries a specific amino acid to the ribosome to add to the elongating peptide chains.
=688  \\$a72; was RNA, SOLUBLE 1965-71
=750  \0$aTransfer RNA$5IEN$0(DLC)sh 85113852

=LDR  01325cz  a2200325n  4500
=001  9880363804402441
=005  20141212205413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012335
=035  \\$aCBA5643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x686
=150  \\$aRNA, Ribosomal
=450  \\$wnnna$a15S RNA
=450  \\$aRibosomal RNA
=450  \\$wnnna$aRNA, 15S
=550  \\$wg$aRNA
=550  \\$wh$aRNA, Ribosomal, 16S
=550  \\$wh$aRNA, Ribosomal, 18S
=550  \\$wh$aRNA, Ribosomal, 23S
=550  \\$wh$aRNA, Ribosomal, 28S
=550  \\$wh$aRNA, Ribosomal, 5.8S
=550  \\$wh$aRNA, Ribosomal, 5S
=550  \\$wh$aRNA, Ribosomal, Self-Splicing
=550  \\$aRibosomes
=667  \\$aIM; /drug eff /ultrastruct permitted; RRNA OPERON is also available
=680  \\$iThe most abundant form of RNA. Together with proteins, it forms the ribosomes, playing a structural role and also a role in ribosomal binding of mRNA and tRNAs. Individual chains are conventionally designated by their sedimentation coefficients. In eukaryotes, four large chains exist, synthesized in the nucleolus and constituting about 50% of the ribosome. (Dorland, 28th ed)
=688  \\$a72(71)
=750  \0$81$wb$aRibosomes$5IEN$0(DLC)sh 85113856
=750  \0$81$wb$aRNA$5IEN-HS$0(DLC)sh 85113850

=LDR  02167cz  a2200469n  4500
=001  9880363804502441
=005  20141212205413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012333
=035  \\$aCBA5640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x544
=150  \\$aRNA, Messenger
=450  \\$aMessenger RNA
=450  \\$aMessenger RNA, Polyadenylated
=450  \\$amRNA
=450  \\$amRNA, Non-Polyadenylated
=450  \\$wnnna$amRNA, Non Polyadenylated
=450  \\$amRNA, Polyadenylated
=450  \\$wnnna$aNon-Polyadenylated mRNA
=450  \\$wnnna$aNon Polyadenylated mRNA
=450  \\$aPoly(A)+ mRNA
=450  \\$aPoly(A)+ RNA
=450  \\$wnnna$aPoly(A) RNA
=450  \\$aPoly(A) Tail
=450  \\$wnnna$aPolyadenylated Messenger RNA
=450  \\$wnnna$aPolyadenylated mRNA
=450  \\$wnnna$aPolyadenylated RNA
=450  \\$aRNA, Messenger, Polyadenylated
=450  \\$aRNA, Polyadenylated
=450  \\$wnnna$aRNA, Polyadenylated Messenger
=550  \\$wg$aRNA
=550  \\$wh$aCodon
=550  \\$wh$aRiboswitch
=550  \\$wh$aRNA Caps
=550  \\$wh$aRNA, Messenger, Stored
=550  \\$wh$aRNA Splice Sites
=550  \\$wh$aUntranslated Regions
=667  \\$aIM; /drug eff /ultrastruct permitted; DF: note short X ref
=680  \\$iRNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
=688  \\$a65(64); MRNA, NON-POLYADENYLATED was NON-POLYADENYLATED MRNA (NM) 1981-94; MRNA, POLYADENYLATED was POLYADENYLATED MRNA (NM) 1980-94; POLY(A)+ RNA was SY to POLY(A) RNA (NM) 1980-94
=750  \0$aMessenger RNA$5IEN$0(DLC)sh 85083975

=LDR  01061cz  a2200253n  4500
=001  9880363804602441
=005  20141212205412.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012330
=035  \\$aCBA5637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x490
=072  \\$aG2.$x111.$x570.$x790.$x486.$x775
=072  \\$aG5.$x360.$x580.$x775
=150  \\$aRNA, Double-Stranded
=450  \\$aDouble-Stranded RNA
=450  \\$wnnna$aDouble Stranded RNA
=450  \\$wnnna$aRNA, Double Stranded
=550  \\$wg$aNucleic Acid Conformation
=550  \\$wg$aRNA
=667  \\$aIM; /drug eff /ultrastruct permitted; DF: DSRNA
=680  \\$iRNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.
=688  \\$a80
=750  \0$aDouble-stranded RNA$5IEN$0(DLC)sh 90004456

=LDR  01940cz  a2200673n  4500
=001  9880363804702441
=005  20160912154644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012328
=035  \\$aCBA5635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820
=150  \\$aRNA Viruses
=450  \\$wnnna$aRNA Rodent Virus
=450  \\$aRNA Rodent Viruses
=450  \\$wnnna$aRNA Virus
=450  \\$wnnna$aRodent Virus, RNA
=450  \\$wnnna$aRodent Viruses, RNA
=450  \\$wnnna$aVirus, RNA
=450  \\$wnnna$aVirus, RNA Rodent
=450  \\$wnnna$aViruses, RNA
=450  \\$wnnna$aViruses, RNA Rodent
=550  \\$wg$aViruses
=550  \\$wh$aArenaviridae
=550  \\$wh$aAstroviridae
=550  \\$wh$aBirnaviridae
=550  \\$wh$aBromoviridae
=550  \\$wh$aBunyaviridae
=550  \\$wh$aCaliciviridae
=550  \\$wh$aClosteroviridae
=550  \\$wh$aComoviridae
=550  \\$wh$aCystoviridae
=550  \\$wh$aDicistroviridae
=550  \\$wh$aEncephalitis Viruses
=550  \\$wh$aFlaviviridae
=550  \\$wh$aFlexiviridae
=550  \\$wh$aHepatitis Delta Virus
=550  \\$wh$aHepevirus
=550  \\$wh$aLeviviridae
=550  \\$wh$aLuteoviridae
=550  \\$wh$aMononegavirales
=550  \\$wh$aNidovirales
=550  \\$wh$aNodaviridae
=550  \\$wh$aOrthomyxoviridae
=550  \\$wh$aPicobirnavirus
=550  \\$wh$aPicornaviridae
=550  \\$wh$aPotyviridae
=550  \\$wh$aReoviridae
=550  \\$wh$aRetroviridae
=550  \\$wh$aSequiviridae
=550  \\$wh$aTenuivirus
=550  \\$wh$aTogaviridae
=550  \\$wh$aTombusviridae
=550  \\$wh$aTotiviridae
=550  \\$wh$aTymoviridae
=667  \\$aavoid: too general; prefer specifics; infection = RNA VIRUS INFECTIONS
=680  \\$iViruses whose genetic material is RNA.
=688  \\$a66; RNA RODENT VIRUSES was heading 1975-93
=750  \0$aRNA viruses$5IEN$0(DLC)sh 85143842

=LDR  01173cz  a2200313n  4500
=001  9880363804802441
=005  20141212205410.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012326
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x750.$x700
=072  \\$aG2.$x149.$x115.$x750.$x700
=072  \\$aG3.$x495.$x839.$x700
=072  \\$aG5.$x355.$x315.$x700.$x700
=150  \\$aRNA Splicing
=450  \\$aRNA, Messenger, Splicing
=450  \\$wnnna$aRNA Splicings
=450  \\$aSplicing, RNA
=450  \\$wnnna$aSplicings, RNA
=550  \\$wg$aRNA Processing, Post-Transcriptional
=550  \\$wh$aAlternative Splicing
=550  \\$wh$aTrans-Splicing
=550  \\$aRNA Cleavage
=550  \\$aRNA Splice Sites
=550  \\$aSpliceosomes
=667  \\$anote category: a physiologic process taking place within the cell nucleus; do not confuse with GENES, SPLICED see DNA, RECOMBINANT; CLONING, MOLECULAR or GENETIC ENGINEERING
=680  \\$iThe ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm.
=688  \\$a82
=750  \0$aRNA splicing$5IEN$0(DLC)sh 88004494

=LDR  01917cz  a2200469n  4500
=001  9880363804902441
=005  20200501110349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012321
=035  \\$aCBA5627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x445.$x308.$x300
=150  \\$aDNA-Directed RNA Polymerases
=450  \\$aDNA-Dependent RNA Polymerases
=450  \\$wnnna$aDNA Dependent RNA Polymerases
=450  \\$wnnna$aDNA-Directed RNA Polymerase
=450  \\$wnnna$aDNA Directed RNA Polymerase
=450  \\$wnnna$aDNA Directed RNA Polymerases
=450  \\$wnnna$aPolymerase, DNA-Directed RNA
=450  \\$wnnna$aPolymerase, RNA
=450  \\$wnnna$aPolymerases, DNA-Dependent RNA
=450  \\$wnnna$aPolymerases, DNA-Directed RNA
=450  \\$wnnna$aPolymerases, RNA
=450  \\$wnnna$aRNA Polymerase
=450  \\$wnnna$aRNA Polymerase, DNA-Directed
=450  \\$aRNA Polymerases
=450  \\$wnnna$aRNA Polymerases, DNA-Dependent
=450  \\$wnnna$aRNA Polymerases, DNA-Directed
=450  \\$wnnna$aTranscriptase
=450  \\$aTranscriptases
=550  \\$wg$aDNA Nucleotidyltransferases
=550  \\$wh$aDNA Polymerase beta
=550  \\$wh$aDNA Polymerase gamma
=550  \\$wh$aDNA Polymerase I
=550  \\$wh$aDNA Polymerase II
=550  \\$wh$aDNA Polymerase III
=550  \\$wh$aRNA-Directed DNA Polymerase
=550  \\$wh$aTaq Polymerase
=667  \\$aGEN or unspecified; prefer specifics RNA POLYMERASE I, etc.
=680  \\$iEnzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992).
=688  \\$a2003(1973)
=750  \0$aRNA polymerases$0(DLC) sh 87001690$5IEN

=LDR  02001cz  a2200541n  4500
=001  9880363805002441
=005  20141212205405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012313
=035  \\$aCBA5619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735
=150  \\$aRNA
=450  \\$wnnna$aAcid, Ribonucleic
=450  \\$wnnna$aGene Products, RNA
=450  \\$wnnna$aNon-Polyadenylated RNA
=450  \\$wnnna$aNon Polyadenylated RNA
=450  \\$aRibonucleic Acid
=450  \\$wnnna$aRNA Gene Products
=450  \\$aRNA, Non-Polyadenylated
=450  \\$wnnna$aRNA, Non Polyadenylated
=550  \\$wg$aNucleic Acids
=550  \\$wh$aRNA, Algal
=550  \\$wh$aRNA, Antisense
=550  \\$wh$aRNA, Archaeal
=550  \\$wh$aRNA, Bacterial
=550  \\$wh$aRNA, Chloroplast
=550  \\$wh$aRNA, Complementary
=550  \\$wh$aRNA, Double-Stranded
=550  \\$wh$aRNA, Fungal
=550  \\$wh$aRNA, Helminth
=550  \\$wh$aRNA Isoforms
=550  \\$wh$aRNA, Messenger
=550  \\$wh$aRNA, Neoplasm
=550  \\$wh$aRNA, Nuclear
=550  \\$wh$aRNA, Plant
=550  \\$wh$aRNA Precursors
=550  \\$wh$aRNA, Protozoan
=550  \\$wh$aRNA, Ribosomal
=550  \\$wh$aRNA, Satellite
=550  \\$wh$aRNA, Transfer
=550  \\$wh$aRNA, Untranslated
=550  \\$wh$aRNA, Viral
=550  \\$aBiopolymers
=667  \\$a/immunol: consider also IMMUNE RNA MANIPULATION see IMMUNOTHERAPY, ACTIVE
=680  \\$iA polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
=688  \\$aRNA, NON-POLYADENYLATED was NON-POLYADENYLATED RNA (NM) 1981-94
=750  \0$aRNA$5IEN$0(DLC)sh 85113850

=LDR  01165cz  a2200361n  4500
=001  9880363805102441
=005  20141212205404.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012312
=035  \\$aCBA5618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x870
=072  \\$aD2.$x33.$x755.$x624.$x870
=072  \\$aD2.$x92.$x63.$x624.$x870
=072  \\$aD2.$x92.$x471.$x683.$x870
=150  \\$aRitodrine
=450  \\$wnnna$aAstra Brand of Ritodrine Hydrochloride
=450  \\$wnnna$aDU-21220
=450  \\$wnnna$aDU 21220
=450  \\$wnnna$aDU21220
=450  \\$wnnna$aHydrochloride, Ritodrine
=450  \\$wnnna$aJanssen Brand of Ritodrine Hydrochloride
=450  \\$wnnna$aPre-Par
=450  \\$wnnna$aPre Par
=450  \\$wnnna$aPrePar
=450  \\$wnnna$aRitodrine Hydrochloride
=450  \\$wnnna$aSolvay Brand of Ritodrine Hydrochloride
=450  \\$wnnna$aYutopar
=550  \\$wg$aPhenethylamines
=550  \\$wg$aPropanolamines
=680  \\$iAn adrenergic beta-2 agonist used to control PREMATURE LABOR.
=688  \\$a86(75); was see under PROPANOLAMINES 1975-85
=750  \0$aRitodrine$5IEN$0(DLC)sh 85114221

=LDR  00997cz  a2200265n  4500
=001  9880363805202441
=005  20141212205404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012309
=035  \\$aCBA5615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x722
=150  \\$aRisk-Taking
=450  \\$wnnna$aBehavior, Risk
=450  \\$wnnna$aBehaviors, Risk
=450  \\$aRisk Behavior
=450  \\$wnnna$aRisk Behaviors
=450  \\$wnnna$aRisk Taking
=550  \\$wg$aBehavior
=550  \\$wh$aGambling
=550  \\$aDangerous Behavior
=667  \\$ano qualif
=680  \\$iUndertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her.
=688  \\$a79(75); was see under GAMBLING 1969-78
=750  \0$aRisk-taking (Psychology)$5IEN$0(DLC)sh 85114203

=LDR  02113cz  a2200493n  4500
=001  9880363805302441
=005  20200622120201.0
=008  781222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012308
=035  \\$aCBA5614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x800
=072  \\$aN4.$x452.$x871
=150  \\$aRisk Management
=450  \\$aHospital Incident Reporting
=450  \\$wnnna$aHospital Incident Reportings
=450  \\$wnnna$aHospital Risk Reporting
=450  \\$wnnna$aHospital Risk Reportings
=450  \\$aIncident Reporting, Hospital
=450  \\$wnnna$aIncident Reportings, Hospital
=450  \\$wnnna$aManagement Risk
=450  \\$wnnna$aManagement, Risk
=450  \\$wnnna$aManagement, Risks
=450  \\$wnnna$aManagement Risks
=450  \\$wnnna$aManagements, Risks
=450  \\$wnnna$aReporting, Hospital Incident
=450  \\$wnnna$aReporting, Hospital Risk
=450  \\$wnnna$aReportings, Hospital Incident
=450  \\$wnnna$aReportings, Hospital Risk
=450  \\$wnnna$aRisk, Management
=450  \\$wnnna$aRisk Reporting, Hospital
=450  \\$wnnna$aRisk Reportings, Hospital
=450  \\$wnnna$aRisks Management
=450  \\$wnnna$aRisks, Management
=450  \\$wnnna$aRisks Managements
=550  \\$wg$aFinancial Management
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aRisk Assessment
=550  \\$wh$aRisk Management
=550  \\$wh$aRisk Sharing, Financial
=550  \\$wh$aSafety Management
=680  \\$iThe process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. (From Slee & Slee: Health care terms, 2d ed)
=688  \\$a90(80); was see under FINANCIAL MANAGEMENT 1980-89
=750  \0$aRisk management$5IEN$0(DLC)sh 85114200

=LDR  01321cz  a2200301n  4500
=001  9880363805402441
=005  20141212205403.0
=008  870501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012307
=035  \\$aCBA5613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x800.$x725
=072  \\$aN5.$x715.$x350.$x200.$x700
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700.$x700
=072  \\$aN6.$x850.$x490.$x625.$x750
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800.$x725
=150  \\$aRisk Factors
=450  \\$wnnna$aFactor, Risk
=450  \\$wnnna$aFactors, Risk
=450  \\$aHealth Risk Assessment$5IEN
=450  \\$wnnna$aRisk Factor
=550  \\$wg$aCausality
=550  \\$wg$aRisk
=550  \\$aOrgans at Risk
=667  \\$ahuman & animal; an epidemiol concept for risk factors in dis, surg, etc.: do not confuse with RISK, a statist concept & aspect of probability; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iAn aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
=688  \\$a88
=750  \0$aHealth risk assessment$0sh 85059598$5IEN

=LDR  01146cz  a2200337n  4500
=001  9880363805502441
=005  20141212205402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x800
=072  \\$aG17.$x680.$x750
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800
=150  \\$aRisk
=450  \\$aRelative Risk
=450  \\$wnnna$aRelative Risks
=450  \\$wnnna$aRisk, Relative
=450  \\$wnnna$aRisks
=450  \\$wnnna$aRisks, Relative
=550  \\$wg$aProbability
=550  \\$wh$aLogistic Models
=550  \\$wh$aProtective Factors
=550  \\$wh$aRisk Assessment
=550  \\$wh$aRisk Factors
=550  \\$aHarm Reduction
=550  \\$aRisk Reduction Behavior
=667  \\$aIM GEN only; for risk as a statis concept; note other risk terms in MeSH
=680  \\$iThe probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.
=688  \\$a88(75); was see under PROBABILITY 1973-87
=750  \0$aRisk$5IEN$0(DLC)sh 85114195

=LDR  00625cz  a2200193n  4500
=001  9880363805602441
=005  20141212205402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012305
=035  \\$aCBA5611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x140.$x652
=150  \\$aRiots
=450  \\$wnnna$aRiot
=550  \\$wg$aCivil Disorders
=550  \\$aMass Behavior
=680  \\$iA form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system.
=688  \\$a70(69)
=750  \0$aRiots$5IEN$0(DLC)sh 85114172

=LDR  00708cz  a2200193n  4500
=001  9880363805702441
=005  20141212205401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012302
=035  \\$aCBA5608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x500.$x675
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x500.$x675
=150  \\$aRinderpest virus
=550  \\$wg$aMorbillivirus
=667  \\$ainfection = RINDERPEST
=680  \\$iA species of MORBILLIVIRUS causing cattle plague, a disease with high mortality. Sheep, goats, pigs, and other animals of the order Artiodactyla can also be infected.
=688  \\$a66(64)
=750  \0$aRinderpest virus$5IEN$0(DLC)sh 85114115

=LDR  00810cz  a2200205n  4500
=001  9880363805802441
=005  20141212205401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012301
=035  \\$aCBA5607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x500.$x700
=072  \\$aC22.$x780
=150  \\$aRinderpest
=450  \\$aCattle Plague
=450  \\$wnnna$aPlague, Cattle
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aMorbillivirus Infections
=680  \\$iA viral disease of cloven-hoofed animals caused by MORBILLIVIRUS. It may be acute, subacute, or chronic with the major lesions characterized by inflammation and ulceration of the entire digestive tract. The disease was declared successfully eradicated worldwide in 2010.
=750  \0$aRinderpest$5IEN$0(DLC)sh 85114113

=LDR  00578cz  a2200169n  4500
=001  9880363805902441
=005  20141212205400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012298
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x224.$x617.$x839
=150  \\$aRigor Mortis
=450  \\$wnnna$aMortis, Rigor
=550  \\$wg$aPostmortem Changes
=680  \\$iMuscular rigidity which develops in the cadaver usually from 4 to 10 hours after death and lasts 3 or 4 days.
=688  \\$a70; was see under DEATH 1963-69
=750  \0$aRigor mortis$5IEN$0(DLC)sh 85114098

=LDR  00821cz  a2200253n  4500
=001  9880363806002441
=005  20141212205400.0
=008  860530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012297
=035  \\$aCBA5603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x650.$x952
=072  \\$aN3.$x706.$x437.$x650.$x750
=150  \\$aRight to Die
=450  \\$aDeath with Dignity
=450  \\$wnnna$aDignity, Death with
=550  \\$wg$aPatient Rights
=550  \\$aAdvance Directives
=550  \\$aEuthanasia
=550  \\$aLiving Wills
=667  \\$adifferentiate from ALLOWING TO DIE see EUTHANASIA, PASSIVE
=680  \\$iThe right of the patient or the patient's representative to make decisions with regard to the patient's dying.
=688  \\$a87
=750  \0$aRight to die$5IEN$0(DLC)sh 85114084

=LDR  01087cz  a2200265n  4500
=001  9880363806102441
=005  20141212205359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012295
=035  \\$aCBA5601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x810
=072  \\$aC2.$x407.$x810
=072  \\$aC2.$x782.$x147.$x810
=072  \\$aC2.$x782.$x417.$x762
=072  \\$aC6.$x552.$x380.$x315.$x430.$x812
=072  \\$aC22.$x467.$x435.$x812
=150  \\$aRift Valley Fever
=450  \\$wnnna$aFever, Rift Valley
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aBunyaviridae Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=550  \\$wg$aHepatitis, Viral, Animal
=680  \\$iAn acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion (ABORTION, VETERINARY); and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.
=750  \0$aRift Valley fever$5IEN$0(DLC)sh 85114065

=LDR  00875cz  a2200229n  4500
=001  9880363806202441
=005  20141212205359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012294
=035  \\$aCBA5600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x549.$x811
=072  \\$aD4.$x345.$x295.$x750
=150  \\$aRifamycins
=450  \\$aRifomycins
=550  \\$wg$aHeterocyclic Compounds with 4 or More Rings
=550  \\$wg$aLactams, Macrocyclic
=550  \\$wh$aRifabutin
=550  \\$wh$aRifampin
=680  \\$iA group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.
=688  \\$a73; was RIFOMYCIN 1963-72
=750  \0$aRifamycins$5IEN$0(DLC)sh 85114063

=LDR  01149cz  a2200253n  4500
=001  9880363806302441
=005  20141212205359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012293
=035  \\$aCBA5599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x549.$x811.$x700
=072  \\$aD4.$x345.$x295.$x750.$x700
=150  \\$aRifampin
=450  \\$wnnna$aBenemycin
=450  \\$wnnna$aRifadin
=450  \\$aRifampicin
=450  \\$wnnna$aRimactan
=450  \\$wnnna$aRimactane
=450  \\$wnnna$aTubocin
=550  \\$wg$aRifamycins
=680  \\$iA semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
=688  \\$a73
=750  \0$aRifampin$5IEN$0(DLC)sh 87003747

=LDR  00664cz  a2200193n  4500
=001  9880363806402441
=005  20141212205358.0
=008  760525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012290
=035  \\$aCBA5596HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x650
=150  \\$aRickettsial Vaccines
=450  \\$wnnna$aVaccines, Rickettsial
=550  \\$wg$aBacterial Vaccines
=667  \\$acoord IM with specific Rickettsia /immunol (IM)
=680  \\$iVaccines for the prevention of diseases caused by various species of Rickettsia.
=688  \\$a91(73); was see under VACCINES 1973-90
=750  \0$aRickettsial vaccines$5IEN$0(DLC)sh 88003767

=LDR  00794cz  a2200217n  4500
=001  9880363806502441
=005  20141212205358.0
=008  760525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012287
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x647
=072  \\$aB3.$x660.$x50.$x765
=150  \\$aRickettsiaceae
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aRickettsieae
=550  \\$wh$aWolbachia
=667  \\$aa family: do not confuse with RICKETTSIEAE, a tribe; infection = RICKETTSIACEAE INFECTIONS
=680  \\$iA family of small, gram-negative organisms, often parasitic in humans and other animals, causing diseases that may be transmitted by invertebrate vectors.
=688  \\$a1975
=750  \0$aRickettsiaceae$5IEN-M$0(DLC)sh 88023321

=LDR  00726cz  a2200205n  4500
=001  9880363806602441
=005  20141212205357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012285
=035  \\$aCBA5591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x647.$x650.$x550
=072  \\$aB3.$x660.$x50.$x765.$x650.$x600
=150  \\$aOrientia tsutsugamushi
=450  \\$aRickettsia tsutsugamushi
=550  \\$wg$aRickettsieae
=667  \\$ainfection = SCRUB TYPHUS
=680  \\$iA gram-negative, rod-shaped to coccoid bacterium. It is the etiologic agent of SCRUB TYPHUS in humans and is transmitted by mites from rodent reservoirs.
=688  \\$a99(66)
=750  \0$aRickettsia tsutsugamushi$5IEN$0(DLC)sh 88023320

=LDR  01250cz  a2200289n  4500
=001  9880363806702441
=005  20200706135028.0
=008  860407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012282
=035  \\$aCBA5588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x790
=150  \\$aRickettsia Infections
=450  \\$wnnna$aInfection, Rickettsia
=450  \\$wnnna$aInfections, Rickettsia
=450  \\$wnnna$aRickettsia Infection
=450  \\$aRickettsial Diseases$5IEN
=550  \\$wg$aRickettsiaceae Infections
=550  \\$wh$aBoutonneuse Fever
=550  \\$wh$aRocky Mountain Spotted Fever
=550  \\$wh$aSpotted Fever Group Rickettsiosis
=550  \\$wh$aTyphus, Endemic Flea-Borne
=550  \\$wh$aTyphus, Epidemic Louse-Borne
=667  \\$agram-neg bact infect; GEN or unspecified; prefer specific infection as shown at the various RICKETTSIA species; infection by genus RICKETTSIA: do not confuse with RICKETTSIACEAE INFECTIONS ("infections with rickettsias of the Family RICKETTSIACEAE"); Rickettsia conorii infection = BOUTONNEUSE FEVER; Rickettsia quintana infection = TRENCH FEVER
=680  \\$iInfections by the genus RICKETTSIA.
=688  \\$a87
=750  \0$aRickettsial diseases$5IEN$0(DLC)sh 85113954

=LDR  01225cz  a2200253n  4500
=001  9880363806802441
=005  20141212205356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012281
=035  \\$aCBA5587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x647.$x650.$x650
=072  \\$aB3.$x660.$x50.$x765.$x650.$x650
=150  \\$aRickettsia
=550  \\$wg$aRickettsieae
=550  \\$wh$aRickettsia akari
=550  \\$wh$aRickettsia conorii
=550  \\$wh$aRickettsia felis
=550  \\$wh$aRickettsia prowazekii
=550  \\$wh$aRickettsia rickettsii
=550  \\$wh$aRickettsia typhi
=667  \\$aclassified with bacteria; infection = RICKETTSIA INFECTIONS or their specifics: see notes on species terms for various infections; Rickettsia quintana infection = TRENCH FEVER; RICKETTSIA TSUTSUGAMUSHI see ORIENTIA TSUTSUGAMUSHI is available
=680  \\$iA genus of gram-negative, aerobic, rod-shaped bacteria often surrounded by a protein microcapsular layer and slime layer. The natural cycle of its organisms generally involves a vertebrate and an invertebrate host. Species of the genus are the etiological agents of human diseases, such as typhus.
=750  \0$aRickettsia$5IEN$0(DLC)sh 85113953

=LDR  01314cz  a2200313n  4500
=001  9880363806902441
=005  20180119102052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012279
=035  \\$aCBA5585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x816
=072  \\$aC18.$x452.$x104.$x816
=072  \\$aC18.$x452.$x174.$x845
=072  \\$aC18.$x654.$x521.$x500.$x133.$x770.$x734
=150  \\$aRickets
=450  \\$wnnna$aRachitides
=450  \\$aRachitis
=550  \\$wg$aBone Diseases, Metabolic
=550  \\$wg$aCalcium Metabolism Disorders
=550  \\$wh$aChronic Kidney Disease-Mineral and Bone Disorder
=550  \\$wg$aVitamin D Deficiency
=550  \\$wh$aOsteomalacia
=550  \\$wh$aRickets, Hypophosphatemic
=550  \\$aGenu Valgum
=550  \\$aGenu Varum
=550  \\$aVitamin D Deficiency
=680  \\$iDisorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.
=750  \0$aRickets$5IEN$0(DLC)sh 85113950

=LDR  01213cz  a2200265n  4500
=001  9880363807002441
=005  20141212205355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012278
=035  \\$aCBA5584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x650
=150  \\$aRicinus
=450  \\$aCastor Oil Plant
=450  \\$wnnna$aCastor Oil Plants
=450  \\$wnnna$aOil Plant, Castor
=450  \\$wnnna$aOil Plants, Castor
=450  \\$wnnna$aPlant, Castor Oil
=450  \\$wnnna$aPlants, Castor Oil
=550  \\$wg$aEuphorbiaceae
=550  \\$wh$aCastor Bean
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. The seed of Ricinus communis L. is the CASTOR BEAN which is the source of CASTOR OIL; RICIN; and other lectins.
=688  \\$a2002; for CASTOR OIL PLANT use EUPHORBIACEAE 1998-2001
=750  \0$aRicinus$5IEN$0(DLC)sh 85113948

=LDR  01388cz  a2200409n  4500
=001  9880363807102441
=005  20141212205355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012276
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x430.$x700.$x750.$x666
=072  \\$aD12.$x776.$x34.$x756
=072  \\$aD12.$x776.$x503.$x499.$x937
=072  \\$aD12.$x776.$x765.$x678.$x906.$x750
=150  \\$aRicin
=450  \\$wnnna$aA Chain, Ricin
=450  \\$wnnna$aB Chain, Ricin
=450  \\$aCastor Bean Lectin
=450  \\$aLectin, Castor Bean
=450  \\$aLectin, Ricinus
=450  \\$wnnna$aRCA 60
=450  \\$wnnna$aRCA60
=450  \\$wnnna$aRicin A Chain
=450  \\$wnnna$aRicin B Chain
=450  \\$wnnna$aRicin D
=450  \\$wnnna$aRicin I
=450  \\$wnnna$aRicinus Lectin
=450  \\$wnnna$aRicinus Toxin
=450  \\$wnnna$aToxin, Ricinus
=550  \\$wg$aAlbumins
=550  \\$wg$aPlant Lectins
=550  \\$wg$aRibosome Inactivating Proteins, Type 2
=550  \\$aRicinus
=667  \\$a/antag: consider also ANTITOXINS
=680  \\$iA protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally.
=688  \\$a78(64); was see under PLANT PROTEINS 1975-77
=750  \0$aRicin$5IEN$0(DLC)sh 85113942

=LDR  00699cz  a2200205n  4500
=001  9880363807202441
=005  20160526090112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012275
=035  \\$aCBA5581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x616
=150  \\$aOryza
=450  \\$wnno$aOryza sativa
=450  \\$aRice
=450  \\$wnnna$aRices
=550  \\$wg$aPoaceae
=667  \\$a"yusho poisoning": index under ORYZA /pois (IM) + PLANT OILS /pois (IM) + POLYCHLOROBIPHENYL COMPOUNDS /pois (IM) + FOOD CONTAMINATION (IM)
=680  \\$iA genus of family POACEAE that includes several rice species.
=750  \0$aOryza$0(DLC)sh 85095847$5IEN-M

=LDR  00523cz  a2200181n  4500
=001  9880363807302441
=005  20181210100525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012272
=035  \\$aCBA5578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x570.$x500
=150  \\$aRibs
=450  \\$wnnna$aRib
=550  \\$wg$aRib Cage
=550  \\$wh$aCervical Rib
=667  \\$a/inj permitted: do not coord with THORACIC INJURIES but note RIB FRACTURES is available
=750  \0$aRibs$5IEN$0(DLC)sh 85113857

=LDR  00749cz  a2200217n  4500
=001  9880363807402441
=005  20170706105633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012270
=035  \\$aCBA5576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x811
=150  \\$aRibosomes
=450  \\$wnnna$aRibosome
=550  \\$wg$aOrganelles
=550  \\$wh$aPolyribosomes
=550  \\$wh$aRibosome Subunits
=550  \\$wh$aMitochondrial Ribosomes
=680  \\$iMulticomponent ribonucleoprotein structures found in the CYTOPLASM of all cells, and in MITOCHONDRIA, and PLASTIDS. They function in PROTEIN BIOSYNTHESIS via GENETIC TRANSLATION.
=688  \\$a65(64)
=750  \0$aRibosomes$0(DLC) sh 85113856$5IEN

=LDR  00499cz  a2200181n  4500
=001  9880363807502441
=005  20141212205351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012266
=035  \\$aCBA5572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x627.$x651
=150  \\$aRibose
=450  \\$wnnna$aD-Ribose
=450  \\$wnnna$aD Ribose
=550  \\$wg$aPentoses
=680  \\$iA pentose active in biological systems usually in its D-form.
=750  \0$aRibose$5IEN$0(DLC)sh 85113854

=LDR  01001cz  a2200217n  4500
=001  9880363807602441
=005  20141212205350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012262
=035  \\$aCBA5568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x810.$x567
=150  \\$aRibonucleoside Diphosphate Reductase
=450  \\$wnnna$aDiphosphate Reductase, Ribonucleoside
=450  \\$wnnna$aReductase, Ribonucleoside Diphosphate
=450  \\$wnnna$aReductase, UDP
=450  \\$wnnna$aUDP Reductase
=550  \\$wg$aRibonucleotide Reductases
=680  \\$iAn enzyme of the oxidoreductase class that catalyzes the formation of 2'-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. (From Dorland, 27th ed) EC 1.17.4.1.
=688  \\$a91(75); was see under RIBONUCLEOTIDE REDUCTASES 1975-90
=750  \0$aRibonucleoside diphosphate reductase$5IEN$0(DLC)sh 88002750

=LDR  01010cz  a2200313n  4500
=001  9880363807702441
=005  20200623171542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012260
=035  \\$aCBA5566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x700
=150  \\$aRibonucleases
=450  \\$wnnna$aAcid Ribonuclease
=450  \\$wnnna$aAlkaline Ribonuclease
=450  \\$aNucleases, RNA
=450  \\$wnnna$aRibonuclease
=450  \\$wnnna$aRibonuclease, Acid
=450  \\$wnnna$aRibonuclease, Alkaline
=450  \\$wnnna$aRNA Nucleases
=450  \\$aRNase
=550  \\$wg$aEsterases
=550  \\$wh$aEndoribonucleases
=550  \\$wh$aExoribonucleases
=550  \\$wh$aExosome Multienzyme Ribonuclease Complex
=550  \\$wh$aSAM Domain and HD Domain-Containing Protein 1
=680  \\$iEnzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-.
=688  \\$a83; was RIBONUCLEASE 1963-82
=750  \0$aRibonucleases$0(DLC) sh 95010177$5IEN-M

=LDR  00952cz  a2200229n  4500
=001  9880363807802441
=005  20141212205349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012257
=035  \\$aCBA5563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x713
=150  \\$aRiboflavin Deficiency
=450  \\$wnnna$aDeficiencies, Riboflavin
=450  \\$wnnna$aDeficiency, Riboflavin
=450  \\$wnnna$aRiboflavin Deficiencies
=450  \\$aRiboflavin$xdeficiency
=450  \\$aVitamin B2 Deficiency$5IEN
=550  \\$wg$aVitamin B Deficiency
=667  \\$aa vitamin B defic
=680  \\$iA dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia. (Dorland, 27th ed)
=750  \0$aVitamin B2 deficiency$5IEN$0(DLC)sh 85143965

=LDR  00969cz  a2200241n  4500
=001  9880363807902441
=005  20141212205349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012256
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x315.$x650
=072  \\$aD3.$x494.$x507.$x650
=072  \\$aD8.$x211.$x474.$x650
=072  \\$aD23.$x767.$x405.$x650
=150  \\$aRiboflavin
=450  \\$aVitamin B 2
=450  \\$wnnna$aVitamin B2
=450  \\$aVitamin G
=550  \\$wg$aFlavins
=550  \\$wh$aFlavin-Adenine Dinucleotide
=550  \\$wh$aFlavin Mononucleotide
=680  \\$iNutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE.
=750  \0$aVitamin B2$5IEN$0(DLC)sh 85143964

=LDR  01487cz  a2200433n  4500
=001  9880363808002441
=005  20141212205348.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012254
=035  \\$aCBA5560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x570.$x800.$x790
=150  \\$aRibavirin
=450  \\$wnnna$aDermatech Brand of Ribavirin
=450  \\$wnnna$aEssex Brand of Ribavirin
=450  \\$wnnna$aGrossman Brand of Ribavirin
=450  \\$wnnna$aICN-1229
=450  \\$wnnna$aICN 1229
=450  \\$wnnna$aICN Brand of Ribavirin
=450  \\$wnnna$aICN1229
=450  \\$wnnna$aMerck Brand of Ribavirin
=450  \\$wnnna$aPfizer Brand of Ribavirin
=450  \\$wnnna$aRebetol
=450  \\$wnnna$aRibamide
=450  \\$wnnna$aRibamidil
=450  \\$wnnna$aRibamidyl
=450  \\$wnnna$aRibasphere
=450  \\$wnnna$aRibavirin Merck Brand
=450  \\$aRibovirin
=450  \\$wnnna$aThree Rivers Pharmaceuticals Brand of Ribavirin
=450  \\$aTribavirin
=450  \\$wnnna$aVilona
=450  \\$wnnna$aViramide
=450  \\$wnnna$aVirazide
=450  \\$wnnna$aVirazole
=550  \\$wg$aRibonucleosides
=680  \\$iA nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.
=688  \\$a91(78); was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91
=750  \0$aRibavirin$5IEN$0(DLC)sh 85113841

=LDR  01019cz  a2200313n  4500
=001  9880363808102441
=005  20141212211014.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015361
=035  \\$aCBA5558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x765
=072  \\$aE4.$x680.$x275.$x700
=150  \\$aRhytidoplasty
=450  \\$aFace Lift
=450  \\$wnnna$aFace Lifts
=450  \\$wnnna$aFacelift
=450  \\$wnnna$aFacelifts
=450  \\$wnnna$aLift, Face
=450  \\$wnnna$aLifts, Face
=450  \\$wnnna$aRhytidectomies
=450  \\$aRhytidectomy
=450  \\$wnnna$aRhytidoplasties
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aDermatologic Surgical Procedures
=667  \\$ado not use /util except by MeSH definition; if of the face, do not coord with FACE or SKIN or related concept
=680  \\$iPlastic surgery performed, usually by excision of skin, for the elimination of wrinkles from the skin.
=688  \\$a89
=750  \0$aFacelift$5IEN$0(DLC)sh 92006037

=LDR  01413cz  a2200289n  4500
=001  9880363808202441
=005  20141212205347.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012252
=035  \\$aCBA5557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x194.$x605
=150  \\$aNatural Family Planning Methods
=450  \\$wnnna$aAbstinence, Periodic
=450  \\$wnnna$aFamily Planning, Natural
=450  \\$aNatural Family Planning
=450  \\$aPeriodic Abstinence
=450  \\$wnnna$aRhythm Method of Family Planning
=450  \\$wnnna$aRhythm Method of Family Planning, Calendar
=450  \\$wnnna$aRhythm Method of Family Planning, Cervical Mucus
=450  \\$wnnna$aRhythm Method of Family Planning, Temperature
=450  \\$wnnna$aSymptothermal Method of Family Planning
=550  \\$wg$aContraception
=550  \\$aFertile Period
=680  \\$iA class of natural contraceptive methods in which SEXUAL ABSTINENCE is practiced a few days before and after the estimated day of ovulation, during the fertile phase. Methods for determining the fertile period or OVULATION DETECTION are based on various physiological indicators, such as circulating hormones, changes in cervical mucus (CERVIX MUCUS), and the basal body temperature.
=688  \\$a2004 (1975); for NATURAL FAMILY PLANNING use FAMILY PLANNING 1988-2003
=750  \0$aNatural family planning$5IEN-M$0(DLC)sh 85090216

=LDR  01796cz  a2200385n  4500
=001  9880363808302441
=005  20141212205347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012251
=035  \\$aCBA5556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x44.$x744
=150  \\$aToxicodendron
=450  \\$wnnna$aIvies, Poison
=450  \\$aIvy, Poison
=450  \\$aOak, Poison
=450  \\$wnnna$aOaks, Poison
=450  \\$wnnna$aPoison Ivies
=450  \\$aPoison Ivy
=450  \\$aPoison Oak
=450  \\$wnnna$aPoison Oaks
=450  \\$aPoison Sumac
=450  \\$wnnna$aPoison Sumacs
=450  \\$wnnna$aRhus toxicodendron
=450  \\$wnnna$aRhus toxicodendrons
=450  \\$aSumac, Poison
=450  \\$wnnna$aSumacs, Poison
=450  \\$wnnna$atoxicodendron, Rhus
=450  \\$wnnna$aToxicodendrons
=450  \\$wnnna$atoxicodendrons, Rhus
=550  \\$wg$aAnacardiaceae
=667  \\$aDERMATITIS, TOXICODENDRON is available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus (formerly part of Rhus genus) of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis (DERMATITIS, TOXICODENDRON). The most toxic species are Toxicodendron vernix (poison sumac), T. diversilobum (poison oak), and T. radicans (poison ivy). T. vernicifera yields a useful varnish from which certain enzymes (laccases) are obtained.
=688  \\$a93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1986-92
=750  \0$aToxicodendron$5IEN$0(DLC)sh 85136328

=LDR  01294cz  a2200301n  4500
=001  9880363808402441
=005  20141212192504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x700
=072  \\$aJ2.$x500.$x850.$x700
=150  \\$aRheum
=450  \\$wnnna$aChinese Rhubarb
=450  \\$wnnna$aDa Huang
=450  \\$wnnna$aHuang, Da
=450  \\$wnnna$arhaponticum, Rheum
=450  \\$wnnna$aRheum rhaponticum
=450  \\$wnnna$aRheum tanguticum
=450  \\$aRhubarb
=450  \\$wnnna$aRhubarb, Chinese
=550  \\$wg$aPolygonaceae
=550  \\$wg$aVegetables
=550  \\$aArctium
=667  \\$anote entry term RHEUM RHAPONTICUM: RHAPONTICUM see LEUZEA is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other ANTHRAQUINONES. The roots were formerly used as PURGATIVES.
=688  \\$a2004(1963)
=750  \0$aRheum$5IEN-HS$0(DLC)sh 88023065

=LDR  01215cz  a2200325n  4500
=001  9880363808502441
=005  20141212205346.0
=008  860328\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012249
=035  \\$aCBA5554M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810
=072  \\$aA8.$x186.$x211.$x865
=150  \\$aRhombencephalon
=450  \\$wnnna$aBrain, Hind
=450  \\$wnnna$aBrains, Hind
=450  \\$wnnna$aHind Brain
=450  \\$wnnna$aHind Brains
=450  \\$aHindbrain
=450  \\$wnnna$aHindbrains
=450  \\$wnnna$aRhombencephalons
=550  \\$wg$aBrain
=550  \\$wg$aBrain Stem
=550  \\$wh$aMedulla Oblongata
=550  \\$wh$aMetencephalon
=550  \\$wh$aMyelencephalon
=550  \\$wh$aTectospinal Fibers
=680  \\$iThe posterior of the three primitive cerebral vesicles of an embryonic brain. It consists of myelencephalon, metencephalon, and isthmus rhombencephali from which develop the major BRAIN STEM components, such as MEDULLA OBLONGATA from the myelencephalon, CEREBELLUM and PONS from the metencephalon, with the expanded cavity forming the FOURTH VENTRICLE.
=688  \\$a87
=750  \0$aRhombencephalon$0(DLC) sh2005002848$5IEN-M

=LDR  00648cz  a2200205n  4500
=001  9880363808602441
=005  20141212205346.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012248
=035  \\$aCBA5553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x750
=072  \\$aB1.$x300.$x930.$x650
=150  \\$aRhodotorula
=450  \\$wnnna$aRhodotorulas
=550  \\$wg$aMitosporic Fungi
=550  \\$wg$aYeasts
=680  \\$iA red yeast-like mitosporic fungal genus generally regarded as nonpathogenic. It is cultured from numerous sources in human patients.
=688  \\$a91(75)
=750  \0$aRhodotorula$5IEN$0(DLC)sh 85113782

=LDR  00643cz  a2200193n  4500
=001  9880363808702441
=005  20141212205346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012247
=035  \\$aCBA5552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x708.$x733.$x650
=072  \\$aB3.$x660.$x50.$x663.$x750.$x733.$x650
=150  \\$aRhodospirillum rubrum
=550  \\$wg$aRhodospirillum
=667  \\$ain mud & stagnant water
=680  \\$iVibrio- to spiral-shaped phototrophic bacteria found in stagnant water and mud exposed to light.
=688  \\$a74(72)
=750  \0$aRhodospirillum rubrum$5IEN$0(DLC)sh 88023319

=LDR  00794cz  a2200205n  4500
=001  9880363808802441
=005  20141212205346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012246
=035  \\$aCBA5551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x708.$x733
=072  \\$aB3.$x660.$x50.$x663.$x750.$x733
=150  \\$aRhodospirillum
=550  \\$wg$aRhodospirillaceae
=550  \\$wh$aRhodospirillum centenum
=550  \\$wh$aRhodospirillum rubrum
=667  \\$ain mud & stagnant water
=680  \\$iA genus of gram-negative, spiral bacteria that possesses internal photosynthetic membranes. Its organisms divide by binary fission, are motile by means of polar flagella, and are found in aquatic environments.
=750  \0$aRhodospirillum$5IEN$0(DLC)sh 85113781

=LDR  01026cz  a2200193n  4500
=001  9880363808902441
=005  20141212205319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012159
=035  \\$aCBA5462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x869.$x697
=150  \\$aReticulum
=450  \\$wnnna$aReticulums
=550  \\$wg$aStomach, Ruminant
=667  \\$aa ruminant's 2d stomach; note category: animal term; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)
=680  \\$iThe second stomach of ruminants. It lies almost in the midline in the front of the abdomen, in contact with the liver and diaphragm and communicates freely with the RUMEN via the ruminoreticular orifice. The lining of the reticulum is raised into folds forming a honeycomb pattern over the surface. (From Concise Veterinary Dictionary, 1988)
=688  \\$a68
=750  \0$aReticulum (Ruminants)$5IEN$0(DLC)sh 87001218

=LDR  01282cz  a2200253n  4500
=001  9880363809002441
=005  20141212205319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012157
=035  \\$aCBA5460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x382.$x812
=150  \\$aMononuclear Phagocyte System
=450  \\$wnnna$aPhagocyte System, Mononuclear
=450  \\$aReticuloendothelial System
=450  \\$wnnna$aSystem, Mononuclear Phagocyte
=450  \\$wnnna$aSystem, Reticuloendothelial
=550  \\$wg$aImmune System
=550  \\$wh$aDendritic Cells
=550  \\$wh$aMacrophages
=550  \\$wh$aMonocytes
=680  \\$iMononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Reticuloendothelial System
=750  \0$aReticulo-endothelial system$0(DLC) sh 85113316$5IEN

=LDR  01043cz  a2200229n  4500
=001  9880363809102441
=005  20141212205318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012156
=035  \\$aCBA5459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x290.$x760
=072  \\$aA11.$x148.$x790
=072  \\$aA11.$x443.$x240.$x665
=072  \\$aA15.$x145.$x229.$x334.$x760
=072  \\$aA15.$x378.$x316.$x790
=150  \\$aReticulocytes
=450  \\$wnnna$aReticulocyte
=550  \\$wg$aBone Marrow Cells
=550  \\$wg$aErythrocytes
=680  \\$iImmature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic "reticulum" (not the same as the ENDOPLASMIC RETICULUM), hence the name reticulocytes.
=750  \0$aReticulocytes$5IEN$0(DLC)sh 85113319

=LDR  00854cz  a2200217n  4500
=001  9880363809202441
=005  20141212205318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012154
=035  \\$aCBA5457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x772
=150  \\$aReticular Formation
=450  \\$wnnna$aFormation, Reticular
=450  \\$wnnna$aFormations, Reticular
=450  \\$wnnna$aReticular Formations
=550  \\$wg$aBrain Stem
=550  \\$wh$aMidbrain Reticular Formation
=550  \\$wh$aRespiratory Center
=680  \\$iA region extending from the PONS & MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network.
=750  \0$aReticular formation$5IEN$0(DLC)sh 85113313

=LDR  00858cz  a2200253n  4500
=001  9880363809302441
=005  20141212192503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012151
=035  \\$aCBA5454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x647
=150  \\$aResuscitation
=450  \\$wnnna$aResuscitations
=550  \\$wg$aEmergency Treatment
=550  \\$wh$aCardiopulmonary Resuscitation
=550  \\$wh$aHeart Massage
=550  \\$wh$aRespiration, Artificial
=550  \\$wh$aResuscitation Orders
=550  \\$aDeath, Sudden
=550  \\$aDrowning
=667  \\$ado not use /util except by MeSH definition; RESUSCITATION is correct translation for French "réanimation"
=680  \\$iThe restoration to life or consciousness of one apparently dead. (Dorland, 27th ed)
=750  \0$aResuscitation$5IEN$0(DLC)sh 85113293

=LDR  01025cz  a2200265n  4500
=001  9880363809402441
=005  20141212205316.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x85.$x700
=072  \\$aE5.$x472.$x760
=150  \\$aRestraint, Physical
=450  \\$wnnna$aImmobilization, Physical
=450  \\$wnnna$aPhysical Immobilization
=450  \\$wnnna$aPhysical Restraint
=450  \\$wnnna$aPhysical Restraints
=450  \\$wnnna$aRestraints, Physical
=550  \\$wg$aBehavior Control
=550  \\$wg$aImmobilization
=550  \\$wh$aHindlimb Suspension
=667  \\$ahuman and animal: NIM with no qualif for restraint of animals in experimental stress states; do not confuse with IMMOBILIZATION: if in doubt use word of text
=680  \\$iUse of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION.
=688  \\$a1977
=750  \0$aRestraint of patients$5IEN$0(DLC)sh 85113276

=LDR  01652cz  a2200433n  4500
=001  9880363809502441
=005  20141212205316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012148
=035  \\$aCBA5450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x803
=072  \\$aC10.$x886.$x425.$x800.$x700
=072  \\$aC10.$x886.$x659.$x634
=072  \\$aF3.$x870.$x400.$x800.$x700
=072  \\$aF3.$x870.$x664.$x634
=150  \\$aRestless Legs Syndrome
=450  \\$wnnna$aDisease, Willis Ekbom
=450  \\$wnnna$aDisease, Willis-Ekbom
=450  \\$wnnna$aRestless Leg Syndrome
=450  \\$wnnna$aRestless Legs
=450  \\$wnnna$aSyndrome, Restless Leg
=450  \\$wnnna$aSyndrome, Willis Ekbom
=450  \\$wnnna$aSyndrome, Willis-Ekbom
=450  \\$wnnna$aSyndrome, Wittmaack Ekbom
=450  \\$wnnna$aSyndrome, Wittmaack-Ekbom
=450  \\$wnnna$aWillis Ekbom Disease
=450  \\$wnnna$aWillis-Ekbom Disease
=450  \\$wnnna$aWillis Ekbom Syndrome
=450  \\$wnnna$aWillis-Ekbom Syndrome
=450  \\$wnnna$aWittmaack Ekbom Syndrome
=450  \\$wnnna$aWittmaack-Ekbom Syndrome
=550  \\$wg$aNervous System Diseases
=550  \\$wg$aParasomnias
=550  \\$wg$aSleep Disorders, Intrinsic
=667  \\$anote entry terms containing "Ekbom": do not confuse with entry terms for DELUSIONAL PARASITOSIS which also contain "Ekbom"
=680  \\$iA disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.
=688  \\$a2000(1973)
=750  \0$aRestless legs syndrome$5IEN-M$0(DLC)sh 96010873

=LDR  00395cz  a2200157n  4500
=001  9880363809602441
=005  20141212205316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012147
=035  \\$aCBA5449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x500.$x700
=150  \\$aRestaurants
=450  \\$wnnna$aRestaurant
=550  \\$wg$aFood Services
=750  \2$aRestaurants$5IEN

=LDR  00504cz  a2200181n  4500
=001  9880363809702441
=005  20141212205315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012146
=035  \\$aCBA5448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x769.$x647
=150  \\$aRest
=450  \\$wnnna$aRests
=550  \\$wg$aRelaxation
=667  \\$ado not confuse with IMMOBILIZATION; /physiol /psychol permitted
=680  \\$iFreedom from activity.
=750  \0$aRest$5IEN$0(DLC)sh 85113239

=LDR  00905cz  a2200253n  4500
=001  9880363809802441
=005  20141212205315.0
=008  840411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012144
=035  \\$aCBA5446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x611.$x470.$x610
=072  \\$aN2.$x421.$x143.$x524.$x470.$x610
=072  \\$aN2.$x421.$x533.$x320.$x610
=150  \\$aRespite Care
=450  \\$wnnna$aCare, Respite
=450  \\$wnnna$aCares, Respite
=450  \\$wnnna$aRespite Cares
=550  \\$wg$aHome Nursing
=550  \\$aHospice Care
=667  \\$a"in the home or institution intermittently in order to provide temporary relief to the family home care giver"
=680  \\$iPatient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver.
=688  \\$a85
=750  \0$aRespite care$5IEN$0(DLC)sh 86000744

=LDR  03241cz  a2200769n  4500
=001  9880363809902441
=005  20141212205315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012143
=035  \\$aCBA5445M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772
=150  \\$aRespiratory Physiological Phenomena
=450  \\$wnnna$aConcept, Respiratory Physiological
=450  \\$wnnna$aConcepts, Respiratory Physiological
=450  \\$wnnna$aPhenomena, Pulmonary Physiological
=450  \\$wnnna$aPhenomena, Respiratory Physiological
=450  \\$wnnna$aPhenomenas, Pulmonary Physiological
=450  \\$wnnna$aPhenomenas, Respiratory Physiological
=450  \\$wnnna$aPhenomenon, Pulmonary Physiological
=450  \\$wnnna$aPhenomenon, Respiratory Physiological
=450  \\$wnnna$aPhenomenons, Pulmonary Physiological
=450  \\$wnnna$aPhenomenons, Respiratory Physiological
=450  \\$wnnna$aPhysiological Concept, Respiratory
=450  \\$wnnna$aPhysiological Concepts, Respiratory
=450  \\$wnnna$aPhysiological Phenomena, Pulmonary
=450  \\$wnnna$aPhysiological Phenomena, Respiratory
=450  \\$wnnna$aPhysiological Phenomenas, Pulmonary
=450  \\$wnnna$aPhysiological Phenomenas, Respiratory
=450  \\$wnnna$aPhysiological Phenomenon, Pulmonary
=450  \\$wnnna$aPhysiological Phenomenon, Respiratory
=450  \\$wnnna$aPhysiological Phenomenons, Pulmonary
=450  \\$wnnna$aPhysiological Phenomenons, Respiratory
=450  \\$wnnna$aPhysiology, Respiratory
=450  \\$wnnna$aPulmonary Physiological Phenomena
=450  \\$wnnna$aPulmonary Physiological Phenomenas
=450  \\$wnnna$aPulmonary Physiological Phenomenon
=450  \\$wnnna$aPulmonary Physiological Phenomenons
=450  \\$aRespiration$xphysiology$5IEN-M
=450  \\$wnnoa$aRespiratory Physiologic Phenomena$5IEN-M
=450  \\$wnnna$aRespiratory Physiological Concept
=450  \\$wnnna$aRespiratory Physiological Concepts
=450  \\$wnnna$aRespiratory Physiological Phenomenas
=450  \\$wnnna$aRespiratory Physiological Phenomenon
=450  \\$wnnna$aRespiratory Physiological Phenomenons
=450  \\$aRespiratory Physiology
=450  \\$aRespiratory System$xphysiology
=550  \\$wg$aCirculatory and Respiratory Physiological Phenomena
=550  \\$wh$aAirway Remodeling
=550  \\$wh$aAirway Resistance
=550  \\$wh$aLung Compliance
=550  \\$wh$aPulmonary Diffusing Capacity
=550  \\$wh$aPulmonary Ventilation
=550  \\$wh$aRespiratory Dead Space
=550  \\$wh$aRespiratory Physiological Processes
=550  \\$wh$aRespiratory Sounds
=550  \\$wh$aTotal Lung Capacity
=550  \\$wh$aValsalva Maneuver
=550  \\$wh$aVentilation-Perfusion Ratio
=550  \\$wh$aVoice
=550  \\$wh$aWork of Breathing
=667  \\$ageneral or unspecified; prefer specifics; DF: RESPIRATORY PHYSIOL
=680  \\$iPhysiological processes and properties of the RESPIRATORY SYSTEM as a whole or of any of its parts.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Respiratory Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aRespiratory organs$xPhysiology$0(IEN)8590798$5IEN-M

=LDR  01063cz  a2200301n  4500
=001  9880363810002441
=005  20141212205314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012142
=035  \\$aCBA5444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797
=072  \\$aC8.$x785
=150  \\$aRespiratory Tract Neoplasms
=450  \\$wnnna$aNeoplasm, Respiratory Tract
=450  \\$wnnna$aNeoplasms, Respiratory Tract
=450  \\$wnnna$aRespiratory Tract Neoplasm
=450  \\$wnnna$aTract Neoplasm, Respiratory
=450  \\$wnnna$aTract Neoplasms, Respiratory
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wg$aThoracic Neoplasms
=550  \\$wh$aLaryngeal Neoplasms
=550  \\$wh$aLung Neoplasms
=550  \\$wh$aNose Neoplasms
=550  \\$wh$aPleural Neoplasms
=550  \\$wh$aTracheal Neoplasms
=667  \\$aGEN: prefer specific precoord; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=750  \0$aRespiratory organs$xTumors$5IEN-M$0(DLC)sh 85113211

=LDR  01995cz  a2200589n  4500
=001  9880363810102441
=005  20141212205313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012141
=035  \\$aCBA5443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x739
=072  \\$aC8.$x730
=150  \\$aRespiratory Tract Infections
=450  \\$wnnna$aInfection, Respiratory Tract
=450  \\$wnnna$aInfections, Respiratory
=450  \\$wnnna$aInfections, Respiratory Tract
=450  \\$wnnna$aInfections, Upper Respiratory
=450  \\$wnnna$aInfections, Upper Respiratory Tract
=450  \\$wnnna$aRespiratory Infection, Upper
=450  \\$wnnna$aRespiratory Infections
=450  \\$wnnna$aRespiratory Tract Infection
=450  \\$wnnna$aUpper Respiratory Infections
=450  \\$aUpper Respiratory Tract Infections
=550  \\$wg$aInfection
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aBovine Respiratory Disease Complex
=550  \\$wh$aBronchitis
=550  \\$wh$aCommon Cold
=550  \\$wh$aEmpyema, Pleural
=550  \\$wh$aInfluenza, Human
=550  \\$wh$aLaryngitis
=550  \\$wh$aLegionellosis
=550  \\$wh$aLung Abscess
=550  \\$wh$aLung Diseases, Fungal
=550  \\$wh$aLung Diseases, Parasitic
=550  \\$wh$aPharyngitis
=550  \\$wh$aPleurisy
=550  \\$wh$aPneumonia
=550  \\$wh$aRhinitis
=550  \\$wh$aRhinoscleroma
=550  \\$wh$aSevere Acute Respiratory Syndrome
=550  \\$wh$aSinusitis
=550  \\$wh$aSupraglottitis
=550  \\$wh$aTracheitis
=550  \\$wh$aTuberculosis, Laryngeal
=550  \\$wh$aTuberculosis, Pleural
=550  \\$wh$aTuberculosis, Pulmonary
=550  \\$wh$aWhooping Cough
=667  \\$ageneral, prefer specifics; DF: RESPIRATORY TRACT INFECT
=680  \\$iInvasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
=750  \0$aRespiratory infections$5IEN$0(DLC)sh 91002859

=LDR  01425cz  a2200397n  4500
=001  9880363810202441
=005  20141212205313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012140
=035  \\$aCBA5442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8
=150  \\$aRespiratory Tract Diseases
=450  \\$wnnna$aDisease, Respiratory Tract
=450  \\$wnnna$aDiseases, Respiratory Tract
=450  \\$wnnna$aRespiratory Tract Disease
=450  \\$wnnna$aTract Disease, Respiratory
=450  \\$wnnna$aTract Diseases, Respiratory
=550  \\$wh$aBronchial Diseases
=550  \\$wh$aCiliary Motility Disorders
=550  \\$wh$aGranuloma, Respiratory Tract
=550  \\$wh$aLaryngeal Diseases
=550  \\$wh$aLung Diseases
=550  \\$wh$aNose Diseases
=550  \\$wh$aPleural Diseases
=550  \\$wh$aRespiration Disorders
=550  \\$wh$aRespiratory Hypersensitivity
=550  \\$wh$aRespiratory System Abnormalities
=550  \\$wh$aRespiratory Tract Fistula
=550  \\$wh$aRespiratory Tract Infections
=550  \\$wh$aRespiratory Tract Neoplasms
=550  \\$wh$aThoracic Diseases
=550  \\$wh$aTracheal Diseases
=667  \\$aGEN or unspecified; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; DF: RESPIRATORY TRACT DIS
=688  \\$a66; was RESPIRATORY DISEASES 1963-65
=750  \0$aRespiratory organs$xDiseases$5IEN$0(DLC)sh 85113200

=LDR  00891cz  a2200217n  4500
=001  9880363810302441
=005  20141212205312.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012139
=035  \\$aCBA5441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x712
=072  \\$aN4.$x452.$x442.$x422.$x712
=150  \\$aRespiratory Therapy Department, Hospital
=450  \\$aHospital Respiratory Therapy Department
=450  \\$wnnna$aRespiratory Therapy Departments, Hospital
=550  \\$wg$aHospital Departments
=667  \\$aDF: RESP THER DEP
=680  \\$iHospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation.
=688  \\$a91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
=750  \0$aHospitals$xRespiratory therapy services$5IEN$0(DLC)sh 85062363

=LDR  01697cz  a2200373n  4500
=001  9880363810402441
=005  20141212205312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012138
=035  \\$aCBA5440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x880
=150  \\$aRespiratory Therapy
=450  \\$wnnna$aInhalation Therapies
=450  \\$aInhalation Therapy
=450  \\$wnnna$aRespiratory Therapies
=450  \\$aRespiratory Therapists$5IEN
=450  \\$wnnna$aTherapies, Inhalation
=450  \\$wnnna$aTherapies, Respiratory
=450  \\$wnnna$aTherapy, Inhalation
=450  \\$wnnna$aTherapy, Respiratory
=550  \\$wg$aTherapeutics
=550  \\$wh$aChest Wall Oscillation
=550  \\$wh$aDrainage, Postural
=550  \\$wh$aExtracorporeal Membrane Oxygenation
=550  \\$wh$aOxygen Inhalation Therapy
=550  \\$wh$aRespiration, Artificial
=550  \\$aAdministration, Inhalation
=550  \\$aAirway Management
=667  \\$ado not use /util except by MeSH definition; do not confuse with ADMINISTRATION, INHALATION
=680  \\$iCare of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.
=688  \\$a78; was INHALATION THERAPY 1963-77
=750  \0$aRespiratory therapists$5IEN-M$0(DLC)sh 85113214
=750  \0$aRespiratory therapy$5IEN-HS$0(DLC)sh 85113215

=LDR  01166cz  a2200325n  4500
=001  9880363810502441
=005  20141212205311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012137
=035  \\$aCBA5439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4
=150  \\$aRespiratory System
=450  \\$wnnna$aRespiratory Systems
=450  \\$wnnna$aRespiratory Tract
=450  \\$wnnna$aRespiratory Tracts
=450  \\$wnnna$aSystem, Respiratory
=450  \\$wnnna$aSystems, Respiratory
=450  \\$wnnna$aTract, Respiratory
=450  \\$wnnna$aTracts, Respiratory
=550  \\$wh$aLarynx
=550  \\$wh$aLung
=550  \\$wh$aNose
=550  \\$wh$aPharynx
=550  \\$wh$aPleura
=550  \\$wh$aRespiratory Mucosa
=550  \\$wh$aTrachea
=667  \\$aGEN: prefer specifics; /abnorm: RESPIRATORY SYSTEM ABNORMALITIES is available but consider also specific part of resp syst with /abnorm or specific abnorm
=680  \\$iThe tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.
=750  \0$aRespiratory organs$5IEN$0(DLC)sh 85113196

=LDR  01427cz  a2200325n  4500
=001  9880363810602441
=005  20141212205311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012136
=035  \\$aCBA5438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x670.$x600.$x750
=072  \\$aB4.$x909.$x777.$x455.$x600.$x670.$x600.$x750
=150  \\$aRespiratory Syncytial Viruses
=450  \\$aChimpanzee Coryza Agent
=450  \\$wnnna$aChimpanzee Coryza Agents
=450  \\$wnnna$aCoryza Agent, Chimpanzee
=450  \\$wnnna$aCoryza Agents, Chimpanzee
=450  \\$wnnna$aRespiratory Syncytial Virus
=450  \\$wnnna$aSyncytial Virus, Respiratory
=450  \\$wnnna$aSyncytial Viruses, Respiratory
=450  \\$wnnna$aVirus, Respiratory Syncytial
=450  \\$wnnna$aViruses, Respiratory Syncytial
=550  \\$wg$aPneumovirus
=550  \\$wh$aRespiratory Syncytial Virus, Bovine
=550  \\$wh$aRespiratory Syncytial Virus, Human
=667  \\$aa group of viruses of the genus Pneumovirus; infection = RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
=680  \\$iA group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
=688  \\$a77; was RESPIRATORY SYNCYTIAL VIRUS 1964-76 (Prov 1964-65)
=750  \0$aRespiratory syncytial virus$5IEN$0(DLC)sh 85113213

=LDR  01482cz  a2200505n  4500
=001  9880363810702441
=005  20141212205311.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012135
=035  \\$aCBA5437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x852.$x779
=072  \\$aE1.$x370.$x386.$x720
=072  \\$aG9.$x772.$x775
=150  \\$aRespiratory Sounds
=450  \\$wnnna$aBreathing Sound
=450  \\$aBreathing Sounds
=450  \\$wnnna$aCrackle
=450  \\$aCrackles
=450  \\$wnnna$aLung Sound
=450  \\$aLung Sounds
=450  \\$aPleural Rub
=450  \\$wnnna$aPleural Rubs
=450  \\$wnnna$aRale
=450  \\$aRales
=450  \\$wnnna$aRespiratory Sound
=450  \\$aRhonchi
=450  \\$wnnna$aRhonchus
=450  \\$wnnna$aRub, Pleural
=450  \\$wnnna$aSound, Breathing
=450  \\$wnnna$aSound, Lung
=450  \\$wnnna$aSound, Respiratory
=450  \\$wnnna$aSounds, Breathing
=450  \\$wnnna$aSounds, Lung
=450  \\$aStridor
=450  \\$wnnna$aStridors
=450  \\$aWheezing
=450  \\$wnnna$aWheezings
=550  \\$wg$aDiagnostic Techniques, Respiratory System
=550  \\$wg$aRespiratory Physiological Phenomena
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wh$aSnoring
=680  \\$iNoises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
=688  \\$a80
=750  \0$aRespiratory organs$xSounds$5IEN$0(DLC)sh 85113209

=LDR  01417cz  a2200397n  4500
=001  9880363810802441
=005  20141212205310.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012134
=035  \\$aCBA5436M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x700
=072  \\$aJ1.$x637.$x708.$x700
=150  \\$aRespiratory Protective Devices
=450  \\$wnnna$aAir-Purifying Respirator
=450  \\$wnnna$aAir-Purifying Respirators
=450  \\$wnnna$aDevice, Respiratory Protective
=450  \\$wnnna$aDevices, Respiratory Protective
=450  \\$wnnna$aGas Mask
=450  \\$aGas Masks
=450  \\$wnnna$aIndustrial Respirator
=450  \\$wnnna$aIndustrial Respirators
=450  \\$wnnna$aMask, Gas
=450  \\$wnnna$aMasks, Gas
=450  \\$wnnna$aProtective Device, Respiratory
=450  \\$wnnna$aProtective Devices, Respiratory
=450  \\$wnnna$aRespirator, Air-Purifying
=450  \\$wnnna$aRespirator, Industrial
=450  \\$aRespirators, Air-Purifying
=450  \\$wnnna$aRespirators, Air Purifying
=450  \\$aRespirators, Industrial
=450  \\$wnnna$aRespiratory Protective Device
=550  \\$wg$aProtective Devices
=680  \\$iRespirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors.
=688  \\$a91(63)
=750  \0$aBreathing apparatus$0(DLC) sh 97008475$5IEN-M

=LDR  00969cz  a2200289n  4500
=001  9880363810902441
=005  20141212205309.0
=008  860402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012132
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x900
=150  \\$aRespiratory Muscles
=450  \\$wnnna$aMuscle, Respiratory
=450  \\$wnnna$aMuscle, Ventilatory
=450  \\$wnnna$aMuscles, Respiratory
=450  \\$wnnna$aMuscles, Ventilatory
=450  \\$wnnna$aRespiratory Muscle
=450  \\$wnnna$aVentilatory Muscle
=450  \\$aVentilatory Muscles
=550  \\$wg$aMuscle, Skeletal
=550  \\$wh$aDiaphragm
=550  \\$wh$aIntercostal Muscles
=550  \\$aThoracic Wall
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThese include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES.
=688  \\$a87
=750  \0$aRespiratory muscles$5IEN$0(DLC)sh 85113195

=LDR  01159cz   2200313n  4500
=001  9880363811002441
=005  20220302164729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012131
=035  \\$aCBA5433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x846
=150  \\$aRespiratory Insufficiency
=450  \\$wnnna$aDepressions, Ventilatory
=450  \\$aRespiratory Depression
=450  \\$aRespiratory Failure
=450  \\$wnnna$aVentilatory Depression
=550  \\$wg$aRespiration Disorders
=550  \\$wh$aAcidosis, Respiratory
=550  \\$wh$aAirway Obstruction
=550  \\$wh$aGranuloma, Laryngeal
=550  \\$wh$aHantavirus Pulmonary Syndrome
=550  \\$wh$aHypoventilation
=550  \\$wh$aBrief, Resolved, Unexplained Event
=550  \\$wh$aPositive-Pressure Respiration, Intrinsic
=550  \\$wh$aRespiratory Paralysis
=667  \\$ado not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN in newborn inf
=680  \\$iFailure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
=750  \0$aRespiratory insufficiency$5IEN$0(DLC)sh 85113193

=LDR  01072cz  a2200301n  4500
=001  9880363811102441
=005  20141212205309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012130
=035  \\$aCBA5432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x674
=072  \\$aC20.$x543.$x480.$x680
=150  \\$aRespiratory Hypersensitivity
=450  \\$wnnna$aHypersensitivities, Respiratory
=450  \\$aHypersensitivity, Respiratory
=450  \\$aRespiratory Allergy$5IEN
=450  \\$wnnna$aRespiratory Hypersensitivities
=550  \\$wg$aHypersensitivity, Immediate
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aAlveolitis, Extrinsic Allergic
=550  \\$wh$aAspergillosis, Allergic Bronchopulmonary
=550  \\$wh$aAsthma
=550  \\$wh$aRhinitis, Allergic
=667  \\$a"respiratory allergy"
=680  \\$iA form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL.
=688  \\$a66; was RESPIRATORY ALLERGY 1963-65
=750  \0$aRespiratory allergy$5IEN$0(DLC)sh 85113188

=LDR  01989cz  a2200541n  4500
=001  9880363811202441
=005  20180820124108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012129
=035  \\$aCBA5431HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700
=150  \\$aRespiratory Function Tests
=450  \\$wnnna$aFunction Test, Lung
=450  \\$wnnna$aFunction Test, Pulmonary
=450  \\$wnnna$aFunction Test, Respiratory
=450  \\$wnnna$aFunction Tests, Lung
=450  \\$wnnna$aFunction Tests, Pulmonary
=450  \\$wnnna$aFunction Tests, Respiratory
=450  \\$wnnna$aLung Function Test
=450  \\$aLung Function Tests
=450  \\$wnnna$aPulmonary Function Test
=450  \\$aPulmonary Function Tests
=450  \\$wnnna$aRespiratory Function Test
=450  \\$wnnna$aTest, Lung Function
=450  \\$wnnna$aTest, Pulmonary Function
=450  \\$wnnna$aTest, Respiratory Function
=450  \\$wnnna$aTests, Lung Function
=450  \\$wnnna$aTests, Pulmonary Function
=450  \\$wnnna$aTests, Respiratory Function
=550  \\$wg$aDiagnostic Techniques, Respiratory System
=550  \\$wh$aAirway Resistance
=550  \\$wh$aBlood Gas Analysis
=550  \\$wh$aBronchial Provocation Tests
=550  \\$wh$aCapnography
=550  \\$wh$aExercise Test
=550  \\$wh$aLung Compliance
=550  \\$wh$aLung Volume Measurements
=550  \\$wh$aMaximal Respiratory Pressures
=550  \\$wh$aPlethysmography, Whole Body
=550  \\$wh$aPulmonary Gas Exchange
=550  \\$wh$aPulmonary Ventilation
=550  \\$wh$aSpirometry
=550  \\$wh$aValsalva Maneuver
=550  \\$wh$aWork of Breathing
=667  \\$aGEN or unspecified; prefer specifics; NIM
=680  \\$iMeasurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.
=750  \0$aPulmonary function tests$5IEN$0(DLC)sh 85109006

=LDR  01605nz  a2200397n  4500
=001  9881821164502441
=005  20220303090527.0
=008  760519\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012128
=035  \\$a(DNLM)D012128
=035  \\$a(NLM)98195426890000041
=040  \\$aDNLM$cDNLM
=060  \0$aWF 140
=072  \\$aC8.$x381.$x840
=072  \\$aC8.$x618.$x840
=150  \\$aRespiratory Distress Syndrome
=450  \\$aARDS, Human
=450  \\$aAcute Respiratory Distress Syndrome
=450  \\$aAdult Respiratory Distress Syndrome
=450  \\$aPediatric Respiratory Distress Syndrome
=450  \\$aRespiratory Distress Syndrome, Acute
=450  \\$aRespiratory Distress Syndrome, Adult
=450  \\$aRespiratory Distress Syndrome, Pediatric
=450  \\$aShock Lung
=450  \\$wnnna$aDistress Syndrome, Respiratory
=450  \\$wnnna$aDistress Syndromes, Respiratory
=450  \\$wnnna$aHuman ARDS
=450  \\$wnnna$aLung, Shock
=450  \\$wnnna$aRespiratory Distress Syndromes
=450  \\$wnnna$aSyndrome, Respiratory Distress
=550  \\$aSystemic Inflammatory Response Syndrome
=550  \\$aAcute Chest Syndrome
=667  \\$aRESPIRATORY DISTRESS SYNDROME, NEWBORN is also available; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME
=680  \\$iA syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
=688  \\$a2021(1977)
=750  \0$aRespiratory distress syndrome, Adult$5IEN$0(DLC)sh 85113192

=LDR  01552cz  a2200301n  4500
=001  9880363811402441
=005  20141212205307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012127
=035  \\$aCBA5429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x842
=072  \\$aC8.$x618.$x842
=072  \\$aC16.$x614.$x521.$x563
=150  \\$aRespiratory Distress Syndrome, Newborn
=450  \\$wnnna$aInfantile Respiratory Distress Syndrome
=450  \\$wnnna$aNeonatal Respiratory Distress Syndrome
=450  \\$wnnoa$aRespiratory Distress Syndrome$5IEN-HS
=450  \\$wnnna$aRespiratory Distress Syndrome, Infant
=550  \\$wg$aInfant, Premature, Diseases
=550  \\$wg$aLung Diseases
=550  \\$wg$aRespiration Disorders
=550  \\$wh$aHyaline Membrane Disease
=550  \\$wh$aTransient Tachypnea of the Newborn
=667  \\$afor adults use RESPIRATORY DISTRESS SYNDROME, ADULT; do not confuse with "respiratory distress" which may be RESPIRATORY INSUFFICIENCY or a specific; do not confuse with SEVERE ACUTE RESPIRATORY SYNDROME
=680  \\$iA condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.
=688  \\$a2004 (1965)
=750  \0$aRespiratory distress syndrome$5IEN$0(DLC)sh 85113191

=LDR  00824cz  a2200229n  4500
=001  9880363811502441
=005  20141212205306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012124
=035  \\$aCBA5426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x493.$x696
=150  \\$aRespiratory Care Units
=450  \\$wnnna$aCare Unit, Respiratory
=450  \\$wnnna$aCare Units, Respiratory
=450  \\$wnnna$aRespiratory Care Unit
=450  \\$wnnna$aUnit, Respiratory Care
=450  \\$wnnna$aUnits, Respiratory Care
=550  \\$wg$aIntensive Care Units
=680  \\$iThe hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance.
=688  \\$a73(71)
=750  \0$aHospitals$xRespiratory services$5IEN$0(DLC)sh 85062362

=LDR  01577cz  a2200385n  4500
=001  9880363811602441
=005  20141212205305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012121
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x625
=072  \\$aE2.$x365.$x647.$x729
=072  \\$aE2.$x880.$x820
=150  \\$aRespiration, Artificial
=450  \\$wnnna$aArtificial Respiration
=450  \\$wnnna$aArtificial Respirations
=450  \\$wnnna$aMechanical Ventilation
=450  \\$wnnna$aMechanical Ventilations
=450  \\$wnnna$aRespirations, Artificial
=450  \\$aVentilation, Mechanical
=450  \\$wnnna$aVentilations, Mechanical
=550  \\$wg$aAirway Management
=550  \\$wg$aRespiratory Therapy
=550  \\$wg$aResuscitation
=550  \\$wh$aHigh-Frequency Ventilation
=550  \\$wh$aInteractive Ventilatory Support
=550  \\$wh$aLiquid Ventilation
=550  \\$wh$aNoninvasive Ventilation
=550  \\$wh$aOne-Lung Ventilation
=550  \\$wh$aPositive-Pressure Respiration
=550  \\$wh$aVentilator Weaning
=550  \\$aVentilators, Mechanical
=667  \\$a/instrum: consider also VENTILATORS, MECHANICAL
=680  \\$iAny method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).
=750  \0$aArtificial respiration$5IEN$0(DLC)sh 85008200

=LDR  01507cz   2200421n  4500
=001  9880363811702441
=005  20220303090706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012120
=035  \\$aCBA5423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618
=150  \\$aRespiration Disorders
=450  \\$wnnna$aDisorder, Respiration
=450  \\$wnnna$aDisorders, Respiration
=450  \\$wnnna$aRespiration Disorder
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aAcute Chest Syndrome
=550  \\$wh$aAltitude Sickness
=550  \\$wh$aApnea
=550  \\$wh$aCheyne-Stokes Respiration
=550  \\$wh$aCough
=550  \\$wh$aDyspnea
=550  \\$wh$aHoarseness
=550  \\$wh$aHyperventilation
=550  \\$wh$aMeconium Aspiration Syndrome
=550  \\$wh$aMouth Breathing
=550  \\$wh$aRespiratory Aspiration
=550  \\$wh$aRespiratory Distress Syndrome
=550  \\$wh$aRespiratory Distress Syndrome, Newborn
=550  \\$wh$aRespiratory Insufficiency
=550  \\$wh$aSarcoglycanopathies
=550  \\$wh$aTachypnea
=550  \\$wh$aVocal Cord Dysfunction
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iDiseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
=688  \\$a77; was NON MESH before 1977; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966
=750  \0$aRespiratory organs$xDiseases$5IEN$0(DLC)sh 85113200

=LDR  01129cz  a2200241n  4500
=001  9880363811802441
=005  20141212205304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012119
=035  \\$aCBA5422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772.$x770.$x755
=150  \\$aRespiration
=450  \\$aBreathing
=550  \\$wg$aRespiratory Physiological Processes
=550  \\$wh$aBreath Holding
=550  \\$wh$aRespiratory Mechanics
=550  \\$wh$aRespiratory Rate
=550  \\$wh$aRespiratory Transport
=550  \\$aLung
=667  \\$alung only: does not refer to tissue respiration ( = probably OXYGEN CONSUMPTION); TN 145: relation to OXYGEN & its qualif
=680  \\$iThe act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION) or cell respiration (= CELL RESPIRATION).
=750  \0$aRespiration$5IEN$0(DLC)sh 85113178

=LDR  00656cz  a2200229n  4500
=001  9880363811902441
=005  20141212205304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012118
=035  \\$aCBA5421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x852
=150  \\$aResorcinols
=450  \\$am-Dihydroxybenzenes
=450  \\$wnnna$am Dihydroxybenzenes
=450  \\$ameta-Dihydroxybenzenes
=450  \\$wnnna$ameta Dihydroxybenzenes
=550  \\$wg$aPhenols
=550  \\$wh$aHexylresorcinol
=550  \\$wh$aZearalenone
=688  \\$a75; was RESORCINOL 1963-74
=750  \0$aResorcinol$5IEN$0(DLC)sh 85113163

=LDR  01198cz  a2200385n  4500
=001  9880363812002441
=005  20141212205304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012117
=035  \\$aCBA5420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x822
=072  \\$aD25.$x339.$x816
=072  \\$aD25.$x720.$x716.$x822
=072  \\$aJ1.$x637.$x51.$x339.$x816
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822
=150  \\$aResins, Synthetic
=450  \\$wnnna$aDental Resin
=450  \\$aDental Resins
=450  \\$wnnna$aResin, Dental
=450  \\$wnnna$aResin, Synthetic
=450  \\$wnnna$aResins, Dental
=450  \\$wnnna$aSynthetic Resin
=450  \\$wnnna$aSynthetic Resins
=550  \\$wg$aDental Materials
=550  \\$wg$aPlastics
=550  \\$wh$aAcrylic Resins
=550  \\$wh$aBone Cements
=550  \\$wh$aComposite Resins
=550  \\$wh$aEpoxy Resins
=550  \\$wh$aResin Cements
=667  \\$aDF: RESINS SYN
=680  \\$iPolymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components.
=688  \\$a75
=750  \0$aGums and resins, Synthetic$5IEN$0(DLC)sh 85057917

=LDR  01340cz  a2200313n  4500
=001  9880363812102441
=005  20180816125814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012116
=035  \\$aCBA5419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x840
=072  \\$aD20.$x215.$x721.$x500
=150  \\$aResins, Plant
=450  \\$wnnna$aPlant Resins
=450  \\$wnnoa$aResins$5IEN-HS
=550  \\$wg$aBiopolymers
=550  \\$wg$aPlant Exudates
=550  \\$wh$aAmber
=550  \\$wh$aBalsams
=550  \\$wh$aFrankincense
=550  \\$wh$aGuaiac
=550  \\$wh$aMastic Resin
=550  \\$wh$aPropolis
=550  \\$wh$aTurpentine
=667  \\$aRESINS, SYNTHETIC is also available
=680  \\$iFlammable, amorphous, vegetable products of secretion or disintegration, usually formed in special cavities of plants. They are generally insoluble in water and soluble in alcohol, carbon tetrachloride, ether, or volatile oils. They are fusible and have a conchoidal fracture. They are the oxidation or polymerization products of the terpenes, and are mixtures of aromatic acids and esters. Most are soft and sticky, but harden after exposure to cold. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed)
=688  \\$a2003 (1963)
=750  \0$aGums and resins$0(DLC) sh 85057914$5IEN

=LDR  01052cz  a2200229n  4500
=001  9880363812202441
=005  20141212205303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012114
=035  \\$aCBA5417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x696
=150  \\$aResidential Treatment
=450  \\$wnnna$aResidential Treatments
=450  \\$wnnna$aTreatment, Residential
=450  \\$wnnna$aTreatments, Residential
=550  \\$wg$aSocioenvironmental Therapy
=667  \\$aSPEC qualif
=680  \\$iA specialized residential treatment program for behavior disorders including substance abuse. It may include therapeutically planned group living and learning situations including teaching of adaptive skills to help patient functioning in the community. (From Kahn, A. P. and Fawcett, J. Encyclopedia of Mental Health, 1993, p320.)
=688  \\$a66(64)
=750  \0$aChild psychotherapy$xResidential treatment$5IEN-M$0(DLC)sh 85023386
=750  \0$aAdolescent psychotherapy$xResidential treatment$5IEN$0(DLC)sh 85000973

=LDR  01386cz  a2200313n  4500
=001  9880363812302441
=005  20141212205301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012110
=035  \\$aCBA5413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x933.$x500
=072  \\$aD3.$x438.$x473.$x402.$x681.$x933.$x500
=150  \\$aReserpine
=450  \\$wnnna$aRaunervil
=450  \\$wnnna$aRaupasil
=450  \\$wnnna$aRausedil
=450  \\$wnnna$aRausedyl
=450  \\$wnnna$aSerpasil
=450  \\$wnnna$aSerpivite
=450  \\$wnnna$aV-Serp
=450  \\$wnnna$aV Serp
=450  \\$wnnna$aVangarde Brand of Reserpine
=450  \\$wnnna$aVitarine Brand of Reserpine
=550  \\$wg$aYohimbine
=667  \\$areserpine derivatives=RESERPINE /analogs
=680  \\$iAn alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
=688  \\$aRESERPINE DERIVATIVES was see under RESERPINE 1975-77, was see under YOHIMBANS 1969-74; /adv eff-pois-tox was RESERPINE TOXICOLOGY 1963-65
=750  \0$aReserpine$5IEN$0(DLC)sh 85113062


=LDR  00695cz  a2200181n  4500
=001  9880363287002441
=005  20141212200328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003355
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x180.$x625
=072  \\$aB3.$x510.$x460.$x400.$x400.$x200.$x625
=150  \\$aCorynebacterium pyogenes
=550  \\$wg$aCorynebacterium
=667  \\$ainfection: coord IM with CORYNEBACTERIUM INFECTIONS (IM); DF: CORYNEBACT PYOGENES
=680  \\$iA species of CORYNEBACTERIUM isolated from abscesses of warm-blooded animals.
=688  \\$a91(72); was see under CORYNEBACTERIUM 1972-90
=750  \0$aCorynebacterium pyogenes$5IEN$0(DLC)sh 85033124

=LDR  00946cz  a2200253n  4500
=001  9880363287102441
=005  20141212200356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003440
=035  \\$aCAZ6585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x535.$x365
=072  \\$aC9.$x400.$x535.$x365
=150  \\$aCroup
=450  \\$wnnna$aCroup, Postintubation
=450  \\$wnnna$aCroup, Spasmodic
=450  \\$wnnna$aCroup, Viral
=450  \\$wnnna$aPostintubation Croup
=450  \\$wnnna$aSpasmodic Croup
=450  \\$wnnna$aViral Croup
=550  \\$wg$aLaryngitis
=680  \\$iInflammation involving the GLOTTIS or VOCAL CORDS and the subglottic larynx. Croup is characterized by a barking cough, HOARSENESS, and persistent inspiratory STRIDOR (a high-pitched breathing sound). It occurs chiefly in infants and children.
=688  \\$a91(75); was see under LARYNGITIS 1975-90
=750  \0$aCroup$5IEN$0(DLC)sh 85034323

=LDR  00910cz  a2200169n  4500
=001  9880363287202441
=005  20141212192120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003353
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x180.$x150
=072  \\$aB3.$x510.$x460.$x400.$x400.$x200.$x150
=150  \\$aCorynebacterium diphtheriae
=550  \\$wg$aCorynebacterium
=667  \\$ainfection in man: usually DIPHTHERIA, otherwise coordinate IM with CORYNEBACTERIUM INFECTIONS (IM)
=680  \\$iA species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.
=750  \0$aCorynebacterium diphtheriae$5IEN$0(DLC)sh 88023241

=LDR  00861cz  a2200217n  4500
=001  9880363287302441
=005  20141212200355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003436
=035  \\$aCAZ6581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x507.$x375
=072  \\$aD10.$x627.$x700.$x315
=072  \\$aD20.$x215.$x784.$x750.$x315
=150  \\$aCroton Oil
=450  \\$wnnna$aOil, Croton
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=667  \\$aa dermatol agent & carcinogen
=680  \\$iViscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality.
=750  \0$aCroton oil$5IEN$0(DLC)sh 85034318

=LDR  01049cz  a2200241n  4500
=001  9880363287402441
=005  20141212200328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003352
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x180
=072  \\$aB3.$x510.$x460.$x400.$x400.$x200
=150  \\$aCorynebacterium
=550  \\$wg$aActinomycetales
=550  \\$wg$aGram-Positive Asporogenous Rods, Irregular
=550  \\$wh$aBrevibacterium flavum
=550  \\$wh$aCorynebacterium diphtheriae
=550  \\$wh$aCorynebacterium glutamicum
=550  \\$wh$aCorynebacterium pseudotuberculosis
=550  \\$wh$aCorynebacterium pyogenes
=667  \\$aGEN; prefer specific; infection = CORYNEBACTERIUM INFECTIONS unless DIPHTHERIA (if C. diphtheriae in man); DF: CORYNEBACT
=680  \\$iA genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
=750  \0$aCorynebacterium$5IEN$0(DLC)sh 85033122

=LDR  01829cz  a2200457n  4500
=001  9880363287502441
=005  20141212200355.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003435
=035  \\$aCAZ6580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x850.$x960.$x200
=072  \\$aD23.$x946.$x833.$x850.$x960.$x200
=150  \\$aCrotalid Venoms
=450  \\$wnnna$aCrotactin
=450  \\$wnnna$aCrotalid Venom
=450  \\$wnnna$aCrotalin
=450  \\$wnnna$aCrotaline Snake Venom
=450  \\$wnnna$aCrotalotoxin
=450  \\$wnnna$aCrotamin
=450  \\$wnnna$aPit Viper Venom
=450  \\$aPit Viper Venoms
=450  \\$wnnna$aRattlesnake Venom
=450  \\$aRattlesnake Venoms
=450  \\$wnnna$aSnake Venom, Crotaline
=450  \\$wnnna$aVenom, Crotalid
=450  \\$wnnna$aVenom, Crotaline Snake
=450  \\$wnnna$aVenom, Pit Viper
=450  \\$wnnna$aVenom, Rattlesnake
=450  \\$wnnna$aVenoms, Crotalid
=450  \\$wnnna$aVenoms, Pit Viper
=450  \\$wnnna$aVenoms, Rattlesnake
=450  \\$wnnna$aViper Venom, Pit
=550  \\$wg$aViper Venoms
=550  \\$wh$aAncrod
=550  \\$wh$aBatroxobin
=550  \\$wh$aCrotoxin
=667  \\$afrom pit vipers (rattlesnake, cottonmouth, etc.); /antag permitted but consider also ANTIVENINS; /enzymology permitted; TN 241: common & scientific names of various crotalids
=680  \\$iVenoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized.
=688  \\$a78
=750  \0$aPit vipers$xVenom$5IEN-M$0(IEN)3998728

=LDR  00960cz  a2200217n  4500
=001  9880363287602441
=005  20141212200327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003348
=035  \\$aCAZ6498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x183
=072  \\$aD6.$x472.$x40.$x585.$x478.$x195
=150  \\$aCortisone
=450  \\$wnnna$aAdreson
=550  \\$wg$a17-Hydroxycorticosteroids
=550  \\$wg$aPregnenes
=667  \\$a/biosyn/physiol permitted
=680  \\$iA naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)
=688  \\$a/adv eff-pois-tox was CORTISONE TOXICOLOGY 1963-65; /ther use was CORTISONE, THERAPEUTIC 1965
=750  \0$aCortisone$5IEN$0(DLC)sh 85033100

=LDR  01371cz  a2200277n  4500
=001  9880363287702441
=005  20141212200354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003434
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x615.$x200
=150  \\$aCrossing Over, Genetic
=450  \\$wnnna$aCrossing Over
=450  \\$wnnna$aCrossing-Over, Genetic
=450  \\$wnnoa$aCrossing Over (Genetics)$5IEN-HS
=450  \\$wnnna$aCrossing Overs
=450  \\$wnnna$aGenetic Crossing Over
=450  \\$wnnna$aGenetic Crossing-Over
=550  \\$wg$aHomologous Recombination
=550  \\$aChromosome Pairing
=550  \\$aPachytene Stage
=550  \\$aSister Chromatid Exchange
=667  \\$ado not confuse with CROSSES, GENETIC, the result of breeding 2 varieties of the same species; DF: CROSSING OVER
=680  \\$iThe reciprocal exchange of segments at corresponding positions along pairs of homologous CHROMOSOMES by symmetrical breakage and crosswise rejoining forming cross-over sites (HOLLIDAY JUNCTIONS) that are resolved during CHROMOSOME SEGREGATION. Crossing-over typically occurs during MEIOSIS but it may also occur in the absence of meiosis, for example, with bacterial chromosomes, organelle chromosomes, or somatic cell nuclear chromosomes.
=688  \\$a2005(1968)
=750  \0$aCrossing over (Genetics)$0(DLC) sh 85034296$5IEN

=LDR  01111cz  a2200313n  4500
=001  9880363287802441
=005  20141212192122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003431
=035  \\$aCAZ6576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x281
=072  \\$aI1.$x880.$x853.$x100.$x257
=150  \\$aCross-Cultural Comparison
=450  \\$wnnna$aComparison, Cross-Cultural
=450  \\$wnnna$aComparisons, Cross-Cultural
=450  \\$wnnna$aCross Cultural Comparison
=450  \\$wnnna$aCross-Cultural Comparisons
=450  \\$wnnna$aStudies, Transcultural
=450  \\$wnnna$aStudy, Transcultural
=450  \\$aTranscultural Studies
=450  \\$wnnna$aTranscultural Study
=550  \\$wg$aCulture
=550  \\$aCultural Characteristics
=550  \\$aCulture
=667  \\$ano qualif
=680  \\$iComparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies.
=688  \\$a68
=750  \0$aCross-cultural studies$5IEN$0(DLC)sh 85034273

=LDR  00788cz  a2200205n  4500
=001  9880363288002441
=005  20141212200326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003345
=035  \\$aCAZ6495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x237
=072  \\$aD6.$x472.$x40.$x585.$x353.$x237
=150  \\$aCorticosterone
=550  \\$wg$a11-Hydroxycorticosteroids
=550  \\$wg$aPregnenediones
=550  \\$wh$a18-Hydroxycorticosterone
=667  \\$a/biosyn /physiol permitted
=680  \\$iAn adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
=750  \0$aCorticosterone$5IEN$0(DLC)sh 85033094

=LDR  01460cz  a2200325n  4500
=001  9880363288102441
=005  20141212192119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003342
=035  \\$aCAZ6492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x487
=150  \\$aCorpus Striatum
=450  \\$aLenticular Nucleus
=450  \\$wnnna$aLentiform Nuclei
=450  \\$aLentiform Nucleus
=450  \\$wnnna$aLentiformis, Nucleus
=450  \\$wnnna$aNuclei, Lentiform
=450  \\$wnnna$aNucleus, Lenticular
=450  \\$wnnna$aNucleus, Lentiform
=450  \\$wnnna$aNucleus Lentiformis
=450  \\$wnnna$aStriatum, Corpus
=550  \\$wg$aBasal Ganglia
=550  \\$wh$aGlobus Pallidus
=550  \\$wh$aNeostriatum
=550  \\$wh$aVentral Striatum
=667  \\$ado not confuse with STRIATE CORTEX see VISUAL CORTEX or with VENTRAL STRIATUM
=680  \\$iStriped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.
=688  \\$a74(72); LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73
=750  \0$aCorpus striatum$5IEN$0(DLC)sh 85033013

=LDR  00739cz  a2200205n  4500
=001  9880363288202441
=005  20141212200323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003338
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x114.$x630.$x278
=072  \\$aA6.$x407.$x312.$x497.$x278
=150  \\$aCorpus Luteum
=450  \\$wnnna$aCorpora Lutea
=450  \\$wnnna$aLutea, Corpora
=550  \\$wg$aOvary
=550  \\$wh$aLuteal Cells
=667  \\$a/cytol: consider also LUTEAL CELLS
=680  \\$iThe yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.
=750  \0$aCorpus luteum$5IEN$0(DLC)sh 85033012

=LDR  01684cz  a2200385n  4500
=001  9880363288302441
=005  20141212200351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003424
=035  \\$aCAZ6570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x731.$x500
=072  \\$aC6.$x405.$x469.$x432.$x500
=150  \\$aCrohn Disease
=450  \\$aColitis, Granulomatous
=450  \\$wnnna$aCrohn's Disease
=450  \\$wnnna$aCrohns Disease
=450  \\$wnnna$aCrohn's Enteritis
=450  \\$aEnteritis, Granulomatous
=450  \\$aEnteritis, Regional
=450  \\$wnnna$aGranulomatous Colitis
=450  \\$wnnna$aGranulomatous Enteritis
=450  \\$aIleitis, Regional
=450  \\$aIleitis, Terminal
=450  \\$aIleocolitis
=450  \\$wnnna$aInflammatory Bowel Disease 1
=450  \\$wnnna$aRegional Enteritis
=450  \\$wnnna$aRegional Ileitides
=450  \\$wnnna$aRegional Ileitis
=450  \\$wnnna$aTerminal Ileitis
=550  \\$wg$aInflammatory Bowel Diseases
=667  \\$acoord IM with ILEITIS (IM) or COLITIS (IM) only if site is particularly discussed; usually chronic so do not coord with CHRONIC DISEASE
=680  \\$iA chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
=688  \\$a80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64
=750  \0$aCrohn's disease$5IEN$0(DLC)sh 85044077

=LDR  01160cz  a2200289n  4500
=001  9880363288402441
=005  20141212192119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003337
=035  \\$aCAZ6487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x390.$x750
=150  \\$aCorpus Callosum
=450  \\$wnnna$aCallosum, Corpus
=450  \\$wnnna$aCallosums, Corpus
=450  \\$wnnna$aCommissure, Interhemispheric
=450  \\$wnnna$aCommissure, Neocortical
=450  \\$wnnna$aCommissures, Interhemispheric
=450  \\$wnnna$aCommissures, Neocortical
=450  \\$wnnna$aCorpus Callosums
=450  \\$wnnna$aInterhemispheric Commissure
=450  \\$wnnna$aInterhemispheric Commissures
=450  \\$wnnna$aNeocortical Commissure
=450  \\$wnnna$aNeocortical Commissures
=550  \\$wg$aTelencephalic Commissures
=680  \\$iBroad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure.
=750  \0$aCorpus callosum$0(DLC) sh 85033006$5IEN

=LDR  00883cz  a2200277n  4500
=001  9880363288602441
=005  20141212200323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003334
=035  \\$aCAZ6484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x230
=072  \\$aN2.$x360.$x230
=150  \\$aCoroners and Medical Examiners
=450  \\$wnnna$aCoroner
=450  \\$wnnna$aCoroners
=450  \\$wnnna$aExaminer, Medical
=450  \\$wnnna$aExaminers, Medical
=450  \\$wnnna$aMedical Examiner
=450  \\$aMedical Examiners
=450  \\$wnnna$aMedical Examiners and Coroners
=550  \\$wg$aHealth Personnel
=667  \\$aIM; DF: CORONERS
=680  \\$iPhysicians appointed to investigate all cases of sudden or violent death.
=750  \0$aCoroners$5IEN-M$0(DLC)sh 85032886
=750  \0$aMedical examiners (Law)$5IEN-HS$0(DLC)sh 85082935

=LDR  00838cz  a2200217n  4500
=001  9880363288702441
=005  20141212200323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003332
=035  \\$aCAZ6482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x504.$x540
=072  \\$aB4.$x909.$x777.$x500.$x540
=150  \\$aCoronaviridae
=550  \\$wg$aNidovirales
=550  \\$wh$aCoronavirus
=550  \\$wh$aTorovirus
=667  \\$ainfection = CORONAVIRIDAE INFECTIONS
=680  \\$iSpherical RNA viruses, in the order NIDOVIRALES, infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS.
=688  \\$a81; was CORONAVIRUSES 1974-80
=750  \0$aCoronaviruses$5IEN$0(DLC)sh 85032882

=LDR  00862cz  a2200277n  4500
=001  9880363288802441
=005  20200501173248.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003422
=035  \\$aCAZ6568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x190
=150  \\$aCritical Care
=450  \\$wnno$aIntensive Care
=450  \\$wnnna$aCare, Critical
=450  \\$aIntensive Care, Surgical
=450  \\$wnnna$aCare, Intensive
=450  \\$aCare, Surgical Intensive
=450  \\$wnnna$aSurgical Intensive Care
=550  \\$wg$aPatient Care
=550  \\$wh$aEarly Goal-Directed Therapy
=550  \\$wh$aIntensive Care, Neonatal
=550  \\$aEmergencies
=680  \\$iHealth care provided to a critically ill patient during a medical emergency or crisis.
=688  \\$a75
=750  \0$aCritical care medicine$5IEN-M$0(DLC)sh 85034133

=LDR  00939cz   2200301n  4500
=001  9880363288902441
=005  20220926162249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003252
=035  \\$aCAZ6402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x241
=150  \\$aConstruction Materials
=450  \\$wnnna$aBuilding Material
=450  \\$wnnna$aBuilding Materials
=450  \\$wnnna$aConstruction Material
=450  \\$wnnna$aMaterial, Building
=450  \\$wnnna$aMaterial, Construction
=450  \\$wnnna$aMaterials, Building
=450  \\$wnnna$aMaterials, Construction
=550  \\$wg$aManufactured Materials
=550  \\$wh$aGlass
=550  \\$wh$aWood
=550  \\$aConstruction Industry
=680  \\$iSupplies used in building.
=688  \\$a74(72)
=750  \0$aBuilding materials$5IEN$0(DLC)sh 85017740
=750  \0$iNarrower mapping$aAlgae as building materials$0(DLC)sh2021008967$4NM$5IEN-M

=LDR  01087cz  a2200313n  4500
=001  9880363289002441
=005  20141212200256.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003251
=035  \\$aCAZ6401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x287
=150  \\$aConstriction, Pathologic
=450  \\$wnnna$aConstriction, Pathological
=450  \\$wnnna$aConstrictions, Pathologic
=450  \\$wnnna$aPathologic Constriction
=450  \\$wnnna$aPathologic Constrictions
=450  \\$wnnna$aPathological Constriction
=450  \\$wnnna$aStenoses
=450  \\$aStenosis
=450  \\$aStricture
=450  \\$wnnna$aStrictures
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$aCoronary Stenosis
=550  \\$aMay-Thurner Syndrome
=667  \\$aalmost never IM; DF: CONSTRICTION PATHOL
=680  \\$iThe condition of an anatomical structure's being constricted beyond normal dimensions.
=688  \\$a76; was included in CONSTRICTION 1968-75 (Prov 1968-74, Cat C & E heading 1968-75)
=750  \0$aStenosis$0(DLC)sh2006001310$5IEN-M

=LDR  00755cz  a2200193n  4500
=001  9880363289102441
=005  20141212200255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003248
=035  \\$aCAZ6398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x150
=150  \\$aConstipation
=450  \\$wnnna$aColonic Inertia
=450  \\$wnnna$aDyschezia
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$aDefecation
=680  \\$iInfrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
=750  \0$aConstipation$5IEN$0(DLC)sh 85031314

=LDR  01444cz  a2200409n  4500
=001  9880363289202441
=005  20161109163215.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003247
=035  \\$aCAZ6397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x256
=072  \\$aN6.$x230.$x80
=150  \\$aConservation of Natural Resources
=450  \\$wnnna$aCapacities, Carrying
=450  \\$wnnna$aCapacity, Carrying
=450  \\$wnnna$aCarrying Capacities
=450  \\$wnnna$aCarrying Capacity
=450  \\$wnnna$aConservation, Natural Resources
=450  \\$wnnna$aDeforestation
=450  \\$wnnna$aDesertification
=450  \\$wnnna$aDevelopment, Sustainable
=450  \\$wnnna$aEnvironmental Protection
=450  \\$wnnna$aNatural Resources Conservation
=450  \\$wnnna$aProtection, Environmental
=450  \\$wnnna$aResources Conservation, Natural
=450  \\$wnnna$aSustainable Development
=550  \\$wg$aEnvironment
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aConservation of Energy Resources
=550  \\$wh$aEndangered Species
=550  \\$wh$aEnvironmental Restoration and Remediation
=550  \\$wh$aGreen Chemistry Technology
=550  \\$wh$aRecycling
=680  \\$iThe protection, preservation, restoration, and rational use of all resources in the total environment.
=688  \\$a77
=750  \0$aConservation of natural resources$5IEN$0(DLC)sh 85031255

=LDR  00964cz  a2200265n  4500
=001  9880363289302441
=005  20141212200254.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003246
=035  \\$aCAZ6396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x256.$x78
=072  \\$aN6.$x230.$x80.$x78
=150  \\$aConservation of Energy Resources
=450  \\$wnnna$aConservation, Energy Resources
=450  \\$wnnna$aConservations, Energy Resources
=450  \\$aEnergy Conservation$5IEN
=450  \\$aEnergy Resources Conservation
=450  \\$wnnna$aEnergy Resources Conservations
=450  \\$wnnna$aResources Conservation, Energy
=450  \\$wnnna$aResources Conservations, Energy
=550  \\$wg$aConservation of Natural Resources
=680  \\$iPlanned management, use, and preservation of energy resources.
=688  \\$a91(80); was see under CONSERVATION OF NATURAL RESOURCES 1980-90
=750  \0$aEnergy conservation$5IEN$0(DLC)sh 85043124

=LDR  00723cz  a2200229n  4500
=001  9880363289402441
=005  20141212200253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003242
=035  \\$aCAZ6393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x500.$x359
=072  \\$aK1.$x559.$x350
=072  \\$aK1.$x752.$x566.$x359
=150  \\$aConscience
=450  \\$wnnna$aConsciences
=550  \\$wg$aMorals
=550  \\$aRefusal to Participate
=667  \\$ano qualif
=680  \\$iThe cognitive and affective processes which constitute an internalized moral governor over an individual's moral conduct.
=688  \\$a91(75); was see under MORALS 1975-90
=750  \0$aConscience$5IEN$0(DLC)sh 85031226

=LDR  00944cz  a2200313n  4500
=001  9880363289502441
=005  20141212200253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x180
=072  \\$aG5.$x355.$x90.$x403.$x180
=150  \\$aConsanguinity
=450  \\$wnnna$aConsanguinities
=450  \\$wnnna$aConsanguinous Mating
=450  \\$wnnna$aConsanguinous Matings
=450  \\$wnnna$aHuman Inbreeding
=450  \\$wnnna$aHuman Inbreedings
=450  \\$aInbreeding, Human
=450  \\$wnnna$aInbreedings, Human
=450  \\$wnnna$aMating, Consanguinous
=450  \\$wnnna$aMatings, Consanguinous
=550  \\$wg$aGenetic Phenomena
=550  \\$wg$aInbreeding
=550  \\$aFamily
=550  \\$aInbreeding
=667  \\$ahuman only: for animals use INBREEDING
=680  \\$iThe magnitude of INBREEDING in humans.
=750  \0$aConsanguinity$5IEN$0(DLC)sh 85031217

=LDR  01995cz  a2200529n  4500
=001  9880363289602441
=005  20200717174630.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003240
=035  \\$aCAZ6391HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300
=150  \\$aConnective Tissue Diseases
=450  \\$wnnna$aConnective Tissue Disease
=450  \\$wnnna$aDisease, Connective Tissue
=450  \\$wnnna$aDiseases, Connective Tissue
=550  \\$wg$aSkin and Connective Tissue Diseases
=550  \\$wh$aAnetoderma
=550  \\$wh$aCartilage Diseases
=550  \\$wh$aCellulitis
=550  \\$wh$aCollagen Diseases
=550  \\$wh$aCutis Laxa
=550  \\$wh$aDermatomyositis
=550  \\$wh$aDupuytren Contracture
=550  \\$wh$aFibromatosis, Plantar
=550  \\$wh$aHomocystinuria
=550  \\$wh$aLipedema
=550  \\$wh$aLupus Erythematosus, Cutaneous
=550  \\$wh$aLupus Erythematosus, Systemic
=550  \\$wh$aMarfan Syndrome
=550  \\$wh$aMixed Connective Tissue Disease
=550  \\$wh$aMucinoses
=550  \\$wh$aNeoplasms, Connective Tissue
=550  \\$wh$aNoonan Syndrome
=550  \\$wh$aOsteopoikilosis
=550  \\$wh$aPanniculitis
=550  \\$wh$aPenile Induration
=550  \\$wh$aPseudoxanthoma Elasticum
=550  \\$wh$aRheumatic Diseases
=550  \\$wh$aScleroderma, Localized
=550  \\$wh$aScleroderma, Systemic
=550  \\$wh$aUndifferentiated Connective Tissue Diseases
=550  \\$wh$aWeill-Marchesani Syndrome
=667  \\$aGEN or unspecified: prefer specifics; note & do not confuse with MIXED CONNECTIVE TISSUE DISEASE, a specific connective tissue dis entity
=680  \\$iA heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.
=688  \\$a80
=750  \0$aConnective tissues$xDiseases$5IEN$0(DLC)sh 85031185

=LDR  01078cz  a2200349n  4500
=001  9880363289702441
=005  20190128104806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003239
=035  \\$aCAZ6390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329
=150  \\$aConnective Tissue Cells
=450  \\$wnnna$aCell, Connective Tissue
=450  \\$wnnna$aCells, Connective Tissue
=450  \\$wnnna$aConnective Tissue Cell
=450  \\$aConnective Tissue$xcytology
=550  \\$wg$aCells
=550  \\$wh$aAdipocytes
=550  \\$wh$aChondrocytes
=550  \\$wh$aFibroblasts
=550  \\$wh$aMacrophages
=550  \\$wh$aMast Cells
=550  \\$wh$aOdontoblasts
=550  \\$wh$aOsteoblasts
=550  \\$wh$aStromal Cells
=550  \\$wh$aSynoviocytes
=550  \\$wh$aTenocytes
=550  \\$wh$aTheca Cells
=680  \\$iA group of cells that includes FIBROBLASTS, cartilage cells, ADIPOCYTES, smooth muscle cells, and bone cells.
=688  \\$a98, 65-77; use explode 1978-97
=750  \0$aConnective tissue cells$5IEN-M$0(DLC)sh 85031182

=LDR  01459cz  a2200313n  4500
=001  9880363289802441
=005  20141212200249.0
=008  850605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003232
=035  \\$aCAZ6384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x325.$x250.$x250
=072  \\$aC2.$x782.$x687.$x359.$x201
=072  \\$aC2.$x782.$x687.$x359.$x213.$x165
=072  \\$aC11.$x187.$x183.$x240.$x216
=072  \\$aC11.$x294.$x800.$x250.$x250
=150  \\$aConjunctivitis, Acute Hemorrhagic
=450  \\$wnnna$aAcute Hemorrhagic Conjunctivitides
=450  \\$wnnna$aAcute Hemorrhagic Conjunctivitis
=450  \\$wnnna$aConjunctivitides, Acute Hemorrhagic
=450  \\$wnnna$aHemorrhagic Conjunctivitides, Acute
=450  \\$wnnna$aHemorrhagic Conjunctivitis, Acute
=550  \\$wg$aConjunctivitis, Viral
=550  \\$wg$aCoxsackievirus Infections
=550  \\$wg$aEnterovirus Infections
=667  \\$acoord IM with precoord virus infect (IM) + specific virus (IM)
=680  \\$iA highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 (EV-70) was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant (CA24v). Epidemics by this organism have appeared most frequently in Asia.
=688  \\$a86
=750  \0$aAcute hemorrhagic conjunctivitis$5IEN$0(DLC)sh 89002254

=LDR  00592cz  a2200205n  4500
=001  9880363289902441
=005  20141212200249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003231
=035  \\$aCAZ6383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187.$x183
=150  \\$aConjunctivitis
=450  \\$wnnna$aConjunctivitides
=550  \\$wg$aConjunctival Diseases
=550  \\$wh$aConjunctivitis, Allergic
=550  \\$wh$aConjunctivitis, Bacterial
=550  \\$wh$aConjunctivitis, Viral
=550  \\$wh$aKeratoconjunctivitis
=750  \0$aConjunctivitis$5IEN$0(DLC)sh 85031146

=LDR  00823cz  a2200253n  4500
=001  9880363290002441
=005  20141212200248.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003230
=035  \\$aCAZ6382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x364.$x235
=072  \\$aC11.$x187.$x169
=072  \\$aC11.$x319.$x217
=150  \\$aConjunctival Neoplasms
=450  \\$wnnna$aConjunctival Neoplasm
=450  \\$wnnna$aNeoplasm, Conjunctival
=450  \\$wnnna$aNeoplasms, Conjunctival
=550  \\$wg$aConjunctival Diseases
=550  \\$wg$aEye Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the CONJUNCTIVA.
=688  \\$a81
=750  \0$aConjunctiva$xTumors$5IEN-M$0(DLC)sh 85031145

=LDR  00755cz  a2200265n  4500
=001  9880363290102441
=005  20141212200248.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003229
=035  \\$aCAZ6381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187
=150  \\$aConjunctival Diseases
=450  \\$wnnna$aConjunctival Disease
=450  \\$wnnna$aDisease, Conjunctival
=450  \\$wnnna$aDiseases, Conjunctival
=550  \\$wg$aEye Diseases
=550  \\$wh$aConjunctival Neoplasms
=550  \\$wh$aConjunctivitis
=550  \\$wh$aPemphigoid, Benign Mucous Membrane
=550  \\$wh$aPinguecula
=550  \\$wh$aPterygium
=550  \\$wh$aXerophthalmia
=688  \\$a81
=750  \0$aConjunctiva$xDiseases$5IEN$0(DLC)sh 85031144

=LDR  01023cz  a2200253n  4500
=001  9880363290202441
=005  20141212200248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003228
=035  \\$aCAZ6380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x200
=072  \\$aA9.$x371.$x337.$x168
=150  \\$aConjunctiva
=450  \\$aBulbar Conjunctiva
=450  \\$wnnna$aConjunctiva, Bulbar
=450  \\$wnnna$aConjunctiva, Palpebral
=450  \\$wnnna$aConjunctivas
=450  \\$aPalpebral Conjunctiva
=550  \\$wg$aAnterior Eye Segment
=550  \\$wg$aEyelids
=667  \\$ainflammation = CONJUNCTIVITIS or specifics; do not confuse with "conjunctive tissue" in translated texts (as for French "tissu conjonctif"): this is CONNECTIVE TISSUE, not CONJUNCTIVA; /blood supply consider also CILIARY ARTERIES
=680  \\$iThe mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.
=750  \0$aConjunctiva$5IEN$0(DLC)sh 85031143

=LDR  00993cz  a2200229n  4500
=001  9880363290302441
=005  20141212200247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x200
=150  \\$aConjugation, Genetic
=450  \\$aBacterial Conjugation
=450  \\$wnnna$aConjugation, Bacterial
=450  \\$wnnna$aGenetic Conjugation
=550  \\$wg$aRecombination, Genetic
=550  \\$aCrosses, Genetic
=550  \\$aPili, Sex
=550  \\$aTransformation, Genetic
=680  \\$iA parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
=688  \\$a68
=750  \0$aConjugation (Biology)$5IEN$0(DLC)sh 85031142

=LDR  01444cz  a2200337n  4500
=001  9880363290402441
=005  20141212200247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003226
=035  \\$aCAZ6378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x199
=150  \\$aCongresses as Topic
=450  \\$wnnna$aConference Proceedings as Topic
=450  \\$aConferences
=450  \\$wnnna$aConferences and Congresses
=450  \\$wnnna$aConferences and Proceedings
=450  \\$wnnna$aCongresses and Conferences
=450  \\$wnnna$aCongresses as Topics
=450  \\$wnnna$aProceedings and Conferences
=450  \\$wnnna$aProfessional Meetings and Conferences
=450  \\$wnnna$aTopics, Congresses as
=550  \\$wg$aOrganizations
=550  \\$wh$aConsensus Development Conferences as Topic
=550  \\$aInternational Cooperation
=667  \\$aused for general articles about congresses, conferences, or meetings as a means of communication; do not add INTERNATIONAL COOPERATION for international congresses; do not confuse with Publication Type CONGRESSES
=680  \\$iConferences, conventions or formal meetings usually attended by delegates representing a special field of interest.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Congresses
=688  \\$aCONFERENCES was see under CONGRESSES 1963-77
=750  \0$aCongresses and conventions$0(DLC) sh 85031115$5IEN-HS

=LDR  00680cz  a2200193n  4500
=001  9880363290502441
=005  20141212200246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003224
=035  \\$aCAZ6376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x555.$x300
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50.$x650.$x250
=072  \\$aD4.$x615.$x638.$x555.$x300
=150  \\$aCongo Red
=450  \\$wnnna$aRed, Congo
=550  \\$wg$aNaphthalenesulfonates
=680  \\$iAn acid dye used in testing for hydrochloric acid in gastric contents. It is also used histologically to test for AMYLOIDOSIS.
=750  \0$aCongo red$5IEN$0(DLC)sh 85031103

=LDR  01685cz  a2200493n  4500
=001  9880363290702441
=005  20170914125407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003219
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x335.$x240
=072  \\$aI1.$x880.$x604.$x473.$x650.$x500
=072  \\$aI1.$x880.$x604.$x583.$x80
=072  \\$aN3.$x706.$x437.$x650.$x124
=072  \\$aN3.$x706.$x535.$x230
=150  \\$aConfidentiality
=450  \\$wnnna$aCommunication, Privileged
=450  \\$wnnna$aCommunications, Privileged
=450  \\$wnnna$aConfidential Information
=450  \\$wnnna$aData Privacy, Patient
=450  \\$wnnna$aInformation, Confidential
=450  \\$aPatient Data Privacy
=450  \\$aPrivacy of Patient Data
=450  \\$wnnna$aPrivacy, Patient Data
=450  \\$aPrivileged Communication
=450  \\$wnnna$aPrivileged Communications
=450  \\$wnnna$aSecrecy
=550  \\$wg$aForensic Psychiatry
=550  \\$wg$aJurisprudence
=550  \\$wg$aPatient Rights
=550  \\$wh$aData Anonymization
=550  \\$wh$aDisclosure
=550  \\$wh$aDuty to Warn
=550  \\$wh$aGenetic Privacy
=550  \\$wh$aPersonally Identifiable Information
=550  \\$aAnonymous Testing
=550  \\$aDisclosure
=550  \\$aDuty to Warn
=550  \\$aParental Notification
=550  \\$aPrivacy
=667  \\$asecrecy goes here
=680  \\$iThe privacy of information and its protection against unauthorized disclosure.
=688  \\$a80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74
=750  \0$aConfidential communications$5IEN-M$0(DLC)sh 85030929

=LDR  01152cz  a2200349n  4500
=001  9880363290802441
=005  20141212200245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003218
=035  \\$aCAZ6370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x650.$x810.$x217
=072  \\$aC2.$x800.$x801.$x220
=072  \\$aC2.$x825.$x810.$x110
=072  \\$aC2.$x928.$x914.$x217
=072  \\$aC17.$x800.$x838.$x790.$x810.$x110
=150  \\$aCondylomata Acuminata
=450  \\$wnnna$aGenital Wart
=450  \\$aGenital Warts
=450  \\$wnnna$aVenereal Wart
=450  \\$aVenereal Warts
=450  \\$wnnna$aWart, Genital
=450  \\$wnnna$aWart, Venereal
=450  \\$aWarts, Genital
=450  \\$aWarts, Venereal
=550  \\$wg$aSexually Transmitted Diseases, Viral
=550  \\$wg$aWarts
=550  \\$wh$aBuschke-Lowenstein Tumor
=667  \\$acoordinate IM with precoordinated organ/disease term (IM) + specific virus (IM) if pertinent
=680  \\$iSexually transmitted form of anogenital warty growth caused by the human papillomaviruses.
=688  \\$a72(64)
=750  \0$aGenital warts$5IEN$0(DLC)sh 90002382

=LDR  01109cz  a2200277n  4500
=001  9880363290902441
=005  20201113170109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003216
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x179.$x509
=150  \\$aConditioning, Operant
=450  \\$wnnna$aConditionings, Operant
=450  \\$aInstrumental Learning
=450  \\$wnnna$aInstrumental Learnings
=450  \\$wnnna$aLearning, Instrumental
=450  \\$wnnna$aLearnings, Instrumental
=450  \\$wnnna$aOperant Conditioning
=450  \\$wnnna$aOperant Conditionings
=550  \\$wg$aConditioning, Psychological
=550  \\$aBehavior Control
=667  \\$ahuman & animal
=680  \\$iLearning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced.
=688  \\$a68(65)
=750  \0$aOperant conditioning$5IEN-M$0(DLC)sh 85094913
=750  \0$aOperant behavior$5IEN-HS$0(DLC)sh 85094912

=LDR  00647cz  a2200205n  4500
=001  9880363291002441
=005  20201113170020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003215
=035  \\$aCAZ6367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x179.$x408
=150  \\$aConditioning, Eyelid
=450  \\$wnnna$aConditionings, Eyelid
=450  \\$aEyelid Conditioning
=450  \\$wnnna$aEyelid Conditionings
=550  \\$wg$aConditioning, Psychological
=680  \\$iReflex closure of the eyelid occurring as a result of classical conditioning.
=688  \\$a69
=750  \0$aEyelid conditioning$5IEN$0(DLC)sh 85046705

=LDR  00873cz  a2200241n  4500
=001  9880363291102441
=005  20201113165903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003214
=035  \\$aCAZ6366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x179.$x308
=150  \\$aConditioning, Classical
=450  \\$wnnna$aClassical Conditioning
=450  \\$wnnna$aClassical Conditionings
=450  \\$wnnna$aConditioned Reflex
=450  \\$wnnna$aConditionings, Classical
=450  \\$aReflex, Conditioned
=550  \\$wg$aConditioning, Psychological
=680  \\$iLearning that takes place when a conditioned stimulus is paired with an unconditioned stimulus.
=688  \\$a73(66); REFLEX, CONDITIONED was heading 1963-72
=750  \0$aConditioned response$5IEN-M$0(DLC)sh 85030776
=750  \0$aClassical conditioning$5IEN-HS$0(DLC)sh 85026696

=LDR  00645cz  a2200193n  4500
=001  9880363291302441
=005  20141212200242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003210
=035  \\$aCAZ6363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x233
=150  \\$aConcept Formation
=450  \\$wnnna$aConcept Formations
=450  \\$wnnna$aFormation, Concept
=450  \\$wnnna$aFormations, Concept
=550  \\$wg$aThinking
=680  \\$iA cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects.
=750  \0$aConcepts$5IEN$0(DLC)sh 85029623

=LDR  00753cz  a2200229n  4500
=001  9880363291502441
=005  20141212200241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003203
=035  \\$aCAZ6356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x280
=150  \\$aComputers, Hybrid
=450  \\$wnnna$aComputer, Hybrid
=450  \\$wnnna$aHybrid Computer
=450  \\$wnnna$aHybrid Computers
=550  \\$wg$aComputers
=550  \\$wh$aAnalog-Digital Conversion
=667  \\$ado not use /util except by MeSH definition
=680  \\$iComputers that combine the functions of analog and digital computers. (Sippl, Computer Dictionary, 4th ed)
=688  \\$a73(64)
=750  \0$aHybrid computers$5IEN$0(DLC)sh 85063268

=LDR  01046cz  a2200265n  4500
=001  9880363291602441
=005  20141212200241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003202
=035  \\$aCAZ6355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x230
=150  \\$aComputers, Analog
=450  \\$wnnna$aAnalog Computer
=450  \\$wnnna$aAnalog Computers
=450  \\$wnnna$aAnalogue Computer
=450  \\$wnnna$aAnalogue Computers
=450  \\$wnnna$aComputer, Analog
=450  \\$wnnna$aComputer, Analogue
=450  \\$wnnna$aComputers, Analogue
=550  \\$wg$aComputers
=667  \\$ado not use /util except by MeSH definition
=680  \\$iComputers in which quantities are represented by physical variables; problem parameters are translated into equivalent mechanical or electrical circuits as an analog for the physical phenomenon being investigated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a66(64)
=750  \0$aAnalog computers$5IEN$0(DLC)sh 85004769

=LDR  01334cz  a2200385n  4500
=001  9880363291702441
=005  20141212200240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003201
=035  \\$aCAZ6354HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260
=150  \\$aComputers
=450  \\$wnnna$aCalculator, Programmable
=450  \\$aCalculators, Programmable
=450  \\$wnnna$aComputer
=450  \\$wnnna$aComputer, Digital
=450  \\$aComputer Hardware
=450  \\$aComputers, Digital
=450  \\$wnnna$aDigital Computer
=450  \\$wnnna$aDigital Computers
=450  \\$aHardware, Computer
=450  \\$wnnna$aProgrammable Calculator
=450  \\$wnnna$aProgrammable Calculators
=550  \\$wg$aComputer Systems
=550  \\$wh$aComputer Peripherals
=550  \\$wh$aComputers, Analog
=550  \\$wh$aComputers, Hybrid
=550  \\$wh$aComputers, Mainframe
=550  \\$wh$aComputers, Molecular
=550  \\$wh$aMicrocomputers
=550  \\$wh$aMinicomputers
=667  \\$aGEN; use of computers in medicine: do not coord with MEDICINE; for processing of data by computer, COMPUTER DATA PROCESSING see AUTOMATIC DATA PROCESSING is available
=688  \\$a66(64); COMPUTERS, DIGITAL was heading 1964-77 (Prov 1964-65)
=750  \0$aComputers$5IEN-HS$0(DLC)sh 85029552

=LDR  01707cz   2200469n  4500
=001  9880363291802441
=005  20230831163300.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003199
=035  \\$aCAZ6352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230
=150  \\$aComputer Systems
=450  \\$wnnna$aArchitecture, Computer
=450  \\$wnnna$aArchitectures, Computer
=450  \\$aComputer Architecture
=450  \\$wnnna$aComputer Architectures
=450  \\$wnnna$aComputer System
=450  \\$aComputer Systems Development
=450  \\$aComputer Systems Evaluation
=450  \\$wnnna$aComputer Systems Evaluations
=450  \\$aComputer Systems Organization
=450  \\$wnnna$aDevelopment, Computer Systems
=450  \\$wnnna$aEvaluation, Computer Systems
=450  \\$wnnna$aEvaluations, Computer Systems
=450  \\$wnnna$aOrganization, Computer Systems
=450  \\$wnnna$aReal-Time System
=450  \\$aReal-Time Systems
=450  \\$wnnna$aReal Time Systems
=450  \\$wnnna$aSystem, Computer
=450  \\$wnnna$aSystem, Real-Time
=450  \\$wnnna$aSystems, Computer
=450  \\$wnnna$aSystems, Real-Time
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aComputer Communication Networks
=550  \\$wh$aComputers
=667  \\$aIM
=680  \\$iSystems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities.
=688  \\$a87
=750  \0$aComputer architecture$5IEN-M$0(DLC)sh 85029479
=750  \0$aComputer systems$5IEN-HS$0(DLC)sh 98003200
=750  \0$iNarrower mapping$aSoftware container technologies$0(DLC)sh2022006629$4NM$5IEN-M

=LDR  01337cz  a2200409n  4500
=001  9880363291902441
=005  20200720142438.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003198
=035  \\$aCAZ6351HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x160
=150  \\$aComputer Simulation
=450  \\$wnnna$aComputer Model
=450  \\$aComputer Models
=450  \\$wnnna$aComputer Simulations
=450  \\$wnnna$aComputerized Model
=450  \\$wnnna$aComputerized Models
=450  \\$wnnna$aIn Silico
=450  \\$wnnna$aIn Silicos
=450  \\$wnnna$aModel, Computer
=450  \\$wnnna$aModel, Computerized
=450  \\$aModels, Computer
=450  \\$wnnna$aModels, Computerized
=450  \\$wnnna$aSilico, In
=450  \\$wnnna$aSilicos, In
=450  \\$wnnna$aSimulation, Computer
=450  \\$wnnna$aSimulations, Computer
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aMolecular Docking Simulation
=550  \\$wh$aMolecular Dynamics Simulation
=550  \\$wh$aPatient-Specific Modeling
=550  \\$wh$aVirtual Reality
=667  \\$acoordinate with specific models heading if pertinent
=680  \\$iComputer-based representation of physical systems and phenomena such as chemical processes.
=688  \\$a87
=750  \0$aComputer simulation$5IEN$0(DLC)sh 85029533

=LDR  00634cz  a2200217n  4500
=001  9880363292002441
=005  20141212200239.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003197
=035  \\$aCAZ6350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x256
=150  \\$aComputer Literacy
=450  \\$wnnna$aComputer Literacies
=450  \\$wnnna$aLiteracies, Computer
=450  \\$wnnna$aLiteracy, Computer
=550  \\$wg$aCommunication
=550  \\$aInformation Literacy
=680  \\$iFamiliarity and comfort in using computers efficiently.
=688  \\$a87
=750  \0$aComputer literacy$5IEN$0(DLC)sh 85029509

=LDR  00839cz  a2200241n  4500
=001  9880363292102441
=005  20141212200238.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003196
=035  \\$aCAZ6349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x108
=072  \\$aL1.$x296.$x110
=150  \\$aComputer Graphics
=450  \\$wnnna$aComputer Graphic
=450  \\$wnnna$aGraphic, Computer
=450  \\$wnnna$aGraphics, Computer
=550  \\$wg$aComputing Methodologies
=550  \\$wg$aData Display
=550  \\$wh$aComputer-Aided Design
=680  \\$iThe process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation.
=688  \\$a87
=750  \0$aComputer graphics$5IEN$0(DLC)sh 85029500

=LDR  02232cz  a2200565n  4500
=001  9880363292202441
=005  20141212200238.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003195
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x110
=150  \\$aComputer Communication Networks
=450  \\$wnnna$aCommunication Network, Computer
=450  \\$wnnna$aCommunication Networks, Computer
=450  \\$wnnna$aCommunication Protocol, Network
=450  \\$wnnna$aCommunication Protocols, Network
=450  \\$wnnna$aComputer Communication Network
=450  \\$aComputer Network Management
=450  \\$wnnna$aDatabase, Distributed
=450  \\$aDatabases, Distributed
=450  \\$wnnna$aDistributed Database
=450  \\$wnnna$aDistributed Databases
=450  \\$wnnna$aDistributed System
=450  \\$aDistributed Systems
=450  \\$wnnna$aExtranet
=450  \\$aExtranets
=450  \\$wnnna$aIntranet
=450  \\$aIntranets
=450  \\$wnnna$aManagement, Computer Network
=450  \\$wnnna$aNetwork Communication Protocol
=450  \\$aNetwork Communication Protocols
=450  \\$wnnna$aNetwork, Computer Communication
=450  \\$wnnna$aNetwork Management, Computer
=450  \\$wnnna$aNetwork, Telecommunication
=450  \\$wnnna$aNetworks, Computer Communication
=450  \\$wnnna$aNetworks, Telecommunication
=450  \\$wnnna$aProtocol, Network Communication
=450  \\$wnnna$aProtocols, Network Communication
=450  \\$wnnna$aSystem, Distributed
=450  \\$wnnna$aSystems, Distributed
=450  \\$wnnna$aTelecommunication Network
=450  \\$aTelecommunication Networks
=550  \\$wg$aComputer Systems
=550  \\$wh$aInternet
=550  \\$wh$aLocal Area Networks
=550  \\$aEducation, Distance
=550  \\$aTelecommunications
=680  \\$iA system containing any combination of computers, computer terminals, printers, audio or visual display devices, or telephones interconnected by telecommunications equipment or cables: used to transmit or receive information. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a1991(1987); use COMPUTER SYSTEMS 1987-1990
=750  \0$aComputer networks$5IEN$0(DLC)sh 85029513

=LDR  01496cz  a2200349n  4500
=001  9880363292302441
=005  20201221145939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003194
=035  \\$aCAZ6347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x903.$x573.$x208
=150  \\$aComputer-Assisted Instruction
=450  \\$wnnna$aComputer Assisted Instruction
=450  \\$wnnna$aComputer-Assisted Instructions
=450  \\$wnnna$aComputerized Programmed Instruction
=450  \\$wnnna$aComputerized Self-Instruction Program
=450  \\$wnnna$aComputerized Self-Instruction Programs
=450  \\$wnnna$aInstruction, Computer-Assisted
=450  \\$wnnna$aInstruction, Computerized Programmed
=450  \\$wnnna$aInstructions, Computer-Assisted
=450  \\$wnnna$aProgram, Computerized Self-Instruction
=450  \\$aProgrammed Instruction, Computerized
=450  \\$wnnna$aPrograms, Computerized Self-Instruction
=450  \\$wnnna$aSelf-Instruction Program, Computerized
=450  \\$aSelf-Instruction Programs, Computerized
=450  \\$wnnna$aSelf Instruction Programs, Computerized
=550  \\$wg$aProgrammed Instructions as Topic
=667  \\$aDIAGNOSIS, COMPUTER-ASSISTED is also available
=680  \\$iA self-learning technique, usually online, involving interaction of the student with programmed instructional materials.
=688  \\$a91; was COMPUTER ASSISTED INSTRUCTION 1974-90
=750  \0$aComputer-assisted instruction$5IEN$0(DLC)sh 85029483

=LDR  00996cz  a2200229n  4500
=001  9880363292402441
=005  20141212200236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003192
=035  \\$aCAZ6345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x527.$x100
=150  \\$aCompulsive Behavior
=450  \\$aBehavior, Compulsive
=450  \\$wnnna$aBehaviors, Compulsive
=450  \\$wnnna$aCompulsive Behaviors
=550  \\$wg$aImpulsive Behavior
=550  \\$wh$aBehavior, Addictive
=667  \\$ause Cat F3 qualif
=680  \\$iThe behavior of performing an act persistently and repetitively without it leading to reward or pleasure. The act is usually a small, circumscribed behavior, almost ritualistic, yet not pathologically disturbing. Examples of compulsive behavior include twirling of hair, checking something constantly, not wanting pennies in change, straightening tilted pictures, etc.
=688  \\$a68
=750  \0$aCompulsive behavior$5IEN$0(DLC)sh 85029465

=LDR  00817cz  a2200253n  4500
=001  9880363292502441
=005  20141212200235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003188
=035  \\$aCAZ6341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x822.$x308
=072  \\$aD25.$x339.$x816.$x500
=072  \\$aD25.$x720.$x716.$x822.$x308
=072  \\$aJ1.$x637.$x51.$x339.$x816.$x500
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x308
=150  \\$aComposite Resins
=450  \\$wnnna$aResins, Composite
=550  \\$wg$aResins, Synthetic
=550  \\$wh$aBisphenol A-Glycidyl Methacrylate
=550  \\$wh$aCompomers
=680  \\$iSynthetic resins, containing an inert filler, that are widely used in dentistry.
=688  \\$a73(72)
=750  \0$aDental resins$5IEN$0(DLC)sh 85036928

=LDR  01840cz  a2200397n  4500
=001  9880363292602441
=005  20141212192116.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003169
=035  \\$aCAZ6322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x274.$x920
=150  \\$aComplement Inactivator Proteins
=450  \\$wnnna$aComplement Cytolysis Inhibiting Proteins
=450  \\$wnnna$aComplement Cytolysis Inhibitor Proteins
=450  \\$wnnna$aComplement Inactivating Proteins
=450  \\$wnnna$aComplement Inactivators, Serum
=450  \\$aComplement System Proteins$xantagonists & inhibitors
=450  \\$wnnna$aInactivating Proteins, Complement
=450  \\$wnnna$aInactivator Proteins, Complement
=450  \\$wnnna$aInactivators, Serum Complement
=450  \\$wnnna$aProteins, Complement Inactivating
=450  \\$wnnna$aProteins, Complement Inactivator
=450  \\$wnnna$aSerum Complement Inactivators
=550  \\$wg$aComplement System Proteins
=550  \\$wh$aAntigens, CD46
=550  \\$wh$aComplement C1 Inactivator Proteins
=550  \\$wh$aComplement C3 Nephritic Factor
=550  \\$wh$aComplement C3b Inactivator Proteins
=550  \\$wh$aComplement C4b-Binding Protein
=667  \\$ado not confuse with COMPLEMENT INACTIVATING AGENTS
=680  \\$iSerum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors.
=688  \\$a2006 (1978)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Complement Inactivators
=688  \\$a78
=750  \0$aComplement inhibition$0(DLC) sh 92002551$5IEN-M

=LDR  01810cz  a2200337n  4500
=001  9880363292702441
=005  20141212200228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003168
=035  \\$aCAZ6321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x150
=072  \\$aE5.$x200.$x812.$x735.$x150
=072  \\$aE5.$x478.$x594.$x760.$x150
=150  \\$aComplement Fixation Tests
=450  \\$aComplement Absorption Test, Conglutinating
=450  \\$wnnna$aComplement Fixation Test
=450  \\$wnnna$aConglutinating Complement Absorption Test
=450  \\$aConglutination Reaction
=450  \\$wnnna$aConglutination Reactions
=450  \\$wnnna$aFixation Test, Complement
=450  \\$wnnna$aFixation Tests, Complement
=450  \\$wnnna$aReaction, Conglutination
=450  \\$wnnna$aReactions, Conglutination
=450  \\$wnnna$aTest, Complement Fixation
=450  \\$wnnna$aTests, Complement Fixation
=550  \\$wg$aSerologic Tests
=550  \\$aComplement Activation
=680  \\$iSerologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.
=688  \\$aCONGLUTINATION REACTION was heading 1975-96 (see under COMPLEMENT FIXATION TESTS 1975-90); COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96
=750  \0$aComplement fixation$0(DLC) sh 85029356$5IEN

=LDR  01011cz  a2200253n  4500
=001  9880363292802441
=005  20141212200228.0
=008  771202\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003167
=035  \\$aCAZ6320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x255
=150  \\$aComplement Activation
=450  \\$wnnna$aActivation, Complement
=450  \\$wnnna$aActivations, Complement
=450  \\$wnnna$aComplement Activations
=550  \\$wg$aImmune System Processes
=550  \\$wh$aComplement Pathway, Alternative
=550  \\$wh$aComplement Pathway, Classical
=550  \\$wh$aComplement Pathway, Mannose-Binding Lectin
=550  \\$aComplement System Proteins
=680  \\$iThe sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES.
=688  \\$a79
=750  \0$aComplement Activation$0(DLC) sh 92002550$5IEN

=LDR  01780cz  a2200469n  4500
=001  9880363292902441
=005  20141212200227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003165
=035  \\$aCAZ6318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x274
=150  \\$aComplement System Proteins
=450  \\$wnnna$aComplement
=450  \\$wnnna$aComplement, Hemolytic
=450  \\$wnnna$aComplement Protein
=450  \\$aComplement Proteins
=450  \\$wnnna$aHemolytic Complement
=450  \\$wnnna$aProtein, Complement
=450  \\$wnnna$aProteins, Complement
=450  \\$wnnna$aProteins, Complement System
=550  \\$wg$aImmunoproteins
=550  \\$wh$aAnaphylatoxins
=550  \\$wh$aComplement Activating Enzymes
=550  \\$wh$aComplement C1
=550  \\$wh$aComplement C2
=550  \\$wh$aComplement C3
=550  \\$wh$aComplement C4
=550  \\$wh$aComplement C5
=550  \\$wh$aComplement C6
=550  \\$wh$aComplement C7
=550  \\$wh$aComplement C8
=550  \\$wh$aComplement C9
=550  \\$wh$aComplement Factor B
=550  \\$wh$aComplement Inactivator Proteins
=550  \\$wh$aComplement Membrane Attack Complex
=550  \\$wh$aProperdin
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iSerum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY).
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Complement
=750  \0$aComplement (Immunology)$0(DLC) sh 85029354$5IEN-M

=LDR  01030cz  a2200301n  4500
=001  9880363293002441
=005  20141212200227.0
=008  850424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003164
=035  \\$aCAZ6317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x100.$x110
=150  \\$aCompetitive Bidding
=450  \\$wnnna$aBidding, Competitive
=450  \\$wnnna$aBidding, Contract
=450  \\$wnnna$aBiddings, Competitive
=450  \\$wnnna$aBiddings, Contract
=450  \\$wnnna$aCompetitive Biddings
=450  \\$aContract Bidding
=450  \\$wnnna$aContract Biddings
=450  \\$wnnna$aProposal, Request for
=450  \\$wnnna$aProposals, Request for
=450  \\$aRequest for Proposal
=450  \\$wnnna$aRequest for Proposals
=550  \\$wg$aContract Services
=680  \\$iPricing statements presented by more than one party for the purpose of securing a contract.
=688  \\$a91(86); was see under FINANCIAL MANAGEMENT 1986-90
=750  \0$aLetting of contracts$5IEN$0(DLC)sh 85031629

=LDR  00689cz  a2200217n  4500
=001  9880363293102441
=005  20141212200226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003163
=035  \\$aCAZ6316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x105
=150  \\$aCompetitive Behavior
=450  \\$wnnna$aBehavior, Competitive
=450  \\$wnnna$aBehaviors, Competitive
=450  \\$wnnna$aCompetitive Behaviors
=550  \\$wg$aSocial Behavior
=667  \\$ahuman & animal
=680  \\$iThe direct struggle between individuals for environmental necessities or for a common goal.
=688  \\$a68
=750  \0$aCompetition (Psychology)$5IEN$0(DLC)sh 85029344

=LDR  00900cz  a2200229n  4500
=001  9880363293202441
=005  20141212200226.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003162
=035  \\$aCAZ6315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x158.$x210
=150  \\$aCompetency-Based Education
=450  \\$wnnna$aCompetency Based Education
=450  \\$wnnna$aCompetency-Based Educations
=450  \\$aEducation, Competency-Based
=450  \\$wnnna$aEducation, Competency Based
=450  \\$wnnna$aEducations, Competency-Based
=550  \\$wg$aCurriculum
=680  \\$iEducational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives.
=688  \\$a91(79); was see under CURRICULUM 1979-90
=750  \0$aCompetency-based education$5IEN-M$0(DLC)sh 85029331

=LDR  01221cz  a2200289n  4500
=001  9880363293302441
=005  20141212200226.0
=008  800514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003161
=035  \\$aCAZ6314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x180
=072  \\$aC14.$x907.$x303
=150  \\$aCompartment Syndromes
=450  \\$wnnna$aCompartment Syndrome
=450  \\$wnnna$aSyndrome, Compartment
=450  \\$wnnna$aSyndromes, Compartment
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAnterior Compartment Syndrome
=550  \\$wh$aIntra-Abdominal Hypertension
=550  \\$wh$aIschemic Contracture
=550  \\$aCrush Syndrome
=680  \\$iConditions in which increased pressure within a limited space compromises the BLOOD CIRCULATION and function of tissue within that space. Some of the causes of increased pressure are TRAUMA, tight dressings, HEMORRHAGE, and exercise. Sequelae include nerve compression (NERVE COMPRESSION SYNDROMES); PARALYSIS; and ISCHEMIC CONTRACTURE.
=688  \\$a1981
=688  \\$a81; VOLKMANN CONTRACTURE was heading VOLKMANN'S CONTRACTURE 1963-80
=750  \0$aCompartment syndrome$0(DLC) sh 85029310$5IEN-M

=LDR  01121cz  a2200301n  4500
=001  9880363293402441
=005  20141212200225.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003159
=035  \\$aCAZ6312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x822.$x210
=150  \\$aCommunity-Institutional Relations
=450  \\$wnnna$aCommunity-Institutional Relation
=450  \\$wnnna$aCommunity Institutional Relations
=450  \\$aCommunity Outreach
=450  \\$wnnna$aCommunity Relation
=450  \\$wnnna$aCommunity Relations
=450  \\$wnnna$aOutreach, Community
=450  \\$wnnna$aRelation, Community
=450  \\$wnnna$aRelation, Community-Institutional
=450  \\$wnnna$aRelations, Community
=450  \\$wnnna$aRelations, Community-Institutional
=550  \\$wg$aPublic Relations
=667  \\$aspecify institution (IM) + geog if pertinent; DF: COMMUNITY INSTITUTIONAL RELAT
=680  \\$iThe interactions between members of a community and representatives of the institutions within that community.
=688  \\$a78
=750  \0$aHospital and community$5IEN$0(DLC)sh 85062234

=LDR  01074cz  a2200253n  4500
=001  9880363293502441
=005  20141212200225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003158
=035  \\$aCAZ6311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x215
=072  \\$aH2.$x403.$x690.$x150
=150  \\$aCommunity Psychiatry
=450  \\$aPsychiatry, Community
=450  \\$wnnna$aPsychiatry, Social
=450  \\$aSocial Psychiatry
=550  \\$wg$aPsychiatry
=550  \\$wh$aPreventive Psychiatry
=667  \\$aSPEC: SPEC qualif
=680  \\$iBranch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community.
=688  \\$a80; was PSYCHIATRY, COMMUNITY 1971-79 (Prov 1971-72)
=750  \0$aSocial psychiatry$5IEN-HS$0(DLC)sh 85123993
=750  \0$aCommunity psychiatry$5IEN-HS$0(DLC)sh 85029261

=LDR  00803cz  a2200217n  4500
=001  9880363293602441
=005  20141212200224.0
=008  780517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003155
=035  \\$aCAZ6309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x158
=150  \\$aCommunity Mental Health Centers
=450  \\$aCMHC
=550  \\$wg$aAmbulatory Care Facilities
=550  \\$wh$aChild Guidance Clinics
=667  \\$aDF: note short X ref
=680  \\$iFacilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community.
=688  \\$a79; was see COMMUNITY MENTAL HEALTH SERVICES 1978
=750  \0$aCommunity mental health services$5IEN-M$0(DLC)sh 85029245
=750  \0$aPsychiatric clinics$5IEN-HS$0(DLC)sh 85108343

=LDR  00984cz  a2200241n  4500
=001  9880363293702441
=005  20141212200222.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003152
=035  \\$aCAZ6307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x150
=072  \\$aN2.$x421.$x143.$x150
=150  \\$aCommunity Health Nursing
=450  \\$wnnna$aNursing, Community Health
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aSpecialties, Nursing
=550  \\$wh$aHome Health Nursing
=550  \\$wh$aParish Nursing
=667  \\$ado not confuse with PUBLIC HEALTH NURSING
=680  \\$iGeneral and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population or community. This is not an official program of a Public Health Department.
=688  \\$a77(75); was see under COMMUNITY HEALTH SERVICES 1975-76
=750  \0$aCommunity health nursing$5IEN$0(DLC)sh 85029230

=LDR  01868cz  a2200505n  4500
=001  9880363293802441
=005  20141212200222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003150
=035  \\$aCAZ6305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x80
=072  \\$aN2.$x360.$x67.$x80
=150  \\$aCommunity Health Workers
=450  \\$wnnna$aAide, Community Health
=450  \\$wnnna$aAides, Community Health
=450  \\$wnnna$aBarefoot Doctor
=450  \\$aBarefoot Doctors
=450  \\$wnnna$aCommunity Health Aide
=450  \\$aCommunity Health Aides
=450  \\$wnnna$aCommunity Health Worker
=450  \\$wnnna$aDoctor, Barefoot
=450  \\$wnnna$aDoctors, Barefoot
=450  \\$wnnna$aFamily Planning Personnel
=450  \\$wnnna$aFamily Planning Personnel Characteristics
=450  \\$wnnna$aHealth Aide, Community
=450  \\$wnnna$aHealth Aides, Community
=450  \\$wnnna$aHealth Worker, Community
=450  \\$wnnna$aHealth Worker, Village
=450  \\$wnnna$aHealth Workers, Community
=450  \\$wnnna$aHealth Workers, Village
=450  \\$wnnna$aPersonnel, Family Planning
=450  \\$wnnna$aPlanning Personnel, Family
=450  \\$aVillage Health Worker
=450  \\$wnnna$aVillage Health Workers
=450  \\$wnnna$aWorker, Community Health
=450  \\$wnnna$aWorker, Village Health
=450  \\$wnnna$aWorkers, Community Health
=450  \\$wnnna$aWorkers, Village Health
=550  \\$wg$aAllied Health Personnel
=667  \\$aIM
=680  \\$iPersons trained to assist professional health personnel in communicating with residents in the community concerning needs and availability of health services.
=688  \\$a71
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Community Health Aides
=750  \0$aCommunity health aides$0(DLC) sh 85029227$5IEN

=LDR  01214cz  a2200289n  4500
=001  9880363293902441
=005  20141212200050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002852
=035  \\$aCAZ6009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x383
=150  \\$aChromatography, Ion Exchange
=450  \\$wnnna$aChromatographies, Ion Exchange
=450  \\$wnnna$aChromatographies, Ion-Exchange
=450  \\$wnnna$aChromatography, Ion-Exchange
=450  \\$wnnna$aIon Exchange Chromatographies
=450  \\$wnnna$aIon-Exchange Chromatographies
=450  \\$wnnna$aIon-Exchange Chromatography
=450  \\$wnnna$aIon Exchange Chromatography
=550  \\$wg$aChromatography, Liquid
=550  \\$wh$aChromatography, DEAE-Cellulose
=550  \\$aIon Exchange Resins
=667  \\$aan anal chem technique; NIM; DF: CHROMATOGR ION EXCHANGE
=680  \\$iSeparation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins.
=688  \\$a66
=750  \0$aIon exchange chromatography$5IEN$0(DLC)sh 85067797

=LDR  00934cz  a2200241n  4500
=001  9880363294002441
=005  20141212200050.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002851
=035  \\$aCAZ6008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x300
=150  \\$aChromatography, High Pressure Liquid
=450  \\$aChromatography, High Performance Liquid
=450  \\$aChromatography, High Speed Liquid
=450  \\$aChromatography, Liquid, High Pressure
=450  \\$aHigh Performance Liquid Chromatography$5IEN
=450  \\$aHPLC
=550  \\$wg$aChromatography, Liquid
=667  \\$aan anal chem technique; NIM; DF: note short X ref
=680  \\$iLiquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
=688  \\$a81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80
=750  \0$aHigh performance liquid chromatography$5IEN$0(DLC)sh 85060677

=LDR  01546cz  a2200373n  4500
=001  9880363294102441
=005  20141212200050.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002850
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x250
=150  \\$aChromatography, Gel
=450  \\$aChromatography, Exclusion
=450  \\$wnnna$aChromatography, Gel Filtration
=450  \\$aChromatography, Gel Permeation
=450  \\$aChromatography, Molecular Sieve
=450  \\$wnnna$aChromatography, Size Exclusion
=450  \\$wnnna$aExclusion Chromatography
=450  \\$wnnna$aExclusion Chromatography, Size
=450  \\$wnnna$aFiltration Chromatography, Gel
=450  \\$wnnna$aFiltration, Gel
=450  \\$wnnna$aGel Chromatography
=450  \\$aGel Filtration
=450  \\$aGel Filtration Chromatography
=450  \\$wnnna$aGel Permeation Chromatography
=450  \\$wnnna$aMolecular Sieve Chromatography
=450  \\$wnnna$aSieve Chromatography, Molecular
=450  \\$wnnna$aSize Exclusion Chromatography
=550  \\$wg$aChromatography, Liquid
=550  \\$wh$aChromatography, Agarose
=667  \\$aDF: CHROMATOGR GEL
=680  \\$iChromatography on non-ionic gels without regard to the mechanism of solute discrimination.
=688  \\$a76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75
=750  \0$aGel permeation chromatography$5IEN$0(DLC)sh 85053680

=LDR  01268cz  a2200301n  4500
=001  9880363294202441
=005  20141212200049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002849
=035  \\$aCAZ6006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x349
=150  \\$aChromatography, Gas
=450  \\$wnnna$aChromatographies, Gas
=450  \\$wnnna$aChromatographies, Gas-Liquid
=450  \\$aChromatography, Gas-Liquid
=450  \\$wnnna$aChromatography, Gas Liquid
=450  \\$wnnna$aGas Chromatographies
=450  \\$wnnna$aGas Chromatography
=450  \\$wnnna$aGas-Liquid Chromatographies
=450  \\$wnnna$aGas-Liquid Chromatography
=550  \\$wg$aChromatography
=550  \\$wh$aFlame Ionization
=550  \\$wh$aGas Chromatography-Mass Spectrometry
=667  \\$aan anal chem technique; NIM; DF: CHROMATOGR GAS
=680  \\$iFractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.
=688  \\$a66
=750  \0$aGas chromatography$5IEN$0(DLC)sh 85053278

=LDR  00954cz  a2200241n  4500
=001  9880363294302441
=005  20210212104052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002846
=035  \\$aCAZ6003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x170
=150  \\$aChromatography, Affinity
=450  \\$wnnna$aAffinity Chromatography
=450  \\$wnnna$aBioaffinity Chromatography
=450  \\$aChromatography, Bioaffinity
=450  \\$aImmunochromatography
=550  \\$wg$aChromatography, Liquid
=550  \\$wh$aTandem Affinity Purification
=667  \\$aDF: CHROMATOGR AFFINITY
=680  \\$iA chromatographic technique that utilizes the ability of biological molecules to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a74(72)
=750  \0$aAffinity chromatography$5IEN$0(DLC)sh 85001506

=LDR  01257cz  a2200253n  4500
=001  9880363294402441
=005  20141212200048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002845
=035  \\$aCAZ6002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181
=150  \\$aChromatography
=450  \\$aChromatographic Analysis$5IEN
=450  \\$wnnna$aChromatographies
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aChromatography, Gas
=550  \\$wh$aChromatography, Liquid
=550  \\$wh$aChromatography, Micellar Electrokinetic Capillary
=550  \\$wh$aChromatography, Supercritical Fluid
=667  \\$aGEN: prefer specifics; NIM; on Sephadex G = GEL FILTRATION see CHROMATOGRAPHY, GEL; on DEAE Sephadex = CHROMATOGRAPHY, ION EXCHANGE; DF: CHROMATOGR
=680  \\$iTechniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts.
=688  \\$a66
=750  \0$aChromatographic analysis$5IEN$0(DLC)sh 85025334

=LDR  00816cz  a2200241n  4500
=001  9880363294502441
=005  20141212200047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x180
=072  \\$aD12.$x776.$x664.$x224
=072  \\$aG5.$x360.$x160.$x180
=150  \\$aChromatin
=450  \\$wnnna$aChromatins
=550  \\$wg$aChromosome Structures
=550  \\$wg$aNucleoproteins
=550  \\$wh$aEuchromatin
=550  \\$wh$aHeterochromatin
=550  \\$wh$aNucleosomes
=680  \\$iThe material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell.
=688  \\$a72
=750  \0$aChromatin$5IEN$0(DLC)sh 85025333

=LDR  00753cz  a2200229n  4500
=001  9880363294602441
=005  20141212200047.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002841
=035  \\$aCAZ5998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x660.$x250.$x110
=150  \\$aChromatiaceae
=450  \\$aBacteria, Purple Sulfur
=450  \\$aPurple Sulfur Bacteria
=550  \\$wg$aGammaproteobacteria
=550  \\$wh$aChromatium
=550  \\$wh$aHalothiobacillus
=550  \\$wh$aThiocapsa
=680  \\$iA family of phototrophic purple sulfur bacteria that deposit globules of elemental sulfur inside their cells. They are found in diverse aquatic environments.
=688  \\$a1976
=750  \0$aChromatiaceae$5IEN$0(DLC)sh 90003534

=LDR  00591cz  a2200205n  4500
=001  9880363294702441
=005  20141212200046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002840
=035  \\$aCAZ5997M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x220.$x150
=072  \\$aD1.$x248.$x497.$x158.$x235
=150  \\$aChromates
=450  \\$aChromic Acid$5IEN-M
=550  \\$wg$aAnions
=550  \\$wg$aChromium Compounds
=550  \\$wh$aPotassium Dichromate
=680  \\$iSalts of chromic acid containing the CrO(2-)4 radical.
=750  \0$aChromic acid$0(DLC)sh2013000232$5IEN-M

=LDR  01182cz  a2200313n  4500
=001  9880363294802441
=005  20141212200045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002835
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x188
=150  \\$aChristianity
=450  \\$wnnna$aChristian Ethic
=450  \\$wnnna$aChristian Ethics
=450  \\$wnnna$aEthic, Christian
=450  \\$wnnna$aEthics, Christian
=450  \\$aStigmata
=550  \\$wg$aReligion
=550  \\$wh$aCatholicism
=550  \\$wh$aChristian Science
=550  \\$wh$aChurch of Jesus Christ of Latter-day Saints
=550  \\$wh$aEastern Orthodoxy
=550  \\$wh$aJehovah's Witnesses
=550  \\$wh$aProtestantism
=550  \\$wh$aSaints
=667  \\$aspecify geog if pertinent
=680  \\$iThe religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men's salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. (From Webster, 3d ed)
=688  \\$a1963
=750  \0$aChristianity$5IEN$0(DLC)sh 85025219

=LDR  00843cz  a2200229n  4500
=001  9880363294902441
=005  20141212200044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002834
=035  \\$aCAZ5991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x188.$x431
=150  \\$aChristian Science
=450  \\$wnnna$aChristian Scientist
=450  \\$wnnna$aChristian Scientists
=450  \\$wnnna$aScience, Christian
=450  \\$wnnna$aScientist, Christian
=450  \\$wnnna$aScientists, Christian
=550  \\$wg$aChristianity
=667  \\$aspecify geographic location if pertinent
=680  \\$iA religion founded by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist. It includes the practice of spiritual healing.
=750  \0$aChristian Science$5IEN$0(DLC)sh 85025190

=LDR  00725cz  a2200241n  4500
=001  9880363295002441
=005  20141212200044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002833
=035  \\$aCAZ5990HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x160.$x478
=072  \\$aC11.$x941.$x879.$x780.$x900.$x300
=150  \\$aChoroiditis
=450  \\$wnnna$aChoroiditides
=550  \\$wg$aChoroid Diseases
=550  \\$wg$aUveitis, Posterior
=550  \\$wh$aChorioretinitis
=550  \\$wh$aPars Planitis
=667  \\$aof the eye, not of the choroid plexus; consider also CHORIORETINITIS
=680  \\$iInflammation of the choroid.
=688  \\$a66(64)
=750  \0$aChoroiditis$5IEN-M$0(DLC)sh 94006541

=LDR  01022cz  a2200229n  4500
=001  9880363295102441
=005  20141212192106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002831
=035  \\$aCAZ5988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x276.$x298
=150  \\$aChoroid Plexus
=450  \\$wnnna$aChorioid Plexus
=450  \\$wnnna$aChoroideus, Plexus
=450  \\$wnnna$aPlexus, Chorioid
=450  \\$wnnna$aPlexus, Choroid
=450  \\$wnnna$aPlexus Choroideus
=550  \\$wg$aCerebral Ventricles
=667  \\$ain the brain: do not confuse with CHOROID (in the eye); diseases: coordinate IM with BRAIN DISEASES (IM); neoplasms = CHOROID PLEXUS NEOPLASMS;  / radiogr: coordinate with CEREBRAL VENTRICULOGRAPHY
=680  \\$iA villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.
=750  \0$aChoroid plexus$5IEN$0(DLC)sh 85024757

=LDR  00717cz  a2200193n  4500
=001  9880363295202441
=005  20141212200043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002829
=035  \\$aCAZ5986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x894.$x223
=150  \\$aChoroid
=450  \\$wnnna$aChoroids
=550  \\$wg$aUvea
=550  \\$wh$aBruch Membrane
=667  \\$ain the eye: do not confuse with CHOROID PLEXUS (in the brain); inflammation = CHOROIDITIS or CHORIORETINITIS; /blood supply consider also CILIARY ARTERIES
=680  \\$iThe thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
=750  \0$aChoroid$5IEN$0(DLC)sh 85024755

=LDR  00824cz  a2200229n  4500
=001  9880363295302441
=005  20141212200042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002825
=035  \\$aCAZ5982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x773.$x348
=072  \\$aC11.$x941.$x160.$x478.$x400
=072  \\$aC11.$x941.$x879.$x780.$x900.$x300.$x318
=150  \\$aChorioretinitis
=450  \\$wnnna$aChorioretinitides
=550  \\$wg$aChoroiditis
=550  \\$wg$aRetinitis
=550  \\$aChoroiditis
=667  \\$ainflamm of choroid & retina
=680  \\$iInflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
=750  \0$aChorioretinitis$5IEN$0(DLC)sh 85024753

=LDR  01989cz  a2200529n  4500
=001  9880363295402441
=005  20141212210910.0
=008  880421\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015193
=035  \\$aCAZ5981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100.$x149
=072  \\$aE1.$x370.$x225.$x500.$x384.$x150
=072  \\$aE1.$x370.$x225.$x998.$x54.$x149
=072  \\$aE1.$x370.$x378.$x630.$x150
=072  \\$aE1.$x370.$x388.$x100.$x150
=072  \\$aE4.$x74.$x149
=072  \\$aE4.$x665.$x160
=072  \\$aE5.$x200.$x500.$x384.$x100.$x149
=072  \\$aE5.$x200.$x500.$x384.$x150
=072  \\$aE5.$x200.$x998.$x54.$x149
=072  \\$aE5.$x200.$x998.$x165
=072  \\$aE5.$x242.$x384.$x100.$x149
=072  \\$aE5.$x242.$x384.$x150
=150  \\$aChorionic Villi Sampling
=450  \\$wnnna$aBiopsies, Chorionic Villi
=450  \\$aBiopsy, Chorionic Villi
=450  \\$wnnna$aChorionic Villi Biopsies
=450  \\$wnnna$aChorionic Villi Biopsy
=450  \\$wnnna$aChorionic Villi Samplings
=450  \\$wnnna$aChorionic Villus Sampling
=450  \\$wnnna$aChorionic Villus Samplings
=450  \\$wnnna$aSampling, Chorionic Villi
=450  \\$wnnna$aSampling, Chorionic Villus
=450  \\$wnnna$aSamplings, Chorionic Villi
=450  \\$wnnna$aSamplings, Chorionic Villus
=550  \\$wg$aBiopsy
=550  \\$wg$aCytodiagnosis
=550  \\$wg$aPrenatal Diagnosis
=550  \\$wg$aPunctures
=550  \\$wg$aSpecimen Handling
=550  \\$aAmniocentesis
=550  \\$aFetal Diseases
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.
=688  \\$a89
=750  \0$aChorionic villus sampling$5IEN$0(DLC)sh 90003772

=LDR  01027cz  a2200289n  4500
=001  9880363295502441
=005  20141212200042.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002824
=035  \\$aCAZ5980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x284.$x473.$x200
=072  \\$aA16.$x254.$x750.$x473.$x200
=072  \\$aA16.$x710.$x189
=150  \\$aChorionic Villi
=450  \\$wnnna$aChorionic Villus
=450  \\$aPlacental Villi
=450  \\$wnnna$aPlacental Villus
=450  \\$wnnna$aVilli, Chorionic
=450  \\$wnnna$aVilli, Placental
=450  \\$wnnna$aVillus, Chorionic
=450  \\$wnnna$aVillus, Placental
=550  \\$wg$aChorion
=550  \\$wg$aPlacenta
=680  \\$iThe threadlike, vascular projections of the chorion. Chorionic villi may be free or embedded within the DECIDUA forming the site for exchange of substances between fetal and maternal blood (PLACENTA).
=688  \\$a85(75); was see under PLACENTA 1975-84
=750  \0$aChorionic villi$5IEN$0(DLC)sh 85024752

=LDR  00865cz  a2200217n  4500
=001  9880363295602441
=005  20141212200041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002823
=035  \\$aCAZ5979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x284.$x473
=072  \\$aA16.$x254.$x750.$x473
=150  \\$aChorion
=450  \\$wnnna$aChorions
=550  \\$wg$aExtraembryonic Membranes
=550  \\$wh$aChorionic Villi
=550  \\$aChorioallantoic Membrane
=680  \\$iThe outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA.
=688  \\$a78(75); was see under FETAL MEMBRANES 1963-77
=750  \0$aChorion$5IEN$0(DLC)sh 85024748

=LDR  01425cz  a2200265n  4500
=001  9880363295702441
=005  20141212200041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x955.$x207
=072  \\$aC4.$x557.$x465.$x955.$x416.$x202
=072  \\$aC4.$x557.$x470.$x200.$x25.$x455
=072  \\$aC4.$x850.$x908.$x416.$x186
=072  \\$aC13.$x703.$x720.$x949.$x416.$x218
=150  \\$aChoriocarcinoma
=450  \\$wnnna$aChoriocarcinomas
=550  \\$wg$aAdenocarcinoma
=550  \\$wg$aGestational Trophoblastic Disease
=550  \\$wg$aTrophoblastic Neoplasms
=550  \\$wh$aChoriocarcinoma, Non-gestational
=550  \\$wh$aTrophoblastic Tumor, Placental Site
=667  \\$acoord IM with UTERINE NEOPLASMS (IM) + FEMALE + PREGNANCY if in the female or TESTICULAR NEOPLASMS (IM) + MALE if in the male or other organ/neopl term applicable
=680  \\$iA malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
=750  \0$aChoriocarcinoma$5IEN$0(DLC)sh 85024747

=LDR  04078cz  a2201021n  4500
=001  9880363295802441
=005  20141212200040.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002819
=035  \\$aCAZ5975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662.$x262.$x249
=072  \\$aC10.$x597.$x350.$x250
=072  \\$aC23.$x888.$x592.$x350.$x250
=150  \\$aChorea
=450  \\$wnnna$aBenign Hereditary Chorea
=450  \\$wnnna$aBenign Hereditary Choreas
=450  \\$wnnna$aChorea, Benign Hereditary
=450  \\$wnnna$aChorea, Chronic Progressive
=450  \\$wnnna$aChorea Disorder
=450  \\$wnnna$aChorea Disorders
=450  \\$wnnna$aChorea, Hereditary
=450  \\$wnnna$aChorea, Rheumatic
=450  \\$wnnna$aChorea, Senile
=450  \\$wnnna$aChorea, Sydenham
=450  \\$wnnna$aChorea, Sydenham's
=450  \\$wnnna$aChorea Syndrome
=450  \\$wnnna$aChorea Syndromes
=450  \\$wnnna$aChoreas
=450  \\$wnnna$aChoreas, Benign Hereditary
=450  \\$wnnna$aChoreas, Chronic Progressive
=450  \\$wnnna$aChoreas, Hereditary
=450  \\$wnnna$aChoreas, Rheumatic
=450  \\$wnnna$aChoreas, Senile
=450  \\$wnnna$aChoreas, Sydenham
=450  \\$wnnna$aChoreatic Disorder
=450  \\$aChoreatic Disorders
=450  \\$wnnna$aChoreatic Syndrome
=450  \\$wnnna$aChoreatic Syndromes
=450  \\$wnnna$aChoreic Movement
=450  \\$wnnna$aChoreic Movements
=450  \\$aChoreiform Movement
=450  \\$wnnna$aChoreiform Movements
=450  \\$wnnna$aChronic Progressive Chorea
=450  \\$wnnna$aChronic Progressive Choreas
=450  \\$wnnna$aDisorder, Chorea
=450  \\$wnnna$aDisorder, Choreatic
=450  \\$wnnna$aDisorders, Chorea
=450  \\$wnnna$aDisorders, Choreatic
=450  \\$wnnna$aDyskinesia, Paroxysmal
=450  \\$wnnna$aDyskinesias, Paroxysmal
=450  \\$wnnna$aHereditary Chorea
=450  \\$wnnna$aHereditary Chorea, Benign
=450  \\$wnnna$aHereditary Choreas
=450  \\$wnnna$aHereditary Choreas, Benign
=450  \\$wnnna$aHereditary Progressive Chorea Without Dementia
=450  \\$wnnna$aMovement, Choreic
=450  \\$wnnna$aMovement, Choreiform
=450  \\$wnnna$aMovements, Choreic
=450  \\$wnnna$aMovements, Choreiform
=450  \\$wnnna$aParoxysmal Dyskinesia
=450  \\$wnnna$aParoxysmal Dyskinesias
=450  \\$wnnna$aProgressive Chorea, Chronic
=450  \\$wnnna$aProgressive Choreas, Chronic
=450  \\$wnnna$aRheumatic Chorea
=450  \\$wnnna$aRheumatic Choreas
=450  \\$wnnna$aSenile Chorea
=450  \\$wnnna$aSenile Choreas
=450  \\$wnnna$aSt. Vitus Dance
=450  \\$wnnna$aSt. Vitus's Dance
=450  \\$wnnna$aSt. Vituss Dance
=450  \\$wnnna$aSt. Vitus's Dances
=450  \\$wnnna$aSydenham Chorea
=450  \\$wnnna$aSydenham Choreas
=450  \\$wnnna$aSydenham's Chorea
=450  \\$wnnna$aSydenhams Chorea
=450  \\$wnnna$aSyndrome, Chorea
=450  \\$wnnna$aSyndrome, Choreatic
=450  \\$wnnna$aSyndromes, Chorea
=450  \\$wnnna$aSyndromes, Choreatic
=550  \\$wg$aDyskinesias
=550  \\$wh$aChorea Gravidarum
=550  \\$wh$aHuntington Disease
=550  \\$wh$aNeuroacanthocytosis
=667  \\$achoreoathetosis = CHOREA (IM) + ATHETOSIS (IM); MORVAN'S CHOREA see MYOKYMIA and CHOREATIC DISORDERS are also available
=680  \\$iInvoluntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES.
=688  \\$a1963; for CHOREATIC DISORDERS; CHOREA, BENIGN HERIDITARY; CHOREA, CHRONIC PROGRESSIVE; CHOREA, RHEUMATIC; CHOREA, SENILE; DYSKINESIAS, PAROXYSMAL; & HEREDITARY CHOREA use CHOREATIC DISORDERS 2000-2007
=750  \0$aChorea$0(DLC) sh 85024740$5IEN

=LDR  00720cz  a2200181n  4500
=001  9880363295902441
=005  20141212200038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002817
=035  \\$aCAZ5974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x220
=150  \\$aChordoma
=450  \\$wnnna$aChordomas
=550  \\$wg$aNeoplasms, Germ Cell and Embryonal
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)
=750  \0$aChordoma$5IEN$0(DLC)sh 85024739

=LDR  00886cz  a2200193n  4500
=001  9880363296002441
=005  20141212200038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002815
=035  \\$aCAZ5972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510.$x240
=150  \\$aChordae Tendineae
=450  \\$wnnna$aTendineae, Chordae
=550  \\$wg$aHeart Valves
=550  \\$aPapillary Muscles
=667  \\$afor disease, coord IM with HEART VALVE DISEASES (IM); PAPILLARY MUSCLES is also available but read MeSH definition; false tendons: index PURKINJE FIBERS but see note there
=680  \\$iThe tendinous cords that connect each cusp of the two atrioventricular HEART VALVES to appropriate PAPILLARY MUSCLES in the HEART VENTRICLES, preventing the valves from reversing themselves when the ventricles contract.
=750  \0$aChordae tendineae$5IEN-M$0(DLC)sh 94002033

=LDR  01017cz  a2200217n  4500
=001  9880363296102441
=005  20141212200037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002812
=035  \\$aCAZ5969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x265
=150  \\$aChondroma
=450  \\$wnnna$aChondromas
=450  \\$aEnchondroma
=450  \\$wnnna$aEnchondromas
=550  \\$wg$aNeoplasms, Connective Tissue
=550  \\$wh$aChondromatosis
=667  \\$asolitary; multiple = CHONDROMATOSIS; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); do not confuse X ref ENCHONDROMA with ENCHONDROMATOSIS
=680  \\$iA benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed)
=750  \0$aEnchondroma$5IEN$0(DLC)sh 85042985

=LDR  02447cz  a2200541n  4500
=001  9880363296202441
=005  20141212200036.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002809
=035  \\$aCAZ5966M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x373.$x200.$x300
=150  \\$aChondroitin Sulfates
=450  \\$wnnna$aBlutal
=450  \\$aChondroitin 4-Sulfate
=450  \\$wnnna$aChondroitin 4 Sulfate
=450  \\$wnnna$aChondroitin 4-Sulfate, Aluminum Salt
=450  \\$wnnna$aChondroitin 4 Sulfate, Aluminum Salt
=450  \\$wnnna$aChondroitin 4-Sulfate, Potassium Salt
=450  \\$wnnna$aChondroitin 4 Sulfate, Potassium Salt
=450  \\$aChondroitin 6-Sulfate
=450  \\$wnnna$aChondroitin 6 Sulfate
=450  \\$wnnna$aChondroitin 6-Sulfate, Potassium Salt
=450  \\$wnnna$aChondroitin 6 Sulfate, Potassium Salt
=450  \\$wnnna$aChondroitin 6-Sulfate, Sodium Salt
=450  \\$wnnna$aChondroitin 6 Sulfate, Sodium Salt
=450  \\$wnnna$aChondroitin Sulfate
=450  \\$wnnna$aChondroitin Sulfate 4-Sulfate, Sodium Salt
=450  \\$wnnna$aChondroitin Sulfate 4 Sulfate, Sodium Salt
=450  \\$aChondroitin Sulfate A
=450  \\$aChondroitin Sulfate C
=450  \\$wnnna$aChondroitin Sulfate, Calcium Salt
=450  \\$wnnna$aChondroitin Sulfate, Iron (+3) Salt
=450  \\$wnnna$aChondroitin Sulfate, Iron Salt
=450  \\$wnnna$aChondroitin Sulfate, Potassium Salt
=450  \\$wnnna$aChondroitin Sulfate, Sodium
=450  \\$wnnna$aChondroitin Sulfate, Sodium Salt
=450  \\$wnnna$aChondroitin Sulfate, Zinc Salt
=450  \\$wnnna$aChonsurid
=450  \\$wnnna$aSodium Chondroitin Sulfate
=450  \\$wnnna$aSulfate, Chondroitin
=450  \\$wnnna$aSulfate, Sodium Chondroitin
=450  \\$wnnna$aSulfates, Chondroitin
=450  \\$wnnna$aTranslagen
=550  \\$wg$aChondroitin
=680  \\$iDerivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
=688  \\$a1991(1976); for TRANSLAGEN use CHONDROITIN SULFATE (NM) 1991-2000
=750  \0$aChondroitin sulfates$0(DLC)sh2007006045$5IEN-M

=LDR  01153cz  a2200301n  4500
=001  9880363296302441
=005  20181210155236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002805
=035  \\$aCAZ5962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x264
=072  \\$aC5.$x550.$x354.$x250
=150  \\$aChondrocalcinosis
=450  \\$aCalcium Pyrophosphate Dihydrate Deposition Disease
=450  \\$aCalcium Pyrophosphate Dihydrate Deposition
=450  \\$wnnna$aChondrocalcinoses
=450  \\$aPseudogout
=550  \\$wg$aArthritis
=550  \\$wg$aCrystal Arthropathies
=550  \\$wh$aRotator Cuff Tear Arthropathy
=550  \\$aCalcinosis
=550  \\$aCalcium Pyrophosphate
=550  \\$aGout
=667  \\$aa form of arthritis; note X ref: do not index under CALCIUM PYROPHOSPHATE unless particularly discussed
=680  \\$iPresence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. (Dorland, 27th ed)
=688  \\$a72
=750  \0$aChondrocalcinosis$5IEN$0(DLC)sh 85024677

=LDR  01070cz  a2200181n  4500
=001  9880363296402441
=005  20141212200034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002804
=035  \\$aCAZ5961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x250
=150  \\$aChondroblastoma
=450  \\$wnnna$aChondroblastomas
=550  \\$wg$aNeoplasms, Connective Tissue
=667  \\$abenign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS or precoord organ/neopl term (IM)
=680  \\$iA usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846)
=750  \0$aChondroblastoma$5IEN$0(DLC)sh 85024676

=LDR  00760cz  a2200241n  4500
=001  9880363296502441
=005  20141212200034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002802
=035  \\$aCAZ5959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x170
=150  \\$aCholinesterases
=450  \\$wnnna$aAcylcholineacylhydrolase
=450  \\$wnnna$aCholase
=450  \\$wnnna$aCholinesterase
=550  \\$wg$aCarboxylic Ester Hydrolases
=550  \\$wh$aAcetylcholinesterase
=550  \\$wh$aButyrylcholinesterase
=550  \\$wh$aPseudocholinesterase
=667  \\$areactivation: index under CHOLINESTERASE REACTIVATORS
=688  \\$a75; was CHOLINESTERASE 1963-74
=750  \0$aCholinesterases$5IEN$0(DLC)sh 85024659

=LDR  02637cz  a2200505n  4500
=001  9880363296602441
=005  20141212200033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002800
=035  \\$aCAZ5957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x275
=072  \\$aD27.$x505.$x519.$x625.$x120.$x300
=072  \\$aD27.$x505.$x696.$x577.$x120.$x300
=150  \\$aCholinesterase Inhibitors
=450  \\$aAcetylcholinesterase$xantagonists & inhibitors
=450  \\$aAcetylcholinesterase Inhibitors
=450  \\$wnnna$aAgents, Anticholinesterase
=450  \\$wnnna$aAnti-Cholinesterases
=450  \\$wnnna$aAnti Cholinesterases
=450  \\$aAnticholinesterase Agents
=450  \\$wnnna$aAnticholinesterase Drugs
=450  \\$wnnna$aAnticholinesterases
=450  \\$aButyrylcholinesterase$xantagonists & inhibitors
=450  \\$wnnna$aCholinesterase Inhibitors, Irreversible
=450  \\$wnnna$aCholinesterase Inhibitors, Reversible
=450  \\$aCholinesterases$xantagonists & inhibitors
=450  \\$wnnna$aDrugs, Anticholinesterase
=450  \\$wnnna$aInhibitors, Acetylcholinesterase
=450  \\$wnnna$aInhibitors, Cholinesterase
=450  \\$wnnna$aInhibitors, Irreversible Cholinesterase
=450  \\$wnnna$aInhibitors, Reversible Cholinesterase
=450  \\$wnnna$aIrreversible Cholinesterase Inhibitors
=450  \\$aPseudocholinesterase$xantagonists & inhibitors
=450  \\$wnnna$aReversible Cholinesterase Inhibitors
=550  \\$wg$aCholinergic Agents
=550  \\$wg$aEnzyme Inhibitors
=550  \\$aInsecticides
=550  \\$aMiotics
=550  \\$aOrganophosphorus Compounds
=550  \\$aParasympathomimetics
=667  \\$aDF: CHOLINESTERASE INHIB
=680  \\$iDrugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.
=688  \\$a65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE & CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 (PHOSPHORUS POISONS, ORGANIC deleted 1965)
=750  \0$aCholinesterase inhibitors$5IEN$0(DLC)sh 85024658

=LDR  00857cz  a2200265n  4500
=001  9880363296702441
=005  20141212192104.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002799
=035  \\$aCAZ5956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x542.$x234
=072  \\$aA11.$x671.$x501.$x234
=150  \\$aCholinergic Fibers
=450  \\$wnnna$aCholinergic Fiber
=450  \\$wnnna$aFiber, Cholinergic
=450  \\$wnnna$aFibers, Cholinergic
=550  \\$wg$aNerve Fibers
=550  \\$wh$aAutonomic Fibers, Preganglionic
=550  \\$wh$aParasympathetic Fibers, Postganglionic
=550  \\$aCholinergic Neurons
=667  \\$aCHOLINERGIC NEURONS is also available
=680  \\$iNerve fibers liberating acetylcholine at the synapse after an impulse.
=688  \\$a77
=750  \0$aCholinergic mechanisms$5IEN$0(DLC)sh 86004795

=LDR  01731cz  a2200505n  4500
=001  9880363296802441
=005  20141212200030.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002794
=035  \\$aCAZ5951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x211
=072  \\$aD2.$x92.$x63.$x291.$x211
=072  \\$aD2.$x92.$x877.$x883.$x333
=072  \\$aD2.$x675.$x276.$x232
=150  \\$aCholine
=450  \\$wnnna$a2-Hydroxy-N,N,N-trimethylethanaminium
=450  \\$wnnna$aBitartrate, Choline
=450  \\$aBursine
=450  \\$wnnna$aChloride, Choline
=450  \\$wnnna$aCholine Bitartrate
=450  \\$wnnna$aCholine Chloride
=450  \\$wnnna$aCholine Citrate
=450  \\$wnnna$aCholine Hydroxide
=450  \\$wnnna$aCholine O-Sulfate
=450  \\$wnnna$aCholine O Sulfate
=450  \\$wnnna$aCitrate, Choline
=450  \\$aFagine
=450  \\$wnnna$aHydroxide, Choline
=450  \\$wnnna$aO-Sulfate, Choline
=450  \\$aVidine
=550  \\$wg$aEthanolamines
=550  \\$wg$aQuaternary Ammonium Compounds
=550  \\$wg$aTrimethyl Ammonium Compounds
=550  \\$wh$aBenzoylcholine
=550  \\$wh$aCarbachol
=550  \\$wh$aCytidine Diphosphate Choline
=550  \\$wh$aPhosphorylcholine
=550  \\$wh$aPlatelet Activating Factor
=550  \\$wh$aPropylbenzilylcholine Mustard
=550  \\$wh$aSuccinylcholine
=550  \\$wh$aThiocholine
=667  \\$a/biosyn /physiol permitted
=680  \\$iA basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.
=750  \0$aCholine$5IEN$0(DLC)sh 85024656

=LDR  00706cz  a2200229n  4500
=001  9880363296902441
=005  20141212200029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002791
=035  \\$aCAZ5948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x347
=072  \\$aD10.$x570.$x938.$x208.$x222
=150  \\$aCholesterol, Dietary
=450  \\$aDietary Cholesterol
=550  \\$wg$aCholesterol
=550  \\$wg$aDietary Fats
=550  \\$aDiet, Atherogenic
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind
=680  \\$iCholesterol present in food, especially in animal products.
=688  \\$a73
=750  \0$aFood$xCholesterol content$5IEN-M$0(DLC)sh 85050190

=LDR  01552cz  a2200373n  4500
=001  9880363297002441
=005  20141212200029.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002790
=035  \\$aCAZ5947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x453.$x915.$x200
=072  \\$aD8.$x811.$x682.$x690.$x708.$x170.$x915.$x200
=072  \\$aD8.$x811.$x682.$x690.$x708.$x783.$x200
=072  \\$aD12.$x776.$x422.$x220.$x453.$x915.$x200
=150  \\$aCholesterol 7-alpha-Hydroxylase
=450  \\$wnnna$aCholesterol 7 alpha Hydroxylase
=450  \\$wnnna$aCholesterol 7-alpha-Monooxygenase
=450  \\$wnnna$aCholesterol 7 alpha Monooxygenase
=450  \\$wnnna$aCholesterol-7-Hydroxylase
=450  \\$wnnna$aCholesterol 7 Hydroxylase
=450  \\$wnnna$aCholesterol 7alpha-Hydroxylase
=450  \\$wnnna$aCholesterol 7alpha Hydroxylase
=450  \\$wnnna$aCYP 7
=450  \\$wnnna$aCYP 7A
=450  \\$aCYP7
=450  \\$aCYP7A
=450  \\$aCytochrome P-450 CYP7
=450  \\$wnnna$aCytochrome P 450 CYP7
=450  \\$wnnna$aCytochrome P450 7
=550  \\$wg$aSteroid Hydroxylases
=680  \\$iA membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.
=688  \\$a2003 (1975)
=750  \0$aCholesterol hydroxylase$5IEN-M$0(DLC)sh 86001362

=LDR  01301cz  a2200349n  4500
=001  9880363297102441
=005  20180928124134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002784
=035  \\$aCAZ5940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x210.$x500.$x247.$x222.$x284
=072  \\$aD4.$x210.$x500.$x247.$x808.$x197
=072  \\$aD10.$x570.$x938.$x208
=150  \\$aCholesterol
=450  \\$wnnna$aEpicholesterol
=550  \\$wg$aCholestenes
=550  \\$wg$aSterols
=550  \\$wh$a19-Iodocholesterol
=550  \\$wh$aAzacosterol
=550  \\$wh$aCholestanol
=550  \\$wh$aCholesterol, Dietary
=550  \\$wh$aCholesterol Esters
=550  \\$wh$aCholesterol, HDL
=550  \\$wh$aCholesterol, LDL
=550  \\$wh$aCholesterol, VLDL
=550  \\$wh$aDehydrocholesterols
=550  \\$wh$aOxysterols
=667  \\$aGEN or unspecified; prefer specifics; /biosyn /physiol permitted; /blood: consider also HYPERCHOLESTEROLEMIA & specifics; cholesterol granuloma = CHOLESTEROL + GRANULOMA, FOREIGN-BODY
=680  \\$iThe principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.
=688  \\$a/blood was BLOOD CHOLESTEROL 1963-67
=750  \0$aCholesterol$0(DLC) sh 85024654$5IEN

=LDR  00866cz  a2200193n  4500
=001  9880363297202441
=005  20141212200025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002781
=035  \\$aCAZ5937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x428.$x260
=150  \\$aCholesteatoma
=450  \\$wnnna$aCholesteatomas
=550  \\$wg$aKeratosis
=550  \\$wh$aCholesteatoma, Middle Ear
=667  \\$acoordinate IM with organ/disease (IM) but CHOLESTEATOMA, MIDDLE EAR is available
=680  \\$iA non-neoplastic mass of keratin-producing squamous EPITHELIUM, frequently occurring in the MENINGES; bones of the skull, and most commonly in the MIDDLE EAR and MASTOID region. Cholesteatoma can be congenital or acquired. Cholesteatoma is not a tumor nor is it associated with high CHOLESTEROL.
=750  \0$aCholesteatoma$5IEN$0(DLC)sh 85024653

=LDR  01091cz  a2200229n  4500
=001  9880364550302441
=005  20150601150155.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x238.$x235
=072  \\$aC19.$x246.$x99.$x625
=150  \\$aDiabetic Cardiomyopathies
=450  \\$wnnna$aCardiomyopathies, Diabetic
=450  \\$wnnna$aCardiomyopathy, Diabetic
=450  \\$wnnna$aDiabetic Cardiomyopathy
=550  \\$wg$aCardiomyopathies
=550  \\$wg$aDiabetes Complications
=667  \\$acoordinate IM with specific heart disease (IM) + specific type of diabetes mellitus (IM) if pertinent
=680  \\$iDiabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
=688  \\$a2011
=750  \0$aDiabetic cardiomyopathies$0(DLC)sh2014002357$5IEN-M

=LDR  01246cz  a2200385n  4500
=001  9880364550402441
=005  20141212221952.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x51.$x479.$x258
=072  \\$aJ1.$x637.$x87.$x500.$x254
=150  \\$aArtificial Cells
=450  \\$wnnna$aArtificial Cell
=450  \\$wnnna$aArtificial Organelle
=450  \\$wnnna$aArtificial Organelles
=450  \\$wnnna$aCell, Artificial
=450  \\$wnnna$aCell, Synthetic
=450  \\$wnnna$aCells, Artificial
=450  \\$wnnna$aCells, Synthetic
=450  \\$wnnna$aOrganelle, Artificial
=450  \\$wnnna$aOrganelle, Synthetic
=450  \\$wnnna$aOrganelles, Artificial
=450  \\$wnnna$aOrganelles, Synthetic
=450  \\$wnnna$aProtocell
=450  \\$wnnna$aProtocells
=450  \\$wnnna$aSynthetic Cell
=450  \\$wnnna$aSynthetic Cells
=450  \\$wnnna$aSynthetic Organelle
=450  \\$wnnna$aSynthetic Organelles
=550  \\$wg$aMembranes, Artificial
=550  \\$aBlood Substitutes
=680  \\$iChemically synthesized structures which functionally resemble natural cells.
=688  \\$a2011
=750  \0$aArtificial cells$0(DLC) sh 90004774$5IEN-M

=LDR  00821cz  a2200193n  4500
=001  9880364550502441
=005  20141212221952.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058027
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x504
=072  \\$aH2.$x403.$x690.$x754
=150  \\$aNeuropsychiatry
=550  \\$wg$aPsychiatry
=550  \\$aNeuropsychology
=667  \\$aspecialty only
=680  \\$iA subfield of psychiatry that emphasizes the somatic substructure on which mental operations and emotions are based, and the functional or organic disturbances of the central nervous system that give rise to, contribute to, or are associated with mental and emotional disorders. (From Campbell's Psychiatric Dictionary, 8th ed.)
=688  \\$a2011
=750  \0$aNeuropsychiatry$0(DLC) sh 85091161$5IEN-M

=LDR  00644cz  a2200193n  4500
=001  9880364550602441
=005  20141212221951.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058025
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x158.$x405
=150  \\$aInterdisciplinary Studies
=450  \\$wnnna$aInterdisciplinary Study
=450  \\$wnnna$aStudies, Interdisciplinary
=450  \\$wnnna$aStudy, Interdisciplinary
=550  \\$wg$aCurriculum
=680  \\$iPrograms of study which span the traditional boundaries of academic scholarship.
=688  \\$a2011
=750  \0$aInterdisciplinary approach in education$0(DLC) sh 85067231$5IEN-M

=LDR  00778cz  a2200229n  4500
=001  9880364550702441
=005  20141212221951.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058016
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x216
=072  \\$aN4.$x452.$x418
=150  \\$aHealth Facility Administration
=450  \\$wnnna$aAdministration, Health Facility
=450  \\$wnnna$aFacility Administration, Health
=450  \\$aHealth Facilities$xorganization & administration
=550  \\$wg$aHealth Facilities
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aHospital Administration
=680  \\$iManagement of the organization of HEALTH FACILITIES.
=688  \\$a2011
=750  \0$aHealth facilities$xAdministration$0(DLC) sh 85059544$5IEN-M

=LDR  00864cz  a2200217n  4500
=001  9880364550802441
=005  20141212221950.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058015
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x350
=072  \\$aN2.$x208
=150  \\$aHealth Communication
=450  \\$wnnna$aCommunication, Health
=450  \\$wnnna$aCommunications, Health
=450  \\$wnnna$aHealth Communications
=550  \\$wg$aCommunication
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=680  \\$iThe transfer of information from experts in the medical and public health fields to patients and the public. The study and use of communication strategies to inform and influence individual and community decisions that enhance health.
=688  \\$a2011
=750  \0$aCommunication in medicine$0(DLC) sh 85029080$5IEN-M

=LDR  01332cz  a2200385n  4500
=001  9880364550902441
=005  20141212221950.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058013
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x399.$x890
=150  \\$aTest Taking Skills
=450  \\$wnnna$aPreparation, Test
=450  \\$wnnna$aPreparations, Test
=450  \\$wnnna$aSkill, Study
=450  \\$wnnna$aSkill, Test Taking
=450  \\$wnnna$aSkills, Study
=450  \\$wnnna$aStrategies, Test Taking
=450  \\$wnnna$aStrategy, Test Taking
=450  \\$wnnna$aStudy Skill
=450  \\$wnnna$aStudy Skills
=450  \\$wnnna$aTest Preparation
=450  \\$wnnna$aTest Preparations
=450  \\$aTest-Taking
=450  \\$wnnna$aTest Taking
=450  \\$wnnna$aTest Taking Skill
=450  \\$wnnna$aTest Taking Strategies
=450  \\$wnnna$aTest Taking Strategy
=450  \\$wnnna$aTest-Takings
=450  \\$aTest Wiseness
=450  \\$wnnna$aWiseness, Test
=550  \\$wg$aEducational Measurement
=680  \\$iSkills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)
=688  \\$a2011
=750  \0$aTest-taking skills$0(DLC) sh 87005816$5IEN-M

=LDR  00874cz  a2200265n  4500
=001  9880364551002441
=005  20141212221949.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058012
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x921
=150  \\$aSmall Business
=450  \\$wnnna$aBusiness, Medium-Sized
=450  \\$wnnna$aBusiness, Small
=450  \\$wnnna$aBusinesses, Medium-Sized
=450  \\$wnnna$aMedium-Sized Business
=450  \\$wnnna$aMedium Sized Business
=450  \\$wnnna$aMedium-Sized Businesses
=450  \\$wnnna$aMicroenterprise
=450  \\$wnnna$aMicroenterprises
=450  \\$wnnna$aSmall Businesses
=550  \\$wg$aCommerce
=680  \\$iFor-profit enterprise with relatively few to moderate number of employees and low to moderate volume of sales.
=688  \\$a2011
=750  \0$aSmall business$0(DLC) sh 85123568$5IEN-M

=LDR  00707cz  a2200157n  4500
=001  9880364551102441
=005  20141212221949.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058010
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x513.$x535
=150  \\$aMillon Clinical Multiaxial Inventory
=550  \\$wg$aPersonality Inventory
=680  \\$iA psychological test consisting of true/false items. It is used as a diagnostic screening or clinical assessment of adults who evidence problematic emotional and interpersonal symptoms or who are undergoing PSYCHOTHERAPY or a psychodiagnostic evaluation.
=688  \\$a2011
=750  \0$aMillon Clinical Multiaxial Inventory$0(DLC) sh 91003915$5IEN-M

=LDR  00923cz  a2200253n  4500
=001  9880364551202441
=005  20141212221949.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058009
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750
=150  \\$aStramenopiles
=450  \\$wnnna$aHeterokont
=450  \\$aHeterokonts
=450  \\$wnnna$aStramenopile
=550  \\$wg$aEukaryota
=550  \\$wh$aChrysophyta
=550  \\$wh$aDiatoms
=550  \\$wh$aOomycetes
=550  \\$wh$aPhaeophyta
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA common name (but used formally) for a group of organisms that are mostly kinds of algae including BACILLARIOPHYTA; OOMYCETES; PHAEOPHYCEAE; and CHRYSOPHYCEAE. They all contain CHLOROPLASTS that are thought to have been derived from the endosymbiosis of ancient RED ALGAE.
=688  \\$a2011
=750  \0$aHeterokontophyta$0(DLC)sh2011002110$5IEN-M

=LDR  00947cz  a2200277n  4500
=001  9880364551302441
=005  20141212221948.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x485
=072  \\$aN2.$x360.$x810.$x485
=150  \\$aGeneral Practitioners
=450  \\$wnnna$aGeneral Practice Physician
=450  \\$wnnna$aGeneral Practice Physicians
=450  \\$wnnna$aGeneral Practitioner
=450  \\$wnnna$aPhysician, General Practice
=450  \\$wnnna$aPhysicians, General Practice
=450  \\$wnnna$aPractice Physicians, General
=450  \\$wnnna$aPractitioner, General
=450  \\$wnnna$aPractitioners, General
=550  \\$wg$aPhysicians
=550  \\$aGeneral Practice
=680  \\$iPhysicians whose practice is not restricted to a specific field of MEDICINE.
=688  \\$a2011
=750  \0$aPhysicians (General practice)$0(DLC) sh 85101634$5IEN

=LDR  00828cz  a2200229n  4500
=001  9880364551402441
=005  20141212221946.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x714
=150  \\$aPosterior Eye Segment
=450  \\$wnnna$aEye Segment, Posterior
=450  \\$wnnna$aEye Segments, Posterior
=450  \\$wnnna$aPosterior Eye Segments
=450  \\$wnnna$aSegment, Posterior Eye
=450  \\$wnnna$aSegments, Posterior Eye
=550  \\$wg$aEye
=550  \\$wh$aVitreous Body
=680  \\$iThe back two-thirds of the eye that includes the anterior hyaloid membrane and all of the optical structures behind it: the VITREOUS HUMOR; RETINA; CHOROID; and OPTIC NERVE.
=688  \\$a2011
=750  \0$aPosterior segment (Eye)$0(DLC) sh 89000351$5IEN-M

=LDR  01285cz  a2200313n  4500
=001  9880364551502441
=005  20141212221945.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x750.$x270.$x500
=150  \\$aCarbon Sequestration
=450  \\$wnnna$aCarbon Sequestration Technique
=450  \\$wnnna$aCarbon Sequestration Techniques
=450  \\$wnnna$aCarbon Sequestrations
=450  \\$wnnna$aCarbon Sink
=450  \\$wnnna$aCarbon Sinks
=450  \\$wnnna$aSequestration, Carbon
=450  \\$wnnna$aSequestration Technique, Carbon
=450  \\$wnnna$aSequestration Techniques, Carbon
=450  \\$wnnna$aSequestrations, Carbon
=450  \\$wnnna$aSink, Carbon
=450  \\$wnnna$aSinks, Carbon
=450  \\$wnnna$aTechnique, Carbon Sequestration
=450  \\$wnnna$aTechniques, Carbon Sequestration
=550  \\$wg$aCarbon Cycle
=680  \\$iAny of several processes for the permanent or long-term artificial or natural capture or removal and storage of carbon dioxide and other forms of carbon, through biological, chemical or physical processes, in a manner that prevents it from being released into the atmosphere.
=688  \\$a2011
=750  \0$aCarbon sequestration$0(DLC) sh 95005769$5IEN-M

=LDR  00935cz  a2200253n  4500
=001  9880364551602441
=005  20141212193141.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776.$x708.$x733
=072  \\$aD27.$x505.$x954.$x578.$x733
=072  \\$aD27.$x720.$x752.$x733
=150  \\$aParenteral Nutrition Solutions
=450  \\$wnnna$aFeeding Solutions, Intravenous
=450  \\$wnnna$aIntravenous Feeding Solutions
=450  \\$wnnna$aSolutions, Intravenous Feeding
=550  \\$wg$aPharmaceutical Solutions
=550  \\$wh$aFat Emulsions, Intravenous
=550  \\$aFood, Formulated
=550  \\$aParenteral Nutrition
=680  \\$iSpecialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS.
=688  \\$a2011
=750  \0$aParenteral solutions$0(DLC) sh 85098003$5IEN-M

=LDR  01121cz  a2200265n  4500
=001  9880364551702441
=005  20141212221944.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057946
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150
=150  \\$aCharophyceae
=450  \\$wnnna$aCharales
=450  \\$wnnna$aCharophyta
=450  \\$wnnna$aCharophyte
=450  \\$aCharophytes
=450  \\$wnnna$aStoneworts
=550  \\$wg$aStreptophyta
=550  \\$wh$aCharaceae
=550  \\$wh$aDesmidiales
=550  \\$wh$aZygnematales
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA group (or class) of aquatic plants, including the streptophyte algae, that are the closest relatives to land plants (EMBRYOPHYTA).
=688  \\$a2011; for CHAROPHYTES and STONEWORTS use CHARACEAE 2004-2010
=750  \0$aCharophyta$0(DLC) sh 85022708$5IEN-M

=LDR  01159cz  a2200325n  4500
=001  9880364551802441
=005  20141212193141.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057929
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x110.$x110.$x45
=072  \\$aE4.$x650.$x110.$x45
=072  \\$aE4.$x680.$x101.$x110.$x45
=150  \\$aArthroplasty, Replacement, Elbow
=450  \\$wnnna$aArthroplasties, Elbow Replacement
=450  \\$wnnna$aArthroplasty, Elbow Replacement
=450  \\$wnnna$aElbow Replacement Arthroplasties
=450  \\$wnnna$aElbow Replacement Arthroplasty
=450  \\$wnnna$aElbow Replacement, Total
=450  \\$wnnna$aElbow Replacements, Total
=450  \\$wnnna$aReplacement Arthroplasties, Elbow
=450  \\$wnnna$aReplacement Arthroplasty, Elbow
=450  \\$wnnna$aReplacement, Total Elbow
=450  \\$wnnna$aReplacements, Total Elbow
=450  \\$wnnna$aTotal Elbow Replacement
=450  \\$wnnna$aTotal Elbow Replacements
=550  \\$wg$aArthroplasty, Replacement
=680  \\$iReplacement of the ELBOW JOINT.
=688  \\$a2011
=750  \0$aTotal elbow replacement$0(DLC) sh 95006317$5IEN-M

=LDR  01187cz  a2200337n  4500
=001  9880364551902441
=005  20170629112202.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x409
=150  \\$aHydrophobic and Hydrophilic Interactions
=450  \\$wnnna$aHydrophilic and Hydrophobic Interactions
=450  \\$wnnna$aHydrophilic Interaction
=450  \\$wnnna$aHydrophilic Interactions
=450  \\$wnnna$aHydrophilicities
=450  \\$wnnna$aHydrophilicity
=450  \\$wnnna$aHydrophobic Interaction
=450  \\$wnnna$aHydrophobic Interactions
=450  \\$wnnna$aHydrophobicities
=450  \\$wnnna$aHydrophobicity
=450  \\$wnnna$aInteraction, Hydrophilic
=450  \\$wnnna$aInteraction, Hydrophobic
=450  \\$wnnna$aInteractions, Hydrophilic
=450  \\$wnnna$aInteractions, Hydrophobic
=550  \\$wg$aChemical Phenomena
=550  \\$wh$aWettability
=667  \\$ado not confuse entry term HYDROPHOBICITY with HYDROPHOBIA see RABIES
=680  \\$iThe thermodynamic interaction between a substance and WATER.
=688  \\$a2011
=750  \0$aHydrophobic surfaces$0(DLC) sh 90003785$5IEN-M

=LDR  01059cz  a2200265n  4500
=001  9880364552002441
=005  20141212221940.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057919
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x80.$x500
=072  \\$aN6.$x850.$x780.$x375.$x349
=150  \\$aBiological Oxygen Demand Analysis
=450  \\$aBiological Oxygen Demand
=450  \\$aBiological Oxygen Demand Analyses
=450  \\$wnnna$aChemical Oxygen Demand
=450  \\$wnnna$aChemical Oxygen Demand Analyses
=450  \\$wnnna$aChemical Oxygen Demand Analysis
=450  \\$wnnna$aDemand, Chemical Oxygen
=450  \\$wnnna$aOxygen Demand, Biological
=450  \\$wnnna$aOxygen Demand, Chemical
=550  \\$wg$aEnvironmental Monitoring
=680  \\$iTesting for the amount of biodegradable organic material in a water sample by measuring the quantity of oxygen consumed by biodegradation of those materials over a specific time period.
=688  \\$a2011
=750  \0$aBiochemical oxygen demand$0(DLC) sh 85014123$5IEN-M

=LDR  01235cz  a2200349n  4500
=001  9880364552102441
=005  20141212221939.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057915
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x307.$x312
=072  \\$aN2.$x421.$x668.$x778.$x500.$x312
=150  \\$aDrug Substitution
=450  \\$wnnna$aDrug Substitutions
=450  \\$wnnna$aDrug Switching
=450  \\$wnnna$aDrug Switchings
=450  \\$wnnna$aGeneric Substitution
=450  \\$wnnna$aGeneric Substitutions
=450  \\$wnnna$aSubstitution, Drug
=450  \\$wnnna$aSubstitution, Generic
=450  \\$wnnna$aSubstitution, Therapeutic
=450  \\$wnnna$aSubstitutions, Drug
=450  \\$wnnna$aSubstitutions, Generic
=450  \\$wnnna$aSubstitutions, Therapeutic
=450  \\$wnnna$aSwitching, Drug
=450  \\$wnnna$aSwitchings, Drug
=450  \\$wnnna$aTherapeutic Substitution
=450  \\$wnnna$aTherapeutic Substitutions
=550  \\$wg$aDrug Prescriptions
=680  \\$iThe practice of replacing one prescribed drug with another that is expected to have the same clinical or psychological effect.
=688  \\$a2011
=750  \0$aDrugs$xGeneric substitution$0(DLC) sh 85039731$5IEN-M

=LDR  01162cz  a2200277n  4500
=001  9880364552302441
=005  20141212221936.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057905
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x242.$x950
=072  \\$aH1.$x770.$x644.$x145.$x512
=150  \\$aStem Cell Research
=450  \\$wnnna$aAdult Stem Cell Research
=450  \\$wnnna$aEmbryonic Stem Cell Research
=450  \\$wnnna$aResearch, Stem Cell
=450  \\$wnnna$aResearchs, Stem Cell
=450  \\$wnnna$aStem Cell Researchs
=550  \\$wg$aBiomedical Research
=550  \\$wg$aCytological Techniques
=550  \\$aEmbryo Research
=550  \\$aStem Cells
=667  \\$aIM for ethical, legal, moral, social, or religious aspects of research on embryos; do not routinely add for research involving stem cells; coordinate with specific type of stem cell if pertinent; note entry term EMBRYONIC STEM CELL RESEARCH: coordinate with EMBRYONIC STEM CELLS but not also with EMBRYO RESEARCH
=680  \\$iExperimentation on STEM CELLS and on the use of stem cells.
=688  \\$a2011
=750  \0$aStem cells$xResearch$0(DLC)sh2006002737$5IEN-M

=LDR  00793cz  a2200217n  4500
=001  9880364552402441
=005  20141212221934.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057894
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x130
=072  \\$aN6.$x230.$x124.$x130
=150  \\$aCoral Reefs
=450  \\$wnnna$aCoral Reef
=450  \\$wnnna$aReef, Coral
=450  \\$wnnna$aReefs, Coral
=550  \\$wg$aEcosystem
=550  \\$aAnthozoa
=680  \\$iMarine ridges composed of living CORALS, coral skeletons, calcareous algae, and other organisms, mixed with minerals and organic matter. They are found most commonly in tropical waters and support other animal and plant life.
=688  \\$a2011
=750  \0$aCoral reefs and islands$0(DLC) sh 85032525$5IEN-M

=LDR  00671cz  a2200205n  4500
=001  9880364552502441
=005  20141212221933.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057890
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x350.$x74
=072  \\$aH1.$x158.$x273.$x343.$x350.$x42
=150  \\$aEpigenomics
=450  \\$wnnna$aEpigenetic
=450  \\$wnnna$aEpigenetics
=450  \\$wnnna$aEpigenomic
=550  \\$wg$aGenomics
=680  \\$iThe systematic study of the global gene expression changes due to EPIGENETIC PROCESSES and not due to DNA base sequence changes.
=688  \\$a2011
=750  \0$aEpigenetics$0(DLC)sh2011005133$5IEN-M

=LDR  00670cz  a2200217n  4500
=001  9880364552602441
=005  20141212221932.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057886
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x642.$x315
=150  \\$aBleaching Agents
=450  \\$wnnna$aAgents, Bleaching
=450  \\$wnnna$aAgents, Whitening
=450  \\$wnnna$aWhitening Agents
=550  \\$wg$aOxidants
=550  \\$wh$aHair Bleaching Agents
=550  \\$wh$aTooth Bleaching Agents
=680  \\$iChemicals that are used to oxidize pigments and thus effect whitening.
=688  \\$a2011
=750  \0$aBleaching materials$0(DLC) sh 85014825$5IEN-M

=LDR  01316cz  a2200397n  4500
=001  9880364552702441
=005  20141212221930.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x192.$x500
=072  \\$aG12.$x450.$x800
=072  \\$aG15.$x602
=150  \\$aPlant Immunity
=450  \\$wnnna$aImmune Response, Plant
=450  \\$wnnna$aImmune Responses, Plant
=450  \\$wnnna$aImmune System, Plant
=450  \\$wnnna$aImmune Systems, Plant
=450  \\$wnnna$aImmunities, Plant
=450  \\$wnnna$aImmunity, Plant
=450  \\$wnnna$aPlant Immune Response
=450  \\$wnnna$aPlant Immune Responses
=450  \\$wnnna$aPlant Immune System
=450  \\$wnnna$aPlant Immune Systems
=450  \\$wnnna$aPlant Immunities
=450  \\$wnnna$aResponse, Plant Immune
=450  \\$wnnna$aResponses, Plant Immune
=450  \\$wnnna$aSystem, Plant Immune
=450  \\$wnnna$aSystems, Plant Immune
=550  \\$wg$aAutoimmunity
=550  \\$wg$aImmunity
=550  \\$wg$aPlant Physiological Phenomena
=550  \\$wh$aDisease Resistance
=680  \\$iThe inherent or induced capacity of plants to withstand or ward off biological attack by pathogens.
=688  \\$a2011
=750  \0$aPlant immunology$0(DLC) sh 86002614$5IEN-M

=LDR  00798cz  a2200217n  4500
=001  9880364552802441
=005  20141212221929.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057850
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x275
=150  \\$aHermaphroditic Organisms
=450  \\$wnnna$aDichogamous Organisms
=450  \\$wnnna$aHeterodichogamous Organisms
=450  \\$wnnna$aProtandrous Organisms
=450  \\$wnnna$aProtogynous Organisms
=550  \\$wg$aOrganism Forms
=667  \\$anatural sex reversal processes are indexed SEX DETERMINATION PROCESSES
=680  \\$iAnimals and plants which have, as their normal mode of reproduction, both male and female sex organs in the same individual.
=688  \\$a2011
=750  \0$aIntersexuality in animals$0(DLC)sh2007005479$5IEN-M

=LDR  01285cz  a2200361n  4500
=001  9880364552902441
=005  20141212221927.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057829
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x906
=150  \\$aSex Reassignment Procedures
=450  \\$wnnna$aGender Change Procedure
=450  \\$wnnna$aGender Change Procedures
=450  \\$wnnna$aGender Reassignment Procedure
=450  \\$wnnna$aGender Reassignment Procedures
=450  \\$wnnna$aProcedure, Gender Change
=450  \\$wnnna$aProcedure, Gender Reassignment
=450  \\$wnnna$aProcedure, Sex Change
=450  \\$wnnna$aProcedure, Sex Reassignment
=450  \\$wnnna$aProcedures, Gender Change
=450  \\$wnnna$aProcedures, Gender Reassignment
=450  \\$wnnna$aProcedures, Sex Change
=450  \\$wnnna$aProcedures, Sex Reassignment
=450  \\$wnnna$aSex Change Procedure
=450  \\$wnnna$aSex Change Procedures
=450  \\$wnnna$aSex Reassignment Procedure
=550  \\$wg$aTherapeutics
=550  \\$wh$aSex Reassignment Surgery
=550  \\$aTranssexualism
=680  \\$iClinical treatments used to change the physiological sexual characteristics of an individual.
=688  \\$a2011
=750  \0$aSex change$0(DLC) sh 85120565$5IEN-M

=LDR  00849cz   2200241n  4500
=001  9880364553002441
=005  20220302163757.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x600
=150  \\$aPets
=450  \\$wnnna$aAnimal, Companion
=450  \\$wnnna$aAnimals, Companion
=450  \\$wnnna$aCompanion Animal
=450  \\$aCompanion Animals
=450  \\$wnnna$aPet
=550  \\$wg$aAnimals, Domestic
=550  \\$aHuman-Animal Bond
=667  \\$acoordinate with specific animal if pertinent
=680  \\$iAnimals kept by humans for companionship and enjoyment, as opposed to DOMESTIC ANIMALS such as livestock or farm animals, which are kept for economic reasons.
=688  \\$a2011; use ANIMALS, DOMESTIC 1983-2010
=750  \0$aPets$0(DLC) sh 85100482$5IEN-M

=LDR  01618cz  a2200373n  4500
=001  9880364553102441
=005  20141212221923.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057791
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130
=150  \\$aCardiac Imaging Techniques
=450  \\$wnnna$aCardiac Imaging Technique
=450  \\$wnnna$aImaging Technique, Cardiac
=450  \\$wnnna$aImaging Technique, Intracardiac
=450  \\$wnnna$aImaging Techniques, Cardiac
=450  \\$wnnna$aImaging Techniques, Intracardiac
=450  \\$wnnna$aIntracardiac Imaging Technique
=450  \\$wnnna$aIntracardiac Imaging Techniques
=450  \\$wnnna$aTechnique, Cardiac Imaging
=450  \\$wnnna$aTechnique, Intracardiac Imaging
=450  \\$wnnna$aTechniques, Cardiac Imaging
=450  \\$wnnna$aTechniques, Intracardiac Imaging
=550  \\$wg$aDiagnostic Imaging
=550  \\$wh$aAngiocardiography
=550  \\$wh$aCardiac-Gated Imaging Techniques
=550  \\$wh$aCoronary Angiography
=550  \\$wh$aEchocardiography
=550  \\$wh$aMyocardial Perfusion Imaging
=550  \\$wh$aRadionuclide Ventriculography
=667  \\$acardioscopy: coordinate CARDIAC IMAGING TECHNIQUES with ENDOSCOPY
=680  \\$iVisualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including ENDOSCOPY (cardiac endoscopy, sometimes refered to as cardioscopy), RADIONUCLIDE IMAGING; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY; or ULTRASONOGRAPHY.
=688  \\$a2011
=750  \0$aHeart$xImaging$0(DLC) sh 87005052$5IEN-M

=LDR  00707cz  a2200229n  4500
=001  9880364553202441
=005  20180323113701.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x132
=150  \\$aCatheters
=450  \\$aCatheter
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aCannula
=550  \\$wh$aCatheter Obstruction
=550  \\$wh$aCatheters, Indwelling
=550  \\$wh$aUrinary Catheters
=550  \\$wh$aVascular Access Devices
=680  \\$iA flexible, tubular device that is used to carry fluids into or from a blood vessel, hollow organ, or body cavity.
=688  \\$a2011
=750  \0$aCatheters$0(DLC) sh 85021026$5IEN

=LDR  01325cz  a2200289n  4500
=001  9880364553302441
=005  20141212221918.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057769
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x719.$x666
=072  \\$aE4.$x928.$x220.$x520.$x610
=150  \\$aTransmyocardial Laser Revascularization
=450  \\$wnnna$aLaser Revascularization, Trans-Myocardial
=450  \\$wnnna$aLaser Revascularization, Transmyocardial
=450  \\$wnnna$aLaser Revascularizations, Transmyocardial
=450  \\$wnnna$aLaser Transmyocardial Revascularization
=450  \\$wnnna$aRevascularization, Laser Transmyocardial
=450  \\$wnnna$aRevascularization, Trans-Myocardial Laser
=450  \\$wnnna$aRevascularization, Transmyocardial Laser
=450  \\$wnnna$aTrans-Myocardial Laser Revascularization
=450  \\$wnnna$aTrans Myocardial Laser Revascularization
=450  \\$wnnna$aTransmyocardial Revascularization, Laser
=550  \\$wg$aMyocardial Revascularization
=680  \\$iA procedure to increase the flow of blood to the MYOCARDIUM by creating transmural channels in the heart wall via the application of laser pulses to epicardial or endocardial surfaces.
=688  \\$a2011
=750  \0$aTransmyocardial laser revascularization$0(DLC) sh 98000373$5IEN-M

=LDR  00694cz  a2200229n  4500
=001  9880364553402441
=005  20180711102621.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057766
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655
=072  \\$aN3.$x623
=150  \\$aPolicy
=450  \\$wnnna$aPolicies
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wg$aSocial Sciences
=550  \\$wh$aFiscal Policy
=550  \\$wh$aSmoke-Free Policy
=550  \\$wh$aSocial Control Policies
=680  \\$iA course or method of action selected to guide and determine present and future decisions.
=688  \\$a2011
=750  \0$aPolicy sciences$0(DLC) sh 85104264$5IEN

=LDR  01390cz  a2200457n  4500
=001  9880364553502441
=005  20141212221914.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x449
=150  \\$aPlant Weeds
=450  \\$wnnna$aAnnual Weed
=450  \\$wnnna$aAnnual Weeds
=450  \\$wnnna$aInvasive Weed
=450  \\$wnnna$aInvasive Weeds
=450  \\$wnnna$aNoxious Weed
=450  \\$wnnna$aNoxious Weeds
=450  \\$wnnna$aParasitic Weed
=450  \\$wnnna$aParasitic Weeds
=450  \\$wnnna$aPerennial Weed
=450  \\$wnnna$aPerennial Weeds
=450  \\$wnnna$aPlant Weed
=450  \\$wnnna$aWeed, Annual
=450  \\$wnnna$aWeed, Invasive
=450  \\$wnnna$aWeed, Noxious
=450  \\$wnnna$aWeed, Parasitic
=450  \\$wnnna$aWeed, Perennial
=450  \\$wnnna$aWeed, Plant
=450  \\$wnnna$aWeeds, Annual
=450  \\$wnnna$aWeeds, Invasive
=450  \\$wnnna$aWeeds, Noxious
=450  \\$wnnna$aWeeds, Parasitic
=450  \\$wnnna$aWeeds, Perennial
=450  \\$wnnna$aWeeds, Plant
=550  \\$wg$aPlants
=550  \\$aWeed Control
=667  \\$acoordinate with specific plant if pertinent
=680  \\$iA plant growing in a location where it is not wanted, often competing with cultivated plants.
=688  \\$a2011
=750  \0$aWeeds$0(DLC) sh 85145920$5IEN-M

=LDR  01759cz  a2200469n  4500
=001  9880364553602441
=005  20141212221913.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057668
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x148
=072  \\$aE4.$x79
=072  \\$aN2.$x421.$x585.$x148
=150  \\$aBloodless Medical and Surgical Procedures
=450  \\$wnnna$aBlood Conservation Strategies
=450  \\$wnnna$aBlood Conservation Strategy
=450  \\$aBloodless Medicine and Surgery Programs
=450  \\$wnnna$aBloodless Surgeries
=450  \\$wnnna$aBloodless Surgery
=450  \\$wnnna$aConservation Strategies, Blood
=450  \\$wnnna$aConservation Strategy, Blood
=450  \\$wnnna$aStrategies, Blood Conservation
=450  \\$wnnna$aStrategies, Transfusion-Alternative
=450  \\$wnnna$aStrategy, Blood Conservation
=450  \\$wnnna$aStrategy, Transfusion-Alternative
=450  \\$wnnna$aSurgeries, Bloodless
=450  \\$wnnna$aSurgeries, Transfusion-Free
=450  \\$wnnna$aSurgery, Bloodless
=450  \\$wnnna$aSurgery, Transfusion-Free
=450  \\$wnnna$aTransfusion-Alternative Strategies
=450  \\$wnnna$aTransfusion Alternative Strategies
=450  \\$wnnna$aTransfusion-Alternative Strategy
=450  \\$wnnna$aTransfusion-Free Surgeries
=450  \\$wnnna$aTransfusion-Free Surgery
=450  \\$wnnna$aTransfusion Free Surgery
=550  \\$wg$aPatient Care
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aBlood Substitutes
=550  \\$aOperative Blood Salvage
=680  \\$iThe treatment of patients without the use of allogeneic BLOOD TRANSFUSIONS or blood products.
=688  \\$a2011
=750  \0$aTransfusion-free surgery$0(DLC)sh2005001266$5IEN-M

=LDR  01417cz  a2200193n  4500
=001  9880364553702441
=005  20141212221911.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057625
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x831
=072  \\$aE5.$x301.$x300.$x831
=150  \\$aIsotachophoresis
=450  \\$wnnna$aDisplacement Electrophoresis
=450  \\$wnnna$aElectrophoresis, Displacement
=550  \\$wg$aElectrophoresis
=680  \\$iA nonlinear electrophoretic technique used to separate a variety of ionic compounds, ranging from small metal ions to large molecules like proteins. Unlike "linear" zone electrophoresis in which separating solute bands continually spread by diffusion or dispersion, isotachophoresis forms self-sharpening, adjacent zones of substantially pure solute whose concentrations often exceed several mgs/ml. In isotachophoresis a multianalyte sample is introduced between the leading electrolyte and the terminating electrolyte where the sample ions have lower electrophoretic mobilities than the leading ion but larger than the terminating ion. (From "Isotachophoresis" on the AES Web Site [Internet]. Madison, WI: The American Electrophoresis Society; c2000-2008 [cited 2009 Aug 20]. Available from http://www.aesociety.org/areas/isotachophoresis.php)
=688  \\$a2011; use Electrophoresis 1985-2010
=750  \0$aIsotachophoresis$0(DLC) sh 85068672$5IEN-M

=LDR  00968cz  a2200313n  4500
=001  9880364553802441
=005  20190322111333.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057567
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x305
=150  \\$aMemory, Long-Term
=450  \\$wnnna$aLong-Term Memories
=450  \\$wnnna$aLong-Term Memory
=450  \\$wnnna$aLongterm Memories
=450  \\$wnnna$aLongterm Memory
=450  \\$wnnna$aMemories, Long-Term
=450  \\$wnnna$aMemories, Longterm
=450  \\$wnnna$aMemories, Remote
=450  \\$wnnna$aMemory, Long Term
=450  \\$wnnna$aMemory, Longterm
=450  \\$wnnna$aMemory, Remote
=450  \\$wnnna$aRemote Memories
=450  \\$wnnna$aRemote Memory
=550  \\$wg$aMemory
=550  \\$wh$aMemory Consolidation
=680  \\$iRemembrance of information from 3 or more years previously.
=688  \\$a2011
=750  \0$aLong-term memory$0(DLC) sh 94006034$5IEN-M

=LDR  00741cz  a2200229n  4500
=001  9880364553902441
=005  20160902143140.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057566
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x750.$x500
=072  \\$aL1.$x280.$x800.$x655
=072  \\$aN5.$x715.$x360.$x300.$x695.$x500
=072  \\$aN6.$x850.$x520.$x308.$x750.$x500
=150  \\$aSelf Report
=450  \\$wnnna$aReport, Self
=450  \\$wnnna$aReports, Self
=450  \\$wnnna$aSelf Reports
=550  \\$wg$aSurveys and Questionnaires
=680  \\$iMethod for obtaining information through verbal responses, written or oral, from subjects.
=688  \\$a2011
=750  \0$aSelf-evaluation$0(DLC) sh 85119743$5IEN

=LDR  00458cz  a2200157n  4500
=001  9880364554002441
=005  20141212221910.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057565
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x137
=150  \\$aApathy
=550  \\$wg$aEmotions
=680  \\$iLack of emotion or emotional expression; a disorder of motivation that persists over time.
=688  \\$a2011
=750  \0$aApathy$0(DLC) sh 85005931$5IEN-M

=LDR  00622cz  a2200193n  4500
=001  9880364554102441
=005  20141212221909.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x840
=150  \\$aSocial Stigma
=450  \\$wnnna$aSocial Stigmas
=450  \\$wnnna$aStigma, Social
=450  \\$wnnna$aStigmas, Social
=550  \\$wg$aSocial Behavior
=680  \\$iA perceived attribute that is deeply discrediting and is considered to be a violation of social norms.
=688  \\$a2011
=750  \0$aStigma (Social psychology)$0(DLC) sh 85128107$5IEN-M

=LDR  01674cz  a2200421n  4500
=001  9880364554202441
=005  20141212193140.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057510
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x529
=072  \\$aE4.$x502.$x382
=150  \\$aEndovascular Procedures
=450  \\$wnnna$aEndovascular Procedure
=450  \\$wnnna$aEndovascular Technique
=450  \\$wnnna$aEndovascular Techniques
=450  \\$wnnna$aIntravascular Procedure
=450  \\$wnnna$aIntravascular Procedures
=450  \\$wnnna$aIntravascular Technique
=450  \\$wnnna$aIntravascular Techniques
=450  \\$wnnna$aProcedure, Endovascular
=450  \\$wnnna$aProcedure, Intravascular
=450  \\$wnnna$aProcedures, Endovascular
=450  \\$wnnna$aProcedures, Intravascular
=450  \\$wnnna$aTechnique, Endovascular
=450  \\$wnnna$aTechnique, Intravascular
=450  \\$wnnna$aTechniques, Endovascular
=450  \\$wnnna$aTechniques, Intravascular
=550  \\$wg$aMinimally Invasive Surgical Procedures
=550  \\$wg$aVascular Surgical Procedures
=550  \\$wh$aAngioplasty
=550  \\$wh$aAngioscopy
=550  \\$wh$aCatheterization, Central Venous
=550  \\$wh$aCatheterization, Peripheral
=550  \\$wh$aPercutaneous Coronary Intervention
=680  \\$iMinimally invasive procedures, diagnostic or therapeutic, performed within the BLOOD VESSELS. They may be perfomed via ANGIOSCOPY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL RADIOGRAPHY; or INTERVENTIONAL ULTRASONOGRAPHY.
=688  \\$a2011
=750  \0$aBlood-vessels$xEndoscopic surgery$0(DLC) sh 92000235$5IEN-M

=LDR  00772cz  a2200169n  4500
=001  9880364554302441
=005  20141212221909.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057509
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868.$x887.$x680
=150  \\$aTrypanosoma rangeli
=550  \\$wg$aTrypanosoma
=667  \\$ainfection: coordinate IM with TRYPANOSOMIASIS (IM)
=680  \\$iA hemoflagellate parasite affecting domestic and wild animals, as well as humans and invertebrates. Though it induces an immune response, it is non-pathogenic in humans and other vertebrates. It is cross-reactive with TRYPANOSOMA CRUZI and can thus cause false positives for CHAGAS DISEASE.
=688  \\$a2011
=750  \0$aTrypanosoma rangeli$0(DLC) sh 88021478$5IEN-M

=LDR  00947cz  a2200289n  4500
=001  9880364554402441
=005  20141212221908.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057506
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x93
=150  \\$aArthropod Antennae
=450  \\$wnnna$aAntenna, Arthropod
=450  \\$wnnna$aAntenna, Insect
=450  \\$wnnna$aAntennae, Arthropod
=450  \\$wnnna$aAntennae, Insect
=450  \\$wnnna$aAntennas, Arthropod
=450  \\$wnnna$aAntennas, Insect
=450  \\$wnnna$aArthropod Antenna
=450  \\$wnnna$aArthropod Antennas
=450  \\$wnnna$aInsect Antenna
=450  \\$wnnna$aInsect Antennae
=450  \\$wnnna$aInsect Antennas
=550  \\$wg$aAnimal Structures
=680  \\$iPaired sense organs connected to the anterior segments of ARTHROPODS that help them navigate through the environment.
=688  \\$a2011
=750  \0$aAntennae (Biology)$0(DLC)sh2010013655$5IEN-M

=LDR  00990cz  a2200289n  4500
=001  9880364554502441
=005  20141212221907.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x950
=150  \\$aVisual Prosthesis
=450  \\$wnnna$aBionic Eye
=450  \\$wnnna$aBionic Eyes
=450  \\$wnnna$aEye, Bionic
=450  \\$wnnna$aEyes, Bionic
=450  \\$wnnna$aProstheses, Retinal
=450  \\$wnnna$aProstheses, Visual
=450  \\$wnnna$aProsthesis, Retinal
=450  \\$wnnna$aProsthesis, Visual
=450  \\$wnnna$aRetinal Prostheses
=450  \\$wnnna$aRetinal Prosthesis
=450  \\$wnnna$aVisual Prostheses
=550  \\$wg$aProstheses and Implants
=680  \\$iArtificial device such as an externally-worn camera attached to a stimulator on the RETINA, OPTIC NERVE, or VISUAL CORTEX, intended to restore or amplify vision.
=688  \\$a2011
=750  \0$aArtificial vision$0(DLC) sh 85008251$5IEN-M

=LDR  01157cz  a2200349n  4500
=001  9880364554602441
=005  20141212221907.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057486
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x607.$x750.$x120
=072  \\$aG2.$x842.$x750.$x270
=072  \\$aG16.$x500.$x240.$x118
=150  \\$aCarbon Cycle
=450  \\$wnnna$aCarbon Cycles
=450  \\$wnnna$aCarbon Fixation
=450  \\$wnnna$aCarbon Fixations
=450  \\$wnnna$aCarbon Flux
=450  \\$wnnna$aCarbon Fluxs
=450  \\$wnnna$aCycle, Carbon
=450  \\$wnnna$aCycles, Carbon
=450  \\$wnnna$aFixation, Carbon
=450  \\$wnnna$aFixations, Carbon
=450  \\$wnnna$aFlux, Carbon
=450  \\$wnnna$aFluxs, Carbon
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aOrganic Chemistry Processes
=550  \\$wg$aPhysicochemical Processes
=550  \\$wh$aCarbon Sequestration
=680  \\$iThe cycle by which the element carbon is exchanged between organic matter and the earth's physical environment.
=688  \\$a2011
=750  \0$aCarbon cycle (Biogeochemistry)$0(DLC) sh 85020105$5IEN-M

=LDR  00679cz  a2200217n  4500
=001  9880364554702441
=005  20141212221906.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x342
=150  \\$aHydrodynamics
=450  \\$wnnna$aDynamic, Fluid
=450  \\$wnnna$aDynamics, Fluid
=450  \\$wnnna$aFluid Dynamic
=450  \\$wnnna$aFluid Dynamics
=450  \\$wnnna$aHydrodynamic
=550  \\$wg$aPhysical Phenomena
=680  \\$iThe motion of fluids, especially noncompressible liquids, under the influence of internal and external forces.
=688  \\$a2011
=750  \0$aHydrodynamics$0(DLC) sh 85063393$5IEN-M

=LDR  00967cz  a2200277n  4500
=001  9880364554802441
=005  20141212221905.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x625.$x875
=072  \\$aG15.$x744.$x300.$x500
=150  \\$aPlant Dormancy
=450  \\$wnnna$aDormancies, Plant
=450  \\$wnnna$aDormancies, Seed
=450  \\$wnnna$aDormancy, Plant
=450  \\$wnnna$aDormancy, Seed
=450  \\$wnnna$aPlant Dormancies
=450  \\$wnnna$aSeed Dormancies
=450  \\$aSeed Dormancy
=550  \\$wg$aGermination
=550  \\$wg$aPlant Development
=680  \\$iThe state of failure to initiate and complete the process of growth, reproduction, or gemination of otherwise normal plants or vegetative structures thereof.
=688  \\$a2011
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Seed Dormancy
=750  \0$aDormancy in plants$0(DLC)sh 85039103$5IEN-M

=LDR  00633cz  a2200193n  4500
=001  9880364554902441
=005  20141212221905.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057386
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x875
=150  \\$aSearch Engine
=450  \\$wnnna$aEngine, Search
=450  \\$wnnna$aSearch Engines
=550  \\$wg$aInformation Storage and Retrieval
=550  \\$aSoftware
=680  \\$iSoftware used to locate data or information stored in machine-readable form locally or at a distance such as an INTERNET site.
=688  \\$a2010
=750  \0$aSearch engines$0(DLC) sh 00001050$5IEN-M

=LDR  01052cz  a2200217n  4500
=001  9880364555102441
=005  20141212193138.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057236
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x850
=150  \\$aTravel Medicine
=450  \\$wnnna$aEmporiatric Medicine
=450  \\$aEmporiatrics
=450  \\$aMedicine, Emporiatric
=450  \\$wnnna$aMedicine, Travel
=550  \\$wg$aMedicine
=667  \\$athe specialty (education, history, etc.) only; use TRAVEL for studies of health and medical issues related to travel; do not confuse with TRAVEL NURSING - nursing practice in which nurses travel to work in temporary positions
=680  \\$iMultidisciplinary field focusing on prevention of infectious diseases and patient safety during international TRAVEL. Key element of patient's pre-travel visit to the physician is a health risk assessment.
=688  \\$a2010; for MEDICINE, EMPORIATRIC & EMPORIATRICS use TRAVEL 1993-2009
=750  \0$aTravel$xHealth aspects$0(DLC) sh 85137151$5IEN-M

=LDR  00748cz  a2200217n  4500
=001  9880364555202441
=005  20141212221902.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057233
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x715
=072  \\$aN4.$x452.$x653.$x500
=150  \\$aRadio Frequency Identification Device
=450  \\$aRadio Frequency Identification
=450  \\$wnnna$aRFID
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aPatient Identification Systems
=550  \\$aRemote Sensing Technology
=680  \\$iMachine readable patient or equipment identification device using radio frequency from 125 kHz to 5.8 Ghz.
=688  \\$a2010
=750  \0$aRadio frequency identification systems$0(DLC) sh 93005118$5IEN-M

=LDR  00667cz  a2200181n  4500
=001  9880364555302441
=005  20141212221902.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057232
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x374.$x500
=150  \\$aGlobal Warming
=450  \\$wnnna$aWarming, Global
=550  \\$wg$aClimate Change
=550  \\$aCarbon Footprint
=680  \\$iIncrease in the temperature of the atmosphere near the Earth's surface and in the troposphere, which can contribute to changes in global climate patterns.
=688  \\$a2010; use GREENHOUSE EFFECT 1994-2009
=750  \0$aGlobal warming$0(DLC) sh 89000812$5IEN-M

=LDR  00916cz  a2200217n  4500
=001  9880364555402441
=005  20141212221902.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057231
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x374
=150  \\$aClimate Change
=450  \\$wnnna$aChange, Climate
=450  \\$wnnna$aChanges, Climate
=450  \\$wnnna$aClimate Changes
=550  \\$wg$aClimatic Processes
=550  \\$wh$aGlobal Warming
=550  \\$wh$aGreenhouse Effect
=680  \\$iAny significant change in measures of climate (such as temperature, precipitation, or wind) lasting for an extended period (decades or longer). It may result from natural factors such as changes in the sun's intensity, natural processes within the climate system such as changes in ocean circulation, or human activities.
=688  \\$a2010
=750  \0$aClimatic changes$0(DLC) sh 85027037$5IEN-M

=LDR  00760cz  a2200217n  4500
=001  9880364555502441
=005  20141212221901.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057229
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x66
=150  \\$aAlcoholics
=450  \\$wnnna$aAlcoholic
=450  \\$wnnna$aAlcoholic, Skid Row
=450  \\$wnnna$aAlcoholics, Skid Row
=450  \\$wnnna$aSkid Row Alcoholic
=450  \\$aSkid Row Alcoholics
=550  \\$wg$aPersons
=680  \\$iPersons who have a history of physical or psychological dependence on ETHANOL.
=688  \\$a2010; SKID ROW ALCOHOLICS was heading 1975-1995; use ALCOHOLISM 1975; use HOMELESS PERSONS for SKID ROW ALCOHOLICS 1996-2009
=750  \0$aAlcoholics$0(DLC) sh 85003287$5IEN-M

=LDR  00632cz  a2200205n  4500
=001  9880364555602441
=005  20141212221901.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057228
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x376
=072  \\$aF1.$x393.$x446.$x250.$x750
=072  \\$aF1.$x752.$x747.$x385.$x200.$x750
=150  \\$aMasculinity
=550  \\$wg$aGender Identity
=550  \\$wg$aSocial Behavior
=667  \\$ahuman only
=680  \\$iMale-associated sex-specific social roles and behaviors unrelated to biologic function.
=688  \\$a2010
=750  \0$aMasculinity$0(DLC) sh 85081797$5IEN-M

=LDR  00632cz  a2200205n  4500
=001  9880364555702441
=005  20141212221901.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x199
=072  \\$aF1.$x393.$x446.$x250.$x500
=072  \\$aF1.$x752.$x747.$x385.$x200.$x500
=150  \\$aFemininity
=550  \\$wg$aGender Identity
=550  \\$wg$aSocial Behavior
=667  \\$ahuman only
=680  \\$iFemale-associated sex-specific social roles and behaviors unrelated to biologic function.
=688  \\$a2010
=750  \0$aFemininity$0(DLC) sh 85047739$5IEN-M

=LDR  00845cz  a2200253n  4500
=001  9880364555802441
=005  20141212221900.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057226
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x372
=072  \\$aF1.$x145.$x535
=072  \\$aL1.$x143.$x458
=150  \\$aInformation Seeking Behavior
=450  \\$wnnna$aBehavior, Information Seeking
=450  \\$wnnna$aBehaviors, Information Seeking
=450  \\$wnnna$aInformation Seeking Behaviors
=450  \\$wnnna$aSeeking Behavior, Information
=550  \\$wg$aBehavior
=550  \\$wg$aCommunication
=550  \\$aInformation Literacy
=680  \\$iHow information is gathered in personal, academic or work environments and the resources used.
=688  \\$a2010
=750  \0$aInformation behavior$0(DLC)sh2005002646$5IEN-M

=LDR  00886cz  a2200241n  4500
=001  9880364556002441
=005  20141212193138.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057220
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x332.$x186.$x500
=072  \\$aL1.$x143.$x450.$x500
=072  \\$aN2.$x421.$x143.$x827.$x407.$x228.$x500
=072  \\$aN2.$x421.$x726.$x407.$x228.$x500
=150  \\$aHealth Literacy
=450  \\$wnnna$aLiteracy, Health
=550  \\$wg$aConsumer Health Information
=550  \\$wg$aInformation Literacy
=550  \\$wh$aPatient Medication Knowledge
=550  \\$aPatient Participation
=680  \\$iDegree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions.
=688  \\$a2010
=750  \0$aHealth literacy$0(DLC)sh2013000623$5IEN-M

=LDR  00703cz  a2200217n  4500
=001  9880364556102441
=005  20141212221900.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057219
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x102
=072  \\$aN6.$x850.$x460.$x150
=072  \\$aN6.$x850.$x540.$x500
=150  \\$aBiofouling
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aEnvironmental Pollution
=550  \\$wg$aEquipment Contamination
=550  \\$aBiofilms
=680  \\$iProcess by which unwanted microbial, plant or animal materials or organisms accumulate on man-made surfaces.
=688  \\$a2010
=750  \0$aFouling$0(DLC) sh 85051042$5IEN-M

=LDR  00548cz  a2200181n  4500
=001  9880364556202441
=005  20141212221859.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057218
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x110.$x500.$x500
=150  \\$aBlogging
=450  \\$wnnna$aBlog
=450  \\$wnnna$aBlogs
=550  \\$wg$aInternet
=680  \\$iUsing an INTERNET based personal journal which may consist of reflections, comments, and often hyperlinks.
=688  \\$a2010
=750  \0$aBlogs$0(DLC)sh2003004628$5IEN-M

=LDR  00724cz  a2200217n  4500
=001  9880364556302441
=005  20161116092841.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057217
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x262
=072  \\$aN3.$x219.$x206
=150  \\$aEconomic Development
=450  \\$wnnna$aDevelopment, Economic
=450  \\$wnnna$aEconomic Growth
=450  \\$wnnna$aGrowth, Economic
=550  \\$wg$aEconomics
=550  \\$wh$aIndustrial Development
=680  \\$iMobilization of human, financial, capital, physical and or natural resources to generate goods and services.
=688  \\$a2010; use ECONOMICS 1978-2009
=750  \0$aEconomic development$0(DLC) sh 85040804$5IEN-M

=LDR  01263cz  a2200349n  4500
=001  9880364556402441
=005  20141212221859.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057215
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x875.$x149
=150  \\$aBody Dysmorphic Disorders
=450  \\$wnnna$aBody Dysmorphic Disorder
=450  \\$wnnna$aBody Image Disfunction
=450  \\$wnnna$aBody Image Disfunctions
=450  \\$wnnna$aBody Image Disorder
=450  \\$wnnna$aBody Image Disorders
=450  \\$wnnna$aDisfunction, Body Image
=450  \\$wnnna$aDisfunctions, Body Image
=450  \\$wnnna$aDisorder, Body Dysmorphic
=450  \\$wnnna$aDisorders, Body Dysmorphic
=450  \\$wnnna$aDisorders, Body Image
=450  \\$wnnna$aDysmorphic Disorder, Body
=450  \\$wnnna$aDysmorphic Disorders, Body
=450  \\$wnnna$aImage Disfunction, Body
=450  \\$wnnna$aImage Disfunctions, Body
=450  \\$wnnna$aImage Disorders, Body
=550  \\$wg$aSomatoform Disorders
=550  \\$aAnorexia Nervosa
=680  \\$iPreoccupations with appearance or self-image causing significant distress or impairment in important areas of functioning.
=688  \\$a2010
=750  \0$aBody dysmorphic disorder$0(DLC) sh 96000257$5IEN-M

=LDR  00872cz  a2200253n  4500
=001  9880364556502441
=005  20141212221858.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057211
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x900.$x500
=150  \\$aWebcasts as Topic
=450  \\$wnnna$aPodcasts as Topic
=450  \\$wnnna$aPodcasts as Topics
=450  \\$wnnna$aReally Simple Syndication as Topic
=450  \\$wnnna$aRSS as Topic
=450  \\$wnnna$aRSS as Topics
=450  \\$wnnna$aStreaming Video as Topic
=450  \\$wnnna$aWebcasts as Topics
=550  \\$wg$aVideoconferencing
=667  \\$ado not confuse with the Publication Type WEBCASTS
=680  \\$iTransmission of live or pre-recorded audio or video content via connection or download from the INTERNET.
=688  \\$a2010
=750  \0$aWebcasting$0(DLC) sh 97008674$5IEN-M

=LDR  00561cz  a2200193n  4500
=001  9880364556602441
=005  20141212221856.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057193
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x883.$x710
=072  \\$aN5.$x300.$x515
=150  \\$aMedical Tourism
=450  \\$wnnna$aTourism, Medical
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aTravel
=680  \\$iTravel to another country for the purpose of medical treatment.
=688  \\$a2010
=750  \0$aMedical tourism$0(DLC) sh2006000258$5IEN-M

=LDR  00731cz  a2200193n  4500
=001  9880364556702441
=005  20141212221855.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057192
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x340.$x843
=072  \\$aG1.$x595.$x340.$x787
=150  \\$aTsunamis
=450  \\$aTsunami
=550  \\$wg$aGeological Processes
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iSeries of ocean waves produced by geologic events or underwater LANDSLIDES. These waves can travel at speeds averaging 450 (and up to 600) miles per hour in the open ocean.
=688  \\$a2010; use TIDAL WAVES (2009)
=750  \0$aTsunamis$0(DLC) sh 85138348$5IEN-M

=LDR  00626cz  a2200193n  4500
=001  9880364556802441
=005  20141212221854.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x906.$x893
=150  \\$aWorkflow
=450  \\$wnnna$aWork Flow
=450  \\$wnnna$aWork Flows
=450  \\$wnnna$aWorkflows
=550  \\$wg$aSystems Analysis
=680  \\$iDescription of pattern of recurrent functions or procedures frequently found in organizational processes, such as notification, decision, and action.
=688  \\$a2010
=750  \0$aWorkflow$0(DLC) sh 97009122$5IEN-M

=LDR  00476cz  a2200181n  4500
=001  9880364557002441
=005  20141212221853.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057181
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x867
=072  \\$aF2.$x830.$x816.$x492
=150  \\$aPleasure
=550  \\$wg$aEmotions
=550  \\$wg$aSensation
=680  \\$iSensation of enjoyment or gratification.
=688  \\$a2010
=750  \0$aPleasure$0(DLC) sh 85103436$5IEN

=LDR  04928cz  a2201081n  4500
=001  9880364557102441
=005  20141212221853.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057180
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x380.$x266.$x299
=072  \\$aC10.$x574.$x950.$x300.$x299
=072  \\$aC18.$x452.$x845.$x800.$x300.$x299
=072  \\$aF3.$x87.$x400.$x380.$x299
=150  \\$aFrontotemporal Dementia
=450  \\$wnnna$aComplex, Disinhibition-Dementia-Parkinsonism-Amyotrophy
=450  \\$wnnna$aComplex, Disinhibition-Dementia-Parkinsonism-Amytrophy
=450  \\$wnnna$aComplices, Disinhibition-Dementia-Parkinsonism-Amyotrophy
=450  \\$wnnna$aComplices, Disinhibition-Dementia-Parkinsonism-Amytrophy
=450  \\$wnnna$aDDPAC
=450  \\$wnnna$aDementia, Frontotemporal
=450  \\$wnnna$aDementia, Frontotemporal Lobe
=450  \\$wnnna$aDementia, Frontotemporal Lobe (FLDEM)
=450  \\$wnnna$aDementia, Frontotemporal, with Parkinsonism
=450  \\$wnnna$aDementia, GRN-Related Frontotemporal
=450  \\$wnnna$aDementia, Hereditary Dysphasic Disinhibition
=450  \\$wnnna$aDementia, Semantic
=450  \\$wnnna$aDementia, Ubiquitin-Positive Frontotemporal
=450  \\$wnnna$aDementias, Frontotemporal
=450  \\$wnnna$aDementias, Frontotemporal Lobe
=450  \\$wnnna$aDementias, Frontotemporal Lobe (FLDEM)
=450  \\$wnnna$aDementias, GRN-Related Frontotemporal
=450  \\$wnnna$aDementias, Semantic
=450  \\$wnnna$aDementias, Ubiquitin-Positive Frontotemporal
=450  \\$wnnna$aDisease, Familial Pick's
=450  \\$wnnna$aDisease, Wilhelmsen-Lynch
=450  \\$wnnna$aDiseases, Familial Pick's
=450  \\$wnnna$aDiseases, Wilhelmsen-Lynch
=450  \\$wnnna$aDisinhibition-Dementia-Parkinsonism-Amyotrophy Complex
=450  \\$wnnna$aDisinhibition Dementia Parkinsonism Amyotrophy Complex
=450  \\$wnnna$aDisinhibition-Dementia-Parkinsonism-Amyotrophy Complices
=450  \\$wnnna$aDisinhibition-Dementia-Parkinsonism-Amytrophy Complex
=450  \\$wnnna$aDisinhibition Dementia Parkinsonism Amytrophy Complex
=450  \\$wnnna$aDisinhibition-Dementia-Parkinsonism-Amytrophy Complices
=450  \\$wnnna$aFamilial Pick Disease
=450  \\$wnnna$aFamilial Pick's Disease
=450  \\$wnnna$aFamilial Picks Disease
=450  \\$wnnna$aFamilial Pick's Diseases
=450  \\$wnnna$aFrontotemporal Dementia, GRN-Related
=450  \\$wnnna$aFrontotemporal Dementia, Ubiquitin-Positive
=450  \\$wnnna$aFrontotemporal Dementia, Ubiquitin Positive
=450  \\$wnnna$aFrontotemporal Dementia with Parkinsonism
=450  \\$wnnna$aFrontotemporal Dementia with Parkinsonism-17
=450  \\$wnnna$aFrontotemporal Dementia with Parkinsonism 17
=450  \\$wnnna$aFrontotemporal Dementias
=450  \\$wnnna$aFrontotemporal Dementias, GRN-Related
=450  \\$wnnna$aFrontotemporal Dementias, Ubiquitin-Positive
=450  \\$wnnna$aFrontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions
=450  \\$wnnna$aFrontotemporal Lobar Degeneration With Ubiquitin Positive Inclusions
=450  \\$wnnna$aFrontotemporal Lobe Dementia
=450  \\$wnnna$aFrontotemporal Lobe Dementia (FLDEM)
=450  \\$wnnna$aFrontotemporal Lobe Dementias
=450  \\$wnnna$aFrontotemporal Lobe Dementias (FLDEM)
=450  \\$wnnna$aFTD-GRN
=450  \\$wnnna$aFTD-PGRN
=450  \\$wnnna$aFTDP-17
=450  \\$wnnna$aFTLD-17 GRN
=450  \\$wnnna$aFTLD-TDP
=450  \\$wnnna$aFTLD with TDP-43 Pathology
=450  \\$wnnna$aFTLD with TDP 43 Pathology
=450  \\$wnnna$aGRN-Related Frontotemporal Dementia
=450  \\$wnnna$aGRN Related Frontotemporal Dementia
=450  \\$wnnna$aGRN-Related Frontotemporal Dementias
=450  \\$wnnna$aHDDD1
=450  \\$wnnna$aHDDD2
=450  \\$wnnna$aHereditary Dysphasic Disinhibition Dementia
=450  \\$wnnna$aLobe Dementia, Frontotemporal
=450  \\$wnnna$aLobe Dementias, Frontotemporal
=450  \\$wnnna$aMultiple System Tauopathy with Presenile Dementia
=450  \\$wnnna$aPick's Disease, Familial
=450  \\$wnnna$aPick's Diseases, Familial
=450  \\$wnnna$aSemantic Dementia
=450  \\$wnnna$aSemantic Dementias
=450  \\$wnnna$aUbiquitin-Positive Frontotemporal Dementia
=450  \\$wnnna$aUbiquitin-Positive Frontotemporal Dementias
=450  \\$wnnna$aWilhelmsen-Lynch Disease
=450  \\$wnnna$aWilhelmsen Lynch Disease
=450  \\$wnnna$aWilhelmsen-Lynch Diseases
=550  \\$wg$aFrontotemporal Lobar Degeneration
=550  \\$wh$aPick Disease of the Brain
=680  \\$iThe most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.
=688  \\$a2010
=750  \0$aFrontotemporal dementia$0(DLC)sh2013003253

=LDR  00846cz  a2200229n  4500
=001  9880364557202441
=005  20141212221849.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057175
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x820.$x90.$x703
=150  \\$aPosters as Topic
=450  \\$wnnna$aas Topic, Posters
=450  \\$wnnna$aas Topics, Posters
=450  \\$wnnna$aPosters as Topics
=450  \\$wnnna$aTopic, Posters as
=450  \\$wnnna$aTopics, Posters as
=550  \\$wg$aAudiovisual Aids
=667  \\$ado not confuse with the Publication Type POSTERS
=680  \\$iSingle or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for display, usually in a public place and are chiefly pictorial.
=688  \\$a2010
=750  \0$aPosters$0(DLC) sh 85105523$5IEN-M

=LDR  00989cz  a2200241n  4500
=001  9880364557302441
=005  20141212221848.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057173
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x580
=150  \\$aRecreation Therapy
=450  \\$wnnna$aRecreation Therapies
=450  \\$wnnna$aRecreational Therapies
=450  \\$wnnna$aRecreational Therapy
=450  \\$wnnna$aTherapies, Recreation
=450  \\$wnnna$aTherapies, Recreational
=450  \\$wnnna$aTherapy, Recreation
=450  \\$wnnna$aTherapy, Recreational
=550  \\$wg$aRehabilitation
=680  \\$iThe enhancement of physical, cognitive, emotional and social skills so an individual may participate in chosen activities. Recreational modalities are used in designed intervention strategies, incorporating individual's interests to make the therapy process meaningful and relevant.
=688  \\$a2010
=750  \0$aRecreational therapy$0(DLC) sh 85111992$5IEN-M

=LDR  01017cz  a2200241n  4500
=001  9880364557402441
=005  20141212221848.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057172
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x425
=150  \\$aEconomic Recession
=450  \\$wnnna$aDepression, Economic
=450  \\$wnnna$aDepressions, Economic
=450  \\$wnnna$aEconomic Depression
=450  \\$wnnna$aEconomic Depressions
=450  \\$wnnna$aEconomic Recessions
=450  \\$aRecession, Economic
=450  \\$wnnna$aRecessions, Economic
=550  \\$wg$aEconomics
=680  \\$iSignificant decline in economic activity spread across the economy, lasting more than a few months, normally visible in real gross domestic product, real income, employment, industrial production, and wholesale-retail sales. (National Bureau of Economic Research, Inc, www.nber.org/cycles.html, accessed 4/23/2009)
=688  \\$a2010; use ECONOMICS 1990-2009
=750  \0$aRecessions$0(DLC) sh 87001333$5IEN-M

=LDR  00999cz  a2200181n  4500
=001  9880364557502441
=005  20141212221846.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057169
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137.$x506.$x162
=150  \\$aEye Movement Desensitization Reprocessing
=450  \\$wnnna$aEMDR
=450  \\$wnnna$aEye Movement Desensitization and Processing
=550  \\$wg$aDesensitization, Psychologic
=680  \\$iA technique that induces the processing of disturbing memories and experiences, by stimulating neural mechanisms that are similar to those activated during REM sleep. The technique consists of eye movements following side-to-side movements of the index and middle fingers, or the alternate tapping of the hands on the knees. This procedure triggers the processing of information, thus facilitating the connection of neural networks.
=688  \\$a2010
=750  \0$aEye movement desensitization and reprocessing$0(DLC) sh 94008550$5IEN-M

=LDR  00548cz  a2200169n  4500
=001  9880364557602441
=005  20141212221846.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057168
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x155.$x249
=150  \\$aDistillation
=450  \\$wnnna$aDistillations
=550  \\$wg$aChemical Fractionation
=680  \\$iA chemical process for separating the components of a liquid mixture by boiling and collecting condensed vapors.
=688  \\$a2010
=750  \0$aDistillation$0(DLC) sh 85038517$5IEN-M

=LDR  02095cz  a2200469n  4500
=001  9880364557702441
=005  20141212221846.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057166
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x680
=150  \\$aHigh-Throughput Screening Assays
=450  \\$wnnna$aAssay, High-Throughput Biological
=450  \\$wnnna$aAssay, High-Throughput Chemical
=450  \\$wnnna$aAssay, High-Throughput Screening
=450  \\$wnnna$aAssays, High-Throughput Biological
=450  \\$wnnna$aAssays, High-Throughput Chemical
=450  \\$wnnna$aBiological Assay, High-Throughput
=450  \\$wnnna$aBiological Assays, High-Throughput
=450  \\$wnnna$aChemical Assay, High-Throughput
=450  \\$wnnna$aChemical Assays, High-Throughput
=450  \\$wnnna$aHigh-Throughput Biological Assay
=450  \\$wnnna$aHigh-Throughput Biological Assays
=450  \\$wnnna$aHigh Throughput Biological Assays
=450  \\$wnnna$aHigh-Throughput Chemical Assay
=450  \\$wnnna$aHigh-Throughput Chemical Assays
=450  \\$wnnna$aHigh Throughput Chemical Assays
=450  \\$wnnna$aHigh-Throughput Screening Assay
=450  \\$wnnna$aHigh Throughput Screening Assays
=450  \\$wnnna$aHigh-Throughput Screening Method
=450  \\$wnnna$aHigh-Throughput Screening Methods
=450  \\$wnnna$aHigh Throughput Screening Methods
=450  \\$wnnna$aMethods, High-Throughput Screening
=450  \\$wnnna$aScreening Assay, High-Throughput
=450  \\$wnnna$aScreening Assays, High-Throughput
=450  \\$wnnna$aScreening Method, High-Throughput
=450  \\$wnnna$aScreening Methods, High-Throughput
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$aCombinatorial Chemistry Techniques
=680  \\$iRapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.
=688  \\$a2010
=750  \2$aHigh throughput screening (Drug development)$0(DLC)sh2001002949$5IEN-M

=LDR  01526cz  a2200361n  4500
=001  9880364557802441
=005  20141212221844.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057148
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x510.$x500
=150  \\$aInsecticide-Treated Bednets
=450  \\$wnnna$aBed Net, Insecticide-Treated
=450  \\$wnnna$aBed Nets, Insecticide-Treated
=450  \\$wnnna$aBednet, Insecticide-Treated
=450  \\$wnnna$aBednets, Insecticide-Treated
=450  \\$wnnna$aInsecticide-Treated Bed Net
=450  \\$wnnna$aInsecticide-Treated Bed Nets
=450  \\$wnnna$aInsecticide Treated Bed Nets
=450  \\$wnnna$aInsecticide-Treated Bednet
=450  \\$wnnna$aInsecticide Treated Bednets
=450  \\$wnnna$aMosquito Net, Treated
=450  \\$wnnna$aMosquito Nets, Treated
=450  \\$wnnna$aNet, Insecticide-Treated Bed
=450  \\$wnnna$aNet, Treated Mosquito
=450  \\$wnnna$aNets, Insecticide-Treated Bed
=450  \\$wnnna$aNets, Treated Mosquito
=450  \\$wnnna$aTreated Mosquito Net
=450  \\$wnnna$aTreated Mosquito Nets
=550  \\$wg$aMosquito Nets
=680  \\$iLightweight meshwork fabric made of cotton, silk, polyester, nylon (polyamides), or other material impregnated with insecticide, having openings too small to allow entry of mosquitoes or other insects, thereby offering protection against insect bite and insect-borne diseases.
=688  \\$a2010
=750  \0$aInsecticide-treated mosquito nets$0(DLC)sh2008000468$5IEN-M

=LDR  01712cz  a2200469n  4500
=001  9880364557902441
=005  20141212221843.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x510
=072  \\$aJ1.$x494.$x221.$x750
=150  \\$aMosquito Nets
=450  \\$wnnna$aBed Net, Mosquito
=450  \\$wnnna$aBed Nets, Mosquito
=450  \\$wnnna$aBednet, Mosquito
=450  \\$wnnna$aBednets, Mosquito
=450  \\$wnnna$aMosquito Bed Net
=450  \\$wnnna$aMosquito Bed Nets
=450  \\$wnnna$aMosquito Bednet
=450  \\$wnnna$aMosquito Bednets
=450  \\$wnnna$aMosquito Net
=450  \\$wnnna$aMosquito Net, Portable
=450  \\$wnnna$aMosquito Nets, Portable
=450  \\$wnnna$aMosquito Netting
=450  \\$wnnna$aMosquito Nettings
=450  \\$wnnna$aNet, Mosquito
=450  \\$wnnna$aNet, Mosquito Bed
=450  \\$wnnna$aNet, Portable Mosquito
=450  \\$wnnna$aNets, Mosquito
=450  \\$wnnna$aNets, Mosquito Bed
=450  \\$wnnna$aNets, Portable Mosquito
=450  \\$wnnna$aNetting, Mosquito
=450  \\$wnnna$aNettings, Mosquito
=450  \\$wnnna$aPortable Mosquito Net
=450  \\$wnnna$aPortable Mosquito Nets
=550  \\$wg$aBedding and Linens
=550  \\$wg$aProtective Devices
=550  \\$wh$aInsecticide-Treated Bednets
=680  \\$iFree-standing or supported lightweight meshwork fabric made of cotton, silk, polyester or other material, having openings too small to allow entry of mosquitoes or other insects, thereby protecting against INSECT BITES; INSECT STINGS, and insect-borne diseases.
=688  \\$a2010
=750  \0$aMosquito nets$0(DLC) sh2008000467$5IEN-M

=LDR  01221cz  a2200373n  4500
=001  9880364558002441
=005  20141212221842.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057140
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x477
=150  \\$aFast Foods
=450  \\$wnnna$aConvenience Food
=450  \\$wnnna$aConvenience Foods
=450  \\$wnnna$aFast Food
=450  \\$wnnna$aFood, Convenience
=450  \\$wnnna$aFood, Fast
=450  \\$wnnna$aFood, Ready-Prepared
=450  \\$wnnna$aFoods, Convenience
=450  \\$wnnna$aFoods, Fast
=450  \\$wnnna$aFoods, Ready-Prepared
=450  \\$wnnna$aMeal, Ready-To-Eat
=450  \\$wnnna$aMeals, Ready-To-Eat
=450  \\$wnnna$aMeals, Ready To Eat
=450  \\$wnnna$aReady-Prepared Food
=450  \\$wnnna$aReady-Prepared Foods
=450  \\$wnnna$aReady Prepared Foods
=450  \\$wnnna$aReady-To-Eat Meal
=450  \\$wnnna$aReady-To-Eat Meals
=450  \\$wnnna$aReady To Eat Meals
=550  \\$wg$aFood
=680  \\$iPrepared food that is ready to eat or partially prepared food that has a final preparation time of a few minutes or less.
=688  \\$a2010
=750  \0$aConvenience foods$0(DLC) sh 85031681$5IEN-M

=LDR  00674cz  a2200169n  4500
=001  9880364558102441
=005  20141212221841.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057139
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x300
=150  \\$aNanofibers
=450  \\$wnnna$aNanofiber
=550  \\$wg$aNanostructures
=680  \\$iSubmicron-sized fibers with diameters typically between 50 and 500 nanometers. The very small dimension of these fibers can generate a high surface area to volume ratio, which makes them potential candidates for various biomedical and other applications.
=688  \\$a2010
=750  \0$aNanofibers$0(DLC)sh2007004894$5IEN-M

=LDR  01186cz  a2200301n  4500
=001  9880364558202441
=005  20141212221834.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057097
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x300.$x400
=150  \\$aHarmful Algal Bloom
=450  \\$wnnna$aAlgal Bloom, Harmful
=450  \\$wnnna$aAlgal Blooms, Harmful
=450  \\$wnnna$aBloom, Harmful Algal
=450  \\$wnnna$aBlooms, Harmful Algal
=450  \\$wnnna$aHarmful Algal Blooms
=450  \\$aRed Tide
=450  \\$wnnna$aRed Tides
=450  \\$wnnna$aTide, Red
=450  \\$wnnna$aTides, Red
=550  \\$wg$aEutrophication
=550  \\$aDinoflagellida
=550  \\$aShellfish Poisoning
=667  \\$aALGAL BLOOM is also available
=680  \\$iAn algal bloom where the algae produce powerful toxins that can kill fish, birds, and mammals, and ultimately cause illness in humans. The harmful bloom can also cause oxygen depletion in the water due to the death and decomposition of non-toxic algae species.
=688  \\$a2010; for RED TIDE use DINOFLAGELLIDA 1979-2009, use INVERTEBRATES 1974-1978
=750  \0$aRed tide$0(DLC) sh 85112101$5IEN-M

=LDR  02195cz  a2200529n  4500
=001  9880364558302441
=005  20141212221833.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057096
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x415.$x792
=150  \\$aShellfish Poisoning
=450  \\$wnnna$aAmnesic Shellfish Poisoning
=450  \\$wnnna$aAmnesic Shellfish Poisonings
=450  \\$wnnna$aDiarrhetic Shellfish Poisoning
=450  \\$wnnna$aDiarrhetic Shellfish Poisonings
=450  \\$wnnna$aNeurotoxic Shellfish Poisoning
=450  \\$wnnna$aNeurotoxic Shellfish Poisonings
=450  \\$wnnna$aParalytic Shellfish Poisoning
=450  \\$wnnna$aParalytic Shellfish Poisonings
=450  \\$wnnna$aPoisoning, Amnesic Shellfish
=450  \\$wnnna$aPoisoning, Diarrhetic Shellfish
=450  \\$wnnna$aPoisoning, Neurotoxic Shellfish
=450  \\$wnnna$aPoisoning, Paralytic Shellfish
=450  \\$wnnna$aPoisoning, Shellfish
=450  \\$wnnna$aPoisonings, Amnesic Shellfish
=450  \\$wnnna$aPoisonings, Diarrhetic Shellfish
=450  \\$wnnna$aPoisonings, Neurotoxic Shellfish
=450  \\$wnnna$aPoisonings, Paralytic Shellfish
=450  \\$wnnna$aPoisonings, Shellfish
=450  \\$aShellfish$xpoisoning
=450  \\$wnnna$aShellfish Poisoning, Amnesic
=450  \\$wnnna$aShellfish Poisoning, Diarrhetic
=450  \\$wnnna$aShellfish Poisoning, Neurotoxic
=450  \\$wnnna$aShellfish Poisoning, Paralytic
=450  \\$wnnna$aShellfish Poisonings
=450  \\$wnnna$aShellfish Poisonings, Amnesic
=450  \\$wnnna$aShellfish Poisonings, Diarrhetic
=450  \\$wnnna$aShellfish Poisonings, Neurotoxic
=450  \\$wnnna$aShellfish Poisonings, Paralytic
=550  \\$wg$aFoodborne Diseases
=550  \\$aHarmful Algal Bloom
=667  \\$acoordinate with specific shellfish if pertinent
=680  \\$iPoisoning from toxins present in bivalve mollusks that have been ingested. Four distinct types of shellfish poisoning are recognized based on the toxin involved.
=688  \\$a2010
=750  \0$aAmnesic shellfish poisoning$0(DLC)sh2005003146$5IEN-M
=750  \0$aParalytic shellfish poisoning$0(DLC) sh 85097840$5IEN-M

=LDR  01388cz  a2200373n  4500
=001  9880364558402441
=005  20141212221830.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057089
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x636.$x475.$x750
=072  \\$aH1.$x158.$x273.$x343.$x595.$x475.$x750
=072  \\$aH1.$x181.$x122.$x650.$x475.$x680
=072  \\$aH2.$x403.$x650.$x505
=150  \\$aPathology, Molecular
=450  \\$wnnna$aDiagnostic, Molecular
=450  \\$wnnna$aDiagnostic Molecular Pathologies
=450  \\$aDiagnostic Molecular Pathology
=450  \\$wnnna$aDiagnostics, Molecular
=450  \\$wnnna$aMolecular Diagnostic
=450  \\$aMolecular Diagnostics
=450  \\$wnnna$aMolecular Pathologies
=450  \\$wnnna$aMolecular Pathologies, Diagnostic
=450  \\$wnnna$aMolecular Pathology
=450  \\$wnnna$aMolecular Pathology, Diagnostic
=450  \\$wnnna$aPathologies, Diagnostic Molecular
=450  \\$wnnna$aPathologies, Molecular
=450  \\$wnnna$aPathology, Diagnostic Molecular
=550  \\$wg$aMolecular Medicine
=550  \\$wg$aPathology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iA subspecialty of pathology concerned with the molecular basis (e.g., mutations) of various diseases.
=688  \\$a2010
=750  \0$aPathology, Molecular$0(DLC) sh 85098691$5IEN-M

=LDR  00813cz  a2200205n  4500
=001  9880364558502441
=005  20141212221828.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057086
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x565.$x280.$x945.$x399
=072  \\$aE4.$x14.$x380
=150  \\$aHigh-Intensity Focused Ultrasound Ablation
=450  \\$wnnna$aHigh Intensity Focused Ultrasound Ablation
=550  \\$wg$aAblation Techniques
=550  \\$wg$aUltrasonic Therapy
=550  \\$wh$aUltrasound, High-Intensity Focused, Transrectal
=680  \\$iThe use of focused, high-frequency sound waves to destroy tissue. It is sometimes used in conjunction with but is distinct from INTERVENTIONAL ULTRASONOGRAPHY.
=688  \\$a2010
=750  \0$aHigh-intensity focused ultrasound$0(DLC)sh2007008790$5IEN-M

=LDR  00809cz  a2200229n  4500
=001  9880364558602441
=005  20141212221828.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057080
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x635.$x50
=150  \\$aPongo abelii
=450  \\$aOrangutan, Sumatran
=450  \\$wnnna$aPongo abelius
=450  \\$wnnna$aPongo pygmaeus abeli
=450  \\$wnnna$aPongo pygmaeus abelii
=450  \\$wnnna$aSumatran Orangutan
=550  \\$wg$aPongo
=667  \\$adiseases: coordinate IM with APE DISEASES (IM) + specific disease /vet (IM)
=680  \\$iA species of orangutan, family HOMINIDAE, found in the forests on the island of Sumatra.
=688  \\$a2010
=750  \0$aSumatran orangutan$0(DLC)sh2014000046$5IEN-M

=LDR  00760cz  a2200205n  4500
=001  9880364558702441
=005  20141212221828.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057079
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x635
=150  \\$aPongo
=450  \\$wnnna$aOrangutans
=550  \\$wg$aHominidae
=550  \\$wh$aPongo abelii
=550  \\$wh$aPongo pygmaeus
=667  \\$adiseases: coordinate IM with APE DISEASES (IM) + specific disease /vet (IM)
=680  \\$iA genus of orangutans in the family HOMINIDAE, comprising two species. Among the PRIMATES, the orangutan is second in size only to the gorilla (GORILLA GORILLA).
=688  \\$a2010
=750  \0$aPongo$0(DLC) sh 90005452$5IEN-M

=LDR  00842cz  a2200241n  4500
=001  9880364558802441
=005  20141212221827.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057078
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x640
=150  \\$aPentastomida
=450  \\$aLinguatula serrata
=450  \\$wnnna$aPentastomidas
=450  \\$wnnna$aTongue Worm
=450  \\$aTongue Worms
=450  \\$wnnna$aWorm, Tongue
=450  \\$wnnna$aWorms, Tongue
=550  \\$wg$aCrustacea
=667  \\$ainfection: coordinate (IM) with PARASITIC DISEASES (IM) or PARASITIC DISEASES, ANIMAL (IM)
=680  \\$iA subclass of CRUSTACEA comprising the tongue worms which are obligatory parasites of reptiles, birds, and mammals including humans.
=688  \\$a2010
=750  \0$aPentastomida$0(DLC) sh 85099621$5IEN-M

=LDR  00688cz  a2200229n  4500
=001  9880364558902441
=005  20141212221827.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057077
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x900
=150  \\$aVarroidae
=450  \\$wnnna$aHoneybee Mite
=450  \\$wnnna$aHoneybee Mites
=450  \\$wnnna$aMite, Honeybee
=450  \\$wnnna$aMites, Honeybee
=450  \\$aVarroa
=450  \\$wnnna$aVarroa destructor
=550  \\$wg$aMites
=680  \\$iA family of MITES in the subclass ACARI. It includes the single genus Varroa.
=688  \\$a2010
=750  \0$aVarroidae$0(DLC) sh 85142346$5IEN-M

=LDR  01051cz  a2200289n  4500
=001  9880364559002441
=005  20141212221825.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057071
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x475.$x650
=150  \\$aPatellofemoral Joint
=450  \\$wnnna$aArticulation, Femoropatellar
=450  \\$wnnna$aArticulation, Patellofemoral
=450  \\$wnnna$aArticulations, Femoropatellar
=450  \\$wnnna$aArticulations, Patellofemoral
=450  \\$wnnna$aFemoropatellar Articulation
=450  \\$wnnna$aFemoropatellar Articulations
=450  \\$wnnna$aJoint, Patellofemoral
=450  \\$wnnna$aJoints, Patellofemoral
=450  \\$wnnna$aPatellofemoral Articulation
=450  \\$wnnna$aPatellofemoral Articulations
=450  \\$wnnna$aPatellofemoral Joints
=550  \\$wg$aKnee Joint
=680  \\$iThe articulation between the articular surface of the PATELLA and the patellar surface of the FEMUR.
=688  \\$a2010
=750  \0$aPatellofemoral joint$0(DLC) sh 92006380$5IEN-M

=LDR  01152cz  a2200325n  4500
=001  9880364559102441
=005  20141212221824.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057057
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x959
=150  \\$aSerine Proteases
=450  \\$wnnna$aProtease, Serine
=450  \\$wnnna$aProteases, Serine
=450  \\$wnnna$aProtein Hydrolases, Serine
=450  \\$wnnna$aProteinase, Serine
=450  \\$wnnna$aProteinases, Serine
=450  \\$wnnna$aSerine Protease
=450  \\$wnnna$aSerine Protein Hydrolases
=450  \\$wnnna$aSerine Proteinase
=450  \\$aSerine Proteinases
=550  \\$wg$aPeptide Hydrolases
=550  \\$wh$aCathepsin A
=550  \\$wh$aDipeptidyl Peptidase 4
=550  \\$wh$aSerine Endopeptidases
=550  \\$wh$aSerine-Type D-Ala-D-Ala Carboxypeptidase
=667  \\$ado not confuse with SERINE ENDOPEPTIDASES
=680  \\$iPeptide hydrolases that contain at the active site a SERINE residue involved in catalysis.
=688  \\$a2010, 1988-1999; use SERINE ENDOPEPTIDASES 2000-2009
=750  \0$aSerine proteinases$0(DLC) sh 90002321$5IEN

=LDR  01032cz  a2200289n  4500
=001  9880364559202441
=005  20141212221823.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057055
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x74
=150  \\$aAspartic Acid Proteases
=450  \\$wnnna$aAcid Proteases, Aspartic
=450  \\$aAspartic Acid Proteinases
=450  \\$aAspartic Proteinases
=450  \\$wnnna$aAspartyl Proteases
=450  \\$aAspartyl Proteinases
=450  \\$wnnna$aProteases, Aspartic Acid
=450  \\$wnnna$aProteases, Aspartyl
=450  \\$wnnna$aProteinases, Aspartic
=450  \\$wnnna$aProteinases, Aspartic Acid
=450  \\$wnnna$aProteinases, Aspartyl
=550  \\$wg$aPeptide Hydrolases
=550  \\$wh$aAspartic Acid Endopeptidases
=680  \\$iA subclass of peptide hydrolases that depend on an ASPARTIC ACID residue for their activity.
=688  \\$a2010; use ASPARTIC ACID ENDOPEPTIDASES 1991-2009
=750  \0$aAspartic proteinases$0(DLC) sh 85008691$5IEN

=LDR  01238cz  a2200325n  4500
=001  9880364559302441
=005  20141212221821.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057051
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x210.$x637
=150  \\$aProduct Recalls and Withdrawals
=450  \\$wnnna$aMarket Withdrawal
=450  \\$wnnna$aMarket Withdrawals
=450  \\$wnnna$aProduct Recall
=450  \\$wnnna$aProduct Recalls
=450  \\$wnnna$aProduct Withdrawal
=450  \\$wnnna$aProduct Withdrawals
=450  \\$wnnna$aRecalls, Product
=450  \\$wnnna$aWithdrawals, Market
=450  \\$wnnna$aWithdrawals, Product
=550  \\$wg$aConsumer Product Safety
=550  \\$wh$aDrug Recalls
=550  \\$wh$aMedical Device Recalls
=550  \\$wh$aSafety-Based Drug Withdrawals
=550  \\$wh$aSafety-Based Medical Device Withdrawals
=667  \\$ageneral; prefer specifics
=680  \\$iThe removal of a consumer product from the market place. The reason for the removal can be due a variety of causes, including the discovery of a manufacturing defect, a safety issue with the product's use, or marketing decisions.
=688  \\$a2010
=750  \0$aProduct recall$0(DLC) sh 85107205$5IEN-M

=LDR  00914cz  a2200229n  4500
=001  9880364559402441
=005  20141212221820.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057048
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x780
=150  \\$aPlant Nectar
=450  \\$aNectar
=450  \\$wnnna$aNectar, Plant
=450  \\$wnnna$aNectars
=450  \\$wnnna$aNectars, Plant
=450  \\$wnnna$aPlant Nectars
=550  \\$wg$aBiological Products
=680  \\$iSugar-rich liquid produced in plant glands called nectaries. It is either produced in flowers or other plant structures, providing a source of attraction for pollinating insects and animals, as well as being a nutrient source to animal mutualists which provide protection of plants against herbivores.
=688  \\$a2010
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Nectar
=750  \0$aNectar$0(DLC) sh 85090578$5IEN-M

=LDR  00903cz  a2200289n  4500
=001  9880364559502441
=005  20141212221819.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x293.$x69
=150  \\$aBioengineering
=450  \\$wnnna$aBio engineering
=450  \\$aBio-Engineering
=450  \\$wnnna$aBio engineerings
=450  \\$wnnna$aBioengineerings
=450  \\$wnnna$aBiological Engineering
=450  \\$wnnna$aengineering, Bio
=450  \\$wnnna$aEngineering, Biological
=450  \\$wnnna$aengineerings, Bio
=550  \\$wg$aEngineering
=550  \\$wh$aBioprinting
=550  \\$wh$aCell Engineering
=550  \\$wh$aSynthetic Biology
=680  \\$iThe application of engineering principles and methods to living organisms or biological systems.
=688  \\$a2010
=750  \0$aBioengineering$0(DLC) sh 85014134$5IEN-M

=LDR  01462cz  a2200349n  4500
=001  9880364559602441
=005  20141212221815.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056969
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x887
=150  \\$aVoltage-Sensitive Dye Imaging
=450  \\$wnnna$aAction Potential Optical Mapping
=450  \\$wnnna$aAnatomic Electrical Activity Optical Mapping
=450  \\$wnnna$aImaging, Voltage-Sensitive Dye
=450  \\$wnnna$aMapping, Optical Vm
=450  \\$wnnna$aMappings, Optical Vm
=450  \\$wnnna$aOptical Action Potential Mapping
=450  \\$wnnna$aOptical Mapping, Action Potential
=450  \\$wnnna$aOptical Mapping, Anatomic Electrical Activity
=450  \\$wnnna$aOptical Mapping, Transmembrane Potential
=450  \\$wnnna$aOptical Transmembrane Potential Mapping
=450  \\$wnnna$aOptical Vm Mapping
=450  \\$wnnna$aOptical Vm Mappings
=450  \\$wnnna$aTransmembrane Potential Optical Mapping
=450  \\$wnnna$aVm Mapping, Optical
=450  \\$wnnna$aVm Mappings, Optical
=450  \\$wnnna$aVoltage Sensitive Dye Imaging
=550  \\$wg$aDiagnostic Imaging
=680  \\$iOptical imaging techniques used for recording patterns of electrical activity in tissues by monitoring transmembrane potentials via FLUORESCENCE imaging with voltage-sensitive fluorescent dyes.
=688  \\$a2010
=750  \0$aVoltage-sensitive dyes$0(DLC)sh2014000740$5IEN-M

=LDR  02150cz  a2200445n  4500
=001  9880364559702441
=005  20141212221813.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056951
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x618
=150  \\$aPhotoelectron Spectroscopy
=450  \\$wnnna$aElectron Spectroscopy for Chemical Analysis
=450  \\$wnnna$aEmission Spectroscopies, Photoelectron
=450  \\$wnnna$aEmission Spectroscopy, Photoelectron
=450  \\$wnnna$aPhotoelectron Emission Spectroscopy
=450  \\$aPhotoelectron Spectrometry
=450  \\$wnnna$aPhotoelectron Spectroscopy, Ultra-Violet
=450  \\$wnnna$aPhotoelectron Spectroscopy, Ultraviolet
=450  \\$wnnna$aPhotoelectron Spectroscopy, X-Ray
=450  \\$wnnna$aPhotoelectron Spectroscopy, Xray
=450  \\$wnnna$aPhotoemission Spectroscopy
=450  \\$wnnna$aSpectrometry, Photoelectron
=450  \\$wnnna$aSpectroscopy, Photoelectron
=450  \\$wnnna$aSpectroscopy, Photoelectron Emission
=450  \\$wnnna$aSpectroscopy, Photoemission
=450  \\$wnnna$aSpectroscopy, Ultra-Violet Photoelectron
=450  \\$wnnna$aSpectroscopy, Ultraviolet Photoelectron
=450  \\$wnnna$aSpectroscopy, X-Ray Photoelectron
=450  \\$wnnna$aSpectroscopy, Xray Photoelectron
=450  \\$wnnna$aUltra-Violet Photoelectron Spectroscopy
=450  \\$wnnna$aUltra Violet Photoelectron Spectroscopy
=450  \\$wnnna$aUltraviolet Photoelectron Spectroscopy
=450  \\$wnnna$aX-Ray Photoelectron Spectroscopy
=450  \\$wnnna$aX Ray Photoelectron Spectroscopy
=450  \\$wnnna$aXray Photoelectron Spectroscopy
=550  \\$wg$aSpectrum Analysis
=680  \\$iThe study of the energy of electrons ejected from matter by the photoelectric effect, i.e., as a direct result of absorption of energy from electromagnetic radiation. As the energies of the electrons are characteristic of a specific element, the measurement of the energy of these electrons is a technique used to determine the chemical composition of surfaces.
=688  \\$a2010
=750  \0$aPhotoelectron spectroscopy$0(DLC) sh 85101164$5IEN-M

=LDR  01057cz  a2200241n  4500
=001  9880364559802441
=005  20141212221811.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056931
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x128.$x150
=072  \\$aD12.$x776.$x189.$x250
=072  \\$aD12.$x776.$x331.$x180
=072  \\$aD12.$x776.$x765.$x593.$x500
=150  \\$aCryptochromes
=450  \\$wnnna$aCryptochrome
=450  \\$aCryptochrome Proteins
=550  \\$wg$aCircadian Rhythm Signaling Peptides and Proteins
=550  \\$wg$aFlavoproteins
=550  \\$wg$aPhotoreceptors, Plant
=680  \\$iFlavoproteins that function as circadian rhythm signaling proteins in ANIMALS and as blue-light photoreceptors in PLANTS. They are structurally-related to DNA PHOTOLYASES and it is believed that both classes of proteins may have originated from an earlier protein that played a role in protecting primitive organisms from the cyclical exposure to UV LIGHT.
=688  \\$a2010(1990)
=750  \0$aCryptochrome$0(DLC) sh 99003783$5IEN-M

=LDR  01403cz  a2200325n  4500
=001  9880364559902441
=005  20141212193136.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056928
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x972
=150  \\$aX-Ray Absorption Spectroscopy
=450  \\$wnnna$aAbsorption Spectroscopy, X-Ray
=450  \\$wnnna$aNear-Edge X-Ray Absorption Fine Structure Spectroscopy
=450  \\$aNear Edge X-Ray Absorption Fine Structure Spectroscopy
=450  \\$wnnna$aNear Edge X Ray Absorption Fine Structure Spectroscopy
=450  \\$wnnna$aNEXAFS Spectroscopy
=450  \\$wnnna$aSpectroscopy, NEXAFS
=450  \\$wnnna$aSpectroscopy, X-Ray Absorption
=450  \\$wnnna$aSpectroscopy, XANES
=450  \\$wnnna$aX-Ray Absorption Near Edge Structure Spectroscopy
=450  \\$wnnna$aX-Ray Absorption Near-Edge Structure Spectroscopy
=450  \\$wnnna$aX Ray Absorption Near Edge Structure Spectroscopy
=450  \\$wnnna$aX Ray Absorption Spectroscopy
=450  \\$wnnna$aXANES Spectroscopy
=550  \\$wg$aSpectrum Analysis
=550  \\$aAbsorption, Radiation
=680  \\$iAnalysis of the energy absorbed across a spectrum of x-ray energies/wavelengths to determine the chemical structure and electronic states of the absorbing medium.
=688  \\$a2010
=750  \0$aX-ray absorption near edge structure$0(DLC) sh 85148727$5IEN-M

=LDR  01244cz  a2200205n  4500
=001  9880364560002441
=005  20200512113537.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056912
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x375.$x175
=150  \\$aBinge-Eating Disorder
=450  \\$wnnna$aBinge Eating Disorder
=450  \\$wnnna$aBinge-Eating Disorders
=450  \\$wnnna$aDisorder, Binge-Eating
=450  \\$wnnna$aDisorders, Binge-Eating
=550  \\$wg$aFeeding and Eating Disorders
=680  \\$iA disorder associated with three or more of the following: eating until feeling uncomfortably full; eating large amounts of food when not physically hungry; eating much more rapidly than normal; eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months. The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)
=688  \\$a2010; use BULIMIA NERVOSA 2000-2009
=750  \0$iRelated mapping$aCompulsive eating$0(DLC) sh 87007395$4RM$5IEN-M

=LDR  00825cz  a2200229n  4500
=001  9880364560102441
=005  20141212221804.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x680.$x150.$x600
=150  \\$aPlasmodiophorida
=450  \\$aPlasmodiophora
=450  \\$wnnna$aPlasmodiophorid
=450  \\$wnnna$aPlasmodiophorids
=450  \\$wnnna$aPlasmodiophoromycetes
=450  \\$aPolymyxa
=550  \\$wg$aCercozoa
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA group of EUKARYOTES that are parasites of plants. Life cycle stages include zoospores and plasmodia.
=688  \\$a2010
=750  \0$aPlasmodiophora$0(DLC) sh 88022214$5IEN-M

=LDR  00831cz  a2200205n  4500
=001  9880364560202441
=005  20141212221803.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x680.$x275
=150  \\$aForaminifera
=450  \\$wnnna$aForam
=450  \\$wnnna$aForaminiferida
=450  \\$wnnna$aForams
=550  \\$wg$aRhizaria
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of amoeboid EUKARYOTES characterized by reticulating pseudopods and a complex life cycle with an alternation of generations. Most are less than 1mm in size and found in marine or brackish water.
=688  \\$a2010
=750  \0$aForaminifera$0(DLC) sh 85050443$5IEN-M

=LDR  00948cz  a2200265n  4500
=001  9880364560302441
=005  20141212221802.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x200
=150  \\$aClinical Alarms
=450  \\$wnnna$aAlarm, Clinical
=450  \\$wnnna$aAlarm, Physiologic Monitor
=450  \\$wnnna$aAlarms, Clinical
=450  \\$wnnna$aAlarms, Physiologic Monitor
=450  \\$wnnna$aClinical Alarm
=450  \\$wnnna$aMonitor Alarm, Physiologic
=450  \\$wnnna$aMonitor Alarms, Physiologic
=450  \\$wnnna$aPhysiologic Monitor Alarm
=450  \\$wnnna$aPhysiologic Monitor Alarms
=550  \\$wg$aDiagnostic Equipment
=680  \\$iComponents of medical instrumentation used for physiological evaluation of patients, that signal when a threshold value is reached.
=688  \\$a2010
=750  \0$aMonitor alarms (Medicine)$0(DLC) sh 92000809$5IEN-M

=LDR  01872cz  a2200493n  4500
=001  9880364094802441
=005  20200817150224.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018123
=035  \\$aCRE7047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420
=150  \\$aReceptors, Interleukin
=450  \\$wnnna$aInterleukin Receptor
=450  \\$aInterleukin Receptors
=450  \\$wnnna$aInterleukins Receptors
=450  \\$wnnna$aReceptor, Interleukin
=450  \\$wnnna$aReceptors, Interleukins
=550  \\$wg$aReceptors, Cytokine
=550  \\$wh$aReceptors, Interleukin-1
=550  \\$wh$aReceptors, Interleukin-10
=550  \\$wh$aReceptors, Interleukin-11
=550  \\$wh$aReceptors, Interleukin-12
=550  \\$wh$aReceptors, Interleukin-13
=550  \\$wh$aReceptors, Interleukin-15
=550  \\$wh$aReceptors, Interleukin-16
=550  \\$wh$aReceptors, Interleukin-17
=550  \\$wh$aReceptors, Interleukin-18
=550  \\$wh$aReceptors, Interleukin-2
=550  \\$wh$aReceptors, Interleukin-21
=550  \\$wh$aReceptors, Interleukin-3
=550  \\$wh$aReceptors, Interleukin-4
=550  \\$wh$aReceptors, Interleukin-5
=550  \\$wh$aReceptors, Interleukin-6
=550  \\$wh$aReceptors, Interleukin-7
=550  \\$wh$aReceptors, Interleukin-8
=550  \\$wh$aReceptors, Interleukin-9
=550  \\$wh$aReceptors, Interleukin-17
=667  \\$aGEN; prefer specific; DF: RECEPT INTERLEUKIN
=680  \\$iCell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aInterleukins$0(DLC)) sh2002002652$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch under the LCSH heading$aInterleukins--Receptors$5IEN-M

=LDR  01416cz  a2200373n  4500
=001  9880364094902441
=005  20190423100749.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018121
=035  \\$aCRE7045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852
=150  \\$aReceptors, Cytokine
=450  \\$wnnna$aCytokine Receptor
=450  \\$aCytokine Receptors
=450  \\$wnnna$aCytokines Receptors
=450  \\$wnnna$aReceptor, Cytokine
=450  \\$wnnna$aReceptors, Cytokines
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aReceptors, Chemokine
=550  \\$wh$aReceptors, Colony-Stimulating Factor
=550  \\$wh$aReceptors, Interferon
=550  \\$wh$aReceptors, Interleukin
=550  \\$wh$aReceptors, Oncostatin M
=550  \\$wh$aReceptors, OSM-LIF
=550  \\$wh$aReceptors, Thrombopoietin
=550  \\$wh$aReceptors, Transforming Growth Factor beta
=550  \\$wh$aReceptors, Tumor Necrosis Factor
=667  \\$aDF: RECEPT CYTOKINE
=680  \\$iCell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aCytokines$0(DLC)sh 85035236$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCytokines--Receptors$5IEN-M

=LDR  01564cz  a2200409n  4500
=001  9880364095002441
=005  20141212192804.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018118
=035  \\$aCRE7042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x175
=072  \\$aD12.$x776.$x543.$x550.$x425.$x175
=072  \\$aD12.$x776.$x543.$x585.$x400.$x175
=150  \\$aChloride Channels
=450  \\$wnnna$aCalcium-Activated Chloride Channels
=450  \\$wnnna$aCalcium Activated Chloride Channels
=450  \\$wnnna$aChannel, Chloride
=450  \\$wnnna$aChannel, Chloride Ion
=450  \\$wnnna$aChannels, Calcium-Activated Chloride
=450  \\$wnnna$aChannels, Chloride
=450  \\$wnnna$aChannels, Chloride Ion
=450  \\$wnnna$aChannels, Chlorine
=450  \\$wnnna$aChloride Channel
=450  \\$wnnna$aChloride Channels, Calcium-Activated
=450  \\$wnnna$aChloride Ion Channel
=450  \\$wnnna$aChloride Ion Channels
=450  \\$wnnna$aChlorine Channels
=450  \\$wnnna$aIon Channel, Chloride
=450  \\$aIon Channels, Chloride
=550  \\$wg$aIon Channels
=550  \\$wh$aCystic Fibrosis Transmembrane Conductance Regulator
=550  \\$wh$aReceptors, GABA-A
=550  \\$wh$aReceptors, Glycine
=680  \\$iCell membrane glycoproteins that form channels to selectively pass chloride ions. Nonselective blockers include FENAMATES; ETHACRYNIC ACID; and TAMOXIFEN.
=688  \\$a94; was CHLORIDE CHANNELS (NM) 1988-93
=750  \0$aChloride channels$5IEN$0(DLC)sh 88002755

=LDR  01385cz  a2200289n  4500
=001  9880364095102441
=005  20190429151809.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018110
=035  \\$aCRE7034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x710
=150  \\$aReceptors, Lipoprotein
=450  \\$wnnna$aLipoprotein Receptor
=450  \\$aLipoprotein Receptors
=450  \\$wnnna$aLipoproteins Receptors
=450  \\$wnnna$aReceptor, Lipoprotein
=450  \\$wnnna$aReceptors, Lipoproteins
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aReceptors, LDL
=550  \\$aLipoproteins
=667  \\$aGEN; RECEPTORS, LDL is available; DF: RECEPT LIPOPROTEIN
=680  \\$iCell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.
=688  \\$a94; was LIPOPROTEIN RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aLipoproteins$0(DLC)sh 85077309$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLipoproteins--Receptors$5IEN-M

=LDR  01298cz  a2200325n  4500
=001  9880364095202441
=005  20190426153812.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018092
=035  \\$aCRE7016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x400.$x500.$x200
=072  \\$aD12.$x776.$x543.$x550.$x450.$x500.$x200.$x200
=072  \\$aD12.$x776.$x543.$x585.$x400.$x500.$x200.$x200
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x450.$x400.$x200
=150  \\$aReceptors, Kainic Acid
=450  \\$wnnna$aKainate Receptor
=450  \\$aKainate Receptors
=450  \\$wnnna$aKainic Acid Receptor
=450  \\$aKainic Acid Receptors
=450  \\$wnnna$aReceptor, Kainate
=450  \\$wnnna$aReceptor, Kainic Acid
=450  \\$aReceptors, Kainate
=550  \\$wg$aReceptors, Ionotropic Glutamate
=550  \\$aKainic Acid
=680  \\$iA class of ionotropic glutamate receptors characterized by their affinity for KAINIC ACID.
=688  \\$a94; was KAINIC ACID RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aKainic acid$0(DLC) sh 85071296$4BM$5IEN-M
=780  \0$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aKainic acid--Receptors$5IEN-M

=LDR  01005cz  a2200193n  4500
=001  9880364095302441
=005  20141212212420.0
=008  930701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018089
=035  \\$aCRE7014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x820
=150  \\$aSuperantigens
=550  \\$wg$aAntigens
=550  \\$wh$aMinor Lymphocyte Stimulatory Antigens
=667  \\$acoordinate IM with specific microbe /immunol (IM); for interaction of superantigens with endotoxins, coordinate with ENDOTOXINS or specifics
=680  \\$iMicrobial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor's pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions.
=688  \\$a94
=750  \0$aSuperantigens$5IEN-M$0(DLC)sh 93007140

=LDR  01892cz  a2200361n  4500
=001  9880364095402441
=005  20141212212420.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018088
=035  \\$aCRE7013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x775
=150  \\$aTuberculosis, Multidrug-Resistant
=450  \\$wnnna$aDrug-Resistant Tuberculosis
=450  \\$wnnna$aMDR Tuberculosis
=450  \\$wnnna$aMulti-Drug Resistant Tuberculosis
=450  \\$wnnna$aMultidrug-Resistant Tuberculosis
=450  \\$aTuberculosis, Drug-Resistant
=450  \\$wnnna$aTuberculosis, Drug Resistant
=450  \\$wnnna$aTuberculosis, MDR
=450  \\$wnnna$aTuberculosis, Multi-Drug Resistant
=450  \\$wnnna$aTuberculosis, Multi Drug Resistant
=450  \\$wnnna$aTuberculosis, Multidrug Resistant
=550  \\$wg$aTuberculosis
=550  \\$wh$aExtensively Drug-Resistant Tuberculosis
=550  \\$aAntitubercular Agents
=550  \\$aDrug Resistance, Bacterial
=550  \\$aDrug Resistance, Microbial
=550  \\$aDrug Resistance, Multiple, Bacterial
=667  \\$acoordinate with specific type of tuberculosis + specific antitubercular agents if pertinent; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS is also available
=680  \\$iTuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.
=688  \\$a94
=750  \0$aMultidrug-resistant tuberculosis$0(DLC) sh2007003767$5IEN-M

=LDR  00963cz  a2200301n  4500
=001  9880364095502441
=005  20141212212419.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018087
=035  \\$aCRE7012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x700
=150  \\$aPlastids
=450  \\$wnnna$aAmyloplast
=450  \\$aAmyloplasts
=450  \\$wnnna$aChromoplast
=450  \\$aChromoplasts
=450  \\$wnnna$aLeucoplast
=450  \\$wnnna$aLeucoplasts
=450  \\$wnnna$aLeukoplast
=450  \\$wnnna$aLeukoplasts
=450  \\$wnnna$aPlastid
=550  \\$wg$aOrganelles
=550  \\$wh$aApicoplasts
=550  \\$wh$aChloroplasts
=680  \\$iSelf-replicating cytoplasmic organelles of plant and algal cells that contain pigments and may synthesize and accumulate various substances. PLASTID GENOMES are used in phylogenetic studies.
=688  \\$a94
=750  \0$aPlastids$5IEN-M$0(DLC)sh 85103222

=LDR  01182cz  a2200277n  4500
=001  9880364095602441
=005  20141212192804.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018084
=035  \\$aCRE7009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x855
=072  \\$aE4.$x502.$x890
=150  \\$aUltrasonography, Interventional
=450  \\$wnnna$aInterventional Ultrasonography
=450  \\$wnnna$aInterventional Ultrasound
=450  \\$wnnna$aIntravascular Ultrasonography
=450  \\$aUltrasonography, Intravascular
=450  \\$aUltrasound, Interventional
=550  \\$wg$aMinimally Invasive Surgical Procedures
=550  \\$wg$aUltrasonography
=550  \\$wh$aEndoscopic Ultrasound-Guided Fine Needle Aspiration
=667  \\$acoordinate with specific minimally invasive procedure if pertinent
=680  \\$iThe use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.
=688  \\$a94
=750  \0$aOperative ultrasonography$5IEN-M$0(DLC)sh 88001876

=LDR  01726cz  a2200349n  4500
=001  9880364095702441
=005  20190423163704.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018079
=035  \\$aCRE7005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x300
=150  \\$aReceptors, GABA
=450  \\$wnnna$aGABA Receptor
=450  \\$aGABA Receptors
=450  \\$wnnna$agamma-Aminobutyric Acid Receptor
=450  \\$wnnna$agamma Aminobutyric Acid Receptor
=450  \\$agamma-Aminobutyric Acid Receptors
=450  \\$wnnna$agamma Aminobutyric Acid Receptors
=450  \\$wnnna$aReceptor, GABA
=450  \\$wnnna$aReceptor, gamma-Aminobutyric Acid
=450  \\$aReceptors, gamma-Aminobutyric Acid
=450  \\$wnnna$aReceptors, gamma Aminobutyric Acid
=550  \\$wg$aReceptors, Amino Acid
=550  \\$wh$aReceptors, GABA-A
=550  \\$wh$aReceptors, GABA-B
=550  \\$aGABA Plasma Membrane Transport Proteins
=550  \\$agamma-Aminobutyric Acid
=667  \\$aGEN; prefer specifics; DF: RECEPT GABA
=680  \\$iCell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.
=688  \\$a94; GABA RECEPTORS & RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93
=750  \0$aGABA$xReceptors$0(DLC)sh 85052650$5IEN-M

=LDR  01754cz  a2200397n  4500
=001  9880364095802441
=005  20190429153830.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018077
=035  \\$aCRE7003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x200.$x450
=150  \\$aReceptors, Leukotriene
=450  \\$wnnna$aLeukotriene Receptor
=450  \\$aLeukotriene Receptors
=450  \\$wnnna$aLeukotrienes Receptors
=450  \\$wnnna$aReceptor, Leukotriene
=450  \\$wnnna$aReceptor, SRS-A
=450  \\$wnnna$aReceptors, Leukotrienes
=450  \\$aReceptors, SRS-A
=450  \\$wnnna$aReceptors, SRS A
=450  \\$wnnna$aSlow Reacting Substance of Anaphylaxis Receptors
=450  \\$wnnna$aSlow Reaction Substance of Anaphylaxis Receptors
=450  \\$wnnna$aSRS-A Receptor
=450  \\$wnnna$aSRS A Receptor
=450  \\$aSRS-A Receptors
=450  \\$wnnna$aSRS A Receptors
=550  \\$wg$aReceptors, Eicosanoid
=550  \\$wh$aReceptors, Leukotriene B4
=550  \\$aLeukotrienes
=667  \\$aRECEPTORS, LEUKOTRIENE B4 is also available; DF: RECEPT LEUKOTRIENE
=680  \\$iCell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4.
=688  \\$a94; was SRS-A RECEPTOR (NM) 1983-93
=750  \0$81$wb$iBroader mapping$aLeukotrienes$ 0(DLC)sh 85076302$ 4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLeukotrienes--Receptors$5IEN-M

=LDR  01480cz  a2200361n  4500
=001  9880364095902441
=005  20141212212414.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018070
=035  \\$aCRE6996M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65
=150  \\$aBiological Specimen Banks
=450  \\$wnnna$aBank, Biological Specimen
=450  \\$wnnna$aBank, Biological Substance
=450  \\$wnnna$aBanks, Biological Specimen
=450  \\$wnnna$aBanks, Biological Substance
=450  \\$wnnna$aBiological Specimen Bank
=450  \\$wnnna$aBiological Substance Bank
=450  \\$aBiological Substance Banks
=450  \\$wnnna$aSpecimen Bank, Biological
=450  \\$wnnna$aSpecimen Banks, Biological
=450  \\$wnnna$aSubstance Bank, Biological
=450  \\$wnnna$aSubstance Banks, Biological
=550  \\$wg$aHealth Facilities
=550  \\$wh$aBlood Banks
=550  \\$wh$aMilk Banks
=550  \\$wh$aSperm Banks
=550  \\$wh$aTissue Banks
=667  \\$ahuman or animal material; GEN or unspecified; prefer specifics; American Type Culture Collection (ATCC) goes here; DF: BIOL SPECIMEN BANKS
=680  \\$iFacilities that collect, store, and distribute tissues, e.g., cell lines, microorganisms, blood, sperm, milk, breast tissue, for use by others. Other uses may include transplantation and comparison of diseased tissues in the identification of cancer.
=688  \\$a94
=750  \0$aBiobanks$0(DLC)sh2007009383$5IEN-M

=LDR  00955cz  a2200289n  4500
=001  9880364096002441
=005  20141212212413.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018067
=035  \\$aCRE6993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250
=072  \\$aB4.$x909.$x777.$x310
=150  \\$aFlaviviridae
=450  \\$aGB Hepatitis Agents$5IEN-HS
=450  \\$wnno$aHepatitis Agents, GB$5IEN-HS
=550  \\$wg$aRNA Viruses
=550  \\$wh$aFlavivirus
=550  \\$wh$aGB virus A
=550  \\$wh$aGB virus C
=550  \\$wh$aHepacivirus
=550  \\$wh$aPestivirus
=550  \\$aArboviruses
=667  \\$ainfection = FLAVIVIRIDAE INFECTIONS
=680  \\$iA family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.
=688  \\$a94
=750  \0$aFlaviviruses$5IEN-M$0(DLC)sh 86002175

=LDR  00910cz  a2200265n  4500
=001  9880364096102441
=005  20141212212411.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018058
=035  \\$aCRE6985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x903
=072  \\$aC26.$x930
=150  \\$aTympanic Membrane Perforation
=450  \\$aEardrum Perforation
=450  \\$wnnna$aMembrane Perforation, Tympanic
=450  \\$wnnna$aMembrane Rupture, Tympanic
=450  \\$wnnna$aPerforation, Eardrum
=450  \\$wnnna$aRupture, Tympanic Membrane
=450  \\$aTympanic Membrane Rupture
=550  \\$wg$aEar Diseases
=550  \\$wg$aWounds and Injuries
=680  \\$iA temporary or persistent opening in the eardrum (TYMPANIC MEMBRANE). Clinical signs depend on the size, location, and associated pathological condition.
=688  \\$a94
=750  \0$aTympanic membrane$xRupture$5IEN-M

=LDR  01162cz  a2200373n  4500
=001  9880364096202441
=005  20170609123046.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018056
=035  \\$aCRE6983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x830.$x250
=072  \\$aG9.$x188.$x370
=072  \\$aG9.$x330.$x380.$x630
=150  \\$aHemorheology
=450  \\$wnnna$aHemorrheology
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aHemodynamics
=550  \\$wg$aRheology
=550  \\$wh$aBlood Flow Velocity
=550  \\$wh$aBlood Viscosity
=550  \\$wh$aErythrocyte Aggregation
=550  \\$wh$aErythrocyte Deformability
=550  \\$wh$aHematocrit
=550  \\$wh$aPlatelet Aggregation
=550  \\$wh$aPulsatile Flow
=550  \\$aBlood Viscosity
=550  \\$aErythrocyte Aggregation
=550  \\$aErythrocyte Deformability
=550  \\$aMaterials Testing
=667  \\$aDF: HEMORHEOL
=680  \\$iThe deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS.
=688  \\$a94
=750  \0$aBlood$xRheology$5IEN-M$0(DLC)sh 88007874

=LDR  01445cz  a2200349n  4500
=001  9880364096302441
=005  20190423144809.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018055
=035  \\$aCRE6982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x75
=072  \\$aD12.$x776.$x543.$x750.$x100.$x200
=150  \\$aReceptors, Eicosanoid
=450  \\$wnnna$aEicosanoid Receptor
=450  \\$aEicosanoid Receptors
=450  \\$wnnna$aEicosanoids Receptor
=450  \\$wnnna$aReceptor, Eicosanoid
=450  \\$wnnna$aReceptor, Eicosanoids
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, Leukotriene
=550  \\$wh$aReceptors, Lipoxin
=550  \\$wh$aReceptors, Prostaglandin
=550  \\$wh$aReceptors, Thromboxane
=550  \\$aEicosanoids
=667  \\$aGEN; prefer specifics; DF: RECEPT EICOSANOID
=680  \\$iCell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behavior of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aEicosanoids$0(DLC) sh 97001640$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \\$iSearch also under the Library of Congress Subject Heading:$aEicosanoids--Receptors$5IEN-M

=LDR  00746cz  a2200241n  4500
=001  9880364096402441
=005  20141212212409.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018054
=035  \\$aCRE6981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x300
=072  \\$aD1.$x139.$x300
=150  \\$aHydrobromic Acid
=450  \\$wnnna$aAcid, Hydrobromic
=450  \\$wnnna$aBromide, Hydrogen
=450  \\$wnnna$aHydrogen Bromide
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aBromine Compounds
=550  \\$wh$aBromides
=680  \\$iHydrobromic acid (HBr). A solution of hydrogen bromide gas in water.
=688  \\$a94; was HYDROBROMIC ACID (NM) 1974-93
=750  \0$aHydrobromic acid$5IEN-M$0(DLC)sh 85063370

=LDR  01982cz  a2200457n  4500
=001  9880364096502441
=005  20190506123457.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018048
=035  \\$aCRE6975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x700.$x720
=072  \\$aD12.$x776.$x543.$x750.$x810.$x720
=150  \\$aReceptors, Purinergic P2
=450  \\$wnnna$aADP Receptor
=450  \\$aADP Receptors
=450  \\$wnnna$aATP Receptor
=450  \\$aATP Receptors
=450  \\$wnnna$aP2 Purinoceptor
=450  \\$aP2 Purinoceptors
=450  \\$wnnna$aP2 Receptor, Purinergic
=450  \\$wnnna$aP2 Receptors, Purinergic
=450  \\$wnnna$aPurinergic P2 Receptor
=450  \\$aPurinergic P2 Receptors
=450  \\$wnnna$aPurinoceptor, P2
=450  \\$wnnna$aPurinoceptors, P2
=450  \\$wnnna$aReceptor, ADP
=450  \\$wnnna$aReceptor, ATP
=450  \\$wnnna$aReceptor, Purinergic P2
=450  \\$aReceptors, ADP
=450  \\$aReceptors, ATP
=550  \\$wg$aReceptors, Purinergic
=550  \\$wh$aReceptors, Purinergic P2X
=550  \\$wh$aReceptors, Purinergic P2Y
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA class of cell surface receptors for PURINES that prefer ATP or ADP over ADENOSINE. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system.
=688  \\$a94; ADP RECEPTORS & ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP & RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993
=750  \0$81$wb$iBroader mapping$aAdenosine diphosphate$0(DLC)sh 89006798$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aAdenosine triphosphate$0(DLC)sh sh 85000849$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings:$aAdenosine diphosphate--Receptors$ior$aAdenosine Triphosphate--Receptors$5IEN-M

=LDR  01843cz  a2200409n  4500
=001  9880364096602441
=005  20190506120858.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018047
=035  \\$aCRE6974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x700.$x700
=072  \\$aD12.$x776.$x543.$x750.$x720.$x700.$x700
=150  \\$aReceptors, Purinergic P1
=450  \\$wnnna$aAdenosine Receptor
=450  \\$aAdenosine Receptors
=450  \\$wnnna$aP1 Purinoceptor
=450  \\$aP1 Purinoceptors
=450  \\$wnnna$aP1 Receptor, Purinergic
=450  \\$wnnna$aP1 Receptors, Purinergic
=450  \\$wnnna$aPurinergic P1 Receptor
=450  \\$aPurinergic P1 Receptors
=450  \\$wnnna$aPurinoceptor, P1
=450  \\$wnnna$aPurinoceptors, P1
=450  \\$wnnna$aReceptor, Adenosine
=450  \\$wnnna$aReceptor, Purinergic P1
=450  \\$aReceptors, Adenosine
=550  \\$wg$aReceptors, Purinergic
=550  \\$wh$aReceptor, Adenosine A1
=550  \\$wh$aReceptor, Adenosine A3
=550  \\$wh$aReceptors, Adenosine A2
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).
=688  \\$a94; ADENOSINE RECEPTORS was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993
=750  \0$81$wb$iBroader mapping$aAdenosine$0(DLC)sh 85000846$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAdenosine--Receptors$5IEN-M

=LDR  01194cz  a2200289n  4500
=001  9880364096702441
=005  20141212212407.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018046
=035  \\$aCRE6973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x822.$x750.$x695.$x700
=072  \\$aD12.$x644.$x861.$x695.$x700
=072  \\$aD12.$x776.$x645.$x750.$x695.$x700
=072  \\$aD12.$x776.$x872.$x695.$x700
=150  \\$aProtein C Inhibitor
=450  \\$wnnna$aActivated Protein C Inhibitor
=450  \\$aPAI-3
=450  \\$aPlasminogen Activator Inhibitor 3
=450  \\$wnnna$aPlasminogen Activator Inhibitor, Type 3
=450  \\$wnnna$aProtein C Inhibitor, Activated
=450  \\$wnnna$aSerpin A5
=450  \\$wnnna$aType 3 Plasminogen Activator Inhibitor
=550  \\$wg$aPlasminogen Inactivators
=680  \\$iA member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and is able to inhibit activated PROTEIN C; THROMBIN; KALLIKREIN; and other SERINE ENDOPEPTIDASES.
=688  \\$a94; was PROTEIN C INHIBITOR (NM) 1981-93; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93
=750  \0$aProtein C$xInhibitors$5IEN-M

=LDR  01514cz  a2200313n  4500
=001  9880364096802441
=005  20190501111700.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018045
=035  \\$aCRE6972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x630
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x630
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x630
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x600
=150  \\$aReceptors, Oxytocin
=450  \\$wnnna$aOxytocin Receptor
=450  \\$aOxytocin Receptors
=450  \\$wnnna$aReceptor, Oxytocin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aOxytocin
=667  \\$aDF: RECEPT OXYTOCIN
=680  \\$iCell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter.
=688  \\$a94; was OXYTOCIN RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aOxytocin$0(DLC)sh 85096354$4BM$5IEN-M
=780  \0$81$bw$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aOxytocin--Receptors$5IEN-M

=LDR  02029cz  a2200421n  4500
=001  9880364096902441
=005  20190423093441.0
=008  930614\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018043
=035  \\$aCRE6971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x285
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x285
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x285
=150  \\$aReceptors, Corticotropin
=450  \\$wnnna$aACTH Receptor
=450  \\$aACTH Receptors
=450  \\$wnnna$aAdrenocorticotropic Hormone Receptor
=450  \\$aAdrenocorticotropic Hormone Receptors
=450  \\$wnnna$aCorticotropin Receptor
=450  \\$aCorticotropin Receptors
=450  \\$wnnna$aHormone Receptor, Adrenocorticotropic
=450  \\$wnnna$aHormone Receptors, Adrenocorticotropic
=450  \\$wnnna$aReceptor, ACTH
=450  \\$wnnna$aReceptor, Adrenocorticotropic Hormone
=450  \\$wnnna$aReceptor, Corticotropin
=450  \\$aReceptors, ACTH
=450  \\$aReceptors, Adrenocorticotropic Hormone
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$wh$aReceptors, Melanocortin
=550  \\$aAdrenocorticotropic Hormone
=667  \\$aDF: RECEPT ACTH
=680  \\$iCell surface receptors that bind CORTICOTROPIN; (ACTH, adrenocorticotropic hormone) with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple ACTH receptors. An ACTH receptor has been cloned and belongs to a subfamily of G-protein-coupled receptors. In addition to the adrenal cortex, ACTH receptors are found in the brain and immune systems.
=688  \\$a94; was CORTICOTROPIN RECEPTOR (NM) 1981-93; CORTICOTROPIN RECEPTORS & ACTH RECEPTORS were SYs 1983-93
=750  \0$81$wb$iBroader mapping$aACTH$0(DLC)sh 85000684$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aACTH--Receptors$5IEN-M

=LDR  02499cz  a2200577n  4500
=001  9880364097002441
=005  20190501100210.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018040
=035  \\$aCRE6968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x862.$x500
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x830.$x500
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x830.$x500
=150  \\$aReceptors, Neurokinin-1
=450  \\$wnnna$aNeurokinin-1 Receptor
=450  \\$wnnna$aNeurokinin 1 Receptor
=450  \\$aNeurokinin-1 Receptors
=450  \\$wnnna$aNeurokinin 1 Receptors
=450  \\$wnnna$aNK-1 Receptor
=450  \\$wnnna$aNK 1 Receptor
=450  \\$aNK-1 Receptors
=450  \\$wnnna$aNK 1 Receptors
=450  \\$wnnna$aP Receptor, Substance
=450  \\$wnnna$aP Receptors, Substance
=450  \\$wnnna$aReceptor, Neurokinin-1
=450  \\$wnnna$aReceptor, NK-1
=450  \\$wnnna$aReceptor, SP-P
=450  \\$wnnna$aReceptor, Substance P
=450  \\$wnnna$aReceptor, Substance-P
=450  \\$wnnna$aReceptors, Neurokinin 1
=450  \\$wnnna$aReceptors, NK-1
=450  \\$wnnna$aReceptors, NK 1
=450  \\$wnnna$aReceptors, SP-P
=450  \\$wnnna$aReceptors, SP P
=450  \\$aReceptors, Substance P
=450  \\$wnnna$aSP-P Receptor
=450  \\$wnnna$aSP P Receptor
=450  \\$aSP-P Receptors
=450  \\$wnnna$aSP P Receptors
=450  \\$wnnna$aSubstance P Receptor
=450  \\$wnnna$aSubstance-P Receptor
=450  \\$aSubstance P Receptors
=450  \\$wnnna$aTachykinin Receptor 1
=550  \\$wg$aReceptors, Tachykinin
=550  \\$aSubstance P
=680  \\$iA class of cell surface receptors for TACHYKININS with a preference for SUBSTANCE P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.
=688  \\$a94; was SUBSTANCE P RECEPTOR (NM) 1981-93; NK-1 RECEPTOR & NEUROKININ-1 RECEPTOR were SY to SUBSTANCE K RECEPTOR 1986-93; NK-1 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93
=750  \0$81$wb$iBroader mapping$aSubstance P$0(DLC)sh 85129540$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSubstance P--Receptors$5IEN-M

=LDR  01516cz  a2200337n  4500
=001  9880364097102441
=005  20190507145552.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018039
=035  \\$aCRE6967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x862
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x830
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x830
=150  \\$aReceptors, Tachykinin
=450  \\$wnnna$aReceptor, Tachykinin
=450  \\$wnnna$aReceptors, Tachykinins
=450  \\$wnnna$aTachykinin Receptor
=450  \\$aTachykinin Receptors
=450  \\$wnnna$aTachykinins Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptors, Neurokinin-1
=550  \\$wh$aReceptors, Neurokinin-2
=550  \\$wh$aReceptors, Neurokinin-3
=550  \\$aTachykinins
=680  \\$iCell surface proteins that bind TACHYKININS with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, SUBSTANCE P; NEUROKININ A; and NEUROKININ B.
=688  \\$a94; was TACHYKININ RECEPTOR (NM) 1984-93
=750  \0$81$wb$iBroader mapping$aTachykinins$0(DLC)sh 85131850$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aTachykinins--Receptors$5IEN-M

=LDR  01272cz  a2200337n  4500
=001  9880364097202441
=005  20141212212403.0
=008  930617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018038
=035  \\$aCRE6966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x810.$x900.$x500
=072  \\$aD1.$x857.$x850
=150  \\$aSodium Selenite
=450  \\$wnnna$aBiselenite, Sodium
=450  \\$wnnna$aDisodium Selenite
=450  \\$wnnna$aMonosodium Selenite
=450  \\$wnnna$aPentahydrate, Sodium Selenite
=450  \\$wnnna$aSelenite, Disodium
=450  \\$wnnna$aSelenite, Monosodium
=450  \\$wnnna$aSelenite Pentahydrate, Sodium
=450  \\$wnnna$aSelenite, Sodium
=450  \\$wnnna$aSelenous Acid Disodium Salt
=450  \\$wnnna$aSelenous Acid, Disodium Salt
=450  \\$wnnna$aSodium Biselenite
=450  \\$wnnna$aSodium Selenite Pentahydrate
=550  \\$wg$aSelenious Acid
=550  \\$wg$aSodium Compounds
=680  \\$iThe disodium salt of selenious acid. It is used therapeutically to supply the trace element selenium and is prepared by the reaction of SELENIUM DIOXIDE with SODIUM HYDROXIDE.
=688  \\$a94; was SODIUM SELENITE (NM) 1992-93; was SY to SELENIOUS ACID (NM) 1980-91
=750  \0$aSelenites$5IEN-M$0(DLC)sh 90001887

=LDR  00722cz  a2200229n  4500
=001  9880364097302441
=005  20141212212403.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018036
=035  \\$aCRE6965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x810
=150  \\$aSelenium Compounds
=450  \\$wnnna$aCompounds, Selenium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aSelenic Acid
=550  \\$wh$aSelenious Acid
=550  \\$wh$aSelenium Oxides
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: SELENIUM CPDS
=680  \\$iInorganic compounds that contain selenium as an integral part of the molecule.
=688  \\$a94
=750  \0$aSelenium compounds$5IEN$0(DLC)sh 85119694

=LDR  01737cz  a2200397n  4500
=001  9880364097402441
=005  20141212212402.0
=008  930628\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018035
=035  \\$aCRE6964M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x600
=072  \\$aD12.$x776.$x543.$x750.$x735
=150  \\$aReceptors, Odorant
=450  \\$wnnna$aOdor Receptor Protein
=450  \\$wnnna$aOdorant Receptor
=450  \\$wnnna$aOdorant Receptor Proteins
=450  \\$aOdorant Receptors
=450  \\$wnnna$aOlfactory Receptor Protein
=450  \\$aOlfactory Receptor Proteins
=450  \\$wnnna$aProtein, Odor Receptor
=450  \\$wnnna$aProtein, Olfactory Receptor
=450  \\$wnnna$aProteins, Odorant Receptor
=450  \\$wnnna$aProteins, Olfactory Receptor
=450  \\$wnnna$aReceptor, Odorant
=450  \\$wnnna$aReceptor Protein, Odor
=450  \\$wnnna$aReceptor Protein, Olfactory
=450  \\$wnnna$aReceptor Proteins, Odorant
=450  \\$wnnna$aReceptor Proteins, Olfactory
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$aOlfactory Receptor Neurons
=667  \\$areceptors on cilia of olfactory receptor neurons; DF: RECEPT ODORANT
=680  \\$iProteins, usually projecting from the cilia of olfactory receptor neurons, that specifically bind odorant molecules and trigger responses in the neurons. The large number of different odorant receptors appears to arise from several gene families or subfamilies rather than from DNA rearrangement.
=688  \\$a94; ODORANT RECEPTORS was ODORANT RECEPTOR (SY) to ODORANT-BINDING PROTEIN (NM) 1993
=750  \0$aOlfactory receptors$0(DLC)sh2009000174$5IEN-M

=LDR  00835cz  a2200205n  4500
=001  9880364097502441
=005  20150601143603.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018031
=035  \\$aCRE6961M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x585.$x250.$x200
=150  \\$aConnexin 43
=450  \\$wnnna$a43, Connexin
=450  \\$wnnna$aConnexin43
=450  \\$aCx43
=550  \\$wg$aConnexins
=680  \\$iA 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes (the alpha-1 gene). It was first isolated from mammalian heart, but is widespread in the body including the brain.
=688  \\$a94; CONNEXIN 43 was (SY) to GAP JUNCTION PROTEIN 1991-93
=750  \0$aConnexin 43$0(DLC)sh2014002428$5IEN-M

=LDR  00645cz  a2200205n  4500
=001  9880364097602441
=005  20141212212401.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018030
=035  \\$aCRE6960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x847
=150  \\$aSilver Compounds
=450  \\$wnnna$aCompounds, Silver
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aSilver Nitrate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: SILVER CPDS
=680  \\$iInorganic compounds that contain silver as an integral part of the molecule.
=688  \\$a94
=750  \0$aSilver compounds$5IEN$0(DLC)sh 85122611

=LDR  01312cz  a2200337n  4500
=001  9880364097702441
=005  20141212212401.0
=008  930615\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018029
=035  \\$aCRE6959NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x393.$x700
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x393.$x700
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x393.$x700
=150  \\$aRho(D) Immune Globulin
=450  \\$aAnti-D-Immunoglobulin
=450  \\$wnnna$aAnti D Immunoglobulin
=450  \\$wnnna$aGamulin Rh
=450  \\$wnnna$aGlobulin, Rh Immune
=450  \\$aImmune Globulin, Rh
=450  \\$wnnna$aMICRhoGAM
=450  \\$aRh Immune Globulin
=450  \\$wnnna$aRho(D) Immune Globulin Intravenous (Human)
=450  \\$wnnna$aRho(D) Immune Human Globulin
=450  \\$wnnna$aRhoGAM
=450  \\$wnnna$aRhophylac
=450  \\$wnnna$aZLB Bioplasma AG Brand of Rho(D) Immune Globulin
=550  \\$wg$aImmunoglobulin G
=680  \\$iImmunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.
=688  \\$a94; was RHO(D) IMMUNE GLOBULIN (NM) 1973-93
=750  \0$aRho(D) Immune Globulin$5IEN-M$0(DLC)sh 85113718

=LDR  00709cz  a2200229n  4500
=001  9880364097802441
=005  20141212212204.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017612
=035  \\$aCRE6611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x379
=150  \\$aGold Compounds
=450  \\$wnnna$aCompounds, Gold
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aGold Alloys
=550  \\$wh$aGold Colloid
=550  \\$wh$aGold Sodium Thiosulfate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: GOLD CPDS
=680  \\$iInorganic compounds that contain gold as an integral part of the molecule.
=688  \\$a94
=750  \0$aGold compounds$5IEN-M$0(DLC)sh 85055716

=LDR  00660cz  a2200205n  4500
=001  9880364097902441
=005  20141212212203.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017611
=035  \\$aCRE6610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x303
=150  \\$aFluorine Compounds
=450  \\$wnnna$aCompounds, Fluorine
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aHydrofluoric Acid
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: FLUORINE CPDS
=680  \\$iInorganic compounds that contain fluorine as an integral part of the molecule.
=688  \\$a94
=750  \0$aFluorine compounds$5IEN-M$0(DLC)sh 85049431

=LDR  00909cz  a2200289n  4500
=001  9880364098002441
=005  20141212212203.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017610
=035  \\$aCRE6609M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146
=150  \\$aCalcium Compounds
=450  \\$wnnna$aCompounds, Calcium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCalcium Carbonate
=550  \\$wh$aCalcium Chloride
=550  \\$wh$aCalcium Citrate
=550  \\$wh$aCalcium, Dietary
=550  \\$wh$aCalcium Fluoride
=550  \\$wh$aCalcium Hydroxide
=550  \\$wh$aCalcium Phosphates
=550  \\$wh$aCalcium Sulfate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: CALCIUM CPDS
=680  \\$iInorganic compounds that contain calcium as an integral part of the molecule.
=688  \\$a94
=750  \0$aCalcium compounds$5IEN-M$0(DLC)sh2001000783

=LDR  00647cz  a2200205n  4500
=001  9880364098102441
=005  20141212212203.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017609
=035  \\$aCRE6608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x103
=150  \\$aBarium Compounds
=450  \\$wnnna$aCompounds, Barium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aBarium Sulfate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: BARIUM CPDS
=680  \\$iInorganic compounds that contain barium as an integral part of the molecule.
=688  \\$a94
=750  \0$aBarium compounds$5IEN-M$0(DLC)sh 85011856

=LDR  00687cz  a2200217n  4500
=001  9880364098202441
=005  20141212212202.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017608
=035  \\$aCRE6607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x220
=150  \\$aChromium Compounds
=450  \\$wnnna$aCompounds, Chromium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aChromates
=550  \\$wh$aChromium Alloys
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: CHROMIUM CPDS
=680  \\$iInorganic compounds that contain chromium as an integral part of the molecule.
=688  \\$a94
=750  \0$aChromium compounds$5IEN-M$0(DLC)sh 85025359

=LDR  00728cz  a2200229n  4500
=001  9880364098302441
=005  20141212212202.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017607
=035  \\$aCRE6606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56
=150  \\$aAluminum Compounds
=450  \\$wnnna$aCompounds, Aluminum
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aAlum Compounds
=550  \\$wh$aAluminum Hydroxide
=550  \\$wh$aAluminum Oxide
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: ALUMINUM CPDS
=680  \\$iInorganic compounds that contain aluminum as an integral part of the molecule.
=688  \\$a94
=750  \0$aAluminum compounds$5IEN-M$0(DLC)sh 85004000

=LDR  01035cz  a2200313n  4500
=001  9880364098402441
=005  20141212212202.0
=008  930629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017606
=035  \\$aCRE6605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210
=150  \\$aChlorine Compounds
=450  \\$wnnna$aChlorine Compounds, Inorganic
=450  \\$wnnna$aCompounds, Chlorine
=450  \\$wnnna$aCompounds, Inorganic Chlorine
=450  \\$wnnna$aInorganic Chlorine Compounds
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aChlorates
=550  \\$wh$aCisplatin
=550  \\$wh$aHydrochloric Acid
=550  \\$wh$aHypochlorous Acid
=550  \\$wh$aPerchlorates
=550  \\$wh$aRuthenium Red
=550  \\$aHydrocarbons, Chlorinated
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iInorganic compounds that contain chlorine as an integral part of the molecule.
=688  \\$a98; use explode 1994-97
=750  \0$aChlorine compounds$5IEN-M$0(DLC)sh 85024545

=LDR  00682cz  a2200217n  4500
=001  9880364098502441
=005  20141212212201.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017605
=035  \\$aCRE6604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x139
=150  \\$aBromine Compounds
=450  \\$wnnna$aCompounds, Bromine
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aBromates
=550  \\$wh$aHydrobromic Acid
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: BROMINE CPDS
=680  \\$iInorganic compounds that contain bromine as an integral part of the molecule.
=688  \\$a94
=750  \0$aBromine compounds$5IEN-M$0(DLC)sh 90006056

=LDR  02198cz  a2200505n  4500
=001  9880364098602441
=005  20141212212201.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017603
=035  \\$aCRE6602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x685.$x814
=072  \\$aF2.$x463.$x593.$x257.$x800
=072  \\$aF2.$x463.$x593.$x710.$x725
=072  \\$aF4.$x96.$x753.$x814
=072  \\$aF4.$x669.$x908
=150  \\$aSignal Detection, Psychological
=450  \\$wnnna$aAnalyses, Signal Detection
=450  \\$wnnna$aAnalysis, Signal Detection
=450  \\$wnnna$aDetection, Psychological Signal
=450  \\$wnnna$aDetection, Signal (Psychology)
=450  \\$wnnna$aDetections, Psychological Signal
=450  \\$wnnna$aDetections, Signal (Psychology)
=450  \\$wnnna$aPsychological Signal Detection
=450  \\$wnnna$aPsychological Signal Detections
=450  \\$wnnna$aSignal Detection Analyses
=450  \\$wnnna$aSignal Detection Analysis
=450  \\$aSignal Detection (Psychology)
=450  \\$wnnna$aSignal Detection Theories
=450  \\$wnnna$aSignal Detection Theory
=450  \\$wnnna$aSignal Detections, Psychological
=450  \\$wnnna$aSignal Detections (Psychology)
=450  \\$wnnna$aTheories, Signal Detection
=450  \\$wnnna$aTheory, Signal Detection
=550  \\$wg$aDiscrimination (Psychology)
=550  \\$wg$aPsychological Techniques
=550  \\$wg$aPsychophysics
=550  \\$wg$aSensory Thresholds
=550  \\$aSensory Thresholds
=667  \\$arestrict to psychol: do not use for detection of signals in telecommunication ( = TELECOMMUNICATIONS) or in cellular processes ( = CELL COMMUNICATION or SIGNAL TRANSDUCTION or related concepts); DF: SIGNAL DETECTION
=680  \\$iPsychophysical technique that permits the estimation of the bias of the observer as well as detectability of the signal (i.e., stimulus) in any sensory modality. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a2009 (1994)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Signal Detection (Psychology)
=688  \\$a1994
=750  \0$aSignal detection (Psychology)$0(DLC) sh 85122394$5IEN

=LDR  02102cz  a2200421n  4500
=001  9880364098702441
=005  20141212212231.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017720
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x416
=072  \\$aE5.$x393.$x522
=072  \\$aH1.$x158.$x201.$x636.$x475.$x500
=072  \\$aH1.$x158.$x273.$x343.$x595.$x475.$x500
=072  \\$aH1.$x181.$x122.$x650.$x475.$x550
=072  \\$aH2.$x403.$x720.$x500.$x300
=072  \\$aN6.$x850.$x520.$x470
=150  \\$aMolecular Epidemiology
=450  \\$wnnna$aEpidemiologies, Genetic
=450  \\$wnnna$aEpidemiologies, Molecular
=450  \\$wnnna$aEpidemiology, Genetic
=450  \\$aEpidemiology, Molecular
=450  \\$wnnna$aGenetic Epidemiologies
=450  \\$wnnna$aGenetic Epidemiology
=450  \\$wnnna$aMolecular Epidemiologies
=550  \\$wg$aEpidemiologic Methods
=550  \\$wg$aEpidemiology
=550  \\$wg$aGenetic Techniques
=550  \\$wg$aMolecular Medicine
=550  \\$wh$aGenome-Wide Association Study
=550  \\$wh$aMendelian Randomization Analysis
=550  \\$aMolecular Typing
=667  \\$athe discipline; also used for epidemiologic application of molecular biology (NIM, no qualifiers); prefer specific epidemiologic concept & specific molecular or genetic concept (IM) coordinated with main headings /epidemiol (IM) & /genet (IM), as "molecular epidemiology of rabies virus in France" = RABIES VIRUS /genet (IM) + RNA, VIRAL /genet (NIM) (molecular aspect from text) + RABIES /epidemiol (IM) (epidemiologic aspect from text) + FRANCE /epidemiol (NIM)
=680  \\$iThe application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.
=688  \\$a2010 (1994)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Epidemiology, Molecular
=688  \\$a94
=750  \0$aMolecular epidemiology$0(DLC) sh 92004253$5IEN-M

=LDR  01046cz  a2200313n  4500
=001  9880364098802441
=005  20141212212200.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017602
=035  \\$aCRE6601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x594.$x550
=072  \\$aE2.$x600.$x500
=072  \\$aE4.$x14.$x520.$x550
=072  \\$aE4.$x943.$x500.$x500
=150  \\$aLithotripsy, Laser
=450  \\$aLaser-Induced Shockwave Lithotripsy
=450  \\$wnnna$aLaser Induced Shockwave Lithotripsy
=450  \\$aLaser Lithotripsy
=450  \\$wnnna$aLithotripsies, Laser
=450  \\$wnnna$aLithotripsy, Laser-Induced Shockwave
=450  \\$wnnna$aShockwave Lithotripsy, Laser-Induced
=450  \\$wnnna$aShockwave Lithotripsy, Laser Induced
=550  \\$wg$aLaser Therapy
=550  \\$wg$aLithotripsy
=667  \\$acoordinate IM with disease /ther, not /surg (IM)
=680  \\$iFragmentation of CALCULI, notably urinary or biliary, by LASER.
=688  \\$a94
=750  \0$aLaser lithotripsy$5IEN-M$0(DLC)sh 88004679

=LDR  00703cz  a2200217n  4500
=001  9880364098902441
=005  20141212212200.0
=008  930629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017601
=035  \\$aCRE6600M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x650
=150  \\$aOxygen Compounds
=450  \\$wnnna$aCompounds, Oxygen
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aOxides
=550  \\$wh$aReactive Oxygen Species
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iInorganic compounds that contain oxygen as an integral part of the molecule.
=688  \\$a98; use explode 1994-97
=750  \0$aOxygen compounds$5IEN-M$0(DLC)sh2012001667

=LDR  01233cz  a2200253n  4500
=001  9880364099002441
=005  20141212212230.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017714
=035  \\$aCRE6686M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x234
=150  \\$aCommunity-Acquired Infections
=450  \\$wnnna$aCommunity-Acquired Infection
=450  \\$wnnna$aCommunity Acquired Infections
=450  \\$wnnna$aInfection, Community-Acquired
=450  \\$wnnna$aInfections, Community-Acquired
=450  \\$wnnna$aInfections, Community Acquired
=550  \\$wg$aInfection
=550  \\$aCross Infection
=667  \\$acontrasted with hospital- or other health facil-acquired ( = CROSS INFECTION); IM GEN only; coord NIM with specific community-acquired infect (IM), if discussed
=680  \\$iAny infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
=688  \\$a94
=750  \0$aCommunity-acquired infections$0(DLC)sh2006001892$5IEN-M

=LDR  01038cz  a2200265n  4500
=001  9880364099102441
=005  20141212212159.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017598
=035  \\$aCRE6597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x227
=150  \\$aEfficiency, Organizational
=450  \\$wnnna$aAdministrative Efficiency
=450  \\$aEfficiency, Administrative
=450  \\$wnnna$aEfficiency, Program
=450  \\$aOrganizational Efficiency
=450  \\$wnnna$aOrganizational Productivity
=450  \\$aProductivity, Organizational
=450  \\$aProgram Efficiency
=550  \\$wg$aOrganization and Administration
=667  \\$aIM; coord with specific organiz, institution, business, department, etc. (IM); DF: EFFICIENCY ORGAN
=680  \\$iThe capacity of an organization, institution, or business to produce desired results with a minimum expenditure of energy, time, money, personnel, materiel, etc.
=688  \\$a94
=750  \0$aOrganizational effectiveness$5IEN-M$0(DLC)sh 85095526

=LDR  01096cz  a2200205n  4500
=001  9880364099202441
=005  20141212212157.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017592
=035  \\$aCRE6591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x547.$x800
=150  \\$aSkin Care
=450  \\$wnnna$aCare, Skin
=550  \\$wg$aHygiene
=550  \\$wh$aSkin Cream
=667  \\$aIM; coord with specific agent used in the care, as SOAPS; OINTMENTS; DETERGENTS; etc. (IM or NIM) or specific type of care, as BATHS (IM or NIM) or specific ther agent (IM or NIM)
=680  \\$iMaintenance of the hygienic state of the skin under optimal conditions of cleanliness and comfort. Effective in skin care are proper washing, bathing, cleansing, and the use of soaps, detergents, oils, etc. In various disease states, therapeutic and protective solutions and ointments are useful. The care of the skin is particularly important in various occupations, in exposure to sunlight, in neonates, and in PRESSURE ULCER.
=688  \\$a94
=750  \0$aSkin$xCare and hygiene$5IEN-M$0(DLC)sh 85123170

=LDR  01239cz  a2200313n  4500
=001  9880364099302441
=005  20141212212230.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017713
=035  \\$aCRE6685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x140.$x650
=150  \\$aPlatelet Transfusion
=450  \\$aBlood Platelet Transfusion
=450  \\$wnnna$aBlood Platelet Transfusions
=450  \\$aBlood Platelets$xtransplantation
=450  \\$wnnna$aPlatelet Transfusion, Blood
=450  \\$wnnna$aPlatelet Transfusions
=450  \\$wnnna$aPlatelet Transfusions, Blood
=450  \\$wnnna$aTransfusion, Blood Platelet
=450  \\$wnnna$aTransfusion, Platelet
=450  \\$wnnna$aTransfusions, Blood Platelet
=450  \\$wnnna$aTransfusions, Platelet
=550  \\$wg$aBlood Component Transfusion
=550  \\$aBlood Platelets
=667  \\$ado not use /util except by MeSH definition; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS (NIM)
=680  \\$iThe transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
=688  \\$a94; was see BLOOD COMPONENT TRANSFUSION 1992-93
=750  \0$aBlood platelets$xTransfusion$5IEN-M$0(DLC)sh 85015008

=LDR  01321cz  a2200301n  4500
=001  9880364099402441
=005  20141212212155.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017588
=035  \\$aCRE6587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x316.$x64.$x500
=072  \\$aC12.$x706.$x316.$x129.$x750
=072  \\$aC13.$x351.$x875.$x253.$x64.$x500
=072  \\$aC13.$x351.$x875.$x253.$x129.$x750
=072  \\$aC16.$x131.$x939.$x316.$x64.$x500
=072  \\$aC16.$x131.$x939.$x316.$x129.$x750
=072  \\$aC19.$x391.$x119.$x64.$x500
=072  \\$aC19.$x391.$x119.$x129.$x750
=150  \\$aHyperandrogenism
=550  \\$wg$a46, XX Disorders of Sex Development
=550  \\$wg$aAdrenogenital Syndrome
=550  \\$aAdrenocortical Hyperfunction
=550  \\$aPolycystic Ovary Syndrome
=667  \\$ageneral or unspecified; prefer specific manifestation such as HIRSUTISM; VIRILISM; etc.
=680  \\$iA condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
=688  \\$a94
=750  \0$aHyperandrogenism$5IEN-M$0(DLC)sh 97002310

=LDR  01653cz  a2200313n  4500
=001  9880364099502441
=005  20141212212155.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017587
=035  \\$aCRE6586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x200.$x200
=150  \\$aDiskectomy, Percutaneous
=450  \\$wnnna$aDiscectomies, Percutaneous
=450  \\$aDiscectomy, Percutaneous
=450  \\$wnnna$aDiskectomies, Percutaneous
=450  \\$wnnna$aNucleotomies, Percutaneous
=450  \\$aNucleotomy, Percutaneous
=450  \\$wnnna$aPercutaneous Discectomies
=450  \\$wnnna$aPercutaneous Discectomy
=450  \\$wnnna$aPercutaneous Diskectomies
=450  \\$wnnna$aPercutaneous Diskectomy
=450  \\$wnnna$aPercutaneous Nucleotomies
=450  \\$wnnna$aPercutaneous Nucleotomy
=550  \\$wg$aDiskectomy
=667  \\$ado not use /util except by MeSH definition; X ref NUCLEOTOMY, PERCUTANEOUS refers only to the nucleus pulposus, not other nerve nuclei
=680  \\$iPercutaneous excision of a herniated or displaced INTERVERTEBRAL DISC by posterolateral approach, always remaining outside the spinal canal. Percutaneous nucleotomy was first described by Hijikata in Japan in 1975. In 1985 Onik introduced automated percutaneous nucleotomy which consists in percutaneous aspiration of the nucleus pulposus. It is carried out under local anesthesia, thus reducing the surgical insult and requiring brief hospitalization, often performed on an outpatient basis. It appears to be a well-tolerated alternative to surgical diskectomy and chymopapain nucleolysis.
=688  \\$a94
=750  \0$aDiskectomy$5IEN

=LDR  02086cz  a2200529n  4500
=001  9880364099602441
=005  20141212212229.0
=008  930708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017712
=035  \\$aCRE6684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x549.$x700
=072  \\$aH1.$x770.$x644.$x487
=072  \\$aI1.$x880.$x604.$x640.$x700
=072  \\$aL1.$x737.$x640
=072  \\$aN3.$x706.$x700.$x700
=150  \\$aPeer Review, Research
=450  \\$wnnna$aGrant, Peer Review
=450  \\$aGrants, Peer Review
=450  \\$wnnna$aGrants Peer Review
=450  \\$wnnna$aGrants Peer Reviews
=450  \\$wnnna$aPeer Review Grant
=450  \\$aPeer Review, Grants
=450  \\$wnnna$aPeer Review Grants
=450  \\$aPeer Review, Publishing
=450  \\$wnnna$aPeer Reviews, Grants
=450  \\$wnnna$aPeer Reviews, Publishing
=450  \\$wnnna$aPeer Reviews, Research
=450  \\$wnnna$aPublishing Peer Review
=450  \\$wnnna$aPublishing Peer Reviews
=450  \\$wnnna$aResearch Peer Review
=450  \\$wnnna$aResearch Peer Reviews
=450  \\$wnnna$aReview Grant, Peer
=450  \\$wnnna$aReview Grants, Peer
=450  \\$wnnna$aReview, Grants Peer
=450  \\$wnnna$aReview, Publishing Peer
=450  \\$wnnna$aReview, Research Peer
=450  \\$wnnna$aReviews, Grants Peer
=450  \\$wnnna$aReviews, Publishing Peer
=450  \\$wnnna$aReviews, Research Peer
=550  \\$wg$aPeer Review
=550  \\$wg$aPublishing
=550  \\$wg$aResearch
=667  \\$aprofessionals evaluating professionals in research, publishing, granting agencies; DF: PEER REV RESEARCH
=680  \\$iThe evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
=688  \\$a94
=750  \0$aPeer review of research grant proposals$5IEN-M$0(DLC)sh 85099226

=LDR  01932cz  a2200397n  4500
=001  9880364099702441
=005  20141212212154.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017585
=035  \\$aCRE6584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x260.$x850
=072  \\$aE1.$x370.$x350.$x700.$x560.$x260.$x850
=072  \\$aE1.$x370.$x350.$x850.$x260.$x850
=072  \\$aE1.$x370.$x350.$x850.$x850.$x870
=072  \\$aE1.$x370.$x376.$x537.$x750.$x260.$x850
=072  \\$aE5.$x629.$x937.$x260.$x850
=150  \\$aUltrasonography, Doppler, Transcranial
=450  \\$aDoppler Sonography, Transcranial
=450  \\$aDoppler Transcranial Sonography
=450  \\$aDoppler Transcranial Ultrasonography
=450  \\$aDoppler Ultrasonography, Transcranial
=450  \\$wnnna$aSonography, Doppler Transcranial
=450  \\$aSonography, Transcranial Doppler
=450  \\$wnnna$aTranscranial Doppler Sonography
=450  \\$wnnna$aTranscranial Doppler Ultrasonography
=450  \\$wnnna$aTranscranial Sonography, Doppler
=450  \\$wnnna$aTranscranial Ultrasonography, Doppler
=450  \\$wnnna$aUltrasonography, Doppler Transcranial
=450  \\$aUltrasonography, Transcranial Doppler
=550  \\$wg$aEchoencephalography
=550  \\$wg$aUltrasonography, Doppler
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER TRANSCRANIAL
=680  \\$iA non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum.
=688  \\$a95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994
=750  \0$aTranscranial Doppler ultrasonography$5IEN-M$0(DLC)sh 86006172

=LDR  02003cz  a2200445n  4500
=001  9880364099802441
=005  20141212212228.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017711
=035  \\$aCRE6683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x850
=072  \\$aH1.$x548.$x675
=150  \\$aNonlinear Dynamics
=450  \\$wnnna$aChaos Theories
=450  \\$aChaos Theory
=450  \\$wnnna$aDynamics, Non-linear
=450  \\$wnnna$aDynamics, Nonlinear
=450  \\$wnnna$aModel, Non-linear
=450  \\$wnnna$aModel, Nonlinear
=450  \\$wnnna$aModels, Non-linear
=450  \\$aModels, Nonlinear
=450  \\$wnnna$aNon-linear Dynamic
=450  \\$wnnna$aNon-linear Dynamics
=450  \\$wnnna$aNon linear Dynamics
=450  \\$wnnna$aNon-linear Model
=450  \\$wnnna$aNon-linear Models
=450  \\$wnnna$aNon linear Models
=450  \\$wnnna$aNonlinear Dynamic
=450  \\$wnnna$aNonlinear Model
=450  \\$wnnna$aNonlinear Models
=450  \\$wnnna$aTheories, Chaos
=450  \\$wnnna$aTheory, Chaos
=550  \\$wg$aMathematics
=550  \\$wg$aModels, Theoretical
=550  \\$aFractals
=667  \\$aa math principle applied to theoret models
=680  \\$iThe study of systems which respond disproportionately (nonlinearly) to initial conditions or perturbing stimuli. Nonlinear systems may exhibit "chaos" which is classically characterized as sensitive dependence on initial conditions. Chaotic systems, while distinguished from more ordered periodic systems, are not random. When their behavior over time is appropriately displayed (in "phase space"), constraints are evident which are described by "strange attractors". Phase space representations of chaotic systems, or strange attractors, usually reveal fractal (FRACTALS) self-similarity across time scales. Natural, including biological, systems often display nonlinear dynamics and chaos.
=688  \\$a94
=750  \0$aNonlinear theories$5IEN-M$0(DLC)sh 85092332

=LDR  01457cz  a2200349n  4500
=001  9880364099902441
=005  20141212212153.0
=008  930702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017583
=035  \\$aCRE6582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x300.$x200
=072  \\$aE2.$x870.$x350.$x300
=072  \\$aE2.$x912.$x400.$x300
=072  \\$aE2.$x912.$x800.$x200
=072  \\$aE4.$x292.$x471.$x350
=072  \\$aE4.$x292.$x975.$x300.$x300
=072  \\$aE5.$x196.$x454.$x807.$x300.$x300
=150  \\$aHemodiafiltration
=450  \\$aAcetate-Free Biofiltration
=450  \\$wnnna$aAcetate Free Biofiltration
=450  \\$wnnna$aAcetate-Free Biofiltrations
=450  \\$aBiofiltration, Acetate-Free
=450  \\$wnnna$aBiofiltration, Acetate Free
=450  \\$wnnna$aBiofiltrations, Acetate-Free
=550  \\$wg$aHemofiltration
=550  \\$wg$aRenal Dialysis
=680  \\$iThe combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport (hemofiltration) may be better for removal of larger molecular weight substances and diffusive transport (hemodialysis) for smaller molecular weight solutes.
=688  \\$a94
=750  \0$81$wb$aHemodialysis$5IEN-M$0(DLC)sh 85060189
=750  \0$81$wb$aBlood$xFiltration$5IEN-HS$0(DLC)sh 85014942
=788  \0$iSearch also under the following headings used together in the same record:$aHemodialysis$iand$aBlood--Filtration$5IEN-M

=LDR  00969cz  a2200241n  4500
=001  9880364100002441
=005  20141212212228.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017710
=035  \\$aCRE6682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x140.$x425.$x445
=150  \\$aLymphocyte Transfusion
=450  \\$wnnna$aLymphocyte Transfusions
=450  \\$aLymphocytes$xtransplantation
=450  \\$wnnna$aTransfusion, Lymphocyte
=450  \\$wnnna$aTransfusions, Lymphocyte
=550  \\$wg$aLeukocyte Transfusion
=550  \\$aLeukocyte Transfusion
=667  \\$ado not use /util except by MeSH definition; coord IM with specific lymphocyte (NIM); for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS (NIM)
=680  \\$iThe transfer of lymphocytes from a donor to a recipient or reinfusion to the donor.
=688  \\$a94; was see BLOOD COMPONENT TRANSFUSION 1992-93
=750  \0$aLymphocytes$xTransfusion$5IEN-M

=LDR  00920cz  a2200277n  4500
=001  9880364100102441
=005  20141212212152.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017579
=035  \\$aCRE6580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x350
=072  \\$aI1.$x880.$x735.$x900.$x350
=150  \\$aDomestic Violence
=450  \\$aFamily Violence
=450  \\$wnnna$aViolence, Domestic
=450  \\$wnnna$aViolence, Family
=550  \\$wg$aViolence
=550  \\$wh$aChild Abuse
=550  \\$wh$aElder Abuse
=550  \\$wh$aSpouse Abuse
=550  \\$aSex Offenses
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iDeliberate, often repetitive, physical abuse by one family member against another: marital partners, parents, children, siblings, or any other member of a household.
=688  \\$a94
=750  \0$aFamily violence$0(DLC) sh 85047071$5IEN-M

=LDR  01269cz  a2200229n  4500
=001  9880364100202441
=005  20141212212228.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017709
=035  \\$aCRE6681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x125
=072  \\$aG17.$x290
=150  \\$aFractals
=450  \\$wnnna$aFractal
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aModels, Theoretical
=550  \\$aNonlinear Dynamics
=667  \\$apatterns which look similar at different magnifications; used in math & theoret models
=680  \\$iPatterns (real or mathematical) which look similar at different scales, for example the network of airways in the lung which shows similar branching patterns at progressively higher magnifications. Natural fractals are self-similar across a finite range of scales while mathematical fractals are the same across an infinite range. Many natural, including biological, structures are fractal (or fractal-like). Fractals are related to "chaos" (see NONLINEAR DYNAMICS) in that chaotic processes can produce fractal structures in nature, and appropriate representations of chaotic processes usually reveal self-similarity over time.
=688  \\$a94
=750  \0$aFractals$5IEN-M$0(DLC)sh 85051147

=LDR  01207cz  a2200289n  4500
=001  9880364100302441
=005  20141212212227.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017708
=035  \\$aCRE6680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x140.$x425
=150  \\$aLeukocyte Transfusion
=450  \\$wnnna$aLeukocyte Transfusions
=450  \\$aLeukocytes$xtransplantation
=450  \\$wnnna$aTransfusion, Leukocyte
=450  \\$wnnna$aTransfusion, White Blood Cell
=450  \\$wnnna$aTransfusions, Leukocyte
=450  \\$wnnna$aTransfusions, White Blood Cell
=450  \\$aWhite Blood Cell Transfusion
=450  \\$wnnna$aWhite Blood Cell Transfusions
=550  \\$wg$aBlood Component Transfusion
=550  \\$wh$aLymphocyte Transfusion
=667  \\$ado not use /util except by MeSH definition; coord IM with specific leukocyte (NIM) but LYMPHOCYTE TRANSFUSION is available; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS (NIM)
=680  \\$iThe transfer of leukocytes from a donor to a recipient or reinfusion to the donor.
=688  \\$a94; was see BLOOD COMPONENT TRANSFUSION 1992-93
=750  \0$aLeucocytes$xTransfusion$5IEN-M

=LDR  01464cz  a2200361n  4500
=001  9880364100402441
=005  20141212212147.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017564
=035  \\$aCRE6567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x675
=072  \\$aC8.$x381.$x520.$x734
=072  \\$aC26.$x733.$x762
=150  \\$aRadiation Pneumonitis
=450  \\$wnnna$aFibrosis, Radiation
=450  \\$aPneumonia, Radiation
=450  \\$wnnna$aPneumonias, Radiation
=450  \\$wnnna$aPneumonitides, Radiation
=450  \\$aPneumonitis, Radiation
=450  \\$wnnna$aRadiation Fibrosis
=450  \\$wnnna$aRadiation Pneumonia
=450  \\$wnnna$aRadiation Pneumonias
=450  \\$wnnna$aRadiation Pneumonitides
=550  \\$wg$aLung Diseases, Interstitial
=550  \\$wg$aLung Injury
=550  \\$wg$aRadiation Injuries
=667  \\$aassume to be caused by radiotherapy so do not coordinate routinely with RADIOTHERAPY /adv eff; coordinate IM with other type or source of radiation with /adv eff (IM) if pertinent; DF: RAD PNEUMONITIS
=680  \\$iInflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.
=688  \\$a94
=750  \0$81$wb$aRadiation injuries$5IEN-M$0(DLC)sh 86007210
=750  \0$81$wb$aPneumonia$5IEN-HS$0(DLC)sh 85103627
=788  \0$iSearch also under the following headings used to gether in the same record:$aRadiation injuries$iand$aPneumonia$5IEN-M

=LDR  01107cz  a2200277n  4500
=001  9880364100502441
=005  20141212212227.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017707
=035  \\$aCRE6679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x140.$x275
=150  \\$aErythrocyte Transfusion
=450  \\$wnnna$aErythrocyte Transfusions
=450  \\$aErythrocytes$xtransplantation
=450  \\$aRed Blood Cell Transfusion
=450  \\$wnnna$aRed Blood Cell Transfusions
=450  \\$wnnna$aTransfusion, Erythrocyte
=450  \\$wnnna$aTransfusion, Red Blood Cell
=450  \\$wnnna$aTransfusions, Erythrocyte
=450  \\$wnnna$aTransfusions, Red Blood Cell
=550  \\$wg$aBlood Component Transfusion
=667  \\$ado not use /util except by MeSH definition; for transfusion back to donor, coord IM with BLOOD TRANSFUSION, AUTOLOGOUS (NIM)
=680  \\$iThe transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.
=688  \\$a94; was see BLOOD COMPONENT TRANSFUSION 1992-93
=750  \0$aErythrocytes$xTransfusion$5IEN$0(DLC)sh 94002804

=LDR  01211cz  a2200277n  4500
=001  9880364100602441
=005  20141212192743.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017558
=035  \\$aCRE6563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x249
=150  \\$aElective Surgical Procedures
=450  \\$wnnna$aElective Surgical Procedure
=450  \\$wnnna$aProcedure, Elective Surgical
=450  \\$wnnna$aProcedures, Elective Surgical
=450  \\$wnnoa$aSurgery, Elective$5IEN
=450  \\$wnnna$aSurgical Procedure, Elective
=450  \\$aSurgical Procedures, Elective
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aProphylactic Surgical Procedures
=680  \\$iSurgery which could be postponed or not done at all without danger to the patient. Elective surgery includes procedures to correct non-life-threatening medical problems as well as to alleviate conditions causing psychological stress or other potential risk to patients, e.g., cosmetic or contraceptive surgery.
=688  \\$a2015(1994)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Surgical Procedures, Elective
=688  \\$a98(94)
=750  \0$aSurgery, Elective$5IEN$0(DLC)sh 85130775

=LDR  00970cz  a2200229n  4500
=001  9880364100702441
=005  20141212212226.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017705
=035  \\$aCRE6677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x140.$x450
=150  \\$aLignans
=450  \\$aNeolignans
=550  \\$wg$aBenzyl Compounds
=550  \\$wh$aFlavonolignans
=550  \\$wh$aMasoprocol
=550  \\$wh$aPodophyllotoxin
=667  \\$ado not confuse with LIGNIN, also found in plants
=680  \\$iA class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=688  \\$a94; was LIGNANS (NM) 1979-93
=750  \0$aLignans$5IEN-M$0(DLC)sh 85076944

=LDR  00936cz  a2200217n  4500
=001  9880364100802441
=005  20141212212145.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017556
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x925
=150  \\$aTechnetium Compounds
=450  \\$wnnna$aCompounds, Technetium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aSodium Pertechnetate Tc 99m
=550  \\$wh$aTechnetium Tc 99m Pyrophosphate
=550  \\$wh$aTechnetium Tc 99m Sulfur Colloid
=667  \\$aGEN or unspecified; prefer specifics; DF: TECHNETIUM CPDS
=680  \\$iInorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.
=688  \\$a94
=750  \0$aTechnetium compounds$5IEN-M$0(DLC)sh 00000215

=LDR  00874cz  a2200253n  4500
=001  9880364100902441
=005  20141212212145.0
=008  930629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017554
=035  \\$aCRE6560M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200
=150  \\$aCarbon Compounds, Inorganic
=450  \\$wnnna$aCompounds, Inorganic Carbon
=450  \\$aInorganic Carbon Compounds
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCarbon Dioxide
=550  \\$wh$aCarbon Disulfide
=550  \\$wh$aCarbon Monoxide
=550  \\$wh$aCarbonic Acid
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iInorganic compounds that contain carbon as an integral part of the molecule but are not derived from hydrocarbons.
=688  \\$a98; use explode 1994-97
=750  \0$aCarbon compounds$5IEN-HS$0(DLC)sh 85020102

=LDR  01253cz  a2200277n  4500
=001  9880364101002441
=005  20141212212226.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017704
=035  \\$aCRE6676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x400.$x90
=072  \\$aG11.$x561.$x600.$x765.$x63
=150  \\$aBaroreflex
=450  \\$wnnna$aBaroreceptor Reflex
=450  \\$wnnna$aBaroreceptor Reflexes
=450  \\$wnnna$aBaroreflexes
=450  \\$aReflex, Baroreceptor
=450  \\$wnnna$aReflexes, Baroreceptor
=550  \\$wg$aHemodynamics
=550  \\$wg$aReflex
=550  \\$aPressoreceptors
=550  \\$aVasomotor System
=680  \\$iA response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.
=688  \\$a94
=750  \0$aBaroreflexes$5IEN-M$0(DLC)sh 92006280

=LDR  00834cz  a2200253n  4500
=001  9880364101102441
=005  20141212212145.0
=008  930629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017553
=035  \\$aCRE6559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x695
=150  \\$aPhosphorus Compounds
=450  \\$wnnna$aCompounds, Phosphorus
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aPhosphines
=550  \\$wh$aPhosphoranes
=550  \\$wh$aPhosphorus Acids
=550  \\$wh$aPhosphorus, Dietary
=550  \\$aOrganophosphorus Compounds
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: PHOSPHORUS CPDS
=680  \\$iInorganic compounds that contain phosphorus as an integral part of the molecule.
=688  \\$a98; use explode 1994-97
=750  \0$aPhosphorus compounds$5IEN-M$0(DLC)sh 85101126

=LDR  01080cz  a2200265n  4500
=001  9880364101202441
=005  20141212212225.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017700
=035  \\$aCRE6673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x350.$x454.$x500
=150  \\$aEmbolism, Cholesterol
=450  \\$aAtheroembolism
=450  \\$wnnna$aAtheroembolisms
=450  \\$aCholesterol Embolism
=450  \\$wnnna$aCholesterol Embolisms
=450  \\$wnnna$aEmbolisms, Cholesterol
=550  \\$wg$aEmbolism, Fat
=550  \\$wh$aBlue Toe Syndrome
=550  \\$aArteriosclerosis
=550  \\$aCholesterol
=680  \\$iBlocking of a blood vessel by CHOLESTEROL-rich atheromatous deposits, generally occurring in the flow from a large artery to small arterial branches. It is also called arterial-arterial embolization or atheroembolism which may be spontaneous or iatrogenic. Patients with spontaneous atheroembolism often have painful, cyanotic digits of acute onset.
=688  \\$a94
=750  \0$aAtheroembolism$5IEN-M$0(DLC)sh 85009128

=LDR  01127cz  a2200253n  4500
=001  9880364101302441
=005  20141212212224.0
=008  930809\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017699
=035  \\$aCRE6672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x646.$x587
=150  \\$aPelvic Pain
=450  \\$wnnna$aPain, Pelvic
=450  \\$wnnna$aPains, Pelvic
=450  \\$wnnna$aPelvic Pains
=550  \\$wg$aPain
=550  \\$wh$aDysmenorrhea
=550  \\$wh$aPelvic Girdle Pain
=550  \\$wh$aPiriformis Muscle Syndrome
=667  \\$arefers to region, not pelvic bones
=680  \\$iPain in the pelvic region of genital and non-genital origin and of organic or psychogenic etiology. Frequent causes of pain are distension or contraction of hollow viscera, rapid stretching of the capsule of a solid organ, chemical irritation, tissue ischemia, and neuritis secondary to inflammatory, neoplastic, or fibrotic processes in adjacent organs. (Kase, Weingold & Gershenson: Principles and Practice of Clinical Gynecology, 2d ed, pp479-508)
=688  \\$a94
=750  \0$aPelvic Pain$5IEN-M$0(DLC)sh 89006481

=LDR  00856cz  a2200241n  4500
=001  9880364101402441
=005  20141212212224.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017697
=035  \\$aCRE6670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x157.$x500.$x812
=072  \\$aG8.$x686.$x785.$x880.$x249.$x500.$x812
=150  \\$aPremenopause
=450  \\$wnnna$aPeriod, Pre-menopausal
=450  \\$wnnna$aPre-menopausal Period
=450  \\$aPre-Menopause
=450  \\$wnnna$aPremenopausal Period
=550  \\$wg$aMenopause
=550  \\$aMenopause
=680  \\$iThe period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
=688  \\$a94
=750  \0$aPerimenopause$0(DLC) sh 97009027$5IEN-M

=LDR  01010cz  a2200229n  4500
=001  9880364101502441
=005  20180404115952.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017695
=035  \\$aCRE6668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x808
=150  \\$aSoft Tissue Injuries
=450  \\$wnnna$aInjuries, Soft Tissue
=450  \\$wnnna$aInjury, Soft Tissue
=450  \\$wnnna$aSoft Tissue Injury
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aDegloving Injuries
=667  \\$aIM GEN or unspecified; coord NIM with specific organ or region /inj (IM); DF: SOFT TISSUE INJ
=680  \\$iInjuries of tissue other than bone. The concept is usually general and does not customarily refer to internal organs or viscera. It is meaningful with reference to regions or organs where soft tissue (muscle, fat, skin) should be differentiated from bones or bone tissue, as "soft tissue injuries of the hand".
=688  \\$a94
=750  \0$aSoft tissue injuries$5IEN-M$0(DLC)sh 95007728

=LDR  02110cz  a2200457n  4500
=001  9880364101602441
=005  20141212192742.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017552
=035  \\$aCRE6558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x406.$x750
=072  \\$aA8.$x186.$x211.$x865.$x467.$x500.$x750
=150  \\$aSolitary Nucleus
=450  \\$wnnna$aComplex, Solitary Nuclear
=450  \\$wnnna$aComplices, Solitary Nuclear
=450  \\$wnnna$aNuclear Complex, Solitary
=450  \\$wnnna$aNuclear Complices, Solitary
=450  \\$wnnna$aNuclei Tractus Solitarii
=450  \\$wnnna$aNuclei Tractus Solitarius
=450  \\$wnnna$aNucleus of Solitary Tract
=450  \\$wnnna$aNucleus of the Solitary Tract
=450  \\$wnnna$aNucleus of Tractus Solitarius
=450  \\$aNucleus Solitarius
=450  \\$wnnna$aNucleus, Solitary
=450  \\$wnnna$aNucleus, Solitary Tract
=450  \\$wnnna$aNucleus Tractus Solitarii
=450  \\$wnnna$aNucleus Tractus Solitarius
=450  \\$wnnna$aSolitarii, Nuclei Tractus
=450  \\$wnnna$aSolitarius, Nuclei Tractus
=450  \\$wnnna$aSolitarius Nucleus, Tractus
=450  \\$wnnna$aSolitary Nuclear Complex
=450  \\$wnnna$aSolitary Nuclear Complices
=450  \\$wnnna$aSolitary Tract Nucleus
=450  \\$wnnna$aTractus Solitarii, Nuclei
=450  \\$wnnna$aTractus Solitarius, Nuclei
=450  \\$wnnna$aTractus Solitarius Nucleus
=550  \\$wg$aMedulla Oblongata
=680  \\$iGRAY MATTER located in the dorsomedial part of the MEDULLA OBLONGATA associated with the solitary tract. The solitary nucleus receives inputs from most organ systems including the terminations of the facial, glossopharyngeal, and vagus nerves. It is a major coordinator of AUTONOMIC NERVOUS SYSTEM regulation of cardiovascular, respiratory, gustatory, gastrointestinal, and chemoreceptive aspects of HOMEOSTASIS. The solitary nucleus is also notable for the large number of NEUROTRANSMITTERS which are found therein.
=688  \\$a94
=750  \0$aSolitary nucleus$5IEN-M$0(DLC)sh 93005112

=LDR  00929cz  a2200229n  4500
=001  9880364101702441
=005  20141212212144.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017550
=035  \\$aCRE6556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726.$x676.$x700
=072  \\$aE5.$x196.$x867.$x826.$x676.$x700
=150  \\$aSpectroscopy, Fourier Transform Infrared
=450  \\$aFourier Transform Infrared Spectroscopy
=450  \\$aFTIR
=450  \\$aSpectroscopy, Infrared, Fourier Transform
=550  \\$wg$aSpectrophotometry, Infrared
=667  \\$aa type of spectrum anal; NIM; DF: note short X ref
=680  \\$iA spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.
=688  \\$a94
=750  \0$aFourier transform infrared spectroscopy$5IEN-M$0(DLC)sh 88002426

=LDR  00951cz  a2200265n  4500
=001  9880364101802441
=005  20141212212222.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017693
=035  \\$aCRE6666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200.$x275.$x150.$x100.$x800
=072  \\$aD1.$x857.$x625
=150  \\$aSodium Bicarbonate
=450  \\$aBaking Soda
=450  \\$wnnna$aBicarbonate, Sodium
=450  \\$wnnna$aCarbonic Acid Monosodium Salt
=450  \\$wnnna$aHydrogen Carbonate, Sodium
=450  \\$wnnna$aSoda, Baking
=450  \\$wnnna$aSodium Hydrogen Carbonate
=550  \\$wg$aBicarbonates
=550  \\$wg$aSodium Compounds
=680  \\$iA white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.
=688  \\$a94; was SODIUM BICARBONATE (NM) 1980-93
=750  \0$aSodium bicarbonate$0(DLC) sh 94006042$5IEN

=LDR  00968cz  a2200217n  4500
=001  9880364101902441
=005  20141212212144.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017548
=035  \\$aCRE6555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x750.$x235
=072  \\$aE1.$x370.$x350.$x850.$x220.$x235
=072  \\$aE1.$x370.$x370.$x380.$x220.$x235
=150  \\$aEchocardiography, Transesophageal
=450  \\$aTransesophageal Echocardiography
=550  \\$wg$aEchocardiography
=667  \\$acoord IM with specific type of echocardiogr (IM) if pertinent; coord IM with specific heart dis /ultrasonogr (IM); /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: TEE
=680  \\$iUltrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus.
=688  \\$a94
=750  \0$aTransesophageal echocardiography$5IEN-M$0(DLC)sh 86004478

=LDR  01384cz  a2200253n  4500
=001  9880364102002441
=005  20141212212222.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017690
=035  \\$aCRE6664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x147.$x500
=072  \\$aE4.$x936.$x225
=150  \\$aCell Transplantation
=450  \\$aCells$xtransplantation
=450  \\$wnnna$aTransplantation, Cell
=550  \\$wg$aCell- and Tissue-Based Therapy
=550  \\$wg$aTransplantation
=550  \\$wh$aIslets of Langerhans Transplantation
=550  \\$wh$aStem Cell Transplantation
=667  \\$ageneral or unspecified only: prefer precoordinated cell/transplantation terms or / transpl with specific cells but note BLOOD COMPONENT TRANSFUSION and specifics are available (Manual 19.7+, 19.8.75); for transplantation of cells of organs (lung cells for example), coordinate CELL TRANSPLANTATION IM with organ / cytol (IM) ( LUNG /* cytol); available also are several types of technical transplantation terms (TRANSPLANTATION, HETEROLOGOUS, TRANSPLANTAIOON, HOMOLOGOUS, etc.); immunology of cell transplantation = TRANSPLANTATION IMMUNOLOGY
=680  \\$iTransference of cells within an individual, between individuals of the same species, or between individuals of different species.
=688  \\$a94
=750  \0$aCell transplantation$5IEN-M$0(DLC)sh 93006573

=LDR  00330cz  a2200121n  4500
=001  9880364102102441
=005  20120717143531.0
=008  960101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCRE6294HS
=035  \\$a(DNLM)D012076Q000494
=040  \\$aDNLM$cDNLM
=150  \\$aRenal Agents$xpharmacology
=750  \0$aRenal pharmacology$5IEN-M$0(DLC)sh 85112821

=LDR  01095cz  a2200229n  4500
=001  9880364102202441
=005  20141212212221.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017687
=035  \\$aCRE6661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x800.$x800
=072  \\$aD1.$x362.$x641.$x745.$x800
=150  \\$aRadon Daughters
=450  \\$wnnna$aDaughters, Radon
=450  \\$wnnna$aDaughters, Thoron
=450  \\$wnnna$aThoron Daughters
=550  \\$wg$aRadon
=667  \\$ashort-lived radioactive decay products of radon
=680  \\$iShort-lived radioactive decay products of radon that include 216-Po, 214-Pb, 214-Bi, and 214-Po. They have an effective half-life of about 30 minutes and are solids that can deposit on the bronchial airways during inhalation and exhalation. This results in exposure of the respiratory airways to alpha radiation and can lead to diseases of the respiratory system, including lung cancer. (From Casarett and Doull's Toxicology, 4th ed, p740)
=688  \\$a94; was RADON DAUGHTERS (NM) 1981-93
=750  \0$aRadon$xDecay$5IEN-M

=LDR  01128cz  a2200289n  4500
=001  9880364102302441
=005  20141212211931.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017145
=035  \\$aCRE6261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x545
=072  \\$aI2.$x903.$x302
=150  \\$aModels, Educational
=450  \\$wnnna$aEducational Model
=450  \\$aEducational Models
=450  \\$wnnna$aInstructional Model
=450  \\$aInstructional Models
=450  \\$wnnna$aModel, Educational
=450  \\$wnnna$aModel, Instructional
=450  \\$wnnna$aModels, Instructional
=550  \\$wg$aModels, Theoretical
=550  \\$wg$aTeaching
=667  \\$ano qualif; TN 128: application of MODELS, THEORETICAL; DF: MODELS EDUC
=680  \\$iTheoretical models which propose methods of learning or teaching as a basis or adjunct to changes in attitude or behavior. These educational interventions are usually applied in the fields of health and patient education but are not restricted to patient care.
=688  \\$a93
=750  \0$aEducation$xMathematical models$5IEN-M$0(DLC)sh2008118966

=LDR  01287cz  a2200265n  4500
=001  9880364102402441
=005  20141212212220.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017686
=035  \\$aCRE6660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x825.$x580.$x600
=150  \\$aOncorhynchus mykiss
=450  \\$wnnna$aRainbow Trout
=450  \\$wnnna$aRedband Trout
=450  \\$aSalmo gairdneri
=450  \\$aSteelhead
=450  \\$wnnna$aSteelheads
=450  \\$aTrout, Rainbow
=450  \\$aTrout, Redband
=550  \\$wg$aOncorhynchus
=667  \\$aa trout; IM; qualif permitted; do not confuse X ref SALMO GAIRDNERI with SALMON
=680  \\$iA large stout-bodied, sometimes anadromous, TROUT found in still and flowing waters of the Pacific coast from southern California to Alaska. It has a greenish back, a whitish belly, and pink, red, or lavender stripes on the sides, with usually a sprinkling of black dots. It is highly regarded as a sport and food fish. Its former name was Salmo gairdneri. The sea-run rainbow trouts are often called steelheads. Redband trouts refer to interior populations of rainbows.
=688  \\$a94; SALMO GAIRDNERI was see TROUT 1987-93
=750  \0$aRainbow trout$0(DLC) sh 85111210$5IEN-M

=LDR  00806cz  a2200229n  4500
=001  9880364102502441
=005  20141212212220.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017685
=035  \\$aCRE6659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x705.$x580.$x400
=150  \\$aOncorhynchus keta
=450  \\$wnnna$aChum Salmon
=450  \\$wnnna$aDog Salmon
=450  \\$aSalmon, Chum
=450  \\$aSalmon, Dog
=550  \\$wg$aOncorhynchus
=667  \\$aa salmon; IM; qualif permitted
=680  \\$iAn anadromous species of SALMON found in the streams of the Pacific coast from Sacramento north, and also common in Japan. It is used frequently in genetic and other medical research.
=688  \\$a94
=750  \0$aChum salmon$5IEN-M$0(DLC)sh 85025487

=LDR  00899cz  a2200229n  4500
=001  9880364102602441
=005  20141212212220.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017684
=035  \\$aCRE6658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x705.$x580.$x410
=150  \\$aOncorhynchus kisutch
=450  \\$wnnna$aCoho Salmon
=450  \\$aSalmon, Coho
=450  \\$aSalmon, Silver
=450  \\$wnnna$aSilver Salmon
=550  \\$wg$aOncorhynchus
=667  \\$aa salmon; IM; qualif permitted
=680  \\$iAn anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor.
=688  \\$a94
=750  \0$aCoho salmon$5IEN-M$0(DLC)sh 85027767

=LDR  01618cz  a2200445n  4500
=001  9880364102702441
=005  20141212192741.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017546
=035  \\$aCRE2700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x65
=072  \\$aE1.$x370.$x388.$x250.$x35
=072  \\$aE4.$x100.$x814.$x529.$x500
=072  \\$aE4.$x502.$x250.$x35
=072  \\$aE4.$x502.$x382.$x500
=150  \\$aAngioscopy
=450  \\$wnnna$aAngioscopic Surgeries
=450  \\$wnnna$aAngioscopic Surgery
=450  \\$wnnna$aAngioscopic, Surgery
=450  \\$wnnna$aAngioscopic Surgical Procedure
=450  \\$aAngioscopic Surgical Procedures
=450  \\$wnnna$aAngioscopics, Surgery
=450  \\$wnnna$aAngioscopies
=450  \\$wnnna$aProcedure, Angioscopic Surgical
=450  \\$wnnna$aProcedures, Angioscopic Surgical
=450  \\$wnnna$aSurgeries, Angioscopic
=450  \\$wnnna$aSurgery Angioscopic
=450  \\$wnnna$aSurgery, Angioscopic
=450  \\$wnnna$aSurgery Angioscopics
=450  \\$wnnna$aSurgical Procedure, Angioscopic
=450  \\$aSurgical Procedures, Angioscopic
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aEndoscopy
=550  \\$wg$aEndovascular Procedures
=550  \\$aAngioscopes
=667  \\$acoordinate with specific vessel (IM); do not confuse with MICROSCOPIC ANGIOSCOPY; /instrum permitted but consider also ANGIOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery performed on the interior of blood vessels.
=688  \\$a93
=750  \0$aAngioscopy$5IEN-M$0(DLC)sh 88004440

=LDR  01263cz  a2200241n  4500
=001  9880364102802441
=005  20141212212220.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017683
=035  \\$aCRE6657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x705.$x580
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x825.$x580
=150  \\$aOncorhynchus
=550  \\$wg$aSalmon
=550  \\$wg$aTrout
=550  \\$wh$aOncorhynchus keta
=550  \\$wh$aOncorhynchus kisutch
=550  \\$wh$aOncorhynchus mykiss
=667  \\$aGEN or unspecified; prefer specifics; salmon & trout belong to this genus; check specific ONCORHYNCHUS headings, their X refs & text carefully; IM; qualif permitted
=680  \\$iA genus of the family SALMONIDAE (salmons and trouts). They are named for their hooked (onco) nose (rhynchus). They are usually anadromous and occasionally inhabit freshwater. They can be found in North Pacific coastal areas from Japan to California and adjacent parts of the Arctic Ocean. Salmon and trout are popular game and food fish. Various species figure heavily in genetic, metabolism, and hormone research.
=688  \\$a94; was see SALMON 1987-93
=750  \0$aOncorhynchus$5IEN-M$0(DLC)sh 93005534

=LDR  01063cz  a2200253n  4500
=001  9880364102902441
=005  20141212212143.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017544
=035  \\$aCRE2698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x75
=072  \\$aC14.$x907.$x109.$x139.$x75
=150  \\$aAortic Aneurysm, Abdominal
=450  \\$wnnna$aAbdominal Aortic Aneurysm
=450  \\$wnnna$aAbdominal Aortic Aneurysms
=450  \\$wnnna$aAneurysm, Abdominal Aortic
=450  \\$wnnna$aAneurysms, Abdominal Aortic
=450  \\$wnnna$aAortic Aneurysms, Abdominal
=550  \\$wg$aAortic Aneurysm
=667  \\$adissecting aneurysm: coordinate IM with ANEURYSM, DISSECTING (IM); rupture: coordinate IM with AORTIC RUPTURE (IM)
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of the ABDOMINAL AORTA which gives rise to the visceral, the parietal, and the terminal (iliac) branches below the aortic hiatus at the diaphragm.
=688  \\$a93
=750  \0$aAbdominal aneurysm$5IEN-M$0(DLC)sh 85000104

=LDR  01467cz  a2200337n  4500
=001  9880364103002441
=005  20141212212219.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017682
=035  \\$aCRE6656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x500.$x375
=072  \\$aC14.$x280.$x647.$x750
=072  \\$aC14.$x907.$x585.$x500.$x375
=072  \\$aC14.$x907.$x585.$x750
=150  \\$aMyocardial Stunning
=450  \\$aHibernation, Myocardial
=450  \\$aMyocardial Hibernation
=450  \\$wnnna$aMyocardium, Stunned
=450  \\$aStunned Myocardium
=450  \\$wnnna$aStunning, Myocardial
=550  \\$wg$aMyocardial Infarction
=550  \\$wg$aMyocardial Ischemia
=550  \\$aMyocardial Contraction
=550  \\$aMyocardial Ischemia
=550  \\$aMyocardial Reperfusion
=550  \\$aMyocardial Reperfusion Injury
=667  \\$aa type of myocardial ischemia, often caused by myocardial reperfusion
=680  \\$iProlonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue. (Braunwald, Heart Disease, 1992, p1176)
=688  \\$a94
=750  \0$aMyocardial Stunning$5IEN-M$0(DLC)sh 92002148

=LDR  01046cz  a2200241n  4500
=001  9880364103102441
=005  20141212212143.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017543
=035  \\$aCRE2697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x55.$x625
=150  \\$aIliac Aneurysm
=450  \\$aAneurysm, Iliac
=450  \\$wnnna$aAneurysms, Iliac
=450  \\$wnnna$aIliac Aneurysms
=550  \\$wg$aAneurysm
=667  \\$adissecting aneurysm: coordinate IM with ANEURYSM, DISSECTING (IM); rupture: coordinate with ANEURYSM, RUPTURED (IM) or if spontaneous, with RUPTURE, SPONTANEOUS (NIM)
=680  \\$iAbnormal balloon- or sac-like dilatation in the wall of any one of the iliac arteries including the common, the internal, or the external ILIAC ARTERY.
=688  \\$a93
=750  \0$81$wb$aAneurysms$5IEN-M$0(DLC)sh 85004986
=750  \0$81$wb$aIliac artery$5IEN-HS$0(DLC)sh 85064262
=788  \0$iSearch also under the following headings used together in the same record:$aIliac Artery$iand$aAneurysms$5IEN-M

=LDR  00894cz  a2200277n  4500
=001  9880364103202441
=005  20141212212218.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017680
=035  \\$aCRE6654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x745
=150  \\$aPotassium Compounds
=450  \\$wnnna$aCompounds, Potassium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aPotassium Acetate
=550  \\$wh$aPotassium Chloride
=550  \\$wh$aPotassium Cyanide
=550  \\$wh$aPotassium Dichromate
=550  \\$wh$aPotassium, Dietary
=550  \\$wh$aPotassium Iodide
=550  \\$wh$aPotassium Permanganate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: POTASSIUM CPDS
=680  \\$iInorganic compounds that contain potassium as an integral part of the molecule.
=688  \\$a94
=750  \0$aPotassium compounds$5IEN$0(DLC)sh 85105604

=LDR  01052cz  a2200289n  4500
=001  9880364103302441
=005  20141212192740.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017533
=035  \\$aCRE2687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500
=072  \\$aI1.$x240.$x361.$x500
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500
=072  \\$aN1.$x224.$x361.$x500
=072  \\$aN1.$x824.$x308.$x500
=150  \\$aMarital Status
=450  \\$wnnna$aStatus, Marital
=550  \\$wg$aFamily Characteristics
=550  \\$wh$aDivorce
=550  \\$wh$aMarriage
=550  \\$wh$aSingle Person
=550  \\$wh$aWidowhood
=667  \\$aa demographic & statist concept: differentiate from MARRIAGE, a sociol & anthropol concept; includes marital state, divorce, widowhood, singleness
=680  \\$iA demographic parameter indicating a person's status with respect to marriage, divorce, widowhood, singleness, etc.
=688  \\$a93; was see MARRIAGE 1990-92
=750  \0$aMarital status$5IEN-M$0(DLC)sh 85081304

=LDR  00986cz  a2200277n  4500
=001  9880364103402441
=005  20141212212218.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017679
=035  \\$aCRE6653HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x258
=150  \\$aCryotherapy
=450  \\$aCold Temperature$xtherapeutic use
=450  \\$wnnna$aCold Therapies
=450  \\$aCold Therapy
=450  \\$wnnna$aCryotherapies
=450  \\$wnnna$aTherapies, Cold
=450  \\$wnnna$aTherapy, Cold
=550  \\$wg$aTherapeutics
=550  \\$wh$aHypothermia, Induced
=550  \\$aCold Temperature
=550  \\$aHypothermia, Induced
=680  \\$iA form of therapy consisting in the local or general use of cold. The selective destruction of tissue by extreme cold or freezing is CRYOSURGERY. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a94; was see CRYOSURGERY 1984-93
=750  \0$aCold$xTherapeutic use$5IEN-M$0(DLC)sh 85027911

=LDR  01629cz  a2200421n  4500
=001  9880364103502441
=005  20201217121055.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017531
=035  \\$aCRE2686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x360
=150  \\$aHealth Care Evaluation Mechanisms
=450  \\$wnnna$aEvaluation Mechanism, Healthcare
=450  \\$wnnna$aEvaluation Mechanisms, Healthcare
=450  \\$wnnna$aHealthcare Evaluation Mechanism
=450  \\$wnnna$aHealthcare Evaluation Mechanisms
=450  \\$wnnna$aMechanism, Healthcare Evaluation
=450  \\$wnnna$aMechanisms, Healthcare Evaluation
=550  \\$wg$aQuality of Health Care
=550  \\$wh$aAdvance Directive Adherence
=550  \\$wh$aData Collection
=550  \\$wh$aEpidemiologic Research Design
=550  \\$wh$aEpidemiologic Study Characteristics as Topic
=550  \\$wh$aEvaluation Studies as Topic
=550  \\$wh$aGuideline Adherence
=550  \\$wh$aIndependent Medical Evaluation
=550  \\$wh$aOrganizational Case Studies
=550  \\$wh$aOutcome and Process Assessment, Health Care
=550  \\$wh$aPatient Satisfaction
=550  \\$wh$aProgram Evaluation
=550  \\$wh$aRoot Cause Analysis
=550  \\$wh$aStatistics as Topic
=550  \\$wh$aTechnology Assessment, Biomedical
=667  \\$aused for searching: indexers apply specifics; may be used by catalogers
=680  \\$iMethods and techniques used in evaluating the quality of health care, its planning, and delivery.
=688  \\$a98; use explode
=750  \0$aMedical care$xEvaluation$5IEN-M$0(DLC)sh 85082876

=LDR  01006cz  a2200253n  4500
=001  9880364103602441
=005  20141212212217.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017678
=035  \\$aCRE6652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x800
=072  \\$aN1.$x224.$x803
=072  \\$aN6.$x850.$x505.$x400.$x850
=150  \\$aSex Distribution
=450  \\$wnnna$aDistribution, Sex
=450  \\$wnnna$aDistributions, Sex
=450  \\$wnnna$aSex Distributions
=550  \\$wg$aDemography
=550  \\$wh$aSex Ratio
=667  \\$aNIM; human & animal; do not confuse with SEX FACTORS
=680  \\$iThe number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.
=688  \\$a94
=750  \0$aSex distribution (Demography)$5IEN-M$0(DLC)sh 88003758

=LDR  00786cz  a2200169n  4500
=001  9880364103702441
=005  20141212212135.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017515
=035  \\$aCRE2676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x859.$x600.$x675
=150  \\$aPityriasis Rosea
=550  \\$wg$aPityriasis
=680  \\$iA mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.
=688  \\$a93
=750  \0$aPityriasis rosea$5IEN-M$0(DLC)sh 85102536

=LDR  01097cz  a2200241n  4500
=001  9880364103802441
=005  20141212212217.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017677
=035  \\$aCRE6651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x50
=072  \\$aN1.$x224.$x33
=072  \\$aN6.$x850.$x505.$x400.$x50
=150  \\$aAge Distribution
=450  \\$wnnna$aAge Distributions
=450  \\$wnnna$aDistribution, Age
=450  \\$wnnna$aDistributions, Age
=550  \\$wg$aDemography
=667  \\$aNIM; no qualif; human & animal; a statist concept: do not confuse with AGE FACTORS, more related to cause & effect; age-sex distribution: coord (NIM) with SEX DISTRIBUTION (NIM)
=680  \\$iThe frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine.
=688  \\$a94
=750  \0$aAge distribution (Demography)$5IEN-M$0(DLC)sh 85002081

=LDR  00991cz  a2200325n  4500
=001  9880364103902441
=005  20141212212215.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017672
=035  \\$aCRE6646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625
=150  \\$aNitrogen Compounds
=450  \\$wnnna$aCompounds, Nitrogen
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aAmmonia
=550  \\$wh$aAmmonium Compounds
=550  \\$wh$aAzides
=550  \\$wh$aCisplatin
=550  \\$wh$aCyanogen Bromide
=550  \\$wh$aHydrogen Cyanide
=550  \\$wh$aNitric Acid
=550  \\$wh$aNitrogen Oxides
=550  \\$wh$aNitrous Acid
=550  \\$wh$aReactive Nitrogen Species
=550  \\$wh$aRuthenium Red
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: NITROGEN CPDS
=680  \\$iInorganic compounds that contain nitrogen as an integral part of the molecule.
=688  \\$a94
=750  \0$aNitrogen compounds$5IEN-M$0(DLC)sh 85092069

=LDR  00786cz  a2200241n  4500
=001  9880364104002441
=005  20141212212215.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017671
=035  \\$aCRE6645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x710
=150  \\$aPlatinum Compounds
=450  \\$wnnna$aCompounds, Inorganic Platinum
=450  \\$wnnna$aCompounds, Platinum
=450  \\$wnnna$aInorganic Platinum Compounds
=450  \\$aPlatinum Compounds, Inorganic
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCisplatin
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: PLATINUM CPDS
=680  \\$iInorganic compounds which contain platinum as the central atom.
=688  \\$a94
=750  \0$aPlatinum compounds$5IEN-M$0(DLC)sh 85103311

=LDR  01125cz  a2200349n  4500
=001  9880364104102441
=005  20170609092951.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017510
=035  \\$aCRE2671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x154.$x651
=072  \\$aG2.$x111.$x688
=150  \\$aProtein Folding
=450  \\$wnnna$aFolding, Globular Protein
=450  \\$wnnna$aFolding, Protein
=450  \\$wnnna$aFoldings, Globular Protein
=450  \\$wnnna$aFoldings, Protein
=450  \\$wnnna$aGlobular Protein Folding
=450  \\$wnnna$aGlobular Protein Foldings
=450  \\$aProtein Folding, Globular
=450  \\$wnnna$aProtein Foldings
=450  \\$wnnna$aProtein Foldings, Globular
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aBiophysical Phenomena
=550  \\$wh$aProtein Refolding
=550  \\$wh$aProtein Unfolding
=550  \\$aIntrinsically Disordered Proteins
=550  \\$aProtein Multimerization
=680  \\$iProcesses involved in the formation of TERTIARY PROTEIN STRUCTURE.
=688  \\$a93
=750  \0$aProtein folding$5IEN-M$0(DLC)sh 89006334

=LDR  01040cz  a2200337n  4500
=001  9880364104202441
=005  20141212212215.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017670
=035  \\$aCRE6644HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x857
=150  \\$aSodium Compounds
=450  \\$wnnna$aCompounds, Sodium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aGold Sodium Thiosulfate
=550  \\$wh$aSodium Azide
=550  \\$wh$aSodium Bicarbonate
=550  \\$wh$aSodium Chloride
=550  \\$wh$aSodium Cyanide
=550  \\$wh$aSodium, Dietary
=550  \\$wh$aSodium Fluoride
=550  \\$wh$aSodium Hydroxide
=550  \\$wh$aSodium Hypochlorite
=550  \\$wh$aSodium Iodide
=550  \\$wh$aSodium Nitrite
=550  \\$wh$aSodium Selenite
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: SODIUM CPDS
=680  \\$iInorganic compounds that contain sodium as an integral part of the molecule.
=688  \\$a94
=750  \0$aSodium compounds$5IEN$0(DLC)sh 85124260

=LDR  00655cz  a2200205n  4500
=001  9880364104302441
=005  20141212212214.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017669
=035  \\$aCRE6643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x538
=150  \\$aMercury Compounds
=450  \\$wnnna$aCompounds, Mercury
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aMercuric Chloride
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: MERCURY CPDS
=680  \\$iInorganic compounds that contain mercury as an integral part of the molecule.
=688  \\$a94
=750  \0$aMercury compounds$5IEN-M$0(DLC)sh 85083809

=LDR  01033cz  a2200289n  4500
=001  9880364104402441
=005  20180205100010.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017667
=035  \\$aCRE6641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x114
=150  \\$aAdipocytes
=450  \\$wnnna$aAdipocyte
=450  \\$wnnna$aCell, Fat
=450  \\$wnnna$aCells, Fat
=450  \\$wnnna$aFat Cell
=450  \\$aFat Cells
=450  \\$wnnna$aLipocyte
=450  \\$wnnna$aLipocytes
=550  \\$wg$aConnective Tissue Cells
=550  \\$wh$aAdipocytes, Beige
=550  \\$wh$aAdipocytes, Brown
=550  \\$wh$aAdipocytes, White
=680  \\$iCells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals.
=688  \\$a94
=750  \0$aFat cells$0(DLC) sh 86006585$5IEN-M

=LDR  00841cz  a2200229n  4500
=001  9880364104502441
=005  20141212212214.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017666
=035  \\$aCRE6640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x435.$x256.$x250
=072  \\$aD1.$x455.$x900.$x200
=150  \\$aDeuterium Oxide
=450  \\$aHeavy Water
=450  \\$wnnna$aOxide, Deuterium
=450  \\$wnnna$aWater, Heavy
=550  \\$wg$aDeuterium
=550  \\$wg$aWater
=680  \\$iThe isotopic compound of hydrogen of mass 2 (deuterium) with oxygen. (From Grant & Hackh's Chemical Dictionary, 5th ed) It is used to study mechanisms and rates of chemical or nuclear reactions, as well as biological processes.
=688  \\$a94; was DEUTERIUM OXIDE (NM) 1980-93
=750  \0$aDeuterium oxide$5IEN-M$0(DLC)sh 85037319

=LDR  01767cz  a2200373n  4500
=001  9880364104602441
=005  20141212212133.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017506
=035  \\$aCRE2667M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25.$x325.$x625
=072  \\$aD12.$x776.$x157.$x530.$x450.$x250.$x875.$x500.$x625
=072  \\$aD12.$x776.$x543.$x585.$x450.$x250.$x875.$x500.$x625
=150  \\$aH(+)-K(+)-Exchanging ATPase
=450  \\$wnnna$aAdenosine Triphosphatase, Hydrogen, Potassium
=450  \\$aAdenosinetriphosphatase, Hydrogen, Potassium
=450  \\$aATPase, Hydrogen, Potassium
=450  \\$wnnna$aATPase Hydrogen, Potassium
=450  \\$wnnna$aATPase, Hydrogen-Potassium-Exchanging
=450  \\$wnnna$aATPase, Potassium Hydrogen
=450  \\$wnnna$aGastric H(+)/K(+) ATPase
=450  \\$aH(+)-K(+)-Transporting ATPase
=450  \\$wnnna$aHydrogen, Potassium, Adenosine Triphosphatase
=450  \\$aHydrogen, Potassium, Adenosinetriphosphatase
=450  \\$aHydrogen, Potassium ATPase
=450  \\$wnnna$aHydrogen-Potassium-Exchanging ATPase
=450  \\$wnnna$aHydrogen Potassium Exchanging ATPase
=450  \\$wnnna$aPotassium Hydrogen ATPase
=550  \\$wg$aProton-Translocating ATPases
=667  \\$ado not confuse entry term H(+)-K(+)-TRANSPORTING ATPASE with PROTON-TRANSLOCATING ATPASES
=680  \\$iAn enzyme isolated from the GASTRIC MUCOSA that catalyzes the hydrolysis of ATP coupled with the exchange of hydrogen and potassium ions across the cell wall. This enzyme was formerly listed as EC 3.6.1.36.
=688  \\$a94; was H(+)-K(+)-TRANSPORTING ATPASE 1993; was POTASSIUM HYDROGEN ATPASE (NM) 1980-92
=750  \0$aHydrogen/potassium ATPase$5IEN-M$0(DLC)sh 98006916

=LDR  00646cz  a2200205n  4500
=001  9880364104702441
=005  20141212212213.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017665
=035  \\$aCRE6639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x459.$x300
=072  \\$aD1.$x339.$x431.$x249
=072  \\$aD1.$x455.$x432
=150  \\$aHydroxyl Radical
=550  \\$wg$aHydroxides
=550  \\$wg$aReactive Oxygen Species
=680  \\$iThe univalent radical OH. Hydroxyl radical is a potent oxidizing agent.
=688  \\$a94; was HYDROXYL RADICAL (NM) 1978-93
=750  \0$aHydroxyl group$5IEN-M$0(DLC)sh 90004255

=LDR  01103cz  a2200301n  4500
=001  9880363580302441
=005  20141212204126.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009990
=035  \\$aCBA3269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x139.$x650
=150  \\$aOryzias
=450  \\$wnnna$aJapanese Killifish
=450  \\$aJapanese Medaka
=450  \\$wnnna$aJapanese Rice Fish
=450  \\$aKillifish, Japanese
=450  \\$wnnna$aKillifish, Medaka
=450  \\$aMedaka
=450  \\$wnnna$aMedaka Killifish
=450  \\$wnnna$aMedakas
=450  \\$wnnna$aOryzias latipes
=450  \\$wnnna$aOryziinae
=550  \\$wg$aBeloniformes
=667  \\$anote X refs JAPANESE KILLIFISH and MEDAKA KILLIFISH; KILLIFISHES is also available
=680  \\$iThe only genus in the family Oryziinae, order BELONIFORMES. Oryzias are egg-layers; other fish of the same order are livebearers. Oryzias are used extensively in testing carcinogens.
=688  \\$a91(87); was see under CYPRINODONTIFORMES 1987-90
=750  \0$aOryzias$5IEN$0(DLC)sh 85095850

=LDR  00864cz  a2200277n  4500
=001  9880363580402441
=005  20141212204126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009989
=035  \\$aCBA3268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x743
=150  \\$aOrthotic Devices
=450  \\$wnnna$aDevice, Orthotic
=450  \\$wnnna$aDevices, Orthotic
=450  \\$aOrthoses
=450  \\$aOrthosis
=450  \\$wnnna$aOrthotic Device
=550  \\$wg$aOrthopedic Equipment
=550  \\$wh$aAthletic Tape
=550  \\$wh$aBraces
=550  \\$wh$aFoot Orthoses
=667  \\$aincludes slings, BRACES, etc.
=680  \\$iApparatus used to support, align, prevent, or correct deformities or to improve the function of movable parts of the body.
=688  \\$a74(72)
=750  \0$aOrthopedic apparatus$5IEN-M$0(DLC)sh 85095801

=LDR  00921cz  a2200253n  4500
=001  9880363580502441
=005  20141212204125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009988
=035  \\$aCBA3267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x730
=072  \\$aH2.$x573
=150  \\$aOrthoptics
=450  \\$wnnna$aOrthoptic
=450  \\$wnnna$aPleoptic
=450  \\$aPleoptics
=550  \\$wg$aHealth Occupations
=550  \\$wg$aTherapeutics
=550  \\$aOphthalmology
=550  \\$aStrabismus
=667  \\$aSPEC: SPEC qualif; X ref PLEOPTICS is seen in foreign lit
=680  \\$iThe study and treatment of defects in binocular vision resulting from defects in the optic musculature or of faulty visual habits. It involves a technique of eye exercises designed to correct the visual axes of eyes not properly coordinated for binocular vision.
=750  \0$aOrthoptics$5IEN$0(DLC)sh 85095824

=LDR  00820cz  a2200265n  4500
=001  9880363580602441
=005  20141212204125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009987
=035  \\$aCBA3266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x678
=150  \\$aOrthoptera
=450  \\$aCaelifera
=450  \\$wnnna$aCaeliferas
=450  \\$aEnsifera
=450  \\$wnnna$aEnsiferas
=450  \\$wnnna$aOrthopteras
=550  \\$wg$aInsects
=550  \\$wh$aGrasshoppers
=550  \\$wh$aGryllidae
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iAn order of insects comprising two suborders: Caelifera and Ensifera. They consist of GRASSHOPPERS, locusts, and crickets (GRYLLIDAE).
=688  \\$a75
=750  \0$aOrthoptera$5IEN$0(DLC)sh 85095822

=LDR  00663cz  a2200181n  4500
=001  9880363580702441
=005  20141212204125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009986
=035  \\$aCBA3265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x528
=150  \\$aOrthopsychiatry
=550  \\$wg$aPsychiatry
=667  \\$aSPEC; SPEC qualif; MDs, psychologists, social workers, etc.
=680  \\$iThe study and treatment of human behavior problems utilizing principles derived from the behavioral, medical, and social science with emphasis on promotion of mental health.
=688  \\$a74
=750  \0$aOrthopsychiatry$5IEN$0(DLC)sh 85095821

=LDR  01012cz  a2200253n  4500
=001  9880363580802441
=005  20180928120952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009985
=035  \\$aCBA3264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x494
=150  \\$aOrthopedics
=450  \\$wnnna$aOrthopedic
=450  \\$wnnna$aOrthopedic Surgeries
=450  \\$aOrthopedic Surgery
=450  \\$wnnna$aSurgeries, Orthopedic
=450  \\$aSurgery, Orthopedic
=550  \\$wg$aSpecialties, Surgical
=550  \\$aOrthopedic Procedures
=550  \\$aOsteology
=667  \\$aSPEC: SPEC qualif; Manual 26.19+; orthopedie dento-faciale in French titles is translated "orthodontics" & is indexed under ORTHODONTICS
=680  \\$iA surgical specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.
=750  \0$aOrthopedics$5IEN-HS$0(DLC)sh 85095799

=LDR  03330cz  a2200733n  4500
=001  9880363580902441
=005  20180719095239.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009980
=035  \\$aCBA3259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x545.$x405.$x400
=150  \\$aInfluenza A virus
=450  \\$aAvian Orthomyxovirus Type A
=450  \\$aFowl Plague Virus
=450  \\$wnnna$aFowl Plague Viruses
=450  \\$wnnoa$aInfluenza A Virus, Avian$5IEN-M
=450  \\$wnnoa$aInfluenza A Virus, Human$5IEN-M
=450  \\$wnnoa$aInfluenza A Virus, Porcine$5IEN-M
=450  \\$wnnna$aInfluenza A viruses
=450  \\$aInfluenza Viruses Type A
=450  \\$wnnna$ainfluenzae-A hominis, Myxovirus
=450  \\$wnnna$ainfluenzae-A suis, Myxovirus
=450  \\$aMyxovirus influenzae-A hominis
=450  \\$wnnna$aMyxovirus influenzae A hominis
=450  \\$aMyxovirus influenzae-A suis
=450  \\$wnnna$aMyxovirus influenzae A suis
=450  \\$aMyxovirus pestis galli
=450  \\$wnnna$aMyxovirus, Pestis galli
=450  \\$wnnna$aMyxoviruses, Pestis galli
=450  \\$aOrthomyxovirus Type A
=450  \\$aOrthomyxovirus Type A, Avian
=450  \\$aOrthomyxovirus Type A, Human
=450  \\$aOrthomyxovirus Type A, Porcine
=450  \\$wnno$aOrthomyxoviruses Type A$5IEN
=450  \\$wnnna$aPestis galli Myxovirus
=450  \\$wnnna$apestis galli, Myxovirus
=450  \\$wnnna$aPestis galli Myxoviruses
=450  \\$wnnna$aPlague Virus, Fowl
=450  \\$wnnna$aPlague Viruses, Fowl
=450  \\$wnnna$aVirus, Fowl Plague
=450  \\$wnnna$aViruses, Fowl Plague
=550  \\$wg$aInfluenzavirus A
=550  \\$wh$aInfluenza A Virus, H10N8 Subtype
=550  \\$wh$aInfluenza A Virus, H1N1 Subtype
=550  \\$wh$aInfluenza A Virus, H1N2 Subtype
=550  \\$wh$aInfluenza A Virus, H2N2 Subtype
=550  \\$wh$aInfluenza A Virus, H3N2 Subtype
=550  \\$wh$aInfluenza A Virus, H3N8 Subtype
=550  \\$wh$aInfluenza A Virus, H5N1 Subtype
=550  \\$wh$aInfluenza A Virus, H5N2 Subtype
=550  \\$wh$aInfluenza A Virus, H5N8 Subtype
=550  \\$wh$aInfluenza A Virus, H7N1 Subtype
=550  \\$wh$aInfluenza A Virus, H7N2 Subtype
=550  \\$wh$aInfluenza A Virus, H7N3 Subtype
=550  \\$wh$aInfluenza A Virus, H7N7 Subtype
=550  \\$wh$aInfluenza A Virus, H7N9 Subtype
=550  \\$wh$aInfluenza A Virus, H9N2 Subtype
=550  \\$wh$aInfluenza A Virus, H10N7 Subtype
=667  \\$ainfection: coordinate IM with INFLUENZA, HUMAN (IM) in humans or ORTHOMYXOVIRIDAE INFECTIONS (IM) in animals other than birds; infection in birds = INFLUENZA IN BIRDS; INFLUENZAVIRUS A is also available
=680  \\$iThe type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
=688  \\$a1997 (1977)
=688  \\$a97; was ORTHOMYXOVIRUSES TYPE A 1977-96; EQUINE INFLUENZA VIRUS was see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-79
=750  \0$aInfluenza A virus$0(DLC) sh2005004823$5IEN-M

=LDR  01278cz  a2200349n  4500
=001  9880363581002441
=005  20141212204122.0
=008  760505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009975
=035  \\$aCBA3254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x545
=072  \\$aB4.$x909.$x777.$x545
=150  \\$aOrthomyxoviridae
=450  \\$wnnna$aInfluenza Virus
=450  \\$aInfluenza Viruses
=450  \\$wnno$aInfluenzavirus A, B$5IEN-HS
=450  \\$wnnna$aMyxovirus
=450  \\$aMyxoviruses
=450  \\$wnnna$aOrthomyxovirus
=450  \\$wnnna$aOrthomyxoviruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aInfluenzavirus A
=550  \\$wh$aInfluenzavirus B
=550  \\$wh$aInfluenzavirus C
=550  \\$wh$aIsavirus
=550  \\$wh$aThogotovirus
=667  \\$ainfection = ORTHOMYXOVIRIDAE INFECTIONS
=680  \\$iA family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.
=688  \\$a81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74
=750  \0$aInfluenza viruses$5IEN-M$0(DLC)sh 85066133
=750  \0$aOrthomyxoviruses$5IEN-HS$0(DLC)sh 85089456

=LDR  01063cz  a2200289n  4500
=001  9880363581102441
=005  20141212204121.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009974
=035  \\$aCBA3253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x630
=072  \\$aF4.$x570.$x400
=150  \\$aOrthomolecular Therapy
=450  \\$wnnna$aMegavitamin Therapies
=450  \\$aMegavitamin Therapy
=450  \\$wnnna$aOrthomolecular Therapies
=450  \\$wnnna$aTherapies, Megavitamin
=450  \\$wnnna$aTherapies, Orthomolecular
=450  \\$wnnna$aTherapy, Megavitamin
=450  \\$wnnna$aTherapy, Orthomolecular
=550  \\$wg$aDrug Therapy
=550  \\$wg$aPsychiatric Somatic Therapies
=667  \\$aa psychother technique; note X ref: /adv eff permitted; DF: ORTHOMOL THER
=680  \\$iThe use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders.
=688  \\$a77
=750  \0$aOrthomolecular therapy$5IEN$0(DLC)sh 85095798

=LDR  00541cz  a2200181n  4500
=001  9880363581202441
=005  20160803124714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009973
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x703
=150  \\$aOrthodontics, Preventive
=450  \\$wnnna$aPreventive Orthodontics
=550  \\$wg$aOrthodontics
=550  \\$wh$aSpace Maintenance, Orthodontic
=667  \\$ado not use /util except by MeSH definition
=688  \\$a65
=750  \0$aOrthodontics, Preventive$5IEN$0(DLC)sh 85095775

=LDR  00662cz  a2200193n  4500
=001  9880363581302441
=005  20141212204121.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x641
=150  \\$aOrthodontics, Interceptive
=450  \\$wnnna$aInterceptive Orthodontics
=550  \\$wg$aOrthodontics
=550  \\$wh$aSerial Extraction
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRecognition and elimination of potential irregularities and malpositions in the developing dentofacial complex.
=688  \\$a75
=750  \0$aOrthodontics, Interceptive$5IEN$0(DLC)sh 85095774

=LDR  00962cz  a2200265n  4500
=001  9880363581402441
=005  20180122100137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009971
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x578
=150  \\$aOrthodontics, Corrective
=450  \\$wnnna$aCorrective Orthodontics
=550  \\$wg$aOrthodontics
=550  \\$wh$aCrown Lengthening
=550  \\$wh$aOcclusal Adjustment
=550  \\$wh$aOrthodontic Extrusion
=550  \\$wh$aOrthodontic Space Closure
=550  \\$wh$aPalatal Expansion Technique
=550  \\$wh$aTooth Movement Techniques
=550  \\$aMalocclusion
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe phase of orthodontics concerned with the correction of malocclusion with proper appliances and prevention of its sequelae (Jablonski's Illus. Dictionary of Dentistry).
=688  \\$a65
=750  \0$aOrthodontics, Corrective$5IEN$0(DLC)sh 85095772

=LDR  01049cz  a2200289n  4500
=001  9880363581502441
=005  20170827172844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009970
=035  \\$aCBA3249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658
=072  \\$aH2.$x163.$x876.$x439
=150  \\$aOrthodontics
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aDental Marginal Adaptation
=550  \\$wh$aMandibular Advancement
=550  \\$wh$aOrthodontic Anchorage Procedures
=550  \\$wh$aOrthodontic Appliance Design
=550  \\$wh$aOrthodontic Appliances
=550  \\$wh$aOrthodontics, Corrective
=550  \\$wh$aOrthodontics, Interceptive
=550  \\$wh$aOrthodontics, Preventive
=667  \\$aSPEC: SPEC qualif; orthopédie dento-faciale in French titles is translated "orthodontics" & indexed here
=680  \\$iA dental specialty concerned with the prevention and correction of dental and oral anomalies (malocclusion).
=750  \0$aOrthodontics$0(DLC)sh 85095770$5IEN-M

=LDR  00814cz  a2200241n  4500
=001  9880363581602441
=005  20141212204120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009968
=035  \\$aCBA3247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x453.$x578
=150  \\$aOrthodontic Appliances, Removable
=450  \\$wnnna$aAppliance, Removable Orthodontic
=450  \\$wnnna$aAppliances, Removable Orthodontic
=450  \\$wnnna$aOrthodontic Appliance, Removable
=450  \\$wnnna$aRemovable Orthodontic Appliance
=450  \\$wnnna$aRemovable Orthodontic Appliances
=550  \\$wg$aOrthodontic Appliances
=550  \\$wh$aActivator Appliances
=550  \\$wh$aExtraoral Traction Appliances
=688  \\$a73(71)
=750  \0$aOrthodontic appliances, Removable$5IEN$0(DLC)sh 85095769

=LDR  01031cz  a2200277n  4500
=001  9880363581702441
=005  20141212204120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009967
=035  \\$aCBA3246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x453
=150  \\$aOrthodontic Appliances
=450  \\$wnnna$aAppliance, Orthodontic
=450  \\$wnnna$aAppliances, Orthodontic
=450  \\$wnnna$aOrthodontic Appliance
=550  \\$wg$aOrthodontics
=550  \\$wh$aOcclusal Splints
=550  \\$wh$aOrthodontic Appliances, Functional
=550  \\$wh$aOrthodontic Appliances, Removable
=550  \\$wh$aOrthodontic Brackets
=550  \\$wh$aOrthodontic Retainers
=550  \\$wh$aOrthodontic Wires
=680  \\$iDevices used for influencing tooth position. Orthodontic appliances may be classified as fixed or removable, active or retaining, and intraoral or extraoral. (Boucher's Clinical Dental Terminology, 4th ed, p19)
=688  \\$a65
=750  \0$aOrthodontic appliances$5IEN$0(DLC)sh 85095767

=LDR  00847cz  a2200241n  4500
=001  9880363581802441
=005  20141212192409.0
=008  840524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x750.$x600
=150  \\$aOrphan Drug Production
=450  \\$wnnna$aDrug, Orphan
=450  \\$wnnna$aDrug Production, Orphan
=450  \\$wnnna$aDrugs, Orphan
=450  \\$wnnna$aOrphan Drug
=450  \\$wnnna$aOrphan Drugs
=450  \\$wnnna$aProduction, Orphan Drug
=550  \\$wg$aDrug Industry
=550  \\$aRare Diseases
=680  \\$iProduction of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.
=688  \\$a91(85); was see under DRUG INDUSTRY 1985-90
=750  \0$aOrphan drugs$5IEN$0(DLC)sh 85095747

=LDR  00710cz  a2200253n  4500
=001  9880363581902441
=005  20141212204119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009963
=035  \\$aCBA3242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x627
=072  \\$aD3.$x383.$x742.$x698.$x875.$x660
=150  \\$aOrotic Acid
=450  \\$wnnna$aAcid, Orotic
=450  \\$wnnna$aOrotate, Potassium
=450  \\$wnnna$aOrotate, Sodium
=450  \\$wnnna$aOrotate, Zinc
=450  \\$wnnna$aPotassium Orotate
=450  \\$wnnna$aSodium Orotate
=450  \\$wnnna$aZinc Orotate
=550  \\$wg$aAcids, Heterocyclic
=550  \\$wg$aUracil
=750  \0$aOrotic acid$5IEN$0(DLC)sh 89003692

=LDR  00694cz  a2200229n  4500
=001  9880363582002441
=005  20141212204116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009957
=035  \\$aCBA3236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x614.$x421
=072  \\$aC23.$x300.$x575.$x500.$x550
=150  \\$aOroantral Fistula
=450  \\$wnnna$aFistula, Oroantral
=450  \\$wnnna$aFistulas, Oroantral
=450  \\$wnnna$aOroantral Fistulas
=550  \\$wg$aOral Fistula
=667  \\$afistula policy: Manual 23.19+
=680  \\$iA fistula between the maxillary sinus and the oral cavity.
=688  \\$a67
=750  \0$aFistula, Oroantral$5IEN$0(DLC)sh 85048901

=LDR  00888cz  a2200217n  4500
=001  9880363582102441
=005  20141212204116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009956
=035  \\$aCBA3235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x210.$x250.$x600
=150  \\$aPsittacosis
=450  \\$wnnna$aOrnithoses
=450  \\$aOrnithosis
=450  \\$wnnna$aPsittacoses
=550  \\$wg$aChlamydophila Infections
=680  \\$iInfection with CHLAMYDOPHILA PSITTACI (formerly Chlamydia psittaci), transmitted to humans by inhalation of dust-borne contaminated nasal secretions or excreta of infected BIRDS. This infection results in a febrile illness characterized by PNEUMONITIS and systemic manifestations.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Ornithosis
=750  \0$aPsittacosis$0(DLC) sh 85108328$5IEN-M

=LDR  00946cz  a2200217n  4500
=001  9880363582202441
=005  20141212192409.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009955
=035  \\$aCBA3234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x224.$x125.$x425
=150  \\$aOrnithine Decarboxylase
=450  \\$wnnna$aCarboxy-lyase, Ornithine
=450  \\$wnnna$aDecarboxylase, Ornithine
=450  \\$aOrnithine Carboxy-lyase
=450  \\$wnnna$aOrnithine Carboxy lyase
=550  \\$wg$aCarboxy-Lyases
=680  \\$iA pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine.
=688  \\$a84(75); was see under CARBOXY-LYASES 1975-83
=750  \0$aOrnithine decarboxylase$5IEN$0(DLC)sh 88004443

=LDR  01147cz  a2200265n  4500
=001  9880363582302441
=005  20141212204115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009954
=035  \\$aCBA3233M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x555.$x275.$x600
=150  \\$aOrnithine Carbamoyltransferase
=450  \\$wnnna$aCarbamoyltransferase, Ornithine
=450  \\$wnnna$aCarbamylphosphate Transferase, Ornithine
=450  \\$wnnna$aOrnithine Carbamylphosphate Transferase
=450  \\$aOrnithine Transcarbamylase
=450  \\$wnnna$aTranscarbamylase, Ornithine
=450  \\$wnnna$aTransferase, Ornithine Carbamylphosphate
=550  \\$wg$aCarboxyl and Carbamoyl Transferases
=550  \\$aOrnithine Carbamoyltransferase Deficiency Disease
=680  \\$iA urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline (CITRULLINE) from CARBAMOYL PHOSPHATE and L-ornithine (ORNITHINE). Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3.
=688  \\$a1965(1964)
=688  \\$a65(64)
=750  \0$aOrnithine carbamoyltransferase$0(DLC) sh2003008339$5IEN-M

=LDR  01413cz  a2200373n  4500
=001  9880363582402441
=005  20141212204114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009952
=035  \\$aCBA3231M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x68.$x665
=072  \\$aD12.$x125.$x95.$x765
=150  \\$aOrnithine
=450  \\$wnnna$a2,5-Diaminopentanoic Acid
=450  \\$wnnna$a2,5 Diaminopentanoic Acid
=450  \\$wnnna$aOrnithine, (D)-Isomer
=450  \\$wnnna$aOrnithine Dihydrochloride, (L)-Isomer
=450  \\$wnnna$aOrnithine, (DL)-Isomer
=450  \\$wnnna$aOrnithine Hydrochloride, (D)-Isomer
=450  \\$wnnna$aOrnithine Hydrochloride, (DL)-Isomer
=450  \\$wnnna$aOrnithine Hydrochloride, (L)-Isomer
=450  \\$wnnna$aOrnithine, (L)-Isomer
=450  \\$wnnna$aOrnithine Monoacetate, (L)-Isomer
=450  \\$wnnna$aOrnithine Monohydrobromide, (L)-Isomer
=450  \\$wnnna$aOrnithine Monohydrochloride, (D)-Isomer
=450  \\$wnnna$aOrnithine Monohydrochloride, (DL)-Isomer
=450  \\$wnnna$aOrnithine Phosphate (1:1), (L)-Isomer
=450  \\$wnnna$aOrnithine Sulfate (1:1), (L)-Isomer
=550  \\$wg$aAmino Acids, Basic
=550  \\$wg$aAmino Acids, Diamino
=550  \\$wh$aEflornithine
=680  \\$iAn amino acid produced in the urea cycle by the splitting off of urea from arginine.
=750  \0$aOrnithine$0(DLC) sh2003008344$5IEN-M

=LDR  00631cz  a2200217n  4500
=001  9880363582502441
=005  20180928114448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009949
=035  \\$aCBA3228HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x58.$x577
=072  \\$aF2.$x830.$x606
=150  \\$aOrientation
=450  \\$wnnna$aOrientations
=550  \\$wg$aAdaptation, Psychological
=550  \\$wg$aPsychophysiology
=550  \\$wh$aOrientation, Spatial
=667  \\$ahuman & animal
=680  \\$iAwareness of oneself in relation to time, place and person.
=750  \0$aOrientation$5IEN-HS$0(DLC)sh 85095629

=LDR  00495cz  a2200181n  4500
=001  9880363582602441
=005  20141212204113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009948
=035  \\$aCBA3227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x460
=150  \\$aOrgasm
=450  \\$wnnna$aOrgasms
=550  \\$wg$aReproduction
=680  \\$iThe crisis of sexual excitement in either humans or animals.
=688  \\$a69
=750  \0$aOrgasm$5IEN$0(DLC)sh 85095593

=LDR  00663cz  a2200217n  4500
=001  9880363582702441
=005  20141212204113.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009947
=035  \\$aCBA3226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x850
=150  \\$aOrganotin Compounds
=450  \\$wnnna$aCompounds, Organotin
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aTrialkyltin Compounds
=550  \\$aTin
=667  \\$aDF: ORGANOTIN CPDS
=680  \\$iOrganic compounds which contain tin in the molecule. Used widely in industry and agriculture.
=688  \\$a75
=750  \0$aOrganotin compounds$5IEN$0(DLC)sh 85095581

=LDR  00904cz  a2200217n  4500
=001  9880363582802441
=005  20141212204112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009945
=035  \\$aCBA3224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x682
=072  \\$aE2.$x190.$x701
=150  \\$aOrganotherapy
=450  \\$wnnna$aOrganotherapies
=550  \\$wg$aBiological Therapy
=550  \\$wg$aComplementary Therapies
=550  \\$wh$aTissue Therapy, Historical
=667  \\$ather using animal organs or their extracts; TISSUE THERAPY is also available; do not use /util except by MeSH definition
=680  \\$iHistorically, the treatment of disease by the administration of animal organs or their extracts (after Brown-Sequard). At present synthetic preparations substitute for the extracts of a gland. (From Stedman, 26th ed)
=750  \0$aOrganotherapy$5IEN$0(DLC)sh 85095580

=LDR  00662cz  a2200217n  4500
=001  9880363582902441
=005  20141212204112.0
=008  770517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009944
=035  \\$aCBA3223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x800
=150  \\$aOrganoplatinum Compounds
=450  \\$wnnna$aCompounds, Organoplatinum
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aCarboplatin
=550  \\$aPlatinum
=667  \\$aDF: ORGANOPLATINUM CPDS
=680  \\$iOrganic compounds which contain platinum as an integral part of the molecule.
=688  \\$a78
=750  \0$aOrganoplatinum compounds$5IEN$0(DLC)sh 85095570

=LDR  01169cz  a2200337n  4500
=001  9880363583002441
=005  20141212204112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009943
=035  \\$aCBA3222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705
=150  \\$aOrganophosphorus Compounds
=450  \\$wnnna$aCompounds, Organophosphorus
=450  \\$wnnna$aCompounds, Organopyrophosphorus
=450  \\$aCrufomate$5IEN
=450  \\$wnnna$aOrganopyrophosphorus Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aOrganophosphates
=550  \\$wh$aOrganophosphonates
=550  \\$wh$aOrganothiophosphorus Compounds
=550  \\$wh$aPhosphines
=550  \\$wh$aPhosphinic Acids
=550  \\$wh$aPhosphoramides
=550  \\$wh$aPhosphoranes
=550  \\$aPhosphorus
=550  \\$aPhosphorus Compounds
=667  \\$aDF: ORGANOPHOSPHORUS CPDS
=680  \\$iOrganic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.
=688  \\$a72(71)
=750  \0$aOrganophosphorus compounds$5IEN$0(DLC)sh 85095568

=LDR  01600cz  a2200469n  4500
=001  9880363583102441
=005  20200528135314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009942
=035  \\$aCBA3221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691
=150  \\$aOrganometallic Compounds
=450  \\$wnnna$aCompounds, Metallo-Organic
=450  \\$wnnna$aCompounds, Metalloorganic
=450  \\$wnnna$aCompounds, Organometallic
=450  \\$aMetallo-Organic Compounds
=450  \\$wnnna$aMetallo Organic Compounds
=450  \\$wnnna$aMetalloorganic Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAntimony Potassium Tartrate
=550  \\$wh$aAntimony Sodium Gluconate
=550  \\$wh$aArsenicals
=550  \\$wh$aCoordination Complexes
=550  \\$wh$aGadolinium DTPA
=550  \\$wh$aIron Compounds
=550  \\$wh$aManeb
=550  \\$wh$aMetal-Organic Frameworks
=550  \\$wh$aMetallocenes
=550  \\$wh$aOrganogold Compounds
=550  \\$wh$aOrganomercury Compounds
=550  \\$wh$aOrganoplatinum Compounds
=550  \\$wh$aOrganotechnetium Compounds
=550  \\$wh$aOrganotin Compounds
=550  \\$wh$aSucralfate
=550  \\$wh$aTetraethyl Lead
=550  \\$wh$aZineb
=550  \\$aMetals
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a68
=750  \0$aOrganometallic compounds$5IEN$0(DLC)sh 85095561

=LDR  00788cz  a2200253n  4500
=001  9880363583202441
=005  20141212204111.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009941
=035  \\$aCBA3220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x750
=150  \\$aOrganomercury Compounds
=450  \\$wnnna$aCompounds, Organomercury
=450  \\$wnno$aDiuretics, Mercurial$5IEN-M
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aAlkylmercury Compounds
=550  \\$wh$aMerbromin
=550  \\$wh$aPhenylmercury Compounds
=550  \\$aMercury
=667  \\$aDF: ORGANOMERCURY CPDS
=680  \\$iOrganic compounds which contain mercury as an integral part of the molecule.
=688  \\$a77
=750  \0$aOrganomercury compounds$5IEN$0(DLC)sh 85095560

=LDR  01148cz  a2200337n  4500
=001  9880363583302441
=005  20141212204110.0
=008  810304\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009939
=035  \\$aCBA3218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x630
=150  \\$aOrganizations, Nonprofit
=450  \\$aCorporations, Nonprofit$5IEN
=450  \\$wnnna$aNon-Profit Organization
=450  \\$wnnna$aNon-Profit Organizations
=450  \\$wnnna$aNon Profit Organizations
=450  \\$wnnna$aNonprofit Organization
=450  \\$aNonprofit Organizations
=450  \\$wnnna$aOrganization, Non-Profit
=450  \\$wnnna$aOrganization, Nonprofit
=450  \\$wnnna$aOrganizations, Non-Profit
=450  \\$wnnna$aOrganizations, Non Profit
=550  \\$wg$aOrganizations
=550  \\$wh$aFoundations
=550  \\$wh$aHealth Level Seven
=550  \\$wh$aVoluntary Health Agencies
=667  \\$aDF: ORGAN NONPROFIT
=680  \\$iOrganizations which are not operated for a profit and may be supported by endowments or private contributions.
=688  \\$a82
=750  \0$aNonprofit organizations$5IEN$0(DLC)sh 85032985

=LDR  01981cz  a2200445n  4500
=001  9880363583402441
=005  20200508150224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009938
=035  \\$aCBA3217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540
=150  \\$aOrganizations
=450  \\$wnnna$aNongovernmental Organization
=450  \\$wnnna$aNongovernmental Organizations
=450  \\$wnnna$aOrganization
=450  \\$wnnna$aOrganization, Nongovernmental
=450  \\$wnnna$aOrganizations, Nongovernmental
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wh$aAcademies and Institutes
=550  \\$wh$aCharities
=550  \\$wh$aCollege Fraternities and Sororities
=550  \\$wh$aCongresses as Topic
=550  \\$wh$aConsumer Organizations
=550  \\$wh$aFaith-Based Organizations
=550  \\$wh$aGovernment
=550  \\$wh$aGovernment Agencies
=550  \\$wh$aHealth Planning Organizations
=550  \\$wh$aHome Care Agencies
=550  \\$wh$aInternational Agencies
=550  \\$wh$aLabor Unions
=550  \\$wh$aNational Academy of Sciences (U.S.)
=550  \\$wh$aOrganizations, Nonprofit
=550  \\$wh$aPublic-Private Sector Partnerships
=550  \\$wh$aSelf-Help Groups
=550  \\$wh$aSocieties
=667  \\$ahas a limited use since there are other more specific terms available; read notes under SOCIETIES; SOCIETIES, MEDICAL & SOCIETIES, SCIENTIFIC for likely exclusions: ORGANIZATIONS tends to be for groups with a common goal based on interest, SOCIETIES tends to be for groups with common educ or professional status: TN 174; policy: Manual 35.9; specify geog: Manual 36.15; DF: ORGAN but do not confuse with ORGAN ADMIN for ORGANIZATION AND ADMINISTRATION
=680  \\$iAdministration and functional structures for the purpose of collectively systematizing activities for a particular goal.
=688  \\$a68
=750  \0$aAssociations, institutions, etc.$5IEN$0(DLC)sh 85008810

=LDR  01097cz  a2200265n  4500
=001  9880363583502441
=005  20141212204109.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009937
=035  \\$aCBA3216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x615
=150  \\$aOrganizational Objectives
=450  \\$wnnna$aGoal, Organizational
=450  \\$aGoals, Organizational
=450  \\$wnnna$aObjective, Organizational
=450  \\$wnnna$aObjectives, Organizational
=450  \\$wnnna$aOrganizational Goal
=450  \\$wnnna$aOrganizational Goals
=450  \\$wnnna$aOrganizational Objective
=550  \\$wg$aOrganization and Administration
=667  \\$aNIM; coord with specific organiz (IM); DF: ORGAN OBJECTIVES
=680  \\$iThe purposes, missions, and goals of an individual organization or its units, established through administrative processes. It includes an organization's long-range plans and administrative philosophy.
=688  \\$a91(82); was see under ORGANIZATION AND ADMINISTRATION 1982-90
=750  \0$aManagement by objectives$5IEN-M$0(DLC)sh 85080353

=LDR  01027cz  a2200277n  4500
=001  9880363583602441
=005  20141212204109.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009936
=035  \\$aCBA3215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x610
=150  \\$aOrganizational Innovation
=450  \\$wnnna$aChange, Organizational
=450  \\$wnnna$aChanges, Organizational
=450  \\$wnnna$aInnovation, Organizational
=450  \\$wnnna$aInnovations, Organizational
=450  \\$aOrganizational Change
=450  \\$wnnna$aOrganizational Changes
=450  \\$wnnna$aOrganizational Innovations
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aEntrepreneurship
=667  \\$aNIM; coord with specific organiz (IM); DF: ORGAN INNOVATION
=680  \\$iIntroduction of changes which are new to the organization and are created by management.
=688  \\$a89(82); was see under ORGANIZATION AND ADMINISTRATION 1982-88
=750  \0$aOrganizational change$5IEN$0(DLC)sh 85095525

=LDR  01072cz  a2200265n  4500
=001  9880363583702441
=005  20141212210945.0
=008  880520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015279
=035  \\$aCBA3214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x606
=150  \\$aOrganizational Culture
=450  \\$aCorporate Culture
=450  \\$wnnna$aCorporate Cultures
=450  \\$wnnna$aCulture, Corporate
=450  \\$wnnna$aCulture, Organizational
=450  \\$wnnna$aCultures, Corporate
=450  \\$wnnna$aCultures, Organizational
=450  \\$wnnna$aOrganizational Cultures
=550  \\$wg$aOrganization and Administration
=667  \\$a"beliefs & values shared by all members of the organization"; NIM; coord with specific organization (IM); no qualif
=680  \\$iBeliefs and values shared by all members of the organization. These shared values are reflected in the day to day operations of the organization.
=688  \\$a91(89); was see under ORGANIZATION AND ADMINISTRATION 1989-90
=750  \0$aCorporate culture$5IEN$0(DLC)sh 85032896

=LDR  03037cz  a2200841n  4500
=001  9880363583802441
=005  20141212204108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009934
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452
=150  \\$aOrganization and Administration
=450  \\$aAdministration
=450  \\$wnnna$aAdministration and Organization
=450  \\$wnnna$aAdministrative Coordination
=450  \\$wnnna$aAdministrative Technic
=450  \\$wnnna$aAdministrative Technics
=450  \\$wnnna$aAdministrative Technique
=450  \\$wnnna$aAdministrative Techniques
=450  \\$wnnna$aCoordination, Administrative
=450  \\$wnnna$aLogistics
=450  \\$wnnna$aSupervision
=450  \\$wnnna$aTechnic, Administrative
=450  \\$wnnna$aTechnics, Administrative
=450  \\$wnnna$aTechnique, Administrative
=450  \\$wnnna$aTechniques, Administrative
=550  \\$wg$aHealth Services Administration
=550  \\$wh$aAnnual Reports as Topic
=550  \\$wh$aAppointments and Schedules
=550  \\$wh$aCapacity Building
=550  \\$wh$aClinical Governance
=550  \\$wh$aCommittee Membership
=550  \\$wh$aConstitution and Bylaws
=550  \\$wh$aDecision Making, Organizational
=550  \\$wh$aEfficiency, Organizational
=550  \\$wh$aEligibility Determination
=550  \\$wh$aFee Schedules
=550  \\$wh$aGoverning Board
=550  \\$wh$aHealth Facility Administration
=550  \\$wh$aHospital Administration
=550  \\$wh$aInstitutional Management Teams
=550  \\$wh$aKnowledge Management
=550  \\$wh$aManagement Audit
=550  \\$wh$aManagement Information Systems
=550  \\$wh$aMandatory Programs
=550  \\$wh$aMedication Systems
=550  \\$wh$aModels, Organizational
=550  \\$wh$aMulti-Institutional Systems
=550  \\$wh$aOrganizational Affiliation
=550  \\$wh$aOrganizational Culture
=550  \\$wh$aOrganizational Innovation
=550  \\$wh$aOrganizational Objectives
=550  \\$wh$aOwnership
=550  \\$wh$aPatient Identification Systems
=550  \\$wh$aPersonnel Management
=550  \\$wh$aPharmacy Administration
=550  \\$wh$aPlanning Techniques
=550  \\$wh$aProfessional Practice
=550  \\$wh$aProgram Development
=550  \\$wh$aPublic Health Administration
=550  \\$wh$aPublic Relations
=550  \\$wh$aRecords as Topic
=550  \\$wh$aRisk Management
=550  \\$wh$aSafety Management
=550  \\$wh$aSecurity Measures
=550  \\$wh$aTime Management
=550  \\$wh$aTotal Quality Management
=550  \\$wh$aVoluntary Programs
=667  \\$aGEN only: prefer /organ: Manual 19.7+, 19.8.49; almost never IM; DF: ORGAN ADMIN but do not confuse with ORGAN for ORGANIZATIONS
=680  \\$iThe planning and managing of programs, services, and resources.
=688  \\$a68; was ADMINISTRATIVE MANAGEMENT 1963-67
=750  \0$aManagement$5IEN-M$0(DLC)sh 85080336
=750  \0$aOrganization$5IEN-HS$0(DLC)sh 85095521

=LDR  02194cz  a2200709n  4500
=001  9880363583902441
=005  20180409112303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009930
=035  \\$aCBA3208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2
=150  \\$aOrganic Chemicals
=450  \\$wnnna$aChemicals, Organic
=550  \\$wh$aAlcohols
=550  \\$wh$aAldehydes
=550  \\$wh$aAmides
=550  \\$wh$aAmidines
=550  \\$wh$aAmines
=550  \\$wh$aAnhydrides
=550  \\$wh$aAza Compounds
=550  \\$wh$aAzides
=550  \\$wh$aAzo Compounds
=550  \\$wh$aBoron Compounds
=550  \\$wh$aCarboxylic Acids
=550  \\$wh$aCatenanes
=550  \\$wh$aCoordination Complexes
=550  \\$wh$aCyanates
=550  \\$wh$aDioxins and Dioxin-like Compounds
=550  \\$wh$aEthers
=550  \\$wh$aFree Radicals
=550  \\$wh$aHydrazines
=550  \\$wh$aHydrocarbons
=550  \\$wh$aImides
=550  \\$wh$aImines
=550  \\$wh$aIsocyanates
=550  \\$wh$aKetones
=550  \\$wh$aLactones
=550  \\$wh$aLewis Acids
=550  \\$wh$aLewis Bases
=550  \\$wh$aNitrates
=550  \\$wh$aNitriles
=550  \\$wh$aNitrites
=550  \\$wh$aNitro Compounds
=550  \\$wh$aNitroso Compounds
=550  \\$wh$aOnium Compounds
=550  \\$wh$aOrganometallic Compounds
=550  \\$wh$aOrganophosphorus Compounds
=550  \\$wh$aOrganoselenium Compounds
=550  \\$wh$aOrganosilicon Compounds
=550  \\$wh$aPeroxides
=550  \\$wh$aQuinones
=550  \\$wh$aRotaxanes
=550  \\$wh$aSemicarbazides
=550  \\$wh$aSulfur Compounds
=550  \\$wh$aTriazenes
=550  \\$wh$aUrea
=550  \\$wh$aVolatile Organic Compounds
=667  \\$aGEN or unspecified; prefer specific groups or specific chemicals
=680  \\$iA broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.
=688  \\$a98; use explode 1967-97
=750  \0$aOrganic compounds$5IEN-M$0(DLC)sh 85095499

=LDR  01178cz  a2200337n  4500
=001  9880363584002441
=005  20141212211021.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015388
=035  \\$aCBA3207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875
=150  \\$aOrganelles
=450  \\$wnnna$aOrganelle
=550  \\$wg$aCytoplasmic Structures
=550  \\$wh$aBacterial Chromatophores
=550  \\$wh$aCell Nucleus
=550  \\$wh$aCytoplasmic Vesicles
=550  \\$wh$aEndoplasmic Reticulum
=550  \\$wh$aGolgi Apparatus
=550  \\$wh$aLipid Droplets
=550  \\$wh$aMagnetosomes
=550  \\$wh$aMitochondria
=550  \\$wh$aPlastids
=550  \\$wh$aRibosomes
=550  \\$wh$aSarcomeres
=550  \\$wh$aVault Ribonucleoprotein Particles
=667  \\$ado not confuse with ORGANOIDS: read MeSH definitions & follow text
=680  \\$iSpecific particles of membrane-bound organized living substances present in eukaryotic cells, such as the MITOCHONDRIA; the GOLGI APPARATUS; ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES.
=688  \\$a89
=750  \0$aCell organelles$5IEN$0(DLC)sh 85021661

=LDR  00944cz  a2200289n  4500
=001  9880363584102441
=005  20141212204106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009929
=035  \\$aCBA3206M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x660
=072  \\$aE5.$x41.$x124.$x715
=072  \\$aG7.$x100.$x100.$x660
=072  \\$aG7.$x700.$x320.$x249.$x690
=150  \\$aOrgan Size
=450  \\$aOrgan Volume
=450  \\$aOrgan Weight
=450  \\$wnnna$aSize, Organ
=450  \\$wnnna$aWeight, Organ
=550  \\$wg$aBody Weights and Measures
=550  \\$wg$aGrowth
=550  \\$wh$aAxial Length, Eye
=667  \\$aalmost never IM; coordinate NIM with organ /anat (IM) or /growth (IM) or /pathol (IM) or disease /pathol (IM)
=680  \\$iThe measurement of an organ in volume, mass, or heaviness.
=688  \\$a2005 (1966)
=750  \0$aOrgans (Anatomy)$xWeight$0(IEN)7208037$5IEN-M

=LDR  01639cz  a2200409n  4500
=001  9880363584202441
=005  20141212204106.0
=008  860530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x911
=150  \\$aTissue and Organ Procurement
=450  \\$wnnna$aCard, Donor
=450  \\$wnnna$aCards, Donor
=450  \\$wnnna$aDonor Card
=450  \\$wnnna$aDonor Cards
=450  \\$wnnna$aOrgan Donation
=450  \\$wnnna$aOrgan Donations
=450  \\$aOrgan Procurement
=450  \\$wnnna$aOrgan Procurement System
=450  \\$aOrgan Procurement Systems
=450  \\$wnnna$aOrgan Procurements
=450  \\$wnnna$aRequired Organ Donation Request
=450  \\$wnnna$aRequired Request
=450  \\$wnnna$aRequired Requests
=450  \\$wnnna$aTissue Donation
=450  \\$wnnna$aTissue Donations
=450  \\$aTissue Procurement
=450  \\$wnnna$aTissue Procurements
=550  \\$wg$aHealth Services
=550  \\$wh$aDirected Tissue Donation
=550  \\$wh$aDonor Selection
=550  \\$aTissue and Organ Harvesting
=680  \\$iThe administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation.
=688  \\$a2005 (1987)
=750  \0$aProcurement of organs, tissues, etc.$0(DLC) sh 95003976$5IEN-M
=750  \0$aDonation of organs, tissues, etc.$0(DLC) sh 85039033$5IEN-M

=LDR  01030cz  a2200241n  4500
=001  9880363584302441
=005  20141212204105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009926
=035  \\$aCBA3203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x792.$x833.$x660
=072  \\$aE5.$x760.$x833.$x660
=150  \\$aOrgan Preservation
=450  \\$wnnna$aOrgan Preservations
=450  \\$wnnna$aPreservation, Organ
=450  \\$wnnna$aPreservations, Organ
=550  \\$wg$aTissue Preservation
=550  \\$aTissue and Organ Harvesting
=667  \\$acryopreservation of organ: coord IM with organ (no qualif) + CRYOPRESERVATION
=680  \\$iThe process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
=688  \\$a84(75); was see under TISSUE PRESERVATION 1969-83
=750  \0$aPreservation of organs, tissues, etc.$5IEN$0(DLC)sh 85106452

=LDR  01092cz  a2200301n  4500
=001  9880363584402441
=005  20141212204105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009925
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x246.$x577
=150  \\$aOrgan of Corti
=450  \\$aBasilar Papilla
=450  \\$wnnna$aCorti Organ
=450  \\$aCorti's Organ
=450  \\$wnnna$aCortis Organ
=450  \\$wnnna$aOrgan, Corti's
=450  \\$wnnna$aOrgan, Spiral
=450  \\$wnnna$aOrgans, Spiral
=450  \\$wnnna$aPapilla, Basilar
=450  \\$aSpiral Organ
=450  \\$wnnna$aSpiral Organs
=550  \\$wg$aCochlea
=550  \\$wh$aHair Cells, Auditory
=550  \\$wh$aLabyrinth Supporting Cells
=680  \\$iThe spiral EPITHELIUM containing sensory AUDITORY HAIR CELLS and supporting cells in the cochlea. Organ of Corti, situated on the BASILAR MEMBRANE and overlaid by a gelatinous TECTORIAL MEMBRANE, converts sound-induced mechanical waves to neural impulses to the brain.
=688  \\$a68(65)
=750  \0$aCorti's organ$5IEN$0(DLC)sh 85033099

=LDR  00960cz  a2200253n  4500
=001  9880363584502441
=005  20141212192409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009924
=035  \\$aCBA3201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500.$x484
=150  \\$aOrgan Culture Techniques
=450  \\$wnnna$aCulture Technique, Organ
=450  \\$wnnna$aCulture Techniques, Organ
=450  \\$wnnna$aOrgan Culture
=450  \\$wnnna$aOrgan Culture Technique
=450  \\$wnnna$aOrgan Cultures
=550  \\$wg$aCulture Techniques
=550  \\$aTissue Engineering
=667  \\$aNIM
=680  \\$iA technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1)
=688  \\$a2005 (1972)
=750  \0$aOrgan culture$0(DLC) sh 85095588$5IEN

=LDR  00765cz  a2200181n  4500
=001  9880363584602441
=005  20141212204103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009920
=035  \\$aCBA3197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x829.$x493
=072  \\$aC19.$x391.$x829.$x493
=150  \\$aOrchitis
=450  \\$wnnna$aOrchitides
=550  \\$wg$aTesticular Diseases
=680  \\$iInflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.
=750  \0$aOrchitis$5IEN$0(DLC)sh 85095342

=LDR  01070cz  a2200289n  4500
=001  9880363584702441
=005  20141212204103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009918
=035  \\$aCBA3195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721.$x656
=072  \\$aC4.$x588.$x364.$x659
=072  \\$aC5.$x116.$x231.$x754.$x659
=072  \\$aC11.$x319.$x457
=072  \\$aC11.$x675.$x659
=150  \\$aOrbital Neoplasms
=450  \\$wnnna$aNeoplasm, Orbital
=450  \\$wnnna$aNeoplasms, Orbital
=450  \\$wnnna$aOrbital Neoplasm
=550  \\$wg$aEye Neoplasms
=550  \\$wg$aOrbital Diseases
=550  \\$wg$aSkull Neoplasms
=667  \\$aneopl of bony cavity & its contents except eyeball ( = EYE NEOPLASMS or specifics); /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iNeoplasms of the bony orbit and contents except the eyeball.
=750  \0$aEye-sockets$xTumors$5IEN-M$0(DLC)sh 85046697
=750  \0$aEye-sockets$xCancer$5IEN-HS$0(DLC)sh 85046692

=LDR  01131cz  a2200313n  4500
=001  9880363584802441
=005  20141212204103.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009917
=035  \\$aCBA3194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x550
=072  \\$aC26.$x404.$x750.$x684
=150  \\$aOrbital Fractures
=450  \\$wnnna$aBlow-Out Fracture
=450  \\$aBlow-Out Fractures
=450  \\$wnnna$aBlow Out Fractures
=450  \\$wnnna$aFracture, Blow-Out
=450  \\$wnnna$aFracture, Orbital
=450  \\$aFractures, Blow-Out
=450  \\$wnnna$aFractures, Blow Out
=450  \\$wnnna$aFractures, Orbital
=450  \\$wnnna$aOrbital Fracture
=550  \\$wg$aMaxillofacial Injuries
=550  \\$wg$aSkull Fractures
=667  \\$aZYGOMATIC FRACTURES & MAXILLARY FRACTURES are also available
=680  \\$iFractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma.
=688  \\$a91(83); was see under SKULL FRACTURES 1983-90
=750  \0$aEye-sockets$xFractures$5IEN$0(DLC)sh 85046694

=LDR  00977cz  a2200313n  4500
=001  9880363584902441
=005  20141212204102.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009916
=035  \\$aCBA3193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x675
=150  \\$aOrbital Diseases
=450  \\$wnnna$aDisease, Orbital
=450  \\$wnnna$aDiseases, Orbital
=450  \\$wnnna$aOrbital Disease
=550  \\$wg$aEye Diseases
=550  \\$wh$aEnophthalmos
=550  \\$wh$aExophthalmos
=550  \\$wh$aOrbital Cellulitis
=550  \\$wh$aOrbital Myositis
=550  \\$wh$aOrbital Neoplasms
=550  \\$wh$aOrbital Pseudotumor
=550  \\$wh$aPott Puffy Tumor
=550  \\$wh$aRetrobulbar Hemorrhage
=667  \\$adis of bony cavity & its contents except eyeball ( = EYE DISEASES or specifics)
=680  \\$iDiseases of the bony orbit and contents except the eyeball.
=688  \\$a81
=750  \0$aEye-sockets$xDiseases$5IEN$0(DLC)sh 85046693

=LDR  00638cz  a2200217n  4500
=001  9880363585002441
=005  20141212204102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009915
=035  \\$aCBA3192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x690
=150  \\$aOrbit
=450  \\$wnnna$aEye Socket
=450  \\$wnnna$aEye Sockets
=450  \\$wnnna$aOrbits
=450  \\$wnnna$aSocket, Eye
=450  \\$wnnna$aSockets, Eye
=550  \\$wg$aFacial Bones
=680  \\$iBony cavity that holds the eyeball and its associated tissues and appendages.
=750  \0$aEye-sockets$5IEN$0(DLC)sh 85046691

=LDR  00928cz  a2200289n  4500
=001  9880363585102441
=005  20141212204101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009912
=035  \\$aCBA3189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x634
=072  \\$aC23.$x888.$x619
=150  \\$aOral Manifestations
=450  \\$wnnna$aManifestation, Oral
=450  \\$wnnna$aManifestations, Oral
=450  \\$wnnna$aOral Manifestation
=550  \\$wg$aMouth Diseases
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aOral Hemorrhage
=550  \\$aMouth
=550  \\$aMouth Diseases
=550  \\$aOral Medicine
=667  \\$anot used for indexing since 1989; prior to 1989 used for oral manifest of non-oral diseases
=680  \\$iDisorders of the mouth attendant upon non-oral disease or injury.
=688  \\$a65
=750  \0$aOral manifestations of general diseases$5IEN$0(DLC)sh 85095243

=LDR  01301cz  a2200277n  4500
=001  9880363585202441
=005  20141212204100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009910
=035  \\$aCBA3187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x547.$x600
=072  \\$aE6.$x761.$x726
=150  \\$aOral Hygiene
=450  \\$aDental Hygiene
=450  \\$wnnna$aHygiene, Dental
=450  \\$wnnna$aHygiene, Oral
=550  \\$wg$aHygiene
=550  \\$wg$aPreventive Dentistry
=550  \\$wh$aDental Devices, Home Care
=550  \\$wh$aToothbrushing
=667  \\$adifferentiate from ORAL HEALTH; oral hyg is care toward maintaining good oral health performed by the person himself or a caregiver in the case of invalid or disabled persons; differentiate also from DENTAL CARE, care by professionals; for oral hyg using dental floss, water picks, etc. use DENTAL DEVICES, HOME CARE or TOOTHBRUSHING
=680  \\$iThe practice of personal hygiene of the mouth. It includes the maintenance of oral cleanliness, tissue tone, and general preservation of oral health.
=688  \\$a73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991
=750  \0$aMouth$xCare and hygiene$5IEN-M$0(DLC)sh 85087992
=750  \0$aTeeth$xCare and hygiene$5IEN-HS$0(DLC)sh 85133209

=LDR  00624cz  a2200181n  4500
=001  9880363585302441
=005  20180928110348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009907
=035  \\$aCBA3184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x553
=150  \\$aOptometry
=450  \\$wnnna$aOptometries
=550  \\$wg$aHealth Occupations
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe professional practice of primary eye and vision care that includes the measurement of visual refractive power and the correction of visual defects with lenses or glasses.
=750  \0$aOptometry$0(DLC)sh 85095209$5IEN-M

=LDR  00790cz  a2200205n  4500
=001  9880363585402441
=005  20141212204059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009905
=035  \\$aCBA3182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x576
=150  \\$aOptical Rotatory Dispersion
=450  \\$wnnna$aDispersion, Optical Rotatory
=450  \\$wnnna$aRotatory Dispersion, Optical
=550  \\$wg$aSpectrum Analysis
=667  \\$aa type of spectrum anal; NIM
=680  \\$iThe method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.
=688  \\$a70(68)
=750  \0$aOptical rotatory dispersion$5IEN$0(DLC)sh 85095168

=LDR  00692cz  a2200229n  4500
=001  9880363585502441
=005  20141212204059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009904
=035  \\$aCBA3181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x590.$x770.$x640
=072  \\$aG1.$x595.$x640.$x640
=150  \\$aOptical Rotation
=450  \\$wnnna$aActivity, Optical
=450  \\$wnnna$aOptical Activity
=450  \\$wnnna$aRotation, Optical
=550  \\$wg$aOptical Processes
=667  \\$aNIM; no qualif
=680  \\$iThe rotation of linearly polarized light as it passes through various media.
=688  \\$a74(71)
=750  \0$aOptical rotation$0(DLC) sh 85095167$5IEN

=LDR  00639cz  a2200205n  4500
=001  9880363585602441
=005  20141212204059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009903
=035  \\$aCBA3180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x446.$x659
=150  \\$aOptical Illusions
=450  \\$wnnna$aIllusion, Optical
=450  \\$wnnna$aIllusions, Optical
=450  \\$wnnna$aOptical Illusion
=550  \\$wg$aIllusions
=680  \\$iAn illusion of vision usually affecting spatial relations.
=688  \\$a91(75); was see under ILLUSIONS 1975-90
=750  \0$aOptical illusions$5IEN$0(DLC)sh 85095148

=LDR  02168cz  a2200457n  4500
=001  9880363585702441
=005  20141212204059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009902
=035  \\$aCBA3179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x700.$x550
=072  \\$aC11.$x640.$x576
=150  \\$aOptic Neuritis
=450  \\$wnnna$aAnterior Optic Neuritides
=450  \\$wnnna$aAnterior Optic Neuritis
=450  \\$wnnna$aNeuritides, Anterior Optic
=450  \\$wnnna$aNeuritides, Optic
=450  \\$wnnna$aNeuritides, Posterior Optic
=450  \\$wnnna$aNeuritides, Retrobulbar
=450  \\$wnnna$aNeuritis, Anterior Optic
=450  \\$wnnna$aNeuritis, Optic
=450  \\$wnnna$aNeuritis, Posterior Optic
=450  \\$wnnna$aNeuritis, Retrobulbar
=450  \\$wnnna$aNeuropapillitides
=450  \\$aNeuropapillitis
=450  \\$wnnna$aOptic Neuritides
=450  \\$wnnna$aOptic Neuritides, Anterior
=450  \\$wnnna$aOptic Neuritides, Posterior
=450  \\$wnnna$aOptic Neuritis, Anterior
=450  \\$wnnna$aOptic Neuritis, Posterior
=450  \\$wnnna$aPosterior Optic Neuritides
=450  \\$wnnna$aPosterior Optic Neuritis
=450  \\$wnnna$aRetrobulbar Neuritides
=450  \\$aRetrobulbar Neuritis
=550  \\$wg$aOptic Nerve Diseases
=550  \\$wh$aNeuromyelitis Optica
=550  \\$aNeuritis
=667  \\$aSMON (Subacute Myelo-Optico-Neuropathy) is indexed here + MYELITIS + SYNDROME
=680  \\$iInflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).
=750  \0$aOptic neuritis$5IEN$0(DLC)sh 85095135

=LDR  02226cz  a2200541n  4500
=001  9880363585802441
=005  20141212204058.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009901
=035  \\$aCBA3178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x700
=072  \\$aC11.$x640
=150  \\$aOptic Nerve Diseases
=450  \\$aCranial Nerve II Diseases
=450  \\$wnnna$aCranial Nerve II Disorder
=450  \\$wnnna$aDisk Disorder, Optic
=450  \\$wnnna$aDisk Disorders, Optic
=450  \\$aFoster-Kennedy Syndrome
=450  \\$wnnna$aFoster Kennedy Syndrome
=450  \\$wnnna$aLesion, Neural-Optical
=450  \\$wnnna$aLesions, Neural-Optical
=450  \\$wnnna$aNeural-Optical Lesion
=450  \\$wnnna$aNeural Optical Lesion
=450  \\$wnnna$aNeural-Optical Lesions
=450  \\$wnnna$aNeuropathies, Optic
=450  \\$wnnna$aNeuropathy, Optic
=450  \\$wnnna$aOptic Disk Disorder
=450  \\$aOptic Disk Disorders
=450  \\$wnnna$aOptic Nerve Disease
=450  \\$wnnna$aOptic Neuropathies
=450  \\$aOptic Neuropathy
=450  \\$aSecond Cranial Nerve Diseases
=450  \\$wnnna$aSyndrome, Foster-Kennedy
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aEye Diseases
=550  \\$wh$aLow Tension Glaucoma
=550  \\$wh$aOptic Atrophy
=550  \\$wh$aOptic Disk Drusen
=550  \\$wh$aOptic Nerve Injuries
=550  \\$wh$aOptic Nerve Neoplasms
=550  \\$wh$aOptic Neuritis
=550  \\$wh$aOptic Neuropathy, Ischemic
=550  \\$wh$aPapilledema
=667  \\$aSMON: see note on OPTIC NEURITIS; inflamm dis = OPTIC NEURITIS
=680  \\$iConditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
=688  \\$a76; was NON MESH before 1976
=750  \0$aOptic nerve$xDiseases$5IEN$0(DLC)sh 85095132

=LDR  01702cz  a2200373n  4500
=001  9880363585902441
=005  20141212192408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009900
=035  \\$aCBA3177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x680
=150  \\$aOptic Nerve
=450  \\$aCranial Nerve II
=450  \\$wnnna$aCranial Nerve IIs
=450  \\$wnnna$aCranial Nerve, Second
=450  \\$wnnna$aCranial Nerves, Second
=450  \\$wnnna$aNerve II, Cranial
=450  \\$wnnna$aNerve IIs, Cranial
=450  \\$wnnna$aNerve, Optic
=450  \\$wnnna$aNerve, Second Cranial
=450  \\$wnnna$aNerves, Optic
=450  \\$wnnna$aNerves, Second Cranial
=450  \\$wnnna$aNervus Opticus
=450  \\$wnnna$aOptic Nerves
=450  \\$wnnna$aOpticus, Nervus
=450  \\$aSecond Cranial Nerve
=450  \\$wnnna$aSecond Cranial Nerves
=550  \\$wg$aCranial Nerves
=550  \\$wh$aOptic Chiasm
=550  \\$wh$aOptic Disk
=667  \\$aneoplasms = OPTIC NERVE NEOPLASMS (IM) + histological type of neoplasm (IM); atrophy = OPTIC ATROPHY; neuritis = OPTIC NEURITIS; OPTIC NERVE HEAD see OPTIC DISK is also available
=680  \\$iThe 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM.
=750  \0$aOptic nerve$5IEN$0(DLC)sh 85095130

=LDR  01292cz  a2200325n  4500
=001  9880363586002441
=005  20141212192408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009899
=035  \\$aCBA3176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x686
=150  \\$aOptic Lobe, Nonmammalian
=450  \\$wnnna$aBigemina, Corpora
=450  \\$aCorpora Bigemina
=450  \\$wnnna$aNon-Mammalian Optic Lobe
=450  \\$wnnna$aNon-Mammalian Optic Lobes
=450  \\$wnnna$aNonmammalian Optic Lobe
=450  \\$wnnna$aNonmammalian Optic Lobes
=450  \\$wnnna$aOptic Lobe, Non-Mammalian
=450  \\$wnnna$aOptic Lobe, Non Mammalian
=450  \\$wnnna$aOptic Lobes, Non-Mammalian
=450  \\$wnnna$aOptic Lobes, Nonmammalian
=550  \\$wg$aAnimal Structures
=667  \\$aOPTIC LOBE, MAMMALIAN see SUPERIOR COLLICULI is also available
=680  \\$iIn invertebrate zoology, a lateral lobe of the FOREBRAIN in certain ARTHROPODS. In vertebrate zoology, either of the corpora bigemina of non-mammalian VERTEBRATES. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1329)
=688  \\$a2008(1964)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Optic Lobe
=688  \\$a70(64)
=750  \0$aOptic lobes$0(DLC) sh 85095129$5IEN

=LDR  01568cz  a2200421n  4500
=001  9880363586102441
=005  20141212204057.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009898
=035  \\$aCBA3175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x680.$x660
=072  \\$aA9.$x371.$x729.$x690
=150  \\$aOptic Disk
=450  \\$aBlind Spot
=450  \\$wnnna$aBlind Spots
=450  \\$wnnna$aDisk, Optic
=450  \\$wnnna$aDisks, Optic
=450  \\$wnnna$aHead, Optic Nerve
=450  \\$wnnna$aHeads, Optic Nerve
=450  \\$wnnna$aNerve Head, Optic
=450  \\$wnnna$aNerve Heads, Optic
=450  \\$aOptic Disc$5IEN
=450  \\$wnnna$aOptic Disks
=450  \\$aOptic Nerve Head
=450  \\$wnnna$aOptic Nerve Heads
=450  \\$aOptic Papilla
=450  \\$wnnna$aOptic Papillas
=450  \\$wnnna$aPapilla, Optic
=450  \\$wnnna$aPapillas, Optic
=450  \\$wnnna$aSpot, Blind
=450  \\$wnnna$aSpots, Blind
=550  \\$wg$aOptic Nerve
=550  \\$wg$aRetina
=667  \\$aneopl: coord IM with OPTIC NERVE NEOPLASMS (IM) + histol type of neopl (IM); do not confuse "optic cup" ( = EYE /embryol) with "optic disk cupping" ( = OPTIC DISK + GLAUCOMA); inflammation = RETINITIS + OPTIC NEURITIS
=680  \\$iThe portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve.
=688  \\$a78(75); was see under OPTIC NERVE 1975-77
=750  \0$aOptic disc$5IEN$0(DLC)sh 85095128

=LDR  01523cz  a2200385n  4500
=001  9880363586202441
=005  20141212192407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009897
=035  \\$aCBA3174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x317.$x578
=072  \\$aA8.$x800.$x800.$x120.$x680.$x600
=150  \\$aOptic Chiasm
=450  \\$wnnna$aChiasm, Optic
=450  \\$wnnna$aChiasma, Optic
=450  \\$aChiasma Opticum
=450  \\$wnnna$aChiasma Opticums
=450  \\$wnnna$aChiasmas, Optic
=450  \\$wnnna$aChiasms, Optic
=450  \\$wnnna$aDecussation, Optic
=450  \\$wnnna$aDecussations, Optic
=450  \\$wnnna$aOptic Chiasma
=450  \\$wnnna$aOptic Chiasmas
=450  \\$wnnna$aOptic Chiasms
=450  \\$wnnna$aOptic Decussation
=450  \\$wnnna$aOptic Decussations
=450  \\$wnnna$aOpticum, Chiasma
=450  \\$wnnna$aOpticums, Chiasma
=550  \\$wg$aDiencephalon
=550  \\$wg$aOptic Nerve
=667  \\$aneopl: coord IM with OPTIC NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes.
=688  \\$a66(64)
=750  \0$aOptic chiasm$5IEN$0(DLC)sh 85095126

=LDR  01074cz  a2200277n  4500
=001  9880363586302441
=005  20141212204056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009895
=035  \\$aCBA3171M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x767
=072  \\$aD12.$x776.$x124.$x486.$x657
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x767
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x767
=150  \\$aOpsonin Proteins
=450  \\$aOpsonins
=450  \\$wnnna$aProteins, Opsonin
=550  \\$wg$aAntibodies
=550  \\$wg$aImmunoproteins
=667  \\$acoordinate with ANTIBODIES or specific antibody term if relevant
=680  \\$iProteins that bind to particles and cells to increase susceptibility to PHAGOCYTOSIS, especially ANTIBODIES bound to EPITOPES that attach to FC RECEPTORS. COMPLEMENT C3B may also participate.
=688  \\$a2006(1964)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Opsonins
=688  \\$a65(64)
=750  \0$aOpsonins and opsonic index$0(DLC) sh 85095125$5IEN-M

=LDR  01163cz  a2200289n  4500
=001  9880363586402441
=005  20141212204056.0
=008  860401\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009894
=035  \\$aCBA3170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x597
=072  \\$aC2.$x597
=072  \\$aC3.$x684
=150  \\$aOpportunistic Infections
=450  \\$wnnna$aInfection, Opportunistic
=450  \\$wnnna$aInfections, Opportunistic
=450  \\$wnnna$aOpportunistic Infection
=550  \\$wg$aInfection
=550  \\$wg$aParasitic Diseases
=550  \\$wg$aVirus Diseases
=550  \\$wh$aAIDS-Related Opportunistic Infections
=550  \\$wh$aSuperinfection
=667  \\$a"an infect caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression"; coord IM with specific name of opportunistic infect (IM) + specific infect to which it is opportunistic (IM), using /compl for all 3
=680  \\$iAn infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
=688  \\$a87
=750  \0$aOpportunistic infections$5IEN$0(DLC)sh 85095114

=LDR  00836cz  a2200217n  4500
=001  9880363586502441
=005  20141212204056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009893
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x575
=150  \\$aOpossums
=450  \\$aDidelphidae
=450  \\$wnnna$aOpossum
=550  \\$wg$aMarsupialia
=550  \\$wh$aDidelphis
=550  \\$wh$aMonodelphis
=667  \\$apossums are indexed under PHALANGERIDAE or specifics
=680  \\$iNew World marsupials of the family Didelphidae. Opossums are omnivorous, largely nocturnal and arboreal MAMMALS, grow to about three feet in length, including the scaly prehensile tail, and have an abdominal pouch in which the young are carried at birth.
=688  \\$a1968
=750  \0$aOpossums$5IEN$0(DLC)sh 85095108

=LDR  01022cz  a2200253n  4500
=001  9880363586602441
=005  20141212204056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009892
=035  \\$aCBA3168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x534
=150  \\$aOpium
=450  \\$aOmnopon
=450  \\$wnnna$aPantopon
=450  \\$aPapaveretum
=450  \\$wnnna$aRoche Brand of Papaveretum
=550  \\$wg$aPlant Extracts
=550  \\$aOpiate Alkaloids
=550  \\$aPapaver
=667  \\$aopium addiction: coord IM with OPIOID-RELATED DISORDERS (IM)
=680  \\$iThe air-dried exudate from the unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. album. It contains a number of alkaloids, but only a few - MORPHINE; CODEINE; and PAPAVERINE - have clinical significance. Opium has been used as an analgesic, antitussive, antidiarrheal, and antispasmodic.
=688  \\$aPANTOPON was see under OPIUM 1963-79
=750  \0$aOpium$5IEN$0(DLC)sh 85095095

=LDR  01169cz  a2200253n  4500
=001  9880363586702441
=005  20141212204055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009891
=035  \\$aCBA3167M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x520.$x700
=150  \\$aOpisthorchis
=450  \\$wnnna$afelineus, Opisthorchis
=450  \\$wnnna$aOpisthorchi
=450  \\$aOpisthorchis felineus
=450  \\$aOpisthorchis viverrini
=450  \\$wnnna$aOpisthorchis viverrinus
=450  \\$wnnna$aviverrini, Opisthorchis
=450  \\$wnnna$aviverrinus, Opisthorchis
=550  \\$wg$aOpisthorchidae
=667  \\$ainfection = OPISTHORCHIASIS but note OPISTHORCHIS SINENSIS see CLONORCHIS SINENSIS: O. sinensis infection = CLONORCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca (Amphimerus noverca), and O. viverrini. The intermediate hosts are snails, fish, and AMPHIBIANS.
=750  \0$aOpisthorchis$0(DLC)sh2012004666$5IEN-M

=LDR  00921cz  a2200205n  4500
=001  9880363586802441
=005  20141212204055.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009890
=035  \\$aCBA3166M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x520
=150  \\$aOpisthorchidae
=550  \\$wg$aTrematoda
=550  \\$wh$aClonorchis sinensis
=550  \\$wh$aOpisthorchis
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of lanceolate liver flukes of the class Trematoda which occurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis.
=688  \\$a82
=750  \0$aOpisthorchiidae$0(DLC)sh2012004667$5IEN-M

=LDR  00651cz  a2200193n  4500
=001  9880363586902441
=005  20141212204055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009889
=035  \\$aCBA3165HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x685
=150  \\$aOpisthorchiasis
=450  \\$wnnna$aOpisthorchiases
=550  \\$wg$aTrematode Infections
=667  \\$atrematode infect caused by genus OPISTHORCHIS but not OPISTHORCHIS SINENSIS ( = CLONORCHIS SINENSIS, causing CLONORCHIASIS)
=680  \\$iInfection with flukes of the genus Opisthorchis.
=688  \\$a68
=750  \0$aOpisthorchiasis$5IEN$0(DLC)sh 85095093

=LDR  00612cz  a2200205n  4500
=001  9880363587002441
=005  20141212204054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009887
=035  \\$aCBA3163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x560
=150  \\$aOphthalmoscopy
=450  \\$wnnna$aOphthalmoscopies
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$wh$aRetinoscopy
=550  \\$aFundus Oculi
=550  \\$aPapilledema
=680  \\$iExamination of the interior of the eye with an ophthalmoscope.
=750  \0$aOphthalmoscopy$5IEN$0(DLC)sh 85095080

=LDR  01763cz  a2200457n  4500
=001  9880363587102441
=005  20141212204054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009886
=035  \\$aCBA3162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x562.$x750
=072  \\$aC10.$x597.$x622.$x447
=072  \\$aC11.$x590.$x472
=072  \\$aC23.$x888.$x592.$x636.$x447
=150  \\$aOphthalmoplegia
=450  \\$wnnna$aExternal Ophthalmoplegia
=450  \\$wnnna$aExternal Ophthalmoplegias
=450  \\$wnnna$aInternal Ophthalmoplegia
=450  \\$wnnna$aInternal Ophthalmoplegias
=450  \\$aOculomotor Paralysis
=450  \\$wnnna$aOphthalmopareses
=450  \\$wnnna$aOphthalmoparesis
=450  \\$wnnna$aOphthalmoplegia, External
=450  \\$wnnna$aOphthalmoplegia, Internal
=450  \\$wnnna$aOphthalmoplegias
=450  \\$wnnna$aOphthalmoplegias, External
=450  \\$wnnna$aOphthalmoplegias, Internal
=450  \\$wnnna$aParalysis, Oculomotor
=550  \\$wg$aOcular Motility Disorders
=550  \\$wg$aParalysis
=550  \\$wh$aOphthalmoplegia, Chronic Progressive External
=550  \\$wh$aOphthalmoplegic Migraine
=550  \\$wh$aSupranuclear Palsy, Progressive
=550  \\$aDuane Retraction Syndrome
=550  \\$aOculomotor Nerve Diseases
=667  \\$ado not confuse X ref OCULOMOTOR PARALYSIS with OCULOMOTOR NERVE PARALYSIS
=680  \\$iParalysis of one or more of the ocular muscles due to disorders of the eye muscles, neuromuscular junction, supporting soft tissue, tendons, or innervation to the muscles.
=688  \\$a1979; was OCULOMOTOR PARALYSIS 1963-1978
=750  \0$aEye$xParalysis$5IEN-M$0(DLC)sh 85046673
=750  \0$aOculomotor paralysis$5IEN-HS$0(DLC)sh 85094055

=LDR  00647cz  a2200181n  4500
=001  9880363587202441
=005  20180928105011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009885
=035  \\$aCBA3161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x468
=150  \\$aOphthalmology
=550  \\$wg$aSpecialties, Surgical
=550  \\$aOphthalmologic Surgical Procedures
=667  \\$aSPEC: SPEC qualif; DF: OPHTHALMOL
=680  \\$iA surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.
=750  \0$aOphthalmology$0(DLC)sh 85095071$5IEN-M

=LDR  00810cz  a2200193n  4500
=001  9880363587302441
=005  20141212204053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009884
=035  \\$aCBA3160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x550
=150  \\$aOphthalmodynamometry
=450  \\$wnnna$aOphthalmodynamometries
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=667  \\$ato measure retinal arterial pressure; do not use /util except by MeSH definition
=680  \\$iMeasurement of the blood pressure of the retinal vessels. It is used also for the determination of the near point of convergence (CONVERGENCE, OCULAR). (From Cline, et al., Dictionary of Visual Science, 4th ed)
=688  \\$a67(64)
=750  \0$aOphthalmodynamometry$5IEN$0(DLC)sh 85095067

=LDR  01089cz  a2200265n  4500
=001  9880363587402441
=005  20141212192407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009883
=035  \\$aCBA3159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776.$x708.$x645
=072  \\$aD27.$x505.$x954.$x578.$x645
=072  \\$aD27.$x720.$x752.$x608
=150  \\$aOphthalmic Solutions
=450  \\$wnnna$aDrops, Eye
=450  \\$wnnna$aEye Drops
=450  \\$aEyedrops
=450  \\$wnnna$aSolutions, Ophthalmic
=550  \\$wg$aPharmaceutical Solutions
=550  \\$wh$aLubricant Eye Drops
=667  \\$asterile solutions for instillation into the eyes: not for solutions for cleaning eyeglass lenses ( = SOLUTIONS + EYEGLASSES); not for solutions for cleaning contact lenses ( = CONTACT LENS SOLUTIONS)
=680  \\$iSterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
=688  \\$a67; was SOLUTIONS, OPHTHALMIC 1963-66
=750  \0$aOphthalmic drugs$5IEN$0(DLC)sh 85082058

=LDR  00818cz  a2200217n  4500
=001  9880363587502441
=005  20141212204053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009881
=035  \\$aCBA3157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x740.$x690
=072  \\$aN2.$x360.$x67.$x740.$x690
=150  \\$aOphthalmic Assistants
=450  \\$wnnna$aAssistant, Ophthalmic
=450  \\$wnnna$aAssistants, Ophthalmic
=450  \\$wnnna$aOphthalmic Assistant
=550  \\$wg$aPhysician Assistants
=680  \\$iPersons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist.
=688  \\$a91(75); was see under PHYSICIANS' ASSISTANTS 1975-90
=750  \0$aOphthalmic assistants$5IEN$0(DLC)sh 85095063

=LDR  01277cz  a2200289n  4500
=001  9880363587602441
=005  20141212204052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009877
=035  \\$aCBA3153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x375.$x265
=072  \\$aC11.$x294.$x265
=150  \\$aEndophthalmitis
=450  \\$wnnna$aEndophthalmitides
=450  \\$wnnna$aEndophthalmitides, Infectious
=450  \\$wnnna$aEndophthalmitis, Infectious
=450  \\$wnnna$aInfectious Endophthalmitides
=450  \\$wnnna$aInfectious Endophthalmitis
=450  \\$aOphthalmia
=450  \\$wnnna$aOphthalmias
=550  \\$wg$aEye Infections
=550  \\$wh$aUveitis, Suppurative
=667  \\$arestrict to endophthalmitis as a specific disease entity, not as a coordinate for inflammation of specific internal parts of the eye: these are available as -ITIS terms; ophthalmitis goes here; PANOPHTHALMITIS is also available: inflammation of all structures of the eye; EGYPTIAN OPHTHALMIA see TRACHOMA is also available
=680  \\$iSuppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
=688  \\$a90; was OPHTHALMIA 1966-89
=750  \0$aEye$xInflammation$5IEN$0(DLC)sh 85046663

=LDR  00852cz  a2200241n  4500
=001  9880363587702441
=005  20141212204051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009876
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x686
=072  \\$aG5.$x360.$x340.$x358.$x207.$x500
=150  \\$aOperon
=450  \\$wnnna$aOperons
=550  \\$wg$aGenome, Bacterial
=550  \\$wg$aGenome Components
=550  \\$wh$aLac Operon
=550  \\$wh$aOperator Regions, Genetic
=550  \\$wh$arRNA Operon
=667  \\$aLAC OPERON & RRNA OPERON are also available
=680  \\$iIn bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION.
=688  \\$a72(69)
=750  \0$aOperons$5IEN$0(DLC)sh 85095032

=LDR  00751cz  a2200289n  4500
=001  9880363587802441
=005  20141212203924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009593
=035  \\$aCBA2859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x672
=072  \\$aD3.$x383.$x129.$x308.$x658
=150  \\$aNitroimidazoles
=550  \\$wg$aImidazoles
=550  \\$wg$aNitro Compounds
=550  \\$wh$aDimetridazole
=550  \\$wh$aEtanidazole
=550  \\$wh$aIpronidazole
=550  \\$wh$aMetronidazole
=550  \\$wh$aMisonidazole
=550  \\$wh$aNimorazole
=550  \\$wh$aOrnidazole
=550  \\$wh$aRonidazole
=550  \\$wh$aTinidazole
=688  \\$a74
=750  \0$aNitroimidazoles$5IEN$0(DLC)sh 85092087

=LDR  00733cz  a2200229n  4500
=001  9880363587902441
=005  20141212203923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009591
=035  \\$aCBA2857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x647
=150  \\$aNitrogenase
=450  \\$aDinitrogenase
=450  \\$wnnna$aNitrogenase, Vanadium
=450  \\$wnnna$aVanadium Nitrogenase
=550  \\$wg$aOxidoreductases
=550  \\$wh$aDinitrogenase Reductase
=550  \\$wh$aMolybdoferredoxin
=680  \\$iAn enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae (CYANOBACTERIA). EC 1.18.6.1.
=688  \\$a74
=750  \0$aNitrogenase$5IEN-M$0(DLC)sh 94006031

=LDR  00836cz  a2200277n  4500
=001  9880363588002441
=005  20141212203923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009589
=035  \\$aCBA2855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x635
=072  \\$aD1.$x625.$x550
=072  \\$aD1.$x650.$x550.$x587
=150  \\$aNitrogen Oxides
=450  \\$wnnna$aOxides, Nitrogen
=550  \\$wg$aGases
=550  \\$wg$aNitrogen Compounds
=550  \\$wg$aOxides
=550  \\$wh$aNitric Oxide
=550  \\$wh$aNitrogen Dioxide
=550  \\$wh$aNitrous Oxide
=667  \\$aGEN or unspecified; prefer specifics; NO = NITRIC OXIDE; N2O = NITROUS OXIDE; NO2 = NITROGEN DIOXIDE
=680  \\$iInorganic oxides that contain nitrogen.
=688  \\$a73(71)
=750  \0$aNitrogen oxides$5IEN$0(DLC)sh 85092082

=LDR  01327cz  a2200325n  4500
=001  9880363588102441
=005  20141212203922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009588
=035  \\$aCBA2854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x728.$x650
=150  \\$aNitrogen Mustard Compounds
=450  \\$wnnna$aCompounds, Nitrogen Mustard
=450  \\$wnnna$aMustard Compounds, Nitrogen
=450  \\$aNitrogen Mustards$5IEN
=550  \\$wg$aMustard Compounds
=550  \\$wh$aAniline Mustard
=550  \\$wh$aChlorambucil
=550  \\$wh$aEstramustine
=550  \\$wh$aMannomustine
=550  \\$wh$aMechlorethamine
=550  \\$wh$aMelphalan
=550  \\$wh$aPhosphoramide Mustards
=550  \\$wh$aPropylbenzilylcholine Mustard
=550  \\$wh$aQuinacrine Mustard
=550  \\$wh$aUracil Mustard
=667  \\$aalkyating antineoplastics; do not confuse with NITROGEN MUSTARD, a specific chemical; DF: NITROGEN MUSTARD CPDS
=680  \\$iA group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens.
=750  \0$aNitrogen mustards$5IEN$0(DLC)sh 85092081

=LDR  00693cz  a2200217n  4500
=001  9880363588202441
=005  20141212203922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009587
=035  \\$aCBA2853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x586
=150  \\$aNitrogen Isotopes
=450  \\$wnnna$aIsotopes, Nitrogen
=550  \\$wg$aIsotopes
=550  \\$wh$aNitrogen Radioisotopes
=550  \\$aNitrogen
=667  \\$aN-15; NIM
=680  \\$iStable nitrogen atoms that have the same atomic number as the element nitrogen, but differ in atomic weight. N-15 is a stable nitrogen isotope.
=688  \\$a73(71)
=750  \0$aNitrogen$xIsotopes$5IEN$0(DLC)sh 85092064

=LDR  01311cz  a2200373n  4500
=001  9880363588302441
=005  20141212203922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009586
=035  \\$aCBA2852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x70.$x630
=072  \\$aG2.$x149.$x115.$x70.$x630
=072  \\$aG3.$x495.$x153.$x630
=072  \\$aG6.$x99.$x112.$x610
=072  \\$aG6.$x590.$x110.$x610
=072  \\$aG6.$x590.$x620
=150  \\$aNitrogen Fixation
=450  \\$wnnna$aActivities, Diazotrophic
=450  \\$wnnna$aActivity, Diazotrophic
=450  \\$wnnna$aDiazotrophic Activities
=450  \\$wnnna$aDiazotrophic Activity
=450  \\$aDiazotrophy
=450  \\$wnnna$aDinitrogen Fixation
=450  \\$wnnna$aFixation, Dinitrogen
=450  \\$wnnna$aFixation, N2
=450  \\$wnnna$aFixation, Nitrogen
=450  \\$wnnna$aN2 Fixation
=550  \\$wg$aAutotrophic Processes
=550  \\$wg$aBacterial Processes
=550  \\$wg$aMicrobiological Processes
=550  \\$aPlant Root Nodulation
=680  \\$iThe process in certain BACTERIA; FUNGI; and CYANOBACTERIA converting free atmospheric NITROGEN to biologically usable forms of nitrogen, such as AMMONIA; NITRATES; and amino compounds.
=750  \0$aNitrogen$xFixation$0(DLC) sh 85092063$5IEN

=LDR  00989cz  a2200241n  4500
=001  9880363588402441
=005  20141212203921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009585
=035  \\$aCBA2851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x635.$x600
=072  \\$aD1.$x625.$x550.$x525
=072  \\$aD1.$x650.$x550.$x587.$x625
=150  \\$aNitrogen Dioxide
=450  \\$wnnna$aDioxide, Nitrogen
=450  \\$wnnna$aNitrogen Peroxide
=450  \\$wnnna$aPeroxide, Nitrogen
=550  \\$wg$aNitrogen Oxides
=667  \\$aa highly poisonous gas
=680  \\$iNitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface.
=688  \\$a65(63)
=750  \0$aNItrogen dioxide$5IEN$0(DLC)sh 85092072

=LDR  00741cz  a2200193n  4500
=001  9880363588502441
=005  20141212203921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009584
=035  \\$aCBA2850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x604
=072  \\$aD1.$x362.$x625
=150  \\$aNitrogen
=550  \\$wg$aElements
=550  \\$wg$aGases
=667  \\$aN-14; /physiol permitted
=680  \\$iAn element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
=750  \0$aNitrogen$5IEN-M$0(DLC)sh 85092062

=LDR  00849cz  a2200313n  4500
=001  9880363588602441
=005  20141212203920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009581
=035  \\$aCBA2847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x600
=072  \\$aD3.$x383.$x312.$x649
=150  \\$aNitrofurans
=450  \\$aNifuroxime$5IEN-M
=550  \\$wg$aFurans
=550  \\$wg$aNitro Compounds
=550  \\$wh$a5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole
=550  \\$wh$aFANFT
=550  \\$wh$aFuragin
=550  \\$wh$aFurazolidone
=550  \\$wh$aFurylfuramide
=550  \\$wh$aNifuratel
=550  \\$wh$aNifurtimox
=550  \\$wh$aNitrofurantoin
=550  \\$wh$aNitrofurazone
=550  \\$wh$aNitrovin
=667  \\$aurinary anti-infectives
=750  \0$aNitrofurans$5IEN$0(DLC)sh 85092061

=LDR  00680cz  a2200217n  4500
=001  9880363588702441
=005  20141212203920.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009579
=035  \\$aCBA2845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x600
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x650
=150  \\$aNitrobenzoates
=450  \\$wnnna$aAcids, Nitrobenzoic
=450  \\$wnnna$aNitrobenzoic Acids
=550  \\$wg$aBenzoates
=550  \\$wh$aDithionitrobenzoic Acid
=680  \\$iBenzoic acid or benzoic acid esters substituted with one or more nitro groups.
=688  \\$a75
=750  \0$aNitrobenzoic acid$5IEN$0(DLC)sh 85092059

=LDR  00649cz  a2200229n  4500
=001  9880363588802441
=005  20141212203919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009578
=035  \\$aCBA2844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x565
=072  \\$aD2.$x640.$x529
=150  \\$aNitrobenzenes
=550  \\$wg$aBenzene Derivatives
=550  \\$wg$aNitro Compounds
=550  \\$wh$aChloramphenicol
=550  \\$wh$aDinitrobenzenes
=550  \\$wh$aDinitrochlorobenzene
=550  \\$wh$aDinitrofluorobenzene
=550  \\$wh$aTrinitrobenzenes
=750  \0$aNitrobenzene$5IEN-M$0(DLC)sh 97009279

=LDR  01060cz  a2200325n  4500
=001  9880363588902441
=005  20210212080317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009574
=035  \\$aCBA2840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640
=150  \\$aNitro Compounds
=450  \\$wnnna$aNitrated Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAristolochic Acids
=550  \\$wh$aDinitrocresols
=550  \\$wh$aNitrobenzenes
=550  \\$wh$aNitrofurans
=550  \\$wh$aNitroglycerin
=550  \\$wh$aNitroimidazoles
=550  \\$wh$aNitroparaffins
=550  \\$wh$aNitrophenols
=550  \\$wh$aNitroquinolines
=550  \\$wh$aThiamethoxam
=550  \\$aNitroglycerin
=667  \\$ado not confuse entry term NITRATED COMPOUNDS with NITRATES; DF: NITRO CPDS
=680  \\$iCompounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES.
=688  \\$a74(71)
=750  \0$aNitro compounds$5IEN$0(DLC)sh 85092057

=LDR  00887cz  a2200229n  4500
=001  9880363589002441
=005  20141212203918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009573
=035  \\$aCBA2839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x635
=072  \\$aD1.$x625.$x600.$x600
=072  \\$aD2.$x633
=150  \\$aNitrites
=550  \\$wg$aAnions
=550  \\$wg$aNitrous Acid
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAmyl Nitrite
=550  \\$wh$aSodium Nitrite
=680  \\$iSalts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aNitrites$5IEN$0(DLC)sh 85092056

=LDR  00985cz  a2200253n  4500
=001  9880363589102441
=005  20141212203918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009571
=035  \\$aCBA2837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x588
=150  \\$aNitrilotriacetic Acid
=450  \\$wnnna$aAcid, Nitrilotriacetic
=450  \\$wnnna$aAluminum Nitrilotriacetate
=450  \\$wnnna$aDysprosium Nitrilotriacetate
=450  \\$wnnna$aNitrilotriacetate, Aluminum
=450  \\$wnnna$aNitrilotriacetate, Dysprosium
=450  \\$wnnna$aNitrilotriacetate, Trisodium
=450  \\$wnnna$aTrisodium Nitrilotriacetate
=550  \\$wg$aAcetates
=680  \\$iA derivative of acetic acid, N(CH2COOH)3. It is a complexing (sequestering) agent that forms stable complexes with Zn2+. (From Miall's Dictionary of Chemistry, 5th ed.)
=688  \\$a91(73); was see under ACETIC ACIDS 1973-90
=750  \0$aNitrilotriacetic acid$5IEN$0(DLC)sh 85092055

=LDR  01288cz  a2200373n  4500
=001  9880363589202441
=005  20171012131111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009570
=035  \\$aCBA2836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x626
=150  \\$aNitriles
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetonitriles
=550  \\$wh$aAcrylonitrile
=550  \\$wh$aAminopropionitrile
=550  \\$wh$aAmygdalin
=550  \\$wh$aCarbonyl Cyanide m-Chlorophenyl Hydrazone
=550  \\$wh$aCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
=550  \\$wh$aCitalopram
=550  \\$wh$aCyanoacrylates
=550  \\$wh$aFadrozole
=550  \\$wh$ao-Chlorobenzylidenemalonitrile
=550  \\$wh$aNitriles
=550  \\$wh$aPregnenolone Carbonitrile
=550  \\$wh$aPyrimidines
=550  \\$wh$aTechnetium Tc 99m Sestamibi
=550  \\$wh$aTyrphostins
=550  \\$aCyanides
=667  \\$aorganic cpds having -CN radical: differentiate from CYANIDES which are inorganic with -CN
=680  \\$iOrganic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.
=688  \\$a68; was see under CYANIDES 1963-67
=750  \0$aNitriles$5IEN$0(DLC)sh 85092054

=LDR  01737cz  a2200385n  4500
=001  9880363589302441
=005  20141212203917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009569
=035  \\$aCBA2835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x339.$x387
=072  \\$aD1.$x625.$x550.$x500
=072  \\$aD1.$x625.$x700.$x500
=072  \\$aD1.$x650.$x550.$x587.$x600
=150  \\$aNitric Oxide
=450  \\$wnnna$aEndogenous Nitrate Vasodilator
=450  \\$wnnna$aEndothelium-Derived Nitric Oxide
=450  \\$wnnna$aMononitrogen Monoxide
=450  \\$wnnna$aMonoxide, Mononitrogen
=450  \\$wnnna$aMonoxide, Nitrogen
=450  \\$wnnna$aNitrate Vasodilator, Endogenous
=450  \\$wnnna$aNitric Oxide, Endothelium-Derived
=450  \\$wnnna$aNitric Oxide, Endothelium Derived
=450  \\$wnnna$aNitrogen Monoxide
=450  \\$wnnna$aOxide, Nitric
=450  \\$wnnna$aVasodilator, Endogenous Nitrate
=550  \\$wg$aFree Radicals
=550  \\$wg$aNitrogen Oxides
=550  \\$wg$aReactive Nitrogen Species
=550  \\$aEndothelium-Dependent Relaxing Factors
=550  \\$aNitric Oxide Donors
=680  \\$iA free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.
=688  \\$a1965
=750  \0$aNitric oxide$5IEN$0(DLC)sh 90001567

=LDR  06672cz  a2201789n  4500
=001  9880363589402441
=005  20141212192357.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009568
=035  \\$aCBA2834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203.$x590
=150  \\$aNitrendipine
=450  \\$wnnna$a1A Brand of Nitrendipine
=450  \\$wnnna$a1A Pharma, Nitren
=450  \\$wnnna$aAbZ Brand of Nitrendipine
=450  \\$wnnna$aAbZ, Nitre
=450  \\$wnnna$aacis Brand of Nitrendipine
=450  \\$wnnna$aacis, Nitren
=450  \\$wnnna$aAL, Nitrendipin
=450  \\$wnnna$aAliud Brand of Nitrendipine
=450  \\$wnnna$aAlmirall Brand of Nitrendipine
=450  \\$wnnna$aAlpharma Brand of Nitrendipine
=450  \\$wnnna$aApogepha Brand of Nitrendipine
=450  \\$wnnna$aApogepha, Nitrendipin
=450  \\$wnnna$aAtid, Nitrendipin
=450  \\$wnnna$aAzupharma Brand of Nitrendipine
=450  \\$wnnna$aBalminil
=450  \\$wnnna$aBasics Brand of Nitrendipine
=450  \\$wnnna$aBasics, Nitrendipin
=450  \\$wnnna$aBay e 5009
=450  \\$wnnna$aBayer Brand of Nitrendipine
=450  \\$wnnna$aBayotensin
=450  \\$wnnna$aBaypresol
=450  \\$wnnna$aBaypress
=450  \\$wnnna$aBayvit Brand of Nitrendipine
=450  \\$wnnna$aBayvit, Nitrendipino
=450  \\$wnnna$aBC Brand of Nitrendipine
=450  \\$wnnna$abeta, Nitrendipin
=450  \\$wnnna$abetapharm Brand of Nitrendipine
=450  \\$wnnna$aBiochemie, Nitrendi
=450  \\$wnnna$aBiomed Brand of Nitrendipine
=450  \\$wnnna$acorax Brand of Nitrendipine
=450  \\$wnnna$act-Arzneimittel Brand of Nitrendipine
=450  \\$wnnna$act Arzneimittel Brand of Nitrendipine
=450  \\$wnnna$act, nitrendipin von
=450  \\$wnnna$aDexcel Brand of Nitrendipine
=450  \\$wnnna$aDocpharm Brand of Nitrendipine
=450  \\$wnnna$aElan Brand of Nitrendipine
=450  \\$wnnna$aElfar Brand of Nitrendipine
=450  \\$wnnna$aGericin
=450  \\$wnnna$aHeumann Brand of Nitrendipine
=450  \\$wnnna$aHeumann, Nitrendipin
=450  \\$wnnna$aHexal Brand of Nitrendipine
=450  \\$wnnna$aJenapharm Brand of Nitrendipine
=450  \\$wnnna$aJenapharm, Nitrendipin
=450  \\$wnnna$aJuta Brand of Nitrendipine
=450  \\$wnnna$aJutapress
=450  \\$wnnna$aKSK, Nitrend
=450  \\$wnnna$aKSK Pharma Brand of Nitrendipine
=450  \\$wnnna$aLich, Nitren
=450  \\$wnnna$aLichtenstein Brand of Nitrendipine
=450  \\$wnnna$aLindo, Nitrendipin
=450  \\$wnnna$aLindopharm Brand of Nitrendipine
=450  \\$wnnna$aMerck dura Brand of Nitrendipine
=450  \\$wnnna$aNidrel
=450  \\$wnnna$aNiprina
=450  \\$wnnna$aNitre AbZ
=450  \\$wnnna$aNitre-Puren
=450  \\$wnnna$aNitre Puren
=450  \\$wnnna$aNitregamma
=450  \\$wnnna$aNitren 1A Pharma
=450  \\$wnnna$aNitren acis
=450  \\$wnnna$aNitren Lich
=450  \\$wnnna$aNitrend KSK
=450  \\$wnnna$aNitrendepat
=450  \\$wnnna$aNitrendi Biochemie
=450  \\$wnnna$aNitrendidoc
=450  \\$wnnna$aNitrendimerck
=450  \\$wnnna$aNitrendipin AL
=450  \\$wnnna$aNitrendipin Apogepha
=450  \\$wnnna$aNitrendipin Atid
=450  \\$wnnna$aNitrendipin Basics
=450  \\$wnnna$aNitrendipin beta
=450  \\$wnnna$anitrendipin-corax
=450  \\$wnnna$anitrendipin corax
=450  \\$wnnna$aNitrendipin Heumann
=450  \\$wnnna$aNitrendipin Jenapharm
=450  \\$wnnna$aNitrendipin Lindo
=450  \\$wnnna$aNitrendipin-ratiopharm
=450  \\$wnnna$aNitrendipin ratiopharm
=450  \\$wnnna$aNitrendipin Stada
=450  \\$wnnna$anitrendipin von ct
=450  \\$wnnna$anitrendipincorax
=450  \\$wnnna$aNitrendipine 1A Brand
=450  \\$wnnna$aNitrendipine AbZ Brand
=450  \\$wnnna$aNitrendipine acis Brand
=450  \\$wnnna$aNitrendipine Aliud Brand
=450  \\$wnnna$aNitrendipine Almirall Brand
=450  \\$wnnna$aNitrendipine Alpharma Brand
=450  \\$wnnna$aNitrendipine Apogepha Brand
=450  \\$wnnna$aNitrendipine Azupharma Brand
=450  \\$wnnna$aNitrendipine Basics Brand
=450  \\$wnnna$aNitrendipine Bayer Brand
=450  \\$wnnna$aNitrendipine Bayvit Brand
=450  \\$wnnna$aNitrendipine BC Brand
=450  \\$wnnna$aNitrendipine betapharm Brand
=450  \\$wnnna$aNitrendipine Biomed Brand
=450  \\$wnnna$aNitrendipine corax Brand
=450  \\$wnnna$aNitrendipine ct-Arzneimittel Brand
=450  \\$wnnna$aNitrendipine Dexcel Brand
=450  \\$wnnna$aNitrendipine Docpharm Brand
=450  \\$wnnna$aNitrendipine Elan Brand
=450  \\$wnnna$aNitrendipine Elfar Brand
=450  \\$wnnna$aNitrendipine Heumann Brand
=450  \\$wnnna$aNitrendipine Hexal Brand
=450  \\$wnnna$aNitrendipine Jenapharm Brand
=450  \\$wnnna$aNitrendipine Juta Brand
=450  \\$wnnna$aNitrendipine Lichtenstein Brand
=450  \\$wnnna$aNitrendipine Lindopharm Brand
=450  \\$wnnna$aNitrendipine Q-Pharm Brand
=450  \\$wnnna$aNitrendipine ratiopharm Brand
=450  \\$wnnna$aNitrendipine Schwarz Brand
=450  \\$wnnna$aNitrendipine Seid Brand
=450  \\$wnnna$aNitrendipine Stadapharm Brand
=450  \\$wnnna$aNitrendipine TAD Brand
=450  \\$wnnna$aNitrendipine Wörwag Brand
=450  \\$wnnna$aNitrendipino Bayvit
=450  \\$wnnna$aNitrendipino Ratiopharm
=450  \\$wnnna$aNitrendipinratiopharm
=450  \\$wnnna$aNitrensal
=450  \\$wnnna$aNitrepress
=450  \\$wnnna$aNitrePuren
=450  \\$wnnna$aPharma, Nitren 1A
=450  \\$wnnna$aPrevision y Salud Brand of Nitrendipine
=450  \\$wnnna$aQ-Pharm Brand of Nitrendipine
=450  \\$wnnna$aratiopharm Brand of Nitrendipine
=450  \\$wnnna$aRatiopharm, Nitrendipino
=450  \\$wnnna$aSchwarz Brand of Nitrendipine
=450  \\$wnnna$aSeid Brand of Nitrendipine
=450  \\$wnnna$aStada, Nitrendipin
=450  \\$wnnna$aStadapharm Brand of Nitrendipine
=450  \\$wnnna$aTAD Brand of Nitrendipine
=450  \\$wnnna$aTensogradal
=450  \\$wnnna$aTrendinol
=450  \\$wnnna$aVastensium
=450  \\$wnnna$avon ct, nitrendipin
=450  \\$wnnna$aWörwag Brand of Nitrendipine
=550  \\$wg$aDihydropyridines
=680  \\$iA calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
=688  \\$a87
=750  \0$aNitrendipine$5IEN$0(DLC)sh 85092046

=LDR  00803cz  a2200265n  4500
=001  9880363589502441
=005  20141212203916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009566
=035  \\$aCBA2832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x606
=072  \\$aD1.$x625.$x525.$x550
=072  \\$aD2.$x583
=150  \\$aNitrates
=550  \\$wg$aAnions
=550  \\$wg$aNitric Acid
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aErythrityl Tetranitrate
=550  \\$wh$aNicorandil
=550  \\$wh$aSilver Nitrate
=550  \\$wh$aUranyl Nitrate
=667  \\$aNITRATED COMPOUNDS is also available
=680  \\$iInorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
=750  \0$aNitrates$5IEN$0(DLC)sh 85092042

=LDR  01124cz  a2200313n  4500
=001  9880363589602441
=005  20141212192354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009562
=035  \\$aCBA2828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x712
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x610
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x248.$x300.$x610
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x811.$x740.$x300.$x610
=072  \\$aA11.$x671.$x693
=150  \\$aNissl Bodies
=450  \\$wnnna$aBodies, Nissl
=450  \\$wnnna$aGranule, Nissl
=450  \\$wnnna$aGranules, Nissl
=450  \\$wnnna$aNissl Granule
=450  \\$aNissl Granules
=550  \\$wg$aCytoplasmic Granules
=550  \\$wg$aEndoplasmic Reticulum, Rough
=550  \\$wg$aNeurons
=550  \\$aRNA
=680  \\$iSubcellular structures found in nerve cell bodies and DENDRITES. They consist of granular endoplasmic reticulum (ENDOPLASMIC RETICULUM, ROUGH) and RIBOSOMES.
=688  \\$a65(64); CHROMATIN, NERVE was see NISSL BODIES 1973-94
=750  \0$aNissl bodies$5IEN$0(DLC)sh 85092038

=LDR  00721cz  a2200217n  4500
=001  9880363589702441
=005  20141212203915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009561
=035  \\$aCBA2827HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x582
=072  \\$aD12.$x644.$x641.$x582
=072  \\$aD12.$x776.$x97.$x151.$x700
=072  \\$aD12.$x776.$x543.$x695.$x110.$x700
=150  \\$aNisin
=550  \\$wg$aBacteriocins
=550  \\$wg$aPeptides, Cyclic
=680  \\$iA 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese.
=688  \\$a73
=750  \0$aNisin$5IEN$0(DLC)sh 85092029

=LDR  01038cz  a2200229n  4500
=001  9880363589802441
=005  20141212203915.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009559
=035  \\$aCBA2825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x400.$x575
=150  \\$aNippostrongylus
=450  \\$wnnna$aNematode, Rat
=450  \\$wnnna$aNematodes, Rat
=450  \\$aRat Nematode
=450  \\$wnnna$aRat Nematodes
=550  \\$wg$aHeligmosomatoidea
=667  \\$aa genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin.
=688  \\$a79(75); was see under HOOKWORMS 1975-78
=750  \0$aNippostrongylus$5IEN$0(DLC)sh 87020013

=LDR  00696cz  a2200205n  4500
=001  9880363589902441
=005  20141212203914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009556
=035  \\$aCBA2822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x615
=072  \\$aD1.$x268.$x956.$x687
=072  \\$aD1.$x552.$x544.$x615
=150  \\$aNiobium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aNb-93; synonym: Columbium (Cb); Nb-88-92, 94-101 = NIOBIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iNiobium. A metal element atomic number 41, atomic weight 92.906, symbol Nb. (From Dorland, 28th ed)
=750  \0$aNiobium$5IEN$0(DLC)sh 85091993

=LDR  01769cz  a2200529n  4500
=001  9880363590002441
=005  20141212203913.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009553
=035  \\$aCBA2818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203.$x570
=072  \\$aD3.$x383.$x725.$x547.$x570
=150  \\$aNimodipine
=450  \\$wnnna$a9736, Bay e
=450  \\$wnnna$aAdmon
=450  \\$wnnna$aAlmirall Brand of Nimodipine
=450  \\$wnnna$aAlpharma Brand of Nimodipine
=450  \\$wnnna$aAndromaco Brand of Nimodipine
=450  \\$wnnna$aBay e 9736
=450  \\$wnnna$aBayer Brand of Nimodipine
=450  \\$wnnna$aBayvit Brand of Nimodipine
=450  \\$wnnna$aBayvit, Nimodipino
=450  \\$wnnna$aBrainal
=450  \\$wnnna$aCalnit
=450  \\$wnnna$aCantabria Brand of Nimodipine
=450  \\$wnnna$ae 9736, Bay
=450  \\$wnnna$aElan Brand of Nimodipine
=450  \\$wnnna$aEsteve Brand of Nimodipine
=450  \\$wnnna$aHexal Brand of Nimodipine
=450  \\$wnnna$aHexal, Nimodipin
=450  \\$wnnna$aKenesil
=450  \\$wnnna$aModus
=450  \\$wnnna$aNimodipin Hexal
=450  \\$wnnna$aNimodipin-ISIS
=450  \\$wnnna$aNimodipin ISIS
=450  \\$wnnna$aNimodipinISIS
=450  \\$wnnna$aNimodipino Bayvit
=450  \\$wnnna$aNimotop
=450  \\$wnnna$aNymalize
=450  \\$wnnna$aRemontal
=450  \\$wnnna$aVita Brand of Nimodipine
=550  \\$wg$aDihydropyridines
=550  \\$wg$aNicotinic Acids
=680  \\$iA calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
=688  \\$a87; use NIMODIPINE (NM) 1981-86
=750  \0$aNimodipine$5IEN$0(DLC)sh 88007606

=LDR  00636cz  a2200229n  4500
=001  9880363590102441
=005  20141212203912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009551
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x564
=072  \\$aN2.$x421.$x585.$x564
=150  \\$aNight Care
=450  \\$wnnna$aCare, Night
=450  \\$wnnna$aCares, Night
=450  \\$wnnna$aNight Cares
=550  \\$wg$aPatient Care
=550  \\$aAfter-Hours Care
=667  \\$ainstitutional care only
=680  \\$iInstitutional night care of patients.
=688  \\$a68
=750  \0$aHospitals$xNight care$5IEN$0(DLC)sh 85062344

=LDR  00982cz  a2200313n  4500
=001  9880363590202441
=005  20141212203911.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009545
=035  \\$aCBA2810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x600.$x410
=072  \\$aD3.$x383.$x129.$x462.$x600.$x600
=072  \\$aD3.$x383.$x312.$x649.$x410
=150  \\$aNifuratel
=450  \\$wnnna$aInimur
=450  \\$wnnna$aItalmex Brand of Nifuratel
=450  \\$wnnna$aMacmiror
=450  \\$aMethylmercadone
=450  \\$wnnna$aMetilmercadon
=450  \\$wnnna$aNifuratel Italmex Brand
=450  \\$wnnna$aNifuratel Taurus Brand
=450  \\$wnnna$aTaurus Brand of Nifuratel
=450  \\$aThiodinon
=550  \\$wg$aNitrofurans
=550  \\$wg$aOxazolidinones
=680  \\$iLocal antiprotozoal and antifungal agent that may also be given orally.
=688  \\$a91(76); was see under NITROFURANS 1976-90
=750  \0$aNifuratel$5IEN$0(DLC)sh 85091842

=LDR  00647cz  a2200181n  4500
=001  9880363963702441
=005  20141212204504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010676
=035  \\$aCBA3963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x706
=150  \\$aPhialophora
=450  \\$wnnna$aPhialophoras
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection: coord IM with MYCOSES or specific mycosis (IM)
=680  \\$iA mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis (CHROMOBLASTOMYCOSIS). Ophiobolus is the teleomorph of Phialophora.
=750  \0$aPhialophora$5IEN$0(DLC)sh 85100714

=LDR  01032cz  a2200289n  4500
=001  9880363963802441
=005  20141212204504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010675
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x641
=150  \\$aPheromones
=450  \\$aAllelochemicals
=450  \\$aAllomones
=450  \\$aEctohormones
=450  \\$aKairomones
=450  \\$aSemiochemicals
=450  \\$wnnna$aSynomones
=550  \\$wg$aBiological Factors
=550  \\$wh$aPheromones, Human
=550  \\$wh$aSex Attractants
=550  \\$aAnimal Communication
=550  \\$aChemotactic Factors
=667  \\$aanimal, plant & microbes; human = PHEROMONES, HUMAN; SEX PHEROMONES is also available
=680  \\$iChemical substances, excreted by an organism into the environment, that elicit behavioral or physiological responses from other organisms of the same species. Perception of these chemical signals may be olfactory or by contact.
=688  \\$a1968
=750  \0$aPheromones$5IEN-HS$0(DLC)sh 85100707

=LDR  01590cz  a2200253n  4500
=001  9880363963902441
=005  20141212204503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010673
=035  \\$aCBA3960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x700.$x725
=072  \\$aC4.$x557.$x580.$x625.$x650.$x700.$x725
=150  \\$aPheochromocytoma
=450  \\$wnnna$aExtra-Adrenal Pheochromocytoma
=450  \\$wnnna$aExtra-Adrenal Pheochromocytomas
=450  \\$aPheochromocytoma, Extra-Adrenal
=450  \\$wnnna$aPheochromocytoma, Extra Adrenal
=450  \\$wnnna$aPheochromocytomas
=450  \\$wnnna$aPheochromocytomas, Extra-Adrenal
=550  \\$wg$aParaganglioma
=667  \\$abenign or malignant; coord IM with usually ADRENAL GLAND NEOPLASMS (IM)
=680  \\$iA usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
=750  \0$aPheochromocytoma$5IEN$0(DLC)sh 85100702

=LDR  01786cz  a2200397n  4500
=001  9880363964002441
=005  20141212192425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010672
=035  \\$aCBA3959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x432.$x555.$x730
=150  \\$aPhenytoin
=450  \\$wnnna$a5,5-Diphenylhydantoin
=450  \\$wnnna$aAntisacer
=450  \\$wnnna$aDifenin
=450  \\$wnnna$aDihydan
=450  \\$wnnna$aDilantin
=450  \\$aDiphenylhydantoin
=450  \\$wnnna$aDiphenylhydantoinate, Sodium
=450  \\$aDiphenylthiohydantoin$5IEN-M
=450  \\$wnnna$aEpamin
=450  \\$wnnna$aEpanutin
=450  \\$aFenitoin
=450  \\$wnnna$aHydantol
=450  \\$wnnna$aPark Davis brand of Phenytoin
=450  \\$wnnna$aPfizer Brand of Phenytoin
=450  \\$wnnna$aPhenytoin Pfizer Brand
=450  \\$wnnna$aPhenytoin Phizer Brand
=450  \\$wnnna$aPhenytoin Sodium
=450  \\$wnnna$aPhizer Brand of Phenytoin
=450  \\$wnnna$aSodium Diphenylhydantoinate
=550  \\$wg$aHydantoins
=680  \\$iAn anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.
=688  \\$a78; was DIPHENYLHYDANTOIN 1963-77
=750  \0$aPhenytoin$5IEN$0(DLC)sh 85100701

=LDR  01184cz  a2200325n  4500
=001  9880363964102441
=005  20171102171843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010665
=035  \\$aCBA3952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x706
=072  \\$aD2.$x33.$x755.$x624.$x706
=072  \\$aD2.$x92.$x63.$x624.$x706
=150  \\$aPhenylpropanolamine
=450  \\$wnnna$aDexatrim
=450  \\$wnnna$aHydrochloride, Phenylpropanolamine
=450  \\$aNorephedrine
=450  \\$wnnna$aPhenylpropanolamine Hydrochloride
=450  \\$wnnna$aProlamine
=450  \\$wnnna$aPropagest
=550  \\$wg$aPropanolamines
=550  \\$wh$aMetaraminol
=550  \\$wh$aNylidrin
=550  \\$wh$aOxyfedrine
=550  \\$wh$ap-Hydroxynorephedrine
=550  \\$wh$aTolterodine Tartrate
=680  \\$iA sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.
=688  \\$a74(63); was see under SYMPATHOMIMETICS 1963-73
=750  \0$aPhenylpropanolamine$5IEN$0(DLC)sh 85100700

=LDR  03956cz  a2200853n  4500
=001  9880363964202441
=005  20200821175235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010661
=035  \\$aCBA3948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x687
=072  \\$aC16.$x320.$x565.$x100.$x766
=072  \\$aC16.$x320.$x565.$x189.$x687
=072  \\$aC18.$x452.$x132.$x100.$x687
=072  \\$aC18.$x452.$x648.$x100.$x766
=072  \\$aC18.$x452.$x648.$x189.$x687
=150  \\$aPhenylketonurias
=450  \\$wnnna$aAtypical Phenylketonuria
=450  \\$wnnna$aAtypical PKU
=450  \\$wnnna$aBH4 Deficiency
=450  \\$wnnna$aClassical Phenylketonuria
=450  \\$wnnna$aDeficiency, BH4
=450  \\$wnnna$aDeficiency, DHPR
=450  \\$wnnna$aDeficiency, Dihydropteridine Reductase
=450  \\$wnnna$aDeficiency Disease, Dihydropteridine Reductase
=450  \\$wnnna$aDeficiency Disease, Phenylalanine Hydroxylase
=450  \\$wnnna$aDeficiency Disease, Phenylalanine Hydroxylase, Severe
=450  \\$wnnna$aDeficiency, PAH
=450  \\$wnnna$aDeficiency, Phenylalanine Hydroxylase
=450  \\$wnnna$aDeficiency, QDPR
=450  \\$wnnna$aDeficiency, Tetrahydrobiopterin
=450  \\$wnnna$aDHPR Deficiency
=450  \\$wnnna$aDihydropteridine Reductase Deficiency
=450  \\$aDihydropteridine Reductase$xdeficiency
=450  \\$aDihydropteridine Reductase Deficiency Disease
=450  \\$wnnna$aDisease, Folling
=450  \\$wnnna$aDisease, Folling's
=450  \\$wnnna$aFolling Disease
=450  \\$wnnna$aFolling's Disease
=450  \\$wnnna$aHPABH4C
=450  \\$wnnna$aHyperphenylalaninaemia
=450  \\$wnnna$aHyperphenylalaninemia, BH4-Deficient, C
=450  \\$wnnna$aHyperphenylalaninemia Caused by a Defect in Biopterin Metabolism
=450  \\$aHyperphenylalaninemia, Non-Phenylketonuric
=450  \\$wnnna$aHyperphenylalaninemia, Non Phenylketonuric
=450  \\$wnnna$aHyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency
=450  \\$wnnna$aNon-Phenylketonuric Hyperphenylalaninemia
=450  \\$wnnna$aNon Phenylketonuric Hyperphenylalaninemia
=450  \\$wnnna$aNon-Phenylketonuric Hyperphenylalaninemias
=450  \\$wnnna$aOligophrenia Phenylpyruvica
=450  \\$wnnna$aPAH Deficiency
=450  \\$wnnna$aPhenylalanine Hydroxylase Deficiency
=450  \\$aPhenylalanine Hydroxylase Deficiency Disease
=450  \\$wnnna$aPhenylalanine Hydroxylase Deficiency Disease, Severe
=450  \\$wnnna$aPhenylketonuria
=450  \\$wnnna$aPhenylketonuria, Atypical
=450  \\$wnnna$aPhenylketonuria, Classical
=450  \\$wnnna$aPhenylketonuria I
=450  \\$wnnna$aPhenylketonuria II
=450  \\$wnnna$aPhenylketonuria Type 2
=450  \\$wnnna$aPKU, Atypical
=450  \\$wnnna$aQDPR Deficiency
=450  \\$wnnna$aQuinoid Dihydropteridine Reductase Deficiency
=450  \\$wnnna$aTetrahydrobiopterin Deficiency
=550  \\$wg$aAmino Acid Metabolism, Inborn Errors
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wh$aPhenylketonuria, Maternal
=550  \\$aPhenylalanine Hydroxylase
=550  \\$aUrine
=667  \\$aGEN: prefer specifics; note X refs: consider also PHENYLALANINE HYDROXYLASE /defic and DIHYDROPTERIDINE REDUCTASE /defic; DF: PKU
=680  \\$iA group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).
=688  \\$a2000(1974)
=750  \0$aPhenylketonurias$0(DLC)sh 85100698$5IEN-M

=LDR  00572cz  a2200181n  4500
=001  9880363964302441
=005  20141212204458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010659
=035  \\$aCBA3946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x442.$x726
=150  \\$aPhenylhydrazines
=550  \\$wg$aHydrazines
=550  \\$wh$aDithizone
=680  \\$iDiazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. (Dorland, 28th ed)
=688  \\$a75; was PHENYLHYDRAZINE 1963-74
=750  \0$aPhenylhydrazine$5IEN-M$0(DLC)sh 97004255

=LDR  00527cz  a2200193n  4500
=001  9880363964402441
=005  20141212204457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010655
=035  \\$aCBA3942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146.$x651
=072  \\$aD2.$x92.$x782.$x258.$x651
=150  \\$aPhenylenediamines
=550  \\$wg$aAniline Compounds
=550  \\$wg$aDiamines
=550  \\$wh$aTetramethylphenylenediamine
=688  \\$a74
=750  \0$aPhenylenediamines$5IEN-M$0(DLC)sh 97002862

=LDR  00988cz  a2200301n  4500
=001  9880363964502441
=005  20141212204457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010653
=035  \\$aCBA3940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x850.$x777
=150  \\$aPhenylbutazone
=450  \\$wnnna$aButacote
=450  \\$wnnna$aButadion
=450  \\$wnnna$aButadione
=450  \\$wnnna$aButapirazol
=450  \\$wnnna$aButapyrazole
=450  \\$wnnna$aButazolidin
=450  \\$aClofezone$5IEN-M
=450  \\$aDiphenylbutazone
=450  \\$aFenilbutazon
=550  \\$wg$aPyrazolones
=550  \\$wh$aFeprazone
=550  \\$wh$aOxyphenbutazone
=550  \\$wh$aSulfinpyrazone
=680  \\$iA butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
=750  \0$aPhenylbutazone$5IEN$0(DLC)sh 85100695

=LDR  00873cz  a2200229n  4500
=001  9880363964602441
=005  20141212204456.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010650
=035  \\$aCBA3937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x232.$x400.$x700
=150  \\$aPhenylalanine Ammonia-Lyase
=450  \\$wnnna$aAmmonia-Lyase, Phenylalanine
=450  \\$wnnna$aAmmonia-lyase, Phenylalanine-Tyrosine
=450  \\$wnnna$aPhenylalanine Ammonia Lyase
=450  \\$wnnna$aPhenylalanine-Tyrosine Ammonia-lyase
=450  \\$wnnna$aPhenylalanine Tyrosine Ammonia lyase
=550  \\$wg$aAmmonia-Lyases
=680  \\$iAn enzyme that catalyzes the deamination of PHENYLALANINE to form trans-cinnamate and ammonia.
=688  \\$a91(75); was see under AMMONIA-LYASES 1975-90
=750  \0$aPhenylalanine ammonia lyase$0(DLC)sh2007010849$5IEN-M

=LDR  00959cz  a2200289n  4500
=001  9880363964702441
=005  20141212204456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010649
=035  \\$aCBA3936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x685
=072  \\$aD12.$x125.$x142.$x666
=150  \\$aPhenylalanine
=450  \\$wnnna$aEndorphenyl
=450  \\$wnnna$aL-Isomer Phenylalanine
=450  \\$wnnna$aL-Phenylalanine
=450  \\$wnnna$aPhenylalanine, L-Isomer
=450  \\$wnnna$aPhenylalanine, L Isomer
=550  \\$wg$aAmino Acids, Aromatic
=550  \\$wg$aAmino Acids, Essential
=550  \\$wh$aDihydroxyphenylalanine
=550  \\$wh$aFenclonine
=550  \\$wh$aMelphalan
=550  \\$wh$ap-Fluorophenylalanine
=680  \\$iAn essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.
=750  \0$aPhenylalanine$5IEN$0(DLC)sh 85100693

=LDR  01266cz  a2200337n  4500
=001  9880363964802441
=005  20141212204455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010648
=035  \\$aCBA3935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x601
=150  \\$aPhenylacetates
=450  \\$wnnna$aAcids, Benzeneacetic
=450  \\$wnnna$aAcids, Phenylacetic
=450  \\$wnnna$aBenzeneacetates
=450  \\$wnnna$aBenzeneacetic Acids
=450  \\$wnnna$aPhenylacetic Acids
=550  \\$wg$aAcids, Carbocyclic
=550  \\$wh$a3,4-Dihydroxyphenylacetic Acid
=550  \\$wh$aCyclopentolate
=550  \\$wh$aDiclofenac
=550  \\$wh$aDiphenylacetic Acids
=550  \\$wh$aGuanfacine
=550  \\$wh$aHalofenate
=550  \\$wh$aHomogentisic Acid
=550  \\$wh$aHomovanillic Acid
=550  \\$wh$aMethylphenidate
=550  \\$wh$aPropanidid
=680  \\$iDerivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID.
=750  \0$aPhenylacetates$5IEN-M$0(DLC)sh 96008818

=LDR  01552cz  a2200385n  4500
=001  9880363964902441
=005  20141212204455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010646
=035  \\$aCBA3933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x754
=150  \\$aPhentolamine
=450  \\$wnnna$aAlliance Brand of Phentolamine Mesylate
=450  \\$aFentolamin
=450  \\$wnnna$aMesilate, Phentolamine
=450  \\$wnnna$aMesylate, Phentolamine
=450  \\$wnnna$aMethanesulfonate, Phentolamine
=450  \\$wnnna$aMono-hydrochloride, Phentolamine
=450  \\$wnnna$aNovartis Brand of Phentolamine Mesylate
=450  \\$wnnna$aPaladin Brand of Phentolamine Mesylate
=450  \\$wnnna$aPhentolamine Mesilate
=450  \\$wnnna$aPhentolamine Mesylate
=450  \\$wnnna$aPhentolamine Methanesulfonate
=450  \\$wnnna$aPhentolamine Mono-hydrochloride
=450  \\$wnnna$aPhentolamine Mono hydrochloride
=450  \\$wnnna$aRegitine
=450  \\$wnnna$aRegityn
=450  \\$wnnna$aRogitine
=450  \\$wnnna$aSchering-Plough Brand of Phentolamine Mesylate
=450  \\$wnnna$aZ-Max
=550  \\$wg$aImidazoles
=680  \\$iA nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
=688  \\$aPHENTOLAMINE MESYLATE was (NM) 1981-95
=750  \0$aPhentolamine$5IEN$0(DLC)sh 85100690

=LDR  00923cz  a2200277n  4500
=001  9880363965002441
=005  20141212204454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010645
=035  \\$aCBA3932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x152.$x766
=150  \\$aPhentermine
=450  \\$wnnna$aAdipex-P
=450  \\$wnnna$aAdipex P
=450  \\$wnnna$aAdipexP
=450  \\$wnnna$aDuromine
=450  \\$wnnna$aHydrochloride, Phentermine
=450  \\$wnnna$aIonamine
=450  \\$wnnna$aPhentermine Hydrochloride
=550  \\$wg$aAmphetamines
=550  \\$wh$aChlorphentermine
=550  \\$wh$aMephentermine
=680  \\$iA central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
=688  \\$a74(66)
=750  \0$aPhentermine$5IEN-M$0(DLC)sh 96010153

=LDR  00778cz  a2200253n  4500
=001  9880363965102441
=005  20141212204453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010642
=035  \\$aCBA3929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682
=072  \\$aD2.$x241.$x511.$x316.$x682
=150  \\$aPhenoxyacetates
=550  \\$wg$aGlycolates
=550  \\$wh$a2,4,5-Trichlorophenoxyacetic Acid
=550  \\$wh$a2,4-Dichlorophenoxyacetic Acid
=550  \\$wh$a2-Methyl-4-chlorophenoxyacetic Acid
=550  \\$wh$aEthacrynic Acid
=550  \\$wh$aHalofenate
=550  \\$wh$aMeclofenoxate
=550  \\$wh$aTicrynafen
=688  \\$a91(75); was see under GLYCOLATES 1975-90
=750  \0$aPhenoxyacetic acid$5IEN$0(DLC)sh 85100688

=LDR  00816cz  a2200265n  4500
=001  9880363965202441
=005  20141212204453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x695
=150  \\$aPhenotype
=450  \\$wnnna$aPhenotypes
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aEcotype
=550  \\$wh$aEndophenotypes
=550  \\$wh$aGene-Environment Interaction
=550  \\$wh$aGenetic Markers
=550  \\$wh$aGenetic Pleiotropy
=550  \\$wh$aPenetrance
=550  \\$wh$aSerogroup
=550  \\$aGene Expression
=680  \\$iThe outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
=688  \\$a68
=750  \0$aPhenotype$5IEN-M$0(DLC)sh 96012165

=LDR  01243cz  a2200433n  4500
=001  9880363965302441
=005  20141212204453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010640
=035  \\$aCBA3927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x369
=072  \\$aD3.$x494.$x741
=150  \\$aPhenothiazines
=450  \\$aPiperacetazine$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aAcepromazine
=550  \\$wh$aAzure Stains
=550  \\$wh$aChlorpromazine
=550  \\$wh$aFluphenazine
=550  \\$wh$aMesoridazine
=550  \\$wh$aMethotrimeprazine
=550  \\$wh$aMethylene Blue
=550  \\$wh$aMoricizine
=550  \\$wh$aNonachlazine
=550  \\$wh$aPerazine
=550  \\$wh$aPerphenazine
=550  \\$wh$aProchlorperazine
=550  \\$wh$aPromazine
=550  \\$wh$aPromethazine
=550  \\$wh$aThiethylperazine
=550  \\$wh$aThioridazine
=550  \\$wh$aTolonium Chloride
=550  \\$wh$aTrifluoperazine
=550  \\$wh$aTriflupromazine
=550  \\$wh$aTrimeprazine
=680  \\$iCompounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
=750  \0$aPhenothiazine$5IEN$0(DLC)sh 85100685

=LDR  01325cz  a2200457n  4500
=001  9880363965402441
=005  20210212103952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010636
=035  \\$aCBA3923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657
=150  \\$aPhenols
=450  \\$aPhenol$xanalogs & derivatives
=550  \\$wg$aBenzene Derivatives
=550  \\$wh$aAminophenols
=550  \\$wh$aBisphenol A-Glycidyl Methacrylate
=550  \\$wh$aBithionol
=550  \\$wh$aBromphenol Blue
=550  \\$wh$aCatechols
=550  \\$wh$aChlorophenols
=550  \\$wh$aCresols
=550  \\$wh$aDesvenlafaxine Succinate
=550  \\$wh$aDienestrol
=550  \\$wh$aHumic Substances
=550  \\$wh$aHydroquinones
=550  \\$wh$aHydroxybenzoates
=550  \\$wh$aIndophenol
=550  \\$wh$aNitrophenols
=550  \\$wh$aPhenol
=550  \\$wh$aPhenolphthaleins
=550  \\$wh$aPhenyl Ethers
=550  \\$wh$aPhloroglucinol
=550  \\$wh$aPolyphenols
=550  \\$wh$aProbucol
=550  \\$wh$aPropofol
=550  \\$wh$aPyrogallol
=550  \\$wh$aResorcinols
=550  \\$wh$aTapentadol
=680  \\$iBenzene derivatives that include one or more hydroxyl groups attached to the ring structure.
=750  \0$aPhenols$5IEN$0(DLC)sh 85100676

=LDR  00764cz  a2200181n  4500
=001  9880363965502441
=005  20141212204451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010629
=035  \\$aCBA3916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x141.$x700
=150  \\$aPhenformin
=450  \\$aFenformin
=450  \\$wnnna$aPhenylethylbiguanide
=550  \\$wg$aBiguanides
=680  \\$iA biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
=750  \0$aPhenformin$5IEN$0(DLC)sh 85100669

=LDR  01513cz  a2200493n  4500
=001  9880363965602441
=005  20171219111347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010627
=035  \\$aCBA3914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683
=150  \\$aPhenethylamines
=450  \\$aPhenylethylamines
=550  \\$wg$aEthylamines
=550  \\$wh$a2-Hydroxyphenethylamine
=550  \\$wh$aAlbuterol
=550  \\$wh$aAmphetamines
=550  \\$wh$aButoxamine
=550  \\$wh$aDexfenfluramine
=550  \\$wh$aDimethoxyphenylethylamine
=550  \\$wh$aDobutamine
=550  \\$wh$aEphedrine
=550  \\$wh$aFendiline
=550  \\$wh$aFenfluramine
=550  \\$wh$aHexoprenaline
=550  \\$wh$aIsoxsuprine
=550  \\$wh$aMescaline
=550  \\$wh$aMethoxamine
=550  \\$wh$aNylidrin
=550  \\$wh$aOctopamine
=550  \\$wh$aOxyfedrine
=550  \\$wh$ap-Methoxy-N-methylphenethylamine
=550  \\$wh$aPrenylamine
=550  \\$wh$aPseudoephedrine
=550  \\$wh$aRitodrine
=550  \\$wh$aSelegiline
=550  \\$wh$aSuloctidil
=550  \\$wh$aTiapamil Hydrochloride
=550  \\$wh$aVenlafaxine Hydrochloride
=550  \\$wh$aVerapamil
=680  \\$iA group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed)
=688  \\$a68; was PHENYLETHYLAMINES 1963-67
=750  \0$aPhenethylamines$5IEN$0(DLC)sh 85100668

=LDR  01026cz  a2200313n  4500
=001  9880363965702441
=005  20141212204448.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010623
=035  \\$aCBA3910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x700
=072  \\$aF3.$x900.$x700
=150  \\$aPhencyclidine Abuse
=450  \\$wnnna$aAbuse, Angel Dust
=450  \\$wnnna$aAbuse, PCP
=450  \\$wnnna$aAbuse, Phencyclidine
=450  \\$aAngel Dust Abuse
=450  \\$aPCP Abuse
=450  \\$wnnna$aPhencyclidine Abuses
=450  \\$wnnna$aPhencyclidine-Related Disorder
=450  \\$aPhencyclidine-Related Disorders
=450  \\$wnnna$aPhencyclidine Related Disorders
=550  \\$wg$aSubstance-Related Disorders
=550  \\$aPhencyclidine
=667  \\$aDF: note short X ref
=680  \\$iThe misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning.
=688  \\$a81
=750  \0$aPhencyclidine abuse$5IEN$0(DLC)sh 85100667

=LDR  01379cz  a2200325n  4500
=001  9880363965802441
=005  20141212204448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010622
=035  \\$aCBA3909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x699
=150  \\$aPhencyclidine
=450  \\$wnnna$a1-(1-Phenylcyclohexyl)piperidine
=450  \\$wnnna$aAngel Dust
=450  \\$wnnna$aCL-395
=450  \\$wnnna$aCL 395
=450  \\$wnnna$aCL395
=450  \\$wnnna$aDust, Angel
=450  \\$wnnna$aGP-121
=450  \\$wnnna$aGP 121
=450  \\$wnnna$aGP121
=450  \\$wnnna$aPhencyclidine Hydrobromide
=450  \\$wnnna$aPhencyclidine Hydrochloride
=450  \\$wnnna$aSernyl
=450  \\$wnnna$aSerylan
=550  \\$wg$aPiperidines
=680  \\$iA hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.
=688  \\$a73(64); was see under PIPERIDINES 1969-72; was see under PIPERIDINES & ANESTHETICS 1968; was see under ANESTHETICS 1967
=750  \0$aPhencyclidine$5IEN$0(DLC)sh 85100665

=LDR  00527cz  a2200193n  4500
=001  9880363965902441
=005  20141212204447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010619
=035  \\$aCBA3906M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x704
=150  \\$aPhenazines
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wh$aClofazimine
=550  \\$wh$aMethylphenazonium Methosulfate
=550  \\$wh$aNeutral Red
=550  \\$wh$aPyocyanine
=750  \0$aPhenazine$0(DLC)sh2007006398$5IEN-M

=LDR  00604cz  a2200217n  4500
=001  9880363966002441
=005  20201123171418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010616
=035  \\$aCBA3903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x723
=072  \\$aD4.$x615.$x723
=150  \\$aPhenanthrenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$aAbietanes
=550  \\$wh$aAristolochic Acids
=550  \\$wh$aChrysenes
=550  \\$wh$aMorphinans
=667  \\$aaromatic hydrocarbons
=750  \0$aPhenanthrene$5IEN$0(DLC)sh 85100664

=LDR  00640cz  a2200181n  4500
=001  9880363966102441
=005  20141212204446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010615
=035  \\$aCBA3902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x92.$x700
=150  \\$aPhenacetin
=450  \\$aAcetophenetidin
=550  \\$wg$aAcetanilides
=680  \\$iA phenylacetamide that was formerly used in ANALGESICS but nephropathy and METHEMOGLOBINEMIA led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology,1991, p431)
=688  \\$a65(63)
=750  \0$aPhenacetin$5IEN$0(DLC)sh 85000465

=LDR  01315cz  a2200301n  4500
=001  9880363966202441
=005  20141212204446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010614
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x750
=072  \\$aA4.$x623
=072  \\$aA14.$x724
=150  \\$aPharynx
=450  \\$wnnna$aPharynxs
=450  \\$aThroat
=450  \\$wnnna$aThroats
=550  \\$wg$aGastrointestinal Tract
=550  \\$wg$aRespiratory System
=550  \\$wg$aStomatognathic System
=550  \\$wh$aHypopharynx
=550  \\$wh$aNasopharynx
=550  \\$wh$aOropharynx
=550  \\$wh$aPharyngeal Muscles
=667  \\$ainflammation = PHARYNGITIS; /surg: consider also PHARYNGECTOMY & PHARYNGOSTOMY; HYPOPHARYNX; NASOPHARYNX; & OROPHARYNX are also available
=680  \\$iA funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx).
=750  \0$aPharynx$5IEN-M$0(DLC)sh 85100628
=750  \0$aThroat$5IEN-HS$0(DLC)sh 85135055

=LDR  00843cz  a2200289n  4500
=001  9880363966302441
=005  20141212204445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010612
=035  \\$aCBA3899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x550.$x781
=072  \\$aC8.$x730.$x561
=072  \\$aC9.$x775.$x649
=150  \\$aPharyngitis
=450  \\$wnnna$aPharyngitides
=450  \\$aSore Throat
=450  \\$wnnna$aSore Throats
=450  \\$wnnna$aThroat, Sore
=550  \\$wg$aPharyngeal Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aNasopharyngitis
=550  \\$wh$aRetropharyngeal Abscess
=550  \\$wh$aTonsillitis
=680  \\$iInflammation of the throat (PHARYNX).
=688  \\$aSORE THROAT was see under PHARYNGITIS 1963-78
=750  \0$aPharyngitis$5IEN$0(DLC)sh 85100626

=LDR  01590cz  a2200493n  4500
=001  9880363966402441
=005  20141212204444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010610
=035  \\$aCBA3897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x710
=072  \\$aC7.$x550.$x745
=072  \\$aC9.$x647.$x710
=072  \\$aC9.$x775.$x549
=150  \\$aPharyngeal Neoplasms
=450  \\$aCancer of Pharynx
=450  \\$wnnna$aCancer of the Pharynx
=450  \\$wnnna$aCancer, Pharnyx
=450  \\$wnnna$aCancer, Pharyngeal
=450  \\$wnnna$aCancers, Pharnyx
=450  \\$wnnna$aCancers, Pharyngeal
=450  \\$wnnna$aNeoplasm, Pharyngeal
=450  \\$wnnna$aNeoplasm, Pharynx
=450  \\$wnnna$aNeoplasms, Pharyngeal
=450  \\$wnnna$aNeoplasms, Pharynx
=450  \\$wnnna$aPharnyx Cancer
=450  \\$wnnna$aPharnyx Cancers
=450  \\$aPharyngeal Cancer
=450  \\$wnnna$aPharyngeal Cancers
=450  \\$wnnna$aPharyngeal Neoplasm
=450  \\$wnnna$aPharynx Cancer
=450  \\$wnnna$aPharynx Cancers
=450  \\$wnnna$aPharynx Neoplasm
=450  \\$wnnna$aPharynx Neoplasms
=550  \\$wg$aOtorhinolaryngologic Neoplasms
=550  \\$wg$aPharyngeal Diseases
=550  \\$wh$aHypopharyngeal Neoplasms
=550  \\$wh$aNasopharyngeal Neoplasms
=550  \\$wh$aOropharyngeal Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the PHARYNX.
=750  \0$aPharynx$xTumors$5IEN-M$0(DLC)sh 85100633
=750  \0$aPharynx$xCancer$5IEN-HS$0(DLC)sh 85100629

=LDR  01202cz  a2200385n  4500
=001  9880363966502441
=005  20141212204443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010608
=035  \\$aCBA3895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x550
=072  \\$aC9.$x775
=150  \\$aPharyngeal Diseases
=450  \\$wnnna$aDisease, Pharyngeal
=450  \\$wnnna$aDisease, Pharynx
=450  \\$wnnna$aDiseases of Pharynx
=450  \\$wnnna$aDiseases, Pharyngeal
=450  \\$wnnna$aDiseases, Pharynx
=450  \\$wnnna$aPharyngeal Disease
=450  \\$wnnna$aPharynx Disease
=450  \\$wnnna$aPharynx Diseases
=550  \\$wg$aOtorhinolaryngologic Diseases
=550  \\$wg$aStomatognathic Diseases
=550  \\$wh$aDeglutition Disorders
=550  \\$wh$aLemierre Syndrome
=550  \\$wh$aNasopharyngeal Diseases
=550  \\$wh$aPharyngeal Neoplasms
=550  \\$wh$aPharyngitis
=550  \\$wh$aVelopharyngeal Insufficiency
=550  \\$aOtorhinolaryngologic Diseases
=667  \\$ainflammatory disease = PHARYNGITIS
=680  \\$iPathological processes involving the PHARYNX.
=688  \\$a66
=750  \0$aPharynx$xDiseases$5IEN$0(DLC)sh 85100630

=LDR  01987cz  a2200517n  4500
=001  9880363966602441
=005  20141212204443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010607
=035  \\$aCBA3894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x603
=072  \\$aN2.$x421.$x668.$x556
=072  \\$aN4.$x452.$x442.$x422.$x603
=150  \\$aPharmacy Service, Hospital
=450  \\$aClinical Pharmacy Service
=450  \\$wnnna$aClinical Pharmacy Services
=450  \\$wnnna$aHospital Pharmaceutic Service
=450  \\$wnnna$aHospital Pharmaceutic Services
=450  \\$wnnna$aHospital Pharmaceutical Service
=450  \\$wnnna$aHospital Pharmaceutical Services
=450  \\$aHospital Pharmacies$5IEN
=450  \\$aHospital Pharmacy Service
=450  \\$wnnna$aHospital Pharmacy Services
=450  \\$wnnna$aPharmaceutic Service, Hospital
=450  \\$wnnna$aPharmaceutic Services, Hospital
=450  \\$wnnna$aPharmaceutical Service, Hospital
=450  \\$wnnna$aPharmaceutical Services, Hospital
=450  \\$aPharmacy Service, Clinical
=450  \\$wnnna$aPharmacy Services, Clinical
=450  \\$wnnna$aPharmacy Services, Hospital
=450  \\$wnnna$aService, Clinical Pharmacy
=450  \\$wnnna$aService, Hospital Pharmaceutic
=450  \\$wnnna$aService, Hospital Pharmaceutical
=450  \\$wnnna$aService, Hospital Pharmacy
=450  \\$wnnna$aServices, Clinical Pharmacy
=450  \\$wnnna$aServices, Hospital Pharmaceutic
=450  \\$wnnna$aServices, Hospital Pharmaceutical
=450  \\$wnnna$aServices, Hospital Pharmacy
=550  \\$wg$aHospital Departments
=550  \\$wg$aPharmaceutical Services
=550  \\$aPharmacy
=667  \\$aDF: PHARM SERV HOSP
=680  \\$iHospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies.
=688  \\$a78; was HOSPITAL PHARMACY SERVICE 1963-77
=750  \0$aHospital pharmacies$5IEN$0(DLC)sh 85062256

=LDR  00898cz  a2200253n  4500
=001  9880363966702441
=005  20141212204442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010605
=035  \\$aCBA3892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x706
=150  \\$aPharmacy Administration
=450  \\$wnnna$aAdministration, Pharmacy
=450  \\$wnnna$aAdministrations, Pharmacy
=450  \\$wnnna$aPharmacy Administrations
=450  \\$aPharmacy Management$5IEN
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aDrug and Narcotic Control
=550  \\$wh$aDrug Utilization
=667  \\$a"the business & managerial aspects of pharmacy in its broadest sense"; SPEC; SPEC qualif; DF: PHARM ADMIN
=680  \\$iThe business and managerial aspects of pharmacy in its broadest sense.
=688  \\$a68
=750  \0$aPharmacy management$5IEN$0(DLC)sh 85100621

=LDR  00623cz  a2200193n  4500
=001  9880363966802441
=005  20180913120916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010604
=035  \\$aCBA3891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x646
=150  \\$aPharmacy
=550  \\$wg$aHealth Occupations
=550  \\$wh$aNuclear Pharmacy
=550  \\$wh$aPharmacy Research
=667  \\$aspecialty: do not confuse with PHARMACIES; / methods: consider TECHNOLOGY, PHARMACEUTICAL
=680  \\$iThe practice of compounding and dispensing medicinal preparations.
=750  \0$aPharmacy$5IEN$0(DLC)sh 85100603

=LDR  01526cz  a2200265n  4500
=001  9880363967002441
=005  20141212204441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010602
=035  \\$aCBA3889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x749
=150  \\$aPharmacopoeias as Topic
=450  \\$wnnna$aFormularies, National
=450  \\$aFormulary, National
=450  \\$wnnna$aNational Formularies
=450  \\$aNational Formulary
=550  \\$wg$aReference Books
=550  \\$wh$aPharmacopoeias, Homeopathic
=550  \\$aFormularies as Topic
=667  \\$ado not confuse with FORMULARIES AS TOPIC which, usually mere lists, are less complete; do not confuse with the Publication Type PHARMACOPOEIAS; specify country if pertinent
=680  \\$iAuthoritative treatises on drugs and preparations, their description, formulation, analytic composition, physical constants, main chemical properties used in identification, standards for strength, purity, and dosage, chemical tests for determining identity and purity, etc. They are usually published under governmental jurisdiction (e.g., USP, the United States Pharmacopoeia; BP, British Pharmacopoeia; P. Helv., the Swiss Pharmacopoeia). They differ from FORMULARIES in that they are far more complete: formularies tend to be mere listings of formulas and prescriptions.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Pharmacopoeias
=750  \0$aPharmacopoeias$0(DLC) sh 85100601$5IEN

=LDR  00848cz  a2200217n  4500
=001  9880363967102441
=005  20141212204441.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010601
=035  \\$aCBA3888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x152
=072  \\$aH2.$x628.$x512
=150  \\$aPharmacology, Clinical
=450  \\$aClinical Pharmacology
=550  \\$wg$aPharmacology
=667  \\$aspecialty only; do not use as an NIM coordinate: the pharmacology of a drug in humans = drug /pharmacol and do not also add PHARMACOLOGY, CLINICAL; DF: PHARMACOL CLIN
=680  \\$iThe branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.
=688  \\$a80
=750  \0$aClinical pharmacology$5IEN$0(DLC)sh 90000174
=750  \0$aClinical pharmacologists$5IEN-M$0(DLC)sh 00009926

=LDR  01535cz  a2200385n  4500
=001  9880363967202441
=005  20141212204440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010600
=035  \\$aCBA3887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703
=072  \\$aH2.$x628
=150  \\$aPharmacology
=450  \\$aPharmaceutical Preparations$xpharmacology
=450  \\$wnnna$aPharmacologies
=450  \\$aPharmacologists$5IEN
=550  \\$wg$aBiological Science Disciplines
=550  \\$wg$aHealth Occupations
=550  \\$wh$aBiopharmaceutics
=550  \\$wh$aChemistry, Pharmaceutical
=550  \\$wh$aEthnopharmacology
=550  \\$wh$aHerbal Medicine
=550  \\$wh$aNeuropharmacology
=550  \\$wh$aPharmacoepidemiology
=550  \\$wh$aPharmacogenetics
=550  \\$wh$aPharmacognosy
=550  \\$wh$aPharmacology, Clinical
=550  \\$wh$aPsychopharmacology
=550  \\$wh$aToxicology
=550  \\$aPharmaceutical Preparations
=667  \\$athe discipline (education, history, etc) only; use PHARMACOLOGICAL PHENOMENA or specifics treed under it for the properties of drugs and their metabolism and interactions; the qualifier /pharmacology is available for use with drugs and chemicals; methods: consider TECHNOLOGY, PHARMACEUTICAL; DF: PHARM
=680  \\$iThe study of the origin, nature, properties, and actions of drugs and their effects on living organisms.
=750  \0$aPharmacologists$5IEN-M$0(DLC)sh 85100598
=750  \0$aPharmacology$5IEN-HS$0(DLC)sh 85100599

=LDR  01718cz  a2200445n  4500
=001  9880363967302441
=005  20180109104833.0
=008  870418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010599
=035  \\$aCBA3886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x787
=072  \\$aG7.$x690.$x725
=150  \\$aPharmacokinetics
=450  \\$aDrug Kinetics
=450  \\$aKinetics, Drug
=450  \\$aPharmaceutical Preparations$xpharmacokinetics
=550  \\$wg$aMetabolism
=550  \\$wg$aPharmacological and Toxicological Phenomena
=550  \\$wh$aAbsorption
=550  \\$wh$aArea Under Curve
=550  \\$wh$aBiological Availability
=550  \\$wh$aBiotransformation
=550  \\$wh$aChronopharmacokinetics
=550  \\$wh$aCutaneous Elimination
=550  \\$wh$aDrug Liberation
=550  \\$wh$aHepatobiliary Elimination
=550  \\$wh$aIntestinal Elimination
=550  \\$wh$aLacrimal Elimination
=550  \\$wh$aLacteal Elimination
=550  \\$wh$aMetabolic Clearance Rate
=550  \\$wh$aPulmonary Elimination
=550  \\$wh$aRenal Elimination
=550  \\$wh$aSalivary Elimination
=550  \\$wh$aTherapeutic Equivalency
=550  \\$wh$aTissue Distribution
=667  \\$ageneral or unspecified; prefer /pharmacokin with drugs
=680  \\$iDynamic and kinetic mechanisms of exogenous chemical and DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.
=688  \\$a88
=750  \0$aPharmacokinetics$5IEN$0(DLC)sh 85100597

=LDR  00969cz  a2200277n  4500
=001  9880363967402441
=005  20141212204440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010598
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x118.$x598
=072  \\$aH1.$x158.$x703.$x60
=150  \\$aPharmacognosy
=450  \\$wnnna$aPharmacognosies
=550  \\$wg$aBotany
=550  \\$wg$aPharmacology
=550  \\$wh$aHerbal Medicine
=550  \\$aEthnopharmacology
=550  \\$aMedicine, Mongolian Traditional
=550  \\$aMedicine, Traditional
=550  \\$aPhytotherapy
=550  \\$aPlants
=550  \\$aPlants, Medicinal
=667  \\$aSPEC
=680  \\$iThe science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY.
=750  \0$aPharmacognosy$5IEN$0(DLC)sh 85100596

=LDR  00938cz  a2200265n  4500
=001  9880363967502441
=005  20160729112959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x750
=072  \\$aH1.$x158.$x703.$x52
=072  \\$aH2.$x628.$x479
=150  \\$aPharmacogenetics
=450  \\$aPharmacogenomics
=550  \\$wg$aGenetics
=550  \\$wg$aPharmacology
=550  \\$wh$aToxicogenetics
=550  \\$aDrug Resistance
=550  \\$aPrecision Medicine
=550  \\$aToxicology
=667  \\$athe discipline (education, history, etc) only; for pharmacogenetic studies, index the specific drug and specific genetic aspect
=680  \\$iA branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).
=688  \\$a70(66)
=750  \0$aPharmacogenetics$5IEN$0(DLC)sh 85100595

=LDR  01006cz  a2200301n  4500
=001  9880363967602441
=005  20180117145833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010596
=035  \\$aCBA3883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x735
=072  \\$aN2.$x360.$x67.$x730
=150  \\$aPharmacy Technicians
=450  \\$wnno$aPharmacists' Aides
=450  \\$wnnna$aAide, Pharmacists'
=450  \\$wnnna$aAides, Pharmacists'
=450  \\$wnnna$aPharmacist Aides
=450  \\$wnnna$aPharmacists' Aide
=450  \\$wnnna$aPharmacist's Aides
=450  \\$wnnna$aPharmacists Aides
=450  \\$wnnna$aPharmacy Technician
=450  \\$wnnna$aTechnician Pharmacy
=450  \\$wnnna$aTechnicians Pharmacy
=550  \\$wg$aAllied Health Personnel
=680  \\$iPersons who perform certain functions under the supervision of the pharmacist.
=688  \\$a2017; use PHARMACISTS' AIDES 1971-2016
=750  \0$aPharmacy technicians$0(DLC)sh 85100623$5IEN -M

=LDR  00764cz  a2200253n  4500
=001  9880363967702441
=005  20141212204439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010595
=035  \\$aCBA3882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x780
=072  \\$aN2.$x360.$x780
=150  \\$aPharmacists
=450  \\$wnnna$aClinical Pharmacist
=450  \\$wnnna$aClinical Pharmacists
=450  \\$wnnna$aPharmacist
=450  \\$wnnna$aPharmacist, Clinical
=450  \\$wnnna$aPharmacists, Clinical
=550  \\$wg$aHealth Personnel
=667  \\$aIM
=680  \\$iThose persons legally qualified by education and training to engage in the practice of pharmacy.
=688  \\$a68
=750  \0$aPharmacists$5IEN$0(DLC)sh 85100592

=LDR  01003cz  a2200301n  4500
=001  9880363967802441
=005  20141212204439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010594
=035  \\$aCBA3881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x678
=150  \\$aPharmacies
=450  \\$aCommunity Pharmacies
=450  \\$wnnna$aCommunity Pharmacy
=450  \\$wnnna$aDistribution, Pharmacy
=450  \\$wnnna$aDistributions, Pharmacy
=450  \\$aDrugstores$5IEN
=450  \\$wnnna$aPharmacies, Community
=450  \\$wnnna$aPharmacy, Community
=450  \\$wnnna$aPharmacy Distribution
=450  \\$wnnna$aPharmacy Distributions
=550  \\$wg$aHealth Facilities
=550  \\$aPharmaceutical Services, Online
=667  \\$athe place: do not confuse with PHARMACY, the field
=680  \\$iFacilities for the preparation and dispensing of drugs.
=688  \\$aCOMMUNITY PHARMACIES was see under PHARMACIES 1968-78
=750  \0$aDrugstores$5IEN$0(DLC)sh 85039770

=LDR  01630cz  a2200433n  4500
=001  9880363967902441
=005  20141212204438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010593
=035  \\$aCBA3880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x668
=150  \\$aPharmaceutical Services
=450  \\$wnnna$aCare, Pharmaceutical
=450  \\$wnnna$aCares, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Service
=450  \\$wnnna$aPharmaceutic Services
=450  \\$wnnna$aPharmaceutical Care
=450  \\$wnnna$aPharmaceutical Cares
=450  \\$wnnna$aPharmaceutical Service
=450  \\$wnnna$aPharmacy Service
=450  \\$wnnna$aPharmacy Services
=450  \\$wnnna$aService, Pharmaceutic
=450  \\$wnnna$aService, Pharmaceutical
=450  \\$wnnna$aService, Pharmacy
=450  \\$wnnna$aServices, Pharmaceutic
=450  \\$wnnna$aServices, Pharmaceutical
=450  \\$wnnna$aServices, Pharmacy
=550  \\$wg$aHealth Services
=550  \\$wh$aCommunity Pharmacy Services
=550  \\$wh$aDrug Information Services
=550  \\$wh$aMedication Therapy Management
=550  \\$wh$aPharmaceutical Services, Online
=550  \\$wh$aPharmacy Service, Hospital
=550  \\$wh$aPrescriptions
=667  \\$aDF: PHARM SERV
=680  \\$iTotal pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.
=688  \\$a68
=750  \0$aPharmaceutical services$5IEN$0(DLC)sh 85100589

=LDR  01720cz  a2200457n  4500
=001  9880363968002441
=005  20141212204438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010591
=035  \\$aCBA3878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762.$x700
=072  \\$aC23.$x550.$x767.$x700.$x500
=072  \\$aC23.$x888.$x592.$x604.$x764.$x700
=072  \\$aC23.$x888.$x646.$x530.$x500
=072  \\$aF1.$x700.$x750.$x700
=150  \\$aPhantom Limb
=450  \\$wnnna$aLimb Pain, Phantom
=450  \\$wnnna$aLimb Pains, Phantom
=450  \\$wnnna$aLimb, Phantom
=450  \\$wnnna$aLimbs, Phantom
=450  \\$wnnna$aPain, Phantom
=450  \\$wnnna$aPain, Phantom Limb
=450  \\$wnnna$aPains, Phantom
=450  \\$wnnna$aPains, Phantom Limb
=450  \\$wnnna$aPhantom Limb Pain
=450  \\$wnnna$aPhantom Limb Pains
=450  \\$wnnna$aPhantom Limbs
=450  \\$wnnna$aPhantom Pain
=450  \\$wnnna$aPhantom Pains
=450  \\$wnnna$aPhantom Sensation
=450  \\$wnnna$aPhantom Sensations
=450  \\$aPseudomelia
=450  \\$wnnna$aPseudomelias
=450  \\$wnnna$aSensation, Phantom
=450  \\$wnnna$aSensations, Phantom
=550  \\$wg$aPain, Postoperative
=550  \\$wg$aPerceptual Disorders
=550  \\$aAmputation Stumps
=680  \\$iPerception of painful and nonpainful phantom sensations that occur following the complete or partial loss of a limb. The majority of individuals with an amputated extremity will experience the impression that the limb is still present, and in many cases, painful. (From Neurol Clin 1998 Nov;16(4):919-36; Brain 1998 Sep;121(Pt 9):1603-30)
=750  \0$aPhantom limb$5IEN$0(DLC)sh 85100573

=LDR  00854cz  a2200241n  4500
=001  9880363968102441
=005  20141212204437.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010590
=035  \\$aCBA3877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x735
=072  \\$aD12.$x644.$x456.$x735
=072  \\$aD12.$x644.$x641.$x735
=072  \\$aD23.$x946.$x587.$x755
=150  \\$aPhalloidine
=450  \\$wnnna$aPhalloidin
=550  \\$wg$aMycotoxins
=550  \\$wg$aOligopeptides
=550  \\$wg$aPeptides, Cyclic
=680  \\$iVery toxic polypeptide isolated mainly from AMANITA phalloides (Agaricaceae) or death cup; causes fatal liver, kidney and CNS damage in mushroom poisoning; used in the study of liver damage.
=688  \\$a91(75); was see under OLIGOPEPTIDES 1975-90
=750  \0$aPhalloidine$5IEN$0(DLC)sh 85100565

=LDR  00850cz  a2200229n  4500
=001  9880363968202441
=005  20180223112657.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010588
=035  \\$aCBA3875M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x700
=150  \\$aPhagosomes
=450  \\$wnnna$aPhagolysosome
=450  \\$aPhagolysosomes
=450  \\$wnnna$aPhagosome
=550  \\$wg$aCytoplasmic Vesicles
=550  \\$wh$aAutophagosomes
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iMembrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material.
=688  \\$a86
=750  \0$aPhagosomes$0(DLC)sh2006007696$5IEN-M

=LDR  00976cz  a2200313n  4500
=001  9880363968302441
=005  20170609124021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010587
=035  \\$aCBA3874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x417.$x350
=072  \\$aG9.$x188.$x665
=072  \\$aG12.$x450.$x564.$x809
=072  \\$aG12.$x688
=150  \\$aPhagocytosis
=450  \\$wnnna$aPhagocytoses
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aEndocytosis
=550  \\$wg$aImmune System Phenomena
=550  \\$wg$aImmunity, Innate
=550  \\$wh$aAutophagy
=550  \\$wh$aCytophagocytosis
=550  \\$aLeukocytes
=550  \\$aMacrophages
=550  \\$aOpsonin Proteins
=550  \\$aPhagosomes
=680  \\$iThe engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES).
=750  \0$aPhagocytosis$5IEN$0(DLC)sh 85100549

=LDR  00831cz  a2200301n  4500
=001  9880363968402441
=005  20141212204436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010586
=035  \\$aCBA3873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x733
=072  \\$aA15.$x382.$x680
=150  \\$aPhagocytes
=450  \\$wnnna$aCell, Phagocytic
=450  \\$wnnna$aCells, Phagocytic
=450  \\$wnnna$aPhagocyte
=450  \\$wnnna$aPhagocytic Cell
=450  \\$wnnna$aPhagocytic Cells
=550  \\$wg$aCells
=550  \\$wg$aImmune System
=550  \\$wh$aMacrophages
=550  \\$wh$aMonocytes
=550  \\$wh$aNeutrophils
=550  \\$aMononuclear Phagocyte System
=680  \\$iCells that can carry out the process of PHAGOCYTOSIS.
=688  \\$a73
=750  \0$aPhagocytes$5IEN$0(DLC)sh 85100548

=LDR  01092cz  a2200265n  4500
=001  9880363968502441
=005  20141212204435.0
=008  790416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010583
=035  \\$aCBA3870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x150.$x500.$x260
=072  \\$aB4.$x123.$x205.$x260
=072  \\$aB4.$x280.$x90.$x500.$x260
=150  \\$aBacteriophage mu
=450  \\$aColiphage mu
=450  \\$aEnterobacteria phage Mu
=450  \\$amu Phage
=450  \\$wnnna$amu Phages
=450  \\$aPhage mu
=550  \\$wg$aColiphages
=550  \\$wg$aMyoviridae
=680  \\$iA temperate coliphage, in the genus Mu-like viruses, family MYOVIRIDAE, composed of a linear, double-stranded molecule of DNA, which is able to insert itself randomly at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial OPERON at the site of insertion.
=688  \\$a93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89
=750  \0$aBacteriophage mu$5IEN$0(DLC)sh 87003056

=LDR  01183cz  a2200277n  4500
=001  9880363968602441
=005  20141212204435.0
=008  790412\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010582
=035  \\$aCBA3869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x150.$x800.$x230
=072  \\$aB4.$x123.$x205.$x230
=072  \\$aB4.$x280.$x90.$x800.$x230
=150  \\$aBacteriophage lambda
=450  \\$aColiphage lambda
=450  \\$aEnterobacteria phage lambda
=450  \\$alambda Phage
=450  \\$aPhage lambda
=550  \\$wg$aColiphages
=550  \\$wg$aSiphoviridae
=550  \\$aCosmids
=667  \\$aLAMBDA-LIKE PHAGES see SIPHOVIRIDAE is also available
=680  \\$iA temperate inducible phage and type species of the genus lambda-like viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its VIRION contains linear double-stranded DNA with single-stranded 12-base 5' sticky ends. The DNA circularizes on infection.
=688  \\$a93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79
=750  \0$aBacteriophage lambda$5IEN$0(DLC)sh 85010877

=LDR  01017cz  a2200253n  4500
=001  9880363968702441
=005  20141212204434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010579
=035  \\$aCBA3866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x885.$x681
=150  \\$aPetrous Bone
=450  \\$wnnna$aBone, Petrous
=450  \\$wnnna$aBones, Petrous
=450  \\$wnnna$aPetrous Bones
=450  \\$aPetrous Pyramid
=450  \\$wnnna$aPetrous Pyramids
=450  \\$wnnna$aPyramid, Petrous
=450  \\$wnnna$aPyramids, Petrous
=550  \\$wg$aTemporal Bone
=667  \\$afractures: coordinate PETROUS BONE /inj (IM) + SKULL FRACTURES (IM); neoplasm: coordinate IM with SKULL NEOPLASMS (IM)
=680  \\$iThe dense rock-like part of temporal bone that contains the INNER EAR. Petrous bone is located at the base of the skull. Sometimes it is combined with the MASTOID PROCESS and called petromastoid part of temporal bone.
=750  \0$aPetrous bone$0(DLC) sh 90001413$5IEN

=LDR  00929cz  a2200289n  4500
=001  9880363968802441
=005  20141212204433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010578
=035  \\$aCBA3865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x630
=072  \\$aN6.$x230.$x132.$x258.$x630
=150  \\$aPetroleum
=450  \\$aCrude Oil
=450  \\$wnnna$aCrude Oils
=450  \\$wnnna$aOil, Crude
=450  \\$wnnna$aOils, Crude
=450  \\$wnnna$aPetroleums
=550  \\$wg$aFossil Fuels
=550  \\$wh$aFuel Oils
=550  \\$wh$aGasoline
=550  \\$wh$aKerosene
=550  \\$aOil and Gas Fields
=680  \\$iNaturally occurring complex liquid hydrocarbons which, after distillation, yield combustible fuels, petrochemicals, and lubricants.
=688  \\$awas in Cat J only 1975-81, was in Cat D & J 1968-74, was in Cat D only 1963-67
=750  \0$aPetroleum$5IEN$0(DLC)sh 85100361

=LDR  00962cz  a2200301n  4500
=001  9880363968902441
=005  20141212204433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010577
=035  \\$aCBA3864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x699
=150  \\$aPetrolatum
=450  \\$wnnna$aHydrophilic Petrolatum
=450  \\$wnnna$aJelly, Paraffin
=450  \\$wnnna$aJelly, Petroleum
=450  \\$aParaffin Jelly
=450  \\$wnnna$aPetrolatum, Hydrophilic
=450  \\$wnnna$aPetrolatum, White
=450  \\$aPetroleum Jelly
=450  \\$wnnna$aVaseline
=450  \\$wnnna$aWhite Petrolatum
=550  \\$wg$aHydrocarbons
=550  \\$wh$aMineral Oil
=667  \\$aD25-26 qualif
=680  \\$iA colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.
=688  \\$awas in Cat D only 1963-82
=750  \0$aPetrolatum$5IEN$0(DLC)sh 85100360

=LDR  01112cz  a2200349n  4500
=001  9880363969002441
=005  20141212204433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010575
=035  \\$aCBA3862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700
=072  \\$aD27.$x720.$x723
=072  \\$aD27.$x888.$x723
=150  \\$aPesticides
=550  \\$wg$aAgrochemicals
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wg$aToxic Actions
=550  \\$wh$aAcaricides
=550  \\$wh$aChemosterilants
=550  \\$wh$aFungicides, Industrial
=550  \\$wh$aHerbicides
=550  \\$wh$aInsect Repellents
=550  \\$wh$aInsecticides
=550  \\$wh$aMolluscacides
=550  \\$wh$aPesticide Residues
=550  \\$wh$aPesticide Synergists
=550  \\$wh$aRodenticides
=550  \\$aAgrochemicals
=667  \\$avery general: prefer specifics or specific types
=680  \\$iChemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc.
=750  \0$aPesticides$5IEN$0(DLC)sh 85100273

=LDR  00889cz  a2200265n  4500
=001  9880363969102441
=005  20141212204432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010573
=035  \\$aCBA3860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x723.$x697
=072  \\$aN6.$x850.$x460.$x200.$x700
=150  \\$aPesticide Residues
=450  \\$wnnna$aPesticide Residue
=450  \\$wnnna$aResidue, Pesticide
=450  \\$wnnna$aResidues, Pesticide
=550  \\$wg$aBody Burden
=550  \\$wg$aPesticides
=550  \\$aBody Burden
=550  \\$aDrug Residues
=667  \\$aIM; coord with specific pesticide or pesticide group (IM)
=680  \\$iPesticides or their breakdown products remaining in the environment following their normal use or accidental contamination.
=688  \\$a73
=750  \0$aPesticides$xEnvironmental aspects$5IEN$0(DLC)sh 85100279

=LDR  01108cz  a2200301n  4500
=001  9880363969202441
=005  20141212204432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010572
=035  \\$aCBA3859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650.$x650
=150  \\$aPest Control, Biological
=450  \\$wnnna$aBiologic Pest Control
=450  \\$wnnna$aBiologic Pest Controls
=450  \\$aBiological Pest Control
=450  \\$wnnna$aBiological Pest Controls
=450  \\$wnnna$aPest Control, Biologic
=450  \\$wnnna$aPest Controls, Biologic
=450  \\$wnnna$aPest Controls, Biological
=550  \\$wg$aPest Control
=550  \\$aInsect Control
=550  \\$aMosquito Control
=550  \\$aSterilization, Reproductive
=667  \\$acoordinate IM with specific insect or other pest (IM) but do not coordinate with INSECT CONTROL & MOSQUITO CONTROL
=680  \\$iUse of naturally-occuring or genetically-engineered organisms to reduce or eliminate populations of pests.
=688  \\$a73
=750  \0$aPests$xBiological control$5IEN$0(DLC)sh 85100294

=LDR  00971cz  a2200277n  4500
=001  9880363969302441
=005  20141212204431.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010571
=035  \\$aCBA3858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650
=150  \\$aPest Control
=450  \\$wnnna$aControl, Pest
=450  \\$wnnna$aManagement, Pest
=450  \\$aPest Management
=550  \\$wg$aCommunicable Disease Control
=550  \\$wh$aInsect Control
=550  \\$wh$aPest Control, Biological
=550  \\$wh$aRodent Control
=550  \\$wh$aTick Control
=550  \\$aWeed Control
=667  \\$ageneral or unspecified; prefer specifics; coordinate with specific pest; WEED CONTROL is also available
=680  \\$iThe reduction or regulation of the population of noxious, destructive, or dangerous insects, or other animals.
=688  \\$a76; was NON MESH before 1976
=750  \0$aPests$xControl$5IEN$0(DLC)sh 85100295

=LDR  00550cz  a2200157n  4500
=001  9880363969402441
=005  20141212204431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010570
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x499
=150  \\$aPessaries
=450  \\$wnnna$aPessary
=550  \\$wg$aSurgical Equipment
=680  \\$iDevices worn in the vagina to provide support to displaced uterus or rectum. Pessaries are used in conditions such as UTERINE PROLAPSE; CYSTOCELE; or RECTOCELE.
=750  \0$aPessaries$5IEN$0(DLC)sh 85100262

=LDR  01015cz  a2200253n  4500
=001  9880363969502441
=005  20141212204431.0
=008  780503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010569
=035  \\$aCBA3856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x149.$x700
=072  \\$aD2.$x455.$x426.$x559.$x847.$x680.$x500
=072  \\$aD4.$x615.$x149.$x700
=072  \\$aD4.$x615.$x680.$x500
=150  \\$aPerylene
=450  \\$wnnna$aPeri-Dinaphthalene
=450  \\$wnnna$aPeri Dinaphthalene
=450  \\$aPerilene
=550  \\$wg$aBenz(a)Anthracenes
=550  \\$wg$aPhenalenes
=680  \\$iA 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic.
=688  \\$a91(79); was see under BENZANTHRACENES 1979-90
=750  \0$aPerylene$5IEN$0(DLC)sh 89003056

=LDR  00761cz  a2200241n  4500
=001  9880363969602441
=005  20141212204429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010565
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x762
=150  \\$aPersuasive Communication
=450  \\$aBrainwashing
=450  \\$wnnna$aCommunication, Persuasive
=450  \\$aPersuasion
=550  \\$wg$aCommunication
=550  \\$aBehavior Control
=550  \\$aPsychological Warfare
=550  \\$aSuggestion
=667  \\$ano qualif
=680  \\$iA mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others.
=688  \\$a69
=750  \0$aPersuasion (Psychology)$5IEN$0(DLC)sh 85100175

=LDR  01031cz  a2200265n  4500
=001  9880363969702441
=005  20141212204429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010564
=035  \\$aCBA3851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x740
=072  \\$aN2.$x360.$x740
=150  \\$aPersonnel, Hospital
=450  \\$aHospital Personnel
=550  \\$wg$aHealth Personnel
=550  \\$wh$aDental Staff, Hospital
=550  \\$wh$aHospital Administrators
=550  \\$wh$aHospital Volunteers
=550  \\$wh$aMedical Staff, Hospital
=550  \\$wh$aNursing Staff, Hospital
=667  \\$a/organ = PERSONNEL ADMINISTRATION, HOSPITAL but consider also other terms under ADMINISTRATIVE PERSONNEL & ALLIED HEALTH PERSONNEL, etc.; "orderlies" & "ward attendants" unspecified go here except for PSYCHIATRIC AIDES (see note there)
=680  \\$iThe individuals employed by the hospital.
=688  \\$a78; was HOSPITAL PERSONNEL 1968-77
=750  \0$aHospitals$xEmployees$5IEN$0(DLC)sh 85062368

=LDR  01107cz  a2200313n  4500
=001  9880363969802441
=005  20141212204428.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010560
=035  \\$aCBA3847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x500
=150  \\$aPersonnel Selection
=450  \\$wnnna$aActivities, Recruitment
=450  \\$wnnna$aActivity, Recruitment
=450  \\$aEmployee Selection$5IEN
=450  \\$aPersonnel Recruitment
=450  \\$wnnna$aPersonnel Recruitments
=450  \\$wnnna$aPersonnel Selections
=450  \\$wnnna$aRecruitment Activities
=450  \\$wnnna$aRecruitment Activity
=450  \\$wnnna$aRecruitment, Personnel
=450  \\$wnnna$aRecruitments, Personnel
=450  \\$wnnna$aSelection, Personnel
=450  \\$wnnna$aSelections, Personnel
=550  \\$wg$aPersonnel Management
=680  \\$iThe process of choosing employees for specific types of employment. The concept includes recruitment.
=688  \\$a91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90
=750  \0$aEmployee selection$5IEN$0(DLC)sh 85042875

=LDR  01705cz  a2200517n  4500
=001  9880363969902441
=005  20200722134948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010559
=035  \\$aCBA3846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677
=150  \\$aPersonnel Management
=450  \\$wnnna$aClient-Staff Ratio
=450  \\$wnnna$aClient Staff Ratio
=450  \\$wnnna$aClient-Staff Ratios
=450  \\$wnnna$aManagement, Personnel
=450  \\$wnnna$aRatio, Client-Staff
=450  \\$wnnna$aRatios, Client-Staff
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aCareer Mobility
=550  \\$wh$aCollective Bargaining
=550  \\$wh$aEmployee Discipline
=550  \\$wh$aEmployee Grievances
=550  \\$wh$aEmployee Incentive Plans
=550  \\$wh$aEmployee Performance Appraisal
=550  \\$wh$aJob Application
=550  \\$wh$aJob Description
=550  \\$wh$aManagement Quality Circles
=550  \\$wh$aNegotiating
=550  \\$wh$aPersonnel Administration, Hospital
=550  \\$wh$aPersonnel Delegation
=550  \\$wh$aPersonnel Downsizing
=550  \\$wh$aPersonnel Loyalty
=550  \\$wh$aPersonnel Selection
=550  \\$wh$aPersonnel Staffing and Scheduling
=550  \\$wh$aPersonnel Turnover
=550  \\$wh$aPhysician Incentive Plans
=550  \\$wh$aSalaries and Fringe Benefits
=550  \\$wh$aStaff Development
=550  \\$wh$aStrikes, Employee
=550  \\$wh$aWork Engagement
=550  \\$wh$aWorkload
=550  \\$wh$aWorkplace
=680  \\$iPlanning, organizing, and administering all activities related to personnel.
=750  \0$aPersonnel management$5IEN$0(DLC)sh 85100143

=LDR  01235cz  a2200325n  4500
=001  9880363970002441
=005  20141212204427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010557
=035  \\$aCBA3844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x565
=072  \\$aN4.$x452.$x442.$x422.$x565
=072  \\$aN4.$x452.$x677.$x440
=150  \\$aPersonnel Administration, Hospital
=450  \\$wnnna$aAdministration, Hospital Personnel
=450  \\$aHospital Personnel Administration
=450  \\$wnnna$aHospital Personnel Management
=450  \\$wnnna$aHospital Personnel Organization and Administration
=450  \\$wnnna$aManagement, Hospital Personnel
=450  \\$aPersonnel, Hospital$xorganization & administration
=450  \\$aPersonnel, Hospital, Organization and Administration
=450  \\$aPersonnel Management, Hospital
=550  \\$wg$aHospital Departments
=550  \\$wg$aPersonnel Management
=550  \\$aPersonnel Management
=667  \\$aDF: PERSONNEL ADMIN HOSP
=680  \\$iManagement activities concerned with hospital employees.
=688  \\$a78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77
=750  \0$aHospitals$xPersonnel management$5IEN$0(DLC)sh 85062349

=LDR  00890cz  a2200265n  4500
=001  9880363970102441
=005  20141212204426.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010556
=035  \\$aCBA3843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647
=150  \\$aPersonality Tests
=450  \\$wnnna$aPersonality Test
=450  \\$wnnna$aTest, Personality
=450  \\$wnnna$aTests, Personality
=550  \\$wg$aPsychological Tests
=550  \\$wh$aBender-Gestalt Test
=550  \\$wh$aPersonality Inventory
=550  \\$wh$aProjective Techniques
=550  \\$wh$aSemantic Differential
=550  \\$wh$aWord Association Tests
=680  \\$iStandardized objective tests designed to facilitate the evaluation of personality.
=688  \\$a76; was NON MESH 1975, was see under PSYCHOLOGICAL TESTS 1963-74
=750  \0$aPersonality tests$5IEN$0(DLC)sh 85100136

=LDR  01777cz  a2200457n  4500
=001  9880363970202441
=005  20141212204426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010554
=035  \\$aCBA3841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675
=150  \\$aPersonality Disorders
=450  \\$aAs If Personality
=450  \\$aAvoidant Personality Disorder
=450  \\$wnnna$aAvoidant Personality Disorders
=450  \\$aImpulse-Ridden Personality
=450  \\$wnnna$aImpulse Ridden Personality
=450  \\$aInadequate Personality
=450  \\$aNarcissistic Personality Disorder
=450  \\$wnnna$aPersonality, As If
=450  \\$wnnna$aPersonality Disorder
=450  \\$wnnna$aPersonality Disorder, Avoidant
=450  \\$wnnna$aPersonality Disorder, Narcissistic
=450  \\$wnnna$aPersonality Disorders, Avoidant
=450  \\$wnnna$aPersonality, Impulse-Ridden
=450  \\$wnnna$aPersonality, Inadequate
=550  \\$wg$aMental Disorders
=550  \\$wh$aAntisocial Personality Disorder
=550  \\$wh$aBorderline Personality Disorder
=550  \\$wh$aCompulsive Personality Disorder
=550  \\$wh$aDependent Personality Disorder
=550  \\$wh$aHistrionic Personality Disorder
=550  \\$wh$aParanoid Personality Disorder
=550  \\$wh$aPassive-Aggressive Personality Disorder
=550  \\$wh$aSchizoid Personality Disorder
=550  \\$wh$aSchizotypal Personality Disorder
=550  \\$aAnomie
=680  \\$iA major deviation from normal patterns of behavior.
=688  \\$a68; AS IF PERSONALITY was see under PERSONALITY DISORDERS 1975-78; IMPULSE-RIDDEN PERSONALITY & INADEQUATE PERSONALITY were see under PERSONALITY DISORDERS 1968-78
=750  \0$aPersonality disorders$5IEN$0(DLC)sh 85100115

=LDR  01179cz  a2200397n  4500
=001  9880363970302441
=005  20201124143433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010553
=035  \\$aCBA3840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747
=150  \\$aPersonality Development
=450  \\$wnnna$aDevelopment, Personality
=550  \\$wg$aPersonality
=550  \\$wh$aEgo
=550  \\$wh$aExtraversion, Psychological
=550  \\$wh$aId
=550  \\$wh$aIdentification, Psychological
=550  \\$wh$aIdentity Crisis
=550  \\$wh$aIndividuation
=550  \\$wh$aIntroversion, Psychological
=550  \\$wh$aMoral Development
=550  \\$wh$aPsychosexual Development
=550  \\$wh$aSelf Concept
=550  \\$wh$aSuperego
=550  \\$wh$aType A Personality
=550  \\$wh$aType B Personality
=550  \\$wh$aType D Personality
=550  \\$wh$aUnconscious, Psychology
=550  \\$aChild Development
=550  \\$aGrowth
=667  \\$ano qualif
=680  \\$iGrowth of habitual patterns of behavior in childhood and adolescence.
=688  \\$a68
=750  \0$aPersonality development$5IEN$0(DLC)sh 87002534

=LDR  00934cz  a2200229n  4500
=001  9880363970402441
=005  20141212204425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010552
=035  \\$aCBA3839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x513
=150  \\$aPersonality Assessment
=450  \\$wnnna$aAssessment, Personality
=450  \\$wnnna$aAssessments, Personality
=450  \\$wnnna$aPersonality Assessments
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wh$aQ-Sort
=667  \\$aby a professional; differentiate from PERSONALITY INVENTORY (by the person himself); DF: PERSONALITY ASSESS
=680  \\$iThe determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term.
=688  \\$a68(66)
=750  \0$aPersonality assessment$5IEN$0(DLC)sh 85100129

=LDR  01005cz  a2200349n  4500
=001  9880363970502441
=005  20201119124827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010551
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752
=150  \\$aPersonality
=450  \\$wnnna$aPersonalities
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aAssertiveness
=550  \\$wh$aAuthoritarianism
=550  \\$wh$aCharacter
=550  \\$wh$aCreativity
=550  \\$wh$aDependency, Psychological
=550  \\$wh$aEmpathy
=550  \\$wh$aIndividuality
=550  \\$wh$aIntelligence
=550  \\$wh$aLeadership
=550  \\$wh$aMachiavellianism
=550  \\$wh$aNegativism
=550  \\$wh$aNeuroticism
=550  \\$wh$aPerfectionism
=550  \\$wh$aPersonality Development
=550  \\$wh$aTemperament
=550  \\$aHuman Characteristics
=680  \\$iBehavior-response patterns that characterize the individual.
=750  \0$aPersonality$5IEN$0(DLC)sh 85100113

=LDR  01087cz  a2200325n  4500
=001  9880363970602441
=005  20141212204424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010550
=035  \\$aCBA3837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x875.$x596
=150  \\$aPersonal Space
=450  \\$aBody Buffer Zone
=450  \\$wnnna$aBody Buffer Zones
=450  \\$wnnna$aBuffer Zone, Body
=450  \\$wnnna$aBuffer Zones, Body
=450  \\$wnnna$aPersonal Spaces
=450  \\$aPrivacy of Space
=450  \\$wnnna$aSpace, Personal
=450  \\$wnnna$aSpace Privacy
=450  \\$wnnna$aSpaces, Personal
=450  \\$wnnna$aZone, Body Buffer
=450  \\$wnnna$aZones, Body Buffer
=550  \\$wg$aSpatial Behavior
=550  \\$aPrivacy
=667  \\$ano qualif
=680  \\$iInvisible boundaries surrounding the individual's body which are maintained in relation to others.
=688  \\$a91(75); was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78
=750  \0$aPersonal space$5IEN$0(DLC)sh 85100111

=LDR  00636cz  a2200205n  4500
=001  9880363970702441
=005  20141212204424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010549
=035  \\$aCBA3836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x677
=150  \\$aPersonal Satisfaction
=450  \\$wnnna$aSatisfaction
=450  \\$wnnna$aSatisfaction, Personal
=550  \\$wg$aBehavior
=667  \\$ano qualif
=680  \\$iThe individual's experience of a sense of fulfillment of a need or want and the quality or state of being satisfied.
=688  \\$a72(70)
=750  \0$aSatisfaction$5IEN$0(DLC)sh 85117681

=LDR  02104cz  a2200385n  4500
=001  9880363970802441
=005  20141212204423.0
=008  790228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010547
=035  \\$aCBA3834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x423.$x694
=072  \\$aC16.$x614.$x694
=150  \\$aPersistent Fetal Circulation Syndrome
=450  \\$wnnna$aACD-MPV
=450  \\$wnnna$aACD MPV
=450  \\$wnnna$aACDMPV
=450  \\$wnnna$aAlveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins
=450  \\$wnnna$aAlveolar Capillary Dysplasia With Misalignment Of Pulmonary Veins And Other Congenital Anomalies
=450  \\$wnnna$aCirculation, Persistent Fetal
=450  \\$wnnna$aFamilial Persistent Pulmonary Hypertension of the Newborn
=450  \\$aFetal Circulation, Persistent
=450  \\$aHypertension, Pulmonary, of Newborn, Persistent
=450  \\$wnnna$aMisalignment of the Pulmonary Vessels
=450  \\$wnnna$aPersistent Fetal Circulation
=450  \\$aPersistent Pulmonary Hypertension of Newborn
=450  \\$wnnna$aPulmonary Hypertension, Familial Persistent, of the Newborn
=550  \\$wg$aHypertension, Pulmonary
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$aDuctus Arteriosus, Patent
=667  \\$aalso known as PPHN; check the tags HUMANS & INFANT, NEWBORN; DF: PFC SYNDROME
=680  \\$iA syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
=688  \\$a1980
=688  \\$a80
=750  \0$aPersistent fetal circulation syndrome$0(DLC) sh 90000431$5IEN

=LDR  01464cz  a2200337n  4500
=001  9880363970902441
=005  20141212204422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010545
=035  \\$aCBA3832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x685.$x750
=072  \\$aD1.$x339.$x431.$x374
=072  \\$aD1.$x650.$x550.$x750
=072  \\$aD2.$x389.$x338
=072  \\$aD2.$x737
=150  \\$aPeroxides
=450  \\$aHydrogen Peroxide$xanalogs & derivatives
=550  \\$wg$aFree Radicals
=550  \\$wg$aOrganic Chemicals
=550  \\$wg$aOxides
=550  \\$wg$aReactive Oxygen Species
=550  \\$wh$aArtemisinins
=550  \\$wh$aHydrogen Peroxide
=550  \\$wh$aLipid Peroxides
=550  \\$wh$aProstaglandin Endoperoxides
=550  \\$wh$aSuperoxides
=550  \\$wh$atert-Butylhydroperoxide
=550  \\$wh$aTetraoxanes
=680  \\$iA group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=750  \0$aPeroxides$5IEN$0(DLC)sh 85100033

=LDR  01096cz  a2200277n  4500
=001  9880363971002441
=005  20141212204422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010543
=035  \\$aCBA3830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x450.$x760.$x640
=150  \\$aPeroneal Nerve
=450  \\$aFibular Nerve
=450  \\$wnnna$aFibular Nerves
=450  \\$wnnna$aNerve, Fibular
=450  \\$wnnna$aNerve, Peroneal
=450  \\$wnnna$aNerves, Fibular
=450  \\$wnnna$aNerves, Peroneal
=450  \\$wnnna$aPeroneal Nerves
=550  \\$wg$aSciatic Nerve
=550  \\$aPudendal Nerve
=667  \\$adisease = PERONEAL NEUROPATHIES (IM); neoplasm = PERONEAL NEUROPATHIES (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histological type of neoplasm (IM); do not confuse with PUDENAL NERVE
=680  \\$iThe lateral of the two terminal branches of the sciatic nerve. The peroneal (or fibular) nerve provides motor and sensory innervation to parts of the leg and foot.
=688  \\$a72(71)
=750  \0$aPeroneal nerve$5IEN$0(DLC)sh 85100022

=LDR  01118cz  a2200301n  4500
=001  9880363971102441
=005  20190225142531.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010542
=035  \\$aCBA3829HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992.$x635.$x75.$x500.$x510.
=150  \\$aPeromyscus
=450  \\$wnnna$aDeer Mice
=450  \\$wnnna$aDeer Mouse
=450  \\$aMice, Deer
=450  \\$aMice, White-Footed
=450  \\$wnnna$aMice, White Footed
=450  \\$wnnna$aMouse, Deer
=450  \\$wnnna$aMouse, White-Footed
=450  \\$wnnna$aMouse, White Footed
=450  \\$wnnna$aWhite-Footed Mice
=450  \\$wnnna$aWhite-Footed Mouse
=550  \\$wg$aSigmodontinae
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted; do not check tag MICE
=680  \\$iA genus of the subfamily SIGMODONTINAE consisting of 49 species. Two of these are widely used in medical research. They are P. leucopus, or the white-footed mouse, and P. maniculatus, or the deer mouse.
=688  \\$a78
=750  \0$aPeromyscus$0(DLC) sh 85100014$5IEN

=LDR  00865cz  a2200217n  4500
=001  9880363971202441
=005  20170725162855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010539
=035  \\$aCBA3826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x723
=150  \\$aPermeability
=450  \\$wnnna$aPermeabilities
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPhysicochemical Phenomena
=550  \\$wh$aOsmosis
=550  \\$wh$aOsmotic Pressure
=667  \\$acoord NIM with substance /pharmacokin (IM) or /metab (IM) or tissue /metab (IM); for nonbiological material coord with substance /chem (IM); note VASCULAR PERMEABILITY see CAPILLARY PERMEABILITY
=680  \\$iProperty of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions.
=750  \0$aPermeability$5IEN$0(DLC)sh 85099987

=LDR  01105cz  a2200253n  4500
=001  9880363971302441
=005  20141212204420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010538
=035  \\$aCBA3824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x463.$x600
=072  \\$aC6.$x844.$x640
=150  \\$aPeritonitis
=450  \\$wnnna$aPeritonitis, Primary
=450  \\$wnnna$aPeritonitis, Secondary
=450  \\$wnnna$aPrimary Peritonitis
=450  \\$wnnna$aSecondary Peritonitis
=550  \\$wg$aIntraabdominal Infections
=550  \\$wg$aPeritoneal Diseases
=550  \\$wh$aPeritonitis, Tuberculous
=550  \\$wh$aSubphrenic Abscess
=680  \\$iINFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
=750  \0$aPeritonitis$5IEN$0(DLC)sh 85099964

=LDR  01455cz  a2200289n  4500
=001  9880363971402441
=005  20141212204420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010537
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x25.$x600
=072  \\$aA10.$x615.$x789.$x596
=150  \\$aPeritoneum
=450  \\$aParietal Peritoneum
=450  \\$aPeritoneum, Parietal
=450  \\$aPeritoneum, Visceral
=450  \\$aVisceral Peritoneum
=550  \\$wg$aAbdominal Cavity
=550  \\$wg$aSerous Membrane
=550  \\$wh$aDouglas' Pouch
=550  \\$wh$aMesentery
=550  \\$wh$aOmentum
=550  \\$wh$aPeritoneal Cavity
=550  \\$wh$aPeritoneal Stomata
=667  \\$ado not confuse with PERITONEAL CAVITY; "peritoneal cells" = probably PERITONEAL CAVITY/cytol or PERITONEAL FLUID (see ASCITIC FLUID)/pathol but not PERITONEUM/cytol; inflammation = PERITONITIS; PERITONEAL LAVAGE is available
=680  \\$iA membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.
=750  \0$aPeritoneum$5IEN$0(DLC)sh 85099958

=LDR  01910cz  a2200421n  4500
=001  9880363971502441
=005  20141212204420.0
=008  800515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010536
=035  \\$aCBA3822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x735
=072  \\$aE4.$x100.$x814.$x750
=072  \\$aE4.$x210.$x790
=150  \\$aPeritoneovenous Shunt
=450  \\$aAscites Shunt, Peritoneovenous
=450  \\$wnnna$aAscites Shunts, Peritoneovenous
=450  \\$aLeVeen Shunt
=450  \\$wnnna$aPeritoneo-Venous Shunt
=450  \\$wnnna$aPeritoneo Venous Shunt
=450  \\$wnnna$aPeritoneo-Venous Shunts
=450  \\$wnnna$aPeritoneovenous Ascites Shunt
=450  \\$wnnna$aPeritoneovenous Ascites Shunts
=450  \\$wnnna$aPeritoneovenous Shunts
=450  \\$wnnna$aShunt, LeVeen
=450  \\$wnnna$aShunt, Peritoneo-Venous
=450  \\$wnnna$aShunt, Peritoneovenous
=450  \\$wnnna$aShunt, Peritoneovenous Ascites
=450  \\$wnnna$aShunts, Peritoneo-Venous
=450  \\$wnnna$aShunts, Peritoneovenous
=450  \\$wnnna$aShunts, Peritoneovenous Ascites
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wg$aVascular Surgical Procedures
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAn operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.
=688  \\$a86(81); was see under VASCULAR SURGERY 1981-85
=750  \0$aPeritoneovenous shunts$5IEN$0(DLC)sh 85099957

=LDR  01674cz  a2200433n  4500
=001  9880363971602441
=005  20200605150602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010535
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x520
=072  \\$aE4.$x502.$x250.$x520
=150  \\$aLaparoscopy
=450  \\$wnnna$aCelioscopies
=450  \\$aCelioscopy
=450  \\$wnnna$aLaparoscopic Surgeries
=450  \\$wnnna$aLaparoscopic Surgery
=450  \\$wnnna$aLaparoscopic Surgical Procedure
=450  \\$aLaparoscopic Surgical Procedures
=450  \\$wnnna$aLaparoscopies
=450  \\$wnnna$aPeritoneoscopies
=450  \\$aPeritoneoscopy
=450  \\$wnnna$aProcedure, Laparoscopic Surgical
=450  \\$wnnna$aProcedures, Laparoscopic Surgical
=450  \\$wnnna$aSurgeries, Laparoscopic
=450  \\$wnnna$aSurgery, Laparoscopic
=450  \\$wnnna$aSurgical Procedure, Laparoscopic
=450  \\$aSurgical Procedures, Laparoscopic
=550  \\$wg$aEndoscopy
=550  \\$wh$aCholecystectomy, Laparoscopic
=550  \\$wh$aHand-Assisted Laparoscopy
=550  \\$wh$aNephrolithotomy, Percutaneous
=550  \\$aLaparoscopes
=550  \\$aPeritoneal Cavity
=550  \\$aPeritoneum
=667  \\$a/ instrum permitted but consider also LAPAROSCOPES
=680  \\$iA procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
=688  \\$a1993, 1971-1977; use PERITONEOSCOPY 1978-1992
=750  \0$aLaparoscopy$5IEN-M$0(DLC)sh 85074661

=LDR  00854cz  a2200277n  4500
=001  9880363971702441
=005  20141212204419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010534
=035  \\$aCBA3820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x33.$x513
=072  \\$aC4.$x588.$x274.$x780
=072  \\$aC6.$x301.$x780
=072  \\$aC6.$x844.$x620
=150  \\$aPeritoneal Neoplasms
=450  \\$wnnna$aNeoplasm, Peritoneal
=450  \\$wnnna$aNeoplasms, Peritoneal
=450  \\$wnnna$aPeritoneal Neoplasm
=550  \\$wg$aAbdominal Neoplasms
=550  \\$wg$aDigestive System Neoplasms
=550  \\$wg$aPeritoneal Diseases
=550  \\$wh$aMesenteric Cyst
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the PERITONEUM.
=750  \0$aPeritoneum$xCancer$0(DLC)sh2010010038$5IEN-M

=LDR  00930cz  a2200301n  4500
=001  9880363971802441
=005  20141212204418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010532
=035  \\$aCBA3818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x844
=150  \\$aPeritoneal Diseases
=450  \\$wnnna$aPeritoneal Disease
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aChylous Ascites
=550  \\$wh$aHemoperitoneum
=550  \\$wh$aMesenteric Ischemia
=550  \\$wh$aMesenteric Lymphadenitis
=550  \\$wh$aMesenteric Vascular Occlusion
=550  \\$wh$aPanniculitis, Peritoneal
=550  \\$wh$aPeritoneal Fibrosis
=550  \\$wh$aPeritoneal Neoplasms
=550  \\$wh$aPeritonitis
=550  \\$wh$aPneumoperitoneum
=667  \\$ainflamm dis = PERITONITIS
=680  \\$iPathological processes involving the PERITONEUM.
=750  \0$aPeritoneum$xDiseases$5IEN$0(DLC)sh 85099960

=LDR  00987cz  a2200241n  4500
=001  9880363971902441
=005  20141212204418.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010531
=035  \\$aCBA3817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x106.$x500
=072  \\$aE2.$x870.$x300.$x650.$x500
=072  \\$aE2.$x912.$x800.$x650.$x500
=072  \\$aN2.$x421.$x585.$x106.$x500
=150  \\$aPeritoneal Dialysis, Continuous Ambulatory
=450  \\$aCAPD
=450  \\$wnnna$aContinuous Ambulatory Peritoneal Dialysis
=550  \\$wg$aAmbulatory Care
=550  \\$wg$aPeritoneal Dialysis
=680  \\$iPortable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution.
=688  \\$a86(82); was see under PERITONEAL DIALYSIS 1982-85
=750  \0$aContinuous ambulatory peritoneal dialysis$5IEN$0(DLC)sh 85031569

=LDR  00858cz  a2200253n  4500
=001  9880363972002441
=005  20141212204418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010530
=035  \\$aCBA3816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x300.$x650
=072  \\$aE2.$x912.$x800.$x650
=150  \\$aPeritoneal Dialysis
=450  \\$wnnna$aDialyses, Peritoneal
=450  \\$wnnna$aDialysis, Peritoneal
=450  \\$wnnna$aPeritoneal Dialyses
=550  \\$wg$aRenal Dialysis
=550  \\$wh$aPeritoneal Dialysis, Continuous Ambulatory
=550  \\$aKidneys, Artificial
=550  \\$aPeritoneal Fibrosis
=680  \\$iDialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.
=688  \\$a66(64)
=750  \0$aPeritoneal dialysis$5IEN$0(DLC)sh 85099955

=LDR  00653cz  a2200181n  4500
=001  9880363972102441
=005  20141212204417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010528
=035  \\$aCBA3814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261.$x326.$x310.$x596
=150  \\$aPeristalsis
=450  \\$wnnna$aPeristalses
=550  \\$wg$aGastrointestinal Motility
=680  \\$iA movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
=688  \\$a91(75); was see under GASTROINTESTINAL MOTILITY 1975-90
=750  \0$aPeristalsis$5IEN$0(DLC)sh 85099949

=LDR  00705cz  a2200193n  4500
=001  9880363972202441
=005  20200508125243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010527
=035  \\$aCBA3813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x984
=150  \\$aPerissodactyla
=450  \\$wnnna$aPerissodactylas
=550  \\$wg$aEutheria
=550  \\$wh$aEquidae
=667  \\$aincludes EQUIDAE (HORSES, asses, donkeys, mules, zebras), tapirs, rhinoceroses; IM; qualif permitted
=680  \\$iAn order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. (Dorland, 27th ed)
=750  \0$aPerissodactyla$5IEN$0(DLC)sh 85099945

=LDR  01210cz  a2200337n  4500
=001  9880363972302441
=005  20141212204417.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010526
=035  \\$aCBA3812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x140.$x580
=150  \\$aPeriplaneta
=450  \\$wnnna$aAmerican Cockroach
=450  \\$wnnna$aAmerican Cockroache
=450  \\$wnnna$aAmerican Cockroaches
=450  \\$wnnna$aAmerican Cockroachs
=450  \\$wnnna$aamericana, Periplaneta
=450  \\$wnnna$aamericanas, Periplaneta
=450  \\$wnnna$aCockroach, American
=450  \\$wnnna$aCockroache, American
=450  \\$wnnna$aCockroaches, American
=450  \\$wnnna$aCockroachs, American
=450  \\$aPeriplaneta americana
=450  \\$wnnna$aPeriplaneta americanas
=450  \\$wnnna$aPeriplanetas
=550  \\$wg$aCockroaches
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iA genus in the family Blattidae containing several species, the most common being P. americana, the American cockroach.
=688  \\$a91(75); for PERIPLANETA AMERICANA use COCKROACHES 1995-97
=750  \0$aPeriplaneta$5IEN$0(DLC)sh 85099937

=LDR  01309cz  a2200337n  4500
=001  9880363972402441
=005  20141212204416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010525
=035  \\$aCBA3811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800
=150  \\$aPeripheral Nerves
=450  \\$aEndoneurium
=450  \\$wnnna$aEndoneuriums
=450  \\$aEpineurium
=450  \\$wnnna$aEpineuriums
=450  \\$wnnna$aNerve, Peripheral
=450  \\$wnnna$aNerves, Peripheral
=450  \\$aPerineurium
=450  \\$wnnna$aPerineuriums
=450  \\$wnnna$aPeripheral Nerve
=550  \\$wg$aPeripheral Nervous System
=550  \\$wh$aAutonomic Pathways
=550  \\$wh$aBlood-Nerve Barrier
=550  \\$wh$aCranial Nerves
=550  \\$wh$aSchwann Cells
=550  \\$wh$aSpinal Nerves
=667  \\$ageneral only; do not use as a coordinate for specific nerves indexed with organ /innerv
=680  \\$iThe nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium.
=750  \0$aNerves, Peripheral$0(DLC) sh 85090903$5IEN

=LDR  01918cz  a2200445n  4500
=001  9880363972502441
=005  20141212204416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010524
=035  \\$aCBA3810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x596
=072  \\$aC10.$x551.$x775
=072  \\$aC10.$x668.$x829.$x725
=150  \\$aPeripheral Nervous System Neoplasms
=450  \\$wnnna$aNeoplasm, Peripheral Nerve
=450  \\$wnnna$aNeoplasms, Peripheral Nerve
=450  \\$wnnna$aNerve Neoplasm, Peripheral
=450  \\$wnnna$aNerve Neoplasms, Peripheral
=450  \\$wnnna$aNerve Tumor, Peripheral
=450  \\$wnnna$aNerve Tumors, Peripheral
=450  \\$wnnna$aPeripheral Nerve Neoplasm
=450  \\$wnnna$aPeripheral Nerve Neoplasms
=450  \\$wnnna$aPeripheral Nerve Neoplasms, Benign
=450  \\$wnnna$aPeripheral Nerve Neoplasms, Malignant
=450  \\$wnnna$aPeripheral Nerve Neoplastic Infiltration
=450  \\$wnnna$aPeripheral Nerve Tumor
=450  \\$wnnna$aPeripheral Nerve Tumors
=450  \\$wnnna$aPeripheral Nervous System Benign Neoplasms
=450  \\$wnnna$aPeripheral Nervous System Malignant Neoplasms
=450  \\$wnnna$aTumor, Peripheral Nerve
=450  \\$wnnna$aTumors, Peripheral Nerve
=550  \\$wg$aNervous System Neoplasms
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aCranial Nerve Neoplasms
=550  \\$wh$aNerve Sheath Neoplasms
=667  \\$acoordinate IM with specific peripheral nerve (IM) + histological type of neoplasm (IM)
=680  \\$iNeoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)
=688  \\$a2000(1966)
=750  \0$aNerves, Peripheral$xTumors$5IEN-M$0(DLC)sh 85090907

=LDR  02213cz  a2200577n  4500
=001  9880363972602441
=005  20181221104751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010523
=035  \\$aCBA3809HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829
=150  \\$aPeripheral Nervous System Diseases
=450  \\$wnnna$aNerve Disease, Peripheral
=450  \\$wnnna$aNerve Diseases, Peripheral
=450  \\$wnnna$aNeuropathy, Peripheral
=450  \\$wnnna$aPeripheral Nerve Disease
=450  \\$aPeripheral Nerve Diseases
=450  \\$wnnna$aPeripheral Nervous System Disease
=450  \\$wnnna$aPeripheral Nervous System Disorders
=450  \\$aPeripheral Neuropathies
=450  \\$wnnna$aPeripheral Neuropathy
=450  \\$wnnna$aPNS Disease
=450  \\$wnnna$aPNS Diseases
=450  \\$wnnna$aPNS (Peripheral Nervous System) Diseases
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wh$aAcrodynia
=550  \\$wh$aAmyloid Neuropathies
=550  \\$wh$aBrachial Plexus Neuropathies
=550  \\$wh$aComplex Regional Pain Syndromes
=550  \\$wh$aDiabetic Neuropathies
=550  \\$wh$aGiant Axonal Neuropathy
=550  \\$wh$aGuillain-Barre Syndrome
=550  \\$wh$aHand-Arm Vibration Syndrome
=550  \\$wh$aIsaacs Syndrome
=550  \\$wh$aMononeuropathies
=550  \\$wh$aNerve Compression Syndromes
=550  \\$wh$aNeuralgia
=550  \\$wh$aNeuritis
=550  \\$wh$aNeurofibromatosis 1
=550  \\$wh$aPain Insensitivity, Congenital
=550  \\$wh$aPeripheral Nerve Injuries
=550  \\$wh$aPeripheral Nervous System Neoplasms
=550  \\$wh$aPolyneuropathies
=550  \\$wh$aRadiculopathy
=550  \\$wh$aSmall Fiber Neuropathy
=550  \\$wh$aTarlov Cysts
=667  \\$aGEN: prefer specifics; coord IM with specific nerve (IM); "diabetic peripheral neuropathy": index only under DIABETIC NEUROPATHIES; DF: PNS DIS
=680  \\$iDiseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
=688  \\$a1994
=750  \0$aNerves, Peripheral$xDiseases$0(DLC) sh 85090904$5IEN-M

=LDR  00482cz  a2200169n  4500
=001  9880363972702441
=005  20141212204414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010521
=035  \\$aCBA3807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x265.$x746
=150  \\$aPeriosteum
=450  \\$wnnna$aPeriosteums
=550  \\$wg$aBone and Bones
=667  \\$ainflammation = PERIOSTITIS; dental = PERIODONTAL LIGAMENT
=750  \0$aPeriosteum$5IEN$0(DLC)sh 85099929

=LDR  01213cz  a2200313n  4500
=001  9880363972802441
=005  20141212204339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010417
=035  \\$aCBA3703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x706.$x690
=150  \\$aPentaerythritol Tetranitrate
=450  \\$wnnna$aAlpharma Brand of Pentaerythritol Tetranitrate
=450  \\$wnnna$aDexo Brand of Pentaerythritol Tetranitrate
=450  \\$wnnna$aDilcoran
=450  \\$wnnna$aErinit
=450  \\$wnnna$aNirason
=450  \\$wnnna$aNitrodex
=450  \\$wnnna$aParke Davis Brand of Pentaerythritol Tetranitrate
=450  \\$wnnna$aPentalog
=450  \\$wnnna$aPeritrate
=450  \\$wnnna$aRavensberg Brand of Pentaerythritol Tetranitrate
=450  \\$wnnna$aTetranitrate, Pentaerythritol
=450  \\$wnnna$aTetrate
=450  \\$wnnna$aVanguard Brand of Pentaerythritol Tetranitrate
=550  \\$wg$aPropylene Glycols
=680  \\$iA vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1025)
=750  \0$aPentaerythritol tetranitrate$5IEN$0(DLC)sh 90003290

=LDR  00987cz  a2200193n  4500
=001  9880363972902441
=005  20141212204339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010416
=035  \\$aCBA3702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x190.$x633
=150  \\$aPentachlorophenol
=450  \\$wnnna$aPentachlorophenate, Sodium
=450  \\$wnnna$aSodium Pentachlorophenate
=550  \\$wg$aChlorophenols
=680  \\$iAn insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool.
=688  \\$a91(71); was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76
=750  \0$aPentachlorophenol$5IEN$0(DLC)sh 85099614

=LDR  00691cz  a2200241n  4500
=001  9880363973002441
=005  20141212204339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010415
=035  \\$aCBA3701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417.$x510
=150  \\$aPensions
=450  \\$wnnna$aBenefit, Retirement
=450  \\$wnnna$aBenefits, Retirement
=450  \\$wnnna$aPension
=450  \\$wnnna$aRetirement Benefit
=450  \\$aRetirement Benefits
=550  \\$wg$aIncome
=550  \\$wh$aEmployee Retirement Income Security Act
=550  \\$aAged
=680  \\$iFixed sums paid regularly to individuals.
=750  \0$aPensions$5IEN$0(DLC)sh 85099592

=LDR  01018cz  a2200241n  4500
=001  9880363973102441
=005  20141212204338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010413
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x492
=150  \\$aPenis
=360  \\$iconsider also terms at$aPENILE
=450  \\$wnnna$aGlans Peni
=450  \\$wnnna$aGlans Penis
=450  \\$wnnna$aPeni, Glans
=450  \\$wnnna$aPenis, Glans
=550  \\$wg$aGenitalia, Male
=550  \\$wh$aForeskin
=550  \\$wh$aUrethra
=667  \\$ainflammation = BALANITIS; penile fracture: index under PENIS /inj (IM) + RUPTURE (NIM)
=680  \\$iThe external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.
=750  \0$aPenis$0(DLC) sh 85099480$5IEN

=LDR  01309cz  a2200421n  4500
=001  9880363973202441
=005  20141212204338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010412
=035  \\$aCBA3698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x440.$x715
=072  \\$aC12.$x294.$x260.$x500
=072  \\$aC12.$x294.$x494.$x591
=072  \\$aC12.$x758.$x409.$x500
=150  \\$aPenile Neoplasms
=450  \\$aCancer of Penis
=450  \\$wnnna$aCancer of the Penis
=450  \\$wnnna$aCancer, Penile
=450  \\$wnnna$aCancer, Penis
=450  \\$wnnna$aCancers, Penile
=450  \\$wnnna$aCancers, Penis
=450  \\$wnnna$aNeoplasm, Penile
=450  \\$wnnna$aNeoplasm, Penis
=450  \\$wnnna$aNeoplasms, Penile
=450  \\$wnnna$aNeoplasms, Penis
=450  \\$aPenile Cancer
=450  \\$wnnna$aPenile Cancers
=450  \\$wnnna$aPenile Neoplasm
=450  \\$wnnna$aPenis Cancer
=450  \\$wnnna$aPenis Cancers
=450  \\$wnnna$aPenis Neoplasm
=450  \\$wnnna$aPenis Neoplasms
=550  \\$wg$aGenital Neoplasms, Male
=550  \\$wg$aPenile Diseases
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iCancers or tumors of the PENIS or of its component tissues.
=750  \0$aPenis$xCancer$5IEN-M$0(DLC)sh 85099482

=LDR  01242cz  a2200301n  4500
=001  9880363973302441
=005  20141212204338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010411
=035  \\$aCBA3697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x494.$x508
=072  \\$aC17.$x300.$x715
=150  \\$aPenile Induration
=450  \\$wnnna$aCavernitides, Fibrous
=450  \\$aCavernitis, Fibrous
=450  \\$wnnna$aFibromatosis, Penile
=450  \\$wnnna$aFibrous Cavernitides
=450  \\$wnnna$aFibrous Cavernitis
=450  \\$wnnna$aPenile Fibromatosis
=450  \\$wnnna$aPeyronie Disease
=450  \\$aPeyronie's Disease
=450  \\$wnnna$aPeyronies Disease
=450  \\$wnnna$aPlastic Induration of the Penis
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aPenile Diseases
=680  \\$iA condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.
=750  \0$aPenile induration$5IEN$0(DLC)sh 85099418

=LDR  00971cz  a2200241n  4500
=001  9880363973402441
=005  20141212204337.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010410
=035  \\$aCBA3696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x717
=150  \\$aPenile Erection
=450  \\$wnnna$aErection, Penile
=450  \\$wnnna$aNocturnal Penile Tumescence
=450  \\$wnnna$aPenile Tumescence
=450  \\$wnnna$aPenile Tumescence, Nocturnal
=450  \\$wnnna$aTumescence, Nocturnal Penile
=450  \\$aTumescence, Penile
=550  \\$wg$aReproduction
=680  \\$iThe state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions.
=688  \\$a86
=750  \0$aPenis$xErection$0(DLC)sh2007006549$5IEN-M

=LDR  01052cz  a2200337n  4500
=001  9880363973502441
=005  20141212204337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010409
=035  \\$aCBA3695HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x494
=150  \\$aPenile Diseases
=450  \\$wnnna$aDisease, Penile
=450  \\$wnnna$aDisease, Penis
=450  \\$wnnna$aDiseases, Penile
=450  \\$wnnna$aDiseases, Penis
=450  \\$wnnna$aPenile Disease
=450  \\$wnnna$aPenis Disease
=450  \\$wnnna$aPenis Diseases
=550  \\$wg$aGenital Diseases, Male
=550  \\$wh$aBalanitis
=550  \\$wh$aHypospadias
=550  \\$wh$aPenile Induration
=550  \\$wh$aPenile Neoplasms
=550  \\$wh$aPhimosis
=550  \\$wh$aPriapism
=667  \\$aInflammatory disease = BALANITIS; penile fracture: index under PENIS /inj (IM) + RUPTURE (NIM)
=680  \\$iPathological processes involving the PENIS or its component tissues.
=688  \\$a66
=750  \0$aPenis$xDiseases$5IEN$0(DLC)sh 85099484

=LDR  00815cz  a2200253n  4500
=001  9880363973602441
=005  20141212204337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010408
=035  \\$aCBA3694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x662.$x592
=150  \\$aPenicillium chrysogenum
=450  \\$wnnna$achrysogenum, Penicillium
=450  \\$wnnna$achrysogenums, Penicillium
=450  \\$wnnna$anotatum, Penicillium
=450  \\$wnnna$anotatums, Penicillium
=450  \\$wnnna$aPenicillium chrysogenums
=450  \\$aPenicillium notatum
=450  \\$wnnna$aPenicillium notatums
=550  \\$wg$aPenicillium
=680  \\$iA mitosporic fungal species used in the production of penicillin.
=688  \\$a91(72)
=750  \0$aPenicillium chrysogenum$5IEN$0(DLC)sh 85099405

=LDR  00787cz  a2200181n  4500
=001  9880363973702441
=005  20141212204336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x662
=150  \\$aPenicillium
=450  \\$wnnna$aPenicilliums
=550  \\$wg$aMitosporic Fungi
=550  \\$wh$aPenicillium chrysogenum
=667  \\$ainfection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)
=680  \\$iA mitosporic Trichocomaceae fungal genus that develops fruiting organs resembling a broom. When identified, teleomorphs include EUPENICILLIUM and TALAROMYCES. Several species (but especially PENICILLIUM CHRYSOGENUM) are sources of the antibiotic penicillin.
=750  \0$aPenicillium$5IEN$0(DLC)sh 85099403

=LDR  01330cz  a2200409n  4500
=001  9880363994002441
=005  20170608095956.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017257
=035  \\$aCRE2447M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100
=150  \\$aRamipril
=450  \\$wnnna$aAcovil
=450  \\$wnnna$aAlmirall Brand of Ramipril
=450  \\$wnnna$aAltace
=450  \\$wnnna$aAstra Brand of Ramipril
=450  \\$wnnna$aAstraZeneca Brand of Ramipril
=450  \\$wnnna$aAventis Brand of Ramipril
=450  \\$wnnna$aAventis Pharma Brand of Ramipril
=450  \\$wnnna$aCarasel
=450  \\$wnnna$aDelix
=450  \\$wnnna$aHOE-498
=450  \\$wnnna$aHOE 498
=450  \\$wnnna$aHOE498
=450  \\$wnnna$aHoechst Brand of Ramipril
=450  \\$wnnna$aMonarch Brand of Ramipril
=450  \\$wnnna$aPromed Brand of Ramipril
=450  \\$wnnna$aRamace
=450  \\$wnnna$aTriatec
=450  \\$wnnna$aTritace
=450  \\$wnnna$aVesdil
=450  \\$wnnna$aZabien
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=680  \\$iA long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.
=688  \\$a93; was RAMIPRIL (NM) 1984-92
=750  \0$aRamipril$5IEN-M$0(DLC)sh2001004824

=LDR  01976cz  a2200469n  4500
=001  9880363994102441
=005  20141212212004.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017253
=035  \\$aCRE2443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x580.$x600.$x580.$x590
=072  \\$aC4.$x700.$x645
=072  \\$aC10.$x562.$x600
=072  \\$aC10.$x574.$x500.$x549
=072  \\$aC16.$x320.$x400.$x560
=072  \\$aC16.$x320.$x700.$x645
=150  \\$aNeurofibromatoses
=450  \\$wnnna$aMultiple Neurofibroma
=450  \\$wnnna$aMultiple Neurofibromas
=450  \\$wnnna$aNeurofibroma, Multiple
=450  \\$wnnna$aNeurofibromas, Multiple
=450  \\$aNeurofibromatosis
=450  \\$wnnna$aNeurofibromatosis 3
=450  \\$wnnna$aNeurofibromatosis 3s
=450  \\$wnnna$aNeurofibromatosis Syndrome
=450  \\$wnnna$aNeurofibromatosis Syndromes
=450  \\$aNeurofibromatosis Type 3
=450  \\$wnnna$aNeurofibromatosis Type 3s
=450  \\$wnnna$aSyndrome, Neurofibromatosis
=450  \\$wnnna$aSyndromes, Neurofibromatosis
=450  \\$wnnna$aType 3, Neurofibromatosis
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wg$aNeurocutaneous Syndromes
=550  \\$wg$aNeurofibroma
=550  \\$wh$aNeurofibromatosis 1
=550  \\$wh$aNeurofibromatosis 2
=667  \\$amultiple neurofibromas; specifics are available
=680  \\$iA group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)
=688  \\$a2000(1993)
=750  \0$aNeurofibromatosis$5IEN-M$0(DLC)sh 85091121

=LDR  01363cz  a2200397n  4500
=001  9880363994202441
=005  20141212211958.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017239
=035  \\$aCRE2431HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x242.$x888.$x777
=072  \\$aD2.$x455.$x849.$x291.$x850.$x777
=150  \\$aPaclitaxel
=450  \\$wnnna$a7-epi-Taxol
=450  \\$wnnna$a7 epi Taxol
=450  \\$wnnna$aAnzatax
=450  \\$wnnna$aBris Taxol
=450  \\$wnnna$aBristol-Myers Brand of Paclitaxel
=450  \\$wnnna$aBristol-Myers Squibb Brand of Paclitaxel
=450  \\$wnnna$aBull Brand of Paclitaxel
=450  \\$wnnna$aIvax Brand of Paclitaxel
=450  \\$wnnna$aLemery Brand of Paclitaxel
=450  \\$wnnna$aNSC-125973
=450  \\$wnnna$aNSC 125973
=450  \\$wnnna$aNSC125973
=450  \\$wnnna$aOnxol
=450  \\$wnnna$aPaclitaxel, (4 alpha)-Isomer
=450  \\$wnnna$aPaxene
=450  \\$wnnna$aPraxel
=450  \\$wnnna$aTaxol
=450  \\$wnnna$aTaxol A
=550  \\$wg$aTaxoids
=680  \\$iA cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.
=688  \\$a95; was TAXOL 1993-94; was TAXOL A (NM) 1977-92
=750  \0$aPaclitaxel$5IEN-M$0(DLC)sh 92003700

=LDR  01630cz  a2200445n  4500
=001  9880363994302441
=005  20141212211956.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017236
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x905.$x850
=072  \\$aF1.$x145.$x126.$x980.$x875.$x300
=072  \\$aI1.$x880.$x735.$x856.$x300
=072  \\$aN2.$x421.$x585.$x905.$x850
=150  \\$aSuicide, Assisted
=450  \\$wnnna$aAssisted Death
=450  \\$wnnna$aAssisted Deaths
=450  \\$aAssisted Suicide
=450  \\$wnnna$aAssisted Suicides
=450  \\$aDeath, Assisted
=450  \\$wnnna$aDeaths, Assisted
=450  \\$aMedically Assisted Suicide
=450  \\$wnnna$aMedically Assisted Suicides
=450  \\$aPhysician-Assisted Suicide
=450  \\$wnnna$aPhysician Assisted Suicide
=450  \\$wnnna$aPhysician-Assisted Suicides
=450  \\$wnnna$aSuicide, Medically Assisted
=450  \\$wnnna$aSuicide, Physician-Assisted
=450  \\$wnnna$aSuicides, Assisted
=450  \\$wnnna$aSuicides, Medically Assisted
=450  \\$wnnna$aSuicides, Physician-Assisted
=550  \\$wg$aSuicide
=550  \\$wg$aTerminal Care
=550  \\$aEuthanasia
=550  \\$aEuthanasia, Active
=550  \\$aEuthanasia, Active, Voluntary
=550  \\$aRight to Die
=680  \\$iProvision (by a physician or other health professional, or by a family member or friend) of support and/or means that gives a patient the power to terminate his or her own life. (from APA, Thesaurus of Psychological Index Terms, 8th ed).
=688  \\$a93
=750  \0$aAssisted suicide$5IEN-M$0(DLC)sh 91004385

=LDR  01034cz  a2200265n  4500
=001  9880363994402441
=005  20141212211953.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017228
=035  \\$aCRE2422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x420
=072  \\$aD12.$x776.$x467.$x374.$x420
=072  \\$aD23.$x529.$x374.$x420
=150  \\$aHepatocyte Growth Factor
=450  \\$wnnna$aFactor, Hepatocyte Growth
=450  \\$wnnna$aFactor, Scatter
=450  \\$wnnna$aGrowth Factor, Hepatocyte
=450  \\$aHepatopoietin
=450  \\$aHepatopoietin A
=450  \\$aScatter Factor
=550  \\$wg$aCytokines
=680  \\$iMultifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is PROTO-ONCOGENE PROTEINS C-MET.
=688  \\$a93; was HEPATOCYTE GROWTH FACTOR (NM) 1984-92 and SCATTER FACTOR (NM) 1987-92
=750  \0$aHepatocyte growth factor$5IEN-M$0(DLC)sh 92004249

=LDR  01164cz  a2200265n  4500
=001  9880363994502441
=005  20141212211952.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017221
=035  \\$aCRE2417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x100.$x550.$x100
=150  \\$aNecator americanus
=450  \\$wnnna$aamericanus, Necator
=450  \\$aHookworm, New World
=450  \\$wnnna$aHookworms, New World
=450  \\$wnnna$aNew World Hookworm
=450  \\$wnnna$aNew World Hookworms
=450  \\$wnnna$aWorld Hookworm, New
=450  \\$wnnna$aWorld Hookworms, New
=550  \\$wg$aNecator
=667  \\$aa species of intestinal hookworm; coord IM with NECATORIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA common parasite of humans in the moist tropics and subtropics. These organisms attach to villi in the small intestine and suck blood causing diarrhea, anorexia, and anemia.
=688  \\$a93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93
=750  \0$aNecator americanus$5IEN-M$0(DLC)sh 85090544

=LDR  01094cz  a2200361n  4500
=001  9880363994602441
=005  20171102155641.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017216
=035  \\$aCRE2412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x840
=072  \\$aL1.$x178.$x847.$x652
=072  \\$aN4.$x590.$x374.$x800
=150  \\$aTelemedicine
=450  \\$wnnna$aeHealth
=450  \\$wnnna$aHealth, Mobile
=450  \\$wnnna$amHealth
=450  \\$wnnna$amHealths
=450  \\$wnnna$aMobile Health
=450  \\$wnnna$aTelehealth
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aMedicine
=550  \\$wg$aTelecommunications
=550  \\$wh$aRemote Consultation
=550  \\$wh$aTelepathology
=550  \\$wh$aTeleradiology
=550  \\$wh$aTelerehabilitation
=550  \\$aTelemetry
=667  \\$anote specifics
=680  \\$iDelivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services.
=688  \\$a93
=750  \0$aTelecommunication in medicine$5IEN-M$0(DLC)sh 93009003

=LDR  01051cz  a2200265n  4500
=001  9880363994702441
=005  20141212211951.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017215
=035  \\$aCRE2411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x550
=150  \\$aSatellite Communications
=450  \\$aCommunication, Satellite
=450  \\$wnnna$aCommunications, Satellite
=450  \\$wnnna$aSatellite Communication
=450  \\$wnnna$aSatellite Telecommunication
=450  \\$wnnna$aSatellite Telecommunications
=450  \\$wnnna$aTelecommunication, Satellite
=450  \\$aTelecommunications, Satellite
=550  \\$wg$aTelecommunications
=550  \\$wh$aSatellite Imagery
=680  \\$iCommunications using an active or passive satellite to extend the range of radio, television, or other electronic transmission by returning signals to earth from an orbiting satellite.
=688  \\$a93; was see TELECOMMUNICATIONS 1985-92
=750  \0$aArtificial satellites in telecommunication$5IEN-M$0(DLC)sh 85008244

=LDR  00991cz  a2200253n  4500
=001  9880363994802441
=005  20141212211950.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017210
=035  \\$aCRE2407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x200.$x800
=150  \\$aTilapia
=450  \\$wnnna$aMozambique Tilapia
=450  \\$wnnna$aMozambique Tilapias
=450  \\$aOreochromis mossambicus
=450  \\$aTilapia mossambica
=450  \\$wnnna$aTilapia, Mozambique
=450  \\$wnnna$aTilapias, Mozambique
=550  \\$wg$aCichlids
=667  \\$aTILAPIA NILOTICA and NILE TILAPIA see CICHLIDS are also available
=680  \\$iA freshwater fish used as an experimental organism and for food. This genus of the family Cichlidae (CICHLIDS) inhabits Central and South America (one species extends north into Texas), West Indies, Africa, Madagascar, Syria, and coastal India.
=688  \\$a93
=750  \0$aTilapia$5IEN-M$0(DLC)sh 85135343

=LDR  02024cz  a2200433n  4500
=001  9880363994902441
=005  20170927145336.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017209
=035  \\$aCRE2406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x146.$x160
=150  \\$aApoptosis
=450  \\$wnnna$aApoptoses, Extrinsic Pathway
=450  \\$wnnna$aApoptoses, Intrinsic Pathway
=450  \\$wnnna$aApoptosis, Extrinsic Pathway
=450  \\$wnnna$aApoptosis, Intrinsic Pathway
=450  \\$wnnna$aExtrinsic Pathway Apoptoses
=450  \\$wnnna$aExtrinsic Pathway Apoptosis
=450  \\$wnnna$aIntrinsic Pathway Apoptoses
=450  \\$wnnna$aIntrinsic Pathway Apoptosis
=450  \\$wnnna$aProgrammed Cell Death, Type I
=550  \\$wg$aCell Death
=550  \\$wh$aAnoikis
=550  \\$wh$aEryptosis
=550  \\$wh$aPyroptosis
=550  \\$aCaspase 1
=550  \\$aCaspases
=550  \\$aCell Death
=550  \\$aCellular Apoptosis Susceptibility Protein
=550  \\$aClonal Deletion
=550  \\$aGenes, Transgenic, Suicide
=550  \\$aIn Situ Nick-End Labeling
=550  \\$aNecrosis
=550  \\$aSuperantigens
=667  \\$ado not confuse with NECROSIS, pathological cell death; unspecified probably goes here; PROGRAMMED CELL DEATH, TYPE II see AUTOPHAGY is also available
=680  \\$iOne of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
=688  \\$a93
=750  \0$aApoptosis$5IEN-M$0(DLC)sh 91000743

=LDR  01441cz  a2200301n  4500
=001  9880363995002441
=005  20141212211947.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017204
=035  \\$aCRE2401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662.$x75
=072  \\$aC16.$x131.$x77.$x95
=072  \\$aC16.$x131.$x260.$x40
=072  \\$aC16.$x320.$x180.$x40
=150  \\$aAngelman Syndrome
=450  \\$wnnna$aChildren, Puppet
=450  \\$aHappy Puppet Syndrome
=450  \\$aPuppet Children
=450  \\$wnnna$aSyndrome, Angelman
=450  \\$wnnna$aSyndrome, Happy Puppet
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aMovement Disorders
=550  \\$aIntellectual Disability
=680  \\$iA syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms (SPASMS, INFANTILE); easily provoked and prolonged paroxysms of laughter (hence "happy"); jerky puppetlike movements (hence "puppet"); continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. (From Am J Med Genet 1998 Dec 4;80(4):385-90; Hum Mol Genet 1999 Jan;8(1):129-35)
=688  \\$a93
=750  \0$aAngelman syndrome$5IEN-M$0(DLC)sh 92000322

=LDR  00738cz  a2200205n  4500
=001  9880363995102441
=005  20141212211943.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017187
=035  \\$aCRE2390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x825
=150  \\$aTylenchida
=450  \\$wnnna$aTylenchidas
=550  \\$wg$aSecernentea
=550  \\$wh$aTylenchoidea
=667  \\$aan order of nematodes in plants; transmit plant viruses
=680  \\$iAn order of nematodes consisting of many species which are plant parasites. Female worms lay eggs that hatch either in soil or in the host plant.
=688  \\$a93; was see TYLENCHOIDEA 1986-92
=750  \0$aTylenchida$5IEN-M$0(DLC)sh 85139070

=LDR  00963cz  a2200229n  4500
=001  9880363995202441
=005  20141212211943.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017186
=035  \\$aCRE2389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x922
=150  \\$aTitrimetry
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aColorimetry
=550  \\$wh$aConductometry
=550  \\$wh$aPotentiometry
=550  \\$aPhase Transition
=667  \\$aGEN & unspecified: prefer specifics; NIM
=680  \\$iThe determination of the concentration of a given component in solution (the analyte) by addition of a liquid reagent of known strength (the titrant) until an equivalence point is reached (when the reactants are present in stoichiometric proportions). Often an indicator is added to make the equivalence point visible (e.g., a change in color).
=688  \\$a93
=750  \0$aVolumetric analysis$5IEN-M$0(DLC)sh 85144332

=LDR  00931cz  a2200265n  4500
=001  9880363995302441
=005  20141212211942.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017183
=035  \\$aCRE2386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775
=150  \\$aStrongylida
=450  \\$wnnna$aStrongylidas
=550  \\$wg$aSecernentea
=550  \\$wh$aAncylostomatoidea
=550  \\$wh$aHeligmosomatoidea
=550  \\$wh$aMetastrongyloidea
=550  \\$wh$aMolineoidae
=550  \\$wh$aStrongyloidea
=550  \\$wh$aTrichostrongyloidea
=667  \\$aan order of nematodes: do not confuse with STRONGYLOIDEA, a superfamily; infection = STRONGYLIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass SECERNENTEA. Characteristics include an H-shaped excretory system with two subventral glands.
=688  \\$a93
=750  \0$aStrongylida$5IEN-M$0(DLC)sh 86003647

=LDR  00894cz  a2200193n  4500
=001  9880363995402441
=005  20141212211941.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017181
=035  \\$aCRE2384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300.$x510.$x850
=150  \\$aOnchocerca volvulus
=450  \\$wnnna$avolvulus, Onchocerca
=550  \\$wg$aOnchocerca
=667  \\$ainfection: coord IM with ONCHOCERCIASIS (IM); coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES
=680  \\$iA species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat.
=688  \\$a93
=750  \0$aOnchocerca volvulus$5IEN-M$0(DLC)sh 88021644

=LDR  01280cz  a2200253n  4500
=001  9880363995502441
=005  20141212211941.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017180
=035  \\$aCRE2383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x845.$x940
=072  \\$aC23.$x550.$x73.$x845.$x940
=150  \\$aTachycardia, Ventricular
=450  \\$wnnna$aTachycardias, Ventricular
=450  \\$aVentricular Tachycardia
=450  \\$wnnna$aVentricular Tachycardias
=550  \\$wg$aTachycardia
=550  \\$wh$aAccelerated Idioventricular Rhythm
=550  \\$wh$aTorsades de Pointes
=667  \\$ado not confuse with TACHYCARDIA, SUPRAVENTRICULAR which originates above the bundle of His
=680  \\$iAn abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
=688  \\$a93
=750  \0$aVentricular tachycardia$5IEN-M$0(DLC)sh 85142755

=LDR  00849cz  a2200217n  4500
=001  9880363995602441
=005  20141212211940.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017174
=035  \\$aCRE2377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750
=150  \\$aSpirurida
=450  \\$wnnna$aSpiruridas
=550  \\$wg$aSecernentea
=550  \\$wh$aCamallanina
=550  \\$wh$aSpirurina
=667  \\$aan order of nematodes; do not confuse with the suborder SPIRURINA or the superfamily SPIRUROIDEA; infection = SPIRURIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass SECERNENTEA. Characteristics include ventral or caudoventral papillae and an esophagus divided into anterior muscular and posterior glandular parts.
=688  \\$a93
=750  \0$aSpirurida$5IEN-M$0(DLC)sh 85126796

=LDR  00773cz  a2200229n  4500
=001  9880363995702441
=005  20141212211939.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017173
=035  \\$aCRE2376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x700.$x660.$x250.$x250
=150  \\$aCaenorhabditis elegans
=450  \\$wnnna$aCaenorhabditis elegan
=450  \\$wnnna$aelegan, Caenorhabditis
=450  \\$wnnna$aelegans, Caenorhabditis
=550  \\$wg$aCaenorhabditis
=550  \\$aCaenorhabditis elegans Proteins
=667  \\$aDF: C ELEGANS
=680  \\$iA species of nematode that is widely used in biological, biochemical, and genetic studies.
=688  \\$a93
=750  \0$aCaenorhabditis elegans$5IEN-M$0(DLC)sh 85018675

=LDR  00797cz  a2200217n  4500
=001  9880363995802441
=005  20141212211938.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017168
=035  \\$aCRE2371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x700
=150  \\$aRhabditida
=450  \\$wnnna$aRhabditidas
=550  \\$wg$aSecernentea
=550  \\$wh$aRhabdiasoidea
=550  \\$wh$aRhabditoidea
=667  \\$aan order of nematodes; do not confuse with the superfamily RHABDITOIDEA; infection = RHABDITIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by an annulated or smooth cuticle and the absence of caudal glands.
=688  \\$a93
=750  \0$aRhabditida$5IEN-M$0(DLC)sh 85113564

=LDR  00709cz  a2200205n  4500
=001  9880363995902441
=005  20141212211938.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017167
=035  \\$aCRE2370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x500
=150  \\$aOxyurida
=450  \\$wnnna$aOxyuridas
=550  \\$wg$aSecernentea
=550  \\$wh$aOxyuroidea
=667  \\$aan order of nematodes; infection = OXYURIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by a single, ventral excretory gland and a relatively stout, short body.
=688  \\$a93
=750  \0$aOxyurida$5IEN-M$0(DLC)sh 85096359

=LDR  01080cz  a2200217n  4500
=001  9880363996002441
=005  20141212211937.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017164
=035  \\$aCRE2367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x100.$x100.$x108.$x425
=150  \\$aAscaris lumbricoides
=450  \\$wnnna$aAscaris lumbricoide
=450  \\$wnnna$alumbricoide, Ascaris
=450  \\$wnnna$alumbricoides, Ascaris
=550  \\$wg$aAscaris
=667  \\$aa species of nematode, the largest found in the human intestine; infection: coord IM with ASCARIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of parasitic nematode that is the largest found in the human intestine. Its distribution is worldwide, but it is more prevalent in areas of poor sanitation. Human infection with A. lumbricoides is acquired by swallowing fully embryonated eggs from contaminated soil.
=688  \\$a93
=750  \0$aAscaris lumbricoides$5IEN-M$0(DLC)sh 85008530

=LDR  00848cz  a2200193n  4500
=001  9880363996102441
=005  20141212211936.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017163
=035  \\$aCRE2366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x100.$x100.$x75
=150  \\$aAnisakis
=450  \\$wnnna$aAnisaki
=550  \\$wg$aAscaridoidea
=667  \\$aa genus of nematodes found in marine animals & birds; infection = ANISAKIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae.
=688  \\$a93; was see NEMATODA 1989-92
=750  \2$aAnisakis$5IEN

=LDR  00758cz  a2200217n  4500
=001  9880363996202441
=005  20141212211936.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017162
=035  \\$aCRE2365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x100
=150  \\$aAscaridida
=450  \\$wnnna$aAscarididas
=550  \\$wg$aSecernentea
=550  \\$wh$aAscaridia
=550  \\$wh$aAscaridoidea
=667  \\$aan order of nematodes; do not confuse with the genus ASCARIDIA; infection = ASCARIDIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae.
=688  \\$a93
=750  \0$aAscaridida$5IEN-M$0(DLC)sh 85008527

=LDR  00882cz  a2200289n  4500
=001  9880363996302441
=005  20141212211936.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017161
=035  \\$aCRE2364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700
=150  \\$aSecernentea
=450  \\$aPhasmidia
=450  \\$wnnna$aPhasmidias
=450  \\$wnnna$aSecernenteas
=550  \\$wg$aNematoda
=550  \\$wh$aAscaridida
=550  \\$wh$aOxyurida
=550  \\$wh$aRhabditida
=550  \\$wh$aSpirurida
=550  \\$wh$aStrongylida
=550  \\$wh$aTylenchida
=667  \\$aa subclass of nematodes; infection = SECERNENTEA INFECTIONS
=680  \\$iA subclass of nematodes characterized by numerous caudal papillae and an excretory system possessing lateral canals.
=688  \\$a93
=750  \0$aSecernentea$5IEN-M$0(DLC)sh 85090709

=LDR  01206cz  a2200265n  4500
=001  9880363996402441
=005  20141212211936.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017160
=035  \\$aCRE2363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275.$x780.$x608.$x700
=150  \\$aTrichinella spiralis
=450  \\$wnnna$aspirali, Trichina
=450  \\$wnnna$aspirali, Trichinella
=450  \\$wnnna$aspiralis, Trichina
=450  \\$wnnna$aspiralis, Trichinella
=450  \\$wnnna$aTrichina spirali
=450  \\$aTrichina spiralis
=450  \\$wnnna$aTrichinella spirali
=550  \\$wg$aTrichinella
=667  \\$aa species of nematode common in rats & swine; infection: coord IM with TRICHINELLOSIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA parasite of carnivorous mammals that causes TRICHINELLOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae.
=688  \\$a93
=750  \0$aTrichinella spiralis$5IEN-M$0(DLC)sh 85137444

=LDR  00815cz  a2200229n  4500
=001  9880363996502441
=005  20141212211935.0
=008  920508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017158
=035  \\$aCRE2361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275
=150  \\$aEnoplida
=450  \\$wnnna$aEnoplidas
=550  \\$wg$aAdenophorea
=550  \\$wh$aDioctophymatoidea
=550  \\$wh$aMermithoidea
=550  \\$wh$aTrichuroidea
=667  \\$aan order of nematodes; infection = ENOPLIDA INFECTIONS
=680  \\$iAn order of nematodes of the subclass ADENOPHOREA. Its organisms commonly have a cylindrical esophagus. The superfamilies of this order are DIOCTOPHYMATOIDEA; MERMITHOIDEA; and TRICHUROIDEA.
=688  \\$a93
=750  \0$aEnoplida$5IEN-M$0(DLC)sh 85044045

=LDR  00978cz  a2200265n  4500
=001  9880363996602441
=005  20141212211934.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017155
=035  \\$aCRE2359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x312.$x500
=072  \\$aG2.$x842.$x850.$x908
=150  \\$aWettability
=450  \\$wnnna$aHygroscopicities
=450  \\$aHygroscopicity
=450  \\$wnnna$aWetabilities
=450  \\$wnnna$aWetability
=450  \\$wnnna$aWettabilities
=550  \\$wg$aHydrophobic and Hydrophilic Interactions
=550  \\$wg$aSurface Properties
=550  \\$aElectrowetting
=680  \\$iThe quality or state of being wettable or the degree to which something can be wet. This is also the ability of any solid surface to be wetted when in contact with a liquid whose surface tension is reduced so that the liquid spreads over the surface of the solid.
=688  \\$a93
=750  \0$aWetting$5IEN-M$0(DLC)sh 85146333

=LDR  01262cz  a2200289n  4500
=001  9880363996702441
=005  20141212211933.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017152
=035  \\$aCRE2356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x323.$x210
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x323.$x210
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x323.$x210
=150  \\$aAntibodies, Antiphospholipid
=450  \\$wnnna$aAntibody, Antiphospholipid
=450  \\$aAntiphospholipid Antibodies
=450  \\$wnnna$aAntiphospholipid Antibody
=550  \\$wg$aAutoantibodies
=550  \\$wh$aAntibodies, Anticardiolipin
=550  \\$wh$aLupus Coagulation Inhibitor
=550  \\$aAntibodies, Phospho-Specific
=550  \\$aPhospholipids
=667  \\$ado not coordinate with ANTIBODY FORMATION for /biosyn
=680  \\$iAutoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
=688  \\$a93
=750  \0$aPhospholipid antibodies$5IEN-M$0(DLC)sh 90002993

=LDR  01070cz  a2200337n  4500
=001  9880363996802441
=005  20141212211933.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017150
=035  \\$aCRE2354HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x795
=072  \\$aN4.$x452.$x633.$x890
=150  \\$aPublic Sector
=450  \\$wnnna$aDomain, Public
=450  \\$wnnna$aDomains, Public
=450  \\$wnnna$aEnterprise, Public
=450  \\$wnnna$aEnterprises, Public
=450  \\$aPublic Domain
=450  \\$wnnna$aPublic Domains
=450  \\$aPublic Enterprise
=450  \\$wnnna$aPublic Enterprises
=450  \\$wnnna$aPublic Sectors
=450  \\$wnnna$aSector, Public
=450  \\$wnnna$aSectors, Public
=550  \\$wg$aOwnership
=550  \\$wg$aSocial Sciences
=667  \\$aIM; specify nature of public endeavor (IM); specify geog if pertinent
=680  \\$iThe area of a nation's economy that is tax-supported and under government control.
=688  \\$a93
=750  \0$aGovernment business enterprises$5IEN-M$0(DLC)sh 85056046

=LDR  00955cz  a2200277n  4500
=001  9880363996902441
=005  20180719111143.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017149
=035  \\$aCRE2353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x791
=072  \\$aN4.$x452.$x633.$x390
=150  \\$aPrivate Sector
=450  \\$wnnna$aEnterprise, Private
=450  \\$wnnna$aEnterprises, Private
=450  \\$aPrivate Enterprise
=450  \\$wnnna$aPrivate Enterprises
=450  \\$wnnna$aSector, Private
=550  \\$wg$aOwnership
=550  \\$wg$aSocial Sciences
=550  \\$wh$aInformal Sector
=667  \\$aIM; specify nature of private endeavor (IM); specify geog if pertinent
=680  \\$iThat distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests.
=688  \\$a93
=750  \0$aFree enterprise$5IEN-M$0(DLC)sh 85073989

=LDR  01507cz  a2200349n  4500
=001  9880363997002441
=005  20141212211932.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017147
=035  \\$aCRE2351HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x159.$x175
=072  \\$aE7.$x305.$x250.$x319.$x175
=072  \\$aE7.$x695.$x175
=072  \\$aE7.$x695.$x202.$x175
=150  \\$aDefibrillators, Implantable
=450  \\$wnnna$aCardioverter-Defibrillator, Implantable
=450  \\$aCardioverter-Defibrillators, Implantable
=450  \\$wnnna$aCardioverter Defibrillators, Implantable
=450  \\$wnnna$aDefibrillator, Implantable
=450  \\$wnnna$aImplantable Cardioverter-Defibrillator
=450  \\$aImplantable Cardioverter-Defibrillators
=450  \\$wnnna$aImplantable Cardioverter Defibrillators
=450  \\$wnnna$aImplantable Defibrillator
=450  \\$aImplantable Defibrillators
=550  \\$wg$aDefibrillators
=550  \\$wg$aElectrodes, Implanted
=550  \\$wg$aProstheses and Implants
=667  \\$acoord dis with /ther, not /surg for treatment with this instrum
=680  \\$iImplantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.
=688  \\$a93
=750  \0$aImplantable cardioverter-defibrillators$5IEN-M$0(DLC)sh 94002996

=LDR  00927cz  a2200241n  4500
=001  9880363997102441
=005  20141212211931.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017146
=035  \\$aCRE2350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x670
=072  \\$aN4.$x452.$x534
=150  \\$aModels, Organizational
=450  \\$wnnna$aModel, Organizational
=450  \\$wnnna$aOrganizational Model
=450  \\$aOrganizational Models
=550  \\$wg$aModels, Theoretical
=550  \\$wg$aOrganization and Administration
=667  \\$ano qualif; TN 128: application of MODELS, THEORETICAL; DF: MODELS ORGAN
=680  \\$iTheoretical representations and constructs that describe or explain the structure and hierarchy of relationships and interactions within or between formal organizational entities or informal social groups.
=688  \\$a93
=750  \0$aOrganization$xMathematical models$5IEN-M

=LDR  00887cz  a2200253n  4500
=001  9880363997202441
=005  20141212192720.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017144
=035  \\$aCRE2348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x112
=072  \\$aL1.$x280.$x269
=072  \\$aN5.$x715.$x360.$x300.$x269
=072  \\$aN6.$x850.$x520.$x308.$x112
=150  \\$aFocus Groups
=450  \\$wnnna$aFocus Group
=450  \\$wnnna$aGroup, Focus
=450  \\$wnnna$aGroups, Focus
=550  \\$wg$aData Collection
=550  \\$aQualitative Research
=680  \\$iA method of data collection and a QUALITATIVE RESEARCH tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.
=688  \\$a93
=750  \0$aFocus groups$5IEN-M$0(DLC)sh 88002322

=LDR  00972cz  a2200241n  4500
=001  9880363997302441
=005  20141212211930.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017143
=035  \\$aCRE2347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x250
=072  \\$aK1.$x752.$x448.$x250
=072  \\$aL1.$x224.$x65.$x250
=150  \\$aFuzzy Logic
=450  \\$aLogic, Fuzzy
=550  \\$wg$aArtificial Intelligence
=550  \\$wg$aLogic
=550  \\$wg$aModels, Theoretical
=667  \\$ano qualif
=680  \\$iApproximate, quantitative reasoning that is concerned with the linguistic ambiguity which exists in natural or synthetic language. At its core are variables such as good, bad, and young as well as modifiers such as more, less, and very. These ordinary terms represent fuzzy sets in a particular problem. Fuzzy logic plays a key role in many medical expert systems.
=688  \\$a93
=750  \0$aFuzzy logic$5IEN-M$0(DLC)sh 93006704

=LDR  01705cz  a2200445n  4500
=001  9880363997402441
=005  20141212211930.0
=008  920519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017137
=035  \\$aCRE2346M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250.$x700.$x620
=072  \\$aD5.$x750.$x741.$x575
=072  \\$aD25.$x720.$x741.$x575
=072  \\$aJ1.$x637.$x51.$x720.$x741.$x575
=150  \\$aNonoxynol
=450  \\$wnnna$aAdvantage-S
=450  \\$wnnna$aAdvantage S
=450  \\$wnnna$aDelfen Cream
=450  \\$wnnna$aDelfen Creams
=450  \\$wnnna$aEmulgen 911
=450  \\$wnnna$aEmulgin 913
=450  \\$wnnna$aMertz Brand of Nonoxinol
=450  \\$wnnna$aNonoxinol
=450  \\$wnnna$aNonoxinol Mertz Brand
=450  \\$wnnna$aNonoxinols
=450  \\$wnnna$aNonoxynol, 1(4)-Sulfate, Sodium Salt
=450  \\$wnnna$aNonoxynol, 4-Sulfate, Ammonium Salt
=450  \\$wnnna$aNonoxynol-9
=450  \\$wnnna$aNonoxynol 9
=450  \\$wnnna$aNonoxynols
=450  \\$wnnna$aNonylphenoxypolyethoxyethanol
=450  \\$aNonylphenoxypolyethoxyethanols
=450  \\$wnnna$aOval, Patentex
=450  \\$wnnna$aPatentex Oval
=550  \\$wg$aPolyethylene Glycols
=680  \\$iNonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.
=688  \\$a1994 (1974)
=688  \\$a94; was NONOXYNOLS 1993; was NONOXYNOLS (NM) 1974-92
=750  \0$aNonoxynol-9$0(DLC)sh2006004801$5IEN-M

=LDR  01333cz  a2200445n  4500
=001  9880363997502441
=005  20141212211929.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017132
=035  \\$aCRE2343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x245.$x925
=072  \\$aN4.$x452.$x677.$x975
=150  \\$aWorkplace
=450  \\$wnnna$aJob Site
=450  \\$wnnna$aJob Sites
=450  \\$wnnna$aLocation, Work
=450  \\$wnnna$aLocations, Work
=450  \\$wnnna$aPlace, Work
=450  \\$wnnna$aPlaces, Work
=450  \\$wnnna$aSite, Job
=450  \\$wnnna$aSites, Job
=450  \\$wnnna$aWork Location
=450  \\$wnnna$aWork Locations
=450  \\$wnnna$aWork Place
=450  \\$wnnna$aWork Places
=450  \\$wnnna$aWork-Site
=450  \\$wnnna$aWork Site
=450  \\$wnnna$aWork-Sites
=450  \\$wnnna$aWorkplaces
=450  \\$wnnna$aWorksite
=450  \\$wnnna$aWorksites
=550  \\$wg$aEmployment
=550  \\$wg$aPersonnel Management
=550  \\$aIndustry
=550  \\$aOccupations
=667  \\$aNIM; coord with specific industry or occupation (IM) or specific milieu (as clinic, laboratory, hosp, school, etc.) (IM)
=680  \\$iPlace or physical location of work or employment.
=688  \\$a93
=750  \0$aWork environment$5IEN-M$0(DLC)sh 85148146

=LDR  00837cz  a2200241n  4500
=001  9880363997602441
=005  20141212211928.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017131
=035  \\$aCRE2342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x842
=150  \\$aThrombectomy
=450  \\$wnnna$aThrombectomies
=550  \\$wg$aVascular Surgical Procedures
=550  \\$wh$aMechanical Thrombolysis
=550  \\$aEmbolectomy
=550  \\$aThrombolytic Therapy
=550  \\$aThrombosis
=680  \\$iSurgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY.
=688  \\$a93
=750  \0$aThrombosis$xSurgery$5IEN-M$0(DLC)sh 87001040
=750  \0$aThrombophlebitis$xSurgery$5IEN-HS

=LDR  01756cz  a2200397n  4500
=001  9880363997702441
=005  20141212192720.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017130
=035  \\$aCRE2341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x50
=072  \\$aE4.$x100.$x814.$x529.$x124
=072  \\$aE4.$x502.$x382.$x124
=150  \\$aAngioplasty
=450  \\$wnnna$aAngioplasties
=450  \\$wnnna$aAngioplasty, Percutaneous Transluminal
=450  \\$aAngioplasty, Transluminal
=450  \\$aEndoluminal Repair
=450  \\$wnnna$aEndoluminal Repairs
=450  \\$aPercutaneous Transluminal Angioplasty
=450  \\$wnnna$aRepair, Endoluminal
=450  \\$wnnna$aRepairs, Endoluminal
=450  \\$wnnna$aTransluminal Angioplasty
=450  \\$wnnna$aTransluminal Angioplasty, Percutaneous
=550  \\$wg$aCatheterization
=550  \\$wg$aEndovascular Procedures
=550  \\$wh$aAngioplasty, Balloon
=550  \\$wh$aAngioplasty, Laser
=550  \\$wh$aAtherectomy
=550  \\$aEndarterectomy
=667  \\$acoordinate IM with disease / ther (IM)
=680  \\$iReconstruction or repair of a blood vessel, which includes the widening of a pathological narrowing of an artery or vein by the removal of atheromatous plaque material and/or the endothelial lining as well, or by dilatation (BALLOON ANGIOPLASTY) to compress an ATHEROMA. Except for ENDARTERECTOMY, usually these procedures are performed via catheterization as minimally invasive ENDOVASCULAR PROCEDURES.
=688  \\$a1993; for ANGIOPLASTY, TRANSLUMINAL use ANGIOPLASTY, BALLOON 1982-2010; for PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY use ANGIOPLASTY, BALLOON 1982-2010
=688  \\$a93
=750  \0$aAngioplasty$5IEN-M$0(DLC)sh 85005031

=LDR  00881cz  a2200217n  4500
=001  9880363997802441
=005  20141212211928.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017129
=035  \\$aCRE2340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x100.$x60
=072  \\$aC3.$x432.$x60
=072  \\$aC6.$x405.$x469.$x452.$x60
=150  \\$aAnisakiasis
=450  \\$wnnna$aAnisakiases
=550  \\$wg$aAscaridida Infections
=550  \\$wg$aIntestinal Diseases, Parasitic
=680  \\$iInfection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute NAUSEA; VOMITING; or penetrate into the wall of the DIGESTIVE TRACT where they give rise to EOSINOPHILIC GRANULOMA in the STOMACH; INTESTINES; or the OMENTUM.
=688  \\$a93
=750  \2$aAnisakiasis$5IEN

=LDR  00916cz  a2200229n  4500
=001  9880363997902441
=005  20141212211928.0
=008  920508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017128
=035  \\$aCRE2339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x445
=150  \\$aEmbolectomy
=450  \\$wnnna$aEmbolectomies
=550  \\$wg$aVascular Surgical Procedures
=550  \\$wh$aBalloon Embolectomy
=550  \\$aEmbolism
=550  \\$aThrombectomy
=667  \\$aremoval of an embolus transported from its origin: differentiate from THROMBECTOMY, removal of clot at its original site; do not use /util except by MeSH definition
=680  \\$iSurgical removal of an obstructing clot or foreign material which has been transported from a distant vessel by the bloodstream. Removal of a clot at its original site is called THROMBECTOMY.
=688  \\$a93
=750  \0$aEmbolism$xSurgery$5IEN-M

=LDR  01397cz  a2200409n  4500
=001  9880363998002441
=005  20141212211926.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017122
=035  \\$aCRE2333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x150.$x500.$x350
=072  \\$aB4.$x123.$x205.$x891.$x200
=072  \\$aB4.$x280.$x90.$x500.$x350
=150  \\$aBacteriophage T4
=450  \\$aBacteriophage T2
=450  \\$aColiphage T2
=450  \\$aColiphage T4
=450  \\$aEnterobacteria phage T2
=450  \\$aEnterobacteria phage T4
=450  \\$aPhage T2
=450  \\$wnnna$aPhage, T2
=450  \\$wnnna$aphage T2, Enterobacteria
=450  \\$aPhage T4
=450  \\$wnnna$aPhage, T4
=450  \\$wnnna$aPhages, T2
=450  \\$wnnna$aPhages, T4
=450  \\$wnnna$aT2, Enterobacteria phage
=450  \\$aT2 Phage
=450  \\$wnnna$aT2 Phages
=450  \\$aT4 Phage
=450  \\$wnnna$aT4 Phages
=550  \\$wg$aMyoviridae
=550  \\$wg$aT-Phages
=680  \\$iVirulent bacteriophage and type species of the genus T4-like phages, in the family MYOVIRIDAE. It infects E. coli and is the best known of the T-even phages. Its virion contains linear double-stranded DNA, terminally redundant and circularly permuted.
=688  \\$a1993; for BACTERIOPHAGE T2 use MYOVIRIDAE 1994-2001
=750  \0$aBacteriophage T4$5IEN-M$0(DLC)sh 85010878

=LDR  02449cz  a2200517n  4500
=001  9880363998102441
=005  20141212211923.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017115
=035  \\$aCRE2326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x110
=072  \\$aE2.$x148.$x442.$x110
=072  \\$aE2.$x154.$x402.$x110
=072  \\$aE4.$x14.$x170.$x402.$x110
=150  \\$aCatheter Ablation
=450  \\$wnnna$aAblation, Catheter
=450  \\$wnnna$aAblation, Electric Catheter
=450  \\$wnnna$aAblation, Electrical Catheter
=450  \\$wnnna$aAblation, Percutaneous Catheter
=450  \\$wnnna$aAblation, Radiofrequency Catheter
=450  \\$wnnna$aAblation, Transvenous Catheter
=450  \\$aAblation, Transvenous Electric
=450  \\$wnnna$aAblation, Transvenous Electrical
=450  \\$aCatheter Ablation, Electric
=450  \\$wnnna$aCatheter Ablation, Electrical
=450  \\$aCatheter Ablation, Percutaneous
=450  \\$aCatheter Ablation, Radiofrequency
=450  \\$aCatheter Ablation, Transvenous
=450  \\$wnnna$aElectric Ablation, Transvenous
=450  \\$wnnna$aElectric Catheter Ablation
=450  \\$wnnna$aElectrical Ablation, Transvenous
=450  \\$wnnna$aElectrical Catheter Ablation
=450  \\$wnnna$aPercutaneous Catheter Ablation
=450  \\$wnnna$aRadiofrequency Catheter Ablation
=450  \\$wnnna$aTransvenous Catheter Ablation
=450  \\$wnnna$aTransvenous Electric Ablation
=450  \\$wnnna$aTransvenous Electrical Ablation
=550  \\$wg$aCardiac Catheterization
=550  \\$wg$aCatheterization
=550  \\$wg$aElectrocoagulation
=550  \\$aAngioplasty, Laser
=667  \\$aremoval of tissue by electrode-fitted catheter; used often in heart surg to treat tachycardia; coord organ or dis with /surg; DF: CATH ABLATION
=680  \\$iRemoval of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.
=688  \\$a93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92
=750  \0$aCatheter ablation$5IEN-M$0(DLC)sh 93008029

=LDR  01369cz  a2200361n  4500
=001  9880363998202441
=005  20141212211922.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017111
=035  \\$aCRE2323HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x150.$x630
=150  \\$aPhodopus
=450  \\$wnnna$acampbelli, Phodopus
=450  \\$wnnna$acampbelli, Phodopus sungorus
=450  \\$wnnna$aDjungarian
=450  \\$aDjungarian Hamsters
=450  \\$wnnna$aHamster, Siberian
=450  \\$aHamsters, Djungarian
=450  \\$aHamsters, Siberian
=450  \\$aPhodopus campbelli
=450  \\$aPhodopus sungorus
=450  \\$aPhodopus sungorus campbelli
=450  \\$aSiberian Hamster
=450  \\$wnnna$aSiberian Hamsters
=450  \\$wnnna$asungorus campbelli, Phodopus
=450  \\$wnnna$asungorus campbellus, Phodopus
=450  \\$wnnna$asungorus, Phodopus
=550  \\$wg$aCricetinae
=667  \\$aNIM; when IM, qualif permitted; don't forget also check tags CRICETINAE and ANIMALS
=680  \\$iA genus of hamsters characterized by small size, very short tail, and short, broad feet with hairy soles.
=688  \\$a93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92
=750  \0$aPhodopus$5IEN-M$0(DLC)sh 87001256

=LDR  01277cz  a2200373n  4500
=001  9880363998302441
=005  20141212211918.0
=008  920508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017097
=035  \\$aCRE2313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x249.$x277.$x350
=150  \\$aElectric Impedance
=450  \\$aBioelectrical Impedance
=450  \\$wnnna$aBiolectric Impedance
=450  \\$aElectric Resistance
=450  \\$wnnna$aElectrical Impedance
=450  \\$wnnna$aElectrical Resistance
=450  \\$aImpedance
=450  \\$wnnna$aImpedance, Bioelectrical
=450  \\$wnnna$aImpedance, Biolectric
=450  \\$wnnna$aImpedance, Electric
=450  \\$wnnna$aImpedance, Electrical
=450  \\$aOhmic Resistance
=450  \\$wnnna$aOhmic Resistances
=450  \\$wnnna$aResistance, Electric
=450  \\$wnnna$aResistance, Electrical
=450  \\$wnnna$aResistance, Ohmic
=450  \\$wnnna$aResistances, Ohmic
=550  \\$wg$aElectric Conductivity
=667  \\$aNIM; bioelectric impedance anal of body composition: coord with BODY COMPOSITION
=680  \\$iThe resistance to the flow of either alternating or direct electrical current.
=688  \\$a93
=750  \0$aImpedance (Electricity)$5IEN-M$0(DLC)sh 85064610

=LDR  02671cz  a2200565n  4500
=001  9880363998402441
=005  20141212211917.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017096
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800
=072  \\$aC10.$x574.$x843
=150  \\$aPrion Diseases
=450  \\$wnnna$aDementia, Transmissible
=450  \\$aDementias, Transmissible
=450  \\$wnnna$aDisorder, Prion-Induced
=450  \\$wnnna$aDisorders, Prion-Induced
=450  \\$wnnna$aEncephalopathies, Spongiform, Transmissible
=450  \\$wnnna$aEncephalopathies, Transmissible Spongiform
=450  \\$wnnna$aEncephalopathy, Transmissible Spongiform
=450  \\$wnnna$aHuman Transmissible Spongiform Encephalopathies, Inherited
=450  \\$wnnna$aInherited Human Transmissible Spongiform Encephalopathies
=450  \\$wnnna$aPrion-Associated Disorders
=450  \\$wnnna$aPrion Disease
=450  \\$wnnna$aPrion-Induced Disorder
=450  \\$wnnna$aPrion Induced Disorder
=450  \\$wnnna$aPrion-Induced Disorders
=450  \\$wnnna$aPrion Protein Disease
=450  \\$wnnna$aPrion Protein Diseases
=450  \\$aSpongiform Encephalopathies, Transmissible
=450  \\$wnnna$aSpongiform Encephalopathy, Transmissible
=450  \\$wnnna$aTransmissible Dementia
=450  \\$aTransmissible Dementias
=450  \\$wnnna$aTransmissible Spongiform Encephalopathies
=450  \\$wnnna$aTransmissible Spongiform Encephalopathy
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wh$aCreutzfeldt-Jakob Syndrome
=550  \\$wh$aEncephalopathy, Bovine Spongiform
=550  \\$wh$aGerstmann-Straussler-Scheinker Disease
=550  \\$wh$aInsomnia, Fatal Familial
=550  \\$wh$aKuru
=550  \\$wh$aScrapie
=550  \\$wh$aWasting Disease, Chronic
=550  \\$aScrapie
=550  \\$aSlow Virus Diseases
=667  \\$aGEN or unspecified: prefer specifics
=680  \\$iA group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)
=688  \\$a1993
=750  \0$aPrion diseases$5IEN-M$0(DLC)sh 92003842

=LDR  01131cz  a2200229n  4500
=001  9880363998502441
=005  20141212211916.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017093
=035  \\$aCRE2309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x308.$x500
=150  \\$aLiver Failure
=450  \\$wnnna$aHepatic Failure
=550  \\$wg$aHepatic Insufficiency
=550  \\$wh$aEnd Stage Liver Disease
=550  \\$wh$aHepatic Encephalopathy
=550  \\$wh$aLiver Failure, Acute
=667  \\$aif coma is present, index under HEPATIC ENCEPHALOPATHY; LIVER FAILURE, ACUTE is also available
=680  \\$iSevere inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
=688  \\$a1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT use HEPATIC ENCEPHALOPATHY 1993-1999
=750  \0$aLiver$xFailure$5IEN-M$0(DLC)sh 85077759

=LDR  00732cz  a2200229n  4500
=001  9880363998602441
=005  20141212192719.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017091
=035  \\$aCRE2307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x265.$x115
=072  \\$aC6.$x405.$x469.$x158.$x188.$x115
=072  \\$aC14.$x907.$x286
=150  \\$aColitis, Ischemic
=450  \\$aIschemic Colitis
=550  \\$wg$aColitis
=550  \\$wg$aVascular Diseases
=550  \\$aMesenteric Ischemia
=680  \\$iInflammation of the COLON due to colonic ISCHEMIA resulting from alterations in systemic circulation or local vasculature.
=688  \\$a93
=750  \0$aIschemic colitis$5IEN-M$0(DLC)sh 85068339

=LDR  01943cz  a2200409n  4500
=001  9880363998702441
=005  20141212211914.0
=008  920513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017088
=035  \\$aCRE2305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x597.$x50
=072  \\$aC2.$x597.$x50
=072  \\$aC2.$x782.$x815.$x616.$x400.$x100
=072  \\$aC3.$x684.$x50
=072  \\$aC20.$x673.$x480.$x100
=150  \\$aAIDS-Related Opportunistic Infections
=450  \\$wnnna$aAIDS-Related Opportunistic Infection
=450  \\$wnnna$aAIDS Related Opportunistic Infections
=450  \\$wnnna$aHIV-Related Opportunistic Infection
=450  \\$aHIV-Related Opportunistic Infections
=450  \\$wnnna$aHIV Related Opportunistic Infections
=450  \\$wnnna$aInfection, HIV-Related Opportunistic
=450  \\$wnnna$aInfections, HIV-Related Opportunistic
=450  \\$wnnna$aOpportunistic Infection, AIDS-Related
=450  \\$wnnna$aOpportunistic Infection, HIV-Related
=450  \\$aOpportunistic Infections, AIDS-Related
=450  \\$wnnna$aOpportunistic Infections, AIDS Related
=450  \\$aOpportunistic Infections, HIV-Related
=450  \\$wnnna$aOpportunistic Infections, HIV Related
=550  \\$wg$aHIV Infections
=550  \\$wg$aOpportunistic Infections
=667  \\$acoord IM with HIV-1 or HIV-2 (IM or NIM if pertinent); coord IM with specific opportunistic infect (IM); DF: AIDS RELAT OPPORTUNISTIC INFECT
=680  \\$iOpportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
=688  \\$a93
=750  \0$81$wb$aOpportunistic infections$5IEN-M$0(DLC)sh 85095114
=750  \0$81$wb$aAIDS (Disease)$5IEN-HS$0(DLC)sh 85002541

=LDR  00822cz  a2200205n  4500
=001  9880363998802441
=005  20141212211913.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017087
=035  \\$aCRE2304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x100.$x100
=150  \\$aAnimal Rights
=450  \\$wnnna$aRights, Animal
=450  \\$aSpeciesism
=550  \\$wg$aAnimal Welfare
=667  \\$arefers to domestic, laboratory or wild animals; ANIMAL WELFARE is also available
=680  \\$iThe moral and ethical bases of the protection of animals from cruelty and abuse. The rights are extended to domestic animals, laboratory animals, and wild animals.
=688  \\$a93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92
=750  \0$aAnimal Rights$5IEN-M$0(DLC)sh 89005495

=LDR  00772cz  a2200205n  4500
=001  9880363998902441
=005  20141212211849.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017006
=035  \\$aCBM5887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x912
=072  \\$aA2.$x880.$x700
=150  \\$aRotator Cuff
=450  \\$aCuff, Rotator
=550  \\$wg$aMuscle, Skeletal
=550  \\$wg$aTendons
=680  \\$iThe musculotendinous sheath formed by the supraspinatus, infraspinatus, subscapularis, and teres minor muscles. These help stabilize the head of the HUMERUS in the glenoid fossa and allow for rotation of the SHOULDER JOINT about its longitudinal axis.
=688  \\$a92
=750  \0$aShoulder joint$xRotator cuff$5IEN-M$0(DLC)sh 86001426

=LDR  00848cz  a2200253n  4500
=001  9880363999102441
=005  20200429105630.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016999
=035  \\$aCBM5881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x900
=150  \\$aSulfur-Reducing Bacteria
=450  \\$wnnna$aSulfur Reducing Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aDesulfitobacterium
=550  \\$wh$aDesulfotomaculum
=550  \\$wh$aDesulfovibrio
=550  \\$wh$aDesulfovibrionaceae
=550  \\$wh$aDesulfuromonas
=667  \\$agram-neg anaerobic bacteria
=680  \\$iA group of gram-negative, anaerobic bacteria that is able to oxidize acetate completely to carbon dioxide using elemental sulfur as the electron acceptor.
=688  \\$a92
=750  \0$aSulfate-reducing bacteria$0(DLC)sh2009002883$5IEN-M

=LDR  00965cz  a2200277n  4500
=001  9880363999202441
=005  20141212211846.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016998
=035  \\$aCBM5880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x500
=072  \\$aB3.$x660.$x150.$x280
=150  \\$aHelicobacter
=450  \\$wnnna$aGastrospirillum
=550  \\$wg$aEpsilonproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aHelicobacter felis
=550  \\$wh$aHelicobacter heilmannii
=550  \\$wh$aHelicobacter hepaticus
=550  \\$wh$aHelicobacter mustelae
=550  \\$wh$aHelicobacter pylori
=667  \\$ainfection = HELICOBACTER INFECTIONS (IM)
=680  \\$iA genus of gram-negative, spiral-shaped bacteria that has been isolated from the intestinal tract of mammals, including humans. It has been associated with PEPTIC ULCER.
=688  \\$a1992
=750  \0$aHelicobacter$0(DLC) sh 90002592$5IEN-M

=LDR  00631cz  a2200181n  4500
=001  9880363999302441
=005  20141212211846.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016997
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x297.$x150.$x100
=072  \\$aB3.$x660.$x250.$x132.$x150.$x100
=150  \\$aCoxiella burnetii
=550  \\$wg$aCoxiella
=667  \\$ainfection = Q FEVER
=680  \\$iA species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER.
=688  \\$a92
=750  \0$aCoxiella burnetii$5IEN-M$0(DLC)sh 88023248

=LDR  00742cz  a2200193n  4500
=001  9880363999402441
=005  20141212211845.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016993
=035  \\$aCBM5875M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190.$x190.$x230.$x249
=150  \\$aChlamydophila pneumoniae
=450  \\$aChlamydia pneumoniae
=550  \\$wg$aChlamydophila
=667  \\$ainfection: coord IM with CHLAMYDOPHILA INFECTIONS (IM); index also PNEUMONIA, BACTERIAL if pertinent
=680  \\$iA species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.
=688  \\$a2001 (1992)
=750  \0$aChlamydophila pneumoniae$5IEN-M$0(DLC)sh 99000103

=LDR  00959cz  a2200241n  4500
=001  9880363999502441
=005  20180626121802.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016983
=035  \\$aCBM5865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x353.$x750.$x250.$x250
=072  \\$aB3.$x510.$x550.$x250.$x250
=150  \\$aEnterococcus
=550  \\$wg$aEnterococcaceae
=550  \\$wh$aEnterococcus faecalis
=550  \\$wh$aEnterococcus faecium
=550  \\$wh$aEnterococcus hirae
=550  \\$wh$aVancomycin-Resistant Enterococci
=667  \\$a"normal flora of the intestinal tract"; usually non-pathogenic
=680  \\$iA genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.
=688  \\$a92
=750  \0$aEnterococcus$5IEN-M$0(DLC)sh 91001166

=LDR  00659cz  a2200181n  4500
=001  9880363999602441
=005  20141212211842.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x475.$x500.$x500
=072  \\$aB3.$x510.$x400.$x500.$x500.$x400
=150  \\$aMicrococcus luteus
=550  \\$wg$aMicrococcus
=667  \\$afound on mammalian skin
=680  \\$iA species of gram-positive, spherical bacteria whose organisms occur in tetrads and in irregular clusters of tetrads. The primary habitat is mammalian skin.
=688  \\$a92
=750  \0$aMicrococcus luteus$5IEN-M$0(DLC)sh 88023285

=LDR  00836cz  a2200193n  4500
=001  9880363999702441
=005  20141212211842.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016980
=035  \\$aCBM5862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x19.$x25.$x380
=072  \\$aB3.$x660.$x250.$x17.$x25.$x380
=150  \\$aAeromonas hydrophila
=550  \\$wg$aAeromonas
=667  \\$apathogenic for frog, fish, humans & other mammals; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria that may be pathogenic for frogs, fish, and mammals, including man. In humans, cellulitis and diarrhea can result from infection with this organism.
=688  \\$a92
=750  \0$aAeromonas hydrophila$5IEN-M$0(DLC)sh 85001305

=LDR  00961cz  a2200181n  4500
=001  9880363999802441
=005  20141212211842.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016979
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x600.$x500
=072  \\$aB3.$x660.$x250.$x550.$x590.$x500
=150  \\$aPasteurella multocida
=550  \\$wg$aPasteurella
=667  \\$ainfection: coord IM with PASTEURELLA INFECTIONS (IM) or specific indentions (IM) if pertinent
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of the mouth and respiratory tract of animals and birds. It causes shipping fever (see PASTEURELLOSIS, PNEUMONIC); HEMORRHAGIC BACTEREMIA; and intestinal disease in animals. In humans, disease usually arises from a wound infection following a bite or scratch from domesticated animals.
=688  \\$a92
=750  \0$aPasteurella multocida$5IEN-M$0(DLC)sh 88023296

=LDR  00755cz  a2200193n  4500
=001  9880363999902441
=005  20141212211840.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016973
=035  \\$aCBM5855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x585.$x120
=072  \\$aB3.$x660.$x250.$x150.$x542.$x120
=150  \\$aPectobacterium carotovorum
=450  \\$aErwinia carotovora
=550  \\$wg$aPectobacterium
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease in CARROTS; and POTATO plants.
=688  \\$a2004 (1992)
=750  \0$aErwinia carotovora$5IEN-M$0(DLC)sh 88023254

=LDR  00794cz  a2200193n  4500
=001  9880364000002441
=005  20141212211840.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016972
=035  \\$aCBM5854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x275.$x200
=072  \\$aB3.$x660.$x250.$x150.$x170.$x100
=150  \\$aEnterobacter cloacae
=550  \\$wg$aEnterobacter
=667  \\$anosocomial; infection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.
=688  \\$a92
=750  \0$aEnterobacter cloacae$5IEN-M$0(DLC)sh 88023251

=LDR  00737cz  a2200205n  4500
=001  9880364000102441
=005  20141212211839.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016969
=035  \\$aCBM5851M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x350.$x875
=072  \\$aB3.$x660.$x125.$x125.$x875
=072  \\$aB3.$x900.$x350.$x875
=150  \\$aDesulfovibrio vulgaris
=550  \\$wg$aDesulfovibrio
=667  \\$ainfection: coord IM with DESULFOVIBRIONACEAE INFECTIONS (IM)
=680  \\$iA species of gram-negative, anaerobic, rod-shaped bacteria isolated from soil, animal intestines and feces, and fresh and salt water.
=688  \\$a92
=750  \0$aDesulfovibrio vulgaris$0(DLC)sh2008007340$5IEN-M

=LDR  00869cz  a2200205n  4500
=001  9880364000202441
=005  20141212211839.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016966
=035  \\$aCBM5848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x94.$x625.$x515
=072  \\$aB3.$x440.$x425.$x410.$x194.$x625.$x515
=150  \\$aPorphyromonas gingivalis
=450  \\$aBacteroides gingivalis
=550  \\$wg$aPorphyromonas
=667  \\$aisolated from human mouth; infection: coord IM with BACTEROIDACEAE INFECTIONS (IM)
=680  \\$iA species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium produces a cell-bound, oxygen-sensitive collagenase and is isolated from the human mouth.
=688  \\$a94; was BACTEROIDES GINGIVALIS 1992-93
=750  \0$aPorphyromonas gingivales$5IEN-M

=LDR  00698cz  a2200193n  4500
=001  9880364000302441
=005  20141212211837.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016962
=035  \\$aCBM5844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700.$x887.$x500
=072  \\$aB3.$x660.$x50.$x730.$x835.$x800
=150  \\$aSinorhizobium meliloti
=450  \\$aRhizobium meliloti
=550  \\$wg$aSinorhizobium
=680  \\$iA species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of sweet clover, MEDICAGO SATIVA, and fenugreek.
=688  \\$a2000(1992)
=750  \0$aRhizobium meliloti$5IEN-M$0(DLC)sh 88023317

=LDR  00682cz  a2200181n  4500
=001  9880364000402441
=005  20141212211837.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016961
=035  \\$aCBM5843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700.$x800.$x450
=072  \\$aB3.$x660.$x50.$x730.$x670.$x450
=150  \\$aRhizobium leguminosarum
=550  \\$wg$aRhizobium
=680  \\$iA species of gram-negative, aerobic bacteria that is found in soil and which causes formation of root nodules on some, but not all, types of field pea, lentil, kidney bean, and clover.
=688  \\$a92
=750  \0$aRhizobium leguminosarum$5IEN-M$0(DLC)sh 88023316

=LDR  00997cz  a2200229n  4500
=001  9880364000502441
=005  20141212211837.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016960
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700.$x24.$x50
=072  \\$aB3.$x660.$x50.$x730.$x24.$x500
=150  \\$aAgrobacterium tumefaciens
=450  \\$wnnna$aAgrobacterium radiobacter
=450  \\$aRhizobium radiobacter
=550  \\$wg$aAgrobacterium
=550  \\$aPlant Tumor-Inducing Plasmids
=680  \\$iA species of gram-negative, aerobic bacteria isolated from soil and the stems, leafs, and roots of plants. Some biotypes are pathogenic and cause the formation of PLANT TUMORS in a wide variety of higher plants. The species is a major research tool in biotechnology.
=688  \\$a2012, 1992-2003
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Rhizobium radiobacter
=688  \\$a2004 (1992)
=750  \0$aAgrobacterium tumefaciens$0(DLC) sh 88023211$5IEN-M

=LDR  00574cz  a2200181n  4500
=001  9880364000602441
=005  20141212211837.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016959
=035  \\$aCBM5841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x967.$x930.$x100
=072  \\$aB3.$x660.$x250.$x915.$x930.$x100
=150  \\$aXanthomonas campestris
=550  \\$wg$aXanthomonas
=680  \\$iA species of gram-negative, aerobic bacteria that is pathogenic for plants.
=688  \\$a92
=750  \0$aXanthomonas campestris$5IEN-M$0(DLC)sh 85148769

=LDR  00771cz  a2200193n  4500
=001  9880364000702441
=005  20141212211835.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016952
=035  \\$aCBM5834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x450.$x450.$x500
=072  \\$aB3.$x660.$x250.$x460.$x460.$x580
=150  \\$aLegionella pneumophila
=550  \\$wg$aLegionella
=667  \\$ainfection = LEGIONNAIRES' DISEASE
=680  \\$iA species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES' DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.
=688  \\$a92
=750  \0$aLegionella pneumophila$5IEN-M$0(DLC)sh 85075799

=LDR  00639cz  a2200205n  4500
=001  9880364000802441
=005  20141212211835.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016951
=035  \\$aCBM5833HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x450
=072  \\$aB3.$x660.$x250.$x460
=150  \\$aLegionellaceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aLegionella
=680  \\$iA family of gram-negative, aerobic bacteria that do not form endospores or microcysts.
=688  \\$a92
=750  \0$aLegionellaceae$5IEN-M$0(DLC)sh 91002869

=LDR  00707cz  a2200205n  4500
=001  9880364000902441
=005  20141212211834.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016949
=035  \\$aCBM5831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x708.$x100
=072  \\$aB3.$x660.$x50.$x663.$x750.$x100
=150  \\$aAzospirillum
=550  \\$wg$aRhodospirillaceae
=550  \\$wh$aAzospirillum brasilense
=550  \\$wh$aAzospirillum lipoferum
=680  \\$iA genus of gram-negative aerobic bacteria that occurs free-living in the soil or associated with the roots of cereal crops or grasses (POACEAE).
=688  \\$a92
=750  \0$aAzospirillum$5IEN-M$0(DLC)sh 85010663

=LDR  00825cz  a2200181n  4500
=001  9880364001002441
=005  20141212211834.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016948
=035  \\$aCBM5830M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x50.$x850
=072  \\$aB3.$x660.$x250.$x580.$x22.$x820
=150  \\$aAzotobacter vinelandii
=550  \\$wg$aAzotobacter
=680  \\$iA species of gram-negative, aerobic bacteria first isolated from soil in Vineland, New Jersey. Ammonium and nitrate are used as nitrogen sources by this bacterium. It is distinguished from other members of its genus by the ability to use rhamnose as a carbon source. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a92
=750  \0$aAzotobacter vinelandii$0(DLC)sh2010012345$5IEN-M

=LDR  00534cz  a2200169n  4500
=001  9880364001102441
=005  20141212211832.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016941
=035  \\$aCBM5823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x660.$x125.$x500.$x605.$x900
=150  \\$aMyxococcus xanthus
=550  \\$wg$aMyxococcus
=680  \\$iA species of gliding bacteria found on soil as well as in surface fresh water and coastal seawater.
=688  \\$a92
=750  \0$aMyxococcus xanthus$5IEN-M$0(DLC)sh 85089452

=LDR  00596cz  a2200181n  4500
=001  9880364001202441
=005  20141212211832.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016940
=035  \\$aCBM5822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x660.$x125.$x500.$x605
=150  \\$aMyxococcus
=550  \\$wg$aMyxococcales
=550  \\$wh$aMyxococcus xanthus
=680  \\$iA genus of gliding bacteria that are common inhabitants on tree bark and decomposing vegetation. The cells are slender rods with tapering ends.
=688  \\$a92
=750  \0$aMyxococcus$5IEN-M$0(DLC)sh 85089451

=LDR  00784cz  a2200205n  4500
=001  9880364001302441
=005  20141212211830.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016931
=035  \\$aCBM5813M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2.$x200.$x400
=150  \\$aHalobacteriales
=450  \\$aHalophiles, Extreme
=550  \\$wg$aEuryarchaeota
=550  \\$wh$aHalobacteriaceae
=667  \\$aan order of the kingdom of Euryarchaeota, of the domain Archaea
=680  \\$iAn order of extremely halophilic archaea, in the kingdom EURYARCHAEOTA. They occur ubiquitously in nature where the salt concentration is high, and are chemoorganotrophic, using amino acids or carbohydrates as a carbon source.
=688  \\$a92
=750  \2$aHalophilic microorganisms$5IEN-M

=LDR  01055cz  a2200241n  4500
=001  9880364001402441
=005  20141212211829.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x300.$x600
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x300.$x600
=150  \\$aMycobacterium avium subsp. paratuberculosis
=450  \\$wnnna$aMycobacterium avium paratuberculosis
=450  \\$wnnna$aMycobacterium avium subspecies paratuberculosis
=450  \\$aMycobacterium paratuberculosis
=550  \\$wg$aMycobacterium avium
=667  \\$ainfection = PARATUBERCULOSIS; DF: MYCOBACT PARATUBERC
=680  \\$iA subspecies of gram-positive, aerobic bacteria. It is the etiologic agent of Johne's disease (PARATUBERCULOSIS), a chronic GASTROENTERITIS in RUMINANTS.
=688  \\$a2008 (1992)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Mycobacterium paratuberculosis
=688  \\$a92
=750  \0$aMycobacterium avium paratuberculosis$0(DLC) sh 88023291$5IEN-M

=LDR  00922cz  a2200181n  4500
=001  9880364001502441
=005  20141212211829.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016925
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x180.$x600
=072  \\$aB3.$x510.$x460.$x400.$x400.$x200.$x600
=150  \\$aCorynebacterium pseudotuberculosis
=550  \\$wg$aCorynebacterium
=667  \\$ainfection: coord IM with CORYNEBACTERIUM INFECTIONS (IM); DF: CORYNEBACT PSEUDOTUBERC
=680  \\$iA species of gram-positive, asporogenous bacteria that was originally isolated from necrotic areas in the kidney of a sheep. It may cause ulcerative lymphangitis, abscesses, and other chronic purulent infections in sheep, horses, and other warm-blooded animals. Human disease may form from contact with infected animals.
=688  \\$a92
=750  \0$aCorynebacterium pseudotuberculosis$0(DLC)sh2008007737$5IEN-M

=LDR  00778cz  a2200241n  4500
=001  9880364001602441
=005  20170620101830.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016923
=035  \\$aCBM5805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x146
=150  \\$aCell Death
=450  \\$wnnna$aDeath, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aApoptosis
=550  \\$wh$aAutophagy
=550  \\$wh$aNecrosis
=550  \\$aCell Aging
=667  \\$aNIM; not for micro-organisms
=680  \\$iThe termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability.
=688  \\$a92; was see CELL SURVIVAL 1978-91
=750  \0$aCell death$5IEN-M$0(DLC)sh 85021644

=LDR  00682cz  a2200193n  4500
=001  9880364001802441
=005  20141212211825.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016915
=035  \\$aCBM5797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x50
=150  \\$aAIDS Vaccines
=450  \\$aHIV Vaccines
=450  \\$aVaccines, AIDS$5IEN-M
=550  \\$wg$aViral Vaccines
=680  \\$iVaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
=688  \\$a92
=750  \0$aAIDS vaccines$5IEN-M$0(DLC)sh 88007929

=LDR  01047cz  a2200181n  4500
=001  9880364001902441
=005  20141212211823.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016911
=035  \\$aCBM5793M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x132.$x150.$x500
=150  \\$aKoro
=550  \\$wg$aAnxiety, Castration
=667  \\$aa depersonalization disord; do not confuse with KURU, a neurol dis; specify ethnic group (IM) if pertinent; check tag MALE
=680  \\$iA culture-specific acute delusional syndrome occurring mostly in the Malay people and Southern Chinese. The syndrome is characterized by the individual's sudden experience of depersonalization depicted by the belief that his penis is shrinking into his abdomen and that he will die when this occurs. Although generally classified as a culture-specific syndrome, koro may be no more than a variant of castration anxiety (ANXIETY, CASTRATION) as it has been described in non-Asian patients.
=688  \\$a92
=750  \0$aKoro (Disease)$5IEN-M$0(DLC)sh 00009280

=LDR  01445cz  a2200373n  4500
=001  9880364002002441
=005  20141212211822.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016908
=035  \\$aCBM5790M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410
=150  \\$aGram-Positive Bacterial Infections
=450  \\$wnnna$aBacterial Infection, Gram-Positive
=450  \\$aBacterial Infections, Gram-Positive
=450  \\$wnnna$aBacterial Infections, Gram Positive
=450  \\$wnnna$aGram-Positive Bacterial Infection
=450  \\$wnnna$aGram Positive Bacterial Infections
=450  \\$wnnna$aInfection, Gram-Positive Bacterial
=450  \\$wnnna$aInfections, Gram-Positive Bacterial
=450  \\$wnnna$aInfections, Gram Positive Bacterial
=550  \\$wg$aBacterial Infections
=550  \\$wh$aActinomycetales Infections
=550  \\$wh$aBacillaceae Infections
=550  \\$wh$aBifidobacteriales Infections
=550  \\$wh$aClostridium Infections
=550  \\$wh$aErysipelothrix Infections
=550  \\$wh$aListeriosis
=550  \\$wh$aStaphylococcal Infections
=550  \\$wh$aStreptococcal Infections
=667  \\$aGEN: avoid; prefer specifics, DF: GRAM POS BACT INFECT
=680  \\$iInfections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
=688  \\$a92
=750  \0$aGram-positive bacterial infections$5IEN-M$0(DLC)sh 98003480

=LDR  02467cz  a2200673n  4500
=001  9880364002102441
=005  20141212211821.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016905
=035  \\$aCBM5787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400
=150  \\$aGram-Negative Bacterial Infections
=450  \\$wnnna$aBacterial Infection, Gram-Negative
=450  \\$aBacterial Infections, Gram-Negative
=450  \\$wnnna$aBacterial Infections, Gram Negative
=450  \\$wnnna$aGram-Negative Bacterial Infection
=450  \\$wnnna$aGram Negative Bacterial Infections
=450  \\$wnnna$aInfection, Gram-Negative Bacterial
=450  \\$wnnna$aInfections, Gram-Negative Bacterial
=450  \\$wnnna$aInfections, Gram Negative Bacterial
=450  \\$wnnoa$aRickettsiales Infections$5IEN-M
=550  \\$wg$aBacterial Infections
=550  \\$wh$aAliivibrio Infections
=550  \\$wh$aAnaplasmataceae Infections
=550  \\$wh$aBacteroidaceae Infections
=550  \\$wh$aBartonellaceae Infections
=550  \\$wh$aBordetella Infections
=550  \\$wh$aBorrelia Infections
=550  \\$wh$aBrucellosis
=550  \\$wh$aBurkholderia Infections
=550  \\$wh$aCampylobacter Infections
=550  \\$wh$aCat-Scratch Disease
=550  \\$wh$aChlamydiaceae Infections
=550  \\$wh$aCytophagaceae Infections
=550  \\$wh$aDesulfovibrionaceae Infections
=550  \\$wh$aEnterobacteriaceae Infections
=550  \\$wh$aFlavobacteriaceae Infections
=550  \\$wh$aFusobacteriaceae Infections
=550  \\$wh$aHelicobacter Infections
=550  \\$wh$aLegionellosis
=550  \\$wh$aLeptospirosis
=550  \\$wh$aMoraxellaceae Infections
=550  \\$wh$aMycoplasmatales Infections
=550  \\$wh$aNeisseriaceae Infections
=550  \\$wh$aPasteurellaceae Infections
=550  \\$wh$aPiscirickettsiaceae Infections
=550  \\$wh$aPseudomonas Infections
=550  \\$wh$aQ Fever
=550  \\$wh$aRat-Bite Fever
=550  \\$wh$aRickettsiaceae Infections
=550  \\$wh$aTick-Borne Diseases
=550  \\$wh$aTreponemal Infections
=550  \\$wh$aTularemia
=550  \\$wh$aVibrio Infections
=667  \\$aGEN: avoid; prefer specifics; DF: GRAM NEG BACT INFECT
=680  \\$iInfections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
=688  \\$a92
=750  \0$aGram-negative bacterial infections$5IEN$0(DLC)sh 90000831

=LDR  00793cz  a2200229n  4500
=001  9880364002202441
=005  20141212211820.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016903
=035  \\$aCBM5785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x200
=150  \\$aDrug Monitoring
=450  \\$wnnna$aDrug Monitoring, Therapeutic
=450  \\$aMonitoring, Drug
=450  \\$wnnna$aMonitoring, Therapeutic Drug
=450  \\$aTherapeutic Drug Monitoring
=550  \\$wg$aMonitoring, Physiologic
=550  \\$aPharmacovigilance
=680  \\$iThe process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
=688  \\$a92
=750  \0$aDrug monitoring$5IEN-M$0(DLC)sh 91006436

=LDR  01183cz  a2200301n  4500
=001  9880364002302441
=005  20141212211820.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016901
=035  \\$aCBM5783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x110
=072  \\$aF1.$x829.$x401.$x190
=150  \\$aIntergenerational Relations
=450  \\$wnnna$aGap, Generation
=450  \\$wnnna$aGaps, Generation
=450  \\$aGeneration Gap
=450  \\$wnnna$aGeneration Gaps
=450  \\$wnnna$aIntergenerational Relation
=450  \\$wnnna$aNest Leaving
=450  \\$wnnna$aRelation, Intergenerational
=450  \\$wnnna$aRelations, Intergenerational
=550  \\$wg$aFamily Relations
=550  \\$wg$aInterpersonal Relations
=667  \\$ainteractions between persons of different generations; not restricted to family; DF: INTERGENERAT RELAT
=680  \\$iThe interactions between individuals of different generations. These interactions include communication, caring, accountability, loyalty, and even conflict between related or non-related individuals.
=688  \\$a92
=750  \0$aIntergenerational relations$5IEN-M$0(DLC)sh 85067264

=LDR  01295cz  a2200337n  4500
=001  9880364002402441
=005  20141212211817.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016895
=035  \\$aCBM5777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x305.$x255
=072  \\$aE7.$x206.$x255
=150  \\$aCulture Media, Serum-Free
=450  \\$wnnna$aCulture Media, Serum Free
=450  \\$wnnna$aLow-Serum Media
=450  \\$wnnna$aLow Serum Media
=450  \\$wnnna$aMedia, Low-Serum
=450  \\$wnnna$aMedia, Protein-Free
=450  \\$wnnna$aMedia, Serum-Free
=450  \\$wnnna$aMedia, Serum-Free Culture
=450  \\$aProtein-Free Media
=450  \\$wnnna$aProtein Free Media
=450  \\$wnnna$aSerum-Free Culture Media
=450  \\$aSerum-Free Media
=450  \\$wnnna$aSerum Free Media
=550  \\$wg$aCulture Media
=667  \\$a"culture media free of serum proteins"; NIM; D25-26 qualif with caution
=680  \\$iCULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.
=688  \\$a92
=750  \0$aSerum-free culture media$5IEN-M$0(DLC)sh 85120335

=LDR  02656cz  a2200625n  4500
=001  9880364002502441
=005  20141212211816.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016893
=035  \\$aCBM5775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x200.$x360
=072  \\$aC14.$x907.$x137.$x230
=072  \\$aC14.$x907.$x253.$x123.$x360
=150  \\$aCarotid Stenosis
=450  \\$wnnna$aArtery Narrowing, Carotid
=450  \\$wnnna$aArtery Narrowings, Carotid
=450  \\$wnnna$aArtery Plaque, Carotid
=450  \\$wnnna$aArtery Plaques, Carotid
=450  \\$wnnna$aArtery Stenoses, Carotid
=450  \\$wnnna$aArtery Stenosis, Carotid
=450  \\$aCarotid Artery Narrowing
=450  \\$wnnna$aCarotid Artery Narrowings
=450  \\$wnnna$aCarotid Artery Plaque
=450  \\$wnnna$aCarotid Artery Plaques
=450  \\$wnnna$aCarotid Artery Stenoses
=450  \\$wnnna$aCarotid Artery Stenosis
=450  \\$wnnna$aCarotid Artery Ulcerating Plaque
=450  \\$wnnna$aCarotid Stenoses
=450  \\$aCarotid Ulcer
=450  \\$wnnna$aCarotid Ulcers
=450  \\$wnnna$aCommon Carotid Artery Stenosis
=450  \\$wnnna$aExternal Carotid Artery Stenosis
=450  \\$wnnna$aInternal Carotid Artery Stenosis
=450  \\$wnnna$aNarrowing, Carotid Artery
=450  \\$wnnna$aNarrowings, Carotid Artery
=450  \\$wnnna$aPlaque, Carotid Artery
=450  \\$wnnna$aPlaque, Ulcerating, Carotid Artery
=450  \\$wnnna$aPlaques, Carotid Artery
=450  \\$wnnna$aStenoses, Carotid
=450  \\$wnnna$aStenoses, Carotid Artery
=450  \\$wnnna$aStenosis, Carotid
=450  \\$wnnna$aStenosis, Carotid Artery
=450  \\$wnnna$aStenosis, Common Carotid Artery
=450  \\$wnnna$aStenosis, External Carotid Artery
=450  \\$wnnna$aUlcer, Carotid
=450  \\$wnnna$aUlcerating Plaque, Carotid Artery
=450  \\$wnnna$aUlcers, Carotid
=550  \\$wg$aArterial Occlusive Diseases
=550  \\$wg$aCarotid Artery Diseases
=550  \\$aEndarterectomy, Carotid
=667  \\$acoordinate IM with specific carotid artery (IM)
=680  \\$iNarrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp822-3)
=688  \\$a1992
=750  \0$aCarotid artery$xStenosis$0(DLC)sh2006001225$5IEN-M

=LDR  01744cz  a2200457n  4500
=001  9880364002602441
=005  20141212211815.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016889
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418.$x948.$x585
=072  \\$aC13.$x351.$x500.$x852.$x762.$x200
=072  \\$aC13.$x351.$x937.$x418.$x875.$x200
=150  \\$aEndometrial Neoplasms
=450  \\$wnnna$aCancer, Endometrial
=450  \\$wnnna$aCancer, Endometrium
=450  \\$aCancer of Endometrium
=450  \\$wnnna$aCancer of the Endometrium
=450  \\$wnnna$aCancers, Endometrial
=450  \\$wnnna$aCancers, Endometrium
=450  \\$wnnna$aCarcinoma, Endometrial
=450  \\$wnnna$aCarcinoma of Endometrium
=450  \\$wnnna$aCarcinomas, Endometrial
=450  \\$aEndometrial Cancer
=450  \\$wnnna$aEndometrial Cancers
=450  \\$aEndometrial Carcinoma
=450  \\$wnnna$aEndometrial Carcinomas
=450  \\$wnnna$aEndometrial Neoplasm
=450  \\$wnnna$aEndometrium Cancer
=450  \\$wnnna$aEndometrium Cancers
=450  \\$wnnna$aEndometrium Carcinoma
=450  \\$wnnna$aEndometrium Carcinomas
=450  \\$wnnna$aNeoplasm, Endometrial
=450  \\$wnnna$aNeoplasms, Endometrial
=550  \\$wg$aUterine Neoplasms
=550  \\$wh$aCarcinoma, Endometrioid
=550  \\$wh$aEndometrial Stromal Tumors
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
=688  \\$a92
=750  \0$aEndometrium$xCancer$5IEN-M$0(DLC)sh 85043081

=LDR  00826cz  a2200193n  4500
=001  9880364002702441
=005  20141212211814.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016888
=035  \\$aCBM5771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x75
=150  \\$aAngiodysplasia
=450  \\$wnnna$aAngiodysplasias
=550  \\$wg$aVascular Diseases
=550  \\$wh$aGastric Antral Vascular Ectasia
=680  \\$iAcquired degenerative dilation or expansion (ectasia) of normal BLOOD VESSELS, often associated with aging. They are isolated, tortuous, thin-walled vessels and sources of bleeding. They occur most often in mucosal capillaries of the GASTROINTESTINAL TRACT leading to GASTROINTESTINAL HEMORRHAGE and ANEMIA.
=688  \\$a92
=750  \0$aBlood-vessels$xAbnormalities$5IEN-M$0(DLC)sh 85015022

=LDR  01511cz  a2200349n  4500
=001  9880364002802441
=005  20141212211814.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016887
=035  \\$aCBM5770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x647.$x110
=150  \\$aCardiopulmonary Resuscitation
=450  \\$aBasic Cardiac Life Support
=450  \\$wnnna$aCardio-Pulmonary Resuscitation
=450  \\$wnnna$aCardio Pulmonary Resuscitation
=450  \\$aCode Blue
=450  \\$aCPR
=450  \\$wnnna$aLife Support, Basic Cardiac
=450  \\$aMouth-to-Mouth Resuscitation
=450  \\$wnnna$aMouth to Mouth Resuscitation
=450  \\$wnnna$aMouth-to-Mouth Resuscitations
=450  \\$wnnna$aResuscitation, Cardio-Pulmonary
=450  \\$wnnna$aResuscitation, Cardiopulmonary
=450  \\$wnnna$aResuscitation, Mouth-to-Mouth
=450  \\$wnnna$aResuscitations, Mouth-to-Mouth
=550  \\$wg$aResuscitation
=550  \\$wh$aAdvanced Cardiac Life Support
=550  \\$aHeart Arrest
=680  \\$iThe artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE.
=688  \\$a92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91
=750  \0$aCPR (First aid)$5IEN$0(DLC)sh 85033691

=LDR  01373cz  a2200349n  4500
=001  9880364002902441
=005  20141212211812.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016883
=035  \\$aCBM5767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x76.$x176.$x652.$x500
=072  \\$aC18.$x452.$x394.$x750.$x535
=072  \\$aC19.$x246.$x99.$x812
=150  \\$aDiabetic Ketoacidosis
=450  \\$wnnna$aAcidoses, Diabetic
=450  \\$aAcidosis, Diabetic
=450  \\$wnnna$aDiabetic Acidoses
=450  \\$aDiabetic Acidosis
=450  \\$wnnna$aDiabetic Ketoacidoses
=450  \\$wnnna$aDiabetic Ketoses
=450  \\$aDiabetic Ketosis
=450  \\$wnnna$aKetoacidoses, Diabetic
=450  \\$aKetoacidosis, Diabetic
=450  \\$wnnna$aKetoses, Diabetic
=450  \\$aKetosis, Diabetic
=550  \\$wg$aDiabetes Complications
=550  \\$wg$aDiabetes Mellitus
=550  \\$wg$aKetosis
=680  \\$iA life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
=688  \\$a92; KETOSIS, DIABETIC was heading 1975-91 (see under ACIDOSIS, DIABETIC 1975-90); ACIDOSIS, DIABETIC was heading 1966-91
=750  \0$aDiabetic acidosis$5IEN$0(DLC)sh 85037467

=LDR  00822cz  a2200253n  4500
=001  9880364003002441
=005  20141212211811.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016881
=035  \\$aCBM5765M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x617
=150  \\$aMicrosporidiosis
=450  \\$wnnna$aInfection, Microspora
=450  \\$wnnna$aInfections, Microspora
=450  \\$wnnna$aMicrospora Infection
=450  \\$aMicrospora Infections
=450  \\$wnnna$aMicrosporidioses
=550  \\$wg$aMycoses
=550  \\$wh$aEncephalitozoonosis
=667  \\$ado not confuse with Microsporum infections, one of the DERMATOMYCOSES (see note at MICROSPORUM)
=680  \\$iInfections with FUNGI of the phylum MICROSPORIDIA.
=688  \\$a1992
=750  \0$aMicrosporidiosis$5IEN-M$0(DLC)sh 98006832

=LDR  01116cz  a2200217n  4500
=001  9880364003102441
=005  20170628105248.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016880
=035  \\$aCBM5764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x590.$x40
=072  \\$aG2.$x50
=150  \\$aAnisotropy
=450  \\$wnnna$aAnisotropies
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aOptical Phenomena
=667  \\$aNIM; no qualif; coord with specific determinative technique (IM or NIM) like NMR; MRI; CRYSTALLOGRAPHY; etc.
=680  \\$iA physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions.
=688  \\$a92
=750  \0$aAnistropy$5IEN-M

=LDR  00811cz  a2200253n  4500
=001  9880364003202441
=005  20141212211810.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016877
=035  \\$aCBM5761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x642
=072  \\$aD27.$x888.$x569.$x540
=150  \\$aOxidants
=450  \\$wnnna$aAgents, Oxidizing
=450  \\$aOxidizing Agents
=550  \\$wg$aNoxae
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aBleaching Agents
=550  \\$wh$aOxidants, Photochemical
=550  \\$aOxidation-Reduction
=680  \\$iElectron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION).
=688  \\$a92
=750  \0$aOxidizing agents$5IEN-M$0(DLC)sh 85096316

=LDR  01829cz  a2200481n  4500
=001  9880364003302441
=005  20141212211809.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016876
=035  \\$aCBM5760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x552.$x33.$x690
=072  \\$aD25.$x58.$x520
=072  \\$aD25.$x339.$x208.$x720
=072  \\$aJ1.$x637.$x51.$x58.$x520
=072  \\$aJ1.$x637.$x51.$x339.$x208.$x720
=150  \\$aMetal Ceramic Alloys
=450  \\$wnnna$aAlloy, Metal Ceramic
=450  \\$wnnna$aAlloy, Metallo-Ceramic
=450  \\$wnnna$aAlloy, Metalloceramic
=450  \\$wnnna$aAlloys, Metal Ceramic
=450  \\$wnnna$aAlloys, Metallo-Ceramic
=450  \\$wnnna$aAlloys, Metalloceramic
=450  \\$wnnna$aAlloys, Porcelain-Metal
=450  \\$aDental ceramic metals$5IEN-M
=450  \\$wnnna$aMetal Ceramic Alloy
=450  \\$aMetal Ceramic Restorations
=450  \\$wnnna$aMetallo-Ceramic Alloy
=450  \\$wnnna$aMetallo Ceramic Alloy
=450  \\$aMetallo-Ceramic Alloys
=450  \\$wnnna$aMetallo Ceramic Alloys
=450  \\$wnnna$aMetalloceramic Alloy
=450  \\$wnnna$aMetalloceramic Alloys
=450  \\$aPorcelain-Metal Alloys
=450  \\$wnnna$aPorcelain Metal Alloys
=450  \\$wnnna$aRestorations, Metal Ceramic
=550  \\$wg$aAlloys
=550  \\$wg$aDental Alloys
=550  \\$wh$aCermet Cements
=667  \\$aa dental alloy; D25-26 qualif; specify metals (IM or NIM) if particularly discussed
=680  \\$iThe fusion of ceramics (porcelain) to an alloy of two or more metals for use in restorative and prosthodontic dentistry. Examples of metal alloys employed include cobalt-chromium, gold-palladium, gold-platinum-palladium, and nickel-based alloys.
=688  \\$a92
=750  \0$aDental ceramic metals$5IEN-M$0(DLC)sh 85036880

=LDR  00894cz  a2200205n  4500
=001  9880364003402441
=005  20141212211808.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016873
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x54.$x160
=072  \\$aC1.$x252.$x400.$x825.$x200
=150  \\$aEhrlichiosis
=450  \\$wnnna$aEhrlichioses
=550  \\$wg$aAnaplasmataceae Infections
=550  \\$wg$aTick-Borne Diseases
=550  \\$wh$aHeartwater Disease
=680  \\$iA tick-borne disease characterized by FEVER; HEADACHE; myalgias; ANOREXIA; and occasionally RASH. It is caused by several bacterial species and can produce disease in DOGS; CATTLE; SHEEP; GOATS; HORSES; and humans. The primary species causing human disease are EHRLICHIA CHAFFEENSIS; ANAPLASMA PHAGOCYTOPHILUM; and Ehrlichia ewingii.
=688  \\$a92
=750  \0$aEhrlichiosis$5IEN-M$0(DLC)sh 90000733

=LDR  00658cz  a2200217n  4500
=001  9880364003502441
=005  20141212211807.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016868
=035  \\$aCBM5752HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x850
=150  \\$aSerratia Infections
=450  \\$wnnna$aInfection, Serratia
=450  \\$wnnna$aInfections, Serratia
=450  \\$wnnna$aSerratia Infection
=550  \\$wg$aEnterobacteriaceae Infections
=667  \\$agram-neg bact infect
=680  \\$iInfections with bacteria of the genus SERRATIA.
=688  \\$a92
=750  \0$aSerratia diseases$5IEN-M$0(DLC)sh 85120325

=LDR  01935cz  a2200421n  4500
=001  9880364003602441
=005  20141212211805.0
=008  910718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016861
=035  \\$aCBM5745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x310
=072  \\$aD27.$x505.$x696.$x663.$x850.$x14.$x40.$x500.$x500
=072  \\$aD27.$x505.$x954.$x158.$x30.$x500
=072  \\$aD27.$x505.$x954.$x329.$x30.$x500
=150  \\$aCyclooxygenase Inhibitors
=450  \\$wnnna$aAntagonists, Prostaglandin Synthesis
=450  \\$wnnna$aCyclo-Oxygenase Inhibitors
=450  \\$wnnna$aCyclo Oxygenase Inhibitors
=450  \\$aCyclooxygenase 1$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, Cyclo-Oxygenase
=450  \\$wnnna$aInhibitors, Cyclo Oxygenase
=450  \\$wnnna$aInhibitors, Cyclooxygenase
=450  \\$wnnna$aInhibitors, Prostaglandin-Endoperoxide Synthase
=450  \\$wnnna$aInhibitors, Prostaglandin Endoperoxide Synthase
=450  \\$wnnna$aInhibitors, Prostaglandin Synthase
=450  \\$aProstaglandin Endoperoxide Synthase Inhibitors
=450  \\$aProstaglandin-Endoperoxide Synthases$xantagonists & inhibitors
=450  \\$aProstaglandin Synthase Inhibitors
=450  \\$aProstaglandin Synthesis Antagonists
=550  \\$wg$aAnti-Inflammatory Agents, Non-Steroidal
=550  \\$wg$aEnzyme Inhibitors
=550  \\$wh$aCyclooxygenase 2 Inhibitors
=550  \\$aProstaglandin Antagonists
=667  \\$aDF: CYCLOOXYGENASE INHIB
=680  \\$iCompounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.
=688  \\$a92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94
=750  \0$aCyclooxygenases$xInhibitors$0(IEN)4198412$5IEN-M

=LDR  02410cz  a2200517n  4500
=001  9880364003702441
=005  20141212211804.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016859
=035  \\$aCBM5743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x480
=150  \\$aLipoxygenase Inhibitors
=450  \\$wnnna$a12-Lipoxygenase Inhibitors
=450  \\$wnnna$a12 Lipoxygenase Inhibitors
=450  \\$wnnna$a12-Lipoxygenase Inhibitors, Arachidonate
=450  \\$wnnna$a15-Lipoxygenase Inhibitors
=450  \\$wnnna$a15 Lipoxygenase Inhibitors
=450  \\$wnnna$a15-Lipoxygenase Inhibitors, Arachidonate
=450  \\$wnnna$a5-Lipoxygenase Inhibitors
=450  \\$wnnna$a5 Lipoxygenase Inhibitors
=450  \\$wnnna$a5-Lipoxygenase Inhibitors, Arachidonate
=450  \\$aArachidonate 12-Lipoxygenase$xantagonists & inhibitors
=450  \\$wnnna$aArachidonate 12-Lipoxygenase Inhibitors
=450  \\$wnnna$aArachidonate 12 Lipoxygenase Inhibitors
=450  \\$aArachidonate 15-Lipoxygenase$xantagonists & inhibitors
=450  \\$aArachidonate 15-Lipoxygenase$xantagonosts & inhibitors$5IEN-M
=450  \\$wnnna$aArachidonate 15-Lipoxygenase Inhibitors
=450  \\$wnnna$aArachidonate 15 Lipoxygenase Inhibitors
=450  \\$aArachidonate 5-Lipoxygenase$xantagonists & inhibitors
=450  \\$wnnna$aArachidonate 5-Lipoxygenase Inhibitors
=450  \\$wnnna$aArachidonate 5 Lipoxygenase Inhibitors
=450  \\$wnnna$aInhibitors, 12-Lipoxygenase
=450  \\$wnnna$aInhibitors, 15-Lipoxygenase
=450  \\$wnnna$aInhibitors, 5-Lipoxygenase
=450  \\$wnnna$aInhibitors, Arachidonate 12-Lipoxygenase
=450  \\$wnnna$aInhibitors, Arachidonate 15-Lipoxygenase
=450  \\$wnnna$aInhibitors, Arachidonate 5-Lipoxygenase
=450  \\$wnnna$aInhibitors, Lipoxygenase
=450  \\$aLipoxygenase$xanatagonists & inhibitors$5IEN-M
=450  \\$aLipoxygenase$xantagonists & inhibitors
=450  \\$aLipoxygenases$xantagonists & inhibitors
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.
=688  \\$a92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94
=750  \0$aLipoxygenases$xInhibitors$5IEN-M

=LDR  01239cz  a2200253n  4500
=001  9880364003802441
=005  20141212211801.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016852
=035  \\$aCBM5736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x224.$x791.$x400.$x410
=072  \\$aN6.$x230.$x150.$x360.$x260
=150  \\$aHousing for the Elderly
=450  \\$aContinuing Care Retirement Centers
=450  \\$aElderly, Housing for the$5IEN-M
=450  \\$aLife Care Centers, Retirement
=550  \\$wg$aHousing
=550  \\$aAged
=550  \\$aHomes for the Aged
=667  \\$afor the able-bodied: do not confuse with HOMES FOR THE AGED, med & nurs care for the aged sick
=680  \\$iHousing arrangements for the elderly or aged, intended to foster independent living. The housing may take the form of group homes or small apartments. It is available to the economically self-supporting but the concept includes housing for the elderly with some physical limitations. The concept should be differentiated from HOMES FOR THE AGED which is restricted to long-term geriatric facilities providing supervised medical and nursing services.
=688  \\$a92
=750  \0$aOlder people$xHousing$5IEN-M$0(DLC)sh2004005948

=LDR  00809cz  a2200217n  4500
=001  9880364003902441
=005  20141212211715.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016699
=035  \\$aCBM5593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x800.$x500
=150  \\$aTarsiidae
=450  \\$wnnna$aTarsier
=450  \\$aTarsiers
=450  \\$aTarsius
=550  \\$wg$aTarsii
=667  \\$adiseases: coordinate IM with PRIMATE DISEASES (IM)
=680  \\$iThe single family of PRIMATES in the infraorder TARSII, suborder HAPLORHINI. It is comprised of one genus, Tarsius, that inhabits southern Sumatra, Borneo, Sulawesi, and the Philippines.
=688  \\$a92; TARSIIDAE & TARSIUS were see PROSIMII 1981-91
=750  \0$aTarsiers$0(DLC) sh 85132696$5IEN-M

=LDR  01190cz  a2200241n  4500
=001  9880364004002441
=005  20141212211714.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016695
=035  \\$aCBM5590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400
=150  \\$aGlycosyltransferases
=450  \\$wnnna$aGlycoside Transferases
=450  \\$wnnna$aTransferases, Glycoside
=550  \\$wg$aTransferases
=550  \\$wh$aHexosyltransferases
=550  \\$wh$aN-Acetylhexosaminyltransferases
=550  \\$wh$aPentosyltransferases
=550  \\$wh$aSialyltransferases
=680  \\$iEnzymes that catalyze the transfer of glycosyl groups to an acceptor. Most often another carbohydrate molecule acts as an acceptor, but inorganic phosphate can also act as an acceptor, such as in the case of PHOSPHORYLASES. Some of the enzymes in this group also catalyze hydrolysis, which can be regarded as transfer of a glycosyl group from the donor to water. Subclasses include the HEXOSYLTRANSFERASES; PENTOSYLTRANSFERASES; SIALYLTRANSFERASES; and those transferring other glycosyl groups. EC 2.4.
=688  \\$a92
=750  \0$aGlycosyltransferases$5IEN-M$0(DLC)sh 85055411

=LDR  01008cz  a2200205n  4500
=001  9880364004102441
=005  20141212211711.0
=008  910125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016686
=035  \\$aCBM5582M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x716.$x500
=072  \\$aD3.$x438.$x772.$x500
=150  \\$aMonocrotaline
=450  \\$wnnna$aMonocrotaline, (all-xi)-Isomer
=450  \\$wnnna$aMonocrotaline Hydrochloride (13alpha,14alpha)-Isomer
=550  \\$wg$aPyrrolizidine Alkaloids
=680  \\$iA pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment.
=688  \\$a92; was MONOCROTALINE (NM) 1973-91
=750  \0$aMonocrotaline$0(DLC)sh2005000094$5IEN-M

=LDR  01451cz  a2200373n  4500
=001  9880363388902441
=005  20141212201628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005720
=035  \\$aCAZ8871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x300
=072  \\$aG1.$x750.$x250.$x300
=072  \\$aG1.$x750.$x750.$x400
=150  \\$aGamma Rays
=450  \\$wnnna$aGamma Radiation
=450  \\$wnnna$aGamma Radiations
=450  \\$wnnna$aGamma Ray
=450  \\$wnnna$aNuclear X-Ray
=450  \\$wnnna$aNuclear X-Rays
=450  \\$wnnna$aNuclear X Rays
=450  \\$wnnna$aRadiation, Gamma
=450  \\$wnnna$aRadiations, Gamma
=450  \\$wnnna$aRay, Gamma
=450  \\$wnnna$aRays, Gamma
=450  \\$wnnna$aX-Ray, Nuclear
=450  \\$wnnna$aX-Rays, Nuclear
=450  \\$wnnna$aX Rays, Nuclear
=550  \\$wg$aElectromagnetic Radiation
=550  \\$wg$aRadiation, Ionizing
=667  \\$aIM: Manual 28.10.2
=680  \\$iPenetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source.
=688  \\$a91(75); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75
=750  \0$aGamma rays$5IEN$0(DLC)sh 85052990

=LDR  01677cz  a2200277n  4500
=001  9880363389002441
=005  20141212201628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005719
=035  \\$aCAZ8870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x397
=072  \\$aD12.$x776.$x124.$x790.$x651.$x397
=072  \\$aD12.$x776.$x377.$x715.$x548.$x397
=150  \\$agamma-Globulins
=450  \\$wnnna$agamma-Globulin
=450  \\$wnnna$agamma Globulin
=450  \\$wnnna$agamma Globulins
=550  \\$wg$aImmunoglobulins
=550  \\$wh$aTuftsin
=667  \\$a/defic = AGAMMAGLOBULINEMIA or DYSGAMMAGLOBULINEMIA; index under IMMUNIZATION, PASSIVE for therapy with gamma-globulins in general or unspecified; anti-gamma globulin antibodies = ANTI-ANTIBODIES (IM) + GAMMA-GLOBULINS (IM); gammopathies: coordinate GAMMA-GLOBULINS (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA, follow text
=680  \\$iSerum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.
=688  \\$a1996 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Gamma-Globulins
=688  \\$a75; was GAMMA GLOBULIN 1963-74; /deficiency was GAMMA GLOBULIN DEFICIENCY see under AGAMMAGLOBULINEMIA 1963-67; IMMUNE SERUM GLOBULIN was heading 1965
=750  \0$aGamma globulins$0(DLC) sh 85052979$5IEN

=LDR  00835cz  a2200241n  4500
=001  9880363389102441
=005  20141212201627.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005718
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x650
=072  \\$aG8.$x686.$x785.$x760.$x310
=150  \\$aGametogenesis
=450  \\$wnnna$aGametogeneses
=550  \\$wg$aCell Differentiation
=550  \\$wg$aReproduction
=550  \\$wh$aGametogenesis, Plant
=550  \\$wh$aOogenesis
=550  \\$wh$aSpermatogenesis
=667  \\$aGAMETOGENESIS, PLANT is also available
=680  \\$iThe process of germ cell development from the primordial GERM CELLS to the mature haploid GAMETES: ova in the female (OOGENESIS) or sperm in the male (SPERMATOGENESIS).
=688  \\$a1985
=750  \0$aGametogenesis$5IEN$0(DLC)sh 85052974

=LDR  00992cz  a2200229n  4500
=001  9880363389202441
=005  20161115131739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005716
=035  \\$aCAZ8866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG17.$x388
=150  \\$aGame Theory
=450  \\$wnnna$aGame Theories
=450  \\$wnnna$aTheories, Game
=450  \\$wnnna$aTheory, Game
=550  \\$wg$aMathematical Concepts
=550  \\$aOperations Research
=667  \\$ano qualif
=680  \\$iTheoretical construct used in applied mathematics to analyze certain situations in which there is an interplay between parties that may have similar, opposed, or mixed interests. In a typical game, decision-making "players," who each have their own goals, try to gain advantage over the other parties by anticipating each other's decisions; the game is finally resolved as a consequence of the players' decisions.
=688  \\$a1969
=750  \0$aGame theory$5IEN$0(DLC)sh 85052941

=LDR  00949cz  a2200265n  4500
=001  9880363389302441
=005  20160428152454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005715
=035  \\$aCAZ8865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x722.$x408
=072  \\$aF3.$x250.$x400
=150  \\$aGambling
=450  \\$wnnna$aGambling, Pathologic
=450  \\$wnnna$aGambling, Pathological
=450  \\$wnnna$aGamblings
=450  \\$wnnna$aGamblings, Pathological
=450  \\$aPathological Gambling
=450  \\$wnnna$aPathological Gamblings
=550  \\$wg$aDisruptive, Impulse Control, and Conduct Disorders
=550  \\$wg$aRisk-Taking
=680  \\$iAn activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.
=688  \\$a91(79)68; was see under RISK-TAKING 1979-90; was heading 1968-78
=750  \0$aGambling$5IEN$0(DLC)sh 85052909

=LDR  01518cz  a2200433n  4500
=001  9880363389402441
=005  20141212201626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005712
=035  \\$aCAZ8862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x702.$x315
=072  \\$aF4.$x669.$x332
=072  \\$aG7.$x265.$x337.$x249
=072  \\$aG7.$x700.$x240.$x249
=072  \\$aG13.$x750.$x829.$x320
=150  \\$aGalvanic Skin Response
=450  \\$wnnna$aConductance, Skin Electric
=450  \\$wnnna$aConductances, Skin Electric
=450  \\$aElectric Conductance, Skin
=450  \\$wnnna$aElectric Conductances, Skin
=450  \\$aElectrodermal Response
=450  \\$wnnna$aElectrodermal Responses
=450  \\$wnnna$aGalvanic Skin Responses
=450  \\$wnnna$aPsychogalvanic Reflex
=450  \\$aReflex, Psychogalvanic
=450  \\$wnnna$aResponse, Electrodermal
=450  \\$wnnna$aResponse, Galvanic Skin
=450  \\$wnnna$aResponses, Electrodermal
=450  \\$wnnna$aResponses, Galvanic Skin
=450  \\$aSkin Electric Conductance
=450  \\$wnnna$aSkin Response, Galvanic
=450  \\$wnnna$aSkin Responses, Galvanic
=550  \\$wg$aElectrophysiological Processes
=550  \\$wg$aPsychological Techniques
=550  \\$wg$aReflex
=550  \\$wg$aSkin Physiological Processes
=680  \\$iA change in electrical resistance of the skin, occurring in emotion and in certain other conditions.
=750  \0$aGalvanic skin response$5IEN$0(DLC)sh 85052883

=LDR  01257cz  a2200349n  4500
=001  9880363389502441
=005  20141212201625.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005711
=035  \\$aCAZ8861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x953.$x395
=150  \\$aGallopamil
=450  \\$wnnna$aAbbott Brand of Gallopamil Hydrochloride
=450  \\$wnnna$abetapharm Brand of Gallopamil Hydrochloride
=450  \\$wnnna$act-Arzneimittel Brand of Gallopamil Hydrochloride
=450  \\$wnnna$act Arzneimittel Brand of Gallopamil Hydrochloride
=450  \\$wnnna$aD-600
=450  \\$wnnna$aD 600
=450  \\$wnnna$aD600
=450  \\$wnnna$aElgiprona
=450  \\$wnnna$aGallobeta
=450  \\$wnnna$aGallopamil Hydrochloride
=450  \\$wnnna$agallopamil von ct
=450  \\$wnnna$aHydrochloride, Gallopamil
=450  \\$aMethoxyverapamil
=450  \\$wnnna$aPrebet
=450  \\$wnnna$aProcorum
=550  \\$wg$aVerapamil
=680  \\$iCoronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.
=688  \\$a87(84); was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83
=750  \0$aGallopamil$5IEN$0(DLC)sh 85052864

=LDR  00683cz  a2200217n  4500
=001  9880363389602441
=005  20141212201625.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005709
=035  \\$aCAZ8859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x360
=150  \\$aGallium Isotopes
=450  \\$wnnna$aIsotopes, Gallium
=550  \\$wg$aIsotopes
=550  \\$wh$aGallium Radioisotopes
=550  \\$aGallium
=667  \\$aGa-71; NIM
=680  \\$iStable gallium atoms that have the same atomic number as the element gallium, but differ in atomic weight. Ga-71 is a stable gallium isotope.
=688  \\$a75
=750  \0$aGallium$xIsotopes$5IEN$0(DLC)sh 85052850

=LDR  00579cz  a2200181n  4500
=001  9880363389702441
=005  20141212201624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005708
=035  \\$aCAZ8858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x289
=072  \\$aD1.$x552.$x544.$x289
=150  \\$aGallium
=550  \\$wg$aMetals, Heavy
=680  \\$iA rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.
=750  \0$aGallium$5IEN-M$0(DLC)sh 85052848
=750  \0$aGallium compounds$5IEN-HS$0(DLC)sh 85052856

=LDR  00880cz  a2200241n  4500
=001  9880363389802441
=005  20141212201624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005707
=035  \\$aCAZ8857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x300.$x200
=072  \\$aD2.$x241.$x511.$x390.$x200
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x200
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x200
=150  \\$aGallic Acid
=450  \\$wnnna$a3,4,5-Trihydroxybenzoic Acid
=450  \\$wnnna$aAcid, Gallic
=550  \\$wg$aHydroxybenzoates
=550  \\$wh$aHydrolyzable Tannins
=550  \\$wh$aPropyl Gallate
=680  \\$iA colorless or slightly yellow crystalline compound obtained from nutgalls. It is used in photography, pharmaceuticals, and as an analytical reagent.
=750  \0$aGallic acid$5IEN$0(DLC)sh 85052839

=LDR  01366cz  a2200409n  4500
=001  9880363389902441
=005  20141212201624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005706
=035  \\$aCAZ8856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x120.$x401
=072  \\$aC6.$x130.$x320.$x401
=072  \\$aC6.$x130.$x564.$x401
=072  \\$aC6.$x301.$x120.$x401
=150  \\$aGallbladder Neoplasms
=450  \\$wnnna$aBladder Cancer, Gall
=450  \\$wnnna$aBladder Cancers, Gall
=450  \\$wnnna$aCancer, Gall Bladder
=450  \\$wnnna$aCancer, Gallbladder
=450  \\$aCancer of Gallbladder
=450  \\$wnnna$aCancer of the Gallbladder
=450  \\$wnnna$aCancers, Gall Bladder
=450  \\$wnnna$aCancers, Gallbladder
=450  \\$wnnna$aGall Bladder Cancer
=450  \\$wnnna$aGall Bladder Cancers
=450  \\$aGallbladder Cancer
=450  \\$wnnna$aGallbladder Cancers
=450  \\$wnnna$aGallbladder Neoplasm
=450  \\$wnnna$aNeoplasm, Gallbladder
=450  \\$wnnna$aNeoplasms, Gallbladder
=550  \\$wg$aBiliary Tract Neoplasms
=550  \\$wg$aGallbladder Diseases
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the gallbladder.
=750  \0$aGallbladder$xCancer$5IEN-M$0(DLC)sh2010009171
=750  \0$aGallbladder$xTumors$5IEN-M$0(IEN)368419

=LDR  01179cz  a2200313n  4500
=001  9880363390002441
=005  20141212201623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005705
=035  \\$aCAZ8855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x564
=150  \\$aGallbladder Diseases
=450  \\$wnnna$aBladder Disease, Gall
=450  \\$wnnna$aBladder Diseases, Gall
=450  \\$wnnna$aDisease, Gall Bladder
=450  \\$wnnna$aDisease, Gallbladder
=450  \\$wnnna$aDiseases, Gall Bladder
=450  \\$wnnna$aDiseases, Gallbladder
=450  \\$wnnna$aGall Bladder Disease
=450  \\$wnnna$aGall Bladder Diseases
=450  \\$wnnna$aGallbladder Disease
=550  \\$wg$aBiliary Tract Diseases
=550  \\$wh$aCholecystitis
=550  \\$wh$aCholecystolithiasis
=550  \\$wh$aGallbladder Neoplasms
=667  \\$ainflamm dis = CHOLECYSTITIS; calculi = GALLSTONES but consider also CHOLECYSTOLITHIASIS
=680  \\$iDiseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases.
=750  \0$aGallbladder$xDiseases$5IEN$0(DLC)sh 85052805

=LDR  00840cz  a2200193n  4500
=001  9880363390102441
=005  20141212201623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005704
=035  \\$aCAZ8854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159.$x439
=150  \\$aGallbladder
=360  \\$iconsider also terms at$aCHOLECYST-
=450  \\$wnnna$aGallbladders
=550  \\$wg$aBiliary Tract
=667  \\$a/surg: consider also CHOLECYSTECTOMY & CHOLECYSTOSTOMY; calculi = GALLSTONES but consider also CHOLECYSTOLITHIASIS; inflammation = CHOLECYSTITIS
=680  \\$iA storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.
=750  \0$aGallbladder$5IEN$0(DLC)sh 85052803

=LDR  01070cz  a2200253n  4500
=001  9880363390202441
=005  20141212201622.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005701
=035  \\$aCAZ8851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x700.$x572.$x408
=150  \\$aGalago
=450  \\$wnnna$aBabies, Bush
=450  \\$wnnna$aBaby, Bush
=450  \\$aBush Babies
=450  \\$wnnna$aBush Baby
=450  \\$aEuoticus
=450  \\$wnnna$aGalagos
=550  \\$wg$aLorisidae
=667  \\$aprosimian; IM; qualif permitted
=680  \\$iA genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus.
=688  \\$a81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77
=750  \0$aGalago (Genus)$5IEN$0(DLC)sh 85052750

=LDR  00854cz  a2200217n  4500
=001  9880363390302441
=005  20141212201622.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005700
=035  \\$aCAZ8850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x400
=150  \\$aGalactosyltransferases
=550  \\$wg$aHexosyltransferases
=550  \\$wh$abeta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase
=550  \\$wh$aGanglioside Galactosyltransferase
=550  \\$wh$aLactose Synthase
=550  \\$wh$aN-Acylsphingosine Galactosyltransferase
=680  \\$iEnzymes that catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.
=688  \\$a76
=750  \0$aGalactosyltransferases$0(DLC) sh 99003605$5IEN-M

=LDR  06597cz  a2201321n  4500
=001  9880363390402441
=005  20141212201620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005693
=035  \\$aCAZ8843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x320
=072  \\$aC16.$x320.$x565.$x189.$x320
=072  \\$aC16.$x320.$x565.$x202.$x355
=072  \\$aC18.$x452.$x132.$x100.$x320
=072  \\$aC18.$x452.$x648.$x189.$x320
=072  \\$aC18.$x452.$x648.$x202.$x355
=150  \\$aGalactosemias
=450  \\$wnnna$aClassic Galactosemia
=450  \\$wnnna$aClassic Galactosemias
=450  \\$wnnna$aDeficiencies, Galactokinase
=450  \\$wnnna$aDeficiencies, Galactose-1-Phosphate Uridyltransferase
=450  \\$wnnna$aDeficiencies, Galactose-1-Phosphate Uridylyltransferase
=450  \\$wnnna$aDeficiencies, Galactose Epimerase
=450  \\$wnnna$aDeficiencies, GALE
=450  \\$wnnna$aDeficiencies, GALK
=450  \\$wnnna$aDeficiencies, GALT
=450  \\$wnnna$aDeficiencies, Hereditary Galactokinase
=450  \\$wnnna$aDeficiencies, UDP-Galactose-4-Epimerase
=450  \\$wnnna$aDeficiency Disease, Galactokinase
=450  \\$wnnna$aDeficiency Disease, Galactose-1-Phosphate Uridyl-Transferase
=450  \\$wnnna$aDeficiency Disease, Galactose 1 Phosphate Uridyl Transferase
=450  \\$wnnna$aDeficiency Disease, UDP-Galactose-4-Epimerase
=450  \\$wnnna$aDeficiency Disease, UDP Galactose 4 Epimerase
=450  \\$wnnna$aDeficiency Disease, UDPglucose 4-Epimerase
=450  \\$wnnna$aDeficiency Disease, UDPglucose 4 Epimerase
=450  \\$wnnna$aDeficiency Diseases, UDP-Galactose-4-Epimerase
=450  \\$wnnna$aDeficiency, Galactokinase
=450  \\$wnnna$aDeficiency, Galactose-1-Phosphate Uridyltransferase
=450  \\$wnnna$aDeficiency, Galactose-1-Phosphate Uridylyltransferase
=450  \\$wnnna$aDeficiency, Galactose Epimerase
=450  \\$wnnna$aDeficiency Galactosemia, Epimerase
=450  \\$wnnna$aDeficiency Galactosemias, Epimerase
=450  \\$wnnna$aDeficiency, GALE
=450  \\$wnnna$aDeficiency, GALK
=450  \\$wnnna$aDeficiency, GALT
=450  \\$wnnna$aDeficiency, Hereditary Galactokinase
=450  \\$wnnna$aDeficiency, UDP-Galactose-4-Epimerase
=450  \\$wnnna$aEpimerase Deficiency Galactosemia
=450  \\$wnnna$aEpimerase Deficiency Galactosemias
=450  \\$wnnna$aGalactokinase Deficiencies
=450  \\$wnnna$aGalactokinase Deficiencies, Hereditary
=450  \\$wnnna$aGalactokinase Deficiency
=450  \\$aGalactokinase Deficiency Disease
=450  \\$wnnna$aGalactokinase Deficiency Diseases
=450  \\$wnnna$aGalactokinase Deficiency, Hereditary
=450  \\$aGalactose-1-Phosphate Uridyl-Transferase Deficiency Disease
=450  \\$wnnna$aGalactose 1 Phosphate Uridyl Transferase Deficiency Disease
=450  \\$wnnna$aGalactose-1-Phosphate Uridyltransferase Deficiencies
=450  \\$wnnna$aGalactose-1-Phosphate Uridyltransferase Deficiency
=450  \\$wnnna$aGalactose 1 Phosphate Uridyltransferase Deficiency
=450  \\$wnnna$aGalactose-1-Phosphate Uridylyltransferase Deficiencies
=450  \\$wnnna$aGalactose-1-Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aGalactose 1 Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aGalactose Epimerase Deficiencies
=450  \\$wnnna$aGalactose Epimerase Deficiency
=450  \\$wnnna$aGalactosemia
=450  \\$wnnna$aGalactosemia 2
=450  \\$wnnna$aGalactosemia 2s
=450  \\$wnnna$aGalactosemia 3
=450  \\$wnnna$aGalactosemia 3s
=450  \\$wnnna$aGalactosemia, Classic
=450  \\$wnnna$aGalactosemia, Epimerase Deficiency
=450  \\$wnnna$aGalactosemia III
=450  \\$wnnna$aGalactosemia IIIs
=450  \\$wnnna$aGalactosemias, Classic
=450  \\$wnnna$aGalactosemias, Epimerase Deficiency
=450  \\$wnnna$aGALE Deficiencies
=450  \\$wnnna$aGALE Deficiency
=450  \\$wnnna$aGALK Deficiencies
=450  \\$wnnna$aGALK Deficiency
=450  \\$wnnna$aGALT Deficiencies
=450  \\$wnnna$aGALT Deficiency
=450  \\$wnnna$aHereditary Galactokinase Deficiencies
=450  \\$wnnna$aHereditary Galactokinase Deficiency
=450  \\$wnnna$aUDP-Galactose-4-Epimerase Deficiencies
=450  \\$wnnna$aUDP-Galactose-4-Epimerase Deficiency
=450  \\$wnnna$aUDP Galactose 4 Epimerase Deficiency
=450  \\$wnnna$aUDP-Galactose-4-Epimerase Deficiency Disease
=450  \\$wnnna$aUDP Galactose 4 Epimerase Deficiency Disease
=450  \\$wnnna$aUDP-Galactose-4-Epimerase Deficiency Diseases
=450  \\$aUDPglucose 4-Epimerase Deficiency Disease
=450  \\$wnnna$aUDPglucose 4 Epimerase Deficiency Disease
=450  \\$wnnna$aUDPGlucose Hexose-1-Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aUDPGlucose Hexose 1 Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aUridyltransferase Deficiencies, Galactose-1-Phosphate
=450  \\$wnnna$aUridyltransferase Deficiency, Galactose-1-Phosphate
=450  \\$wnnna$aUridylyltransferase Deficiencies, Galactose-1-Phosphate
=450  \\$wnnna$aUridylyltransferase Deficiency, Galactose-1-Phosphate
=450  \\$wnnna$aUTP Hexose-1-Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aUTP Hexose 1 Phosphate Uridylyltransferase Deficiency
=450  \\$wnnna$aUTP-Hexose-1-Phosphate Uridylyltransferase Deficiency Disease
=450  \\$wnnna$aUTP Hexose 1 Phosphate Uridylyltransferase Deficiency Disease
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$aGalactokinase
=550  \\$aGalactose
=550  \\$aUDPglucose 4-Epimerase
=550  \\$aUDPglucose-Hexose-1-Phosphate Uridylyltransferase
=550  \\$aUTP-Hexose-1-Phosphate Uridylyltransferase
=680  \\$iA group of inherited enzyme deficiencies which feature elevations of GALACTOSE in the blood. This condition may be associated with deficiencies of GALACTOKINASE; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; or UDPGLUCOSE 4-EPIMERASE. The classic form is caused by UDPglucose-Hexose-1-Phosphate Uridylyltransferase deficiency, and presents in infancy with FAILURE TO THRIVE; VOMITING; and INTRACRANIAL HYPERTENSION. Affected individuals also may develop MENTAL RETARDATION; JAUNDICE; hepatosplenomegaly; ovarian failure (PRIMARY OVARIAN INSUFFICIENCY); and cataracts. (From Menkes, Textbook of Child Neurology, 5th ed, pp61-3)
=688  \\$a2000(1966)
=750  \0$aGalactosemia$5IEN$0(DLC)sh 85052749

=LDR  00971cz  a2200241n  4500
=001  9880363390502441
=005  20141212201617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005690
=035  \\$aCAZ8840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x359.$x377
=150  \\$aGalactose
=450  \\$wnnna$aD-Galactose
=450  \\$wnnna$aD Galactose
=450  \\$wnnna$aGalactopyranose
=450  \\$wnnna$aGalactopyranoside
=550  \\$wg$aHexoses
=550  \\$aGalactans
=550  \\$aGalactosemias
=667  \\$a/blood: consider also GALACTOSEMIAS
=680  \\$iAn aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood.
=750  \0$aGalactose$5IEN$0(DLC)sh 85052748

=LDR  00638cz  a2200217n  4500
=001  9880363390602441
=005  20141212201616.0
=008  771215\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005685
=035  \\$aCAZ8835M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x360
=150  \\$aGalactans
=450  \\$aPolygalactoses
=550  \\$wg$aPolysaccharides
=550  \\$wh$aAgar
=550  \\$aGalactose
=667  \\$apolysaccharides
=680  \\$iPolysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages.
=688  \\$a79
=750  \0$aGalactans$5IEN-M$0(DLC)sh 00004792

=LDR  00860cz  a2200289n  4500
=001  9880363390702441
=005  20190201163320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005684
=035  \\$aCAZ8834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x250
=072  \\$aG11.$x427.$x410.$x568.$x900.$x750
=150  \\$aGait
=450  \\$wnnna$aGaits
=450  \\$wnnna$aNavigation, Stair
=450  \\$wnnna$aNavigations, Stair
=450  \\$wnnna$aStair Navigation
=450  \\$wnnna$aStair Navigations
=550  \\$wg$aPhysical Examination
=550  \\$wg$aWalking
=550  \\$wh$aWalking Speed
=550  \\$aLocomotion
=667  \\$adifferentiate from LOCOMOTION & WALKING
=680  \\$iManner or style of walking.
=750  \0$aGait disorders$5IEN-M$0(DLC)sh 85077991
=750  \0$aGait in humans$5IEN-M$0(DLC)sh 85052741

=LDR  00901cz  a2200205n  4500
=001  9880363390802441
=005  20141212201615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005682
=035  \\$aCAZ8832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x484
=072  \\$aD1.$x268.$x558.$x362.$x484
=072  \\$aD1.$x552.$x550.$x399.$x484
=150  \\$aGadolinium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Gd-158; Gd-154-157, 160 = GADOLINIUM (IM) + ISOTOPES (NIM); Gd-145-153, 159, 161 = GADOLINIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iGadolinium. An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
=750  \0$aGadolinium$5IEN-M$0(DLC)sh 85052688
=750  \0$aGadolinium earths$5IEN-HS$0(DLC)sh 85052691

=LDR  01661cz  a2200457n  4500
=001  9880363390902441
=005  20141212201615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005680
=035  \\$aCAZ8830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x500.$x350
=072  \\$aD12.$x125.$x190.$x350
=150  \\$agamma-Aminobutyric Acid
=450  \\$wnnna$a4-Aminobutanoic Acid
=450  \\$wnnna$a4 Aminobutanoic Acid
=450  \\$a4-Aminobutyric Acid
=450  \\$wnnna$a4 Aminobutyric Acid
=450  \\$wnnna$aAcid, Hydrochloride gamma-Aminobutyric
=450  \\$wnnna$aAminalon
=450  \\$wnnna$aAminalone
=450  \\$aGABA
=450  \\$wnnna$aGABA, Lithium
=450  \\$wnnna$agamma Aminobutyric Acid
=450  \\$wnnna$agamma-Aminobutyric Acid, Calcium Salt (2:1)
=450  \\$wnnna$agamma-Aminobutyric Acid, Hydrochloride
=450  \\$wnnna$agamma Aminobutyric Acid, Hydrochloride
=450  \\$wnnna$agamma-Aminobutyric Acid, Monolithium Salt
=450  \\$wnnna$agamma Aminobutyric Acid, Monolithium Salt
=450  \\$wnnna$agamma-Aminobutyric Acid, Monosodium Salt
=450  \\$wnnna$agamma Aminobutyric Acid, Monosodium Salt
=450  \\$wnnna$agamma-Aminobutyric Acid, Zinc Salt (2:1)
=450  \\$wnnna$aGammalon
=450  \\$wnnna$aHydrochloride gamma-Aminobutyric Acid
=450  \\$wnnna$aLithium GABA
=550  \\$wg$aAminobutyrates
=550  \\$wh$aBaclofen
=550  \\$wh$aVigabatrin
=680  \\$iThe most common inhibitory neurotransmitter in the central nervous system.
=688  \\$a2001(1975); use AMINOBUTYRIC ACIDS 1966-1974
=750  \0$aGABA$5IEN$0(DLC)sh 85052647

=LDR  02142cz  a2200529n  4500
=001  9880363391002441
=005  20141212201613.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005676
=035  \\$aCAZ8826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x440
=150  \\$aGravity Suits
=450  \\$aAnti-Shock Trousers
=450  \\$wnnna$aAnti Shock Trousers
=450  \\$wnnna$aAnti-Shock Trousers, Military
=450  \\$aAntigravity Suits
=450  \\$wnnna$aAntishock Trousers
=450  \\$wnnna$aAntishock Trousers, Military
=450  \\$wnno$aG Suits$5IEN-M
=450  \\$wnnna$aGravity Suit
=450  \\$aMilitary Anti-Shock Trousers
=450  \\$wnnna$aMilitary Anti Shock Trousers
=450  \\$wnnna$aMilitary Antishock Trousers
=450  \\$wnnna$aPneumatic Suit
=450  \\$aPneumatic Suits
=450  \\$wnnna$aPressure Suit
=450  \\$aPressure Suits
=450  \\$wnnna$aSuit, Antigravity
=450  \\$wnnna$aSuit, Gravity
=450  \\$wnnna$aSuit, Pneumatic
=450  \\$wnnna$aSuit, Pressure
=450  \\$wnnna$aSuits, Antigravity
=450  \\$wnnna$aSuits, Gravity
=450  \\$wnnna$aSuits, Pneumatic
=450  \\$wnnna$aSuits, Pressure
=450  \\$wnnna$aTrousers, Anti-Shock
=450  \\$wnnna$aTrousers, Antishock
=450  \\$wnnna$aTrousers, Military Anti-Shock
=450  \\$wnnna$aTrousers, Military Antishock
=550  \\$wg$aEquipment and Supplies
=550  \\$aIntermittent Pneumatic Compression Devices
=667  \\$aMAST suit (Military or Medical Anti-Shock Trousers) goes here (do not add MILITARY MEDICINE); SPACE SUITS is also available; DF: MAST
=680  \\$iDouble-layered inflatable suits which, when inflated, exert pressure on the lower part of the wearer's body. The suits are used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. The suits are also used by pilots under positive acceleration.
=688  \\$a76(75); was see under CLOTHING 1975
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a G Suits
=750  \0$aPressure suits$0(DLC) sh 85106545$5IEN-M

=LDR  00989cz  a2200241n  4500
=001  9880363391102441
=005  20141212201612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005673
=035  \\$aCAZ8823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x370.$x250
=072  \\$aB3.$x440.$x425.$x410.$x420
=150  \\$aFusobacterium
=450  \\$aSphaerophorus
=550  \\$wg$aFusobacteria
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$wh$aFusobacterium necrophorum
=550  \\$wh$aFusobacterium nucleatum
=667  \\$ainfection = FUSOBACTERIUM INFECTIONS; DF: FUSOBACT
=680  \\$iA genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections.
=688  \\$aSPHAEROPHORUS was heading 1963-76 (see under BACTEROIDACEAE 1976)
=750  \0$aFusobacterium$5IEN$0(DLC)sh 88023261

=LDR  00656cz  a2200193n  4500
=001  9880363391202441
=005  20141212201611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005670
=035  \\$aCAZ8820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x366
=150  \\$aFusarium
=450  \\$wnnna$aFusariums
=550  \\$wg$aMitosporic Fungi
=550  \\$aGibberella
=667  \\$ainfection = FUSARIOSIS
=680  \\$iA mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA.
=750  \0$aFusarium$0(DLC) sh 85052585$5IEN

=LDR  01151cz  a2200301n  4500
=001  9880363391302441
=005  20141212201610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005667
=035  \\$aCAZ8817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x868.$x820.$x270
=072  \\$aC1.$x252.$x825.$x770.$x270
=072  \\$aC1.$x539.$x800.$x720.$x770.$x270
=072  \\$aC17.$x800.$x838.$x765.$x770.$x270
=072  \\$aC22.$x362.$x224
=150  \\$aFurunculosis
=450  \\$aBoils
=450  \\$wnnna$aFuruncle
=450  \\$wnnna$aFuruncles
=450  \\$wnnna$aFurunculoses
=550  \\$wg$aFish Diseases
=550  \\$wg$aStaphylococcal Skin Infections
=550  \\$wh$aCarbuncle
=550  \\$aCarbuncle
=667  \\$aconsider also CARBUNCLE, also usually caused by Staph (but not malignant carbuncle which = ANTHRAX)
=680  \\$iA persistent skin infection marked by the presence of furuncles, often chronic and recurrent. In humans, the causative agent is various species of STAPHYLOCOCCUS. In salmonid fish (SALMONIDS), the pathogen is AEROMONAS SALMONICIDA.
=750  \0$aFurunculosis$5IEN$0(DLC)sh 85052580

=LDR  01050cz  a2200313n  4500
=001  9880363391402441
=005  20141212201609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x300
=072  \\$aD2.$x92.$x146.$x807.$x300
=072  \\$aD2.$x886.$x590.$x700.$x725.$x300
=150  \\$aFurosemide
=450  \\$wnnna$aErrolon
=450  \\$wnnna$aFrusemid
=450  \\$aFrusemide
=450  \\$wnnna$aFuranthril
=450  \\$wnnna$aFurantral
=450  \\$wnnna$aFurosemide Monohydrochloride
=450  \\$wnnna$aFurosemide Monosodium Salt
=450  \\$aFursemide
=450  \\$wnnna$aFusid
=450  \\$wnnna$aLasix
=450  \\$wnnna$aSalix (brand of furosemide)
=550  \\$wg$aSulfanilamides
=680  \\$iA benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
=688  \\$a67(65); FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91
=750  \0$aFurosemide$5IEN$0(DLC)sh 85052572

=LDR  00836cz  a2200241n  4500
=001  9880363391502441
=005  20141212201609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005664
=035  \\$aCAZ8814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x600.$x313
=072  \\$aD3.$x383.$x129.$x462.$x600.$x500
=072  \\$aD3.$x383.$x312.$x649.$x313
=150  \\$aFurazolidone
=450  \\$wnnna$aFurazol
=450  \\$wnnna$aFurazolidine
=450  \\$wnnna$aFuroxone
=450  \\$aNifurazolidone
=550  \\$wg$aNitrofurans
=550  \\$wg$aOxazolidinones
=680  \\$iA nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
=750  \0$aFurazolidone$5IEN-M$0(DLC)sh 97006431

=LDR  00910cz  a2200301n  4500
=001  9880363391602441
=005  20170103105122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x312
=150  \\$aFurans
=450  \\$aTetrahydrofurans
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$a4-Butyrolactone
=550  \\$wh$aAcetogenins
=550  \\$wh$aCitraconic Anhydrides
=550  \\$wh$aDarunavir
=550  \\$wh$aFuraldehyde
=550  \\$wh$aLasalocid
=550  \\$wh$aMaleic Anhydrides
=550  \\$wh$aMonensin
=550  \\$wh$aNafronyl
=550  \\$wh$aNigericin
=550  \\$wh$aNitrofurans
=550  \\$wh$aRanitidine
=680  \\$iCompounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran.
=750  \0$aFurans$5IEN$0(DLC)sh 85052502

=LDR  01749cz  a2200493n  4500
=001  9880363391702441
=005  20141212201608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005658
=035  \\$aCAZ8808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300
=150  \\$aFungi
=360  \\$iconsider also terms at$aMYCO-
=450  \\$wnnna$aFilamentous Fungi
=450  \\$wnnna$aFilamentous Fungus
=450  \\$aFungi, Filamentous
=450  \\$wnnna$aFungus
=450  \\$wnnna$aFungus, Filamentous
=450  \\$wnnna$aMold
=450  \\$aMolds
=450  \\$aPhycomycetes$5IEN-M
=450  \\$wnno$aZygomycota$5IEN-M
=550  \\$wg$aEukaryota
=550  \\$wh$aAgricultural Inoculants
=550  \\$wh$aAscomycota
=550  \\$wh$aBasidiomycota
=550  \\$wh$aBlastocladiomycota
=550  \\$wh$aBlood-Borne Pathogens
=550  \\$wh$aChytridiomycota
=550  \\$wh$aFungi, Unclassified
=550  \\$wh$aGlomeromycota
=550  \\$wh$aLichens
=550  \\$wh$aMicrosporidia
=550  \\$wh$aMitosporic Fungi
=550  \\$wh$aMycorrhizae
=550  \\$wh$aNeocallimastigomycota
=550  \\$wh$aYeasts
=550  \\$aAllergens
=550  \\$aFungal Proteins
=550  \\$aMicrobiology
=667  \\$aGEN or unspecified; prefer specifics: Manual 22.32; fungal dis = MYCOSES, fungal dis of skin = DERMATOMYCOSES
=680  \\$iA kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.
=750  \0$aFungi$5IEN$0(DLC)sh 85052433

=LDR  01157cz  a2200349n  4500
=001  9880363391802441
=005  20141212201607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005656
=035  \\$aCAZ8806M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x354
=150  \\$aFungal Proteins
=450  \\$aFungal Gene Products
=450  \\$aFungal Gene Proteins
=450  \\$aFungal Peptides
=450  \\$aGene Products, Fungal
=450  \\$wnnna$aGene Proteins, Fungal
=450  \\$wnnna$aPeptides, Fungal
=450  \\$wnnna$aProteins, Fungal
=450  \\$aYeast Proteins
=550  \\$wg$aProteins
=550  \\$wh$aKiller Factors, Yeast
=550  \\$wh$aMinichromosome Maintenance 1 Protein
=550  \\$wh$aSaccharomyces cerevisiae Proteins
=550  \\$wh$aSchizosaccharomyces pombe Proteins
=550  \\$aFungi
=550  \\$aYeasts
=667  \\$a/drug eff /ultrastruct permitted; /physiol permitted for function within the fungus; coord IM with specific protein (IM) + specific fungus (IM)
=680  \\$iProteins found in any species of fungus.
=688  \\$a73
=750  \0$aFungal proteins$0(DLC)sh2008002773$5IEN-M

=LDR  00946cz  a2200301n  4500
=001  9880363391902441
=005  20141212201606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005655
=035  \\$aCAZ8805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x550
=150  \\$aFuneral Rites
=450  \\$wnnna$aCustom, Mortuary
=450  \\$wnnna$aCustoms, Mortuary
=450  \\$wnnna$aFuneral Rite
=450  \\$wnnna$aMortuary Custom
=450  \\$aMortuary Customs
=450  \\$wnnna$aRite, Funeral
=450  \\$wnnna$aRites, Funeral
=550  \\$wg$aCulture
=550  \\$wh$aBurial
=550  \\$wh$aCremation
=550  \\$wh$aEmbalming
=667  \\$aspecify geog if pertinent
=680  \\$iThose customs and ceremonies pertaining to the dead.
=688  \\$a83(75); was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82
=750  \0$aFuneral rites and ceremonies$5IEN$0(DLC)sh 85052380

=LDR  00854cz  a2200169n  4500
=001  9880363392002441
=005  20141212201606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005654
=035  \\$aCAZ8804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x729.$x313
=150  \\$aFundus Oculi
=550  \\$wg$aRetina
=667  \\$ano qualif; what is seen through an ophthalmoscope: do not confuse with RETINA & RETINAL VESSELS, the correct terms with subheadings, not FUNDUS OCULI; early coord for fundus fluorescent angiography: see hist notes under FLUORESCEIN ANGIOGRAPHY
=680  \\$iThe concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aFundus oculi$5IEN$0(DLC)sh 85052375

=LDR  00768cz  a2200217n  4500
=001  9880363392102441
=005  20141212201606.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005653
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x360
=150  \\$aFund Raising
=450  \\$wnnna$aFund, Philanthropic
=450  \\$wnnna$aFunds, Philanthropic
=450  \\$wnnna$aPhilanthropic Fund
=450  \\$aPhilanthropic Funds
=550  \\$wg$aFinancial Management
=550  \\$aGift Giving
=680  \\$iUsually organized community efforts to raise money to promote financial programs of institutions. The funds may include individual gifts.
=688  \\$a91(78); was see under FINANCIAL MANAGEMENT 1978-90
=750  \0$aFund raising$5IEN$0(DLC)sh 85052363

=LDR  00554cz  a2200169n  4500
=001  9880363392202441
=005  20141212201605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005651
=035  \\$aCAZ8801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x300
=150  \\$aFumigation
=450  \\$wnnna$aFumigations
=550  \\$wg$aCommunicable Disease Control
=680  \\$iThe application of smoke, vapor, or gas for the purpose of disinfecting or destroying pests or microorganisms.
=750  \0$aFumigation$5IEN$0(DLC)sh 85052305

=LDR  00817cz  a2200217n  4500
=001  9880363392302441
=005  20141212201605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005648
=035  \\$aCAZ8798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x630.$x500
=072  \\$aN6.$x230.$x132.$x258.$x630.$x500
=150  \\$aFuel Oils
=450  \\$wnnna$aFuel Oil
=450  \\$wnnna$aOil, Fuel
=450  \\$wnnna$aOils, Fuel
=550  \\$wg$aPetroleum
=680  \\$iComplex petroleum hydrocarbons consisting mainly of residues from crude oil distillation. These liquid products include heating oils, stove oils, and furnace oils and are burned to generate energy.
=688  \\$a91(75); was see under PETROLEUM 1975-90; was in Cat J only 1975-81
=750  \0$aPetroleum as fuel$5IEN$0(DLC)sh 85100416

=LDR  00853cz  a2200169n  4500
=001  9880363392402441
=005  20141212201604.0
=008  780309\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005647
=035  \\$aCAZ8797M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x300
=150  \\$aFucosyltransferases
=550  \\$wg$aHexosyltransferases
=680  \\$iEnzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.
=688  \\$a91(79); was see under HEXOSYLTRANSFERASES 1979-90
=750  \0$aFucosyltransferases$5IEN-M$0(DLC)sh2003001143

=LDR  01564cz  a2200265n  4500
=001  9880363392502441
=005  20141212201601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005640
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x322.$x576.$x288
=072  \\$aD6.$x472.$x699.$x631.$x525.$x343.$x288
=072  \\$aD12.$x644.$x548.$x691.$x525.$x343.$x288
=150  \\$aFollicle Stimulating Hormone
=450  \\$wnnna$aFollicle-Stimulating Hormone
=450  \\$wnnna$aFollitropin
=450  \\$aFSH (Follicle Stimulating Hormone)
=550  \\$wg$aGonadotropins, Pituitary
=550  \\$wh$aFollicle Stimulating Hormone, beta Subunit
=550  \\$wh$aFollicle Stimulating Hormone, Human
=550  \\$wh$aGlycoprotein Hormones, alpha Subunit
=667  \\$afor alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT is also available; FOLLICLE STIMULATING HORMONE, HUMAN is also available
=680  \\$iA major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
=688  \\$a2002(1963)
=750  \0$aFollicle-stimulating hormone$0(DLC) sh 85050152$5IEN

=LDR  00562cz  a2200181n  4500
=001  9880363392602441
=005  20141212201601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005639
=035  \\$aCAZ8789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x405
=150  \\$aFrustration
=450  \\$wnnna$aFrustrations
=550  \\$wg$aEmotions
=667  \\$ahuman & animal; no qualif
=680  \\$iThe motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated.
=750  \0$aFrustration$5IEN$0(DLC)sh 85052192

=LDR  01223cz  a2200397n  4500
=001  9880363392702441
=005  20141212201601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005638
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x500
=072  \\$aJ2.$x500.$x562
=150  \\$aFruit
=450  \\$wnnna$aAril, Plant
=450  \\$wnnna$aArils, Plant
=450  \\$aBerries
=450  \\$wnnna$aBerry
=450  \\$wnnna$aCapsule, Plant
=450  \\$wnnna$aCapsules, Plant
=450  \\$wnnna$aFruits
=450  \\$aLegume Pod
=450  \\$wnnna$aLegume Pods
=450  \\$aPlant Aril
=450  \\$wnnna$aPlant Arils
=450  \\$aPlant Capsule
=450  \\$wnnna$aPlant Capsules
=450  \\$wnnna$aPod, Legume
=450  \\$wnnna$aPods, Legume
=550  \\$wg$aFood
=550  \\$wg$aPlant Components, Aerial
=550  \\$wh$aNuts
=550  \\$wh$aSeeds
=667  \\$aas plant & food; for health effects or therapeutic use of fruit, index FRUIT (IM) + specific plant (IM) if pertinent + disease / diet ther; PHYTOTHERAPY is also available
=680  \\$iThe fleshy or dry ripened ovary of a plant, enclosing the seed or seeds.
=688  \\$a66
=750  \0$aFruit$5IEN$0(DLC)sh 85052105

=LDR  00977cz  a2200241n  4500
=001  9880363392802441
=005  20161114170117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005544
=035  \\$aCAZ8691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x320
=150  \\$aForecasting
=450  \\$wnnna$aFuture
=450  \\$aFuturology
=450  \\$wnnna$aPredictions and Projections
=450  \\$aProjections and Predictions
=550  \\$wg$aSocial Sciences
=550  \\$wh$aPopulation Forecast
=667  \\$aIM general only; consider also as IM coord with specific subject /trends (IM) if future is particularly significant: Manual 19.8.76, 35.2.9
=680  \\$iThe prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology.
=688  \\$a80; was FUTUROLOGY 1971-79
=750  \0$aForecasting$5IEN$0(DLC)sh 85050485

=LDR  00896cz  a2200241n  4500
=001  9880363392902441
=005  20141212201532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005543
=035  \\$aCAZ8690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x88.$x268
=150  \\$aForearm Injuries
=450  \\$aForearm$xinjuries
=450  \\$wnnna$aForearm Injury
=450  \\$wnnna$aInjuries, Forearm
=450  \\$wnnna$aInjury, Forearm
=550  \\$wg$aArm Injuries
=550  \\$wh$aRadius Fractures
=550  \\$wh$aUlna Fractures
=667  \\$aGEN & unspecified for soft tissue & bones; consider also /inj with specific bones & also specific fracture terms; available also are HAND INJURIES; FINGER INJURIES & WRIST INJURIES
=680  \\$iInjuries to the part of the upper limb of the body between the wrist and elbow.
=750  \0$aForearm$xWounds and injuries$5IEN$0(IEN)368395

=LDR  00563cz  a2200157n  4500
=001  9880363393002441
=005  20141212201532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x585
=150  \\$aForearm
=450  \\$wnnna$aForearms
=550  \\$wg$aUpper Extremity
=667  \\$aprimates only: use FORELIMB for non-primate vertebrates & EXTREMITIES for invertebrates: TN 117; for bones use RADIUS or ULNA; NIM when merely locational as in skin dis (IM)
=750  \0$aForearm$5IEN$0(DLC)sh 85050484

=LDR  00919cz  a2200229n  4500
=001  9880363393102441
=005  20141212201531.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005538
=035  \\$aCAZ8685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x300
=150  \\$aFootball
=450  \\$wnnna$aFootballs
=450  \\$wnnna$aRugbies
=450  \\$aRugby
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15+; note X ref RUGBY; does not include non-North American "football" ( = SOCCER)
=680  \\$iA competitive team sport played on a rectangular field. This is the American or Canadian version of the game and also includes the form known as rugby. It does not include non-North American football (= SOCCER).
=688  \\$a76
=750  \0$aFootball$5IEN-M$0(DLC)sh 85050405
=750  \0$aFootballs$5IEN-HS$0(DLC)sh 85050423

=LDR  00936cz  a2200253n  4500
=001  9880363393202441
=005  20141212201531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005537
=035  \\$aCAZ8684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x70
=072  \\$aB4.$x909.$x777.$x618.$x70
=150  \\$aAphthovirus
=450  \\$wnnna$aAphthoviruses
=450  \\$aEquine rhinitis A virus
=450  \\$aEquine rhinovirus 1
=450  \\$wnnna$arhinovirus 1, Equine
=550  \\$wg$aPicornaviridae
=550  \\$wh$aFoot-and-Mouth Disease Virus
=667  \\$ainfection: coord IM with PICORNAVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species.
=688  \\$a1994 (1963)
=750  \0$aAphthoviruses$0(DLC)sh2007007583$5IEN-M

=LDR  00737cz  a2200229n  4500
=001  9880363393302441
=005  20141212201530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005536
=035  \\$aCAZ8683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x484
=072  \\$aC22.$x380
=150  \\$aFoot-and-Mouth Disease
=450  \\$wnnna$aDisease, Foot-and-Mouth
=450  \\$wnnna$aDiseases, Foot-and-Mouth
=450  \\$wnnna$aFoot and Mouth Disease
=450  \\$wnnna$aFoot-and-Mouth Diseases
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aPicornaviridae Infections
=667  \\$ado not confuse with HAND, FOOT AND MOUTH DISEASE; check tag ANIMALS
=750  \0$aFoot-and-mouth disease$5IEN$0(DLC)sh 85050400

=LDR  01041cz  a2200253n  4500
=001  9880363393402441
=005  20141212201530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005535
=035  \\$aCAZ8682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x394
=150  \\$aFoot Rot
=450  \\$wnnna$aFoot Rots
=450  \\$wnnna$aRot, Foot
=450  \\$wnnna$aRots, Foot
=550  \\$wg$aAnimal Diseases
=550  \\$aDichelobacter nodosus
=550  \\$aDigital Dermatitis
=550  \\$aFusobacterium necrophorum
=667  \\$acoordinate IM with appropriate infection term (IM) + precoordinated animal/disease term (IM) if pertinent
=680  \\$iA disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus (see DICHELOBACTER NODOSUS). It is also known as interdigital necrobacillosis. (From Black's Veterinary Dictionary, 18th ed)
=688  \\$a70
=750  \0$aFootrot in animals$5IEN$0(DLC)sh 88004976

=LDR  01053cz  a2200337n  4500
=001  9880363393502441
=005  20180709114112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005534
=035  \\$aCAZ8681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x360
=072  \\$aC17.$x800.$x321
=150  \\$aFoot Diseases
=450  \\$wnnna$aDisease, Foot
=450  \\$wnnna$aDiseases, Foot
=450  \\$wnnna$aFoot Disease
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wg$aSkin Diseases
=550  \\$wh$aFasciitis, Plantar
=550  \\$wh$aFibromatosis, Plantar
=550  \\$wh$aFoot Dermatoses
=550  \\$wh$aFoot Ulcer
=550  \\$wh$aHeel Spur
=550  \\$wh$aImmersion Foot
=550  \\$wh$aMetatarsalgia
=550  \\$wh$aPosterior Tibial Tendon Dysfunction
=550  \\$aPodiatry
=667  \\$askin dis on foot = FOOT DERMATOSES; neopl of foot: use neopl coords (IM) + FOOT DISEASES (IM)
=680  \\$iAnatomical and functional disorders affecting the foot.
=750  \0$aFoot$xDiseases$5IEN$0(DLC)sh 85050368

=LDR  00951cz  a2200241n  4500
=001  9880363393602441
=005  20141212201529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005533
=035  \\$aCAZ8680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x321.$x125
=150  \\$aFoot Dermatoses
=450  \\$wnnna$aDermatoses, Foot
=450  \\$wnnna$aDermatosis, Foot
=450  \\$wnnna$aFoot Dermatosis
=550  \\$wg$aFoot Diseases
=550  \\$wh$aTinea Pedis
=667  \\$aGEN & coord for specific diseases of the foot; not as coord for neoplasms of the foot (use neopl coords (IM) with FOOT DISEASES (IM)); consider synonym for dermatitis of foot & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH
=680  \\$iSkin diseases of the foot, general or unspecified.
=688  \\$a66
=750  \0$81$wb$aFoot$xDiseases$5IEN$0(DLC)sh 85050368
=750  \0$81$wb$aSkin$xDiseases$5IEN-HS$0(DLC)sh 85123171

=LDR  01155cz  a2200313n  4500
=001  9880363393702441
=005  20180316141158.0
=008  870402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005532
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x495
=072  \\$aC5.$x660.$x585.$x512.$x380
=072  \\$aC16.$x131.$x621.$x585.$x512.$x500
=150  \\$aFoot Deformities, Congenital
=450  \\$wnnna$aCongenital Foot Deformities
=450  \\$wnnna$aCongenital Foot Deformity
=450  \\$wnnna$aDeformities, Congenital Foot
=450  \\$wnnna$aDeformity, Congenital Foot
=450  \\$aFoot$xabnormalities
=450  \\$aFoot Deformities$xcongenital
=450  \\$wnnna$aFoot Deformity, Congenital
=550  \\$wg$aFoot Deformities
=550  \\$wg$aLower Extremity Deformities, Congenital
=550  \\$wh$aTalipes
=550  \\$wh$aTarsal Coalition
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iAlterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.
=688  \\$a88
=750  \0$aFoot$xAbnormalities$5IEN$0(DLC)sh 85050353

=LDR  00970cz  a2200289n  4500
=001  9880363393802441
=005  20180316120928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005531
=035  \\$aCAZ8678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x488
=150  \\$aFoot Deformities, Acquired
=450  \\$wnnna$aAcquired Foot Deformities
=450  \\$wnnna$aAcquired Foot Deformity
=450  \\$wnnna$aDeformities, Acquired Foot
=450  \\$wnnna$aDeformity, Acquired Foot
=450  \\$wnnna$aFoot Deformity, Acquired
=550  \\$wg$aFoot Deformities
=550  \\$wh$aBunion
=550  \\$wh$aHallux Limitus
=550  \\$wh$aHallux Rigidus
=550  \\$wh$aTalipes
=667  \\$adeformity of bone, joint, muscle, etc.
=680  \\$iDistortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.
=688  \\$a71
=750  \0$iNarrower mapping$aFootbinding$0(DLC)sh 85050424$4NM$5IEN-M

=LDR  00920cz  a2200217n  4500
=001  9880363393902441
=005  20141212201528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005528
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x250
=150  \\$aFoot
=450  \\$wnnna$aFeet
=550  \\$wg$aLower Extremity
=550  \\$wh$aAnkle
=550  \\$wh$aForefoot, Human
=550  \\$wh$aHeel
=550  \\$aFoot Bones
=667  \\$avertebrates only: for invertebrates use EXTREMITIES: dis of foot = FOOT DISEASES; skin dis on foot = FOOT DERMATOSES: see note there; neopl of foot: use neopl coords (IM) + FOOT DISEASES (IM); foot prints (like finger prints) = PLANTAR PRINTS see DERMATOGLYPHICS
=680  \\$iThe distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones.
=750  \0$aFoot$5IEN$0(DLC)sh 85050352

=LDR  01349cz  a2200301n  4500
=001  9880363394002441
=005  20141212192217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005527
=035  \\$aCAZ8674HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x525.$x400
=150  \\$aFood, Fortified
=450  \\$aEnriched Food
=450  \\$wnnna$aEnriched Foods
=450  \\$wnnna$aFood, Enriched
=450  \\$aFood, Supplemented
=450  \\$wnnna$aFoods, Enriched
=450  \\$wnnna$aFoods, Fortified
=450  \\$wnnna$aFortified Food
=450  \\$wnnna$aFortified Foods
=550  \\$wg$aFoods, Specialized
=550  \\$wh$aPrebiotics
=667  \\$acoordinate IM with added nutrient if relevant (IM); do not confuse with FOOD, FORMULATED or DIETARY SUPPLEMENTS
=680  \\$iAny food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the food normally. Fortified food includes also food to which various nutrients have been added to compensate for those removed by refinement or processing. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a1970; for FOOD, SUPPLEMENTED use DIETARY SUPPLEMENTS 1998-2014
=688  \\$a73; was FOODS, FORTIFIED 1970-72 (Prov)
=750  \0$aEnriched foods$5IEN$0(DLC)sh 85050240

=LDR  01903cz  a2200469n  4500
=001  9880363394102441
=005  20141212201527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005526
=035  \\$aCAZ8673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x525.$x350
=150  \\$aFood, Formulated
=450  \\$wnnna$aChemically Defined Diet
=450  \\$wnnna$aChemically Defined Diets
=450  \\$aDiet, Chemically Defined
=450  \\$aDiet, Elemental
=450  \\$aDiet, Formula
=450  \\$aDiet, Synthetic
=450  \\$wnnna$aDietary Formulation
=450  \\$aDietary Formulations
=450  \\$wnnna$aDiets, Chemically Defined
=450  \\$wnnna$aDiets, Elemental
=450  \\$wnnna$aDiets, Formula
=450  \\$wnnna$aDiets, Synthetic
=450  \\$wnnna$aElemental Diet
=450  \\$wnnna$aElemental Diets
=450  \\$wnnna$aFoods, Formulated
=450  \\$wnnna$aFormulated Food
=450  \\$wnnna$aFormulated Foods
=450  \\$wnnna$aFormulation, Dietary
=450  \\$wnnna$aFormulations, Dietary
=450  \\$wnnna$aSynthetic Diet
=550  \\$wg$aFoods, Specialized
=550  \\$wh$aInfant Formula
=550  \\$aEnteral Nutrition
=550  \\$aParenteral Nutrition Solutions
=667  \\$aINFANT FORMULA and INFANT FOOD are also available; do not confuse with FOOD, FORTIFIED which emphasizes addition of essential nutrients
=680  \\$iFood and dietary formulations including elemental (chemically defined formula) diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, complete liquid diets, and supplemental liquid and solid diets.
=688  \\$a80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1973-78 (Prov 1973-74); was FOODS, ARTIFICIAL 1972 (Prov)
=750  \0$aElemental diet$5IEN-M$0(DLC)sh 85042490
=750  \0$aArtificial foods$5IEN-HS$0(DLC)sh 85050232

=LDR  00941cz  a2200301n  4500
=001  9880363394202441
=005  20141212201526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005523
=035  \\$aCAZ8670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x750
=150  \\$aFood Supply
=450  \\$wnnna$aFood Insecurities
=450  \\$wnnna$aFood Insecurity
=450  \\$wnnna$aFood Security
=450  \\$wnnna$aFood Supplies
=450  \\$aFood$xsupply & distribution
=450  \\$wnnna$aInsecurities, Food
=450  \\$wnnna$aInsecurity, Food
=450  \\$wnnna$aSecurity, Food
=450  \\$wnnna$aSupplies, Food
=450  \\$wnnna$aSupply, Food
=550  \\$wg$aFood Industry
=550  \\$aFood Storage
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe production and movement of food items from point of origin to use or consumption.
=750  \0$aFood supply$5IEN$0(DLC)sh 85050339

=LDR  00963cz  a2200277n  4500
=001  9880363394302441
=005  20141212201526.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005522
=035  \\$aCAZ8669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x500
=150  \\$aFood Services
=450  \\$wnnna$aFood Service
=450  \\$wnnna$aMeal on Wheels
=450  \\$aMeals on Wheels
=450  \\$wnnna$aService, Food
=450  \\$wnnna$aServices, Food
=550  \\$wg$aFood Industry
=550  \\$wh$aFood Service, Hospital
=550  \\$wh$aMenu Planning
=550  \\$wh$aRestaurants
=667  \\$ado not confuse with DIETARY SERVICES where nutrition is emphasized; do not confuse with FOOD ASSISTANCE
=680  \\$iFunctions, equipment, and facilities concerned with the preparation and distribution of ready-to-eat food.
=688  \\$a76; was FOOD SERVICE (NON MESH) before 1976
=750  \0$aFood service$5IEN$0(DLC)sh 85050320

=LDR  01101cz  a2200325n  4500
=001  9880363394402441
=005  20141212201526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005521
=035  \\$aCAZ8668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x500.$x300
=072  \\$aN2.$x278.$x354.$x422.$x374
=072  \\$aN2.$x421.$x242.$x472
=072  \\$aN4.$x452.$x442.$x422.$x374
=150  \\$aFood Service, Hospital
=450  \\$wnnna$aFood Services, Hospital
=450  \\$aHospital Food Service
=450  \\$wnnna$aHospital Food Services
=450  \\$wnnna$aService, Hospital Food
=450  \\$wnnna$aServices, Hospital Food
=550  \\$wg$aDietary Services
=550  \\$wg$aFood Services
=550  \\$wg$aHospital Departments
=550  \\$wh$aMenu Planning
=550  \\$aDietetics
=667  \\$aDF: FOOD SERV HOSP
=680  \\$iHospital department that manages and supervises the dietary program in accordance with the patients' requirements.
=688  \\$a78; was HOSPITAL FOOD SERVICE 1963-77
=750  \0$aHospitals$xFood service$5IEN$0(DLC)sh 85062330

=LDR  00744cz  a2200217n  4500
=001  9880363394502441
=005  20141212201525.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005520
=035  \\$aCAZ8667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x368.$x385
=072  \\$aJ2.$x500.$x512.$x700
=150  \\$aFood Preservatives
=450  \\$wnnna$aPreservatives, Food
=550  \\$wg$aFood Additives
=550  \\$aFood Preservation
=667  \\$aFOOD, PRESERVED and FOOD PRESERVATION are also available
=680  \\$iSubstances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods.
=688  \\$a75
=750  \0$aFood preservatives$5IEN$0(DLC)sh 85050306

=LDR  00672cz  a2200217n  4500
=001  9880363394602441
=005  20141212201525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005519
=035  \\$aCAZ8666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x700
=150  \\$aFood Preservation
=450  \\$aPreservation, Food
=550  \\$wg$aFood Technology
=550  \\$wh$aPasteurization
=550  \\$aFood, Preserved
=550  \\$aFood Storage
=667  \\$aFOOD, PRESERVED and FOOD PRESERVATIVES is also available
=680  \\$iProcedures or techniques used to keep food from spoiling.
=750  \0$aFood$xPreservation$5IEN$0(DLC)sh 85050212

=LDR  00756cz  a2200265n  4500
=001  9880363394702441
=005  20141212201525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005518
=035  \\$aCAZ8665HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x516
=150  \\$aFood Preferences
=450  \\$wnnna$aFood Preference
=450  \\$aFood Selection
=450  \\$wnnna$aFood Selections
=450  \\$wnnna$aPreference, Food
=450  \\$wnnna$aPreferences, Food
=450  \\$wnnna$aSelection, Food
=450  \\$wnnna$aSelections, Food
=550  \\$wg$aFeeding Behavior
=667  \\$ahuman & animal
=680  \\$iThe selection of one food over another.
=688  \\$a69
=750  \0$aFood preferences$5IEN$0(DLC)sh 85050304

=LDR  02084cz  a2200505n  4500
=001  9880363394802441
=005  20141212201525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005517
=035  \\$aCAZ8664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x415
=150  \\$aFoodborne Diseases
=450  \\$wnnna$aDisease, Food-borne
=450  \\$wnnna$aDisease, Foodborne
=450  \\$wnnna$aDiseases, Food-borne
=450  \\$wnnna$aDiseases, Foodborne
=450  \\$wnnna$aFood-borne Disease
=450  \\$wnnna$aFood-borne Diseases
=450  \\$wnnna$aFood borne Diseases
=450  \\$wnnna$aFood-borne Illnesses
=450  \\$wnnna$aFood borne Illnesses
=450  \\$aFood Poisoning
=450  \\$aFood$xpoisoning
=450  \\$wnnna$aFood Poisonings
=450  \\$wnnna$aFoodborne Disease
=450  \\$wnnna$aFoodborne Illnesses
=450  \\$wnnna$aIllnesses, Food-borne
=450  \\$wnnna$aIllnesses, Foodborne
=450  \\$wnnna$aPoisoning, Food
=450  \\$wnnna$aPoisonings, Food
=550  \\$wg$aPoisoning
=550  \\$wh$aBotulism
=550  \\$wh$aCiguatera Poisoning
=550  \\$wh$aFavism
=550  \\$wh$aMushroom Poisoning
=550  \\$wh$aSalmonella Food Poisoning
=550  \\$wh$aShellfish Poisoning
=550  \\$wh$aStaphylococcal Food Poisoning
=550  \\$aFood Hypersensitivity
=667  \\$acoordinate with specific food item / pois; note several specific precoordinated food poisoning terms are also available
=680  \\$iAcute illnesses, usually affecting the GASTROINTESTINAL TRACT, brought on by consuming contaminated food or beverages. Most of these diseases are infectious, caused by a variety of bacteria, viruses, or parasites that can be foodborne. Sometimes the diseases are caused by harmful toxins from the microbes or other chemicals present in the food. Especially in the latter case, the condition is often called food poisoning.
=688  \\$a2010 (1963)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Food Poisoning
=750  \0$aFoodborne diseases$0(DLC) sh 88007645$5IEN

=LDR  01146cz  a2200277n  4500
=001  9880363394902441
=005  20141212201524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005516
=035  \\$aCAZ8663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x274.$x332
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500.$x249.$x300
=072  \\$aN6.$x850.$x425.$x200
=072  \\$aN6.$x850.$x460.$x400.$x300
=072  \\$aN6.$x850.$x601.$x500.$x249.$x300
=150  \\$aFood Microbiology
=450  \\$aFood$xmicrobiology
=450  \\$wnnna$aMicrobiology, Food
=550  \\$wg$aEnvironmental Microbiology
=550  \\$wg$aFood Contamination
=667  \\$acoordinate with specific food / microbiol or / virol and specific microbe; FOOD PARASITOLOGY is also available
=680  \\$iThe presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept.
=688  \\$a1966
=688  \\$a66
=750  \0$aFood$xMicrobiology$5IEN$0(DLC)sh 85050202

=LDR  01020cz  a2200289n  4500
=001  9880363395002441
=005  20141212201524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005515
=035  \\$aCAZ8662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x600.$x400
=072  \\$aJ1.$x576.$x761.$x400.$x450
=150  \\$aFood Labeling
=450  \\$wnnna$aFood Labelling
=450  \\$wnnna$aFood Product Labeling
=450  \\$aLabeling, Food
=450  \\$wnnna$aLabeling, Food Product
=450  \\$wnnna$aLabeling, Nutrition
=450  \\$wnnna$aLabelling, Food
=450  \\$aNutrition Labeling
=450  \\$aProduct Labeling, Food
=550  \\$wg$aFood Packaging
=550  \\$aFood Quality
=680  \\$iUse of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, NUTRITIONAL VALUE, directions, warnings, and other relevant information.
=688  \\$a74
=750  \0$aFood$xLabeling$5IEN$0(DLC)sh 85050201

=LDR  00867cz  a2200265n  4500
=001  9880363395102441
=005  20141212201523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005514
=035  \\$aCAZ8661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x700.$x700.$x500
=150  \\$aFood Irradiation
=450  \\$aFood, Irradiated
=450  \\$wnnna$aFood Irradiations
=450  \\$wnnna$aFoods, Irradiated
=450  \\$wnnna$aIrradiated Food
=450  \\$wnnna$aIrradiated Foods
=450  \\$wnnna$aIrradiation, Food
=450  \\$wnnna$aIrradiations, Food
=550  \\$wg$aPasteurization
=667  \\$ado not confuse with FOOD CONTAMINATION, RADIOACTIVE
=680  \\$iTreatment of food with RADIATION.
=750  \0$aIrradiated foods$5IEN-M$0(DLC)sh 85050245
=750  \0$aRadiation preservation of food$5IEN-HS$0(DLC)sh 85110356

=LDR  00890cz  a2200229n  4500
=001  9880363395202441
=005  20141212201523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005513
=035  \\$aCAZ8660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500.$x500
=072  \\$aN6.$x850.$x601.$x500.$x500
=072  \\$aN6.$x850.$x780.$x200.$x800.$x325
=150  \\$aFood Inspection
=450  \\$wnnna$aFood Inspections
=450  \\$wnnna$aInspection, Food
=450  \\$wnnna$aInspections, Food
=550  \\$wg$aFood Safety
=550  \\$wg$aSanitation
=680  \\$iExamination of foods to assure wholesome and clean products free from unsafe microbes or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc.
=750  \0$aFood adulteration and inspection$5IEN$0(DLC)sh 85050256

=LDR  01189cz  a2200337n  4500
=001  9880363395302441
=005  20200608180409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005512
=035  \\$aCAZ8659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x480.$x370
=150  \\$aFood Hypersensitivity
=450  \\$wnnna$aAllergies, Food
=450  \\$aAllergy, Food
=450  \\$wnnna$aFood Allergies
=450  \\$aFood Allergy
=450  \\$wnnna$aFood Hypersensitivities
=450  \\$wnnna$aHypersensitivities, Food
=450  \\$aHypersensitivity, Food
=550  \\$wg$aHypersensitivity, Immediate
=550  \\$wh$aEgg Hypersensitivity
=550  \\$wh$aMilk Hypersensitivity
=550  \\$wh$aNut and Peanut Hypersensitivity
=550  \\$wh$aShellfish Hypersensitivity
=550  \\$wh$aWheat Hypersensitivity
=550  \\$aFoodborne Diseases
=667  \\$aGEN: Prefer specific precoord; coord IM with specific food /adv eff (IM): Manual 31.12
=680  \\$iGastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.
=688  \\$a66; was FOOD ALLERGY 1963-65
=750  \0$aFood allergy$5IEN$0(DLC)sh 85050258

=LDR  00987cz  a2200301n  4500
=001  9880363395402441
=005  20141212201522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005511
=035  \\$aCAZ8658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200
=150  \\$aFood Handling
=450  \\$aFood Processing
=450  \\$wnnna$aHandling, Food
=450  \\$wnnna$aProcessing, Food
=550  \\$wg$aFood Industry
=550  \\$wh$aCooking
=550  \\$wh$aCooking and Eating Utensils
=550  \\$wh$aFood Dispensers, Automatic
=550  \\$wh$aFood Packaging
=550  \\$wh$aFood-Processing Industry
=550  \\$wh$aFood Storage
=550  \\$wh$aMeat-Packing Industry
=550  \\$wh$aPasteurization
=550  \\$aFood Quality
=680  \\$iAny aspect of the operations in the preparation, processing, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food.
=750  \0$aFood handling$5IEN$0(DLC)sh 85050276

=LDR  01321cz  a2200445n  4500
=001  9880363395502441
=005  20141212201522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005510
=035  \\$aCAZ8657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x432
=072  \\$aF1.$x145.$x466.$x349
=150  \\$aFood Habits
=450  \\$wnnna$aDiet Habit
=450  \\$wnnna$aDiet Habits
=450  \\$wnnna$aDiet Modification
=450  \\$wnnna$aDiet Modifications
=450  \\$wnnna$aDietary Habit
=450  \\$aDietary Habits
=450  \\$aDietary Modification
=450  \\$wnnna$aDietary Modifications
=450  \\$wnnna$aFood Habit
=450  \\$wnnna$aHabit, Diet
=450  \\$wnnna$aHabit, Dietary
=450  \\$wnnna$aHabit, Food
=450  \\$wnnna$aHabits, Diet
=450  \\$wnnna$aHabits, Dietary
=450  \\$wnnna$aHabits, Food
=450  \\$wnnna$aModification, Diet
=450  \\$wnnna$aModification, Dietary
=450  \\$wnnna$aModifications, Diet
=450  \\$wnnna$aModifications, Dietary
=550  \\$wg$aFeeding Behavior
=550  \\$wg$aHabits
=550  \\$wh$aMeals
=667  \\$aIM
=680  \\$iAcquired or learned food preferences.
=688  \\$a69; DIETARY HABITS was see under FOOD HABITS 1969-78
=750  \0$aFood habits$5IEN$0(DLC)sh 85050275

=LDR  00969cz  a2200265n  4500
=001  9880363395602441
=005  20141212201521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005507
=035  \\$aCAZ8654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500.$x249.$x250
=072  \\$aN6.$x850.$x460.$x400.$x250
=072  \\$aN6.$x850.$x601.$x500.$x249.$x250
=072  \\$aN6.$x850.$x810.$x125
=150  \\$aFood Contamination, Radioactive
=450  \\$wnnna$aContamination, Radioactive Food
=450  \\$wnnna$aContaminations, Radioactive Food
=450  \\$wnnna$aFood Contaminations, Radioactive
=450  \\$wnnna$aRadioactive Food Contamination
=450  \\$wnnna$aRadioactive Food Contaminations
=550  \\$wg$aFood Contamination
=550  \\$wg$aRadiologic Health
=667  \\$ado not confuse with FOOD IRRADIATION: food preservation by irradiation
=750  \0$aRadioactive contamination of food$5IEN$0(DLC)sh 85110594

=LDR  01550cz  a2200337n  4500
=001  9880363395702441
=005  20141212201521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005506
=035  \\$aCAZ8653HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500.$x249
=072  \\$aN6.$x850.$x460.$x400
=072  \\$aN6.$x850.$x601.$x500.$x249
=150  \\$aFood Contamination
=450  \\$wnnna$aAdulteration, Food
=450  \\$wnnna$aAdulterations, Food
=450  \\$wnnna$aContamination, Food
=450  \\$wnnna$aContaminations, Food
=450  \\$aFood Adulteration
=450  \\$wnnna$aFood Adulterations
=450  \\$wnnna$aFood Contaminations
=550  \\$wg$aEnvironmental Pollution
=550  \\$wg$aFood Safety
=550  \\$wh$aFood Contamination, Radioactive
=550  \\$wh$aFood Microbiology
=550  \\$wh$aFood Parasitology
=667  \\$acoordinate with specific food item; contamination by dirt, dust, chemicals & toxic substances, organisms; contamination by microbes: consider FOOD MICROBIOLOGY + specific microbe + specific food item /microbiol; contamination by parasites: consider FOOD PARASITOLOGY + specific parasite + specific food item /parasitol
=680  \\$iThe presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage.
=750  \0$aFood adulteration and inspection$5IEN-M$0(DLC)sh 85050256
=750  \0$aFood contamination$5IEN-HS$0(DLC)sh 85050272

=LDR  00756cz  a2200253n  4500
=001  9880363395802441
=005  20141212201520.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005505
=035  \\$aCAZ8652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x233.$x674
=072  \\$aD27.$x720.$x368.$x355
=150  \\$aFood Coloring Agents
=450  \\$wnnna$aAgents, Food Coloring
=450  \\$wnnna$aColorants, Food
=450  \\$aColoring Agents, Food
=450  \\$aFood Colorants
=550  \\$wg$aColoring Agents
=550  \\$wg$aFood Additives
=667  \\$aD25-26 qualif
=680  \\$iNatural or synthetic dyes used as coloring agents in processed foods.
=688  \\$a75
=750  \0$aColoring matter in food$5IEN$0(DLC)sh 85028698

=LDR  00789cz  a2200253n  4500
=001  9880363395902441
=005  20141212201520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005504
=035  \\$aCAZ8651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x362
=072  \\$aJ1.$x576.$x423.$x850.$x100
=150  \\$aFood Analysis
=450  \\$wnnna$aAnalyses, Food
=450  \\$wnnna$aAnalysis, Food
=450  \\$wnnna$aFood Analyses
=450  \\$aFood$xanalysis
=550  \\$wg$aFood Technology
=550  \\$wg$aInvestigative Techniques
=550  \\$aFood Quality
=667  \\$ageneral only; prefer /anal with specific food item
=680  \\$iMeasurement and evaluation of the components of substances to be taken as FOOD.
=750  \0$aFood$xAnalysis$5IEN$0(DLC)sh 85050185

=LDR  01254cz  a2200289n  4500
=001  9880363396002441
=005  20200512124848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005503
=035  \\$aCAZ8650HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x372.$x300
=072  \\$aG7.$x203.$x300.$x514.$x500
=072  \\$aJ2.$x500.$x514.$x500
=150  \\$aFood Additives
=450  \\$wnnna$aAdditive, Food
=450  \\$wnnna$aAdditives, Food
=450  \\$wnnna$aFood Additive
=550  \\$wg$aFood
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aFat Substitutes
=550  \\$wh$aFlavoring Agents
=550  \\$wh$aFood Coloring Agents
=550  \\$wh$aFood Preservatives
=667  \\$aD25-26 qualif
=680  \\$iSubstances which are of little or no nutritive value, but are used in the processing or storage of foods or animal feed, especially in the developed countries; includes ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS (both plain and LOCAL); VEHICLES; EXCIPIENTS and other similarly used substances. Many of the same substances are PHARMACEUTIC AIDS when added to pharmaceuticals rather than to foods.
=750  \0$aFood additives$5IEN$0(DLC)sh 85050253

=LDR  02214cz  a2200613n  4500
=001  9880363396102441
=005  20200512124212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005502
=035  \\$aCAZ8649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x300
=072  \\$aJ2.$x500
=150  \\$aFood
=450  \\$wnnna$aFoods
=450  \\$wnnna$aNutrients
=550  \\$wg$aDiet, Food, and Nutrition
=550  \\$wg$aFood and Beverages
=550  \\$wh$aBread
=550  \\$wh$aCandy
=550  \\$wh$aChocolate
=550  \\$wh$aCondiments
=550  \\$wh$aCrops, Agricultural
=550  \\$wh$aDairy Products
=550  \\$wh$aDietary Carbohydrates
=550  \\$wh$aDietary Fats
=550  \\$wh$aDietary Fiber
=550  \\$wh$aDietary Proteins
=550  \\$wh$aDietary Supplements
=550  \\$wh$aEggs
=550  \\$wh$aFast Foods
=550  \\$wh$aFlour
=550  \\$wh$aFood Additives
=550  \\$wh$aFood, Genetically Modified
=550  \\$wh$aFood Ingredients
=550  \\$wh$aFood, Organic
=550  \\$wh$aFood, Preserved
=550  \\$wh$aFoods, Specialized
=550  \\$wh$aFruit
=550  \\$wh$aHoney
=550  \\$wh$aMeals
=550  \\$wh$aMeat
=550  \\$wh$aMicronutrients
=550  \\$wh$aMolasses
=550  \\$wh$aNuts
=550  \\$wh$aRaw Foods
=550  \\$wh$aSeeds
=550  \\$wh$aVegetables
=550  \\$aNutritional Physiological Phenomena
=550  \\$aNutritional Requirements
=667  \\$a/adv eff = probably FOOD HYPERSENSITIVITY or FOOD POISONING; /rad eff = probably FOOD IRRADIATION or FOOD CONTAMINATION, RADIOACTIVE; Manual 31.5-31.12; food consumption = FOOD or EATING or FOOD SUPPLY; food for animals = ANIMAL FEED; refeeding after starvation goes here; microbes found in food: consider FOOD MICROBIOLOGY (IM) + specific microbe (IM); parasites found in food: consider FOOD PARASITOLOGY (IM) + specific parasite (IM); differentiation from DIET & nutrition: see note under NUTRITIONAL PHYSIOLOGIC PHENOMENA & Manual 31.5
=680  \\$iAny substances taken in by the body that provide nourishment.
=750  \0$aFood$0(DLC) sh 85050184$5IEN-M
=750  \0$aFood$xPasteurization$0(DLC)sh2005003525$5IEN-M

=LDR  00681cz  a2200193n  4500
=001  9880363396202441
=005  20141212201518.0
=008  840531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005496
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x280
=150  \\$aFollicular Atresia
=450  \\$aAtresia, Follicular
=450  \\$wnnna$aAtresias, Follicular
=450  \\$wnnna$aFollicular Atresias
=550  \\$wg$aReproductive Physiological Processes
=680  \\$iThe degeneration and resorption of an OVARIAN FOLLICLE before it reaches maturity and ruptures.
=688  \\$a91(85); was see under FOLLICULAR PHASE 1985-90
=750  \0$aOvarian atresia$0(DLC)sh2005008476$5IEN-M

=LDR  00590cz  a2200193n  4500
=001  9880363396302441
=005  20170705094626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005495
=035  \\$aCAZ8642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x515
=150  \\$aFolklore
=450  \\$wnnna$aFolklores
=550  \\$wg$aCulture
=550  \\$wh$aLegendary Creatures
=667  \\$ano qualif
=680  \\$iThe common orally transmitted traditions, myths, festivals, songs, superstitions, and stories of all peoples.
=750  \0$aFolklore$5IEN$0(DLC)sh 85050104

=LDR  01448cz  a2200253n  4500
=001  9880363396402441
=005  20141212201517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005494
=035  \\$aCAZ8641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x308
=150  \\$aFolic Acid Deficiency
=450  \\$wnnna$aAcid Deficiencies, Folic
=450  \\$wnnna$aAcid Deficiency, Folic
=450  \\$wnnna$aDeficiencies, Folic Acid
=450  \\$wnnna$aDeficiency, Folic Acid
=450  \\$wnnna$aFolic Acid Deficiencies
=450  \\$aFolic Acid$xdeficiency
=550  \\$wg$aVitamin B Deficiency
=667  \\$aa vitamin B defic; DF: FOLIC ACID DEFIC
=680  \\$iA nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. (Merck Manual, 16th ed)
=688  \\$a66(64)
=750  \0$aFolic acid deficiency$5IEN$0(DLC)sh 85143996

=LDR  01142cz  a2200265n  4500
=001  9880363396502441
=005  20141212192216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005493
=035  \\$aCAZ8640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x350
=150  \\$aFolic Acid Antagonists
=450  \\$wnnna$aAcid Antagonists, Folic
=450  \\$wnnna$aAntagonists, Folic Acid
=450  \\$aAntifolates
=450  \\$wnnna$aDihydrofolate Reductase Inhibitors
=450  \\$aFolic Acid$xantagonists & inhibitors
=450  \\$wnnna$aFolic Acid Metabolism Inhibitors
=450  \\$wnnna$aInhibitors, Dihydrofolate Reductase
=450  \\$wnnna$aReductase Inhibitors, Dihydrofolate
=450  \\$aTetrahydrofolate Dehydrogenase$xantagonists & inhibitors
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iInhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)
=750  \0$aFolic acid$xAntagonists$5IEN$0(DLC)sh 85049647

=LDR  01375cz  a2200361n  4500
=001  9880363396602441
=005  20141212201517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005492
=035  \\$aCAZ8639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x631.$x400
=150  \\$aFolic Acid
=450  \\$wnnna$aB9, Vitamin
=450  \\$wnnna$aFolacin
=450  \\$wnnna$aFolate
=450  \\$wnnna$aFolic Acid, Calcium Salt (1:1)
=450  \\$wnnna$aFolic Acid, (D)-Isomer
=450  \\$wnnna$aFolic Acid, (DL)-Isomer
=450  \\$wnnna$aFolic Acid, Monopotassium Salt
=450  \\$wnnna$aFolic Acid, Monosodium Salt
=450  \\$wnnna$aFolic Acid, Potassium Salt
=450  \\$wnnna$aFolic Acid, Sodium Salt
=450  \\$wnnna$aFolvite
=450  \\$aPteroylglutamic Acid
=450  \\$wnnna$aVitamin B9
=450  \\$aVitamin M
=550  \\$wg$aPterins
=550  \\$wh$aPteroylpolyglutamic Acids
=550  \\$wh$aTetrahydrofolates
=680  \\$iA member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.
=688  \\$aHOMOFOLIC ACID was heading 1975-84
=750  \0$aFolic acid$5IEN$0(DLC)sh 85143995

=LDR  01004cz  a2200265n  4500
=001  9880363396702441
=005  20141212201516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005491
=035  \\$aCAZ8638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x392.$x433
=072  \\$aC7.$x793.$x348
=150  \\$aFocal Infection, Dental
=450  \\$aDental Focal Infection
=450  \\$wnnna$aDental Focal Infections
=450  \\$wnnna$aFocal Infections, Dental
=450  \\$wnnna$aInfection, Dental Focal
=450  \\$wnnna$aInfections, Dental Focal
=550  \\$wg$aFocal Infection
=550  \\$wg$aTooth Diseases
=667  \\$aIM; coord with precoord organ/dis site of infection (IM) + name of infection (IM); DF: FOCAL INFECT DENT
=680  \\$iSecondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues.
=688  \\$a64
=750  \0$aFocal infection, Dental$5IEN$0(DLC)sh 85049612

=LDR  00631cz  a2200205n  4500
=001  9880363396802441
=005  20141212201516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005490
=035  \\$aCAZ8637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x392
=150  \\$aFocal Infection
=450  \\$wnnna$aFocal Infections
=450  \\$wnnna$aInfection, Focal
=450  \\$wnnna$aInfections, Focal
=550  \\$wg$aInfection
=550  \\$wh$aFocal Infection, Dental
=667  \\$aIM; coord with precoord organ/dis site of infection (IM) + name of infection (IM)
=750  \0$aFocal infection$5IEN$0(DLC)sh 85049611

=LDR  03229cz  a2200997n  4500
=001  9880363396902441
=005  20141212201514.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005485
=035  \\$aCAZ8632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x420
=150  \\$aFlutamide
=450  \\$wnnna$a1A Brand of Flutamide
=450  \\$wnnna$aAlphapharm Brand of Flutamide
=450  \\$wnnna$aApimid
=450  \\$wnnna$aApo-Flutamide
=450  \\$wnnna$aApo Flutamide
=450  \\$wnnna$aApoFlutamide
=450  \\$wnnna$aApogepha Brand of Flutamide
=450  \\$wnnna$aApotex Brand of Flutamide
=450  \\$wnnna$aAzupharma Brand of Flutamide
=450  \\$wnnna$acell pharm Brand of Flutamide
=450  \\$wnnna$aChephasaar Brand of Flutamide
=450  \\$wnnna$aChimax
=450  \\$wnnna$aChiron Brand of Flutamide
=450  \\$wnnna$aCiclum Brand of Flutamide
=450  \\$wnnna$aCytamid
=450  \\$wnnna$aDrogenil
=450  \\$wnnna$aesparma Brand of Flutamide
=450  \\$wnnna$aEssex Brand of Flutamide
=450  \\$wnnna$aEuflex
=450  \\$wnnna$aEulexin
=450  \\$wnnna$aEulexine
=450  \\$wnnna$aFluken
=450  \\$wnnna$aFlulem
=450  \\$wnnna$aFlumid
=450  \\$wnnna$aFluta 1A Pharma
=450  \\$wnnna$aFluta-cell
=450  \\$wnnna$aFluta cell
=450  \\$wnnna$aFluta-GRY
=450  \\$wnnna$aFluta GRY
=450  \\$wnnna$aFlutacell
=450  \\$wnnna$aFlutaGRY
=450  \\$wnnna$aFlutamin
=450  \\$wnnna$aFlutandrona
=450  \\$wnnna$aFlutaplex
=450  \\$wnnna$aFlutexin
=450  \\$wnnna$aFugerel
=450  \\$wnnna$aGrisetin
=450  \\$wnnna$aGry Brand of Flutamide
=450  \\$wnnna$aHexal Brand of Flutamide
=450  \\$wnnna$aInibsa Brand of Flutamide
=450  \\$wnnna$aIpsen Brand of Flutamide
=450  \\$wnnna$aJuta Brand of Flutamide
=450  \\$wnnna$aKendrick Brand of Flutamide
=450  \\$wnnna$aLemery Brand of Flutamide
=450  \\$aNiftolid
=450  \\$wnnna$aNiftolide
=450  \\$wnnna$aNovo-Flutamide
=450  \\$wnnna$aNovo Flutamide
=450  \\$wnnna$aNovoFlutamide
=450  \\$wnnna$aNovopharm Brand of Flutamide
=450  \\$wnnna$aOncosal
=450  \\$wnnna$aPharmascience Brand of Flutamide
=450  \\$wnnna$aPMS-Flutamide
=450  \\$wnnna$aPMS Flutamide
=450  \\$wnnna$aPrasfarma Brand of Flutamide
=450  \\$wnnna$aProstacur
=450  \\$wnnna$aProstica
=450  \\$wnnna$aProstogenat
=450  \\$wnnna$aQ-Pharm Brand of Flutamide
=450  \\$wnnna$aQ Pharm Brand of Flutamide
=450  \\$wnnna$aSCH-13521
=450  \\$wnnna$aSCH 13521
=450  \\$wnnna$aSCH13521
=450  \\$wnnna$aSchering Brand of Flutamide
=450  \\$wnnna$aSchering-Plough Brand of Flutamide
=450  \\$wnnna$aSchering Plough Brand of Flutamide
=450  \\$wnnna$aTAD Brand of Flutamide
=450  \\$wnnna$aTedec Meiji Brand of Flutamide
=450  \\$wnnna$aTestotard
=550  \\$wg$aAnilides
=680  \\$iAn antiandrogen with about the same potency as cyproterone in rodent and canine species.
=688  \\$a91(75); was see under ANILIDES 1975-90
=750  \0$aFlutamide$5IEN$0(DLC)sh 91005137

=LDR  00637cz  a2200205n  4500
=001  9880363397002441
=005  20141212201513.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005481
=035  \\$aCAZ8628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x417.$x515
=150  \\$aFlurothyl
=450  \\$wnnna$aFluorothyl
=450  \\$wnnna$aFlurotyl
=450  \\$wnnna$aIndoklon
=550  \\$wg$aEthyl Ethers
=680  \\$iA convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.
=688  \\$a73
=750  \0$aFlurothyl$5IEN$0(DLC)sh 85049449

=LDR  02642cz  a2200745n  4500
=001  9880363397102441
=005  20141212201513.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005480
=035  \\$aCAZ8627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x751.$x161
=072  \\$aD2.$x455.$x426.$x559.$x389.$x185.$x350
=150  \\$aFlurbiprofen
=450  \\$wnnna$a2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic Acid
=450  \\$wnnna$aAbbott Brand of Flurbiprofen
=450  \\$wnnna$aAllergan Brand of Flurbiprofen Sodium
=450  \\$wnnna$aAnsaid
=450  \\$wnnna$aApo-Flurbiprofen
=450  \\$wnnna$aApo Flurbiprofen
=450  \\$wnnna$aApotex Brand of Flurbiprofen
=450  \\$wnnna$aBTS-18322
=450  \\$wnnna$aBTS 18322
=450  \\$wnnna$aBTS18322
=450  \\$wnnna$aCantabria Brand of Flurbiprofen
=450  \\$wnnna$aCebutid
=450  \\$wnnna$aCrookes Brand of Flurbiprofen
=450  \\$wnnna$aDobrofen
=450  \\$wnnna$aE-7869
=450  \\$wnnna$aE 7869
=450  \\$wnnna$aE7869
=450  \\$wnnna$aFlubiprofen
=450  \\$wnnna$aFlugalin
=450  \\$wnnna$aFlurbiprofen Pfizer Brand
=450  \\$wnnna$aFlurbiprofen Sodium
=450  \\$wnnna$aFluriproben
=450  \\$wnnna$aFroben
=450  \\$wnnna$aFroben SR
=450  \\$wnnna$aKlosterfrau Brand of Flurbiprofen
=450  \\$wnnna$aKnoll Brand of Flurbiprofen
=450  \\$wnnna$aNeo Artrol
=450  \\$wnnna$aNovo-Flurprofen
=450  \\$wnnna$aNovo Flurprofen
=450  \\$wnnna$aNovopharm Brand of Flurbiprofen
=450  \\$wnnna$aNu-Flurbiprofen
=450  \\$wnnna$aNu Flurbiprofen
=450  \\$wnnna$aNu-Pharm Brand of Flurbiprofen
=450  \\$wnnna$aNu Pharm Brand of Flurbiprofen
=450  \\$wnnna$aOcufen
=450  \\$wnnna$aOcuflur
=450  \\$wnnna$aPfizer Brand of Flurbiprofen
=450  \\$wnnna$aPharm-Allergan Brand of Flurbiprofen Sodium
=450  \\$wnnna$aPharm Allergan Brand of Flurbiprofen Sodium
=450  \\$wnnna$aratio-Flurbiprofen
=450  \\$wnnna$aratio Flurbiprofen
=450  \\$wnnna$aRatiopharm Brand of Flurbiprofen
=450  \\$wnnna$aRecordati Brand of Flurbiprofen
=450  \\$wnnna$aShire Brand of Flurbiprofen
=450  \\$wnnna$aSodium, Flurbiprofen
=450  \\$wnnna$aStrefen
=550  \\$wg$aBiphenyl Compounds
=550  \\$wg$aPropionates
=680  \\$iAn anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
=688  \\$a90(76)
=750  \0$aFlurbiprofen$5IEN$0(DLC)sh 92003786

=LDR  01430cz  a2200397n  4500
=001  9880363397202441
=005  20141212201512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005479
=035  \\$aCAZ8626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x348
=150  \\$aFlurazepam
=450  \\$wnnna$aAllphar Brand of Flurazepam Monohydrochloride
=450  \\$wnnna$aApo-Flurazepam
=450  \\$wnnna$aApo Flurazepam
=450  \\$wnnna$aApotex Brand of Flurazepam Monohydrochloride
=450  \\$wnnna$aDalmadorm
=450  \\$wnnna$aDalmane
=450  \\$wnnna$aDihydrochloride, Flurazepam
=450  \\$wnnna$aDolorgiet Brand of Flurazepam
=450  \\$wnnna$aDormodor
=450  \\$wnnna$aFlurazepam Dihydrochloride
=450  \\$wnnna$aFlurazepam Hydrochloride
=450  \\$wnnna$aFlurazepam Mono-Perchlorate
=450  \\$wnnna$aFlurazepam Mono Perchlorate
=450  \\$wnnna$aFlurazepam Monohydrochloride
=450  \\$wnnna$aHydrochloride, Flurazepam
=450  \\$wnnna$aICN Brand of Flurazepam Monohydrochloride
=450  \\$wnnna$aMono-Perchlorate, Flurazepam
=450  \\$wnnna$aMonohydrochloride, Flurazepam
=450  \\$wnnna$aStaurodorm
=550  \\$wg$aBenzodiazepinones
=680  \\$iA benzodiazepine derivative used mainly as a hypnotic.
=688  \\$a80(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-79
=750  \0$aFlurazepam$5IEN$0(DLC)sh 85049448

=LDR  00974cz  a2200265n  4500
=001  9880363397302441
=005  20141212201510.0
=008  771209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005473
=035  \\$aCAZ8620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x831.$x280
=150  \\$aFluoxetine
=450  \\$wnnna$aFluoxetin
=450  \\$wnnna$aFluoxetine Hydrochloride
=450  \\$wnnna$aLilly-110140
=450  \\$wnnna$aLilly 110140
=450  \\$wnnna$aLilly110140
=450  \\$wnnna$aN-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
=450  \\$wnnna$aProzac
=450  \\$wnnna$aSarafem
=550  \\$wg$aPropylamines
=680  \\$iThe first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
=688  \\$a90(79); was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989
=750  \0$aFluoxetine$5IEN$0(DLC)sh 90005418

=LDR  02977cz  a2200841n  4500
=001  9880363397402441
=005  20161216100548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005472
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x875.$x404
=150  \\$aFluorouracil
=450  \\$wnnna$a5-Fluorouracil
=450  \\$wnnna$a5 Fluorouracil
=450  \\$wnnna$a5-Fluorouracil-biosyn
=450  \\$wnnna$a5 Fluorouracil biosyn
=450  \\$wnnna$a5-FU
=450  \\$wnnna$a5-FU Lederle
=450  \\$wnnna$a5 FU Lederle
=450  \\$wnnna$a5-FU medac
=450  \\$wnnna$a5 FU medac
=450  \\$wnnna$a5-HU Hexal
=450  \\$wnnna$a5 HU Hexal
=450  \\$wnnna$a5FU
=450  \\$wnnna$aAdrucil
=450  \\$wnnna$aAllergan Brand of Fluorouracil
=450  \\$wnnna$abiosyn Brand of Fluorouracil
=450  \\$wnnna$aCarac
=450  \\$wnnna$aCSP Brand of Fluorouracil
=450  \\$wnnna$aDakota Brand of Fluorouracil
=450  \\$wnnna$aDakota, Fluorouracile
=450  \\$wnnna$aDermatech Brand of Fluorouracil
=450  \\$wnnna$aDermik Brand of Fluorouracil
=450  \\$wnnna$aEfudex
=450  \\$wnnna$aEfudix
=450  \\$wnnna$aFerrer Brand of Fluorouracil
=450  \\$wnnna$aFluoro-Uracile ICN
=450  \\$wnnna$aFluoro Uracile ICN
=450  \\$wnnna$aFluoroplex
=450  \\$wnnna$aFluorouracil-GRY
=450  \\$wnnna$aFluorouracil GRY
=450  \\$wnnna$aFluorouracil Mononitrate
=450  \\$wnnna$aFluorouracil Monopotassium Salt
=450  \\$wnnna$aFluorouracil Monosodium Salt
=450  \\$wnnna$aFluorouracil Potassium Salt
=450  \\$wnnna$aFluorouracil Teva Brand
=450  \\$wnnna$aFluorouracile Dakota
=450  \\$wnnna$aFluorouracilo Ferrer Far
=450  \\$wnnna$aFluoruracil
=450  \\$wnnna$aFluracedyl
=450  \\$wnnna$aFlurodex
=450  \\$wnnna$aGry Brand of Fluorouracil
=450  \\$wnnna$aHaemato Brand of Fluorouracil
=450  \\$wnnna$aHaemato-fu
=450  \\$wnnna$aHaemato fu
=450  \\$wnnna$aHexal Brand of Fluorouracil
=450  \\$wnnna$aICN Brand of Fluorouracil
=450  \\$wnnna$amedac Brand of Fluorouracil
=450  \\$wnnna$aNeocorp Brand of Fluorouracil
=450  \\$wnnna$aNeofluor
=450  \\$wnnna$aOnkofluor
=450  \\$wnnna$aOnkoworks Brand of Fluorouracil
=450  \\$wnnna$aPharmachemie Brand of Fluorouracil Monosodium Salt
=450  \\$wnnna$aRibofluor
=450  \\$wnnna$aribosepharm Brand of Fluorouracil
=450  \\$wnnna$aRiemser Brand of Fluorouracil
=450  \\$wnnna$aRoche Brand of Fluorouracil
=450  \\$wnnna$aTeva Brand of Fluorouracil
=550  \\$wg$aUracil
=550  \\$wh$aCapecitabine
=550  \\$wh$aTegafur
=680  \\$iA pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
=750  \0$aFluorouracil$5IEN$0(DLC)sh 85049443

=LDR  00627cz  a2200205n  4500
=001  9880363397502441
=005  20180306104419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005471
=035  \\$aCAZ8618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x225
=150  \\$aFluoroscopy
=450  \\$wnnna$aFluoroscopies
=550  \\$wg$aRadiography
=550  \\$wh$aBarium Enema
=550  \\$wh$aPhotofluorography
=667  \\$aNIM; do not use /util except by MeSH definition
=680  \\$iProduction of an image when x-rays strike a fluorescent screen.
=750  \0$aFluoroscopy$5IEN$0(DLC)sh 85049441

=LDR  00953cz  a2200265n  4500
=001  9880363397602441
=005  20141212201508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005470
=035  \\$aCAZ8617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x516.$x600
=150  \\$aFluorometry
=450  \\$wnnna$aAnalysis, Fluorometric
=450  \\$aFluorimetry
=450  \\$wnnna$aFluorometric Analysis
=550  \\$wg$aLuminescent Measurements
=550  \\$wh$aCytophotometry
=550  \\$wh$aFluorescence Polarization
=550  \\$wh$aFluorescence Recovery After Photobleaching
=550  \\$wh$aFluorophotometry
=550  \\$wh$aSpectrometry, Fluorescence
=680  \\$iAn analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS.
=688  \\$a66(64)
=750  \0$aFluorimetry$5IEN$0(DLC)sh 85049422

=LDR  01586cz  a2200373n  4500
=001  9880363397702441
=005  20141212201507.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005466
=035  \\$aCAZ8612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x510.$x435
=150  \\$aFluorocarbons
=450  \\$wnnna$aAlcohols, Fluorinated Telomer
=450  \\$wnnna$aAlcohols, Fluoro-Telomer
=450  \\$wnnna$aAlcohols, Polyfluorinated Telomer
=450  \\$wnnna$aEmulsions, Fluorocarbon
=450  \\$wnnna$aFluorinated Telomer Alcohols
=450  \\$wnnna$aFluoro-Telomer Alcohols
=450  \\$wnnna$aFluoro Telomer Alcohols
=450  \\$aFluorocarbon Emulsions
=450  \\$wnnna$aFluorocarbons, Telomer
=450  \\$aPerfluorobutyl Tetrahydrofuran$5IEN-M
=450  \\$aPerfluorocarbons
=450  \\$wnnna$aPolyfluorinated Telomer Alcohols
=450  \\$wnnna$aTelomer Alcohols, Fluorinated
=450  \\$wnnna$aTelomer Alcohols, Polyfluorinated
=450  \\$wnnna$aTelomer Fluorocarbons
=550  \\$wg$aHydrocarbons, Fluorinated
=550  \\$aLiquid Ventilation
=667  \\$ado not confuse with HYDROCARBONS, FLUORINATED or CHLOROFLUOROCARBONS or TELOMERE
=680  \\$iLiquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes.
=688  \\$a77(75); was see under FLUOROCARBON POLYMERS 1975-76
=750  \0$aFluorocarbons$5IEN$0(DLC)sh 85049435

=LDR  00791cz  a2200277n  4500
=001  9880363397802441
=005  20141212201506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005465
=035  \\$aCAZ8611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x395
=072  \\$aD25.$x720.$x395
=072  \\$aJ1.$x637.$x51.$x720.$x395
=150  \\$aFluorocarbon Polymers
=450  \\$aFluorinated Polymers
=450  \\$aFluorocarbon Resins
=450  \\$wnnna$aPolymers, Fluorinated
=450  \\$wnnna$aPolymers, Fluorocarbon
=450  \\$wnnna$aResins, Fluorocarbon
=550  \\$wg$aPolymers
=550  \\$wh$aPolytetrafluoroethylene
=550  \\$aHydrocarbons, Fluorinated
=667  \\$aD25-26 qualif
=688  \\$a66
=750  \0$aFluoropolymers$5IEN-M$0(DLC)sh 99003886

=LDR  00767cz  a2200205n  4500
=001  9880363397902441
=005  20141212201506.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005462
=035  \\$aCAZ8608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x340
=150  \\$aFluorine Radioisotopes
=450  \\$wnnna$aRadioisotopes, Fluorine
=550  \\$wg$aRadioisotopes
=550  \\$aFluorine
=667  \\$aF-17, 18, 20-22; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.
=688  \\$a88
=750  \0$aFluorine$xIsotopes$5IEN-M$0(DLC)sh 85049425

=LDR  00674cz  a2200169n  4500
=001  9880363398002441
=005  20141212201505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005461
=035  \\$aCAZ8607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x380.$x300
=150  \\$aFluorine
=550  \\$wg$aHalogens
=667  \\$aF-19; F-17, 18, 20-22 = FLUORINE RADIOISOTOPES (IM); if discussed as a trace element, coordinate with TRACE ELEMENTS
=680  \\$iA nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as flouride (FLUORIDES) to prevent dental caries.
=750  \0$aFluorine$5IEN-M$0(DLC)sh 85049424

=LDR  00995cz  a2200265n  4500
=001  9880363398102441
=005  20141212201505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005459
=035  \\$aCAZ8605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x380
=072  \\$aD1.$x303.$x350.$x300
=150  \\$aFluorides
=450  \\$wnnna$aFluoride
=550  \\$wg$aAnions
=550  \\$wg$aHydrofluoric Acid
=550  \\$wh$aCalcium Fluoride
=550  \\$wh$aFluorides, Topical
=550  \\$wh$aSodium Fluoride
=550  \\$wh$aSulfur Hexafluoride
=550  \\$wh$aTin Fluorides
=667  \\$aonly for inorganic cpds or fluoride ion; /admin: consider also FLUORIDES, TOPICAL
=680  \\$iInorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices.
=750  \0$aFluorides$5IEN$0(DLC)sh 85049419

=LDR  00631cz  a2200205n  4500
=001  9880363398202441
=005  20141212201504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005458
=035  \\$aCAZ8604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x380
=150  \\$aFluoride Poisoning
=450  \\$wnnna$aFluoride Poisonings
=450  \\$aFluorides$xpoisoning
=450  \\$wnnna$aPoisoning, Fluoride
=450  \\$wnnna$aPoisonings, Fluoride
=550  \\$wg$aPoisoning
=667  \\$ageneral or unspecified fluoride; prefer /pois with specific fluoride term
=750  \0$aFluorides$xToxicology$5IEN$0(IEN)368385

=LDR  00757cz  a2200217n  4500
=001  9880363398302441
=005  20141212201504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005457
=035  \\$aCAZ8603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x761.$x382
=072  \\$aN6.$x890.$x235
=150  \\$aFluoridation
=550  \\$wg$aPreventive Dentistry
=550  \\$wg$aPublic Health Dentistry
=550  \\$aCariostatic Agents
=667  \\$a/adv eff permitted but more likely is FLUORIDES /adv eff or specific fluoride terms /adv eff; = "fluoridation of water supply" so do not also coord with WATER SUPPLY
=688  \\$a65
=750  \0$aWater$xFluoridation$5IEN-M$0(DLC)sh 85145458
=750  \0$aMilk$xFluoridation$5IEN-HS$0(DLC)sh 85085325

=LDR  01292cz  a2200337n  4500
=001  9880363398402441
=005  20141212201504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005456
=035  \\$aCAZ8602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x233.$x348
=072  \\$aD27.$x720.$x470.$x330.$x348
=072  \\$aD27.$x720.$x470.$x410.$x505.$x500
=150  \\$aFluorescent Dyes
=450  \\$wnnna$aAgents, Fluorescence
=450  \\$wnnna$aAgents, Fluorescent
=450  \\$wnnna$aDyes, Fluorescent
=450  \\$wnnna$aFluorescence Agents
=450  \\$wnnna$aFluorescent Agents
=450  \\$aFluorescent Probes
=450  \\$aFluorochromes
=450  \\$wnnna$aFluorogenic Substrate
=450  \\$wnnna$aProbes, Fluorescent
=450  \\$wnnna$aSubstrate, Fluorogenic
=550  \\$wg$aColoring Agents
=550  \\$wg$aLuminescent Agents
=550  \\$aLuminescent Agents
=667  \\$aD25-26 qualif
=680  \\$iAgents that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.
=750  \0$aFluorescent probes$5IEN-M$0(DLC)sh 93005286

=LDR  03255cz  a2200745n  4500
=001  9880363398502441
=005  20141212201504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005455
=035  \\$aCAZ8601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x607.$x512.$x240
=072  \\$aE1.$x370.$x225.$x750.$x551.$x512.$x240
=072  \\$aE5.$x200.$x500.$x607.$x512.$x240
=072  \\$aE5.$x200.$x750.$x551.$x512.$x240
=072  \\$aE5.$x478.$x412
=072  \\$aE5.$x478.$x583.$x375
=150  \\$aFluorescent Antibody Technique
=450  \\$wnnna$aAntibody Technic, Fluorescent
=450  \\$wnnna$aAntibody Technics, Fluorescent
=450  \\$wnnna$aAntibody Technique, Fluorescent
=450  \\$wnnna$aAntibody Techniques, Fluorescent
=450  \\$aAntinuclear Antibody Test, Fluorescent
=450  \\$wnnna$aCoon Technic
=450  \\$wnnna$aCoon Technique
=450  \\$wnnna$aCoon's Technic
=450  \\$wnnna$aCoons Technic
=450  \\$aCoon's Technique
=450  \\$wnnna$aCoons Technique
=450  \\$wnnna$aFluorescent Antibody Technic
=450  \\$wnnna$aFluorescent Antibody Technics
=450  \\$wnnna$aFluorescent Antibody Techniques
=450  \\$aFluorescent Antinuclear Antibody Test
=450  \\$aFluorescent Protein Tracing
=450  \\$wnnna$aFluorescent Protein Tracings
=450  \\$wnnna$aImmunofluorescence
=450  \\$wnnna$aImmunofluorescence Technic
=450  \\$wnnna$aImmunofluorescence Technics
=450  \\$aImmunofluorescence Technique
=450  \\$wnnna$aImmunofluorescence Techniques
=450  \\$wnnna$aProtein Tracing, Fluorescent
=450  \\$wnnna$aProtein Tracings, Fluorescent
=450  \\$wnnna$aTechnic, Coon's
=450  \\$wnnna$aTechnic, Fluorescent Antibody
=450  \\$wnnna$aTechnic, Immunofluorescence
=450  \\$wnnna$aTechnics, Fluorescent Antibody
=450  \\$wnnna$aTechnics, Immunofluorescence
=450  \\$wnnna$aTechnique, Coon's
=450  \\$wnnna$aTechnique, Fluorescent Antibody
=450  \\$wnnna$aTechnique, Immunofluorescence
=450  \\$wnnna$aTechniques, Fluorescent Antibody
=450  \\$wnnna$aTechniques, Immunofluorescence
=450  \\$wnnna$aTracing, Fluorescent Protein
=450  \\$wnnna$aTracings, Fluorescent Protein
=550  \\$wg$aImmunohistochemistry
=550  \\$wg$aImmunologic Techniques
=550  \\$wh$aAntibody-Coated Bacteria Test, Urinary
=550  \\$wh$aFluorescent Antibody Technique, Direct
=550  \\$wh$aFluorescent Antibody Technique, Indirect
=550  \\$wh$aFluoroimmunoassay
=667  \\$aNIM; GEN or unspecified; prefer specifics; DF: FANA TEST
=680  \\$iTest for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy.
=688  \\$a91; was FLUORESCENT ANTIBODY TECHNIC 1963-90
=750  \0$aFluorescent antigen technique$5IEN-M$0(DLC)sh 85049413
=750  \0$aFluorescent antibody technique$5IEN-HS$0(DLC)sh 85049412

=LDR  00950cz  a2200181n  4500
=001  9880363398602441
=005  20141212201502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005453
=035  \\$aCAZ8599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650.$x665.$x500
=072  \\$aG1.$x590.$x540.$x665.$x500
=150  \\$aFluorescence
=550  \\$wg$aLuminescence
=667  \\$ano qualif; IM for principle of physics but be careful of use of word describing many "fluorescence" techniques as main headings; fluorescence-activated cell sorting: index under CELL SEPARATION + FLOW CYTOMETRY
=680  \\$iThe property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
=750  \0$aFluorescence$5IEN$0(DLC)sh 85049407

=LDR  01329cz  a2200289n  4500
=001  9880363398702441
=005  20141212201502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005451
=035  \\$aCAZ8597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x50.$x350
=072  \\$aE1.$x370.$x380.$x250
=150  \\$aFluorescein Angiography
=450  \\$wnnna$aAngiography, Fluorescein
=450  \\$wnnna$aAngiography, Fluorescence
=450  \\$aFluorescence Angiography
=450  \\$wnnna$aFluorescence Photography, Fundus
=450  \\$aFundus Fluorescence Photography
=450  \\$wnnna$aPhotography, Fundus Fluorescence
=550  \\$wg$aAngiography
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$aRetinal Vessels
=667  \\$a/drug eff /rad eff permitted; coord disease with /diag, not /radiogr since this is not a radiogr technique; DF: FLUORESCEIN ANGIOGR
=680  \\$iVisualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
=688  \\$a79; was FLUORESCENCE ANGIOGRAPHY 1973-78; FUNDUS FLUORESCENCE PHOTOGRAPHY was see under FLUORESCENCE ANGIOGRAPHY 1973-78
=750  \0$aFluorescence angiography$5IEN$0(DLC)sh 85049409

=LDR  00657cz  a2200205n  4500
=001  9880363398802441
=005  20141212201501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005449
=035  \\$aCAZ8595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x389
=072  \\$aD4.$x615.$x389
=150  \\$aFluorenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$a2-Acetylaminofluorene
=550  \\$wh$aTilorone
=667  \\$acarcinogenic aromatic hydrocarbons; do not confuse with FLUORINE; D25-26 qualif
=680  \\$iA family of diphenylenemethane derivatives.
=750  \0$aFluorene$5IEN$0(DLC)sh 85049405

=LDR  00760cz  a2200157n  4500
=001  9880363348202441
=005  20141212194814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x90.$x72
=150  \\$aAnthrax
=550  \\$wg$aBacillaceae Infections
=667  \\$aBacillus infect; human & animal; /vet permitted
=680  \\$iAn acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.
=750  \0$aAnthrax$5IEN$0(DLC)sh 85005563

=LDR  00846cz  a2200241n  4500
=001  9880363348302441
=005  20201102111250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000880
=035  \\$aCAZ4031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x117.$x159
=072  \\$aD2.$x806.$x100
=072  \\$aD4.$x615.$x117.$x159
=150  \\$aAnthraquinones
=450  \\$aAnthracenediones
=450  \\$wnnna$aAnthranoids
=450  \\$wnnna$aAnthraquinone Compounds
=450  \\$wnnna$aAnthraquinone Derivatives
=450  \\$wnnna$aCompounds, Anthraquinone
=450  \\$wnnna$aDerivatives, Anthraquinone
=680  \\$iCompounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups.
=750  \0$aAnthraquinones$5IEN$0(DLC)sh 85005561

=LDR  00729cz  a2200229n  4500
=001  9880363348402441
=005  20141212194812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000873
=035  \\$aCAZ4024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x117
=072  \\$aD4.$x615.$x117
=150  \\$aAnthracenes
=450  \\$wnnna$aAnthrones
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$aAnthralin
=550  \\$wh$aAnthraquinones
=550  \\$wh$aMaprotiline
=667  \\$aX ref ANTHRONES: for two ketone groups use ANTHRAQUINONES
=680  \\$iA group of compounds with three aromatic rings joined in linear arrangement.
=750  \0$aAnthracene$5IEN$0(DLC)sh 85005547

=LDR  01013cz  a2200265n  4500
=001  9880363348502441
=005  20141212194812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000872
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x87
=072  \\$aD3.$x830.$x219.$x266.$x450.$x87
=072  \\$aD9.$x408.$x84
=072  \\$aD23.$x767.$x124
=150  \\$aAnthocyanins
=450  \\$wnnna$aAnthocyanidin
=450  \\$wnnna$aAnthocyanidins
=450  \\$wnnna$aAnthocyanin
=450  \\$wnnna$aLeucoanthocyanidins
=550  \\$wg$aFlavonoids
=550  \\$wg$aGlycosides
=550  \\$wg$aPigments, Biological
=680  \\$iA group of FLAVONOIDS derived from FLAVONOLS, which lack the ketone oxygen at the 4-position. They are glycosylated versions of cyanidin, pelargonidin or delphinidin. The conjugated bonds result in blue, red, and purple colors in flowers of plants.
=688  \\$a1963; for ANTHOCYANIN use ANTHOCYANINS (NM)
=750  \0$aAnthocyanins$0(DLC) sh 85005532$5IEN

=LDR  00841cz  a2200253n  4500
=001  9880363348602441
=005  20141212194812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000871
=035  \\$aCAZ4022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250.$x75
=150  \\$aAnthelmintics
=450  \\$wnnna$aAntihelmintics
=450  \\$aVermifuges
=550  \\$wg$aAntiparasitic Agents
=550  \\$wh$aAntinematodal Agents
=550  \\$wh$aAntiplatyhelmintic Agents
=550  \\$aAnti-Infective Agents
=550  \\$aHelminthiasis
=550  \\$aParasites
=667  \\$ageneral or unspecified; prefer specific groups
=680  \\$iAgents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.
=750  \0$aAnthelmintics$5IEN$0(DLC)sh 85005522

=LDR  01048cz  a2200325n  4500
=001  9880363348702441
=005  20141212194811.0
=008  840430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000869
=035  \\$aCAZ4020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60
=150  \\$aAnterior Eye Segment
=450  \\$wnnna$aAnterior Eye Segments
=450  \\$wnnna$aEye Segment, Anterior
=450  \\$wnnna$aEye Segments, Anterior
=450  \\$wnnna$aSegment, Anterior Eye
=450  \\$wnnna$aSegments, Anterior Eye
=550  \\$wg$aEye
=550  \\$wh$aAnterior Chamber
=550  \\$wh$aCiliary Body
=550  \\$wh$aConjunctiva
=550  \\$wh$aCornea
=550  \\$wh$aIris
=550  \\$wh$aLens, Crystalline
=550  \\$wh$aTrabecular Meshwork
=667  \\$ado not confuse with ANTERIOR CHAMBER
=680  \\$iThe front third of the eyeball that includes the structures between the front surface of the cornea and the front of the VITREOUS BODY.
=688  \\$a85
=750  \0$aAnterior segment (Eye)$5IEN$0(DLC)sh 88003027

=LDR  01238cz  a2200241n  4500
=001  9880363348802441
=005  20141212194811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000867
=035  \\$aCAZ4018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x67
=150  \\$aAnterior Chamber
=450  \\$wnnna$aAnterior Chambers
=450  \\$wnnna$aChamber, Anterior
=450  \\$wnnna$aChambers, Anterior
=550  \\$wg$aAnterior Eye Segment
=550  \\$wh$aAqueous Humor
=550  \\$wh$aEndothelium, Corneal
=667  \\$athe space between the cornea & lens which contains the aqueous humor; do not confuse with ANTERIOR EYE SEGMENT; hemorrhage within anterior chamber = HYPHEMA; anterior chamber endothelium = ENDOTHELIUM, ANTERIOR CHAMBER see ENDOTHELIUM, CORNEAL
=680  \\$iThe space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109)
=688  \\$a66(64); was see under AQUEOUS HUMOR 1963-65
=750  \0$aAnterior chamber (Eye)$5IEN$0(DLC)sh 85005517

=LDR  00861cz  a2200241n  4500
=001  9880363348902441
=005  20141212194810.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000866
=035  \\$aCAZ4017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x100
=150  \\$aAntelopes
=450  \\$wnnna$aAntelope
=450  \\$wnnna$aAntelopine
=450  \\$aAntelopines
=450  \\$wnnna$aHippotragine
=450  \\$aHippotragines
=550  \\$wg$aRuminants
=667  \\$aincludes dik-dik, eland, gazelle, gnu, hartebeest, impala, springbok, wildebeest; IM; qualif permitted
=680  \\$iAny of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn.
=688  \\$a91(75); was see under ARTIODACTYLA 1975-90
=750  \0$aAntelopes$5IEN$0(DLC)sh 85005500

=LDR  00703cz  a2200217n  4500
=001  9880363349002441
=005  20141212191953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000863
=035  \\$aCAZ4014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x170
=072  \\$aD27.$x505.$x954.$x483.$x80
=150  \\$aAntacids
=450  \\$wnnna$aAgents, Alkalinizing
=450  \\$wnnna$aAlkalinizing Agents
=550  \\$wg$aGastrointestinal Agents
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$aAnti-Ulcer Agents
=680  \\$iSubstances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
=750  \0$aAntacids$5IEN$0(DLC)sh 85005479

=LDR  00996cz  a2200277n  4500
=001  9880363349102441
=005  20141212194809.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000862
=035  \\$aCAZ4013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65.$x55
=072  \\$aD23.$x946.$x833.$x65.$x55
=150  \\$aAnt Venoms
=450  \\$wnnna$aAnt Venom
=450  \\$wnnna$aFire Ant Venoms
=450  \\$aFormicoidea Venoms
=450  \\$wnnna$aVenom, Ant
=450  \\$wnnna$aVenoms, Ant
=450  \\$wnnna$aVenoms, Fire Ant
=450  \\$wnnna$aVenoms, Formicoidea
=550  \\$wg$aArthropod Venoms
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted
=680  \\$iVenoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic.
=688  \\$a91(78); was see under ARTHROPOD VENOMS 1978-90
=750  \0$aAnts$xVenom$5IEN-M$0(IEN)3998725

=LDR  00655cz  a2200217n  4500
=001  9880363349202441
=005  20141212194809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000861
=035  \\$aCAZ4012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x345.$x159
=150  \\$aAnserine
=450  \\$wnnna$aBalanine
=450  \\$wnnna$aBeta-Alanyl-3-Methylhistidine
=450  \\$wnnna$aBeta Alanyl 3 Methylhistidine
=450  \\$wnnna$aOphidine
=550  \\$wg$aDipeptides
=667  \\$aa dipeptide
=688  \\$a91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
=750  \0$aAnserine$5IEN$0(DLC)sh 85005474

=LDR  01422cz  a2200373n  4500
=001  9880363349302441
=005  20170525105721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000860
=035  \\$aCAZ4011HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x852.$x79
=150  \\$aHypoxia
=450  \\$wnno$aAnoxia
=450  \\$wnnna$aAnoxemia
=450  \\$wnnna$aAnoxemias
=450  \\$wnnna$aAnoxias
=450  \\$wnnna$aDeficiencies, Oxygen
=450  \\$wnnna$aDeficiency, Oxygen
=450  \\$wnnna$aHypoxemia
=450  \\$wnnna$aHypoxemias
=450  \\$wnnna$aHypoxias
=450  \\$wnnna$aOxygen Deficiencies
=450  \\$aOxygen Deficiency
=450  \\$aOxygen$xdeficiency
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wh$aFetal Hypoxia
=550  \\$aHypoxia, Brain
=550  \\$aHypoxia-Ischemia, Brain
=667  \\$ado not confuse with HYPEROXIA; restrict to disease or clinical state in humans and vertebrates: do not use for anoxic or hypoxic state in invertebrates or micro-organisms (= OXYGEN or ANAEROBIOSIS); FETAL HYPOXIA, HYPOXIA, BRAIN and CELL HYPOXIA are also available
=680  \\$iSub-optimal OXYGEN levels in the ambient air of living organisms.
=688  \\$a2017 (1966); for HYPOXIA see ANOXIA 1999-2016
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Anoxemia
=750  \0$aAnoxemia$0(DLC) sh 85005466$5IEN-M

=LDR  00761cz  a2200217n  4500
=001  9880363349402441
=005  20141212194808.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000858
=035  \\$aCAZ4009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x630.$x50
=072  \\$aC19.$x391.$x630.$x50
=072  \\$aG8.$x686.$x785.$x760.$x690.$x80
=150  \\$aAnovulation
=450  \\$wnnna$aAnovulations
=550  \\$wg$aOvarian Diseases
=550  \\$wg$aOvulation
=680  \\$iSuspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
=688  \\$a75
=750  \0$aAnovulation$5IEN$0(DLC)sh 85005465

=LDR  01067cz  a2200325n  4500
=001  9880363349502441
=005  20141212194808.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000857
=035  \\$aCAZ4008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x600
=072  \\$aC23.$x888.$x592.$x763.$x550
=150  \\$aOlfaction Disorders
=450  \\$aAnosmia
=450  \\$wnnna$aCacosmia
=450  \\$wnnna$aCacosmias
=450  \\$wnnna$aDysosmia
=450  \\$wnnna$aDysosmias
=450  \\$wnnna$aOlfaction Disorder
=450  \\$aParaosmia
=450  \\$wnnna$aParaosmias
=450  \\$wnnna$aSmell Disorder
=450  \\$aSmell Disorders
=550  \\$wg$aSensation Disorders
=550  \\$aOlfactory Nerve Diseases
=550  \\$aSmell
=680  \\$iLoss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions.
=688  \\$a2000(1963)
=750  \0$aSmell disorders$5IEN-HS$0(DLC)sh 85123633

=LDR  01013cz  a2200229n  4500
=001  9880363349602441
=005  20160429144811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000856
=035  \\$aCAZ4007HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x375.$x100
=150  \\$aAnorexia Nervosa
=450  \\$wnnna$aAnorexia Nervosas
=450  \\$wnnna$aNervosa, Anorexia
=450  \\$wnnna$aNervosas, Anorexia
=550  \\$wg$aFeeding and Eating Disorders
=550  \\$aAnorexia
=550  \\$aBody Dysmorphic Disorders
=667  \\$aANOREXIA is also available
=680  \\$iAn eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994)
=750  \0$aAnorexia nervosa$0(DLC) sh 85005453$5IEN

=LDR  00739cz  a2200205n  4500
=001  9880363349702441
=005  20141212194807.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000855
=035  \\$aCAZ4006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x108
=150  \\$aAnorexia
=450  \\$wnnna$aAnorexias
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$aAnorexia Nervosa
=667  \\$aANOREXIA NERVOSA is also available
=680  \\$iThe lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
=688  \\$a91(75); was see under EATING DISORDERS 1975-90
=750  \0$aAnorexia$0(DLC) sh 85005451$5IEN

=LDR  01365cz  a2200409n  4500
=001  9880363349802441
=005  20141212194807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000854
=035  \\$aCAZ4005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x690.$x60
=150  \\$aAnoplura
=450  \\$wnnna$aAnopluras
=450  \\$aHaematopinus
=450  \\$aHoplopleura
=450  \\$wnnna$aHoplopleuras
=450  \\$wnnna$aLice, Sucking
=450  \\$wnnna$aLices, Sucking
=450  \\$aLinognathus
=450  \\$wnnna$aLouse, Sucking
=450  \\$wnnna$aLouses, Sucking
=450  \\$aPolyplax
=450  \\$wnnna$aPolyplaxs
=450  \\$wnnna$aSolenopote
=450  \\$aSolenopotes
=450  \\$aSucking Lice
=450  \\$wnnna$aSucking Lices
=450  \\$wnnna$aSucking Louse
=450  \\$wnnna$aSucking Louses
=550  \\$wg$aPhthiraptera
=550  \\$wh$aPediculus
=550  \\$wh$aPhthirus
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iAn order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.
=688  \\$a72
=750  \0$aAnoplura$5IEN$0(DLC)sh 85005450

=LDR  00654cz  a2200193n  4500
=001  9880363349902441
=005  20141212194807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000852
=035  \\$aCAZ4003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x275.$x120
=150  \\$aAnopheles
=450  \\$wnnna$aAnophele
=550  \\$wg$aCulicidae
=550  \\$wh$aAnopheles gambiae
=667  \\$amosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of mosquitoes (CULICIDAE) that are known vectors of MALARIA.
=750  \0$aAnopheles$5IEN$0(DLC)sh 85005436

=LDR  00823cz  a2200229n  4500
=001  9880363350002441
=005  20141212194806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000851
=035  \\$aCAZ4002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x400.$x556.$x283
=150  \\$aAnonyms and Pseudonyms
=450  \\$wnnna$aAnonym
=450  \\$wnnna$aAnonyms
=450  \\$wnnna$aPseudonym
=450  \\$aPseudonyms
=450  \\$wnnna$aPseudonyms and Anonyms
=550  \\$wg$aNames
=667  \\$ano qualif; DF: ANONYMS
=680  \\$iDesignations for persons whose names are not known or who wish to remain anonymous (anonyms) and for persons who wish to conceal or obscure their identity by assuming a fictitious name (pseudonyms).
=750  \0$aAnonyms and pseudonyms$5IEN$0(DLC)sh 85005416

=LDR  01186cz  a2200277n  4500
=001  9880363350102441
=005  20141212191953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000850
=035  \\$aCAZ4001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x93
=072  \\$aI1.$x880.$x853.$x450.$x283
=150  \\$aAnomie
=450  \\$wnnna$aAnomies
=450  \\$aAnomy$5IEN
=450  \\$wnnna$aDisorganization, Social
=450  \\$wnnna$aDisorganizations, Social
=450  \\$aSocial Disorganization
=450  \\$wnnna$aSocial Disorganizations
=550  \\$wg$aSocial Behavior
=550  \\$wg$aSocial Conditions
=667  \\$ano qualif; "state of social disorganization & demoralization in society..."; sometimes called "anomia" but do not confuse with ANOMIA ("inability to name objects")
=680  \\$iA state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.
=688  \\$a71
=750  \0$aAnomy$5IEN$0(DLC)sh 85005412

=LDR  01784cz  a2200433n  4500
=001  9880363350202441
=005  20141212194806.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000849
=035  \\$aCAZ4000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x90
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x90
=150  \\$aAnomia
=450  \\$wnnna$aAmnesic Aphasia
=450  \\$wnnna$aAnomia, Color
=450  \\$wnnna$aAnomias, Color
=450  \\$wnnna$aAnomic Aphasia
=450  \\$wnnna$aAnomic Dysphasia
=450  \\$wnnna$aAnomic Dysphasias
=450  \\$aAphasia, Amnesic
=450  \\$aAphasia, Anomic
=450  \\$aAphasia, Nominal
=450  \\$aColor Anomia
=450  \\$wnnna$aColor Anomias
=450  \\$aDysnomia
=450  \\$wnnna$aDysnomias
=450  \\$wnnna$aDysphasia, Anomic
=450  \\$wnnna$aDysphasia, Nominal
=450  \\$wnnna$aDysphasias, Anomic
=450  \\$wnnna$aDysphasias, Nominal
=450  \\$wnnna$aNominal Aphasia
=450  \\$wnnna$aNominal Dysphasia
=450  \\$wnnna$aNominal Dysphasias
=550  \\$wg$aLanguage Disorders
=667  \\$ainability to name objects: do not confuse with ANOMIE ("state of social disorganization & demoralization in society...", often called "anomia")
=680  \\$iA language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, p484)
=688  \\$a1991(1980); use APHASIA 1975-1979
=750  \0$aAnomia$5IEN-M$0(DLC)sh 96011320

=LDR  01299cz  a2200253n  4500
=001  9880363350302441
=005  20141212194805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000848
=035  \\$aCAZ3999M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x650.$x800.$x100
=072  \\$aC7.$x793.$x700.$x100
=072  \\$aC16.$x131.$x850.$x800.$x100
=150  \\$aAnodontia
=450  \\$aHypodontia
=450  \\$wnnna$aHypodontia/Oligodontia 1
=450  \\$wnnna$aTooth Agenesis, Familial
=450  \\$wnnna$aTooth Agenesis, Selective, 1
=550  \\$wg$aTooth Abnormalities
=667  \\$acongen absence of teeth; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; congen absence of one or more teeth: do not confuse with JAW, EDENTULOUS (total lack of teeth in either jaw through disease or extraction), JAW, EDENTULOUS, PARTIALLY (partial lack in either jaw) or MOUTH, EDENTULOUS (total lack of teeth in both jaws through disease or extraction)
=680  \\$iCongenital absence of the teeth; it may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. (Dorland, 27th ed)
=688  \\$a65
=750  \0$aHypodontia$0(DLC)sh2010013988$5IEN-M

=LDR  00996cz  a2200265n  4500
=001  9880363350402441
=005  20141212194804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000845
=035  \\$aCAZ3996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x91
=150  \\$aAnnelida
=450  \\$wnnna$aAnnelidas
=450  \\$wnnna$aSegmented Worm
=450  \\$aSegmented Worms
=450  \\$wnnna$aWorm, Segmented
=450  \\$aWorms, Segmented
=550  \\$wg$aInvertebrates
=550  \\$wh$aLeeches
=550  \\$wh$aOligochaeta
=550  \\$wh$aPolychaeta
=667  \\$aa phylum of segmented worms; GEN or unspecified; prefer specifics; /microbiol /parasitol /virol permitted
=680  \\$iA phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids (POLYCHAETA), freshwater annelids, earthworms (OLIGOCHAETA), and LEECHES. Only the leeches are of medical interest. (Dorland, 27th ed)
=750  \0$aAnnelida$5IEN$0(DLC)sh 85005348

=LDR  00491cz  a2200181n  4500
=001  9880363350502441
=005  20141212194804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000844
=035  \\$aCAZ3995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x69
=150  \\$aAnkylosis
=450  \\$wnnna$aAnkyloses
=550  \\$wg$aJoint Diseases
=550  \\$wh$aSpondylitis, Ankylosing
=680  \\$iFixation and immobility of a joint.
=750  \0$aAnkylosis$5IEN$0(DLC)sh 85005329

=LDR  00861cz  a2200229n  4500
=001  9880363350602441
=005  20141212194803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000842
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x250.$x149
=150  \\$aAnkle
=450  \\$wnnna$aAnkles
=450  \\$wnnna$aRegio tarsalis
=450  \\$aTarsus
=550  \\$wg$aFoot
=550  \\$aAnkle Joint
=550  \\$aTarsal Bones
=667  \\$aprimates only; use TARSUS, ANIMAL for non-primate vertebrates; differentiate from ANKLE JOINT; ANKLE BONES see TARSAL BONES is also available; do not confuse X ref TARSUS with tarsus or tarsal referring to the eyelid
=680  \\$iThe region of the lower limb between the FOOT and the LEG.
=688  \\$a1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91
=750  \0$aAnkle$5IEN$0(DLC)sh 85005314

=LDR  01215cz  a2200457n  4500
=001  9880363350702441
=005  20141212194802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000838
=035  \\$aCAZ3989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158
=150  \\$aAnions
=550  \\$wg$aIons
=550  \\$wh$aArsenates
=550  \\$wh$aArsenites
=550  \\$wh$aBorates
=550  \\$wh$aBromates
=550  \\$wh$aBromides
=550  \\$wh$aCarbonates
=550  \\$wh$aChlorates
=550  \\$wh$aChlorides
=550  \\$wh$aChromates
=550  \\$wh$aCyanides
=550  \\$wh$aFluorides
=550  \\$wh$aHydroxides
=550  \\$wh$aIodates
=550  \\$wh$aIodides
=550  \\$wh$aNitrates
=550  \\$wh$aNitrites
=550  \\$wh$aOxides
=550  \\$wh$aPhosphates
=550  \\$wh$aPhosphites
=550  \\$wh$aSulfates
=550  \\$wh$aSulfides
=550  \\$wh$aSulfites
=550  \\$wh$aVanadates
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iNegatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis.
=688  \\$a74
=750  \0$aAnions$5IEN$0(DLC)sh 85005295

=LDR  00622cz  a2200205n  4500
=001  9880363350802441
=005  20141212194802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000836
=035  \\$aCAZ3987HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x448
=150  \\$aAnimals, Zoo
=450  \\$wnnna$aAnimal, Zoo
=450  \\$wnnna$aZoo Animal
=450  \\$wnnna$aZoo Animals
=550  \\$wg$aAnimal Population Groups
=667  \\$aIM; qualif permitted; coord IM with specific zoo animal (IM); do not forget also to check tag ANIMALS
=688  \\$a68
=750  \0$aZoo animals$5IEN$0(DLC)sh 85149970

=LDR  00695cz  a2200217n  4500
=001  9880363350902441
=005  20141212194801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000832
=035  \\$aCAZ3983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x286
=150  \\$aAnimals, Poisonous
=450  \\$wnnna$aAnimal, Poisonous
=450  \\$wnnna$aPoisonous Animal
=450  \\$wnnna$aPoisonous Animals
=550  \\$wg$aAnimal Population Groups
=550  \\$wh$aFishes, Poisonous
=667  \\$aIM; qualif permitted; coord IM with specific poisonous animal (IM); do not forget also to check tag ANIMALS
=688  \\$a68
=750  \0$aPoisonous animals$5IEN$0(DLC)sh 85103941

=LDR  00994cz  a2200289n  4500
=001  9880363351002441
=005  20141212194801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000831
=035  \\$aCAZ3982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x282
=150  \\$aAnimals, Newborn
=450  \\$wnnna$aAnimal, Neonatal
=450  \\$wnnna$aAnimal, Newborn
=450  \\$aAnimals, Neonatal
=450  \\$wnnna$aNeonatal Animal
=450  \\$wnnna$aNeonatal Animals
=450  \\$wnnna$aNewborn Animal
=450  \\$wnnna$aNewborn Animals
=450  \\$aVeterinary Neonatology$5IEN
=550  \\$wg$aAnimal Population Groups
=550  \\$aInfant, Newborn
=550  \\$aPregnancy, Animal
=667  \\$anot for humans; NIM when experimental animal: no qualifiers; when IM, qualifiers permitted; do not forget also to check tag ANIMALS
=680  \\$iRefers to animals in the period of time just after birth.
=750  \0$aVeterinary neonatology$5IEN$0(DLC)sh 90001162

=LDR  00749cz  a2200229n  4500
=001  9880363351102441
=005  20141212194800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000830
=035  \\$aCAZ3981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x199
=150  \\$aAnimals, Laboratory
=450  \\$wnnna$aAnimal, Laboratory
=450  \\$wnnna$aLaboratory Animal
=450  \\$aLaboratory Animals
=550  \\$wg$aAnimal Population Groups
=550  \\$wh$aAnimals, Congenic
=550  \\$wh$aAnimals, Inbred Strains
=550  \\$aDisease Models, Animal
=667  \\$aGEN or unspecified; prefer specifics; IM; qualif permitted; do not forget also to check tag ANIMALS
=750  \0$aLaboratory animals$5IEN$0(DLC)sh 85073746

=LDR  01384cz  a2200337n  4500
=001  9880363351202441
=005  20141212194800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000829
=035  \\$aCAZ3980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x116
=150  \\$aAnimals, Domestic
=450  \\$wnnna$aAnimal, Domestic
=450  \\$wnnna$aAnimal, Domesticated
=450  \\$wnnna$aAnimal, Farm
=450  \\$wnnna$aAnimals, Domesticated
=450  \\$wnnna$aAnimals, Farm
=450  \\$wnnna$aDomestic Animal
=450  \\$wnnna$aDomestic Animals
=450  \\$wnnna$aDomesticated Animal
=450  \\$wnnna$aDomesticated Animals
=450  \\$wnnna$aFarm Animal
=450  \\$aFarm Animals
=550  \\$wg$aAnimal Population Groups
=550  \\$wh$aLivestock
=550  \\$wh$aPets
=550  \\$wh$aPoultry
=667  \\$ageneral or unspecified; domestication goes here
=680  \\$iAnimals which have become adapted through breeding in captivity to a life intimately associated with humans. They include animals domesticated by humans to live and breed in a tame condition on farms or ranches for economic reasons, including LIVESTOCK (specifically CATTLE; SHEEP; HORSES; etc.), POULTRY; and those raised or kept for pleasure and companionship, e.g., PETS; or specifically DOGS; CATS; etc.
=750  \0$aDomestic animals$5IEN$0(DLC)sh 85038908

=LDR  00837cz  a2200253n  4500
=001  9880363351302441
=005  20141212194759.0
=008  850225\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000827
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x100
=150  \\$aAnimal Welfare
=450  \\$wnnna$aAnimal Cruelty
=450  \\$wnnna$aCruelty, Animal
=450  \\$wnnna$aWelfare, Animal
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aAnimal Care Committees
=550  \\$wh$aAnimal Rights
=550  \\$aAnimal Use Alternatives
=550  \\$aEuthanasia, Animal
=550  \\$aVivisection
=680  \\$iThe protection of animals in laboratories or other specific environments by promoting their health through better nutrition, housing, and care.
=688  \\$a1986
=750  \0$aAnimal welfare$5IEN-M$0(DLC)sh 85005274

=LDR  00964cz  a2200253n  4500
=001  9880363351402441
=005  20141212194759.0
=008  840611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000826
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x17.$x80.$x100
=150  \\$aAnimal Testing Alternatives
=450  \\$wnnna$aAlternative, Animal Testing
=450  \\$wnnna$aAlternatives, Animal Testing
=450  \\$aAlternatives to Animal Testing
=450  \\$wnnna$aAnimal Testing Alternative
=450  \\$wnnna$aTesting Alternative, Animal
=450  \\$wnnna$aTesting Alternatives, Animal
=550  \\$wg$aAnimal Use Alternatives
=550  \\$aAnimals, Laboratory
=667  \\$aSPEC qualif
=680  \\$iProcedures, such as TISSUE CULTURE TECHNIQUES; mathematical models; etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories.
=688  \\$a85
=750  \0$aAlternative toxicity testing$5IEN-M$0(DLC)sh 00009650

=LDR  01582cz  a2200397n  4500
=001  9880363351502441
=005  20141212194757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000824
=035  \\$aCAZ3975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x161
=150  \\$aAnimal Nutritional Physiological Phenomena
=450  \\$wnno$aAnimal Nutrition$5IEN-M
=450  \\$aAnimal Nutrition Physiology
=450  \\$wnnna$aAnimal Nutritional Physiological Phenomenon
=450  \\$wnnna$aAnimal Nutritional Physiology
=450  \\$aAnimal Nutritional Physiology Phenomena
=450  \\$wnnna$aAnimal Nutritional Physiology Phenomenon
=450  \\$wnnna$aNutrition Physiologies, Animal
=450  \\$wnnna$aNutrition Physiology, Animal
=450  \\$wnnna$aNutritional Physiology, Animal
=450  \\$wnnna$aNutritional Physiology, Veterinary
=450  \\$wnnna$aPhysiology, Animal Nutrition
=450  \\$wnnna$aPhysiology, Animal Nutritional
=450  \\$wnnna$aPhysiology, Veterinary Nutritional
=450  \\$wnnna$aVeterinary Nutritional Physiology
=550  \\$wg$aNutritional Physiological Phenomena
=667  \\$adifferentiate from ANIMAL FEED & DIET; ANIMAL NUTRITION SCIENCES is available for the discipline
=680  \\$iNutritional physiology of animals.
=688  \\$a2009(1968)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Animal Nutrition Physiology
=688  \\$a2007(1968)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Animal Nutrition
=688  \\$a68
=750  \0$aAnimal nutrition$0(DLC) sh 85005216$5IEN

=LDR  00838cz  a2200241n  4500
=001  9880363351602441
=005  20141212194757.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000822
=035  \\$aCAZ3973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x90
=150  \\$aAnimal Husbandry
=450  \\$aAnimal Culture$5IEN
=450  \\$wnnna$aAnimal Husbandries
=450  \\$wnnna$aHusbandries, Animal
=450  \\$wnnna$aHusbandry, Animal
=550  \\$wg$aAgriculture
=550  \\$wh$aAnimal Culling
=667  \\$aincludes animal "breeding, feeding & care ... housing & nutrition"; do not confuse with VETERINARY MEDICINE; SPEC: SPEC qualif
=680  \\$iThe science of breeding, feeding and care of domestic animals; includes housing and nutrition.
=688  \\$a76
=750  \0$aAnimal culture$5IEN$0(DLC)sh 85005169

=LDR  00889cz  a2200325n  4500
=001  9880363351702441
=005  20160801105031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000821
=035  \\$aCAZ3972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x300.$x100
=150  \\$aAnimal Feed
=450  \\$wnnna$aAnimal Feeds
=450  \\$wnnna$aFeed, Animal
=450  \\$wnnna$aFeeds, Animal
=550  \\$wg$aCrops, Agricultural
=550  \\$wh$aAvena sativa
=550  \\$wh$aFagopyrum
=550  \\$wh$aHelianthus
=550  \\$wh$aLolium
=550  \\$wh$aMedicago sativa
=550  \\$wh$aMustard Plant
=550  \\$wh$aPanicum
=550  \\$wh$aSilage
=550  \\$wh$aSoybeans
=550  \\$wh$aZea mays
=667  \\$aTN 50: differentiate from ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA & DIET
=688  \\$a68(66)
=750  \0$aFeeds$5IEN$0(DLC)sh 85047658

=LDR  02555cz  a2200733n  4500
=001  9880363351802441
=005  20141212194756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000820
=035  \\$aCAZ3971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22
=150  \\$aAnimal Diseases
=450  \\$aDisease$xveterinary
=450  \\$wnnna$aDiseases, Animal
=550  \\$wh$aAbortion, Veterinary
=550  \\$wh$aActinobacillosis
=550  \\$wh$aAleutian Mink Disease
=550  \\$wh$aAnal Gland Neoplasms
=550  \\$wh$aAnaplasmosis
=550  \\$wh$aBird Diseases
=550  \\$wh$aBorna Disease
=550  \\$wh$aCat Diseases
=550  \\$wh$aCattle Diseases
=550  \\$wh$aDigital Dermatitis
=550  \\$wh$aDisease Models, Animal
=550  \\$wh$aDog Diseases
=550  \\$wh$aEnterotoxemia
=550  \\$wh$aErysipelothrix Infections
=550  \\$wh$aFish Diseases
=550  \\$wh$aFoot-and-Mouth Disease
=550  \\$wh$aFoot Rot
=550  \\$wh$aGoat Diseases
=550  \\$wh$aHeartwater Disease
=550  \\$wh$aHepatitis, Animal
=550  \\$wh$aHorse Diseases
=550  \\$wh$aKeratoconjunctivitis, Infectious
=550  \\$wh$aLameness, Animal
=550  \\$wh$aMammary Neoplasms, Animal
=550  \\$wh$aMink Viral Enteritis
=550  \\$wh$aMuscular Dystrophy, Animal
=550  \\$wh$aMyxomatosis, Infectious
=550  \\$wh$aParasitic Diseases, Animal
=550  \\$wh$aParatuberculosis
=550  \\$wh$aParturient Paresis
=550  \\$wh$aPeste-des-Petits-Ruminants
=550  \\$wh$aPleuropneumonia, Contagious
=550  \\$wh$aPrimate Diseases
=550  \\$wh$aPseudorabies
=550  \\$wh$aPythiosis
=550  \\$wh$aRinderpest
=550  \\$wh$aRodent Diseases
=550  \\$wh$aSalmonella Infections, Animal
=550  \\$wh$aSheep Diseases
=550  \\$wh$aSteatitis
=550  \\$wh$aSwine Diseases
=550  \\$wh$aVenereal Tumors, Veterinary
=550  \\$wh$aVesicular Stomatitis
=550  \\$wh$aWasting Disease, Chronic
=550  \\$wh$aZoonoses
=550  \\$aVeterinary Medicine
=667  \\$aavoid: too general; IM general only for unspecified animal & unspecified disease; NIM with specific animal (IM) for which no precoord animal/diseases term exists; do not use at all when a specific dis /vet is used; do not forget also to check tag ANIMALS; policy: Manual 23.33+; animal neopl: Manual 24.6+; TN 136; TN 193
=688  \\$a66; was see under VETERINARY MEDICINE & ZOONOSES 1963-65
=750  \0$aAnimals$xDiseases$5IEN$0(DLC)sh 85005251

=LDR  00872cz  a2200241n  4500
=001  9880363351902441
=005  20141212194755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000819
=035  \\$aCAZ3970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x55
=150  \\$aAnimal Communication
=450  \\$wnnna$aAnimal Communications
=450  \\$wnnna$aCommunication, Animal
=450  \\$wnnna$aCommunications, Animal
=550  \\$wg$aBehavior, Animal
=550  \\$wh$aEcholocation
=550  \\$wh$aVocalization, Animal
=667  \\$ano qualif; do not forget also to check tag ANIMALS
=680  \\$iCommunication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.
=688  \\$a68
=750  \0$aAnimal communication$5IEN$0(DLC)sh 85005167

=LDR  01082cz   2200265n  4500
=001  9880363352002441
=005  20230831160648.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000818
=035  \\$aCAZ3969M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50
=150  \\$aAnimals
=450  \\$aAnimal
=450  \\$wnnna$aAnimalia
=450  \\$aMetazoa
=550  \\$wg$aEukaryota
=550  \\$wh$aAnimal Population Groups
=550  \\$wh$aChordata
=550  \\$wh$aInvertebrates
=667  \\$aNIM as check tag; Manual 18.7+; relation to /vet: Manual 19.8.81
=680  \\$iUnicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.
=688  \\$a2004 (1974); was check tag only (not a descriptor) 1974-2003
=750  \0$aAnimals$5IEN-M$0(DLC)sh 85005249
=750  \0$iNarrower mapping$aTerrestrial animals$0(DLC)sh2022006689$4NM$5IEN-M

=LDR  01110cz  a2200373n  4500
=001  9880363352102441
=005  20141212194753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000814
=035  \\$aCAZ3965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146
=150  \\$aAniline Compounds
=450  \\$wnnna$aCompounds, Aniline
=450  \\$aPhenylamines
=550  \\$wg$aAmines
=550  \\$wh$aAminophenols
=550  \\$wh$aAnilino Naphthalenesulfonates
=550  \\$wh$aBenzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide
=550  \\$wh$aBenzophenoneidum
=550  \\$wh$aBromhexine
=550  \\$wh$aDiphenylamine
=550  \\$wh$aFenamates
=550  \\$wh$aGentian Violet
=550  \\$wh$aMethyl Green
=550  \\$wh$aMethylenebis(chloroaniline)
=550  \\$wh$ap-Aminoazobenzene
=550  \\$wh$ap-Dimethylaminoazobenzene
=550  \\$wh$aPhenylenediamines
=550  \\$wh$aRosaniline Dyes
=550  \\$wh$aSulfanilamides
=550  \\$wh$aToluidines
=667  \\$aDF: ANILINE CPDS
=750  \0$aAniline$5IEN$0(DLC)sh 85005157

=LDR  00705cz  a2200277n  4500
=001  9880363352202441
=005  20141212194753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000813
=035  \\$aCAZ3964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199
=150  \\$aAnilides
=550  \\$wg$aAmides
=550  \\$wh$aAcetanilides
=550  \\$wh$aBenzoylarginine Nitroanilide
=550  \\$wh$aBupivacaine
=550  \\$wh$aCarbanilides
=550  \\$wh$aCarboxin
=550  \\$wh$aEncainide
=550  \\$wh$aFlutamide
=550  \\$wh$aPrilocaine
=550  \\$wh$aPropanil
=550  \\$wh$aSalicylanilides
=550  \\$wh$aTocainide
=750  \0$aAnilides$5IEN$0(DLC)sh 91005148

=LDR  00707cz  a2200241n  4500
=001  9880363352302441
=005  20141212194753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000812
=035  \\$aCAZ3963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x113
=150  \\$aAnhydrides
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetic Anhydrides
=550  \\$wh$aCitraconic Anhydrides
=550  \\$wh$aMaleic Anhydrides
=550  \\$wh$aPhthalic Anhydrides
=550  \\$wh$aPolyanhydrides
=550  \\$wh$aSuccinic Anhydrides
=680  \\$iChemical compounds derived from acids by the elimination of a molecule of water.
=688  \\$a66
=750  \0$aAnhydrides$5IEN$0(DLC)sh 85005152

=LDR  00517cz  a2200181n  4500
=001  9880363352402441
=005  20141212194752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000811
=035  \\$aCAZ3962M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x338.$x282
=150  \\$aAnguilla
=450  \\$wnnna$aAnguillas
=550  \\$wg$aEels
=667  \\$aeel; NIM when exper animal: no qualif; when IM, qualif permitted
=688  \\$a72
=750  \0$aAnguilla (Fish)$0(DLC) sh85005135$5IEN-M

=LDR  01156cz  a2200325n  4500
=001  9880363352502441
=005  20141212194752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000809
=035  \\$aCAZ3960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x94
=072  \\$aD12.$x644.$x400.$x70
=072  \\$aD12.$x644.$x456.$x73
=072  \\$aD12.$x644.$x548.$x58
=072  \\$aD12.$x776.$x641.$x650.$x70
=072  \\$aD23.$x469.$x50.$x50
=150  \\$aAngiotensins
=450  \\$aAngiotensin
=550  \\$wg$aAutacoids
=550  \\$wg$aNeuropeptides
=550  \\$wg$aOligopeptides
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aAngiotensin I
=550  \\$wh$aAngiotensin II
=550  \\$wh$aAngiotensin III
=550  \\$wh$aAngiotensinogen
=680  \\$iOligopeptides which are important in the regulation of blood pressure (VASOCONSTRICTION) and fluid homeostasis via the RENIN-ANGIOTENSIN SYSTEM. These include angiotensins derived naturally from precursor ANGIOTENSINOGEN, and those synthesized.
=688  \\$a1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999
=750  \0$aAngiotensins$5IEN$0(DLC)sh 85005038

=LDR  02254cz  a2200457n  4500
=001  9880363352602441
=005  20200720142036.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000806
=035  \\$aCAZ3957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x85
=150  \\$aAngiotensin-Converting Enzyme Inhibitors
=450  \\$aACE Inhibitors
=450  \\$wnnna$aAngiotensin-Converting Enzyme Antagonists
=450  \\$wnnna$aAngiotensin Converting Enzyme Antagonists
=450  \\$wnnna$aAngiotensin Converting Enzyme Inhibitors
=450  \\$wnnna$aAngiotensin I-Converting Enzyme Inhibitors
=450  \\$wnnna$aAngiotensin I Converting Enzyme Inhibitors
=450  \\$wnnna$aAntagonists, Angiotensin-Converting Enzyme
=450  \\$wnnna$aAntagonists, Angiotensin Converting Enzyme
=450  \\$wnnna$aAntagonists, Kininase II
=450  \\$wnnna$aEnzyme Antagonists, Angiotensin-Converting
=450  \\$wnnna$aEnzyme Inhibitors, Angiotensin-Converting
=450  \\$wnnna$aInhibitors, ACE
=450  \\$wnnna$aInhibitors, Angiotensin-Converting Enzyme
=450  \\$wnnna$aInhibitors, Angiotensin Converting Enzyme
=450  \\$wnnna$aInhibitors, Kininase II
=450  \\$aKinase II$xantagonists & inhibitors$5IEN-M
=450  \\$wnnna$aKininase II Antagonists
=450  \\$aKininase II Inhibitors
=450  \\$aPeptidyl-Dipeptidase A$xantagonists & inhibitors
=550  \\$wg$aProtease Inhibitors
=550  \\$aAngiotensin II Type 1 Receptor Blockers
=550  \\$aAntihypertensive Agents
=550  \\$aRenin-Angiotensin System
=550  \\$wh$aVasopeptidase Inhibitors
=667  \\$aprotease inhib & antihypertensives; DF: ACE INHIB
=680  \\$iA class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
=688  \\$a88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93
=750  \0$aAngiotensin converting enzyme$xinhibitors$5IEN$0(DLC)sh 85005040

=LDR  00823cz  a2200229n  4500
=001  9880363352702441
=005  20141212194711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x66
=150  \\$aAmylases
=450  \\$wnnna$aAmylase
=450  \\$aDiastase
=550  \\$wg$aGlycoside Hydrolases
=550  \\$wh$aalpha-Amylases
=550  \\$wh$abeta-Amylase
=550  \\$aHyperamylasemia
=667  \\$aamylase isoenzymes: index under AMYLASES (IM) + ISOENZYMES (IM), not ISOAMYLASE; amylases/blood: consider HYPERAMYLASEMIA
=680  \\$iA group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-.
=688  \\$a78; was AMYLASE 1963-77
=750  \0$aAmylases$5IEN$0(DLC)sh 85004721

=LDR  01900cz  a2200433n  4500
=001  9880363352802441
=005  20141212194750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000804
=035  \\$aCAZ3955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x94.$x78
=072  \\$aD12.$x644.$x400.$x70.$x78
=072  \\$aD12.$x644.$x456.$x73.$x41
=072  \\$aD12.$x644.$x548.$x58.$x78
=072  \\$aD12.$x776.$x641.$x650.$x70.$x78
=072  \\$aD23.$x469.$x50.$x50.$x50
=150  \\$aAngiotensin II
=450  \\$wnnna$a5-L-Isoleucine Angiotensin II
=450  \\$wnnna$a5 L Isoleucine Angiotensin II
=450  \\$wnnna$aANG-(1-8)Octapeptide
=450  \\$wnnna$aAngiotensin-(1-8) Octapeptide
=450  \\$wnnna$aAngiotensin II, 5-L-Isoleucine
=450  \\$aAngiotensin II, Ile(5)-
=450  \\$wnnna$aAngiotensin II, Isoleucine(5)-
=450  \\$aAngiotensin II, Val(5)-
=450  \\$wnnna$aAngiotensin II, Valine(5)-
=450  \\$aHypotensin$5IEN-M
=450  \\$wnnna$aII, 5-L-Isoleucine Angiotensin
=450  \\$wnnna$aIsoleucine(5)-Angiotensin
=450  \\$wnnna$aIsoleucyl(5)-Angiotensin II
=450  \\$wnnna$aValyl(5)-Angiotensin II
=550  \\$wg$aAngiotensins
=550  \\$wh$a1-Sarcosine-8-Isoleucine Angiotensin II
=550  \\$wh$aAngiotensin Amide
=550  \\$wh$aSaralasin
=680  \\$iAn octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS.
=688  \\$a1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999
=750  \0$aAngiotensin II$5IEN$0(DLC)sh 00000074

=LDR  00979cz  a2200241n  4500
=001  9880363352902441
=005  20141212194750.0
=008  770609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000803
=035  \\$aCAZ3954M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x94.$x75
=072  \\$aD12.$x644.$x400.$x70.$x75
=072  \\$aD12.$x644.$x456.$x73.$x21
=072  \\$aD12.$x644.$x548.$x58.$x75
=072  \\$aD12.$x776.$x641.$x650.$x70.$x75
=072  \\$aD23.$x469.$x50.$x50.$x25
=150  \\$aAngiotensin I
=450  \\$wnnna$aI, Angiotensin
=550  \\$wg$aAngiotensins
=680  \\$iA decapeptide that is cleaved from precursor angiotensinogen by RENIN. Angiotensin I has limited biological activity. It is converted to angiotensin II, a potent vasoconstrictor, after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME.
=688  \\$a87(78); was see under ANGIOTENSINS 1978-86
=750  \0$aAngiotensin I$5IEN-M$0(DLC)sh2003008375

=LDR  02093cz  a2200565n  4500
=001  9880363353002441
=005  20141212191950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000679
=035  \\$aCAZ3828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x90
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x152
=150  \\$aAmygdala
=450  \\$wnnna$aAmygdalae, Nucleus
=450  \\$wnnna$aAmygdaloid Bodies
=450  \\$aAmygdaloid Body
=450  \\$wnnna$aAmygdaloid Nuclear Complex
=450  \\$wnnna$aAmygdaloid Nuclear Complices
=450  \\$wnnna$aAmygdaloid Nuclei, Intercalated
=450  \\$wnnna$aAmygdaloid Nucleus
=450  \\$wnnna$aAmygdaloid Nucleus, Intercalated
=450  \\$wnnna$aAmygdaloideum, Corpus
=450  \\$wnnna$aAmygdaloideums, Corpus
=450  \\$wnnna$aArchistriatum
=450  \\$wnnna$aArchistriatums
=450  \\$wnnna$aComplex, Amygdaloid Nuclear
=450  \\$wnnna$aComplices, Amygdaloid Nuclear
=450  \\$wnnna$aCorpus Amygdaloideum
=450  \\$wnnna$aCorpus Amygdaloideums
=450  \\$wnnna$aIntercalata, Massa
=450  \\$wnnna$aIntercalatas, Massa
=450  \\$wnnna$aIntercalated Amygdaloid Nuclei
=450  \\$wnnna$aIntercalated Amygdaloid Nucleus
=450  \\$wnnna$aMassa Intercalata
=450  \\$wnnna$aMassa Intercalatas
=450  \\$wnnna$aNuclear Complex, Amygdaloid
=450  \\$wnnna$aNuclear Complices, Amygdaloid
=450  \\$wnnna$aNuclei, Intercalated Amygdaloid
=450  \\$wnnna$aNucleus Amygdalae
=450  \\$wnnna$aNucleus, Amygdaloid
=450  \\$wnnna$aNucleus, Intercalated Amygdaloid
=550  \\$wg$aBasal Ganglia
=550  \\$wg$aLimbic System
=550  \\$wh$aBasolateral Nuclear Complex
=550  \\$wh$aCentral Amygdaloid Nucleus
=550  \\$wh$aCorticomedial Nuclear Complex
=680  \\$iAlmond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system.
=688  \\$a2000(1966)
=750  \0$aAmygdaloid body$5IEN$0(DLC)sh 85004720

=LDR  01016cz  a2200193n  4500
=001  9880363353102441
=005  20141212194749.0
=008  800328\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000801
=035  \\$aCAZ3952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x588.$x80
=150  \\$aAngiostrongylus
=550  \\$wg$aMetastrongyloidea
=550  \\$wh$aAngiostrongylus cantonensis
=667  \\$aa genus of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.
=688  \\$a91(81); was see under METASTRONGYLOIDEA 1981-90
=750  \0$aAngiostrongylosis$5IEN$0(DLC)sh 85005036

=LDR  00861cz  a2200265n  4500
=001  9880363353202441
=005  20141212194710.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000678
=035  \\$aCAZ3827HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x626.$x175
=072  \\$aD9.$x408.$x348.$x50
=150  \\$aAmygdalin
=450  \\$aAmygdaloside
=450  \\$wnnna$aLaetrile
=450  \\$aMandelonitrile-beta-Gentiobioside
=450  \\$wnnna$aMandelonitrile beta Gentiobioside
=450  \\$wnnna$aNeoamygdalin
=550  \\$wg$aGlucosides
=550  \\$wg$aNitriles
=667  \\$a/biosyn permitted if by plant
=680  \\$iA cyanogenic glycoside found in the seeds of Rosaceae.
=688  \\$a79(76); was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78
=750  \0$aLaetrile$5IEN$0(DLC)sh 85073922

=LDR  00476cz  a2200169n  4500
=001  9880363353302441
=005  20141212194709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000674
=035  \\$aCAZ3823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150.$x100
=150  \\$aAmputees
=450  \\$wnnna$aAmputee
=550  \\$wg$aDisabled Persons
=667  \\$ado not coord ARM (NIM) or LEG (NIM) unless specifically relevant
=750  \0$aAmputees$5IEN$0(DLC)sh 85004669

=LDR  01442cz  a2200313n  4500
=001  9880363353402441
=005  20141212191952.0
=008  810223\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000800
=035  \\$aCAZ3951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x50.$x60
=072  \\$aE4.$x100.$x814.$x529.$x124.$x60
=072  \\$aE4.$x502.$x382.$x124.$x60
=150  \\$aAngioplasty, Balloon
=450  \\$wnnna$aArterial Dilation, Transluminal
=450  \\$wnnna$aArterial Dilations, Transluminal
=450  \\$aBalloon Angioplasty
=450  \\$wnnna$aDilation, Transluminal Arterial
=450  \\$wnnna$aDilations, Transluminal Arterial
=450  \\$wnnna$aTransluminal Arterial Dilation
=450  \\$wnnna$aTransluminal Arterial Dilations
=550  \\$wg$aAngioplasty
=550  \\$wh$aAngioplasty, Balloon, Coronary
=550  \\$wh$aAngioplasty, Balloon, Laser-Assisted
=667  \\$acoordinate IM with disease / ther (IM)
=680  \\$iUse of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available.
=688  \\$a93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92
=750  \0$aTransluminal angioplasty$5IEN$0(DLC)sh 85136979

=LDR  00814cz  a2200205n  4500
=001  9880363353502441
=005  20141212194709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000672
=035  \\$aCAZ3821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x100
=150  \\$aAmputation Stumps
=450  \\$wnnna$aAmputation Stump
=450  \\$wnnna$aStump, Amputation
=450  \\$wnnna$aStumps, Amputation
=550  \\$wg$aExtremities
=667  \\$arestrict to extremities: do not use for gastric stump ( = GASTRIC STUMP), appendiceal stump, ureteral stump, cervical stump & the like (indexed probably under relevant -ECTOMY or other surg term)
=680  \\$iThe part of a limb or tail following amputation that is proximal to the amputated section.
=750  \0$aResidual limbs$5IEN$0(DLC)sh 85004663

=LDR  01536nz  a2200409n  4500
=001  9882549680102441
=005  20250214141202.0
=008  990101\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000671
=035  \\$a(DNLM)D000671
=035  \\$a(NLM)98197278950000041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 170
=072  \\$aE4.$x555.$x80
=150  \\$aAmputation, Surgical
=450  \\$aAmputation
=450  \\$aAmputation, Multiple, Surgical
=450  \\$aMultiple Amputation, Surgical
=450  \\$aSurgical Amputation Procedures
=450  \\$wnnna$aAmputation Procedures, Surgical
=450  \\$wnnna$aAmputation Procedure, Surgical
=450  \\$wnnna$aAmputations
=450  \\$wnnna$aAmputations, Surgical
=450  \\$wnnna$aAmputations, Surgical Multiple
=450  \\$wnnna$aAmputation, Surgical Multiple
=450  \\$wnnna$aMultiple Amputations, Surgical
=450  \\$wnnna$aProcedures, Surgical Amputation
=450  \\$wnnna$aProcedure, Surgical Amputation
=450  \\$wnnna$aSurgical Amputation
=450  \\$wnnna$aSurgical Amputation Procedure
=450  \\$wnnna$aSurgical Amputations
=450  \\$wnnna$aSurgical Multiple Amputation
=450  \\$wnnna$aSurgical Multiple Amputations
=667  \\$aa surgical procedure: do not confuse with AMPUTATION, TRAUMATIC OR MULTIPLE AMPUTATION, TRAUMATIC
=680  \\$iThe surgical removal of part of, or all of, a limb or other appendage or outgrowth of the body.
=688  \\$a2023 (1966)
=750  \0$aAmputation$5IEN$0(DLC)sh 85004661

=LDR  00873cz  a2200241n  4500
=001  9880363353702441
=005  20141212194708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000669
=035  \\$aCAZ3818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x61
=150  \\$aAmplifiers, Electronic
=450  \\$wnnna$aAmplifier, Electronic
=450  \\$wnnna$aElectronic Amplifier
=450  \\$wnnna$aElectronic Amplifiers
=550  \\$wg$aElectrical Equipment and Supplies
=680  \\$iElectronic devices that increase the magnitude of a signal's power level or current.
=688  \\$a2009 (1967)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Amplifiers
=688  \\$a73(66)
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20090831: 150:##:_{dollar}a Amplifiers, Electronic
=750  \0$aAmplifiers (Electronics)$0(DLC) sh 85004652$5IEN-M

=LDR  00800cz  a2200229n  4500
=001  9880363353802441
=005  20141212194707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000666
=035  \\$aCAZ3815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x50
=150  \\$aAmphotericin B
=450  \\$wnnna$aAmphocil
=450  \\$wnnna$aAmphotericin
=450  \\$wnnna$aAmphotericin B Cholesterol Dispersion
=450  \\$wnnna$aAmphotericin B Colloidal Dispersion
=450  \\$wnnna$aFungizone
=550  \\$wg$aMacrolides
=680  \\$iMacrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
=688  \\$a98; for AMPHOCIL use AMPHOTERICIN B (NM) 1992-97
=750  \0$aAmphotericin B$0(DLC) sh 85004643$5IEN

=LDR  01410cz  a2200409n  4500
=001  9880363353902441
=005  20141212194749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000799
=035  \\$aCAZ3950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x79
=072  \\$aC17.$x800.$x862.$x945.$x66
=072  \\$aC20.$x543.$x480.$x904.$x66
=150  \\$aAngioedema
=450  \\$wnnna$aAngioedemas
=450  \\$wnnna$aAngioneurotic Edema
=450  \\$wnnna$aAngioneurotic Edemas
=450  \\$wnnna$aEdema, Angioneurotic
=450  \\$wnnna$aEdema, Quincke's
=450  \\$wnnna$aEdemas, Angioneurotic
=450  \\$wnnna$aGiant Urticaria
=450  \\$wnnna$aGiant Urticarias
=450  \\$wnnna$aQuincke Edema
=450  \\$aQuincke's Edema
=450  \\$wnnna$aQuinckes Edema
=450  \\$aUrticaria, Giant
=450  \\$wnnna$aUrticarias, Giant
=550  \\$wg$aUrticaria
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAngioedemas, Hereditary
=550  \\$aEdema
=667  \\$a/genet: consider also ANGIOEDEMAS, HEREDITARY
=680  \\$iSwelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Angioneurotic Edema
=750  \0$aAngioneurotic edema$0(DLC) sh 85005030$5IEN

=LDR  01440cz  a2200373n  4500
=001  9880363354002441
=005  20141212194707.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000664
=035  \\$aCAZ3813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x33
=072  \\$aD23.$x946.$x833.$x33
=150  \\$aAmphibian Venoms
=450  \\$wnnna$aAmphibian Venom
=450  \\$wnnna$aFrog Venom
=450  \\$aFrog Venoms
=450  \\$wnnna$aToad Venom
=450  \\$aToad Venoms
=450  \\$wnnna$aVenom, Amphibian
=450  \\$wnnna$aVenom, Frog
=450  \\$wnnna$aVenom, Toad
=450  \\$wnnna$aVenoms, Amphibian
=450  \\$wnnna$aVenoms, Frog
=450  \\$wnnna$aVenoms, Toad
=550  \\$wg$aVenoms
=550  \\$wh$aBatrachotoxins
=550  \\$wh$aBombesin
=550  \\$wh$aBufotenin
=550  \\$wh$aPhysalaemin
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific amphibian (IM or NIM)
=680  \\$iVenoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin.
=688  \\$a78
=750  \0$aAmphibians$xVenom$5IEN-M$0(IEN)3706742

=LDR  00961cz  a2200241n  4500
=001  9880363354102441
=005  20141212194748.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000798
=035  \\$aCAZ3949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x77
=150  \\$aAngiomatosis
=450  \\$wnnna$aAngiomatoses
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAngiomatosis, Bacillary
=550  \\$wh$aKlippel-Trenaunay-Weber Syndrome
=550  \\$wh$aSturge-Weber Syndrome
=550  \\$wh$avon Hippel-Lindau Disease
=550  \\$aArteriovenous Malformations
=667  \\$acoordinate IM with precoordinated organ disease term (IM)
=680  \\$iA condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
=750  \0$aAngiomatosis$5IEN$0(DLC)sh 85005029

=LDR  00835cz  a2200241n  4500
=001  9880363354202441
=005  20141212194706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90
=150  \\$aAmphibians
=450  \\$aAmphibia
=450  \\$wnnna$aAmphibian
=550  \\$wg$aVertebrates
=550  \\$wh$aAnura
=550  \\$wh$aUrodela
=550  \\$aAmphibian Proteins
=667  \\$ageneral or unspecified; prefer specific available genera; NIM when experimental animal
=680  \\$iVERTEBRATES belonging to the class amphibia such as frogs, toads, newts and salamanders that live in a semiaquatic environment.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Amphibia
=750  \0$aAmphibians$0(DLC) sh 85004598$5IEN

=LDR  01302cz  a2200313n  4500
=001  9880363354302441
=005  20141212194706.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000662
=035  \\$aCAZ3811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x152
=150  \\$aAmphetamines
=450  \\$aAmphetamine$xanalogs & derivatives
=550  \\$wg$aPhenethylamines
=550  \\$wh$a2,5-Dimethoxy-4-Methylamphetamine
=550  \\$wh$a3,4-Methylenedioxyamphetamine
=550  \\$wh$aAmphetamine
=550  \\$wh$aIofetamine
=550  \\$wh$aMethamphetamine
=550  \\$wh$aN-Methyl-3,4-methylenedioxyamphetamine
=550  \\$wh$ap-Chloroamphetamine
=550  \\$wh$ap-Hydroxyamphetamine
=550  \\$wh$aPhentermine
=550  \\$aAdrenergic Uptake Inhibitors
=667  \\$aGEN or unspecified; prefer specifics; do not confuse with AMPHETAMINE, a specific chem; N-methylamphetamine = METHAMPHETAMINE
=680  \\$iAnalogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
=688  \\$a76; was NON MESH before 1976
=750  \0$aAmphetamines$5IEN$0(DLC)sh 85004595

=LDR  00589cz  a2200205n  4500
=001  9880363354402441
=005  20141212194746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000793
=035  \\$aCAZ3944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x94
=150  \\$aAngioid Streaks
=450  \\$wnnna$aAngioid Streak
=450  \\$wnnna$aStreak, Angioid
=450  \\$wnnna$aStreaks, Angioid
=550  \\$wg$aRetinal Diseases
=550  \\$aRetina
=680  \\$iSmall breaks in the elastin-filled tissue of the retina.
=750  \0$aAngioid streaks$5IEN$0(DLC)sh 85005027

=LDR  01394cz  a2200409n  4500
=001  9880363354502441
=005  20141212194746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000792
=035  \\$aCAZ3943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x60
=072  \\$aE1.$x370.$x370.$x50
=150  \\$aAngiography
=450  \\$wnnna$aAngiographies
=450  \\$aArteries$xradiography
=450  \\$wnnna$aArteriographies
=450  \\$aArteriography
=450  \\$aBlood Vessels$xradiography
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aRadiography
=550  \\$wh$aAngiocardiography
=550  \\$wh$aAngiography, Digital Subtraction
=550  \\$wh$aAortography
=550  \\$wh$aCerebral Angiography
=550  \\$wh$aCineangiography
=550  \\$wh$aCoronary Angiography
=550  \\$wh$aFluorescein Angiography
=550  \\$wh$aMagnetic Resonance Angiography
=550  \\$wh$aPhlebography
=550  \\$wh$aPortography
=550  \\$wh$aRadionuclide Angiography
=550  \\$aArteries
=550  \\$aBlood Vessels
=667  \\$aNIM; GEN or unspecified; prefer /radiogr with specific blood vessels but CORONARY ANGIOGRAPHY is available; /drug eff /rad eff permitted; DF: ANGIOGR
=680  \\$iRadiography of blood vessels after injection of a contrast medium.
=750  \0$aAngiography$5IEN$0(DLC)sh 85005025

=LDR  01016cz  a2200253n  4500
=001  9880363354602441
=005  20141212194745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000790
=035  \\$aCAZ3941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x249
=072  \\$aE1.$x370.$x350.$x700.$x60.$x50
=072  \\$aE1.$x370.$x370.$x50.$x50
=072  \\$aE1.$x370.$x370.$x380.$x50
=150  \\$aAngiocardiography
=450  \\$wnnna$aAngiocardiographies
=550  \\$wg$aAngiography
=550  \\$wg$aCardiac Imaging Techniques
=550  \\$wg$aHeart Function Tests
=550  \\$aHeart
=667  \\$aNIM; a specific x-ray (not radionuclide) technique: do not confuse with HEART /radiogr or CORONARY ANGIOGRAPHY; coord with disease /radiogr; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ANGIOCARDIOGR
=680  \\$iRadiography of the heart and great vessels after injection of a contrast medium.
=750  \0$aAngiocardiography$5IEN$0(DLC)sh 85005024

=LDR  02127cz  a2200589n  4500
=001  9880363354702441
=005  20141212194705.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000658
=035  \\$aCAZ3807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x750.$x50.$x50
=072  \\$aD2.$x886.$x108.$x750.$x750.$x50.$x50
=072  \\$aD3.$x438.$x260.$x825.$x750.$x50.$x50
=072  \\$aD3.$x605.$x84.$x737.$x750.$x50.$x50
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x750.$x50.$x50
=150  \\$aAmoxicillin
=450  \\$wnnna$aActimoxi
=450  \\$wnnna$aAmoxicillin Anhydrous
=450  \\$wnnna$aAmoxicillin Clariana Brand
=450  \\$wnnna$aAmoxicillin Monopotassium Salt
=450  \\$wnnna$aAmoxicillin Monosodium Salt
=450  \\$wnnna$aAmoxicillin, (R*)-Isomer
=450  \\$wnnna$aAmoxicillin Sodium
=450  \\$wnnna$aAmoxicillin Trihydrate
=450  \\$wnnna$aAmoxicilline
=450  \\$wnnna$aAmoxil
=450  \\$wnnna$aAmoxycillin
=450  \\$wnnna$aAnhydrous, Amoxicillin
=450  \\$wnnna$aBRL-2333
=450  \\$wnnna$aBRL 2333
=450  \\$wnnna$aBRL2333
=450  \\$wnnna$aClamoxyl
=450  \\$wnnna$aClamoxyl G.A.
=450  \\$wnnna$aClamoxyl parenteral
=450  \\$wnnna$aClariana Brand of Amoxicillin
=450  \\$wnnna$aG.A., Clamoxyl
=450  \\$aHydroxyampicillin
=450  \\$wnnna$aparenteral, Clamoxyl
=450  \\$wnnna$aPenamox
=450  \\$wnnna$aPfizer Brand of Amoxicillin Sodium Salt
=450  \\$wnnna$aPolymox
=450  \\$wnnna$aSmithKline Beecham Brand of Amoxicillin Sodium Salt
=450  \\$wnnna$aSodium, Amoxicillin
=450  \\$wnnna$aTrihydrate, Amoxicillin
=450  \\$wnnna$aTrimox
=450  \\$wnnna$aWymox
=550  \\$wg$aAmpicillin
=550  \\$wh$aAmoxicillin-Potassium Clavulanate Combination
=680  \\$iA broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
=688  \\$a80(75); was see under AMPICILLIN 1975-79
=750  \0$aAmoxicillin$5IEN$0(DLC)sh 85004587

=LDR  00938cz  a2200217n  4500
=001  9880363354802441
=005  20180621152910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000656
=035  \\$aCAZ3805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100.$x700.$x89
=150  \\$aAmoeba
=450  \\$aAmeba
=450  \\$wnnna$aAmebas
=450  \\$wnnna$aAmoebas
=550  \\$wg$aTubulina
=550  \\$wh$aEndamoeba histolytica
=667  \\$athe genus name: entry term AMEBA sometimes used loosely for the common nouns ameba & amoeba; infection = AMEBIASIS; for antigens, coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several lodopodia, one of which is dominant at a given time. Reproduction occurs asexually by binary fission.
=750  \0$aAmoeba$5IEN$0(DLC)sh 85004568

=LDR  01355cz  a2200313n  4500
=001  9880363354902441
=005  20141212194703.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000653
=035  \\$aCAZ3802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x98
=072  \\$aA16.$x378.$x149
=150  \\$aAmniotic Fluid
=450  \\$aAmniotic Fluid Index
=450  \\$wnnna$aAmniotic Fluid Indices
=450  \\$wnnna$aAmniotic Fluids
=450  \\$wnnna$aFluid, Amniotic
=450  \\$wnnna$aFluid Index, Amniotic
=450  \\$wnnna$aFluid Indices, Amniotic
=450  \\$wnnna$aFluids, Amniotic
=450  \\$wnnna$aIndex, Amniotic Fluid
=450  \\$wnnna$aIndices, Amniotic Fluid
=550  \\$wg$aFetus
=550  \\$wg$aFluids and Secretions
=550  \\$aFetoscopy
=667  \\$aintra-amniotic injections do not go here: use AMNION + INJECTIONS; excess fluid and hydramnios = POLYHYDRAMNIOS; fluid deficiency = OLIGOHYDRAMNIOS
=680  \\$iA clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS).
=750  \0$aAmniotic liquid$5IEN$0(DLC)sh 85004565

=LDR  01083cz  a2200289n  4500
=001  9880363355002441
=005  20141212194744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000787
=035  \\$aCAZ3938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x187
=072  \\$aC14.$x907.$x585.$x187
=072  \\$aC23.$x888.$x646.$x215.$x500
=150  \\$aAngina Pectoris
=450  \\$aAngor Pectoris
=450  \\$aStenocardia
=450  \\$wnnna$aStenocardias
=550  \\$wg$aChest Pain
=550  \\$wg$aMyocardial Ischemia
=550  \\$wh$aAcute Coronary Syndrome
=550  \\$wh$aAngina, Stable
=550  \\$wh$aAngina, Unstable
=550  \\$wh$aMicrovascular Angina
=550  \\$aChest Pain
=680  \\$iThe symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
=750  \0$aAngina pectoris$5IEN$0(DLC)sh 85005022

=LDR  00572cz  a2200205n  4500
=001  9880363355102441
=005  20141212194744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000786
=035  \\$aCAZ3937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x93
=150  \\$aAnger
=450  \\$wnnna$aAngers
=550  \\$wg$aEmotions
=550  \\$wh$aRage
=667  \\$ahuman & animal
=680  \\$iA strong emotional feeling of displeasure aroused by being interfered with, injured or threatened.
=688  \\$a72(69)
=750  \0$aAnger$5IEN$0(DLC)sh 85005009

=LDR  00987cz  a2200253n  4500
=001  9880363355202441
=005  20141212194702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000650
=035  \\$aCAZ3799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x284.$x277
=072  \\$aA16.$x254.$x750.$x277
=150  \\$aAmnion
=450  \\$wnnna$aAmnions
=450  \\$aAmniotic Membrane
=450  \\$wnnna$aAmniotic Membranes
=450  \\$wnnna$aMembrane, Amniotic
=450  \\$wnnna$aMembranes, Amniotic
=550  \\$wg$aExtraembryonic Membranes
=550  \\$aFetoscopy
=667  \\$anot restricted to mammals; intra-amniotic injections = AMNION + INJECTIONS; amniotomy = AMNION /surg + probably LABOR, INDUCED
=680  \\$iThe innermost membranous sac that surrounds and protects the developing embryo which is bathed in the AMNIOTIC FLUID. Amnion cells are secretory EPITHELIAL CELLS and contribute to the amniotic fluid.
=750  \0$aAmnion$5IEN$0(DLC)sh 85004562

=LDR  01038cz  a2200289n  4500
=001  9880363355302441
=005  20141212194702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000649
=035  \\$aCAZ3798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x50
=072  \\$aE1.$x370.$x225.$x998.$x329.$x309
=072  \\$aE1.$x370.$x378.$x630.$x50
=072  \\$aE4.$x665.$x600.$x309
=072  \\$aE5.$x200.$x500.$x384.$x50
=072  \\$aE5.$x200.$x998.$x329.$x309
=072  \\$aE5.$x242.$x384.$x50
=150  \\$aAmniocentesis
=450  \\$wnnna$aAmniocenteses
=550  \\$wg$aCytodiagnosis
=550  \\$wg$aParacentesis
=550  \\$wg$aPrenatal Diagnosis
=667  \\$ado not use /util except by MeSH definition
=680  \\$iPercutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions.
=688  \\$a73(71)
=750  \0$aAmniocentesis$5IEN$0(DLC)sh 85004560

=LDR  01469cz  a2200373n  4500
=001  9880363355402441
=005  20180821131129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000783
=035  \\$aCAZ3934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x55
=150  \\$aAneurysm
=450  \\$wnnna$aAneurysm, Fusiform
=450  \\$wnnna$aAneurysms
=450  \\$wnnna$aAneurysms, Fusiform
=450  \\$wnnna$aFusiform Aneurysm
=450  \\$wnnna$aFusiform Aneurysms
=450  \\$aSaccular Aneurysm
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAneurysm, Dissecting
=550  \\$wh$aAneurysm, False
=550  \\$wh$aAneurysm, Infected
=550  \\$wh$aAneurysm, Ruptured
=550  \\$wh$aAortic Aneurysm
=550  \\$wh$aCoronary Aneurysm
=550  \\$wh$aEndoleak
=550  \\$wh$aHeart Aneurysm
=550  \\$wh$aIliac Aneurysm
=550  \\$wh$aIntracranial Aneurysm
=550  \\$wh$aMicroaneurrsm
=667  \\$ageneral; prefer specifics; coordinate IM with specific vessel (IM) or precoordinated vascular disease if available (IM); rupture = ANEURYSM, RUPTURED (see note there)
=680  \\$iPathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics.
=750  \0$aAneurysms$5IEN$0(DLC)sh 85004986

=LDR  02318cz  a2200613n  4500
=001  9880363355502441
=005  20200403143852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000647
=035  \\$aCAZ3796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x525.$x100
=072  \\$aC23.$x888.$x592.$x604.$x529.$x100
=072  \\$aF1.$x700.$x625.$x100
=072  \\$aF3.$x87.$x200
=150  \\$aAmnesia
=450  \\$wnnna$aAmnesia, Dissociative
=450  \\$wnnna$aAmnesia, Global
=450  \\$wnnna$aAmnesia, Hysterical
=450  \\$wnnna$aAmnesia-Memory Loss
=450  \\$wnnna$aAmnesia Memory Loss
=450  \\$wnnna$aAmnesia-Memory Losses
=450  \\$wnnna$aAmnesia, Tactile
=450  \\$wnnna$aAmnesia, Temporary
=450  \\$wnnna$aAmnesias
=450  \\$wnnna$aAmnesias, Dissociative
=450  \\$wnnna$aAmnesias, Global
=450  \\$wnnna$aAmnesias, Hysterical
=450  \\$wnnna$aAmnesias, Tactile
=450  \\$wnnna$aAmnesias, Temporary
=450  \\$wnnna$aAmnestic State
=450  \\$wnnna$aAmnestic States
=450  \\$wnnna$aDissociative Amnesia
=450  \\$wnnna$aDissociative Amnesias
=450  \\$wnnna$aGlobal Amnesia
=450  \\$wnnna$aGlobal Amnesias
=450  \\$wnnna$aHysterical Amnesia
=450  \\$wnnna$aHysterical Amnesias
=450  \\$wnnna$aState, Amnestic
=450  \\$wnnna$aStates, Amnestic
=450  \\$wnnna$aTactile Amnesia
=450  \\$wnnna$aTactile Amnesias
=450  \\$wnnna$aTemporary Amnesia
=450  \\$wnnna$aTemporary Amnesias
=550  \\$wg$aNeurocognitive Disorders
=550  \\$wg$aMemory Disorders
=550  \\$wh$aAlcohol Amnestic Disorder
=550  \\$wh$aAlcoholic Korsakoff Syndrome
=550  \\$wh$aAmnesia, Anterograde
=550  \\$wh$aAmnesia, Retrograde
=550  \\$wh$aAmnesia, Transient Global
=680  \\$iPathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)
=750  \0$aAmnesia$0(DLC) sh 85004557$5IEN
=750  \0$aAmnesiacs$0(DLC) sh2005005502$5IEN-M

=LDR  00600cz  a2200193n  4500
=001  9880363355602441
=005  20141212194700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000645
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x62.$x374
=072  \\$aD1.$x875.$x800.$x800.$x850.$x50
=150  \\$aAmmonium Sulfate
=450  \\$wnnna$aSulfate, Ammonium
=550  \\$wg$aAmmonium Compounds
=550  \\$wg$aSulfates
=680  \\$iSulfuric acid diammonium salt. It is used in CHEMICAL FRACTIONATION of proteins.
=688  \\$a74(71)
=750  \0$aAmmonium sulfate$5IEN-M$0(DLC)sh 96011270

=LDR  00778cz  a2200229n  4500
=001  9880363355702441
=005  20141212194659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000643
=035  \\$aCAZ3792M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150.$x50
=072  \\$aD1.$x625.$x62.$x249
=150  \\$aAmmonium Chloride
=450  \\$wnnna$aAmmoniac, Sal
=450  \\$wnnna$aChloride, Ammonium
=450  \\$wnnna$aSal Ammoniac
=550  \\$wg$aAmmonium Compounds
=550  \\$wg$aChlorides
=667  \\$a/analogs = probably AMMONIUM COMPOUNDS
=680  \\$iAn acidifying agent that has expectorant and diuretic effects. Also used in etching and batteries and as a flux in electroplating.
=750  \0$aAmmonium chloride$0(DLC)sh2009008354$5IEN-M

=LDR  00702cz  a2200193n  4500
=001  9880363355802441
=005  20141212194659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000641
=035  \\$aCAZ3790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x75
=072  \\$aD1.$x625.$x50
=150  \\$aAmmonia
=550  \\$wg$aGases
=550  \\$wg$aNitrogen Compounds
=550  \\$aAmmonium Hydroxide
=680  \\$iA colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.
=750  \0$aAmmonia$5IEN-HS$0(DLC)sh 85004538

=LDR  02156cz  a2200565n  4500
=001  9880363355902441
=005  20141212191945.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000638
=035  \\$aCAZ3787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x127.$x75
=150  \\$aAmiodarone
=450  \\$wnnna$aAlphapharm Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aAmiobeta
=450  \\$wnnna$aAmiodarex
=450  \\$wnnna$aAmiodarona
=450  \\$wnnna$aAmiodarone Hydrochloride
=450  \\$wnnna$aAmiohexal
=450  \\$wnnna$aAratac
=450  \\$wnnna$aArmstrong Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aASTA Medica Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aBerenguer Infale Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aBetapharm Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aBraxan
=450  \\$wnnna$aCorbionax
=450  \\$wnnna$aCordarex
=450  \\$wnnna$aCordarone
=450  \\$wnnna$aG Gam Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aHexal Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aHydrochloride, Amiodarone
=450  \\$wnnna$aKordaron
=450  \\$wnnna$aL-3428
=450  \\$wnnna$aL 3428
=450  \\$wnnna$aL3428
=450  \\$wnnna$aLeurquin Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aOrtacrone
=450  \\$wnnna$aPharma Investi Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aRytmarone
=450  \\$wnnna$aSanofi Winthrop Brand of Amiodarone Hydrochloride
=450  \\$wnnna$aSKF 33134-A
=450  \\$wnnna$aSKF 33134 A
=450  \\$wnnna$aSKF 33134A
=450  \\$wnnna$aTachydaron
=450  \\$wnnna$aTrangorex
=450  \\$wnnna$aWyeth Brand of Amiodarone Hydrochloride
=550  \\$wg$aBenzofurans
=680  \\$iAn antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
=688  \\$a87(75); was see under BENZOFURANS 1975-86
=750  \0$aAmiodarone$5IEN$0(DLC)sh 85004509

=LDR  01443cz  a2200361n  4500
=001  9880363356002441
=005  20141212194658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000637
=035  \\$aCAZ3786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x477.$x700
=150  \\$aTransaminases
=450  \\$aAminotransferases
=550  \\$wg$aNitrogenous Group Transferases
=550  \\$wh$a2-Aminoadipate Transaminase
=550  \\$wh$a4-Aminobutyrate Transaminase
=550  \\$wh$aAlanine Transaminase
=550  \\$wh$aAspartate Aminotransferases
=550  \\$wh$abeta-Alanine-Pyruvate Transaminase
=550  \\$wh$aD-Alanine Transaminase
=550  \\$wh$aGlutamate Synthase
=550  \\$wh$aGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
=550  \\$wh$aGlycine Transaminase
=550  \\$wh$aL-Lysine 6-Transaminase
=550  \\$wh$aLeucine Transaminase
=550  \\$wh$aOrnithine-Oxo-Acid Transaminase
=550  \\$wh$aSuccinyldiaminopimelate Transaminase
=550  \\$wh$aTryptophan Transaminase
=550  \\$wh$aTyrosine Transaminase
=680  \\$iA subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1.
=688  \\$a98(63)
=750  \0$aAminotransferases$5IEN$0(DLC)sh 85004508

=LDR  00830cz  a2200277n  4500
=001  9880363356102441
=005  20141212194656.0
=008  771208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000631
=035  \\$aCAZ3780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x80
=072  \\$aD3.$x383.$x725.$x50
=150  \\$aAminopyridines
=550  \\$wg$aAmines
=550  \\$wg$aPyridines
=550  \\$wh$a4-Aminopyridine
=550  \\$wh$aAmrinone
=550  \\$wh$aMethapyrilene
=550  \\$wh$aPhenazopyridine
=550  \\$wh$aPyrilamine
=550  \\$wh$aTripelennamine
=667  \\$a= pyridinamines & pyridylamines
=680  \\$iPyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond.
=688  \\$a79
=750  \0$aAminopyridines$5IEN$0(DLC)sh 85004507

=LDR  00793cz  a2200229n  4500
=001  9880363356202441
=005  20141212194653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000626
=035  \\$aCAZ3775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x100
=150  \\$aAminopeptidases
=550  \\$wg$aExopeptidases
=550  \\$wh$aAntigens, CD13
=550  \\$wh$aCystinyl Aminopeptidase
=550  \\$wh$aGlutamyl Aminopeptidase
=550  \\$wh$aLeucyl Aminopeptidase
=550  \\$wh$aMethionyl Aminopeptidases
=550  \\$wh$aPyroglutamyl-Peptidase I
=680  \\$iA subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11.
=750  \0$aAminopeptidases$0(DLC) sh 85004505$5IEN

=LDR  00924cz  a2200313n  4500
=001  9880363356302441
=005  20141212194650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000617
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51
=150  \\$aAminoglycosides
=550  \\$wg$aGlycosides
=550  \\$wh$aAnthracyclines
=550  \\$wh$aButirosin Sulfate
=550  \\$wh$aGentamicins
=550  \\$wh$aHygromycin B
=550  \\$wh$aKanamycin
=550  \\$wh$aMetrizamide
=550  \\$wh$aNeomycin
=550  \\$wh$aPuromycin
=550  \\$wh$aSpectinomycin
=550  \\$wh$aStreptomycin
=550  \\$wh$aStreptothricins
=550  \\$wh$aStreptozocin
=550  \\$aAmino Sugars
=680  \\$iGlycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
=688  \\$a74
=750  \0$aAminoglycosides$5IEN$0(DLC)sh 85004504

=LDR  01151cz  a2200301n  4500
=001  9880363356402441
=005  20141212194649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000613
=035  \\$aCAZ3762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x500
=072  \\$aD12.$x125.$x190
=150  \\$aAminobutyrates
=450  \\$wnnna$aAcid, Aminobutyric
=450  \\$wnnna$aAcids, Aminobutyric
=450  \\$wnnna$aAminobutyric Acid
=450  \\$aAminobutyric Acids
=550  \\$wg$aAmino Acids
=550  \\$wg$aButyrates
=550  \\$wh$aAminoisobutyric Acids
=550  \\$wh$agamma-Aminobutyric Acid
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iDerivatives of BUTYRIC ACID that contain one or more amino groups attached to the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure.
=688  \\$a1975(2013)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Aminobutyric Acids
=688  \\$a75; was AMINOBUTYRIC ACID 1963-74
=750  \0$aAminobutyric acid$5IEN$0(DLC)sh 85004502

=LDR  00542cz  a2200193n  4500
=001  9880363356502441
=005  20141212194647.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000607
=035  \\$aCAZ3756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x626.$x80.$x85
=150  \\$aAminoacetonitrile
=450  \\$aCyanomethylamine
=450  \\$aGlycinonitrile
=550  \\$wg$aAcetonitriles
=680  \\$iCyanomethylamine.
=688  \\$a91(75); was see under ACETONITRILES 1975-90
=750  \0$aAminoacetonitrile$5IEN$0(DLC)sh 85004496

=LDR  00666cz  a2200217n  4500
=001  9880363356602441
=005  20141212194647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000606
=035  \\$aCAZ3755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x67
=150  \\$aAmino Sugars
=450  \\$wnnna$aSugars, Amino
=550  \\$wg$aCarbohydrates
=550  \\$wh$aHexosamines
=550  \\$wh$aMuramic Acids
=550  \\$wh$aNeuraminic Acids
=550  \\$aAminoglycosides
=680  \\$iSUGARS containing an amino group. GLYCOSYLATION of other compounds with these amino sugars results in AMINOGLYCOSIDES.
=750  \0$aAmino sugars$5IEN$0(DLC)sh 88001137

=LDR  00740cz  a2200265n  4500
=001  9880363356702441
=005  20141212194647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000605
=035  \\$aCAZ3754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100
=072  \\$aD2.$x92.$x63
=150  \\$aAmino Alcohols
=450  \\$wnnna$aAlcohols, Amino
=550  \\$wg$aAlcohols
=550  \\$wg$aAmines
=550  \\$wh$aEthanolamines
=550  \\$wh$aHeptaminol
=550  \\$wh$aIsoetharine
=550  \\$wh$aNorepinephrine
=550  \\$wh$aPropanolamines
=550  \\$wh$aSphingosine
=680  \\$iCompounds possessing both a hydroxyl (-OH) and an amino group (-NH2).
=750  \0$aAmino alcohols$5IEN$0(DLC)sh 85004493

=LDR  02084cz  a2200577n  4500
=001  9880363356802441
=005  20141212194647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000604
=035  \\$aCAZ3753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464.$x263.$x200
=150  \\$aAmino Acyl-tRNA Synthetases
=450  \\$wnnna$aAcyl-tRNA Ligases, Amino
=450  \\$wnnna$aAcyl-tRNA Synthetases, Amino
=450  \\$aAmino Acyl T RNA Synthetases
=450  \\$aAmino Acyl-tRNA Ligases
=450  \\$wnnna$aAmino Acyl tRNA Ligases
=450  \\$wnnna$aAmino Acyl tRNA Synthetases
=450  \\$wnnna$aAminoacyl Transfer RNA Synthetase
=450  \\$wnnna$aAminoacyl-tRNA Synthetase
=450  \\$wnnna$aAminoacyl tRNA Synthetase
=450  \\$wnnna$aLigases, Amino Acyl-tRNA
=450  \\$wnnna$aRNA Synthetase, Transfer
=450  \\$wnnna$aSynthetase, Aminoacyl-tRNA
=450  \\$wnnna$aSynthetase, Transfer RNA
=450  \\$wnnna$aSynthetase, tRNA
=450  \\$wnnna$aSynthetases, Amino Acyl-tRNA
=450  \\$wnnna$aTransfer RNA Synthetase
=450  \\$wnnna$atRNA Synthetase
=550  \\$wg$aCarbon-Oxygen Ligases
=550  \\$wh$aAlanine-tRNA Ligase
=550  \\$wh$aArginine-tRNA Ligase
=550  \\$wh$aAspartate-tRNA Ligase
=550  \\$wh$aGlutamate-tRNA Ligase
=550  \\$wh$aGlycine-tRNA Ligase
=550  \\$wh$aHistidine-tRNA Ligase
=550  \\$wh$aIsoleucine-tRNA Ligase
=550  \\$wh$aLeucine-tRNA Ligase
=550  \\$wh$aLysine-tRNA Ligase
=550  \\$wh$aMethionine-tRNA Ligase
=550  \\$wh$aPhenylalanine-tRNA Ligase
=550  \\$wh$aSerine-tRNA Ligase
=550  \\$wh$aThreonine-tRNA Ligase
=550  \\$wh$aTryptophan-tRNA Ligase
=550  \\$wh$aTyrosine-tRNA Ligase
=550  \\$wh$aValine-tRNA Ligase
=550  \\$aTransfer RNA Aminoacylation
=680  \\$iA subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.
=688  \\$a2005(1972); use LIGASES 1966-1971
=750  \0$aAminoacyl-tRNA synthetases$0(DLC) sh 85004499$5IEN-M

=LDR  00850cz  a2200325n  4500
=001  9880363356902441
=005  20141212194646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000603
=035  \\$aCAZ3752HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30
=072  \\$aD12.$x125.$x166
=150  \\$aAmino Acids, Sulfur
=450  \\$wnnna$aAcids, Sulfur Amino
=450  \\$aSulfur Amino Acids
=550  \\$wg$aAmino Acids
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aCystathionine
=550  \\$wh$aCysteic Acid
=550  \\$wh$aCysteine
=550  \\$wh$aEthionine
=550  \\$wh$aHomocysteine
=550  \\$wh$aHomocystine
=550  \\$wh$aMethionine
=550  \\$wh$aPenicillamine
=550  \\$wh$aThiorphan
=550  \\$wh$aTiopronin
=688  \\$a74
=750  \0$aSulfur amino acids$5IEN$0(DLC)sh 85130369

=LDR  00908cz  a2200337n  4500
=001  9880363357002441
=005  20141212194645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000599
=035  \\$aCAZ3748M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x95
=150  \\$aAmino Acids, Diamino
=450  \\$wnnna$aAcids, Diamino Amino
=450  \\$wnnna$aAcids, Dibasic Amino
=450  \\$aAmino Acids, Dibasic
=450  \\$aDiamino Amino Acids
=450  \\$wnnna$aDibasic Amino Acids
=550  \\$wg$aAmino Acids
=550  \\$wh$aArginine
=550  \\$wh$aAsparagine
=550  \\$wh$aCitrulline
=550  \\$wh$aCystathionine
=550  \\$wh$aCystine
=550  \\$wh$aDiaminopimelic Acid
=550  \\$wh$aGlutamine
=550  \\$wh$aHomocystine
=550  \\$wh$aLysine
=550  \\$wh$aOrnithine
=688  \\$a74
=750  \0$aDiamino amino acids$0(DLC)sh2008004603$5IEN-M

=LDR  00753cz  a2200253n  4500
=001  9880363357102441
=005  20141212194644.0
=008  780516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000597
=035  \\$aCAZ3746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x70
=150  \\$aAmino Acids, Branched-Chain
=450  \\$wnnna$aAcids, Branched-Chain Amino
=450  \\$wnnna$aAmino Acids, Branched Chain
=450  \\$wnnna$aBranched-Chain Amino Acids
=550  \\$wg$aAmino Acids
=550  \\$wh$aAminoisobutyric Acids
=550  \\$wh$aIsoleucine
=550  \\$wh$aLeucine
=550  \\$wh$aValine
=680  \\$iAmino acids which have a branched carbon chain.
=688  \\$a79
=750  \0$aBranched chain amino acids$5IEN$0(DLC)sh 85004489

=LDR  01757cz  a2200505n  4500
=001  9880363357202441
=005  20141212194644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000596
=035  \\$aCAZ3745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125
=150  \\$aAmino Acids
=450  \\$wnnna$aAcids, Amino
=550  \\$wg$aAmino Acids, Peptides, and Proteins
=550  \\$wh$aAlanine
=550  \\$wh$aAmino Acid Chloromethyl Ketones
=550  \\$wh$aAmino Acids, Acidic
=550  \\$wh$aAmino Acids, Basic
=550  \\$wh$aAmino Acids, Branched-Chain
=550  \\$wh$aAmino Acids, Cyclic
=550  \\$wh$aAmino Acids, Diamino
=550  \\$wh$aAmino Acids, Dicarboxylic
=550  \\$wh$aAmino Acids, Essential
=550  \\$wh$aAmino Acids, Neutral
=550  \\$wh$aAmino Acids, Sulfur
=550  \\$wh$aAminobutyrates
=550  \\$wh$aAminocaproates
=550  \\$wh$aAminolevulinic Acid
=550  \\$wh$aCanavanine
=550  \\$wh$aCreatine
=550  \\$wh$aExcitatory Amino Acids
=550  \\$wh$aGlycine
=550  \\$wh$aHomoserine
=550  \\$wh$aKynurenine
=550  \\$wh$aOxamic Acid
=550  \\$wh$aPhosphoamino Acids
=550  \\$wh$aQuisqualic Acid
=550  \\$wh$aRNA, Transfer, Amino Acyl
=550  \\$wh$aSerine
=550  \\$wh$aThreonine
=667  \\$a/urine permitted but consider also RENAL AMINOACIDURIAS
=680  \\$iOrganic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
=688  \\$a/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64
=750  \0$aAmino acids$5IEN$0(DLC)sh 85004486

=LDR  01617cz  a2200421n  4500
=001  9880363357302441
=005  20141212194643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000595
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x60
=072  \\$aL1.$x453.$x245.$x667.$x60
=150  \\$aAmino Acid Sequence
=450  \\$wnnna$aAmino Acid Sequences
=450  \\$wnnna$aPrimary Protein Structure
=450  \\$wnnna$aPrimary Protein Structures
=450  \\$aProtein Structure, Primary
=450  \\$wnnna$aProtein Structures, Primary
=450  \\$wnnna$aSequence, Amino Acid
=450  \\$wnnna$aSequences, Amino Acid
=450  \\$wnnna$aStructure, Primary Protein
=450  \\$wnnna$aStructures, Primary Protein
=550  \\$wg$aMolecular Sequence Data
=550  \\$wg$aMolecular Structure
=550  \\$wh$aAmino Acid Motifs
=550  \\$wh$aExteins
=550  \\$wh$aHistone Code
=550  \\$wh$aImmunoglobulin Variable Region
=550  \\$wh$aInteins
=550  \\$wh$aPeptide Library
=550  \\$wh$aProtein Sorting Signals
=550  \\$wh$aRepetitive Sequences, Amino Acid
=550  \\$aPeptides
=550  \\$aProteins
=667  \\$aIM general; coordinate NIM with specific protein or peptide; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: AMINO ACID SEQ or AA SEQ
=680  \\$iThe order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
=688  \\$a66
=750  \0$aAmino acid sequence$5IEN$0(DLC)sh 85004484

=LDR  02177cz  a2200505n  4500
=001  9880363357402441
=005  20141212194642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000592
=035  \\$aCAZ3741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x100
=072  \\$aC18.$x452.$x648.$x100
=150  \\$aAmino Acid Metabolism, Inborn Errors
=450  \\$wnnna$aAmino Acid Metabolism Disorders, Inborn
=450  \\$wnnna$aAmino Acid Metabolism, Inborn Error
=450  \\$wnnna$aAmino Acid Metabolism, Inherited Disorders
=450  \\$aAmino Acidopathies, Congenital
=450  \\$wnnna$aAmino Acidopathies, Inborn
=450  \\$wnnna$aAmino Acidopathy, Congenital
=450  \\$wnnna$aAmino Acidopathy, Inborn
=450  \\$wnnna$aCongenital Amino Acidopathies
=450  \\$wnnna$aCongenital Amino Acidopathy
=450  \\$wnnna$aInborn Amino Acidopathies
=450  \\$wnnna$aInborn Amino Acidopathy
=450  \\$wnnna$aInborn Errors, Amino Acid Metabolism
=450  \\$wnnna$aInherited Errors of Amino Acid Metabolism
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aAlbinism
=550  \\$wh$aAlkaptonuria
=550  \\$wh$aHyperglycinemia, Nonketotic
=550  \\$wh$aHyperhomocysteinemia
=550  \\$wh$aHyperlysinemias
=550  \\$wh$aMaple Syrup Urine Disease
=550  \\$wh$aMultiple Acyl Coenzyme A Dehydrogenase Deficiency
=550  \\$wh$aMultiple Carboxylase Deficiency
=550  \\$wh$aPhenylketonurias
=550  \\$wh$aProlidase Deficiency
=550  \\$wh$aPropionic Acidemia
=550  \\$wh$aTyrosinemias
=550  \\$wh$aUrea Cycle Disorders, Inborn
=667  \\$acoord IM with specific amino acid /metab (IM); DF: AA METAB INBORN ERR
=680  \\$iDisorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.
=688  \\$a1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964
=750  \0$aAmino acids$xMetabolism$xDisorders$5IEN$0(DLC)sh 85004483

=LDR  01130cz  a2200373n  4500
=001  9880363357502441
=005  20141212194641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000588
=035  \\$aCAZ3737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92
=150  \\$aAmines
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$a1-Naphthylamine
=550  \\$wh$a2-Naphthylamine
=550  \\$wh$aAllylamine
=550  \\$wh$aAmino Alcohols
=550  \\$wh$aAminopyridines
=550  \\$wh$aAniline Compounds
=550  \\$wh$aBenzylamines
=550  \\$wh$aBiogenic Amines
=550  \\$wh$aButylamines
=550  \\$wh$aCatecholamines
=550  \\$wh$aCyclohexylamines
=550  \\$wh$aEthylamines
=550  \\$wh$aHydroxylamines
=550  \\$wh$aMannich Bases
=550  \\$wh$aMethylamines
=550  \\$wh$aPolyamines
=550  \\$wh$aPropylamines
=550  \\$wh$aQuaternary Ammonium Compounds
=680  \\$iA group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAmines$5IEN$0(DLC)sh 85004479

=LDR  01744cz  a2200421n  4500
=001  9880363357602441
=005  20141212194640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000587
=035  \\$aCAZ3736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x662
=150  \\$aOxidoreductases Acting on CH-NH Group Donors
=450  \\$wnno$aAmine Oxidoreductases$5IEN
=450  \\$wnnna$aAmine Oxidoreductases, Secondary
=450  \\$wnnna$aAmine Oxidoreductases, Secondary Amine
=450  \\$wnnna$aOxidoreductases Acting on CH NH Group Donors
=450  \\$wnnna$aOxidoreductases, Secondary Amine
=450  \\$aSecondary Amine Oxidoreductases
=550  \\$wg$aOxidoreductases
=550  \\$wh$a1-Pyrroline-5-Carboxylate Dehydrogenase
=550  \\$wh$aDihydropteridine Reductase
=550  \\$wh$aFMN Reductase
=550  \\$wh$aMethylenetetrahydrofolate Dehydrogenase (NAD+)
=550  \\$wh$aMethylenetetrahydrofolate Dehydrogenase (NADP)
=550  \\$wh$aMethylenetetrahydrofolate Reductase (NADPH2)
=550  \\$wh$aOxidoreductases, N-Demethylating
=550  \\$wh$aProline Oxidase
=550  \\$wh$aPyridoxaminephosphate Oxidase
=550  \\$wh$aPyrroline Carboxylate Reductases
=550  \\$wh$aSaccharopine Dehydrogenases
=550  \\$wh$aTetrahydrofolate Dehydrogenase
=667  \\$ado not confuse with OXIDOREDUCTASES ACTING ON CH-NH2 GROUP DONORS
=680  \\$iEnzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.
=688  \\$a2006(1975)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Amine Oxidoreductases
=688  \\$a75
=750  \0$aAmine oxidase$0(DLC) sh 85004478$5IEN

=LDR  00844cz  a2200241n  4500
=001  9880363357702441
=005  20170608115227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000586
=035  \\$aCAZ3735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x53
=072  \\$aG2.$x607.$x110
=072  \\$aG3.$x68
=150  \\$aAmination
=450  \\$wnnna$aAminations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic amination: coord NIM with TRANSAMINASES (IM) + substrate (NIM) or specific transaminase (IM)
=680  \\$iThe creation of an amine. It can be produced by the addition of an amino group to an organic compound or reduction of a nitro group.
=688  \\$a74(71)
=750  \0$aAmination$5IEN$0(DLC)sh 85004477

=LDR  02001cz  a2200421n  4500
=001  9880363357802441
=005  20141212194639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000584
=035  \\$aCAZ3733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x679.$x149
=150  \\$aAmiloride
=450  \\$wnnna$aAlphapharm Brand of Amiloride Hydrochloride
=450  \\$wnnna$aAmidal
=450  \\$wnnna$aAmiduret Trom
=450  \\$wnnna$aAmiloberag
=450  \\$wnnna$aAmiloride Hydrochloride
=450  \\$wnnna$aAmiloride Hydrochloride, Anhydrous
=450  \\$wnnna$aAmrad Brand of Amiloride Hydrochloride
=450  \\$wnnna$aAnhydrous Amiloride Hydrochloride
=450  \\$wnnna$aBerolina Brand of Amiloride Hydrochloride
=450  \\$wnnna$aCahill May Roberts Brand of Amiloride Hydrochloride
=450  \\$wnnna$aDouglas Brand of Amiloride Hydrochloride
=450  \\$wnnna$aHydrochloride, Amiloride
=450  \\$wnnna$aHydrochloride, Anhydrous Amiloride
=450  \\$wnnna$aKaluril
=450  \\$wnnna$aMerck Brand of Amiloride Hydrochloride
=450  \\$wnnna$aMerck Sharp & Dohme Brand of Amiloride Hydrochloride
=450  \\$wnnna$aMidamor
=450  \\$wnnna$aMidoride
=450  \\$wnnna$aModamide
=450  \\$wnnna$aTrom, Amiduret
=450  \\$wnnna$aTrommsdorff Brand of Amiloride Hydrochloride
=550  \\$wg$aPyrazines
=680  \\$iA pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)
=688  \\$a86(72); was see under PYRAZINES 1975-85, was Prov 1972-74
=750  \0$aAmiloride$5IEN$0(DLC)sh 85004476

=LDR  01022cz  a2200349n  4500
=001  9880363357902441
=005  20141212194637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000581
=035  \\$aCAZ3730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87
=150  \\$aAmidohydrolases
=450  \\$aAmidases
=550  \\$wg$aHydrolases
=550  \\$wh$aAllophanate Hydrolase
=550  \\$wh$aArylformamidase
=550  \\$wh$aAsparaginase
=550  \\$wh$aAspartylglucosylaminase
=550  \\$wh$abeta-Lactamases
=550  \\$wh$aBiotinidase
=550  \\$wh$aCeramidases
=550  \\$wh$aDihydroorotase
=550  \\$wh$aGlutaminase
=550  \\$wh$aHistone Deacetylases
=550  \\$wh$aN-Acetylmuramoyl-L-alanine Amidase
=550  \\$wh$aNicotinamidase
=550  \\$wh$aPenicillin Amidase
=550  \\$wh$aPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
=550  \\$wh$aPyroglutamate Hydrolase
=550  \\$wh$aUrease
=750  \0$aAmidases$5IEN$0(DLC)sh 91006084

=LDR  00490cz  a2200193n  4500
=001  9880363358002441
=005  20141212194636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000578
=035  \\$aCAZ3727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78
=150  \\$aAmidines
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aBenzamidines
=550  \\$wh$aChlorphenamidine
=550  \\$wh$aGuanidines
=550  \\$wh$aStilbamidines
=750  \0$aAmidines$5IEN$0(DLC)sh 85004465

=LDR  01044cz  a2200325n  4500
=001  9880363358102441
=005  20141212194636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000577
=035  \\$aCAZ3726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65
=150  \\$aAmides
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetamides
=550  \\$wh$aAcrylamides
=550  \\$wh$aAnilides
=550  \\$wh$aBenzamides
=550  \\$wh$aBenzoylarginine-2-Naphthylamide
=550  \\$wh$aCeramides
=550  \\$wh$aCerulenin
=550  \\$wh$aDibucaine
=550  \\$wh$aFormamides
=550  \\$wh$aLactams
=550  \\$wh$aPolyunsaturated Alkamides
=550  \\$wh$aSalicylamides
=550  \\$wh$aSulfonamides
=550  \\$wh$aThioamides
=680  \\$iOrganic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAmides$5IEN$0(DLC)sh 85004464

=LDR  00770cz  a2200193n  4500
=001  9881486568702441
=005  20201111172920.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001680
=035  \\$a(NLM)98195459430000041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x517.$x211
=150  \\$aBiographies as Topic
=450  \\$aBiography as Topic
=667  \\$ause only for biography as a subject; memoirs as a subject go under AUTOBIOGRAPHIES AS TOPIC. For biographies of persons use the Publication Type BIOGRAPHY
=680  \\$iWorks about a written account of a person's life and the branch of literature concerned with the lives of people.
=688  \\$a2008(1963)
=750  \0$aBiography$0(DLC) sh 85014152$5IEN-M
=750  \0$aBiographers$0(DLC) sh 85014148$5IEN-M

=LDR  01634cz  a2200421n  4500
=001  9881486658702441
=005  20201112180150.0
=008  910530\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D017004
=035  \\$a(NLM)98199202700000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x194
=150  \\$aCodependency, Psychological
=450  \\$wnnna$aCo Dependence, Psychology
=450  \\$wnnna$aCo Dependency, Psychology
=450  \\$wnnna$aCo-Dependency, Psychological
=450  \\$wnnna$aCo-Dependency, Psychology
=450  \\$wnnna$aCodependence
=450  \\$wnnna$aCodependency
=450  \\$wnnna$aCodependency, Psychology
=450  \\$wnnna$aPsychological Co-Dependence
=450  \\$wnnna$aPsychological Co-Dependency
=450  \\$wnnna$aPsychological Codependence
=450  \\$wnnna$aPsychological Codependency
=450  \\$wnnna$aCo Dependency, Psychological
=450  \\$wnnna$aCo-Dependence, Psychological
=450  \\$wnnna$aCodependence, Psychological
=450  \\$wnnna$aPsychological Co Dependence
=450  \\$wnnna$aPsychological Co Dependency
=450  \\$wnnna$aPsychology Co Dependence
=450  \\$wnnna$aPsychology Co Dependency
=450  \\$wnnna$aPsychology Co-Dependency
=450  \\$wnnna$aPsychology Codependency
=550  \\$aInterpersonal Relations
=550  \\$aSubstance-Related Disorders
=680  \\$iA relational pattern in which a person attempts to derive a sense of purpose through relationships with others.
=688  \\$a2020 (1992); was CODEPENDENCY (PSYCHOLOGY) 1998-2019; was CO-DEPENDENCY (PSYCHOLOGY) 1992-1997
=750  \0$aCodependency$0(DLC)sh 87000232$5IEN-M

=LDR  02133cz  a2200541n  4500
=001  9881486658802441
=005  20201112175304.0
=008  800507\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002522
=035  \\$a(NLM)98199587260000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x112.$x199.$x120.$x126.$x110
=150  \\$aChlorocebus aethiops
=450  \\$wnnna$aSavannah Monkey
=450  \\$aAfrican Green Monkey
=450  \\$aCercopithecus aethiops
=450  \\$aCercopithecus griseoviridis
=450  \\$aCercopithecus griseus
=450  \\$aCercopithecus pygerythrus
=450  \\$aCercopithecus sabeus
=450  \\$aCercopithecus tantalus
=450  \\$aChlorocebus cynosuros
=450  \\$aChlorocebus cynosurus
=450  \\$aChlorocebus pygerythrus
=450  \\$aGreen Monkey
=450  \\$aGrivet Monkey
=450  \\$aLasiopyga weidholzi
=450  \\$aMalbrouck
=450  \\$aMalbrouck Monkey
=450  \\$aMonkey, African Green
=450  \\$aMonkey, Green
=450  \\$aMonkey, Grivet
=450  \\$aMonkey, Vervet
=450  \\$aVervet Monkey
=450  \\$wnnna$aChlorocebus cynosuro
=450  \\$wnnna$aGreen Monkey, African
=450  \\$wnnna$aGreen Monkeys
=450  \\$wnnna$aGrivet Monkeys
=450  \\$wnnna$aMalbrouck Monkeys
=450  \\$wnnna$aMalbroucks
=450  \\$wnnna$aMonkey, Malbrouck
=450  \\$wnnna$aMonkey, Savannah
=450  \\$wnnna$aSavannah Monkeys
=450  \\$wnnna$aVervet Monkeys
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
=688  \\$a2020(1981); see under CERCOPITHECUS 1981-1990; for CERCOPITHECUS PYGERYTHRUS & CERCOPITHECUS SABEUS see under CERCOPITHECUS 1975-1980; see under CERCOPITHECUS AETHIOPS 1991-2019
=750  \0$aCercopithecus aethiops$0(DLC)sh 85022060$5IEN-M

=LDR  01114cz  a2200325n  4500
=001  9881486765902441
=005  20201112131751.0
=008  770512\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002391
=035  \\$a(NLM)98196101050000041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 541
=072  \\$aN1.$x224.$x791.$x200
=072  \\$aN3.$x349.$x650.$x95
=072  \\$aN6.$x850.$x505.$x400.$x800.$x200
=150  \\$aCatchment Area, Health
=450  \\$wnnna$aHealth Catchment Area
=450  \\$wnnna$aService Area, Health
=450  \\$aHealth Service Area
=450  \\$wnnna$aArea, Health Catchment
=450  \\$wnnna$aArea, Health Service
=450  \\$wnnna$aAreas, Health Catchment
=450  \\$wnnna$aAreas, Health Service
=450  \\$wnnna$aCatchment Areas, Health
=450  \\$wnnna$aHealth Catchment Areas
=450  \\$wnnna$aHealth Service Areas
=450  \\$wnnna$aService Areas, Health
=680  \\$iA geographic area defined and served by a health program or institution.
=688  \\$a2020 (1978); was CATCHMENT AREA (HEALTH) 1978-2019
=750  \0$aHealth service areas$0(DLC)sh 85059599$5IEN-M

=LDR  01430cz  a2200337n  4500
=001  9881487466702441
=005  20201112111121.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001634
=035  \\$a(NLM)98200024610000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x99
=072  \\$aL1.$x453.$x183
=150  \\$aBibliographies as Topic
=450  \\$aBibliography as Topic
=450  \\$wnnna$aBibliographies as Topics
=450  \\$wnnna$aBibliography as Topics
=450  \\$wnnna$aTopic, Bibliographies as
=450  \\$wnnna$aTopic, Bibliography as
=450  \\$wnnna$aTopics, Bibliographies as
=450  \\$wnnna$aTopics, Bibliography as
=450  \\$wnnna$aas Topic, Bibliographies
=450  \\$wnnna$aas Topic, Bibliography
=450  \\$wnnna$aas Topics, Bibliographies
=450  \\$wnnna$aas Topics, Bibliography
=667  \\$ado not confuse with Publication Type BIBLIOGRAPHY; for bibliography on specific subject, index under subject (IM) + the Publication Type BIBLIOGRAPHY; differentiate from LITERATURE; medical bibliography: see note on BIBLIOGRAPHY OF MEDICINE; lists of books: consider also BOOK SELECTION
=680  \\$iWorks about lists of books, articles, and other publications.
=688  \\$a2008(1963)
=750  \0$aBibliographers$0(DLC) sh 85013831$5IEN-M
=750  \0$aBibliographical citations$0(DLC) sh 85013833$5IEN-M
=750  \0$aBibliography$0(DLC) sh 85013838$5IEN-M

=LDR  00689cz  a2200181n  4500
=001  9881491441502441
=005  20201125152009.0
=008  741212\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006372
=035  \\$a(NLM)98197228830000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x750.$x450
=150  \\$aHelix, Snails
=450  \\$aHelix (Snails)
=450  \\$wnnna$aSnails Helix
=680  \\$iA genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.
=688  \\$a2020 (1975); was HELIX (SNAILS) 1978-2019; was indexed under SNAILS 1975-1977
=750  \0$aHelix (Mollusks)$0(DLC) sh 85060055$5IEN-M

=LDR  01942cz  a2200385n  4500
=001  9881491449302441
=005  20201123174459.0
=008  940602\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018479
=035  \\$a(NLM)98195307000000041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 320
=072  \\$aN2.$x421.$x143.$x130.$x320
=072  \\$aN2.$x421.$x726.$x320
=150  \\$aEarly Intervention, Educational
=450  \\$aEarly Intervention (Education)
=450  \\$aEarly Intervention Education
=450  \\$aEarly Intervention, Education
=450  \\$aHead Start Program
=450  \\$wnnna$aEducation Early Intervention
=450  \\$wnnna$aEducation, Early Intervention
=450  \\$wnnna$aEducational Early Intervention
=450  \\$wnnna$aHead Start Programs
=450  \\$wnnna$aIntervention Education, Early
=450  \\$wnnna$aIntervention, Early (Education)
=450  \\$wnnna$aIntervention, Education Early
=450  \\$wnnna$aIntervention, Educational Early
=450  \\$wnnna$aProgram, Head Start
=550  \\$aChild, Exceptional
=550  \\$aDisabled Persons
=550  \\$aRehabilitation
=667  \\$aEARLY MEDICAL INTERVENTION is also available
=680  \\$iProcedures and programs that facilitate the development or skill acquisition in infants and young children who have disabilities, who are at risk for developing disabilities, or who are gifted. It includes programs that are designed to prevent handicapping conditions in infants and young children and family-centered programs designed to affect the functioning of infants and children with special needs. (From Journal of Early Intervention, Editorial, 1989, vol. 13, no. 1, p. 3; A Discursive Dictionary of Health Care, prepared for the U.S. House of Representatives Committee on Interstate and Foreign Commerce, 1976)
=688  \\$a2020 (1995); was EARLY INTERVENTION (EDUCATION) 1995-2019
=750  \0$aHead Start Programs$0(DLC) sh 87000100$5IEN-M

=LDR  00739cz  a2200193n  4500
=001  9881491450102441
=005  20201123165620.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004208
=035  \\$a(NLM)98195523820000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 193.5.D5
=072  \\$aF1.$x393.$x246
=150  \\$aDisplacement, Psychological
=450  \\$wnnna$aDisplacement, Psychology
=450  \\$wnnna$aPsychological Displacement
=680  \\$iThe process by which an emotional or behavioral response that is appropriate for one situation appears in another situation for which it is inappropriate.
=688  \\$a2020 (1968); was DISPLACEMENT (PSYCHOLOGY) 1968-2019
=750  \0$aDisplacement (Psychology)$0(DLC)sh 85038464$5IEN-M

=LDR  00886cz  a2200229n  4500
=001  9881491547602441
=005  20201130180545.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007239
=035  \\$a(NLM)98197408760000041
=040  \\$aDNLM$cDNLM
=072  \\$aC1
=150  \\$aInfections
=450  \\$aInfection
=450  \\$aInfection and Infestation
=450  \\$aInfections and Infestations
=450  \\$wnnna$aInfestation and Infection
=450  \\$wnnna$aInfestations and Infections
=667  \\$ageneral only; prefer specifics; /prev = INFECTION CONTROL but see note there
=680  \\$iInvasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
=688  \\$a2020; was Infection 1963-2019; /prevention & control was INFECTION/prevention & control 1966-91
=750  \\$aInfection$0(DLC)sh 85066076

=LDR  01183cz  a2200277n  4500
=001  9881491547702441
=005  20201130175321.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007173
=035  \\$a(NLM)98195252780000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x448
=150  \\$aImprinting, Psychological
=450  \\$aImprinting (Psychology)
=450  \\$aImprinting, Psychology
=450  \\$wnnna$aImprintings (Psychology)
=450  \\$wnnna$aImprintings, Psychological
=450  \\$wnnna$aImprintings, Psychology
=450  \\$wnnna$aPsychological Imprinting
=450  \\$wnnna$aPsychological Imprintings
=450  \\$wnnna$aPsychology Imprinting
=450  \\$wnnna$aPsychology Imprintings
=667  \\$ahuman & animal
=680  \\$iA particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction. Imprinted behavior includes most (or all) behavior commonly called instinctive, but imprinting is used purely descriptively.
=688  \\$a2020 (1965); was IMPRINTING (PSYCHOLOGY) 1964-2019
=750  \0$aImprinting (Psychology)$0(DLC)sh 85064671$5IEN-M

=LDR  00929cz  a2200205n  4500
=001  9881491551602441
=005  20201124151111.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005329
=035  \\$a(NLM)98199682540000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 610
=072  \\$aF3.$x657.$x350
=150  \\$aFetishism, Psychiatric
=450  \\$aFetishism (Psychiatric)
=450  \\$wnnna$aPsychiatric Fetishism
=667  \\$abelief in religious or magic fetishes goes under RELIGION; SUPERSTITION & its indentions, ANTHROPOLOGY, CULTURAL or other pertinent term
=680  \\$iA condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal.
=688  \\$a2020 (1975); was FETISHISM (PSYCHIATRIC) 1991-2019; was indexed under PARAPHILIAS 1981-1990; was indexed under SEX DEVIATION 1975-1980; use SEX DEVIATION 1968-1974
=750  \0$aFetishism$0(DLC) sh 85047960$5IEN-M

=LDR  01123cz  a2200313n  4500
=001  9881491551702441
=005  20201124144112.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005120
=035  \\$a(NLM)98198746990000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x747.$x246
=072  \\$aF2.$x739.$x794.$x253
=150  \\$aExtraversion, Psychological
=450  \\$wnnna$aExtraversion
=450  \\$wnnna$aExtroversion
=450  \\$wnnna$aExtroversion (Psychology)
=450  \\$aExtraversion (Psychology)
=450  \\$aExtraversion, Psychology
=450  \\$aExtroversion, Psychological
=450  \\$aExtroversion, Psychology
=450  \\$wnnna$aPsychological Extraversion
=450  \\$wnnna$aPsychological Extroversion
=450  \\$wnnna$aPsychology Extraversion
=450  \\$wnnna$aPsychology Extraversions
=450  \\$wnnna$aPsychology Extroversion
=680  \\$iA state in which attention is largely directed outward from the self.
=688  \\$a2020 (1968); was EXTRAVERSION (PSYCHOLOGY) 1978-2019; was EXTROVERSION (PSYCHOLOGY) 1968-197
=750  \0$aExtraversion$0(DLC)sh 85046595$5IEN-M

=LDR  00751cz  a2200217n  4500
=001  9881491551802441
=005  20201124135109.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005085
=035  \\$a(NLM)98198801570000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x269
=072  \\$aL1.$x178.$x820.$x90.$x269
=150  \\$aExhibitions as Topic
=450  \\$aExhibits as Topic
=450  \\$wnnna$aExhibits as Topics
=450  \\$wnnna$aTopics, Exhibitions as
=667  \\$ado not confuse with the Publication Type EXHIBITION
=680  \\$iWorks about discussions, descriptions or catalogs of public displays or items representative of a given subject.
=688  \\$a2008(1963)
=750  \0$aExhibitions$0(DLC) sh 85046354$5IEN

=LDR  01205cz  a2200385n  4500
=001  9881491552002441
=005  20201124131040.0
=008  900606\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016081
=035  \\$a(NLM)98198878440000041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x60.$x75.$x730.$x700.$x200.$x500
=150  \\$aMoon
=450  \\$wnnna$aMoon Cycle
=450  \\$wnnna$aMoon Phases
=450  \\$aLunar Cycle
=450  \\$aLunar Phases
=450  \\$wnnna$aCycle, Lunar
=450  \\$wnnna$aCycle, Moon
=450  \\$wnnna$aCycles, Lunar
=450  \\$wnnna$aCycles, Moon
=450  \\$wnnna$aLunar Cycles
=450  \\$wnnna$aLunar Phase
=450  \\$wnnna$aMoon Cycles
=450  \\$wnnna$aMoon Phase
=450  \\$wnnna$aMoons
=450  \\$wnnna$aPhase, Lunar
=450  \\$wnnna$aPhase, Moon
=450  \\$wnnna$aPhases, Lunar
=450  \\$wnnna$aPhases, Moon
=550  \\$aExtraterrestrial Environment
=667  \\$amoon illusion: coordinate with OPTICAL ILLUSIONS
=680  \\$iThe natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
=688  \\$a91
=750  \0$aMoon$0(DLC)sh 85087107$5IEN-M

=LDR  00620cz  a2200181n  4500
=001  9881491552302441
=005  20201124130021.0
=008  940607\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018534
=035  \\$a(NLM)98196207680000041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x60.$x75.$x730.$x700.$x200
=150  \\$aEarth, Planet
=450  \\$aEarth (Planet)
=450  \\$aPlanet Earth
=680  \\$iPlanet that is the third in order from the sun. It is one of the four inner or terrestrial planets of the SOLAR SYSTEM.
=688  \\$a2020 (1995); was EARTH (PLANET) 1995-2019
=750  \0$aEarth (Planet)$0(DLC)sh 85040427$5IEN-M

=LDR  00622cz  a2200193n  4500
=001  9881491564802441
=005  20201118175358.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003717
=035  \\$a(NLM)98199025100000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 193.5.D3
=072  \\$aF1.$x393.$x200
=150  \\$aDenial, Psychological
=450  \\$wnnna$aDenial, Psychology
=450  \\$wnnna$aPsychological Denial
=680  \\$iRefusal to admit the truth or reality of a situation or experience.
=688  \\$a2020 (1975); was DENIAL (PSYCHOLOGY) 1975-2019
=750  \0$aDenial (Psychology)$0(DLC)sh 85036731$5IEN-M

=LDR  01409cz  a2200325n  4500
=001  9881491564902441
=005  20201118173607.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D033364
=035  \\$a(NLM)98195985240000041
=040  \\$aDNLM$cDNLM
=060  \0$aQL 444.M33
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190
=150  \\$aDecapoda
=450  \\$wnnna$aDecapod Crustaceans
=450  \\$wnnna$aDecapods
=450  \\$wnnna$aSicyoniidae
=450  \\$aRock Shrimp
=450  \\$aShrimp, Rock
=450  \\$aSicyonia
=450  \\$wnnna$aCrustacean, Decapod
=450  \\$wnnna$aCrustaceans, Decapod
=450  \\$wnnna$aDecapod
=450  \\$wnnna$aDecapod Crustacean
=450  \\$wnnna$aRock Shrimps
=450  \\$wnnna$aShrimps, Rock
=667  \\$aas animal & food; as food coordinate with SHELLFISH; note entry term ROCK SHRIMP: several other shrimp terms are available; unspecified shrimp as food is probably PENAEIDAE
=680  \\$iThe largest order of CRUSTACEA, comprising over 10,000 species. They are characterized by three pairs of thoracic appendages modified as maxillipeds, and five pairs of thoracic legs. The order includes the familiar shrimps, crayfish (ASTACOIDEA), true crabs (BRACHYURA), and lobsters (NEPHROPIDAE and PALINURIDAE), among others.
=688  \\$a2020 (2003); was DECAPODA (CRUSTACEA) 2003-2019
=750  \0$aDecapoda (Crustacea)$0(DLC)sh 85036164$5IEN-M

=LDR  00962cz  a2200241n  4500
=001  9881491565002441
=005  20201118172330.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003423
=035  \\$a(NLM)98195611530000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x209
=150  \\$aCritical Period, Psychological
=450  \\$wnnna$aCritical Period, Psychology
=450  \\$wnnna$aCritical Periods, Psychological
=450  \\$wnnna$aCritical Periods, Psychology
=450  \\$wnnna$aPeriod, Psychological Critical
=450  \\$wnnna$aPeriod, Psychology Critical
=450  \\$wnnna$aPsychological Critical Period
=667  \\$ahuman & animal
=680  \\$iA specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life.
=688  \\$a2020 (1968); was CRITICAL PERIOD (PSYCHOLOGY) 1968-2019
=750  \0$iRelated mapping$aCritical periods (Biology)$0(DLC)sh 85034139$4RM$5IEN

=LDR  00719cz  a2200181n  4500
=001  9881491565102441
=005  20201118170238.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003379
=035  \\$a(NLM)98199128400000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 62
=072  \\$aF4.$x754.$x720.$x864.$x363
=150  \\$aCountertransference
=450  \\$wnnna$aCountertransference, Psychology
=680  \\$iConscious or unconscious emotional reaction of the therapist to the patient which may interfere with treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a2020 (1968); was COUNTERTRANSFERENCE (PSYCHOLOGY) 1968-2020
=750  \0$aCountertransference (Psychology)$0(DLC)sh 85033449$5IEN

=LDR  00774cz  a2200229n  4500
=001  9881491638902441
=005  20201202175028.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007439
=035  \\$a(NLM)98196545660000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x747.$x511
=072  \\$aF2.$x739.$x794.$x438
=150  \\$aIntroversion, Psychological
=450  \\$wnnna$aIntroversion
=450  \\$aIntroversion (Psychology)
=450  \\$aIntroversion, Psychology
=450  \\$wnnna$aPsychological Introversion
=450  \\$wnnna$aPsychology Introversion
=680  \\$iA state in which attention is largely directed inward upon one's self.
=688  \\$a2020 (1968); was INTROVERSION (PSYCHOLOGY) 1968-2019
=750  \0$aIntroversion$0(DLC)sh 85067649$5IEN-M

=LDR  01910cz  a2200373n  4500
=001  9881491646402441
=005  20201130114302.0
=008  950608\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019018
=035  \\$a(NLM)98199108510000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.I3
=072  \\$aE2.$x190.$x525.$x249
=072  \\$aF4.$x754.$x462
=150  \\$aImagery, Psychotherapy
=450  \\$aDirected Reverie Therapy
=450  \\$aGuided Imagery
=450  \\$aImagery (Psychotherapy)
=450  \\$aImagery Psychotherapy
=450  \\$aImagery, Guided
=450  \\$aImagery, Psychotherapeutic
=450  \\$aPsychotherapeutic Imagery
=450  \\$aPsychotherapy Imagery
=450  \\$wnnna$aDirected Reverie Therapies
=450  \\$wnnna$aPsychotherapy, Imagery
=450  \\$wnnna$aReverie Therapies, Directed
=450  \\$wnnna$aReverie Therapy, Directed
=450  \\$wnnna$aTherapies, Directed Reverie
=450  \\$wnnna$aTherapy, Directed Reverie
=550  \\$aImagination
=667  \\$aa psychotherapy technique; do not confuse with the imagery or mental images produced by the imagination ( = IMAGINATION)
=680  \\$iThe use of mental images produced by the imagination as a form of psychotherapy. It can be classified by the modality of its content: visual, verbal, auditory, olfactory, tactile, gustatory, or kinesthetic. Common themes derive from nature imagery (e.g., forests and mountains), water imagery (e.g., brooks and oceans), travel imagery, etc. Imagery is used in the treatment of mental disorders and in helping patients cope with other diseases. Imagery often forms a part of HYPNOSIS, of AUTOGENIC TRAINING, of RELAXATION TECHNIQUES, and of BEHAVIOR THERAPY. (From Encyclopedia of Human Behavior, vol. 4, pp29-30, 1994)
=688  \\$a2020 (1996); was IMAGERY (PSYCHOTHERAPY) 1996-2019
=750  \0$aImagery (Psychology)$xTherapeutic use$0(DLC)sh2008104270$5IEN-M

=LDR  01181cz  a2200265n  4500
=001  9881491647402441
=005  20190903000000.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007062
=035  \\$a(NLM)98199915150000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x446
=072  \\$aF1.$x752.$x747.$x385
=150  \\$aIdentification, Psychological
=450  \\$aIdentification (Psychology)
=450  \\$aIdentification, Psychology
=450  \\$wnnna$aIdentifications (Psychology)
=450  \\$wnnna$aIdentifications, Psychological
=450  \\$wnnna$aIdentifications, Psychology
=450  \\$wnnna$aPsychological Identification
=450  \\$wnnna$aPsychological Identifications
=450  \\$wnnna$aPsychology Identification
=450  \\$wnnna$aPsychology Identifications
=680  \\$iA process by which an individual unconsciously endeavors to pattern himself after another. This process is also important in the development of the personality, particularly the superego or conscience, which is modeled largely on the behavior of adult significant others.
=688  \\$a2020 (1968); was IDENTIFICATION (PSYCHOLOGY) 1968-2019; use DEFENSE MECHANISMS 1963-1967

=LDR  00777cz  a2200205n  4500
=001  9881491758202441
=005  20201119131600.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078646
=035  \\$a(NLM)9811675422300041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x517.$x211.$x361
=150  \\$aDiaries as Topic
=450  \\$wnnna$aDiary as Topic
=450  \\$wnnna$aDiaries as Topics
=450  \\$wnnna$aDiary as Topics
=667  \\$ado not confuse with the Publication Type DIARY
=680  \\$iWorks on or about records, usually private, of writers' experiences, observations, feelings, attitudes, etc. They may also be works marked in calendar order in which to note appointments and the like.
=688  \\$a2020(2019)
=750  \0$aDiaries$0(DLC) sh 85037601$5IEN-M

=LDR  00873cz  a2200241n  4500
=001  9881491758502441
=005  20201119125233.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003858
=035  \\$a(NLM)98194812570000041
=040  \\$aDNLM$cDNLM
=060  \0$aBF 575.D34
=072  \\$aF1.$x752.$x330
=150  \\$aDependency, Psychological
=450  \\$wnnna$aDependency Burden
=450  \\$wnnna$aDependency, Psychology
=450  \\$wnnna$aPsychological Dependence
=450  \\$wnnna$aPsychological Dependency
=450  \\$wnnna$aBurden, Dependency
=450  \\$wnnna$aDependence, Psychological
=680  \\$iThe tendency of an individual or individuals to rely on others for advice, guidance, or support.
=688  \\$a2020 (1990); was DEPENDENCY (PSYCHOLOGY) 1975-2019; use PERSONALITY 1975-1990
=750  \0$aDependency (Psychology)$0(DLC)sh 85037025$5IEN-M

=LDR  01144cz  a2200301n  4500
=001  9881491844402441
=005  20201202113422.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007266
=035  \\$a(NLM)98199877740000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x544
=072  \\$aF2.$x463.$x425.$x475
=072  \\$aF2.$x739.$x794.$x405
=150  \\$aInhibition, Psychological
=450  \\$aInhibition (Psychology)
=450  \\$aInhibition, Psychology
=450  \\$aPsychological Inhibition
=450  \\$wnnna$aInhibitions (Psychology)
=450  \\$wnnna$aInhibitions, Psychological
=450  \\$wnnna$aInhibitions, Psychology
=450  \\$wnnna$aPsychological Inhibitions
=450  \\$wnnna$aPsychology Inhibition
=450  \\$wnnna$aPsychology Inhibitions
=667  \\$ahuman & animal
=680  \\$iThe interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process.
=688  \\$a2020 (1971); was INHIBITION (PSYCHOLOGY) 1971-2019
=750  \0$aInhibition$0(DLC)sh 85066403$5IEN-M

=LDR  01088cz  a2200241n  4500
=001  9881491871702441
=005  20201116151100.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003220
=035  \\$a(NLM)98194492170000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x658.$x209
=150  \\$aConflict, Psychological
=450  \\$wnnna$aConflict, Psychology
=450  \\$wnnna$aPsychological Conflict
=450  \\$wnnna$aConflicts, Psychological
=450  \\$wnnna$aConflicts, Psychology
=450  \\$wnnna$aPsychological Conflicts
=550  \\$aDissent and Disputes
=667  \\$ahuman & animal; individual & group
=680  \\$iThe internal individual struggle resulting from incompatible or opposing needs, drives, or external and internal demands. In group interactions, competitive or opposing action of incompatibles: antagonistic state or action (as of divergent ideas, interests, or persons). (from Merriam-Webster's Collegiate Dictionary, 10th ed)
=688  \\$a2020 (1965); was CONFLICT (PSYCHOLOGY) 1965-2019
=750  \0$aConflict (Psychology)$0(DLC)sh 85030956$5IEN-M

=LDR  02094cz  a2200397n  4500
=001  9881519068202441
=005  20201207172839.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007983
=035  \\$a(NLM)98198421100000041
=040  \\$aDNLM$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x544
=072  \\$aD23.$x50.$x705.$x230.$x544
=150  \\$aLewis Blood Group Antigens
=450  \\$wnnna$aLe Antigens
=450  \\$wnnna$aLe(a) Blood Group System
=450  \\$aBlood Group Lewis Related Antigens
=450  \\$aLewis Antigen Related Tumor-Associated Antigens
=450  \\$aLewis Antigens
=450  \\$aLewis Blood Group Related Antigens
=450  \\$aLewis Blood Group Related Tumor-Associated Antigens
=450  \\$aLewis Blood-Group System
=450  \\$aLewis Related Antigens
=450  \\$aLewis System
=450  \\$aSialyl Lewis Antigens
=450  \\$wnnna$aAntigens, Lewis
=450  \\$wnnna$aAntigens, Lewis Related
=450  \\$wnnna$aAntigens, Sialyl Lewis
=450  \\$wnnna$aBlood-Group System, Lewis
=450  \\$wnnna$aLewis Antigen Related Tumor Associated Antigens
=450  \\$wnnna$aLewis Blood Group Related Tumor Associated Antigens
=450  \\$wnnna$aLewis Blood Group System
=667  \\$acoordinate with disease  /blood, not  /immunol nor  /genet
=680  \\$iCarbohydrate antigens structurally related to the ABH BLOOD-GROUP SYSTEM. They may occur as a modification of saccharide chains on glycolipids or glycoproteins on cell surfaces or in plasma, or as free oligosaccharides in secretions. Lewis  antigens are not synthesized in blood cells. Instead Lewis glycolipids present in plasma are absorbed onto the surface of ERYTHROCYTES; LYMPHOCYTES; and PLATELETS. The phenotypes Le(a) and Le(b) are the result of the actions of two genes the Le gene (fucosyltransferase FUT3) and the Se gene (fucosyltransferase FUT2) on the precursor carbohydrate, glycolipid or glycoprotein. Other FUCOSYLTRANSFERASES can also synthesize the Lewis antigens.
=688  \\$a2020 (1963)
=750  \0$aBlood groups$xLewis system$0(DLC)sh 85014988$5IEN-M

=LDR  02429cz  a2200565n  4500
=001  9881520973902441
=005  20201208124148.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007859
=035  \\$a(NLM)98196349230000041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x550
=072  \\$aC23.$x888.$x592.$x604.$x150.$x550
=072  \\$aF3.$x625.$x562
=150  \\$aLearning Disabilities
=450  \\$wnnna$aAcademic Disorder, Developmental
=450  \\$wnnna$aAdult Learning Disorders
=450  \\$wnnna$aDevelopmental Disorders of Scholastic Skills
=450  \\$wnnna$aLearning Disorders, Adult
=450  \\$wnnna$aLearning Disturbance
=450  \\$wnnna$aScholastic Skills Development Disorders
=450  \\$aAdult Learning Disabilities
=450  \\$aDevelopmental Academic Disability
=450  \\$aDevelopmental Academic Disorder
=450  \\$aDevelopmental Disabilities of Scholastic Skills
=450  \\$wnnna$aAcademic Disabilities, Developmental
=450  \\$wnnna$aAcademic Disability, Developmental
=450  \\$wnnna$aAcademic Disorders, Developmental
=450  \\$wnnna$aAdult Learning Disability
=450  \\$wnnna$aAdult Learning Disorder
=450  \\$wnnna$aDevelopmental Academic Disabilities
=450  \\$wnnna$aDevelopmental Academic Disorders
=450  \\$wnnna$aDisabilities, Adult Learning
=450  \\$wnnna$aDisabilities, Developmental Academic
=450  \\$wnnna$aDisabilities, Learning
=450  \\$wnnna$aDisability, Adult Learning
=450  \\$wnnna$aDisability, Developmental Academic
=450  \\$wnnna$aDisability, Learning
=450  \\$wnnna$aDisturbance, Learning
=450  \\$wnnna$aDisturbances, Learning
=450  \\$wnnna$aLearning Disabilities, Adult
=450  \\$wnnna$aLearning Disability
=450  \\$wnnna$aLearning Disability, Adult
=450  \\$wnnna$aLearning Disorder, Adult
=450  \\$wnnna$aLearning Disturbances
=550  \\$aDyslexia
=680  \\$iConditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
=688  \\$a2020(1966)
=750  \0$aLearning disabilities$0(DLC)sh 85075538$5IEN-M
=750  \0$aLearning disabled$0(DLC)sh 91000027$5IEN-M

=LDR  00928cz  a2200241n  4500
=001  9881521172102441
=005  20201209133341.0
=008  860415\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008282
=035  \\$a(NLM)98194879850000041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x158.$x600
=072  \\$aI2.$x233.$x213.$x600
=150  \\$aMainstreaming, Education
=450  \\$aEducational Mainstreaming
=450  \\$aMainstreaming (Education)
=450  \\$aMainstreaming, Educational
=450  \\$wnnna$aEducation Mainstreaming
=550  \\$aChild, Exceptional
=550  \\$aDisabled Persons
=680  \\$iMost frequently refers to the integration of a physically or mentally disabled child into the regular class of normal peers and provision of the appropriately determined educational program.
=688  \\$a2020 (1987); was MAINSTREAMING (EDUCATION) 1987-2019
=750  \0$aMainstreaming in education$0(DLC) sh 85079929$5IEN-M

=LDR  01149cz  a2200313n  4500
=001  9881521172502441
=005  20201209103918.0
=008  760416\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013287
=035  \\$a(NLM)98197078880000041
=040  \\$aDNLM$cDNLM
=072  \\$aD26.$x878
=150  \\$aIllicit Drugs
=450  \\$wnnna$aClub Drugs
=450  \\$aDrugs, Illegal
=450  \\$aIllegal Drugs
=450  \\$aRecreational Drugs
=450  \\$aStreet Drugs
=450  \\$wnnna$aDrugs, Club
=450  \\$wnnna$aDrugs, Illicit
=450  \\$wnnna$aDrugs, Recreational
=450  \\$wnnna$aDrugs, Street
=550  \\$aDesigner Drugs
=550  \\$aSubstance-Related Disorders
=550  \\$aPrescription Drug Diversion
=667  \\$acoordinate with specific drug or chemical
=680  \\$iDrugs that are manufactured, obtained, or sold illegally. They include prescription drugs obtained or sold without prescription and non-prescription drugs. Illicit drugs are widely distributed, tend to be grossly impure and may cause unexpected toxicity.
=688  \\$a2020 (1977); use DRUGS 1977-1986
=750  \0$aDrugs of abuse$0(DLC)sh 94005490$5IEN-M

=LDR  00879nz  a2200265n  4500
=001  9881532149302441
=005  20201224140048.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077213
=035  \\$a(NLM)9811683566800041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x931.$x480
=150  \\$aLamotrigine
=450  \\$wnnna$a3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
=450  \\$wnnna$a3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
=450  \\$wnnna$aBW-430C
=450  \\$wnnna$aCrisomet
=450  \\$wnnna$aLabileno
=450  \\$wnnna$aLamictal
=450  \\$wnnna$aLamiktal
=450  \\$wnnna$aBW 430C
=450  \\$wnnna$aBW430C
=680  \\$iA phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER.
=688  \\$a2019 (1986)
=750  \0$aLamotrigine$0(DLC) sh 96009056$5IEN-M

=LDR  00863nz  a2200229n  4500
=001  9881532149602441
=005  20201224135615.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078334
=035  \\$a(NLM)9811675302300041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x64.$x416
=072  \\$aD2.$x241.$x81.$x18.$x110.$x432
=150  \\$aLacosamide
=450  \\$wnnna$aN-benzyl-2-acetamido-3-methoxypropionamide
=450  \\$wnnna$aN-benzyl-AcMeOPrNH2
=450  \\$wnnna$aVimpat
=450  \\$wnnna$aN benzyl 2 acetamido 3 methoxypropionamide
=450  \\$wnnna$aN benzyl AcMeOPrNH2
=680  \\$iAn acetamide derivative that acts as a blocker of VOLTAGE-GATED SODIUM CHANNELS. It is used as an anticonvulsant, for adjunctive or monotherapy, in the treatment of PARTIAL SEIZURES.
=688  \\$a2019 (2000)
=750  \0$aVimpat$0(DLC)sh2011003472$5IEN-M

=LDR  01263nz  a2200337n  4500
=001  9881532149702441
=005  20201224135000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077550
=035  \\$a(NLM)9811675183700041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x79.$x801
=150  \\$aIvabradine
=450  \\$wnnna$a7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one
=450  \\$wnnna$aCorlanor
=450  \\$wnnna$aS 16257
=450  \\$wnnna$aS 16257-2
=450  \\$wnnna$aS 16260-2
=450  \\$wnnna$aS-16257
=450  \\$wnnna$aS-16257-2
=450  \\$wnnna$aS-16260-2
=450  \\$wnnna$aS 16257 2
=450  \\$wnnna$aS 162572
=450  \\$wnnna$aS 16260 2
=450  \\$wnnna$aS 162602
=450  \\$wnnna$aS16257
=450  \\$wnnna$aS162572
=450  \\$wnnna$aS162602
=680  \\$iA benzazepine derivative and selective HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS inhibitor that lowers the heart rate. It is used in the treatment of CHRONIC STABLE ANGINA in patients unable to take BETA-ADRENERGIC BLOCKERS, and in the treatment of HEART FAILURE.
=688  \\$a2019 (1994)
=750  \0$aIvabradine$0(DLC) sh2004007525$5IEN-M

=LDR  00924cz  a2200289n  4500
=001  9881532159602441
=005  20201218172041.0
=008  870409\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011209
=035  \\$a(NLM)98198989140000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x658.$x780
=150  \\$aPower, Psychological
=450  \\$wnnna$aPower
=450  \\$aPower (Psychology)
=450  \\$aPower, Personal
=450  \\$aPower, Professional
=450  \\$aPower, Social
=450  \\$wnnna$aPersonal Power
=450  \\$wnnna$aPowers, Psychological
=450  \\$wnnna$aProfessional Power
=450  \\$wnnna$aPsychological Power
=450  \\$wnnna$aPsychological Powers
=450  \\$wnnna$aSocial Power
=680  \\$iThe exertion of a strong influence or control over others in a variety of settings--administrative, social, academic, etc.
=688  \\$a88
=750  \0$aControl (Psychology)$0(DLC)sh 85031655$5IEN-M

=LDR  01271nz  a2200325n  4500
=001  9881532241602441
=005  20210108150322.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077276
=035  \\$a(NLM)9811675598200041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x216
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x213
=072  \\$aD2.$x455.$x849.$x131.$x216
=072  \\$aD23.$x767.$x261.$x375
=150  \\$aLycopene
=450  \\$wnnna$aAll-trans-Lycopene
=450  \\$wnnna$aLYC-O-MATO
=450  \\$wnnna$aLycopene, (13-cis)-isomer
=450  \\$wnnna$aLycopene, (7-cis,7'-cis,9-cis,9'-cis)-isomer -
=450  \\$wnnna$aLycopene, (cis)-isomer
=450  \\$wnnna$aPro-Lycopene
=450  \\$wnnna$aProlycopene
=450  \\$wnnna$aAll trans Lycopene
=450  \\$wnnna$aLYC O MATO
=450  \\$wnnna$aLYCOMATO
=450  \\$wnnna$aPro Lycopene
=680  \\$iA carotenoid and red pigment produced by tomatoes, other red fruits and vegetables, and photosynthetic algae. It is a key intermediate in the biosynthesis of other carotenoids, and has antioxidant, anti-carcinogenic, radioprotective, and anti-inflammatory properties.
=688  \\$a2019 (1978)
=750  \0$aLycopene$0(DLC) sh 85079087$5IEN-M

=LDR  00796nz  a2200205n  4500
=001  9881532245202441
=005  20210107173123.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076542
=035  \\$a(NLM)9811684067700041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x388.$x75
=150  \\$aClinical Observation Units
=450  \\$wnnna$aClinical Decision Units
=450  \\$wnnna$aObservation Units
=450  \\$wnnna$aClinical Decision Unit
=450  \\$wnnna$aObservation Unit
=680  \\$iA hospital unit that serves as a dedicated observation area for emergency room patients when a decision to admit or not is unclear. Also known as clinical decision units or short-stay observation units.
=688  \\$a2019
=750  \0$aHospitals$xObservation units$0(DLC) sh2001006285$5IEN-M

=LDR  00852cz  a2200241n  4500
=001  9881532246102441
=005  20210107173415.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077215
=035  \\$a(NLM)9811683561100041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x721.$x250
=072  \\$aG1.$x311.$x820.$x250
=072  \\$aG16.$x500.$x275.$x815.$x250
=072  \\$aN6.$x230.$x600.$x250
=150  \\$aClay
=450  \\$wnnna$aHalloysite
=450  \\$wnnna$aClays
=450  \\$wnnna$aHalloysites
=550  \\$aCalcium Aluminosilicate
=680  \\$iA naturally-occurring rock or soil constituent characterized by particles with a diameter of less than 0.005 mm. It is composed primarily of hydrous aluminum silicates, trace amounts of metal OXIDES, and organic matter.
=688  \\$a2019 (1976)
=750  \0$aClay$0(DLC) sh 85026864$5IEN-M

=LDR  00630nz  a2200205n  4500
=001  9881532246302441
=005  20210107173357.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077262
=035  \\$a(NLM)9811683923200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x727.$x150
=072  \\$aB1.$x50.$x500.$x272.$x727.$x150
=150  \\$aCiona
=450  \\$wnnna$aCiona savignyi
=450  \\$wnnna$aPacific Transparent Sea Squirt
=450  \\$wnnna$aSea Squirt, Transparent, Pacific
=680  \\$iA genus of SEA SQUIRTS in the family Cionidae.
=688  \\$a2019
=750  \0$aCiona$0(DLC) sh 87020403$5IEN-M

=LDR  00748nz  a2200169n  4500
=001  9881532254002441
=005  20210104173732.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078062
=035  \\$a(NLM)9811675147500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x100.$x503
=150  \\$aLeucanthemum
=450  \\$wnnna$aLeucanthemums
=680  \\$iA genus of flowering plants in the family ASTERACEAE, mainly distributed in southern and central Europe, and on other continents as introduced species. Leucanthemum species include annuals and perennials grown for their daisy flowers, which are usually gleaming white with yellow centers.
=688  \\$a2019
=750  \0$aLeucanthemum$0(DLC) sh 88002146$5IEN-M

=LDR  00755cz  a2200205n  4500
=001  9881532256802441
=005  20201222174629.0
=008  750204\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012059
=035  \\$a(NLM)98194364610000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x565
=150  \\$aRejection, Psychology
=450  \\$aPsychological Rejection
=450  \\$aRejection (Psychology)
=450  \\$wnnna$aPsychology Rejection
=450  \\$wnnna$aRejection, Psychological
=680  \\$iNon-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection.
=688  \\$a2020 (1975); was REJECTION (PSYCHOLOGY) 1975-2019
=750  \0$aRejection (Psychology)$0(DLC)sh 85112479$5IEN-M

=LDR  00788cz  a2200217n  4500
=001  9881532258902441
=005  20201221151956.0
=008  000622\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D021641
=035  \\$a(NLM)98199957590000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x706
=150  \\$aRecognition, Psychology
=450  \\$aFamiliarity
=450  \\$aPsychological Recognition
=450  \\$aRecognition (Psychology)
=450  \\$wnnna$aPsychology Recognition
=450  \\$wnnna$aRecognition, Psychological
=680  \\$iThe knowledge or perception that someone or something present has been previously encountered.
=688  \\$a2020 (1998); was RECOGNITION (PSYCHOLOGY) 2001-2019; use MEMORY 1998-2000
=750  \0$aRecognition (Psychology)$0(DLC)sh 85111840$5IEN-M

=LDR  01186cz  a2200277n  4500
=001  9881532259702441
=005  20201221150247.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011380
=035  \\$a(NLM)98194439930000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x818.$x500
=072  \\$aI2.$x903.$x771.$x500
=150  \\$aProgrammed Instructions as Topic
=450  \\$aProgrammed Instruction as Topic
=450  \\$aProgrammed Learning
=450  \\$aSelf-Instruction Programs
=450  \\$aTextbooks, Programmed
=450  \\$wnnna$aProgram, Self-Instruction
=450  \\$wnnna$aProgrammed Textbook
=450  \\$wnnna$aProgrammed Textbooks
=450  \\$wnnna$aSelf Instruction Programs
=667  \\$ado not confuse with the Publication Type PROGRAMMED INSTRUCTION
=680  \\$iWorks about instruction in which learners progress at their own rate using workbooks, textbooks, or electromechanical devices that provide information in discrete steps, test learning at each step, and provide immediate feedback about achievement. (ERIC, Thesaurus of ERIC Descriptors, 1996).
=688  \\$a2008(1966)
=750  \0$aProgrammed instruction$0(DLC) sh 85107307$5IEN

=LDR  02461cz  a2200505n  4500
=001  9881532270902441
=005  20201216141733.0
=008  910125\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016571
=035  \\$a(NLM)98196070820000041
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x485
=072  \\$aL1.$x224.$x50.$x375.$x605
=150  \\$aNeural Networks, Computer
=450  \\$aComputational Neural Networks
=450  \\$aConnectionist Models
=450  \\$aModels, Neural Network
=450  \\$aNeural Network Models
=450  \\$aNeural Networks (Computer)
=450  \\$aPerceptrons
=450  \\$wnnna$aComputational Neural Network
=450  \\$wnnna$aComputer Neural Network
=450  \\$wnnna$aComputer Neural Networks
=450  \\$wnnna$aConnectionist Model
=450  \\$wnnna$aModel, Connectionist
=450  \\$wnnna$aModel, Neural Network
=450  \\$wnnna$aModels, Connectionist
=450  \\$wnnna$aNetwork Model, Neural
=450  \\$wnnna$aNetwork Models, Neural
=450  \\$wnnna$aNetwork, Computational Neural
=450  \\$wnnna$aNetwork, Computer Neural
=450  \\$wnnna$aNetwork, Neural (Computer)
=450  \\$wnnna$aNetworks, Computational Neural
=450  \\$wnnna$aNetworks, Computer Neural
=450  \\$wnnna$aNetworks, Neural (Computer)
=450  \\$wnnna$aNeural Network (Computer)
=450  \\$wnnna$aNeural Network Model
=450  \\$wnnna$aNeural Network, Computational
=450  \\$wnnna$aNeural Network, Computer
=450  \\$wnnna$aNeural Networks, Computational
=450  \\$wnnna$aPerceptron
=667  \\$ado not confuse with NEURAL NETWORKS (ANATOMIC) see NERVE NET
=680  \\$iA computer architecture, implementable in either hardware or software, modeled after biological neural networks. Like the biological system in which the processing capability is a result of the interconnection strengths between arrays of nonlinear processing nodes, computerized neural networks, often called perceptrons or multilayer connectionist models, consist of neuron-like units. A homogeneous group of units makes up a layer. These networks are good at pattern recognition. They are adaptive, performing tasks by example, and thus are better for decision-making than are linear learning machines or cluster analysis. They do not require explicit programming.
=688  \\$a2020 (1992); was NEURAL NETWORKS (COMPUTER) 1992-2019
=750  \0$aNeural networks (Computer science)$0(DLC)sh 90001937$5IEN-M

=LDR  00659cz  a2200181n  4500
=001  9881532271802441
=005  20201216121728.0
=008  940607\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018537
=035  \\$a(NLM)98196207650000041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x60.$x75.$x730.$x700.$x762
=150  \\$aMercury, Planet
=450  \\$aMercury (Planet)
=450  \\$aPlanet Mercury
=680  \\$iThe first planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system.
=688  \\$a2020 (1995); was MERCURY (PLANET) 1995-2019
=750  \0$aMercury (Planet)$0(DLC) sh 85083791$5IEN-M

=LDR  01575nz  a2200349n  4500
=001  9881532856502441
=005  20201228123210.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077272
=035  \\$a(NLM)9811683899900041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x250.$x338
=072  \\$aG17.$x35.$x625
=072  \\$aL1.$x224.$x50.$x687
=072  \\$aN5.$x715.$x360.$x750.$x200.$x375
=072  \\$aN6.$x850.$x520.$x830.$x250.$x338
=150  \\$aLatent Class Analysis
=450  \\$wnnna$aLatent Class Model
=450  \\$wnnna$aLatent Variable Modeling
=450  \\$wnnna$aProbabilistic Latent Semantic Analysis
=450  \\$wnnna$aStructural Equation Modeling
=450  \\$wnnna$aLatent Class Analyses
=450  \\$wnnna$aLatent Class Models
=450  \\$wnnna$aLatent Variable Modelings
=450  \\$wnnna$aModel, Latent Class
=450  \\$wnnna$aModeling, Latent Variable
=450  \\$wnnna$aModeling, Structural Equation
=450  \\$wnnna$aStructural Equation Modelings
=450  \\$wnnna$aVariable Modeling, Latent
=680  \\$iA statistical algorithm used to analyze clusters of observed variables by constructing categorical unobserved or latent segment based on weighted analysis and the average probabilities. Such latent classes are used to infer variables whose relationships are not directly observed. In biomedical research, it is often used to categorize data that allows the determination of symptom clusters.
=688  \\$a2019
=750  \0$iRelated mapping$aLatent semantic indexing$0(DLC) sh2006020234$4RM$5IEN-M

=LDR  01023nz  a2200265n  4500
=001  9881532856602441
=005  20201228121301.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077341
=035  \\$a(NLM)9811675707800041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x786.$x516
=150  \\$aLapatinib
=450  \\$wnnna$aGW 282974X
=450  \\$wnnna$aGW 572016
=450  \\$wnnna$aGW-282974X
=450  \\$wnnna$aGW-572016
=450  \\$wnnna$aGW282974X
=450  \\$wnnna$aGW572016
=450  \\$wnnna$aLapatinib Ditosylate
=450  \\$wnnna$aN-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine
=450  \\$wnnna$aTykerb
=680  \\$iA quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
=688  \\$a2019 (2004)
=750  \0$aLapatinib$0(DLC)sh2012000689$5IEN-M

=LDR  01223cz  a2200349n  4500
=001  9881532858102441
=005  20201223123338.0
=008  860415\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012860
=035  \\$a(NLM)98196360750000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x870
=072  \\$aB1.$x50.$x150.$x900.$x493.$x378.$x682
=150  \\$aSkates, Fish
=450  \\$aRaja
=450  \\$aRajidae
=450  \\$aRajiformes
=450  \\$aRays (Fish)
=450  \\$aRays, Fish
=450  \\$aSkates (Fish)
=450  \\$wnnna$aFish Ray
=450  \\$wnnna$aFish Rays
=450  \\$wnnna$aFish Skate
=450  \\$wnnna$aFish Skates
=450  \\$wnnna$aRay (Fish)
=450  \\$wnnna$aRay, Fish
=450  \\$wnnna$aSkate (Fish)
=450  \\$wnnna$aSkate, Fish
=667  \\$ado not confuse entry term RAYS (FISH) with ELECTRIC RAYS see TORPEDO
=680  \\$iThe common name for all members of the Rajidae family. Skates and rays are members of the same order (Rajiformes). Skates have weak electric organs.
=688  \\$a2020 (1987); was SKATES (FISH) 1987-2019; RAYS, FISH was RAYS (FISH) 1992-2019; use ELECTRIC FISH 1987-1990
=750  \0$aSkates (Fishes)$0(DLC) sh 85123103$5IEN-M

=LDR  00736cz  a2200229n  4500
=001  9881532858302441
=005  20201223120001.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012718
=035  \\$a(NLM)98195375100000041
=040  \\$aDNLM$cDNLM
=060  \0$aBF 321
=072  \\$aF2.$x463.$x425.$x838
=150  \\$aSet, Psychology
=450  \\$aPsychological Set
=450  \\$aSet (Psychology)
=450  \\$wnnna$aPsychology Set
=450  \\$wnnna$aSet, Psychological
=550  \\$aAttitude
=680  \\$iReadiness to think or respond in a predetermined way when confronted with a problem or stimulus situation.
=688  \\$a2020 (1965); was SET (PSYCHOLOGY) 1965-2019
=750  \0$aSet (Psychology)$0(DLC)sh 85120380$5IEN-M

=LDR  01333cz  a2200265n  4500
=001  9881532867802441
=005  20201217121806.0
=008  780516\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010043
=035  \\$a(NLM)98198204730000041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x761.$x559
=072  \\$aN5.$x715.$x360.$x575
=150  \\$aOutcome and Process Assessment, Health Care
=450  \\$wnnna$aDonabedian Model
=450  \\$wnnna$aDonabedian Triad
=450  \\$wnnna$aOutcome and Process Assessment
=450  \\$wnnna$aStructure Process Outcome Triad
=450  \\$aOutcome and Process Assessment (Health Care)
=450  \\$wnnna$aModel, Donabedian
=450  \\$wnnna$aTriad, Donabedian
=667  \\$amust discuss both outcome & process: OUTCOME ASSESSMENT (HEALTH CARE) is available for only outcome, PROCESS ASSESSMENT (HEALTH CARE) is available for only process
=680  \\$iEvaluation procedures that focus on both the outcome or status (OUTCOMES ASSESSMENT) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (ASSESSMENT, PROCESS) - what is done for the patient diagnostically and therapeutically.
=688  \\$a2020 (1979); was OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-2019
=750  \0$aMedical care$xEvaluation$0(DLC)sh 85082876$5IEN-M

=LDR  01579nz  a2200397n  4500
=001  9881533051302441
=005  20210107172201.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077442
=035  \\$a(NLM)9811675653300041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x199.$x92.$x500.$x500
=072  \\$aD2.$x65.$x199.$x750.$x500
=072  \\$aD2.$x92.$x146.$x113.$x92.$x500.$x500
=072  \\$aD2.$x92.$x146.$x113.$x750.$x500
=072  \\$aD26.$x310.$x454
=150  \\$aLidocaine, Prilocaine Drug Combination
=450  \\$wnnna$aEMLA Cream
=450  \\$wnnna$aEutectic Lidocaine-Prilocaine
=450  \\$wnnna$aEutectic Mixture of Local Anesthetics
=450  \\$wnnna$aFortacin
=450  \\$wnnna$aLidocaine Prilocaine
=450  \\$wnnna$aLidocaine-Prilocaine Drug Combination
=450  \\$wnnna$aOraqix
=450  \\$wnnna$aPSD 502
=450  \\$wnnna$aPSD-502
=450  \\$wnnna$aPSD502
=450  \\$wnnna$aTopical Eutectic-Like Mixture for Premature Ejaculation
=450  \\$wnnna$aEutectic Lidocaine Prilocaine
=450  \\$wnnna$aLidocaine Prilocaine Drug Combination
=450  \\$wnnna$aLidocaine-Prilocaine, Eutectic
=450  \\$wnnna$aPrilocaine, Lidocaine
=450  \\$wnnna$aTopical Eutectic Like Mixture for Premature Ejaculation
=680  \\$iA topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION.
=688  \\$a2019 (1983)
=750  \0$aEMLA IAnesthetics)$0(DLC) sh 94005674$5IEN-M

=LDR  01060cz  a2200289n  4500
=001  9881533061402441
=005  20201223135256.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D014163
=035  \\$a(NLM)98194059630000041
=040  \\$aDNLM$cDNLM
=060  \0$aLB 1059
=072  \\$aF2.$x463.$x425.$x910
=150  \\$aTransfer, Psychology
=450  \\$aTransfer (Psychology)
=450  \\$aTransfer of Learning
=450  \\$aTransfer of Training
=450  \\$wnnna$aLearning Transfer
=450  \\$wnnna$aPsychology Transfer
=450  \\$wnnna$aPsychology Transfers
=450  \\$wnnna$aTraining Transfer
=450  \\$wnnna$aTransfers (Psychology)
=450  \\$wnnna$aTransfers, Psychology
=667  \\$ahuman & animal
=680  \\$iChange in learning in one situation due to prior learning in another situation. The transfer can be positive (with second learning improved by first) or negative (where the reverse holds).
=688  \\$a2020 (1965); was TRANSFER (PSYCHOLOGY) 1965-2019
=750  \0$aTransfer of training$0(DLC)sh 85136907$5IEN-M

=LDR  01369cz  a2200373n  4500
=001  9881533063102441
=005  20201221175842.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012054
=035  \\$a(NLM)98194364660000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x770
=150  \\$aReinforcement, Psychology
=450  \\$aNegative Reinforcement
=450  \\$aPositive Reinforcement
=450  \\$aPsychological Reinforcement
=450  \\$aReinforcement (Psychology)
=450  \\$wnnna$aNegative Reinforcements
=450  \\$wnnna$aPositive Reinforcements
=450  \\$wnnna$aPsychological Reinforcements
=450  \\$wnnna$aPsychology Reinforcement
=450  \\$wnnna$aPsychology Reinforcements
=450  \\$wnnna$aReinforcement, Negative
=450  \\$wnnna$aReinforcement, Positive
=450  \\$wnnna$aReinforcement, Psychological
=450  \\$wnnna$aReinforcements (Psychology)
=450  \\$wnnna$aReinforcements, Negative
=450  \\$wnnna$aReinforcements, Positive
=450  \\$wnnna$aReinforcements, Psychological
=450  \\$wnnna$aReinforcements, Psychology
=667  \\$ahuman & animal
=680  \\$iThe strengthening of a conditioned response.
=688  \\$a2020 (1965); was REINFORCEMENT (PSYCHOLOGY) 1965-2019; was REINFORCEMENT LEARNING 1963-1964
=750  \0$aReinforcement (Psychology)$5IEN$0(DLC)sh 85112459

=LDR  00915cz  a2200205n  4500
=001  9881533063202441
=005  20201221174506.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012043
=035  \\$a(NLM)98197081560000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x784
=150  \\$aRegression, Psychology
=450  \\$aPsychological Regression
=450  \\$aRegression (Psychology)
=450  \\$wnnna$aPsychology Regression
=667  \\$ado not confuse with REMISSION, SPONTANEOUS
=680  \\$iA return to earlier, especially to infantile, patterns of thought or behavior, or stage of functioning, e.g., feelings of helplessness and dependency in a patient with a serious physical illness. (From APA, Thesaurus of Psychological Index Terms, 1994).
=688  \\$a2020 (1963); was REGRESSION (PSYCHOLOGY) 1980-2019; was REGRESSION 1963-1979
=750  \0$aRegression (Psychology)$0(DLC)sh 85112391$5IEN-M

=LDR  00766cz  a2200253n  4500
=001  9881533072502441
=005  20201216180004.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009724
=035  \\$a(NLM)98198270520000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x160.$x500
=072  \\$aN2.$x278.$x617
=072  \\$aN2.$x421.$x143.$x98.$x500
=150  \\$aNurseries, Infant
=450  \\$aNurseries
=450  \\$wnnna$aInfant Nurseries
=450  \\$wnnna$aInfant Nursery
=450  \\$wnnna$aNursery, Infant
=550  \\$aChild Day Care Centers
=667  \\$aNURSERIES, HOSPITAL is also available
=680  \\$iFacilities which provide care for infants.
=688  \\$a2020(1973); was NURSERIES 1973-2019
=750  \0$aNurseries$0(DLC)sh 85093318$5IEN-M

=LDR  01468cz  a2200337n  4500
=001  9881533072602441
=005  20201216175303.0
=008  930615\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D017924
=035  \\$a(NLM)98197132310000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x280.$x65.$x500
=072  \\$aB4.$x525.$x100.$x500
=150  \\$aNucleopolyhedroviruses
=450  \\$wnnna$aAlphabaculovirus
=450  \\$wnnna$aGammabaculovirus
=450  \\$aDeltabaculovirus
=450  \\$aNuclear Polyhedrosis Virus
=450  \\$aNucleopolyhedrovirus
=450  \\$wnnna$aAlphabaculoviruses
=450  \\$wnnna$aDeltabaculoviruses
=450  \\$wnnna$aGammabaculoviruses
=450  \\$wnnna$aNuclear Polyhedrosis Viruses
=450  \\$wnnna$aPolyhedrosis Virus, Nuclear
=450  \\$wnnna$aPolyhedrosis Viruses, Nuclear
=450  \\$wnnna$aVirus, Nuclear Polyhedrosis
=450  \\$wnnna$aViruses, Nuclear Polyhedrosis
=667  \\$acoordinate with specific insect /virol
=680  \\$iGenera of the family BACULOVIRIDAE, characterized by the formation of crystalline, polyhedral occlusion bodies in the host cell nucleus. Nucleopolyhedrovirus is the common name for viruses from the Alphabaculovirus, Deltabaculovirus, or Gammabaculovirus genera.
=688  \\$a2020 (1994); for NUCLEAR POLYHEDROSIS VIRUSES use BACULOVIRIDAE 1991-1993; use POLYHEDROSIS VIRUSES 1975-1990; use INSECT VIRUSES 1973-1977
=750  \0$aNucleopolyhedroviruses$0(DLC)sh2007010418$5IEN-M

=LDR  00860nz  a2200229n  4500
=001  9881533154802441
=005  20201229151535.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077339
=035  \\$a(NLM)9811675712800041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x129.$x385.$x475
=150  \\$aLeflunomide
=450  \\$wnnna$aArava
=450  \\$wnnna$aHWA 486
=450  \\$wnnna$aHWA-486
=450  \\$wnnna$aN-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
=450  \\$wnnna$aSU101
=450  \\$wnnna$aHWA486
=680  \\$iAn isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
=688  \\$a2019 (1985)
=750  \0$aLeflunomide$0(DLC) sh 94008779$5IEN-M

=LDR  01944cz  a2200409n  4500
=001  9881533170302441
=005  20201217172613.0
=008  910620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D017063
=035  \\$a(NLM)98199155540000041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x431
=072  \\$aN4.$x761.$x559.$x590
=072  \\$aN5.$x715.$x360.$x575.$x575
=150  \\$aOutcome Assessment, Health Care
=450  \\$wnnna$aAssessment, Outcomes
=450  \\$wnnna$aOutcome Measures
=450  \\$wnnna$aOutcome Studies
=450  \\$wnnna$aOutcomes Assessment
=450  \\$aOutcome Assessment (Health Care)
=450  \\$aOutcomes Research
=450  \\$wnnna$aAssessment, Outcome (Health Care)
=450  \\$wnnna$aAssessments, Outcome (Health Care)
=450  \\$wnnna$aAssessments, Outcomes
=450  \\$wnnna$aMeasure, Outcome
=450  \\$wnnna$aMeasures, Outcome
=450  \\$wnnna$aOutcome Assessments (Health Care)
=450  \\$wnnna$aOutcome Measure
=450  \\$wnnna$aOutcome Study
=450  \\$wnnna$aOutcomes Assessments
=450  \\$wnnna$aResearch, Outcomes
=450  \\$wnnna$aStudies, Outcome
=450  \\$wnnna$aStudy, Outcome
=667  \\$anote category: for admin aspects of patient assessment; outcome only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) and TREATMENT OUTCOME are available
=680  \\$iResearch aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).
=688  \\$a2020 (1992); was OUTCOME ASSESSMENT (HEALTH CARE) 1992-2019; for PATIENT OUTCOME ASSESSMENT use OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-1991
=750  \0$aOutcome assessment (Medical care)$0(DLC)sh 94002382$5IEN-M

=LDR  00541nz  a2200157n  4500
=001  9881550869902441
=005  20210111175956.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077142
=035  \\$a(NLM)9811684174200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x821
=150  \\$aMalvales
=680  \\$iAn order of mostly woody plants in the superorder ROSANAE. Members of the MALVALES grow in various habitats around the world.
=688  \\$a2019
=750  \0$aMalvales$0(DLC) sh 85080232$5IEN-M

=LDR  00945cz  a2200205n  4500
=001  9881550870202441
=005  20210111180322.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076622
=035  \\$a(NLM)9811684063200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x797
=150  \\$aMalpighiales
=450  \\$wnnna$aCaryocaraceae
=450  \\$aCaryocar
=450  \\$aMalesherbiales
=450  \\$wnnna$aMalesherbiale
=680  \\$iOrder of flowering plants which includes many tropical species. Well-characterized members include SALICACEAE (willow family), VIOLACEAE (violet family), PASSIFLORACEAE (passion-flower family), EUPHORBIACEAE (spurge or croton family), RHIZOPHORACEAE (mangrove family), and ERYTHROXYLACEAE (coca family).
=688  \\$a2019; for Caryocaraceae was under Ericales 2017-2020; Theales 2009-2016
=750  \0$iNarrower mapping$aCaryocaraceae$0(DLC) sh 85020550$4NM$5IEN-M

=LDR  00979cz  a2200217n  4500
=001  9881569466302441
=005  20180904000000.0
=008  900607\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016079
=035  \\$a(NLM)98198878900000041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x233.$x727.$x605
=072  \\$aN5.$x300.$x100.$x675
=150  \\$aRefusal to Treat
=450  \\$aPatient Abandonment
=450  \\$aPhysician Refusal to Treat
=450  \\$wnnna$aAbandonment, Patient
=550  \\$aRefusal to Participate
=667  \\$arefusal of a health professional to treat a patient: do not confuse with PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL
=680  \\$iRefusal of the health professional to initiate or continue treatment of a patient or group of patients. The refusal can be based on any reason. The concept is differentiated from PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL which originates with the patient and not the health professional.
=688  \\$a91

=LDR  01467cz  a2200397n  4500
=001  9881569470702441
=005  20210113214735.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077144
=035  \\$a(NLM)9811684164500041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 190
=072  \\$aD2.$x886.$x778.$x823.$x500.$x500
=072  \\$aD3.$x383.$x725.$x849.$x500.$x500
=072  \\$aD3.$x383.$x903.$x830.$x500.$x500
=072  \\$aD3.$x633.$x100.$x928.$x500.$x500
=150  \\$aClopidogrel
=450  \\$wnnna$aClopidogrel Besilate
=450  \\$wnnna$aClopidogrel Besylate
=450  \\$wnnna$aClopidogrel Bisulfate
=450  \\$wnnna$aClopidogrel Hydrochloride
=450  \\$wnnna$aClopidogrel Napadisilate
=450  \\$wnnna$aClopidogrel Sandoz
=450  \\$wnnna$aClopidogrel, (+)(S)-isomer
=450  \\$wnnna$aClopidogrel-Mepha
=450  \\$wnnna$aIscover
=450  \\$wnnna$aPCR 4099
=450  \\$wnnna$aPCR-4099
=450  \\$wnnna$aPlavix
=450  \\$wnnna$aSC 25989C
=450  \\$wnnna$aSC 25990C
=450  \\$wnnna$aSR 25989
=450  \\$wnnna$aClopidogrel Mepha
=680  \\$iA ticlopidine analog and platelet purinergic P2Y receptor antagonist that inhibits adenosine diphosphate-mediated PLATELET AGGREGATION. It is used to prevent THROMBOEMBOLISM in patients with ARTERIAL OCCLUSIVE DISEASES; MYOCARDIAL INFARCTION; STROKE; or ATRIAL FIBRILLATION.
=688  \\$a2019 (1988)
=750  \0$aClopidogrel$0(DLC) sh2009007795$5IEN-M

=LDR  00683cz  a2200169n  4500
=001  9881569874302441
=005  20210118180721.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076563
=035  \\$a(NLM)9811684078600041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x467
=150  \\$aMentalization
=450  \\$aMentalizing
=680  \\$iThe mental process by which an individual implicitly and explicitly interprets the actions of self and others as meaningful on the basis of intentional mental states such as personal desires, needs, feelings, beliefs, and reasons.
=688  \\$a2019
=750  \0$iRelated mapping$aMentalization Based Therapy$0(DLC)sh2017000495$4RM$5IEN-M

=LDR  01014nz  a2200241n  4500
=001  9881569959702441
=005  20210125124703.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076984
=035  \\$a(NLM)9811684497100041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x668.$x829.$x100.$x750
=072  \\$aC16.$x614.$x131.$x294
=072  \\$aC26.$x141.$x294
=150  \\$aNeonatal Brachial Plexus Palsy
=450  \\$wnnna$aObstetrical Brachial Plexus Lesion
=450  \\$wnnna$aObstetrical Brachial Plexus Palsy
=680  \\$iPerinatal nerve injury involving the BRACHIAL PLEXUS involving a weak or paralyzed upper extremity.
=688  \\$a2019
=750  \0$81$wb$aBrachial plexus$0(DLC)sh 85016236$5IEN-M
=780  \0$81$wb$xParalysis$0(DLC)sh 00006916$5IEN-M
=750  \0$81$wb$aNewborn infants$0(DLC)sh 85066048$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings headings used together in the same record:$aBrachial plexus--Paralysis$iand$aNewborn infants$5IEN-M

=LDR  01101nz  a2200325n  4500
=001  9881569962502441
=005  20210121174622.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077266
=035  \\$a(NLM)9811683916000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x810.$x835.$x322.$x327
=150  \\$aMoxifloxacin
=450  \\$wnnna$a1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
=450  \\$wnnna$aActira
=450  \\$wnnna$aAvalox
=450  \\$wnnna$aAvelox
=450  \\$wnnna$aBAY 12-8039
=450  \\$wnnna$aBAY 128039
=450  \\$wnnna$aBAY-12-8039
=450  \\$wnnna$aBAY-128039
=450  \\$wnnna$aIzilox
=450  \\$wnnna$aMoxifloxacin Hydrochloride
=450  \\$wnnna$aOctegra
=450  \\$wnnna$aProflox
=450  \\$wnnna$aBAY 12 8039
=450  \\$wnnna$aBAY128039
=680  \\$iA fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.
=688  \\$a2019 (1997)
=750  \0$aMoxifloxacin$0(DLC) sh 99011760$5IEN-M

=LDR  00726nz  a2200157n  4500
=001  9881570663002441
=005  20210122115845.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077148
=035  \\$a(NLM)9811684156700041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x833
=150  \\$aMyrtales
=680  \\$iOrder of flowering plants distributed throughout the tropics and warmer regions of the world. The majority of these species belong to two families, Melastomataceae and Myrtaceae. Myrtales includes many trees (notably Eucalyptus), shrubs, such as the classic myrtle, several food, spices, and ornamental plants.
=688  \\$a2019
=750  \0$aMyrtales$0(DLC) sh 85089318$5IEN-M

=LDR  02260cz  a2200637n  4500
=001  9881570747202441
=005  20210127175350.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078183
=035  \\$a(NLM)9811675332800041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x132.$x436.$x511
=072  \\$aD3.$x633.$x100.$x473.$x402.$x528
=072  \\$aD3.$x633.$x100.$x496.$x500.$x500.$x511
=150  \\$aOxindoles
=450  \\$wnnna$aIndolinone Derivatives
=450  \\$wnnna$aIndolinones
=450  \\$wnnna$aOxazolidinone Derivatives
=450  \\$wnnna$aOxindole Alkaloid Derivatives
=450  \\$wnnna$aOxindole Alkaloids
=450  \\$wnnna$aOxindole Derivatives
=450  \\$aAjmalicine Oxindole
=450  \\$aAjmalicine Oxindoles
=450  \\$aAjmalicine-Type Oxindole
=450  \\$aAjmalicine-Type Oxindoles
=450  \\$aIndolinone
=450  \\$aIndolinone Derivative
=450  \\$aMacroline Oxindole
=450  \\$aMacroline Oxindoles
=450  \\$aMacroline-Type Oxindole
=450  \\$aMacroline-Type Oxindoles
=450  \\$aOxazolidinone Derivative
=450  \\$aOxindole Alkaloid
=450  \\$aOxindole Alkaloid Derivative
=450  \\$aOxindole Derivative
=450  \\$wnnna$aAjmalicine Type Oxindole
=450  \\$wnnna$aAjmalicine Type Oxindoles
=450  \\$wnnna$aAlkaloid Derivative, Oxindole
=450  \\$wnnna$aAlkaloid, Oxindole
=450  \\$wnnna$aDerivative, Indolinone
=450  \\$wnnna$aDerivative, Oxazolidinone
=450  \\$wnnna$aDerivative, Oxindole
=450  \\$wnnna$aDerivative, Oxindole Alkaloid
=450  \\$wnnna$aMacroline Type Oxindole
=450  \\$wnnna$aMacroline Type Oxindoles
=450  \\$wnnna$aOxindole, Ajmalicine
=450  \\$wnnna$aOxindole, Ajmalicine-Type
=450  \\$wnnna$aOxindole, Macroline
=450  \\$wnnna$aOxindole, Macroline-Type
=450  \\$wnnna$aOxindoles, Ajmalicine
=450  \\$wnnna$aOxindoles, Ajmalicine-Type
=450  \\$wnnna$aOxindoles, Macroline
=450  \\$wnnna$aOxindoles, Macroline-Type
=680  \\$iBenzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl and a carbonyl at the pyrrole ring typically at the 2-position.
=688  \\$a2019
=750  \0$aOxindoles$0(DLC)sh2019000814$5IEN-M

=LDR  01730cz  a2200361n  4500
=001  9881570747402441
=005  20210127173924.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077150
=035  \\$a(NLM)9811684152000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x257.$x750
=150  \\$aOxaliplatin
=450  \\$wnnna$a1,2-Diaminocyclohexane Platinum Oxalate
=450  \\$wnnna$a1,2-Diamminocyclohexane(trans-1)oxolatoplatinum(II)
=450  \\$wnnna$aACT 078
=450  \\$wnnna$aACT-078
=450  \\$wnnna$aCis-oxalato-(trans-l)-1,2-diaminocyclohexane-platinum(II)
=450  \\$wnnna$aEloxatin
=450  \\$wnnna$aEloxatine
=450  \\$wnnna$aL-OHP Cpd
=450  \\$wnnna$aOxalato-(1,2-cyclohexanediamine)platinum II
=450  \\$wnnna$aOxaliplatin, (SP-4-2-(1R-trans))-isomer
=450  \\$wnnna$aOxaliplatin, (SP-4-2-(1S-trans))-isomer
=450  \\$wnnna$aOxaliplatin, (SP-4-3-(cis))-isomer
=450  \\$wnnna$aOxaliplatine
=450  \\$wnnna$aPlatinum(II)-1,2-cyclohexanediamine Oxalate
=450  \\$aPlatinum(2+) ethanedioate (1R,2R)-1,2-cyclohexanediamine (1:1:1)
=450  \\$wnnna$a1,2 Diaminocyclohexane Platinum Oxalate
=450  \\$wnnna$aACT078
=680  \\$iAn organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS.
=688  \\$a2019 (1981)
=750  \0$aOxaliplatin$0(DLC) sh2006000592$5IEN-M

=LDR  00872nz  a2200253n  4500
=001  9881570747602441
=005  20210127172710.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077403
=035  \\$a(NLM)9811675689100041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x540.$x529
=150  \\$aOrlistat
=450  \\$wnnna$a1-((3-Hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
=450  \\$wnnna$aAlli
=450  \\$wnnna$aRo-18-0647
=450  \\$wnnna$aTHLP
=450  \\$wnnna$aTetrahydrolipastatin
=450  \\$wnnna$aTetrahydrolipstatin
=450  \\$wnnna$aXenical
=450  \\$wnnna$aRo 18 0647
=680  \\$iA lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.
=688  \\$a2019 (1988)
=750  \0$aOrlistat$0(DLC) sh 99011743$5IEN-M

=LDR  00629nz  a2200181n  4500
=001  9881570752102441
=005  20210126175635.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077253
=035  \\$a(NLM)9811683926000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x910.$x250
=150  \\$aOnline Social Networking
=450  \\$wnnna$aNetworking, Online Social
=450  \\$wnnna$aSocial Networking, Online
=680  \\$iConnectivity facilitated by computer-based communications among persons with family, work, or other common interests.
=688  \\$a2019
=750  \0$aOnline social networks$0(DLC)sh2006006990$5IEN-M

=LDR  01084cz  a2200253n  4500
=001  9881574969802441
=005  20210126152321.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077152
=035  \\$a(NLM)9811684149400041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x79.$x80.$x738
=150  \\$aOlanzapine
=450  \\$wnnna$a2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
=450  \\$wnnna$aLY 170053
=450  \\$wnnna$aLY-170052
=450  \\$wnnna$aOlanzapine Pamoate
=450  \\$wnnna$aZolafren
=450  \\$wnnna$aZyprexa
=450  \\$wnnna$aLY 170052
=450  \\$wnnna$aLY170052
=680  \\$iA benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy.
=688  \\$a2019 (1992)
=750  \0$aOlanzapine$0(DLC) sh 97006549$5IEN-M

=LDR  01041nz  a2200277n  4500
=001  9881575365102441
=005  20210201174442.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078002
=035  \\$a(NLM)9811675148600041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x58.$x683
=072  \\$aF2.$x647
=150  \\$aPosttraumatic Growth, Psychological
=450  \\$wnnna$aPost-traumatic Growth, Psychological
=450  \\$wnnna$aPosttraumatic Growth
=450  \\$wnnna$aGrowth, Posttraumatic
=450  \\$wnnna$aGrowth, Psychological Post-traumatic
=450  \\$wnnna$aGrowth, Psychological Posttraumatic
=450  \\$wnnna$aPost traumatic Growth, Psychological
=450  \\$wnnna$aPsychological Post-traumatic Growth
=450  \\$wnnna$aPsychological Post-traumatic Growths
=450  \\$wnnna$aPsychological Posttraumatic Growth
=680  \\$iPositive change experienced as a result of the struggle with a major life crisis or a traumatic event.
=688  \\$a2019
=750  \0$aPosttraumatic growth$0(DLC)sh2014002552$5IEN-M

=LDR  00627nz  a2200181n  4500
=001  9881575370702441
=005  20210129151306.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077780
=035  \\$a(NLM)9811675622700041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x792.$x400
=072  \\$aE5.$x760.$x400
=150  \\$aPlastination
=450  \\$wnnna$aPlastinations
=680  \\$iPreservation technique in which epoxy polymers are used to preserve tissue or an organ resulting in anatomically authentic dry specimens often used in teaching of anatomy.
=688  \\$a2019
=750  \0$aPlastination$0(DLC) sh2006000168$5IEN-M

=LDR  01745cz  a2200433n  4500
=001  9881575370902441
=005  20210129150608.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077489
=035  \\$a(NLM)9811675214600041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x606.$x768
=150  \\$aPiperazine
=450  \\$wnnna$a1,4-Diazacyclohexane
=450  \\$wnnna$a1,4-Piperazine
=450  \\$wnnna$aPiperazine Diacetate
=450  \\$wnnna$aPiperazine Dihydrochloride
=450  \\$wnnna$aPiperazine Hexahydrate
=450  \\$wnnna$aPiperazine Hydrate
=450  \\$wnnna$aPiperazine Hydrobromide
=450  \\$wnnna$aPiperazine Hydrochloride
=450  \\$wnnna$aPiperazine Monohydrochloride
=450  \\$wnnna$aPiperazine Phosphate
=450  \\$wnnna$aPiperazine Phosphate (1:1)
=450  \\$wnnna$aPiperazine Phosphate Anhydrous
=450  \\$wnnna$aPiperazine Salt
=450  \\$wnnna$aPiperazine Sulfate
=450  \\$wnnna$aPiperazine Tartrate
=450  \\$wnnna$aPiperazine Tartrate (1:1), (R-(R*,R*))-isomer
=450  \\$wnnna$aPiperazine Tartrate, (R-(R*,R*))-isomer
=450  \\$wnnna$aPiperazinium Oleate
=450  \\$wnnna$aPripsen
=450  \\$wnnna$a1,4 Diazacyclohexane
=450  \\$wnnna$a1,4 Piperazine
=450  \\$aPiperazines$xanalogs & derivatives
=667  \\$aPIPERAZINES is also available
=680  \\$iAn anti-nematodal agent effective against the intestinal nematodes ASCARIS LUMBRICOIDES (roundworm) and ENTEROBIUS VERMICULARIS (pinworm, threadworm).  It produces a neuromuscular block leading to flaccid muscle paralysis in susceptible worms, which are then dislodged from the gut and expelled in feces.
=688  \\$a2019 (1982)
=750  \0$aPiperazine$0(DLC)sh 85102399$5IEN

=LDR  00866cz  a2200265n  4500
=001  9881575458802441
=005  20210202171249.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076682
=035  \\$a(NLM)9811684519400041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x733
=072  \\$aL1.$x737.$x736
=150  \\$aPreprints as Topic
=450  \\$wnnna$aPre-Prints as Topic
=450  \\$wnnna$aPre Prints as Topic
=450  \\$wnnna$aPre-Prints as Topics
=450  \\$wnnna$aTopic, Pre-Prints as
=450  \\$wnnna$aTopics, Pre-Prints as
=450  \\$wnnna$aas Topic, Pre-Prints
=450  \\$wnnna$aas Topics, Pre-Prints
=667  \\$ado not confuse with the Publication Type PREPRINT
=680  \\$iWorks about scientific manuscripts made available prior to PEER REVIEW.
=688  \\$a2019
=750  \0$aPreprints$0(DLC) sh 85106389$5IEN-M

=LDR  01765nz  a2200457n  4500
=001  9881575459002441
=005  20210202170112.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077487
=035  \\$a(NLM)9811675043500041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x129.$x708.$x89.$x514
=072  \\$aD3.$x633.$x100.$x185.$x514
=150  \\$aPramipexole
=450  \\$wnnna$a2-Amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
=450  \\$wnnna$a2-Amino-6-propylaminotetrahydrobenzothiazole
=450  \\$wnnna$a4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazole-diamine
=450  \\$wnnna$a6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate
=450  \\$wnnna$aDexpramipexole
=450  \\$wnnna$aKNS 760704
=450  \\$wnnna$aKNS-760704
=450  \\$wnnna$aKNS760704
=450  \\$wnnna$aMirapex
=450  \\$wnnna$aPramipexol
=450  \\$wnnna$aPramipexol Dihydrobromide, (+-)-isomer
=450  \\$wnnna$aPramipexol Dihydrochloride, (S)-isomer
=450  \\$wnnna$aPramipexol, (+-)-isomer
=450  \\$wnnna$aPramipexol, (R)-isomer
=450  \\$wnnna$aPramipexole Dihydrochloride
=450  \\$wnnna$aPramipexole Dihydrochloride Anhydrous
=450  \\$wnnna$aPramipexole Hydrochloride Monohydrate
=450  \\$wnnna$aSND 919CL2x
=450  \\$wnnna$aSND-919
=450  \\$wnnna$aSND-919CL2x
=450  \\$wnnna$aSND919CL2x
=450  \\$wnnna$aSifrol
=450  \\$wnnna$a2 Amino 6 propylaminotetrahydrobenzothiazole
=450  \\$wnnna$aSND 919
=680  \\$iA benzothiazole derivative and dopamine agonist with antioxidant properties that is used in the treatment of PARKINSON DISEASE and RESTLESS LEGS SYNDROME.
=688  \\$a2019 (1989)
=750  \0$aPramipexole$0(DLC) sh 00001887$5IEN-M

=LDR  01294nz  a2200325n  4500
=001  9881575573502441
=005  20210128130616.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077268
=035  \\$a(NLM)9811683910800041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x705.$x429.$x500.$x858
=150  \\$aPamidronate
=450  \\$wnnna$a(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
=450  \\$wnnna$a1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
=450  \\$wnnna$aAHPrBP
=450  \\$wnnna$aAmidronate
=450  \\$wnnna$aAmino-1-hydroxypropane-1,1-diphosphonate
=450  \\$wnnna$aAminohydroxypropylidene Diphosphonate
=450  \\$wnnna$aAminopropanehydroxydiphosphonate
=450  \\$wnnna$aAredia
=450  \\$wnnna$aPamidronate Calcium
=450  \\$wnnna$aPamidronate Disodium
=450  \\$wnnna$aPamidronate Monosodium
=450  \\$wnnna$aPamidronic Acid
=450  \\$wnnna$a1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
=450  \\$wnnna$aAmino 1 hydroxypropane 1,1 diphosphonate
=680  \\$iAn aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies.
=688  \\$a2019 (1979)
=750  \0$aDisodium pamidronate$0(DLC) sh 89003994$5IEN-M

=LDR  01405cz  a2200349n  4500
=001  9881575734402441
=005  20210205145702.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077185
=035  \\$a(NLM)9811684603300041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x700.$x725.$x875
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x715.$x500
=150  \\$aResveratrol
=450  \\$wnnna$a3,4',5-Stilbenetriol
=450  \\$wnnna$a3,4',5-Trihydroxystilbene
=450  \\$wnnna$a3,5,4'-Trihydroxystilbene
=450  \\$wnnna$aResveratrol, (Z)-
=450  \\$wnnna$aResveratrol-3-sulfate
=450  \\$wnnna$aSRT 501
=450  \\$wnnna$aSRT-501
=450  \\$wnnna$aSRT501
=450  \\$wnnna$acis-Resveratrol
=450  \\$wnnna$atrans-Resveratrol
=450  \\$wnnna$atrans-Resveratrol-3-O-sulfate
=450  \\$wnnna$aResveratrol 3 sulfate
=450  \\$wnnna$acis Resveratrol
=450  \\$wnnna$atrans Resveratrol
=450  \\$wnnna$atrans Resveratrol 3 O sulfate
=680  \\$iA stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA HELICASES in vitro.
=688  \\$a2019 (1989)
=750  \0$aResveratrol$0(DLC) sh2005001764$5IEN-M

=LDR  00654nz  a2200193n  4500
=001  9881575734602441
=005  20210205145112.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078682
=035  \\$a(NLM)9811675421500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x907
=150  \\$aRespect
=450  \\$wnnna$aDignity
=450  \\$wnnna$aPersonal Respect
=450  \\$wnnna$aRespect, Personal
=680  \\$iA feeling of deep admiration for someone or something elicited by their abilities, qualities, or achievements and regard for the feelings, wishes, or rights of others.
=688  \\$a2019
=750  \0$aRespect$0(DLC) sh 85113175$5IEN-M

=LDR  00516nz  a2200169n  4500
=001  9881575735802441
=005  20210205135934.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076664
=035  \\$a(NLM)9811684527600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x836
=150  \\$aRanunculales
=450  \\$wnnna$aRanunculale
=680  \\$iAn order of flowering plants also known as the buttercup family.
=688  \\$a2019
=750  \0$aRanunculales$0(DLC) sh 85111389$5IEN-M

=LDR  01234cz  a2200289n  4500
=001  9881575737302441
=005  20210205134817.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078702
=035  \\$a(NLM)9811675421400041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x808
=150  \\$aRadiofrequency Therapy
=450  \\$wnnna$aRadio-Frequency Therapy
=450  \\$wnnna$aRadio Frequency Therapy
=450  \\$wnnna$aRadio-Frequency Therapies
=450  \\$wnnna$aRadiofrequency Therapies
=450  \\$wnnna$aTherapies, Radio-Frequency
=450  \\$wnnna$aTherapies, Radiofrequency
=450  \\$wnnna$aTherapy, Radio-Frequency
=450  \\$wnnna$aTherapy, Radiofrequency
=450  \\$aRadio Waves$xtherapeutic use
=680  \\$iThe use of RADIO WAVES to conduct therapeutic procedures. The specific frequency, dosage, and intensity used vary depending on the desired effects which include heating, electrical stimulation, or ablation of tissues.
=688  \\$a2019
=750  \0$81$wb$iNarrower mapping$aRadio waves$0(DLC) sh 85110586$4NM$5IEN-M
=780  \0$81$wb$xTherapeutic use$0(DLC) sh2001008985$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aRadio waves--Therapeutic use$5IEN-M

=LDR  00989nz  a2200277n  4500
=001  9881575739602441
=005  20210204175023.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077583
=035  \\$a(NLM)9811675379500041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x531.$x820.$x250
=150  \\$aQuinapril
=450  \\$wnnna$a2-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid
=450  \\$wnnna$aAccupril
=450  \\$wnnna$aCI 906
=450  \\$wnnna$aCI-906
=450  \\$wnnna$aPD 109452-2
=450  \\$wnnna$aPD-109,452-2
=450  \\$wnnna$aQuinapril Hydrochloride
=450  \\$wnnna$aPD 109,452 2
=450  \\$wnnna$aPD 109452 2
=450  \\$wnnna$aPD 1094522
=680  \\$iA tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE.
=688  \\$a2019 (1984)
=750  \0$aQuinapril$0(DLC) sh 93006010$5IEN-M

=LDR  00545cz  a2200181n  4500
=001  9881575740302441
=005  20210204150232.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077319
=035  \\$a(NLM)9811675541900041
=040  \\$aDNLM$cDNLM
=060  \0$aTP 156.P9
=072  \\$aG2.$x785
=150  \\$aPyrolysis
=450  \\$wnnna$aPyrolyses
=680  \\$iHigh temperature decomposition without addition of extra air or oxygen. It yields syngas, bio-oil and bio-char.
=688  \\$a2019
=750  \0$aPyrolysis$0(DLC) sh 85109347$5IEN-M

=LDR  00528nz  a2200169n  4500
=001  9881575740602441
=005  20210204145626.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077108
=035  \\$a(NLM)9811683455800041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x840
=150  \\$aPublic Expenditures
=450  \\$wnnna$aExpenditures, Public
=680  \\$iExpenses of public funds incurred by government bodies:  state, regional and local.
=688  \\$a2019
=750  \0$aExpenditures, Public$0(DLC)sh 85046427$5IEN-M

=LDR  01144nz  a2200277n  4500
=001  9881575839602441
=005  20210205172000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077285
=035  \\$a(NLM)9811675586100041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x888
=072  \\$aD3.$x383.$x621.$x834
=150  \\$aRimonabant
=450  \\$wnnna$aAcomplia
=450  \\$wnnna$aN-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride
=450  \\$wnnna$aRimonabant Hydrochloride
=450  \\$wnnna$aSR 141716
=450  \\$wnnna$aSR 141716A
=450  \\$wnnna$aSR-141716A
=450  \\$wnnna$aSR141716
=450  \\$wnnna$aSR141716A
=450  \\$wnnna$aZimulti
=680  \\$iA pyrazole and piperidine derivative that acts as a selective cannabinoid type-1 receptor (CB1 RECEPTOR) antagonist. It inhibits the proliferation and maturation of ADIPOCYTES, improves lipid and glucose metabolism, and regulates food intake and energy balance. It is used in the management of OBESITY.
=688  \\$a2019 (1994)
=750  \0$aRimonabant$0(DLC) sh2007005971$5IEN-M

=LDR  00609cz  a2200169n  4500
=001  9881575839802441
=005  20210205170651.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076944
=035  \\$a(NLM)9811684504300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x664
=072  \\$aB3.$x660.$x50.$x783
=150  \\$aRickettsiales
=680  \\$iOrder in class ALPHAPROTEOBACTERIA that are endosymbionts in eukaryotic cells. High morbidity and mortality are frequently associated with Rickettsiales transmitted by INSECT VECTORS.
=688  \\$a2019
=750  \0$aRickettsiales$0(DLC) sh 88023322$5IEN-M

=LDR  00680cz  a2200193n  4500
=001  9881575843502441
=005  20210203180322.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077283
=035  \\$a(NLM)9811675581300041
=040  \\$aDNLM$cDNLM
=060  \0$aW 740
=072  \\$aF4.$x96.$x628.$x49
=072  \\$aI1.$x198.$x780.$x960
=150  \\$aForensic Psychology
=450  \\$wnnna$aPsychology, Forensic
=680  \\$iA specialty in professional psychology characterized by activities primarily intended to provide professional psychological expertise within the judicial and legal systems.
=688  \\$a2019
=750  \0$aForensic psychology$0(DLC) sh 85108475$5IEN-M

=LDR  00585nz  a2200217n  4500
=001  9881575847202441
=005  20210203145743.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078822
=035  \\$a(NLM)9811675263800041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x219
=150  \\$aEx-Smokers
=450  \\$wnnna$aExsmokers
=450  \\$wnnna$aEx-Smoker
=450  \\$wnnna$aExsmoker
=550  \\$aSmokers
=550  \\$aNon-Smokers
=680  \\$iPersons who do not smoke but that have a history of SMOKING.
=688  \\$a2019
=750  \0$aEx-smokers$0(DLC) sh 89003877$5IEN-M

=LDR  00583nz  a2200193n  4500
=001  9881575847702441
=005  20210203141309.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078122
=035  \\$a(NLM)9811675140000041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x33
=072  \\$aD20.$x215.$x784.$x750.$x33
=150  \\$aEucalyptus Oil
=450  \\$wnnna$aEucalyptus globulus Oil
=550  \\$aEucalyptol
=680  \\$iAn oily liquid that is extracted from the leaves of EUCALYPTUS trees.
=688  \\$a2019
=750  \0$aEucalyptus oil$0(DLC) sh 85045502$5IEN-M

=LDR  00770cz  a2200229n  4500
=001  9881575848302441
=005  20190903000000.0
=008  180712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076663
=035  \\$a(NLM)9811684529400041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 256
=072  \\$aE2.$x760.$x169.$x63.$x500.$x387.$x250
=072  \\$aE2.$x779.$x483.$x250
=072  \\$aE2.$x831.$x535.$x483.$x250
=072  \\$aG11.$x427.$x410.$x698.$x277.$x311.$x188
=072  \\$aI3.$x350.$x311.$x188
=150  \\$aEndurance Training
=450  \\$wnnna$aTraining, Endurance
=550  \\$aPhysical Endurance
=680  \\$iExercise programs of relatively long duration and moderate intensity, which enhance maximal oxygen uptake, increasing PHYSICAL STAMINA.
=688  \\$a2019

=LDR  00457nz  a2200157n  4500
=001  9881575853002441
=005  20210202155027.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078385
=035  \\$a(NLM)9811675296800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x483.$x666.$x500
=150  \\$aEmbarrassment
=680  \\$iA feeling of self-consciousness, shame, or awkwardness.
=688  \\$a2019
=750  \0$aEmbarrassment$0(DLC) sh 85042668$5IEN-M

=LDR  00601cz  a2200193n  4500
=001  9881575853402441
=005  20210202154654.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078663
=035  \\$a(NLM)9811675421700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x343
=072  \\$aF1.$x752.$x747.$x792.$x379
=150  \\$aEgocentrism
=450  \\$aEgocentricity
=667  \\$aEGO is also available
=680  \\$iSelf-centered preoccupation or concern regarding one's own needs, abilities, wishes, desires, or preferences.
=688  \\$a2019
=750  \0$aEgoism$0(DLC) sh 85041257$5IEN-M

=LDR  00594nz  a2200169n  4500
=001  9881575854002441
=005  20210202141223.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078022
=035  \\$a(NLM)9811675147900041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x268
=072  \\$aN1.$x824.$x98
=150  \\$aEconomic Status
=680  \\$iPersonal or family variables such as household income, assets such as inherited wealth, savings, employment benefits, or ownership of homes or other property.
=688  \\$a2019
=750  \0$aEconomic status$0(DLC) sh 85040846$5IEN-M

=LDR  00993nz  a2200277n  4500
=001  9881575855402441
=005  20210219093216.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078142
=035  \\$a(NLM)9811675138100041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x687.$x750
=072  \\$aD2.$x886.$x108.$x750.$x687.$x750
=072  \\$aD2.$x886.$x590.$x841
=072  \\$aD3.$x633.$x100.$x300.$x750.$x687.$x750
=150  \\$aTazobactam
=450  \\$wnnna$aTazobactam Sodium
=450  \\$wnnna$aYTR 830
=450  \\$wnnna$aYTR 830H
=450  \\$wnnna$aYTR-830
=450  \\$wnnna$aYTR830
=550  \\$wg$aPenicillanic Acid
=550  \\$wh$aPiperacillin, Tazobactam Drug Combination
=680  \\$iA penicillanic acid and sulfone derivative and potent BETA-LACTAMASE inhibitor that enhances the activity of other anti-bacterial agents against beta-lactamase producing bacteria.
=688  \\$a2019 (1985)
=750  \0$aTazobactam$0(DLC) sh 93005757 {dollar}5 IEN-M

=LDR  01222cz  a2200325n  4500
=001  9881575856102441
=005  20210201145846.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076722
=035  \\$a(NLM)9811684516000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 745
=072  \\$aE5.$x290
=072  \\$aH1.$x158.$x703.$x7.$x338
=072  \\$aH1.$x181.$x466.$x338
=150  \\$aDrug Development
=450  \\$wnnna$aMedication Development
=450  \\$wnnna$aPharmaceutical Development
=450  \\$aComputational Prediction of Drug-Target Interactions
=450  \\$aDrug Target Prediction
=450  \\$wnnna$aDevelopment, Drug
=450  \\$wnnna$aDevelopment, Medication
=450  \\$wnnna$aDevelopment, Pharmaceutical
=450  \\$wnnna$aDrug Target Predictions
=450  \\$wnnna$aPrediction, Drug Target
=450  \\$wnnna$aTarget Prediction, Drug
=667  \\$ado not confuse with DRUG DISCOVERY which is the process of finding chemicals for potential therapeutic use
=680  \\$iThe entire process of bringing a new drug to the market. It includes both preclinical and clinical testing, and regulatory approval.
=688  \\$a2019
=750  \0$aDrug Development$0(DLC) sh 97007921$5IEN-M

=LDR  01054nz  a2200301n  4500
=001  9881575856302441
=005  20180904000000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077143
=035  \\$a(NLM)9811684172100041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x242.$x888.$x389
=072  \\$aD2.$x455.$x849.$x291.$x850.$x389
=150  \\$aDocetaxel
=450  \\$wnnna$aDocetaxel Anhydrous
=450  \\$wnnna$aDocetaxel Hydrate
=450  \\$wnnna$aDocetaxel Trihydrate
=450  \\$wnnna$aDocetaxol
=450  \\$wnnna$aN-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol
=450  \\$wnnna$aNSC 628503
=450  \\$wnnna$aRP 56976
=450  \\$wnnna$aRP-56976
=450  \\$wnnna$aTaxoltere Metro
=450  \\$wnnna$aTaxotere
=450  \\$wnnna$aN Debenzoyl N tert butoxycarbonyl 10 deacetyltaxol
=450  \\$wnnna$aRP56976
=680  \\$iA semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.
=688  \\$a2019 (1991)

=LDR  00532nz  a2200181n  4500
=001  9881575857102441
=005  20210201143651.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078382
=035  \\$a(NLM)9811675297300041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x307
=150  \\$aDisgust
=450  \\$wnnna$aContempt
=450  \\$wnnna$aRevulsion
=680  \\$iA feeling of revulsion or strong disapproval aroused by something unpleasant or offensive.
=688  \\$a2019
=750  \0$aAversion$0(DLC) sh 96009014$5IEN-M

=LDR  00503nz  a2200157n  4500
=001  9881575857402441
=005  20210201142547.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077109
=035  \\$a(NLM)9811683454800041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x158.$x405.$x500
=150  \\$aDisability Studies
=680  \\$iInterdisciplinary programs of academic study that de-stigmatize disease, illness, and impairment.
=688  \\$a2019
=750  \0$aDisability studies$0(DLC) sh 97005575$5IEN-M

=LDR  00500nz  a2200145n  4500
=001  9881575857702441
=005  20180904000000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076625
=035  \\$a(NLM)9811684057900041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x836.$x500.$x343
=150  \\$aDicentra
=680  \\$iA genus of herbaceous plants with asymmetrically-shaped flowers and finely divided leaves, native to east Asia and North America.
=688  \\$a2019

=LDR  00746nz  a2200181n  4500
=001  9881575858702441
=005  20210201123626.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077252
=035  \\$a(NLM)9811683927300041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x754.$x137.$x628
=150  \\$aDialectical Behavior Therapy
=450  \\$wnnna$aBehavior Therapy, Dialectical
=450  \\$wnnna$aDialectical Behavior Therapies
=680  \\$iA flexible, stage-based therapy that combines principles of behavior therapy, cognitive behavior therapy, and MINDFULNESS. It concurrently promotes acceptance and change, especially with difficult-to-treat patients.
=688  \\$a2019
=750  \0$aDialectical behavior therapy$0(DLC)sh2005001982$5IEN-M

=LDR  01427cz  a2200361n  4500
=001  9880363973802441
=005  20170608095607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010406
=035  \\$aCBA3692HS
=040  \\$aDNLM$beng$cDNLM
=060  \0$aQV 354
=072  \\$aD2.$x65.$x589.$x99.$x750
=072  \\$aD2.$x886.$x108.$x750
=072  \\$aD3.$x633.$x100.$x300.$x750
=150  \\$aPenicillins
=450  \\$aAntibiotics, Penicillin
=450  \\$wnnna$aPenicillin
=450  \\$wnnna$aPenicillin Antibiotics
=550  \\$wg$abeta-Lactams
=550  \\$wh$aAmdinocillin
=550  \\$wh$aCyclacillin
=550  \\$wh$aMethicillin
=550  \\$wh$aNafcillin
=550  \\$wh$aOxacillin
=550  \\$wh$aPenicillanic Acid
=550  \\$wh$aPenicillin G
=550  \\$wh$aPenicillin V
=550  \\$wh$aSulbactam
=550  \\$wh$aTicarcillin
=680  \\$iA group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
=688  \\$a75; was PENICILLIN 1963-74; /adv eff-pois-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84
=750  \0$aPenicillin$5IEN$0(DLC)sh 85099402

=LDR  00892cz  a2200253n  4500
=001  9880363973902441
=005  20210211153902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010397
=035  \\$aCBA3683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x687
=072  \\$aD2.$x886.$x108.$x750.$x687
=072  \\$aD3.$x438.$x260.$x825.$x687
=072  \\$aD3.$x605.$x84.$x737.$x687
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x687
=150  \\$aPenicillanic Acid
=450  \\$wnnna$aAcid, Penicillanic
=550  \\$wg$aPenicillins
=550  \\$ah$aTazobactam
=667  \\$ado not confuse with PENICILLIC ACID
=680  \\$iA building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
=688  \\$a94,73-74(71-72); was PENICILLANIC ACIDS 1975-93
=750  \0$aPenicillanic acids$5IEN-M$0(DLC)sh 93005759

=LDR  01253cz  a2200361n  4500
=001  9880363974002441
=005  20141212204334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010396
=035  \\$aCBA3682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x786
=072  \\$aD12.$x125.$x166.$x786
=150  \\$aPenicillamine
=450  \\$abeta,beta-Dimethylcysteine
=450  \\$wnnna$abeta,beta Dimethylcysteine
=450  \\$wnnna$aCopper Penicillaminate
=450  \\$wnnna$aCuprenil
=450  \\$wnnna$aCuprimine
=450  \\$wnnna$aD-3-Mercaptovaline
=450  \\$wnnna$aD 3 Mercaptovaline
=450  \\$wnnna$aD-Penicillamine
=450  \\$wnnna$aD Penicillamine
=450  \\$aDimethylcysteine
=450  \\$aMercaptovaline
=450  \\$wnnna$aMetalcaptase
=450  \\$wnnna$aPenicillaminate, Copper
=550  \\$wg$aAmino Acids, Sulfur
=550  \\$wh$aS-Nitroso-N-Acetylpenicillamine
=667  \\$adegradation product of the penicillin antibiotics
=680  \\$i3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
=688  \\$a64(63)
=750  \0$aPenicillamine$5IEN$0(DLC)sh 85099401

=LDR  00748cz  a2200229n  4500
=001  9880363974102441
=005  20141212204334.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010395
=035  \\$aCBA3681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x620
=150  \\$aPenfluridol
=450  \\$wnnna$aJanssen Brand of Penfluridol
=450  \\$wnnna$aR-16341
=450  \\$wnnna$aR 16341
=450  \\$wnnna$aR16341
=450  \\$wnnna$aSemap
=550  \\$wg$aPiperidines
=680  \\$iOne of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.
=688  \\$a91(75); was see under PIPERIDINES 1975-90
=750  \0$aPenfluridol$5IEN$0(DLC)sh 85099392

=LDR  00818cz  a2200229n  4500
=001  9880363974202441
=005  20141212204333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010392
=035  \\$aCBA3678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x865.$x716
=072  \\$aC20.$x111.$x736
=150  \\$aPemphigus
=450  \\$wnnna$aFoliaceus, Pemphigus
=450  \\$wnnna$aPemphigus Foliaceus
=450  \\$aPemphigus Vulgaris
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aSkin Diseases, Vesiculobullous
=667  \\$ado not confuse with PEMPHIGOID; /genet: consider also PEMPHIGUS, BENIGN FAMILIAL
=680  \\$iGroup of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
=750  \0$aPemphigus$5IEN$0(DLC)sh 85099338

=LDR  00830cz  a2200217n  4500
=001  9880363974302441
=005  20141212204332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x600
=150  \\$aPelvis
=450  \\$wnnna$aPelvic Region
=450  \\$wnnna$aRegion, Pelvic
=550  \\$wg$aTorso
=550  \\$wh$aLesser Pelvis
=550  \\$wh$aPelvic Floor
=550  \\$aPelvimetry
=667  \\$ainternal pelvic region, not PELVIC BONES; / surg: consider also PELVIC EXENTERATION; LESSER PELVIS is also available
=680  \\$iThe space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.
=750  \0$aPelvis$5IEN$0(DLC)sh 85099317

=LDR  01167cz  a2200349n  4500
=001  9880363974402441
=005  20141212212701.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018582
=035  \\$aCSK5553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417.$x700.$x662
=072  \\$aN4.$x452.$x677.$x800.$x662
=150  \\$aSick Leave
=450  \\$wnnna$aDay, Illness
=450  \\$wnnna$aDay, Sick
=450  \\$wnnna$aDays, Illness
=450  \\$wnnna$aDays, Sick
=450  \\$aDisability Leave
=450  \\$wnnna$aDisability Leaves
=450  \\$wnnna$aIllness Day
=450  \\$aIllness Days
=450  \\$wnnna$aLeave, Disability
=450  \\$wnnna$aLeave, Sick
=450  \\$wnnna$aLeaves, Disability
=450  \\$wnnna$aSick Day
=450  \\$aSick Days
=550  \\$wg$aSalaries and Fringe Benefits
=667  \\$apermitted absence for sickness, often paid leave
=680  \\$iAn absence from work permitted because of illness or the number of days per year for which an employer agrees to pay employees who are sick. (Webster's New Collegiate Dictionary, 1981)
=688  \\$a95
=750  \0$aSick leave$5IEN-M$0(DLC)sh 85122289

=LDR  01371cz  a2200301n  4500
=001  9880363974502441
=005  20141212212741.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018707
=035  \\$aCSK5549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x340.$x900
=072  \\$aG1.$x595.$x340.$x900
=150  \\$aVolcanic Eruptions
=450  \\$wnnna$aAsh, Volcanic
=450  \\$wnnna$aEruption, Volcanic
=450  \\$wnnna$aEruptions, Volcanic
=450  \\$wnnna$aGases, Volcanic
=450  \\$aVolcanic Ash
=450  \\$aVolcanic Eruption
=450  \\$aVolcanic Gases
=550  \\$wg$aGeological Processes
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe ash, dust, gases, and lava released by volcanic explosion. The gases are volatile matter composed principally of about 90% water vapor, and carbon dioxide, sulfur dioxide, hydrogen, carbon monoxide, and nitrogen. The ash or dust is pyroclastic ejecta and lava is molten extrusive material consisting mainly of magnesium silicate. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a2009 (1995); use NATURAL DISASTERS 1982-1994
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Volcanic Eruption
=688  \\$a95; was VOLCANIC ERUPTIONS see NATURAL DISASTERS 1982-94
=750  \0$aVolcanic eruptions$0(DLC)sh2003006489$5IEN-M

=LDR  02346cz  a2200481n  4500
=001  9880363974602441
=005  20141212212742.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x995
=072  \\$aN5.$x715.$x360.$x750.$x760
=072  \\$aN6.$x850.$x520.$x830.$x995
=150  \\$aStatistics, Nonparametric
=450  \\$aKolmogorov-Smirnov Test
=450  \\$wnnna$aKolmogorov Smirnov Test
=450  \\$aKruskal-Wallis H Statistic
=450  \\$aMann-Whitney U Test
=450  \\$wnnna$aMann Whitney U Test
=450  \\$wnnna$aNon-Parametric Statistics
=450  \\$wnnna$aNon Parametric Statistics
=450  \\$wnnna$aNonparametric Statistics
=450  \\$wnnna$aRank-Sum Test
=450  \\$aRank-Sum Tests
=450  \\$wnnna$aRank Sum Tests
=450  \\$wnnna$aRank Test, Wilcoxon
=450  \\$aSpearman Rank Correlation Coefficient
=450  \\$wnnna$aStatistics, Non-Parametric
=450  \\$wnnna$aStatistics, Non Parametric
=450  \\$wnnna$aTest, Kolmogorov-Smirnov
=450  \\$wnnna$aTest, Mann-Whitney U
=450  \\$wnnna$aTest, Rank-Sum
=450  \\$wnnna$aTest, Wilcox
=450  \\$wnnna$aTest, Wilcoxon Rank
=450  \\$wnnna$aTests, Rank-Sum
=450  \\$wnnna$aU Test, Mann-Whitney
=450  \\$aWilcox Test
=450  \\$aWilcoxon Rank Test
=550  \\$wg$aStatistics as Topic
=667  \\$aIM GEN only; coord NIM with specific disease /epidemiol (IM) or specific non-disease term /statist (IM); no qualif
=680  \\$iA class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5)
=688  \\$a95
=750  \0$aNonparametric statistics$5IEN-M$0(DLC)sh 85092349

=LDR  01395cz  a2200325n  4500
=001  9880363974702441
=005  20141212212718.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018633
=035  \\$aCSK5545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x850.$x937
=072  \\$aC14.$x280.$x484.$x640
=072  \\$aC16.$x131.$x240.$x850.$x906
=150  \\$aPulmonary Atresia
=450  \\$aAtresia, Pulmonary
=450  \\$wnnna$aAtresia, Pulmonary Valve
=450  \\$wnnna$aAtresias, Pulmonary
=450  \\$wnnna$aAtresias, Pulmonary Valve
=450  \\$wnnna$aPulmonary Atresias
=450  \\$aPulmonary Valve Atresia
=450  \\$wnnna$aPulmonary Valve Atresias
=450  \\$wnnna$aValve Atresia, Pulmonary
=450  \\$wnnna$aValve Atresias, Pulmonary
=550  \\$wg$aHeart Valve Diseases
=550  \\$wg$aVascular Malformations
=667  \\$aDF: PULM ATRESIA
=680  \\$iA congenital heart defect characterized by the narrowing or complete absence of the opening between the RIGHT VENTRICLE and the PULMONARY ARTERY. Lacking a normal PULMONARY VALVE, unoxygenated blood in the right ventricle can not be effectively pumped into the lung for oxygenation. Clinical features include rapid breathing, CYANOSIS, right ventricle atrophy, and abnormal heart sounds (HEART MURMURS).
=688  \\$a95
=750  \0$aPulmonary artery$xAtresia$5IEN-M$0(DLC)sh 88007137

=LDR  01205cz  a2200289n  4500
=001  9880363974802441
=005  20141212212807.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018798
=035  \\$aCSK5539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x196.$x300
=072  \\$aC18.$x452.$x565.$x100
=150  \\$aAnemia, Iron-Deficiency
=450  \\$wnnna$aAnemia, Iron Deficiency
=450  \\$wnnna$aAnemias, Iron-Deficiency
=450  \\$wnnna$aAnemias, Iron Deficiency
=450  \\$aIron-Deficiency Anemia
=450  \\$wnnna$aIron Deficiency Anemia
=450  \\$wnnna$aIron-Deficiency Anemias
=450  \\$wnnna$aIron Deficiency Anemias
=550  \\$wg$aAnemia, Hypochromic
=550  \\$wg$aIron Metabolism Disorders
=667  \\$aDF: ANEMIA IRON DEFIC
=680  \\$iAnemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
=688  \\$a95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94
=750  \0$aIron deficiency anemia$0(DLC) sh 85068186$5IEN-M

=LDR  01527cz  a2200373n  4500
=001  9880363974902441
=005  20141212212822.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x200
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x646.$x500
=072  \\$aD12.$x644.$x360.$x250
=072  \\$aD12.$x776.$x167.$x200
=072  \\$aD12.$x776.$x476.$x250
=150  \\$aCyclin-Dependent Kinases
=450  \\$acdk Proteins
=450  \\$wnnna$aCyclin Dependent Kinases
=450  \\$wnnna$aCyclin-Dependent Protein Kinases
=450  \\$wnnna$aCyclin Dependent Protein Kinases
=550  \\$wg$aCell Cycle Proteins
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aProline-Directed Protein Kinases
=550  \\$wg$aProtein-Serine-Threonine Kinases
=550  \\$wh$aCDC2-CDC28 Kinases
=550  \\$wh$aCyclin-Dependent Kinase 2
=550  \\$wh$aCyclin-Dependent Kinase 3
=550  \\$wh$aCyclin-Dependent Kinase 4
=550  \\$wh$aCyclin-Dependent Kinase 6
=550  \\$wh$aCyclin-Dependent Kinase 8
=550  \\$wh$aMaturation-Promoting Factor
=680  \\$iProtein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events.
=688  \\$a95
=750  \0$aCyclin-dependent kinases$5IEN-M$0(DLC)sh 97004870

=LDR  01151cz  a2200301n  4500
=001  9880363975002441
=005  20141212212819.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018832
=035  \\$aCSK5529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x580
=150  \\$aMolecular Chaperones
=450  \\$wnnna$aChaperone, Molecular
=450  \\$aChaperones, Molecular
=450  \\$wnnna$aMolecular Chaperone
=550  \\$wg$aProteins
=550  \\$wh$aalpha-Crystallins
=550  \\$wh$aClusterin
=550  \\$wh$aHeat-Shock Proteins
=550  \\$wh$aHistone Chaperones
=550  \\$wh$aMetallochaperones
=550  \\$wh$aNeuroendocrine Secretory Protein 7B2
=550  \\$wh$aSMN Complex Proteins
=667  \\$aa class of proteins; GEN or unspecified; prefer specifics; DF: MOL CHAPERONES
=680  \\$iA family of cellular proteins that mediate the correct assembly or disassembly of polypeptides and their associated ligands. Although they take part in the assembly process, molecular chaperones are not components of the final structures.
=688  \\$a95
=750  \0$aMolecular chaperones$5IEN-M$0(DLC)sh 95008221

=LDR  01350cz  a2200313n  4500
=001  9880363975102441
=005  20141212212802.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018786
=035  \\$aCSK5526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x130.$x325
=072  \\$aJ1.$x637.$x51.$x130.$x325
=150  \\$aBone Substitutes
=450  \\$wnnna$aBone Replacement Material
=450  \\$aBone Replacement Materials
=450  \\$wnnna$aBone Substitute
=450  \\$wnnna$aMaterial, Bone Replacement
=450  \\$wnnna$aMaterials, Bone Replacement
=450  \\$wnnna$aReplacement Material, Bone
=450  \\$wnnna$aReplacement Materials, Bone
=450  \\$wnnna$aSubstitute, Bone
=450  \\$wnnna$aSubstitutes, Bone
=550  \\$wg$aBiocompatible Materials
=550  \\$aOsseointegration
=667  \\$aIM; coord with specific bone (IM) if relevant + substitute material (IM) if significant
=680  \\$iSynthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.
=688  \\$a95
=750  \0$aBone substitutes$5IEN-M$0(DLC)sh 92001157

=LDR  02047cz  a2200493n  4500
=001  9880363975202441
=005  20141212212801.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018781
=035  \\$aCSK5524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x546.$x399.$x875
=150  \\$aTension-Type Headache
=450  \\$wnnna$aHeadache, Idiopathic
=450  \\$wnnna$aHeadache, Psychogenic
=450  \\$wnnna$aHeadache, Stress
=450  \\$aHeadache, Tension
=450  \\$wnnna$aHeadache, Tension-Type
=450  \\$wnnna$aHeadache, Tension-Vascular
=450  \\$wnnna$aHeadaches, Idiopathic
=450  \\$wnnna$aHeadaches, Psychogenic
=450  \\$wnnna$aHeadaches, Stress
=450  \\$wnnna$aHeadaches, Tension
=450  \\$wnnna$aHeadaches, Tension-Type
=450  \\$wnnna$aHeadaches, Tension-Vascular
=450  \\$wnnna$aIdiopathic Headache
=450  \\$wnnna$aIdiopathic Headaches
=450  \\$aPsychogenic Headache
=450  \\$wnnna$aPsychogenic Headaches
=450  \\$aStress Headache
=450  \\$wnnna$aStress Headaches
=450  \\$wnnna$aTension Headache
=450  \\$wnnna$aTension Headaches
=450  \\$wnnna$aTension Type Headache
=450  \\$wnnna$aTension-Type Headaches
=450  \\$aTension-Vascular Headache
=450  \\$wnnna$aTension Vascular Headache
=450  \\$wnnna$aTension-Vascular Headaches
=550  \\$wg$aHeadache Disorders, Primary
=680  \\$iA common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
=688  \\$a2006 (1995)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Tension Headache
=688  \\$a1995
=750  \0$aTension headache$0(DLC) sh 90004459$5IEN-M

=LDR  01527cz  a2200265n  4500
=001  9880363975302441
=005  20141212212716.0
=008  940512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018629
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x566.$x760
=150  \\$aSpectrometry, Mass, Secondary Ion
=450  \\$aMass Spectrometry, Secondary Ion
=450  \\$aMass Spectroscopy, Secondary Ion
=450  \\$aSecondary Ion Mass Spectrometry
=450  \\$aSecondary Ion Mass Spectrometry Microscopy
=450  \\$wnnna$aSecondary Ion Mass Spectroscopy
=450  \\$wnnna$aSecondary Ion Mass Spectroscopy Microscopy
=450  \\$aSIMS Microscopy
=450  \\$aSpectroscopy, Mass, Secondary Ion
=550  \\$wg$aMass Spectrometry
=667  \\$afor SIMS microscopy, coordinate with type of microscopy
=680  \\$iA mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts (keV) bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Digital imaging can be generated from the secondary ion beams and their intensity can be measured. Ionic images can be correlated with images from light or other microscopy providing useful tools in the study of molecular and drug actions.
=688  \\$a95
=750  \0$aSecondary ion mass spectrometry$5IEN-M$0(DLC)sh 85119424

=LDR  00730cz  a2200217n  4500
=001  9880363975402441
=005  20141212212725.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018658
=035  \\$aCSK5521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x470.$x475.$x900
=150  \\$aVentricular Septal Rupture
=450  \\$wnnna$aSeptal Rupture, Ventricular
=450  \\$wnnna$aSeptal Ruptures, Ventricular
=450  \\$aVentricular Septal Perforation
=450  \\$wnnna$aVentricular Septal Ruptures
=550  \\$wg$aHeart Rupture, Post-Infarction
=680  \\$iLaceration or tearing of the VENTRICULAR SEPTUM, usually caused by MYOCARDIAL INFARCTION.
=688  \\$a95
=750  \0$aHeart septum$xRupture$5IEN-M

=LDR  01189cz  a2200265n  4500
=001  9880363975502441
=005  20141212212725.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018660
=035  \\$aCSK5520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x140.$x100
=072  \\$aE1.$x370.$x520.$x500.$x100
=150  \\$aBlood Pressure Monitoring, Ambulatory
=450  \\$aAmbulatory Blood Pressure Monitoring
=450  \\$wnnna$aBlood Pressure Monitoring, Home
=450  \\$wnnna$aBlood Pressure Monitoring, Self
=450  \\$wnnna$aHome Blood Pressure Monitoring
=450  \\$aMonitoring, Ambulatory Blood Pressure
=450  \\$wnnna$aSelf Blood Pressure Monitoring
=550  \\$wg$aBlood Pressure Determination
=550  \\$wg$aMonitoring, Ambulatory
=680  \\$iMethod in which repeated blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of HYPERTENSION, and can assess the effectiveness of antihypertensive therapy.
=688  \\$a95
=750  \0$aAmbulatory blood pressure monitoring$5IEN-M$0(DLC)sh 91005567

=LDR  02001cz  a2200385n  4500
=001  9880363975602441
=005  20141212212654.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018563
=035  \\$aCSK5518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x362
=072  \\$aN6.$x850.$x520.$x373
=072  \\$aN6.$x850.$x780.$x200.$x262
=150  \\$aDisease Notification
=450  \\$wnnna$aDisease Notifications
=450  \\$wnnna$aDisease Reporting, Infectious
=450  \\$wnnna$aDisease Reportings, Infectious
=450  \\$aExposure Notification
=450  \\$wnnna$aExposure Notifications
=450  \\$aInfectious Disease Reporting
=450  \\$wnnna$aInfectious Disease Reportings
=450  \\$aNotification, Disease
=450  \\$wnnna$aNotification, Exposure
=450  \\$wnnna$aNotifications, Disease
=450  \\$wnnna$aNotifications, Exposure
=450  \\$wnnna$aReporting, Infectious Disease
=450  \\$wnnna$aReportings, Infectious Disease
=550  \\$wg$aCommunicable Disease Control
=550  \\$wg$aEpidemiologic Methods
=550  \\$aMandatory Reporting
=667  \\$afor reporting occur of contagious dis: do not confuse with MANDATORY REPORTING, reporting of "suspected incidence of abuse & neglect"; IM GEN only; NIM with specific dis IM; DF: DIS NOTIF
=680  \\$iNotification or reporting by a physician or other health care provider of the occurrence of specified contagious diseases such as tuberculosis and HIV infections to designated public health agencies. The United States system of reporting notifiable diseases evolved from the Quarantine Act of 1878, which authorized the US Public Health Service to collect morbidity data on cholera, smallpox, and yellow fever; each state in the US has its own list of notifiable diseases and depends largely on reporting by the individual health care provider. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a95
=750  \0$aDiseases$xReporting$5IEN-M$0(DLC)sh 85038415

=LDR  01469cz  a2200361n  4500
=001  9880363975702441
=005  20141212212732.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018675
=035  \\$aCSK5517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x940
=150  \\$aToxicity Tests
=450  \\$wnnna$aTest, Toxicity
=450  \\$wnnna$aTests, Toxicity
=450  \\$wnnna$aToxicity Test
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aCarcinogenicity Tests
=550  \\$wh$aCytotoxicity Tests, Immunologic
=550  \\$wh$aInhibitory Concentration 50
=550  \\$wh$aLethal Dose 50
=550  \\$wh$aMaximum Tolerated Dose
=550  \\$wh$aMutagenicity Tests
=550  \\$wh$aNo-Observed-Adverse-Effect Level
=550  \\$wh$aToxicity Tests, Acute
=550  \\$wh$aToxicity Tests, Chronic
=550  \\$wh$aToxicity Tests, Subacute
=550  \\$wh$aToxicity Tests, Subchronic
=550  \\$aDrug Evaluation, Preclinical
=667  \\$aGEN or unspecified; prefer specifics; used for tests of drugs, food, environ pollutants, etc.; when the test itself is emphasized; coord IM with substance /tox (IM); toxic eff of a specific substance = specific substance /tox; DF: TOX TESTS
=680  \\$iAn array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants.
=688  \\$a95
=750  \0$aToxicity testing$5IEN-M$0(DLC)sh 85136327

=LDR  00988cz  a2200253n  4500
=001  9880363975802441
=005  20141212212755.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018758
=035  \\$aCSK5513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x888
=150  \\$aStimulants, Historical
=450  \\$wnnna$aHistorical Stimulants
=450  \\$wnnna$aHistorical Tonics
=450  \\$wnnna$aStimulants (Historical)
=450  \\$aTonics, Historical
=550  \\$wg$aTherapeutic Uses
=667  \\$ahistorical articles & historical contexts only: do not confuse with CNS, ganglionic or cardiac stimulants; do not confuse entry term Tonics, Historical with CARDIOTONIC AGENTS
=680  \\$iAgents or remedies that historically have produced stimulation or excited functional activity.
=688  \\$a2007 (1995)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Stimulants (Historical)
=688  \\$a95
=750  \0$aStimulants$0(DLC) sh 85128149$5IEN-M

=LDR  00543cz  a2200205n  4500
=001  9880363975902441
=005  20141212212721.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018648
=035  \\$aCSK5512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x80
=150  \\$aAmbergris
=550  \\$wg$aComplex Mixtures
=550  \\$aSperm Whale
=550  \\$aWhales
=680  \\$iA gray substance found in the GASTROINTESTINAL TRACT of the SPERM WHALE.
=688  \\$a1995
=688  \\$a95
=750  \0$aAmbergris$5IEN-M$0(DLC)sh 85004146

=LDR  00955cz  a2200241n  4500
=001  9880363976002441
=005  20141212212726.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018662
=035  \\$aCSK5510M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x390
=150  \\$aFundoplication
=450  \\$aNissen Operation
=450  \\$wnnna$aOperation, Nissen
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aGastric Fundus
=550  \\$aGastroesophageal Reflux
=550  \\$aStomach
=667  \\$afundo- refers to the gastric fundus; do not use /util except by MeSH definition
=680  \\$iMobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed)
=688  \\$a95
=750  \0$aFundoplication$5IEN-M$0(DLC)sh2001006293

=LDR  00978cz  a2200253n  4500
=001  9880363976102441
=005  20141212212740.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018699
=035  \\$aCSK5509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x880.$x180
=150  \\$aCoated Vesicles
=450  \\$wnnna$aCoated Vesicle
=450  \\$wnnna$aVesicle, Coated
=450  \\$wnnna$aVesicles, Coated
=550  \\$wg$aTransport Vesicles
=550  \\$wh$aCaveolae
=550  \\$wh$aClathrin-Coated Vesicles
=550  \\$wh$aCOP-Coated Vesicles
=667  \\$aGEN: prefer specifics
=680  \\$iVesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles are covered with a lattice-like network of coat proteins, such as CLATHRIN, coat protein complex proteins, or CAVEOLINS.
=688  \\$a95
=750  \0$aCoated vesicles$0(DLC) sh 85027501$5IEN-M

=LDR  01820cz  a2200457n  4500
=001  9880363976302441
=005  20141212192833.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018734
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791.$x295.$x305
=150  \\$aGenes, erbB-2
=450  \\$wnnna$ac-erbB-2 Gene
=450  \\$ac-erbB-2 Genes
=450  \\$wnnna$ac erbB 2 Genes
=450  \\$wnnna$ac-erbB-2 Proto-Oncogene
=450  \\$wnnna$ac-erbB-2 Proto-Oncogenes
=450  \\$wnnna$ac erbB 2 Proto Oncogenes
=450  \\$wnnna$aerbB-2 Gene
=450  \\$aerbB-2 Genes
=450  \\$wnnna$aerbB 2 Genes
=450  \\$wnnna$aerbb2 Gene
=450  \\$wnnna$aerbb2 Genes
=450  \\$wnnna$aGene, erbb2
=450  \\$wnnna$aGene, HER2
=450  \\$wnnna$aGenes, erbb2
=450  \\$aGenes, HER-2
=450  \\$wnnna$aGenes, HER2
=450  \\$aGenes, neu
=450  \\$wnnna$aHER-2 Gene
=450  \\$wnnna$aHER-2 Genes
=450  \\$wnnna$aHER2 Gene
=450  \\$wnnna$aHER2 Genes
=450  \\$wnnna$aneu Gene
=450  \\$wnnna$aneu Genes
=550  \\$wg$aGenes, erbB
=550  \\$aReceptor, ErbB-2
=667  \\$ain titles & translations spell as erbB-2; GENES, ERBB-1 is also available
=680  \\$iThe erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (RECEPTOR, ERBB-2), a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog (v-erbB) which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.
=688  \\$a95
=750  \0$aHER-2 gene$5IEN-M$0(DLC)sh 98002673

=LDR  00943cz  a2200229n  4500
=001  9880363976402441
=005  20141212212810.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018806
=035  \\$aCSK5497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x475.$x365
=150  \\$aAPACHE
=450  \\$aAcute Physiology and Chronic Health Evaluation
=450  \\$wnnna$aAPACHE I
=450  \\$wnnna$aAPACHE II
=450  \\$wnnna$aAPACHE III
=550  \\$wg$aHealth Status Indicators
=667  \\$aan acronym explained by X ref; no qualif
=680  \\$iAn acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.
=688  \\$a95
=750  \0$aAPACHE (Disease classification system)$5IEN-M$0(DLC)sh 86001621

=LDR  00801cz  a2200217n  4500
=001  9880363976502441
=005  20141212212728.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018667
=035  \\$aCSK5496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x750
=150  \\$aTilt-Table Test
=450  \\$wnnna$aTest, Tilt-Table
=450  \\$wnnna$aTilt Table Test
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$aHead-Down Tilt
=667  \\$acoordinate with HEAD-DOWN TILT if pertinent
=680  \\$iA standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. (From Braunwald, Heart Disease, 7th ed)
=688  \\$a95
=750  \0$aTilt table$5IEN-M$0(DLC)sh 85135379

=LDR  00748cz  a2200277n  4500
=001  9880363976602441
=005  20141212212749.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018737
=035  \\$aCSK5494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x425.$x500
=072  \\$aG11.$x427.$x560.$x500
=150  \\$aHand Strength
=450  \\$aGrasp
=450  \\$wnnna$aGrasps
=450  \\$aGrip
=450  \\$wnnna$aGrips
=450  \\$wnnna$aHand Strengths
=450  \\$wnnna$aStrength, Hand
=450  \\$wnnna$aStrengths, Hand
=550  \\$wg$aMuscle Strength
=550  \\$wh$aPinch Strength
=680  \\$iForce exerted when gripping or grasping.
=688  \\$a95
=750  \0$aGrip strength$5IEN-M$0(DLC)sh 88000120

=LDR  01816cz  a2200469n  4500
=001  9880363976702441
=005  20141212212730.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018671
=035  \\$aCSK5492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x827.$x708
=072  \\$aN2.$x421.$x726.$x708
=150  \\$aNeedle-Exchange Programs
=450  \\$wnnna$aCenter, Supervised Injecting
=450  \\$wnnna$aCenters, Supervised Injecting
=450  \\$wnnna$aFacilities, Supervised Injecting
=450  \\$wnnna$aFacility, Supervised Injecting
=450  \\$wnnna$aInjecting Center, Supervised
=450  \\$wnnna$aInjecting Centers, Supervised
=450  \\$wnnna$aInjecting Facilities, Supervised
=450  \\$wnnna$aInjecting Facility, Supervised
=450  \\$wnnna$aNeedle-Exchange Program
=450  \\$wnnna$aNeedle Exchange Programs
=450  \\$wnnna$aProgram, Needle-Exchange
=450  \\$wnnna$aProgram, Syringe-Exchange
=450  \\$wnnna$aPrograms, Needle-Exchange
=450  \\$wnnna$aPrograms, Syringe-Exchange
=450  \\$wnnna$aSupervised Injecting Center
=450  \\$aSupervised Injecting Centers
=450  \\$aSupervised Injecting Facilities
=450  \\$wnnna$aSupervised Injecting Facility
=450  \\$wnnna$aSyringe-Exchange Program
=450  \\$aSyringe-Exchange Programs
=450  \\$wnnna$aSyringe Exchange Programs
=550  \\$wg$aPreventive Health Services
=550  \\$aNeedle Sharing
=550  \\$aSubstance Abuse, Intravenous
=550  \\$aSubstance Abuse Treatment Centers
=680  \\$iOrganized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases.
=688  \\$a95
=750  \0$aNeedle exchange programs$5IEN-M$0(DLC)sh 92006702

=LDR  01596cz  a2200409n  4500
=001  9880363976802441
=005  20141212212711.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018613
=035  \\$aCSK5490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x395
=072  \\$aE5.$x595.$x395
=150  \\$aMicroscopy, Confocal
=450  \\$wnnna$aConfocal Laser Scanning Microscopy
=450  \\$wnnna$aConfocal Microscopies
=450  \\$aConfocal Microscopy
=450  \\$aConfocal Microscopy, Scanning Laser
=450  \\$wnnna$aLaser Microscopies
=450  \\$aLaser Microscopy
=450  \\$aLaser Scanning Confocal Microscopy
=450  \\$wnnna$aLaser Scanning Microscopies
=450  \\$aLaser Scanning Microscopy
=450  \\$wnnna$aMicroscopies, Confocal
=450  \\$wnnna$aMicroscopies, Laser
=450  \\$wnnna$aMicroscopies, Laser Scanning
=450  \\$aMicroscopy, Confocal, Laser Scanning
=450  \\$wnnna$aMicroscopy, Laser
=450  \\$wnnna$aMicroscopy, Laser Scanning
=450  \\$wnnna$aScanning Microscopies, Laser
=450  \\$wnnna$aScanning Microscopy, Laser
=550  \\$wg$aMicroscopy
=550  \\$wh$aLaser Scanning Cytometry
=667  \\$aNIM
=680  \\$iA light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible.
=688  \\$a95
=750  \0$aConfocal microscopy$5IEN-M$0(DLC)sh 90001543

=LDR  00647cz  a2200205n  4500
=001  9880363976902441
=005  20141212212718.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018634
=035  \\$aCSK5489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x905
=072  \\$aN2.$x360.$x905
=150  \\$aVeterinarians
=450  \\$wnnna$aVeterinarian
=550  \\$wg$aHealth Personnel
=667  \\$aIM
=680  \\$iIndividuals with a degree in veterinary medicine that provides them with training and qualifications to treat diseases and injuries of animals.
=688  \\$a95
=750  \0$aVeterinarians$5IEN-M$0(DLC)sh 85142999

=LDR  01161cz  a2200361n  4500
=001  9880363977002441
=005  20141212212620.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x325.$x400
=150  \\$aHomeless Youth
=450  \\$wnnna$aChild, Homeless
=450  \\$wnnna$aChild, Street
=450  \\$wnnna$aChildren, Homeless
=450  \\$wnnna$aChildren, Street
=450  \\$wnnna$aHomeless Child
=450  \\$aHomeless Children
=450  \\$wnnna$aHomeless Youths
=450  \\$wnnna$aRunaway
=450  \\$wnnna$aRunaways
=450  \\$wnnna$aStreet Child
=450  \\$aStreet Children
=450  \\$aStreet Youth
=450  \\$wnnna$aYouth, Homeless
=450  \\$wnnna$aYouth, Street
=450  \\$wnnna$aYouths, Homeless
=450  \\$wnnna$aYouths, Street
=550  \\$wg$aHomeless Persons
=667  \\$acheck the tag CHILD or specific age group; specify geog if pertinent
=680  \\$iRunaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence.
=688  \\$a95
=750  \0$aHomeless youth$5IEN-M$0(DLC)sh 86005962

=LDR  01056cz  a2200277n  4500
=001  9880363977102441
=005  20141212212702.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018585
=035  \\$aCSK5485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x975.$x155
=150  \\$aBattered Women
=450  \\$wnnna$aAbused Woman
=450  \\$aAbused Women
=450  \\$wnnna$aBattered Woman
=450  \\$wnnna$aWoman, Abused
=450  \\$wnnna$aWoman, Battered
=450  \\$aWomen, Abused
=450  \\$aWomen, Battered
=550  \\$wg$aWomen
=550  \\$aViolence
=667  \\$aprefer SPOUSE ABUSE for battering of wives; check tags HUMANS & FEMALE
=680  \\$iWomen who are physically and mentally abused over an extended period, usually by a husband or other dominant male figure. Characteristics of the battered woman syndrome are helplessness, constant fear, and a perceived inability to escape. (From American Heritage Dictionary of the English Language, 3d ed)
=688  \\$a95
=750  \0$aAbused women$5IEN-M$0(DLC)sh 86001790

=LDR  01248cz  a2200253n  4500
=001  9880363977202441
=005  20141212212756.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018763
=035  \\$aCSK5484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x550
=150  \\$aMuscle Fatigue
=450  \\$aFatigue, Muscle
=450  \\$wnnna$aFatigue, Muscular
=450  \\$wnnna$aMuscular Fatigue
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$aMuscle Contraction
=667  \\$anote category
=680  \\$iA state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle.
=688  \\$a95
=750  \0$81$wb$aMuscles$5IEN-M$0(DLC)sh 85088687
=750  \0$81$wb$aFatigue$5IEN-HS$0(DLC)sh 85047465
=788  \0$iSearch also under the following headings used together in the same record:$aMuscles$iand$aFatigue$5IEN-M

=LDR  01376cz  a2200277n  4500
=001  9880363977302441
=005  20190314153443.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018441
=035  \\$aCSK5483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA20.$x593
=072  \\$aG6.$x120
=150  \\$aBiofilms
=450  \\$wnnna$aBiofilm
=550  \\$wg$aBacterial Structures
=550  \\$wg$aMicrobiological Phenomena
=550  \\$wh$aExtracellular Polymeric Substance Matrix
=550  \\$aAdhesins, Bacterial
=550  \\$aBiofouling
=550  \\$aDental Deposits
=550  \\$aProsthesis-Related Infections
=667  \\$acoordinate IM with specific organism /physiol (IM); occurrence of biofilms on prostheses or other devices: coordinate IM with specific device (IM); infection of prostheses by biofilms: coordinate BIOFILMS (IM) with specific prosthesis (IM) + PROSTHESIS-RELATED INFECTIONS (IM) + specific infection (IM)
=680  \\$iEncrustations, formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedding in extracellular polymers, that adhere to surfaces such as teeth (DENTAL DEPOSITS); PROSTHESES AND IMPLANTS; and catheters. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and antifouling agents.
=688  \\$a95
=750  \0$aBiofilms$5IEN-M$0(DLC)sh 89001286

=LDR  02268cz  a2200493n  4500
=001  9880363977402441
=005  20141212212705.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018592
=035  \\$aCSK5479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x780.$x150
=072  \\$aN5.$x715.$x360.$x780.$x150
=072  \\$aN6.$x850.$x520.$x445.$x150
=150  \\$aCross-Over Studies
=450  \\$wnnna$aCross-Over Design
=450  \\$wnnna$aCross Over Design
=450  \\$wnnna$aCross-Over Designs
=450  \\$wnnna$aCross Over Studies
=450  \\$wnnna$aCross-Over Study
=450  \\$wnnna$aCross-Over Trials
=450  \\$wnnna$aCross Over Trials
=450  \\$wnnna$aCrossover Design
=450  \\$wnnna$aCrossover Designs
=450  \\$wnnna$aCrossover Studies
=450  \\$wnnna$aCrossover Study
=450  \\$wnnna$aCrossover Trials
=450  \\$wnnna$aDesign, Cross-Over
=450  \\$wnnna$aDesign, Crossover
=450  \\$wnnna$aDesigns, Cross-Over
=450  \\$wnnna$aDesigns, Crossover
=450  \\$wnnna$aStudies, Cross-Over
=450  \\$wnnna$aStudies, Crossover
=450  \\$wnnna$aStudy, Cross-Over
=450  \\$wnnna$aStudy, Crossover
=450  \\$wnnna$aTrial, Cross-Over
=450  \\$wnnna$aTrial, Crossover
=450  \\$wnnna$aTrials, Cross-Over
=450  \\$wnnna$aTrials, Crossover
=550  \\$wg$aEpidemiologic Research Design
=667  \\$ausually drug or other ther study; IM GEN only; coord NIM with specific ther (IM); coord NIM also with any other study design such as RANDOM ALLOCATION; DOUBLE-BLIND METHOD; etc. (NIM); when pertinent add CLINICAL TRIAL (PT) or RANDOMIZED CONTROLLED TRIAL (PT); no qualif
=680  \\$iStudies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
=688  \\$a95
=750  \0$aCrossover trials$5IEN-M$0(DLC)sh 89001948

=LDR  01148cz  a2200253n  4500
=001  9880363977502441
=005  20141212212809.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018804
=035  \\$aCSK5478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x147.$x420.$x380
=072  \\$aC8.$x618.$x846.$x450
=150  \\$aHantavirus Pulmonary Syndrome
=450  \\$wnnna$aHantavirus-Associated Respiratory Distress Syndrome
=450  \\$wnnna$aHantavirus Associated Respiratory Distress Syndrome
=450  \\$wnnna$aHantavirus Pulmonary Syndromes
=450  \\$wnnna$aHARDS
=550  \\$wg$aHantavirus Infections
=550  \\$wg$aRespiratory Insufficiency
=667  \\$acauses resp failure; DF: HANTAVIRUS PULM SYNDROME
=680  \\$iAcute respiratory illness in humans caused by the Muerto Canyon virus whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.
=688  \\$a95
=750  \0$aHantavirus pulmonary syndrome$0(DLC) sh2005006237$5IEN-M

=LDR  01028cz  a2200229n  4500
=001  9880363977602441
=005  20141212212800.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018778
=035  \\$aCSK5477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x147.$x420
=150  \\$aHantavirus Infections
=450  \\$wnnna$aHantavirus Infection
=450  \\$wnnna$aInfections, Hantavirus
=550  \\$wg$aBunyaviridae Infections
=550  \\$wh$aHantavirus Pulmonary Syndrome
=550  \\$wh$aHemorrhagic Fever with Renal Syndrome
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iInfections with viruses of the genus HANTAVIRUS. This is associated with at least four clinical syndromes: HEMORRHAGIC FEVER WITH RENAL SYNDROME caused by viruses of the Hantaan group; a milder form of HFRS caused by SEOUL VIRUS; nephropathia epidemica caused by PUUMALA VIRUS; and HANTAVIRUS PULMONARY SYNDROME caused by SIN NOMBRE VIRUS.
=688  \\$a95
=750  \0$aHantavirus infections$5IEN-M$0(DLC)sh 96009073

=LDR  01334cz  a2200361n  4500
=001  9880363977702441
=005  20141212192816.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018565
=035  \\$aCSK5476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x240.$x511
=072  \\$aG7.$x700.$x680.$x240.$x511
=150  \\$aFood-Drug Interactions
=450  \\$wnnna$aDrug-Food Interaction
=450  \\$aDrug-Food Interactions
=450  \\$wnnna$aDrug Food Interactions
=450  \\$wnnna$aFood-Drug Interaction
=450  \\$wnnna$aFood Drug Interactions
=450  \\$wnnna$aFood Interaction
=450  \\$aFood Interactions
=450  \\$wnnna$aInteraction, Drug-Food
=450  \\$wnnna$aInteraction, Food
=450  \\$wnnna$aInteraction, Food-Drug
=450  \\$wnnna$aInteractions, Drug-Food
=450  \\$wnnna$aInteractions, Food
=450  \\$wnnna$aInteractions, Food-Drug
=550  \\$wg$aDrug Interactions
=550  \\$aMetabolic Side Effects of Drugs and Substances
=667  \\$aIM; coord with specific food (IM) + specific drug (IM) with pertinent qualif
=680  \\$iThe pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed)
=688  \\$a95
=750  \0$aDrug-nutrient interactions$5IEN-M$0(DLC)sh 85039702

=LDR  01231cz  a2200337n  4500
=001  9880363977802441
=005  20141212212613.0
=008  940421\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018427
=035  \\$aCSK5474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x140
=150  \\$aBreast Implants
=450  \\$wnnna$aBreast Implant
=450  \\$wnnna$aBreast Prostheses, Internal
=450  \\$aBreast Prosthesis, Internal
=450  \\$wnnna$aImplant, Breast
=450  \\$aImplants, Breast
=450  \\$wnnna$aInternal Breast Prostheses
=450  \\$wnnna$aInternal Breast Prosthesis
=450  \\$wnnna$aProstheses, Internal Breast
=450  \\$wnnna$aProsthesis, Internal Breast
=550  \\$wg$aProstheses and Implants
=550  \\$aBreast Implantation
=550  \\$aMammaplasty
=550  \\$aSilicone Elastomers
=550  \\$aSilicone Gels
=667  \\$aIM; coord with implant material (IM or NIM)
=680  \\$iImplants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured.
=688  \\$a95
=750  \2$aBreast implants$5IEN-M

=LDR  01108cz  a2200277n  4500
=001  9880363977902441
=005  20141212212751.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018743
=035  \\$aCSK5473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x703
=072  \\$aN2.$x421.$x88.$x120.$x180
=072  \\$aN2.$x421.$x143.$x620.$x550
=072  \\$aN2.$x421.$x585.$x703
=150  \\$aPerinatal Care
=450  \\$wnnna$aCare, Perinatal
=550  \\$wg$aInfant Care
=550  \\$wg$aMaternal Health Services
=550  \\$wg$aPatient Care
=550  \\$wh$aPostnatal Care
=550  \\$aPerinatology
=667  \\$afrom 28th wk of pregn through 7 days after birth; care of fetus & neonate: differentiate from PRENATAL CARE & POSTNATAL CARE which are care of the mother; check the tags FEMALE & PREGNANCY & INFANT, NEWBORN if relevant
=680  \\$iThe care of women and a fetus or newborn given before, during, and after delivery from the 28th week of gestation through the 7th day after delivery.
=688  \\$a95
=750  \0$aNewborn infants$xMedical care$5IEN-M$0(DLC)sh 92004388

=LDR  01462cz  a2200349n  4500
=001  9880363978002441
=005  20141212212715.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018625
=035  \\$aCSK5467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x666.$x400
=072  \\$aE5.$x595.$x666.$x400
=150  \\$aMicroscopy, Atomic Force
=450  \\$wnnna$aAtomic Force Microscopies
=450  \\$aAtomic Force Microscopy
=450  \\$wnnna$aForce Microscopies
=450  \\$wnnna$aForce Microscopies, Scanning
=450  \\$aForce Microscopy
=450  \\$wnnna$aForce Microscopy, Scanning
=450  \\$wnnna$aMicroscopies, Atomic Force
=450  \\$wnnna$aMicroscopies, Force
=450  \\$wnnna$aMicroscopies, Scanning Force
=450  \\$wnnna$aMicroscopy, Force
=450  \\$wnnna$aMicroscopy, Scanning Force
=450  \\$wnnna$aScanning Force Microscopies
=450  \\$aScanning Force Microscopy
=550  \\$wg$aMicroscopy, Scanning Probe
=550  \\$aMicroscopy, Scanning Tunneling
=680  \\$iA type of scanning probe microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. These deflections produce a topographic map of the sample.
=688  \\$a95
=750  \0$aAtomic force microscopy$5IEN-M$0(DLC)sh 94008704

=LDR  01127cz  a2200289n  4500
=001  9880363978102441
=005  20141212212722.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018649
=035  \\$aCSK5465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x647.$x500
=150  \\$aOcimum basilicum
=450  \\$aBasil
=450  \\$wnnna$aBasil, Sweet
=450  \\$wnnna$abasilicum, Ocimum
=450  \\$wnnna$abasilicums, Ocimum
=450  \\$wnnna$aBasils
=450  \\$wnnna$aBasils, Sweet
=450  \\$wnnna$aOcimum basilicums
=450  \\$aSweet Basil
=450  \\$wnnna$aSweet Basils
=550  \\$wg$aOcimum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus OCIMUM, family LAMIACEAE. It is a condiment with carminative properties.
=688  \\$a2003(1995)
=750  \0$aBasil$5IEN-M$0(DLC)sh 85012089

=LDR  00790cz  a2200181n  4500
=001  9880363978202441
=005  20141212212721.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x840.$x109
=072  \\$aD20.$x215.$x721.$x500.$x109
=150  \\$aAmber
=550  \\$wg$aResins, Plant
=667  \\$aa resin; do not confuse with AMBER (Advanced Multiple Beam Equalization Radiography) or amber codon or amber suppressor; D25-26 qualif
=680  \\$iA yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber.
=688  \\$a95
=750  \0$aAmber$5IEN-M$0(DLC)sh 85004143

=LDR  01168cz  a2200301n  4500
=001  9880363978302441
=005  20141212212657.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018574
=035  \\$aCSK5462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x483
=150  \\$aHome Care Agencies
=450  \\$wnnna$aAgencies, Home Care
=450  \\$wnnna$aAgencies, Home Health
=450  \\$wnnna$aAgency, Home Care
=450  \\$wnnna$aAgency, Home Health
=450  \\$wnnna$aCare Agencies, Home
=450  \\$wnnna$aCare Agency, Home
=450  \\$wnnna$aHome Care Agency
=450  \\$aHome Health Agencies
=450  \\$wnnna$aHome Health Agency
=450  \\$aHome Health Care Agencies
=550  \\$wg$aOrganizations
=667  \\$apublic or private agencies; coord IM with specific home care (IM)
=680  \\$iPublic or private organizations that provide, either directly or through arrangements with other organizations, home health services in the patient's home. (Hospital Administration Terminology, 2d ed)
=688  \\$a95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94
=750  \0$aHome care services$5IEN-M$0(DLC)sh 85061666

=LDR  00842cz  a2200229n  4500
=001  9880363978402441
=005  20141212212707.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018599
=035  \\$aCSK5461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x901.$x968
=072  \\$aI1.$x76.$x201.$x450.$x897.$x439.$x925
=150  \\$aWitchcraft
=450  \\$wnnna$aSorceries
=450  \\$aSorcery
=550  \\$wg$aMagic
=550  \\$wg$aSpiritual Therapies
=667  \\$aIM; MAGIC is also available
=680  \\$iAn act of employing sorcery (the use of power gained from the assistance or control of spirits), especially with malevolent intent, and the exercise of supernatural powers and alleged intercourse with the devil or a familiar. (From Webster, 3d ed)
=688  \\$a95
=750  \0$aWitchcraft$5IEN-M$0(DLC)sh 85147143

=LDR  00836cz  a2200217n  4500
=001  9880363978502441
=005  20141212212707.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018600
=035  \\$aCSK5460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x529.$x500
=072  \\$aH1.$x158.$x273.$x200.$x350.$x500
=150  \\$aTeratology
=450  \\$wnnna$aTeratologies
=550  \\$wg$aEmbryology
=550  \\$aTeratogenesis
=667  \\$athe discipline only (education, history, etc); corresponding disease term is CONGENITAL ABNORMALITIES or specifics; for "monsters" in the historical literature, use ABNORMALITIES, SEVERE TERATOID
=680  \\$iA branch of embryology for the study of congenital malformations and developmental abnormalities.
=688  \\$a95
=750  \0$aTeratology$5IEN-M$0(DLC)sh 94009175

=LDR  01604cz  a2200325n  4500
=001  9880363978602441
=005  20141212212708.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018605
=035  \\$aCSK5459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x149.$x767.$x830
=072  \\$aG2.$x842.$x750.$x830
=072  \\$aN6.$x230.$x216.$x750
=150  \\$aSpontaneous Combustion
=450  \\$wnnna$aCombustibilities, Preternatural Human
=450  \\$wnnna$aCombustibility, Preternatural Human
=450  \\$wnnna$aCombustion, Spontaneous
=450  \\$wnnna$aCombustions, Spontaneous
=450  \\$wnnna$aHuman Combustibilities, Preternatural
=450  \\$wnnna$aHuman Combustibility, Preternatural
=450  \\$wnnna$aPreternatural Human Combustibilities
=450  \\$aPreternatural Human Combustibility
=450  \\$wnnna$aSpontaneous Combustions
=550  \\$wg$aFires
=550  \\$wg$aPhysicochemical Processes
=667  \\$amaterial or human: read MeSH definition; only /hist
=680  \\$iA circumstance where a substance or organism takes fire and burns without an exogenous source. Spontaneous human combustion differs from preternatural human combustibility in that in the latter, some spark or trivial flame sets the fire and the body tissues, which have a greatly enhanced inflammability, continue to undergo incineration without any external heat source or combustible materials. (Bergman NA. Spontaneous human combustion: its role in literature and science. Pharos 1988;Fall;51(4):18-21)
=688  \\$a95
=750  \0$aCombustion, Spontaneous$5IEN-M$0(DLC)sh 85028834

=LDR  01719cz  a2200301n  4500
=001  9880363978702441
=005  20141212212800.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018780
=035  \\$aCSK5453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x240.$x100
=072  \\$aE1.$x370.$x370.$x380.$x240.$x850.$x100
=072  \\$aE1.$x370.$x405.$x240.$x100
=072  \\$aE1.$x370.$x405.$x240.$x850.$x100
=150  \\$aBody Surface Potential Mapping
=450  \\$aBody Surface Mapping
=450  \\$wnnna$aBody Surface Mappings
=450  \\$wnnna$aMapping, Body Surface
=450  \\$wnnna$aMappings, Body Surface
=450  \\$wnnna$aSurface Mapping, Body
=450  \\$wnnna$aSurface Mappings, Body
=550  \\$wg$aElectrocardiography
=550  \\$wg$aVectorcardiography
=667  \\$aan ECG & vectorcardiogr technique: do not confuse with BODY SURFACE AREA, an anthropometric method
=680  \\$iRecording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed)
=688  \\$a95
=750  \0$aBody surface mapping$5IEN-M$0(DLC)sh 85015254

=LDR  00656cz  a2200181n  4500
=001  9880363978802441
=005  20141212212721.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018646
=035  \\$aCSK5449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x100.$x100
=150  \\$aAbsinthe
=550  \\$wg$aAlcoholic Beverages
=667  \\$aan alcoholic beverage
=680  \\$iAn extract of absinthium and other bitter herbs, containing 60% alcohol. Prolonged ingestion causes nervousness, convulsions, trismus, amblyopia, optic neuritis, and mental deterioration. (Dorland, 27th ed)
=688  \\$a95
=750  \0$aAbsinthe$5IEN-M$0(DLC)sh 85000238

=LDR  01284cz  a2200289n  4500
=001  9880363978902441
=005  20190501105815.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018028
=035  \\$aCRE6958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x550
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x560
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x560
=150  \\$aReceptors, Neurotensin
=450  \\$wnnna$aNeurotensin Receptor
=450  \\$aNeurotensin Receptors
=450  \\$wnnna$aReceptor, Neurotensin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$aNeurotensin
=667  \\$aDF: RECEPT NEUROTENSIN
=680  \\$iCell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behavior of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery.
=688  \\$a94; was NEUROTENSIN RECEPTOR (NM) 1980-93
=750  \0$81$wb$iBroader mapping$aNeurotensin$0(DLC)sh 85091178$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNeurotensin--Receptors$5IEN-M

=LDR  01320cz  a2200277n  4500
=001  9880363979002441
=005  20190503154828.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018027
=035  \\$aCRE6957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x330
=072  \\$aD12.$x776.$x543.$x750.$x750.$x580.$x350
=150  \\$aReceptors, Glucagon
=450  \\$wnnna$aGlucagon Receptor
=450  \\$aGlucagon Receptors
=450  \\$wnnna$aReceptor, Glucagon
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Pancreatic Hormone
=550  \\$aGlucagon
=667  \\$aDF: RECEPT GLUCAGON
=680  \\$iCell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.
=688  \\$a94; was GLUCAGON RECEPTOR (NM) 1980-93
=750  \0$81$wb$iBroader mapping$aGlucagon$0(DLC)sh 85055353$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGlucagon--Receptors$5IEN-M

=LDR  01980cz  a2200421n  4500
=001  9880363979102441
=005  20190507155556.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018025
=035  \\$aCRE6955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x860
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x860
=072  \\$aD12.$x776.$x543.$x750.$x750.$x700.$x840
=150  \\$aReceptors, Thyrotropin-Releasing Hormone
=450  \\$wnnna$aProtirelin Receptor
=450  \\$aProtirelin Receptors
=450  \\$wnnna$aReceptor, Protirelin
=450  \\$wnnna$aReceptor, TRH
=450  \\$aReceptors, Protirelin
=450  \\$aReceptors, Thyroliberin
=450  \\$wnnna$aReceptors, Thyrotropin Releasing Hormone
=450  \\$aReceptors, TRH
=450  \\$aThyroliberin Receptors
=450  \\$wnnna$aThyrotropin Releasing Hormone Receptor
=450  \\$aThyrotropin Releasing Hormone Receptors
=450  \\$wnnna$aThyrotropin-Releasing Hormone Receptors
=450  \\$wnnna$aTRH Receptor
=450  \\$aTRH Receptors
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone-Regulating Hormone
=550  \\$aThyrotropin-Releasing Hormone
=667  \\$aDF: RECEPT TRH
=680  \\$iCell surface receptors that bind thyrotropin releasing hormone (TRH) with high affinity and trigger intracellular changes which influence the behavior of cells. Activated TRH receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, TSH); TRH receptors on neurons mediate neurotransmission by TRH.
=688  \\$a94; was THYROTROPIN RELEASING HORMONE RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aThyrotropin releasing factor$0(DLC)sh 85135181$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThyrotropin releasing factor--Receptors$5IEN-M

=LDR  00689cz  a2200217n  4500
=001  9880363979202441
=005  20141212212358.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018021
=035  \\$aCRE6951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150.$x450
=072  \\$aD1.$x510.$x500
=150  \\$aLithium Chloride
=450  \\$wnnna$aChloride, Lithium
=550  \\$wg$aChlorides
=550  \\$wg$aLithium Compounds
=667  \\$ain exper med as immunomodulator
=680  \\$iA salt of lithium that has been used experimentally as an immunomodulator.
=688  \\$a94; was LITHIUM CHLORIDE (NM) 1977-93
=750  \0$aLithium chloride$5IEN-M$0(DLC)sh 85077583

=LDR  00706cz  a2200229n  4500
=001  9880363979302441
=005  20141212212358.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018020
=035  \\$aCRE6950M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x510
=150  \\$aLithium Compounds
=450  \\$wnnna$aCompounds, Lithium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aLithium Carbonate
=550  \\$wh$aLithium Chloride
=550  \\$aLithium
=667  \\$atherapeutic use of lithium = LITHIUM COMPOUNDS/ ther use
=680  \\$iInorganic compounds that contain lithium as an integral part of the molecule.
=688  \\$a94
=750  \0$aLithium compounds$5IEN-M$0(DLC)sh 98005205

=LDR  02581cz  a2200445n  4500
=001  9880363979502441
=005  20190506112702.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018017
=035  \\$aCRE6947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x700
=150  \\$aReceptors, Pituitary Hormone-Regulating Hormone
=450  \\$aHypothalamic Release-Inhibiting Hormone Receptors
=450  \\$wnnna$aHypothalamic Release Inhibiting Hormone Receptors
=450  \\$aHypothalamic Releasing Hormone Receptors
=450  \\$aPituitary Hormone-Regulating Hormone Receptors
=450  \\$wnnna$aPituitary Hormone Regulating Hormone Receptors
=450  \\$aPituitary Hormone-Releasing Hormone Receptors
=450  \\$wnnna$aPituitary Hormone Releasing Hormone Receptors
=450  \\$aReceptors, Hypothalamic Release-Inhibiting Hormones
=450  \\$wnnna$aReceptors, Hypothalamic Release Inhibiting Hormones
=450  \\$aReceptors, Hypothalamic Releasing Hormones
=450  \\$wnnna$aReceptors, Pituitary Hormone Regulating Hormone
=450  \\$aReceptors, Pituitary Hormone Release Inhibiting Hormones
=450  \\$aReceptors, Pituitary Hormone-Releasing Hormone
=450  \\$wnnna$aReceptors, Pituitary Hormone Releasing Hormone
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aReceptors, Corticotropin-Releasing Hormone
=550  \\$wh$aReceptors, LHRH
=550  \\$wh$aReceptors, Somatostatin
=550  \\$wh$aReceptors, Thyrotropin-Releasing Hormone
=550  \\$aPituitary Hormone Release Inhibiting Hormones
=550  \\$aPituitary Hormone-Releasing Hormones
=667  \\$aDF: RECEPT PHRH
=680  \\$iCell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aPituitary hormone releasing factors$0(DLC)sh 85102528$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aPituitary hormone releasing factors-Receptors$5IEN-M

=LDR  01401cz  a2200277n  4500
=001  9880363979602441
=005  20190502114632.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018016
=035  \\$aCRE6946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x650
=072  \\$aD12.$x776.$x543.$x750.$x750.$x600
=150  \\$aReceptors, Parathyroid Hormone
=450  \\$aParathyroid Hormone Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aReceptor, Parathyroid Hormone, Type 1
=550  \\$wh$aReceptor, Parathyroid Hormone, Type 2
=550  \\$aParathyroid Hormone-Related Protein
=667  \\$aGEN or unspecified; prefer specifics; DF: RECEPT PARATHYROID HORMONE
=680  \\$iCell surface proteins that bind PARATHYROID HORMONE with high affinity and trigger intracellular changes which influence the behavior of cells. Parathyroid hormone receptors on BONE; KIDNEY; and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis.
=688  \\$a94; was PARATHYROID HORMONE RECEPTOR (NM) 1980-93
=750  \0$81$wb$iBroader mapping$aParathyroid hormone$0(DLC)sh 85097938$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aParathyroid hormone--Receptors$5IEN-M

=LDR  01774cz  a2200337n  4500
=001  9880363979702441
=005  20190422150741.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018015
=035  \\$aCRE6945HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x105
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x260
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x260
=150  \\$aReceptors, Calcitonin Gene-Related Peptide
=450  \\$wnnna$aCalcitonin-Gene Related Peptide Receptor
=450  \\$wnnna$aCalcitonin Gene Related Peptide Receptor
=450  \\$aCalcitonin Gene-Related Peptide Receptors
=450  \\$wnnna$aCalcitonin Gene Related Peptide Receptors
=450  \\$wnnna$aCGRP Receptor
=450  \\$aCGRP Receptors
=450  \\$wnnna$aReceptors, Calcitonin Gene Related Peptide
=450  \\$aReceptors, CGRP
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$aCalcitonin Gene-Related Peptide
=680  \\$iCell surface proteins that bind CALCITONIN GENE-RELATED PEPTIDE with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the CENTRAL NERVOUS SYSTEM and the periphery. They are formed via the heterodimerization of the CALCITONIN RECEPTOR-LIKE PROTEIN and RECEPTOR ACTIVITY-MODIFYING PROTEIN 1.
=688  \\$a94; CALCITONIN GENE-RELATED PEPTIDE RECEPTOR was SY to CALCITONIN RECEPTOR (NM) 1986-93
=750  \0$81$wb$iBroader mapping$aCalcitonin gene-related peptide$0(DLC)sh 92001843$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCalcitonin gene-related peptide$5IEN-M

=LDR  02284cz  a2200577n  4500
=001  9880363979802441
=005  20190501103059.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018013
=035  \\$aCRE6943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555
=150  \\$aReceptors, Neuropeptide
=450  \\$wnnna$aNeuropeptide Receptor
=450  \\$aNeuropeptide Receptors
=450  \\$wnnna$aNeuropeptides Receptors
=450  \\$wnnna$aReceptor, Neuropeptide
=450  \\$wnnna$aReceptors, Neuropeptides
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aOrexin Receptors
=550  \\$wh$aReceptors, Bombesin
=550  \\$wh$aReceptors, Bradykinin
=550  \\$wh$aReceptors, Calcitonin Gene-Related Peptide
=550  \\$wh$aReceptors, Cholecystokinin
=550  \\$wh$aReceptors, Corticotropin
=550  \\$wh$aReceptors, Corticotropin-Releasing Hormone
=550  \\$wh$aReceptors, FSH
=550  \\$wh$aReceptors, Galanin
=550  \\$wh$aReceptors, LH
=550  \\$wh$aReceptors, LHRH
=550  \\$wh$aReceptors, Neuropeptide Y
=550  \\$wh$aReceptors, Neurotensin
=550  \\$wh$aReceptors, Opioid
=550  \\$wh$aReceptors, Oxytocin
=550  \\$wh$aReceptors, Prolactin
=550  \\$wh$aReceptors, Somatostatin
=550  \\$wh$aReceptors, Somatotropin
=550  \\$wh$aReceptors, Tachykinin
=550  \\$wh$aReceptors, Thyrotropin
=550  \\$wh$aReceptors, Thyrotropin-Releasing Hormone
=550  \\$wh$aReceptors, Vasoactive Intestinal Peptide
=550  \\$wh$aReceptors, Vasopressin
=550  \\$aNeuropeptides
=667  \\$aGEN; prefer specifics; DF: RECEPT NEUROPEPTIDE
=680  \\$iCell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aNeuropeptides$0(DLC)sh 85091156$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNeuropeptides--Receptors$5IEN-M

=LDR  00783cz  a2200265n  4500
=001  9880363979902441
=005  20141212212354.0
=008  930826\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018011
=035  \\$aCRE6942M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185
=150  \\$aChalcogens
=450  \\$wnnna$aElements, Group 16
=450  \\$wnnna$aGroup 16 Elements
=550  \\$wg$aElements
=550  \\$wh$aOxygen
=550  \\$wh$aPolonium
=550  \\$wh$aSelenium
=550  \\$wh$aSulfur
=550  \\$wh$aTellurium
=667  \\$aGEN; prefer specifics
=680  \\$iThe elements OXYGEN; POLONIUM; SELENIUM; SULFUR; and TELLURIUM; that form group 16 (formerly group VI) of the periodic table.
=688  \\$a1998
=750  \0$aChalcogens$5IEN-M$0(DLC)sh2002008811

=LDR  01633cz  a2200361n  4500
=001  9880363980002441
=005  20190506102548.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018009
=035  \\$aCRE6940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x175.$x781
=072  \\$aD12.$x776.$x157.$x530.$x400.$x400.$x100.$x200
=072  \\$aD12.$x776.$x543.$x550.$x450.$x175.$x781
=072  \\$aD12.$x776.$x543.$x550.$x450.$x500.$x100.$x200
=072  \\$aD12.$x776.$x543.$x585.$x400.$x175.$x781
=072  \\$aD12.$x776.$x543.$x585.$x400.$x500.$x100.$x200
=072  \\$aD12.$x776.$x543.$x750.$x130.$x625
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x470
=150  \\$aReceptors, Glycine
=450  \\$wnnna$aGlycine Receptor
=450  \\$aGlycine Receptors
=450  \\$wnnna$aReceptor, Glycine
=550  \\$wg$aChloride Channels
=550  \\$wg$aCysteine Loop Ligand-Gated Ion Channel Receptors
=550  \\$wg$aReceptors, Amino Acid
=550  \\$aGlycine
=550  \\$aGlycine Plasma Membrane Transport Proteins
=680  \\$iCell surface receptors that bind GLYCINE with high affinity and trigger intracellular changes which influence the behavior of cells. Glycine receptors in the CENTRAL NERVOUS SYSTEM have an intrinsic chloride channel and are usually inhibitory.
=688  \\$a94; was GLYCINE RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aGlycine$0(DLC)sh 85055394$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGlycine--Receptors$5IEN-M

=LDR  01622cz  a2200361n  4500
=001  9880363980102441
=005  20190507164645.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018005
=035  \\$aCRE6937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x900
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x915
=072  \\$aD12.$x776.$x543.$x750.$x750.$x360.$x900
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x915
=150  \\$aReceptors, Vasoactive Intestinal Peptide
=450  \\$wnnna$aReceptor, VIP
=450  \\$aReceptors, VIP
=450  \\$wnnna$aVasoactive Intestinal Peptide Receptor
=450  \\$aVasoactive Intestinal Peptide Receptors
=450  \\$wnnna$aVIP Receptor
=450  \\$aVIP Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Gastrointestinal Hormone
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptors, Vasoactive Intestinal Peptide, Type II
=550  \\$wh$aReceptors, Vasoactive Intestinal Polypeptide, Type I
=667  \\$aDF: RECEPT VIP
=680  \\$iCell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; (VIP); with high affinity and trigger intracellular changes which influence the behavior of cells.
=688  \\$a94; was VASOACTIVE INTESTINAL PEPTIDE RECEPTOR (NM) 1980-93
=750  \0$81$wb$iBroader mapping$aVasoactive intestinal peptide$0(DLC)sh 85142400$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aVasoactive intestinal peptide--Receptors$5IEN-M

=LDR  02121cz  a2200469n  4500
=001  9880363980202441
=005  20190422141441.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018004
=035  \\$aCRE6936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x70
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x200
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x200
=150  \\$aReceptors, Bombesin
=450  \\$wnnna$aB Receptor, Neuromedin
=450  \\$wnnna$aB Receptors, Neuromedin
=450  \\$wnnna$aBombesin Receptor
=450  \\$aBombesin Receptors
=450  \\$wnnna$aGastrin-Releasing Peptide Receptor
=450  \\$wnnna$aGastrin Releasing Peptide Receptor
=450  \\$aGastrin-Releasing Peptide Receptors
=450  \\$wnnna$aGastrin Releasing Peptide Receptors
=450  \\$wnnna$aNeuromedin B Receptor
=450  \\$aNeuromedin B Receptors
=450  \\$wnnna$aPeptide Receptor, Gastrin-Releasing
=450  \\$wnnna$aPeptide Receptors, Gastrin-Releasing
=450  \\$wnnna$aReceptor, Bombesin
=450  \\$wnnna$aReceptor, Gastrin-Releasing Peptide
=450  \\$wnnna$aReceptor, Neuromedin B
=450  \\$aReceptors, Gastrin-Releasing Peptide
=450  \\$wnnna$aReceptors, Gastrin Releasing Peptide
=450  \\$aReceptors, Neuromedin B
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$aBombesin
=667  \\$aDF: RECEPT BOMBESIN
=680  \\$iCell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide (GRP); GRP 18-27 (neuromedin C), and neuromedin B are endogenous ligands of bombesin receptors in mammals.
=688  \\$a94; was BOMBESIN RECEPTOR (NM) 1982-93; NEUROMEDIN B RECEPTOR was (NM) 1992-93
=750  \0$81$wb$iBroader mapping$aBombesin$0(DLC)sh 88007757$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aBombesin--Receptors$5IEN-M

=LDR  01261cz  a2200277n  4500
=001  9880363980302441
=005  20190422151858.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018003
=035  \\$aCRE6935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x100
=072  \\$aD12.$x776.$x543.$x750.$x750.$x200
=150  \\$aReceptors, Calcitonin
=450  \\$wnnna$aCalcitonin Receptor
=450  \\$aCalcitonin Receptors
=450  \\$wnnna$aReceptor, Calcitonin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$aCalcitonin
=667  \\$aDF: RECEPT CALCITONIN
=680  \\$iCell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.
=688  \\$a94; was CALCITONIN RECEPTOR (NM) 1981-93
=750  \0$81$wb$iBroader mapping$aCalcitonin$0(DLC)sh 85018767$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCalcitonin--Receptors$5IEN-M

=LDR  01441cz  a2200313n  4500
=001  9880363980402441
=005  20190422145821.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018002
=035  \\$aCRE6934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x80
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x220
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x220
=150  \\$aReceptors, Bradykinin
=450  \\$wnnna$aBradykinin Receptor
=450  \\$aBradykinin Receptors
=450  \\$wnnna$aReceptor, Bradykinin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptor, Bradykinin B1
=550  \\$wh$aReceptor, Bradykinin B2
=550  \\$aBradykinin
=667  \\$anote specific subtypes
=680  \\$iCell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types (B-1 and B-2, or BK-1 and BK-2) recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself.
=688  \\$a94; was KININ RECEPTOR (NM) 1980-93
=750  \0$81$wb$iBroader mapping$aBradykinin$0(DLC)sh 85016289$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aBradykinin--Receptors$5IEN-M

=LDR  02165cz  a2200565n  4500
=001  9880363980502441
=005  20200619121049.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018000
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750
=150  \\$aReceptors, Peptide
=450  \\$wnnna$aHormone Receptor, Peptide
=450  \\$wnnna$aHormone Receptors, Peptide
=450  \\$wnnna$aHormones Receptors, Peptide
=450  \\$wnnna$aPeptide Hormone Receptor
=450  \\$aPeptide Hormone Receptors
=450  \\$wnnna$aPeptide Hormones Receptors
=450  \\$wnnna$aPeptide Receptor
=450  \\$aPeptide Receptors
=450  \\$wnnna$aPeptides Receptors
=450  \\$wnnna$aReceptor, Peptide
=450  \\$wnnna$aReceptor, Peptide Hormone
=450  \\$wnnna$aReceptors, Peptide Hormone
=450  \\$wnnna$aReceptors, Peptide Hormones
=450  \\$wnnna$aReceptors, Peptides
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aReceptors, Adrenomedullin
=550  \\$wh$aReceptors, Albumin
=550  \\$wh$aReceptors, Angiotensin
=550  \\$wh$aReceptors, Atrial Natriuretic Factor
=550  \\$wh$aReceptors, Calcitonin
=550  \\$wh$aReceptors, Endothelin
=550  \\$wh$aReceptors, Enterotoxin
=550  \\$wh$aReceptors, Formyl Peptide
=550  \\$wh$aReceptors, Gastrointestinal Hormone
=550  \\$wh$aReceptors, Growth Factor
=550  \\$wh$aReceptors, Invertebrate Peptide
=550  \\$wh$aReceptors, Kisspeptin-1
=550  \\$wh$aReceptors, Neuropeptide
=550  \\$wh$aReceptors, Pancreatic Hormone
=550  \\$wh$aReceptors, Parathyroid Hormone
=550  \\$wh$aReceptors, Pituitary Hormone
=550  \\$wh$aReceptors, Pituitary Hormone-Regulating Hormone
=550  \\$wh$aReceptors, Thrombin
=550  \\$aPeptide Hormones
=667  \\$aGEN; prefer specifics; coord IM with specific peptide (IM); DF: RECEPT PEPTIDE
=680  \\$iCell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells.
=688  \\$a94
=750  \0$aPeptide hormones$xReceptors$0(DLC)sh 85099690$5IEN-M

=LDR  01195cz  a2200241n  4500
=001  9880363980602441
=005  20141212212348.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017993
=035  \\$aCRE6926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x580.$x650.$x600.$x325.$x660
=072  \\$aB4.$x909.$x204.$x671.$x650.$x600.$x325.$x660
=150  \\$aParvovirus, Canine
=450  \\$aCanine parvovirus
=450  \\$wnnna$aCanine Parvoviruses
=450  \\$wnnna$aParvoviruses, Canine
=550  \\$wg$aFeline panleukopenia virus
=667  \\$ainfection: coordinate IM with PARVOVIRIDAE INFECTIONS (IM); do not confuse with CANINE MINUTE VIRUS; infection in cats: coordinate IM with FELINE PANLEUKOPENIA (IM); infection in mink: coordinate IM with MINK VIRAL ENTERITIS (IM)
=680  \\$iA species of the genus PARVOVIRUS and a host range variant of FELINE PANLEUKOPENIA VIRUS. It causes a highly infectious fulminating ENTERITIS in dogs producing high mortality. It is distinct from CANINE MINUTE VIRUS, a species in the genus BOCAVIRUS. This virus can also infect cats and mink.
=688  \\$a1994
=688  \\$a94
=750  \0$aCanine parvovirus$5IEN-M$0(DLC)sh 91003596

=LDR  01579cz  a2200349n  4500
=001  9880363980702441
=005  20190422164648.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017983
=035  \\$aCRE6917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x670.$x300
=072  \\$aD12.$x776.$x543.$x750.$x695.$x150
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.
=150  \\$aReceptors, Catecholamine
=450  \\$wnnna$aCatecholamine Receptor
=450  \\$aCatecholamine Receptors
=450  \\$wnnna$aCatecholamines Receptors
=450  \\$wnnna$aReceptor, Catecholamine
=450  \\$wnnna$aReceptors, Catecholamines
=550  \\$wg$aReceptors, Biogenic Amine
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wh$aReceptors, Adrenergic
=550  \\$wh$aReceptors, Dopamine
=550  \\$aCatecholamines
=667  \\$aGEN; prefer specifics; DF: RECEPT CATECHOLAMINE
=680  \\$iCell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behavior of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesized from tyrosine by a common biosynthetic pathway.
=688  \\$a94; was CATECHOLAMINE RECEPTOR (NM) 1982-93
=750  \0$81$wb$iBroader mapping$aCatecholamines$0(DLC)sh 85020986$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCatecholamines--Receptors$5IEN-M

=LDR  01498cz  a2200313n  4500
=001  9880363980802441
=005  20190422140127.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017982
=035  \\$aCRE6916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x670
=150  \\$aReceptors, Biogenic Amine
=450  \\$wnnna$aBiogenic Amine Receptor
=450  \\$aBiogenic Amine Receptors
=450  \\$wnnna$aBiogenic Amines Receptors
=450  \\$wnnna$aReceptor, Biogenic Amine
=450  \\$wnnna$aReceptors, Biogenic Amines
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aReceptors, Catecholamine
=550  \\$wh$aReceptors, Histamine
=550  \\$wh$aReceptors, Serotonin
=550  \\$aBiogenic Amines
=667  \\$aGEN; prefer specifics; DF: RECEPT BIOGENIC AMINE
=680  \\$iCell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aBiogenic amines$0(DLC)sh 85014143$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aBiogenic amines--Receptors$5IEN-M

=LDR  02966cz  a2200589n  4500
=001  9880363980902441
=005  20190430153244.0
=008  930615\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017981
=035  \\$aCRE6915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720
=150  \\$aReceptors, Neurotransmitter
=450  \\$aNeurohumor Receptors
=450  \\$wnnna$aNeuromediator Receptor
=450  \\$aNeuromediator Receptors
=450  \\$wnnna$aNeuromediators Receptors
=450  \\$wnnna$aNeuromodulator Receptor
=450  \\$aNeuromodulator Receptors
=450  \\$wnnna$aNeuromodulators Receptors
=450  \\$wnnna$aNeuroregulator Receptor
=450  \\$aNeuroregulator Receptors
=450  \\$wnnna$aNeuroregulators Receptors
=450  \\$wnnna$aNeurotransmitter Receptor
=450  \\$wnnna$aNeurotransmitter Receptors
=450  \\$wnnna$aNeurotransmitters Receptors
=450  \\$wnnna$aReceptor, Neuromediator
=450  \\$wnnna$aReceptor, Neuromodulator
=450  \\$wnnna$aReceptor, Neuroregulator
=450  \\$wnnna$aReceptor, Neurotransmitter
=450  \\$aReceptors, Neurohumor
=450  \\$wnnna$aReceptors, Neuromediator
=450  \\$wnnna$aReceptors, Neuromediators
=450  \\$wnnna$aReceptors, Neuromodulator
=450  \\$wnnna$aReceptors, Neuromodulators
=450  \\$wnnna$aReceptors, Neuroregulator
=450  \\$wnnna$aReceptors, Neuroregulators
=450  \\$wnnna$aReceptors, Neurotransmitters
=450  \\$aReceptors, Synaptic
=450  \\$aSynaptic Receptors
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aReceptors, Amino Acid
=550  \\$wh$aReceptors, Biogenic Amine
=550  \\$wh$aReceptors, Catecholamine
=550  \\$wh$aReceptors, Cholinergic
=550  \\$wh$aReceptors, Neuropeptide
=550  \\$wh$aReceptors, Presynaptic
=550  \\$wh$aReceptors, Purinergic
=667  \\$aGEN; prefer specifics; DF: RECEPT NEUROTRANSM
=680  \\$iCell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.
=688  \\$a94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1970-93; was SYNAPTIC RECEPTORS 1970-90 (Prov 1970-72); NEUROTRANSMITTER RECEPTORS & SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, & NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93
=750  \0$aNeurotransmitter receptors$0(DLC)sh 85091182$5IEN

=LDR  00601cz  a2200217n  4500
=001  9880363981002441
=005  20141212212343.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017979
=035  \\$aCRE6913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x379.$x400
=150  \\$aGold Colloid
=450  \\$wnnna$aColloid, Gold
=450  \\$aColloidal Gold
=450  \\$wnnna$aGold, Colloidal
=550  \\$wg$aGold Compounds
=550  \\$wh$aGold Colloid, Radioactive
=680  \\$iA suspension of metallic gold particles.
=688  \\$a94
=750  \0$aColloidal gold$5IEN-M$0(DLC)sh 88004931

=LDR  01870cz  a2200433n  4500
=001  9880363981102441
=005  20190506111639.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017978
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400
=150  \\$aReceptors, Growth Factor
=450  \\$wnnna$aFactor Receptor, Trophic
=450  \\$aGrowth Factor Receptors
=450  \\$wnnna$aGrowth Factors Receptors
=450  \\$wnnna$aReceptor, Trophic Factor
=450  \\$wnnna$aReceptors, Growth Factors
=450  \\$wnnna$aReceptors, Trophic Factor
=450  \\$wnnna$aTrophic Factor Receptor
=450  \\$aTrophic Factor Receptors
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aBone Morphogenetic Protein Receptors
=550  \\$wh$aErbB Receptors
=550  \\$wh$aProto-Oncogene Proteins c-met
=550  \\$wh$aReceptors, Colony-Stimulating Factor
=550  \\$wh$aReceptors, Fibroblast Growth Factor
=550  \\$wh$aReceptors, Nerve Growth Factor
=550  \\$wh$aReceptors, Platelet-Derived Growth Factor
=550  \\$wh$aReceptors, Somatomedin
=550  \\$wh$aReceptors, Transforming Growth Factor beta
=550  \\$wh$aReceptors, Vascular Endothelial Growth Factor
=550  \\$aGrowth Substances
=550  \\$aIntercellular Signaling Peptides and Proteins
=667  \\$aGEN; prefer specifics; DF: RECEPT GROWTH FACTOR
=680  \\$iCell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.
=688  \\$a94
=750  \0$81$wb$iBroader mapping$aGrowth factors$0(DLC) sh 85057532$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGrowth factors--Receptors$5IEN-M

=LDR  02071cz  a2200409n  4500
=001  9880363981202441
=005  20141212212342.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017977
=035  \\$aCRE6911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x200
=072  \\$aB4.$x909.$x574.$x807.$x200
=072  \\$aB4.$x909.$x777.$x731.$x200
=150  \\$aDeltaretrovirus
=450  \\$aBLV-HTLV Viruses
=450  \\$wnnna$aBLV HTLV Viruses
=450  \\$aHTLV-BLV Viruses
=450  \\$wnnna$aHTLV BLV Viruses
=450  \\$aHTLV Viruses
=450  \\$wnnna$aHuman T Cell Leukemia Lymphoma Viruses
=450  \\$aHuman T-Cell Leukemia-Lymphoma Viruses
=450  \\$wnnna$aHuman T Cell Leukemia Viruses
=450  \\$aHuman T-Cell Leukemia Viruses
=450  \\$wnnna$aLeukemia Viruses, Human T Cell
=450  \\$aLeukemia Viruses, Human T-Cell
=450  \\$wnnna$aT Cell Leukemia Viruses, Human
=450  \\$aT-Cell Leukemia Viruses, Human
=550  \\$wg$aRetroviridae
=550  \\$wh$aLeukemia Virus, Bovine
=550  \\$wh$aPrimate T-lymphotropic virus 1
=550  \\$wh$aPrimate T-lymphotropic virus 2
=550  \\$wh$aPrimate T-lymphotropic virus 3
=667  \\$ainfection = DELTARETROVIRUS INFECTIONS + TUMOR VIRUS INFECTIONS if pertinent
=680  \\$iA genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE.
=688  \\$a2002 (1994); for HTLV VIRUSES use HTLV VIRUSES 1989-1993, use HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES & LEUKEMIA VIRUSES, HUMAN T-CELL use HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, use HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES & T-CELL LEUKEMIA VIRUSES, HUMAN use HTLV VIRUSES 1989-1993
=750  \0$aHTLV (Viruses)$5IEN$0(DLC)sh 85062897

=LDR  00659cz  a2200205n  4500
=001  9880363981302441
=005  20141212212341.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017975
=035  \\$aCRE6909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x765
=150  \\$aRuthenium Compounds
=450  \\$wnnna$aCompounds, Ruthenium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aRuthenium Red
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: RUTHENIUM CPDS
=680  \\$iInorganic compounds that contain ruthenium as an integral part of the molecule.
=688  \\$a94
=750  \0$aRuthenium compounds$5IEN$0(DLC)sh 85116090

=LDR  00650cz  a2200205n  4500
=001  9880363981402441
=005  20141212212341.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017974
=035  \\$aCRE6908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x950
=150  \\$aUranium Compounds
=450  \\$wnnna$aCompounds, Uranium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aUranyl Nitrate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: URANIUM CPDS
=680  \\$iInorganic compounds that contain uranium as an integral part of the molecule.
=688  \\$a94
=750  \0$aUranium compounds$5IEN$0(DLC)sh 85141285

=LDR  00661cz  a2200205n  4500
=001  9880363981502441
=005  20141212212341.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017973
=035  \\$aCRE6907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x940
=150  \\$aTungsten Compounds
=450  \\$wnnna$aCompounds, Tungsten
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aPhosphotungstic Acid
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: TUNGSTEN CPDS
=680  \\$iInorganic compounds that contain tungsten as an integral part of the molecule.
=688  \\$a94
=750  \0$aTungsten compounds$5IEN$0(DLC)sh 85138618

=LDR  00667cz  a2200217n  4500
=001  9880363981602441
=005  20141212212340.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017971
=035  \\$aCRE6905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x935
=150  \\$aTin Compounds
=450  \\$wnnna$aCompounds, Tin
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aTin Fluorides
=550  \\$wh$aTin Polyphosphates
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: TIN CPDS
=680  \\$iInorganic compounds that contain tin as an integral part of the molecule.
=688  \\$a94
=750  \0$aTin compounds$5IEN$0(DLC)sh 85135492

=LDR  00654cz  a2200205n  4500
=001  9880363981702441
=005  20141212212340.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017970
=035  \\$aCRE6904M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x930
=150  \\$aThorium Compounds
=450  \\$wnnna$aCompounds, Thorium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aThorium Dioxide
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: THORIUM CPDS
=680  \\$iInorganic compounds that contain thorium as an integral part of the molecule.
=688  \\$a94
=750  \0$aThorium compounds$0(DLC)sh2012003208$5IEN-M

=LDR  00663cz  a2200217n  4500
=001  9880363981902441
=005  20141212212339.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017967
=035  \\$aCRE6901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x975
=150  \\$aZinc Compounds
=450  \\$wnnna$aCompounds, Zinc
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aZinc Oxide
=550  \\$wh$aZinc Sulfate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: ZINC CPDS
=680  \\$iInorganic compounds that contain zinc as an integral part of the molecule.
=688  \\$a94
=750  \0$aZinc compounds$5IEN$0(DLC)sh 85149856

=LDR  01788cz  a2200493n  4500
=001  9880363982002441
=005  20141212212338.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017963
=035  \\$aCRE6897M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x250.$x50
=150  \\$aAzithromycin
=450  \\$wnnna$aAzadose
=450  \\$wnnna$aAzithromycin Dihydrate
=450  \\$wnnna$aAzithromycin Monohydrate
=450  \\$wnnna$aAzithromycin Pfizer Brand
=450  \\$wnnna$aAzitrocin
=450  \\$wnnna$aAzythromycin
=450  \\$wnnna$aBayer Brand of Azithromycin Dihydrate
=450  \\$wnnna$aCP-62993
=450  \\$wnnna$aCP 62993
=450  \\$wnnna$aCP62993
=450  \\$wnnna$aDihydrate, Azithromycin
=450  \\$wnnna$aFunk Brand of Azithromycin Dihydrate
=450  \\$wnnna$aGoxal
=450  \\$wnnna$aLesvi Brand of Azithromycin Dihydrate
=450  \\$wnnna$aMack Brand of Azithromycin Dihydrate
=450  \\$wnnna$aMonohydrate, Azithromycin
=450  \\$wnnna$aPfizer Brand of Azithromycin
=450  \\$wnnna$aPfizer Brand of Azithromycin Dihydrate
=450  \\$wnnna$aPharmacia Brand of Azithromycin Dihydrate
=450  \\$wnnna$aSumamed
=450  \\$wnnna$aToraseptol
=450  \\$wnnna$aUltreon
=450  \\$wnnna$aVinzam
=450  \\$wnnna$aVita Brand of Azithromycin Dihydrate
=450  \\$wnnna$aZentavion
=450  \\$wnnna$aZithromax
=450  \\$wnnna$aZitromax
=550  \\$wg$aErythromycin
=680  \\$iA semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
=688  \\$a94; was AZITHROMYCIN (NM) 1987-93
=750  \0$aAzithromycin$5IEN-M$0(DLC)sh2002010977

=LDR  01943cz  a2200433n  4500
=001  9880363982102441
=005  20141212192800.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017956
=035  \\$aCRE6891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x850.$x625.$x660
=072  \\$aA8.$x675.$x650.$x915.$x937.$x650
=072  \\$aA8.$x800.$x950.$x937.$x650
=072  \\$aA9.$x371.$x729.$x831.$x625.$x660
=072  \\$aA11.$x671.$x650.$x850.$x625.$x660
=072  \\$aA11.$x671.$x650.$x915.$x937.$x650
=072  \\$aA13.$x750
=150  \\$aPhotoreceptor Cells, Invertebrate
=450  \\$wnnna$aCell, Invertebrate Photoreceptor
=450  \\$wnnna$aCells, Invertebrate Photoreceptor
=450  \\$wnnna$aInvertebrate Photoreceptor
=450  \\$wnnna$aInvertebrate Photoreceptor Cell
=450  \\$wnnna$aInvertebrate Photoreceptor Cells
=450  \\$aInvertebrate Photoreceptors
=450  \\$wnnna$aPhotoreceptor Cell, Invertebrate
=450  \\$wnnna$aPhotoreceptor, Invertebrate
=450  \\$aPhotoreceptors, Invertebrate
=550  \\$wg$aAnimal Structures
=550  \\$wg$aPhotoreceptor Cells
=550  \\$aCompound Eye, Arthropod
=667  \\$aDF: PHOTORECEPT INVERTEBRATE
=680  \\$iSpecialized cells in the invertebrates that detect and transduce light. They are predominantly rhabdomeric with an array of photosensitive microvilli. Illumination depolarizes invertebrate photoreceptors by stimulating Na+ influx across the plasma membrane.
=688  \\$a2009 (1994)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Photoreceptors, Invertebrate
=688  \\$a94
=750  \0$81$wb$aInvertebrates$xPhysiology$0(DLC) sh 85067695$5IEN-M$0(DLC)sh 85067695
=750  \0$81$wb$aPhotoreceptors$0(DLC) sh 85101407$5IEN-HS$0(DLC)sh 85101407
=788  \0$iSearch also under the following headings used together in the same record:$aPhotoreceptors$iand$aInvertebrates--Physiology$5IEN-M

=LDR  01507cz  a2200361n  4500
=001  9880363982202441
=005  20141212212336.0
=008  930615\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017955
=035  \\$aCRE6890M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x284.$x664
=072  \\$aB4.$x909.$x777.$x618.$x284.$x689
=150  \\$aPoliovirus
=450  \\$aBrunhilde Virus
=450  \\$aHuman poliovirus 1
=450  \\$aHuman poliovirus 2
=450  \\$aHuman poliovirus 3
=450  \\$aLansing Virus
=450  \\$aLeon Virus
=450  \\$wnnna$apoliovirus 1, Human
=450  \\$wnnna$apoliovirus 2, Human
=450  \\$wnnna$apoliovirus 3, Human
=450  \\$wnnna$aPoliovirus Type 1
=450  \\$wnnna$aPoliovirus Type 2
=450  \\$wnnna$aPoliovirus Type 3
=450  \\$wnnna$aPolioviruses
=450  \\$wnnoa$aPolioviruses, Human 1-3$5IEN-HS
=550  \\$wg$aEnterovirus
=667  \\$ainfection = POLIOMYELITIS; vaccine-derived poliovirus: coordinate with VIRUS SHEDDING and with specific vaccine if appropriate
=680  \\$iA species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.
=688  \\$a2002 (1994); POLIOVIRUSES was also a heading 1994-2006
=750  \0$aPoliovirus$0(DLC) sh 85104279$5IEN

=LDR  00566cz  a2200193n  4500
=001  9880363982302441
=005  20141212212335.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017953
=035  \\$aCRE6888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x500
=150  \\$aIsocyanates
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aIsothiocyanates
=550  \\$wh$aToluene 2,4-Diisocyanate
=680  \\$iOrganic compounds that contain the -NCO radical.
=688  \\$a94; ISOCYANATES was see CYANATES 1993
=750  \0$aIsocyanates$5IEN-M$0(DLC)sh 86000419

=LDR  01032cz  a2200301n  4500
=001  9880363982402441
=005  20141212212334.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017950
=035  \\$aCRE6885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x340.$x390
=072  \\$aA8.$x800.$x350
=150  \\$aGanglia, Sensory
=450  \\$wnnna$aGanglion, Sensory
=450  \\$aSensory Ganglia
=450  \\$wnnna$aSensory Ganglion
=550  \\$wg$aGanglia
=550  \\$wg$aPeripheral Nervous System
=550  \\$wh$aGanglia, Spinal
=550  \\$wh$aGeniculate Ganglion
=550  \\$wh$aNodose Ganglion
=550  \\$wh$aSpiral Ganglion
=550  \\$wh$aTrigeminal Ganglion
=667  \\$aganglia of the peripheral nerv syst
=680  \\$iClusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells.
=688  \\$a94
=750  \0$aGanglia, Sensory$5IEN$0(DLC)sh 85053020

=LDR  00957cz  a2200229n  4500
=001  9880363982502441
=005  20141212212333.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017942
=035  \\$aCRE6878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x550
=072  \\$aD1.$x625.$x525
=150  \\$aNitric Acid
=450  \\$wnnna$aAcid, Nitric
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aNitrogen Compounds
=550  \\$wh$aNitrates
=667  \\$ado not confuse with NITROUS ACID
=680  \\$iNitric acid (HNO3). A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. (From Merck Index, 11th ed)
=688  \\$a94; was NITRIC ACID (NM) 1974-93
=750  \0$aNitric acid$5IEN-M$0(DLC)sh 85092048

=LDR  00765cz  a2200205n  4500
=001  9880363982602441
=005  20141212212330.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017930
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x435
=150  \\$aGenes, Reporter
=450  \\$wnnna$aGene, Reporter
=450  \\$wnnna$aReporter Gene
=450  \\$aReporter Genes
=550  \\$wg$aGenes
=550  \\$aPromoter Regions, Genetic
=680  \\$iGenes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest.
=688  \\$a1994
=750  \0$aReporter genes$0(DLC)sh2007001094$5IEN-M

=LDR  01056cz  a2200253n  4500
=001  9880363982702441
=005  20141212212329.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017925
=035  \\$aCRE6861M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x120.$x150
=072  \\$aB4.$x909.$x204.$x120.$x150
=150  \\$aCircovirus
=450  \\$aBeak and feather disease virus
=450  \\$aCircovirus, Porcine
=450  \\$wnnna$aCircoviruses, Porcine
=450  \\$aPorcine circovirus
=450  \\$wnnna$aPorcine Circoviruses
=550  \\$wg$aCircoviridae
=667  \\$ainfection: coordinate IM with CIRCOVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of the family CIRCOVIRIDAE that infects SWINE; PSITTACINES; and non-psittacine BIRDS. Species include Beak and feather disease virus causing a fatal disease in psittacine birds, and Porcine circovirus causing postweaning multisystemic wasting syndrome in pigs (PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME).
=688  \\$a94
=750  \0$aCircoviruses$0(DLC)sh2010013161$5IEN-M

=LDR  00977cz  a2200289n  4500
=001  9880363982902441
=005  20141212212325.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017912
=035  \\$aCRE6849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x370.$x400
=072  \\$aB4.$x280.$x400.$x400
=150  \\$aInovirus
=450  \\$wnnna$aBacteriophage, Filamentous
=450  \\$aBacteriophages, Filamentous
=450  \\$wnnna$aFilamentous Bacteriophage
=450  \\$aFilamentous Bacteriophages
=450  \\$wnnna$aInoviruses
=550  \\$wg$aInoviridae
=550  \\$wh$aBacteriophage IKe
=550  \\$wh$aBacteriophage M13
=550  \\$wh$aBacteriophage Pf1
=667  \\$acoord with specific bacterium /virol
=680  \\$iA genus of filamentous bacteriophages of the family INOVIRIDAE. Organisms of this genus infect enterobacteria, PSEUDOMONAS; VIBRIO; and XANTHOMONAS.
=688  \\$a94
=750  \0$aBacteriophage fd$5IEN-M$0(DLC)sh 89004024

=LDR  00748cz  a2200217n  4500
=001  9880363983002441
=005  20141212192757.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017898
=035  \\$aCRE6835M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x464.$x725
=150  \\$aTobamovirus
=450  \\$aOdontoglossum ringspot virus
=450  \\$wnnna$aOdontoglossum ringspot viruses
=450  \\$wnnna$aTobamoviruses
=550  \\$wg$aMosaic Viruses
=550  \\$wh$aTobacco Mosaic Virus
=680  \\$iA genus of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type species is TOBACCO MOSAIC VIRUS.
=688  \\$a94
=750  \0$aTobamoviruses$0(DLC)sh2007002844$5IEN-M

=LDR  00670cz  a2200205n  4500
=001  9880363983102441
=005  20141212212321.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017895
=035  \\$aCRE6834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x530
=150  \\$aManganese Compounds
=450  \\$wnnna$aCompounds, Manganese
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aPotassium Permanganate
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: MANGANESE CPDS
=680  \\$iInorganic chemicals that contain manganese as an integral part of the molecule.
=688  \\$a94
=750  \0$aManganese compounds$5IEN-M$0(DLC)sh 85080489

=LDR  00649cz  a2200205n  4500
=001  9880363983202441
=005  20141212212320.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017892
=035  \\$aCRE6832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x640
=150  \\$aOsmium Compounds
=450  \\$wnnna$aCompounds, Osmium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aOsmium Tetroxide
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: OSMIUM CPDS
=680  \\$iInorganic compounds that contain osmium as an integral part of the molecule.
=688  \\$a94
=750  \0$aOsmium compounds$5IEN-M$0(DLC)sh 85095931

=LDR  01446cz  a2200265n  4500
=001  9880363983302441
=005  20141212212320.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017891
=035  \\$aCRE6831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x45
=072  \\$aH2.$x403.$x720.$x500.$x650
=072  \\$aH2.$x628.$x413
=150  \\$aPharmacoepidemiology
=450  \\$wnnna$aEpidemiologies, Pharmaceutical
=450  \\$aEpidemiology, Pharmaceutical
=450  \\$wnnna$aPharmaceutical Epidemiologies
=450  \\$wnnna$aPharmaceutical Epidemiology
=550  \\$wg$aEpidemiology
=550  \\$wg$aPharmacology
=667  \\$aSPEC: SPEC qualif; DF: PHARMACOEPIDEMIOL
=680  \\$iThe science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))
=688  \\$a94
=750  \0$aPharmacoepidemiology$5IEN-M$0(DLC)sh 89004031

=LDR  01526cz  a2200433n  4500
=001  9880363983402441
=005  20141212212318.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017886
=035  \\$aCRE6826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374.$x75.$x25.$x300.$x150
=072  \\$aD1.$x146.$x360.$x50.$x300.$x200
=072  \\$aD1.$x578.$x122.$x477.$x300
=072  \\$aD1.$x695.$x625.$x675.$x650.$x75.$x25.$x300.$x150
=150  \\$aDurapatite
=450  \\$wnnna$aAlveograf
=450  \\$wnnna$aCalcitite
=450  \\$aCalcium Hydroxyapatite
=450  \\$aHydroxyapatite
=450  \\$wnnna$aHydroxyapatite, Calcium
=450  \\$aHydroxylapatite
=450  \\$wnnna$aInterpore-200
=450  \\$wnnna$aInterpore 200
=450  \\$wnnna$aInterpore-500
=450  \\$wnnna$aInterpore 500
=450  \\$wnnna$aInterpore200
=450  \\$wnnna$aInterpore500
=450  \\$wnnna$aOsprovit
=450  \\$wnnna$aOssein-Hydroxyapatite Compound
=450  \\$wnnna$aOssein Hydroxyapatite Compound
=450  \\$wnnna$aOssopan
=450  \\$wnnna$aOsteogen
=450  \\$wnnna$aPeriograf
=550  \\$wg$aHydroxyapatites
=667  \\$amineral component of bones & teeth; used as a biocompatible material
=680  \\$iThe mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.
=688  \\$a94; was HYDROXYAPATITE (NM) 1981-93
=750  \0$aHydroxyapatite$5IEN-M$0(DLC)sh 85063508

=LDR  01614cz  a2200397n  4500
=001  9880363983502441
=005  20141212212317.0
=008  930826\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017880
=035  \\$aCRE6820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x660.$x585
=072  \\$aC16.$x131.$x621.$x585
=150  \\$aLimb Deformities, Congenital
=450  \\$wnnna$aCongenital Limb Deformities
=450  \\$wnnna$aCongenital Limb Deformity
=450  \\$wnnna$aDeformities, Congenital Limb
=450  \\$wnnna$aDeformity, Congenital Limb
=450  \\$aExtremities$xabnormalities
=450  \\$wnnna$aLimb Deformity, Congenital
=550  \\$wg$aMusculoskeletal Abnormalities
=550  \\$wh$aArachnodactyly
=550  \\$wh$aBrachydactyly
=550  \\$wh$aEctromelia
=550  \\$wh$aFoot Deformities, Congenital
=550  \\$wh$aHand Deformities, Congenital
=550  \\$wh$aLower Extremity Deformities, Congenital
=550  \\$wh$aPolydactyly
=550  \\$wh$aProteus Syndrome
=550  \\$wh$aSyndactyly
=550  \\$wh$aThanatophoric Dysplasia
=550  \\$wh$aUpper Extremity Deformities, Congenital
=667  \\$ageneral or unspecified; LOWER EXTREMITY DEFORMITIES, CONGENITAL and UPPER EXTREMITY DEFORMITIES, CONGENITAL are available as well as /abnorm with specifics treed under UPPER EXTREMITIES and LOWER EXTREMITIES; DF: LIMB DEFORMITIES CONGEN
=680  \\$iCongenital structural deformities of the upper and lower extremities collectively or unspecified.
=688  \\$a98; use explode 1994-97
=750  \0$aExtremities (Anatomy)$xAbnormalities$5IEN-M$0(DLC)sh 85046620

=LDR  00817cz  a2200217n  4500
=001  9880363983602441
=005  20141212212316.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017877
=035  \\$aCRE6817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x385.$x850
=150  \\$aUmbridae
=450  \\$wnnna$aMudminnow
=450  \\$aMudminnows
=450  \\$aUmbra
=550  \\$wg$aEsociformes
=667  \\$anote X ref; MINNOWS see CYPRINIDAE is also available
=680  \\$iA family of ESOCIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra, with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere.
=688  \\$a1994
=750  \0$aMudminnows$5IEN-M$0(DLC)sh 85139535

=LDR  00716cz  a2200217n  4500
=001  9880363983702441
=005  20141212212312.0
=008  930615\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017863
=035  \\$aCRE6806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x260.$x575
=072  \\$aB4.$x820.$x260.$x575
=150  \\$aPotexvirus
=450  \\$aPotato virus X
=450  \\$wnnna$aPotexviruses
=450  \\$wnnna$avirus X, Potato
=550  \\$wg$aFlexiviridae
=680  \\$iA genus of plant viruses in the family FLEXIVIRIDAE, that cause mosaic and ringspot symptoms. Transmission occurs mechanically. Potato virus X is the type species.
=688  \\$a94
=750  \0$aPotexviruses$0(DLC)sh2007002842$5IEN-M

=LDR  00961cz  a2200217n  4500
=001  9880363983802441
=005  20141212212311.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017861
=035  \\$aCRE6804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x94.$x625
=072  \\$aB3.$x440.$x425.$x410.$x194.$x625
=150  \\$aPorphyromonas
=550  \\$wg$aBacteroidaceae
=550  \\$wh$aPorphyromonas endodontalis
=550  \\$wh$aPorphyromonas gingivalis
=667  \\$ainfection: coord IM with BACTEROIDACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods or coccobacilli. Organisms in this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Bacteroides species, and hence, this new genus was created.
=688  \\$a94
=750  \0$aPorphyromonas$5IEN-M$0(DLC)sh 93003440

=LDR  00943cz  a2200229n  4500
=001  9880363983902441
=005  20141212212311.0
=008  930629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017860
=035  \\$aCRE6803M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x150.$x500
=072  \\$aB4.$x820.$x150.$x500
=150  \\$aNepovirus
=450  \\$wnnna$aNepoviruses
=450  \\$aTobacco ringspot virus
=450  \\$wnnna$aTobacco ringspot viruses
=550  \\$wg$aComoviridae
=667  \\$acoord IM with specific plant /virol
=680  \\$iA genus of polyhedral plant viruses of the family COMOVIRIDAE causing ringspots and spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Tobacco ringspot virus is the type species.
=688  \\$a94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96
=750  \0$aNepoviruses$5IEN-M$0(DLC)sh2002009418

=LDR  00851cz  a2200217n  4500
=001  9880363712002441
=005  20141212203538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008956
=035  \\$aCBA2208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x495
=150  \\$aModels, Chemical
=450  \\$wnnna$aChemical Model
=450  \\$aChemical Models
=450  \\$wnnna$aModel, Chemical
=550  \\$wg$aModels, Theoretical
=667  \\$ano qualif; TN 37: relation to MODELS, STRUCTURAL; TN 128: definition & relation to MODELS, THEORETICAL; DF: MODELS CHEM
=680  \\$iTheoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a68
=750  \0$aChemical models$5IEN$0(DLC)sh 85022926

=LDR  00868cz  a2200217n  4500
=001  9880363712102441
=005  20141212203538.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008955
=035  \\$aCBA2207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395.$x161
=150  \\$aModels, Cardiovascular
=450  \\$wnnna$aCardiovascular Model
=450  \\$wnnna$aCardiovascular Models
=450  \\$wnnna$aModel, Cardiovascular
=550  \\$wg$aModels, Biological
=667  \\$ano qualif; apply TN 128 for relation to MODELS, THEORETICAL
=680  \\$iTheoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment.
=688  \\$a80
=750  \0$aCardiovascular system$xMathematical models$5IEN-M$0(IEN)369302

=LDR  01251cz  a2200325n  4500
=001  9880363712202441
=005  20141212192334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008954
=035  \\$aCBA2206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395
=150  \\$aModels, Biological
=450  \\$wnnna$aBiologic Model
=450  \\$wnnna$aBiologic Models
=450  \\$wnnna$aBiological Model
=450  \\$wnnna$aBiological Models
=450  \\$wnnna$aModel, Biologic
=450  \\$wnnna$aModel, Biological
=450  \\$wnnna$aModels, Biologic
=550  \\$wg$aModels, Theoretical
=550  \\$wh$aDisease Models, Animal
=550  \\$wh$aModels, Cardiovascular
=550  \\$wh$aModels, Genetic
=550  \\$wh$aModels, Immunological
=550  \\$wh$aModels, Neurological
=550  \\$wh$aPatient-Specific Modeling
=680  \\$iTheoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a73; was MODELS, BIOLOGIC 1968-72
=750  \0$aBiological models$5IEN$0(DLC)sh 85014180

=LDR  01362cz  a2200373n  4500
=001  9880363712302441
=005  20141212203537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008953
=035  \\$aCBA2205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x545.$x129
=072  \\$aL1.$x178.$x820.$x90.$x545.$x129
=150  \\$aModels, Anatomic
=450  \\$wnnna$aAnatomic Model
=450  \\$aAnatomic Models
=450  \\$wnnna$aAnatomical Model
=450  \\$wnnna$aAnatomical Models
=450  \\$wnnna$aModel, Anatomic
=450  \\$wnnna$aModel, Anatomical
=450  \\$wnnna$aModel, Surgical
=450  \\$wnnna$aModels, Anatomical
=450  \\$aModels, Surgical
=450  \\$wnnna$aMoulage
=450  \\$aMoulages
=450  \\$wnnna$aSurgical Model
=450  \\$wnnna$aSurgical Models
=550  \\$wg$aModels, Structural
=550  \\$wh$aManikins
=550  \\$wh$aVisible Human Projects
=667  \\$ano qualif; note X ref MOULAGES; DF: MODELS ANAT
=680  \\$iThree-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study.
=688  \\$a84(75); was ANATOMIC MODELS see under MODELS, STRUCTURAL 1968-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83
=750  \0$aHuman anatomy$xModels$5IEN$0(DLC)sh 85004842

=LDR  01550cz  a2200481n  4500
=001  9880363712402441
=005  20141212203537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008952
=035  \\$aCBA2204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x702
=072  \\$aN2.$x421.$x143.$x827.$x233.$x628
=150  \\$aMobile Health Units
=450  \\$wnnna$aClinic, Mobile
=450  \\$wnnna$aClinics, Mobile
=450  \\$wnnna$aField Hospital
=450  \\$wnnna$aField Hospitals
=450  \\$wnnna$aHealth Unit, Mobile
=450  \\$wnnna$aHealth Units, Mobile
=450  \\$wnnna$aHealth Van, Mobile
=450  \\$wnnna$aHealth Vans, Mobile
=450  \\$wnnna$aHospital, Field
=450  \\$wnnna$aHospital, Mobile
=450  \\$wnnna$aHospitals, Field
=450  \\$wnnna$aHospitals, Mobile
=450  \\$wnnna$aMobile Clinic
=450  \\$wnnna$aMobile Clinics
=450  \\$wnnna$aMobile Health Unit
=450  \\$wnnna$aMobile Health Van
=450  \\$wnnna$aMobile Health Vans
=450  \\$wnnna$aMobile Hospital
=450  \\$wnnna$aMobile Hospitals
=450  \\$wnnna$aUnit, Mobile Health
=450  \\$wnnna$aUnits, Mobile Health
=450  \\$wnnna$aVan, Mobile Health
=450  \\$wnnna$aVans, Mobile Health
=550  \\$wg$aDiagnostic Services
=550  \\$wg$aHospitals
=680  \\$iMovable or portable facilities in which diagnostic and therapeutic services are provided to the community.
=688  \\$a1970
=688  \\$a70
=750  \0$aMobile hospitals$0(DLC)sh 85062393$5IEN-M

=LDR  01124cz  a2200265n  4500
=001  9880363712502441
=005  20141212203537.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008951
=035  \\$aCBA2203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x606
=072  \\$aD23.$x50.$x705.$x230.$x606
=150  \\$aMNSs Blood-Group System
=450  \\$wnnna$aBlood-Group System, MNSs
=450  \\$wnnna$aBlood-Group Systems, MNSs
=450  \\$wnnna$aMNSs Blood Group System
=450  \\$wnnna$aMNSs Blood-Group Systems
=450  \\$wnnna$aSystem, MNSs Blood-Group
=450  \\$wnnna$aSystems, MNSs Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iA system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.
=688  \\$a76
=750  \0$aBlood groups$xMNSs system$5IEN$0(DLC)sh 85014989

=LDR  00661cz  a2200169n  4500
=001  9880363712602441
=005  20141212203536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008950
=035  \\$aCBA2202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x513.$x607
=150  \\$aMMPI
=450  \\$aMinnesota Multiphasic Personality Inventory
=550  \\$wg$aPersonality Inventory
=680  \\$iA personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.
=750  \0$aMinnesota Multiphasic Personality Inventory$5IEN$0(DLC)sh 85085774

=LDR  02051cz  a2200517n  4500
=001  9880363712702441
=005  20141212203535.0
=008  771206\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008945
=035  \\$aCBA2198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x400.$x500
=150  \\$aMitral Valve Prolapse
=450  \\$wnnna$aClick-Murmur Syndrome
=450  \\$wnnna$aClick Murmur Syndrome
=450  \\$wnnna$aClick-Murmur Syndrome, Mitral
=450  \\$wnnna$aClick-Murmur Syndrome, Systolic
=450  \\$wnnna$aClick-Murmur Syndromes
=450  \\$aFloppy Mitral Valve
=450  \\$wnnna$aFloppy Mitral Valves
=450  \\$aMitral Click-Murmur Syndrome
=450  \\$wnnna$aMitral Click Murmur Syndrome
=450  \\$wnnna$aMitral Valve, Floppy
=450  \\$wnnna$aMitral Valve Prolapse Syndrome
=450  \\$wnnna$aMitral Valve, Prolapsed
=450  \\$wnnna$aMitral Valve Prolapses
=450  \\$wnnna$aMitral Valves, Floppy
=450  \\$wnnna$aMitral Valves, Prolapsed
=450  \\$wnnna$aProlapse, Mitral Valve
=450  \\$wnnna$aProlapsed Mitral Valve
=450  \\$wnnna$aProlapsed Mitral Valves
=450  \\$wnnna$aProlapses, Mitral Valve
=450  \\$wnnna$aSyndrome, Click-Murmur
=450  \\$wnnna$aSyndrome, Mitral Click-Murmur
=450  \\$wnnna$aSyndrome, Systolic Click-Murmur
=450  \\$wnnna$aSyndromes, Click-Murmur
=450  \\$aSystolic Click-Murmur Syndrome
=450  \\$wnnna$aSystolic Click Murmur Syndrome
=450  \\$wnnna$aValve Prolapse, Mitral
=450  \\$wnnna$aValve, Prolapsed Mitral
=450  \\$wnnna$aValve Prolapses, Mitral
=450  \\$wnnna$aValves, Prolapsed Mitral
=550  \\$wg$aHeart Valve Prolapse
=680  \\$iAbnormal protrusion or billowing of one or both of the leaflets of MITRAL VALVE into the LEFT ATRIUM during SYSTOLE. This allows the backflow of blood into left atrium leading to MITRAL VALVE INSUFFICIENCY; SYSTOLIC MURMURS; or CARDIAC ARRHYTHMIA.
=688  \\$a79
=750  \0$aMitral valve$xDisplacement$5IEN$0(DLC)sh 85086296

=LDR  01271cz  a2200337n  4500
=001  9880363712802441
=005  20141212203534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008944
=035  \\$aCBA2197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x461
=150  \\$aMitral Valve Insufficiency
=450  \\$wnnna$aIncompetence, Mitral
=450  \\$wnnna$aIncompetence, Mitral Valve
=450  \\$wnnna$aInsufficiency, Mitral
=450  \\$wnnna$aInsufficiency, Mitral Valve
=450  \\$aMitral Incompetence
=450  \\$wnnna$aMitral Insufficiency
=450  \\$aMitral Regurgitation
=450  \\$aMitral Valve Incompetence
=450  \\$wnnna$aMitral Valve Regurgitation
=450  \\$wnnna$aRegurgitation, Mitral
=450  \\$wnnna$aRegurgitation, Mitral Valve
=450  \\$wnnna$aValve Incompetence, Mitral
=450  \\$wnnna$aValve Insufficiency, Mitral
=450  \\$wnnna$aValve Regurgitation, Mitral
=550  \\$wg$aHeart Valve Diseases
=680  \\$iBackflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
=688  \\$a67; was MITRAL INSUFFICIENCY 1963-66
=750  \0$aMitral valve insufficiency$5IEN$0(DLC)sh 85086298

=LDR  00765cz  a2200253n  4500
=001  9880363712902441
=005  20141212203534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008943
=035  \\$aCBA2196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510.$x507
=150  \\$aMitral Valve
=450  \\$aBicuspid Valve
=450  \\$wnnna$aBicuspid Valves
=450  \\$wnnna$aMitral Valves
=450  \\$wnnna$aValve, Bicuspid
=450  \\$wnnna$aValve, Mitral
=450  \\$wnnna$aValves, Bicuspid
=450  \\$wnnna$aValves, Mitral
=550  \\$wg$aHeart Valves
=667  \\$aatresia: index MITRAL VALVE /abnorm
=680  \\$iThe valve between the left atrium and left ventricle of the heart.
=750  \0$aMitral valve$5IEN$0(DLC)sh 85086294

=LDR  02132cz  a2200649n  4500
=001  9880363713002441
=005  20141212203533.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008942
=035  \\$aCBA2195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x117.$x159.$x500
=072  \\$aD2.$x806.$x100.$x500
=072  \\$aD4.$x615.$x117.$x159.$x500
=150  \\$aMitoxantrone
=450  \\$wnnna$aAcetate, Mitoxantrone
=450  \\$wnnna$aAHP Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aAmgen Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aASTA Medica Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aBaxter Oncology Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aCL-232325
=450  \\$wnnna$aCL 232325
=450  \\$wnnna$aCL232325
=450  \\$wnnna$aColumbia Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aDHAQ
=450  \\$wnnna$aHydrochloride, Mitoxantrone
=450  \\$wnnna$aInibsa Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aLederle Brand of Mitoxantrone Hydrochloride
=450  \\$wnnna$aMitoxantrone Acetate
=450  \\$wnnna$aMitoxantrone Hydrochloride
=450  \\$aMitozantrone
=450  \\$wnnna$aMitroxone
=450  \\$wnnna$aNovantron
=450  \\$wnnna$aNovantrone
=450  \\$wnnna$aNSC-279836
=450  \\$wnnna$aNSC 279836
=450  \\$wnnna$aNSC-287836
=450  \\$wnnna$aNSC 287836
=450  \\$wnnna$aNSC-299195
=450  \\$wnnna$aNSC 299195
=450  \\$wnnna$aNSC-301739
=450  \\$wnnna$aNSC 301739
=450  \\$wnnna$aNSC-301739D
=450  \\$wnnna$aNSC 301739D
=450  \\$wnnna$aNSC279836
=450  \\$wnnna$aNSC287836
=450  \\$wnnna$aNSC299195
=450  \\$wnnna$aNSC301739
=450  \\$wnnna$aNSC301739D
=450  \\$wnnna$aOnkotrone
=450  \\$wnnna$aPralifan
=450  \\$wnnna$aRalenova
=450  \\$wnnna$aWyeth Brand of Mitoxantrone Hydrochloride
=550  \\$wg$aAnthraquinones
=680  \\$iAn anthracenedione-derived antineoplastic agent.
=688  \\$a87
=750  \0$aMitoxantrone hydrochloride$5IEN$0(DLC)sh 85086290

=LDR  01550cz  a2200409n  4500
=001  9880363713102441
=005  20141212203533.0
=008  830224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008941
=035  \\$aCBA2194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x820
=150  \\$aSpindle Apparatus
=450  \\$wnnna$aApparatus, Meiotic Spindle
=450  \\$wnnna$aApparatus, Mitotic
=450  \\$wnnna$aApparatus, Mitotic Spindle
=450  \\$wnnna$aApparatus, Spindle
=450  \\$wnnna$aMeiotic Spindle
=450  \\$wnnna$aMeiotic Spindle Apparatus
=450  \\$wnnna$aMeiotic Spindles
=450  \\$aMitotic Apparatus
=450  \\$wnnna$aMitotic Spindle
=450  \\$aMitotic Spindle Apparatus
=450  \\$wnnna$aMitotic Spindles
=450  \\$wnnna$aSpindle Apparatus, Meiotic
=450  \\$aSpindle Apparatus, Mitotic
=450  \\$wnnna$aSpindle, Meiotic
=450  \\$wnnna$aSpindle, Mitotic
=450  \\$wnnna$aSpindles, Meiotic
=450  \\$wnnna$aSpindles, Mitotic
=550  \\$wg$aCytoskeleton
=550  \\$wh$aSpindle Poles
=667  \\$acoordinate with MITOSIS or MEIOSIS if pertinent
=680  \\$iA microtubule structure that forms during CELL DIVISION. It consists of two SPINDLE POLES, and sets of MICROTUBULES that may include the astral microtubules, the polar microtubules, and the kinetochore microtubules.
=688  \\$a84
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Mitotic Spindle Apparatus
=750  \0$aSpindle (Cell division)$5IEN$0(DLC)sh 85126689

=LDR  01165cz  a2200325n  4500
=001  9880363713202441
=005  20141212203532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008938
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x134.$x220.$x220.$x781
=072  \\$aG5.$x355.$x105.$x220.$x781
=150  \\$aMitosis
=450  \\$wnnna$aM Phase, Mitotic
=450  \\$wnnna$aM Phases, Mitotic
=450  \\$wnnna$aMitoses
=450  \\$wnnna$aMitotic M Phase
=450  \\$wnnna$aMitotic M Phases
=450  \\$wnnna$aPhase, Mitotic M
=450  \\$wnnna$aPhases, Mitotic M
=550  \\$wg$aCell Nucleus Division
=550  \\$wh$aAnaphase
=550  \\$wh$aM Phase Cell Cycle Checkpoints
=550  \\$wh$aMetaphase
=550  \\$wh$aPrometaphase
=550  \\$wh$aProphase
=550  \\$wh$aTelophase
=680  \\$iA type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species.
=688  \\$a68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80
=750  \0$aMitosis$5IEN$0(DLC)sh 85086289

=LDR  00775cz  a2200181n  4500
=001  9880363713302441
=005  20141212203530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008934
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x593.$x624
=150  \\$aMitogens
=450  \\$wnnna$aPhytomitogens
=550  \\$wg$aMitosis Modulators
=550  \\$aMitosis
=680  \\$iSubstances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed)
=688  \\$a1973(1972); for PHYTOMITOGENS use PLANT LECTINS 1978-2002
=750  \0$aMitogens$0(DLC) sh 85086283$5IEN

=LDR  02235cz  a2200313n  4500
=001  9880363713402441
=005  20170706110138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008928
=035  \\$aCBA2181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x564
=072  \\$aA11.$x284.$x835.$x626
=150  \\$aMitochondria
=450  \\$wnnna$aContraction, Mitochondrial
=450  \\$wnnna$aContractions, Mitochondrial
=450  \\$aMitochondrial Contraction
=450  \\$wnnna$aMitochondrial Contractions
=450  \\$wnnna$aMitochondrion
=550  \\$wg$aOrganelles
=550  \\$wg$aSubcellular Fractions
=550  \\$wh$aMitochondria, Liver
=550  \\$wh$aMitochondria, Muscle
=550  \\$wh$aMitochondrial Ribosomes
=550  \\$wh$aSubmitochondrial Particles
=667  \\$aA 11 qualif except /cytol; /genet permitted; coord with organ /metab (IM) but not also organ /ultrastruct for metab studies, coord with organ /ultrastruct (IM) for morphol studies: TN 126; mitochondria of vasc or smooth musc tissue goes under MITOCHONDRIA, MUSCLE & do not coord with MUSCLE, SMOOTH or MUSCLE, SMOOTH, VASCULAR unless particularly discussed & then probably only NIM
=680  \\$iSemiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed)
=688  \\$aMITOCHONDRIAL CONTRACTION was heading 1969-96 (was see under MITOCHONDRIA 1975, was Prov 1969-74)
=750  \0$aMitochondria$0(DLC) sh 85086280$5IEN

=LDR  01304cz  a2200289n  4500
=001  9880363713502441
=005  20141212203528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008925
=035  \\$aCBA2178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419
=150  \\$aMites
=450  \\$aAcarus
=450  \\$wnnna$aMite
=550  \\$wg$aAcari
=550  \\$wh$aAcaridae
=550  \\$wh$aPsoroptidae
=550  \\$wh$aPyroglyphidae
=550  \\$wh$aSarcoptidae
=550  \\$wh$aTetranychidae
=550  \\$wh$aTrombiculidae
=550  \\$wh$aVarroidae
=550  \\$aAcaricides
=667  \\$aInfection = MITE INFESTATIONS; for miticides (chemicals killing or controlling mites) index under ACARICIDES; mite vectors = ARACHNID VECTORS (IM) + MITES (IM); mite control: coordinate IM with TICK CONTROL (IM).
=680  \\$iAny arthropod of the subclass ACARI except the TICKS. They are minute animals related to the spiders, usually having transparent or semitransparent bodies. They may be parasitic on humans and domestic animals, producing various irritations of the skin (MITE INFESTATIONS). Many mite species are important to human and veterinary medicine as both parasite and vector. Mites also infest plants.
=750  \0$aMites$5IEN$0(DLC)sh 85086270

=LDR  01255cz  a2200325n  4500
=001  9880363713602441
=005  20200508150801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008921
=035  \\$aCBA2174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x777
=072  \\$aN3.$x540.$x297.$x500
=150  \\$aReligious Missions
=450  \\$wnnna$aMission, Religious
=450  \\$aMissions
=450  \\$wnnoa$aMissions and Missionaries$5IEN-M
=450  \\$wnnna$aMissions, Religious
=450  \\$wnnna$aReligious Mission
=550  \\$wg$aFaith-Based Organizations
=550  \\$wg$aReligion
=550  \\$aMedical Missions, Official
=550  \\$aMissionaries
=550  \\$aMonks
=550  \\$aNuns
=667  \\$aMEDICAL MISSIONS, OFFICIAL and MISSIONARIES are also available
=680  \\$iPermanent offices or institutions, such as clinics or hospitals, established by religious groups to provide centers for missionary activities, including spreading faith or providing educational, medical, or other assistance.
=688  \\$a2015(1991); was indexed under MISSIONS AND MISSIONARIES 1992-2014
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Missions and Missionaries
=750  \0$aMissions$0(DLC)sh 85086032$5IEN-M

=LDR  00565cz  a2200181n  4500
=001  9880363713702441
=005  20141212203524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008917
=035  \\$aCBA2170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x659
=150  \\$aMirex
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iAn organochlorine insecticide that is carcinogenic.
=688  \\$a91(72); was see under INSECTICIDES, ORGANOCHLORINE 1972-90
=750  \0$aMirex$5IEN$0(DLC)sh 85085949

=LDR  00942cz  a2200265n  4500
=001  9880363713802441
=005  20141212203524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008914
=035  \\$aCBA2167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x493
=072  \\$aD3.$x383.$x742.$x418
=150  \\$aMinoxidil
=450  \\$wnnna$aLoniten
=450  \\$wnnna$aMinoxidil Pfizer Brand
=450  \\$wnnna$aPfizer Brand of Minoxidil
=450  \\$wnnna$aRegaine
=450  \\$wnnna$aRogaine
=450  \\$wnnna$aU 10858
=550  \\$wg$aPiperidines
=550  \\$wg$aPyrimidines
=680  \\$iA potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
=688  \\$a86(72); was see under PYRIMIDINES 1975-85, was Prov 1972-74
=750  \0$aMinoxidil$5IEN-M$0(DLC)sh 94006275

=LDR  00776cz  a2200229n  4500
=001  9880363713902441
=005  20141212192331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008913
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x300
=150  \\$aMinority Groups
=450  \\$wnnna$aGroup, Minority
=450  \\$wnnna$aGroups, Minority
=450  \\$wnnna$aMinority Group
=550  \\$wg$aSociological Factors
=550  \\$aMinority Health
=667  \\$aIM; coord with specific minority group (IM) & geog
=680  \\$iA subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group.
=688  \\$a1968
=688  \\$a68
=750  \0$aMinorities$5IEN-HS$0(DLC)sh 85085792

=LDR  01053cz  a2200313n  4500
=001  9880363714002441
=005  20141212203521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008907
=035  \\$aCBA2160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x550.$x500
=150  \\$aMink
=450  \\$aAmerican Mink
=450  \\$aEuropean Mink
=450  \\$wnnna$aMink, American
=450  \\$wnnna$aMink, European
=450  \\$wnnna$aMink, Sea
=450  \\$wnnna$aMinks
=450  \\$wnnna$aMinks, Sea
=450  \\$aMustela lutreola
=450  \\$aMustela macrodon
=450  \\$aMustela vison
=450  \\$aSea Mink
=450  \\$wnnna$aSea Minks
=550  \\$wg$aMustelidae
=680  \\$iCarnivores of genus Mustela of the family MUSTELIDAE. The European mink, which has white upper and lower lips, was widely trapped for commercial purposes and is classified as endangered. The American mink, lacking a white upper lip, is farmed commercially.
=688  \\$a68
=750  \0$aMinks$5IEN$0(DLC)sh 85085750

=LDR  00816cz  a2200241n  4500
=001  9880363714102441
=005  20141212192330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008906
=035  \\$aCBA2159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x500
=150  \\$aMining
=450  \\$aMineral Industries$5IEN
=450  \\$aMiners$5IEN
=450  \\$aMines and Mineral Resources$5IEN
=450  \\$wnnna$aMinings
=550  \\$wg$aExtraction and Processing Industry
=550  \\$wh$aCoal Mining
=667  \\$aSPEC: SPEC qualif; coord IM with substance being mined (IM or NIM); COAL MINING is also available
=750  \0$aMines and mineral resources$5IEN-M$0(DLC)sh 85085614
=750  \0$aMiners$5IEN-HS$0(DLC)sh 85085603
=750  \0$aMineral industries$5IEN-HS$0(DLC)sh 85085548

=LDR  00833cz  a2200193n  4500
=001  9880363714202441
=005  20141212203520.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008905
=035  \\$aCBA2158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x580
=150  \\$aMinicomputers
=450  \\$wnnna$aMinicomputer
=550  \\$wg$aComputers
=667  \\$ado not confuse with MICROCOMPUTERS; personal computers: index under MICROCOMPUTERS
=680  \\$iSmall computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers.
=688  \\$a91(80); was see under COMPUTERS 1980-90
=750  \0$aMinicomputers$5IEN$0(DLC)sh 85085693

=LDR  01251cz  a2200301n  4500
=001  9880363714302441
=005  20141212203520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008903
=035  \\$aCBA2156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578
=150  \\$aMinerals
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aApatites
=550  \\$wh$aCalcium Carbonate
=550  \\$wh$aCalcium Sulfate
=550  \\$wh$aFerrosoferric Oxide
=550  \\$wh$aGraphite
=550  \\$wh$aMineral Fibers
=550  \\$wh$aSelenium
=550  \\$wh$aSilicates
=550  \\$wh$aSilicon Dioxide
=667  \\$aGEN: prefer specifics; trace minerals = TRACE ELEMENTS; "bone minerals" = MINERALS (IM) + BONE AND BONES (IM)
=680  \\$iNative, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a/metabolism was MINERAL METABOLISM 1963-65
=750  \0$aMinerals in nutrition$5IEN-M$0(DLC)sh 85085598
=750  \0$aMinerals$5IEN-HS$0(DLC)sh 90001070

=LDR  01124cz  a2200241n  4500
=001  9880363714402441
=005  20141212203520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008901
=035  \\$aCBA2154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x673
=150  \\$aMineralocorticoids
=450  \\$wnnna$aEffect, Mineralocorticoid
=450  \\$wnnna$aEffects, Mineralocorticoid
=450  \\$wnnna$aMineralocorticoid Effect
=450  \\$wnnna$aMineralocorticoid Effects
=450  \\$wnnoa$aMineralocorticoids, Synthetic$5IEN-M
=550  \\$wg$aHormones
=667  \\$anote entry term MINERALOCORTICOID EFFECT: use only for the mineralocorticoid effect of a chemical substance
=680  \\$iA group of CORTICOSTEROIDS primarily associated with water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II.
=688  \\$a67
=750  \0$aMineralocorticoids$5IEN$0(DLC)sh 85085585

=LDR  00804cz  a2200265n  4500
=001  9880363714502441
=005  20141212203519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008900
=035  \\$aCBA2153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x900.$x600
=072  \\$aD1.$x650.$x550.$x925.$x600
=150  \\$aMineral Waters
=450  \\$wnnna$aMineral Water
=450  \\$wnnna$aWater, Mineral
=450  \\$wnnna$aWaters, Mineral
=550  \\$wg$aWater
=550  \\$wh$aCarbonated Water
=550  \\$aBalneology
=550  \\$aNatural Springs
=550  \\$aWater
=667  \\$acoordinate with DRINKING WATER or BALNEOLOGY as appropriate
=680  \\$iWater naturally or artificially infused with mineral salts or gases.
=750  \0$aMineral waters$5IEN$0(DLC)sh 85085578

=LDR  00914cz  a2200277n  4500
=001  9880363714602441
=005  20141212203519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008899
=035  \\$aCBA2152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x699.$x500
=150  \\$aMineral Oil
=450  \\$wnnna$aDrakeol
=450  \\$aLiquid Paraffin
=450  \\$wnnna$aLiquid Petrolatum
=450  \\$wnnna$aOil, Mineral
=450  \\$wnnna$aOil, Vaseline
=450  \\$wnnna$aParaffin, Liquid
=450  \\$aPetrolatum, Liquid
=450  \\$wnnna$aVaseline Oil
=550  \\$wg$aPetrolatum
=667  \\$aD25-26 qualif
=680  \\$iA mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.
=688  \\$a66; was in Cat D only 1966-82, was PETROLATUM LIQUID in Cat D only 1963-65
=750  \0$aMineral oils$5IEN$0(DLC)sh 85085568

=LDR  00783cz  a2200253n  4500
=001  9880363714702441
=005  20141212203519.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008898
=035  \\$aCBA2151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x791.$x550
=072  \\$aD12.$x125.$x42.$x500
=150  \\$aMimosine
=450  \\$wnnna$aLeucaenine
=450  \\$wnnna$aLeucaenol
=450  \\$aLeucenine
=450  \\$aLeucenol
=550  \\$wg$aAlanine
=550  \\$wg$aPyridones
=667  \\$aan antineoplastic
=680  \\$i3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.
=688  \\$a91(75); was see under PYRIDONES 1975-90
=750  \0$aMimosine$5IEN$0(DLC)sh 85085461

=LDR  01387cz  a2200349n  4500
=001  9880363714802441
=005  20160422112158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008897
=035  \\$aCBA2150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x680
=072  \\$aJ2.$x500.$x200.$x733
=072  \\$aJ2.$x500.$x300.$x100.$x606
=150  \\$aPanicum
=450  \\$wnnna$aBroomcorn Millet
=450  \\$wnnna$aCommon Millet
=450  \\$wnnna$aLittle Millet
=450  \\$aMillet
=450  \\$aMillet, Broomcorn
=450  \\$aMillet, Common
=450  \\$aMillet, Little
=450  \\$wnnna$aMillets
=450  \\$aPanicgrass
=450  \\$wnnna$aPanicum Miliaceum
=450  \\$wnnna$aPanicum miliare
=550  \\$wg$aAnimal Feed
=550  \\$wg$aPoaceae
=667  \\$aother millet plants are available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The seed is one of the millets used in CEREALS and in feed for birds and livestock (ANIMAL FEED). It contains diosgenin (SAPONINS).
=688  \\$a2003(1963)
=750  \0$aPanicum$5IEN-M$0(DLC)sh 85097440

=LDR  00773cz  a2200277n  4500
=001  9880363714902441
=005  20141212203518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008895
=035  \\$aCBA2148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x467
=072  \\$aJ2.$x200.$x700.$x500
=072  \\$aJ2.$x500.$x350.$x525.$x500
=150  \\$aMilk, Human
=450  \\$aBreast Milk
=450  \\$wnnna$aBreast Milks
=450  \\$wnnna$aHuman Milk
=450  \\$wnnna$aMilk, Breast
=550  \\$wg$aBodily Secretions
=550  \\$wg$aMilk
=550  \\$aBreast Feeding
=550  \\$aInfant Nutritional Physiological Phenomena
=550  \\$aLactation
=667  \\$a/secret: consider also LACTATION
=750  \0$aBreast milk$5IEN$0(DLC)sh 85085341

=LDR  01137cz  a2200301n  4500
=001  9880363715002441
=005  20171219134925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008894
=035  \\$aCBA2147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x256.$x626
=072  \\$aG7.$x203.$x300.$x350.$x525.$x520
=072  \\$aG7.$x203.$x300.$x428.$x626
=072  \\$aJ2.$x500.$x350.$x525.$x520
=072  \\$aJ2.$x500.$x428.$x626
=150  \\$aMilk Proteins
=450  \\$wnnna$aMilk Protein
=450  \\$wnnna$aProtein, Milk
=450  \\$wnnna$aProteins, Milk
=550  \\$wg$aDietary Proteins
=550  \\$wg$aMilk
=550  \\$wh$aCaseins
=550  \\$wh$aWhey Proteins
=667  \\$ado not use /analogs /defic /physiol
=680  \\$iThe major protein constituents of milk are CASEINS and whey proteins such as LACTALBUMIN and LACTOGLOBULINS. IMMUNOGLOBULINS occur in high concentrations in COLOSTRUM and in relatively lower concentrations in milk. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p554)
=688  \\$a73
=750  \0$aMilk proteins$5IEN$0(DLC)sh 85085363

=LDR  01248cz  a2200349n  4500
=001  9880363715102441
=005  20180319101940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008892
=035  \\$aCBA2145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x455
=072  \\$aG7.$x203.$x100.$x700
=072  \\$aG7.$x203.$x300.$x350.$x525
=072  \\$aJ2.$x200.$x700
=072  \\$aJ2.$x500.$x350.$x525
=150  \\$aMilk
=550  \\$wg$aBeverages
=550  \\$wg$aBodily Secretions
=550  \\$wg$aDairy Products
=550  \\$wh$aButtermilk
=550  \\$wh$aKefir
=550  \\$wh$aKoumiss
=550  \\$wh$aMilk, Human
=550  \\$wh$aMilk Proteins
=550  \\$wh$aWhey
=550  \\$aInfant Nutritional Physiological Phenomena
=550  \\$aLactation
=667  \\$aassume to be cow's milk & do not coord with CATTLE; coord IM with other animal source (NIM), as goat's milk = MILK (IM) + GOATS (NIM); /secret: consider also LACTATION; /adv eff; consider also MILK HYPERSENSITIVITY
=680  \\$iThe white liquid secreted by the mammary glands. It contains proteins, sugar, lipids, vitamins, and minerals.
=750  \0$aMilk$0(DLC) sh 85085317$5IEN-M
=750  \0$aMilk$xPasteurization$0(DLC) sh 85085327$5IEN-M

=LDR  00795cz  a2200265n  4500
=001  9880363715202441
=005  20141212203517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008891
=035  \\$aCBA2144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x675
=150  \\$aMilitary Science
=450  \\$aMilitary Art and Science$5IEN
=450  \\$wnnna$aMilitary Sciences
=450  \\$aNaval Science
=450  \\$wnnna$aNaval Sciences
=450  \\$wnnna$aScience, Military
=450  \\$wnnna$aScience, Naval
=450  \\$wnnna$aSciences, Military
=450  \\$wnnna$aSciences, Naval
=550  \\$wg$aTechnology, Industry, and Agriculture
=667  \\$aspecify country
=688  \\$aNAVAL SCIENCE was heading 1963-82
=750  \0$aMilitary art and science$5IEN$0(DLC)sh 85085132

=LDR  00779cz  a2200205n  4500
=001  9880363715302441
=005  20141212203516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008890
=035  \\$aCBA2143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x480
=072  \\$aH2.$x403.$x690.$x508
=150  \\$aMilitary Psychiatry
=450  \\$aPsychiatry, Military
=550  \\$wg$aPsychiatry
=667  \\$aSPEC only: SPEC qualif; not for MENTAL DISORDERS in soldiers, etc.
=680  \\$iBranch of psychiatry concerned with problems related to the prevention, diagnosis, etiology, and treatment of mental or emotional disorders of Armed Forces personnel.
=688  \\$a80; was PSYCHIATRY, MILITARY 1963-79
=750  \0$aMilitary psychiatry$5IEN$0(DLC)sh 85108395

=LDR  01386cz  a2200409n  4500
=001  9880363715402441
=005  20141212192330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008889
=035  \\$aCBA2142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x625
=150  \\$aMilitary Personnel
=450  \\$aAir Force Personnel
=450  \\$aArmed Forces Personnel
=450  \\$aArmy Personnel
=450  \\$aCoast Guard
=450  \\$wnnna$aForce Personnel, Air
=450  \\$aMarines
=450  \\$wnnna$aMilitary
=450  \\$aNavy Personnel
=450  \\$wnnna$aPersonnel, Air Force
=450  \\$wnnna$aPersonnel, Armed Forces
=450  \\$wnnna$aPersonnel, Army
=450  \\$wnnna$aPersonnel, Military
=450  \\$wnnna$aPersonnel, Navy
=450  \\$wnnna$aSailor
=450  \\$aSailors
=450  \\$wnnna$aSoldier
=450  \\$aSoldiers
=450  \\$wnnna$aSubmariner
=450  \\$aSubmariners
=550  \\$wg$aOccupational Groups
=550  \\$aMilitary Family
=667  \\$atheir physiol & diseases go here: reserve MILITARY MEDICINE for the specialty; includes all uniformed personnel: note X refs; /psychol: consider also the specialties PSYCHOLOGY, MILITARY & MILITARY PSYCHIATRY; specify country; Manual 28.8, 34.15
=680  \\$iPersons including soldiers involved with the armed forces.
=750  \0$aSoldiers$5IEN$0(DLC)sh 85124554

=LDR  00722cz  a2200229n  4500
=001  9880363715502441
=005  20141212203516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008888
=035  \\$aCBA2141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x458
=150  \\$aMilitary Nursing
=450  \\$wnnna$aMilitary and Naval Nursing
=450  \\$wnnna$aMilitary Nursings
=450  \\$wnnna$aNursing, Military
=450  \\$aNursing, Military and Naval
=450  \\$wnnna$aNursings, Military
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif; specify country
=680  \\$iThe practice of nursing in military environments.
=750  \0$aMilitary nursing$5IEN$0(DLC)sh 85085245

=LDR  00762cz  a2200181n  4500
=001  9880363715602441
=005  20141212203516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008887
=035  \\$aCBA2140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x500
=150  \\$aMilitary Medicine
=450  \\$wnnna$aMedicine, Military
=550  \\$wg$aMedicine
=667  \\$aSPEC: SPEC qualif; specify country; Manual 23.6, 28.8, 34.15; Uniformed Services University of the Health Sciences, under US Dept of Defense, goes under SCHOOLS, MEDICAL (IM) + UNITED STATES (NIM); DF: MILITARY MED
=680  \\$iThe practice of medicine as applied to special circumstances associated with military operations.
=750  \0$aMedicine, Military$5IEN$0(DLC)sh 85083153

=LDR  00550cz  a2200193n  4500
=001  9880363715702441
=005  20141212203516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008886
=035  \\$aCBA2139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x670.$x300
=150  \\$aMilitary Hygiene
=450  \\$wnnna$aHygiene, Military
=450  \\$wnnna$aHygienes, Military
=450  \\$wnnna$aMilitary Hygienes
=550  \\$wg$aHygiene
=667  \\$aSPEC: SPEC qualif; specify country
=750  \0$aMilitary hygiene$5IEN$0(DLC)sh 85085220

=LDR  00712cz  a2200217n  4500
=001  9880363715802441
=005  20141212203515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008885
=035  \\$aCBA2138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x592
=150  \\$aMilitary Dentistry
=450  \\$wnnna$aDentistries, Military
=450  \\$wnnna$aDentistry, Military
=450  \\$wnnna$aMilitary Dentistries
=550  \\$wg$aDentistry
=667  \\$aSPEC: SPEC qualif; specify country; DF: MILITARY DENT
=680  \\$iThe practice of dentistry as applied to special circumstances associated with military operations.
=688  \\$a65
=750  \0$aDentistry, Military$5IEN$0(DLC)sh 85036966

=LDR  01092cz  a2200277n  4500
=001  9880363715902441
=005  20141212203515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008884
=035  \\$aCBA2137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x392
=150  \\$aMilieu Therapy
=450  \\$wnnna$aMilieu Therapies
=450  \\$wnnna$aSituational Therapies
=450  \\$aSituational Therapy
=450  \\$wnnna$aTherapies, Milieu
=450  \\$wnnna$aTherapies, Situational
=450  \\$wnnna$aTherapy, Milieu
=450  \\$wnnna$aTherapy, Situational
=550  \\$wg$aSocioenvironmental Therapy
=550  \\$wh$aTherapeutic Community
=667  \\$aa form of socioenvir ther; DF: MILIEU THER
=680  \\$iA treatment program based on manipulation of the patient's environment by the medical staff. The patient does not participate in planning the treatment regimen.
=688  \\$a69(67); SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78
=750  \0$aMilieu therapy$5IEN$0(DLC)sh 85085123

=LDR  02476cz  a2200649n  4500
=001  9880363716002441
=005  20141212203514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008881
=035  \\$aCBA2134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x546.$x399.$x750
=150  \\$aMigraine Disorders
=450  \\$wnnna$aAbdominal Migraine
=450  \\$wnnna$aAbdominal Migraines
=450  \\$aAcute Confusional Migraine
=450  \\$wnnna$aAcute Confusional Migraines
=450  \\$wnnna$aCervical Migraine Syndrome
=450  \\$wnnna$aCervical Migraine Syndromes
=450  \\$wnnna$aDisorder, Migraine
=450  \\$wnnna$aDisorders, Migraine
=450  \\$aHeadache, Migraine
=450  \\$wnnna$aHeadache, Sick
=450  \\$wnnna$aHeadaches, Migraine
=450  \\$wnnna$aHeadaches, Sick
=450  \\$wnnna$aHemicrania Migraine
=450  \\$wnnna$aHemicrania Migraines
=450  \\$wnnna$aMigraine
=450  \\$wnnna$aMigraine, Abdominal
=450  \\$wnnna$aMigraine, Acute Confusional
=450  \\$wnnna$aMigraine Disorder
=450  \\$wnnna$aMigraine Headache
=450  \\$wnnna$aMigraine Headaches
=450  \\$wnnna$aMigraine, Hemicrania
=450  \\$wnnna$aMigraine Syndrome, Cervical
=450  \\$wnnna$aMigraine Syndromes, Cervical
=450  \\$wnnna$aMigraine Variant
=450  \\$wnnna$aMigraine Variants
=450  \\$wnnna$aMigraines
=450  \\$wnnna$aMigraines, Abdominal
=450  \\$wnnna$aMigraines, Acute Confusional
=450  \\$wnnna$aMigraines, Hemicrania
=450  \\$wnnna$aSick Headache
=450  \\$wnnna$aSick Headaches
=450  \\$aStatus Migrainosus
=450  \\$wnnna$aVariant, Migraine
=450  \\$wnnna$aVariants, Migraine
=550  \\$wg$aHeadache Disorders, Primary
=550  \\$wh$aAlice in Wonderland Syndrome
=550  \\$wh$aMigraine with Aura
=550  \\$wh$aMigraine without Aura
=550  \\$wh$aOphthalmoplegic Migraine
=667  \\$anote many specifics; use word of text
=680  \\$iA class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Migraine
=750  \0$aMigraine$0(DLC) sh 85085064$5IEN

=LDR  00800cz  a2200253n  4500
=001  9880363716102441
=005  20141212203514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008880
=035  \\$aCBA2133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x416
=150  \\$aMidwifery
=450  \\$wnnna$aBirth Attendant, Traditional
=450  \\$wnnna$aBirth Attendants, Traditional
=450  \\$wnnna$aMidwife
=450  \\$wnnna$aMidwives
=450  \\$aTraditional Birth Attendant
=450  \\$wnnna$aTraditional Birth Attendants
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif; check also tag PREGNANCY
=680  \\$iThe practice of assisting women in childbirth.
=688  \\$a66; was MIDWIVES 1963-65
=750  \0$aMidwifery$5IEN$0(DLC)sh 96006072

=LDR  00641cz  a2200193n  4500
=001  9880363716202441
=005  20141212203512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008875
=035  \\$aCBA2127HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x116.$x630
=150  \\$aMiddle Aged
=450  \\$wnnna$aMiddle Age
=550  \\$wg$aAdult
=667  \\$aage 45-64; IM as psychol, sociol entity: Manual 18.5.12; NIM as check tag; Manual 34.10 for indexing examples
=688  \\$a2004(1966); was MIDDLE AGE 1966-2003
=750  \0$aMiddle age$0(DLC) sh 85084992$5IEN-M
=750  \0$aMiddle-aged persons$0(DLC) sh 89000477$5IEN-M

=LDR  01144cz  a2200277n  4500
=001  9880363716302441
=005  20141212203511.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008874
=035  \\$aCBA2126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x575
=150  \\$aMidazolam
=450  \\$wnnna$aDormicum
=450  \\$wnnna$aHydrochloride, Midazolam
=450  \\$wnnna$aMaleate, Midazolam
=450  \\$wnnna$aMidazolam Hydrochloride
=450  \\$wnnna$aMidazolam Maleate
=450  \\$wnnna$aRo 21-3981
=450  \\$wnnna$aRo 21 3981
=450  \\$wnnna$aRo 213981
=450  \\$wnnna$aVersed
=550  \\$wg$aBenzodiazepines
=680  \\$iA short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
=688  \\$a87
=750  \0$aMidazolam$5IEN$0(DLC)sh 89000885

=LDR  01173cz  a2200337n  4500
=001  9880363716402441
=005  20141212203511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008872
=035  \\$aCBA2124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x810.$x500
=072  \\$aG1.$x750.$x250.$x810.$x500
=072  \\$aG1.$x750.$x770.$x721.$x500
=150  \\$aMicrowaves
=450  \\$wnnna$aEHF Wave
=450  \\$aEHF Waves
=450  \\$aExtremely High Frequency Radio Waves
=450  \\$wnnna$aFrequency Wave, Ultrahigh
=450  \\$wnnna$aFrequency Waves, Ultrahigh
=450  \\$wnnna$aMicrowave
=450  \\$wnnna$aUltrahigh Frequency Wave
=450  \\$aUltrahigh Frequency Waves
=450  \\$wnnna$aWave, EHF
=450  \\$wnnna$aWave, Ultrahigh Frequency
=450  \\$wnnna$aWaves, EHF
=450  \\$wnnna$aWaves, Ultrahigh Frequency
=550  \\$wg$aRadio Waves
=667  \\$asee Manual for radiation indexing policy
=680  \\$iThat portion of the electromagnetic spectrum from the UHF (ultrahigh frequency) radio waves and extending into the INFRARED RAYS frequencies.
=750  \0$aMicrowaves$5IEN$0(DLC)sh 85084975

=LDR  00944cz  a2200289n  4500
=001  9880363716502441
=005  20141212192329.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008871
=035  \\$aCBA2123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x180.$x565
=150  \\$aMicrovilli
=450  \\$wnnna$aBorder, Brush
=450  \\$wnnna$aBorder, Striated
=450  \\$wnnna$aBorders, Brush
=450  \\$wnnna$aBorders, Striated
=450  \\$aBrush Border
=450  \\$wnnna$aBrush Borders
=450  \\$wnnna$aMicrovillus
=450  \\$aStriated Border
=450  \\$wnnna$aStriated Borders
=550  \\$wg$aCell Surface Extensions
=667  \\$acoordinate with specific cell / ultrastruct
=680  \\$iMinute projections of cell membranes which greatly increase the surface area of the cell.
=688  \\$a84(78); was see under CELL MEMBRANE 1978-83
=750  \0$aBrush border membrane$5IEN-M$0(DLC)sh 86001809

=LDR  00766cz  a2200229n  4500
=001  9880363716602441
=005  20141212203510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008870
=035  \\$aCBA2122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x602
=150  \\$aMicrotubules
=450  \\$wnnna$aMicrotubule
=550  \\$wg$aCytoskeleton
=550  \\$wh$aAxoneme
=550  \\$wh$aNeuropil Threads
=550  \\$aSpindle Apparatus
=550  \\$aTubulin Modulators
=680  \\$iSlender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS.
=688  \\$a72(70)
=750  \0$aMicrotubules$5IEN$0(DLC)sh 85084941

=LDR  00752cz  a2200253n  4500
=001  9880363716702441
=005  20141212203509.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008868
=035  \\$aCBA2120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x734
=072  \\$aD12.$x776.$x220.$x600
=150  \\$aMicrotubule Proteins
=450  \\$wnnna$aProteins, Microtubule
=550  \\$wg$aBiopolymers
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wh$aDyneins
=550  \\$wh$aMicrotubule-Associated Proteins
=550  \\$wh$aTubulin
=667  \\$a/biosyn /drug eff /physiol permitted; TUBULIN is available
=680  \\$iProteins found in the microtubules.
=688  \\$a85
=750  \0$aTubulins$0(DLC) sh 89000902$5IEN

=LDR  01070cz  a2200265n  4500
=001  9880363716802441
=005  20141212203509.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008867
=035  \\$aCBA2119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x530
=072  \\$aE1.$x370.$x225.$x750.$x600.$x530
=072  \\$aE5.$x200.$x500.$x620.$x530
=072  \\$aE5.$x200.$x750.$x600.$x530
=150  \\$aMicrotomy
=450  \\$wnnna$aSectioning, Thin
=450  \\$wnnna$aSectionings, Thin
=450  \\$aThin Sectioning
=450  \\$wnnna$aThin Sectionings
=450  \\$aUltramicrotomy
=550  \\$wg$aHistocytological Preparation Techniques
=550  \\$wh$aCryoultramicrotomy
=680  \\$iThe technique of using a microtome to cut thin or ultrathin sections of tissues embedded in a supporting substance. The microtome is an instrument that hold a steel, glass or diamond knife in clamps at an angle to the blocks of prepared tissues, which it cuts in sections of equal thickness.
=750  \0$aMicrotomy$5IEN$0(DLC)sh 85084937

=LDR  00720cz  a2200241n  4500
=001  9880363716902441
=005  20171102181914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008866
=035  \\$aCBA2118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x494
=072  \\$aE5.$x591.$x580
=150  \\$aMicrosurgery
=550  \\$wg$aMicromanipulation
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCerebral Revascularization
=550  \\$wh$aMohs Surgery
=550  \\$wh$aTransanal Endoscopic Microsurgery
=550  \\$aMicrodissection
=680  \\$iThe performance of surgical procedures with the aid of a microscope.
=688  \\$a72(69)
=750  \0$aMicrosurgery$5IEN$0(DLC)sh 85084932

=LDR  01070cz  a2200217n  4500
=001  9880363717002441
=005  20141212203508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008864
=035  \\$aCBA2116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x560
=150  \\$aMicrosporum
=450  \\$aMicrosporon
=450  \\$wnnna$aMicrosporons
=450  \\$wnnna$aMicrosporums
=550  \\$wg$aMitosporic Fungi
=550  \\$aArthrodermataceae
=667  \\$ado not confuse with the phylum MICROSPORIDIA, the class MICROSPOREA, nor with the order MICROSPORIDA; infection: coordinate IM with DERMATOMYCOSES (IM) or specific (IM); do not confuse with MICROSPORIDIOSIS
=680  \\$iA mitosporic Oxygenales fungal genus causing various diseases of the skin and hair. The species Microsporum canis produces TINEA CAPITIS and tinea corporis, which usually are acquired from domestic cats and dogs. Teleomorphs includes Arthroderma (Nannizzia). (Alexopoulos et al., Introductory Mycology, 4th edition, p305)
=750  \0$aMicrosporum$5IEN$0(DLC)sh 88022076

=LDR  01304cz  a2200373n  4500
=001  9880363717102441
=005  20141212203508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008863
=035  \\$aCBA2115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x565
=150  \\$aMicrospheres
=450  \\$wnnna$aBead, Latex
=450  \\$wnnna$aBeads, Latex
=450  \\$wnnna$aLatex Bead
=450  \\$aLatex Beads
=450  \\$wnnna$aLatex Particle
=450  \\$aLatex Particles
=450  \\$wnnna$aLatex Sphere
=450  \\$aLatex Spheres
=450  \\$wnnna$aMicrobead
=450  \\$wnnna$aMicrobeads
=450  \\$wnnna$aMicrosphere
=450  \\$wnnna$aParticle, Latex
=450  \\$wnnna$aParticles, Latex
=450  \\$wnnna$aSphere, Latex
=450  \\$wnnna$aSpheres, Latex
=550  \\$wg$aEquipment and Supplies
=550  \\$aMicrobubbles
=667  \\$anote X refs: do not coord with LATEX unless particularly discussed; note MICROCAPSULES see CAPSULES: do not coord with MICROSPHERES
=680  \\$iSmall uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers.
=688  \\$a74(72); LATEX PARTICLES was heading 1968-80
=750  \0$aMicrospheres (Pharmacy)$5IEN$0(DLC)sh 85084924

=LDR  00969cz  a2200205n  4500
=001  9880363717202441
=005  20141212203507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008861
=035  \\$aCBA2113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x835.$x540
=150  \\$aMicrosomes
=450  \\$wnnna$aMicrosome
=550  \\$wg$aSubcellular Fractions
=550  \\$wh$aMicrosomes, Liver
=667  \\$aA 11 qualif except /cytol
=680  \\$iArtifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
=688  \\$a65(64)
=750  \0$aMicrosomes$5IEN$0(DLC)sh 85084921

=LDR  00748cz  a2200229n  4500
=001  9880363717302441
=005  20141212203507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008860
=035  \\$aCBA2112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x680
=072  \\$aE5.$x595.$x680
=150  \\$aMicroscopy, Ultraviolet
=450  \\$wnnna$aMicroscopies, Ultraviolet
=450  \\$wnnna$aUltraviolet Microscopies
=450  \\$aUltraviolet Microscopy
=550  \\$wg$aMicroscopy
=667  \\$aNIM
=680  \\$iMicroscopy in which the image is formed by ultraviolet radiation and is displayed and recorded by means of photographic film.
=688  \\$a73
=750  \0$aUltraviolet microscopy$5IEN-M$0(DLC)sh 94006000

=LDR  01160cz  a2200301n  4500
=001  9880363717402441
=005  20141212203507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008859
=035  \\$aCBA2111HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x624
=072  \\$aE5.$x595.$x624
=150  \\$aMicroscopy, Polarization
=450  \\$wnnna$aLight Microscopies, Polarized
=450  \\$wnnna$aLight Microscopy, Polarized
=450  \\$wnnna$aMicroscopies, Polarization
=450  \\$wnnna$aMicroscopies, Polarized Light
=450  \\$aMicroscopy, Polarized Light
=450  \\$wnnna$aPolarization Microscopies
=450  \\$aPolarization Microscopy
=450  \\$wnnna$aPolarized Light Microscopies
=450  \\$wnnna$aPolarized Light Microscopy
=550  \\$wg$aMicroscopy
=667  \\$aNIM
=680  \\$iMicroscopy using polarized light in which phenomena due to the preferential orientation of optical properties with respect to the vibration plane of the polarized light are made visible and correlated parameters are made measurable.
=688  \\$a67(64)
=750  \0$aPolarization microscopy$5IEN$0(DLC)sh 92003379

=LDR  01538cz  a2200313n  4500
=001  9880363717502441
=005  20141212203506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008857
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x513
=072  \\$aE5.$x490.$x630
=072  \\$aE5.$x595.$x513
=150  \\$aMicroscopy, Interference
=450  \\$wnnna$aInterference Microscopy
=450  \\$wnnna$aInterference Reflection Microscopy
=450  \\$aInterferometry, Microscopic
=450  \\$aMicrointerferometry
=450  \\$wnnna$aMicroscopic Interferometry
=450  \\$wnnna$aMicroscopy, Differential Interference Contrast
=450  \\$wnnna$aMicroscopy, Interference Reflection
=450  \\$wnnna$aMicroscopy, Nomarski Interference Contrast
=450  \\$wnnna$aReflection Microscopy, Interference
=550  \\$wg$aInterferometry
=550  \\$wg$aMicroscopy
=550  \\$wh$aMicroscopy, Phase-Contrast
=680  \\$iThe science and application of a double-beam transmission interference microscope in which the illuminating light beam is split into two paths. One beam passes through the specimen while the other beam reflects off a reference mirror before joining and interfering with the other. The observed optical path difference between the two beams can be measured and used to discriminate minute differences in thickness and refraction of non-stained transparent specimens, such as living cells in culture.
=688  \\$a65(64)
=750  \0$aInterference microscopy$5IEN$0(DLC)sh 92003373

=LDR  01143cz  a2200277n  4500
=001  9880363717602441
=005  20141212203506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008856
=035  \\$aCBA2108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x458
=072  \\$aE5.$x595.$x458
=150  \\$aMicroscopy, Fluorescence
=450  \\$wnnna$aFluorescence Microscopies
=450  \\$aFluorescence Microscopy
=450  \\$wnnna$aImmunofluorescence Microscopies
=450  \\$aImmunofluorescence Microscopy
=450  \\$wnnna$aMicroscopies, Fluorescence
=450  \\$wnnna$aMicroscopies, Immunofluorescence
=450  \\$aMicroscopy, Immunofluorescence
=550  \\$wg$aMicroscopy
=550  \\$wh$aMicroscopy, Fluorescence, Multiphoton
=667  \\$aNIM
=680  \\$iMicroscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye.
=750  \0$aFluorescence microscopy$5IEN$0(DLC)sh 85049410

=LDR  01880cz  a2200337n  4500
=001  9880363717702441
=005  20141212203505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008855
=035  \\$aCBA2107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402.$x541
=072  \\$aE5.$x595.$x402.$x541
=150  \\$aMicroscopy, Electron, Scanning
=450  \\$wnnna$aElectron Microscopies, Scanning
=450  \\$wnnna$aElectron Microscopy, Scanning
=450  \\$wnnna$aElectron Scanning Microscopies
=450  \\$wnnna$aElectron Scanning Microscopy
=450  \\$wnnna$aMicroscopies, Electron Scanning
=450  \\$wnnna$aMicroscopies, Scanning Electron
=450  \\$wnnna$aMicroscopy, Electron Scanning
=450  \\$wnnna$aMicroscopy, Scanning Electron
=450  \\$wnnna$aScanning Electron Microscopies
=450  \\$aScanning Electron Microscopy
=450  \\$wnnna$aScanning Microscopies, Electron
=450  \\$wnnna$aScanning Microscopy, Electron
=550  \\$wg$aMicroscopy, Electron
=667  \\$aNIM; do not confuse with MICROSCOPY, ELECTRON, SCANNING TRANSMISSION or STEM; if in doubt, follow words of author; MICROSCOPY, SCANNING TUNNELING is also available
=680  \\$iMicroscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point. The image is constructed by detecting the products of specimen interactions that are projected above the plane of the sample, such as backscattered electrons. Although SCANNING TRANSMISSION ELECTRON MICROSCOPY also scans the specimen point by point with the electron beam, the image is constructed by detecting the electrons, or their interaction products that are transmitted through the sample plane, so that is a form of TRANSMISSION ELECTRON MICROSCOPY.
=688  \\$a72(69)
=750  \0$aScanning electron microscopes$5IEN$0(DLC)sh 85117990

=LDR  01316cz  a2200241n  4500
=001  9880363717802441
=005  20141212203505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008854
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402
=072  \\$aE5.$x595.$x402
=150  \\$aMicroscopy, Electron
=450  \\$aElectron Microscopy
=550  \\$wg$aMicroscopy
=550  \\$wh$aCryoelectron Microscopy
=550  \\$wh$aElectron Probe Microanalysis
=550  \\$wh$aMicroscopy, Electron, Scanning
=550  \\$wh$aMicroscopy, Electron, Transmission
=550  \\$wh$aMicroscopy, Immunoelectron
=667  \\$aGEN: prefer specifics; relation to /ultrastruct: Manual 26.12.1
=680  \\$iMicroscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
=750  \0$aElectron microscopy$5IEN$0(DLC)sh 85042221

=LDR  01791cz  a2200409n  4500
=001  9880363717902441
=005  20200608175547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008853
=035  \\$aCBA2105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515
=072  \\$aE5.$x595
=072  \\$aH1.$x671.$x617.$x562
=150  \\$aMicroscopy
=450  \\$wnnna$aMicroscopies
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aOptics and Photonics
=550  \\$wh$aDermoscopy
=550  \\$wh$aIntravital Microscopy
=550  \\$wh$aMicroscopy, Acoustic
=550  \\$wh$aMicroscopy, Confocal
=550  \\$wh$aMicroscopy, Electron
=550  \\$wh$aMicroscopy, Fluorescence
=550  \\$wh$aMicroscopy, Interference
=550  \\$wh$aMicroscopy, Polarization
=550  \\$wh$aMicroscopy, Scanning Probe
=550  \\$wh$aMicroscopy, Ultraviolet
=550  \\$wh$aMicroscopy, Video
=550  \\$wh$aNonlinear Optical Microscopy
=550  \\$wh$aNuclear Microscopy
=550  \\$wh$aPhotomicrography
=550  \\$wh$aSingle Molecule Imaging
=667  \\$ado not index here routinely for histol & cytol studies: Manual 26.12+
=680  \\$iThe use of instrumentation and techniques for visualizing material and details that cannot be seen by the unaided eye. It is usually done by enlarging images, transmitted by light or electron beams, with optical or magnetic lenses that magnify the entire image field. With scanning microscopy, images are generated by collecting output from the specimen in a point-by-point fashion, on a magnified scale, as it is scanned by a narrow beam of light or electrons, a laser, a conductive probe, or a topographical probe.
=750  \0$aMicroscopy$5IEN$0(DLC)sh 92003369

=LDR  00849cz  a2200181n  4500
=001  9880363718002441
=005  20141212203504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008852
=035  \\$aCBA2104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x510
=150  \\$aMicroradiography
=450  \\$wnnna$aMicroradiographies
=550  \\$wg$aRadiography
=667  \\$aNIM; DF: MICRORADIOGR
=680  \\$iProduction of a radiographic image of a small or very thin object on fine-grained photographic film under conditions which permit subsequent microscopic examination or enlargement of the radiograph at linear magnifications of up to several hundred and with a resolution approaching the resolving power of the photographic emulsion (about 1000 lines per millimeter).
=750  \0$aMicroradiography$5IEN$0(DLC)sh 85084905

=LDR  00757cz  a2200193n  4500
=001  9880363718102441
=005  20141212203502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008847
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x500.$x500
=072  \\$aB3.$x510.$x24.$x49.$x500.$x500
=072  \\$aB3.$x510.$x415.$x400.$x500.$x500
=072  \\$aB3.$x510.$x460.$x410.$x500.$x500
=150  \\$aMicromonospora
=550  \\$wg$aMicromonosporaceae
=667  \\$ain soil; a genus: do not confuse with the family MICROMONOSPORACEAE
=680  \\$iA genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments.
=750  \0$aMicromonospora$5IEN$0(DLC)sh 85084864

=LDR  00791cz  a2200241n  4500
=001  9880363718202441
=005  20141212203502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008846
=035  \\$aCBA2097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x591
=150  \\$aMicromanipulation
=450  \\$wnnna$aMicromanipulations
=450  \\$aMicrurgy$5IEN
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aMicrodissection
=550  \\$wh$aMicroinjections
=550  \\$wh$aMicrosurgery
=550  \\$aMicrochip Analytical Procedures
=680  \\$iThe performance of dissections, injections, surgery, etc., by the use of micromanipulators (attachments to a microscope) that manipulate tiny instruments.
=688  \\$a73(64)
=750  \0$aMicrurgy$5IEN$0(DLC)sh 85084978

=LDR  00657cz  a2200217n  4500
=001  9880363718302441
=005  20141212203501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008845
=035  \\$aCBA2096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x690
=072  \\$aE5.$x591.$x570
=150  \\$aMicroinjections
=450  \\$wnnna$aMicroinjection
=550  \\$wg$aInjections
=550  \\$wg$aMicromanipulation
=667  \\$aDF: MICROINJECT
=680  \\$iThe injection of very small amounts of fluid, often with the aid of a microscope and microsyringes.
=688  \\$a73
=750  \0$aMicroinjections$5IEN$0(DLC)sh 85084857

=LDR  00564cz  a2200217n  4500
=001  9880363718402441
=005  20141212203501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008843
=035  \\$aCBA2094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x240.$x630
=150  \\$aMicrofilming
=450  \\$wnnna$aMicrofilmings
=450  \\$wnnna$aMicroform
=450  \\$wnnna$aMicroforms
=450  \\$aMicrophotography$5IEN
=550  \\$wg$aCopying Processes
=550  \\$aPhotography
=667  \\$aIM
=750  \0$aMicrophotography$5IEN$0(DLC)sh 85084884

=LDR  00853cz  a2200241n  4500
=001  9880363718502441
=005  20141212203500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008839
=035  \\$aCBA2090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x500
=150  \\$aMicroelectrodes
=450  \\$wnnna$aElectrode, Miniaturized
=450  \\$aElectrodes, Miniaturized
=450  \\$wnnna$aMicroelectrode
=450  \\$wnnna$aMiniaturized Electrode
=450  \\$wnnna$aMiniaturized Electrodes
=550  \\$wg$aElectrodes
=667  \\$aNIM
=680  \\$iElectrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. (Dorland, 28th ed)
=688  \\$a73(71)
=750  \0$aMicroelectrodes$5IEN$0(DLC)sh 85084820

=LDR  01271cz  a2200289n  4500
=001  9880363718602441
=005  20200721142759.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008838
=035  \\$aCBA2089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x550
=150  \\$aMicrocomputers
=450  \\$wnnna$aComputer, Personal
=450  \\$aComputers, Personal
=450  \\$wnnna$aMicrocomputer
=450  \\$wnnna$aMicroprocessor
=450  \\$aMicroprocessors
=450  \\$wnnna$aPersonal Computer
=450  \\$wnnna$aPersonal Computers
=550  \\$wg$aComputers
=550  \\$wh$aComputers, Handheld
=550  \\$wh$aSmart Glasses
=667  \\$ado not confuse with MINICOMPUTERS
=680  \\$iSmall computers using LSI (large-scale integration) microprocessor chips as the CPU (central processing unit) and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. "Microprocessor" may refer to just the CPU or the entire microcomputer.
=688  \\$a89(80); was see under COMPUTERS 1980-88
=750  \0$aMicrocomputers$5IEN$0(DLC)sh 85084804

=LDR  00779cz  a2200193n  4500
=001  9880363718702441
=005  20141212203459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008837
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x475.$x500
=072  \\$aB3.$x510.$x400.$x500.$x500
=150  \\$aMicrococcus
=550  \\$wg$aMicrococcaceae
=550  \\$wh$aMicrococcus luteus
=667  \\$afound in soil & fresh water & on mammalian skin
=680  \\$iA genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.
=688  \\$aGAFFKYA TETRAGENA was see MICROCOCCUS 1979-91; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75
=750  \0$aMicrococcus$5IEN$0(DLC)sh 88023284

=LDR  00631cz  a2200205n  4500
=001  9880363718802441
=005  20141212203459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008835
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x475
=072  \\$aB3.$x510.$x400.$x500
=150  \\$aMicrococcaceae
=550  \\$wg$aActinomycetales
=550  \\$wg$aGram-Positive Cocci
=550  \\$wh$aArthrobacter
=550  \\$wh$aMicrococcus
=680  \\$iA family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms.
=688  \\$a75
=750  \0$aMicrococcaceae$5IEN$0(DLC)sh 88023283

=LDR  00936cz  a2200241n  4500
=001  9880363718902441
=005  20141212203347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008593
=035  \\$aCBA1844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x157.$x500
=072  \\$aG8.$x686.$x785.$x880.$x249.$x500
=150  \\$aMenopause
=450  \\$aChange of Life, Female
=550  \\$wg$aClimacteric
=550  \\$wh$aMenopause, Premature
=550  \\$wh$aPerimenopause
=550  \\$wh$aPostmenopause
=550  \\$wh$aPremenopause
=667  \\$aPERIMENOPAUSE; PREMENOPAUSE; and POSTMENOPAUSE are available
=680  \\$iThe last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
=750  \0$aMenopause$5IEN$0(DLC)sh 85083590

=LDR  01543cz  a2200337n  4500
=001  9880363719002441
=005  20141212203347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008591
=035  \\$aCBA1842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x610
=072  \\$aC16.$x131.$x666.$x680.$x610
=150  \\$aMeningomyelocele
=450  \\$wnnna$aAcquired Meningomyelocele
=450  \\$wnnna$aAcquired Meningomyeloceles
=450  \\$wnnna$aAcquired Myelomeningocele
=450  \\$wnnna$aAcquired Myelomeningoceles
=450  \\$wnnna$aMeningomyelocele, Acquired
=450  \\$wnnna$aMeningomyeloceles
=450  \\$wnnna$aMeningomyeloceles, Acquired
=450  \\$aMyelocele
=450  \\$wnnna$aMyeloceles
=450  \\$aMyelomeningocele
=450  \\$wnnna$aMyelomeningocele, Acquired
=450  \\$wnnna$aMyelomeningoceles
=450  \\$wnnna$aMyelomeningoceles, Acquired
=550  \\$wg$aNeural Tube Defects
=680  \\$iCongenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. (From Joynt, Clinical Neurology, 1992, Ch55, pp35-6)
=688  \\$a78(75); was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77
=750  \0$aMyelomeningocele$5IEN$0(DLC)sh 85089224

=LDR  01330cz  a2200325n  4500
=001  9880363719102441
=005  20141212203346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008590
=035  \\$aCBA1841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x430.$x550
=072  \\$aC10.$x228.$x228.$x245.$x550
=072  \\$aC10.$x228.$x228.$x507.$x850
=072  \\$aC10.$x228.$x228.$x553
=072  \\$aC10.$x228.$x566.$x500
=150  \\$aMeningoencephalitis
=450  \\$wnnna$aCerebromeningitides
=450  \\$aCerebromeningitis
=450  \\$wnnna$aEncephalomeningitides
=450  \\$wnnna$aEncephalomeningitis
=450  \\$wnnna$aMeningoencephalitides
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aEncephalitis
=550  \\$wg$aMeningitis
=550  \\$wh$aLupus Vasculitis, Central Nervous System
=550  \\$wh$aUveomeningoencephalitic Syndrome
=667  \\$acoord IM with precoord or specific infection term (IM) or other cause (IM); DF: MENINGOENCEPH
=680  \\$iAn inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.
=750  \0$aMeningoencephalitis$5IEN$0(DLC)sh 85083569

=LDR  00817cz  a2200205n  4500
=001  9880363719202441
=005  20150529143631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008589
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x625.$x549
=150  \\$aMeningococcal Infections
=450  \\$wnnna$aInfection, Meningococcal
=450  \\$wnnna$aInfections, Meningococcal
=450  \\$wnnna$aMeningococcal Infection
=550  \\$wg$aNeisseriaceae Infections
=550  \\$wh$aMeningitis, Meningococcal
=667  \\$aMENINGITIS, MENINGOCOCCAL is also available; coord IM with specific Neisseria meningitidis serogroup (IM) if given; DF: MENINGOCOCCAL INFECT
=680  \\$iInfections with bacteria of the species NEISSERIA MENINGITIDIS.
=750  \0$aMeningococcal infections$0(DLC)sh2014001390$5IEN-M

=LDR  01648cz  a2200457n  4500
=001  9880363719302441
=005  20141212203346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008588
=035  \\$aCBA1839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x598
=072  \\$aC16.$x131.$x666.$x680.$x598
=072  \\$aC23.$x300.$x707.$x968
=150  \\$aMeningocele
=450  \\$wnnna$aAcquired Meningocele
=450  \\$wnnna$aAcquired Meningoceles
=450  \\$wnnna$aHerniation, Meningeal
=450  \\$aHerniation of Meninges
=450  \\$wnnna$aHerniations, Meningeal
=450  \\$aMeningeal Herniation
=450  \\$wnnna$aMeningeal Herniations
=450  \\$wnnna$aMeninges Herniation
=450  \\$wnnna$aMeninges Herniations
=450  \\$aMeningo-Encephalocele$5IEN
=450  \\$wnnna$aMeningocele, Acquired
=450  \\$wnnna$aMeningocele, Rudimentary
=450  \\$wnnna$aMeningocele, Traumatic
=450  \\$wnnna$aMeningoceles
=450  \\$wnnna$aMeningoceles, Acquired
=450  \\$wnnna$aMeningoceles, Rudimentary
=450  \\$wnnna$aMeningoceles, Traumatic
=450  \\$wnnna$aRudimentary Meningocele
=450  \\$wnnna$aRudimentary Meningoceles
=450  \\$wnnna$aTraumatic Meningocele
=450  \\$wnnna$aTraumatic Meningoceles
=550  \\$wg$aHernia
=550  \\$wg$aNeural Tube Defects
=667  \\$ameningoencephalocele: coordinate IM with ENCEPHALOCELE (IM)
=680  \\$iA congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.
=750  \0$aMeningo-encephalocele$5IEN$0(DLC)sh 85083567

=LDR  02829cz  a2200493n  4500
=001  9880363719402441
=005  20141212203344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x500.$x550
=072  \\$aC1.$x252.$x400.$x625.$x549.$x449
=072  \\$aC10.$x228.$x228.$x180.$x500.$x750
=072  \\$aC10.$x228.$x228.$x507.$x280.$x505
=150  \\$aMeningitis, Meningococcal
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup A
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup B
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup C
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup W-135
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup W135
=450  \\$wnnna$aMeningitis, Meningococcal, Serogroup Y
=450  \\$wnnna$aMeningitis, Meningococcic
=450  \\$wnnna$aMeningococcal Meningitis
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup A
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup B
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup C
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup W-135
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup W 135
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup W135
=450  \\$wnnna$aMeningococcal Meningitis, Serogroup Y
=450  \\$wnnna$aSerogroup A Meningococcal Meningitis
=450  \\$wnnna$aSerogroup B Meningococcal Meningitis
=450  \\$wnnna$aSerogroup C Meningococcal Meningitis
=450  \\$wnnna$aSerogroup W-135, Meningococcal Meningitis
=450  \\$wnnna$aSerogroup W 135, Meningococcal Meningitis
=450  \\$wnnna$aSerogroup W135, Meningococcal Meningitis
=450  \\$wnnna$aSerogroup Y, Meningococcal Meningitis
=550  \\$wg$aMeningitis, Bacterial
=550  \\$wg$aMeningococcal Infections
=550  \\$wh$aWaterhouse-Friderichsen Syndrome
=667  \\$ado not coord with NEISSERIA MENINGITIDIS unless organism is particularly discussed but coord with specific serogroup (IM) if given
=680  \\$iA fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8)
=688  \\$a1978(1963)
=750  \0$aMeningitis, Cerebrospinal$5IEN$0(DLC)sh 85083564

=LDR  02112cz  a2200469n  4500
=001  9880363719502441
=005  20141212203343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008583
=035  \\$aCBA1834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x500.$x450
=072  \\$aC1.$x252.$x400.$x700.$x433.$x615
=072  \\$aC10.$x228.$x228.$x180.$x500.$x425
=072  \\$aC10.$x228.$x228.$x507.$x280.$x393
=150  \\$aMeningitis, Haemophilus
=450  \\$wnnna$aHaemophilus influenzae Meningitis Type B
=450  \\$wnnna$aHaemophilus Meningitides
=450  \\$wnnna$aHaemophilus Meningitis
=450  \\$wnnna$aHaemophilus parainfluenzae Meningitides
=450  \\$wnnna$aHaemophilus parainfluenzae Meningitis
=450  \\$wnnna$aHemophilus influenzae Meningitis Type B
=450  \\$wnnna$aHemophilus Meningitides
=450  \\$wnnna$aHemophilus Meningitis
=450  \\$wnnna$aHiB Meninigitis
=450  \\$wnnna$aMeningitides, Haemophilus
=450  \\$wnnna$aMeningitides, Haemophilus parainfluenzae
=450  \\$wnnna$aMeningitides, Hemophilus
=450  \\$wnnna$aMeningitis, Haemophilus influenzae Type F
=450  \\$wnnna$aMeningitis, Haemophilus parainfluenzae
=450  \\$wnnna$aMeningitis, Hemophilus
=450  \\$wnnna$aMeningitis, Hemophilus influenzae, Type B
=450  \\$wnnna$aMeningitis, Hemophilus influenzae Type F
=450  \\$wnnna$aMeninigitis, HiB
=450  \\$wnnna$aType B Haemophilus influenzae Meningitis
=450  \\$wnnna$aType B Hemophilus influenzae Meningitis
=550  \\$wg$aHaemophilus Infections
=550  \\$wg$aMeningitis, Bacterial
=550  \\$aHaemophilus influenzae type b
=667  \\$acoordinate IM with Haemophilus species (IM) if available
=680  \\$iInfections of the nervous system caused by bacteria of the genus HAEMOPHILUS, and marked by prominent inflammation of the MENINGES. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults.
=750  \0$aHaemophilus meningitis$0(DLC) sh 85060221$5IEN

=LDR  01680cz  a2200325n  4500
=001  9880363719602441
=005  20141212203342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008581
=035  \\$aCBA1832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x507
=072  \\$aC10.$x228.$x566
=150  \\$aMeningitis
=450  \\$wnnna$aMeningitides
=450  \\$wnnna$aPachymeningitides
=450  \\$aPachymeningitis
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wh$aArachnoiditis
=550  \\$wh$aMeningitis, Aseptic
=550  \\$wh$aMeningitis, Bacterial
=550  \\$wh$aMeningitis, Fungal
=550  \\$wh$aMeningitis, Viral
=550  \\$wh$aMeningoencephalitis
=550  \\$aMeningeal Carcinomatosis
=550  \\$aSubdural Effusion
=667  \\$ageneral; prefer specifics; for pachymeningitis (DURA MATER) or leptomeningitis (ARACHNOIDITIS or PIA MATER) do not specify meninx unless particularly discussed; purulent, suppurative or pyogenic: do not coordinate with SUPPURATION (NIM) unless particularly discussed
=680  \\$iInflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
=750  \0$aMeningitis$5IEN$0(DLC)sh 85083562

=LDR  06329cz  a2201525n  4500
=001  9880363719702441
=005  20141212203341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008579
=035  \\$aCBA1830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x580.$x520
=072  \\$aC4.$x557.$x645.$x520
=072  \\$aC4.$x588.$x614.$x250.$x580.$x500
=072  \\$aC10.$x551.$x240.$x500.$x500
=150  \\$aMeningioma
=450  \\$wnnna$aAngioblastic Meningioma
=450  \\$wnnna$aAngioblastic Meningiomas
=450  \\$wnnna$aAngiomatous Meningioma
=450  \\$wnnna$aAngiomatous Meningiomas
=450  \\$aBenign Meningioma
=450  \\$wnnna$aBenign Meningiomas
=450  \\$wnnna$aCerebral Convexity Meningioma
=450  \\$wnnna$aCerebral Convexity Meningiomas
=450  \\$wnnna$aClear Cell Meningioma
=450  \\$wnnna$aClear Cell Meningiomas
=450  \\$wnnna$aConvexity Meningioma, Cerebral
=450  \\$wnnna$aConvexity Meningiomas, Cerebral
=450  \\$wnnna$aFibrous Meningioma
=450  \\$wnnna$aFibrous Meningiomas
=450  \\$wnnna$aGroove Meningiomas, Olfactory
=450  \\$wnnna$aHemangioblastic Meningioma
=450  \\$wnnna$aHemangioblastic Meningiomas
=450  \\$wnnna$aHemangiopericytic Meningioma
=450  \\$wnnna$aHemangiopericytic Meningiomas
=450  \\$wnnna$aIntracranial Meningioma
=450  \\$wnnna$aIntracranial Meningiomas
=450  \\$wnnna$aIntraorbital Meningioma
=450  \\$wnnna$aIntraorbital Meningiomas
=450  \\$wnnna$aIntraventricular Meningioma
=450  \\$wnnna$aIntraventricular Meningiomas
=450  \\$aMalignant Meningioma
=450  \\$wnnna$aMalignant Meningiomas
=450  \\$wnnna$aMeningioma, Angioblastic
=450  \\$wnnna$aMeningioma, Angiomatous
=450  \\$wnnna$aMeningioma, Benign
=450  \\$wnnna$aMeningioma, Cerebral Convexity
=450  \\$wnnna$aMeningioma, Clear Cell
=450  \\$wnnna$aMeningioma, Fibrous
=450  \\$wnnna$aMeningioma, Hemangioblastic
=450  \\$wnnna$aMeningioma, Hemangiopericytic
=450  \\$wnnna$aMeningioma, Intracranial
=450  \\$wnnna$aMeningioma, Intraorbital
=450  \\$wnnna$aMeningioma, Intraventricular
=450  \\$wnnna$aMeningioma, Malignant
=450  \\$wnnna$aMeningioma, Meningotheliomatous
=450  \\$wnnna$aMeningioma, Microcystic
=450  \\$wnnna$aMeningioma, Multiple
=450  \\$wnnna$aMeningioma, Olfactory Groove
=450  \\$wnnna$aMeningioma, Papillary
=450  \\$wnnna$aMeningioma, Parasagittal
=450  \\$wnnna$aMeningioma, Posterior Fossa
=450  \\$wnnna$aMeningioma, Psammomatous
=450  \\$wnnna$aMeningioma, Secretory
=450  \\$wnnna$aMeningioma, Sphenoid Wing
=450  \\$wnnna$aMeningioma, Spinal
=450  \\$wnnna$aMeningioma, Transitional
=450  \\$wnnna$aMeningioma, Xanthomatous
=450  \\$wnnna$aMeningiomas
=450  \\$wnnna$aMeningiomas, Angioblastic
=450  \\$wnnna$aMeningiomas, Angiomatous
=450  \\$wnnna$aMeningiomas, Benign
=450  \\$wnnna$aMeningiomas, Cerebral Convexity
=450  \\$wnnna$aMeningiomas, Clear Cell
=450  \\$wnnna$aMeningiomas, Fibrous
=450  \\$wnnna$aMeningiomas, Hemangioblastic
=450  \\$wnnna$aMeningiomas, Hemangiopericytic
=450  \\$wnnna$aMeningiomas, Intracranial
=450  \\$wnnna$aMeningiomas, Intraorbital
=450  \\$wnnna$aMeningiomas, Intraventricular
=450  \\$wnnna$aMeningiomas, Malignant
=450  \\$wnnna$aMeningiomas, Meningotheliomatous
=450  \\$wnnna$aMeningiomas, Microcystic
=450  \\$aMeningiomas, Multiple
=450  \\$wnnna$aMeningiomas, Olfactory Groove
=450  \\$wnnna$aMeningiomas, Papillary
=450  \\$wnnna$aMeningiomas, Parasagittal
=450  \\$wnnna$aMeningiomas, Posterior Fossa
=450  \\$wnnna$aMeningiomas, Psammomatous
=450  \\$wnnna$aMeningiomas, Secretory
=450  \\$wnnna$aMeningiomas, Sphenoid Wing
=450  \\$wnnna$aMeningiomas, Spinal
=450  \\$wnnna$aMeningiomas, Transitional
=450  \\$wnnna$aMeningiomas, Xanthomatous
=450  \\$wnnna$aMeningiomatoses
=450  \\$aMeningiomatosis
=450  \\$wnnna$aMeningotheliomatous Meningioma
=450  \\$wnnna$aMeningotheliomatous Meningiomas
=450  \\$wnnna$aMicrocystic Meningioma
=450  \\$wnnna$aMicrocystic Meningiomas
=450  \\$wnnna$aMultiple Meningioma
=450  \\$wnnna$aMultiple Meningiomas
=450  \\$wnnna$aOlfactory Groove Meningioma
=450  \\$wnnna$aOlfactory Groove Meningiomas
=450  \\$wnnna$aPapillary Meningioma
=450  \\$wnnna$aPapillary Meningiomas
=450  \\$wnnna$aParasagittal Meningioma
=450  \\$wnnna$aParasagittal Meningiomas
=450  \\$wnnna$aPosterior Fossa Meningioma
=450  \\$wnnna$aPosterior Fossa Meningiomas
=450  \\$wnnna$aPsammomatous Meningioma
=450  \\$wnnna$aPsammomatous Meningiomas
=450  \\$wnnna$aSecretory Meningioma
=450  \\$wnnna$aSecretory Meningiomas
=450  \\$wnnna$aSphenoid Wing Meningioma
=450  \\$wnnna$aSphenoid Wing Meningiomas
=450  \\$wnnna$aSpinal Meningioma
=450  \\$wnnna$aSpinal Meningiomas
=450  \\$wnnna$aTransitional Meningioma
=450  \\$wnnna$aTransitional Meningiomas
=450  \\$wnnna$aWing Meningioma, Sphenoid
=450  \\$wnnna$aWing Meningiomas, Sphenoid
=450  \\$wnnna$aXanthomatous Meningioma
=450  \\$wnnna$aXanthomatous Meningiomas
=550  \\$wg$aMeningeal Neoplasms
=550  \\$wg$aNeoplasms, Nerve Tissue
=550  \\$wg$aNeoplasms, Vascular Tissue
=667  \\$abenign or malignant; coord IM with MENINGEAL NEOPLASMS (IM) but not with BRAIN NEOPLASMS nor SPINAL CORD NEOPLASMS for intracranial or spinal meningioma unless site is particularly discussed
=680  \\$iA relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
=750  \0$aMeningioma$5IEN$0(DLC)sh 85083561

=LDR  00628cz  a2200193n  4500
=001  9880363719802441
=005  20141212203338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008578
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x566
=150  \\$aMeninges
=550  \\$wg$aCentral Nervous System
=550  \\$wh$aArachnoid
=550  \\$wh$aDura Mater
=550  \\$wh$aPia Mater
=667  \\$ainflammation = MENINGITIS & its specifics
=680  \\$iThe three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.
=750  \0$aMeninges$5IEN$0(DLC)sh 85083559

=LDR  00631cz  a2200193n  4500
=001  9880363719902441
=005  20200706141816.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008689
=035  \\$aCBA1941M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x69.$x600
=150  \\$aMethacrylates
=550  \\$wg$aAcrylates
=550  \\$wh$aBisphenol A-Glycidyl Methacrylate
=550  \\$wh$aStrobilurins
=680  \\$iAcrylic acids or acrylates which are substituted in the C-2 position with a methyl group.
=688  \\$a91(75); was see under ACRYLATES 1975-90
=750  \0$aMethacrylic acid$0(DLC) sh 89000007$5IEN-M

=LDR  00932cz  a2200217n  4500
=001  9880363720002441
=005  20171024155537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008687
=035  \\$aCBA1939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x141.$x450
=150  \\$aMetformin
=450  \\$wnnna$aDimethylbiguanidine
=450  \\$aDimethylguanylguanidine
=450  \\$wnnna$aGlucophage
=550  \\$wg$aBiguanides
=550  \\$wh$aSitagliptin Phosphate, Metformin Hydrochloride Drug Combination
=667  \\$aa hypoglycemic
=680  \\$iA biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
=750  \0$aMetformin$0(DLC)sh2007006278$5IEN-M

=LDR  02970cz  a2200685n  4500
=001  9880363720102441
=005  20141212203338.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008577
=035  \\$aCBA1828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x580
=072  \\$aC10.$x551.$x240.$x500
=150  \\$aMeningeal Neoplasms
=450  \\$wnnna$aBenign Meningeal Neoplasm
=450  \\$wnnna$aBenign Meningeal Neoplasms
=450  \\$wnnna$aCancer, Meningeal
=450  \\$wnnna$aCancers, Meningeal
=450  \\$wnnna$aIntracranial Meningeal Neoplasm
=450  \\$aIntracranial Meningeal Neoplasms
=450  \\$wnnna$aLeptomeningeal Neoplasm
=450  \\$wnnna$aLeptomeningeal Neoplasms
=450  \\$wnnna$aMalignant Meningeal Neoplasm
=450  \\$wnnna$aMalignant Meningeal Neoplasms
=450  \\$wnnna$aMeningeal Cancer
=450  \\$wnnna$aMeningeal Cancers
=450  \\$wnnna$aMeningeal Neoplasm
=450  \\$wnnna$aMeningeal Neoplasm, Benign
=450  \\$wnnna$aMeningeal Neoplasm, Intracranial
=450  \\$wnnna$aMeningeal Neoplasm, Malignant
=450  \\$wnnna$aMeningeal Neoplasm, Spinal
=450  \\$wnnna$aMeningeal Neoplasms, Benign
=450  \\$wnnna$aMeningeal Neoplasms, Intracranial
=450  \\$wnnna$aMeningeal Neoplasms, Malignant
=450  \\$wnnna$aMeningeal Neoplasms, Spinal
=450  \\$wnnna$aMeningeal Tumor
=450  \\$wnnna$aMeningeal Tumors
=450  \\$wnnna$aNeoplasm, Benign Meningeal
=450  \\$wnnna$aNeoplasm, Intracranial Meningeal
=450  \\$wnnna$aNeoplasm, Leptomeningeal
=450  \\$wnnna$aNeoplasm, Malignant Meningeal
=450  \\$wnnna$aNeoplasm, Meningeal
=450  \\$wnnna$aNeoplasm, Spinal Meningeal
=450  \\$wnnna$aNeoplasms, Benign Meningeal
=450  \\$wnnna$aNeoplasms, Intracranial Meningeal
=450  \\$wnnna$aNeoplasms, Leptomeningeal
=450  \\$wnnna$aNeoplasms, Malignant Meningeal
=450  \\$wnnna$aNeoplasms, Meningeal
=450  \\$wnnna$aNeoplasms, Spinal Meningeal
=450  \\$wnnna$aSpinal Meningeal Neoplasm
=450  \\$aSpinal Meningeal Neoplasms
=450  \\$wnnna$aTumor, Meningeal
=450  \\$wnnna$aTumors, Meningeal
=550  \\$wg$aCentral Nervous System Neoplasms
=550  \\$wh$aMeningeal Carcinomatosis
=550  \\$wh$aMeningioma
=667  \\$acoord IM with histol type of neopl (IM); for intracranial or spinal meningioma, see note on MENINGIOMA; intradural extramedullary neopl do not go here: index under SPINAL CORD NEOPLASMS & do not try to locate "intradural" or "extramedullary"; meningeal leukemia does not go here: index under MENINGES /pathol (IM) + LEUKEMIC INFILTRATION (IM) (see note there) + specific type of leukemia (IM) if relevant
=680  \\$iBenign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
=688  \\$a78
=750  \0$aMeninges$xCancer$0(DLC)sh2010009741$5IEN-M

=LDR  01384cz  a2200397n  4500
=001  9880363720202441
=005  20141212203416.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008685
=035  \\$aCBA1937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x750
=072  \\$aN6.$x230.$x300
=150  \\$aMeteorological Concepts
=450  \\$wnnna$aConcept, Meteorological
=450  \\$wnnna$aConcepts, Meteorological
=450  \\$wnnna$aFactor, Meteorologic
=450  \\$wnnna$aFactor, Meteorological
=450  \\$wnnna$aFactors, Meteorologic
=450  \\$wnnna$aFactors, Meteorological
=450  \\$wnnna$aMeteorologic Factor
=450  \\$wnnna$aMeteorologic Factors
=450  \\$wnnna$aMeteorological Concept
=450  \\$wnnna$aMeteorological Factor
=450  \\$aMeteorological Factors
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aEnvironment
=550  \\$wh$aAtmosphere
=550  \\$wh$aAtmospheric Pressure
=550  \\$wh$aWeather
=667  \\$ano qualif
=680  \\$iThe atmospheric properties, characteristics and other atmospheric phenomena especially pertaining to WEATHER or CLIMATE.
=688  \\$a2009 (1977)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Meteorological Factors
=688  \\$a77; was METEOROLOGY see under WEATHER 1963-76
=750  \0$aMeteorology$0(DLC) sh 85084334$5IEN

=LDR  00556cz  a2200193n  4500
=001  9880363720302441
=005  20141212203337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008576
=035  \\$aCBA1827HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x545
=150  \\$aMeningeal Arteries
=450  \\$wnnna$aArteries, Meningeal
=450  \\$wnnna$aArtery, Meningeal
=450  \\$wnnna$aMeningeal Artery
=550  \\$wg$aArteries
=680  \\$iArteries which supply the dura mater.
=750  \0$aMeningeal artery$5IEN$0(DLC)sh 85083558

=LDR  00588cz  a2200169n  4500
=001  9880363720402441
=005  20141212203416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008684
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x250.$x300.$x480
=150  \\$aMetatarsus
=550  \\$wg$aForefoot, Human
=550  \\$aMetatarsal Bones
=667  \\$anot restricted to primates; METATARSUS refers to the anat area, METATARSAL BONES is available for the bones
=680  \\$iThe part of the foot between the tarsa and the TOES.
=750  \0$aMetatarsus$5IEN-M$0(DLC)sh 95001273

=LDR  00873cz  a2200205n  4500
=001  9880363720502441
=005  20141212203415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008681
=035  \\$aCBA1933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x588
=150  \\$aMetastrongyloidea
=450  \\$aMetastrongylidae$5IEN
=450  \\$wnnna$aMetastrongyloideas
=550  \\$wg$aStrongylida
=550  \\$wh$aAngiostrongylus
=667  \\$aa superfamily of nematodes; infection: coord IM with STRONGYLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA superfamily of nematodes of the order STRONGYLIDA. Characteristics include a fluid-filled outer layer of cuticle and a reduced mouth and bursa.
=750  \0$aMetastrongylidae$5IEN$0(DLC)sh 87020012

=LDR  00589cz  a2200181n  4500
=001  9880363720602441
=005  20141212203414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008679
=035  \\$aCBA1931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x589
=150  \\$aMetaplasia
=550  \\$wg$aPathologic Processes
=550  \\$wh$aNeovascularization, Pathologic
=667  \\$aNIM; coord with organ /pathol (IM)
=680  \\$iA condition in which there is a change of one adult cell type to another similar adult cell type.
=750  \0$aMetaplasia$5IEN$0(DLC)sh 85084287

=LDR  00660cz  a2200181n  4500
=001  9880363720702441
=005  20141212203414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008678
=035  \\$aCBA1930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x511
=150  \\$aMetaphysics
=450  \\$wnnna$aMetaphysic
=550  \\$wg$aPhilosophy
=667  \\$aonly /hist
=680  \\$iThe branch of philosophy that treats of first principles, including ontology (the nature of existence or being) and cosmology (the origin and structure of the universe). (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aMetaphysics$5IEN$0(DLC)sh 85084286

=LDR  00878cz  a2200241n  4500
=001  9880363720802441
=005  20170830164334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008675
=035  \\$aCBA1927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x550
=150  \\$aMetamorphosis, Biological
=450  \\$wnnna$aBiological Metamorphoses
=450  \\$wnnna$aBiological Metamorphosis
=450  \\$wnnna$aMetamorphoses, Biological
=550  \\$wg$aMorphogenesis
=550  \\$wh$aLife Cycle Stages
=550  \\$wh$aMolting
=550  \\$wh$aParasite Encystment
=667  \\$aManual 22.5; DF: METAMORPHOSIS BIOL
=680  \\$iProfound physical changes during maturation of living organisms from the immature forms to the adult forms, such as from TADPOLES to frogs; caterpillars to BUTTERFLIES.
=750  \0$aMetamorphosis$5IEN$0(DLC)sh 85084271

=LDR  02215cz  a2200613n  4500
=001  9880363720902441
=005  20141212192320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008575
=035  \\$aCBA1826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x568.$x217.$x500
=150  \\$aMeniere Disease
=450  \\$wnnna$aAuditory Vertigo
=450  \\$wnnna$aAuditory Vertigos
=450  \\$wnnna$aAural Vertigo
=450  \\$wnnna$aDisease, Ménière
=450  \\$wnnna$aDisease, Ménière's
=450  \\$wnnna$aDisease, Meniere
=450  \\$wnnna$aDisease, Meniere's
=450  \\$wnnna$aDiseases, Ménière
=450  \\$wnnna$aDiseases, Ménière's
=450  \\$wnnna$aMénière Disease
=450  \\$wnnna$aMénière Diseases
=450  \\$wnnna$aMénière Vertigo
=450  \\$wnnna$aMénière's Disease
=450  \\$wnnna$aMénières Disease
=450  \\$wnnna$aMénière's Diseases
=450  \\$wnnna$aMénière's Vertigo
=450  \\$wnnna$aMénières Vertigo
=450  \\$wnnna$aMénière's Vertigos
=450  \\$wnnna$aMeniere Syndrome
=450  \\$aMeniere's Disease
=450  \\$wnnna$aMenieres Disease
=450  \\$aMeniere's Syndrome
=450  \\$wnnna$aMenieres Syndrome
=450  \\$wnnna$aOtogenic Vertigo
=450  \\$wnnna$aOtogenic Vertigos
=450  \\$wnnna$aSyndrome, Meniere's
=450  \\$wnnna$aVertigo, Auditory
=450  \\$aVertigo, Aural
=450  \\$wnnna$aVertigo, Ménière's
=450  \\$wnnna$aVertigo, Otogenic
=450  \\$wnnna$aVertigos, Auditory
=450  \\$wnnna$aVertigos, Ménière's
=450  \\$wnnna$aVertigos, Otogenic
=550  \\$wg$aEndolymphatic Hydrops
=550  \\$aEndolymphatic Hydrops
=550  \\$aTranstympanic Micropressure Treatment
=667  \\$aspell with one accent (Menière's) in translations
=680  \\$iA disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Meniere's Disease
=750  \0$aM�eni�ere's disease$0(DLC) sh 85083557$5IEN

=LDR  01066cz  a2200265n  4500
=001  9880363721002441
=005  20141212203413.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008674
=035  \\$aCBA1926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x558
=072  \\$aD1.$x552.$x550
=150  \\$aMetals, Rare Earth
=450  \\$wnnna$aEarth Metals, Rare
=450  \\$aRare Earth Metals
=550  \\$wg$aElements
=550  \\$wg$aMetals
=550  \\$wh$aLanthanoid Series Elements
=550  \\$wh$aScandium
=550  \\$wh$aYttrium
=667  \\$aGEN: prefer specifics
=680  \\$iA group of elements that include SCANDIUM; YTTRIUM; and the LANTHANOID SERIES ELEMENTS. Historically, the rare earth metals got their name from the fact that they were never found in their pure elemental form, but as an oxide. In addition they were very difficult to purify. They are not truly rare and comprise about 25% of the metals in the earth's crust.
=688  \\$a76; was NON MESH before 1976
=750  \0$aRare earth metals$5IEN$0(DLC)sh 85111458

=LDR  00770cz  a2200229n  4500
=001  9880363721102441
=005  20141212203337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008573
=035  \\$aCBA1824M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x525
=072  \\$aD1.$x268.$x271.$x100.$x525
=072  \\$aD1.$x268.$x556.$x494
=072  \\$aD1.$x552.$x20.$x561
=072  \\$aD1.$x552.$x544.$x494
=150  \\$aMendelevium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$aman-made radioactive element; IM
=680  \\$iMendelevium. A man-made radioactive element of the actinide family with atomic symbol Md, atomic number 101, and atomic weight 258.
=750  \0$aMendelevium$0(DLC)sh2012003626$5IEN-M

=LDR  00518cz  a2200181n  4500
=001  9880363721202441
=005  20141212203336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008572
=035  \\$aCBA1823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x760.$x410
=072  \\$aG8.$x686.$x785.$x880.$x374.$x410
=150  \\$aMenarche
=550  \\$wg$aPuberty
=680  \\$iThe first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.
=688  \\$a73(69)
=750  \0$aMenarche$5IEN$0(DLC)sh 85083534

=LDR  00983cz  a2200325n  4500
=001  9880363721302441
=005  20141212203413.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008673
=035  \\$aCBA1925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552
=072  \\$aD1.$x552.$x539
=150  \\$aMetals, Alkaline Earth
=450  \\$aAlkaline Earth Metals
=450  \\$wnnna$aEarth Metals, Alkaline
=450  \\$wnnna$aElements, Group 2
=450  \\$wnnna$aGroup 2 Elements
=550  \\$wg$aElements
=550  \\$wg$aMetals
=550  \\$wh$aBarium
=550  \\$wh$aBeryllium
=550  \\$wh$aCalcium
=550  \\$wh$aMagnesium
=550  \\$wh$aRadium
=550  \\$wh$aStrontium
=667  \\$ado not confuse with METALS, ALKALI; GEN: prefer specifics
=680  \\$iMetals that constitute the group 2 (formerly group IIa) of the periodic table.
=688  \\$a76; was NON MESH before 1976
=750  \0$aAlkaline earth metals$5IEN$0(DLC)sh 85003595

=LDR  00759cz  a2200193n  4500
=001  9880363721402441
=005  20141212203336.0
=008  790427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008571
=035  \\$aCBA1822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x390
=150  \\$aMen
=550  \\$wg$aPersons
=550  \\$wh$aNurses, Male
=667  \\$afor men or boys only as a cultural, social, sociological, political, economic force; do not confuse with the check tag MALE; when indexing MEN, check the tags HUMANS & MALE; Manual 18.9.6, 34.12; CATALOG: Coordinate with age group if appropriate
=680  \\$iHuman males as cultural, psychological, sociological, political, and economic entities.
=688  \\$a80
=750  \0$aMen$5IEN-M$0(DLC)sh 85083510

=LDR  01095cz  a2200313n  4500
=001  9880363721502441
=005  20141212203412.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008672
=035  \\$aCBA1924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549
=072  \\$aD1.$x552.$x528
=150  \\$aMetals, Alkali
=450  \\$aAlkali Metals
=450  \\$wnnna$aElements, Group 1
=450  \\$wnnna$aGroup 1 Elements
=550  \\$wg$aElements
=550  \\$wg$aMetals
=550  \\$wh$aCesium
=550  \\$wh$aFrancium
=550  \\$wh$aLithium
=550  \\$wh$aPotassium
=550  \\$wh$aRubidium
=550  \\$wh$aSodium
=667  \\$ado not confuse with METALS, ALKALINE EARTH; GEN: prefer specifics
=680  \\$iMetals that constitute group 1(formerly group Ia) of the periodic table. They are the most strongly electropositive of the metals. Note that HYDROGEN is not considered an alkali metal even though it falls under the group 1 heading in the periodic table.
=688  \\$a76; was NON MESH before 1976
=750  \0$aAlkali metals$5IEN$0(DLC)sh 85003587

=LDR  01392cz  a2200493n  4500
=001  9880363721602441
=005  20141212203412.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008671
=035  \\$aCBA1923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33
=072  \\$aD1.$x268.$x271.$x100
=072  \\$aD1.$x552.$x20
=150  \\$aActinoid Series Elements
=450  \\$wnnna$aActinide Metals
=450  \\$aActinides
=450  \\$wnnna$aActinoid Metals
=450  \\$aActinoids
=450  \\$wnnna$aElements, Actinoid Series
=450  \\$wnnna$aMetals, Actinide
=450  \\$aMetals, Actinoid
=550  \\$wg$aElements
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aMetals
=550  \\$wh$aActinium
=550  \\$wh$aAmericium
=550  \\$wh$aBerkelium
=550  \\$wh$aCalifornium
=550  \\$wh$aCurium
=550  \\$wh$aEinsteinium
=550  \\$wh$aFermium
=550  \\$wh$aLawrencium
=550  \\$wh$aMendelevium
=550  \\$wh$aNeptunium
=550  \\$wh$aNobelium
=550  \\$wh$aPlutonium
=550  \\$wh$aProtactinium
=550  \\$wh$aThorium
=550  \\$wh$aUranium
=667  \\$aGEN: prefer specifics
=680  \\$iA series of radioactive elements from ACTINIUM, atomic number 89, to and including LAWRENCIUM, atomic number 103.
=688  \\$a2002(1976)
=750  \0$aActinide elements$5IEN$0(DLC)sh 85000700

=LDR  01243cz  a2200385n  4500
=001  9880363721702441
=005  20141212203336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008570
=035  \\$aCBA1821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x407
=150  \\$aMemory, Short-Term
=450  \\$wnnna$aImmediate Memories
=450  \\$wnnna$aImmediate Memory
=450  \\$aImmediate Recall
=450  \\$wnnna$aImmediate Recalls
=450  \\$wnnna$aMemories, Immediate
=450  \\$wnnna$aMemories, Short-Term
=450  \\$wnnna$aMemories, Shortterm
=450  \\$aMemory, Immediate
=450  \\$wnnna$aMemory, Short Term
=450  \\$wnnna$aMemory, Shortterm
=450  \\$wnnna$aRecall, Immediate
=450  \\$wnnna$aRecalls, Immediate
=450  \\$wnnna$aShort-Term Memories
=450  \\$wnnna$aShort-Term Memory
=450  \\$wnnna$aShortterm Memories
=450  \\$wnnna$aShortterm Memory
=450  \\$wnnna$aWorking Memories
=450  \\$aWorking Memory
=550  \\$wg$aMemory
=680  \\$iRemembrance of information for a few seconds to hours.
=688  \\$a69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78
=750  \0$aShort-term memory$5IEN$0(DLC)sh 85121972

=LDR  01145cz  a2200265n  4500
=001  9880363721802441
=005  20141212203411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008670
=035  \\$aCBA1922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x552
=150  \\$aMetals
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aActinoid Series Elements
=550  \\$wh$aAlloys
=550  \\$wh$aMetals, Alkali
=550  \\$wh$aMetals, Alkaline Earth
=550  \\$wh$aMetals, Heavy
=550  \\$wh$aMetals, Light
=550  \\$wh$aMetals, Rare Earth
=667  \\$ageneral or unspecified: prefer specific metal groups or specific metals; allergic reactions to metals is probably DERMATITIS, CONTACT, not DRUG HYPERSENSITIVITY; METALLOIDS is also available
=680  \\$iElectropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aMetals in the body$5IEN-M$0(DLC)sh 85084267
=750  \0$aMetals$5IEN-HS$0(DLC)sh 85084167

=LDR  01380cz  a2200229n  4500
=001  9880363721902441
=005  20141212192324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008669
=035  \\$aCBA1921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x400
=150  \\$aMetallurgy
=450  \\$aHeavy Industries
=450  \\$wnnna$aHeavy Industry
=450  \\$wnnna$aIndustries, Heavy
=450  \\$wnnna$aIndustry, Heavy
=550  \\$wg$aExtraction and Processing Industry
=550  \\$wh$aWelding
=667  \\$aSPEC: SPEC qualif; note X ref HEAVY INDUSTRIES for iron, steel, etc., industries; in dent lit, the working & manipulation of metals for orthodontic or prosthodontic appliances is probably DENTAL SOLDERING but if not soldering, coord specific appliance (IM) + METALLURGY (NIM)
=680  \\$iThe science, art, or technology dealing with processes involved in the separation of metals from their ores, the technique of making or compounding the alloys, the techniques of working or heat-treating metals, and the mining of metals. It includes industrial metallurgy as well as metallurgical techniques employed in the preparation and working of metals used in dentistry, with special reference to orthodontic and prosthodontic appliances. (From Jablonski, Dictionary of Dentistry, 1992, p494)
=750  \0$aMetallurgy$5IEN$0(DLC)sh 85084158

=LDR  00704cz  a2200169n  4500
=001  9880363449102441
=005  20141212200212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003124
=035  \\$aCAZ6281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x922.$x250
=150  \\$aColorimetry
=550  \\$wg$aTitrimetry
=667  \\$aan anal chem technique; NIM
=680  \\$iAny technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aColorimetry$5IEN$0(DLC)sh 85028695

=LDR  00626cz  a2200205n  4500
=001  9880363449202441
=005  20141212200211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003119
=035  \\$aCAZ6275HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850.$x150
=150  \\$aColor Perception Tests
=450  \\$wnnna$aColor Perception Test
=450  \\$wnnna$aPerception Test, Color
=450  \\$wnnna$aPerception Tests, Color
=450  \\$wnnna$aTest, Color Perception
=450  \\$wnnna$aTests, Color Perception
=550  \\$wg$aVision Tests
=750  \0$aColor vision$xTesting$5IEN$0(DLC)sh 85028657

=LDR  02049cz  a2200529n  4500
=001  9880363449302441
=005  20141212200210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003117
=035  \\$aCAZ6273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x256
=072  \\$aC11.$x966.$x256
=072  \\$aC23.$x888.$x592.$x763.$x941.$x256
=150  \\$aColor Vision Defects
=450  \\$aAchromatopsia
=450  \\$wnnna$aAcquired Color Blindness
=450  \\$wnnna$aBlindness, Color
=450  \\$wnnna$aBlue Color Blindness
=450  \\$aColor Blindness
=450  \\$wnnna$aColor Blindness, Acquired
=450  \\$wnnna$aColor Blindness, Blue
=450  \\$wnnna$aColor Blindness, Green
=450  \\$wnnna$aColor Blindness, Inherited
=450  \\$wnnna$aColor Blindness, Red
=450  \\$wnnna$aColor Blindness, Red-Green
=450  \\$wnnna$aColor Blindness, Red Green
=450  \\$wnnna$aColor Vision Defect
=450  \\$wnnna$aColor Vision Deficiency
=450  \\$wnnna$aDefect, Color Vision
=450  \\$wnnna$aDefect, Deutan
=450  \\$wnnna$aDefects, Color Vision
=450  \\$wnnna$aDeutan Defect
=450  \\$wnnna$aGreen Color Blindness
=450  \\$wnnna$aInherited Color Blindness
=450  \\$aMonochromatopsia
=450  \\$wnnna$aProtan Defect
=450  \\$wnnna$aRed Color Blindness
=450  \\$wnnna$aRed-Green Color Blindness
=450  \\$wnnna$aTritan Defect
=450  \\$wnnna$aVision Defect, Color
=450  \\$wnnna$aVision Defects, Color
=550  \\$wg$aVision Disorders
=550  \\$aColor Perception
=680  \\$iDefects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES (RETINA). Severity of hereditary defects of color vision depends on the degree of mutation of the ROD OPSINS genes (on X CHROMOSOME and CHROMOSOME 3) that code the photopigments for red, green and blue.
=688  \\$a90; was COLOR BLINDNESS 1963-89
=750  \0$aColor blindness$5IEN$0(DLC)sh 85028584

=LDR  00623cz  a2200181n  4500
=001  9880363449402441
=005  20141212200209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003116
=035  \\$aCAZ6272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x590.$x540.$x199
=150  \\$aColor
=450  \\$wnnna$aColors
=550  \\$wg$aLight
=667  \\$aNIM; differentiate from PIGMENTATION in that PIGMENTATION is related to PIGMENTS, BIOLOGICAL
=680  \\$iThe visually perceived property of objects created by absorption or reflection of specific wavelengths of light.
=750  \0$aColor$5IEN-M$0(DLC)sh 85028577

=LDR  02133cz  a2200469n  4500
=001  9880363449502441
=005  20141212200209.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003115
=035  \\$aCAZ6271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240
=072  \\$aD12.$x776.$x395.$x240
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240
=072  \\$aD23.$x529.$x374.$x410.$x240
=150  \\$aColony-Stimulating Factors
=450  \\$wnnna$aCell-Growth Inducer, Myeloid
=450  \\$wnnna$aColony Stimulating Factor
=450  \\$wnnna$aColony-Stimulating Factor
=450  \\$wnnna$aColony Stimulating Factors
=450  \\$wnnna$aInducer, Macrophage-Granulocyte
=450  \\$wnnna$aInducer, Myeloid Cell-Growth
=450  \\$aMacrophage-Granulocyte Inducer
=450  \\$wnnna$aMacrophage Granulocyte Inducer
=450  \\$aMGI-1
=450  \\$wnnna$aMGI-1 Protein
=450  \\$wnnna$aMGI 1 Protein
=450  \\$wnnna$aMGI, Protein Inducer
=450  \\$wnnna$aMyeloid Cell-Growth Inducer
=450  \\$wnnna$aMyeloid Cell Growth Inducer
=450  \\$wnnna$aProtein Inducer MGI
=550  \\$wg$aGlycoproteins
=550  \\$wg$aHematopoietic Cell Growth Factors
=550  \\$wh$aErythropoietin
=550  \\$wh$aGranulocyte Colony-Stimulating Factor
=550  \\$wh$aGranulocyte-Macrophage Colony-Stimulating Factor
=550  \\$wh$aInterleukin-3
=550  \\$wh$aMacrophage Colony-Stimulating Factor
=550  \\$wh$aThrombopoietin
=680  \\$iGlycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF).
=688  \\$a79(76); was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89
=750  \0$aColony-stimulating factors (Physiology)$0(DLC) sh 85028573$5IEN

=LDR  02425cz  a2200637n  4500
=001  9880363449602441
=005  20141212210902.0
=008  880408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015169
=035  \\$aCAZ6269M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x220
=072  \\$aE5.$x200.$x875.$x220
=150  \\$aColony Count, Microbial
=450  \\$aAgar Dilution Count
=450  \\$wnnna$aAgar Dilution Counts
=450  \\$wnnna$aColony Counts, Microbial
=450  \\$wnnna$aColony Forming Units Assay, Microbial
=450  \\$aColony-Forming Units Assay, Microbial
=450  \\$wnnna$aColony Forming Units Assays, Microbial
=450  \\$wnnna$aCount, Agar Dilution
=450  \\$wnnna$aCount, Fungal
=450  \\$wnnna$aCount, Microbial Colony
=450  \\$wnnna$aCount, Pour Plate
=450  \\$wnnna$aCount, Spore
=450  \\$wnnna$aCount, Spread Plate
=450  \\$wnnna$aCount, Streak Plate
=450  \\$wnnna$aCounts, Agar Dilution
=450  \\$wnnna$aCounts, Fungal
=450  \\$wnnna$aCounts, Microbial Colony
=450  \\$wnnna$aCounts, Pour Plate
=450  \\$wnnna$aCounts, Spore
=450  \\$wnnna$aCounts, Spread Plate
=450  \\$wnnna$aCounts, Streak Plate
=450  \\$wnnna$aDilution Count, Agar
=450  \\$wnnna$aDilution Counts, Agar
=450  \\$aFungal Count
=450  \\$wnnna$aFungal Counts
=450  \\$wnnna$aMicrobial Colony Count
=450  \\$wnnna$aMicrobial Colony Counts
=450  \\$aPour Plate Count
=450  \\$wnnna$aPour Plate Counts
=450  \\$aSpore Count
=450  \\$wnnna$aSpore Counts
=450  \\$aSpread Plate Count
=450  \\$wnnna$aSpread Plate Counts
=450  \\$aStreak Plate Count
=450  \\$wnnna$aStreak Plate Counts
=550  \\$wg$aMicrobiological Techniques
=550  \\$wh$aBacterial Load
=550  \\$aMicrobial Viability
=550  \\$aParasite Load
=667  \\$acoordinate NIM with organism /growth or /isol (IM) as appropriate
=680  \\$iEnumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
=688  \\$a89
=750  \0$aMicrobial viability counts$0(DLC) sh 87006418$5IEN-M

=LDR  01397cz  a2200397n  4500
=001  9880363449702441
=005  20141212192114.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003113
=035  \\$aCAZ6268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x200
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x160
=072  \\$aE4.$x210.$x240.$x250.$x160
=072  \\$aE4.$x502.$x250.$x250.$x250.$x160
=150  \\$aColonoscopy
=450  \\$wnnna$aColonoscopic Surgeries
=450  \\$wnnna$aColonoscopic Surgery
=450  \\$wnnna$aColonoscopic Surgical Procedure
=450  \\$aColonoscopic Surgical Procedures
=450  \\$wnnna$aColonoscopies
=450  \\$wnnna$aProcedure, Colonoscopic Surgical
=450  \\$wnnna$aProcedures, Colonoscopic Surgical
=450  \\$wnnna$aSurgeries, Colonoscopic
=450  \\$wnnna$aSurgery, Colonoscopic
=450  \\$wnnna$aSurgical Procedure, Colonoscopic
=450  \\$aSurgical Procedures, Colonoscopic
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$wh$aSigmoidoscopy
=550  \\$aColon
=550  \\$aColonography, Computed Tomographic
=550  \\$aColonoscopes
=667  \\$a/ instrum permitted but consider also COLONOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the luminal surface of the colon.
=688  \\$a81
=750  \0$aColonoscopy$5IEN$0(DLC)sh 85028572

=LDR  00709cz  a2200205n  4500
=001  9880363449802441
=005  20141212200208.0
=008  830531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003111
=035  \\$aCAZ6266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x825.$x411.$x235
=150  \\$aColonic Polyps
=450  \\$wnnna$aColonic Polyp
=450  \\$wnnna$aPolyp, Colonic
=450  \\$wnnna$aPolyps, Colonic
=550  \\$wg$aIntestinal Polyps
=680  \\$iDiscrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.
=688  \\$a84
=750  \0$aIntestinal polyps$5IEN$0(DLC)sh 85067570

=LDR  01653cz  a2200469n  4500
=001  9880363449902441
=005  20141212200207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003110
=035  \\$aCAZ6265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411.$x307.$x180
=072  \\$aC6.$x301.$x371.$x411.$x307.$x180
=072  \\$aC6.$x405.$x249.$x411.$x307.$x180
=072  \\$aC6.$x405.$x469.$x158.$x356.$x180
=072  \\$aC6.$x405.$x469.$x491.$x307.$x180
=150  \\$aColonic Neoplasms
=450  \\$wnnna$aCancer, Colon
=450  \\$wnnna$aCancer, Colonic
=450  \\$aCancer of Colon
=450  \\$wnnna$aCancer of the Colon
=450  \\$wnnna$aCancers, Colon
=450  \\$wnnna$aCancers, Colonic
=450  \\$aColon Cancer
=450  \\$wnnna$aColon Cancers
=450  \\$wnnna$aColon Neoplasm
=450  \\$wnnna$aColon Neoplasms
=450  \\$wnnna$aColonic Cancer
=450  \\$wnnna$aColonic Cancers
=450  \\$wnnna$aColonic Neoplasm
=450  \\$wnnna$aNeoplasm, Colon
=450  \\$wnnna$aNeoplasm, Colonic
=450  \\$wnnna$aNeoplasms, Colon
=450  \\$wnnna$aNeoplasms, Colonic
=550  \\$wg$aColorectal Neoplasms
=550  \\$wh$aAdenomatous Polyposis Coli
=550  \\$wh$aSigmoid Neoplasms
=667  \\$acoord IM with histol type of neopl (IM); note SIGMOID NEOPLASMS is available; familial: consider also ADENOMATOUS POLYPOSIS COLI & COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS
=680  \\$iTumors or cancer of the COLON.
=688  \\$a64
=750  \0$aColon (Anatomy)$xCancer$5IEN-M$0(DLC)sh 85028544
=750  \0$aColon (Anatomy)$xTumors$5IEN-M$0(IEN)367058

=LDR  00918cz  a2200289n  4500
=001  9880363450002441
=005  20141212200207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003108
=035  \\$aCAZ6263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x158
=150  \\$aColonic Diseases
=450  \\$wnnna$aColonic Disease
=450  \\$wnnna$aDisease, Colonic
=450  \\$wnnna$aDiseases, Colonic
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aChilaiditi Syndrome
=550  \\$wh$aColitis
=550  \\$wh$aColonic Diseases, Functional
=550  \\$wh$aColorectal Neoplasms
=550  \\$wh$aDiverticulosis, Colonic
=550  \\$wh$aMegacolon
=550  \\$wh$aSigmoid Diseases
=667  \\$ainflamm dis = COLITIS
=680  \\$iPathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
=750  \0$aColon (Anatomy)$xDiseases$5IEN$0(DLC)sh 85028545

=LDR  01336cz  a2200325n  4500
=001  9880363450102441
=005  20141212200206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003107
=035  \\$aCAZ6262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x208
=150  \\$aColorectal Surgery
=450  \\$wnnna$aColon and Rectal Surgery Specialty
=450  \\$wnnna$aColon Surgery Specialty
=450  \\$aProctology
=450  \\$wnnna$aRectal Surgery Specialty
=450  \\$wnnna$aSpecialty, Colon Surgery
=450  \\$wnnna$aSpecialty, Rectal Surgery
=450  \\$wnnna$aSurgery, Colorectal
=450  \\$wnnna$aSurgery Specialty, Colon
=450  \\$wnnna$aSurgery Specialty, Colon and Rectal
=450  \\$wnnna$aSurgery Specialty, Rectal
=550  \\$wg$aSpecialties, Surgical
=667  \\$aGEN only: do not confuse with COLON /surg & RECTUM /surg; SPEC: SPEC qualif DF: COLORECTAL SURG
=680  \\$iA surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the COLON; RECTUM; and ANAL CANAL.
=688  \\$a98; was COLON AND RECTAL SURGERY (SPECIALTY) 1980-97; was PROCTOLOGY 1963-79
=750  \0$aColon (Anatomy)$xSurgery$5IEN-M$0(DLC)sh 85028550
=750  \0$aRectum$xSurgery$5IEN-HS$0(DLC)sh 85112008
=750  \0$aProctology$5IEN-HS$0(DLC)sh 85107168

=LDR  01378cz  a2200241n  4500
=001  9880363450202441
=005  20141212200205.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003104
=035  \\$aCAZ6260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x150.$x150
=150  \\$aColobus
=450  \\$wnnna$aColobus Monkey
=450  \\$wnnna$aColobus Monkeys
=450  \\$aMonkey, Colobus
=450  \\$wnnna$aMonkeys, Colobus
=450  \\$aProcolobus
=550  \\$wg$aColobinae
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of Old World monkeys, subfamily COLOBINAE, family CERCOPITHECIDAE, that inhabits the forests of Africa. It consists of eight species: C. angolensis (Angolan colobus), C. badius or C. rufomitratus (Red or Bay colobus), C. guereza (Guereza or Eastern black-and-white colobus), C. kirkii (Kirk's colobus), C. polykomos (King colobus or Western black-and-white colobus), C. satanas (Black colobus), and C. verus (Olive colobus). Some authors recognize Procolobus as a separate genus and then the olive colobus is recognized as the species P. verus.
=688  \\$a91(75); was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80
=750  \0$aColobus$5IEN$0(DLC)sh 85028467

=LDR  01086cz  a2200301n  4500
=001  9880363450302441
=005  20141212192114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003102
=035  \\$aCAZ6258HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x280
=072  \\$aD26.$x255.$x165
=150  \\$aColloids
=450  \\$wnnna$aColloid
=450  \\$wnnna$aHydrocolloid
=450  \\$wnnna$aHydrocolloids
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aDosage Forms
=550  \\$wh$aAerosols
=550  \\$wh$aEmulsions
=550  \\$wh$aGels
=550  \\$wh$aSuspensions
=550  \\$aLiquid Crystals
=550  \\$aMicelles
=667  \\$aIM general only; NIM (no qualifiers) with specific drug IM
=680  \\$iTwo-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other.
=750  \0$aColloids$5IEN$0(DLC)sh 85028453

=LDR  01126cz  a2200265n  4500
=001  9880363450402441
=005  20141212200205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003101
=035  \\$aCAZ6257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x720.$x99.$x500.$x439
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x500.$x439
=150  \\$aCollodion
=450  \\$wnnna$aCelloidin
=450  \\$wnnna$aCellulose Nitrate
=450  \\$wnnna$aCollodion Cotton
=450  \\$wnnna$aCotton, Collodion
=450  \\$wnnna$aNitrate, Cellulose
=450  \\$aNitrocellulose
=450  \\$wnnna$aPyroxylin
=550  \\$wg$aCellulose
=667  \\$ado not index here for the dermatologic condition collodion membrane or collodion baby: consider ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL
=680  \\$iA nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.
=750  \0$aCollodion$5IEN$0(DLC)sh 85028450

=LDR  00909cz  a2200265n  4500
=001  9880363450502441
=005  20141212200204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003098
=035  \\$aCAZ6254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x571.$x356
=072  \\$aN4.$x452.$x677.$x356
=150  \\$aCollective Bargaining
=450  \\$wnnna$aBargaining, Collective
=450  \\$wnnna$aBargainings, Collective
=450  \\$wnnna$aCollective Bargainings
=550  \\$wg$aLabor Unions
=550  \\$wg$aPersonnel Management
=550  \\$aLabor Unions
=550  \\$aNegotiating
=680  \\$iThe process of negotiation between representatives of an employee organization, association or union, and representatives of the employer.
=688  \\$a71
=750  \0$aCollective bargaining$5IEN-M$0(DLC)sh 85027996
=750  \0$aCollective labor agreements$5IEN-HS$0(DLC)sh 85028110

=LDR  01350cz  a2200313n  4500
=001  9880363450602441
=005  20141212200203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003097
=035  \\$aCAZ6253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x248
=150  \\$aCollateral Circulation
=450  \\$aBlood Circulation, Collateral
=450  \\$wnnna$aBlood Collateral Circulation
=450  \\$wnnna$aCirculation, Blood Collateral
=450  \\$wnnna$aCirculation, Collateral
=450  \\$wnnna$aCirculation, Collateral Blood
=450  \\$wnnna$aCollateral Blood Circulation
=450  \\$wnnna$aCollateral Blood Circulations
=450  \\$wnnna$aCollateral Circulation, Blood
=450  \\$wnnna$aCollateral Circulations
=450  \\$wnnna$aCollateral Circulations, Blood
=550  \\$wg$aBlood Circulation
=550  \\$aNeovascularization, Physiologic
=667  \\$aa naturally occurring physiol phenomenon: not for restoration of funct by surg; not restricted to coronary vessels; do not confuse with NEOVASCULARIZATION, PHYSIOLOGIC: see MeSH scope notes; DF: COLLATERAL CIRC
=680  \\$iMaintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.
=688  \\$a66(64)
=750  \0$aCollateral circulation$5IEN$0(DLC)sh 85027980

=LDR  01525cz  a2200241n  4500
=001  9880363450702441
=005  20141212200203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003096
=035  \\$aCAZ6252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928.$x600.$x220
=150  \\$aCollapse Therapy
=450  \\$wnnna$aCollapse Therapies
=450  \\$wnnna$aTherapies, Collapse
=450  \\$wnnna$aTherapy, Collapse
=550  \\$wg$aPulmonary Surgical Procedures
=550  \\$wh$aPneumonolysis
=550  \\$wh$aPneumothorax, Artificial
=550  \\$aTuberculosis, Pulmonary
=667  \\$aa method of surg ther of tuberc; do not use /util except by MeSH definition
=680  \\$iSurgical treatment of pulmonary tuberculosis whereby the lung is totally or partially, temporarily or permanently, immobilized. The procedure was based on the popular concept that collapsing the affected portion of a tuberculous lung allowed the infected area to rest and thereby recover. At the beginning of the 20th century artificially induced pneumothorax (PNEUMOTHORAX, ARTIFICIAL) was popular. Later a variety of other techniques was used to encourage collapse of the infected portion of the lung: unilateral phrenic nerve division, PNEUMONOLYSIS, pneumoperitoneum (PNEUMOPERITONEUM, ARTIFICIAL), and THORACOPLASTY. Collapse therapy has declined since the advent of antitubercular chemotherapy. (Stedman, 25th ed; from Sabiston Jr, Textbook of Surgery, 14th ed, p1733-4)
=750  \0$aCollapse therapy$5IEN$0(DLC)sh 85027974

=LDR  01487cz  a2200409n  4500
=001  9880363450802441
=005  20141212200202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003094
=035  \\$aCAZ6251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x280
=072  \\$aD12.$x776.$x860.$x300.$x250
=150  \\$aCollagen
=450  \\$wnnna$aalpha-Collagen
=450  \\$wnnna$aalpha Collagen
=450  \\$wnnna$aAvicon
=450  \\$wnnna$aAvitene
=450  \\$wnnna$aCollagen Felt
=450  \\$wnnna$aCollagen Fleece
=450  \\$wnnna$aCollagen Hemostat, Microfibril
=450  \\$wnnna$aCollagenfleece
=450  \\$wnnna$aCollastat
=450  \\$wnnna$aDermodress
=450  \\$wnnna$aMicrofibril Collagen Hemostat
=450  \\$wnnna$aPangen
=450  \\$wnnna$aZyderm
=550  \\$wg$aBiopolymers
=550  \\$wg$aExtracellular Matrix Proteins
=550  \\$wh$aFibrillar Collagens
=550  \\$wh$aNon-Fibrillar Collagens
=550  \\$wh$aProcollagen
=550  \\$wh$aTropocollagen
=550  \\$aConnective Tissue
=667  \\$aGEN; prefer specifics; precusor = PROCOLLAGEN; do not confuse X ref MICROFIBRIL COLLAGEN HEMOSTAT with FIBRILLAR COLLAGENS
=680  \\$iA polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).
=750  \0$aCollagen$5IEN$0(DLC)sh 85027969

=LDR  01023cz  a2200265n  4500
=001  9880363450902441
=005  20141212200202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003093
=035  \\$aCAZ6250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x265.$x231
=072  \\$aC6.$x405.$x205.$x731.$x249
=072  \\$aC6.$x405.$x469.$x158.$x188.$x231
=072  \\$aC6.$x405.$x469.$x432.$x249
=150  \\$aColitis, Ulcerative
=450  \\$wnnna$aColitis Gravis
=450  \\$wnnna$aIdiopathic Proctocolitis
=450  \\$wnnna$aInflammatory Bowel Disease, Ulcerative Colitis Type
=450  \\$wnnna$aUlcerative Colitis
=550  \\$wg$aColitis
=550  \\$wg$aInflammatory Bowel Diseases
=667  \\$ausually chronic so do not coord with CHRONIC DISEASE
=680  \\$iInflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
=750  \0$aUlcerative colitis$5IEN$0(DLC)sh 85139426

=LDR  00890cz  a2200253n  4500
=001  9880363451002441
=005  20141212200201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003092
=035  \\$aCAZ6249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x265
=072  \\$aC6.$x405.$x469.$x158.$x188
=150  \\$aColitis
=450  \\$wnnna$aColitides
=550  \\$wg$aColonic Diseases
=550  \\$wg$aGastroenteritis
=550  \\$wh$aColitis, Ischemic
=550  \\$wh$aColitis, Microscopic
=550  \\$wh$aColitis, Ulcerative
=550  \\$wh$aProctocolitis
=667  \\$ageneral; note specifics; ENTEROCOLITIS is also available
=680  \\$iInflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
=750  \0$aColitis$5IEN$0(DLC)sh 85027957

=LDR  00835cz  a2200253n  4500
=001  9880363451102441
=005  20141212200200.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003088
=035  \\$aCAZ6245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350.$x650.$x300
=150  \\$aColinus
=450  \\$wnnna$aBob-White
=450  \\$wnnna$aBob White
=450  \\$wnnna$aBob-Whites
=450  \\$aBobwhite
=450  \\$wnnna$aBobwhites
=450  \\$wnnna$aColinis
=550  \\$wg$aQuail
=667  \\$adiseases: coord IM with BIRD DISEASES (IM)
=680  \\$iA genus of QUAIL, in the family Odontophoridae, comprised of at least four different species of bobwhites.
=688  \\$a91(75); was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94
=750  \0$aBobwhites$5IEN-M$0(DLC)sh 95002447

=LDR  01343cz  a2200433n  4500
=001  9880363451202441
=005  20141212200200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003087
=035  \\$aCAZ6244M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97.$x200
=072  \\$aD12.$x776.$x97.$x275.$x750
=150  \\$aColicins
=450  \\$wnnna$aColicin A
=450  \\$wnnna$aColicin B
=450  \\$wnnna$aColicin E
=450  \\$wnnna$aColicin E1
=450  \\$wnnna$aColicin E2
=450  \\$wnnna$aColicin E3
=450  \\$wnnna$aColicin E8
=450  \\$wnnna$aColicin HSC10
=450  \\$wnnna$aColicin Ia
=450  \\$wnnna$aColicin Ib
=450  \\$wnnna$aColicin K
=450  \\$wnnna$aColicin K-K235
=450  \\$wnnna$aColicin K K235
=450  \\$wnnna$aColicin M
=450  \\$wnnna$aColicin N
=450  \\$wnnna$aColicin V
=450  \\$aColicines
=450  \\$wnnna$aColicins E
=450  \\$wnnna$aColicins E9
=450  \\$wnnna$aPrecolicin E1
=550  \\$wg$aBacterial Proteins
=550  \\$wg$aEscherichia coli Proteins
=680  \\$iBacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species.
=688  \\$a66(65)
=750  \0$aColicins$0(DLC)sh2007002456$5IEN-M

=LDR  01045cz  a2200277n  4500
=001  9880363451302441
=005  20161109162855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003085
=035  \\$aCAZ6242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x646.$x100.$x600
=072  \\$aC23.$x888.$x821.$x30.$x500
=150  \\$aColic
=450  \\$wnnna$aAbdominal Cramp
=450  \\$aAbdominal Cramps
=450  \\$wnnna$aColic, Infantile
=450  \\$wnnna$aCramp, Abdominal
=450  \\$wnnna$aCramps, Abdominal
=450  \\$wnnna$aInfantile Colic
=550  \\$wg$aAbdominal Pain
=550  \\$wh$aRenal Colic
=550  \\$aAbdominal Pain
=667  \\$acoord IM with organ/diseases (IM), as biliary colic = COLIC (IM) + BILIARY TRACT DISEASES or specific (IM)
=680  \\$iA clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.
=750  \0$aColic$5IEN$0(DLC)sh 85027951

=LDR  00662cz  a2200217n  4500
=001  9880363451402441
=005  20141212200158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003082
=035  \\$aCAZ6239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x219
=150  \\$aColectomy
=450  \\$wnnna$aColectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wh$aProctocolectomy, Restorative
=550  \\$aColon
=667  \\$ado not use /util except by MeSH definition
=680  \\$iExcision of a portion of the colon or of the whole colon. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aColectomy$5IEN$0(DLC)sh 85027939

=LDR  01547cz  a2200337n  4500
=001  9880363451502441
=005  20141212200157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003079
=035  \\$aCAZ6237HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x200
=150  \\$aColchicum
=450  \\$aAutumn Crocus
=450  \\$wnnna$aautumnale, Colchicum
=450  \\$wnnna$aautumnales, Colchicum
=450  \\$wnnna$aColchicum autumnale
=450  \\$wnnna$aColchicum autumnales
=450  \\$wnnna$aColchicums
=450  \\$aCrocus, Autumn
=450  \\$wnnna$aCrocus, Fall
=450  \\$aFall Crocus
=450  \\$aMeadow Saffron
=450  \\$wnnna$aMeadow Saffrons
=450  \\$wnnna$aSaffron, Meadow
=450  \\$wnnna$aSaffrons, Meadow
=550  \\$wg$aLiliaceae
=667  \\$aCOLCHICINE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of poisonous, liliaceous plants. The roots (corms) of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics.
=688  \\$a91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
=750  \0$aColchicum$0(DLC) sh 92005214$5IEN

=LDR  00799cz  a2200217n  4500
=001  9880363451602441
=005  20141212200157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003078
=035  \\$aCAZ6236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x225
=150  \\$aColchicine
=450  \\$wnnna$aColchicine, (+-)-Isomer
=450  \\$wnnna$aColchicine, (R)-Isomer
=550  \\$wg$aAlkaloids
=550  \\$wh$aDemecolcine
=550  \\$wh$aLumicolchicines
=550  \\$aColchicum
=680  \\$iA major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE).
=750  \0$aColchicine$5IEN$0(DLC)sh 92005259

=LDR  00645cz  a2200205n  4500
=001  9880363451702441
=005  20141212200156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003077
=035  \\$aCAZ6235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x108.$x110
=072  \\$aN6.$x230.$x132.$x258.$x108.$x110
=150  \\$aCoke
=450  \\$wnnna$aCokes
=550  \\$wg$aCoal
=667  \\$aa coal residue used as fuel
=680  \\$iA residue of coal, left after dry (destructive) distillation, used as a fuel.
=688  \\$a91(75); was see under COAL 1975-90; was in Cat J only 1975-81
=750  \0$aCoke$5IEN$0(DLC)sh 85027885

=LDR  00655cz  a2200205n  4500
=001  9880363451802441
=005  20141212200156.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003076
=035  \\$aCAZ6234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x194.$x250
=072  \\$aF1.$x145.$x802.$x188.$x300
=150  \\$aCoitus Interruptus
=450  \\$wnnna$aInterruptus, Coitus
=550  \\$wg$aCoitus
=550  \\$wg$aContraception
=680  \\$iA contraceptive method whereby coitus is purposely interrupted in order to prevent EJACULATION of SEMEN into the VAGINA.
=688  \\$a75
=750  \0$aCoitus interruptus$5IEN$0(DLC)sh 85027883

=LDR  01073cz  a2200325n  4500
=001  9880363451902441
=005  20141212200156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003075
=035  \\$aCAZ6233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x188
=072  \\$aG8.$x686.$x785.$x760.$x41
=150  \\$aCoitus
=450  \\$wnnna$aCoital Frequencies
=450  \\$wnnna$aCoital Frequency
=450  \\$wnnna$aFirst Intercourse
=450  \\$wnnna$aFirst Intercourses
=450  \\$wnnna$aFrequencies, Coital
=450  \\$wnnna$aFrequency, Coital
=450  \\$wnnna$aIntercourse, First
=450  \\$wnnna$aIntercourse, Sexual
=450  \\$wnnna$aIntercourses, First
=450  \\$aSexual Intercourse
=550  \\$wg$aReproduction
=550  \\$wg$aSexual Behavior
=550  \\$wh$aCoitus Interruptus
=667  \\$ahuman only: animal = COPULATION; for anal or oral sex index under SEX BEHAVIOR
=680  \\$iThe sexual union of a male and a female, a term used for human only.
=750  \0$aSexual intercourse$5IEN$0(DLC)sh 85120739

=LDR  02280cz  a2200577n  4500
=001  9880363452002441
=005  20141212192639.0
=008  880601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015331
=035  \\$aCAZ6231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x500.$x750
=072  \\$aN5.$x715.$x360.$x775.$x175.$x250
=072  \\$aN6.$x850.$x520.$x450.$x500.$x750
=150  \\$aCohort Studies
=450  \\$wnnna$aAnalyses, Cohort
=450  \\$wnnna$aAnalysis, Cohort
=450  \\$aClosed Cohort Studies
=450  \\$wnnna$aClosed Cohort Study
=450  \\$wnnna$aCohort Analyses
=450  \\$aCohort Analysis
=450  \\$wnnna$aCohort Studies, Closed
=450  \\$wnnna$aCohort Studies, Historical
=450  \\$wnnna$aCohort Study
=450  \\$wnnna$aCohort Study, Closed
=450  \\$wnnna$aCohort Study, Historical
=450  \\$aConcurrent Studies
=450  \\$wnnna$aConcurrent Study
=450  \\$aHistorical Cohort Studies
=450  \\$wnnna$aHistorical Cohort Study
=450  \\$aIncidence Studies
=450  \\$wnnna$aIncidence Study
=450  \\$wnnna$aStudies, Closed Cohort
=450  \\$wnnna$aStudies, Cohort
=450  \\$wnnna$aStudies, Concurrent
=450  \\$wnnna$aStudies, Historical Cohort
=450  \\$wnnna$aStudies, Incidence
=450  \\$wnnna$aStudy, Closed Cohort
=450  \\$wnnna$aStudy, Cohort
=450  \\$wnnna$aStudy, Concurrent
=450  \\$wnnna$aStudy, Historical Cohort
=450  \\$wnnna$aStudy, Incidence
=550  \\$wg$aEpidemiologic Studies
=550  \\$wh$aFollow-Up Studies
=550  \\$wh$aLongitudinal Studies
=550  \\$wh$aProspective Studies
=550  \\$wh$aRetrospective Studies
=667  \\$aIM general only; coordinate NIM with specific disease (IM); add geographic term if pertinent
=680  \\$iStudies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
=688  \\$a89; INCIDENCE STUDIES was heading 1989
=750  \0$aCohort analysis$5IEN$0(DLC)sh 85027772

=LDR  00804cz  a2200229n  4500
=001  9880363452102441
=005  20141212200155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003073
=035  \\$aCAZ6230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x305
=150  \\$aCognitive Dissonance
=450  \\$wnnna$aCognitive Dissonances
=450  \\$wnnna$aDissonance, Cognitive
=450  \\$wnnna$aDissonances, Cognitive
=550  \\$wg$aCognition
=550  \\$aMotivation
=667  \\$ano qualif
=680  \\$iMotivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant.
=688  \\$a69
=750  \0$aCognitive dissonance$5IEN$0(DLC)sh 85027753

=LDR  00800cz  a2200253n  4500
=001  9880363452202441
=005  20160405153907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003072
=035  \\$aCAZ6229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x87.$x250
=150  \\$aCognition Disorders
=450  \\$aCognitive Disorders$5IEN-M
=450  \\$wnnna$aDisorder, Cognition
=450  \\$wnnna$aDisorders, Cognition
=450  \\$aOverinclusion
=550  \\$wg$aNeurocognitive Disorders
=550  \\$wh$aAuditory Perceptual Disorders
=550  \\$wh$aHuntington Disease
=550  \\$wh$aMild Cognitive Impairment
=680  \\$iDisturbances in the mental process related to thinking, reasoning, and judgment.
=688  \\$a69
=750  \0$aCognition disorders$5IEN$0(DLC)sh 85027745

=LDR  00755cz  a2200253n  4500
=001  9880363452302441
=005  20190325114732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003071
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188
=150  \\$aCognition
=550  \\$wg$aMental Processes
=550  \\$wh$aAwareness
=550  \\$wh$aCognitive Dissonance
=550  \\$wh$aCognitive Reserve
=550  \\$wh$aComprehension
=550  \\$wh$aConsciousness
=550  \\$wh$aImagination
=550  \\$wh$aIntuition
=550  \\$wh$aMetacognition
=550  \\$wh$aRumination, Cognitive
=680  \\$iIntellectual or mental process whereby an organism becomes aware of or obtains knowledge.
=750  \0$aCognition$5IEN-M$0(DLC)sh 85027742

=LDR  01015cz  a2200349n  4500
=001  9880363452402441
=005  20141212200154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003067
=035  \\$aCAZ6225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x211
=150  \\$aCoenzymes
=450  \\$wnnna$aCofactors, Enzyme
=450  \\$wnnna$aEnzyme Cofactors
=550  \\$wg$aEnzymes and Coenzymes
=550  \\$wh$aBiopterin
=550  \\$wh$aBiotin
=550  \\$wh$aCobamides
=550  \\$wh$aCoenzyme A
=550  \\$wh$aFlavins
=550  \\$wh$aNAD
=550  \\$wh$aNADP
=550  \\$wh$aPQQ Cofactor
=550  \\$wh$aPyridoxal Phosphate
=550  \\$wh$aSphingolipid Activator Proteins
=550  \\$wh$aTetrahydrofolates
=550  \\$wh$aThiamine Pyrophosphate
=550  \\$wh$aThioctic Acid
=550  \\$wh$aUbiquinone
=680  \\$iSmall molecules that are required for the catalytic function of ENZYMES. Many VITAMINS are coenzymes.
=750  \0$aCoenzymes$5IEN$0(DLC)sh 85027690

=LDR  00935cz  a2200277n  4500
=001  9880363452502441
=005  20141212200152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003063
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308
=150  \\$aCnidaria
=450  \\$wnnna$aCnidarian
=450  \\$wnnna$aCnidarians
=450  \\$wnnna$aCnidarias
=550  \\$wg$aInvertebrates
=550  \\$wh$aAnthozoa
=550  \\$wh$aCubozoa
=550  \\$wh$aHydrozoa
=550  \\$wh$aMyxozoa
=550  \\$wh$aScyphozoa
=550  \\$aCnidarian Venoms
=667  \\$apoisoning: coord with CNIDARIAN VENOMS if pertinent
=680  \\$iA phylum of radially symmetrical invertebrates characterized by possession of stinging cells called nematocysts. It includes the classes ANTHOZOA; CUBOZOA; HYDROZOA, and SCYPHOZOA. Members carry CNIDARIAN VENOMS.
=688  \\$a1995 (1963)
=750  \0$aCnidaria$5IEN$0(DLC)sh 98001754

=LDR  01089cz  a2200301n  4500
=001  9880363452602441
=005  20190318103536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003061
=035  \\$aCAZ6218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x562.$x149
=072  \\$aD3.$x633.$x400.$x686.$x607.$x204
=072  \\$aD3.$x605.$x497.$x607.$x204
=072  \\$aD4.$x615.$x723.$x795.$x576.$x149
=150  \\$aCodeine
=450  \\$wnnna$aArdinex
=450  \\$wnnna$aCodeine Phosphate
=450  \\$wnnna$aIsocodeine
=450  \\$wnnna$aN-Methylmorphine
=450  \\$wnnna$aN Methylmorphine
=550  \\$wg$aMorphine Derivatives
=550  \\$wh$aHydrocodone
=550  \\$wh$aOxycodone
=667  \\$acodeine derivatives = CODEINE /analogs
=680  \\$iAn opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.
=688  \\$aCODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74
=750  \0$aCodeine$5IEN$0(DLC)sh 85027648

=LDR  00826cz  a2200241n  4500
=001  9880363452702441
=005  20141212200151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003060
=035  \\$aCAZ6217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x360
=072  \\$aD10.$x212.$x507.$x325
=072  \\$aD10.$x627.$x430.$x354
=150  \\$aCod Liver Oil
=450  \\$wnnna$aLiver Oil, Cod
=450  \\$wnnna$aOil, Cod Liver
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aFish Oils
=680  \\$iOil obtained from fresh livers of the cod family, Gadidae. It is a source of VITAMIN A and VITAMIN D.
=688  \\$a91(75); was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82
=750  \0$aCod-liver oil$5IEN$0(DLC)sh 85027638

=LDR  01237cz  a2200289n  4500
=001  9880363452802441
=005  20141212200151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003059
=035  \\$aCAZ6216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x211
=150  \\$aCocos
=450  \\$wnnna$aCoco
=450  \\$wnnna$aCocoanut
=450  \\$wnnna$aCocoanuts
=450  \\$aCoconut
=450  \\$wnnna$aCoconuts
=450  \\$wnnna$aCocos nucifera
=450  \\$wnnna$aCocos nuciferas
=450  \\$wnnna$anucifera, Cocos
=450  \\$wnnna$anuciferas, Cocos
=550  \\$wg$aArecaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARECACEAE. It is a tropical palm tree that yields a large, edible hard-shelled fruit from which oil and fiber are also obtained.
=688  \\$a91(86)63; was see under NUTS 1986-90; was heading 1963-85; was in Cat J only 1963-80
=750  \0$aCoconut palm$5IEN$0(DLC)sh 85027629

=LDR  01145cz  a2200349n  4500
=001  9880363452902441
=005  20141212200150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003058
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x140
=150  \\$aCockroaches
=450  \\$aBlaberidae
=450  \\$aBlattaria
=450  \\$wnnna$aBlattarias
=450  \\$aBlattidae
=450  \\$aBlattodea
=450  \\$wnnna$aBlattodeas
=450  \\$wnnna$aCockroach
=450  \\$wnnna$aCockroache
=450  \\$wnnna$aCockroachs
=450  \\$aCryptocercidae
=450  \\$aDictyoptera
=450  \\$wnnna$aDictyopteras
=450  \\$aPolyphagidae
=550  \\$wg$aInsects
=550  \\$wh$aBlattellidae
=550  \\$wh$aPeriplaneta
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iInsects of the order Dictyoptera comprising several families including Blaberidae, BLATTELLIDAE, Blattidae (containing the American cockroach PERIPLANETA americana), Cryptocercidae, and Polyphagidae.
=688  \\$a72; for DICTYOPTERA use ORTHOPTERA 1975-98
=750  \0$aCockroaches$5IEN$0(DLC)sh 85027610

=LDR  01578cz  a2200373n  4500
=001  9880363453002441
=005  20141212200149.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003054
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x319.$x381.$x500.$x500
=072  \\$aE7.$x695.$x150
=072  \\$aE7.$x695.$x202.$x381.$x500.$x500
=072  \\$aE7.$x814.$x458.$x150
=150  \\$aCochlear Implants
=450  \\$wnnna$aAuditory Prostheses
=450  \\$aAuditory Prosthesis
=450  \\$wnnna$aCochlear Implant
=450  \\$wnnna$aCochlear Prostheses
=450  \\$aCochlear Prosthesis
=450  \\$wnnna$aImplant, Cochlear
=450  \\$aImplants, Cochlear
=450  \\$wnnna$aProstheses, Auditory
=450  \\$wnnna$aProstheses, Cochlear
=450  \\$wnnna$aProsthesis, Auditory
=450  \\$wnnna$aProsthesis, Cochlear
=550  \\$wg$aHearing Aids
=550  \\$wg$aNeural Prostheses
=550  \\$wg$aProstheses and Implants
=550  \\$aCochlear Implantation
=667  \\$asubcutaneous electronic implants: do not confuse with French "prothese auditive" translated as "hearing aid" & indexed under HEARING AIDS
=680  \\$iElectronic hearing devices typically used for patients with normal outer and middle ear function, but defective inner ear function. In the COCHLEA, the hair cells (HAIR CELLS, VESTIBULAR) may be absent or damaged but there are residual nerve fibers. The device electrically stimulates the COCHLEAR NERVE to create sound sensation.
=688  \\$a98(80)
=750  \0$aCochlear implants$5IEN$0(DLC)sh 85027592

=LDR  01030cz  a2200301n  4500
=001  9880363453102441
=005  20141212200147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003051
=035  \\$aCAZ6208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x246
=150  \\$aCochlea
=450  \\$wnnna$aCochleas
=550  \\$wg$aEar, Inner
=550  \\$wh$aBasilar Membrane
=550  \\$wh$aCochlear Aqueduct
=550  \\$wh$aCochlear Duct
=550  \\$wh$aOrgan of Corti
=550  \\$wh$aRound Window, Ear
=550  \\$wh$aScala Tympani
=550  \\$wh$aScala Vestibuli
=550  \\$wh$aSpiral Ganglion
=550  \\$wh$aSpiral Lamina
=550  \\$wh$aSpiral Ligament of Cochlea
=667  \\$adiseases = COCHLEAR DISEASES
=680  \\$iThe part of the inner ear (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH.
=750  \0$aCochlea$5IEN$0(DLC)sh 85027588

=LDR  00492cz  a2200157n  4500
=001  9880363453202441
=005  20141212200147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003050
=035  \\$aCAZ6207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x229
=150  \\$aCoccyx
=550  \\$wg$aSpine
=667  \\$aa bone of the spine; do not confuse with COCCYGEAL REGION, merely locational; coord IM with specific disease (IM)
=750  \0$aCoccyx$5IEN$0(DLC)sh 85027576

=LDR  01329cz  a2200313n  4500
=001  9880363453302441
=005  20141212200147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003048
=035  \\$aCAZ6205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x250
=150  \\$aCoccidiosis
=450  \\$wnnna$aBesnoitiases
=450  \\$aBesnoitiasis
=450  \\$wnnna$aBesnoitioses
=450  \\$wnnna$aBesnoitiosis
=450  \\$wnnna$aCoccidioses
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aCryptosporidiosis
=550  \\$wh$aCyclosporiasis
=550  \\$wh$aIsosporiasis
=550  \\$wh$aSarcocystosis
=550  \\$wh$aToxoplasmosis
=667  \\$aprotozoan infect caused by COCCIDIA, not COCCIDIOIDES; /drug ther: consider also COCCIDIOSTATS
=680  \\$iProtozoan infection found in animals and man. It is caused by several different genera of COCCIDIA.
=688  \\$a1995; for BESNOITIASIS use PROTOZOAN INFECTIONS 1985-1994, was heading 1968-1984; for EIMERIA INFECTIONS & ISOSPORA INFECTIONS use COCCIDIOSIS 1975-1991, use COCCIDIOSIS 1967-1974
=688  \\$aBESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS & ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74
=750  \0$aCoccidiosis$5IEN$0(DLC)sh 85027570

=LDR  01354cz  a2200265n  4500
=001  9880363453402441
=005  20141212200146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003047
=035  \\$aCAZ6204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x203
=150  \\$aCoccidioidomycosis
=450  \\$wnnna$aCoccidioides immitis Infection
=450  \\$wnnna$aCoccidioides immitis Infections
=450  \\$wnnna$aCoccidioidomycoses
=450  \\$wnnna$aInfection, Coccidioides immitis
=450  \\$wnnna$aInfections, Coccidioides immitis
=450  \\$wnnna$aSan Joaquin Valley Fever
=450  \\$wnnna$aValley Fever
=450  \\$wnnna$aValley Fevers
=550  \\$wg$aMycoses
=667  \\$afungus disease caused by COCCIDIOIDES, not COCCIDIA
=680  \\$iInfection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN.
=750  \0$aCoccidioidomycosis$5IEN$0(DLC)sh 85027569

=LDR  01013cz  a2200217n  4500
=001  9880363453502441
=005  20141212200145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003044
=035  \\$aCAZ6201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189
=150  \\$aCoccidia
=450  \\$wnnna$aCoccidias
=550  \\$wg$aApicomplexa
=550  \\$wh$aEimeriida
=550  \\$wh$aEucoccidiida
=667  \\$ainfection = COCCIDIOSIS; "coccidial" refers to COCCIDIA: do not confuse with "coccidioidal" (refers to COCCIDIOIDES, a fungus); coordinate with specific protozoal terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise two orders: EIMERIIDA and EUCOCCIDIIDA.
=688  \\$a79(75); was see under SPOROZOA 1963-78
=750  \0$aCoccidia$5IEN$0(DLC)sh 85027567

=LDR  00720cz  a2200229n  4500
=001  9880363453602441
=005  20141212200145.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003043
=035  \\$aCAZ6200HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x98.$x875
=072  \\$aC23.$x550.$x727.$x98.$x750
=150  \\$aCocarcinogenesis
=450  \\$wnnna$aCocarcinogeneses
=550  \\$wg$aCarcinogenesis
=550  \\$aCarcinogens
=550  \\$aDrug Synergism
=667  \\$ado not confuse with NEOPLASMS, MULTIPLE PRIMARY; Manual 24.4.1.14
=680  \\$iThe combination of two or more different factors in the production of cancer.
=688  \\$a77
=750  \0$aCocarcinogenesis$5IEN$0(DLC)sh 85027564

=LDR  01394cz  a2200265n  4500
=001  9880363453702441
=005  20141212200145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x74.$x722.$x388
=072  \\$aD3.$x132.$x889.$x354
=072  \\$aD3.$x605.$x869.$x388
=072  \\$aD4.$x75.$x80.$x875.$x99.$x722.$x388
=150  \\$aCocaine
=450  \\$wnnna$aCocaine HCl
=450  \\$wnnna$aCocaine Hydrochloride
=450  \\$wnnna$aHCl, Cocaine
=450  \\$wnnna$aHydrochloride, Cocaine
=550  \\$wg$aTropanes
=550  \\$wh$aCrack Cocaine
=667  \\$acocaine derivatives = COCAINE /analogs;CRACK COCAINE is available; cocaine addiction = COCAINE-RELATED DISORDERS
=680  \\$iAn alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
=688  \\$aCOCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74
=750  \0$aCocaine$5IEN$0(DLC)sh 85027558

=LDR  00696cz  a2200205n  4500
=001  9880363453802441
=005  20141212200145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003041
=035  \\$aCAZ6198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x346.$x500
=150  \\$aCoca
=450  \\$wnnna$aCocas
=450  \\$aErythroxylon
=450  \\$wnnna$aErythroxylons
=550  \\$wg$aErythroxylaceae
=667  \\$ado not confuse with cocoa see CACAO
=680  \\$iAny of several South American shrubs of the Erythroxylon genus (and family) that yield COCAINE; the leaves are chewed with alum for CNS stimulation.
=750  \0$aCoca$5IEN$0(DLC)sh 85027554

=LDR  00656cz  a2200205n  4500
=001  9880363453902441
=005  20141212200143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003036
=035  \\$aCAZ6193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x239
=150  \\$aCobalt Isotopes
=450  \\$wnnna$aIsotopes, Cobalt
=550  \\$wg$aIsotopes
=550  \\$wh$aCobalt Radioisotopes
=550  \\$aCobalt
=667  \\$aCo-59; NIM
=680  \\$iStable cobalt atoms that have the same atomic number as the element cobalt, but differ in atomic weight. Co-59 is a stable cobalt isotope.
=750  \0$aCobalt$xIsotopes$5IEN$0(DLC)sh 85027514

=LDR  00923cz  a2200241n  4500
=001  9880363454002441
=005  20141212200143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003035
=035  \\$aCAZ6192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x185
=072  \\$aD1.$x268.$x956.$x155
=072  \\$aD1.$x552.$x544.$x185
=150  \\$aCobalt
=450  \\$aCobalt Compounds$5IEN
=450  \\$aOrganocobalt Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aCo-59
=680  \\$iA trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.
=750  \0$aCobalt compounds$5IEN-M$0(DLC)sh 85027523
=750  \0$aCobalt$5IEN-HS$0(DLC)sh 85027513

=LDR  00877cz  a2200205n  4500
=001  9880363454102441
=005  20141212200142.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003033
=035  \\$aCAZ6190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x749.$x354
=150  \\$aCoal Tar
=450  \\$wnnna$aClinitar
=450  \\$wnnna$aEstar
=450  \\$wnnna$aTar, Coal
=550  \\$wg$aTars
=667  \\$aD25-26 qualif
=680  \\$iA by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985) (Merck Index, 11th ed).
=750  \0$aCoal-tar$5IEN$0(DLC)sh 85027406

=LDR  00662cz  a2200205n  4500
=001  9880363454202441
=005  20141212192112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003032
=035  \\$aCAZ6189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x500.$x500
=150  \\$aCoal Mining
=450  \\$wnnna$aCoal Minings
=450  \\$wnnna$aMining, Coal
=450  \\$wnnna$aMinings, Coal
=550  \\$wg$aMining
=667  \\$aSPEC: SPEC qualif; consider also PNEUMOCONIOSIS but particularly SILICOSIS & ANTHRACOSILICOSIS
=750  \0$aCoal miners$5IEN-M$0(DLC)sh 85027354
=750  \0$aCoal mines and mining$5IEN-HS$0(DLC)sh 85027364

=LDR  01604cz  a2200505n  4500
=001  9880363454302441
=005  20141212200142.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003031
=035  \\$aCAZ6188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x108
=072  \\$aN6.$x230.$x132.$x258.$x108
=150  \\$aCoal
=450  \\$wnnna$aAnthracite
=450  \\$wnnna$aAnthracites
=450  \\$wnnna$aBituminous Coal
=450  \\$wnnna$aBituminous Coals
=450  \\$wnnna$aBrown Coal
=450  \\$wnnna$aBrown Coals
=450  \\$wnnna$aCoal, Bituminous
=450  \\$wnnna$aCoal, Brown
=450  \\$wnnna$aCoal, Lignitious
=450  \\$wnnna$aCoal, Peat
=450  \\$wnnna$aCoal, Soft
=450  \\$wnnna$aCoals
=450  \\$wnnna$aCoals, Bituminous
=450  \\$wnnna$aCoals, Brown
=450  \\$wnnna$aCoals, Lignitious
=450  \\$wnnna$aCoals, Peat
=450  \\$wnnna$aCoals, Soft
=450  \\$wnnna$aLignite
=450  \\$wnnna$aLignites
=450  \\$wnnna$aLignitious Coal
=450  \\$wnnna$aLignitious Coals
=450  \\$wnnna$aPeat Coal
=450  \\$wnnna$aPeat Coals
=450  \\$wnnna$aSoft Coal
=450  \\$wnnna$aSoft Coals
=550  \\$wg$aFossil Fuels
=550  \\$wh$aCoke
=667  \\$a/adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal
=680  \\$iA natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions.
=688  \\$a68(64); was in Cat J only 1964-81
=750  \0$aCoal$5IEN$0(DLC)sh 85027307

=LDR  01624cz  a2200313n  4500
=001  9880363454402441
=005  20141212200141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003030
=035  \\$aCAZ6187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x174
=072  \\$aD12.$x776.$x97.$x181
=150  \\$aCoagulase
=450  \\$wnnna$aClumping Factor (Staphylococcal)
=450  \\$wnnna$aClumping Factor, Staphylococcal
=450  \\$wnnna$aFactor, Staphylococcal Clumping
=450  \\$aStaphylocoagulase
=450  \\$aStaphylococcal Clumping Factor
=450  \\$wnnna$aStaphylococcus aureus clone pSCa2 of Coagulase
=450  \\$wnnna$aStaphylococcus aureus strain 213 of Coagulase
=450  \\$wnnna$aStaphylococcus aureus strain 8325-4 of Coagulase
=450  \\$wnnna$aStaphylococcus aureus strain 8325 4 of Coagulase
=550  \\$wg$aBacterial Proteins
=550  \\$wg$aEndopeptidases
=667  \\$ado not routinely add when indexing coagulase negative organisms; index only when discussed
=680  \\$iEnzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.
=688  \\$a66(64); was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67
=750  \0$aCoagulase$5IEN$0(DLC)sh 85027303

=LDR  01268cz  a2200481n  4500
=001  9880363454502441
=005  20141212200141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003029
=035  \\$aCAZ6186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x270
=150  \\$aCoagulants
=550  \\$wg$aHematologic Agents
=550  \\$wh$aHemostatics
=550  \\$wh$aHeparin Antagonists
=550  \\$aBlood Coagulation
=550  \\$aBlood Coagulation Factors
=550  \\$aFactor IX
=550  \\$aFactor IXa
=550  \\$aFactor V
=550  \\$aFactor Va
=550  \\$aFactor VII
=550  \\$aFactor VIIa
=550  \\$aFactor VIIIa
=550  \\$aFactor X
=550  \\$aFactor Xa
=550  \\$aFactor XI
=550  \\$aFactor XIa
=550  \\$aFactor XII
=550  \\$aFactor XIIa
=550  \\$aFactor XIII
=550  \\$aFibrinogen
=550  \\$aKallikreins
=550  \\$aPrekallikrein
=550  \\$aProthrombin
=550  \\$aThrombin
=550  \\$aThromboplastin
=550  \\$avon Willebrand Factor
=667  \\$aconsider also BLOOD COAGULATION /drug eff
=680  \\$iAgents that cause clotting.
=688  \\$a75; was see under HEMOSTATICS 1963-74
=750  \0$aCoagulants$5IEN$0(DLC)sh 85027302

=LDR  02937cz  a2200697n  4500
=001  9880363454602441
=005  20141212200140.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003027
=035  \\$aCAZ6184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x546.$x399.$x937.$x500
=150  \\$aCluster Headache
=450  \\$wnnna$aAtypical Cluster Headache
=450  \\$wnnna$aAtypical Cluster Headaches
=450  \\$wnnna$aCephalgia, Histamine
=450  \\$wnnna$aCephalgias, Histamine
=450  \\$wnnna$aChronic Cluster Headache
=450  \\$wnnna$aChronic Cluster Headaches
=450  \\$aCiliary Neuralgia
=450  \\$wnnna$aCiliary Neuralgias
=450  \\$wnnna$aCluster Headache, Atypical
=450  \\$wnnna$aCluster Headache, Chronic
=450  \\$wnnna$aCluster Headache, Episodic
=450  \\$wnnna$aCluster Headache Syndrome
=450  \\$wnnna$aCluster Headache Syndromes
=450  \\$wnnna$aCluster Headaches
=450  \\$wnnna$aCluster Headaches, Atypical
=450  \\$wnnna$aCluster Headaches, Chronic
=450  \\$wnnna$aCluster Headaches, Episodic
=450  \\$wnnna$aEpisodic Cluster Headache
=450  \\$wnnna$aEpisodic Cluster Headaches
=450  \\$wnnna$aHeadache, Atypical Cluster
=450  \\$wnnna$aHeadache, Chronic Cluster
=450  \\$aHeadache, Cluster
=450  \\$wnnna$aHeadache, Episodic Cluster
=450  \\$wnnna$aHeadache Syndrome, Cluster
=450  \\$wnnna$aHeadache Syndromes, Cluster
=450  \\$wnnna$aHeadaches, Atypical Cluster
=450  \\$wnnna$aHeadaches, Chronic Cluster
=450  \\$wnnna$aHeadaches, Cluster
=450  \\$wnnna$aHeadaches, Episodic Cluster
=450  \\$aHistamine Cephalgia
=450  \\$wnnna$aHistamine Cephalgias
=450  \\$aHorton Syndrome
=450  \\$wnnna$aHorton's Syndrome
=450  \\$wnnna$aHortons Syndrome
=450  \\$wnnna$aMigraine, Neuralgic
=450  \\$wnnna$aMigraines, Neuralgic
=450  \\$wnnna$aNeuralgia, Ciliary
=450  \\$wnnna$aNeuralgias, Ciliary
=450  \\$aNeuralgic Migraine
=450  \\$wnnna$aNeuralgic Migraines
=450  \\$wnnna$aSyndrome, Cluster Headache
=450  \\$wnnna$aSyndrome, Horton
=450  \\$wnnna$aSyndrome, Horton's
=450  \\$wnnna$aSyndromes, Cluster Headache
=550  \\$wg$aTrigeminal Autonomic Cephalalgias
=680  \\$iA primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
=688  \\$a1991(1978)
=750  \0$aCluster headache$5IEN$0(DLC)sh 85027252

=LDR  01103cz  a2200325n  4500
=001  9880363454702441
=005  20180316145141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003025
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x488.$x655.$x63
=072  \\$aC5.$x330.$x495.$x681.$x63
=072  \\$aC5.$x660.$x585.$x512.$x380.$x813.$x63
=072  \\$aC16.$x131.$x621.$x585.$x512.$x500.$x681.$x63
=150  \\$aClubfoot
=450  \\$aClubfeet
=450  \\$wnnna$aClubfeet, Congenital
=450  \\$wnnna$aClubfoot, Congenital
=450  \\$wnnna$aCongenital Clubfeet
=450  \\$wnnna$aCongenital Clubfoot
=450  \\$wnnna$aCongenital Talipes Equinovarus
=450  \\$aEquinovarus
=450  \\$wnnna$aPie Torcido
=450  \\$wnnna$aPie Torcidos
=450  \\$aTalipes Equinovarus
=450  \\$wnnna$aTalipes Equinovarus, Congenital
=550  \\$wg$aTalipes
=667  \\$aentry term EQUINOV ARUS: do not confuse with EQUINUS DEFORMITY
=680  \\$iA deformed foot in which the foot is plantarflexed, inverted and adducted.
=750  \0$aClubfoot$5IEN$0(DLC)sh 85027228

=LDR  01059cz  a2200193n  4500
=001  9880363454802441
=005  20141212200139.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003024
=035  \\$aCAZ6181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x240.$x220
=150  \\$aClozapine
=450  \\$wnnna$aClozaril
=450  \\$wnnna$aLeponex
=550  \\$wg$aDibenzazepines
=680  \\$iA tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
=688  \\$a91(75); was see under DIBENZAZEPINES 1975-90
=750  \0$aClozapine$5IEN$0(DLC)sh 91005516

=LDR  00477cz  a2200181n  4500
=001  9880363454902441
=005  20141212200138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003020
=035  \\$aCAZ6177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x215
=150  \\$aClothing
=450  \\$wnnna$aClothings
=550  \\$wg$aManufactured Materials
=550  \\$wh$aProtective Clothing
=550  \\$wh$aShoes
=750  \0$aClothing and dress$5IEN$0(DLC)sh 85027160

=LDR  00715cz  a2200181n  4500
=001  9880363455002441
=005  20141212200137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003017
=035  \\$aCAZ6174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x725
=072  \\$aB3.$x510.$x415.$x400.$x200.$x725
=150  \\$aClostridium tetani
=550  \\$wg$aClostridium
=667  \\$ainfection = TETANUS
=680  \\$iThe cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin.
=750  \0$aClostridium tetani$0(DLC) sh 88023240$5IEN

=LDR  00767cz  a2200193n  4500
=001  9880363455102441
=005  20141212200137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003016
=035  \\$aCAZ6173HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x575
=072  \\$aB3.$x510.$x415.$x400.$x200.$x575
=150  \\$aClostridium perfringens
=450  \\$aClostridium welchii
=550  \\$wg$aClostridium
=667  \\$ainfection = GAS GANGRENE if in text; otherwise coord IM with CLOSTRIDIUM INFECTIONS (IM)
=680  \\$iThe most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins.
=750  \0$aClostridium perfringens$0(DLC) sh 86007486$5IEN

=LDR  00915cz  a2200277n  4500
=001  9880363455202441
=005  20141212200137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003015
=035  \\$aCAZ6172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x222
=150  \\$aClostridium Infections
=450  \\$wnnna$aClostridium Infection
=450  \\$wnnna$aInfection, Clostridium
=450  \\$wnnna$aInfections, Clostridium
=550  \\$wg$aGram-Positive Bacterial Infections
=550  \\$wh$aBotulism
=550  \\$wh$aEnterocolitis, Pseudomembranous
=550  \\$wh$aEnterotoxemia
=550  \\$wh$aGas Gangrene
=550  \\$wh$aTetanus
=667  \\$agram-pos bact infect; GEN: prefer specifics
=680  \\$iInfections with bacteria of the genus CLOSTRIDIUM.
=688  \\$a68; HEMOGLOBINURIA, BACILLARY was heading 1968-81
=750  \0$aClostridium diseases$0(DLC) sh 85027145$5IEN

=LDR  01284cz  a2200265n  4500
=001  9880363455302441
=005  20141212200136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003014
=035  \\$aCAZ6171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x160
=072  \\$aB3.$x510.$x415.$x400.$x200.$x160
=150  \\$aClostridium botulinum
=550  \\$wg$aClostridium
=550  \\$wh$aClostridium botulinum type A
=550  \\$wh$aClostridium botulinum type B
=550  \\$wh$aClostridium botulinum type C
=550  \\$wh$aClostridium botulinum type D
=550  \\$wh$aClostridium botulinum type E
=550  \\$wh$aClostridium botulinum type F
=550  \\$wh$aClostridium botulinum type G
=667  \\$anote specific types; infection = BOTULISM
=680  \\$iA species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.
=750  \0$aClostridium botulinum$0(DLC) sh 85027143$5IEN

=LDR  01790cz  a2200469n  4500
=001  9880363455402441
=005  20170317160952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003013
=035  \\$aCAZ6170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200
=072  \\$aB3.$x353.$x625.$x500
=072  \\$aB3.$x510.$x415.$x400.$x200
=150  \\$aClostridium
=150  \\$wg$aClostridiales
=550  \\$wg$aGram-Positive Endospore-Forming Rods
=550  \\$wg$aFirmicutes
=550  \\$wh$aClostridium acetobutylicum
=550  \\$wh$aClostridium beijerinckii
=550  \\$wh$aClostridium bifermentans
=550  \\$wh$aClostridium botulinum
=550  \\$wh$aClostridium butyricum
=550  \\$wh$aClostridium cellulolyticum
=550  \\$wh$aClostridium cellulovorans
=550  \\$wh$aClostridium chauvoei
=550  \\$wh$aClostridium difficile
=550  \\$wh$aClostridium histolyticum
=550  \\$wh$aClostridium kluyveri
=550  \\$wh$aClostridium perfringens
=550  \\$wh$aClostridium septicum
=550  \\$wh$aClostridium sordellii
=550  \\$wh$aClostridium sticklandii
=550  \\$wh$aClostridium symbiosum
=550  \\$wh$aClostridium tertium
=550  \\$wh$aClostridium tetani
=550  \\$wh$aClostridium tetanomorphum
=550  \\$wh$aClostridium thermocellum
=550  \\$wh$aClostridium tyrobutyricum
=667  \\$aGEN or unspecified; prefer specifics; infection = CLOSTRIDIUM INFECTIONS or its specifics
=680  \\$iA genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.
=750  \0$aClostridium$0(DLC) sh 85027142$5IEN

=LDR  00831cz  a2200229n  4500
=001  9880363455502441
=005  20141212200134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003006
=035  \\$aCAZ6163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x952.$x305
=072  \\$aD3.$x494.$x953.$x704.$x269
=150  \\$aClopenthixol
=450  \\$wnnna$aalpha-Clopenthixol
=450  \\$wnnna$aalpha Clopenthixol
=450  \\$wnnna$aCisordinol
=450  \\$wnnna$aZuclopenthixol
=550  \\$wg$aThioxanthenes
=680  \\$iA thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.
=688  \\$a91(63); was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74
=750  \0$aClopenthixol$5IEN-M$0(DLC)sh 97004598

=LDR  01204cz  a2200265n  4500
=001  9880363455602441
=005  20141212200134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003004
=035  \\$aCAZ6161M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x520.$x210
=150  \\$aClonorchis sinensis
=450  \\$wnnna$aClonorchis sinenses
=450  \\$wnnna$aOpisthorchis sinenses
=450  \\$aOpisthorchis sinensis
=450  \\$wnnna$asinenses, Clonorchis
=450  \\$wnnna$asinenses, Opisthorchis
=450  \\$wnnna$asinensis, Clonorchis
=450  \\$wnnna$asinensis, Opisthorchis
=550  \\$wg$aOpisthorchidae
=667  \\$ainfection = CLONORCHIASIS; note X ref: OPISTHORCHIS SINENSIS infection = CLONORCHIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts.
=688  \\$a72; was see under OPISTHORCHIS 1963-71
=750  \0$aClonorchis sinensis$0(DLC)sh2012004668$5IEN-M

=LDR  00980cz  a2200181n  4500
=001  9880363455702441
=005  20141212200133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003003
=035  \\$aCAZ6160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x148
=150  \\$aClonorchiasis
=450  \\$wnnna$aClonorchiases
=550  \\$wg$aTrematode Infections
=667  \\$atrematode infect caused by CLONORCHIS SINENSIS; OPISTHORCHIS SINENSIS infection = CLONORCHIASIS, not OPISTHORCHIASIS which is Opisthorchis infect by Opisthorchis species other than O. sinensis
=680  \\$iInfection of the biliary passages with CLONORCHIS SINENSIS, also called Opisthorchis sinensis. It may lead to inflammation of the biliary tract, proliferation of biliary epithelium, progressive portal fibrosis, and sometimes bile duct carcinoma. Extension to the liver may lead to fatty changes and cirrhosis. (From Dorland, 27th ed)
=750  \0$aClonorchiasis$5IEN$0(DLC)sh 85027123

=LDR  01023cz  a2200241n  4500
=001  9880363455802441
=005  20141212200133.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003001
=035  \\$aCAZ6158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x220
=150  \\$aCloning, Molecular
=450  \\$aMolecular Cloning
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aArtificial Gene Fusion
=550  \\$wh$aTwo-Hybrid System Techniques
=550  \\$aCloning, Organism
=550  \\$aCosmids
=667  \\$adifferentiate from CLONE CELLS and CLONING, ORGANISM; "clonal analysis": index under CLONE CELLS; DF: CLONING MOL or MOL CLONING
=680  \\$iThe insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
=688  \\$a80
=750  \0$aMolecular cloning$0(DLC) sh 85086580$5IEN-M

=LDR  01644cz  a2200505n  4500
=001  9880363455902441
=005  20141212200132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003000
=035  \\$aCAZ6157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x436.$x500
=150  \\$aClonidine
=450  \\$wnnna$aBoehringer Ingelheim Brand of Clonidine Hydrochloride
=450  \\$wnnna$aCatapres
=450  \\$wnnna$aCatapresan
=450  \\$wnnna$aCatapressan
=450  \\$wnnna$aChlophazolin
=450  \\$wnnna$aClofelin
=450  \\$wnnna$aClofenil
=450  \\$wnnna$aClonidine Dihydrochloride
=450  \\$wnnna$aClonidine Hydrochloride
=450  \\$wnnna$aClonidine Monohydrobromide
=450  \\$wnnna$aClonidine Monohydrochloride
=450  \\$wnnna$aClopheline
=450  \\$wnnna$aDihydrochloride, Clonidine
=450  \\$wnnna$aDixarit
=450  \\$wnnna$aGemiton
=450  \\$wnnna$aHemiton
=450  \\$wnnna$aHydrochloride, Clonidine
=450  \\$wnnna$aIsoglaucon
=450  \\$wnnna$aKlofelin
=450  \\$wnnna$aKlofenil
=450  \\$wnnna$aM-5041T
=450  \\$wnnna$aM 5041T
=450  \\$wnnna$aM5041T
=450  \\$wnnna$aMonohydrobromide, Clonidine
=450  \\$wnnna$aMonohydrochloride, Clonidine
=450  \\$wnnna$aST-155
=450  \\$wnnna$aST 155
=450  \\$wnnna$aST155
=550  \\$wg$aImidazolines
=680  \\$iAn imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
=688  \\$a73(72)
=750  \0$aClonidine$5IEN$0(DLC)sh 85027121

=LDR  01131cz  a2200265n  4500
=001  9880363456002441
=005  20141212200131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002999
=035  \\$aCAZ6156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x251.$x353
=150  \\$aClone Cells
=450  \\$wnnna$aCell, Clone
=450  \\$wnnna$aCells, Clone
=450  \\$wnnna$aClone
=450  \\$wnnna$aClone Cell
=450  \\$aClones
=550  \\$wg$aCells, Cultured
=550  \\$wh$aHybridomas
=550  \\$aCulture Techniques
=667  \\$aNIM; A 11 qualif; cells derived by natural asexual reprod or by nuclear cloning; differentiate from CLONING, MOLECULAR and CLONING, ORGANISM; "clonal analysis" goes here
=680  \\$iA group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed)
=688  \\$a68(64)
=750  \0$aClone cells$5IEN-M$0(DLC)sh 85027120

=LDR  00944cz  a2200217n  4500
=001  9880363456102441
=005  20141212200131.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002998
=035  \\$aCAZ6155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x150
=150  \\$aClonazepam
=450  \\$wnnna$aAntelepsin
=450  \\$wnnna$aRivotril
=450  \\$wnnna$aRo 5-4023
=450  \\$wnnna$aRo 54023
=550  \\$wg$aBenzodiazepinones
=680  \\$iAn anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
=688  \\$a87(75); was see under BENZODIAZEPINONES 1975-86
=750  \0$aClonazepam$5IEN-M$0(DLC)sh 93005964

=LDR  01044cz  a2200289n  4500
=001  9880363456202441
=005  20141212200130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002994
=035  \\$aCAZ6151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x968.$x500.$x500.$x195
=072  \\$aD2.$x355.$x726.$x305.$x500.$x195
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x305.$x500.$x195
=150  \\$aClofibrate
=450  \\$wnnna$aAthromidin
=450  \\$wnnna$aAtromid
=450  \\$wnnna$aAtromid S
=450  \\$wnnna$aChlorophenoxyisobutyrate, Ethyl
=450  \\$wnnna$aClofibric Acid, Ethyl Ester
=450  \\$wnnna$aEthyl Chlorophenoxyisobutyrate
=450  \\$wnnna$aMiscleron
=450  \\$wnnna$aMiskleron
=550  \\$wg$aClofibric Acid
=680  \\$iA fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986)
=688  \\$a72(69)
=750  \0$aClofibrate$5IEN$0(DLC)sh 85027111

=LDR  00820cz  a2200205n  4500
=001  9880363456302441
=005  20141212200128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002988
=035  \\$aCAZ6145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x223
=072  \\$aA16.$x178
=150  \\$aCloaca
=450  \\$wnnna$aCloacas
=550  \\$wg$aAnimal Structures
=550  \\$wg$aEmbryonic Structures
=680  \\$iA dilated cavity extended caudally from the hindgut. In adult birds, reptiles, amphibians, and many fishes but few mammals, cloaca is a common chamber into which the digestive, urinary and reproductive tracts discharge their contents. In most mammals, cloaca gives rise to LARGE INTESTINE; URINARY BLADDER; and GENITALIA.
=688  \\$a68
=750  \0$aCloaca (Zoology)$5IEN$0(DLC)sh 85027088

=LDR  00340cz  a2200133n  4500
=001  9880363456402441
=005  20141212200128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002987
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x887.$x436
=150  \\$aClitoris
=550  \\$wg$aVulva
=750  \0$aClitoris$5IEN$0(DLC)sh 85027086

=LDR  02033cz  a2200409n  4500
=001  9880363456502441
=005  20160520143343.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002986
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x535
=072  \\$aE5.$x337.$x250
=072  \\$aN5.$x715.$x360.$x775.$x235
=072  \\$aN6.$x850.$x520.$x450.$x535
=150  \\$aClinical Trials as Topic
=450  \\$wnnna$aClinical Trial as Topic
=550  \\$wg$aEpidemiologic Study Characteristics as Topic
=550  \\$wg$aEvaluation Studies as Topic
=550  \\$wh$aClinical Trials, Phase I as Topic
=550  \\$wh$aClinical Trials, Phase II as Topic
=550  \\$wh$aClinical Trials, Phase III as Topic
=550  \\$wh$aClinical Trials, Phase IV as Topic
=550  \\$wh$aControlled Clinical Trials as Topic
=550  \\$wh$aEarly Termination of Clinical Trials
=550  \\$wh$aMulticenter Studies as Topic
=550  \\$wh$aObservational Studies as Topic
=550  \\$aClinical Protocols
=550  \\$aClinical Trials Data Monitoring Committees
=550  \\$aDrug Evaluation
=550  \\$aDrugs, Investigational
=550  \\$aTherapies, Investigational
=667  \\$afor general design, methodology, economics, etc. of clinical trials; a different heading CLINICAL TRIAL is used for reports of a specific clinical trial
=680  \\$iPre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
=688  \\$a2008(1965)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Clinical Trials
=688  \\$a80; for articles that were clinical trials 1980-90; CLINICAL RESEARCH was check tag 1965-79
=750  \0$aClinical trials$0(DLC) sh 85027069$5IEN

=LDR  01530cz  a2200385n  4500
=001  9880363456602441
=005  20190102103653.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002985
=035  \\$aCAZ6142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x183
=072  \\$aN5.$x715.$x360.$x775.$x225
=150  \\$aClinical Protocols
=450  \\$wnnna$aClinical Protocol
=450  \\$wnnna$aClinical Research Protocol
=450  \\$wnnna$aClinical Research Protocols
=450  \\$aMedical Protocols$5IEN
=450  \\$wnnna$aProtocol, Clinical
=450  \\$wnnna$aProtocol, Clinical Research
=450  \\$aProtocols, Clinical
=450  \\$wnnna$aProtocols, Clinical Research
=450  \\$wnnna$aProtocols, Treatment
=450  \\$wnnna$aResearch Protocol, Clinical
=450  \\$aResearch Protocols, Clinical
=450  \\$wnnna$aTreatment Protocol
=450  \\$aTreatment Protocols
=550  \\$wg$aEpidemiologic Study Characteristics as Topic
=550  \\$wg$aTherapeutics
=550  \\$wh$aAntineoplastic Protocols
=550  \\$wh$aStanding Orders
=667  \\$a"precise & detailed plans for the study of a med or biomed problem" or "plans for a regimen of ther"; IM GEN only; do not use for cancer polychemother protocols ( = ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS); DF: CLIN PROTOCOLS
=680  \\$iPrecise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy.
=688  \\$a88
=750  \0$aMedical protocols$5IEN$0(DLC)sh 85083005

=LDR  01015cz  a2200277n  4500
=001  9880363456702441
=005  20141212192111.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002983
=035  \\$aCAZ6139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x399.$x630.$x210
=072  \\$aN4.$x761.$x210
=150  \\$aClinical Competence
=450  \\$wnnna$aClinical Skill
=450  \\$aClinical Skills
=450  \\$aCompetence, Clinical
=450  \\$wnnna$aSkill, Clinical
=450  \\$wnnna$aSkills, Clinical
=550  \\$wg$aProfessional Competence
=550  \\$wg$aQuality of Health Care
=550  \\$aCulturally Competent Care
=667  \\$acompetence in professional activities directly related to patient care: differentiate from PROFESSIONAL COMPETENCE which refers to competence not necessarily related to patient care
=680  \\$iThe capability to perform acceptably those duties directly related to patient care.
=688  \\$a75
=750  \0$aClinical competence$5IEN$0(DLC)sh 90000072

=LDR  00899cz  a2200217n  4500
=001  9880363456802441
=005  20141212200126.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002982
=035  \\$aCAZ6138M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x105
=150  \\$aClinical Clerkship
=450  \\$wnnna$aClerkship, Clinical
=450  \\$wnnna$aClerkships, Clinical
=450  \\$wnnna$aClinical Clerkships
=550  \\$wg$aEducation, Professional
=667  \\$aan undergrad med educ program; DF: CLIN CLERKSHIP
=680  \\$iUndergraduate education programs for second- , third- , and fourth-year students in health sciences in which the students receive clinical training and experience in teaching hospitals or affiliated health centers.
=688  \\$a91(83); was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90
=750  \0$aClinical clerkship$0(DLC) sh 00000057$5IEN-M

=LDR  01161cz  a2200337n  4500
=001  9880363456902441
=005  20141212200126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002981
=035  \\$aCAZ6137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x773.$x532.$x500.$x125
=072  \\$aD9.$x408.$x471.$x500.$x125
=150  \\$aClindamycin
=450  \\$wnnna$a7-Chloro-7-deoxylincomycin
=450  \\$wnnna$a7 Chloro 7 deoxylincomycin
=450  \\$wnnna$aChlolincocin
=450  \\$wnnna$aChlorlincocin
=450  \\$wnnna$aCleocin
=450  \\$wnnna$aClindamycin Hydrochloride
=450  \\$wnnna$aClindamycin Monohydrochloride
=450  \\$wnnna$aClindamycin Monohydrochloride, Monohydrate
=450  \\$wnnna$aDalacin C
=450  \\$wnnna$aHydrochloride, Clindamycin
=450  \\$wnnna$aMonohydrate Clindamycin Monohydrochloride
=450  \\$wnnna$aMonohydrochloride, Clindamycin
=450  \\$wnnna$aMonohydrochloride, Monohydrate Clindamycin
=550  \\$wg$aLincomycin
=680  \\$iAn antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
=688  \\$a74(72)
=750  \0$aClindamycin$5IEN$0(DLC)sh 85027057

=LDR  00983cz  a2200277n  4500
=001  9880363457002441
=005  20141212200125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002979
=035  \\$aCAZ6136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x157
=072  \\$aG8.$x686.$x785.$x880.$x249
=150  \\$aClimacteric
=450  \\$aChange of Life
=450  \\$wnnna$aClimacterics
=450  \\$wnnna$aLife Change
=450  \\$wnnna$aLife Changes
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wg$aSexual Development
=550  \\$wh$aAndropause
=550  \\$wh$aMenopause
=667  \\$afemale and male; consider also MENOPAUSE or ANDROPAUSE
=680  \\$iPhysiologic period, characterized by endocrine, somatic, and psychic changes with the termination of ovarian function in the female. It may also accompany the normal diminution of sexual activity in the male.
=688  \\$a1966
=750  \0$aClimacteric$5IEN$0(DLC)sh 85027034

=LDR  01021cz  a2200373n  4500
=001  9880363457102441
=005  20141212192110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002977
=035  \\$aCAZ6134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x799.$x500
=150  \\$aClergy
=450  \\$wnnna$aChaplain
=450  \\$wnnna$aChaplains
=450  \\$wnnna$aCleric
=450  \\$wnnna$aClerics
=450  \\$wnnna$aDeacon
=450  \\$wnnna$aDeacons
=450  \\$wnnna$aImam
=450  \\$wnnna$aImams
=450  \\$wnnna$aMinister
=450  \\$wnnna$aMinisters
=450  \\$wnnna$aPastor
=450  \\$wnnna$aPastors
=450  \\$wnnna$aPriest
=450  \\$wnnna$aPriests
=450  \\$wnnna$aRabbi
=450  \\$wnnna$aRabbis
=550  \\$wg$aReligious Personnel
=667  \\$aspecify religion if pertinent
=680  \\$iPersons ordained for religious duties, who serve as leaders and perform religious services.
=688  \\$a73(69)
=750  \0$aClergy$5IEN$0(DLC)sh 85026944

=LDR  01158cz  a2200325n  4500
=001  9880363457202441
=005  20141212200124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002972
=035  \\$aCAZ6129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x460.$x185
=072  \\$aC5.$x660.$x207.$x540.$x460.$x185
=072  \\$aC7.$x320.$x440.$x185
=072  \\$aC7.$x465.$x525.$x185
=072  \\$aC7.$x650.$x500.$x460.$x185
=072  \\$aC7.$x650.$x525.$x185
=072  \\$aC16.$x131.$x621.$x207.$x540.$x460.$x185
=072  \\$aC16.$x131.$x850.$x500.$x460.$x185
=072  \\$aC16.$x131.$x850.$x525.$x185
=150  \\$aCleft Palate
=450  \\$wnnna$aCleft Palate, Isolated
=450  \\$wnnna$aCleft Palates
=450  \\$wnnna$aPalate, Cleft
=450  \\$wnnna$aPalates, Cleft
=550  \\$wg$aJaw Abnormalities
=550  \\$wg$aMouth Abnormalities
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT LIP, do not also use ABNORMALITIES, MULTIPLE
=680  \\$iCongenital fissure of the soft and/or hard palate, due to faulty fusion.
=750  \0$aCleft palate$5IEN$0(DLC)sh 85026926

=LDR  01089cz  a2200289n  4500
=001  9880363457302441
=005  20141212200123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002971
=035  \\$aCAZ6128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x409.$x225
=072  \\$aC7.$x465.$x525.$x164
=072  \\$aC7.$x650.$x525.$x164
=072  \\$aC16.$x131.$x850.$x525.$x164
=150  \\$aCleft Lip
=450  \\$wnnna$aCleft Lips
=450  \\$aHarelip
=450  \\$wnnna$aHarelips
=450  \\$wnnna$aLip, Cleft
=450  \\$wnnna$aLips, Cleft
=550  \\$wg$aLip Diseases
=550  \\$wg$aMouth Abnormalities
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; when with CLEFT PALATE, do not also use ABNORMALITIES, MULTIPLE
=680  \\$iCongenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.
=688  \\$a65; was HARELIP 1963-64
=750  \0$aCleft lip$5IEN$0(DLC)sh 85058909

=LDR  00416cz  a2200157n  4500
=001  9880363457402441
=005  20141212200123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002968
=035  \\$aCAZ6125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x227
=150  \\$aClavicle
=450  \\$wnnna$aClavicles
=550  \\$wg$aBones of Upper Extremity
=750  \0$aClavicle$5IEN$0(DLC)sh 85026854

=LDR  00713cz  a2200205n  4500
=001  9880363457502441
=005  20141212200122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002967
=035  \\$aCAZ6124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501.$x200
=150  \\$aClaviceps
=450  \\$wnnna$aClavicep
=450  \\$aErgot Fungus
=450  \\$wnnna$aFungus, Ergot
=550  \\$wg$aHypocreales
=680  \\$iA genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses (POACEAE). The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ergotism.
=688  \\$a74(63)
=750  \0$aClaviceps$5IEN$0(DLC)sh 85026843

=LDR  00847cz  a2200253n  4500
=001  9880363457602441
=005  20141212200122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x100
=072  \\$aL1.$x453.$x245.$x275
=150  \\$aClassification
=450  \\$wnnna$aClassifications
=450  \\$aSystematics
=450  \\$wnnna$aTaxonomies
=450  \\$aTaxonomy
=550  \\$wg$aDocumentation
=550  \\$wg$aInformation Science
=550  \\$wh$aPhylogeny
=550  \\$aPhylogeny
=667  \\$aGEN only; prefer /class: Manual 19.7+, 19.8.6; DF; CLASS
=680  \\$iThe systematic arrangement of entities in any field into categories classes based on common characteristics such as properties, morphology, subject matter, etc.
=750  \0$aClassification$5IEN$0(DLC)sh 85026719

=LDR  00744cz  a2200193n  4500
=001  9880363457702441
=005  20141212200122.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002963
=035  \\$aCAZ6120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x200
=150  \\$aCladosporium
=450  \\$wnnna$aCladosporiums
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection: coord IM with probably MYCOSES or TINEA (IM)
=680  \\$iA mitosporic Loculoascomycetes fungal genus including some economically important plant parasites. Teleomorphs include Mycosphaerella and Venturia.
=688  \\$a91(75); was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85
=750  \0$aCladosporium$5IEN$0(DLC)sh 85026524

=LDR  00605cz  a2200205n  4500
=001  9880363457802441
=005  20141212200121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002962
=035  \\$aCAZ6119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x226
=150  \\$aCivilization
=450  \\$wnnna$aCivilizations
=550  \\$wg$aCulture
=550  \\$wh$aArab World
=550  \\$wh$aWestern World
=667  \\$aspecify geog if pertinent
=680  \\$iThe distinctly human attributes and attainments of a particular society.
=750  \0$aCivilization$5IEN$0(DLC)sh 85026423

=LDR  01458cz  a2200409n  4500
=001  9880363457902441
=005  20141212200121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002961
=035  \\$aCAZ6118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x352
=072  \\$aN3.$x706.$x437.$x352
=150  \\$aCivil Rights
=450  \\$wnnna$aCivil Right
=450  \\$aDue Process
=450  \\$wnnna$aEqual Protection
=450  \\$wnnna$aLegal Right
=450  \\$wnnna$aLegal Rights
=450  \\$wnnna$aProtection, Equal
=450  \\$wnnna$aRight, Civil
=450  \\$wnnna$aRight, Legal
=450  \\$wnnna$aRight, Voting
=450  \\$wnnna$aRights, Civil
=450  \\$wnnna$aRights, Legal
=450  \\$wnnna$aRights, Voting
=450  \\$wnnna$aVoting Right
=450  \\$wnnna$aVoting Rights
=550  \\$wg$aHuman Rights
=550  \\$wh$aPrivacy
=550  \\$aHuman Rights
=550  \\$aRace Relations
=550  \\$aSocial Justice
=667  \\$aSpecify geog; consider also HUMAN RIGHTS & SOCIAL JUSTICE; PRIVACY ACT see PRIVACY is also available
=680  \\$iLegal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. (from http://www.usccr.gov/ accessed 1/31/2003)
=688  \\$a68
=750  \0$aCivil rights$5IEN$0(DLC)sh 85026371

=LDR  00806cz  a2200241n  4500
=001  9880363458002441
=005  20141212200120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002959
=035  \\$aCAZ6116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x451.$x227
=150  \\$aCivil Defense
=450  \\$wnnna$aCivil Defenses
=450  \\$wnnna$aDefense, Civil
=450  \\$wnnna$aDefenses, Civil
=450  \\$aEmergency Preparedness
=450  \\$wnnna$aPreparedness, Emergency
=550  \\$wg$aGovernment Programs
=550  \\$aDisaster Planning
=550  \\$aUnited States Department of Homeland Security
=680  \\$iPreventive emergency measures and programs designed to protect the individual or community in times of hostile attack.
=750  \0$aCivil defense$5IEN$0(DLC)sh 85026326

=LDR  00880cz  a2200301n  4500
=001  9880363458102441
=005  20141212200120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002958
=035  \\$aCAZ6115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x709.$x202
=150  \\$aCity Planning
=450  \\$wnnna$aCity Plannings
=450  \\$wnnna$aPlanning, City
=450  \\$wnnna$aPlanning, Town
=450  \\$wnnna$aPlanning, Urban
=450  \\$wnnna$aPlannings, City
=450  \\$wnnna$aPlannings, Town
=450  \\$wnnna$aPlannings, Urban
=450  \\$aTown Planning
=450  \\$wnnna$aTown Plannings
=450  \\$aUrban Planning
=450  \\$wnnna$aUrban Plannings
=550  \\$wg$aSocial Planning
=667  \\$aIM
=680  \\$iComprehensive planning for the physical development of the city.
=750  \0$aCity planning$5IEN$0(DLC)sh 85026282

=LDR  04337cz  a2201213n  4500
=001  9880363458202441
=005  20141212200120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002957
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177
=150  \\$aCitrus
=450  \\$wnnna$aaurantium, Citrus
=450  \\$wnnna$aaurantiums, Citrus
=450  \\$wnnna$abergamia, Citrus
=450  \\$wnnna$abergamias, Citrus
=450  \\$wnnna$aBitter Orange Tree
=450  \\$wnnna$aBitter Orange Trees
=450  \\$aCitron Tree
=450  \\$wnnna$aCitron Trees
=450  \\$wnnna$aCitrus aurantium
=450  \\$wnnna$aCitrus aurantiums
=450  \\$wnnna$aCitrus bergamia
=450  \\$wnnna$aCitrus bergamias
=450  \\$wnnna$aCitrus Fruit
=450  \\$wnnna$aCitrus Fruits
=450  \\$wnnna$aCitrus grandi
=450  \\$wnnna$aCitrus grandis
=450  \\$wnnna$aCitrus hystrices
=450  \\$wnnna$aCitrus hystrix
=450  \\$wnnna$aCitrus limon
=450  \\$wnnna$aCitrus limons
=450  \\$wnnna$aCitrus maxima
=450  \\$wnnna$aCitrus maximas
=450  \\$wnnna$aCitrus medica
=450  \\$wnnna$aCitrus medicas
=450  \\$wnnna$aCitrus reticulata
=450  \\$wnnna$aCitrus reticulatas
=450  \\$aFruit, Citrus
=450  \\$wnnna$aFruits, Citrus
=450  \\$wnnna$agrandi, Citrus
=450  \\$wnnna$agrandis, Citrus
=450  \\$wnnna$ahystrices, Citrus
=450  \\$wnnna$ahystrix, Citrus
=450  \\$wnnna$aKaffir Lime
=450  \\$wnnna$aKaffir Limes
=450  \\$aLemon Tree
=450  \\$wnnna$aLemon Trees
=450  \\$wnnna$aLime, Kaffir
=450  \\$wnnna$aLimes, Kaffir
=450  \\$wnnna$alimon, Citrus
=450  \\$wnnna$alimons, Citrus
=450  \\$wnnna$aMandarin Orange Tree
=450  \\$wnnna$aMandarin Orange Trees
=450  \\$wnnna$amaxima, Citrus
=450  \\$wnnna$amaximas, Citrus
=450  \\$wnnna$amedica, Citrus
=450  \\$wnnna$amedicas, Citrus
=450  \\$aOrange Tree, Bitter
=450  \\$aOrange Tree, Mandarin
=450  \\$aOrange Tree, Seville
=450  \\$aOrange Tree, Sour
=450  \\$wnnna$aOrange Trees, Bitter
=450  \\$wnnna$aOrange Trees, Mandarin
=450  \\$wnnna$aOrange Trees, Seville
=450  \\$wnnna$aOrange Trees, Sour
=450  \\$aPomelo Tree
=450  \\$wnnna$aPomelo Trees
=450  \\$aPummelo Tree
=450  \\$wnnna$aPummelo Trees
=450  \\$wnnna$areticulata, Citrus
=450  \\$wnnna$areticulatas, Citrus
=450  \\$wnnna$aSeville Orange Tree
=450  \\$wnnna$aSeville Orange Trees
=450  \\$wnnna$aSour Orange Tree
=450  \\$wnnna$aSour Orange Trees
=450  \\$aTangerine Tree
=450  \\$wnnna$aTangerine Trees
=450  \\$wnnna$aTree, Bitter Orange
=450  \\$wnnna$aTree, Citron
=450  \\$wnnna$aTree, Lemon
=450  \\$wnnna$aTree, Mandarin Orange
=450  \\$wnnna$aTree, Pomelo
=450  \\$wnnna$aTree, Pummelo
=450  \\$wnnna$aTree, Seville Orange
=450  \\$wnnna$aTree, Sour Orange
=450  \\$wnnna$aTree, Tangerine
=450  \\$wnnna$aTrees, Bitter Orange
=450  \\$wnnna$aTrees, Citron
=450  \\$wnnna$aTrees, Lemon
=450  \\$wnnna$aTrees, Mandarin Orange
=450  \\$wnnna$aTrees, Pomelo
=450  \\$wnnna$aTrees, Pummelo
=450  \\$wnnna$aTrees, Seville Orange
=450  \\$wnnna$aTrees, Sour Orange
=450  \\$wnnna$aTrees, Tangerine
=550  \\$wg$aRutaceae
=550  \\$wh$aCitrus aurantiifolia
=550  \\$wh$aCitrus paradisi
=550  \\$wh$aCitrus sinensis
=667  \\$aX ref CITRUS BERGAMIA: The common name of Bergamot is also used for MONARDA, check ref; prefer specifics; as plant & fruit; juices: coord IM with BEVERAGES (IM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.
=688  \\$awas Citrus Fruits 1966-1997
=750  \0$aCitrus fruits$5IEN$0(DLC)sh 85026231

=LDR  01977cz  a2200517n  4500
=001  9880363458302441
=005  20141212200118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002955
=035  \\$aCAZ6112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x631.$x400.$x800.$x350.$x450
=072  \\$aD8.$x211.$x840.$x300.$x500
=150  \\$aLeucovorin
=450  \\$wnnna$a5-Formyltetrahydrofolate
=450  \\$wnnna$a5 Formyltetrahydrofolate
=450  \\$wnnna$a5-Formyltetrahydropteroylglutamate
=450  \\$wnnna$a5 Formyltetrahydropteroylglutamate
=450  \\$wnnna$aAcid, Folinic
=450  \\$wnnna$aCalcium Folinate
=450  \\$aCalcium Leucovorin
=450  \\$aCitrovorum Factor
=450  \\$wnnna$aFactor, Citrovorum
=450  \\$wnnna$aFolinate, Calcium
=450  \\$aFolinic Acid
=450  \\$wnnna$aFolinic Acid-SF
=450  \\$wnnna$aFolinic Acid SF
=450  \\$wnnna$aLeucovorin, Calcium
=450  \\$wnnna$aLeucovorin, Calcium (1:1) Salt
=450  \\$wnnna$aLeucovorin, Calcium (1:1) Salt, (DL)-Isomer
=450  \\$wnnna$aLeucovorin, Calcium (1:1) Salt, Pentahydrate
=450  \\$wnnna$aLeucovorin, (D)-Isomer
=450  \\$wnnna$aLeucovorin, (DL)-Isomer
=450  \\$wnnna$aLeucovorin, Monosodium Salt
=450  \\$wnnna$aLeucovorin, (R)-Isomer
=450  \\$wnnna$aLeukovorin
=450  \\$wnnna$aLeukovorum
=450  \\$wnnna$aMonosodium Salt Leucovorin
=450  \\$aN(5)-Formyltetrahydrofolate
=450  \\$wnnna$aWellcovorin
=550  \\$wg$aFormyltetrahydrofolates
=550  \\$wh$aLevoleucovorin
=667  \\$adeficiency: coordinate LEUCOVORIN /defic (IM) with FOLIC ACID DEFICIENCY (IM)
=680  \\$iThe active metabolite of FOLIC ACID. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid.
=688  \\$a90; was CITROVORUM FACTOR 1964-89
=750  \0$aFolinic acid$5IEN$0(DLC)sh 86002117

=LDR  01238cz  a2200337n  4500
=001  9880363458402441
=005  20170608132935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002952
=035  \\$aCAZ6109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x165
=072  \\$aG3.$x295.$x342
=072  \\$aG3.$x493.$x170
=150  \\$aCitric Acid Cycle
=450  \\$wnnna$aCitric Acid Cycles
=450  \\$wnnna$aCycle, Citric Acid
=450  \\$wnnna$aCycle, Krebs
=450  \\$wnnna$aCycle, Tricarboxylic Acid
=450  \\$wnnna$aCycles, Citric Acid
=450  \\$wnnna$aCycles, Tricarboxylic Acid
=450  \\$aKrebs Cycle
=450  \\$aTricarboxylic Acid Cycle
=450  \\$wnnna$aTricarboxylic Acid Cycles
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aEnergy Metabolism
=550  \\$wg$aMetabolic Networks and Pathways
=550  \\$aCitrates
=680  \\$iA series of oxidative reactions in the breakdown of acetyl units derived from GLUCOSE; FATTY ACIDS; or AMINO ACIDS by means of tricarboxylic acid intermediates. The end products are CARBON DIOXIDE, water, and energy in the form of phosphate bonds.
=688  \\$a85; was KREBS CYCLE 1963-84
=750  \0$aKrebs cycle$5IEN$0(DLC)sh 85073260

=LDR  00690cz  a2200217n  4500
=001  9880363458502441
=005  20141212200116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002951
=035  \\$aCAZ6108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x901.$x434
=150  \\$aCitrates
=450  \\$aCalcium Citrate$xanalogs & derivatives
=450  \\$aPotassium Citrate$xanalogs & derivatives
=550  \\$wg$aTricarboxylic Acids
=550  \\$wh$aCitric Acid
=550  \\$wh$aIsocitrates
=667  \\$a/metab: consider also CITRIC ACID CYCLE
=688  \\$aRENACIDIN was see under PHARMACEUTIC AIDS 1964-80 (Prov 1964-74)
=750  \0$aCitrates$5IEN$0(DLC)sh 85026215

=LDR  01543cz  a2200445n  4500
=001  9880363458602441
=005  20150408100038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002947
=035  \\$aCAZ6104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x69
=072  \\$aN6.$x230.$x69
=072  \\$aZ1.$x433
=150  \\$aCities
=450  \\$aMunicipalities
=550  \\$wg$aEnvironment
=550  \\$wg$aGeographic Locations
=550  \\$wh$aBaltimore (Md.)
=550  \\$wh$aBerlin (Germany)
=550  \\$wh$aBoston (Mass.)
=550  \\$wh$aChicago (Ill.)
=550  \\$wh$aDistrict of Columbia
=550  \\$wh$aLondon (England)
=550  \\$wh$aLos Angeles (Calif.)
=550  \\$wh$aMoscow (Russia)
=550  \\$wh$aNew Orleans (La.)
=550  \\$wh$aNew York (N.Y.)
=550  \\$wh$aParis (France)
=550  \\$wh$aPhiladelphia (Pa.)
=550  \\$wh$aRome (Italy)
=550  \\$wh$aSan Francisco (Calf.)
=550  \\$wh$aSeoul  (Korea)
=550  \\$wh$aTokyo (Japan)
=550  \\$aUrban Population
=550  \\$aUrbanization
=667  \\$aIM for cities as sociol or population entities; specific indentions are available (NIM only) for epidemiol or ethnol studies; URBANIZATION is available for the develop from rural to urban society; URBAN POPULATION and URBAN HEALTH are also available
=680  \\$iA large or important municipality of a country, usually a major metropolitan center.
=688  \\$a98; use explode 1967-97
=750  \0$aCities and towns$5IEN-M$0(DLC)sh 85026130

=LDR  01640cz  a2200385n  4500
=001  9880363458702441
=005  20141212200115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002945
=035  \\$aCAZ6101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x375
=072  \\$aD1.$x625.$x125
=072  \\$aD1.$x710.$x100
=150  \\$aCisplatin
=450  \\$wnnna$aBiocisplatinum
=450  \\$wnnna$acis-Diamminedichloroplatinum
=450  \\$wnnna$acis Diamminedichloroplatinum
=450  \\$acis-Diamminedichloroplatinum(II)
=450  \\$acis-Dichlorodiammineplatinum(II)
=450  \\$wnnna$acis-Platinum
=450  \\$wnnna$acis Platinum
=450  \\$wnnna$aDiamminodichloride, Platinum
=450  \\$wnnna$aDichlorodiammineplatinum
=450  \\$wnnna$aNSC-119875
=450  \\$wnnna$aPlatidiam
=450  \\$wnnna$aPlatino
=450  \\$wnnna$aPlatinol
=450  \\$aPlatinum Diamminodichloride
=550  \\$wg$aChlorine Compounds
=550  \\$wg$aNitrogen Compounds
=550  \\$wg$aPlatinum Compounds
=680  \\$iAn inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
=688  \\$a84(81); was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83
=750  \0$aCisplatin$5IEN$0(DLC)sh 85026108

=LDR  00998cz  a2200289n  4500
=001  9880363458802441
=005  20160428094834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002944
=035  \\$aCAZ6100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x85.$x170
=072  \\$aE4.$x85.$x170
=072  \\$aE4.$x950.$x774.$x860.$x226
=150  \\$aCircumcision, Male
=450  \\$wnnna$aCircumcision$5IEN-M
=450  \\$wnnna$aCircumcisions, Male
=450  \\$wnnna$aMale Circumcision
=450  \\$wnnna$aMale Circumcisions
=550  \\$wg$aBody Modification, Non-Therapeutic
=550  \\$wg$aUrologic Surgical Procedures, Male
=550  \\$aForeskin
=667  \\$ageneral or unspecified, usually male; for female, CIRCUMCISION, FEMALE is available
=680  \\$iExcision of the prepuce of the penis (FORESKIN) or part of it.
=688  \\$a2007 (1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Circumcision
=750  \0$aCircumcision$0(DLC) sh 85026074$5IEN

=LDR  00785cz  a2200193n  4500
=001  9880363458902441
=005  20141212200114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x151
=150  \\$aCircular Dichroism
=450  \\$aCircular Dichroism, Vibrational
=450  \\$wnnna$aDichroism, Circular
=450  \\$wnnna$aVibrational Circular Dichroism
=550  \\$wg$aSpectrum Analysis
=680  \\$iA change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a91(70); was see under SPECTRUM ANALYSIS 1970-90
=750  \0$aCircular dichroism$5IEN$0(DLC)sh 85026067

=LDR  01150cz  a2200337n  4500
=001  9880363459002441
=005  20141212200113.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002939
=035  \\$aCAZ6096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x835.$x322.$x186
=150  \\$aCiprofloxacin
=450  \\$wnnna$aAnhydrous, Ciprofloxacin Hydrochloride
=450  \\$wnnna$aBay-09867
=450  \\$wnnna$aBay 09867
=450  \\$wnnna$aBay09867
=450  \\$wnnna$aCiprinol
=450  \\$wnnna$aCipro
=450  \\$wnnna$aCiprofloxacin Hydrochloride
=450  \\$wnnna$aCiprofloxacin Hydrochloride Anhydrous
=450  \\$wnnna$aCiprofloxacin Monohydrochloride Monohydrate
=450  \\$wnnna$aHydrochloride Anhydrous, Ciprofloxacin
=450  \\$wnnna$aHydrochloride, Ciprofloxacin
=450  \\$wnnna$aMonohydrate, Ciprofloxacin Monohydrochloride
=450  \\$wnnna$aMonohydrochloride Monohydrate, Ciprofloxacin
=550  \\$wg$aFluoroquinolones
=550  \\$wh$aFleroxacin
=680  \\$iA broad-spectrum antimicrobial carboxyfluoroquinoline.
=688  \\$a87
=750  \0$aCiprofloxacin$5IEN$0(DLC)sh 86003520

=LDR  01014cz  a2200241n  4500
=001  9880363569902441
=005  20141212200708.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004023
=035  \\$aCAZ7149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x550.$x200.$x300
=150  \\$aDictyostelium
=450  \\$aDictyostelium discoideum
=450  \\$wnnna$aDictyostelium discoideums
=450  \\$wnnna$aDictyosteliums
=450  \\$wnnna$adiscoideum, Dictyostelium
=450  \\$wnnna$adiscoideums, Dictyostelium
=550  \\$wg$aDictyosteliida
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa, formerly also considered a fungus. Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research.
=688  \\$a79(75)
=750  \0$aDictyostelium$5IEN$0(DLC)sh 85037706

=LDR  00761cz  a2200181n  4500
=001  9880363570002441
=005  20141212200707.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004021
=035  \\$aCAZ7147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x746.$x300
=150  \\$aDictyocaulus
=550  \\$wg$aTrichostrongyloidea
=667  \\$aa genus of nematodes; infection = DICTYOCAULUS INFECTIONS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iNematodes parasitic in the bronchi of herbivorous animals.
=688  \\$a91(75); was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85
=750  \0$aDictyocaulus$5IEN$0(DLC)sh 87020006

=LDR  01146cz  a2200301n  4500
=001  9880363570502441
=005  20190529121757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004014
=035  \\$aCAZ7140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x285
=150  \\$aDictionaries as Topic
=450  \\$wnnna$aDictionaries as Topics
=450  \\$wnnna$aGlossaries as Topic
=450  \\$wnnna$aGlossaries as Topics
=550  \\$wg$aReference Books
=550  \\$wh$aDictionaries, Chemical as Topic
=550  \\$wh$aDictionaries, Classical as Topic
=550  \\$wh$aDictionaries, Dental as Topic
=550  \\$wh$aDictionaries, Medical as Topic
=550  \\$wh$aDictionaries, Pharmaceutic as Topic
=550  \\$aTerminology as Topic
=667  \\$ado not confuse with Publication Type DICTIONARY
=680  \\$iLists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Dictionaries
=750  \0$aEncyclopedias and dictionaries$0(DLC) sh 85042997$5IEN

=LDR  00916cz  a2200193n  4500
=001  9880363570602441
=005  20141212200704.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004012
=035  \\$aCAZ7138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x300
=150  \\$aDicrocoeliidae
=550  \\$wg$aTrematoda
=550  \\$wh$aDicrocoelium
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of flattened, translucent flukes (TREMATODA) occurring in the gut, gallbladder, bile ducts, liver or pancreatic ducts of amphibians, reptiles, birds, and mammals. (Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p188)
=688  \\$a98; use explode 1982-97
=750  \0$aDicrocoeliidae$5IEN-M$0(DLC)sh 88021731

=LDR  00544cz  a2200193n  4500
=001  9880363570702441
=005  20141212200704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004011
=035  \\$aCAZ7137M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x224
=150  \\$aDicrocoeliasis
=450  \\$wnnna$aDicrocoeliases
=550  \\$wg$aTrematode Infections
=667  \\$atrematode infect
=680  \\$iInfection with flukes of the genus Dicrocoelium.
=688  \\$a68
=750  \0$aDicrocoeliasis$0(DLC)sh2008009230$5IEN-M

=LDR  01245cz  a2200421n  4500
=001  9880363570802441
=005  20141212200703.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004008
=035  \\$aCAZ7134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x601.$x210
=150  \\$aDiclofenac
=450  \\$wnnna$aDichlofenal
=450  \\$wnnna$aDiclofenac Potassium
=450  \\$wnnna$aDiclofenac Sodium
=450  \\$wnnna$aDiclofenac, Sodium
=450  \\$wnnna$aDiclonate P
=450  \\$aDiclophenac
=450  \\$wnnna$aDicrofenac
=450  \\$wnnna$aFeloran
=450  \\$wnnna$aGP-45,840
=450  \\$wnnna$aGP 45,840
=450  \\$wnnna$aGP45,840
=450  \\$wnnna$aNovapirina
=450  \\$wnnna$aOrthofen
=450  \\$wnnna$aOrthophen
=450  \\$wnnna$aOrtofen
=450  \\$wnnna$aSodium Diclofenac
=450  \\$wnnna$aSR-38
=450  \\$wnnna$aSR 38
=450  \\$wnnna$aSR38
=450  \\$wnnna$aVoltaren
=450  \\$wnnna$aVoltarol
=550  \\$wg$aPhenylacetates
=680  \\$iA non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
=688  \\$a1986(1977)
=750  \0$aDiclofenac$5IEN$0(DLC)sh 85037684

=LDR  00887cz  a2200241n  4500
=001  9880363570902441
=005  20141212200702.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004007
=035  \\$aCAZ7133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x200
=150  \\$aDichotic Listening Tests
=450  \\$wnnna$aDichotic Listening Test
=450  \\$wnnna$aListening Test, Dichotic
=450  \\$wnnna$aListening Tests, Dichotic
=450  \\$wnnna$aTest, Dichotic Listening
=450  \\$wnnna$aTests, Dichotic Listening
=550  \\$wg$aHearing Tests
=667  \\$adichotic refers to the "competing message technique"
=680  \\$iTests for central hearing disorders based on the competing message technique (binaural separation).
=688  \\$a91(80); was see under HEARING TESTS 1980-90
=750  \0$aDichotic listening tests$5IEN$0(DLC)sh 88004613

=LDR  01162cz  a2200277n  4500
=001  9880363571002441
=005  20141212200702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004006
=035  \\$aCAZ7132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x130
=150  \\$aDichlorvos
=450  \\$aDDVP
=450  \\$wnnna$aDichlofos
=450  \\$wnnna$aDichlorophos
=450  \\$wnnna$aDimethyl Dichlorovinyl Phosphate
=450  \\$wnnna$aDivipan
=450  \\$wnnna$aNovotox
=450  \\$wnnna$aPhosphoric acid 2,2-dichloroethenyl dimethyl ester
=450  \\$wnnna$aPhosphoric acid 2,2 dichloroethenyl dimethyl ester
=550  \\$wg$aOrganophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organophosphorus insecticide that inhibits ACETYLCHOLINESTERASE.
=688  \\$a73(71)
=750  \0$aDichlorvos$0(DLC)sh2011003123$5IEN-M

=LDR  00956cz  a2200229n  4500
=001  9880363571102441
=005  20141212200700.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004000
=035  \\$aCAZ7126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x367.$x300
=072  \\$aD2.$x455.$x526.$x439.$x350
=150  \\$aDichloroethylenes
=450  \\$wnnna$aChlorides, Vinylidene
=450  \\$aVinylidene Chlorides
=550  \\$wg$aEthylenes
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$ado not confuse with ETHYLENE DICHLORIDES
=680  \\$iToxic chlorinated unsaturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. Both isomers are toxic, but 1,1-dichloroethylene is the more potent CNS depressant and hepatotoxin. It is used in the manufacture of thermoplastic polymers.
=688  \\$a91(76); was see under HYDROCARBONS, CHLORINATED 1976-90
=750  \0$aDichloroethylene$5IEN$0(DLC)sh 85037667

=LDR  00863cz  a2200241n  4500
=001  9880363571202441
=005  20141212200658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003992
=035  \\$aCAZ7118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x355
=072  \\$aD3.$x438.$x810.$x125
=150  \\$aDibucaine
=450  \\$aCincain
=450  \\$aCinchocaine
=450  \\$wnnna$aNupercainal
=450  \\$wnnna$aNupercaine
=450  \\$wnnna$aSovcaine
=550  \\$wg$aAmides
=550  \\$wg$aQuinolines
=680  \\$iA local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
=750  \0$aDibucaine$5IEN$0(DLC)sh 85093298

=LDR  00578cz  a2200205n  4500
=001  9880363571302441
=005  20141212200656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003983
=035  \\$aCAZ7109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x245
=150  \\$aDibenzylchlorethamine
=450  \\$wnnna$aChlorethylamine, Dibenzyl
=450  \\$aDibenamine
=450  \\$wnnna$aDibenzyl Chlorethylamine
=550  \\$wg$aEthylamines
=680  \\$iAn alpha adrenergic antagonist.
=688  \\$a2005(1963)
=750  \0$aDibenamine$0(DLC) sh 85037648$5IEN

=LDR  00437cz  a2200169n  4500
=001  9880363571402441
=005  20141212200655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003978
=035  \\$aCAZ7104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x172.$x383.$x383
=150  \\$aDiazomethane
=450  \\$wnnna$aDiazirine
=550  \\$wg$aDiazonium Compounds
=688  \\$a68(67)
=750  \0$aDiazomethane$5IEN$0(DLC)sh 85037642

=LDR  01099cz  a2200253n  4500
=001  9880363571502441
=005  20141212200655.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003976
=035  \\$aCAZ7102M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x200
=072  \\$aD2.$x705.$x539.$x345.$x200
=072  \\$aD2.$x886.$x300.$x692.$x200
=150  \\$aDiazinon
=450  \\$wnnna$aBazudine
=450  \\$wnnna$aDimpylate
=450  \\$wnnna$aNeocidol
=450  \\$wnnna$aNeotsidol
=550  \\$wg$aOrganothiophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iA cholinesterase inhibitor that is used as an organothiophosphorus insecticide.
=688  \\$a91(75); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90
=750  \0$aDiazinon$5IEN-M$0(DLC)sh 98005684

=LDR  00989cz  a2200289n  4500
=001  9880363571602441
=005  20141212200654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003975
=035  \\$aCAZ7101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x216
=150  \\$aDiazepam
=450  \\$wnnna$a7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
=450  \\$wnnna$aApaurin
=450  \\$wnnna$aDiazemuls
=450  \\$wnnna$aFaustan
=450  \\$wnnna$aRelanium
=450  \\$wnnna$aSeduxen
=450  \\$wnnna$aSibazon
=450  \\$wnnna$aStesolid
=450  \\$wnnna$aValium
=550  \\$wg$aBenzodiazepinones
=550  \\$wh$aNordazepam
=680  \\$iA benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
=688  \\$a65(63)
=750  \0$aDiazepam$5IEN$0(DLC)sh 88005436

=LDR  00716cz  a2200229n  4500
=001  9880363571702441
=005  20141212200653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003972
=035  \\$aCAZ7098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x565.$x280
=072  \\$aE2.$x779.$x496.$x280
=150  \\$aDiathermy
=450  \\$wnnna$aDiathermies
=550  \\$wg$aHyperthermia, Induced
=550  \\$wh$aShort-Wave Therapy
=550  \\$wh$aUltrasonic Therapy
=550  \\$aMicrowaves
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe induction of local hyperthermia by either short radio waves or high-frequency sound waves.
=750  \0$aDiathermy$5IEN$0(DLC)sh 85037624

=LDR  00667cz  a2200205n  4500
=001  9880363571802441
=005  20141212200651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003968
=035  \\$aCAZ7094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x214.$x500
=150  \\$aDiarrhea, Infantile
=450  \\$wnnna$aDiarrheas, Infantile
=450  \\$wnnna$aInfantile Diarrhea
=450  \\$wnnna$aInfantile Diarrheas
=550  \\$wg$aDiarrhea
=667  \\$ahuman only; don't forget infant check tags as pertinent
=680  \\$iDIARRHEA occurring in infants from newborn to 24-months old.
=750  \0$aDiarrhea, Infantile$5IEN$0(DLC)sh 85037606

=LDR  00893cz  a2200217n  4500
=001  9880363571902441
=005  20141212200651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003967
=035  \\$aCAZ7093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x214
=150  \\$aDiarrhea
=450  \\$wnnna$aDiarrheas
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$wh$aDiarrhea, Infantile
=550  \\$aDefecation
=550  \\$aFoodborne Diseases
=667  \\$ain infants = DIARRHEA, INFANTILE + appropriate check tags
=680  \\$iAn increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
=750  \0$aDiarrhea$5IEN$0(DLC)sh 85037604

=LDR  00966cz  a2200229n  4500
=001  9880363572002441
=005  20141212200650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003964
=035  \\$aCAZ7090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x900.$x300
=150  \\$aDiaphragm
=450  \\$wnnna$aDiaphragm, Respiratory
=450  \\$wnnna$aDiaphragms
=450  \\$wnnna$aDiaphragms, Respiratory
=450  \\$wnnna$aRespiratory Diaphragm
=450  \\$wnnna$aRespiratory Diaphragms
=550  \\$wg$aRespiratory Muscles
=667  \\$aIM when organ of respiration; NIM in studies on muscle tissue; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.
=750  \0$aDiaphragm$5IEN$0(DLC)sh 85037585

=LDR  01026cz  a2200217n  4500
=001  9880363572102441
=005  20170628112806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003956
=035  \\$aCAZ7081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x353
=072  \\$aG2.$x186
=150  \\$aDialysis
=450  \\$wnnna$aDialyses
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aMicrodialysis
=667  \\$aanal & phys chem process; NIM; in ther of kidney dis "dialysis" is likely to be RENAL DIALYSIS or PERITONEAL DIALYSIS; nothing to do with "dialysis retinae" ( = RETINAL DIALYSES see RETINAL PERFORATIONS)
=680  \\$iA process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aDialysis$5IEN$0(DLC)sh 85037540

=LDR  00883cz  a2200277n  4500
=001  9880363572202441
=005  20141212200647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003954
=035  \\$aCAZ7079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x827.$x233
=072  \\$aN2.$x421.$x726.$x233
=150  \\$aDiagnostic Services
=450  \\$wnnna$aDiagnostic Service
=450  \\$wnnna$aService, Diagnostic
=450  \\$wnnna$aServices, Diagnostic
=550  \\$wg$aPreventive Health Services
=550  \\$wh$aClinical Laboratory Services
=550  \\$wh$aGenetic Testing
=550  \\$wh$aMass Screening
=550  \\$wh$aMobile Health Units
=667  \\$aDF: DIAG SERV
=680  \\$iOrganized services for the purpose of providing diagnosis to promote and maintain health.
=688  \\$a68
=750  \0$aDiagnostic services$5IEN$0(DLC)sh 85037510

=LDR  01668cz  a2200373n  4500
=001  9880363572302441
=005  20141212200646.0
=008  850520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003953
=035  \\$aCAZ7078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x710.$x305.$x200.$x80
=150  \\$aDiagnosis-Related Groups
=450  \\$aCase Mix
=450  \\$wnnna$aCase Mixes
=450  \\$wnnna$aDiagnosis-Related Group
=450  \\$wnnna$aDiagnosis Related Groups
=450  \\$wnnna$aDiagnostic-Related Group
=450  \\$wnnna$aDiagnostic Related Group
=450  \\$wnnna$aDiagnostic-Related Groups
=450  \\$aDRG
=450  \\$wnnna$aDRGs
=450  \\$wnnna$aGroup, Diagnosis-Related
=450  \\$wnnna$aGroup, Diagnostic-Related
=450  \\$wnnna$aGroup, Diagnostic Related
=450  \\$wnnna$aGroups, Diagnosis-Related
=450  \\$wnnna$aGroups, Diagnostic-Related
=450  \\$wnnna$aGroups, Diagnostic Related
=550  \\$wg$aProspective Payment System
=550  \\$wh$aOutliers, DRG
=667  \\$aDF: note short X ref
=680  \\$iA system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.
=688  \\$a92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85
=750  \0$aDiagnosis related groups$0(DLC) sh 85037505$5IEN-M

=LDR  01690cz  a2200481n  4500
=001  9880363572402441
=005  20141212200646.0
=008  870316\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003952
=035  \\$aCAZ7077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350
=150  \\$aDiagnostic Imaging
=450  \\$aImaging, Diagnostic
=450  \\$aImaging, Medical
=450  \\$aMedical Imaging
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aCardiac Imaging Techniques
=550  \\$wh$aImage Interpretation, Computer-Assisted
=550  \\$wh$aImaging, Three-Dimensional
=550  \\$wh$aMicroscopy
=550  \\$wh$aMolecular Imaging
=550  \\$wh$aMultimodal Imaging
=550  \\$wh$aNeuroimaging
=550  \\$wh$aOptical Imaging
=550  \\$wh$aPhotography
=550  \\$wh$aRadiography
=550  \\$wh$aRadionuclide Imaging
=550  \\$wh$aRespiratory-Gated Imaging Techniques
=550  \\$wh$aSpectroscopy, Near-Infrared
=550  \\$wh$aStroboscopy
=550  \\$wh$aSubtraction Technique
=550  \\$wh$aTerahertz Imaging
=550  \\$wh$aThermography
=550  \\$wh$aTomography
=550  \\$wh$aUltrasonography
=550  \\$wh$aVoltage-Sensitive Dye Imaging
=550  \\$wh$aWhole Body Imaging
=550  \\$aImage Processing, Computer-Assisted
=667  \\$ageneral: prefer specific techniques
=680  \\$iAny visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.
=688  \\$a88
=750  \0$aDiagnostic imaging$5IEN$0(DLC)sh 85037507

=LDR  01057cz  a2200301n  4500
=001  9880363572502441
=005  20141212200645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003951
=035  \\$aCAZ7076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x354
=072  \\$aN2.$x421.$x450.$x280
=150  \\$aDiagnostic Errors
=450  \\$wnnna$aDiagnostic Error
=450  \\$wnnna$aError, Diagnostic
=450  \\$wnnna$aErrors, Diagnostic
=450  \\$wnnna$aMisdiagnoses
=450  \\$wnnna$aMisdiagnosis
=550  \\$wg$aDiagnosis
=550  \\$wg$aMedical Errors
=550  \\$wh$aFalse Negative Reactions
=550  \\$wh$aFalse Positive Reactions
=550  \\$wh$aObserver Variation
=667  \\$acoordinate IM with specific disease / diag (IM) & specific diagnostic procedure; do not confuse with DIAGNOSIS, DIFFERENTIAL; DELAYED DIAGNOSIS is also available
=680  \\$iIncorrect diagnoses after clinical examination or technical diagnostic procedures.
=688  \\$a73(70)
=750  \0$aDiagnostic errors$5IEN$0(DLC)sh 85037506

=LDR  01449cz  a2200373n  4500
=001  9880363572602441
=005  20141212200644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003949
=035  \\$aCAZ7074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388
=150  \\$aDiagnostic Techniques, Surgical
=450  \\$wnnoa$aDiagnosis, Surgical$5IEN
=450  \\$wnnna$aDiagnostic Technic, Surgical
=450  \\$wnnna$aDiagnostic Technics, Surgical
=450  \\$wnnna$aDiagnostic Technique, Surgical
=450  \\$wnnna$aSurgical Diagnostic Technic
=450  \\$wnnna$aSurgical Diagnostic Technics
=450  \\$wnnna$aSurgical Diagnostic Technique
=450  \\$wnnna$aSurgical Diagnostic Techniques
=450  \\$wnnna$aTechnic, Surgical Diagnostic
=450  \\$wnnna$aTechnics, Surgical Diagnostic
=450  \\$wnnna$aTechnique, Surgical Diagnostic
=450  \\$wnnna$aTechniques, Surgical Diagnostic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aBiopsy
=550  \\$wh$aEndoscopy
=550  \\$wh$aPneumomediastinum, Diagnostic
=550  \\$wh$aPneumoperitoneum, Artificial
=667  \\$aGEN: prefer specifics; DF: DIAG TECHNIQUES SURG
=680  \\$iMethods and procedures for the diagnosis of disease or dysfunction by examination of the pathological site or operative field during surgical intervention.
=688  \\$a98(66)
=750  \0$aDiagnosis, Surgical$5IEN$0(DLC)sh 85037501

=LDR  01637cz  a2200385n  4500
=001  9880363572702441
=005  20141212200643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003947
=035  \\$aCAZ7072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x384
=150  \\$aDiagnostic Techniques, Radioisotope
=450  \\$wnnoa$aDiagnosis, Radioisotope$5IEN
=450  \\$wnnna$aDiagnostic Technic, Radioisotope
=450  \\$wnnna$aDiagnostic Technics, Radioisotope
=450  \\$wnnna$aDiagnostic Technique, Radioisotope
=450  \\$wnnna$aRadioisotope Diagnostic Technic
=450  \\$wnnna$aRadioisotope Diagnostic Technics
=450  \\$wnnna$aRadioisotope Diagnostic Technique
=450  \\$wnnna$aRadioisotope Diagnostic Techniques
=450  \\$wnnna$aTechnic, Radioisotope Diagnostic
=450  \\$wnnna$aTechnics, Radioisotope Diagnostic
=450  \\$wnnna$aTechnique, Radioisotope Diagnostic
=450  \\$wnnna$aTechniques, Radioisotope Diagnostic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aRadioimmunoassay
=550  \\$wh$aRadioisotope Dilution Technique
=550  \\$wh$aRadioligand Assay
=550  \\$wh$aRadionuclide Imaging
=550  \\$wh$aSchilling Test
=667  \\$aGEN only: prefer /radionuclide with dis; DF: DIAG TECHNIQUES RADIOISOTOPE
=680  \\$iAny diagnostic evaluation using radioactive (unstable) isotopes. This diagnosis includes many nuclear medicine procedures as well as radioimmunoassay tests.
=688  \\$a98(88); was DIAGNOSIS, RADIOISOTOPE (NON MESH) 1974-87
=750  \0$aRadioisotopes in medical diagnosis$5IEN$0(DLC)sh 85110741

=LDR  01242cz  a2200337n  4500
=001  9880363572802441
=005  20141212200642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003945
=035  \\$aCAZ7070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x342
=150  \\$aDiagnosis, Oral
=450  \\$wnnna$aDiagnoses, Oral
=450  \\$wnnna$aExamination, Oral
=450  \\$wnnna$aExaminations, Oral
=450  \\$wnnna$aOral Diagnoses
=450  \\$wnnna$aOral Diagnosis
=450  \\$aOral Examination
=450  \\$wnnna$aOral Examinations
=550  \\$wg$aDentistry
=550  \\$wh$aDental Caries Activity Tests
=550  \\$wh$aDental Pulp Test
=550  \\$wh$aPhotography, Dental
=550  \\$wh$aRadiography, Dental
=550  \\$aMouth Diseases
=550  \\$aOral Health
=667  \\$aGEN or unspecified; avoid as NIM coord: prefer /diag with specific mouth or tooth dis; includes both clinical & radiogr exam of mouth but for radiogr of teeth use RADIOGRAPHY, DENTAL; DF: DIAG ORAL
=680  \\$iExamination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.
=688  \\$a65
=750  \0$aMouth$xExamination$5IEN$0(DLC)sh 85087997

=LDR  02599cz  a2200637n  4500
=001  9880363572902441
=005  20141212200640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003941
=035  \\$aCAZ7066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380
=150  \\$aDiagnostic Techniques, Ophthalmological
=450  \\$wnnna$aDiagnostic Technic, Ophthalmologic
=450  \\$wnnna$aDiagnostic Technic, Ophthalmological
=450  \\$wnnna$aDiagnostic Technics, Ophthalmologic
=450  \\$wnnna$aDiagnostic Technics, Ophthalmological
=450  \\$wnnna$aDiagnostic Technique, Ophthalmologic
=450  \\$wnnna$aDiagnostic Technique, Ophthalmological
=450  \\$wnnna$aDiagnostic Techniques, Ophthalmologic
=450  \\$wnnna$aOphthalmologic Diagnostic Technic
=450  \\$wnnna$aOphthalmologic Diagnostic Technics
=450  \\$wnnna$aOphthalmologic Diagnostic Technique
=450  \\$wnnna$aOphthalmologic Diagnostic Techniques
=450  \\$wnnna$aOphthalmological Diagnostic Technic
=450  \\$wnnna$aOphthalmological Diagnostic Technics
=450  \\$wnnna$aOphthalmological Diagnostic Technique
=450  \\$wnnna$aOphthalmological Diagnostic Techniques
=450  \\$wnnna$aTechnic, Ophthalmologic Diagnostic
=450  \\$wnnna$aTechnic, Ophthalmological Diagnostic
=450  \\$wnnna$aTechnics, Ophthalmologic Diagnostic
=450  \\$wnnna$aTechnics, Ophthalmological Diagnostic
=450  \\$wnnna$aTechnique, Ophthalmologic Diagnostic
=450  \\$wnnna$aTechnique, Ophthalmological Diagnostic
=450  \\$wnnna$aTechniques, Ophthalmologic Diagnostic
=450  \\$wnnna$aTechniques, Ophthalmological Diagnostic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aAberrometry
=550  \\$wh$aCorneal Pachymetry
=550  \\$wh$aCorneal Topography
=550  \\$wh$aElectroretinography
=550  \\$wh$aEye Movement Measurements
=550  \\$wh$aFlicker Fusion
=550  \\$wh$aFluorescein Angiography
=550  \\$wh$aFluorophotometry
=550  \\$wh$aGonioscopy
=550  \\$wh$aOphthalmodynamometry
=550  \\$wh$aOphthalmoscopy
=550  \\$wh$aScanning Laser Polarimetry
=550  \\$wh$aSlit Lamp
=550  \\$wh$aTonometry, Ocular
=550  \\$wh$aVision Tests
=667  \\$adiag of eye dis or vision disord; GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES OPHTHALMOL
=680  \\$iMethods and procedures for the diagnosis of diseases of the eye or of vision disorders.
=688  \\$a98; use explode 1975-97
=750  \0$aEye$xExamination$5IEN-M$0(DLC)sh 85046659

=LDR  01650cz  a2200409n  4500
=001  9880363573002441
=005  20141212200639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003940
=035  \\$aCAZ7065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x374
=150  \\$aDiagnostic Techniques, Endocrine
=450  \\$wnnna$aDiagnostic Technic, Endocrine
=450  \\$wnnna$aDiagnostic Technics, Endocrine
=450  \\$wnnna$aDiagnostic Technique, Endocrine
=450  \\$wnnna$aEndocrine Diagnostic Technic
=450  \\$wnnna$aEndocrine Diagnostic Technics
=450  \\$wnnna$aEndocrine Diagnostic Technique
=450  \\$wnnna$aEndocrine Diagnostic Techniques
=450  \\$wnnna$aTechnic, Endocrine Diagnostic
=450  \\$wnnna$aTechnics, Endocrine Diagnostic
=450  \\$wnnna$aTechnique, Endocrine Diagnostic
=450  \\$wnnna$aTechniques, Endocrine Diagnostic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aAdrenal Cortex Function Tests
=550  \\$wh$aBlood Glucose Self-Monitoring
=550  \\$wh$aGlucose Tolerance Test
=550  \\$wh$aOvarian Function Tests
=550  \\$wh$aPituitary-Adrenal Function Tests
=550  \\$wh$aPituitary Function Tests
=550  \\$wh$aRadioligand Assay
=550  \\$wh$aThyroid Function Tests
=667  \\$aGEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES ENDOCRINE
=680  \\$iMethods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes.
=688  \\$a98; use explode 1975-97
=750  \0$aEndocrine function tests$5IEN-M$0(DLC)sh 85043058

=LDR  02048cz  a2200493n  4500
=001  9880363573102441
=005  20141212200639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003939
=035  \\$aCAZ7064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382
=150  \\$aDiagnostic Techniques, Otological
=450  \\$wnnna$aDiagnostic Technic, Otologic
=450  \\$wnnna$aDiagnostic Technic, Otological
=450  \\$wnnna$aDiagnostic Technics, Otologic
=450  \\$wnnna$aDiagnostic Technics, Otological
=450  \\$wnnna$aDiagnostic Technique, Otologic
=450  \\$wnnna$aDiagnostic Technique, Otological
=450  \\$wnnna$aDiagnostic Techniques, Otologic
=450  \\$wnnna$aOtologic Diagnostic Technic
=450  \\$wnnna$aOtologic Diagnostic Technics
=450  \\$wnnna$aOtologic Diagnostic Technique
=450  \\$wnnna$aOtologic Diagnostic Techniques
=450  \\$wnnna$aOtological Diagnostic Technic
=450  \\$wnnna$aOtological Diagnostic Technics
=450  \\$wnnna$aOtological Diagnostic Technique
=450  \\$wnnna$aOtological Diagnostic Techniques
=450  \\$wnnna$aTechnic, Otologic Diagnostic
=450  \\$wnnna$aTechnic, Otological Diagnostic
=450  \\$wnnna$aTechnics, Otologic Diagnostic
=450  \\$wnnna$aTechnics, Otological Diagnostic
=450  \\$wnnna$aTechnique, Otologic Diagnostic
=450  \\$wnnna$aTechnique, Otological Diagnostic
=450  \\$wnnna$aTechniques, Otologic Diagnostic
=450  \\$wnnna$aTechniques, Otological Diagnostic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aHearing Tests
=550  \\$wh$aOtoscopy
=550  \\$wh$aVestibular Function Tests
=667  \\$adiag of ear dis or hearing disord; GEN or unspecified; prefer specifics; DF: DIAG TECHNIQUES OTOL
=680  \\$iMethods and procedures for the diagnosis of diseases of the ear or of hearing disorders or demonstration of hearing acuity or loss.
=688  \\$a98; use explode 1975-97
=750  \0$aEar$xExamination$5IEN-M$0(DLC)sh 85040390

=LDR  00978cz  a2200205n  4500
=001  9880363573202441
=005  20141212200637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003937
=035  \\$aCAZ7062HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x171
=150  \\$aDiagnosis, Differential
=450  \\$wnnna$aDiagnoses, Differential
=450  \\$wnnna$aDifferential Diagnoses
=450  \\$wnnna$aDifferential Diagnosis
=550  \\$wg$aDiagnosis
=667  \\$aNIM; no qualif; correct NIM coord for "mimicking", "simulating"; Manual 26.13+; in Chinese traditional med index bianzheng shizhi ("differentiation of symptoms & signs") under DIAGNOSIS, DIFFERENTIAL (IM) + MEDICINE, CHINESE TRADITIONAL (IM); DF: DIAG DIFFER
=680  \\$iDetermination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.
=750  \0$aDiagnosis, Differential$5IEN$0(DLC)sh 85037493

=LDR  01086cz  a2200277n  4500
=001  9880363573302441
=005  20141212200637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003936
=035  \\$aCAZ7061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x158
=072  \\$aL1.$x700.$x508.$x100.$x158
=150  \\$aDiagnosis, Computer-Assisted
=450  \\$wnnna$aComputer-Assisted Diagnoses
=450  \\$aComputer-Assisted Diagnosis
=450  \\$wnnna$aComputer Assisted Diagnosis
=450  \\$wnnna$aDiagnoses, Computer-Assisted
=450  \\$wnnna$aDiagnosis, Computer Assisted
=550  \\$wg$aDecision Making, Computer-Assisted
=550  \\$wg$aDiagnosis
=550  \\$wh$aImage Interpretation, Computer-Assisted
=667  \\$aGEN: prefer specifics; restrict to MeSH definition; IM; DF: DIAG COMPUTER ASSISTED
=680  \\$iApplication of computer programs designed to assist the physician in solving a diagnostic problem.
=688  \\$a91(69); was DIAGNOSIS, COMPUTER ASSISTED 1969-90 (Prov 1969-72)
=750  \0$aDiagnosis$xData processing$5IEN$0(DLC)sh 85037490

=LDR  01885cz  a2200445n  4500
=001  9880363573402441
=005  20171102162642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003933
=035  \\$aCAZ7058HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1
=150  \\$aDiagnosis
=450  \\$wnnna$aAntemortem Diagnoses
=450  \\$wnnna$aAntemortem Diagnosis
=450  \\$wnnna$aDiagnoses
=450  \\$wnnna$aDiagnoses and Examinations
=450  \\$wnnna$aDiagnoses, Antemortem
=450  \\$wnnna$aDiagnoses, Postmortem
=450  \\$wnnna$aDiagnosis, Antemortem
=450  \\$wnnna$aDiagnosis, Postmortem
=450  \\$aDisease$xdiagnosis
=450  \\$wnnna$aExaminations and Diagnoses
=450  \\$wnnna$aPostmortem Diagnoses
=450  \\$wnnna$aPostmortem Diagnosis
=550  \\$wh$aClinical Decision-Making
=550  \\$wh$aDelayed Diagnosis
=550  \\$wh$aDiagnosis, Computer-Assisted
=550  \\$wh$aDiagnosis, Differential
=550  \\$wh$aDiagnosis, Dual (Psychiatry)
=550  \\$wh$aDiagnostic Errors
=550  \\$wh$aDiagnostic Techniques and Procedures
=550  \\$wh$aEarly Diagnosis
=550  \\$wh$aIncidental Findings
=550  \\$wh$aProdromal Symptoms
=550  \\$wh$aPrognosis
=550  \\$wh$aTheranostic Nanomedicine
=667  \\$ageneral only; prefer /diag with disease term: Manual 19.7+, 19.8.22; in Chinese traditional medicine, diagnosis & therapy based on overall analysis of the patient's state is bianzheng shizhi: see note under DIAGNOSIS, DIFFERENTIAL; DF: DIAG
=680  \\$iThe determination of the nature of a disease or condition, or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the likes. Computerized programs may be used to enhance the decision-making process.
=750  \0$aDiagnosis$5IEN$0(DLC)sh 85037489

=LDR  01336cz  a2200337n  4500
=001  9880363573502441
=005  20141212200635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003932
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x562.$x445
=072  \\$aD3.$x549.$x686.$x607.$x490
=072  \\$aD3.$x605.$x497.$x607.$x490
=072  \\$aD4.$x615.$x723.$x795.$x576.$x445
=150  \\$aHeroin
=450  \\$wnnna$aAPS Brand of Heroin Hydrochloride
=450  \\$aDiacetylmorphine
=450  \\$wnnna$aDiacetylmorphine Hydrochloride
=450  \\$wnnna$aDiagesil
=450  \\$wnnna$aDiamorf
=450  \\$aDiamorphine
=450  \\$wnnna$aEvans Vaccines Brand of Heroin Hydrochloride
=450  \\$wnnna$aHeroin Hydrochloride
=450  \\$wnnna$aHydrochloride, Diacetylmorphine
=450  \\$wnnna$aHydrochloride, Heroin
=450  \\$wnnna$aMin-I-Jet Morphine Sulphate
=450  \\$wnnna$aMin I Jet Morphine Sulphate
=550  \\$wg$aMorphine Derivatives
=680  \\$iA narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)
=688  \\$a99(63)
=750  \0$aHeroin$5IEN-M$0(DLC)sh 85060444

=LDR  00690cz  a2200241n  4500
=001  9880363573602441
=005  20141212200635.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003931
=035  \\$aCAZ7056M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x296.$x400
=150  \\$aDiacetyl
=450  \\$a2,3-Butanedione
=450  \\$wnnna$a2,3 Butanedione
=450  \\$aBiacetyl
=450  \\$aDiketobutane
=450  \\$aDimethyldiketone
=450  \\$aDimethylglyoxal
=550  \\$wg$aButanones
=680  \\$iCarrier of aroma of butter, vinegar, coffee, and other foods.
=688  \\$a91(75); was see under BUTANONES 1975-90
=750  \0$aDiacetyl$0(DLC)sh2007008577$5IEN-M

=LDR  00966cz  a2200241n  4500
=001  9880363573702441
=005  20141212200635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003930
=035  \\$aCAZ7055HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x257
=072  \\$aC14.$x907.$x320.$x382
=072  \\$aC19.$x246.$x99.$x500.$x382
=150  \\$aDiabetic Retinopathy
=450  \\$wnnna$aDiabetic Retinopathies
=450  \\$wnnna$aRetinopathies, Diabetic
=450  \\$wnnna$aRetinopathy, Diabetic
=550  \\$wg$aDiabetic Angiopathies
=550  \\$wg$aRetinal Diseases
=667  \\$acoordinate IM with specific type of diabetes mellitus (IM) if pertinent
=680  \\$iDisease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
=750  \0$aDiabetic retinopathy$5IEN$0(DLC)sh 85037472

=LDR  03537cz  a2200745n  4500
=001  9880363573802441
=005  20141212200634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003929
=035  \\$aCAZ7054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x300
=072  \\$aC19.$x246.$x99.$x937
=150  \\$aDiabetic Neuropathies
=450  \\$wnnna$aAmyotrophies, Diabetic
=450  \\$wnnna$aAmyotrophy, Diabetic
=450  \\$wnnna$aAsymmetric Diabetic Proximal Motor Neuropathy
=450  \\$wnnna$aAsymmetric Polyneuropathies, Diabetic
=450  \\$wnnna$aAsymmetric Polyneuropathy, Diabetic
=450  \\$wnnna$aAutonomic Neuropathies, Diabetic
=450  \\$wnnna$aAutonomic Neuropathy, Diabetic
=450  \\$wnnna$aDiabetic Amyotrophies
=450  \\$aDiabetic Amyotrophy
=450  \\$wnnna$aDiabetic Asymmetric Polyneuropathies
=450  \\$wnnna$aDiabetic Asymmetric Polyneuropathy
=450  \\$wnnna$aDiabetic Autonomic Neuropathies
=450  \\$aDiabetic Autonomic Neuropathy
=450  \\$wnnna$aDiabetic Mononeuropathies
=450  \\$wnnna$aDiabetic Mononeuropathy
=450  \\$wnnna$aDiabetic Mononeuropathy Simplex
=450  \\$wnnna$aDiabetic Mononeuropathy Simplices
=450  \\$aDiabetic Neuralgia
=450  \\$wnnna$aDiabetic Neuralgias
=450  \\$wnnna$aDiabetic Neuropathies, Painful
=450  \\$wnnna$aDiabetic Neuropathy
=450  \\$wnnna$aDiabetic Neuropathy, Painful
=450  \\$wnnna$aDiabetic Polyneuropathies
=450  \\$aDiabetic Polyneuropathy
=450  \\$wnnna$aMononeuropathies, Diabetic
=450  \\$wnnna$aMononeuropathy, Diabetic
=450  \\$wnnna$aMononeuropathy Simplex, Diabetic
=450  \\$wnnna$aMononeuropathy Simplices, Diabetic
=450  \\$aNeuralgia, Diabetic
=450  \\$wnnna$aNeuralgias, Diabetic
=450  \\$wnnna$aNeuropathies, Diabetic
=450  \\$wnnna$aNeuropathies, Diabetic Autonomic
=450  \\$wnnna$aNeuropathies, Painful Diabetic
=450  \\$wnnna$aNeuropathy, Diabetic
=450  \\$wnnna$aNeuropathy, Diabetic Autonomic
=450  \\$wnnna$aNeuropathy, Painful Diabetic
=450  \\$wnnna$aPainful Diabetic Neuropathies
=450  \\$wnnna$aPainful Diabetic Neuropathy
=450  \\$wnnna$aPolyneuropathies, Diabetic
=450  \\$wnnna$aPolyneuropathies, Diabetic Asymmetric
=450  \\$wnnna$aPolyneuropathy, Diabetic
=450  \\$wnnna$aPolyneuropathy, Diabetic Asymmetric
=450  \\$wnnna$aSimplex, Diabetic Mononeuropathy
=450  \\$wnnna$aSimplices, Diabetic Mononeuropathy
=450  \\$wnnna$aSymmetric Diabetic Proximal Motor Neuropathy
=550  \\$wg$aDiabetes Complications
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aDiabetic Foot
=667  \\$acoord IM with specific neurol dis (IM) but do not coord with PERIPHERAL NERVOUS SYSTEM DISEASES for "diabetic peripheral neuropathy"
=680  \\$iPeripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
=750  \0$aDiabetic neuropathies$5IEN$0(DLC)sh 85037471

=LDR  01895cz  a2200421n  4500
=001  9880363573902441
=005  20141212200633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003928
=035  \\$aCAZ7053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x192
=072  \\$aC13.$x351.$x968.$x419.$x192
=072  \\$aC19.$x246.$x99.$x875
=150  \\$aDiabetic Nephropathies
=450  \\$aDiabetic Glomerulosclerosis
=450  \\$wnnna$aDiabetic Kidney Disease
=450  \\$wnnna$aDiabetic Kidney Diseases
=450  \\$wnnna$aDiabetic Nephropathy
=450  \\$aGlomerulosclerosis, Diabetic
=450  \\$wnnna$aGlomerulosclerosis, Nodular
=450  \\$wnnna$aIntracapillary Glomerulosclerosis
=450  \\$wnnna$aKidney Disease, Diabetic
=450  \\$wnnna$aKidney Diseases, Diabetic
=450  \\$wnnna$aKimmelstiel-Wilson Disease
=450  \\$wnnna$aKimmelstiel Wilson Disease
=450  \\$wnnna$aKimmelstiel-Wilson Syndrome
=450  \\$wnnna$aKimmelstiel Wilson Syndrome
=450  \\$wnnna$aNephropathies, Diabetic
=450  \\$wnnna$aNephropathy, Diabetic
=450  \\$wnnna$aNodular Glomerulosclerosis
=450  \\$wnnna$aSyndrome, Kimmelstiel-Wilson
=550  \\$wg$aDiabetes Complications
=550  \\$wg$aKidney Diseases
=667  \\$acoord IM with specific kidney dis (IM); do not confuse with DIABETES INSIPIDUS, NEPHROGENIC, a form of diabetes insipidus
=680  \\$iKIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
=688  \\$a65(64); KIMMELSTIEL-WILSON SYNDROME was heading 1963-76
=750  \0$aDiabetic nephropathies$5IEN$0(DLC)sh 85037470

=LDR  01039cz  a2200253n  4500
=001  9880363574002441
=005  20160428143516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003927
=035  \\$aCAZ7052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x240
=072  \\$aG7.$x203.$x650.$x240.$x240
=150  \\$aDiet, Diabetic
=450  \\$wnno$aDiabetic Diet
=450  \\$wnnna$aDiabetic Diets
=450  \\$wnnna$aDiets, Diabetic
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$aDiabetes Mellitus
=667  \\$aIM; a specific dietary regimen for diabetics: not all diet ther of diabetes is DIABETIC DIET; when specified by author as a diabetic diet, coord with DIABETES MELLITUS /diet ther (IM) or specific type of diabetes /diet ther (IM) + specific dietary element /ther use (IM)
=680  \\$iA course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX.
=688  \\$a2016 (1966)
=750  \0$aDiabetes$xDiet therapy$0(DLC)sh2008102238$5IEN

=LDR  00838cz  a2200217n  4500
=001  9880363574102441
=005  20141212200632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003926
=035  \\$aCAZ7051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x246.$x99.$x750
=150  \\$aDiabetic Coma
=450  \\$wnnna$aComa, Diabetic
=450  \\$wnnna$aComas, Diabetic
=450  \\$wnnna$aDiabetic Comas
=550  \\$wg$aDiabetes Complications
=550  \\$wh$aHyperglycemic Hyperosmolar Nonketotic Coma
=667  \\$acoordinate IM with specific type of diabetes mellitus (IM) if pertinent
=680  \\$iA state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.
=750  \0$aDiabetic coma$5IEN$0(DLC)sh 85037469

=LDR  01431cz  a2200397n  4500
=001  9880363574202441
=005  20141212200632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003925
=035  \\$aCAZ7050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x320
=072  \\$aC19.$x246.$x99.$x500
=150  \\$aDiabetic Angiopathies
=450  \\$wnnna$aAngiopathies, Diabetic
=450  \\$wnnna$aAngiopathy, Diabetic
=450  \\$wnnna$aDiabetic Angiopathy
=450  \\$wnnna$aDiabetic Microangiopathies
=450  \\$wnnna$aDiabetic Microangiopathy
=450  \\$wnnna$aDiabetic Vascular Complication
=450  \\$aDiabetic Vascular Complications
=450  \\$wnnna$aDiabetic Vascular Disease
=450  \\$aDiabetic Vascular Diseases
=450  \\$wnnna$aMicroangiopathies, Diabetic
=450  \\$aMicroangiopathy, Diabetic
=450  \\$wnnna$aVascular Complication, Diabetic
=450  \\$wnnna$aVascular Complications, Diabetic
=450  \\$wnnna$aVascular Disease, Diabetic
=450  \\$wnnna$aVascular Diseases, Diabetic
=550  \\$wg$aDiabetes Complications
=550  \\$wg$aVascular Diseases
=550  \\$wh$aDiabetic Foot
=550  \\$wh$aDiabetic Retinopathy
=667  \\$acoordinate IM with specific vascular dis (IM) + specific type of diabetes
=680  \\$iVASCULAR DISEASES that are associated with DIABETES MELLITUS.
=750  \0$aDiabetic angiopathies$5IEN$0(DLC)sh 85037468

=LDR  02356cz   2200541n  4500
=001  9880363574302441
=005  20220926172443.0
=008  830405\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003924
=035  \\$aCAZ7049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x750.$x149
=072  \\$aC19.$x246.$x300
=150  \\$aDiabetes Mellitus, Type 2
=450  \\$wnnna$aAdult-Onset Diabetes Mellitus
=450  \\$aDiabetes Mellitus, Adult-Onset
=450  \\$wnnna$aDiabetes Mellitus, Adult Onset
=450  \\$aDiabetes Mellitus, Ketosis-Resistant
=450  \\$wnnna$aDiabetes Mellitus, Ketosis Resistant
=450  \\$aDiabetes Mellitus, Maturity-Onset
=450  \\$wnnna$aDiabetes Mellitus, Maturity Onset
=450  \\$wnnna$aDiabetes Mellitus, Non Insulin Dependent
=450  \\$aDiabetes Mellitus, Non-Insulin-Dependent
=450  \\$wnnna$aDiabetes Mellitus, Noninsulin Dependent
=450  \\$wnnna$aDiabetes Mellitus, Noninsulin-Dependent
=450  \\$aDiabetes Mellitus, Slow-Onset
=450  \\$wnnna$aDiabetes Mellitus, Slow Onset
=450  \\$aDiabetes Mellitus, Stable
=450  \\$wnnna$aDiabetes Mellitus, Type II
=450  \\$wnnna$aKetosis-Resistant Diabetes Mellitus
=450  \\$wnnna$aMaturity-Onset Diabetes
=450  \\$aMaturity-Onset Diabetes Mellitus
=450  \\$wnnna$aMaturity Onset Diabetes Mellitus
=450  \\$aMODY
=450  \\$aNIDDM
=450  \\$wnnna$aNon-Insulin-Dependent Diabetes Mellitus
=450  \\$wnnna$aNoninsulin-Dependent Diabetes Mellitus
=450  \\$wnnna$aSlow-Onset Diabetes Mellitus
=450  \\$wnnna$aStable Diabetes Mellitus
=450  \\$wnnna$aType 2 Diabetes Mellitus
=450  \\$aType II Diabetes Mellitus$5IEN-HS
=550  \\$wg$aDiabetes Mellitus
=550  \\$wh$aDiabetes Mellitus, Lipoatrophic
=550  \\$aMetabolic Syndrome X
=550  \\$aRats, Inbred OLETF
=680  \\$iA subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
=688  \\$a2005 (1984)
=750  \0$aType 2 diabetes$0(DLC) sh 85092226$5IEN

=LDR  01096cz  a2200289n  4500
=001  9880363574402441
=005  20141212204332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010387
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x605
=072  \\$aE1.$x370.$x600.$x24.$x690
=072  \\$aE5.$x41.$x690
=150  \\$aPelvimetry
=450  \\$aCephalopelvic Proportion
=450  \\$wnnna$aCephalopelvic Proportions
=450  \\$wnnna$aCephalopelvimetries
=450  \\$aCephalopelvimetry
=450  \\$wnnna$aPelvimetries
=450  \\$wnnna$aProportion, Cephalopelvic
=450  \\$wnnna$aProportions, Cephalopelvic
=550  \\$wg$aAnthropometry
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$aPelvis
=667  \\$aNIM
=680  \\$iMeasurement of the dimensions and capacity of the pelvis. It includes cephalopelvimetry (measurement of fetal head size in relation to maternal pelvic capacity), a prognostic guide to the management of LABOR, OBSTETRIC associated with disproportion.
=750  \0$aPelvimetry$5IEN$0(DLC)sh 85099316

=LDR  01397cz  a2200397n  4500
=001  9880363574502441
=005  20141212204331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010386
=035  \\$aCBA3672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x699
=150  \\$aPelvic Neoplasms
=450  \\$aCancer of Pelvis
=450  \\$wnnna$aCancer of the Pelvis
=450  \\$wnnna$aCancer, Pelvic
=450  \\$wnnna$aCancer, Pelvis
=450  \\$wnnna$aCancers, Pelvic
=450  \\$wnnna$aCancers, Pelvis
=450  \\$wnnna$aNeoplasm, Pelvic
=450  \\$wnnna$aNeoplasm, Pelvis
=450  \\$wnnna$aNeoplasms of Pelvis
=450  \\$wnnna$aNeoplasms, Pelvic
=450  \\$wnnna$aNeoplasms, Pelvis
=450  \\$aPelvic Cancer
=450  \\$wnnna$aPelvic Cancers
=450  \\$wnnna$aPelvic Neoplasm
=450  \\$wnnna$aPelvis Cancer
=450  \\$wnnna$aPelvis Cancers
=450  \\$wnnna$aPelvis Neoplasm
=450  \\$wnnna$aPelvis Neoplasms
=550  \\$wg$aNeoplasms by Site
=667  \\$ainternal pelvic organs & region, not bones; if referring to pelvic region as an external site (as in skin lesions) ignore; GEN: prefer specific precoord; coord IM with histol type of neopl if possible (IM)
=680  \\$iTumors or cancer of the pelvic region.
=750  \0$aPelvis$xCancer$5IEN-M$0(DLC)sh 85099322
=750  \0$aPelvis$xTumors$5IEN-HS$0(DLC)sh 85099328

=LDR  00843cz  a2200217n  4500
=001  9880363574602441
=005  20141212204331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010385
=035  \\$aCBA3671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x584
=150  \\$aPelvic Exenteration
=450  \\$wnnna$aExenteration, Pelvic
=450  \\$wnnna$aExenterations, Pelvic
=450  \\$wnnna$aPelvic Exenterations
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aPelvis
=667  \\$asurg removal of pelvic organs; do not use /util except by MeSH definition
=680  \\$iRemoval of all of the organs and adjacent structures of the pelvis. It is usually performed to surgically remove cancer involving the bladder, uterine cervix, or rectum. (Stedman, 25th ed)
=750  \0$aPelvic exenteration$5IEN$0(DLC)sh 85099313

=LDR  00692cz  a2200241n  4500
=001  9880363574702441
=005  20141212204331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010384
=035  \\$aCBA3670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x825
=150  \\$aPelvic Bones
=450  \\$wnnna$aBone, Pelvic
=450  \\$wnnna$aBones, Pelvic
=450  \\$wnnna$aPelvic Bone
=550  \\$wg$aBones of Lower Extremity
=550  \\$wh$aAcetabulum
=550  \\$wh$aIlium
=550  \\$wh$aIschium
=550  \\$wh$aPubic Bone
=667  \\$a/anat: CEPHALOPELVIC PROPORTION see PELVIMETRY is also available
=750  \0$aPelvic Bones$5IEN-M$0(DLC)sh 85099315

=LDR  00641cz  a2200169n  4500
=001  9880363574802441
=005  20141212204330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010383
=035  \\$aCBA3669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x529
=150  \\$aPellagra
=450  \\$wnnna$aPellagras
=550  \\$wg$aVitamin B Deficiency
=680  \\$iA disease due to deficiency of NIACIN, a B-complex vitamin, or its precursor TRYPTOPHAN. It is characterized by scaly DERMATITIS which is often associated with DIARRHEA and DEMENTIA (the three D's).
=750  \0$aPellagra$5IEN$0(DLC)sh 85099272

=LDR  01228cz  a2200289n  4500
=001  9880363574902441
=005  20141212204330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010380
=035  \\$aCBA3665HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x549
=072  \\$aI1.$x880.$x604.$x640
=072  \\$aN3.$x706.$x700
=150  \\$aPeer Review
=450  \\$wnnna$aPeer Reviews
=450  \\$wnnna$aReview, Peer
=450  \\$wnnna$aReviews, Peer
=550  \\$wg$aGroup Processes
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aPeer Review, Health Care
=550  \\$wh$aPeer Review, Research
=550  \\$aEthical Review
=667  \\$aprofessionals evaluating professionals
=680  \\$iAn organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of their specialty. Review by peers is used by editors in the evaluation of articles and other papers submitted for publication. Peer review is used also in the evaluation of grant applications. It is applied also in evaluating the quality of health care provided to patients.
=688  \\$a71
=750  \0$aPeer review$0(DLC) sh 85099224$5IEN

=LDR  00776cz  a2200181n  4500
=001  9880363575002441
=005  20160609131133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010378
=035  \\$aCBA3663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x600
=150  \\$aPedophilia
=450  \\$wnnna$aPedophilias
=550  \\$wg$aParaphilic Disorders
=680  \\$iA sexual disorder occurring in a person 16 years or older and that is recurrent with intense sexually arousing fantasies, sexual urges, or behaviors involving sexual activity with a prepubescent child (generally age 13 or younger). (from APA, DSM-IV, 1994).
=688  \\$a91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80
=750  \0$aPedophilia$5IEN$0(DLC)sh 85099210

=LDR  00833cz  a2200229n  4500
=001  9880363575102441
=005  20141212204329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010377
=035  \\$aCBA3662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x700
=072  \\$aH2.$x163.$x876.$x600
=150  \\$aPediatric Dentistry
=450  \\$aDentistry, Pediatric
=450  \\$aPedodontics
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=667  \\$aSPEC: SPEC qualif; DF: PEDIATRIC DENT
=680  \\$iThe practice of dentistry concerned with the dental problems of children, proper maintenance, and treatment. The dental care may include the services provided by dental specialists.
=688  \\$a93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64
=750  \0$aPedodontics$5IEN$0(DLC)sh 85099208

=LDR  01276cz  a2200385n  4500
=001  9880363575202441
=005  20141212204329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010375
=035  \\$aCBA3660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x673
=150  \\$aPedigree
=450  \\$aFamily Tree
=450  \\$wnnna$aFamily Trees
=450  \\$wnnna$aGenealogic Tree
=450  \\$wnnna$aGenealogic Trees
=450  \\$aGenealogical Tree
=450  \\$wnnna$aGenealogical Trees
=450  \\$wnnna$aGenetic Identities
=450  \\$wnnna$aGenetic Identity
=450  \\$wnnna$aIdentities, Genetic
=450  \\$wnnna$aIdentity, Genetic
=450  \\$wnnna$aTree, Family
=450  \\$wnnna$aTree, Genealogic
=450  \\$wnnna$aTree, Genealogical
=450  \\$wnnna$aTrees, Family
=450  \\$wnnna$aTrees, Genealogic
=450  \\$wnnna$aTrees, Genealogical
=550  \\$wg$aGenetic Techniques
=550  \\$aGenetic Privacy
=667  \\$ahuman & animal
=680  \\$iThe record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
=688  \\$a68
=750  \0$aGenealogy$5IEN$0(DLC)sh 85053742

=LDR  01099cz  a2200265n  4500
=001  9880363575402441
=005  20141212204328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010373
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x858.$x211.$x465
=072  \\$aC17.$x800.$x838.$x775.$x580
=150  \\$aLice Infestations
=450  \\$wnnna$aInfestation, Lice
=450  \\$wnnna$aInfestations, Lice
=450  \\$wnnna$aLice Infestation
=450  \\$wnnna$aPediculoses
=450  \\$aPediculosis
=550  \\$wg$aEctoparasitic Infestations
=550  \\$wg$aSkin Diseases, Parasitic
=550  \\$aPhthiraptera
=667  \\$acoord IM with specific louse (IM); head lice: coord IM with SCALP DERMATOSES (IM) and PEDICULUS (IM)
=680  \\$iParasitic attack or subsistence on the skin by members of the order Phthiraptera, especially on humans by Pediculus humanus of the family Pediculidae. The hair of the head, eyelashes, and pubis is a frequent site of infestation. (From Dorland, 28th ed; Stedman, 26th ed)
=688  \\$a1999(1966)
=750  \0$aPediculosis$5IEN-M$0(DLC)sh 85099199

=LDR  00696cz  a2200205n  4500
=001  9880363575502441
=005  20181008102431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010372
=035  \\$aCBA3657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x670
=150  \\$aPediatrics
=550  \\$wg$aMedicine
=550  \\$wh$aNeonatology
=550  \\$wh$aPediatric Emergency Medicine
=550  \\$wh$aPerinatology
=667  \\$aSPEC: SPEC qualif; when permitted for "pediatric dis": Manual 28.10.1
=680  \\$iA medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.
=750  \0$aPediatrics$0(DLC)sh 85099185$5IEN-M

=LDR  00870cz  a2200253n  4500
=001  9880363575602441
=005  20141212204327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010371
=035  \\$aCBA3656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x631
=072  \\$aN2.$x421.$x533.$x691
=150  \\$aPediatric Nursing
=450  \\$wnnna$aNursing, Pediatric
=450  \\$wnnna$aNursings, Pediatric
=450  \\$wnnna$aPediatric Nursings
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=550  \\$wh$aNeonatal Nursing
=667  \\$aSPEC; SPEC qualif; check also tag CHILD or specific
=680  \\$iThe nursing specialty concerning care of children from birth to adolescence. It includes the clinical and psychological aspects of nursing care.
=688  \\$a67
=750  \0$aPediatric nursing$5IEN$0(DLC)sh 85099163

=LDR  00861cz  a2200193n  4500
=001  9880363575702441
=005  20141212204327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x738
=072  \\$aD9.$x698.$x670
=072  \\$aD20.$x215.$x784.$x500.$x618
=150  \\$aPectins
=550  \\$wg$aBiopolymers
=550  \\$wg$aPlant Extracts
=550  \\$wg$aPolysaccharides
=680  \\$iHigh molecular weight polysaccharides present in the cell walls of all plants. Pectins cement cell walls together. They are used as emulsifiers and stabilizers in the food industry. They have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.
=750  \0$aPectin$5IEN$0(DLC)sh 85099115

=LDR  01019cz  a2200229n  4500
=001  9880363575802441
=005  20160418110802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010367
=035  \\$aCBA3652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x77
=150  \\$aArachis
=450  \\$wnno$aArachis hypogaea
=450  \\$wnnna$aPeanuts
=450  \\$aPeanuts
=550  \\$wg$aFabaceae
=667  \\$aas plant & food; /adv eff: consider also PEANUT HYPERSENSITIVITY; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that includes peanuts.
=688  \\$a2016; use ARACHIS HYPOGAEA 2002-2015, PEANUTS 1963-2001
=750  \0$aPeanuts$0(DLC)sh 85099000$5IEN-M
=750  \0$aArachis$0(DLC)sh 87006544$5IEN-M

=LDR  00870cz  a2200241n  4500
=001  9880363575902441
=005  20170209103736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010364
=035  \\$aCBA3649HS
=040  \\$aDNLM$beng$cDNLM
=060  \0$aWW 105
=072  \\$aF2.$x463.$x593.$x524.$x500
=072  \\$aF2.$x463.$x593.$x932.$x622
=150  \\$aPattern Recognition, Visual
=450  \\$wnnna$aRecognition, Visual Pattern
=450  \\$wnnna$aVisual Pattern Recognition
=550  \\$wg$aPattern Recognition, Physiological
=550  \\$wg$aVisual Perception
=550  \\$wh$aFacial Recognition
=680  \\$iMental process to visually perceive a critical number of facts (the pattern), such as characters, shapes, displays, or designs.
=688  \\$a91(75); was see under FORM PERCEPTION 1975-90
=750  \0$aPattern perception$5IEN$0(DLC)sh 85098789

=LDR  01107cz  a2200265n  4500
=001  9880363576002441
=005  20201216141349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010363
=035  \\$aCBA3648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x725
=150  \\$aPattern Recognition, Automated
=450  \\$wnnna$aAutomated Pattern Recognition
=450  \\$wnnoa$aPattern Recognition$5IEN-HS
=450  \\$wnnna$aPattern Recognition System
=450  \\$wnnna$aPattern Recognition Systems
=550  \\$wg$aInformation Science
=550  \\$wh$aBiometric Identification
=550  \\$wh$aNeural Networks, Computer
=550  \\$wh$aSupport Vector Machine
=667  \\$anot physiological: physiol pattern recognition is PATTERN RECOGNITION, PHYSIOLOGICAL
=680  \\$iIn INFORMATION RETRIEVAL, machine-sensing or identification of visible patterns (shapes, forms, and configurations). (Harrod's Librarians' Glossary, 7th ed)
=688  \\$a2005; use PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972
=750  \0$aPattern recognition systems$0(DLC) sh 85098791$5IEN

=LDR  01209cz  a2200313n  4500
=001  9880363576102441
=005  20141212204325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010361
=035  \\$aCBA3646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x643
=150  \\$aPatients
=450  \\$wnnna$aClient
=450  \\$wnnna$aClients
=450  \\$wnnna$aPatient
=550  \\$wg$aPersons
=550  \\$wh$aAdolescent, Hospitalized
=550  \\$wh$aAdolescent, Institutionalized
=550  \\$wh$aChild, Hospitalized
=550  \\$wh$aChild, Institutionalized
=550  \\$wh$aInpatients
=550  \\$wh$aOutpatients
=550  \\$wh$aPatient Dropouts
=550  \\$wh$aSurvivors
=667  \\$aGEN only, irrespective of disease; patients as people or as a social, sociol, psychol, etc., group; do not confuse the patient with the disease: the "tuberculotic patient" = TUBERCULOSIS & not also PATIENTS; Manual 34.13
=680  \\$iIndividuals participating in the health care system for the purpose of receiving therapeutic, diagnostic, or preventive procedures.
=688  \\$a/education was used for indexing 1966-79; was in Cat G & M 1963-67
=750  \0$aPatients$5IEN$0(DLC)sh 85098709

=LDR  01009cz  a2200253n  4500
=001  9880363576202441
=005  20141212204324.0
=008  860530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010360
=035  \\$aCBA3645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x400.$x630
=072  \\$aN2.$x421.$x585.$x400.$x630
=150  \\$aPatient Transfer
=450  \\$wnnna$aDumping, Patient
=450  \\$aPatient Dumping
=450  \\$wnnna$aPatient Transfers
=450  \\$wnnna$aTransfer, Patient
=450  \\$wnnna$aTransfers, Patient
=550  \\$wg$aHospitalization
=667  \\$a"interfacility or intrahospital transfer": do not confuse with TRANSPORTATION OF PATIENTS or MOVING AND LIFTING PATIENTS
=680  \\$iInterfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as type of care provided.
=688  \\$a87
=750  \0$aPatient dumping$0(DLC)sh2007010687$5IEN-M

=LDR  01367cz  a2200397n  4500
=001  9880363576302441
=005  20180102091101.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010358
=035  \\$aCBA3643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x262.$x300
=072  \\$aN3.$x540.$x245.$x360.$x300
=072  \\$aN5.$x300.$x150.$x600.$x620
=150  \\$aPatient Participation
=450  \\$wnnna$aActivation, Patient
=450  \\$wnnna$aEmpowerment, Patient
=450  \\$wnnna$aEngagement, Patient
=450  \\$wnnna$aInvolvement, Patient
=450  \\$wnnna$aParticipation, Patient
=450  \\$wnnna$aParticipation Rate, Patient
=450  \\$wnnna$aParticipation Rates, Patient
=450  \\$wnnna$aPatient Activation
=450  \\$wnnna$aPatient Empowerment
=450  \\$wnnna$aPatient Engagement
=450  \\$wnnna$aPatient Involvement
=450  \\$wnnna$aPatient Participation Rate
=450  \\$wnnna$aPatient Participation Rates
=550  \\$wg$aCommunity Participation
=550  \\$wg$aPatient Acceptance of Health Care
=550  \\$aRefusal to Participate
=667  \\$ado not confuse with PATIENT COMPLIANCE
=680  \\$iPatient involvement in the decision-making process in matters pertaining to health.
=688  \\$a1978
=688  \\$a78
=750  \0$aPatient participation$0(DLC) sh 97002539$5IEN-M

=LDR  01074cz  a2200289n  4500
=001  9880363576402441
=005  20141212204324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010357
=035  \\$aCBA3642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x755
=150  \\$aPatient Isolators
=450  \\$wnnna$aIsland, Life
=450  \\$wnnna$aIslands, Life
=450  \\$wnnna$aIsolator, Patient
=450  \\$wnnna$aIsolators, Patient
=450  \\$wnnna$aLife Island
=450  \\$aLife Islands
=450  \\$wnnna$aPatient Isolator
=550  \\$wg$aEquipment and Supplies, Hospital
=550  \\$aCross Infection
=550  \\$aEnvironment, Controlled
=667  \\$aDF: do NOT shorten: short form can be confused with PATIENT ISOL for PATIENT ISOLATION
=680  \\$iEquipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients.
=688  \\$a68
=750  \0$aIsolation (Hospital care)$5IEN$0(DLC)sh 85068640

=LDR  01074cz  a2200241n  4500
=001  9880363576502441
=005  20141212204323.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010356
=035  \\$aCBA3641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x770
=072  \\$aN6.$x850.$x780.$x200.$x450.$x650
=150  \\$aPatient Isolation
=450  \\$aIsolation, Patient
=550  \\$wg$aInfection Control
=550  \\$wg$aTherapeutics
=550  \\$aCross Infection
=550  \\$aQuarantine
=667  \\$ado not confuse with PATIENT ISOLATORS; DF: PATIENT ISOL
=680  \\$iThe segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection.
=688  \\$a77
=750  \0$aIsolation (Hospital care)$5IEN$0(DLC)sh 85068640

=LDR  00892cz  a2200241n  4500
=001  9880363576602441
=005  20141212204323.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010354
=035  \\$aCBA3639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x360.$x740.$x400.$x650
=150  \\$aPatient Escort Service
=450  \\$wnnna$aEscort Service, Patient
=450  \\$wnnna$aEscort Services, Patient
=450  \\$wnnna$aPatient Escort Services
=450  \\$wnnna$aService, Patient Escort
=450  \\$wnnna$aServices, Patient Escort
=550  \\$wg$aHospital Volunteers
=667  \\$aDF: PATIENT ESCORT SERV
=680  \\$iA special service provided by volunteers to accompany patients who need help in moving about the health facility.
=688  \\$a91(Aug 77); was see under HOSPITAL VOLUNTEERS 1977-90
=750  \0$aHospital patients$xEscort services$5IEN$0(DLC)sh 85062251

=LDR  01079cz  a2200313n  4500
=001  9880363576702441
=005  20141212192416.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010353
=035  \\$aCBA3638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x332.$x500
=072  \\$aN2.$x421.$x143.$x827.$x407.$x680
=072  \\$aN2.$x421.$x726.$x407.$x680
=150  \\$aPatient Education as Topic
=450  \\$aEducation of Patients
=450  \\$wnnna$aEducation, Patient
=450  \\$wnnna$aPatient Education
=450  \\$aPatients$xeducation
=550  \\$wg$aHealth Education
=550  \\$wh$aPrenatal Education
=550  \\$aHealth Literacy
=550  \\$aPatient Participation
=667  \\$ado not confuse with the Publication Type PATIENT EDUCATION HANDOUT
=680  \\$iThe teaching or training of patients concerning their own health needs.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Patient Education
=688  \\$a80; was PATIENTS/education 1966-79
=750  \0$aPatient education$0(DLC) sh 85098703$5IEN

=LDR  00957cz  a2200289n  4500
=001  9880363576802441
=005  20141212204322.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010351
=035  \\$aCBA3636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x400.$x610
=072  \\$aN2.$x421.$x585.$x400.$x610
=150  \\$aPatient Discharge
=450  \\$wnnna$aDischarge, Patient
=450  \\$aDischarge Planning
=450  \\$wnnna$aDischarge Plannings
=450  \\$wnnna$aDischarges, Patient
=450  \\$wnnna$aPatient Discharges
=450  \\$wnnna$aPlanning, Discharge
=450  \\$wnnna$aPlannings, Discharge
=550  \\$wg$aHospitalization
=550  \\$aHospitalization
=550  \\$aPatient Discharge Summaries
=680  \\$iThe administrative process of discharging the patient, live or dead, from hospitals or other health facilities.
=688  \\$a78
=750  \0$aHospitals$xAdmission and discharge$5IEN$0(DLC)sh 85062295

=LDR  01639cz  a2200445n  4500
=001  9880363576902441
=005  20200717112756.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010349
=035  \\$aCBA3634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x488.$x887.$x500.$x600
=072  \\$aF1.$x100.$x150.$x800.$x500.$x600
=072  \\$aN5.$x300.$x150.$x600.$x600
=150  \\$aPatient Compliance
=450  \\$wnnna$aAdherence, Patient
=450  \\$wnnna$aCompliance, Patient
=450  \\$wnnna$aCooperation, Patient
=450  \\$wnnna$aNon-Adherence, Patient
=450  \\$wnnna$aNon-Compliance, Patient
=450  \\$wnnna$aNonadherence, Patient
=450  \\$wnnna$aNoncompliance, Patient
=450  \\$aPatient Adherence
=450  \\$aPatient Cooperation
=450  \\$wnnna$aPatient Non-Adherence
=450  \\$wnnna$aPatient Non Adherence
=450  \\$wnnna$aPatient Non-Compliance
=450  \\$wnnna$aPatient Non Compliance
=450  \\$wnnna$aPatient Nonadherence
=450  \\$aPatient Noncompliance
=550  \\$wg$aPatient Acceptance of Health Care
=550  \\$wh$aMedication Adherence
=550  \\$wh$aNo-Show Patients
=550  \\$aDirectly Observed Therapy
=550  \\$aTreatment Refusal
=667  \\$adistinguish entry term PATIENT NON-COMPLIANCE from TREATMENT REFUSAL
=680  \\$iVoluntary cooperation of the patient in following a prescribed regimen.
=688  \\$a1975; for PATIENT NON-COMPLIANCE use TREATMENT REFUSAL 1997-2008, use PATIENT COMPLIANCE 1982-1990, use PATIENT DROPOUTS 1975-1981
=688  \\$a75
=750  \0$aPatient compliance$0(DLC) sh 85098702$5IEN

=LDR  01916cz  a2200529n  4500
=001  9880363577002441
=005  20141212204321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010348
=035  \\$aCBA3633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x715
=150  \\$aPatient Care Team
=450  \\$wnnna$aCare Team, Health
=450  \\$wnnna$aCare Team, Medical
=450  \\$wnnna$aCare Team, Patient
=450  \\$wnnna$aCare Teams, Health
=450  \\$wnnna$aCare Teams, Medical
=450  \\$wnnna$aCare Teams, Patient
=450  \\$aHealth Care Team
=450  \\$wnnna$aHealth Care Teams
=450  \\$wnnna$aHealth Team, Interdisciplinary
=450  \\$wnnna$aHealth Teams, Interdisciplinary
=450  \\$wnnna$aHealthcare Team
=450  \\$wnnna$aHealthcare Teams
=450  \\$aInterdisciplinary Health Team
=450  \\$wnnna$aInterdisciplinary Health Teams
=450  \\$aMedical Care Team
=450  \\$wnnna$aMedical Care Teams
=450  \\$wnnna$aPatient Care Teams
=450  \\$wnnna$aTeam, Health Care
=450  \\$wnnna$aTeam, Healthcare
=450  \\$wnnna$aTeam, Interdisciplinary Health
=450  \\$wnnna$aTeam, Medical Care
=450  \\$wnnna$aTeam, Patient Care
=450  \\$wnnna$aTeams, Health Care
=450  \\$wnnna$aTeams, Healthcare
=450  \\$wnnna$aTeams, Interdisciplinary Health
=450  \\$wnnna$aTeams, Medical Care
=450  \\$wnnna$aTeams, Patient Care
=550  \\$wg$aPatient Care Management
=550  \\$wh$aHospital Rapid Response Team
=550  \\$wh$aNursing, Team
=667  \\$aconsider also NURSING, TEAM
=680  \\$iCare of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.
=688  \\$a68
=750  \0$aHealth care teams$0(DLC) sh 85059533$5IEN

=LDR  01237cz  a2200361n  4500
=001  9880363577102441
=005  20141212204320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010347
=035  \\$aCBA3632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x624
=150  \\$aPatient Care Planning
=450  \\$wnnna$aCare Goal
=450  \\$wnnna$aCare Goals
=450  \\$wnnna$aCare Plan, Nursing
=450  \\$wnnna$aCare Planning, Patient
=450  \\$wnnna$aCare Plans, Nursing
=450  \\$wnnna$aGoals of Care
=450  \\$wnnna$aNursing Care Plan
=450  \\$aNursing Care Plans
=450  \\$wnnna$aPlan, Nursing Care
=450  \\$wnnna$aPlanning, Patient Care
=450  \\$wnnna$aPlans, Nursing Care
=550  \\$wg$aComprehensive Health Care
=550  \\$wh$aAdvance Care Planning
=550  \\$wh$aCase Management
=550  \\$wh$aCritical Pathways
=550  \\$aClinical Protocols
=667  \\$afor individual patient: do not confuse with PATIENT-CENTERED CARE which is institutional & administrative management
=680  \\$iUsually a written medical and nursing care program designed for a particular patient.
=688  \\$a68
=750  \0$aNursing care plans$5IEN$0(DLC)sh 85093387

=LDR  01146cz  a2200349n  4500
=001  9880363577202441
=005  20141212204320.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010344
=035  \\$aCBA3629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x631
=072  \\$aN3.$x706.$x678
=150  \\$aPatient Advocacy
=450  \\$wnnna$aAdvocacy, Patient
=450  \\$wnnna$aClinical Ombudsman
=450  \\$wnnna$aOmbudsman, Clinical
=450  \\$wnnna$aOmbudsman, Patient
=450  \\$wnnna$aOmbudsmen, Patient
=450  \\$wnnna$aPatient Ombudsman
=450  \\$aPatient Ombudsmen
=450  \\$wnnna$aPatient Representative
=450  \\$aPatient Representatives
=450  \\$wnnna$aRepresentative, Patient
=450  \\$wnnna$aRepresentatives, Patient
=550  \\$wg$aSocial Control, Formal
=550  \\$aCommitment of Mentally Ill
=550  \\$aPatient Rights
=680  \\$iPromotion and protection of the rights of patients, frequently through a legal process.
=688  \\$a76
=750  \0$aPatient representatives$5IEN-M$0(DLC)sh 85098707
=750  \0$aPatient advocacy$5IEN-HS$0(DLC)sh 87006731

=LDR  00930cz  a2200265n  4500
=001  9880363577302441
=005  20141212204319.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010343
=035  \\$aCBA3628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x400.$x600
=072  \\$aN2.$x421.$x585.$x400.$x600
=150  \\$aPatient Admission
=450  \\$wnnna$aAdmission, Patient
=450  \\$wnnna$aAdmission, Voluntary
=450  \\$wnnna$aAdmissions, Patient
=450  \\$wnnna$aAdmissions, Voluntary
=450  \\$wnnna$aPatient Admissions
=450  \\$wnnna$aVoluntary Admission
=450  \\$wnnna$aVoluntary Admissions
=550  \\$wg$aHospitalization
=680  \\$iThe process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution.
=688  \\$a78
=750  \0$aHospitals$xAdmission and discharge$5IEN$0(DLC)sh 85062295

=LDR  00723cz  a2200181n  4500
=001  9880363577402441
=005  20141212204319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010341
=035  \\$aCBA3626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x956.$x465
=150  \\$aPathology, Veterinary
=450  \\$wnnna$aVeterinary Pathology
=550  \\$wg$aVeterinary Medicine
=667  \\$aSPEC only; SPEC qualif; not a substitute for /pathol of organs or dis in vet animals nor for ANIMAL DISEASES or specific animal dis; DF: PATHOL VET
=680  \\$iThe field of veterinary medicine concerned with the causes of and changes produced in the body by disease.
=750  \0$aVeterinary pathology$5IEN$0(DLC)sh 85143066

=LDR  00620cz  a2200181n  4500
=001  9880363577502441
=005  20141212204319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010340
=035  \\$aCBA3625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x650.$x510
=150  \\$aPathology, Surgical
=450  \\$wnnna$aSurgical Pathology
=550  \\$wg$aPathology
=667  \\$aSPEC only: SPEC qualif; DF: PATHOL SURG
=680  \\$iA field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.
=750  \0$aPathology, Surgical$5IEN$0(DLC)sh 85098692

=LDR  01112cz  a2200277n  4500
=001  9880363577602441
=005  20181002114612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010336
=035  \\$aCBA3621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x650
=150  \\$aPathology
=450  \\$aDisease$xpathology
=450  \\$wnnna$aPathologies
=450  \\$aPathologists$5IEN
=550  \\$wg$aMedicine
=550  \\$wh$aForensic Pathology
=550  \\$wh$aNeuropathology
=550  \\$wh$aPathology, Clinical
=550  \\$wh$aPathology, Molecular
=550  \\$wh$aPathology, Surgical
=550  \\$wh$aTelepathology
=667  \\$aSPEC only: SPEC qualif; prefer /pathol with organs & diseases: Manual 19.7+, 19.8.52; definition of /pathol applicable to PATHOLOGY: Manual 21.22+, 23.15; "postmortem pathol": consider AUTOPSY or CADAVER or merely /pathol; DF: PATHOL
=680  \\$iA specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process.
=750  \0$aPathology$5IEN-M$0(DLC)sh 85098685

=LDR  00577cz  a2200193n  4500
=001  9880363577702441
=005  20141212204316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010334
=035  \\$aCBA3619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x780.$x937.$x766
=150  \\$aPaternity
=450  \\$wnnna$aPaternities
=550  \\$wg$aForensic Medicine
=667  \\$ano qualif
=680  \\$iEstablishing the father relationship of a man and a child.
=750  \0$aPaternity testing$5IEN-M$0(DLC)sh 85098676
=750  \0$aPaternity$5IEN-HS$0(DLC)sh 85098671

=LDR  00946cz  a2200253n  4500
=001  9880363577802441
=005  20141212204142.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010033
=035  \\$aCBA3314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x705.$x663
=150  \\$aOtitis Media
=450  \\$wnnna$aInflammation, Middle Ear
=450  \\$wnnna$aMiddle Ear Inflammation
=550  \\$wg$aOtitis
=550  \\$wh$aMastoiditis
=550  \\$wh$aOtitis Media, Suppurative
=550  \\$wh$aOtitis Media with Effusion
=550  \\$wh$aPetrositis
=667  \\$ageneral or unspecified; prefer specifics; nonsuppurative otitis media: index under OTITIS MEDIA WITH EFFUSION
=680  \\$iInflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.
=688  \\$aGRADENIGO'S SYNDROME was see under OTITIS MEDIA 1963-81, was see OTITIS MEDIA 1982-92
=750  \0$aOtitis media$5IEN$0(DLC)sh 85096036

=LDR  00740cz  a2200229n  4500
=001  9880363577902441
=005  20141212204141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010032
=035  \\$aCBA3313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x705.$x496
=150  \\$aOtitis Externa
=450  \\$wnnna$aExterna, Otitis
=450  \\$wnnna$aExternal Otitides
=450  \\$aExternal Otitis
=450  \\$wnnna$aOtitides, External
=450  \\$wnnna$aOtitis, External
=550  \\$wg$aOtitis
=550  \\$aOtomycosis
=680  \\$iInflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.
=750  \0$aOtitis externa$5IEN$0(DLC)sh 85096035

=LDR  00943cz  a2200265n  4500
=001  9880363578002441
=005  20141212204141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010031
=035  \\$aCBA3312M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x705
=150  \\$aOtitis
=450  \\$wnnna$aEar Inflammation
=450  \\$wnnna$aEar Inflammations
=450  \\$wnnna$aInflammation, Ear
=450  \\$wnnna$aInflammations, Ear
=450  \\$wnnna$aOtitides
=550  \\$wg$aEar Diseases
=550  \\$wh$aLabyrinthitis
=550  \\$wh$aOtitis Externa
=550  \\$wh$aOtitis Media
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iInflammation of the ear, which may be marked by pain (EARACHE), fever, HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.
=750  \0$aOtitis$5IEN-M$0(DLC)sh 99005626

=LDR  01126cz  a2200337n  4500
=001  9880363578102441
=005  20141212204141.0
=008  870515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010030
=035  \\$aCBA3311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x579
=150  \\$aOstomy
=450  \\$wnnna$aOstomies
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCystostomy
=550  \\$wh$aDacryocystorhinostomy
=550  \\$wh$aEnterostomy
=550  \\$wh$aEsophagostomy
=550  \\$wh$aGastrostomy
=550  \\$wh$aMiddle Ear Ventilation
=550  \\$wh$aNephrostomy, Percutaneous
=550  \\$wh$aPharyngostomy
=550  \\$wh$aSclerostomy
=550  \\$wh$aThoracostomy
=550  \\$wh$aTracheostomy
=550  \\$wh$aUreterostomy
=667  \\$asurg creation of an artif opening (stoma) "for external fistulization"; GEN only: prefer specific
=680  \\$iSurgical construction of an artificial opening (stoma) for external fistulization of a duct or vessel by insertion of a tube with or without a supportive stent.
=688  \\$a88
=750  \0$aOstomates$5IEN$0(DLC)sh 85096000

=LDR  00724cz  a2200241n  4500
=001  9880363578202441
=005  20141212204140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010027
=035  \\$aCBA3308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x580
=150  \\$aOsteotomy
=450  \\$wnnna$aOsteotomies
=550  \\$wg$aOrthopedic Procedures
=550  \\$wh$aOrthognathic Surgical Procedures
=550  \\$wh$aOsteotomy, Le Fort
=550  \\$wh$aOsteotomy, Sagittal Split Ramus
=550  \\$aBone and Bones
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe surgical cutting of a bone. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aOsteotomy$0(DLC) sh 85095989$5IEN

=LDR  00608cz  a2200205n  4500
=001  9880363578302441
=005  20141212204140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010026
=035  \\$aCBA3307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x702
=150  \\$aOsteosclerosis
=450  \\$wnnna$aOsteoscleroses
=550  \\$wg$aOsteochondrodysplasias
=550  \\$wh$aMelorheostosis
=550  \\$wh$aOsteopetrosis
=550  \\$wh$aOsteopoikilosis
=680  \\$iAn abnormal hardening or increased density of bone tissue.
=750  \0$aOsteosclerosis$5IEN$0(DLC)sh 85095988

=LDR  01400cz  a2200337n  4500
=001  9880363578402441
=005  20141212205506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012516
=035  \\$aCBA3306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x575.$x650
=072  \\$aC4.$x557.$x450.$x795.$x620
=150  \\$aOsteosarcoma
=450  \\$wnnna$aOsteogenic Sarcoma
=450  \\$wnnna$aOsteogenic Sarcomas
=450  \\$wnnna$aOsteosarcoma Tumor
=450  \\$wnnna$aOsteosarcoma Tumors
=450  \\$wnnna$aOsteosarcomas
=450  \\$aSarcoma, Osteogenic
=450  \\$wnnna$aSarcomas, Osteogenic
=450  \\$wnnna$aTumor, Osteosarcoma
=450  \\$wnnna$aTumors, Osteosarcoma
=550  \\$wg$aNeoplasms, Bone Tissue
=550  \\$wg$aSarcoma
=550  \\$wh$aOsteosarcoma, Juxtacortical
=550  \\$wh$aSarcoma, Ewing
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS (IM) or specific precoord bone/neopl term (IM) or specific bone (IM) + BONE NEOPLASMS (IM)
=680  \\$iA sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
=688  \\$a89; was SARCOMA, OSTEOGENIC 1963-88
=750  \0$aOsteosarcoma$5IEN$0(DLC)sh 85095987

=LDR  01935cz  a2200469n  4500
=001  9880363578502441
=005  20141212204139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010024
=035  \\$aCBA3304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x579
=150  \\$aOsteoporosis
=450  \\$wnnna$aAge-Related Bone Loss
=450  \\$wnnna$aAge-Related Bone Losses
=450  \\$wnnna$aAge-Related Osteoporoses
=450  \\$aAge-Related Osteoporosis
=450  \\$wnnna$aAge Related Osteoporosis
=450  \\$aBone Loss, Age-Related
=450  \\$wnnna$aBone Loss, Age Related
=450  \\$wnnna$aBone Losses, Age-Related
=450  \\$wnnna$aOsteoporoses
=450  \\$wnnna$aOsteoporoses, Age-Related
=450  \\$wnnna$aOsteoporoses, Senile
=450  \\$aOsteoporosis, Age-Related
=450  \\$wnnna$aOsteoporosis, Age Related
=450  \\$wnnna$aOsteoporosis, Involutional
=450  \\$aOsteoporosis, Post-Traumatic
=450  \\$wnnna$aOsteoporosis, Post Traumatic
=450  \\$aOsteoporosis, Senile
=450  \\$wnnna$aPost-Traumatic Osteoporoses
=450  \\$wnnna$aPost-Traumatic Osteoporosis
=450  \\$wnnna$aSenile Osteoporoses
=450  \\$aSenile Osteoporosis
=550  \\$wg$aBone Diseases, Metabolic
=550  \\$wh$aFemale Athlete Triad Syndrome
=550  \\$wh$aOsteoporosis, Postmenopausal
=550  \\$aBone Demineralization, Pathologic
=550  \\$aBone Density Conservation Agents
=667  \\$arelated to aging: note X refs; age-related osteoporosis in men goes here; age-related osteoporosis in women is probably OSTEOPOROSIS, POSTMENOPAUSAL
=680  \\$iReduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
=750  \0$aOsteoporosis$5IEN$0(DLC)sh 85095984

=LDR  01827cz  a2200445n  4500
=001  9880363578602441
=005  20141212192411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010022
=035  \\$aCBA3302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x702.$x678
=150  \\$aOsteopetrosis
=450  \\$wnnna$aAlbers-Schönberg Disease
=450  \\$wnnna$aAlbers Schönberg Disease
=450  \\$aAlbers-Schoenberg Disease
=450  \\$wnnna$aAlbers Schoenberg Disease
=450  \\$wnnna$aAlbers-Schonberg Disease
=450  \\$wnnna$aAlbers Schonberg Disease
=450  \\$wnnna$aAlbers-Schonberg Disease, Autosomal Dominant
=450  \\$wnnna$aAlbers Schonberg Disease, Autosomal Dominant
=450  \\$wnnna$aAutosomal Dominant Osteopetrosis Type 2
=450  \\$wnnna$aCongenital Osteopetrosis
=450  \\$wnnna$aDisease, Albers-Schönberg
=450  \\$wnnna$aDisease, Albers-Schoenberg
=450  \\$wnnna$aDisease, Albers-Schonberg
=450  \\$wnnna$aDisease, Marble Bone
=450  \\$aMarble Bone Disease
=450  \\$wnnna$aMarble Bones, Autosomal Dominant
=450  \\$wnnna$aOsteopetroses
=450  \\$wnnna$aOsteopetrosis, Autosomal Dominant 2
=450  \\$wnnna$aOsteopetrosis Autosomal Dominant Type 2
=450  \\$wnnna$aOsteopetrosis, Autosomal Dominant, Type II
=450  \\$aOsteosclerosis Fragilis
=450  \\$wnnna$aOsteosclerosis Fragilis Generalisata
=450  \\$wnnna$aOsteosclerosis Fragilis Generalisatas
=550  \\$wg$aOsteosclerosis
=667  \\$ado not confuse with OSTEOPOROSIS
=680  \\$iExcessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).
=750  \0$aOsteopetrosis$5IEN$0(DLC)sh 85095983

=LDR  01198cz  a2200253n  4500
=001  9880363578702441
=005  20141212204138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010021
=035  \\$aCBA3301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x640
=150  \\$aOsteopathic Medicine
=450  \\$wnnna$aManipulative Medicine, Osteopathic
=450  \\$wnnna$aMedicine, Osteopathic
=450  \\$wnnna$aMedicine, Osteopathic Manipulative
=450  \\$wnnna$aOsteopathic Manipulative Medicine
=450  \\$aOsteopaths$5IEN
=550  \\$wg$aMedicine
=550  \\$aOsteopathic Physicians
=667  \\$ause for the medical discipline only; use OSTEOPATHIC MANIPULATION for therapy
=680  \\$iA medical discipline that is based on the philosophy that all body systems are interrelated and dependent upon one another for good health. This philosophy, developed in 1874 by Dr. Andrew Taylor Still, recognizes the concept of "wellness" and the importance of treating illness within the context of the whole body. Special attention is placed on the MUSCULOSKELETAL SYSTEM.
=688  \\$a87; was OSTEOPATHY 1963-86
=750  \0$aOsteopathic medicine$0(DLC) sh 85095977$5IEN-M

=LDR  01250cz  a2200361n  4500
=001  9880363578802441
=005  20141212204138.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010020
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x852
=072  \\$aC23.$x550.$x717.$x732
=150  \\$aOsteonecrosis
=450  \\$aAseptic Necrosis of Bone
=450  \\$aAvascular Necrosis of Bone
=450  \\$wnnna$aBone Aseptic Necrosis
=450  \\$wnnna$aBone Avascular Necrosis
=450  \\$aKienbock Disease
=450  \\$wnnna$aKienbock's Disease
=450  \\$wnnna$aKienboeck Disease
=450  \\$wnnna$aKienboeck's Disease
=450  \\$wnnna$aKienboecks Disease
=450  \\$aNecrosis, Aseptic, of Bone
=450  \\$aNecrosis, Avascular, of Bone
=450  \\$wnnna$aOsteonecroses
=550  \\$wg$aBone Diseases
=550  \\$wg$aNecrosis
=550  \\$wh$aBisphosphonate-Associated Osteonecrosis of the Jaw
=550  \\$wh$aFemur Head Necrosis
=667  \\$aOSTEORADIONECROSIS & FEMUR HEAD NECROSIS are available
=680  \\$iDeath of a bone or part of a bone, either atraumatic or posttraumatic.
=688  \\$a1977; for KIENBOCK DISEASE, use OSTEOCHONDRITIS 1963-2002
=750  \0$aBones$xNecrosis$5IEN$0(DLC)sh 85015549

=LDR  00536cz  a2200193n  4500
=001  9880363578902441
=005  20141212204137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010019
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x160.$x495
=072  \\$aC5.$x116.$x165.$x495
=150  \\$aOsteomyelitis
=450  \\$wnnna$aOsteomyelitides
=550  \\$wg$aBone Diseases, Infectious
=550  \\$wh$aMastoiditis
=550  \\$wh$aPetrositis
=550  \\$wh$aPott Puffy Tumor
=750  \0$aOsteomyelitis$5IEN$0(DLC)sh 85095971

=LDR  00811cz  a2200205n  4500
=001  9880363579002441
=005  20141212204137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010018
=035  \\$aCBA3298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x816.$x640
=072  \\$aC18.$x452.$x174.$x845.$x640
=072  \\$aC18.$x654.$x521.$x500.$x133.$x770.$x734.$x640
=150  \\$aOsteomalacia
=450  \\$wnnna$aAdult Rickets
=450  \\$wnnna$aRickets, Adult
=550  \\$wg$aRickets
=680  \\$iDisorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
=750  \0$aOsteomalacia$5IEN$0(DLC)sh 85095970

=LDR  01504cz  a2200385n  4500
=001  9880363579102441
=005  20141212204136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010013
=035  \\$aCBA3293HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x685
=072  \\$aC16.$x320.$x737
=072  \\$aC17.$x300.$x200.$x540
=150  \\$aOsteogenesis Imperfecta
=450  \\$wnnna$aBrittle Bone Disease
=450  \\$wnnna$aDisease, Lobstein
=450  \\$wnnna$aDisease, Lobstein's
=450  \\$aFragilitas Ossium
=450  \\$aLobstein Disease
=450  \\$wnnna$aLobstein's Disease
=450  \\$wnnna$aLobsteins Disease
=450  \\$wnnna$aOssiums, Fragilitas
=450  \\$wnnna$aOsteogenesis Imperfecta Tarda
=450  \\$wnnna$aOsteogenesis Imperfecta Tardas
=450  \\$wnnna$aOsteogenesis Imperfecta, Type 1
=450  \\$wnnna$aOsteogenesis Imperfecta, Type I
=450  \\$wnnna$aOsteogenesis Imperfecta with Blue Sclerae
=550  \\$wg$aCollagen Diseases
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aOsteochondrodysplasias
=550  \\$aCollagen Type I
=550  \\$aDentinogenesis Imperfecta
=680  \\$iCOLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.
=750  \0$aOsteogenesis imperfecta$5IEN$0(DLC)sh 85095985

=LDR  00649cz  a2200181n  4500
=001  9880363579202441
=005  20141212204135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010011
=035  \\$aCBA3291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x629.$x500
=150  \\$aOsteocytes
=450  \\$wnnna$aOsteocyte
=550  \\$wg$aOsteoblasts
=680  \\$iMature osteoblasts that have become embedded in the BONE MATRIX. They occupy a small cavity, called lacuna, in the matrix and are connected to adjacent osteocytes via protoplasmic projections called canaliculi.
=688  \\$a65
=750  \0$aOsteocytes$5IEN$0(DLC)sh 91003881

=LDR  00898cz  a2200265n  4500
=001  9880363579302441
=005  20141212204135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010010
=035  \\$aCBA3290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x372.$x700
=072  \\$aA11.$x627.$x482.$x700
=150  \\$aOsteoclasts
=450  \\$wnnna$aCementoclast
=450  \\$wnnna$aCementoclasts
=450  \\$wnnna$aOdontoclast
=450  \\$aOdontoclasts
=450  \\$wnnna$aOsteoclast
=550  \\$wg$aMacrophages
=550  \\$aBone Resorption
=550  \\$aOsteoblasts
=680  \\$iA large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.
=688  \\$aODONTOCLASTS was heading 1965-77
=750  \0$aOsteoclasts$0(DLC) sh 90003255$5IEN

=LDR  00672cz  a2200229n  4500
=001  9880363579402441
=005  20141212204132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010007
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x791
=072  \\$aC5.$x182.$x520
=072  \\$aC17.$x300.$x182.$x520
=150  \\$aOsteochondritis
=450  \\$wnnna$aOsteochondritides
=550  \\$wg$aBone Diseases
=550  \\$wg$aCartilage Diseases
=550  \\$wh$aOsteochondritis Dissecans
=550  \\$aCartilage Diseases
=550  \\$aOsteitis
=680  \\$iInflammation of a bone and its overlaying CARTILAGE.
=750  \0$aOsteochondrosis$0(DLC) sh 85095963$5IEN

=LDR  00643cz  a2200205n  4500
=001  9880363579502441
=005  20141212204132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010006
=035  \\$aCBA3286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x629
=150  \\$aOsteoblasts
=450  \\$wnnna$aOsteoblast
=550  \\$wg$aConnective Tissue Cells
=550  \\$wh$aOsteocytes
=550  \\$aOsteoclasts
=680  \\$iBone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
=688  \\$a65(64)
=750  \0$aOsteoblasts$5IEN-M$0(DLC)sh2012001687

=LDR  01280cz  a2200325n  4500
=001  9880363579602441
=005  20141212204131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010003
=035  \\$aCBA3282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x606
=072  \\$aC5.$x799.$x613
=150  \\$aOsteoarthritis
=450  \\$wnnna$aArthritides, Degenerative
=450  \\$aArthritis, Degenerative
=450  \\$wnnna$aDegenerative Arthritides
=450  \\$wnnna$aDegenerative Arthritis
=450  \\$wnnna$aOsteoarthritides
=450  \\$wnnna$aOsteoarthroses
=450  \\$aOsteoarthrosis
=450  \\$aOsteoarthrosis Deformans
=550  \\$wg$aArthritis
=550  \\$wg$aRheumatic Diseases
=550  \\$wh$aOsteoarthritis, Hip
=550  \\$wh$aOsteoarthritis, Knee
=550  \\$wh$aOsteoarthritis, Spine
=667  \\$amost common form of arthritis
=680  \\$iA progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
=750  \0$aOsteoarthritis$5IEN$0(DLC)sh 85095960

=LDR  00933cz  a2200217n  4500
=001  9880363579702441
=005  20141212204130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010001
=035  \\$aCBA3280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x692
=150  \\$aOsteitis Deformans
=450  \\$wnnna$aOsseous Paget's Disease
=450  \\$wnnna$aPaget Disease, Bone
=450  \\$wnnna$aPaget Disease of Bone
=450  \\$wnnna$aPagets Disease, Bone
=450  \\$aPaget's Disease of Bone
=550  \\$wg$aBone Diseases
=680  \\$iA disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.
=750  \0$aOsteitis deformans$0(DLC) sh 85095957$5IEN

=LDR  00611cz  a2200217n  4500
=001  9880363579802441
=005  20141212204130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010000
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x160.$x412
=072  \\$aC5.$x116.$x165.$x412
=072  \\$aC5.$x116.$x680
=150  \\$aOsteitis
=450  \\$aBone Inflammation
=450  \\$wnnna$aInflammation, Bone
=550  \\$wg$aBone Diseases
=550  \\$wg$aBone Diseases, Infectious
=550  \\$aOsteochondritis
=667  \\$acoord IM with specific bone (IM)
=750  \0$aOsteitis$5IEN$0(DLC)sh 85095956

=LDR  00961cz  a2200265n  4500
=001  9880363579902441
=005  20150529155806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009999
=035  \\$aCBA3278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x751
=150  \\$aOssification, Heterotopic
=450  \\$wnnna$aEctopic Ossification
=450  \\$wnnna$aHeterotopic Ossification
=450  \\$wnnna$aOssification, Ectopic
=450  \\$aOssification, Pathologic
=450  \\$wnnna$aOssification, Pathological
=450  \\$wnnna$aPathologic Ossification
=450  \\$wnnna$aPathological Ossification
=550  \\$wg$aPathologic Processes
=550  \\$wh$aOssification of Posterior Longitudinal Ligament
=680  \\$iThe development of bony substance in normally soft structures.
=688  \\$a92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64
=750  \0$aHeterotopic ossification$0(DLC)sh2014001798$5IEN-M

=LDR  00903cz  a2200265n  4500
=001  9880363580002441
=005  20170608154240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009995
=035  \\$aCBA3274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x154.$x90.$x750
=072  \\$aG2.$x111.$x655
=072  \\$aG2.$x691
=072  \\$aG2.$x723.$x495
=150  \\$aOsmosis
=450  \\$wnnna$aOsmoses
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aBiomechanical Phenomena
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPermeability
=550  \\$wh$aElectroosmosis
=667  \\$acoordinate with substance / pharmacokin or tissue / metab; OSMOTIC SHOCK see OSMOTIC PRESSURE is also available
=680  \\$iTendency of fluids (e.g., water) to move from the less concentrated to the more concentrated side of a semipermeable membrane.
=750  \0$aOsmosis$0sh 85095934$5IEN

=LDR  00914cz  a2200241n  4500
=001  9880363580102441
=005  20141212204127.0
=008  780320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009993
=035  \\$aCBA3272M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x640.$x500
=072  \\$aD1.$x650.$x550.$x600
=150  \\$aOsmium Tetroxide
=450  \\$wnnna$aAcid, Osmic
=450  \\$aOsmic Acid
=450  \\$wnnna$aTetroxide, Osmium
=550  \\$wg$aOsmium Compounds
=550  \\$wg$aOxides
=667  \\$aindust & histol uses
=680  \\$i(T-4)-Osmium oxide (OsO4). A highly toxic and volatile oxide of osmium used in industry as an oxidizing agent. It is also used as a histological fixative and stain and as a synovectomy agent in arthritic joints. Its vapor can cause eye, skin, and lung damage.
=688  \\$a91(79); was see under OSMIUM 1979-90
=750  \0$aOsmium tetroxide$0(DLC)sh2007005729$5IEN-M

=LDR  00777cz  a2200205n  4500
=001  9880363580202441
=005  20141212204126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009992
=035  \\$aCBA3271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x660
=072  \\$aD1.$x268.$x956.$x702
=072  \\$aD1.$x552.$x544.$x660
=150  \\$aOsmium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aOs-192; Os-184, 186-190, = OSMIUM (IM) + ISOTOPES (NIM); Os-181-183, 185, 191, 193-195 = OSMIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iOsmium. A very hard, gray, toxic, and nearly infusible metal element, atomic number 76, atomic weight 190.2, symbol Os. (From Dorland, 28th ed)
=750  \0$aOsmium$5IEN-M$0(DLC)sh 85095926

=LDR  02020cz  a2200505n  4500
=001  9880363398902441
=005  20141212201501.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005445
=035  \\$aCAZ8591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x320
=150  \\$aFlunitrazepam
=450  \\$wnnna$a1A Brand of Flunitrazepam
=450  \\$wnnna$abetapharm Brand of Flunitrazepam
=450  \\$wnnna$act-Arzneimittel Brand of Flunitrazepam
=450  \\$wnnna$act Arzneimittel Brand of Flunitrazepam
=450  \\$wnnna$aFluni 1A Pharma
=450  \\$wnnna$aFlunibeta
=450  \\$wnnna$aFlunimerck
=450  \\$wnnna$aFluninoc
=450  \\$wnnna$aFlunitrazepam-neuraxpharm
=450  \\$wnnna$aFlunitrazepam neuraxpharm
=450  \\$wnnna$aFlunitrazepam-ratiopharm
=450  \\$wnnna$aFlunitrazepam ratiopharm
=450  \\$wnnna$aFlunitrazepam-Teva
=450  \\$wnnna$aFlunitrazepam Teva
=450  \\$wnnna$aflunizep von ct
=450  \\$aFluridrazepam
=450  \\$wnnna$aHexal Brand of Flunitrazepam
=450  \\$wnnna$aMerck dura Brand of Flunitrazepam
=450  \\$wnnna$aNarcozep
=450  \\$wnnna$aneuraxpharm Brand of Flunitrazepam
=450  \\$wnnna$aratiopharm Brand of Flunitrazepam
=450  \\$wnnna$aRO-5-4200
=450  \\$wnnna$aRO54200
=450  \\$wnnna$aRoche Brand of Flunitrazepam
=450  \\$wnnna$aRohipnol
=450  \\$aRohypnol
=450  \\$wnnna$aTeva Brand of Flunitrazepam
=550  \\$wg$aBenzodiazepinones
=667  \\$acolloquially called "rophies" & "roofies" from X ref ROHYPNOL
=680  \\$iA benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.
=688  \\$a84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83
=750  \0$aFlunitrazepam$5IEN$0(DLC)sh 85049403

=LDR  01009cz  a2200289n  4500
=001  9880363399002441
=005  20141212201500.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005442
=035  \\$aCAZ8588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x305
=150  \\$aFlumazenil
=450  \\$wnnna$aAnexate
=450  \\$aFlumazepil
=450  \\$wnnna$aHoffman-La Roche Brand of Flumazenil
=450  \\$wnnna$aHoffman La Roche Brand of Flumazenil
=450  \\$wnnna$aLanexat
=450  \\$wnnna$aRo 15-1788
=450  \\$wnnna$aRo 15 1788
=450  \\$wnnna$aRo 151788
=450  \\$wnnna$aRoche Brand of Flumazenil
=450  \\$wnnna$aRomazicon
=550  \\$wg$aBenzodiazepinones
=680  \\$iA potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
=688  \\$a91; was FLUMAZEPIL 1987-90
=750  \0$aFlumazenil$5IEN-M$0(DLC)sh 93006128

=LDR  01822cz  a2200433n  4500
=001  9880363399102441
=005  20141212201459.0
=008  771128\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005440
=035  \\$aCAZ8586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x360
=150  \\$aFluid Therapy
=450  \\$wnnna$aFluid Therapies
=450  \\$wnnna$aOral Rehydration
=450  \\$wnnna$aOral Rehydration Therapies
=450  \\$aOral Rehydration Therapy
=450  \\$wnnna$aOral Rehydrations
=450  \\$aRehydration
=450  \\$aRehydration, Oral
=450  \\$wnnna$aRehydration Therapies, Oral
=450  \\$wnnna$aRehydration Therapy, Oral
=450  \\$wnnna$aRehydrations
=450  \\$wnnna$aRehydrations, Oral
=450  \\$wnnna$aTherapies, Fluid
=450  \\$wnnna$aTherapies, Oral Rehydration
=450  \\$wnnna$aTherapy, Fluid
=450  \\$wnnna$aTherapy, Oral Rehydration
=550  \\$wg$aDrug Therapy
=550  \\$wh$aHypodermoclysis
=550  \\$aDehydration
=550  \\$aElectrolytes
=550  \\$aInfusions, Parenteral
=550  \\$aWater-Electrolyte Balance
=550  \\$aWater-Electrolyte Imbalance
=667  \\$a"to restore volume & composition of body fluids...with respect to water-electrolyte balance"; for other nourishment use PARENTERAL FEEDING or specifics; do not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther; do not specify route of admin unless particularly significant (& then only NIM)
=680  \\$iTherapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS.
=688  \\$a79
=750  \0$aFluid therapy$5IEN$0(DLC)sh 85049386

=LDR  02552cz  a2200505n  4500
=001  9880363399202441
=005  20141212201457.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005434
=035  \\$aCAZ8580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x363.$x342
=072  \\$aE1.$x370.$x225.$x500.$x386.$x350
=072  \\$aE5.$x196.$x712.$x516.$x600.$x240.$x350
=072  \\$aE5.$x200.$x500.$x363.$x342
=072  \\$aE5.$x200.$x500.$x386.$x350
=072  \\$aE5.$x242.$x363.$x342
=072  \\$aE5.$x242.$x386.$x350
=150  \\$aFlow Cytometry
=450  \\$wnnna$aCell Sorting, Fluorescence-Activated
=450  \\$wnnna$aCell Sortings, Fluorescence-Activated
=450  \\$wnnna$aCytofluorometries, Flow
=450  \\$aCytofluorometry, Flow
=450  \\$wnnna$aCytometries, Flow
=450  \\$aCytometry, Flow
=450  \\$wnnna$aFlow Cytofluorometries
=450  \\$wnnna$aFlow Cytofluorometry
=450  \\$wnnna$aFlow Cytometries
=450  \\$aFlow Microfluorimetry
=450  \\$wnnna$aFlow Microfluorometries
=450  \\$wnnna$aFlow Microfluorometry
=450  \\$aFluorescence-Activated Cell Sorting
=450  \\$wnnna$aFluorescence Activated Cell Sorting
=450  \\$wnnna$aFluorescence-Activated Cell Sortings
=450  \\$wnnna$aMicrofluorimetry, Flow
=450  \\$wnnna$aMicrofluorometries, Flow
=450  \\$aMicrofluorometry, Flow
=450  \\$wnnna$aSorting, Fluorescence-Activated Cell
=450  \\$wnnna$aSortings, Fluorescence-Activated Cell
=550  \\$wg$aCell Separation
=550  \\$wg$aCytophotometry
=667  \\$aflow cell sorting & FLUORESCENCE-ACTIVATED CELL SORTING: coord with CELL SEPARATION
=680  \\$iTechnique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
=688  \\$a82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90
=750  \0$aFlow cytometry$5IEN$0(DLC)sh 85049287

=LDR  00647cz   2200217n  4500
=001  9880363399302441
=005  20220926145527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005433
=035  \\$aCAZ8579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x484
=150  \\$aFlour
=450  \\$wnnna$aFlour, Semolina
=450  \\$wnnna$aFlours
=450  \\$wnnna$aSemolina Flour
=550  \\$wg$aFood
=667  \\$arestrict to wheat or other grains; FISH FLOUR is available
=680  \\$iGround up seed of WHEAT.
=750  \0$aFlour$5IEN$0(DLC)sh 85049267
=750  \0$iNarrower mapping$aComposite flour$0(DLC)sh2021007044$4NM$5IEN-M

=LDR  00697cz  a2200229n  4500
=001  9880363399502441
=005  20141212201455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005427
=035  \\$aCAZ8573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x150.$x347
=072  \\$aG2.$x149.$x767.$x502.$x347
=072  \\$aG2.$x842.$x750.$x502.$x347
=150  \\$aFlocculation
=450  \\$wnnna$aFlocculations
=550  \\$wg$aChemical Precipitation
=550  \\$wh$aFlocculation Tests
=667  \\$aNIM
=680  \\$iThe aggregation of suspended solids into larger clumps.
=688  \\$a91(72); was see under PRECIPITATION 1972-90
=750  \0$aFlocculation$5IEN$0(DLC)sh 85049146

=LDR  00778cz  a2200241n  4500
=001  9880363399602441
=005  20141212201455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005426
=035  \\$aCAZ8572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x568.$x304
=072  \\$aG11.$x427.$x590.$x530.$x698.$x416
=150  \\$aFlight, Animal
=450  \\$wnnna$aAnimal Flight
=450  \\$wnnna$aAnimal Flights
=450  \\$wnnna$aFlights, Animal
=550  \\$wg$aLocomotion
=550  \\$wg$aMotor Activity
=667  \\$ado not confuse with FLIGHT REACTION see ESCAPE REACTION
=680  \\$iThe use of wings or wing-like appendages to remain aloft and move through the air.
=688  \\$a74(72)
=750  \0$aAnimal flight$5IEN$0(DLC)sh 85005182

=LDR  00842cz  a2200253n  4500
=001  9880363399702441
=005  20141212201455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005425
=035  \\$aCAZ8571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x245
=072  \\$aF2.$x463.$x593.$x932.$x458
=072  \\$aG14.$x370
=150  \\$aFlicker Fusion
=450  \\$wnnna$aFlicker Fusions
=450  \\$wnnna$aFusion, Flicker
=450  \\$wnnna$aFusions, Flicker
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aVisual Perception
=667  \\$aalso called flicker fusion frequency (FFF)
=680  \\$iThe point or frequency at which all flicker of an intermittent light stimulus disappears.
=750  \0$aFlicker fusion$5IEN$0(DLC)sh 85049103

=LDR  01009cz  a2200301n  4500
=001  9880363399802441
=005  20200515133336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005423
=035  \\$aCAZ8569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x968
=150  \\$aSiphonaptera
=450  \\$aAphaniptera
=450  \\$wnnna$aAphanipteras
=450  \\$wnnna$aFlea
=450  \\$aFleas
=450  \\$wnnna$aSiphonapteras
=550  \\$wg$aHolometabola
=550  \\$wh$aCtenocephalides
=550  \\$wh$aTunga
=550  \\$wh$aXenopsylla
=667  \\$ainfestation = FLEA INFESTATIONS; for killing Siphonaptera with insecticides, see note at INSECTICIDES
=680  \\$iAn order of parasitic, blood-sucking, wingless INSECTS with the common name of fleas.
=688  \\$a2011, 1975-1979; (1963)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Fleas
=688  \\$aSIPHONAPTERA was heading 1975-79
=750  \0$aFleas$0(DLC) sh 85049052$5IEN

=LDR  00852cz  a2200253n  4500
=001  9880363399902441
=005  20141212201453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005421
=035  \\$aCAZ8567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x364
=072  \\$aJ2.$x500.$x512.$x400
=150  \\$aFlavoring Agents
=450  \\$wnnna$aAgent, Flavoring
=450  \\$wnnna$aAgents, Flavoring
=450  \\$wnnna$aFlavoring Agent
=550  \\$wg$aFood Additives
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aSweetening Agents
=667  \\$aIM; coord with specific substance if pertinent (IM)
=680  \\$iSubstances added to foods and medicine to improve the quality of taste.
=688  \\$aVANILLIN was see FLAVORING AGENTS 1983, was heading 1963-82
=750  \0$aFlavoring essences$5IEN$0(DLC)sh 85049035

=LDR  01347cz  a2200421n  4500
=001  9880363400002441
=005  20141212201453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005420
=035  \\$aCAZ8566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x331
=150  \\$aFlavoproteins
=450  \\$wnnna$aFlavoprotein
=550  \\$wg$aProteins
=550  \\$wh$aAcetolactate Synthase
=550  \\$wh$aAcyl-CoA Dehydrogenase
=550  \\$wh$aAcyl-CoA Dehydrogenase, Long-Chain
=550  \\$wh$aAcyl-CoA Oxidase
=550  \\$wh$aApoptosis Inducing Factor
=550  \\$wh$aButyryl-CoA Dehydrogenase
=550  \\$wh$aCryptochromes
=550  \\$wh$aCytochrome-B(5) Reductase
=550  \\$wh$aDihydrolipoamide Dehydrogenase
=550  \\$wh$aElectron-Transferring Flavoproteins
=550  \\$wh$aFlavodoxin
=550  \\$wh$aGlutamate Synthase (NADH)
=550  \\$wh$aMethylenetetrahydrofolate Reductase (NADPH2)
=550  \\$wh$aNADH Dehydrogenase
=550  \\$wh$aNADPH Oxidase
=550  \\$wh$aNitrate Reductase (NAD(P)H)
=550  \\$wh$aNitrate Reductase (NADH)
=550  \\$wh$aNitrate Reductase (NADPH)
=550  \\$wh$aRetinal Dehydrogenase
=550  \\$wh$aSarcosine Oxidase
=550  \\$wh$aThioredoxin-Disulfide Reductase
=688  \\$a73(71)
=750  \0$aFlavoproteins$5IEN$0(DLC)sh 85049033

=LDR  01104cz  a2200373n  4500
=001  9880363400102441
=005  20141212201452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005419
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450
=072  \\$aD3.$x830.$x219.$x266.$x450
=150  \\$aFlavonoids
=450  \\$wnnna$a2-Phenyl-Benzopyrans
=450  \\$wnnna$a2 Phenyl Benzopyrans
=450  \\$wnnna$a2-Phenyl-Chromenes
=450  \\$wnnna$a2 Phenyl Chromenes
=450  \\$aBioflavonoids
=550  \\$wg$aChromones
=550  \\$wh$aAnthocyanins
=550  \\$wh$aBenzoflavones
=550  \\$wh$aBiflavonoids
=550  \\$wh$aCatechin
=550  \\$wh$aChalcones
=550  \\$wh$aFlavanones
=550  \\$wh$aFlavones
=550  \\$wh$aFlavonolignans
=550  \\$wh$aFlavonols
=550  \\$wh$aIsoflavones
=550  \\$wh$aProanthocyanidins
=667  \\$ado not confuse with FLAVINS, pigments
=680  \\$iA group of phenyl benzopyrans named for having structures like FLAVONES.
=688  \\$a2004(1963)
=750  \0$aFlavonoids$5IEN-M$0(DLC)sh 85049031

=LDR  01152cz  a2200301n  4500
=001  9880363400202441
=005  20190225161523.0
=008  800514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005416
=035  \\$aCAZ8562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250.$x350
=150  \\$aFlavivirus
=450  \\$wnnna$aArbovirus, Group B
=450  \\$wnnna$aArboviruses, Group B
=450  \\$wnnna$aFlaviviruses
=450  \\$wnnna$aGroup B Arbovirus
=450  \\$wnnna$aGroup B Arboviruses
=550  \\$wg$aFlaviviridae
=550  \\$wh$aDengue Virus
=550  \\$wh$aEncephalitis Viruses, Japanese
=550  \\$wh$aEncephalitis Viruses, Tick-Borne
=550  \\$wh$aYellow fever virus
=550  \\$wh$aZika Virus
=667  \\$ainfection = FLAVIVIRUS INFECTIONS
=680  \\$iA genus of FLAVIVIRIDAE containing several subgroups and many species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS.
=688  \\$a94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93
=750  \0$aFlaviviruses$5IEN$0(DLC)sh 86002175

=LDR  00861cz  a2200253n  4500
=001  9880363400302441
=005  20141212201451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005415
=035  \\$aCAZ8561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x315
=072  \\$aD3.$x494.$x507
=072  \\$aD8.$x211.$x474
=072  \\$aD23.$x767.$x405
=150  \\$aFlavins
=550  \\$wg$aCoenzymes
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wg$aPigments, Biological
=550  \\$wg$aPteridines
=550  \\$wh$aRiboflavin
=667  \\$ado not confuse with FLAVONES
=680  \\$iDerivatives of the dimethylisoalloxazine (7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione) skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.
=750  \0$aFlavins$5IEN$0(DLC)sh 85049030

=LDR  00636cz  a2200181n  4500
=001  9880363400402441
=005  20141212201451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005414
=035  \\$aCAZ8560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x360
=150  \\$aFlatulence
=450  \\$aFlatus
=550  \\$wg$aSigns and Symptoms, Digestive
=667  \\$a/drug ther: consider also ANTIFOAMING AGENTS; see note on "intestinal gases" under GASES
=680  \\$iProduction or presence of gas in the gastrointestinal tract which may be expelled through the anus.
=750  \0$aFlatulence$5IEN-HS$0(DLC)sh 85049026

=LDR  01473cz  a2200457n  4500
=001  9880363400502441
=005  20180319091219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005413
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x488.$x655.$x250
=072  \\$aC5.$x330.$x495.$x681.$x250
=072  \\$aC5.$x660.$x585.$x512.$x380.$x813.$x250
=072  \\$aC16.$x131.$x621.$x585.$x512.$x500.$x681.$x250
=150  \\$aFlatfoot
=450  \\$wnnna$aAcquired Adult Flatfoot Deformity
=450  \\$wnnna$aCalcaneovalgus, Talipes
=450  \\$wnnna$aConvex Foot
=450  \\$wnnna$aConvex Pes Valgus
=450  \\$wnnna$aFeet, Flat
=450  \\$wnnna$aFlat Feet
=450  \\$wnnna$aFlat Foot
=450  \\$wnnna$aFlatfoot, Flexible
=450  \\$wnnna$aFlatfoot, Rigid
=450  \\$wnnna$aFlatfeet
=450  \\$wnnna$aFlexible Flatfoot
=450  \\$wnnna$aFoot, Convex
=450  \\$wnnna$aFoot, Flat
=450  \\$aPes Planus
=450  \\$aPes Valgus, Convex
=450  \\$wnnna$aRigid Flatfoot
=450  \\$wnnna$aTalipes Calcaneovalgus
=450  \\$wnnna$aTalipes Valgus
=450  \\$wnnna$aTalus, Vertical
=450  \\$wnnna$aValgus, Talipes
=450  \\$wnnna$aVertical Talus
=550  \\$wg$aTalipes
=550  \\$aPosterior Tibial Tendon Dysfunction
=667  \\$acongenital or acquired
=680  \\$iA condition in which one or more of the arches of the foot have flattened out.
=750  \0$aFlatfoot$5IEN$0(DLC)sh 85049021

=LDR  01009cz  a2200265n  4500
=001  9880363400602441
=005  20141212201450.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005412
=035  \\$aCAZ8558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x418
=150  \\$aFlatfishes
=450  \\$aPleuronectiformes
=450  \\$wnnna$aPsetta maxima
=450  \\$aScophthalmus maximus
=450  \\$wnnna$aSolea
=450  \\$aTurbot
=450  \\$wnnna$aTurbots
=550  \\$wg$aFishes
=550  \\$wh$aFlounder
=667  \\$asole may be SOLEA see FLATFISHES or FLOUNDER (Pleuronectidae); check text
=680  \\$iCommon name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swim on the eyeless side. FLOUNDER, sole, and turbot, along with several others, are included in this order.
=688  \\$a1987
=750  \0$aFlatfishes$5IEN$0(DLC)sh 85049020

=LDR  00791cz  a2200229n  4500
=001  9880363400702441
=005  20141212201450.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005411
=035  \\$aCAZ8557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x361
=150  \\$aFlame Retardants
=450  \\$wnnna$aAgents, Fireproofing
=450  \\$aFire Retardants
=450  \\$aFireproofing Agents
=450  \\$wnnna$aRetardants, Fire
=450  \\$wnnna$aRetardants, Flame
=550  \\$wg$aSpecialty Uses of Chemicals
=680  \\$iMaterials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm.
=688  \\$a78; was in Cat D & J 1978-82
=750  \0$aFireproofing agents$5IEN$0(DLC)sh 85048568

=LDR  01026cz  a2200193n  4500
=001  9880363400802441
=005  20141212201449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005407
=035  \\$aCAZ8553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x180.$x290
=150  \\$aFlagella
=450  \\$wnnna$aFlagellum
=550  \\$wg$aCell Surface Extensions
=550  \\$wh$aSperm Tail
=680  \\$iA whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
=688  \\$a65(64)
=750  \0$aFlagella (Microbiology)$5IEN$0(DLC)sh 85048954

=LDR  00723cz  a2200217n  4500
=001  9880363400902441
=005  20141212201448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005403
=035  \\$aCAZ8549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x640.$x260.$x253
=150  \\$aFixation, Ocular
=450  \\$aFocusing, Ocular
=450  \\$aOcular Fixation
=450  \\$wnnna$aOcular Focusing
=550  \\$wg$aEye Movements
=680  \\$iThe positioning and accommodation of eyes that allows the image to be brought into place on the FOVEA CENTRALIS of each eye.
=688  \\$a68(64)
=750  \0$aEye$xMovements$xRegulation$5IEN-M$0(DLC)sh 85046668
=750  \0$aGaze$xRegulation$5IEN-HS$0(DLC)sh 85053592

=LDR  01129cz  a2200265n  4500
=001  9880363401002441
=005  20141212201447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005402
=035  \\$aCAZ8548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x575
=150  \\$aFistula
=450  \\$wnnna$aFistulas
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aCutaneous Fistula
=550  \\$wh$aDigestive System Fistula
=550  \\$wh$aOral Fistula
=550  \\$wh$aRespiratory Tract Fistula
=550  \\$wh$aUrinary Fistula
=550  \\$wh$aVaginal Fistula
=550  \\$wh$aVascular Fistula
=667  \\$aGEN or unspecified; prefer specifics; coord IM with organ (IM) or precoord organ/dis term (IM); policy: Manual 23.19+; anal fistula or fistula in ano: index RECTAL FISTULA, not FISSURE IN ANO; artificial fistula: Manual 23.19.7; ECK FISTULA see PORTACAVAL SHUNT, SURGICAL is also available
=680  \\$iAbnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
=750  \0$aFistula$5IEN$0(DLC)sh 85048892

=LDR  00563cz  a2200205n  4500
=001  9880363401102441
=005  20141212201447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005400
=035  \\$aCAZ8546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x286.$x500
=072  \\$aB1.$x50.$x150.$x900.$x493.$x392
=150  \\$aFishes, Poisonous
=450  \\$wnnna$aPoisonous Fishes
=550  \\$wg$aAnimals, Poisonous
=550  \\$wg$aFishes
=667  \\$aIM; qualif permitted
=688  \\$a68
=750  \0$aPoisonous fishes$5IEN$0(DLC)sh 85103943

=LDR  01254cz  a2200409n  4500
=001  9880363401202441
=005  20141212201447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005399
=035  \\$aCAZ8545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493
=150  \\$aFishes
=550  \\$wg$aVertebrates
=550  \\$wh$aBatrachoidiformes
=550  \\$wh$aCatfishes
=550  \\$wh$aCharaciformes
=550  \\$wh$aCypriniformes
=550  \\$wh$aEels
=550  \\$wh$aElasmobranchii
=550  \\$wh$aElectric Fish
=550  \\$wh$aEsociformes
=550  \\$wh$aFishes, Poisonous
=550  \\$wh$aFlatfishes
=550  \\$wh$aGadiformes
=550  \\$wh$aHagfishes
=550  \\$wh$aLampreys
=550  \\$wh$aOsmeriformes
=550  \\$wh$aPerciformes
=550  \\$wh$aSalmoniformes
=550  \\$wh$aSmegmamorpha
=550  \\$wh$aTetraodontiformes
=550  \\$aFish Proteins
=667  \\$aGEN or unspecified; prefer specifics; canned fish: see note on FISH PRODUCTS
=680  \\$iA group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.
=688  \\$a1968 (1963)
=750  \0$aFishes$5IEN-M$0(DLC)sh 85048726

=LDR  00661cz  a2200193n  4500
=001  9880363401302441
=005  20180816122206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005398
=035  \\$aCAZ8544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x168.$x300
=150  \\$aFisheries
=450  \\$wnnna$aFishery
=550  \\$wg$aAquaculture
=550  \\$wg$aManufacturing and Industrial Facilities
=667  \\$aspecify geog if pertinent
=680  \\$iPlaces for cultivation and harvesting of fish, particularly in sea waters. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aFisheries$5IEN$0(DLC)sh 85048666

=LDR  00931cz  a2200265n  4500
=001  9880363401402441
=005  20141212201446.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005397
=035  \\$aCAZ8543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x370
=072  \\$aD23.$x946.$x580.$x370
=072  \\$aD23.$x946.$x833.$x370
=150  \\$aFish Venoms
=450  \\$wnnna$aFish Venom
=450  \\$wnnna$aVenom, Fish
=450  \\$wnnna$aVenoms, Fish
=550  \\$wg$aMarine Toxins
=550  \\$wg$aVenoms
=550  \\$aFishes, Poisonous
=667  \\$a/antag permitted but consider also ANTIVENINS
=680  \\$iVenoms produced by FISHES, including SHARKS and sting rays, usually delivered by spines. They contain various substances, including very labile toxins that affect the HEART specifically and all MUSCLES generally.
=688  \\$a78
=750  \0$aPoisonous fishes$xVenom$5IEN-M$0(DLC)sh 85103945

=LDR  00825cz  a2200229n  4500
=001  9880363401502441
=005  20141212201446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005396
=035  \\$aCAZ8542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x600.$x875.$x400
=150  \\$aFish Products
=450  \\$wnnna$aFish Product
=450  \\$wnnna$aProduct, Fish
=450  \\$wnnna$aProducts, Fish
=550  \\$wg$aSeafood
=550  \\$wh$aFish Flour
=667  \\$a"food products manufactured from fish (e.g., FISH FLOUR, fish meal)" but for canned fish coord FISHES (IM) or specific fish (IM) + FOOD PRESERVATION (IM); coord IM with fish source (NIM)
=680  \\$iFood products manufactured from fish (e.g., FISH FLOUR, fish meal).
=688  \\$a68
=750  \0$aFishery products$5IEN$0(DLC)sh 85048704

=LDR  01000cz  a2200253n  4500
=001  9880363401602441
=005  20141212201445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005395
=035  \\$aCAZ8541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627.$x430
=150  \\$aFish Oils
=450  \\$aFish Liver Oils
=450  \\$wnnna$aLiver Oils, Fish
=450  \\$wnnna$aOils, Fish
=450  \\$wnnna$aOils, Fish Liver
=550  \\$wg$aOils
=550  \\$wh$aCod Liver Oil
=550  \\$wh$aFatty Acids, Omega-3
=667  \\$acoord IM with specific fish (NIM)
=680  \\$iOils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the livers. Those from the liver are usually high in vitamin A. The oils are used as dietary supplements, in soaps and detergents, as protective coatings, and as a base for other food products such as vegetable shortenings.
=688  \\$a83; was FISH LIVER OILS 1963-82
=750  \0$aFish oils$5IEN$0(DLC)sh 85048643

=LDR  00705cz  a2200217n  4500
=001  9880363401702441
=005  20141212201445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005394
=035  \\$aCAZ8540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x600.$x875.$x400.$x400
=150  \\$aFish Flour
=450  \\$wnnna$aFish Flours
=450  \\$wnnna$aFlour, Fish
=450  \\$wnnna$aFlours, Fish
=550  \\$wg$aFish Products
=667  \\$anot for "fish meal", which is indexed under FISH PRODUCTS
=680  \\$iA flour made of pulverized, dried fish or fish parts.
=688  \\$a91(75); was see under FISH PRODUCTS 1975-90
=750  \0$aFish protein concentrate$5IEN$0(DLC)sh 85048650

=LDR  00998cz  a2200241n  4500
=001  9880363401802441
=005  20141212201445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005393
=035  \\$aCAZ8539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x362
=150  \\$aFish Diseases
=450  \\$wnnna$aDisease, Fish
=450  \\$wnnna$aDiseases, Fish
=450  \\$wnnna$aFish Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aFurunculosis
=550  \\$wh$aHemorrhagic Septicemia, Viral
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) & specific fish (IM); for abnormalities or injuries, index under FISHES /abnorm or FISHES /inj; don't forget also FISHES (NIM) & check tag ANIMALS; DF: FISH DIS
=680  \\$iDiseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).
=688  \\$a72(70)
=750  \0$aFishes$xDiseases$5IEN$0(DLC)sh 85048745

=LDR  00599cz  a2200217n  4500
=001  9880363401902441
=005  20141212201445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005392
=035  \\$aCAZ8538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x305
=150  \\$aFirst Aid
=450  \\$wnnna$aAid, First
=450  \\$wnnna$aAids, First
=450  \\$wnnna$aFirst Aids
=550  \\$wg$aEmergency Treatment
=550  \\$aEmergencies
=550  \\$aEmergency Medical Services
=550  \\$aWounds and Injuries
=750  \0$aFirst aid in illness and injury$5IEN$0(DLC)sh 85048581

=LDR  00863cz  a2200265n  4500
=001  9880363402002441
=005  20160428152309.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005391
=035  \\$aCAZ8537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x250.$x300
=150  \\$aFiresetting Behavior
=450  \\$aArson
=450  \\$wnnna$aArsons
=450  \\$wnnna$aBehavior, Firesetting
=450  \\$wnnna$aBehaviors, Firesetting
=450  \\$wnnna$aFiresetting Behaviors
=450  \\$aPyromania
=450  \\$wnnna$aPyromanias
=550  \\$wg$aDisruptive, Impulse Control, and Conduct Disorders
=680  \\$iA compulsion to set fires.
=688  \\$a91(76); was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80
=750  \0$aPyromania$5IEN-M$0(DLC)sh 85109348
=750  \0$aArson$5IEN-HS$0(DLC)sh 85007458

=LDR  00501cz  a2200193n  4500
=001  9880363402102441
=005  20200722121953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005390
=035  \\$aCAZ8536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x216
=150  \\$aFires
=450  \\$wnnna$aFire
=550  \\$wg$aEnvironment
=550  \\$wh$aFire Extinguishing Systems
=550  \\$wh$aSpontaneous Combustion
=550  \\$wh$aWildfires
=750  \0$aFires$5IEN-HS$0(DLC)sh 85048572

=LDR  00725cz  a2200217n  4500
=001  9880363402202441
=005  20141212201444.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005389
=035  \\$aCAZ8535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x870.$x350
=150  \\$aFirearms
=450  \\$aGuns
=450  \\$aRifles
=450  \\$aShotguns
=550  \\$wg$aWeapons
=667  \\$aballistics goes here only if pertinent to nature of firearm; wound ballistics goes under BALLISTICS, WOUND see WOUNDS, GUNSHOT & FORENSIC MEDICINE if pertinent
=680  \\$iSmall-arms weapons, including handguns, pistols, revolvers, rifles, shotguns, etc.
=688  \\$a87
=750  \0$aFirearms$5IEN$0(DLC)sh 85048533

=LDR  00821cz  a2200241n  4500
=001  9880363402302441
=005  20141212201444.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005388
=035  \\$aCAZ8534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x216.$x500
=150  \\$aFire Extinguishing Systems
=450  \\$wnnna$aExtinguishing System, Fire
=450  \\$wnnna$aExtinguishing Systems, Fire
=450  \\$aFire Extinguishers$5IEN
=450  \\$wnnna$aFire Extinguishing System
=450  \\$wnnna$aSystem, Fire Extinguishing
=450  \\$wnnna$aSystems, Fire Extinguishing
=550  \\$wg$aFires
=680  \\$iAutomatic or hand operated equipment used to control and extinguish fires.
=688  \\$a91(Aug 77); was see under FIRES 1977-90
=750  \0$aFire extinguishers$5IEN$0(DLC)sh 85048491

=LDR  00728cz  a2200229n  4500
=001  9880363402402441
=005  20141212201443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005386
=035  \\$aCAZ8532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x466.$x263
=150  \\$aFingersucking
=450  \\$wnnna$aFinger Sucking
=450  \\$wnnna$aSucking, Finger
=450  \\$wnnna$aSucking, Thumb
=450  \\$wnnna$aThumb Sucking
=450  \\$aThumbsucking
=550  \\$wg$aHabits
=680  \\$iSucking of the finger. This is one of the most common manipulations of the body found in young children.
=750  \0$aThumb sucking$5IEN-M$0(DLC)sh 86004502
=750  \0$aFinger sucking$5IEN-HS$0(DLC)sh 85048334

=LDR  00604cz  a2200169n  4500
=001  9880363402502441
=005  20141212201443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005385
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x667.$x430
=150  \\$aFingers
=450  \\$wnnna$aFinger
=550  \\$wg$aHand
=550  \\$wh$aThumb
=667  \\$aprimates only: TN 117; /inj = FINGER INJURIES but consider also THUMB /inj; TN 238: differentiation from FINGER JOINT & indexing instructions; NIM when merely locational as in HAND DERMATOSES (IM)
=750  \0$aFingers$5IEN$0(DLC)sh 85048339

=LDR  01029cz  a2200289n  4500
=001  9880363402602441
=005  20141212201443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005384
=035  \\$aCAZ8530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x405.$x350
=150  \\$aFinger Joint
=450  \\$wnnna$aFinger Interphalangeal Joint
=450  \\$wnnna$aFinger Interphalangeal Joints
=450  \\$wnnna$aFinger Joints
=450  \\$wnnna$aHand Interphalangeal Joint
=450  \\$wnnna$aHand Interphalangeal Joints
=450  \\$wnnna$aInterphalangeal Joint of Finger
=450  \\$aInterphalangeal Joint of Hand
=450  \\$wnnna$aJoint, Finger
=450  \\$wnnna$aJoints, Finger
=550  \\$wg$aHand Joints
=667  \\$aprimates only: TN 117; TN 238: differentiation from FINGERS & indexing instructions
=680  \\$iThe articulation between the head of one phalanx and the base of the one distal to it, in each finger.
=688  \\$a65
=750  \0$aFinger joint$5IEN$0(DLC)sh 85048329

=LDR  00687cz  a2200229n  4500
=001  9880363402702441
=005  20141212201442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005383
=035  \\$aCAZ8529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x448.$x429
=150  \\$aFinger Injuries
=450  \\$wnnna$aFinger Injury
=450  \\$aFinger Joint$xinjuries
=450  \\$aFingers$xinjuries
=450  \\$wnnna$aInjuries, Finger
=450  \\$wnnna$aInjury, Finger
=550  \\$wg$aHand Injuries
=667  \\$aconsider also THUMB /inj
=680  \\$iGeneral or unspecified injuries involving the fingers.
=750  \0$aFingers$xWounds and injuries$5IEN$0(DLC)sh 85048342

=LDR  00481cz  a2200157n  4500
=001  9880363402802441
=005  20141212201256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005054
=035  \\$aCAZ8196M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x200.$x54.$x500
=150  \\$aEugenol
=550  \\$wg$aCaffeic Acids
=680  \\$iA cinnamate derivative of the shikamate pathway found in CLOVE OIL and other PLANTS.
=750  \0$aEugenol$0(DLC)sh2009000810$5IEN-M

=LDR  00934cz  a2200217n  4500
=001  9880363402902441
=005  20141212201256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005053
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x307
=150  \\$aEugenics
=450  \\$wnnna$aEugenics, Negative
=450  \\$wnnna$aEugenics, Positive
=450  \\$wnnna$aNegative Eugenics
=450  \\$wnnna$aPositive Eugenics
=550  \\$wg$aHistory
=550  \\$aGenetic Counseling
=550  \\$aGenetics, Medical
=680  \\$iThe attempt to improve the PHENOTYPES of future generations of the human population by fostering the reproduction of those with favorable phenotypes and GENOTYPES and hampering or preventing BREEDING by those with "undesirable" phenotypes and genotypes. The concept is largely discredited. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aEugenics$5IEN$0(DLC)sh 85045538

=LDR  00730cz  a2200169n  4500
=001  9880363403002441
=005  20141212201256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005052
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x366
=150  \\$aEucalyptus
=550  \\$wg$aMyrtaceae
=667  \\$achiefly Australian
=680  \\$iA genus of Australian trees of the Myrtaceae family that yields gums, oils, and resins which are used as flavoring agents, astringents, and aromatics, and formerly to treat diarrhea, asthma, bronchitis, and respiratory tract infections.
=688  \\$a91(86)63; was see under TREES 1986-90; was heading 1963-86
=750  \0$aEucalyptus$0(DLC) sh 85045486$5IEN

=LDR  01176cz  a2200337n  4500
=001  9880363403102441
=005  20141212201255.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005050
=035  \\$aCAZ8192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x250
=072  \\$aD2.$x455.$x849.$x131.$x495.$x250
=072  \\$aD23.$x767.$x261.$x700.$x250
=150  \\$aEtretinate
=450  \\$wnnna$aB10-9359
=450  \\$wnnna$aB10 9359
=450  \\$wnnna$aB109359
=450  \\$wnnna$aEthyl Etrinoate
=450  \\$wnnna$aEtrinoate, Ethyl
=450  \\$wnnna$aRo 10-9359
=450  \\$wnnna$aRo-10-9359
=450  \\$wnnna$aRo 10 9359
=450  \\$wnnna$aRo 109359
=450  \\$wnnna$aRo109359
=450  \\$wnnna$aTigason
=450  \\$wnnna$aTigazon
=550  \\$wg$aRetinoids
=680  \\$iAn oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.
=688  \\$a84(80); was RO 10-9359 see under TRETINOIN 1980-83
=750  \0$aEtretinate$5IEN$0(DLC)sh 85045462

=LDR  03351cz  a2200841n  4500
=001  9880363403202441
=005  20141212192201.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005047
=035  \\$aCAZ8189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x960.$x675.$x250
=072  \\$aD4.$x615.$x638.$x960.$x675.$x250
=072  \\$aD9.$x408.$x348.$x275
=150  \\$aEtoposide
=450  \\$wnnna$aalpha-D-Glucopyranosyl Isomer Etoposide
=450  \\$wnnna$aBaxter Brand of Etoposide
=450  \\$wnnna$aBaxter Oncology Brand of Etoposide
=450  \\$wnnna$aBristol-Myers Brand of Etoposide
=450  \\$wnnna$aBristol Myers Brand of Etoposide
=450  \\$wnnna$aBristol-Myers Squibb Brand of Etoposide
=450  \\$wnnna$aBristol Myers Squibb Brand of Etoposide
=450  \\$wnnna$aCelltop
=450  \\$aDemethyl Epipodophyllotoxin Ethylidine Glucoside
=450  \\$wnnna$aEposide
=450  \\$wnnna$aEposin
=450  \\$wnnna$aEto-GRY
=450  \\$wnnna$aEto GRY
=450  \\$wnnna$aEtomedac
=450  \\$wnnna$aEtopos
=450  \\$wnnna$aEtoposide, (5a alpha,9 alpha)-Isomer
=450  \\$wnnna$aEtoposide, (5a alpha)-Isomer
=450  \\$wnnna$aEtoposide, (5S)-Isomer
=450  \\$wnnna$aEtoposide, alpha-D-Glucopyranosyl Isomer
=450  \\$wnnna$aEtoposide, alpha D Glucopyranosyl Isomer
=450  \\$wnnna$aEtoposide Pierre Fabre
=450  \\$wnnna$aEtoposide Teva
=450  \\$wnnna$aEtoposido Ferrer Farma
=450  \\$wnnna$aExitop
=450  \\$wnnna$aFerrer Brand of Etoposide
=450  \\$wnnna$aGry Brand of Etoposide
=450  \\$wnnna$aLastet
=450  \\$wnnna$aLemery Brand of Etoposide
=450  \\$wnnna$aMedac Brand of Etoposide
=450  \\$wnnna$aNovartis Brand of Etoposide
=450  \\$wnnna$aNSC-141540
=450  \\$wnnna$aNSC 141540
=450  \\$wnnna$aNSC141540
=450  \\$wnnna$aOnkoposid
=450  \\$wnnna$aOnkoworks Brand of Etoposide
=450  \\$wnnna$aPharmachemie Brand of Etoposide
=450  \\$wnnna$aPierre Fabre Brand of Etoposide
=450  \\$wnnna$aPrasfarma Brand of Etoposide
=450  \\$wnnna$aRiboposid
=450  \\$wnnna$aribosepharm Brand of Etoposide
=450  \\$wnnna$aSanfer Brand of Etoposide
=450  \\$wnnna$aTedec Meiji Brand of Etoposide
=450  \\$wnnna$aTeva Brand of Etoposide
=450  \\$wnnna$aToposar
=450  \\$wnnna$aVépéside-Sandoz
=450  \\$wnnna$aVépéside Sandoz
=450  \\$wnnna$aVepesid
=450  \\$wnnna$aVP-16
=450  \\$wnnna$aVP 16
=450  \\$wnnna$aVP 16-213
=450  \\$wnnna$aVP 16 213
=450  \\$wnnna$aVP 16213
=450  \\$wnnna$aVP16
=550  \\$wg$aGlucosides
=550  \\$wg$aPodophyllotoxin
=680  \\$iA semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.
=688  \\$a87(81); was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80
=750  \0$aEtoposide$5IEN$0(DLC)sh 85045458

=LDR  00807cz  a2200241n  4500
=001  9880363403302441
=005  20141212201255.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005045
=035  \\$aCAZ8187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x265
=150  \\$aEtomidate
=450  \\$wnnna$aEthomidate
=450  \\$wnnna$aHypnomidate
=450  \\$wnnna$aR-26490
=450  \\$wnnna$aR 26490
=450  \\$wnnna$aR26490
=450  \\$wnnna$aRadenarkon
=550  \\$wg$aImidazoles
=680  \\$iImidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
=688  \\$a86(77); was see under IMIDAZOLES 1977-85
=750  \0$aEtomidate$5IEN$0(DLC)sh 85045455

=LDR  00871cz  a2200253n  4500
=001  9880363403402441
=005  20141212201251.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005031
=035  \\$aCAZ8173M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x948.$x898.$x323
=072  \\$aD3.$x383.$x129.$x308.$x432.$x500
=150  \\$aEthylenethiourea
=450  \\$wnnna$a2-Mercaptoimidazoline
=450  \\$wnnna$a2 Mercaptoimidazoline
=450  \\$wnnna$aImidazolidine-2-thione
=450  \\$aImidazolidinethione
=550  \\$wg$aImidazolidines
=550  \\$wg$aThiourea
=680  \\$iA degradation product of ethylenebis(dithiocarbamate) fungicides. It has been found to be carcinogenic and to cause THYROID hyperplasia.
=688  \\$a1991(1977)
=688  \\$a91(77); was see under IMIDAZOLES 1977-90
=750  \0$aEthylenethiourea$0(DLC)sh2011002553$5IEN-M

=LDR  00571cz  a2200181n  4500
=001  9880363403502441
=005  20141212201251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005030
=035  \\$aCAZ8172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x367
=150  \\$aEthylenes
=550  \\$wg$aAlkenes
=550  \\$wh$aDichloroethylenes
=680  \\$iDerivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.
=688  \\$a75; was ETHYLENE 1963-74
=750  \0$aEthylene$5IEN$0(DLC)sh 85045433

=LDR  00607cz  a2200229n  4500
=001  9880363403602441
=005  20141212201251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005029
=035  \\$aCAZ8171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782.$x258.$x368
=150  \\$aEthylenediamines
=550  \\$wg$aDiamines
=550  \\$wh$aAminophylline
=550  \\$wh$aEdetic Acid
=550  \\$wh$aEgtazic Acid
=550  \\$wh$aEthambutol
=550  \\$wh$aMethapyrilene
=550  \\$wh$aTrientine
=550  \\$wh$aTripelennamine
=750  \0$aEthylenediamine$5IEN-M$0(DLC)sh 97004242

=LDR  00707cz  a2200229n  4500
=001  9880363403702441
=005  20141212201251.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005028
=035  \\$aCAZ8170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x869.$x265
=072  \\$aD2.$x886.$x706.$x250
=150  \\$aEthylenebis(dithiocarbamates)
=450  \\$aEBDC$5IEN
=550  \\$wg$aThiocarbamates
=550  \\$wh$aManeb
=550  \\$wh$aZineb
=667  \\$aan antifungal
=680  \\$iA class of thiocarbamate derivatives whose salts possess fungicidal activity.
=688  \\$a91(77); was see under THIOCARBAMATES 1977-90
=750  \0$aEBDC (Fungicide)$5IEN$0(DLC)sh 90005936

=LDR  00896cz  a2200181n  4500
=001  9880363403802441
=005  20141212201250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005027
=035  \\$aCAZ8169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x411.$x417
=150  \\$aEthylene Oxide
=450  \\$wnnna$aOxide, Ethylene
=450  \\$wnnna$aOxirane
=550  \\$wg$aEpoxy Compounds
=680  \\$iA colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794)
=750  \0$aEthylene oxide$5IEN$0(DLC)sh 85045441

=LDR  01062cz  a2200277n  4500
=001  9880363403902441
=005  20141212201250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005026
=035  \\$aCAZ8168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250
=150  \\$aEthylene Glycols
=450  \\$aDihydroxyethanes
=450  \\$aEthanediols
=450  \\$aEthylene Glycol$xanalogs & derivatives
=450  \\$wnnna$aGlycols, Ethylene
=550  \\$wg$aGlycols
=550  \\$wh$aChloral Hydrate
=550  \\$wh$aEthylene Glycol
=550  \\$wh$aMethoxyhydroxyphenylglycol
=550  \\$wh$aPolyethylene Glycols
=667  \\$aETHYLENE GLYCOL is also available
=680  \\$iAn ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze.
=688  \\$a75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74
=750  \0$aEthylene glycols$0(DLC)sh2006002244$5IEN-M

=LDR  01013cz  a2200241n  4500
=001  9880363404002441
=005  20141212201250.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005025
=035  \\$aCAZ8167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x379.$x350
=072  \\$aD2.$x455.$x526.$x439.$x458
=150  \\$aEthylene Dichlorides
=450  \\$wnnna$aDichlorides, Ethylene
=450  \\$aDichloroethanes
=450  \\$aEthylene Dichloride$5IEN
=550  \\$wg$aEthane
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$ado not confuse with DICHLOROETHYLENES
=680  \\$iToxic, chlorinated, saturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. The latter is considerably more toxic. It has a sweet taste, ethereal odor and has been used as a fumigant and intoxicant among sniffers. Has many household and industrial uses.
=688  \\$a91(76); was see under HYDROCARBONS, CHLORINATED 1976-90
=750  \0$aEthylene dichloride$5IEN$0(DLC)sh 85045438

=LDR  00745cz  a2200277n  4500
=001  9880363404102441
=005  20141212201249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005021
=035  \\$aCAZ8163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471
=150  \\$aEthylamines
=550  \\$wg$aAmines
=550  \\$wh$aCystamine
=550  \\$wh$aDibenzylchlorethamine
=550  \\$wh$aDiethylamines
=550  \\$wh$aDiethylpropion
=550  \\$wh$aDiphenhydramine
=550  \\$wh$aHistamine
=550  \\$wh$aMercaptoethylamines
=550  \\$wh$aOrphenadrine
=550  \\$wh$aPhenethylamines
=550  \\$wh$aPhenoxybenzamine
=550  \\$wh$aTiapride Hydrochloride
=750  \0$aEthylamines$5IEN$0(DLC)sh 85045432

=LDR  01175cz  a2200289n  4500
=001  9880363404202441
=005  20141212201249.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005020
=035  \\$aCAZ8162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x100.$x50.$x500.$x300
=072  \\$aD2.$x886.$x645.$x600.$x55.$x50.$x510.$x300
=150  \\$aEthyl Methanesulfonate
=450  \\$wnnna$aEthyl Mesilate
=450  \\$wnnna$aEthyl Mesylate
=450  \\$wnnna$aEthylmesilate
=450  \\$wnnna$aEthylmesylate
=450  \\$aEthylmethane Sulfonate
=450  \\$wnnna$aMesilate, Ethyl
=450  \\$wnnna$aMesylate, Ethyl
=450  \\$wnnna$aMethanesulfonate, Ethyl
=450  \\$wnnna$aSulfonate, Ethylmethane
=550  \\$wg$aMesylates
=680  \\$iAn antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect.
=688  \\$a80(75); was see under METHANESULFONATES 1975-79; ETHYLMESYLATE & MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93
=750  \0$aEthyl methanesulfonate$5IEN-M$0(DLC)sh 93006918

=LDR  01285cz  a2200313n  4500
=001  9880363404302441
=005  20141212201248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005018
=035  \\$aCAZ8160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x447
=150  \\$aEthyl Chloride
=450  \\$wnnna$aChemirosa, Cloretilo
=450  \\$wnnna$aChloraethyl Dr. Henning
=450  \\$wnnna$aChloride, Ethyl
=450  \\$aChloroethane
=450  \\$wnnna$aCloretilo Chemirosa
=450  \\$wnnna$aErn Brand of Ethyl Chloride
=450  \\$wnnna$aGebauer Brand of Ethyl Chloride
=450  \\$wnnna$aGebauer Ethyl Chloride
=450  \\$wnnna$aGebauer's Ethyl Chloride
=450  \\$wnnna$aGebauers Ethyl Chloride
=450  \\$wnnna$aHenning Walldorf Brand of Ethyl Chloride
=450  \\$wnnna$aRitter Brand of Ethyl Chloride
=450  \\$wnnna$aWariActiv
=550  \\$wg$aHydrocarbons, Chlorinated
=680  \\$iA gas that condenses under slight pressure. Because of its low boiling point ethyl chloride sprayed on skin produces an intense cold by evaporation. Cold blocks nerve conduction. Ethyl chloride has been used in surgery but is primarily used to relieve local pain in sports medicine.
=750  \0$aEthyl chloride$5IEN$0(DLC)sh 85045430

=LDR  00576cz  a2200181n  4500
=001  9880363404402441
=005  20141212201246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005010
=035  \\$aCAZ8152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x208
=150  \\$aEthology
=550  \\$wg$aBehavioral Sciences
=667  \\$a"the study of animal behavior"; do not confuse with ETHNOLOGY; SPEC: SPEC qualif; DF: ETHOL
=680  \\$iThe discipline pertaining to the study of animal behavior.
=688  \\$a69
=750  \0$aAnimal behavior$5IEN$0(DLC)sh 85005162

=LDR  01149cz  a2200301n  4500
=001  9880363404502441
=005  20141212201246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005008
=035  \\$aCAZ8150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x275
=072  \\$aF4.$x96.$x628.$x317
=150  \\$aEthnopsychology
=450  \\$wnnna$aCultural Psychiatry
=450  \\$wnnna$aEthnopsychiatry
=450  \\$wnnna$aPsychiatry, Cultural
=450  \\$wnnna$aPsychiatry, Transcultural
=450  \\$wnnna$aPsychology, Transcultural
=450  \\$wnnna$aTranscultural Psychiatry
=450  \\$wnnna$aTranscultural Psychology
=550  \\$wg$aPsychiatry
=550  \\$wg$aPsychology
=550  \\$aAnthropology, Cultural
=550  \\$aTranscultural Nursing
=667  \\$afor psychological aspects of a specific ethnic group, index under ethnic group /psychol (IM), as "psychology of Italian-Americans" = ETHNIC GROUPS /psychol (IM) + ITALY /ethnol (NIM) + UNITED STATES (NIM); Manual 27.15
=680  \\$iComparative PSYCHOLOGY of different ethnic and cultural groups.
=750  \0$aEthnopsychology$5IEN$0(DLC)sh 85045425

=LDR  00889cz  a2200217n  4500
=001  9880363404602441
=005  20141212201245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005007
=035  \\$aCAZ8149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x457
=150  \\$aEthnology
=450  \\$wnnna$aPrimitive Societies
=450  \\$wnnna$aPrimitive Society
=450  \\$wnnna$aSocieties, Primitive
=450  \\$wnnna$aSociety, Primitive
=550  \\$wg$aCulture
=667  \\$ado not confuse with ETHOLOGY, the study of animal behavior; prefer /ethnol: Manual 19.7+; IM as SPEC; SPEC qualif; Manual 30.6; don't forget /ethnol with Cat Z: Manual 19.8.32; note other categories with /ethnology; DF: ETHNOL
=680  \\$iThe comparative and theoretical study of culture, often synonymous with cultural anthropology.
=750  \0$aEthnology$5IEN$0(DLC)sh 85045198

=LDR  00845cz  a2200253n  4500
=001  9882104696202441
=005  20230109163200.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005006
=035  \\$a(DNLM)D005006
=035  \\$a(NLM)98194160760000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x477.$x625.$x188
=072  \\$aN1.$x224.$x317
=150  \\$aEthnicity
=450  \\$aEthnic Groups
=450  \\$aNationality
=450  \\$wnnna$aEthnic Group
=450  \\$wnnna$aNationalities
=667  \\$ado not confuse ethnicity with RACIAL GROUPS
=680  \\$iA group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.
=688  \\$a2022(1968)
=750  \0$aEthnic groups$5IEN-HS$0(DLC)sh 85045172
=750  \0$aEthnicity$5IEN-M$0(DLC)sh 85045187

=LDR  01183cz  a2200277n  4500
=001  9880363404802441
=005  20141212201244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005004
=035  \\$aCAZ8146HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x292
=150  \\$aEthmoid Bone
=450  \\$wnnna$aBone, Ethmoid
=450  \\$wnnna$aBones, Ethmoid
=450  \\$aCribriform Plate
=450  \\$wnnna$aCribriform Plates
=450  \\$wnnna$aEthmoid Bones
=450  \\$wnnna$aHorizontal Plate of Ethmoid Bone
=450  \\$wnnna$aPlate, Cribriform
=450  \\$wnnna$aPlates, Cribriform
=550  \\$wg$aSkull
=667  \\$afractures: coordinate ETHMOID BONE /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with SKULL NEOPLASMS (IM)
=680  \\$iA light and spongy (pneumatized) bone that lies between the orbital part of FRONTAL BONE and the anterior of SPHENOID BONE. Ethmoid bone separates the ORBIT from the ETHMOID SINUS. It consists of a horizontal plate, a perpendicular plate, and two lateral labyrinths.
=688  \\$aCRIBRIFORM PLATE was see under ETHMOID BONE 1963-78
=750  \0$aCribriform plate$5IEN$0(DLC)sh 85033963

=LDR  02647cz  a2200685n  4500
=001  9880363404902441
=005  20141212201243.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004999
=035  \\$aCAZ8141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x50
=072  \\$aD2.$x705.$x539.$x345.$x50
=072  \\$aD2.$x886.$x300.$x692.$x50
=150  \\$aAmifostine
=450  \\$wnnna$aAlza Brand of Amifostine
=450  \\$wnnna$aAmifostine Alza Brand
=450  \\$wnnna$aAmifostine Anhydrous
=450  \\$wnnna$aAmifostine Disodium Salt
=450  \\$wnnna$aAmifostine Essex Brand
=450  \\$wnnna$aAmifostine Lilly Brand
=450  \\$wnnna$aAmifostine Monohydrate
=450  \\$wnnna$aAmifostine Monohydrochloride
=450  \\$wnnna$aAmifostine Schering-Plough Brand
=450  \\$wnnna$aAmifostine Trihydrate
=450  \\$wnnna$aAminopropyl Aminoethylthiophosphate
=450  \\$wnnna$aAminopropylaminoethylthiophosphate
=450  \\$wnnna$aAminopropylaminoethylthiophosphoric Acid
=450  \\$wnnna$aAnhydrous, Amifostine
=450  \\$wnnna$aAnhydrous, Ethiofos
=450  \\$wnnna$aAPAETP
=450  \\$wnnna$aDisodium Salt, Amifostine
=450  \\$wnnna$aEssex Brand of Amifostine
=450  \\$aEthiofos
=450  \\$wnnna$aEthiofos Anhydrous
=450  \\$wnnna$aEthyol
=450  \\$aGammaphos
=450  \\$wnnna$aLilly Brand of Amifostine
=450  \\$wnnna$aMonohydrate, Amifostine
=450  \\$wnnna$aMonohydrochloride, Amifostine
=450  \\$wnnna$aNSC-296961
=450  \\$wnnna$aNSC 296961
=450  \\$wnnna$aNSC296961
=450  \\$wnnna$aS-(N-(3-Aminopropyl)-2-aminoethyl)thiophosphoric Acid
=450  \\$wnnna$aSchering-Plough Brand of Amifostine
=450  \\$wnnna$aSchering Plough Brand of Amifostine
=450  \\$wnnna$aTrihydrate, Amifostine
=450  \\$wnnna$aUS Bioscience Brand of Amifostine
=450  \\$wnnna$aWR-2721
=450  \\$wnnna$aWR 2721
=450  \\$wnnna$aWR2721
=450  \\$wnnna$aYM-08310
=450  \\$wnnna$aYM 08310
=450  \\$wnnna$aYM08310
=550  \\$wg$aOrganothiophosphates
=667  \\$aD25-26 qualif
=680  \\$iA phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
=688  \\$a1994; was ETHIOFOS 1985-1993 (see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-1990); was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-1984
=688  \\$a94; was ETHIOFOS 1985-93 (see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90); was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84
=750  \0$aEthiofos$5IEN$0(DLC)sh 92006316

=LDR  02030cz  a2200505n  4500
=001  9880363405002441
=005  20141212201242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004997
=035  \\$aCAZ8139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x668.$x651.$x568.$x291
=072  \\$aD6.$x472.$x334.$x851.$x437.$x968.$x500
=150  \\$aEthinyl Estradiol
=450  \\$wnnna$aEffik Brand of Ethinyl Estradiol
=450  \\$wnnna$aEstinyl
=450  \\$wnnna$aEstradiol, Ethinyl
=450  \\$wnnna$aEstradiol, Ethynyl
=450  \\$wnnna$aEthinyl Estradiol, (8 alpha,17 alpha)-Isomer
=450  \\$wnnna$aEthinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer
=450  \\$wnnna$aEthinyl Estradiol, (8 alpha)-Isomer
=450  \\$wnnna$aEthinyl Estradiol, (9 beta,17 alpha)-Isomer
=450  \\$wnnna$aEthinyl Estradiol Hemihydrate
=450  \\$wnnna$aEthinyl-Oestradiol Effik
=450  \\$wnnna$aEthinyl Oestradiol Effik
=450  \\$wnnna$aEthinylestradiol Jenapharm
=450  \\$wnnna$aEthinyloestradiol
=450  \\$aEthynyl Estradiol
=450  \\$wnnna$aHemihydrate, Ethinyl Estradiol
=450  \\$wnnna$aJenapharm Brand of Ethinyl Estradiol
=450  \\$wnnna$aJenapharm, Ethinylestradiol
=450  \\$wnnna$aLynoral
=450  \\$wnnna$aMicrofollin
=450  \\$wnnna$aMicrofollin Forte
=450  \\$wnnna$aOrganon Brand of Ethinyl Estradiol
=450  \\$wnnna$aProgynon C
=450  \\$wnnna$aSchering Brand of Ethinyl Estradiol
=450  \\$wnnna$aSchering-Plough Brand of Ethinyl Estradiol
=550  \\$wg$aEstrogenic Steroids, Alkylated
=550  \\$wg$aNorpregnatrienes
=550  \\$wh$aEthinyl Estradiol-Norgestrel Combination
=550  \\$wh$aMestranol
=550  \\$wh$aQuinestrol
=680  \\$iA semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
=750  \0$aEthinyl estradiol$5IEN$0(DLC)sh 85045126

=LDR  01039cz  a2200277n  4500
=001  9880363405102441
=005  20170927131639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004995
=035  \\$aCAZ8137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x333
=072  \\$aN5.$x350.$x340
=150  \\$aEthics, Professional
=450  \\$wnnna$aEthic, Professional
=450  \\$wnnna$aProfessional Ethic
=450  \\$wnnna$aProfessional Ethics
=550  \\$wg$aEthics
=550  \\$wh$aCodes of Ethics
=550  \\$wh$aEthics, Clinical
=550  \\$wh$aProfessionalism
=550  \\$aProfessional Misconduct
=667  \\$aspecify geog if pertinent
=680  \\$iThe principles of proper conduct concerning the rights and duties of the professional, relations with patients or consumers and fellow practitioners, as well as actions of the professional and interpersonal relations with patient or consumer families. (From Stedman, 25th ed)
=688  \\$a68
=750  \0$aProfessional ethics$5IEN$0(DLC)sh 85107258

=LDR  01354cz  a2200337n  4500
=001  9880363405202441
=005  20141212201240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004994
=035  \\$aCAZ8136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x333.$x132.$x937
=072  \\$aN5.$x350.$x340.$x162.$x875
=150  \\$aEthics, Pharmacy
=450  \\$wnnna$aEthic, Pharmaceutic
=450  \\$wnnna$aEthic, Pharmaceutical
=450  \\$wnnna$aEthic, Pharmacy
=450  \\$wnnna$aEthics, Pharmaceutic
=450  \\$wnnna$aEthics, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Ethic
=450  \\$wnnna$aPharmaceutic Ethics
=450  \\$wnnna$aPharmaceutical Ethic
=450  \\$wnnna$aPharmaceutical Ethics
=450  \\$wnnna$aPharmacy Ethic
=450  \\$wnnna$aPharmacy Ethics
=450  \\$aPharmacy$xethics
=550  \\$wg$aEthics, Clinical
=667  \\$aspecify geographic term if pertinent; DF: ETHICS PHARM
=680  \\$iThe principles of proper professional conduct concerning the rights and duties of the pharmacist, relations with patients and fellow practitioners, as well as actions of the pharmacist in health care and interpersonal relations with patient families. (From Stedman, 25th ed)
=688  \\$a68; was ETHICS, PHARMACEUTICAL 1963-67
=750  \0$aPharmaceutical ethics$5IEN$0(DLC)sh 85100584

=LDR  01004cz  a2200265n  4500
=001  9880363405302441
=005  20141212201240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004993
=035  \\$aCAZ8135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x333.$x132.$x875
=072  \\$aK1.$x752.$x712.$x416
=072  \\$aN5.$x350.$x340.$x162.$x750
=150  \\$aEthics, Nursing
=450  \\$wnnna$aEthic, Nursing
=450  \\$aNurses$xethics
=450  \\$wnnna$aNursing Ethic
=450  \\$aNursing Ethics
=450  \\$aNursing$xethics
=550  \\$wg$aEthics, Clinical
=550  \\$wg$aPhilosophy, Nursing
=667  \\$aspecify geographic term if pertinent; DF: ETHICS NURS
=680  \\$iThe principles of proper professional conduct concerning the rights and duties of nurses themselves, their patients, and their fellow practitioners, as well as their actions in the care of patients and in relations with their families.
=750  \0$aNursing ethics$5IEN$0(DLC)sh 85093389

=LDR  01041cz  a2200241n  4500
=001  9880363405402441
=005  20141212201240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004992
=035  \\$aCAZ8134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x333.$x132.$x750
=072  \\$aN5.$x350.$x340.$x162.$x500
=150  \\$aEthics, Medical
=450  \\$wnnna$aMedical Ethics
=450  \\$aMedicine$xethics
=550  \\$wg$aEthics, Clinical
=550  \\$wh$aHippocratic Oath
=550  \\$wh$aTherapeutic Equipoise
=550  \\$aBioethics
=667  \\$arestrict to ethics in relation to the physician; BIOETHICS and BIOETHICAL ISSUES are also available; specify geographic term if pertinent; DF: ETHICS MED
=680  \\$iThe principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families.
=750  \0$aMedical ethics$5IEN$0(DLC)sh 85082929

=LDR  00992cz  a2200253n  4500
=001  9880363405502441
=005  20141212201239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004990
=035  \\$aCAZ8132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x333.$x132.$x500
=072  \\$aK1.$x752.$x622.$x416
=072  \\$aN5.$x350.$x340.$x162.$x249
=150  \\$aEthics, Dental
=450  \\$wnnna$aDental Ethic
=450  \\$wnnna$aDental Ethics
=450  \\$aDentistry$xethics
=450  \\$wnnna$aEthic, Dental
=550  \\$wg$aEthics, Clinical
=550  \\$wg$aPhilosophy, Dental
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe principles of proper professional conduct concerning the rights and duties of the dentist, relations with patients and fellow practitioners, as well as actions of the dentist in patient care and interpersonal relations with patient families. (From Stedman, 25th ed)
=750  \0$aDental ethics$5IEN$0(DLC)sh 85036889

=LDR  01949cz  a2200625n  4500
=001  9880363405602441
=005  20141212201239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004989
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x500.$x519
=072  \\$aK1.$x559.$x411
=072  \\$aK1.$x752.$x566.$x479
=072  \\$aN5.$x350
=150  \\$aEthics
=450  \\$wnnna$aEgoism
=450  \\$wnnna$aEthical Issue
=450  \\$wnnna$aEthical Issues
=450  \\$wnnna$aEthics, Situational
=450  \\$wnnna$aIssue, Ethical
=450  \\$wnnna$aIssues, Ethical
=450  \\$wnnna$aLaw, Natural
=450  \\$wnnna$aLaws, Natural
=450  \\$wnnna$aMetaethics
=450  \\$wnnna$aMoral Policies
=450  \\$wnnna$aMoral Policy
=450  \\$wnnna$aNatural Law
=450  \\$wnnna$aNatural Laws
=450  \\$wnnna$aPolicies, Moral
=450  \\$wnnna$aPolicy, Moral
=450  \\$wnnna$aSituational Ethics
=550  \\$wg$aHealth Care Quality, Access, and Evaluation
=550  \\$wg$aMorals
=550  \\$wh$aBioethical Issues
=550  \\$wh$aBioethics
=550  \\$wh$aCodes of Ethics
=550  \\$wh$aComplicity
=550  \\$wh$aConflict of Interest
=550  \\$wh$aDouble Effect Principle
=550  \\$wh$aEthical Analysis
=550  \\$wh$aEthical Relativism
=550  \\$wh$aEthical Review
=550  \\$wh$aEthical Theory
=550  \\$wh$aEthicists
=550  \\$wh$aEthics, Business
=550  \\$wh$aEthics Committees
=550  \\$wh$aEthics, Institutional
=550  \\$wh$aEthics, Professional
=550  \\$wh$aEthics, Research
=550  \\$wh$aHumanism
=550  \\$wh$aPersonhood
=550  \\$wh$aPrinciple-Based Ethics
=550  \\$wh$aProfessional Misconduct
=680  \\$iThe philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.
=750  \0$aEthics$5IEN$0(DLC)sh 85045096

=LDR  00622cz  a2200241n  4500
=001  9880363405702441
=005  20141212201238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004987
=035  \\$aCAZ8129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355
=150  \\$aEthers
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetals
=550  \\$wh$aEthers, Cyclic
=550  \\$wh$aEthoglucid
=550  \\$wh$aEthyl Ethers
=550  \\$wh$aGlyceryl Ethers
=550  \\$wh$aMethyl Ethers
=550  \\$wh$aPhenyl Ethers
=667  \\$ado not confuse with ETHER
=750  \0$aEthers$5IEN$0(DLC)sh 85045088

=LDR  00927cz  a2200241n  4500
=001  9880363405802441
=005  20141212201237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004986
=035  \\$aCAZ8128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x417.$x332
=150  \\$aEther
=450  \\$aDiethyl Ether
=450  \\$wnnna$aEther, Diethyl
=450  \\$aEther, Ethyl
=450  \\$aEthyl Ether
=550  \\$wg$aEthyl Ethers
=680  \\$iA mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.
=688  \\$a2014(1963)
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Ether, Ethyl
=688  \\$a91(75)63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64
=750  \0$aEther$0(DLC) sh 85045081$5IEN

=LDR  01352cz  a2200481n  4500
=001  9880363405902441
=005  20170712131042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004983
=035  \\$aCAZ8125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291
=072  \\$aD2.$x33.$x375.$x291
=072  \\$aD2.$x92.$x63.$x291
=150  \\$aEthanolamines
=450  \\$aAminoethanols
=450  \\$aEthanolamine$xanalogs & derivatives
=550  \\$wg$aAmino Alcohols
=550  \\$wg$aEthanol
=550  \\$wh$a2-Hydroxyphenethylamine
=550  \\$wh$aAlbuterol
=550  \\$wh$aCholine
=550  \\$wh$aClenbuterol
=550  \\$wh$aDeanol
=550  \\$wh$aEpinephrine
=550  \\$wh$aEthanolamine
=550  \\$wh$aFormoterol Fumarate
=550  \\$wh$aIsoproterenol
=550  \\$wh$aLabetalol
=550  \\$wh$aMetaproterenol
=550  \\$wh$aMidodrine
=550  \\$wh$aNorepinephrine
=550  \\$wh$aNebivolol
=550  \\$wh$aOctopamine
=550  \\$wh$aPhenylephrine
=550  \\$wh$aProcaterol
=550  \\$wh$aSotalol
=550  \\$wh$aSynephrine
=550  \\$wh$aTerbutaline
=667  \\$aETHANOLAMINE is also available
=680  \\$iAMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives.
=688  \\$a73
=750  \0$aEthanolamines$5IEN$0(DLC)sh 85045075

=LDR  00424cz  a2200169n  4500
=001  9880363406002441
=005  20141212201236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004980
=035  \\$aCAZ8122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x379
=150  \\$aEthane
=550  \\$wg$aAlkanes
=550  \\$wh$aEthylene Dichlorides
=688  \\$a73
=750  \0$aEthanes$5IEN$0(DLC)sh 85045073

=LDR  01229cz  a2200301n  4500
=001  9880363406102441
=005  20141212201234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004976
=035  \\$aCAZ8118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x300
=072  \\$aD2.$x241.$x511.$x316.$x682.$x200
=150  \\$aEthacrynic Acid
=450  \\$wnnna$aAcid, Etacrynic
=450  \\$wnnna$aAcid, Ethacrinic
=450  \\$wnnna$aAcid, Ethacrynic
=450  \\$wnnna$aEdecrin
=450  \\$wnnna$aEtacrynic Acid
=450  \\$wnnna$aEthacrinic Acid
=450  \\$wnnna$aEthacrynate Sodium
=450  \\$wnnna$aEthacrynic Acid, Sodium Salt
=450  \\$wnnna$aHydromedin
=450  \\$wnnna$aSodium, Ethacrynate
=550  \\$wg$aPhenoxyacetates
=680  \\$iA compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.
=688  \\$a66(63)
=750  \0$aEthacrynic acid$5IEN$0(DLC)sh 85045071

=LDR  00583cz  a2200181n  4500
=001  9880363406202441
=005  20141212201233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004971
=035  \\$aCAZ8113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x195.$x500
=150  \\$aEstrus
=550  \\$wg$aEstrous Cycle
=550  \\$wh$aEstrus Synchronization
=667  \\$anon-primate mammals only
=680  \\$iThe period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
=750  \0$aEstrus$5IEN$0(DLC)sh 85045017

=LDR  01359cz  a2200361n  4500
=001  9880363406302441
=005  20141212201233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004970
=035  \\$aCAZ8112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x365.$x415.$x414
=072  \\$aD4.$x808.$x578.$x502.$x497
=072  \\$aD6.$x472.$x40.$x502.$x497
=072  \\$aD6.$x472.$x334.$x851.$x437.$x996
=150  \\$aEstrone
=450  \\$wnnna$aEstrone, (+-)-Isomer
=450  \\$wnnna$aEstrone, (8 alpha)-Isomer
=450  \\$wnnna$aEstrone, (9 beta)-Isomer
=450  \\$wnnna$aEstrovarin
=450  \\$wnnna$aFolliculin
=450  \\$wnnna$aHauck Brand of Estrone
=450  \\$wnnna$aHyrex Brand of Estrone
=450  \\$wnnna$aKestrone
=450  \\$wnnna$aUnigen
=450  \\$wnnna$aVortech Brand of Estrone
=450  \\$wnnna$aWehgen
=550  \\$wg$a17-Ketosteroids
=550  \\$wg$aEstradiol Congeners
=550  \\$wg$aEstrenes
=550  \\$wh$aHydroxyestrones
=680  \\$iAn aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
=750  \0$aEstrone$5IEN$0(DLC)sh 85045016

=LDR  01717cz  a2200385n  4500
=001  9880363406402441
=005  20141212192159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004967
=035  \\$aCAZ8109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x277
=150  \\$aEstrogens
=450  \\$wnnna$aAgents, Estrogenic
=450  \\$wnnna$aAgonists, Estrogen Receptor
=450  \\$wnnna$aCompounds, Estrogenic
=450  \\$wnnna$aEffects, Estrogen
=450  \\$wnnna$aEffects, Estrogenic
=450  \\$wnnna$aEstrogen
=450  \\$wnnna$aEstrogen Effect
=450  \\$wnnna$aEstrogen Effects
=450  \\$wnnna$aEstrogen Receptor Agonists
=450  \\$wnnna$aEstrogenic Agents
=450  \\$wnnna$aEstrogenic Compounds
=450  \\$wnnna$aEstrogenic Effect
=450  \\$wnnna$aEstrogenic Effects
=450  \\$wnnna$aReceptor Agonists, Estrogen
=550  \\$wg$aHormones
=550  \\$wh$aEstrogens, Non-Steroidal
=550  \\$aEstrogen Antagonists
=550  \\$aEstrogen Receptor Modulators
=667  \\$a/defic: consider also HYPOGONADISM & other GONADAL DISORDERS; /antag = ESTROGEN ANTAGONISTS or specifics; note entry term ESTROGEN EFFECT: use only for the estrogenic effect of a chemical substance
=680  \\$iCompounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
=688  \\$a1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965
=750  \0$aEstrogen$5IEN$0(DLC)sh 85045012

=LDR  01022cz  a2200289n  4500
=001  9880363406502441
=005  20141212192158.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004965
=035  \\$aCAZ8107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x295
=072  \\$aD27.$x505.$x696.$x399.$x450.$x327
=150  \\$aEstrogen Antagonists
=450  \\$wnnna$aAntagonists, Estradiol
=450  \\$wnnna$aAntagonists, Estrogen
=450  \\$wnnna$aEstradiol Antagonists
=450  \\$aEstradiol$xantagonists & inhibitors
=450  \\$aEstrogens$xantagonists & inhibitors
=550  \\$wg$aHormone Antagonists
=550  \\$wh$aAromatase Inhibitors
=550  \\$wh$aEstrogen Receptor Antagonists
=550  \\$aEstrogen Receptor Modulators
=667  \\$ado not confuse with ANTIESTROGENS see ESTROGEN RECEPTOR MODULATORS
=680  \\$iCompounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.
=688  \\$a78
=750  \0$aEstrogen$xAntagonists$5IEN$0(DLC)sh 85045013

=LDR  02463cz  a2200625n  4500
=001  9880363406602441
=005  20141212192158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004958
=035  \\$aCAZ8100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x365.$x415.$x248
=072  \\$aD6.$x472.$x334.$x851.$x437.$x500
=150  \\$aEstradiol
=450  \\$a17 beta-Estradiol
=450  \\$wnnna$a17 beta Estradiol
=450  \\$wnnna$a17 beta-Oestradiol
=450  \\$wnnna$a17 beta Oestradiol
=450  \\$wnnna$aAerodiol
=450  \\$wnnna$aEstrace
=450  \\$wnnna$aEstraderm TTS
=450  \\$wnnna$aEstradiol, (+-)-Isomer
=450  \\$wnnna$aEstradiol, (16 alpha,17 alpha)-Isomer
=450  \\$wnnna$aEstradiol, (16 alpha,17 beta)-Isomer
=450  \\$wnnna$aEstradiol-17 alpha
=450  \\$wnnna$aEstradiol 17 alpha
=450  \\$wnnna$aEstradiol, (17-alpha)-Isomer
=450  \\$aEstradiol-17 beta
=450  \\$wnnna$aEstradiol 17 beta
=450  \\$wnnna$aEstradiol-17beta
=450  \\$wnnna$aEstradiol 17beta
=450  \\$wnnna$aEstradiol, (8 alpha,17 beta)-(+-)-Isomer
=450  \\$wnnna$aEstradiol, (8 alpha,17 beta)-Isomer
=450  \\$wnnna$aEstradiol, (9 beta,17 alpha)-Isomer
=450  \\$wnnna$aEstradiol, (9 beta,17 beta)-Isomer
=450  \\$wnnna$aEstradiol Anhydrous
=450  \\$wnnna$aEstradiol Hemihydrate
=450  \\$wnnna$aEstradiol Hemihydrate, (17 alpha)-Isomer
=450  \\$wnnna$aEstradiol, (-)-Isomer
=450  \\$wnnna$aEstradiol Monohydrate
=450  \\$wnnna$aEstradiol, Monosodium Salt
=450  \\$wnnna$aEstradiol Orion Brand
=450  \\$wnnna$aEstradiol, Sodium Salt
=450  \\$wnnna$aNovartis Pharmaceuticals Brand of Estradiol
=450  \\$aOestradiol
=450  \\$wnnna$aOrion Brand of Estradiol
=450  \\$wnnna$aOvocyclin
=450  \\$wnnna$aVivelle
=550  \\$wg$aEstradiol Congeners
=550  \\$wg$aEstrenes
=550  \\$wh$aEstramustine
=667  \\$afor /antag also consider: ESTROGEN RECEPTOR MODULATORS; ESTROGEN RECEPTOR ANTAGONISTS; and AROMATASE INHIBITORS.
=680  \\$iThe 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
=688  \\$a63; for OVOCYCLIN use ESTRADIOL DIPROPIONATE (NM) 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965
=750  \0$aEstradiol$5IEN$0(DLC)sh 85045006

=LDR  01123cz  a2200301n  4500
=001  9880363406702441
=005  20141212201229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004955
=035  \\$aCAZ8097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x420
=150  \\$aEsthetics, Dental
=450  \\$wnnna$aAesthetics, Dental
=450  \\$wnnna$aCosmetic Dentistries
=450  \\$aCosmetic Dentistry
=450  \\$wnnna$aDental Esthetic
=450  \\$wnnna$aDental Esthetics
=450  \\$wnnna$aDentistries, Cosmetic
=450  \\$wnnna$aDentistry, Cosmetic
=450  \\$wnnna$aEsthetic, Dental
=550  \\$wg$aDentistry
=550  \\$wh$aEnamel Microabrasion
=550  \\$wh$aTooth Bleaching
=667  \\$aincludes teeth, mouth or face; DF: ESTHETICS DENT
=680  \\$iSkills, techniques, standards, and principles used to improve the art and symmetry of the teeth and face to improve the appearance as well as the function of the teeth, mouth, and face. (From Boucher's Clinical Dental Terminology, 4th ed, p108)
=688  \\$a65
=750  \0$aDentistry$xAesthetic aspects$5IEN$0(DLC)sh 85036954

=LDR  00458cz  a2200169n  4500
=001  9880363406902441
=005  20141212201228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004952
=035  \\$aCAZ8094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x400
=150  \\$aEsters
=550  \\$wg$aCarboxylic Acids
=667  \\$aNIM; avoid qualif
=688  \\$a91(68); was see under CARBOXYLIC ACIDS 1968-90
=750  \0$aEsters$5IEN$0(DLC)sh 85044949

=LDR  00987cz  a2200241n  4500
=001  9880363407002441
=005  20170608143244.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004951
=035  \\$aCAZ8093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x270
=072  \\$aG2.$x607.$x250
=072  \\$aG3.$x344
=150  \\$aEsterification
=450  \\$wnnna$aEsterifications
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM
=680  \\$iThe process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes.
=688  \\$a91(76); was see under CHEMISTRY, ORGANIC 1976-90
=750  \0$aEsterification$0(DLC) sh 85044947$5IEN

=LDR  00771cz  a2200265n  4500
=001  9880363407102441
=005  20141212201228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004950
=035  \\$aCAZ8092HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352
=150  \\$aEsterases
=550  \\$wg$aHydrolases
=550  \\$wh$aCarboxylic Ester Hydrolases
=550  \\$wh$aDeoxyribonucleases
=550  \\$wh$aEndonucleases
=550  \\$wh$aExonucleases
=550  \\$wh$aPhosphoric Diester Hydrolases
=550  \\$wh$aPhosphoric Monoester Hydrolases
=550  \\$wh$aPhosphoric Triester Hydrolases
=550  \\$wh$aRibonucleases
=550  \\$wh$aSulfatases
=550  \\$wh$aThiolester Hydrolases
=750  \0$aEsterases$5IEN$0(DLC)sh 89000683

=LDR  01983cz  a2200529n  4500
=001  9880363407202441
=005  20141212201227.0
=008  790522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004948
=035  \\$aCAZ8090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x562.$x887.$x300
=072  \\$aC11.$x590.$x810.$x400
=150  \\$aEsotropia
=450  \\$wnnna$aConvergent Strabismus
=450  \\$wnnna$aCross-Eye
=450  \\$wnnna$aCross Eye
=450  \\$wnnna$aCross-Eyes
=450  \\$wnnna$aEsodeviation
=450  \\$wnnna$aEsodeviations
=450  \\$aEsophoria
=450  \\$wnnna$aEsophorias
=450  \\$wnnna$aEsotropia, Intermittent
=450  \\$wnnna$aEsotropia, Monocular
=450  \\$wnnna$aEsotropia, Primary
=450  \\$wnnna$aEsotropia, Secondary
=450  \\$wnnna$aEsotropias
=450  \\$wnnna$aEsotropias, Intermittent
=450  \\$wnnna$aEsotropias, Monocular
=450  \\$wnnna$aEsotropias, Primary
=450  \\$wnnna$aEsotropias, Secondary
=450  \\$wnnna$aIntermittent Esotropia
=450  \\$wnnna$aIntermittent Esotropias
=450  \\$wnnna$aInternal Strabismus
=450  \\$wnnna$aMonocular Esotropia
=450  \\$wnnna$aMonocular Esotropias
=450  \\$wnnna$aPrimary Esotropia
=450  \\$wnnna$aPrimary Esotropias
=450  \\$wnnna$aSecondary Esotropia
=450  \\$wnnna$aSecondary Esotropias
=450  \\$aStrabismus, Convergent
=450  \\$aStrabismus, Internal
=550  \\$wg$aStrabismus
=667  \\$ado not confuse with EXOTROPIA, eye turning outward
=680  \\$iA form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a "cross-eye" appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.
=688  \\$a90(80); was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79
=750  \0$aConvergent strabismus$5IEN$0(DLC)sh 85031695

=LDR  01220cz  a2200205n  4500
=001  9880363407302441
=005  20180702110531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004947
=035  \\$aCAZ8089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x500
=150  \\$aEsophagus
=550  \\$wg$aUpper Gastrointestinal Tract
=550  \\$wh$aEsophageal Sphincter, Upper
=550  \\$wh$aEsophageal Mucosa
=550  \\$wh$aEsophagogastric Junction
=667  \\$a/blood supply: ESOPHAGEAL AND GASTRIC VARICES is available: see note there; /surg: consider also ESOPHAGECTOMY; ESOPHAGOPLASTY; or ESOPHAGOSTOMY; inflammation = ESOPHAGITIS; hemorrhage = ESOPHAGEAL DISEASES (IM) + GASTROINTESTINAL HEMORRHAGE (NIM); rupture: index under ESOPHAGUS /inj (IM) + RUPTURE (NIM) or ESOPHAGEAL DISEASES (IM) + RUPTURE, SPONTANEOUS (NIM); peristalsis of the esophagus = ESOPHAGUS /physiol (IM) + PERISTALSIS (NIM); esophageal intubation = ESOPHAGUS (IM) + INTUBATION (IM); esophageal obturator airway = ESOPHAGUS (IM) + INTUBATION /instrum (IM)
=680  \\$iThe muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
=750  \0$aEsophagus$5IEN$0(DLC)sh 85044855

=LDR  01309cz  a2200361n  4500
=001  9880363407402441
=005  20141212192157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004945
=035  \\$aCAZ8087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x275
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x260
=072  \\$aE4.$x210.$x240.$x250.$x260
=072  \\$aE4.$x502.$x250.$x250.$x250.$x260
=150  \\$aEsophagoscopy
=450  \\$wnnna$aEsophagoscopic Surgeries
=450  \\$wnnna$aEsophagoscopic Surgery
=450  \\$wnnna$aEsophagoscopic Surgical Procedure
=450  \\$aEsophagoscopic Surgical Procedures
=450  \\$wnnna$aEsophagoscopies
=450  \\$wnnna$aProcedure, Esophagoscopic Surgical
=450  \\$wnnna$aProcedures, Esophagoscopic Surgical
=450  \\$wnnna$aSurgeries, Esophagoscopic
=450  \\$wnnna$aSurgery, Esophagoscopic
=450  \\$wnnna$aSurgical Procedure, Esophagoscopic
=450  \\$aSurgical Procedures, Esophagoscopic
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$aEsophagoscopes
=550  \\$aEsophagus
=667  \\$a/ instrum permitted but consider also ESOPHAGOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the esophagus.
=750  \0$aEsophagoscopy$5IEN$0(DLC)sh 85044854

=LDR  00594cz  a2200193n  4500
=001  9880363407502441
=005  20141212201226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004944
=035  \\$aCAZ8086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x355
=150  \\$aEsophagoplasty
=450  \\$wnnna$aEsophagoplasties
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aEsophagus
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA plastic operation on the esophagus. (Dorland, 28th ed)
=750  \0$aEsophagoplasty$5IEN$0(DLC)sh 85044853

=LDR  01108cz  a2200277n  4500
=001  9880363407602441
=005  20141212201226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004943
=035  \\$aCAZ8085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x500.$x414
=072  \\$aA3.$x556.$x875.$x875.$x330
=150  \\$aEsophagogastric Junction
=450  \\$aGastroesophageal Junction
=450  \\$wnnna$aGastroesophageal Junctions
=450  \\$wnnna$aJunction, Esophagogastric
=450  \\$wnnna$aJunction, Gastroesophageal
=450  \\$wnnna$aJunctions, Gastroesophageal
=550  \\$wg$aEsophagus
=550  \\$wg$aStomach
=550  \\$wh$aEsophageal Sphincter, Lower
=667  \\$adiseases: coordinate IM with ESOPHAGEAL DISEASES (IM) or specific esophageal disease (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS (IM) or ESOPHAGEAL NEOPLASMS (IM) depending on text
=680  \\$iThe area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
=688  \\$a66(64)
=750  \0$aEsophagogastric junction$5IEN$0(DLC)sh 85044851

=LDR  00784cz  a2200229n  4500
=001  9880363407702441
=005  20141212201225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004940
=035  \\$aCAZ8082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x544
=150  \\$aEsophageal Stenosis
=450  \\$wnnna$aEsophageal Stenoses
=450  \\$aEsophageal Stricture
=450  \\$wnnna$aStenoses, Esophageal
=450  \\$wnnna$aStenosis, Esophageal
=450  \\$wnnna$aStricture, Esophageal
=550  \\$wg$aEsophageal Diseases
=667  \\$acaustic stenosis is indexed ESOPHAGEAL STENOSIS /chem ind + BURNS, CHEMICAL
=680  \\$iA stricture of the ESOPHAGUS. Most are acquired but can be congenital.
=750  \0$aEsophagus$xStenosis$5IEN$0(DLC)sh 85044847

=LDR  01023cz  a2200265n  4500
=001  9880363407802441
=005  20141212201116.0
=008  770516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004745
=035  \\$aCAZ7883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x575.$x281
=072  \\$aD12.$x644.$x468.$x281
=072  \\$aD12.$x776.$x641.$x650.$x575.$x281
=150  \\$aEnkephalins
=450  \\$wnnna$aEnkephalin
=550  \\$wg$aOpioid Peptides
=550  \\$wh$aEnkephalin, Ala(2)-MePhe(4)-Gly(5)-
=550  \\$wh$aEnkephalin, D-Penicillamine (2,5)-
=550  \\$wh$aEnkephalin, Leucine
=550  \\$wh$aEnkephalin, Methionine
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iOne of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla.
=688  \\$a83(Aug 77); was see under ENDORPHINS Aug 1977-82
=750  \0$aEnkephalins$5IEN$0(DLC)sh 85044029

=LDR  00871cz  a2200277n  4500
=001  9880363407902441
=005  20141212201114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004738
=035  \\$aCAZ7876HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x293
=150  \\$aEngineering
=450  \\$wnnna$aEngineerings
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aBioengineering
=550  \\$wh$aBiomedical Engineering
=550  \\$wh$aChemical Engineering
=550  \\$wh$aHuman Engineering
=550  \\$wh$aHydrology
=550  \\$wh$aOptics and Photonics
=550  \\$wh$aQuality Improvement
=550  \\$wh$aSanitary Engineering
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe practical application of physical, mechanical, and mathematical principles. (Stedman, 25th ed)
=750  \0$aEngineering$5IEN$0(DLC)sh 85043176

=LDR  00990cz  a2200289n  4500
=001  9880363408002441
=005  20141212201114.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004737
=035  \\$aCAZ7875HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601.$x400
=150  \\$aEnflurane
=450  \\$wnnna$aAbbott Brand of Enflurane
=450  \\$wnnna$aAlyrane
=450  \\$wnnna$aAstraZeneca Brand of Enflurane
=450  \\$wnnna$aBaxter Anaesthesia Brand of Enflurane
=450  \\$wnnna$aEnfran
=450  \\$wnnna$aEnlirane
=450  \\$wnnna$aEthrane
=450  \\$wnnna$aEtran
=450  \\$wnnna$aPisa Brand of Enflurane
=450  \\$wnnna$aZeneca Brand of Enflurane
=550  \\$wg$aMethyl Ethers
=680  \\$iAn extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.
=688  \\$a80(75); was see under METHYL ETHERS 1975-79
=750  \0$aEnflurane$5IEN$0(DLC)sh 90004981

=LDR  01420cz  a2200409n  4500
=001  9880363408102441
=005  20141212201113.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004736
=035  \\$aCAZ7874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x132
=150  \\$aEnergy-Generating Resources
=450  \\$wnnna$aEnergy-Generating Resource
=450  \\$wnnna$aEnergy Generating Resources
=450  \\$wnnna$aEnergy Resource, Primary
=450  \\$wnnna$aEnergy Resource, Secondary
=450  \\$wnnna$aEnergy Resources, Primary
=450  \\$wnnna$aEnergy Resources, Secondary
=450  \\$wnnna$aPrimary Energy Resource
=450  \\$wnnna$aPrimary Energy Resources
=450  \\$wnnna$aResource, Energy-Generating
=450  \\$wnnna$aResource, Primary Energy
=450  \\$wnnna$aResource, Secondary Energy
=450  \\$wnnna$aResources, Energy-Generating
=450  \\$wnnna$aResources, Primary Energy
=450  \\$wnnna$aResources, Secondary Energy
=450  \\$wnnna$aSecondary Energy Resource
=450  \\$wnnna$aSecondary Energy Resources
=550  \\$wg$aEnvironment
=550  \\$wh$aFossil Fuels
=550  \\$wh$aNuclear Energy
=550  \\$wh$aRenewable Energy
=550  \\$aElectric Power Supplies
=680  \\$iMaterials or phenomena which can provide energy directly or via conversion.
=688  \\$a82
=750  \0$aPower resources$0(DLC) sh 85105992$5IEN-M

=LDR  01223cz  a2200385n  4500
=001  9880363408202441
=005  20141212201112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004734
=035  \\$aCAZ7872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x335
=150  \\$aEnergy Metabolism
=450  \\$wnnna$aBioenergetic
=450  \\$aBioenergetics
=450  \\$aEnergy Expenditure
=450  \\$wnnna$aEnergy Expenditures
=450  \\$wnnna$aEnergy Metabolisms
=450  \\$wnnna$aExpenditure, Energy
=450  \\$wnnna$aExpenditures, Energy
=450  \\$wnnna$aMetabolism, Energy
=450  \\$wnnna$aMetabolisms, Energy
=550  \\$wg$aMetabolism
=550  \\$wh$aBasal Metabolism
=550  \\$wh$aCitric Acid Cycle
=550  \\$wh$aGlycolysis
=550  \\$wh$aOxidation-Reduction
=550  \\$wh$aOxidative Phosphorylation
=550  \\$wh$aPentose Phosphate Pathway
=550  \\$wh$aPhotophosphorylation
=550  \\$wh$aProton-Motive Force
=550  \\$wh$aSubstrate Cycling
=680  \\$iThe chemical reactions involved in the production and utilization of various forms of energy in cells.
=688  \\$a74,63-65
=750  \0$aEnergy metabolism$0(DLC) sh 85043143$5IEN-M

=LDR  00704cz  a2200217n  4500
=001  9880363408302441
=005  20180306104123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004733
=035  \\$aCAZ7871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x347
=150  \\$aEnema
=450  \\$wnnna$aEnemas
=450  \\$wnnna$aEnemata
=450  \\$wnnna$aEnematas
=550  \\$wg$aDrug Therapy
=550  \\$wh$aBarium Enema
=667  \\$abarium enema: coordinate with BARIUM SULFATE /diag use, not BARIUM
=680  \\$iA solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.
=750  \0$aEnema$5IEN$0(DLC)sh 85043118

=LDR  00661cz  a2200193n  4500
=001  9880363408402441
=005  20141212201112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004732
=035  \\$aCAZ7870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x416
=150  \\$aEndrin
=450  \\$wnnna$aHexadrin
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iAn organochlorine compound that was formerly used as an insecticide. Its manufacture and use has been discontinued in the United States. (From Merck Index, 11th ed)
=688  \\$a74(71)
=750  \0$aEndrin$5IEN-M$0(DLC)sh 00008601

=LDR  00818cz  a2200193n  4500
=001  9880363408502441
=005  20141212201112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004731
=035  \\$aCAZ7869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946.$x123.$x329
=150  \\$aEndotoxins
=550  \\$wg$aBacterial Toxins
=550  \\$wh$aLipopolysaccharides
=550  \\$aPyrogens
=667  \\$aantag permitted but consider also ANTITOXINS; coordinate IM with specific bacterium (IM with no qualifiers); for interaction of endotoxins with SUPERANTIGENS
=680  \\$iToxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells.
=750  \0$aEndotoxins$5IEN$0(DLC)sh 85043104

=LDR  00846cz  a2200241n  4500
=001  9880363408602441
=005  20141212201110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004727
=035  \\$aCAZ7865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x272.$x491
=150  \\$aEndothelium
=450  \\$wnnna$aEndotheliums
=550  \\$wg$aEpithelium
=550  \\$wh$aEndothelium, Corneal
=550  \\$wh$aEndothelium, Lymphatic
=550  \\$wh$aEndothelium, Vascular
=550  \\$aEndothelial Cells
=667  \\$aGEN or unspecified; prefer specifics; usually NIM with specific organ IM
=680  \\$iA layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body.
=688  \\$a74(73)
=750  \0$aEndothelium$5IEN$0(DLC)sh 85043102

=LDR  01134cz  a2200277n  4500
=001  9880363408702441
=005  20141212201110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004726
=035  \\$aCAZ7864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x92.$x408
=072  \\$aD3.$x438.$x197.$x408
=150  \\$aEndosulfan
=450  \\$wnnna$aalpha-Endosulfan
=450  \\$wnnna$aalpha Endosulfan
=450  \\$wnnna$abeta-Endosulfan
=450  \\$wnnna$abeta Endosulfan
=450  \\$wnnna$aThiodan
=450  \\$wnnna$aThiodon
=450  \\$wnnna$aThiotox
=550  \\$wg$aBenzothiepins
=667  \\$aTN 111 for eff on insects
=680  \\$iA polychlorinated compound used for controlling a variety of insects. It is practically water-insoluble, but readily adheres to clay particles and persists in soil and water for several years. Its mode of action involves repetitive nerve-discharges positively correlated to increase in temperature. This compound is extremely toxic to most fish. (From Comp Biochem Physiol (C) 1993 Jul;105(3):347-61)
=688  \\$a74(72)
=750  \0$aEndosulfan$5IEN$0(DLC)sh 85043099

=LDR  00886cz  a2200205n  4500
=001  9880363408802441
=005  20141212201110.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004725
=035  \\$aCAZ7863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300
=150  \\$aEndospore-Forming Bacteria
=450  \\$wnnna$aEndospore Forming Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aGram-Positive Endospore-Forming Bacteria
=667  \\$aavoid: too general; prefer specific families & genera; DF: ENDOSPORE FORMING BACT
=680  \\$iA group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods.
=688  \\$a98; use explode 1976-97
=750  \0$aSporeforming bacteria$5IEN-M$0(DLC)sh 85010837

=LDR  01014cz   2200265n  4500
=001  9880364064602441
=005  20230831155229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013850
=035  \\$aCBA7181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785
=150  \\$aThinking
=450  \\$aThought and Thinking$5IEN
=550  \\$wg$aMental Processes
=550  \\$wh$aConcept Formation
=550  \\$wh$aCreativity
=550  \\$wh$aDecision Making
=550  \\$wh$aEsthetics
=550  \\$wh$aJudgment
=550  \\$wh$aProblem Solving
=667  \\$athe thought process: do not confuse with MEDITATION, a relaxation technique; differentiate from COGNITION: see treeing & MeSH definition
=680  \\$iMental activity, not predominantly perceptual, by which one apprehends some aspect of an object or situation based on past learning and experience.
=750  \0$aThought and thinking$5IEN$0(DLC)sh 85134988
=750  \0$iNarrower mapping$aConvergent thinking$0(DLC)sh2022005517$4NM$5IEN-M

=LDR  00493cz  a2200157n  4500
=001  9880364064702441
=005  20141212210158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013848
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x750
=150  \\$aThigh
=450  \\$wnnna$aThighs
=550  \\$wg$aLower Extremity
=667  \\$afor bone use FEMUR; NIM when merely locational as in skin dis (IM); TN 117: use for human & other vertebrates
=750  \0$aThigh$5IEN$0(DLC)sh 85134858

=LDR  00534cz  a2200205n  4500
=001  9880364064802441
=005  20141212210157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013846
=035  \\$aCBA7177M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x680
=072  \\$aD3.$x383.$x886
=150  \\$aThiepins
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aDibenzothiepins
=550  \\$wh$aThiazepines
=688  \\$a68
=750  \0$aThiepins$0(DLC)sh2007002602$5IEN-M

=LDR  01338cz  a2200505n  4500
=001  9880364064902441
=005  20210212080420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013844
=035  \\$aCBA7175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675
=072  \\$aD3.$x383.$x129.$x708
=150  \\$aThiazoles
=550  \\$wg$aAzoles
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aBenzothiazoles
=550  \\$wh$aChlormethiazole
=550  \\$wh$aCobicistat
=550  \\$wh$aDasatinib
=550  \\$wh$aDithiazanine
=550  \\$wh$aEthoxzolamide
=550  \\$wh$aFamotidine
=550  \\$wh$aFANFT
=550  \\$wh$aFebuxostat
=550  \\$wh$aFirefly Luciferin
=550  \\$wh$aLevamisole
=550  \\$wh$aLurasidone Hydrochloride
=550  \\$wh$aNiridazole
=550  \\$wh$aNizatidine
=550  \\$wh$aOxythiamine
=550  \\$wh$aRhodanine
=550  \\$wh$aRiluzole
=550  \\$wh$aRitonavir
=550  \\$wh$aSaccharin
=550  \\$wh$aSulfathiazoles
=550  \\$wh$aTetramisole
=550  \\$wh$aThiabendazole
=550  \\$wh$aThiadiazoles
=550  \\$wh$aThiamine
=550  \\$wh$aThiazolidinediones
=550  \\$wh$aThiazolidines
=550  \\$wh$aThiamethoxam
=667  \\$aincludes thiazolines, thiazolidines
=750  \0$aThiazoles$5IEN$0(DLC)sh 85134844

=LDR  00691cz  a2200253n  4500
=001  9880364065002441
=005  20141212210156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013843
=035  \\$aCBA7174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x665
=072  \\$aD3.$x383.$x855
=150  \\$aThiazines
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aCephalosporins
=550  \\$wh$aChlormezanone
=550  \\$wh$aNifurtimox
=550  \\$wh$aPiroxicam
=550  \\$wh$aThiadiazines
=550  \\$wh$aXylazine
=688  \\$aPYRIDOBENZOTHIAZINES was heading 1963-84
=750  \0$aThiazines$5IEN$0(DLC)sh 91001994

=LDR  00995cz  a2200301n  4500
=001  9880364065102441
=005  20141212210156.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013839
=035  \\$aCBA7170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x706.$x300.$x850
=072  \\$aD2.$x455.$x426.$x559.$x389.$x565.$x175.$x850
=072  \\$aD2.$x640.$x529.$x175.$x850
=150  \\$aThiamphenicol
=450  \\$aDextrosulfenidol
=450  \\$wnnna$aRaceophenidol
=450  \\$wnnna$aSanofi Brand of Thiamphenicol
=450  \\$wnnna$aThiamcol
=450  \\$wnnna$aThiomycetin
=450  \\$aThiophenicol
=450  \\$wnnna$aUrfamycin
=450  \\$wnnna$aVicemycetin
=450  \\$wnnna$aZambon Brand of Thiamphenicol
=550  \\$wg$aChloramphenicol
=680  \\$iA methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent.
=688  \\$a79(75); was see under ANTIBIOTICS 1975-78
=750  \0$aThiamphenicol$5IEN$0(DLC)sh 85134842

=LDR  01078cz  a2200277n  4500
=001  9880364065202441
=005  20141212210154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013835
=035  \\$aCBA7166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x900.$x702
=072  \\$aD3.$x383.$x129.$x708.$x900.$x702
=072  \\$aD3.$x383.$x742.$x795.$x702
=072  \\$aD8.$x211.$x878
=150  \\$aThiamine Pyrophosphate
=450  \\$wnnna$aBerolase
=450  \\$aCocarboxylase
=450  \\$wnnna$aPyrophosphate, Thiamine
=450  \\$aThiamin Pyrophosphate$5IEN
=450  \\$aThiamine Diphosphate
=550  \\$wg$aCoenzymes
=550  \\$wg$aThiamine
=667  \\$ado not confuse with THIAMINE PYROPHOSPHATASE; deficiency: coordinate THIAMINE PYROPHOSPHATE /defic (IM) with THIAMINE DEFICIENCY (IM)
=680  \\$iThe coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX.
=750  \0$aThiamin pyrophosphate$5IEN$0(DLC)sh 87001972

=LDR  00914cz  a2200301n  4500
=001  9880364065302441
=005  20141212210153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013831
=035  \\$aCBA7162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x900
=072  \\$aD3.$x383.$x129.$x708.$x900
=072  \\$aD3.$x383.$x742.$x795
=150  \\$aThiamine
=450  \\$aAneurin
=450  \\$wnnna$aMononitrate, Thiamine
=450  \\$wnnna$aThiamine Mononitrate
=450  \\$aVitamin B 1
=450  \\$wnnna$aVitamin B1
=550  \\$wg$aPyrimidines
=550  \\$wg$aThiazoles
=550  \\$wh$aFursultiamin
=550  \\$wh$aThiamine Monophosphate
=550  \\$wh$aThiamine Pyrophosphate
=550  \\$wh$aThiamine Triphosphate
=680  \\$i3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride.
=750  \0$aVitamin B1$5IEN$0(DLC)sh 85143962

=LDR  00627cz  a2200229n  4500
=001  9880364065402441
=005  20170705112404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013830
=035  \\$aCBA7161M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x867
=072  \\$aD3.$x383.$x129.$x708.$x824
=150  \\$aThiadiazoles
=550  \\$wg$aThiadiazoles
=550  \\$wh$aAcetazolamide
=550  \\$wh$aBenzolamide
=550  \\$wh$aMethazolamide
=550  \\$wh$aTimolol
=667  \\$aincludes thiadiazolines, thiadiazolidines
=688  \\$a73(71)
=750  \0$aThiadiazoles$0(DLC) sh2004007280$5IEN-M

=LDR  00848cz  a2200241n  4500
=001  9880364065502441
=005  20141212210152.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013826
=035  \\$aCBA7157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x300.$x150.$x937
=072  \\$aE1.$x370.$x405.$x245.$x287.$x937
=072  \\$aG7.$x265.$x87.$x937
=072  \\$aG11.$x561.$x127.$x937
=150  \\$aTheta Rhythm
=450  \\$wnnna$aRhythm, Theta
=450  \\$wnnna$aRhythms, Theta
=450  \\$wnnna$aTheta Rhythms
=550  \\$wg$aBrain Waves
=680  \\$iBrain waves characterized by a frequency of 4-7 Hz, usually observed in the temporal lobes when the individual is awake, but relaxed and sleepy.
=688  \\$a91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90
=750  \0$aTheta rhythm$5IEN$0(DLC)sh 89001957

=LDR  00898cz  a2200217n  4500
=001  9880364065602441
=005  20141212192603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013823
=035  \\$aCBA7154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x968
=072  \\$aA8.$x800.$x950.$x968
=072  \\$aA11.$x671.$x650.$x915.$x968
=150  \\$aThermoreceptors
=450  \\$wnnna$aThermoreceptor
=550  \\$wg$aSensory Receptor Cells
=667  \\$asensory receptors for temperature; DF: THERMORECEPT
=680  \\$iCellular receptors which mediate the sense of temperature. Thermoreceptors in vertebrates are mostly located under the skin. In mammals there are separate types of thermoreceptors for cold and for warmth and NOCICEPTORS which detect cold or heat extreme enough to cause pain.
=688  \\$a74(71)
=750  \0$aThermoreceptors$5IEN$0(DLC)sh 85134815

=LDR  00699cz  a2200193n  4500
=001  9880364065702441
=005  20141212210151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013821
=035  \\$aCBA7152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x900
=150  \\$aThermometers
=450  \\$wnnna$aThermometer
=550  \\$wg$aEquipment and Supplies
=550  \\$aBody Temperature
=550  \\$aTemperature
=680  \\$iMeasuring instruments for determining the temperature of matter. Most thermometers used in the field of medicine are designed for measuring body temperature or for use in the clinical laboratory. (From UMDNS, 1999)
=750  \0$aThermometers$5IEN$0(DLC)sh 85134802

=LDR  00982cz  a2200229n  4500
=001  9880364065802441
=005  20141212210151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013819
=035  \\$aCBA7150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x638.$x785
=072  \\$aN6.$x850.$x810.$x370.$x420
=150  \\$aThermoluminescent Dosimetry
=450  \\$wnnna$aDosimetries, Thermoluminescent
=450  \\$wnnna$aDosimetry, Thermoluminescent
=450  \\$wnnna$aThermoluminescent Dosimetries
=450  \\$aThermoluminscence Dosimetry$5IEN
=550  \\$wg$aRadiation Monitoring
=680  \\$iThe use of a device composed of thermoluminescent material for measuring exposure to IONIZING RADIATION. The thermoluminescent material emits light when heated. The amount of light emitted is proportional to the amount of ionizing radiation to which the material has been exposed.
=688  \\$a73(71)
=750  \0$aThermoluminescence dosimetry$5IEN$0(DLC)sh 85134799

=LDR  00700cz  a2200193n  4500
=001  9880364065902441
=005  20141212210150.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013818
=035  \\$aCBA7149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x904
=150  \\$aThermogravimetry
=450  \\$wnnna$aThermogravimetries
=550  \\$wg$aChemistry Techniques, Analytical
=667  \\$aNIM
=680  \\$iTechnique whereby the weight of a sample can be followed over a period of time while its temperature is being changed (usually increased at a constant rate).
=688  \\$a91(77); was see under CHEMISTRY, ANALYTICAL 1977-90
=750  \0$aThermogravimetry$5IEN$0(DLC)sh 85134795

=LDR  01043cz  a2200265n  4500
=001  9880364066002441
=005  20141212210150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013817
=035  \\$aCBA7148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x800
=072  \\$aE5.$x933.$x500
=150  \\$aThermography
=450  \\$wnnna$aMapping, Temperature
=450  \\$wnnna$aMappings, Temperature
=450  \\$wnnna$aTemperature Mapping
=450  \\$wnnna$aTemperature Mappings
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aThermometry
=550  \\$aBody Temperature
=667  \\$ain diagnosis, coordinate IM with disease /diag, not /radiogr
=680  \\$iImaging the temperatures in a material, or in the body or an organ. Imaging is based on self-emanating infrared radiation (HEAT WAVES), or on changes in properties of the material or tissue that vary with temperature, such as ELASTICITY; MAGNETIC FIELD; or LUMINESCENCE.
=688  \\$a67(65)
=750  \0$aMedical thermography$5IEN$0(DLC)sh 85083048

=LDR  00888cz  a2200229n  4500
=001  9880364066102441
=005  20141212210150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013816
=035  \\$aCBA7147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906
=150  \\$aThermodynamics
=450  \\$wnnna$aThermodynamic
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aConvection
=550  \\$wh$aEntropy
=550  \\$wh$aTemperature
=550  \\$wh$aThermal Conductivity
=667  \\$ano qualif
=680  \\$iA rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed)
=750  \0$aThermodynamics$5IEN$0(DLC)sh 85134783

=LDR  00856cz  a2200217n  4500
=001  9880364066202441
=005  20141212210149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013814
=035  \\$aCBA7145M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x730
=150  \\$aThermal Conductivity
=450  \\$wnnna$aCoefficient of Conductivity
=450  \\$wnnna$aConductivity, Heat
=450  \\$wnnna$aConductivity, Thermal
=450  \\$wnnna$aHeat Conductivity
=550  \\$wg$aThermodynamics
=680  \\$iThe heat flow across a surface per unit area per unit time, divided by the negative of the rate of change of temperature with distance in a direction perpendicular to the surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a74(71)
=750  \0$aThermal conductivity$0(DLC)sh2003011072$5IEN-M

=LDR  03632cz  a2201189n  4500
=001  9880364066302441
=005  20200609110547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013812
=035  \\$aCBA7143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2
=150  \\$aTherapeutics
=450  \\$aDisease$xtherapy
=450  \\$wnnna$aTherapeutic
=450  \\$wnnna$aTherapies
=450  \\$wnnna$aTherapy
=450  \\$wnnna$aTreatment
=450  \\$wnnna$aTreatments
=550  \\$wh$aAcoustic Stimulation
=550  \\$wh$aAirway Management
=550  \\$wh$aApitherapy
=550  \\$wh$aBalneology
=550  \\$wh$aBariatrics
=550  \\$wh$aBed Rest
=550  \\$wh$aBehavior Control
=550  \\$wh$aBiological Therapy
=550  \\$wh$aBlood Component Removal
=550  \\$wh$aCatheterization
=550  \\$wh$aCautery
=550  \\$wh$aChronotherapy
=550  \\$wh$aClimatotherapy
=550  \\$wh$aClinical Protocols
=550  \\$wh$aCombined Modality Therapy
=550  \\$wh$aComplementary Therapies
=550  \\$wh$aConservative Treatment
=550  \\$wh$aCosmetic Techniques
=550  \\$wh$aCryotherapy
=550  \\$wh$aDecompression
=550  \\$wh$aDelayed Diagnosis
=550  \\$wh$aDirectly Observed Therapy
=550  \\$wh$aDrainage
=550  \\$wh$aDrug Therapy
=550  \\$wh$aElectric Stimulation Therapy
=550  \\$wh$aEmergency Treatment
=550  \\$wh$aEndotamponade
=550  \\$wh$aFeeding Methods
=550  \\$wh$aFetal Therapies
=550  \\$wh$aHemodilution
=550  \\$wh$aHemostatic Techniques
=550  \\$wh$aHydrotherapy
=550  \\$wh$aHygiene
=550  \\$wh$aHyperthermia, Induced
=550  \\$wh$aInsufflation
=550  \\$wh$aIntubation
=550  \\$wh$aIschemic Postconditioning
=550  \\$wh$aIschemic Preconditioning
=550  \\$wh$aLaser Therapy
=550  \\$wh$aLeeching
=550  \\$wh$aLithotripsy
=550  \\$wh$aMagnetic Field Therapy
=550  \\$wh$aMechanical Thrombolysis
=550  \\$wh$aNutrition Therapy
=550  \\$wh$aObesity Management
=550  \\$wh$aOrgan Sparing Treatments
=550  \\$wh$aOrthokeratologic Procedures
=550  \\$wh$aOrthopedic Procedures
=550  \\$wh$aOrthoptics
=550  \\$wh$aPain Management
=550  \\$wh$aPatient Care
=550  \\$wh$aPatient Care Bundles
=550  \\$wh$aPatient Isolation
=550  \\$wh$aPhototherapy
=550  \\$wh$aPhysical Therapy Modalities
=550  \\$wh$aPlacebos
=550  \\$wh$aPrecision Medicine
=550  \\$wh$aPreservation, Biological
=550  \\$wh$aProsthesis Fitting
=550  \\$wh$aPunctures
=550  \\$wh$aRadiotherapy
=550  \\$wh$aRehabilitation
=550  \\$wh$aRejuvenation
=550  \\$wh$aRemission Induction
=550  \\$wh$aRenal Replacement Therapy
=550  \\$wh$aReproductive Techniques
=550  \\$wh$aRespiratory Therapy
=550  \\$wh$aRetreatment
=550  \\$wh$aRewarming
=550  \\$wh$aSalvage Therapy
=550  \\$wh$aSecondary Prevention
=550  \\$wh$aSelf Care
=550  \\$wh$aSex Reassignment Procedures
=550  \\$wh$aSorption Detoxification
=550  \\$wh$aTheranostic Nanomedicine
=550  \\$wh$aTherapeutic Occlusion
=550  \\$wh$aTherapies, Investigational
=550  \\$wh$aTherapy, Computer-Assisted
=550  \\$wh$aTherapy with Helminths
=550  \\$wh$aTertiary Prevention
=667  \\$aavoid: too general: prefer /ther with diseases
=680  \\$iProcedures concerned with the remedial treatment or prevention of diseases.
=750  \0$aTherapeutics$5IEN$0(DLC)sh 85134723

=LDR  01272cz  a2200349n  4500
=001  9880364066402441
=005  20141212210148.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013810
=035  \\$aCBA7141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x787.$x559
=072  \\$aG7.$x690.$x725.$x898
=150  \\$aTherapeutic Equivalency
=450  \\$aBioequivalence
=450  \\$wnnna$aBioequivalences
=450  \\$wnnna$aClinical Equivalencies
=450  \\$aClinical Equivalency
=450  \\$wnnna$aEquivalencies, Clinical
=450  \\$wnnna$aEquivalencies, Generic
=450  \\$wnnna$aEquivalencies, Therapeutic
=450  \\$wnnna$aEquivalency, Clinical
=450  \\$wnnna$aEquivalency, Generic
=450  \\$aEquivalency, Therapeutic
=450  \\$wnnna$aGeneric Equivalencies
=450  \\$aGeneric Equivalency
=450  \\$wnnna$aTherapeutic Equivalencies
=550  \\$wg$aPharmacokinetics
=667  \\$acoordinate NIM with specific drug / pharmacokin (IM)
=680  \\$iThe relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.
=688  \\$a70
=750  \0$aDrugs$xTherapeutic equivalency$5IEN$0(DLC)sh 85039756

=LDR  00880cz  a2200217n  4500
=001  9880364066502441
=005  20141212210148.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013808
=035  \\$aCBA7139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x392.$x701
=150  \\$aTherapeutic Community
=450  \\$wnnna$aCommunities, Therapeutic
=450  \\$wnnna$aCommunity, Therapeutic
=450  \\$wnnna$aTherapeutic Communities
=550  \\$wg$aMilieu Therapy
=667  \\$ano qualif
=680  \\$iPsychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients.
=688  \\$a69(67)
=750  \0$aTherapeutic communities$5IEN$0(DLC)sh 85134719

=LDR  03499cz  a2201033n  4500
=001  9880364066602441
=005  20141212192600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013806
=035  \\$aCBA7137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x960.$x751
=072  \\$aD3.$x438.$x759.$x758.$x824.$x751
=150  \\$aTheophylline
=450  \\$wnnna$a1,3-Dimethylxanthine
=450  \\$wnnna$a1,3 Dimethylxanthine
=450  \\$wnnna$a3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione
=450  \\$wnnna$aAccurbron
=450  \\$wnnna$aAerobin
=450  \\$wnnna$aAerolate
=450  \\$wnnna$aAfonilum Retard
=450  \\$wnnna$aAnhydrous, Theophylline
=450  \\$wnnna$aAquaphyllin
=450  \\$wnnna$aArmophylline
=450  \\$wnnna$aBronchoparat
=450  \\$wnnna$aBronkodyl
=450  \\$wnnna$aConstant-T
=450  \\$wnnna$aConstant T
=450  \\$wnnna$aConstantT
=450  \\$wnnna$act-Arzneimittel Brand of Theophylline Sodium Glycinate
=450  \\$wnnna$act Arzneimittel Brand of Theophylline Sodium Glycinate
=450  \\$wnnna$act, theo von
=450  \\$wnnna$aElixophyllin
=450  \\$wnnna$aEuphylong
=450  \\$wnnna$aFameasan Brand of Theophylline Sodium Glycinate
=450  \\$wnnna$aFujisawa Brand of Theophylline Sodium Glycinate
=450  \\$wnnna$aGlycinate, Theophylline Sodium
=450  \\$wnnna$aGlycine Theophyllinate
=450  \\$wnnna$aLodrane
=450  \\$wnnna$aMonospan
=450  \\$wnnna$aMundipharma Brand of Theophylline Sodium Glycinate
=450  \\$wnnna$aNuelin
=450  \\$wnnna$aNuelin S.A.
=450  \\$wnnna$aQuibron T-SR
=450  \\$wnnna$aQuibron T SR
=450  \\$wnnna$aQuibron TSR
=450  \\$wnnna$aSlo-Phyllin
=450  \\$wnnna$aSlo Phyllin
=450  \\$wnnna$aSloPhyllin
=450  \\$wnnna$aSodium Glycinate, Theophylline
=450  \\$wnnna$aSomophyllin-T
=450  \\$wnnna$aSomophyllin T
=450  \\$wnnna$aSomophyllinT
=450  \\$wnnna$aSustaire
=450  \\$wnnna$aSynophylate
=450  \\$wnnna$aTheo-24
=450  \\$wnnna$aTheo 24
=450  \\$wnnna$aTheo-Dur
=450  \\$wnnna$aTheo Dur
=450  \\$wnnna$atheo von ct
=450  \\$wnnna$aTheo24
=450  \\$wnnna$aTheobid
=450  \\$wnnna$aTheocin
=450  \\$wnnna$aTheoconfin Continuous
=450  \\$wnnna$aTheodur
=450  \\$wnnna$aTheolair
=450  \\$wnnna$aTheolix
=450  \\$wnnna$aTheon
=450  \\$wnnna$aTheonite
=450  \\$wnnna$aTheopek
=450  \\$wnnna$aTheophyllinate, Glycine
=450  \\$wnnna$aTheophylline Anhydrous
=450  \\$wnnna$aTheophylline Sodium Glycinate
=450  \\$wnnna$aTheospan
=450  \\$wnnna$aTheostat
=450  \\$wnnna$aTheovent
=450  \\$wnnna$aUniphyl
=450  \\$wnnna$aUniphyllin
=450  \\$wnnna$aUniphylline
=450  \\$wnnna$avon ct, theo
=550  \\$wg$aXanthines
=550  \\$wh$a1-Methyl-3-isobutylxanthine
=550  \\$wh$aAminophylline
=550  \\$wh$aDimenhydrinate
=550  \\$wh$aDyphylline
=550  \\$wh$aXanthinol Niacinate
=550  \\$aTea
=680  \\$iA methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLATE CYCLASE and cyclic AMP.
=750  \0$aTheophylline$5IEN$0(DLC)sh 85134710

=LDR  01276cz  a2200217n  4500
=001  9880364066702441
=005  20141212210147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013803
=035  \\$aCBA7134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x622.$x851
=150  \\$aThematic Apperception Test
=450  \\$wnnna$aApperception Test, Thematic
=450  \\$wnnna$aApperception Tests, Thematic
=450  \\$wnnna$aTest, Thematic Apperception
=450  \\$wnnna$aTests, Thematic Apperception
=450  \\$wnnna$aThematic Apperception Tests
=550  \\$wg$aProjective Techniques
=680  \\$iA projective technique which focuses primarily on the dynamics of interpersonal relationships. It consists of a series of 31 pictures that depict various social situations and interpersonal relations. A subset is selected by the examiner and presented to the subject who is asked to tell a story about each picture. The stories are interpreted in terms of the subject's relations to authority figures, to contemporaries of both sexes, and in terms of the compromises between external demands and the needs of the id, the ego, and the superego. (From Campbell, Psychiatric Dictionary, 1996)
=750  \0$aThematic Apperception Test$5IEN$0(DLC)sh 85134637

=LDR  01223cz  a2200337n  4500
=001  9880364066802441
=005  20141212210146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013801
=035  \\$aCBA7132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x688.$x735
=072  \\$aC3.$x752.$x625.$x735
=072  \\$aC3.$x752.$x875.$x850
=072  \\$aC22.$x196.$x831
=072  \\$aC22.$x674.$x710.$x735
=150  \\$aTheileriasis
=450  \\$wnnna$aCoast Fever, East
=450  \\$aCorridor Disease
=450  \\$wnnna$aDisease, Corridor
=450  \\$aEast Coast Fever
=450  \\$wnnna$aFever, East Coast
=450  \\$wnnna$aTheileriases
=450  \\$wnnna$aTheilerioses
=450  \\$wnnna$aTheileriosis
=550  \\$wg$aCattle Diseases
=550  \\$wg$aProtozoan Infections, Animal
=550  \\$wg$aTick-Borne Diseases
=680  \\$iInfection of cattle, sheep, or goats with protozoa of the genus THEILERIA. This infection results in an acute or chronic febrile condition.
=688  \\$a68; GONDERIASIS was see THEILERIASIS 1975-91; CORRIDOR DISEASE was see under THEILERIASIS 1968-78; EAST COAST FEVER was see under THEILERIASIS 1968-81
=750  \0$aTheileriosis$5IEN$0(DLC)sh 85134623

=LDR  00582cz  a2200229n  4500
=001  9880364066902441
=005  20141212210146.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013800
=035  \\$aCBA7131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x810
=072  \\$aI1.$x880.$x735.$x191.$x410
=150  \\$aTheft
=450  \\$aLarceny$5IEN
=450  \\$aStealing
=450  \\$wnnna$aStealings
=450  \\$wnnna$aThefts
=550  \\$wg$aCrime
=680  \\$iUnlawful act of taking property.
=688  \\$a78
=750  \0$aTheft$0(DLC)sh 85127634$5IEN-M

=LDR  00651cz  a2200193n  4500
=001  9880364067002441
=005  20141212210144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013795
=035  \\$aCBA7126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x827
=150  \\$aThanatology
=550  \\$wg$aPhilosophy
=550  \\$aDeath
=667  \\$a"the study of the theory, philosophy & doctrine of death"; do not confuse with DEATH, the physiol concept; DF: THANATOL
=680  \\$iThe study of the theory, philosophy, and doctrine of death.
=688  \\$a90(75); was see under DEATH 1974-89
=750  \0$aThanatology$5IEN$0(DLC)sh 86006398

=LDR  00778cz  a2200205n  4500
=001  9880364067102441
=005  20141212210144.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013794
=035  \\$aCBA7125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x900
=150  \\$aThallium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Thallium
=550  \\$wg$aRadioisotopes
=550  \\$aThallium
=667  \\$aTl-198-202, 204, 206-210; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes.
=688  \\$a88
=750  \0$aThallium$xIsotopes$5IEN-M$0(DLC)sh 85134474

=LDR  00736cz  a2200205n  4500
=001  9880364067202441
=005  20141212210144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013793
=035  \\$aCBA7124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x847
=072  \\$aD1.$x552.$x544.$x847
=150  \\$aThallium
=450  \\$aThallium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=667  \\$aTl-205; Tl-203 = THALLIUM (IM) + ISOTOPES (NIM); Tl-198-202, 204, 206-210 = THALLIUM RADIOISOTOPES (IM)
=680  \\$iA heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl.
=750  \0$aThallium compounds$5IEN-M$0(DLC)sh 85134478
=750  \0$aThallium$5IEN-HS$0(DLC)sh 85134473

=LDR  01030cz  a2200229n  4500
=001  9880364067302441
=005  20141212210143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013792
=035  \\$aCBA7123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x805.$x810.$x800
=072  \\$aD3.$x383.$x621.$x808.$x800
=072  \\$aD3.$x438.$x513.$x750.$x750
=150  \\$aThalidomide
=450  \\$wnnna$aCelgene Brand of Thalidomide
=450  \\$wnnna$aSedoval
=450  \\$wnnna$aThalomid
=550  \\$wg$aPhthalimides
=550  \\$wg$aPiperidones
=680  \\$iA piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
=750  \0$aThalidomide$5IEN$0(DLC)sh 85134471

=LDR  00721cz  a2200229n  4500
=001  9880364067402441
=005  20141212210143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013790
=035  \\$aCBA7121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x175
=150  \\$aClimatotherapy
=450  \\$wnnna$aClimate Therapy
=450  \\$aThalassotherapy
=450  \\$wnnna$aTherapy, Climate
=550  \\$wg$aTherapeutics
=550  \\$aSeawater
=680  \\$iRelocating a patient to a CLIMATE more suitable for health or for management of a health condition.
=688  \\$a2007(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Thalassotherapy
=750  \0$aClimatotherapy$0(DLC) sh 85027049$5IEN-M

=LDR  01227cz  a2200277n  4500
=001  9880364067502441
=005  20141212210143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013789
=035  \\$aCBA7120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x150.$x875
=072  \\$aC15.$x378.$x420.$x826
=072  \\$aC16.$x320.$x70.$x875
=072  \\$aC16.$x320.$x365.$x826
=150  \\$aThalassemia
=450  \\$wnnna$aThalassemias
=550  \\$wg$aAnemia, Hemolytic, Congenital
=550  \\$wg$aHemoglobinopathies
=550  \\$wh$aalpha-Thalassemia
=550  \\$wh$abeta-Thalassemia
=550  \\$wh$adelta-Thalassemia
=667  \\$aa congen hemolytic anemia; GEN or unspecified: prefer specifics; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
=688  \\$a65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92
=750  \0$aThalassemia$0(DLC) sh 85134466$5IEN

=LDR  00627cz  a2200193n  4500
=001  9880364067602441
=005  20141212192559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013788
=035  \\$aCBA7119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x317.$x826
=150  \\$aThalamus
=450  \\$wnnna$aThalamencephalon
=450  \\$wnnna$aThalamencephalons
=550  \\$wg$aDiencephalon
=550  \\$wh$aThalamic Nuclei
=680  \\$iPaired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain.
=750  \0$aThalamus$5IEN$0(DLC)sh 85134464

=LDR  01288cz  a2200289n  4500
=001  9880364067702441
=005  20141212210142.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013786
=035  \\$aCBA7117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x915
=150  \\$aThalamic Diseases
=450  \\$aDejerine-Roussy Syndrome
=450  \\$wnnna$aDejerine Roussy Syndrome
=450  \\$wnnna$aDisease, Thalamic
=450  \\$wnnna$aDiseases, Thalamic
=450  \\$wnnna$aSyndrome, Dejerine-Roussy
=450  \\$wnnna$aSyndrome, Thalamic
=450  \\$wnnna$aSyndromes, Thalamic
=450  \\$wnnna$aThalamic Disease
=450  \\$wnnna$aThalamic Syndrome
=450  \\$wnnna$aThalamic Syndromes
=550  \\$wg$aBrain Diseases
=680  \\$iDisorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.
=688  \\$a1981
=750  \0$aThalamus$xDiseases$5IEN-M$0(DLC)sh 93006261

=LDR  00697cz   2200241n  4500
=001  9880364067802441
=005  20230901100839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013784
=035  \\$aCBA7115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x937.$x800
=150  \\$aTextiles
=450  \\$wnnna$aTextile
=450  \\$aTextile Fabrics$5IEN
=550  \\$wg$aTextile Industry
=550  \\$wh$aCotton Fiber
=550  \\$wh$aNylons
=550  \\$wh$aWool
=550  \\$aSilk
=667  \\$atextile mesh is probably SURGICAL MESH
=750  \0$aTextile fabrics$5IEN$0(DLC)sh 85134321
=750  \0$iNarrower mapping$aTzeltal textile fabrics$0(DLC)sh2022007199$4NM$5IEN-M

=LDR  00724cz  a2200217n  4500
=001  9880364067902441
=005  20141212192558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013783
=035  \\$aCBA7114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x937
=150  \\$aTextile Industry
=450  \\$wnnna$aIndustries, Textile
=450  \\$wnnna$aIndustry, Textile
=450  \\$wnnna$aTextile Industries
=550  \\$wg$aManufacturing Industry
=550  \\$wh$aTextiles
=667  \\$aSPEC: SPEC qualif; DF: TEXTILE INDUST
=680  \\$iThe aggregate business enterprise of manufacturing textiles. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aTextile industry$5IEN$0(DLC)sh 85134373

=LDR  00838cz  a2200241n  4500
=001  9880364068002441
=005  20141212210142.0
=008  800519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013782
=035  \\$aCBA7113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x900
=072  \\$aL1.$x178.$x820.$x900
=150  \\$aTextbooks as Topic
=550  \\$wg$aBooks
=550  \\$wg$aTeaching Materials
=550  \\$aReference Books
=667  \\$ado not confuse with the Publication Type TEXTBOOKS
=680  \\$iBooks used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.
=688  \\$a2008(1981)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Textbooks
=688  \\$a91(81); was see under BOOKS 1981-90
=750  \0$aTextbooks$0(DLC) sh 85134296$5IEN

=LDR  00933cz  a2200265n  4500
=001  9880364068102441
=005  20141212210141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013779
=035  \\$aCBA7110HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x786.$x910
=072  \\$aD23.$x946.$x580.$x910
=150  \\$aTetrodotoxin
=450  \\$aFugu Toxin
=450  \\$aTarichatoxin
=450  \\$wnnna$aTetradotoxin
=450  \\$wnnna$aToxin, Fugu
=550  \\$wg$aMarine Toxins
=550  \\$wg$aQuinazolines
=550  \\$aFishes, Poisonous
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iAn aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.
=688  \\$a68(64)
=750  \0$aTetrodotoxin$5IEN$0(DLC)sh 85134227

=LDR  00849cz  a2200193n  4500
=001  9880364068202441
=005  20141212210141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013778
=035  \\$aCBA7109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x617.$x700
=150  \\$aTetrazolium Salts
=450  \\$wnnna$aSalts, Tetrazolium
=550  \\$wg$aTetrazoles
=550  \\$wh$aNitroblue Tetrazolium
=667  \\$aindicators & reagents; D25-26 qualif
=680  \\$iQuaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. (From Mall's Dictionary of Chemistry, 5th ed, p455)
=750  \0$aTetrazolium salts$5IEN-M$0(DLC)sh2002008940

=LDR  00584cz  a2200217n  4500
=001  9880364068302441
=005  20171215153228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013777
=035  \\$aCBA7108M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x617
=150  \\$aTetrazoles
=550  \\$wg$aAzoles
=550  \\$wh$aCefotetan
=550  \\$wh$aLosartan
=550  \\$wh$aOlmesartan Medoxomil
=550  \\$wh$aTetrazolium Salts
=550  \\$wg$aValsartan
=688  \\$a91(73); was see under AZOLES 1973-90
=750  \0$aTetrazoles$5IEN-M$0(DLC)sh2002008941

=LDR  01369cz  a2200337n  4500
=001  9880364068402441
=005  20141212210140.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013775
=035  \\$aCBA7106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x203.$x87.$x50.$x750
=150  \\$aTetraphenylborate
=450  \\$wnnna$aAmmonium Salt Tetraphenylborate
=450  \\$wnnna$aKalignost
=450  \\$wnnna$aPotassium Salt Tetraphenylborate
=450  \\$wnnna$aSodium Salt, Tetraphenylborate
=450  \\$aSodium Tetraphenylborate
=450  \\$wnnna$aSodium, Tetraphenylboron
=450  \\$wnnna$aTetraphenylborate, Ammonium Salt
=450  \\$wnnna$aTetraphenylborate, Barium Salt (2:1)
=450  \\$wnnna$aTetraphenylborate, Potassium Salt
=450  \\$wnnna$aTetraphenylborate, Sodium
=450  \\$wnnna$aTetraphenylborate Sodium Salt
=450  \\$wnnna$aTetraphenylboron
=450  \\$aTetraphenylboron Sodium
=550  \\$wg$aBorohydrides
=667  \\$aD25-26 qualif
=680  \\$iAn anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays.
=688  \\$a91(75); was see under BORON COMPOUNDS 1975-90
=750  \0$aTetraphenylborates$5IEN$0(DLC)sh 85134220

=LDR  01148cz  a2200277n  4500
=001  9880364068502441
=005  20141212210139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013771
=035  \\$aCBA7102HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x849
=072  \\$aC14.$x280.$x400.$x849
=072  \\$aC16.$x131.$x240.$x400.$x849
=150  \\$aTetralogy of Fallot
=450  \\$wnnna$aFallot Tetralogy
=450  \\$aFallot's Tetralogy
=450  \\$wnnna$aFallots Tetralogy
=450  \\$wnnna$aTetralogy, Fallot
=450  \\$wnnna$aTetralogy, Fallot's
=450  \\$wnnna$aTetralogy, Fallots
=550  \\$wg$aHeart Defects, Congenital
=550  \\$aPentalogy of Cantrell
=667  \\$ado not confuse with TRILOGY OF FALLOT
=680  \\$iA combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
=750  \0$aTetralogy of Fallot$5IEN$0(DLC)sh 85134202

=LDR  00810cz  a2200217n  4500
=001  9880364068602441
=005  20141212210138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013769
=035  \\$aCBA7100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375.$x750.$x850.$x700
=150  \\$aTetrahymena pyriformis
=450  \\$wnnna$apyriformi, Tetrahymena
=450  \\$wnnna$apyriformis, Tetrahymena
=450  \\$wnnna$aTetrahymena pyriformi
=550  \\$wg$aTetrahymena
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of ciliate protozoa used extensively in genetic research.
=688  \\$a72
=750  \0$aTetrahymena pyriformis$5IEN$0(DLC)sh 88021454

=LDR  00769cz  a2200205n  4500
=001  9880364068702441
=005  20141212210138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013768
=035  \\$aCBA7099HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375.$x750.$x850
=150  \\$aTetrahymena
=450  \\$wnnna$aTetrahymenas
=550  \\$wg$aTetrahymenina
=550  \\$wh$aTetrahymena pyriformis
=550  \\$wh$aTetrahymena thermophila
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of ciliate protozoa commonly used in genetic, cytological, and other research.
=750  \0$aTetrahymena$5IEN$0(DLC)sh 88021453

=LDR  01301cz  a2200265n  4500
=001  9880364068802441
=005  20141212210136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013762
=035  \\$aCBA7093M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x662.$x825
=150  \\$aTetrahydrofolate Dehydrogenase
=450  \\$wnnna$aAcid Reductase, Folic
=450  \\$wnnna$aDehydrogenase, Dihydrofolate
=450  \\$wnnna$aDehydrogenase, Tetrahydrofolate
=450  \\$aDihydrofolate Dehydrogenase
=450  \\$aDihydrofolate Reductase
=450  \\$aFolic Acid Reductase
=450  \\$wnnna$aReductase, Dihydrofolate
=450  \\$wnnna$aReductase, Folic Acid
=550  \\$wg$aOxidoreductases Acting on CH-NH Group Donors
=680  \\$iAn enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3.
=688  \\$a66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88
=750  \0$aTetrahydrofolate dehydrogenase$0(DLC)sh2010012341$5IEN-M

=LDR  00845cz  a2200217n  4500
=001  9880364068902441
=005  20141212210030.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013574
=035  \\$aCBA6904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x835.$x859
=150  \\$aSynaptosomes
=450  \\$wnnna$aSynaptosome
=550  \\$wg$aSubcellular Fractions
=550  \\$aSynapses
=550  \\$aSynaptic Membranes
=667  \\$aA 11 qualif except /cytol
=680  \\$iPinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates.
=688  \\$a74(72)
=750  \0$aSynaptosomes$5IEN$0(DLC)sh 85131594

=LDR  01050cz  a2200241n  4500
=001  9880364069002441
=005  20141212210029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013572
=035  \\$aCBA6902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x850.$x840
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x880.$x830
=150  \\$aSynaptic Vesicles
=450  \\$wnnna$aSynaptic Vesicle
=450  \\$wnnna$aVesicle, Synaptic
=450  \\$wnnna$aVesicles, Synaptic
=550  \\$wg$aSynapses
=550  \\$wg$aTransport Vesicles
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iMembrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.
=688  \\$a72(70)
=750  \0$aSynaptic vesicles$0(DLC)sh2009008713$5IEN-M

=LDR  01201cz  a2200301n  4500
=001  9880364069102441
=005  20141212210029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013570
=035  \\$aCBA6900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x850.$x800
=072  \\$aA11.$x284.$x149.$x165.$x420.$x780.$x800
=072  \\$aA11.$x284.$x149.$x844
=150  \\$aSynaptic Membranes
=450  \\$wnnna$aMembrane, Synaptic
=450  \\$wnnna$aMembranes, Synaptic
=450  \\$wnnna$aSynaptic Membrane
=550  \\$wg$aCell Membrane
=550  \\$wg$aSynapses
=550  \\$wh$aPost-Synaptic Density
=550  \\$aCell Membrane
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iCell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters.
=688  \\$a73(70)
=750  \0$81$wb$aSynapses$5IEN$0(DLC)sh 85131591
=750  \0$81$wb$aMembranes (Biology)$5IEN-HS$0(DLC)sh 85083472
=788  \2$iSearch also under the following headings used together in the same record:$aSynapses$iand$aMembranes (Biology)$5IEN

=LDR  01546cz  a2200277n  4500
=001  9880364069202441
=005  20141212210028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013569
=035  \\$aCBA6899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x850
=072  \\$aA11.$x284.$x149.$x165.$x420.$x780
=150  \\$aSynapses
=450  \\$wnnna$aSynapse
=550  \\$wg$aIntercellular Junctions
=550  \\$wg$aNervous System
=550  \\$wh$aElectrical Synapses
=550  \\$wh$aNeuroeffector Junction
=550  \\$wh$aPresynaptic Terminals
=550  \\$wh$aSynaptic Membranes
=550  \\$wh$aSynaptic Vesicles
=550  \\$aSynaptic Transmission
=667  \\$anote specifics; IMMUNOLOGICAL SYNAPSES is also available; / physiol: consider also SYNAPTIC TRANSMISSION; do not confuse with SYNAPSIS see CHROMOSOME PAIRING
=680  \\$iSpecialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.
=750  \0$aSynapses$5IEN$0(DLC)sh 85131591

=LDR  00547cz  a2200193n  4500
=001  9880364069302441
=005  20141212210028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013567
=035  \\$aCBA6897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x910
=150  \\$aSymphysiotomy
=450  \\$aSymphyseotomy$5IEN
=450  \\$wnnna$aSymphysiotomies
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aPubic Symphysis
=667  \\$ado not use /util except by MeSH definition
=750  \0$aSymphyseotomy$5IEN$0(DLC)sh 85131548

=LDR  01309cz  a2200313n  4500
=001  9880364069402441
=005  20141212210028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013566
=035  \\$aCBA6896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x870
=150  \\$aSympathomimetics
=450  \\$wnnna$aAgents, Sympathomimetic
=450  \\$aAmines, Sympathomimetic
=450  \\$wnnna$aDrugs, Sympathomimetic
=450  \\$wnnna$aEffect, Sympathomimetic
=450  \\$wnnna$aEffects, Sympathomimetic
=450  \\$wnnna$aSympathomimetic Agents
=450  \\$wnnna$aSympathomimetic Amines
=450  \\$wnnna$aSympathomimetic Drugs
=450  \\$wnnna$aSympathomimetic Effect
=450  \\$wnnna$aSympathomimetic Effects
=550  \\$wg$aAutonomic Agents
=550  \\$aAdrenergic Agents
=550  \\$aSympathetic Nervous System
=667  \\$anote entry term SYMPATHOMIMETIC EFFECT: use only for the sympathomimetic effect of a chemical substance
=680  \\$iDrugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
=750  \0$aSympathomimetic agents$5IEN$0(DLC)sh 85131450

=LDR  01692cz  a2200361n  4500
=001  9880364069502441
=005  20141212210027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013565
=035  \\$aCBA6895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x850
=150  \\$aSympatholytics
=450  \\$wnnna$aAgents, Sympathetic-Blocking
=450  \\$wnnna$aAgents, Sympatholytic
=450  \\$wnnna$aDrugs, Sympatholytic
=450  \\$wnnna$aEffect, Sympatholytic
=450  \\$wnnna$aEffects, Sympatholytic
=450  \\$aSympathetic-Blocking Agents
=450  \\$wnnna$aSympathetic Blocking Agents
=450  \\$wnnna$aSympatholytic Agents
=450  \\$wnnna$aSympatholytic Drugs
=450  \\$wnnna$aSympatholytic Effect
=450  \\$wnnna$aSympatholytic Effects
=550  \\$wg$aAutonomic Agents
=550  \\$aAdrenergic Agents
=550  \\$aAdrenergic Antagonists
=550  \\$aMiotics
=550  \\$aSympathetic Nervous System
=667  \\$anote entry term SYMPATHOLYTIC EFFECT: use only for the sympatholytic effect of a chemical substance
=680  \\$iDrugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
=688  \\$aADRENERGIC FALSE TRANSMITTERS was heading 1973-81
=750  \0$aSympatholytic agents$5IEN$0(DLC)sh 85131449

=LDR  01345cz  a2200265n  4500
=001  9880364069602441
=005  20141212210027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013564
=035  \\$aCBA6894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x800
=150  \\$aSympathetic Nervous System
=450  \\$wnnna$aNervous System, Sympathetic
=450  \\$wnnna$aNervous Systems, Sympathetic
=450  \\$wnnna$aSympathetic Nervous Systems
=450  \\$wnnna$aSystem, Sympathetic Nervous
=450  \\$wnnna$aSystems, Sympathetic Nervous
=550  \\$wg$aAutonomic Nervous System
=550  \\$wh$aGanglia, Sympathetic
=550  \\$wh$aSplanchnic Nerves
=550  \\$wh$aVasomotor System
=667  \\$a/drug eff: consider also SYMPATHOLYTICS & SYMPATHOMIMETICS; /surg: probably SYMPATHECTOMY
=680  \\$iThe thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
=750  \0$aSympathetic nervous system$5IEN$0(DLC)sh 85090943

=LDR  01120cz  a2200265n  4500
=001  9880364069702441
=005  20141212210026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013562
=035  \\$aCBA6892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x210.$x80.$x800
=150  \\$aSympathectomy
=450  \\$aDenervation, Sympathetic
=450  \\$wnnna$aDenervations, Sympathetic
=450  \\$wnnna$aSympathectomies
=450  \\$aSympathetic Denervation
=450  \\$wnnna$aSympathetic Denervations
=550  \\$wg$aAutonomic Denervation
=550  \\$wh$aGanglionectomy
=550  \\$wh$aSympathectomy, Chemical
=550  \\$aSympathetic Nervous System
=667  \\$ado not use /util except by MeSH definition; coord with nerve /surg or plexus /surg (IM or NIM) but note that GANGLIONECTOMY is also available: see note there; lumbar sympathectomy: coord with LUMBOSACRAL PLEXUS/surg; coord IM with disease /surg (IM)
=680  \\$iThe removal or interruption of some part of the sympathetic nervous system for therapeutic or research purposes.
=750  \0$aSympathectomy$5IEN$0(DLC)sh 85131447

=LDR  01237cz  a2200277n  4500
=001  9880364069802441
=005  20190304102751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013561
=035  \\$aCBA6891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x899
=072  \\$aK1.$x752.$x798
=150  \\$aSymbolism
=450  \\$wnnna$aSymbolism (Psychology)
=450  \\$wnnna$aSymbolisms
=450  \\$wnnna$aSymbolisms (Psychology)
=550  \\$wg$aHistory
=550  \\$wg$aPhilosophy
=550  \\$wh$aMetaphor
=550  \\$wh$aSymbolic Interactionism
=667  \\$ano qualif; symbolism in art, music, literature, etc. goes here; graphic symbols go in a variety of places where pertinent (EMBLEMS AND INSIGNIA; LANGUAGE; COMMUNICATION; WRITING; etc.); coord IM with the object or concept symbolized (IM)
=680  \\$iA concept that stands for or suggests something else by reason of its relationship, association, convention, or resemblance. The symbolism may be mental or a visible sign or representation. (From Webster, 3d ed)
=688  \\$a96; was SYMBOLISM (PSYCHOLOGY) 1979-95; was heading 1963-78
=750  \0$aSymbolism$5IEN$0(DLC)sh 85131408
=750  \0$aSymbolism (Psychology)$5IEN-HS$0(DLC)sh 85131411

=LDR  00825cz  a2200229n  4500
=001  9880364069902441
=005  20170609110821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013559
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x550.$x800
=072  \\$aG16.$x840
=150  \\$aSymbiosis
=450  \\$wnnna$aCommensalism
=450  \\$aEndosymbiosis
=450  \\$wnnna$aMutualism
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aMicrobial Interactions
=550  \\$aEndophytes
=550  \\$aMycorrhizae
=680  \\$iThe relationship between two different species of organisms that are interdependent; each gains benefits from the other or a relationship between different species where both of the organisms in question benefit from the presence of the other.
=750  \0$aSymbiosis$5IEN$0(DLC)sh 85131402

=LDR  00903cz  a2200229n  4500
=001  9880364070002441
=005  20141212210024.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013555
=035  \\$aCBA6885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x359.$x855
=072  \\$aC22.$x905.$x850
=150  \\$aSwine Vesicular Disease
=450  \\$wnnna$aSwine Vesicular Diseases
=450  \\$wnnna$aVesicular Disease, Swine
=450  \\$wnnna$aVesicular Diseases, Swine
=550  \\$wg$aEnterovirus Infections
=550  \\$wg$aSwine Diseases
=680  \\$iAn enterovirus infection of swine clinically indistinguishable from FOOT-AND-MOUTH DISEASE, vesicular stomatitis, and VESICULAR EXANTHEMA OF SWINE. It is caused by a strain of HUMAN ENTEROVIRUS B.
=688  \\$a91(75); was see under ENTEROVIRUS INFECTIONS 1975-90
=750  \0$aSwine vesicular disease$5IEN$0(DLC)sh 87000745

=LDR  00816cz  a2200217n  4500
=001  9880364070102441
=005  20141212210024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013554
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x334.$x776
=072  \\$aC22.$x331.$x693
=072  \\$aC22.$x905.$x832
=150  \\$aSwine Erysipelas
=450  \\$wnnna$aErysipelas, Swine
=550  \\$wg$aErysipelothrix Infections
=550  \\$wg$aSwine Diseases
=667  \\$aErysipelothrix infect; don't forget also SWINE (NIM) & check tag ANIMALS
=680  \\$iAn acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa.
=688  \\$a91(75); was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67
=750  \0$aSwine erysipelas$5IEN$0(DLC)sh 85131255

=LDR  01460cz  a2200349n  4500
=001  9880364070202441
=005  20141212210024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013553
=035  \\$aCBA6883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x905
=150  \\$aSwine Diseases
=450  \\$wnnna$aDisease, Swine
=450  \\$wnnna$aDiseases, Swine
=450  \\$wnnna$aSwine Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aAfrican Swine Fever
=550  \\$wh$aClassical Swine Fever
=550  \\$wh$aEdema Disease of Swine
=550  \\$wh$aEncephalomyelitis, Enzootic Porcine
=550  \\$wh$aEpidermitis, Exudative, of Swine
=550  \\$wh$aGastroenteritis, Transmissible, of Swine
=550  \\$wh$aPneumonia of Swine, Mycoplasmal
=550  \\$wh$aPorcine Postweaning Multisystemic Wasting Syndrome
=550  \\$wh$aPorcine Reproductive and Respiratory Syndrome
=550  \\$wh$aSwine Erysipelas
=550  \\$wh$aSwine Vesicular Disease
=550  \\$wh$aVesicular Exanthema of Swine
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific swine dis (IM); for abnormalities or injuries, index under SWINE /abnorm or SWINE /inj; don't forget also SWINE (NIM) & check tag ANIMALS; swine fever & swine plague = CLASSICAL SWINE FEVER; DF: SWINE DIS
=680  \\$iDiseases of domestic swine and of the wild boar of the genus Sus.
=750  \0$aSwine$xDiseases$5IEN$0(DLC)sh 85131240

=LDR  01141cz  a2200277n  4500
=001  9880364070302441
=005  20141212210023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013552
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x880
=150  \\$aSwine
=360  \\$iconsider also terms at$aHOG$aPORCINE
=450  \\$wnnna$aHog, Wart
=450  \\$wnnna$aHogs, Wart
=450  \\$aPhacochoerus
=450  \\$aPigs
=450  \\$aSuidae
=450  \\$wnnna$aWart Hog
=450  \\$wnnna$aWart Hogs
=450  \\$aWarthogs
=550  \\$wg$aArtiodactyla
=550  \\$wh$aSus scrofa
=667  \\$aincludes boars & wart hogs; PIG, DOMESTIC see SUS SCROFA is available; unspecified swine or pigs goes here
=680  \\$iAny of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
=750  \0$aSwine$5IEN$0(DLC)sh 85131235

=LDR  00518cz  a2200181n  4500
=001  9880364070402441
=005  20170830172452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013551
=035  \\$aCBA6881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x410.$x500
=150  \\$aSwimming Pools
=450  \\$wnnna$aPool, Swimming
=450  \\$wnnna$aPools, Swimming
=450  \\$wnnna$aSwimming Pool
=550  \\$wg$aSports and Recreational Facilities
=750  \0$aSwimming pools$5IEN$0(DLC)sh 85131230

=LDR  01312cz   2200277n  4500
=001  9880364070502441
=005  20230901100449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013550
=035  \\$aCBA6880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x568.$x800
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x875
=072  \\$aI3.$x350.$x875
=072  \\$aI3.$x450.$x642.$x845.$x945.$x500
=150  \\$aSwimming
=450  \\$aSwimmers$5IEN
=550  \\$wg$aExercise
=550  \\$wg$aLocomotion
=550  \\$wg$aWater Sports
=550  \\$wh$aDiving
=667  \\$ahuman & animal; / inj: coordinate IM with specific injury (IM); includes body-surfing, does not include surfboarding, windsurfing or water-skiing (index under SPORTS); consider also DIVING; index NIM for swimming in animal experiments on PHYSICAL EXERTION
=680  \\$iAn activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of PHYSICAL EXERTION or endurance.
=750  \0$aSwimmers$5IEN-M$0(DLC)sh 85131205
=750  \0$aSwimming$5IEN-HS$0(DLC)sh 85131207
=750  \0$iNarrower mapping$aOpen water swimming$0(DLC)sh2022006138$4NM$5IEN-M

=LDR  01320cz  a2200385n  4500
=001  9880364070602441
=005  20141212210023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013549
=035  \\$aCBA6879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x364.$x609
=072  \\$aD27.$x720.$x888
=072  \\$aJ2.$x500.$x512.$x400.$x700
=150  \\$aSweetening Agents
=450  \\$wnnna$aAgent, Sweetening
=450  \\$wnnna$aAgents, Sweetening
=450  \\$wnnna$aArtificial Sweetener
=450  \\$aArtificial Sweeteners
=450  \\$wnnna$aSubstitute, Sugar
=450  \\$wnnna$aSubstitutes, Sugar
=450  \\$wnnna$aSugar Substitute
=450  \\$aSugar Substitutes
=450  \\$wnnna$aSweetener
=450  \\$wnnna$aSweetener, Artificial
=450  \\$wnnna$aSweeteners
=450  \\$wnnna$aSweeteners, Artificial
=450  \\$wnnna$aSweetening Agent
=550  \\$wg$aFlavoring Agents
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aNon-Nutritive Sweeteners
=550  \\$wh$aNutritive Sweeteners
=667  \\$aD25-26 qualif
=680  \\$iSubstances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aSweeteners$5IEN$0(DLC)sh 85131197

=LDR  00811cz  a2200241n  4500
=001  9880364070702441
=005  20141212210022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x336.$x899
=072  \\$aA17.$x815.$x830
=150  \\$aSweat Glands
=450  \\$wnnna$aGland, Sweat
=450  \\$wnnna$aGlands, Sweat
=450  \\$wnnna$aSweat Gland
=550  \\$wg$aExocrine Glands
=550  \\$wg$aSkin
=550  \\$wh$aApocrine Glands
=550  \\$wh$aEccrine Glands
=667  \\$a/secret: see also SWEAT or SWEATING; inflammation = HIDRADENITIS
=680  \\$iSweat-producing structures that are embedded in the DERMIS. Each gland consists of a single tube, a coiled body, and a superficial duct.
=750  \0$aSweat glands$5IEN$0(DLC)sh 85131026

=LDR  00774cz  a2200241n  4500
=001  9880364070802441
=005  20141212210021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013544
=035  \\$aCBA6874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x805.$x776
=072  \\$aC17.$x800.$x882.$x743
=072  \\$aC17.$x800.$x946.$x743
=150  \\$aSweat Gland Neoplasms
=450  \\$wnnna$aNeoplasm, Sweat Gland
=450  \\$wnnna$aNeoplasms, Sweat Gland
=450  \\$wnnna$aSweat Gland Neoplasm
=550  \\$wg$aSkin Neoplasms
=550  \\$wg$aSweat Gland Diseases
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=688  \\$a68
=750  \0$aSweat glands$xTumors$0(IEN)380664$5IEN-M

=LDR  00818cz  a2200277n  4500
=001  9880364070902441
=005  20141212210021.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013543
=035  \\$aCBA6873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x946
=150  \\$aSweat Gland Diseases
=450  \\$wnnna$aDisease, Sweat Gland
=450  \\$wnnna$aDiseases, Sweat Gland
=450  \\$wnnna$aSweat Gland Disease
=550  \\$wg$aSkin Diseases
=550  \\$wh$aHidradenitis
=550  \\$wh$aHyperhidrosis
=550  \\$wh$aHypohidrosis
=550  \\$wh$aMiliaria
=550  \\$wh$aSweat Gland Neoplasms
=667  \\$ainflamm dis = HIDRADENITIS
=680  \\$iDiseases of the SWEAT GLANDS.
=688  \\$a76; was NON MESH before 1976
=750  \0$aSweat glands$xDiseases$5IEN$0(DLC)sh 85131027

=LDR  00648cz  a2200193n  4500
=001  9880364071002441
=005  20141212210021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013542
=035  \\$aCBA6872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x849
=150  \\$aSweat
=450  \\$aPerspiration$5IEN
=450  \\$wnnna$aSweats
=550  \\$wg$aBodily Secretions
=667  \\$aTN 181: relation to SWEAT GLANDS & SWEATING
=680  \\$iThe fluid excreted by the SWEAT GLANDS. It consists of water containing sodium chloride, phosphate, urea, ammonia, and other waste products.
=750  \0$aPerspiration$5IEN$0(DLC)sh 85100174

=LDR  01175cz  a2200313n  4500
=001  9880364071102441
=005  20141212210020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013539
=035  \\$aCBA6869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x640.$x615.$x700
=072  \\$aB4.$x909.$x204.$x210.$x620.$x615.$x700
=072  \\$aB4.$x909.$x574.$x204.$x670.$x615.$x700
=072  \\$aB4.$x909.$x675.$x615.$x700
=150  \\$aSimian virus 40
=450  \\$wnnna$aPolyomavirus macacae
=450  \\$wnnna$aSV 40 Virus
=450  \\$wnnna$aSV 40 Viruses
=450  \\$aSV40 Virus
=450  \\$wnnna$aSV40 Viruses
=450  \\$aVacuolating Agent
=450  \\$wnnna$aVacuolating Agents
=450  \\$wnnna$avirus 40, Simian
=550  \\$wg$aPolyomavirus
=667  \\$aX ref SV40 VIRUS is from Simian Vacuolating virus; infection: coord IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)
=680  \\$iA species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures.
=688  \\$a2001 (1965)
=750  \0$aSV40 (Virus)$5IEN$0(DLC)sh 85122722

=LDR  00864cz  a2200253n  4500
=001  9880364071202441
=005  20141212210020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013537
=035  \\$aCBA6867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x690.$x820
=150  \\$aSutures
=450  \\$wnnna$aStaple, Surgical
=450  \\$aStaples, Surgical
=450  \\$wnnna$aSurgical Staple
=450  \\$aSurgical Staples
=450  \\$wnnna$aSuture
=550  \\$wg$aSurgical Fixation Devices
=550  \\$wh$aCatgut
=550  \\$aSilk
=667  \\$a/adv eff permitted but do not confuse adv eff of the suture with the adv eff of the material of which suture is made or the adv eff of the suture method
=680  \\$iMaterials used in closing a surgical or traumatic wound. (From Dorland, 28th ed)
=750  \0$aSutures$5IEN$0(DLC)sh 85130917

=LDR  00955cz  a2200301n  4500
=001  9880364071302441
=005  20141212210019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013536
=035  \\$aCBA6866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x987.$x775
=150  \\$aSuture Techniques
=450  \\$wnnna$aSuture Technic
=450  \\$wnnna$aSuture Technics
=450  \\$wnnna$aSuture Technique
=450  \\$aSutures$xmethods
=450  \\$aSuturing$5IEN
=450  \\$wnnna$aTechnic, Suture
=450  \\$wnnna$aTechnics, Suture
=450  \\$wnnna$aTechnique, Suture
=450  \\$wnnna$aTechniques, Suture
=550  \\$wg$aWound Closure Techniques
=550  \\$wh$aSurgical Stapling
=550  \\$wh$aTenodesis
=680  \\$iTechniques for securing together the edges of a wound, with loops of thread or similar materials (SUTURES).
=688  \\$a91; was SUTURE TECHNICS 1963-90
=750  \0$aSuturing$5IEN$0(DLC)sh 85130918

=LDR  00846cz  a2200181n  4500
=001  9880364071402441
=005  20141212192553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013535
=035  \\$aCBA6865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x280.$x810
=072  \\$aD26.$x255.$x165.$x810
=150  \\$aSuspensions
=550  \\$wg$aColloids
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in suspension, not the "suspension"
=680  \\$iColloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOLS) and other colloidal systems; water-insoluble drugs may be given as suspensions.
=750  \0$aSuspensions (Chemistry)$5IEN$0(DLC)sh 85130899

=LDR  00591cz  a2200169n  4500
=001  9880364071502441
=005  20141212192553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013534
=035  \\$aCBA6864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x784
=150  \\$aSurvival
=550  \\$wg$aHuman Activities
=667  \\$ause for survival after adverse events such as disasters, plane crashes, shipwrecks
=680  \\$iContinuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.
=750  \0$aSurvival$0(DLC)sh 85130882$5IEN-M

=LDR  01349cz  a2200385n  4500
=001  9880364071602441
=005  20141212192552.0
=008  850320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013533
=035  \\$aCBA6863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x500.$x320.$x892
=072  \\$aI1.$x880.$x853.$x150.$x500.$x340.$x892
=072  \\$aM1.$x620.$x892
=150  \\$aSurrogate Mothers
=450  \\$wnnna$aCarrier, Gestational
=450  \\$wnnna$aCarriers, Gestational
=450  \\$wnnna$aGestational Carrier
=450  \\$aGestational Carriers
=450  \\$wnnna$aGestational Mother
=450  \\$aGestational Mothers
=450  \\$wnnna$aHost Mother
=450  \\$wnnna$aHost Mothers
=450  \\$wnnna$aMother, Gestational
=450  \\$wnnna$aMother, Host
=450  \\$wnnna$aMother, Surrogate
=450  \\$aMothers, Gestational
=450  \\$wnnna$aMothers, Host
=450  \\$aMothers, Surrogate
=450  \\$wnnna$aSurrogate Mother
=550  \\$wg$aParents
=667  \\$ahuman only; check tags HUMAN; FEMALE & PREGNANCY
=680  \\$iWomen who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate.
=688  \\$a90(86); was see under MOTHERS 1986-89
=750  \0$aSurrogate mothers$5IEN$0(DLC)sh 85130850

=LDR  00855cz  a2200229n  4500
=001  9880364071702441
=005  20141212210019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013531
=035  \\$aCBA6861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x652
=072  \\$aN2.$x278.$x421.$x556.$x868
=150  \\$aSurgicenters
=450  \\$aSurgical Clinics$5IEN
=450  \\$wnnna$aSurgicenter
=550  \\$wg$aAmbulatory Care Facilities
=550  \\$wg$aHospitals, Special
=550  \\$aAmbulatory Surgical Procedures
=680  \\$iFacilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician's office yet not of such proportion as to require hospitalization.
=688  \\$a78(72); was see under HOSPITALS, SPECIAL 1975-77
=750  \0$aSurgical clinics$5IEN$0(DLC)sh 85130794

=LDR  01231cz  a2200325n  4500
=001  9880364071802441
=005  20141212210018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013530
=035  \\$aCBA6860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x947.$x692
=072  \\$aC23.$x550.$x767.$x925
=150  \\$aSurgical Wound Infection
=450  \\$wnnna$aInfection, Postoperative Wound
=450  \\$wnnna$aInfection, Surgical Wound
=450  \\$wnnna$aInfections, Postoperative Wound
=450  \\$wnnna$aInfections, Surgical Wound
=450  \\$aPostoperative Wound Infection
=450  \\$wnnna$aPostoperative Wound Infections
=450  \\$wnnna$aSurgical Wound Infections
=450  \\$wnnna$aWound Infection, Postoperative
=450  \\$wnnna$aWound Infection, Surgical
=450  \\$wnnna$aWound Infections, Postoperative
=450  \\$wnnna$aWound Infections, Surgical
=550  \\$wg$aPostoperative Complications
=550  \\$wg$aWound Infection
=667  \\$acoordinate IM with specific infection term (IM); do not coordinate with POSTOPERATIVE COMPLICATIONS
=680  \\$iInfection occurring at the site of a surgical incision.
=750  \0$aSurgical wound infections$5IEN$0(DLC)sh 85130804

=LDR  00820cz  a2200205n  4500
=001  9880364071902441
=005  20141212210018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013528
=035  \\$aCBA6858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x700.$x750
=150  \\$aSurgical Staplers
=450  \\$wnnna$aStapler, Surgical
=450  \\$wnnna$aStaplers, Surgical
=450  \\$wnnna$aSurgical Stapler
=550  \\$wg$aSurgical Instruments
=680  \\$iFastening devices composed of steel-tantalum alloys used to close operative wounds, especially of the skin, which minimizes infection by not introducing a foreign body that would connect external and internal regions of the body. (From Segen, Current Med Talk, 1995)
=688  \\$a66(64)
=750  \0$aStaplers (Surgery)$5IEN$0(DLC)sh 85127367

=LDR  01224cz  a2200337n  4500
=001  9880364072002441
=005  20141212210017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013527
=035  \\$aCBA6857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x731.$x500
=072  \\$aH2.$x478.$x676.$x650
=072  \\$aN2.$x421.$x533.$x710
=072  \\$aN2.$x421.$x585.$x722.$x500
=150  \\$aPerioperative Nursing
=450  \\$wnnna$aNursing, Perianesthesia
=450  \\$wnnna$aNursing, Perioperative
=450  \\$wnnna$aNursing, Surgical
=450  \\$wnnna$aPerianesthesia Nursing
=450  \\$aSurgical Nursing
=550  \\$wg$aNursing Care
=550  \\$wg$aPerioperative Care
=550  \\$wg$aSpecialties, Nursing
=550  \\$wh$aOperating Room Nursing
=550  \\$wh$aPostanesthesia Nursing
=667  \\$aOPERATING ROOM NURSING is also available
=680  \\$iNursing care of the surgical patient before, during, and after surgery.
=688  \\$a1996 (1968); for PERIOPERATIVE NURSING use OPERATING ROOM NURSING 1988-1995
=688  \\$a96; was SURGICAL NURSING 1968-95; PERIOPERATIVE NURSING was see OPERATING ROOM NURSING 1988-95
=750  \0$aSurgical nursing$5IEN$0(DLC)sh 85130801

=LDR  02123cz  a2200649n  4500
=001  9880364072102441
=005  20141212210017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013525
=035  \\$aCBA6855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x700
=150  \\$aSurgical Instruments
=450  \\$wnnna$aClamp, Surgical
=450  \\$aClamps, Surgical
=450  \\$wnnna$aClip
=450  \\$wnnna$aClip, Surgical
=450  \\$wnnna$aClip, Tantalum
=450  \\$wnnna$aClips
=450  \\$aClips, Surgical
=450  \\$aClips, Tantalum
=450  \\$wnnna$aForcep
=450  \\$aForceps
=450  \\$wnnna$aHook, Surgical
=450  \\$aHooks, Surgical
=450  \\$wnnna$aInstrument, Surgical
=450  \\$wnnna$aInstruments, Surgical
=450  \\$wnnna$aPlug, Surgical
=450  \\$aPlugs, Surgical
=450  \\$aScissors, Surgical
=450  \\$aSpeculum
=450  \\$wnnna$aSpeculums
=450  \\$wnnna$aSurgical Clamp
=450  \\$aSurgical Clamps
=450  \\$wnnna$aSurgical Clip
=450  \\$aSurgical Clips
=450  \\$wnnna$aSurgical Hook
=450  \\$aSurgical Hooks
=450  \\$wnnna$aSurgical Instrument
=450  \\$wnnna$aSurgical Plug
=450  \\$aSurgical Plugs
=450  \\$aSurgical Scissors
=450  \\$wnnna$aSurgical Valve
=450  \\$aSurgical Valves
=450  \\$wnnna$aTantalum Clip
=450  \\$wnnna$aTantalum Clips
=450  \\$aTrocar
=450  \\$wnnna$aTrocars
=450  \\$wnnna$aValve, Surgical
=450  \\$aValves, Surgical
=550  \\$wg$aSurgical Equipment
=550  \\$wh$aObstetrical Forceps
=550  \\$wh$aSurgical Staplers
=667  \\$aGEN or unspecified; prefer /instrum with specialty or with surg technique; differentiate from SURGICAL EQUIPMENT on basis of size (instruments are holdable in the hand); surg instrum left in the operative field: coord IM with FOREIGN BODIES (IM)
=680  \\$iHand-held tools or implements used by health professionals for the performance of surgical tasks.
=688  \\$a65
=750  \0$aSurgical instruments and apparatus$0(DLC) sh 85130799$5IEN

=LDR  01362cz  a2200337n  4500
=001  9880364072202441
=005  20141212210016.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013524
=035  \\$aCBA6854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x850.$x710
=072  \\$aE7.$x862.$x710
=150  \\$aSurgical Flaps
=450  \\$wnnna$aFlap, Pedicled
=450  \\$wnnna$aFlap, Surgical
=450  \\$wnnna$aFlaps, Pedicled
=450  \\$wnnna$aFlaps, Surgical
=450  \\$aIsland Flaps
=450  \\$wnnna$aPedicled Flap
=450  \\$wnnna$aPedicled Flaps
=450  \\$wnnna$aSurgical Flap
=550  \\$wg$aSurgically-Created Structures
=550  \\$wh$aFree Tissue Flaps
=550  \\$wh$aMyocutaneous Flap
=550  \\$wh$aPerforator Flap
=550  \\$aSkin Transplantation
=667  \\$aincludes skin & muscle tissue but do not specify site or tissue unless particularly discussed; do not coordinate with TRANSPLANTATION, AUTOLOGOUS
=680  \\$iTongues of skin and subcutaneous tissue, sometimes including muscle, cut away from the underlying parts but often still attached at one end. They retain their own microvasculature which is also transferred to the new site. They are often used in plastic surgery for filling a defect in a neighboring region.
=688  \\$a80
=750  \0$aFlaps (Surgery)$5IEN$0(DLC)sh 85049002

=LDR  01126cz  a2200301n  4500
=001  9880364072302441
=005  20141212210013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013518
=035  \\$aCBA6848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x788
=150  \\$aSurgery, Plastic
=450  \\$aCosmetic Surgery
=450  \\$wnnna$aEsthetic Surgeries
=450  \\$aEsthetic Surgery
=450  \\$aPlastic Surgeons$5IEN
=450  \\$aPlastic Surgery
=450  \\$wnnna$aSurgeries, Esthetic
=450  \\$aSurgery, Cosmetic
=450  \\$aSurgery, Esthetic
=550  \\$wg$aSpecialties, Surgical
=550  \\$aDermatologic Surgical Procedures
=550  \\$aReconstructive Surgical Procedures
=667  \\$aSPEC; do not confuse with RECONSTRUCTIVE SURGICAL PROCEDURES, the technique; not for -plasty in internal surgery: Manual 26.18
=680  \\$iThe branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures.
=750  \0$aSurgery, Plastic$5IEN-M$0(DLC)sh 85130786
=750  \0$aPlastic surgeons$5IEN-HS$0(DLC)sh 85103145

=LDR  02035cz  a2200469n  4500
=001  9880364072402441
=005  20141212210013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013517
=035  \\$aCBA6847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580
=150  \\$aOtorhinolaryngologic Surgical Procedures
=450  \\$wnnna$aOtorhinolaryngologic Surgical Procedure
=450  \\$wnnna$aOtorhinolaryngological Surgical Procedure
=450  \\$wnnna$aOtorhinolaryngological Surgical Procedures
=450  \\$wnnna$aProcedure, Otorhinolaryngologic Surgical
=450  \\$wnnna$aProcedure, Otorhinolaryngological Surgical
=450  \\$wnnna$aProcedures, Otorhinolaryngologic Surgical
=450  \\$wnnna$aProcedures, Otorhinolaryngological Surgical
=450  \\$wnnna$aSurgical Procedure, Otorhinolaryngologic
=450  \\$wnnna$aSurgical Procedure, Otorhinolaryngological
=450  \\$wnnna$aSurgical Procedures, Otorhinolaryngologic
=450  \\$wnnna$aSurgical Procedures, Otorhinolaryngological
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aAdenoidectomy
=550  \\$wh$aLaryngectomy
=550  \\$wh$aLaryngoplasty
=550  \\$wh$aLaryngoscopy
=550  \\$wh$aNasal Surgical Procedures
=550  \\$wh$aNeck Dissection
=550  \\$wh$aOtologic Surgical Procedures
=550  \\$wh$aPharyngectomy
=550  \\$wh$aPharyngostomy
=550  \\$wh$aTonsillectomy
=550  \\$wh$aTracheostomy
=550  \\$wh$aTracheotomy
=550  \\$aOtolaryngology
=667  \\$aGEN or unspecified; prefer specifics; consider also EAR /surg, NOSE /surg, LARYNX /surg & /surg with specific parts of these organs; also OTORHINOLARYNGOLOGIC DISEASES /surg & /surg with specific ORL dis; DF: ORL SURG PROCEDURES
=680  \\$iSurgery performed on the ear and its parts, the nose and nasal cavity, or the throat, including surgery of the adenoids, tonsils, pharynx, and trachea.
=688  \\$a98; use explode 1970-97
=750  \0$aOtolaryngology, Operative$5IEN-M$0(DLC)sh 85096058

=LDR  01263cz  a2200289n  4500
=001  9880364072502441
=005  20170827165531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013515
=035  \\$aCBA6845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x892
=072  \\$aH2.$x163.$x876.$x886
=150  \\$aSurgery, Oral
=450  \\$aExodontics
=450  \\$wnnna$aMaxillofacial Surgery
=450  \\$wnnna$aOral Surgery
=450  \\$aSurgery, Maxillofacial
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aOrthognathic Surgery
=550  \\$aMouth
=550  \\$aOral Surgical Procedures
=667  \\$aspecialty of surgical therapy of diseases, injuries & defects of soft tissue of mouth & jaws; do not confuse with DENTISTRY, OPERATIVE: to restore tooth function; cranio-maxillo-facial surgery does not go here; use instead SPECIALTIES, SURGICAL; see also note at ORAL SURGICAL PROCEDURES
=680  \\$iA dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.
=688  \\$aEXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64
=750  \0$aMouth$xSurgery$5IEN-HS$0(DLC)sh 85088002

=LDR  04073cz  a2201033n  4500
=001  9880364072602441
=005  20200530174226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013514
=035  \\$aCBA6844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4
=150  \\$aSurgical Procedures, Operative
=450  \\$wnnna$aGhost Surgery
=450  \\$wnnna$aOperative Procedure
=450  \\$wnnna$aOperative Procedures
=450  \\$wnnna$aOperative Surgical Procedure
=450  \\$wnnna$aOperative Surgical Procedures
=450  \\$wnnna$aProcedure, Operative
=450  \\$wnnna$aProcedure, Operative Surgical
=450  \\$wnnna$aProcedures, Operative
=450  \\$wnnna$aProcedures, Operative Surgical
=450  \\$wnnna$aSurgery, Ghost
=450  \\$wnno$aSurgery, Operative$5IEN
=450  \\$wnnna$aSurgical Procedure, Operative
=550  \\$wh$aAblation Techniques
=550  \\$wh$aAmbulatory Surgical Procedures
=550  \\$wh$aAnastomosis, Surgical
=550  \\$wh$aAssisted Circulation
=550  \\$wh$aBariatric Surgery
=550  \\$wh$aBiopsy
=550  \\$wh$aBloodless Medical and Surgical Procedures
=550  \\$wh$aBody Modification, Non-Therapeutic
=550  \\$wh$aCardiovascular Surgical Procedures
=550  \\$wh$aCurettage
=550  \\$wh$aCytoreduction Surgical Procedures
=550  \\$wh$aDebridement
=550  \\$wh$aDecompression, Surgical
=550  \\$wh$aDeep Brain Stimulation
=550  \\$wh$aDevice Removal
=550  \\$wh$aDigestive System Surgical Procedures
=550  \\$wh$aDissection
=550  \\$wh$aDrainage
=550  \\$wh$aElective Surgical Procedures
=550  \\$wh$aElectrosurgery
=550  \\$wh$aEndocrine Surgical Procedures
=550  \\$wh$aExtracorporeal Circulation
=550  \\$wh$aFasciotomy
=550  \\$wh$aHemostasis, Surgical
=550  \\$wh$aKeratectomy
=550  \\$wh$aLaparotomy
=550  \\$wh$aLigation
=550  \\$wh$aLymph Node Excision
=550  \\$wh$aMastectomy
=550  \\$wh$aMetastasectomy
=550  \\$wh$aMicrosurgery
=550  \\$wh$aMinimally Invasive Surgical Procedures
=550  \\$wh$aMinor Surgical Procedures
=550  \\$wh$aMonitoring, Intraoperative
=550  \\$wh$aMyotomy
=550  \\$wh$aNeurosurgical Procedures
=550  \\$wh$aObstetric Surgical Procedures
=550  \\$wh$aOphthalmologic Surgical Procedures
=550  \\$wh$aOral Surgical Procedures
=550  \\$wh$aOrthopedic Procedures
=550  \\$wh$aOstomy
=550  \\$wh$aOtorhinolaryngologic Surgical Procedures
=550  \\$wh$aPelvic Exenteration
=550  \\$wh$aPerioperative Care
=550  \\$wh$aPerioperative Period
=550  \\$wh$aProphylactic Surgical Procedures
=550  \\$wh$aProsthesis Implantation
=550  \\$wh$aPunctures
=550  \\$wh$aReconstructive Surgical Procedures
=550  \\$wh$aReoperation
=550  \\$wh$aSecond-Look Surgery
=550  \\$wh$aSplenectomy
=550  \\$wh$aSurgery, Computer-Assisted
=550  \\$wh$aSymphysiotomy
=550  \\$wh$aThoracic Surgical Procedures
=550  \\$wh$aTransplantation
=550  \\$wh$aUltrasonic Surgical Procedures
=550  \\$wh$aUrogenital Surgical Procedures
=550  \\$wh$aWound Closure Techniques
=550  \\$aGeneral Surgery
=667  \\$anot the field nor specialty ( = GENERAL SURGERY); only the surgery patient or surgical procedures; prefer /surg with organs or disease; /instrum = SURGICAL INSTRUMENTS or SURGICAL EQUIPMENT; surgical injury = SURGICAL INJURIES see INTRAOPERATIVE COMPLICATIONS: see TN 179; /hist = GENERAL SURGERY /hist; differentiation from GENERAL SURGERY: Manual 26.15+; unnecessary surgery = SURGERY, UNNECESSARY see UNNECESSARY PROCEDURES (IM) + specific surg procedure (IM); SECOND-LOOK SURGERY and REOPERATION are also available
=680  \\$iOperations carried out for the correction of deformities and defects, repair of injuries, and diagnosis and cure of certain diseases. (Taber, 18th ed.)
=688  \\$a98(63)
=750  \0$aSurgery, Operative$0(DLC) sh 85130782$5IEN

=LDR  02112cz  a2200529n  4500
=001  9880364072702441
=005  20141212210010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013513
=035  \\$aCBA6843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520
=150  \\$aObstetric Surgical Procedures
=450  \\$wnnna$aObstetric Surgeries
=450  \\$wnnna$aObstetric Surgery
=450  \\$wnnna$aObstetric Surgical Procedure
=450  \\$wnnna$aObstetrical Surgeries
=450  \\$wnnna$aObstetrical Surgery
=450  \\$wnnna$aObstetrical Surgical Procedure
=450  \\$wnnna$aObstetrical Surgical Procedures
=450  \\$wnnna$aProcedure, Obstetric Surgical
=450  \\$wnnna$aProcedure, Obstetrical Surgical
=450  \\$wnnna$aProcedures, Obstetric Surgical
=450  \\$wnnna$aProcedures, Obstetrical Surgical
=450  \\$wnnna$aSurgeries, Obstetric
=450  \\$wnnna$aSurgeries, Obstetrical
=450  \\$wnnna$aSurgery, Obstetric
=450  \\$wnnna$aSurgery, Obstetrical
=450  \\$wnnna$aSurgical Procedure, Obstetric
=450  \\$wnnna$aSurgical Procedure, Obstetrical
=450  \\$wnnna$aSurgical Procedures, Obstetric
=450  \\$wnnna$aSurgical Procedures, Obstetrical
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aAbortion, Induced
=550  \\$wh$aCerclage, Cervical
=550  \\$wh$aColposcopy
=550  \\$wh$aColpotomy
=550  \\$wh$aCuldoscopy
=550  \\$wh$aDelivery, Obstetric
=550  \\$wh$aFetoscopy
=550  \\$wh$aHysteroscopy
=550  \\$wh$aHysterotomy
=550  \\$aObstetrics
=667  \\$aGEN or unspecified; prefer specifics; consider also PREGNANCY COMPLICATIONS /surg & OBSTETRIC LABOR COMPLICATIONS /surg or /surg with specific pregn & labor compl; check the tags FEMALE & PREGNANCY; DF: OBSTET SURG PROCEDURES
=680  \\$iSurgery performed on the pregnant woman for conditions associated with pregnancy, labor, or the puerperium. It does not include surgery of the newborn infant.
=688  \\$a98; use explode 1970-97
=750  \0$aObstetrics$xSurgery$5IEN-M$0(DLC)sh 85093782

=LDR  01086cz  a2200313n  4500
=001  9880364072802441
=005  20141212192549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013511
=035  \\$aCBA6841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x506
=150  \\$aMinor Surgical Procedures
=450  \\$wnnna$aMinor Surgeries
=450  \\$aMinor Surgery
=450  \\$wnnna$aMinor Surgical Procedure
=450  \\$wnnna$aProcedure, Minor Surgical
=450  \\$wnnna$aProcedures, Minor Surgical
=450  \\$wnnna$aSurgeries, Minor
=450  \\$wnnna$aSurgery, Minor
=450  \\$wnnna$aSurgical Procedure, Minor
=450  \\$aSurgical Procedures, Minor
=550  \\$wg$aSurgical Procedures, Operative
=667  \\$aIM general only
=680  \\$iSurgery for problems and injuries that are of relatively slight extent, and with a low risk for life threatening complications.
=688  \\$a2015(1963)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Surgical Procedures, Minor
=688  \\$a98(63)
=750  \0$aSurgery, Minor$5IEN$0(DLC)sh 85130780

=LDR  01883cz  a2200493n  4500
=001  9880364072902441
=005  20141212210008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013508
=035  \\$aCBA6838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540
=150  \\$aOphthalmologic Surgical Procedures
=450  \\$aEye$xsurgery
=450  \\$wnnna$aOphthalmologic Surgical Procedure
=450  \\$wnnna$aOphthalmological Surgical Procedure
=450  \\$wnnna$aOphthalmological Surgical Procedures
=450  \\$wnnna$aProcedure, Ophthalmologic Surgical
=450  \\$wnnna$aProcedure, Ophthalmological Surgical
=450  \\$wnnna$aProcedures, Ophthalmologic Surgical
=450  \\$wnnna$aProcedures, Ophthalmological Surgical
=450  \\$wnnna$aSurgical Procedure, Ophthalmologic
=450  \\$wnnna$aSurgical Procedure, Ophthalmological
=450  \\$wnnna$aSurgical Procedures, Ophthalmologic
=450  \\$wnnna$aSurgical Procedures, Ophthalmological
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aBlepharoplasty
=550  \\$wh$aDacryocystorhinostomy
=550  \\$wh$aEndotamponade
=550  \\$wh$aEye Enucleation
=550  \\$wh$aEye Evisceration
=550  \\$wh$aFiltering Surgery
=550  \\$wh$aIridectomy
=550  \\$wh$aLight Coagulation
=550  \\$wh$aOrbit Evisceration
=550  \\$wh$aRefractive Surgical Procedures
=550  \\$wh$aScleral Buckling
=550  \\$wh$aVitrectomy
=550  \\$wh$aVitreoretinal Surgery
=550  \\$aOphthalmology
=667  \\$aGEN or unspecified; prefer specifics; consider also /surg with specific parts of the eye; also EYE DISEASES /surg or /surg with specific eye dis; DF: OPHTHALMOL SURG PROCEDURES
=680  \\$iSurgery performed on the eye or any of its parts.
=688  \\$a98; use explode 1975-97
=750  \0$aEye$xSurgery$0(DLC) sh 85046678$5IEN-M

=LDR  02416cz  a2200649n  4500
=001  9880364073002441
=005  20200522121949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013505
=035  \\$aCBA6835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210
=150  \\$aDigestive System Surgical Procedures
=450  \\$aDigestive System$xsurgery
=450  \\$wnnna$aDigestive System Surgical Procedure
=450  \\$wnnna$aGastrointestinal Surgical Procedure
=450  \\$aGastrointestinal Surgical Procedures
=450  \\$wnnna$aProcedure, Digestive System Surgical
=450  \\$wnnna$aProcedure, Gastrointestinal Surgical
=450  \\$wnnna$aProcedures, Digestive System Surgical
=450  \\$wnnna$aProcedures, Gastrointestinal Surgical
=450  \\$wnnna$aSurgical Procedure, Digestive System
=450  \\$wnnna$aSurgical Procedure, Gastrointestinal
=450  \\$wnnna$aSurgical Procedures, Digestive System
=450  \\$wnnna$aSurgical Procedures, Gastrointestinal
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aAnastomosis, Roux-en-Y
=550  \\$wh$aAppendectomy
=550  \\$wh$aBiliary Tract Surgical Procedures
=550  \\$wh$aBiliopancreatic Diversion
=550  \\$wh$aColectomy
=550  \\$wh$aEndoscopy, Digestive System
=550  \\$wh$aEnterostomy
=550  \\$wh$aEsophagectomy
=550  \\$wh$aEsophagoplasty
=550  \\$wh$aEsophagostomy
=550  \\$wh$aFundoplication
=550  \\$wh$aGastrectomy
=550  \\$wh$aGastroenterostomy
=550  \\$wh$aGastropexy
=550  \\$wh$aGastroplasty
=550  \\$wh$aGastrostomy
=550  \\$wh$aHeller Myotomy
=550  \\$wh$aHemorrhoidectomy
=550  \\$wh$aHepatectomy
=550  \\$wh$aJejunoileal Bypass
=550  \\$wh$aLateral Internal Sphincterotomy
=550  \\$wh$aLiver Transplantation
=550  \\$wh$aPancreas Transplantation
=550  \\$wh$aPancreatectomy
=550  \\$wh$aPancreaticoduodenectomy
=550  \\$wh$aPancreaticojejunostomy
=550  \\$wh$aPeritoneovenous Shunt
=667  \\$aGEN or unspecified; prefer specifics; consider also /surg with specific parts of the digest syst; also /surg with specific digest dis; DF: DIGESTIVE SYSTEM SURG PROCEDURES
=680  \\$iSurgery performed on the digestive system or its parts.
=688  \\$a98; use explode 1970-74
=750  \0$aDigestive organs$xSurgery$5IEN-M$0(DLC)sh 85037967

=LDR  01245cz  a2200301n  4500
=001  9880364073102441
=005  20141212210005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013504
=035  \\$aCBA6834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100
=150  \\$aCardiovascular Surgical Procedures
=450  \\$wnnna$aCardiovascular Surgical Procedure
=450  \\$aCardiovascular System$xsurgery
=450  \\$wnnna$aProcedure, Cardiovascular Surgical
=450  \\$wnnna$aProcedures, Cardiovascular Surgical
=450  \\$wnnna$aSurgical Procedure, Cardiovascular
=450  \\$wnnna$aSurgical Procedures, Cardiovascular
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCardiac Surgical Procedures
=550  \\$wh$aReperfusion
=550  \\$wh$aVascular Surgical Procedures
=550  \\$aThoracic Surgery
=667  \\$aGEN or unspecified; prefer specifics; consider also /surg with specific parts of the cardiovasc system; also CARDIOVASCULAR DISEASES /surg or /surg with specific cardiovasc dis; DF: CARDIOVASC SURG PROCEDURES
=680  \\$iSurgery performed on the heart or blood vessels.
=688  \\$a98; use explode 1970-97
=750  \0$aCardiovascular system$xSurgery$5IEN-M$0(DLC)sh 85020237

=LDR  00900cz  a2200229n  4500
=001  9880364073202441
=005  20141212192549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013502
=035  \\$aCBA6832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x300
=150  \\$aGeneral Surgery
=450  \\$aSurgery
=450  \\$wnnna$aSurgery, General
=550  \\$wg$aSpecialties, Surgical
=550  \\$aSurgical Procedures, Operative
=667  \\$ause for the specialty only; prefer /surg with organs and diseases; use SURGICAL PROCEDURES, OPERATIVE or specifics for the surgery patient or surgical procedures
=680  \\$iA specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.
=688  \\$a2009 (1974)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Surgery
=750  \0$aSurgery$0(DLC) sh 85130766$5IEN-HS

=LDR  01235cz  a2200349n  4500
=001  9880364073302441
=005  20141212210005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013501
=035  \\$aCBA6831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x877
=150  \\$aSurface-Active Agents
=450  \\$wnnna$aActive Agents, Surface
=450  \\$wnnna$aAgents, Amphiphilic
=450  \\$wnnna$aAgents, Surface Active
=450  \\$wnnna$aAgents, Surface-Active
=450  \\$wnnna$aAmphiphilic Agents
=450  \\$wnnna$aSurface Active Agents
=450  \\$aSurfactants
=450  \\$wnnna$aTensides
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aAntifoaming Agents
=550  \\$wh$aDemulcents
=550  \\$wh$aDetergents
=550  \\$wh$aEmulsifying Agents
=550  \\$wh$aImmunosorbents
=550  \\$wh$aWetting Agents
=550  \\$aLubricants
=680  \\$iAgents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
=688  \\$a1963
=750  \0$aSurface active agents$5IEN$0(DLC)sh 85130716

=LDR  00785cz  a2200229n  4500
=001  9880364073402441
=005  20141212210004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013500
=035  \\$aCBA6830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x850.$x816
=150  \\$aSurface Tension
=450  \\$wnnna$aInterfacial Force
=450  \\$wnnna$aInterfacial Tension
=450  \\$wnnna$aSurface Tensions
=450  \\$wnnna$aTension, Surface
=450  \\$wnnna$aTensions, Surface
=550  \\$wg$aSurface Properties
=667  \\$aNIM
=680  \\$iThe force acting on the surface of a liquid, tending to minimize the area of the surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aSurface tension$5IEN$0(DLC)sh 85130727

=LDR  01354cz  a2200337n  4500
=001  9880364073502441
=005  20141212210004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013498
=035  \\$aCBA6828M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x555.$x750
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50.$x650.$x750
=072  \\$aD4.$x615.$x638.$x555.$x750
=150  \\$aSuramin
=450  \\$wnnna$aGermanin
=450  \\$wnnna$aHexasodium Salt Suramin
=450  \\$wnnna$aMonosodium Salt Suramin
=450  \\$wnnna$aMoranil
=450  \\$wnnna$aNaganin
=450  \\$wnnna$aNaganol
=450  \\$wnnna$aNaphuride
=450  \\$wnnna$aSalt Suramin, Hexasodium
=450  \\$wnnna$aSalt Suramin, Monosodium
=450  \\$wnnna$aSodium, Suramin
=450  \\$wnnna$aSuramin, Hexasodium Salt
=450  \\$wnnna$aSuramin, Monosodium Salt
=450  \\$wnnna$aSuramin Sodium
=550  \\$wg$aNaphthalenesulfonates
=680  \\$iA polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
=750  \0$aSuramin$0(DLC)sh2007001497$5IEN-M

=LDR  00776cz  a2200241n  4500
=001  9880364073602441
=005  20141212210003.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013496
=035  \\$aCBA6826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x701.$x700
=150  \\$aSuprofen
=450  \\$wnnna$aR-25061
=450  \\$wnnna$aR 25061
=450  \\$wnnna$aR25061
=450  \\$wnnna$aTN-762
=450  \\$wnnna$aTN 762
=450  \\$wnnna$aTN762
=550  \\$wg$aPhenylpropionates
=680  \\$iAn IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.
=688  \\$a90(78); was see under PHENYLPROPIONATES 1978-89
=750  \0$aSuprofen$5IEN$0(DLC)sh 89007060

=LDR  02821cz  a2200565n  4500
=001  9880364073702441
=005  20141212210903.0
=008  880413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015173
=035  \\$aCBA6825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195.$x885
=072  \\$aC10.$x228.$x140.$x211.$x885
=072  \\$aC10.$x551.$x240.$x250.$x700
=150  \\$aSupratentorial Neoplasms
=450  \\$wnnna$aBenign Supratentorial Neoplasm
=450  \\$wnnna$aBenign Supratentorial Neoplasms
=450  \\$aCancer, Supratentorial
=450  \\$wnnna$aCancers, Supratentorial
=450  \\$wnnna$aMalignant Supratentorial Neoplasm
=450  \\$wnnna$aMalignant Supratentorial Neoplasms
=450  \\$wnnna$aNeoplasm, Benign Supratentorial
=450  \\$wnnna$aNeoplasm, Malignant Supratentorial
=450  \\$wnnna$aNeoplasm, Primary Supratentorial
=450  \\$wnnna$aNeoplasm, Supratentorial
=450  \\$wnnna$aNeoplasms, Benign Supratentorial
=450  \\$wnnna$aNeoplasms, Malignant Supratentorial
=450  \\$wnnna$aNeoplasms, Primary Supratentorial
=450  \\$wnnna$aNeoplasms, Supratentorial
=450  \\$wnnna$aPrimary Supratentorial Neoplasm
=450  \\$wnnna$aPrimary Supratentorial Neoplasms
=450  \\$wnnna$aSupratentorial Cancer
=450  \\$wnnna$aSupratentorial Cancers
=450  \\$wnnna$aSupratentorial Neoplasm
=450  \\$wnnna$aSupratentorial Neoplasm, Benign
=450  \\$wnnna$aSupratentorial Neoplasm, Malignant
=450  \\$wnnna$aSupratentorial Neoplasm, Primary
=450  \\$wnnna$aSupratentorial Neoplasms, Benign
=450  \\$wnnna$aSupratentorial Neoplasms, Malignant
=450  \\$wnnna$aSupratentorial Neoplasms, Primary
=450  \\$wnnna$aSupratentorial Tumor
=450  \\$wnnna$aSupratentorial Tumors
=450  \\$wnnna$aTumor, Supratentorial
=450  \\$wnnna$aTumors, Supratentorial
=550  \\$wg$aBrain Neoplasms
=550  \\$wh$aHypothalamic Neoplasms
=667  \\$aGEN: prefer specifics; coord IM with histol type of neopl (IM)
=680  \\$iPrimary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation.
=688  \\$a1989
=750  \0$aSupratentorial brain tumors$5IEN$0(DLC)sh 91000319

=LDR  01157cz  a2200313n  4500
=001  9880364073802441
=005  20141212192548.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013495
=035  \\$aCBA6824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x497.$x342.$x650
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x342.$x650
=150  \\$aSupraoptic Nucleus
=450  \\$wnnna$aAccessory Supraoptic Group
=450  \\$wnnna$aAccessory Supraoptic Groups
=450  \\$wnnna$aGroup, Accessory Supraoptic
=450  \\$wnnna$aGroups, Accessory Supraoptic
=450  \\$wnnna$aHypothalamus Supraoptic Nucleus
=450  \\$wnnna$aNucleus, Supraoptic
=450  \\$wnnna$aNucleus Supraopticus
=450  \\$wnnna$aSupraoptic Group, Accessory
=450  \\$wnnna$aSupraoptic Groups, Accessory
=450  \\$wnnna$aSupraoptic Nucleus of Hypothalamus
=450  \\$wnnna$aSupraopticus, Nucleus
=550  \\$wg$aHypothalamus, Anterior
=680  \\$iHypothalamic nucleus overlying the beginning of the OPTIC TRACT.
=688  \\$a83(75); was see under HYPOTHALAMUS 1975-82
=750  \0$aSupraoptic nucleus$5IEN$0(DLC)sh 85130701

=LDR  02240cz  a2200469n  4500
=001  9880364073902441
=005  20141212210003.0
=008  860401\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013494
=035  \\$aCBA6823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x882
=072  \\$aC10.$x228.$x662.$x700
=072  \\$aC10.$x292.$x562.$x750.$x500
=072  \\$aC10.$x574.$x945.$x500
=072  \\$aC10.$x597.$x622.$x447.$x690
=072  \\$aC11.$x590.$x472.$x500
=072  \\$aC23.$x888.$x592.$x636.$x447.$x690
=150  \\$aSupranuclear Palsy, Progressive
=450  \\$aOphthalmoplegia, Progressive Supranuclear
=450  \\$wnnna$aPalsy, Progressive Supranuclear
=450  \\$aProgressive Supranuclear Ophthalmoplegia
=450  \\$wnnna$aProgressive Supranuclear Palsies
=450  \\$wnnna$aProgressive Supranuclear Palsy
=450  \\$wnnna$aRichardson Syndrome
=450  \\$wnnna$aRichardson's Syndrome
=450  \\$wnnna$aSteele-Richardson-Olszewski Disease
=450  \\$wnnna$aSteele Richardson Olszewski Disease
=450  \\$aSteele-Richardson-Olszewski Syndrome
=450  \\$wnnna$aSteele Richardson Olszewski Syndrome
=450  \\$wnnna$aSupranuclear Ophthalmoplegia, Progressive
=450  \\$wnnna$aSupranuclear Palsies, Progressive
=450  \\$wnnna$aSupranuclear Palsy, Progressive, 1
=450  \\$wnnna$aSyndrome, Richardson's
=450  \\$wnnna$aSyndrome, Steele-Richardson-Olszewski
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aMovement Disorders
=550  \\$wg$aOphthalmoplegia
=550  \\$wg$aTauopathies
=680  \\$iA degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
=688  \\$a1987
=750  \0$aProgressive supranuclear palsy$5IEN$0(DLC)sh 91005961

=LDR  00770cz  a2200205n  4500
=001  9880364074002441
=005  20200710123235.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013493
=035  \\$aCBA6822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x497.$x342.$x625
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x342.$x625
=150  \\$aSuprachiasmatic Nucleus
=450  \\$wnnna$aNucleus, Suprachiasmatic
=550  \\$wg$aHypothalamus, Anterior
=550  \\$wh$aSuprachiasmatic Nucleus Neurons
=680  \\$iAn ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the OPTIC CHIASM.
=688  \\$a83
=750  \0$aSuprachiasmatic nucleus$5IEN$0(DLC)sh 90004270

=LDR  00872cz  a2200301n  4500
=001  9880364074102441
=005  20141212210002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013492
=035  \\$aCBA6821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830
=072  \\$aC23.$x550.$x470.$x756
=150  \\$aSuppuration
=450  \\$aPus
=550  \\$wg$aInfection
=550  \\$wg$aInflammation
=550  \\$wh$aAbscess
=550  \\$wh$aCellulitis
=550  \\$wh$aEmpyema
=550  \\$wh$aHidradenitis Suppurativa
=550  \\$wh$aOtitis Media, Suppurative
=550  \\$wh$aPyomyositis
=550  \\$wh$aThyroiditis, Suppurative
=550  \\$wh$aUveitis, Suppurative
=667  \\$aNIM; TN 178: for suppurative dis & coord
=680  \\$iA pathologic process consisting in the formation of pus.
=750  \0$aSuppuration$5IEN$0(DLC)sh 85130699

=LDR  01108cz  a2200253n  4500
=001  9880364074202441
=005  20141212192548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x785
=150  \\$aSuppositories
=450  \\$aRectal Suppositories
=450  \\$wnnna$aSuppositories, Rectal
=450  \\$wnnna$aSuppositories, Vaginal
=450  \\$wnnna$aSuppository, Vaginal
=450  \\$aVaginal Suppositories
=450  \\$wnnna$aVaginal Suppository
=550  \\$wg$aDosage Forms
=550  \\$aAdministration, Rectal
=550  \\$aRectal Absorption
=667  \\$aIM GEN only; coord NIM (no qualif) with specific drug IM
=680  \\$iMedicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature.
=750  \0$aSuppositories$5IEN$0(DLC)sh 85130697

=LDR  00571cz  a2200181n  4500
=001  9880364074302441
=005  20141212205959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013483
=035  \\$aCBA6812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x897
=150  \\$aSuperstitions
=450  \\$wnnna$aSuperstition
=550  \\$wg$aCulture
=550  \\$wh$aMagic
=680  \\$iA belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance.
=750  \0$aSuperstition$5IEN$0(DLC)sh 85130658

=LDR  01585cz  a2200337n  4500
=001  9880364074402441
=005  20141212212931.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019034
=035  \\$aCSK5849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x668.$x800.$x250.$x100
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x800.$x250.$x100
=072  \\$aL1.$x178.$x590.$x875.$x800.$x250.$x100
=072  \\$aL1.$x178.$x820.$x90.$x668.$x800.$x250.$x100
=072  \\$aL1.$x178.$x820.$x90.$x898.$x800.$x250.$x100
=072  \\$aL1.$x224.$x230.$x260.$x115.$x475.$x600.$x325.$x500
=072  \\$aL1.$x240.$x960.$x800.$x250.$x100
=150  \\$aCD-I
=450  \\$aCompact Disk Interactive
=450  \\$wnnna$aCompact Disk, Interactive
=450  \\$wnnna$aCompact Disks, Interactive
=450  \\$wnnna$aDisk, Interactive Compact
=450  \\$wnnna$aDisks, Interactive Compact
=450  \\$wnnna$aInteractive Compact Disk
=450  \\$wnnna$aInteractive Compact Disks
=550  \\$wg$aCompact Disks
=667  \\$aa type of compact disk; X ref explains acronym; do not use /util except by MeSH definition
=680  \\$iAn optical disk storage system used on specialized players that combine the functions of computer and CD player in a self-contained box, designed to be connected to a television set and a home stereo for video and sound output. The player is controlled with a hand-held remote unit resembling a television remote control. (J Allied Health 1993 Winter;22(1):131-8)
=688  \\$a96
=750  \0$aCD-I technology$5IEN-M$0(DLC)sh 87002388

=LDR  01198cz  a2200277n  4500
=001  9880364074502441
=005  20141212212901.0
=008  950317\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018961
=035  \\$aCSK5847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280
=150  \\$aEducational Technology
=450  \\$wnnna$aEducational Technologies
=450  \\$wnnna$aInstructional Technologies
=450  \\$aInstructional Technology
=450  \\$wnnna$aTechnologies, Educational
=450  \\$wnnna$aTechnologies, Instructional
=450  \\$aTechnology, Educational
=450  \\$wnnna$aTechnology, Instructional
=550  \\$wg$aTechnology
=550  \\$wh$aAudiovisual Aids
=667  \\$aIM; coord with field or medium of educ (IM); DF: EDUC TECHNOL
=680  \\$iSystematic identification, development, organization, or utilization of educational resources and the management of these processes. It is occasionally used also in a more limited sense to describe the use of equipment-oriented techniques or audiovisual aids in educational settings. (Thesaurus of ERIC Descriptors, December 1993, p132)
=688  \\$a96
=750  \0$aEducational technology$5IEN-M$0(DLC)sh 85041150

=LDR  00763cz  a2200229n  4500
=001  9880363752302441
=005  20170831102058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008011
=035  \\$aCBA1246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x340
=072  \\$aB5.$x350
=150  \\$aLichens
=450  \\$wnnna$aLichen
=550  \\$wg$aFungi
=550  \\$wg$aOrganism Forms
=550  \\$wh$aParmeliaceae
=550  \\$wh$aUsnea
=667  \\$aplant, not skin disease
=680  \\$iAny of a group of plants formed by a symbiotic combination of a fungus with an algae or CYANOBACTERIA, and sometimes both. The fungal component makes up the bulk of the lichen and forms the basis for its name.
=750  \0$aLichens$5IEN$0(DLC)sh 85076770

=LDR  01242cz  a2200205n  4500
=001  9880363752402441
=005  20141212202911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008010
=035  \\$aCBA1245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x859.$x475.$x560
=150  \\$aLichen Planus
=450  \\$aLichen Ruber Planus
=450  \\$wnnna$aLichen Rubra Planus
=550  \\$wg$aLichenoid Eruptions
=550  \\$wh$aLichen Planus, Oral
=667  \\$aa skin dis; sometimes called simply "lichen": check text & its bibliog; lichen planus atrophicus: index here & do not confuse with LICHEN SCLEROSUS ET ATROPHICUS
=680  \\$iAn inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a "saw-tooth" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.
=750  \0$aLichen planus$5IEN$0(DLC)sh 85076767

=LDR  00798cz  a2200229n  4500
=001  9880363752502441
=005  20141212202910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008008
=035  \\$aCBA1243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x110.$x510.$x490
=072  \\$aN5.$x700.$x200.$x450.$x550
=150  \\$aLicensure, Nursing
=450  \\$wnnna$aLicensures, Nursing
=450  \\$wnnna$aNursing Licensure
=450  \\$wnnna$aNursing Licensures
=550  \\$wg$aLicensure
=667  \\$aby the state; differentiate from ACCREDITATION (by the profession); IM; various boards can go here; specify geog; DF: LICENSURE NURS
=680  \\$iThe granting of a license to practice the profession of nursing.
=688  \\$a66
=750  \0$aNurses$xLicenses$5IEN$0(IEN)369010

=LDR  00687cz  a2200193n  4500
=001  9880363752602441
=005  20141212202910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008007
=035  \\$aCBA1242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x110.$x510.$x410
=072  \\$aN5.$x700.$x200.$x450.$x500
=150  \\$aLicensure, Medical
=450  \\$wnnna$aMedical Licensure
=550  \\$wg$aLicensure
=667  \\$aby the state; differentiate from ACCREDITATION (by the profession); IM; various boards can go here; specify geog; DF: LICENSURE MED
=680  \\$iThe granting of a license to practice medicine.
=750  \0$aPhysicians$xLicenses$5IEN$0(DLC)sh 85101617

=LDR  00773cz  a2200229n  4500
=001  9880363752702441
=005  20141212202910.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008006
=035  \\$aCBA1241HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x110.$x510.$x290
=072  \\$aN5.$x700.$x200.$x450.$x380
=150  \\$aLicensure, Hospital
=450  \\$aHospital Licensure
=450  \\$wnnna$aHospital Licensures
=450  \\$wnnna$aLicensures, Hospital
=550  \\$wg$aLicensure
=667  \\$aby the state; differentiate from ACCREDITATION (by the profession); IM; specify geog
=680  \\$iThe granting of a license to a hospital.
=688  \\$a91(Aug 77); was see under LICENSURE 1977-90
=750  \0$aHospitals$xLicenses$5IEN$0(DLC)sh 85062338

=LDR  01619cz  a2200433n  4500
=001  9880363752802441
=005  20141212202909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008004
=035  \\$aCBA1239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x110.$x510
=072  \\$aN5.$x700.$x200.$x450
=150  \\$aLicensure
=450  \\$aInstitutional Personnel Licensure
=450  \\$wnnna$aInstitutional Personnel Licensures
=450  \\$wnnna$aLicense
=450  \\$aLicenses
=450  \\$wnnna$aLicensing
=450  \\$aLicensure, Institutional, Personnel
=450  \\$wnnna$aLicensure, Institutional Personnel
=450  \\$wnnna$aLicensures
=450  \\$wnnna$aLicensures, Institutional Personnel
=450  \\$wnnna$aPermit
=450  \\$wnnna$aPermits
=450  \\$wnnna$aPersonnel Licensure, Institutional
=450  \\$wnnna$aPersonnel Licensures, Institutional
=550  \\$wg$aCredentialing
=550  \\$wh$aLicensure, Dental
=550  \\$wh$aLicensure, Hospital
=550  \\$wh$aLicensure, Medical
=550  \\$wh$aLicensure, Nursing
=550  \\$wh$aLicensure, Pharmacy
=550  \\$aAccreditation
=550  \\$aCertification
=550  \\$aLegislation as Topic
=667  \\$aby the state; differentiate from ACCREDITATION (by the profession); IM; various boards can go here; specify geog
=680  \\$iThe legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals.
=750  \0$aLicenses$5IEN$0(DLC)sh 85076763

=LDR  01051cz  a2200289n  4500
=001  9880363752902441
=005  20141212202909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008003
=035  \\$aCBA1238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x690
=150  \\$aPhthiraptera
=450  \\$aLice
=450  \\$wnnna$aLouse
=450  \\$wnnoa$aMallophaga$5IEN-M
=450  \\$aRhyncophthirina
=550  \\$wg$aInsects
=550  \\$wh$aAmblycera
=550  \\$wh$aAnoplura
=550  \\$wh$aIschnocera
=667  \\$ainfestation = LICE INFESTATIONS; for killing Phthiraptera with insecticides, see note at INSECTICIDES
=680  \\$iAn order of small, wingless parasitic insects, commonly known as lice. The suborders include ANOPLURA (sucking lice); AMBLYCERA; ISCHNOCERA; and Rhynchophthirina (elephant and warthog lice).
=688  \\$a2011, 1975-1979
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Lice
=688  \\$aPHTHIRAPTERA was heading 1975-79
=750  \0$aLice$0(DLC) sh 85076759$5IEN

=LDR  01437cz  a2200373n  4500
=001  9880363753002441
=005  20141212202908.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008001
=035  \\$aCBA1236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x819
=072  \\$aL1.$x583.$x782
=150  \\$aLibrary Technical Services
=450  \\$wnnna$aLibraries, Technical Services
=450  \\$wnnna$aLibrary Service, Technical
=450  \\$wnnna$aLibrary Services Technical
=450  \\$wnnna$aLibrary Services, Technical
=450  \\$wnnna$aLibrary Technical Service
=450  \\$wnnna$aLibrary, Technical Services
=450  \\$wnnna$aServices, Library Technical
=450  \\$wnnna$aServices, Technical Library
=450  \\$wnnna$aServices Technical, Library
=450  \\$wnnna$aTechnical Library Service
=450  \\$wnnna$aTechnical Library Services
=450  \\$wnnna$aTechnical Services Libraries
=450  \\$wnnna$aTechnical Services Library
=550  \\$wg$aInformation Services
=550  \\$wg$aLibrary Science
=550  \\$wh$aCataloging
=667  \\$aIM; DF: LIBRARY TECHNICAL SERV
=680  \\$iAcquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation.
=688  \\$a76; was LIBRARY TECHNICAL PROCESSES (NON MESH) before 1976
=750  \0$aTechnical services (Libraries)$5IEN$0(DLC)sh 85107141

=LDR  00743cz  a2200205n  4500
=001  9880363753102441
=005  20141212202908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008000
=035  \\$aCBA1235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583.$x564
=150  \\$aLibrary Surveys
=450  \\$wnnna$aLibrary Survey
=450  \\$wnnna$aSurvey, Library
=450  \\$wnnna$aSurveys, Library
=550  \\$wg$aLibrary Science
=667  \\$aIM
=680  \\$iCollection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development.
=750  \0$aLibrary surveys$5IEN$0(DLC)sh 85076739

=LDR  00775cz  a2200253n  4500
=001  9880363753202441
=005  20141212202907.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007999
=035  \\$aCBA1234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x639
=072  \\$aL1.$x583.$x464
=150  \\$aLibrary Services
=450  \\$wnnna$aLibrary Service
=450  \\$wnnna$aService, Library
=450  \\$wnnna$aServices, Library
=550  \\$wg$aInformation Services
=550  \\$wg$aLibrary Science
=550  \\$wh$aInterlibrary Loans
=667  \\$aIM; DF: LIBRARY SERV
=680  \\$iServices offered to the library user. They include reference and circulation.
=688  \\$a76; was NON MESH before 1976
=750  \0$aLibraries$5IEN$0(DLC)sh 85076502

=LDR  01022cz  a2200313n  4500
=001  9880363753302441
=005  20141212202907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007998
=035  \\$aCBA1233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583
=150  \\$aLibrary Science
=450  \\$aLibrarianship
=450  \\$wnnna$aLibrary Sciences
=450  \\$wnnna$aScience, Library
=450  \\$wnnna$aSciences, Library
=550  \\$wg$aInformation Science
=550  \\$wh$aLibrary Administration
=550  \\$wh$aLibrary Associations
=550  \\$wh$aLibrary Automation
=550  \\$wh$aLibrary Collection Development
=550  \\$wh$aLibrary Schools
=550  \\$wh$aLibrary Services
=550  \\$wh$aLibrary Surveys
=550  \\$wh$aLibrary Technical Services
=667  \\$aSPEC: SPEC qualif; med librarianship: do not coord with MEDICINE
=680  \\$iStudy of the principles and practices of library administration and services.
=750  \0$aLibrary science$0(DLC) sh 85076723$5IEN

=LDR  00704cz  a2200229n  4500
=001  9880363753402441
=005  20141212202907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007997
=035  \\$aCBA1232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x388
=072  \\$aL1.$x583.$x430
=150  \\$aLibrary Schools
=450  \\$wnnna$aLibrary School
=450  \\$wnnna$aSchool, Library
=450  \\$aSchools, Library
=550  \\$wg$aLibrary Science
=550  \\$wg$aSchools
=667  \\$aspecify geog if pertinent
=680  \\$iEducational institutions for individuals specializing in the field of library science or information.
=750  \0$aLibrary schools$5IEN$0(DLC)sh 85076719

=LDR  00633cz  a2200205n  4500
=001  9880363753502441
=005  20141212202907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007996
=035  \\$aCBA1231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583.$x390
=150  \\$aLibrary Associations
=450  \\$wnnna$aAssociation, Library
=450  \\$wnnna$aAssociations, Library
=450  \\$wnnna$aLibrary Association
=550  \\$wg$aLibrary Science
=550  \\$aSocieties
=667  \\$amed libr assoc: do not coord with MEDICINE; DF: LIBRARY ASSOC
=750  \0$aLibrary science$xSocieties, etc.$5IEN$0(DLC)sh 85076664

=LDR  00650cz  a2200205n  4500
=001  9880363753602441
=005  20141212202906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007995
=035  \\$aCBA1230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x583.$x363
=150  \\$aLibrary Administration
=450  \\$wnnna$aAdministration, Library
=450  \\$wnnna$aAdministrations, Library
=450  \\$wnnna$aLibrary Administrations
=550  \\$wg$aLibrary Science
=667  \\$aSPEC: SPEC qualif
=680  \\$iPlanning, organizing, staffing, direction, and control of libraries.
=750  \0$aLibrary administration$5IEN$0(DLC)sh 85076655

=LDR  00584cz  a2200205n  4500
=001  9880363753702441
=005  20141212202906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007994
=035  \\$aCBA1229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x346.$x596.$x663
=150  \\$aLibraries, Nursing
=450  \\$wnnna$aLibrary, Nursing
=450  \\$aNursing Libraries
=450  \\$wnnna$aNursing Library
=550  \\$wg$aLibraries
=667  \\$aIM; specify geog or other site; DF: LIBRARIES NURS
=688  \\$a67(65)
=750  \0$aNursing libraries$5IEN$0(DLC)sh 85093415

=LDR  00962cz  a2200277n  4500
=001  9880363753802441
=005  20141212202906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007993
=035  \\$aCBA1228HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x346.$x596.$x563
=150  \\$aLibraries, Medical
=450  \\$wnnna$aHealth Science Libraries
=450  \\$wnnna$aHealth Science Library
=450  \\$aLibraries, Health Science
=450  \\$wnnna$aLibrary, Health Science
=450  \\$wnnna$aLibrary, Medical
=450  \\$wnnna$aMedical Libraries
=450  \\$wnnna$aMedical Library
=450  \\$wnnna$aScience Libraries, Health
=450  \\$wnnna$aScience Library, Health
=550  \\$wg$aLibraries
=550  \\$wh$aNational Library of Medicine (U.S.)
=667  \\$aprivate & public libraries; includes private collections of books; IM; specify geog or other site; DF: LIBRARIES MED
=750  \0$aMedical libraries$5IEN$0(DLC)sh 85082970

=LDR  01170cz  a2200349n  4500
=001  9880363753902441
=005  20141212202702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007620
=035  \\$aCBA0823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x617
=072  \\$aE5.$x200.$x500.$x384.$x467
=072  \\$aE5.$x242.$x384.$x467
=150  \\$aKaryometry
=450  \\$wnnna$aAnalyses, Karyometric
=450  \\$wnnna$aAnalyses, Karyometric Image
=450  \\$wnnna$aAnalysis, Karyometric
=450  \\$wnnna$aAnalysis, Karyometric Image
=450  \\$wnnna$aImage Analyses, Karyometric
=450  \\$wnnna$aImage Analysis, Karyometric
=450  \\$wnnna$aKaryometric Analyses
=450  \\$wnnna$aKaryometric Analysis
=450  \\$wnnna$aKaryometric Image Analyses
=450  \\$wnnna$aKaryometric Image Analysis
=550  \\$wg$aCytodiagnosis
=550  \\$aCell Nucleus
=550  \\$aCytogenetic Analysis
=550  \\$aKaryotyping
=680  \\$iMicroscopic study of the spacial distribution pattern of CHROMATIN in CELL NUCLEI and CELL NUCLEOLI.
=688  \\$a67(64)
=750  \0$aKaryometry$5IEN$0(DLC)sh 85071685

=LDR  01007cz  a2200229n  4500
=001  9880363754002441
=005  20141212202700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007616
=035  \\$aCBA0819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x50.$x75.$x350
=072  \\$aD1.$x578.$x725.$x25.$x350
=072  \\$aD1.$x650.$x550.$x50.$x75.$x350
=072  \\$aD1.$x837.$x725.$x700.$x760.$x50.$x400
=150  \\$aKaolin
=450  \\$wnnna$aKaolinite
=550  \\$wg$aAluminum Silicates
=667  \\$aan antidiarrheal
=680  \\$iThe most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: "high ridge"), the original site. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aKaolinite$5IEN-M$0(DLC)sh 85071543
=750  \0$aKaolin$5IEN-HS$0(DLC)sh 85071542

=LDR  01094cz  a2200373n  4500
=001  9880363754102441
=005  20141212202659.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007614
=035  \\$aCBA0817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x500
=150  \\$aMacropodidae
=450  \\$wnnna$aKangaroo
=450  \\$aKangaroos
=450  \\$aMacropus
=450  \\$wnnna$aMacropus robustus
=450  \\$aPetrogale
=450  \\$wnnna$aPetrogales
=450  \\$wnnna$aQuokka
=450  \\$aQuokkas
=450  \\$wnnna$aRock Wallabies
=450  \\$wnnna$aRock Wallaby
=450  \\$aSetonix
=450  \\$aWallabies
=450  \\$aWallabies, Rock
=450  \\$wnnna$aWallaby
=450  \\$wnnna$aWallaby, Rock
=450  \\$aWallaroo
=450  \\$wnnna$aWallaroos
=550  \\$wg$aMarsupialia
=680  \\$iA family of herbivorous leaping MAMMALS of Australia, New Guinea, and adjacent islands. Members include kangaroos, wallabies, quokkas, and wallaroos.
=688  \\$a2005 (1975)
=750  \0$aKangaroos$0(DLC) sh 85071465$5IEN

=LDR  02084cz  a2200457n  4500
=001  9880363754202441
=005  20141212202659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007611
=035  \\$aCBA0814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x83
=150  \\$aAprotinin
=450  \\$wnnna$aAntilysin
=450  \\$wnnna$aArzneimittelwerk Dresden Brand of Aprotinin
=450  \\$aBasic Pancreatic Trypsin Inhibitor
=450  \\$wnnna$aBayer Brand of Aprotinin
=450  \\$aBovine Kunitz Pancreatic Trypsin Inhibitor
=450  \\$wnnna$aBovine Pancreatic Trypsin Inhibitor
=450  \\$aBPTI, Basic Pancreatic Trypsin Inhibitor
=450  \\$wnnna$aContrical
=450  \\$wnnna$aContrykal
=450  \\$wnnna$aDilmintal
=450  \\$wnnna$aInactivator, Kallikrein-Trypsin
=450  \\$wnnna$aIniprol
=450  \\$aKallikrein-Trypsin Inactivator
=450  \\$wnnna$aKallikrein Trypsin Inactivator
=450  \\$wnnna$aKontrikal
=450  \\$wnnna$aKontrykal
=450  \\$aKunitz Pancreatic Trypsin Inhibitor
=450  \\$wnnna$aPulmin
=450  \\$wnnna$aSanofi Winthrop Brand of Aprotinin
=450  \\$wnnna$aTraskolan
=450  \\$wnnna$aTrasylol
=450  \\$aTrypsin Inhibitor, Basic, Pancreatic
=450  \\$aTrypsin Inhibitor, Kunitz, Pancreatic
=450  \\$wnnna$aZymofren
=550  \\$wg$aProteins
=680  \\$iA single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
=688  \\$a90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89
=750  \0$aAprotinin$5IEN-M$0(DLC)sh 95002315

=LDR  01973cz  a2200505n  4500
=001  9880363754302441
=005  20141212202658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007610
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x442
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x442
=072  \\$aD12.$x776.$x124.$x125.$x597
=072  \\$aD23.$x119.$x597
=150  \\$aKallikreins
=450  \\$wnnna$aalpha-Kallikrein
=450  \\$wnnna$aalpha Kallikrein
=450  \\$wnnna$abeta-Kallikrein
=450  \\$wnnna$abeta Kallikrein
=450  \\$wnnna$abeta-Kallikrein B
=450  \\$wnnna$abeta Kallikrein B
=450  \\$wnnna$aCallicrein
=450  \\$wnnna$aDilminal
=450  \\$wnnna$aEnzyme, Kinin-Forming
=450  \\$wnnna$aKallidinogenase
=450  \\$wnnna$aKalliginogenase
=450  \\$aKallikrein
=450  \\$wnnna$aKallikrein A
=450  \\$wnnna$aKallikrein B'
=450  \\$wnnna$aKallikrein Light Chain
=450  \\$wnnna$aKinin-Forming Enzyme
=450  \\$wnnna$aKinin Forming Enzyme
=450  \\$aKininogenase
=450  \\$wnnna$aLight Chain, Kallikrein
=450  \\$wnnna$aPadutin
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aSerine Endopeptidases
=550  \\$wh$aPlasma Kallikrein
=550  \\$wh$aPrekallikrein
=550  \\$wh$aProstate-Specific Antigen
=550  \\$wh$aTissue Kallikreins
=667  \\$a/antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR
=680  \\$iProteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77).
=688  \\$a2000(1963)
=750  \0$aKallikrein$5IEN$0(DLC)sh 85071358

=LDR  01058cz  a2200229n  4500
=001  9880363754402441
=005  20141212202657.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007608
=035  \\$aCBA0811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x773.$x400
=150  \\$aKainic Acid
=450  \\$wnnna$aAcid, Digenic
=450  \\$wnnna$aAcid, Kainic
=450  \\$aDigenic Acid
=450  \\$wnnna$aKainate
=550  \\$wg$aPyrrolidines
=667  \\$aan antinematodal agent & excitatory amino acid agonist
=680  \\$i(2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.
=688  \\$a86(78); was see under PYRROLIDINES 1978-85
=750  \0$aKainic acid$5IEN$0(DLC)sh 85071296

=LDR  01141cz  a2200193n  4500
=001  9880363754502441
=005  20141212202657.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007606
=035  \\$aCBA0809HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x324.$x359.$x520
=072  \\$aA5.$x810.$x453.$x736.$x520.$x520
=150  \\$aJuxtaglomerular Apparatus
=450  \\$wnnna$aApparatus, Juxtaglomerular
=550  \\$wg$aKidney Glomerulus
=680  \\$iA complex of cells consisting of juxtaglomerular cells, extraglomerular mesangium lacis cells, the macula densa of the distal convoluted tubule, and granular epithelial peripolar cells. Juxtaglomerular cells are modified SMOOTH MUSCLE CELLS found in the walls of afferent glomerular arterioles and sometimes the efferent arterioles. Extraglomerular mesangium lacis cells are located in the angle between the afferent and efferent glomerular arterioles. Granular epithelial peripolar cells are located at the angle of reflection of the parietal to visceral angle of the renal corpuscle.
=688  \\$a66(64)
=750  \0$aJuxtaglomerular apparatus$5IEN$0(DLC)sh 85071190

=LDR  00826cz  a2200253n  4500
=001  9880363754602441
=005  20141212202656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007605
=035  \\$aCBA0808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x445.$x573.$x666
=150  \\$aJuvenile Hormones
=450  \\$wnnna$aGrowth Regulators, Insect
=450  \\$wnnna$aHormones, Juvenile
=450  \\$aInsect Growth Regulators
=450  \\$wnnna$aRegulators, Insect Growth
=550  \\$wg$aInsect Hormones
=550  \\$wh$aDiflubenzuron
=550  \\$wh$aMethoprene
=667  \\$ainsects only; coord IM with specific insect (IM)
=680  \\$iCompounds, either natural or synthetic, which block development of the growing insect.
=688  \\$a72(66)
=750  \0$aJuvenile hormones$5IEN$0(DLC)sh 85071181

=LDR  00597cz  a2200181n  4500
=001  9880363754702441
=005  20141212202656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007604
=035  \\$aCBA0807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x479
=150  \\$aJuvenile Delinquency
=450  \\$wnnna$aDelinquency, Juvenile
=550  \\$wg$aSocial Problems
=667  \\$aIM
=680  \\$iThe antisocial acts of children or persons under age which are illegal or lawfully interpreted as constituting delinquency.
=750  \0$aJuvenile delinquency$5IEN$0(DLC)sh 85071166

=LDR  00640cz  a2200205n  4500
=001  9880363754902441
=005  20141212202655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007601
=035  \\$aCBA0804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x498
=150  \\$aJugular Veins
=450  \\$wnnna$aJugular Vein
=450  \\$wnnna$aVein, Jugular
=450  \\$wnnna$aVeins, Jugular
=550  \\$wg$aVeins
=680  \\$iVeins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins.
=688  \\$a78; was JUGULAR VEIN 1963-77
=750  \0$aJugular vein$5IEN$0(DLC)sh 85070979

=LDR  00728cz  a2200181n  4500
=001  9880363755002441
=005  20141212202654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007600
=035  \\$aCBA0803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x626
=150  \\$aJudgment
=450  \\$wnnna$aJudgments
=550  \\$wg$aThinking
=680  \\$iThe process of discovering or asserting an objective or intrinsic relation between two objects or concepts; a faculty or power that enables a person to make judgments; the process of bringing to light and asserting the implicit meaning of a concept; a critical evaluation of a person or situation.
=688  \\$a66
=750  \0$aJudgment$5IEN$0(DLC)sh 85070913

=LDR  00796cz  a2200229n  4500
=001  9880363755102441
=005  20141212202654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007599
=035  \\$aCBA0802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x385
=150  \\$aJudaism
=450  \\$wnnna$aEthic, Jewish
=450  \\$wnnna$aEthics, Jewish
=450  \\$wnnna$aJewish Ethic
=450  \\$wnnna$aJewish Ethics
=550  \\$wg$aReligion
=550  \\$aJews
=667  \\$athe religion: JEWS are the ethnic group; specify geog if pertinent
=680  \\$iThe religion of the Jews characterized by belief in one God and in the mission of the Jews to teach the Fatherhood of God as revealed in the Hebrew Scriptures. (Webster, 3d ed)
=750  \0$aJudaism$5IEN$0(DLC)sh 85070835

=LDR  00934cz  a2200229n  4500
=001  9880363755202441
=005  20141212202654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007598
=035  \\$aCBA0801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x498.$x500
=150  \\$aJournalism, Dental
=450  \\$wnnna$aDental Journalism
=450  \\$wnnna$aDental Periodicals Publishing
=450  \\$aPeriodicals Publishing, Dental
=450  \\$aPublishing, Dental Periodicals
=550  \\$wg$aJournalism
=667  \\$awriting for or in dent publ or on dent subjects; dental journals go under PERIODICALS AS TOPIC & required coord, not here; DF: JOURNALISM DENT
=680  \\$iContent, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins.
=688  \\$a91(64); was see under PUBLISHING 1964-90
=750  \0$aJournalism, Dental$5IEN$0(DLC)sh 85070762

=LDR  01336cz  a2200409n  4500
=001  9880363755302441
=005  20141212202653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007596
=035  \\$aCBA0799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583
=150  \\$aJoints
=360  \\$iconsider also terms at$aARTHR-
=450  \\$wnnna$aJoint
=550  \\$wg$aSkeleton
=550  \\$wh$aAcromioclavicular Joint
=550  \\$wh$aAtlanto-Axial Joint
=550  \\$wh$aAtlanto-Occipital Joint
=550  \\$wh$aBursa, Synovial
=550  \\$wh$aCartilage, Articular
=550  \\$wh$aElbow Joint
=550  \\$wh$aFoot Joints
=550  \\$wh$aHand Joints
=550  \\$wh$aHip Joint
=550  \\$wh$aJoint Capsule
=550  \\$wh$aKnee Joint
=550  \\$wh$aLigaments, Articular
=550  \\$wh$aPubic Symphysis
=550  \\$wh$aSacroiliac Joint
=550  \\$wh$aShoulder Joint
=550  \\$wh$aSternoclavicular Joint
=550  \\$wh$aSternocostal Joints
=550  \\$wh$aTemporomandibular Joint
=550  \\$wh$aZygapophyseal Joint
=667  \\$aGEN; joints of animals: TN 117; differentiation of sites & joints: TN 238; inflammation = ARTHRITIS; /surg: consider also ARTHROPLASTY; joint revision: index as ARTHROPLASTY (IM) + REOPERATION (NIM)
=750  \0$aJoints$5IEN$0(DLC)sh 85070658

=LDR  00940cz  a2200289n  4500
=001  9880363755402441
=005  20141212202653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007595
=035  \\$aCBA0798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x400
=150  \\$aJoint Prosthesis
=450  \\$aArtificial Joints$5IEN
=450  \\$wnnna$aJoint Prostheses
=450  \\$wnnna$aProstheses, Joint
=450  \\$wnnna$aProsthesis, Joint
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aElbow Prosthesis
=550  \\$wh$aHip Prosthesis
=550  \\$wh$aKnee Prosthesis
=550  \\$wh$aMetal-on-Metal Joint Prostheses
=550  \\$aArthroplasty, Replacement
=667  \\$aHIP PROSTHESIS & KNEE PROSTHESIS are also available
=680  \\$iProstheses used to partially or totally replace a human or animal joint. (from UMDNS, 1999)
=688  \\$a71
=750  \0$aArtificial joints$5IEN$0(DLC)sh 85008184

=LDR  01064cz  a2200313n  4500
=001  9880363755502441
=005  20141212202652.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007593
=035  \\$aCBA0796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x521
=150  \\$aJoint Instability
=450  \\$wnnna$aHypermobilities, Joint
=450  \\$aHypermobility, Joint
=450  \\$wnnna$aInstabilities, Joint
=450  \\$aInstability, Joint
=450  \\$wnnna$aJoint Hypermobilities
=450  \\$wnnna$aJoint Hypermobility
=450  \\$wnnna$aJoint Instabilities
=450  \\$wnnna$aJoint Laxities
=450  \\$wnnna$aJoint Laxity
=450  \\$wnnna$aLaxities, Joint
=450  \\$aLaxity, Joint
=550  \\$wg$aJoint Diseases
=667  \\$anote category
=680  \\$iLack of stability of a joint or joint prosthesis. Factors involved are intra-articular disease and integrity of extra-articular structures such as joint capsule, ligaments, and muscles.
=688  \\$a83
=750  \0$aJoints$xHypermobility$5IEN$0(DLC)sh 85070662

=LDR  01630cz  a2200517n  4500
=001  9880363755602441
=005  20180403125634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007592
=035  \\$aCBA0795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550
=150  \\$aJoint Diseases
=450  \\$wnnna$aDisease, Joint
=450  \\$wnnna$aDiseases, Joint
=450  \\$wnnna$aJoint Disease
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aAnkylosis
=550  \\$wh$aArthralgia
=550  \\$wh$aArthritis
=550  \\$wh$aArthrogryposis
=550  \\$wh$aArthropathy, Neurogenic
=550  \\$wh$aBursitis
=550  \\$wh$aChondromatosis, Synovial
=550  \\$wh$aContracture
=550  \\$wh$aCrystal Arthropathies
=550  \\$wh$aFemoracetabular Impingement
=550  \\$wh$aHallux Limitus
=550  \\$wh$aHallux Rigidus
=550  \\$wh$aHemarthrosis
=550  \\$wh$aHydrarthrosis
=550  \\$wh$aJoint Deformities, Acquired
=550  \\$wh$aJoint Dislocations
=550  \\$wh$aJoint Instability
=550  \\$wh$aJoint Loose Bodies
=550  \\$wh$aMetatarsalgia
=550  \\$wh$aNail-Patella Syndrome
=550  \\$wh$aOsteoarthropathy, Primary Hypertrophic
=550  \\$wh$aOsteoarthropathy, Secondary Hypertrophic
=550  \\$wh$aPatellofemoral Pain Syndrome
=550  \\$wh$aShoulder Impingement Syndrome
=550  \\$wh$aSynovitis
=550  \\$wh$aTemporomandibular Joint Disorders
=667  \\$aGEN; prefer specifics; inflamm dis = ARTHRITIS
=688  \\$aSHOULDER ARTHROSES was heading 1963-64
=750  \0$aJoints$xDiseases$5IEN$0(DLC)sh 85070660

=LDR  00860cz  a2200229n  4500
=001  9880363755702441
=005  20141212192254.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007590
=035  \\$aCBA0793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x568.$x610.$x320
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x750.$x320
=072  \\$aI3.$x350.$x750.$x320
=072  \\$aI3.$x450.$x642.$x845.$x610.$x320
=150  \\$aJogging
=450  \\$wnnna$aJoggings
=550  \\$wg$aRunning
=667  \\$ahuman & animal; /inj: coord IM with specific inj (IM); /physiol permitted
=680  \\$iRunning at a low rate of speed. It can be done as a means of conditioning or for general health and well being.
=688  \\$a90(76); was see under RUNNING 1980-89; was see under SPORTS 1976-79
=750  \0$aJogging$5IEN$0(DLC)sh 85070599

=LDR  00814cz  a2200277n  4500
=001  9880363755802441
=005  20141212202650.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007588
=035  \\$aCBA0791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x692.$x425
=150  \\$aJob Satisfaction
=450  \\$wnnna$aJob Satisfactions
=450  \\$wnnna$aSatisfaction, Job
=450  \\$wnnna$aSatisfaction, Work
=450  \\$wnnna$aSatisfactions, Job
=450  \\$wnnna$aSatisfactions, Work
=450  \\$aWork Satisfaction
=450  \\$wnnna$aWork Satisfactions
=550  \\$wg$aPsychology, Industrial
=550  \\$aEmployment
=667  \\$ano qualif
=680  \\$iPersonal satisfaction relative to the work situation.
=688  \\$a76
=750  \0$aJob satisfaction$5IEN$0(DLC)sh 85070581

=LDR  00903cz  a2200253n  4500
=001  9880363755902441
=005  20141212202650.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007587
=035  \\$aCBA0790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x410
=150  \\$aJob Description
=450  \\$wnnna$aDescription, Job
=450  \\$wnnna$aDescription, Position
=450  \\$wnnna$aDescriptions, Job
=450  \\$wnnna$aDescriptions, Position
=450  \\$wnnna$aJob Descriptions
=450  \\$aPosition Description
=450  \\$wnnna$aPosition Descriptions
=550  \\$wg$aPersonnel Management
=680  \\$iStatement of the position requirements, qualifications for the position, wage range, and any special conditions expected of the employee.
=688  \\$a91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90
=750  \0$aJob descriptions$5IEN$0(DLC)sh 85070575

=LDR  01070cz  a2200325n  4500
=001  9880363756002441
=005  20141212202649.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007586
=035  \\$aCBA0789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x400
=150  \\$aJob Application
=450  \\$wnnna$aApplication, Employment
=450  \\$wnnna$aApplication, Job
=450  \\$wnnna$aApplications, Employment
=450  \\$wnnna$aApplications, Job
=450  \\$aEmployment Application
=450  \\$wnnna$aEmployment Applications
=450  \\$wnnna$aJob Applications
=450  \\$wnnna$aJob Resume
=450  \\$wnnna$aJob Resumes
=450  \\$aResume, Job
=450  \\$wnnna$aResumes, Job
=550  \\$wg$aPersonnel Management
=550  \\$aEmployment
=667  \\$ano qualif
=680  \\$iProcess of applying for employment. It includes written application for employment or personal appearance.
=688  \\$a91(83); was see under PERSONNEL MANAGEMENT 1983-90
=750  \0$aApplications for positions$0(DLC) sh 85006165$5IEN

=LDR  00555cz  a2200193n  4500
=001  9880363756102441
=005  20141212202649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007585
=035  \\$aCBA0788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x754.$x600
=150  \\$aJews
=450  \\$wnnna$aJew
=550  \\$wg$aEthnic Groups
=550  \\$aJudaism
=667  \\$aspecify geog if relevant
=680  \\$iAn ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.
=750  \0$aJews$5IEN$0(DLC)sh 85070361

=LDR  00856cz  a2200205n  4500
=001  9880363756202441
=005  20141212202649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007583
=035  \\$aCBA0786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x684.$x500
=072  \\$aA3.$x556.$x249.$x750
=150  \\$aJejunum
=450  \\$wnnna$aJejunums
=550  \\$wg$aIntestine, Small
=550  \\$wg$aLower Gastrointestinal Tract
=667  \\$ainflammation or jejunitis = JEJUNAL DISEASES (IM) + ENTERITIS (IM); jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS (note XR ref)
=680  \\$iThe middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.
=750  \0$aJejunum$5IEN$0(DLC)sh 85069873

=LDR  00727cz  a2200229n  4500
=001  9880363756302441
=005  20141212202649.0
=008  870319\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007582
=035  \\$aCBA0785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x338.$x523
=072  \\$aE4.$x579.$x338.$x523
=150  \\$aJejunostomy
=450  \\$wnnna$aJejunostomies
=550  \\$wg$aEnterostomy
=550  \\$aJejunum
=550  \\$aSurgical Stomas
=667  \\$aJEJUNOILEAL BYPASS & PANCREATICOJEJUNOSTOMY are available
=680  \\$iSurgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.
=688  \\$a88
=750  \0$aJejunostomy$5IEN$0(DLC)sh 85069872

=LDR  01641cz  a2200433n  4500
=001  9880363756402441
=005  20141212202648.0
=008  850617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007581
=035  \\$aCBA0784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x65.$x62.$x875
=072  \\$aE4.$x35.$x415
=072  \\$aE4.$x62.$x875
=072  \\$aE4.$x210.$x626
=150  \\$aJejunoileal Bypass
=450  \\$wnnna$aBypass, Ileojejunal
=450  \\$wnnna$aBypass, Intestinal
=450  \\$wnnna$aBypass, Jejuno-Ileal
=450  \\$wnnna$aBypass, Jejunoileal
=450  \\$wnnna$aBypasses, Ileojejunal
=450  \\$wnnna$aBypasses, Intestinal
=450  \\$wnnna$aBypasses, Jejuno-Ileal
=450  \\$wnnna$aBypasses, Jejunoileal
=450  \\$aIleojejunal Bypass
=450  \\$wnnna$aIleojejunal Bypasses
=450  \\$aIntestinal Bypass
=450  \\$wnnna$aIntestinal Bypasses
=450  \\$wnnna$aJejuno-Ileal Bypass
=450  \\$wnnna$aJejuno Ileal Bypass
=450  \\$wnnna$aJejuno-Ileal Bypasses
=450  \\$wnnna$aJejunoileal Bypasses
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aBariatric Surgery
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aObesity, Morbid
=680  \\$iA procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.
=688  \\$a86
=750  \0$aJejunoileal bypass$5IEN$0(DLC)sh 85069871

=LDR  00558cz  a2200181n  4500
=001  9880363756502441
=005  20141212202647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007578
=035  \\$aCBA0781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x653
=150  \\$aJealousy
=450  \\$wnnna$aJealousies
=550  \\$wg$aEmotions
=667  \\$ahuman & animal; no qualif
=680  \\$iAn irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and self criticism.
=750  \0$aJealousy$5IEN$0(DLC)sh 85069852

=LDR  01095cz  a2200313n  4500
=001  9880363756602441
=005  20141212202646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007574
=035  \\$aCBA0777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x520
=150  \\$aJaw Relation Record
=450  \\$aAxiography
=450  \\$aBite Registration
=450  \\$wnnna$aBite Registrations
=450  \\$wnnna$aJaw Relation Records
=450  \\$wnnna$aRecord, Jaw Relation
=450  \\$wnnna$aRecords, Jaw Relation
=450  \\$wnnna$aRegistration, Bite
=450  \\$wnnna$aRegistrations, Bite
=450  \\$aSirognathography
=550  \\$wg$aDentistry
=550  \\$wh$aCentric Relation
=550  \\$aDental Occlusion
=667  \\$aNIM; DF: JAW RELAT RECORD
=680  \\$iA registration of any positional relationship of the mandible in reference to the maxillae. These records may be any of the many vertical, horizontal, or orientation relations. (Jablonski, Illustrated Dictionary of Dentistry)
=688  \\$a70
=750  \0$aJaw relation records$5IEN$0(DLC)sh 85069802

=LDR  01302cz  a2200385n  4500
=001  9880363756702441
=005  20141212202646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007573
=035  \\$aCBA0776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721.$x450
=072  \\$aC5.$x116.$x231.$x754.$x450
=072  \\$aC5.$x500.$x499
=072  \\$aC7.$x320.$x515
=150  \\$aJaw Neoplasms
=450  \\$wnnna$aCancer, Jaw
=450  \\$aCancer of Jaw
=450  \\$wnnna$aCancer of the Jaw
=450  \\$wnnna$aCancers, Jaw
=450  \\$aJaw Cancer
=450  \\$wnnna$aJaw Cancers
=450  \\$wnnna$aJaw Neoplasm
=450  \\$wnnna$aNeoplasm, Jaw
=450  \\$wnnna$aNeoplasms, Jaw
=550  \\$wg$aJaw Diseases
=550  \\$wg$aSkull Neoplasms
=550  \\$wh$aMandibular Neoplasms
=550  \\$wh$aMaxillary Neoplasms
=550  \\$wh$aPalatal Neoplasms
=667  \\$aGEN: prefer specific precoord; coord IM with histol type of neopl (IM)
=680  \\$iCancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.
=688  \\$a67
=750  \0$aJaws$xTumors$5IEN-M$0(DLC)sh 85069815
=750  \0$aJaws$xCancer$5IEN-HS$0(DLC)sh 85069809

=LDR  00742cz  a2200265n  4500
=001  9880363756802441
=005  20141212202645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007572
=035  \\$aCBA0775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x400
=072  \\$aC26.$x404.$x750.$x467
=150  \\$aJaw Fractures
=450  \\$wnnna$aFracture, Jaw
=450  \\$wnnna$aFractures, Jaw
=450  \\$wnnna$aJaw Fracture
=550  \\$wg$aMaxillofacial Injuries
=550  \\$wg$aSkull Fractures
=550  \\$wh$aMandibular Fractures
=550  \\$wh$aMaxillary Fractures
=667  \\$aGEN
=680  \\$iFractures of the upper or lower jaw.
=688  \\$a66
=750  \0$aJaws$xFracture$5IEN$0(IEN)368964

=LDR  00979cz  a2200349n  4500
=001  9880363756902441
=005  20141212202645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007571
=035  \\$aCBA0774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500
=072  \\$aC7.$x320
=150  \\$aJaw Diseases
=450  \\$wnnna$aDisease, Jaw
=450  \\$wnnna$aDiseases, Jaw
=450  \\$wnnna$aJaw Disease
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wg$aStomatognathic Diseases
=550  \\$wh$aBisphosphonate-Associated Osteonecrosis of the Jaw
=550  \\$wh$aCherubism
=550  \\$wh$aGranuloma, Giant Cell
=550  \\$wh$aJaw Abnormalities
=550  \\$wh$aJaw Cysts
=550  \\$wh$aJaw, Edentulous
=550  \\$wh$aJaw Neoplasms
=550  \\$wh$aMandibular Diseases
=550  \\$wh$aMaxillary Diseases
=550  \\$wh$aPeriapical Diseases
=667  \\$aGEN
=688  \\$a67
=750  \0$aJaws$xDiseases$5IEN$0(DLC)sh 85069811

=LDR  01109cz  a2200277n  4500
=001  9880363757002441
=005  20141212202645.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007570
=035  \\$aCBA0773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530
=072  \\$aC5.$x500.$x470
=072  \\$aC7.$x320.$x450
=150  \\$aJaw Cysts
=450  \\$wnnna$aCyst, Jaw
=450  \\$wnnna$aCysts, Jaw
=450  \\$wnnna$aJaw Cyst
=550  \\$wg$aBone Cysts
=550  \\$wg$aJaw Diseases
=550  \\$wh$aNonodontogenic Cysts
=550  \\$wh$aOdontogenic Cysts
=667  \\$anon-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term (IM)
=680  \\$iSaccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic.
=688  \\$a80
=750  \0$aJaws$xCysts$5IEN$0(DLC)sh 85069810

=LDR  01195cz  a2200361n  4500
=001  9880363757102441
=005  20141212202644.0
=008  771207\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007569
=035  \\$aCBA0772HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x460
=072  \\$aC5.$x660.$x207.$x540.$x460
=072  \\$aC7.$x320.$x440
=072  \\$aC7.$x650.$x500.$x460
=072  \\$aC16.$x131.$x621.$x207.$x540.$x460
=072  \\$aC16.$x131.$x850.$x500.$x460
=150  \\$aJaw Abnormalities
=450  \\$wnnna$aAbnormalities, Jaw
=450  \\$wnnna$aAbnormality, Jaw
=450  \\$aJaw$xabnormalities
=450  \\$wnnna$aJaw Abnormality
=550  \\$wg$aJaw Diseases
=550  \\$wg$aMaxillofacial Abnormalities
=550  \\$wh$aCleft Palate
=550  \\$wh$aMicrognathism
=550  \\$wh$aPierre Robin Syndrome
=550  \\$wh$aPrognathism
=550  \\$wh$aRetrognathia
=667  \\$aGEN only: prefer specifics: MAXILLA /abnorm or MANDIBLE /abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iCongenital absence of or defects in structures of the jaw.
=688  \\$a66
=750  \0$aJaws$xAbnormalities$5IEN$0(DLC)sh 85069807

=LDR  00991cz  a2200301n  4500
=001  9880363757202441
=005  20141212202644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007568
=035  \\$aCBA0771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502
=072  \\$aA14.$x521
=150  \\$aJaw
=360  \\$iconsider also terms at$aMANDIB-$aMAXILL-
=450  \\$wnnna$aJaws
=550  \\$wg$aFacial Bones
=550  \\$wg$aStomatognathic System
=550  \\$wh$aAlveolar Process
=550  \\$wh$aDental Arch
=550  \\$wh$aMandible
=550  \\$wh$aMaxilla
=550  \\$wh$aPalate
=550  \\$wh$aPalate, Hard
=667  \\$a/injuries: TN 115; upper jaw = MAXILLA; lower jaw = MANDIBLE; French "maxillaires" usually means jaws not necessarily maxilla
=680  \\$iBony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA.
=688  \\$a65; was JAWS 1963-64
=750  \0$aJaws$5IEN$0(DLC)sh 85069806

=LDR  01395cz  a2200313n  4500
=001  9880363757302441
=005  20141212202644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007567
=035  \\$aCBA0770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x451.$x500
=072  \\$aC23.$x550.$x429.$x249.$x500
=150  \\$aJaundice, Neonatal
=450  \\$wnnna$aIcterus Gravis Neonatorum
=450  \\$wnnna$aJaundice, Physiological Neonatal
=450  \\$wnnna$aNeonatal Jaundice
=450  \\$wnnna$aNeonatal Jaundice, Physiological
=450  \\$wnnna$aPhysiological Neonatal Jaundice
=450  \\$wnnna$aSevere Jaundice in Neonate
=450  \\$wnnna$aSevere Jaundice in Newborn
=550  \\$wg$aHyperbilirubinemia, Neonatal
=550  \\$wh$aJaundice, Chronic Idiopathic
=550  \\$aErythroblastosis, Fetal
=550  \\$aHyperbilirubinemia, Neonatal
=667  \\$acheck the tag INFANT, NEWBORN
=680  \\$iYellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.
=688  \\$a1966; for ICTERUS GRAVIS NEONATORUM use ERYTHROBLASTOSIS FETAL 1975-2005
=750  \0$aJaundice, Neonatal$0(DLC) sh 85069784$5IEN

=LDR  01017cz  a2200277n  4500
=001  9880363757402441
=005  20141212202643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007565
=035  \\$aCBA0768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x429.$x500
=072  \\$aC23.$x888.$x885.$x375
=150  \\$aJaundice
=450  \\$wnnna$aHemolytic Jaundice
=450  \\$wnnna$aHemolytic Jaundices
=450  \\$aIcterus
=450  \\$aJaundice, Hemolytic
=450  \\$wnnna$aJaundices, Hemolytic
=550  \\$wg$aHyperbilirubinemia
=550  \\$wg$aSkin Manifestations
=550  \\$wh$aJaundice, Obstructive
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
=688  \\$a1965; for JAUNDICE, HEMOLYTIC use ANEMIA, HEMOLYTIC 1975-2012
=750  \0$aJaundice$5IEN$0(DLC)sh 85069783

=LDR  03515cz  a2200685n  4500
=001  9880363757502441
=005  20141212202642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007562
=035  \\$aCBA0765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x380.$x165
=072  \\$aC10.$x228.$x228.$x800.$x230
=072  \\$aF3.$x87.$x400.$x300
=150  \\$aCreutzfeldt-Jakob Syndrome
=450  \\$wnnna$aCJD (Creutzfeldt-Jakob Disease)
=450  \\$wnnna$aCJD (Creutzfeldt Jakob Disease)
=450  \\$wnnna$aCreutzfeldt Jacob Disease
=450  \\$wnnna$aCreutzfeldt-Jakob Disease
=450  \\$wnnna$aCreutzfeldt Jakob Disease
=450  \\$wnnna$aCreutzfeldt-Jakob Disease, Familial
=450  \\$wnnna$aCreutzfeldt Jakob Disease, Familial
=450  \\$wnnna$aCreutzfeldt-Jakob Disease, New Variant
=450  \\$wnnna$aCreutzfeldt Jakob Disease, New Variant
=450  \\$wnnna$aCreutzfeldt-Jakob Disease, Variant
=450  \\$wnnna$aCreutzfeldt Jakob Disease, Variant
=450  \\$wnnna$aCreutzfeldt-Jakob Diseases, Familial
=450  \\$wnnna$aCreutzfeldt Jakob Syndrome
=450  \\$wnnna$aDisease, Creutzfeldt Jacob
=450  \\$wnnna$aDisease, Creutzfeldt-Jakob
=450  \\$wnnna$aDisease, Familial Creutzfeldt-Jakob
=450  \\$wnnna$aDisease, Jakob-Creutzfeldt
=450  \\$wnnna$aEncephalopathies, Subacute Spongiform
=450  \\$wnnna$aEncephalopathy, Subacute Spongiform
=450  \\$wnnna$aFamilial Creutzfeldt-Jakob Disease
=450  \\$wnnna$aFamilial Creutzfeldt Jakob Disease
=450  \\$wnnna$aFamilial Creutzfeldt-Jakob Diseases
=450  \\$wnnna$aJacob Disease, Creutzfeldt
=450  \\$wnnna$aJakob-Creutzfeldt Disease
=450  \\$wnnna$aJakob Creutzfeldt Disease
=450  \\$wnnna$aJakob-Creutzfeldt Syndrome
=450  \\$wnnna$aJakob Creutzfeldt Syndrome
=450  \\$aNew Variant Creutzfeldt-Jakob Disease
=450  \\$wnnna$aNew Variant Creutzfeldt Jakob Disease
=450  \\$wnnna$aSpongiform Encephalopathies, Subacute
=450  \\$aSpongiform Encephalopathy, Subacute
=450  \\$wnnna$aSubacute Spongiform Encephalopathies
=450  \\$wnnna$aSubacute Spongiform Encephalopathy
=450  \\$wnnna$aSyndrome, Creutzfeldt-Jakob
=450  \\$wnnna$aSyndrome, Jakob-Creutzfeldt
=450  \\$wnnna$aV-CJD (Variant-Creutzfeldt-Jakob Disease)
=450  \\$wnnna$aV CJD (Variant Creutzfeldt Jakob Disease)
=450  \\$wnnna$aVariant Creutzfeldt-Jakob Disease
=450  \\$wnnna$aVariant Creutzfeldt Jakob Disease
=550  \\$wg$aDementia
=550  \\$wg$aPrion Diseases
=680  \\$iA rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
=688  \\$a1991; use JAKOB-CREUTZFELDT SYNDROME 1981-1990, use CREUTZFELDT-JAKOB DISEASE 1969-1980
=688  \\$a91; was JAKOB-CREUTZFELDT SYNDROME 1981-90; was CREUTZFELDT-JAKOB DISEASE 1969-80 (Prov 1969-72)
=750  \0$aCreutzfeldt-Jakob disease$5IEN$0(DLC)sh 85069294

=LDR  01193cz  a2200277n  4500
=001  9880363757602441
=005  20141212202641.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007559
=035  \\$aCBA0762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x330
=150  \\$aIvermectin
=450  \\$wnnna$aEqvalan
=450  \\$wnnna$aIvermectin Merck Brand
=450  \\$wnnna$aIvomec
=450  \\$wnnna$aMectizan
=450  \\$wnnna$aMerck Brand of Ivermectin
=450  \\$wnnna$aMK-933
=450  \\$wnnna$aMK 933
=450  \\$wnnna$aMK933
=450  \\$wnnna$aStromectol
=550  \\$wg$aMacrolides
=680  \\$iA mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.
=688  \\$a1987; for MECTIZAN use IVERMECTIN (NM) 1987-1999
=750  \0$aIvermectin$5IEN$0(DLC)sh 85069082

=LDR  01117cz  a2200313n  4500
=001  9880363757702441
=005  20141212211055.0
=008  880609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015474
=035  \\$aCBA0757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x325
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700.$x325
=072  \\$aD2.$x455.$x849.$x131.$x495.$x325
=072  \\$aD23.$x767.$x261.$x700.$x325
=150  \\$aIsotretinoin
=450  \\$a13-cis-Retinoic Acid
=450  \\$wnnna$a13 cis Retinoic Acid
=450  \\$wnnna$aAccutane
=450  \\$wnnna$aIsotretinoin Zinc Salt, 13-cis-Isomer
=450  \\$wnnna$aIsotretinoin Zinc Salt, 13 cis Isomer
=450  \\$wnnna$aRo 4-3780
=450  \\$wnnna$aRo 4 3780
=450  \\$wnnna$aRo 43780
=450  \\$wnnna$aRoaccutane
=550  \\$wg$aRetinoids
=680  \\$iA topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects.
=688  \\$a89
=750  \0$aIsotretinoin$5IEN$0(DLC)sh 85068685

=LDR  01575cz  a2200481n  4500
=001  9880363757802441
=005  20141212202639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007554
=035  \\$aCBA0756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496
=150  \\$aIsotopes
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCalcium Isotopes
=550  \\$wh$aCarbon Isotopes
=550  \\$wh$aCerium Isotopes
=550  \\$wh$aCesium Isotopes
=550  \\$wh$aChromium Isotopes
=550  \\$wh$aCobalt Isotopes
=550  \\$wh$aDeuterium
=550  \\$wh$aGallium Isotopes
=550  \\$wh$aGold Isotopes
=550  \\$wh$aIodine Isotopes
=550  \\$wh$aIron Isotopes
=550  \\$wh$aMercury Isotopes
=550  \\$wh$aNitrogen Isotopes
=550  \\$wh$aOxygen Isotopes
=550  \\$wh$aPhosphorus Isotopes
=550  \\$wh$aPotassium Isotopes
=550  \\$wh$aRadioisotopes
=550  \\$wh$aSodium Isotopes
=550  \\$wh$aStrontium Isotopes
=550  \\$wh$aSulfur Isotopes
=550  \\$wh$aXenon Isotopes
=550  \\$wh$aYttrium Isotopes
=550  \\$wh$aZinc Isotopes
=550  \\$aElements
=550  \\$aRadioisotopes
=667  \\$afor stable isotopes only; GEN: avoid as IM; NIM as coord; Manual 25.20+; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope
=680  \\$iAtomic species differing in mass number but having the same atomic number. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a74; was see under RADIOISOTOPES 1963-73
=750  \0$aIsotopes$5IEN$0(DLC)sh 85068681

=LDR  01650cz  a2200325n  4500
=001  9880363757902441
=005  20141212202639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007553
=035  \\$aCBA0755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x522
=150  \\$aIsotope Labeling
=450  \\$wnnna$aAffinity Tagging, Isotope-Coded
=450  \\$wnnna$aAffinity Tagging, Isotopically-Coded
=450  \\$wnnna$aIsotope-Coded Affinity Tagging
=450  \\$wnnna$aIsotope Coded Affinity Tagging
=450  \\$wnnna$aIsotope Labeling, Stable
=450  \\$wnnna$aIsotopically-Coded Affinity Tagging
=450  \\$wnnna$aLabeling, Isotope
=450  \\$wnnna$aLabeling, Stable Isotope
=450  \\$wnnna$aStable Isotope Labeling
=450  \\$wnnna$aTagging, Isotope-Coded Affinity
=450  \\$wnnna$aTagging, Isotopically-Coded Affinity
=550  \\$wg$aInvestigative Techniques
=550  \\$aRadioisotopes
=667  \\$arestrict to techniques of labeling with isotopes (stable or radioactive): do not use for radioisotope tracer studies of "labeled" cells, microorganisms or chemicals ( = chemical with no qualify (NIM) or /diag use (NIM): Manual 19.8.23), as Cr51-labeled erythrocytes = ERYTHROCYTES + CHROMIUM RADIOISOTOPES /diag use but not ISOTOPE LABELING
=680  \\$iTechniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.
=688  \\$a73(71)
=750  \0$aRadiolabeling$5IEN$0(DLC)sh 91005211

=LDR  00772cz  a2200181n  4500
=001  9880363758002441
=005  20141212202638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007552
=035  \\$aCBA0754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776.$x498
=150  \\$aIsotonic Solutions
=450  \\$wnnna$aSolutions, Isotonic
=550  \\$wg$aSolutions
=667  \\$aGEN; NIM; no qualif when NIM coord; qualif is usually attached to specific drug in solution; when IM, only D25-26 qualif; DF: ISOTONIC SOL
=680  \\$iSolutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (From Grant & Hackh's Chemical Dictionary, 5th ed & Dorland, 28th ed)
=750  \0$aPhysiologic salines$5IEN$0(DLC)sh 85101675

=LDR  01052cz  a2200301n  4500
=001  9880363758102441
=005  20141212202637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007546
=035  \\$aCBA0748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x531
=150  \\$aIsoquinolines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
=550  \\$wh$aBenzylisoquinolines
=550  \\$wh$aDebrisoquin
=550  \\$wh$aEmetine
=550  \\$wh$aNaphthalimides
=550  \\$wh$aNelfinavir
=550  \\$wh$aNomifensine
=550  \\$wh$aNoscapine
=550  \\$wh$aPraziquantel
=550  \\$wh$aSaquinavir
=550  \\$wh$aTetrahydroisoquinolines
=680  \\$iA group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
=688  \\$a69; TYLOCREBRINE was heading 1972-84 (Prov 1972)
=750  \0$aIsoquinoline$5IEN$0(DLC)sh 85068668

=LDR  01431cz  a2200409n  4500
=001  9880363758202441
=005  20141212202636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007545
=035  \\$aCBA0747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x439
=072  \\$aD2.$x92.$x63.$x291.$x439
=072  \\$aD2.$x92.$x311.$x649
=150  \\$aIsoproterenol
=450  \\$wnnna$a4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol
=450  \\$wnnna$aEuspiran
=450  \\$wnnna$aHydrochloride, Isoproterenol
=450  \\$wnnna$aIsadrin
=450  \\$wnnna$aIsadrine
=450  \\$aIsoprenaline
=450  \\$wnnna$aIsopropyl Noradrenaline
=450  \\$aIsopropylarterenol
=450  \\$wnnna$aIsopropylnoradrenaline
=450  \\$wnnna$aIsopropylnorepinephrine
=450  \\$wnnna$aIsoproterenol Hydrochloride
=450  \\$wnnna$aIsoproterenol Sulfate
=450  \\$wnnna$aIsuprel
=450  \\$wnnna$aIzadrin
=450  \\$wnnna$aNoradrenaline, Isopropyl
=450  \\$wnnna$aNorisodrine
=450  \\$wnnna$aNovodrin
=450  \\$wnnna$aSulfate, Isoproterenol
=550  \\$wg$aCatecholamines
=550  \\$wg$aEthanolamines
=680  \\$iIsopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
=750  \0$aIsoproterenol$5IEN$0(DLC)sh 85068667

=LDR  00955cz  a2200313n  4500
=001  9880363758302441
=005  20141212202635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007539
=035  \\$aCBA0741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x349
=072  \\$aD3.$x383.$x725.$x394
=150  \\$aIsonicotinic Acids
=450  \\$wnnna$aAcid, Isonicotinic
=450  \\$wnnna$aAcids, Isonicotinic
=450  \\$wnnna$aIsonicotinic Acid
=550  \\$wg$aAcids, Heterocyclic
=550  \\$wg$aPyridines
=550  \\$wh$aEthionamide
=550  \\$wh$aIproniazid
=550  \\$wh$aIsoniazid
=550  \\$wh$aNialamide
=550  \\$wh$aProthionamide
=550  \\$wh$aPyridoxic Acid
=667  \\$ahydrazide = ISONIAZID
=680  \\$iHeterocyclic acids that are derivatives of 4-pyridinecarboxylic acid (isonicotinic acid).
=688  \\$a75; was ISONICOTINIC ACID 1963-74
=750  \0$aIsonicotinic acid$5IEN$0(DLC)sh 87001832

=LDR  01116cz  a2200325n  4500
=001  9880363758402441
=005  20141212202635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007538
=035  \\$aCBA0740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x442.$x436
=072  \\$aD3.$x66.$x349.$x410
=072  \\$aD3.$x383.$x725.$x394.$x582
=150  \\$aIsoniazid
=450  \\$wnnna$aAcid Vanillylidenehydrazide, Isonicotinic
=450  \\$wnnna$aFtivazide
=450  \\$wnnna$aHydrazide, Isonicotinic Acid
=450  \\$wnnna$aIsonex
=450  \\$aIsonicotinic Acid Hydrazide
=450  \\$wnnna$aIsonicotinic Acid Vanillylidenehydrazide
=450  \\$wnnna$aPhthivazid
=450  \\$wnnna$aPhthivazide
=450  \\$wnnna$aTubazide
=450  \\$wnnna$aVanillylidenehydrazide, Isonicotinic Acid
=550  \\$wg$aHydrazines
=550  \\$wg$aIsonicotinic Acids
=680  \\$iAntibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
=688  \\$a/adv eff-pois-tox was ISONIAZID TOXICOLOGY 1963-65
=750  \0$aIsoniazid$5IEN$0(DLC)sh 87001831

=LDR  00807cz  a2200229n  4500
=001  9880363758502441
=005  20141212202634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007536
=035  \\$aCBA0738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x575.$x249
=072  \\$aG2.$x607.$x500
=150  \\$aIsomerism
=450  \\$wnnna$aIsomerisms
=550  \\$wg$aMolecular Structure
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$wh$aStereoisomerism
=667  \\$aNIM; no qualif
=680  \\$iThe phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=688  \\$a74(71)
=750  \0$aIsomerism$0(DLC) sh 85068647$5IEN

=LDR  01008cz  a2200253n  4500
=001  9880363758602441
=005  20141212202634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007535
=035  \\$aCBA0737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399
=150  \\$aIsomerases
=550  \\$wg$aEnzymes
=550  \\$wh$acis-trans-Isomerases
=550  \\$wh$aDNA Helicases
=550  \\$wh$aDNA Topoisomerases
=550  \\$wh$aIntramolecular Lyases
=550  \\$wh$aIntramolecular Oxidoreductases
=550  \\$wh$aIntramolecular Transferases
=550  \\$wh$aRacemases and Epimerases
=667  \\$aGEN only; see Tree D8 under ISOMERASES & choose the most specific
=680  \\$iA class of enzymes that catalyze geometric or structural changes within a molecule to form a single product. The reactions do not involve a net change in the concentrations of compounds other than the substrate and the product.(from Dorland, 28th ed) EC 5.
=750  \0$aIsomerases$5IEN$0(DLC)sh 85068646

=LDR  00542cz  a2200169n  4500
=001  9880363758702441
=005  20141212202632.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007530
=035  \\$aCBA0732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601.$x570
=150  \\$aIsoflurane
=550  \\$wg$aMethyl Ethers
=680  \\$iA stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
=688  \\$a87(75); was see under METHYL ETHERS 1975-86
=750  \0$aIsoflurane$5IEN$0(DLC)sh 86005547

=LDR  01025cz  a2200301n  4500
=001  9880363758802441
=005  20141212202632.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007529
=035  \\$aCBA0731M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x400
=072  \\$aD3.$x830.$x219.$x266.$x450.$x400
=150  \\$aIsoflavones
=450  \\$wnnna$a3-Benzylchroman-4-Ones
=450  \\$wnnna$a3 Benzylchroman 4 Ones
=450  \\$wnnna$a3-Benzylidene-4-Chromanones
=450  \\$wnnna$a3 Benzylidene 4 Chromanones
=450  \\$aHomoisoflavones
=550  \\$wg$aFlavonoids
=550  \\$wh$aCoumestrol
=550  \\$wh$aEquol
=550  \\$wh$aGenistein
=550  \\$wh$aPterocarpans
=550  \\$wh$aRotenone
=680  \\$i3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.
=688  \\$a91(75); was see under FLAVONES 1975-90
=750  \0$aIsoflavones$5IEN-M$0(DLC)sh 00009581

=LDR  00810cz  a2200241n  4500
=001  9880363758902441
=005  20141212202632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007527
=035  \\$aCBA0729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x348
=072  \\$aD12.$x776.$x800.$x300
=150  \\$aIsoenzymes
=450  \\$wnnna$aAlloenzymes
=450  \\$wnnna$aAllozymes
=450  \\$aIsozymes
=550  \\$wg$aEnzymes
=550  \\$wg$aProtein Isoforms
=667  \\$aIM general only; coordinate NIM with specific enzyme (IM)
=680  \\$iStructurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics.
=688  \\$a67(65)
=750  \0$aIsoenzymes$5IEN$0(DLC)sh 85068633

=LDR  00811cz  a2200229n  4500
=001  9880363759002441
=005  20141212202631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007525
=035  \\$aCBA0727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x663
=072  \\$aE5.$x301.$x300.$x663
=150  \\$aIsoelectric Focusing
=450  \\$aElectrofocusing
=450  \\$wnnna$aFocusing, Isoelectric
=550  \\$wg$aElectrophoresis
=550  \\$wh$aIsoelectric Point
=667  \\$aa type of electrophoresis; NIM
=680  \\$iElectrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.
=688  \\$a74(70)
=750  \0$aIsoelectric focusing$5IEN$0(DLC)sh 85068632

=LDR  00822cz  a2200229n  4500
=001  9880363759102441
=005  20141212202630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007519
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x705
=150  \\$aIsoantigens
=450  \\$wnnna$aAlloantigen
=450  \\$aAlloantigens
=450  \\$wnnna$aIsoantigen
=550  \\$wg$aAntigens
=550  \\$wh$aAntigens, Human Platelet
=550  \\$wh$aBlood Group Antigens
=550  \\$wh$aHistocompatibility Antigens
=680  \\$iAntigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS.
=688  \\$a67(64)
=750  \0$aIsoantigens$5IEN$0(DLC)sh 85068629

=LDR  01822cz  a2200421n  4500
=001  9880363759202441
=005  20141212202628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007515
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x734.$x414
=072  \\$aA6.$x407.$x414
=150  \\$aIslets of Langerhans
=450  \\$wnnna$aCell, Islet
=450  \\$wnnna$aCells, Islet
=450  \\$wnnna$aEndocrine Pancreas
=450  \\$aIslands of Langerhans
=450  \\$wnnna$aIslet Cell
=450  \\$aIslet Cells
=450  \\$wnnna$aIslet, Pancreatic
=450  \\$wnnna$aIslets, Pancreatic
=450  \\$wnnna$aLangerhans Islands
=450  \\$wnnna$aLangerhans Islets
=450  \\$wnnna$aNesidioblast
=450  \\$aNesidioblasts
=450  \\$aPancreas, Endocrine
=450  \\$wnnna$aPancreatic Islet
=450  \\$aPancreatic Islets
=550  \\$wg$aEndocrine Glands
=550  \\$wg$aPancreas
=550  \\$wh$aGlucagon-Secreting Cells
=550  \\$wh$aInsulin-Secreting Cells
=550  \\$wh$aPancreatic Polypeptide-Secreting Cells
=550  \\$wh$aSomatostatin-Secreting Cells
=667  \\$ado not confuse with LANGERHANS CELLS (skin); neoplasms = ADENOMA, ISLET CELL or CARCINOMA, ISLET CELL or their specifics
=680  \\$iIrregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN.
=688  \\$a91; was ISLANDS OF LANGERHANS 1963-90
=750  \0$aIslands of Langerhans$5IEN$0(DLC)sh 85068605

=LDR  00797cz  a2200277n  4500
=001  9880363759302441
=005  20141212202628.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007514
=035  \\$aCBA0716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x275
=150  \\$aIslam
=450  \\$wnnna$aEthic, Islamic
=450  \\$wnnna$aEthics, Islamic
=450  \\$wnnna$aIslamic Ethic
=450  \\$wnnna$aIslamic Ethics
=450  \\$aMohammedanism
=450  \\$wnnna$aMuslim
=450  \\$aMuslims
=550  \\$wg$aReligion
=550  \\$aArabs
=667  \\$aIM; specify geog if pertinent
=680  \\$iA monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity.
=688  \\$a76; was MOHAMMEDANISM 1963-75
=750  \0$aIslam$5IEN$0(DLC)sh 85068390

=LDR  00922cz  a2200241n  4500
=001  9880363759402441
=005  20141212202627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007511
=035  \\$aCBA0713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x513
=150  \\$aIschemia
=450  \\$wnnna$aIschemias
=550  \\$wg$aPathologic Processes
=550  \\$wh$aInfarction
=550  \\$wh$aNo-Reflow Phenomenon
=550  \\$aBlood Circulation
=550  \\$aCold Ischemia
=550  \\$aWarm Ischemia
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific organ /blood supply (IM); for prevention and control, consider ISCHEMIC PRECONDITIONING
=680  \\$iA hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
=750  \0$aIschemia$0(DLC) sh 85068338$5IEN

=LDR  00719cz  a2200205n  4500
=001  9880363759502441
=005  20141212202627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007510
=035  \\$aCBA0712M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x525
=150  \\$aIsatin
=450  \\$wnnna$a2,3-Dioxoindoline
=450  \\$wnnna$a2,3 Dioxoindoline
=550  \\$wg$aIndoles
=667  \\$ado not confuse with isatan
=680  \\$iAn indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients.
=688  \\$a91(75); was see under INDOLES 1975-90
=750  \0$aIsatin$0(DLC)sh2007009981$5IEN-M

=LDR  01343cz  a2200301n  4500
=001  9880363759602441
=005  20141212202627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007509
=035  \\$aCBA0711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x400
=072  \\$aD27.$x720.$x821.$x498
=072  \\$aD27.$x888.$x569.$x300
=072  \\$aD27.$x888.$x569.$x734.$x498
=150  \\$aIrritants
=450  \\$aCounterirritants
=450  \\$aPustulants
=450  \\$aRubefacients
=450  \\$aVesicants
=550  \\$wg$aNoxae
=550  \\$wg$aRiot Control Agents, Chemical
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aTear Gases
=667  \\$anote X ref COUNTERIRRITANTS but use no qualif with it (i.e., adv eff of a counterirritant is COUNTERIRRITANTS, not COUNTERIRRITANTS /adv eff since this would print as a misleading IRRITANTS /adv eff)
=680  \\$iDrugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.
=688  \\$aRUBEFACIENTS & VESICANTS were see under IRRITANTS 1963-79
=750  \0$aIrritants (Drugs)$0(DLC)sh2006007986$5IEN-M

=LDR  01240cz  a2200349n  4500
=001  9880363759702441
=005  20141212202626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007507
=035  \\$aCBA0709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x533.$x500
=072  \\$aE5.$x927
=150  \\$aTherapeutic Irrigation
=450  \\$aDouching
=450  \\$wnnna$aDouchings
=450  \\$wnnna$aIrrigation, Therapeutic
=450  \\$wnnna$aIrrigations, Therapeutic
=450  \\$aLavage
=450  \\$wnnna$aLavages
=450  \\$wnnna$aTherapeutic Irrigations
=550  \\$wg$aHydrotherapy
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aBronchoalveolar Lavage
=550  \\$wh$aGastric Lavage
=550  \\$wh$aNasal Lavage
=550  \\$wh$aPeritoneal Lavage
=550  \\$wh$aVaginal Douching
=667  \\$aIM only as general procedure; NIM for irrigation of specific organ or site; entry term LAVAGE: note several precoordinated lavage terms are also available.
=680  \\$iThe washing of a body cavity or surface by flowing water or solution for therapy or diagnosis.
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Irrigation
=750  \0$aIrrigation (Medicine)$0(DLC) sh 85068290$5IEN

=LDR  01454cz  a2200361n  4500
=001  9880363759802441
=005  20141212202626.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007506
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x427.$x374.$x375
=072  \\$aD12.$x776.$x556.$x579.$x374.$x375
=150  \\$aIron-Sulfur Proteins
=450  \\$wnnna$aIron Sulfur Proteins
=450  \\$wnnna$aProteins, Iron Sulfur
=450  \\$wnnna$aProteins, Iron-Sulfur
=450  \\$wnnna$aSulfur Proteins, Iron
=550  \\$wg$aNonheme Iron Proteins
=550  \\$wh$aAdrenodoxin
=550  \\$wh$aElectron Transport Complex I
=550  \\$wh$aElectron Transport Complex II
=550  \\$wh$aElectron Transport Complex III
=550  \\$wh$aFerredoxin-Nitrite Reductase
=550  \\$wh$aFerredoxins
=550  \\$wh$aFerrochelatase
=550  \\$wh$aIron Regulatory Protein 1
=550  \\$wh$aIron Regulatory Protein 2
=550  \\$wh$aNitrate Reductase (NAD(P)H)
=550  \\$wh$aNitrate Reductase (NADPH)
=667  \\$a/biosyn /physiol permitted
=680  \\$iA group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation.
=688  \\$a91(77); was see under METALLOPROTEINS 1977-90
=750  \0$aIron-sulfur proteins$5IEN-M$0(DLC)sh 85068237

=LDR  00826cz  a2200229n  4500
=001  9880363759902441
=005  20141212202625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007504
=035  \\$aCBA0706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x473.$x498
=072  \\$aD1.$x496.$x749.$x514
=150  \\$aIron Radioisotopes
=450  \\$wnnna$aRadioisotopes, Iron
=550  \\$wg$aIron Isotopes
=550  \\$wg$aRadioisotopes
=550  \\$aIron
=667  \\$aFe-52, 53, 55, 59-61; NIM; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes.
=688  \\$a74
=750  \0$aIron$xIsotopes$5IEN$0(DLC)sh 85068140

=LDR  00660cz  a2200205n  4500
=001  9880363760002441
=005  20141212202624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007503
=035  \\$aCBA0705HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x473
=150  \\$aIron Isotopes
=450  \\$wnnna$aIsotopes, Iron
=550  \\$wg$aIsotopes
=550  \\$wh$aIron Radioisotopes
=550  \\$aIron
=667  \\$aFe-54, 57, 58; NIM
=680  \\$iStable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes.
=750  \0$aIron$xIsotopes$5IEN$0(DLC)sh 85068140

=LDR  01033cz  a2200277n  4500
=001  9880363760102441
=005  20141212202624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007502
=035  \\$aCBA0704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x914.$x500.$x410
=072  \\$aD27.$x720.$x832.$x500.$x410
=150  \\$aIron Chelating Agents
=450  \\$wnnna$aAgents, Iron Chelating
=450  \\$wnnna$aChelates, Iron
=450  \\$wnnna$aChelating Agents, Iron
=450  \\$aIron Chelates
=550  \\$wg$aChelating Agents
=550  \\$wh$aSiderophores
=550  \\$aChelating Agents
=550  \\$aHemoglobins
=550  \\$aIron Carbonyl Compounds
=680  \\$iOrganic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems.
=688  \\$a98(63)
=750  \0$aIron chelates$5IEN$0(DLC)sh 85068178

=LDR  01177cz  a2200253n  4500
=001  9880363760202441
=005  20141212202624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007501
=035  \\$aCBA0703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x412
=072  \\$aD1.$x268.$x956.$x287
=072  \\$aD1.$x552.$x544.$x412
=150  \\$aIron
=450  \\$aOrganoiron Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=550  \\$aFerric Compounds
=550  \\$aFerrous Compounds
=667  \\$aFe-56; Fe(II) = FERROUS COMPOUNDS, Fe(III) = FERRIC COMPOUNDS; /defic: permitted but consider ANEMIA, IRON DEFICIENCY; pneumoconiosis caused by iron particles = SIDEROSIS; /metab: consider also IRON OVERLOAD; metabolic disorders = IRON METABOLISM DISORDERS
=680  \\$iA metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.
=688  \\$a/metabolism was IRON METABOLISM 1963-65
=750  \0$aIron$5IEN-M$0(DLC)sh 85068131

=LDR  00721cz  a2200205n  4500
=001  9880363760302441
=005  20141212202623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007500
=035  \\$aCBA0702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x375.$x385
=072  \\$aC11.$x941.$x879.$x780.$x880.$x448
=150  \\$aIritis
=450  \\$wnnna$aIritides
=550  \\$wg$aIris Diseases
=550  \\$wg$aUveitis, Anterior
=667  \\$aa type of anterior uveitis
=680  \\$iInflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris.
=750  \0$aIritis$5IEN$0(DLC)sh 85068127

=LDR  00802cz  a2200277n  4500
=001  9880363760402441
=005  20141212202623.0
=008  800407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007499
=035  \\$aCBA0701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x375
=150  \\$aIris Diseases
=450  \\$wnnna$aDisease, Iris
=450  \\$wnnna$aDiseases, Iris
=450  \\$wnnna$aIris Disease
=550  \\$wg$aUveal Diseases
=550  \\$wh$aAniridia
=550  \\$wh$aExfoliation Syndrome
=550  \\$wh$aIridocorneal Endothelial Syndrome
=550  \\$wh$aIridocyclitis
=550  \\$wh$aIris Neoplasms
=550  \\$wh$aIritis
=680  \\$iDiseases, dysfunctions, or disorders of or located in the iris.
=688  \\$a81
=750  \0$aIris (Eye)$xDiseases$5IEN$0(DLC)sh 85068077

=LDR  00968cz  a2200205n  4500
=001  9880363760502441
=005  20141212202623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007498
=035  \\$aCBA0700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x450
=072  \\$aA9.$x371.$x894.$x513
=150  \\$aIris
=550  \\$wg$aAnterior Eye Segment
=550  \\$wg$aUvea
=550  \\$wh$aPupil
=667  \\$ainflammation = IRITIS but note IRIDOCYCLITIS is also available; color = EYE COLOR; /blood supply consider also CILIARY ARTERIES; pigmented epithelium of iris: coord IRIS with PIGMENT EPITHELIUM OF EYE
=680  \\$iThe most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.
=750  \0$aIris (Eye)$5IEN$0(DLC)sh 85068076

=LDR  01364cz  a2200361n  4500
=001  9880363760602441
=005  20141212202623.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007497
=035  \\$aCBA0699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x410
=072  \\$aB4.$x909.$x204.$x490
=150  \\$aIridoviridae
=450  \\$aChloriridovirus
=450  \\$wnnna$aChloriridoviruses
=450  \\$wnnna$aCytoplasmic Deoxyriboviruses, Icosahedral
=450  \\$wnnna$aDeoxyriboviruses, Icosahedral Cytoplasmic
=450  \\$wnnna$aGoldfish Virus
=450  \\$aGoldfish Viruses
=450  \\$aIcosahedral Cytoplasmic Deoxyriboviruses
=450  \\$aLymphocystivirus
=450  \\$wnnna$aLymphocystiviruses
=450  \\$aMegalocytivirus
=450  \\$wnnna$aMegalocytiviruses
=450  \\$wnnna$aViruses, Goldfish
=550  \\$wg$aDNA Viruses
=550  \\$wh$aIridovirus
=550  \\$wh$aRanavirus
=667  \\$ainfection in insects: coordinate IM with specific insect /virol (IM); infection in vertebrates: coordinate IM with DNA VIRUS INFECTIONS (IM)
=680  \\$iA family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS; RANAVIRUS; Chloriridovirus; Megalocytivirus; and Lymphocystivirus.
=688  \\$a1981 (1978)
=750  \0$aIridoviruses$5IEN$0(DLC)sh 89004919

=LDR  00703cz  a2200205n  4500
=001  9880363760702441
=005  20141212202622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007495
=035  \\$aCBA0697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x401
=072  \\$aD1.$x268.$x956.$x280
=072  \\$aD1.$x552.$x544.$x401
=150  \\$aIridium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aIr-193; Ir-191 = IRIDIUM (IM) + ISOTOPES (NIM); Ir-182-190, 192, 194-198 = IRIDIUM RADIOISOTOPES (IM)
=680  \\$iA metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.
=750  \0$aIridium$5IEN$0(DLC)sh 85068067

=LDR  00854cz  a2200217n  4500
=001  9880363760802441
=005  20141212202620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007486
=035  \\$aCBA0688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x450
=150  \\$aIpecac
=450  \\$wnnna$aIpecac (Syrup)
=450  \\$wnnna$aIpecac Syrup
=450  \\$aSyrup of Ipecac
=550  \\$wg$aPlant Extracts
=550  \\$aCephaelis
=680  \\$iA syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.
=688  \\$a99(63)
=750  \0$aIpecac (Drug)$5IEN$0(DLC)sh 85067865

=LDR  00880cz  a2200193n  4500
=001  9880363760902441
=005  20141212202617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007478
=035  \\$aCBA0680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x650
=072  \\$aE5.$x301.$x300.$x575
=150  \\$aIontophoresis
=450  \\$wnnna$aIontophoreses
=550  \\$wg$aDrug Administration Routes
=550  \\$wg$aElectrophoresis
=680  \\$iTherapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE; AIR IONIZATION nor PHONOPHORESIS, none of which requires current.
=750  \0$aIontophoresis$5IEN$0(DLC)sh 85067846

=LDR  00766cz  a2200193n  4500
=001  9880363761002441
=005  20141212202617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007477
=035  \\$aCBA0679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497
=150  \\$aIons
=550  \\$wg$aElectrolytes
=550  \\$wh$aAnions
=550  \\$wh$aCations
=667  \\$aavoid: too general; GEN; ionization chamber: index under RADIOMETRY /instrum
=680  \\$iAn atom or group of atoms that have a positive or negative electric charge due to a gain (negative charge) or loss (positive charge) of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.
=750  \0$aIons$5IEN$0(DLC)sh 85067842

=LDR  01136cz  a2200265n  4500
=001  9880363761102441
=005  20141212202617.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007476
=035  \\$aCBA0678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x374
=072  \\$aD27.$x720.$x395
=150  \\$aIonophores
=550  \\$wg$aMembrane Transport Modulators
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aCalcium Ionophores
=550  \\$wh$aPotassium Ionophores
=550  \\$wh$aProton Ionophores
=550  \\$wh$aSodium Ionophores
=550  \\$aCell Membrane Permeability
=550  \\$aUncoupling Agents
=680  \\$iChemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.
=688  \\$a76
=750  \0$aIonophores$5IEN$0(DLC)sh 85067832

=LDR  00783cz  a2200217n  4500
=001  9880363761202441
=005  20141212202616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007475
=035  \\$aCBA0677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x420
=150  \\$aIon Exchange Resins
=450  \\$wnnna$aExchange Resins, Ion
=450  \\$wnnna$aResins, Ion Exchange
=550  \\$wg$aLaboratory Chemicals
=550  \\$wh$aAnion Exchange Resins
=550  \\$wh$aCation Exchange Resins
=667  \\$aD25-26 qualif
=680  \\$iHigh molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions.
=750  \0$aIon exchange resins$5IEN$0(DLC)sh 85067798

=LDR  00778cz  a2200181n  4500
=001  9880363761302441
=005  20170629112641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007474
=035  \\$aCBA0676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x437
=150  \\$aIon Exchange
=450  \\$wnnna$aExchange, Ion
=550  \\$wg$aChemical Phenomena
=667  \\$aa physicochem process: do not confuse with ION TRANSPORT, which takes place in biol systems; NIM; no qualif
=680  \\$iReversible chemical reaction between a solid, often one of the ION EXCHANGE RESINS, and a fluid whereby ions may be exchanged from one substance to another. This technique is used in water purification, in research, and in industry.
=750  \0$aIon exchange$5IEN$0(DLC)sh 85067796

=LDR  01830cz  a2200469n  4500
=001  9880363761402441
=005  20141212202616.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007473
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400
=072  \\$aD12.$x776.$x543.$x550.$x425
=072  \\$aD12.$x776.$x543.$x585.$x400
=150  \\$aIon Channels
=450  \\$wnnna$aChannel, Ion
=450  \\$wnnna$aChannel, Ionic
=450  \\$wnnna$aChannel, Membrane
=450  \\$wnnna$aChannels, Ion
=450  \\$wnnna$aChannels, Ionic
=450  \\$wnnna$aChannels, Membrane
=450  \\$wnnna$aIon Channel
=450  \\$wnnna$aIonic Channel
=450  \\$wnnna$aIonic Channels
=450  \\$wnnna$aMembrane Channel
=450  \\$aMembrane Channels
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wg$aMembrane Transport Proteins
=550  \\$wh$aCalcium Channels
=550  \\$wh$aChloride Channels
=550  \\$wh$aCyclic Nucleotide-Gated Cation Channels
=550  \\$wh$aHyperpolarization-Activated Cyclic Nucleotide-Gated Channels
=550  \\$wh$aLigand-Gated Ion Channels
=550  \\$wh$aPorins
=550  \\$wh$aPotassium Channels
=550  \\$wh$aSodium Channels
=550  \\$wh$aTransient Receptor Potential Channels
=550  \\$aSignal Transduction
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific ion / metab (IM)
=680  \\$iGated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.
=688  \\$a79
=750  \0$aIon channels$5IEN-M$0(DLC)sh 85067794
=750  \0$aIon-permeable membranes$5IEN-HS$0(DLC)sh 85067803

=LDR  00841cz  a2200205n  4500
=001  9880363761502441
=005  20141212202614.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007466
=035  \\$aCBA0668M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x475.$x557
=150  \\$aIodophors
=450  \\$wnnna$aIodine, Tamed
=450  \\$wnnna$aTamed Iodine
=550  \\$wg$aIodine Compounds
=550  \\$wh$aPovidone-Iodine
=680  \\$iComplexes of iodine and non-ionic SURFACE-ACTIVE AGENTS acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. (From Merck Index, 11th ed)
=688  \\$a91(75); was see under IODINE 1975-90
=750  \0$aIodophors$0(DLC)sh2013000291$5IEN-M

=LDR  01325cz  a2200337n  4500
=001  9880363761602441
=005  20141212202613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007464
=035  \\$aCBA0666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x350.$x625.$x400
=150  \\$aClioquinol
=450  \\$wnnna$a5-Chloro-7-iodo-8-quinolinol
=450  \\$wnnna$a5 Chloro 7 iodo 8 quinolinol
=450  \\$wnnna$aChinoform
=450  \\$aChloroiodoquine
=450  \\$wnnna$aEntero-Septol
=450  \\$wnnna$aEntero Septol
=450  \\$wnnna$aEntero-Vioform
=450  \\$wnnna$aEntero Vioform
=450  \\$wnnna$aEnteroquinol
=450  \\$wnnna$aEnteroSeptol
=450  \\$wnnna$aEnteroVioform
=450  \\$aIodochlorhydroxyquin
=450  \\$aIodochloroxyquinoline
=450  \\$wnnna$aVioform
=550  \\$wg$aOxyquinoline
=680  \\$iA potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
=688  \\$a93; was IODOCHLORHYDROXYQUIN 1963-92 (see under HYDROXYQUINOLINES 1983-90); CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92
=750  \0$aIodochlorhydroxyquin$5IEN$0(DLC)sh 85067783

=LDR  00704cz  a2200253n  4500
=001  9880363761702441
=005  20141212202613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007462
=035  \\$aCBA0664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x454
=072  \\$aD2.$x455.$x526.$x581.$x496
=150  \\$aIodobenzenes
=450  \\$aIocetamic Acid$5IEN-M
=550  \\$wg$aBenzene Derivatives
=550  \\$wg$aHydrocarbons, Iodinated
=550  \\$wh$a3-Iodobenzylguanidine
=550  \\$wh$aIopanoic Acid
=550  \\$wh$aIophendylate
=550  \\$wh$aIpodate
=550  \\$wh$aTyropanoate
=688  \\$a73(72)
=750  \0$aIodobenzene$5IEN$0(DLC)sh 85067782

=LDR  01018cz  a2200241n  4500
=001  9880363761802441
=005  20141212202611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007457
=035  \\$aCBA0659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x448.$x496
=072  \\$aD1.$x496.$x749.$x474
=150  \\$aIodine Radioisotopes
=450  \\$wnnna$aRadioisotopes, Iodine
=550  \\$wg$aIodine Isotopes
=550  \\$wg$aRadioisotopes
=550  \\$wh$aSerum Albumin, Radio-Iodinated
=550  \\$aIodine
=667  \\$aI-117 through I-139 except I-127; NIM; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
=688  \\$a74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65
=750  \0$aIodine$xIsotopes$5IEN$0(DLC)sh 85067771

=LDR  00814cz  a2200217n  4500
=001  9880363761902441
=005  20141212202611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007456
=035  \\$aCBA0658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x448
=150  \\$aIodine Isotopes
=450  \\$wnnna$aIsotopes, Iodine
=550  \\$wg$aIsotopes
=550  \\$wh$aIodine Radioisotopes
=550  \\$aIodine
=667  \\$aI-127; NIM
=680  \\$iStable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope.
=688  \\$a/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65
=750  \0$aIodine$xIsotopes$5IEN$0(DLC)sh 85067771

=LDR  00694cz  a2200169n  4500
=001  9880363762002441
=005  20141212202611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007455
=035  \\$aCBA0657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x380.$x400
=150  \\$aIodine
=550  \\$wg$aHalogens
=667  \\$aI-127
=680  \\$iA nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
=750  \0$aIodine$5IEN-M$0(DLC)sh 85067769

=LDR  00619cz  a2200217n  4500
=001  9880363762102441
=005  20141212202610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007454
=035  \\$aCBA0656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x490
=072  \\$aD1.$x475.$x410
=150  \\$aIodides
=550  \\$wg$aAnions
=550  \\$wg$aIodine Compounds
=550  \\$wh$aPotassium Iodide
=550  \\$wh$aSodium Iodide
=667  \\$ainorganic cpds or iodide ion only
=680  \\$iInorganic binary compounds of iodine or the I- ion.
=750  \0$aIodides$5IEN$0(DLC)sh 85067768

=LDR  02517cz  a2200637n  4500
=001  9880363762202441
=005  20141212202610.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007453
=035  \\$aCBA0655HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x732.$x525
=150  \\$aIodide Peroxidase
=450  \\$wnnna$a5'-Deiodinase
=450  \\$wnnna$a5' Deiodinase
=450  \\$wnnna$a5'-Deiodinase, Iodothyronine
=450  \\$wnnna$a5'-Deiodinase, Reverse Triiodothyronine
=450  \\$wnnna$a5'-Deiodinase, Tetraiodothyronine
=450  \\$wnnna$a5'-Deiodinase, Thyroxine
=450  \\$wnnna$a5'-Monodeiodinase, Thyroxine
=450  \\$wnnna$aDeiodase, Iodotyrosine
=450  \\$wnnna$aDeiodinase
=450  \\$wnnna$aDeiodinase, Iodothyronine
=450  \\$wnnna$aDeiodinase, Iodotyrosine
=450  \\$wnnna$aDeiodinase, Triiodothyronine
=450  \\$wnnna$aEnzyme, Thyroxine Converting
=450  \\$aIodinase
=450  \\$aIodothyronine 5'-Deiodinase
=450  \\$wnnna$aIodothyronine 5' Deiodinase
=450  \\$aIodothyronine Deiodinase
=450  \\$aIodotyrosine Deiodase
=450  \\$wnnna$aIodotyrosine Deiodinase
=450  \\$wnnna$aMonodeiodinase
=450  \\$wnnna$aPeroxidase, Iodide
=450  \\$wnnna$aPeroxidase, Thyroid
=450  \\$wnnna$aReverse Triiodothyronine 5'-Deiodinase
=450  \\$wnnna$aReverse Triiodothyronine 5' Deiodinase
=450  \\$wnnna$aT4-5'-Deiodinase
=450  \\$wnnna$aT4 5' Deiodinase
=450  \\$wnnna$aT4-Monodeiodinase
=450  \\$wnnna$aT4 Monodeiodinase
=450  \\$wnnna$aTetraiodothyronine 5'-Deiodinase
=450  \\$wnnna$aTetraiodothyronine 5' Deiodinase
=450  \\$aThyroid Peroxidase
=450  \\$aThyroxine 5'-Deiodinase
=450  \\$wnnna$aThyroxine 5' Deiodinase
=450  \\$aThyroxine 5'-Monodeiodinase
=450  \\$wnnna$aThyroxine 5' Monodeiodinase
=450  \\$wnnna$aThyroxine Converting Enzyme
=450  \\$wnnna$aTriiodothyronine 5'-Deiodinase, Reverse
=450  \\$wnnna$aTriiodothyronine Deiodinase
=550  \\$wg$aPeroxidases
=667  \\$a/defic: consider also MONOIODOTYROSINE /metab (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM) + CONGENITAL HYPOTHYROIDISM
=680  \\$iA hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.
=688  \\$a86(76); was see under PEROXIDASES 1976-85
=750  \0$aIodide peroxidase$5IEN$0(DLC)sh 91004202

=LDR  01352cz  a2200325n  4500
=001  9880364446302441
=005  20141212221541.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055617
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x343
=072  \\$aJ1.$x637.$x509
=150  \\$aMicro-Electrical-Mechanical Systems
=450  \\$wnnna$aBioMEMS
=450  \\$wnnna$aMEMS
=450  \\$wnnna$aMicro-Electrical-Mechanical System
=450  \\$wnnna$aMicro Electrical Mechanical Systems
=450  \\$wnnna$aMicro-Electro-Mechanical System
=450  \\$wnnna$aMicro-Electro-Mechanical Systems
=450  \\$wnnna$aMicro Electro Mechanical Systems
=450  \\$wnnna$aSystem, Micro-Electrical-Mechanical
=450  \\$wnnna$aSystem, Micro-Electro-Mechanical
=450  \\$wnnna$aSystems, Micro-Electrical-Mechanical
=450  \\$wnnna$aSystems, Micro-Electro-Mechanical
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wg$aManufactured Materials
=550  \\$wh$aLab-On-A-Chip Devices
=680  \\$iA class of devices combining electrical and mechanical components that have at least one of the dimensions in the micrometer range (between 1 micron and 1 millimeter). They include sensors, actuators, microducts, and micropumps.
=688  \\$a2009
=750  \0$aMicroelectromechanical systems$0(DLC) sh 97007351$5IEN-M

=LDR  00856cz  a2200241n  4500
=001  9880364446402441
=005  20141212221647.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056084
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x347
=150  \\$aGenetic Fitness
=450  \\$wnnna$aDarwinian Fitness
=450  \\$wnnna$aFitness, Darwinian
=450  \\$wnnna$aFitness, Genetic
=450  \\$wnnna$aFitness, Reproductive
=450  \\$wnnna$aReproductive Fitness
=550  \\$wg$aGenetic Phenomena
=550  \\$aGene-Environment Interaction
=550  \\$aSelection, Genetic
=680  \\$iThe capability of an organism to survive and reproduce. The phenotypic expression of the genotype in a particular environment determines how genetically fit an organism will be.
=688  \\$a2010
=750  \0$aBiological fitness$0(DLC)sh2010001786$5IEN-M

=LDR  00569cz  a2200193n  4500
=001  9880364446502441
=005  20141212221646.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056044
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x49
=072  \\$aE5.$x3.$x500
=150  \\$aActigraphy
=550  \\$wg$aAccelerometry
=550  \\$wg$aMonitoring, Physiologic
=550  \\$aPolysomnography
=680  \\$iThe measurement and recording of MOTOR ACTIVITY to assess rest/activity cycles.
=688  \\$a2010
=750  \0$aActigraphy$0(DLC) sh 95007216$5IEN-M

=LDR  01147cz  a2200277n  4500
=001  9880364446602441
=005  20141212221540.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055616
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x570
=072  \\$aJ1.$x897.$x520.$x500
=150  \\$aMicrotechnology
=450  \\$wnnna$aMicrofabrication
=450  \\$wnnna$aMicrofabrications
=450  \\$wnnna$aMicromachining
=450  \\$wnnna$aMicromachinings
=450  \\$wnnna$aMicromanufacturing
=450  \\$wnnna$aMicromanufacturings
=450  \\$wnnna$aMicrotechnologies
=550  \\$wg$aMiniaturization
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aMicrofluidics
=680  \\$iManufacturing technology for making microscopic devices in the micrometer range (typically 1-100 micrometers), such as integrated circuits or MEMS. The process usually involves replication and parallel fabrication of hundreds or millions of identical structures using various thin film deposition techniques and carried out in environmentally-controlled clean rooms.
=688  \\$a2009
=750  \0$aMicrotechnology$0(DLC)sh2001012575$5IEN-M

=LDR  01077cz  a2200325n  4500
=001  9880364446702441
=005  20200721135725.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305
=150  \\$aElectrical Equipment and Supplies
=450  \\$aElectronic Equipment and Supplies
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aAmplifiers, Electronic
=550  \\$wh$aBrain-Computer Interfaces
=550  \\$wh$aCathode Ray Tube
=550  \\$wh$aElectric Power Supplies
=550  \\$wh$aElectric Wiring
=550  \\$wh$aElectrodes
=550  \\$wh$aElectronic Nose
=550  \\$wh$aMicro-Electrical-Mechanical Systems
=550  \\$wh$aPower Plants
=550  \\$wh$aSemiconductors
=550  \\$wh$aTransducers
=550  \\$wh$aWearable Electronic Devices
=550  \\$aElectronics
=680  \\$iApparatus and instruments that generate and operate with ELECTRICITY, and their electrical components.
=688  \\$a2009
=750  \0$aElectronics$xEquipment and supplies$0(DLC) sh 85042392$5IEN-M

=LDR  01091cz  a2200313n  4500
=001  9880364446802441
=005  20141212221645.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056004
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x595.$x500
=072  \\$aG2.$x575.$x750
=072  \\$aL1.$x224.$x160.$x500
=150  \\$aMolecular Dynamics Simulation
=450  \\$wnnna$aDynamic, Molecular
=450  \\$wnnna$aDynamics, Molecular
=450  \\$wnnna$aDynamics Simulation, Molecular
=450  \\$wnnna$aDynamics Simulations, Molecular
=450  \\$wnnna$aMolecular Dynamic
=450  \\$wnnna$aMolecular Dynamics
=450  \\$aMolecular Dynamics Simulations
=450  \\$wnnna$aSimulation, Molecular Dynamics
=450  \\$wnnna$aSimulations, Molecular Dynamics
=550  \\$wg$aComputer Simulation
=550  \\$wg$aModels, Molecular
=550  \\$wg$aMolecular Structure
=680  \\$iA computer simulation developed to study the motion of molecules over a period of time.
=688  \\$a2010
=750  \0$aMolecular dynamics$xSimulation methods$0(IEN)9148143$5IEN-M

=LDR  00682cz  a2200193n  4500
=001  9880364446902441
=005  20141212221537.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055609
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x249.$x750
=150  \\$aStars, Celestial
=450  \\$wnnna$aCelestial Star
=450  \\$wnnna$aCelestial Stars
=450  \\$wnnna$aStar, Celestial
=550  \\$wg$aAstronomical Objects
=680  \\$iLarge bodies consisting of self-luminous gas held together by their own gravity. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2009; use ASTRONOMY 1996-2008
=750  \0$aStars$0(DLC) sh 85127415$5IEN

=LDR  00856cz  a2200217n  4500
=001  9880364447002441
=005  20141212221645.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055994
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x625
=150  \\$aLimnology
=550  \\$wg$aEarth Sciences
=550  \\$wh$aFreshwater Biology
=550  \\$aHydrobiology
=550  \\$aHydrology
=550  \\$aOceanography
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the physical, chemical, hydrological, and biological aspects of fresh water bodies. (EPA Terms of Environment: Glossary, Abbreviations and Acronyms [Internet] US Environmental Protection Agency [cited 2008 Sep 25] available from http://www.epa.gov/OCEPAterms/aterms.html)
=688  \\$a2010
=750  \0$aLimnology$0(DLC) sh 85077053$5IEN-M

=LDR  00573cz  a2200169n  4500
=001  9880364447102441
=005  20141212221537.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x249.$x320
=150  \\$aGalaxies
=450  \\$wnnna$aGalaxy
=550  \\$wg$aAstronomical Objects
=680  \\$iLarge aggregates of CELESTIAL STARS; COSMIC DUST; and gas. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2009; use ASTRONOMY 1995-2008
=750  \0$aGalaxies$0(DLC) sh 85052763$5IEN-M

=LDR  00761cz  a2200241n  4500
=001  9880364447202441
=005  20141212221642.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055986
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x875
=150  \\$aVital Signs
=450  \\$wnnna$aSign, Vital
=450  \\$wnnna$aSigns, Vital
=450  \\$wnnna$aVital Sign
=550  \\$wg$aPhysical Examination
=550  \\$wh$aBlood Pressure
=550  \\$wh$aBody Temperature
=550  \\$wh$aHeart Rate
=550  \\$wh$aRespiratory Rate
=680  \\$iThe signs of life that may be monitored or measured, namely pulse rate, respiratory rate, body temperature, and blood pressure.
=688  \\$a2010
=750  \0$aVital signs$0(DLC) sh 85143947$5IEN-M

=LDR  01355cz  a2200313n  4500
=001  9880364447302441
=005  20190430170918.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055607
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x895
=150  \\$aReceptors, Natural Killer Cell
=450  \\$wnnna$aCell Receptors, NK
=450  \\$wnnna$aNatural Killer Cell Activating Receptors
=450  \\$wnnna$aNatural Killer Cell Inhibitory Receptors
=450  \\$wnnna$aNatural Killer Cell Receptors
=450  \\$wnnna$aNK Cell Receptors
=450  \\$wnnna$aReceptors, NK Cell
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aReceptors, KIR
=550  \\$wh$aReceptors, Natural Cytotoxicity Triggering
=550  \\$wh$aReceptors, NK Cell Lectin-Like
=550  \\$aKiller Cells, Natural
=667  \\$anot for receptors on NATURAL KILLER T-CELLS
=680  \\$iReceptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.
=688  \\$a2009(1993)
=750  \0$81$wb$iBroader mapping$aKiller cells$0(DLC)sh 85072328$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aKiller cells--Receptors$5IEN-M

=LDR  01247cz  a2200277n  4500
=001  9880364447402441
=005  20141212221642.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055984
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x92
=150  \\$aCathode Ray Tube
=450  \\$wnnna$aCathode Ray
=450  \\$aCathode Ray Tube Display
=450  \\$wnnna$aCathode Ray Tubes
=450  \\$aCathode Rays
=450  \\$wnnna$aRay, Cathode
=450  \\$wnnna$aRay Tube, Cathode
=450  \\$wnnna$aRay Tubes, Cathode
=450  \\$wnnna$aRays, Cathode
=450  \\$wnnna$aTube, Cathode Ray
=450  \\$wnnna$aTubes, Cathode Ray
=550  \\$wg$aElectrical Equipment and Supplies
=680  \\$iA vacuum tube equipped with an electron emitting CATHODE and a fluorescent screen which emits visible light when excited by the cathode ray. Cathode ray tubes are used as imaging devises for TELEVISIONS; COMPUTER TERMINALS; TEXT TELECOMMUNICATION DEVICES; oscilloscopes; and other DATA DISPLAY devices.
=688  \\$a2010; for CATHODE RAYS use BETA RAYS 1985-2009, RADIATION, IONIZING 1976-1984, use RADIATION 1963-1975; for CATHODE RAY TUBE DISPLAY see DATA DISPLAY 1991-2009
=750  \0$aCathode ray tubes$0(DLC) sh 85021033$5IEN-M

=LDR  01043cz  a2200205n  4500
=001  9880364447502441
=005  20141212221637.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055951
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x525.$x425
=150  \\$aFunctional Food
=450  \\$wnnna$aFood, Functional
=450  \\$wnnna$aFoods, Functional
=450  \\$wnnna$aFunctional Foods
=550  \\$wg$aFoods, Specialized
=667  \\$ado not confuse with FOOD, FORTIFIED; FOOD, FORMULATED; FOOD ADDITIVES; or DIETARY SUPPLEMENTS; coordinate IM with specific nutrient if relevant (IM)
=680  \\$iComponents of the usual diet that may provide health benefits beyond basic nutrients. Examples of functional foods include soy, nuts, chocolate, and cranberries (From NCCAM Backgrounder, March 2004, p3). Soy, for example, provides not only protein but also PHYTOESTROGENS (isoflavones), which help reduce total blood cholesterol by lowering LDL CHOLESTEROL.
=688  \\$a2010
=750  \0$aFunctional foods$0(DLC) sh 97005981$5IEN-M

=LDR  00730cz  a2200217n  4500
=001  9880364447702441
=005  20141212221635.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055944
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x450
=072  \\$aA20.$x859
=150  \\$aMagnetosomes
=450  \\$wnnna$aMagnetosome
=550  \\$wg$aBacterial Structures
=550  \\$wg$aOrganelles
=550  \\$aFerrosoferric Oxide
=550  \\$aMagnetospirillum
=680  \\$iMembrane-bound prokaryotic organelles of magnetotactic bacteria that contain chains of MAGNETITE crystals which orient the bacteria to geomagnetic fields.
=688  \\$a2010
=750  \0$aMagnetosomes$0(DLC)sh2007001020$5IEN-M

=LDR  01224cz  a2200397n  4500
=001  9880364447802441
=005  20141212221533.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055595
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374
=150  \\$aMechanical Phenomena
=450  \\$wnnna$aConcept, Mechanical
=450  \\$wnnna$aConcepts, Mechanical
=450  \\$wnnna$aMechanical Concept
=450  \\$aMechanical Concepts
=450  \\$wnnna$aMechanical Phenomenon
=450  \\$wnnna$aPhenomena, Mechanical
=450  \\$wnnna$aPhenomenon, Mechanical
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aBiomechanical Phenomena
=550  \\$wh$aCompressive Strength
=550  \\$wh$aElasticity
=550  \\$wh$aFriction
=550  \\$wh$aHardness
=550  \\$wh$aKinetics
=550  \\$wh$aMechanical Processes
=550  \\$wh$aPliability
=550  \\$wh$aPorosity
=550  \\$wh$aPressure
=550  \\$wh$aShear Strength
=550  \\$wh$aTensile Strength
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe properties and processes of materials that affect their behavior under force.
=688  \\$a2009
=750  \0$aMatter$xProperties$0(DLC) sh 85082249$5IEN-M

=LDR  01073cz  a2200325n  4500
=001  9880364447902441
=005  20141212221635.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x200.$x500
=072  \\$aL1.$x178.$x682.$x192.$x402
=150  \\$aCookbooks as Topic
=450  \\$wnnna$aas Topic, Cookbooks
=450  \\$wnnna$aas Topic, Recipes
=450  \\$wnnna$aas Topics, Cookbooks
=450  \\$wnnna$aas Topics, Recipes
=450  \\$wnnna$aCookbooks as Topics
=450  \\$wnnna$aRecipes as Topic
=450  \\$wnnna$aRecipes as Topics
=450  \\$wnnna$aTopic, Cookbooks as
=450  \\$wnnna$aTopic, Recipes as
=450  \\$wnnna$aTopics, Cookbooks as
=450  \\$wnnna$aTopics, Recipes as
=550  \\$wg$aBooks
=550  \\$wg$aCooking
=667  \\$ado not confuse with the Publication Type COOKBOOKS
=680  \\$iSet of instructions about how to prepare food for eating using specific instructions.
=688  \\$a2009
=750  \0$aCookbooks$0(DLC)sh2010007517$5IEN-M

=LDR  01295cz  a2200337n  4500
=001  9880364448002441
=005  20141212221634.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x621
=150  \\$aMagnetic Field Therapy
=450  \\$aElectromagnetic Fields$xtherapeutic use
=450  \\$wnnna$aField Therapies, Magnetic
=450  \\$wnnna$aField Therapy, Magnetic
=450  \\$wnnna$aMagnetic Field Therapies
=450  \\$wnnna$aMagnetic Stimulation Therapies
=450  \\$wnnna$aMagnetic Stimulation Therapy
=450  \\$wnnna$aStimulation Therapies, Magnetic
=450  \\$wnnna$aStimulation Therapy, Magnetic
=450  \\$wnnna$aTherapies, Magnetic Field
=450  \\$wnnna$aTherapies, Magnetic Stimulation
=450  \\$wnnna$aTherapy, Magnetic Field
=450  \\$wnnna$aTherapy, Magnetic Stimulation
=550  \\$wg$aTherapeutics
=550  \\$wh$aTranscranial Magnetic Stimulation
=550  \\$aElectric Stimulation Therapy
=550  \\$aMagnets
=680  \\$iThe magnetic stimulation of specific target tissues or areas of the body for therapeutic purposes via the application of magnetic fields generated by MAGNETS or ELECTROMAGNETS.
=688  \\$a2009
=750  \0$aMagnetotherapy$0(DLC) sh 85079761$5IEN-M

=LDR  01596cz  a2200433n  4500
=001  9880364448102441
=005  20190107110537.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055590
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500
=150  \\$aElectromagnetic Phenomena
=450  \\$wnnna$aConcept, Electrical
=450  \\$wnnna$aConcept, Electromagnetic
=450  \\$wnnna$aConcepts, Electrical
=450  \\$wnnna$aConcepts, Electromagnetic
=450  \\$wnnna$aElectrical Concept
=450  \\$aElectrical Concepts
=450  \\$wnnna$aElectrical Phenomena
=450  \\$wnnna$aElectrical Phenomenon
=450  \\$wnnna$aElectromagnetic Concept
=450  \\$aElectromagnetic Concepts
=450  \\$wnnna$aElectromagnetic Phenomenas
=450  \\$wnnna$aElectromagnetic Phenomenon
=450  \\$wnnna$aElectromagnetics
=450  \\$wnnna$aPhenomena, Electrical
=450  \\$wnnna$aPhenomena, Electromagnetic
=450  \\$wnnna$aPhenomenon, Electrical
=450  \\$wnnna$aPhenomenon, Electromagnetic
=550  \\$wg$aMagnetic Phenomena
=550  \\$wh$aElectricity
=550  \\$wh$aElectromagnetic Fields
=550  \\$wh$aElectromagnetic Radiation
=550  \\$wh$aElectrons
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iCharacteristics of ELECTRICITY and magnetism such as charged particles and the properties and behavior of charged particles, and other phenomena related to or associated with electromagnetism.
=688  \\$a2009
=750  \\$wh$aSuperconductivity
=750  \0$aElectromagnetism$0(DLC) sh 85042184$5IEN-M

=LDR  00755cz  a2200193n  4500
=001  9880364448202441
=005  20141212221525.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055549
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x974
=150  \\$aVolatile Organic Compounds
=450  \\$wnnna$aCompounds, Volatile Organic
=450  \\$wnnna$aOrganic Compounds, Volatile
=550  \\$wg$aOrganic Chemicals
=667  \\$ageneral or unspecified; do not add routinely as a coordinate with specific organic compounds; index only when volatility is specifically discussed
=680  \\$iOrganic compounds that have a relatively high VAPOR PRESSURE at room temperature.
=688  \\$a2009
=750  \0$aVolatile organic compounds$0(DLC) sh 93000972$5IEN-M

=LDR  01072cz  a2200253n  4500
=001  9880364448302441
=005  20141212221634.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x968.$x74
=072  \\$aN6.$x850.$x135.$x195.$x249
=150  \\$aBhopal Accidental Release
=450  \\$wnnna$aAccident, Bhopal Chemical
=450  \\$wnnna$aAccidental Release, Bhopal
=450  \\$wnnna$aBhopal Chemical Accident
=450  \\$wnnna$aChemical Accident, Bhopal
=450  \\$wnnna$aRelease, Bhopal Accidental
=550  \\$wg$aChemical Hazard Release
=550  \\$wg$aHistory, 20th Century
=667  \\$acoordinate with DISASTERS if pertinent
=680  \\$i1984 accident in Bhopal, INDIA at a PESTICIDES facility, resulting when WATER entered a storage tank containing ISOCYANATES. The following accidental chemical release and uncontrolled reaction resulted in several thousand deaths.
=688  \\$a2009
=750  \0$aBhopal Union Carbide Plant Disaster, Bhopal, India, 1984$0(DLC) sh 85013554$5IEN-M

=LDR  01076cz  a2200217n  4500
=001  9880364448402441
=005  20141212221632.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055904
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x687
=072  \\$aH1.$x671.$x547
=150  \\$aMeteorology
=450  \\$wnnna$aBiometeorology
=450  \\$wnnna$aClimatology
=550  \\$wg$aEarth Sciences
=550  \\$wg$aPhysics
=667  \\$athe discipline (education, history, etc) only; use METEOROLOGICAL CONCEPTS or specifics treed under it for atmospheric and climatic characteristics and phenomena
=680  \\$iThe science of studying the characteristics of the atmosphere such as its temperature, density, winds, clouds, precipitation, and other atmospheric phenomena and aiming to account for the weather in terms of external influences and the basic laws of physics. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2009; use METEROLOGY CONCEPTS 1977-2008 & WEATHER 1963-1976
=750  \0$aMeteorology$0(DLC) sh 85084334$5IEN-M

=LDR  00573cz  a2200181n  4500
=001  9880364448502441
=005  20141212221524.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055548
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x715.$x951
=150  \\$aVapor Pressure
=450  \\$wnnna$aPressure, Vapor
=450  \\$wnnna$aVapor Pressures
=550  \\$wg$aPressure
=680  \\$iThe contribution to barometric PRESSURE of gaseous substance in equilibrium with its solid or liquid phase.
=688  \\$a2009
=750  \0$aVapor pressure$0(DLC) sh 85142070$5IEN-M

=LDR  00709cz  a2200229n  4500
=001  9880364448602441
=005  20141212221522.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055539
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x820.$x90.$x615
=150  \\$aMP3-Player
=450  \\$wnnna$ai-POD
=450  \\$wnnna$ai POD
=450  \\$wnnna$aiPOD
=450  \\$wnnna$aiPODs
=450  \\$wnnna$aMP3 Player
=450  \\$wnnna$aMP3-Players
=550  \\$wg$aAudiovisual Aids
=680  \\$iPortable electronics device for storing and playing audio and or media files. MP3 for MPEG-1 audio layer 3, is a digital coding format.
=688  \\$a2009
=750  \0$aMP3 players$0(DLC) sh 99011234$5IEN-M

=LDR  01287cz  a2200301n  4500
=001  9880364448702441
=005  20141212221632.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055885
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x190
=150  \\$aBiohazard Release
=450  \\$wnnna$aAccidental Release, Biological
=450  \\$wnnna$aAccidents, Biohazard
=450  \\$aAccidents, Biological
=450  \\$wnnna$aBiohazard Releases
=450  \\$wnnna$aBiological Incident
=450  \\$wnnna$aBiological Incidents
=450  \\$wnnna$aIncident, Biological
=450  \\$wnnna$aIncidents, Biological
=450  \\$wnnna$aRelease, Biohazard
=450  \\$wnnna$aReleases, Biohazard
=550  \\$wg$aAccidents
=550  \\$wh$aSverdlovsk Accidental Release
=667  \\$afor release resulting in disaster, coordinate with DISASTERS; for deliberate release of biological material, coordinate BIOHAZARD RELEASE with BIOTERRORISM; specify geographic location
=680  \\$iUncontrolled release of biological material from its containment. This either threatens to, or does, cause exposure to a biological hazard. Such an incident may occur accidentally or deliberately.
=688  \\$a2009
=750  \0$aHazardous substances$xAccidents$0(DLC)sh2007010478$5IEN-M

=LDR  01044cz  a2200217n  4500
=001  9880364448802441
=005  20141212221518.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055519
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x593
=150  \\$aPhotoreceptors, Plant
=450  \\$wnnna$aPlant Photoreceptors
=550  \\$wg$aPlant Proteins
=550  \\$wh$aCryptochromes
=550  \\$wh$aPhototropins
=550  \\$aLight Signal Transduction
=667  \\$anot for plant photosynthetic apparatus, use PHOTOSYNTHETIC REACTION CENTER, PLANT see PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS
=680  \\$iPlant proteins that mediate LIGHT SIGNAL TRANSDUCTION. They are involved in PHOTOTROPISM and other light adaption responses during plant growth and development . They include the phototropins, phytochromes (PHYTOCHROME), and members of the ubiquitous cryptochrome family.
=688  \\$a2009; use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1999-2008
=750  \0$aPlant photoreceptors$0(DLC) sh 99003782$5IEN-M

=LDR  00697cz  a2200193n  4500
=001  9880364448902441
=005  20141212221514.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055500
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x940
=150  \\$aResilience, Psychological
=450  \\$wnnna$aPsychological Resilience
=450  \\$wnnna$aPsychological Resiliences
=450  \\$wnnna$aResiliences, Psychological
=550  \\$wg$aPsychological Phenomena and Processes
=680  \\$iThe human ability to adapt in the face of tragedy, trauma, adversity, hardship, and ongoing significant life stressors.
=688  \\$a2009
=750  \0$aResilience (Personality trait)$0(DLC) sh 86006788$5IEN-M

=LDR  00584cz  a2200169n  4500
=001  9880364449002441
=005  20141212221513.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055498
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x502
=150  \\$aJewelry
=450  \\$wnnna$aJewelries
=550  \\$wg$aManufactured Materials
=680  \\$iObjects of precious metal usually containing gems and worn to enhance personal appearance. Health concerns include possible contamination from lead content or bacteria.
=688  \\$a2009
=750  \0$aJewelry$0(DLC) sh 85070195$5IEN-M

=LDR  00847cz  a2200241n  4500
=001  9880364449102441
=005  20180829122918.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055495
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x152.$x912.$x750
=072  \\$aG7.$x345.$x500.$x325.$x377.$x687
=072  \\$aG8.$x686.$x784.$x170.$x450.$x500
=072  \\$aG11.$x561.$x620
=150  \\$aNeurogenesis
=450  \\$wnnna$aNeurogeneses
=550  \\$wg$aCell Differentiation
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aOrganogenesis
=550  \\$wh$aNeuronal Outgrowth
=680  \\$iFormation of NEURONS which involves the differentiation and division of STEM CELLS in which one or both of the daughter cells become neurons.
=688  \\$a2009
=750  \0$aDevelopmental neurobiology$0(DLC) sh 85037357$5IEN-M

=LDR  01984cz  a2200481n  4500
=001  9880364449202441
=005  20141212221632.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055884
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x195
=150  \\$aChemical Hazard Release
=450  \\$wnnna$aAccident, Chemical
=450  \\$wnnna$aAccidental Release, Chemical
=450  \\$wnnna$aAccidental Releases, Chemical
=450  \\$aAccidents, Chemical
=450  \\$wnnna$aChemical Accident
=450  \\$wnnna$aChemical Accidental Releases
=450  \\$wnnna$aChemical Accidents
=450  \\$wnnna$aChemical Hazard Releases
=450  \\$wnnna$aChemical Hazrad Release
=450  \\$wnnna$aChemical Hazrad Releases
=450  \\$wnnna$aChemical Incident
=450  \\$wnnna$aChemical Incidents
=450  \\$wnnna$aHazard Release, Chemical
=450  \\$wnnna$aHazard Releases, Chemical
=450  \\$wnnna$aHazrad Release, Chemical
=450  \\$wnnna$aHazrad Releases, Chemical
=450  \\$wnnna$aIncident, Chemical
=450  \\$wnnna$aIncidents, Chemical
=450  \\$wnnna$aRelease, Chemical Accidental
=450  \\$wnnna$aRelease, Chemical Hazard
=450  \\$wnnna$aRelease, Chemical Hazrad
=450  \\$wnnna$aReleases, Chemical Accidental
=450  \\$wnnna$aReleases, Chemical Hazard
=450  \\$wnnna$aReleases, Chemical Hazrad
=550  \\$wg$aAccidents
=550  \\$wh$aBhopal Accidental Release
=550  \\$wh$aSeveso Accidental Release
=667  \\$afor release resulting in disaster, coordinate with DISASTERS; for deliberate release of chemicals, coordinate CHEMICAL HAZARD RELEASE with TERRORISM; specify geographic location
=680  \\$iUncontrolled release of a chemical from its containment that either threatens to, or does, cause exposure to a chemical hazard. Such an incident may occur accidentally or deliberately.
=688  \\$a2009
=750  \0$aHazardous substances$xAccidents$0(DLC)sh2007010478$5IEN-M

=LDR  00499cz  a2200157n  4500
=001  9880364449302441
=005  20141212221512.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055492
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x760.$x675
=150  \\$aPolyporus
=550  \\$wg$aPolyporaceae
=680  \\$iA genus of basidiomyceteous fungi in the family POLYPORACEAE found mostly on living trees or dead wood.
=688  \\$a2009
=750  \0$aPolyporus$0(DLC) sh 88022196$5IEN-M

=LDR  00773cz  a2200289n  4500
=001  9880364449402441
=005  20141212221510.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x174
=150  \\$aCoriolaceae
=450  \\$aBjerkandera
=450  \\$wnnna$aBjerkanderas
=450  \\$wnnna$aCeriporiopses
=450  \\$aCeriporiopsis
=450  \\$wnnna$aFome
=450  \\$aFomes
=450  \\$wnnna$aFomitopses
=450  \\$aFomitopsis
=550  \\$wg$aPolyporales
=550  \\$wh$aAntrodia
=550  \\$wh$aPoria
=550  \\$wh$aTrametes
=680  \\$iA family of fungi, order POLYPORALES, found on decaying wood.
=688  \\$a2009
=750  \0$aCoriolaceae$0(DLC) sh 99001395$5IEN-M

=LDR  00693cz  a2200217n  4500
=001  9880364449502441
=005  20180109102926.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055442
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x500
=150  \\$aMetabolome
=450  \\$wnnna$aMetabolic Profile
=450  \\$wnnna$aMetabolic Profiles
=450  \\$wnnna$aMetabolomes
=450  \\$wnnna$aProfile, Metabolic
=450  \\$wnnna$aProfiles, Metabolic
=550  \\$wg$aMetabolism
=680  \\$iThe dynamic collection of metabolites which represent a cell's or organism's net metabolic response to current conditions.
=688  \\$a2009
=750  \0$aMetabolites$0(DLC) sh 91005229$5IEN-M

=LDR  00514cz  a2200169n  4500
=001  9880364449602441
=005  20141212221508.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x174.$x600
=150  \\$aPoria
=450  \\$wnnna$aPorias
=550  \\$wg$aCoriolaceae
=680  \\$iA genus of basiodiomycetous fungi in the family Coriolaceae. Members are known for infesting wood.
=688  \\$a2009
=750  \0$aPoria$0(DLC) sh 88022202$5IEN-M

=LDR  01782cz  a2200565n  4500
=001  9880364449702441
=005  20141212221631.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055883
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x750
=150  \\$aStructure Collapse
=450  \\$wnnna$aBridge Collapse
=450  \\$wnnna$aBridge Collapses
=450  \\$wnnna$aBridge Failure
=450  \\$wnnna$aBridge Failures
=450  \\$wnnna$aBuilding Collapse
=450  \\$wnnna$aBuilding Collapses
=450  \\$wnnna$aCollapse, Bridge
=450  \\$wnnna$aCollapse, Building
=450  \\$wnnna$aCollapse, Dam
=450  \\$wnnna$aCollapse, Levee
=450  \\$wnnna$aCollapse, Structure
=450  \\$wnnna$aCollapses, Building
=450  \\$wnnna$aCollapses, Dam
=450  \\$wnnna$aCollapses, Levee
=450  \\$wnnna$aDam Collapse
=450  \\$wnnna$aDam Collapses
=450  \\$wnnna$aDike Failure
=450  \\$wnnna$aDike Failures
=450  \\$wnnna$aFailure, Bridge
=450  \\$wnnna$aFailure, Dike
=450  \\$wnnna$aFailure, Levee
=450  \\$wnnna$aFailure, Structure
=450  \\$wnnna$aFailures, Bridge
=450  \\$wnnna$aFailures, Dike
=450  \\$wnnna$aFailures, Levee
=450  \\$wnnna$aFailures, Structure
=450  \\$wnnna$aLevee Collapse
=450  \\$wnnna$aLevee Collapses
=450  \\$wnnna$aLevee Failure
=450  \\$wnnna$aLevee Failures
=450  \\$wnnna$aStructure Collapses
=450  \\$wnnna$aStructure Failure
=450  \\$wnnna$aStructure Failures
=550  \\$wg$aEnvironment
=667  \\$acoordinate with DISASTERS if pertinent
=680  \\$iFailure in built environment with loss of functional integrity.
=688  \\$a2009
=750  \0$aStructural failures$0(DLC) sh 85129201$5IEN-M

=LDR  00549cz  a2200169n  4500
=001  9880364449802441
=005  20141212221508.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055439
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x790
=150  \\$aTricholoma
=450  \\$wnnna$aTricholomas
=550  \\$wg$aAgaricales
=680  \\$iA large genus of gilled mushrooms in the family Tricholomataceae. They are most often found in mountain and northern forests.
=688  \\$a2009
=750  \0$aTricholoma$0(DLC) sh 85137466$5IEN-M

=LDR  00531cz  a2200169n  4500
=001  9880364449902441
=005  20141212221506.0
=008  080709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055434
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x780
=150  \\$aTermitomyces
=450  \\$wnnna$aTermitomyce
=550  \\$wg$aAgaricales
=680  \\$iA paleotropical genus of fungi in the family Tricholomataceae. They are obligate symbionts of termites.
=688  \\$a2009
=750  \0$aTermitomyces$0(DLC) sh 85134036$5IEN-M

=LDR  00826cz  a2200229n  4500
=001  9880364450002441
=005  20141212221629.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055876
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x340.$x674
=072  \\$aG1.$x595.$x340.$x674
=150  \\$aLandslides
=450  \\$wnnna$aLandslide
=450  \\$wnnna$aMudslides
=450  \\$wnnna$aRockslide
=450  \\$wnnna$aRockslides
=550  \\$wg$aGeological Processes
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iDownslope movements of soil and and/or rock resulting from natural phenomena or man made actions. These can be secondary effects of severe storms, VOLCANIC ERUPTIONS and EARTHQUAKES.
=688  \\$a2009
=750  \0$aLandslides$0(DLC) sh 85074477$5IEN-M

=LDR  00515cz  a2200157n  4500
=001  9880364450102441
=005  20141212221506.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055433
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x550
=150  \\$aMarasmius
=550  \\$wg$aAgaricales
=680  \\$iA genus of tiny mushrooms in the family Tricholomataceae. They help break down the decaying organic matter of the forest floor.
=688  \\$a2009
=750  \0$aMarasmius$0(DLC) sh 88022189$5IEN-M

=LDR  00636cz  a2200205n  4500
=001  9880364450202441
=005  20200722150823.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055875
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x85.
=072  \\$aN6.$x230.$x100.$x230.$x50
=150  \\$aAvalanches
=450  \\$aAvalanche
=550  \\$wg$aGeological Phenomena
=550  \\$wg$aNatural Disasters
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iMass of snow and/or ice falling down a mountain or incline.
=688  \\$a2009
=750  \0$aAvalanches$0(DLC) sh 85010490$5IEN-M

=LDR  01143cz  a2200265n  4500
=001  9880364450402441
=005  20141212221627.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055870
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x168.$x500
=072  \\$aE2.$x319.$x283.$x400
=150  \\$aDrug Chronotherapy
=450  \\$wnnna$aChronotherapies, Drug
=450  \\$wnnna$aChronotherapy, Drug
=450  \\$wnnna$aDrug Chronotherapies
=550  \\$wg$aChronotherapy
=550  \\$wg$aDrug Administration Schedule
=550  \\$aAdministration, Metronomic
=550  \\$aChronobiology Discipline
=550  \\$aChronobiology Phenomena
=667  \\$acoordinate with specific drug with probably / admin (IM) but do not coordinate with DRUG ADMINISTRATION SCHEDULE or CIRCADIAN RHYTHM
=680  \\$iThe adaptation of drug administration to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect.
=688  \\$a2009
=750  \0$aChronopharmacology$0(DLC) sh 89003698$5IEN-M

=LDR  00728cz  a2200193n  4500
=001  9880364450502441
=005  20141212221627.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x750.$x775.$x745
=150  \\$aTornadoes
=450  \\$wnnna$aTornado
=450  \\$wnnna$aTornadoe
=550  \\$wg$aWeather
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iRotating column of air extending from a thunderstorm to the ground. Tornadoes generally produce damage paths of 100 yards wide or less, with path lengths of a couple miles.
=688  \\$a2009; use DISASTERS 1990-2008
=750  \0$aTornadoes$0(DLC) sh 85136123$5IEN-M

=LDR  00720cz  a2200205n  4500
=001  9880364450602441
=005  20141212221502.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x950
=150  \\$aVenous Valves
=450  \\$wnnna$aValve, Venous
=450  \\$wnnna$aValves, Venous
=450  \\$wnnna$aVenous Valve
=550  \\$wg$aVeins
=667  \\$acoordinate with specific vein term if pertinent
=680  \\$iFlaps within the VEINS that allow the blood to flow only in one direction. They are usually in the medium size veins that carry blood to the heart against gravity.
=688  \\$a2009
=750  \0$aVenous valves$0(DLC) sh 91002940$5IEN-M

=LDR  00872cz  a2200217n  4500
=001  9880364450702441
=005  20141212221626.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055868
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x812
=150  \\$aFloods
=450  \\$wnnna$aCatastrophic Flooding
=450  \\$wnnna$aCatastrophic Floodings
=450  \\$aFlooding, Catastrophic
=450  \\$wnnna$aFloodings, Catastrophic
=550  \\$wg$aClimatic Processes
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iSudden onset water phenomena with different speed of occurrence. These include flash floods, seasonal river floods, and coastal floods, associated with CYCLONIC STORMS; TIDALWAVES; and storm surges.
=688  \\$a2009; use DISASTERS 1982-2008
=750  \0$aFloods$0(DLC) sh 85049168$5IEN-M

=LDR  00617cz  a2200169n  4500
=001  9880364450802441
=005  20141212221456.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055392
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x125
=150  \\$aArmillaria
=450  \\$wnnna$aArmillarias
=550  \\$wg$aAgaricales
=680  \\$iA genus of root and butt rot fungi in the family Tricholomataceae that produce rhizomorphs and are facultatively parasitic. Many species are pathogenic to trees causing Armillaria root disease.
=688  \\$a2009
=750  \0$aArmillaria$0(DLC) sh 85007322$5IEN-M

=LDR  00537cz  a2200169n  4500
=001  9880364450902441
=005  20141212221456.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055391
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x660
=150  \\$aPsilocybe
=450  \\$wnnna$aPsilocybes
=550  \\$wg$aAgaricales
=550  \\$wg$aAgaricales
=680  \\$iA genus of small mushrooms in the family Strophariaceae. Some species are known for their hallucinogenic properties.
=688  \\$a2009
=750  \0$aPsilocybe$0(DLC) sh 85108317$5IEN-M

=LDR  00745cz  a2200205n  4500
=001  9880364451202441
=005  20141212221625.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055864
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x781
=072  \\$aG16.$x500.$x750.$x775.$x154
=150  \\$aDroughts
=450  \\$aDrought
=550  \\$wg$aClimatic Processes
=550  \\$wg$aWeather
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iProlonged dry periods in natural climate cycle. They are slow-onset phenomena caused by rainfall deficit combined with other predisposing factors.
=688  \\$a2009; use DISASTERS 1990-2008
=750  \0$aDroughts$0(DLC) sh 85039663$5IEN-M

=LDR  01519cz  a2200397n  4500
=001  9880364451302441
=005  20141212221455.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055370
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x520
=072  \\$aC26.$x891.$x554
=150  \\$aLung Injury
=450  \\$wnnna$aChronic Lung Injuries
=450  \\$wnnna$aChronic Lung Injury
=450  \\$wnnna$aInjuries, Lung
=450  \\$wnnna$aInjuries, Pulmonary
=450  \\$wnnna$aInjury, Lung
=450  \\$wnnna$aInjury, Pulmonary
=450  \\$wnnna$aLung Injuries
=450  \\$aLung$xinjuries
=450  \\$wnnna$aLung Injuries, Chronic
=450  \\$wnnna$aLung Injury, Chronic
=450  \\$wnnna$aPulmonary Injuries
=450  \\$wnnna$aPulmonary Injury
=550  \\$wg$aLung Diseases
=550  \\$wg$aThoracic Injuries
=550  \\$wh$aAcute Lung Injury
=550  \\$wh$aMeconium Aspiration Syndrome
=550  \\$wh$aPneumoconiosis
=550  \\$wh$aRadiation Pneumonitis
=550  \\$wh$aVentilator-Induced Lung Injury
=667  \\$aACUTE LUNG INJURY and VENTILATOR-INDUCED LUNG INJURY are also available
=680  \\$iDamage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.
=688  \\$a2009
=750  \0$aLungs$xWounds and injuries$0(DLC) sh 85078922$5IEN-M

=LDR  00729cz  a2200229n  4500
=001  9880364451402441
=005  20141212221624.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055848
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x437.$x600
=072  \\$aE7.$x710.$x600.$x500
=072  \\$aJ1.$x780.$x600
=150  \\$aNuclear Power Plants
=450  \\$wnnna$aNuclear Power Plant
=450  \\$wnnna$aPower Plant, Nuclear
=450  \\$wnnna$aPower Plants, Nuclear
=550  \\$wg$aNuclear Reactors
=550  \\$wg$aPower Plants
=680  \\$iFacilities that convert NUCLEAR ENERGY into electrical energy.
=688  \\$a2009; use POWER PLANTS 1995-2008
=750  \0$aNuclear power plants$0(DLC) sh 85093030$5IEN-M

=LDR  01046cz   2200289n  4500
=001  9880364451502441
=005  20220926171021.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055826
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x094
=072  \\$aK1.$x400.$x504.$x984.$x124
=150  \\$aAfghan Campaign 2001-
=450  \\$wnnna$a2001- Afghan War
=450  \\$wnnna$a2001- Afghan Wars
=450  \\$wnnna$aAfghan War, 2001-
=450  \\$wnnna$aAfghan War, 2001
=450  \\$wnnna$aAfghan Wars, 2001-
=450  \\$wnnna$aOperation Enduring Freedom
=450  \\$wnnna$aOperation Enduring Freedoms
=450  \\$wnnna$aWar, 2001- Afghan
=450  \\$wnnna$aWars, 2001- Afghan
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 21st Century
=680  \\$iMultinational coalition military operation initiated in October 2001 to counter terrorism and bring security to AFGHANISTAN in collaboration with Afghan forces.
=688  \\$a2009
=750  \0$aAfghan War, 2001-2021$0(DLC)sh2004004460$5IEN-M

=LDR  00519cz  a2200169n  4500
=001  9880364451602441
=005  20141212221454.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x645
=150  \\$aPholiota
=450  \\$wnnna$aPholiotas
=550  \\$wg$aAgaricales
=680  \\$iA genus of basidiomycetous mushroom in the family Strophariaceae, exhibiting a bipolar mating system.
=688  \\$a2009
=750  \0$aPholiota$0(DLC) sh 85101046$5IEN-M

=LDR  00602cz  a2200169n  4500
=001  9880364451702441
=005  20141212221454.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x875
=150  \\$aVolvariella
=450  \\$wnnna$aVolvariellas
=550  \\$wg$aAgaricales
=680  \\$iA genus of edible mushrooms in the family Pluteaceae. They have pink gills and a volva at the stem base, and species can be confused with those of the poisonous genus AMANITA.
=688  \\$a2009
=750  \0$aVolvariella$0(DLC) sh 85144376$5IEN-M

=LDR  00586cz  a2200181n  4500
=001  9880364451802441
=005  20141212221453.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055364
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x360
=150  \\$aHebeloma
=450  \\$wnnna$aHebelomas
=550  \\$wg$aAgaricales
=667  \\$apoisoning: coordinate with MUSHROOM POISONING
=680  \\$iA genus of ectomycorrhizae basidiomycetous fungi in the family Cortinariaceae. Some species are poisonous.
=688  \\$a2009
=750  \0$aHebeloma$0(DLC) sh 85059857$5IEN-M

=LDR  00999cz  a2200277n  4500
=001  9880364451902441
=005  20141212221622.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055819
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x330
=150  \\$aHospitals, Isolation
=450  \\$wnnna$aHospital, Isolation
=450  \\$wnnna$aIsolation Hospital
=450  \\$wnnna$aIsolation Hospitals
=450  \\$wnnna$aLazaretto
=450  \\$wnnna$aLazarettos
=450  \\$wnnna$aQuarantine Station
=450  \\$wnnna$aQuarantine Stations
=450  \\$wnnna$aStation, Quarantine
=450  \\$wnnna$aStations, Quarantine
=550  \\$wg$aHospitals, Special
=667  \\$acoordinate with hospital ownership term (e.g., HOSPITALS, COUNTY); specify geographic location if pertinent
=680  \\$iHospitals designed or used to isolate or quarantine persons with communicable diseases.
=688  \\$a2009
=750  \0$aCommunicable diseases$xHospitals$0(DLC) sh 85029018$5IEN-M

=LDR  00628cz  a2200169n  4500
=001  9880364452002441
=005  20141212221453.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055363
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x205
=150  \\$aCortinarius
=550  \\$wg$aAgaricales
=667  \\$apoisoning: coordinate with MUSHROOM POISONING
=680  \\$iA genus of mushrooms in the family Cortinariaceae. When ingested, species of Cortinarius cause delayed acute RENAL FAILURE.
=688  \\$a2009, 1991-1996; use AGARICALES 1997-2008 and 1986-1990
=750  \0$aCortinarius$0(DLC) sh 88022161$5IEN-M

=LDR  00850cz  a2200193n  4500
=001  9880364452102441
=005  20141212221452.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x520.$x830.$x562
=150  \\$aMultilevel Analysis
=450  \\$wnnna$aAnalyses, Multilevel
=450  \\$wnnna$aAnalysis, Multilevel
=450  \\$wnnna$aMultilevel Analyses
=550  \\$wg$aStatistics as Topic
=680  \\$iThe statistical manipulation of hierarchically and non-hierarchically nested data. It includes clustered data, such as a sample of subjects within a group of schools. Prevalent in the social, behavioral sciences, and biomedical sciences, both linear and nonlinear regression models are applied.
=688  \\$a2009
=750  \0$aMultilevel models (Statistics)$0(DLC)sh2001008306$5IEN-M

=LDR  01626cz  a2200385n  4500
=001  9880364452202441
=005  20141212221622.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055818
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x843
=072  \\$aN3.$x540.$x706
=150  \\$aPublic-Private Sector Partnerships
=450  \\$wnnna$aCooperation, Public-Private
=450  \\$wnnna$aCooperation, Public-Private Sector
=450  \\$wnnna$aPartnership, Public-Private
=450  \\$wnnna$aPartnership, Public-Private Sector
=450  \\$wnnna$aPartnerships, Public-Private
=450  \\$wnnna$aPartnerships, Public-Private Sector
=450  \\$wnnna$aPublic-Private Cooperation
=450  \\$wnnna$aPublic Private Cooperation
=450  \\$wnnna$aPublic-Private Cooperations
=450  \\$wnnna$aPublic-Private Partnership
=450  \\$wnnna$aPublic-Private Partnerships
=450  \\$wnnna$aPublic Private Partnerships
=450  \\$wnnna$aPublic-Private Sector Cooperation
=450  \\$wnnna$aPublic Private Sector Cooperation
=450  \\$wnnna$aPublic-Private Sector Cooperations
=450  \\$wnnna$aPublic-Private Sector Partnership
=450  \\$wnnna$aPublic Private Sector Partnerships
=550  \\$wg$aCommerce
=550  \\$wg$aOrganizations
=680  \\$iAn organizational enterprise between a public sector agency, federal, state or local, and a private sector entity. Skills and assets of each sector are shared to deliver a service or facility for the benefit or use of the general public.
=688  \\$a2009
=750  \0$aPublic-private sector cooperation$0(DLC) sh 96011049$5IEN-M

=LDR  00623cz  a2200205n  4500
=001  9880364452302441
=005  20141212221621.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055815
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x116.$x815
=150  \\$aYoung Adult
=450  \\$wnnna$aAdult, Young
=450  \\$wnnna$aAdults, Young
=450  \\$wnnna$aYoung Adults
=550  \\$wg$aAdult
=667  \\$aage 19-24; IM only as social, political, psychological entity; NIM as check tag
=680  \\$iA person between 19 and 24 years of age.
=688  \\$a2009
=750  \0$aYoung adults$0(DLC) sh 85149273$5IEN-M

=LDR  00503cz  a2200157n  4500
=001  9880364452402441
=005  20141212221621.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055814
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x965
=150  \\$aWilderness
=550  \\$wg$aEnvironment
=680  \\$iEnvironment un-modified by human activity. Areas in which natural processes operate without human interference.
=688  \\$a2009
=750  \0$aWilderness areas$0(DLC) sh 85146698$5IEN-M

=LDR  01198cz   2200301n  4500
=001  9880364452502441
=005  20220915094242.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055812
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x193
=072  \\$aN5.$x425.$x104
=150  \\$aCommunity-Based Participatory Research
=450  \\$wnnna$aCommunity Based Participatory Research
=450  \\$wnnna$aCommunity-Based Research, Consumer-Driven
=450  \\$wnnna$aCommunity-Based Researchs, Consumer-Driven
=450  \\$wnnna$aConsumer-Driven Community-Based Research
=450  \\$wnnna$aConsumer Driven Community Based Research
=450  \\$wnnna$aConsumer-Driven Community-Based Researchs
=450  \\$wnnna$aParticipatory Research, Community-Based
=450  \\$wnnna$aResearch, Consumer-Driven Community-Based
=450  \\$wnnna$aResearchs, Consumer-Driven Community-Based
=550  \\$wg$aHealth Services Research
=550  \\$wg$aResearch
=680  \\$iCollaborative process of research involving researchers and community representatives.
=688  \\$a2009
=750  \0$aCommunity-based research$0(DLC)sh2021008255$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  00929cz  a2200253n  4500
=001  9880364452602441
=005  20141212221619.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055809
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x499
=150  \\$aIllness Behavior
=450  \\$wnnna$aBehavior, Illness
=450  \\$wnnna$aBehavior, Sickness
=450  \\$wnnna$aBehaviors, Illness
=450  \\$wnnna$aBehaviors, Sickness
=450  \\$wnnna$aIllness Behaviors
=450  \\$wnnna$aSickness Behavior
=450  \\$wnnna$aSickness Behaviors
=550  \\$wg$aBehavior
=550  \\$aSick Role
=680  \\$iCoordinate set of non-specific behavioral responses to non-psychiatric illness. These may include loss of APPETITE or LIBIDO; disinterest in ACTIVITIES OF DAILY LIVING; or withdrawal from social interaction.
=688  \\$a2009; use Sick Role 1975-2008
=750  \0$aSick$xPsychology$0(DLC) sh 85122274$5IEN

=LDR  00769cz  a2200193n  4500
=001  9880364452702441
=005  20141212221619.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055807
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x950.$x500
=072  \\$aI1.$x880.$x735.$x223.$x500
=150  \\$aStalking
=450  \\$wnnna$aStalkings
=550  \\$wg$aDangerous Behavior
=550  \\$wg$aObsessive Behavior
=680  \\$iCourse of conduct directed at a specific person that involves repeated (two or more occasions) visual or physical proximity, nonconsensual communication, or verbal, written, or implied threats, or a combination thereof, that would cause a reasonable person fear.
=688  \\$a2009
=750  \0$aStalking$0(DLC) sh 93005214$5IEN-M

=LDR  00981cz  a2200277n  4500
=001  9880364452802441
=005  20141212221452.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055360
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x722
=072  \\$aN2.$x360.$x810.$x722
=150  \\$aOsteopathic Physicians
=450  \\$wnnna$aDoctor of Osteopathy
=450  \\$wnnna$aOsteopath
=450  \\$wnnna$aOsteopathic Physician
=450  \\$aOsteopaths
=450  \\$wnnna$aOsteopathy Doctor
=450  \\$wnnna$aOsteopathy Doctors
=450  \\$wnnna$aPhysician, Osteopathic
=450  \\$wnnna$aPhysicians, Osteopathic
=550  \\$wg$aPhysicians
=550  \\$aOsteopathic Medicine
=680  \\$iLicensed physicians trained in OSTEOPATHIC MEDICINE. An osteopathic physician, also known as D.O. (Doctor of Osteopathy), is able to perform surgery and prescribe medications.
=688  \\$a2009
=750  \0$aOsteopathic physicians$0(DLC) sh 85095975$5IEN-M

=LDR  01803cz  a2200433n  4500
=001  9880364452902441
=005  20141212221617.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055772
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x256.$x350
=072  \\$aJ1.$x897.$x360
=150  \\$aGreen Chemistry Technology
=450  \\$wnnna$aChemical Technique, Green
=450  \\$wnnna$aChemical Techniques, Green
=450  \\$wnnna$aChemistry Technologies, Green
=450  \\$wnnna$aChemistry Technologies, Sustainable
=450  \\$wnnna$aChemistry Technology, Green
=450  \\$wnnna$aChemistry Technology, Sustainable
=450  \\$wnnna$aEnvironmentally Friendly Chemical Techniques
=450  \\$wnnna$aEnvironmentally Friendly Chemical Technology
=450  \\$wnnna$aEnvironmentally Friendly Chemistry Technology
=450  \\$wnnna$aGreen Chemical Technique
=450  \\$wnnna$aGreen Chemical Techniques
=450  \\$wnnna$aGreen Chemistry Technologies
=450  \\$wnnna$aSustainable Chemistry Technologies
=450  \\$wnnna$aSustainable Chemistry Technology
=450  \\$wnnna$aTechnique, Green Chemical
=450  \\$wnnna$aTechniques, Green Chemical
=450  \\$wnnna$aTechnologies, Green Chemistry
=450  \\$wnnna$aTechnologies, Sustainable Chemistry
=450  \\$wnnna$aTechnology, Green Chemistry
=450  \\$wnnna$aTechnology, Sustainable Chemistry
=550  \\$wg$aConservation of Natural Resources
=550  \\$wg$aTechnology
=550  \\$aClick Chemistry
=680  \\$iPollution prevention through the design of effective chemical products that have low or no toxicity and use of chemical processes that reduce or eliminate the use and generation of hazardous substances.
=688  \\$a2009
=750  \0$aGreen chemistry$0(DLC) sh 99011713$5IEN-M

=LDR  00885cz  a2200265n  4500
=001  9880364453002441
=005  20141212221452.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055359
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x66
=150  \\$aAntistatic Agents
=450  \\$wnnna$aAgents, Anti-Static
=450  \\$wnnna$aAgents, Antistatic
=450  \\$wnnna$aAnti-Static Agents
=450  \\$wnnna$aAnti Static Agents
=450  \\$wnnna$aAnti-Static Material
=450  \\$wnnna$aAnti Static Material
=450  \\$wnnna$aAntistatic Materials
=450  \\$wnnna$aMaterial, Anti-Static
=450  \\$wnnna$aMaterials, Antistatic
=550  \\$wg$aSpecialty Uses of Chemicals
=680  \\$iChemical compounds applied to materials to reduce their retention of an electrostatic charge.
=688  \\$a2009
=750  \0$aStatic eliminators$0(DLC) sh 85127548$5IEN-M

=LDR  00608cz  a2200169n  4500
=001  9880364453102441
=005  20141212221448.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501.$x550
=150  \\$aNectria
=450  \\$wnnna$aNectrias
=550  \\$wg$aHypocreales
=680  \\$iA genus of ascomycetous fungi in the family Nectriaceae, order HYPOCREALES. They are found as saprophytes on decaying wood or parasites of trees. Anamorphs include FUSARIUM and Cylindrocarpon.
=688  \\$a2009
=750  \0$aNectria$0(DLC) sh 88021987$5IEN-M

=LDR  01617cz  a2200421n  4500
=001  9880364453202441
=005  20141212221616.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055768
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x726.$x601
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x601
=150  \\$aHalogenated Diphenyl Ethers
=450  \\$wnnna$aBrominated Diphenyl Ethers
=450  \\$wnnna$aChlorinated Diphenyl Ethers
=450  \\$wnnna$aDiphenyl Ethers, Brominated
=450  \\$wnnna$aDiphenyl Ethers, Chlorinated
=450  \\$wnnna$aDiphenyl Ethers, Fluorinated
=450  \\$wnnna$aDiphenyl Ethers, Halogenated
=450  \\$wnnna$aDiphenyl Ethers, Iodinated
=450  \\$wnnna$aDiphenyl Ethers, Polybrominated
=450  \\$wnnna$aEthers, Brominated Diphenyl
=450  \\$wnnna$aEthers, Chlorinated Diphenyl
=450  \\$wnnna$aEthers, Fluorinated Diphenyl
=450  \\$wnnna$aEthers, Halogenated Diphenyl
=450  \\$wnnna$aEthers, Iodinated Diphenyl
=450  \\$wnnna$aEthers, Polybrominated Diphenyl
=450  \\$wnnna$aFluorinated Diphenyl Ethers
=450  \\$wnnna$aIodinated Diphenyl Ethers
=450  \\$wnnna$aPBDE Compounds
=450  \\$wnnna$aPBDEs
=450  \\$wnnna$aPCDE Compounds
=450  \\$wnnna$aPCDEs
=450  \\$wnnna$aPolybrominated Diphenyl Ethers
=550  \\$wg$aPhenyl Ethers
=680  \\$iCompounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.
=688  \\$a2009
=750  \0$aPolybrominated diphenyl ethers$0sh2001008175$5IEN-M

=LDR  00587cz  a2200169n  4500
=001  9880364453302441
=005  20141212221448.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055329
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501.$x310
=150  \\$aEpichloe
=450  \\$wnnna$aEpichloes
=550  \\$wg$aHypocreales
=680  \\$iA genus of ascomycetous fungi in the family Clavicipitaceae, order HYPOCREALES, which are fungal symbionts of grasses. Anamorphic forms are in the genus NEOTYPHODIUM.
=688  \\$a2009
=750  \0$aEpichlo�$0(DLC) sh 97004689$5IEN-M

=LDR  00722cz  a2200193n  4500
=001  9880364453402441
=005  20141212221615.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055767
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x463
=150  \\$aImmobilized Proteins
=450  \\$wnnna$aProteins, Immobilized
=550  \\$wg$aProteins
=550  \\$wh$aAntibodies, Immobilized
=550  \\$wh$aEnzymes, Immobilized
=680  \\$iProteins that are chemically bound to a substrate material which renders their location fixed. The immobilization of proteins allows their use in chemical reactions without being diluted by solvent.
=688  \\$a2009
=750  \0$aImmobilized proteins$0(DLC) sh 85064526$5IEN-M

=LDR  00524cz  a2200169n  4500
=001  9880364453502441
=005  20141212221448.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x570
=150  \\$aNeotyphodium
=450  \\$wnnna$aNeotyphodiums
=550  \\$wg$aMitosporic Fungi
=680  \\$iThe anamorphic form of the fungus EPICHLOE. Many Neotyphodium species produce ERGOT ALKALOIDS.
=688  \\$a2009
=750  \0$aNeotyphodium$0(DLC) sh 97004688$5IEN-M

=LDR  00907cz  a2200241n  4500
=001  9880364453602441
=005  20141212221614.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055764
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x550
=150  \\$aMyxozoa
=450  \\$wnnna$aMalacosporea
=450  \\$wnnna$aMalacosporeas
=450  \\$wnnna$aMyxosporea
=450  \\$wnnna$aMyxosporeas
=450  \\$wnnna$aMyxozoas
=550  \\$wg$aCnidaria
=550  \\$wh$aMyxobolus
=667  \\$ainfection: coordinate IM with PARASITIC DISEASES, ANIMAL (IM) or PARASITIC DISEASES if in humans
=680  \\$iSingle-celled, aquatic endoparasitic worms that are currently considered belonging to the phylum CNIDARIA. They have a complex life cycle and parasitize a wide range of hosts including FISHES; ANNELIDA; and BRYOZOA.
=688  \\$a2009
=750  \0$aMyxozoa$0(DLC) sh 88007622$5IEN-M

=LDR  00568cz  a2200169n  4500
=001  9880364453702441
=005  20141212221447.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x320.$x215
=150  \\$aEupenicillium
=450  \\$wnnna$aEupenicilliums
=550  \\$wg$aEurotiales
=680  \\$iA genus of endophytic, ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PENICILLIUM.
=688  \\$a2009
=750  \0$aEupenicillium$0(DLC) sh 85045585$5IEN-M

=LDR  01041cz  a2200253n  4500
=001  9880364453802441
=005  20141212221610.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797.$x520.$x109.$x220.$x624
=072  \\$aC8.$x381.$x540.$x140.$x750
=072  \\$aC8.$x785.$x520.$x100.$x220.$x750
=150  \\$aSmall Cell Lung Carcinoma
=450  \\$wnnna$aCarcinoma, Small Cell Lung
=450  \\$aOat Cell Carcinoma of Lung
=450  \\$wnnna$aOat Cell Lung Cancer
=450  \\$wnnna$aSmall Cell Cancer Of The Lung
=450  \\$wnnna$aSmall Cell Lung Cancer
=550  \\$wg$aCarcinoma, Bronchogenic
=667  \\$acoordinate IM with LUNG NEOPLASMS (IM); CARCINOMA, NON-SMALL-CELL LUNG and CARCINOMA, SMALL CELL are also available
=680  \\$iA form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).
=688  \\$a2009; use CARCINOMA, SMALL CELL 1994-2008
=750  \0$aSmall cell lung cancer$0(DLC) sh 86005665$5IEN-M

=LDR  00987cz  a2200241n  4500
=001  9880364453902441
=005  20141212221445.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055318
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x249.$x875
=072  \\$aH2.$x478.$x197
=150  \\$aEvidence-Based Nursing
=450  \\$wnnna$aEvidence Based Nursing
=450  \\$aNursing, Evidence-Based
=450  \\$wnnna$aNursing, Evidence Based
=550  \\$wg$aEvidence-Based Practice
=550  \\$wg$aNursing
=550  \\$aEvidence-Based Dentistry
=550  \\$aEvidence-Based Medicine
=680  \\$iA way of providing nursing care that is guided by the integration of the best available scientific knowledge with nursing expertise. This approach requires nurses to critically assess relevant scientific data or research evidence, and to implement high-quality interventions for their nursing practice.
=688  \\$a2009
=750  \0$aEvidence-based nursing$0(DLC)sh2004000696$5IEN-M

=LDR  00819cz  a2200205n  4500
=001  9880364454002441
=005  20141212221444.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055314
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x725
=150  \\$aSeed Storage Proteins
=450  \\$wnnna$aProteins, Seed Storage
=450  \\$wnnna$aStorage Proteins, Seed
=550  \\$wg$aPlant Proteins
=550  \\$wh$a2S Albumins, Plant
=550  \\$wh$aProlamins
=680  \\$iOne or more types of plant seed proteins providing the large amounts of AMINO ACIDS utilized in GERMINATION and SEEDLING growth. As seeds are the major food source from AGRICULTURAL CROPS, seed storage proteins are a major source of DIETARY PROTEINS.
=688  \\$a2009
=750  \0$aSeed storage compounds$0(DLC) sh 93002693$5IEN-M

=LDR  00916cz  a2200241n  4500
=001  9880364454102441
=005  20141212221439.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055254
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x964.$x249
=072  \\$aG11.$x561.$x600.$x810.$x964.$x249
=072  \\$aG14.$x640.$x816.$x249
=150  \\$aNight Vision
=450  \\$aRod Vision
=450  \\$aScotopic Vision
=450  \\$wnnna$aVision, Night
=450  \\$wnnna$aVision, Rod
=450  \\$wnnna$aVision, Scotopic
=550  \\$wg$aVision, Ocular
=680  \\$iFunction of the human eye that is used in dim illumination (scotopic intensities) or at nighttime. Scotopic vision is performed by RETINAL ROD PHOTORECEPTORS with high sensitivity to light and peak absorption wavelength at 507 nm near the blue end of the spectrum.
=688  \\$a2009
=750  \0$aNight vision$0(DLC) sh 85091908$5IEN

=LDR  01114cz  a2200289n  4500
=001  9880364454202441
=005  20141212221439.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055253
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x964.$x124
=072  \\$aG11.$x561.$x600.$x810.$x964.$x124
=072  \\$aG14.$x640.$x816.$x124
=150  \\$aColor Vision
=450  \\$wnnna$aColor Visions
=450  \\$wnnna$aDaylight Vision
=450  \\$aPhotopic Vision
=450  \\$wnnna$aVision, Color
=450  \\$wnnna$aVision, Daylight
=450  \\$wnnna$aVision, Photopic
=450  \\$wnnna$aVisions, Color
=550  \\$wg$aVision, Ocular
=550  \\$aColor Perception
=667  \\$ado not confuse with COLOR PERCEPTION
=680  \\$iFunction of the human eye that is used in bright illumination or in daylight (at photopic intensities). Photopic vision is performed by the three types of RETINAL CONE PHOTORECEPTORS with varied peak absorption wavelengths in the color spectrum (from violet to red, 400 - 700 nm).
=688  \\$a2009 (1986)
=750  \0$aColor vision$0(DLC) sh 85028654$5IEN

=LDR  01515cz  a2200433n  4500
=001  9880364454302441
=005  20141212221435.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055171
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x165.$x407.$x550
=072  \\$aA4.$x531.$x413
=150  \\$aNasal Cartilages
=450  \\$wnnna$aAlar Nasal Cartilage
=450  \\$wnnna$aAlar Nasal Cartilages
=450  \\$wnnna$aCartilage, Alar Nasal
=450  \\$wnnna$aCartilage, Lateral Nasal
=450  \\$wnnna$aCartilage, Nasal
=450  \\$wnnna$aCartilage, Septal Nasal
=450  \\$wnnna$aCartilages, Alar Nasal
=450  \\$wnnna$aCartilages, Lateral Nasal
=450  \\$wnnna$aCartilages, Nasal
=450  \\$wnnna$aCartilages, Septal Nasal
=450  \\$wnnna$aLateral Nasal Cartilage
=450  \\$wnnna$aLateral Nasal Cartilages
=450  \\$wnnna$aNasal Cartilage
=450  \\$wnnna$aNasal Cartilage, Alar
=450  \\$wnnna$aNasal Cartilage, Lateral
=450  \\$wnnna$aNasal Cartilage, Septal
=450  \\$wnnna$aNasal Cartilages, Alar
=450  \\$wnnna$aNasal Cartilages, Lateral
=450  \\$wnnna$aNasal Cartilages, Septal
=450  \\$wnnna$aSeptal Nasal Cartilage
=450  \\$wnnna$aSeptal Nasal Cartilages
=550  \\$wg$aHyaline Cartilage
=550  \\$wg$aNose
=680  \\$iHyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.
=688  \\$a2009
=750  \0$aNasal capsule$0(DLC) sh 85089874$5IEN-M

=LDR  00706cz  a2200193n  4500
=001  9880364454402441
=005  20141212221434.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055169
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x250
=072  \\$aB1.$x300.$x930.$x350
=150  \\$aEremothecium
=450  \\$wnnna$aEremotheciums
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=680  \\$iA genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Species in the genus are plant pathogens.
=688  \\$a2009; for EREMOTHECIUM use SACCHAROMYCETALES 1986-2008, use ASCOMYCOTA 1963-1985
=750  \0$aEremothecium$0(DLC) sh 88021950$5IEN-M

=LDR  00590cz  a2200193n  4500
=001  9880364454502441
=005  20141212221434.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055168
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x137
=072  \\$aB1.$x300.$x930.$x150
=150  \\$aBrettanomyces
=450  \\$wnnna$aBrettanomyce
=550  \\$wg$aMitosporic Fungi
=550  \\$wg$aYeasts
=680  \\$iThe anamorphic form of the yeast DEKKERA. It is implicated as a spoilage microorganism in wines.
=688  \\$a2009
=750  \0$aBrettanomyces$0(DLC) sh 88022021$5IEN-M

=LDR  00655cz  a2200217n  4500
=001  9880364454602441
=005  20170608124320.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x86
=072  \\$aG2.$x130.$x500
=072  \\$aG3.$x105
=150  \\$aBiocatalysis
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aCatalysis
=550  \\$wg$aMetabolism
=667  \\$aCATALYSIS is also available
=680  \\$iThe facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.
=688  \\$a2009
=750  \0$aBiocatalysis$0(DLC)sh2013002148$5IEN-M

=LDR  00680cz  a2200193n  4500
=001  9880364454702441
=005  20141212221431.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055159
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x230
=072  \\$aB1.$x300.$x930.$x340
=150  \\$aEndomyces
=450  \\$wnnna$aEndomyce
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=680  \\$iA genus of ascomycetous yeast in the family Endomycetaceae, order SACCHAROMYCETALES. They have been described as ascus-bearing parasites of basidiocarps, the fruiting bodies of BASIDIOMYCOTA.
=688  \\$a2009
=750  \0$aEndomyces$0(DLC) sh 85043086$5IEN-M

=LDR  00671cz  a2200181n  4500
=001  9880364454802441
=005  20141212221431.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055157
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x200
=072  \\$aB1.$x300.$x930.$x330
=150  \\$aDipodascus
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=680  \\$iA genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES. It is characterized by asci which have persistent walls and by smooth-walled ascospores. Anamorphs are in the genus GEOTRICHUM.
=688  \\$a2009
=750  \0$aDipodascus$0(DLC) sh 88021940$5IEN-M

=LDR  00632cz  a2200181n  4500
=001  9880364454902441
=005  20141212221431.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055156
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x655.$x600
=150  \\$aOphiostoma
=450  \\$wnnna$aOphiostomas
=550  \\$wg$aOphiostomatales
=667  \\$aAscomycota (1963-2008)
=680  \\$iA genus of fungi in the family Ophiostomataceae, order OPHIOSTOMATALES. Several species are the source of Dutch elm disease, which is spread by the elm bark beetle.
=688  \\$a2009
=750  \0$aOphiostoma$0(DLC) sh 85095048$5IEN-M

=LDR  00560cz  a2200169n  4500
=001  9880364455002441
=005  20141212221429.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055135
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x230.$x200
=150  \\$aCoelomomyces
=450  \\$wnnna$aCoelomomyce
=550  \\$wg$aBlastocladiomycota
=680  \\$iA genus of fungi in the phylum BLASTOCLADIOMYCOTA. They exhibit complex life cycles and are parasitic on the larvae of MOSQUITOES.
=688  \\$a2009
=750  \0$aCoelomomyces$0(DLC) sh 85027675$5IEN-M

=LDR  00558cz  a2200169n  4500
=001  9880364455102441
=005  20141212221429.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055134
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x230.$x74
=150  \\$aAllomyces
=450  \\$wnnna$aAllomyce
=550  \\$wg$aBlastocladiomycota
=680  \\$iA genus of aquatic fungi in the phylum BLASTOCLADIOMYCOTA. It is abundant in warmer climates and exhibits true alternation of generations.
=688  \\$a2009
=750  \0$aAllomyces$0(DLC) sh 88021870$5IEN-M

=LDR  00687cz  a2200229n  4500
=001  9880364455202441
=005  20141212221429.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055133
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x230
=150  \\$aBlastocladiomycota
=450  \\$wnnna$aBlastocladiale
=450  \\$wnnna$aBlastocladiales
=450  \\$wnnna$aBlastocladiomycotas
=550  \\$wg$aFungi
=550  \\$wh$aAllomyces
=550  \\$wh$aBlastocladiella
=550  \\$wh$aCoelomomyces
=680  \\$iA phylum of flagellated fungi, formerly the order Blastocladiales under CHYTRIDIOMYCOTA.
=688  \\$a2009
=750  \0$aBlastocladiales$0(DLC) sh 85014800$5IEN-M

=LDR  01179cz  a2200349n  4500
=001  9880364455302441
=005  20141212221425.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055110
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x669
=150  \\$aRadiometric Dating
=450  \\$wnnna$aCarbon Dating
=450  \\$wnnna$aCarbon Datings
=450  \\$wnnna$aDating, Carbon
=450  \\$wnnna$aDating, Radio-Carbon
=450  \\$wnnna$aDating, Radiocarbon
=450  \\$wnnna$aDating, Radiometric
=450  \\$wnnna$aDatings, Carbon
=450  \\$wnnna$aDatings, Radio-Carbon
=450  \\$wnnna$aDatings, Radiocarbon
=450  \\$wnnna$aDatings, Radiometric
=450  \\$wnnna$aRadio-Carbon Dating
=450  \\$wnnna$aRadio Carbon Dating
=450  \\$wnnna$aRadio-Carbon Datings
=450  \\$wnnna$aRadiocarbon Dating
=450  \\$wnnna$aRadiocarbon Datings
=450  \\$wnnna$aRadiometric Datings
=550  \\$wg$aRadiometry
=680  \\$iTechniques used to determine the age of materials, based on the content and half-lives of the RADIOACTIVE ISOTOPES they contain.
=688  \\$a2009
=750  \0$aRadioactive dating$0(DLC) sh 85110596$5IEN-M

=LDR  00508cz  a2200181n  4500
=001  9880364455402441
=005  20141212221424.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x922
=150  \\$aSunbathing
=450  \\$aSuntanning
=550  \\$wg$aRecreation
=550  \\$aSuntan
=680  \\$iExposing oneself to SUNLIGHT or ULTRAVIOLET RAYS.
=688  \\$a2009; use HELIOTHERAPY 1985-2008
=750  \0$aSun-baths$0(DLC) sh 85130485$5IEN

=LDR  00605cz  a2200169n  4500
=001  9880364455502441
=005  20141212221424.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055107
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG13.$x750.$x829.$x833.$x500
=150  \\$aSuntan
=550  \\$wg$aSkin Pigmentation
=550  \\$aSunbathing
=680  \\$iAn induced skin pigment (MELANIN) darkening after exposure to SUNLIGHT or ULTRAVIOLET RAYS. The degree of tanning depends on the intensity and duration of UV exposure, and genetic factors.
=688  \\$a2009
=750  \0$aSuntan$0(DLC) sh 85130566$5IEN-M

=LDR  01197cz  a2200313n  4500
=001  9880364455602441
=005  20141212221422.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x992
=072  \\$aE5.$x200.$x992
=150  \\$aSemen Analysis
=450  \\$wnnna$aAnalyses, Semen Quality
=450  \\$wnnna$aAnalysis, Semen Quality
=450  \\$wnnna$aQualities, Semen
=450  \\$wnnna$aQuality Analyses, Semen
=450  \\$wnnna$aQuality, Semen
=450  \\$wnnna$aSemen Analyses
=450  \\$wnnna$aSemen Qualities
=450  \\$aSemen Quality
=450  \\$wnnna$aSemen Quality Analyses
=450  \\$wnnna$aSemen Quality Analysis
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wh$aSperm Count
=550  \\$wh$aSperm Motility
=680  \\$iThe quality of SEMEN, an indicator of male fertility, can be determined by semen volume, pH, sperm concentration (SPERM COUNT), total sperm number, sperm viability, sperm vigor (SPERM MOTILITY), normal sperm morphology, ACROSOME integrity, and the concentration of WHITE BLOOD CELLS.
=688  \\$a2009
=750  \0$aSemen$xanalysis$0(IEN) 8842769$5IEN-M

=LDR  00904cz  a2200277n  4500
=001  9880364455702441
=005  20141212221422.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055100
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x750
=150  \\$aOptical Fibers
=450  \\$wnnna$aCable, Fiber Optic
=450  \\$wnnna$aCables, Fiber Optic
=450  \\$wnnna$aFiber Optic Cable
=450  \\$wnnna$aFiber Optic Cables
=450  \\$wnnna$aFiber, Optical
=450  \\$wnnna$aFibers, Optical
=450  \\$wnnna$aOptic Cable, Fiber
=450  \\$wnnna$aOptic Cables, Fiber
=450  \\$wnnna$aOptical Fiber
=550  \\$wg$aOptical Devices
=550  \\$aFiber Optic Technology
=680  \\$iThin strands of transparent material, usually glass, that are used for transmitting light waves over long distances.
=688  \\$a2009
=750  \0$aOptical fibers$0(DLC) sh 85095145$5IEN-M

=LDR  01124cz  a2200265n  4500
=001  9880364455802441
=005  20141212221422.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055099
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x382.$x944
=150  \\$aNeuroendocrine Cells
=450  \\$wnnna$aCell, Neuroendocrine
=450  \\$wnnna$aCells, Neuroendocrine
=450  \\$wnnna$aEndocrine Neuron
=450  \\$wnnna$aEndocrine Neurons
=450  \\$wnnna$aNeuroendocrine Cell
=450  \\$wnnna$aNeuron, Endocrine
=450  \\$wnnna$aNeurons, Endocrine
=550  \\$wg$aEndocrine Cells
=550  \\$wh$aAPUD Cells
=667  \\$acoordinate with specific organ
=680  \\$iSpecialized NEURONS that produce hormones, such as NEUROPEPTIDES or BIOGENIC AMINES. They generally are in the NERVOUS SYSTEM, such as HYPOTHALAMUS, but can be found in other organs or systems. These neurons contain dense neurosecretory granules and PROPROTEIN CONVERTASES allowing the rapidly release of NEUROHORMONES into the blood circulation upon stimulation.
=688  \\$a2009
=750  \0$aParaneurons$0(DLC) sh 86002390$5IEN-M

=LDR  01130cz  a2200349n  4500
=001  9880364455902441
=005  20141212221421.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055096
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632
=150  \\$aOptical Devices
=450  \\$wnnna$aComponent, Optical
=450  \\$wnnna$aComponents, Optical
=450  \\$wnnna$aDevice, Optical
=450  \\$wnnna$aDevices, Optical
=450  \\$wnnna$aOptical Component
=450  \\$wnnna$aOptical Components
=450  \\$wnnna$aOptical Device
=450  \\$wnnna$aOptical System
=450  \\$wnnna$aOptical Systems
=450  \\$wnnna$aSystem, Optical
=450  \\$wnnna$aSystems, Optical
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aLasers
=550  \\$wh$aLenses
=550  \\$wh$aOptical Fibers
=550  \\$wh$aTelescopes
=550  \\$aOptics and Photonics
=680  \\$iProducts or parts of products used to detect, manipulate, or analyze light, such as LENSES, refractors, mirrors, filters, prisms, and OPTICAL FIBERS.
=688  \\$a2009
=750  \0$aOptical instruments$0(DLC) sh 85095150$5IEN-M

=LDR  00317cz  a2200109n  4500
=001  9880364456002441
=005  20090210105332.0
=008  080708\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D055095Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aOptics and Photonics$xinstrumentation
=750  \0$aOptical instruments$0(DLC) sh 85095150$5IEN-M

=LDR  01134cz  a2200277n  4500
=001  9880364456102441
=005  20141212221420.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055095
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x617
=072  \\$aJ1.$x293.$x688
=150  \\$aOptics and Photonics
=450  \\$wnnoa$aOptics$5IEN-M
=450  \\$wnnna$aPhotonics
=450  \\$wnnna$aPhotonics and Optics
=550  \\$wg$aEngineering
=550  \\$wg$aPhysics
=550  \\$wh$aFiber Optic Technology
=550  \\$wh$aMicroscopy
=550  \\$wh$aRefractometry
=550  \\$aOptical Devices
=667  \\$athe discipline (education, history, etc) only; use OPTICAL PHENOMENA or specifics treed under it for processes and properties of light and materials interacting with light
=680  \\$iA specialized field of physics and engineering involved in studying the behavior and properties of light and the technology of analyzing, generating, transmitting, and manipulating ELECTROMAGNETIC RADIATION in the visible, infrared, and ultraviolet range.
=688  \\$a2009
=750  \0$aOptics$0(DLC) sh 85095181$5IEN-M

=LDR  01148cz  a2200265n  4500
=001  9880364456202441
=005  20141212221420.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055094
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x232
=072  \\$aH2.$x249.$x500
=150  \\$aEvidence-Based Dentistry
=450  \\$wnnna$aDentistries, Evidence-Based
=450  \\$aDentistry, Evidence-Based
=450  \\$wnnna$aDentistry, Evidence Based
=450  \\$wnnna$aEvidence-Based Dentistries
=450  \\$wnnna$aEvidence Based Dentistry
=550  \\$wg$aDentistry
=550  \\$wg$aEvidence-Based Practice
=550  \\$aEvidence-Based Medicine
=550  \\$aEvidence-Based Nursing
=680  \\$iAn approach or process of practicing oral health care that requires the judicious integration of systematic assessments of clinical relevant scientific evidence, relating to the patient's oral and medical condition and history, with the dentist's clinical expertise and the patient's treatment needs and preferences. (from J Am Dent Assoc 134: 689, 2003)
=688  \\$a2009
=750  \0$aEvidence-based dentistry$0(DLC) sh 99000814$5IEN-M

=LDR  01001cz  a2200289n  4500
=001  9880364456302441
=005  20141212221418.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055088
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x390.$x500
=150  \\$aEarly Detection of Cancer
=450  \\$wnnna$aCancer Early Detection
=450  \\$wnnna$aCancer Early Diagnosis
=450  \\$wnnna$aCancer Screening
=450  \\$wnnna$aCancer Screening Test
=450  \\$wnnna$aCancer Screening Tests
=450  \\$wnnna$aEarly Diagnosis of Cancer
=450  \\$wnnna$aScreening, Cancer
=450  \\$wnnna$aScreening Test, Cancer
=450  \\$wnnna$aScreening Tests, Cancer
=450  \\$wnnna$aTest, Cancer Screening
=450  \\$wnnna$aTests, Cancer Screening
=550  \\$wg$aEarly Diagnosis
=680  \\$iMethods to identify and characterize cancer in the early stages of disease and predict tumor behavior.
=688  \\$a2009
=750  \0$aCancer$xEarly detection$5IEN-M$0(DLC)sh2012002014

=LDR  02122cz  a2200481n  4500
=001  9880364456402441
=005  20141212221418.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x483.$x875
=072  \\$aE2.$x831.$x387.$x875
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x500
=072  \\$aI3.$x350.$x500
=150  \\$aResistance Training
=450  \\$wnnna$aExercise Program, Weight-Bearing
=450  \\$wnnna$aExercise Program, Weight-Lifting
=450  \\$wnnna$aExercise Programs, Weight-Bearing
=450  \\$wnnna$aExercise Programs, Weight-Lifting
=450  \\$aStrength Training
=450  \\$wnnna$aStrengthening Program, Weight-Bearing
=450  \\$wnnna$aStrengthening Program, Weight-Lifting
=450  \\$wnnna$aStrengthening Programs, Weight-Bearing
=450  \\$wnnna$aStrengthening Programs, Weight-Lifting
=450  \\$wnnna$aTraining, Resistance
=450  \\$wnnna$aTraining, Strength
=450  \\$wnnna$aWeight-Bearing Exercise Program
=450  \\$wnnna$aWeight Bearing Exercise Program
=450  \\$wnnna$aWeight-Bearing Exercise Programs
=450  \\$aWeight-Bearing Strengthening Program
=450  \\$wnnna$aWeight Bearing Strengthening Program
=450  \\$wnnna$aWeight-Bearing Strengthening Programs
=450  \\$wnnna$aWeight-Lifting Exercise Program
=450  \\$wnnna$aWeight Lifting Exercise Program
=450  \\$wnnna$aWeight-Lifting Exercise Programs
=450  \\$aWeight-Lifting Strengthening Program
=450  \\$wnnna$aWeight Lifting Strengthening Program
=450  \\$wnnna$aWeight-Lifting Strengthening Programs
=550  \\$wg$aExercise
=550  \\$wg$aExercise Therapy
=680  \\$iA type of strength-building exercise program that requires the body muscle to exert a force against some form of resistance, such as weight, stretch bands, water, or immovable objects. Resistance exercise is a combination of static and dynamic contractions involving shortening and lengthening of skeletal muscles.
=688  \\$a2009
=750  \0$aWeight training$0(DLC) sh 87006261$5IEN-M

=LDR  01417cz  a2200361n  4500
=001  9880364014302441
=005  20141212211436.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016207
=035  \\$aCBG6557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374
=072  \\$aD12.$x776.$x467.$x374
=072  \\$aD23.$x529.$x374
=150  \\$aCytokines
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aChemokines
=550  \\$wh$aGrowth Differentiation Factor 15
=550  \\$wh$aHematopoietic Cell Growth Factors
=550  \\$wh$aHepatocyte Growth Factor
=550  \\$wh$aInterferons
=550  \\$wh$aInterleukin 1 Receptor Antagonist Protein
=550  \\$wh$aInterleukins
=550  \\$wh$aLeukemia Inhibitory Factor
=550  \\$wh$aLymphokines
=550  \\$wh$aMonokines
=550  \\$wh$aOncostatin M
=550  \\$wh$aOsteopontin
=550  \\$wh$aTransforming Growth Factor beta
=550  \\$wh$aTumor Necrosis Factors
=680  \\$iNon-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
=688  \\$a91
=750  \0$aCytokines$5IEN$0(DLC)sh 85035236

=LDR  01113cz  a2200229n  4500
=001  9880364014402441
=005  20141212211435.0
=008  900814\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016206
=035  \\$aCBG6556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x500
=072  \\$aL1.$x700.$x508.$x300.$x188.$x300
=150  \\$aDatabases, Bibliographic
=450  \\$wnnna$aBibliographic Database
=450  \\$wnnna$aBibliographic Databases
=450  \\$wnnna$aDatabase, Bibliographic
=550  \\$wg$aDatabases as Topic
=550  \\$wh$aPubMed
=680  \\$iExtensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.
=688  \\$a91; DATABASES was see INFORMATION SYSTEMS 1982-90
=750  \0$aMachine-readable bibliographic data$5IEN-M$0(DLC)sh 85079330

=LDR  01367cz  a2200373n  4500
=001  9880364014502441
=005  20190225142828.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016205
=035  \\$aCBG6555M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992.$x635.$x75.$x500
=150  \\$aSigmodontinae
=450  \\$wnnna$aCotton Rat
=450  \\$wnnna$aCotton Rats
=450  \\$wnnna$aHesperomyinae
=450  \\$wnnna$aHesperomyines
=450  \\$aNeotoma
=450  \\$aOryzomys
=450  \\$wnnna$aRat, Cotton
=450  \\$wnnna$aRat, Rice
=450  \\$aRats, Cotton
=450  \\$aRats, Rice
=450  \\$wnnna$aRice Rat
=450  \\$wnnna$aRice Rats
=450  \\$aSigmodon
=550  \\$wg$aArvicolinae
=550  \\$wh$aPeromyscus
=667  \\$afor entry term RATS, RICE and other species commonly called "rats" but taxonomically SIGMODONTINAE, do not use the check tag RATS.
=680  \\$iA subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.
=688  \\$a2006 (1991); for NEOTOMA, SIGMODON, and RATS, COTTON use ARVICOLINAE 1982-1990
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Hesperomyinae
=688  \\$a91; NEOTOMA, SIGMODON, and RATS, COTTON were see CRICETIDAE 1982-90
=750  \0$aCotton rats$0(DLC) sh 85033342$5IEN-M

=LDR  00972cz  a2200277n  4500
=001  9880364014602441
=005  20141212211434.0
=008  900629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016202
=035  \\$aCBG6553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x67.$x500.$x400
=072  \\$aD12.$x125.$x119.$x170.$x400
=150  \\$aN-Methylaspartate
=450  \\$wnnna$aAcid, N-Methyl-D-aspartic
=450  \\$aN-Methyl-D-aspartate
=450  \\$wnnna$aN Methyl D aspartate
=450  \\$wnnna$aN-Methyl-D-aspartic Acid
=450  \\$wnnna$aN Methyl D aspartic Acid
=450  \\$wnnna$aN Methylaspartate
=450  \\$aNMDA
=550  \\$wg$aAspartic Acid
=667  \\$aa glutamate agonist; /biosyn /physiol permitted; DF: note short X ref
=680  \\$iAn amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA).
=688  \\$a91
=750  \0$aMethyl aspartate$5IEN$0(DLC)sh 88004080

=LDR  02179cz  a2200385n  4500
=001  9880364014702441
=005  20190430171421.0
=008  900531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016194
=035  \\$aCBG6545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x400.$x500.$x500
=072  \\$aD12.$x776.$x543.$x550.$x425.$x500.$x200.$x500
=072  \\$aD12.$x776.$x543.$x585.$x400.$x500.$x200.$x500
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x450.$x400.$x500
=150  \\$aReceptors, N-Methyl-D-Aspartate
=450  \\$aN-Methyl-D-Aspartate Receptors
=450  \\$wnnna$aN Methyl D Aspartate Receptors
=450  \\$wnnna$aN-Methylaspartate Receptors
=450  \\$wnnna$aN Methylaspartate Receptors
=450  \\$aNMDA Receptor-Ionophore Complex
=450  \\$wnnna$aNMDA Receptor Ionophore Complex
=450  \\$aNMDA Receptors
=450  \\$wnno$aReceptor, N-Methyl-D-Aspartate$5IEN-M
=450  \\$wnnna$aReceptors, N Methyl D Aspartate
=450  \\$wnnna$aReceptors, N-Methylaspartate
=450  \\$wnnna$aReceptors, N Methylaspartate
=450  \\$aReceptors, NMDA
=550  \\$wg$aReceptors, Ionotropic Glutamate
=550  \\$aN-Methylaspartate
=680  \\$iA class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
=688  \\$a93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92
=750  \0$81$wb$iBroader mapping$aMethyl aspartate$0(DLC)sh 88004080$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMethyl aspartate--Receptors$5IEN-M

=LDR  01331cz  a2200241n  4500
=001  9880364014802441
=005  20141212211430.0
=008  900617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016189
=035  \\$aCBG6540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x210.$x500.$x250
=072  \\$aD12.$x776.$x220.$x250
=072  \\$aD12.$x776.$x543.$x250
=150  \\$aDystrophin
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wg$aMembrane Proteins
=550  \\$wg$aMuscle Proteins
=550  \\$aMuscular Dystrophy, Duchenne
=667  \\$aa muscle protein: see MeSH definition for relation to musc dystrophy; /biosyn /drug eff /physiol /ultrastruct permitted
=680  \\$iA muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.
=688  \\$a91
=750  \0$aDystrophin$5IEN-M$0(DLC)sh 96011005

=LDR  02309cz  a2200409n  4500
=001  9880364014902441
=005  20190506103335.0
=008  900705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016187
=035  \\$aCBG6538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x150.$x310
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x200.$x420
=150  \\$aReceptors, Granulocyte-Macrophage Colony-Stimulating Factor
=450  \\$wnnna$aAntigen, CD116
=450  \\$aAntigens, CD116
=450  \\$wnnna$aCD116 Antigen
=450  \\$aCD116 Antigens
=450  \\$wnnna$aGM-CSF Receptor
=450  \\$wnnna$aGM CSF Receptor
=450  \\$aGM-CSF Receptors
=450  \\$wnnna$aGM CSF Receptors
=450  \\$wnnna$aReceptor, GM-CSF
=450  \\$wnnna$aReceptor, Granulocyte-Macrophage Colony-Stimulating Factor
=450  \\$wnnna$aReceptor, Granulocyte Macrophage Colony Stimulating Factor
=450  \\$wnnna$aReceptors, GM-CSF
=450  \\$wnnna$aReceptors, GM CSF
=450  \\$wnnna$aReceptors, Granulocyte Macrophage Colony Stimulating Factor
=550  \\$wg$aReceptors, Colony-Stimulating Factor
=550  \\$wh$aCytokine Receptor Common beta Subunit
=550  \\$aGranulocyte-Macrophage Colony-Stimulating Factor
=667  \\$aDF: RECEPT GMCSF
=680  \\$iReceptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
=688  \\$a93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92
=750  \0$81$wb$iBroader mapping$aGranulocyte-macrophage colony-stimulating factor$0(DLC) sh 92005139$4BM$5IEN
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGranulocyte-macrophage colony-stimulating factor$5IEN-M

=LDR  02007cz  a2200481n  4500
=001  9880364015002441
=005  20190426134721.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016185
=035  \\$aCBG6536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x150.$x360
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x340
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x200.$x480
=150  \\$aReceptors, Interleukin-3
=450  \\$wnnna$aIL-3 Receptor
=450  \\$wnnna$aIL 3 Receptor
=450  \\$aIL-3 Receptors
=450  \\$wnnna$aIL 3 Receptors
=450  \\$wnnna$aIL3 Receptor
=450  \\$wnnna$aIL3 Receptors
=450  \\$wnnna$aInterleukin-3 Receptor
=450  \\$wnnna$aInterleukin 3 Receptor
=450  \\$aInterleukin-3 Receptors
=450  \\$wnnna$aInterleukin 3 Receptors
=450  \\$wnnna$aReceptor, IL-3
=450  \\$wnnna$aReceptor, IL3
=450  \\$wnnna$aReceptor, Interleukin-3
=450  \\$aReceptors, IL-3
=450  \\$wnnna$aReceptors, IL 3
=450  \\$wnnna$aReceptors, IL3
=450  \\$wnnna$aReceptors, Interleukin 3
=550  \\$wg$aReceptors, Colony-Stimulating Factor
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aCytokine Receptor Common beta Subunit
=550  \\$wh$aInterleukin-3 Receptor alpha Subunit
=550  \\$aInterleukin-3
=667  \\$aDF: RECEPT IL 3 or RECEPT IL3
=680  \\$iHigh affinity receptors for INTERLEUKIN-3. They are found on early HEMATOPOIETIC PROGENITOR CELLS; progenitors of MYELOID CELLS; EOSINOPHILS; and BASOPHILS. Interleukin-3 receptors are formed by the dimerization of the INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.
=688  \\$a91
=750  \0$81$wb$iBroader mapping$aInterleukin-3$0(DLC) sh 92005138$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-3--Receptors$5IEN-M

=LDR  00989cz  a2200289n  4500
=001  9880364015102441
=005  20141212211426.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016182
=035  \\$aCBG6533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x900
=072  \\$aC2.$x839.$x900
=072  \\$aC22.$x836.$x900
=150  \\$aVisna
=450  \\$wnnna$aEncephalomyelitides, Ovine
=450  \\$aEncephalomyelitis, Ovine
=450  \\$wnnna$aOvine Encephalomyelitides
=450  \\$wnnna$aOvine Encephalomyelitis
=450  \\$wnnna$aVisnas
=550  \\$wg$aLentivirus Infections
=550  \\$wg$aSheep Diseases
=550  \\$wg$aSlow Virus Diseases
=667  \\$acaused by a lentivirus; don't forget also SHEEP (NIM) & check tag ANIMALS
=680  \\$iDemyelinating leukoencephalomyelitis of sheep caused by the VISNA-MAEDI VIRUS. It is similar to but not the same as SCRAPIE.
=688  \\$a91
=750  \0$aMaedi-visna disease$5IEN$0(DLC)sh 89004922

=LDR  01084cz  a2200289n  4500
=001  9880364015202441
=005  20141212211425.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016180
=035  \\$aCBG6531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616
=150  \\$aLentivirus Infections
=450  \\$wnnna$aInfection, Lentivirus
=450  \\$wnnna$aInfections, Lentivirus
=450  \\$wnnna$aLentivirus Infection
=550  \\$wg$aRetroviridae Infections
=550  \\$wh$aEquine Infectious Anemia
=550  \\$wh$aFeline Acquired Immunodeficiency Syndrome
=550  \\$wh$aHIV Infections
=550  \\$wh$aPneumonia, Progressive Interstitial, of Sheep
=550  \\$wh$aSimian Acquired Immunodeficiency Syndrome
=550  \\$wh$aVisna
=667  \\$acaused by a retrovirus; GEN or unspecified: prefer specifics
=680  \\$iVirus diseases caused by the Lentivirus genus. They are multi-organ diseases characterized by long incubation periods and persistent infection.
=688  \\$a91
=750  \0$aLentivirus infections$5IEN-M$0(DLC)sh 94005194

=LDR  01171cz  a2200253n  4500
=001  9880364015302441
=005  20170228161230.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016179
=035  \\$aCBG6530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x350
=072  \\$aD12.$x776.$x395.$x240.$x200
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x350
=072  \\$aD23.$x529.$x374.$x410.$x240.$x350
=150  \\$aGranulocyte Colony-Stimulating Factor
=450  \\$aG-CSF
=450  \\$wnnoa$aGranulocyte Colony-Stimulating Factor, Recombinant$5IEN-M
=550  \\$wg$aColony-Stimulating Factors
=550  \\$wh$aFilgrastim
=667  \\$aDF: GCSF
=680  \\$iA glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.
=688  \\$a91
=750  \0$aFilgrastim$0(DLC) sh 93005046$5IEN-M

=LDR  02122cz  a2200373n  4500
=001  9880364015402441
=005  20141212211425.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016178
=035  \\$aCBG6529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x375
=072  \\$aD12.$x776.$x395.$x240.$x300
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x375
=072  \\$aD23.$x529.$x374.$x410.$x240.$x375
=150  \\$aGranulocyte-Macrophage Colony-Stimulating Factor
=450  \\$wnnna$aCell-Stimulating Factor, Histamine-Producing
=450  \\$aColony-Stimulating Factor, Granulocyte-Macrophage
=450  \\$wnnna$aColony Stimulating Factor, Granulocyte Macrophage
=450  \\$wnnna$aCSF-2
=450  \\$aCSF-GM
=450  \\$aGM-CSF
=450  \\$wnnna$aGranulocyte Macrophage Colony Stimulating Factor
=450  \\$wnnoa$aGranulocyte-Macrophage Colony-Stimulating Factor, Recombinant$5IEN-M
=450  \\$aHistamine-Producing Cell-Stimulating Factor
=450  \\$wnnna$aHistamine Producing Cell Stimulating Factor
=450  \\$wnnna$aTC-GM-CSF
=450  \\$wnnna$aTumor-Cell Human GM Colony-Stimulating Factor
=450  \\$wnnna$aTumor Cell Human GM Colony Stimulating Factor
=550  \\$wg$aColony-Stimulating Factors
=667  \\$aDF: GMCSF
=680  \\$iAn acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.
=688  \\$a91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91
=750  \0$aGranulocyte-macrophage colony-stimulating factor$0(DLC) sh 92005139$5IEN

=LDR  01043cz  a2200301n  4500
=001  9880364015502441
=005  20141212211422.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016174
=035  \\$aCBG6525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x450.$x410
=072  \\$aB4.$x820.$x250.$x475
=072  \\$aB4.$x909.$x777.$x310.$x475
=150  \\$aHepacivirus
=450  \\$wnnna$aHepaciviruses
=450  \\$wnnna$aHepatitis C-Like Virus
=450  \\$wnnna$aHepatitis C-Like Viruses
=450  \\$wnnna$aHepatitis C Like Viruses
=450  \\$aHepatitis C virus
=450  \\$wnnna$aHepatitis C viruses
=550  \\$wg$aFlaviviridae
=550  \\$wg$aHepatitis Viruses
=550  \\$wh$aGB virus B
=667  \\$ainfection = HEPATITIS C or HEPATITIS C, CHRONIC
=680  \\$iA genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
=688  \\$a2002 (1991)
=750  \0$aHepatitis C virus$5IEN-M$0(DLC)sh 94002666

=LDR  02327cz  a2200565n  4500
=001  9880364015602441
=005  20141212211422.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016172
=035  \\$aCBG6523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x225.$x500.$x500
=072  \\$aE5.$x393.$x290
=072  \\$aI1.$x198.$x780.$x937.$x375
=150  \\$aDNA Fingerprinting
=450  \\$wnnna$aDNA Fingerprint
=450  \\$wnnna$aDNA Fingerprintings
=450  \\$aDNA Fingerprints
=450  \\$aDNA Profiling
=450  \\$wnnna$aDNA Profilings
=450  \\$aDNA Typing
=450  \\$wnnna$aDNA Typings
=450  \\$wnnna$aFingerprint, DNA
=450  \\$wnnna$aFingerprinting, DNA
=450  \\$wnnna$aFingerprinting, Genetic
=450  \\$wnnna$aFingerprintings, DNA
=450  \\$wnnna$aFingerprintings, Genetic
=450  \\$wnnna$aFingerprints, DNA
=450  \\$aGenetic Fingerprinting
=450  \\$wnnna$aGenetic Fingerprintings
=450  \\$wnnna$aProfiling, DNA
=450  \\$wnnna$aTyping, DNA
=450  \\$wnnna$aTypings, DNA
=550  \\$wg$aBiometric Identification
=550  \\$wg$aForensic Medicine
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aAmplified Fragment Length Polymorphism Analysis
=550  \\$wh$aDNA Contamination
=550  \\$wh$aRibotyping
=550  \\$aDatabases, Nucleic Acid
=550  \\$aGenetic Privacy
=550  \\$aGenotyping Techniques
=550  \\$aMinisatellite Repeats
=550  \\$aPaternity
=550  \\$aPolymorphism, Restriction Fragment Length
=550  \\$aRandom Amplified Polymorphic DNA Technique
=667  \\$aDNA FOOTPRINTING is available; do not confuse X ref DNA PROFILING with GENE EXPRESSION PROFILING
=680  \\$iA technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.
=688  \\$a91
=750  \0$aDNA fingerprinting$5IEN$0(DLC)sh 89001022

=LDR  00856cz  a2200241n  4500
=001  9880364015702441
=005  20141212211419.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016164
=035  \\$aCBG6517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x120
=150  \\$aBison
=450  \\$wnnna$aAmerican Buffalo
=450  \\$wnnna$aAmerican Buffaloes
=450  \\$wnnna$aBisons
=450  \\$aBuffalo, American
=450  \\$wnnna$aBuffaloes, American
=550  \\$wg$aRuminants
=667  \\$ado not confuse with BUFFALOES but note X ref; IM; qualif permitted
=680  \\$iA genus of the family Bovidae having two species: B. bison and B. bonasus. This concept is differentiated from BUFFALOES, which refers to Bubalus arnee and Syncerus caffer.
=688  \\$a91
=750  \0$aBison$5IEN$0(DLC)sh 85014451

=LDR  01451cz  a2200385n  4500
=001  9880364015802441
=005  20141212211417.0
=008  900619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016159
=035  \\$aCBG6512M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x820
=072  \\$aD12.$x776.$x624.$x776.$x775
=072  \\$aD12.$x776.$x660.$x825
=072  \\$aD12.$x776.$x744.$x845
=150  \\$aTumor Suppressor Protein p53
=450  \\$wnnna$aCellular Tumor Antigen p53
=450  \\$wnnna$aOncoprotein p53
=450  \\$wnnna$ap53 Antigen
=450  \\$ap53 Tumor Suppressor Protein
=450  \\$wnnna$aPhosphoprotein, pp53
=450  \\$wnnna$app53 Phosphoprotein
=450  \\$wnno$aProtein p53$5IEN-M
=450  \\$wnnna$aTP53 Protein
=450  \\$wnnna$aTRP53 Protein
=550  \\$wg$aDNA-Binding Proteins
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aPhosphoproteins
=550  \\$wg$aTumor Suppressor Proteins
=550  \\$aGenes, p53
=680  \\$iNuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER.
=688  \\$a2005(1991);
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Protein p53
=688  \\$a91; TP53 PROTEIN was TP53 PROTEIN, HUMAN (NM) 1992-93
=750  \0$ap53 protein$0(DLC) sh2002008819$5IEN-M

=LDR  00838cz  a2200265n  4500
=001  9880364015902441
=005  20141212211416.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016158
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x249.$x385
=072  \\$aG5.$x360.$x340.$x24.$x340.$x415.$x400.$x385
=150  \\$aGenes, p53
=450  \\$wnnna$aGene, p53
=450  \\$wnnna$aGene, TP53
=450  \\$aGenes, TP53
=450  \\$wnnna$ap53 Gene
=450  \\$ap53 Genes
=450  \\$wnnna$aTP53 Gene
=450  \\$aTP53 Genes
=550  \\$wg$aGenes, Tumor Suppressor
=550  \\$aLi-Fraumeni Syndrome
=680  \\$iTumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53.
=688  \\$a91
=750  \0$ap53 antioncogene$5IEN-M$0(DLC)sh 95000658

=LDR  02248cz  a2200469n  4500
=001  9880364016002441
=005  20141212192652.0
=008  900424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016142
=035  \\$aCBG6503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x660.$x207.$x410
=072  \\$aC10.$x500.$x34.$x875
=072  \\$aC16.$x131.$x77.$x410
=072  \\$aC16.$x131.$x260.$x380
=072  \\$aC16.$x131.$x621.$x207.$x410
=072  \\$aC16.$x131.$x666.$x34.$x875
=072  \\$aC16.$x320.$x180.$x380
=150  \\$aHoloprosencephaly
=450  \\$wnnna$aAlobar Holoprosencephalies
=450  \\$aAlobar Holoprosencephaly
=450  \\$wnnna$aArhinencephalies
=450  \\$aArhinencephaly
=450  \\$wnnna$aHoloprosencephalies
=450  \\$wnnna$aHoloprosencephalies, Alobar
=450  \\$wnnna$aHoloprosencephalies, Lobar
=450  \\$wnnna$aHoloprosencephalies, Semilobar
=450  \\$wnnna$aHoloprosencephaly, Alobar
=450  \\$wnnna$aHoloprosencephaly, Familial Alobar
=450  \\$wnnna$aHoloprosencephaly, Lobar
=450  \\$wnnna$aHoloprosencephaly, Semilobar
=450  \\$wnnna$aLobar Holoprosencephalies
=450  \\$aLobar Holoprosencephaly
=450  \\$wnnna$aSemilobar Holoprosencephalies
=450  \\$aSemilobar Holoprosencephaly
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aAgenesis of Corpus Callosum
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aCraniofacial Abnormalities
=680  \\$iAnterior midline brain, cranial, and facial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. Alobar prosencephaly is the most severe form and features anophthalmia; cyclopia; severe INTELLECTUAL DISABILITY; CLEFT LIP; CLEFT PALATE; SEIZURES; and microcephaly. Semilobar holoprosencepaly is characterized by hypotelorism, microphthalmia, coloboma, nasal malformations, and variable degrees of INTELLECTUAL DISABILITY. Lobar holoprosencephaly is associated with mild (or absent) facial malformations and intellectual abilities that range from mild INTELLECTUAL DISABILITY to normal. Holoprosencephaly is associated with CHROMOSOME ABNORMALITIES.
=688  \\$a91
=750  \0$aHoloprosencephaly$5IEN$0(DLC)sh 89007234

=LDR  00990cz  a2200301n  4500
=001  9880364016102441
=005  20141212211413.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016139
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x560
=150  \\$aMartial Arts
=450  \\$wnnna$aAikido
=450  \\$wnnna$aArts, Martial
=450  \\$wnnna$aFu, Gong
=450  \\$aGong Fu
=450  \\$aGongfu
=450  \\$aJudo
=450  \\$aKarate
=450  \\$aKung Fu
=450  \\$aTae Kwon Do
=550  \\$wg$aSports
=550  \\$wh$aTai Ji
=550  \\$aWrestling
=667  \\$a/inj: coord IM with specific inj (IM); Manual 30.15.1
=680  \\$iActivities in which participants learn self-defense mainly through the use of hand-to-hand combat. Judo involves throwing an opponent to the ground while karate (which includes kung fu and tae kwon do) involves kicking and punching an opponent.
=688  \\$a91
=750  \0$aMartial arts$5IEN$0(DLC)sh 85081626

=LDR  00973cz  a2200265n  4500
=001  9880364016202441
=005  20190102095624.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016138
=035  \\$aCBG6501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x410.$x568.$x900.$x875
=072  \\$aG11.$x427.$x410.$x698.$x277.$x937.$x500
=072  \\$aI3.$x350.$x937
=150  \\$aWalking
=450  \\$aAmbulation
=550  \\$wg$aExercise
=550  \\$wg$aLocomotion
=550  \\$wg$aSports
=550  \\$wh$aDependent Ambulation
=550  \\$wh$aStair Climbing
=667  \\$ahuman & animal; /inj: coordinate IM with specific injury (IM); differentiate from GAIT, the way one walks
=680  \\$iAn activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.
=688  \\$a91
=750  \0$aWalking$5IEN$0(DLC)sh 85144900

=LDR  01335cz  a2200253n  4500
=001  9880364016302441
=005  20141212211412.0
=008  900605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016136
=035  \\$aCBG6499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x800.$x750
=072  \\$aC16.$x131.$x666.$x680.$x800.$x750
=150  \\$aSpina Bifida Occulta
=450  \\$wnnna$aClosed Spinal Bifida
=450  \\$aDermal Sinus
=450  \\$wnnna$aOccult Spina Bifida
=450  \\$wnnna$aSinus, Dermal
=450  \\$wnnna$aSpina Bifida, Occult
=450  \\$aSpinal Bifida, Closed
=550  \\$wg$aSpinal Dysraphism
=680  \\$iA common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. (From Joynt, Clinical Neurology, 1992, Ch55, p34)
=688  \\$a1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS use NEURAL TUBE DEFECTS 1979-1990
=750  \0$aDiastematomyelia$5IEN$0(DLC)sh 85037621

=LDR  01550cz  a2200409n  4500
=001  9880364016402441
=005  20141212211410.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016130
=035  \\$aCBG6495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x447
=072  \\$aE5.$x200.$x812.$x447
=072  \\$aE5.$x478.$x594.$x450
=150  \\$aImmunophenotyping
=450  \\$wnnna$aImmunologic Subtyping
=450  \\$wnnna$aImmunologic Subtypings
=450  \\$wnnna$aImmunophenotyping, Lymphocyte
=450  \\$wnnna$aImmunophenotypings
=450  \\$wnnna$aImmunophenotypings, Lymphocyte
=450  \\$aLymphocyte Immunophenotyping
=450  \\$wnnna$aLymphocyte Immunophenotypings
=450  \\$wnnna$aLymphocyte Phenotyping
=450  \\$wnnna$aLymphocyte Phenotypings
=450  \\$aLymphocyte Subtyping
=450  \\$wnnna$aLymphocyte Subtypings
=450  \\$wnnna$aPhenotyping, Lymphocyte
=450  \\$wnnna$aPhenotypings, Lymphocyte
=450  \\$wnnna$aSubtyping, Immunologic
=450  \\$wnnna$aSubtyping, Lymphocyte
=450  \\$wnnna$aSubtypings, Immunologic
=450  \\$wnnna$aSubtypings, Lymphocyte
=550  \\$wg$aImmunologic Tests
=550  \\$aLymphocyte Subsets
=680  \\$iProcess of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry.
=688  \\$a91
=750  \0$aImmunophenotyping$5IEN-M$0(DLC)sh 94006122

=LDR  00967cz  a2200277n  4500
=001  9880364016502441
=005  20141212211409.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016127
=035  \\$aCBG6494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x400
=150  \\$aHeart Valve Prolapse
=450  \\$wnnna$aHeart Valve Prolapses
=450  \\$wnnna$aProlapse, Heart Valve
=450  \\$wnnna$aProlapses, Heart Valve
=450  \\$wnnna$aValve Prolapse, Heart
=450  \\$wnnna$aValve Prolapses, Heart
=550  \\$wg$aHeart Valve Diseases
=550  \\$wh$aAortic Valve Prolapse
=550  \\$wh$aMitral Valve Prolapse
=550  \\$wh$aTricuspid Valve Prolapse
=667  \\$ageneral or unspecified: prefer specific valve prolapse
=680  \\$iDownward displacement of any one of the HEART VALVES from its normal position. This usually results in failed valve closure.
=688  \\$a91
=750  \0$aHeart valves$xDisplacement$5IEN

=LDR  00807cz  a2200193n  4500
=001  9880364016602441
=005  20141212211409.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016123
=035  \\$aCBG6492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x180.$x425
=072  \\$aB3.$x660.$x150.$x100.$x375
=150  \\$aCampylobacter jejuni
=550  \\$wg$aCampylobacter
=667  \\$ainfection: coord IM with CAMPYLOBACTER INFECTIONS (IM)
=680  \\$iA species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.
=688  \\$a91; was see CAMPYLOBACTER FETUS 1984-90
=750  \0$aCampylobacter jejuni$5IEN$0(DLC)sh 92000186

=LDR  01497cz  a2200361n  4500
=001  9880364016702441
=005  20141212211408.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016118
=035  \\$aCBG6488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x513.$x514.$x100
=072  \\$aA2.$x835.$x583.$x512.$x100
=150  \\$aAnterior Cruciate Ligament
=450  \\$wnnna$aAnterior Cranial Cruciate Ligament
=450  \\$wnnna$aAnterior Cruciate Ligaments
=450  \\$wnnna$aCranial Cruciate Ligament
=450  \\$wnnna$aCranial Cruciate Ligaments
=450  \\$aCruciate Ligament, Anterior
=450  \\$wnnna$aCruciate Ligament, Cranial
=450  \\$wnnna$aCruciate Ligaments, Anterior
=450  \\$wnnna$aCruciate Ligaments, Cranial
=450  \\$wnnna$aLigament, Anterior Cruciate
=450  \\$wnnna$aLigament, Cranial Cruciate
=450  \\$wnnna$aLigaments, Anterior Cruciate
=450  \\$wnnna$aLigaments, Cranial Cruciate
=550  \\$wg$aLigaments, Articular
=550  \\$aPatellar Ligament
=550  \\$aPosterior Cruciate Ligament
=667  \\$a/surg: consider also ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION
=680  \\$iA strong ligament of the knee that originates from the posteromedial portion of the lateral condyle of the femur, passes anteriorly and inferiorly between the condyles, and attaches to the depression in front of the intercondylar eminence of the tibia.
=688  \\$a91
=750  \0$aAnterior cruciate ligament$5IEN$0(DLC)sh 86004623

=LDR  00884cz  a2200253n  4500
=001  9880364016802441
=005  20141212211402.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016106
=035  \\$aCBG6476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x99.$x225.$x500.$x600.$x525
=072  \\$aG6.$x225.$x347.$x500.$x600.$x525
=072  \\$aG7.$x690.$x320.$x269.$x347.$x500.$x600.$x525
=150  \\$aMethicillin Resistance
=450  \\$wnnna$aMethicillin-Resistant
=450  \\$wnnna$aMethicillin Resistant
=450  \\$wnnna$aResistance, Methicillin
=550  \\$wg$aPenicillin Resistance
=550  \\$aMethicillin
=550  \\$aMethicillin-Resistant Staphylococcus aureus
=680  \\$iNon-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.
=688  \\$a91
=750  \0$aMethicillin resistance$5IEN$0(DLC)sh 91005976

=LDR  00559cz  a2200193n  4500
=001  9880364016902441
=005  20141212211401.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016105
=035  \\$aCBG6475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x270.$x694
=150  \\$aParathyroidectomy
=450  \\$wnnna$aParathyroidectomies
=550  \\$wg$aEndocrine Surgical Procedures
=550  \\$aParathyroid Glands
=680  \\$iExcision of one or more of the parathyroid glands.
=688  \\$a91
=750  \0$aParathyroidectomy$5IEN$0(DLC)sh 85097939

=LDR  00717cz  a2200253n  4500
=001  9880364017002441
=005  20141212211401.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016103
=035  \\$aCBG6473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x117.$x500.$x500
=072  \\$aC26.$x404.$x812
=072  \\$aC26.$x831.$x600
=150  \\$aSpinal Fractures
=450  \\$wnnna$aFracture, Spinal
=450  \\$wnnna$aFractures, Spinal
=450  \\$wnnna$aSpinal Fracture
=550  \\$wg$aFractures, Bone
=550  \\$wg$aSpinal Injuries
=667  \\$acoord IM with specific vertebrae /inj (IM)
=680  \\$iBroken bones in the vertebral column.
=688  \\$a91
=750  \0$aSpine$xFractures$5IEN

=LDR  02285cz  a2200565n  4500
=001  9880364017102441
=005  20200618140205.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016099
=035  \\$aCBG6472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250
=072  \\$aE4.$x210.$x240.$x250
=072  \\$aE4.$x502.$x250.$x250.$x250
=150  \\$aEndoscopy, Gastrointestinal
=450  \\$wnnna$aEndoscopic Gastrointestinal Surgeries
=450  \\$wnnna$aEndoscopic Gastrointestinal Surgery
=450  \\$aEndoscopic Gastrointestinal Surgical Procedures
=450  \\$wnnna$aEndoscopies, Gastrointestinal
=450  \\$wnnna$aGastrointestinal Endoscopic Surgical Procedures
=450  \\$wnnna$aGastrointestinal Endoscopies
=450  \\$wnnna$aGastrointestinal Endoscopy
=450  \\$wnnna$aGastrointestinal Surgeries, Endoscopic
=450  \\$wnnna$aGastrointestinal Surgery, Endoscopic
=450  \\$wnnna$aProcedure, Endoscopic Gastrointestinal, Surgical
=450  \\$wnnna$aProcedure, Gastrointestinal Endoscopic Surgical
=450  \\$wnnna$aProcedures, Endoscopic Gastrointestinal, Surgical
=450  \\$wnnna$aProcedures, Gastrointestinal Endoscopic Surgical
=450  \\$wnnna$aSurgeries, Endoscopic Gastrointestinal
=450  \\$wnnna$aSurgery, Endoscopic Gastrointestinal
=450  \\$wnnna$aSurgical Procedure, Endoscopic Gastrointestinal
=450  \\$aSurgical Procedures, Endoscopic Gastrointestinal
=550  \\$wg$aEndoscopy, Digestive System
=550  \\$wh$aBalloon Enteroscopy
=550  \\$wh$aCapsule Endoscopy
=550  \\$wh$aColonoscopy
=550  \\$wh$aDouble-Balloon Enteroscopy
=550  \\$wh$aDuodenoscopy
=550  \\$wh$aEndoscopic Mucosal Resection
=550  \\$wh$aEsophagoscopy
=550  \\$wh$aGastroscopy
=550  \\$wh$aProctoscopy
=550  \\$wh$aPyloromyotomy
=550  \\$wh$aSphincterotomy, Endoscopic
=550  \\$aEndoscopes, Gastrointestinal
=667  \\$ageneral or unspecified; prefer specifics; / instrum permitted but consider ENDOSCOPES, GASTROINTESTINAL
=680  \\$iEndoscopic examination, therapy or surgery of the gastrointestinal tract.
=688  \\$a91
=750  \0$aEnteroscopy$5IEN-M$0(DLC)sh 98003117

=LDR  02443cz  a2200553n  4500
=001  9880364017202441
=005  20141212211359.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016092
=035  \\$aCBG6467M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x850
=072  \\$aB4.$x909.$x777.$x731.$x850
=150  \\$aSpumavirus
=450  \\$aAfrican green monkey simian foamy virus
=450  \\$aBovine foamy virus
=450  \\$wnnna$aBovine foamy viruses
=450  \\$aBovine Syncytial Virus
=450  \\$wnnna$aBovine Syncytial Viruses
=450  \\$aFeline foamy virus
=450  \\$wnnna$aFeline foamy viruses
=450  \\$aFeline Syncytium-Forming Virus
=450  \\$wnnna$aFeline Syncytium Forming Virus
=450  \\$wnnna$aFeline Syncytium-Forming Viruses
=450  \\$aFoamy Virus
=450  \\$wnnna$afoamy virus, Bovine
=450  \\$wnnna$afoamy virus, Feline
=450  \\$wnnna$aFoamy Viruses
=450  \\$wnnna$afoamy viruses, Bovine
=450  \\$wnnna$afoamy viruses, Feline
=450  \\$aMacaque simian foamy virus
=450  \\$aSimian foamy virus 1
=450  \\$aSimian foamy virus 3
=450  \\$aSpumavirinae
=450  \\$wnnna$aSpumaviruses
=450  \\$wnnna$aSyncytial Virus, Bovine
=450  \\$wnnna$aSyncytial Viruses, Bovine
=450  \\$wnnna$aSyncytium-Forming Virus, Feline
=450  \\$wnnna$aSyncytium-Forming Viruses, Feline
=450  \\$wnnna$avirus, Bovine foamy
=450  \\$wnnna$avirus, Feline foamy
=450  \\$wnnna$aviruses, Bovine foamy
=450  \\$wnnna$aviruses, Feline foamy
=550  \\$wg$aRetroviridae
=550  \\$wh$aSimian foamy virus
=667  \\$ainfection: coordinate IM with RETROVIRIDAE INFECTIONS (IM); note HUMAN SPUMAVIRUS and CHIMPANZEE FOAMY VIRUS are entry terms to SIMIAN FOAMY VIRUS
=680  \\$iGenus of non-oncogenic retroviruses which establish persistent infections in many animal species but are considered non-pathogenic. Its species have been isolated from primates (including humans), cattle, cats, hamsters, horses, and sea lions. Spumaviruses have a foamy or lace-like appearance and are often accompanied by syncytium formation. SIMIAN FOAMY VIRUS is the type species.
=688  \\$a94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, & was see under LEUKEMOGENIC VIRUSES 1975-77.
=750  \0$aFoamy viruses$0(DLC)sh2003008385$5IEN-M

=LDR  01624cz  a2200349n  4500
=001  9880364017302441
=005  20141212211358.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016089
=035  \\$aCBG6464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x589.$x530.$x400
=072  \\$aB4.$x909.$x777.$x731.$x589.$x530.$x400
=150  \\$aImmunodeficiency Virus, Feline
=450  \\$aFeline Immunodeficiency Virus
=450  \\$wnnna$aFeline Immunodeficiency Viruses
=450  \\$aFeline T-Lymphotropic Lentivirus
=450  \\$wnnna$aFeline T Lymphotropic Lentivirus
=450  \\$wnnna$aFeline T-Lymphotropic Virus
=450  \\$wnnna$aFeline T Lymphotropic Virus
=450  \\$aFIV
=450  \\$aFTLV
=450  \\$wnnna$aLentivirus, Feline T-Lymphotropic
=450  \\$aLentivirus, Puma
=450  \\$aPuma lentivirus
=450  \\$wnnna$aT-Lymphotropic Lentivirus, Feline
=450  \\$wnnna$aT-Lymphotropic Virus, Feline
=550  \\$wg$aLentiviruses, Feline
=667  \\$ainfection: coord IM with LENTIVIRUS INFECTIONS (IM) or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME (IM) if so specified by author; DF: FIV
=680  \\$iA species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells.
=688  \\$a94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93
=750  \0$aFeline immunodeficiency virus$5IEN-M$0(DLC)sh 94004456

=LDR  01322cz  a2200277n  4500
=001  9880364017402441
=005  20141212211357.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016086
=035  \\$aCBG6461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x589
=072  \\$aB4.$x909.$x777.$x731.$x589
=150  \\$aLentivirus
=450  \\$aLentivirinae
=450  \\$wnnna$aLentiviruses
=550  \\$wg$aRetroviridae
=550  \\$wh$aLentiviruses, Bovine
=550  \\$wh$aLentiviruses, Equine
=550  \\$wh$aLentiviruses, Feline
=550  \\$wh$aLentiviruses, Ovine-Caprine
=550  \\$wh$aLentiviruses, Primate
=667  \\$aa genus of the family Retroviridae; Latin lenti-, slow, refers to its long incubation period; infection = LENTIVIRUS INFECTIONS
=680  \\$iA genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.
=688  \\$a94; was LENTIVIRINAE 1991-93
=750  \0$aLentiviruses$5IEN-M$0(DLC)sh 94005195

=LDR  01236cz  a2200337n  4500
=001  9880364017502441
=005  20141212211357.0
=008  900606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016085
=035  \\$aCBG6460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x100
=072  \\$aD27.$x505.$x954.$x796.$x170
=150  \\$aBronchoconstrictor Agents
=450  \\$wnnna$aAgents, Bronchial-Constricting
=450  \\$wnnna$aAgents, Bronchoconstrictor
=450  \\$aBronchial-Constricting Agents
=450  \\$wnnna$aBronchial Constricting Agents
=450  \\$wnnna$aBronchoconstrictor Effect
=450  \\$wnnna$aBronchoconstrictor Effects
=450  \\$wnnna$aBronchoconstrictors
=450  \\$wnnna$aEffect, Bronchoconstrictor
=450  \\$wnnna$aEffects, Bronchoconstrictor
=550  \\$wg$aAutonomic Agents
=550  \\$wg$aRespiratory System Agents
=550  \\$aBronchi
=550  \\$aBronchoconstriction
=667  \\$anote entry term BRONCHOCONSTRICTOR EFFECT: use only for the bronchoconstrictor effect of a chemical substance
=680  \\$iAgents causing the narrowing of the lumen of a bronchus or bronchiole.
=688  \\$a91
=750  \0$aBronchoconstrictor agents$5IEN$0(DLC)sh 85017083

=LDR  01155cz  a2200325n  4500
=001  9880364017602441
=005  20201216121254.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016083
=035  \\$aCBG6458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x249.$x680
=072  \\$aG1.$x60.$x249.$x730.$x700
=150  \\$aPlanets
=450  \\$wnnna$aPlanet
=550  \\$wg$aAstronomical Objects
=550  \\$wg$aSolar System
=550  \\$wh$aEarth, Planet
=550  \\$wh$aJupiter
=550  \\$wh$aMars
=550  \\$wh$aMercury, Planet
=550  \\$wh$aNeptune
=550  \\$wh$aSaturn
=550  \\$wh$aUranus
=550  \\$wh$aVenus
=550  \\$aExtraterrestrial Environment
=667  \\$ano qualif; does not include comets or meteors: METEOROIDS is available; natural satellites: index under SOLAR SYSTEM
=680  \\$iHeavenly bodies with their own motion among the stars, revolving, in the case of the solar system, around the sun, along the plane of the ecliptic. They are grouped into inner planets and outer planets, based on distance from the sun and common characteristics.
=688  \\$a91
=750  \2$aPlanets$5IEN

=LDR  00676cz  a2200205n  4500
=001  9880364017702441
=005  20141212211352.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016064
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x992
=150  \\$aVaginal Birth after Cesarean
=450  \\$wnnna$aVaginal Birth after Cesareans
=450  \\$wnnna$aVaginal Births after Cesarean
=550  \\$wg$aDelivery, Obstetric
=550  \\$aCesarean Section
=667  \\$aDF: VBAC
=680  \\$iDelivery of an infant through the vagina in a female who has had a prior cesarean section.
=688  \\$a91
=750  \0$aVaginal birth after Cesarean$5IEN$0(DLC)sh 92000347

=LDR  00629cz  a2200193n  4500
=001  9880364017802441
=005  20141212211351.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016062
=035  \\$aCBG6448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x710
=150  \\$aPorosity
=450  \\$wnnna$aPorosities
=550  \\$wg$aMechanical Phenomena
=667  \\$aalmost never IM
=680  \\$iCondition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance.
=688  \\$a91
=750  \0$aPorosity$5IEN$0(DLC)sh 85105017

=LDR  01033cz  a2200265n  4500
=001  9880364017902441
=005  20141212211350.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016059
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x700
=072  \\$aG11.$x427.$x760
=150  \\$aRange of Motion, Articular
=450  \\$wnnna$aFlexibility, Joint
=450  \\$wnnna$aJoint Flexibility
=450  \\$wnnna$aJoint Range of Motion
=450  \\$aPassive Range of Motion
=450  \\$wnnna$aRange of Motion
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wg$aPhysical Examination
=550  \\$wh$aArthrometry, Articular
=550  \\$aPliability
=680  \\$iThe distance and direction to which a bone joint can be extended. Range of motion is a function of the condition of the joints, muscles, and connective tissues involved. Joint flexibility can be improved through appropriate MUSCLE STRETCHING EXERCISES.
=688  \\$a91
=750  \0$aJoints$xRange of motion$5IEN$0(DLC)sh 85070664

=LDR  01097cz  a2200217n  4500
=001  9880364018002441
=005  20141212211349.0
=008  900323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016058
=035  \\$aCBG6444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x91.$x120
=150  \\$aAnalgesia, Patient-Controlled
=450  \\$wnnna$aAnalgesia, Patient Controlled
=450  \\$wnnna$aPatient-Controlled Analgesia
=450  \\$wnnna$aPatient Controlled Analgesia
=550  \\$wg$aAnalgesia
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRelief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).
=688  \\$a91
=750  \0$aPatient-controlled analgesia$5IEN-M$0(DLC)sh 93002701

=LDR  00725cz  a2200217n  4500
=001  9880364018102441
=005  20141212211347.0
=008  900212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016052
=035  \\$aCBG6438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x582
=150  \\$aProtozoan Vaccines
=450  \\$wnnna$aVaccines, Protozoan
=550  \\$wg$aVaccines
=550  \\$wh$aLeishmaniasis Vaccines
=550  \\$wh$aMalaria Vaccines
=667  \\$acoord IM with specific protozoon /immunol (IM)
=680  \\$iSuspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease.
=688  \\$a91
=750  \0$aProtozoan vaccines$5IEN$0(DLC)sh 88003766

=LDR  00370cz  a2200133n  4500
=001  9880364018202441
=005  20120717143454.0
=008  660101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBG3889HS
=035  \\$a(DNLM)D006967Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aHypersensitivity$xveterinary
=450  \\$aVeterinary Allergy$5IEN
=750  \0$aAllergy in animals$5IEN$0(DLC)sh 87000421

=LDR  00295cz  a2200109n  4500
=001  9880364018302441
=005  20120717143454.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D009765Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aObesity$xveterinary
=750  \0$aObesity in animals$5IEN$0(DLC)sh 99004541

=LDR  01113cz  a2200301n  4500
=001  9880364018402441
=005  20141212201111.0
=008  870508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004730
=035  \\$aCBG3515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x330
=072  \\$aA10.$x272.$x491.$x355
=150  \\$aEndothelium, Vascular
=450  \\$aCapillary Endothelium
=450  \\$wnnna$aCapillary Endotheliums
=450  \\$wnnna$aEndothelium, Capillary
=450  \\$wnnna$aEndotheliums, Capillary
=450  \\$wnnna$aEndotheliums, Vascular
=450  \\$aVascular Endothelium
=450  \\$wnnna$aVascular Endotheliums
=550  \\$wg$aBlood Vessels
=550  \\$wg$aEndothelium
=550  \\$wh$aPericytes
=550  \\$wh$aTunica Intima
=680  \\$iSingle pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components from interstitium to lumen; this function has been most intensively studied in the blood capillaries.
=688  \\$a88
=750  \0$aVascular endothelium$5IEN$0(DLC)sh 88005427

=LDR  00364cz  a2200133n  4500
=001  9880364018502441
=005  20120717143454.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBG2152HS
=035  \\$a(DNLM)D014599Q000098
=040  \\$aDNLM$cDNLM
=150  \\$aUterus$xblood supply
=450  \\$aUterine Circulation$5IEN
=750  \0$aUterine circulation$5IEN$0(DLC)sh 89003959

=LDR  02122cz  a2200589n  4500
=001  9880364018602441
=005  20200514112401.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016247
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x313.$x500.$x750.$x280
=072  \\$aL1.$x470
=150  \\$aInformation Storage and Retrieval
=450  \\$wnnna$aData File
=450  \\$wnnna$aData File, Machine-Readable
=450  \\$wnnna$aData Files
=450  \\$wnnna$aData Files, Machine-Readable
=450  \\$wnnna$aData Linkage
=450  \\$wnnna$aData Retrieval
=450  \\$wnnna$aData Storage
=450  \\$wnnna$aData Storage and Retrieval
=450  \\$wnnna$aData Source
=450  \\$wnnna$aData Sources
=450  \\$wnnna$aExtraction, Information
=450  \\$wnnna$aExtractions, Information
=450  \\$wnnna$aFiles, Machine-Readable Data
=450  \\$wnnna$aInformation Extraction
=450  \\$wnnna$aInformation Extractions
=450  \\$aInformation Retrieval
=450  \\$wnnna$aInformation Storage
=450  \\$wnnna$aMachine-Readable Data File
=450  \\$wnnna$aMachine Readable Data Files
=450  \\$wnnna$aMachine-Readable Data Files
=450  \\$wnnna$aRetrieval, Data
=450  \\$wnnna$aStorage, Data
=550  \\$wg$aInformation Science
=550  \\$wg$aMedical Informatics Applications
=550  \\$wh$aData Compression
=550  \\$wh$aData Mining
=550  \\$wh$aData Warehousing
=550  \\$wh$aDatabases as Topic
=550  \\$wh$aGrateful Med
=550  \\$wh$aHealth Information Interoperability
=550  \\$wh$aMEDLARS
=550  \\$wh$aMedlinePlus
=550  \\$wh$aPubMed
=550  \\$wh$aRxNorm
=550  \\$wh$aSearch Engine
=550  \\$wh$aWeb Browser
=680  \\$iOrganized activities related to the storage, location, search, and retrieval of information.
=688  \\$a1991; was see INFORMATION SYSTEMS 1982-1990; for DATA FILES use AUTOMATIC DATA PROCESSING, 1994-2015, for DATA SOURCES use DATA COLLECTION 1987-2015; for DATA LINKAGE use DATA COLLECTION 1989-2015
=750  \0$aInformation retrieval$5IEN$0(DLC)sh 85066148

=LDR  02068cz  a2200589n  4500
=001  9880364018702441
=005  20141212195336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001845
=035  \\$aCBF9047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89
=072  \\$aC5.$x116.$x70
=150  \\$aBone Cysts
=450  \\$wnnna$aBone Cyst
=450  \\$wnnna$aCyst, Bone
=450  \\$wnnna$aCyst, Solitary
=450  \\$wnnna$aCyst, Subchondral
=450  \\$wnnna$aCysts, Bone
=450  \\$wnnna$aCysts, Solitary
=450  \\$wnnna$aCysts, Subchondral
=450  \\$wnnna$aGanglia, Intra-Osseous
=450  \\$wnnna$aGanglia, Intra Osseous
=450  \\$aGanglia, Intraosseous
=450  \\$wnnna$aGanglias, Intra-Osseous
=450  \\$wnnna$aGanglias, Intraosseous
=450  \\$wnnna$aGanglion, Intra-Osseous
=450  \\$wnnna$aGanglion, Intra Osseous
=450  \\$wnnna$aGanglion, Intraosseous
=450  \\$wnnna$aGanglions, Intra-Osseous
=450  \\$wnnna$aIntra-Osseous Ganglia
=450  \\$wnnna$aIntra Osseous Ganglia
=450  \\$wnnna$aIntra-Osseous Ganglias
=450  \\$wnnna$aIntra-Osseous Ganglion
=450  \\$wnnna$aIntra Osseous Ganglion
=450  \\$wnnna$aIntra-Osseous Ganglions
=450  \\$wnnna$aIntraosseous Ganglia
=450  \\$wnnna$aIntraosseous Ganglias
=450  \\$aIntraosseous Ganglion
=450  \\$wnnna$aIntraosseous Ganglions
=450  \\$wnnna$aSolitary Cyst
=450  \\$aSolitary Cysts
=450  \\$wnnna$aSubchondral Cyst
=450  \\$aSubchondral Cysts
=550  \\$wg$aBone Diseases
=550  \\$wg$aCysts
=550  \\$wh$aBone Cysts, Aneurysmal
=550  \\$wh$aJaw Cysts
=667  \\$acoord IM with specific bone (IM)
=680  \\$iBenign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.
=688  \\$a80; was BONE CYST 1963-79
=750  \0$aBones$xCysts$5IEN

=LDR  00441cz  a2200133n  4500
=001  9880364018802441
=005  20060526082054.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D003165Q000172
=035  \\$aCBF7937HS
=040  \\$aDNLM$cDNLM
=150  \\$aComplement System Proteins$xdeficiency
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Complement _{dollar}x deficiency
=750  \0$aComplement deficiency (Immunology)$0(DLC) sh 85029355$5IEN

=LDR  00331cz  a2200121n  4500
=001  9880364018902441
=005  20120717143454.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1561HS
=035  \\$a(DNLM)D012046Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aRehabilitation$xnursing
=750  \0$aRehabilitation nursing$5IEN-M$0(DLC)sh 85112410

=LDR  00343cz  a2200121n  4500
=001  9880364019002441
=005  20120717143453.0
=008  720101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1558HS
=035  \\$a(DNLM)D014551Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aUrinary Tract$xradionuclide imaging
=750  \0$aRadioisotopes in urology$5IEN$0(DLC)sh 85110761

=LDR  00339cz  a2200121n  4500
=001  9880364019102441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1555HS
=035  \\$a(DNLM)D005123Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aEye$xradionuclide imaging
=750  \0$aRadioisotopes in ophthalmology$5IEN$0(DLC)sh 85110748

=LDR  00346cz  a2200121n  4500
=001  9880364019202441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1553HS
=035  \\$a(DNLM)D009420Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aNervous System$xradionuclide imaging
=750  \0$aRadioisotopes in neurology$5IEN$0(DLC)sh 85110745

=LDR  00339cz  a2200121n  4500
=001  9880364019302441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1549HS
=035  \\$a(DNLM)D007668Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aKidney$xradionuclide imaging
=750  \0$aRadioisotopes in nephrology$5IEN$0(DLC)sh 85110744

=LDR  00353cz  a2200121n  4500
=001  9880364019402441
=005  20120717143453.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1547HS
=035  \\$a(DNLM)D006402Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aHematologic Diseases$xradionuclide imaging
=750  \0$aRadioisotopes in hematology$5IEN$0(DLC)sh 85110737

=LDR  00338cz  a2200121n  4500
=001  9880364019502441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1543HS
=035  \\$a(DNLM)D006321Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aHeart$xradionuclide imaging
=750  \0$aRadioisotopes in cardiology$5IEN$0(DLC)sh 85110727

=LDR  00337cz  a2200121n  4500
=001  9880364019602441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1542HS
=035  \\$a(DNLM)D001842Q000530
=040  \\$aDNLM$cDNLM
=150  \\$aBone and Bones$xradiography
=750  \0$aRadiography in orthopedics$5IEN$0(DLC)sh 85110705

=LDR  00327cz  a2200121n  4500
=001  9880364019702441
=005  20120717143453.0
=008  780619\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1539HS
=035  \\$a(DNLM)D005333Q000530
=040  \\$aDNLM$cDNLM
=150  \\$aFetus$xradiography
=750  \0$aRadiography in obstetrics$5IEN$0(DLC)sh 85110704

=LDR  00318cz  a2200121n  4500
=001  9880364019802441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1257HS
=035  \\$a(DNLM)D005123Q000294
=040  \\$aDNLM$cDNLM
=150  \\$aEye$xinnervation
=750  \0$aNeuroophthalmology$5IEN$0(DLC)sh 85091111

=LDR  00322cz  a2200121n  4500
=001  9880364019902441
=005  20120717143453.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1242HS
=035  \\$a(DNLM)D007109Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aImmunity$xdrug effects
=750  \0$aImmunotoxicology$5IEN$0(DLC)sh 85064594

=LDR  00330cz  a2200121n  4500
=001  9880364020002441
=005  20120717143453.0
=008  670101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1147HS
=035  \\$a(DNLM)D003879Q000633
=040  \\$aDNLM$cDNLM
=150  \\$aDermatologic Agents$xtoxicity
=750  \0$aDermatotoxicology$5IEN$0(DLC)sh 85037104

=LDR  00331cz  a2200121n  4500
=001  9880364020102441
=005  20120717143452.0
=008  670101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF1145HS
=035  \\$a(DNLM)D003879Q000506
=040  \\$aDNLM$cDNLM
=150  \\$aDermatologic Agents$xpoisoning
=750  \0$aDermatotoxicology$5IEN$0(DLC)sh 85037104

=LDR  00327cz  a2200121n  4500
=001  9880364020202441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF0875HS
=035  \\$a(DNLM)D014054Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aTomography$xveterinary
=750  \0$aVeterinary tomography$5IEN$0(DLC)sh 90003606

=LDR  00343cz  a2200121n  4500
=001  9880364020302441
=005  20120717143452.0
=008  870316\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBF0873HS
=035  \\$a(DNLM)D003952Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDiagnostic Imaging$xveterinary
=750  \0$aVeterinary diagnostic imaging$5IEN$0(DLC)sh 90003605

=LDR  00399cz  a2200133n  4500
=001  9880364020402441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE9790HS
=035  \\$a(DNLM)D002319Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aCardiovascular System$xdrug effects
=450  \\$aCardiovascular Pharmacology$5IEN-M
=750  \0$aCardiovascular pharmacology$5IEN-M$0(DLC)sh 90001899

=LDR  00329cz  a2200121n  4500
=001  9880364020502441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE9789HS
=035  \\$a(DNLM)D002006Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aBrucellosis$xveterinary
=750  \0$aBrucellosis in animals$5IEN$0(DLC)sh 90002256

=LDR  00324cz  a2200121n  4500
=001  9880364020602441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7507HS
=035  \\$a(DNLM)D015032Q000172
=040  \\$aDNLM$cDNLM
=150  \\$aZinc$xdeficiency
=750  \0$aZinc deficiency diseases$5IEN$0(DLC)sh 85149858

=LDR  00338cz  a2200121n  4500
=001  9880364020702441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7493HS
=035  \\$a(DNLM)D014947Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aWounds and Injuries$xveterinary
=750  \0$aVeterinary traumatology$5IEN$0(DLC)sh 85143083

=LDR  00361cz  a2200133n  4500
=001  9880364020802441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE7487HS
=035  \\$a(DNLM)D014815Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aVitamins$xtherapeutic use
=450  \\$aVitamin Therapy$5IEN
=750  \0$aVitamin therapy$5IEN$0(DLC)sh 85144004

=LDR  00315cz  a2200121n  4500
=001  9880364020902441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7296HS
=035  \\$a(DNLM)D014780Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aViruses$xgenetics
=750  \0$aViral genetics$5IEN$0(DLC)sh 85143730

=LDR  00329cz  a2200121n  4500
=001  9880364021002441
=005  20120717143452.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7294HS
=035  \\$a(DNLM)D014777Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aVirus Diseases$xveterinary
=750  \0$aVeterinary virology$5IEN$0(DLC)sh 85143086

=LDR  00332cz  a2200121n  4500
=001  9880364021102441
=005  20120717143451.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7209HS
=035  \\$a(DNLM)D000820Q000276
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Diseases$ximmunology
=750  \0$aVeterinary immunology$5IEN$0(DLC)sh 85143040

=LDR  00397cz  a2200133n  4500
=001  9880364021202441
=005  20120717143451.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$aCBE7208HS
=035  \\$a(DNLM)D000828Q000382
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Population Groups$xmicrobiology
=450  \\$wnnoa$aAnimals$xmicrobiology$5IEN-HS
=750  \0$aVeterinary microbiology$5IEN$0(DLC)sh 85143055

=LDR  00326cz  a2200121n  4500
=001  9880364021302441
=005  20120717143451.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7207HS
=035  \\$a(DNLM)D000820Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Diseases$xnursing
=750  \0$aVeterinary nursing$5IEN$0(DLC)sh 85143059

=LDR  00336cz  a2200121n  4500
=001  9880364021402441
=005  20120717143451.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7206HS
=035  \\$a(DNLM)D000820Q000382
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Diseases$xmicrobiology
=750  \0$aVeterinary microbiology$5IEN$0(DLC)sh 85143055

=LDR  00328cz  a2200121n  4500
=001  9880364021502441
=005  20120717143451.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7158HS
=035  \\$a(DNLM)D014570Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aUrologic Diseases$xnursing
=750  \0$aUrological nursing$5IEN$0(DLC)sh 85141449

=LDR  00331cz  a2200121n  4500
=001  9880364021602441
=005  20120717143451.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE7103HS
=035  \\$a(DNLM)D014376Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aTuberculosis$xveterinary
=750  \0$aTuberculosis in animals$5IEN$0(DLC)sh 85138438

=LDR  00330cz  a2200121n  4500
=001  9880364021702441
=005  20120717143451.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE6645HS
=035  \\$a(DNLM)D014076Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aTooth Diseases$xveterinary
=750  \0$aVeterinary dentistry$5IEN$0(DLC)sh 85143016

=LDR  00389cz  a2200133n  4500
=001  9880364021802441
=005  20120717143451.0
=008  640901\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE6048HS
=035  \\$a(DNLM)D001334Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aAutomobile Driving$xeducation
=450  \\$aAutomobile Driver Education$5IEN
=750  \0$aAutomobile driver education$5IEN$0(DLC)sh 85010121

=LDR  01105cz  a2200241n  4500
=001  9880364021902441
=005  20141212210015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013522
=035  \\$aCBE6024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x956.$x692
=150  \\$aSurgery, Veterinary
=450  \\$aAnimals, Domestic$xsurgery$5IEN-M
=450  \\$aAnimals$xsurgery$5IEN-M
=450  \\$wnnna$aSurgeries, Veterinary
=450  \\$wnnna$aVeterinary Surgeries
=450  \\$wnnna$aVeterinary Surgery
=550  \\$wg$aVeterinary Medicine
=667  \\$aSPEC: SPEC qualif; see note on VETERINARY MEDICINE; DF: SURG VET
=680  \\$iA board-certified specialty of VETERINARY MEDICINE, requiring at least four years of special education, training, and practice of veterinary surgery after graduation from veterinary school. In the written, oral, and practical examinations candidates may choose either large or small animal surgery. (From AVMA Directory, 43d ed, p278)
=688  \\$a91(75); was see under VETERINARY MEDICINE 1975-90
=750  \0$aVeterinary surgery$5IEN$0(DLC)sh 85143080

=LDR  03012cz  a2200841n  4500
=001  9880364022002441
=005  20141212211414.0
=008  900507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x249
=072  \\$aG5.$x360.$x340.$x24.$x340.$x415.$x400
=150  \\$aGenes, Tumor Suppressor
=450  \\$wnnna$aAnti-Oncogene
=450  \\$wnnna$aAnti-Oncogenes
=450  \\$wnnna$aAnti Oncogenes
=450  \\$wnnna$aAntioncogene
=450  \\$aAntioncogenes
=450  \\$wnnna$aCancer Suppressor Gene
=450  \\$aCancer Suppressor Genes
=450  \\$wnnna$aEmerogene
=450  \\$aEmerogenes
=450  \\$wnnna$aGene, Cancer Suppressor
=450  \\$wnnna$aGene, Growth Suppressor
=450  \\$wnnna$aGene, Metastasis Suppressor
=450  \\$wnnna$aGene, Onco-Suppressor
=450  \\$wnnna$aGene, Tumor Suppressing
=450  \\$wnnna$aGene, Tumor Suppressor
=450  \\$aGenes, Cancer Suppressor
=450  \\$aGenes, Growth Suppressor
=450  \\$aGenes, Metastasis Suppressor
=450  \\$wnnna$aGenes, Onco-Suppressor
=450  \\$wnnna$aGenes, Onco Suppressor
=450  \\$wnnna$aGenes, Tumor Suppressing
=450  \\$wnnna$aGrowth Suppressor Gene
=450  \\$aGrowth Suppressor Genes
=450  \\$wnnna$aMetastasis Suppressor Gene
=450  \\$aMetastasis Suppressor Genes
=450  \\$wnnna$aOnco-Suppressor Gene
=450  \\$wnnna$aOnco-Suppressor Genes
=450  \\$wnnna$aOncogene, Recessive
=450  \\$wnnna$aOncogenes, Recessive
=450  \\$wnnna$aRecessive Oncogene
=450  \\$wnnna$aRecessive Oncogenes
=450  \\$wnnna$aSuppressor Gene, Cancer
=450  \\$wnnna$aSuppressor Gene, Growth
=450  \\$wnnna$aSuppressor Gene, Metastasis
=450  \\$wnnna$aSuppressor Genes, Cancer
=450  \\$wnnna$aSuppressor Genes, Growth
=450  \\$wnnna$aSuppressor Genes, Metastasis
=450  \\$wnnna$aTumor Suppressing Gene
=450  \\$wnnna$aTumor Suppressing Genes
=450  \\$wnnna$aTumor Suppressor Gene
=450  \\$aTumor Suppressor Genes
=550  \\$wg$aGenes, Neoplasm
=550  \\$wg$aGenes, Recessive
=550  \\$wh$aGenes, APC
=550  \\$wh$aGenes, BRCA1
=550  \\$wh$aGenes, BRCA2
=550  \\$wh$aGenes, DCC
=550  \\$wh$aGenes, MCC
=550  \\$wh$aGenes, Neurofibromatosis 1
=550  \\$wh$aGenes, Neurofibromatosis 2
=550  \\$wh$aGenes, p16
=550  \\$wh$aGenes, p53
=550  \\$wh$aGenes, Retinoblastoma
=550  \\$wh$aGenes, Wilms Tumor
=550  \\$aNeoplasms
=550  \\$aTumor Suppressor Proteins
=667  \\$aManual 24.4.4.3
=680  \\$iGenes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible.
=688  \\$a2002 (1991)
=750  \0$aAntioncogenes$5IEN$0(DLC)sh 90002154

=LDR  00340cz  a2200121n  4500
=001  9880364022102441
=005  20120717143450.0
=008  680101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5950HS
=035  \\$a(DNLM)D001265Q000534
=040  \\$aDNLM$cDNLM
=150  \\$aAthletic Injuries$xrehabilitation
=750  \0$aSports physical therapy$5IEN$0(DLC)sh 89002576

=LDR  00327cz  a2200121n  4500
=001  9880364022202441
=005  20120717143450.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5946HS
=035  \\$a(DNLM)D013280Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aStomatitis$xveterinary
=750  \0$aStomatitis in animals$5IEN$0(DLC)sh 85128279

=LDR  00323cz  a2200121n  4500
=001  9880364022302441
=005  20120717143450.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5861HS
=035  \\$a(DNLM)D013064Q000628
=040  \\$aDNLM$cDNLM
=150  \\$aSpeech Disorders$xtherapy
=750  \0$aSpeech therapy$5IEN$0(DLC)sh 85126455

=LDR  00327cz  a2200121n  4500
=001  9880364022402441
=005  20120717143450.0
=008  781221\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5858HS
=035  \\$a(DNLM)D001193Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aArytenoid Cartilage$xsurgery
=750  \0$aArytenoidectomy$5IEN$0(DLC)sh 85008504

=LDR  00335cz  a2200121n  4500
=001  9880364022502441
=005  20120717143450.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5765HS
=035  \\$a(DNLM)D013053Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aSpectrophotometry$xinstrumentation
=750  \0$aSpectrophotometer$5IEN$0(DLC)sh 85126417

=LDR  00352cz  a2200121n  4500
=001  9880364022602441
=005  20120717143450.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5593HS
=035  \\$a(DNLM)D012947Q000458
=040  \\$aDNLM$cDNLM
=150  \\$aSocial Work$xorganization & administration
=750  \0$aSocial work administration$5IEN$0(DLC)sh 85124085

=LDR  00327cz  a2200121n  4500
=001  9880364022702441
=005  20120717143450.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5589HS
=035  \\$a(DNLM)D012947Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aSocial Work$xeducation
=750  \0$aSocial work education$5IEN$0(DLC)sh 85124086

=LDR  00331cz  a2200121n  4500
=001  9880364022802441
=005  20120717143449.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5576HS
=035  \\$a(DNLM)D012871Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aSkin Diseases$xveterinary
=750  \0$aVeterinary dermatology$5IEN$0(DLC)sh 85143017

=LDR  00326cz  a2200121n  4500
=001  9880364022902441
=005  20120717143449.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5575HS
=035  \\$a(DNLM)D012871Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aSkin Diseases$xnursing
=750  \0$aDermatologic nursing$5IEN$0(DLC)sh 85037088

=LDR  00375cz  a2200133n  4500
=001  9880364023002441
=005  20120717143449.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE5564HS
=035  \\$a(DNLM)D012871Q000188
=040  \\$aDNLM$cDNLM
=150  \\$aSkin Diseases$xdrug therapy
=450  \\$aDermatopharmacology$5IEN-M
=750  \0$aDermatopharmacology$5IEN-M$0(DLC)sh 85037098

=LDR  00334cz  a2200121n  4500
=001  9880364023102441
=005  20120717143449.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE5562HS
=035  \\$a(DNLM)D012871Q000139
=040  \\$aDNLM$cDNLM
=150  \\$aSkin Diseases$xchemically induced
=750  \0$aDermatotoxicology$5IEN$0(DLC)sh 85037104

=LDR  00366cz  a2200133n  4500
=001  9880364023202441
=005  20120717143449.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE5559HS
=035  \\$a(DNLM)D012867Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aSkin$xdrug effects
=450  \\$aDermatopharmacology$5IEN-M
=750  \0$aDermatopharmacology$5IEN-M$0(DLC)sh 85037098

=LDR  00421cz  a2200133n  4500
=001  9880364023302441
=005  20120717143449.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D012735Q000628
=035  \\$aCBE5451HS
=040  \\$aDNLM$cDNLM
=150  \\$aSexual Dysfunction, Physiological$xtherapy
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Sex Disorders _{dollar}x therapy
=750  \0$aSex therapy$5IEN$0(DLC)sh 85120674

=LDR  00346cz  a2200121n  4500
=001  9880364023402441
=005  20120717143449.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE4723HS
=035  \\$a(DNLM)D012140Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aRespiratory Tract Diseases$xnursing
=750  \0$aRespiratory disease nursing$5IEN$0(DLC)sh 85113190

=LDR  00391cz  a2200133n  4500
=001  9880364023502441
=005  20120717143449.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$aCBE4367HS
=035  \\$a(DNLM)D000828Q000502
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Population Groups$xphysiology
=450  \\$wnnoa$aAnimals$xphysiology$5IEN-HS
=750  \0$aVeterinary physiology$5IEN$0(DLC)sh 85143069

=LDR  00391cz  a2200133n  4500
=001  9880364023602441
=005  20120717143449.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$aCBE4366HS
=035  \\$a(DNLM)D000828Q000276
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Population Groups$ximmunology
=450  \\$wnnoa$aAnimals$ximmunology$5IEN-HS
=750  \0$aVeterinary immunology$5IEN$0(DLC)sh 85143040

=LDR  00562cz  a2200181n  4500
=001  9880364023702441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE4176HS
=035  \\$a(DNLM)D000758Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aAnesthesia$xveterinary
=450  \\$aAnesthesia, Animal$5IEN-M
=450  \\$aAnesthesia, Veterinary$5IEN-M
=450  \\$aAnimal Anesthesia$5IEN-M
=450  \\$aVeterinary Anesthesia$5IEN-M
=750  \0$aVeterinary anesthesia$5IEN-M$0(DLC)sh 85004968
=750  \0$aAnimal anesthesia$5IEN-M$0(DLC)sh 85005160

=LDR  00329cz  a2200121n  4500
=001  9880364023802441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE3535HS
=035  \\$a(DNLM)D011859Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aRadiography$xveterinary
=750  \0$aVeterinary radiography$5IEN$0(DLC)sh 85143073

=LDR  00932cz  a2200229n  4500
=001  9880364023902441
=005  20141212211132.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x300.$x500
=072  \\$aG7.$x610.$x240.$x300.$x500
=150  \\$aDiet, Macrobiotic
=450  \\$wnnna$aDiets, Macrobiotic
=450  \\$wnnna$aMacrobiotic Diet
=450  \\$wnnna$aMacrobiotic Diets
=550  \\$wg$aDiet, Vegetarian
=550  \\$aHealth Food
=667  \\$acoord with specific disease /diet ther
=680  \\$iAn approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese YIN-YANG principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods.
=688  \\$a90
=750  \0$aMacrobiotic diet$5IEN$0(DLC)sh 85079431

=LDR  01521cz  a2200385n  4500
=001  9880364024002441
=005  20141212211131.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015619
=035  \\$aCBD0656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x695
=072  \\$aC16.$x131.$x740
=150  \\$aRespiratory System Abnormalities
=450  \\$wnnna$aAbnormalities, Respiratory System
=450  \\$wnnna$aAbnormality, Respiratory System
=450  \\$aRespiratory System$xabnormalities
=450  \\$wnnna$aRespiratory System Abnormality
=450  \\$wnnna$aSystem Abnormalities, Respiratory
=450  \\$wnnna$aSystem Abnormality, Respiratory
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aBronchogenic Cyst
=550  \\$wh$aBronchopulmonary Sequestration
=550  \\$wh$aChoanal Atresia
=550  \\$wh$aCystic Adenomatoid Malformation of Lung, Congenital
=550  \\$wh$aKartagener Syndrome
=550  \\$wh$aLaryngocele
=550  \\$wh$aLaryngostenosis
=550  \\$wh$aScimitar Syndrome
=550  \\$wh$aTracheobronchomegaly
=667  \\$afor congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: RESPIRATORY SYSTEM ABNORM
=680  \\$iCongenital structural abnormalities of the respiratory system.
=688  \\$a98; use explode 1990-97
=750  \0$aRespiratory organs$xAbnormalities$5IEN-M$0(DLC)sh2007006640

=LDR  00738cz  a2200229n  4500
=001  9880364024102441
=005  20171012162722.0
=008  890413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015607
=035  \\$aCBD0645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x750
=150  \\$aStents
=450  \\$wnnna$aStent
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aDrug-Eluting Stents
=550  \\$wh$aSelf Expandable Metallic Stents
=550  \\$aSplints
=667  \\$ado not use /util except by MeSH definition
=680  \\$iDevices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.
=688  \\$a90
=750  \0$aStents (Surgery)$5IEN-M$0(DLC)sh 85127966

=LDR  00889cz  a2200217n  4500
=001  9880364024202441
=005  20141212211125.0
=008  890703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015603
=035  \\$aCBD0643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x397
=150  \\$aKeratinocytes
=450  \\$wnnna$aKeratinocyte
=550  \\$wg$aEpithelial Cells
=550  \\$aKeratins
=550  \\$aSkin
=667  \\$aepidermal cells synthesizing keratin; A 11 qualif
=680  \\$iEpidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.
=688  \\$a90
=750  \0$aKeratinocytes$0(DLC) sh 85072034$5IEN

=LDR  00696cz  a2200193n  4500
=001  9880363882902441
=005  20141212210134.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013756
=035  \\$aCBA7087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x950
=150  \\$aTetraethyl Lead
=450  \\$wnnna$aLead, Tetraethyl
=450  \\$wnnna$aTetraethyllead
=550  \\$wg$aOrganometallic Compounds
=680  \\$iA highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin.
=688  \\$a91(76); was see under ORGANOMETALLIC COMPOUNDS 1976-90
=750  \0$aTetraethyllead$5IEN$0(DLC)sh 87006520

=LDR  01127cz  a2200337n  4500
=001  9880363883002441
=005  20210217132124.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013754
=035  \\$aCBA7085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x900
=072  \\$aD4.$x615.$x562.$x900
=150  \\$aTetracyclines
=450  \\$aMorphocycline$5IEN-M
=450  \\$aTetracycline$xanalogs & derivatives
=550  \\$wg$aNaphthacenes
=550  \\$wh$aChlortetracycline
=550  \\$wh$aDemeclocycline
=550  \\$wh$aDoxycycline
=550  \\$wh$aLymecycline
=550  \\$wh$aMethacycline
=550  \\$wh$aMinocycline
=550  \\$wh$aOxytetracycline
=550  \\$wh$aRolitetracycline
=550  \\$wh$aTetracycline
=550  \\$wh$aTigecycline
=667  \\$aTETRACYCLINE is also available
=680  \\$iClosely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
=688  \\$a76; was NON MESH before 1976
=750  \0$aTetracyclines$5IEN$0(DLC)sh 85134191

=LDR  00930cz  a2200289n  4500
=001  9880363883102441
=005  20141212210133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013752
=035  \\$aCBA7083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x900.$x875
=072  \\$aD4.$x615.$x562.$x900.$x875
=150  \\$aTetracycline
=450  \\$wnnna$a4-Epitetracycline
=450  \\$wnnna$a4 Epitetracycline
=450  \\$wnnna$aAchromycin
=450  \\$wnnna$aAchromycin V
=450  \\$wnnna$aHostacyclin
=450  \\$wnnna$aSustamycin
=450  \\$wnnna$aTetrabid
=450  \\$wnnna$aTetracycline Hydrochloride
=450  \\$wnnna$aTetracycline Monohydrochloride
=450  \\$wnnna$aTopicycline
=550  \\$wg$aTetracyclines
=680  \\$iA naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
=750  \0$aTetracycline$5IEN$0(DLC)sh 85134190

=LDR  01546cz  a2200325n  4500
=001  9880363883302441
=005  20141212210132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013746
=035  \\$aCBA7077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x875
=072  \\$aC18.$x452.$x174.$x509.$x700
=072  \\$aC23.$x888.$x592.$x608.$x875
=150  \\$aTetany
=450  \\$wnnna$aNeonatal Tetanies
=450  \\$wnnna$aNeonatal Tetany
=450  \\$aSpasmophilia
=450  \\$wnnna$aSpasmophilias
=450  \\$wnnna$aTetanies
=450  \\$wnnna$aTetanies, Neonatal
=450  \\$wnnna$aTetanilla
=450  \\$wnnna$aTetanillas
=450  \\$aTetany, Neonatal
=550  \\$wg$aHypocalcemia
=550  \\$wg$aNeuromuscular Manifestations
=667  \\$ado not confuse with TETANUS, a Clostridium tetani infection; tetanic spasm of muscle = SPASM; tetanic contraction = MUSCLE CONTRACTION; coordinate with cause if given
=680  \\$iA disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1490)
=688  \\$aSPASMOPHILIA was heading 1963-76
=750  \0$aTetany$0(DLC) sh 85134169$5IEN

=LDR  01311cz  a2200301n  4500
=001  9880363883402441
=005  20141212210131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013744
=035  \\$aCBA7075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97.$x872
=072  \\$aD23.$x946.$x123.$x893
=150  \\$aTetanus Toxin
=450  \\$aClostridial Neurotoxin
=450  \\$aClostridium tetani Toxin
=450  \\$wnnna$aNeurotoxin, Clostridial
=450  \\$wnnna$aTetanus Toxins
=450  \\$wnnna$aToxin, Clostridium tetani
=450  \\$wnnna$aToxin, Tetanus
=450  \\$wnnna$aToxins, Tetanus
=550  \\$wg$aBacterial Proteins
=550  \\$wg$aBacterial Toxins
=550  \\$aClostridium tetani
=667  \\$a/antag permitted but consider also TETANUS ANTITOXIN
=680  \\$iProtein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.
=688  \\$a65
=750  \0$aTetanus toxin$5IEN$0(DLC)sh 88005049

=LDR  00875cz  a2200253n  4500
=001  9880363883502441
=005  20141212210130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013743
=035  \\$aCBA7074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x301.$x849
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573.$x601.$x849
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x301.$x849
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x301.$x849
=072  \\$aD20.$x215.$x121.$x824
=150  \\$aTetanus Antitoxin
=450  \\$wnnna$aAntitoxin, Tetanus
=550  \\$wg$aAntitoxins
=550  \\$aTetanus Toxin
=550  \\$aTetanus Toxoid
=667  \\$afor therapy: for prevention index under TETANUS TOXOID
=680  \\$iAn antitoxin used for the treatment of TETANUS.
=750  \0$aTetanus antitoxin$5IEN$0(DLC)sh 85134168

=LDR  01037cz  a2200181n  4500
=001  9880363883602441
=005  20141212210130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013742
=035  \\$aCBA7073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x222.$x864
=150  \\$aTetanus
=550  \\$wg$aClostridium Infections
=550  \\$aTrismus
=667  \\$acaused by Clostridium tetani; do not confuse with TETANY; do not use for tonic spasm of muscle ( = SPASM) or for tetanic contraction ( = MUSCLE CONTRACTION)
=680  \\$iA disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.
=750  \0$aTetanus$5IEN$0(DLC)sh 85134166

=LDR  02891cz  a2200697n  4500
=001  9880363883702441
=005  20141212210129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013739
=035  \\$aCBA7070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54.$x79.$x429.$x824
=072  \\$aD6.$x472.$x334.$x851.$x968.$x984
=150  \\$aTestosterone
=450  \\$wnnna$a17-beta-Hydroxy-4-Androsten-3-one
=450  \\$wnnna$a17 beta Hydroxy 4 Androsten 3 one
=450  \\$wnnna$a17-beta-Hydroxy-8 alpha-4-Androsten-3-one
=450  \\$wnnna$a17 beta Hydroxy 8 alpha 4 Androsten 3 one
=450  \\$wnnna$a8-Isotestosterone
=450  \\$wnnna$a8 Isotestosterone
=450  \\$wnnna$aAndroderm
=450  \\$wnnna$aAndroGel
=450  \\$wnnna$aAndropatch
=450  \\$wnnna$aAndrotop
=450  \\$wnnna$aAstraZeneca Brand of Testosterone
=450  \\$wnnna$aAuxilium Pharmaceuticals Inc. Brand of Testosterone
=450  \\$wnnna$aBartor Brand of Testosterone
=450  \\$wnnna$aCEPA Brand of Testosterone
=450  \\$wnnna$aDr. Kade Brand of Testosterone
=450  \\$wnnna$aFaulding Brand of Testosterone
=450  \\$wnnna$aFerring Brand of Testosterone
=450  \\$wnnna$aGlaxoSmithKline Brand of Testosterone
=450  \\$wnnna$aHauck Brand of Testosterone
=450  \\$wnnna$aHisterone
=450  \\$wnnna$aOrtho Brand of Testosterone
=450  \\$wnnna$aPaladin Brand of Testosterone
=450  \\$wnnna$aPasadena Brand of Testosterone
=450  \\$wnnna$aSchering Brand of Testosterone
=450  \\$wnnna$aSmithKline Beecham Brand of Testosterone
=450  \\$wnnna$aSolvay Brand of Testosterone
=450  \\$wnnna$aSterotate
=450  \\$wnnna$aSustanon
=450  \\$wnnna$aTestim
=450  \\$wnnna$aTestoderm
=450  \\$wnnna$aTestolin
=450  \\$wnnna$aTestopel
=450  \\$wnnna$aTestosterone Sulfate
=450  \\$wnnna$aUlmer Brand of Testosterone
=450  \\$wnnna$aUnimed Brand of Testosterone
=450  \\$wnnna$aWatson Brand of Testosterone
=550  \\$wg$aAndrostenols
=550  \\$wg$aTestosterone Congeners
=550  \\$wh$aEpitestosterone
=550  \\$wh$aHydroxytestosterones
=550  \\$wh$aMethenolone
=550  \\$wh$aMethyltestosterone
=550  \\$wh$aTestosterone Propionate
=667  \\$aTESTOSTERONE PROPIONATE is also available
=680  \\$iA potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
=688  \\$a1963; for SUSTANON use TESTOSTERONE (NM) 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965
=750  \0$aTestosterone$5IEN$0(DLC)sh 85134159

=LDR  01203cz  a2200289n  4500
=001  9880363883802441
=005  20141212210128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013737
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x849
=072  \\$aA5.$x360.$x576.$x782
=072  \\$aA6.$x407.$x312.$x782
=150  \\$aTestis
=360  \\$iconsider also terms at$aORCHI-
=450  \\$wnnna$aTestes
=450  \\$wnnna$aTesticle
=450  \\$aTesticles
=550  \\$wg$aGenitalia, Male
=550  \\$wg$aGonads
=550  \\$wh$aLeydig Cells
=550  \\$wh$aRete Testis
=550  \\$wh$aSeminiferous Tubules
=550  \\$wh$aSertoli Cells
=667  \\$atorsion = SPERMATIC CORD TORSION; inflammation = ORCHITIS; /abnorm: agenesis or dysgenesis: coord TESTIS /abnorm (IM) with GONADAL DYSGENESIS (IM); /cytol: consider also LEYDIG CELLS; /surg is probably ORCHIECTOMY; excision = ORCHIECTOMY
=680  \\$iThe male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.
=750  \0$aTestis$5IEN$0(DLC)sh 85134157

=LDR  02017cz  a2200601n  4500
=001  9880363883902441
=005  20141212210127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013736
=035  \\$aCBA7067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x762
=072  \\$aC4.$x588.$x945.$x440.$x915
=072  \\$aC12.$x294.$x260.$x937
=072  \\$aC12.$x758.$x409.$x937
=072  \\$aC19.$x344.$x762
=072  \\$aC19.$x391.$x829.$x782
=150  \\$aTesticular Neoplasms
=450  \\$aCancer of Testis
=450  \\$aCancer of the Testes
=450  \\$wnnna$aCancer of the Testis
=450  \\$wnnna$aCancer, Testicular
=450  \\$wnnna$aCancer, Testis
=450  \\$wnnna$aCancers, Testicular
=450  \\$wnnna$aCancers, Testis
=450  \\$wnnna$aNeoplasm, Testicular
=450  \\$wnnna$aNeoplasm, Testis
=450  \\$wnnna$aNeoplasms, Testicular
=450  \\$wnnna$aNeoplasms, Testis
=450  \\$wnnna$aRete Testis Tumor
=450  \\$wnnna$aRete Testis Tumors
=450  \\$aTesticular Cancer
=450  \\$wnnna$aTesticular Cancers
=450  \\$wnnna$aTesticular Neoplasm
=450  \\$wnnna$aTesticular Tumors
=450  \\$aTestis Cancer
=450  \\$wnnna$aTestis Cancers
=450  \\$wnnna$aTestis Neoplasm
=450  \\$wnnna$aTestis Neoplasms
=450  \\$wnnna$aTestis Tumor, Rete
=450  \\$wnnna$aTestis Tumors, Rete
=450  \\$wnnna$aTumor of Rete Testis
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aGenital Neoplasms, Male
=550  \\$wg$aTesticular Diseases
=550  \\$wh$aSertoli-Leydig Cell Tumor
=550  \\$aGerminoma
=667  \\$acoordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
=688  \\$a1963
=688  \\$aRETE CELL TUMOR was heading 1963-83
=750  \0$aTestis$xCancer$5IEN-M$0(DLC)sh2010010377
=750  \0$aTestis$xTumors$0(IEN)380666$5IEN-M

=LDR  00644cz  a2200217n  4500
=001  9880363884002441
=005  20141212210127.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013735
=035  \\$aCBA7066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x984
=150  \\$aTesticular Hormones
=450  \\$wnnna$aHormones, Testicular
=550  \\$wg$aGonadal Hormones
=550  \\$wh$aAnti-Mullerian Hormone
=667  \\$a/biosyn /physiol permitted
=680  \\$iHormones produced in the testis.
=688  \\$a75
=750  \0$81$wb$aTestis$5IEN$0(DLC)sh 85134157
=750  \0$81$wb$aHormones, Sex$5IEN-HS$0(DLC)sh 85061983

=LDR  00809cz  a2200277n  4500
=001  9880363884102441
=005  20141212210125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013733
=035  \\$aCBA7064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x829
=072  \\$aC19.$x391.$x829
=150  \\$aTesticular Diseases
=450  \\$wnnna$aDisease, Testicular
=450  \\$wnnna$aDiseases, Testicular
=450  \\$wnnna$aTesticular Disease
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aGonadal Disorders
=550  \\$wh$aCryptorchidism
=550  \\$wh$aOrchitis
=550  \\$wh$aTesticular Neoplasms
=667  \\$ainflammatory disease = ORCHITIS
=680  \\$iPathological processes of the TESTIS.
=688  \\$a66
=750  \0$aTestis$xDiseases$5IEN$0(DLC)sh 85134158

=LDR  00597cz  a2200193n  4500
=001  9880363884202441
=005  20141212210125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013731
=035  \\$aCBA7062HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x875.$x864
=150  \\$aTerritoriality
=450  \\$wnnna$aTerritorialities
=550  \\$wg$aSpatial Behavior
=667  \\$ano qualif
=680  \\$iBehavior in defense of an area against another individual or individuals primarily of the same species.
=688  \\$a68
=750  \0$aTerritoriality (Zoology)$5IEN$0(DLC)sh 85134108

=LDR  00832cz  a2200229n  4500
=001  9880363884302441
=005  20141212210124.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013730
=035  \\$aCBA7061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x805
=150  \\$aTerphenyl Compounds
=450  \\$wnnna$aCompounds, Terphenyl
=450  \\$wnnna$aCompounds, Triphenyl
=450  \\$aTriphenyl Compounds
=550  \\$wg$aBenzene Derivatives
=550  \\$wh$aPolychloroterphenyl Compounds
=667  \\$aDF: TERPHENYL CPDS
=680  \\$iCompounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed.
=688  \\$a75
=750  \0$aTerphenyl$5IEN$0(DLC)sh 85134048

=LDR  00950cz  a2200337n  4500
=001  9880363884402441
=005  20201123172845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013729
=035  \\$aCBA7060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849
=150  \\$aTerpenes
=450  \\$aCarvacrol$5IEN-M
=450  \\$wnnna$aIsoprenoids
=450  \\$aPolychloropinene$5IEN-M
=450  \\$wnnna$aTerpenoids
=550  \\$wg$aHydrocarbons
=550  \\$wh$aCannabinoids
=550  \\$wh$aCarotenoids
=550  \\$wh$aDiterpenes
=550  \\$wh$aDolichols
=550  \\$wh$aGefarnate
=550  \\$wh$aHemiterpenes
=550  \\$wh$aMonoterpenes
=550  \\$wh$aPolyisoprenyl Phosphates
=550  \\$wh$aSesquiterpenes
=550  \\$wh$aSesterterpenes
=550  \\$wh$aTriterpenes
=680  \\$iA class of compounds composed of repeating 5-carbon units of HEMITERPENES.
=750  \0$aTerpenes$5IEN$0(DLC)sh 85134045

=LDR  01101cz  a2200325n  4500
=001  9880363884502441
=005  20141212210123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013727
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x905
=072  \\$aN2.$x421.$x585.$x905
=150  \\$aTerminal Care
=450  \\$wnnna$aCare End, Life
=450  \\$wnnna$aCare Ends, Life
=450  \\$wnnna$aCare, Terminal
=450  \\$wnnna$aEnd of Life Care
=450  \\$wnnna$aLife Care End
=450  \\$wnnna$aLife Care Ends
=550  \\$wg$aPatient Care
=550  \\$wh$aEuthanasia
=550  \\$wh$aHospice Care
=550  \\$wh$aResuscitation Orders
=550  \\$wh$aSuicide, Assisted
=550  \\$aAdvance Care Planning
=550  \\$aDeath
=667  \\$amedical & nursing care for the patient; TERMINALLY ILL refers to the patient; also available is HOSPICE CARE (palliative & supportive care for the patient & family)
=680  \\$iMedical and nursing care of patients in the terminal stage of an illness.
=688  \\$a68(64)
=750  \0$aTerminal care$5IEN-M$0(DLC)sh 85134007

=LDR  00710cz  a2200193n  4500
=001  9880363884602441
=005  20141212210122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013725
=035  \\$aCBA7056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x968
=072  \\$aD1.$x268.$x558.$x362.$x968
=072  \\$aD1.$x552.$x550.$x399.$x968
=150  \\$aTerbium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Tb-159; Tb-147-158, 160-164 = TERBIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iTerbium. An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.
=750  \0$aTerbium$5IEN$0(DLC)sh 85133986

=LDR  01925cz  a2200457n  4500
=001  9880363884702441
=005  20141212210122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013724
=035  \\$aCBA7055HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x910
=150  \\$aTeratoma
=450  \\$wnnna$aBenign Teratoma
=450  \\$wnnna$aBenign Teratomas
=450  \\$aDysembryoma
=450  \\$wnnna$aDysembryomas
=450  \\$wnnna$aImmature Teratoma
=450  \\$wnnna$aImmature Teratomas
=450  \\$wnnna$aMalignant Teratoma
=450  \\$wnnna$aMalignant Teratomas
=450  \\$aTeratoid Tumor
=450  \\$wnnna$aTeratoid Tumors
=450  \\$wnnna$aTeratoma, Benign
=450  \\$aTeratoma, Cystic
=450  \\$wnnna$aTeratoma, Immature
=450  \\$wnnna$aTeratoma, Malignant
=450  \\$aTeratoma, Mature
=450  \\$wnnna$aTeratomas
=450  \\$wnnna$aTeratomas, Benign
=450  \\$wnnna$aTeratomas, Immature
=450  \\$wnnna$aTeratomas, Malignant
=450  \\$wnnna$aTumor, Teratoid
=450  \\$wnnna$aTumors, Teratoid
=550  \\$wg$aNeoplasms, Germ Cell and Embryonal
=550  \\$wh$aDermoid Cyst
=550  \\$wh$aStruma Ovarii
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
=688  \\$a82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC & TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84
=750  \0$aTeratoma$5IEN$0(DLC)sh 85133985

=LDR  00828cz  a2200241n  4500
=001  9880363884802441
=005  20141212210121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013723
=035  \\$aCBA7054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x864
=150  \\$aTeratogens
=450  \\$aEmbryotoxins
=450  \\$aFetotoxins
=450  \\$aTeratogenic Agents$5IEN
=550  \\$wg$aNoxae
=550  \\$aAbnormalities, Drug-Induced
=550  \\$aTeratogenesis
=667  \\$abe careful: "teratogenic effect" of a drug or chem is probably ABNORMALITIES, DRUG-INDUCED + drug or chem named (with required qualif) & not TERATOGENS
=680  \\$iAn agent that causes the production of physical defects in the developing embryo.
=688  \\$a75
=750  \0$aTeratogenic agents$5IEN$0(DLC)sh 85133984

=LDR  01028cz  a2200193n  4500
=001  9880363884902441
=005  20141212210120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013717
=035  \\$aCBA7048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x869.$x870
=150  \\$aTenosynovitis
=450  \\$wnnna$aTenosynovitides
=550  \\$wg$aTendinopathy
=550  \\$wh$aTendon Entrapment
=667  \\$ado not confuse with TENDINITIS (inflammation of tendon) or SYNOVITIS (inflammation of synovial membrane); STENOSING TENOSYNOVITIS see TENDON ENTRAPMENT is available
=680  \\$iInflammation of the synovial lining of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the hand, wrist, shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced.
=750  \0$aTenosynovitis$0(DLC) sh 85133921$5IEN

=LDR  01430cz  a2200325n  4500
=001  9880363885002441
=005  20180612150118.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013716
=035  \\$aCBA7047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x869.$x435.$x500
=072  \\$aC26.$x88.$x890
=072  \\$aC26.$x874.$x800.$x500.$x500
=150  \\$aTennis Elbow
=450  \\$wnnna$aElbow, Tennis
=450  \\$wnnna$aElbows, Tennis
=450  \\$wnnna$aEpicondylitides, Lateral Humeral
=450  \\$aEpicondylitis, Lateral Humeral
=450  \\$wnnna$aHumeral Epicondylitides, Lateral
=450  \\$wnnna$aHumeral Epicondylitis, Lateral
=450  \\$wnnna$aLateral Humeral Epicondylitides
=450  \\$wnnna$aLateral Humeral Epicondylitis
=450  \\$wnnna$aTennis Elbows
=550  \\$wg$aArm Injuries
=550  \\$wg$aElbow Tendinopathy
=667  \\$ain "housewives, artisans & violinists" as well as in tennis players; do not coord with TENNIS (NIM) unless the sport is particularly discussed; do not coord with ATHLETIC INJURIES (IM) unless tennis elbow is discussed as an athletic inj
=680  \\$iA condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs in tennis players as well as housewives, artisans, and violinists.
=688  \\$a82
=750  \0$aTennis elbow$5IEN$0(DLC)sh 85133907

=LDR  00629cz  a2200181n  4500
=001  9880363885102441
=005  20141212210119.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013715
=035  \\$aCBA7046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x600.$x900
=150  \\$aTennis
=550  \\$wg$aRacquet Sports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted
=680  \\$iA game played by two or four players with rackets and an elastic ball on a level court divided by a low net.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aTennis$5IEN$0(DLC)sh 85133890

=LDR  00644cz  a2200217n  4500
=001  9880363885202441
=005  20141212210118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013712
=035  \\$aCBA7043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x69.$x615
=150  \\$aTenebrio
=450  \\$aMealworm
=450  \\$wnnna$aMealworms
=450  \\$wnnna$aTenebrios
=550  \\$wg$aBeetles
=667  \\$abeetle; /microbiol /parasitol /virol permitted
=680  \\$iA genus of beetles which infests grain products. Its larva is called mealworm.
=688  \\$a72
=750  \0$aTenebrio$5IEN$0(DLC)sh 85133850

=LDR  01647cz  a2200361n  4500
=001  9880363885302441
=005  20180717100707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013710
=035  \\$aCBA7041HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x880
=150  \\$aTendons
=450  \\$wnnna$aPara-Articular Tendon
=450  \\$wnnna$aPara-Articular Tendons
=450  \\$wnnna$aParaarticular Tendon
=450  \\$wnnna$aParaarticular Tendons
=450  \\$wnnna$aTendon
=450  \\$wnnna$aTendon, Para-Articular
=450  \\$wnnna$aTendon, Paraarticular
=450  \\$wnnna$aTendons, Para-Articular
=450  \\$wnnna$aTendons, Para Articular
=450  \\$wnnna$aTendons, Paraarticular
=550  \\$wg$aMusculoskeletal System
=550  \\$wh$aAchilles Tendon
=550  \\$wh$aHamstring Tendons
=550  \\$wh$aPatellar Ligament
=550  \\$wh$aRotator Cuff
=667  \\$atendon rupture = TENDON INJURIES (IM) + RUPTURE (NIM); /surg: consider TENDON TRANSFER; /transpl permitted: do not confuse with TENDON TRANSFER; for specifically located tendons coordinate IM with general area of tendon, not a bone term, as metacarpal tendon: TENDONS (IM) + HAND or FINGERS (IM), not METACARPUS; "false tendons" of heart = PURKINJE FIBERS; PATELLAR TENDON is also available
=680  \\$iFibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.
=688  \\$a1963; /transplantation was TENDON TRANSPLANTATION 1963-65
=688  \\$a/transplantation was TENDON TRANSPLANTATION 1963-65
=750  \0$aTendons$0(DLC) sh 85133841$5IEN

=LDR  00773cz  a2200241n  4500
=001  9880363885402441
=005  20181210172540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013708
=035  \\$aCBA7039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x874
=150  \\$aTendon Injuries
=450  \\$wnnna$aInjuries, Tendon
=450  \\$wnnna$aInjury, Tendon
=450  \\$wnnna$aTendon Injury
=450  \\$aTendons$xinjuries
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aRotator Cuff Injuries
=550  \\$wh$aTendinopathy
=680  \\$iInjuries to the fibrous cords of connective tissue which attach muscles to bones or other structures.
=688  \\$a73; was TENDON INJURY 1963-72
=750  \0$aTendons$xWounds and injuries$5IEN$0(DLC)sh 93005916

=LDR  01763cz  a2200385n  4500
=001  9880363885502441
=005  20141212210117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013706
=035  \\$aCBA7037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x607.$x221.$x897.$x897
=072  \\$aC5.$x550.$x905.$x905
=072  \\$aC5.$x651.$x243.$x897.$x897
=072  \\$aC5.$x651.$x550.$x905
=072  \\$aC7.$x320.$x610.$x291.$x897.$x897
=072  \\$aC7.$x678.$x949
=150  \\$aTemporomandibular Joint Dysfunction Syndrome
=450  \\$wnnna$aCosten Syndrome
=450  \\$wnnna$aCosten's Syndrome
=450  \\$wnnna$aCostens Syndrome
=450  \\$wnnna$aJoint Syndrome, Temporomandibular
=450  \\$aMyofascial Pain Dysfunction Syndrome, Temporomandibular Joint
=450  \\$wnnna$aSyndrome, Costen's
=450  \\$wnnna$aSyndrome, Temporomandibular Joint
=450  \\$wnnna$aSyndrome, TMJ
=450  \\$aTemporomandibular Joint Syndrome
=450  \\$aTMJ Syndrome
=550  \\$wg$aMyofascial Pain Syndromes
=550  \\$wg$aTemporomandibular Joint Disorders
=550  \\$aFacial Pain
=667  \\$aDF: note short X ref TMJ SYNDROME
=680  \\$iA symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.
=688  \\$a97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN'S SYNDROME 1966-72; COSTEN'S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96
=750  \0$aCosten's syndrome$5IEN$0(DLC)sh 85033232

=LDR  02649cz  a2200541n  4500
=001  9880363885602441
=005  20141212210116.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013705
=035  \\$aCBA7036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x607.$x221.$x897
=072  \\$aC5.$x550.$x905
=072  \\$aC5.$x651.$x243.$x897
=072  \\$aC7.$x320.$x610.$x291.$x897
=072  \\$aC7.$x678
=150  \\$aTemporomandibular Joint Disorders
=450  \\$wnnna$aDisease, Temporomandibular Joint
=450  \\$wnnna$aDisease, TMJ
=450  \\$wnnna$aDiseases, Temporomandibular Joint
=450  \\$wnnna$aDiseases, TMJ
=450  \\$wnnna$aDisorder, Temporomandibular
=450  \\$wnnna$aDisorder, Temporomandibular Joint
=450  \\$wnnna$aDisorder, TMJ
=450  \\$wnnna$aDisorders, Temporomandibular
=450  \\$wnnna$aDisorders, Temporomandibular Joint
=450  \\$wnnna$aDisorders, TMJ
=450  \\$wnnna$aJoint Disease, Temporomandibular
=450  \\$wnnna$aJoint Diseases, Temporomandibular
=450  \\$wnnna$aJoint Disorder, Temporomandibular
=450  \\$wnnna$aJoint Disorders, Temporomandibular
=450  \\$wnnna$aTemporomandibular Disorder
=450  \\$wnnna$aTemporomandibular Disorders
=450  \\$wnnna$aTemporomandibular Joint Disease
=450  \\$wnnna$aTemporomandibular Joint Diseases
=450  \\$wnnna$aTemporomandibular Joint Disorder
=450  \\$wnnna$aTMJ Disease
=450  \\$wnnna$aTMJ Diseases
=450  \\$wnnna$aTMJ Disorder
=450  \\$aTMJ Disorders
=550  \\$wg$aCraniomandibular Disorders
=550  \\$wg$aJoint Diseases
=550  \\$wg$aStomatognathic Diseases
=550  \\$wh$aTemporomandibular Joint Dysfunction Syndrome
=667  \\$aGEN or unspecified; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME is also available; DF: TMJ DIS
=680  \\$iA variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)
=688  \\$a97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96
=750  \0$aTemporomandibular joint$xDiseases$5IEN$0(DLC)sh 85133795

=LDR  00866cz  a2200277n  4500
=001  9880363885702441
=005  20141212210115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013704
=035  \\$aCBA7035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x861
=072  \\$aA14.$x907
=150  \\$aTemporomandibular Joint
=450  \\$wnnna$aJoint, Temporomandibular
=450  \\$wnnna$aJoints, Temporomandibular
=450  \\$wnnna$aTemporomandibular Joints
=450  \\$aTMJ
=550  \\$wg$aJoints
=550  \\$wg$aStomatognathic System
=550  \\$wh$aTemporomandibular Joint Disc
=550  \\$aJaw
=550  \\$aMandible
=550  \\$aMandibular Condyle
=680  \\$iAn articulation between the condyle of the mandible and the articular tubercle of the temporal bone.
=750  \0$aTemporomandibular joint$0(DLC) sh 85133793$5IEN

=LDR  00876cz  a2200241n  4500
=001  9880363885802441
=005  20141212210115.0
=008  790312\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013703
=035  \\$aCBA7034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x600.$x850
=072  \\$aA14.$x530.$x940
=150  \\$aTemporal Muscle
=450  \\$wnnna$aMuscle, Temporal
=450  \\$wnnna$aMuscles, Temporal
=450  \\$wnnna$aTemporal Muscles
=450  \\$aTemporalis Muscle$5IEN
=550  \\$wg$aMasticatory Muscles
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iA masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible.
=688  \\$a91(80); was see under MASTICATORY MUSCLES 1980-90
=750  \0$aTemporalis muscle$5IEN$0(DLC)sh 85133790

=LDR  03190cz  a2200853n  4500
=001  9880363885902441
=005  20181008113810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013702
=035  \\$aCBA7033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x863
=150  \\$aTemporal Lobe
=450  \\$wnnna$aCortex, Temporal
=450  \\$wnnna$aCortices, Temporal
=450  \\$wnnna$aFusiform Gyrus
=450  \\$wnnna$aFusiformi, Gyrus
=450  \\$wnnna$aFusiformis, Gyrus
=450  \\$wnnna$aGyrus, Fusiform
=450  \\$wnnna$aGyrus Fusiformi
=450  \\$wnnna$aGyrus Fusiformis
=450  \\$wnnna$aGyrus, Lateral Occipito-Temporal
=450  \\$wnnna$aGyrus, Lateral Occipitotemporal
=450  \\$wnnna$aGyrus, Occipitotemporal
=450  \\$wnnna$aGyrus, Superior Temporal
=450  \\$wnnna$aGyrus, Temporal
=450  \\$wnnna$aGyrus Temporalis Superior
=450  \\$wnnna$aGyrus Temporalis Superiors
=450  \\$wnnna$aHorn, Temporal
=450  \\$wnnna$aHorns, Temporal
=450  \\$wnnna$aInferior Horn of Lateral Ventricle
=450  \\$wnnna$aInferior Horn of the Lateral Ventricle
=450  \\$wnnna$aLateral Occipito-Temporal Gyrus
=450  \\$wnnna$aLateral Occipito Temporal Gyrus
=450  \\$wnnna$aLateral Occipitotemporal Gyrus
=450  \\$wnnna$aLobe, Temporal
=450  \\$wnnna$aLobes, Temporal
=450  \\$wnnna$aOccipito-Temporal Gyrus, Lateral
=450  \\$wnnna$aOccipitotemporal Gyrus
=450  \\$wnnna$aOccipitotemporal Gyrus, Lateral
=450  \\$wnnna$aOperculum, Temporal
=450  \\$wnnna$aOperculums, Temporal
=450  \\$wnnna$aPlanum Polare
=450  \\$wnnna$aPlanum Polares
=450  \\$wnnna$aPolare, Planum
=450  \\$wnnna$aPolares, Planum
=450  \\$wnnna$aRegion, Temporal
=450  \\$wnnna$aRegions, Temporal
=450  \\$wnnna$aSulcus, Temporal
=450  \\$wnnna$aSuperior, Gyrus Temporalis
=450  \\$wnnna$aSuperior Temporal Gyrus
=450  \\$wnnna$aSuperiors, Gyrus Temporalis
=450  \\$wnnna$aTemporal Cortex
=450  \\$wnnna$aTemporal Cortices
=450  \\$wnnna$aTemporal Gyrus
=450  \\$wnnna$aTemporal Gyrus, Superior
=450  \\$wnnna$aTemporal Horn
=450  \\$wnnna$aTemporal Horn of the Lateral Ventricle
=450  \\$wnnna$aTemporal Horns
=450  \\$wnnna$aTemporal Lobes
=450  \\$wnnna$aTemporal Operculum
=450  \\$wnnna$aTemporal Operculums
=450  \\$wnnna$aTemporal Region
=450  \\$wnnna$aTemporal Regions
=450  \\$wnnna$aTemporal Sulcus
=450  \\$wnnna$aTemporalis Superior, Gyrus
=450  \\$wnnna$aTemporalis Superiors, Gyrus
=550  \\$wg$aCerebral Cortex
=550  \\$wh$aAuditory Cortex
=550  \\$wh$aPerirhinal Cortex
=550  \\$wh$aWernicke Area
=667  \\$adiseases: coordinate IM with BRAIN DISEASES (IM); neoplasms: coordinate IM with BRAIN NEOPLASMS (IM)
=680  \\$iLower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE.
=750  \0$aTemporal lobes$5IEN$0(DLC)sh 85133786

=LDR  01093cz  a2200229n  4500
=001  9880363886002441
=005  20141212210115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013701
=035  \\$aCBA7032HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x885
=150  \\$aTemporal Bone
=450  \\$wnnna$aBone, Temporal
=450  \\$wnnna$aBones, Temporal
=450  \\$wnnna$aTemporal Bones
=550  \\$wg$aSkull
=550  \\$wh$aMastoid
=550  \\$wh$aPetrous Bone
=667  \\$afractures: coordinate TEMPORAL BONE /inj (IM) + SKULL FRACTURES (IM); neoplasm: coordinate IM with SKULL NEOPLASMS (IM)
=680  \\$iEither of a pair of compound bones forming the lateral (left and right) surfaces and base of the skull which contains the organs of hearing. It is a large bone formed by the fusion of parts: the squamous (the flattened anterior-superior part), the tympanic (the curved anterior-inferior part), the mastoid (the irregular posterior portion), and the petrous (the part at the base of the skull).
=750  \0$aTemporal bone$5IEN$0(DLC)sh 85133778

=LDR  02875cz  a2200685n  4500
=001  9880363886102441
=005  20141212210115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013700
=035  \\$aCBA7031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x875.$x700
=072  \\$aC10.$x228.$x140.$x300.$x850.$x500
=072  \\$aC14.$x907.$x184.$x438
=072  \\$aC14.$x907.$x253.$x946.$x700
=072  \\$aC14.$x907.$x940.$x90.$x530
=072  \\$aC14.$x907.$x940.$x907.$x700
=072  \\$aC17.$x800.$x862.$x252
=072  \\$aC20.$x111.$x258.$x962.$x800
=150  \\$aGiant Cell Arteritis
=450  \\$aAortic Arteritis, Giant Cell
=450  \\$wnnna$aAortitides, Giant Cell
=450  \\$aAortitis, Giant Cell
=450  \\$wnnna$aArteritides, Cranial
=450  \\$wnnna$aArteritides, Giant Cell
=450  \\$wnnna$aArteritides, Juvenile Temporal
=450  \\$wnnna$aArteritides, Temporal
=450  \\$wnnna$aArteritis, Cranial
=450  \\$wnnna$aArteritis, Giant Cell
=450  \\$wnnna$aArteritis, Giant Cell, Horton
=450  \\$wnnna$aArteritis, Giant Cell, Horton's
=450  \\$wnnna$aArteritis, Juvenile Temporal
=450  \\$aArteritis, Temporal
=450  \\$wnnna$aCranial Arteritides
=450  \\$aCranial Arteritis
=450  \\$wnnna$aGiant Cell Aortic Arteritis
=450  \\$wnnna$aGiant Cell Aortitides
=450  \\$wnnna$aGiant Cell Aortitis
=450  \\$wnnna$aGiant Cell Aortitis, Horton's
=450  \\$wnnna$aGiant Cell Arteritides
=450  \\$wnnna$aGiant Cell Arteritis, Horton
=450  \\$aHorton Disease
=450  \\$aHorton Giant Cell Arteritis
=450  \\$wnnna$aHorton's Disease
=450  \\$wnnna$aHortons Disease
=450  \\$wnnna$aHorton's Giant Cell Arteritis
=450  \\$wnnna$aJuvenile Temporal Arteritides
=450  \\$aJuvenile Temporal Arteritis
=450  \\$wnnna$aTemporal Arteritides
=450  \\$wnnna$aTemporal Arteritides, Juvenile
=450  \\$aTemporal Arteritis
=450  \\$wnnna$aTemporal Arteritis, Juvenile
=550  \\$wg$aArteritis
=550  \\$wg$aSkin Diseases, Vascular
=550  \\$wg$aVasculitis, Central Nervous System
=550  \\$aPolymyalgia Rheumatica
=680  \\$iA systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Temporal Arteritis
=750  \0$aGiant cell arteritis$0(DLC) sh 85054832$5IEN

=LDR  00856cz  a2200229n  4500
=001  9880363886202441
=005  20141212210113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013698
=035  \\$aCBA7029M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x840
=150  \\$aTemplates, Genetic
=450  \\$wnnna$aGenetic Template
=450  \\$wnnna$aGenetic Templates
=450  \\$wnnna$aTemplate, Genetic
=450  \\$wnnoa$aTemplates$5IEN-HS
=550  \\$wg$aGenetic Structures
=667  \\$abiol context only: not for metal templates or patterns or gauges; NIM
=680  \\$iMacromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES.
=688  \\$a2003
=750  \0$aBiochemical templates$5IEN-M$0(DLC)sh 85014124

=LDR  00811cz  a2200253n  4500
=001  9880363886302441
=005  20141212210113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013697
=035  \\$aCBA7028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x781
=072  \\$aG7.$x700.$x850
=072  \\$aG11.$x561.$x600.$x810.$x781
=150  \\$aThermosensing
=450  \\$wnnna$aSense, Temperature
=450  \\$aTemperature Sense
=450  \\$wnnna$aThermosensings
=550  \\$wg$aPhysiological Processes
=550  \\$wg$aSensation
=680  \\$iThe sensation of cold, heat, coolness, and warmth as detected by THERMORECEPTORS.
=688  \\$a2011 (1963)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Temperature Sense
=750  \0$aTemperature sense$0(DLC) sh 85133721$5IEN

=LDR  01078cz  a2200289n  4500
=001  9880363886402441
=005  20141212210113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013696
=035  \\$aCBA7027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x595
=072  \\$aG16.$x500.$x275.$x63.$x725.$x710
=072  \\$aG16.$x500.$x750.$x775.$x710
=072  \\$aN6.$x230.$x150.$x450
=072  \\$aN6.$x230.$x300.$x100.$x725.$x710
=150  \\$aTemperature
=450  \\$wnnna$aTemperatures
=550  \\$wg$aEnvironment, Controlled
=550  \\$wg$aThermodynamics
=550  \\$wg$aWeather
=550  \\$wh$aCold Temperature
=550  \\$wh$aHot Temperature
=550  \\$wh$aTransition Temperature
=667  \\$aprefer specifics HOT TEMPERATURE or COLD TEMPERATURE
=680  \\$iThe property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.
=750  \0$aTemperature$5IEN$0(DLC)sh 85133712

=LDR  00662cz  a2200205n  4500
=001  9880363886502441
=005  20141212210113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013695
=035  \\$aCBA7026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x914
=150  \\$aTemperance
=450  \\$wnnna$aTemperances
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$aAlcohol Drinking
=550  \\$aAlcoholism
=667  \\$aALCOHOL ABSTINENCE is also available
=680  \\$iHabitual moderation in the indulgence of a natural appetite, especially but not exclusively the consumption of alcohol.
=750  \0$aTemperance$5IEN$0(DLC)sh 85133698

=LDR  00571cz  a2200181n  4500
=001  9880363886602441
=005  20141212210112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013694
=035  \\$aCBA7025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x898
=150  \\$aTemperament
=450  \\$wnnna$aTemperaments
=550  \\$wg$aPersonality
=680  \\$iPredisposition to react to one's environment in a certain way; usually refers to mood changes.
=688  \\$a91(75); was see under PERSONALITY 1975-90
=750  \0$aTemperament$0(DLC) sh 85133695$5IEN

=LDR  00987cz  a2200217n  4500
=001  9880363886702441
=005  20141212210111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013691
=035  \\$aCBA7022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185.$x950
=072  \\$aD1.$x268.$x513.$x968
=150  \\$aTellurium
=450  \\$aTellurium Compounds$5IEN
=550  \\$wg$aChalcogens
=550  \\$wg$aMetalloids
=667  \\$aTe-130; Te-120, 122-126, 128 = TELLURIUM (IM) + ISOTOPES (NIM); Te-115-119, 121, 127, 129, 131-135 = TELLURIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iTellurium. An element that is a member of the chalcogen family. It has the atomic symbol Te, atomic number 52, and atomic weight 127.60. It has been used as a coloring agent and in the manufacture of electrical equipment. Exposure may cause nausea, vomiting, and CNS depression.
=750  \0$aTellurium compounds$5IEN-M$0(DLC)sh 85133649
=750  \0$aTellurium$5IEN-HS$0(DLC)sh 85133642

=LDR  01161cz  a2200277n  4500
=001  9880363886802441
=005  20141212210110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013690
=035  \\$aCBA7021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x898
=072  \\$aL1.$x178.$x590.$x875
=072  \\$aL1.$x178.$x820.$x90.$x898
=072  \\$aL1.$x178.$x847.$x823
=150  \\$aTelevision
=450  \\$wnnna$aTelevisions
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aMass Media
=550  \\$wg$aTelecommunications
=550  \\$wh$aMicroscopy, Video
=550  \\$wh$aVideodisc Recording
=550  \\$wh$aVideotape Recording
=667  \\$afor color TV do not coord with COLOR unless specifically emphasized & then NIM only
=680  \\$iThe transmission and reproduction of transient images of fixed or moving objects. An electronic system of transmitting such images together with sound over a wire or through space by apparatus that converts light and sound into electrical waves and reconverts them into visible light rays and audible sound. (From Webster, 3rd ed)
=750  \0$aTelevision$5IEN$0(DLC)sh 85133456

=LDR  00807cz  a2200265n  4500
=001  9880363886902441
=005  20141212210110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013689
=035  \\$aCBA7020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x698
=150  \\$aTelephone
=450  \\$wnnna$aService, Switchboard
=450  \\$wnnna$aServices, Switchboard
=450  \\$aSwitchboard Service
=450  \\$wnnna$aSwitchboard Services
=450  \\$wnnna$aTelephones
=550  \\$wg$aTelecommunications
=550  \\$wh$aAnswering Services
=550  \\$wh$aCell Phones
=550  \\$wh$aModems
=680  \\$iAn instrument for reproducing sounds especially articulate speech at a distance. (Webster, 3rd ed)
=688  \\$a74(71)
=750  \0$aTelephone$5IEN$0(DLC)sh 85133365

=LDR  00562cz  a2200169n  4500
=001  9880363887002441
=005  20141212210110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013688
=035  \\$aCBA7019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x550.$x847
=150  \\$aTelepathy
=550  \\$wg$aParapsychology
=550  \\$aParapsychology
=680  \\$iThe knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes.
=750  \0$aTelepathy$5IEN$0(DLC)sh 85133364

=LDR  00963cz  a2200289n  4500
=001  9880363887102441
=005  20141212192557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013687
=035  \\$aCBA7018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885
=150  \\$aTelencephalon
=450  \\$wnnna$aEndbrain
=450  \\$wnnna$aEndbrains
=550  \\$wg$aProsencephalon
=550  \\$wh$aCerebrum
=550  \\$wh$aDiagonal Band of Broca
=550  \\$wh$aExternal Capsule
=550  \\$wh$aInternal Capsule
=550  \\$wh$aOlfactory Bulb
=550  \\$wh$aSeptum of Brain
=550  \\$wh$aTelencephalic Commissures
=680  \\$iThe anterior subdivision of the embryonic PROSENCEPHALON or the corresponding part of the adult prosencephalon that includes the cerebrum and associated structures.
=688  \\$a1963
=688  \\$a1963; for CEREBRUM use BRAIN 1975-2000
=750  \0$aTelencephalon$5IEN-M$0(DLC)sh 85133359

=LDR  00894cz  a2200253n  4500
=001  9880363887202441
=005  20141212210110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013686
=035  \\$aCBA7017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x750
=072  \\$aE5.$x925
=072  \\$aL1.$x178.$x847.$x675
=150  \\$aTelemetry
=450  \\$wnnna$aTelemetries
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aMonitoring, Physiologic
=550  \\$wg$aTelecommunications
=550  \\$wh$aRemote Sensing Technology
=550  \\$aTelemedicine
=667  \\$acoordinate with specific procedure if relevant
=680  \\$iTransmission of the readings of instruments to a remote location by means of wires, radio waves, or other means. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aBiotelemetry$5IEN$0(DLC)sh 85014265

=LDR  01045cz  a2200361n  4500
=001  9880363887302441
=005  20141212210109.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013685
=035  \\$aCBA7016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847
=150  \\$aTelecommunications
=450  \\$wnnna$aTelecommunication
=450  \\$aTeleconference
=450  \\$wnnna$aTeleconferences
=450  \\$wnnna$aTelegraphies
=450  \\$aTelegraphy
=550  \\$wg$aCommunications Media
=550  \\$wh$aElectronic Mail
=550  \\$wh$aRadar
=550  \\$wh$aRadio
=550  \\$wh$aSatellite Communications
=550  \\$wh$aTelefacsimile
=550  \\$wh$aTelemedicine
=550  \\$wh$aTelemetry
=550  \\$wh$aTelephone
=550  \\$wh$aTelevision
=550  \\$wh$aVideoconferencing
=550  \\$wh$aWireless Technology
=680  \\$iTransmission of information over distances via electronic means.
=688  \\$a76; was NON MESH before 1976
=750  \0$aTelecommunication$5IEN-M$0(DLC)sh 85133270

=LDR  03821cz  a2200949n  4500
=001  9880363887402441
=005  20141212192556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013681
=035  \\$aCBA7012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x413.$x875
=072  \\$aA8.$x186.$x211.$x653.$x413.$x500
=150  \\$aTegmentum Mesencephali
=450  \\$wnnna$aAccessory Oculomotor Nuclei
=450  \\$wnnna$aAnnular Nucleus
=450  \\$wnnna$aAnnulari, Nucleus
=450  \\$wnnna$aAnnularis, Nucleus
=450  \\$wnnna$aCajal Interstitial Nucleus
=450  \\$wnnna$aDarkschewitsch Nucleus
=450  \\$wnnna$aDarkshevich Nucleus
=450  \\$wnnna$aDarkshevich's Nucleus
=450  \\$wnnna$aDarkshevichs Nucleus
=450  \\$wnnna$aInterstitial Nucleus of Cajal
=450  \\$wnnna$aMesencephali, Tegmentum
=450  \\$wnnna$aMesencephalic Tegmentum
=450  \\$wnnna$aMesencephalic Tegmentums
=450  \\$wnnna$aMesencephalic Trigeminal Nucleus
=450  \\$wnnna$aMesencephalus, Tegmentum
=450  \\$wnnna$aMidbrain Tegmentum
=450  \\$wnnna$aMidbrain Tegmentums
=450  \\$wnnna$aMidbrain Trigeminal Nucleus
=450  \\$wnnna$aNervi Trochleari, Nucleus
=450  \\$wnnna$aNervi Trochlearis, Nucleus
=450  \\$wnnna$aNuclei, Accessory Oculomotor
=450  \\$wnnna$aNucleus, Annular
=450  \\$wnnna$aNucleus Annulari
=450  \\$wnnna$aNucleus Annularis
=450  \\$wnnna$aNucleus, Darkshevich's
=450  \\$wnnna$aNucleus, Mesencephalic Trigeminal
=450  \\$wnnna$aNucleus, Midbrain Trigeminal
=450  \\$wnnna$aNucleus Nervi Trochleari
=450  \\$wnnna$aNucleus Nervi Trochlearis
=450  \\$wnnna$aNucleus of Darkschewitsch
=450  \\$wnnna$aNucleus, Peripeduncular
=450  \\$wnnna$aNucleus Sagulum
=450  \\$wnnna$aNucleus, Sagulum
=450  \\$wnnna$aNucleus Sagulums
=450  \\$wnnna$aNucleus Tractus Mesencephalici Nervi Trigemini
=450  \\$wnnna$aNucleus, Trochlear
=450  \\$wnnna$aNucleus, Ventral Tegmental
=450  \\$wnnna$aOculomotor Nuclei, Accessory
=450  \\$wnnna$aPeripeduncular Nucleus
=450  \\$wnnna$aSagulum Nucleus
=450  \\$wnnna$aSagulum, Nucleus
=450  \\$wnnna$aSagulums, Nucleus
=450  \\$wnnna$aTegmental Nucleus, Ventral
=450  \\$wnnna$aTegmentum, Mesencephalic
=450  \\$wnnna$aTegmentum Mesencephalus
=450  \\$wnnna$aTegmentum, Midbrain
=450  \\$wnnna$aTegmentum of Midbrain
=450  \\$wnnna$aTegmentums, Mesencephalic
=450  \\$wnnna$aTegmentums, Midbrain
=450  \\$wnnna$aTrigeminal Nucleus, Mesencephalic
=450  \\$wnnna$aTrigeminal Nucleus, Midbrain
=450  \\$wnnna$aTrochlear Nucleus
=450  \\$wnnna$aTrochleari, Nucleus Nervi
=450  \\$wnnna$aTrochlearis, Nucleus Nervi
=450  \\$wnnna$aVentral Tegmental Nucleus
=550  \\$wg$aCerebral Peduncle
=550  \\$wh$aCerebral Aqueduct
=550  \\$wh$aMidbrain Reticular Formation
=550  \\$wh$aOculomotor Nuclear Complex
=550  \\$wh$aPeriaqueductal Gray
=550  \\$wh$aRaphe Nuclei
=550  \\$wh$aRed Nucleus
=550  \\$wh$aVentral Tegmental Area
=667  \\$ado not confuse with TECTUM MESENCEPHALI
=680  \\$iPortion of midbrain situated under the dorsal TECTUM MESENCEPHALI. The two ventrolateral cylindrical masses or peduncles are large nerve fiber bundles providing a tract of passage between the FOREBRAIN with the HINDBRAIN. Ventral MIDBRAIN also contains three colorful structures: the GRAY MATTER (PERIAQUEDUCTAL GRAY), the black substance (SUBSTANTIA NIGRA), and the RED NUCLEUS.
=688  \\$a1974(1971); for CEREBRAL PEDUNCLES use MESENCEPHALON 1976-2007
=688  \\$a74(71)
=750  \0$aMesencephalic tegmentum$5IEN$0(DLC)sh 90003408

=LDR  01367cz  a2200289n  4500
=001  9880363887502441
=005  20141212210107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013679
=035  \\$aCBA7010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x920
=072  \\$aH2.$x10.$x850
=072  \\$aJ1.$x897.$x891
=150  \\$aTechnology, Radiologic
=450  \\$aRadiologic Technologists$5IEN
=450  \\$wnnna$aRadiologic Technology
=450  \\$wnnna$aRadiological Technology
=450  \\$wnnna$aTechnology, Radiological
=550  \\$wg$aAllied Health Occupations
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aTechnology
=550  \\$wh$aTeleradiology
=550  \\$aRadiography
=667  \\$aSPEC: SPEC qualif; do not confuse with RADIOGRAPHY ( = x-ray diag); TECHNOLOGY, RADIOLOGIC is not restricted to radiography & the emphasis is on the technol; IM general only, NIM as the technol coord for a specific radiologic technol; DF: TECHNOL RADIOL
=680  \\$iThe application of scientific knowledge or technology to the field of radiology. The applications center mostly around x-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology.
=750  \0$aRadiologic technologists$5IEN$0(DLC)sh 85110771

=LDR  01634cz  a2200433n  4500
=001  9880363887602441
=005  20180913121348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013678
=035  \\$aCBA7009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916
=072  \\$aJ1.$x897.$x836
=150  \\$aTechnology, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Technology
=450  \\$wnnna$aPharmaceutical Technology
=450  \\$wnnna$aPharmacy Technology
=450  \\$wnnna$aTechnology, Pharmaceutic
=450  \\$aTechnology, Pharmacy
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aTechnology
=550  \\$wh$aChemistry Techniques, Synthetic
=550  \\$wh$aClick Chemistry
=550  \\$wh$aDosage Forms
=550  \\$wh$aDrug Compounding
=550  \\$wh$aDrug Incompatibility
=550  \\$wh$aDrug Labeling
=550  \\$wh$aDrug Packaging
=550  \\$wh$aDrug Stability
=550  \\$wh$aDrug Storage
=550  \\$wh$aEnzyme Stability
=550  \\$wh$aHigh-Throughput Screening Assays
=550  \\$wh$aMolecular Farming
=550  \\$wh$aSolid-Phase Synthesis Techniques
=550  \\$aDrug Industry
=667  \\$aDF: TECHNOL PHARM
=680  \\$iThe application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.
=688  \\$a68
=750  \0$aPharmaceutical technology$5IEN$0(DLC)sh 85100590

=LDR  01873cz  a2200457n  4500
=001  9880363887702441
=005  20141212210106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013677
=035  \\$aCBA7008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x10.$x450
=072  \\$aJ1.$x897.$x480
=150  \\$aMedical Laboratory Science
=450  \\$wnnna$aClinical Laboratory Science
=450  \\$wnnna$aClinical Laboratory Sciences
=450  \\$wnnna$aLaboratory Science, Clinical
=450  \\$wnnna$aLaboratory Science, Medical
=450  \\$wnnna$aLaboratory Sciences, Clinical
=450  \\$wnnna$aLaboratory Sciences, Medical
=450  \\$wnnna$aLaboratory Technologies, Medical
=450  \\$wnnna$aLaboratory Technology, Medical
=450  \\$wnnna$aMedical Laboratory Sciences
=450  \\$wnnna$aMedical Laboratory Technologies
=450  \\$aMedical Laboratory Technology
=450  \\$wnnna$aScience, Clinical Laboratory
=450  \\$wnnna$aScience, Medical Laboratory
=450  \\$wnnna$aSciences, Clinical Laboratory
=450  \\$wnnna$aSciences, Medical Laboratory
=450  \\$wnnna$aTechnologies, Medical Laboratory
=450  \\$aTechnology, Medical Laboratory
=550  \\$wg$aAllied Health Occupations
=550  \\$wg$aTechnology
=550  \\$aClinical Laboratory Techniques
=550  \\$aMedical Laboratory Personnel
=667  \\$aSPEC: SPEC qualif; DF: TECHNOL MED
=680  \\$iThe specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications.
=688  \\$a2012 (1966)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Technology, Medical
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20120905: 150:##:_{dollar}a Technology, Medical
=750  \0$aMedical technology$0(DLC) sh 85083046$5IEN

=LDR  01256cz  a2200361n  4500
=001  9880363887802441
=005  20141212210105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013674
=035  \\$aCBA7005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x912
=072  \\$aH2.$x10.$x800
=072  \\$aJ1.$x897.$x724
=150  \\$aTechnology, Dental
=450  \\$wnnna$aDental Technology
=550  \\$wg$aAllied Health Occupations
=550  \\$wg$aDentistry
=550  \\$wg$aTechnology
=550  \\$wh$aDental Casting Technique
=550  \\$wh$aDental Impression Technique
=550  \\$wh$aDental Prosthesis Design
=550  \\$wh$aDental Prosthesis Repair
=550  \\$wh$aDental Soldering
=550  \\$wh$aDenture Design
=550  \\$wh$aDenture Identification Marking
=550  \\$wh$aDenture Rebasing
=550  \\$wh$aDenture Repair
=550  \\$wh$aGingival Retraction Techniques
=550  \\$wh$aOrthodontic Appliance Design
=667  \\$aSPEC: SPEC qualif; DF: TECHNOL DENT
=680  \\$iThe field of dentistry involved in procedures for designing and constructing dental appliances. It includes also the application of any technology to the field of dentistry.
=750  \0$aDental technology$5IEN$0(DLC)sh 85036939

=LDR  01353cz  a2200325n  4500
=001  9880363887902441
=005  20141212210105.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013673
=035  \\$aCBA7004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x880
=072  \\$aN5.$x715.$x360.$x825
=150  \\$aTechnology Assessment, Biomedical
=450  \\$wnnna$aAssessment, Biomedical Technology
=450  \\$wnnna$aAssessment, Technology
=450  \\$wnnna$aAssessments, Biomedical Technology
=450  \\$wnnna$aAssessments, Technology
=450  \\$wnnna$aBiomedical Technology Assessment
=450  \\$wnnna$aBiomedical Technology Assessments
=450  \\$wnnna$aTechnology Assessment
=450  \\$wnnna$aTechnology Assessments
=450  \\$wnnna$aTechnology Assessments, Biomedical
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wg$aHealth Care Evaluation Mechanisms
=550  \\$wh$aTechnology, High-Cost
=667  \\$arestrict to MeSH definition: do not use as routine coord for "evaluation" of a specific technique or "technol"; DF: TECHNOL ASSESS BIOMED
=680  \\$iEvaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
=688  \\$a80
=750  \0$aMedical innovations$xEvaluation$0(IEN)379102$5IEN

=LDR  01443cz  a2200409n  4500
=001  9880363888002441
=005  20200526132942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013672
=035  \\$aCBA7003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897
=150  \\$aTechnology
=450  \\$wnnna$aArts, Industrial
=450  \\$aIndustrial Arts
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aAutomation
=550  \\$wh$aCulturally Appropriate Technology
=550  \\$wh$aBiomedical Technology
=550  \\$wh$aBiotechnology
=550  \\$wh$aEducational Technology
=550  \\$wh$aGreen Chemistry Technology
=550  \\$wh$aInventions
=550  \\$wh$aMan-Machine Systems
=550  \\$wh$aMaterials Science
=550  \\$wh$aMedical Laboratory Science
=550  \\$wh$aMiniaturization
=550  \\$wh$aPrinting, Three-Dimensional
=550  \\$wh$aQuality Control
=550  \\$wh$aTechnology, Dental
=550  \\$wh$aTechnology, Pharmaceutical
=550  \\$wh$aTechnology, Radiologic
=550  \\$wh$aTechnology Transfer
=667  \\$aSPEC: SPEC qualif; DF: TECHNOL
=680  \\$iThe application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation.
=688  \\$aINDUSTRIAL ARTS was see under TECHNOLOGY 1967-78; was see under OCCUPATIONS AND PROFESSIONS 1963-66
=750  \0$aTechnology$5IEN$0(DLC)sh 85133147

=LDR  01168cz  a2200241n  4500
=001  9880363888102441
=005  20141212210102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013667
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x870
=072  \\$aD1.$x268.$x556.$x843
=072  \\$aD1.$x268.$x956.$x875
=072  \\$aD1.$x552.$x544.$x843
=150  \\$aTechnetium
=450  \\$wnnna$a99m, Technetium
=450  \\$aTechnetium 99m
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$anote X ref: many specific Technetium Tc 99m terms are available
=680  \\$iThe first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.
=750  \0$aTechnetium$5IEN$0(DLC)sh 85133086

=LDR  00849cz  a2200277n  4500
=001  9880363888202441
=005  20141212210101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013665
=035  \\$aCBA6996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x400.$x800
=072  \\$aD27.$x720.$x821.$x498.$x697
=072  \\$aD27.$x888.$x569.$x300.$x800
=072  \\$aD27.$x888.$x569.$x734.$x498.$x697
=072  \\$aJ1.$x637.$x870.$x800
=150  \\$aTear Gases
=450  \\$wnnna$aGas, Tear
=450  \\$wnnna$aGases, Tear
=450  \\$wnnna$aTear Gas
=550  \\$wg$aIrritants
=550  \\$wg$aWeapons
=550  \\$aChemical Warfare Agents
=680  \\$iGases that irritate the eyes, throat, or skin. Severe lacrimation develops upon irritation of the eyes.
=688  \\$a73(68)
=750  \0$aTear gas$5IEN$0(DLC)sh 85133079

=LDR  00746cz  a2200253n  4500
=001  9880363888302441
=005  20141212210101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013664
=035  \\$aCBA6995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x820
=150  \\$aTeaching Materials
=450  \\$wnnna$aMaterial, Teaching
=450  \\$wnnna$aMaterials, Teaching
=450  \\$wnnna$aTeaching Material
=550  \\$wg$aCommunications Media
=550  \\$wh$aAudiovisual Aids
=550  \\$wh$aManuals as Topic
=550  \\$wh$aTextbooks as Topic
=550  \\$aEducational Technology
=680  \\$iInstructional materials used in teaching.
=688  \\$a74
=750  \0$aTeaching$xAids and devices$5IEN$0(DLC)sh 85133053

=LDR  02149cz  a2200661n  4500
=001  9880363888402441
=005  20201223134728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013663
=035  \\$aCBA6994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x903
=150  \\$aTeaching
=450  \\$wnnna$aAcademic Training
=450  \\$wnnna$aActivities, Training
=450  \\$wnnna$aEducational Personnel
=450  \\$wnnna$aEducational Technic
=450  \\$wnnna$aEducational Technics
=450  \\$wnnna$aEducational Technique
=450  \\$wnnna$aEducational Techniques
=450  \\$wnnna$aMethod, Teaching
=450  \\$wnnna$aMethods, Teaching
=450  \\$wnnna$aPedagogies
=450  \\$wnnna$aPedagogy
=450  \\$wnnna$aPersonnel, Educational
=450  \\$wnnna$aTeaching Method
=450  \\$wnnna$aTeaching Methods
=450  \\$wnnna$aTechnic, Educational
=450  \\$wnnna$aTechnic, Training
=450  \\$wnnna$aTechnics, Educational
=450  \\$wnnna$aTechnics, Training
=450  \\$wnnna$aTechnique, Educational
=450  \\$wnnna$aTechnique, Training
=450  \\$wnnna$aTechniques, Educational
=450  \\$wnnna$aTechniques, Training
=450  \\$wnnna$aTrainers Training
=450  \\$wnnna$aTraining, Academic
=450  \\$wnnna$aTraining Activities
=450  \\$wnnna$aTraining Activity
=450  \\$wnnna$aTraining of Trainers
=450  \\$wnnna$aTraining Technic
=450  \\$wnnna$aTraining Technics
=450  \\$wnnna$aTraining Technique
=450  \\$wnnna$aTraining Techniques
=550  \\$wg$aEducation
=550  \\$wh$aComputer User Training
=550  \\$wh$aModels, Educational
=550  \\$wh$aPatient Simulation
=550  \\$wh$aProblem-Based Learning
=550  \\$wh$aProgrammed Instruction as Topic
=550  \\$wh$aRemedial Teaching
=550  \\$wh$aSelf-Directed Learning as Topic
=550  \\$wh$aSimulation Training
=550  \\$wh$aStudy Guides as Topic
=550  \\$aEducation
=667  \\$adifferentiate from FACULTY: Manual 30.10
=680  \\$iThe educational process of instructing.
=750  \0$aTeaching$5IEN$0(DLC)sh 85133052

=LDR  01073cz  a2200265n  4500
=001  9880363888502441
=005  20250501163405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013662
=035  \\$aCBA6993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x875
=072  \\$aJ2.$x200.$x900
=150  \\$aTea
=550  \\$wg$aBeverages
=550  \\$wg$aPlant Preparations
=550  \\$wh$aKombucha Tea
=550  \\$aCamellia sinensis
=667  \\$arestrict to drink prepared from tea plant, CAMELLIA SINENSIS (formerly Thea sinensis); "teas" from other plants go under plant term (IM) + BEVERAGES (IM)
=680  \\$iThe infusion of leaves of CAMELLIA SINENSIS (formerly Thea sinensis) as a beverage, the familiar Oriental tea, which contains CATECHIN (especially epigallocatechin gallate) and CAFFEINE.
=688  \\$a66
=750  \0$aTea$5IEN$0(DLC)sh 85132924
=750  \0$iNarrower mapping$aBlack tea$0(DLC)sh2021008130$4NM$5IEN-M
=750  \0$iNarrower mapping$aChai $0(DLC)sh2023001310$4NM$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  03390cz  a2200709n  4500
=001  9880363888602441
=005  20141212210100.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013661
=035  \\$aCBA6992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x300.$x300.$x500
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x300.$x300.$x500
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x350.$x300.$x850
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x300.$x300.$x840
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x300.$x300.$x500
=072  \\$aC18.$x452.$x584.$x687.$x803.$x350.$x300.$x850
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x300.$x300.$x500
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x350.$x300.$x850
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x300.$x300.$x840
=150  \\$aTay-Sachs Disease
=450  \\$wnnna$aAmaurotic Familial Idiocy
=450  \\$wnnna$aAmaurotic Idiocy, Familial
=450  \\$wnnna$aB Variant GM2-Gangliosidoses
=450  \\$wnnna$aB Variant GM2 Gangliosidosis
=450  \\$wnnna$aB Variant GM2-Gangliosidosis
=450  \\$abeta-Hexosaminidase alpha Chain$xdeficiency
=450  \\$wnnna$aDeficiency Disease Hexosaminidase A
=450  \\$wnnna$aDeficiency, Hexosaminidase A
=450  \\$wnnna$aDeficiency, Hexosaminidase alpha-Subunit (Variant B)
=450  \\$wnnna$aFamilial Amaurotic Idiocy
=450  \\$aG(M2) Gangliosidosis, Type I
=450  \\$aGangliosidosis G(M2), Type I
=450  \\$aGangliosidosis GM2, B Variant
=450  \\$wnnna$aGangliosidosis GM2 , Type 1
=450  \\$wnnna$aGangliosidosis GM2, Type I
=450  \\$wnnna$aGM2 Gangliosidosis, B Variant
=450  \\$wnnna$aGM2-Gangliosidosis, B Variant
=450  \\$wnnna$aGM2 Gangliosidosis, Type 1
=450  \\$wnnna$aGM2 Gangliosidosis, Type I
=450  \\$wnnna$aGM2-Gangliosidosis, Type I
=450  \\$wnnna$aHexA Deficiency
=450  \\$wnnna$aHexosaminidase A Deficiency
=450  \\$aHexosaminidase A Deficiency Disease
=450  \\$wnnna$aHexosaminidase alpha-Subunit Deficiency (Variant B)
=450  \\$wnnna$aHexosaminidase alpha Subunit Deficiency (Variant B)
=450  \\$wnnna$aSphingolipidosis, Tay-Sachs
=450  \\$wnnna$aSphingolipidosis, Tay Sachs
=450  \\$wnnna$aTay Sachs Disease
=450  \\$aTay-Sachs Disease, B Variant
=450  \\$wnnna$aTay Sachs Disease, B Variant
=450  \\$wnnna$aTay-Sachs Sphingolipidosis
=450  \\$wnnna$aType I GM2-Gangliosidosis
=550  \\$wg$aGangliosidoses, GM2
=550  \\$abeta-N-Acetylhexosaminidases
=550  \\$aG(M2) Ganglioside
=550  \\$aHexosaminidase A
=667  \\$aTAY-SACHS DISEASE, AB VARIANT is also available
=680  \\$iAn autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.
=688  \\$a1979; for AMAUROTIC FAMILIAL IDIOCY use LIPOIDOSIS 1985-2006
=688  \\$a1979; use AMAUROTIC FAMILIAL IDIOCY 1963-1978
=750  \0$aTay-Sachs disease$5IEN$0(DLC)sh 85132905

=LDR  00925cz  a2200289n  4500
=001  9880363888702441
=005  20141212210059.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013660
=035  \\$aCBA6991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x900
=150  \\$aTaxes
=450  \\$aInstitutional Tax
=450  \\$wnnna$aInstitutional Taxes
=450  \\$wnnna$aTax
=450  \\$wnnna$aTax, Institutional
=450  \\$wnnna$aTaxation
=450  \\$wnnna$aTaxes, Institutional
=550  \\$wg$aEconomics
=550  \\$wh$aIncome Tax
=550  \\$wh$aTax Equity and Fiscal Responsibility Act
=550  \\$wh$aTax Exemption
=667  \\$acoord IM with subject of tax (IM); specify geog; INCOME TAX is also available
=680  \\$iGovernmental levies on property, inheritance, gifts, etc.
=688  \\$aINSTITUTIONAL TAX was see under TAXES 1978-82
=750  \0$aTaxation$5IEN$0(DLC)sh 85132846

=LDR  00897cz  a2200253n  4500
=001  9880363888802441
=005  20141212210056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013654
=035  \\$aCBA6985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x100.$x850
=072  \\$aD2.$x886.$x645.$x600.$x55.$x850
=150  \\$aTaurine
=450  \\$wnnna$aTaufon
=450  \\$wnnna$aTauphon
=450  \\$wnnna$aTaurine Hydrochloride
=450  \\$wnnna$aTaurine, Monopotassium Salt
=450  \\$wnnna$aTaurine Zinc Salt (2:1)
=550  \\$wg$aAlkanesulfonic Acids
=550  \\$wh$aTaurocholic Acid
=667  \\$a/biosyn /physiol permitted
=680  \\$iA conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.
=750  \0$aTaurine$5IEN$0(DLC)sh 85132790

=LDR  00756cz  a2200193n  4500
=001  9880363888902441
=005  20141212210056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013653
=035  \\$aCBA6984HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x85.$x840
=072  \\$aE4.$x85.$x840
=150  \\$aTattooing
=450  \\$wnnna$aTattooings
=550  \\$wg$aBody Modification, Non-Therapeutic
=667  \\$aincludes tattooing as body decoration among various cultures and as an aid in endoscopic procedures
=680  \\$iThe indelible marking of TISSUES, primarily SKIN, by pricking it with NEEDLES to imbed various COLORING AGENTS. Tattooing of the CORNEA is done to colorize LEUKOMA spots.
=750  \0$aTattooing$5IEN$0(DLC)sh 85132770

=LDR  00852cz  a2200253n  4500
=001  9880363889002441
=005  20141212210056.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013652
=035  \\$aCBA6983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x710.$x790
=072  \\$aG11.$x561.$x600.$x810.$x724.$x880
=072  \\$aG11.$x561.$x840
=150  \\$aTaste Threshold
=450  \\$wnnna$aTaste Thresholds
=450  \\$wnnna$aThreshold, Taste
=450  \\$wnnna$aThresholds, Taste
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aSensory Thresholds
=550  \\$wg$aTaste
=680  \\$iThe minimum concentration at which taste sensitivity to a particular substance or food can be perceived.
=688  \\$a91(76); was see under TASTE 1976-90
=750  \0$aTaste$xThreshold$5IEN-M$0(DLC)sh 85132735

=LDR  01871cz  a2200457n  4500
=001  9880363889102441
=005  20141212210056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013651
=035  \\$aCBA6982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x861
=072  \\$aC23.$x888.$x592.$x763.$x861
=150  \\$aTaste Disorders
=450  \\$wnnna$aMetallic Taste
=450  \\$wnnna$aMetallic Tastes
=450  \\$wnnna$aPrimary Taste Disorder
=450  \\$wnnna$aPrimary Taste Disorders
=450  \\$wnnna$aSecondary Taste Disorder
=450  \\$wnnna$aSecondary Taste Disorders
=450  \\$wnnna$aTaste Disorder
=450  \\$wnnna$aTaste Disorder, Anterior Tongue
=450  \\$wnnna$aTaste Disorder, Posterior Tongue
=450  \\$aTaste Disorder, Primary
=450  \\$wnnna$aTaste Disorder, Primary, Bitter
=450  \\$wnnna$aTaste Disorder, Primary, Salt
=450  \\$wnnna$aTaste Disorder, Primary, Sweet
=450  \\$aTaste Disorder, Secondary
=450  \\$wnnna$aTaste Disorder, Secondary, Bitter
=450  \\$wnnna$aTaste Disorder, Secondary, Salt
=450  \\$wnnna$aTaste Disorder, Secondary, Sweet
=450  \\$wnnna$aTaste Disorders, Primary
=450  \\$wnnna$aTaste Disorders, Secondary
=450  \\$aTaste, Metallic
=450  \\$wnnna$aTastes, Metallic
=550  \\$wg$aSensation Disorders
=550  \\$wh$aAgeusia
=550  \\$wh$aDysgeusia
=680  \\$iConditions characterized by an alteration in gustatory function or perception. Taste disorders are frequently associated with OLFACTION DISORDERS. Additional potential etiologies include METABOLIC DISEASES; DRUG TOXICITY; and taste pathway disorders (e.g., TASTE BUD diseases; FACIAL NERVE DISEASES; GLOSSOPHARYNGEAL NERVE DISEASES; and BRAIN STEM diseases).
=688  \\$a1973(1971)
=750  \0$aTaste disorders$5IEN$0(DLC)sh 85132737

=LDR  01154cz  a2200301n  4500
=001  9880363889202441
=005  20141212192555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013650
=035  \\$aCBA6981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x885.$x779
=072  \\$aA8.$x675.$x650.$x915.$x500.$x800
=072  \\$aA8.$x800.$x950.$x500.$x800
=072  \\$aA9.$x846
=072  \\$aA11.$x671.$x650.$x915.$x500.$x800
=072  \\$aA14.$x549.$x885.$x779
=150  \\$aTaste Buds
=450  \\$wnnna$aBud, Taste
=450  \\$wnnna$aBuds, Taste
=450  \\$wnnna$aTaste Bud
=550  \\$wg$aChemoreceptor Cells
=550  \\$wg$aSense Organs
=550  \\$wg$aTongue
=550  \\$aNeuroepithelial Cells
=667  \\$achemoreceptors on the tongue, palate & pharynx
=680  \\$iSmall sensory organs which contain gustatory receptor cells, basal cells, and supporting cells. Taste buds in humans are found in the epithelia of the tongue, palate, and pharynx. They are innervated by the CHORDA TYMPANI NERVE (a branch of the facial nerve) and the GLOSSOPHARYNGEAL NERVE.
=750  \0$aTaste buds$5IEN$0(DLC)sh 85132736

=LDR  00965cz  a2200277n  4500
=001  9880363889302441
=005  20141212210055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013649
=035  \\$aCBA6980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x724
=072  \\$aG11.$x561.$x600.$x810.$x724
=150  \\$aTaste
=450  \\$wnnna$aGustation
=450  \\$wnnna$aGustations
=450  \\$wnnna$aSense, Taste
=450  \\$wnnna$aSenses, Taste
=450  \\$wnnna$aTaste Sense
=450  \\$wnnna$aTaste Senses
=450  \\$wnnna$aTastes
=550  \\$wg$aSensation
=550  \\$wh$aTaste Threshold
=667  \\$adifferentiate from TASTE PERCEPTION: TASTE takes place in the mouth, TASTE PERCEPTION takes place in the brain
=680  \\$iThe ability to detect chemicals through gustatory receptors in the mouth, including those on the TONGUE; the PALATE; the PHARYNX; and the EPIGLOTTIS.
=750  \0$aTaste$0(DLC) sh 85132732$5IEN

=LDR  01960cz  a2200517n  4500
=001  9880363889402441
=005  20141212210054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013647
=035  \\$aCBA6978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x412.$x846
=072  \\$aF2.$x784.$x692.$x746
=072  \\$aF2.$x808.$x600
=150  \\$aTask Performance and Analysis
=450  \\$wnnna$aCritical Incident Technic
=450  \\$wnnna$aCritical Incident Technics
=450  \\$aCritical Incident Technique
=450  \\$wnnna$aCritical Incident Techniques
=450  \\$wnnna$aIncident Technic, Critical
=450  \\$wnnna$aIncident Technics, Critical
=450  \\$wnnna$aIncident Technique, Critical
=450  \\$wnnna$aIncident Techniques, Critical
=450  \\$wnnna$aPerformance, Analysis Task
=450  \\$wnnna$aPerformance, Task
=450  \\$wnnna$aPerformances, Analysis Task
=450  \\$wnnna$aPerformances, Task
=450  \\$aTask Analysis$5IEN
=450  \\$wnnna$aTask Performance
=450  \\$wnnna$aTask Performance, Analysis
=450  \\$wnnna$aTask Performances
=450  \\$wnnna$aTask Performances, Analysis
=450  \\$wnnna$aTechnic, Critical Incident
=450  \\$wnnna$aTechnics, Critical Incident
=450  \\$wnnna$aTechnique, Critical Incident
=450  \\$wnnna$aTechniques, Critical Incident
=550  \\$wg$aHuman Engineering
=550  \\$wg$aPsychology, Industrial
=550  \\$wg$aPsychomotor Performance
=550  \\$wh$aTime and Motion Studies
=550  \\$wh$aWork Simplification
=550  \\$aSystems Analysis
=667  \\$ado not use for anal of performance on individual tasks in learning exper; no qualif; DF: TASK PERFORMANCE
=680  \\$iThe detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work.
=688  \\$a73(72)
=750  \0$aTask analysis$5IEN$0(DLC)sh 86002281

=LDR  00684cz  a2200193n  4500
=001  9880363889502441
=005  20141212210052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013638
=035  \\$aCBA6969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x749
=150  \\$aTars
=550  \\$wg$aComplex Mixtures
=550  \\$wh$aCoal Tar
=550  \\$wh$aTar-Water
=667  \\$aD25-26 qualif
=680  \\$iViscous materials composed of complex, high-molecular-weight compounds derived from the distillation of petroleum or the destructive distillation of wood or coal. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aTar$5IEN$0(DLC)sh 85132442

=LDR  00793cz  a2200277n  4500
=001  9880363889602441
=005  20141212210051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013637
=035  \\$aCBA6968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x846
=072  \\$aL1.$x178.$x820.$x90.$x846
=072  \\$aL1.$x240.$x940
=150  \\$aTape Recording
=450  \\$wnnna$aAudiotape
=450  \\$wnnna$aAudiotapes
=450  \\$wnnna$aRecording, Tape
=450  \\$wnnna$aTape Recordings
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aCopying Processes
=550  \\$wh$aVideotape Recording
=667  \\$aIM
=680  \\$iRecording of information on magnetic or punched paper tape.
=688  \\$a67(64)
=750  \0$aAudiotapes$5IEN$0(DLC)sh 85101069

=LDR  00886cz  a2200205n  4500
=001  9880363889702441
=005  20141212210051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013635
=035  \\$aCBA6966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x837
=072  \\$aD1.$x268.$x956.$x859
=072  \\$aD1.$x552.$x544.$x837
=150  \\$aTantalum
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aTa-181; Ta-180 = TANTALUM (IM) + ISOTOPES (NIM); Ta-172-179, 182-186 = TANTALUM (IM) + RADIOISOTOPES (IM)
=680  \\$iTantalum. A rare metallic element, atomic number 73, atomic weight 180.948, symbol Ta. It is a noncorrosive and malleable metal that has been used for plates or disks to replace cranial defects, for wire sutures, and for making prosthetic devices. (Dorland, 28th ed)
=750  \0$aTantalum$5IEN$0(DLC)sh 85132346

=LDR  01134cz  a2200241n  4500
=001  9880363889802441
=005  20141212210051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013634
=035  \\$aCBA6965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x937
=150  \\$aTannins
=450  \\$wnnna$aAcid, Tannic
=450  \\$wnnna$aAcids, Tannic
=450  \\$wnnna$aTannic Acid
=450  \\$wnnna$aTannic Acids
=550  \\$wg$aBiopolymers
=550  \\$wh$aHydrolyzable Tannins
=550  \\$wh$aProanthocyanidins
=667  \\$aHYDROLYZABLE TANNINS is also available
=680  \\$iPolyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS). The two main types are HYDROLYZABLE TANNINS and CONDENSED TANNINS. Historically, the term has applied to many compounds and plant extracts able to render skin COLLAGEN impervious to degradation. The word tannin derives from the Celtic word for OAK TREE which was used for leather processing.
=750  \0$aTannins$0(DLC) sh 85132335$5IEN

=LDR  00801cz  a2200181n  4500
=001  9880363889902441
=005  20141212210050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013633
=035  \\$aCBA6964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x852
=150  \\$aTanning
=450  \\$wnnna$aTannings
=550  \\$wg$aIndustry
=667  \\$athe leather industry, not suntanning; SPEC: SPEC qualif
=680  \\$iA process of preserving animal hides by chemical treatment (using vegetable tannins, metallic sulfates, and sulfurized phenol compounds, or syntans) to make them immune to bacterial attack, and subsequent treatments with fats and greases to make them pliable. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=750  \0$aTanning$5IEN$0(DLC)sh 85132332

=LDR  01390cz  a2200397n  4500
=001  9880363890002441
=005  20141212210049.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013629
=035  \\$aCBA6960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x700.$x900
=150  \\$aTamoxifen
=450  \\$wnnna$aCitrate, Tamoxifen
=450  \\$wnnna$aICI-46,474
=450  \\$wnnna$aICI 46,474
=450  \\$wnnna$aICI-46474
=450  \\$wnnna$aICI 46474
=450  \\$wnnna$aICI-47699
=450  \\$wnnna$aICI 47699
=450  \\$wnnna$aICI46,474
=450  \\$wnnna$aICI46474
=450  \\$wnnna$aICI47699
=450  \\$wnnna$aNolvadex
=450  \\$wnnna$aNovaldex
=450  \\$wnnna$aSavient brand of Tamoxifen Citrate
=450  \\$wnnna$aSoltamox
=450  \\$wnnna$aTamoxifen Citrate
=450  \\$wnnna$aTomaxithen
=450  \\$wnnna$aZitazonium
=550  \\$wg$aStilbenes
=550  \\$wh$aRaloxifene
=550  \\$wh$aToremifene
=680  \\$iOne of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.
=688  \\$a78(75); was see under STILBENES 1975-77
=750  \0$aTamoxifen$5IEN$0(DLC)sh 85132219

=LDR  00734cz  a2200241n  4500
=001  9880363890102441
=005  20141212210049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013628
=035  \\$aCBA6959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x300.$x710.$x780
=150  \\$aTalus
=450  \\$aAnklebone$5IEN
=450  \\$aAstragalus Bone
=450  \\$wnnna$aAstragalus Bones
=450  \\$wnnna$aBone, Astragalus
=450  \\$wnnna$aBones, Astragalus
=450  \\$aOs Trigonum
=550  \\$wg$aTarsal Bones
=550  \\$aHeel
=680  \\$iThe second largest of the TARSAL BONES. It articulates with the TIBIA and FIBULA to form the ANKLE JOINT.
=750  \0$aAnklebone$5IEN$0(DLC)sh 85005322

=LDR  00890cz  a2200205n  4500
=001  9880363890202441
=005  20141212210048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013627
=035  \\$aCBA6958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x524.$x500.$x850
=072  \\$aD1.$x578.$x725.$x500.$x800
=072  \\$aD1.$x837.$x725.$x700.$x760.$x535.$x800
=150  \\$aTalc
=450  \\$wnnna$aTalcum Powder
=550  \\$wg$aMagnesium Silicates
=667  \\$atalc granuloma = TALC /adv eff + GRANULOMA, FOREIGN-BODY /etiol (not /chem ind)
=680  \\$iFinely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. (From Merck Index, 11th ed)
=750  \0$aTalc$5IEN$0(DLC)sh 85132075

=LDR  00508cz  a2200181n  4500
=001  9880363890302441
=005  20141212210047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013623
=035  \\$aCBA6954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x895
=150  \\$aTail
=450  \\$wnnna$aTails
=550  \\$wg$aAnimal Structures
=667  \\$aavoid such combinations as TAIL /metab or TAIL /chem, etc. where tail is merely test tissue
=688  \\$a68
=750  \0$aTail$5IEN$0(DLC)sh 85131941

=LDR  01230cz  a2200253n  4500
=001  9880363890402441
=005  20141212210046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x895
=150  \\$aTaenia
=450  \\$aTaeniarhynchus
=450  \\$wnnna$aTaenias
=550  \\$wg$aCestoda
=550  \\$wh$aCysticercus
=550  \\$wh$aTaenia saginata
=550  \\$wh$aTaenia solium
=550  \\$aCysticercosis
=550  \\$aNeurocysticercosis
=667  \\$aa tapeworm: do not confuse with TINEA (ringworm, a disease); do not confuse with TAENIA COLI see COLON; do not confuse X ref TAENIARHYNCHUS with Taeniorhyncus, a mosquito; infection = TAENIASIS; Taenia echinococcus = Echinococcus granulosus, its infection = ECHINOCOCCOSIS; larval form of TAENIA SAGINATA = Cysticercus bovis, its infection = CYSTICERCOSIS; larval form of TAENIA SOLIUM = CYSTICERCUS; its infection = CYSTICERCOSIS or NEUROCYSTICERCOSIS; coord with specific precoord helminth term (ANTIGENS, HELMINTH, etc) if pertinent
=680  \\$iA genus of large tapeworms.
=688  \\$aTAENIARHYNCHUS was see under TAENIA 1966-78
=750  \0$aTaenia$5IEN$0(DLC)sh 85131885

=LDR  00919cz  a2200217n  4500
=001  9880363890502441
=005  20141212210045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013618
=035  \\$aCBA6949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x260.$x910
=072  \\$aG7.$x700.$x680.$x260.$x910
=072  \\$aG12.$x425.$x746.$x425.$x910
=150  \\$aTachyphylaxis
=550  \\$wg$aDrug Tolerance
=550  \\$wg$aImmune Tolerance
=667  \\$a"rapidly decreasing response to a drug or physiol active agent after admin of a few doses"
=680  \\$iRapidly decreasing response to a drug or physiologically active agent after administration of a few doses. In immunology, it is the rapid immunization against the effect of toxic doses of an extract or serum by previous injection of small doses. (Dorland, 28th ed)
=688  \\$a66(63)
=750  \0$aTachyphylaxis$5IEN$0(DLC)sh 86000070

=LDR  01557cz  a2200349n  4500
=001  9880363890602441
=005  20141212211000.0
=008  880531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015320
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x812.$x900
=072  \\$aD12.$x644.$x400.$x800
=072  \\$aD12.$x644.$x456.$x800
=072  \\$aD12.$x776.$x467.$x812.$x900
=072  \\$aD12.$x776.$x641.$x650.$x800
=072  \\$aD23.$x469.$x50.$x375.$x850
=072  \\$aD23.$x529.$x812.$x900
=150  \\$aTachykinins
=450  \\$wnnna$aTachykinin
=550  \\$wg$aKinins
=550  \\$wg$aNeuropeptides
=550  \\$wg$aOligopeptides
=550  \\$wh$aEledoisin
=550  \\$wh$aKassinin
=550  \\$wh$aNeurokinin A
=550  \\$wh$aNeurokinin B
=550  \\$wh$aPhysalaemin
=550  \\$wh$aSubstance P
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.
=688  \\$a89; PHYSALAEMIN was see under KININS 1977-88
=750  \0$aTachykinins$5IEN$0(DLC)sh 85131850

=LDR  01002cz  a2200277n  4500
=001  9880363890702441
=005  20141212210044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013614
=035  \\$aCBA6944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x845.$x695
=072  \\$aC23.$x550.$x73.$x845.$x695
=150  \\$aTachycardia, Paroxysmal
=450  \\$wnnna$aParoxysmal Reciprocal Tachycardia
=450  \\$wnnna$aParoxysmal Reciprocal Tachycardias
=450  \\$wnnna$aParoxysmal Tachycardia
=450  \\$wnnna$aParoxysmal Tachycardias
=450  \\$wnnna$aReciprocal Tachycardia, Paroxysmal
=450  \\$wnnna$aReciprocal Tachycardias, Paroxysmal
=450  \\$wnnna$aTachycardia, Paroxysmal Reciprocal
=450  \\$wnnna$aTachycardias, Paroxysmal
=450  \\$wnnna$aTachycardias, Paroxysmal Reciprocal
=550  \\$wg$aTachycardia
=680  \\$iAbnormally rapid heartbeats with sudden onset and cessation.
=750  \0$aParoxysmal tachycardia$5IEN$0(DLC)sh 85098277

=LDR  01061cz  a2200265n  4500
=001  9880363890802441
=005  20141212210043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013610
=035  \\$aCBA6940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x845
=072  \\$aC23.$x550.$x73.$x845
=150  \\$aTachycardia
=450  \\$aTachyarrhythmia
=450  \\$wnnna$aTachyarrhythmias
=450  \\$wnnna$aTachycardias
=550  \\$wg$aArrhythmias, Cardiac
=550  \\$wh$aTachycardia, Paroxysmal
=550  \\$wh$aTachycardia, Reciprocating
=550  \\$wh$aTachycardia, Supraventricular
=550  \\$wh$aTachycardia, Ventricular
=667  \\$ageneral or unspecified: prefer specific types; exercise tachycardia = HEART RATE (IM) + PHYSICAL EXERTION (NIM)
=680  \\$iAbnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
=750  \0$aTachycardia$0(DLC) sh 85131847$5IEN

=LDR  00546cz  a2200169n  4500
=001  9880363890902441
=005  20141212210042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013609
=035  \\$aCBA6939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x948
=150  \\$aTaboo
=450  \\$wnnna$aTaboos
=550  \\$wg$aCulture
=680  \\$iAny negative tradition or behavior that is generally regarded as harmful to social welfare and forbidden within a cultural or social group.
=750  \0$aTaboo$5IEN$0(DLC)sh 85131822

=LDR  00924cz  a2200217n  4500
=001  9880363891002441
=005  20141212192554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013608
=035  \\$aCBA6938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x210.$x860
=072  \\$aD26.$x255.$x830.$x860
=150  \\$aTablets, Enteric-Coated
=450  \\$wnnna$aEnteric-Coated Tablets
=450  \\$wnnna$aTablets, Enteric Coated
=550  \\$wg$aDelayed-Action Preparations
=550  \\$wg$aTablets
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) when drug in tablet form is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the "tablet"
=680  \\$iTablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed)
=750  \0$aEnteric-coated tablets$5IEN$0(DLC)sh 85044075

=LDR  00877cz  a2200193n  4500
=001  9880363891102441
=005  20141212192554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013607
=035  \\$aCBA6937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x830
=150  \\$aTablets
=550  \\$wg$aDosage Forms
=550  \\$wh$aTablets, Enteric-Coated
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) when drug in tablet form is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in the tablet, not the "tablet"
=680  \\$iSolid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)
=750  \0$aTablets (Medicine)$5IEN-M$0(DLC)sh 85131814
=750  \0$aTableting$5IEN-HS$0(DLC)sh 88001152

=LDR  02016cz  a2200421n  4500
=001  9880363891202441
=005  20141212210042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013606
=035  \\$aCBA6936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x744.$x456.$x778
=072  \\$aC1.$x252.$x847.$x840.$x744.$x456.$x778
=072  \\$aC10.$x228.$x228.$x180.$x600.$x800
=072  \\$aC10.$x228.$x854.$x889
=150  \\$aTabes Dorsalis
=450  \\$wnnna$aAtaxia, Locomotor
=450  \\$wnnna$aAtaxias, Locomotor
=450  \\$aLocomotor Ataxia
=450  \\$wnnna$aLocomotor Ataxias
=450  \\$wnnna$aMeningomyelitides, Syphilitic
=450  \\$wnnna$aMeningomyelitis, Syphilitic
=450  \\$wnnna$aMeningovascular Syphilis, Spinal
=450  \\$aMyelosyphilis
=450  \\$wnnna$aNeurosyphilis, Tabetic
=450  \\$wnnna$aSpinal Cord Syphilis
=450  \\$wnnna$aSpinal Meningovascular Syphilis
=450  \\$wnnna$aSpinalis, Tabes
=450  \\$aSyphilis, Spinal Cord
=450  \\$wnnna$aSyphilis, Spinal Meningovascular
=450  \\$wnnna$aSyphilitic Meningomyelitides
=450  \\$wnnna$aSyphilitic Meningomyelitis
=450  \\$wnnna$aTabes Spinalis
=450  \\$wnnna$aTabetic Neurosyphilis
=550  \\$wg$aNeurosyphilis
=550  \\$wg$aSpinal Cord Diseases
=680  \\$iParenchymatous NEUROSYPHILIS marked by slowly progressive degeneration of the posterior columns, posterior roots, and ganglia of the spinal cord. The condition tends to present 15 to 20 years after the initial infection and is characterized by lightening-like pains in the lower extremities, URINARY INCONTINENCE; ATAXIA; severely impaired position and vibratory sense, abnormal gait (see GAIT DISORDERS, NEUROLOGIC), OPTIC ATROPHY; Argyll-Robertson pupils, hypotonia, hyperreflexia, and trophic joint degeneration (Charcot's Joint; see ARTHROPATHY, NEUROGENIC). (From Adams et al., Principles of Neurology, 6th ed, p726)
=750  \0$aLocomotor ataxia$5IEN$0(DLC)sh 85078031

=LDR  01808cz  a2200409n  4500
=001  9880363891302441
=005  20141212210040.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013601
=035  \\$aCBA6931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569
=150  \\$aT-Lymphocytes
=450  \\$wnnna$aLymphocyte, Thymus-Dependent
=450  \\$wnnna$aLymphocytes, Thymus-Dependent
=450  \\$wnnna$aT-Cell
=450  \\$aT-Cells
=450  \\$wnnna$aT Cells
=450  \\$wnnna$aT-Lymphocyte
=450  \\$wnnna$aT Lymphocytes
=450  \\$wnnna$aThymus-Dependent Lymphocyte
=450  \\$aThymus-Dependent Lymphocytes
=450  \\$wnnna$aThymus Dependent Lymphocytes
=550  \\$wg$aLymphocytes
=550  \\$wh$aCD4-Positive T-Lymphocytes
=550  \\$wh$aCD8-Positive T-Lymphocytes
=550  \\$wh$aJurkat Cells
=550  \\$wh$aNatural Killer T-Cells
=550  \\$wh$aPrecursor Cells, T-Lymphoid
=550  \\$wh$aT-Lymphocyte Subsets
=667  \\$ageneral; prefer specifics; subpopulations: coordinate T-LYMPHOCYTE SUBSETS (IM) with specific T-LYMPHOCYTE (IM)
=680  \\$iLymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
=688  \\$a1990 (1973)
=688  \\$a90; was T LYMPHOCYTES 1973-89; T-LYMPHOCYTES, REGULATORY was heading 1985-94
=750  \0$aT cells$5IEN$0(DLC)sh 85131766

=LDR  01352cz  a2200349n  4500
=001  9880363891402441
=005  20141212210039.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013598
=035  \\$aCBA6928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x808
=150  \\$aSystems Theory
=450  \\$wnnna$aGeneral Systems Theories
=450  \\$aGeneral Systems Theory
=450  \\$wnnna$aQueuing Theories
=450  \\$aQueuing Theory
=450  \\$aSystem Theory$5IEN
=450  \\$wnnna$aSystems Theories
=450  \\$wnnna$aSystems Theories, General
=450  \\$wnnna$aSystems Theory, General
=450  \\$wnnna$aTheories, General Systems
=450  \\$wnnna$aTheories, Queuing
=450  \\$wnnna$aTheories, Systems
=450  \\$wnnna$aTheory, General Systems
=450  \\$wnnna$aTheory, Queuing
=450  \\$wnnna$aTheory, Systems
=550  \\$wg$aScience
=550  \\$aSystems Biology
=680  \\$iPrinciples, models, and laws that apply to complex interrelationships and interdependencies of sets of linked components which form a functioning whole, a system. Any system may be composed of components which are systems in their own right (sub-systems), such as several organs within an individual organism.
=688  \\$a80; was see SYSTEMS ANALYSIS 1976-79
=750  \0$aSystem theory$5IEN$0(DLC)sh 85131743

=LDR  00970cz  a2200289n  4500
=001  9880363891502441
=005  20141212210039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013597
=035  \\$aCBA6927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x906
=150  \\$aSystems Analysis
=450  \\$wnnna$aAnalyses, Systems
=450  \\$wnnna$aAnalysis, Systems
=450  \\$aSystem Analysis$5IEN
=450  \\$wnnna$aSystems Analyses
=550  \\$wg$aInformation Science
=550  \\$wh$aOperations Research
=550  \\$wh$aSystems Integration
=550  \\$wh$aWorkflow
=550  \\$aResearch
=550  \\$aSystems Theory
=667  \\$ano qualif
=680  \\$iThe analysis of an activity, procedure, method, technique, or business to determine what must be accomplished and how the necessary operations may best be accomplished.
=688  \\$a66(65); was see under HUMAN ENGINEERING 1963-65
=750  \0$aSystem analysis$5IEN$0(DLC)sh 85131733

=LDR  01430cz  a2200289n  4500
=001  9880363891602441
=005  20141212210038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013595
=035  \\$aCBA6925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x854.$x833
=150  \\$aSyringomyelia
=450  \\$aHydrosyringomyelia
=450  \\$wnnna$aHydrosyringomyelias
=450  \\$aMorvan Disease
=450  \\$wnnna$aMorvan Diseases
=450  \\$wnnna$aMorvan's Disease
=450  \\$wnnna$aMorvans Disease
=450  \\$wnnna$aMorvan's Diseases
=450  \\$wnnna$aMyelosyringoses
=450  \\$wnnna$aMyelosyringosis
=450  \\$wnnna$aSyringomyelias
=450  \\$wnnna$aSyringomyelus
=550  \\$wg$aSpinal Cord Diseases
=680  \\$iLongitudinal cavities in the spinal cord, most often in the cervical region, which may extend for multiple spinal levels. The cavities are lined by dense, gliogenous tissue and may be associated with SPINAL CORD NEOPLASMS; spinal cord traumatic injuries; and vascular malformations. Syringomyelia is marked clinically by pain and PARESTHESIA, muscular atrophy of the hands, and analgesia with thermoanesthesia of the hands and arms, but with the tactile sense preserved (sensory dissociation). Lower extremity spasticity and incontinence may also develop. (From Adams et al., Principles of Neurology, 6th ed, p1269)
=750  \0$aSyringomyelia$5IEN$0(DLC)sh 85131723

=LDR  00727cz  a2200241n  4500
=001  9880363891702441
=005  20141212210038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013594
=035  \\$aCBA6924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x877
=150  \\$aSyringes
=450  \\$wnnna$aHypodermic Syringe
=450  \\$wnnna$aHypodermic Syringes
=450  \\$wnnna$aKarman Syringe
=450  \\$wnnna$aSyringe
=450  \\$wnnna$aSyringe, Hypodermic
=450  \\$wnnna$aSyringe, Karman
=450  \\$wnnna$aSyringes, Hypodermic
=550  \\$wg$aEquipment and Supplies
=680  \\$iInstruments used for injecting or withdrawing fluids. (Stedman, 25th ed)
=750  \0$aSyringes$5IEN$0(DLC)sh 85131721

=LDR  01180cz  a2200289n  4500
=001  9880363891802441
=005  20141212210037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013590
=035  \\$aCBA6920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x744.$x725
=072  \\$aC1.$x252.$x847.$x840.$x744.$x725
=072  \\$aC16.$x614.$x868
=150  \\$aSyphilis, Congenital
=450  \\$wnnna$aCongenital Syphilis
=450  \\$wnnna$aHutchinson Teeth
=450  \\$aHutchinson's Teeth
=450  \\$wnnna$aHutchinsons Teeth
=450  \\$aSyphilis$xcongenital
=450  \\$wnnna$aTeeth, Hutchinson's
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aSyphilis
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iSyphilis acquired in utero and manifested by any of several characteristic tooth (Hutchinson's teeth) or bone malformations and by active mucocutaneous syphilis at birth or shortly thereafter. Ocular and neurologic changes may also occur.
=688  \\$aHUTCHINSON'S TEETH was heading 1965-91
=750  \0$aSyphilis, Congenital, hereditary, and infantile$5IEN-M$0(DLC)sh 85131688

=LDR  01440cz  a2200301n  4500
=001  9880363891902441
=005  20141212210037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013589
=035  \\$aCBA6919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x744.$x657
=072  \\$aC1.$x252.$x847.$x840.$x744.$x657
=072  \\$aC1.$x539.$x190.$x500
=072  \\$aC14.$x260.$x500
=150  \\$aSyphilis, Cardiovascular
=450  \\$wnnna$aAortitides, Syphilitic
=450  \\$aAortitis, Syphilitic
=450  \\$aCardiovascular Syphilis
=450  \\$wnnna$aSyphilitic Aortitides
=450  \\$wnnna$aSyphilitic Aortitis
=550  \\$wg$aCardiovascular Infections
=550  \\$wg$aSyphilis
=667  \\$acoordinate IM with specific cardiovascular term (IM) or specific cardiovascular disease (IM); note entry term AORTITIS, SYPHILITIC
=680  \\$iCardiovascular manifestations of SYPHILIS, an infection of TREPONEMA PALLIDUM. In the late stage of syphilis, sometimes 20-30 years after the initial infection, damages are often seen in the blood vessels including the AORTA and the AORTIC VALVE. Clinical signs include syphilitic aortitis, aortic insufficiency, or aortic ANEURYSM.
=688  \\$aAORTITIS, SYPHILITIC was see under SYPHILIS, CARDIOVASCULAR 1963-83 (Prov 1963-74)
=750  \0$aHeart$xSyphilis$5IEN-M$0(DLC)sh 85059720
=750  \0$aCardiovascular system$xSyphilis$5IEN-HS$0(DLC)sh 85020239

=LDR  01130cz  a2200325n  4500
=001  9880363892002441
=005  20141212210036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013588
=035  \\$aCBA6918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x850
=072  \\$aE5.$x200.$x812.$x735.$x850
=072  \\$aE5.$x478.$x594.$x760.$x850
=150  \\$aSyphilis Serodiagnosis
=450  \\$aKahn Test
=450  \\$wnnna$aReaction, Wassermann
=450  \\$wnnna$aSerodiagnoses, Syphilis
=450  \\$wnnna$aSerodiagnosis, Syphilis
=450  \\$wnnna$aSyphilis Serodiagnoses
=450  \\$wnnna$aTest, Kahn
=450  \\$aWassermann Reaction
=550  \\$wg$aSerologic Tests
=550  \\$wh$aFluorescent Treponemal Antibody-Absorption Test
=550  \\$wh$aTreponema Immobilization Test
=550  \\$aCardiolipins
=667  \\$ado not use /util except by MeSH definition; DF: SYPHILIS SERODIAG
=680  \\$iSerologic tests for syphilis.
=688  \\$aWASSERMANN REACTION was heading 1963-96; KAHN TEST was heading 1963-91
=750  \0$aSyphilis$xSerodiagnosis$0(IEN)4263345$5IEN-M

=LDR  01105cz  a2200325n  4500
=001  9880363892102441
=005  20141212210036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013587
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x744
=072  \\$aC1.$x252.$x810.$x859
=072  \\$aC1.$x252.$x847.$x840.$x744
=072  \\$aC1.$x539.$x778.$x281.$x859
=072  \\$aC12.$x294.$x668.$x281.$x859
=072  \\$aC13.$x351.$x500.$x711.$x281.$x859
=150  \\$aSyphilis
=450  \\$aGreat Pox
=450  \\$wnnna$aPox, Great
=550  \\$wg$aSexually Transmitted Diseases, Bacterial
=550  \\$wg$aTreponemal Infections
=550  \\$wh$aChancre
=550  \\$wh$aNeurosyphilis
=550  \\$wh$aSyphilis, Cardiovascular
=550  \\$wh$aSyphilis, Congenital
=550  \\$wh$aSyphilis, Cutaneous
=550  \\$wh$aSyphilis, Latent
=667  \\$a/diag: consider also SYPHILIS SERODIAGNOSIS; note terms for specific types of syphilis
=680  \\$iA contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.
=750  \0$aSyphilis$5IEN$0(DLC)sh 85131679

=LDR  00798cz  a2200205n  4500
=001  9880363892202441
=005  20180712135606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013585
=035  \\$aCBA6915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x870
=150  \\$aSynovitis
=450  \\$wnnna$aSynovitides
=550  \\$wg$aJoint Diseases
=550  \\$wh$aGiant Cell Tumor of Tendon Sheath
=550  \\$wh$aSynovitis, Pigmented Villonodular
=667  \\$ainflamm of synovial membrane: do not confuse with TENOSYNOVITIS, inflamm of tendon sheath
=680  \\$iInflammation of a synovial membrane. It is usually painful, particularly on motion, and is characterized by a fluctuating swelling due to effusion within a synovial sac. (Dorland, 27th ed)
=750  \2$aSynovitis$5IEN

=LDR  01458cz  a2200265n  4500
=001  9880363892302441
=005  20141212210035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013584
=035  \\$aCBA6914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x835
=072  \\$aC4.$x557.$x450.$x795.$x875
=150  \\$aSarcoma, Synovial
=450  \\$wnnna$aSarcomas, Synovial
=450  \\$wnnna$aSynovial Sarcoma
=450  \\$wnnna$aSynovial Sarcomas
=450  \\$aSynovioma
=450  \\$wnnna$aSynoviomas
=550  \\$wg$aNeoplasms, Connective Tissue
=550  \\$wg$aSarcoma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)
=688  \\$a94; was SYNOVIOMA 1963-93
=750  \0$aSynovioma$5IEN$0(DLC)sh 85131651

=LDR  00880cz  a2200253n  4500
=001  9880363892402441
=005  20141212210035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013583
=035  \\$aCBA6913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x443.$x800
=150  \\$aSynovial Membrane
=450  \\$wnnna$aMembrana Synovialis Capsulae Articularis
=450  \\$wnnna$aMembrane, Synovial
=450  \\$wnnna$aMembranes, Synovial
=450  \\$wnnna$aSynovial Membranes
=450  \\$aSynovium
=550  \\$wg$aJoint Capsule
=550  \\$wh$aSynovial Fluid
=550  \\$aMembranes
=667  \\$ainflammation = SYNOVITIS
=680  \\$iThe inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID.
=750  \0$aSynovial membranes$5IEN$0(DLC)sh 85131649

=LDR  00771cz  a2200229n  4500
=001  9880363892502441
=005  20141212210034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013582
=035  \\$aCBA6912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x443.$x800.$x800
=072  \\$aA12.$x207.$x270.$x847
=150  \\$aSynovial Fluid
=450  \\$wnnna$aFluid, Synovial
=450  \\$wnnna$aFluids, Synovial
=450  \\$aSynovia
=450  \\$wnnna$aSynovial Fluids
=550  \\$wg$aExtracellular Fluid
=550  \\$wg$aSynovial Membrane
=680  \\$iThe clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints.
=750  \0$aSynovial fluid$5IEN$0(DLC)sh 85131647

=LDR  00713cz  a2200241n  4500
=001  9880363892602441
=005  20141212210033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013577
=035  \\$aCBA6907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x288.$x500
=150  \\$aSyndrome
=450  \\$wnnna$aCluster, Symptom
=450  \\$wnnna$aClusters, Symptom
=450  \\$wnnna$aSymptom Cluster
=450  \\$wnnna$aSymptom Clusters
=450  \\$wnnna$aSyndromes
=550  \\$wg$aDisease
=667  \\$aNIM; policy: Manual 23.20.2.1, 23.26+
=680  \\$iA characteristic symptom complex.
=688  \\$a91(72); was see under DISEASE 1972-90
=750  \0$aSyndromes$0(DLC) sh 85131629$5IEN-M

=LDR  03279cz  a2200901n  4500
=001  9880363892702441
=005  20141212210032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013575
=035  \\$aCBA6905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x358.$x800.$x600
=072  \\$aC23.$x888.$x592.$x604.$x359.$x800.$x600
=150  \\$aSyncope
=450  \\$wnnna$aAttack, Drop
=450  \\$wnnna$aCardiogenic Syncope
=450  \\$wnnna$aCardiogenic Syncopes
=450  \\$wnnna$aCarotid Sinus Syncope
=450  \\$wnnna$aCarotid Sinus Syncopes
=450  \\$wnnna$aConvulsive Syncope
=450  \\$wnnna$aConvulsive Syncopes
=450  \\$wnnna$aDeglutitional Syncope
=450  \\$wnnna$aDeglutitional Syncopes
=450  \\$aDrop Attack
=450  \\$wnnna$aDrop Attacks
=450  \\$wnnna$aEffort Syncope
=450  \\$wnnna$aEffort Syncopes
=450  \\$wnnna$aEpisode, Syncopal
=450  \\$aFainting
=450  \\$wnnna$aHyperventilation Syncope
=450  \\$wnnna$aHyperventilation Syncopes
=450  \\$wnnna$aMicturition Syncope
=450  \\$wnnna$aMicturition Syncopes
=450  \\$wnnna$aPostural Syncope
=450  \\$wnnna$aPostural Syncopes
=450  \\$aPresyncope
=450  \\$wnnna$aPresyncopes
=450  \\$wnnna$aSituational Syncope
=450  \\$wnnna$aSituational Syncopes
=450  \\$wnnna$aStokes-Adams Syncope
=450  \\$wnnna$aStokes-Adams Syncopes
=450  \\$wnnna$aSyncopal Episode
=450  \\$wnnna$aSyncopal Episodes
=450  \\$wnnna$aSyncopal Vertigo
=450  \\$wnnna$aSyncope, Cardiogenic
=450  \\$wnnna$aSyncope, Carotid Sinus
=450  \\$wnnna$aSyncope, Convulsive
=450  \\$wnnna$aSyncope, Deglutitional
=450  \\$wnnna$aSyncope, Effort
=450  \\$wnnna$aSyncope, Hyperventilation
=450  \\$wnnna$aSyncope, Micturition
=450  \\$aSyncope, Postural
=450  \\$wnnna$aSyncope, Situational
=450  \\$wnnna$aSyncope, Stokes-Adams
=450  \\$wnnna$aSyncope, Stokes Adams
=450  \\$wnnna$aSyncope, Tussive
=450  \\$wnnna$aSyncopes
=450  \\$wnnna$aSyncopes, Cardiogenic
=450  \\$wnnna$aSyncopes, Carotid Sinus
=450  \\$wnnna$aSyncopes, Convulsive
=450  \\$wnnna$aSyncopes, Deglutitional
=450  \\$wnnna$aSyncopes, Effort
=450  \\$wnnna$aSyncopes, Hyperventilation
=450  \\$wnnna$aSyncopes, Micturition
=450  \\$wnnna$aSyncopes, Postural
=450  \\$wnnna$aSyncopes, Situational
=450  \\$wnnna$aSyncopes, Stokes-Adams
=450  \\$wnnna$aSyncopes, Tussive
=450  \\$wnnna$aTussive Syncope
=450  \\$wnnna$aTussive Syncopes
=450  \\$wnnna$aVertigo, Syncopal
=450  \\$wnnna$aVertigos, Syncopal
=550  \\$wg$aUnconsciousness
=550  \\$wh$aSyncope, Vasovagal
=550  \\$aImmobility Response, Tonic
=550  \\$aUnconsciousness
=680  \\$iA transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
=750  \0$aSyncope (Pathology)$5IEN-M$0(DLC)sh 85131622

=LDR  00935cz  a2200229n  4500
=001  9880363892802441
=005  20141212192544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013378
=035  \\$aCBA6704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x413.$x656
=072  \\$aA8.$x186.$x211.$x653.$x413.$x374
=150  \\$aSubstantia Nigra
=450  \\$wnnna$aNigra, Substantia
=450  \\$wnnna$aNigras, Substantia
=450  \\$wnnna$aSubstantia Nigras
=550  \\$wg$aCerebral Peduncle
=550  \\$wh$aPars Compacta
=550  \\$wh$aPars Reticulata
=680  \\$iThe black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis.
=750  \0$aSubstantia nigra$5IEN$0(DLC)sh 90003406

=LDR  02163cz  a2200397n  4500
=001  9880363892902441
=005  20141212205931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013375
=035  \\$aCBA6701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x835
=072  \\$aF3.$x900.$x825
=150  \\$aSubstance Withdrawal Syndrome
=450  \\$wnnna$aDrug Withdrawal Symptom
=450  \\$aDrug Withdrawal Symptoms
=450  \\$wnnna$aSubstance Withdrawal Syndromes
=450  \\$wnnna$aSymptom, Drug Withdrawal
=450  \\$wnnna$aSymptom, Withdrawal
=450  \\$wnnna$aSymptoms, Drug Withdrawal
=450  \\$wnnna$aSymptoms, Withdrawal
=450  \\$wnnna$aSyndrome, Substance Withdrawal
=450  \\$wnnna$aSyndromes, Substance Withdrawal
=450  \\$wnnna$aWithdrawal Symptom
=450  \\$wnnna$aWithdrawal Symptom, Drug
=450  \\$aWithdrawal Symptoms
=450  \\$wnnna$aWithdrawal Symptoms, Drug
=450  \\$wnnna$aWithdrawal Syndrome, Substance
=450  \\$wnnna$aWithdrawal Syndromes, Substance
=550  \\$wg$aSubstance-Related Disorders
=550  \\$wh$aAlcohol Withdrawal Delirium
=550  \\$wh$aAlcohol Withdrawal Seizures
=667  \\$aincludes withdrawal from addictive drugs or other substances, administered drugs, smoking & alcohol (but DELIRIUM TREMENS see ALCOHOL WITHDRAWAL DELIRIUM is also available); do not use /compl for the symptom; coord IM with specific substance /adv eff (IM) + specific dis or symptom following withdrawal /chem ind (IM), e.g., hypertension after propranolol withdrawal = SUBSTANCE WITHDRAWAL SYNDROME (IM) + PROPRANOLOL /adv eff (IM) + HYPERTENSION /chem ind (IM); babies born to addicted mothers & developing withdraw symp = NEONATAL ABSTINENCE SYNDROME: see note there
=680  \\$iPhysiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
=688  \\$a81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 (Prov 1964-66)
=750  \0$aDrug withdrawal symptoms$5IEN$0(DLC)sh 85039718

=LDR  00912cz  a2200265n  4500
=001  9880914663702441
=005  20200424125218.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074067
=035  \\$a(NLM)9810900846900041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x256.$x100
=072  \\$aN6.$x230.$x80.$x100
=150  \\$aConservation of Water Resources
=450  \\$wnnna$aWater Conservation
=450  \\$wnnna$aWater Resources Conservation
=450  \\$wnnna$aConservation, Water
=450  \\$wnnna$aConservation, Water Resources
=450  \\$wnnna$aResources Conservation, Water
=450  \\$wnnna$aWater Resources Conservations
=550  \\$aWater Resources
=550  \\$wg$aConservation of Natural Resources
=680  \\$iPreservation and or management of WATER RESOURCES especially under conditions of scarce supply.
=688  \\$a2018
=750  \0$aWater conservation$0(DLC) sh 85145542

=LDR  00676cz  a2200193n  4500
=001  9880914664002441
=005  20200424123855.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076282
=035  \\$a(NLM)9810901620500041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x700.$x500
=072  \\$aN6.$x850.$x860.$x510.$x900.$x600.$x200
=150  \\$aComposting
=450  \\$wnnna$aCompost
=550  \\$wg$aRefuse Disposal
=680  \\$iA process of waste disposal involving the conversion of green waste (i.e. leaves, organic matter, food waste, manure) into soil-enhancing matter.
=688  \\$a2018
=750  \0$aCompost$0(DLC) sh 85029409$5IEN-M

=LDR  00525cz  a2200181n  4500
=001  9880914664102441
=005  20200424121818.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074263
=035  \\$a(NLM)9810900977500041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x186
=150  \\$aCoconut Oil
=450  \\$wnnna$aOil, Coconut
=550  \\$wg$aPlant Oils
=680  \\$iOil derived from fruits of the coconut plant, COCOS NUCIFERA.
=688  \\$a2018(1982)
=750  \0$aCoconut oil$0(DLC) sh 85027628$5IEN-M

=LDR  00632cz  a2200205n  4500
=001  9880914664402441
=005  20200423125243.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073865
=035  \\$a(NLM)9810900789600041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x805.$x375.$x750
=072  \\$aF1.$x145.$x958.$x875.$x750
=150  \\$aCigarette Smoking
=450  \\$wnnna$aSmoking, Cigarette
=550  \\$wg$aTobacco Smoking
=550  \\$aTobacco Products
=680  \\$iThe SMOKING of CIGARETTES.
=688  \\$a2018; use SMOKING 2008-2017
=750  \0$iRelated mapping$aCigarette smokers$0(DLC) sh 85025963$4RM$5IEN-M

=LDR  00562cz  a2200205n  4500
=001  9880914664502441
=005  20200423122942.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073863
=035  \\$a(NLM)9810900789900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 290
=072  \\$aF1.$x145.$x805.$x375.$x500
=072  \\$aF1.$x145.$x958.$x875.$x500
=150  \\$aCigar Smoking
=450  \\$wnnna$aSmoking, Cigar
=550  \\$wg$aTobacco Smoking
=550  \\$aTobacco Products
=680  \\$iThe SMOKING of CIGARS.
=688  \\$a2018; use SMOKING 2013-2017

=LDR  00784cz  a2200253n  4500
=001  9880914664702441
=005  20200423121343.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073921
=035  \\$a(NLM)9810900748000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x107
=150  \\$aChild, Foster
=450  \\$wnnna$aChildren, Foster
=450  \\$wnnna$aFoster Child
=450  \\$wnnna$aFoster Children
=450  \\$wnnna$aFoster Youth
=450  \\$wnnna$aFoster Youths
=450  \\$wnnna$aYouth, Foster
=450  \\$wnnna$aYouths, Foster
=550  \\$wg$aPersons
=680  \\$iIndividual who is unable to live safely with his or her family, usually due to abuse or neglect in the family home.
=688  \\$a2018
=750  \0$aFoster children$0(DLC) sh 86000380$5IEN-M

=LDR  00677cz  a2200229n  4500
=001  9880914664902441
=005  20200423120322.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073922
=035  \\$a(NLM)9810900747300041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x100
=150  \\$aChild, Adopted
=450  \\$wnnna$aAdopted, Children
=450  \\$wnnna$aChildren, Adopted
=450  \\$wnnna$aAdopted Child
=450  \\$wnnna$aAdopted Children
=450  \\$wnnna$aChildren Adopted
=550  \\$wg$aPersons
=680  \\$iIndividual who becomes a child of a family by means of legal action.
=688  \\$a2018
=750  \0$aAdopted children$0(DLC) sh 85023496$5IEN-M

=LDR  00928cz  a2200301n  4500
=001  9880914666102441
=005  20200422123043.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075782
=035  \\$a(NLM)9810901357900041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x209.$x186
=072  \\$aF1.$x145.$x813.$x537
=150  \\$aCell Phone Use
=450  \\$wnnna$aMobile Phone Use
=450  \\$wnnna$aCell Phone Uses
=450  \\$wnnna$aMobile Phone Uses
=450  \\$wnnna$aPhone Use, Cell
=450  \\$wnnna$aPhone Use, Mobile
=450  \\$wnnna$aUse, Cell Phone
=450  \\$wnnna$aUse, Mobile Phone
=450  \\$wnnna$aUses, Cell Phone
=450  \\$wnnna$aUses, Mobile Phone
=550  \\$wg$aCommunication
=550  \\$wg$aSocial Behavior
=680  \\$iUtilization of wireless phones for communication.
=688  \\$a2018
=750  \0$iRelated mapping$aCell phone users$0(DLC)sh2014000128$4RM$5IEN-M

=LDR  00571cz  a2200181n  4500
=001  9880914666202441
=005  20200422114459.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074423
=035  \\$a(NLM)9810901100500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x500
=150  \\$aCelastrales
=550  \\$wg$aRosanae
=550  \\$wh$aCelastraceae
=680  \\$iA taxonomic order of plants within the class MAGNOLIOPSIDA, which includes the staff vine.
=688  \\$a2018
=750  \2$aCelastrales$0(DLC) sh 88022658$5IEN-M

=LDR  01104cz  a2200325n  4500
=001  9880914770502441
=005  20200422112041.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073559
=035  \\$a(NLM)9810900684100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500
=150  \\$aCaryophyllales
=450  \\$wnnna$aCaryophyllale
=550  \\$wg$aCaryophyllanae
=550  \\$wh$aAizoaceae
=550  \\$wh$aAmaranthaceae
=550  \\$wh$aCactaceae
=550  \\$wh$aCaryophyllaceae
=550  \\$wh$aDioncophyllaceae
=550  \\$wh$aDroseraceae
=550  \\$wh$aMolluginaceae
=550  \\$wh$aNyctaginaceae
=550  \\$wh$aPhytolaccaceae
=550  \\$wh$aPlumbaginaceae
=550  \\$wh$aPortulacaceae
=550  \\$wh$aTamaricaceae
=680  \\$iDiverse and ecologically specialized dicotyledonous flowering plants that include trees, annuals, shrubs, lianas, mangroves, stem or leaf succulents, and insectivores; acting as important food sources in many cases.
=688  \\$a2018
=750  \0$aCaryophyllales$0(DLC)sh 85021959$5IEN-M

=LDR  01102cz  a2200301n  4500
=001  9880914869202441
=005  20200427180448.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073562
=035  \\$a(NLM)9810900678400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937.$x240
=150  \\$aCrotalinae
=450  \\$wnnna$aCrotalids
=450  \\$wnnna$aPit Viper
=450  \\$wnnna$aCrotalid
=450  \\$wnnna$aPit Vipers
=450  \\$wnnna$aViper, Pit
=450  \\$wnnna$aVipers, Pit
=550  \\$wg$aViperidae
=550  \\$wh$aAgkistrodon
=550  \\$wh$aBothrops
=550  \\$wh$aCrotalus
=550  \\$wh$aTrimeresurus
=667  \\$avenom = CROTALID VENOMS
=680  \\$iA subfamily of snakes commonly known as pit vipers, crotaline snakes, or pit adders in the family VIPERIDAE. They are distinguished by a deep pit called a fossa or loreal, which functions as a heat-sensing organ located between the eye and nostril on either side of the head.
=688  \\$a2018; use Viperidae 1994-2017
=750  \0$aPit vipers$0(DLC) sh 85102485$5IEN-M

=LDR  00731cz  a2200217n  4500
=001  9880914873802441
=005  20200415181636.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073930
=035  \\$a(NLM)9810900743800041
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x45.$x125
=072  \\$aG16.$x75.$x125
=150  \\$aBiological Coevolution
=450  \\$wnnna$aBiological Co-Evolution
=450  \\$wnnna$aCo-Evolution, Biological
=450  \\$wnnna$aCoevolution, Biological
=550  \\$wg$aBiological Evolution
=680  \\$iThe process of reciprocal evolutionary change occurring between pairs of species or among groups of species as they interact.
=688  \\$a2018
=750  \0$aCoevolution$0(DLC) sh 85027695$5IEN-M

=LDR  01002cz  a2200301n  4500
=001  9880914965502441
=005  20200428112830.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073920
=035  \\$a(NLM)9810900749400041
=040  \\$aDNLM$cDNLM
=060  \0$aQH 324.9.C7
=072  \\$aH1.$x158.$x273.$x195
=150  \\$aCryobiology
=450  \\$wnnna$aHibernation Biology
=450  \\$wnnna$aLow Temperature Biology
=450  \\$wnnna$aBiologies, Low Temperature
=450  \\$wnnna$aBiology, Hibernation
=450  \\$wnnna$aBiology, Low Temperature
=450  \\$wnnna$aHibernation Biologies
=450  \\$wnnna$aLow Temperature Biologies
=450  \\$wnnna$aTemperature Biologies, Low
=450  \\$wnnna$aTemperature Biology, Low
=550  \\$wg$aBiology
=667  \\$ause for the discipline only
=680  \\$iThe study of biological materials or systems subjected to temperatures below their normal range.
=688  \\$a2018
=750  \0$aCryobiology$0(DLC) sh 85034412$5IEN-M

=LDR  01349cz  a2200385n  4500
=001  9880914966002441
=005  20200427122132.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073181
=035  \\$a(NLM)9810900535500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x319
=150  \\$aCoral Snakes
=450  \\$wnnna$aAmerican Coral Snake
=450  \\$wnnna$aMicruroides
=450  \\$wnnna$aSonoran Coral Snake
=450  \\$aCoral Snake
=450  \\$aMicrurus
=450  \\$wnnna$aAmerican Coral Snakes
=450  \\$wnnna$aCoral Snake, American
=450  \\$wnnna$aCoral Snake, Sonoran
=450  \\$wnnna$aCoral Snakes, American
=450  \\$wnnna$aCoral Snakes, Sonoran
=450  \\$wnnna$aSnake, American Coral
=450  \\$wnnna$aSnake, Coral
=450  \\$wnnna$aSnake, Sonoran Coral
=450  \\$wnnna$aSnakes, American Coral
=450  \\$wnnna$aSnakes, Coral
=450  \\$wnnna$aSnakes, Sonoran Coral
=450  \\$wnnna$aSonoran Coral Snakes
=450  \\$wg$aElapidae
=550  \\$aElapid Venoms
=680  \\$iElapid snakes indigenous to the Southern United States, Central, and South America. They are generally less than 1 meter in length and have colored ring patterns.
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aCoral snakes$0(DLC) sh 93003424$5IEN-M

=LDR  01403cz  a2200397n  4500
=001  9880914966302441
=005  20200427111331.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073516
=035  \\$a(NLM)9810900688200041
=040  \\$aDNLM$cDNLM
=060  \0$aWP 630
=072  \\$aE2.$x875.$x194.$x573
=150  \\$aContraceptive Effectiveness
=450  \\$wnnna$aBirth Control Effectiveness
=450  \\$wnnna$aBirth Control Failure
=450  \\$wnnna$aContraception Failure
=450  \\$wnnna$aContraceptive Failure
=450  \\$wnnna$aBirth Control Failures
=450  \\$wnnna$aContraception Failures
=450  \\$wnnna$aContraceptive Failures
=450  \\$wnnna$aControl Failure, Birth
=450  \\$wnnna$aControl Failures, Birth
=450  \\$wnnna$aEffectiveness, Birth Control
=450  \\$wnnna$aEffectiveness, Contraceptive
=450  \\$wnnna$aFailure, Birth Control
=450  \\$wnnna$aFailure, Contraception
=450  \\$wnnna$aFailure, Contraceptive
=450  \\$wnnna$aFailures, Birth Control
=450  \\$wnnna$aFailures, Contraception
=450  \\$wnnna$aFailures, Contraceptive
=550  \\$wg$aContraception
=550  \\$aPregnancy, Unplanned
=680  \\$iThe rate of success or failure of a method of CONTRACEPTION; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.
=688  \\$a2018
=750  \0$aContraception$xFailures$0(DLC)sh 85031591$5IEN-M

=LDR  01287cz  a2200253n  4500
=001  9880914969202441
=005  20200420121039.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075224
=035  \\$a(NLM)9810901297300041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x280.$x123
=150  \\$aCardiac Conduction System Disease
=450  \\$wnnna$aCardiac Conduction Defect
=450  \\$wnnna$aCardiac Conduction Defects
=450  \\$wnnna$aCardiac Conduction System Diseases
=450  \\$wnnna$aConduction Defect, Cardiac
=450  \\$wnnna$aDefect, Cardiac Conduction
=550  \\$wg$aHeart Diseases
=680  \\$iDiseases characterized by pathological irregularities in the HEART CONDUCTION SYSTEM. They may be associated with other heart diseases and syndromes (e.g., BRUGADA SYNDROME; NEUROMUSCULAR DISEASE, HEART BLOCKS), isolated or may result from injuries. You can have a conduction disorder without having an arrhythmia, but some arrhythmias arise from conduction disorders. OMIM: 601144.
=688  \\$a2018(2013)
=750  \0$81$wb$iBroader mapping$aHeart conduction system$0(DLC) sh 85059743$4BM$IEN-M
=750  \0$81$wb$iBroader mapping$aDiseases$0(DLC) sh 99002330$4BM$5IEN-M
=788  \0$iSearch under the LCSH heading$aHeart conduction system$xDiseases$5IEN-M

=LDR  01991cz  a2200457n  4500
=001  9880914969302441
=005  20200420113713.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074409
=035  \\$a(NLM)9810901111600041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x820.$x289
=150  \\$aCarbonyl Reductase (NADPH)
=450  \\$wnnna$a13,14-dihydroprostaglandin F2 alpha Synthetase
=450  \\$wnnna$a13,14-dihydroprostaglandin F2alpha Synthetase
=450  \\$wnnna$aCarbonyl Reductase 1
=450  \\$wnnna$aDaunorubicin Reductase
=450  \\$wnnna$aIsatin Reductase
=450  \\$wnnna$aMonomeric Short-Chain Dehydrogenase-Reductase
=450  \\$wnnna$aNADPH-Carbonyl Reductase
=450  \\$wnnna$aNADPH-dependent Carbonyl Reductase
=450  \\$wnnna$aOvarian Carbonyl Reductase
=450  \\$wnnna$a13,14 dihydroprostaglandin F2 alpha Synthetase
=450  \\$wnnna$a13,14 dihydroprostaglandin F2alpha Synthetase
=450  \\$wnnna$aCarbonyl Reductase, NADPH-dependent
=450  \\$wnnna$aCarbonyl Reductase, Ovarian
=450  \\$wnnna$aDehydrogenase-Reductase, Monomeric Short-Chain
=450  \\$wnnna$aMonomeric Short Chain Dehydrogenase Reductase
=450  \\$wnnna$aNADPH Carbonyl Reductase
=450  \\$wnnna$aNADPH dependent Carbonyl Reductase
=450  \\$wnnna$aReductase, Daunorubicin
=450  \\$wnnna$aReductase, Isatin
=450  \\$wnnna$aReductase, NADPH-Carbonyl
=450  \\$wnnna$aReductase, NADPH-dependent Carbonyl
=450  \\$wnnna$aReductase, Ovarian Carbonyl
=450  \\$wnnna$aShort-Chain Dehydrogenase-Reductase, Monomeric
=450  \\$wnnna$aSynthetase, 13,14-dihydroprostaglandin F2alpha
=550  \\$wg$aNAD (+) and NADP (+) Dependent Alcohol Oxidoreductases
=680  \\$iNADPH-dependent reductase that catalyzes the reduction of many carbonyl compounds including QUINONES; PROSTAGLANDINS; and XENOBIOTICS.
=688  \\$a2018 (1974)
=750  \0$aCarbonyl reductase$0(DLC) sh 88007236$5IEN-M

=LDR  00823cz  a2200277n  4500
=001  9880914970102441
=005  20200417174224.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074262
=035  \\$a(NLM)9810900979400041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x66
=072  \\$aD20.$x215.$x784.$x750.$x66
=150  \\$aRapeseed Oil
=450  \\$wnnna$aCanadian Oil
=450  \\$wnnna$aCanola Oil
=450  \\$wnnna$aLEAR Oil
=450  \\$wnnna$aLow Erucic Acid Rapeseed Oil
=450  \\$wnnna$aOil, Canadian
=450  \\$wnnna$aOil, Canola
=450  \\$wnnna$aOil, LEAR
=450  \\$wnnna$aOil, Rapeseed
=550  \\$wg$aPlant Oils
=680  \\$iPLANT OILS derived from RAPESEED species known as BRASSICA RAPA.
=688  \\$a2019(2018)
=750  \0$aCanola oil$0(DLC) sh 94005036$5IEN-M

=LDR  01184cz  a2200337n  4500
=001  9880914970702441
=005  20200417112447.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073116
=035  \\$a(NLM)9810900547600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x860.$x350
=150  \\$aCancer Survivors
=450  \\$wnnna$aLong-Term Cancer Survivors
=450  \\$aSurvivors of Childhood Cancer
=450  \\$wnnna$aCancer Survivor
=450  \\$wnnna$aCancer Survivor, Childhood
=450  \\$wnnna$aCancer Survivor, Long-Term
=450  \\$wnnna$aCancer Survivors, Childhood
=450  \\$wnnna$aCancer Survivors, Long-Term
=450  \\$wnnna$aChildhood Cancer Survivor
=450  \\$wnnna$aChildhood Cancer Survivors
=450  \\$wnnna$aLong Term Cancer Survivors
=450  \\$wnnna$aLong-Term Cancer Survivor
=450  \\$wnnna$aSurvivor, Long-Term Cancer
=450  \\$wnnna$aSurvivors, Cancer
=450  \\$wnnna$aSurvivors, Long-Term Cancer
=550  \\$wg$aSurvivors
=680  \\$iPersons who have experienced prolonged survival with or following malignant neoplastic disease.
=688  \\$a2018
=750  \0$aCancer$xPatients$0(DLC) sh 85019519$5IEN-M

=LDR  00683cz  a2200193n  4500
=001  9880914971402441
=005  20200417104029.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D063405
=035  \\$a(NLM)98196563600000041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x49
=072  \\$aG16.$x117.$x500
=150  \\$aAnatomic Variation
=550  \\$wg$aBiological Variation, Population
=550  \\$wg$aPhysiological Phenomena
=680  \\$iPeculiarities associated with the internal structure, form, topology, or architecture of organisms that distinguishes them from others of the same species or group.
=688  \\$a2013
=750  \0$aAnatomy$xVariation$0(DLC) sh2002008921$5IEN-M

=LDR  00687cz  a2200181n  4500
=001  9880917869302441
=005  20200506175252.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075222
=035  \\$a(NLM)9810901309100041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x489.$x165
=150  \\$aEssential Hypertension
=450  \\$wnnna$aHypertension, Essential
=550  \\$wg$aHypertension
=680  \\$iHypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500
=688  \\$a2018(2013)
=750  \0$aEssential hypertension$0(DLC) sh 86007019$5IEN-M

=LDR  01978cz  a2200517n  4500
=001  9880917870502441
=005  20200506112958.0
=008  910530\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D017034
=035  \\$a(NLM)98194878820000041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x360.$x270
=072  \\$aC10.$x228.$x140.$x490.$x493.$x188
=150  \\$aEpilepsy, Frontal Lobe
=450  \\$wnnna$aBenign Frontal Childhood Epilepsy
=450  \\$wnnna$aChildhood Benign Frontal Epilepsy
=450  \\$wnnna$aEpilepsy, Anterior Fronto-Polar
=450  \\$wnnna$aEpilepsy, Benign Frontal, Childhood
=450  \\$wnnna$aEpilepsy, Cingulate
=450  \\$wnnna$aEpilepsy, Opercular
=450  \\$wnnna$aEpilepsy, Orbito-Frontal
=450  \\$wnnna$aEpilepsy, Supplementary Motor
=450  \\$aFrontal Epilepsy, Benign, Childhood
=450  \\$aFrontal Lobe Epilepsy
=450  \\$wnnna$aAnterior Fronto-Polar Epilepsies
=450  \\$wnnna$aAnterior Fronto-Polar Epilepsy
=450  \\$wnnna$aCingulate Epilepsies
=450  \\$wnnna$aCingulate Epilepsy
=450  \\$wnnna$aEpilepsies, Anterior Fronto-Polar
=450  \\$wnnna$aEpilepsies, Cingulate
=450  \\$wnnna$aEpilepsies, Orbito-Frontal
=450  \\$wnnna$aEpilepsies, Supplementary Motor
=450  \\$wnnna$aEpilepsy, Anterior Fronto Polar
=450  \\$wnnna$aEpilepsy, Orbito Frontal
=450  \\$wnnna$aFrontal Lobe Epilepsies
=450  \\$wnnna$aOpercular Epilepsies
=450  \\$wnnna$aOpercular Epilepsy
=450  \\$wnnna$aOrbito-Frontal Epilepsies
=450  \\$wnnna$aOrbito-Frontal Epilepsy
=450  \\$wnnna$aSupplementary Motor Epilepsies
=450  \\$wnnna$aSupplementary Motor Epilepsy
=550  \\$wg$aEpileptic Syndrome
=550  \\$wg$aEpilepsies, Partial
=680  \\$iA localization-related (focal) form of epilepsy characterized by seizures which arise in the FRONTAL LOBE.
=688  \\$a1992
=750  \0$aFrontal lobe epilepsy$0(DLC) sh 91003620$5IEN-M

=LDR  01337cz  a2200349n  4500
=001  9880917874002441
=005  20200504112925.0
=008  170713\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074062
=035  \\$a(NLM)9810900848100041
=040  \\$aDNLM$cDNLM
=060  \0$aQH 541.15.I5
=072  \\$aD23.$x101.$x258
=072  \\$aG16.$x505
=072  \\$aN6.$x850.$x460.$x350.$x80.$x250
=150  \\$aEnvironmental Biomarkers
=450  \\$wnnna$aBioindicator
=450  \\$wnnna$aBiological Indicator
=450  \\$wnnna$aBioindicators
=450  \\$wnnna$aBiological Indicators
=450  \\$wnnna$aBiomarker, Environmental
=450  \\$wnnna$aBiomarkers, Environmental
=450  \\$wnnna$aEnvironmental Biomarker
=450  \\$wnnna$aIndicator, Biological
=450  \\$wnnna$aIndicators, Biological
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aBiomarkers
=550  \\$wg$aEnvironmental Monitoring
=550  \\$aEnvironmental Indicators
=680  \\$iA factor associated with the well-being of living organisms that is used as a measure of environmental change and or influence. For example, aldehyde dehydrogenase expression in earthworm tissue is used as an indication of heavy metal pollution in soils. Distinguish from BIOMARKERS.
=688  \\$a2018
=750  \0$aIndicators (Biology)$0(DLC)sh 85065657$5IEN-M

=LDR  01362cz  a2200337n  4500
=001  9880917874202441
=005  20200504105836.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074283
=035  \\$a(NLM)9810900965100041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 55.7
=072  \\$aD12.$x776.$x395.$x550.$x294
=072  \\$aD12.$x776.$x543.$x550.$x294
=072  \\$aD12.$x776.$x543.$x750.$x45
=150  \\$aEndothelial Protein C Receptor
=450  \\$wnnna$aAntigen, CD201
=450  \\$wnnna$aAntigens, CD201
=450  \\$wnnna$aCD201 Antigen
=450  \\$wnnna$aEPCR
=450  \\$wnnna$aPROCR
=450  \\$wnnna$aProtein C Receptor
=450  \\$wnnna$aCD201 Antigens
=450  \\$wnnna$aReceptor, Protein C
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aMembrane Glycoproteins
=680  \\$iA glycosylated transmembrane receptor for PROTEIN C that is highly expressed by endothelial cells on the surface of large blood vessels in the heart and lungs.  It facilitates protein C activation by the THROMBIN and THROMBOMODULIN complex in blood coagulation.
=688  \\$a2018
=750  \0$81$wb$iBroader mapping$aProtein C$0(DLC)sh 85107656$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \\$iSearch under the Library of Congress Subject Heading$aProtein C--Receptors$5IEN-M

=LDR  01131cz  a2200229n  4500
=001  9880925271402441
=005  20200508151241.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073576
=035  \\$a(NLM)9810900663500041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x540.$x297
=150  \\$aFaith-Based Organizations
=450  \\$wnnna$aFaith Based Organizations
=450  \\$wnnna$aFaith-Based Organization
=450  \\$wnnna$aOrganization, Faith-Based
=450  \\$wnnna$aOrganizations, Faith-Based
=550  \\$wg$aOrganizations
=550  \\$wh$aReligious Missions
=680  \\$iOrganizations such as (1) congregations; (2) national networks, which include national denominations, their social service arms (for example, Catholic Charities, Lutheran Social Services), and networks of related organizations (such as YMCA and YWCA); and (3) freestanding religious organizations, which are incorporated separately from congregations and national networks. http://www.huduser.gov/portal/publications/faithbased.pdf
=688  \\$a2018
=750  \0$iRelated mapping$aFaith-based human services$0(DLC) sh2006002128$4RM$5IEN-M

=LDR  00709cz  a2200217n  4500
=001  9880925271502441
=005  20200508145025.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073567
=035  \\$a(NLM)9810900671200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x750
=150  \\$aFagales
=550  \\$wg$aRosanae
=550  \\$wh$aBetulaceae
=550  \\$wh$aFagaceae
=550  \\$wh$aJuglandaceae
=550  \\$wh$aMyricaceae
=680  \\$iOrder of dicotyledonous flowering plants in the superorder ROSANAE, and class MAGNOLIOPSIDA. They include birch, beech, bayberry, and walnut species.
=688  \\$a2018
=750  \0$aFagales$0(DLC)sh 85046872$5IEN-M

=LDR  01690cz  a2200385n  4500
=001  9880925271702441
=005  20200508141256.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074059
=035  \\$a(NLM)9810900854500041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x565.$x280.$x945.$x200
=072  \\$aE2.$x779.$x488
=072  \\$aE2.$x831.$x535.$x488
=150  \\$aExtracorporeal Shockwave Therapy
=450  \\$wnnna$aExtracorporeal High-Intensity Focused Ultrasound Therapy
=450  \\$wnnna$aExtracorporeal Shock Wave Therapy
=450  \\$wnnna$aHIFU Therapy
=450  \\$wnnna$aHigh-Intensity Focused Ultrasound Therapy
=450  \\$wnnna$aShock Wave Therapy
=450  \\$wnnna$aExtracorporeal High Intensity Focused Ultrasound Therapy
=450  \\$wnnna$aExtracorporeal Shockwave Therapies
=450  \\$wnnna$aHIFU Therapies
=450  \\$wnnna$aHigh Intensity Focused Ultrasound Therapy
=450  \\$wnnna$aShock Wave Therapies
=450  \\$wnnna$aShockwave Therapies, Extracorporeal
=450  \\$wnnna$aShockwave Therapy, Extracorporeal
=450  \\$wnnna$aTherapy, Extracorporeal Shockwave
=450  \\$wnnna$aTherapy, HIFU
=450  \\$wnnna$aTherapy, Shock Wave
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aUltrasonic Therapy
=680  \\$iA nonsurgical treatment that uses either HIGH-ENERGY SHOCK WAVES or low energy ACOUSTIC WAVES to treat various musculoskeletal conditions (e.g., PLANTAR FASCIITIS; TENNIS ELBOW). A probe placed on the skin conducts the shock waves thereby delivering a mechanical force to the body's tissues.
=688  \\$a2018
=750  \0$aExtracorporeal shock wave therapy$0(DLC) sh 97005686$5IEN-M

=LDR  00897cz  a2200193n  4500
=001  9880926172102441
=005  20200512141429.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073923
=035  \\$a(NLM)9810900746100041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x821.$x387
=150  \\$aFood Intolerance
=450  \\$wnnna$aFood, Sensitivity
=450  \\$wnnna$aIntolerance, Food
=550  \\$wg$aSigns and Symptoms, Digestive
=680  \\$iDigestive system disorder where a particular food irritates the digestive tract or cannot be properly digested (i.e., due to a lack of a digestive enzyme). It differs from FOOD HYPERSENSITIVITY which is an immune system disorder, usually due to specific proteins in food.  http://my.clevelandclinic.org/health/articles/problem-foods-is-it-an-allergy-or-intolerance.
=688  \\$a2018
=750  \0$aFood intolerance$0(DLC)sh2013001029$5IEN-M

=LDR  01132nz  a2200289n  4500
=001  9882104695902441
=005  20230109165446.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000074421
=035  \\$a(DNLM)D000074421
=035  \\$a(NLM)9810901102500041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x200
=072  \\$aJ2.$x350
=150  \\$aFermented Foods
=450  \\$wnnna$aCultured Foods
=450  \\$aFermented Foods and Beverages
=450  \\$wnnna$aCultured Food
=450  \\$wnnna$aFermented Food
=450  \\$wnnna$aFood, Cultured
=450  \\$wnnna$aFood, Fermented
=450  \\$wnnna$aFoods, Cultured
=450  \\$wnnna$aFoods, Fermented
=680  \\$iFoods that are prepared by using microorganisms to convert their components into various FERMENTATION end products. Some pickled foods are considered fermented foods as their pickling results from the microbial production of LACTIC ACID.
=688  \\$a2022 (2018)
=750  \0$iNarrower mapping$aFermented foods$0(DLC) sh 85050241$4NM$5IEN-M
=750  \0$iNarrower mapping$aFermented beverages$0(DLC)sh2014002425$4NM$5IEN-M

=LDR  00792cz  a2200169n  4500
=001  9880926173802441
=005  20200511101539.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074440
=035  \\$a(NLM)9810901070400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x696.$x480
=150  \\$aFascism
=550  \\$wg$aPolitical Systems
=680  \\$iPolitical movement which combines nationalism with demands for political and social renewal. Characteristics include militaristic nationalism, belief in a natural social hierarchy and the rule of elites, and the desire to create a "people's community", in which individual interests would be subordinated to the good of the nation. (From www.britannica.com/topic/fascism)
=688  \\$a2018
=750  \0$aFascism$0(DLC) sh 85047355$5IEN-M

=LDR  00818cz  a2200241n  4500
=001  9880926272802441
=005  20200512113318.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073932
=035  \\$a(NLM)9810900741400041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 175
=072  \\$aF1.$x145.$x527.$x100.$x120.$x500
=072  \\$aF3.$x400.$x813
=150  \\$aFood Addiction
=450  \\$aCompulsive Eating
=450  \\$wnnna$aEating, Compulsive
=450  \\$wnnna$aFood Addictions
=550  \\$wg$aBehavior, Addictive
=550  \\$wg$aFeeding and Eating Disorders
=680  \\$iA cluster of chemical dependencies to specific foods or food in general in which there develops a physical craving for these foods.
=688  \\$a2018
=750  \0$iRelated mapping$aCompulsive eating$0(DLC)sh 87007395$4RM$5IEN-M

=LDR  00829cz  a2200229n  4500
=001  9880926471802441
=005  20200513152759.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073924
=035  \\$a(NLM)9810900744100041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x117.$x500
=072  \\$aL1.$x178.$x682.$x192.$x289.$x500
=150  \\$aGraphic Novels as Topic
=450  \\$wnnna$aComic Books as Topic
=450  \\$wnnna$aGraphic Medicine as Topic
=450  \\$wnnna$aManga as Topic
=550  \\$wg$aBooks, Illustrated
=667  \\$ado not confuse with the Publication Type GRAPHIC NOVEL
=680  \\$iWorks about book-length narratives told using a combination of words and sequential art, often presented in comic book style.
=688  \\$a2018
=750  \0$aGraphic novels$0(DLC)sh 94008233$5IEN-M

=LDR  01324cz  a2200349n  4500
=001  9880926472102441
=005  20200513151710.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075423
=035  \\$a(NLM)9810901431900041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x393.$x420.$x175.$x500
=150  \\$aGene Drive Technology
=450  \\$wnnna$aGene Drive Systems
=450  \\$wnnna$aGene Drives
=450  \\$wnnna$aDrive System, Gene
=450  \\$wnnna$aDrive Systems, Gene
=450  \\$wnnna$aDrive Technologies, Gene
=450  \\$wnnna$aDrive Technology, Gene
=450  \\$wnnna$aDrive, Gene
=450  \\$wnnna$aDrives, Gene
=450  \\$wnnna$aGene Drive
=450  \\$wnnna$aGene Drive System
=450  \\$wnnna$aGene Drive Technologies
=450  \\$wnnna$aSystem, Gene Drive
=450  \\$wnnna$aSystems, Gene Drive
=450  \\$wnnna$aTechnologies, Gene Drive
=450  \\$wnnna$aTechnology, Gene Drive
=550  \\$wg$aDirected Molecular Evolution
=680  \\$iThe techniques involved in creating and inserting synthetic selfish genetic elements called gene drives. Gene drives carry a "payload gene" and are designed to increase in frequency in the population over time, eventually to all members of the population.
=688  \\$a2018
=750  \0$aGene Drives$0(DLC)sh2018000137$5IEN-M

=LDR  00672cz  a2200193n  4500
=001  9880926472602441
=005  20200513121004.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074100
=035  \\$a(NLM)9810901026900041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x240
=150  \\$aFuneral Homes
=450  \\$wnnna$aFuneral Home
=450  \\$wnnna$aHomes, Funeral
=550  \\$wg$aNon-Medical Public and Private Facilities
=680  \\$iFacilities for the preparation of the dead for burial or cremation, for the viewing of the body, and for funeral services.
=688  \\$a2018; use MORTUARY PRACTICE 1963-2017
=750  \0$aFuneral homes$0(DLC) sh 87007426$5IEN-M

=LDR  00761cz  a2200253n  4500
=001  9880926572102441
=005  20200512125437.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074385
=035  \\$a(NLM)9810901129300041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x720.$x372
=072  \\$aG7.$x203.$x300.$x514
=072  \\$aJ2.$x500.$x514
=150  \\$aFood Ingredients
=450  \\$wnnna$aFood Ingredient
=450  \\$wnnna$aIngredient, Food
=450  \\$wnnna$aIngredients, Food
=550  \\$wg$aFood
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aFood Additives
=680  \\$iSubstances included in prepared foods and beverages.
=688  \\$a2018
=750  \0$iRelated mapping$aFood$xComposition$0(DLC) sh 85050191$4RM$5IEN-M

=LDR  01206cz  a2200325n  4500
=001  9880937770302441
=005  20200520120854.0
=008  770422\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013244
=035  \\$a(NLM)98199910270000041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x950.$x599.$x450
=072  \\$aI1.$x880.$x604.$x528.$x750
=150  \\$aSterilization, Involuntary
=450  \\$wnnna$aCompulsory Sterilization
=450  \\$wnnna$aForced Sterilization
=450  \\$wnnna$aInvoluntary Sterilization
=450  \\$wnnna$aCompulsory Sterilizations
=450  \\$wnnna$aForced Sterilizations
=450  \\$wnnna$aInvoluntary Sterilizations
=450  \\$wnnna$aSterilization, Compulsory
=450  \\$wnnna$aSterilization, Forced
=450  \\$wnnna$aSterilizations, Compulsory
=450  \\$wnnna$aSterilizations, Forced
=450  \\$wnnna$aSterilizations, Involuntary
=550  \\$wg$aInvoluntary Treatment
=550  \\$wg$aSterilization, Reproductive
=680  \\$iInterference of a person's reproductive ability without the consent of the person or guardian.
=688  \\$a91(78); was see under STERILIZATION, SEXUAL 1978-90
=750  \0$aInvoluntary sterilization$0(DLC) sh 85128028$5IEN-M

=LDR  01085cz  a2200301n  4500
=001  9880937770502441
=005  20200520115357.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074441
=035  \\$a(NLM)9810901069800041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x528
=150  \\$aInvoluntary Treatment
=450  \\$wnnna$aInvoluntary Hospitalization
=450  \\$wnnna$aHospitalization, Involuntary
=450  \\$wnnna$aHospitalizations, Involuntary
=450  \\$wnnna$aInvoluntary Hospitalizations
=450  \\$wnnna$aInvoluntary Treatments
=450  \\$wnnna$aTreatment, Involuntary
=450  \\$wnnna$aTreatments, Involuntary
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aDirectly Observed Therapy
=550  \\$wh$aInvoluntary Fertility Control
=550  \\$wh$aInvoluntary Treatment, Psychiatric
=550  \\$wh$aSterilization, Involuntary
=680  \\$iProcedures, surgery, or other treatment without consent of person or persons receiving treatment.
=688  \\$a2018
=750  \0$aInvoluntary treatment$0(DLC) sh 93005498$5IEN-M

=LDR  00758cz  a2200253n  4500
=001  9880937773902441
=005  20200514110243.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074382
=035  \\$a(NLM)9810900935000041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 754
=072  \\$aD1.$x362.$x311
=072  \\$aD27.$x888.$x284.$x101.$x696
=150  \\$aGreenhouse Gases
=450  \\$wnnna$aGreenhouse Gas
=450  \\$wnnna$aGas, Greenhouse
=550  \\$wg$aAir Pollutants
=550  \\$wg$aGases
=550  \\$aGreenhouse Effect
=550  \\$aGlobal Warming
=680  \\$iGaseous elements, chemicals that are in the atmosphere that may contribute to GREENHOUSE EFFECT.
=688  \\$a2018
=750  \0$aGreenhouse gases$0(DLC) sh 90000985$5IEN-M

=LDR  00907cz  a2200265n  4500
=001  9880937872202441
=005  20200518180426.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073919
=035  \\$a(NLM)9810900750100041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x578
=150  \\$aInterdisciplinary Placement
=450  \\$wnnna$aCollaborative Learning
=450  \\$wnnna$aShared Learning
=450  \\$wnnna$aCollaborative Learnings
=450  \\$wnnna$aInterdisciplinary Placements
=450  \\$wnnna$aLearning, Collaborative
=450  \\$wnnna$aLearning, Shared
=450  \\$wnnna$aPlacement, Interdisciplinary
=450  \\$wnnna$aPlacements, Interdisciplinary
=550  \\$wg$aEducation
=680  \\$iTeaching strategy of shared learning based cross-discipline experiences and placements.
=688  \\$a2018
=750  \0$aInterdisciplinary approach in education$0(DLC) sh 850672315IEN-M

=LDR  01829cz  a2200349n  4500
=001  9880937872402441
=005  20180904000000.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D033183
=035  \\$a(NLM)98198492620000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x401.$x205.$x249
=072  \\$aL1.$x143.$x865.$x500
=150  \\$aInterdisciplinary Communication
=450  \\$wnnna$aCommunication Research
=450  \\$wnnna$aCross-Disciplinary Communication
=450  \\$wnnna$aMultidisciplinary Communication
=450  \\$wnnna$aCommunication, Cross-Disciplinary
=450  \\$wnnna$aCommunication, Interdisciplinary
=450  \\$wnnna$aCommunication, Multidisciplinary
=450  \\$wnnna$aCommunications, Cross-Disciplinary
=450  \\$wnnna$aCommunications, Interdisciplinary
=450  \\$wnnna$aCommunications, Multidisciplinary
=450  \\$wnnna$aCross Disciplinary Communication
=450  \\$wnnna$aCross-Disciplinary Communications
=450  \\$wnnna$aInterdisciplinary Communications
=450  \\$wnnna$aMultidisciplinary Communications
=450  \\$wnnna$aResearch, Communication
=550  \\$aInterprofessional Relations
=667  \\$ause only for communication across disciplines; for relations between individuals in different disciplines, use instead INTERPROFESSIONAL RELATIONS; coord IM with specific disciplines (IM)
=680  \\$iCommunication, in the sense of cross-fertilization of ideas, involving two or more academic disciplines (such as the disciplines that comprise the cross-disciplinary field of bioethics, including the health and biological sciences, the humanities, and the social sciences and law). Also includes differences in patterns of language usage in different academic or medical disciplines.
=688  \\$a2003; use INTERPROFESSIONAL RELATIONS 1992-2002

=LDR  00926cz  a2200253n  4500
=001  9880937971802441
=005  20200519165803.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075762
=035  \\$a(NLM)9810901360100041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x287
=150  \\$aInterdisciplinary Research
=450  \\$wnnna$aMultidisciplinary Research
=450  \\$wnnna$aTeam Science
=450  \\$wnnna$aTransdisciplinary Research
=450  \\$wnnna$aResearch, Interdisciplinary
=450  \\$wnnna$aResearch, Multidisciplinary
=450  \\$wnnna$aResearch, Transdisciplinary
=450  \\$wnnna$aTeam Sciences
=550  \\$wg$aResearch
=680  \\$iResearch combining mastery in distinct fields or disciplines that apply and exchange tools, concepts, ideas, data methods, or results around a common project.
=688  \\$a2018
=750  \0$aInterdisciplinary research$0(DLC)sh 88006165$5IEN-M

=LDR  00850cz  a2200193n  4500
=001  9880937973002441
=005  20200517150906.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073256
=035  \\$a(NLM)9810900725300041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x479
=150  \\$aInformation Technology
=450  \\$wnnna$aInformation Technologies
=450  \\$wnnna$aTechnology, Information
=550  \\$wg$aInformation Science
=680  \\$iInterconnected system that is used in the automatic acquisition, storage, manipulation, movement, control, display, interchange, transmission, routing or reception of data or information, including computers, ancillary equipment, system software, support services, and related resources. (NAL Agricultural Thesaurus)
=688  \\$a2018
=750  \0$aInformation technology$0(DLC) sh 87002293$5IEN-M

=LDR  01089cz  a2200241n  4500
=001  9880937973602441
=005  20200515144441.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073180
=035  \\$a(NLM)9810900537300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x564
=150  \\$aHydrophiidae
=450  \\$wnnna$aHydrophidae
=450  \\$wnnna$aHydrophiinae
=450  \\$wnnna$aSea Snakes
=450  \\$wnnna$aSea Snake
=450  \\$wnnna$aSnake, Sea
=450  \\$wnnna$aSnakes, Sea
=550  \\$wg$aElapidae
=680  \\$iA subfamily of marine elapid snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159)
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aSea Snakes$0(DLC) sh 85119249$5IEN-M

=LDR  00846cz  a2200241n  4500
=001  9880937973702441
=005  20200515142019.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074705
=035  \\$a(NLM)9810901208300041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 450
=072  \\$aH1.$x158.$x273.$x343.$x385
=150  \\$aHuman Genetics
=450  \\$aGenetics, Human
=550  \\$wg$aGenetics
=550  \\$wh$aGenetics, Medical
=550  \\$wh$aHapMap Project
=550  \\$wh$aHuman Genome Project
=667  \\$ause for the discipline only; note that Medical Genetics is available for the subfield of human genetics dealing with genetic or hereditary disorders
=680  \\$iThe scientific study of inherited human variation.
=688  \\$a2018; use GENETICS, MEDICAL 1980-2017
=750  \0$aHuman genetics$0(DLC) sh 85062875$5IEN-M

=LDR  00712cz  a2200217n  4500
=001  9880937973802441
=005  20200515115742.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074743
=035  \\$a(NLM)9810901195400041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 141.5.H3
=072  \\$aE1.$x370.$x370.$x428
=072  \\$aE1.$x370.$x520.$x365
=150  \\$aHemodynamic Monitoring
=450  \\$wnnna$aMonitoring, Hemodynamic
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aMonitoring, Physiologic
=680  \\$iContinuous measurement of the movement and forces of blood in the CARDIOVASCULAR SYSTEM.
=688  \\$a2018
=750  \0$aHemodynamic monitoring$0(DLC)sh 89000489$5IEN-M

=LDR  00833cz  a2200205n  4500
=001  9880938067002441
=005  20200520141754.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075663
=035  \\$a(NLM)9810901398800041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x867.$x427
=150  \\$aIon Mobility Spectrometry
=450  \\$wnnna$aDifferential Mobility Analysis
=450  \\$wnnna$aAnalysis, Differential Mobility
=450  \\$wnnna$aSpectrometry, Ion Mobility
=550  \\$wg$aSpectrum Analysis
=680  \\$iTechniques for separation and identification of ionized molecules based on their drift through a gas phase after being accelerated by an electric field. Their mobilities will be effected by their shape, size, and charge.
=688  \\$a2018
=750  \0$aIon mobility spectroscopy$0(DLC) sh 89005249$5IEN-M

=LDR  00908cz  a2200277n  4500
=001  9880938070502441
=005  20200517144748.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075282
=035  \\$a(NLM)9810901277600041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x301
=072  \\$aI1.$x880.$x735.$x461
=150  \\$aIncivility
=450  \\$wnnna$aRudeness
=450  \\$wnnna$aUncivil Behavior
=450  \\$wnnna$aWorkplace Incivility
=450  \\$wnnna$aBehavior, Uncivil
=450  \\$wnnna$aBehaviors, Uncivil
=450  \\$wnnna$aIncivility, Workplace
=450  \\$wnnna$aUncivil Behaviors
=550  \\$wg$aSocial Behavior
=550  \\$wg$aSocial Problems
=680  \\$iLow-intensity deviant behavior with ambiguous intent to harm the target, in violation of norms for mutual respect.
=688  \\$a2018
=750  \0$iRelated mapping$aCourtesy$0(DLC) sh 85033563$4RM$5IEN-M

=LDR  00702cz  a2200217n  4500
=001  9880940269602441
=005  20200601113209.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073177
=035  \\$a(NLM)9810900542700041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x612.$x250
=150  \\$aNaja haje
=450  \\$wnnna$aEgyptian Cobra
=450  \\$wnnna$aCobra, Egyptian
=450  \\$wnnna$aCobras, Egyptian
=450  \\$wnnna$aEgyptian Cobras
=550  \\$wg$aNaja
=680  \\$iA species of cobra (Naja) that is indigenous primarily to Northern Africa.
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aEgyptian cobra$0(DLC)sh2011001124$5IEN-M

=LDR  00856cz  a2200253n  4500
=001  9880940269802441
=005  20200601112255.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073156
=035  \\$a(NLM)9810900546300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x612
=150  \\$aNaja
=450  \\$wnnna$aBoulengerina
=450  \\$wnnna$aWater Cobra
=450  \\$wnnna$aCobra, Water
=450  \\$wnnna$aCobras, Water
=450  \\$wnnna$aWater Cobras
=550  \\$wg$aElapidae
=550  \\$wh$aNaja haje
=550  \\$wh$aNaja naja
=680  \\$iA genus of elapid snakes, also known as cobras, that are indigenous to Africa, Central and Southern Asia, and adjacent islands such as Taiwan and the Philippines.
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aCobras$0(DLC) sh 85027551$5IEN-M

=LDR  00681cz  a2200181n  4500
=001  9880940364402441
=005  20210212080232.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073943
=035  \\$a(NLM)9810900930700041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x464
=150  \\$aNeonicotinoids
=450  \\$wnnna$aNeonicotinoid
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aThiamethoxam
=680  \\$iA class of insecticides that are structurally similar to NICOTINE and have physiologically similar effects as agonists of NICOTINIC ACETYLCHOLINE RECEPTORS, but are less toxic to vertebrates. They are widely used in agriculture.
=688  \\$a2018

=LDR  01402cz  a2200325n  4500
=001  9880940373202441
=005  20200525115704.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073890
=035  \\$a(NLM)9810900751800041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100.$x396
=072  \\$aE1.$x370.$x225.$x998.$x54.$x396
=072  \\$aE5.$x200.$x500.$x384.$x100.$x396
=072  \\$aE5.$x200.$x998.$x54.$x396
=072  \\$aE5.$x242.$x384.$x100.$x396
=150  \\$aLiquid Biopsy
=450  \\$wnnna$aLiquid Biopsies
=450  \\$wnnna$aBiopsies, Liquid
=450  \\$wnnna$aBiopsy, Liquid
=550  \\$wg$aBiopsy
=550  \\$wh$aNoninvasive Prenatal Testing
=550  \\$aCell-Free Nucleic Acids
=550  \\$aBlood Specimen Collection
=667  \\$ausually NIM with specific organ /pathol + disease /diag or /pathol
=680  \\$iObtaining material for pathological examination and analysis, from bodily fluids. Material retrieved includes CELL-FREE NUCLEIC ACIDS; CELL-DERIVED MICROPARTICLES; EXOSOMES; CIRCULATING NEOPLASM CELLS; and other circulating cells and CELLULAR STRUCTURES.
=688  \\$a2018
=750  \0$81$wb$iBroader mapping$aBody fluids$0(DLC) sh 85015244$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xBiopsy$0(DLC) sh 00007764$4BM$5IEN-NM
=788  \\$iSearch under the Library of Congress Subject Heading$aBody fluids--Biopsy$5IEN-M

=LDR  01017cz  a2200325n  4500
=001  9880940373902441
=005  20200522125511.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073571
=035  \\$a(NLM)9810900665600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x595
=150  \\$aLaurales
=450  \\$wnnna$aAtherospermatales
=450  \\$wnnna$aCalycanthales
=450  \\$wnnna$aGyrocarpales
=450  \\$wnnna$aHernandiales
=450  \\$wnnna$aIlligerales
=450  \\$wnnna$aMonimiales
=450  \\$wnnna$aAtherospermatale
=450  \\$wnnna$aCalycanthale
=450  \\$wnnna$aGyrocarpale
=450  \\$wnnna$aHernandiale
=450  \\$wnnna$aIlligerale
=450  \\$wnnna$aLaurale
=450  \\$wnnna$aMonimiale
=550  \\$wg$aMagnoliopsida
=680  \\$iOrder of flowering plants in the superorder Magnolianae. Common examples are bay laurel, AVOCADO; sassafras and CINNAMON.
=688  \\$a2018
=750  \0$aMagnoliales$0(DLC) sh 85079807$5IEN-M

=LDR  00753cz  a2200229n  4500
=001  9880940374102441
=005  20200522123029.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073476
=035  \\$a(NLM)9810900693600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x576
=150  \\$aLaticauda
=450  \\$wnnna$aLaticaudinae
=450  \\$wnnna$aSea Krait
=450  \\$wnnna$aKrait, Sea
=450  \\$wnnna$aKraits, Sea
=450  \\$wnnna$aSea Kraits
=550  \\$wg$aElapidae
=680  \\$iA genus of semi-aquatic elapid snake that inhabits coastal waters of the tropical Indian and Western Pacific Oceans.
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aSea kraits$0(DLC) sh 85074873$5IEN-M

=LDR  01556cz  a2200445n  4500
=001  9880940569802441
=005  20200605112902.0
=008  840611\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008840
=035  \\$a(NLM)98194075930000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 55.3
=072  \\$aD5.$x750.$x78.$x730
=072  \\$aD12.$x776.$x220.$x525
=150  \\$aMicrofilament Proteins
=450  \\$aActin-Binding Proteins
=450  \\$wnnna$aActin Binding Proteins
=450  \\$wnnna$aProteins, Actin-Binding
=450  \\$wnnna$aProteins, Microfilament
=550  \\$wg$aBiopolymers
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wh$aActin Capping Proteins
=550  \\$wh$aActin Depolymerizing Factors
=550  \\$wh$aActin-Related Protein 2-3 Complex
=550  \\$wh$aActinin
=550  \\$wh$aActins
=550  \\$wh$aCortactin
=550  \\$wh$aFilamins
=550  \\$wh$aFormins
=550  \\$wh$aGelsolin
=550  \\$wh$aMyosins
=550  \\$wh$aMyristoylated Alanine-Rich C Kinase Substrate
=550  \\$wh$aProfilins
=550  \\$wh$aTensins
=550  \\$wh$aTropomyosin
=550  \\$wh$aTroponin
=550  \\$wh$aWiskott-Aldrich Syndrome Protein Family
=680  \\$iMonomeric subunits of primarily globular ACTIN and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.
=688  \\$a85
=750  \0$aMicrofilament proteins$0(DLC) sh 96001121$5IEN-M

=LDR  00888cz  a2200265n  4500
=001  9880940570002441
=005  20200529151242.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073456
=035  \\$a(NLM)9810900695200041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x666
=150  \\$aMultitasking Behavior
=450  \\$wnnna$aMulti-Tasking Behavior
=450  \\$wnnna$aBehavior, Multi-Tasking
=450  \\$wnnna$aBehavior, Multitasking
=450  \\$wnnna$aBehaviors, Multi-Tasking
=450  \\$wnnna$aBehaviors, Multitasking
=450  \\$wnnna$aMulti Tasking Behavior
=450  \\$wnnna$aMulti-Tasking Behaviors
=450  \\$wnnna$aMultitasking Behaviors
=550  \\$wg$aBehavior
=680  \\$iSimultaneous task performance, or switching between tasks in a concentrated period of time.
=688  \\$a2018
=750  \0$aHuman multitasking$0(DLC) sh2009008394$5IEN-M

=LDR  01104cz  a2200229n  4500
=001  9880940570202441
=005  20200529144300.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D048868
=035  \\$a(NLM)98198946320000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x24
=072  \\$aD12.$x776.$x157.$x57
=072  \\$aD12.$x776.$x476.$x24
=150  \\$aAdaptor Proteins, Signal Transducing
=450  \\$aSignal Transducing Adaptor Proteins
=550  \\$wg$aCarrier Proteins
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wh$amTOR Associated Protein, LST8 Homolog
=680  \\$iA broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes
=688  \\$a2005
=750  \0$aSignal transducing adaptor proteins$0(DLC)sh2018000011$5IEN-M

=LDR  00921cz  a2200229n  4500
=001  9880940570402441
=005  20200529133445.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073276
=035  \\$a(NLM)9810900724200041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x599.$x835.$x893
=150  \\$aModels, Spatial Interaction
=450  \\$wnnna$aInteraction Models, Spatial
=450  \\$wnnna$aSpatial Interaction Model
=450  \\$wnnna$aSpatial Interaction Models
=550  \\$wg$aModels, Spatial
=680  \\$iEstimates of the flow of people, material or information between locations in geographic space.
=688  \\$a2018
=750  \0$81$wb$iRelated mapping$aSpatial behavior$0(DLC) sh 85126348$4RM$5IEN-M
=780  \0$81$wb$iRelated mapping$xMathematical models$0(DLC) sh 2002007921$4RM$5IEN-M
=788  \0$iSearch under the Library of Comgress Subject Heading$aSpatial Behavior--Mathematical models$5IEN

=LDR  00610cz  a2200181n  4500
=001  9880940763202441
=005  20180904000000.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075384
=035  \\$a(NLM)9810901246800041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 170
=072  \\$aF1.$x752.$x723
=150  \\$aNeuroticism
=450  \\$wnnna$aNeuroticism Traits
=450  \\$wnnna$aNeuroticism Trait
=680  \\$iPersonality trait related to tendency to respond to threat, frustration or a loss with negative emotions (e.g., ANGER; ANXIETY; FRUSTRATION; embarrassment and sadness).
=688  \\$a2018(2013)

=LDR  00762cz  a2200241n  4500
=001  9880940763602441
=005  20200605124736.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073935
=035  \\$a(NLM)9810900738400041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 102
=072  \\$aF1.$x145.$x209.$x459.$x500
=072  \\$aN4.$x590.$x233.$x727.$x407.$x250
=072  \\$aN5.$x715.$x520
=150  \\$aNarrative Medicine
=450  \\$wnnna$aMedicine, Narrative
=550  \\$wg$aNarration
=550  \\$wg$aPatient-Centered Care
=550  \\$wg$aQuality of Health Care
=680  \\$iNARRATION as a tool to collect and interpret information on a patient's experience of illness
=688  \\$a2018
=750  \0$aNarrative medicine$0(DLC)sh2005004628$5IEN-M

=LDR  00665cz  a2200193n  4500
=001  9880940768802441
=005  20200528150122.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074041
=035  \\$a(NLM)9810900867800041
=040  \\$aDNLM$cDNLM
=072  \\$aB5.$x620.$x368
=150  \\$aMicroorganisms, Genetically-Modified
=450  \\$wnnna$aGenetically-Modified Microorganisms
=550  \\$wg$aOrganisms, Genetically Modified
=667  \\$acoordinate with specific microorganism /genet
=680  \\$iMicroorganisms whose GENOME has been altered by GENETIC ENGINEERING.
=688  \\$a2018
=750  \0$aRecombinant microorganisms$0(DLC) sh 92000610$5IEN-M

=LDR  00622cz  a2200181n  4500
=001  9880940769002441
=005  20200528135457.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075163
=035  \\$a(NLM)9810901306700041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x691.$x657
=150  \\$aMetallocenes
=450  \\$wnnna$aFerrocenes
=550  \\$wg$aOrganometallic Compounds
=680  \\$iOrganometallic compounds that generally consist of two cylcopentadiene ANIONS joined in their centers by a metallic cation such as NICKEL; IRON; or TITANIUM.
=688  \\$a2018
=750  \0$aMetallocenes$0(DLC) sh 85084129$5IEN-M

=LDR  01657cz  a2200433n  4500
=001  9880940769402441
=005  20200528130641.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D0000732
=035  \\$a(NLM)9810900727400041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x711.$x513.$x603
=150  \\$aMental Status and Dementia Tests
=450  \\$wnnna$aCOGNISTAT
=450  \\$wnnna$aClinical Dementia Rating
=450  \\$wnnna$aClinical Dementia Rating Scale
=450  \\$wnnna$aCognitive Assessment Screening Instrument
=450  \\$wnnna$aDementia Rating Scale
=450  \\$wnnna$aFolstein Mini-Mental State Examination
=450  \\$wnnna$aGPCOG
=450  \\$wnnna$aGeneral Practitioner Assessment of Cognition
=450  \\$wnnna$aMMSE, Mini Mental State Examination
=450  \\$wnnna$aMental Status Tests
=450  \\$wnnna$aMicroCog
=450  \\$wnnna$aMini Mental State Examination
=450  \\$wnnna$aMini Mental Status Examination
=450  \\$wnnna$aMini-Cog
=450  \\$wnnna$aMontreal Cognitive Assessment
=450  \\$wnnna$aNeurobehavioral Cognitive Status Examination
=450  \\$wnnna$aNeurocognitive Tests
=450  \\$wnnna$aUPDRS Panel
=450  \\$wnnna$aUnified Parkinson's Disease Rating Scale
=450  \\$wnnna$aMental Status Test
=450  \\$wnnna$aNeurocognitive Test
=550  \\$wg$aNeuropsychological Tests
=680  \\$iTests designed to assess various aspects of neurocognitive function or dementia.
=688  \\$a2018
=750  \0$iRelated mapping$aCognition$xTesting$0(DLC) sh 86004315$4RM$5IEN-M
=750  \0$iRelated mapping$aMental status examination$0(DLC) sh 93000862$4RM$5IEN-M

=LDR  00729cz  a2200181n  4500
=001  9880940770402441
=005  20200527115505.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073038
=035  \\$a(NLM)9810900551500041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x421.$x784.$x444
=150  \\$aMental Health Recovery
=450  \\$wnnna$aRecovery, Mental Health
=550  \\$wg$aRehabilitation
=680  \\$iRecovery from mental disorders and/or substance abuse. The process of change in which individuals improve their MENTAL HEALTH and wellness, live a self-directed life, and work to achieve their full potential.
=688  \\$a2018
=750  \0$iRelated mapping$aMentally ill$xRehabilitation$0(DLC) sh 85083707$4RM$5IEN-M

=LDR  00849cz  a2200277n  4500
=001  9880940770702441
=005  20200527112430.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074403
=035  \\$a(NLM)9810901122100041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 312
=072  \\$aE4.$x555.$x490
=150  \\$aMeniscectomy
=450  \\$wnnna$aArthroscopic Meniscectomy
=450  \\$wnnna$aMeniscal Resection
=450  \\$wnnna$aArthroscopic Meniscectomies
=450  \\$wnnna$aMeniscal Resections
=450  \\$wnnna$aMeniscectomies
=450  \\$wnnna$aMeniscectomies, Arthroscopic
=450  \\$wnnna$aMeniscectomy, Arthroscopic
=450  \\$wnnna$aResection, Meniscal
=550  \\$wg$aOrthopedic Procedures
=680  \\$iSurgical incision of a torn MENISCUS.
=688  \\$a2018
=750  \0$aMeniscectomy$0(DLC) sh 85083573$5IEN-M

=LDR  00802cz  a2200205n  4500
=001  9880940771002441
=005  20200527104418.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073220
=035  \\$a(NLM)9810900726200041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x711.$x141.$x493.$x822.$x500
=072  \\$aF4.$x711.$x513.$x401.$x500
=150  \\$aWechsler Memory Scale
=450  \\$wnnna$aBrief Cognitive Status Exam
=550  \\$wg$aWechsler Scales
=550  \\$wg$aMemory and Learning Tests
=680  \\$iA neuropsychological test designed to assess different memory functions. It may incorporate an optional cognitive exam (Brief Cognitive Status Exam) that helps to assess memory related cognitive function.
=688  \\$a2018
=750  \0$aWechsler Memory Scale$0(DLC) sh2001006347$5IEN-M

=LDR  01113cz  a2200277n  4500
=001  9880940771202441
=005  20200527111429.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073219
=035  \\$a(NLM)9810900726600041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x711.$x513.$x401
=150  \\$aMemory and Learning Tests
=450  \\$wnnna$aCalifornia Verbal Learning Test
=450  \\$wnnna$aRey Auditory Verbal Learning Test
=450  \\$wnnna$aRivermead Behavioural Memory Test
=450  \\$wnnna$aTOMAL
=450  \\$wnnna$aTest of Memory Malingering
=450  \\$wnnna$aTest of Memory and Learning
=550  \\$wg$aNeuropsychological Tests
=550  \\$wh$aWechsler Memory Scale
=680  \\$iTests designed to evaluate general and specific areas of behaviors and abilities associated with memory and/or learning.
=688  \\$a2018
=750  \0$iNarrower mapping$aLearning ability$xTesting$0(DLC) sh 85075528$4NM$5IEN-M
=750  \0$iNarrower mapping$aMemory$xTesting$0(DLC) sh 91006009$4NM$5IEN-M
=750  \0$iNarrower mapping$aTest of Memory and Learning$0(DLC) sh2008003627$4NM$5IEN-M

=LDR  01093cz  a2200277n  4500
=001  9880940772402441
=005  20200526133314.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074266
=035  \\$a(NLM)9810900974800041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x413
=072  \\$aJ1.$x897.$x461
=150  \\$aMaterials Science
=450  \\$wnnna$aMaterial Science
=450  \\$wnnna$aMaterial Sciences
=450  \\$wnnna$aMaterials Sciences
=450  \\$wnnna$aScience, Material
=450  \\$wnnna$aScience, Materials
=450  \\$wnnna$aSciences, Material
=450  \\$wnnna$aSciences, Materials
=550  \\$wg$aNatural Science Disciplines
=550  \\$wg$aTechnology
=680  \\$iAn interdisciplinary study of the microstructure and composition of various materials such as metals, semiconductors, ceramics, and polymers, in relation to their macromolecular physical and chemical properties. Materials science enables the custom creation of new materials with specific properties and uses.
=688  \\$a2018
=750  \0$aMaterials science$0(DLC) sh 85082094$5IEN-M

=LDR  01399cz  a2200361n  4500
=001  9880940772602441
=005  20200526131352.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074406
=035  \\$a(NLM)9810901116500041
=040  \\$aDNLM$cDNLM
=060  \0$aWV 233
=072  \\$aE4.$x580.$x450.$x375
=150  \\$aMastoidectomy
=450  \\$wnnna$aComplete Mastoidectomy
=450  \\$wnnna$aModified Radical Mastoidectomy
=450  \\$wnnna$aRadical Mastoidectomy
=450  \\$wnnna$aComplete Mastoidectomies
=450  \\$wnnna$aMastoidectomies
=450  \\$wnnna$aMastoidectomies, Complete
=450  \\$wnnna$aMastoidectomies, Modified Radical
=450  \\$wnnna$aMastoidectomies, Radical
=450  \\$wnnna$aMastoidectomy, Complete
=450  \\$wnnna$aMastoidectomy, Modified Radical
=450  \\$wnnna$aMastoidectomy, Radical
=450  \\$wnnna$aModified Radical Mastoidectomies
=450  \\$wnnna$aRadical Mastoidectomies
=450  \\$wnnna$aRadical Mastoidectomies, Modified
=450  \\$wnnna$aRadical Mastoidectomy, Modified
=550  \\$wg$aOtologic Surgical Procedures
=680  \\$iSurgical removal of the diseased cells from the MASTOID PROCESS. It often involves simultaneous resection and/or repair of the MIDDLE EAR and EAR DRUM in MIDDLE EAR CHOLESTEATOMAS and MASTOIDITIS.
=688  \\$a2018
=750  \0$aMastoidectomy$0(DL$5C) sh 94004103$5IEN-M

=LDR  01281cz  a2200373n  4500
=001  9880940772802441
=005  20200526122044.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074609
=035  \\$a(NLM)9810901226000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x610
=072  \\$aF3.$x900.$x643
=150  \\$aMarijuana Use
=450  \\$wnnna$aMarijuana-Related Disorder
=450  \\$wnnna$aRecreational Marijuana Use
=450  \\$wnnna$aDisorder, Marijuana-Related
=450  \\$wnnna$aDisorders, Marijuana-Related
=450  \\$wnnna$aMarijuana Related Disorder
=450  \\$wnnna$aMarijuana Use, Recreational
=450  \\$wnnna$aMarijuana Uses
=450  \\$wnnna$aMarijuana Uses, Recreational
=450  \\$wnnna$aMarijuana-Related Disorders
=450  \\$wnnna$aRecreational Marijuana Uses
=450  \\$wnnna$aUse, Marijuana
=450  \\$wnnna$aUse, Recreational Marijuana
=450  \\$wnnna$aUses, Marijuana
=450  \\$wnnna$aUses, Recreational Marijuana
=550  \\$wg$aBehavior
=550  \\$wg$aSubstance-Related Disorders
=550  \\$wh$aMarijuana Smoking
=680  \\$iMedicinal or recreational utilization of MARIJUANA.
=688  \\$a2018
=750  \0$iNarrower mapping$aMarijuana$xTherapeutic use$0(DLC) sh 99010191$4NM$5IEN-M

=LDR  01114cz  a2200313n  4500
=001  9880940773102441
=005  20200526115013.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073297
=035  \\$a(NLM)9810900722000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x190.$x599.$x750.$x750.$x500
=072  \\$aE2.$x309.$x416
=072  \\$aE2.$x779.$x867.$x880.$x750.$x500
=072  \\$aE2.$x831.$x535.$x867.$x880.$x750.$x500
=150  \\$aManual Lymphatic Drainage
=450  \\$wnnna$aLymphatic Drainage Massage
=450  \\$wnnna$aManual Lymph Drainage
=450  \\$wnnna$aDrainage Massage, Lymphatic
=450  \\$wnnna$aDrainage, Manual Lymph
=450  \\$wnnna$aDrainage, Manual Lymphatic
=450  \\$wnnna$aLymph Drainage, Manual
=450  \\$wnnna$aLymphatic Drainage, Manual
=450  \\$wnnna$aMassage, Lymphatic Drainage
=550  \\$wg$aDrainage
=550  \\$wg$aMassage
=680  \\$iThe application of massage to control EDEMA and improve circulation by manually moving excess lymph out of a tissue.
=688  \\$a2018
=750  \0$aLymphatics$xMassage$0(DLC) sh2008006136$5IEN-M

=LDR  00561cz  a2200193n  4500
=001  9880940774202441
=005  20200522172850.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076244
=035  \\$a(NLM)9810901445800041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x576
=150  \\$aLepisma
=450  \\$wnnna$aLepisma saccharina
=450  \\$wnnna$aSilverfish
=550  \\$wg$aInsecta
=680  \\$iA small nocturnal wingless insect with tapering physical outline.
=688  \\$a2018
=750  \0$aLepisma$0(DLC) sh 85076076$5IEN-M

=LDR  01415cz  a2200325n  4500
=001  9880943373902441
=005  20200608173722.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073296
=035  \\$a(NLM)9810900723200041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x291.$x898
=150  \\$aNoncommunicable Diseases
=450  \\$wnnna$aNon-communicable Chronic Diseases
=450  \\$wnnna$aNon-communicable Diseases
=450  \\$wnnna$aNon-infectious Diseases
=450  \\$wnnna$aNoninfectious Diseases
=450  \\$wnnna$aChronic Disease, Non-communicable
=450  \\$wnnna$aDisease, Non-communicable
=450  \\$wnnna$aNon communicable Chronic Diseases
=450  \\$wnnna$aNon communicable Diseases
=450  \\$wnnna$aNon infectious Diseases
=450  \\$wnnna$aNon-communicable Chronic Disease
=450  \\$wnnna$aNon-communicable Disease
=450  \\$wnnna$aNon-infectious Disease
=450  \\$wnnna$aNoncommunicable Disease
=450  \\$wnnna$aNoninfectious Disease
=550  \\$wg$aDisease Attributes
=680  \\$iDiseases which are typically non-infectious in origin and do not transmit from an affected individual to others. The four main types of noncommunicable diseases are CARDIOVASCULAR DISEASES (e.g., heart attacks and stroke), CANCER, chronic respiratory diseases (e.g., CHRONIC OBSTRUCTIVE PULMONARY DISEASE and ASTHMA) and DIABETES MELLITUS.
=688  \\$a2018

=LDR  01207cz  a2200241n  4500
=001  9880943874002441
=005  20200608133808.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075602
=035  \\$a(NLM)9810901403100041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x460.$x790.$x205
=150  \\$aNon-Point Source Pollution
=450  \\$wnnna$aNonpoint Source Pollution
=450  \\$wnnna$aNon Point Source Pollution
=450  \\$wnnna$aPollution, Non-Point Source
=450  \\$wnnna$aPollution, Nonpoint Source
=450  \\$wnnna$aSource Pollution, Non-Point
=450  \\$wnnna$aSource Pollution, Nonpoint
=550  \\$wg$aWater Pollution
=680  \\$iWater pollution from a variety of diffuse sources carried over or through the ground and into water sources such as LAKES; RIVERS; WETLANDS; coastal waters; and GROUNDWATER. Such diffuse sources include roadways and parking lots (GASOLINE; HEAVY METALS; and motor oil), lawns or agricultural land (excess FERTILIZERS, livestock excrement, and PESTICIDES), landfill seepage, and construction sites (chemicals and trash used in construction processes).
=688  \\$a2018
=750  \0$aNonpoint source pollution$0(DLC) sh 93004937$5IEN-M

=LDR  00767cz  a2200205n  4500
=001  9880943874302441
=005  20200608111414.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074043
=035  \\$a(NLM)9810900863200041
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x400.$x844
=150  \\$aNight Eating Syndrome
=450  \\$wnnna$aEating Syndrome, Night
=450  \\$wnnna$aEating Syndromes, Night
=450  \\$wnnna$aNight Eating Syndromes
=667  \\$acoordinate with SLEEP WAKE DISORDERS if pertinent
=680  \\$iLittle or no appetite for breakfast due to eating more food after dinner than during the meal and eating more than half of daily food intake after dinner hour.
=688  \\$a2018
=750  \0$aNight eating syndrome$0(DLC)sh2012003307$5IEN-M

=LDR  00922cz  a2200217n  4500
=001  9880944273802441
=005  20200609144458.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073197
=035  \\$a(NLM)9810900729200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x806
=150  \\$aOphiophagus hannah
=450  \\$wnnna$aKing Cobra
=450  \\$wnnna$aCobra, King
=450  \\$wnnna$aCobras, King
=450  \\$wnnna$aKing Cobras
=550  \\$wg$aElapidae
=680  \\$iThe longest of all venomous snakes and largest Elapid. It is not a member of the Naja genus, although its hood resembles the hood of Naja species. Its bite can deliver large quantities of neurotoxic and cardiotoxic venom, consisting primarily of ALPHA-NEUROTOXINS. King cobras are indigenous to forests of India and Southeast Asia.
=688  \\$a2018
=750  \0$aKing cobra$0(DLC) sh 85072395$5IEN-M

=LDR  01908cz  a2200541n  4500
=001  9880944274002441
=005  20200609120942.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073397
=035  \\$a(NLM)9810900702900041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 495
=072  \\$aC24.$x580
=072  \\$aF1.$x145.$x126.$x990.$x734
=072  \\$aF2.$x830.$x900.$x666
=150  \\$aOccupational Stress
=450  \\$wnnna$aJob Stress
=450  \\$wnnna$aJob-related Stress
=450  \\$wnnna$aProfessional Stress
=450  \\$wnnna$aWork Place Stress
=450  \\$wnnna$aWork-related Stress
=450  \\$wnnna$aWorkplace Stress
=450  \\$wnnna$aJob Stresses
=450  \\$wnnna$aJob related Stress
=450  \\$wnnna$aJob-related Stresses
=450  \\$wnnna$aOccupational Stresses
=450  \\$wnnna$aProfessional Stresses
=450  \\$wnnna$aStress, Job
=450  \\$wnnna$aStress, Job-related
=450  \\$wnnna$aStress, Occupational
=450  \\$wnnna$aStress, Professional
=450  \\$wnnna$aStress, Work Place
=450  \\$wnnna$aStress, Work-related
=450  \\$wnnna$aStress, Workplace
=450  \\$wnnna$aStresses, Job
=450  \\$wnnna$aStresses, Job-related
=450  \\$wnnna$aStresses, Occupational
=450  \\$wnnna$aStresses, Professional
=450  \\$wnnna$aStresses, Work Place
=450  \\$wnnna$aStresses, Work-related
=450  \\$wnnna$aStresses, Workplace
=450  \\$wnnna$aWork Place Stresses
=450  \\$wnnna$aWork related Stress
=450  \\$wnnna$aWork-related Stresses
=450  \\$wnnna$aWorkplace Stresses
=680  \\$iAdverse psychological and behavioral reactions caused by the pressures and demands of employers or clients or other factors, such as the physical environment of the workplace, WORKPLACE VIOLENCE; or WORKPLACE BULLYING.
=688  \\$a2018
=750  \0$aJob stress$0(DLC) sh 85070588$5IEN-M

=LDR  00836cz  a2200229n  4500
=001  9880945371802441
=005  20200611172055.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074284
=035  \\$a(NLM)9810900962100041
=040  \\$aDNLM$cDNLM
=072  \\$aB5.$x80.$x250
=072  \\$aG6.$x591.$x937
=072  \\$aG16.$x500.$x275.$x157.$x49.$x100.$x500.$x937
=072  \\$aN6.$x230.$x124.$x49.$x100.$x500.$x875
=150  \\$aPeriphyton
=450  \\$wnnna$aPeriphytons
=550  \\$wg$aAquatic Organisms
=550  \\$wg$aMicrobiota
=680  \\$iA complex mixture of organisms (algae, cyanobacteria, heterotrophic microbes, detritus, etc.) clinging on the surfaces of plants and other objects projecting from the bottom sediments of aquatic ecosystems.
=688  \\$a2018
=750  \0$aPeriphyton$0(DLC) sh 85099936$5IEN-M

=LDR  00669cz  a2200241n  4500
=001  9880945371902441
=005  20200611162807.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074241
=035  \\$a(NLM)9810900985900041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x809
=150  \\$aPeanut Oil
=450  \\$wnnna$aArachis Oil
=450  \\$wnnna$aGround Nut Oil
=450  \\$wnnna$aNut Oil, Ground
=450  \\$wnnna$aOil, Arachis
=450  \\$wnnna$aOil, Ground Nut
=450  \\$wnnna$aOil, Peanut
=550  \\$wg$aPlant Oils
=680  \\$iOil derived from PEANUTS.
=688  \\$a2018 (1975)
=750  \0$aPeanut oil$0(DLC) sh 85098998$5IEN-M

=LDR  00986cz  a2200337n  4500
=001  9880945474102441
=005  20200610120733.0
=008  170713\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074607
=035  \\$a(NLM)9810901233900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 286
=072  \\$aC25.$x775.$x643.$x500.$x800
=072  \\$aF3.$x900.$x647.$x500.$x800
=150  \\$aOpium Dependence
=450  \\$wnnna$aOpium Abuse
=450  \\$wnnna$aOpium Addiction
=450  \\$wnnna$aOpium Smoking
=450  \\$wnnna$aOpium Use
=450  \\$wnnna$aAbuse, Opium
=450  \\$wnnna$aAbuses, Opium
=450  \\$wnnna$aAddiction, Opium
=450  \\$wnnna$aDependence, Opium
=450  \\$wnnna$aOpium Abuses
=450  \\$wnnna$aOpium Uses
=450  \\$wnnna$aSmoking, Opium
=450  \\$wnnna$aUse, Opium
=450  \\$wnnna$aUses, Opium
=680  \\$iStrong physiological and emotional dependence on OPIUM.
=688  \\$a2018
=750  \0$aOpium abuse$0(DLC)sh 85095096$5IEN-M

=LDR  00637cz  a2200205n  4500
=001  9880945673902441
=005  20200611122015.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073878
=035  \\$a(NLM)9810900774700041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x798
=072  \\$aD20.$x215.$x784.$x750.$x728
=150  \\$aPalm Oil
=450  \\$wnnna$aPalmolein
=450  \\$wnnna$aOil, Palm
=550  \\$wg$aPlant Oils
=680  \\$iNutritive oil extracted from the fleshy mesocarp of the fruit of the African palm tree, Elaeis guineensis.
=688  \\$a2018(1984)
=750  \0$aPalm oil$0(DLC) sh 85097227$5IEN-M

=LDR  00632cz  a2200193n  4500
=001  9880946373502441
=005  20200721123509.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073868
=035  \\$a(NLM)9810900782400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x805.$x63
=150  \\$aPipe Smoking
=450  \\$wnnna$aSmoking, Pipe
=550  \\$wg$aSmoking
=550  \\$wh$aWater Pipe Smoking
=680  \\$iSMOKING by use of a narrow conveying tube which feeds from an open cavity where smoked product is loaded and burned.
=688  \\$a2018; use SMOKING 2013-2017
=750  \0$aPipe smoking$0(DLC) sh2005002477$5IEN

=LDR  00480cz  a2200169n  4500
=001  9880946774102441
=005  20200615105338.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073356
=035  \\$a(NLM)9810900714400041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x93.$x701
=150  \\$aPictorial Works as Topic
=550  \\$wg$aArt
=680  \\$iWorks that discuss pictures but not technical drawings.
=688  \\$a2018
=750  \0$aPictorial works$0(DLC) sh 86002267$5IEN-M

=LDR  00735cz  a2200181n  4500
=001  9880947271102441
=005  20200616145950.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075485
=035  \\$a(NLM)9810901421500041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 300
=072  \\$aN1.$x400.$x548
=150  \\$aPopulation Health
=550  \\$wg$aHealth
=680  \\$iThe health outcomes of a group of individuals, including the distribution of such outcomes within the group. These populations are often geographic regions, such as nations or communities, but they can also be other groups. (From Am J Public Health. 2003 March; 93(3): 380-383)
=688  \\$a2018
=750  \0$aPopulation$xHealth aspects$0(DLC)sh2020001146$5IEN-M

=LDR  00709cz  a2200217n  4500
=001  9880947271302441
=005  20200616145000.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076207
=035  \\$a(NLM)9810901466300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x715
=072  \\$aI1.$x880.$x853.$x100.$x628
=150  \\$aPopular Culture
=450  \\$wnnna$aPop Culture
=450  \\$wnnna$aCulture, Pop
=450  \\$wnnna$aCulture, Popular
=550  \\$wg$aCulture
=680  \\$iChoices and ways of doing things that predominate or are fashionable among ordinary people in a society during a point in time.
=688  \\$a2018
=750  \0$aPopular culture$0(DLC)sh 85104904$5IEN-M

=LDR  00641cz  a2200193n  4500
=001  9880947271502441
=005  20200616130725.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074439
=035  \\$a(NLM)9810901070600041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738.$x708
=150  \\$aPolitical Activism
=450  \\$wnnna$aSocial Activism
=550  \\$wg$aPolitics
=550  \\$aCommunity Participation
=680  \\$iActive involvement in the political process including promoting, impeding or raising awareness of a certain issue or set of issues.
=688  \\$a2018
=750  \0$aPolitical participation$0(DLC)sh 85104370$5IEN-M

=LDR  01568cz  a2200301n  4500
=001  9880948271902441
=005  20200618170317.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075370
=035  \\$a(NLM)9810901254200041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x826.$x313
=150  \\$aReceptors for Activated C Kinase
=450  \\$wnnna$aGNB2-RS1 Protein
=450  \\$wnnna$aGNB2L1 Protein
=450  \\$wnnna$aProtein Kinase C Receptor
=450  \\$wnnna$aProtein Kinase C Receptors
=450  \\$wnnna$aRACK1 Protein
=450  \\$wnnna$aReceptor for Activated C Kinase
=450  \\$wnnna$aReceptor of Activated C Kinase 1
=450  \\$wnnna$aReceptor, Protein Kinase C
=450  \\$wnnna$aGNB2 RS1 Protein
=550  \\$wg$aCytoplasmic and Nuclear Receptors
=680  \\$iReceptors for PROTEIN KINASE C that consist of seven WD40 REPEATS. They function in a wide variety of cellular and physiologic processes including the assembly of signaling complexes, protein translation, cell growth and proliferation, APOPTOSIS, and MUSCARINIC RECEPTOR transport. RACK1 depends on protein kinase C activity to translocate from the perinuclear region to the cell periphery and associates with the plasma membrane through interactions with KERATIN-1 and INTEGRIN BETA-1.
=688  \\$a2018 (1992)
=750  \0$iBroader mapping$aProtein kinase C$0(DLC)sh 94007950$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aProtein kinase C--Receptors

=LDR  00433cz  a2200157n  4500
=001  9880948273502441
=005  20180904000000.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075682
=035  \\$a(NLM)9810901396500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x661
=072  \\$aF2.$x463.$x617
=150  \\$aProcrastination
=680  \\$iThe deferment of actions or tasks to a later time, or to infinity.
=688  \\$a2018

=LDR  01826nz  a2200481n  4500
=001  9880948274302441
=005  20200617120834.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077443
=035  \\$a(NLM)9811675646900041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x100.$x850.$x438
=072  \\$aD2.$x886.$x645.$x600.$x55.$x850.$x400
=150  \\$aAcamprosate
=450  \\$wnnna$aAcamprosate Calcium
=450  \\$wnnna$aAcamprostate
=450  \\$wnnna$aAotal
=450  \\$wnnna$aCalcium Acetyl Homotaurinate
=450  \\$wnnna$aCalcium Acetylhomotaurinate
=450  \\$wnnna$aCalcium Acetylhomotaurine
=450  \\$wnnna$aCampral
=450  \\$wnnna$aCampral EC
=450  \\$wnnna$aN-Acetylhomotaurine
=450  \\$wnnna$aN-Acetylhomotaurine, Calcium (2:1) Salt
=450  \\$wnnna$aN-Acetylhomotaurine, Magnesium (2:1) Salt
=450  \\$wnnna$aN-Acetylhomotaurine, Monolithium Salt
=450  \\$wnnna$aN-Acetylhomotaurine, Monopotassium Salt
=450  \\$wnnna$aN-Acetylhomotaurine, Monosodium Salt
=450  \\$wnnna$aN-Acetylhomotaurine, Zinc (2:1) Salt
=450  \\$wnnna$aRegtect
=450  \\$wnnna$aSodium Acetylhomotaurine
=450  \\$wnnna$aZulex
=450  \\$wnnna$aAcetyl Homotaurinate, Calcium
=450  \\$wnnna$aAcetylhomotaurinate, Calcium
=450  \\$wnnna$aAcetylhomotaurine, Calcium
=450  \\$wnnna$aAcetylhomotaurine, Sodium
=450  \\$wnnna$aN Acetylhomotaurine
=450  \\$wnnna$aN Acetylhomotaurine, Monolithium Salt
=450  \\$wnnna$aN Acetylhomotaurine, Monopotassium Salt
=450  \\$wnnna$aN Acetylhomotaurine, Monosodium Salt
=680  \\$iStructural analog of taurine that is used for the prevention of relapse in individuals with ALCOHOLISM.
=688  \\$a2019 (1985)
=750  \0$aAcamprosate$0(DLC)sh 96003120$5IEN-M

=LDR  01241cz  a2200397n  4500
=001  9880948761102441
=005  20200630141750.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075387
=035  \\$a(NLM)9810901243600041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x767.$x750.$x500
=150  \\$aSmoking Water Pipes
=450  \\$wnnna$aHookahs
=450  \\$wnnna$aHookas
=450  \\$wnnna$aNarghiles
=450  \\$wnnna$aSheeshas
=450  \\$wnnna$aShishas
=450  \\$wnnna$aSmoking Waterpipes
=450  \\$wnnna$aHooka
=450  \\$wnnna$aHookah
=450  \\$wnnna$aNarghile
=450  \\$wnnna$aPipe, Smoking Water
=450  \\$wnnna$aPipes, Smoking Water
=450  \\$wnnna$aSheesha
=450  \\$wnnna$aShisha
=450  \\$wnnna$aSmoking Water Pipe
=450  \\$wnnna$aSmoking Waterpipe
=450  \\$wnnna$aWater Pipe, Smoking
=450  \\$wnnna$aWater Pipes, Smoking
=450  \\$wnnna$aWaterpipe, Smoking
=450  \\$wnnna$aWaterpipes, Smoking
=550  \\$wh$aSmoking Pipes
=680  \\$iPipes for smoking tobacco, cannabis, and other substances, in which smoke is drawn through water. Do not confuse with SMOKING PIPES.
=688  \\$a2018
=750  \0$aHookahs$0(DLC) sh 98003181$5IEN-M

=LDR  01330cz  a2200361n  4500
=001  9880949063302441
=005  20200629180927.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074606
=035  \\$a(NLM)9810901036800041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x233.$x332.$x812
=072  \\$aN2.$x421.$x726.$x407.$x840
=150  \\$aSmoking Prevention
=450  \\$wnnna$aAnti-Smoking Campaign
=450  \\$wnnna$aAnti-Smoking Education
=450  \\$wnnna$aAnti Smoking Campaign
=450  \\$wnnna$aAnti Smoking Education
=450  \\$wnnna$aAnti-Smoking Campaigns
=450  \\$wnnna$aAnti-Smoking Educations
=450  \\$wnnna$aCampaign, Anti-Smoking
=450  \\$wnnna$aCampaigns, Anti-Smoking
=450  \\$wnnna$aEducation, Anti-Smoking
=450  \\$wnnna$aPrevention, Smoking
=450  \\$wnnna$aPreventions, Smoking
=450  \\$wnnna$aSmoking Preventions
=450  \\$aSmoking$xprevention & control
=550  \\$wg$aHealth Education
=680  \\$iEfforts directed at preventing SMOKING of TOBACCO and non-tobacco products.
=688  \\$a2018
=750  \0$81$wb$iBroader mapping$aSmoking$0(DLC)sh 85123693$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xPrevention$0(DLC)sh 99002416$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aSmoking--Prevention$5IEN-M

=LDR  00610cz  a2200205n  4500
=001  9880949063402441
=005  20200629175126.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074604
=035  \\$a(NLM)9810901038000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x767.$x750
=150  \\$aSmoking Pipes
=450  \\$wnnna$aSmoking, Pipes
=450  \\$wnnna$aSmoking Pipe
=550  \\$wg$aSmoking Devices
=550  \\$wh$aSmoking Water Pipes
=680  \\$iDevices used for SMOKING which convey SMOKE directly into the mouth.
=688  \\$a2018
=750  \0$aTobacco pipes$0(DLC) sh 85135743$5IEN-M

=LDR  00744cz  a2200241n  4500
=001  9880949063902441
=005  20200629172843.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074602
=035  \\$a(NLM)9810901040300041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x767
=150  \\$aSmoking Devices
=450  \\$wnnna$aDevice, Smoking
=450  \\$wnnna$aDevices, Smoking
=450  \\$wnnna$aSmoking Device
=550  \\$wg$aManufactured Materials
=550  \\$wh$aElectronic Nicotine Delivery Systems
=550  \\$wh$aSmoking Pipes
=550  \\$wh$aTobacco Products
=680  \\$iGadgets, utensils, apparatuses or instruments used for SMOKING.
=688  \\$a2018
=750  \0$aSmoking paraphernalia$0(DLC) sh 85123698$5IEN-M

=LDR  00637cz  a2200205n  4500
=001  9880949065802441
=005  20200626123852.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074384
=035  \\$a(NLM)9810901131700041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 620
=072  \\$aN1.$x400.$x663
=150  \\$aSexual Health
=450  \\$wnnna$aHealth, Sexual
=550  \\$wg$aHealth
=550  \\$aSex Education
=680  \\$iA state of physical, emotional, mental and social well-being in relation to SEXUALITY, according to the World Health Organization.
=688  \\$a2018
=750  \0$aSexual health$0(DLC) sh 850635285$5IEN-M

=LDR  00844cz  a2200253n  4500
=001  9880949066102441
=005  20200626112852.0
=008  860618\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003205
=035  \\$a(NLM)98193833930000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224
=150  \\$aComputing Methodologies
=450  \\$aHigh Performance Computing
=450  \\$aMethodologies, Computing
=450  \\$wnnna$aComputing Methodology
=450  \\$wnnna$aComputing, High Performance
=450  \\$wnnna$aMethodology, Computing
=450  \\$wnnna$aPerformance Computing, High
=550  \\$wg$aInformation Science
=550  \\$wh$aSemantic Web
=680  \\$iComputer-assisted analysis and processing of problems in a particular area.
=688  \\$a97; was NON MESH 1987-96
=750  \0$aHigh performance computing$0(DLC) sh 95008935$5IEN-M

=LDR  01109cz  a2200289n  4500
=001  9880949066402441
=005  20200626113409.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075403
=035  \\$a(NLM)9810901431500041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x740
=150  \\$aSemantic Web
=450  \\$wnnna$aLinked Data
=450  \\$wnnna$aSemantic Network
=450  \\$wnnna$aData, Linked
=450  \\$wnnna$aDatas, Linked
=450  \\$wnnna$aLinked Datas
=450  \\$wnnna$aNetwork, Semantic
=450  \\$wnnna$aNetworks, Semantic
=450  \\$wnnna$aSemantic Networks
=450  \\$wnnna$aSemantic Webs
=450  \\$wnnna$aWeb, Semantic
=550  \\$wg$aComputing Methodologies
=680  \\$iA framework for development and promotion of common data formats and exchange protocols linked in a way that can be read directly by computers. Semantic Web is a platform for sharing and reusing data across application, enterprise, and community boundaries, by linking concepts rather than just documents.
=688  \\$a2018
=750  \0$aSemantic Web$0(DLC) sh2002000569$5IEN-M

=LDR  00685cz  a2200205n  4500
=001  9880949073802441
=005  20200619131659.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073017
=035  \\$a(NLM)9810900552800041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x340.$x825
=150  \\$aRefugee Camps
=450  \\$wnnna$aCamp, Refugee
=450  \\$wnnna$aCamps, Refugee
=450  \\$wnnna$aRefugee Camp
=550  \\$wg$aHousing
=680  \\$iAreas of shelter and protection for people who leave their own country or habitual residence to escape danger, persecution, or disaster.
=688  \\$a2018; use REFUGEES 1993-2017
=750  \0$aRefugee camps$0(DLC) sh 87007802$5IEN-M

=LDR  00442cz  a2200169n  4500
=001  9880949074102441
=005  20200619121920.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075665
=035  \\$a(NLM)9810901397600041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x679
=150  \\$aRecidivism
=550  \\$wg$aCrime
=680  \\$iRepeated criminal behavior.
=688  \\$a2018
=750  \0$aRecidivism$0(DLC) sh 86001921$5IEN-M

=LDR  02974cz  a2200685n  4500
=001  9880949074302441
=005  20200619112132.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074261
=035  \\$a(NLM)9810900981300041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x520.$x650.$x600.$x500.$x250
=072  \\$aD12.$x776.$x543.$x750.$x700.$x250
=072  \\$aD12.$x776.$x543.$x750.$x750.$x330
=150  \\$aReceptors, Enterotoxin
=450  \\$wnnna$aEnterotoxin Receptor
=450  \\$wnnna$aEnterotoxin Receptors
=450  \\$wnnna$aEnterotoxin-Guanylin Receptor
=450  \\$wnnna$aEnterotoxin-Guanylin Receptors
=450  \\$wnnna$aGC-C Receptor
=450  \\$wnnna$aGC-C Receptors
=450  \\$wnnna$aGuanyl Cyclase-C Receptor
=450  \\$wnnna$aGuanyl Cyclase-C Receptors
=450  \\$wnnna$aGuanylin-Uroguanylin Receptor
=450  \\$wnnna$aGuanylin-Uroguanylin Receptors
=450  \\$wnnna$aGuanylyl Cyclase C
=450  \\$wnnna$aHeat-Stable Enterotoxin Receptor
=450  \\$wnnna$aHeat-Stable Enterotoxin Receptors
=450  \\$wnnna$aReceptor, Enterotoxin
=450  \\$wnnna$aReceptor, Guanyl Cyclase-C
=450  \\$wnnna$aReceptors, Guanyl Cyclase-C
=450  \\$wnnna$aCyclase C, Guanylyl
=450  \\$wnnna$aCyclase-C Receptors, Guanyl
=450  \\$wnnna$aEnterotoxin Guanylin Receptor
=450  \\$wnnna$aEnterotoxin Guanylin Receptors
=450  \\$wnnna$aEnterotoxin Receptor, Heat-Stable
=450  \\$wnnna$aEnterotoxin Receptors, Heat-Stable
=450  \\$wnnna$aGC C Receptor
=450  \\$wnnna$aGC C Receptors
=450  \\$wnnna$aGuanyl Cyclase C Receptor
=450  \\$wnnna$aGuanyl Cyclase C Receptors
=450  \\$wnnna$aGuanylin Uroguanylin Receptor
=450  \\$wnnna$aGuanylin Uroguanylin Receptors
=450  \\$wnnna$aHeat Stable Enterotoxin Receptor
=450  \\$wnnna$aHeat Stable Enterotoxin Receptors
=450  \\$wnnna$aReceptor, Enterotoxin-Guanylin
=450  \\$wnnna$aReceptor, GC-C
=450  \\$wnnna$aReceptor, Guanyl Cyclase C
=450  \\$wnnna$aReceptor, Guanylin-Uroguanylin
=450  \\$wnnna$aReceptor, Heat-Stable Enterotoxin
=450  \\$wnnna$aReceptors, Enterotoxin-Guanylin
=450  \\$wnnna$aReceptors, GC-C
=450  \\$wnnna$aReceptors, Guanyl Cyclase C
=450  \\$wnnna$aReceptors, Guanylin-Uroguanylin
=450  \\$wnnna$aReceptors, Heat-Stable Enterotoxin
=550  \\$wg$aReceptors, Guanylate Cyclase-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$aEnterotoxins
=680  \\$iGuanylate cyclase-coupled receptors that bind bacterial ENTEROTOXINS, as well as the endogenous peptides guanylin and uroguanylin. Ligand binding stimulates production of CYCLIC GMP by EPITHELIAL CELLS of the intestinal lumen, altering barrier permeability and mucus secretion. Mutations in the gene (GUCY2C) encoding this receptor are associated with some cases of hereditary diarrhea (Diarrhea 6) and MECONIUM ILEUS.
=688  \\$a2018 (1981)

=LDR  00705cz  a2200217n  4500
=001  9880949166102441
=005  20200629122004.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076248
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x821.$x500.$x777
=150  \\$aSida Plant
=450  \\$wnnna$aFanpetals
=450  \\$wnnna$aSida Plants
=450  \\$wnnna$aFanpetal
=450  \\$wnnna$aPlant, Sida
=450  \\$wnnna$aPlants, Sida
=550  \\$wg$aMalvaceae
=680  \\$iA genus of flowering plants in the family of mallows (MALVACEAE). Their common name is fanpetals.
=688  \\$a2018; use MALVACEAE 2003-2017
=750  \0$aSida$0(DLC) sh 88023106$5IEN-M

=LDR  00963cz  a2200277n  4500
=001  9880949166302441
=005  20200629110702.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073577
=035  \\$a(NLM)9810900662400041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x946.$x225.$x250
=072  \\$aN4.$x452.$x677.$x650.$x250
=150  \\$aShift Work Schedule
=450  \\$wnnna$aNight Shift Work
=450  \\$wnnna$aRotating Shift Work
=450  \\$wnnna$aSchedule, Shift Work
=450  \\$wnnna$aSchedules, Shift Work
=450  \\$wnnna$aShift Work, Night
=450  \\$wnnna$aShift Work, Rotating
=450  \\$wnnna$aWork Schedule, Shift
=550  \\$wg$aPersonnel Staffing and Scheduling
=550  \\$aSleep Disorders, Circadian Rhythm
=680  \\$iJob schedule in which working hours deviate from the standard hours (e.g., evening shift, night shift or rotating shift).
=688  \\$a2018
=750  \0$aShift Systems$0(DLC) sh 85121411$5IEN-M

=LDR  01744cz  a2200529n  4500
=001  9880363590302441
=005  20141212203910.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009543
=035  \\$aCBA2808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203.$x540
=150  \\$aNifedipine
=450  \\$wnnna$aAdalat
=450  \\$wnnna$aAdcock Ingram Brand of Nifedipine
=450  \\$wnnna$aAWD Pharma Brand of Nifedipine
=450  \\$wnnna$aBay-1040
=450  \\$wnnna$aBay 1040
=450  \\$wnnna$aBAY-a-1040
=450  \\$wnnna$aBAY a 1040
=450  \\$wnnna$aBay1040
=450  \\$wnnna$aBAYa1040
=450  \\$wnnna$aBayer Brand of Nifedipine
=450  \\$wnnna$aCordipin
=450  \\$wnnna$aCordipine
=450  \\$wnnna$aCorinfar
=450  \\$wnnna$aFenigidin
=450  \\$wnnna$aKorinfar
=450  \\$wnnna$aKRKA Brand of Nifedipine
=450  \\$wnnna$aMonohydrochloride, Nifedipine
=450  \\$wnnna$aNifangin
=450  \\$wnnna$aNifedipine Bayer Brand
=450  \\$wnnna$aNifedipine-GTIS
=450  \\$wnnna$aNifedipine GTIS
=450  \\$wnnna$aNifedipine KRKA Brand
=450  \\$wnnna$aNifedipine Monohydrochloride
=450  \\$wnnna$aNifedipine Orion Brand
=450  \\$wnnna$aNifedipine Pfizer Brand
=450  \\$wnnna$aOrion Brand of Nifedipine
=450  \\$wnnna$aPfizer Brand of Nifedipine
=450  \\$wnnna$aProcardia
=450  \\$wnnna$aProcardia XL
=450  \\$wnnna$aVascard
=550  \\$wg$aDihydropyridines
=680  \\$iA potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
=688  \\$a84(75); was see under PYRIDINES 1975-83
=750  \0$aNifedipine$5IEN$0(DLC)sh 85091841

=LDR  01826cz  a2200397n  4500
=001  9880363590402441
=005  20141212203910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009542
=035  \\$aCBA2807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x700
=072  \\$aC15.$x604.$x250.$x410.$x625
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x700
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x730
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x700
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x700
=072  \\$aC18.$x452.$x584.$x687.$x803.$x730
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x700
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x730
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x700
=150  \\$aNiemann-Pick Diseases
=450  \\$aNiemann-Pick Disease
=450  \\$wnnna$aNiemann Pick Disease
=450  \\$wnnna$aNiemann Pick Diseases
=550  \\$wg$aHistiocytosis, Non-Langerhans-Cell
=550  \\$wg$aSphingolipidoses
=550  \\$wh$aNiemann-Pick Disease, Type A
=550  \\$wh$aNiemann-Pick Disease, Type B
=550  \\$wh$aNiemann-Pick Disease, Type C
=550  \\$aSea-Blue Histiocyte Syndrome
=550  \\$aSphingomyelin Phosphodiesterase
=667  \\$anote specific types are available
=680  \\$iA group of autosomal recessive disorders in which harmful quantities of lipids accumulate in the viscera and the central nervous system. They can be caused by deficiencies of enzyme activities (SPHINGOMYELIN PHOSPHODIESTERASE) or defects in intracellular transport, resulting in the accumulation of SPHINGOMYELINS and CHOLESTEROL. There are various subtypes based on their clinical and genetic differences.
=688  \\$a2000(1966)
=750  \0$aNiemann-Pick diseases$0(DLC)sh2006001837$5IEN-M

=LDR  00960cz  a2200253n  4500
=001  9880363590502441
=005  20141212203908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009538
=035  \\$aCBA2803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x760.$x570
=072  \\$aD3.$x383.$x725.$x518
=150  \\$aNicotine
=450  \\$wnnna$aBitartrate, Nicotine
=450  \\$wnnna$aNicotine Bitartrate
=450  \\$wnnna$aNicotine Tartrate
=450  \\$wnnna$aTartrate, Nicotine
=550  \\$wg$aPyridines
=550  \\$wg$aSolanaceous Alkaloids
=550  \\$aTobacco
=667  \\$a/biosyn permitted if by plant
=680  \\$iNicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.
=750  \0$aNicotine$5IEN$0(DLC)sh 85091817

=LDR  01923cz  a2200481n  4500
=001  9880363590602441
=005  20141212192354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009536
=035  \\$aCBA2801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x515.$x530
=072  \\$aD3.$x383.$x725.$x547.$x530
=150  \\$aNiacinamide
=450  \\$wnnna$a3-Pyridinecarboxamide
=450  \\$wnnna$a3 Pyridinecarboxamide
=450  \\$wnnna$aAstra Brand of Niacinamide
=450  \\$wnnna$aB 3, Vitamin
=450  \\$wnnna$aB3, Vitamin
=450  \\$wnnna$aEnduramide
=450  \\$wnnna$aJenapharm Brand of Niacinamide
=450  \\$wnnna$aJenapharm, Nicotinsäureamid
=450  \\$wnnna$aMerck Brand of Niacinamide
=450  \\$wnnna$aNiacinamide Astra Brand
=450  \\$wnnna$aNiacinamide Jenapharm Brand
=450  \\$wnnna$aNiacinamide Merck Brand
=450  \\$wnnna$aNiacinamide Pharmagenix Brand
=450  \\$wnnna$aNicobion
=450  \\$aNicotinamide
=450  \\$wnnna$aNicotinsäureamid Jenapharm
=450  \\$wnnna$aPapulex
=450  \\$wnnna$aPharmagenix Brand of Niacinamide
=450  \\$aVitamin B 3
=450  \\$wnnna$aVitamin B3
=450  \\$aVitamin PP
=550  \\$wg$aNicotinic Acids
=550  \\$wh$a6-Aminonicotinamide
=550  \\$wh$aNicorandil
=550  \\$wh$aNikethamide
=667  \\$a/defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iAn important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.
=688  \\$a93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92
=750  \0$aNicotinamide$0(DLC) sh 85144000$5IEN

=LDR  00845cz  a2200229n  4500
=001  9880363590702441
=005  20141212203907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009532
=035  \\$aCBA2797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x607
=072  \\$aD1.$x268.$x956.$x625
=072  \\$aD1.$x552.$x544.$x607
=150  \\$aNickel
=450  \\$aNickel Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aNi-58; Ni-60-62, 64 = NICKEL (IM) + ISOTOPES (NIM); Ni-56, 57, 59, 63, 65-67 = NICKEL (IM) + RADIOISOTOPES (IM)
=680  \\$iA trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.
=750  \0$aNickel$5IEN-M$0(DLC)sh 85091772
=750  \0$aNickel compounds$5IEN-HS$0(DLC)sh 85091787

=LDR  02287cz  a2200625n  4500
=001  9880363590802441
=005  20141212203906.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009530
=035  \\$aCBA2795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327.$x287.$x730
=072  \\$aD3.$x549.$x439.$x730
=150  \\$aNicergoline
=450  \\$wnnna$aAventis Brand of Nicergoline
=450  \\$wnnna$abetapharm Brand of Nicergoline
=450  \\$wnnna$aCirco-Maren
=450  \\$wnnna$aCirco Maren
=450  \\$wnnna$act-Arzneimittel Brand of Nicergoline
=450  \\$wnnna$act Arzneimittel Brand of Nicergoline
=450  \\$wnnna$aDexcel Brand of Nicergoline
=450  \\$wnnna$aergobel
=450  \\$wnnna$aF.I. 6714
=450  \\$wnnna$aFisifax
=450  \\$wnnna$aHexal Brand of Nicergoline
=450  \\$wnnna$aHormosan Brand of Nicergoline
=450  \\$wnnna$aKenfarma Brand of Nicergoline
=450  \\$wnnna$aKrewel Brand of Nicergoline
=450  \\$wnnna$aLindopharm Brand of Nicergoline
=450  \\$wnnna$aneuraxpharm Brand of Nicergoline
=450  \\$wnnna$aNicergobeta
=450  \\$wnnna$aNicergolin Atid
=450  \\$wnnna$aNicergolin Lindo
=450  \\$wnnna$aNicergolin-neuraxpharm
=450  \\$wnnna$aNicergolin neuraxpharm
=450  \\$wnnna$aNicergolin-ratiopharm
=450  \\$wnnna$aNicergolin ratiopharm
=450  \\$wnnna$aNicergolin-TEVA
=450  \\$wnnna$aNicergolin TEVA
=450  \\$wnnna$anicergolin von ct
=450  \\$wnnna$aNicergoline Hexal Brand
=450  \\$wnnna$aNicergoline Pfizer Brand
=450  \\$wnnna$aNicergoline Teva Brand
=450  \\$wnnna$aNicerium
=450  \\$wnnna$aNicotergoline
=450  \\$aNimergoline
=450  \\$wnnna$aPfizer Brand of Nicergoline
=450  \\$wnnna$aratiopharm Brand of Nicergoline
=450  \\$wnnna$aReig Jofre Brand of Nicergoline
=450  \\$wnnna$aSermion
=450  \\$wnnna$aTeva Brand of Nicergoline
=550  \\$wg$aErgolines
=680  \\$iAn ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.
=688  \\$a91(75); was see under ERGOLINES 1975-90
=750  \0$aNicergoline$5IEN$0(DLC)sh 85091758

=LDR  02987cz  a2200829n  4500
=001  9880363590902441
=005  20141212203904.0
=008  820506\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009525
=035  \\$aCBA2790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x515.$x475
=072  \\$aD3.$x383.$x725.$x547.$x475
=150  \\$aNiacin
=450  \\$wnnna$a3-Pyridinecarboxylic Acid
=450  \\$wnnna$a3 Pyridinecarboxylic Acid
=450  \\$wnnna$aAcid, 3-Pyridinecarboxylic
=450  \\$wnnna$aAcid, Nicotinic
=450  \\$wnnna$aAluminum Salt, Niacin
=450  \\$wnnna$aAmmonium Salt, Niacin
=450  \\$wnnna$aCalcium Salt, Niacin
=450  \\$wnnna$aEnduracin
=450  \\$wnnna$aHydrochloride, Niacin
=450  \\$wnnna$aInduracin
=450  \\$wnnna$aLithium Nicotinate
=450  \\$wnnna$aLithium Salt, Niacin
=450  \\$wnnna$aMagnesium Salt, Niacin
=450  \\$wnnna$aNiacin Aluminum Salt
=450  \\$wnnna$aNiacin Ammonium Salt
=450  \\$wnnna$aNiacin Calcium Salt
=450  \\$wnnna$aNiacin Cobalt (2+) Salt
=450  \\$wnnna$aNiacin Copper (2+) Salt
=450  \\$wnnna$aNiacin Hydrochloride
=450  \\$wnnna$aNiacin Iron (2+) Salt
=450  \\$wnnna$aNiacin Lithium Salt
=450  \\$wnnna$aNiacin Lithium Salt, Hemihydrate
=450  \\$wnnna$aNiacin Magnesium Salt
=450  \\$wnnna$aNiacin Manganese (2+) Salt
=450  \\$wnnna$aNiacin Potassium Salt
=450  \\$wnnna$aNiacin Sodium Salt
=450  \\$wnnna$aNiacin Tartrate
=450  \\$wnnna$aNiacin Tosylate
=450  \\$wnnna$aNiacin Zinc Salt
=450  \\$wnnna$aNicamin
=450  \\$wnnna$aNico-400
=450  \\$wnnna$aNico 400
=450  \\$wnnna$aNico400
=450  \\$wnnna$aNicobid
=450  \\$wnnna$aNicocap
=450  \\$wnnna$aNicolar
=450  \\$wnnna$aNicotinate
=450  \\$wnnna$aNicotinate, Lithium
=450  \\$aNicotinic Acid
=450  \\$wnnna$aPotassium Salt, Niacin
=450  \\$wnnna$aSalt, Niacin Aluminum
=450  \\$wnnna$aSalt, Niacin Ammonium
=450  \\$wnnna$aSalt, Niacin Calcium
=450  \\$wnnna$aSalt, Niacin Lithium
=450  \\$wnnna$aSalt, Niacin Magnesium
=450  \\$wnnna$aSalt, Niacin Potassium
=450  \\$wnnna$aSalt, Niacin Sodium
=450  \\$wnnna$aSalt, Niacin Zinc
=450  \\$wnnna$aSodium Salt, Niacin
=450  \\$wnnna$aTartrate, Niacin
=450  \\$wnnna$aTosylate, Niacin
=450  \\$wnnna$aWampocap
=450  \\$wnnna$aZinc Salt, Niacin
=550  \\$wg$aNicotinic Acids
=667  \\$a/defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
=688  \\$a83; was see NICOTINIC ACIDS 1975-82 & NICOTINIC ACID 1963-74
=750  \0$aNiacin$5IEN$0(DLC)sh 85091698

=LDR  00856cz  a2200181n  4500
=001  9880363591002441
=005  20141212203903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009524
=035  \\$aCBA2789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x829.$x481
=150  \\$aNewspapers
=450  \\$wnnna$aNewspaper
=550  \\$wg$aSerial Publications
=667  \\$amed newspapers: do not coord with MEDICINE; do not confuse with NEWSLETTERS see PERIODICALS; do not confuse with Publication Types NEWS or NEWSPAPER ARTICLE
=680  \\$iPublications printed and distributed daily, weekly, or at some other regular and usually short interval, containing news, articles of opinion (as editorials and letters), features, advertising, and announcements of current interest. (Webster's 3d ed)
=750  \0$aNewspapers$5IEN$0(DLC)sh 85091588

=LDR  01022cz  a2200217n  4500
=001  9880363591102441
=005  20141212203903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009522
=035  \\$aCBA2787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x70.$x600
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x70.$x600
=150  \\$aNewcastle disease virus
=450  \\$aAvian Paramyxovirus 1
=450  \\$aParamyxovirus 1, Avian
=550  \\$wg$aAvulavirus
=667  \\$ainfection = NEWCASTLE DISEASE
=680  \\$iThe most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food.
=688  \\$a63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96
=750  \0$aNewcastle disease virus$5IEN$0(DLC)sh 85091547

=LDR  00889cz  a2200205n  4500
=001  9880363591202441
=005  20141212203902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009521
=035  \\$aCBA2786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x80.$x600
=072  \\$aC22.$x131.$x630
=150  \\$aNewcastle Disease
=450  \\$wnnna$aDisease, Newcastle
=550  \\$wg$aAvulavirus Infections
=550  \\$wg$aBird Diseases
=667  \\$adon't forget also BIRDS (NIM) or POULTRY (NIM) or specific bird or fowl (IM) & check tag ANIMALS
=680  \\$iAn acute febrile, contagious, viral disease of birds caused by an AVULAVIRUS called NEWCASTLE DISEASE VIRUS. It is characterized by respiratory and nervous symptoms in fowl and is transmissible to man causing a severe, but transient conjunctivitis.
=750  \0$aNewcastle disease$5IEN$0(DLC)sh 85091545

=LDR  01284cz  a2200325n  4500
=001  9880363591302441
=005  20141212203859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009508
=035  \\$aCBA2773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x665.$x560.$x615
=150  \\$aNevus, Pigmented
=450  \\$wnnna$aMelanocytic Nevi
=450  \\$wnnna$aMelanocytic Nevus
=450  \\$aMole (Dermatology)$5IEN
=450  \\$wnnna$aNevi, Melanocytic
=450  \\$wnnna$aNevi, Pigmented
=450  \\$aNevus, Melanocytic
=450  \\$wnnna$aPigmented Moles
=450  \\$wnnna$aPigmented Nevi
=450  \\$wnnna$aPigmented Nevus
=550  \\$wg$aNevus
=550  \\$wh$aMongolian Spot
=550  \\$wh$aNevus, Blue
=550  \\$wh$aNevus of Ota
=550  \\$wh$aNevus, Spindle Cell
=667  \\$a/blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant
=680  \\$iA nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi.
=750  \0$aMole (Dermatology)$5IEN$0(DLC)sh 85086568

=LDR  01059cz  a2200301n  4500
=001  9880363591402441
=005  20141212203858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009506
=035  \\$aCBA2771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x665.$x560
=150  \\$aNevus
=450  \\$aBirthmarks$5IEN
=450  \\$aMole, Skin
=450  \\$aMoles, Skin
=450  \\$wnnna$aNevi
=450  \\$aSkin Mole
=450  \\$wnnna$aSkin Moles
=550  \\$wg$aNevi and Melanomas
=550  \\$wh$aDysplastic Nevus Syndrome
=550  \\$wh$aNevus, Halo
=550  \\$wh$aNevus, Intradermal
=550  \\$wh$aNevus, Pigmented
=550  \\$wh$aNevus, Sebaceous of Jadassohn
=667  \\$acoordinate IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant; general; note many specific nevus terms
=680  \\$iA circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin.
=750  \0$aBirthmarks$5IEN$0(DLC)sh 85014393

=LDR  01668cz  a2200421n  4500
=001  9880363591502441
=005  20141212192352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009504
=035  \\$aCBA2769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x415.$x583
=072  \\$aA11.$x627.$x340.$x583
=072  \\$aA11.$x733.$x689
=072  \\$aA15.$x145.$x229.$x637.$x415.$x583
=072  \\$aA15.$x382.$x490.$x315.$x583
=072  \\$aA15.$x382.$x680.$x689
=150  \\$aNeutrophils
=450  \\$wnnna$aBand Cell, Neutrophil
=450  \\$wnnna$aBand Cells, Neutrophil
=450  \\$wnnna$aCell, LE
=450  \\$wnnna$aCells, LE
=450  \\$wnnna$aLE Cell
=450  \\$aLE Cells
=450  \\$wnnna$aLeukocyte, Polymorphonuclear
=450  \\$aLeukocytes, Polymorphonuclear
=450  \\$wnnna$aNeutrophil
=450  \\$wnnna$aNeutrophil Band Cell
=450  \\$wnnna$aNeutrophil Band Cells
=450  \\$wnnna$aPolymorphonuclear Leukocyte
=450  \\$aPolymorphonuclear Leukocytes
=550  \\$wg$aGranulocytes
=550  \\$wg$aPhagocytes
=550  \\$aExtracellular Traps
=667  \\$adecrease in number = NEUTROPENIA; neutrophil chemotaxis: coordinate with CHEMOTAXIS, LEUKOCYTE; note entry term LE CELLS: do not coordinate with LUPUS ERYTHEMATOSUS, SYSTEMIC unless disease is particularly discussed
=680  \\$iGranular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
=688  \\$a65; LE CELLS was heading 1963-95 (Prov 1963-64)
=750  \0$aNeutrophils$5IEN$0(DLC)sh 85091230

=LDR  00890cz  a2200193n  4500
=001  9880363591602441
=005  20180914112941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009502
=035  \\$aCBA2767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x660.$x250
=150  \\$aNeutrons
=450  \\$wnnna$aNeutron
=550  \\$wg$aNucleons
=550  \\$wh$aFast Neutrons
=667  \\$aelementary particles; IM; FAST NEUTRONS is available
=680  \\$iElectrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay.
=750  \0$aNeutrons$5IEN$0(DLC)sh 85091222

=LDR  01071cz  a2200253n  4500
=001  9880363591702441
=005  20141212203857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009501
=035  \\$aCBA2766HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x39.$x564
=150  \\$aNeutron Activation Analysis
=450  \\$wnnna$aActivation Analyses, Neutron
=450  \\$wnnna$aActivation Analysis, Neutron
=450  \\$wnnna$aAnalyses, Neutron Activation
=450  \\$wnnna$aAnalysis, Neutron Activation
=450  \\$wnnna$aNeutron Activation Analyses
=450  \\$aNuclear Activation Analysis$5IEN
=550  \\$wg$aActivation Analysis
=667  \\$aan anal chem technique; NIM; DF: NEUTRON ACTIVATION ANAL
=680  \\$iActivation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a91(75); was see under ACTIVATION ANALYSIS 1975-90
=750  \0$aNuclear activation analysis$5IEN$0(DLC)sh 85110592

=LDR  01244cz  a2200265n  4500
=001  9880363591802441
=005  20141212203856.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009498
=035  \\$aCBA2763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x504
=150  \\$aNeurotoxins
=450  \\$wnnna$aAlpha-Neurotoxins
=450  \\$wnnna$aAlpha Neurotoxins
=450  \\$wnnna$aExcitatory Neurotoxins
=450  \\$wnnna$aExcitotoxin
=450  \\$aExcitotoxins
=450  \\$aNeurotoxic Agents$5IEN
=450  \\$wnnna$aNeurotoxins, Excitatory
=550  \\$wg$aNoxae
=667  \\$a/antag permitted but consider also ANTITOXINS; coordinate IM with toxin or venom heading which is the source of the neurotoxin (IM or NIM); do not use for neurotoxicity of various chemicals & drugs ( = NERVOUS SYSTEM /drug eff or specific nervous system term /drug eff or nervous system disease heading /chem ind + Category D term /adv eff-pois-tox)
=680  \\$iToxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept.
=688  \\$a78
=750  \0$aNeurotoxic agents$0(DLC) sh 85091181$5IEN

=LDR  00936cz  a2200241n  4500
=001  9880363591902441
=005  20141212203856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009497
=035  \\$aCBA2762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x650
=150  \\$aNeurotic Disorders
=450  \\$wnnna$aDisorder, Neurotic
=450  \\$wnnna$aDisorders, Neurotic
=450  \\$aNeuroses
=450  \\$wnnna$aNeurotic Disorder
=450  \\$aPsychoneuroses
=550  \\$wg$aMental Disorders
=680  \\$iDisorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
=688  \\$a81; was NEUROSES 1963-80
=750  \0$aNeurotics$5IEN$0(DLC)sh 85091179
=750  \0$aNeuroses$5IEN-HS$0(DLC)sh 85091169

=LDR  00875cz  a2200193n  4500
=001  9880363592002441
=005  20141212203856.0
=008  770523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009496
=035  \\$aCBA2761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x550
=072  \\$aD12.$x776.$x641.$x650.$x550
=150  \\$aNeurotensin
=550  \\$wg$aNeuropeptides
=667  \\$aa neurotransmitter isolated from the hypothalamus; /biosyn /physiol permitted
=680  \\$iA biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.
=688  \\$a78
=750  \0$aNeurotensin$5IEN$0(DLC)sh 85091178

=LDR  02520cz  a2200553n  4500
=001  9880363592102441
=005  20141212203856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009494
=035  \\$aCBA2759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x750
=072  \\$aC1.$x252.$x400.$x840.$x744.$x456
=072  \\$aC1.$x252.$x847.$x840.$x744.$x456
=072  \\$aC10.$x228.$x228.$x180.$x600
=150  \\$aNeurosyphilis
=450  \\$wnnna$aAsymptomatic Neurosyphilis
=450  \\$wnnna$aCentral Nervous System Syphilis
=450  \\$wnnna$aGeneral Paralyses
=450  \\$wnnna$aGeneral Paralysis
=450  \\$wnnna$aGeneral Pareses
=450  \\$aGeneral Paresis
=450  \\$wnnna$aGeneral Paresis of the Insane
=450  \\$wnnna$aGummatous Neurosyphilis
=450  \\$wnnna$aJuvenile Neurosyphilis
=450  \\$wnnna$aJuvenile Pareses
=450  \\$aJuvenile Paresis
=450  \\$wnnna$aNeurosyphilis, Asymptomatic
=450  \\$wnnna$aNeurosyphilis, Gummatous
=450  \\$wnnna$aNeurosyphilis, Juvenile
=450  \\$wnnna$aNeurosyphilis, Paretic
=450  \\$wnnna$aNeurosyphilis, Secondary
=450  \\$wnnna$aNeurosyphilis, Symptomatic
=450  \\$wnnna$aParalyses, General
=450  \\$wnnna$aParalysis, General
=450  \\$wnnna$aPareses, General
=450  \\$wnnna$aPareses, Juvenile
=450  \\$wnnna$aParesis, General
=450  \\$wnnna$aParesis, Juvenile
=450  \\$aParetic Neurosyphilis
=450  \\$wnnna$aSecondary Neurosyphilis
=450  \\$aSyphilis, Central Nervous System
=450  \\$wnnna$aSyphilis, CNS
=550  \\$wg$aCentral Nervous System Bacterial Infections
=550  \\$wg$aSyphilis
=550  \\$wh$aTabes Dorsalis
=680  \\$iInfections of the central nervous system caused by TREPONEMA PALLIDUM which present with a variety of clinical syndromes. The initial phase of infection usually causes a mild or asymptomatic meningeal reaction. The meningovascular form may present acutely as BRAIN INFARCTION. The infection may also remain subclinical for several years. Late syndromes include general paresis; TABES DORSALIS; meningeal syphilis; syphilitic OPTIC ATROPHY; and spinal syphilis. General paresis is characterized by progressive DEMENTIA; DYSARTHRIA; TREMOR; MYOCLONUS; SEIZURES; and Argyll-Robertson pupils. (Adams et al., Principles of Neurology, 6th ed, pp722-8)
=688  \\$a1963; for GENERAL PARALYSIS & PARALYSIS, GENERAL use PARESIS 1963-93
=750  \0$aNeurosyphilis$5IEN$0(DLC)sh 85091177

=LDR  00675cz  a2200193n  4500
=001  9880363592202441
=005  20170807104753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009493
=035  \\$aCBA2758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x425
=150  \\$aNeurosurgery
=450  \\$wnnna$aNeurosurgeries
=550  \\$wg$aSpecialties, Surgical
=550  \\$aNeurosurgical Procedures
=667  \\$aSPEC: SPEC qualif
=680  \\$iA surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system.
=750  \0$aNervous system$xSurgery$5IEN-M$0(DLC)sh 85090934

=LDR  00769cz  a2200217n  4500
=001  9880363592302441
=005  20141212203854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009492
=035  \\$aCBA2757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x800.$x629.$x564
=150  \\$aNeurospora crassa
=450  \\$wnnna$acrassa, Neurospora
=450  \\$wnnna$acrassas, Neurospora
=450  \\$wnnna$aNeurospora crassas
=550  \\$wg$aNeurospora
=667  \\$ado not confuse with NEOSPORA, a protozoan; DF: N CRASSA
=680  \\$iA species of ascomycetous fungi of the family Sordariaceae, order SORDARIALES, much used in biochemical, genetic, and physiologic studies.
=688  \\$a91(72)
=750  \0$aNeurospora crassa$5IEN$0(DLC)sh 85091173

=LDR  00806cz  a2200193n  4500
=001  9880363592402441
=005  20141212203854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009491
=035  \\$aCBA2756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x800.$x629
=150  \\$aNeurospora
=450  \\$wnnna$aNeurosporas
=550  \\$wg$aSordariales
=550  \\$wh$aNeurospora crassa
=667  \\$aan ascomycete much used in genetic & enzyme research; do not confuse with NEOSPORA, a protozoon
=680  \\$iA genus of ascomycetous fungi, family Sordariaceae, order SORDARIALES, comprising bread molds. They are capable of converting tryptophan to nicotinic acid and are used extensively in genetic and enzyme research. (Dorland, 27th ed)
=750  \0$aNeurospora$5IEN$0(DLC)sh 85091172

=LDR  01298cz  a2200361n  4500
=001  9880363592502441
=005  20141212192352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009490
=035  \\$aCBA2755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x688
=072  \\$aA8.$x713
=150  \\$aNeurosecretory Systems
=450  \\$aNeuroendocrine System
=450  \\$wnnna$aNeuroendocrine Systems
=450  \\$wnnna$aNeurosecretory System
=450  \\$wnnna$aSystem, Neuroendocrine
=450  \\$wnnna$aSystem, Neurosecretory
=450  \\$wnnna$aSystems, Neuroendocrine
=450  \\$wnnna$aSystems, Neurosecretory
=550  \\$wg$aEndocrine System
=550  \\$wg$aNervous System
=550  \\$wh$aCircumventricular Organs
=550  \\$wh$aCorpora Allata
=550  \\$wh$aGlomus Tympanicum
=550  \\$wh$aHypothalamo-Hypophyseal System
=550  \\$wh$aPineal Gland
=550  \\$aNeurosecretion
=667  \\$a/secret = probably /physiol or NEUROSECRETION
=680  \\$iA system of NEURONS that has the specialized function to produce and secrete HORMONES, and that constitutes, in whole or in part, an ENDOCRINE SYSTEM or organ.
=688  \\$a70; NEUROHEMAL ORGAN was see under NEUROSECRETORY SYSTEMS 1970-83
=750  \0$aNeurohemal organs$5IEN$0(DLC)sh 85091125

=LDR  00619cz  a2200193n  4500
=001  9880363592602441
=005  20141212203854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009489
=035  \\$aCBA2754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x640
=150  \\$aNeurosecretion
=450  \\$wnnna$aNeurosecretions
=550  \\$wg$aNervous System Physiological Processes
=550  \\$aNeurosecretory Systems
=680  \\$iThe production and release of substances such as NEUROTRANSMITTERS or HORMONES from nerve cells.
=688  \\$a65(64)
=750  \0$aNeurosecretion$5IEN$0(DLC)sh 85091168

=LDR  00954cz  a2200289n  4500
=001  9880363592702441
=005  20170807103107.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009488
=035  \\$aCBA2753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x610
=150  \\$aNeurosciences
=450  \\$wnnna$aNeuroscience
=550  \\$wg$aBiological Science Disciplines
=550  \\$wh$aCognitive Neuroscience
=550  \\$wh$aNeuroanatomy
=550  \\$wh$aNeurobiology
=550  \\$wh$aNeurochemistry
=550  \\$wh$aNeuroendocrinology
=550  \\$wh$aNeuropharmacology
=550  \\$wh$aNeurophysiology
=650  \\$wh$aNeuropathology
=667  \\$ause for the discipline only (education, history, etc) only
=680  \\$iThe scientific disciplines concerned with the embryology, anatomy, physiology, biochemistry, pharmacology, etc., of the nervous system.
=688  \\$a86
=750  \0$aNeurosciences$5IEN$0(DLC)sh 91006099

=LDR  01037cz  a2200301n  4500
=001  9880363592802441
=005  20141212203853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009485
=035  \\$aCBA2750HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937
=072  \\$aE1.$x370.$x350.$x700.$x560
=072  \\$aE1.$x370.$x376.$x537.$x750
=072  \\$aE5.$x629.$x937
=150  \\$aNeuroradiography
=450  \\$wnnna$aNeuroradiographies
=550  \\$wg$aNeuroimaging
=550  \\$wg$aRadiography
=550  \\$wh$aCerebral Angiography
=550  \\$wh$aCerebral Ventriculography
=550  \\$wh$aEchoencephalography
=550  \\$wh$aMyelography
=550  \\$wh$aPneumoencephalography
=667  \\$aGEN or technical only: not coord for specific nerve /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: NEURORADIOGR
=680  \\$iRadiography of the central nervous system.
=688  \\$a73
=750  \0$aNervous system$xRadiography$5IEN$0(DLC)sh 85090932

=LDR  01006cz  a2200229n  4500
=001  9880363592902441
=005  20141212203853.0
=008  840501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009484
=035  \\$aCBA2749HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x795.$x600
=072  \\$aH1.$x158.$x782.$x795.$x110
=150  \\$aNeuropsychology
=450  \\$aClinical Neuropsychology$5IEN
=450  \\$wnnna$aNeuropsychologies
=550  \\$wg$aPsychophysiology
=550  \\$aNeuropsychiatry
=667  \\$aSPEC: not for coord of NERVOUS SYSTEM DISEASES /psychol; IM, SPEC qualif; NIM coord, no qualif; DF: NEUROPSYCHOL
=680  \\$iA branch of psychology which investigates the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system. It is a more narrowly defined field than physiological psychology or psychophysiology.
=688  \\$a85
=750  \0$aNeuropsychology$5IEN-M$0(DLC)sh 85091163

=LDR  01600cz  a2200409n  4500
=001  9880363593002441
=005  20200722123609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009483
=035  \\$aCBA2748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x513
=150  \\$aNeuropsychological Tests
=450  \\$wnnna$aAphasia Test
=450  \\$aAphasia Tests
=450  \\$aMemory for Designs Test
=450  \\$wnnna$aNeuropsychologic Test
=450  \\$wnnna$aNeuropsychologic Tests
=450  \\$wnnna$aNeuropsychological Test
=450  \\$wnnna$aTest, Aphasia
=450  \\$wnnna$aTest, Neuropsychologic
=450  \\$wnnna$aTest, Neuropsychological
=450  \\$wnnna$aTests, Aphasia
=450  \\$wnnna$aTests, Neuropsychologic
=450  \\$wnnna$aTests, Neuropsychological
=550  \\$wg$aPsychological Tests
=550  \\$wh$aBender-Gestalt Test
=550  \\$wh$aLuria-Nebraska Neuropsychological Battery
=550  \\$wh$aMemory and Learning Tests
=550  \\$wh$aMental Navigation Tests
=550  \\$wh$aStroop Test
=550  \\$wh$aTrail Making Test
=550  \\$wh$aWisconsin Card Sorting Test
=667  \\$aDF: NEUROPSYCHOL TESTS
=680  \\$iTests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
=688  \\$a85; was NON MESH before 1985; MEMORY FOR DESIGNS TEST was heading 1971-84 (Prov 1971-72); APHASIA TESTS was see under LANGUAGE TESTS 1979-84
=750  \0$aNeuropsychological tests$5IEN$0(DLC)sh 85091162

=LDR  00746cz  a2200229n  4500
=001  9880363593102441
=005  20141212203852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009482
=035  \\$aCBA2747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x610.$x268
=072  \\$aH1.$x158.$x782.$x562
=150  \\$aNeurophysiology
=450  \\$aNeurophysiologists$5IEN
=550  \\$wg$aNeurosciences
=550  \\$wg$aPhysiology
=667  \\$aSPEC only: not for NERVOUS SYSTEM PHYSIOLOGY;DF: NEUROPHYSIOL
=680  \\$iThe scientific discipline concerned with the physiology of the nervous system.
=688  \\$a65
=750  \0$aNeurophysiologists$0(DLC) sh 89006682$5IEN-M
=750  \0$aNeurophysiology$0(DLC) sh 85091159$5IEN-HS

=LDR  01472cz  a2200361n  4500
=001  9880363593202441
=005  20141212203852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009481
=035  \\$aCBA2746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x525
=072  \\$aD12.$x776.$x157.$x597
=072  \\$aD12.$x776.$x641.$x650.$x525
=150  \\$aNeurophysins
=450  \\$wnnna$aI, Neurophysin
=450  \\$wnnna$aII, Neurophysin
=450  \\$wnnna$aIII, Neurophysin
=450  \\$wnnna$aNeurophysin I
=450  \\$wnnna$aNeurophysin II
=450  \\$wnnna$aNeurophysin III
=450  \\$wnnna$aNeurophysin, Oxytocin-Associated
=450  \\$wnnna$aNeurophysin, Vasopressin-Associated
=450  \\$wnnna$aOxytocin-Associated Neurophysin
=450  \\$wnnna$aOxytocin Associated Neurophysin
=450  \\$wnnna$aVasopressin-Associated Neurophysin
=450  \\$wnnna$aVasopressin Associated Neurophysin
=550  \\$wg$aCarrier Proteins
=550  \\$wg$aNeuropeptides
=550  \\$aPituitary Hormones, Posterior
=680  \\$iCarrier proteins for OXYTOCIN and VASOPRESSIN. They are polypeptides of about 10-kDa, synthesized in the HYPOTHALAMUS. Neurophysin I is associated with oxytocin and neurophysin II is associated with vasopressin in their respective precursors and during transportation down the axons to the neurohypophysis (PITUITARY GLAND, POSTERIOR).
=688  \\$a73
=750  \0$aNeurophysins$5IEN$0(DLC)sh 85091158

=LDR  00876cz  a2200253n  4500
=001  9880363593302441
=005  20141212203852.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009480
=035  \\$aCBA2745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x610.$x208
=072  \\$aH1.$x158.$x703.$x30
=072  \\$aH2.$x628.$x280
=150  \\$aNeuropharmacology
=450  \\$wnnna$aNeuropharmacologies
=450  \\$aNeuropsychopharmacology$5IEN
=550  \\$wg$aNeurosciences
=550  \\$wg$aPharmacology
=667  \\$aSPEC: SPEC qualif: not for NERVOUS SYSTEM /drug eff; DF: NEUROPHARMACOL
=680  \\$iThe branch of pharmacology dealing especially with the action of drugs upon various parts of the nervous system.
=688  \\$a86
=750  \0$aNeuropsychopharmacology$5IEN-M$0(DLC)sh 85091165
=750  \0$aNeuropharmacology$5IEN-HS$0(DLC)sh 85091157

=LDR  01965cz  a2200625n  4500
=001  9880363593402441
=005  20200618164214.0
=008  860411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009479
=035  \\$aCBA2744HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400
=072  \\$aD12.$x776.$x641.$x650
=150  \\$aNeuropeptides
=450  \\$wnnna$aNeuropeptide
=550  \\$wg$aNerve Tissue Proteins
=550  \\$wg$aPeptides
=550  \\$wh$aAngiotensins
=550  \\$wh$aBombesin
=550  \\$wh$aBradykinin
=550  \\$wh$aCalcitonin
=550  \\$wh$aCalcitonin Gene-Related Peptide
=550  \\$wh$aCarnosine
=550  \\$wh$aCholecystokinin
=550  \\$wh$aDelta Sleep-Inducing Peptide
=550  \\$wh$aFMRFamide
=550  \\$wh$aGalanin
=550  \\$wh$aGalanin-Like Peptide
=550  \\$wh$aGastric Inhibitory Polypeptide
=550  \\$wh$aGastrin-Releasing Peptide
=550  \\$wh$aGastrins
=550  \\$wh$aHypothalamic Hormones
=550  \\$wh$aKisspeptins
=550  \\$wh$aMelanocyte-Stimulating Hormones
=550  \\$wh$aMotilin
=550  \\$wh$aNeuropeptide Y
=550  \\$wh$aNeurophysins
=550  \\$wh$aNeurotensin
=550  \\$wh$aomega-Agatoxin IVA
=550  \\$wh$aOpioid Peptides
=550  \\$wh$aOrexins
=550  \\$wh$aPancreatic Polypeptide
=550  \\$wh$aPeptide PHI
=550  \\$wh$aPituitary Adenylate Cyclase-Activating Polypeptide
=550  \\$wh$aRas Homolog Enriched in Brain Protein
=550  \\$wh$aSecretin
=550  \\$wh$aTachykinins
=550  \\$wh$aThyrotropin-Releasing Hormone
=550  \\$wh$aUrocortins
=550  \\$wh$aVasoactive Intestinal Peptide
=550  \\$wh$aVasopressins
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iPeptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells.
=688  \\$a87
=750  \0$aNeuropeptides$5IEN$0(DLC)sh 85091156

=LDR  01103cz  a2200253n  4500
=001  9880363593502441
=005  20141212203851.0
=008  860414\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009478
=035  \\$aCBA2743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x500
=072  \\$aD12.$x776.$x641.$x650.$x500
=150  \\$aNeuropeptide Y
=450  \\$wnnna$aNeuropeptide Tyrosine
=450  \\$wnnna$aNeuropeptide Y Like Immunoreactive Peptide
=450  \\$aNeuropeptide Y-Like Immunoreactive Peptide
=450  \\$wnnna$aTyrosine, Neuropeptide
=450  \\$wnnna$aY, Neuropeptide
=550  \\$wg$aNeuropeptides
=667  \\$aa neurotransmitter; /biosyn /physiol permitted
=680  \\$iA 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.
=688  \\$a87
=750  \0$aNeuropeptide Y$5IEN$0(DLC)sh 90000480

=LDR  01775cz  a2200565n  4500
=001  9880363593602441
=005  20200710123053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009474
=035  \\$aCBA2739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675
=072  \\$aA11.$x671
=150  \\$aNeurons
=450  \\$wnnna$aCell, Nerve
=450  \\$wnnna$aCells, Nerve
=450  \\$wnnna$aNerve Cell
=450  \\$aNerve Cells
=450  \\$wnnna$aNeuron
=550  \\$wg$aCells
=550  \\$wg$aNervous System
=550  \\$wh$aAdrenergic Neurons
=550  \\$wh$aAxons
=550  \\$wh$aCholinergic Neurons
=550  \\$wh$aDendrites
=550  \\$wh$aDopaminergic Neurons
=550  \\$wh$aGABAergic Neurons
=550  \\$wh$aGrid Cells
=550  \\$wh$aGrowth Cones
=550  \\$wh$aInterneurons
=550  \\$wh$aLewy Bodies
=550  \\$wh$aMirror Neurons
=550  \\$wh$aNerve Fibers
=550  \\$wh$aNerve Fibers, Myelinated
=550  \\$wh$aNeural Analyzers
=550  \\$wh$aNeurites
=550  \\$wh$aNeurofibrils
=550  \\$wh$aNeurons, Afferent
=550  \\$wh$aNeurons, Efferent
=550  \\$wh$aNeuropil
=550  \\$wh$aNissl Bodies
=550  \\$wh$aNitrergic Neurons
=550  \\$wh$aPurkinje Cells
=550  \\$wh$aPyramidal Cells
=550  \\$wh$aSerotonergic Neurons
=550  \\$wh$aSuprachiasmatic Nucleus Neurons
=667  \\$ado not use as a substitute or synonym for BRAIN /cytol
=680  \\$iThe basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
=688  \\$aNERVE CELLS was see under NEUROGLIA & NEURONS 1963-74
=750  \0$aNeurons$5IEN$0(DLC)sh 85091153

=LDR  01049cz  a2200313n  4500
=001  9880363593702441
=005  20161216095303.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009473
=035  \\$aCBA2738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x635
=150  \\$aNeuronal Plasticity
=450  \\$wnnna$aNeuronal Plasticities
=450  \\$wnnna$aNeuroplasticities
=450  \\$wnnna$aNeuroplasticity
=450  \\$wnnna$aPlasticities, Neuronal
=450  \\$wnnna$aPlasticities, Synaptic
=450  \\$aPlasticity, Neuronal
=450  \\$wnnna$aPlasticity, Synaptic
=450  \\$wnnna$aSynaptic Plasticities
=450  \\$wnnna$aSynaptic Plasticity
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wh$aLong-Term Potentiation
=550  \\$wh$aLong-Term Synaptic Depression
=550  \\$aCell Plasticity
=680  \\$iThe capacity of the NERVOUS SYSTEM to change its reactivity as the result of successive activations.
=688  \\$a82
=750  \0$aNeuroplasticity$5IEN$0(DLC)sh 85091160

=LDR  05534cz  a2201249n  4500
=001  9880363593802441
=005  20200821173339.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009472
=035  \\$aCBA2737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x574.$x500.$x550
=072  \\$aC16.$x320.$x400.$x600
=072  \\$aC16.$x320.$x565.$x398.$x641.$x509
=072  \\$aC18.$x452.$x584.$x687.$x509
=072  \\$aC18.$x452.$x648.$x398.$x641.$x509
=150  \\$aNeuronal Ceroid-Lipofuscinoses
=450  \\$wnnna$aAdult Neuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aAmaurotic Idiocy, Adult Type
=450  \\$aBatten Disease
=450  \\$wnnna$aBatten Disease, Juvenile
=450  \\$wnnna$aBatten Diseases, Juvenile
=450  \\$wnnna$aBatten-Mayou Disease
=450  \\$wnnna$aBatten Mayou Disease
=450  \\$wnnna$aBatten-Spielmeyer-Vogt Disease
=450  \\$wnnna$aBatten Spielmeyer Vogt Disease
=450  \\$wnnna$aCerebroretinal Degeneration, Juvenile
=450  \\$wnnna$aCerebroretinal Degenerations, Juvenile
=450  \\$wnnna$aCeroid-Lipofuscinoses, CLN3-Related Neuronal
=450  \\$wnnna$aCeroid-Lipofuscinosis, CLN3-Related Neuronal
=450  \\$aCeroid-Lipofuscinosis, Neuronal
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal, 3
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal 3, Juvenile
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal 4
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal, 4A, Autosomal Recessive
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal, 4B, Autosomal Dominant
=450  \\$wnnna$aCeroid Lipofuscinosis, Neuronal, Parry Type
=450  \\$wnnna$aCeroid Storage Disease
=450  \\$wnnna$aCeroid Storage Diseases
=450  \\$wnnna$aCLN3-Related Neuronal Ceroid-Lipofuscinoses
=450  \\$wnnna$aCLN3-Related Neuronal Ceroid-Lipofuscinosis
=450  \\$wnnna$aCLN3 Related Neuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aCLN4A
=450  \\$wnnna$aCLN4As
=450  \\$wnnna$aCLN4B
=450  \\$wnnna$aDisease, Ceroid Storage
=450  \\$wnnna$aDisease, Juvenile Batten
=450  \\$wnnna$aDisease, Kuf's
=450  \\$wnnna$aDisease, Lipofuscin Storage
=450  \\$wnnna$aDisease, Spielmeyer-Sjogren
=450  \\$wnnna$aDisease, Vogt Spielmeyer
=450  \\$wnnna$aDisease, Vogt-Spielmeyer
=450  \\$wnnna$aDiseases, Ceroid Storage
=450  \\$wnnna$aDiseases, Juvenile Batten
=450  \\$wnnna$aDiseases, Lipofuscin Storage
=450  \\$wnnna$aInfantile Neuronal Ceroid Lipofuscinosis
=450  \\$aJansky-Bielschowsky Disease
=450  \\$wnnna$aJansky Bielschowsky Disease
=450  \\$wnnna$aJuvenile Batten Disease
=450  \\$wnnna$aJuvenile Batten Diseases
=450  \\$wnnna$aJuvenile Cerebroretinal Degeneration
=450  \\$wnnna$aJuvenile Cerebroretinal Degenerations
=450  \\$wnnna$aJuvenile Neuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aKuf Disease
=450  \\$wnnna$aKuf's Disease
=450  \\$aKufs Disease
=450  \\$wnnna$aKufs Disease, Autosomal Dominant
=450  \\$wnnna$aKufs Disease Autosomal Recessive
=450  \\$wnnna$aKufs Disease, Autosomal Recessive
=450  \\$wnnna$aKufs Type Neuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aLate-Infantile Neuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aLipofuscin Storage Disease
=450  \\$wnnna$aLipofuscin Storage Diseases
=450  \\$wnnna$aLipofuscinosis, Neuronal Ceroid
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinoses
=450  \\$wnnna$aNeuronal Ceroid-Lipofuscinoses, CLN3-Related
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis
=450  \\$wnnna$aNeuronal Ceroid-Lipofuscinosis
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Adult
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Adult Type
=450  \\$wnnna$aNeuronal Ceroid-Lipofuscinosis, CLN3-Related
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Infantile
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Juvenile
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis Juvenile Type
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Late Infantile
=450  \\$wnnna$aNeuronal Ceroid Lipofuscinosis, Late-Infantile
=450  \\$aSantavuori-Haltia Disease
=450  \\$wnnna$aSantavuori Haltia Disease
=450  \\$wnnna$aSpielmeyer Disease, Vogt
=450  \\$wnnna$aSpielmeyer-Sjogren Disease
=450  \\$wnnna$aSpielmeyer Sjogren Disease
=450  \\$aSpielmeyer-Vogt Disease
=450  \\$wnnna$aSpielmeyer Vogt Disease
=450  \\$wnnna$aStorage Disease, Ceroid
=450  \\$wnnna$aStorage Disease, Lipofuscin
=450  \\$wnnna$aStorage Diseases, Ceroid
=450  \\$wnnna$aStorage Diseases, Lipofuscin
=450  \\$wnnna$aVogt Spielmeyer Disease
=450  \\$wnnna$aVogt-Spielmeyer Disease
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aLipidoses
=680  \\$iA group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.
=688  \\$a2007 (1983)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Neuronal Ceroid-Lipofuscinosis
=688  \\$a83
=750  \0$aNeuronal ceroid-lipofuscinoses$0(DLC) sh 85091152$5IEN

=LDR  01656cz  a2200397n  4500
=001  9880363593902441
=005  20141212192348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009470
=035  \\$aCBA2735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x750.$x500
=072  \\$aA8.$x800.$x950.$x750.$x500
=072  \\$aA10.$x690.$x552.$x500.$x750
=072  \\$aA11.$x671.$x650.$x915.$x750.$x500
=150  \\$aMuscle Spindles
=450  \\$wnnna$aMuscle Spindle
=450  \\$wnnna$aMuscle Stretch Receptor
=450  \\$aMuscle Stretch Receptors
=450  \\$wnnna$aNeuromuscular Spindle
=450  \\$aNeuromuscular Spindles
=450  \\$wnnna$aReceptor, Muscle Stretch
=450  \\$wnnna$aReceptors, Muscle Stretch
=450  \\$aReceptors, Stretch, Muscle
=450  \\$wnnna$aSpindle, Muscle
=450  \\$wnnna$aSpindle, Neuromuscular
=450  \\$wnnna$aSpindles, Muscle
=450  \\$wnnna$aSpindles, Neuromuscular
=450  \\$wnnna$aStretch Receptor, Muscle
=450  \\$aStretch Receptors, Muscle
=550  \\$wg$aMechanoreceptors
=550  \\$wg$aMuscle, Skeletal
=550  \\$aMotor Neurons, Gamma
=680  \\$iSkeletal muscle structures that function as the MECHANORECEPTORS responsible for the stretch or myotactic reflex (REFLEX, STRETCH). They are composed of a bundle of encapsulated SKELETAL MUSCLE FIBERS, i.e., the intrafusal fibers (nuclear bag 1 fibers, nuclear bag 2 fibers, and nuclear chain fibers) innervated by SENSORY NEURONS.
=688  \\$a93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64
=750  \0$aNeuromuscular spindles$5IEN$0(DLC)sh 85091150

=LDR  01435cz  a2200373n  4500
=001  9880363594002441
=005  20141212203847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009469
=035  \\$aCBA2734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x550.$x550.$x550
=072  \\$aA8.$x850.$x550.$x550
=072  \\$aA11.$x284.$x149.$x165.$x420.$x780.$x550.$x550
=150  \\$aNeuromuscular Junction
=450  \\$wnnna$aJunction, Myoneural
=450  \\$wnnna$aJunction, Neuromuscular
=450  \\$wnnna$aJunctions, Myoneural
=450  \\$wnnna$aJunctions, Neuromuscular
=450  \\$aMyoneural Junction
=450  \\$wnnna$aMyoneural Junctions
=450  \\$aNerve-Muscle Preparation
=450  \\$wnnna$aNerve Muscle Preparation
=450  \\$wnnna$aNerve-Muscle Preparations
=450  \\$wnnna$aNeuromuscular Junctions
=450  \\$wnnna$aPreparation, Nerve-Muscle
=450  \\$wnnna$aPreparations, Nerve-Muscle
=550  \\$wg$aNeuroeffector Junction
=550  \\$wh$aMotor Endplate
=550  \\$aMotor Neurons
=667  \\$a/drug eff: consider also NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + NEURAL TRANSMISSION; dis = NEUROMUSCULAR JUNCTION DISEASES
=680  \\$iThe synapse between a neuron and a muscle.
=688  \\$a68; was MYONEURAL JUNCTION 1963-67
=750  \0$aMyoneural junction$5IEN$0(DLC)sh 85089266

=LDR  02147cz  a2200517n  4500
=001  9880363594102441
=005  20141212203846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009468
=035  \\$aCBA2733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668
=150  \\$aNeuromuscular Diseases
=450  \\$aAmyotonia Congenita
=450  \\$wnnna$aBenign Fasciculation-Cramp Syndrome
=450  \\$wnnna$aBenign Fasciculation-Cramp Syndromes
=450  \\$wnnna$aCramp-Fasciculation Syndrome
=450  \\$wnnna$aCramp Fasciculation Syndrome
=450  \\$wnnna$aCramp-Fasciculation Syndromes
=450  \\$wnnna$aFasciculation-Cramp Syndrome, Benign
=450  \\$wnnna$aFasciculation Cramp Syndrome, Benign
=450  \\$wnnna$aFasciculation-Cramp Syndromes, Benign
=450  \\$wnnna$aFoley-Denny-Brown Syndrome
=450  \\$wnnna$aFoley Denny Brown Syndrome
=450  \\$wnnna$aNeuromuscular Disease
=450  \\$aOppenheim Disease
=450  \\$wnnna$aOppenheim's Disease
=450  \\$wnnna$aOppenheims Disease
=450  \\$wnnna$aSyndrome, Cramp-Fasciculation
=450  \\$wnnna$aSyndrome, Foley-Denny-Brown
=450  \\$wnnna$aSyndromes, Cramp-Fasciculation
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aFatigue Syndrome, Chronic
=550  \\$wh$aIsaacs Syndrome
=550  \\$wh$aMotor Neuron Disease
=550  \\$wh$aMuscular Atrophy, Spinal
=550  \\$wh$aMuscular Diseases
=550  \\$wh$aMuscular Disorders, Atrophic
=550  \\$wh$aNeuromuscular Junction Diseases
=550  \\$wh$aPeripheral Nervous System Diseases
=550  \\$wh$aPoliomyelitis
=550  \\$wh$aStiff-Person Syndrome
=667  \\$aGEN; do not confuse xref AMYOTONIA CONGENITA with MYOTONIA CONGENITA
=680  \\$iA general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
=688  \\$a1971; AMYOTONIA CONGENITA was heading 1963-96
=750  \0$aNeuromuscular diseases$5IEN$0(DLC)sh 85091146

=LDR  01463cz  a2200289n  4500
=001  9880363594202441
=005  20141212203845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009467
=035  \\$aCBA2732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x700.$x710.$x550
=150  \\$aNeuromuscular Depolarizing Agents
=450  \\$wnnna$aAgents, Neuromuscular Depolarizing
=450  \\$wnnna$aBlockers, Depolarizing
=450  \\$wnnna$aDepolarizing Agents, Neuromuscular
=450  \\$wnnna$aDepolarizing Blockers
=450  \\$aDepolarizing Muscle Relaxants
=450  \\$aMuscle Relaxants, Depolarizing
=450  \\$wnnna$aRelaxants, Depolarizing Muscle
=550  \\$wg$aNeuromuscular Blocking Agents
=550  \\$aDecamethonium Compounds
=550  \\$aNeuromuscular Junction
=667  \\$aGEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff
=680  \\$iDrugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.
=688  \\$a70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69
=750  \0$aNeuromuscular depolarizing agents$5IEN$0(DLC)sh 85091145

=LDR  01465cz  a2200277n  4500
=001  9880363594302441
=005  20141212203844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009466
=035  \\$aCBA2731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x700.$x710
=150  \\$aNeuromuscular Blocking Agents
=450  \\$wnnna$aAgents, Neuromuscular Blocking
=450  \\$wnnna$aBlockers, Neuromuscular
=450  \\$wnnna$aBlocking Agents, Neuromuscular
=450  \\$wnnna$aNeuromuscular Blockers
=550  \\$wg$aNeuromuscular Agents
=550  \\$wh$aNeuromuscular Depolarizing Agents
=550  \\$wh$aNeuromuscular Nondepolarizing Agents
=550  \\$aNeuromuscular Blockade
=550  \\$aNeuromuscular Junction
=667  \\$aGEN or unspecified; prefer specifics; consider also NEUROMUSCULAR JUNCTION /drug eff
=680  \\$iDrugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.
=688  \\$a75; was see under CURARE-LIKE AGENTS & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74
=750  \0$aNeuromuscular blocking agents$5IEN$0(DLC)sh 85091144

=LDR  03110cz  a2200769n  4500
=001  9880363594402441
=005  20141212203843.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009464
=035  \\$aCBA2729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x595.$x610
=072  \\$aC4.$x557.$x580.$x600.$x610.$x595.$x610
=072  \\$aC4.$x557.$x580.$x625.$x650.$x595.$x610
=072  \\$aC4.$x588.$x614.$x596.$x240.$x15
=072  \\$aC9.$x218.$x807.$x800.$x675
=072  \\$aC9.$x647.$x675
=072  \\$aC10.$x292.$x225.$x750
=072  \\$aC10.$x292.$x910.$x600
=150  \\$aNeuroma, Acoustic
=450  \\$wnnna$aAcoustic Neurilemmoma
=450  \\$wnnna$aAcoustic Neurilemmomas
=450  \\$wnnna$aAcoustic Neurilemoma
=450  \\$wnnna$aAcoustic Neurilemomas
=450  \\$wnnna$aAcoustic Neurinoma
=450  \\$wnnna$aAcoustic Neurinomas
=450  \\$aAcoustic Neuroma
=450  \\$wnnna$aAcoustic Neuroma, Cerebellopontine Angle
=450  \\$wnnna$aAcoustic Neuromas
=450  \\$wnnna$aAcoustic Schwannoma
=450  \\$wnnna$aAcoustic Schwannomas
=450  \\$wnnna$aAcoustic Tumor
=450  \\$wnnna$aAcoustic Tumors
=450  \\$wnnna$aAngle Tumor
=450  \\$wnnna$aCerebellopontine Angle Acoustic Neuroma
=450  \\$wnnna$aCerebellopontine Angle Tumor
=450  \\$aMelanocytic Vestibular Schwannoma
=450  \\$wnnna$aMelanocytic Vestibular Schwannomas
=450  \\$wnnna$aNeurilemmoma, Acoustic
=450  \\$wnnna$aNeurilemmomas, Acoustic
=450  \\$wnnna$aNeurilemoma, Acoustic
=450  \\$wnnna$aNeurilemomas, Acoustic
=450  \\$wnnna$aNeurinoma, Acoustic
=450  \\$wnnna$aNeurinoma of the Acoustic Nerve
=450  \\$wnnna$aNeurinomas, Acoustic
=450  \\$wnnna$aNeuroma, Acoustic, Unilateral
=450  \\$wnnna$aNeuromas, Acoustic
=450  \\$aSchwannoma, Acoustic
=450  \\$wnnna$aSchwannoma, Melanocytic Vestibular
=450  \\$aSchwannoma, Vestibular
=450  \\$wnnna$aSchwannomas, Acoustic
=450  \\$wnnna$aSchwannomas, Melanocytic Vestibular
=450  \\$wnnna$aSchwannomas, Vestibular
=450  \\$wnnna$aTumor, Acoustic
=450  \\$wnnna$aTumors, Acoustic
=450  \\$wnnna$aVestibular Schwannoma
=450  \\$wnnna$aVestibular Schwannoma, Melanocytic
=450  \\$wnnna$aVestibular Schwannomas
=450  \\$wnnna$aVestibular Schwannomas, Melanocytic
=550  \\$wg$aCranial Nerve Neoplasms
=550  \\$wg$aNeurilemmoma
=550  \\$wg$aOtorhinolaryngologic Neoplasms
=550  \\$wg$aVestibulocochlear Nerve Diseases
=550  \\$wh$aNeurofibromatosis 2
=680  \\$iA benign SCHWANNOMA of the eighth cranial nerve (VESTIBULOCOCHLEAR NERVE), mostly arising from the vestibular branch (VESTIBULAR NERVE) during the fifth or sixth decade of life. Clinical manifestations include HEARING LOSS; HEADACHE; VERTIGO; TINNITUS; and FACIAL PAIN. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. (From Adams et al., Principles of Neurology, 6th ed, p673)
=688  \\$a78
=750  \0$aAcoustic neuroma$5IEN$0(DLC)sh 92003432

=LDR  00642cz  a2200193n  4500
=001  9880363594502441
=005  20141212203842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009463
=035  \\$aCBA2728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x580.$x600.$x610
=150  \\$aNeuroma
=450  \\$wnnna$aNeuromas
=550  \\$wg$aNerve Sheath Neoplasms
=550  \\$wh$aNeurilemmoma
=667  \\$a/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA tumor made up of nerve cells and nerve fibers. (Dorland, 27th ed)
=750  \0$aNeuromas$5IEN$0(DLC)sh 92003433

=LDR  00654cz  a2200205n  4500
=001  9880363594602441
=005  20170807102643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009462
=035  \\$aCBA2727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x600
=150  \\$aNeurology
=550  \\$wg$aMedicine
=550  \\$wh$aNeuropathology
=550  \\$wh$aNeurotology
=667  \\$aSPEC: SPEC qualif; DF: NEUROL
=680  \\$iA medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.
=750  \0$aNeurologists$5IEN-M$0(DLC)sh 85091135
=750  \0$aNeurology$5IEN-HS$0(DLC)sh 85091139

=LDR  03106cz  a2200889n  4500
=001  9880363594702441
=005  20180314112558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009461
=035  \\$aCBA2726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597
=072  \\$aC23.$x888.$x592
=150  \\$aNeurologic Manifestations
=450  \\$wnnna$aDeficit, Focal Neurologic
=450  \\$wnnna$aDeficit, Neurologic
=450  \\$wnnna$aDeficits, Focal Neurologic
=450  \\$wnnna$aDeficits, Neurologic
=450  \\$wnnna$aDysfunction, Neurologic
=450  \\$wnnna$aDysfunctions, Neurologic
=450  \\$wnnna$aFinding, Neurologic
=450  \\$wnnna$aFindings, Neurologic
=450  \\$wnnna$aFocal Neurologic Deficit
=450  \\$wnnna$aFocal Neurologic Deficits
=450  \\$wnnna$aManifestation, Neurologic
=450  \\$wnnna$aManifestation, Neurological
=450  \\$wnnna$aManifestations, Neurologic
=450  \\$wnnna$aManifestations, Neurological
=450  \\$wnnna$aNeurologic Deficit
=450  \\$wnnna$aNeurologic Deficit, Focal
=450  \\$aNeurologic Deficits
=450  \\$wnnna$aNeurologic Deficits, Focal
=450  \\$wnnna$aNeurologic Dysfunction
=450  \\$wnnna$aNeurologic Dysfunctions
=450  \\$wnnna$aNeurologic Finding
=450  \\$wnnna$aNeurologic Findings
=450  \\$wnnna$aNeurologic Manifestation
=450  \\$wnnna$aNeurologic Sign
=450  \\$wnnna$aNeurologic Signs
=450  \\$aNeurologic Signs and Symptoms
=450  \\$wnnna$aNeurologic Symptom
=450  \\$wnnna$aNeurologic Symptoms
=450  \\$wnnna$aNeurological Manifestation
=450  \\$wnnna$aNeurological Manifestations
=450  \\$wnnna$aSign, Neurologic
=450  \\$wnnna$aSigns, Neurologic
=450  \\$wnnna$aSymptom, Neurologic
=450  \\$wnnna$aSymptoms, Neurologic
=550  \\$wg$aNervous System Diseases
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aBilateral Vestibulopathy
=550  \\$wh$aCerebrospinal Fluid Leak
=550  \\$wh$aDecerebrate State
=550  \\$wh$aDyskinesias
=550  \\$wh$aGait Disorders, Neurologic
=550  \\$wh$aMeningism
=550  \\$wh$aNeurobehavioral Manifestations
=550  \\$wh$aNeurogenic Inflammation
=550  \\$wh$aNeuromuscular Manifestations
=550  \\$wh$aOrthostatic Intolerance
=550  \\$wh$aPain
=550  \\$wh$aParalysis
=550  \\$wh$aParesis
=550  \\$wh$aPsychophysiologic Disorders
=550  \\$wh$aPupil Disorders
=550  \\$wh$aReflex, Abnormal
=550  \\$wh$aSeizures
=550  \\$wh$aSensation Disorders
=550  \\$wh$aSleep Wake Disorders
=550  \\$wh$aSusac Syndrome
=550  \\$wh$aUrinary Bladder, Neurogenic
=550  \\$wh$aVertigo
=550  \\$wh$aVoice Disorders
=550  \\$aNervous System
=667  \\$anot used for indexing since 1989; prior to 1989 used for neurol manifest of non-neural diseases
=680  \\$iClinical signs and symptoms caused by nervous system injury or dysfunction.
=750  \0$aNeurologic manifestations of general diseases$5IEN$0(DLC)sh 85091132

=LDR  00948cz  a2200301n  4500
=001  9880363594802441
=005  20141212203840.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009460
=035  \\$aCBA2725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x550
=072  \\$aE1.$x370.$x600.$x550
=150  \\$aNeurologic Examination
=450  \\$wnnna$aExamination, Neurologic
=450  \\$wnnna$aExamination, Neurological
=450  \\$wnnna$aExaminations, Neurologic
=450  \\$wnnna$aExaminations, Neurological
=450  \\$wnnna$aNeurologic Examinations
=450  \\$wnnna$aNeurological Examination
=450  \\$wnnna$aNeurological Examinations
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aPhysical Examination
=550  \\$wh$aPain Measurement
=550  \\$wh$aReflex
=667  \\$aNIM; DF: NEUROL EXAM
=688  \\$a66(64)
=750  \0$aNeurologic examination$5IEN$0(DLC)sh 85091131

=LDR  01814cz  a2200325n  4500
=001  9880363594902441
=005  20141212203840.0
=008  840605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009459
=035  \\$aCBA2724HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x737
=072  \\$aC10.$x720.$x737
=072  \\$aC25.$x723.$x705.$x600
=150  \\$aNeuroleptic Malignant Syndrome
=450  \\$aNeuroleptic-Induced Neuroleptic Malignant Syndrome
=450  \\$wnnna$aNeuroleptic Induced Neuroleptic Malignant Syndrome
=450  \\$aNeuroleptic-Malignant Syndrome, Neuroleptic Induced
=450  \\$wnnna$aNeuroleptic Malignant Syndrome, Neuroleptic Induced
=450  \\$wnnna$aNeuroleptic Malignant Syndromes
=450  \\$wnnna$aNMS (Neuroleptic Malignant Syndrome)
=450  \\$wnnna$aNMSs (Neuroleptic Malignant Syndrome)
=450  \\$wnnna$aSyndrome, Neuroleptic Malignant
=450  \\$wnnna$aSyndromes, Neuroleptic Malignant
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aNeurotoxicity Syndromes
=667  \\$acaused by tranquilizing agents so do not use /chem ind
=680  \\$iA potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
=688  \\$a1986(1985)
=750  \0$aNeuroleptic malignant syndrome$5IEN$0(DLC)sh 89002389

=LDR  00837cz  a2200205n  4500
=001  9880363595002441
=005  20141212203839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009458
=035  \\$aCBA2723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x91.$x646
=150  \\$aNeuroleptanalgesia
=450  \\$aNeuroleptanesthesia$5IEN
=450  \\$wnnna$aNeuroleptoanalgesia
=550  \\$wg$aAnalgesia
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic.
=688  \\$a79; was NEUROLEPTOANALGESIA 1966-78 (Prov 1966-67)
=750  \0$aNeuroleptanesthesia$5IEN$0(DLC)sh 85091128

=LDR  01195cz  a2200361n  4500
=001  9880363595102441
=005  20141212210918.0
=008  880504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015213
=035  \\$aCBA2721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x337.$x620
=072  \\$aG7.$x700.$x240.$x620
=072  \\$aG11.$x561.$x600.$x630
=072  \\$aG12.$x425.$x746.$x575
=150  \\$aNeuroimmunomodulation
=450  \\$wnnna$aMechanism, Neuroimmune
=450  \\$wnnna$aMechanisms, Neuroimmune
=450  \\$wnnna$aNeuroimmune Mechanism
=450  \\$wnnna$aNeuroimmune Mechanisms
=450  \\$wnnna$aNeuroimmune Process
=450  \\$aNeuroimmune Processes
=450  \\$wnnna$aProcess, Neuroimmune
=550  \\$wg$aElectrophysiological Processes
=550  \\$wg$aImmunomodulation
=550  \\$wg$aNervous System Physiological Processes
=550  \\$aHomeostasis
=550  \\$aNeurogenic Inflammation
=550  \\$aNeurosecretory Systems
=550  \\$aPsychoneuroimmunology
=680  \\$iThe biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM.
=688  \\$a89
=750  \0$aNeuroimmunology$5IEN$0(DLC)sh 85091127

=LDR  01628cz  a2200385n  4500
=001  9880363595202441
=005  20200609125736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009457
=035  \\$aCBA2720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637
=072  \\$aA11.$x650
=150  \\$aNeuroglia
=450  \\$wnnna$aCell, Glial
=450  \\$wnnna$aCell, Neuroglial
=450  \\$wnnna$aCells, Glial
=450  \\$wnnna$aCells, Neuroglial
=450  \\$aGlia
=450  \\$wnnna$aGlial Cell
=450  \\$wnnna$aGlial Cells
=450  \\$wnnna$aNeuroglial Cell
=450  \\$wnnna$aNeuroglial Cells
=550  \\$wg$aCells
=550  \\$wg$aNervous System
=550  \\$wh$aAstrocytes
=550  \\$wh$aEpendymoglial Cells
=550  \\$wh$aMicroglia
=550  \\$wh$aNeuropil
=550  \\$wh$aOligodendrocyte Precursor Cells
=550  \\$wh$aOligodendroglia
=550  \\$wh$aSatellite Cells, Perineuronal
=550  \\$wh$aSchwann Cells
=680  \\$iThe non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear.
=750  \0$aNeuroglia$5IEN$0(DLC)sh 85091124

=LDR  01361cz  a2200241n  4500
=001  9880363595302441
=005  20141212203837.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009455
=035  \\$aCBA2718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x580.$x600.$x580
=072  \\$aC10.$x551.$x775.$x500.$x750
=072  \\$aC10.$x668.$x829.$x725.$x500.$x600
=150  \\$aNeurofibroma
=450  \\$wnnna$aNeurofibromas
=550  \\$wg$aNerve Sheath Neoplasms
=550  \\$wh$aNeurofibroma, Plexiform
=550  \\$wh$aNeurofibromatoses
=550  \\$wh$aNeurofibrosarcoma
=667  \\$asolitary; multiple = NEUROFIBROMATOSES but see MeSH definition; coord IM with precoord organ/neopl term (IM)
=680  \\$iA moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. (From Adams et al., Principles of Neurology, 6th ed, p1016)
=750  \0$aNeurofibroma$5IEN$0(DLC)sh 85091120

=LDR  00896cz  a2200253n  4500
=001  9880363595402441
=005  20141212192347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009454
=035  \\$aCBA2717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x609
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x640
=072  \\$aA11.$x671.$x573
=150  \\$aNeurofibrils
=450  \\$wnnna$aNeurofibril
=550  \\$wg$aCytoskeleton
=550  \\$wg$aNeurons
=550  \\$wh$aNeurofibrillary Tangles
=550  \\$aNeurofibrillary Tangles
=667  \\$ado not confuse with NERVE FIBERS
=680  \\$iThe delicate interlacing threads, formed by aggregations of neurofilaments and neurotubules, coursing through the CYTOPLASM of the body of a NEURON and extending from one DENDRITE into another or into the AXON.
=688  \\$a65
=750  \0$aNeurofibrils$5IEN$0(DLC)sh 85091119

=LDR  00802cz  a2200217n  4500
=001  9880363595502441
=005  20141212203837.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009452
=035  \\$aCBA2715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x610.$x160
=072  \\$aH1.$x158.$x782.$x323.$x200
=150  \\$aNeuroendocrinology
=450  \\$aPsychoneuroendocrinology$5IEN
=550  \\$wg$aEndocrinology
=550  \\$wg$aNeurosciences
=667  \\$aSPEC only, SPEC qualif; not for coord of NERVOUS SYSTEM + ENDOCRINE GLANDS nor for ENDOCRINE GLANDS /innerv; DF: NEUROENDOCRINOL
=680  \\$iThe study of the anatomical and functional relationships between the nervous system and the endocrine system.
=688  \\$a86
=750  \0$aNeuroendocrinology$5IEN-M$0(DLC)sh 85091118

=LDR  00886cz  a2200241n  4500
=001  9880363595602441
=005  20141212203836.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009448
=035  \\$aCBA2711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x687
=072  \\$aH1.$x158.$x610.$x110
=072  \\$aH1.$x181.$x122.$x709
=150  \\$aNeurochemistry
=450  \\$wnnna$aNeurochemistries
=550  \\$wg$aBiochemistry
=550  \\$wg$aNeurosciences
=550  \\$aChemistry
=667  \\$athe discipline only (education, history, etc); for the chemistry of the nervous system, use the qualifier /chem with NERVOUS SYSTEM or specific nervous system component
=680  \\$iThe study of the composition, chemical structures, and chemical reactions of the NERVOUS SYSTEM or its components.
=688  \\$a64
=750  \0$aNeurochemistry$5IEN$0(DLC)sh 85091116

=LDR  01520cz  a2200229n  4500
=001  9880363595702441
=005  20141212203835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009447
=035  \\$aCBA2710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x590.$x650.$x550
=072  \\$aC4.$x557.$x470.$x670.$x590.$x650.$x550
=072  \\$aC4.$x557.$x580.$x625.$x600.$x590.$x650.$x550
=150  \\$aNeuroblastoma
=450  \\$wnnna$aNeuroblastomas
=550  \\$wg$aNeuroectodermal Tumors, Primitive, Peripheral
=550  \\$wh$aEsthesioneuroblastoma, Olfactory
=550  \\$wh$aGanglioneuroblastoma
=667  \\$acoord IM with precoord organ/neopl term (IM); for NEUROBLASTOMA, RETINAL see RETINOBLASTOMA
=680  \\$iA common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)
=750  \0$aNeuroblastoma$5IEN$0(DLC)sh 85091115

=LDR  00870cz  a2200265n  4500
=001  9880363595802441
=005  20141212203835.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009446
=035  \\$aCBA2709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x610
=072  \\$aH1.$x158.$x610.$x80
=150  \\$aNeurobiology
=450  \\$aCellular Neurobiology
=450  \\$aMolecular Neurobiology
=450  \\$wnnna$aNeurobiology, Cellular
=450  \\$wnnna$aNeurobiology, Molecular
=550  \\$wg$aBiology
=550  \\$wg$aNeurosciences
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the structure, growth, activities, and functions of NEURONS and the NERVOUS SYSTEM.
=688  \\$a86
=750  \0$aNeurobiology$0(DLC) sh 85091114$5IEN-M
=750  \0$aNeurobiologists$0(DLC)sh2006000762$5IEN-M

=LDR  00723cz  a2200241n  4500
=001  9880363595902441
=005  20141212203835.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009445
=035  \\$aCBA2708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x700
=072  \\$aH1.$x158.$x610.$x60
=150  \\$aNeuroanatomy
=450  \\$wnnna$aNeuranatomies
=450  \\$wnnna$aNeuranatomy
=450  \\$wnnna$aNeuroanatomies
=550  \\$wg$aAnatomy
=550  \\$wg$aNeurosciences
=667  \\$aSPEC only, SPEC qualif; not for NERVOUS SYSTEM /anat
=680  \\$iStudy of the anatomy of the nervous system as a specialty or discipline.
=688  \\$a76
=750  \0$aNeuroanatomy$5IEN$0(DLC)sh 85091113

=LDR  01774cz  a2200397n  4500
=001  9880363596002441
=005  20141212203834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009443
=035  \\$aCBA2706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x650
=150  \\$aNeuritis
=450  \\$wnnna$aMotor Neuritides
=450  \\$wnnna$aMotor Neuritis
=450  \\$wnnna$aNeuritides
=450  \\$wnnna$aNeuritides, Motor
=450  \\$wnnna$aNeuritides, Peripheral
=450  \\$wnnna$aNeuritides, Sensory
=450  \\$wnnna$aNeuritis, Motor
=450  \\$wnnna$aNeuritis, Peripheral
=450  \\$wnnna$aNeuritis, Sensory
=450  \\$wnnna$aPeripheral Neuritides
=450  \\$wnnna$aPeripheral Neuritis
=450  \\$wnnna$aPolyneuritides
=450  \\$aPolyneuritis
=450  \\$wnnna$aSensory Neuritides
=450  \\$wnnna$aSensory Neuritis
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aBrachial Plexus Neuritis
=550  \\$wh$aNeuritis, Autoimmune, Experimental
=550  \\$aOptic Neuritis
=550  \\$aVestibular Neuronitis
=667  \\$acoord IM with specific nerve disease or specific nerve (IM); do not confuse with NEURITES, a hairlike projection of a neuron & in French & other foreign titles do not confuse "neurite" referring to a neurite (i.e., NEURITES) with "nevrite" meaning neuritis; neuritis of optic nerve = OPTIC NEURITIS; retrobulbar neuritis = OPTIC NEURITIS; SMON (subacute myelo-optico-neuropathy) is indexed OPTIC NEURITIS (IM) + MYELITIS (IM) + SYNDROME (NIM)
=680  \\$iA general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.
=750  \0$aNeuritis$5IEN$0(DLC)sh 85091109

=LDR  00647cz  a2200205n  4500
=001  9880363596102441
=005  20141212203832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009440
=035  \\$aCBA2703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x875.$x600
=150  \\$aNeurasthenia
=450  \\$aNeurasthenic Neuroses
=450  \\$aNeuroses, Neurasthenic
=550  \\$wg$aSomatoform Disorders
=550  \\$aAsthenia
=667  \\$aremember also NEUROCIRCULATORY ASTHENIA exists
=680  \\$iA mental disorder characterized by chronic fatigue and concomitant physiologic symptoms.
=750  \0$aNeurasthenia$5IEN$0(DLC)sh 85091106

=LDR  01073cz  a2200253n  4500
=001  9880363596202441
=005  20141212203832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009439
=035  \\$aCBA2702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x692
=150  \\$aNeuraminidase
=450  \\$wnnna$aExo-alpha-Sialidase
=450  \\$wnnna$aExo alpha Sialidase
=450  \\$wnnna$aGlycohydrolases, N-Acylneuraminate
=450  \\$wnnna$aN-Acylneuraminate Glycohydrolases
=450  \\$wnnna$aN Acylneuraminate Glycohydrolases
=450  \\$wnnna$aOligosaccharide Sialidase
=450  \\$aSialidase
=450  \\$wnnna$aSialidase, Oligosaccharide
=550  \\$wg$aGlycoside Hydrolases
=680  \\$iAn enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)
=750  \0$aNeuraminidase$5IEN-M$0(DLC)sh 93004707

=LDR  02902cz  a2200841n  4500
=001  9880363596302441
=005  20180821172250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009437
=035  \\$aCBA2700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x682
=072  \\$aC10.$x668.$x829.$x600
=072  \\$aC23.$x888.$x592.$x612.$x664
=150  \\$aNeuralgia
=450  \\$wnnna$aAtypical Neuralgia
=450  \\$wnnna$aAtypical Neuralgias
=450  \\$wnnna$aIliohypogastric Nerve Neuralgia
=450  \\$wnnna$aIliohypogastric Nerve Neuralgias
=450  \\$wnnna$aIlioinguinal Neuralgia
=450  \\$wnnna$aIlioinguinal Neuralgias
=450  \\$wnnna$aNerve Neuralgia, Iliohypogastric
=450  \\$wnnna$aNerve Neuralgias, Iliohypogastric
=450  \\$aNerve Pain
=450  \\$wnnna$aNerve Pain, Paroxysmal
=450  \\$wnnna$aNerve Pains
=450  \\$wnnna$aNerve Pains, Paroxysmal
=450  \\$wnnna$aNeuralgia, Atypical
=450  \\$wnnna$aNeuralgia, Iliohypogastric Nerve
=450  \\$wnnna$aNeuralgia, Ilioinguinal
=450  \\$wnnna$aNeuralgia, Perineal
=450  \\$wnnna$aNeuralgia, Stump
=450  \\$wnnna$aNeuralgia, Supraorbital
=450  \\$wnnna$aNeuralgia, Vidian
=450  \\$wnnna$aNeuralgias
=450  \\$wnnna$aNeuralgias, Atypical
=450  \\$wnnna$aNeuralgias, Iliohypogastric Nerve
=450  \\$wnnna$aNeuralgias, Ilioinguinal
=450  \\$wnnna$aNeuralgias, Perineal
=450  \\$wnnna$aNeuralgias, Stump
=450  \\$wnnna$aNeuralgias, Supraorbital
=450  \\$wnnna$aNeuralgias, Vidian
=450  \\$aNeurodynia
=450  \\$wnnna$aNeurodynias
=450  \\$wnnna$aNeuropathic Pain
=450  \\$wnnna$aNeuropathic Pains
=450  \\$wnnna$aPain, Nerve
=450  \\$wnnna$aPain, Neuropathic
=450  \\$wnnna$aPain, Paroxysmal Nerve
=450  \\$wnnna$aPains, Nerve
=450  \\$wnnna$aPains, Neuropathic
=450  \\$wnnna$aPains, Paroxysmal Nerve
=450  \\$aParoxysmal Nerve Pain
=450  \\$wnnna$aParoxysmal Nerve Pains
=450  \\$wnnna$aPerineal Neuralgia
=450  \\$wnnna$aPerineal Neuralgias
=450  \\$wnnna$aStump Neuralgia
=450  \\$wnnna$aStump Neuralgias
=450  \\$wnnna$aSupraorbital Neuralgia
=450  \\$wnnna$aSupraorbital Neuralgias
=450  \\$wnnna$aVidian Neuralgia
=450  \\$wnnna$aVidian Neuralgias
=550  \\$wg$aPain
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aCausalgia
=550  \\$wh$aMorton Neuroma
=550  \\$wh$aNeuralgia, Postherpetic
=550  \\$wh$aPiriformis Muscle Syndrome
=550  \\$wh$aPudendal Neuralgia
=550  \\$wh$aSciatica
=667  \\$acoordinate IM with specific nerve (IM) if pertinent
=680  \\$iIntense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
=750  \0$aNeuralgia$5IEN$0(DLC)sh 85091099

=LDR  03084cz  a2200733n  4500
=001  9880363596402441
=005  20141212203831.0
=008  780515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009436
=035  \\$aCBA2699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680
=072  \\$aC16.$x131.$x666.$x680
=150  \\$aNeural Tube Defects
=450  \\$wnnna$aAcrania
=450  \\$wnnna$aAcranias
=450  \\$wnnna$aCraniorachischises
=450  \\$aCraniorachischisis
=450  \\$wnnna$aCyst, Neurenteric
=450  \\$wnnna$aCyst, Neuroenteric
=450  \\$wnnna$aCysts, Neurenteric
=450  \\$wnnna$aCysts, Neuroenteric
=450  \\$wnnna$aDefect, Neural Tube
=450  \\$wnnna$aDefects, Neural Tube
=450  \\$aDevelopmental Defects, Neural Tube
=450  \\$wnnna$aDevelopmental Neural Tube Defects
=450  \\$aDiastematomyelia
=450  \\$wnnna$aDiastematomyelias
=450  \\$wnnna$aDysraphism, Occult Spinal
=450  \\$wnnna$aDysraphisms, Occult Spinal
=450  \\$wnnna$aExencephalies
=450  \\$aExencephaly
=450  \\$wnnna$aIniencephalies
=450  \\$wnnna$aIniencephaly
=450  \\$wnnna$aMyelodysplasia, Spinal Cord
=450  \\$wnnna$aMyelodysplasias, Spinal Cord
=450  \\$wnnna$aNeural Tube Defect
=450  \\$wnnna$aNeural Tube Developmental Defects
=450  \\$aNeurenteric Cyst
=450  \\$wnnna$aNeurenteric Cysts
=450  \\$wnnna$aNeuroenteric Cyst
=450  \\$wnnna$aNeuroenteric Cysts
=450  \\$wnnna$aOccult Spinal Dysraphism
=450  \\$wnnna$aOccult Spinal Dysraphism Sequence
=450  \\$wnnna$aOccult Spinal Dysraphisms
=450  \\$aSpinal Cord Myelodysplasia
=450  \\$wnnna$aSpinal Cord Myelodysplasias
=450  \\$wnnna$aSpinal Dysraphism, Occult
=450  \\$wnnna$aSpinal Dysraphisms, Occult
=450  \\$aTethered Cord Syndrome
=450  \\$wnnna$aTethered Cord Syndromes
=450  \\$wnnna$aTethered Spinal Cord Syndrome
=550  \\$wg$aNervous System Malformations
=550  \\$wh$aAnencephaly
=550  \\$wh$aArnold-Chiari Malformation
=550  \\$wh$aEncephalocele
=550  \\$wh$aMeningocele
=550  \\$wh$aMeningomyelocele
=550  \\$wh$aPentalogy of Cantrell
=550  \\$wh$aSpinal Dysraphism
=667  \\$ado not confuse entry term SPINAL CORD MYELODYSPLASIA with MYELODYSPLASTIC SYNDROMES, a defect of bone marrow formation
=680  \\$iCongenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)
=688  \\$a1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME use SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST use SPINA BIFIDA OCCULTA 1991-1999, use NEURAL TUBE DEFECTS 1979-1990
=750  \0$aNeural tube$xAbnormalities$5IEN$0(DLC)sh 85040346

=LDR  01897cz  a2200361n  4500
=001  9880363596502441
=005  20141212203829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009435
=035  \\$aCBA2698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x800.$x850
=072  \\$aG2.$x149.$x115.$x800.$x850
=072  \\$aG4.$x299.$x880.$x850
=072  \\$aG7.$x265.$x337.$x900
=072  \\$aG7.$x700.$x240.$x900
=072  \\$aG11.$x561.$x600.$x835
=150  \\$aSynaptic Transmission
=450  \\$aNeural Transmission
=450  \\$aNeurotransmission
=450  \\$wnnna$aTransmission, Neural
=450  \\$wnnna$aTransmission, Synaptic
=550  \\$wg$aElectrophysiological Processes
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aSignal Transduction
=550  \\$wh$aPostsynaptic Potential Summation
=550  \\$wh$aSynaptic Potentials
=550  \\$aNeural Conduction
=550  \\$aSynapses
=667  \\$adifferentiate entry term NEURAL TRANSMISSION from NEURAL CONDUCTION; consider also NEURAL INHIBITION; neuromuscular transmission = NEUROMUSCULAR JUNCTION / physiol + SYNAPTIC TRANSMISSION
=680  \\$iThe communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES.
=688  \\$a94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION 1969-93
=750  \0$aNeural transmission$5IEN$0(DLC)sh 85091095

=LDR  00868cz  a2200241n  4500
=001  9880363596602441
=005  20141212203829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009433
=035  \\$aCBA2696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x337.$x615
=072  \\$aG7.$x700.$x240.$x615
=072  \\$aG11.$x561.$x600.$x625
=150  \\$aNeural Inhibition
=450  \\$aInhibition, Neural
=550  \\$wg$aElectrophysiological Processes
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wh$aInhibitory Postsynaptic Potentials
=550  \\$aRefractory Period, Electrophysiological
=680  \\$iThe function of opposing or restraining the excitation of neurons or their target excitable cells.
=688  \\$a74; was INHIBITION, NEURAL 1972-73 (Prov)
=750  \0$aNeural transmission$xRegulation$5IEN$0(DLC)sh 85091097

=LDR  01328cz  a2200349n  4500
=001  9880363596702441
=005  20141212192346.0
=008  771205\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009432
=035  \\$aCBA2695HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x627
=150  \\$aNeural Crest
=450  \\$wnnna$aCell, Neural Crest
=450  \\$wnnna$aCells, Neural Crest
=450  \\$wnnna$aCrest, Neural
=450  \\$wnnna$aCrests, Neural
=450  \\$wnnna$aFold, Neural
=450  \\$wnnna$aFolds, Neural
=450  \\$wnnna$aGroove, Neural
=450  \\$wnnna$aGrooves, Neural
=450  \\$wnnna$aNeural Crest Cell
=450  \\$wnnna$aNeural Crest Cells
=450  \\$wnnna$aNeural Crests
=450  \\$wnnna$aNeural Fold
=450  \\$wnnna$aNeural Folds
=450  \\$wnnna$aNeural Groove
=450  \\$wnnna$aNeural Grooves
=550  \\$wg$aEmbryonic Structures
=680  \\$iThe two longitudinal ridges along the PRIMITIVE STREAK appearing near the end of GASTRULATION during development of nervous system (NEURULATION). The ridges are formed by folding of NEURAL PLATE. Between the ridges is a neural groove which deepens as the fold become elevated. When the folds meet at midline, the groove becomes a closed tube, the NEURAL TUBE.
=688  \\$a79
=750  \0$aNeural crest$5IEN$0(DLC)sh 85091092

=LDR  01488cz  a2200361n  4500
=001  9880363596802441
=005  20141212203828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009431
=035  \\$aCBA2694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x337.$x600
=072  \\$aG7.$x700.$x240.$x600
=072  \\$aG11.$x561.$x600.$x620
=150  \\$aNeural Conduction
=450  \\$wnnna$aConduction, Nerve
=450  \\$wnnna$aConduction, Neural
=450  \\$wnnna$aConductions, Nerve
=450  \\$wnnna$aConductions, Neural
=450  \\$aNerve Conduction
=450  \\$wnnna$aNerve Conductions
=450  \\$wnnna$aNeural Conductions
=550  \\$wg$aElectrophysiological Processes
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wh$aRecruitment, Neurophysiological
=550  \\$wh$aRefractory Period, Electrophysiological
=550  \\$aAction Potentials
=550  \\$aNeurons
=667  \\$aalong a single nerve; differentiate from NEURAL TRANSMISSION (between nerves)
=680  \\$iThe propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus.
=688  \\$a1968 (1965)
=688  \\$a68; was NERVE CONDUCTION 1965-67; WEDENSKY INHIBITION was heading 1977-96 (see under NEURAL CONDUCTION 1977-90), was VVEDENSKII'S INHIBITION see under NEURAL CONDUCTION 1965-76 (Prov 1965-74); VVEDENSKII'S INHIBITION was see WEDENSKY INHIBITION 1990-96
=750  \0$aNeural conduction$5IEN$0(DLC)sh 85091091

=LDR  00792cz  a2200205n  4500
=001  9880363596902441
=005  20141212192346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009430
=035  \\$aCBA2693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x575
=150  \\$aNeural Analyzers
=450  \\$wnnna$aAnalyzer, Neural
=450  \\$aAnalyzers, Neural
=450  \\$wnnna$aNeural Analyzer
=550  \\$wg$aNeurons
=680  \\$iA term used in Eastern European research literature for the functional neural unit that provides the basis for differential sensitivity; the analyzer consists of receptor, afferent nerves, and their central connections. (From Campbell's Psychiatric Dictionary, 8th ed.)
=688  \\$a65(64)
=750  \0$aNeural analyzers$5IEN$0(DLC)sh 85091088

=LDR  00783cz  a2200217n  4500
=001  9880363597002441
=005  20141212203827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009425
=035  \\$aCBA2688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x252.$x478
=150  \\$aNesting Behavior
=450  \\$wnnna$aBehavior, Nesting
=450  \\$wnnna$aBehaviors, Nesting
=450  \\$wnnna$aNesting Behaviors
=550  \\$wg$aConsummatory Behavior
=667  \\$aanimal only
=680  \\$iAnimal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young.
=688  \\$a69(67)
=750  \0$aNest building$5IEN$0(DLC)sh 85090957

=LDR  02535cz  a2200697n  4500
=001  9880363597102441
=005  20180402111246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009424
=035  \\$aCBA2687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561
=150  \\$aNervous System Physiological Phenomena
=450  \\$wnnoa$aNervous System Physiologic Phenomena$5IEN-M
=450  \\$wnnna$aNervous System Physiological Concepts
=450  \\$wnnna$aNervous System Physiological Phenomenon
=450  \\$wnnna$aNervous System Physiological Process
=450  \\$aNervous System Physiologic Processes
=450  \\$wnno$aNervous System Physiological Processes$5IEN-M
=450  \\$aNervous System Physiology
=450  \\$aNervous System$xphysiology
=450  \\$wnnna$aPhysiology, Nervous System
=450  \\$wnnna$aSystem Physiology, Nervous
=550  \\$wg$aMusculoskeletal and Neural Physiological Phenomena
=550  \\$wh$aArousal
=550  \\$wh$aAxonal Transport
=550  \\$wh$aBrain Waves
=550  \\$wh$aCentral Nervous System Sensitization
=550  \\$wh$aCerebrospinal Fluid Pressure
=550  \\$wh$aChronaxy
=550  \\$wh$aCortical Excitability
=550  \\$wh$aDominance, Cerebral
=550  \\$wh$aHabituation, Psychophysiologic
=550  \\$wh$aHigher Nervous Activity
=550  \\$wh$aKindling, Neurologic
=550  \\$wh$aMembrane Potentials
=550  \\$wh$aNerve Regeneration
=550  \\$wh$aNeural Conduction
=550  \\$wh$aNeural Inhibition
=550  \\$wh$aNeurogenesis
=550  \\$wh$aNeuroimmunomodulation
=550  \\$wh$aNeuronal Plasticity
=550  \\$wh$aNeuroprotection
=550  \\$wh$aNeurosecretion
=550  \\$wh$aPsychomotor Performance
=550  \\$wh$aReaction Time
=550  \\$wh$aReflex
=550  \\$wh$aRefractory Period, Electrophysiological
=550  \\$wh$aSensation
=550  \\$wh$aSensory Gating
=550  \\$wh$aSleep
=550  \\$wh$aSpeech
=550  \\$wh$aSpeech Acoustics
=550  \\$wh$aSynaptic Transmission
=550  \\$wh$aTaste Threshold
=667  \\$ageneral or unspecified; prefer specifics; DF: NERVOUS SYSTEM PHYSIOL
=680  \\$iCharacteristic properties and processes of the NERVOUS SYSTEM as a whole or with reference to the peripheral or the CENTRAL NERVOUS SYSTEM.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Nervous System Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aNeurophysiology$0(DLC) sh 85091159$5IEN-M

=LDR  01587cz  a2200361n  4500
=001  9880363597202441
=005  20141212203826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009423
=035  \\$aCBA2686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614
=072  \\$aC10.$x551
=150  \\$aNervous System Neoplasms
=450  \\$wnnna$aNeoplasm, Nervous System
=450  \\$aNeoplasms, Nervous System
=450  \\$wnnna$aNervous System Neoplasm
=450  \\$wnnna$aNervous System Tumor
=450  \\$wnnna$aNervous System Tumors
=450  \\$wnnna$aTumor, Nervous System
=450  \\$wnnna$aTumors, Nervous System
=450  \\$wnnna$aTumors of the Nervous System
=550  \\$wg$aNeoplasms by Site
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aCentral Nervous System Neoplasms
=550  \\$wh$aCranial Nerve Neoplasms
=550  \\$wh$aParaneoplastic Syndromes, Nervous System
=550  \\$wh$aPeripheral Nervous System Neoplasms
=667  \\$aGEN: prefer specific precoord; do not confuse with NEOPLASMS, NERVOUS TISSUE (neopl composed of nerve tissue; TN 135); coord IM with histol type of neopl (IM)
=680  \\$iBenign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.
=688  \\$a80; was NON MESH before 1980
=750  \0$aNervous system$xCancer$5IEN-M$0(DLC)sh 00008550
=750  \0$aNervous system$xTumors$5IEN-HS$0(DLC)sh 85090936

=LDR  02300cz  a2200553n  4500
=001  9880363597302441
=005  20141212203826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009422
=035  \\$aCBA2685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10
=150  \\$aNervous System Diseases
=450  \\$wnnna$aDisease, Nervous System
=450  \\$wnnna$aDiseases, Nervous System
=450  \\$wnnna$aDisorder, Nervous System
=450  \\$wnnna$aDisorder, Neurologic
=450  \\$wnnna$aDisorder, Neurological
=450  \\$wnnna$aDisorders, Nervous System
=450  \\$wnnna$aDisorders, Neurologic
=450  \\$wnnna$aDisorders, Neurological
=450  \\$wnnna$aNervous System Disease
=450  \\$wnnna$aNervous System Disorder
=450  \\$wnnna$aNervous System Disorders
=450  \\$wnnna$aNeurologic Disorder
=450  \\$aNeurologic Disorders
=450  \\$wnnna$aNeurological Disorder
=450  \\$wnnna$aNeurological Disorders
=550  \\$wh$aAutoimmune Diseases of the Nervous System
=550  \\$wh$aAutonomic Nervous System Diseases
=550  \\$wh$aCentral Nervous System Diseases
=550  \\$wh$aChronobiology Disorders
=550  \\$wh$aCranial Nerve Diseases
=550  \\$wh$aDemyelinating Diseases
=550  \\$wh$aNervous System Malformations
=550  \\$wh$aNervous System Neoplasms
=550  \\$wh$aNeurocutaneous Syndromes
=550  \\$wh$aNeurodegenerative Diseases
=550  \\$wh$aNeurologic Manifestations
=550  \\$wh$aNeuromuscular Diseases
=550  \\$wh$aNeurotoxicity Syndromes
=550  \\$wh$aRestless Legs Syndrome
=550  \\$wh$aSleep Disorders
=550  \\$wh$aTrauma, Nervous System
=550  \\$aNeurology
=667  \\$aGEN or unspecified; prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; inflamm dis = NEURITIS; "diabetic neuropathy" & "diabetic peripheral neuropathy": index only under DIABETIC NEUROPATHIES;/chem ind: consider NEUROTOXICITY SYNDROMES
=680  \\$iDiseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
=688  \\$a1965
=750  \0$aNervous system$xDiseases$5IEN$0(DLC)sh 85090924

=LDR  02458cz  a2200589n  4500
=001  9880363597402441
=005  20141212203825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009421
=035  \\$aCBA2684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500
=072  \\$aC16.$x131.$x666
=150  \\$aNervous System Malformations
=450  \\$wnnna$aAbnormalities, Congenital, Nervous System
=450  \\$wnnna$aAbnormalities, Nervous System
=450  \\$wnnna$aAbnormality, Nervous System
=450  \\$wnnna$aAnomalies, Nervous System
=450  \\$wnnna$aAnomaly, Nervous System
=450  \\$wnnna$aCongenital Abnormalities, Nervous System
=450  \\$wnnna$aCongenital Anomalies, Nervous System
=450  \\$wnnna$aCongenital Malformations, Nervous System
=450  \\$wnnna$aCranioschises
=450  \\$wnnna$aCranioschisis
=450  \\$wnnna$aMalformation, Nervous System
=450  \\$wnnna$aMalformations, Nervous System
=450  \\$wnnna$aMalformations, Nervous System, Congenital
=450  \\$aNervous System Abnormalities
=450  \\$aNervous System$xabnormalities
=450  \\$wnnna$aNervous System Abnormality
=450  \\$wnnna$aNervous System Anomalies
=450  \\$wnnna$aNervous System Anomaly
=450  \\$wnnna$aNervous System Congenital Abnormalities
=450  \\$wnnna$aNervous System Congenital Malformations
=450  \\$wnnna$aNervous System Malformation
=450  \\$wnnna$aNervous System Malformations, Congenital
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aAgenesis of Corpus Callosum
=550  \\$wh$aCentral Nervous System Cysts
=550  \\$wh$aCentral Nervous System Vascular Malformations
=550  \\$wh$aDandy-Walker Syndrome
=550  \\$wh$aHereditary Sensory and Autonomic Neuropathies
=550  \\$wh$aHereditary Sensory and Motor Neuropathy
=550  \\$wh$aHydranencephaly
=550  \\$wh$aMalformations of Cortical Development
=550  \\$wh$aNeural Tube Defects
=550  \\$wh$aSepto-Optic Dysplasia
=667  \\$afor congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ/abnorm; DF: NERVOUS SYSTEM ABNORM
=680  \\$iStructural abnormalities of the central or peripheral nervous system resulting primarily from defects of embryogenesis.
=688  \\$a2000(1966); use explode 1971-1997
=750  \0$aNervous system$xAbnormalities$5IEN-M$0(DLC)sh 85090918

=LDR  01430cz  a2200325n  4500
=001  9880363597502441
=005  20141212203824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009420
=035  \\$aCBA2683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8
=150  \\$aNervous System
=360  \\$iconsider also terms at$aNERVE$aNEUR-
=450  \\$wnnna$aNervous Systems
=450  \\$wnnna$aSystem, Nervous
=450  \\$wnnna$aSystems, Nervous
=550  \\$wh$aCentral Nervous System
=550  \\$wh$aGanglia
=550  \\$wh$aNerve Net
=550  \\$wh$aNerve Tissue
=550  \\$wh$aNeural Pathways
=550  \\$wh$aNeuroglia
=550  \\$wh$aNeurons
=550  \\$wh$aNeurosecretory Systems
=550  \\$wh$aPeripheral Nervous System
=550  \\$wh$aSynapses
=667  \\$aGEN only; /innerv is available for organs: Manual 19.8.39, 21.7+; for "nerves" but not for a specific nerve nor NERVE TISSUE; NERVOUS SYSTEM /anat as a SPEC = NEUROANATOMY; NERVOUS SYSTEM /chem as a SPEC = NEUROCHEMISTRY; NERVOUS SYSTEM /physiol as a SPEC = NEUROPHYSIOLOGY; NERVOUS SYSTEM /radiogr as a SPEC = NEURORADIOGRAPHY; NERVOUS SYSTEM /surg as a SPEC = NEUROSURGERY;
=680  \\$iThe entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)
=750  \0$aNervous system$5IEN$0(DLC)sh 85090917

=LDR  02056cz  a2200601n  4500
=001  9880363597602441
=005  20200625123149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009419
=035  \\$aCBA2682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x631
=150  \\$aNerve Tissue Proteins
=450  \\$aNerve Proteins$5IEN
=450  \\$wnnna$aProteins, Nerve Tissue
=450  \\$wnnna$aTissue Proteins, Nerve
=550  \\$wg$aProteins
=550  \\$wh$aAcid Sensing Ion Channels
=550  \\$wh$aAgrin
=550  \\$wh$aCalbindin 1
=550  \\$wh$aChimerin Proteins
=550  \\$wh$aChromogranins
=550  \\$wh$aDopamine and cAMP-Regulated Phosphoprotein 32
=550  \\$wh$aDysbindin
=550  \\$wh$aFatty Acid-Binding Protein 7
=550  \\$wh$aFragile X Mental Retardation Protein
=550  \\$wh$aGAP-43 Protein
=550  \\$wh$aGlucose Transporter Type 3
=550  \\$wh$aHu Paraneoplastic Encephalomyelitis Antigens
=550  \\$wh$aMicrotubule-Associated Proteins
=550  \\$wh$aMyelin Proteins
=550  \\$wh$aNatriuretic Peptide, Brain
=550  \\$wh$aNerve Growth Factors
=550  \\$wh$aNestin
=550  \\$wh$aNeuroendocrine Secretory Protein 7B2
=550  \\$wh$aNeurofilament Proteins
=550  \\$wh$aNeurogranin
=550  \\$wh$aNeuronal Apoptosis-Inhibitory Protein
=550  \\$wh$aNeuronal Calcium-Sensor Proteins
=550  \\$wh$aNeuropeptides
=550  \\$wh$aNogo Receptors
=550  \\$wh$aOlfactory Marker Protein
=550  \\$wh$aOligodendrocyte Transcription Factor 2
=550  \\$wh$aS100 Proteins
=550  \\$wh$aSAP90-PSD95 Associated Proteins
=550  \\$wh$aSynapsins
=550  \\$wh$aSynaptogyrins
=550  \\$wh$aSynaptophysin
=550  \\$wh$aSynucleins
=550  \\$wh$aTubulin
=550  \\$wh$aVoltage-Gated Sodium Channels
=667  \\$aIM & coord with specific protein (IM) + specific nerve or nerve tissue (IM); /biosyn /drug eff /physiol /ultrastruct permitted
=750  \0$aNerve tissue proteins$5IEN$0(DLC)sh 85090896

=LDR  00754cz  a2200253n  4500
=001  9880363597702441
=005  20141212203823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009417
=035  \\$aCBA2680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x561
=072  \\$aA10.$x755
=150  \\$aNerve Tissue
=450  \\$wnnna$aNerve Tissues
=450  \\$wnnna$aTissue, Nerve
=450  \\$wnnna$aTissues, Nerve
=550  \\$wg$aNervous System
=550  \\$wg$aTissues
=550  \\$wh$aEpendyma
=550  \\$wh$aMyelin Sheath
=550  \\$wh$aNeurilemma
=667  \\$anerve as tissue: not for specific nerves (see Cat 8) or unspecified nerves ( = NERVOUS SYSTEM); inflammation = NEURITIS
=750  \0$aNerve tissue$5IEN$0(DLC)sh 85090897

=LDR  01319cz  a2200301n  4500
=001  9880363597802441
=005  20141212203754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009336
=035  \\$aCBA2600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x717
=072  \\$aG4.$x299.$x139.$x638
=150  \\$aNecrosis
=450  \\$wnnna$aNecroses
=550  \\$wg$aCell Death
=550  \\$wg$aPathologic Processes
=550  \\$wh$aDental Pulp Necrosis
=550  \\$wh$aDNA Degradation, Necrotic
=550  \\$wh$aFat Necrosis
=550  \\$wh$aGangrene
=550  \\$wh$aInfarction
=550  \\$wh$aOsteonecrosis
=550  \\$aApoptosis
=550  \\$aCell Death
=667  \\$aIM for general or for necrotic process; necrosis in an organ or tissue: index organ or tissue /pathol (IM) + NECROSIS (NIM); note specific necrosis terms; radionecrosis: index RADIATION INJURIES/pathol (IM) + organ /pathol (IM) + NECROSIS (NIM)
=680  \\$iThe pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. Distinguish it from APOPTOSIS which is a normal, regulated cellular process.
=750  \0$aNecrosis$5IEN$0(DLC)sh 85090575

=LDR  00905cz  a2200193n  4500
=001  9880363597902441
=005  20171031103504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009333
=035  \\$aCBA2597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x598
=150  \\$aNeck
=360  \\$iconsider also terms at$aCERVICAL$aCERVICO-
=450  \\$wnnna$aNecks
=550  \\$wg$aBody Regions
=550  \\$wh$aSuperficial Musculoaponeurotic System
=667  \\$aas a region & for soft parts but note that NECK MUSCLES is also available; bones = CERVICAL VERTEBRAE; "cervical lymph nodes" = LYMPH NODES (IM) + NECK (NIM); "pterygium colli": index under NECK /abnorm; "neck dissection" probably refers to dissection of lymph nodes in cancer: index under LYMPH NODE EXCISION (IM) + NECK (NIM) for general or unspecified or RADICAL NECK DISSECTION if so specified
=750  \0$aNeck$5IEN$0(DLC)sh 85090554

=LDR  00965cz  a2200205n  4500
=001  9880363598002441
=005  20141212203753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009331
=035  \\$aCBA2595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x100.$x550
=150  \\$aNecator
=450  \\$wnnna$aNecators
=550  \\$wg$aAncylostomatoidea
=550  \\$wh$aNecator americanus
=667  \\$aa genus of intestinal hookworm found in man & pig; infection = NECATORIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of intestinal parasite worms which includes one of the most important hookworms of man, NECATOR AMERICANUS. The only other known species, N. suillus, has been recovered from pigs.
=688  \\$aANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92
=750  \0$aNecator$5IEN$0(DLC)sh 85090543

=LDR  01410cz  a2200433n  4500
=001  9880363598102441
=005  20141212203752.0
=008  860604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009330
=035  \\$aCBA2594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x605
=072  \\$aE7.$x858.$x400
=150  \\$aNebulizers and Vaporizers
=450  \\$wnnna$aAtomizer
=450  \\$aAtomizers
=450  \\$wnnna$aDevice, Inhalation
=450  \\$wnnna$aDevices, Inhalation
=450  \\$wnnna$aInhalation Device
=450  \\$aInhalation Devices
=450  \\$wnnna$aInhalator
=450  \\$aInhalators
=450  \\$wnnna$aInhaler
=450  \\$aInhalers
=450  \\$wnnna$aNebulizer
=450  \\$wnnna$aNebulizers
=450  \\$wnnna$aVaporizer
=450  \\$aVaporizers
=450  \\$wnnna$aVaporizers and Nebulizers
=450  \\$aVolatilization$xinstrumentation
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aSurgical Equipment
=550  \\$wh$aDry Powder Inhalers
=550  \\$wh$aMetered Dose Inhalers
=550  \\$aAdministration, Inhalation
=550  \\$aAdministration, Intranasal
=680  \\$iDevices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.
=688  \\$a87
=750  \0$aAtomizers$5IEN$0(DLC)sh 85009332

=LDR  00870cz  a2200217n  4500
=001  9880363598202441
=005  20141212203751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009326
=035  \\$aCBA2590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x560
=150  \\$aNaval Medicine
=450  \\$wnnna$aMedicine, Nautical
=450  \\$wnnna$aMedicine, Naval
=450  \\$aNautical Medicine
=550  \\$wg$aMedicine
=550  \\$wh$aSubmarine Medicine
=667  \\$aSPEC: SPEC qualif; Manual 28.8 & 34.15; use as coord for physiol, psychol & dis of nautical personnel whether of national navy, merchant marine or liner: read MeSH definition; DF: NAVAL MED
=680  \\$iThe practice of medicine concerned with conditions affecting the health of individuals associated with the marine environment.
=750  \0$aMedicine, Naval$5IEN$0(DLC)sh 85083156

=LDR  00754cz  a2200181n  4500
=001  9880363598302441
=005  20141212203751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009325
=035  \\$aCBA2589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x712
=150  \\$aNausea
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$wh$aPostoperative Nausea and Vomiting
=667  \\$a/chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS
=680  \\$iAn unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
=750  \0$aNausea$5IEN$0(DLC)sh 85090324

=LDR  00791cz  a2200193n  4500
=001  9880363598402441
=005  20141212203751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009324
=035  \\$aCBA2588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x655
=150  \\$aNaturopathy
=450  \\$aMedicine, Naturopathic
=450  \\$wnnna$aNaturopathic Medicine
=550  \\$wg$aComplementary Therapies
=550  \\$aHerbal Medicine
=680  \\$iA drugless system of therapy, making use of physical forces such as air, light, water, heat, massage. Treatments are often diet- and nutrition-oriented with attention given to the patient's personal history and lifestyle. (From Cassileth, Alternative Medicine Handbook, 1998, p329)
=750  \0$aNaturopathy$5IEN$0(DLC)sh 85090300

=LDR  00602cz  a2200181n  4500
=001  9880363598502441
=005  20141212203750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x490.$x249
=150  \\$aNatural Childbirth
=450  \\$wnnna$aChildbirth, Natural
=550  \\$wg$aParturition
=550  \\$aLabor, Obstetric
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iLabor and delivery without medical intervention, usually involving RELAXATION THERAPY.
=750  \0$aNatural childbirth$5IEN$0(DLC)sh 85090211

=LDR  03427cz  a2200817n  4500
=001  9880363598602441
=005  20141212203750.0
=008  850425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009320
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x584.$x500
=072  \\$aD12.$x644.$x548.$x585.$x500
=150  \\$aAtrial Natriuretic Factor
=450  \\$wnnna$aalpha ANP
=450  \\$wnnna$aalpha-ANP Dimer
=450  \\$wnnna$aalpha ANP Dimer
=450  \\$wnnna$aalpha-Atrial Natriuretic Peptide
=450  \\$wnnna$aalpha Atrial Natriuretic Peptide
=450  \\$aANF
=450  \\$wnnna$aANF (1-126)
=450  \\$wnnna$aANF (1-28)
=450  \\$wnnna$aANF (99-126)
=450  \\$wnnna$aANF Precursors
=450  \\$aANP
=450  \\$wnnna$aANP (1-126)
=450  \\$wnnna$aANP (1-28)
=450  \\$wnnna$aANP-(99-126)
=450  \\$wnnna$aANP Prohormone (99-126)
=450  \\$wnnna$aAtrial Natriuretic Factor (1-126)
=450  \\$wnnna$aAtrial Natriuretic Factor (1-28)
=450  \\$wnnna$aAtrial Natriuretic Factor (99-126)
=450  \\$wnnna$aAtrial Natriuretic Factor Precursors
=450  \\$wnnna$aAtrial Natriuretic Factor Prohormone
=450  \\$wnnna$aAtrial Natriuretic Peptide (1-126)
=450  \\$aAtrial Natriuretic Peptides
=450  \\$wnnna$aAtrial Pronatriodilatin
=450  \\$wnnna$aAtriopeptigen
=450  \\$wnnna$aAtriopeptin (1-28)
=450  \\$wnnna$aAtriopeptin 126
=450  \\$wnnna$aAtriopeptin (99-126)
=450  \\$wnnna$aAtriopeptin Prohormone (1-126)
=450  \\$aAtriopeptins
=450  \\$aAuriculin
=450  \\$wnnna$abeta-ANP
=450  \\$wnnna$abeta ANP
=450  \\$wnnna$abeta-Atrial Natriuretic Peptide
=450  \\$wnnna$abeta Atrial Natriuretic Peptide
=450  \\$wnnna$aCardiodilatin (99-126)
=450  \\$wnnna$aCardiodilatin Precursor
=450  \\$wnnna$aCardionatrin I
=450  \\$wnnna$aCardionatrin IV
=450  \\$wnnna$agamma ANP (99-126)
=450  \\$wnnna$agamma-Atrial Natriuretic Peptide
=450  \\$wnnna$agamma Atrial Natriuretic Peptide
=450  \\$aNatriuretic Peptides, Atrial
=450  \\$wnnna$aPeptides, Atrial Natriuretic
=450  \\$wnnna$aPrepro-ANP
=450  \\$wnnna$aPrepro ANP
=450  \\$wnnna$aPrepro-Cardiodilatin-Atrial Natriuretic Factor
=450  \\$wnnna$aPrepro Cardiodilatin Atrial Natriuretic Factor
=450  \\$wnnna$aPrepro-CDD-ANF
=450  \\$wnnna$aPrepro CDD ANF
=450  \\$wnnna$aPro-ANF
=450  \\$wnnna$aPro ANF
=450  \\$wnnna$aProANF
=450  \\$wnnna$aProatrial Natriuretic Factor
=450  \\$wnnna$aPronatriodilatin
=550  \\$wg$aNatriuretic Peptides
=680  \\$iA potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
=688  \\$a1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (99-126) 1987-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (1-28) 1992-2003; use ATRIAL NATRIURETIC FACTOR (NM) for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003
=750  \0$aAtrial natriuretic peptides$5IEN-M$0(DLC)sh 86008139

=LDR  00658cz  a2200193n  4500
=001  9880363598702441
=005  20141212203749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009318
=035  \\$aCBA2582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852.$x796.$x241.$x557
=150  \\$aNatriuresis
=450  \\$wnnna$aNatriureses
=550  \\$wg$aDiuresis
=550  \\$aSodium
=667  \\$adifferentiate from SODIUM /urine in that in natriuresis emphasis is on the physiological process of urinary excretion of sodium; NATRIURETIC HORMONES is available
=680  \\$iSodium excretion by URINATION.
=750  \0$aNatriuresis$5IEN$0(DLC)sh 85090179

=LDR  01565cz  a2200421n  4500
=001  9880363598802441
=005  20141212203747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009313
=035  \\$aCBA2577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x550
=150  \\$aNational Health Programs
=450  \\$wnnna$aHealth Insurance, National
=450  \\$wnnna$aHealth Program, National
=450  \\$wnnna$aHealth Programs, National
=450  \\$wnnna$aHealth Service, National
=450  \\$wnnna$aHealth Services, National
=450  \\$wnnna$aInsurance, National Health
=450  \\$wnnna$aNational Health Insurance
=450  \\$wnnna$aNational Health Insurance, Non U.S.
=450  \\$aNational Health Insurance, Non-U.S.
=450  \\$wnnna$aNational Health Program
=450  \\$wnnna$aNational Health Service
=450  \\$wnnna$aNational Health Services
=450  \\$wnnna$aProgram, National Health
=450  \\$wnnna$aPrograms, National Health
=450  \\$wnnna$aService, National Health
=450  \\$wnnna$aServices, National Health
=550  \\$wg$aHealth Planning
=550  \\$wh$aNational Health Insurance, United States
=550  \\$wh$aSingle-Payer System
=550  \\$wh$aState Medicine
=550  \\$aGovernment Programs
=667  \\$aspecify country
=680  \\$iComponents of a national health care system which administer specific services, e.g., national health insurance.
=688  \\$a77(75); was see under STATE MEDICINE 1963-76
=750  \0$aNational health insurance$5IEN-M$0(DLC)sh 92004306

=LDR  00735cz  a2200217n  4500
=001  9880363598902441
=005  20141212203746.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009310
=035  \\$aCBA2574HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x900
=072  \\$aN3.$x349.$x550.$x610
=150  \\$aNational Health Insurance, United States
=450  \\$aFederal Health Insurance Plans, United States
=450  \\$aUnited States National Health Insurance
=550  \\$wg$aInsurance, Health
=550  \\$wg$aNational Health Programs
=667  \\$aadd UNITED STATES (NIM); DF: NATL HEALTH INSUR US
=688  \\$a78
=750  \0$aNational health insurance$zUnited States$5IEN-M$0(DLC)sh2008108210

=LDR  00856cz  a2200253n  4500
=001  9880363599002441
=005  20141212203744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009305
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x623.$x557
=072  \\$aA14.$x724.$x557
=150  \\$aNasopharynx
=450  \\$wnnna$aChoanae
=450  \\$wnnna$aNasopharynges
=450  \\$wnnna$aNasopharynxes
=450  \\$wnnna$aRhinopharynges
=450  \\$aRhinopharynx
=450  \\$wnnna$aRhinopharynxes
=550  \\$wg$aPharynx
=550  \\$wh$aAdenoids
=667  \\$ainflammation = NASOPHARYNGITIS
=680  \\$iThe top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.
=750  \0$aNasopharynx$5IEN$0(DLC)sh 85089895

=LDR  00918cz  a2200253n  4500
=001  9880363599102441
=005  20141212203744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009304
=035  \\$aCBA2568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x550.$x350.$x700
=072  \\$aC7.$x550.$x781.$x500
=072  \\$aC8.$x730.$x561.$x500
=072  \\$aC9.$x775.$x350.$x700
=072  \\$aC9.$x775.$x649.$x500
=150  \\$aNasopharyngitis
=450  \\$wnnna$aNasopharyngitides
=550  \\$wg$aNasopharyngeal Diseases
=550  \\$wg$aPharyngitis
=667  \\$ainflammation of nasopharyngeal portion of PHARYNX, not nose & pharynx
=680  \\$iInflammation of the NASOPHARYNX, usually including its mucosa, related lymphoid structure, and glands.
=688  \\$a91(65); was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89
=750  \0$aNasopharyngitis$5IEN$0(DLC)sh 85089893

=LDR  01574cz  a2200457n  4500
=001  9880363599202441
=005  20141212203743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009303
=035  \\$aCBA2567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x710.$x650
=072  \\$aC7.$x550.$x350.$x650
=072  \\$aC7.$x550.$x745.$x650
=072  \\$aC9.$x647.$x710.$x650
=072  \\$aC9.$x775.$x350.$x650
=072  \\$aC9.$x775.$x549.$x650
=150  \\$aNasopharyngeal Neoplasms
=450  \\$wnnna$aCancer, Nasopharyngeal
=450  \\$wnnna$aCancer, Nasopharynx
=450  \\$aCancer of Nasopharynx
=450  \\$wnnna$aCancer of the Nasopharynx
=450  \\$wnnna$aCancers, Nasopharyngeal
=450  \\$wnnna$aCancers, Nasopharynx
=450  \\$aNasopharyngeal Cancer
=450  \\$wnnna$aNasopharyngeal Cancers
=450  \\$wnnna$aNasopharyngeal Neoplasm
=450  \\$wnnna$aNasopharynx Cancer
=450  \\$wnnna$aNasopharynx Cancers
=450  \\$wnnna$aNasopharynx Neoplasm
=450  \\$wnnna$aNasopharynx Neoplasms
=450  \\$wnnna$aNeoplasm, Nasopharyngeal
=450  \\$wnnna$aNeoplasm, Nasopharynx
=450  \\$wnnna$aNeoplasms, Nasopharyngeal
=450  \\$wnnna$aNeoplasms, Nasopharynx
=550  \\$wg$aNasopharyngeal Diseases
=550  \\$wg$aPharyngeal Neoplasms
=667  \\$acoordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the NASOPHARYNX.
=750  \0$aNasopharynx$xTumors$5IEN-M$0(DLC)sh 85089900
=750  \0$aNasopharynx$xCancer$5IEN-HS$0(DLC)sh 85089897

=LDR  00966cz  a2200289n  4500
=001  9880363599302441
=005  20141212203743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009302
=035  \\$aCBA2566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x550.$x350
=072  \\$aC9.$x775.$x350
=150  \\$aNasopharyngeal Diseases
=450  \\$wnnna$aDisease, Nasopharyngeal
=450  \\$wnnna$aDiseases, Nasopharyngeal
=450  \\$wnnna$aDiseases of Nasopharynx
=450  \\$wnnna$aNasopharyngeal Disease
=450  \\$wnnna$aNasopharynx Disease
=450  \\$wnnna$aNasopharynx Diseases
=550  \\$wg$aPharyngeal Diseases
=550  \\$wh$aNasopharyngeal Neoplasms
=550  \\$wh$aNasopharyngitis
=667  \\$ainflammatory disease = NASOPHARYNGITIS
=680  \\$iPathological processes involving the NASOPHARYNX.
=688  \\$a66; NASOPHARYNGITIS was see under PHARYNGITIS 1965-89
=750  \0$aNasopharynx$xDiseases$5IEN$0(DLC)sh 85089898

=LDR  00689cz  a2200205n  4500
=001  9880363599402441
=005  20141212203742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009300
=035  \\$aCBA2564M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x591
=150  \\$aNasal Septum
=450  \\$wnnna$aNasal Septums
=450  \\$wnnna$aSeptum, Nasal
=450  \\$wnnna$aSeptums, Nasal
=550  \\$wg$aNose
=550  \\$wh$aVomer
=680  \\$iThe partition separating the two NASAL CAVITIES in the midplane. It is formed by the SEPTAL NASAL CARTILAGE, parts of skull bones (ETHMOID BONE; VOMER), and membranous parts.
=750  \0$aNasal septum$0(DLC)sh2009002020$5IEN-M

=LDR  00803cz  a2200229n  4500
=001  9880363599502441
=005  20141212203742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009298
=035  \\$aCBA2562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x572
=072  \\$aC9.$x603.$x557
=072  \\$aC23.$x300.$x825.$x557
=150  \\$aNasal Polyps
=450  \\$wnnna$aNasal Polyp
=450  \\$wnnna$aPolyp, Nasal
=450  \\$wnnna$aPolyps, Nasal
=550  \\$wg$aNose Diseases
=550  \\$wg$aPolyps
=680  \\$iFocal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.
=750  \0$aNasal polyps$5IEN$0(DLC)sh 85089877

=LDR  01162cz  a2200313n  4500
=001  9880363599602441
=005  20141212203742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009297
=035  \\$aCBA2561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x520
=072  \\$aA4.$x760.$x600
=072  \\$aA10.$x615.$x550.$x760.$x600
=150  \\$aNasal Mucosa
=450  \\$wnnna$aEpithelium, Nasal
=450  \\$wnnna$aMembrane, Schneiderian
=450  \\$wnnna$aMembranes, Schneiderian
=450  \\$wnnna$aMucosa, Nasal
=450  \\$aNasal Epithelium
=450  \\$wnnna$aSchneiderian Membrane
=450  \\$wnnna$aSchneiderian Membranes
=550  \\$wg$aNose
=550  \\$wg$aRespiratory Mucosa
=550  \\$wh$aGoblet Cells
=550  \\$wh$aOlfactory Mucosa
=667  \\$ainflammation = RHINITIS
=680  \\$iThe mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
=750  \0$aNasal mucosa$5IEN$0(DLC)sh 85089876

=LDR  00994cz  a2200229n  4500
=001  9880363599702441
=005  20141212203741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009296
=035  \\$aCBA2560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x449
=150  \\$aNasal Cavity
=450  \\$wnnna$aCavities, Nasal
=450  \\$wnnna$aCavity, Nasal
=450  \\$wnnna$aNasal Cavities
=450  \\$aNasal Fossa$5IEN
=550  \\$wg$aNose
=667  \\$a/ abnorm permitted for congenital deformities but acquired deformities = NOSE DEFORMITIES, ACQUIRED; neoplasms: coordinate NASAL CAVITY (IM) + NOSE NEOPLASMS (IM); inflammation = RHINITIS; / secret = NASAL MUCOSA / secret
=680  \\$iThe proximal portion of the respiratory passages on either side of the NASAL SEPTUM. Nasal cavities, extending from the nares to the NASOPHARYNX, are lined with ciliated NASAL MUCOSA.
=688  \\$a78(75); was see under NOSE 1963-77
=750  \0$aNasal fossa$0(DLC) sh 85089875$5IEN

=LDR  00986cz  a2200241n  4500
=001  9880363599802441
=005  20141212203741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009295
=035  \\$aCBA2559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x665
=072  \\$aA4.$x531.$x378
=150  \\$aNasal Bone
=450  \\$wnnna$aBone, Nasal
=450  \\$wnnna$aBones, Nasal
=450  \\$wnnna$aNasal Bones
=550  \\$wg$aFacial Bones
=550  \\$wg$aNose
=667  \\$a/abnorm permitted for congenital deformities but acquired deformities = NOSE DEFORMITIES, ACQUIRED; / surg: consider also RHINOPLASTY; fractures: coordinate NASAL BONE / inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate NASAL BONE (IM) + NOSE NEOPLASMS (IM)
=680  \\$iEither one of the two small elongated rectangular bones that together form the bridge of the nose.
=688  \\$a78(75); was see under NOSE 1963-77
=750  \0$aNasal bone$5IEN$0(DLC)sh 85089873

=LDR  01371cz  a2200313n  4500
=001  9880363599902441
=005  20141212203741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009294
=035  \\$aCBA2558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x600
=072  \\$aD27.$x505.$x696.$x663.$x850.$x14.$x760
=072  \\$aD27.$x505.$x954.$x427.$x40.$x550
=072  \\$aD27.$x505.$x954.$x427.$x210.$x600
=150  \\$aNarcotics
=450  \\$aAnalgesics, Narcotic
=450  \\$wnnna$aEffect, Narcotic
=450  \\$wnnna$aEffects, Narcotic
=450  \\$aNarcotic Analgesics
=450  \\$wnnna$aNarcotic Effect
=450  \\$wnnna$aNarcotic Effects
=550  \\$wg$aAnalgesics
=550  \\$wg$aCentral Nervous System Depressants
=550  \\$wh$aAnalgesics, Opioid
=667  \\$aNARCOTIC ADDICTION see OPIOID-RELATED DISORDERS is available; note entry term NARCOTIC EFFECT: use only for the narcotic effect of a chemical substance
=680  \\$iAgents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.
=688  \\$afor NARCOTIC ANALGESICS use ANALGESICS, OPIOID 1975-2006
=750  \0$aNarcotics$5IEN$0(DLC)sh 85089815

=LDR  01261cz  a2200349n  4500
=001  9880363600102441
=005  20141212192343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009292
=035  \\$aCBA2556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x543
=072  \\$aD27.$x505.$x696.$x663.$x850.$x512
=072  \\$aD27.$x505.$x954.$x427.$x550
=150  \\$aNarcotic Antagonists
=450  \\$wnnna$aAntagonists, Competitive Opioid
=450  \\$wnnna$aAntagonists, Narcotic
=450  \\$wnnna$aAntagonists, Opioid
=450  \\$wnnna$aAntagonists, Opioid Receptor
=450  \\$wnnna$aCompetitive Opioid Antagonists
=450  \\$aNarcotics$xantagonists & inhibitors
=450  \\$aOpioid Antagonists
=450  \\$wnnna$aOpioid Antagonists, Competitive
=450  \\$wnnna$aOpioid Receptor Antagonists
=450  \\$wnnna$aReceptor Antagonists, Opioid
=450  \\$aReceptors, Opioid$xantagonists & inhibitors
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wg$aSensory System Agents
=550  \\$aDrug Antagonism
=680  \\$iAgents inhibiting the effect of narcotics on the central nervous system.
=750  \0$aNarcotic antagonists$5IEN$0(DLC)sh 85089806

=LDR  00902cz  a2200217n  4500
=001  9880363600202441
=005  20141212203740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009291
=035  \\$aCBA2555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x570.$x505.$x557
=150  \\$aNarcotherapy
=450  \\$wnnna$aNarcosyntheses
=450  \\$aNarcosynthesis
=450  \\$wnnna$aNarcotherapies
=550  \\$wg$aPsychopharmacology
=667  \\$aa psychother technique using adjuvant sodium amytal or pentothal; DF: NARCOTHER
=680  \\$iIntravenous injections of sodium amytal or sodium pentothal to induce a state in which the patient is more relaxed and communicative. Narcosuggestion, narcosynthesis, and narcoanalysis are therapeutic processes using these drug adjuncts.
=688  \\$aNARCOSYNTHESIS was see under NARCOTHERAPY 1968-78
=750  \0$aNarcotherapy$5IEN$0(DLC)sh 85089802

=LDR  01764cz  a2200409n  4500
=001  9880363600302441
=005  20141212203740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009290
=035  \\$aCBA2554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x425.$x800.$x200.$x750
=072  \\$aF3.$x870.$x400.$x800.$x200.$x750
=150  \\$aNarcolepsy
=450  \\$aGelineau Syndrome
=450  \\$wnnna$aGelineau's Syndrome
=450  \\$wnnna$aGelineaus Syndrome
=450  \\$wnnna$aGelineau's Syndromes
=450  \\$aNarcolepsy-Cataplexy Syndrome
=450  \\$wnnna$aNarcolepsy Cataplexy Syndrome
=450  \\$wnnna$aNarcolepsy-Cataplexy Syndromes
=450  \\$wnnna$aNarcoleptic Syndrome
=450  \\$wnnna$aNarcoleptic Syndromes
=450  \\$aParoxysmal Sleep
=450  \\$wnnna$aSleep, Paroxysmal
=450  \\$wnnna$aSyndrome, Gelineau
=450  \\$wnnna$aSyndrome, Gelineau's
=450  \\$wnnna$aSyndrome, Narcolepsy-Cataplexy
=450  \\$wnnna$aSyndrome, Narcoleptic
=450  \\$wnnna$aSyndromes, Gelineau's
=450  \\$wnnna$aSyndromes, Narcolepsy-Cataplexy
=450  \\$wnnna$aSyndromes, Narcoleptic
=550  \\$wg$aDisorders of Excessive Somnolence
=550  \\$wh$aCataplexy
=680  \\$iA condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)
=688  \\$a67(63)
=750  \0$aNarcolepsy$5IEN$0(DLC)sh 85089801

=LDR  00606cz  a2200217n  4500
=001  9880363610502441
=005  20141212203606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009048
=035  \\$aCBA2305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x808.$x260
=150  \\$aMotor Skills
=450  \\$aMotor Ability$5IEN
=450  \\$wnnna$aMotor Skill
=450  \\$wnnna$aSkill, Motor
=450  \\$wnnna$aSkills, Motor
=550  \\$wg$aPsychomotor Performance
=550  \\$aChild Development
=680  \\$iPerformance of complex motor acts.
=750  \0$aMotor ability$5IEN$0(DLC)sh 85087575

=LDR  01189cz  a2200397n  4500
=001  9880363610602441
=005  20141212192337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009046
=035  \\$aCBA2303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x655.$x500
=072  \\$aA11.$x671.$x655.$x500
=150  \\$aMotor Neurons
=450  \\$wnnna$aAlpha Motor Neuron
=450  \\$wnnna$aAlpha Motor Neurons
=450  \\$wnnna$aAlpha Motorneuron
=450  \\$wnnna$aAlpha Motorneurons
=450  \\$wnnna$aMotoneuron
=450  \\$wnnna$aMotoneurons
=450  \\$wnnna$aMotor Neuron
=450  \\$wnnna$aMotor Neuron, Alpha
=450  \\$wnnna$aMotor Neurons, Alpha
=450  \\$wnnna$aMotorneuron, Alpha
=450  \\$wnnna$aMotorneurons, Alpha
=450  \\$wnnna$aNeuron, Alpha Motor
=450  \\$wnnna$aNeuron, Motor
=450  \\$wnnna$aNeurons, Alpha Motor
=450  \\$aNeurons, Motor
=550  \\$wg$aNeurons, Efferent
=550  \\$wh$aAnterior Horn Cells
=550  \\$wh$aMotor Neurons, Gamma
=550  \\$aSpinal Cord
=680  \\$iNeurons which activate MUSCLE CELLS.
=688  \\$a66(64)
=750  \0$aMotor neurons$5IEN$0(DLC)sh 85087586

=LDR  03916cz  a2201009n  4500
=001  9880363610702441
=005  20141212192336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009044
=035  \\$aCBA2301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x270.$x548
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814.$x624
=150  \\$aMotor Cortex
=450  \\$wnnna$aArea, Motor
=450  \\$wnnna$aArea, Precentral Motor
=450  \\$wnnna$aArea, Premotor
=450  \\$wnnna$aArea, Primary Motor
=450  \\$wnnna$aArea, Secondary Motor
=450  \\$wnnna$aArea, Somatic Motor
=450  \\$wnnna$aArea, Somatomotor
=450  \\$wnnna$aArea, Supplementary Motor
=450  \\$wnnna$aAreas, Motor
=450  \\$wnnna$aAreas, Precentral Motor
=450  \\$wnnna$aAreas, Premotor
=450  \\$wnnna$aAreas, Primary Motor
=450  \\$wnnna$aAreas, Secondary Motor
=450  \\$wnnna$aAreas, Somatic Motor
=450  \\$wnnna$aAreas, Somatomotor
=450  \\$wnnna$aAreas, Supplementary Motor
=450  \\$wnnna$aCortex, Motor
=450  \\$wnnna$aCortex, Precentral Motor
=450  \\$wnnna$aCortex, Premotor
=450  \\$wnnna$aCortex, Primary Motor
=450  \\$wnnna$aCortex, Secondary Motor
=450  \\$wnnna$aCortices, Precentral Motor
=450  \\$wnnna$aCortices, Premotor
=450  \\$wnnna$aCortices, Primary Motor
=450  \\$wnnna$aCortices, Secondary Motor
=450  \\$wnnna$aMotor Area
=450  \\$wnnna$aMotor Area, Precentral
=450  \\$wnnna$aMotor Area, Primary
=450  \\$wnnna$aMotor Area, Secondary
=450  \\$wnnna$aMotor Area, Somatic
=450  \\$wnnna$aMotor Area, Supplementary
=450  \\$wnnna$aMotor Areas
=450  \\$wnnna$aMotor Areas, Precentral
=450  \\$wnnna$aMotor Areas, Primary
=450  \\$wnnna$aMotor Areas, Secondary
=450  \\$wnnna$aMotor Areas, Somatic
=450  \\$wnnna$aMotor Areas, Supplementary
=450  \\$wnnna$aMotor Cortex, Precentral
=450  \\$wnnna$aMotor Cortex, Primary
=450  \\$wnnna$aMotor Cortex, Secondary
=450  \\$wnnna$aMotor Cortices, Precentral
=450  \\$wnnna$aMotor Cortices, Primary
=450  \\$wnnna$aMotor Cortices, Secondary
=450  \\$wnnna$aMotor Strip
=450  \\$wnnna$aMotor Strips
=450  \\$wnnna$aPrecentral Motor Area
=450  \\$wnnna$aPrecentral Motor Areas
=450  \\$wnnna$aPrecentral Motor Cortex
=450  \\$wnnna$aPrecentral Motor Cortices
=450  \\$wnnna$aPremotor Area
=450  \\$wnnna$aPremotor Areas
=450  \\$wnnna$aPremotor Cortex
=450  \\$wnnna$aPrimary Motor Area
=450  \\$wnnna$aPrimary Motor Areas
=450  \\$wnnna$aPrimary Motor Cortex
=450  \\$wnnna$aPrimary Motor Cortices
=450  \\$wnnna$aSecondary Motor Area
=450  \\$wnnna$aSecondary Motor Areas
=450  \\$wnnna$aSecondary Motor Cortex
=450  \\$wnnna$aSecondary Motor Cortices
=450  \\$wnnna$aSomatic Motor Area
=450  \\$wnnna$aSomatic Motor Areas
=450  \\$wnnna$aSomatomotor Area
=450  \\$wnnna$aSomatomotor Areas
=450  \\$wnnna$aStrip, Motor
=450  \\$wnnna$aStrips, Motor
=450  \\$wnnna$aSupplementary Motor Area
=450  \\$wnnna$aSupplementary Motor Areas
=550  \\$wg$aFrontal Lobe
=550  \\$wg$aSensorimotor Cortex
=680  \\$iArea of the FRONTAL LOBE concerned with primary motor control located in the dorsal PRECENTRAL GYRUS immediately anterior to the central sulcus. It is comprised of three areas: the primary motor cortex located on the anterior paracentral lobule on the medial surface of the brain; the premotor cortex located anterior to the primary motor cortex; and the supplementary motor area located on the midline surface of the hemisphere anterior to the primary motor cortex.
=688  \\$a71
=750  \0$aMotor cortex$5IEN$0(DLC)sh 85087578

=LDR  01246cz  a2200385n  4500
=001  9880363610802441
=005  20201218172556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658
=072  \\$aF1.$x752.$x543.$x500.$x750
=150  \\$aMotivation
=450  \\$wnnna$aDisincentive
=450  \\$wnnna$aDisincentives
=450  \\$wnnna$aIncentive
=450  \\$aIncentives
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wg$aEmotional Intelligence
=550  \\$wh$aAchievement
=550  \\$wh$aAspirations, Psychological
=550  \\$wh$aConflict, Psychological
=550  \\$wh$aDrive
=550  \\$wh$aExploratory Behavior
=550  \\$wh$aFood Deprivation
=550  \\$wh$aGoals
=550  \\$wh$aHandling, Psychological
=550  \\$wh$aInstinct
=550  \\$wh$aIntention
=550  \\$wh$aPower, Psychological
=550  \\$wh$aWater Deprivation
=550  \\$aDrive
=667  \\$ahuman & animal
=680  \\$iThose factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli.
=750  \0$aMotivation (Psychology)$5IEN$0(DLC)sh 85087562

=LDR  01060cz  a2200301n  4500
=001  9880363610902441
=005  20141212203604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x571
=150  \\$aMotion Sickness
=450  \\$wnnna$aAir Sickness
=450  \\$aAirsickness
=450  \\$wnnna$aCar Sickness
=450  \\$aCarsickness
=450  \\$wnnna$aSea Sickness
=450  \\$aSeasickness
=450  \\$wnnna$aSickness, Air
=450  \\$wnnna$aSickness, Car
=450  \\$wnnna$aSickness, Motion
=450  \\$wnnna$aSickness, Sea
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aSpace Motion Sickness
=667  \\$aSPACE MOTION SICKNESS is also available
=680  \\$iDisorder caused by motion, as sea sickness, train sickness, car sickness, air sickness, or SPACE MOTION SICKNESS. It may include nausea, vomiting and dizziness.
=688  \\$aAIRSICKNESS, CARSICKNESS & SEASICKNESS were see under MOTION SICKNESS 1963-78
=750  \0$aMotion sickness$5IEN$0(DLC)sh 85087559

=LDR  00577cz  a2200181n  4500
=001  9880363611102441
=005  20141212203604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009039
=035  \\$aCBA2296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932.$x567
=150  \\$aMotion Perception
=450  \\$wnnna$aPerception, Motion
=550  \\$wg$aVisual Perception
=667  \\$aTN 129: relation to KINESTHESIS
=680  \\$iThe real or apparent movement of objects through the visual field.
=750  \0$aMotion perception (Vision)$5IEN$0(DLC)sh 85087558

=LDR  00944cz  a2200253n  4500
=001  9880363611202441
=005  20141212203603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009038
=035  \\$aCBA2295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x560
=150  \\$aMotion
=450  \\$wnnna$aMotions
=550  \\$wg$aPhysical Processes
=550  \\$wh$aAcceleration
=550  \\$wh$aCoriolis Force
=550  \\$wh$aPulsatile Flow
=550  \\$wh$aRotation
=550  \\$aMovement
=667  \\$ano qualif; a concept in physics: a bullet shot from a gun is MOTION: differentiate from MOVEMENT, a concept in physiol; see note there
=680  \\$iPhysical motion, i.e., a change in position of a body or subject as a result of an external force. It is distinguished from MOVEMENT, a process resulting from biological activity.
=688  \\$a68; was see under MOVEMENT 1963-67
=750  \0$aMotion$5IEN$0(DLC)sh 85087557

=LDR  00822cz  a2200229n  4500
=001  9880363611302441
=005  20141212203603.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009037
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x525
=072  \\$aD6.$x472.$x699.$x500
=072  \\$aD12.$x644.$x400.$x470
=072  \\$aD12.$x644.$x548.$x500
=072  \\$aD12.$x776.$x641.$x650.$x463
=150  \\$aMotilin
=550  \\$wg$aGastrointestinal Hormones
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=680  \\$iA peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.
=688  \\$a86(77); was see under GASTROINTESTINAL HORMONES 1977-85
=750  \0$aMotilin$5IEN$0(DLC)sh 89003565

=LDR  01162cz  a2200337n  4500
=001  9880363611502441
=005  20141212192335.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009035
=035  \\$aCBA2292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x500.$x320.$x200
=072  \\$aI1.$x880.$x853.$x150.$x500.$x340.$x270
=072  \\$aM1.$x620.$x630
=150  \\$aMothers
=450  \\$wnnna$aClub, Mothers'
=450  \\$wnnna$aClubs, Mothers'
=450  \\$wnnna$aMother
=450  \\$wnnna$aMother Clubs
=450  \\$aMotherhood$5IEN
=450  \\$wnnna$aMothers' Club
=450  \\$wnnna$aMothers' Clubs
=450  \\$wnnna$aMother's Clubs
=450  \\$wnnna$aMothers Clubs
=450  \\$aTeenage Mothers$5IEN
=550  \\$wg$aParents
=667  \\$ahuman & animal; /psychol: consider also MOTHER-CHILD RELATIONS; permitted for legal aspects of establishing maternity (as counterpart of PATERNITY); note category: do not confuse with PREGNANCY, a physiol state
=680  \\$iFemale parents, human or animal.
=688  \\$a78
=750  \0$aMotherhood$5IEN-M$0(DLC)sh 85087522
=750  \0$aMothers$5IEN-HS$0(DLC)sh 85087526

=LDR  01732cz  a2200493n  4500
=001  9880363611602441
=005  20141212203602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009034
=035  \\$aCBA2291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x290.$x170
=150  \\$aMother-Child Relations
=450  \\$wnnna$aInteraction, Mother-Child
=450  \\$wnnna$aInteraction, Mother-Infant
=450  \\$wnnna$aInteractions, Mother-Child
=450  \\$wnnna$aInteractions, Mother-Infant
=450  \\$aMother and Child$5IEN
=450  \\$wnnna$aMother-Child Interaction
=450  \\$wnnna$aMother Child Interaction
=450  \\$wnnna$aMother-Child Interactions
=450  \\$wnnna$aMother-Child Relation
=450  \\$wnnna$aMother Child Relations
=450  \\$wnnna$aMother-Child Relationship
=450  \\$wnnna$aMother Child Relationship
=450  \\$wnnna$aMother-Child Relationships
=450  \\$wnnna$aMother-Infant Interaction
=450  \\$wnnna$aMother Infant Interaction
=450  \\$wnnna$aMother-Infant Interactions
=450  \\$wnnna$aMother-Infant Relation
=450  \\$wnnna$aMother-Infant Relations
=450  \\$wnnna$aMother Infant Relations
=450  \\$wnnna$aRelation, Mother-Child
=450  \\$wnnna$aRelation, Mother-Infant
=450  \\$wnnna$aRelations, Mother-Child
=450  \\$wnnna$aRelations, Mother-Infant
=450  \\$wnnna$aRelationship, Mother-Child
=450  \\$wnnna$aRelationships, Mother-Child
=550  \\$wg$aParent-Child Relations
=550  \\$wh$aMaternal-Fetal Relations
=667  \\$ahuman only
=680  \\$iInteraction between a mother and child.
=688  \\$a68
=750  \0$aMother and child$5IEN$0(DLC)sh 85087517

=LDR  01166cz  a2200253n  4500
=001  9880363611702441
=005  20200428114635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009033
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x750.$x712.$x500.$x875
=150  \\$aCulicidae
=450  \\$wnnna$aMosquito
=450  \\$aMosquitoes
=450  \\$wnnna$aMosquitos
=550  \\$wg$aCulicomorpha
=550  \\$wh$aAedes
=550  \\$wh$aAnopheles
=550  \\$wh$aCulex
=550  \\$wh$aOchlerotatus
=667  \\$ado not confuse with CULICOIDES (see CERATOPOGONIDAE); general: prefer specifics; for killing Culicidae with insecticides, see note at INSECTICIDES; mosquito bites = CULICIDAE or specific genus (IM) + INSECT BITES AND STINGS (IM)
=680  \\$iA family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic wing venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.
=688  \\$a95; was MOSQUITOES 1963-94
=750  \0$aMosquitoes$5IEN$0(DLC)sh 85087477

=LDR  00710cz  a2200193n  4500
=001  9880363611802441
=005  20141212203602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009032
=035  \\$aCBA2289HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650.$x425.$x500
=150  \\$aMosquito Control
=450  \\$wnnna$aControl, Mosquito
=550  \\$wg$aInsect Control
=667  \\$acoord IM with specific mosquito (IM) if pertinent
=680  \\$iThe reduction or regulation of the population of mosquitoes through chemical, biological, or other means.
=750  \0$aMosquitoes$xControl$5IEN-M$0(DLC)sh 85087479
=750  \0$aMosquitoes$xBiological control$5IEN-HS$0(DLC)sh2010001999

=LDR  00686cz  a2200181n  4500
=001  9880363611902441
=005  20141212203601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009030
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365.$x590.$x175.$x595
=150  \\$aMosaicism
=550  \\$wg$aChromosome Aberrations
=550  \\$aChimera
=550  \\$aChimerism
=680  \\$iThe occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
=688  \\$a67(64)
=750  \0$aMosaicism$0(DLC) sh 85087417$5IEN

=LDR  00984cz  a2200313n  4500
=001  9880363612002441
=005  20141212192334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009029
=035  \\$aCBA2286M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x464
=150  \\$aMosaic Viruses
=450  \\$wnnna$aMosaic Virus
=450  \\$wnnna$aVirus, Mosaic
=450  \\$wnnna$aViruses, Mosaic
=550  \\$wg$aPlant Viruses
=550  \\$wh$aAlfamovirus
=550  \\$wh$aBromovirus
=550  \\$wh$aCaulimovirus
=550  \\$wh$aComovirus
=550  \\$wh$aCucumovirus
=550  \\$wh$aPotyvirus
=550  \\$wh$aTobamovirus
=550  \\$wh$aTymovirus
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific plant / virol (IM or NIM)
=680  \\$iViruses which produce a mottled appearance of the leaves of plants.
=688  \\$a79(73); was see under PLANT VIRUSES 1975-78
=750  \0$aMosaic viruses$0(DLC)sh2007002831$5IEN-M

=LDR  00804cz  a2200241n  4500
=001  9880363612102441
=005  20141212203601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009027
=035  \\$aCBA2284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x438
=150  \\$aMortuary Practice
=450  \\$wnnna$aMortuary Practices
=450  \\$wnnna$aPractice, Mortuary
=450  \\$wnnna$aPractices, Mortuary
=450  \\$aUndertaking
=450  \\$wnnna$aUndertakings
=550  \\$wg$aHealth Occupations
=550  \\$aDeath
=680  \\$iActivities associated with the disposition of the dead. It excludes cultural practices such as funeral rites.
=688  \\$aCEMETERIES & CREMATION were see under MORTUARY PRACTICE 1963-78
=750  \0$aUndertakers and undertaking$5IEN$0(DLC)sh 85139607

=LDR  02898cz  a2200793n  4500
=001  9880363612202441
=005  20141212203600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009026
=035  \\$aCBA2283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550
=072  \\$aL1.$x280.$x975.$x550
=072  \\$aN1.$x224.$x935.$x698
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550
=150  \\$aMortality
=450  \\$wnnna$aAge Specific Death Rate
=450  \\$wnnna$aAge-Specific Death Rate
=450  \\$wnnna$aAge-Specific Death Rates
=450  \\$wnnna$aCase Fatality Rate
=450  \\$wnnna$aCase Fatality Rates
=450  \\$aDeath Rate
=450  \\$wnnna$aDeath Rate, Age-Specific
=450  \\$wnnna$aDeath Rates
=450  \\$wnnna$aDeath Rates, Age-Specific
=450  \\$wnnna$aDecline, Mortality
=450  \\$wnnna$aDeclines, Mortality
=450  \\$wnnna$aDeterminant, Mortality
=450  \\$wnnna$aDeterminants, Mortality
=450  \\$wnnna$aDifferential Mortalities
=450  \\$wnnna$aDifferential Mortality
=450  \\$aDisease$xmortality
=450  \\$wnnna$aExcess Mortalities
=450  \\$wnnna$aExcess Mortality
=450  \\$wnnna$aMortalities
=450  \\$wnnna$aMortalities, Differential
=450  \\$wnnna$aMortalities, Excess
=450  \\$wnnna$aMortality Decline
=450  \\$wnnna$aMortality Declines
=450  \\$wnnna$aMortality Determinant
=450  \\$wnnna$aMortality Determinants
=450  \\$wnnna$aMortality, Differential
=450  \\$wnnna$aMortality, Excess
=450  \\$wnnna$aMortality Rate
=450  \\$wnnna$aMortality Rates
=450  \\$wnnna$aRate, Age-Specific Death
=450  \\$wnnna$aRate, Case Fatality
=450  \\$wnnna$aRate, Death
=450  \\$wnnna$aRate, Mortality
=450  \\$wnnna$aRates, Age-Specific Death
=450  \\$wnnna$aRates, Case Fatality
=450  \\$wnnna$aRates, Death
=450  \\$wnnna$aRates, Mortality
=550  \\$wg$aVital Statistics
=550  \\$wh$aCause of Death
=550  \\$wh$aChild Mortality
=550  \\$wh$aFatal Outcome
=550  \\$wh$aFetal Mortality
=550  \\$wh$aHospital Mortality
=550  \\$wh$aInfant Mortality
=550  \\$wh$aMaternal Mortality
=550  \\$wh$aMortality, Premature
=550  \\$wh$aPerinatal Mortality
=550  \\$wh$aSurvival Rate
=667  \\$ahuman & animal; a statistical concept, not for individual deaths in case reports ( = FATAL OUTCOME); do not confuse with DEATH, the biological, physiological or psychological concept; IM general only; prefer / mortal with diseases: Manual 19.7+, 19.8.47; specify geographic term if pertinent
=680  \\$iAll deaths reported in a given population.
=688  \\$a1963; for MORTALITY, PREMATURE use INFANT MORTALITY 1995-2004
=750  \0$aMortality$0(DLC) sh 85087372$5IEN

=LDR  00766cz  a2200289n  4500
=001  9880363612302441
=005  20171012133714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009025
=035  \\$aCBA2282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x533.$x640
=150  \\$aMorpholines
=450  \\$aFominoben$5IEN-M
=450  \\$aTetrahydro-1,4-Oxazines
=450  \\$wnnna$aTetrahydro 1,4 Oxazines
=550  \\$wg$aOxazines
=550  \\$wh$aDextromoramide
=550  \\$wh$aMolsidomine
=550  \\$wh$aMoricizine
=550  \\$wh$aMorpholinos
=550  \\$wh$aPhenmetrazine
=550  \\$wh$aRivaroxaban
=550  \\$wh$aTimolol
=550  \\$wh$aViloxazine
=550  \\$wh$aXamoterol
=750  \0$aMorpholine$0(DLC)sh2008020245$5IEN-M

=LDR  00847cz  a2200229n  4500
=001  9880363612402441
=005  20141212203559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009024
=035  \\$aCBA2281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500
=150  \\$aMorphogenesis
=550  \\$wg$aGrowth and Development
=550  \\$wh$aBody Patterning
=550  \\$wh$aEmbryonic and Fetal Development
=550  \\$wh$aMetamorphosis, Biological
=550  \\$aEpigenesis, Genetic
=667  \\$acoordinate with specific organ or organism / embryol or /growth
=680  \\$iThe development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.
=688  \\$a72(68)
=750  \0$aMorphogenesis$5IEN$0(DLC)sh 85087346

=LDR  00846cz  a2200265n  4500
=001  9880363612502441
=005  20141212203558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009021
=035  \\$aCBA2278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x675.$x600
=072  \\$aF3.$x900.$x675.$x600
=150  \\$aMorphine Dependence
=450  \\$wnnna$aAbuse, Morphine
=450  \\$wnnna$aAddiction, Morphine
=450  \\$wnnna$aDependence, Morphine
=450  \\$aMorphine Abuse
=450  \\$aMorphine Addiction
=450  \\$aMorphine Habit$5IEN
=550  \\$wg$aOpioid-Related Disorders
=667  \\$aHEROIN DEPENDENCE is also available
=680  \\$iStrong dependence, both physiological and emotional, upon morphine.
=688  \\$a81; was MORPHINE ADDICTION 1963-80
=750  \0$aMorphine abuse$5IEN$0(DLC)sh 85087343

=LDR  01430cz  a2200421n  4500
=001  9880363612602441
=005  20141212203558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009020
=035  \\$aCBA2277HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x562.$x571
=072  \\$aD3.$x549.$x686.$x607.$x587
=072  \\$aD3.$x605.$x497.$x607.$x587
=072  \\$aD4.$x615.$x723.$x795.$x576.$x571
=150  \\$aMorphine
=450  \\$wnnna$aChloride, Morphine
=450  \\$wnnna$aContin, MS
=450  \\$wnnna$aDuramorph
=450  \\$wnnna$aMorphia
=450  \\$wnnna$aMorphine Chloride
=450  \\$aMorphine Sulfate
=450  \\$wnnna$aMorphine Sulfate (2:1), Anhydrous
=450  \\$wnnna$aMorphine Sulfate (2:1), Pentahydrate
=450  \\$wnnna$aMS Contin
=450  \\$wnnna$aOramorph SR
=450  \\$wnnna$aSDZ 202-250
=450  \\$wnnna$aSDZ 202 250
=450  \\$wnnna$aSDZ 202250
=450  \\$wnnna$aSDZ202-250
=450  \\$wnnna$aSDZ202 250
=450  \\$wnnna$aSDZ202250
=450  \\$wnnna$aSulfate, Morphine
=550  \\$wg$aMorphine Derivatives
=667  \\$a/analogs = MORPHINE DERIVATIVES
=680  \\$iThe principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
=688  \\$aMORPHINE SULFATE was (NM) 1980-96
=750  \0$aMorphine$5IEN$0(DLC)sh 85087342

=LDR  00901cz  a2200265n  4500
=001  9880363612702441
=005  20141212203557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009017
=035  \\$aCBA2274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x525
=072  \\$aL1.$x280.$x975.$x525
=072  \\$aN1.$x224.$x935.$x597
=072  \\$aN6.$x850.$x505.$x400.$x975.$x525
=072  \\$aN6.$x850.$x520.$x308.$x985.$x525
=150  \\$aMorbidity
=450  \\$wnnna$aMorbidities
=550  \\$wg$aVital Statistics
=550  \\$wh$aBasic Reproduction Number
=550  \\$wh$aIncidence
=550  \\$wh$aPrevalence
=667  \\$aIM GEN only; coord NIM with disease /epidemiol (IM); specify geog if possible
=680  \\$iThe proportion of patients with a particular disease during a given year per given unit of population.
=750  \0$aDiseases$5IEN$0(DLC)sh 85038411

=LDR  00780cz  a2200205n  4500
=001  9880363612802441
=005  20141212203458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008833
=035  \\$aCBA2084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x645
=150  \\$aMicrocirculation
=450  \\$aMicrocirculation Disorders$5IEN
=550  \\$wg$aBlood Circulation
=667  \\$acoordinate with specific organ / blood supply; not for lymphatic microcirculation ( = LYMPHATIC SYSTEM / physiol); DF: MICROCIRC
=680  \\$iThe circulation of the BLOOD through the MICROVASCULAR NETWORK.
=688  \\$a72(70)
=750  \0$aMicrocirculation disorders$5IEN-M$0(DLC)sh 88005549
=750  \0$aMicrocirculation$0(DLC) sh 85084802$5IEN-HS$0(DLC)sh 85084802

=LDR  00760cz  a2200217n  4500
=001  9880363612902441
=005  20141212203458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008832
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x620
=072  \\$aH1.$x181.$x650
=150  \\$aMicrochemistry
=550  \\$wg$aChemistry
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$aBiosensing Techniques
=550  \\$aLab-On-A-Chip Devices
=550  \\$aMiniaturization
=550  \\$aNanotechnology
=680  \\$iThe development and use of techniques and equipment to study or perform chemical reactions, with small quantities of materials, frequently less than a milligram or a milliliter.
=750  \0$aMicrochemistry$5IEN$0(DLC)sh 85084800

=LDR  01264cz  a2200325n  4500
=001  9880363613002441
=005  20141212192328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008831
=035  \\$aCBA2082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x660.$x207.$x620
=072  \\$aC10.$x500.$x507.$x400.$x500
=072  \\$aC16.$x131.$x621.$x207.$x620
=072  \\$aC16.$x131.$x666.$x507.$x400.$x500
=150  \\$aMicrocephaly
=450  \\$wnnna$aCongenital Microcephalies, Severe
=450  \\$wnnna$aCongenital Microcephaly, Severe
=450  \\$wnnna$aMicrocephalies
=450  \\$wnnna$aMicrocephalies, Severe Congenital
=450  \\$wnnna$aMicrocephaly, Severe Congenital
=450  \\$wnnna$aMicrolissencephalies
=450  \\$aMicrolissencephaly
=450  \\$wnnna$aSevere Congenital Microcephalies
=450  \\$wnnna$aSevere Congenital Microcephaly
=550  \\$wg$aCraniofacial Abnormalities
=550  \\$wg$aMalformations of Cortical Development, Group I
=550  \\$wh$aPorencephaly
=680  \\$iA congenital abnormality in which the CEREBRUM is underdeveloped, the fontanels close prematurely, and, as a result, the head is small. (Desk Reference for Neuroscience, 2nd ed.)
=750  \0$aMicrocephaly$0(DLC) sh 85084798$5IEN

=LDR  00851cz  a2200253n  4500
=001  9880363613102441
=005  20141212203458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008830
=035  \\$aCBA2081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x585
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x755
=150  \\$aMicrobodies
=450  \\$wnnna$aGlycosome
=450  \\$aGlycosomes
=450  \\$wnnna$aMicrobody
=550  \\$wg$aCytoplasmic Granules
=550  \\$wh$aGlyoxysomes
=550  \\$wh$aPeroxisomes
=550  \\$aPeroxisome Proliferators
=680  \\$iElectron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes.
=688  \\$a84(73); was see under ORGANOIDS 1975-83
=750  \0$aMicrobodies$5IEN$0(DLC)sh 85084791

=LDR  01196cz  a2200301n  4500
=001  9880363613202441
=005  20141212203457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008829
=035  \\$aCBA2080HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540
=150  \\$aMicrobiology
=450  \\$aMedical Microbiology$5IEN
=550  \\$wg$aBiology
=550  \\$wh$aBacteriology
=550  \\$wh$aEnvironmental Microbiology
=550  \\$wh$aGenetics, Microbial
=550  \\$wh$aIndustrial Microbiology
=550  \\$wh$aMycology
=550  \\$wh$aPlant Pathology
=550  \\$wh$aVirology
=550  \\$aInfectious Disease Medicine
=667  \\$athe discipline (education, history, etc) only; use MICROBIOLOGICAL PHENOMENA or specifics treed under it for physiologic characteristics and processes of microorganisms, or the qualifier /microbiol with specific anatomical terms, organisms and diseases
=680  \\$iThe study of microorganisms such as fungi, bacteria, algae, archaea, and viruses.
=750  \0$aMedical microbiology$5IEN-M$0(DLC)sh 85082974
=750  \0$aMicroorganisms$5IEN-HS$0(DLC)sh 85084725
=750  \0$aMicrobiology$5IEN-HS$0(DLC)sh 85084783

=LDR  01981cz  a2200505n  4500
=001  9880363613302441
=005  20141212203457.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008828
=035  \\$aCBA2079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875
=072  \\$aE5.$x200.$x875
=150  \\$aMicrobiological Techniques
=450  \\$wnnna$aMicrobiologic Technic
=450  \\$wnnna$aMicrobiologic Technics
=450  \\$wnnna$aMicrobiologic Technique
=450  \\$wnnna$aMicrobiologic Techniques
=450  \\$wnnna$aMicrobiological Technic
=450  \\$wnnna$aMicrobiological Technics
=450  \\$wnnna$aMicrobiological Technique
=450  \\$aMicrobiology$xmethods
=450  \\$wnnna$aTechnic, Microbiologic
=450  \\$wnnna$aTechnic, Microbiological
=450  \\$wnnna$aTechnics, Microbiologic
=450  \\$wnnna$aTechnics, Microbiological
=450  \\$wnnna$aTechnique, Microbiologic
=450  \\$wnnna$aTechnique, Microbiological
=450  \\$wnnna$aTechniques, Microbiologic
=450  \\$wnnna$aTechniques, Microbiological
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wh$aAxenic Culture
=550  \\$wh$aBacteriological Techniques
=550  \\$wh$aColony Count, Microbial
=550  \\$wh$aMicrobial Sensitivity Tests
=550  \\$wh$aMycological Typing Techniques
=550  \\$wh$aSerial Passage
=550  \\$wh$aViral Load
=550  \\$wh$aVirus Cultivation
=550  \\$wh$aVirus Inactivation
=550  \\$wh$aXenodiagnosis
=667  \\$aGEN or unspecified; bacteriologic techniques = BACTERIOLOGICAL TECHNIQUES; virologic techniques = VIROLOGY /methods; mycologic techniques = MYCOLOGY /methods; parasitologic techniques = PARASITOLOGY /methods; do not use /util except by MeSH definition: DF: MICROBIOL TECHNIQUES
=680  \\$iTechniques used in microbiology.
=688  \\$a91; was MICROBIOLOGICAL TECHNICS 1978-90
=750  \0$aMicrobiology$xTechnique$5IEN$0(DLC)sh 85084788

=LDR  02736cz  a2200601n  4500
=001  9880363613402441
=005  20141212203456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008826
=035  \\$aCBA2077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x595
=072  \\$aE5.$x200.$x875.$x595
=072  \\$aE5.$x337.$x550.$x400
=150  \\$aMicrobial Sensitivity Tests
=450  \\$wnnna$aAntibacterial Susceptibility Breakpoint Determination
=450  \\$wnnna$aAntibiogram
=450  \\$wnnna$aAntibiograms
=450  \\$wnnna$aAntimicrobial Susceptibility Breakpoint Determination
=450  \\$wnnna$aBacterial Sensitivity Test
=450  \\$aBacterial Sensitivity Tests
=450  \\$wnnna$aBreakpoint Determination, Antibacterial Susceptibility
=450  \\$wnnna$aBreakpoint Determination, Antimicrobial Susceptibility
=450  \\$wnnna$aConcentration, Minimum Inhibitory
=450  \\$wnnna$aConcentrations, Minimum Inhibitory
=450  \\$aDrug Sensitivity Assay, Microbial
=450  \\$wnnna$aFungal Drug Sensitivity Tests
=450  \\$wnnna$aFungus Drug Sensitivity Tests
=450  \\$wnnna$aInhibitory Concentration, Minimum
=450  \\$wnnna$aInhibitory Concentrations, Minimum
=450  \\$wnnna$aMicrobial Sensitivity Test
=450  \\$aMinimum Inhibitory Concentration
=450  \\$wnnna$aMinimum Inhibitory Concentrations
=450  \\$wnnna$aSensitivity Test, Bacterial
=450  \\$wnnna$aSensitivity Test, Microbial
=450  \\$wnnna$aSensitivity Tests, Bacterial
=450  \\$wnnna$aSensitivity Tests, Microbial
=450  \\$wnnna$aTest, Bacterial Sensitivity
=450  \\$wnnna$aTest, Microbial Sensitivity
=450  \\$wnnna$aTests, Bacterial Sensitivity
=450  \\$wnnna$aTests, Microbial Sensitivity
=450  \\$wnnna$aViral Drug Sensitivity Tests
=450  \\$wnnna$aVirus Drug Sensitivity Tests
=550  \\$wg$aDrug Evaluation, Preclinical
=550  \\$wg$aMicrobiological Techniques
=550  \\$wh$aDisk Diffusion Antimicrobial Tests
=550  \\$wh$aSerum Bactericidal Test
=550  \\$aDrug Resistance, Microbial
=550  \\$aInhibitory Concentration 50
=667  \\$aIM when general; NIM when with specific drug (IM) & specific micro-organisms (IM); note entry term MINIMUM INHIBITORY CONCENTRATION but bactericidal effect of an antimicrobial drug using patient's blood (= SERUM BACTERICIDAL TEST + specific drug); PARASITIC SENSITIVITY TESTS is also available
=680  \\$iAny tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
=688  \\$a70
=750  \0$aMicrobial sensitivity tests$5IEN$0(DLC)sh 85084774

=LDR  01351cz  a2200385n  4500
=001  9880363613502441
=005  20141212192328.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008825
=035  \\$aCBA2076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x550
=150  \\$aMiconazole
=450  \\$wnnna$aBrentan
=450  \\$wnnna$aDactarin
=450  \\$wnnna$aEsteve Brand of Miconazole
=450  \\$wnnna$aJanssen-Cilag Brand of Miconazole
=450  \\$wnnna$aJanssen Cilag Brand of Miconazole
=450  \\$wnnna$aJohnston & Johnston Brand of Miconazole Nitrate
=450  \\$wnnna$aMiconasil Nitrate
=450  \\$wnnna$aMiconazole Esteve Brand
=450  \\$wnnna$aMiconazole Janssen-Cilag Brand
=450  \\$wnnna$aMiconazole Nitrate
=450  \\$wnnna$aMonistat
=450  \\$wnnna$aNitrate, Miconasil
=450  \\$wnnna$aNitrate, Miconazole
=450  \\$wnnna$aR-14,889
=450  \\$wnnna$aR 14,889
=450  \\$wnnna$aR14,889
=550  \\$wg$aImidazoles
=680  \\$iAn imidazole antifungal agent that is used topically and by intravenous infusion.
=688  \\$a1984(1975); for MONISTAT use TIOCONAZOLE (NM) 2004-2010
=688  \\$a1984(1975); for MONSTAT use TIOCONAZOLE (NM) 2004-2010
=688  \\$a84(75); was see under IMIDAZOLES 1975-83
=750  \0$aMiconazole$5IEN$0(DLC)sh 85084719

=LDR  00886cz  a2200205n  4500
=001  9880363613602441
=005  20141212192328.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008823
=035  \\$aCBA2074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x374
=072  \\$aD26.$x255.$x560
=150  \\$aMicelles
=550  \\$wg$aDosage Forms
=550  \\$wg$aMacromolecular Substances
=550  \\$aEmulsions
=680  \\$iParticles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS.
=688  \\$a91(75); was see under COLLOIDS 1975-90
=750  \0$aMicelles$5IEN$0(DLC)sh 85084678

=LDR  01172cz  a2200325n  4500
=001  9880363613702441
=005  20141212203455.0
=008  870508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008822
=035  \\$aCBA2073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x136.$x500
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x500.$x800
=150  \\$aMice, Transgenic
=450  \\$wnnna$aFounder Mice, Transgenic
=450  \\$wnnna$aMice, Transgenic Founder
=450  \\$wnnna$aMouse, Founder, Transgenic
=450  \\$wnnna$aMouse, Transgenic
=450  \\$wnnna$aTransgenic Founder Mice
=450  \\$aTransgenic Mice
=450  \\$wnnna$aTransgenic Mouse
=550  \\$wg$aAnimals, Genetically Modified
=550  \\$wg$aMice
=550  \\$wh$aMice, Knockout
=550  \\$aGenetic Engineering
=550  \\$aMosaicism
=667  \\$aNIM with no qualifiers when experimental animal; check the tag MICE; for transgenic founder mice, coordinate with FOUNDER EFFECT
=680  \\$iLaboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
=688  \\$a88
=750  \0$aTransgenic mice$5IEN$0(DLC)sh 90000185

=LDR  01002cz  a2200265n  4500
=001  9880363613802441
=005  20141212203454.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008819
=035  \\$aCBA2070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x500.$x550.$x500
=150  \\$aMice, Nude
=450  \\$aAthymic Mice
=450  \\$wnnna$aAthymic Mouse
=450  \\$aMice, Athymic
=450  \\$wnnna$aMouse, Athymic
=450  \\$wnnna$aMouse, Nude
=450  \\$aNude Mice
=450  \\$wnnna$aNude Mouse
=550  \\$wg$aMice, Mutant Strains
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted; do not confuse with MICE, HAIRLESS see MICE, INBRED HRS; do not forget also to check tag MICE
=680  \\$iMutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
=688  \\$a75
=750  \0$aNude mouse$5IEN$0(DLC)sh 85093171

=LDR  02174cz  a2200553n  4500
=001  9880363613902441
=005  20141212203452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008815
=035  \\$aCBA2066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x157.$x520
=072  \\$aB1.$x50.$x50.$x199.$x520.$x520
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x500.$x400
=150  \\$aMice, Inbred Strains
=450  \\$wnnna$aInbred Mouse Strain
=450  \\$wnnna$aInbred Mouse Strains
=450  \\$wnnna$aInbred Strain of Mice
=450  \\$wnnna$aInbred Strain of Mouse
=450  \\$wnnna$aInbred Strains of Mice
=450  \\$wnnna$aMouse, Inbred Strain
=450  \\$wnnna$aMouse Inbred Strain
=450  \\$wnnna$aMouse Inbred Strains
=450  \\$wnnna$aMouse Strain, Inbred
=450  \\$wnnna$aMouse Strains, Inbred
=450  \\$wnnna$aStrain, Inbred Mouse
=450  \\$wnnna$aStrains, Inbred Mouse
=550  \\$wg$aAnimals, Inbred Strains
=550  \\$wg$aMice
=550  \\$wh$aMice, 129 Strain
=550  \\$wh$aMice, Hairless
=550  \\$wh$aMice, Inbred A
=550  \\$wh$aMice, Inbred AKR
=550  \\$wh$aMice, Inbred BALB C
=550  \\$wh$aMice, Inbred C3H
=550  \\$wh$aMice, Inbred C57BL
=550  \\$wh$aMice, Inbred CBA
=550  \\$wh$aMice, Inbred CFTR
=550  \\$wh$aMice, Inbred DBA
=550  \\$wh$aMice, Inbred ICR
=550  \\$wh$aMice, Inbred MRL lpr
=550  \\$wh$aMice, Inbred NOD
=550  \\$wh$aMice, Inbred NZB
=550  \\$wh$aMice, Inbred SENCAR
=667  \\$aGEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag MICE; Manual 22.36
=680  \\$iGenetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.
=688  \\$a72
=750  \0$81$wb$aInbreeding$5IEN$0(DLC)sh 85064709
=750  \0$81$wb$aMice$5IEN-HS$0(DLC)sh 85084671

=LDR  01217cz  a2200373n  4500
=001  9880363614002441
=005  20141212203447.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008801
=035  \\$aCBA2052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x831.$x500
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x675
=150  \\$aMexiletine
=450  \\$wnnna$aBoehringer Ingelheim Brand of Mexiletine Hydrochloride
=450  \\$wnnna$aKO-1173
=450  \\$wnnna$aKO 1173
=450  \\$wnnna$aKO1173
=450  \\$wnnna$aKOE-1173
=450  \\$wnnna$aKOE 1173
=450  \\$wnnna$aKOE1173
=450  \\$wnnna$aMexiletene
=450  \\$wnnna$aMexiletine Hydrochloride
=450  \\$wnnna$aMexitil
=450  \\$wnnna$aMexitil PL
=450  \\$wnnna$aMexityl
=450  \\$wnnna$aNovo-Mexiletine
=450  \\$wnnna$aNovo Mexiletine
=450  \\$wnnna$aNovopharm Brand of Mexiletine Hydrochloride
=550  \\$wg$aPhenyl Ethers
=550  \\$wg$aPropylamines
=680  \\$iAntiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
=688  \\$a87(75); was see under PROPYLAMINES 1975-86
=750  \0$aMexiletine$5IEN$0(DLC)sh 85084629

=LDR  00963cz  a2200217n  4500
=001  9880363614102441
=005  20141212203447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008799
=035  \\$aCBA2050M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x501
=150  \\$aMevinphos
=450  \\$wnnna$aFosdrin
=450  \\$wnnna$aFosdrine
=450  \\$wnnna$aPhosdrin
=550  \\$wg$aOrganophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organophosphate cholinesterase inhibitor that is used as an insecticide.
=688  \\$a91(73); was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90
=750  \0$aMevinphos$5IEN-M$0(DLC)sh 98007807

=LDR  00451cz  a2200169n  4500
=001  9880363614202441
=005  20141212203446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008798
=035  \\$aCBA2049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x511.$x579
=150  \\$aMevalonic Acid
=450  \\$wnnna$aAcid, Mevalonic
=450  \\$wnnna$aMevalonate
=550  \\$wg$aHydroxy Acids
=750  \0$aMevalonic acid$5IEN$0(DLC)sh 85084470

=LDR  01781cz  a2200469n  4500
=001  9880363614302441
=005  20141212203446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008795
=035  \\$aCBA2046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x672.$x500
=072  \\$aD3.$x383.$x129.$x308.$x658.$x500
=150  \\$aMetronidazole
=450  \\$wnnna$a2-Methyl-5-nitroimidazole-1-ethanol
=450  \\$wnnna$a2 Methyl 5 nitroimidazole 1 ethanol
=450  \\$wnnna$aBayer 5360
=450  \\$wnnna$aClont
=450  \\$wnnna$aDanizol
=450  \\$wnnna$aFlagyl
=450  \\$wnnna$aGineflavir
=450  \\$wnnna$aHydrochloride, Metronidazole
=450  \\$wnnna$aMetric
=450  \\$wnnna$aMetrodzhil
=450  \\$wnnna$aMetroGel
=450  \\$wnnna$aMetrogyl
=450  \\$wnnna$aMetronidazole Hydrochloride
=450  \\$wnnna$aMetronidazole Monohydrochloride
=450  \\$wnnna$aMetronidazole Phosphate
=450  \\$wnnna$aMetronidazole Phosphoester
=450  \\$wnnna$aMonohydrochloride, Metronidazole
=450  \\$wnnna$aPhosphate, Metronidazole
=450  \\$wnnna$aPhosphoester, Metronidazole
=450  \\$wnnna$aSatric
=450  \\$wnnna$aTrichazol
=450  \\$wnnna$aTrichopol
=450  \\$wnnna$aTrivazol
=450  \\$wnnna$aVagilen
=550  \\$wg$aNitroimidazoles
=680  \\$iA nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed).
=688  \\$a64
=750  \0$aMetronidazole$5IEN$0(DLC)sh 85084449

=LDR  00864cz  a2200229n  4500
=001  9880363614402441
=005  20141212203445.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008793
=035  \\$aCBA2044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x400.$x880.$x520
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x375.$x880.$x520
=072  \\$aD9.$x408.$x51.$x545
=150  \\$aMetrizamide
=450  \\$wnnna$aAmipak
=450  \\$wnnna$aAmipaque
=550  \\$wg$aAminoglycosides
=550  \\$wg$aTriiodobenzoic Acids
=680  \\$iA solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.
=688  \\$a78(75); was see under IODOBENZOATES 1975-77
=750  \0$aMetrizamide$5IEN$0(DLC)sh 85084446

=LDR  00868cz  a2200205n  4500
=001  9880363614502441
=005  20141212203445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008792
=035  \\$aCBA2043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x978.$x539
=150  \\$aMetric System
=450  \\$wnnna$aMetric Systems
=450  \\$wnnna$aSystem, Metric
=450  \\$wnnna$aSystems, Metric
=550  \\$wg$aWeights and Measures
=680  \\$iA system of units used in scientific work throughout the world and employed in general commercial transactions and engineering applications. Its units of length, time, and mass are the meter, second, and kilogram respectively, or decimal multiples and submultiples thereof. ( McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a74
=750  \0$aMetric system$5IEN$0(DLC)sh 85084442

=LDR  00698cz  a2200217n  4500
=001  9880363614602441
=005  20141212203444.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008791
=035  \\$aCBA2042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x600
=150  \\$aMetrial Gland
=450  \\$wnnna$aGland, Metrial
=450  \\$wnnna$aGlands, Metrial
=450  \\$wnnna$aMetrial Glands
=550  \\$wg$aAnimal Structures
=667  \\$afemale; animal only
=680  \\$iCollection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals.
=688  \\$a75
=750  \0$aMetrial gland$5IEN$0(DLC)sh 88006473

=LDR  01739cz  a2200517n  4500
=001  9880363614702441
=005  20141212203444.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008790
=035  \\$aCBA2041HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x573
=072  \\$aD2.$x33.$x755.$x624.$x550
=072  \\$aD2.$x33.$x755.$x624.$x698.$x573
=072  \\$aD2.$x92.$x63.$x624.$x698.$x573
=150  \\$aMetoprolol
=450  \\$wnnna$aAstraZeneca Brand of Metaoprolol Tartrate
=450  \\$wnnna$aAstraZeneca Brand of Seloken
=450  \\$wnnna$aBeloc-Duriles
=450  \\$wnnna$aBeloc Duriles
=450  \\$wnnna$aBelocDuriles
=450  \\$wnnna$aBetaloc
=450  \\$wnnna$aBetaloc-Astra
=450  \\$wnnna$aBetaloc Astra
=450  \\$wnnna$aBetalocAstra
=450  \\$wnnna$aBetalok
=450  \\$wnnna$aCGP-2175
=450  \\$wnnna$aCGP 2175
=450  \\$wnnna$aCGP2175
=450  \\$wnnna$aH 93-26
=450  \\$wnnna$aH 93 26
=450  \\$wnnna$aH 9326
=450  \\$wnnna$aLeiras Brand of Metoprolol Succinate or Metoprolol Tartrate
=450  \\$wnnna$aLopressor
=450  \\$wnnna$aMetoprolol Tartrate
=450  \\$wnnna$aNovartis Brand of Metprolol Tartrate
=450  \\$wnnna$aSeloken
=450  \\$wnnna$aSeloken AstraZeneca Brand
=450  \\$wnnna$aSpesicor
=450  \\$wnnna$aSpesikor
=450  \\$wnnna$aTartrate, Metoprolol
=550  \\$wg$aPhenoxypropanolamines
=550  \\$wg$aPropanolamines
=680  \\$iA selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
=688  \\$a84(77); was see under PROPANOLAMINES 1977-83
=750  \0$aMetoprolol$5IEN$0(DLC)sh 85084438

=LDR  01467cz  a2200361n  4500
=001  9880363614802441
=005  20141212203442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008780
=035  \\$aCBA2031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x555.$x500
=150  \\$aMethyltransferases
=550  \\$wg$aOne-Carbon Group Transferases
=550  \\$wh$a5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
=550  \\$wh$aAcetylserotonin O-Methyltransferase
=550  \\$wh$aBetaine-Homocysteine S-Methyltransferase
=550  \\$wh$aCatechol O-Methyltransferase
=550  \\$wh$aDNA Modification Methylases
=550  \\$wh$aGlycine N-Methyltransferase
=550  \\$wh$aGuanidinoacetate N-Methyltransferase
=550  \\$wh$aHistamine N-Methyltransferase
=550  \\$wh$aHomocysteine S-Methyltransferase
=550  \\$wh$aNicotinamide N-Methyltransferase
=550  \\$wh$aPhenylethanolamine N-Methyltransferase
=550  \\$wh$aPhosphatidyl-N-Methylethanolamine N-Methyltransferase
=550  \\$wh$aPhosphatidylethanolamine N-Methyltransferase
=550  \\$wh$aProtein Methyltransferases
=550  \\$wh$aThymidylate Synthase
=550  \\$wh$atRNA Methyltransferases
=680  \\$iA subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1.
=688  \\$a72(71)
=750  \0$aMethyltransferases$5IEN$0(DLC)sh 85084428

=LDR  01680cz  a2200433n  4500
=001  9880363614902441
=005  20141212192326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008774
=035  \\$aCBA2025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x601.$x600
=072  \\$aD3.$x383.$x621.$x460
=150  \\$aMethylphenidate
=450  \\$wnnna$aCelltech Brand of Methylphenidate Hydrochloride
=450  \\$wnnna$aCentedrin
=450  \\$wnnna$aCephalon Brand of Methylphenidate Hydrochloride
=450  \\$wnnna$aConcerta
=450  \\$wnnna$aDaytrana
=450  \\$wnnna$aEquasym
=450  \\$wnnna$aHydrochloride, Methylphenidate
=450  \\$wnnna$aMallinckrodt Brand of Methylphenidate Hydrochloride
=450  \\$wnnna$aMetadate
=450  \\$wnnna$aMethylin
=450  \\$wnnna$aMethylphenidate Hydrochloride
=450  \\$wnnna$aNovartis Brand 1 of Methylphenidate Hydrochloride
=450  \\$wnnna$aNovartis Brand 2 of Methylphenidate Hydrochloride
=450  \\$wnnna$aPhenidylate
=450  \\$wnnna$aRitalin
=450  \\$wnnna$aRitalin-SR
=450  \\$wnnna$aRitalin SR
=450  \\$wnnna$aRitaline
=450  \\$wnnna$aTsentedrin
=550  \\$wg$aPhenylacetates
=550  \\$wg$aPiperidines
=550  \\$wh$aDexmethylphenidate
=680  \\$iA central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE.
=688  \\$aPHENIDYLATE was see METHYLPHENIDATE 1978-94
=750  \0$aMethylphenidate$5IEN-M$0(DLC)sh 91001552

=LDR  00975cz  a2200277n  4500
=001  9880363615002441
=005  20141212203439.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008772
=035  \\$aCBA2023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x500
=072  \\$aB3.$x660.$x250.$x500
=150  \\$aMethylococcaceae
=450  \\$wnnna$aMethane Oxidizing Bacteria
=450  \\$aMethane-Oxidizing Bacteria
=450  \\$aMethanomonadaceae
=450  \\$wnnna$aMethylmonadaceae
=450  \\$aMethylomonadaceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aMethylococcus
=550  \\$wh$aMethylomonas
=680  \\$iA family of gram-negative, aerobic bacteria utilizing only one-carbon organic compounds and isolated from in soil and water.
=688  \\$a92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975
=750  \0$aMethylomonadaceae$5IEN-M$0(DLC)sh 85084426

=LDR  00987cz  a2200241n  4500
=001  9880363615102441
=005  20141212203438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008768
=035  \\$aCBA2019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x69.$x800.$x550
=072  \\$aD5.$x750.$x716.$x822.$x111.$x650.$x605
=072  \\$aD25.$x720.$x716.$x822.$x111.$x650.$x605
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x111.$x650.$x605
=150  \\$aMethylmethacrylates
=550  \\$wg$aPolymethacrylic Acids
=550  \\$wh$aMethylmethacrylate
=550  \\$wh$aPolymethyl Methacrylate
=667  \\$aD25-26 qualif
=680  \\$iThe methyl esters of methacrylic acid that polymerize easily and are used as tissue cements, dental materials, and absorbent for biological substances.
=688  \\$a83; was METHYLMETHACRYLATE 1972-82 (Prov 1972), was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72
=750  \0$aPolymethylmethacrylate$5IEN$0(DLC)sh 89000009

=LDR  00780cz  a2200229n  4500
=001  9880363615202441
=005  20141212203437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008767
=035  \\$aCBA2018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x750.$x100.$x738
=150  \\$aMethylmercury Compounds
=450  \\$wnnna$aCompounds, Methyl Mercury
=450  \\$wnnna$aCompounds, Methylmercury
=450  \\$wnnna$aMercury Compounds, Methyl
=450  \\$aMethyl Mercury Compounds
=550  \\$wg$aAlkylmercury Compounds
=667  \\$aDF: METHYLMERCURY CPDS
=680  \\$iOrganic compounds in which mercury is attached to a methyl group.
=688  \\$a80; was METHYL MERCURY COMPOUNDS 1972-79 (Prov 1972-73)
=750  \0$aMethylmercury$5IEN$0(DLC)sh 87000667

=LDR  01002cz  a2200265n  4500
=001  9880363615302441
=005  20141212203434.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008752
=035  \\$aCBA2003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x642
=150  \\$aMethylene Chloride
=450  \\$wnnna$aBichloride, Methylene
=450  \\$wnnna$aChloride, Methylene
=450  \\$wnnna$aDichloride, Methylene
=450  \\$aDichloromethane
=450  \\$aMethylene Bichloride
=450  \\$aMethylene Dichloride
=450  \\$wnnna$aSolaesthin
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$ado not confuse with METHYL CHLORIDE
=680  \\$iA chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology.
=688  \\$a91(75); was see under HYDROCARBONS, CHLORINATED 1975-90
=750  \0$aDichloromethane$5IEN$0(DLC)sh 86002590

=LDR  01142cz  a2200289n  4500
=001  9880363615402441
=005  20141212203434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008751
=035  \\$aCBA2002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x369.$x517
=072  \\$aD3.$x494.$x741.$x517
=150  \\$aMethylene Blue
=450  \\$wnnna$aBlue, Methylene
=450  \\$wnnna$aBlue N, Methylene
=450  \\$wnnna$aBlue, Swiss
=450  \\$wnnna$aChromosmon
=450  \\$wnnna$aMethylene Blue N
=450  \\$aMethylthionine Chloride
=450  \\$wnnna$aMethylthioninium Chloride
=450  \\$wnnna$aN, Methylene Blue
=450  \\$aSwiss Blue
=450  \\$wnnna$aUrolene Blue
=550  \\$wg$aPhenothiazines
=680  \\$iA compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.
=750  \0$aMethylene blue$5IEN$0(DLC)sh 85084425

=LDR  01054cz  a2200253n  4500
=001  9880363615502441
=005  20141212203432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008745
=035  \\$aCBA1996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x29.$x538
=072  \\$aG2.$x149.$x115.$x29.$x538
=072  \\$aG2.$x149.$x465.$x40.$x538
=072  \\$aG2.$x607.$x750.$x40.$x538
=072  \\$aG3.$x495.$x130.$x538
=150  \\$aMethylation
=450  \\$wnnna$aMethylations
=550  \\$wg$aAlkylation
=550  \\$wh$aDNA Methylation
=667  \\$aalmost never IM; enzymatic methylation: coord NIM with METHYLTRANSFERASES (IM) + substrate (NIM) or specific methyltransferase (IM); DNA METHYLATION is also available
=680  \\$iAddition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed)
=688  \\$a68
=750  \0$aMethylation$5IEN$0(DLC)sh 85084424

=LDR  00419cz  a2200169n  4500
=001  9880363615602441
=005  20141212203432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008744
=035  \\$aCBA1995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x668
=150  \\$aMethylamines
=550  \\$wg$aAmines
=550  \\$wh$aDimethylamines
=688  \\$a73(71)
=750  \0$aMethylamines$5IEN$0(DLC)sh 85084423

=LDR  01173cz  a2200289n  4500
=001  9880363615702441
=005  20141212203431.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008741
=035  \\$aCBA1992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x100.$x50.$x500.$x500
=072  \\$aD2.$x886.$x645.$x600.$x55.$x50.$x510.$x500
=150  \\$aMethyl Methanesulfonate
=450  \\$wnnna$aDimethylsulfonate
=450  \\$wnnna$aMesilate, Methyl
=450  \\$wnnna$aMesylate, Methyl
=450  \\$wnnna$aMethanesulfonate, Methyl
=450  \\$wnnna$aMethyl Mesilate
=450  \\$wnnna$aMethyl Mesylate
=450  \\$wnnna$aMethyl Methylenesulfonate
=450  \\$wnnna$aMethylmesilate
=450  \\$aMethylmethane Sulfonate
=550  \\$wg$aMesylates
=680  \\$iAn alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.
=688  \\$a80(75); was see under METHANESULFONATES 1975-79; MESILATE, METHYL & METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93
=750  \0$aMethyl methanesulfonate$5IEN-M$0(DLC)sh 93006921

=LDR  00770cz  a2200265n  4500
=001  9880363615802441
=005  20141212203431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008738
=035  \\$aCBA1989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601
=150  \\$aMethyl Ethers
=450  \\$aChloromethyl Methyl Ether$5IEN
=450  \\$wnnna$aEthers, Methyl
=550  \\$wg$aEthers
=550  \\$wh$aAnisoles
=550  \\$wh$aBis(Chloromethyl) Ether
=550  \\$wh$aEnflurane
=550  \\$wh$aGuaiacol
=550  \\$wh$aIsoflurane
=550  \\$wh$aMethoxyflurane
=680  \\$iA group of compounds that contain the general formula R-OCH3.
=688  \\$a74; was METHYL ETHER 1972-73 (Prov)
=750  \0$aMethyl ether$5IEN$0(DLC)sh 85084420

=LDR  00737cz  a2200193n  4500
=001  9880363615902441
=005  20141212203430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008737
=035  \\$aCBA1988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x632
=150  \\$aMethyl Chloride
=450  \\$wnnna$aChloride, Methyl
=450  \\$wnnna$aChloromethane
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$ado not confuse with METHYLENE CHLORIDE
=680  \\$iA hydrocarbon used as an industrial solvent. It has been used as an aerosal propellent, as a refrigerant and as a local anesthetic. (From Martindale, The Extra Pharmacopoeia, 31st ed, p1403)
=750  \0$aMethyl chloride$5IEN$0(DLC)sh 93000117

=LDR  01427cz  a2200325n  4500
=001  9880363616002441
=005  20141212203430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008734
=035  \\$aCBA1986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250.$x610
=150  \\$aMethoxyhydroxyphenylglycol
=450  \\$wnnna$a4-Hydroxy-3-methoxyphenylethylene Glycol
=450  \\$wnnna$a4 Hydroxy 3 methoxyphenylethylene Glycol
=450  \\$wnnna$a4-Hydroxy-3-methoxyphenylethyleneglycol
=450  \\$wnnna$a4 Hydroxy 3 methoxyphenylethyleneglycol
=450  \\$wnnna$a4-Hydroxy-3-methoxyphenylglycol
=450  \\$wnnna$a4 Hydroxy 3 methoxyphenylglycol
=450  \\$aHydroxymethoxyphenylglycol
=450  \\$wnnna$aMethoxyhydroxyphenylglycol, (+)-Isomer
=450  \\$wnnna$aMethoxyhydroxyphenylglycol, (+-)-Isomer
=450  \\$wnnna$aMethoxyhydroxyphenylglycol, (-)-Isomer
=450  \\$aMHPG
=450  \\$aMOPEG
=450  \\$aVanylglycol
=550  \\$wg$aEthylene Glycols
=680  \\$iSynthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover.
=688  \\$a91(77); was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76; was METHOXYHYDROXYPHENYL GLYCOL 1973-74 (Prov)
=750  \0$aMethoxyhydroxyphenylglycol$5IEN$0(DLC)sh 85084419

=LDR  00987cz  a2200241n  4500
=001  9880363616102441
=005  20141212203429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008733
=035  \\$aCBA1985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x417.$x600
=072  \\$aD2.$x355.$x601.$x620
=150  \\$aMethoxyflurane
=450  \\$wnnna$aAnecotan
=450  \\$aMethofluranum
=450  \\$wnnna$aPenthrane
=450  \\$wnnna$aPentrane
=550  \\$wg$aEthyl Ethers
=550  \\$wg$aMethyl Ethers
=680  \\$iAn inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)
=688  \\$a65(63)
=750  \0$aPenthrane$5IEN$0(DLC)sh 85099643

=LDR  00704cz  a2200229n  4500
=001  9880363616202441
=005  20141212203428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008731
=035  \\$aCBA1983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x610
=150  \\$aMethoxychlor
=450  \\$aDianisyl Trichloroethane
=450  \\$wnnna$aDMDT
=450  \\$wnnna$aMetox
=450  \\$wnnna$aTrichloroethane, Dianisyl
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iAn insecticide. Methoxychlor has estrogenic effects in mammals, among other effects.
=688  \\$a74(72)
=750  \0$aMethoxychlor$5IEN$0(DLC)sh 87006753

=LDR  01164cz  a2200301n  4500
=001  9880363616302441
=005  20141212203428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008727
=035  \\$aCBA1979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x631.$x192.$x500
=150  \\$aMethotrexate
=450  \\$aAmethopterin
=450  \\$wnnna$aDicesium Salt Methotrexate
=450  \\$wnnna$aHydrate, Methotrexate
=450  \\$wnnna$aMethotrexate, (D)-Isomer
=450  \\$wnnna$aMethotrexate, Dicesium Salt
=450  \\$wnnna$aMethotrexate, Disodium Salt
=450  \\$wnnna$aMethotrexate, (DL)-Isomer
=450  \\$wnnna$aMethotrexate Hydrate
=450  \\$wnnna$aMethotrexate Sodium
=450  \\$wnnna$aMethotrexate, Sodium Salt
=450  \\$wnnna$aMexate
=450  \\$wnnna$aSodium, Methotrexate
=550  \\$wg$aAminopterin
=680  \\$iAn antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
=750  \0$aMethotrexate$5IEN$0(DLC)sh 85084418

=LDR  00746cz  a2200241n  4500
=001  9880363616402441
=005  20141212203427.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008724
=035  \\$aCBA1976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x525
=072  \\$aD2.$x886.$x706.$x537
=150  \\$aMethomyl
=450  \\$wnnna$a20, Lannate
=450  \\$wnnna$aLannate
=450  \\$wnnna$aLannate 20
=550  \\$wg$aCarbamates
=550  \\$wg$aThiocarbamates
=667  \\$afor effect on insects, see note at INSECTICIDES
=680  \\$iA carbamate insecticide with anticholinesterase activity.
=688  \\$a91(75); was see under INSECTICIDES, CARBAMATE 1975-90
=750  \0$aMethomyl$5IEN$0(DLC)sh 85084417

=LDR  00844cz  a2200265n  4500
=001  9880363616502441
=005  20141212203426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008722
=035  \\$aCBA1974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x581
=150  \\$aMethods
=450  \\$wnnna$aMethodological Studies
=450  \\$wnnna$aMethodological Study
=450  \\$wnnna$aProcedure
=450  \\$wnnna$aProcedures
=450  \\$wnnna$aStudies, Methodological
=450  \\$wnnna$aStudy, Methodological
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aObservation
=550  \\$wh$aResearch Design
=667  \\$aprefer / methods (Manual 19.7+) with techniques, procedures or programs; policy: Manual 19.8.45
=688  \\$a91(67); was see under SCIENCE 1967-90
=750  \0$aMethodology$5IEN$0(DLC)sh 85084414

=LDR  00683cz  a2200229n  4500
=001  9880363616602441
=005  20141212203425.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008720
=035  \\$aCBA1972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x845.$x746.$x703.$x450
=072  \\$aD2.$x886.$x803.$x450
=072  \\$aD3.$x438.$x473.$x615
=150  \\$aMethisazone
=450  \\$wnnna$aMarboran
=450  \\$wnnna$aMetisazone
=550  \\$wg$aIndoles
=550  \\$wg$aThiosemicarbazones
=680  \\$iAn antiviral agent effective against pox viruses.
=688  \\$a91(75); was see under THIOSEMICARBAZONES 1975-90
=750  \0$aMethisazone$5IEN-M$0(DLC)sh 93006561

=LDR  01119cz  a2200361n  4500
=001  9880363616702441
=005  20141212203424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008715
=035  \\$aCBA1967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x676
=072  \\$aD12.$x125.$x142.$x557
=072  \\$aD12.$x125.$x154.$x549
=072  \\$aD12.$x125.$x166.$x676
=150  \\$aMethionine
=450  \\$wnnna$aL-Isomer Methionine
=450  \\$wnnna$aL-Methionine
=450  \\$wnnna$aLiquimeth
=450  \\$wnnna$aMethionine, L-Isomer
=450  \\$wnnna$aMethionine, L Isomer
=450  \\$wnnna$aPedameth
=550  \\$wg$aAmino Acids, Essential
=550  \\$wg$aAmino Acids, Neutral
=550  \\$wg$aAmino Acids, Sulfur
=550  \\$wh$aMethionine Sulfoximine
=550  \\$wh$aN-Formylmethionine
=550  \\$wh$aRacemethionine
=550  \\$wh$aS-Adenosylmethionine
=550  \\$wh$aSelenomethionine
=550  \\$wh$aVitamin U
=680  \\$iA sulfur-containing essential L-amino acid that is important in many body functions.
=750  \0$aMethionine$5IEN$0(DLC)sh 85084391

=LDR  01161cz  a2200313n  4500
=001  9880363616802441
=005  20141212203423.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008712
=035  \\$aCBA1964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x500
=072  \\$aD2.$x886.$x108.$x750.$x500
=072  \\$aD3.$x438.$x260.$x825.$x500
=072  \\$aD3.$x605.$x84.$x737.$x500
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x500
=150  \\$aMethicillin
=450  \\$wnnna$aCSL Brand of Methicillin Sodium
=450  \\$wnnna$aDimethoxyphenyl Penicillin
=450  \\$wnnna$aMethicillin Hydrate, Monosodium Salt
=450  \\$wnnna$aMethicillin Monohydrate, Monosodium Salt
=450  \\$wnnna$aMethicillin Sodium
=450  \\$wnnna$aMeticillin
=450  \\$wnnna$aMetin
=450  \\$aPenicillin, Dimethoxyphenyl
=450  \\$wnnna$aStaphcillin
=550  \\$wg$aPenicillins
=680  \\$iOne of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.
=750  \0$aMethicillin$5IEN$0(DLC)sh 91005975

=LDR  01085cz  a2200301n  4500
=001  9880363616902441
=005  20141212203422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008709
=035  \\$aCBA1961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782.$x500
=072  \\$aD2.$x455.$x426.$x100.$x50.$x392
=150  \\$aMethenamine
=450  \\$wnnna$aAminoform
=450  \\$aHexamethylenetetramine
=450  \\$aHexamine
=450  \\$wnnna$aHexamine Silver
=450  \\$wnnna$aMethenamine Silver
=450  \\$wnnna$aMethenamine, Silver
=450  \\$wnnna$aSilver, Hexamine
=450  \\$wnnna$aSilver Methenamine
=450  \\$wnnna$aSilver, Methenamine
=450  \\$wnnna$aUrotropin
=550  \\$wg$aAdamantane
=550  \\$wg$aPolyamines
=680  \\$iAn anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
=750  \0$aMethenamine$0(DLC)sh2011002550$5IEN-M

=LDR  01014cz  a2200193n  4500
=001  9880363617002441
=005  20141212203422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008708
=035  \\$aCBA1960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x619
=150  \\$aMethemoglobinemia
=450  \\$aMethemoglobin$xblood
=450  \\$wnnna$aMethemoglobinemias
=550  \\$wg$aHematologic Diseases
=667  \\$apresence of methemoglobin in blood
=680  \\$iThe presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)
=750  \0$aMethemoglobinemia$5IEN$0(DLC)sh 85084389

=LDR  00909cz  a2200253n  4500
=001  9880363617102441
=005  20141212203421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008702
=035  \\$aCBA1954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x786.$x830.$x666
=150  \\$aMethaqualone
=450  \\$wnnna$aHydrochloride, Methaqualone
=450  \\$wnnna$aMethaqualone Hydrochloride
=450  \\$aMetolquizolone
=450  \\$wnnna$aOptimil
=450  \\$aOrtonal
=450  \\$wnnna$aQuaalude
=450  \\$wnnna$aWallace Brand of Methaqualone Hydrochloride
=550  \\$wg$aQuinazolinones
=680  \\$iA quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)
=688  \\$a68
=750  \0$aMethaqualone$5IEN$0(DLC)sh 85084387

=LDR  00845cz  a2200277n  4500
=001  9880363617202441
=005  20141212203420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008698
=035  \\$aCBA1950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x100.$x50.$x500
=072  \\$aD2.$x886.$x645.$x600.$x55.$x50.$x510
=150  \\$aMesylates
=450  \\$aMesilate
=450  \\$wnnna$aMesilates
=450  \\$wnnna$aMesylate
=450  \\$aMethanesulfonates
=450  \\$wnnna$aMethylenesulfonates
=550  \\$wg$aAlkanesulfonates
=550  \\$wh$aBusulfan
=550  \\$wh$aEthyl Methanesulfonate
=550  \\$wh$aMethyl Methanesulfonate
=680  \\$iOrganic salts or esters of methanesulfonic acid.
=688  \\$a94; was METHANESULFONATES 1974-93
=750  \0$aMethanesulfonates$5IEN-M$0(DLC)sh 93006919

=LDR  00667cz  a2200169n  4500
=001  9880363617302441
=005  20141212203420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008697
=035  \\$aCBA1949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x571
=150  \\$aMethane
=550  \\$wg$aAlkanes
=550  \\$wh$aTetranitromethane
=680  \\$iThe simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aMethane$5IEN$0(DLC)sh 85084379

=LDR  00829cz  a2200241n  4500
=001  9880363617402441
=005  20141212203420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008696
=035  \\$aCBA1948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54.$x79.$x129.$x453
=150  \\$aMethandrostenolone
=450  \\$aDehydromethyltestosterone
=450  \\$wnnna$aDianabol
=450  \\$wnnna$aMetanabol
=450  \\$aMetandienone
=450  \\$aMethandienone
=450  \\$wnnna$aNerobol
=550  \\$wg$aAndrostadienes
=680  \\$iA synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1188)
=688  \\$a65(63)
=750  \0$aMethandrostenolone$5IEN$0(DLC)sh 89003352

=LDR  01332cz  a2200337n  4500
=001  9880363617502441
=005  20141212203419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008694
=035  \\$aCBA1946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x152.$x619
=150  \\$aMethamphetamine
=450  \\$wnnna$aAbbott Brand of Methamphetamine Hydrochloride
=450  \\$aChlormethamphetamine$5IEN
=450  \\$aDeoxyephedrine
=450  \\$wnnna$aDesoxyephedrine
=450  \\$wnnna$aDesoxyn
=450  \\$wnnna$aHydrochloride, Methamphetamine
=450  \\$wnnna$aLangly Brand of Methamphetamine Hydrochloride
=450  \\$wnnna$aMadrine
=450  \\$wnnna$aMetamfetamine
=450  \\$wnnna$aMethamphetamine Hydrochloride
=450  \\$wnnna$aMethylamphetamine
=450  \\$wnnna$aN-Methylamphetamine
=450  \\$wnnna$aN Methylamphetamine
=550  \\$wg$aAmphetamines
=550  \\$wh$aBenzphetamine
=667  \\$aa CNS stimulant; smokable crystal methamphetamine, called "ice" by drug abusers, goes here
=680  \\$iA central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.
=750  \0$aMethamphetamine$5IEN$0(DLC)sh 85084377

=LDR  01371cz  a2200385n  4500
=001  9880363617602441
=005  20141212203418.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008692
=035  \\$aCBA1944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x675.$x500
=150  \\$aMethadyl Acetate
=450  \\$wnnna$a(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane
=450  \\$wnnna$a6-(Dimethylamino)-4,4-Diphenyl-3-Heptanol Acetate
=450  \\$wnnna$aAcemethadone
=450  \\$wnnna$aAcetate, Levomethadyl
=450  \\$aAcetylmethadol
=450  \\$aAlphacetylmethadol
=450  \\$wnnna$aAmidolacetate
=450  \\$wnnna$aDimepheptanol
=450  \\$wnnna$aLAAM
=450  \\$wnnna$aLevo-alpha-Acetylmethadol
=450  \\$wnnna$aLevo alpha Acetylmethadol
=450  \\$wnnna$aLevoacetylmethadol
=450  \\$wnnna$aLevomethadyl
=450  \\$wnnna$aLevomethadyl Acetate
=450  \\$wnnna$aLevomethadyl Acetate Hydrochloride
=450  \\$wnnna$aMethadol
=450  \\$wnnna$aORLAAM
=450  \\$wnnna$aRoxane Brand of Levomethadyl Acetate Hydrochloride
=550  \\$wg$aMethadone
=680  \\$iA narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.
=688  \\$a91(75); was see under METHADONE 1975-90
=750  \0$aMethadyl acetate$5IEN$0(DLC)sh 85084376

=LDR  02081cz  a2200517n  4500
=001  9880363617702441
=005  20141212203418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008691
=035  \\$aCBA1943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x675
=150  \\$aMethadone
=450  \\$wnnna$aaddiCare Brand of Methadone Hydrochloride
=450  \\$wnnna$aAmidone
=450  \\$wnnna$aBiodone
=450  \\$wnnna$aBiomet Brand of Methadone Hydrochloride
=450  \\$wnnna$aDolophine
=450  \\$wnnna$aEsteve Brand of Methadone Hydrochloride
=450  \\$wnnna$aGenerics Brand of Methadone Hydrochloride
=450  \\$wnnna$aGlaxoSmithKline Brand of Methadone Hydrochloride
=450  \\$wnnna$aHydrochloride, Methadone
=450  \\$wnnna$aMallinckrodt Brand of Methadone Hydrochloride
=450  \\$wnnna$aMartindale Brand of Methadone Hydrochloride
=450  \\$wnnna$aMetadol
=450  \\$wnnna$aMetasedin
=450  \\$wnnna$aMethaddict
=450  \\$wnnna$aMethadone Hydrochloride
=450  \\$wnnna$aMethadose
=450  \\$wnnna$aMethex
=450  \\$wnnna$aPharmascience Brand of Methadone Hydrochloride
=450  \\$wnnna$aPhenadone
=450  \\$wnnna$aPhymet
=450  \\$wnnna$aPhyseptone
=450  \\$wnnna$aPinadone
=450  \\$wnnna$aPinewood Brand of Methadone Hydrochloride
=450  \\$wnnna$aRosemont Brand of Methadone Hydrochloride
=450  \\$wnnna$aRoxane Brand of Methadone Hydrochloride
=450  \\$wnnna$aSymoron
=450  \\$wnnna$aYamanouchi Brand of Methadone Hydrochloride
=550  \\$wg$aKetones
=550  \\$wh$aMethadyl Acetate
=550  \\$aOpiate Substitution Treatment
=667  \\$afor methadone maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT
=680  \\$iA synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
=750  \0$aMethadone hydrochloride$5IEN$0(DLC)sh 85084373

=LDR  01235cz  a2200289n  4500
=001  9880363617802441
=005  20141212203152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x930.$x500
=072  \\$aG6.$x590.$x875.$x750.$x500
=072  \\$aG6.$x920.$x875.$x750.$x500
=150  \\$aLysogeny
=450  \\$aIntegration, Prophage
=450  \\$wnnna$aIntegrations, Prophage
=450  \\$aProphage Integration
=450  \\$wnnna$aProphage Integrations
=550  \\$wg$aVirus Integration
=550  \\$aAttachment Sites, Microbiological
=550  \\$aBacteriophages
=550  \\$aProphages
=550  \\$aVirus Activation
=667  \\$afor bacteriophages only
=680  \\$iThe phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between PROPHAGE and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium. Upon induction (VIRUS ACTIVATION) by various agents, such as ultraviolet radiation, the phage is released, which then becomes virulent and lyses the bacterium.
=688  \\$a70(68)
=750  \0$aLysogeny$5IEN$0(DLC)sh 85079194

=LDR  00987cz  a2200325n  4500
=001  9880363617902441
=005  20141212203151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008239
=035  \\$aCBA1480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x68.$x555
=072  \\$aD12.$x125.$x95.$x647
=072  \\$aD12.$x125.$x142.$x497
=150  \\$aLysine
=450  \\$wnnna$aAcetate, Lysine
=450  \\$wnnna$aEnisyl
=450  \\$wnnna$aL-Lysine
=450  \\$wnnna$aL Lysine
=450  \\$wnnna$aLysine Acetate
=450  \\$wnnna$aLysine Hydrochloride
=550  \\$wg$aAmino Acids, Basic
=550  \\$wg$aAmino Acids, Diamino
=550  \\$wg$aAmino Acids, Essential
=550  \\$wh$aHydroxylysine
=550  \\$wh$aLysinoalanine
=550  \\$wh$aPolylysine
=667  \\$a/biosyn /defic /physiol permitted; POLYLYSINE is also available
=680  \\$iAn essential amino acid. It is often added to animal feed.
=750  \0$aLysine$0(DLC) sh 85079188$5IEN

=LDR  01195cz  a2200277n  4500
=001  9880363618002441
=005  20141212203150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008238
=035  \\$aCBA1479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327.$x287.$x572.$x522
=072  \\$aD3.$x549.$x439.$x572.$x522
=150  \\$aLysergic Acid Diethylamide
=450  \\$a2-Bromolysergic Acid Diethylamide$5IEN-M
=450  \\$wnnna$aAcid Diethylamide, Lysergic
=450  \\$wnnna$aDiethylamide, Lysergic Acid
=450  \\$aLSD
=450  \\$wnnna$aLSD-25
=450  \\$wnnna$aLSD 25
=450  \\$wnnna$aLysergic Acid Diethylamide Tartrate
=450  \\$aLysergide
=550  \\$wg$aLysergic Acid
=667  \\$aDF: note short X ref
=680  \\$iSemisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
=750  \0$aLSD (Drug)$0(DLC) sh 85079185$5IEN

=LDR  04050cz  a2200985n  4500
=001  9880363618102441
=005  20200516142113.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008232
=035  \\$aCBA1473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x515
=072  \\$aC20.$x683.$x515
=150  \\$aLymphoproliferative Disorders
=450  \\$wnnna$aDisease, Duncan
=450  \\$wnnna$aDisease, X-Linked Lymphoproliferative
=450  \\$wnnna$aDiseases, X-Linked Lymphoproliferative
=450  \\$wnnna$aDisorder, Lymphoproliferative
=450  \\$wnnna$aDisorder, X-Linked Lymphoproliferative
=450  \\$wnnna$aDisorders, Lymphoproliferative
=450  \\$wnnna$aDisorders, X-Linked Lymphoproliferative
=450  \\$wnnna$aDuncan Disease
=450  \\$aDuncan's Syndrome
=450  \\$wnnna$aEpstein-Barr Virus-Induced Lymphoproliferative Disease In Males
=450  \\$wnnna$aEpstein Barr Virus Induced Lymphoproliferative Disease In Males
=450  \\$wnnna$aEpstein-Barr Virus Infection, Familial Fatal
=450  \\$wnnna$aEpstein Barr Virus Infection, Familial Fatal
=450  \\$wnnna$aFamilial Fatal Epstein-Barr Infection
=450  \\$wnnna$aFamilial Fatal Epstein Barr Infection
=450  \\$wnnna$aImmunodeficiency 5
=450  \\$wnnna$aImmunodeficiency 5s
=450  \\$wnnna$aImmunodeficiency, X-Linked Progressive Combined Variable
=450  \\$wnnna$aImmunodeficiency, X Linked Progressive Combined Variable
=450  \\$wnnna$aLymphoproliferative Disease, X-Linked
=450  \\$wnnna$aLymphoproliferative Disease, X Linked
=450  \\$wnnna$aLymphoproliferative Diseases, X-Linked
=450  \\$wnnna$aLymphoproliferative Disorder
=450  \\$wnnna$aLymphoproliferative Disorder, X-Linked
=450  \\$wnnna$aLymphoproliferative Disorders, X-Linked
=450  \\$wnnna$aLymphoproliferative Syndrome, X-Linked
=450  \\$wnnna$aLymphoproliferative Syndrome, X-Linked, 1
=450  \\$wnnna$aLymphoproliferative Syndromes, X-Linked
=450  \\$wnnna$aPurtilo Syndrome
=450  \\$wnnna$aPurtilo Syndromes
=450  \\$wnnna$aSyndrome, Purtilo
=450  \\$wnnna$aSyndrome, X-Linked Lymphoproliferative
=450  \\$wnnna$aSyndromes, Purtilo
=450  \\$wnnna$aSyndromes, X-Linked Lymphoproliferative
=450  \\$wnnna$aX-Linked Lymphoproliferative Disease
=450  \\$wnnna$aX Linked Lymphoproliferative Disease
=450  \\$wnnna$aX-Linked Lymphoproliferative Diseases
=450  \\$wnnna$aX-Linked Lymphoproliferative Disorder
=450  \\$wnnna$aX Linked Lymphoproliferative Disorder
=450  \\$wnnna$aX-Linked Lymphoproliferative Disorders
=450  \\$aX-Linked Lymphoproliferative Syndrome
=450  \\$wnnna$aX Linked Lymphoproliferative Syndrome
=450  \\$wnnna$aX-Linked Lymphoproliferative Syndromes
=550  \\$wg$aImmunoproliferative Disorders
=550  \\$wg$aLymphatic Diseases
=550  \\$wh$aAgammaglobulinemia
=550  \\$wh$aAutoimmune Lymphoproliferative Syndrome
=550  \\$wh$aGiant Lymph Node Hyperplasia
=550  \\$wh$aGranuloma
=550  \\$wh$aHeavy Chain Disease
=550  \\$wh$aImmunoblastic Lymphadenopathy
=550  \\$wh$aImmunogloulin Light-chain Amyloidosis
=550  \\$wh$aImmunoproliferative Small Intestinal Disease
=550  \\$wh$aInfectious Mononucleosis
=550  \\$wh$aLeukemia, Hairy Cell
=550  \\$wh$aLeukemia, Lymphoid
=550  \\$wh$aLymphangiomyoma
=550  \\$wh$aLymphoma
=550  \\$wh$aMacrophage Activation Syndrome
=550  \\$wh$aMarek Disease
=550  \\$wh$aMultiple Myeloma
=550  \\$wh$aPlasmacytoma
=550  \\$wh$aSarcoidosis
=550  \\$wh$aSezary Syndrome
=550  \\$wh$aTumor Lysis Syndrome
=550  \\$wh$aWaldenstrom Macroglobulinemia
=550  \\$aAmyloidosis
=667  \\$aGEN or unspecified: prefer specifics
=680  \\$iDisorders characterized by proliferation of lymphoid tissue, general or unspecified.
=688  \\$a79
=750  \0$aLymphoproliferative disorders$5IEN$0(DLC)sh 85079155

=LDR  07129cz  a2201729n  4500
=001  9880363618202441
=005  20141212203146.0
=008  860624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008228
=035  \\$aCBA1469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386.$x480
=072  \\$aC15.$x604.$x515.$x569.$x480
=072  \\$aC20.$x683.$x515.$x761.$x480
=150  \\$aLymphoma, Non-Hodgkin
=450  \\$wnnna$aDiffuse Lymphoma
=450  \\$wnnna$aDiffuse Lymphomas
=450  \\$wnnna$aDiffuse Mixed-Cell Lymphoma
=450  \\$wnnna$aDiffuse Mixed Cell Lymphoma
=450  \\$wnnna$aDiffuse Mixed-Cell Lymphomas
=450  \\$wnnna$aDiffuse Mixed Small and Large Cell Lymphoma
=450  \\$wnnna$aDiffuse Small Cleaved-Cell Lymphoma
=450  \\$wnnna$aDiffuse Small Cleaved Cell Lymphoma
=450  \\$wnnna$aDiffuse Undifferentiated Lymphoma
=450  \\$wnnna$aDiffuse Undifferentiated Lymphomas
=450  \\$wnnna$aHigh-Grade Lymphoma
=450  \\$wnnna$aHigh-Grade Lymphomas
=450  \\$wnnna$aIntermediate-Grade Lymphoma
=450  \\$wnnna$aIntermediate-Grade Lymphomas
=450  \\$wnnna$aLow-Grade Lymphoma
=450  \\$wnnna$aLow-Grade Lymphomas
=450  \\$wnnna$aLymphatic Sarcoma
=450  \\$wnnna$aLymphatic Sarcomas
=450  \\$wnnna$aLymphocytic-Histiocytic Lymphoma, Mixed
=450  \\$wnnna$aLymphocytic-Histiocytic Lymphomas, Mixed
=450  \\$wnnna$aLymphoma, Atypical Diffuse Small Lymphoid
=450  \\$wnnna$aLymphoma, Diffuse
=450  \\$wnnna$aLymphoma, Diffuse Mixed-Cell
=450  \\$wnnna$aLymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
=450  \\$wnnna$aLymphoma, Diffuse Undifferentiated
=450  \\$wnnna$aLymphoma, High-Grade
=450  \\$wnnna$aLymphoma, High Grade
=450  \\$wnnna$aLymphoma, Intermediate-Grade
=450  \\$wnnna$aLymphoma, Intermediate Grade
=450  \\$wnnna$aLymphoma, Low-Grade
=450  \\$wnnna$aLymphoma, Low Grade
=450  \\$wnnna$aLymphoma, Mixed
=450  \\$wnnna$aLymphoma, Mixed-Cell
=450  \\$wnnna$aLymphoma, Mixed Cell
=450  \\$wnnna$aLymphoma, Mixed Cell, Diffuse
=450  \\$wnnna$aLymphoma, Mixed-Cell, Diffuse
=450  \\$wnnna$aLymphoma, Mixed Lymphocytic-Histiocytic
=450  \\$wnnna$aLymphoma, Mixed Lymphocytic Histiocytic
=450  \\$wnnna$aLymphoma, Mixed Small and Large Cell, Diffuse
=450  \\$wnnna$aLymphoma, Non Hodgkin
=450  \\$wnnna$aLymphoma, Non-Hodgkin, Familial
=450  \\$wnnna$aLymphoma, Non-Hodgkin's
=450  \\$wnnna$aLymphoma, Non-Hodgkins
=450  \\$wnnna$aLymphoma, Non Hodgkin's
=450  \\$wnnna$aLymphoma, Non Hodgkins
=450  \\$wnnna$aLymphoma, Nonhodgkin
=450  \\$wnnna$aLymphoma, Nonhodgkin's
=450  \\$wnnna$aLymphoma, Nonhodgkins
=450  \\$wnnna$aLymphoma, Pleomorphic
=450  \\$wnnna$aLymphoma, Small and Large Cleaved-Cell, Diffuse
=450  \\$wnnna$aLymphoma, Small Cleaved Cell, Diffuse
=450  \\$wnnna$aLymphoma, Small Cleaved-Cell, Diffuse
=450  \\$wnnna$aLymphoma, Small Non-Cleaved-Cell
=450  \\$wnnna$aLymphoma, Small Non Cleaved Cell
=450  \\$wnnna$aLymphoma, Small Noncleaved-Cell
=450  \\$wnnna$aLymphoma, Small Noncleaved Cell
=450  \\$wnnna$aLymphoma, Undifferentiated
=450  \\$wnnna$aLymphoma, Undifferentiated, Diffuse
=450  \\$wnnna$aLymphomas, Diffuse
=450  \\$wnnna$aLymphomas, Diffuse Mixed-Cell
=450  \\$wnnna$aLymphomas, Diffuse Undifferentiated
=450  \\$wnnna$aLymphomas, High-Grade
=450  \\$wnnna$aLymphomas, Intermediate-Grade
=450  \\$wnnna$aLymphomas, Low-Grade
=450  \\$wnnna$aLymphomas, Mixed
=450  \\$wnnna$aLymphomas, Mixed-Cell
=450  \\$wnnna$aLymphomas, Mixed Lymphocytic-Histiocytic
=450  \\$wnnna$aLymphomas, Pleomorphic
=450  \\$wnnna$aLymphomas, Small Non-Cleaved-Cell
=450  \\$wnnna$aLymphomas, Small Noncleaved-Cell
=450  \\$wnnna$aLymphomas, Undifferentiated
=450  \\$wnnna$aLymphosarcoma
=450  \\$wnnna$aLymphosarcomas
=450  \\$wnnna$aMixed-Cell Lymphoma
=450  \\$wnnna$aMixed Cell Lymphoma
=450  \\$wnnna$aMixed-Cell Lymphoma, Diffuse
=450  \\$wnnna$aMixed Cell Lymphoma, Diffuse
=450  \\$wnnna$aMixed-Cell Lymphomas
=450  \\$wnnna$aMixed-Cell Lymphomas, Diffuse
=450  \\$wnnna$aMixed Lymphocytic-Histiocytic Lymphoma
=450  \\$wnnna$aMixed Lymphocytic-Histiocytic Lymphomas
=450  \\$wnnna$aMixed Lymphoma
=450  \\$wnnna$aMixed Lymphomas
=450  \\$wnnna$aMixed Small and Large Cell Lymphoma, Diffuse
=450  \\$wnnna$aNon-Cleaved-Cell Lymphoma, Small
=450  \\$wnnna$aNon-Cleaved-Cell Lymphomas, Small
=450  \\$aNon-Hodgkin Lymphoma
=450  \\$wnnna$aNon Hodgkin Lymphoma
=450  \\$wnnna$aNon-Hodgkin's Lymphoma
=450  \\$wnnna$aNon Hodgkin's Lymphoma
=450  \\$wnnna$aNon-Hodgkins Lymphoma
=450  \\$wnnna$aNoncleaved-Cell Lymphoma, Small
=450  \\$wnnna$aNoncleaved-Cell Lymphomas, Small
=450  \\$wnnna$aNonhodgkin's Lymphoma
=450  \\$wnnna$aNonhodgkins Lymphoma
=450  \\$wnnna$aPleomorphic Lymphoma
=450  \\$wnnna$aPleomorphic Lymphomas
=450  \\$wnnna$aReticulosarcoma
=450  \\$wnnna$aReticulosarcomas
=450  \\$wnnna$aReticulum Cell Sarcoma
=450  \\$wnnna$aReticulum-Cell Sarcoma
=450  \\$wnnna$aReticulum-Cell Sarcomas
=450  \\$wnnna$aSarcoma, Lymphatic
=450  \\$wnnna$aSarcoma, Reticulum-Cell
=450  \\$wnnna$aSarcoma, Reticulum Cell
=450  \\$wnnna$aSarcomas, Lymphatic
=450  \\$wnnna$aSarcomas, Reticulum-Cell
=450  \\$wnnna$aSmall Cleaved-Cell Lymphoma, Diffuse
=450  \\$wnnna$aSmall Cleaved Cell Lymphoma, Diffuse
=450  \\$wnnna$aSmall Non-Cleaved-Cell Lymphoma
=450  \\$wnnna$aSmall Non Cleaved Cell Lymphoma
=450  \\$wnnna$aSmall Non-Cleaved-Cell Lymphomas
=450  \\$wnnna$aSmall Noncleaved-Cell Lymphoma
=450  \\$wnnna$aSmall Noncleaved Cell Lymphoma
=450  \\$wnnna$aSmall Noncleaved-Cell Lymphomas
=450  \\$wnnna$aUndifferentiated Lymphoma
=450  \\$wnnna$aUndifferentiated Lymphoma, Diffuse
=450  \\$wnnna$aUndifferentiated Lymphomas
=450  \\$wnnna$aUndifferentiated Lymphomas, Diffuse
=550  \\$wg$aLymphoma
=550  \\$wh$aBurkitt Lymphoma
=550  \\$wh$aLymphoma, B-Cell
=550  \\$wh$aLymphoma, Follicular
=550  \\$wh$aLymphoma, Large-Cell, Anaplastic
=550  \\$wh$aLymphoma, Large-Cell, Immunoblastic
=550  \\$wh$aLymphoma, Mantle-Cell
=550  \\$wh$aLymphoma, T-Cell
=667  \\$ageneral & unspecified only: prefer specifics
=680  \\$iAny of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
=688  \\$a1997(1987)
=688  \\$a97(87)
=750  \0$aReticulum cell sarcoma$0(DLC) sh 85113321$5IEN-M

=LDR  01611cz  a2200445n  4500
=001  9880363618302441
=005  20141212203141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008223
=035  \\$aCBA1464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386
=072  \\$aC15.$x604.$x515.$x569
=072  \\$aC20.$x683.$x515.$x761
=150  \\$aLymphoma
=450  \\$wnnna$aGerminoblastic Sarcoma
=450  \\$wnnna$aGerminoblastic Sarcomas
=450  \\$aGerminoblastoma
=450  \\$wnnna$aGerminoblastomas
=450  \\$aLymphoma, Malignant
=450  \\$wnnna$aLymphomas
=450  \\$wnnna$aLymphomas, Malignant
=450  \\$wnnna$aMalignant Lymphoma
=450  \\$wnnna$aMalignant Lymphomas
=450  \\$aReticulolymphosarcoma
=450  \\$wnnna$aReticulolymphosarcomas
=450  \\$aSarcoma, Germinoblastic
=450  \\$wnnna$aSarcomas, Germinoblastic
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wg$aNeoplasms by Histologic Type
=550  \\$wh$aComposite Lymphoma
=550  \\$wh$aHodgkin Disease
=550  \\$wh$aImmunoproliferative Small Intestinal Disease
=550  \\$wh$aIntraocular Lymphoma
=550  \\$wh$aLymphoma, Non-Hodgkin
=550  \\$aHematologic Neoplasms
=550  \\$aLymphatic Diseases
=667  \\$aGEN only or unspecified: prefer specific; do not confuse X ref LYMPHOMA, MALIGNANT with LYMPHOGRANULOMA, MALIGNANT see HODGKIN DISEASE; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED
=680  \\$iA general term for various neoplastic diseases of the lymphoid tissue.
=750  \0$aLymphomas$0(DLC) sh 85079154$5IEN

=LDR  01130cz  a2200325n  4500
=001  9880363618402441
=005  20141212203141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008222
=035  \\$aCBA1463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x480
=072  \\$aD12.$x776.$x467.$x374.$x480
=072  \\$aD23.$x529.$x374.$x480
=150  \\$aLymphokines
=450  \\$aLymphocyte Mediators
=450  \\$wnnna$aMediators, Lymphocyte
=550  \\$wg$aCytokines
=550  \\$wh$aInterferon-gamma
=550  \\$wh$aInterleukin-2
=550  \\$wh$aLeukocyte Migration-Inhibitory Factors
=550  \\$wh$aLymphotoxin-alpha
=550  \\$wh$aMacrophage-Activating Factors
=550  \\$wh$aMacrophage Migration-Inhibitory Factors
=550  \\$wh$aSuppressor Factors, Immunologic
=550  \\$wh$aTransfer Factor
=667  \\$a/biosyn /drug eff /physiol /ultrastruct permitted
=680  \\$iSoluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.
=688  \\$a74
=750  \0$aLymphokines$5IEN$0(DLC)sh 85079153

=LDR  01348cz  a2200385n  4500
=001  9880363618502441
=005  20190128111632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008221
=035  \\$aCBA1462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x549
=072  \\$aA15.$x382.$x520.$x604
=150  \\$aLymphoid Tissue
=450  \\$wnnna$aLymphatic Tissue
=450  \\$wnnna$aLymphatic Tissues
=450  \\$wnnna$aLymphoid Tissues
=450  \\$wnnna$aTissue, Lymphatic
=450  \\$wnnna$aTissue, Lymphoid
=450  \\$wnnna$aTissues, Lymphatic
=450  \\$wnnna$aTissues, Lymphoid
=550  \\$wg$aLymphatic System
=550  \\$wg$aTissues
=550  \\$wh$aAdenoids
=550  \\$wh$aBursa of Fabricius
=550  \\$wh$aGerminal Center
=550  \\$wh$aLymph Nodes
=550  \\$wh$aPalatine Tonsil
=550  \\$wh$aPeyer's Patches
=550  \\$wh$aSpleen
=550  \\$wh$aTertiary Lymphoid Structures
=550  \\$wh$aThymus Gland
=667  \\$a/radiogr permitted: not necessarily LYMPHOGRAPHY
=680  \\$iSpecialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS.
=750  \0$aLymphoid tissue$5IEN$0(DLC)sh 85079152

=LDR  00839cz  a2200253n  4500
=001  9880363618602441
=005  20141212203140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008220
=035  \\$aCBA1461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x475
=150  \\$aLymphography
=450  \\$wnnna$aLymphangiographies
=450  \\$aLymphangiography
=450  \\$aLymphatic System$xradiography
=450  \\$wnnna$aLymphographies
=550  \\$wg$aRadiography
=550  \\$aLymph Nodes
=550  \\$aLymphatic System
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: LYMPHOGR
=680  \\$iRadiographic study of the lymphatic system following injection of dye or contrast medium.
=688  \\$a64(63)
=750  \0$aLymphangiography$5IEN$0(DLC)sh 85079128

=LDR  01050cz  a2200229n  4500
=001  9880363618702441
=005  20141212203140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008219
=035  \\$aCBA1460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x210.$x210.$x490
=072  \\$aC1.$x252.$x810.$x301.$x490
=072  \\$aC1.$x539.$x778.$x281.$x301.$x490
=072  \\$aC12.$x294.$x668.$x281.$x301.$x490
=072  \\$aC13.$x351.$x500.$x711.$x281.$x301.$x490
=150  \\$aLymphogranuloma Venereum
=450  \\$aLymphogranuloma Inguinale
=550  \\$wg$aChlamydia Infections
=667  \\$acaused by Chlamydia trachomatis
=680  \\$iSubacute inflammation of the inguinal lymph glands caused by certain immunotypes of CHLAMYDIA TRACHOMATIS. It is a sexually transmitted disease in the U.S. but is more widespread in developing countries. It is distinguished from granuloma venereum (see GRANULOMA INGUINALE), which is caused by Calymmatobacterium granulomatis.
=750  \0$aLymphogranuloma venereum$5IEN$0(DLC)sh 85079151

=LDR  01258cz  a2200241n  4500
=001  9880363618802441
=005  20141212203139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008217
=035  \\$aCBA1458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x57.$x70.$x100.$x550
=072  \\$aB4.$x909.$x777.$x80.$x70.$x100.$x550
=150  \\$aLymphocytic choriomeningitis virus
=450  \\$wnnna$aLCM Virus
=450  \\$aLCM Viruses
=450  \\$aLCMV
=450  \\$wnnna$aLymphocytic choriomeningitis viruses
=550  \\$wg$aArenaviruses, Old World
=667  \\$ainfection = LYMPHOCYTIC CHORIOMENINGITIS or LYMPHOCYTIC CHORIOMENINGITIS VIRUS (IM) + ARENAVIRIDAE INFECTIONS (IM); DF: LCMV
=680  \\$iThe type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host.
=688  \\$a73(65)
=750  \0$aLymphocytic choriomeningitis virus$5IEN$0(DLC)sh 85079149

=LDR  01562cz  a2200301n  4500
=001  9880363618902441
=005  20141212203139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008216
=035  \\$aCBA1457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182.$x550.$x500
=072  \\$aC2.$x587.$x580
=072  \\$aC2.$x782.$x82.$x580
=072  \\$aC10.$x228.$x228.$x210.$x500.$x500
=072  \\$aC10.$x228.$x228.$x507.$x700.$x500
=150  \\$aLymphocytic Choriomeningitis
=450  \\$aArmstrong Syndrome
=450  \\$wnnna$aArmstrong's Syndrome
=450  \\$wnnna$aChoriomeningitis, Lymphocytic
=450  \\$wnnna$aEncephalomyelitis, Lymphocytic Choriomeningitis Virus
=450  \\$wnnna$aLymphocytic Choriomeningitis Virus Encephalomyelitis
=450  \\$wnnna$aSyndrome, Armstrong
=450  \\$wnnna$aSyndrome, Armstrong's
=550  \\$wg$aArenaviridae Infections
=550  \\$wg$aMeningitis, Viral
=680  \\$iA form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)
=750  \0$aLymphocytic choriomeningitis$5IEN$0(DLC)sh 85079148

=LDR  01398cz  a2200325n  4500
=001  9880363619002441
=005  20141212203138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008214
=035  \\$aCBA1455HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567
=072  \\$aA15.$x382.$x490.$x555.$x567
=150  \\$aLymphocytes
=450  \\$wnnna$aCell, Lymphoid
=450  \\$wnnna$aCells, Lymphoid
=450  \\$wnnna$aLymphocyte
=450  \\$wnnna$aLymphoid Cell
=450  \\$aLymphoid Cells
=550  \\$wg$aLeukocytes, Mononuclear
=550  \\$wh$aB-Lymphocytes
=550  \\$wh$aKiller Cells, Natural
=550  \\$wh$aLymphocyte Subsets
=550  \\$wh$aLymphocytes, Null
=550  \\$wh$aLymphocytes, Tumor-Infiltrating
=550  \\$wh$aT-Lymphocytes
=667  \\$ageneral; prefer specifics; decrease in number = LYMPHOPENIA; excess number = LYMPHOCYTOSIS; note many specific precoordinated lymphocyte terms are available
=680  \\$iWhite blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.
=750  \0$aLymphocytes$5IEN$0(DLC)sh 85079147

=LDR  01998cz  a2200409n  4500
=001  9880363619102441
=005  20141212203138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008213
=035  \\$aCBA1454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x482
=072  \\$aE5.$x200.$x812.$x482
=072  \\$aE5.$x478.$x594.$x530
=072  \\$aG12.$x425.$x747
=072  \\$aG12.$x450.$x50.$x400.$x545
=150  \\$aLymphocyte Activation
=450  \\$wnnna$aActivation, Lymphocyte
=450  \\$aBlast Transformation
=450  \\$aBlastogenesis
=450  \\$aLymphoblast Transformation
=450  \\$aLymphocyte Stimulation
=450  \\$aLymphocyte Transformation
=450  \\$wnnna$aStimulation, Lymphocyte
=450  \\$wnnna$aTransformation, Blast
=450  \\$wnnna$aTransformation, Lymphoblast
=450  \\$wnnna$aTransformation, Lymphocyte
=550  \\$wg$aImmune System Processes
=550  \\$wg$aImmunity, Cellular
=550  \\$wg$aImmunologic Tests
=550  \\$wh$aCross-Priming
=550  \\$aAntigen-Presenting Cells
=550  \\$aBlast Crisis
=667  \\$alymphocyte transformation test goes here but do not index under specific agent inducing transformation unless particularly discussed; do not use for neoplastic transformation of lymphocytes ( = CELL TRANSFORMATION, NEOPLASTIC) or viral transformation of lymphocytes ( = CELL TRANSFORMATION, VIRAL); blast transformation in chronic myelogenous leukemia does not go here: index BLAST CRISIS; DF: LYMPHOCYTE TRANSFORM
=680  \\$iMorphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.
=688  \\$a2003 (1969); for BLAST TRANSFORMATION use BLAST CRISIS 1987-1992
=750  \0$aLymphocyte transformation$5IEN$0(DLC)sh 85079146

=LDR  02807cz  a2200757n  4500
=001  9880363619202441
=005  20180316101227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008209
=035  \\$aCBA1450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x496
=150  \\$aLymphedema
=450  \\$wnnna$aCongenital Familial Lymphedema
=450  \\$wnnna$aCongenital Hereditary Lymphedema
=450  \\$wnnna$aCongenital Hereditary Lymphedemas
=450  \\$wnnna$aCongenital Lymphedema, Primary
=450  \\$wnnna$aCongenital Lymphedemas, Primary
=450  \\$wnnna$aEarly Onset Lymphedema
=450  \\$wnnna$aEarly-Onset Lymphedema
=450  \\$wnnna$aEarly Onset Lymphedemas
=450  \\$wnnna$aEarly-Onset Lymphedemas
=450  \\$wnnna$aHereditary Lymphedema
=450  \\$wnnna$aHereditary Lymphedema 1
=450  \\$wnnna$aHereditary Lymphedema 1s
=450  \\$wnnna$aHereditary Lymphedema, Congenital
=450  \\$wnnna$aHereditary Lymphedema Type I
=450  \\$wnnna$aHereditary Lymphedemas
=450  \\$wnnna$aHereditary Lymphedemas, Congenital
=450  \\$wnnna$aLymphedema, Congenital Hereditary
=450  \\$wnnna$aLymphedema, Early-Onset
=450  \\$wnnna$aLymphedema, Early Onset
=450  \\$wnnna$aLymphedema, Hereditary
=450  \\$wnnna$aLymphedema, Hereditary, Ia
=450  \\$wnnna$aLymphedema, Nonne-Milroy
=450  \\$wnnna$aLymphedema, Primary Congenital
=450  \\$wnnna$aLymphedemas
=450  \\$wnnna$aLymphedemas, Congenital Hereditary
=450  \\$wnnna$aLymphedemas, Early Onset
=450  \\$wnnna$aLymphedemas, Early-Onset
=450  \\$wnnna$aLymphedemas, Hereditary
=450  \\$wnnna$aLymphedemas, Primary Congenital
=450  \\$wnnna$aMilroy Disease
=450  \\$aMilroy's Disease
=450  \\$wnnna$aMilroys Disease
=450  \\$wnnna$aNonne-Milroy Disease
=450  \\$wnnna$aNonne Milroy Disease
=450  \\$wnnna$aNonne-Milroy Lymphedema
=450  \\$wnnna$aNonne Milroy Lymphedema
=450  \\$wnnna$aNonne-Milroy-Meige Disease
=450  \\$wnnna$aNonne Milroy Meige Disease
=450  \\$wnnna$aPrimary Congenital Lymphedema
=450  \\$wnnna$aPrimary Congenital Lymphedemas
=550  \\$wg$aLymphatic Diseases
=550  \\$wh$aBreast Cancer Lymphedema
=550  \\$wh$aElephantiasis
=550  \\$wh$aElephantiasis, Filarial
=550  \\$wh$aNon-Filarial Lymphedema
=550  \\$aEdema
=550  \\$aLipedema
=550  \\$aYellow Nail Syndrome
=667  \\$aentry term MILROY'S DISEASE goes under LYMPHEDEMA/ congen
=680  \\$iEdema due to obstruction of lymph vessels or disorders of the lymph nodes.
=688  \\$aMILROY'S DISEASE was heading 1963-1983
=688  \\$aMILROY'S DISEASE was heading 1963-83
=750  \0$aLymphedema$5IEN$0(DLC)sh 85079142

=LDR  00698cz  a2200217n  4500
=001  9880363619302441
=005  20141212203136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008208
=035  \\$aCBA1449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x382.$x520
=150  \\$aLymphatic System
=450  \\$wnnna$aLymphatic Systems
=550  \\$wg$aImmune System
=550  \\$wh$aLymph
=550  \\$wh$aLymphatic Vessels
=550  \\$wh$aLymphoid Tissue
=667  \\$aLYMPHOID TISSUE & LYMPH NODES are available; inflammation = LYMPHANGITIS
=680  \\$iA system of organs and tissues that process and transport immune cells and LYMPH.
=750  \0$aLymphatics$0(DLC) sh 85079132$5IEN

=LDR  00916cz  a2200229n  4500
=001  9880363619402441
=005  20141212203136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008207
=035  \\$aCBA1448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x650.$x560
=072  \\$aC23.$x550.$x727.$x650.$x560
=150  \\$aLymphatic Metastasis
=450  \\$wnnna$aLymphatic Metastases
=450  \\$wnnna$aMetastases, Lymphatic
=450  \\$wnnna$aMetastasis, Lymphatic
=550  \\$wg$aNeoplasm Metastasis
=550  \\$aSentinel Lymph Node Biopsy
=667  \\$aNIM, no qualif; IM for GEN or lymphatic metastatic process; when IM, qualif permitted; policy on metastases: Manual 24.3.1, 24.4.1.3+, 24.4.1.4
=680  \\$iTransfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
=750  \0$aLymphatic metastasis$5IEN$0(DLC)sh 85079131

=LDR  01670cz  a2200457n  4500
=001  9880363619502441
=005  20180815125658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008206
=035  \\$aCBA1446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604
=150  \\$aLymphatic Diseases
=450  \\$wnnna$aDisease, Lymphatic
=450  \\$wnnna$aDiseases, Lymphatic
=450  \\$aLymphadenopathy
=450  \\$wnnna$aLymphatic Disease
=450  \\$aLymphatism
=450  \\$wnno$aReticuloendotheliosis$5IEN-M
=450  \\$aStatus Lymphaticus
=550  \\$wg$aHemic and Lymphatic Diseases
=550  \\$wh$aHistiocytosis
=550  \\$wh$aLymphadenitis
=550  \\$wh$aLymphadenopathy
=550  \\$wh$aLymphangiectasis
=550  \\$wh$aLymphangitis
=550  \\$wh$aLymphatic Abnormalities
=550  \\$wh$aLymphedema
=550  \\$wh$aLymphocele
=550  \\$wh$aLymphoproliferative Disorders
=550  \\$wh$aMucocutaneous Lymph Node Syndrome
=550  \\$wh$aPseudolymphoma
=550  \\$wh$aSplenic Diseases
=550  \\$wh$aThymus Hyperplasia
=550  \\$wh$aThymus Neoplasms
=550  \\$wh$aTuberculosis, Lymph Node
=667  \\$ageneral or unspecified; prefer specifics; note entry term LYMPHADENOPATHY: unspecified goes here but LYMPHADENOPATHY SYNDROME see AIDS-RELATED COMPLEX & IMMUNOBLASTIC LYMPHADENOPATHY are also available; inflammatory disease = LYMPHANGITIS
=680  \\$iDiseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.
=688  \\$a70(68); LYMPHATISM was heading 1963-78
=750  \0$aLymph nodes$xDiseases$0(DLC) sh 87004915$5IEN-M
=750  \0$aLymphatics$xDiseases$0(DLC) sh 85079135$5IEN-M

=LDR  00850cz  a2200253n  4500
=001  9880363619602441
=005  20141212203133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008199
=035  \\$aCBA1439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x315
=150  \\$aLymphadenitis
=450  \\$wnnna$aAdenitides
=450  \\$aAdenitis
=450  \\$wnnna$aLymphadenitides
=550  \\$wg$aLymphatic Diseases
=550  \\$wh$aCat-Scratch Disease
=550  \\$wh$aHistiocytic Necrotizing Lymphadenitis
=550  \\$wh$aMesenteric Lymphadenitis
=550  \\$wh$aTuberculosis, Lymph Node
=667  \\$ainflamm of lymph nodes: do not confuse with LYMPHANGITIS, inflamm of lymphatic vessels; consider also MESENTERIC LYMPHADENITIS
=680  \\$iInflammation of the lymph nodes.
=750  \0$aLymphadenitis$5IEN$0(DLC)sh 85079127

=LDR  01006cz  a2200229n  4500
=001  9880363619702441
=005  20181214141803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008198
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x549.$x400
=072  \\$aA15.$x382.$x520.$x604.$x412
=150  \\$aLymph Nodes
=450  \\$wnnna$aLymph Node
=450  \\$wnnna$aNode, Lymph
=450  \\$wnnna$aNodes, Lymph
=550  \\$wg$aLymphoid Tissue
=550  \\$wh$aGerminal Center
=550  \\$wh$aSentinel Lymph Node
=667  \\$a/radiogr permitted: not necessarily LYMPHOGRAPHY; /surg: probably LYMPH NODE EXCISION or specifics; GIANT LYMPH NODE HYPERPLASIA is also available; "axillary lymph nodes" = LYMPH NODES (IM) + AXILLA (NIM, no qualif); "cervical lymph nodes" = LYMPH NODES (IM) + NECK (NIM, no qualif); inflammation = LYMPHADENITIS
=680  \\$iThey are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
=750  \0$aLymph nodes$5IEN$0(DLC)sh 85079126

=LDR  01242cz  a2200337n  4500
=001  9880363619802441
=005  20141212203133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008197
=035  \\$aCBA1437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x446
=150  \\$aLymph Node Excision
=450  \\$wnnna$aDissection, Lymph Node
=450  \\$wnnna$aDissections, Lymph Node
=450  \\$wnnna$aExcision, Lymph Node
=450  \\$wnnna$aExcisions, Lymph Node
=450  \\$aLymph Node Dissection
=450  \\$wnnna$aLymph Node Dissections
=450  \\$wnnna$aLymph Node Excisions
=450  \\$wnnna$aLymphadenectomies
=450  \\$aLymphadenectomy
=450  \\$wnnna$aNode Dissection, Lymph
=450  \\$wnnna$aNode Dissections, Lymph
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aNeck Dissection
=550  \\$wh$aSentinel Lymph Node Biopsy
=550  \\$aLymph Nodes
=667  \\$acoord IM with site of lymph nodes (NIM) but RADICAL NECK DISSECTION is available; do not use /util except by MeSH definition
=680  \\$iSurgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
=750  \0$aLymph nodes$xSurgery$5IEN$0(IEN)369055

=LDR  00569cz  a2200205n  4500
=001  9880363619902441
=005  20141212203132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008196
=035  \\$aCBA1436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x270.$x606
=072  \\$aA15.$x382.$x520.$x150
=150  \\$aLymph
=450  \\$wnnna$aLymphs
=550  \\$wg$aExtracellular Fluid
=550  \\$wg$aLymphatic System
=550  \\$wh$aChyle
=680  \\$iThe interstitial fluid that is in the LYMPHATIC SYSTEM.
=750  \0$aLymph$5IEN$0(DLC)sh 85079124

=LDR  00704cz  a2200217n  4500
=001  9880363620002441
=005  20141212203132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008195
=035  \\$aCBA1435HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x750.$x645
=150  \\$aLymnaea
=450  \\$wnnna$aLymnaeas
=450  \\$wnnna$aLymnea
=450  \\$wnnna$aLymneas
=550  \\$wg$aSnails
=667  \\$afreshwater snail; /microbiol /parasitol /virol permitted
=680  \\$iA genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes.
=688  \\$a72
=750  \0$aLymnaea$5IEN$0(DLC)sh 88021028

=LDR  01427cz  a2200313n  4500
=001  9880363620102441
=005  20141212203132.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008193
=035  \\$aCBA1433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x155.$x569
=072  \\$aC1.$x252.$x400.$x825.$x480
=072  \\$aC1.$x252.$x847.$x193.$x569
=150  \\$aLyme Disease
=450  \\$wnnna$aArthritis, Lyme
=450  \\$wnnna$aBorreliosis, Lyme
=450  \\$wnnna$aDisease, Lyme
=450  \\$wnnna$aLyme Arthritis
=450  \\$aLyme Borreliosis
=550  \\$wg$aBorrelia Infections
=550  \\$wg$aTick-Borne Diseases
=550  \\$wh$aErythema Chronicum Migrans
=550  \\$wh$aLyme Neuroborreliosis
=550  \\$aBorrelia burgdorferi Group
=667  \\$acoord IM with specific Borrelia (IM)
=680  \\$iAn infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.
=688  \\$a85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS l979-84
=750  \0$aLyme disease$5IEN$0(DLC)sh 87003150

=LDR  00792cz  a2200277n  4500
=001  9880363620202441
=005  20141212203131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008192
=035  \\$aCBA1432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x157
=150  \\$aDeception
=450  \\$wnnna$aAllegation, False
=450  \\$wnnna$aAllegations, False
=450  \\$wnnna$aDeceptions
=450  \\$wnnna$aFalse Allegation
=450  \\$aFalse Allegations
=450  \\$aLying
=550  \\$wg$aSocial Behavior
=550  \\$aFraud
=550  \\$aProfessional Misconduct
=667  \\$ano qualif
=680  \\$iThe act of deceiving or the fact (or condition) of being deceived.
=688  \\$a98(66)
=750  \0$aTruthfulness and falsehood$5IEN$0(DLC)sh 85138286

=LDR  00772cz  a2200193n  4500
=001  9880363620302441
=005  20141212203131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008191
=035  \\$aCBA1431HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45.$x250.$x400
=072  \\$aD1.$x455.$x450
=150  \\$aLye
=550  \\$wg$aHydroxides
=667  \\$aa caustic
=680  \\$iGenerally speaking, it is the alkaline substance obtained from wood ashes by percolation. Preparations of lye can be solutions of either potassium or sodium hydroxide. The term lye, is also used to refer to the household product which is a mixture of sodium hydroxide and sodium carbonate.
=688  \\$a91(75); was see under CAUSTICS 1975-90
=750  \0$aLye$5IEN$0(DLC)sh 85079104

=LDR  00857cz  a2200253n  4500
=001  9880363620402441
=005  20141212203131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008190
=035  \\$aCBA1430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520
=150  \\$aLyases
=450  \\$aDesmolases
=550  \\$wg$aEnzymes
=550  \\$wh$aCarbon-Carbon Lyases
=550  \\$wh$aCarbon-Nitrogen Lyases
=550  \\$wh$aCarbon-Oxygen Lyases
=550  \\$wh$aCarbon-Sulfur Lyases
=550  \\$wh$aFerrochelatase
=550  \\$wh$aPhosphorus-Oxygen Lyases
=680  \\$iA class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. (Enzyme Nomenclature, 1992) EC 4.
=688  \\$aDESMOLASES was see under LYASES 1963-80
=750  \0$aLyases$5IEN$0(DLC)sh 85079067

=LDR  00887cz  a2200229n  4500
=001  9880363620502441
=005  20141212203130.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008188
=035  \\$aCBA1428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x552
=072  \\$aD23.$x50.$x705.$x230.$x552
=150  \\$aLutheran Blood-Group System
=450  \\$wnnna$aBlood-Group System, Lutheran
=450  \\$wnnna$aLutheran Blood Group System
=450  \\$wnnna$aSystem, Lutheran Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iA complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor.
=688  \\$a76
=750  \0$aBlood groups$xLutheran system$5IEN$0(DLC)sh 88003254

=LDR  01715cz  a2200445n  4500
=001  9880363419002441
=005  20141212200913.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004398
=035  \\$aCAZ7532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25.$x193.$x249
=072  \\$aD12.$x776.$x220.$x600.$x200
=150  \\$aDyneins
=450  \\$wnnna$aAdenosine Triphosphatase, Dynein
=450  \\$aAdenosinetriphosphatase, Dynein
=450  \\$aATPase, Dynein
=450  \\$wnnna$aChains, Dynein Heavy
=450  \\$wnnna$aChains, Dynein Intermediate
=450  \\$wnnna$aChains, Dynein Light
=450  \\$aDynein
=450  \\$wnnna$aDynein Adenosine Triphosphatase
=450  \\$aDynein Adenosinetriphosphatase
=450  \\$aDynein ATPase
=450  \\$wnnna$aDynein Heavy Chains
=450  \\$wnnna$aDynein Intermediate Chains
=450  \\$wnnna$aDynein Light Chains
=450  \\$wnnna$aDynein Light Intermediate Chains
=450  \\$wnnna$aHeavy Chains, Dynein
=450  \\$wnnna$aIntermediate Chains, Dynein
=450  \\$wnnna$aLight Chains, Dynein
=550  \\$wg$aMicrotubule Proteins
=550  \\$wg$aMolecular Motor Proteins
=550  \\$wh$aAxonemal Dyneins
=550  \\$wh$aCytoplasmic Dyneins
=680  \\$iA family of multisubunit cytoskeletal motor proteins that use the energy of ATP hydrolysis to power a variety of cellular functions. Dyneins fall into two major classes based upon structural and functional criteria.
=688  \\$a2010(1993)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Dynein ATPase
=688  \\$a93; was DYNEIN 1977-92 (see under ADENOSINE TRIPHOSPHATASE 1977-90)
=750  \0$aDynein$0(DLC) sh 88004414$5IEN

=LDR  01434cz  a2200409n  4500
=001  9880363419102441
=005  20141212200912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004396
=035  \\$aCAZ7530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x233
=072  \\$aD27.$x720.$x470.$x330
=150  \\$aColoring Agents
=450  \\$aDyes
=450  \\$wnnna$aInorganic Pigments
=450  \\$wnnna$aOrganic Pigments
=450  \\$wnno$aPhthalein Dyes$5IEN-M
=450  \\$wnnna$aPigments, Inorganic
=450  \\$wnnna$aPigments, Organic
=450  \\$aStains
=450  \\$wnnna$aStains, Tissue
=450  \\$aTissue Stains
=550  \\$wg$aLaboratory Chemicals
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aChromogenic Compounds
=550  \\$wh$aFluorescent Dyes
=550  \\$wh$aFood Coloring Agents
=550  \\$wh$aHair Dyes
=550  \\$aIndicators and Reagents
=550  \\$aStaining and Labeling
=667  \\$adifferentiate from PIGMENTS, BIOLOGICAL
=680  \\$iChemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS.
=688  \\$a2006(1963); for STAINS use STAINS AND STAINING 1991-1995
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Dyes
=688  \\$a63; STAINS was see STAINS AND STAINING 1991-95
=750  \0$aDyes and dyeing$0(DLC) sh 85040281$5IEN

=LDR  01674cz  a2200385n  4500
=001  9880363419202441
=005  20141212200911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004393
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x343.$x445
=072  \\$aC5.$x116.$x132.$x358
=072  \\$aC10.$x228.$x140.$x617.$x738.$x300.$x300
=072  \\$aC19.$x297.$x312
=072  \\$aC19.$x700.$x482.$x311
=150  \\$aDwarfism, Pituitary
=450  \\$wnnna$aDwarfism, Growth Hormone Deficiency
=450  \\$aGrowth Hormone Deficiency Dwarfism
=450  \\$aHypophysial Dwarf
=450  \\$aHyposomatotrophic Dwarfism
=450  \\$wnnna$aIsolated GH Deficiency
=450  \\$wnnna$aIsolated Growth Hormone Deficiency
=450  \\$wnnna$aIsolated HGH Deficiency
=450  \\$wnnna$aIsolated Human Growth Hormone Deficiency
=450  \\$wnnna$aIsolated Somatotropin Deficiency
=450  \\$wnnna$aIsolated Somatotropin Deficiency Disorder
=450  \\$wnnna$aNanism, Pituitary
=450  \\$aPituitary Dwarf
=450  \\$wnnna$aPituitary Dwarfism
=450  \\$wnnna$aPituitary Nanism
=550  \\$wg$aBone Diseases, Endocrine
=550  \\$wg$aDwarfism
=550  \\$wg$aHypopituitarism
=680  \\$iA form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene (GH1) in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.
=750  \0$aDwarfism, Pituitary$5IEN$0(DLC)sh 85040187

=LDR  01103cz  a2200325n  4500
=001  9880363419302441
=005  20141212200911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004392
=035  \\$aCAZ7526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x343
=072  \\$aC16.$x320.$x240
=072  \\$aC19.$x297
=150  \\$aDwarfism
=450  \\$aNanism
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aEndocrine System Diseases
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wh$aAchondroplasia
=550  \\$wh$aCockayne Syndrome
=550  \\$wh$aCongenital Hypothyroidism
=550  \\$wh$aDwarfism, Pituitary
=550  \\$wh$aLaron Syndrome
=550  \\$wh$aMulibrey Nanism
=550  \\$wh$aSilver-Russell Syndrome
=550  \\$wh$aWeill-Marchesani Syndrome
=550  \\$aGrowth Disorders
=680  \\$iA genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
=750  \0$aDwarfism$5IEN$0(DLC)sh 85040186

=LDR  00793cz  a2200229n  4500
=001  9880363419402441
=005  20141212200910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004391
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x222
=150  \\$aDust
=450  \\$wnnna$aDust, House
=450  \\$aHouse Dust
=450  \\$wnnna$aHousedust
=550  \\$wg$aParticulate Matter
=550  \\$wh$aCosmic Dust
=550  \\$aAllergens
=550  \\$aPyroglyphidae
=667  \\$acoord with specific substance yielding dust: GOLD + DUST; COAL + DUST; do not index here for specific dusts in pneumoconiosis: see note under PNEUMOCONIOSIS
=680  \\$iEarth or other matter in fine, dry particles. (Random House Unabridged Dictionary, 2d ed)
=750  \0$aDust$5IEN$0(DLC)sh 85040073

=LDR  00861cz  a2200277n  4500
=001  9880363419502441
=005  20141212192147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004388
=035  \\$aCAZ7522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x566.$x395
=150  \\$aDura Mater
=450  \\$wnnna$aCerebelli, Falx
=450  \\$wnnna$aCerebellus, Falx
=450  \\$wnnna$aDura Maters
=450  \\$wnnna$aFalx Cerebelli
=450  \\$wnnna$aFalx Cerebellus
=450  \\$wnnna$aMater, Dura
=450  \\$wnnna$aMaters, Dura
=450  \\$wnnna$aPachymeninx
=450  \\$wnnna$aPachymeninxs
=550  \\$wg$aMeninges
=550  \\$wh$aSubdural Space
=680  \\$iThe outermost of the three MENINGES, a fibrous membrane of connective tissue that covers the brain and the spinal cord.
=750  \0$aDura mater$5IEN$0(DLC)sh 85040017

=LDR  01150cz  a2200301n  4500
=001  9880363419602441
=005  20141212200909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004387
=035  \\$aCAZ7521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x197.$x270
=072  \\$aC17.$x300.$x270
=150  \\$aDupuytren Contracture
=450  \\$wnnna$aContracture, Dupuytren
=450  \\$wnnna$aContracture, Dupuytren's
=450  \\$wnnna$aDupuytren Disease
=450  \\$aDupuytren's Contracture
=450  \\$wnnna$aDupuytrens Contracture
=450  \\$wnnna$aDupuytren's Disease
=450  \\$wnnna$aDupuytrens Disease
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aContracture
=667  \\$acontracture of fingers
=680  \\$iA fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.
=688  \\$a2010(1963)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Dupuytren's Contracture
=750  \0$aDupuytren's contracture$0(DLC) sh 85040014$5IEN-M

=LDR  01071cz  a2200241n  4500
=001  9880363419702441
=005  20141212200909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004386
=035  \\$aCAZ7520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x684.$x124
=072  \\$aA3.$x556.$x875.$x249
=150  \\$aDuodenum
=450  \\$wnnna$aDuodenums
=550  \\$wg$aIntestine, Small
=550  \\$wg$aUpper Gastrointestinal Tract
=550  \\$wh$aAmpulla of Vater
=550  \\$wh$aBrunner Glands
=667  \\$ainflammation = DUODENITIS; fistula = DUODENAL DISEASES (IM) + INTESTINAL FISTULA (IM); duodenal atresia = DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM); duodenal juice = DUODENUM (IM) + INTESTINAL SECRETIONS (IM) (not DUODENUM /secret)
=680  \\$iThe shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
=688  \\$aDUODENAL INTUBATION was heading 1963-65
=750  \0$aDuodenum$5IEN$0(DLC)sh 85039998

=LDR  01334cz  a2200373n  4500
=001  9880363419802441
=005  20141212192147.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004384
=035  \\$aCAZ7518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x225
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x200
=072  \\$aE4.$x210.$x240.$x250.$x200
=072  \\$aE4.$x502.$x250.$x250.$x250.$x200
=150  \\$aDuodenoscopy
=450  \\$wnnna$aDuodenoscopic Surgeries
=450  \\$wnnna$aDuodenoscopic Surgery
=450  \\$wnnna$aDuodenoscopic Surgical Procedure
=450  \\$aDuodenoscopic Surgical Procedures
=450  \\$wnnna$aDuodenoscopies
=450  \\$wnnna$aProcedure, Duodenoscopic Surgical
=450  \\$wnnna$aProcedures, Duodenoscopic Surgical
=450  \\$wnnna$aSurgeries, Duodenoscopic
=450  \\$wnnna$aSurgery, Duodenoscopic
=450  \\$wnnna$aSurgical Procedure, Duodenoscopic
=450  \\$aSurgical Procedures, Duodenoscopic
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$aDuodenoscopes
=550  \\$aDuodenum
=667  \\$a/ instrum permitted but consider also DUODENOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the luminal surface of the duodenum.
=688  \\$a81
=750  \0$aDuodenoscopy$5IEN$0(DLC)sh 85039997

=LDR  00991cz  a2200277n  4500
=001  9880363419902441
=005  20141212200908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004381
=035  \\$aCAZ7515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x275.$x800.$x348
=072  \\$aC6.$x405.$x608.$x173
=150  \\$aDuodenal Ulcer
=450  \\$wnnna$aCurling Ulcer
=450  \\$aCurling's Ulcer
=450  \\$wnnna$aCurlings Ulcer
=450  \\$wnnna$aDuodenal Ulcers
=450  \\$wnnna$aUlcer, Curling
=450  \\$wnnna$aUlcer, Duodenal
=450  \\$wnnna$aUlcers, Duodenal
=550  \\$wg$aPeptic Ulcer
=667  \\$aperforation = DUODENAL ULCER /compl (IM) + PEPTIC ULCER PERFORATION (IM); hemorrhage = DUODENAL ULCER /compl (IM) + PEPTIC ULCER HEMORRHAGE (IM)
=680  \\$iA PEPTIC ULCER located in the DUODENUM.
=688  \\$aCURLING'S ULCER was heading 1975-96 (see under DUODENAL ULCER 1975-90)
=750  \0$aDuodenum$xUlcers$5IEN$0(DLC)sh 85040004

=LDR  01046cz  a2200325n  4500
=001  9880363420002441
=005  20141212200907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004379
=035  \\$aCAZ7513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411.$x445
=072  \\$aC6.$x301.$x371.$x411.$x445
=072  \\$aC6.$x405.$x249.$x411.$x445
=072  \\$aC6.$x405.$x469.$x275.$x270
=072  \\$aC6.$x405.$x469.$x491.$x445
=150  \\$aDuodenal Neoplasms
=450  \\$wnnna$aCancer, Duodenal
=450  \\$wnnna$aCancer of Duodenum
=450  \\$wnnna$aCancer of the Duodenum
=450  \\$wnnna$aDuodenal Cancer
=450  \\$wnnna$aDuodenal Neoplasm
=450  \\$wnnna$aDuodenum Cancer
=450  \\$wnnna$aNeoplasm, Duodenal
=450  \\$wnnna$aNeoplasms, Duodenal
=550  \\$wg$aDuodenal Diseases
=550  \\$wg$aIntestinal Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the DUODENUM.
=750  \0$aDuodenum$xCancer$5IEN-M$0(DLC)sh 85039999

=LDR  00944cz  a2200265n  4500
=001  9880363420102441
=005  20141212200907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004378
=035  \\$aCAZ7512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x275
=150  \\$aDuodenal Diseases
=450  \\$wnnna$aDisease, Duodenal
=450  \\$wnnna$aDiseases, Duodenal
=450  \\$wnnna$aDuodenal Disease
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aDuodenal Neoplasms
=550  \\$wh$aDuodenal Obstruction
=550  \\$wh$aDuodenitis
=550  \\$wh$aDuodenogastric Reflux
=550  \\$wh$aPeptic Ulcer
=667  \\$aGEN; prefer specifics; inflamm dis = DUODENITIS; duodenal atresia = DUODENAL OBSTRUCTION /congen (IM) + INTESTINAL ATRESIA (IM)
=680  \\$iPathological conditions in the DUODENUM region of the small intestine (INTESTINE, SMALL).
=750  \0$aDuodenum$xDiseases$5IEN$0(DLC)sh 85040000

=LDR  00661cz  a2200205n  4500
=001  9880363420202441
=005  20141212200907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004377
=035  \\$aCAZ7511HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x630.$x310
=072  \\$aC23.$x550.$x767.$x812.$x500
=150  \\$aDumping Syndrome
=450  \\$wnnna$aDumping Syndromes
=450  \\$wnnna$aSyndrome, Dumping
=450  \\$wnnna$aSyndromes, Dumping
=550  \\$wg$aPostgastrectomy Syndromes
=680  \\$iGastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.
=750  \0$aDumping syndrome$5IEN$0(DLC)sh 85039959

=LDR  00949cz  a2200229n  4500
=001  9880363420302441
=005  20141212200906.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004375
=035  \\$aCAZ7509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x301
=072  \\$aD23.$x50.$x705.$x230.$x301
=150  \\$aDuffy Blood-Group System
=450  \\$wnnna$aBlood-Group System, Duffy
=450  \\$wnnna$aDuffy Blood Group System
=450  \\$wnnna$aSystem, Duffy Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iA blood group consisting mainly of the antigens Fy(a) and Fy(b), determined by allelic genes, the frequency of which varies profoundly in different human groups; amorphic genes are common.
=688  \\$a91(76); was see under BLOOD GROUPS 1976-90
=750  \0$aBlood groups$xDuffy system$5IEN$0(DLC)sh 88003252

=LDR  01038cz  a2200241n  4500
=001  9880363420402441
=005  20141212200906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004374
=035  \\$aCAZ7508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x340
=072  \\$aC14.$x280.$x400.$x340
=072  \\$aC16.$x131.$x240.$x400.$x340
=150  \\$aDuctus Arteriosus, Patent
=450  \\$wnnna$aPatency of the Ductus Arteriosus
=450  \\$wnnna$aPatent Ductus Arteriosus
=450  \\$aPatent Ductus Arteriosus Familial
=550  \\$wg$aHeart Defects, Congenital
=550  \\$aPersistent Fetal Circulation Syndrome
=680  \\$iA congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.
=688  \\$a65(64)
=750  \0$aPatent ductus arteriosus$5IEN$0(DLC)sh 85098642

=LDR  00630cz  a2200193n  4500
=001  9880363420502441
=005  20141212200906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004373
=035  \\$aCAZ7507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x278.$x395
=072  \\$aA16.$x378.$x303.$x395
=150  \\$aDuctus Arteriosus
=450  \\$wnnna$aArteriosus, Ductus
=550  \\$wg$aFetal Heart
=667  \\$anormal; abnormal is probably DUCTUS ARTERIOSUS, PATENT
=680  \\$iA fetal blood vessel connecting the pulmonary artery with the descending aorta.
=750  \0$aDuctus arteriosus$5IEN$0(DLC)sh 85039885

=LDR  00686cz  a2200205n  4500
=001  9880363420602441
=005  20141212200905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004372
=035  \\$aCAZ7506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x50.$x200
=072  \\$aB1.$x50.$x150.$x900.$x248.$x617.$x345
=150  \\$aDucks
=450  \\$wnnna$aDuck
=550  \\$wg$aAnseriformes
=550  \\$wg$aPoultry
=667  \\$adomestic or wild; IM; qualif permitted; diseases: coord IM with POULTRY DISEASES (IM); diseases of wild ducks: coord IM with BIRD DISEASES (IM), not POULTRY DISEASES
=688  \\$a68
=750  \0$aDucks$5IEN$0(DLC)sh 85039879

=LDR  01991cz  a2200613n  4500
=001  9880363420702441
=005  20141212200903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004369
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782.$x590
=072  \\$aD2.$x241.$x81.$x18.$x639
=150  \\$aPentetic Acid
=450  \\$wnnna$aAcid, Diethylenetriamine Pentaacetic
=450  \\$wnnna$aCa-DTPA
=450  \\$wnnna$aCa DTPA
=450  \\$wnnna$aCaDTPA
=450  \\$wnnna$aCalcium Trisodium Pentetate
=450  \\$wnnna$aCalcium Trisodium, Pentetate
=450  \\$wnnna$aCaNa-DTPA
=450  \\$wnnna$aCaNa DTPA
=450  \\$wnnna$aDETAPAC
=450  \\$aDiethylenetriamine Pentaacetic Acid
=450  \\$aDTPA
=450  \\$wnnna$aIndium-DTPA
=450  \\$wnnna$aIndium DTPA
=450  \\$wnnna$aMn-Dtpa
=450  \\$wnnna$aMn Dtpa
=450  \\$wnnna$aPentaacetic Acid, Diethylenetriamine
=450  \\$wnnna$aPentacin
=450  \\$wnnna$aPentacine
=450  \\$wnnna$aPentaind
=450  \\$wnnna$aPentetate Calcium Trisodium
=450  \\$wnnna$aPentetate, Calcium Trisodium
=450  \\$wnnna$aPentetate Zinc Trisodium
=450  \\$aPentetates
=450  \\$aPenthanil
=450  \\$wnnna$aSn-DTPA
=450  \\$wnnna$aSn DTPA
=450  \\$wnnna$aTrisodium Pentetate, Calcium
=450  \\$wnnna$aTrisodium, Pentetate Calcium
=450  \\$wnnna$aTrisodium, Pentetate Zinc
=450  \\$wnnna$aZinc-DTPA
=450  \\$wnnna$aZinc DTPA
=450  \\$wnnna$aZinc Trisodium, Pentetate
=550  \\$wg$aAcetates
=550  \\$wg$aPolyamines
=550  \\$wh$aGadolinium DTPA
=550  \\$wh$aTechnetium Tc 99m Pentetate
=667  \\$aGADOLINIUM DTPA is also available
=680  \\$iAn iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
=688  \\$a1999(1966)
=688  \\$a99(66)
=750  \0$aDiethylenetriaminepentaacetic acid$5IEN-M$0(DLC)sh 85037868

=LDR  00695cz  a2200241n  4500
=001  9880363420802441
=005  20141212200902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004367
=035  \\$aCAZ7501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200.$x200.$x250
=072  \\$aD1.$x650.$x550.$x200.$x250
=150  \\$aDry Ice
=450  \\$aCarbon Dioxide Snow
=450  \\$wnnna$aDioxide Snow, Carbon
=450  \\$wnnna$aIce, Dry
=450  \\$wnnna$aSnow, Carbon Dioxide
=550  \\$wg$aCarbon Dioxide
=550  \\$aIce
=667  \\$anote X ref; a refrigerant
=680  \\$iA solid form of carbon dioxide used as a refrigerant.
=750  \0$aDry ice$5IEN$0(DLC)sh 85039805

=LDR  01123cz  a2200253n  4500
=001  9880363420902441
=005  20141212211012.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015352
=035  \\$aCAZ7500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x496.$x260
=150  \\$aDry Eye Syndromes
=450  \\$wnnna$aDry Eye Syndrome
=450  \\$wnnna$aSyndrome, Dry Eye
=450  \\$wnnna$aSyndromes, Dry Eye
=550  \\$wg$aLacrimal Apparatus Diseases
=550  \\$wh$aKeratoconjunctivitis Sicca
=550  \\$wh$aSjogren's Syndrome
=550  \\$wh$aXerophthalmia
=667  \\$adefic tear production; GEN or unspecified: prefer specifics; do not confuse with XEROPHTHALMIA: read MeSH definitions
=680  \\$iCorneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.
=688  \\$a89
=750  \0$aDry eye syndromes$5IEN$0(DLC)sh 91005269

=LDR  01234cz  a2200361n  4500
=001  9880363421002441
=005  20141212200902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004366
=035  \\$aCAZ7499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x530
=150  \\$aNonprescription Drugs
=450  \\$aDrugs, Non-Prescription
=450  \\$wnnna$aDrugs, Non Prescription
=450  \\$wnnna$aDrugs, Nonprescription
=450  \\$wnnna$aDrugs, OTC
=450  \\$wnnna$aDrugs, Over-the-Counter
=450  \\$wnnna$aMedicines, Patent
=450  \\$wnnna$aNon-Prescription Drugs
=450  \\$wnnna$aNon Prescription Drugs
=450  \\$aOTC Drugs
=450  \\$aOver-the-Counter Drugs
=450  \\$wnnna$aOver the Counter Drugs
=450  \\$aPatent Medicines
=550  \\$wg$aPharmaceutical Preparations
=550  \\$wh$aBehind-the-Counter Drugs
=667  \\$aentry term OVER-THE-COUNTER DRUGS: BEHIND-THE-COUNTER DRUGS is also available
=680  \\$iMedicines that can be sold legally without a DRUG PRESCRIPTION.
=688  \\$a2009(1973)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Drugs, Non-Prescription
=688  \\$a74(73)
=750  \0$aDrugs, Nonprescription$0(DLC) sh 85039761$5IEN-M

=LDR  01266cz  a2200313n  4500
=001  9880363421102441
=005  20141212200902.0
=008  870325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004365
=035  \\$aCAZ7498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x350
=072  \\$aD26.$x335
=150  \\$aDrugs, Chinese Herbal
=450  \\$wnnna$aChinese Drugs, Plant
=450  \\$aChinese Herbal Drugs
=450  \\$wnnna$aChinese Plant Extracts
=450  \\$wnnna$aExtracts, Chinese Plant
=450  \\$wnnna$aHerbal Drugs, Chinese
=450  \\$aPlant Extracts, Chinese
=550  \\$wg$aPharmaceutical Preparations
=550  \\$wg$aPlant Extracts
=550  \\$aMedicine, Chinese Traditional
=550  \\$aPhytotherapy
=550  \\$aReishi
=667  \\$adrugs used in MEDICINE, CHINESE TRADITIONAL or MEDICINE, KAMPO not synthetic drugs manufactured in China; D25-26 qualif; Chinese names of these drugs not capitalized in titles or translations; TN J: indexing instructions
=680  \\$iChinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.
=688  \\$a88
=750  \0$aHerbs$zChina$5IEN$0(IEN)367434

=LDR  01927cz  a2200565n  4500
=001  9880363421202441
=005  20201209104742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004364
=035  \\$aCAZ7497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26
=150  \\$aPharmaceutical Preparations
=450  \\$aDrugs
=450  \\$wnnna$aPharmaceutic Preparations
=450  \\$wnnna$aPharmaceutical Products
=450  \\$wnnna$aPreparations, Pharmaceutic
=450  \\$wnnna$aPreparations, Pharmaceutical
=450  \\$wnnna$aProducts, Pharmaceutical
=550  \\$wh$aControlled Substances
=550  \\$wh$aCosmeceuticals
=550  \\$wh$aCounterfeit Drugs
=550  \\$wh$aDesigner Drugs
=550  \\$wh$aDosage Forms
=550  \\$wh$aDrug Combinations
=550  \\$wh$aDrugs, Chinese Herbal
=550  \\$wh$aDrugs, Essential
=550  \\$wh$aDrugs, Generic
=550  \\$wh$aDrugs, Investigational
=550  \\$wh$aMateria Medica
=550  \\$wh$aMedical Marijuana
=550  \\$wh$aNonprescription Drugs
=550  \\$wh$aNostrums
=550  \\$wh$aPharmaceutic Aids
=550  \\$wh$aPharmaceutical Preparations, Dental
=550  \\$wh$aPlacebos
=550  \\$wh$aPlant Extracts
=550  \\$wh$aPrescription Drugs
=550  \\$wh$aProdrugs
=550  \\$wh$aSolutions
=550  \\$wh$aIllicit Drugs
=550  \\$wh$aVaginal Creams, Foams, and Jellies
=550  \\$wh$aVeterinary Drugs
=550  \\$wh$aXenobiotics
=550  \\$aDrug Dosage Calculations
=550  \\$aPharmacology
=667  \\$ageneral or unspecified only; prefer specific drugs; drug names: use NOMENCLATURE; policy: Manual chapter 25
=680  \\$iDrugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
=688  \\$a98(63)
=750  \0$aDrugs$0(DLC) sh 85039719$5IEN

=LDR  00951cz  a2200241n  4500
=001  9880363421302441
=005  20141212200901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004363
=035  \\$aCAZ7496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x706.$x477
=150  \\$aDrug Utilization
=450  \\$wnnna$aDrug Utilizations
=450  \\$wnnna$aUtilization, Drug
=450  \\$wnnna$aUtilizations, Drug
=550  \\$wg$aPharmacy Administration
=550  \\$wh$aDrug Utilization Review
=550  \\$aOff-Label Use
=667  \\$anot for "use" in therapy from patient's viewpoint ( = drug /ther use): for use by MDs, hospitals, clinics, pharmacies, localities, etc
=680  \\$iThe utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
=688  \\$a73(68)
=750  \0$aDrug utilization$5IEN$0(DLC)sh 85039716

=LDR  01057cz  a2200217n  4500
=001  9880363421402441
=005  20160930141517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004361
=035  \\$aCAZ7494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x773.$x992
=150  \\$aDrug Tolerance
=450  \\$wnnna$aDrug Tolerances
=450  \\$wnnna$aTolerance, Drug
=450  \\$wnnna$aTolerances, Drug
=550  \\$wg$aPharmacological Phenomena
=550  \\$wh$aTachyphylaxis
=667  \\$adifferentiate from DRUG RESISTANCE; not for tolerability ( = drug /adv eff): Manual 28.19
=680  \\$iProgressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.
=750  \0$aDrug tolerance$5IEN$0(DLC)sh 85039712

=LDR  01656cz  a2200409n  4500
=001  9880363421502441
=005  20141212200900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004359
=035  \\$aCAZ7492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x310
=150  \\$aDrug Therapy, Combination
=450  \\$wnnna$aChemotherapies, Combination
=450  \\$wnnna$aChemotherapy, Combination
=450  \\$wnnna$aCombination Chemotherapies
=450  \\$aCombination Chemotherapy
=450  \\$wnnna$aCombination Drug Therapies
=450  \\$wnnna$aCombination Drug Therapy
=450  \\$wnnna$aDrug Polytherapies
=450  \\$wnnna$aDrug Polytherapy
=450  \\$wnnna$aDrug Therapies, Combination
=450  \\$wnnna$aPolychemotherapies
=450  \\$aPolychemotherapy
=450  \\$wnnna$aPolytherapies, Drug
=450  \\$wnnna$aPolytherapy, Drug
=450  \\$wnnna$aTherapies, Combination Drug
=450  \\$wnnna$aTherapy, Combination Drug
=550  \\$wg$aDrug Therapy
=550  \\$wh$aAntineoplastic Combined Chemotherapy Protocols
=550  \\$wh$aAntiretroviral Therapy, Highly Active
=550  \\$aDrug Combinations
=550  \\$aPolypharmacy
=667  \\$aIM when general; NIM when with specific drugs; differentiate from DRUG COMBINATIONS which is single preparation of multiple drugs; note entry term POLYCHEMOTHERAPY: do not confuse with POLYPHARMACY which is available for the use of multiple drugs administered to the same patient
=680  \\$iTherapy with two or more separate preparations given for a combined effect.
=688  \\$a74
=750  \0$aChemotherapy, Combination$5IEN$0(DLC)sh 85023042

=LDR  02585cz  a2200721n  4500
=001  9880363421602441
=005  20200501122241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004358
=035  \\$aCAZ7491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319
=150  \\$aDrug Therapy
=450  \\$wnnna$aChemotherapies
=450  \\$aChemotherapy
=450  \\$aDisease$xdrug therapy
=450  \\$wnnna$aDrug Therapies
=450  \\$aPharmaceutical Preparations$xtherapeutic use
=450  \\$wnnna$aPharmacotherapies
=450  \\$aPharmacotherapy
=450  \\$wnnna$aTherapies, Drug
=450  \\$wnnna$aTherapy, Drug
=550  \\$wg$aTherapeutics
=550  \\$wh$aAntineoplastic Protocols
=550  \\$wh$aChelation Therapy
=550  \\$wh$aChemoprevention
=550  \\$wh$aChemoradiotherapy
=550  \\$wh$aChemotherapy, Adjuvant
=550  \\$wh$aConsolidation Chemotherapy
=550  \\$wh$aDrug Administration Routes
=550  \\$wh$aDrug Administration Schedule
=550  \\$wh$aDrug Delivery Systems
=550  \\$wh$aDrug Dosage Calculations
=550  \\$wh$aDrug Misuse
=550  \\$wh$aDrug Prescriptions
=550  \\$wh$aDrug Therapy, Combination
=550  \\$wh$aDrug Therapy, Computer-Assisted
=550  \\$wh$aElectrochemotherapy
=550  \\$wh$aEnema
=550  \\$wh$aEnzyme Therapy
=550  \\$wh$aFluid Therapy
=550  \\$wh$aHome Infusion Therapy
=550  \\$wh$aHormone Replacement Therapy
=550  \\$wh$aInappropriate Prescribing
=550  \\$wh$aInduction Chemotherapy
=550  \\$wh$aMaintenance Chemotherapy
=550  \\$wh$aMedication Errors
=550  \\$wh$aMolecular Targeted Therapy
=550  \\$wh$aOpiate Substitution Treatment
=550  \\$wh$aOrthomolecular Therapy
=550  \\$wh$aPhotochemotherapy
=550  \\$wh$aPleurodesis
=550  \\$wh$aPolypharmacy
=550  \\$wh$aPremedication
=550  \\$wh$aPrescription Drug Misuse
=550  \\$wh$aSclerotherapy
=550  \\$wh$aSelf Administration
=550  \\$wh$aSelf Medication
=550  \\$wh$aThrombolytic Therapy
=550  \\$aPharmacologic Actions
=667  \\$ageneral only: prefer /drug ther with disease term: Manual 19.7+, 19.8.26; note entry term CHEMOTHERAPY: prefer specific chemical or chemical group, e.g., chemotherapy of lymphoma = LYMPHOMA /drug ther + ANTINEOPLASTIC AGENTS /ther use, not DRUG THERAPY
=680  \\$iThe use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.
=750  \0$aChemotherapy$5IEN$0(DLC)sh 85023041

=LDR  01134cz  a2200349n  4500
=001  9880363421702441
=005  20141212200858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004357
=035  \\$aCAZ7490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x240.$x477
=072  \\$aG7.$x700.$x680.$x240.$x477
=150  \\$aDrug Synergism
=450  \\$wnnna$aAugmentation, Drug
=450  \\$wnnna$aAugmentations, Drug
=450  \\$wnnna$aDrug Augmentation
=450  \\$wnnna$aDrug Augmentations
=450  \\$aDrug Potentiation
=450  \\$wnnna$aDrug Potentiations
=450  \\$wnnna$aDrug Synergisms
=450  \\$wnnna$aPotentiation, Drug
=450  \\$wnnna$aPotentiations, Drug
=450  \\$wnnna$aSynergism, Drug
=450  \\$wnnna$aSynergisms, Drug
=550  \\$wg$aDrug Interactions
=550  \\$aDrug Combinations
=550  \\$aDrug Therapy, Combination
=667  \\$aIM when general; NIM when with specific drugs (IM)
=680  \\$iThe action of a drug in promoting or enhancing the effectiveness of another drug.
=688  \\$a66(65)
=750  \0$aDrug synergism$5IEN$0(DLC)sh 85039711

=LDR  00579cz  a2200205n  4500
=001  9880363421802441
=005  20141212200858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004356
=035  \\$aCAZ7489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x350
=150  \\$aDrug Storage
=450  \\$wnnna$aDrug Storages
=450  \\$wnnna$aStorage, Drug
=450  \\$wnnna$aStorages, Drug
=550  \\$wg$aTechnology, Pharmaceutical
=667  \\$aIM when general; NIM when with specific drug (IM)
=688  \\$a68
=750  \0$aDrugs$xStorage$5IEN$0(DLC)sh 85039750

=LDR  00651cz  a2200205n  4500
=001  9880363421902441
=005  20141212200857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004355
=035  \\$aCAZ7488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x330
=150  \\$aDrug Stability
=450  \\$wnnna$aDrug Stabilities
=450  \\$wnnna$aStabilities, Drug
=450  \\$wnnna$aStability, Drug
=550  \\$wg$aTechnology, Pharmaceutical
=667  \\$aIM when general; NIM when with specific drug (IM); no qualif; for stability of enzymes use ENZYME STABILITY
=688  \\$a68(65)
=750  \0$aDrug stability$5IEN$0(DLC)sh 85039710

=LDR  01395cz  a2200325n  4500
=001  9880363422002441
=005  20141212200856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004352
=035  \\$aCAZ7485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x225
=072  \\$aG7.$x690.$x320.$x269
=150  \\$aDrug Resistance, Microbial
=450  \\$aAntibiotic Resistance
=450  \\$aAntibiotic Resistance, Microbial
=450  \\$wnnna$aAntimicrobial Drug Resistance
=450  \\$wnnna$aAntimicrobial Drug Resistances
=450  \\$wnnna$aDrug Resistances, Microbial
=450  \\$wnnna$aResistance, Antibiotic
=550  \\$wg$aDrug Resistance
=550  \\$wg$aMicrobiological Phenomena
=550  \\$wh$aDrug Resistance, Bacterial
=550  \\$wh$aDrug Resistance, Fungal
=550  \\$wh$aDrug Resistance, Viral
=550  \\$aMicrobial Sensitivity Tests
=667  \\$ageneral or unspecified; prefer specifics; not for protozoa: index DRUG RESISTANCE
=680  \\$iThe ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
=688  \\$a1963; for ANTIBIOTIC RESISTANCE use DRUG RESISTANCE 2002-2007
=750  \0$aDrug resistance in microorganisms$5IEN$0(DLC)sh 85039709

=LDR  01210cz  a2200277n  4500
=001  9880363422102441
=005  20141212200855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004351
=035  \\$aCAZ7484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x320
=150  \\$aDrug Resistance
=450  \\$wnnna$aResistance, Drug
=550  \\$wg$aPharmacological Phenomena
=550  \\$wh$aDrug Resistance, Microbial
=550  \\$wh$aDrug Resistance, Multiple
=550  \\$wh$aDrug Resistance, Neoplasm
=550  \\$wh$aHerbicide Resistance
=550  \\$wh$aInsecticide Resistance
=550  \\$wh$aInsulin Resistance
=550  \\$aPharmacogenetics
=667  \\$ageneral or unspecified; prefer specifics; differentiate from DRUG TOLERANCE; resistance of parasites including protozoa goes here
=680  \\$iDiminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
=688  \\$a1972
=750  \0$aDrug resistance$5IEN$0(DLC)sh 85039708

=LDR  01607cz  a2200337n  4500
=001  9880363422202441
=005  20141212192146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004349
=035  \\$aCAZ7482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x320
=072  \\$aJ1.$x576.$x655.$x750.$x321
=072  \\$aJ1.$x576.$x761.$x300
=150  \\$aDrug Packaging
=450  \\$wnnna$aContainer, Drug
=450  \\$wnnna$aContainers, Drug
=450  \\$wnnna$aDrug Container
=450  \\$wnnna$aDrug Containers
=450  \\$aDrug Containers and Closures
=450  \\$wnnna$aDrug Packagings
=450  \\$aPackaging, Drug
=450  \\$wnnna$aPackagings, Drug
=550  \\$wg$aDrug Industry
=550  \\$wg$aProduct Packaging
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$wh$aDrug Labeling
=667  \\$aincludes containers, packaging methods, packaging materials; IM; DRUG LABELING is also available
=680  \\$iContainers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.
=688  \\$a78; was DRUG CONTAINERS AND CLOSURES 1968-77
=750  \0$aDrugs$xPackaging$5IEN$0(DLC)sh 85039741

=LDR  01370cz  a2200361n  4500
=001  9880363422302441
=005  20141212192146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004348
=035  \\$aCAZ7481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x310
=072  \\$aJ1.$x576.$x655.$x750.$x321.$x400
=072  \\$aJ1.$x576.$x761.$x300.$x400
=150  \\$aDrug Labeling
=450  \\$wnnna$aDrug Labelling
=450  \\$wnnna$aDrug Package Insert
=450  \\$wnnna$aDrug Package Inserts
=450  \\$wnnna$aDrug Product Labeling
=450  \\$wnnna$aInsert, Drug Package
=450  \\$wnnna$aInserts, Drug Package
=450  \\$aLabeling, Drug
=450  \\$wnnna$aLabeling, Drug Product
=450  \\$wnnna$aLabelling, Drug
=450  \\$wnnna$aPackage Insert, Drug
=450  \\$aPackage Inserts, Drug
=450  \\$aProduct Labeling, Drug
=550  \\$wg$aDrug Packaging
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$aOff-Label Use
=680  \\$iUse of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
=688  \\$a68
=750  \0$aDrugs$xLabeling$5IEN$0(DLC)sh 85039733

=LDR  01102cz  a2200313n  4500
=001  9880363422402441
=005  20160930141130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004347
=035  \\$aCAZ7480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x773.$x968
=150  \\$aDrug Interactions
=450  \\$wnnna$aDrug Interaction
=450  \\$wnnna$aInteraction, Drug
=450  \\$wnnna$aInteractions, Drug
=550  \\$wg$aPharmacological Phenomena
=550  \\$wh$aDrug Agonism
=550  \\$wh$aDrug Antagonism
=550  \\$wh$aDrug Inverse Agonism
=550  \\$wh$aDrug Synergism
=550  \\$wh$aFood-Drug Interactions
=550  \\$wh$aHerb-Drug Interactions
=550  \\$aDrug-Related Side Effects and Adverse Reactions
=550  \\$aMetabolic Side Effects of Drugs and Substances
=667  \\$ado not confuse with DRUG INCOMPATIBILITY; IM when general; NIM with specific drugs (IM)
=680  \\$iThe action of a drug that may affect the activity, metabolism, or toxicity of another drug.
=688  \\$a72
=750  \0$aDrug interactions$0(DLC) sh 85039701$5IEN

=LDR  01133cz  a2200313n  4500
=001  9880363422502441
=005  20200618112307.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004346
=035  \\$aCAZ7479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x270
=072  \\$aN2.$x421.$x668.$x320
=150  \\$aDrug Information Services
=450  \\$wnnna$aDrug Information Service
=450  \\$wnnna$aInformation Service, Drug
=450  \\$wnnna$aInformation Services, Drug
=450  \\$wnnna$aService, Drug Information
=450  \\$wnnna$aServices, Drug Information
=550  \\$wg$aInformation Services
=550  \\$wg$aPharmaceutical Services
=550  \\$wh$aAdverse Drug Reaction Reporting Systems
=550  \\$wh$aClinical Pharmacy Information Systems
=550  \\$wh$aPharmacovigilance
=550  \\$wh$aPrescription Drug Monitoring Programs
=667  \\$aIM; DF: DRUG INFORMATION SERV
=680  \\$iServices providing pharmaceutic and therapeutic drug information and consultation.
=688  \\$a81(77); was see under INFORMATION SERVICES 1977-80
=750  \2$aPharmacy$xInformation services$5IEN

=LDR  01318cz  a2200325n  4500
=001  9880363422602441
=005  20141212192145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004345
=035  \\$aCAZ7478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x750
=150  \\$aDrug Industry
=450  \\$wnnna$aDrug Industries
=450  \\$wnnna$aIndustries, Drug
=450  \\$wnnna$aIndustries, Pharmaceutic
=450  \\$wnnna$aIndustries, Pharmaceutical
=450  \\$wnnna$aIndustry, Drug
=450  \\$wnnna$aIndustry, Pharmaceutic
=450  \\$wnnna$aIndustry, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Industries
=450  \\$wnnna$aPharmaceutic Industry
=450  \\$wnnna$aPharmaceutical Industries
=450  \\$wnnna$aPharmaceutical Industry
=550  \\$wg$aManufacturing Industry
=550  \\$wh$aDrug Packaging
=550  \\$wh$aOrphan Drug Production
=667  \\$aSPEC: SPEC qualif; /instrum /methods: consider probably better TECHNOLOGY, PHARMACEUTICAL; DF: DRUG INDUST
=680  \\$iThat segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
=750  \0$aPharmaceutical industry$5IEN$0(DLC)sh 85039713

=LDR  01167cz  a2200217n  4500
=001  9880363422702441
=005  20141212200854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004344
=035  \\$aCAZ7477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x290
=150  \\$aDrug Incompatibility
=450  \\$wnnna$aDrug Incompatibilities
=450  \\$wnnna$aIncompatibilities, Drug
=450  \\$wnnna$aIncompatibility, Drug
=550  \\$wg$aTechnology, Pharmaceutical
=667  \\$a"one drug is not of suitable composition to be combined or mixed with another": do not confuse with DRUG INTERACTIONS, "the action of one drug on the metab, effect or tox of another"; IM when general; NIM when with specific drug; no qualif
=680  \\$iThe quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed)
=688  \\$a73(65)
=750  \0$aIncompatibles (Pharmacy)$5IEN$0(DLC)sh 85064793

=LDR  01289cz  a2200337n  4500
=001  9880363422802441
=005  20141212200853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004342
=035  \\$aCAZ7475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x206
=072  \\$aC25.$x100.$x468
=150  \\$aDrug Hypersensitivity
=450  \\$wnnna$aAllergies, Drug
=450  \\$aAllergy, Drug
=450  \\$wnnna$aDrug Allergies
=450  \\$wnnna$aDrug Allergy
=450  \\$wnnna$aDrug Hypersensitivities
=450  \\$wnnna$aHypersensitivities, Drug
=450  \\$aHypersensitivity$xchemically induced
=450  \\$aHypersensitivity, Drug
=550  \\$wg$aDrug-Related Side Effects and Adverse Reactions
=550  \\$wg$aHypersensitivity
=550  \\$wh$aAsthma, Aspirin-Induced
=550  \\$wh$aDrug Eruptions
=550  \\$aDrug Hypersensitivity Syndrome
=667  \\$ause in conventional sense and not for allergy to every category D term; allergy to non-drug chemical substance=substance /ad eff + HYPERSENSITIVITY or its specifics /etiol; manual 23.24+
=680  \\$iImmunologically mediated adverse reactions to medicinal substances used legally or illegally.
=688  \\$a66; was DRUG ALLERGY 1963-65
=750  \0$aDrug allergy$5IEN$0(DLC)sh 85039696

=LDR  01325cz  a2200301n  4500
=001  9880363422902441
=005  20141212200853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004341
=035  \\$aCAZ7474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x337.$x425
=150  \\$aDrug Evaluation
=450  \\$wnnna$aDrug Evaluation Studies
=450  \\$wnnna$aDrug Evaluation Study
=450  \\$wnnna$aDrug Evaluations
=450  \\$wnnna$aEvaluation, Drug
=450  \\$aEvaluation Studies, Drug
=450  \\$wnnna$aEvaluation Study, Drug
=450  \\$wnnna$aEvaluations, Drug
=450  \\$wnnna$aStudies, Drug Evaluation
=450  \\$wnnna$aStudy, Drug Evaluation
=550  \\$wg$aEvaluation Studies as Topic
=550  \\$aDrugs, Investigational
=667  \\$aGEN: more likely CLINICAL TRIAL & its indentations or CLINICAL TRIALS AS TOPIC & its indentations; differentiate from DRUG EVALUATION, PRECLINICAL which is used for studies in exper animals or in vitro
=680  \\$iAny process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
=688  \\$a74; was in Cat E & G 1974-79
=750  \0$aDrugs$xTesting$5IEN$0(DLC)sh 85039755

=LDR  01303cz  a2200301n  4500
=001  9880363423002441
=005  20141212210911.0
=008  880421\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015195
=035  \\$aCAZ7473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x295.$x500
=072  \\$aH1.$x158.$x703.$x7.$x675.$x500
=072  \\$aH1.$x181.$x466.$x675.$x500
=150  \\$aDrug Design
=450  \\$wnnna$aDesign, Drug
=450  \\$wnnna$aDesigns, Drug
=450  \\$wnnna$aDrug Designs
=450  \\$aDrug Modeling
=450  \\$wnnna$aDrug Modelings
=450  \\$wnnna$aModeling, Drug
=450  \\$wnnna$aModelings, Drug
=550  \\$wg$aDrug Discovery
=550  \\$wh$aPolypharmacology
=667  \\$ano qualif; do not confuse with DESIGNER DRUGS
=680  \\$iThe molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis.
=688  \\$a89
=750  \0$aDrugs$xDesign$5IEN$0(DLC)sh 88001157

=LDR  00902cz  a2200265n  4500
=001  9880363423102441
=005  20141212200852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004340
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x360
=150  \\$aDrug Contamination
=450  \\$wnnna$aAdulteration, Drug
=450  \\$wnnna$aAdulterations, Drug
=450  \\$wnnna$aContamination, Drug
=450  \\$wnnna$aContaminations, Drug
=450  \\$aDrug Adulteration
=450  \\$wnnna$aDrug Adulterations
=450  \\$wnnna$aDrug Contaminations
=450  \\$aDrug Impurity
=550  \\$wg$aPublic Health
=667  \\$acan be used for contamination of any Category D term
=680  \\$iThe presence of organisms, or any foreign material that makes a drug preparation impure.
=688  \\$a74; DRUG ADULTERATION was heading 1963-76
=750  \0$aDrug adulteration$5IEN$0(DLC)sh 85039693

=LDR  01071cz  a2200277n  4500
=001  9880363423202441
=005  20141212200852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004339
=035  \\$aCAZ7471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x270
=150  \\$aDrug Compounding
=450  \\$wnnna$aCompounding, Drug
=450  \\$aDrug Preparation
=450  \\$wnnna$aDrug Preparations
=450  \\$aMicroencapsulation
=450  \\$wnnna$aMicroencapsulations
=450  \\$wnnna$aPreparation, Drug
=450  \\$wnnna$aPreparations, Drug
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$aBiopharmaceutics
=550  \\$aChemistry, Pharmaceutical
=667  \\$aIM when general; do not confuse with DRUG PRESCRIPTIONS (prescribing is by the MD, cpding by the pharmacist or drug co.) or with DRUG FORMULATION see CHEMISTRY, PHARMACEUTICAL
=680  \\$iThe preparation, mixing, and assembling of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814)
=750  \0$aDrugs$xDosage forms$0(DLC) sh 85039727$5IEN

=LDR  01358cz  a2200289n  4500
=001  9880363423302441
=005  20141212192144.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004337
=035  \\$aCAZ7469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x260
=072  \\$aE2.$x319.$x300.$x380
=150  \\$aDrug Carriers
=450  \\$wnnna$aDrug Carrier
=550  \\$wg$aDosage Forms
=550  \\$wg$aDrug Delivery Systems
=550  \\$wh$aDendrimers
=550  \\$wh$aLiposomes
=550  \\$wh$aNanocapsules
=550  \\$wh$aNanoconjugates
=550  \\$wh$aVirosomes
=550  \\$aDrug Delivery Systems
=667  \\$acoord with specific drug
=680  \\$iForms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
=688  \\$a88
=750  \0$aDrug carriers (Pharmacy)$0(DLC) sh 85039758$5IEN

=LDR  01068cz  a2200253n  4500
=001  9880363423402441
=005  20141212200852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004336
=035  \\$aCAZ7468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x240.$x310
=072  \\$aG7.$x700.$x680.$x240.$x310
=150  \\$aDrug Antagonism
=450  \\$wnnna$aAntagonism, Drug
=450  \\$wnnna$aAntagonisms, Drug
=450  \\$wnnna$aDrug Antagonisms
=450  \\$aPharmaceutical Preparations$xantagonists & inhibitors
=550  \\$wg$aDrug Interactions
=550  \\$aPolypharmacy
=667  \\$ageneral only; prefer specific drug with /antag; DF: DRUG ANTAG
=680  \\$iPhenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy.
=688  \\$a68(66)
=750  \0$aDrug antagonism$5IEN$0(DLC)sh 85039697

=LDR  01900cz  a2200481n  4500
=001  9880363423502441
=005  20141212200851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004335
=035  \\$aCAZ7467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x605.$x250
=072  \\$aN3.$x706.$x615.$x402.$x250
=072  \\$aN4.$x452.$x706.$x310
=150  \\$aDrug and Narcotic Control
=450  \\$wnnna$aControl, Drug
=450  \\$wnnna$aControl, Narcotic
=450  \\$wnnna$aControls, Drug
=450  \\$wnnna$aControls, Narcotic
=450  \\$wnnna$aDrug Control
=450  \\$wnnna$aDrug Controls
=450  \\$wnnna$aDrug Regulation
=450  \\$aDrug Regulations
=450  \\$wnnna$aNarcotic and Drug Control
=450  \\$aNarcotic Control
=450  \\$wnnna$aNarcotic Controls
=450  \\$wnnna$aPharmaceutic Policy
=450  \\$wnnna$aPharmaceutical Policies
=450  \\$aPharmaceutical Policy
=450  \\$wnnna$aPolicies, Pharmaceutical
=450  \\$wnnna$aPolicy, Pharmaceutical
=450  \\$wnnna$aRegulation, Drug
=450  \\$wnnna$aRegulations, Drug
=550  \\$wg$aLegislation, Drug
=550  \\$wg$aPharmacy Administration
=550  \\$wh$aDrug Approval
=550  \\$wh$aDrug Recalls
=550  \\$wh$aSafety-Based Drug Withdrawals
=550  \\$aSubstance-Related Disorders
=667  \\$aPublic Law 91-513; includes international agreement; specify country or state
=680  \\$iControl of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.
=688  \\$a68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67
=750  \0$aDrug control$5IEN$0(DLC)sh 85089820

=LDR  01136cz  a2200277n  4500
=001  9880363423602441
=005  20141212200851.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004334
=035  \\$aCAZ7466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x283
=150  \\$aDrug Administration Schedule
=450  \\$aAdministration Schedule, Drug
=450  \\$wnnna$aAdministration Schedules, Drug
=450  \\$wnnna$aDrug Administration Schedules
=450  \\$wnnna$aSchedule, Drug Administration
=450  \\$wnnna$aSchedules, Drug Administration
=550  \\$wg$aDrug Therapy
=550  \\$wh$aAdministration, Metronomic
=550  \\$wh$aDrug Chronotherapy
=550  \\$wh$aPulse Therapy, Drug
=667  \\$acoordinate NIM with drug term / admin (IM); drug administration based on circadian rhythm = DRUG CHRONOTHERAPY: do not coordinate with DRUG ADMINISTRATION SCHEDULE or CIRCADIAN RHYTHM; DF: DRUG ADMIN SCHEDULE
=680  \\$iTime schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
=688  \\$a75
=750  \0$aDrugs$xAdministration$0(DLC) sh 85039720$5IEN

=LDR  01572cz  a2200421n  4500
=001  9880363423702441
=005  20141212200850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004333
=035  \\$aCAZ7465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267
=150  \\$aDrug Administration Routes
=450  \\$wnnna$aAdministration Route, Drug
=450  \\$wnnna$aAdministration Routes, Drug
=450  \\$wnnna$aDrug Administration Route
=450  \\$wnnna$aRoute, Drug Administration
=450  \\$wnnna$aRoutes, Drug Administration
=550  \\$wg$aDrug Therapy
=550  \\$wh$aAdministration, Inhalation
=550  \\$wh$aAdministration, Intranasal
=550  \\$wh$aAdministration, Intravenous
=550  \\$wh$aAdministration, Mucosal
=550  \\$wh$aAdministration, Oral
=550  \\$wh$aAdministration, Rectal
=550  \\$wh$aAdministration, Topical
=550  \\$wh$aChemotherapy, Cancer, Regional Perfusion
=550  \\$wh$aInfusions, Parenteral
=550  \\$wh$aInjections
=550  \\$wh$aInstillation, Drug
=550  \\$wh$aIontophoresis
=550  \\$wh$aPhonophoresis
=550  \\$aDosage Forms
=550  \\$aDrug Delivery Systems
=667  \\$ageneral or unspecified; prefer specifics; NIM
=680  \\$iThe various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue.
=688  \\$a87; was DRUG ADMINISTRATION (NON MESH) before 1987
=750  \0$aDrugs$xAdministration$0(DLC) sh 85039720$5IEN

=LDR  00693cz  a2200241n  4500
=001  9880363423802441
=005  20141212200850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004332
=035  \\$aCAZ7464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x393
=072  \\$aC26.$x304
=072  \\$aN6.$x850.$x135.$x696
=150  \\$aDrowning
=450  \\$wnnna$aDrownings
=550  \\$wg$aAccidents
=550  \\$wg$aDeath
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aNear Drowning
=550  \\$aImmersion
=680  \\$iDeath that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.
=750  \0$aDrowning$5IEN$0(DLC)sh 85039668

=LDR  00858cz  a2200229n  4500
=001  9880363423902441
=005  20141212200849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004331
=035  \\$aCAZ7463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x310.$x250.$x500
=150  \\$aDrosophila melanogaster
=450  \\$wnnna$aDrosophila melanogasters
=450  \\$wnnna$amelanogaster, Drosophila
=450  \\$wnnna$amelanogasters, Drosophila
=550  \\$wg$aDrosophila
=550  \\$aDrosophila Proteins
=667  \\$a/microbiol /parasitol /virol permitted; NIM when merely research organism in genetic studies; DF: D MELANOGASTER
=680  \\$iA species of fruit fly much used in genetics because of the large size of its chromosomes.
=688  \\$a72
=750  \0$aDrosophila melanogaster$0(DLC) sh 85039645$5IEN

=LDR  00992cz  a2200265n  4500
=001  9880363424002441
=005  20170106113918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x310.$x250
=150  \\$aDrosophila
=450  \\$wnnna$aDrosophila Fruit Flies
=450  \\$wnnna$aDrosophila Fruit Fly
=450  \\$wnnna$aDrosophilas
=450  \\$wnnna$aFlies, Drosophila Fruit
=450  \\$wnnna$aFly, Drosophila Fruit
=450  \\$wnnna$aFruit Flies, Drosophila
=450  \\$aFruit Fly, Drosophila
=550  \\$wg$aDrosophilidae
=550  \\$wh$aDrosophila melanogaster
=550  \\$wh$aDrosophila simulans
=550  \\$aDrosophila Proteins
=680  \\$iA genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.
=750  \0$aDrosophila$0(DLC) sh 85039637$5IEN

=LDR  00895cz  a2200241n  4500
=001  9880363424102441
=005  20141212200848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004327
=035  \\$aCAZ7459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x317
=150  \\$aDrinking Behavior
=450  \\$wnnna$aBehavior, Drinking
=450  \\$wnnna$aBehaviors, Drinking
=450  \\$wnnna$aDrinking Behaviors
=550  \\$wg$aBehavior
=550  \\$wh$aAlcohol Abstinence
=550  \\$wh$aAlcohol Drinking
=667  \\$adoes not refer to drinking alcohol ( = ALCOHOL DRINKING); human & animal; differentiate from DRINKING
=680  \\$iBehaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking (time intervals - onset and duration), frequency and satiety.
=688  \\$a69
=750  \0$aDrinking behavior$5IEN$0(DLC)sh 85039580

=LDR  00753cz  a2200241n  4500
=001  9880363424202441
=005  20141212200848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004326
=035  \\$aCAZ7458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x593.$x260.$x249
=072  \\$aG7.$x700.$x620.$x260.$x249
=072  \\$aG10.$x261.$x326.$x240.$x249
=150  \\$aDrinking
=450  \\$wnnna$aDrinkings
=450  \\$aWater Consumption
=450  \\$aWater Intake
=550  \\$wg$aEating
=667  \\$anot for drinking alcohol or alcohol consumption ( = ALCOHOL DRINKING); differentiate from DRINKING BEHAVIOR
=680  \\$iThe consumption of liquids.
=688  \\$a70(66)
=750  \0$aDrinking (Physiology)$5IEN$0(DLC)sh 85039575

=LDR  00771cz  a2200229n  4500
=001  9880363424302441
=005  20141212200848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004325
=035  \\$aCAZ7457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x634.$x309
=072  \\$aF2.$x830.$x855.$x268
=150  \\$aDreams
=450  \\$wnnna$aDream
=450  \\$wnnna$aNightmare
=450  \\$aNightmares
=550  \\$wg$aImagination
=550  \\$wg$aSleep
=667  \\$aconsider also NIGHT TERRORS & PAVOR NOCTURNUS (both see SLEEP DISORDERS)
=680  \\$iA series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state.
=750  \0$aDreams$5IEN-M$0(DLC)sh 85039483

=LDR  00825cz  a2200193n  4500
=001  9880363424402441
=005  20141212200847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004324
=035  \\$aCAZ7456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x333
=150  \\$aDrama
=450  \\$wnnna$aDramas
=550  \\$wg$aLiterature
=667  \\$acoord IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM); docudrama as a stage presentation goes here
=680  \\$iA composition in prose or verse presenting in dialogue or pantomime a story involving various characters, usually intended to be acted on a stage and to be regarded as a form of entertainment. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a91(75); was see under LITERATURE 1975-90
=750  \0$aDrama$5IEN$0(DLC)sh 85039316

=LDR  00803cz  a2200253n  4500
=001  9880363424502441
=005  20200526114009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004322
=035  \\$aCAZ7454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x309
=072  \\$aE4.$x237
=150  \\$aDrainage
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wg$aTherapeutics
=550  \\$wh$aDrainage, Postural
=550  \\$wh$aManual Lymphatic Drainage
=550  \\$wh$aNegative-Pressure Wound Therapy
=550  \\$wh$aParacentesis
=550  \\$wh$aSuction
=667  \\$aDRAINAGE, SUCTION see SUCTION is also available
=680  \\$iThe removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
=750  \0$aDrainage, Surgical$5IEN$0(DLC)sh 85039300

=LDR  01376cz  a2200373n  4500
=001  9880363424602441
=005  20141212200847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004321
=035  \\$aCAZ7453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x225.$x250.$x250
=150  \\$aDracunculus Nematode
=450  \\$wnnoa$aDracunculus$5IEN-HS
=450  \\$wnnna$aDracunculus medinenses
=450  \\$aDracunculus medinensis
=450  \\$wnnna$aDracunculus Nematodes
=450  \\$aGuinea Worm
=450  \\$wnnna$aGuinea Worms
=450  \\$aMedina Worm
=450  \\$wnnna$aMedina Worms
=450  \\$wnnna$amedinenses, Dracunculus
=450  \\$wnnna$amedinensis, Dracunculus
=450  \\$wnnna$aNematode, Dracunculus
=450  \\$wnnna$aNematodes, Dracunculus
=450  \\$wnnna$aWorm, Guinea
=450  \\$wnnna$aWorm, Medina
=450  \\$wnnna$aWorms, Guinea
=450  \\$wnnna$aWorms, Medina
=550  \\$wg$aDracunculoidea
=667  \\$ainfection = DRACUNCULIASIS; coord with specific helminth terms (ANTIGENS, HELMINTH, etc if pertinent)
=680  \\$iA genus of nematode parasites which inhabit the body cavity, serous membranes, and connective tissues of vertebrates. The parasitic species in humans is Dracunculus medinensis.
=688  \\$a2003(1963)
=750  \0$aDracunculus$5IEN$0(DLC)sh 85039260

=LDR  01158cz  a2200301n  4500
=001  9880363424702441
=005  20141212200846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004320
=035  \\$aCAZ7452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x750.$x299
=150  \\$aDracunculiasis
=450  \\$wnnna$aDisease, Guinea Worm
=450  \\$wnnna$aDiseases, Guinea Worm
=450  \\$wnnna$aDracunculiases
=450  \\$wnnna$aDracunculoses
=450  \\$aDracunculosis
=450  \\$wnnna$aGuinea Worm Disease
=450  \\$wnnna$aGuinea Worm Diseases
=450  \\$aGuinea Worm Infection
=450  \\$wnnna$aInfection, Guinea Worm
=450  \\$wnnna$aWorm Disease, Guinea
=550  \\$wg$aSpirurida Infections
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iInfection with nematodes of the genus Dracunculus. One or more worms may be seen at a time, with the legs and feet being the most commonly infected areas. Symptoms include pruritus, nausea, vomiting, diarrhea, or asthmatic attacks.
=688  \\$a93; was DRACUNCULOSIS 1963-92
=750  \0$aDracunculiasis$5IEN$0(DLC)sh 87007835

=LDR  02706cz  a2200709n  4500
=001  9880363424802441
=005  20141212200845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004317
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x50.$x200.$x175
=072  \\$aD4.$x615.$x562.$x50.$x200.$x175
=072  \\$aD9.$x408.$x51.$x59.$x200.$x175
=150  \\$aDoxorubicin
=450  \\$wnnna$aAdriablastin
=450  \\$wnnna$aAdriablastine
=450  \\$aAdriamycin
=450  \\$wnnna$aAdriblastin
=450  \\$wnnna$aAdriblastina
=450  \\$wnnna$aAdriblastine
=450  \\$wnnna$aAdrimedac
=450  \\$wnnna$aBaxter Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aBedford Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aBristol-Myers Squibb Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$acell pharm Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aColumbia Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aDOXO-cell
=450  \\$wnnna$aDOXO cell
=450  \\$wnnna$aDoxolem
=450  \\$wnnna$aDoxorubicin Hexal
=450  \\$wnnna$aDoxorubicin Hydrochloride
=450  \\$wnnna$aDoxorubicin NC
=450  \\$wnnna$aDoxorubicina Ferrer Farm
=450  \\$wnnna$aDoxorubicina Funk
=450  \\$wnnna$aDoxorubicina Tedec
=450  \\$wnnna$aDoxorubicine Baxter
=450  \\$wnnna$aDoxotec
=450  \\$wnnna$aElan Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aFarmiblastina
=450  \\$wnnna$aFerrer Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aHexal Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aHydrochloride, Doxorubicin
=450  \\$wnnna$aKenfarma Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aLemery Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$amedac Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aMyocet
=450  \\$wnnna$aNeocorp Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aOnkodox
=450  \\$wnnna$aOnkoworks Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aPfizer Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aPrasfarma Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aRibodoxo
=450  \\$wnnna$aribosepharm Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aRubex
=450  \\$wnnna$aTedec Meiji Brand of Doxorubicin Hydrochloride
=450  \\$wnnna$aUrokit Doxo-cell
=450  \\$wnnna$aUrokit Doxo cell
=550  \\$wg$aDaunorubicin
=550  \\$wh$aEpirubicin
=680  \\$iAntineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
=688  \\$a78(73)
=750  \0$aDoxorubicin$5IEN$0(DLC)sh 85001015

=LDR  03837cz  a2200973n  4500
=001  9880363424902441
=005  20141212200844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004316
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x852.$x500
=072  \\$aD3.$x494.$x382.$x393
=150  \\$aDoxepin
=450  \\$wnnna$aAliud Brand of Doxepin Hydrochloride
=450  \\$wnnna$aAlphapharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aApo-Doxepin
=450  \\$wnnna$aApo Doxepin
=450  \\$wnnna$aApoDoxepin
=450  \\$wnnna$aAponal
=450  \\$wnnna$aApotex Brand of Doxepin Hydrochloride
=450  \\$wnnna$aAzupharma Brand of Doxepin Hydrochloride
=450  \\$wnnna$abetapharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aBioglan Brand of Doxepin Hydrochloride
=450  \\$wnnna$abiomo Brand of Doxepin Hydrochloride
=450  \\$wnnna$aDeptran
=450  \\$wnnna$aDesidox
=450  \\$wnnna$aDesitin Brand of Doxepin Hydrochloride
=450  \\$wnnna$aDoneurin
=450  \\$wnnna$aDoxepia
=450  \\$wnnna$aDoxepin AL
=450  \\$wnnna$aDoxepin AZU
=450  \\$wnnna$aDoxepin beta
=450  \\$wnnna$adoxepin-biomo
=450  \\$wnnna$adoxepin biomo
=450  \\$wnnna$aDoxepin dura
=450  \\$wnnna$aDoxepin Holsten
=450  \\$wnnna$aDoxepin Hydrochloride
=450  \\$wnnna$aDoxepin Hydrochloride, Cis-Trans Isomer Mixture (approximately 1:5)
=450  \\$wnnna$aDoxepin Lindo
=450  \\$wnnna$aDoxepin-neuraxpharm
=450  \\$wnnna$aDoxepin neuraxpharm
=450  \\$wnnna$aDoxepin-ratiopharm
=450  \\$wnnna$aDoxepin ratiopharm
=450  \\$wnnna$aDoxepin-RPh
=450  \\$wnnna$aDoxepin RPh
=450  \\$wnnna$aDoxepin Stada
=450  \\$wnnna$aDoxepin-TEVA
=450  \\$wnnna$aDoxepin TEVA
=450  \\$wnnna$adoxepinbiomo
=450  \\$wnnna$aEspadox
=450  \\$wnnna$aesparma Brand of Doxepin Hydrochloride
=450  \\$wnnna$aHealthpoint Brand of Doxepin Hydrochloride
=450  \\$wnnna$aHexal Brand of Doxepin Hydrochloride
=450  \\$wnnna$aHolsten Brand of Doxepin Hydrochloride
=450  \\$wnnna$aHydrochloride, Doxepin
=450  \\$wnnna$aKrewel Brand of Doxepin Hydrochloride
=450  \\$wnnna$aLindo, Doxepin
=450  \\$wnnna$aLindopharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aMareen
=450  \\$wnnna$aMerck dura Brand of Doxepin Hydrochloride
=450  \\$wnnna$aNepalm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aneuraxpharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aNovo-Doxepin
=450  \\$wnnna$aNovo Doxepin
=450  \\$wnnna$aNovopharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aPfizer Brand of Doxepin Hydrochloride
=450  \\$wnnna$aPrudoxin
=450  \\$wnnna$aQuitaxon
=450  \\$wnnna$aratiopharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aRoche Brand of Doxepin Hydrochloride
=450  \\$wnnna$aRodleben Brand of Doxepin Hydrochloride
=450  \\$wnnna$aSinequan
=450  \\$wnnna$aSinquan
=450  \\$wnnna$aStada, Doxepin
=450  \\$wnnna$aStadapharm Brand of Doxepin Hydrochloride
=450  \\$wnnna$aTemmler Brand of Doxepin Hydrochloride
=450  \\$wnnna$aTeva Brand of Doxepin Hydrochloride
=450  \\$wnnna$aXepin
=450  \\$wnnna$aZonalon
=550  \\$wg$aDibenzoxepins
=550  \\$wg$aOxepins
=680  \\$iA dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
=688  \\$a74
=750  \0$aDoxepin$5IEN$0(DLC)sh 85039247

=LDR  02052cz  a2200397n  4500
=001  9880363425002441
=005  20141212200842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004314
=035  \\$aCAZ7446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x220
=072  \\$aC16.$x131.$x77.$x327
=072  \\$aC16.$x131.$x260.$x260
=072  \\$aC16.$x320.$x180.$x260
=150  \\$aDown Syndrome
=450  \\$wnnna$a47,XX,+21
=450  \\$wnnna$a47,XY,+21
=450  \\$wnnna$aDown Syndrome, Partial Trisomy 21
=450  \\$wnnna$aDown's Syndrome
=450  \\$wnnna$aDowns Syndrome
=450  \\$aMongolism
=450  \\$wnnna$aPartial Trisomy 21 Down Syndrome
=450  \\$wnnna$aSyndrome, Down
=450  \\$wnnna$aSyndrome, Down's
=450  \\$aTrisomy 21
=450  \\$wnnna$aTrisomy 21, Meiotic Nondisjunction
=450  \\$wnnna$aTrisomy 21, Mitotic Nondisjunction
=450  \\$wnnna$aTrisomy G
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aIntellectual Disability
=550  \\$aIntellectual Disability
=680  \\$iA chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)
=688  \\$a93; was DOWN'S SYNDROME 1975-92 & 1963-64; was MONGOLISM 1965-74
=750  \0$aDown syndrome$5IEN-M$0(DLC)sh 85039232

=LDR  01005cz  a2200265n  4500
=001  9880363425102441
=005  20141212200841.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004313
=035  \\$aCAZ7445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x688.$x367
=072  \\$aC3.$x752.$x300.$x200
=072  \\$aC3.$x752.$x300.$x900.$x226
=072  \\$aC3.$x752.$x625.$x367
=072  \\$aC22.$x674.$x710.$x367
=150  \\$aDourine
=450  \\$wnnna$aDourines
=550  \\$wg$aEuglenozoa Infections
=550  \\$wg$aProtozoan Infections, Animal
=550  \\$wg$aTrypanosomiasis
=667  \\$atrypanosome infect in horses; coord IM with HORSE DISEASES (IM) + HORSES (NIM); if in donkeys, coord IM with PERISSODACTYLA (IM); check tag ANIMALS
=680  \\$iA disease of horses and donkeys caused by Trypanosoma equiperdum. The disease occurs in Africa, the Americas, and Asia.
=688  \\$a91(75); was see under TRYPANOSOMIASIS 1975-90
=750  \0$aDourine$5IEN$0(DLC)sh 85039208

=LDR  00954cz  a2200265n  4500
=001  9880363425202441
=005  20141212200839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004309
=035  \\$aCAZ7441M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x131
=150  \\$aDouble Bind Interaction
=450  \\$wnnna$aDouble Bind Interactions
=450  \\$wnnna$aDouble Bind Theories
=450  \\$aDouble Bind Theory
=450  \\$wnnna$aInteraction, Double Bind
=450  \\$wnnna$aInteractions, Double Bind
=450  \\$wnnna$aTheories, Double Bind
=450  \\$wnnna$aTheory, Double Bind
=550  \\$wg$aPsychology, Social
=667  \\$ano qualif
=680  \\$iSimultaneous communication of conflicting messages in which the response to either message evokes rejection or disapproval. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a2000(1972)
=750  \0$aDouble bind (Psychology)$5IEN-M$0(DLC)sh 85039174

=LDR  01394cz  a2200361n  4500
=001  9880363425302441
=005  20141212200838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004307
=035  \\$aCAZ7439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x513.$x500
=072  \\$aG1.$x750.$x740.$x500
=072  \\$aG4.$x299.$x680.$x500
=072  \\$aG7.$x225
=072  \\$aG7.$x700.$x760.$x500
=072  \\$aN6.$x850.$x810.$x250.$x180
=150  \\$aDose-Response Relationship, Radiation
=450  \\$wnnna$aDose Response Relationship, Radiation
=450  \\$wnnna$aDose-Response Relationships, Radiation
=450  \\$wnnna$aRadiation Dose-Response Relationship
=450  \\$wnnna$aRadiation Dose-Response Relationships
=450  \\$wnnna$aRelationship, Radiation Dose-Response
=450  \\$wnnna$aRelationships, Radiation Dose-Response
=550  \\$wg$aPhysiological Phenomena
=550  \\$wg$aRadiation Dosage
=550  \\$wg$aRadiation Tolerance
=550  \\$aRadiation Dosage
=550  \\$aRadiotherapy Dosage
=667  \\$ano qualif; IM if general, NIM when coord for specific radiation; DF: DOSE RESPONSE RELAT RAD
=680  \\$iThe relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
=688  \\$a73
=750  \0$aIonizing radiation$xDose-response relationship$5IEN$0(DLC)sh 85067828

=LDR  01026cz  a2200265n  4500
=001  9880363425402441
=005  20141212200837.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004305
=035  \\$aCAZ7437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x220
=150  \\$aDose-Response Relationship, Drug
=450  \\$wnnna$aDose Response Relationship, Drug
=450  \\$wnnna$aDose-Response Relationships, Drug
=450  \\$wnnna$aDrug Dose-Response Relationship
=450  \\$wnnna$aDrug Dose-Response Relationships
=450  \\$wnnna$aRelationship, Drug Dose-Response
=450  \\$wnnna$aRelationships, Drug Dose-Response
=550  \\$wg$aPharmacological Phenomena
=550  \\$wh$aHormesis
=667  \\$ano qualif; IM if general, NIM when coord for specific drug; DF: DOSE RESPONSE RELAT DRUG
=680  \\$iThe relationship between the dose of an administered drug and the response of the organism to the drug.
=688  \\$a73
=750  \0$aDrugs$xDose-response relationship$5IEN$0(DLC)sh 85039728

=LDR  01455cz  a2200385n  4500
=001  9880363425502441
=005  20141212192144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004304
=035  \\$aCAZ7436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255
=072  \\$aE5.$x916.$x250
=150  \\$aDosage Forms
=450  \\$wnnna$aDosage Form
=450  \\$wnnna$aForm, Dosage
=450  \\$wnnna$aForms, Dosage
=550  \\$wg$aPharmaceutical Preparations
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$wh$aCapsules
=550  \\$wh$aColloids
=550  \\$wh$aDelayed-Action Preparations
=550  \\$wh$aDrug Carriers
=550  \\$wh$aLiniments
=550  \\$wh$aMicelles
=550  \\$wh$aOintments
=550  \\$wh$aPowders
=550  \\$wh$aSuppositories
=550  \\$wh$aTablets
=550  \\$wh$aVaginal Creams, Foams, and Jellies
=550  \\$aDrug Administration Routes
=550  \\$aDrug Delivery Systems
=667  \\$ageneral only: prefer specifics
=680  \\$iCompleted forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.
=750  \0$aDrugs$xDosage forms$0(DLC) sh 85039727$5IEN

=LDR  00960cz  a2200217n  4500
=001  9880363425602441
=005  20141212200836.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004301
=035  \\$aCAZ7433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x210
=150  \\$aDoppler Effect
=450  \\$aDoppler Shift
=450  \\$wnnna$aEffect, Doppler
=450  \\$wnnna$aShift, Doppler
=550  \\$wg$aPhysical Processes
=667  \\$ano qualif; note DOPPLER ULTRASOUND IMAGING see ULTRASONOGRAPHY, DOPPLER; Doppler flowmetry goes under ULTRASONICS; ULTRASONOGRAPHY; their specifics or LASER-DOPPLER FLOWMETRY
=680  \\$iChanges in the observed frequency of waves (as sound, light, or radio waves) due to the relative motion of source and observer. The effect was named for the 19th century Austrian physicist Johann Christian Doppler.
=688  \\$a91(75); was see under PHYSICS 1975-90
=750  \0$aDoppler effect$5IEN$0(DLC)sh 85039083

=LDR  01182cz  a2200373n  4500
=001  9880363425702441
=005  20141212200836.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004300
=035  \\$aCAZ7432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x265
=150  \\$aDoping in Sports
=450  \\$aBlood Doping
=450  \\$wnnna$aBlood Doping, Sports
=450  \\$wnnna$aBlood Dopings
=450  \\$wnnna$aBlood Dopings, Sports
=450  \\$wnnna$aDoping, Blood
=450  \\$wnnna$aDoping in Sport
=450  \\$wnnna$aDopings, Blood
=450  \\$wnnna$aDopings, Sports Blood
=450  \\$wnnna$ain Sport, Doping
=450  \\$wnnna$ain Sports, Doping
=450  \\$wnnna$aSport, Doping in
=450  \\$wnnna$aSports Blood Doping
=450  \\$wnnna$aSports Blood Dopings
=450  \\$wnnna$aSports, Doping in
=550  \\$wg$aSocial Problems
=550  \\$aPerformance-Enhancing Substances
=550  \\$aSports
=667  \\$ahuman & animal
=680  \\$iIllegitimate use of substances for a desired effect in competitive sports. It includes humans and animals.
=688  \\$a78
=750  \0$aDoping in sports$0(DLC) sh 85039081$5IEN

=LDR  01195cz  a2200301n  4500
=001  9880363425802441
=005  20141212200835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004298
=035  \\$aCAZ7429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x311.$x342
=072  \\$aD2.$x92.$x311.$x342
=150  \\$aDopamine
=450  \\$wnnna$a3,4-Dihydroxyphenethylamine
=450  \\$wnnna$a3,4 Dihydroxyphenethylamine
=450  \\$wnnna$a4-(2-Aminoethyl)-1,2-benzenediol
=450  \\$wnnna$aDopamine Hydrochloride
=450  \\$wnnna$aHydrochloride, Dopamine
=450  \\$aHydroxytyramine
=450  \\$wnnna$aIntropin
=550  \\$wg$aCatecholamines
=550  \\$wh$aDeoxyepinephrine
=550  \\$wh$aHydroxydopamines
=550  \\$aDihydroxyphenylalanine
=550  \\$aLevodopa
=680  \\$iOne of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
=750  \0$aDopamine$5IEN$0(DLC)sh 85039075

=LDR  01422cz  a2200361n  4500
=001  9880363425902441
=005  20141212200835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004295
=035  \\$aCAZ7426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x311.$x200
=072  \\$aD12.$x125.$x72.$x50.$x685.$x400
=072  \\$aD12.$x125.$x72.$x50.$x875.$x130
=150  \\$aDihydroxyphenylalanine
=450  \\$wnnna$a3,4-Dihydroxyphenylalanine
=450  \\$wnnna$a3,4 Dihydroxyphenylalanine
=450  \\$wnnna$a3-Hydroxy-DL-tyrosine
=450  \\$wnnna$a3 Hydroxy DL tyrosine
=450  \\$wnnna$abeta-Hydroxytyrosine
=450  \\$wnnna$abeta Hydroxytyrosine
=450  \\$wnnna$aDihydroxyphenylalanine Hydrochloride, (2:1)
=450  \\$aDopa
=550  \\$wg$aCatecholamines
=550  \\$wg$aPhenylalanine
=550  \\$wg$aTyrosine
=550  \\$wh$aCysteinyldopa
=550  \\$wh$aLevodopa
=550  \\$wh$aMethyldopa
=667  \\$acheck text to see if LEVODOPA; (L-DOPA); is not meant instead
=680  \\$iA beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
=688  \\$a2002(1966); for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE (NM) 1989-1991
=750  \0$aDopa$5IEN$0(DLC)sh 87004151

=LDR  02819cz  a2200781n  4500
=001  9880363426002441
=005  20141212192142.0
=008  810513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004294
=035  \\$aCAZ7425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x210
=072  \\$aD3.$x438.$x103.$x370
=150  \\$aDomperidone
=450  \\$wnnna$aAliud Brand of Domperidone Maleate
=450  \\$wnnna$aApo-Domperidone
=450  \\$wnnna$aApo Domperidone
=450  \\$wnnna$aApotex Brand of Domperidone Maleate
=450  \\$wnnna$aDomidon
=450  \\$wnnna$aDomperidon
=450  \\$wnnna$aDomperidon AL
=450  \\$wnnna$aDomperidon Hexal
=450  \\$wnnna$aDomperidon Stada
=450  \\$wnnna$aDomperidon-TEVA
=450  \\$wnnna$aDomperidon TEVA
=450  \\$wnnna$aDomperidona Gamir
=450  \\$wnnna$aDomperidone Maleate
=450  \\$wnnna$aDomperidone Maleate (1:1)
=450  \\$wnnna$aDomperidone Monohydrochloride
=450  \\$wnnna$aGamir, Domperidona
=450  \\$wnnna$aGastrocure
=450  \\$wnnna$aGry Brand of Domperidone Maleate
=450  \\$wnnna$aHexal Brand of Domperidone Maleate
=450  \\$wnnna$aHexal, Domperidon
=450  \\$wnnna$aJanssen Brand of Domperidone
=450  \\$wnnna$aMaleate, Domperidone
=450  \\$wnnna$aMonohydrochloride, Domperidone
=450  \\$wnnna$aMotilium
=450  \\$wnnna$aNauzelin
=450  \\$wnnna$aNovo-Domperidone
=450  \\$wnnna$aNovo Domperidone
=450  \\$wnnna$aNovopharm Brand of Domperidone Maleate
=450  \\$wnnna$aNu-Domperidone
=450  \\$wnnna$aNu Domperidone
=450  \\$wnnna$aNu-Pharm Brand of Domperidone Maleate
=450  \\$wnnna$aNu Pharm Brand of Domperidone Maleate
=450  \\$wnnna$aPéridys
=450  \\$wnnna$aPharmascience Brand of Domperidone Maleate
=450  \\$wnnna$aPierre Fabre Brand of Domperidone
=450  \\$wnnna$aPMS-Domperidone
=450  \\$wnnna$aPMS Domperidone
=450  \\$wnnna$aR-33,812
=450  \\$wnnna$aR-33812
=450  \\$wnnna$aR33,812
=450  \\$wnnna$aR33812
=450  \\$wnnna$aratio-Domperidone
=450  \\$wnnna$aratio Domperidone
=450  \\$wnnna$aRatiopharm Brand of Domperidone Maleate
=450  \\$wnnna$aRottapharm Brand of Domperidone
=450  \\$wnnna$aStada, Domperidon
=450  \\$wnnna$aStadapharm Brand of Domperidone Maleate
=450  \\$wnnna$aTaxandria Brand of Domperidone Maleate
=450  \\$wnnna$aTeva Brand of Domperidone Maleate
=550  \\$wg$aBenzimidazoles
=550  \\$wg$aPiperidines
=680  \\$iA specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
=688  \\$a82
=750  \0$aDomperidone$5IEN$0(DLC)sh 90004346

=LDR  00911cz  a2200265n  4500
=001  9880363426102441
=005  20141212200834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004292
=035  \\$aCAZ7423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x297
=072  \\$aG11.$x561.$x225
=150  \\$aDominance, Cerebral
=450  \\$aCerebral Dominance
=450  \\$wnnna$aDominances, Cerebral
=450  \\$wnnna$aHemispheric Specialization
=450  \\$wnnna$aSpecialization, Hemispheric
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aPsychophysiology
=550  \\$wh$aFunctional Laterality
=680  \\$iDominance of one cerebral hemisphere over the other in cerebral functions.
=688  \\$a1967(1965)
=688  \\$a67; was DOMINANCE 1965-66 (Prov); MIRROR WRITING was see under HANDWRITING 1963-75
=750  \0$aCerebral dominance$5IEN$0(DLC)sh 85022090

=LDR  04828cz  a2201381n  4500
=001  9880363426202441
=005  20141212200833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004289
=035  \\$aCAZ7420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267
=150  \\$aDolphins
=450  \\$aAmazon Dolphins
=450  \\$wnnna$aAmazon River Dolphins
=450  \\$aBaiji
=450  \\$aCephalorhynchus
=450  \\$aChinese River Dolphin
=450  \\$aDelphinidae
=450  \\$wnnna$aDolphin
=450  \\$wnnna$aDolphin, Ganges
=450  \\$wnnna$aDolphin, Ganges River
=450  \\$wnnna$aDolphin, Humpback
=450  \\$wnnna$aDolphin, Irrawaddy River
=450  \\$wnnna$aDolphin, La Plata
=450  \\$wnnna$aDolphin, Marine
=450  \\$wnnna$aDolphin, Ocean
=450  \\$wnnna$aDolphin, Tucuxi
=450  \\$wnnna$aDolphin, Yangtze River
=450  \\$wnnna$aDolphins, Amazon
=450  \\$wnnna$aDolphins, Amazon River
=450  \\$wnnna$aDolphins, Humpback
=450  \\$wnnna$aDolphins, Marine
=450  \\$wnnna$aDolphins, Ocean
=450  \\$wnnna$aDolphins, Piebald
=450  \\$wnnna$aDolphins, Right Whale
=450  \\$wnnna$aDolphins, Tucuxi
=450  \\$aFalse Killer Whale
=450  \\$wnnna$aFalse Killer Whales
=450  \\$wnnna$aFeresa attenuata
=450  \\$aFranciscana
=450  \\$wnnna$aFraser Dolphin
=450  \\$aFraser's Dolphin
=450  \\$wnnna$aFrasers Dolphin
=450  \\$aGanges Dolphin
=450  \\$wnnna$aGanges River Dolphin
=450  \\$wnnna$aGrampus griseus
=450  \\$aGray Grampus
=450  \\$wnnna$aHumpback Dolphin
=450  \\$aHumpback Dolphins
=450  \\$wnnna$aInia geoffrensis
=450  \\$aIrrawaddy River Dolphin
=450  \\$wnnna$aKiller Whale, False
=450  \\$wnnna$aKiller Whale, Pygmy
=450  \\$wnnna$aKiller Whales, False
=450  \\$wnnna$aKiller Whales, Pygmy
=450  \\$aLa Plata Dolphin
=450  \\$wnnna$aLagenodelphis hosei
=450  \\$aLagenorhynchus
=450  \\$wnnna$aLagenorhynchus acutus
=450  \\$wnnna$aLagenorhynchus albirostris
=450  \\$wnnna$aLangenorhynchus obliquidens
=450  \\$wnnna$aLipotes vexillifer
=450  \\$aLissodelphis
=450  \\$aMany-Toothed Blackfish
=450  \\$wnnna$aMarine Dolphin
=450  \\$aMarine Dolphins
=450  \\$aMelon-Headed Whale
=450  \\$wnnna$aMelon Headed Whale
=450  \\$wnnna$aMelon-Headed Whales
=450  \\$wnnna$aOcean Dolphin
=450  \\$aOcean Dolphins
=450  \\$wnnna$aOrcaella brevirostris
=450  \\$wnnna$aPeponocephala electra
=450  \\$aPiebald Dolphins
=450  \\$wnnna$aPlanista gangetica
=450  \\$aPlatanista
=450  \\$aPontoporia blainvillei
=450  \\$wnnna$aPseudorca crassidens
=450  \\$aPygmy Killer Whale
=450  \\$wnnna$aPygmy Killer Whales
=450  \\$aRight Whale Dolphins
=450  \\$wnnna$aRisso Dolphin
=450  \\$aRisso's Dolphin
=450  \\$wnnna$aRiver Dolphin, Chinese
=450  \\$aRough-Toothed Dolphin
=450  \\$wnnna$aRough Toothed Dolphin
=450  \\$wnnna$aRough-Toothed Dolphins
=450  \\$wnnna$aSotalia fluviatilis
=450  \\$aSousa
=450  \\$wnnna$aSteno bredanensis
=450  \\$aSusus
=450  \\$aTucuxi Dolphin
=450  \\$wnnna$aTucuxi Dolphins
=450  \\$aWhale, False Killer
=450  \\$aWhale, Melon-Headed
=450  \\$wnnna$aWhale, Melon Headed
=450  \\$aWhale, Pygmy Killer
=450  \\$wnnna$aWhales, Melon-Headed
=450  \\$wnnna$aWhales, Pygmy Killer
=450  \\$wnnna$aWhite-Beaked Dolphin
=450  \\$aWhite-Beaked Dolphins
=450  \\$wnnna$aWhite Beaked Dolphins
=450  \\$wnnna$aWhite-Sided Dolphin
=450  \\$aWhite-Sided Dolphins
=450  \\$wnnna$aWhite Sided Dolphins
=450  \\$wnnna$aYangtze River Dolphin
=550  \\$wg$aCetacea
=550  \\$wh$aBottle-Nosed Dolphin
=550  \\$wh$aCommon Dolphins
=550  \\$wh$aStenella
=550  \\$wh$aWhale, Killer
=550  \\$wh$aWhales, Pilot
=667  \\$ado not confuse with DOLPHIN FISH see PERCIFORMES; note "whales" X refs: these are common misnomers and are taxonomically DOLPHINS not WHALES
=680  \\$iMammals of the families Delphinidae (ocean dolphins), Iniidae, Lipotidae, Pontoporiidae, and Platanistidae (all river dolphins). Among the most well-known species are the BOTTLE-NOSED DOLPHIN and the KILLER WHALE (a dolphin). The common name dolphin is applied to small cetaceans having a beaklike snout and a slender, streamlined body, whereas PORPOISES are small cetaceans with a blunt snout and rather stocky body. (From Walker's Mammals of the World, 5th ed, pp978-9)
=688  \\$a1968
=688  \\$a68
=750  \0$aDolphins$0(DLC) sh 85038890$5IEN-M

=LDR  00898cz  a2200229n  4500
=001  9880363426302441
=005  20141212200830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004285
=035  \\$aCAZ7416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x200
=150  \\$aDogs
=360  \\$iconsider also terms at$aCANINE
=450  \\$aCanis familiaris
=450  \\$wnnna$aDog
=450  \\$wnnna$afamiliaris, Canis
=550  \\$wg$aCanidae
=667  \\$acheck tag: no qualif; when IM, qualif permitted; TN 3: spelling of breeds
=680  \\$iThe domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
=750  \0$aPuppies$5IEN-M$0(DLC)sh 85109152
=750  \0$aDogs$5IEN-HS$0(DLC)sh 85038796

=LDR  00778cz  a2200217n  4500
=001  9880363426402441
=005  20210322155157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004284
=035  \\$aCAZ7415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x853.$x392
=150  \\$aDogfish
=450  \\$wnnna$aDogfishes
=450  \\$aSqualidae
=550  \\$wg$aSharks
=550  \\$wh$aSqualus
=680  \\$iSharks of the family Squalidae, also called dogfish sharks. They comprise at least eight genera and 44 species. Their LIVER is valued for its oil and its flesh is often made into fertilizer.
=688  \\$a91(75); was see under SHARKS 1975-90
=750  \0$aDogfish$0(DLC)sh 85038776$5IEN
=750  \0$aSqualidae$0(DLC)sh 85127073$5IEN-M

=LDR  01229cz  a2200301n  4500
=001  9880363426502441
=005  20141212200829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004283
=035  \\$aCAZ7414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x268
=150  \\$aDog Diseases
=450  \\$wnnna$aCanine Disease
=450  \\$wnnna$aCanine Diseases
=450  \\$wnnna$aDisease, Canine
=450  \\$wnnna$aDisease, Dog
=450  \\$wnnna$aDiseases, Canine
=450  \\$wnnna$aDiseases, Dog
=450  \\$wnnna$aDog Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aDistemper
=550  \\$wh$aHepatitis, Infectious Canine
=550  \\$wh$aHip Dysplasia, Canine
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific dog dis (IM); for abnormalities or injuries, index under DOGS /abnorm or DOGS /inj; don't forget also DOGS (NIM) & check tag ANIMALS; DF: DOG DIS
=680  \\$iDiseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.
=750  \0$aDogs$xDiseases$5IEN-M$0(DLC)sh 85038798
=750  \0$aPuppies$xDiseases$5IEN-HS$0(DLC)sh 85109153

=LDR  01074cz  a2200277n  4500
=001  9880363426602441
=005  20141212200829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x245
=150  \\$aDocumentation
=450  \\$wnnna$aDocumentations
=550  \\$wg$aInformation Services
=550  \\$wh$aAbstracting and Indexing as Topic
=550  \\$wh$aCataloging
=550  \\$wh$aClassification
=550  \\$wh$aData Curation
=550  \\$wh$aFiling
=550  \\$wh$aMolecular Sequence Data
=550  \\$wh$aVocabulary, Controlled
=550  \\$aBibliography as Topic
=667  \\$amed docum: do not coord with MEDICINE
=680  \\$iSystematic organization, storage, retrieval, and dissemination of specialized information, especially of a scientific or technical nature (From ALA Glossary of Library and Information Science, 1983). It often involves authenticating or validating information.
=688  \\$a66; was see under BIBLIOGRAPHY 1963-65
=750  \0$aDocumentation$5IEN$0(DLC)sh 85038731

=LDR  01581cz  a2200373n  4500
=001  9880363426702441
=005  20141212200828.0
=008  870331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x410.$x210
=072  \\$aD10.$x251.$x355.$x337.$x250
=072  \\$aD10.$x627.$x430.$x450.$x375
=150  \\$aDocosahexaenoic Acids
=450  \\$wnnna$aAcids, Docosahexaenoic
=450  \\$wnnna$aAcids, Docosahexenoic
=450  \\$aDocosahexaenoate
=450  \\$wnnna$aDocosahexaenoic Acid, 3,6,9,12,15,18-Isomer
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer)
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-Isomer
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt
=450  \\$wnnna$aDocosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer)
=450  \\$wnnna$aDocosahexaenoic Acid (All-Z Isomer)
=450  \\$wnnna$aDocosahexaenoic Acid Dimer (All-Z Isomer)
=450  \\$wnnna$aDocosahexaenoic Acid, Sodium Salt
=450  \\$aDocosahexenoic Acids
=550  \\$wg$aFatty Acids, Omega-3
=550  \\$wh$aNeuroprostanes
=680  \\$iC22-unsaturated fatty acids found predominantly in FISH OILS.
=688  \\$a88
=750  \0$aDocosahexaenoic acid$5IEN-M$0(DLC)sh 98006843

=LDR  02748cz  a2200673n  4500
=001  9880363426802441
=005  20141212200828.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004280
=035  \\$aCAZ7411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x311.$x220
=072  \\$aD2.$x92.$x471.$x683.$x410
=150  \\$aDobutamine
=450  \\$wnnna$aBoehringer Ingelheim Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aDobucor
=450  \\$wnnna$aDobuject
=450  \\$wnnna$aDobutamin Fresenius
=450  \\$wnnna$aDobutamin Hexal
=450  \\$wnnna$aDobutamin-ratiopharm
=450  \\$wnnna$aDobutamin ratiopharm
=450  \\$wnnna$aDobutamin Solvay
=450  \\$wnnna$aDobutamina Inibsa
=450  \\$wnnna$aDobutamina Rovi
=450  \\$wnnna$aDobutamine (+)-Isomer
=450  \\$wnnna$aDobutamine Hydrobromide
=450  \\$wnnna$aDobutamine Hydrochloride
=450  \\$wnnna$aDobutamine, (-)-Isomer
=450  \\$wnnna$aDobutamine Lactobionate
=450  \\$wnnna$aDobutamine, Phosphate (1:1) Salt (+)-Isomer
=450  \\$wnnna$aDobutamine Phosphate (1:1) Salt, (-)-Isomer
=450  \\$wnnna$aDobutamine Tartrate
=450  \\$wnnna$aDobutamine Tartrate (1:1), (R-(R*,R*))-Isomer
=450  \\$wnnna$aDobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
=450  \\$wnnna$aDobutrex
=450  \\$wnnna$aEli Lilly Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aFresenius Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aHexal Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aHydrobromide, Dobutamine
=450  \\$wnnna$aHydrochloride, Dobutamine
=450  \\$wnnna$aInibsa Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aIrisfarma Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aJuste Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aKendrick Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aLactobionate, Dobutamine
=450  \\$wnnna$aLilly 81929
=450  \\$wnnna$aLilly Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aOxiken
=450  \\$wnnna$aPisa Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aPosiject
=450  \\$wnnna$aratiopharm Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aRovi Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aSolvay Brand of Dobutamine Hydrochloride
=450  \\$wnnna$aTartrate, Dobutamine
=550  \\$wg$aCatecholamines
=550  \\$wg$aPhenethylamines
=680  \\$iA catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
=688  \\$a86(76); was see under CATECHOLAMINES 1976-85
=750  \0$aDobutamine$5IEN$0(DLC)sh 85038697

=LDR  00671cz  a2200217n  4500
=001  9880363426902441
=005  20141212200827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004279
=035  \\$aCAZ7410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x568
=150  \\$aDNA, Viral
=450  \\$aViral DNA
=550  \\$wg$aDNA
=550  \\$aDNA Viruses
=550  \\$aGenes, Viral
=667  \\$aIM; coord with specific virus (IM); /drug eff /ultrastruct permitted
=680  \\$iDeoxyribonucleic acid that makes up the genetic material of viruses.
=750  \0$81$wb$aDNA$5IEN$0(DLC)sh 85037008
=750  \0$81$wb$aViruses$5IEN-HS$0(DLC)sh 85143833

=LDR  01707cz  a2200349n  4500
=001  9880363427002441
=005  20141212200826.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004276
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x480
=072  \\$aG2.$x111.$x570.$x80.$x708.$x800.$x150
=072  \\$aG5.$x360.$x80.$x708.$x800.$x150
=072  \\$aG5.$x360.$x340.$x24.$x220.$x150
=072  \\$aG5.$x360.$x340.$x24.$x850.$x150
=150  \\$aDNA, Satellite
=450  \\$wnnna$aDNA, Satellite I
=450  \\$wnnna$aDNAs, Satellite
=450  \\$wnnna$aDNAs, Satellite I
=450  \\$wnnna$aI DNA, Satellite
=450  \\$wnnna$aI DNAs, Satellite
=450  \\$aSatellite DNA
=450  \\$wnnna$aSatellite DNAs
=450  \\$wnnna$aSatellite I DNA
=450  \\$wnnna$aSatellite I DNAs
=550  \\$wg$aDNA
=550  \\$wg$aDNA, Intergenic
=550  \\$wg$aTandem Repeat Sequences
=550  \\$aCentromere
=680  \\$iHighly repetitive DNA sequences found in HETEROCHROMATIN, mainly near centromeres. They are composed of simple sequences (very short) (see MINISATELLITE REPEATS) repeated in tandem many times to form large blocks of sequence. Additionally, following the accumulation of mutations, these blocks of repeats have been repeated in tandem themselves. The degree of repetition is on the order of 1000 to 10 million at each locus. Loci are few, usually one or two per chromosome. They were called satellites since in density gradients, they often sediment as distinct, satellite bands separate from the bulk of genomic DNA owing to a distinct BASE COMPOSITION.
=688  \\$a80(75); was see under DNA 1975-79
=750  \0$aSatellite DNA$5IEN$0(DLC)sh 86001588

=LDR  01801cz  a2200361n  4500
=001  9880363427102441
=005  20141212200825.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004274
=035  \\$aCAZ7405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x460
=150  \\$aDNA, Recombinant
=450  \\$wnnna$aDNA Research, Recombinant
=450  \\$aGenes, Spliced
=450  \\$wnnna$aJoint, Recombination
=450  \\$aRecombinant DNA
=450  \\$wnnna$aRecombinant DNA Research
=450  \\$wnnna$aRecombination Joint
=450  \\$wnnna$aResearch, Recombinant DNA
=450  \\$wnnna$aSpliced Genes
=550  \\$wg$aDNA
=550  \\$aArtificial Gene Fusion
=550  \\$aCloning, Molecular
=550  \\$aDNA Transposable Elements
=550  \\$aGene Library
=550  \\$aGenetic Engineering
=550  \\$aGenetic Vectors
=550  \\$aGenomic Library
=667  \\$aIM; /drug eff /ultrastruct permitted; formed by in vitro joining of DNA from 2 different species: do not confuse with RECOMBINATION, GENETIC (within same species); for guidelines for preventing hazards of recombinant DNA research, coord IM with CONTAINMENT OF BIOHAZARDS (IM) if by MeSH definition (procedures, facilities, programs, equipmt, etc.); for ethical, moral or religious aspects of DNA research: coord with specific ethical, moral or religious aspect (IM); for legal aspects, coord with LEGISLATION AS TOPIC (IM), not LEGISLATION, DRUG nor LEGISLATION, MEDICAL
=680  \\$iBiologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected.
=688  \\$a77
=750  \0$aRecombinant DNA$5IEN$0(DLC)sh 85111851

=LDR  00598cz  a2200193n  4500
=001  9880363427202441
=005  20141212200825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004273
=035  \\$aCAZ7404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x425
=150  \\$aDNA, Neoplasm
=450  \\$aNeoplasm DNA
=550  \\$wg$aDNA
=550  \\$aNeoplasms
=667  \\$aIM; coord with required neoplasm term(s) (IM); /drug eff /ultrastruct permitted; Manual 24.4.4.2; DF: DNA NEOPL
=680  \\$iDNA present in neoplastic tissue.
=750  \0$81$wb$aDNA$5IEN$0(DLC)sh 85037008

=LDR  00814cz  a2200229n  4500
=001  9880363427302441
=005  20141212200825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004272
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x283.$x225
=150  \\$aDNA, Mitochondrial
=450  \\$aMitochondrial DNA
=450  \\$amtDNA
=550  \\$wg$aDNA, Circular
=550  \\$wh$aDNA, Kinetoplast
=550  \\$aExtrachromosomal Inheritance
=550  \\$aGenes, Mitochondrial
=667  \\$aIM; /drug eff /ultrastruct permitted; DF: note short X ref
=680  \\$iDouble-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins.
=688  \\$a74(73)
=750  \0$aMitochondrial DNA$0(DLC) sh 92006022$5IEN

=LDR  01611cz  a2200301n  4500
=001  9880363427402441
=005  20141212200824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004270
=035  \\$aCAZ7401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x283
=072  \\$aG2.$x111.$x570.$x790.$x486.$x212
=072  \\$aG5.$x360.$x580.$x156
=150  \\$aDNA, Circular
=450  \\$wnnna$aCircular DNA
=450  \\$wnnna$aCircular DNAs
=450  \\$wnnna$aDNAs, Circular
=550  \\$wg$aDNA
=550  \\$wg$aNucleic Acid Conformation
=550  \\$wh$aDNA, Catenated
=550  \\$wh$aDNA, Chloroplast
=550  \\$wh$aDNA, Mitochondrial
=550  \\$wh$aDNA, Superhelical
=667  \\$aIM; /drug eff /ultrastruct permitted
=680  \\$iAny of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a74(73)
=750  \0$aCircular DNA$5IEN$0(DLC)sh 89004810

=LDR  00642cz  a2200193n  4500
=001  9880363427502441
=005  20141212200824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004269
=035  \\$aCAZ7400HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x212
=150  \\$aDNA, Bacterial
=450  \\$aBacterial DNA
=550  \\$wg$aDNA
=667  \\$aIM; coord with specific bacterium (IM); /drug eff /ultrastruct permitted; DF: DNA BACT
=680  \\$iDeoxyribonucleic acid that makes up the genetic material of bacteria.
=750  \0$81$wb$aDNA$5IEN$0(DLC)sh 85037008
=750  \0$81$wb$aBacteria$5IEN-HS$0(DLC)sh 85010813

=LDR  04834cz  a2201201n  4500
=001  9880363427602441
=005  20200722143844.0
=008  830317\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004268
=035  \\$aCAZ7399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260
=150  \\$aDNA-Binding Proteins
=450  \\$wnnna$aBinding Protein, DNA
=450  \\$wnnna$aDNA Binding Protein
=450  \\$wnnna$aDNA-Binding Protein, Single-Stranded
=450  \\$wnnna$aDNA Binding Proteins
=450  \\$aDNA Helix Destabilizing Proteins
=450  \\$wnnna$aDNA Single-Stranded Binding Protein
=450  \\$wnnna$aDNA Single Stranded Binding Protein
=450  \\$wnnna$aSingle-Stranded DNA-Binding Protein
=450  \\$wnnna$aSingle Stranded DNA Binding Protein
=450  \\$aSingle-Stranded DNA Binding Proteins
=450  \\$wnnna$aSingle Stranded DNA Binding Proteins
=450  \\$wnnna$aSS DNA BP
=550  \\$wg$aProteins
=550  \\$wh$aAdenovirus E2 Proteins
=550  \\$wh$aBasic Helix-Loop-Helix Transcription Factors
=550  \\$wh$aBasic-Leucine Zipper Transcription Factors
=550  \\$wh$aButyrate Response Factor 1
=550  \\$wh$aCentromere Protein B
=550  \\$wh$aEarly Growth Response Transcription Factors
=550  \\$wh$aErythroid-Specific DNA-Binding Factors
=550  \\$wh$aFactor For Inversion Stimulation Protein
=550  \\$wh$aG-Box Binding Factors
=550  \\$wh$aGATA Transcription Factors
=550  \\$wh$aHeat Shock Transcription Factors
=550  \\$wh$aHepatocyte Nuclear Factors
=550  \\$wh$aHeterogeneous-Nuclear Ribonucleoprotein K
=550  \\$wh$aHMGA Proteins
=550  \\$wh$aHMGB Proteins
=550  \\$wh$aHomeodomain Proteins
=550  \\$wh$aI-kappa B Proteins
=550  \\$wh$aImmunoglobulin J Recombination Signal Sequence-Binding Protein
=550  \\$wh$aIntegration Host Factors
=550  \\$wh$aInterferon Regulatory Factors
=550  \\$wh$aInterferon-Stimulated Gene Factor 3
=550  \\$wh$aKruppel-Like Transcription Factors
=550  \\$wh$aKu Autoantigen
=550  \\$wh$aLeucine-Responsive Regulatory Protein
=550  \\$wh$aLIM-Homeodomain Proteins
=550  \\$wh$aLiver X Receptors
=550  \\$wh$aMatrix Attachment Region Binding Proteins
=550  \\$wh$aMDS1 and EVI1 Complex Locus Protein
=550  \\$wh$aMethyl-CpG-Binding Protein 2
=550  \\$wh$aMinichromosome Maintenance 1 Protein
=550  \\$wh$aMRE11 Homologue Protein
=550  \\$wh$aMutL Proteins
=550  \\$wh$aMutS Proteins
=550  \\$wh$aMutS Homolog 2 Protein
=550  \\$wh$aMyeloid-Lymphoid Leukemia Protein
=550  \\$wh$aNF-kappa B
=550  \\$wh$aNFI Transcription Factors
=550  \\$wh$aNuclear Respiratory Factors
=550  \\$wh$aOncogene Protein p55(v-myc)
=550  \\$wh$aOrigin Recognition Complex
=550  \\$wh$aPaired Box Transcription Factors
=550  \\$wh$aPeptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4
=550  \\$wh$aPOU Domain Factors
=550  \\$wh$aProto-Oncogene Proteins c-bcl-6
=550  \\$wh$aProto-Oncogene Proteins c-ets
=550  \\$wh$aProto-Oncogene Proteins c-myb
=550  \\$wh$aProto-Oncogene Proteins c-myc
=550  \\$wh$aProto-Oncogene Proteins c-rel
=550  \\$wh$aProto-Oncogene Proteins c-sis
=550  \\$wh$aPTB-Associated Splicing Factor
=550  \\$wh$aRad51 Recombinase
=550  \\$wh$aRad52 DNA Repair and Recombination Protein
=550  \\$wh$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aReplication Protein A
=550  \\$wh$aReplication Protein C
=550  \\$wh$aRepressor Proteins
=550  \\$wh$aRetinoblastoma Protein
=550  \\$wh$aSmad Proteins
=550  \\$wh$aSMARCB1 Protein
=550  \\$wh$aSOX Transcription Factors
=550  \\$wh$aT-Box Domain Proteins
=550  \\$wh$aTCF Transcription Factors
=550  \\$wh$aTelomere-Binding Proteins
=550  \\$wh$aToll-Like Receptor 9
=550  \\$wh$aTrans-Activators
=550  \\$wh$aTranscription Factor AP-2
=550  \\$wh$aTranscription Factors, General
=550  \\$wh$aTristetraprolin
=550  \\$wh$aTumor Protein p73
=550  \\$wh$aTumor Suppressor p53-Binding Protein 1
=550  \\$wh$aTumor Suppressor Protein p53
=550  \\$wh$aWinged-Helix Transcription Factors
=550  \\$wh$aX-ray Repair Cross Complementing Protein 1
=550  \\$wh$aXeroderma Pigmentosum Group A Protein
=680  \\$iProteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.
=688  \\$a84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83
=750  \0$aDNA-binding proteins$0(DLC) sh 97006173$5IEN-M

=LDR  01625cz  a2200589n  4500
=001  9880363427702441
=005  20190201160926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004267
=035  \\$aCAZ7398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280
=150  \\$aDNA Viruses
=450  \\$wnnna$aDNA Virus
=450  \\$wnnna$aVirus, DNA
=450  \\$wnnna$aViruses, DNA
=550  \\$wg$aViruses
=550  \\$wh$aAdenoviridae
=550  \\$wh$aAnelloviridae
=550  \\$wh$aAscoviridae
=550  \\$wh$aAsfarviridae
=550  \\$wh$aBaculoviridae
=550  \\$wh$aCaudovirales
=550  \\$wh$aCaulimoviridae
=550  \\$wh$aCircoviridae
=550  \\$wh$aDNA Tumor Viruses
=550  \\$wh$aFuselloviridae
=550  \\$wh$aGeminiviridae
=550  \\$wh$aGiant Viruses
=550  \\$wh$aGuttaviridae
=550  \\$wh$aHepadnaviridae
=550  \\$wh$aHerpesviridae
=550  \\$wh$aInoviridae
=550  \\$wh$aIridoviridae
=550  \\$wh$aLipothrixviridae
=550  \\$wh$aMicroviridae
=550  \\$wh$aMimiviridae
=550  \\$wh$aNanoviridae
=550  \\$wh$aNimaviridae
=550  \\$wh$aPapillomaviridae
=550  \\$wh$aParvoviridae
=550  \\$wh$aPhycodnaviridae
=550  \\$wh$aPolydnaviridae
=550  \\$wh$aPolyomaviridae
=550  \\$wh$aPoxviridae
=550  \\$wh$aRudiviridae
=550  \\$wh$aTectiviridae
=550  \\$wh$aVirophages
=667  \\$aavoid: too general; prefer specifics; infection = DNA VIRUS INFECTIONS
=680  \\$iViruses whose nucleic acid is DNA.
=688  \\$a66
=750  \0$aDNA viruses$5IEN$0(DLC)sh 85143841

=LDR  00716cz  a2200253n  4500
=001  9880363427802441
=005  20180621155429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003815
=035  \\$aCAZ6942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x330
=072  \\$aN2.$x360.$x330
=150  \\$aDentists
=450  \\$wnnna$aDentist
=550  \\$wg$aHealth Personnel
=550  \\$wh$aEndodontists
=550  \\$wh$aDentists, Women
=550  \\$wh$aOral and Maxillofacial Surgeons
=550  \\$wh$aOrthodontists
=667  \\$a/educ = EDUCATION, DENTAL or specific
=680  \\$iIndividuals licensed to practice dentistry.
=688  \\$a65
=750  \0$aDentists$5IEN$0(DLC)sh 85036974

=LDR  01432cz  a2200289n  4500
=001  9880363427902441
=005  20141212200553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003814
=035  \\$aCAZ6941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323
=072  \\$aH2.$x163.$x180
=150  \\$aDentistry, Operative
=450  \\$wnnna$aOperative Dentistry
=550  \\$wg$aDentistry
=550  \\$wh$aCrown Lengthening
=550  \\$wh$aDental Cavity Lining
=550  \\$wh$aDental Marginal Adaptation
=550  \\$wh$aDental Restoration Failure
=550  \\$wh$aDental Restoration, Permanent
=550  \\$wh$aDental Restoration, Temporary
=550  \\$aSurgery, Oral
=667  \\$aSPEC; SPEC qualif; to restore tooth function (filling, inlay, etc.); do not confuse with SURGERY, ORAL (surg ther of dis, inj or defects of soft tissues of mouth or of jaws); DF: DENT OPERATIVE
=680  \\$iThat phase of clinical dentistry concerned with the restoration of parts of existing teeth that are defective through disease, trauma, or abnormal development, to the state of normal function, health, and esthetics, including preventive, diagnostic, biological, mechanical, and therapeutic techniques, as well as material and instrument science and application. (Jablonski's Dictionary of Dentistry, 2d ed, p237)
=688  \\$a65; was in Cat E only 1972-79
=750  \0$aDentistry, Operative$0(DLC) sh 85036968$5IEN

=LDR  02780cz  a2200757n  4500
=001  9880363428002441
=005  20141212200553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003813
=035  \\$aCAZ6940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6
=072  \\$aH2.$x163
=150  \\$aDentistry
=550  \\$wg$aHealth Occupations
=550  \\$wh$aAir Abrasion, Dental
=550  \\$wh$aAnesthesia, Dental
=550  \\$wh$aDental Atraumatic Restorative Treatment
=550  \\$wh$aDental Bonding
=550  \\$wh$aDental Care
=550  \\$wh$aDental Debonding
=550  \\$wh$aDental Equipment
=550  \\$wh$aDental Health Surveys
=550  \\$wh$aDental High-Speed Technique
=550  \\$wh$aDental Implantation
=550  \\$wh$aDental Models
=550  \\$wh$aDental Occlusion
=550  \\$wh$aDental Pins
=550  \\$wh$aDental Polishing
=550  \\$wh$aDental Research
=550  \\$wh$aDental Stress Analysis
=550  \\$wh$aDentistry, Operative
=550  \\$wh$aDiagnosis, Oral
=550  \\$wh$aElectrogalvanism, Intraoral
=550  \\$wh$aEndodontics
=550  \\$wh$aEsthetics, Dental
=550  \\$wh$aEvidence-Based Dentistry
=550  \\$wh$aForensic Dentistry
=550  \\$wh$aGeneral Practice, Dental
=550  \\$wh$aGeriatric Dentistry
=550  \\$wh$aInfection Control, Dental
=550  \\$wh$aJaw Relation Record
=550  \\$wh$aMilitary Dentistry
=550  \\$wh$aMouth Rehabilitation
=550  \\$wh$aMyofunctional Therapy
=550  \\$wh$aOccupational Dentistry
=550  \\$wh$aOdontometry
=550  \\$wh$aOral Medicine
=550  \\$wh$aOral Surgical Procedures
=550  \\$wh$aOrthodontics
=550  \\$wh$aPathology, Oral
=550  \\$wh$aPediatric Dentistry
=550  \\$wh$aPeriodontics
=550  \\$wh$aPreventive Dentistry
=550  \\$wh$aProsthodontics
=550  \\$wh$aSchool Dentistry
=550  \\$wh$aSpecialties, Dental
=550  \\$wh$aSurgery, Oral
=550  \\$wh$aTechnology, Dental
=550  \\$wh$aTooth Preparation
=550  \\$wh$aTooth Remineralization
=550  \\$aOral Medicine
=667  \\$aspecialty; /instrum = DENTAL INSTRUMENTS; DENTAL EQUIPMENT or other specifics; /legislation & jurisprudence = LEGISLATION, DENTAL or DENTISTRY (IM) + JURISPRUDENCE (IM) or FORENSIC DENTISTRY; /man permissible but consider also DENTISTS /supply; veterinary dentistry = DENTISTRY /vet (IM) + VETERINARY MEDICINE (IM)
=680  \\$iThe profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue.
=688  \\$aAVIATION DENTISTRY was heading 1965-79
=750  \0$aDentistry$5IEN-M$0(DLC)sh 85036953

=LDR  01003cz  a2200289n  4500
=001  9880363428102441
=005  20141212200552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003812
=035  \\$aCAZ6939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x650.$x410
=072  \\$aN5.$x300.$x660.$x325
=150  \\$aDentist-Patient Relations
=450  \\$wnnna$aDentist-Patient Relation
=450  \\$wnnna$aDentist Patient Relations
=450  \\$wnnna$aDentist-Patient Relationship
=450  \\$wnnna$aDentist Patient Relationship
=450  \\$wnnna$aDentist-Patient Relationships
=450  \\$wnnna$aRelation, Dentist-Patient
=450  \\$wnnna$aRelations, Dentist-Patient
=450  \\$wnnna$aRelationship, Dentist-Patient
=450  \\$wnnna$aRelationships, Dentist-Patient
=550  \\$wg$aProfessional-Patient Relations
=680  \\$iThe psychological relations between the dentist and patient.
=688  \\$a65
=750  \0$aDentist and patient$5IEN$0(DLC)sh 85036952

=LDR  01444cz  a2200337n  4500
=001  9880363428202441
=005  20141212200551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003811
=035  \\$aCAZ6938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x650.$x800.$x270
=072  \\$aC7.$x793.$x700.$x270
=072  \\$aC16.$x131.$x850.$x800.$x270
=150  \\$aDentinogenesis Imperfecta
=450  \\$wnnna$aDentinogenesis Imperfecta, Shields Type 2
=450  \\$wnnna$aDentinogenesis Imperfecta without Osteogenesis Imperfecta
=450  \\$wnnna$aDentinogenesis Imperfectas
=450  \\$aHereditary Opalescent Dentin
=450  \\$wnnna$aHereditary Opalescent Dentins
=450  \\$wnnna$aImperfecta, Dentinogenesis
=450  \\$wnnna$aImperfectas, Dentinogenesis
=450  \\$wnnna$aOpalescent Dentin, Hereditary
=450  \\$wnnna$aOpalescent Dentins, Hereditary
=450  \\$wnnna$aOpalescent Teeth without Osteogenesis Imperfecta
=550  \\$wg$aTooth Abnormalities
=550  \\$aOsteogenesis Imperfecta
=667  \\$aa dentin abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iAn autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth. The dentin develops poorly with low mineral content while the pulp canal is obliterated.
=688  \\$a65
=750  \0$aDentinogenesis imperfecta$5IEN$0(DLC)sh 85036951

=LDR  01094cz  a2200205n  4500
=001  9880363428302441
=005  20141212200551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003810
=035  \\$aCAZ6937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x186
=150  \\$aDentinogenesis
=450  \\$wnnna$aDentinogeneses
=550  \\$wg$aOrganogenesis
=550  \\$aDentin
=667  \\$aformation of primary dentin; formation of secondary dentin = DENTIN, SECONDARY /growth; AMELOGENESIS, formation of dent enamel, is also available
=680  \\$iThe formation of dentin. Dentin first appears in the layer between the ameloblasts and odontoblasts and becomes calcified immediately. Formation progresses from the tip of the papilla over its slope to form a calcified cap becoming thicker by the apposition of new layers pulpward. A layer of uncalcified dentin intervenes between the calcified tissue and the odontoblast and its processes. (From Jablonski, Dictionary of Dentistry, 1992)
=688  \\$a65
=750  \0$aDentinogenesis$5IEN$0(DLC)sh 85036950

=LDR  01045cz  a2200229n  4500
=001  9880363428402441
=005  20141212200549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003803
=035  \\$aCAZ6931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530.$x690.$x310
=072  \\$aC5.$x500.$x470.$x690.$x310
=072  \\$aC7.$x320.$x450.$x670.$x275
=150  \\$aDentigerous Cyst
=450  \\$wnnna$aCyst, Dentigerous
=450  \\$wnnna$aCysts, Dentigerous
=450  \\$wnnna$aDentigerous Cysts
=550  \\$wg$aOdontogenic Cysts
=667  \\$anon-neoplastic; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term (IM)
=680  \\$iMost common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation.
=750  \0$aDentigerous cyst$5IEN$0(DLC)sh 85036946

=LDR  00953cz  a2200277n  4500
=001  9880363428502441
=005  20141212200549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003802
=035  \\$aCAZ6930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x376
=072  \\$aD27.$x720.$x269.$x380
=072  \\$aJ1.$x637.$x51.$x376
=150  \\$aDentifrices
=450  \\$wnnna$aDental Polishes
=450  \\$wnnna$aDentifrice
=450  \\$aPolishes, Dental
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aCosmetics
=550  \\$wh$aDenture Cleansers
=550  \\$wh$aToothpastes
=550  \\$aMouthwashes
=667  \\$aD25-26 qualif
=680  \\$iAny preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives.
=750  \0$aDentifrices$0(DLC) sh 85036945$5IEN

=LDR  01048cz  a2200289n  4500
=001  9880363428602441
=005  20141212200548.0
=008  830209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003801
=035  \\$aCAZ6929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x737.$x250
=072  \\$aE6.$x780.$x345.$x750
=150  \\$aDental Veneers
=450  \\$wnnna$aDental Laminate
=450  \\$aDental Laminates
=450  \\$wnnna$aDental Veneer
=450  \\$wnnna$aLaminate, Dental
=450  \\$wnnna$aLaminates, Dental
=450  \\$wnnna$aVeneer, Dental
=450  \\$wnnna$aVeneers, Dental
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aDental Restoration, Permanent
=667  \\$aIM; coord with specific material (IM) if pertinent; DF: DENT VENEERS
=680  \\$iThe use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of natural teeth, crowns, or pontics by fusion, cementation, or mechanical retention.
=688  \\$a84
=750  \0$aDental veneers$5IEN$0(DLC)sh 87006659

=LDR  00782cz  a2200229n  4500
=001  9880363428702441
=005  20141212200548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003800
=035  \\$aCAZ6928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x105.$x503
=072  \\$aN2.$x360.$x67.$x105.$x503
=150  \\$aDental Technicians
=450  \\$wnnna$aDental Technician
=450  \\$wnnna$aTechnician, Dental
=450  \\$wnnna$aTechnicians, Dental
=550  \\$wg$aDental Auxiliaries
=667  \\$aexecutes dentists' prescripts for mechanical fabrication of dental appliances; DF: DENT TECHNICIANS
=680  \\$iIndividuals responsible for fabrication of dental appliances.
=688  \\$a65
=750  \0$aDental technicians$5IEN$0(DLC)sh 85036938

=LDR  00729cz  a2200241n  4500
=001  9880363428802441
=005  20141212200547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003797
=035  \\$aCAZ6925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x290
=072  \\$aN2.$x360.$x290
=150  \\$aDental Staff
=450  \\$wnnna$aDental Staffs
=450  \\$wnnna$aStaff, Dental
=450  \\$wnnna$aStaffs, Dental
=550  \\$wg$aHealth Personnel
=550  \\$wh$aDental Staff, Hospital
=667  \\$aDF: DENT STAFF
=680  \\$iPersonnel who provide dental service to patients in an organized facility, institution or agency.
=688  \\$a73
=750  \0$aDental personnel$5IEN$0(DLC)sh 85036910

=LDR  00914cz  a2200277n  4500
=001  9880363428902441
=005  20141212200547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003796
=035  \\$aCAZ6924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x298
=072  \\$aN2.$x421.$x240.$x200
=072  \\$aN4.$x452.$x442.$x422.$x298
=150  \\$aDental Service, Hospital
=450  \\$wnnna$aDental Services, Hospital
=450  \\$aHospital Dental Service
=450  \\$wnnna$aHospital Dental Services
=450  \\$wnnna$aService, Hospital Dental
=450  \\$wnnna$aServices, Hospital Dental
=550  \\$wg$aDental Health Services
=550  \\$wg$aHospital Departments
=667  \\$aDF: DENT SERV HOSP
=680  \\$iHospital department providing dental care.
=688  \\$a78; was HOSPITAL DENTAL SERVICE 1963-77
=750  \0$aHospital dental service$5IEN$0(DLC)sh 85062241

=LDR  01007cz  a2200217n  4500
=001  9880364044402441
=005  20141212210559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014599
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x679
=150  \\$aUterus
=360  \\$iconsider also terms at$aHYSTER-
=450  \\$wnnna$aUteri
=550  \\$wg$aGenitalia, Female
=550  \\$wh$aCervix Uteri
=550  \\$wh$aEndometrium
=550  \\$wh$aMyometrium
=667  \\$a/blood supply: consider PLACENTAL CIRCULATION; /surg: consider HYSTERECTOMY or HYSTEROTOMY; inflammation = ENDOMETRITIS
=680  \\$iThe hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
=750  \0$aUterus$5IEN-HS$0(DLC)sh 85141607

=LDR  01098cz  a2200241n  4500
=001  9880364044502441
=005  20141212210559.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014598
=035  \\$aCBA7936M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x861.$x500
=150  \\$aUteroglobin
=450  \\$aBlastokinin
=450  \\$wnnna$aClara Cell Secretory Protein
=450  \\$wnnna$aClara Cell-Specific Protein
=450  \\$wnnna$aClara Cell Specific Protein
=450  \\$wnnna$aSecretoglobin, Family 1A, Member 1
=550  \\$wg$aSecretoglobins
=680  \\$iA steroid-inducible protein that was originally identified in uterine fluid. It is a secreted homodimeric protein with identical 70-amino acid subunits that are joined in an antiparallel orientation by two disulfide bridges. A variety of activities are associated with uteroglobin including the sequestering of hydrophobic ligands and the inhibition of SECRETORY PHOSPHOLIPASE A2.
=688  \\$a1991(1975)
=688  \\$a91(75); was see under GLYCOPROTEINS 1975-90
=750  \0$aUteroglobin$5IEN-M$0(DLC)sh 00000064

=LDR  01004cz  a2200265n  4500
=001  9880364044602441
=005  20141212210559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014597
=035  \\$aCBA7935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x904
=072  \\$aC13.$x703.$x420.$x904
=072  \\$aC26.$x761.$x853
=150  \\$aUterine Rupture
=450  \\$wnnna$aRupture, Uterine
=450  \\$wnnna$aRuptures, Uterine
=450  \\$wnnna$aUterine Ruptures
=550  \\$wg$aObstetric Labor Complications
=550  \\$wg$aRupture
=550  \\$wg$aUterine Diseases
=550  \\$wh$aUterine Perforation
=667  \\$aspontaneous or traumatic but do not coordinate with RUPTURE or RUPTURE, SPONTANEOUS
=680  \\$iA complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.
=750  \0$aUterus$xRupture$5IEN$0(DLC)sh 85141617

=LDR  01086cz  a2200277n  4500
=001  9880364044702441
=005  20141212210558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014596
=035  \\$aCBA7934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x833
=072  \\$aC23.$x300.$x842.$x624.$x750
=150  \\$aUterine Prolapse
=450  \\$wnnna$aProlapse, Uterine
=450  \\$wnnna$aProlapse, Vaginal
=450  \\$wnnna$aProlapses, Uterine
=450  \\$wnnna$aProlapses, Vaginal
=450  \\$wnnna$aUterine Prolapses
=450  \\$aVaginal Prolapse
=450  \\$wnnna$aVaginal Prolapses
=550  \\$wg$aPelvic Organ Prolapse
=550  \\$wg$aUterine Diseases
=667  \\$ado not confuse with UTERINE INVERSION
=680  \\$iDownward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.
=750  \0$aUterus$xProlapse$5IEN$0(DLC)sh 85141615

=LDR  01538cz  a2200445n  4500
=001  9880364044802441
=005  20141212210558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014594
=035  \\$aCBA7932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418.$x948
=072  \\$aC13.$x351.$x500.$x852.$x762
=072  \\$aC13.$x351.$x937.$x418.$x875
=150  \\$aUterine Neoplasms
=450  \\$wnnna$aCancer of the Uterus
=450  \\$aCancer of Uterus
=450  \\$wnnna$aCancer, Uterine
=450  \\$wnnna$aCancer, Uterus
=450  \\$wnnna$aCancers, Uterine
=450  \\$wnnna$aCancers, Uterus
=450  \\$wnnna$aNeoplasm, Uterine
=450  \\$wnnna$aNeoplasm, Uterus
=450  \\$wnnna$aNeoplasms, Uterine
=450  \\$wnnna$aNeoplasms, Uterus
=450  \\$aUterine Cancer
=450  \\$wnnna$aUterine Cancers
=450  \\$wnnna$aUterine Neoplasm
=450  \\$wnnna$aUterus Cancer
=450  \\$wnnna$aUterus Cancers
=450  \\$wnnna$aUterus Neoplasm
=450  \\$wnnna$aUterus Neoplasms
=550  \\$wg$aGenital Neoplasms, Female
=550  \\$wg$aUterine Diseases
=550  \\$wh$aEndometrial Neoplasms
=550  \\$wh$aUterine Cervical Neoplasms
=667  \\$afibroma = LEIOMYOMA (IM) + UTERINE NEOPLASMS (IM); coord IM with histol type of neopl (IM); UTERINE CERVICAL NEOPLASMS & ENDOMETRIAL NEOPLASMS are available
=680  \\$iTumors or cancer of the UTERUS.
=750  \0$aUterus$xTumors$5IEN-M$0(DLC)sh 85141620
=750  \0$aUterus$xCancer$5IEN-HS$0(DLC)sh 85141610

=LDR  01022cz  a2200325n  4500
=001  9880364044902441
=005  20141212210557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014592
=035  \\$aCBA7930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x691
=072  \\$aC23.$x550.$x414.$x993
=150  \\$aUterine Hemorrhage
=450  \\$wnnna$aBleeding, Uterine
=450  \\$wnnna$aBleeding, Vaginal
=450  \\$wnnna$aBleedings, Vaginal
=450  \\$aHemorrhage, Uterine
=450  \\$wnnna$aUterine Bleeding
=450  \\$wnnna$aUterine Bleedings
=450  \\$wnnna$aUterine Hemorrhages
=450  \\$aVaginal Bleeding
=450  \\$wnnna$aVaginal Bleedings
=550  \\$wg$aHemorrhage
=550  \\$wg$aUterine Diseases
=550  \\$wh$aMenorrhagia
=550  \\$wh$aMetrorrhagia
=550  \\$wh$aPostpartum Hemorrhage
=680  \\$iBleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
=750  \0$aUterine Hemorrhage$5IEN$0(DLC)sh 85060226

=LDR  01204cz  a2200397n  4500
=001  9880364045002441
=005  20141212210557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014591
=035  \\$aCBA7929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852
=150  \\$aUterine Diseases
=450  \\$wnnna$aDisease, Endometrial
=450  \\$wnnna$aDisease, Uterine
=450  \\$wnnna$aDiseases, Endometrial
=450  \\$wnnna$aDiseases, Uterine
=450  \\$wnnna$aEndometrial Disease
=450  \\$aEndometrial Diseases
=450  \\$wnnna$aUterine Disease
=550  \\$wg$aGenital Diseases, Female
=550  \\$wh$aAdenomyosis
=550  \\$wh$aEndometrial Hyperplasia
=550  \\$wh$aEndometritis
=550  \\$wh$aHematometra
=550  \\$wh$aPyometra
=550  \\$wh$aUterine Cervical Diseases
=550  \\$wh$aUterine Hemorrhage
=550  \\$wh$aUterine Inversion
=550  \\$wh$aUterine Neoplasms
=550  \\$wh$aUterine Prolapse
=550  \\$wh$aUterine Retroversion
=550  \\$wh$aUterine Rupture
=680  \\$iPathological processes involving any part of the UTERUS.
=688  \\$a66
=750  \0$aUterus$xDiseases$5IEN$0(DLC)sh 85141611

=LDR  00873cz  a2200277n  4500
=001  9880364045102441
=005  20141212210556.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014590
=035  \\$aCBA7928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x326.$x700
=072  \\$aG11.$x427.$x590.$x540.$x890
=150  \\$aUterine Contraction
=450  \\$wnnna$aContraction, Myometrial
=450  \\$wnnna$aContraction, Uterine
=450  \\$wnnna$aContractions, Myometrial
=450  \\$wnnna$aContractions, Uterine
=450  \\$aMyometrial Contraction
=450  \\$wnnna$aMyometrial Contractions
=450  \\$wnnna$aUterine Contractions
=550  \\$wg$aLabor, Obstetric
=550  \\$wg$aMuscle Contraction
=680  \\$iContraction of the UTERINE MUSCLE.
=688  \\$a75
=750  \0$aUterus$xContraction$5IEN-M$0(DLC)sh 93004641

=LDR  00604cz  a2200193n  4500
=001  9880364045202441
=005  20141212210556.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014588
=035  \\$aCBA7926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x853.$x800
=150  \\$aUstilago
=450  \\$wnnna$aUstilagos
=550  \\$wg$aUstilaginales
=667  \\$aa basidiomycete representing the smuts
=680  \\$iA genus of basidiomycetous smut fungi comprising the loose smuts.
=688  \\$a91(75); was see under BASIDIOMYCETES 1975-90
=750  \0$aUstilago$5IEN$0(DLC)sh 88022132

=LDR  00713cz  a2200217n  4500
=001  9880364045302441
=005  20141212210555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014587
=035  \\$aCBA7925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x853
=150  \\$aUstilaginales
=450  \\$aSmut Fungi$5IEN
=450  \\$wnnna$aUstilaginale
=550  \\$wg$aBasidiomycota
=550  \\$wh$aUstilago
=667  \\$aan order of basidiomycetes; parasitic on POACEAE & corn
=680  \\$iAn order of basidiomycetous fungi; some species are parasitic on grasses (POACEAE) and maize.
=688  \\$a91(75); was see under BASIDIOMYCETES 1975-90
=750  \0$aSmut fungi$5IEN$0(DLC)sh 85123716

=LDR  01216cz  a2200349n  4500
=001  9880364045402441
=005  20141212210555.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014584
=035  \\$aCBA7922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x910
=150  \\$aUser-Computer Interface
=450  \\$aComputer-User Interface$5IEN-M
=450  \\$aInterface, User Computer
=450  \\$wnnna$aInterface, User-Computer
=450  \\$wnnna$aInterfaces, User Computer
=450  \\$wnnna$aInterfaces, User-Computer
=450  \\$wnnna$aSystem, Virtual
=450  \\$wnnna$aSystems, Virtual
=450  \\$wnnna$aUser Computer Interface
=450  \\$wnnna$aUser Computer Interfaces
=450  \\$wnnna$aUser-Computer Interfaces
=450  \\$wnnna$aVirtual System
=450  \\$aVirtual Systems
=550  \\$wg$aSoftware
=550  \\$aBrain-Computer Interfaces
=550  \\$aSpeech Recognition Software
=667  \\$aIM; no qualif
=680  \\$iThe portion of an interactive computer program that issues messages to and receives commands from a user.
=688  \\$a91(87); was see under SOFTWARE 1987-90
=750  \0$aUser interfaces (Computer systems)$5IEN-M$0(DLC)sh 88001679

=LDR  00824cz  a2200229n  4500
=001  9880364045502441
=005  20141212210554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014581
=035  \\$aCBA7919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x862.$x945
=072  \\$aC20.$x543.$x480.$x904
=150  \\$aUrticaria
=450  \\$aHives
=450  \\$wnnna$aUrticarias
=550  \\$wg$aHypersensitivity, Immediate
=550  \\$wg$aSkin Diseases, Vascular
=550  \\$wh$aAngioedema
=667  \\$aa form of immediate hypersensitivity; note X ref
=680  \\$iA vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
=750  \0$aUrticaria$5IEN$0(DLC)sh 85141474

=LDR  02823cz  a2200673n  4500
=001  9880364045602441
=005  20141212210554.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014580
=035  \\$aCBA7918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x105.$x225.$x272.$x962
=072  \\$aD4.$x808.$x221.$x430.$x342.$x925
=150  \\$aUrsodeoxycholic Acid
=450  \\$wnnna$a3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
=450  \\$wnnna$a3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid
=450  \\$wnnna$aAcid, Deoxyursocholic
=450  \\$wnnna$aAcid, Ursacholic
=450  \\$wnnna$aAcid, Ursodeoxycholic
=450  \\$wnnna$aAntigen Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aAventis Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aAxcan Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aCholit-Ursan
=450  \\$wnnna$aCholofalk
=450  \\$wnnna$aCP Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aDelursan
=450  \\$aDeoxyursocholic Acid
=450  \\$wnnna$aDestolit
=450  \\$wnnna$aEstedi Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aFalk Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aFarmasa Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aGalen Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aHeumann Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aNiddapharm Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aNorgine Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aOrphan Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aProvalis Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aSanofi Synthelabo Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aSodium Ursodeoxycholate
=450  \\$wnnna$aTramedico Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aUrdox
=450  \\$wnnna$aUrsacholic Acid
=450  \\$wnnna$aUrso
=450  \\$wnnna$aUrso Heumann
=450  \\$wnnna$aUrsobilane
=450  \\$wnnna$aUrsochol
=450  \\$wnnna$aUrsodeoxycholate, Sodium
=450  \\$wnnna$aUrsodiol
=450  \\$wnnna$aUrsofalk
=450  \\$wnnna$aUrsogal
=450  \\$wnnna$aUrsolite
=450  \\$wnnna$aUrsolvan
=450  \\$wnnna$aVita Brand of Ursodeoxycholic Acid
=450  \\$wnnna$aZambon Brand of Ursodeoxycholic Acid
=550  \\$wg$aDeoxycholic Acid
=667  \\$a/biosyn /defic /physiol permitted; urso- refers to its first isol from URSIDAE (Latin ursus)
=680  \\$iAn epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.
=688  \\$a91(80); was see under DEOXYCHOLIC ACID 1980-90
=750  \0$aUrsodeoxycholic acid$5IEN$0(DLC)sh 85141467

=LDR  00814cz  a2200241n  4500
=001  9880364045702441
=005  20141212210551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014574
=035  \\$aCBA7912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x915
=072  \\$aD2.$x241.$x152.$x811
=072  \\$aD2.$x241.$x511.$x902.$x915
=072  \\$aD9.$x811.$x922
=150  \\$aUronic Acids
=450  \\$wnnna$aAcids, Uronic
=550  \\$wg$aAcids, Aldehydic
=550  \\$wg$aSugar Acids
=550  \\$wh$aGlucuronates
=550  \\$wh$aHexuronic Acids
=680  \\$iAcids derived from monosaccharides by the oxidation of the terminal (-CH2OH) group farthest removed from the carbonyl group to a (-COOH) group. (From Stedmans, 26th ed)
=750  \0$aUronic acids$5IEN$0(DLC)sh 85141454

=LDR  00740cz  a2200181n  4500
=001  9880364045802441
=005  20190131123337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014572
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x860
=150  \\$aUrology
=550  \\$wg$aSpecialties, Surgical
=550  \\$aAndrology
=550  \\$aUrologic Surgical Procedures
=667  \\$aSPEC; DF: UROL
=680  \\$iA surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.
=750  \0$aUrology$0(DLC)sh 85141451$5IEN-HS

=LDR  02069cz  a2200589n  4500
=001  9880364045902441
=005  20141212210550.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014571
=035  \\$aCBA7909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x947
=072  \\$aC12.$x758.$x820
=072  \\$aC13.$x351.$x937.$x820
=150  \\$aUrologic Neoplasms
=450  \\$wnnna$aCancer of the Urinary Tract
=450  \\$aCancer of Urinary Tract
=450  \\$wnnna$aCancer, Urinary Tract
=450  \\$wnnna$aCancer, Urologic
=450  \\$wnnna$aCancer, Urological
=450  \\$wnnna$aCancers, Urinary Tract
=450  \\$wnnna$aCancers, Urologic
=450  \\$wnnna$aCancers, Urological
=450  \\$wnnna$aNeoplasm, Urinary Tract
=450  \\$wnnna$aNeoplasm, Urologic
=450  \\$wnnna$aNeoplasm, Urological
=450  \\$wnnna$aNeoplasms, Urinary Tract
=450  \\$wnnna$aNeoplasms, Urologic
=450  \\$wnnna$aNeoplasms, Urological
=450  \\$wnnna$aTract Neoplasm, Urinary
=450  \\$wnnna$aTract Neoplasms, Urinary
=450  \\$aUrinary Tract Cancer
=450  \\$wnnna$aUrinary Tract Cancers
=450  \\$wnnna$aUrinary Tract Neoplasm
=450  \\$wnnna$aUrinary Tract Neoplasms
=450  \\$aUrologic Cancer
=450  \\$wnnna$aUrologic Cancers
=450  \\$wnnna$aUrologic Neoplasm
=450  \\$wnnna$aUrological Cancer
=450  \\$wnnna$aUrological Cancers
=450  \\$wnnna$aUrological Neoplasm
=450  \\$wnnna$aUrological Neoplasms
=550  \\$wg$aUrogenital Neoplasms
=550  \\$wh$aKidney Neoplasms
=550  \\$wh$aUreteral Neoplasms
=550  \\$wh$aUrethral Neoplasms
=550  \\$wh$aUrinary Bladder Neoplasms
=667  \\$ageneral or unspecified: prefer specifics; coordinate IM with histological type of neoplasm (IM); DF: UROL NEOPL
=680  \\$iTumors or cancer of the URINARY TRACT in either the male or the female.
=688  \\$a78
=750  \0$aUrinary organs$xCancer$0(DLC)sh2010010465$5IEN-M
=750  \0$aUrinary organs$xTumors$0(IEN)381454$5IEN-M

=LDR  01388cz  a2200433n  4500
=001  9880364046002441
=005  20141212210550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014570
=035  \\$aCBA7908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777
=072  \\$aC13.$x351.$x968
=150  \\$aUrologic Diseases
=450  \\$wnnna$aDisease, Urinary Tract
=450  \\$wnnna$aDisease, Urologic
=450  \\$wnnna$aDisease, Urological
=450  \\$wnnna$aDiseases, Urinary Tract
=450  \\$wnnna$aDiseases, Urologic
=450  \\$wnnna$aDiseases, Urological
=450  \\$wnnna$aUrinary Tract Disease
=450  \\$aUrinary Tract Diseases
=450  \\$wnnna$aUrologic Disease
=450  \\$wnnna$aUrological Disease
=450  \\$wnnna$aUrological Diseases
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wh$aKidney Diseases
=550  \\$wh$aUreteral Diseases
=550  \\$wh$aUrethral Diseases
=550  \\$wh$aUrinary Bladder Diseases
=550  \\$wh$aUrinary Tract Infections
=550  \\$wh$aUrination Disorders
=550  \\$wh$aUrolithiasis
=550  \\$aUrology
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iPathological processes of the URINARY TRACT in both males and females.
=688  \\$a65
=750  \0$aUrinary organs$xDiseases$5IEN$0(DLC)sh 85141407

=LDR  01601cz  a2200373n  4500
=001  9880364046102441
=005  20141212210549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014568
=035  \\$aCBA7906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x910
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x910
=072  \\$aD12.$x776.$x124.$x125.$x662.$x884
=150  \\$aUrokinase-Type Plasminogen Activator
=450  \\$wnnna$aAbbokinase
=450  \\$wnnna$aKidney Plasminogen Activator
=450  \\$aPlasminogen Activator, Urokinase-Type
=450  \\$wnnna$aRenokinase
=450  \\$wnnna$aSingle-Chain Urokinase-Type Plasminogen Activator
=450  \\$wnnna$aSingle Chain Urokinase Type Plasminogen Activator
=450  \\$wnnna$aU-PA
=450  \\$aU-Plasminogen Activator
=450  \\$wnnna$aU Plasminogen Activator
=450  \\$aUrinary Plasminogen Activator
=450  \\$aUrokinase
=450  \\$wnnna$aUrokinase Type Plasminogen Activator
=550  \\$wg$aPlasminogen Activators
=550  \\$wg$aSerine Endopeptidases
=680  \\$iA proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES.
=688  \\$a2009(1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Urinary Plasminogen Activator
=688  \\$a2000(1963); for UROKINASE-TYPE PLASMINOGEN ACTIVATOR use URINARY PLASMINOGEN ACTIVATOR (NM) 1984-1999
=750  \0$aUrokinase$0(DLC) sh 85141448$5IEN

=LDR  01092cz  a2200325n  4500
=001  9880364046202441
=005  20180404103334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014567
=035  \\$aCBA7905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x830
=072  \\$aE1.$x370.$x390.$x830
=150  \\$aUrography
=450  \\$wnnna$aPyelogram
=450  \\$wnnna$aPyelograms
=450  \\$wnnna$aPyelographies
=450  \\$aPyelography
=450  \\$wnnna$aUrogram
=450  \\$wnnna$aUrogram
=450  \\$wnnna$aUrographies
=550  \\$wg$aDiagnostic Techniques, Urological
=550  \\$wg$aRadiography
=550  \\$wh$aCystography
=550  \\$aUrinary Tract
=550  \\$aUrogenital System
=667  \\$aGEN only: prefer specific organ with /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: UROGR
=680  \\$iRadiography of any part of the urinary tract.
=750  \0$aUrinary organs$xRadiography$5IEN-M$0(DLC)sh 85141412
=750  \0$aGenitourinary organs$xRadiography$5IEN-HS$0(DLC)sh 85053904

=LDR  01319cz  a2200265n  4500
=001  9880364046302441
=005  20141212210548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014566
=035  \\$aCBA7904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5
=150  \\$aUrogenital System
=450  \\$aGenitourinary System
=450  \\$wnnna$aGenitourinary Systems
=450  \\$wnnna$aSystem, Genitourinary
=450  \\$wnnna$aSystem, Urogenital
=450  \\$wnnna$aSystems, Genitourinary
=450  \\$wnnna$aSystems, Urogenital
=450  \\$wnnna$aUrogenital Systems
=550  \\$wh$aGenitalia
=550  \\$wh$aUrinary Tract
=667  \\$amust be both uro + genital; GEN or unspecified; prefer specifics; UROGENITAL ABNORMALITIES is available but consider also specific urogenital organs with /abnorm; UROGRAPHY is available but consider also specific organs with /radiogr; /surg: consider also UROGENITAL SURGICAL PROCEDURES
=680  \\$iAll the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.
=750  \0$aGenitourinary organs$5IEN$0(DLC)sh 85053895

=LDR  01972cz  a2200553n  4500
=001  9880364046402441
=005  20141212210548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014565
=035  \\$aCBA7903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945
=072  \\$aC12.$x758
=072  \\$aC13.$x351.$x937
=150  \\$aUrogenital Neoplasms
=450  \\$wnnna$aCancer, Genito-urinary
=450  \\$wnnna$aCancer, Genitourinary
=450  \\$wnnna$aCancer, Urogenital
=450  \\$wnnna$aCancers, Genito-urinary
=450  \\$wnnna$aCancers, Genitourinary
=450  \\$wnnna$aCancers, Urogenital
=450  \\$wnnna$aGenito-urinary Cancer
=450  \\$wnnna$aGenito urinary Cancer
=450  \\$wnnna$aGenito-urinary Cancers
=450  \\$wnnna$aGenito-urinary Neoplasm
=450  \\$wnnna$aGenito-urinary Neoplasms
=450  \\$aGenitourinary Cancer
=450  \\$wnnna$aGenitourinary Cancers
=450  \\$wnnna$aGenitourinary Neoplasm
=450  \\$aGenitourinary Neoplasms
=450  \\$wnnna$aNeoplasm, Genito-urinary
=450  \\$wnnna$aNeoplasm, Genitourinary
=450  \\$wnnna$aNeoplasm, Urogenital
=450  \\$wnnna$aNeoplasms, Genito-urinary
=450  \\$wnnna$aNeoplasms, Genitourinary
=450  \\$wnnna$aNeoplasms, Urogenital
=450  \\$aUrogenital Cancer
=450  \\$wnnna$aUrogenital Cancers
=450  \\$wnnna$aUrogenital Neoplasm
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aGenital Neoplasms, Female
=550  \\$wh$aGenital Neoplasms, Male
=550  \\$wh$aUrologic Neoplasms
=550  \\$wh$aVenereal Tumors, Veterinary
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
=750  \0$aGenitourinary organs$xTumors$5IEN-M$0(DLC)sh 85053907

=LDR  01598cz  a2200445n  4500
=001  9880364046502441
=005  20141212210547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014564
=035  \\$aCBA7902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706
=072  \\$aC13.$x351.$x875
=072  \\$aC16.$x131.$x939
=150  \\$aUrogenital Abnormalities
=450  \\$wnnna$aAbnormalities, Genitourinary
=450  \\$wnnna$aAbnormalities, Urogenital
=450  \\$wnnna$aAbnormality, Genitourinary
=450  \\$wnnna$aAbnormality, Urogenital
=450  \\$aGenitourinary Abnormalities
=450  \\$wnnna$aGenitourinary Abnormality
=450  \\$wnnna$aUrogenital Abnormality
=450  \\$aUrogenital System$xabnormalities
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wh$aBladder Exstrophy
=550  \\$wh$aCryptorchidism
=550  \\$wh$aDisorders of Sex Development
=550  \\$wh$aEpispadias
=550  \\$wh$aHypospadias
=550  \\$wh$aMulticystic Dysplastic Kidney
=550  \\$wh$aNephritis, Hereditary
=550  \\$wh$aPyelectasis
=550  \\$wh$aRetrocaval Ureter
=550  \\$wh$aUrinary Fistula
=667  \\$ageneral or unspecified; prefer specifics or specific parts of urogenital system /abnorm; DF: UROGENITAL ABNORM
=680  \\$iCongenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.
=688  \\$a98; use explode 1972-97
=750  \0$aGenitourinary organs$xAbnormalities$5IEN-M$0(DLC)sh 85053896

=LDR  00671cz  a2200193n  4500
=001  9880364046602441
=005  20141212210547.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014563
=035  \\$aCBA7901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852.$x898
=150  \\$aUrodynamics
=450  \\$wnnna$aUrodynamic
=550  \\$wg$aUrinary Tract Physiological Phenomena
=667  \\$asame relation to URINARY TRACT that HEMODYNAMICS is to CARDIOVASCULAR SYSTEM; urine volume: index under URINE probably NIM
=680  \\$iThe mechanical laws of fluid dynamics as they apply to urine transport.
=688  \\$a78
=750  \0$aUrodynamics$5IEN$0(DLC)sh 85141443

=LDR  01182cz  a2200313n  4500
=001  9880364046702441
=005  20141212210547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014562
=035  \\$aCBA7900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608
=150  \\$aUrodela
=450  \\$aAmphiuma
=450  \\$aCaudata
=450  \\$wnnna$aCongo Eel
=450  \\$wnnna$aCongo Eels
=450  \\$aEel, Congo
=450  \\$wnnna$aEels, Congo
=450  \\$wnnna$aSalamander
=450  \\$aSalamanders
=550  \\$wg$aAmphibians
=550  \\$wh$aAmbystomatidae
=550  \\$wh$aProteidae
=550  \\$wh$aSalamandridae
=667  \\$aincludes SALAMANDERS (note X ref below), mudpuppies ( = NECTURUS & specific) & NEWTS ( = SALAMANDRIDAE & specifics); NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iAn order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size (except in Sirenidae), and a reduction in skull bones.
=688  \\$a81; was SALAMANDERS 1963-80
=750  \0$aSalamanders$0(DLC) sh 85116685$5IEN

=LDR  00960cz  a2200325n  4500
=001  9880364046802441
=005  20141212210546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014561
=035  \\$aCBA7899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x727
=072  \\$aB1.$x50.$x500.$x272.$x727
=150  \\$aUrochordata
=450  \\$aAscidia
=450  \\$wnnna$aAscidian
=450  \\$wnnna$aAscidians
=450  \\$wnnna$aAscidias
=450  \\$aTunicata
=450  \\$wnnna$aTunicatas
=450  \\$wnnna$aTunicate
=450  \\$wnnna$aTunicates
=450  \\$wnnna$aUrochordatas
=450  \\$wnnna$aUrochordate
=450  \\$wnnna$aUrochordates
=550  \\$wg$aChordata, Nonvertebrate
=550  \\$wh$aCiona intestinalis
=680  \\$iA subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians.
=688  \\$a73
=750  \0$aTunicata$5IEN$0(DLC)sh 85138640

=LDR  00569cz  a2200193n  4500
=001  9880364046902441
=005  20141212210545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014557
=035  \\$aCBA7895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x249.$x727
=072  \\$aD3.$x549.$x909.$x249.$x727
=072  \\$aD4.$x345.$x783.$x249.$x727
=072  \\$aD23.$x767.$x193.$x727
=150  \\$aUrobilin
=550  \\$wg$aBile Pigments
=667  \\$aa bile pigment; /biosyn /physiol permitted
=750  \0$aUrobilin$5IEN$0(DLC)sh 85141438

=LDR  00600cz  a2200181n  4500
=001  9880364047002441
=005  20141212210545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014556
=035  \\$aCBA7894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x927
=150  \\$aUrine
=450  \\$aWater$xurine
=550  \\$wg$aBody Fluids
=550  \\$aRenal Aminoacidurias
=667  \\$aGEN only: prefer /urine with higher animals, substances & diseases: Manual 19.7+, 19.8.79; for microbiol, see TN 190; urine volume: index under URINE probably NIM
=750  \0$aUrine$5IEN$0(DLC)sh 85141420

=LDR  01034cz  a2200325n  4500
=001  9880364047102441
=005  20141212210545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014555
=035  \\$aCBA7893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934
=072  \\$aC13.$x351.$x968.$x934
=150  \\$aUrination Disorders
=450  \\$wnnna$aDisorder, Urination
=450  \\$wnnna$aDisorders, Urination
=450  \\$wnnna$aUrination Disorder
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aAnuria
=550  \\$wh$aEnuresis
=550  \\$wh$aGlycosuria
=550  \\$wh$aHematuria
=550  \\$wh$aOliguria
=550  \\$wh$aPolyuria
=550  \\$wh$aProteinuria
=550  \\$wh$aUrinary Incontinence
=550  \\$wh$aUrinary Retention
=550  \\$aUrological Manifestations
=680  \\$iAbnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
=750  \0$aUrination disorders$5IEN$0(DLC)sh 87005081

=LDR  00572cz  a2200181n  4500
=001  9880364047202441
=005  20141212210544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014554
=035  \\$aCBA7892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852.$x796.$x877
=150  \\$aUrination
=450  \\$aMicturition
=550  \\$wg$aUrinary Tract Physiological Processes
=667  \\$aurine volume: index under URINE probably NIM
=680  \\$iDischarge of URINE, liquid waste processed by the KIDNEY, from the body.
=750  \0$aUrination$5IEN$0(DLC)sh 85141419

=LDR  02059cz  a2200517n  4500
=001  9880364047302441
=005  20141212210544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014553
=035  \\$aCBA7891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852
=150  \\$aUrinary Tract Physiological Phenomena
=450  \\$wnnna$aConcept, Urinary Physiological
=450  \\$wnnna$aConcept, Urinary Physiology
=450  \\$wnnna$aConcepts, Urinary Physiological
=450  \\$wnnna$aConcepts, Urinary Physiology
=450  \\$wnnna$aPhenomena, Urinary Physiology
=450  \\$wnnna$aPhenomenon, Urinary Physiology
=450  \\$wnnna$aPhysiological Concept, Urinary
=450  \\$wnnna$aPhysiology Concept, Urinary
=450  \\$wnnna$aPhysiology Concepts, Urinary
=450  \\$wnnna$aPhysiology, Urinary
=450  \\$wnnna$aPhysiology, Urinary Tract
=450  \\$wnnna$aTract Physiology, Urinary
=450  \\$wnnna$aUrinary Physiological Concept
=450  \\$wnnna$aUrinary Physiological Concepts
=450  \\$wnnna$aUrinary Physiology
=450  \\$wnnna$aUrinary Physiology Concept
=450  \\$wnnna$aUrinary Physiology Concepts
=450  \\$wnnna$aUrinary Physiology Phenomena
=450  \\$wnnna$aUrinary Physiology Phenomenon
=450  \\$wnnna$aUrinary Tract Physiological Phenomenon
=450  \\$aUrinary Tract Physiology
=450  \\$aUrinary Tract$xphysiology
=550  \\$wg$aReproductive and Urinary Physiological Phenomena
=550  \\$wh$aGlomerular Filtration Rate
=550  \\$wh$aKidney Concentrating Ability
=550  \\$wh$aUrinary Tract Physiological Processes
=550  \\$wh$aUrodynamics
=667  \\$ageneral or unspecified; prefer specifics; DF: URINARY TRACT PHYSIOL
=680  \\$iProperties, functions, and processes of the URINARY TRACT as a whole or of any of its parts.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Urinary Tract Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aUrinary organs$xPhysiology$0(IEN)4707333$5IEN-M

=LDR  01130cz  a2200301n  4500
=001  9880364047402441
=005  20141212210544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014552
=035  \\$aCBA7890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x895
=072  \\$aC12.$x777.$x892
=072  \\$aC13.$x351.$x968.$x892
=150  \\$aUrinary Tract Infections
=450  \\$wnnna$aInfection, Urinary Tract
=450  \\$wnnna$aInfections, Urinary Tract
=450  \\$wnnna$aTract Infection, Urinary
=450  \\$wnnna$aTract Infections, Urinary
=450  \\$wnnna$aUrinary Tract Infection
=550  \\$wg$aInfection
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aBacteriuria
=550  \\$wh$aPyuria
=550  \\$wh$aSchistosomiasis haematobia
=667  \\$ageneral or unspecified; prefer specific organ/disease term coordinated with specific infection term
=680  \\$iInflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
=750  \0$aUrinary tract infections$5IEN$0(DLC)sh 85141416

=LDR  00886cz  a2200253n  4500
=001  9880364047502441
=005  20141212210543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014551
=035  \\$aCBA7889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810
=150  \\$aUrinary Tract
=450  \\$wnnna$aTract, Urinary
=450  \\$wnnna$aTracts, Urinary
=450  \\$wnnna$aUrinary Tracts
=550  \\$wg$aUrogenital System
=550  \\$wh$aKidney
=550  \\$wh$aUreter
=550  \\$wh$aUrethra
=550  \\$wh$aUrinary Bladder
=667  \\$aGEN: prefer specific organ; /radiogr = UROGRAPHY but for general only: prefer /radiogr with specific organs of the urinary tract; /surg: consider also UROLOGIC SURGICAL PROCEDURES; dis = UROLOGIC DISEASES; neopl = UROLOGIC NEOPLASMS but prefer specifics
=688  \\$a72
=750  \0$aUrinary organs$5IEN$0(DLC)sh 85141406

=LDR  01094cz  a2200229n  4500
=001  9880364047602441
=005  20141212210543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014550
=035  \\$aCBA7888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x852.$x249
=072  \\$aC13.$x351.$x968.$x934.$x814.$x500
=072  \\$aC23.$x888.$x942.$x343.$x800.$x500
=150  \\$aUrinary Incontinence, Stress
=450  \\$wnnna$aIncontinence, Urinary Stress
=450  \\$wnnna$aStress Incontinence, Urinary
=450  \\$wnnna$aUrinary Stress Incontinence
=550  \\$wg$aUrinary Incontinence
=667  \\$astress refers to coughing, sneezing & other forces
=680  \\$iInvoluntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.
=750  \0$aUrinary stress incontinence$5IEN$0(DLC)sh 85141415

=LDR  00900cz  a2200229n  4500
=001  9880364047702441
=005  20141212210543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014549
=035  \\$aCBA7887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x852
=072  \\$aC13.$x351.$x968.$x934.$x814
=072  \\$aC23.$x888.$x942.$x343.$x800
=150  \\$aUrinary Incontinence
=450  \\$wnnna$aIncontinence, Urinary
=550  \\$wg$aLower Urinary Tract Symptoms
=550  \\$wg$aUrination Disorders
=550  \\$wh$aUrinary Incontinence, Stress
=550  \\$wh$aUrinary Incontinence, Urge
=680  \\$iInvoluntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.
=750  \0$aUrinary incontinence$0(DLC) sh 85141423$5IEN

=LDR  00956cz  a2200253n  4500
=001  9880364047802441
=005  20141212210542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014548
=035  \\$aCBA7886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x881
=072  \\$aC13.$x351.$x875.$x881
=072  \\$aC23.$x300.$x575.$x825
=150  \\$aUrinary Fistula
=450  \\$wnnna$aFistula, Urinary
=450  \\$wnnna$aFistulas, Urinary
=450  \\$wnnna$aUrinary Fistulas
=550  \\$wg$aFistula
=550  \\$wg$aUrogenital Abnormalities
=550  \\$wh$aUrinary Bladder Fistula
=667  \\$ageneral or unspecified; coordinate IM with pre-coordinated urinary organ/diseases (IM); fistula policy: Manual 23.19+; URINARY BLADDER FISTULA & VESICOVAGINAL FISTULA are available
=680  \\$iAn abnormal passage in any part of the URINARY TRACT between itself or with other organs.
=750  \0$aFistula, Urinary$5IEN$0(DLC)sh 85048904

=LDR  01401cz  a2200313n  4500
=001  9880364047902441
=005  20141212210542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014547
=035  \\$aCBA7885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x774.$x852
=150  \\$aUrinary Diversion
=450  \\$wnnna$aConduit, Ileal
=450  \\$wnnna$aConduits, Ileal
=450  \\$wnnna$aDiversion, Urinary
=450  \\$wnnna$aDiversions, Urinary
=450  \\$aIleal Conduit
=450  \\$wnnna$aIleal Conduits
=450  \\$wnnna$aUrinary Diversions
=550  \\$wg$aUrologic Surgical Procedures
=550  \\$wh$aCystostomy
=550  \\$wh$aNephrostomy, Percutaneous
=550  \\$wh$aUreterostomy
=550  \\$aCystectomy
=550  \\$aUreter
=667  \\$aGEN or unspecified; note specifics in tree; if not in tree, coord IM with organ /surg (NIM); TN 189: do not coord with URETER; Manual 26.17.1; do not use /util except by MeSH defintion
=680  \\$iTemporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)
=750  \0$aUrinary diversion$5IEN$0(DLC)sh 85141404

=LDR  01380cz  a2200397n  4500
=001  9880364048002441
=005  20141212210542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014546
=035  \\$aCBA7884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x390.$x820
=072  \\$aE2.$x148.$x947
=150  \\$aUrinary Catheterization
=450  \\$wnnna$aCatheterization, Foley
=450  \\$aCatheterization, Ureteral
=450  \\$aCatheterization, Urethral
=450  \\$aCatheterization, Urinary
=450  \\$wnnna$aCatheterizations, Ureteral
=450  \\$wnnna$aCatheterizations, Urethral
=450  \\$wnnna$aCatheterizations, Urinary
=450  \\$wnnna$aFoley Catheterization
=450  \\$wnnna$aUreteral Catheterization
=450  \\$wnnna$aUreteral Catheterizations
=450  \\$wnnna$aUrethral Catheterization
=450  \\$wnnna$aUrethral Catheterizations
=450  \\$wnnna$aUrinary Catheterizations
=550  \\$wg$aCatheterization
=550  \\$wg$aDiagnostic Techniques, Urological
=550  \\$wh$aIntermittent Urethral Catheterization
=550  \\$aUrinary Bladder
=550  \\$aUrinary Catheters
=550  \\$aUrinary Retention
=667  \\$acoordinate IM with specific site (NIM) if pertinent
=680  \\$iPassage of a CATHETER into the URINARY BLADDER or kidney.
=750  \0$aUrinary catheterization$5IEN$0(DLC)sh 85141403

=LDR  01445cz  a2200385n  4500
=001  9880364048102441
=005  20141212210541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014545
=035  \\$aCBA7883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x967.$x500
=072  \\$aC13.$x351.$x968.$x967.$x500
=072  \\$aC23.$x300.$x175.$x850
=150  \\$aUrinary Calculi
=450  \\$wnnna$aCalculi, Urinary
=450  \\$wnnna$aCalculus, Urinary
=450  \\$wnnna$aStone, Urinary
=450  \\$wnnna$aStone, Urinary Tract
=450  \\$wnnna$aStones, Urinary
=450  \\$wnnna$aStones, Urinary Tract
=450  \\$wnnna$aUrinary Calculus
=450  \\$wnnna$aUrinary Stone
=450  \\$aUrinary Stones
=450  \\$wnnna$aUrinary Tract Stone
=450  \\$wnnna$aUrinary Tract Stones
=550  \\$wg$aCalculi
=550  \\$wg$aUrolithiasis
=550  \\$wh$aKidney Calculi
=550  \\$wh$aUreteral Calculi
=550  \\$wh$aUrinary Bladder Calculi
=667  \\$ageneral or unspecified; consider URINARY BLADDER CALCULI; KIDNEY CALCULI; URETERAL CALCULI; chemical composition of calculi: use /chem; /ultrastruct permitted
=680  \\$iLow-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.
=688  \\$a1963
=750  \0$aUrinary organs$xCalculi$0(DLC) sh 85018801$5IEN

=LDR  00936cz  a2200325n  4500
=001  9880364048202441
=005  20141212210535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014529
=035  \\$aCBA7867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x852
=072  \\$aD13.$x570.$x685.$x852
=072  \\$aD13.$x570.$x800.$x892
=150  \\$aUridine
=450  \\$wnnna$aAllo-Uridine
=450  \\$wnnna$aAllo Uridine
=450  \\$wnnna$aAllouridine
=550  \\$wg$aPyrimidine Nucleosides
=550  \\$wg$aRibonucleosides
=550  \\$wh$a3-Deazauridine
=550  \\$wh$aArabinofuranosyluracil
=550  \\$wh$aAzauridine
=550  \\$wh$aDeoxyuridine
=550  \\$wh$aPseudouridine
=550  \\$wh$aTetrahydrouridine
=550  \\$wh$aThiouridine
=667  \\$a/biosyn /physiol permitted
=688  \\$a66(64); was see under NUCLEOSIDES 1963-65
=750  \0$aUridine$5IEN$0(DLC)sh 85141399

=LDR  01649cz  a2200445n  4500
=001  9880364048302441
=005  20141212210535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014527
=035  \\$aCBA7865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x960.$x877
=072  \\$aD3.$x438.$x759.$x758.$x824.$x877
=150  \\$aUric Acid
=450  \\$wnnna$a2,6,8-Trihydroxypurine
=450  \\$wnnna$aAcid Urate, Ammonium
=450  \\$wnnna$aAcid Urate, Sodium
=450  \\$wnnna$aAcid, Uric
=450  \\$wnnna$aAmmonium Acid Urate
=450  \\$wnnna$aMonohydrate, Monosodium Urate
=450  \\$wnnna$aMonohydrate, Sodium Urate
=450  \\$wnnna$aMonosodium Urate
=450  \\$wnnna$aMonosodium Urate Monohydrate
=450  \\$wnnna$aPotassium Urate
=450  \\$wnnna$aSodium Acid Urate
=450  \\$wnnna$aSodium Acid Urate Monohydrate
=450  \\$wnnna$aSodium Urate
=450  \\$wnnna$aSodium Urate Monohydrate
=450  \\$wnnna$aTrioxopurine
=450  \\$wnnna$aUrate
=450  \\$wnnna$aUrate, Ammonium Acid
=450  \\$wnnna$aUrate Monohydrate, Monosodium
=450  \\$wnnna$aUrate Monohydrate, Sodium
=450  \\$wnnna$aUrate, Monosodium
=450  \\$wnnna$aUrate, Potassium
=450  \\$wnnna$aUrate, Sodium
=450  \\$wnnna$aUrate, Sodium Acid
=550  \\$wg$aXanthines
=680  \\$iAn oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
=750  \0$aUric acid$5IEN$0(DLC)sh 85141398

=LDR  00636cz  a2200181n  4500
=001  9880364048402441
=005  20141212210534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014526
=035  \\$aCBA7864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x767.$x851
=072  \\$aC13.$x351.$x968.$x767.$x851
=150  \\$aUrethritis
=450  \\$wnnna$aUrethritides
=550  \\$wg$aUrethral Diseases
=680  \\$iInflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
=750  \0$aUrethritis$5IEN$0(DLC)sh 85141392

=LDR  01352cz  a2200361n  4500
=001  9880364048502441
=005  20141212210534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014525
=035  \\$aCBA7863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x767.$x700.$x700
=072  \\$aC13.$x351.$x968.$x767.$x700.$x700
=150  \\$aUrethral Stricture
=450  \\$wnnna$aAnterior Urethral Stricture
=450  \\$wnnna$aAnterior Urethral Strictures
=450  \\$wnnna$aPosterior Urethral Stricture
=450  \\$wnnna$aPosterior Urethral Strictures
=450  \\$wnnna$aStenoses, Urethral
=450  \\$wnnna$aStenosis, Urethral
=450  \\$wnnna$aStricture, Urethral
=450  \\$wnnna$aStrictures, Urethral
=450  \\$wnnna$aUrethral Stenoses
=450  \\$aUrethral Stenosis
=450  \\$wnnna$aUrethral Stricture, Anterior
=450  \\$wnnna$aUrethral Stricture, Posterior
=450  \\$wnnna$aUrethral Strictures
=450  \\$wnnna$aUrethral Strictures, Anterior
=450  \\$wnnna$aUrethral Strictures, Posterior
=550  \\$wg$aUrethral Obstruction
=667  \\$ado not confuse with URETHRAL OBSTRUCTION
=680  \\$iNarrowing of any part of the URETHRA. It is characterized by decreased urinary stream and often other obstructive voiding symptoms.
=750  \0$aUrethra$xStricture$5IEN$0(DLC)sh 85141390

=LDR  00945cz  a2200277n  4500
=001  9880364048602441
=005  20141212210533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014522
=035  \\$aCBA7860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x767
=072  \\$aC13.$x351.$x968.$x767
=150  \\$aUrethral Diseases
=450  \\$wnnna$aDisease, Urethral
=450  \\$wnnna$aDiseases, Urethral
=450  \\$wnnna$aUrethral Disease
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aEpispadias
=550  \\$wh$aUrethral Neoplasms
=550  \\$wh$aUrethral Obstruction
=550  \\$wh$aUrethritis
=667  \\$ado not confuse with URETERAL DISEASES, especially in Romance languages: see note on "ureteral" & "urethral" under URETERAL DISEASES; inflammatory disease = URETHRITIS
=680  \\$iPathological processes involving the URETHRA.
=688  \\$a66
=750  \0$aUrethra$xDiseases$5IEN$0(DLC)sh 85141387

=LDR  00947cz  a2200253n  4500
=001  9880364048702441
=005  20141212210533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014521
=035  \\$aCBA7859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x492.$x726
=072  \\$aA5.$x810.$x876
=150  \\$aUrethra
=450  \\$wnnna$aSphincter, Urethral
=450  \\$wnnna$aSphincters, Urethral
=450  \\$wnnna$aUrethral Sphincter
=450  \\$wnnna$aUrethral Sphincters
=450  \\$wnnna$aUrethras
=550  \\$wg$aPenis
=550  \\$wg$aUrinary Tract
=667  \\$ado not confuse with URETER, especially in Romance language: see note on URETER; inflammation = URETHRITIS
=680  \\$iA tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.
=750  \0$aUrethra$5IEN$0(DLC)sh 85141386

=LDR  00776cz  a2200229n  4500
=001  9880364048802441
=005  20141212210532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014520
=035  \\$aCBA7858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x944
=150  \\$aUrethane
=450  \\$wnnna$aCarbamate, Ethyl
=450  \\$aEthyl Carbamate
=450  \\$wnnna$aUrethan
=550  \\$wg$aCarbamates
=550  \\$wh$aNitrosomethylurethane
=550  \\$wh$aPolyurethanes
=667  \\$aPOLYURETHANES is available
=680  \\$iAntineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen.
=750  \0$aUrethane$5IEN$0(DLC)sh 88004640

=LDR  02180cz  a2200517n  4500
=001  9880364048902441
=005  20141212210357.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014212
=035  \\$aCBA7548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x818.$x500
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700.$x860.$x500
=072  \\$aD2.$x455.$x849.$x131.$x495.$x818.$x800
=072  \\$aD23.$x767.$x261.$x700.$x780
=150  \\$aTretinoin
=450  \\$wnnna$aAcid, all-trans-Retinoic
=450  \\$wnnna$aAcid, beta-all-trans-Retinoic
=450  \\$wnnna$aAcid, Retinoic
=450  \\$wnnna$aAcid, trans-Retinoic
=450  \\$wnnna$aAcid, Vitamin A
=450  \\$wnnna$aall-trans-Retinoic Acid
=450  \\$wnnna$aall trans Retinoic Acid
=450  \\$wnnna$abeta-all-trans-Retinoic Acid
=450  \\$wnnna$abeta all trans Retinoic Acid
=450  \\$wnnna$aPotassium Salt, Tretinoin
=450  \\$wnnna$aRetin-A
=450  \\$wnnna$aRetin A
=450  \\$aRetinoic Acid
=450  \\$wnnna$aSalt, Tretinoin Potassium
=450  \\$wnnna$aSalt, Tretinoin Sodium
=450  \\$wnnna$aSalt, Tretinoin Zinc
=450  \\$wnnna$aSodium Salt, Tretinoin
=450  \\$wnnna$atrans-Retinoic Acid
=450  \\$wnnna$atrans Retinoic Acid
=450  \\$wnnna$aTretinoin Potassium Salt
=450  \\$wnnna$aTretinoin Sodium Salt
=450  \\$wnnna$aTretinoin Zinc Salt
=450  \\$wnnna$aVesanoid
=450  \\$aVitamin A Acid
=450  \\$wnnna$aZinc Salt, Tretinoin
=550  \\$wg$aRetinoids
=550  \\$wg$aVitamin A
=680  \\$iAn important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
=688  \\$a80(75); was see under VITAMIN A 1975-79
=750  \0$aTretinoin$5IEN$0(DLC)sh 89000901

=LDR  01073cz  a2200313n  4500
=001  9880364049002441
=005  20141212210356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014211
=035  \\$aCBA7547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840
=072  \\$aC1.$x252.$x847.$x840
=150  \\$aTreponemal Infections
=450  \\$aBejel
=450  \\$wnnna$aBejels
=450  \\$wnnna$aInfection, Treponemal
=450  \\$wnnna$aInfections, Treponemal
=450  \\$wnnna$aTreponemal Infection
=450  \\$aTreponematoses$5IEN
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wg$aSpirochaetales Infections
=550  \\$wh$aPinta
=550  \\$wh$aSyphilis
=550  \\$wh$aYaws
=667  \\$agram-neg bact infect; Treponema pallidum infection = SYPHILIS or YAWS
=680  \\$iInfections with bacteria of the genus TREPONEMA.
=688  \\$aBEJEL was heading 1963-67, 75-96 (see under TREPONEMAL INFECTIONS 1975-90); was see under TREPONEMAL INFECTIONS 1968-74
=750  \0$aTreponematoses$5IEN$0(DLC)sh 85137299

=LDR  00581cz  a2200181n  4500
=001  9880364049102441
=005  20141212210356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014210
=035  \\$aCBA7546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711.$x795.$x840
=072  \\$aB3.$x851.$x595.$x795.$x840
=150  \\$aTreponema pallidum
=550  \\$wg$aTreponema
=667  \\$ainfection = SYPHILIS or YAWS
=680  \\$iThe causative agent of venereal and non-venereal syphilis as well as yaws.
=750  \0$aTreponema pallidum$5IEN$0(DLC)sh 88023353

=LDR  00824cz  a2200217n  4500
=001  9880364049202441
=005  20141212210355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014208
=035  \\$aCBA7544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711.$x795
=072  \\$aB3.$x851.$x595.$x795
=150  \\$aTreponema
=550  \\$wg$aSpirochaetaceae
=550  \\$wh$aTreponema denticola
=550  \\$wh$aTreponema pallidum
=550  \\$aDigital Dermatitis
=667  \\$ainfection = TREPONEMAL INFECTIONS or its specifics; Treponema hyodysenteriae = BRACHYSPIRA HYODYSENTERIAE, Treponema innocens = BRACHYSPIRA
=680  \\$iA genus of microorganisms of the order SPIROCHAETALES, many of which are pathogenic and parasitic for man and animals.
=750  \0$aTreponema$5IEN$0(DLC)sh 88023352

=LDR  00689cz  a2200241n  4500
=001  9880364049302441
=005  20141212210355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014207
=035  \\$aCBA7543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x190.$x840
=150  \\$aTrephining
=450  \\$wnnna$aTrepanation
=450  \\$wnnna$aTrepanations
=450  \\$wnnna$aTrepanning
=450  \\$wnnna$aTrepannings
=450  \\$wnnna$aTrephination
=550  \\$wg$aCraniotomy
=550  \\$aSkull
=667  \\$arestrict to skull: do not use for other tissues
=680  \\$iThe removal of a circular disk of the cranium.
=750  \0$aTrephining$5IEN$0(DLC)sh 85137298

=LDR  00800cz  a2200205n  4500
=001  9880364049402441
=005  20141212210354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014205
=035  \\$aCBA7541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x126.$x100.$x800
=150  \\$aTrench Fever
=450  \\$wnnna$aFever, Trench
=450  \\$wnnna$aFevers, Trench
=450  \\$wnnna$aTrench Fevers
=550  \\$wg$aBartonella Infections
=667  \\$acaused by Bartonella quintana; do not confuse with TRENCH FOOT
=680  \\$iAn intermittent fever characterized by intervals of chills, fever, and splenomegaly each of which may last as long as 40 hours. It is caused by BARTONELLA QUINTANA and transmitted by the human louse.
=750  \0$aTrench fever$5IEN$0(DLC)sh 85137282

=LDR  04455cz  a2201309n  4500
=001  9880364049502441
=005  20141212210354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014202
=035  \\$aCBA7538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x850
=072  \\$aC23.$x888.$x592.$x350.$x850
=150  \\$aTremor
=450  \\$aAction Tremor
=450  \\$wnnna$aAction Tremors
=450  \\$wnnna$aCoarse Tremor
=450  \\$wnnna$aCoarse Tremors
=450  \\$wnnna$aContinuous Tremor
=450  \\$wnnna$aContinuous Tremors
=450  \\$wnnna$aDarkness Tremor
=450  \\$wnnna$aDarkness Tremors
=450  \\$wnnna$aFine Tremor
=450  \\$wnnna$aFine Tremors
=450  \\$aIntention Tremor
=450  \\$wnnna$aIntention Tremors
=450  \\$wnnna$aIntermittent Tremor
=450  \\$wnnna$aIntermittent Tremors
=450  \\$wnnna$aInvoluntary Quiver
=450  \\$wnnna$aInvoluntary Quivers
=450  \\$wnnna$aLimb Tremor
=450  \\$wnnna$aLimb Tremors
=450  \\$wnnna$aMassive Tremor
=450  \\$wnnna$aMassive Tremors
=450  \\$wnnna$aMuscle Tremor
=450  \\$wnnna$aMuscle Tremors
=450  \\$wnnna$aNeonatal Tremor
=450  \\$wnnna$aNeonatal Tremors
=450  \\$wnnna$aNerve Tremor
=450  \\$wnnna$aNerve Tremors
=450  \\$wnnna$aPassive Tremor
=450  \\$wnnna$aPassive Tremors
=450  \\$wnnna$aPerioral Tremor
=450  \\$wnnna$aPerioral Tremors
=450  \\$wnnna$aPersistent Tremor
=450  \\$wnnna$aPersistent Tremors
=450  \\$wnnna$aPill Rolling Tremor
=450  \\$wnnna$aPill Rolling Tremors
=450  \\$wnnna$aQuiver, Involuntary
=450  \\$wnnna$aQuivers, Involuntary
=450  \\$wnnna$aRest Tremor
=450  \\$wnnna$aRest Tremors
=450  \\$aResting Tremor
=450  \\$wnnna$aResting Tremors
=450  \\$wnnna$aRolling Tremor, Pill
=450  \\$wnnna$aRolling Tremors, Pill
=450  \\$wnnna$aSaturnine Tremor
=450  \\$wnnna$aSaturnine Tremors
=450  \\$wnnna$aSemirhythmic Tremor
=450  \\$wnnna$aSemirhythmic Tremors
=450  \\$wnnna$aSenile Tremor
=450  \\$wnnna$aSenile Tremors
=450  \\$wnnna$aStatic Tremor
=450  \\$wnnna$aStatic Tremors
=450  \\$wnnna$aTremor, Action
=450  \\$wnnna$aTremor, Coarse
=450  \\$wnnna$aTremor, Continuous
=450  \\$wnnna$aTremor, Darkness
=450  \\$wnnna$aTremor, Fine
=450  \\$wnnna$aTremor, Intention
=450  \\$wnnna$aTremor, Intermittent
=450  \\$wnnna$aTremor, Limb
=450  \\$wnnna$aTremor, Massive
=450  \\$wnnna$aTremor, Muscle
=450  \\$wnnna$aTremor, Neonatal
=450  \\$wnnna$aTremor, Nerve
=450  \\$wnnna$aTremor, Passive
=450  \\$wnnna$aTremor, Perioral
=450  \\$wnnna$aTremor, Persistent
=450  \\$wnnna$aTremor, Pill Rolling
=450  \\$wnnna$aTremor, Rest
=450  \\$wnnna$aTremor, Resting
=450  \\$wnnna$aTremor, Saturnine
=450  \\$wnnna$aTremor, Semirhythmic
=450  \\$wnnna$aTremor, Senile
=450  \\$wnnna$aTremor, Static
=450  \\$wnnna$aTremors
=450  \\$wnnna$aTremors, Action
=450  \\$wnnna$aTremors, Coarse
=450  \\$wnnna$aTremors, Continuous
=450  \\$wnnna$aTremors, Darkness
=450  \\$wnnna$aTremors, Fine
=450  \\$wnnna$aTremors, Intention
=450  \\$wnnna$aTremors, Intermittent
=450  \\$wnnna$aTremors, Limb
=450  \\$wnnna$aTremors, Massive
=450  \\$wnnna$aTremors, Muscle
=450  \\$wnnna$aTremors, Neonatal
=450  \\$wnnna$aTremors, Nerve
=450  \\$wnnna$aTremors, Passive
=450  \\$wnnna$aTremors, Perioral
=450  \\$wnnna$aTremors, Persistent
=450  \\$wnnna$aTremors, Pill Rolling
=450  \\$wnnna$aTremors, Rest
=450  \\$wnnna$aTremors, Resting
=450  \\$wnnna$aTremors, Saturnine
=450  \\$wnnna$aTremors, Semirhythmic
=450  \\$wnnna$aTremors, Senile
=450  \\$wnnna$aTremors, Static
=550  \\$wg$aDyskinesias
=680  \\$iCyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
=750  \0$aTremor$5IEN$0(DLC)sh 85137280

=LDR  01465cz  a2200385n  4500
=001  9880364049602441
=005  20141212210351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014200
=035  \\$aCBA7536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715
=150  \\$aTrematoda
=450  \\$wnnna$aEchinochasmus
=450  \\$wnnna$aFluke
=450  \\$aFlukes
=450  \\$wnnna$aHimasthla
=450  \\$wnnna$aHimasthlas
=450  \\$wnnna$aParyphostomum
=450  \\$wnnna$aParyphostomums
=450  \\$wnnna$aTrematodas
=450  \\$wnnna$aTroglotrema
=450  \\$wnnna$aTroglotremas
=550  \\$wg$aPlatyhelminths
=550  \\$wh$aDicrocoeliidae
=550  \\$wh$aEchinostomatidae
=550  \\$wh$aFasciolidae
=550  \\$wh$aHeterophyidae
=550  \\$wh$aOpisthorchidae
=550  \\$wh$aParamphistomatidae
=550  \\$wh$aSchistosomatidae
=550  \\$wh$aTroglotrematidae
=667  \\$aGEN or unspecified; prefer specifics; infection = TREMATODE INFECTIONS; /drug eff: consider also ANTIPLATYHELMINTIC AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iClass of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle.
=750  \0$aTrematoda$5IEN$0(DLC)sh 85137270

=LDR  00579cz  a2200193n  4500
=001  9880364049702441
=005  20150608164233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014199
=035  \\$aCBA7535M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x365.$x900
=072  \\$aD9.$x698.$x629.$x305.$x880
=150  \\$aTrehalose
=550  \\$wg$aDisaccharides
=550  \\$wg$aGlucans
=667  \\$acalled ergot sugar & mycose; do not confuse with TREHALASE
=688  \\$a91(73); was see under DISACCHARIDES 1973-90
=750  \0$aTrehalose$0(DLC)sh2014100270I$5IEN-M

=LDR  00642cz  a2200205n  4500
=001  9880364049802441
=005  20141212192611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014197
=035  \\$aCBA7533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x915
=150  \\$aTrees
=450  \\$wnnna$aTree
=550  \\$wg$aPlants
=550  \\$aForestry
=550  \\$aForests
=680  \\$iWoody, usually tall, perennial higher plants (Angiosperms, Gymnosperms, and some Pterophyta) having usually a main stem and numerous branches.
=688  \\$aACACIA & EUCALYPTUS were headings 1963-85
=750  \0$aTrees$5IEN$0(DLC)sh 85137241

=LDR  00973cz  a2200229n  4500
=001  9880364049902441
=005  20200716175741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014195
=035  \\$aCBA7531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x883
=150  \\$aTravel
=450  \\$wnnna$aTravels
=550  \\$wg$aHuman Activities
=550  \\$wh$aAir Travel
=550  \\$wh$aExpeditions
=550  \\$wh$aMedical Tourism
=550  \\$wh$aTravel-Related Illness
=667  \\$acoordinate with specific type of travel (AUTOMOBILES, SHIPS, etc if pertinent); not for study tours to various countries: index object of study + geographic location, as HOSPITALS + GHANA; PEDIATRICS + CHINA; consider also MEDICAL MISSIONS, OFFICIAL or MISSIONS AND MISSIONARIES; traveler's diarrhea: coordinate IM with DIARRHEA (IM); TRAVEL MEDICINE is also available
=680  \\$iAspects of health and disease related to travel.
=750  \0$aTravel$5IEN$0(DLC)sh 85137149

=LDR  00753cz  a2200205n  4500
=001  9880364050002441
=005  20141212210349.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014194
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x850
=150  \\$aTraumatology
=450  \\$wnnna$aSurgical Traumatology
=450  \\$wnnna$aTraumatology, Surgical
=550  \\$wg$aSpecialties, Surgical
=550  \\$aAdvanced Trauma Life Support Care
=667  \\$ause for the specialty dealing with physical trauma, not psychological trauma
=680  \\$iThe medical specialty which deals with WOUNDS and INJURIES as well as resulting disability and disorders from physical traumas.
=688  \\$a87
=750  \0$aTraumatology$5IEN$0(DLC)sh 85137143

=LDR  00881cz  a2200277n  4500
=001  9880364050102441
=005  20141212210349.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014193
=035  \\$aCBA7529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x336.$x500
=072  \\$aN2.$x421.$x297.$x195.$x480
=072  \\$aN4.$x452.$x442.$x422.$x336.$x400
=150  \\$aTrauma Centers
=450  \\$wnnna$aCenter, Trauma
=450  \\$wnnna$aCenters, Trauma
=450  \\$wnnna$aTrauma Center
=450  \\$wnnna$aTrauma Unit
=450  \\$aTrauma Units
=450  \\$wnnna$aUnit, Trauma
=450  \\$wnnna$aUnits, Trauma
=550  \\$wg$aEmergency Service, Hospital
=680  \\$iSpecialized hospital facilities which provide diagnostic and therapeutic services for trauma patients.
=688  \\$a75
=750  \0$aTrauma centers$5IEN$0(DLC)sh 85137135

=LDR  00924cz  a2200217n  4500
=001  9880364050202441
=005  20190322145459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014190
=035  \\$aCBA7526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x800
=150  \\$aTransvestism
=450  \\$wnnna$aFetishism, Transvestic
=450  \\$wnnna$aFetishisms, Transvestic
=450  \\$aTransvestic Fetishism
=450  \\$wnnna$aTransvestic Fetishisms
=450  \\$wnnna$aTransvestisms
=550  \\$wg$aParaphilic Disorders
=680  \\$iDisorder characterized by recurrent, intense sexually arousing fantasies, sexual urges, or behaviors involving cross-dressing in a heterosexual male. The fantasies, urges, or behaviors cause clinically significant distress or impairment in social, occupational or other areas of functioning. (from APA, DSM-IV, 1994)
=750  \0$aCross-dressing$0(DLC)sh 85137104$5IEN-M

=LDR  00920cz  a2200253n  4500
=001  9880364050302441
=005  20160511173642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014189
=035  \\$aCBA7525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x800.$x800.$x800
=150  \\$aTranssexualism
=450  \\$wnnna$aTranssexualisms
=550  \\$wg$aSexual Dysfunctions, Psychological
=550  \\$aDisorders of Sex Development
=550  \\$aSex Reassignment Procedures
=550  \\$aSex Reassignment Surgery
=550  \\$aTransgender Persons
=667  \\$aindex both MALE and FEMALE check tags
=680  \\$iSevere gender dysphoria, coupled with a persistent desire for the physical characteristics and social roles that connote the opposite biological sex. (APA, DSM-IV, 1994)
=688  \\$a68
=750  \0$aTranssexualism$5IEN-M$0(DLC)sh 94005829
=750  \0$aTranssexuals$5IEN-M$0(DLC)sh 85137086

=LDR  01487cz  a2200289n  4500
=001  9880364050402441
=005  20141212210348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014188
=035  \\$aCBA7524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x915
=072  \\$aC14.$x280.$x400.$x915
=072  \\$aC16.$x131.$x240.$x400.$x915
=150  \\$aTransposition of Great Vessels
=450  \\$wnnna$aDextro-Looped Transposition of the Great Arteries
=450  \\$wnnna$aDextro Looped Transposition of the Great Arteries
=450  \\$wnnna$aGreat Arteries Transposition
=450  \\$wnnna$aGreat Arteries Transpositions
=450  \\$wnnna$aGreat Vessels Transposition
=450  \\$wnnna$aGreat Vessels Transpositions
=450  \\$wnnna$aTransposition of Great Arteries
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wh$aDouble Outlet Right Ventricle
=680  \\$iA congenital cardiovascular malformation in which the AORTA arises entirely from the RIGHT VENTRICLE, and the PULMONARY ARTERY from the LEFT VENTRICLE. Consequently, the pulmonary and the systemic circulations are parallel and not sequential, so that the venous return from the peripheral circulation is re-circulated by the right ventricle via aorta to the systemic circulation without being oxygenated in the lungs. This is a potentially lethal form of heart disease in newborns and infants.
=688  \\$a65
=750  \0$aTransposition of great vessels$5IEN$0(DLC)sh 85137085

=LDR  01294cz  a2200325n  4500
=001  9880364050502441
=005  20141212210347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014187
=035  \\$aCBA7523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x839
=072  \\$aN2.$x421.$x297.$x879
=150  \\$aTransportation of Patients
=450  \\$wnnna$aPatients Transportation
=450  \\$wnnna$aPatients Transportations
=450  \\$aTransport of Wounded and Sick
=450  \\$wnnna$aTransport, Wounded and Sick
=550  \\$wg$aEmergency Medical Services
=550  \\$wg$aEmergency Treatment
=550  \\$wh$aAmbulance Diversion
=550  \\$wh$aAmbulances
=550  \\$wh$aStretchers
=550  \\$aMoving and Lifting Patients
=550  \\$aStretchers
=550  \\$aWounds and Injuries
=667  \\$aincludes transport inside (e.g., bed to bed) & outside the hosp or elsewhere but do not confuse with PATIENT TRANSFER (interfacility or intrahospital transfer for admin reasons with regard to special care or economics)
=680  \\$iConveying ill or injured individuals from one place to another.
=688  \\$a78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963
=750  \0$aTransport of sick and wounded$0(DLC) sh 85137017$5IEN

=LDR  00740cz  a2200241n  4500
=001  9880364050602441
=005  20141212210347.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014186
=035  \\$aCBA7522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937
=150  \\$aTransportation
=450  \\$wnnna$aCommuting
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aAviation
=550  \\$wh$aMotor Vehicles
=550  \\$wh$aRailroads
=550  \\$wh$aShips
=667  \\$aspecify industry or geog if pertinent
=680  \\$iThe means of moving persons, animals, goods, or materials from one place to another.
=688  \\$a76; was NON MESH before 1976
=750  \0$aTransportation$5IEN$0(DLC)sh 85137027

=LDR  01115cz  a2200301n  4500
=001  9880364050702441
=005  20141212210346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014182
=035  \\$aCBA7518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x664
=150  \\$aTransplantation, Autologous
=450  \\$wnnna$aAutografting
=450  \\$wnnna$aAutograftings
=450  \\$wnnna$aAutologous Transplantation
=450  \\$wnnna$aAutologous Transplantations
=450  \\$aAutotransplantation$5IEN
=450  \\$wnnna$aAutotransplantion
=450  \\$wnnna$aAutotransplantions
=450  \\$wnnna$aTransplantations, Autologous
=550  \\$wg$aTransplantation
=550  \\$aAutografts
=667  \\$aadd as NIM coordinate only if discussed: Manual 19.8.75; for skin or muscle flaps in plastic surgery index under SKIN TRANSPLANTATION or SURGICAL FLAPS & not also here
=680  \\$iTransplantation of an individual's own tissue from one site to another site.
=688  \\$a65
=750  \0$aAutotransplantation$5IEN-M$0(DLC)sh 85010471
=750  \0$aAutografts$5IEN-HS$0(DLC)sh 85010065

=LDR  01094cz  a2200277n  4500
=001  9880364050802441
=005  20141212192610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014181
=035  \\$aCBA7517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x901
=150  \\$aTransplantation Immunology
=450  \\$aImmunology, Transplantation
=550  \\$wg$aImmune System Processes
=550  \\$wh$aGraft vs Host Reaction
=550  \\$wh$aHistocompatibility
=550  \\$wh$aHost vs Graft Reaction
=550  \\$aCell Transplantation
=550  \\$aOrgan Transplantation
=550  \\$aTissue Transplantation
=550  \\$aTransplantation
=667  \\$aIM; DF: TRANSPL IMMUNOL
=680  \\$iA general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection.
=688  \\$a65
=750  \0$aTransplantation immunology$5IEN$0(DLC)sh 85137007

=LDR  01481cz  a2200337n  4500
=001  9880364050902441
=005  20141212192610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014180
=035  \\$aCBA7516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936
=150  \\$aTransplantation
=450  \\$wnnna$aTransplantations
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCell Transplantation
=550  \\$wh$aCold Ischemia
=550  \\$wh$aOrgan Transplantation
=550  \\$wh$aReplantation
=550  \\$wh$aTissue and Organ Harvesting
=550  \\$wh$aTissue Transplantation
=550  \\$wh$aTransplantation, Autologous
=550  \\$wh$aTransplantation, Heterologous
=550  \\$wh$aTransplantation, Heterotopic
=550  \\$wh$aTransplantation, Homologous
=550  \\$wh$aWarm Ischemia
=550  \\$aTransplantation Conditioning
=550  \\$aTransplantation Immunology
=667  \\$ause for the surgical procedure; use TRANSPLANTS or specifics for the transplant itself; general or unspecified only; prefer /transpl with specific organ, tissue or cell terms or precoordinated transplantation terms (ORGAN TRANSPLANTATION, HEART TRANSPLANTATION, etc.)
=680  \\$iTransference of a tissue or organ from either an alive or deceased donor, within an individual, between individuals of the same species, or between individuals of different species.
=750  \0$aTransplantation of organs, tissues, etc.$0(DLC) sh 85137008$5IEN

=LDR  02106cz  a2200349n  4500
=001  9880364051002441
=005  20171012164459.0
=008  840501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014179
=035  \\$aCBA7515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x437
=072  \\$aD27.$x505.$x519.$x625.$x600
=072  \\$aD27.$x505.$x696.$x577.$x600
=150  \\$aNeurotransmitter Uptake Inhibitors
=450  \\$wnnna$aInhibitors, Neurotransmitter Reuptake
=450  \\$wnnna$aInhibitors, Neurotransmitter Uptake
=450  \\$wnnna$aNeurotransmitter Reuptake Inhibitors
=450  \\$aReuptake Inhibitors, Neurotransmitter
=450  \\$aTransmitter Uptake Inhibitors, Neuronal
=450  \\$wnnna$aUptake Inhibitors, Neurotransmitter
=550  \\$wg$aMembrane Transport Modulators
=550  \\$wg$aNeurotransmitter Agents
=550  \\$wh$aAdrenergic Uptake Inhibitors
=550  \\$wh$aDopamine Uptake Inhibitors
=550  \\$wh$aGABA Uptake Inhibitors
=550  \\$wh$aSerotonin and Noradrenaline Reuptake Inhibitors
=550  \\$wh$aSerotonin Uptake Inhibitors
=667  \\$aGEN or unspecified; prefer specific groups or specific drugs; coord IM with specific neurotransmitters /physiol (IM); DF: NEUROTRANSM UPTAKE INHIB
=680  \\$iDrugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
=688  \\$a93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE & UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92
=750  \0$aNeurotransmitter uptake inhibitors$5IEN$0(DLC)sh 94000399

=LDR  01245cz  a2200325n  4500
=001  9880364051102441
=005  20141212210345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014178
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x870
=072  \\$aG5.$x355.$x600.$x860
=072  \\$aG5.$x365.$x590.$x175.$x870
=150  \\$aTranslocation, Genetic
=450  \\$aChromosomal Translocation
=450  \\$wnnna$aChromosomal Translocations
=450  \\$wnnna$aGenetic Translocation
=450  \\$wnnna$aGenetic Translocations
=450  \\$aTranslocation, Chromosomal
=450  \\$wnnoa$aTranslocation (Genetics)$5IEN-HS
=450  \\$wnnna$aTranslocations, Chromosomal
=450  \\$wnnna$aTranslocations, Genetic
=550  \\$wg$aChromosome Aberrations
=550  \\$wg$aMutagenesis
=550  \\$wh$aPhiladelphia Chromosome
=550  \\$aGene Rearrangement
=667  \\$ado not confuse with PROTEIN BIOSYNTHESIS (RNA-directed formation of peptides)
=680  \\$iA type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.
=688  \\$a2005(1968)
=750  \0$aTranslocation (Genetics)$0(DLC) sh 85136978$5IEN

=LDR  00458cz  a2200157n  4500
=001  9880364051202441
=005  20141212210345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014177
=035  \\$aCBA7513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x920
=150  \\$aTranslations
=550  \\$wg$aPublications
=680  \\$iProducts resulting from the conversion of one language to another.
=750  \0$aTranslations$5IEN$0(DLC)sh 85136967

=LDR  02443cz  a2200565n  4500
=001  9880364051302441
=005  20141212210345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014176
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x675.$x871
=072  \\$aG2.$x149.$x115.$x675.$x871
=072  \\$aG3.$x495.$x770.$x871
=072  \\$aG5.$x355.$x310.$x670
=150  \\$aProtein Biosynthesis
=450  \\$wnnna$aBiosynthesis, Protein
=450  \\$wnnna$aBiosynthesis, Ribosomal Peptide
=450  \\$wnnna$aBiosynthesis, Ribosomal Protein
=450  \\$aGenetic Translation
=450  \\$wnnna$aGenetic Translations
=450  \\$wnnna$amRNA Translation
=450  \\$wnnna$amRNA Translations
=450  \\$aPeptide Biosynthesis, Ribosomal
=450  \\$wnnna$aProtein Biosynthesis, Ribosomal
=450  \\$wnnna$aProtein Synthesis, Ribosomal
=450  \\$aProtein Translation
=450  \\$aProteins$xbiosynthesis
=450  \\$wnnna$aRibosomal Peptide Biosynthesis
=450  \\$wnnna$aRibosomal Protein Biosynthesis
=450  \\$wnnna$aRibosomal Protein Synthesis
=450  \\$wnnna$aSynthesis, Ribosomal Protein
=450  \\$aTranslation, Genetic
=450  \\$wnnna$aTranslation, mRNA
=450  \\$wnnna$aTranslation, Protein
=550  \\$wg$aGene Expression
=550  \\$wg$aPeptide Biosynthesis
=550  \\$wh$aFrameshifting, Ribosomal
=550  \\$wh$aPeptide Chain Elongation, Translational
=550  \\$wh$aPeptide Chain Initiation, Translational
=550  \\$wh$aPeptide Chain Termination, Translational
=550  \\$wh$aProtein Modification, Translational
=550  \\$wh$aTransfer RNA Aminoacylation
=550  \\$aCodon, Initiator
=550  \\$aCodon, Terminator
=550  \\$aGenetic Code
=550  \\$aPeptide Biosynthesis
=667  \\$ado not confuse the ribosome translocation step of PROTEIN BIOSYNTHESIS with TRANSLOCATION, GENETIC a chromosome aberration; coordinate with the specific protein/biosyn only when genetic translation is discussed; PEPTIDE BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available; for "protein anabolism" and "protein catabolism" use PROTEINS/metab
=680  \\$iThe biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS.
=688  \\$a2005 (1973)
=750  \0$aProteins$xSynthesis$0(DLC) sh 85107655$5IEN-M

=LDR  00931cz  a2200229n  4500
=001  9880364051502441
=005  20141212210343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014173
=035  \\$aCBA7509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x625.$x714
=150  \\$aTransistors, Electronic
=450  \\$wnnna$aElectronic Transistor
=450  \\$wnnna$aElectronic Transistors
=450  \\$wnnna$aTransistor, Electronic
=550  \\$wg$aSemiconductors
=680  \\$iElectrical devices that are composed of semiconductor material, with at least three connections to an external electronic circuit. They are used to amplify electrical signals, detect signals, or as switches.
=688  \\$a2010 (1975)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Transistors
=688  \\$a91(75); was see under SEMICONDUCTORS 1975-90; was in Cat H & J 1975-82
=750  \0$aTransistors$0(DLC) sh 85136935$5IEN

=LDR  00710cz  a2200229n  4500
=001  9880364051602441
=005  20141212210343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014172
=035  \\$aCBA7508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x589.$x500
=072  \\$aE5.$x642.$x500
=150  \\$aTransillumination
=450  \\$wnnna$aDiaphanographies
=450  \\$aDiaphanography
=450  \\$wnnna$aDiaphanoscopies
=450  \\$aDiaphanoscopy
=450  \\$wnnna$aTransilluminations
=550  \\$wg$aOptical Imaging
=680  \\$iPassage of light through body tissues or cavities for examination of internal structures.
=750  \0$aTransillumination$5IEN$0(DLC)sh 85136926

=LDR  01136cz  a2200385n  4500
=001  9880364051702441
=005  20141212210343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014171
=035  \\$aCBA7507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x920
=150  \\$aTransients and Migrants
=450  \\$wnnna$aIllegal Migrants
=450  \\$wnnna$aMigrant
=450  \\$wnnna$aMigrant Worker
=450  \\$wnnna$aMigrant Workers
=450  \\$aMigrants
=450  \\$wnnna$aMigrants and Transients
=450  \\$wnnna$aNomad
=450  \\$wnnna$aNomads
=450  \\$wnnna$aNonmigrant
=450  \\$wnnna$aNonmigrants
=450  \\$wnnna$aSquatter
=450  \\$wnnna$aSquatters
=450  \\$wnnna$aTransient
=450  \\$wnnna$aTransients
=450  \\$wnnna$aWorker, Migrant
=450  \\$wnnna$aWorkers, Migrant
=550  \\$wg$aPersons
=550  \\$aEmigration and Immigration
=667  \\$aspecify geog if possible; DF: TRANSIENTS
=680  \\$iPeople who frequently change their place of residence.
=750  \0$aTramps$5IEN-M$0(DLC)sh 85136853
=750  \0$aMigrant labor$5IEN-HS$0(DLC)sh 85085067

=LDR  01533cz  a2200325n  4500
=001  9880364051802441
=005  20141212210950.0
=008  880524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015291
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x954.$x800
=072  \\$aD12.$x644.$x276.$x963
=072  \\$aD12.$x776.$x467.$x942.$x800
=072  \\$aD12.$x776.$x467.$x960
=072  \\$aD23.$x529.$x942.$x800
=072  \\$aD23.$x529.$x960
=150  \\$aTransforming Growth Factors
=450  \\$wnnna$aFactor, Transforming Growth
=450  \\$wnnna$aFactors, Transforming Growth
=450  \\$wnnna$aGrowth Factor, Transforming
=450  \\$wnnna$aGrowth Factors, Transforming
=450  \\$wnnna$aTransforming Growth Factor
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wg$aTGF-beta Superfamily Proteins
=550  \\$wh$aTransforming Growth Factor alpha
=550  \\$wh$aTransforming Growth Factor beta
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iHormonally active polypeptides that can induce the transformed phenotype when added to normal, non-transformed cells. They have been found in culture fluids from retrovirally transformed cells and in tumor-derived cells as well as in non-neoplastic sources. Their transforming activities are due to the simultaneous action of two otherwise unrelated factors, TRANSFORMING GROWTH FACTOR ALPHA and TRANSFORMING GROWTH FACTOR BETA.
=688  \\$a89
=750  \0$aTransforming growth factors$5IEN$0(DLC)sh 89003813

=LDR  01045cz  a2200253n  4500
=001  9880364051902441
=005  20141212210342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x865
=150  \\$aTransformation, Genetic
=450  \\$wnnna$aGenetic Transformation
=450  \\$wnnna$aGenetic Transformations
=450  \\$wnnna$aTransformations, Genetic
=550  \\$wg$aRecombination, Genetic
=550  \\$wh$aTransformation, Bacterial
=550  \\$aCrosses, Genetic
=550  \\$aTransduction, Genetic
=550  \\$aTransfection
=667  \\$aGEN: prefer specifics; DF: TRANSFORM GENET
=680  \\$iChange brought about to an organisms genetic composition by unidirectional transfer (TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.) and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell's genome.
=688  \\$a68
=750  \0$aGenetic transformation$5IEN$0(DLC)sh 85053873

=LDR  01018cz  a2200253n  4500
=001  9880364052002441
=005  20170607114518.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014169
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x350.$x810.$x500
=072  \\$aG5.$x728.$x860.$x500
=072  \\$aG5.$x728.$x865.$x820
=072  \\$aG6.$x99.$x850
=150  \\$aTransformation, Bacterial
=450  \\$wnnna$aBacterial Transformation
=550  \\$wg$aBacterial Physiological Phenomena
=550  \\$wg$aTransfection
=550  \\$wg$aTransformation, Genetic
=550  \\$wh$aDNA Transformation Competence
=667  \\$acoord with specific bact transformed/genet; DF: TRANSFORM BACT
=680  \\$iThe heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.
=688  \\$a78
=750  \0$aBacterial transformation$5IEN$0(DLC)sh 85010857

=LDR  01641cz  a2200421n  4500
=001  9880364052102441
=005  20141212210342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014168
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x50.$x800
=072  \\$aD12.$x776.$x124.$x790.$x223.$x839
=072  \\$aD12.$x776.$x157.$x427.$x750.$x500
=072  \\$aD12.$x776.$x377.$x715.$x182.$x839
=072  \\$aD12.$x776.$x556.$x579.$x750.$x500
=150  \\$aTransferrin
=450  \\$wnnna$abeta-1 Metal-Binding Globulin
=450  \\$wnnna$abeta 1 Metal Binding Globulin
=450  \\$wnnna$abeta 2-Transferrin
=450  \\$wnnna$abeta 2 Transferrin
=450  \\$wnnna$aGlobulin, beta-1 Metal-Binding
=450  \\$wnnna$aIsotransferrin
=450  \\$wnnna$aMetal-Binding Globulin, beta-1
=450  \\$wnnna$aMonoferric Transferrins
=450  \\$wnnna$aSerotransferrin
=450  \\$aSiderophilin
=450  \\$wnnna$atau-Transferrin
=450  \\$wnnna$atau Transferrin
=450  \\$wnnna$aTransferrin B
=450  \\$wnnna$aTransferrin C
=450  \\$wnnna$aTransferrins, Monoferric
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aBeta-Globulins
=550  \\$wg$aTransferrins
=550  \\$aIron
=667  \\$aTRANSFERRINS is also available
=680  \\$iAn iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states.
=750  \0$aTransferrin$5IEN$0(DLC)sh 85136915

=LDR  01080cz  a2200265n  4500
=001  9880364052302441
=005  20141212210341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014166
=035  \\$aCBA7501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913
=150  \\$aTransferases
=450  \\$wnnna$aTransferase
=550  \\$wg$aEnzymes
=550  \\$wh$aAcyltransferases
=550  \\$wh$aAldehyde-Ketone Transferases
=550  \\$wh$aAlkyl and Aryl Transferases
=550  \\$wh$aGlycosyltransferases
=550  \\$wh$aNitrogenous Group Transferases
=550  \\$wh$aOne-Carbon Group Transferases
=550  \\$wh$aPhosphotransferases
=550  \\$wh$aSulfur Group Transferases
=680  \\$iTransferases are enzymes transferring a group, for example, the methyl group or a glycosyl group, from one compound (generally regarded as donor) to another compound (generally regarded as acceptor). The classification is based on the scheme "donor:acceptor group transferase". (Enzyme Nomenclature, 1992) EC 2.
=750  \0$aTransferases$5IEN$0(DLC)sh 85136913

=LDR  00961cz  a2200253n  4500
=001  9880364052402441
=005  20141212210341.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014165
=035  \\$aCBA7500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x480.$x750
=072  \\$aD12.$x776.$x467.$x374.$x480.$x750
=072  \\$aD23.$x529.$x374.$x480.$x750
=150  \\$aTransfer Factor
=450  \\$wnnna$aDialyzable Leukocyte Extract
=450  \\$wnnna$aExtract, Dialyzable Leukocyte
=450  \\$wnnna$aFactor, Transfer
=450  \\$wnnna$aLeukocyte Extract, Dialyzable
=550  \\$wg$aLymphokines
=667  \\$aderived from leukocytes; /biosyn /drug eff /physiol /ultrastruct permitted
=680  \\$iFactor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients.
=688  \\$a75
=750  \0$aTransfer factor (Immunology)$5IEN$0(DLC)sh 85136904

=LDR  01116cz  a2200241n  4500
=001  9880364052602441
=005  20141212210340.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x350.$x810
=072  \\$aG5.$x355.$x760.$x860
=150  \\$aTransfection
=450  \\$wnnna$aTransfections
=550  \\$wg$aGene Transfer Techniques
=550  \\$wg$aRecombination, Genetic
=550  \\$wh$aTransformation, Bacterial
=550  \\$aTransformation, Bacterial
=550  \\$aTransformation, Genetic
=667  \\$acoordinate with recipient/genet if permitted + specific donor/genet; do not confuse with genetic transvection, an epigenetic phenomenon (index under EPIGENESIS, GENETIC)
=680  \\$iThe uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
=688  \\$a78(75); was see under TRANSFORMATION, GENETIC 1975-77
=750  \0$aTransfection$5IEN$0(DLC)sh 85136898

=LDR  00939cz  a2200241n  4500
=001  9880364052702441
=005  20141212210339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x350.$x800
=072  \\$aG5.$x355.$x760.$x850
=150  \\$aTransduction, Genetic
=450  \\$wnnna$aGenetic Transduction
=450  \\$wnnna$aGenetic Transductions
=450  \\$wnnna$aTransductions, Genetic
=550  \\$wg$aGene Transfer Techniques
=550  \\$wg$aRecombination, Genetic
=550  \\$aCrosses, Genetic
=550  \\$aTransformation, Genetic
=680  \\$iThe transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE.
=688  \\$a68
=750  \0$aTransduction$5IEN$0(DLC)sh 85136897

=LDR  00687cz  a2200217n  4500
=001  9880364052802441
=005  20141212210339.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014160
=035  \\$aCBA7494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x812.$x901
=150  \\$aTransducers, Pressure
=450  \\$wnnna$aPressure Transducer
=450  \\$wnnna$aPressure Transducers
=450  \\$wnnna$aTransducer, Pressure
=550  \\$wg$aTransducers
=667  \\$aNIM
=680  \\$iTransducers that are activated by pressure changes, e.g., blood pressure.
=688  \\$a91(80); was see under TRANSDUCERS 1980-90
=750  \0$aPressure transducers$5IEN$0(DLC)sh 85106546

=LDR  00859cz  a2200193n  4500
=001  9880364052902441
=005  20141212210339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014159
=035  \\$aCBA7493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x812
=150  \\$aTransducers
=450  \\$wnnna$aTransducer
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wh$aTransducers, Pressure
=680  \\$iAny device or element which converts an input signal into an output signal of a different form. Examples include the microphone, phonographic pickup, loudspeaker, barometer, photoelectric cell, automobile horn, doorbell, and underwater sound transducer. (McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a73; was TRANSDUCER 1966-72 (Prov 1966-67)
=750  \0$aTransducers$5IEN-M$0(DLC)sh 85136892

=LDR  01231cz  a2200349n  4500
=001  9880364053002441
=005  20170609091107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014158
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x873.
=072  \\$aG5.$x297.$x700
=150  \\$aTranscription, Genetic
=450  \\$aEarly Gene Transcription
=450  \\$wnnna$aGene Transcription, Early
=450  \\$wnnna$aGene Transcription, Late
=450  \\$aGenetic Transcription
=450  \\$aLate Gene Transcription
=450  \\$wnnna$aTranscription, Early Gene
=450  \\$wnnna$aTranscription, Late Gene
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aGene Expression
=550  \\$wh$aReverse Transcription
=550  \\$wh$aTranscription Elongation, Genetic
=550  \\$wh$aTranscription Initiation, Genetic
=550  \\$wh$aTranscription Termination, Genetic
=550  \\$wh$aTranscriptome
=550  \\$aAntisense Elements (Genetics)
=550  \\$aDNA, Ribosomal
=680  \\$iThe biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
=688  \\$a1973
=750  \0$aGenetic transcription$5IEN$0(DLC)sh 85053872

=LDR  04433cz  a2201141n  4500
=001  9880364053102441
=005  20200716165419.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014157
=035  \\$aCBA7491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x930
=150  \\$aTranscription Factors
=450  \\$wnnna$aFactor, Transcription
=450  \\$wnnna$aFactors, Transcription
=450  \\$wnnna$aTranscription Factor
=550  \\$wg$aProteins
=550  \\$wh$aAdenovirus E1A Proteins
=550  \\$wh$aAdenovirus E1B Proteins
=550  \\$wh$aAntennapedia Homeodomain Protein
=550  \\$wh$aAraC Transcription Factor
=550  \\$wh$aBasic Helix-Loop-Helix Transcription Factors
=550  \\$wh$aBasic-Leucine Zipper Transcription Factors
=550  \\$wh$abeta Catenin
=550  \\$wh$aBRCA1 Protein
=550  \\$wh$aCDX2 Transcription Factor
=550  \\$wh$aCore Binding Factors
=550  \\$wh$aCyclic AMP Receptor Protein
=550  \\$wh$aE2F Transcription Factors
=550  \\$wh$aEarly Growth Response Transcription Factors
=550  \\$wh$aElongin
=550  \\$wh$aErythroid-Specific DNA-Binding Factors
=550  \\$wh$aFushi Tarazu Transcription Factors
=550  \\$wh$aG-Box Binding Factors
=550  \\$wh$aGATA Transcription Factors
=550  \\$wh$aGoosecoid Protein
=550  \\$wh$aHeat Shock Transcription Factors
=550  \\$wh$aHepatocyte Nuclear Factors
=550  \\$wh$aHomeobox Protein Nkx-2.5
=550  \\$wh$aHost Cell Factor C1
=550  \\$wh$aI-kappa B Proteins
=550  \\$wh$aImmunoglobulin J Recombination Signal Sequence-Binding Protein
=550  \\$wh$aInhibitor of Differentiation Proteins
=550  \\$wh$aInterferon Regulatory Factors
=550  \\$wh$aInterferon-Stimulated Gene Factor 3
=550  \\$wh$aKruppel-Like Transcription Factors
=550  \\$wh$aLeucine-Responsive Regulatory Protein
=550  \\$wh$aMADS Domain Proteins
=550  \\$wh$aMDS1 and EVI1 Complex Locus Protein
=550  \\$wh$aMSX1 Transcription Factor
=550  \\$wh$aMyeloid Ecotropic Viral Integration Site 1 Protein
=550  \\$wh$aMyeloid-Lymphoid Leukemia Protein
=550  \\$wh$aNanog Homeobox Protein
=550  \\$wh$aNF-kappa B
=550  \\$wh$aNFATC Transcription Factors
=550  \\$wh$aNFI Transcription Factors
=550  \\$wh$aNuclear Factor 90 Proteins
=550  \\$wh$aNuclear Receptor Coactivators
=550  \\$wh$aNuclear Respiratory Factors
=550  \\$wh$aOnecut Transcription Factors
=550  \\$wh$aOtx Transcription Factors
=550  \\$wh$ap300-CBP Transcription Factors
=550  \\$wh$aPaired Box Transcription Factors
=550  \\$wh$aPOU Domain Factors
=550  \\$wh$aPre-B-Cell Leukemia Transcription Factor 1
=550  \\$wg$aPromyelocytic Leukemia Protein
=550  \\$wh$aProto-Oncogene Proteins c-bcl-6
=550  \\$wh$aProto-Oncogene Proteins c-ets
=550  \\$wh$aProto-Oncogene Proteins c-myb
=550  \\$wh$aProto-Oncogene Proteins c-rel
=550  \\$wh$aReceptors, Aryl Hydrocarbon
=550  \\$wh$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aReceptors, Notch
=550  \\$wh$aRepressor Proteins
=550  \\$wh$aRho Factor
=550  \\$wh$aSigma Factor
=550  \\$wh$aSmad Proteins
=550  \\$wh$aSMARCB1 Protein
=550  \\$wh$aSnail Family Transcription Factors
=550  \\$wh$aSOX Transcription Factors
=550  \\$wh$aSTAT Transcription Factors
=550  \\$wh$aT-Box Domain Proteins
=550  \\$wh$aTCF Transcription Factors
=550  \\$wh$aThyroid Nuclear Factor 1
=550  \\$wh$aTrans-Activators
=550  \\$wh$aTranscription Factor AP-2
=550  \\$wh$aTranscription Factor DP1
=550  \\$wh$aTranscription Factors, General
=550  \\$wh$aTranscriptional Elongation Factors
=550  \\$wh$aTristetraprolin
=550  \\$wh$aTumor Protein p73
=550  \\$wh$aWinged-Helix Transcription Factors
=550  \\$aGene Expression Regulation
=550  \\$aTranscription, Genetic
=667  \\$ain genetic transcription; /biosyn /physiol permitted; regulatory proteins go here or under REPRESSOR PROTEINS or VIRAL REGULATORY PROTEINS
=680  \\$iEndogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
=688  \\$a77
=750  \0$aTranscription factors$5IEN-M$0(DLC)sh 92005483

=LDR  00883cz  a2200217n  4500
=001  9880364053202441
=005  20141212210335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014152
=035  \\$aCBA7486HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x709.$x838
=150  \\$aTransactional Analysis
=450  \\$wnnna$aAnalyses, Transactional
=450  \\$wnnna$aAnalysis, Transactional
=450  \\$wnnna$aTransactional Analyses
=550  \\$wg$aPsychoanalytic Therapy
=667  \\$aa psychoanal technique; DF: TRANSACTIONAL ANAL
=680  \\$iA psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state (whether parent-like, child-like, or adult-like) as a basis for understanding behavior.
=688  \\$a79(73); was see under PSYCHOANALYTIC THERAPY 1975-78
=750  \0$aTransactional analysis$5IEN$0(DLC)sh 85136871

=LDR  02497cz  a2200505n  4500
=001  9880364053302441
=005  20141212210334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014150
=035  \\$aCBA7484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x950.$x40
=072  \\$aD27.$x505.$x954.$x427.$x210.$x950.$x40
=072  \\$aD27.$x505.$x954.$x427.$x700.$x872.$x331
=150  \\$aAntipsychotic Agents
=450  \\$wnnna$aAgents, Antipsychotic
=450  \\$wnnna$aAgents, Major Tranquilizing
=450  \\$wnnna$aAgents, Major Tranquillizing
=450  \\$wnnna$aAgents, Neuroleptic
=450  \\$wnnoa$aAntipsychotic Agents, Butyrophenone$5IEN-M
=450  \\$wnnoa$aAntipsychotic Agents, Phenothiazine$5IEN-M
=450  \\$wnnna$aAntipsychotic Drugs
=450  \\$wnnna$aAntipsychotic Effect
=450  \\$wnnna$aAntipsychotic Effects
=450  \\$wnnna$aAntipsychotics
=450  \\$wnnna$aDrugs, Antipsychotic
=450  \\$wnnna$aDrugs, Neuroleptic
=450  \\$wnnna$aEffect, Antipsychotic
=450  \\$wnnna$aEffects, Antipsychotic
=450  \\$wnnna$aMajor Tranquilizers
=450  \\$wnnna$aMajor Tranquilizing Agents
=450  \\$wnnna$aMajor Tranquillizing Agents
=450  \\$wnnna$aNeuroleptic Agents
=450  \\$wnnna$aNeuroleptic Drugs
=450  \\$aNeuroleptics
=450  \\$wnnna$aTranquilizers, Major
=450  \\$aTranquilizing Agents, Major
=450  \\$wnnna$aTranquillizing Agents, Major
=550  \\$wg$aTranquilizing Agents
=550  \\$aButyrophenones
=550  \\$aPhenothiazines
=667  \\$anote entry term ANTIPSYCHOTIC EFFECT: use only for the antipsychotic effect of a chemical substance
=680  \\$iAgents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
=688  \\$a95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74
=750  \0$aAntipsychotic drugs$5IEN-M$0(DLC)sh 89002390

=LDR  01723cz  a2200397n  4500
=001  9880364053402441
=005  20141212210334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014149
=035  \\$aCBA7483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x950
=072  \\$aD27.$x505.$x954.$x427.$x210.$x950
=072  \\$aD27.$x505.$x954.$x427.$x700.$x872
=150  \\$aTranquilizing Agents
=450  \\$wnnna$aAgents, Tranquilizing
=450  \\$wnnna$aAgents, Tranquillizing
=450  \\$aAtaractics
=450  \\$wnnna$aDrugs, Tranquilizing
=450  \\$wnnna$aDrugs, Tranquillizing
=450  \\$wnnna$aEffect, Tranquilizing
=450  \\$wnnna$aEffects, Tranquilizing
=450  \\$wnnna$aTranquilizing Drugs
=450  \\$wnnna$aTranquilizing Effect
=450  \\$wnnna$aTranquilizing Effects
=450  \\$wnnna$aTranquillizing Agents
=450  \\$wnnna$aTranquillizing Drugs
=550  \\$wg$aCentral Nervous System Depressants
=550  \\$wg$aPsychotropic Drugs
=550  \\$wh$aAnti-Anxiety Agents
=550  \\$wh$aAntimanic Agents
=550  \\$wh$aAntipsychotic Agents
=550  \\$aHypnotics and Sedatives
=667  \\$ageneral or unspecified; prefer specifics; note entry term TRANQUILIZING EFFECT: use only for the tranquilizing effect of a chemical substance
=680  \\$iA traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes.
=750  \0$aTranquilizing drugs$5IEN$0(DLC)sh 85136865

=LDR  01498cz  a2200433n  4500
=001  9880364053502441
=005  20141212210330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014146
=035  \\$aCBA7480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x483.$x838
=150  \\$aTraining Support
=450  \\$wnnna$aEducational Grant
=450  \\$wnnna$aEducational Grants
=450  \\$wnnna$aEducational Grants and Subsidies
=450  \\$wnnna$aEducational Subsidies
=450  \\$wnnna$aEducational Subsidy
=450  \\$wnnna$aGrant, Educational
=450  \\$aGrants and Subsidies, Educational
=450  \\$wnnna$aGrants, Educational
=450  \\$wnnna$aLoan, Student
=450  \\$wnnna$aLoans, Student
=450  \\$wnnna$aStudent Loan
=450  \\$aStudent Loans
=450  \\$aSubsidies, Educational
=450  \\$wnnna$aSubsidy, Educational
=450  \\$wnnna$aSupport, Training
=450  \\$wnnna$aSupports, Training
=450  \\$wnnna$aTraineeship
=450  \\$wnnna$aTraineeships
=450  \\$wnnna$aTraining Supports
=550  \\$wg$aFinancial Support
=550  \\$wh$aFellowships and Scholarships
=550  \\$aEducation
=667  \\$aspecify agency or government & geographic term if possible
=680  \\$iFinancial support for training including both student stipends and loans and training grants to institutions.
=688  \\$a66; STUDENT LOANS was see under TRAINING SUPPORT 1966-77
=750  \0$aStudent aid$5IEN-M$0(DLC)sh 85129251

=LDR  00801cz  a2200169n  4500
=001  9880364053602441
=005  20141212210329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014143
=035  \\$aCBA7477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x720
=150  \\$aTraction
=450  \\$wnnna$aTractions
=550  \\$wg$aOrthopedic Procedures
=680  \\$iThe pull on a limb or a part thereof. Skin traction (indirect traction) is applied by using a bandage to pull on the skin and fascia where light traction is required. Skeletal traction (direct traction), however, uses pins or wires inserted through bone and is attached to weights, pulleys, and ropes. (From Blauvelt & Nelson, A Manual of Orthopaedic Terminology, 5th ed)
=750  \0$aOrthopedic traction$5IEN$0(DLC)sh 85095814

=LDR  00954cz  a2200289n  4500
=001  9880364053702441
=005  20141212210328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014141
=035  \\$aCBA7475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x354.$x225.$x800
=072  \\$aC1.$x252.$x400.$x210.$x210.$x800
=072  \\$aC1.$x539.$x375.$x354.$x220.$x800
=072  \\$aC11.$x187.$x183.$x220.$x889
=072  \\$aC11.$x204.$x813
=072  \\$aC11.$x294.$x354.$x220.$x800
=150  \\$aTrachoma
=450  \\$aEgyptian Ophthalmia
=450  \\$wnnna$aOphthalmia, Egyptian
=450  \\$wnnna$aTrachomas
=550  \\$wg$aChlamydia Infections
=550  \\$wg$aConjunctivitis, Bacterial
=550  \\$wg$aCorneal Diseases
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iA chronic infection of the CONJUNCTIVA and CORNEA caused by CHLAMYDIA TRACHOMATIS.
=750  \0$aTrachoma$5IEN$0(DLC)sh 85136427

=LDR  00726cz  a2200229n  4500
=001  9880364053802441
=005  20141212210328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014140
=035  \\$aCBA7474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x907
=072  \\$aE4.$x928.$x790
=150  \\$aTracheotomy
=450  \\$wnnna$aTracheotomies
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$aTrachea
=667  \\$ado not use /util except by MeSH definition; do not confuse with TRACHEOSTOMY
=680  \\$iSurgical incision of the trachea.
=688  \\$aTRACHEOSTOMY was heading 1963-66
=750  \0$aTracheotomy$5IEN$0(DLC)sh 85136417

=LDR  00917cz  a2200277n  4500
=001  9880364053902441
=005  20141212210328.0
=008  870325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014139
=035  \\$aCBA7473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x750
=072  \\$aE4.$x579.$x935
=072  \\$aE4.$x580.$x900
=072  \\$aE4.$x928.$x780
=150  \\$aTracheostomy
=450  \\$wnnna$aTracheostomies
=550  \\$wg$aAirway Management
=550  \\$wg$aOstomy
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$aTrachea
=667  \\$ado not use /util except by MeSH definition; do not confuse with TRACHEOTOMY
=680  \\$iSurgical formation of an opening into the trachea through the neck, or the opening so created.
=688  \\$a88,63-66; was see TRACHEOTOMY 1967-87
=750  \0$aTracheotomy$5IEN$0(DLC)sh 85136417

=LDR  01186cz  a2200337n  4500
=001  9880364054002441
=005  20141212210328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014138
=035  \\$aCBA7472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x250.$x725
=072  \\$aC6.$x405.$x117.$x367.$x725
=072  \\$aC8.$x702.$x750
=072  \\$aC8.$x907.$x863
=072  \\$aC23.$x300.$x575.$x185.$x250.$x725
=150  \\$aTracheoesophageal Fistula
=450  \\$aEsophagotracheal Fistula
=450  \\$wnnna$aEsophagotracheal Fistulas
=450  \\$wnnna$aFistula, Esophagotracheal
=450  \\$wnnna$aFistula, Tracheoesophageal
=450  \\$wnnna$aFistulas, Esophagotracheal
=450  \\$wnnna$aFistulas, Tracheoesophageal
=450  \\$wnnna$aTracheoesophageal Fistulas
=550  \\$wg$aEsophageal Fistula
=550  \\$wg$aRespiratory Tract Fistula
=550  \\$wg$aTracheal Diseases
=667  \\$afistula policy: Manual 23.19+
=680  \\$iAbnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.
=688  \\$a65(63)
=750  \0$aFistula, Tracheoesophageal$5IEN$0(DLC)sh 85048903

=LDR  00484cz  a2200181n  4500
=001  9880364054102441
=005  20141212210327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014136
=035  \\$aCBA7470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x730.$x848
=072  \\$aC8.$x907.$x763
=150  \\$aTracheitis
=450  \\$wnnna$aTracheitides
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wg$aTracheal Diseases
=750  \0$aTracheitis$5IEN$0(DLC)sh 85136410

=LDR  00506cz  a2200181n  4500
=001  9880364054202441
=005  20141212210327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014135
=035  \\$aCBA7469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x907.$x663
=150  \\$aTracheal Stenosis
=450  \\$wnnna$aStenoses, Tracheal
=450  \\$wnnna$aStenosis, Tracheal
=450  \\$wnnna$aTracheal Stenoses
=550  \\$wg$aTracheal Diseases
=750  \0$aTrachea$xStenosis$5IEN$0(DLC)sh 85136405

=LDR  00826cz  a2200253n  4500
=001  9880364054302441
=005  20141212210327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014134
=035  \\$aCBA7468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x925
=072  \\$aC4.$x588.$x894.$x797.$x760
=072  \\$aC8.$x785.$x760
=072  \\$aC8.$x907.$x563
=150  \\$aTracheal Neoplasms
=450  \\$wnnna$aNeoplasm, Tracheal
=450  \\$wnnna$aNeoplasms, Tracheal
=450  \\$wnnna$aTracheal Neoplasm
=550  \\$wg$aHead and Neck Neoplasms
=550  \\$wg$aRespiratory Tract Neoplasms
=550  \\$wg$aTracheal Diseases
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=750  \0$aTrachea$xCancer$0(DLC)sh2010010458$5IEN-M

=LDR  00798cz  a2200277n  4500
=001  9880364054402441
=005  20141212210326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014133
=035  \\$aCBA7467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x907
=150  \\$aTracheal Diseases
=450  \\$wnnna$aDisease, Tracheal
=450  \\$wnnna$aDiseases, Tracheal
=450  \\$wnnna$aTracheal Disease
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aTracheal Neoplasms
=550  \\$wh$aTracheal Stenosis
=550  \\$wh$aTracheitis
=550  \\$wh$aTracheobronchomalacia
=550  \\$wh$aTracheobronchomegaly
=550  \\$wh$aTracheoesophageal Fistula
=667  \\$ainflamm dis = TRACHEITIS
=688  \\$a68
=750  \0$aTrachea$xDiseases$5IEN$0(DLC)sh 85136402

=LDR  00666cz  a2200181n  4500
=001  9880364054502441
=005  20141212210326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014132
=035  \\$aCBA7466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x889
=150  \\$aTrachea
=450  \\$wnnna$aTracheas
=550  \\$wg$aRespiratory System
=667  \\$a/surg: consider also TRACHEOSTOMY & TRACHEOTOMY; inflammation = TRACHEITIS; tracheal cyst = TRACHEAL CYST see MEDIASTINAL CYST
=680  \\$iThe cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.
=750  \0$aTrachea$5IEN$0(DLC)sh 85136401

=LDR  00842cz  a2200181n  4500
=001  9880364327502441
=005  20141212214754.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x346
=150  \\$aErythroxylaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCoca
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Linales, subclass Rosidae, class Magnoliopsida best known for the coca plant.
=688  \\$a2002
=750  \0$aErythroxylaceae$5IEN-M$0(DLC)sh 85044759

=LDR  01262cz  a2200373n  4500
=001  9880364327602441
=005  20141212214753.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x46
=072  \\$aI1.$x880.$x604.$x583.$x80.$x134
=072  \\$aL1.$x143.$x335
=150  \\$aDisclosure
=450  \\$wnnna$aDisclosure, Financial
=450  \\$wnnna$aDisclosure, Information
=450  \\$wnnna$aDisclosures, Financial
=450  \\$aFinancial Disclosure
=450  \\$wnnna$aFinancial Disclosures
=450  \\$aInformation Disclosure
=550  \\$wg$aCommunication
=550  \\$wg$aConfidentiality
=550  \\$wg$aInterpersonal Relations
=550  \\$wh$aMandatory Reporting
=550  \\$wh$aParental Notification
=550  \\$wh$aTruth Disclosure
=550  \\$wh$aWhistleblowing
=550  \\$aConfidentiality
=550  \\$aInformed Consent
=550  \\$aPatient Access to Records
=667  \\$aTRUTH DISCLOSURE is also available
=680  \\$iRevealing of information, by oral or written communication.
=688  \\$a2002; use TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING use TRUTH DISCLOSURE 1997-2001
=750  \0$aDisclosure of information$5IEN-M$0(DLC)sh 90003174

=LDR  00798cz  a2200193n  4500
=001  9880364327702441
=005  20141212214752.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x100
=072  \\$aI1.$x696.$x100
=150  \\$aCapitalism
=550  \\$wg$aEconomics
=550  \\$wg$aPolitical Systems
=667  \\$aspecify geog
=680  \\$iA political and economic system characterized by individual rights, by private or corporate ownership of capital goods, and by prices, production, and the distribution of goods that are determined mainly by competition in a free market. (From Merriam-Webster's Collegiate Dictionary, 10th ed)
=688  \\$a2002; use POLITICAL SYSTEMS 1990-2001
=750  \0$aCapitalism$5IEN-M$0(DLC)sh 85019958

=LDR  00935cz  a2200289n  4500
=001  9880364327802441
=005  20141212214752.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x518
=150  \\$aFood, Genetically Modified
=450  \\$wnnna$aFood, GMO
=450  \\$wnnna$aFoods, Genetically Modified
=450  \\$wnnna$aFoods, GMO
=450  \\$aGenetically Modified Food
=450  \\$wnnna$aGenetically Modified Foods
=450  \\$wnnna$aGMO Food
=450  \\$wnnna$aGMO Foods
=550  \\$wg$aFood
=550  \\$aAnimals, Genetically Modified
=550  \\$aOrganisms, Genetically Modified
=550  \\$aPlants, Genetically Modified
=667  \\$acoord with specific food
=680  \\$iFood derived from genetically modified organisms (ORGANISMS, GENETICALLY MODIFIED).
=688  \\$a2002
=750  \0$aGenetically modified foods$5IEN-M$0(DLC)sh 00006274

=LDR  01656cz  a2200493n  4500
=001  9880364327902441
=005  20141212214751.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x520
=072  \\$aB5.$x620.$x600
=150  \\$aPlants, Genetically Modified
=450  \\$wnnna$aEngineered Plant, Genetically
=450  \\$wnnna$aEngineered Plants, Genetically
=450  \\$wnnna$aGenetically Engineered Plant
=450  \\$wnnna$aGenetically Engineered Plants
=450  \\$wnnna$aGenetically Modified Plant
=450  \\$aGenetically Modified Plants
=450  \\$wnnna$aGMO Plant
=450  \\$wnnna$aGMO Plants
=450  \\$wnnna$aModified Plant, Genetically
=450  \\$wnnna$aModified Plants, Genetically
=450  \\$wnnna$aPlant, Genetically Engineered
=450  \\$wnnna$aPlant, Genetically Modified
=450  \\$wnnna$aPlant, GMO
=450  \\$wnnna$aPlant, Transgenic
=450  \\$wnnna$aPlants, Genetically Engineered
=450  \\$wnnna$aPlants, GMO
=450  \\$aPlants, Transgenic
=450  \\$wnnna$aTransgenic Plant
=450  \\$aTransgenic Plants
=550  \\$wg$aOrganisms, Genetically Modified
=550  \\$wg$aPlants
=550  \\$aFood, Genetically Modified
=550  \\$aGenetic Engineering
=550  \\$aMolecular Farming
=550  \\$aPlantibodies
=550  \\$aSalt-Tolerant Plants
=550  \\$aTransgenes
=667  \\$acoordinate with specific plant /genet
=680  \\$iPLANTS, or their progeny, whose GENOME has been altered by GENETIC ENGINEERING.
=688  \\$a2002
=750  \0$aTransgenic plants$5IEN-M$0(DLC)sh 90003137

=LDR  01996cz  a2200565n  4500
=001  9880364328002441
=005  20141212214750.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x136
=072  \\$aB5.$x620.$x136
=150  \\$aAnimals, Genetically Modified
=450  \\$wnnna$aAnimal, Genetically Engineered
=450  \\$wnnna$aAnimal, Genetically Modified
=450  \\$wnnna$aAnimal, GMO
=450  \\$wnnna$aAnimal, Transgenic
=450  \\$wnnna$aAnimal, Transgenic Founder
=450  \\$wnnna$aAnimals, Genetically Engineered
=450  \\$wnnna$aAnimals, GMO
=450  \\$aAnimals, Transgenic
=450  \\$wnnna$aAnimals, Transgenic Founder
=450  \\$wnnna$aEngineered Animal, Genetically
=450  \\$wnnna$aEngineered Animals, Genetically
=450  \\$wnnna$aFounder Animal, Transgenic
=450  \\$wnnna$aFounder Animals, Transgenic
=450  \\$wnnna$aGenetically Engineered Animal
=450  \\$wnnna$aGenetically Engineered Animals
=450  \\$wnnna$aGenetically Modified Animal
=450  \\$aGenetically Modified Animals
=450  \\$wnnna$aGMO Animal
=450  \\$wnnna$aGMO Animals
=450  \\$wnnna$aModified Animal, Genetically
=450  \\$wnnna$aModified Animals, Genetically
=450  \\$wnnna$aTransgenic Animal
=450  \\$aTransgenic Animals
=450  \\$wnnna$aTransgenic Founder Animal
=450  \\$wnnna$aTransgenic Founder Animals
=550  \\$wg$aAnimal Population Groups
=550  \\$wg$aOrganisms, Genetically Modified
=550  \\$wh$aMice, Transgenic
=550  \\$wh$aRats, Transgenic
=550  \\$aFood, Genetically Modified
=550  \\$aGenetic Engineering
=550  \\$aMolecular Farming
=550  \\$aTransgenes
=667  \\$acoord with specific animal /genet
=680  \\$iANIMALS whose GENOME has been altered by GENETIC ENGINEERING, or their offspring.
=688  \\$a2002
=750  \0$aTransgenic animals$5IEN$0(DLC)sh 89007259

=LDR  01762cz  a2200469n  4500
=001  9880364328102441
=005  20200528145714.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x620
=150  \\$aOrganisms, Genetically Modified
=450  \\$wnnna$aEngineered Organism, Genetically
=450  \\$wnnna$aEngineered Organisms, Genetically
=450  \\$wnnna$aGenetically Engineered Organism
=450  \\$wnnna$aGenetically Engineered Organisms
=450  \\$wnnna$aGenetically Modified Organism
=450  \\$aGenetically Modified Organisms
=450  \\$wnnna$aGMO Organism
=450  \\$wnnna$aGMO Organisms
=450  \\$wnnna$aModified Organism, Genetically
=450  \\$wnnna$aModified Organisms, Genetically
=450  \\$wnnna$aOrganism, Genetically Engineered
=450  \\$wnnna$aOrganism, Genetically Modified
=450  \\$wnnna$aOrganism, GMO
=450  \\$wnnna$aOrganism, Transgenic
=450  \\$wnnna$aOrganisms, Genetically Engineered
=450  \\$wnnna$aOrganisms, GMO
=450  \\$aOrganisms, Transgenic
=450  \\$wnnna$aTransgenic Organism
=450  \\$aTransgenic Organisms
=550  \\$wg$aOrganism Forms
=550  \\$wh$aAnimals, Genetically Modified
=550  \\$wh$aMicroorganisms, Genetically-Modified
=550  \\$wh$aPlants, Genetically Modified
=550  \\$aFood, Genetically Modified
=550  \\$aGenetic Engineering
=550  \\$aTransgenes
=667  \\$ageneral or unspecified; prefer ANIMALS, GENETICALLY MODIFIED or PLANTS, GENETICALLY MODIFIED or their specifics
=680  \\$iOrganisms whose GENOME has been changed by a GENETIC ENGINEERING technique.
=688  \\$a2002
=750  \0$aTransgenic organisms$5IEN-M$0(DLC)sh 93002326

=LDR  01131cz  a2200277n  4500
=001  9880364328202441
=005  20141212214748.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030721
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x776.$x500
=150  \\$aNymphaea
=450  \\$wnnna$aLilies, Water
=450  \\$aLily, Water
=450  \\$wnnna$alotus, Nymphaea
=450  \\$wnnna$aNymphaea lotus
=450  \\$wnnna$aNymphaeas
=450  \\$wnnna$aWater Lilies
=450  \\$aWater Lily
=450  \\$wnnna$aWaterlilies
=450  \\$wnnna$aWaterlily
=550  \\$wg$aNymphaeaceae
=667  \\$aX ref NYMPHAEA LOTUS: LOTUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NYMPHAEACEAE. The common name of lotus is also used for LOTUS and NELUMBO.
=688  \\$a2002
=750  \0$aNymphaea$5IEN-M$0(DLC)sh 85093527

=LDR  00993cz  a2200193n  4500
=001  9880364328302441
=005  20141212214748.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030702
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x776
=150  \\$aNymphaeaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aNuphar
=550  \\$wh$aNymphaea
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe sour gum plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. All have horizontal or hanging branches and broad alternate leaves, and they are dioecious (male and female flowers on different plants).
=688  \\$a2002
=750  \0$aNymphaeaceae$5IEN-M$0(DLC)sh 85093530

=LDR  00906cz  a2200193n  4500
=001  9880364328402441
=005  20141212214747.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x778
=150  \\$aNyssaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCamptotheca
=550  \\$wh$aNyssa
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Cornales, subclass Rosidae, class Magnoliopsida. Some botanical classifications do not recognize this family and place the members in CORNACEAE.
=688  \\$a2002
=750  \0$aNyssaceae$5IEN-M$0(DLC)sh 88022946

=LDR  00978cz  a2200217n  4500
=001  9880364328502441
=005  20141212214747.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x500
=150  \\$aFicus
=450  \\$wnnna$aFig
=450  \\$aFigs
=450  \\$aRubberplant
=450  \\$wnnna$aRubberplants
=550  \\$wg$aMoraceae
=667  \\$aX ref RUBBERPLANT: RUBBER TREE see HEVEA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE. It is the source of the familiar fig fruit and the latex from this tree contains FICAIN.
=688  \\$a2002
=750  \0$aFicus (Plants)$5IEN-M$0(DLC)sh 85048072

=LDR  00945cz  a2200205n  4500
=001  9880364328602441
=005  20141212214746.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x204
=150  \\$aCistaceae
=450  \\$aHelianthemum
=450  \\$wnnna$aHelianthemums
=550  \\$wg$aAngiosperms
=550  \\$wh$aCistus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. The common name of rock rose is used with several plants of this family.
=688  \\$a2002
=750  \0$aCistaceae$5IEN-M$0(DLC)sh 88022675

=LDR  01620cz  a2200445n  4500
=001  9880364328702441
=005  20141212214746.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x750.$x300.$x750
=072  \\$aL1.$x470.$x750.$x750.$x325.$x710
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x300.$x750
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x325.$x710
=150  \\$aDatabases, Protein
=450  \\$aAmino Acid Sequence Databases
=450  \\$wnnna$aDatabase, Protein
=450  \\$wnnna$aDatabase, Protein Sequence
=450  \\$wnnna$aDatabase, Protein Structure
=450  \\$aDatabases, Amino Acid Sequence
=450  \\$wnnna$aDatabases, Protein Sequence
=450  \\$wnnna$aDatabases, Protein Structure
=450  \\$wnnna$aProtein Database
=450  \\$aProtein Databases
=450  \\$wnnna$aProtein Sequence Database
=450  \\$aProtein Sequence Databases
=450  \\$wnnna$aProtein Structure Database
=450  \\$wnnna$aProtein Structure Databases
=450  \\$wnnna$aSequence Database, Protein
=450  \\$wnnna$aSequence Databases, Protein
=450  \\$wnnna$aStructure Database, Protein
=450  \\$wnnna$aStructure Databases, Protein
=450  \\$aSWISS-PROT
=450  \\$wnnna$aSWISS PROT
=450  \\$wnnna$aSwissProt
=550  \\$wg$aDatabases, Chemical
=550  \\$wg$aDatabases, Genetic
=680  \\$iDatabases containing information about PROTEINS such as AMINO ACID SEQUENCE; PROTEIN CONFORMATION; and other properties.
=688  \\$a2002
=750  \0$aProteins$xDatabases$5IEN-M

=LDR  02634cz  a2200721n  4500
=001  9880364328802441
=005  20141212214745.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x750.$x300.$x500
=072  \\$aL1.$x470.$x750.$x750.$x325.$x630
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x300.$x500
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x325.$x630
=150  \\$aDatabases, Nucleic Acid
=450  \\$wnnna$aBank, DNA Data
=450  \\$wnnna$aBanks, DNA Data
=450  \\$wnnna$aData Bank, DNA
=450  \\$wnnna$aData Banks, DNA
=450  \\$wnnna$aDatabank, DNA
=450  \\$wnnna$aDatabanks, DNA
=450  \\$wnnna$aDatabase, DNA
=450  \\$wnnna$aDatabase, DNA Sequence
=450  \\$wnnna$aDatabase, Nucleic Acid
=450  \\$wnnna$aDatabase, RNA
=450  \\$wnnna$aDatabase, RNA Sequence
=450  \\$aDatabases, DNA
=450  \\$aDatabases, DNA Sequence
=450  \\$aDatabases, Nucleic Acid Sequence
=450  \\$aDatabases, RNA
=450  \\$aDatabases, RNA Sequence
=450  \\$aDDBJ
=450  \\$wnnna$aDNA Data Bank
=450  \\$aDNA Data Bank of Japan
=450  \\$aDNA Data Banks
=450  \\$wnnna$aDNA Databank
=450  \\$wnnna$aDNA Databanks
=450  \\$wnnna$aDNA Database
=450  \\$aDNA Databases
=450  \\$wnnna$aDNA Sequence Database
=450  \\$wnnna$aDNA Sequence Databases
=450  \\$aEMBL Nucleotide Sequence Database
=450  \\$wnnna$aEuropean Molecular Biology Laboratory Nucleotide Sequence Database
=450  \\$aGenBank
=450  \\$wnnna$aNucleic Acid Database
=450  \\$aNucleic Acid Databases
=450  \\$wnnna$aNucleic Acid Sequence Databases
=450  \\$wnnna$aRNA Database
=450  \\$aRNA Databases
=450  \\$wnnna$aRNA Sequence Database
=450  \\$wnnna$aRNA Sequence Databases
=450  \\$wnnna$aSequence Database, DNA
=450  \\$wnnna$aSequence Database, RNA
=450  \\$wnnna$aSequence Databases, DNA
=450  \\$wnnna$aSequence Databases, RNA
=550  \\$wg$aDatabases, Chemical
=550  \\$wg$aDatabases, Genetic
=550  \\$aDNA Fingerprinting
=550  \\$aGene Library
=550  \\$aGenetic Testing
=680  \\$iDatabases containing information about NUCLEIC ACIDS such as BASE SEQUENCE; SNPS; NUCLEIC ACID CONFORMATION; and other properties. Information about the DNA fragments kept in a GENE LIBRARY or GENOMIC LIBRARY is often maintained in DNA databases.
=688  \\$a2002; for DNA DATABANKS use DATABASES, FACTUAL 1994-2001
=750  \0$aDNA data banks$5IEN-M$0(DLC)sh2003006467

=LDR  02075cz  a2200589n  4500
=001  9880364328902441
=005  20141212214744.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x750.$x325
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x325
=150  \\$aDatabases, Genetic
=450  \\$wnnna$aBank, Genetic Data
=450  \\$wnnna$aBanks, Genetic Data
=450  \\$wnnna$aData Bank, Genetic
=450  \\$wnnna$aData Banks, Genetic
=450  \\$wnnna$aData Base, Genetic
=450  \\$wnnna$aData Bases, Genetic
=450  \\$wnnna$aDatabank, Genetic
=450  \\$wnnna$aDatabanks, Genetic
=450  \\$wnnna$aDatabase, Genetic
=450  \\$wnnna$aDatabase, Genetic Information
=450  \\$wnnna$aDatabase, Genetic Sequence
=450  \\$wnnna$aDatabases, Genetic Information
=450  \\$wnnna$aDatabases, Genetic Sequence
=450  \\$wnnna$aGenetic Data Bank
=450  \\$wnnna$aGenetic Data Banks
=450  \\$wnnna$aGenetic Data Base
=450  \\$wnnna$aGenetic Data Bases
=450  \\$wnnna$aGenetic Databank
=450  \\$wnnna$aGenetic Databanks
=450  \\$wnnna$aGenetic Database
=450  \\$aGenetic Databases
=450  \\$wnnna$aGenetic Information Database
=450  \\$wnnna$aGenetic Information Databases
=450  \\$wnnna$aGenetic Sequence Database
=450  \\$aGenetic Sequence Databases
=450  \\$wnnna$aInformation Database, Genetic
=450  \\$wnnna$aInformation Databases, Genetic
=450  \\$aOMIM
=450  \\$aOnline Mendelian Inheritance In Man
=450  \\$wnnna$aSequence Database, Genetic
=450  \\$wnnna$aSequence Databases, Genetic
=550  \\$wg$aDatabases, Factual
=550  \\$wh$aDatabases, Nucleic Acid
=550  \\$wh$aDatabases, Protein
=550  \\$aGenetic Testing
=667  \\$aDATABASES, NUCLEIC ACID and DATABASES, PROTEIN are also available
=680  \\$iDatabases devoted to knowledge about specific genes and gene products.
=688  \\$a2002
=750  \0$aGenetics$xDatabases$5IEN-M

=LDR  01395cz  a2200349n  4500
=001  9880364329002441
=005  20141212214743.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x900
=150  \\$aZingiberaceae
=450  \\$aAframomum
=450  \\$wnnna$aAframomums
=450  \\$aBoesenbergia
=450  \\$wnnna$aBoesenbergias
=450  \\$aHedychium
=450  \\$wnnna$aHedychiums
=450  \\$aKaempferia
=450  \\$wnnna$aKaempferias
=450  \\$aRenealmia
=450  \\$wnnna$aRenealmias
=550  \\$wg$aZingiberales
=550  \\$wh$aAlpinia
=550  \\$wh$aAmomum
=550  \\$wh$aCurcuma
=550  \\$wh$aElettaria
=550  \\$wh$aGinger
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).
=688  \\$a2002; use ZINGIBERALES 1997-2001
=750  \0$aZingiberaceae$5IEN-M$0(DLC)sh 85149877

=LDR  01162cz  a2200253n  4500
=001  9880364329102441
=005  20141212214742.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x700
=150  \\$aSaussurea
=450  \\$wnnna$acostus, Saussurea
=450  \\$wnnna$alappa, Saussurea
=450  \\$wnnna$alappas, Saussurea
=450  \\$wnnna$aSaussurea costus
=450  \\$wnnna$aSaussurea lappa
=450  \\$wnnna$aSaussurea lappas
=450  \\$wnnna$aSaussureas
=550  \\$wg$aAsteraceae
=667  \\$ado not confuse X ref SAUSSUREA COSTUS with COSTUS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE, order Asterales, subclass Asteridae. It is a source of costus root oil and should not be confused with the genus COSTUS.
=688  \\$a2002
=750  \0$aSaussurea$5IEN-M$0(DLC)sh 87005065

=LDR  01047cz  a2200277n  4500
=001  9880364329202441
=005  20141212214741.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x600.$x800
=072  \\$aD1.$x625.$x700.$x750
=150  \\$aPeroxynitrous Acid
=450  \\$wnnna$aAcid, Peroxynitrous
=450  \\$wnnna$aAcids, Peroxynitrous
=450  \\$wnnna$aPeroxonitrite
=450  \\$wnnna$aPeroxonitrites
=450  \\$aPeroxynitrite
=450  \\$wnnna$aPeroxynitrites
=450  \\$wnnna$aPeroxynitrous Acid, Potassium Salt
=450  \\$wnnna$aPeroxynitrous Acids
=550  \\$wg$aNitrous Acid
=550  \\$wg$aReactive Nitrogen Species
=680  \\$iA potent oxidant synthesized by the cell during its normal metabolism. Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion (SUPEROXIDES).
=688  \\$a2002; for PEROXYNITRITE use PEROXYNITROUS ACID (NM) 1990-2001
=750  \0$aPeroxynitrite$5IEN-M$0(DLC)sh2012001690

=LDR  00707cz  a2200205n  4500
=001  9880364329302441
=005  20141212214740.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x650
=072  \\$aC2.$x928.$x725
=150  \\$aPapillomavirus Infections
=450  \\$wnnna$aPapillomavirus Infection
=550  \\$wg$aDNA Virus Infections
=550  \\$wg$aTumor Virus Infections
=550  \\$wh$aWarts
=680  \\$iNeoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
=688  \\$a2002
=750  \0$aPapillomavirus diseases$5IEN-M$0(DLC)sh 85097678

=LDR  00324cz  a2200109n  4500
=001  9880364329402441
=005  20120717143732.0
=008  010725\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D030342Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aGenetic Diseases, Inborn$xveterinary
=750  \0$aGenetic disorders in animals$5IEN-M$0(DLC)sh 98005816

=LDR  04075cz  a2201093n  4500
=001  9880364329502441
=005  20180329112641.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320
=150  \\$aGenetic Diseases, Inborn
=450  \\$wnnna$aDefect, Single-Gene
=450  \\$wnnna$aDefects, Single-Gene
=450  \\$wnnna$aDisease, Genetic
=450  \\$wnnna$aDisease, Hereditary
=450  \\$wnnna$aDisease, Inborn Genetic
=450  \\$wnnna$aDiseases, Genetic
=450  \\$wnnna$aDiseases, Hereditary
=450  \\$wnnna$aDiseases, Inborn Genetic
=450  \\$wnnna$aDisorder, Genetic
=450  \\$wnnna$aDisorders, Genetic
=450  \\$wnnna$aGenetic Disease, Inborn
=450  \\$wnnna$aGenetic Disease
=450  \\$aGenetic Diseases$5IEN-M
=450  \\$wnnna$aGenetic Disorder
=450  \\$aGenetic Disorders$5IEN-M
=450  \\$wnnna$aHereditary Disease
=450  \\$aHereditary Diseases
=450  \\$wnnna$aInborn Genetic Disease
=450  \\$wnnna$aInborn Genetic Diseases
=450  \\$wnnna$aSingle-Gene Defect
=450  \\$wnnna$aSingle-Gene Defects
=450  \\$wnnna$aSingle Gene Defects
=550  \\$wg$aCongenital, Hereditary, and Neonatal Diseases and Abnormalities
=550  \\$wh$aAdrenal Hyperplasia, Congenital
=550  \\$wh$aAlagille Syndrome
=550  \\$wh$aalpha 1-Antitrypsin Deficiency
=550  \\$wh$aAnemia, Hemolytic, Congenital
=550  \\$wh$aAnemia, Hypoplastic, Congenital
=550  \\$wh$aAngioedemas, Hereditary
=550  \\$wh$aAtaxia Telangiectasia
=550  \\$wh$aAutoimmune Lymphoproliferative Syndrome
=550  \\$wh$aBlood Coagulation Disorders, Inherited
=550  \\$wh$aBrugada Syndrome
=550  \\$wh$aCADASIL
=550  \\$wh$aCamurati-Engelmann Syndrome
=550  \\$wh$aCardiomyopathy, Hypertrophic, Familial
=550  \\$wh$aCHARGE Syndrome
=550  \\$wh$aCherubism
=550  \\$wh$aChromosome Disorders
=550  \\$wh$aCiliopathies
=550  \\$wh$aCostello Syndrome
=550  \\$wh$aCystic Fibrosis
=550  \\$wh$aDonohue Syndrome
=550  \\$wh$aDwarfism
=550  \\$wh$aEye Diseases, Hereditary
=550  \\$wh$aFamilial Multiple Lipomatosis
=550  \\$wh$aFrasier Syndrome
=550  \\$wh$aGenetic Diseases, X-Linked
=550  \\$wh$aGenetic Diseases, Y-Linked
=550  \\$wh$aHajdu-Cheney Syndrome
=550  \\$wh$aHemoglobinopathies
=550  \\$wh$aHereditary Autoinflammatory Diseases
=550  \\$wh$aHeredodegenerative Disorders, Nervous System
=550  \\$wh$aHyper-IgM Immunodeficiency Syndrome
=550  \\$wh$aHyperthyroxinemia, Familial Dysalbuminemic
=550  \\$wh$aKallmann Syndrome
=550  \\$wh$aKartagener Syndrome
=550  \\$wh$aLennox Gastaut Syndrome
=550  \\$wh$aLoeys-Dietz Syndrome
=550  \\$wh$aMarfan Syndrome
=550  \\$wh$aMetabolism, Inborn Errors
=550  \\$wh$aMuscular Dystrophies
=550  \\$wh$aMyasthenic Syndromes, Congenital
=550  \\$wh$aNail-Patella Syndrome
=550  \\$wh$aNeoplastic Syndromes, Hereditary
=550  \\$wh$aOculocerebrorenal Syndrome
=550  \\$wh$aOrofaciodigital Syndromes
=550  \\$wh$aOsteoarthropathy, Primary Hypertrophic
=550  \\$wh$aOsteochondrodysplasias
=550  \\$wh$aOsteogenesis Imperfecta
=550  \\$wh$aPain Insensitivity, Congenital
=550  \\$wh$aPelger-Huet Anomaly
=550  \\$wh$aPolycystic Kidney Diseases
=550  \\$wh$aPycnodysostosis
=550  \\$wh$aSkin Diseases, Genetic
=550  \\$wh$aWerner Syndrome
=550  \\$wh$aYellow Nail Syndrome
=550  \\$aGenetics, Medical
=667  \\$aGEN only: prefer /genet with specific diseases; Manual 23.22+; Manual 19.8.34
=680  \\$iDiseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent's genome or they may be acquired in utero.
=688  \\$a2002
=750  \0$aGenetic disorders$5IEN$0(DLC)sh 87001834

=LDR  00914cz  a2200277n  4500
=001  9880364329602441
=005  20141212214735.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x741
=072  \\$aJ2.$x500.$x850.$x500.$x700.$x500.$x750
=150  \\$aSoybean Proteins
=450  \\$wnnna$aDietary Soybean Proteins
=450  \\$wnnna$aProteins, Soy
=450  \\$wnnna$aSoy Bean Proteins
=450  \\$wnnna$aSoy Protein
=450  \\$wnnna$aSoy Proteins
=550  \\$wg$aPlant Proteins
=550  \\$wg$aSoy Foods
=550  \\$wh$aTrypsin Inhibitor, Bowman-Birk Soybean
=550  \\$wh$aTrypsin Inhibitor, Kunitz Soybean
=667  \\$acoordinate IM with VEGETABLE PROTEINS if appropriate
=680  \\$iProteins which are present in or isolated from SOYBEANS.
=688  \\$a2002(1997)
=750  \0$aSoy proteins$5IEN-M$0(DLC)sh 91003350

=LDR  01004cz  a2200277n  4500
=001  9880364329702441
=005  20141212214731.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030141
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x58.$x288
=072  \\$aF4.$x754.$x308
=072  \\$aL1.$x143.$x283.$x425.$x624
=150  \\$aFeedback, Psychological
=450  \\$wnnna$aFeedbacks, Psychological
=450  \\$aPsychological Feedback
=450  \\$wnnna$aPsychological Feedbacks
=550  \\$wg$aAdaptation, Psychological
=550  \\$wg$aFeedback
=550  \\$wg$aPsychotherapy
=550  \\$wh$aBiofeedback, Psychology
=550  \\$wh$aFeedback, Sensory
=667  \\$aBIOFEEDBACK, PSYCHOLOGY is also available
=680  \\$iA mechanism of information stimulus and response that may control subsequent behavior, cognition, perception, or performance. (From APA Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a2002
=750  \0$aFeedback (Psychology)$5IEN-M$0(DLC)sh 85047647

=LDR  00896cz  a2200217n  4500
=001  9880364329802441
=005  20141212214728.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x450.$x420.$x410
=072  \\$aB4.$x820.$x565.$x400.$x410
=072  \\$aB4.$x909.$x777.$x618.$x400.$x410
=150  \\$aHepatitis A virus
=450  \\$wnnna$aHepatitis A viruses
=550  \\$wg$aHepatovirus
=550  \\$wh$aHepatitis A Virus, Human
=667  \\$ainfection = HEPATITIS A; HEPATITIS A VIRUS, HUMAN is also available
=680  \\$iA species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.
=688  \\$a2002, 1977-1993; use HEPATOVIRUS 1994-2001
=750  \0$aHepatitis A virus$5IEN-M$0(DLC)sh 88002563

=LDR  01437cz  a2200373n  4500
=001  9880364329902441
=005  20141212214728.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030024
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x900.$x166
=150  \\$aCurcuma
=450  \\$wnnna$aCurcuma longa
=450  \\$wnnna$aCurcuma longas
=450  \\$wnnna$aCurcuma zedoaria
=450  \\$wnnna$aCurcuma zedoarias
=450  \\$wnnna$aCurcumas
=450  \\$wnnna$alonga, Curcuma
=450  \\$wnnna$alongas, Curcuma
=450  \\$aTumeric
=450  \\$wnnna$aTumerics
=450  \\$aTurmeric
=450  \\$wnnna$aTurmerics
=450  \\$wnnna$azedoaria, Curcuma
=450  \\$wnnna$azedoaria, Zedoary
=450  \\$wnnna$azedoarias, Curcuma
=450  \\$wnnna$azedoarias, Zedoary
=450  \\$aZedoary zedoaria
=450  \\$wnnna$aZedoary zedoarias
=550  \\$wg$aZingiberaceae
=667  \\$aX ref TUMERIC: TURMERIC YELLOW see CURCUMIN is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZINGIBERACEAE that contains CURCUMIN and curcuminoids.
=688  \\$a2002
=750  \0$aCurcuma$5IEN-M$0(DLC)sh 85034848

=LDR  01360cz  a2200277n  4500
=001  9880364330002441
=005  20141212214726.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x96.$x211
=150  \\$aAristolochia
=450  \\$wnnna$aAristolochias
=450  \\$aBirthwort
=450  \\$wnnna$aBirthworts
=450  \\$wnnna$aDutchman Pipe
=450  \\$aDutchman's Pipe
=450  \\$wnnna$aDutchmans Pipe
=450  \\$wnnna$aDutchman's Pipes
=450  \\$wnnna$aPipe, Dutchman's
=450  \\$wnnna$aPipes, Dutchman's
=550  \\$wg$aAristolochiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARISTOLOCHIACEAE. Species of this genus have been used in traditional medicine but they contain aristolochic acid which is associated with nephropathy. These are sometimes called 'snakeroot' but that name is also used with a number of other plants such as POLYGALA; SANICULA; ASARUM; ARISTOLOCHIA; AGERATINA; and others.
=688  \\$a2002
=750  \0$aAristolochia$5IEN-M$0(DLC)sh 88022571

=LDR  00962cz  a2200229n  4500
=001  9880364330102441
=005  20141212214725.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030020
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x84.$x500.$x875
=150  \\$aIlex vomitoria
=450  \\$wnnna$aIlex vomitorias
=450  \\$wnnna$avomitoria, Ilex
=450  \\$wnnna$avomitorias, Ilex
=450  \\$aYaupon
=450  \\$wnnna$aYaupons
=550  \\$wg$aIlex
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family AQUIFOLIACEAE. It has been used to induce vomiting in purification rites.
=688  \\$a2002
=750  \0$aIlex vomitoria$5IEN-M$0(DLC)sh 85064261

=LDR  01128cz  a2200253n  4500
=001  9880364330202441
=005  20141212214725.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030019
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x84.$x500.$x750
=150  \\$aIlex paraguariensis
=450  \\$wnnna$aIlex paraguarienses
=450  \\$aMate, Yerba
=450  \\$wnnna$aMates, Yerba
=450  \\$wnnna$aparaguarienses, Ilex
=450  \\$wnnna$aparaguariensis, Ilex
=450  \\$aYerba Mate
=450  \\$wnnna$aYerba Mates
=550  \\$wg$aIlex
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family AQUIFOLIACEAE. An infusion of the leaves is commonly drunk in South America for stimulating effect in much the same manner as coffee is in other cultures.
=688  \\$a2002
=750  \0$aMate plant$5IEN-M$0(DLC)sh 85082047

=LDR  01558cz  a2200361n  4500
=001  9880364330302441
=005  20141212214724.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030017
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x84.$x500
=150  \\$aIlex
=450  \\$aAlder, Black
=450  \\$wnnna$aAlders, Black
=450  \\$wnnna$aBlack Alder
=450  \\$wnnna$aBlack Alders
=450  \\$wnnna$aHollies
=450  \\$aHolly
=450  \\$wnnna$aIlex verticillata
=450  \\$wnnna$aIlex verticillatas
=450  \\$wnnna$aIlices
=450  \\$wnnna$averticillata, Ilex
=450  \\$wnnna$averticillatas, Ilex
=450  \\$wnnna$aWinterberries
=450  \\$aWinterberry
=550  \\$wg$aAquifoliaceae
=550  \\$wh$aIlex guayusa
=550  \\$wh$aIlex paraguariensis
=550  \\$wh$aIlex vomitoria
=667  \\$aX ref HOLLY: restrict to ILEX; SEA HOLLY see ERYNGIUM is also available; X ref ALDER, BLACK: ALDER see ALNUS is also available; prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family AQUIFOLIACEAE. The common name of 'holly' usually refers to this genus but may sometimes refer to similar looking plants of the MAHONIA or QUERCUS genus.
=688  \\$a2002
=750  \0$aHollies$5IEN-M$0(DLC)sh 85061501

=LDR  01035cz  a2200253n  4500
=001  9880364330402441
=005  20141212214722.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030014
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x888
=150  \\$aTabernaemontana
=450  \\$aIboga
=450  \\$wnnna$aiboga, Tabernanthe
=450  \\$wnnna$aIbogas
=450  \\$wnnna$aibogas, Tabernanthe
=450  \\$wnnna$aTabernaemontanas
=450  \\$wnnna$aTabernanthe iboga
=450  \\$wnnna$aTabernanthe ibogas
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE that contains bisindole alkaloids and IBOGAINE.
=688  \\$a2002
=750  \0$aTabernaemontana$5IEN-M$0(DLC)sh 88022696

=LDR  00769cz  a2200169n  4500
=001  9880364330502441
=005  20141212214722.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030013
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x833
=150  \\$aStrophanthus
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE that contains OUABAIN cardiac glycosides.
=688  \\$a2002
=750  \0$aStrophanthus$5IEN-M$0(DLC)sh 88023136

=LDR  00909cz  a2200205n  4500
=001  9880364330602441
=005  20141212214721.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030012
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x450.$x391
=150  \\$aGentiana
=450  \\$aGentian
=450  \\$wnnna$aGentianas
=450  \\$wnnna$aGentians
=550  \\$wg$aGentianaceae
=667  \\$ado not confuse with GENTIAN VIOLET; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family GENTIANACEAE. Members contain secoiridoids.
=688  \\$a2003 (2002); use RAUWOLFIA 1998-2001
=750  \0$aGentiana$5IEN-M$0(DLC)sh 93006995

=LDR  01010cz  a2200241n  4500
=001  9880364330702441
=005  20141212193020.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030010
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x131
=150  \\$aApocynum
=450  \\$wnnna$aApocynum cannabinum
=450  \\$wnnna$aApocynums
=450  \\$aDogbane
=450  \\$wnnna$aDogbanes
=450  \\$wnnna$aPoacynum
=450  \\$wnnna$aPoacynums
=550  \\$wg$aApocynaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family APOCYNACEAE. On rare occasions it is called Milkweed, but should not be confused with true Milkweed (ASCLEPIAS).
=688  \\$a2002
=750  \0$aApocynum$5IEN-M$0(DLC)sh 85006012

=LDR  01036cz  a2200253n  4500
=001  9880364330802441
=005  20141212214721.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030009
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x174
=150  \\$aAspidosperma
=450  \\$wnnna$aAspidospermas
=450  \\$wnnna$aBox Tree, Brazilian
=450  \\$wnnna$aBox Trees, Brazilian
=450  \\$aBrazilian Box Tree
=450  \\$wnnna$aBrazilian Box Trees
=450  \\$wnnna$aTree, Brazilian Box
=450  \\$wnnna$aTrees, Brazilian Box
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE. It contains ellipticine.
=688  \\$a2002
=750  \0$aAspidosperma$5IEN-M$0(DLC)sh 88022578

=LDR  01098cz  a2200265n  4500
=001  9880364330902441
=005  20141212214720.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030008
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x260
=150  \\$aCatharanthus
=450  \\$wnnna$aCatharanthus roseus
=450  \\$wnnna$aMadagascar Periwinkle
=450  \\$aPeriwinkle, Madagascar
=450  \\$wnnna$arosea, Vinca
=450  \\$wnnna$aroseas, Vinca
=450  \\$wnnna$aroseus, Catharanthus
=450  \\$aVinca rosea
=450  \\$wnnna$aVinca roseas
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Apocynaceae. It is the source of VINCA ALKALOIDS, used in leukemia chemotherapy.
=688  \\$a2002
=750  \0$aCatharanthus$5IEN-M$0(DLC)sh 88022653

=LDR  01023cz  a2200253n  4500
=001  9880364331002441
=005  20141212214720.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030007
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x432
=150  \\$aNerium
=450  \\$wnnna$aNerium oleander
=450  \\$wnnna$aNerium oleanders
=450  \\$wnnna$aNeriums
=450  \\$aOleander
=450  \\$wnnna$aoleander, Nerium
=450  \\$wnnna$aOleanders
=450  \\$wnnna$aoleanders, Nerium
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE. It is a very poisonous plant that contains cardioactive agents.
=688  \\$a2002
=750  \0$aNerium$5IEN-M$0(DLC)sh 93009541

=LDR  00996cz  a2200205n  4500
=001  9880364331102441
=005  20141212214719.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x875
=150  \\$aSanicula
=450  \\$aSanicle
=450  \\$wnnna$aSanicles
=450  \\$wnnna$aSaniculas
=550  \\$wg$aApiaceae
=667  \\$ado not confuse with other snakeroots such as ASARUM; ARISTOLOCHIA; and Polygala; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Apiaceae. Commonly called snakeroot but that name is used for many other plants such as ASARUM; ARISTOLOCHIA; and Polygala.
=688  \\$a2002
=750  \0$aSanicula$5IEN-M$0(DLC)sh 85117273

=LDR  00777cz  a2200181n  4500
=001  9880364331202441
=005  20141212214717.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x411
=150  \\$aHeracleum
=450  \\$wnnna$aHeracleums
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. Members contain COUMARINS.
=688  \\$a2002
=750  \0$aHeracleum$5IEN-M$0(DLC)sh 87001410

=LDR  01044cz  a2200253n  4500
=001  9880364331302441
=005  20141212214717.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D030001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x333
=150  \\$aFoeniculum
=450  \\$aFennel
=450  \\$wnnna$aFennels
=450  \\$wnnna$aFoeniculum vulgare
=450  \\$wnnna$aFoeniculum vulgares
=450  \\$wnnna$aFoeniculums
=450  \\$wnnna$avulgare, Foeniculum
=450  \\$wnnna$avulgares, Foeniculum
=550  \\$wg$aApiaceae
=667  \\$aX ref FENNEL: FENNEL, DOG see ANTHEMIS are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE used in SPICES.
=688  \\$a2002
=750  \0$aFennel$5IEN-M$0(DLC)sh 85047800

=LDR  01210cz  a2200277n  4500
=001  9880364331402441
=005  20141212214716.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x388.$x188
=150  \\$aConium
=450  \\$aConium maculatum
=450  \\$wnnna$aConium maculatums
=450  \\$wnnna$aConiums
=450  \\$aHemlock, Poison
=450  \\$wnnna$aHemlocks, Poison
=450  \\$wnnna$amaculatum, Conium
=450  \\$wnnna$amaculatums, Conium
=450  \\$aPoison Hemlock
=450  \\$wnnna$aPoison Hemlocks
=550  \\$wg$aHemlock
=667  \\$anote X ref POISON HEMLOCK: use only for this plant and not for poisoning by other HEMLOCK plants; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE that is a source of coniine.
=688  \\$a2002; for CONIUM MACULATUM use HEMLOCK 1995-2001
=750  \0$aConium$0(DLC) sh 85031138$5IEN-M

=LDR  01667cz  a2200445n  4500
=001  9880364331502441
=005  20141212214715.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x388.$x155
=150  \\$aCicuta
=450  \\$wnnna$aCicuta maculata
=450  \\$wnnna$aCicuta maculatas
=450  \\$aCicuta major
=450  \\$wnnna$aCicuta majors
=450  \\$aCicuta virosa
=450  \\$wnnna$aCicuta virosas
=450  \\$wnnna$aCicutas
=450  \\$aHemlock, Spotted Water
=450  \\$aHemlock, Water
=450  \\$wnnna$aHemlocks, Spotted Water
=450  \\$wnnna$aHemlocks, Water
=450  \\$wnnna$amaculata, Cicuta
=450  \\$wnnna$amaculatas, Cicuta
=450  \\$wnnna$amajor, Cicuta
=450  \\$wnnna$amajors, Cicuta
=450  \\$wnnna$aSpotted Water Hemlock
=450  \\$wnnna$aSpotted Water Hemlocks
=450  \\$wnnna$avirosa, Cicuta
=450  \\$wnnna$avirosas, Cicuta
=450  \\$aWater Hemlock
=450  \\$wnnna$aWater Hemlock, Spotted
=450  \\$wnnna$aWater Hemlocks
=450  \\$wnnna$aWater Hemlocks, Spotted
=550  \\$wg$aHemlock
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. It is a source of cicutoxin.
=688  \\$a2002; for CICUTA MAJOR & CICUTA VIROSA use HEMLOCK 1995-2001
=750  \0$aCicuta$5IEN-M$0(DLC)sh 85025937

=LDR  01207cz  a2200325n  4500
=001  9880364331602441
=005  20141212214714.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x144
=150  \\$aBupleurum
=450  \\$wnnna$aBupleurums
=450  \\$aChai Hu
=450  \\$wnnna$aChai Hus
=450  \\$wnnna$aEar, Hare's
=450  \\$wnnna$aEars, Hare's
=450  \\$wnnna$aHare Ear
=450  \\$aHare's Ear
=450  \\$wnnna$aHares Ear
=450  \\$wnnna$aHare's Ears
=450  \\$wnnna$aHu, Chai
=450  \\$wnnna$aHus, Chai
=450  \\$aSaiko
=450  \\$wnnna$aSaikos
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE that is the source of bupleurum root and of bupleurotoxin and is an ingredient of sho-saiko-to.
=688  \\$a2002
=750  \0$aBupleurum$5IEN-M$0(DLC)sh 85018027

=LDR  00861cz  a2200205n  4500
=001  9880364331702441
=005  20141212214709.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029969
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x88
=150  \\$aAngelica
=450  \\$wnnna$aAngelicas
=550  \\$wg$aApiaceae
=550  \\$wh$aAngelica archangelica
=550  \\$wh$aAngelica sinensis
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Apiaceae.
=688  \\$a2002
=750  \0$aAngelica$5IEN-M$0(DLC)sh 85004997

=LDR  00886cz  a2200205n  4500
=001  9880364331802441
=005  20141212193020.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029967
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x450.$x594
=150  \\$aSwertia
=450  \\$wnnna$aSwertia chirata
=450  \\$wnnna$aSwertia chirayita
=450  \\$wnnna$aSwertias
=550  \\$wg$aGentianaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and IRIDOID GLYCOSIDES.
=688  \\$a2002
=750  \0$aSwertia$5IEN-M$0(DLC)sh 88023141

=LDR  01161cz  a2200253n  4500
=001  9880364331902441
=005  20141212193020.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x450.$x188
=150  \\$aCentaurium
=450  \\$wnnna$aCentauries, Small
=450  \\$wnnna$aCentaurium erythraea
=450  \\$wnnna$aCentaurium minus
=450  \\$wnnna$aCentaury, Small
=450  \\$wnnna$aminus, Centaurium
=450  \\$wnnna$aSmall Centauries
=450  \\$wnnna$aSmall Centaury
=550  \\$wg$aGentianaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus. The common name of century plant has also been used for the AGAVE genus.
=688  \\$a2002
=750  \0$aCentaurium$5IEN-M$0(DLC)sh 88022662

=LDR  00982cz  a2200241n  4500
=001  9880364332002441
=005  20180711151626.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x456.$x750
=150  \\$aGentianaceae
=450  \\$wnnna$aCanscora
=450  \\$wnnna$aCanscoras
=550  \\$wg$aGentianales
=550  \\$wh$aCentaurium
=550  \\$wh$aGentiana
=550  \\$wh$aGentianella
=550  \\$wh$aSwertia
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aGentianaceae$5IEN-M$0(DLC)sh 85053944

=LDR  00761cz  a2200193n  4500
=001  9880364332102441
=005  20141212214708.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029964
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x425.$x249
=150  \\$aFagus
=450  \\$aBeech
=450  \\$wnnna$aBeechs
=550  \\$wg$aFagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FAGACEAE.
=688  \\$a2002
=750  \0$aBeech$5IEN-M$0(DLC)sh 85012802

=LDR  01547cz  a2200433n  4500
=001  9880364332202441
=005  20141212214707.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029963
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x425.$x500
=150  \\$aQuercus
=450  \\$wnnna$aCork Oak Tree
=450  \\$wnnna$aCork Oak Trees
=450  \\$aHolly Oak
=450  \\$wnnna$aHolly Oaks
=450  \\$wnnna$ailex, Quercus
=450  \\$wnnna$ailices, Quercus
=450  \\$wnnna$aOak, Holly
=450  \\$aOak Tree
=450  \\$wnnna$aOak Tree, Cork
=450  \\$wnnna$aOak Trees
=450  \\$wnnna$aOak Trees, Cork
=450  \\$wnnna$aOaks, Holly
=450  \\$wnnna$aQuercus ilex
=450  \\$wnnna$aQuercus ilices
=450  \\$wnnna$aQuercus suber
=450  \\$wnnna$aQuercus subers
=450  \\$wnnna$asuber, Quercus
=450  \\$wnnna$asubers, Quercus
=450  \\$wnnna$aTree, Cork Oak
=450  \\$wnnna$aTree, Oak
=450  \\$wnnna$aTrees, Cork Oak
=450  \\$wnnna$aTrees, Oak
=550  \\$wg$aFagaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FAGACEAE that is a source of TANNINS. Do not confuse with Holly (ILEX).
=688  \\$a2002
=750  \0$aOak$5IEN-M$0(DLC)sh 85093565

=LDR  00843cz  a2200193n  4500
=001  9880364332302441
=005  20200508143847.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029962
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x750.$x300
=150  \\$aFagaceae
=550  \\$wg$aFagales
=550  \\$wh$aFagus
=550  \\$wh$aQuercus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aFagaceae$5IEN-M$0(DLC)sh 85046871

=LDR  01249cz  a2200301n  4500
=001  9880364332402441
=005  20141212214705.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x906
=150  \\$aTrifolium
=450  \\$aClover, Red
=450  \\$wnnna$apratense, Trifolium
=450  \\$wnnna$apratenses, Trifolium
=450  \\$aRed Clover
=450  \\$wnnna$arepen, Trifolium
=450  \\$wnnna$arepens, Trifolium
=450  \\$wnnna$aTrifolium pratense
=450  \\$wnnna$aTrifolium pratenses
=450  \\$wnnna$aTrifolium repen
=450  \\$wnnna$aTrifolium repens
=450  \\$wnnna$aTrifoliums
=550  \\$wg$aFabaceae
=667  \\$anote X ref RED CLOVER: CLOVER see MEDICAGO; BUSH CLOVER see LESPEDEZA; and SWEET CLOVER see MELILOTUS are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE.
=688  \\$a2002
=750  \0$aClover$5IEN-M$0(DLC)sh 85027202

=LDR  01208cz  a2200205n  4500
=001  9880364332502441
=005  20141212214704.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029911
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x93
=150  \\$aCaesalpinia
=450  \\$aBrazilwood
=450  \\$wnnna$aBrazilwoods
=450  \\$wnnna$aCaesalpinias
=550  \\$wg$aFabaceae
=667  \\$aCAT'S CLAW is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. The common name of "Bird-Of-Paradise" is also used for other plants such as Heliconia (HELICONIACEAE) and Strelitzia (STRELITZIACEAE) and some birds. The common name of "Cat's-Claw" is more often used with UNCARIA. The common name of "Pernambuco" also refers to a state in Brazil. Furanoditerpenoid lactones and caesalpin are produced by members of this genus.
=688  \\$a2002
=750  \0$aCaesalpinia$5IEN-M$0(DLC)sh 88022614

=LDR  01201cz  a2200313n  4500
=001  9880364332602441
=005  20141212214703.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029910
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x937
=150  \\$aTrigonella
=450  \\$aFenugreek
=450  \\$wnnna$aFenugreeks
=450  \\$wnnna$afoenum-graecum, Trigonella
=450  \\$wnnna$afoenum-graecums, Trigonella
=450  \\$wnnna$aFoenumgraecum
=450  \\$wnnna$aFoenumgraecums
=450  \\$wnnna$aPoenumgraecum
=450  \\$wnnna$aPoenumgraecums
=450  \\$wnnna$aTrigonella foenum-graecum
=450  \\$wnnna$aTrigonella foenum graecum
=450  \\$wnnna$aTrigonella foenum-graecums
=450  \\$wnnna$aTrigonellas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE.
=688  \\$a2002
=750  \0$aFenugreek$5IEN-M$0(DLC)sh 88023166

=LDR  00986cz  a2200253n  4500
=001  9880364332702441
=005  20141212214703.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x734
=150  \\$aSophora
=450  \\$wnnna$aBean Plant, Mescal
=450  \\$wnnna$aBean Plants, Mescal
=450  \\$aMescal Bean Plant
=450  \\$wnnna$aMescal Bean Plants
=450  \\$wnnna$aPlant, Mescal Bean
=450  \\$wnnna$aPlants, Mescal Bean
=450  \\$wnnna$aSophoras
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE.
=688  \\$a2002
=750  \0$aSophora$5IEN-M$0(DLC)sh 85125279

=LDR  01613cz  a2200385n  4500
=001  9880364332802441
=005  20141212214702.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x714
=150  \\$aPueraria
=450  \\$aKudzu
=450  \\$wnnna$aKudzus
=450  \\$wnnna$alobata, Pueraria
=450  \\$wnnna$alobatas, Pueraria
=450  \\$wnnna$amontana, Pueraria
=450  \\$wnnna$amontanas, Pueraria
=450  \\$aPachyrhizus thunbergianus
=450  \\$wnnna$aPueraria lobata
=450  \\$wnnna$aPueraria lobatas
=450  \\$wnnna$aPueraria montana
=450  \\$wnnna$aPueraria montanas
=450  \\$wnnna$aPueraria tuberosa
=450  \\$wnnna$aPueraria tuberosas
=450  \\$wnnna$aPuerariae
=450  \\$wnnna$aPuerarias
=450  \\$wnnna$athunbergianus, Pachyrhizus
=450  \\$wnnna$atuberosa, Pueraria
=450  \\$wnnna$atuberosas, Pueraria
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin, kakkalide, daidzein (isoflavonoids), and kudzusaponins (oleanene-type triterpene glycosides).
=688  \\$a2002
=750  \0$aPueraria$5IEN-M$0(DLC)sh 88023048

=LDR  00786cz  a2200181n  4500
=001  9880364332902441
=005  20141212214702.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029907
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x710
=150  \\$aPsoralea
=450  \\$wnnna$aPsoraleas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is a source of psoralen (FICUSIN).
=688  \\$a2002
=750  \0$aPsoralea$5IEN-M$0(DLC)sh 92006695

=LDR  01109cz  a2200277n  4500
=001  9880364333002441
=005  20141212214701.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x694
=150  \\$aPhysostigma
=450  \\$wnnna$aBean, Calabar
=450  \\$wnnna$aBeans, Calabar
=450  \\$aCalabar Bean
=450  \\$wnnna$aCalabar Beans
=450  \\$wnnna$aPhysostigma venenosum
=450  \\$wnnna$aPhysostigma venenosums
=450  \\$wnnna$aPhysostigmas
=450  \\$wnnna$avenenosum, Physostigma
=450  \\$wnnna$avenenosums, Physostigma
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is a source of PHYSOSTIGMINE.
=688  \\$a2002
=750  \0$aCalabar bean$5IEN-M$0(DLC)sh 85018730

=LDR  01332cz  a2200289n  4500
=001  9880364333102441
=005  20141212214700.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029905
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x611
=150  \\$aPachyrhizus
=450  \\$aBean, Yam
=450  \\$wnnna$aBeans, Yam
=450  \\$wnnna$aerosus, Pachyrhizus
=450  \\$aJicama
=450  \\$wnnna$aJicamas
=450  \\$wnnna$aPachyrhizus erosus
=450  \\$wnnna$aPachyrhizus tuberosus
=450  \\$wnnna$atuberosus, Pachyrhizus
=450  \\$wnnna$aYam Bean
=450  \\$wnnna$aYam Beans
=550  \\$wg$aFabaceae
=667  \\$aPACHYRHIZUS THUNBERGIANUS see PUERARIA; YAM see DIOSCOREA; YAM BEAN, AFRICAN see SPHENOSTYLIS; PSEUDO-YAM see IPOMOEA BATATAS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Some Pachyrhizus have been reclassified to PUERARIA. Do not confuse with yam (IPOMOEA; or DIOSCOREA) or African yam bean (SPHENOSTYLIS).
=688  \\$a2002
=750  \0$aPachyrhizus$5IEN-M$0(DLC)sh 93006873

=LDR  01145cz  a2200253n  4500
=001  9880364333202441
=005  20141212214659.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029904
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x601
=150  \\$aMyroxylon
=450  \\$wnnna$abalsamum, Myroxylon
=450  \\$wnnna$abalsamums, Myroxylon
=450  \\$aMyroxylon balsamum
=450  \\$wnnna$aMyroxylon balsamums
=450  \\$wnnna$aMyroxylon pereirae
=450  \\$wnnna$aMyroxylons
=450  \\$wnnna$apereirae, Myroxylon
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is a source of aromatic resinous balsams (Balsam of Tolu and Balsam of Peru) used in perfumery and as a constituent in cough syrups and lozenge.
=688  \\$a2002
=750  \0$aMyroxylon$5IEN-M$0(DLC)sh 88022931

=LDR  01108cz  a2200229n  4500
=001  9880364333302441
=005  20141212214658.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x590
=150  \\$aMedicago
=450  \\$aClover
=450  \\$wnnna$aClovers
=450  \\$wnnna$aMedicagos
=550  \\$wg$aFabaceae
=550  \\$wh$aMedicago sativa
=550  \\$wh$aMedicago truncatula
=667  \\$anote X ref CLOVER: BUSH CLOVER see LESPEDEZA; SWEET CLOVER see MELILOTUS; and RED CLOVER see TRIFOLIUM are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. It is distinct from Sweet Clover (MELILOTUS), from Bush Clover (LESPEDEZA), and from Red Clover (TRIFOLIUM).
=688  \\$a2002
=750  \0$aMedicago$0(DLC) sh 87006314$5IEN-M

=LDR  01001cz  a2200229n  4500
=001  9880364333502441
=005  20141212214655.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029884
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x525
=150  \\$aLespedeza
=450  \\$aBush Clover
=450  \\$wnnna$aBush Clovers
=450  \\$aClover, Bush
=450  \\$wnnna$aClovers, Bush
=450  \\$wnnna$aLespedezas
=550  \\$wg$aFabaceae
=667  \\$anote X ref BUSH CLOVER: SWEET CLOVER see MELILOTUS; CLOVER see MEDICAGO; and RED CLOVER see TRIFOLIUM are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE.
=688  \\$a2002
=750  \0$aLespedeza$5IEN-M$0(DLC)sh 85076189

=LDR  00833cz  a2200181n  4500
=001  9880364333602441
=005  20141212214655.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029883
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x337
=150  \\$aIndigofera
=450  \\$wnnna$aIndigoferas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. The common name of indigo also refers to Baptisia or Amorpha genera (FABACEAE).
=688  \\$a2002
=750  \0$aIndigofera$5IEN-M$0(DLC)sh 88022852

=LDR  01592cz  a2200421n  4500
=001  9880364333702441
=005  20141212214653.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x250
=150  \\$aGalega
=450  \\$wnnna$aGalega officinali
=450  \\$wnnna$aGalega officinalis
=450  \\$wnnna$aGalega orientali
=450  \\$wnnna$aGalega orientalis
=450  \\$wnnna$aGalegas
=450  \\$wnnna$aGoat Rue
=450  \\$wnnna$aGoat Rues
=450  \\$wnnna$aGoats Rue
=450  \\$aGoat's Rue
=450  \\$wnnna$aGoat's Rues
=450  \\$wnnna$aGoats Rues
=450  \\$wnnna$aofficinali, Galega
=450  \\$wnnna$aofficinalis, Galega
=450  \\$wnnna$aorientali, Galega
=450  \\$wnnna$aorientalis, Galega
=450  \\$wnnna$aRue, Goat
=450  \\$aRue, Goat's
=450  \\$wnnna$aRue, Goats
=450  \\$wnnna$aRues, Goat
=450  \\$wnnna$aRues, Goat's
=450  \\$wnnna$aRues, Goats
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains galegine (GUANIDINES). Most of the other species have been reclassified to TEPHROSIA; a few to ASTRAGALUS PLANT; and INDIGOFERA.
=688  \\$a2002
=750  \0$aGalega$5IEN-M$0(DLC)sh 92001107

=LDR  01676cz  a2200373n  4500
=001  9880364333802441
=005  20141212214652.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x191
=150  \\$aDerris
=450  \\$wnnna$aDerri
=450  \\$wnnna$aDerris trifoliata
=450  \\$wnnna$aDerris trifoliatas
=450  \\$wnnna$aDerris urucu
=450  \\$wnnna$aDerris urucus
=450  \\$wnnna$aLonchocarpus urucu
=450  \\$wnnna$aLonchocarpus urucus
=450  \\$wnnna$aPongamia uliginosa
=450  \\$wnnna$aPongamia uliginosas
=450  \\$wnnna$atrifoliata, Derris
=450  \\$wnnna$atrifoliatas, Derris
=450  \\$wnnna$auliginosa, Pongamia
=450  \\$wnnna$auliginosas, Pongamia
=450  \\$wnnna$aurucu, Derris
=450  \\$wnnna$aurucu, Lonchocarpus
=450  \\$wnnna$aurucus, Derris
=450  \\$wnnna$aurucus, Lonchocarpus
=550  \\$wg$aFabaceae
=667  \\$aX ref PONGAMIA ULIGINOSA: Pongamia unspecified, PONGAMIA see FABACEAE is available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. The root is a source of rotenoids (ROTENONE) and flavonoids. Some species of Pongamia have been reclassified to this genus and some to MILLETTIA. Some species of Deguelia have been reclassified to this genus.
=688  \\$a2002
=750  \0$aDerris$5IEN-M$0(DLC)sh 88022740

=LDR  01252cz  a2200289n  4500
=001  9880364333902441
=005  20141212214652.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x187
=150  \\$aCytisus
=450  \\$aBroom
=450  \\$aBroom, Scotch
=450  \\$wnnna$aBrooms
=450  \\$wnnna$aBrooms, Scotch
=450  \\$wnnna$aCytisus scoparius
=450  \\$wnnna$aSarothamnus scoparius
=450  \\$wnnna$ascoparius, Cytisus
=450  \\$wnnna$ascoparius, Sarothamnus
=450  \\$wnnna$aScotch Broom
=450  \\$wnnna$aScotch Brooms
=550  \\$wg$aFabaceae
=667  \\$aX ref BROOM, DESERT: several other Broom terms are also available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is sometimes called broom because of the shape of the plant. Members produce SPARTEINE.
=688  \\$a2002
=750  \0$aCytisus$5IEN-M$0(DLC)sh 87006212

=LDR  00940cz  a2200229n  4500
=001  9880364334002441
=005  20141212214651.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029864
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x175
=150  \\$aCrotalaria
=450  \\$wnnna$aChipilin, Rattlepod
=450  \\$wnnna$aChipilins, Rattlepod
=450  \\$wnnna$aCrotalarias
=450  \\$aRattlepod Chipilin
=450  \\$wnnna$aRattlepod Chipilins
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains crotalarin.
=688  \\$a2002
=750  \0$aCrotalaria$5IEN-M$0(DLC)sh 88022718

=LDR  01035cz  a2200277n  4500
=001  9880364334102441
=005  20141212214650.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x150
=150  \\$aCicer
=450  \\$wnnna$aarietinum, Cicer
=450  \\$wnnna$aarietinums, Cicer
=450  \\$aChickpea
=450  \\$wnnna$aChickpeas
=450  \\$wnnna$aCicer arietinum
=450  \\$wnnna$aCicer arietinums
=450  \\$wnnna$aCicers
=450  \\$aGarbanzo
=450  \\$wnnna$aGarbanzos
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE known for the edible beans.
=688  \\$a2002
=750  \0$aCicer$5IEN-M$0(DLC)sh 85025920

=LDR  00894cz  a2200229n  4500
=001  9880364334202441
=005  20141212214650.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029862
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x702
=150  \\$aProsopis
=450  \\$aAlgarrobo
=450  \\$wnnna$aAlgarrobos
=450  \\$aMesquite
=450  \\$wnnna$aMesquites
=450  \\$wnnna$aProsopi
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is a source of prosopis gum.
=688  \\$a2002
=750  \0$aMesquite$5IEN-M$0(DLC)sh 85083971

=LDR  02227cz  a2200505n  4500
=001  9880364334302441
=005  20141212214649.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029846
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x718
=150  \\$aSenna Plant
=450  \\$wnnna$aalexandrina, Senna
=450  \\$wnnna$aalexandrinas, Senna
=450  \\$wnnna$aangustifolia, Cassia
=450  \\$wnnna$aangustifolias, Cassia
=450  \\$wnnna$aCassia angustifolia
=450  \\$wnnna$aCassia angustifolias
=450  \\$wnnna$aCassia occidentali
=450  \\$wnnna$aCassia occidentalis
=450  \\$wnnna$aCassia senna
=450  \\$wnnna$aCassia sennas
=450  \\$aCoffee Senna
=450  \\$wnnna$aCoffee Sennas
=450  \\$wnnna$aoccidentali, Cassia
=450  \\$wnnna$aoccidentali, Senna
=450  \\$wnnna$aoccidentalis, Cassia
=450  \\$wnnna$aoccidentalis, Senna
=450  \\$wnnna$aPlant, Senna
=450  \\$wnnna$aPlants, Senna
=450  \\$wnnoa$aSenna$5IEN-HS
=450  \\$wnnna$aSenna alexandrina
=450  \\$wnnna$aSenna alexandrinas
=450  \\$wnnna$asenna, Cassia
=450  \\$wnnna$aSenna, Coffee
=450  \\$wnnna$aSenna occidentali
=450  \\$wnnna$aSenna occidentalis
=450  \\$wnnna$aSenna Plants
=450  \\$wnnna$asennas, Cassia
=450  \\$wnnna$aSennas, Coffee
=550  \\$wg$aFabaceae
=667  \\$anote entry terms: CASSIA and CASSIA TREE see CINNAMOMUM AROMATICUM are also available; SENNA EXTRACT is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. SENNA EXTRACT is obtained from members of this genus. Members contain ANTHRAQUINONES and have been an ingredient in laxatives (CATHARTICS). Many species of the CASSIA genus have been reclassified into this genus. This bush should not be confused with the Cassia tree (CINNAMOMUM).
=688  \\$a2002
=750  \0$aSenna (Genus)$0(DLC)sh2008007840$5IEN-M

=LDR  01652cz  a2200397n  4500
=001  9880364334402441
=005  20141212214646.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x284.$x182
=072  \\$aB4.$x909.$x777.$x618.$x284.$x182
=150  \\$aEnterovirus B, Human
=450  \\$aBornholm Disease Virus
=450  \\$wnnna$aCoxsackie A9 Virus
=450  \\$wnnna$aCoxsackie B Viruses
=450  \\$aCoxsackievirus A9, Human
=450  \\$wnnna$aCoxsackieviruses B
=450  \\$wnnna$aDisease Virus, Bornholm
=450  \\$wnnna$aEcho Virus
=450  \\$wnnna$aEcho Viruses
=450  \\$wnnna$aEchovirus
=450  \\$aEchoviruses
=450  \\$aHuman coxsackievirus A9
=450  \\$aHuman enterovirus B
=450  \\$aPleurodynia Virus
=450  \\$wnnna$aPleurodynia Viruses
=450  \\$aSwine vesicular disease virus
=450  \\$wnnna$aVirus, Bornholm Disease
=550  \\$wg$aEnterovirus
=550  \\$wh$aEchovirus 6, Human
=550  \\$wh$aEchovirus 9
=667  \\$ainfection: coordinate IM with ENTEROVIRUS INFECTIONS (IM) or COXSACKIEVIRUS INFECTIONS (IM) or ECHOVIRUS INFECTIONS (IM) as required by specific entry terms or text; for entry term SWINE VESICULAR DISEASE VIRUS infection = SWINE VESICULAR DISEASE
=680  \\$iA species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B.
=688  \\$a2002; for COXSACKIE A9 VIRUS see ENTEROVIRUSES 1979-2001
=750  \0$aECHO viruses$5IEN-M$0(DLC)sh 85040721

=LDR  01163cz  a2200277n  4500
=001  9880364334502441
=005  20141212214645.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029803
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x622
=150  \\$aPhyllanthus
=450  \\$wnnna$aamarus, Phyllanthus
=450  \\$aBahupatra
=450  \\$wnnna$aBahupatras
=450  \\$wnnna$anirurii, Phyllanthus
=450  \\$wnnna$anirurius, Phyllanthus
=450  \\$wnnna$aPhyllanthus amarus
=450  \\$wnnna$aPhyllanthus nirurii
=450  \\$wnnna$aPhyllanthus nirurius
=550  \\$wg$aEuphorbiaceae
=550  \\$wh$aPhyllanthus emblica
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE. Bahupatra (MEDICINE, AYURVEDIC) is prepared from this.
=688  \\$a2002
=750  \0$aPhyllanthus$5IEN-M$0(DLC)sh 85101469

=LDR  01274cz  a2200301n  4500
=001  9880364334602441
=005  20141212214644.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x199
=150  \\$aCroton
=450  \\$wnnna$aCroton tiglium
=450  \\$wnnna$aCroton tigliums
=450  \\$wnnna$aCrotons
=450  \\$wnnna$ade Drago, Sangre
=450  \\$wnnna$ade Dragos, Sangre
=450  \\$wnnna$aDrago, Sangre de
=450  \\$wnnna$aDragos, Sangre de
=450  \\$aSangre de Drago
=450  \\$wnnna$aSangre de Dragos
=450  \\$wnnna$atiglium, Croton
=450  \\$wnnna$atigliums, Croton
=550  \\$wg$aEuphorbiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE. The common name of dragon's blood is also used for DRACAENA and Daemonorops (ARECACEAE). Croton tiglium is the source of CROTON OIL.
=688  \\$a2002
=750  \0$aCroton (Genus)$5IEN-M$0(DLC)sh 85034314

=LDR  00995cz  a2200241n  4500
=001  9880364334702441
=005  20141212214643.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774.$x937
=150  \\$aVaccinium vitis-idaea
=450  \\$wnnna$aLingonberries
=450  \\$aLingonberry
=450  \\$wnnna$aVaccinium vitis idaea
=450  \\$wnnna$aVaccinium vitis-idaeas
=450  \\$wnnna$avitis-idaea, Vaccinium
=450  \\$wnnna$avitis-idaeas, Vaccinium
=550  \\$wg$aVaccinium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus VACCINIUM.
=688  \\$a2002
=750  \0$aVaccinium vitis-idaea$5IEN-M$0(DLC)sh 85141724

=LDR  00904cz  a2200229n  4500
=001  9880364334802441
=005  20141212214642.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029800
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774.$x875
=150  \\$aVaccinium myrtillus
=450  \\$wnnna$aBilberries
=450  \\$aBilberry
=450  \\$wnnna$amyrtillus, Vaccinium
=450  \\$wnnna$aWhortleberries
=450  \\$aWhortleberry
=550  \\$wg$aVaccinium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family VACCINIUM.
=688  \\$a2002
=750  \0$aBilberry$5IEN-M$0(DLC)sh 85141723

=LDR  01090cz  a2200229n  4500
=001  9880364334902441
=005  20141212214642.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029799
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774.$x750
=150  \\$aVaccinium macrocarpon
=450  \\$wnnna$aCranberries
=450  \\$aCranberry
=450  \\$wnnna$amacrocarpon, Vaccinium
=450  \\$wnnna$amacrocarpons, Vaccinium
=450  \\$wnnna$aVaccinium macrocarpons
=550  \\$wg$aVaccinium
=667  \\$adistinguish from Highbush Cranberry = VIBURNUM; specify Plant Components; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family VACCINIUM known for the sour fruit which is sometimes used for urinary tract infections.
=688  \\$a2002
=750  \0$aCranberries$5IEN-M$0(DLC)sh 85033725

=LDR  00961cz  a2200229n  4500
=001  9880364335002441
=005  20170616093749.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029798
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774.$x249
=150  \\$aBlueberry Plants
=450  \\$wnnna$aBlueberries
=450  \\$wnnna$aBlueberry
=450  \\$wnno$aBlueberry Plant
=450  \\$wnnna$aPlant, Blueberry
=450  \\$wnnna$aPlants, Blueberry
=550  \\$wg$aVaccinium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iSeveral plant species of the genus VACCINIUM known for the edible blueberry fruit.
=688  \\$a2002
=750  \0$aBlueberries$5IEN-M$0(DLC)sh 85015096

=LDR  00978cz  a2200229n  4500
=001  9880364335102441
=005  20141212214641.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029797
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774.$x500
=150  \\$aHuckleberry Plant
=450  \\$wnnna$aHuckleberries
=450  \\$wnnna$aHuckleberry
=450  \\$wnnna$aHuckleberry Plants
=450  \\$wnnna$aPlant, Huckleberry
=450  \\$wnnna$aPlants, Huckleberry
=550  \\$wg$aVaccinium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iSeveral plant species of the genus VACCINIUM known for the edible huckleberry fruit.
=688  \\$a2002
=750  \0$aHuckleberries$5IEN-M$0(DLC)sh 85062768

=LDR  00982cz  a2200241n  4500
=001  9880364335202441
=005  20141212214640.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029796
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x774
=150  \\$aVaccinium
=450  \\$wnnna$aVacciniums
=550  \\$wg$aEricaceae
=550  \\$wh$aBlueberry Plant
=550  \\$wh$aHuckleberry Plant
=550  \\$wh$aVaccinium macrocarpon
=550  \\$wh$aVaccinium myrtillus
=550  \\$wh$aVaccinium vitis-idaea
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE known for species with edible fruits.
=688  \\$a2002
=750  \0$aVaccinium$5IEN-M$0(DLC)sh 85141722

=LDR  00893cz  a2200229n  4500
=001  9880364335302441
=005  20141212214640.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029795
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x211
=150  \\$aCalluna
=450  \\$wnnna$aCallunas
=450  \\$wnnna$aHeather, Scotch
=450  \\$wnnna$aHeathers, Scotch
=450  \\$aScotch Heather
=450  \\$wnnna$aScotch Heathers
=550  \\$wg$aEricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE.
=688  \\$a2002
=750  \0$aCalluna$0(DLC)sh2005000232$5IEN-M

=LDR  01354cz  a2200373n  4500
=001  9880364335402441
=005  20141212214639.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029794
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x324
=150  \\$aLedum
=450  \\$wnnna$agroenlandicum, Ledum
=450  \\$wnnna$agroenlandicums, Ledum
=450  \\$aLabrador Tea
=450  \\$wnnna$aLabrador Teas
=450  \\$wnnna$aLedum groenlandicum
=450  \\$wnnna$aLedum groenlandicums
=450  \\$wnnna$aLedum palustre
=450  \\$wnnna$aLedum palustres
=450  \\$wnnna$aLedums
=450  \\$wnnna$apalustre, Ledum
=450  \\$wnnna$apalustres, Ledum
=450  \\$wnnna$aRosemaries, Wild
=450  \\$wnnna$aRosemary, Wild
=450  \\$wnnna$aTea, Labrador
=450  \\$wnnna$aTeas, Labrador
=450  \\$wnnna$aWild Rosemaries
=450  \\$aWild Rosemary
=550  \\$wg$aEricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE.
=688  \\$a2002
=750  \0$aLabrador tea$0(DLC)sh2006001128$5IEN-M

=LDR  00760cz  a2200181n  4500
=001  9880364335502441
=005  20141212214638.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029793
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x549
=150  \\$aRhododendron
=450  \\$wnnna$aRhododendrons
=550  \\$wg$aEricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE.
=688  \\$a2002
=750  \0$aRhododendrons$5IEN$0(DLC)sh 85113765

=LDR  01147cz  a2200301n  4500
=001  9880364335602441
=005  20141212214638.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029792
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x99
=150  \\$aArctostaphylos
=450  \\$wnnna$aArctostaphylo
=450  \\$wnnna$aArctostaphylos uva-ursi
=450  \\$wnnna$aArctostaphylos uva ursi
=450  \\$wnnna$aArctostaphylos uva-ursus
=450  \\$wnnna$aBearberries
=450  \\$aBearberry
=450  \\$aUva-ursi
=450  \\$wnnna$aUva ursi
=450  \\$wnnna$auva-ursi, Arctostaphylos
=450  \\$wnnna$aUva-ursus
=450  \\$wnnna$auva-ursus, Arctostaphylos
=550  \\$wg$aEricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE.
=688  \\$a2002
=750  \0$aArctostaphylos$5IEN-M$0(DLC)sh 85006969

=LDR  00840cz  a2200193n  4500
=001  9880364335802441
=005  20141212214636.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029789
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x344.$x222
=150  \\$aEphedra
=450  \\$wnnna$aEphedras
=550  \\$wg$aGnetophyta
=550  \\$wh$aEphedra sinica
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta.
=688  \\$a2002
=750  \0$aEphedra$5IEN-M$0(DLC)sh 85044252

=LDR  01256cz  a2200301n  4500
=001  9880364335902441
=005  20141212214636.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029788
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x333.$x500
=150  \\$aDiospyros
=450  \\$wnnna$aBlack Sapote
=450  \\$wnnna$aBlack Sapotes
=450  \\$wnnna$adigyna, Diospyros
=450  \\$wnnna$adigynas, Diospyros
=450  \\$wnnna$aDiospyro
=450  \\$wnnna$aDiospyros digyna
=450  \\$wnnna$aDiospyros digynas
=450  \\$aPersimmon
=450  \\$wnnna$aPersimmons
=450  \\$aSapote, Black
=450  \\$wnnna$aSapotes, Black
=550  \\$wg$aEbenaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EBENACEAE, order Ebenales, subclass Dilleniidae, class Magnoliopsida best known for the edible fruit and the antibacterial activity and compounds of the wood.
=688  \\$a2002
=750  \0$aDiospyros$5IEN-M$0(DLC)sh 85038138

=LDR  00950cz  a2200205n  4500
=001  9880364336002441
=005  20141212214635.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029787
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x329.$x500
=150  \\$aDrosera
=450  \\$wnnna$aDroseras
=450  \\$aSundew
=450  \\$wnnna$aSundews
=550  \\$wg$aDroseraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Droseraceae, order Nepenthales, subclass Dilleniidae, class Magnoliopsida, that contains naphthoquinone glucosides. The name sundew is rarely used for PYROLA.
=688  \\$a2002
=750  \0$aSundews$5IEN-M$0(DLC)sh 85039633

=LDR  01363cz  a2200385n  4500
=001  9880364336102441
=005  20141212214635.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029786
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x312.$x199
=150  \\$aCyperus
=450  \\$wnnna$aChufa
=450  \\$wnnna$aChufas
=450  \\$wnnna$aCyperus esculentus
=450  \\$wnnna$aesculentus, Cyperus
=450  \\$aFlat Sedge
=450  \\$wnnna$aFlat Sedges
=450  \\$aFlatsedge
=450  \\$wnnna$aFlatsedges
=450  \\$aNut Sedge
=450  \\$wnnna$aNut Sedges
=450  \\$wnnna$aNutgrass, Yellow
=450  \\$wnnna$aNutgrasses, Yellow
=450  \\$aSedge, Flat
=450  \\$aSedge, Nut
=450  \\$wnnna$aSedges, Flat
=450  \\$wnnna$aSedges, Nut
=450  \\$aYellow Nutgrass
=450  \\$wnnna$aYellow Nutgrasses
=550  \\$wg$aCyperaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.
=688  \\$a2002
=750  \0$aCyperus$0(DLC) sh 85035166$5IEN-M

=LDR  00894cz  a2200205n  4500
=001  9880364336202441
=005  20141212214634.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x312
=150  \\$aCyperaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCarex Plant
=550  \\$wh$aCyperus
=550  \\$wh$aEleocharis
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe sedge plant family of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons)
=688  \\$a2002
=750  \0$aCyperaceae$5IEN-M$0(DLC)sh 85035164

=LDR  01754cz  a2200469n  4500
=001  9880364336302441
=005  20141212214633.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x188.$x799
=150  \\$aThuja
=450  \\$aArbor Vitae
=450  \\$wnnna$aBiota orientali
=450  \\$wnnna$aBiota orientalis
=450  \\$aCedar, Western Red
=450  \\$wnnna$aCedars, Western Red
=450  \\$wnnna$aoccidentali, Thuja
=450  \\$wnnna$aoccidentalis, Thuja
=450  \\$wnnna$aorientali, Biota
=450  \\$wnnna$aorientali, Thuja
=450  \\$wnnna$aorientalis, Biota
=450  \\$wnnna$aorientalis, Thuja
=450  \\$wnnna$aplicata, Thuja
=450  \\$wnnna$aplicatas, Thuja
=450  \\$wnnna$aRed Cedar, Western
=450  \\$wnnna$aRed Cedars, Western
=450  \\$wnnna$aThuja occidentali
=450  \\$wnnna$aThuja occidentalis
=450  \\$wnnna$aThuja orientali
=450  \\$wnnna$aThuja orientalis
=450  \\$wnnna$aThuja plicata
=450  \\$wnnna$aThuja plicatas
=450  \\$wnnna$aThujas
=450  \\$wnnna$aVitae, Arbor
=450  \\$wnnna$aWestern Red Cedar
=450  \\$wnnna$aWestern Red Cedars
=550  \\$wg$aCupressaceae
=667  \\$aX ref CEDAR, WESTERN RED: do not confuse with other cedar terms in MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUPRESSACEAE.
=688  \\$a2002
=750  \0$aThuja$5IEN-M$0(DLC)sh 88023156

=LDR  00869cz  a2200169n  4500
=001  9880364336402441
=005  20141212214633.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x188.$x599
=150  \\$aLibocedrus
=550  \\$wg$aCupressaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUPRESSACEAE. The common name of 'Cedar' makes this easily confused with other trees using that name including cedrus, JUNIPERUS; and CHAMAECYPARIS.
=688  \\$a2002
=750  \0$aLibocedrus$5IEN-M$0(DLC)sh 85076489

=LDR  02778cz  a2200685n  4500
=001  9880364336502441
=005  20141212214632.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029780
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x188.$x199
=150  \\$aChamaecyparis
=450  \\$aAtlantic White Cedar
=450  \\$wnnna$aAtlantic White Cedars
=450  \\$aCedar, Atlantic White
=450  \\$aCedar, Yellow
=450  \\$wnnna$aCedars, Atlantic White
=450  \\$wnnna$aCedars, Yellow
=450  \\$wnnna$aChamaecypari
=450  \\$wnnna$aChamaecyparis lawsoniana
=450  \\$wnnna$aChamaecyparis lawsonianas
=450  \\$wnnna$aChamaecyparis nootkatenses
=450  \\$wnnna$aChamaecyparis nootkatensis
=450  \\$wnnna$aChamaecyparis obtusa
=450  \\$wnnna$aChamaecyparis obtusas
=450  \\$wnnna$aChamaecyparis thyoide
=450  \\$wnnna$aChamaecyparis thyoides
=450  \\$wnnna$aCypress, Hinoki
=450  \\$wnnna$aCypress, Lawson False
=450  \\$aCypress, Lawson's False
=450  \\$wnnna$aCypress, Lawsons False
=450  \\$aCypress, Yellow
=450  \\$wnnna$aCypresses, Lawson's False
=450  \\$wnnna$aCypresses, Yellow
=450  \\$wnnna$aFalse Cypress, Lawson's
=450  \\$wnnna$aFalse Cypresses, Lawson's
=450  \\$aHinoki Cypress
=450  \\$wnnna$aLawson False Cypress
=450  \\$wnnna$alawsoniana, Chamaecyparis
=450  \\$wnnna$alawsonianas, Chamaecyparis
=450  \\$aLawson's False Cypress
=450  \\$wnnna$aLawsons False Cypress
=450  \\$wnnna$aLawson's False Cypresses
=450  \\$wnnna$anootkatenses, Chamaecyparis
=450  \\$wnnna$anootkatensis, Chamaecyparis
=450  \\$wnnna$aobtusa, Chamaecyparis
=450  \\$wnnna$aobtusas, Chamaecyparis
=450  \\$wnnna$athyoide, Chamaecyparis
=450  \\$wnnna$athyoides, Chamaecyparis
=450  \\$wnnna$aWhite Cedar, Atlantic
=450  \\$wnnna$aWhite Cedars, Atlantic
=450  \\$wnnna$aYellow Cedar
=450  \\$wnnna$aYellow Cedars
=450  \\$wnnna$aYellow Cypress
=450  \\$wnnna$aYellow Cypresses
=550  \\$wg$aCupressaceae
=667  \\$anote X refs containing cedar and cypress: check text to distinguish from other cedar and cypress terms in MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUPRESSACEAE which should not be confused with other cedar and cypress trees of THUJA or CUPRESSUS genera.
=688  \\$a2002
=750  \0$aChamaecyparis$5IEN-M$0(DLC)sh 85022406

=LDR  01155cz  a2200277n  4500
=001  9880364336702441
=005  20141212214630.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029778
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x827
=150  \\$aTrichosanthes
=450  \\$aGourd, Snake
=450  \\$wnnna$aGourds, Snake
=450  \\$wnnna$akirilowii, Trichosanthes
=450  \\$wnnna$akirilowius, Trichosanthes
=450  \\$aSnake Gourd
=450  \\$wnnna$aSnake Gourds
=450  \\$wnnna$aTrichosanthe
=450  \\$wnnna$aTrichosanthes kirilowii
=450  \\$wnnna$aTrichosanthes kirilowius
=550  \\$wg$aCucurbitaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family CUCURBITACEAE that is a source of TRICHOSANTHIN (a ribosomal inhibitory protein).
=688  \\$a2002
=750  \0$aTrichosanthes$5IEN-M$0(DLC)sh 85137478

=LDR  01285cz  a2200325n  4500
=001  9880364336802441
=005  20141212193019.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029777
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x655.$x249
=150  \\$aMomordica charantia
=450  \\$aBitter Gourd
=450  \\$wnnna$aBitter Gourds
=450  \\$wnnna$aBitter Melon
=450  \\$wnnna$aBitter Melons
=450  \\$wnnna$acharantia, Momordica
=450  \\$wnnna$acharantias, Momordica
=450  \\$aGourd, Bitter
=450  \\$wnnna$aGourds, Bitter
=450  \\$aKarela
=450  \\$wnnna$aKarelas
=450  \\$wnnna$aMelon, Bitter
=450  \\$wnnna$aMelons, Bitter
=450  \\$wnnna$aMomordica charantias
=550  \\$wg$aMomordica
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant species of the family CUCURBITACEAE. It is a source of ribosome-inactivating proteins and triterpene glycosides.
=688  \\$a2002
=750  \0$aMomordica charantia$0(DLC)sh2006000610$5IEN-M

=LDR  01047cz  a2200253n  4500
=001  9880364336902441
=005  20141212214630.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029776
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x522
=150  \\$aLuffa
=450  \\$aLoofah
=450  \\$wnnna$aLoofahs
=450  \\$wnnna$aluffa, Momordica
=450  \\$wnnna$aLuffas
=450  \\$wnnna$aluffas, Momordica
=450  \\$aMomordica luffa
=450  \\$wnnna$aMomordica luffas
=550  \\$wg$aCucurbitaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE known for the fruit which is the source of the luffa sponge and the seeds which contain luffin.
=688  \\$a2002
=750  \0$aLuffa$5IEN-M$0(DLC)sh2001007792

=LDR  00942cz   2200205n  4500
=001  9880364337002441
=005  20230831160001.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029775
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x655
=150  \\$aMomordica
=450  \\$wnnna$aMomordicas
=550  \\$wg$aCucurbitaceae
=550  \\$wh$aMomordica charantia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE. It is a source of momordin.
=688  \\$a2002
=750  \0$aMomordica$0(DLC)sh2006001109$5IEN-M
=750  \0$iNarrower mapping$aMomordica cochinchinensis$0(DLC)sh2022005937$4NM$5IEN-M

=LDR  01009cz  a2200229n  4500
=001  9880364337102441
=005  20141212214629.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029774
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x444
=150  \\$aGynostemma
=450  \\$wnnna$aGynostemma pentaphyllum
=450  \\$wnnna$aGynostemma pentaphyllums
=450  \\$wnnna$aGynostemmas
=450  \\$wnnna$apentaphyllum, Gynostemma
=450  \\$wnnna$apentaphyllums, Gynostemma
=550  \\$wg$aCucurbitaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE. It is a source of gypenosides and triterpenoid SAPONINS.
=688  \\$a2002
=750  \0$aGynostemma$5IEN-M$0(DLC)sh 98007562

=LDR  00857cz  a2200205n  4500
=001  9880364337202441
=005  20141212214628.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029773
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x140
=150  \\$aCitrullus
=450  \\$aWatermelon
=450  \\$wnnna$aWatermelons
=550  \\$wg$aCucurbitaceae
=550  \\$wh$aCitrullus colocynthis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE known for the edible fruit.
=688  \\$a2002
=750  \0$aCitrullus$5IEN-M$0(DLC)sh 85026224

=LDR  01194cz  a2200253n  4500
=001  9880364337302441
=005  20141212214627.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029771
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x249.$x500
=150  \\$aRhodiola
=450  \\$wnnna$aRhodiola rosea
=450  \\$wnnna$aRhodiola roseas
=450  \\$wnnna$aRhodiolas
=450  \\$wnnna$arosea, Rhodiola
=450  \\$wnnna$aroseas, Rhodiola
=450  \\$aRoseroot
=450  \\$wnnna$aRoseroots
=550  \\$wg$aCrassulaceae
=667  \\$ado not confuse X ref ROSEROOT with ROSE see ROSA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CRASSULACEAE. Members contain rhodioloside. This roseroot is unrelated to the familiar rose (ROSA). Some species in this genus are called stonecrop which is also a common name for SEDUM.
=688  \\$a2002
=750  \0$aRoseroot$5IEN-M$0(DLC)sh 85115442

=LDR  01015cz  a2200193n  4500
=001  9880364337402441
=005  20141212193019.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029770
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x124
=150  \\$aCostus
=450  \\$wnnna$aCostus spicatus
=450  \\$wnnna$aspicatus, Costus
=550  \\$wg$aZingiberales
=667  \\$ado not confuse with SAUSSUREA COSTUS see SAUSSUREA; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family Costaceae (sometimes classified in Zingiberaceae), order Zingiberales, subclass Zingiberidae, class Liliopsida (monocotyledons). It is a source of SAPONINS and furostanol glycosides.
=688  \\$a2002
=750  \0$aCostus$5IEN-M$0(DLC)sh 85033278

=LDR  00837cz  a2200181n  4500
=001  9880364337502441
=005  20141212214627.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029769
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x778.$x188
=150  \\$aCamptotheca
=450  \\$wnnna$aCamptothecas
=550  \\$wg$aNyssaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NYSSACEAE (sometimes classified in the CORNACEAE family). It is a source of CAMPTOTHECIN.
=688  \\$a2002
=750  \0$aCamptotheca$5IEN-M$0(DLC)sh 88022630

=LDR  00889cz  a2200217n  4500
=001  9880364337602441
=005  20141212214627.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029768
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x241.$x299
=150  \\$aCornus
=450  \\$aCorni Fructus
=450  \\$aDogwood
=450  \\$wnnna$aDogwoods
=450  \\$wnnna$aFructus, Corni
=550  \\$wg$aCornaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CORNACEAE. It is widely cultivated for the attractive flowers.
=688  \\$a2002
=750  \0$aDogwoods$5IEN-M$0(DLC)sh 85038828

=LDR  00848cz  a2200241n  4500
=001  9880364276902441
=005  20141212220341.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267.$x920
=150  \\$aWhales, Pilot
=450  \\$aGlobicephala
=450  \\$wnnna$aGlobicephala macrorhynchus
=450  \\$wnnna$aGlobicephala melaena
=450  \\$wnnna$aGlobicephala melas
=450  \\$wnnna$aPilot Whale
=450  \\$aPilot Whales
=450  \\$wnnna$aWhale, Pilot
=550  \\$wg$aDolphins
=680  \\$iThe genus Globicephala, in the family Delphinidae, consisting of two species of DOLPHINS. They are mostly black with a stocky shape and bulbous foreheads.
=688  \\$a2006; use DOLPHINS 1998-2005
=750  \0$aGlobicephala$0(DLC) sh 85055297$5IEN-M

=LDR  00812cz  a2200205n  4500
=001  9880364277002441
=005  20141212220340.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267.$x900
=150  \\$aWhale, Killer
=450  \\$aKiller Whale
=450  \\$wnnna$aKiller Whales
=450  \\$wnnna$aOrcinus orca
=450  \\$wnnna$aWhales, Killer
=550  \\$wg$aDolphins
=680  \\$iThe species Orcinus orca, in the family Delphinidae, characterized by its black and white coloration, and huge triangular dorsal fin. It is the largest member of the DOLPHINS and derives its name from the fact that it is a fearsome predator.
=688  \\$a2006; use DOLPHINS 1998-2005
=750  \0$aKiller whale$0(DLC) sh 85072329$5IEN-M

=LDR  01397cz  a2200385n  4500
=001  9880364277102441
=005  20141212220339.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267.$x100
=150  \\$aBottle-Nosed Dolphin
=450  \\$wnnna$aBottle-Nose Dolphin
=450  \\$wnnna$aBottle-Nose Dolphins
=450  \\$wnnna$aBottle Nose Dolphins
=450  \\$wnnna$aBottle Nosed Dolphin
=450  \\$wnnna$aBottle-Nosed Dolphins
=450  \\$wnnna$aBottle Nosed Dolphins
=450  \\$wnnna$aBottlenose Dolphin
=450  \\$wnnna$aBottlenose Dolphins
=450  \\$wnnna$aBottlenosed Dolphin
=450  \\$wnnna$aBottlenosed Dolphins
=450  \\$wnnna$aDolphin, Bottle-Nose
=450  \\$wnnna$aDolphin, Bottle-Nosed
=450  \\$wnnna$aDolphin, Bottlenose
=450  \\$wnnna$aDolphin, Bottlenosed
=450  \\$wnnna$aDolphins, Bottle-Nose
=450  \\$wnnna$aDolphins, Bottle-Nosed
=450  \\$wnnna$aDolphins, Bottlenose
=450  \\$wnnna$aDolphins, Bottlenosed
=450  \\$wnnna$aTursiops truncatus
=550  \\$wg$aDolphins
=680  \\$iThe species Tursiops truncatus, in the family Delphinidae, characterized by a bottle-shaped beak and slightly hooked broad dorsal fin.
=688  \\$a2006; use DOLPHINS 1998-2005
=750  \0$aBottlenose dolphin$0(DLC) sh 85009170$5IEN-M

=LDR  00996cz  a2200217n  4500
=001  9880364277202441
=005  20141212220336.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x750
=150  \\$aSperm Whale
=450  \\$wnnna$aPhyseter catodon
=450  \\$wnnna$aPhyseter macrocephalus
=450  \\$wnnna$aWhale, Sperm
=550  \\$wg$aWhales
=550  \\$aAmbergris
=667  \\$ado not confuse with the Pygmy Sperm Whale or Dwarf Sperm Whale = WHALES
=680  \\$iThe species Physeter catodon (also called Physeter macrocephalus), in the family Physeteridae. The common name is derived from the milky wax substance in its head (spermaceti). The species also produces an intestinal secretion AMBERGRIS, which was previously used in perfumes. The sperm whale is the largest toothed MAMMAL in the world.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aSperm whale$0(DLC) sh 85126535$5IEN-M

=LDR  00804cz  a2200229n  4500
=001  9880364277302441
=005  20141212220331.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050643
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x110
=150  \\$aBeluga Whale
=450  \\$wnnna$aBeluga Whales
=450  \\$wnnna$aDelphinapterus leucas
=450  \\$wnnna$aWhale, White
=450  \\$wnnna$aWhales, White
=450  \\$aWhite Whale
=450  \\$wnnna$aWhite Whales
=550  \\$wg$aWhales
=680  \\$iThe species Delphinapterus leucas, in the family Monodontidae, found primarily in the Arctic Ocean and adjoining seas. They are small WHALES lacking a dorsal fin.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aWhite whale$0(DLC) sh 85146532$5IEN-M

=LDR  01000cz  a2200265n  4500
=001  9880364277402441
=005  20141212220331.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x130
=150  \\$aBowhead Whale
=450  \\$wnnna$aBalaena mysticetus
=450  \\$wnnna$aBowhead Whales
=450  \\$wnnna$aGreenland, Right Whale
=450  \\$wnnna$aGreenland Right Whale
=450  \\$wnnna$aGreenland Right Whales
=450  \\$aRight Whale, Greenland
=450  \\$wnnna$aRight Whale Greenland
=450  \\$wnnna$aRight Whales, Greenland
=450  \\$wnnna$aWhales, Greenland Right
=550  \\$wg$aWhales
=680  \\$iThe species Balaena mysticetus, in the family Balaenidae, found in the colder waters of the Northern Hemisphere. The common name is derived from the extreme arching of the lower jaw.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aBowhead whale$0(DLC) sh 85016154$5IEN-M

=LDR  00790cz  a2200205n  4500
=001  9880364277502441
=005  20141212220330.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050640
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x400
=150  \\$aHumpback Whale
=450  \\$wnnna$aHumpback Whales
=450  \\$wnnna$aMegaptera novaeangliae
=450  \\$wnnna$aWhale, Humpback
=450  \\$wnnna$aWhales, Humpback
=550  \\$wg$aWhales
=680  \\$iThe species Megaptera novaeangliae, in the family Balaenopteridae, characterized by its huge flippers and the arching of their back when diving. They are also known for their breaching and singing.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aHumpback whale$0(DLC) sh 85062918$5IEN-M

=LDR  00838cz  a2200205n  4500
=001  9880364277602441
=005  20141212220330.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050636
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x100.$x500
=150  \\$aMinke Whale
=450  \\$wnnna$aBalaenoptera acutorostrata
=450  \\$wnnna$aBalaenoptera acutorostrata bonaerensis
=450  \\$wnnna$aBalaenoptera bonaerensis
=450  \\$wnnna$aMinke Whales
=550  \\$wg$aBalaenoptera
=680  \\$iThe species Balaenoptera acutorostrata, in the family Balaenopteridae. It is the smallest of the WHALES in the family and though mainly oceanic, is often found in coastal waters including bays and estuaries.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aMinke whale$0(DLC) sh 85011108$5IEN-M

=LDR  00874cz  a2200229n  4500
=001  9880364277702441
=005  20141212220329.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050617
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x100.$x350
=150  \\$aFin Whale
=450  \\$wnnna$aBalaenoptera physalus
=450  \\$wnnna$aFin Whales
=450  \\$wnnna$aFinback Whale
=450  \\$wnnna$aFinback Whales
=450  \\$wnnna$aWhale, Finback
=450  \\$wnnna$aWhales, Finback
=550  \\$wg$aBalaenoptera
=680  \\$iThe species Balaenoptera physalus, in the family Balaenopteridae, characterized by a large, strongly curved, dorsal fin. It is the second largest of the WHALES, highly migratory, but rarely seen near the shore.
=688  \\$a2006; use WHALES 1998-2005
=750  \0$aFinback whale$0(DLC) sh 85048320$5IEN-M

=LDR  00999cz  a2200265n  4500
=001  9880364277802441
=005  20141212220214.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049875
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x225
=150  \\$aDreissena
=450  \\$wnnna$aDreissena polymorpha
=450  \\$wnnna$aDreissena polymorphas
=450  \\$wnnna$aDreissenas
=450  \\$wnnna$aMussel, Zebra
=450  \\$aMussels, Zebra
=450  \\$wnnna$apolymorpha, Dreissena
=450  \\$wnnna$apolymorphas, Dreissena
=450  \\$wnnna$aZebra Mussel
=450  \\$wnnna$aZebra Mussels
=550  \\$wg$aBivalvia
=680  \\$iA genus of mussels in the family Dreissenidae, class BIVALVIA. They are found in both fresh and brackish water and are not native to North America. Accidentally introduced into the Great Lakes in 1986, they now proliferate widely throughout the United States.
=688  \\$a2006
=750  \0$aDreissena$0(DLC) sh sh 88021197$5IEN-M

=LDR  00600cz  a2200169n  4500
=001  9880364277902441
=005  20141212220214.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049874
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x175
=150  \\$aCorbicula
=450  \\$wnnna$aCorbiculas
=550  \\$wg$aBivalvia
=680  \\$iA genus of freshwater clams, in the family Corbiculidae, class BIVALVIA. It originated in Asia but was introduced in North America and is now found throughout the United States.
=688  \\$a2006
=750  \0$aCorbicula$0(DLC) sh 88021186$5IEN-M

=LDR  00639cz  a2200205n  4500
=001  9880364278002441
=005  20141212220213.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049873
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x150
=150  \\$aCardiidae
=450  \\$aCerastoderma
=450  \\$wnnna$aCerastodermas
=450  \\$wnnna$aCockle
=450  \\$aCockles
=550  \\$wg$aBivalvia
=680  \\$iA family of bivalve MOLLUSKS with heart-shaped shells, commonly known as cockles. Unlike most BIVALVES, cockles are hermaphroditic.
=688  \\$a2006
=750  \2$aCardiidae$0(DLC) sh 88021178$5IEN-M

=LDR  01367cz  a2200421n  4500
=001  9880364278102441
=005  20141212220213.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049872
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80
=150  \\$aBivalvia
=450  \\$wnnna$aBivalve
=450  \\$wnnna$aBivalves
=450  \\$wnnna$aBivalvias
=450  \\$wnnna$aClam
=450  \\$wnnna$aClams
=450  \\$wnnna$aMussel
=450  \\$aMussels
=550  \\$wg$aMollusca
=550  \\$wh$aArcidae
=550  \\$wh$aCardiidae
=550  \\$wh$aCorbicula
=550  \\$wh$aDreissena
=550  \\$wh$aMercenaria
=550  \\$wh$aMya
=550  \\$wh$aMytilidae
=550  \\$wh$aOstreidae
=550  \\$wh$aPectinidae
=550  \\$wh$aPinctada
=550  \\$wh$aSpisula
=550  \\$wh$aUnionidae
=550  \\$aShellfish
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA class in the phylum MOLLUSCA comprised of mussels; clams; OYSTERS; COCKLES; and SCALLOPS. They are characterized by a bilaterally symmetrical hinged shell and a muscular foot used for burrowing and anchoring.
=688  \\$a2006
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20061114: 150:##:_{dollar}a Clams
=750  \0$aBivalves$0(DLC) sh 85014492$5IEN-M

=LDR  00754cz  a2200217n  4500
=001  9880364278202441
=005  20141212220213.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049871
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x800
=150  \\$aTritonia Sea Slug
=450  \\$wnnna$aSea Slug, Tritonia
=450  \\$wnnna$aSea Slugs, Tritonia
=450  \\$wnnna$aSlug, Tritonia Sea
=450  \\$wnnna$aSlugs, Tritonia Sea
=450  \\$wnnna$aTritonia Sea Slugs
=550  \\$wg$aGastropoda
=680  \\$iA genus of large marine sea slugs in the family Tritoniidae found in the northern Pacific Ocean. They are used in neurological research.
=688  \\$a2006
=750  \0$aTritonia (Mollusks)$0(DLC) sh 88021146$5IEN-M

=LDR  00608cz  a2200169n  4500
=001  9880364278302441
=005  20141212220212.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049853
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x600
=150  \\$aPleurobranchaea
=450  \\$wnnna$aPleurobranchaeas
=550  \\$wg$aGastropoda
=680  \\$iA genus of side-gilled sea slugs in the family Pleurobranchidae, superorder GASTROPODA. They are opportunistic voracious feeders but prefer the sea anemone.
=688  \\$a2006
=750  \0$aPleurobranchaea (Genus)$0(DLC) sh 88021083$5IEN-M

=LDR  00808cz  a2200217n  4500
=001  9880364278402441
=005  20141212220212.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049852
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x150
=150  \\$aClione
=450  \\$wnnna$aClione limacina
=450  \\$wnnna$aClione limacinas
=450  \\$wnnna$aCliones
=450  \\$wnnna$alimacina, Clione
=450  \\$wnnna$alimacinas, Clione
=550  \\$wg$aGastropoda
=680  \\$iA genus of small, shell-less, marine mollusks in the family Clione, superorder GASTROPODA. These pteropod (possessing a foot developed into wing-like organ for swimming) sea slugs feed exclusively on another pteropod mollusk, Limacina.
=688  \\$a2006
=750  \0$aClione$0(DLC)sh2005007545$5IEN-M

=LDR  01372cz   2200385n  4500
=001  9880364278502441
=005  20230831171215.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049851
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400
=150  \\$aGastropoda
=450  \\$wnnna$aGastropod
=450  \\$wnnna$aGastropodas
=450  \\$wnnna$aGastropods
=450  \\$wnnna$aSlug
=450  \\$aSlugs
=550  \\$wg$aMollusca
=550  \\$wh$aAplysia
=550  \\$wh$aClione
=550  \\$wh$aConus Snail
=550  \\$wh$aHermissenda
=550  \\$wh$aPleurobranchaea
=550  \\$wh$aSnails
=550  \\$wh$aTritonia Sea Slug
=550  \\$aShellfish
=680  \\$iA class in the phylum MOLLUSCA comprised of SNAILS and slugs. The former have coiled external shells and the latter usually lack shells.
=688  \\$a2006
=750  \0$aGastropoda$0(DLC) sh 85053446$5IEN-M
=750  \0$iNarrower mapping$aRadix$0(DLC)sh2021008737$4NM$5IEN-M
=750  \0$iNarrower mapping$aRadix peregra$0(DLC)sh2021008736$4NM$5IEN-M
=750  \0$iNarrower mapping$aArchitaenioglossa$0(DLC)sh2022005910$4NM$5IEN-M
=750  \0$iNarrower mapping$aOstodes strigatus$0(DLC)sh2022005894$4NM$5IEN-M
=750  \0$iNarrower mapping$aNeocyclotidae$0(DLC)sh2022005908$4NM$5IEN-M
=750  \0$iNarrower mapping$aOstodes$0(DLC)sh2022005907$4NM$5IEN-M

=LDR  00536cz  a2200157n  4500
=001  9880364278602441
=005  20141212220211.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049850
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116.$x550
=150  \\$aNautilus
=550  \\$wg$aCephalopoda
=680  \\$iThe sole genus in the family Nautilidae, order Nautilida, comprised of CEPHALOPODS with spiral external shells that are separated into chambers.
=688  \\$a2006
=750  \0$aNautilus$0(DLC) sh 87000050$5IEN-M

=LDR  00670cz  a2200169n  4500
=001  9880364278702441
=005  20141212220211.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049834
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116.$x150.$x500
=150  \\$aLoligo
=450  \\$wnnna$aLoligos
=550  \\$wg$aDecapodiformes
=680  \\$iA genus of SQUID in the family Loliginidae, superorder DECAPODIFORMES, with a spindle-shaped body. They are well-studied, common inshore squids of the Atlantic and eastern Pacific Oceans, but their various species are taxonomically unresolved.
=688  \\$a2006
=750  \0$aLoligo$0(DLC) sh 85078163$5IEN-M

=LDR  00541cz  a2200169n  4500
=001  9880364278802441
=005  20141212220211.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049833
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116.$x150.$x700
=150  \\$aSepia
=450  \\$wnnna$aSepias
=550  \\$wg$aDecapodiformes
=680  \\$iA genus of cuttlefish in the family Sepiidae. They live in tropical, subtropical and temperate waters in most oceans.
=688  \\$a2006
=750  \0$aSepia$0(DLC) sh 87020097$5IEN-M

=LDR  01219cz  a2200349n  4500
=001  9880364278902441
=005  20141212220211.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049832
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116.$x150
=150  \\$aDecapodiformes
=450  \\$aCuttlefish
=450  \\$wnnna$aCuttlefishs
=450  \\$wnnna$aDecapodiforme
=450  \\$aIllex
=450  \\$wnnna$aIllices
=450  \\$aSepiidae
=450  \\$aSquid
=450  \\$wnnna$aSquids
=450  \\$wnnna$aTodarode
=450  \\$aTodarodes
=550  \\$wg$aCephalopoda
=550  \\$wh$aLoligo
=550  \\$wh$aSepia
=667  \\$aSQUID as animal & food; squid giant axon: coordinate NIM with AXONS (IM)
=680  \\$iA superorder of CEPHALOPODS comprised of squid, cuttlefish, and their relatives. Their distinguishing feature is the modification of their fourth pair of arms into tentacles, resulting in 10 limbs.
=688  \\$a2006; for CUTTLEFISH use MOLLUSCA 1995-2005
=750  \0$aCuttlefish$0(DLC) sh 87020092$5IEN-M
=750  \0$aSquids$0(DLC) sh sh 85127108$5IEN-M
=750  \0$aOmmastrephidae$0(DLC) sh 85094694$5IEN-M
=750  \0$aTodarodes$0(DLC) sh 87004177$5IEN-M

=LDR  00847cz  a2200241n  4500
=001  9880364279002441
=005  20141212220210.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049831
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116.$x600
=150  \\$aOctopodiformes
=450  \\$aOctopoda
=450  \\$wnnna$aOctopodas
=450  \\$wnnna$aOctopodiforme
=450  \\$aOctopus
=450  \\$wnnna$aOctopuse
=450  \\$wnnna$aOctopuses
=550  \\$wg$aCephalopoda
=667  \\$aOCTOPUS as animal and food
=680  \\$iA superorder in the class CEPHALOPODA, consisting of the orders Octopoda (octopus) with over 200 species and Vampyromorpha with a single species. The latter is a phylogenetic relic but holds the key to the origins of Octopoda.
=688  \\$a2006
=750  \0$aOctopoda$0(DLC) sh 85094043$5IEN-M

=LDR  00770cz  a2200241n  4500
=001  9880364279102441
=005  20141212220210.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049830
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x116
=150  \\$aCephalopoda
=450  \\$wnnna$aCephalopod
=450  \\$wnnna$aCephalopodas
=450  \\$wnnna$aCephalopods
=550  \\$wg$aMollusca
=550  \\$wh$aDecapodiformes
=550  \\$wh$aNautilus
=550  \\$wh$aOctopodiformes
=550  \\$aShellfish
=680  \\$iA class in the phylum MOLLUSCA comprised of SQUID; CUTTLEFISH; OCTOPUS; and NAUTILUS. These marine animals are the most highly organized of all the mollusks.
=688  \\$a2006
=750  \0$aCephalopoda$0(DLC) sh 85021974$5IEN-M

=LDR  00662cz  a2200217n  4500
=001  9880364279202441
=005  20160418101924.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049811
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x38
=072  \\$aB4.$x970.$x270
=150  \\$aAnelloviridae
=150  \\$wnno$aAnellovirus
=450  \\$wnnna$aAnelloviruses
=550  \\$wg$aDNA Viruses
=550  \\$wg$aViruses, Unclassified
=550  \\$wh$aTorque teno virus
=680  \\$iA family of non-enverloped, vertebrate, single-stranded DNA Viruses.
=688  \\$a2006; use Anellovirus (NM) 2006-2015
=750  \0$aAnelloviruses$0(DLC)sh2010013165$5IEN-M

=LDR  00891cz  a2200229n  4500
=001  9880364279302441
=005  20141212213020.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x789
=072  \\$aN2.$x421.$x533.$x889
=150  \\$aRehabilitation Nursing
=450  \\$aNursing, Rehabilitation
=450  \\$wnnna$aNursings, Rehabilitation
=450  \\$wnnna$aRehabilitation Nursings
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC; SPEC qualif; DF: REHABIL NURS
=680  \\$iA nursing specialty invovled in the diagnosis and treatment of human responses of individuals and groups to actual or potential health problems with the characteristics of altered functional ability and altered life-style.
=688  \\$a97
=750  \0$aRehabilitation nursing$5IEN-M$0(DLC)sh 85112410

=LDR  01278cz  a2200361n  4500
=001  9880364279402441
=005  20141212220208.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049711
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504
=150  \\$aHistory, Modern 1601-
=450  \\$wnnna$a1601- History, Modern
=450  \\$aHistory, Modern
=450  \\$wnnna$aHistory, Modern 1601
=450  \\$wnnna$aHistory, Modern (Medicine)
=450  \\$wnnna$aHistory of Medicine, Modern
=450  \\$wnnna$aMedicine, Modern
=450  \\$wnnna$aModern 1601- History
=450  \\$aModern History
=450  \\$wnnna$aModern History (Medicine)
=450  \\$wnnna$aModern Medicine
=550  \\$wg$aHistory
=550  \\$wh$aHistory, 17th Century
=550  \\$wh$aHistory, 18th Century
=550  \\$wh$aHistory, 19th Century
=550  \\$wh$aHistory, 20th Century
=550  \\$wh$aHistory, 21st Century
=667  \\$aused for searching: indexers apply specifics; may be used by catalogers
=680  \\$iThe period of history from 1601 of the common era to the present.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, Modern
=750  \0$aHistory, Modern$0(DLC) sh 85061236$5IEN-M

=LDR  01197cz  a2200325n  4500
=001  9880364279502441
=005  20141212220207.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049691
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x500
=150  \\$aHistory, Medieval
=450  \\$wnnna$aHistories, Medieval (Medicine)
=450  \\$wnnna$aHistory Medicine, Medieval
=450  \\$wnnna$aHistory, Medieval (Medicine)
=450  \\$wnnna$aHistory of Medicine, Medieval
=450  \\$wnnna$aHistory of Medicine, Renaissance
=450  \\$wnnna$aMedicine, Medieval History
=450  \\$wnnna$aMedicine, Renaissance
=450  \\$wnnna$aMedieval Histories (Medicine)
=450  \\$aMedieval History
=450  \\$wnnna$aMedieval History (Medicine)
=450  \\$wnnna$aMedieval History Medicine
=450  \\$wnnna$aRenaissance Medicine
=550  \\$wg$aHistory
=667  \\$aIM general only; NIM as check tag
=680  \\$iThe period of history from the year 500 through 1450 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, Medieval
=750  \0$aMiddle Ages$0(DLC) sh 85085003$5IEN-M

=LDR  01321cz  a2200349n  4500
=001  9880364279602441
=005  20141212220207.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049690
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x470
=150  \\$aHistory, Ancient
=450  \\$wnnna$aAncient Histories (Medicine)
=450  \\$aAncient History
=450  \\$wnnna$aAncient History (Medicine)
=450  \\$wnnna$aAncient History Medicine
=450  \\$wnnna$aAncient History Medicines
=450  \\$wnnna$aAncient History of Medicine
=450  \\$wnnna$aHistories, Ancient (Medicine)
=450  \\$wnnna$aHistory, Ancient (Medicine)
=450  \\$wnnna$aHistory Medicine, Ancient
=450  \\$wnnna$aHistory Medicines, Ancient
=450  \\$wnnna$aHistory of Medicine, Ancient
=450  \\$wnnna$aMedicine, Ancient History
=450  \\$wnnna$aMedicine Ancient History
=450  \\$wnnna$aMedicines, Ancient History
=550  \\$wg$aHistory
=667  \\$abefore 500 AD; IM general only; NIM as check tag; note ANCIENT LANDS in Category Z
=680  \\$iThe period of history before 500 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, Ancient
=750  \0$aHistory, Ancient$0(DLC) sh 85061232$5IEN-M

=LDR  02198cz  a2200565n  4500
=001  9880364279702441
=005  20141212220206.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049674
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x984
=150  \\$aHistory, 21st Century
=450  \\$wnnna$a21st Cent. Histories (Medicine)
=450  \\$wnnna$a21st Cent. History (Medicine)
=450  \\$wnnna$a21st Cent. History of Medicine
=450  \\$wnnna$a21st Cent. Medicine
=450  \\$wnnna$a21st Cent. Medicines
=450  \\$wnnna$a21st Century Histories
=450  \\$a21st Century History
=450  \\$wnnna$aCent. Histories, 21st (Medicine)
=450  \\$wnnna$aCent. History, 21st (Medicine)
=450  \\$wnnna$aCent. Medicine, 21st
=450  \\$wnnna$aCent. Medicines, 21st
=450  \\$wnnna$aCentury Histories, 21st
=450  \\$wnnna$aCentury Histories, Twenty-first
=450  \\$wnnna$aCentury History, 21st
=450  \\$wnnna$aCentury History, Twenty-first
=450  \\$wnnna$aHistorical Events, 21st Century
=450  \\$wnnna$aHistories, 21st Cent. (Medicine)
=450  \\$wnnna$aHistories, 21st Century
=450  \\$wnnna$aHistories, Twenty-first Century
=450  \\$wnnna$aHistory, 21st Cent. (Medicine)
=450  \\$wnnna$aHistory of Medicine, 21st Cent.
=450  \\$wnnna$aHistory, Twenty-first Century
=450  \\$wnnna$aHistory, Twenty first Century
=450  \\$wnnna$aMedical History, 21st Cent.
=450  \\$wnnna$aMedicine, 21st Cent.
=450  \\$wnnna$aMedicines, 21st Cent.
=450  \\$wnnna$aTwenty-first Century Histories
=450  \\$wnnna$aTwenty-first Century History
=550  \\$wg$aHistory, Modern 1601-
=550  \\$wh$aAfghan Campaign 2001-
=550  \\$wh$aFukushima Nuclear Accident
=550  \\$wh$aIraq War, 2003-2011
=550  \\$wh$aSeptember 11 Terrorist Attacks
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 2001 through 2100 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 21st Cent.
=750  \0$aHistory, Modern$y21st century$0(DLC) sh 99010892$5IEN-M

=LDR  02209cz  a2200589n  4500
=001  9880364279802441
=005  20141212220205.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049673
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x968
=150  \\$aHistory, 20th Century
=450  \\$wnnna$a20th Cent. Histories (Medicine)
=450  \\$wnnna$a20th Cent. History (Medicine)
=450  \\$wnnna$a20th Cent. History of Medicine
=450  \\$wnnna$a20th Cent. Medicine
=450  \\$wnnna$a20th Century Histories
=450  \\$a20th Century History
=450  \\$wnnna$aCent. Histories, 20th (Medicine)
=450  \\$wnnna$aCent. History, 20th (Medicine)
=450  \\$wnnna$aCentury Histories, 20th
=450  \\$wnnna$aCentury Histories, Twentieth
=450  \\$wnnna$aCentury History, 20th
=450  \\$wnnna$aCentury History, Twentieth
=450  \\$wnnna$aHistorical Events, 20th Century
=450  \\$wnnna$aHistories, 20th Cent. (Medicine)
=450  \\$wnnna$aHistories, 20th Century
=450  \\$wnnna$aHistories, Twentieth Century
=450  \\$wnnna$aHistory, 20th Cent. (Medicine)
=450  \\$wnnna$aHistory of Medicine, 20th Cent.
=450  \\$wnnna$aHistory, Twentieth Century
=450  \\$wnnna$aMedical History, 20th Cent.
=450  \\$wnnna$aMedicine, 20th Cent.
=450  \\$wnnna$aTwentieth Century Histories
=450  \\$wnnna$aTwentieth Century History
=550  \\$wg$aHistory, Modern 1601-
=550  \\$wh$aBhopal Accidental Release
=550  \\$wh$aChernobyl Nuclear Accident
=550  \\$wh$aGulf War
=550  \\$wh$aInfluenza Pandemic, 1918-1919
=550  \\$wh$aKorean War
=550  \\$wh$aRussian-Japanese War
=550  \\$wh$aSeveso Accidental Release
=550  \\$wh$aSverdlovsk Accidental Release
=550  \\$wh$aVietnam Conflict
=550  \\$wh$aWorld War I
=550  \\$wh$aWorld War II
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 1901 through 2000 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 20th Cent.
=750  \0$aHistory, Modern$y20th century$0(DLC) sh 85061241$5IEN-M

=LDR  01899cz  a2200493n  4500
=001  9880364279902441
=005  20141212220205.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x937
=150  \\$aHistory, 19th Century
=450  \\$wnnna$a19th Cent. Histories (Medicine)
=450  \\$wnnna$a19th Cent. History (Medicine)
=450  \\$wnnna$a19th Cent. History of Medicine
=450  \\$wnnna$a19th Cent. Medicine
=450  \\$wnnna$a19th Century Histories
=450  \\$a19th Century History
=450  \\$wnnna$aCent. Histories, 19th (Medicine)
=450  \\$wnnna$aCent. History, 19th (Medicine)
=450  \\$wnnna$aCentury Histories, 19th
=450  \\$wnnna$aCentury Histories, Nineteenth
=450  \\$wnnna$aCentury History, 19th
=450  \\$wnnna$aCentury History, Nineteenth
=450  \\$wnnna$aHistorical Events, 19th Century
=450  \\$wnnna$aHistories, 19th Cent. (Medicine)
=450  \\$wnnna$aHistories, 19th Century
=450  \\$wnnna$aHistories, Nineteenth Century
=450  \\$wnnna$aHistory, 19th Cent. (Medicine)
=450  \\$wnnna$aHistory, Nineteenth Century
=450  \\$wnnna$aHistory of Medicine, 19th Cent.
=450  \\$wnnna$aMedical History, 19th Cent.
=450  \\$wnnna$aMedicine, 19th Cent.
=450  \\$wnnna$aNineteenth Century Histories
=450  \\$wnnna$aNineteenth Century History
=550  \\$wg$aHistory, Modern 1601-
=550  \\$wh$aAmerican Civil War
=550  \\$wh$aCrimean War
=550  \\$wh$aSpanish-American War, 1898
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 1801 through 1900 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 19th Cent.
=750  \0$aHistory, Modern$y19th century$0(DLC) sh 85061240$5IEN-M

=LDR  01739cz  a2200457n  4500
=001  9880364280002441
=005  20141212220204.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049671
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x875
=150  \\$aHistory, 18th Century
=450  \\$wnnna$a18th Cent. History (Medicine)
=450  \\$wnnna$a18th Cent. History of Medicine
=450  \\$wnnna$a18th Cent. Medicine
=450  \\$wnnna$a18th Century Histories
=450  \\$a18th Century History
=450  \\$wnnna$aCent. History, 18th (Medicine)
=450  \\$wnnna$aCent. Medicine, 18th
=450  \\$wnnna$aCentury Histories, 18th
=450  \\$wnnna$aCentury Histories, Eighteenth
=450  \\$wnnna$aCentury History, 18th
=450  \\$wnnna$aCentury History, Eighteenth
=450  \\$wnnna$aEighteenth Century Histories
=450  \\$wnnna$aEighteenth Century History
=450  \\$wnnna$aHistorical Events, 18th Century
=450  \\$wnnna$aHistories, 18th Century
=450  \\$wnnna$aHistories, Eighteenth Century
=450  \\$wnnna$aHistory, 18th Cent. (Medicine)
=450  \\$wnnna$aHistory, Eighteenth Century
=450  \\$wnnna$aHistory of Medicine, 18th Cent.
=450  \\$wnnna$aMedical History, 18th Cent.
=450  \\$wnnna$aMedicine, 18th Cent.
=550  \\$wg$aHistory, Modern 1601-
=550  \\$wh$aAmerican Revolution
=550  \\$wh$aFrench Revolution
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 1701 through 1800 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 18th Cent.
=750  \0$aHistory, Modern$y18th century$0(DLC) sh 85061239$5IEN-M

=LDR  01691cz  a2200433n  4500
=001  9880364280102441
=005  20141212220203.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049670
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x750
=150  \\$aHistory, 17th Century
=450  \\$wnnna$a17th Cent. Histories (Medicine)
=450  \\$wnnna$a17th Cent. History (Medicine)
=450  \\$wnnna$a17th Cent. History of Medicine
=450  \\$wnnna$a17th Cent. Medicine
=450  \\$wnnna$a17th Century Histories
=450  \\$a17th Century History
=450  \\$wnnna$aCent. Histories, 17th (Medicine)
=450  \\$wnnna$aCentury Histories, Seventeenth
=450  \\$wnnna$aCentury History, 17th
=450  \\$wnnna$aCentury History, Seventeenth
=450  \\$wnnna$aHistorical Events, 17th Century
=450  \\$wnnna$aHistories, 17th Cent. (Medicine)
=450  \\$wnnna$aHistories, 17th Century
=450  \\$wnnna$aHistories, Seventeenth Century
=450  \\$wnnna$aHistory, 17th Cent. (Medicine)
=450  \\$wnnna$aHistory of Medicine, 17th Cent.
=450  \\$wnnna$aHistory, Seventeenth Century
=450  \\$wnnna$aMedical History, 17th Cent.
=450  \\$wnnna$aMedicine, 17th Cent.
=450  \\$wnnna$aSeventeenth Century Histories
=450  \\$wnnna$aSeventeenth Century History
=550  \\$wg$aHistory, Modern 1601-
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 1601 through 1700 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 17th Cent.
=750  \0$aHistory, Modern$y17th century$0(DLC) sh 85061238$5IEN-M

=LDR  01788cz  a2200457n  4500
=001  9880364280202441
=005  20141212220203.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049669
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x475.$x750
=150  \\$aHistory, 16th Century
=450  \\$wnnna$a16th Cent. Histories (Medicine)
=450  \\$wnnna$a16th Cent. History (Medicine)
=450  \\$wnnna$a16th Cent. History of Medicine
=450  \\$wnnna$a16th Cent. Medicine
=450  \\$wnnna$a16th Century Histories
=450  \\$a16th Century History
=450  \\$wnnna$aCent. Histories, 16th (Medicine)
=450  \\$wnnna$aCent. History, 16th (Medicine)
=450  \\$wnnna$aCentury Histories, 16th
=450  \\$wnnna$aCentury Histories, Sixteenth
=450  \\$wnnna$aCentury History, 16th
=450  \\$wnnna$aCentury History, Sixteenth
=450  \\$wnnna$aHistorical Events, 16th Century
=450  \\$wnnna$aHistories, 16th Cent. (Medicine)
=450  \\$wnnna$aHistories, 16th Century
=450  \\$wnnna$aHistories, Sixteenth Century
=450  \\$wnnna$aHistory, 16th Cent. (Medicine)
=450  \\$wnnna$aHistory of Medicine, 16th Cent.
=450  \\$wnnna$aHistory, Sixteenth Century
=450  \\$wnnna$aMedical History, 16th Cent.
=450  \\$wnnna$aMedicine, 16th Cent.
=450  \\$wnnna$aSixteenth Century Histories
=450  \\$wnnna$aSixteenth Century History
=550  \\$wg$aHistory, Early Modern 1451-1600
=667  \\$aIM general only; NIM as check tag
=680  \\$iTime period from 1501 through 1600 of the common era.
=688  \\$a2005
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a History of Medicine, 16th Cent.
=750  \0$aHistory, Modern$y16th century$0(DLC) sh 85061237$5IEN-M

=LDR  01050cz  a2200253n  4500
=001  9880364280302441
=005  20141212220201.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049631
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x800.$x360
=072  \\$aA3.$x556.$x875.$x500.$x360
=072  \\$aA4.$x623.$x617.$x360
=072  \\$aA14.$x724.$x617.$x360
=150  \\$aEsophageal Sphincter, Upper
=450  \\$wnnna$aSphincter, Upper Esophageal
=450  \\$aUpper Esophageal Sphincter
=550  \\$wg$aEsophagus
=550  \\$wg$aPharyngeal Muscles
=550  \\$aLaryngopharyngeal Reflux
=667  \\$adiseases: coordinate IM with ESOPHAGEAL DISEASES (IM) or specific esophageal disease (IM); neoplasms: coordinate IM with ESOPHAGEAL NEOPLASMS (IM)
=680  \\$iThe structure at the pharyngoesophageal junction consisting chiefly of the CRICOPHARYNGEUS MUSCLE. It normally occludes the lumen of the ESOPHAGUS, except during SWALLOWING.
=688  \\$a2005
=750  \0$aPharyngoesophageal sphincter$0(DLC) sh 85100627$5IEN-M

=LDR  00906cz  a2200301n  4500
=001  9880364280402441
=005  20141212220200.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049628
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160
=072  \\$aE5.$x41.$x124.$x160
=072  \\$aG7.$x100.$x100.$x160
=072  \\$aG7.$x700.$x320.$x249.$x314
=150  \\$aBody Size
=450  \\$wnnna$aBody Sizes
=450  \\$wnnna$aSize, Body
=450  \\$wnnna$aSizes, Body
=550  \\$wg$aBody Weights and Measures
=550  \\$wg$aGrowth
=550  \\$wh$aBody Height
=550  \\$wh$aBody Weight
=550  \\$wh$aSagittal Abdominal Diameter
=550  \\$wh$aWaist Circumference
=550  \\$wh$aWaist-Height Ratio
=680  \\$iThe physical measurements of a body.
=688  \\$a2005; use BODY CONSTITUTION 1984-2004
=750  \0$aBody size$0(DLC) sh 85015252$5IEN-M

=LDR  01003cz  a2200241n  4500
=001  9880364280502441
=005  20141212220200.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049590
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x702
=150  \\$aPostpartum Period
=450  \\$wnnna$aPeriod, Postpartum
=450  \\$wnnna$aPostpartum
=450  \\$wnnna$aPostpartum Women
=450  \\$aPuerperium
=450  \\$wnnna$aWomen, Postpartum
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wh$aLactation
=667  \\$ahuman & animal; qualif permitted as for PREGNANCY; check the tag FEMALE: Manual 18.4.3; puerperal psychoses = PUERPERAL DISORDERS (IM) + PSYCHOTIC DISORDERS (IM); "postpartum amenorrhea" is indexed under PUERPERIUM (IM) + AMENORRHEA (IM) & not LACTATION unless lactation is particularly discussed
=680  \\$iIn females, the period that is shortly after giving birth (PARTURITION).
=688  \\$a2005
=750  \0$aPuerperium$0(DLC) sh 85108919$5IEN

=LDR  00732cz  a2200181n  4500
=001  9880364280602441
=005  20141212220159.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049490
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x800
=150  \\$aSystems Biology
=450  \\$wnnna$aBiology, Systems
=550  \\$wg$aComputational Biology
=550  \\$aSystems Theory
=680  \\$iComprehensive, methodical analysis of complex biological systems by monitoring responses to perturbations of biological processes. Large scale, computerized collection and analysis of the data are used to develop and test models of biological systems.
=688  \\$a2005
=750  \0$aSystems biology$0(DLC)sh2008002926$5IEN-M

=LDR  00471cz  a2200157n  4500
=001  9880364280702441
=005  20141212220159.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049489
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x755
=150  \\$aStroboscopy
=550  \\$wg$aDiagnostic Imaging
=680  \\$iThe observation of successive phases of MOVEMENT by use of a flashing light.
=688  \\$a2005
=750  \0$aStroboscopes$0(DLC) sh 85129158$5IEN-M

=LDR  00917cz  a2200205n  4500
=001  9880364280802441
=005  20141212220156.0
=008  040708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049452
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x532.$x265
=150  \\$aGreen Fluorescent Proteins
=450  \\$wnnna$aFluorescent Proteins, Green
=450  \\$wnnna$aGreen-Fluorescent Proteins
=450  \\$wnnna$aProteins, Green Fluorescent
=450  \\$wnnna$aProteins, Green-Fluorescent
=550  \\$wg$aLuminescent Proteins
=680  \\$iProtein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH.
=688  \\$a2005(1992)
=750  \0$aGreen fluorescent protein$0(DLC) sh 97006933$5IEN-M

=LDR  01468cz  a2200373n  4500
=001  9880364280902441
=005  20141212220156.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049451
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x789.$x650
=072  \\$aE5.$x318.$x740.$x500.$x625
=072  \\$aE5.$x599.$x835.$x895
=072  \\$aG17.$x582
=072  \\$aN5.$x715.$x360.$x750.$x530.$x530
=072  \\$aN6.$x850.$x520.$x830.$x500.$x625
=150  \\$aNomograms
=450  \\$wnnna$aNomogram
=450  \\$wnnna$aNomogram, Partin
=450  \\$wnnna$aNomograms, Partin
=450  \\$wnnna$aPartin Nomogram
=450  \\$wnnna$aPartin Nomograms
=450  \\$wnnna$aPartin Table
=450  \\$wnnna$aPartin Tables
=450  \\$wnnna$aTable, Partin
=450  \\$wnnna$aTables, Partin
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aModels, Statistical
=550  \\$wg$aPrognosis
=550  \\$aNeoplasm Grading
=550  \\$aNeoplasm Staging
=680  \\$iGraphical representation of a statistical model containing scales for calculating the prognostic weight of a value for each individual variable. Nomograms are instruments that can be used to predict outcomes using specific clinical parameters. They use ALGORITHMS that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical endpoint.
=688  \\$a2005
=750  \0$aNomography (Mathematics)$0(DLC) sh 85092214$5IEN-M

=LDR  01157cz  a2200289n  4500
=001  9880364281002441
=005  20141212220155.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049449
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650.$x665
=072  \\$aG1.$x590.$x540.$x665
=072  \\$aG1.$x750.$x250.$x650.$x665
=072  \\$aG1.$x750.$x770.$x578.$x665
=150  \\$aLuminescence
=450  \\$wnnna$aChemiluminescence
=450  \\$wnnna$aChemiluminescence, Physical
=450  \\$aLuminescence, Physical
=450  \\$wnnna$aPhysical Chemiluminescence
=450  \\$wnnna$aPhysical Luminescence
=550  \\$wg$aLight
=550  \\$wh$aFluorescence
=680  \\$iEmission of LIGHT when ELECTRONS return to the electronic ground state from an excited state and lose the energy as PHOTONS. It is sometimes called cool light in contrast to INCANDESCENCE. LUMINESCENT MEASUREMENTS take advantage of this type of light emitted from LUMINESCENT AGENTS.
=688  \\$a2006
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Luminescence, Physical
=688  \\$a2005
=750  \0$aLuminescence$0(DLC) sh 85078838$5IEN-M

=LDR  00679cz  a2200217n  4500
=001  9880364281102441
=005  20141212220155.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x330.$x300
=072  \\$aH2.$x403.$x650.$x249
=072  \\$aI1.$x198.$x780.$x937.$x460
=150  \\$aForensic Pathology
=450  \\$aPathology, Forensic
=550  \\$wg$aForensic Medicine
=550  \\$wg$aPathology
=667  \\$aspecialty; may also be used for forensic aspects in pathology
=680  \\$iThe application of pathology to questions of law.
=688  \\$a2005
=750  \0$aForensic pathology$0(DLC) sh 85050556$5IEN-M

=LDR  00679cz  a2200205n  4500
=001  9880364281202441
=005  20141212220154.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x517.$x875
=072  \\$aD12.$x776.$x532.$x510.$x750
=150  \\$aLuciferases, Renilla
=450  \\$wnnna$aLuciferases, Sea Pansy
=450  \\$wnnna$aRenilla Luciferases
=450  \\$wnnna$aSea Pansy Luciferases
=550  \\$wg$aLuciferases
=680  \\$iLuciferases from RENILLA that oxidizes certain LUMINESCENT AGENTS to cause emission of PHOTONS.
=688  \\$a2005
=750  \0$aRenilla luciferase$0(DLC)sh2007005939$5IEN-M

=LDR  03024cz  a2200805n  4500
=001  9880364281302441
=005  20190429160036.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049349
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x420.$x500
=150  \\$aReceptors, Lysosphingolipid
=450  \\$wnnna$a1-Phosphate Receptor, Sphingosine
=450  \\$wnnna$aAGR16 Protein
=450  \\$wnnna$aedg-1 Protein
=450  \\$wnnna$aedg 1 Protein
=450  \\$wnnna$aedg-1 Receptor
=450  \\$wnnna$aedg 1 Receptor
=450  \\$wnnna$aedg-3 Protein
=450  \\$wnnna$aedg 3 Protein
=450  \\$wnnna$aEdg-5 Receptor
=450  \\$wnnna$aEdg 5 Receptor
=450  \\$wnnna$aedg-6 Receptor
=450  \\$wnnna$aedg 6 Receptor
=450  \\$wnnna$aedg-8 Protein
=450  \\$wnnna$aedg 8 Protein
=450  \\$wnnna$aEdg Receptors
=450  \\$wnnna$aEDG5 Protein
=450  \\$wnnna$aG-Protein Coupled Receptor H218
=450  \\$wnnna$aG Protein Coupled Receptor H218
=450  \\$wnnna$aH218 Protein
=450  \\$wnnna$aLysosphingolipid Receptor
=450  \\$aLysosphingolipid Receptors
=450  \\$wnnna$aNrg-1 Receptor
=450  \\$wnnna$aNrg 1 Receptor
=450  \\$wnnna$aPhosphorylcholine Receptors, Sphingosine
=450  \\$wnnna$aProtein, edg-3
=450  \\$wnnna$aProtein, edg-8
=450  \\$wnnna$aReceptor, edg-1
=450  \\$wnnna$aReceptor, Edg-5
=450  \\$wnnna$aReceptor, edg-6
=450  \\$wnnna$aReceptor, Lysosphingolipid
=450  \\$wnnna$aReceptor, Nrg-1
=450  \\$wnnna$aReceptor, S1P2
=450  \\$wnnna$aReceptor, S1P3
=450  \\$wnnna$aReceptor, S1P4
=450  \\$wnnna$aReceptor, S1P5
=450  \\$wnnna$aReceptor, Sphingosine-1-Phosphate
=450  \\$wnnna$aReceptor, Sphingosine 1 Phosphate
=450  \\$wnnna$aReceptors, Edg
=450  \\$wnnna$aReceptors, Sphingosine-1-Phosphate
=450  \\$wnnna$aReceptors, Sphingosine Phosphorylcholine
=450  \\$wnnna$aS1P Receptor
=450  \\$wnnna$aS1P1 Receptor
=450  \\$wnnna$aS1P2 Receptor
=450  \\$wnnna$aS1P3 Receptor
=450  \\$wnnna$aS1P4 Receptor
=450  \\$wnnna$aS1P5 Receptor
=450  \\$wnnna$aSphingosine 1-Phosphate Receptor
=450  \\$wnnna$aSphingosine-1-Phosphate Receptor
=450  \\$wnnna$aSphingosine 1 Phosphate Receptor
=450  \\$wnnna$aSphingosine-1-Phosphate Receptors
=450  \\$wnnna$aSphingosine 1 Phosphate Receptors
=450  \\$wnnna$aSphingosine Phosphorylcholine Receptors
=550  \\$wg$aReceptors, Lysophospholipid
=680  \\$iA subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine.
=688  \\$a2005(1996)
=750  \0$81$wb$iBroader mapping$aSphingolipids$0(DLC)sh 85126606$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSphingolipids--Receptors$5IEN-M

=LDR  01111cz  a2200337n  4500
=001  9880364281402441
=005  20141212220152.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049329
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512
=150  \\$aNanostructures
=450  \\$wnnna$aMaterial, Nanostructured
=450  \\$wnnna$aMaterials, Nanostructured
=450  \\$wnnna$aNanomaterial
=450  \\$aNanomaterials
=450  \\$wnnna$aNanostructure
=450  \\$wnnna$aNanostructured Material
=450  \\$aNanostructured Materials
=550  \\$wg$aManufactured Materials
=550  \\$wh$aNanocomposites
=550  \\$wh$aNanofibers
=550  \\$wh$aNanoparticles
=550  \\$wh$aNanopores
=550  \\$wh$aNanotubes
=550  \\$wh$aNanowires
=550  \\$aMolecular Imprinting
=550  \\$aNanotechnology
=680  \\$iMaterials which have structured components with at least one dimension in the range of 1 to 100 nanometers. These include NANOCOMPOSITES; NANOPARTICLES; NANOTUBES; and NANOWIRES.
=688  \\$a2005
=750  \0$aNanostructures$0(DLC) sh 91006390$5IEN-M

=LDR  00891cz  a2200217n  4500
=001  9880364281502441
=005  20141212220151.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x665.$x560.$x615.$x530
=150  \\$aMongolian Spot
=450  \\$wnnna$aBlue Spot, Mongolian
=450  \\$wnnna$aMongolian Blue Spot
=450  \\$wnnna$aSpot, Mongolian
=550  \\$wg$aNevus, Pigmented
=550  \\$aNevus, Blue
=667  \\$acoordinate IM with SKIN NEOPLASMS (IM) + site (IM or NIM) if relevant
=680  \\$iA bluish-gray to gray-brown benign, melanocytic nevus found usually in the LUMBOSACRAL REGION of dark-skinned people, especially those of East Asian ancestry. It is usually congenital or appears shortly after birth, and disappears in childhood.
=688  \\$a2005
=750  \0$aMongolian spot$0(DLC) sh 85086821$5IEN-M

=LDR  01055cz  a2200217n  4500
=001  9880364281602441
=005  20190429155142.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049312
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x420
=150  \\$aReceptors, Lysophospholipid
=450  \\$aLysophospholipid Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, Lysophosphatidic Acid
=550  \\$wh$aReceptors, Lysosphingolipid
=680  \\$iA family of G-protein-coupled receptors that bind to specific LYSOPHOSPHOLIPIDS such as lysophosphatidic acid and lysosphinglipids such as sphingosine-1-phosphate. They play an important role in the formation and function of the CARDIOVASCULAR SYSTEM.
=688  \\$a2005(1996)
=750  \0$81$wb$iBroader mapping$aLysophospholipids$0(DLC)sh 85126606$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLysophospholipids--Receptors$5IEN-M

=LDR  00785cz  a2200205n  4500
=001  9880364281702441
=005  20141212220146.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049269
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x900
=150  \\$aVideoconferencing
=450  \\$wnnna$aVideoconference
=450  \\$wnnna$aVideoconferences
=450  \\$wnnna$aVideoconferencings
=550  \\$wg$aTelecommunications
=550  \\$wh$aWebcasts as Topic
=680  \\$iCommunications via an interactive conference between two or more participants at different sites, using computer networks (COMPUTER COMMUNICATION NETWORKS) or other telecommunication links to transmit audio, video, and data.
=688  \\$a2005
=750  \0$aVideoconferencing$0(DLC) sh 88004839$5IEN-M

=LDR  00844cz  a2200241n  4500
=001  9880364281802441
=005  20141212220145.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x889
=150  \\$aSpeech Recognition Software
=450  \\$wnnna$aRecognition Software, Speech
=450  \\$wnnna$aRecognition Software, Voice
=450  \\$wnnna$aSoftware, Speech Recognition
=450  \\$wnnna$aSoftware, Voice Recognition
=450  \\$aVoice Recognition Software
=550  \\$wg$aSoftware
=550  \\$aCommunication Aids for Disabled
=550  \\$aUser-Computer Interface
=680  \\$iSoftware capable of recognizing dictation and transcribing the spoken words into written text.
=688  \\$a2005
=750  \0$aAutomatic speech recognition$0(DLC) sh 85010109$5IEN-M

=LDR  00482cz  a2200169n  4500
=001  9880364281902441
=005  20141212220145.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049249
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x780.$x937.$x422
=150  \\$aExhumation
=450  \\$wnnna$aExhumations
=550  \\$wg$aForensic Medicine
=680  \\$iRemoval of a dead body from the earth after burial.
=688  \\$a2005
=750  \0$aExhumation$0(DLC) sh 85046361$5IEN-M

=LDR  00519cz  a2200169n  4500
=001  9880364282002441
=005  20141212220145.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049248
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x986.$x224
=150  \\$aDecapitation
=450  \\$wnnna$aDecapitations
=550  \\$wg$aWounds, Penetrating
=680  \\$iTraumatic or experimentally induced separation of the head from the body in an animal or human.
=688  \\$a2005
=750  \0$aBeheading$5IEN-M$0(DLC)sh 89006220

=LDR  00847cz  a2200229n  4500
=001  9880364282102441
=005  20141212220143.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x824
=150  \\$aPrenatal Injuries
=450  \\$aEmbryo, Mammalian$xinjuries
=450  \\$aFetus$xinjuries
=450  \\$wnnna$aInjuries, Prenatal
=450  \\$wnnna$aInjury, Prenatal
=450  \\$wnnna$aPrenatal Injury
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aPrenatal Exposure Delayed Effects
=680  \\$iDamages to the EMBRYO, MAMMALIAN or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.
=688  \\$a2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004
=750  \0$aFetus$xWounds and injuries$0(IEN)7309126$5IEN-M

=LDR  00976cz  a2200301n  4500
=001  9880364282202441
=005  20141212220142.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x233.$x750
=072  \\$aG7.$x700.$x320.$x249.$x410.$x750
=150  \\$aCell Proliferation
=450  \\$aCell Growth in Number
=450  \\$wnnna$aCell Multiplication
=450  \\$wnnna$aCell Number Growth
=450  \\$aCellular Proliferation
=450  \\$wnnna$aGrowth, Cell Number
=450  \\$wnnna$aMultiplication, Cell
=450  \\$wnnna$aNumber Growth, Cell
=450  \\$wnnna$aProliferation, Cell
=450  \\$wnnna$aProliferation, Cellular
=550  \\$wg$aCell Growth Processes
=550  \\$wh$aCell Division
=550  \\$aHyperplasia
=680  \\$iAll of the processes involved in increasing CELL NUMBER including CELL DIVISION.
=688  \\$a2005
=750  \0$aCell proliferation$0(DLC) sh 85021664$5IEN-M

=LDR  00809cz  a2200217n  4500
=001  9880364282302441
=005  20141212220137.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048968
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x407
=072  \\$aC23.$x888.$x821.$x937.$x49
=150  \\$aMorning Sickness
=450  \\$wnnna$aSickness, Morning
=550  \\$wg$aPregnancy Complications
=550  \\$wg$aVomiting
=550  \\$wh$aHyperemesis Gravidarum
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iSymptoms of NAUSEA and VOMITING in pregnant women that usually occur in the morning during the first 2 to 3 months of PREGNANCY. Severe persistent vomiting during pregnancy is called HYPEREMESIS GRAVIDARUM.
=688  \\$a2005
=750  \0$aMorning sickness$0(DLC) sh 92006613$5IEN-M

=LDR  01603cz  a2200373n  4500
=001  9880364282402441
=005  20141212220135.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x246.$x99
=150  \\$aDiabetes Complications
=450  \\$wnnna$aComplications of Diabetes Mellitus
=450  \\$wnnna$aDiabetes Complication
=450  \\$wnnna$aDiabetes Mellitus Complication
=450  \\$wnnna$aDiabetes Mellitus Complications
=450  \\$aDiabetes Mellitus$xcomplications
=450  \\$wnnna$aDiabetes-Related Complication
=450  \\$wnnna$aDiabetes-Related Complications
=450  \\$wnnna$aDiabetes Related Complications
=450  \\$wnnna$aDiabetic Complication
=450  \\$wnnna$aDiabetic Complications
=550  \\$wg$aDiabetes Mellitus
=550  \\$wh$aDiabetic Angiopathies
=550  \\$wh$aDiabetic Cardiomyopathies
=550  \\$wh$aDiabetic Coma
=550  \\$wh$aDiabetic Ketoacidosis
=550  \\$wh$aDiabetic Nephropathies
=550  \\$wh$aDiabetic Neuropathies
=550  \\$wh$aFetal Macrosomia
=667  \\$ageneral only; prefer /compl with specific type of diabetes + specific complication: Manual 23.25.3.1
=680  \\$iConditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
=688  \\$a2005
=750  \0$aDiabetes$xComplications$0(DLC) sh 85037457$5IEN-M

=LDR  00763cz  a2200205n  4500
=001  9880364282502441
=005  20141212220134.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x50.$x860
=072  \\$aB3.$x660.$x250.$x830.$x50.$x860
=150  \\$aAliivibrio fischeri
=450  \\$aVibrio fischeri
=550  \\$wg$aAliivibrio
=680  \\$iA species of gram-negative bacteria in the genus ALIIVIBRIO, which exhibits LUMINESCENCE. A. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.
=688  \\$a2012 (2005)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Vibrio fischeri
=688  \\$a2005
=750  \0$aVibrio fischeri$0(DLC) sh 88023359$5IEN-M

=LDR  00604cz  a2200181n  4500
=001  9880364282602441
=005  20141212220134.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048889
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x69.$x900
=150  \\$aWeevils
=450  \\$aCurculionidae
=450  \\$wnnna$aWeevil
=550  \\$wg$aBeetles
=680  \\$iBEETLES in the family Curculionidae and the largest family in the order COLEOPTERA. They have a markedly convex shape and many are considered pests.
=688  \\$a2005
=750  \0$aCurculionidae$0(DLC) sh 85034847$5IEN-M

=LDR  00726cz  a2200217n  4500
=001  9880364282702441
=005  20141212220134.0
=008  040715\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048888
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x69.$x307
=150  \\$aFireflies
=450  \\$wnnna$aFirefly
=450  \\$aLampyridae
=450  \\$wnnna$aLuciola
=450  \\$wnnna$aLuciolas
=450  \\$wnnna$aPhotinus
=550  \\$wg$aBeetles
=680  \\$iThe family Lampyidae, which are bioluminescent BEETLES. They contain FIREFLY LUCIFERIN and LUCIFERASES. Oxidation of firefly luciferin results in luminescence.
=688  \\$a2005; use BEETLES 1993-2004
=750  \0$aFireflies$0(DLC) sh 85048559$5IEN-M

=LDR  00496cz  a2200169n  4500
=001  9880364282802441
=005  20141212220008.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046890
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x110
=072  \\$aB3.$x440.$x475.$x100.$x110
=150  \\$aAphanizomenon
=550  \\$wg$aCyanobacteria
=680  \\$iA form-genus of planktonic CYANOBACTERIA in the order Nostocales.
=688  \\$a2005
=750  \0$aAphanizomenon$0(DLC) sh2002010426$5IEN-M

=LDR  00506cz  a2200169n  4500
=001  9880364282902441
=005  20141212220007.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046870
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x100.$x900
=072  \\$aB3.$x440.$x475.$x100.$x100.$x900
=150  \\$aAnabaena variabilis
=550  \\$wg$aAnabaena
=680  \\$iA species of ANABAENA that can form SPORES called akinetes.
=688  \\$a2005
=750  \0$aAnabaena variabilis$0(DLC) sh 90004564$5IEN

=LDR  00787cz  a2200193n  4500
=001  9880364283002441
=005  20141212220004.0
=008  040719\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046789
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x182.$x100
=072  \\$aC17.$x300.$x182.$x100
=150  \\$aChondromalacia Patellae
=450  \\$wnnna$aPatella, Chondromalacia Of
=550  \\$wg$aCartilage Diseases
=550  \\$aPatellofemoral Pain Syndrome
=680  \\$iA degeneration of the ARTICULAR CARTILAGE of the PATELLA, caused by a decrease in sulfated MUCOPOLYSACCHARIDES in the ground substance. When accompanied by pain, it is sometimes considered part of or confused with PATELLOFEMORAL PAIN SYNDROME.
=688  \\$a2005
=750  \0$aChondromalacia patellae$0(DLC) sh 85024682$5IEN-M

=LDR  00680cz  a2200229n  4500
=001  9880364283102441
=005  20141212220003.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046749
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x712
=150  \\$aStarlings
=450  \\$wnnna$aMynah
=450  \\$aMynahs
=450  \\$wnnna$aOxpecker
=450  \\$wnnna$aOxpeckers
=450  \\$wnnna$aStarling
=450  \\$aSturnidae
=550  \\$wg$aSongbirds
=680  \\$iThe family Sturnidae, in the order PASSERIFORMES. The starling family also includes mynahs and oxpeckers.
=688  \\$a2005
=750  \0$aStarlings$0(DLC) sh 85127410$5IEN-M

=LDR  00575cz  a2200181n  4500
=001  9880364283202441
=005  20141212220001.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046710
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x710.$x672.$x40
=150  \\$aAgapornis
=450  \\$wnnna$aLovebird
=450  \\$aLovebirds
=550  \\$wg$aParrots
=680  \\$iA genus comprised of nine species of small PARROTS from Africa. They are noted for showing affection for their mates.
=688  \\$a2005
=750  \0$aLovebirds$0(DLC) sh 85078613$5IEN-M

=LDR  00677cz  a2200205n  4500
=001  9880364283302441
=005  20141212220001.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046708
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x710.$x672.$x50
=150  \\$aAmazona
=450  \\$wnnna$aAmazon Parrot
=450  \\$aAmazon Parrots
=450  \\$wnnna$aParrot, Amazon
=450  \\$wnnna$aParrots, Amazon
=550  \\$wg$aParrots
=680  \\$iOne of the largest genera of PARROTS, ranging from South American to Northern Mexico. Many species are commonly kept as house pets.
=688  \\$a2005
=750  \0$aAmazon parrots$0(DLC) sh 85004134$5IEN-M

=LDR  01183cz  a2200277n  4500
=001  9880364283402441
=005  20141212220000.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046690
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x342.$x250
=072  \\$aE4.$x190
=150  \\$aDeep Brain Stimulation
=450  \\$aBrain Stimulation, Deep
=450  \\$wnnna$aBrain Stimulations, Deep
=450  \\$wnnna$aDeep Brain Stimulations
=450  \\$wnnna$aElectrical Stimulation of the Brain
=450  \\$wnnna$aStimulation, Deep Brain
=450  \\$wnnna$aStimulations, Deep Brain
=550  \\$wg$aElectric Stimulation Therapy
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aElectric Stimulation
=667  \\$acoord with disease /ther
=680  \\$iTherapy for MOVEMENT DISORDERS, especially PARKINSON DISEASE, that applies electricity via stereotactic implantation of ELECTRODES in specific areas of the BRAIN such as the THALAMUS. The electrodes are attached to a neurostimulator placed subcutaneously.
=688  \\$a2005; for ELECTRICAL STIMULATION OF THE BRAIN use ELECTRIC STIMULATION 1997-2003
=750  \0$aBrain stimulation$0(DLC) sh 85016370$5IEN-M

=LDR  00930cz  a2200253n  4500
=001  9880364283502441
=005  20141212220000.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046688
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x287
=072  \\$aL1.$x280.$x975.$x550.$x287
=072  \\$aN1.$x224.$x935.$x698.$x150
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x287
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x287
=150  \\$aChild Mortality
=450  \\$wnnna$aChild Mortalities
=450  \\$wnnna$aMortalities, Child
=450  \\$wnnna$aMortality, Child
=550  \\$wg$aMortality
=667  \\$aa statistical concept; check the tag CHILD, PRESCHOOL or CHILD
=680  \\$iNumber of deaths of children between one year of age to 12 years of age in a given population.
=688  \\$a2005; use INFANT MORTALITY 1980-2004
=750  \0$aChildren$xMortality$0(DLC) sh 85023461$5IEN-M

=LDR  00887cz  a2200265n  4500
=001  9880364283602441
=005  20141212215958.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046609
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x346.$x596.$x413
=072  \\$aL1.$x700.$x508.$x300.$x742.$x470
=150  \\$aLibraries, Digital
=450  \\$wnnna$aDigital Libraries
=450  \\$wnnna$aDigital Library
=450  \\$wnnna$aLibraries, Virtual
=450  \\$wnnna$aLibrary, Digital
=450  \\$wnnna$aLibrary, Virtual
=450  \\$wnnna$aVirtual Libraries
=450  \\$wnnna$aVirtual Library
=550  \\$wg$aLibraries
=550  \\$wg$aOnline Systems
=680  \\$iLibraries in which a major proportion of the resources are available in machine-readable format, rather than on paper or MICROFORM.
=688  \\$a2005
=750  \0$aDigital libraries$0(DLC) sh 95008857$5IEN-M

=LDR  01311cz  a2200217n  4500
=001  9880364283702441
=005  20141212215957.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046590
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x838
=150  \\$aSpectroscopy, Electron Energy-Loss
=450  \\$aElectron Energy-Loss Spectroscopy
=450  \\$wnnna$aElectron Energy Loss Spectroscopy
=450  \\$wnnna$aEnergy-Loss Spectroscopy, Electron
=450  \\$wnnna$aSpectroscopy, Electron Energy Loss
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aMicroscopy, Energy-Filtering Transmission Electron
=680  \\$iA technique for analysis of the chemical composition of molecules. A substance is bombarded with monochromatic ELECTRONS. Some of the electrons passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The energy loss is element dependent. Analysis of the energy loss spectrum reveals the elemental composition of a specimen. ENERGY-FILTERED TRANSMISSION ELECTRON MICROSCOPY is a type of electron energy loss spectroscopy carried out in electron microscopes specially outfitted to analyze the spectrum of electron energy loss.
=688  \\$a2005
=750  \0$aElectron energy loss spectroscopy$0(DLC) sh 85042209$5IEN-M

=LDR  01267cz  a2200289n  4500
=001  9880364283802441
=005  20141212215955.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046529
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402.$x580
=072  \\$aE5.$x595.$x402.$x580
=150  \\$aMicroscopy, Electron, Transmission
=450  \\$wnnna$aDiffraction Microscopy, Electron
=450  \\$aElectron Diffraction Microscopy
=450  \\$aElectron Microscopy, Transmission
=450  \\$aMicroscopy, Electron Diffraction
=450  \\$wnnna$aMicroscopy, Transmission Electron
=450  \\$aTransmission Electron Microscopy
=550  \\$wg$aMicroscopy, Electron
=550  \\$wh$aElectron Microscope Tomography
=550  \\$wh$aMicroscopy, Electron, Scanning Transmission
=550  \\$wh$aMicroscopy, Energy-Filtering Transmission Electron
=667  \\$anote specifics
=680  \\$iElectron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen.
=688  \\$a2005; use MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY use MICROSCOPY, ELECTRON 2003-2004
=750  \0$aTransmission electron microscopy$0(DLC) sh 93001918$5IEN-M

=LDR  00884cz  a2200217n  4500
=001  9880364283902441
=005  20141212193055.0
=008  040715\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046509
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500.$x617
=150  \\$aTissue Culture Techniques
=450  \\$wnnna$aCulture Technique, Tissue
=450  \\$wnnna$aCulture Techniques, Tissue
=450  \\$wnno$aTissue Culture$5IEN-M
=450  \\$wnnoa$aTissue Culture$xmethods$5IEN-M
=450  \\$wnnna$aTissue Culture Technique
=550  \\$wg$aCulture Techniques
=680  \\$iA technique for maintaining or growing TISSUE in vitro, usually by DIFFUSION, perifusion, or PERFUSION. The tissue is cultured directly after removal from the host without being dispersed for cell culture.
=688  \\$a2005; use TISSUE CULTURE 1966-2004
=750  \0$aTissue culture$0(DLC) sh 85135588$5IEN

=LDR  01356cz  a2200313n  4500
=001  9880364284002441
=005  20141212193055.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046508
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500
=150  \\$aCulture Techniques
=450  \\$wnnna$aCulture Technique
=450  \\$wnnna$aTechnique, Culture
=450  \\$wnnna$aTechniques, Culture
=550  \\$wg$aIn Vitro Techniques
=550  \\$wh$aAxenic Culture
=550  \\$wh$aCell Culture Techniques
=550  \\$wh$aCell Engineering
=550  \\$wh$aCoculture Techniques
=550  \\$wh$aEmbryo Culture Techniques
=550  \\$wh$aOrgan Culture Techniques
=550  \\$wh$aPlant Somatic Embryogenesis Techniques
=550  \\$wh$aTissue Culture Techniques
=550  \\$aDiffusion Chambers, Culture
=667  \\$ageneral or unspecified; prefer specifics; NIM; Manual 18.7.2-.3, 22.26.1, 26.23+
=680  \\$iMethods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types.
=688  \\$a2005
=750  \0$aCultures (Biology)$0(DLC) sh 85034765$5IEN-M

=LDR  01599cz  a2200541n  4500
=001  9880364284102441
=005  20141212215954.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046448
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x400
=072  \\$aG16.$x500.$x275.$x410.$x500
=072  \\$aN6.$x230.$x291.$x500
=150  \\$aIce Cover
=450  \\$wnnna$aCover, Ice
=450  \\$wnnna$aCover, Sea Ice
=450  \\$wnnna$aCovers, Ice
=450  \\$wnnna$aCovers, Sea Ice
=450  \\$wnnna$aGlacier
=450  \\$wnnna$aGlacier, Marine
=450  \\$wnnna$aGlaciers
=450  \\$wnnna$aGlaciers, Marine
=450  \\$wnnna$aIce Cover, Sea
=450  \\$wnnna$aIce Covers
=450  \\$wnnna$aIce Covers, Sea
=450  \\$wnnna$aIce, Sea
=450  \\$wnnna$aIce Sheet
=450  \\$wnnna$aIce Sheets
=450  \\$wnnna$aIce Shelf, Polar
=450  \\$wnnna$aIce Shelfs, Polar
=450  \\$wnnna$aIceberg
=450  \\$wnnna$aIcebergs
=450  \\$wnnna$aMarine Glacier
=450  \\$wnnna$aMarine Glaciers
=450  \\$wnnna$aPolar Ice Shelf
=450  \\$wnnna$aPolar Ice Shelfs
=450  \\$wnnna$aSea Ice
=450  \\$aSea Ice Cover
=450  \\$wnnna$aSea Ice Covers
=450  \\$wnnna$aSheet, Ice
=450  \\$wnnna$aSheets, Ice
=450  \\$wnnna$aShelf, Polar Ice
=450  \\$wnnna$aShelfs, Polar Ice
=550  \\$wg$aGeological Phenomena
=550  \\$wg$aIce
=680  \\$iA thick mass of ICE formed over large regions of land; RIVERS; LAKES; ponds; or SEAWATER.
=688  \\$a2005
=750  \0$aIce sheets$0(DLC) sh 85064007$5IEN-M

=LDR  00662cz  a2200193n  4500
=001  9880364284202441
=005  20141212215953.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x860
=150  \\$aSpheniscidae
=450  \\$wnnna$aPenguin
=450  \\$aPenguins
=450  \\$aSphenisciformes
=550  \\$wg$aBirds
=680  \\$iThe sole family in the order Sphenisciformes, comprised of 17 species of penguins in six genera. They are flightless seabirds of the Southern Hemisphere, highly adapted for marine life.
=688  \\$a2005
=750  \0$aPenguins$0(DLC) sh 85099397$5IEN-M

=LDR  00665cz  a2200181n  4500
=001  9880364284302441
=005  20141212215953.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046428
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x250.$x400
=072  \\$aB1.$x50.$x150.$x900.$x248.$x815.$x350.$x400
=150  \\$aHawks
=450  \\$wnnna$aHawk
=550  \\$wg$aFalconiformes
=680  \\$iCommon name for many members of the FALCONIFORMES order, family Accipitridae, generally smaller than EAGLES, and containing short, rounded wings and a long tail.
=688  \\$a2005; use RAPTORS 1999-2004
=750  \0$aHawks$0(DLC) sh 85059392$5IEN-M

=LDR  00739cz  a2200217n  4500
=001  9880364284402441
=005  20141212215953.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x710.$x251
=150  \\$aCockatoos
=450  \\$aCacatuidae
=450  \\$wnnna$aCockatiel
=450  \\$aCockatiels
=450  \\$wnnna$aCockatoo
=450  \\$aNymphicus hollandicus
=550  \\$wg$aPsittaciformes
=680  \\$iLarge crested BIRDS in the family Cacatuidae, found in Australia, New Guinea, and islands adjacent to the Philippines. The cockatiel (species Nymphicus hollandicus) is much smaller.
=688  \\$a2005
=750  \0$aCockatoos$0(DLC) sh 85027599$5IEN-M

=LDR  00645cz  a2200181n  4500
=001  9880364284502441
=005  20141212215953.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046408
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x710.$x672.$x650.$x500
=150  \\$aMelopsittacus
=450  \\$wnnna$aBudgerigar
=450  \\$aBudgerigars
=550  \\$wg$aParakeets
=680  \\$iA genus, commonly called budgerigars, in the family PSITTACIDAE. In the United States they are considered one of the five species of PARAKEETS.
=688  \\$a2005; use PARROTS 1995-2004
=750  \0$aMelopsittacus$0(DLC) sh 91004831$5IEN-M

=LDR  00701cz  a2200217n  4500
=001  9880364284602441
=005  20141212215952.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x725
=150  \\$aSwallows
=450  \\$wnnna$aBarn Swallow
=450  \\$wnnna$aBarn Swallows
=450  \\$aHirundinidae
=450  \\$wnnna$aSwallow, Barn
=450  \\$wnnna$aSwallows, Barn
=550  \\$wg$aSongbirds
=680  \\$iThe family Hirundinidae, comprised of small BIRDS that hunt flying INSECTS while in sustained flight.
=688  \\$a2005; use SONGBIRDS 1999-2004
=750  \0$aSwallows$0(DLC) sh 85130972$5IEN-M

=LDR  00585cz  a2200181n  4500
=001  9880364284702441
=005  20141212215952.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046370
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x700
=150  \\$aSparrows
=450  \\$aPasseridae
=450  \\$wnnna$aSparrow
=550  \\$wg$aSongbirds
=680  \\$iThe family Passeridae comprised of small, mainly brown and grey seed-eating birds with conical bills.
=688  \\$a2005; use SONGBIRDS 1999-2004
=750  \0$aSparrows$0(DLC) sh 85126325$5IEN-M

=LDR  00822cz  a2200229n  4500
=001  9880364284902441
=005  20141212215952.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x150
=150  \\$aCrows
=450  \\$wnnna$aCorvus
=450  \\$wnnna$aCrow
=450  \\$wnnna$aJackdaw
=450  \\$wnnna$aJackdaws
=450  \\$wnnna$aRaven
=450  \\$aRavens
=550  \\$wg$aSongbirds
=680  \\$iCommon name for the largest birds in the order PASSERIFORMES, family Corvidae. These omnivorous black birds comprise most of the species in the genus Corvus, along with ravens and jackdaws (which are often also referred to as crows).
=688  \\$a2005; use SONGBIRDS 1999-2004
=750  \0$aCrows$0(DLC) sh 85034351$5IEN-M

=LDR  00751cz  a2200229n  4500
=001  9880364285002441
=005  20141212215949.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046348
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x545
=150  \\$aGophers
=450  \\$aGeomyidae
=450  \\$wnnna$aGopher
=450  \\$wnnna$aGopher, Pocket
=450  \\$wnnna$aGophers, Pocket
=450  \\$wnnna$aPocket Gopher
=450  \\$wnnna$aPocket Gophers
=550  \\$wg$aRodentia
=680  \\$iThe family Geomyidae of burrowing rodents, commonly called pocket gophers. There are six genera, all found in North America.
=688  \\$a2005; use RODENTIA 1998-2004
=750  \0$aPocket gophers$0(DLC) sh 85103651$5IEN-M

=LDR  00609cz  a2200181n  4500
=001  9880364285102441
=005  20141212215949.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x640
=150  \\$aMyoxidae
=450  \\$aDormice
=450  \\$wnnna$aDormouse
=550  \\$wg$aRodentia
=680  \\$iA family of nocturnal rodents, similar in appearance to SQUIRRELS, but smaller. There are 28 species, half of which are found in Africa.
=688  \\$a2005; use RODENTIA 1982-2004
=750  \0$aDormice$0(DLC) sh 85039104$5IEN-M

=LDR  00584cz  a2200169n  4500
=001  9880364285202441
=005  20141212215948.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046329
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x663
=150  \\$aOctodon
=450  \\$wnnna$aOctodon degus
=550  \\$wg$aRodentia
=680  \\$iA genus of diurnal rats in the family Octodonidae, found in South America. The species Octodon degus is frequently used for research.
=688  \\$a2005; use RODENTIA 1982-2004
=750  \0$aDegus$0(DLC) sh 00004650$5IEN-M

=LDR  00703cz  a2200193n  4500
=001  9880364285302441
=005  20141212215948.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x692
=150  \\$aPorcupines
=450  \\$aCoendou
=450  \\$aHystrix
=450  \\$wnnna$aPorcupine
=550  \\$wg$aRodentia
=680  \\$iCommon name for large, quilled rodents (RODENTIA) comprised of two families: Old World porcupines (Hystricidae) and New World porcupines (Erethizontidae).
=688  \\$a2005; use RODENTIA 1982-2004; for COENDOU & HYSTRIX use RODENTIA 1982-2004
=750  \0$aPorcupines$0(DLC) sh 85104996$5IEN-M

=LDR  00737cz  a2200181n  4500
=001  9880364285402441
=005  20141212215948.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046308
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x600.$x700
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x700
=150  \\$aSpalax
=550  \\$wg$aMole Rats
=550  \\$wg$aMuridae
=680  \\$iA genus of blind, subterranean MOLE RATS, in the subfamily Spalacidae, family MURIDAE, used as a animal model in neurophysiology. There are at least five different species described, all found in the Ukraine.
=688  \\$a2005; use MOLE RATS 1998-2004
=750  \0$aUkrainian blind mole rats$0(DLC) sh 85126202$5IEN-M

=LDR  01549cz  a2200517n  4500
=001  9880364285502441
=005  20141212215947.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046288
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x85.$x90
=072  \\$aE2.$x800.$x90
=072  \\$aE4.$x85.$x90
=150  \\$aBody Piercing
=450  \\$wnnna$aBody Piercings
=450  \\$aEar Piercing
=450  \\$wnnna$aEar Piercings
=450  \\$aEyebrow Piercing
=450  \\$wnnna$aEyebrow Piercings
=450  \\$aLip Piercing
=450  \\$wnnna$aLip Piercings
=450  \\$aNavel Piercing
=450  \\$wnnna$aNavel Piercings
=450  \\$aNipple Piercing
=450  \\$wnnna$aNipple Piercings
=450  \\$aPiercing, Body
=450  \\$wnnna$aPiercing, Ear
=450  \\$wnnna$aPiercing, Eyebrow
=450  \\$wnnna$aPiercing, Lip
=450  \\$wnnna$aPiercing, Navel
=450  \\$wnnna$aPiercing, Nipple
=450  \\$wnnna$aPiercing, Tongue
=450  \\$wnnna$aPiercings, Body
=450  \\$wnnna$aPiercings, Ear
=450  \\$wnnna$aPiercings, Eyebrow
=450  \\$wnnna$aPiercings, Lip
=450  \\$wnnna$aPiercings, Navel
=450  \\$wnnna$aPiercings, Nipple
=450  \\$wnnna$aPiercings, Tongue
=450  \\$aTongue Piercing
=450  \\$wnnna$aTongue Piercings
=550  \\$wg$aBody Modification, Non-Therapeutic
=550  \\$wg$aPunctures
=680  \\$iThe perforation of an anatomical region for the wearing of jewelry.
=688  \\$a2005
=750  \0$aBody piercing$0(DLC) sh 93005224$5IEN-M

=LDR  01085cz  a2200229n  4500
=001  9880364285602441
=005  20141212215946.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046269
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x675
=072  \\$aN3.$x706.$x437.$x675
=150  \\$aReproductive Rights
=450  \\$wnnna$aReproduction Right
=450  \\$wnnna$aReproduction Rights
=450  \\$wnnna$aRight, Reproduction
=450  \\$wnnna$aRights, Reproduction
=450  \\$wnnna$aRights, Reproductive
=550  \\$wg$aHuman Rights
=680  \\$iReproductive rights rest on the recognition of the basic right of all couples and individuals to decide freely and responsibly the number, spacing and timing of their children and to have the information and means to do so, and the right to attain the highest standard of sexual and reproductive health. They also include the right of all to make decisions concerning reproduction free of discrimination, coercion and violence.
=688  \\$a2005
=750  \0$aReproductive rights$0(DLC)sh2008005212$5IEN-M

=LDR  01467cz  a2200349n  4500
=001  9880364285702441
=005  20141212215942.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046152
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x370
=072  \\$aC6.$x301.$x371.$x308
=072  \\$aC6.$x405.$x249.$x308
=150  \\$aGastrointestinal Stromal Tumors
=450  \\$wnnna$aGastrointestinal Stromal Neoplasm
=450  \\$wnnna$aGastrointestinal Stromal Neoplasms
=450  \\$wnnna$aGastrointestinal Stromal Sarcoma
=450  \\$wnnna$aGastrointestinal Stromal Tumor
=450  \\$wnnna$aNeoplasm, Gastrointestinal Stromal
=450  \\$wnnna$aNeoplasms, Gastrointestinal Stromal
=450  \\$wnnna$aStromal Neoplasm, Gastrointestinal
=450  \\$wnnna$aStromal Neoplasms, Gastrointestinal
=450  \\$wnnna$aStromal Tumor, Gastrointestinal
=450  \\$wnnna$aStromal Tumors, Gastrointestinal
=450  \\$wnnna$aTumor, Gastrointestinal Stromal
=450  \\$wnnna$aTumors, Gastrointestinal Stromal
=550  \\$wg$aGastrointestinal Neoplasms
=550  \\$wg$aNeoplasms, Connective Tissue
=667  \\$acoordinate IM with GASTROINTESTINAL NEOPLASMS (IM)
=680  \\$iAll tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells (MESODERM) except those of smooth muscle cells (LEIOMYOMA) or Schwann cells (SCHWANNOMA).
=688  \\$a2005
=750  \0$aGastrointestinal stromal tumors$0(DLC)sh2006007119$5IEN-M

=LDR  01489cz  a2200361n  4500
=001  9880364285802441
=005  20141212215941.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046150
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x343.$x679
=072  \\$aC16.$x320.$x240.$x750
=072  \\$aC19.$x297.$x656
=150  \\$aLaron Syndrome
=450  \\$wnnna$aDwarfism II, Pituitary
=450  \\$wnnna$aDwarfism IIs, Pituitary
=450  \\$wnnna$aDwarfism, Laron
=450  \\$wnnna$aGH Resistance, Primary
=450  \\$aGrowth Hormone Insensitivity Syndrome
=450  \\$wnnna$aGrowth Hormone Receptor Defect
=450  \\$wnnna$aGrowth Hormone Receptor Deficiency
=450  \\$wnnna$aLaron Dwarfism
=450  \\$wnnna$aLaron Type Dwarfism I
=450  \\$wnnna$aPituitary Dwarfism II
=450  \\$wnnna$aPituitary Dwarfism IIs
=450  \\$wnnna$aPrimary GH Resistance
=450  \\$wnnna$aPrimary Growth Hormone Resistance
=450  \\$wnnna$aSevere GH Insensitivity
=450  \\$wnnna$aSyndrome, Laron
=550  \\$wg$aDwarfism
=680  \\$iAn autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism (GROWTH HORMONE DEFICIENCY DWARFISM) but the result of mutation of the human GHR gene on chromosome 5.
=688  \\$a2005
=750  \0$aLaron dwarfism$0(DLC) sh 93001158$5IEN-M

=LDR  01109cz  a2200253n  4500
=001  9880364285902441
=005  20141212193055.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500.$x468
=150  \\$aEmbryo Culture Techniques
=450  \\$wnnna$aBlastocyst Culture Technique
=450  \\$wnnna$aBlastocyst Culture Techniques
=450  \\$wnnna$aCulture Technique, Blastocyst
=450  \\$wnnna$aCulture Technique, Embryo
=450  \\$wnnna$aCulture Techniques, Blastocyst
=450  \\$wnnna$aCulture Techniques, Embryo
=450  \\$wnnna$aEmbryo Culture Technique
=550  \\$wg$aCulture Techniques
=667  \\$arestrict to whole mammalian embryos; for cultures of embryonic tissue or cells, use TISSUE CULTURE TECHNIQUES or CELL CULTURE
=680  \\$iThe technique of maintaining or growing mammalian EMBRYOS in vitro. This method offers an opportunity to observe EMBRYONIC DEVELOPMENT; METABOLISM; and susceptibility to TERATOGENS
=688  \\$a2005
=750  \0$aEmbryology$xCultures and culture media$0(DLC) sh 85042725$5IEN-M

=LDR  00934cz  a2200229n  4500
=001  9880364286002441
=005  20141212215940.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046128
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x467
=150  \\$aFetal Therapies
=450  \\$aFetal Therapy
=450  \\$wnnna$aTherapies, Fetal
=450  \\$wnnna$aTherapy, Fetal
=550  \\$wg$aTherapeutics
=550  \\$wh$aBlood Transfusion, Intrauterine
=550  \\$wh$aFetoscopy
=667  \\$aGeneral only; prefer specifics
=680  \\$iPrenatal interventions to correct fetal anomalies or treat FETAL DISEASES in utero. Fetal therapies include several major areas, such as open surgery; FETOSCOPY; pharmacological therapy; INTRAUTERINE TRANSFUSION; STEM CELL TRANSPLANTATION; and GENETIC THERAPY.
=688  \\$a2005; use FETAL DISEASES 1993-2004, use FETUS 1986-1992
=750  \0$aFetus$xDiseases$xTreatment$0(IEN)7267478$5IEN-M

=LDR  01676cz  a2200361n  4500
=001  9880364286102441
=005  20141212215940.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046110
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x395
=072  \\$aC14.$x907.$x489.$x480
=150  \\$aHypertension, Pregnancy-Induced
=450  \\$wnnna$aGestational Hypertension
=450  \\$wnnna$aHypertension, Gestational
=450  \\$wnnna$aHypertension, Pregnancy Induced
=450  \\$wnnna$aHypertension, Pregnancy Transient
=450  \\$wnnna$aHypertensions, Pregnancy Induced
=450  \\$wnnna$aInduced Hypertension, Pregnancy
=450  \\$wnnna$aInduced Hypertensions, Pregnancy
=450  \\$wnnna$aPregnancy Induced Hypertension
=450  \\$wnnna$aPregnancy-Induced Hypertension
=450  \\$wnnna$aPregnancy Transient Hypertension
=450  \\$wnnna$aTransient Hypertension, Pregnancy
=550  \\$wg$aHypertension
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aEclampsia
=550  \\$wh$aHELLP Syndrome
=550  \\$wh$aPre-Eclampsia
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iA condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.
=688  \\$a2005
=750  \2$aHypertension in pregnancy$0(DLC) sh 85063727$5IEN-M

=LDR  00541cz  a2200169n  4500
=001  9880364286202441
=005  20141212215939.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620
=150  \\$aPasseriformes
=550  \\$wg$aBirds
=550  \\$wh$aSongbirds
=680  \\$iA widely distributed order of perching BIRDS, including more than half of all bird species.
=688  \\$a2005; use SONGBIRDS 1999-2004
=750  \0$aPasseriformes$0(DLC) sh 85098509$5IEN-M

=LDR  00815cz  a2200241n  4500
=001  9880364286302441
=005  20141212215939.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x600
=150  \\$aPalaeognathae
=450  \\$wnnna$aBird, Kiwi
=450  \\$wnnna$aKiwi Bird
=450  \\$wnnna$aRatite
=450  \\$aRatites
=550  \\$wg$aBirds
=550  \\$wh$aDromaiidae
=550  \\$wh$aRheiformes
=550  \\$wh$aStruthioniformes
=680  \\$iA superorder of large, mostly flightless birds, named for their distinctive PALATE morphology. It includes the orders Apterygiformes, Casuriiformes, Dinornithiformes, RHEIFORMES; STRUTHIONIFORMES and Tinamiformes.
=688  \\$a2005
=750  \0$aRatites$0(DLC) sh 85111532$5IEN

=LDR  00615cz  a2200205n  4500
=001  9880364286402441
=005  20141212215939.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046094
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350
=150  \\$aGalliformes
=450  \\$wnnna$aGalliforme
=550  \\$wg$aBirds
=550  \\$wh$aChickens
=550  \\$wh$aQuail
=550  \\$wh$aTurkeys
=680  \\$iAn order of heavy-bodied, largely terrestrial BIRDS including pheasants, TURKEYS, grouse, QUAIL, and CHICKENS.
=688  \\$a2005
=750  \0$aGalliformes$0(DLC) sh 85052842$5IEN-M

=LDR  00620cz  a2200205n  4500
=001  9880364286502441
=005  20141212215938.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046093
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x250
=072  \\$aB1.$x50.$x150.$x900.$x248.$x815.$x350
=150  \\$aFalconiformes
=550  \\$wg$aBirds
=550  \\$wg$aRaptors
=550  \\$wh$aEagles
=550  \\$wh$aHawks
=680  \\$iAn order of diurnal BIRDS of prey, including EAGLES; HAWKS; buzzards; vultures; and falcons.
=688  \\$a2005
=750  \0$aFalconiformes$0(DLC) sh 85046956$5IEN-M

=LDR  00546cz  a2200181n  4500
=001  9880364286602441
=005  20141212215938.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046092
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x165
=150  \\$aColumbiformes
=450  \\$wnnna$aRaphidae
=550  \\$wg$aBirds
=550  \\$wh$aColumbidae
=680  \\$iAn order of BIRDS comprised of PIGEONS; DOVES; and an extinct family that includes dodos.
=688  \\$a2005
=750  \0$aColumbiformes$0(DLC) sh 85028750$5IEN-M

=LDR  00823cz  a2200253n  4500
=001  9880364286702441
=005  20141212215938.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x150
=150  \\$aCharadriiformes
=450  \\$aCiconiiformes$5IEN-M
=450  \\$wnnna$aGull
=450  \\$aGulls
=450  \\$aLaridae
=450  \\$wnnna$aTern
=450  \\$wnnna$aTerns
=550  \\$wg$aBirds
=680  \\$iAn order of BIRDS including over 300 species that primarily inhabit coastal waters, beaches, and marshes. They are comprised of shorebirds, gulls, and terns.
=688  \\$a2006 (2005)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Charadriformes
=688  \\$a2005
=750  \0$aCharadriiformes$0(DLC) sh 85022628$5IEN-M

=LDR  00535cz  a2200181n  4500
=001  9880364286802441
=005  20141212215938.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046090
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x50
=150  \\$aAnseriformes
=550  \\$wg$aBirds
=550  \\$wh$aDucks
=550  \\$wh$aGeese
=680  \\$iAn order of BIRDS comprising the waterfowl, particularly DUCKS; GEESE; swans; and screamers.
=688  \\$a2005
=750  \0$aAnseriformes$0(DLC) sh 85005473$5IEN-M

=LDR  01224cz  a2200265n  4500
=001  9880363439102441
=005  20141212200443.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003602
=035  \\$aCAZ6743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x270
=150  \\$aCytotoxicity, Immunologic
=450  \\$wnnna$aImmunologic Cytotoxicity
=450  \\$wnnna$aImmunologic Tumoricidal Activities
=450  \\$wnnna$aImmunologic Tumoricidal Activity
=450  \\$wnnna$aTumoricidal Activities, Immunologic
=450  \\$aTumoricidal Activity, Immunologic
=550  \\$wg$aImmune System Processes
=550  \\$wh$aAntibody-Dependent Cell Cytotoxicity
=550  \\$wh$aMacrophage Activation
=667  \\$anote category: reserve for process: do not confuse with CYTOTOXICITY TESTS, IMMUNOLOGIC; DF: CYTOTOX IMMUNOL
=680  \\$iThe phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.
=688  \\$a78
=750  \0$aCell-mediated cytotoxicity$5IEN$0(DLC)sh 85021652

=LDR  00715cz  a2200229n  4500
=001  9880363439202441
=005  20141212200442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003600
=035  \\$aCAZ6741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x200
=072  \\$aA11.$x284.$x430.$x429.$x200
=072  \\$aA11.$x284.$x835.$x450.$x200
=150  \\$aCytosol
=450  \\$wnnna$aCytosols
=550  \\$wg$aCytoplasm
=550  \\$wg$aIntracellular Fluid
=667  \\$aA 11 qualif except /cytol
=680  \\$iIntracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.
=688  \\$a73
=750  \0$aCytosol$5IEN$0(DLC)sh 85035257

=LDR  01605cz  a2200433n  4500
=001  9880363439302441
=005  20141212200442.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003599
=035  \\$aCAZ6740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750
=150  \\$aCytoskeleton
=450  \\$wnnna$aCytoplasmic Filament
=450  \\$aCytoplasmic Filaments
=450  \\$wnnna$aCytoskeletal Filament
=450  \\$aCytoskeletal Filaments
=450  \\$wnnna$aCytoskeletons
=450  \\$wnnna$aFilament, Cytoplasmic
=450  \\$wnnna$aFilament, Cytoskeletal
=450  \\$wnnna$aFilaments, Cytoplasmic
=450  \\$wnnna$aFilaments, Cytoskeletal
=450  \\$wnnna$aLattice, Microtrabecular
=450  \\$wnnna$aLattices, Microtrabecular
=450  \\$aMicrotrabecular Lattice
=450  \\$wnnna$aMicrotrabecular Lattices
=550  \\$wg$aCytoplasmic Structures
=550  \\$wh$aActin Cytoskeleton
=550  \\$wh$aIntermediate Filaments
=550  \\$wh$aMicrotubule-Organizing Center
=550  \\$wh$aMicrotubules
=550  \\$wh$aMyofibrils
=550  \\$wh$aNeurofibrils
=550  \\$wh$aSpindle Apparatus
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iThe network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm.
=688  \\$a86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79
=750  \0$aCytoskeleton$0(DLC) sh 85035256$5IEN-M
=750  \0$aCytoplasmic filaments$0(DLC) sh 85035252$5IEN-HS

=LDR  01413cz  a2200409n  4500
=001  9880363439402441
=005  20181204094257.0
=008  840611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003598
=035  \\$aCAZ6739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x220
=150  \\$aCytoskeletal Proteins
=450  \\$wnnna$aProteins, Cytoskeletal
=550  \\$wg$aProteins
=550  \\$wh$aAdenomatous Polyposis Coli Protein
=550  \\$wh$aCatenins
=550  \\$wh$aCornified Envelope Proline-Rich Proteins
=550  \\$wh$aDystrophin
=550  \\$wh$aDystrophin-Associated Proteins
=550  \\$wh$aIntermediate Filament Proteins
=550  \\$wh$aMicrofilament Proteins
=550  \\$wh$aMicrotubule Proteins
=550  \\$wh$aPlakins
=550  \\$wh$aPlakophilins
=550  \\$wh$aPyrin
=550  \\$wh$aSeptins
=550  \\$wh$aSpectrin
=550  \\$wh$aTalin
=550  \\$wh$aUtrophin
=550  \\$wh$aVinculin
=550  \\$wh$aZyxin
=550  \\$aCytoskeleton
=667  \\$a/biosyn /drug eff /physiol permitted; do not use /analogs
=680  \\$iMajor constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible.
=688  \\$a85
=750  \0$aCytoskeletal proteins$0(DLC) sh 87006318$5IEN

=LDR  01218cz  a2200301n  4500
=001  9880363439502441
=005  20170609103807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003595
=035  \\$aCAZ6736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x143.$x355
=072  \\$aG4.$x392
=150  \\$aCytoplasmic Streaming
=450  \\$wnnna$aCytoplasmic Streamings
=450  \\$aProtoplasmic Streaming
=450  \\$wnnna$aProtoplasmic Streamings
=450  \\$wnnna$aStreaming, Cytoplasmic
=450  \\$wnnna$aStreaming, Protoplasmic
=450  \\$wnnna$aStreamings, Cytoplasmic
=450  \\$wnnna$aStreamings, Protoplasmic
=550  \\$wg$aBiological Transport
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aAxonal Transport
=667  \\$apermitted for micro-organisms also; do not confuse with CYTOKINESIS or CELL MOVEMENT
=680  \\$iThe movement of CYTOPLASM within a CELL. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the AMOEBA, it is responsible for the movement (CELL MOVEMENT) of the entire cell.
=688  \\$a70(67)
=750  \0$aProtoplasmic streaming$5IEN$0(DLC)sh 85107804

=LDR  01003cz  a2200301n  4500
=001  9880363439602441
=005  20141212200440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003594
=035  \\$aCAZ6735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190
=150  \\$aCytoplasmic Granules
=450  \\$wnnna$aCytoplasmic Granule
=450  \\$wnnna$aGranule, Cytoplasmic
=450  \\$wnnna$aGranules, Cytoplasmic
=550  \\$wg$aCytoplasmic Structures
=550  \\$wg$aCytoplasmic Vesicles
=550  \\$wh$aChromaffin Granules
=550  \\$wh$aMelanosomes
=550  \\$wh$aMicrobodies
=550  \\$wh$aNissl Bodies
=550  \\$wh$aWeibel-Palade Bodies
=667  \\$aZYMOGEN GRANULES see SECRETORY VESICLES is also available
=680  \\$iCondensed areas of cellular material that may be bounded by a membrane.
=688  \\$a65(64)
=750  \0$aCytoplasmic granules$5IEN$0(DLC)sh 92000011

=LDR  00864cz  a2200241n  4500
=001  9880363439702441
=005  20141212200439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003593
=035  \\$aCAZ6734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214
=150  \\$aCytoplasm
=450  \\$wnnna$aCytoplasms
=450  \\$aProtoplasm
=450  \\$wnnna$aProtoplasms
=550  \\$wg$aIntracellular Space
=550  \\$wh$aCytoplasmic Structures
=550  \\$wh$aCytosol
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iThe part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)
=688  \\$a65(64); PROTOPLASM was heading 1963-64
=750  \0$aCytoplasm$5IEN-HS$0(DLC)sh 85035251

=LDR  01031cz  a2200277n  4500
=001  9880363439802441
=005  20141212200439.0
=008  850228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003592
=035  \\$aCAZ6733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x386
=072  \\$aE5.$x196.$x712.$x516.$x600.$x240
=072  \\$aE5.$x200.$x500.$x386
=072  \\$aE5.$x242.$x386
=150  \\$aCytophotometry
=450  \\$wnnna$aCytophotometries
=450  \\$wnnna$aMicrofluorometries
=450  \\$aMicrofluorometry
=550  \\$wg$aCytological Techniques
=550  \\$wg$aFluorometry
=550  \\$wh$aFlow Cytometry
=550  \\$wh$aImage Cytometry
=680  \\$iA method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope.
=688  \\$a86
=750  \0$aCytophotometry$5IEN$0(DLC)sh 85035250

=LDR  00606cz  a2200181n  4500
=001  9880363439902441
=005  20141212200439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003589
=035  \\$aCAZ6730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x130.$x150
=072  \\$aB3.$x440.$x400.$x425.$x300.$x150
=150  \\$aCytophaga
=550  \\$wg$aCytophagaceae
=667  \\$ainfection: coord IM with CYTOPHAGACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative gliding bacteria found in SOIL; HUMUS; and FRESHWATER and marine habitats.
=750  \0$aCytophaga$5IEN$0(DLC)sh 85035245

=LDR  01314cz  a2200301n  4500
=001  9880363440002441
=005  20141212200438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003587
=035  \\$aCAZ6728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x150.$x150
=072  \\$aB4.$x909.$x204.$x382.$x150.$x150
=150  \\$aCytomegalovirus
=450  \\$wnnna$aCytomegaloviruses
=450  \\$wnnna$aHerpesvirus 5 (beta), Human
=450  \\$aHerpesvirus 5, Human
=450  \\$wnnna$aHHV 5
=450  \\$aHuman Herpesvirus 5
=450  \\$wnnna$aSalivary Gland Virus
=450  \\$aSalivary Gland Viruses
=450  \\$wnnna$aVirus, Salivary Gland
=450  \\$wnnna$aViruses, Salivary Gland
=550  \\$wg$aBetaherpesvirinae
=667  \\$ainfection = CYTOMEGALOVIRUS INFECTIONS; DF: HHV 5
=680  \\$iA genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
=688  \\$a94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78
=750  \0$aCytomegaloviruses$5IEN$0(DLC)sh 85035244

=LDR  01596cz  a2200337n  4500
=001  9880363440102441
=005  20141212200438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003586
=035  \\$aCAZ6727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x245
=150  \\$aCytomegalovirus Infections
=450  \\$aCytomegalic Inclusion Disease
=450  \\$wnnna$aCytomegalic Inclusion Diseases
=450  \\$wnnna$aCytomegalovirus Infection
=450  \\$wnnna$aDisease, Cytomegalic Inclusion
=450  \\$wnnna$aDiseases, Cytomegalic Inclusion
=450  \\$aInclusion Disease
=450  \\$wnnna$aInclusion Disease, Cytomegalic
=450  \\$wnnna$aInclusion Diseases
=450  \\$wnnna$aInclusion Diseases, Cytomegalic
=450  \\$wnnna$aInfection, Cytomegalovirus
=450  \\$wnnna$aInfections, Cytomegalovirus
=450  \\$aSalivary Gland Virus Disease
=550  \\$wg$aHerpesviridae Infections
=550  \\$wh$aCytomegalovirus Retinitis
=667  \\$ainfection by MUROMEGALOVIRUS (MOUSE CYTOMEGALOVIRUS or RAT CYTOMEGALOVIRUS) does not go here: coordinate MUROMEGALOVIRUS (IM) with HERPESVIRIDAE INFECTIONS (IM)
=680  \\$iInfection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
=688  \\$a94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93
=750  \0$aCytomegalovirus infections$5IEN-M$0(DLC)sh 89005872

=LDR  01157cz  a2200313n  4500
=001  9880363440202441
=005  20141212200437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003585
=035  \\$aCAZ6726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x433
=072  \\$aH1.$x158.$x273.$x190
=150  \\$aCell Biology
=450  \\$wnnna$aBiologies, Cell
=450  \\$wnnna$aBiologies, Cellular
=450  \\$wnnna$aBiology, Cell
=450  \\$wnnna$aBiology, Cellular
=450  \\$wnnna$aCell Biologies
=450  \\$wnnna$aCellular Biologies
=450  \\$wnnna$aCellular Biology
=450  \\$aCytology
=550  \\$wg$aAnatomy
=550  \\$wg$aBiology
=667  \\$athe discipline only (education, history, etc); entry term CYTOLOGY: for cytological structures use the qualifier /cytol with specific anatomical term or organism
=680  \\$iThe study of the structure, behavior, growth, reproduction, and pathology of cells; and the function and chemistry of cellular components.
=688  \\$a2010 (1984)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Cytology
=750  \0$aCytology$0(DLC) sh 85035240$5IEN

=LDR  01974cz  a2200601n  4500
=001  9880363440302441
=005  20161216104052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003584
=035  \\$aCAZ6725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500
=072  \\$aE5.$x200.$x500
=072  \\$aE5.$x242
=150  \\$aCytological Techniques
=450  \\$aCell Biology$xmethods
=450  \\$wnnna$aCytologic Technic
=450  \\$wnnna$aCytologic Technics
=450  \\$wnnna$aCytological Technic
=450  \\$wnnna$aCytological Technics
=450  \\$wnnna$aCytological Technique
=450  \\$wnnna$aTechnic, Cytologic
=450  \\$wnnna$aTechnic, Cytological
=450  \\$wnnna$aTechnics, Cytologic
=450  \\$wnnna$aTechnics, Cytological
=450  \\$wnnna$aTechnique, Cytological
=450  \\$wnnna$aTechniques, Cytological
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aCell Count
=550  \\$wh$aCell Culture Techniques
=550  \\$wh$aCell Fractionation
=550  \\$wh$aCell Fusion
=550  \\$wh$aCell Migration Assays
=550  \\$wh$aCell Separation
=550  \\$wh$aCell Tracking
=550  \\$wh$aCellular Reprogramming Techniques
=550  \\$wh$aColony-Forming Units Assay
=550  \\$wh$aCytodiagnosis
=550  \\$wh$aCytogenetic Analysis
=550  \\$wh$aCytophotometry
=550  \\$wh$aDrug Screening Assays, Antitumor
=550  \\$wh$aElectroporation
=550  \\$wh$aEnzyme-Linked Immunospot Assay
=550  \\$wh$aHistocytochemistry
=550  \\$wh$aHistocytological Preparation Techniques
=550  \\$wh$aMetabolic Flux Analysis
=550  \\$wh$aPatch-Clamp Techniques
=550  \\$wh$aSingle-Cell Analysis
=550  \\$wh$aStem Cell Research
=667  \\$aavoid: too general; usually NIM
=688  \\$a91; was CYTOLOGICAL TECHNICS 1973-90
=750  \0$aCytology$xTechnique$5IEN$0(DLC)sh 85035242

=LDR  00693cz  a2200205n  4500
=001  9880363440402441
=005  20141212200436.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003583
=035  \\$aCAZ6724HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x138.$x525
=150  \\$aCytokinins
=550  \\$wg$aAdenine
=550  \\$wh$aIsopentenyladenosine
=550  \\$wh$aKinetin
=550  \\$wh$aZeatin
=680  \\$iPlant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives.
=688  \\$a91(75); was see under PLANT GROWTH REGULATORS 1975-90
=750  \0$aCytokinins$5IEN$0(DLC)sh 85035238

=LDR  00977cz  a2200229n  4500
=001  9880363440502441
=005  20141212200436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x180
=150  \\$aCytogenetics
=450  \\$wnnna$aCytogenetic
=550  \\$wg$aGenetics
=550  \\$aChromosome Disorders
=550  \\$aCytogenetic Analysis
=550  \\$aSex Chromosome Disorders
=667  \\$aSPEC; avoid as coord: Manual 28.22.5; /methods: consider CYTOGENETIC ANALYSIS: Manual 28.22.5.2; CYTOGENETIC ABERRATIONS see CHROMOSOME ABERRATIONS is also available
=680  \\$iA subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE.
=688  \\$a67
=750  \0$aCytogenetics$5IEN$0(DLC)sh 85035235
=750  \0$aCytogeneticists$5IEN-HS$0(DLC)sh 92001433

=LDR  00949cz  a2200277n  4500
=001  9880363440602441
=005  20141212200435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003581
=035  \\$aCAZ6722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384
=072  \\$aE5.$x200.$x500.$x384
=072  \\$aE5.$x242.$x384
=150  \\$aCytodiagnosis
=450  \\$wnnna$aCytodiagnoses
=550  \\$wg$aCytological Techniques
=550  \\$wh$aAmniocentesis
=550  \\$wh$aBiopsy
=550  \\$wh$aChorionic Villi Sampling
=550  \\$wh$aCytopathogenic Effect, Viral
=550  \\$wh$aKaryometry
=550  \\$aCytological Techniques
=667  \\$aGEN; NIM; DF: CYTODIAG
=680  \\$iDiagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed)
=750  \0$aCytodiagnosis$5IEN$0(DLC)sh 85037491

=LDR  01287cz  a2200277n  4500
=001  9880363440702441
=005  20141212200435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003580
=035  \\$aCAZ6721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244
=072  \\$aD12.$x776.$x422.$x220
=150  \\$aCytochromes
=450  \\$wnnna$aCytochrome
=550  \\$wg$aEnzymes and Coenzymes
=550  \\$wg$aHemeproteins
=550  \\$wh$aCytochrome a Group
=550  \\$wh$aCytochrome b Group
=550  \\$wh$aCytochrome c Group
=550  \\$wh$aCytochrome d Group
=550  \\$wh$aCytochrome P-450 Enzyme System
=550  \\$wh$aCytochromes f
=667  \\$aGEN or unspecified; prefer specific cytochrome
=680  \\$iHemeproteins whose characteristic mode of action involves transfer of reducing equivalents which are associated with a reversible change in oxidation state of the prosthetic group. Formally, this redox change involves a single-electron, reversible equilibrium between the Fe(II) and Fe(III) states of the central iron atom (From Enzyme Nomenclature, 1992, p539). The various cytochrome subclasses are organized by the type of HEME and by the wavelength range of their reduced alpha-absorption bands.
=750  \0$aCytochromes$5IEN$0(DLC)sh 87005369

=LDR  02815cz  a2200589n  4500
=001  9880363440802441
=005  20141212192127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003577
=035  \\$aCAZ6718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x453
=072  \\$aD8.$x811.$x682.$x690.$x708.$x170
=072  \\$aD12.$x776.$x422.$x220.$x453
=150  \\$aCytochrome P-450 Enzyme System
=450  \\$aCytochrome P-450
=450  \\$wnnna$aCytochrome P 450
=450  \\$aCytochrome P-450-Dependent Monooxygenase
=450  \\$wnnna$aCytochrome P 450 Dependent Monooxygenase
=450  \\$wnnna$aCytochrome P 450 Enzyme System
=450  \\$wnnna$aCytochrome P-450 Enzymes
=450  \\$wnnna$aCytochrome P 450 Enzymes
=450  \\$wnnna$aCytochrome P-450 Monooxygenase
=450  \\$wnnna$aCytochrome P 450 Monooxygenase
=450  \\$wnnna$aCytochrome P-450 Oxygenase
=450  \\$wnnna$aCytochrome P 450 Oxygenase
=450  \\$wnnna$aCytochrome P450
=450  \\$wnnna$aEnzymes, Cytochrome P-450
=450  \\$wnnna$aEnzymes, P-450
=450  \\$wnnna$aEnzymes, P450
=450  \\$wnnna$aMonooxygenase, Cytochrome P-450
=450  \\$wnnna$aMonooxygenase, Cytochrome P-450-Dependent
=450  \\$wnnna$aP-450 Enzymes
=450  \\$wnnna$aP 450 Enzymes
=450  \\$wnnna$aP-450 Enzymes, Cytochrome
=450  \\$wnnna$aP450 Enzymes
=550  \\$wg$aCytochromes
=550  \\$wg$aMixed Function Oxygenases
=550  \\$wh$aAryl Hydrocarbon Hydroxylases
=550  \\$wh$aCamphor 5-Monooxygenase
=550  \\$wh$aCytochrome P-450 CYP2A6
=550  \\$wh$aCytochrome P-450 CYP2E1
=550  \\$wh$aCytochrome P-450 CYP3A
=550  \\$wh$aCytochrome P-450 CYP4A
=550  \\$wh$aLimonene Hydroxylases
=550  \\$wh$aSteroid Hydroxylases
=550  \\$wh$aTrans-Cinnamate 4-Monooxygenase
=550  \\$wh$aVitamin D3 24-Hydroxylase
=667  \\$ageneral or unspecified; prefer specific cytochrome P-450's
=680  \\$iA superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.
=688  \\$a73; CYTOCHROME P-450 OXYGENASE was NM 1977-96
=750  \0$aCytochrome P-450$0(DLC) sh 85035233$5IEN

=LDR  02710cz  a2200553n  4500
=001  9880363440902441
=005  20141212200434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003576
=035  \\$aCAZ6717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x562.$x374
=072  \\$aD8.$x811.$x600.$x250.$x687
=072  \\$aD8.$x811.$x682.$x285
=072  \\$aD12.$x776.$x157.$x530.$x450.$x250.$x875.$x304
=072  \\$aD12.$x776.$x543.$x277.$x687
=072  \\$aD12.$x776.$x543.$x585.$x450.$x250.$x875.$x484
=150  \\$aElectron Transport Complex IV
=450  \\$wnnna$aCytochrome a,a3
=450  \\$aCytochrome aa3
=450  \\$aCytochrome-c Oxidase
=450  \\$wnnna$aCytochrome c Oxidase
=450  \\$wnnna$aCytochrome-c Oxidase (Complex IV)
=450  \\$wnnna$aCytochrome-c Oxidase Subunit III
=450  \\$wnnna$aCytochrome c Oxidase Subunit III
=450  \\$wnnna$aCytochrome-c Oxidase Subunit IV
=450  \\$wnnna$aCytochrome c Oxidase Subunit IV
=450  \\$wnnna$aCytochrome c Oxidase Subunit VIa
=450  \\$aCytochrome Oxidase
=450  \\$wnnna$aCytochrome Oxidase Subunit III
=450  \\$wnnna$aFerrocytochrome c Oxygen Oxidoreductase
=450  \\$wnnna$aHeme aa3 Cytochrome Oxidase
=450  \\$wnnna$aOxidase, Cytochrome
=450  \\$wnnna$aOxidase, Cytochrome-c
=450  \\$wnnna$ap25 Presequence Peptide-Cytochrome Oxidase
=450  \\$wnnna$ap25 Presequence Peptide Cytochrome Oxidase
=450  \\$wnnna$aPre-CTOX p25
=450  \\$wnnna$aSignal Peptide p25-Subunit IV Cytochrome Oxidase
=450  \\$wnnna$aSignal Peptide p25 Subunit IV Cytochrome Oxidase
=450  \\$wnnna$aSubunit III, Cytochrome Oxidase
=550  \\$wg$aElectron Transport Chain Complex Proteins
=550  \\$wg$aMultienzyme Complexes
=550  \\$wg$aOxidoreductases
=550  \\$wg$aProton Pumps
=550  \\$aCytochrome-c Oxidase Deficiency
=667  \\$aspell in titles & translations with lowercase c: cytochrome-c oxidase
=680  \\$iA multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane.
=688  \\$a2004(1963); for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE (NM) 1988-2001; for CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE (NM) 1998-2001
=750  \0$aCytochrome oxidase$5IEN-M$0(DLC)sh 85035231

=LDR  01045cz  a2200289n  4500
=001  9880363441002441
=005  20141212200433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003574
=035  \\$aCAZ6715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x286
=072  \\$aD12.$x776.$x422.$x220.$x286
=150  \\$aCytochrome c Group
=450  \\$wnnoa$aCytochrome c$5IEN-HS
=450  \\$wnnna$aCytochromes Type c
=450  \\$wnnna$aGroup, Cytochrome c
=450  \\$wnnna$aType c, Cytochromes
=550  \\$wg$aCytochromes
=550  \\$wh$aCytochromes c
=550  \\$wh$aCytochromes c1
=550  \\$wh$aCytochromes c2
=550  \\$wh$aCytochromes c6
=667  \\$aspell in titles & translations with lowercase c: cytochrome c; do not confuse with CYTOCHROMES C
=680  \\$iA group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. (Enzyme Nomenclature, 1992, p539)
=688  \\$a2004(1973)
=750  \0$aCytochrome c$5IEN$0(DLC)sh 85035230

=LDR  01177cz  a2200337n  4500
=001  9880363441102441
=005  20141212200433.0
=008  820511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003573
=035  \\$aCAZ6714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x187
=072  \\$aD12.$x776.$x422.$x220.$x187
=150  \\$aCytochrome b Group
=450  \\$wnnna$ab Cytochromes, Heme
=450  \\$wnnna$ab, Cytochromes Type
=450  \\$wnnna$ab Group, Cytochrome
=450  \\$wnnoa$aCytochrome b$5IEN-HS
=450  \\$wnnna$aCytochromes, Heme b
=450  \\$wnnna$aCytochromes Type b
=450  \\$wnnna$aGroup, Cytochrome b
=450  \\$wnnna$aHeme b Cytochromes
=450  \\$wnnna$aType b, Cytochromes
=550  \\$wg$aCytochromes
=550  \\$wh$aCytochromes b
=550  \\$wh$aCytochromes b5
=550  \\$wh$aCytochromes b6
=667  \\$a/biosyn /physiol permitted; spell in titles & translations with lowercase b: cytochrome b; do not confuse with CYTOCHROMES B
=680  \\$iCytochromes (electron-transporting proteins) with protoheme (HEME B) as the prosthetic group.
=688  \\$a2004(1983);
=750  \0$aCytochrome b$5IEN-M$0(DLC)sh 94006755

=LDR  00847cz  a2200229n  4500
=001  9880363441202441
=005  20141212200432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003572
=035  \\$aCAZ6713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x231
=072  \\$aD23.$x946.$x587.$x370
=150  \\$aCytochalasins
=550  \\$wg$aIndoles
=550  \\$wg$aMycotoxins
=550  \\$wh$aCytochalasin B
=550  \\$wh$aCytochalasin D
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$i11- to 14-membered macrocyclic lactones with a fused isoindolone. Members with INDOLES attached at the C10 position are called chaetoglobosins. They are produced by various fungi. Some members interact with ACTIN and inhibit CYTOKINESIS.
=688  \\$a74(73)
=750  \0$aCytochalasins$5IEN$0(DLC)sh 85035226

=LDR  01241cz  a2200361n  4500
=001  9880363441302441
=005  20141212200431.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003566
=035  \\$aCAZ6707HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x883.$x333.$x130
=072  \\$aD2.$x675.$x276.$x232.$x130
=072  \\$aD3.$x383.$x742.$x686.$x246.$x150.$x180
=072  \\$aD13.$x695.$x740.$x246.$x150.$x180
=072  \\$aD13.$x695.$x827.$x232.$x150.$x180
=150  \\$aCytidine Diphosphate Choline
=450  \\$wnnna$a5'-Diphosphocholine, Cytidine
=450  \\$aCDP Choline
=450  \\$wnnna$aCholine, CDP
=450  \\$wnnna$aCholine, Cytidine Diphosphate
=450  \\$wnnna$aCidifos
=450  \\$wnnna$aCiticholine
=450  \\$aCiticoline
=450  \\$wnnna$aCyticholine
=450  \\$wnnna$aCytidine 5'-Diphosphocholine
=450  \\$wnnna$aCytidine 5' Diphosphocholine
=450  \\$wnnna$aDiphosphate Choline, Cytidine
=550  \\$wg$aCholine
=550  \\$wg$aCytidine Diphosphate
=680  \\$iDonor of choline in biosynthesis of choline-containing phosphoglycerides.
=688  \\$a91(75); was see under CHOLINE 1975-90
=750  \0$aCytidine diphosphate choline$5IEN$0(DLC)sh 85035223

=LDR  01788cz  a2200529n  4500
=001  9880363441402441
=005  20141212200428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003560
=035  \\$aCAZ6701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182
=072  \\$aC23.$x300.$x306
=150  \\$aCysts
=450  \\$wnnna$aCyst
=550  \\$wg$aNeoplasms
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aArachnoid Cysts
=550  \\$wh$aBone Cysts
=550  \\$wh$aBranchioma
=550  \\$wh$aBreast Cyst
=550  \\$wh$aBronchogenic Cyst
=550  \\$wh$aChalazion
=550  \\$wh$aCholedochal Cyst
=550  \\$wh$aColloid Cysts
=550  \\$wh$aDermoid Cyst
=550  \\$wh$aEpidermal Cyst
=550  \\$wh$aEsophageal Cyst
=550  \\$wh$aFollicular Cyst
=550  \\$wh$aGanglion Cysts
=550  \\$wh$aLymphocele
=550  \\$wh$aMediastinal Cyst
=550  \\$wh$aMesenteric Cyst
=550  \\$wh$aMucocele
=550  \\$wh$aOvarian Cysts
=550  \\$wh$aPancreatic Cyst
=550  \\$wh$aParovarian Cyst
=550  \\$wh$aPilonidal Sinus
=550  \\$wh$aRanula
=550  \\$wh$aSpermatocele
=550  \\$wh$aSynovial Cyst
=550  \\$wh$aTarlov Cysts
=550  \\$wh$aThyroglossal Cyst
=550  \\$wh$aUrachal Cyst
=667  \\$acoord with organ/diseases term; specific terms indented under CYSTS are either neoplastic or non-neopl: check under each; intestinal gas cysts = PNEUMATOSIS CYSTOIDES INTESTINALIS; CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL is also available
=680  \\$iAny fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.
=750  \0$aCysts (Pathology)$5IEN$0(DLC)sh 85035220

=LDR  01317cz  a2200385n  4500
=001  9880363441502441
=005  20141212192126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003558
=035  \\$aCAZ6699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x180
=072  \\$aE1.$x370.$x390.$x175
=072  \\$aE4.$x502.$x250.$x180
=072  \\$aE4.$x950.$x774.$x155
=150  \\$aCystoscopy
=450  \\$wnnna$aCystoscopic Surgeries
=450  \\$wnnna$aCystoscopic Surgery
=450  \\$wnnna$aCystoscopic Surgical Procedure
=450  \\$aCystoscopic Surgical Procedures
=450  \\$wnnna$aCystoscopies
=450  \\$wnnna$aProcedure, Cystoscopic Surgical
=450  \\$wnnna$aProcedures, Cystoscopic Surgical
=450  \\$wnnna$aSurgeries, Cystoscopic
=450  \\$wnnna$aSurgery, Cystoscopic
=450  \\$wnnna$aSurgical Procedure, Cystoscopic
=450  \\$aSurgical Procedures, Cystoscopic
=550  \\$wg$aDiagnostic Techniques, Urological
=550  \\$wg$aEndoscopy
=550  \\$wg$aUrologic Surgical Procedures
=550  \\$aCystoscopes
=550  \\$aUrinary Bladder
=667  \\$a/ instrum permitted but consider also CYSTOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the urinary bladder.
=750  \0$aCystoscopy$5IEN$0(DLC)sh 85035219

=LDR  00748cz  a2200205n  4500
=001  9880363441602441
=005  20141212200427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003556
=035  \\$aCAZ6697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829.$x495
=072  \\$aC13.$x351.$x968.$x829.$x495
=150  \\$aCystitis
=450  \\$wnnna$aCystitides
=550  \\$wg$aUrinary Bladder Diseases
=550  \\$wh$aCystitis, Interstitial
=550  \\$wh$aPyelocystitis
=680  \\$iInflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
=750  \0$aCystitis$5IEN$0(DLC)sh 85014731

=LDR  00964cz  a2200229n  4500
=001  9880363441702441
=005  20141212200427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003555
=035  \\$aCAZ6696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x815.$x885.$x250
=072  \\$aC13.$x351.$x968.$x419.$x815.$x885.$x250
=072  \\$aC16.$x320.$x565.$x861.$x885.$x250
=072  \\$aC18.$x452.$x648.$x861.$x885.$x250
=150  \\$aCystinuria
=450  \\$aCystine$xurine
=450  \\$wnnna$aCystinurias
=550  \\$wg$aRenal Aminoacidurias
=550  \\$aUrine
=680  \\$iAn inherited disorder due to defective reabsorption of CYSTINE and other BASIC AMINO ACIDS by the PROXIMAL RENAL TUBULES. This form of aminoaciduria is characterized by the abnormally high urinary levels of cystine; LYSINE; ARGININE; and ORNITHINE. Mutations involve the amino acid transport protein gene SLC3A1.
=750  \0$aCystinuria$5IEN$0(DLC)sh 85035213

=LDR  01646cz  a2200397n  4500
=001  9880363441802441
=005  20141212200427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003554
=035  \\$aCAZ6695HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x595.$x377
=072  \\$aC18.$x452.$x648.$x595.$x377
=150  \\$aCystinosis
=450  \\$wnnna$aCystine Diatheses
=450  \\$wnnna$aCystine Diathesis
=450  \\$wnnna$aCystine Disease
=450  \\$wnnna$aCystine Diseases
=450  \\$wnnna$aCystine Storage Disease
=450  \\$wnnna$aCystine Storage Diseases
=450  \\$wnnna$aCystinoses
=450  \\$wnnna$aCystinoses, Nephropathic
=450  \\$wnnna$aCystinosin, Defect of
=450  \\$wnnna$aCystinosis, Nephropathic
=450  \\$wnnna$aDiatheses, Cystine
=450  \\$wnnna$aDiathesis, Cystine
=450  \\$wnnna$aDisease, Cystine Storage
=450  \\$wnnna$aDiseases, Cystine Storage
=450  \\$wnnna$aLysosomal Cystine Transport Protein, Defect Of
=450  \\$wnnna$aNephropathic Cystinoses
=450  \\$wnnna$aNephropathic Cystinosis
=450  \\$wnnna$aStorage Disease, Cystine
=450  \\$wnnna$aStorage Diseases, Cystine
=550  \\$wg$aLysosomal Storage Diseases
=680  \\$iA metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME.
=750  \0$aCystinosis$5IEN$0(DLC)sh 85035212

=LDR  00690cz  a2200181n  4500
=001  9880363441902441
=005  20141212200426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003552
=035  \\$aCAZ6693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x895.$x286
=150  \\$aCysticercus
=550  \\$wg$aTaenia
=667  \\$alarval form of tapeworm; infection = CYSTICERCOSIS or NEUROCYSTICERCOSIS; coord with specific precoord helminth terms (ANTIGENS, HELMINTH, etc) if pertinent
=680  \\$iThe larval form of various tapeworms of the genus Taenia.
=688  \\$a91(75); was see under TAENIA 1975-90
=750  \0$aCysticercus$5IEN$0(DLC)sh 85035209

=LDR  00921cz  a2200217n  4500
=001  9880363442002441
=005  20141212200426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003551
=035  \\$aCAZ6692HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x902.$x185
=150  \\$aCysticercosis
=450  \\$wnnna$aCysticercoses
=550  \\$wg$aTaeniasis
=550  \\$wh$aNeurocysticercosis
=550  \\$aTaenia
=550  \\$aTaeniasis
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; NEUROCYSTICERCOSIS is also available.
=680  \\$iInfection with CYSTICERCUS, the larval form of the various tapeworms of the genus Taenia (usually T. solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS.
=750  \0$aCysticercosis$5IEN$0(DLC)sh 85035207

=LDR  01784cz  a2200385n  4500
=001  9880363442102441
=005  20141212200425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003550
=035  \\$aCAZ6691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x689.$x202
=072  \\$aC8.$x381.$x187
=072  \\$aC16.$x320.$x190
=072  \\$aC16.$x614.$x213
=150  \\$aCystic Fibrosis
=450  \\$wnnna$aCystic Fibrosis of Pancreas
=450  \\$wnnna$aCystic Fibrosis, Pancreatic
=450  \\$wnnna$aCystic Fibrosis, Pulmonary
=450  \\$wnnna$aFibrocystic Disease of Pancreas
=450  \\$wnnna$aFibrosis, Cystic
=450  \\$aMucoviscidosis
=450  \\$wnnna$aPancreas Fibrocystic Disease
=450  \\$wnnna$aPancreas Fibrocystic Diseases
=450  \\$wnnna$aPancreatic Cystic Fibrosis
=450  \\$wnnna$aPulmonary Cystic Fibrosis
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aLung Diseases
=550  \\$wg$aPancreatic Diseases
=550  \\$aSweating
=667  \\$aa specific disease entity: do not use for fibrocystic states of various organs
=680  \\$iAn autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
=688  \\$a67; was PANCREATIC CYSTIC FIBROSIS 1963-66
=750  \0$aCystic fibrosis$5IEN$0(DLC)sh 85035204

=LDR  01161cz  a2200361n  4500
=001  9880363442202441
=005  20141212200424.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003546
=035  \\$aCAZ6687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x262.$x500
=072  \\$aD8.$x811.$x277.$x656.$x300.$x200
=150  \\$aCysteine Endopeptidases
=550  \\$wg$aCysteine Proteases
=550  \\$wg$aEndopeptidases
=550  \\$wh$aBromelains
=550  \\$wh$aCalpain
=550  \\$wh$aCaspases
=550  \\$wh$aCathepsin B
=550  \\$wh$aCathepsin F
=550  \\$wh$aCathepsin H
=550  \\$wh$aCathepsin K
=550  \\$wh$aCathepsin L
=550  \\$wh$aCathepsin W
=550  \\$wh$aChymopapain
=550  \\$wh$aFicain
=550  \\$wh$aPapain
=550  \\$wh$aSeparase
=667  \\$ado not confuse with CYSTEINE PROTEASES
=680  \\$iENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
=688  \\$a2000(1988)
=750  \0$aCysteine proteinases$5IEN$0(DLC)sh 86007065

=LDR  01087cz  a2200361n  4500
=001  9880363442302441
=005  20150529163824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003545
=035  \\$aCAZ6686M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x230
=072  \\$aD2.$x886.$x489.$x155
=072  \\$aD12.$x125.$x154.$x299
=072  \\$aD12.$x125.$x166.$x230
=150  \\$aCysteine
=450  \\$wnnna$aCysteine Hydrochloride
=450  \\$wnnna$aHalf-Cystine
=450  \\$wnnna$aHalf Cystine
=450  \\$wnnna$aL-Cysteine
=450  \\$wnnna$aL Cysteine
=450  \\$wnnna$aZinc Cysteinate
=550  \\$wg$aAmino Acids, Neutral
=550  \\$wg$aAmino Acids, Sulfur
=550  \\$wg$aSulfhydryl Compounds
=550  \\$wh$aAcetylcysteine
=550  \\$wh$aCarbocysteine
=550  \\$wh$aCysteinyldopa
=550  \\$wh$aCystine
=550  \\$wh$aSelenocysteine
=667  \\$ado not confuse with CYSTINE
=680  \\$iA thiol-containing non-essential amino acid that is oxidized to form CYSTINE.
=750  \0$aCysteine$0(DLC)sh2014002134$5IEN-M

=LDR  01425cz  a2200361n  4500
=001  9880363442402441
=005  20141212200423.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003542
=035  \\$aCAZ6683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x300.$x250
=150  \\$aCystathionine gamma-Lyase
=450  \\$aCystathionase
=450  \\$wnnna$aCystathionine gamma Lyase
=450  \\$aCysteine Desulfhydrase
=450  \\$aCystine Desulfhydrase
=450  \\$wnnna$aCystine Desulfohydrolase
=450  \\$wnnna$aDeaminase, Homoserine
=450  \\$wnnna$aDehydratase, Homoserine
=450  \\$wnnna$aDesulfhydrase, Cysteine
=450  \\$wnnna$aDesulfhydrase, Cystine
=450  \\$wnnna$aDesulfohydrolase, Cystine
=450  \\$agamma-Cystathionase
=450  \\$wnnna$agamma Cystathionase
=450  \\$wnnna$agamma-Lyase, Cystathionine
=450  \\$aHomoserine Deaminase
=450  \\$aHomoserine Dehydratase
=550  \\$wg$aCarbon-Sulfur Lyases
=667  \\$a/defic: consider also CYSTATHIONINE /urine (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)
=680  \\$iA multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia, and 2-ketobutyrate. EC 4.4.1.1.
=688  \\$a91(75); was see under LYASES 1975-90
=750  \0$aCystathionine gamma-lyase$5IEN$0(DLC)sh 85035203

=LDR  01271cz  a2200289n  4500
=001  9880363442502441
=005  20141212200419.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003532
=035  \\$aCAZ6673M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x280
=150  \\$aCyprinodontiformes
=450  \\$wnnna$aFish, Mosquito
=450  \\$aGambusia
=450  \\$wnnna$aGambusias
=450  \\$aMosquito Fish
=450  \\$aPlatyfish
=450  \\$aXiphophorus
=550  \\$wg$aSmegmamorpha
=550  \\$wh$aFundulidae
=550  \\$wh$aKillifishes
=550  \\$wh$aPoecilia
=667  \\$aGEN; prefer specifics; do not confuse with CYPRINIDAE or CYPRINIFORMES or CYPRINODON see KILLIFISHES
=680  \\$iAn order of fish with eight families and numerous species of both egg-laying and livebearing fish. Families include Cyprinodontidae (egg-laying KILLIFISHES;), FUNDULIDAEl; (topminnows), Goodeidae (Mexican livebearers), Jenynsiidae (jenynsiids), Poeciliidae (livebearers), Profundulidae (Middle American killifishes), Aplocheilidae, and Rivulidae (rivulines). In the family Poeciliidae, the guppy and molly belong to the genus POECILIA.
=688  \\$a1987(1975)
=750  \0$aCyprinodontiformes$0(DLC) sh2005001366$5IEN-M

=LDR  00920cz  a2200289n  4500
=001  9880363442602441
=005  20141212200419.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003531
=035  \\$aCAZ6672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x200
=150  \\$aCypriniformes
=450  \\$wnnna$aCatastomus
=450  \\$wnnna$aCatostomidae
=450  \\$aCatostomus
=450  \\$wnnna$aCobitidae
=450  \\$aLoaches
=450  \\$aMisgurnus
=450  \\$wnnna$aSucker (Fish)
=450  \\$aSuckers (Fish)
=550  \\$wg$aFishes
=550  \\$wh$aCyprinidae
=667  \\$ado not confuse with CYPRINODONTIFORMES
=680  \\$iAn order of fish with 26 families and over 3,000 species. This order includes the families CYPRINIDAE (minnows and CARPS), Cobitidae (loaches), and Catostomidae (suckers).
=688  \\$a1987
=750  \0$aCypriniformes$5IEN$0(DLC)sh 85035175

=LDR  01179cz   2200409n  4500
=001  9880363442702441
=005  20230831163826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003530
=035  \\$aCAZ6671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x200.$x244
=150  \\$aCyprinidae
=450  \\$aBarbels
=450  \\$wnnna$aBarbus
=450  \\$aChub
=450  \\$wnnna$aChubs
=450  \\$aDace
=450  \\$aMinnows
=450  \\$aRoach (Fish)
=450  \\$wnnna$aRutilus rutilus
=450  \\$aShiner
=450  \\$wnnna$aShiners
=450  \\$aTench
=450  \\$aTinca
=450  \\$wnnna$aTinca tinca
=450  \\$wnnna$atinca, Tinca
=450  \\$wnnna$aTinca tincas
=450  \\$wnnna$atincas, Tinca
=550  \\$wg$aCypriniformes
=550  \\$wh$aCarps
=550  \\$wh$aZebrafish
=667  \\$aGEN or unspecified; prefer specifics; note X ref; MUDMINNOWS see UMBRIDAE is also available
=680  \\$iA family of freshwater fish comprising the minnows or CARPS.
=688  \\$a1968
=750  \0$aCyprinidae$5IEN$0(DLC)sh 85035173
=750  \0$iNarrower mapping$aPugnose shiner$0(DLC)sh2022006933$4NM$5IEN-M

=LDR  01377cz  a2200409n  4500
=001  9880363442802441
=005  20141212200322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003331
=035  \\$aCAZ6481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x269
=072  \\$aA7.$x231.$x908.$x194
=150  \\$aCoronary Vessels
=450  \\$wnnna$aArteries, Coronary
=450  \\$wnnna$aArteries, Sinus Node
=450  \\$wnnna$aArtery, Coronary
=450  \\$wnnna$aArtery, Sinus Node
=450  \\$aCoronary Arteries
=450  \\$wnnna$aCoronary Artery
=450  \\$wnnna$aCoronary Vein
=450  \\$wnnna$aCoronary Veins
=450  \\$wnnna$aCoronary Vessel
=450  \\$aHeart$xblood supply
=450  \\$aMyocardium$xblood supply
=450  \\$wnnna$aSinus Node Arteries
=450  \\$aSinus Node Artery
=450  \\$wnnna$aVein, Coronary
=450  \\$wnnna$aVeins, Coronary
=450  \\$wnnna$aVessel, Coronary
=450  \\$wnnna$aVessels, Coronary
=550  \\$wg$aArteries
=550  \\$wg$aVeins
=550  \\$wh$aCoronary Sinus
=667  \\$aconsider also CORONARY CIRCULATION; /surg: consider also CORONARY ARTERY BYPASS; /radiogr: use CORONARY ANGIOGRAPHY for radiography of coronary vessels using CONTRAST MEDIA
=680  \\$iThe veins and arteries of the HEART.
=750  \0$aHeart$xBlood-vessels$5IEN-M$0(DLC)sh 85059644

=LDR  00991cz  a2200253n  4500
=001  9880363442902441
=005  20141212200322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003330
=035  \\$aCAZ6480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x210
=072  \\$aC14.$x280.$x400.$x210
=072  \\$aC16.$x131.$x240.$x400.$x210
=150  \\$aCoronary Vessel Anomalies
=450  \\$wnnna$aAnomalies, Coronary Vessel
=450  \\$wnnna$aAnomaly, Coronary Vessel
=450  \\$wnnna$aCoronary Vessel Anomaly
=450  \\$aCoronary Vessels$xabnormalities
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wh$aBland White Garland Syndrome
=550  \\$wh$aMyocardial Bridging
=680  \\$iMalformations of CORONARY VESSELS, either arteries or veins. Included are anomalous origins of coronary arteries; ARTERIOVENOUS FISTULA; CORONARY ANEURYSM; MYOCARDIAL BRIDGING; and others.
=750  \0$aHeart$xBlood vessels$xAbnormalities$5IEN-M$0(DLC)sh 85059645

=LDR  00948cz  a2200289n  4500
=001  9880363443002441
=005  20141212200321.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003329
=035  \\$aCAZ6479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x250.$x295
=072  \\$aC14.$x907.$x585.$x250.$x295
=150  \\$aCoronary Vasospasm
=450  \\$wnnna$aArtery Vasospasm, Coronary
=450  \\$wnnna$aArtery Vasospasms, Coronary
=450  \\$aCoronary Artery Vasospasm
=450  \\$wnnna$aCoronary Artery Vasospasms
=450  \\$wnnna$aCoronary Vasospasms
=450  \\$wnnna$aVasospasm, Coronary
=450  \\$wnnna$aVasospasm, Coronary Artery
=450  \\$wnnna$aVasospasms, Coronary
=450  \\$wnnna$aVasospasms, Coronary Artery
=550  \\$wg$aCoronary Disease
=680  \\$iSpasm of the large- or medium-sized coronary arteries.
=688  \\$a82
=750  \0$aCoronary vasospasm$5IEN$0(DLC)sh 85032874

=LDR  01457cz  a2200373n  4500
=001  9880363443102441
=005  20141212200321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003327
=035  \\$aCAZ6477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x250
=072  \\$aC14.$x907.$x585.$x250
=150  \\$aCoronary Disease
=450  \\$wnnna$aCoronary Diseases
=450  \\$aCoronary Heart Disease
=450  \\$wnnna$aCoronary Heart Diseases
=450  \\$wnnna$aDisease, Coronary
=450  \\$wnnna$aDisease, Coronary Heart
=450  \\$wnnna$aDiseases, Coronary
=450  \\$wnnna$aDiseases, Coronary Heart
=450  \\$wnnna$aHeart Disease, Coronary
=450  \\$wnnna$aHeart Diseases, Coronary
=550  \\$wg$aMyocardial Ischemia
=550  \\$wh$aCoronary Aneurysm
=550  \\$wh$aCoronary Artery Disease
=550  \\$wh$aCoronary Occlusion
=550  \\$wh$aCoronary Stenosis
=550  \\$wh$aCoronary-Subclavian Steal Syndrome
=550  \\$wh$aCoronary Thrombosis
=550  \\$wh$aCoronary Vasospasm
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iAn imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
=750  \0$aCoronary heart disease$0(DLC) sh 85032870$5IEN

=LDR  00638cz  a2200205n  4500
=001  9880363443202441
=005  20141212200320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003326
=035  \\$aCAZ6476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x324
=150  \\$aCoronary Circulation
=450  \\$wnnna$aCirculation, Coronary
=550  \\$wg$aBlood Circulation
=550  \\$wh$aFractional Flow Reserve, Myocardial
=667  \\$aDF: CORONARY CIRC
=680  \\$iThe circulation of blood through the CORONARY VESSELS of the HEART.
=688  \\$a72
=750  \0$aCoronary circulation$5IEN$0(DLC)sh 85032869

=LDR  00787cz  a2200241n  4500
=001  9880363443302441
=005  20141212200320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003325
=035  \\$aCAZ6475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x493.$x211
=150  \\$aCoronary Care Units
=450  \\$wnnna$aCare Unit, Coronary
=450  \\$wnnna$aCare Units, Coronary
=450  \\$wnnna$aCoronary Care Unit
=450  \\$wnnna$aUnit, Coronary Care
=450  \\$wnnna$aUnits, Coronary Care
=550  \\$wg$aIntensive Care Units
=550  \\$aCardiology Service, Hospital
=680  \\$iThe hospital unit in which patients with acute cardiac disorders receive intensive care.
=688  \\$a72(70)
=750  \0$aCoronary care units$5IEN$0(DLC)sh 85032867

=LDR  00932cz  a2200277n  4500
=001  9880363443402441
=005  20141212200319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003320
=035  \\$aCAZ6470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x375.$x177
=072  \\$aC11.$x204.$x564.$x225
=072  \\$aC11.$x294.$x177
=150  \\$aCorneal Ulcer
=450  \\$wnnna$aKeratitides, Ulcerative
=450  \\$aKeratitis, Ulcerative
=450  \\$wnnna$aUlcer, Corneal
=450  \\$wnnna$aUlcerative Keratitides
=450  \\$wnnna$aUlcerative Keratitis
=550  \\$wg$aEye Infections
=550  \\$wg$aKeratitis
=667  \\$aa form of keratitis
=680  \\$iLoss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection.
=688  \\$a65(64)
=750  \0$aCornea$xUlcers$5IEN$0(DLC)sh 85032803

=LDR  01064cz  a2200349n  4500
=001  9880363443502441
=005  20141212200317.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003316
=035  \\$aCAZ6466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x204
=150  \\$aCorneal Diseases
=450  \\$wnnna$aCorneal Disease
=450  \\$wnnna$aDisease, Corneal
=450  \\$wnnna$aDiseases, Corneal
=550  \\$wg$aEye Diseases
=550  \\$wh$aCorneal Dystrophies, Hereditary
=550  \\$wh$aCorneal Edema
=550  \\$wh$aCorneal Endothelial Cell Loss
=550  \\$wh$aCorneal Injuries
=550  \\$wh$aCorneal Neovascularization
=550  \\$wh$aCorneal Opacity
=550  \\$wh$aCorneal Wavefront Aberration
=550  \\$wh$aIridocorneal Endothelial Syndrome
=550  \\$wh$aKeratitis
=550  \\$wh$aKeratoconus
=550  \\$wh$aTrachoma
=667  \\$ainflamm dis = KERATITIS & specific
=680  \\$iDiseases of the cornea.
=688  \\$a76; was NON MESH before 1976
=750  \0$aCornea$xDiseases$5IEN$0(DLC)sh 85032797

=LDR  01581cz  a2200277n  4500
=001  9880363443602441
=005  20141212192117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003315
=035  \\$aCAZ6465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x217
=150  \\$aCornea
=360  \\$iconsider also terms at$aKERAT-
=450  \\$wnnna$aCorneas
=550  \\$wg$aAnterior Eye Segment
=550  \\$wh$aBowman Membrane
=550  \\$wh$aCorneal Stroma
=550  \\$wh$aDescemet Membrane
=550  \\$wh$aEndothelium, Corneal
=550  \\$wh$aEpithelium, Corneal
=550  \\$wh$aLimbus Corneae
=667  \\$ainflammation = KERATITIS; neoplasms = CORNEAL DISEASES (IM) + EYE NEOPLASMS (IM) + histological type of neoplasm (IM); /anat: consider CORNEAL TOPOGRAPHY
=680  \\$iThe transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)
=688  \\$a/transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89
=750  \0$aCornea$5IEN$0(DLC)sh 85032796

=LDR  00981cz  a2200337n  4500
=001  9880363443702441
=005  20141212200317.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003314
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x370
=072  \\$aD10.$x212.$x507.$x340
=072  \\$aD10.$x627.$x700.$x240
=072  \\$aD20.$x215.$x784.$x750.$x240
=072  \\$aJ2.$x500.$x375.$x400.$x250
=150  \\$aCorn Oil
=450  \\$wnnna$aCorn Oils
=450  \\$wnnna$aLipomul
=450  \\$wnnna$aLipomuls
=450  \\$aMaize Oil
=450  \\$wnnna$aMaize Oils
=450  \\$wnnna$aOil, Corn
=450  \\$wnnna$aOil, Maize
=450  \\$wnnna$aOils, Corn
=450  \\$wnnna$aOils, Maize
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=680  \\$iOil from ZEA MAYS or corn plant.
=688  \\$a91(87); was see under PLANT OILS 1987-90
=750  \0$aCorn oil$5IEN$0(DLC)sh 85032777

=LDR  01191cz  a2200289n  4500
=001  9880363443802441
=005  20160422112420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003313
=035  \\$aCAZ6463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x966
=072  \\$aJ2.$x500.$x200.$x909
=072  \\$aJ2.$x500.$x300.$x100.$x977
=150  \\$aZea mays
=450  \\$aCorn
=450  \\$wnnna$aCorn, Indian
=450  \\$aIndian Corn
=450  \\$aMaize
=450  \\$aTeosinte
=450  \\$aZea
=550  \\$wg$aAnimal Feed
=550  \\$wg$aPoaceae
=667  \\$arestrict to American corn, Zea mays: for ancient & non-American use of the word "corn" index under CEREALS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family POACEAE. It is a tall grass grown for its seed, corn, used as food and animal fodder.
=688  \\$a2003(1963)
=750  \0$aCorn$5IEN-M$0(DLC)sh 85032625

=LDR  01356cz  a2200265n  4500
=001  9880363443902441
=005  20141212200316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003312
=035  \\$aCAZ6462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x560.$x311
=150  \\$aCoriolis Force
=450  \\$wnnna$aAcceleration, Coriolis
=450  \\$aCoriolis Acceleration
=450  \\$aCoriolis Effect
=450  \\$aCoriolis Stimulation
=450  \\$wnnna$aEffect, Coriolis
=450  \\$wnnna$aForce, Coriolis
=450  \\$wnnna$aStimulation, Coriolis
=550  \\$wg$aMotion
=667  \\$aa principle of motion; named for Gaspard Coriolis (d. 1843), a French civil engineer; no qualif
=680  \\$iThe apparent deflection (Coriolis acceleration) of a body in motion with respect to the earth, as seen by an observer on the earth, attributed to a fictitious force (Coriolis force) but actually caused by the rotation of the earth. In a medical context it refers to the physiological effects (nausea, vertigo, dizziness, etc.) felt by a person moving radially in a rotating system, as a rotating space station. (From Random House Unabridged Dictionary, 2d ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a70; was CORIOLIS EFFECT 1964-69 (Prov)
=750  \0$aCoriolis force$5IEN$0(DLC)sh 85032605

=LDR  01018cz  a2200301n  4500
=001  9880363444102441
=005  20141212200315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003308
=035  \\$aCAZ6457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x240
=150  \\$aCopying Processes
=450  \\$wnnna$aCopying Process
=450  \\$wnnna$aDuplicating Process
=450  \\$aDuplicating Processes
=450  \\$aPhotocopying
=450  \\$wnnna$aProcess, Copying
=450  \\$wnnna$aProcess, Duplicating
=450  \\$wnnna$aProcesses, Copying
=450  \\$wnnna$aProcesses, Duplicating
=550  \\$wg$aInformation Science
=550  \\$wh$aMicrofilming
=550  \\$wh$aTape Recording
=550  \\$wh$aTelefacsimile
=550  \\$wh$aVideo Recording
=680  \\$iReproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source.
=750  \0$aCopying processes$5IEN$0(DLC)sh 85032443

=LDR  00620cz  a2200205n  4500
=001  9880363444202441
=005  20141212200315.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003307
=035  \\$aCAZ6456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x252.$x748.$x200
=150  \\$aCopulation
=450  \\$wnnna$aCopulations
=450  \\$aSexual Intercourse$5IEN
=550  \\$wg$aSexual Behavior, Animal
=667  \\$aanimal only: for human, use COITUS
=680  \\$iSexual union of a male and a female in non-human species.
=688  \\$a75
=750  \0$aSexual intercourse$5IEN$0(DLC)sh 85120739

=LDR  00627cz  a2200181n  4500
=001  9880363444302441
=005  20141212200313.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003302
=035  \\$aCAZ6451HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x200
=150  \\$aCoprinus
=550  \\$wg$aAgaricales
=667  \\$aa basidiomycete
=680  \\$iA genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible.
=688  \\$a91(75); was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85
=750  \0$aCoprinus$5IEN$0(DLC)sh 88022155

=LDR  00763cz  a2200205n  4500
=001  9880363444402441
=005  20141212200313.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003301
=035  \\$aCAZ6450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x270
=150  \\$aCopper Radioisotopes
=450  \\$wnnna$aRadioisotopes, Copper
=550  \\$wg$aRadioisotopes
=550  \\$aCopper
=667  \\$aCu-58-62, 64, 66-68; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes.
=688  \\$a88
=750  \0$aCopper$xIsotopes$5IEN-M$0(DLC)sh 85032301

=LDR  01083cz  a2200289n  4500
=001  9880363444502441
=005  20141212200312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003299
=035  \\$aCAZ6449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x115
=150  \\$aCooperative Behavior
=450  \\$wnnna$aBehavior, Compliant
=450  \\$wnnna$aBehavior, Cooperative
=450  \\$wnnna$aBehaviors, Compliant
=450  \\$wnnna$aBehaviors, Cooperative
=450  \\$aCollaboration
=450  \\$wnnna$aCollaborations
=450  \\$aCompliant Behavior
=450  \\$wnnna$aCompliant Behaviors
=450  \\$wnnna$aCooperative Behaviors
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iThe interaction of two or more persons or organizations directed toward a common goal which is mutually beneficial. An act or instance of working or acting together for a common purpose or benefit, i.e., joint action. (From Random House Dictionary Unabridged, 2d ed)
=688  \\$a73(71)
=750  \0$aCooperativeness$5IEN$0(DLC)sh 85032227

=LDR  02838cz  a2200673n  4500
=001  9880363444602441
=005  20141212200312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003298
=035  \\$aCAZ6448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x50.$x375.$x150
=072  \\$aE5.$x200.$x812.$x735.$x50.$x375.$x150
=072  \\$aE5.$x478.$x594.$x760.$x50.$x375.$x150
=150  \\$aCoombs Test
=450  \\$aAnti-Human Globulin Consumption Test
=450  \\$wnnna$aAnti Human Globulin Consumption Test
=450  \\$aAntiglobulin Consumption Test
=450  \\$wnnna$aAntiglobulin Consumption Tests
=450  \\$aAntiglobulin Test
=450  \\$wnnna$aAntiglobulin Test, Direct
=450  \\$wnnna$aAntiglobulin Test, Indirect
=450  \\$wnnna$aAntiglobulin Tests
=450  \\$wnnna$aAntiglobulin Tests, Direct
=450  \\$wnnna$aAntiglobulin Tests, Indirect
=450  \\$wnnna$aAntihuman Globulin Consumption Test
=450  \\$wnnna$aConsumption Test, Antiglobulin
=450  \\$wnnna$aConsumption Tests, Antiglobulin
=450  \\$wnnna$aCoomb Test
=450  \\$aCoombs' Test
=450  \\$wnnna$aCoomb's Test
=450  \\$wnnna$aCoombs Test, Direct
=450  \\$wnnna$aCoombs Test, Indirect
=450  \\$wnnna$aDirect Antiglobulin Test
=450  \\$wnnna$aDirect Antiglobulin Tests
=450  \\$wnnna$aDirect Coombs Test
=450  \\$wnnna$aIndirect Antiglobulin Test
=450  \\$wnnna$aIndirect Antiglobulin Tests
=450  \\$wnnna$aIndirect Coombs Test
=450  \\$wnnna$aTest, Antiglobulin
=450  \\$wnnna$aTest, Antiglobulin Consumption
=450  \\$wnnna$aTest, Coombs
=450  \\$wnnna$aTest, Coombs'
=450  \\$wnnna$aTest, Direct Antiglobulin
=450  \\$wnnna$aTest, Direct Coombs
=450  \\$wnnna$aTest, Indirect Antiglobulin
=450  \\$wnnna$aTest, Indirect Coombs
=450  \\$wnnna$aTests, Antiglobulin
=450  \\$wnnna$aTests, Antiglobulin Consumption
=450  \\$wnnna$aTests, Direct Antiglobulin
=450  \\$wnnna$aTests, Indirect Antiglobulin
=550  \\$wg$aHemagglutination Tests
=550  \\$aBlood Group Antigens
=667  \\$afor erythrocytes only: for lymphocytes consider HISTOCOMPATIBILITY TESTING or CYTOTOXICITY TESTS, IMMUNOLOGIC
=680  \\$iA test to detect non-agglutinating ANTIBODIES against ERYTHROCYTES by use of anti-antibodies (the Coombs' reagent.) The direct test is applied to freshly drawn blood to detect antibody bound to circulating red cells. The indirect test is applied to serum to detect the presence of antibodies that can bind to red blood cells.
=688  \\$a2013 (1966)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Coombs' Test
=750  \0$aDirect Coombs' test$5IEN-M$0(DLC)sh 88003528
=750  \0$aCoombs' test$5IEN-HS$0(DLC)sh 85032195

=LDR  00936cz  a2200313n  4500
=001  9880363444702441
=005  20141212200311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003297
=035  \\$aCAZ6447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x494.$x300
=072  \\$aJ1.$x576.$x423.$x200.$x300
=072  \\$aJ1.$x637.$x370
=150  \\$aCooking and Eating Utensils
=450  \\$wnnna$aCooking Utensil
=450  \\$wnnna$aCooking Utensils
=450  \\$wnnna$aEating Utensil
=450  \\$aEating Utensils
=450  \\$wnnna$aUtensil, Cooking
=450  \\$wnnna$aUtensil, Eating
=450  \\$wnnna$aUtensils, Cooking
=450  \\$wnnna$aUtensils, Eating
=550  \\$wg$aFood Handling
=550  \\$wg$aHousehold Articles
=550  \\$wg$aManufactured Materials
=667  \\$aDF: COOKING UTENSILS
=750  \0$aKitchen utensils$5IEN-M$0(DLC)sh 85072573
=750  \0$aTableware$5IEN-HS$0(DLC)sh 85131816

=LDR  01615cz  a2200409n  4500
=001  9880363444902441
=005  20141212200311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003295
=035  \\$aCAZ6445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x570.$x200
=150  \\$aConvulsive Therapy
=450  \\$wnnna$aComa Therapies, Insulin
=450  \\$wnnna$aComa Therapy, Insulin
=450  \\$wnnna$aConvulsive Therapies
=450  \\$wnnna$aInsulin Coma Therapies
=450  \\$aInsulin Coma Therapy
=450  \\$wnnna$aInsulin Shock Therapy
=450  \\$wnnna$aShock Therapies
=450  \\$aShock Therapy
=450  \\$aShock Therapy, Insulin
=450  \\$wnnna$aTherapies, Convulsive
=450  \\$wnnna$aTherapies, Insulin Coma
=450  \\$wnnna$aTherapies, Shock
=450  \\$wnnna$aTherapy, Convulsive
=450  \\$wnnna$aTherapy, Insulin Coma
=450  \\$wnnna$aTherapy, Insulin Shock
=450  \\$wnnna$aTherapy, Shock
=550  \\$wg$aPsychiatric Somatic Therapies
=550  \\$wh$aElectroconvulsive Therapy
=550  \\$wh$aTranscranial Direct Current Stimulation
=550  \\$aInsulin Coma
=667  \\$ado not confuse with CONVULSIONS /ther; do not confuse X ref SHOCK THERAPY with SHOCK /ther nor X ref INSULIN COMA THERAPY with INSULIN COMA; DF: CONVULSIVE THER
=680  \\$iConvulsions induced in order to treat MENTAL DISORDERS. It is used primarily in the treatment of severe affective disorders and SCHIZOPHRENIA.
=688  \\$a81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80
=750  \0$aShock therapy$5IEN$0(DLC)sh 85121713

=LDR  02534cz  a2200565n  4500
=001  9880363445002441
=005  20141212200310.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003294
=035  \\$aCAZ6444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x650
=150  \\$aSeizures, Febrile
=450  \\$wnnna$aConvulsion, Febrile
=450  \\$wnnna$aConvulsion, Fever
=450  \\$wnnna$aConvulsion, Pyrexial
=450  \\$aConvulsions, Febrile
=450  \\$wnnna$aConvulsions, Fever
=450  \\$wnnna$aConvulsions, Pyrexial
=450  \\$wnnna$aFebrile Convulsion
=450  \\$wnnna$aFebrile Convulsion Seizure
=450  \\$wnnna$aFebrile Convulsion Seizures
=450  \\$wnnna$aFebrile Convulsions
=450  \\$wnnna$aFebrile Fit
=450  \\$wnnna$aFebrile Fits
=450  \\$wnnna$aFebrile Seizure
=450  \\$aFebrile Seizures
=450  \\$wnnna$aFever Convulsion
=450  \\$wnnna$aFever Convulsions
=450  \\$wnnna$aFever Seizure
=450  \\$wnnna$aFever Seizures
=450  \\$wnnna$aFit, Febrile
=450  \\$wnnna$aFits, Febrile
=450  \\$wnnna$aPyrexial Convulsion
=450  \\$wnnna$aPyrexial Convulsions
=450  \\$aPyrexial Seizure
=450  \\$wnnna$aPyrexial Seizures
=450  \\$wnnna$aSeizure, Febrile
=450  \\$wnnna$aSeizure, Febrile, Complex
=450  \\$wnnna$aSeizure, Febrile Convulsion
=450  \\$wnnna$aSeizure, Febrile, Simple
=450  \\$wnnna$aSeizure, Fever
=450  \\$wnnna$aSeizure, Pyrexial
=450  \\$wnnna$aSeizures, Febrile Convulsion
=450  \\$wnnna$aSeizures, Fever
=450  \\$wnnna$aSeizures, Pyrexial
=550  \\$wg$aEpilepsy
=680  \\$iSeizures that occur during a febrile episode. It is a common condition, affecting 2-5% of children aged 3 months to five years. An autosomal dominant pattern of inheritance has been identified in some families. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy (i.e., a nonfebrile seizure disorder) following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. (From Menkes, Textbook of Child Neurology, 5th ed, p784)
=688  \\$a2000(1977)
=750  \0$aFebrile convulsions$5IEN$0(DLC)sh 85031757

=LDR  01096cz  a2200253n  4500
=001  9880363445102441
=005  20141212200309.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003292
=035  \\$aCAZ6443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x282.$x224
=072  \\$aD27.$x505.$x954.$x427.$x220.$x224
=150  \\$aConvulsants
=450  \\$wnnna$aConvulsant Effect
=450  \\$wnnna$aConvulsant Effects
=450  \\$wnnna$aEffect, Convulsant
=450  \\$wnnna$aEffects, Convulsant
=550  \\$wg$aCentral Nervous System Stimulants
=550  \\$aSeizures
=667  \\$anote entry term CONVULSANT EFFECT: use only for the convulsant effect of a chemical substance
=680  \\$iSubstances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools.
=688  \\$a75; was see ANALEPTICS 1963-74
=750  \0$aConvulsants$0(DLC)sh2007004827$5IEN-M

=LDR  01538cz  a2200325n  4500
=001  9880363445202441
=005  20141212200309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003291
=035  \\$aCAZ6442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x875.$x300
=150  \\$aConversion Disorder
=450  \\$aAstasia-Abasia
=450  \\$wnnna$aAstasia Abasia
=450  \\$wnnna$aConversion Disorders
=450  \\$wnnna$aConversion Hysteria
=450  \\$wnnna$aConversion Hysterias
=450  \\$wnnna$aConversion Reaction
=450  \\$wnnna$aConversion Reactions
=450  \\$aGlobus Hystericus
=450  \\$aHysteria, Conversion
=450  \\$wnnna$aHysterias, Conversion
=450  \\$wnnna$aReaction, Conversion
=450  \\$wnnna$aReactions, Conversion
=550  \\$wg$aSomatoform Disorders
=667  \\$ause Cat F3 qualif; X ref GLOBUS HYSTERICUS: of psychogenic origin but globus sensation of non-psychogenic origin is indexed under DEGLUTITION DISORDERS or specific organ/dis or other disease heading
=680  \\$iA disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
=688  \\$a81; was CONVERSION REACTION 1969-80; GLOBUS HYSTERICUS was see under CONVERSION REACTION 1974-80; ASTASIA-ABASIA was see under CONVERSION REACTION 1970-78; HYSTERIA, CONVERSION was see under CONVERSION REACTION 1969-78
=750  \0$aConversion disorder.$5IEN$0(DLC)sh 85031703

=LDR  00567cz  a2200193n  4500
=001  9880363445302441
=005  20141212200308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003289
=035  \\$aCAZ6440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x562
=150  \\$aConvalescence
=450  \\$wnnna$aConvalescences
=550  \\$wg$aDisease Attributes
=550  \\$aRecovery of Function
=667  \\$acoord IM with specific dis (IM)
=680  \\$iThe period of recovery following an illness.
=750  \0$aConvalescence$5IEN$0(DLC)sh 85031675

=LDR  01033cz  a2200265n  4500
=001  9880363445402441
=005  20141212211011.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015350
=035  \\$aCAZ6438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850.$x950.$x500
=072  \\$aF2.$x463.$x593.$x932.$x869.$x435.$x110
=072  \\$aF2.$x463.$x593.$x932.$x901.$x500
=072  \\$aG14.$x940.$x500
=150  \\$aContrast Sensitivity
=450  \\$wnnna$aSensitivity, Contrast
=450  \\$wnnna$aSensitivity, Visual Contrast
=450  \\$aVisual Contrast Sensitivity
=550  \\$wg$aForm Perception
=550  \\$wg$aVisual Acuity
=550  \\$aForm Perception
=680  \\$iThe ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease.
=688  \\$a89
=750  \0$aContrast sensitivity (Vision)$5IEN$0(DLC)sh 89005244

=LDR  01223cz  a2200361n  4500
=001  9880363445502441
=005  20141212200308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003287
=035  \\$aCAZ6437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x259.$x500
=072  \\$aD27.$x720.$x259
=150  \\$aContrast Media
=450  \\$wnnna$aAgent, Radiocontrast
=450  \\$wnnna$aAgents, Contrast
=450  \\$wnnna$aAgents, Radiocontrast
=450  \\$wnnna$aContrast Agents
=450  \\$wnnna$aContrast Materials
=450  \\$wnnna$aMaterials, Contrast
=450  \\$wnnna$aMedia, Contrast
=450  \\$wnnna$aMedia, Radiocontrast
=450  \\$wnnna$aMedia, Radiopaque
=450  \\$wnnna$aRadiocontrast Agent
=450  \\$wnnna$aRadiocontrast Agents
=450  \\$wnnna$aRadiocontrast Media
=450  \\$aRadiopaque Media
=550  \\$wg$aDiagnostic Uses of Chemicals
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$aRadiography
=667  \\$a/adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS
=680  \\$iSubstances used to allow enhanced visualization of tissues.
=750  \0$aContrast media (Diagnostic imaging)$0(DLC)sh2007006024$5IEN

=LDR  01027cz  a2200265n  4500
=001  9880363445602441
=005  20180709114438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003286
=035  \\$aCAZ6436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x323
=072  \\$aC5.$x651.$x197
=150  \\$aContracture
=450  \\$wnnna$aContractures
=550  \\$wg$aJoint Diseases
=550  \\$wg$aMuscular Diseases
=550  \\$wh$aDupuytren Contracture
=550  \\$wh$aFibromatosis, Plantar
=550  \\$wh$aHip Contracture
=550  \\$wh$aIschemic Contracture
=550  \\$aImplant Capsular Contracture
=667  \\$acoordinate IM with specific muscle or other tissue or site (IM) but not with MUSCLES, skeletal; also available are DUPUYTREN'S CONTRACTURE; HIP CONTRACTURE; VOLKMANN CONTRACTURE & EQUINUS CONTRACTURE
=680  \\$iProlonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.
=750  \0$aContracture (Pathology)$0(DLC) sh 85031649$5IEN-M

=LDR  00815cz  a2200241n  4500
=001  9880363445702441
=005  20141212200307.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003284
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x100
=150  \\$aContract Services
=450  \\$wnnna$aContract Service
=450  \\$wnnna$aService, Contract
=450  \\$wnnna$aServices, Contract
=550  \\$wg$aFinancial Management
=550  \\$wh$aCompetitive Bidding
=550  \\$wh$aOutsourced Services
=550  \\$aContracts
=667  \\$aDF: CONTRACT SERV; CONTRACTS is also available
=680  \\$iOutside services provided to an institution under a formal financial agreement.
=688  \\$a91(78); was see under FINANCIAL MANAGEMENT 1978-90
=750  \0$aContracting out$5IEN$0(DLC)sh 85031614

=LDR  01673cz  a2200385n  4500
=001  9880363445802441
=005  20141212200306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003281
=035  \\$aCAZ6431HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276.$x310
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276.$x310
=150  \\$aContraceptives, Postcoital
=450  \\$wnnna$aContraceptive Agents, Post-Coital
=450  \\$wnnna$aContraceptive Agents, Post Coital
=450  \\$wnnna$aContraceptive Agents, Postcoital
=450  \\$wnnna$aContraceptives, Emergency
=450  \\$wnnna$aContraceptives, Post-Coital
=450  \\$wnnna$aContraceptives, Post Coital
=450  \\$wnnna$aEmergency Contraceptives
=450  \\$aMorning-After Pill
=450  \\$wnnna$aMorning After Pill
=450  \\$wnnna$aPost-Coital Contraceptive Agents
=450  \\$wnnna$aPost-Coital Contraceptives
=450  \\$wnnna$aPostcoital Contraceptive Agents
=450  \\$aPostcoital Contraceptives
=550  \\$wg$aContraceptive Agents, Female
=550  \\$wh$aContraceptives, Postcoital, Hormonal
=550  \\$wh$aContraceptives, Postcoital, Synthetic
=550  \\$aContraception, Postcoital
=667  \\$apregnancy despite use = contraceptive term with no qualifiers, not with /adv eff
=680  \\$iContraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; ANTIMETABOLITES; ALKALOIDS, and PROSTAGLANDINS.
=688  \\$a73(71); MORNING AFTER PILL was see under CONTRACEPTIVES, POSTCOITAL 1973-83
=750  \0$aEmergency contraceptives$5IEN$0(DLC)sh 85031598

=LDR  01280cz  a2200313n  4500
=001  9880363445902441
=005  20141212200305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003278
=035  \\$aCAZ6428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276.$x210.$x277
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276.$x210.$x277
=150  \\$aContraceptives, Oral, Hormonal
=450  \\$wnnna$aAgents, Estrogen Contraceptive
=450  \\$wnnna$aContraceptive Agents, Estrogen
=450  \\$wnnna$aContraceptive Agents, Oral, Hormonal
=450  \\$wnnna$aContraceptives, Hormonal Oral
=450  \\$wnnna$aEstrogen Contraceptive Agents
=450  \\$wnnna$aHormonal Oral Contraceptive Agents
=450  \\$wnnna$aHormonal Oral Contraceptives
=450  \\$wnnna$aOral Contraceptive Agents, Hormonal
=450  \\$wnnna$aOral Contraceptives, Hormonal
=550  \\$wg$aContraceptives, Oral
=667  \\$apregn despite use: see note on CONTRACEPTIVE AGENTS
=680  \\$iOral contraceptives which owe their effectiveness to hormonal preparations.
=688  \\$a86(75); was see under CONTRACEPTIVES, ORAL 1975-85
=750  \0$81$wb$aSteroid hormones$5IEN$0(DLC)sh 85128053
=750  \0$81$wb$aOral contraceptives$5IEN-HS$0(DLC)sh 85095227

=LDR  01338cz  a2200325n  4500
=001  9880363446002441
=005  20141212200304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003276
=035  \\$aCAZ6426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276.$x210
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276.$x210
=150  \\$aContraceptives, Oral
=450  \\$wnnna$aContraceptives, Low-Dose Oral
=450  \\$wnnna$aContraceptives, Phasic Oral
=450  \\$wnnna$aLow-Dose Oral Contraceptives
=450  \\$wnnna$aOral Contraceptives
=450  \\$wnnna$aOral Contraceptives, Low-Dose
=450  \\$wnnna$aOral Contraceptives, Low Dose
=450  \\$wnnna$aOral Contraceptives, Phasic
=450  \\$wnnna$aPhasic Oral Contraceptives
=550  \\$wg$aContraceptive Agents, Female
=550  \\$wh$aContraceptives, Oral, Combined
=550  \\$wh$aContraceptives, Oral, Hormonal
=550  \\$wh$aContraceptives, Oral, Sequential
=550  \\$wh$aContraceptives, Oral, Synthetic
=667  \\$apregn despite use: see note on CONTRACEPTIVE AGENTS
=680  \\$iCompounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
=750  \0$aOral Contraceptives$5IEN$0(DLC)sh 85095227

=LDR  00910cz  a2200265n  4500
=001  9880363446102441
=005  20141212200304.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003275
=035  \\$aCAZ6425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x270
=150  \\$aContraceptive Devices, Male
=450  \\$wnnna$aContraceptive Device, Male
=450  \\$wnnna$aDevice, Male Contraceptive
=450  \\$wnnna$aDevices, Male Contraceptive
=450  \\$wnnna$aMale Contraceptive Device
=450  \\$wnnna$aMale Contraceptive Devices
=450  \\$aMale Contraceptives$5IEN
=550  \\$wg$aContraceptive Devices
=550  \\$wh$aCondoms
=667  \\$amechanical devices, not chemicals; pregnancy despite use = contraceptive term with no qualif, not /adv eff
=680  \\$iContraceptive devices used by males.
=688  \\$a75
=750  \0$aMale contraceptives$5IEN-M$0(DLC)sh 86005312

=LDR  01840cz  a2200553n  4500
=001  9880363446202441
=005  20141212200303.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003274
=035  \\$aCAZ6424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x250
=150  \\$aContraceptive Devices, Female
=450  \\$wnnna$aCap, Cervical
=450  \\$wnnna$aCaps, Cervical
=450  \\$wnnna$aCervical Cap
=450  \\$wnnna$aCervical Caps
=450  \\$wnnna$aCoiled Spring
=450  \\$wnnna$aCoiled Springs
=450  \\$wnnna$aContraceptive Device, Female
=450  \\$wnnna$aDevice, Female Contraceptive
=450  \\$wnnna$aDevices, Female Contraceptive
=450  \\$wnnna$aDiaphragm, Vaginal
=450  \\$wnnna$aDiaphragms, Vaginal
=450  \\$wnnna$aFemale Contraceptive Device
=450  \\$wnnna$aFemale Contraceptive Devices
=450  \\$wnnna$aRing, Vaginal
=450  \\$wnnna$aRings, Vaginal
=450  \\$wnnna$aShield, Vaginal
=450  \\$wnnna$aShields, Vaginal
=450  \\$wnnna$aSponge, Vaginal
=450  \\$wnnna$aSponges, Vaginal
=450  \\$wnnna$aSpring, Coiled
=450  \\$wnnna$aSprings, Coiled
=450  \\$wnnna$aVaginal Diaphragm
=450  \\$wnnna$aVaginal Diaphragms
=450  \\$wnnna$aVaginal Ring
=450  \\$wnnna$aVaginal Rings
=450  \\$wnnna$aVaginal Shield
=450  \\$wnnna$aVaginal Shields
=450  \\$wnnna$aVaginal Sponge
=450  \\$wnnna$aVaginal Sponges
=550  \\$wg$aContraceptive Devices
=550  \\$wh$aCondoms, Female
=550  \\$wh$aIntrauterine Devices
=667  \\$amechanical devices, not chemicals; pregnancy despite use = contraceptive term with no qualif, not /adv eff
=680  \\$iContraceptive devices used by females.
=688  \\$a75
=750  \0$aContraceptives, Vaginal$5IEN-HS$0(DLC)sh 85031599

=LDR  00947cz  a2200253n  4500
=001  9880363446302441
=005  20141212200303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003273
=035  \\$aCAZ6423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190
=150  \\$aContraceptive Devices
=450  \\$wnnna$aContraceptive Device
=450  \\$aContraceptives$5IEN
=450  \\$wnnna$aDevice, Contraceptive
=450  \\$wnnna$aDevices, Contraceptive
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aContraceptive Devices, Female
=550  \\$wh$aContraceptive Devices, Male
=667  \\$amechanical devices, not chemicals ( = CONTRACEPTIVE AGENTS); pregnancy despite use = contraceptive term with no qualif, not /adv eff
=680  \\$iDevices that diminish the likelihood of or prevent conception. (From Dorland, 28th ed)
=688  \\$a67; was CONTRACEPTIVES 1963-66
=750  \0$aContraceptives$5IEN$0(DLC)sh 85031597

=LDR  00952cz  a2200253n  4500
=001  9880363446402441
=005  20141212200303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003272
=035  \\$aCAZ6422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x443
=072  \\$aD27.$x505.$x954.$x705.$x360.$x443
=150  \\$aContraceptive Agents, Male
=450  \\$wnnna$aAgents, Male Contraceptive
=450  \\$wnnna$aContraceptives, Male
=450  \\$wnnna$aMale Contraceptive Agents
=450  \\$wnnna$aMale Contraceptives
=550  \\$wg$aContraceptive Agents
=550  \\$wh$aAntispermatogenic Agents
=667  \\$apregn despite use: see note on CONTRACEPTIVE AGENTS
=680  \\$iChemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.
=688  \\$a75
=750  \0$aMale contraceptives$5IEN$0(DLC)sh 86005312

=LDR  01185cz  a2200313n  4500
=001  9880363446502441
=005  20141212200302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003271
=035  \\$aCAZ6421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276
=150  \\$aContraceptive Agents, Female
=450  \\$wnnna$aAgents, Female Contraceptive
=450  \\$wnnna$aContraceptives, Female
=450  \\$wnnna$aFemale Contraceptive Agents
=450  \\$wnnna$aFemale Contraceptives
=550  \\$wg$aContraceptive Agents
=550  \\$wh$aContraceptives, Oral
=550  \\$wh$aContraceptives, Postcoital
=550  \\$wh$aLuteolytic Agents
=550  \\$wh$aMenstruation-Inducing Agents
=550  \\$wh$aSperm Immobilizing Agents
=550  \\$wh$aSpermatocidal Agents
=667  \\$apregn despite use: see note on CONTRACEPTIVE AGENTS
=680  \\$iChemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
=688  \\$a75
=750  \0$aContraceptives, Vaginal$0(DLC) sh 85031599$5IEN-M

=LDR  01209cz  a2200301n  4500
=001  9880363446602441
=005  20141212200302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003270
=035  \\$aCAZ6420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360
=072  \\$aD27.$x505.$x954.$x705.$x360
=150  \\$aContraceptive Agents
=450  \\$wnnna$aAgents, Contraceptive
=450  \\$aContraceptive Drugs$5IEN
=450  \\$wnnna$aContraceptive Effect
=450  \\$wnnna$aContraceptive Effects
=450  \\$wnnna$aContraceptives
=450  \\$wnnna$aEffect, Contraceptive
=450  \\$wnnna$aEffects, Contraceptive
=550  \\$wg$aReproductive Control Agents
=550  \\$wh$aContraceptive Agents, Female
=550  \\$wh$aContraceptive Agents, Male
=667  \\$achemical, not mechanical (= CONTRACEPTIVE DEVICES); pregnancy despite use = CONTRACEPTIVE AGENTS with no qualifiers, not with /adv eff; note entry term CONTRACEPTIVE EFFECT: use only for the contraceptive effect of a chemical substance
=680  \\$iChemical substances that prevent or reduce the probability of CONCEPTION.
=688  \\$a67
=750  \0$aContraceptive drugs$5IEN$0(DLC)sh 85031595

=LDR  01557cz  a2200385n  4500
=001  9880363446702441
=005  20141212200301.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003269
=035  \\$aCAZ6419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x194.$x300
=150  \\$aContraception, Immunologic
=450  \\$wnnna$aContraception, Immunological
=450  \\$wnnna$aContraceptive Technic, Immunological
=450  \\$wnnna$aContraceptive Technics, Immunological
=450  \\$wnnna$aContraceptive Technique, Immunological
=450  \\$wnnna$aContraceptive Techniques, Immunological
=450  \\$wnnna$aFertility Control, Immunological
=450  \\$aImmunocontraception
=450  \\$wnnna$aImmunocontraceptive Technique
=450  \\$wnnna$aImmunocontraceptive Techniques
=450  \\$wnnna$aImmunologic Contraception
=450  \\$wnnna$aImmunological Contraception
=450  \\$wnnna$aImmunological Contraceptive Technic
=450  \\$wnnna$aImmunological Contraceptive Technics
=450  \\$wnnna$aImmunological Contraceptive Technique
=450  \\$wnnna$aImmunological Contraceptive Techniques
=450  \\$wnnna$aImmunological Fertility Control
=550  \\$wg$aContraception
=550  \\$aVaccines, Contraceptive
=667  \\$aDF: CONTRACEPTION IMMUNOL
=680  \\$iContraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.
=688  \\$a91(75); was see under CONTRACEPTION 1975-90
=750  \0$aContraception, Immunological$5IEN$0(DLC)sh 85031594

=LDR  01819cz  a2200469n  4500
=001  9880363446802441
=005  20200525120227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003267
=035  \\$aCAZ6417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x194
=150  \\$aContraception
=450  \\$aBirth Control
=450  \\$wnnna$aContraception, Female
=450  \\$wnnna$aContraception, Male
=450  \\$wnnna$aContraceptions, Female
=450  \\$wnnna$aContraceptions, Male
=450  \\$wnnna$aContraceptive Method
=450  \\$wnnna$aContraceptive Methods
=450  \\$wnnna$aFemale Contraception
=450  \\$wnnna$aFemale Contraceptions
=450  \\$wnnna$aFertility Control
=450  \\$wnnna$aFertilization Inhibition
=450  \\$wnnna$aInhibition of Fertilization
=450  \\$wnnna$aMale Contraception
=450  \\$wnnna$aMale Contraceptions
=550  \\$wg$aReproductive Techniques
=550  \\$wh$aCoitus Interruptus
=550  \\$wh$aContraception, Barrier
=550  \\$wh$aContraception, Immunologic
=550  \\$wh$aContraception, Postcoital
=550  \\$wh$aContraceptive Effectiveness
=550  \\$wh$aLong-Acting Reversible Contraception
=550  \\$wh$aNatural Family Planning Methods
=550  \\$wh$aOvulation Inhibition
=550  \\$wh$aSterilization, Reproductive
=550  \\$aFamily Planning Services
=550  \\$aPopulation Control
=680  \\$iPrevention of CONCEPTION by blocking fertility temporarily, or permanently (STERILIZATION, REPRODUCTIVE). Common means of reversible contraception include NATURAL FAMILY PLANNING METHODS; CONTRACEPTIVE AGENTS; or CONTRACEPTIVE DEVICES.
=688  \\$a1963; for BIRTH CONTROL use FAMILY PLANNING 1968-1974, use BIRTH CONTROL 1963-1967
=750  \0$aContraception$5IEN$0(DLC)sh 85031589

=LDR  01190cz  a2200337n  4500
=001  9880363446902441
=005  20171211161515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003266
=035  \\$aCAZ6416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x169
=072  \\$aN2.$x421.$x585.$x169
=072  \\$aN4.$x590.$x233.$x727.$x210
=150  \\$aContinuity of Patient Care
=450  \\$wnnna$aCare Continuity
=450  \\$wnnna$aCare Continuity, Patient
=450  \\$wnnna$aCare Continuum
=450  \\$wnnna$aContinuity of Care
=450  \\$aContinuum of Care
=450  \\$wnnna$aPatient Care Continuity
=550  \\$wg$aPatient Care
=550  \\$wg$aPrimary Health Care
=550  \\$wh$aAftercare
=550  \\$wh$aPatient Discharge
=550  \\$wh$aPatient Handoff
=550  \\$wh$aTransition to Adult Care
=550  \\$wh$aTransitional Care
=680  \\$iHealth care provided on a continuing basis from the initial contact, following the patient through all phases of medical care.
=688  \\$a91(75); was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78
=750  \0$aContinuum of care$5IEN$0(DLC)sh 87001584

=LDR  01635cz  a2200313n  4500
=001  9880363447002441
=005  20141212200300.0
=008  790309\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003264
=035  \\$aCAZ6414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x235
=150  \\$aContainment of Biohazards
=450  \\$wnnna$aBiohazard Containment
=450  \\$aBiohazards Containment
=450  \\$wnnna$aBiologic Containment
=450  \\$wnnna$aBiological Containment
=450  \\$wnnna$aContainment
=450  \\$wnnna$aContainment, Biohazard
=450  \\$wnnna$aContainment, Biohazards
=450  \\$wnnna$aContainment, Biologic
=450  \\$wnnna$aContainment, Biological
=450  \\$wnnna$aContainment, Physical
=450  \\$wnnna$aPhysical Containment
=550  \\$wg$aInvestigative Techniques
=667  \\$afor procedures, facilities, programs & equipment for containing hazardous biologic agents; do not use for radiation ( = RADIATION PROTECTION); for recombinant DNA research: use only by MeSH definition: not for ethical, moral or religious aspects
=680  \\$iProvision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents (bacteria, viruses, recombinant DNA, etc.). Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimize the risk should the agent escape the containment facility.
=688  \\$a80
=750  \0$aBiotechnology$xSafety measures$5IEN$0(DLC)sh2009117114

=LDR  01244cz  a2200325n  4500
=001  9880363447102441
=005  20141212200259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003263
=035  \\$aCAZ6413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x500.$x276.$x360
=150  \\$aContact Lenses, Hydrophilic
=450  \\$wnnna$aContact Lens, Hydrophilic
=450  \\$wnnna$aContact Lens, Soft
=450  \\$wnnna$aContact Lenses, Soft
=450  \\$wnnna$aHydrophilic Contact Lens
=450  \\$wnnna$aHydrophilic Contact Lenses
=450  \\$wnnna$aLens, Hydrophilic Contact
=450  \\$wnnna$aLens, Soft Contact
=450  \\$aLenses, Contact, Hydrophilic
=450  \\$wnnna$aLenses, Hydrophilic Contact
=450  \\$wnnna$aLenses, Soft Contact
=450  \\$wnnna$aSoft Contact Lens
=450  \\$aSoft Contact Lenses
=550  \\$wg$aContact Lenses
=550  \\$wh$aContact Lenses, Extended-Wear
=680  \\$iSoft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilized.
=688  \\$a74(71)
=750  \0$aSoft contact lenses$5IEN$0(DLC)sh 85031505

=LDR  00520cz  a2200169n  4500
=001  9880363447202441
=005  20141212200259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003261
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x500.$x276
=150  \\$aContact Lenses
=450  \\$aLenses, Contact
=550  \\$wg$aLenses
=550  \\$wh$aContact Lenses, Hydrophilic
=680  \\$iLenses designed to be worn on the front surface of the eyeball. (UMDNS, 1999)
=750  \0$aContact lenses$5IEN$0(DLC)sh 85031503

=LDR  00903cz  a2200289n  4500
=001  9880363447302441
=005  20150129163906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003258
=035  \\$aCAZ6408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x236
=150  \\$aConsumer Behavior
=450  \\$wnnna$aBehavior, Consumer
=450  \\$wnnna$aBehaviors, Consumer
=450  \\$wnnna$aConsumer Behaviors
=450  \\$aConsumer Preference
=450  \\$wnnna$aConsumer Preferences
=450  \\$aConsumer Satisfaction
=450  \\$wnnna$aPreference, Consumer
=450  \\$wnnna$aPreferences, Consumer
=450  \\$wnnna$aSatisfaction, Consumer
=550  \\$wg$aBehavior
=688  \\$a68
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Consumer Satisfaction
=750  \0$aConsumer behavior$0(DLC)sh 87006429
=750  \0$aConsumer satisfaction$5IEN$0(DLC)sh 85031490

=LDR  00800cz  a2200265n  4500
=001  9880363447402441
=005  20141212200258.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003257
=035  \\$aCAZ6407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x210
=150  \\$aConsumer Product Safety
=450  \\$wnnna$aApproval, Product
=450  \\$wnnna$aApprovals, Product
=450  \\$wnnna$aProduct Approval
=450  \\$wnnna$aProduct Approvals
=450  \\$wnnna$aProduct Safety, Consumer
=450  \\$aSafety, Consumer Product
=550  \\$wg$aPublic Health
=550  \\$wh$aDevice Approval
=550  \\$wh$aProduct Recalls and Withdrawals
=688  \\$a82
=750  \0$aProduct safety$5IEN-M$0(DLC)sh 85107207
=750  \0$aConsumer protection$5IEN-HS$0(DLC)sh 85031486

=LDR  00851cz  a2200253n  4500
=001  9880363447502441
=005  20180102090955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003255
=035  \\$aCAZ6405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x245
=150  \\$aConsumer Organizations
=450  \\$wnnna$aConsumer Organization
=450  \\$wnnna$aOrganization, Consumer
=450  \\$wnnna$aOrganizations, Consumer
=550  \\$wg$aOrganizations
=550  \\$wh$aCommunity Participation
=667  \\$aIM; specify services, area of interest or geog if pertinent
=680  \\$iOrganized groups of users of goods and services.
=688  \\$a68
=750  \0$aConsumer cooperatives$5IEN-M$0(DLC)sh 85031478
=750  \0$aConsumer panels$5IEN-HS$0(DLC)sh 85031484
=750  \0$aCooperative societies$5IEN-HS$0(DLC)sh 85032217

=LDR  00805cz  a2200265n  4500
=001  9880363447602441
=005  20141212200257.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003254
=035  \\$aCAZ6404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x368
=072  \\$aN3.$x706.$x437.$x368
=150  \\$aConsumer Advocacy
=450  \\$wnnna$aAdvocacies, Consumer
=450  \\$wnnna$aAdvocacies, Public
=450  \\$wnnna$aAdvocacy, Consumer
=450  \\$wnnna$aAdvocacy, Public
=450  \\$wnnna$aConsumer Advocacies
=450  \\$wnnna$aPublic Advocacies
=450  \\$aPublic Advocacy
=550  \\$wg$aHuman Rights
=680  \\$iThe promotion and support of consumers' rights and interests.
=688  \\$a82
=750  \0$aConsumer protection$5IEN$0(DLC)sh 85031486

=LDR  00688cz  a2200241n  4500
=001  9880363447702441
=005  20141212200257.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003253
=035  \\$aCAZ6403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x120
=150  \\$aConsultants
=450  \\$wnnna$aAdvisory Service
=450  \\$wnnna$aAdvisory Services
=450  \\$wnnna$aConsultant
=450  \\$wnnna$aService, Advisory
=450  \\$wnnna$aServices, Advisory
=550  \\$wg$aPersons
=667  \\$afew qualif apply
=680  \\$iIndividuals referred to for expert or professional advice or services.
=688  \\$a78
=750  \0$aConsultants$5IEN$0(DLC)sh 85031469

=LDR  00650cz  a2200193n  4500
=001  9880363447802441
=005  20141212200221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003148
=035  \\$aCAZ6303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696.$x232
=150  \\$aCommunism
=450  \\$aLeninism
=450  \\$aMarxism
=550  \\$wg$aPolitical Systems
=667  \\$aspecify geog if pertinent
=680  \\$iA totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society.
=750  \0$aCommunism$5IEN$0(DLC)sh 85029120

=LDR  02551cz  a2200601n  4500
=001  9880363447902441
=005  20201208124921.0
=008  840411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003147
=035  \\$aCAZ6302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150
=072  \\$aC23.$x888.$x592.$x604.$x150
=072  \\$aF3.$x625.$x374
=150  \\$aCommunication Disorders
=450  \\$wnnna$aAcquired Communication Disorder
=450  \\$wnnna$aAcquired Communication Disorders
=450  \\$wnnna$aChildhood Communication Disorder
=450  \\$wnnna$aChildhood Communication Disorders
=450  \\$wnnna$aCommunication Disabilities
=450  \\$wnnna$aCommunication Disability
=450  \\$wnnna$aCommunication Disorder
=450  \\$wnnna$aCommunication Disorder, Acquired
=450  \\$wnnna$aCommunication Disorder, Childhood
=450  \\$wnnna$aCommunication Disorder, Developmental
=450  \\$wnnna$aCommunication Disorder, Neurogenic
=450  \\$wnnna$aCommunication Disorders, Acquired
=450  \\$wnnna$aCommunication Disorders, Childhood
=450  \\$wnnna$aCommunication Disorders, Developmental
=450  \\$wnnna$aCommunication Disorders, Neurogenic
=450  \\$wnnna$aCommunicative Disorder
=450  \\$wnnna$aCommunicative Disorders
=450  \\$wnnna$aCommunicative Dysfunction
=450  \\$wnnna$aCommunicative Dysfunctions
=450  \\$wnnna$aDevelopmental Communication Disorder
=450  \\$wnnna$aDevelopmental Communication Disorders
=450  \\$wnnna$aDisabilities, Communication
=450  \\$wnnna$aDisability, Communication
=450  \\$wnnna$aDysfunction, Communicative
=450  \\$wnnna$aDysfunctions, Communicative
=450  \\$wnnna$aNeurogenic Communication Disorder
=450  \\$wnnna$aNeurogenic Communication Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wh$aChildhood-Onset Fluency Disorder
=550  \\$wh$aLanguage Disorders
=550  \\$wh$aLearning Disabilities
=550  \\$wh$aSocial Communication Disorder
=550  \\$wh$aSpeech Sound Disorder
=667  \\$aGEN or unspecified: prefer specifics HEARING DISORDERS; LANGUAGE DISORDERS or SPEECH DISORDERS
=680  \\$iDisorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction (e.g., MENTAL RETARDATION), psychiatric conditions, and HEARING DISORDERS.
=688  \\$a1998(1985)
=750  \0$aCommunicative disorders$5IEN$0(DLC)sh 85029113

=LDR  01861cz  a2200433n  4500
=001  9880363448002441
=005  20141212200219.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003143
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x796.$x250
=150  \\$aCommunication Aids for Disabled
=450  \\$aAugmentative and Alternative Communications Systems
=450  \\$aCommunication Aids for Handicapped
=450  \\$wnnna$aCommunication Board
=450  \\$aCommunication Boards
=450  \\$wnnna$aSpeech Synthesizer
=450  \\$aSpeech Synthesizers
=450  \\$wnnna$aSynthesizer, Speech
=450  \\$wnnna$aSynthesizers, Speech
=450  \\$wnnna$aTDD
=450  \\$wnnna$aTelecommunication Device, Text
=450  \\$wnnna$aTelecommunication Devices, Text
=450  \\$wnnna$aTelecommunication, Text
=450  \\$aTelecommunications Devices for the Deaf
=450  \\$wnnna$aTelecommunications, Text
=450  \\$wnnna$aText Telecommunication
=450  \\$wnnna$aText Telecommunication Device
=450  \\$wnnna$aText Telecommunication Devices
=450  \\$wnnna$aText Telecommunications
=450  \\$wnnna$aText Telephone
=450  \\$wnnna$aText Telephones
=450  \\$wnnna$aTTY Telephone
=450  \\$wnnna$aTTY Telephones
=550  \\$wg$aSelf-Help Devices
=550  \\$aSpeech Recognition Software
=680  \\$iEquipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.
=688  \\$a93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 (see under SELF-HELP DEVICES 1980-90)
=750  \0$aCommunication devices for people with disabilities$5IEN$0(DLC)sh 85029047

=LDR  01041cz  a2200301n  4500
=001  9880363448102441
=005  20171219120150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003141
=035  \\$aCAZ6297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x221
=150  \\$aCommunicable Diseases
=450  \\$wnnna$aCommunicable Disease
=450  \\$wnnna$aDisease, Communicable
=450  \\$wnnna$aDisease, Infectious
=450  \\$wnnna$aDiseases, Communicable
=450  \\$wnnna$aDiseases, Infectious
=450  \\$wnnna$aInfectious Disease
=450  \\$aInfectious Diseases
=550  \\$wg$aInfection
=550  \\$wh$aCommunicable Diseases, Emerging
=550  \\$wh$aCommunicable Diseases, Imported
=550  \\$wh$aWaterborne Diseases
=550  \\$aDisease Outbreaks
=550  \\$aDisease Transmission, Infectious
=667  \\$a/prev = COMMUNICABLE DISEASE CONTROL for GEN only; do not confuse X ref INFECTIOUS DISEASES with INFECTION: see note there
=750  \0$aCommunicable diseases$5IEN$0(DLC)sh 85029015

=LDR  01047cz  a2200277n  4500
=001  9880363448202441
=005  20141212200217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003139
=035  \\$aCAZ6296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x207
=072  \\$aC8.$x730.$x162
=150  \\$aCommon Cold
=450  \\$wnnna$aAcute Coryza
=450  \\$wnnna$aCatarrh
=450  \\$wnnna$aCatarrhs
=450  \\$aCold, Common
=450  \\$wnnna$aColds, Common
=450  \\$wnnna$aCommon Colds
=450  \\$aCoryza, Acute
=550  \\$wg$aPicornaviridae Infections
=550  \\$wg$aRespiratory Tract Infections
=667  \\$aoften caused by a picornavirus; do not confuse CATARRH in animals with MALIGNANT CATARRH, a herpesvirus infection of cattle or with NASAL CATARRH see RHINITIS
=680  \\$iA catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing.
=750  \0$aCold (Disease)$5IEN$0(DLC)sh 85027912

=LDR  01355cz  a2200361n  4500
=001  9880363448302441
=005  20141212200216.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003134
=035  \\$aCAZ6291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x335.$x200
=072  \\$aN3.$x706.$x535.$x351.$x200
=150  \\$aCommitment of Mentally Ill
=450  \\$wnnna$aCommitment Duration
=450  \\$wnnna$aCommitment Durations
=450  \\$wnnna$aCommitment, Involuntary
=450  \\$wnnna$aCommitment, Outpatient
=450  \\$wnnna$aCommitments, Involuntary
=450  \\$wnnna$aCommitments, Outpatient
=450  \\$wnnna$aDuration of Commitment
=450  \\$aInvoluntary Commitment
=450  \\$wnnna$aInvoluntary Commitments
=450  \\$wnnna$aMentally Ill Commitment
=450  \\$wnnna$aMentally Ill Commitments
=450  \\$wnnna$aOutpatient Commitment
=450  \\$wnnna$aOutpatient Commitments
=550  \\$wg$aForensic Psychiatry
=550  \\$aMentally Ill Persons
=667  \\$ado not coord with HOSPITALIZATION since this is inherent in the definition
=680  \\$iLegal process required for the institutionalization of a patient with severe mental problems.
=688  \\$a83(75); was see under FORENSIC PSYCHIATRY 1975-82
=750  \0$aMentally ill$xCommitment and detention$5IEN$0(DLC)sh 85066555

=LDR  01419cz  a2200385n  4500
=001  9880363448402441
=005  20141212200215.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003132
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219
=150  \\$aCommerce
=450  \\$aBusiness
=450  \\$wnnna$aBusinesses
=450  \\$wnnna$aCommerces
=450  \\$wnnna$aCommercial Sector
=450  \\$wnnna$aCommercial Sectors
=450  \\$wnnna$aPrice
=450  \\$wnnna$aPrices
=450  \\$wnnna$aSale
=450  \\$wnnna$aSales
=450  \\$wnnna$aSector, Commercial
=450  \\$wnnna$aSectors, Commercial
=450  \\$wnnna$aVendor
=450  \\$wnnna$aVendors
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aCommodification
=550  \\$wh$aEntrepreneurship
=550  \\$wh$aMarketing
=550  \\$wh$aPublic-Private Sector Partnerships
=550  \\$wh$aSmall Business
=550  \\$aEthics, Business
=550  \\$aIndustry
=680  \\$iThe interchange of goods or commodities, especially on a large scale, between different countries or between populations within the same country. It includes trade (the buying, selling, or exchanging of commodities, whether wholesale or retail) and business (the purchase and sale of goods to make a profit). (From Random House Unabridged Dictionary, 2d ed, p411, p2005 & p283)
=750  \0$aCommerce$5IEN$0(DLC)sh 85028901

=LDR  01794cz  a2200385n  4500
=001  9880363448502441
=005  20141212200214.0
=008  830610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003131
=035  \\$aCAZ6288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x186
=150  \\$aCombined Modality Therapy
=450  \\$wnnna$aCombined Modality Therapies
=450  \\$wnnna$aModality Therapies, Combined
=450  \\$wnnna$aModality Therapy, Combined
=450  \\$aMultimodal Treatment
=450  \\$wnnna$aMultimodal Treatments
=450  \\$wnnna$aTherapies, Combined Modality
=450  \\$aTherapy, Combined Modality
=450  \\$wnnna$aTreatment, Multimodal
=450  \\$wnnna$aTreatments, Multimodal
=550  \\$wg$aTherapeutics
=550  \\$wh$aChemoradiotherapy
=550  \\$wh$aChemotherapy, Adjuvant
=550  \\$wh$aElectroacupuncture
=550  \\$wh$aNeoadjuvant Therapy
=550  \\$wh$aPhotochemotherapy
=550  \\$wh$aRadioimmunotherapy
=550  \\$wh$aRadiotherapy, Adjuvant
=550  \\$wh$aSalvage Therapy
=667  \\$aalmost never IM; coordinate disease term with specific ther qualif (IM) + specific ther (IM or NIM): TN 6; for combined ther of drugs DRUG COMBINATIONS or DRUG THERAPY, COMBINATION is available, for combined anticancer ther ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; CHEMOTHERAPY, ADJUVANT is also available; Manual 24.4.2.2+
=680  \\$iThe treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
=688  \\$a84
=750  \0$aCombined modality therapy$5IEN$0(DLC)sh 90000377

=LDR  01630cz  a2200445n  4500
=001  9880363448602441
=005  20141212200214.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003130
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x931.$x249
=150  \\$aCombat Disorders
=450  \\$wnnna$aCombat Disorder
=450  \\$wnnna$aCombat Neuroses
=450  \\$wnnna$aCombat Neurosis
=450  \\$wnnna$aCombat Stress Disorder
=450  \\$wnnna$aCombat Stress Disorders
=450  \\$wnnna$aDisorder, Combat
=450  \\$wnnna$aDisorder, Combat Stress
=450  \\$wnnna$aDisorders, Combat
=450  \\$wnnna$aDisorders, Combat Stress
=450  \\$wnnna$aNeuroses, Combat
=450  \\$aNeuroses, War
=450  \\$wnnna$aNeurosis, Combat
=450  \\$wnnna$aNeurosis, War
=450  \\$wnnna$aShell Shock
=450  \\$wnnna$aShell Shocks
=450  \\$wnnna$aShock, Shell
=450  \\$wnnna$aShocks, Shell
=450  \\$wnnna$aStress Disorder, Combat
=450  \\$wnnna$aStress Disorders, Combat
=450  \\$aWar Neuroses
=450  \\$wnnna$aWar Neurosis
=550  \\$wg$aStress Disorders, Traumatic
=550  \\$aStress Disorders, Post-Traumatic
=550  \\$aWar
=667  \\$anote category: do not confuse with war wounds ( = WOUNDS AND INJURIES or specific injury (IM) + WAR (IM or NIM) ); STRESS DISORDERS, POST-TRAUMATIC is also available
=680  \\$iNeurotic reactions to unusual, severe, or overwhelming military stress.
=688  \\$a91(81); was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80
=750  \0$aWar neuroses$5IEN$0(DLC)sh 85145190

=LDR  00994cz  a2200265n  4500
=001  9880363448702441
=005  20141212200213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003128
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x358.$x800.$x200
=072  \\$aC23.$x888.$x592.$x604.$x359.$x800.$x200
=150  \\$aComa
=450  \\$wnnna$aComas
=450  \\$aComatose
=450  \\$aPseudocoma
=450  \\$wnnna$aPseudocomas
=550  \\$wg$aUnconsciousness
=550  \\$wh$aBrain Death
=550  \\$wh$aComa, Post-Head Injury
=550  \\$wh$aInsulin Coma
=550  \\$aPersistent Vegetative State
=667  \\$acheck MeSH for specific coma terms
=680  \\$iA profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
=750  \0$aComa$0(DLC) sh 85028781$5IEN

=LDR  01472cz  a2200409n  4500
=001  9880363448802441
=005  20141212192115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003127
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x150
=072  \\$aE1.$x370.$x388.$x250.$x150
=072  \\$aE4.$x502.$x250.$x150
=072  \\$aE4.$x520.$x150
=072  \\$aE4.$x950.$x300.$x210
=150  \\$aColposcopy
=450  \\$wnnna$aColposcopic Surgeries
=450  \\$wnnna$aColposcopic Surgery
=450  \\$wnnna$aColposcopic Surgical Procedure
=450  \\$aColposcopic Surgical Procedures
=450  \\$wnnna$aColposcopies
=450  \\$wnnna$aProcedure, Colposcopic Surgical
=450  \\$wnnna$aProcedures, Colposcopic Surgical
=450  \\$wnnna$aSurgeries, Colposcopic
=450  \\$wnnna$aSurgery, Colposcopic
=450  \\$wnnna$aSurgical Procedure, Colposcopic
=450  \\$aSurgical Procedures, Colposcopic
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wg$aEndoscopy
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$wg$aObstetric Surgical Procedures
=550  \\$aCervix Uteri
=550  \\$aColposcopes
=550  \\$aVagina
=667  \\$a/ instrum permitted but consider also COLPOSCOPES
=680  \\$iThe examination, therapy or surgery of the cervix and vagina by means of a specially designed endoscope introduced vaginally.
=750  \0$aColposcopy$5IEN$0(DLC)sh 85028718

=LDR  00734cz  a2200193n  4500
=001  9880363448902441
=005  20141212200213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003126
=035  \\$aCAZ6283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x194
=150  \\$aColostrum
=450  \\$wnnna$aColostrums
=550  \\$wg$aBodily Secretions
=550  \\$aLactation
=667  \\$acheck the tags FEMALE & PREGNANCY
=680  \\$iThe thin, yellow, serous fluid secreted by the mammary glands during pregnancy and immediately postpartum before lactation begins. It consists of immunologically active substances, white blood cells, water, protein, fat, and carbohydrates.
=750  \0$aColostrum$5IEN$0(DLC)sh 85028714

=LDR  00806cz  a2200229n  4500
=001  9880363449002441
=005  20141212200212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003125
=035  \\$aCAZ6282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x338.$x225
=072  \\$aE4.$x579.$x338.$x225
=150  \\$aColostomy
=450  \\$wnnna$aColostomies
=550  \\$wg$aEnterostomy
=550  \\$aColon
=550  \\$aSurgical Stomas
=667  \\$aartificial anus goes here; pathological artificial anus in historical literature is indexed under INTESTINAL FISTULA or its specifics
=680  \\$iThe surgical construction of an opening between the colon and the surface of the body.
=688  \\$aANUS, ARTIFICIAL was see COLOSTOMY 1975-97
=750  \0$aColostomy$0(DLC) sh 85028713$5IEN

=LDR  01533cz  a2200397n  4500
=001  9880363529302441
=005  20141212201344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005193
=035  \\$aCAZ8338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x401
=072  \\$aN2.$x421.$x800.$x249
=150  \\$aFamily Planning Services
=450  \\$aFamily Planning
=450  \\$wnnna$aFamily Planning Program
=450  \\$wnnna$aFamily Planning Programs
=450  \\$wnnna$aFamily Planning Service
=450  \\$wnnna$aPlanned Pregnancies
=450  \\$wnnna$aPlanned Pregnancy
=450  \\$wnnna$aPlanning Service, Family
=450  \\$wnnna$aPlanning Services, Family
=450  \\$wnnna$aPregnancies, Planned
=450  \\$wnnna$aPregnancy, Planned
=450  \\$wnnna$aProgram, Family Planning
=450  \\$wnnna$aPrograms, Family Planning
=450  \\$wnnna$aService, Family Planning
=450  \\$wnnna$aServices, Family Planning
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aReproductive Health Services
=550  \\$aContraception
=550  \\$aPopulation Control
=667  \\$a/legis: consider also FAMILY PLANNING POLICY
=680  \\$iHealth care programs or services designed to assist individuals in the planning of family size. Various methods of CONTRACEPTION can be used to control the number and timing of childbirths.
=688  \\$a2004 (1968); for FAMILY PLANNING PROGRAMS use HEALTH PLANNING 1980-2003
=750  \0$aFamily planning$0(DLC)sh2009005770$5IEN-M

=LDR  00847cz  a2200193n  4500
=001  9880363529402441
=005  20141212201344.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005192
=035  \\$aCAZ8337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x300
=150  \\$aFamily Health
=450  \\$wnnna$aHealth, Family
=550  \\$wg$aHealth
=667  \\$ahealth status of family as a unit & impact on individual members; /ethnol permitted
=680  \\$iThe health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members.
=688  \\$a91(79); was see under FAMILY 1979-90
=750  \0$aFamilies$xHealth and hygiene$5IEN-M$0(DLC)sh 85047013

=LDR  03080cz  a2200949n  4500
=001  9880363529502441
=005  20141212192209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005191
=035  \\$aCAZ8336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315
=072  \\$aI1.$x240.$x361
=072  \\$aI1.$x880.$x853.$x150.$x423
=072  \\$aN1.$x224.$x361
=072  \\$aN1.$x824.$x308
=072  \\$aN6.$x850.$x505.$x400.$x400
=150  \\$aFamily Characteristics
=450  \\$wnnna$aAverage Family Size
=450  \\$wnnna$aAverage Family Sizes
=450  \\$wnnna$aCharacteristic, Family
=450  \\$wnnna$aCharacteristics, Family
=450  \\$wnnna$aCompleted Family Size
=450  \\$wnnna$aCompleted Family Sizes
=450  \\$wnnna$aCouples
=450  \\$wnnna$aDemographies, Family
=450  \\$wnnna$aDemography, Family
=450  \\$wnnna$aDesired Family Size
=450  \\$wnnna$aDesired Family Sizes
=450  \\$wnnna$aExpected Family Size
=450  \\$wnnna$aExpected Family Sizes
=450  \\$wnnna$aFamily and Household
=450  \\$wnnna$aFamily Characteristic
=450  \\$wnnna$aFamily Demographies
=450  \\$wnnna$aFamily Demography
=450  \\$wnnna$aFamily Life Survey
=450  \\$wnnna$aFamily Life Surveys
=450  \\$aFamily Size
=450  \\$wnnna$aFamily Size, Average
=450  \\$wnnna$aFamily Size, Completed
=450  \\$wnnna$aFamily Size, Desired
=450  \\$wnnna$aFamily Size, Expected
=450  \\$wnnna$aFamily Size, Ideal
=450  \\$wnnna$aFamily Sizes
=450  \\$wnnna$aFamily Sizes, Average
=450  \\$wnnna$aFamily Sizes, Completed
=450  \\$wnnna$aFamily Sizes, Desired
=450  \\$wnnna$aFamily Sizes, Expected
=450  \\$wnnna$aFamily Sizes, Ideal
=450  \\$wnnna$aGenerations
=450  \\$wnnna$aHead of Household
=450  \\$wnnna$aHousehold
=450  \\$wnnna$aHousehold and Family
=450  \\$wnnna$aHousehold Head
=450  \\$wnnna$aHousehold Heads
=450  \\$wnnna$aHousehold, One-Person
=450  \\$wnnna$aHouseholds
=450  \\$wnnna$aHouseholds, One-Person
=450  \\$wnnna$aIdeal Family Size
=450  \\$wnnna$aIdeal Family Sizes
=450  \\$wnnna$aLife Survey, Family
=450  \\$wnnna$aLife Surveys, Family
=450  \\$wnnna$aMatriarchies
=450  \\$wnnna$aMatriarchy
=450  \\$wnnna$aOne-Person Household
=450  \\$wnnna$aOne Person Household
=450  \\$wnnna$aOne-Person Households
=450  \\$wnnna$aPatriarchies
=450  \\$wnnna$aPatriarchy
=450  \\$wnnna$aSurvey, Family Life
=450  \\$wnnna$aSurveys, Family Life
=550  \\$wg$aDemography
=550  \\$wg$aFamily
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aBirth Intervals
=550  \\$wh$aBirth Order
=550  \\$wh$aMarital Status
=680  \\$iSize and composition of the family.
=688  \\$a68
=750  \0$aFamily demography$5IEN-M$0(DLC)sh 86007368
=750  \0$aFamily size$5IEN-HS$0(DLC)sh 85047065
=750  \0$aHouseholds$5IEN-HS$0(DLC)sh 85062594

=LDR  01969cz  a2200601n  4500
=001  9880363529602441
=005  20170329103824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005190
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263
=072  \\$aI1.$x880.$x853.$x150
=150  \\$aFamily
=450  \\$wnnna$aExtended Families
=450  \\$wnnna$aExtended Family
=450  \\$wnnna$aFamilies
=450  \\$wnnna$aFamilies, Extended
=450  \\$wnnna$aFamilies, Reconstituted
=450  \\$wnnna$aFamily, Extended
=450  \\$wnnna$aFamily Life Cycle
=450  \\$aFamily Life Cycles
=450  \\$wnnna$aFamily Member
=450  \\$aFamily Members
=450  \\$aFamily, Reconstituted
=450  \\$wnnna$aFamily Research
=450  \\$wnnna$aFiliation
=450  \\$wnnna$aKinship Network
=450  \\$wnnna$aKinship Networks
=450  \\$wnnna$aLife Cycle, Family
=450  \\$wnnna$aLife Cycles, Family
=450  \\$wnnna$aNetwork, Kinship
=450  \\$wnnna$aNetworks, Kinship
=450  \\$wnnna$aReconstituted Families
=450  \\$wnnna$aReconstituted Family
=450  \\$wnnna$aRelatives
=450  \\$wnnna$aResearch, Family
=450  \\$wnnna$aStepfamilies
=450  \\$aStepfamily
=550  \\$wg$aPsychology, Social
=550  \\$wg$aSociological Factors
=550  \\$wh$aAdoption
=550  \\$wh$aAdult Children
=550  \\$wh$aBirth Order
=550  \\$wh$aFamily Characteristics
=550  \\$wh$aFamily Relations
=550  \\$wh$aGrandparents
=550  \\$wh$aIllegitimacy
=550  \\$wh$aMilitary Family
=550  \\$wh$aNuclear Family
=550  \\$wh$aSingle-Parent Family
=667  \\$aentry term FAMILY LIFE CYCLES refers to stages through which the family evolves (e.g., marriage, childbearing & death): do not confuse with LIFE CHANGE EVENTS
=680  \\$iA social group consisting of parents or parent substitutes and children.
=750  \0$aFamilies$5IEN$0(DLC)sh 85047009

=LDR  01583cz  a2200349n  4500
=001  9880363529702441
=005  20141212201343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005187
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x114.$x373
=072  \\$aA13.$x706.$x500
=150  \\$aFallopian Tubes
=450  \\$wnnna$aFallopian Tube
=450  \\$wnnna$aMammalian Oviduct
=450  \\$wnnna$aMammalian Oviducts
=450  \\$wnnna$aOviduct, Mammalian
=450  \\$aOviducts, Mammalian
=450  \\$wnnna$aSalpinges
=450  \\$wnnna$aSalpinx
=450  \\$wnnna$aTube, Fallopian
=450  \\$wnnna$aTube, Uterine
=450  \\$wnnna$aTubes, Fallopian
=450  \\$wnnna$aTubes, Uterine
=450  \\$wnnna$aUterine Tube
=450  \\$wnnna$aUterine Tubes
=550  \\$wg$aAdnexa Uteri
=550  \\$wg$aOviducts
=550  \\$aOviducts
=667  \\$amammalian only; non-mammalian use OVIDUCTS; inflammation = SALPINGITIS; tubal sterilization = STERILIZATION, TUBAL; "fallopian" is not capitalized in titles or translations
=680  \\$iA pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.
=750  \0$aFallopian tubes$5IEN$0(DLC)sh 85046977

=LDR  00974cz  a2200277n  4500
=001  9880363529802441
=005  20141212201342.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005184
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x390
=150  \\$aFallopian Tube Diseases
=450  \\$wnnna$aDisease, Fallopian Tube
=450  \\$wnnna$aDiseases, Fallopian Tube
=450  \\$wnnna$aFallopian Tube Disease
=450  \\$wnnna$aObstruction, Tubal
=450  \\$wnnna$aObstructions, Tubal
=450  \\$wnnna$aTubal Obstruction
=450  \\$wnnna$aTubal Obstructions
=550  \\$wg$aAdnexal Diseases
=550  \\$wh$aFallopian Tube Neoplasms
=550  \\$wh$aSalpingitis
=667  \\$ainflamm dis = SALPINGITIS
=680  \\$iDiseases involving the FALLOPIAN TUBES including neoplasms (FALLOPIAN TUBE NEOPLASMS); SALPINGITIS; tubo-ovarian abscess; and blockage.
=688  \\$a80
=750  \0$aFallopian tubes$xDiseases$5IEN$0(DLC)sh2005006502

=LDR  00603cz  a2200193n  4500
=001  9880363529902441
=005  20141212201341.0
=008  830224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005183
=035  \\$aCAZ8328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x338
=150  \\$aFailure to Thrive
=450  \\$wnnna$aThrive, Failure to
=550  \\$wg$aSigns and Symptoms
=667  \\$apermitted with all age groups
=680  \\$iA condition of substandard growth or diminished capacity to maintain normal function.
=688  \\$a84
=750  \0$aFailure to thrive syndrome$5IEN$0(DLC)sh 85046886

=LDR  00874cz  a2200277n  4500
=001  9880363530002441
=005  20150623160223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005181
=035  \\$aCAZ8326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x463.$x473
=072  \\$aM1.$x526.$x339.$x473
=072  \\$aM1.$x526.$x485.$x390
=072  \\$aN2.$x360.$x390
=150  \\$aFaculty, Nursing
=450  \\$wnnna$aFaculties, Nursing
=450  \\$wnnna$aNursing Faculties
=450  \\$aNursing Faculty
=550  \\$wg$aFaculty
=550  \\$wg$aHealth Personnel
=667  \\$aManual 30.9; DF: FACULTY NURS
=680  \\$iThe teaching staff and members of the administrative staff having academic rank in a nursing school.
=688  \\$a66
=750  \0$aNursing schools$xFaculty$5IEN$0(DLC)sh 85093429
=750  \0$aNurse educators$0(DLC)sh2015000667$5IEN-M

=LDR  00851cz  a2200265n  4500
=001  9880363530102441
=005  20141212201341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005180
=035  \\$aCAZ8325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x463.$x373
=072  \\$aM1.$x526.$x339.$x373
=072  \\$aM1.$x526.$x485.$x375
=072  \\$aN2.$x360.$x375
=150  \\$aFaculty, Medical
=450  \\$wnnna$aFaculties, Medical
=450  \\$wnnna$aMedical Faculties
=450  \\$wnnna$aMedical Faculty
=550  \\$wg$aFaculty
=550  \\$wg$aHealth Personnel
=667  \\$aManual 30.9; see also note under FACULTY; DF: FACULTY MED
=680  \\$iThe teaching staff and members of the administrative staff having academic rank in a medical school.
=688  \\$a66
=750  \0$aMedical colleges$xFaculty$5IEN$0(DLC)sh 85082903

=LDR  00811cz  a2200265n  4500
=001  9880363530202441
=005  20141212201340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005179
=035  \\$aCAZ8324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x463.$x273
=072  \\$aM1.$x526.$x339.$x273
=072  \\$aM1.$x526.$x485.$x360
=072  \\$aN2.$x360.$x360
=150  \\$aFaculty, Dental
=450  \\$wnnna$aDental Faculties
=450  \\$wnnna$aDental Faculty
=450  \\$wnnna$aFaculties, Dental
=550  \\$wg$aFaculty
=550  \\$wg$aHealth Personnel
=667  \\$aManual 30.9; DF: FACULTY DENT
=680  \\$iThe teaching staff and members of the administrative staff having academic rank in a dental school.
=688  \\$a66
=750  \0$aDental schools$xFaculty$5IEN$0(IEN)367684

=LDR  01183cz  a2200289n  4500
=001  9880363530302441
=005  20180703111319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005178
=035  \\$aCAZ8323HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x702.$x250
=150  \\$aFaculty
=450  \\$wnnna$aUniversity Professor
=450  \\$wnnna$aProfessor, University
=450  \\$wnnna$aProfessors, University
=450  \\$wnnna$aUniversity Professors
=550  \\$wg$aEducational Personnel
=550  \\$wh$aFaculty, Dental
=550  \\$wh$aFaculty, Medical
=550  \\$wh$aFaculty, Nursing
=550  \\$wh$aFaculty, Pharmacy
=550  \\$aTeaching
=667  \\$anot for Faculté de Médecine nor Facultad de Medicina ( = SCHOOLS, MEDICAL); do not confuse FACULTY with TEACHING: FACULTY suggests differentiation from student or administrator, teaching suggests the imparting of knowledge (Manual 30.10); Manual 30.9, 34.14
=680  \\$iTEACHING and administrative staff having academic rank in a post-secondary educational institution.
=688  \\$a68; FACULTY, PHARMACY was heading 1968-85
=750  \0$aFaculty (Education)$0(DLC)sh 85046860$5IEN-M

=LDR  01392cz  a2200349n  4500
=001  9880363530402441
=005  20141212201340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005176
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125.$x475
=072  \\$aD23.$x119.$x475
=150  \\$aFactor XIII
=450  \\$wnnna$aBlood Coagulation Factor XIII
=450  \\$aCoagulation Factor XIII
=450  \\$wnnna$aFactor XIII A-Chain
=450  \\$wnnna$aFactor XIII A Chain
=450  \\$wnnna$aFactor XIII, Coagulation
=450  \\$aFactor XIII Transamidase
=450  \\$aFibrin Stabilizing Factor
=450  \\$aFibrinase
=450  \\$wnnna$aLaki Lorand Factor
=450  \\$aLaki-Lorand Factor
=450  \\$wnnna$aStabilizing Factor, Fibrin
=450  \\$wnnna$aTransamidase, Factor XIII
=450  \\$wnnna$aXIII, Coagulation Factor
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wh$aFactor XIIIa
=667  \\$aactivated form use FACTOR XIIIA
=680  \\$iA fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade.
=688  \\$a1970(1964); for FACTOR XIII TRANSAMIDASE see TRANSGLUTAMINASES (1990-2001)
=750  \0$aBlood coagulation factor XIII$5IEN$0(DLC)sh 85014974

=LDR  01458cz  a2200385n  4500
=001  9880363530502441
=005  20141212201337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005169
=035  \\$aCAZ8314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125.$x350
=072  \\$aD23.$x119.$x350
=150  \\$aFactor VIII
=450  \\$wnnna$aBlood Coagulation Factor VIII
=450  \\$aCoagulation Factor VIII
=450  \\$wnnna$aF VIII-C
=450  \\$wnnna$aF VIII C
=450  \\$aFactor VIII Clotting Antigen
=450  \\$aFactor VIII Coagulant Antigen
=450  \\$aFactor VIII Procoagulant Activity
=450  \\$wnnna$aFactor VIIIC
=450  \\$wnnna$aHyate-C
=450  \\$wnnna$aHyate C
=450  \\$wnnna$aHyateC
=450  \\$wnnna$aHyatt-C
=450  \\$wnnna$aHyatt C
=450  \\$wnnna$aHyattC
=450  \\$wnnna$aSpeywood Brand of Porcine Factor VIII Preparation
=450  \\$aThromboplastinogen
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wh$aFactor VIIIa
=550  \\$aHemophilia A
=680  \\$iBlood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.
=750  \0$aBlood coagulation factor VIII$5IEN$0(DLC)sh 85014972

=LDR  01307cz  a2200349n  4500
=001  9880363530602441
=005  20141212201335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005164
=035  \\$aCAZ8309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125.$x375
=072  \\$aD23.$x119.$x375
=150  \\$aFactor IX
=450  \\$aAutoprothrombin II
=450  \\$wnnna$aBlood Coagulation Factor IX
=450  \\$aChristmas Factor
=450  \\$aCoagulation Factor IX
=450  \\$wnnna$aComplex, Factor IX
=450  \\$wnnna$aFactor IX, Coagulation
=450  \\$wnnna$aFactor IX Complex
=450  \\$wnnna$aFactor IX Fraction
=450  \\$wnnna$aFraction, Factor IX
=450  \\$wnnna$aIX, Coagulation Factor
=450  \\$wnnna$aIX Complex, Factor
=450  \\$wnnna$aIX Fraction, Factor
=450  \\$aPlasma Thromboplastin Component
=450  \\$aPTC
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wh$aFactor IXa
=680  \\$iStorage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease).
=750  \0$aBlood coagulation factor IX$5IEN$0(DLC)sh 91000506

=LDR  01404cz  a2200301n  4500
=001  9880363530702441
=005  20141212201335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005163
=035  \\$aCAZ8308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x400
=072  \\$aN5.$x715.$x360.$x750.$x350
=072  \\$aN6.$x850.$x520.$x830.$x400
=150  \\$aFactor Analysis, Statistical
=450  \\$wnnna$aAnalyses, Factor
=450  \\$wnnna$aAnalyses, Statistical Factor
=450  \\$wnnna$aAnalysis, Factor
=450  \\$wnnna$aAnalysis, Statistical Factor
=450  \\$wnnna$aFactor Analyses
=450  \\$wnnna$aFactor Analyses, Statistical
=450  \\$wnnna$aFactor Analysis
=450  \\$wnnna$aStatistical Factor Analyses
=450  \\$wnnna$aStatistical Factor Analysis
=550  \\$wg$aStatistics as Topic
=667  \\$aa specific statist technique: not a synonym for "analysis of various factors..."; IM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires.
=750  \0$aFactor analysis$5IEN$0(DLC)sh 85046817

=LDR  00988cz  a2200265n  4500
=001  9880363530802441
=005  20141212201334.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005162
=035  \\$aCAZ8307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x400
=150  \\$aFactitious Disorders
=450  \\$wnnna$aDisorders, Factitious
=450  \\$aGanser Syndrome
=450  \\$aPseudodementia
=450  \\$aPseudopsychosis
=450  \\$wnnna$aSyndrome, Ganser
=550  \\$wg$aMental Disorders
=550  \\$wh$aMunchausen Syndrome
=550  \\$wh$aMunchausen Syndrome by Proxy
=667  \\$adifferentiate from SOMATOFORM DISORDERS: factitious are phys or psychol sympt under voluntary control, somatoform are phys sympt linked to psychol factors but not under voluntary control
=680  \\$iDisorders characterized by physical or psychological symptoms that are not real, genuine, or natural.
=688  \\$a81
=750  \0$aFactitious disorders$5IEN$0(DLC)sh 93000060

=LDR  02189cz  a2200529n  4500
=001  9880363530902441
=005  20141212201333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005158
=035  \\$aCAZ8303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x327
=072  \\$aC10.$x597.$x622.$x214
=072  \\$aC23.$x888.$x592.$x636.$x214
=150  \\$aFacial Paralysis
=450  \\$wnnna$aCentral Facial Paralyses
=450  \\$wnnna$aCentral Facial Paralysis
=450  \\$wnnna$aFacial Palsies
=450  \\$aFacial Palsy
=450  \\$wnnna$aFacial Palsy, Lower Motor Neuron
=450  \\$wnnna$aFacial Palsy, Upper Motor Neuron
=450  \\$wnnna$aFacial Paralyses, Central
=450  \\$wnnna$aFacial Paralyses, Peripheral
=450  \\$wnnna$aFacial Paralysis, Central
=450  \\$wnnna$aFacial Paralysis, Peripheral
=450  \\$wnnna$aFacial Paresis
=450  \\$aHemifacial Paralysis
=450  \\$wnnna$aLower Motor Neuron Facial Palsy
=450  \\$wnnna$aPalsies, Facial
=450  \\$wnnna$aPalsy, Facial
=450  \\$wnnna$aParalyses, Central Facial
=450  \\$wnnna$aParalyses, Facial
=450  \\$wnnna$aParalyses, Hemifacial
=450  \\$wnnna$aParalysis, Central Facial
=450  \\$wnnna$aParalysis, Facial
=450  \\$wnnna$aParalysis, Hemifacial
=450  \\$wnnna$aParalysis, Peripheral Facial
=450  \\$wnnna$aPareses, Facial
=450  \\$wnnna$aParesis, Facial
=450  \\$wnnna$aPeripheral Facial Paralysis
=450  \\$wnnna$aUpper Motor Neuron Facial Palsy
=550  \\$wg$aMouth Diseases
=550  \\$wg$aParalysis
=550  \\$aHerpes Zoster Oticus
=550  \\$aMobius Syndrome
=680  \\$iSevere or complete loss of facial muscle motor function. This condition may result from central or peripheral lesions. Damage to CNS motor pathways from the cerebral cortex to the facial nuclei in the pons leads to facial weakness that generally spares the forehead muscles. FACIAL NERVE DISEASES generally results in generalized hemifacial weakness. NEUROMUSCULAR JUNCTION DISEASES and MUSCULAR DISEASES may also cause facial paralysis or paresis.
=750  \0$aFacial paralysis$5IEN$0(DLC)sh 85097835

=LDR  01425cz  a2200373n  4500
=001  9880363531002441
=005  20141212201332.0
=008  850507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005157
=035  \\$aCAZ8302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x364
=072  \\$aC23.$x888.$x592.$x612.$x330
=072  \\$aC23.$x888.$x646.$x429
=150  \\$aFacial Pain
=450  \\$aCraniofacial Pain
=450  \\$wnnna$aFace Pain
=450  \\$wnnna$aFacial Pain, Neuralgic
=450  \\$aMyofacial Pain
=450  \\$wnnna$aNeuralgic Facial Pain
=450  \\$aOrofacial Pain
=450  \\$wnnna$aPain, Craniofacial
=450  \\$wnnna$aPain, Face
=450  \\$aPain, Facial
=450  \\$wnnna$aPain, Myofacial
=450  \\$wnnna$aPain, Neuralgic Facial
=450  \\$wnnna$aPain, Orofacial
=550  \\$wg$aPain
=550  \\$wh$aToothache
=550  \\$aFacial Neuralgia
=680  \\$iPain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.
=688  \\$a1986
=750  \0$aOrofacial pain$5IEN-M$0(DLC)sh 85095738
=750  \0$aFacial pain$5IEN-HS$0(DLC)sh 85046810

=LDR  01951cz  a2200517n  4500
=001  9880363531102441
=005  20141212201332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005156
=035  \\$aCAZ8301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x313
=072  \\$aC10.$x292.$x300.$x625
=072  \\$aC10.$x292.$x375
=150  \\$aFacial Neuralgia
=450  \\$wnnna$aCraniofacial Pain Syndrome
=450  \\$wnnna$aCraniofacial Pain Syndromes
=450  \\$wnnna$aFacial Neuralgias
=450  \\$wnnna$aFacial Pain Syndrome
=450  \\$aFacial Pain Syndromes
=450  \\$wnnna$aMyofacial Pain Syndrome
=450  \\$wnnna$aMyofacial Pain Syndromes
=450  \\$wnnna$aNeuralgia, Facial
=450  \\$wnnna$aNeuralgia, Sphenopalatine
=450  \\$wnnna$aNeuralgias, Facial
=450  \\$wnnna$aNeuralgias, Sphenopalatine
=450  \\$wnnna$aPain Syndrome, Craniofacial
=450  \\$wnnna$aPain Syndrome, Facial
=450  \\$wnnna$aPain Syndrome, Myofacial
=450  \\$wnnna$aPain Syndromes, Craniofacial
=450  \\$wnnna$aPain Syndromes, Facial
=450  \\$wnnna$aPain Syndromes, Myofacial
=450  \\$aSphenopalatine Neuralgia
=450  \\$wnnna$aSphenopalatine Neuralgias
=450  \\$wnnna$aSyndrome, Craniofacial Pain
=450  \\$wnnna$aSyndrome, Facial Pain
=450  \\$wnnna$aSyndrome, Myofacial Pain
=450  \\$wnnna$aSyndromes, Craniofacial Pain
=450  \\$wnnna$aSyndromes, Facial Pain
=450  \\$wnnna$aSyndromes, Myofacial Pain
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aFacial Nerve Diseases
=550  \\$wg$aMouth Diseases
=550  \\$aFacial Pain
=680  \\$iNeuralgic syndromes and other conditions which feature chronic or recurrent FACIAL PAIN as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.
=750  \0$aNeuralgia, Facial$5IEN$0(DLC)sh 85091102

=LDR  02908cz  a2200733n  4500
=001  9880363531202441
=005  20141212201331.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005155
=035  \\$aCAZ8300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x300
=150  \\$aFacial Nerve Diseases
=450  \\$wnnna$aAcquired Facial Neuropathies
=450  \\$aAcquired Facial Neuropathy
=450  \\$aCranial Nerve VII Diseases
=450  \\$wnnna$aCranial Nerve VII Disorders
=450  \\$wnnna$aDisease, Facial Nerve
=450  \\$wnnna$aDiseases, Facial Nerve
=450  \\$wnnna$aDisorder, Facial Nerve
=450  \\$wnnna$aDisorders, Facial Nerve
=450  \\$aFacial Myokymia
=450  \\$wnnna$aFacial Myokymias
=450  \\$wnnna$aFacial Nerve Disease
=450  \\$wnnna$aFacial Nerve Disorder
=450  \\$wnnna$aFacial Nerve Disorders
=450  \\$wnnna$aFacial Nerve Motor Disorders
=450  \\$wnnna$aFacial Nerve Sensory Disorders
=450  \\$wnnna$aFacial Neuritides
=450  \\$wnnna$aFacial Neuritis
=450  \\$wnnna$aFacial Neuropathies
=450  \\$wnnna$aFacial Neuropathies, Acquired
=450  \\$wnnna$aFacial Neuropathies, Familial
=450  \\$aFacial Neuropathy
=450  \\$wnnna$aFacial Neuropathy, Acquired
=450  \\$wnnna$aFacial Neuropathy, Familial
=450  \\$wnnna$aFamilial Facial Neuropathies
=450  \\$wnnna$aFamilial Facial Neuropathy
=450  \\$wnnna$aGanglionitides, Geniculate
=450  \\$wnnna$aGanglionitis, Geniculate
=450  \\$wnnna$aGeniculate Ganglionitides
=450  \\$aGeniculate Ganglionitis
=450  \\$wnnna$aMotor Disorders, Facial Nerve
=450  \\$wnnna$aMyokymia, Facial
=450  \\$wnnna$aMyokymias, Facial
=450  \\$wnnna$aNeuritides, Facial
=450  \\$wnnna$aNeuritis, Facial
=450  \\$wnnna$aNeuropathies, Facial
=450  \\$wnnna$aNeuropathies, Familial Facial
=450  \\$wnnna$aNeuropathy, Facial
=450  \\$wnnna$aNeuropathy, Familial Facial
=450  \\$wnnna$aSensory Disorders, Facial Nerve
=450  \\$wnnna$aSeventh Cranial Nerve Diseases
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aBell Palsy
=550  \\$wh$aFacial Hemiatrophy
=550  \\$wh$aFacial Nerve Injuries
=550  \\$wh$aFacial Neuralgia
=550  \\$wh$aHerpes Zoster Oticus
=550  \\$wh$aMelkersson-Rosenthal Syndrome
=550  \\$wh$aMobius Syndrome
=680  \\$iDiseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.
=688  \\$a81
=750  \0$aFacial nerve$xDiseases$5IEN$0(DLC)sh 85046808

=LDR  01919cz  a2200469n  4500
=001  9880363531302441
=005  20141212192206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005154
=035  \\$aCAZ8299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x275
=072  \\$aA8.$x800.$x50.$x600.$x149
=072  \\$aA8.$x800.$x800.$x60.$x275
=072  \\$aA8.$x800.$x800.$x120.$x250
=150  \\$aFacial Nerve
=450  \\$wnnna$aCranial Nerve, Seventh
=450  \\$aCranial Nerve VII
=450  \\$wnnna$aCranial Nerve VIIs
=450  \\$wnnna$aCranial Nerves, Seventh
=450  \\$wnnna$aFacial Nerves
=450  \\$wnnna$aFaciali, Nervus
=450  \\$wnnna$aFacialis, Nervus
=450  \\$wnnna$aNerve, Facial
=450  \\$wnnna$aNerve, Seventh Cranial
=450  \\$wnnna$aNerve VII
=450  \\$wnnna$aNerve VIIs
=450  \\$wnnna$aNerves, Facial
=450  \\$wnnna$aNerves, Seventh Cranial
=450  \\$wnnna$aNervus Faciali
=450  \\$wnnna$aNervus Facialis
=450  \\$aSeventh Cranial Nerve
=450  \\$wnnna$aSeventh Cranial Nerves
=550  \\$wg$aAutonomic Pathways
=550  \\$wg$aCranial Nerves
=550  \\$wg$aParasympathetic Nervous System
=550  \\$wh$aChorda Tympani Nerve
=550  \\$wh$aGeniculate Ganglion
=550  \\$aFacial Nucleus
=667  \\$aneoplasm = FACIAL NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm(IM)
=680  \\$iThe 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and SALIVARY GLANDS, and convey afferent information for TASTE from the anterior two-thirds of the TONGUE and for TOUCH from the EXTERNAL EAR.
=750  \0$aFacial nerve$5IEN$0(DLC)sh 85046807

=LDR  00842cz  a2200205n  4500
=001  9880363531402441
=005  20141212201330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005153
=035  \\$aCAZ8298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x392
=150  \\$aFacial Neoplasms
=450  \\$wnnna$aFacial Neoplasm
=450  \\$wnnna$aNeoplasm, Facial
=450  \\$wnnna$aNeoplasms, Facial
=550  \\$wg$aHead and Neck Neoplasms
=550  \\$wh$aEyelid Neoplasms
=667  \\$ausually of soft part of face; not for facial bone neopl ( = FACIAL BONES (IM) + SKULL NEOPLASMS (IM) ); HEAD AND NECK NEOPLASMS is also available; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with site (NIM) as merely locational + histol type of neopl (IM)
=750  \0$aFace$xCancer$5IEN-M$0(DLC)sh 85046787

=LDR  01075cz  a2200301n  4500
=001  9880363531502441
=005  20141212201330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005152
=035  \\$aCAZ8297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x400
=072  \\$aA14.$x363
=150  \\$aFacial Muscles
=450  \\$wnnna$aFacial Muscle
=450  \\$wnnna$aMimetic Muscle
=450  \\$aMimetic Muscles
=450  \\$wnnna$aMuscle, Facial
=450  \\$wnnna$aMuscle, Mimetic
=450  \\$wnnna$aMuscles, Facial
=450  \\$wnnna$aMuscles, Mimetic
=550  \\$wg$aMuscle, Skeletal
=550  \\$wg$aStomatognathic System
=550  \\$aMyofunctional Therapy
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iMuscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. (From Stedman, 25th ed)
=688  \\$a65
=750  \0$aFace$xMuscles$5IEN$0(DLC)sh 85046806

=LDR  00927cz  a2200241n  4500
=001  9880363531602441
=005  20141212201329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005151
=035  \\$aCAZ8296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275
=150  \\$aFacial Injuries
=450  \\$aFace$xinjuries
=450  \\$wnnna$aFacial Injury
=450  \\$wnnna$aInjuries, Facial
=450  \\$wnnna$aInjury, Facial
=550  \\$wg$aCraniocerebral Trauma
=550  \\$wh$aEye Injuries
=550  \\$wh$aMaxillofacial Injuries
=667  \\$aGEN or unspecified for soft tissue or bony portions of face; consider also /inj with FACIAL BONES or specific facial bones; fractures: see note on FACIAL BONES; TN 115: use of FACIAL INJURIES & jaw inj
=680  \\$iGeneral or unspecified injuries to the soft tissue or bony portions of the face.
=750  \0$aFace$xWounds and Injuries$5IEN$0(DLC)sh 85046793

=LDR  00890cz  a2200253n  4500
=001  9880363531702441
=005  20141212201328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005149
=035  \\$aCAZ8294HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x225
=072  \\$aF1.$x145.$x209.$x530.$x385
=150  \\$aFacial Expression
=450  \\$wnnna$aExpression, Facial
=450  \\$wnnna$aExpressions, Facial
=450  \\$wnnna$aFacial Expressions
=550  \\$wg$aNonverbal Communication
=550  \\$wg$aPhysical Examination
=550  \\$wh$aSmiling
=550  \\$aPhysiognomy
=667  \\$ahuman & animal; a psychol response: do not confuse with FACIES, phys appearance characteristic of various dis; no qualif
=680  \\$iObservable changes of expression in the face in response to emotional stimuli.
=750  \0$aFacial expression$5IEN$0(DLC)sh 85046804

=LDR  01522cz  a2200277n  4500
=001  9880363531802441
=005  20141212201328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324
=150  \\$aFacial Bones
=450  \\$wnnna$aBone, Facial
=450  \\$wnnna$aBones, Facial
=450  \\$wnnna$aFacial Bone
=550  \\$wg$aSkull
=550  \\$wh$aJaw
=550  \\$wh$aNasal Bone
=550  \\$wh$aOrbit
=550  \\$wh$aTurbinates
=550  \\$wh$aVomer
=550  \\$wh$aZygoma
=550  \\$aHead
=667  \\$aconsider specifics; do not confuse with FACE (locational & soft tissue) or its specifics; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; fractures: coord FACIAL BONES /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM + SKULL NEOPLASMS; craniofacial dysmorphism: index under CRANIOFACIAL ABNORMALITIES; craniofacial dysplasia or craniofacial fibrous dysplasia: index under FACIAL BONES (IM) + SKULL (IM) + FIBROUS DYSPLASIA, POLYOSTOTIC (IM)
=680  \\$iThe facial skeleton, consisting of bones situated between the cranial base and the mandibular region. While some consider the facial bones to comprise the hyoid (HYOID BONE), palatine (HARD PALATE), and zygomatic (ZYGOMA) bones, MANDIBLE, and MAXILLA, others include also the lacrimal and nasal bones, inferior nasal concha, and vomer but exclude the hyoid bone. (Jablonski, Dictionary of Dentistry, 1992, p113)
=750  \0$aFacial bones$5IEN$0(DLC)sh 85046801

=LDR  01102cz  a2200289n  4500
=001  9880363531902441
=005  20171031103729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005145
=035  \\$aCAZ8290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505
=150  \\$aFace
=450  \\$wnnna$aFaces
=550  \\$wg$aHead
=550  \\$wh$aCheek
=550  \\$wh$aChin
=550  \\$wh$aEye
=550  \\$wh$aForehead
=550  \\$wh$aMouth
=550  \\$wh$aNasolabial Fold
=550  \\$wh$aNose
=550  \\$wh$aParotid Region
=550  \\$wh$aSuperficial Musculoaponeurotic System
=667  \\$ausually NIM as site; soft parts = FACE, bones = FACIAL BONES or specifics; /abnorm permitted but FACIAL BONES /abnorm is more likely; facial fractures: see note on FACIAL BONES; craniofacial dysmorphism & craniofacial fibrous dysplasia & long face syndrome: see note also on FACIAL BONES
=680  \\$iThe anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw.
=750  \0$aFace$5IEN$0(DLC)sh 85046785

=LDR  00683cz  a2200229n  4500
=001  9880363532002441
=005  20141212201326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005143
=035  \\$aCAZ8288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x420.$x504
=072  \\$aA9.$x371.$x337
=150  \\$aEyelids
=360  \\$iconsider also terms at$aBLEPHAR-
=450  \\$wnnna$aEyelid
=550  \\$wg$aEye
=550  \\$wh$aConjunctiva
=550  \\$wh$aEyelashes
=550  \\$wh$aMeibomian Glands
=667  \\$ainflammation = BLEPHARITIS; plasty = BLEPHAROPLASTY; ptosis = BLEPHAROPTOSIS; spasm = BLEPHAROSPASM
=750  \0$aEyelids$5IEN$0(DLC)sh 85046706

=LDR  00827cz  a2200265n  4500
=001  9880363532102441
=005  20141212201326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005142
=035  \\$aCAZ8287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x392.$x500
=072  \\$aC11.$x319.$x421
=072  \\$aC11.$x338.$x526
=150  \\$aEyelid Neoplasms
=450  \\$wnnna$aEyelid Neoplasm
=450  \\$wnnna$aNeoplasm, Eyelid
=450  \\$wnnna$aNeoplasms, Eyelid
=550  \\$wg$aEye Neoplasms
=550  \\$wg$aEyelid Diseases
=550  \\$wg$aFacial Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iTumors of cancer of the EYELIDS.
=688  \\$a70
=750  \0$aEyelids$xTumors$5IEN-M$0(DLC)sh 85046709

=LDR  00898cz  a2200325n  4500
=001  9880363532202441
=005  20141212201325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005141
=035  \\$aCAZ8286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x338
=150  \\$aEyelid Diseases
=450  \\$wnnna$aDisease, Eyelid
=450  \\$wnnna$aDiseases, Eyelid
=450  \\$wnnna$aEyelid Disease
=550  \\$wg$aEye Diseases
=550  \\$wh$aBlepharitis
=550  \\$wh$aBlepharophimosis
=550  \\$wh$aBlepharoptosis
=550  \\$wh$aBlepharospasm
=550  \\$wh$aChalazion
=550  \\$wh$aEctropion
=550  \\$wh$aEntropion
=550  \\$wh$aEyelid Neoplasms
=550  \\$wh$aHordeolum
=550  \\$wh$aTrichiasis
=667  \\$aGEN; many specifics are available; inflamm dis = BLEPHARITIS
=688  \\$a70
=750  \0$aEyelids$xDiseases$5IEN$0(DLC)sh 85046707

=LDR  00514cz  a2200181n  4500
=001  9880363532302441
=005  20141212201325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005140
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x420.$x504.$x421
=072  \\$aA9.$x371.$x337.$x338
=072  \\$aA17.$x360.$x421
=150  \\$aEyelashes
=550  \\$wg$aEyelids
=550  \\$wg$aHair
=680  \\$iThe hairs which project from the edges of the EYELIDS.
=750  \0$aEyelashes$5IEN$0(DLC)sh 85046703

=LDR  00902cz  a2200229n  4500
=001  9880363532402441
=005  20141212201325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005139
=035  \\$aCAZ8284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x500.$x300
=150  \\$aEyeglasses
=450  \\$aGlasses
=450  \\$wnnna$aGlasses, Prescription Sun
=450  \\$wnnna$aPrescription Sun Glasses
=450  \\$aSpectacles
=450  \\$aSun Glasses, Prescription
=550  \\$wg$aLenses
=667  \\$aprescription lenses to aid vision: do not confuse with EYE PROTECTIVE DEVICES
=680  \\$iA pair of ophthalmic lenses in a frame or mounting which is supported by the nose and ears. The purpose is to aid or improve vision. It does not include goggles or nonprescription sun glasses for which EYE PROTECTIVE DEVICES is available.
=750  \0$aEyeglasses$5IEN$0(DLC)sh 85046700

=LDR  00507cz  a2200181n  4500
=001  9880363532502441
=005  20141212201325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005138
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x420.$x338
=072  \\$aA17.$x360.$x296
=150  \\$aEyebrows
=450  \\$wnnna$aEyebrow
=550  \\$wg$aEye
=550  \\$wg$aHair
=680  \\$iCurved rows of HAIR located on the upper edges of the eye sockets.
=750  \0$aEyebrows$5IEN$0(DLC)sh 85046698

=LDR  01029cz  a2200253n  4500
=001  9880363532602441
=005  20141212201324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005137
=035  \\$aCAZ8282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x225
=150  \\$aEye, Artificial
=450  \\$aArtificial Eye
=450  \\$wnnna$aArtificial Eyes
=450  \\$wnnna$aEyes, Artificial
=450  \\$wnnna$aOcular Prostheses
=450  \\$aOcular Prosthesis
=450  \\$wnnna$aProstheses, Ocular
=450  \\$wnnna$aProsthesis, Ocular
=550  \\$wg$aProstheses and Implants
=550  \\$aOrbital Implants
=680  \\$iA ready-made or custom-made prosthesis of glass or plastic shaped and colored to resemble the anterior portion of a normal eye and used for cosmetic reasons. It is attached to the anterior portion of an orbital implant (ORBITAL IMPLANTS) which is placed in the socket of an enucleated or eviscerated eye. (From Dorland, 28th ed)
=750  \0$aEyes, Artificial$5IEN$0(DLC)sh 85046711

=LDR  01261cz  a2200349n  4500
=001  9880363532702441
=005  20171219154615.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005135
=035  \\$aCAZ8280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x708.$x560.$x500
=150  \\$aEye Protective Devices
=450  \\$wnnna$aDevice, Eye Protective
=450  \\$wnnna$aDevices, Eye Protective
=450  \\$wnnna$aEye Protective Device
=450  \\$wnnna$aGlasse, Nonprescription Sun
=450  \\$wnnna$aGlasses, Nonprescription Sun
=450  \\$wnnna$aGlasses, Safety
=450  \\$aGoggles
=450  \\$wnnna$aLenses, Safety
=450  \\$wnnna$aNonprescription Sun Glasses
=450  \\$wnnna$aProtective Device, Eye
=450  \\$wnnna$aProtective Devices, Eye
=450  \\$aSafety Glasses
=450  \\$aSafety Lenses
=450  \\$aSun Glasses, Nonprescription
=550  \\$wg$aPersonal Protective Equipment
=667  \\$afor physical protection: do not confuse with EYEGLASSES which is for improvement of vision
=680  \\$iPersonal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.
=688  \\$a91(75)
=750  \0$aEyeglasses, Protective$0(DLC)sh 85046701$5IEN-M

=LDR  01239cz  a2200409n  4500
=001  9880363532802441
=005  20141212201323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005134
=035  \\$aCAZ8279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x364
=072  \\$aC11.$x319
=150  \\$aEye Neoplasms
=450  \\$wnnna$aCancer, Eye
=450  \\$aCancer of Eye
=450  \\$wnnna$aCancer of the Eye
=450  \\$wnnna$aCancers, Eye
=450  \\$aEye Cancer
=450  \\$wnnna$aEye Cancers
=450  \\$wnnna$aEye Neoplasm
=450  \\$wnnna$aNeoplasm, Eye
=450  \\$wnnna$aNeoplasms, Eye
=550  \\$wg$aEye Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aConjunctival Neoplasms
=550  \\$wh$aEyelid Neoplasms
=550  \\$wh$aIntraocular Lymphoma
=550  \\$wh$aOrbital Neoplasms
=550  \\$wh$aParaneoplastic Syndromes, Ocular
=550  \\$wh$aRetinal Neoplasms
=550  \\$wh$aUveal Neoplasms
=550  \\$aOrbital Neoplasms
=667  \\$acoord IM with specific site in eye (IM) + histol type of neopl (IM)
=680  \\$iTumors or cancer of the EYE.
=750  \0$aEye$xCancer$5IEN-M$0(DLC)sh2010009159
=750  \0$aEye$xTumors$5IEN-HS$0(DLC)sh 85046682

=LDR  00985cz  a2200313n  4500
=001  9880363532902441
=005  20141212201323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005133
=035  \\$aCAZ8278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x140
=072  \\$aG14.$x640.$x260
=150  \\$aEye Movements
=450  \\$wnnna$aEye Movement
=450  \\$wnnna$aMovement, Eye
=450  \\$wnnna$aMovements, Eye
=550  \\$wg$aMovement
=550  \\$wg$aOcular Physiological Processes
=550  \\$wh$aConvergence, Ocular
=550  \\$wh$aFixation, Ocular
=550  \\$wh$aNystagmus, Physiologic
=550  \\$wh$aPursuit, Smooth
=550  \\$wh$aSaccades
=550  \\$aEye Movement Measurements
=667  \\$aEYE MOVEMENT MEASUREMENTS is also available
=680  \\$iVoluntary or reflex-controlled movements of the eye.
=750  \0$aNeuroophthalmology$5IEN-M$0(DLC)sh 85091111
=750  \0$aEye$xMovements$5IEN-HS$0(DLC)sh 85046666

=LDR  00984cz  a2200301n  4500
=001  9880363533002441
=005  20141212201323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005132
=035  \\$aCAZ8277HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x300
=072  \\$aC23.$x888.$x307
=150  \\$aEye Manifestations
=450  \\$wnnna$aEye Manifestation
=450  \\$wnnna$aManifestation, Eye
=450  \\$wnnna$aManifestations, Eye
=550  \\$wg$aEye Diseases
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aEye Hemorrhage
=550  \\$wh$aEye Pain
=550  \\$wh$aSusac Syndrome
=550  \\$aEye
=550  \\$aEye Diseases
=667  \\$anot used for indexing since 1989; prior to 1989 used for eye manifest of non-eye diseases
=680  \\$iOcular disorders attendant upon non-ocular disease or injury.
=750  \0$aNeuroophthalmology$5IEN-M$0(DLC)sh 85091111
=750  \0$aOcular manifestations of general diseases$5IEN-HS$0(DLC)sh 85094052

=LDR  01123cz  a2200313n  4500
=001  9880363533102441
=005  20141212201322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005131
=035  \\$aCAZ8276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x297
=072  \\$aC26.$x260.$x275.$x250
=150  \\$aEye Injuries
=450  \\$aEye$xinjuries
=450  \\$wnnna$aEye Injury
=450  \\$wnnna$aInjuries, Eye
=450  \\$wnnna$aInjury, Eye
=550  \\$wg$aEye Diseases
=550  \\$wg$aFacial Injuries
=550  \\$wh$aAnterior Capsular Rupture, Ocular
=550  \\$wh$aCorneal Injuries
=550  \\$wh$aEye Burns
=550  \\$wh$aEye Foreign Bodies
=550  \\$wh$aEye Injuries, Penetrating
=550  \\$wh$aPosterior Capsular Rupture, Ocular
=667  \\$ageneral or unspecified; consider also /inj with specific parts of eye; EYE INJURIES, PENETRATING & EYE BURNS are also available
=680  \\$iDamage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.
=750  \0$aEye$xWounds and injuries$5IEN$0(DLC)sh 85046683

=LDR  00582cz  a2200205n  4500
=001  9880363533202441
=005  20141212201322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005129
=035  \\$aCAZ8274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x250.$x260
=072  \\$aC26.$x392.$x421
=150  \\$aEye Foreign Bodies
=450  \\$wnnna$aEye Foreign Body
=450  \\$wnnna$aForeign Bodies, Eye
=450  \\$wnnna$aForeign Body, Eye
=550  \\$wg$aEye Injuries
=550  \\$wg$aForeign Bodies
=750  \0$aEye$xForeign bodies$5IEN$0(DLC)sh 85046661

=LDR  01740cz  a2200541n  4500
=001  9880363533302441
=005  20141212201321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005128
=035  \\$aCAZ8272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11
=150  \\$aEye Diseases
=450  \\$wnnna$aDisease, Eye
=450  \\$wnnna$aDiseases, Eye
=450  \\$wnnna$aEye Disease
=550  \\$wh$aAsthenopia
=550  \\$wh$aCogan Syndrome
=550  \\$wh$aConjunctival Diseases
=550  \\$wh$aCorneal Diseases
=550  \\$wh$aEye Abnormalities
=550  \\$wh$aEye Diseases, Hereditary
=550  \\$wh$aEye Hemorrhage
=550  \\$wh$aEye Infections
=550  \\$wh$aEye Injuries
=550  \\$wh$aEye Manifestations
=550  \\$wh$aEye Neoplasms
=550  \\$wh$aEyelid Diseases
=550  \\$wh$aLacrimal Apparatus Diseases
=550  \\$wh$aLens Diseases
=550  \\$wh$aOcular Hypertension
=550  \\$wh$aOcular Hypotension
=550  \\$wh$aOcular Motility Disorders
=550  \\$wh$aOptic Nerve Diseases
=550  \\$wh$aOrbital Diseases
=550  \\$wh$aPupil Disorders
=550  \\$wh$aRefractive Errors
=550  \\$wh$aRetinal Diseases
=550  \\$wh$aScleral Diseases
=550  \\$wh$aUveal Diseases
=550  \\$wh$aVision Disorders
=550  \\$wh$aVitreoretinopathy, Proliferative
=550  \\$wh$aVitreous Detachment
=550  \\$aOphthalmology
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific part of eye (IM); /diag: consider also DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL
=680  \\$iDiseases affecting the eye.
=688  \\$a65; was see under OPHTHALMOLOGY 1963-64
=750  \0$aEye$xDiseases$5IEN-M$0(DLC)sh 85046653

=LDR  00670cz  a2200241n  4500
=001  9880363533402441
=005  20141212201321.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005127
=035  \\$aCAZ8271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x340
=072  \\$aG16.$x690.$x360
=150  \\$aEye Color
=450  \\$wnnna$aColor, Eye
=450  \\$wnnna$aColors, Eye
=450  \\$wnnna$aEye Colors
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aPigmentation
=667  \\$a= color of iris, not the color of the eye as in disease
=680  \\$iColor of the iris.
=688  \\$a76
=750  \0$aColor of eyes$5IEN$0(DLC)sh 85028610

=LDR  00719cz  a2200229n  4500
=001  9880363533502441
=005  20141212201320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005126
=035  \\$aCAZ8270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x200.$x503
=072  \\$aC26.$x260.$x275.$x250.$x250
=150  \\$aEye Burns
=450  \\$wnnna$aBurn, Eye
=450  \\$wnnna$aBurns, Eye
=450  \\$wnnna$aEye Burn
=550  \\$wg$aBurns
=550  \\$wg$aEye Injuries
=667  \\$achem burns of eye = EYE BURNS /chem ind (IM) + BURNS, CHEMICAL (IM)
=680  \\$iInjury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.
=750  \0$aEye burns$5IEN$0(DLC)sh 85046688

=LDR  00646cz  a2200217n  4500
=001  9880363533602441
=005  20141212201320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005125
=035  \\$aCAZ8269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65.$x900.$x400
=150  \\$aEye Banks
=450  \\$wnnna$aBank, Eye
=450  \\$wnnna$aBanks, Eye
=450  \\$wnnna$aEye Bank
=550  \\$wg$aTissue Banks
=550  \\$aCorneal Transplantation
=680  \\$iCenters for storing various parts of the eye for future use.
=688  \\$a91(75); was see under TISSUE BANKS 1975-90
=750  \0$aEye banks$5IEN$0(DLC)sh 85046686

=LDR  01256cz  a2200373n  4500
=001  9880363533702441
=005  20141212201320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005124
=035  \\$aCAZ8268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x250
=072  \\$aC16.$x131.$x384
=150  \\$aEye Abnormalities
=450  \\$wnnna$aAbnormalities, Eye
=450  \\$wnnna$aAbnormality, Eye
=450  \\$aEye$xabnormalities
=450  \\$wnnna$aEye Abnormality
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aEye Diseases
=550  \\$wh$aAniridia
=550  \\$wh$aAnophthalmos
=550  \\$wh$aBlepharophimosis
=550  \\$wh$aColoboma
=550  \\$wh$aEctopia Lentis
=550  \\$wh$aFraser Syndrome
=550  \\$wh$aHydrophthalmos
=550  \\$wh$aMicrophthalmos
=550  \\$wh$aPersistent Hyperplastic Primary Vitreous
=550  \\$wh$aRetinal Dysplasia
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; these are structural abnorm: EYE DISEASES, HEREDITARY is also available
=680  \\$iCongenital absence of or defects in structures of the eye; may also be hereditary.
=688  \\$a90; was NON MESH 1977-89
=750  \0$aEye$xAbnormalities$5IEN$0(DLC)sh 85046643

=LDR  01118cz  a2200361n  4500
=001  9880363533802441
=005  20141212201320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005123
=035  \\$aCAZ8267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x420
=072  \\$aA9.$x371
=150  \\$aEye
=360  \\$iconsider also terms at$aOCUL-$aOPHTHALM-$aOPT-$aVIS-
=450  \\$wnnna$aEyes
=550  \\$wg$aFace
=550  \\$wg$aSense Organs
=550  \\$wh$aAnterior Capsule of the Lens
=550  \\$wh$aAnterior Eye Segment
=550  \\$wh$aAxial Length, Eye
=550  \\$wh$aEyebrows
=550  \\$wh$aEyelids
=550  \\$wh$aLacrimal Apparatus
=550  \\$wh$aOculomotor Muscles
=550  \\$wh$aPigment Epithelium of Eye
=550  \\$wh$aPosterior Eye Segment
=550  \\$wh$aRetina
=550  \\$wh$aSclera
=550  \\$wh$aTenon Capsule
=550  \\$wh$aUvea
=667  \\$ainflammation of the eye = ENDOPHTHALMITIS or specific -ITIS terms in Category C11, Eye Diseases; COMPOUND EYE, ARTHROPOD is available for arthropods
=750  \0$aEye$5IEN$0(DLC)sh 85046642

=LDR  01104cz  a2200289n  4500
=001  9880363533902441
=005  20141212201319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005122
=035  \\$aCAZ8266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x383
=150  \\$aExudates and Transudates
=450  \\$wnnna$aExudate
=450  \\$wnnna$aExudates
=450  \\$wnnna$aTransudate
=450  \\$aTransudates
=450  \\$wnnna$aTransudates and Exudates
=550  \\$wg$aFluids and Secretions
=550  \\$wh$aCyst Fluid
=550  \\$wh$aDentinal Fluid
=550  \\$wh$aGingival Crevicular Fluid
=550  \\$wh$aSubretinal Fluid
=550  \\$aPlant Exudates
=550  \\$aSeroma
=680  \\$iExudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
=750  \0$aExudates and transudates$5IEN$0(DLC)sh 85046634

=LDR  00684cz  a2200229n  4500
=001  9880363534002441
=005  20141212201319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005121
=035  \\$aCAZ8265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378
=150  \\$aExtremities
=450  \\$wnnna$aExtremity
=450  \\$wnnna$aLimb
=450  \\$aLimbs
=550  \\$wg$aBody Regions
=550  \\$wh$aAmputation Stumps
=550  \\$wh$aLower Extremity
=550  \\$wh$aUpper Extremity
=667  \\$aTN 75: extremities of animals; TN 117: joints of animals & table of human, primate & non-primate extremities
=750  \0$aExtremities (Anatomy)$5IEN$0(DLC)sh 85046619

=LDR  01058cz  a2200301n  4500
=001  9880363534202441
=005  20141212201318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005118
=035  \\$aCAZ8262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x249.$x159
=072  \\$aG16.$x500.$x275.$x240
=150  \\$aExtraterrestrial Environment
=450  \\$wnnna$aEnvironment, Extraterrestrial
=450  \\$wnnna$aEnvironments, Extraterrestrial
=450  \\$wnnna$aExtraterrestrial Environments
=450  \\$aSpace (Astronomy)
=450  \\$aSpace Environment$5IEN
=450  \\$wnnna$aSpaces (Astronomy)
=550  \\$wg$aAstronomical Objects
=550  \\$wg$aEnvironment
=550  \\$wh$aCosmic Dust
=550  \\$aExobiology
=550  \\$aPlanets
=550  \\$aSpace Flight
=680  \\$iThe environment outside the earth or its atmosphere. The environment may refer to a closed cabin (such as a space shuttle or space station) or to space itself, the moon, or other planets.
=750  \0$aSpace environment$5IEN$0(DLC)sh 85125922

=LDR  01636cz  a2200397n  4500
=001  9880363534302441
=005  20141212201318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005117
=035  \\$aCAZ8261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x325
=072  \\$aC23.$x550.$x73.$x325
=150  \\$aCardiac Complexes, Premature
=450  \\$wnnna$aBeat, Premature
=450  \\$wnnna$aBeats, Premature
=450  \\$wnnna$aCardiac Complex, Premature
=450  \\$wnnna$aComplexes, Premature Cardiac
=450  \\$wnnna$aEctopic Heartbeat
=450  \\$aEctopic Heartbeats
=450  \\$aExtrasystole
=450  \\$wnnna$aExtrasystoles
=450  \\$wnnna$aHeartbeat, Ectopic
=450  \\$wnnna$aHeartbeats, Ectopic
=450  \\$wnnna$aPremature Beat
=450  \\$aPremature Beats
=450  \\$wnnna$aPremature Cardiac Complex
=450  \\$aPremature Cardiac Complexes
=450  \\$wnnna$aPremature Cardiac Complices
=550  \\$wg$aArrhythmias, Cardiac
=550  \\$wh$aAtrial Premature Complexes
=550  \\$wh$aVentricular Premature Complexes
=667  \\$ageneral or unspecified: atrial = ATRIAL PREMATURE COMPLEXES; ventricular = VENTRICULAR PREMATURE COMPLEXES
=680  \\$iA group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases.
=688  \\$a96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95
=750  \0$aExtrasystole$5IEN$0(DLC)sh 85046589

=LDR  00598cz  a2200205n  4500
=001  9880363534402441
=005  20141212201317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005116
=035  \\$aCAZ8260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x854.$x253
=072  \\$aA8.$x612.$x380.$x239
=150  \\$aExtrapyramidal Tracts
=450  \\$wnnna$aExtrapyramidal Tract
=450  \\$wnnna$aTract, Extrapyramidal
=450  \\$wnnna$aTracts, Extrapyramidal
=550  \\$wg$aEfferent Pathways
=550  \\$wg$aSpinal Cord
=750  \0$aExtrapyramidal tracts$5IEN$0(DLC)sh 85046586

=LDR  01674cz  a2200409n  4500
=001  9880363534502441
=005  20141212201317.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005115
=035  \\$aCAZ8259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x453.$x578.$x360
=150  \\$aExtraoral Traction Appliances
=450  \\$wnnna$aAppliance, Extraoral Traction
=450  \\$wnnna$aAppliances, Extraoral Traction
=450  \\$wnnna$aBow, Orthodontic Face
=450  \\$wnnna$aBows, Orthodontic Face
=450  \\$aChincap, Orthodontic
=450  \\$wnnna$aChincaps, Orthodontic
=450  \\$wnnna$aExtraoral Traction Appliance
=450  \\$aFace Bow, Orthodontic
=450  \\$wnnna$aFace Bows, Orthodontic
=450  \\$aHeadgear, Orthodontic
=450  \\$wnnna$aHeadgears, Orthodontic
=450  \\$aOrthodontic Appliances, Extraoral Traction$5IEN
=450  \\$wnnna$aOrthodontic Chincap
=450  \\$wnnna$aOrthodontic Chincaps
=450  \\$wnnna$aOrthodontic Face Bow
=450  \\$wnnna$aOrthodontic Face Bows
=450  \\$wnnna$aOrthodontic Headgear
=450  \\$wnnna$aOrthodontic Headgears
=450  \\$wnnna$aTraction Appliance, Extraoral
=450  \\$wnnna$aTraction Appliances, Extraoral
=550  \\$wg$aOrthodontic Appliances, Removable
=680  \\$iExtraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible.
=688  \\$a91(77); was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90
=750  \0$aOrthodontic appliances, Extraoral traction$5IEN-M$0(DLC)sh 85095768

=LDR  00893cz  a2200265n  4500
=001  9880363534602441
=005  20141212201316.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005114
=035  \\$aCAZ8258HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x295
=150  \\$aExtramarital Relations
=450  \\$aAdultery
=450  \\$wnnna$aBehavior, Extramarital Sex
=450  \\$wnnna$aExtramarital Relation
=450  \\$wnnna$aExtramarital Sex Behavior
=450  \\$wnnna$aRelation, Extramarital
=450  \\$wnnna$aRelations, Extramarital
=450  \\$wnnna$aSex Behavior, Extramarital
=550  \\$wg$aSexual Behavior
=667  \\$aDF: EXTRAMARITAL RELAT
=680  \\$iVoluntary SEXUAL INTERCOURSE between a married person and someone other than the SPOUSE.
=688  \\$a91(75); was see under SEX BEHAVIOR 1975-90
=750  \0$aAdultery$5IEN$0(DLC)sh 85001045

=LDR  00877cz  a2200253n  4500
=001  9880363534702441
=005  20141212201316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005113
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x875
=150  \\$aExtraction, Obstetrical
=450  \\$wnnna$aExtraction, Obstetric
=450  \\$wnnna$aExtractions, Obstetric
=450  \\$wnnna$aExtractions, Obstetrical
=450  \\$wnnna$aObstetric Extraction
=450  \\$wnnna$aObstetric Extractions
=450  \\$wnnna$aObstetrical Extraction
=450  \\$wnnna$aObstetrical Extractions
=550  \\$wg$aDelivery, Obstetric
=550  \\$wh$aVacuum Extraction, Obstetrical
=667  \\$ado not use /util except by MeSH definition
=680  \\$iExtraction of the fetus by means of obstetrical instruments.
=750  \0$aObstetrical extraction$5IEN$0(DLC)sh 85093759

=LDR  01205cz  a2200277n  4500
=001  9880363534802441
=005  20141212210913.0
=008  880423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015199
=035  \\$aCAZ8256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x880.$x301
=072  \\$aE4.$x292.$x451
=150  \\$aExtracorporeal Membrane Oxygenation
=450  \\$aECMO
=450  \\$wnnna$aExtracorporeal Membrane Oxygenations
=450  \\$wnnna$aMembrane Oxygenation, Extracorporeal
=450  \\$wnnna$aMembrane Oxygenations, Extracorporeal
=450  \\$aOxygenation, Extracorporeal Membrane
=450  \\$wnnna$aOxygenations, Extracorporeal Membrane
=550  \\$wg$aExtracorporeal Circulation
=550  \\$wg$aRespiratory Therapy
=667  \\$ado not use /util except by MeSH definition; note short X ref
=680  \\$iApplication of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.
=688  \\$a89
=750  \0$aExtracorporeal membrane oxygenation$5IEN-M$0(DLC)sh 92005395

=LDR  01383cz  a2200313n  4500
=001  9880363534902441
=005  20141212201316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005112
=035  \\$aCAZ8255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x292
=150  \\$aExtracorporeal Circulation
=450  \\$wnnna$aCirculation, Extracorporeal
=450  \\$wnnna$aCirculations, Extracorporeal
=450  \\$wnnna$aExtracorporeal Circulations
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCardiopulmonary Bypass
=550  \\$wh$aChemotherapy, Cancer, Regional Perfusion
=550  \\$wh$aExtracorporeal Membrane Oxygenation
=550  \\$wh$aHeart Bypass, Left
=550  \\$wh$aHemofiltration
=550  \\$wh$aHemoperfusion
=550  \\$wh$aPhotopheresis
=550  \\$wh$aUltrafiltration
=667  \\$a"diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation"; GEN & unspecified: prefer specifics; do not confuse with CARDIOPULMONARY BYPASS or ASSISTED CIRCULATION; do not use /util except by MeSH definition; DF: EXTRACORPOREAL CIRC
=680  \\$iDiversion of blood flow through a circuit located outside the body but continuous with the bodily circulation.
=688  \\$a67; was see under HEART, MECHANICAL 1963-66
=750  \0$aBlood$xCirculation, Artificial$5IEN$0(DLC)sh 85014933

=LDR  01054cz  a2200289n  4500
=001  9880363535002441
=005  20180820115659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005111
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x420.$x275
=150  \\$aExtrachromosomal Inheritance
=450  \\$aCytoplasmic Inheritance
=450  \\$aExtranuclear Inheritance
=450  \\$wnnna$aInheritance, Cytoplasmic
=450  \\$wnnna$aInheritance, Extrachromosomal
=450  \\$wnnna$aInheritance, Extranuclear
=550  \\$wg$aInheritance Patterns
=550  \\$wh$aGenes, Chloroplast
=550  \\$wh$aGenes, Mitochondrial
=550  \\$wh$aMaternal Inheritance
=550  \\$aDNA, Chloroplast
=550  \\$aPlasmids
=680  \\$iVertical transmission of hereditary characters by DNA from cytoplasmic organelles such as MITOCHONDRIA; CHLOROPLASTS; and PLASTIDS, or from PLASMIDS or viral episomal DNA.
=688  \\$a68
=750  \0$aCytoplasmic inheritance$5IEN-M$0(DLC)sh 85035253
=750  \0$aExtrachromosomal DNA$5IEN-HS$0(DLC)sh 85046578

=LDR  01313cz  a2200361n  4500
=001  9880363535102441
=005  20170209101650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005110
=035  \\$aCAZ8253HS
=040  \\$aDNLM$beng$cDNLM
=060  \0$aQU 105
=072  \\$aA10.$x82.$x500
=072  \\$aA11.$x284.$x295
=150  \\$aExtracellular Space
=450  \\$wnnna$aExtracellular Spaces
=450  \\$aIntercellular Space
=450  \\$wnnna$aIntercellular Spaces
=450  \\$wnnna$aSpace, Extracellular
=450  \\$wnnna$aSpace, Intercellular
=450  \\$wnnna$aSpaces, Extracellular
=450  \\$wnnna$aSpaces, Intercellular
=550  \\$wg$aBody Fluid Compartments
=550  \\$wg$aCellular Structures
=550  \\$wh$aExtracellular Fluid
=550  \\$wh$aExtracellular Matrix
=550  \\$wh$aExtracellular Traps
=550  \\$wh$aExtracellular Vesicles
=550  \\$wh$aPeriplasm
=550  \\$aIntracellular Space
=680  \\$iInterstitial space between cells, occupied by INTERSTITIAL FLUID as well as amorphous and fibrous substances. For organisms with a CELL WALL, the extracellular space includes everything outside of the CELL MEMBRANE including the PERIPLASM and the cell wall.
=688  \\$a1966(1964)
=750  \0$aExtracellular space$5IEN-HS$0(DLC)sh 85046577

=LDR  00995cz  a2200253n  4500
=001  9880363535202441
=005  20141212201315.0
=008  830531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005109
=035  \\$aCAZ8252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x295.$x310
=150  \\$aExtracellular Matrix
=450  \\$wnnna$aExtracellular Matrices
=450  \\$wnnna$aMatrices, Extracellular
=450  \\$aMatrix, Extracellular
=550  \\$wg$aExtracellular Space
=550  \\$wh$aGlomerular Basement Membrane
=550  \\$wh$aMicrofibrils
=550  \\$wh$aZona Pellucida
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iA meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.
=688  \\$a84
=750  \0$aExtracellular matrix$5IEN$0(DLC)sh 85057464

=LDR  01032cz  a2200253n  4500
=001  9880363535302441
=005  20201221175530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005108
=035  \\$aCAZ8251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x770.$x232
=150  \\$aExtinction, Psychological
=450  \\$wnnna$aExtinction (Psychology)
=450  \\$wnnna$aExtinctions, Psychological
=450  \\$wnnna$aExtinctions (Psychology)
=450  \\$aPsychological Extinction
=450  \\$wnnna$aPsychological Extinctions
=550  \\$wg$aReinforcement, Psychology
=680  \\$iThe procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure.
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Extinction (Psychology)
=688  \\$a65; was EXTINCTION LEARNING 1963-64
=750  \0$aExtinction (Psychology)$0(DLC) sh 85046569$5IEN

=LDR  00396cz  a2200157n  4500
=001  9880363535402441
=005  20141212201314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005107
=035  \\$aCAZ8250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x208
=150  \\$aExplosions
=450  \\$wnnna$aExplosion
=550  \\$wg$aEnvironment
=750  \0$aExplosions$5IEN$0(DLC)sh 85046465

=LDR  01146cz  a2200325n  4500
=001  9880363535502441
=005  20141212201314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005106
=035  \\$aCAZ8249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x387
=072  \\$aF1.$x658.$x370
=150  \\$aExploratory Behavior
=450  \\$wnnna$aBehavior, Exploratory
=450  \\$wnnna$aBehavior, Novelty-Seeking
=450  \\$wnnna$aBehaviors, Exploratory
=450  \\$wnnna$aBehaviors, Novelty-Seeking
=450  \\$wnnna$aCuriosities
=450  \\$aCuriosity
=450  \\$wnnna$aExploratory Behaviors
=450  \\$aNovelty-Seeking Behavior
=450  \\$wnnna$aNovelty Seeking Behavior
=450  \\$wnnna$aNovelty-Seeking Behaviors
=550  \\$wg$aBehavior
=550  \\$wg$aMotivation
=667  \\$ahuman & animal
=680  \\$iThe tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity.
=688  \\$a68; was BEHAVIOR, EXPLORATORY 1965-67; CURIOSITY was see under EXPLORATORY BEHAVIOR 1969-78
=750  \0$aCuriosity$5IEN$0(DLC)sh 85034861

=LDR  00952cz  a2200301n  4500
=001  9880363535602441
=005  20141212201313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005104
=035  \\$aCAZ8247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x232
=072  \\$aN3.$x706.$x535.$x253
=150  \\$aExpert Testimony
=450  \\$aEvidence, Expert$5IEN
=450  \\$aExpert Opinion
=450  \\$wnnna$aExpert Opinions
=450  \\$wnnna$aExpert Testimonies
=450  \\$aExpert Witness
=450  \\$wnnna$aExpert Witnesses
=450  \\$wnnna$aOpinion, Expert
=450  \\$wnnna$aTestimony, Expert
=450  \\$wnnna$aWitness, Expert
=450  \\$wnnna$aWitnesses, Expert
=550  \\$wg$aJurisprudence
=680  \\$iPresentation of pertinent data by one with special skill or knowledge representing mastery of a particular subject.
=688  \\$a66
=750  \0$aEvidence, Expert$5IEN$0(DLC)sh 85046005

=LDR  00859cz  a2200217n  4500
=001  9880363535702441
=005  20141212201313.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005103
=035  \\$aCAZ8246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x65.$x190
=150  \\$aExpert Systems
=450  \\$wnnna$aExpert System
=450  \\$wnnna$aSystem, Expert
=450  \\$wnnna$aSystems, Expert
=550  \\$wg$aArtificial Intelligence
=667  \\$aIM; restrict to field of computer programs & artificial intelligence
=680  \\$iComputer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved.
=688  \\$a87
=750  \0$aExpert systems (Computer science)$0(DLC) sh 85046450$5IEN

=LDR  00554cz  a2200181n  4500
=001  9880363535802441
=005  20141212201312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005101
=035  \\$aCAZ8244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x883.$x420
=150  \\$aExpeditions
=450  \\$wnnna$aExpedition
=550  \\$wg$aTravel
=667  \\$aIM; coord with type of exped & geog destination (IM)
=680  \\$iUsually refers to planned scientific data-gathering excursions.
=750  \0$aScientific expeditions$5IEN$0(DLC)sh 85118684

=LDR  00769cz  a2200229n  4500
=001  9880363535902441
=005  20141212201312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005100
=035  \\$aCAZ8243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x796.$x250
=150  \\$aExpectorants
=450  \\$wnnna$aAgents, Mucolytic
=450  \\$aMucolytic Agents
=450  \\$wnnna$aMucolytics
=550  \\$wg$aRespiratory System Agents
=550  \\$aAntitussive Agents
=550  \\$aCough
=667  \\$aGEN or unspecified; prefer specifics; D25-26 qualif
=680  \\$iAgents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.
=750  \0$aExpectorants$5IEN$0(DLC)sh 85046421

=LDR  00776cz  a2200217n  4500
=001  9880363536002441
=005  20141212201310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005096
=035  \\$aCAZ8239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x540.$x310
=150  \\$aExostoses
=450  \\$wnnna$aExostosis
=550  \\$wg$aHyperostosis
=550  \\$wh$aExostoses, Multiple Hereditary
=550  \\$wh$aHeel Spur
=550  \\$wh$aOsteophyte
=667  \\$acartilaginous & osteocartilaginous exostoses: index under OSTEOCHONDROMA; EXOSTOSES, MULTIPLE HEREDITARY is also available
=680  \\$iBenign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.
=750  \0$aExostosis$5IEN$0(DLC)sh 85046397

=LDR  00711cz  a2200205n  4500
=001  9880363536102441
=005  20141212201310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005094
=035  \\$aCAZ8237HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x675.$x349
=150  \\$aExophthalmos
=450  \\$wnnna$aProptoses
=450  \\$aProptosis
=550  \\$wg$aOrbital Diseases
=550  \\$wh$aGraves Disease
=667  \\$aprotrusion of eye: do not confuse with ENOPHTHALMOS, recession
=680  \\$iAbnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.
=750  \0$aExophthalmos$5IEN$0(DLC)sh 85046393

=LDR  01044cz  a2200289n  4500
=001  9880363536202441
=005  20141212201309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005092
=035  \\$aCAZ8235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x365
=150  \\$aExonucleases
=450  \\$wnnna$a3'-5'-Exonuclease
=450  \\$wnnna$a3' 5' Exonuclease
=450  \\$wnnna$a3'-5'-Exonucleases
=450  \\$wnnna$a3' 5' Exonucleases
=450  \\$wnnna$a5'-3'-Exonuclease
=450  \\$wnnna$a5' 3' Exonuclease
=450  \\$wnnna$a5'-3'-Exonucleases
=450  \\$wnnna$a5' 3' Exonucleases
=550  \\$wg$aEsterases
=550  \\$wh$aExodeoxyribonucleases
=550  \\$wh$aExoribonucleases
=680  \\$iEnzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains.
=688  \\$a1973; for 3'-5'-EXONUCLEASE use EXODEOXYRIBONUCLEASE V & 5'-3'-EXONUCLEASE (NM) 1992-2003
=750  \0$aExonucleases$5IEN-M$0(DLC)sh 96010370

=LDR  00801cz  a2200241n  4500
=001  9880363536302441
=005  20141212201309.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x137.$x232
=150  \\$aExons
=450  \\$wnnna$aExon
=450  \\$wnnna$aMini-Exon
=450  \\$wnnna$aMini Exon
=450  \\$wnnna$aMini-Exons
=550  \\$wg$aGene Components
=550  \\$wh$aHinge Exons
=550  \\$wh$aVDJ Exons
=550  \\$aExome
=680  \\$iThe parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.
=688  \\$a87; was see BASE SEQUENCE 1980-86
=750  \0$aExons (Genetics)$0(DLC) sh 91002875$5IEN-M

=LDR  00694cz  a2200217n  4500
=001  9880363536402441
=005  20170620113724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005089
=035  \\$aCAZ8232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x468
=150  \\$aExocytosis
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aCell Degranulation
=550  \\$wh$aSecretory Pathway
=550  \\$wh$aTranscytosis
=550  \\$aCell Degranulation
=680  \\$iCellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.
=688  \\$a76(73); was see under CELLS 1975
=750  \0$aExocytosis$5IEN$0(DLC)sh 91000909

=LDR  00908cz  a2200325n  4500
=001  9880363536502441
=005  20141212201308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005088
=035  \\$aCAZ8231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x336
=150  \\$aExocrine Glands
=450  \\$wnnna$aExocrine Gland
=450  \\$wnnna$aGland, Exocrine
=450  \\$wnnna$aGlands, Exocrine
=550  \\$wg$aTissues
=550  \\$wh$aBartholin's Glands
=550  \\$wh$aBulbourethral Glands
=550  \\$wh$aLacrimal Apparatus
=550  \\$wh$aMammary Glands, Animal
=550  \\$wh$aMammary Glands, Human
=550  \\$wh$aPancreas, Exocrine
=550  \\$wh$aProstate
=550  \\$wh$aSalivary Glands
=550  \\$wh$aSebaceous Glands
=550  \\$wh$aSweat Glands
=667  \\$aGEN: prefer specifics
=688  \\$a70(67)
=750  \0$aExocrine glands$5IEN$0(DLC)sh 85046385

=LDR  01056cz  a2200217n  4500
=001  9880363536602441
=005  20141212201307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005086
=035  \\$aCAZ8229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x418
=072  \\$aK1.$x752.$x304
=150  \\$aExistentialism
=450  \\$aExistential Psychology
=450  \\$wnnna$aPsychology, Existential
=550  \\$wg$aPhilosophy
=550  \\$wg$aPsychological Theory
=680  \\$iPhilosophy based on the analysis of the individual's existence in the world which holds that human existence cannot be completely described in scientific terms. Existentialism also stresses the freedom and responsibility of the individual as well as the uniqueness of religious and ethical experiences and the analysis of subjective phenomena such as anxiety, guilt, and suffering. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$aEXISTENTIAL PSYCHOLOGY was see under EXISTENTIALISM 1974-78
=750  \0$aExistentialism$5IEN$0(DLC)sh 85046376

=LDR  00716cz  a2200181n  4500
=001  9880363536802441
=005  20160609130751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005084
=035  \\$aCAZ8227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x300
=150  \\$aExhibitionism
=450  \\$wnnna$aExhibitionisms
=550  \\$wg$aParaphilic Disorders
=680  \\$iA disorder in which fantasies about or the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger.
=688  \\$a91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80
=750  \0$aExhibitionism$5IEN$0(DLC)sh 85046353

=LDR  01188cz  a2200337n  4500
=001  9880363536902441
=005  20141212192204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005081
=035  \\$aCAZ8224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x483
=072  \\$aE2.$x831.$x387
=150  \\$aExercise Therapy
=450  \\$wnnna$aExercise Therapies
=450  \\$wnnna$aTherapies, Exercise
=450  \\$wnnna$aTherapy, Exercise
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aRehabilitation
=550  \\$wh$aMotion Therapy, Continuous Passive
=550  \\$wh$aMuscle Stretching Exercises
=550  \\$wh$aPlyometric Exercise
=550  \\$wh$aResistance Training
=550  \\$aCircuit-Based Exercise
=550  \\$aExercise
=550  \\$aExercise Movement Techniques
=550  \\$aPhysical Fitness
=550  \\$aSports
=667  \\$aEXERCISE is also available
=680  \\$iA regimen or plan of physical activities designed and prescribed for specific therapeutic goals. Its purpose is to restore normal musculoskeletal function or to reduce pain caused by diseases or injuries.
=750  \0$aExercise therapy$5IEN$0(DLC)sh 85046341

=LDR  02292cz  a2200613n  4500
=001  9880363537002441
=005  20190201162003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005080
=035  \\$aCAZ8223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x250
=072  \\$aE1.$x370.$x386.$x700.$x250
=072  \\$aE5.$x333.$x250
=150  \\$aExercise Test
=450  \\$aArm Ergometry Test
=450  \\$wnnna$aArm Ergometry Tests
=450  \\$aBicycle Ergometry Test
=450  \\$wnnna$aBicycle Ergometry Tests
=450  \\$wnnna$aCardiopulmonary Exercise Test
=450  \\$wnnna$aCardiopulmonary Exercise Tests
=450  \\$wnnna$aErgometry Test, Arm
=450  \\$wnnna$aErgometry Test, Bicycle
=450  \\$wnnna$aErgometry Tests, Arm
=450  \\$wnnna$aErgometry Tests, Bicycle
=450  \\$wnnna$aExercise Test, Cardiopulmonary
=450  \\$wnnna$aExercise Tests
=450  \\$wnnna$aExercise Tests, Cardiopulmonary
=450  \\$aStep Test
=450  \\$wnnna$aStep Tests
=450  \\$aStress Test
=450  \\$wnnna$aTest, Arm Ergometry
=450  \\$wnnna$aTest, Bicycle Ergometry
=450  \\$wnnna$aTest, Cardiopulmonary Exercise
=450  \\$wnnna$aTest, Exercise
=450  \\$wnnna$aTest, Step
=450  \\$wnnna$aTest, Treadmill
=450  \\$wnnna$aTests, Arm Ergometry
=450  \\$wnnna$aTests, Bicycle Ergometry
=450  \\$wnnna$aTests, Cardiopulmonary Exercise
=450  \\$wnnna$aTests, Exercise
=450  \\$wnnna$aTests, Step
=450  \\$wnnna$aTests, Treadmill
=450  \\$aTreadmill Test
=450  \\$wnnna$aTreadmill Tests
=550  \\$wg$aErgometry
=550  \\$wg$aHeart Function Tests
=550  \\$wg$aRespiratory Function Tests
=550  \\$wh$aWalk Test
=550  \\$aEchocardiography, Stress
=667  \\$afor "exercise electrocardiogram" or "stress electrocardiogram" coordinate with ELECTROCARDIOGRAPHY or specifics
=680  \\$iControlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.
=688  \\$a66(63)
=750  \0$aExercise tests$5IEN$0(DLC)sh 85046340

=LDR  02279cz  a2200565n  4500
=001  9880363537102441
=005  20180718105158.0
=008  880608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x410.$x698.$x277
=072  \\$aI3.$x350
=150  \\$aExercise
=450  \\$aAerobic Exercise
=450  \\$wnnna$aAerobic Exercises
=450  \\$aExercise, Aerobic
=450  \\$aExercise, Isometric
=450  \\$aExercise, Physical
=450  \\$wnnna$aExercises
=450  \\$wnnna$aExercises, Aerobic
=450  \\$wnnna$aExercises, Isometric
=450  \\$wnnna$aExercises, Physical
=450  \\$aIsometric Exercise
=450  \\$wnnna$aIsometric Exercises
=450  \\$wnnna$aPhysical Exercise
=450  \\$wnnna$aPhysical Exercises
=550  \\$wg$aHuman Activities
=550  \\$wg$aMotor Activity
=550  \\$wh$aCircuit-Based Exercise
=550  \\$wh$aCool-Down Exercise
=550  \\$wh$aGymnastics
=550  \\$wh$aHigh-Intensity Interval Training
=550  \\$wh$aMuscle Stretching Exercises
=550  \\$wh$aPhysical Conditioning, Animal
=550  \\$wh$aPhysical Conditioning, Human
=550  \\$wh$aPlyometric Exercise
=550  \\$wh$aResistance Training
=550  \\$wh$aRunning
=550  \\$wh$aSwimming
=550  \\$wh$aWalking
=550  \\$wh$aWarm-Up Exercise
=550  \\$aExercise Movement Techniques
=550  \\$aExercise Therapy
=550  \\$aPhysical Exertion
=550  \\$aPhysical Fitness
=550  \\$aSports
=667  \\$arestrict to humans: for animals use PHYSICAL CONDITIONING, ANIMAL; EXERCISE THERAPY & EXERCISE TEST are also available; includes body building unless article specifies WEIGHT LIFTING; do not confuse with PHYSICAL EXERTION
=680  \\$iPhysical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.
=688  \\$a89; was see under EXERTION & SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88
=750  \0$aExercise$0(DLC) sh 85046328$5IEN

=LDR  00891cz  a2200229n  4500
=001  9880363537202441
=005  20141212201305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005079
=035  \\$aCAZ8221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x650.$x700.$x419
=072  \\$aD27.$x720.$x744.$x770.$x419
=150  \\$aExcipients
=450  \\$wnnna$aAgents, Stabilizing
=450  \\$wnnna$aAgents, Suspending
=450  \\$aStabilizing Agents
=450  \\$aSuspending Agents
=550  \\$wg$aPharmaceutical Vehicles
=680  \\$iUsually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.
=688  \\$a80(75); was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74
=750  \0$aExcipients$5IEN-HS$0(DLC)sh 89002897

=LDR  01003cz  a2200229n  4500
=001  9880363537302441
=005  20141212201304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005076
=035  \\$aCAZ8218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x257
=150  \\$aExanthema
=450  \\$wnnna$aExanthem
=450  \\$aRash
=450  \\$wnnna$aRash, Skin
=450  \\$aSkin Rash
=550  \\$wg$aSkin Diseases
=550  \\$wh$aExanthema Subitum
=667  \\$aa skin eruption usually chem- or viral-induced; EXANTHEMA SUBITUM is also available
=680  \\$iDiseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
=750  \0$aExanthemata$5IEN$0(DLC)sh 85046091

=LDR  01170cz  a2200313n  4500
=001  9880363537402441
=005  20200415181348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005075
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x45
=072  \\$aG16.$x75
=150  \\$aBiological Evolution
=450  \\$wnnna$aEvolution, Biological
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aBiological Coevolution
=550  \\$wh$aEvolution, Molecular
=550  \\$wh$aGenetic Drift
=550  \\$wh$aGenetic Speciation
=550  \\$wh$aPhylogeny
=550  \\$wh$aLife History Traits
=550  \\$wh$aReproductive Isolation
=550  \\$aSociobiology
=667  \\$aMan in the evolutionary process is HOMINIDAE; evolution at the molecular level of DNA sequence is EVOLUTION, MOLECULAR
=680  \\$iThe process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics.
=688  \\$a2011 (1989)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Evolution
=750  \0$aEvolution (Biology)$0(DLC) sh 90004042$5IEN-M

=LDR  01190cz  a2200349n  4500
=001  9880363537502441
=005  20141212201303.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005074
=035  \\$aCAZ8216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x500.$x425
=072  \\$aG11.$x561.$x270.$x425
=072  \\$aG14.$x330
=150  \\$aEvoked Potentials, Visual
=450  \\$wnnna$aEvoked Potential, Visual
=450  \\$wnnna$aEvoked Response, Visual
=450  \\$wnnna$aEvoked Responses, Visual
=450  \\$wnnna$aPotential, Visual Evoked
=450  \\$wnnna$aPotentials, Visual Evoked
=450  \\$wnnna$aResponse, Visual Evoked
=450  \\$wnnna$aResponses, Visual Evoked
=450  \\$wnnna$aVisual Evoked Potential
=450  \\$wnnna$aVisual Evoked Potentials
=450  \\$aVisual Evoked Response
=450  \\$wnnna$aVisual Evoked Responses
=550  \\$wg$aEvoked Potentials
=550  \\$wg$aOcular Physiological Phenomena
=667  \\$aIM
=680  \\$iThe electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
=688  \\$a82
=750  \0$aVisual evoked response$5IEN$0(DLC)sh 85143921

=LDR  00836cz  a2200241n  4500
=001  9880363537602441
=005  20141212192204.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005073
=035  \\$aCAZ8215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x500.$x400
=072  \\$aG11.$x561.$x270.$x400
=150  \\$aEvoked Potentials, Somatosensory
=450  \\$wnnna$aEvoked Potential, Somatosensory
=450  \\$wnnna$aSomatosensory Evoked Potential
=450  \\$aSomatosensory Evoked Potentials
=550  \\$wg$aEvoked Potentials
=550  \\$wh$aLaser-Evoked Potentials
=667  \\$aIM
=680  \\$iThe electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM.
=688  \\$a82
=750  \0$aSomatosensory evoked potentials$5IEN$0(DLC)sh 90001867

=LDR  01139cz  a2200325n  4500
=001  9880363537702441
=005  20141212192203.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005072
=035  \\$aCAZ8214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x500.$x370
=072  \\$aG11.$x561.$x270.$x370
=150  \\$aEvoked Potentials, Auditory
=450  \\$wnnna$aAuditory Evoked Potential
=450  \\$aAuditory Evoked Potentials
=450  \\$aAuditory Evoked Response
=450  \\$wnnna$aAuditory Evoked Responses
=450  \\$wnnna$aEvoked Potential, Auditory
=450  \\$wnnna$aEvoked Response, Auditory
=450  \\$wnnna$aEvoked Responses, Auditory
=450  \\$wnnna$aPotentials, Auditory Evoked
=550  \\$wg$aEvoked Potentials
=550  \\$wh$aCochlear Microphonic Potentials
=550  \\$wh$aEvoked Potentials, Auditory, Brain Stem
=550  \\$aAcoustic Stimulation
=667  \\$aIM
=680  \\$iThe electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS.
=688  \\$a80
=750  \0$aAuditory evoked response$5IEN$0(DLC)sh 85009493

=LDR  03860cz  a2201045n  4500
=001  9880363537802441
=005  20180402112801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005071
=035  \\$aCAZ8213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x265.$x216.$x500
=072  \\$aG11.$x561.$x200.$x500
=150  \\$aEvoked Potentials
=450  \\$wnnna$aEvent-Related Potential
=450  \\$aEvent-Related Potentials
=450  \\$wnnna$aEvent Related Potentials
=450  \\$wnnna$aEvoked Potential
=450  \\$wnnna$aEvoked Potential, N100
=450  \\$wnnna$aEvoked Potential, N200
=450  \\$wnnna$aEvoked Potential, N300
=450  \\$wnnna$aEvoked Potential, N400
=450  \\$wnnna$aEvoked Potential, P200
=450  \\$wnnna$aEvoked Potential, P50
=450  \\$wnnna$aEvoked Potential, P600
=450  \\$wnnna$aEvoked Potentials, N100
=450  \\$wnnna$aEvoked Potentials, N200
=450  \\$wnnna$aEvoked Potentials, N300
=450  \\$wnnna$aEvoked Potentials, N400
=450  \\$wnnna$aEvoked Potentials, P200
=450  \\$wnnna$aEvoked Potentials, P50
=450  \\$wnnna$aEvoked Potentials, P600
=450  \\$wnnna$aN1 Wave
=450  \\$wnnna$aN1 Waves
=450  \\$wnnna$aN100 Evoked Potential
=450  \\$wnnna$aN100 Evoked Potentials
=450  \\$wnnna$aN2 Wave
=450  \\$wnnna$aN2 Waves
=450  \\$wnnna$aN200 Evoked Potential
=450  \\$wnnna$aN200 Evoked Potentials
=450  \\$wnnna$aN3 Wave
=450  \\$wnnna$aN3 Waves
=450  \\$wnnna$aN300 Evoked Potential
=450  \\$wnnna$aN300 Evoked Potentials
=450  \\$wnnna$aN4 Wave
=450  \\$wnnna$aN4 Waves
=450  \\$wnnna$aN400 Evoked Potential
=450  \\$wnnna$aN400 Evoked Potentials
=450  \\$wnnna$aP2 Wave
=450  \\$wnnna$aP2 Waves
=450  \\$wnnna$aP200 Evoked Potential
=450  \\$wnnna$aP200 Evoked Potentials
=450  \\$wnnna$aP50 Evoked Potential
=450  \\$wnnna$aP50 Evoked Potentials
=450  \\$wnnna$aP50 Wave
=450  \\$wnnna$aP50 Waves
=450  \\$wnnna$aP600 Evoked Potential
=450  \\$wnnna$aP600 Evoked Potentials
=450  \\$wnnna$aPotential, Event-Related
=450  \\$wnnna$aPotential, Evoked
=450  \\$wnnna$aPotentials, Event-Related
=450  \\$wnnna$aPotentials, Event Related
=450  \\$wnnna$aPotentials, Evoked
=450  \\$wnnna$aPotentials, N400 Evoked
=450  \\$wnnna$aWave, N1
=450  \\$wnnna$aWave, N2
=450  \\$wnnna$aWave, N3
=450  \\$wnnna$aWave, N4
=450  \\$wnnna$aWave, P2
=450  \\$wnnna$aWave, P50
=450  \\$wnnna$aWaves, N1
=450  \\$wnnna$aWaves, N2
=450  \\$wnnna$aWaves, N3
=450  \\$wnnna$aWaves, N4
=450  \\$wnnna$aWaves, P2
=450  \\$wnnna$aWaves, P50
=550  \\$wg$aCortical Excitability
=550  \\$wh$aContingent Negative Variation
=550  \\$wh$aCortical Spreading Depression
=550  \\$wh$aEvent-Related Potentials, P300
=550  \\$wh$aEvoked Potentials, Auditory
=550  \\$wh$aEvoked Potentials, Motor
=550  \\$wh$aEvoked Potentials, Somatosensory
=550  \\$wh$aEvoked Potentials, Visual
=550  \\$aCortical Synchronization
=550  \\$aElectroencephalography Phase Synchronization
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iElectrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported.
=688  \\$a68(67)
=750  \0$aEvoked potentials (Electrophysiology)$0(DLC) sh 85046028$5IEN

=LDR  01209cz  a2200325n  4500
=001  9880363537902441
=005  20141212201303.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005070
=035  \\$aCAZ8212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x172.$x560
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x555.$x400
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50.$x650.$x300
=072  \\$aD4.$x615.$x638.$x555.$x400
=150  \\$aEvans Blue
=450  \\$wnnna$aAzovan Blue
=450  \\$wnnna$aBlue, Azovan
=450  \\$wnnna$aBlue, Evan's
=450  \\$wnnna$aBlue, Evans
=450  \\$wnnna$aC.I. 23860
=450  \\$wnnna$aC.I. Direct Blue 53
=450  \\$wnnna$aEvan Blue
=450  \\$wnnna$aEvan's Blue
=550  \\$wg$aAzo Compounds
=550  \\$wg$aNaphthalenesulfonates
=667  \\$aD25-26 qualif
=680  \\$iAn azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly.
=688  \\$a91(76); was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU & T-1824 were see EVANS BLUE 1976-93
=750  \0$aEvans blue$5IEN$0(DLC)sh 85045947

=LDR  02888cz  a2200757n  4500
=001  9880363538002441
=005  20141212201302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005069
=035  \\$aCAZ8211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x337
=072  \\$aN5.$x715.$x360.$x335
=150  \\$aEvaluation Studies as Topic
=450  \\$wnnna$aCritique
=450  \\$wnnna$aCritiques
=450  \\$wnnna$aEffectiveness, Theoretical
=450  \\$wnnna$aEvaluation
=450  \\$wnnna$aEvaluation Indexes
=450  \\$wnnna$aEvaluation Methodologies
=450  \\$wnnna$aEvaluation Methodology
=450  \\$wnnna$aEvaluation, Qualitative
=450  \\$wnnna$aEvaluation, Quantitative
=450  \\$wnnna$aEvaluation Report
=450  \\$wnnna$aEvaluation Reports
=450  \\$wnnna$aEvaluation Research
=450  \\$wnnna$aEvaluations
=450  \\$wnnna$aEvaluations, Qualitative
=450  \\$wnnna$aEvaluations, Quantitative
=450  \\$wnnna$aIndexes, Evaluation
=450  \\$wnnna$aMethodologies, Evaluation
=450  \\$wnnna$aMethodology, Evaluation
=450  \\$wnnna$aPre-Post Test
=450  \\$wnnna$aPre-Post Tests
=450  \\$wnnna$aPre Post Tests
=450  \\$wnnna$aQualitative Evaluation
=450  \\$wnnna$aQualitative Evaluations
=450  \\$wnnna$aQuantitative Evaluation
=450  \\$wnnna$aQuantitative Evaluations
=450  \\$wnnna$aReport, Evaluation
=450  \\$wnnna$aReports, Evaluation
=450  \\$wnnna$aResearch, Evaluation
=450  \\$wnnna$aTest, Pre-Post
=450  \\$wnnna$aTests, Pre-Post
=450  \\$wnnna$aTheoretical Effectiveness
=450  \\$wnnna$aUse-Effectiveness
=450  \\$wnnna$aUse Effectiveness
=550  \\$wg$aHealth Care Evaluation Mechanisms
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aClinical Trials as Topic
=550  \\$wh$aDevice Approval
=550  \\$wh$aDrug Approval
=550  \\$wh$aDrug Evaluation
=550  \\$wh$aDrug Evaluation, Preclinical
=550  \\$wh$aFeasibility Studies
=550  \\$wh$aPilot Projects
=550  \\$wh$aProduct Surveillance, Postmarketing
=550  \\$wh$aProgram Evaluation
=550  \\$wh$aReproducibility of Results
=550  \\$wh$aValidation Studies as Topic
=667  \\$afor general design, methodology, economics, etc. of evaluation studies; a different heading EVALUATION STUDIES is used for reports of a specific evaluation study
=680  \\$iStudies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.
=688  \\$a2008(1966)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Evaluation Studies
=688  \\$a74(71)(66-67)
=750  \0$aEvaluation$0(DLC) sh 85045926$5IEN

=LDR  01192cz  a2200277n  4500
=001  9880363538102441
=005  20141212201301.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005068
=035  \\$aCAZ8210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x300
=150  \\$aEutrophication
=450  \\$aAlgal Bloom
=450  \\$wnnna$aAlgal Blooms
=450  \\$wnnna$aBloom, Algal
=450  \\$wnnna$aBlooms, Algal
=450  \\$wnnna$aEutrophications
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wh$aHarmful Algal Bloom
=550  \\$aPlankton
=550  \\$aWater Pollution, Chemical
=667  \\$aentry term ALGAL BLOOM: HARMFUL ALGAL BLOOM is also available
=680  \\$iThe enrichment of a terrestrial or aquatic ECOSYSTEM by the addition of nutrients, especially nitrogen and phosphorus, that results in a superabundant growth of plants, ALGAE, or other primary producers. It can be a natural process or result from human activity such as agriculture runoff or sewage pollution. In aquatic ecosystems, an increase in the algae population is termed an algal bloom.
=688  \\$a76
=750  \0$aEutrophication$5IEN$0(DLC)sh 85045914

=LDR  01285cz  a2200325n  4500
=001  9880363538202441
=005  20141212201300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x905.$x199
=072  \\$aI1.$x880.$x735.$x344.$x500
=072  \\$aN2.$x421.$x585.$x905.$x199
=150  \\$aEuthanasia
=450  \\$wnnna$aEuthanasia, Involuntary
=450  \\$wnnna$aInvoluntary Euthanasia
=450  \\$wnnna$aKilling, Mercy
=450  \\$wnnna$aKillings, Mercy
=450  \\$aMercy Killing
=450  \\$wnnna$aMercy Killings
=550  \\$wg$aHomicide
=550  \\$wg$aTerminal Care
=550  \\$wh$aEuthanasia, Active
=550  \\$wh$aEuthanasia, Passive
=550  \\$aBioethical Issues
=550  \\$aRight to Die
=550  \\$aSuicide, Assisted
=667  \\$aHUMAN only; EUTHANASIA, ANIMAL is available for animals; EUTHANASIA, ACTIVE and EUTHANASIA, PASSIVE are also available
=680  \\$iThe act or practice of killing or allowing death from natural causes, for reasons of mercy, i.e., in order to release a person from incurable disease, intolerable suffering, or undignified death. (from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed)
=750  \0$aEuthanasia$5IEN$0(DLC)sh 85045906

=LDR  00997cz  a2200301n  4500
=001  9880363538302441
=005  20141212201300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005064
=035  \\$aCAZ8206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x397.$x369
=150  \\$aEustachian Tube
=450  \\$aAuditory Tube
=450  \\$wnnna$aAuditory Tubes
=450  \\$wnnna$aEustachian Tubes
=450  \\$wnnna$aPharyngotympanic Tube
=450  \\$wnnna$aPharyngotympanic Tubes
=450  \\$wnnna$aTube, Auditory
=450  \\$wnnna$aTube, Eustachian
=450  \\$wnnna$aTube, Pharyngotympanic
=450  \\$wnnna$aTubes, Auditory
=450  \\$wnnna$aTubes, Eustachian
=450  \\$wnnna$aTubes, Pharyngotympanic
=550  \\$wg$aEar, Middle
=667  \\$a"eustachian" is not capitalized in titles or translations
=680  \\$iA narrow passageway that connects the upper part of the throat to the TYMPANIC CAVITY.
=750  \0$aEustachian tube$5IEN$0(DLC)sh 85045895

=LDR  00895cz  a2200193n  4500
=001  9880363538402441
=005  20141212201300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005063
=035  \\$aCAZ8205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x468
=072  \\$aD1.$x268.$x558.$x362.$x468
=072  \\$aD1.$x552.$x550.$x399.$x468
=150  \\$aEuropium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aEu-153; Eu-151 = EUROPIUM (IM) + ISOTOPES (NIM); Eu-144-150, 152, 154-160 = EUROPIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iEuropium. An element of the rare earth family of metals. It has the atomic symbol Eu, atomic number 63, and atomic weight 152. Europium is used in the form of its salts as coatings for cathode ray tubes and in the form of its organic derivatives as shift reagents in NMR spectroscopy.
=750  \0$aEuropium$5IEN$0(DLC)sh 85045863

=LDR  00628cz  a2200181n  4500
=001  9880363538502441
=005  20141212201257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005059
=035  \\$aCAZ8201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x323
=150  \\$aEuphoria
=450  \\$aElation$5IEN
=450  \\$wnnna$aEuphorias
=550  \\$wg$aEmotions
=680  \\$iAn exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states.
=750  \0$aElation$5IEN$0(DLC)sh 85041526

=LDR  00684cz  a2200217n  4500
=001  9880363538602441
=005  20141212201257.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005057
=035  \\$aCAZ8199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x450
=150  \\$aEukaryotic Cells
=450  \\$wnnna$aCell, Eukaryotic
=450  \\$wnnna$aCells, Eukaryotic
=450  \\$wnnna$aEukaryotic Cell
=550  \\$wg$aCells
=667  \\$ado not confuse with EUKARYOTA
=680  \\$iCells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.
=688  \\$a91(78); was see under CELLS 1978-90
=750  \0$aEukaryotic cells$5IEN$0(DLC)sh 85045546

=LDR  00765cz  a2200217n  4500
=001  9880363538702441
=005  20141212201257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005056
=035  \\$aCAZ8198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x250.$x320.$x418
=150  \\$aEuglena gracilis
=450  \\$wnnna$aEuglena gracili
=450  \\$wnnna$agracili, Euglena
=450  \\$wnnna$agracilis, Euglena
=550  \\$wg$aEuglena
=667  \\$ainfection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of fresh-water, flagellated EUKARYOTES in the phylum EUGLENIDA.
=688  \\$a72
=750  \0$aEuglena gracilis$5IEN$0(DLC)sh 88022362

=LDR  00801cz  a2200205n  4500
=001  9880363538802441
=005  20141212201256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005055
=035  \\$aCAZ8197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x250.$x320
=150  \\$aEuglena
=450  \\$wnnna$aEuglenas
=550  \\$wg$aEuglenida
=550  \\$wh$aEuglena gracilis
=550  \\$wh$aEuglena longa
=667  \\$ainfection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of EUKARYOTES, in the phylum EUGLENIDA, found mostly in stagnant water. Characteristics include a pellicle usually marked by spiral or longitudinal striations.
=750  \0$aEuglena$5IEN$0(DLC)sh 88022361

=LDR  01504cz  a2200457n  4500
=001  9880363538902441
=005  20141212201224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004938
=035  \\$aCAZ8079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x205
=072  \\$aC4.$x588.$x443.$x353
=072  \\$aC6.$x301.$x371.$x205
=072  \\$aC6.$x405.$x117.$x430
=072  \\$aC6.$x405.$x249.$x205
=150  \\$aEsophageal Neoplasms
=450  \\$wnnna$aCancer, Esophageal
=450  \\$wnnna$aCancer, Esophagus
=450  \\$aCancer of Esophagus
=450  \\$wnnna$aCancer of the Esophagus
=450  \\$wnnna$aCancers, Esophageal
=450  \\$wnnna$aCancers, Esophagus
=450  \\$aEsophageal Cancer
=450  \\$wnnna$aEsophageal Cancers
=450  \\$wnnna$aEsophageal Neoplasm
=450  \\$wnnna$aEsophagus Cancer
=450  \\$wnnna$aEsophagus Cancers
=450  \\$wnnna$aEsophagus Neoplasm
=450  \\$wnnna$aEsophagus Neoplasms
=450  \\$wnnna$aNeoplasm, Esophageal
=450  \\$wnnna$aNeoplasm, Esophagus
=450  \\$wnnna$aNeoplasms, Esophageal
=450  \\$wnnna$aNeoplasms, Esophagus
=550  \\$wg$aEsophageal Diseases
=550  \\$wg$aGastrointestinal Neoplasms
=550  \\$wg$aHead and Neck Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the ESOPHAGUS.
=750  \0$aEsophagus$xTumors$5IEN-M$0(DLC)sh 85044870
=750  \0$aEsophagus$xCancer$5IEN-HS$0(DLC)sh 85044858

=LDR  01625cz  a2200361n  4500
=001  9880363539002441
=005  20141212210858.0
=008  880322\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015154
=035  \\$aCAZ8078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x119.$x500
=150  \\$aEsophageal Motility Disorders
=450  \\$wnnna$aDisorder, Esophageal Motility
=450  \\$wnnna$aDisorders, Esophageal Motility
=450  \\$wnnna$aDysmotilities, Esophageal
=450  \\$wnnna$aDysmotility, Esophageal
=450  \\$wnnna$aEsophageal Dysmotilities
=450  \\$aEsophageal Dysmotility
=450  \\$wnnna$aEsophageal Motility Disorder
=450  \\$wnnna$aEsophagus, Nutcracker
=450  \\$wnnna$aMotility Disorder, Esophageal
=450  \\$wnnna$aMotility Disorders, Esophageal
=450  \\$aNutcracker Esophagus
=550  \\$wg$aDeglutition Disorders
=550  \\$wh$aCREST Syndrome
=550  \\$wh$aEsophageal Achalasia
=550  \\$wh$aEsophageal Spasm, Diffuse
=550  \\$wh$aGastroesophageal Reflux
=550  \\$wh$aPlummer-Vinson Syndrome
=680  \\$iDisorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
=688  \\$a1989
=750  \0$aEsophagus$xMotility$xDisorders$5IEN$0(DLC)sh 85044867

=LDR  00824cz  a2200241n  4500
=001  9880363539102441
=005  20141212201223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004936
=035  \\$aCAZ8076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x415.$x625
=150  \\$aDiverticulum, Esophageal
=450  \\$wnnna$aDiverticula, Esophageal
=450  \\$wnnna$aEsophageal Diverticula
=450  \\$aEsophageal Diverticulum
=550  \\$wg$aDiverticulum
=550  \\$wh$aZenker Diverticulum
=550  \\$aDiverticulosis, Esophageal
=667  \\$ainflamm divertic or diverticulitis: coord IM with DIVERTICULITIS (IM)
=680  \\$iSaccular protrusion beyond the wall of the ESOPHAGUS.
=688  \\$a92; was ESOPHAGEAL DIVERTICULA 1963-91
=750  \0$aEsophagus$xDiverticula$5IEN-M$0(DLC)sh 85044861

=LDR  01278cz  a2200349n  4500
=001  9880363539202441
=005  20141212201223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004935
=035  \\$aCAZ8075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117
=150  \\$aEsophageal Diseases
=450  \\$wnnna$aDisease, Esophageal
=450  \\$wnnna$aDiseases, Esophageal
=450  \\$wnnna$aEsophageal Disease
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wh$aBarrett Esophagus
=550  \\$wh$aDeglutition Disorders
=550  \\$wh$aDiverticulosis, Esophageal
=550  \\$wh$aEsophageal and Gastric Varices
=550  \\$wh$aEsophageal Atresia
=550  \\$wh$aEsophageal Cyst
=550  \\$wh$aEsophageal Fistula
=550  \\$wh$aEsophageal Neoplasms
=550  \\$wh$aEsophageal Perforation
=550  \\$wh$aEsophageal Stenosis
=550  \\$wh$aEsophagitis
=667  \\$ainflamm dis = ESOPHAGITIS; hemorrhage: coord IM with HEMORRHAGE, GASTROINTESTINAL (IM); motility disord = ESOPHAGEAL MOTILITY DISORDERS or specific; esophageal varix or varices = ESOPHAGEAL AND GASTRIC VARICES & see note there
=680  \\$iPathological processes in the ESOPHAGUS.
=688  \\$a66
=750  \0$aEsophagus$xDiseases$5IEN$0(DLC)sh 85044860

=LDR  00919cz  a2200253n  4500
=001  9880363539302441
=005  20141212201223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004933
=035  \\$aCAZ8073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x198.$x330
=072  \\$aC6.$x405.$x117.$x260
=072  \\$aC16.$x131.$x314.$x330
=150  \\$aEsophageal Atresia
=450  \\$aAtresia, Esophageal
=450  \\$wnnna$aAtresias, Esophageal
=450  \\$wnnna$aEsophageal Atresias
=550  \\$wg$aDigestive System Abnormalities
=550  \\$wg$aEsophageal Diseases
=550  \\$aEsophageal Diseases
=680  \\$iCongenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.
=688  \\$a70(66)
=750  \0$aEsophagus$xAtresia$5IEN$0(DLC)sh 85044857

=LDR  01306cz  a2200313n  4500
=001  9880363539402441
=005  20141212201222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004932
=035  \\$aCAZ8072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x240
=072  \\$aC6.$x552.$x494.$x414
=150  \\$aEsophageal and Gastric Varices
=450  \\$aEsophageal Varices
=450  \\$wnnna$aEsophageal Varix
=450  \\$aGastric Varices
=450  \\$wnnna$aGastric Varix
=450  \\$wnnna$aVarices, Esophageal
=450  \\$wnnna$aVarices, Gastric
=450  \\$wnnna$aVarix, Esophageal
=450  \\$wnnna$aVarix, Gastric
=550  \\$wg$aEsophageal Diseases
=550  \\$wg$aHypertension, Portal
=550  \\$aVaricose Veins
=667  \\$ado not specify esophageal or gastric aspect unless particularly discussed; hemorrhaging esophageal or gastric varices: coord IM with HEMORRHAGE, GASTROINTESTINAL (IM)
=680  \\$iDilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).
=688  \\$a85; was ESOPHAGEAL VARICES 1963-84
=750  \0$aEsophageal varices$5IEN$0(DLC)sh 85044848

=LDR  00552cz  a2200205n  4500
=001  9880363600402441
=005  20141212203739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009289
=035  \\$aCBA2553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794.$x582
=150  \\$aNarcissism
=450  \\$wnnna$aNarcissisms
=550  \\$wg$aPsychoanalytic Theory
=550  \\$aSelf Psychology
=667  \\$ano qualif
=680  \\$iA psychoanalytic term meaning self-love.
=688  \\$a68(66)
=750  \0$aNarcissism$5IEN$0(DLC)sh 85089796

=LDR  01087cz  a2200301n  4500
=001  9880363600502441
=005  20141212203739.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009288
=035  \\$aCBA2552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x472.$x500
=072  \\$aD4.$x615.$x638.$x472.$x450
=150  \\$aNaproxen
=450  \\$wnnna$aAleve
=450  \\$wnnna$aAnaprox
=450  \\$wnnna$aMethoxypropiocin
=450  \\$wnnna$aMNPA
=450  \\$wnnna$aNaprosin
=450  \\$wnnna$aNaprosyn
=450  \\$wnnna$aNaproxen Sodium
=450  \\$wnnna$aProxen
=450  \\$wnnna$aSodium, Naproxen
=450  \\$wnnna$aSynflex
=550  \\$wg$aNaphthaleneacetic Acids
=680  \\$iAn anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.
=688  \\$a78(75); was see under NAPHTHALENEACETIC ACIDS 1975-77
=750  \0$aNaproxen$5IEN$0(DLC)sh 85089785

=LDR  00428cz  a2200157n  4500
=001  9880363600602441
=005  20141212203738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009287
=035  \\$aCBA2551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x612
=150  \\$aNaphthyridines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aNalidixic Acid
=750  \0$aNaphthyridines$0(DLC)sh2007020075$5IEN-M

=LDR  00864cz  a2200277n  4500
=001  9880363600702441
=005  20141212203738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009285
=035  \\$aCBA2549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x721
=072  \\$aD2.$x806.$x550
=072  \\$aD4.$x615.$x638.$x721
=150  \\$aNaphthoquinones
=450  \\$aNaphthalenediones
=450  \\$aNaphthazarins
=550  \\$wg$aNaphthalenes
=550  \\$wg$aQuinones
=550  \\$wh$aAtovaquone
=550  \\$wh$aVitamin K
=550  \\$wh$aVitamin K 1
=550  \\$wh$aVitamin K 2
=550  \\$wh$aVitamin K 3
=680  \\$iNaphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
=750  \0$aNaphthoquinone$5IEN$0(DLC)sh 85089713

=LDR  00747cz  a2200193n  4500
=001  9880363600802441
=005  20141212203738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009284
=035  \\$aCBA2548M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x638
=072  \\$aD4.$x615.$x638.$x638
=150  \\$aNaphthols
=450  \\$aHydroxynaphthalenes
=550  \\$wg$aNaphthalenes
=680  \\$iNaphthalene derivatives carrying one or more hydroxyl (-OH) groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications.
=688  \\$a73(72)
=750  \0$aNaphthol$0(DLC)sh2013003298$5IEN

=LDR  01362cz  a2200409n  4500
=001  9880363600902441
=005  20210212073255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009281
=035  \\$aCBA2545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638
=072  \\$aD4.$x615.$x638
=150  \\$aNaphthalenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$a1-Naphthylamine
=550  \\$wh$a1-Naphthylisothiocyanate
=550  \\$wh$a2-Naphthylamine
=550  \\$wh$aAcenaphthenes
=550  \\$wh$aBunaftine
=550  \\$wh$aCarbaryl
=550  \\$wh$aDansyl Compounds
=550  \\$wh$aLovastatin
=550  \\$wh$aNaphthaleneacetic Acids
=550  \\$wh$aNaphthalenesulfonates
=550  \\$wh$aNaphthalimides
=550  \\$wh$aNaphthols
=550  \\$wh$aNaphthoquinones
=550  \\$wh$aNaphthylvinylpyridine
=550  \\$wh$aPravastatin
=550  \\$wh$aPropranolol
=550  \\$wh$aTetrahydronaphthalenes
=550  \\$wh$aTolnaftate
=550  \\$wh$aTerbinafine
=667  \\$aaromatic hydrocarbons
=680  \\$iTwo-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
=750  \0$aNaphthalene$5IEN$0(DLC)sh 85089710

=LDR  00765cz  a2200205n  4500
=001  9880363601002441
=005  20141212203736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009280
=035  \\$aCBA2544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x472
=072  \\$aD4.$x615.$x638.$x472
=150  \\$aNaphthaleneacetic Acids
=450  \\$wnnna$aAcids, Naphthaleneacetic
=550  \\$wg$aNaphthalenes
=550  \\$wh$aNaproxen
=680  \\$iNaphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc.
=688  \\$a68
=750  \0$aNaphthaleneacetic acid$5IEN$0(DLC)sh 85089711

=LDR  01457cz  a2200241n  4500
=001  9880363601102441
=005  20141212203734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009275
=035  \\$aCBA2539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x400.$x556
=150  \\$aNames
=450  \\$wnnna$aIsonymies
=450  \\$aIsonymy
=450  \\$wnnna$aName
=550  \\$wg$aTerminology as Topic
=550  \\$wh$aAbbreviations as Topic
=550  \\$wh$aAnonyms and Pseudonyms
=550  \\$wh$aEponyms
=667  \\$afor articles & books on personal given or surnames; history of names & name changes of agencies, societies, organizations, universities, medical schools, hospitals & other corporate bodies go here (NIM) + specific body if in MeSH as main heading (IM) or GOVERNMENT AGENCIES; SOCIETIES; UNIVERSITIES; HOSPITALS or other generic heading if specific corporate body is not in MeSH (IM); no qualif
=680  \\$iPersonal names, given or surname, as cultural characteristics, as ethnological or religious patterns, as indications of the geographic distribution of families and inbreeding, etc. Analysis of isonymy, the quality of having the same or similar names, is useful in the study of population genetics. NAMES is used also for the history of names or name changes of corporate bodies, such as medical societies, universities, hospitals, government agencies, etc.
=750  \0$aNames$5IEN$0(DLC)sh 85089592

=LDR  00771cz  a2200265n  4500
=001  9880363601202441
=005  20141212203733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009273
=035  \\$aCBA2537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60
=150  \\$aAge Groups
=450  \\$wnnna$aAge Group
=450  \\$wnnna$aGroup, Age
=450  \\$wnnna$aGroups, Age
=550  \\$wg$aPersons
=550  \\$wh$aAdolescent
=550  \\$wh$aAdult
=550  \\$wh$aChild
=550  \\$wh$aInfant
=667  \\$anot used for indexing or cataloging
=680  \\$iPersons classified by age from birth (INFANT, NEWBORN) to octogenarians and older (AGED, 80 AND OVER).
=688  \\$a98; use explode 1975-97
=750  \0$aAge Groups$5IEN-M$0(DLC)sh 85002083

=LDR  02771cz  a2200913n  4500
=001  9880363601302441
=005  20201026143742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009272
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1
=150  \\$aPersons
=450  \\$wnnna$aPerson
=550  \\$wh$aAbortion Applicants
=550  \\$wh$aAdult Children
=550  \\$wh$aAge Groups
=550  \\$wh$aAlcoholics
=550  \\$wh$aAthletes
=550  \\$wh$aCaregivers
=550  \\$wh$aChild, Adopted
=550  \\$wh$aChild, Abandoned
=550  \\$wh$aChild, Exceptional
=550  \\$wh$aChild, Foster
=550  \\$wh$aChild of Impaired Parents
=550  \\$wh$aChild, Orphaned
=550  \\$wh$aChild, Unwanted
=550  \\$wh$aConsultants
=550  \\$wh$aCrime Victims
=550  \\$wh$aCriminals
=550  \\$wh$aDisabled Persons
=550  \\$wh$aDisaster Victims
=550  \\$wh$aDrug Users
=550  \\$wh$aEmigrants and Immigrants
=550  \\$wh$aEnslaved Persons
=550  \\$wh$aFamous Persons
=550  \\$wh$aFriends
=550  \\$wh$aGrandparents
=550  \\$wh$aHomebound Persons
=550  \\$wh$aHomeless Persons
=550  \\$wh$aJehovah's Witnesses
=550  \\$wh$aLegal Guardians
=550  \\$wh$aMedically Uninsured
=550  \\$wh$aMen
=550  \\$wh$aMentors
=550  \\$wh$aMinors
=550  \\$wh$aMissionaries
=550  \\$wh$aMultiple Birth Offspring
=550  \\$wh$aOccupational Groups
=550  \\$wh$aParents
=550  \\$wh$aPatients
=550  \\$wh$aPedestrians
=550  \\$wh$aPopulation Groups
=550  \\$wh$aPrisoners
=550  \\$wh$aRefugees
=550  \\$wh$aResearch Personnel
=550  \\$wh$aResearch Subjects
=550  \\$wh$aSex Workers
=550  \\$wh$aSexual Partners
=550  \\$wh$aSiblings
=550  \\$wh$aSingle Person
=550  \\$wh$aSmokers
=550  \\$wh$aSpouses
=550  \\$wh$aStudents
=550  \\$wh$aSurvivors
=550  \\$wh$aTerminally Ill
=550  \\$wh$aTissue Donors
=550  \\$wh$aTransgender Persons
=550  \\$wh$aTransients and Migrants
=550  \\$wh$aTransplant Recipients
=550  \\$wh$aVeterans
=550  \\$wh$aVisitors to Patients
=550  \\$wh$aVolunteers
=550  \\$wh$aVulnerable Populations
=550  \\$wh$aWomen
=550  \\$wh$aWorking Poor
=667  \\$aused for searching: indexers and catalogers apply specifics
=680  \\$iPersons as individuals (e.g., ABORTION APPLICANTS) or as members of a group (e.g., HISPANIC AMERICANS). It is not used for members of the various professions (e.g., PHYSICIANS) or occupations (e.g., LIBRARIANS) for which OCCUPATIONAL GROUPS is available.
=688  \\$a98; use explode
=750  \0$aPersons$5IEN-M$0(DLC)sh 85100163

=LDR  01952cz  a2200457n  4500
=001  9880363601402441
=005  20141212203732.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009271
=035  \\$aCBA2535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x706.$x550
=072  \\$aD3.$x549.$x686.$x750.$x550
=072  \\$aD3.$x605.$x497.$x750.$x550
=072  \\$aD4.$x615.$x723.$x795.$x706.$x550
=150  \\$aNaltrexone
=450  \\$wnnna$aAntaxone
=450  \\$wnnna$aBristol-Myers Squibb Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aBristol Myers Squibb Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aCelupan
=450  \\$wnnna$aDu Pont Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aEN-1639A
=450  \\$wnnna$aEN 1639A
=450  \\$wnnna$aEN1639A
=450  \\$wnnna$aHydrochloride, Naltrexone
=450  \\$wnnna$aLacer Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aLamepro Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aNalorex
=450  \\$wnnna$aNaltrexone Hydrochloride
=450  \\$wnnna$aNemexin
=450  \\$wnnna$aOrphan Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aPharmazam Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aReVia
=450  \\$wnnna$aSchering-Plough Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aSchering Plough Brand of Naltrexone Hydrochloride
=450  \\$wnnna$aTrexan
=450  \\$wnnna$aUnited Drug Brand of Naltrexone Hydrochloride
=550  \\$wg$aNaloxone
=680  \\$iDerivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
=688  \\$a86(76); was see under NALOXONE 1976-85
=750  \0$aNaltrexone$5IEN$0(DLC)sh 90000798

=LDR  02527cz  a2200661n  4500
=001  9880363601502441
=005  20161215115612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009270
=035  \\$aCBA2534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x706
=072  \\$aD3.$x549.$x686.$x750
=072  \\$aD3.$x605.$x497.$x750
=072  \\$aD4.$x615.$x723.$x795.$x706
=150  \\$aNaloxone
=450  \\$wnnna$aAbello Brand of Naloxone Hydrochloride
=450  \\$wnnna$aAbello, Naloxone
=450  \\$wnnna$aBoots Brand of Naloxone Hydrochloride
=450  \\$wnnna$aBristol-Myers Squibb Brand of Naloxone Hydrochloride
=450  \\$wnnna$aBristol Myers Squibb Brand of Naloxone Hydrochloride
=450  \\$wnnna$aCuramed Brand of Naloxone Hydrochloride
=450  \\$wnnna$aCuramed, Naloxon
=450  \\$wnnna$aDihydride, Naloxone Hydrochloride
=450  \\$wnnna$aEndo Brand of Naloxone Hydrochloride
=450  \\$wnnna$aHydrobromide, Naloxone
=450  \\$wnnna$aHydrochloride Dihydride, Naloxone
=450  \\$wnnna$aHydrochloride, Naloxone
=450  \\$wnnna$aLamepro Brand of Naloxone Hydrochloride
=450  \\$wnnna$aMRZ-2593
=450  \\$wnnna$aMRZ 2593
=450  \\$wnnna$aMRZ 2593-Br
=450  \\$wnnna$aMRZ 2593 Br
=450  \\$wnnna$aMRZ 2593Br
=450  \\$wnnna$aMRZ2593
=450  \\$wnnna$aNalone
=450  \\$wnnna$aNaloxon Curamed
=450  \\$wnnna$aNaloxon-ratiopharm
=450  \\$wnnna$aNaloxon ratiopharm
=450  \\$wnnna$aNaloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer
=450  \\$wnnna$aNaloxone Abello
=450  \\$wnnna$aNaloxone Hydrobromide
=450  \\$wnnna$aNaloxone Hydrochloride
=450  \\$wnnna$aNaloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer
=450  \\$wnnna$aNaloxone Hydrochloride Dihydride
=450  \\$wnnna$aNaloxonratiopharm
=450  \\$wnnna$aNarcan
=450  \\$wnnna$aNarcanti
=450  \\$wnnna$aratiopharm Brand of Naloxone Hydrochloride
=450  \\$wnnna$aSERB Brand of Naloxone Hydrochloride
=450  \\$wnnna$aUnited Drug Brand of Naloxone Hydrochloride
=550  \\$wg$aMorphinans
=550  \\$wh$aBuprenorphine, Naloxone Drug Combination
=550  \\$wh$aNaltrexone
=680  \\$iA specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
=688  \\$a1973(1972); for MRZ-2593 use OXYMORPHONE 1985-2009
=688  \\$a73(72)
=750  \0$aNaloxone$5IEN$0(DLC)sh 85089574

=LDR  01102cz  a2200325n  4500
=001  9880363601602441
=005  20141212203729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009266
=035  \\$aCBA2530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x606
=072  \\$aD3.$x549.$x686.$x639
=072  \\$aD3.$x605.$x497.$x639
=072  \\$aD4.$x615.$x723.$x795.$x606
=150  \\$aNalbuphine
=450  \\$wnnna$aEN-2234A
=450  \\$wnnna$aEN 2234A
=450  \\$wnnna$aEN2234A
=450  \\$wnnna$aHydrochloride, Nalbuphine
=450  \\$wnnna$aNalbuphine Hydrochloride
=450  \\$wnnna$aNalbuphine Serb
=450  \\$wnnna$analbuphine SERB brand
=450  \\$wnnna$aNubain
=450  \\$wnnna$aSERB brand of nalbuphine
=450  \\$wnnna$aSerb, Nalbuphine
=550  \\$wg$aMorphinans
=680  \\$iA narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.
=688  \\$a91(72); was see under MORPHINANS 1972-90
=750  \0$aNalbuphine$5IEN$0(DLC)sh 91004127

=LDR  00750cz  a2200229n  4500
=001  9880363601702441
=005  20141212203728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA17.$x600
=150  \\$aNails
=360  \\$iconsider also terms at$aONYCHO-
=450  \\$wnnna$aFingernail
=450  \\$aFingernails
=450  \\$wnnna$aNail
=450  \\$wnnna$aToenail
=450  \\$aToenails
=550  \\$wg$aIntegumentary System
=667  \\$aprimates only: use HOOF AND CLAW for other vertebrates: Manual 21.58;
=680  \\$iThe thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates.
=750  \0$aNails (Anatomy)$5IEN$0(DLC)sh 85089542

=LDR  00968cz  a2200301n  4500
=001  9880363601802441
=005  20141212203727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009260
=035  \\$aCBA2524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x529
=150  \\$aNail Diseases
=450  \\$wnnna$aDisease, Nail
=450  \\$wnnna$aDiseases, Nail
=450  \\$wnnna$aNail Disease
=550  \\$wg$aSkin Diseases
=550  \\$wh$aNail-Patella Syndrome
=550  \\$wh$aNails, Ingrown
=550  \\$wh$aOnycholysis
=550  \\$wh$aOnychomycosis
=550  \\$wh$aPachyonychia Congenita
=550  \\$wh$aParonychia
=550  \\$wh$aYellow Nail Syndrome
=667  \\$aprimates only; neopl: coord IM with SKIN NEOPLASMS (IM)
=680  \\$iDiseases of the nail plate and tissues surrounding it. The concept is limited to primates.
=688  \\$a79; was NON MESH before 1979
=750  \0$aNails (Anatomy)$xDiseases$5IEN$0(DLC)sh 98008069

=LDR  00524cz  a2200181n  4500
=001  9880363601902441
=005  20141212203727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009259
=035  \\$aCBA2523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x466.$x554
=150  \\$aNail Biting
=450  \\$wnnna$aBiting, Nail
=450  \\$aOnychophagia
=550  \\$wg$aHabits
=680  \\$iCommon form of habitual body manipulation which is an expression of tension.
=750  \0$aNail-biting$5IEN$0(DLC)sh 85089535

=LDR  00888cz  a2200205n  4500
=001  9880363602002441
=005  20141212203726.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009253
=035  \\$aCBA2517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x700.$x710
=150  \\$aNaegleria
=450  \\$wnnna$aNaeglerias
=550  \\$wg$aSchizopyrenida
=550  \\$wh$aNaegleria fowleri
=667  \\$ainfection: coordinate IM with CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA free-living soil amoeba pathogenic to humans and animals. It occurs also in water and sewage. The most commonly found species in man is NAEGLERIA FOWLERI which is the pathogen for primary amebic meningoencephalitis in primates.
=688  \\$a88
=750  \0$aNaegleria$5IEN$0(DLC)sh 88021380

=LDR  00880cz  a2200253n  4500
=001  9880363602102441
=005  20141212203724.0
=008  860625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009248
=035  \\$aCBA2512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x601
=072  \\$aD2.$x33.$x755.$x624.$x698.$x601
=072  \\$aD2.$x92.$x63.$x624.$x698.$x601
=150  \\$aNadolol
=450  \\$wnnna$aCorgard
=450  \\$wnnna$aSolgol
=450  \\$wnnna$aSQ-11725
=450  \\$wnnna$aSQ 11725
=450  \\$wnnna$aSQ11725
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
=688  \\$a87
=750  \0$aNadolol$5IEN$0(DLC)sh 85089485

=LDR  01505cz  a2200361n  4500
=001  9880363602202441
=005  20141212203722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009243
=035  \\$aCBA2506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x138.$x694
=072  \\$aD8.$x211.$x589
=072  \\$aD13.$x695.$x667.$x138.$x694
=072  \\$aD13.$x695.$x827.$x68.$x694
=150  \\$aNAD
=450  \\$wnnna$aAdenine Dinucleotide, Dihydronicotinamide
=450  \\$aCoenzyme I
=450  \\$wnnna$aDihydronicotinamide Adenine Dinucleotide
=450  \\$wnnna$aDinucleotide, Dihydronicotinamide Adenine
=450  \\$wnnna$aDinucleotide, Nicotinamide-Adenine
=450  \\$aDiphosphopyridine Nucleotide
=450  \\$aDPN
=450  \\$wnnna$aNADH
=450  \\$aNadide
=450  \\$aNicotinamide-Adenine Dinucleotide
=450  \\$wnnna$aNicotinamide Adenine Dinucleotide
=450  \\$wnnna$aNucleotide, Diphosphopyridine
=550  \\$wg$aAdenine Nucleotides
=550  \\$wg$aCoenzymes
=667  \\$aa coenzyme; NAD or NADP probably correct for indexing of pyridine nucleotides
=680  \\$iA coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)
=750  \0$aNAD (Coenzyme)$5IEN$0(DLC)sh 89003360

=LDR  01036cz  a2200229n  4500
=001  9880363602302441
=005  20141212200740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004130
=035  \\$aCBA2505HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x801.$x451
=072  \\$aD3.$x438.$x473.$x914.$x237
=150  \\$aN,N-Dimethyltryptamine
=450  \\$aDimethyltryptamine
=450  \\$wnnna$aN,N Dimethyltryptamine
=550  \\$wg$aTryptamines
=550  \\$wh$aBufotenin
=550  \\$wh$aMethoxydimethyltryptamines
=680  \\$iAn N-methylated indoleamine derivative and serotonergic hallucinogen which occurs naturally and ubiquitously in several plant species including Psychotria veridis. It also occurs in trace amounts in mammalian brain, blood, and urine, and is known to act as an agonist or antagonist of certain SEROTONIN RECEPTORS.
=688  \\$a91(89); was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1973-88 (Prov 1973-74)
=750  \0$aDimethyltryptamine$5IEN-M$0(DLC)sh 00000063

=LDR  01435cz  a2200385n  4500
=001  9880363602402441
=005  20141212203718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009235
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x550.$x550
=150  \\$aMyxomycetes
=450  \\$wnnna$aMold, Plasmodial Slime
=450  \\$wnnna$aMold, True Slime
=450  \\$wnnna$aMolds, Plasmodial Slime
=450  \\$wnnna$aMolds, True Slime
=450  \\$wnnna$aMyxomycete
=450  \\$aMyxomycota
=450  \\$wnnna$aMyxomycotas
=450  \\$wnnna$aPlasmodial Slime Mold
=450  \\$wnnna$aPlasmodial Slime Molds
=450  \\$wnnna$aProtosteliomycete
=450  \\$aProtosteliomycetes
=450  \\$wnnna$aSlime Mold, Plasmodial
=450  \\$wnnna$aSlime Mold, True
=450  \\$aSlime Molds, Plasmodial
=450  \\$aSlime Molds, True
=450  \\$wnnna$aTrue Slime Mold
=450  \\$wnnna$aTrue Slime Molds
=550  \\$wg$aMycetozoa
=550  \\$wh$aPhysarida
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are now classed as protozoa but formerly were considered fungi.
=688  \\$a99(63)
=750  \0$aMyxomycetes$0(DLC) sh 85089454$5IEN

=LDR  01019cz  a2200229n  4500
=001  9880363602502441
=005  20141212203717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009232
=035  \\$aCBA2494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x550
=150  \\$aMyxoma
=450  \\$aAngiomyxoma
=450  \\$wnnna$aAngiomyxomas
=450  \\$wnnna$aMyxomas
=550  \\$wg$aNeoplasms, Connective Tissue
=550  \\$wh$aCarney Complex
=550  \\$wh$aNeurothekeoma
=667  \\$a/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed)
=750  \0$aMyxoma$5IEN$0(DLC)sh 85089453

=LDR  00779cz  a2200265n  4500
=001  9880363602602441
=005  20141212203717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009231
=035  \\$aCBA2493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x660.$x125.$x500
=150  \\$aMyxococcales
=450  \\$aMyxobacterales
=450  \\$aMyxobacteria
=450  \\$wnnoa$aMyxococcaceae$5IEN-M
=450  \\$aPolyangiaceae
=450  \\$aPolyangium
=450  \\$aSlime Bacteria
=550  \\$wg$aDeltaproteobacteria
=550  \\$wh$aMyxococcus
=550  \\$wh$aStigmatella
=680  \\$iAn order of rod-shaped, gram-negative fruiting gliding bacteria found in SOIL; WATER; and HUMUS.
=688  \\$a1992 (1974)
=750  \0$aMyxobacterales$5IEN-M$0(DLC)sh 85089449

=LDR  00980cz  a2200241n  4500
=001  9880363602702441
=005  20141212203717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009230
=035  \\$aCBA2492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x550.$x590
=072  \\$aC19.$x874.$x482.$x638
=150  \\$aMyxedema
=450  \\$wnnna$aMyxedemas
=550  \\$wg$aHypothyroidism
=550  \\$wg$aMucinoses
=550  \\$aCongenital Hypothyroidism
=550  \\$aHypothyroidism
=550  \\$aScleromyxedema
=667  \\$apretibial myxedema = MYXEDEMA (IM) + LEG DERMATOSES (IM)
=680  \\$iA condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
=750  \0$aMyxedema$0(DLC) sh 85089446$5IEN

=LDR  01704cz  a2200301n  4500
=001  9880363602802441
=005  20141212203652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009157
=035  \\$aCBA2414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x656
=072  \\$aC10.$x668.$x758.$x725
=072  \\$aC20.$x111.$x258.$x500
=150  \\$aMyasthenia Gravis
=450  \\$wnnna$aGeneralized Myasthenia Gravis
=450  \\$wnnna$aMyasthenia Gravis, Generalized
=450  \\$wnnna$aMyasthenia Gravis, Ocular
=450  \\$wnnna$aOcular Myasthenia Gravis
=550  \\$wg$aAutoimmune Diseases of the Nervous System
=550  \\$wg$aNeuromuscular Junction Diseases
=550  \\$wh$aMyasthenia Gravis, Autoimmune, Experimental
=550  \\$wh$aMyasthenia Gravis, Neonatal
=550  \\$aMyasthenic Syndromes, Congenital
=550  \\$aThymus Hyperplasia
=667  \\$a"myasthenia" unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congen consider MYASTHENIC SYNDROMES, CONGENITAL or specifics
=680  \\$iA disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
=750  \0$aMyasthenia gravis$5IEN$0(DLC)sh 85089173

=LDR  02065cz  a2200493n  4500
=001  9880363602902441
=005  20170717164915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009155
=035  \\$aCBA2412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x500
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x500
=072  \\$aF3.$x625.$x875
=150  \\$aMutism
=450  \\$wnnna$aAphasia, Kussmaul
=450  \\$wnnna$aAphasia, Kussmaul's
=450  \\$wnnna$aConversion Mutism
=450  \\$wnnna$aConversion Mutisms
=450  \\$wnnna$aElective Mutism
=450  \\$wnnna$aElective Mutisms
=450  \\$aKussmaul Aphasia
=450  \\$wnnna$aKussmaul's Aphasia
=450  \\$wnnna$aKussmauls Aphasia
=450  \\$wnnna$aMutism, Conversion
=450  \\$wnnna$aMutism, Elective
=450  \\$wnnna$aMutism, Organic
=450  \\$wnnna$aMutism, Selective
=450  \\$wnnna$aMutism, Voluntary
=450  \\$wnnna$aMutisms
=450  \\$wnnna$aMutisms, Conversion
=450  \\$wnnna$aMutisms, Elective
=450  \\$wnnna$aMutisms, Organic
=450  \\$wnnna$aMutisms, Voluntary
=450  \\$wnnna$aOrganic Mutism
=450  \\$wnnna$aOrganic Mutisms
=450  \\$aSelective Mutism
=450  \\$wnnna$aVoluntary Mutism
=450  \\$wnnna$aVoluntary Mutisms
=550  \\$wg$aNeurodevelopmental Disorders
=550  \\$wg$aSpeech Disorders
=680  \\$iThe inability to generate oral-verbal expression, despite normal comprehension of speech. This may be associated with BRAIN DISEASES or MENTAL DISORDERS. Organic mutism may be associated with damage to the FRONTAL LOBE; BRAIN STEM; THALAMUS; and CEREBELLUM. Selective mutism is a psychological condition that usually affects children characterized by continuous refusal to speak in social situations by a child who is able and willing to speak to selected persons. Kussmal aphasia refers to mutism in psychosis. (From Fortschr Neurol Psychiatr 1994; 62(9):337-44)
=688  \\$a1969(1963)
=750  \0$aMutism$5IEN$0(DLC)sh 85089141

=LDR  01894cz  a2200481n  4500
=001  9880363603002441
=005  20200525120908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009154
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365.$x590
=150  \\$aMutation
=450  \\$wnnna$aMutations
=550  \\$wg$aGenetic Variation
=550  \\$wh$aAllelic Imbalance
=550  \\$wh$aBase Pair Mismatch
=550  \\$wh$aChromosome Aberrations
=550  \\$wh$aCodon, Nonsense
=550  \\$wh$aDNA Repeat Expansion
=550  \\$wh$aFrameshift Mutation
=550  \\$wh$aGain of Function Mutation
=550  \\$wh$aGene Amplification
=550  \\$wh$aGene Duplication
=550  \\$wh$aGenomic Instability
=550  \\$wh$aGerm-Line Mutation
=550  \\$wh$aINDEL Mutation
=550  \\$wh$aLoss of Function Mutation
=550  \\$wh$aMutagenesis, Insertional
=550  \\$wh$aMutation Accumulation
=550  \\$wh$aMutation, Missense
=550  \\$wh$aMutation Rate
=550  \\$wh$aPoint Mutation
=550  \\$wh$aSequence Deletion
=550  \\$wh$aSequence Inversion
=550  \\$wh$aSilent Mutation
=550  \\$wh$aSuppression, Genetic
=550  \\$wh$aSynthetic Lethal Mutations
=550  \\$aDNA Damage
=550  \\$aPolymorphism, Restriction Fragment Length
=667  \\$adrug-induced mutation = MUTATION (IM) + specific drug with pertinent qualif (IM); radiation-induced mutation = MUTATION (IM) + RADIATION EFFECTS or specific rad term (IM); /drug eff & /rad eff permitted only for eff of drugs or eff of rad on an already mutated organism or after mutation but read text carefully
=680  \\$iAny detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
=688  \\$a64
=750  \0$aMutation (Biology)$0(DLC) sh 85089128$5IEN

=LDR  00781cz  a2200253n  4500
=001  9880363603102441
=005  20141212203650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009153
=035  \\$aCBA2410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x468
=150  \\$aMutagens
=450  \\$aClastogens
=450  \\$aGenotoxins
=550  \\$wg$aNoxae
=550  \\$wh$aAneugens
=550  \\$aCarcinogens
=550  \\$aMutagenesis
=550  \\$aMutation
=667  \\$aconsider also MUTATION
=680  \\$iChemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.
=688  \\$a66(65)
=750  \0$aMutagens$5IEN$0(DLC)sh 85089127

=LDR  01338cz  a2200409n  4500
=001  9880363603202441
=005  20141212203650.0
=008  800519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009152
=035  \\$aCBA2409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x560
=072  \\$aE5.$x940.$x560
=150  \\$aMutagenicity Tests
=450  \\$wnnna$aGenetic Toxicity Test
=450  \\$aGenetic Toxicity Tests
=450  \\$wnnna$aGenotoxicity Test
=450  \\$aGenotoxicity Tests
=450  \\$aMutagen Screening
=450  \\$wnnna$aMutagen Screenings
=450  \\$wnnna$aMutagenicity Test
=450  \\$wnnna$aScreening, Mutagen
=450  \\$wnnna$aScreenings, Mutagen
=450  \\$wnnna$aTest, Genotoxicity
=450  \\$wnnna$aTests, Genetic Toxicity
=450  \\$wnnna$aTests, Genotoxicity
=450  \\$wnnna$aToxicity Test, Genetic
=450  \\$wnnna$aToxicity Tests, Genetic
=550  \\$wg$aGenetic Techniques
=550  \\$wg$aToxicity Tests
=550  \\$wh$aComet Assay
=550  \\$wh$aMicronucleus Tests
=550  \\$aCarcinogenicity Tests
=667  \\$aNIM
=680  \\$iTests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests.
=688  \\$a81
=750  \0$aMutagenicity testing$5IEN$0(DLC)sh 85089126

=LDR  01400cz  a2200349n  4500
=001  9880363603302441
=005  20190412120106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009151
=035  \\$aCBA2408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x728.$x468
=150  \\$aMustard Gas
=450  \\$wnnna$aBis(beta-chloroethyl)
=450  \\$wnnna$aDi-2-chloroethyl Sulfide
=450  \\$wnnna$aDi 2 chloroethyl Sulfide
=450  \\$aDichlorodiethyl Sulfide
=450  \\$wnnna$aGas, Mustard
=450  \\$aHD (Chemical
=450  \\$wnnna$aMustard, Sulfur
=450  \\$wnnna$aMustardgas
=450  \\$wnnna$aPsoriazin
=450  \\$wnnna$aSulfide, Di-2-chloroethyl
=450  \\$wnnna$aSulfide, Dichlorodiethyl
=450  \\$aSulfur Mustard
=450  \\$wnnna$aYellow Cross Liquid
=450  \\$wnnna$aYperite
=550  \\$wg$aMustard Compounds
=667  \\$aD25-26 qualif
=680  \\$iSevere irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed).
=688  \\$a91(75)63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67
=750  \0$aMustard gas$5IEN$0(DLC)sh 85089113

=LDR  01631cz  a2200337n  4500
=001  9880363603402441
=005  20141212203649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x200.$x500
=072  \\$aJ2.$x500.$x300.$x100.$x575
=072  \\$aJ2.$x500.$x850.$x537
=150  \\$aMustard Plant
=450  \\$wnnna$aBrassica alba
=450  \\$aBrassica juncea
=450  \\$wnnna$aBrassica nigra
=450  \\$wnnna$aFood, Mustard
=450  \\$wnnna$aFoods, Mustard
=450  \\$aMustard
=450  \\$wnnna$aMustard Food
=450  \\$wnnna$aMustard Foods
=450  \\$wnnna$aMustard Plants
=550  \\$wg$aAnimal Feed
=550  \\$wg$aBrassica
=550  \\$wg$aVegetables
=550  \\$aSinapis
=667  \\$afor mustard plant family use BRASSICACEAE; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAny of several BRASSICA species that are commonly called mustard. Brassica alba is white mustard, B. juncea is brown or Chinese mustard, and B. nigra is black, brown, or red mustard. The plant is grown both for mustard seed from which oil is extracted and for greens or animal feed. It was formerly used as an emetic, counter-irritant, and carminative. There is no relationship to MUSTARD COMPOUNDS.
=688  \\$a2004(1963)
=750  \0$aBrassica juncea$0(DLC)sh2012000104$5IEN-M

=LDR  00733cz  a2200241n  4500
=001  9880363603502441
=005  20141212203648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009147
=035  \\$aCBA2404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x888.$x500
=072  \\$aE2.$x831.$x440
=072  \\$aF4.$x754.$x549
=150  \\$aMusic Therapy
=450  \\$wnnna$aTherapy, Music
=550  \\$wg$aPsychotherapy
=550  \\$wg$aRehabilitation
=550  \\$wg$aSensory Art Therapies
=550  \\$aAcoustic Stimulation
=680  \\$iThe use of music as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.
=688  \\$a74
=750  \0$aMusic therapy$5IEN$0(DLC)sh 85088942

=LDR  00854cz  a2200289n  4500
=001  9880363603602441
=005  20141212203648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009146
=035  \\$aCBA2403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x602
=150  \\$aMusic
=450  \\$wnnna$aMelodies, Vocal
=450  \\$wnnna$aMelody, Vocal
=450  \\$aMusicians$5IEN
=450  \\$wnnna$aSong
=450  \\$wnnna$aSongs
=450  \\$wnnna$aVocal Melodies
=450  \\$wnnna$aVocal Melody
=550  \\$wg$aHumanities
=550  \\$aSinging
=667  \\$aMUSIC THERAPY is also available
=680  \\$iSound that expresses emotion through rhythm, melody, and harmony.
=688  \\$a1966; for SONGS and VOCAL MELODY, use SINGING 2013
=750  \0$aMusic$5IEN-M$0(DLC)sh 85088762
=750  \0$aMusicians$5IEN-HS$0(DLC)sh 85089027

=LDR  00889cz  a2200265n  4500
=001  9880363603702441
=005  20141212203648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009145
=035  \\$aCBA2402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x415.$x551
=072  \\$aC25.$x723.$x680.$x551
=150  \\$aMushroom Poisoning
=450  \\$wnnna$aMushroom Poisonings
=450  \\$wnnna$aPoisoning, Mushroom
=450  \\$wnnna$aPoisonings, Mushroom
=550  \\$wg$aFoodborne Diseases
=550  \\$wg$aMycotoxicosis
=550  \\$aAlpha-Amanitin
=550  \\$aMycotoxins
=667  \\$a= pois by mushroom toxins; TN 133: relation to food pois from canned mushrooms
=680  \\$iPoisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties.
=688  \\$a68
=750  \0$aMushrooms, Poisonous$xToxicology$5IEN$0(DLC)sh 85088761

=LDR  00450cz  a2200169n  4500
=001  9880363603802441
=005  20141212203648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009144
=035  \\$aCBA2401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x152.$x552
=150  \\$aMuseums
=450  \\$wnnna$aMuseum
=550  \\$wg$aArchives
=667  \\$amedical museums: do not coord with MEDICINE
=750  \0$aMuseums$5IEN$0(DLC)sh 85088723

=LDR  01927cz  a2200469n  4500
=001  9880363603902441
=005  20141212203647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009142
=035  \\$aCBA2399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427
=150  \\$aMusculoskeletal Physiological Phenomena
=450  \\$wnnna$aConcept, Musculoskeletal Physiological
=450  \\$wnnna$aConcepts, Musculoskeletal Physiological
=450  \\$wnnoa$aMusculoskeletal Physiologic Phenomena$5IEN-M
=450  \\$wnnna$aMusculoskeletal Physiological Concept
=450  \\$wnnna$aMusculoskeletal Physiological Concepts
=450  \\$wnnna$aMusculoskeletal Physiological Phenomenon
=450  \\$aMusculoskeletal Physiology
=450  \\$aMusculoskeletal System$xphysiology
=450  \\$wnnna$aPhenomena, Musculoskeletal Physiological
=450  \\$wnnna$aPhenomenon, Musculoskeletal Physiological
=450  \\$wnnna$aPhysiology, Musculoskeletal
=550  \\$wg$aMusculoskeletal and Neural Physiological Phenomena
=550  \\$wh$aBone Density
=550  \\$wh$aMuscle Fatigue
=550  \\$wh$aMuscle Strength
=550  \\$wh$aMuscle Tonus
=550  \\$wh$aMusculoskeletal Physiological Processes
=550  \\$wh$aPhysical Endurance
=550  \\$wh$aPhysical Fitness
=550  \\$wh$aPostural Balance
=550  \\$wh$aPosture
=550  \\$wh$aPsychomotor Performance
=550  \\$wh$aRange of Motion, Articular
=667  \\$ageneral or unspecified; prefer specifics; consider also MUSCLES /physiol & BONE AND BONES /physiol or /physiol with specific muscle & bone terms; DF: MUSCULOSKELETAL PHYSIOL
=680  \\$iProcesses and properties of the MUSCULOSKELETAL SYSTEM.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Musculoskeletal Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aMusculoskeletal system$xPhysiology$0(IEN)4729855$5IEN-M

=LDR  00902cz  a2200289n  4500
=001  9880363604002441
=005  20180221144408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009141
=035  \\$aCBA2398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2
=150  \\$aMusculoskeletal System
=450  \\$wnnna$aMusculoskeletal Systems
=450  \\$wnnna$aSystem, Musculoskeletal
=450  \\$wnnna$aSystems, Musculoskeletal
=550  \\$wh$aAponeurosis
=550  \\$wh$aCartilage
=550  \\$wh$aFascia
=550  \\$wh$aLigaments
=550  \\$wh$aMuscles
=550  \\$wh$aSkeleton
=550  \\$wh$aTendons
=550  \\$aMusculoskeletal Development
=667  \\$aGEN; must be both musculo + skeletal, otherwise prefer BONE AND BONES or MUSCLES
=680  \\$iThe MUSCLES, bones (BONE AND BONES), and CARTILAGE of the body.
=750  \0$aMusculoskeletal system$5IEN$0(DLC)sh 85088699

=LDR  01221cz  a2200349n  4500
=001  9880363604102441
=005  20141212203646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009140
=035  \\$aCBA2397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5
=150  \\$aMusculoskeletal Diseases
=450  \\$wnnna$aDisease, Musculoskeletal
=450  \\$wnnna$aDiseases, Musculoskeletal
=450  \\$wnnna$aMusculoskeletal Disease
=550  \\$wh$aBone Diseases
=550  \\$wh$aCartilage Diseases
=550  \\$wh$aFasciitis
=550  \\$wh$aFoot Deformities
=550  \\$wh$aFoot Diseases
=550  \\$wh$aHand Deformities
=550  \\$wh$aJaw Diseases
=550  \\$wh$aJoint Diseases
=550  \\$wh$aMuscular Diseases
=550  \\$wh$aMusculoskeletal Abnormalities
=550  \\$wh$aRheumatic Diseases
=550  \\$wh$aTennis Elbow
=667  \\$aGEN: prefer MUSCULAR DISEASES & BONE DISEASES or specifics
=680  \\$iDiseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.
=688  \\$a92; was MUSCULOSKELETAL DISEASES (NON MESH) 1967-91
=750  \0$aMusculoskeletal System$xDiseases$5IEN-M$0(DLC)sh 85088700

=LDR  01591cz  a2200421n  4500
=001  9880363604202441
=005  20141212203646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009139
=035  \\$aCBA2396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x660
=072  \\$aC16.$x131.$x621
=150  \\$aMusculoskeletal Abnormalities
=450  \\$wnnna$aAbnormalities, Musculoskeletal
=450  \\$wnnna$aAbnormality, Musculoskeletal
=450  \\$wnnna$aMusculoskeletal Abnormality
=450  \\$aMusculoskeletal System$xabnormalities
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aArthrogryposis
=550  \\$wh$aCampomelic Dysplasia
=550  \\$wh$aCervical Rib Syndrome
=550  \\$wh$aCraniofacial Abnormalities
=550  \\$wh$aFunnel Chest
=550  \\$wh$aGastroschisis
=550  \\$wh$aHajdu-Cheney Syndrome
=550  \\$wh$aHip Dislocation, Congenital
=550  \\$wh$aKlippel-Feil Syndrome
=550  \\$wh$aLaryngomalacia
=550  \\$wh$aLimb Deformities, Congenital
=550  \\$wh$aPectus Carinatum
=550  \\$wh$aSynostosis
=550  \\$wh$aTracheobronchomalacia
=667  \\$afor congen struct abnorm only; GEN or unspecified; prefer specifics or specific organ /abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: MUSCULOSKELETAL ABNORM
=680  \\$iCongenital structural abnormalities and deformities of the musculoskeletal system.
=688  \\$a98; use explode 1971-97
=750  \0$aMusculoskeletal system$xAbnormalities$0(DLC) sh 93003278$5IEN-M

=LDR  00990cz  a2200205n  4500
=001  9880363604302441
=005  20141212203645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009138
=035  \\$aCBA2395HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x50.$x540
=150  \\$aMusculocutaneous Nerve
=450  \\$wnnna$aMusculocutaneous Nerves
=450  \\$wnnna$aNerve, Musculocutaneous
=450  \\$wnnna$aNerves, Musculocutaneous
=550  \\$wg$aBrachial Plexus
=667  \\$adis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl
=680  \\$iA major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord (usually C5 to C7), travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm.
=750  \0$aMusculocutaneous nerve$5IEN$0(DLC)sh 85088697

=LDR  01564cz  a2200409n  4500
=001  9880363604402441
=005  20141212203645.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009136
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x534.$x500
=072  \\$aC10.$x668.$x491.$x175.$x500
=072  \\$aC16.$x320.$x577
=150  \\$aMuscular Dystrophies
=450  \\$wnnna$aDystrophies, Muscular
=450  \\$wnnna$aDystrophy, Muscular
=450  \\$aMuscular Dystrophy
=450  \\$wnnna$aMyodystrophica
=450  \\$wnnna$aMyodystrophicas
=450  \\$wnnna$aMyodystrophies
=450  \\$wnnna$aMyodystrophy
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aMuscular Disorders, Atrophic
=550  \\$wh$aDistal Myopathies
=550  \\$wh$aGlycogen Storage Disease Type VII
=550  \\$wh$aMuscular Dystrophies, Limb-Girdle
=550  \\$wh$aMuscular Dystrophy, Duchenne
=550  \\$wh$aMuscular Dystrophy, Emery-Dreifuss
=550  \\$wh$aMuscular Dystrophy, Facioscapulohumeral
=550  \\$wh$aMuscular Dystrophy, Oculopharyngeal
=550  \\$wh$aMyotonic Dystrophy
=550  \\$wh$aWalker-Warburg Syndrome
=550  \\$aMice, Inbred mdx
=667  \\$aGEN: prefer specifics; do not confuse with MYOTONIC DYSTROPHY
=680  \\$iA heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.
=688  \\$a2000(1966)
=750  \0$aMuscular dystrophy$5IEN$0(DLC)sh 85088693

=LDR  01966cz  a2200589n  4500
=001  9880363604502441
=005  20141212203644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009135
=035  \\$aCBA2392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651
=072  \\$aC10.$x668.$x491
=150  \\$aMuscular Diseases
=450  \\$wnnna$aMuscle Disorder
=450  \\$aMuscle Disorders
=450  \\$wnnna$aMuscular Disease
=450  \\$wnnna$aMyopathic Condition
=450  \\$wnnna$aMyopathic Conditions
=450  \\$aMyopathies
=450  \\$wnnna$aMyopathy
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wh$aArthrogryposis
=550  \\$wh$aCompartment Syndromes
=550  \\$wh$aContracture
=550  \\$wh$aCraniomandibular Disorders
=550  \\$wh$aEosinophilia-Myalgia Syndrome
=550  \\$wh$aFatigue Syndrome, Chronic
=550  \\$wh$aFibromyalgia
=550  \\$wh$aIsaacs Syndrome
=550  \\$wh$aMedial Tibial Stress Syndrome
=550  \\$wh$aMitochondrial Myopathies
=550  \\$wh$aMuscle Cramp
=550  \\$wh$aMuscle Neoplasms
=550  \\$wh$aMuscle Rigidity
=550  \\$wh$aMuscle Spasticity
=550  \\$wh$aMuscle Weakness
=550  \\$wh$aMuscular Disorders, Atrophic
=550  \\$wh$aMusculoskeletal Pain
=550  \\$wh$aMyalgia
=550  \\$wh$aMyofascial Pain Syndromes
=550  \\$wh$aMyopathies, Structural, Congenital
=550  \\$wh$aMyositis
=550  \\$wh$aMyotonic Disorders
=550  \\$wh$aParalyses, Familial Periodic
=550  \\$wh$aPolymyalgia Rheumatica
=550  \\$wh$aRhabdomyolysis
=550  \\$wh$aTendinopathy
=667  \\$aGEN; prefer specifics; inflamm dis = MYOSITIS. /congen: consider also Myopathies, Structural, Congenital & its indentions
=680  \\$iAcquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
=750  \0$aMuscles$xDiseases$5IEN$0(DLC)sh 85088688

=LDR  03540cz  a2200769n  4500
=001  9880363604602441
=005  20141212203643.0
=008  870310\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009134
=035  \\$aCBA2391HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x854.$x468
=072  \\$aC10.$x574.$x562.$x500
=072  \\$aC10.$x668.$x467.$x500
=072  \\$aC10.$x668.$x475
=150  \\$aMuscular Atrophy, Spinal
=450  \\$wnnna$aAdult-Onset Spinal Muscular Atrophy
=450  \\$wnnna$aAdult Onset Spinal Muscular Atrophy
=450  \\$wnnna$aAdult Spinal Muscular Atrophy
=450  \\$wnnna$aAmyotrophies, Spinal
=450  \\$wnnna$aAmyotrophy, Neurogenic Scapuloperoneal, New England Type
=450  \\$wnnna$aAmyotrophy, Spinal
=450  \\$wnnna$aAtrophies, Progressive Muscular
=450  \\$wnnna$aAtrophy, Myelopathic Muscular
=450  \\$wnnna$aAtrophy, Progressive Muscular
=450  \\$wnnna$aAtrophy, Spinal Muscular
=450  \\$wnnna$aBulbospinal Neuronopathies
=450  \\$aBulbospinal Neuronopathy
=450  \\$wnnna$aDistal Spinal Muscular Atrophy
=450  \\$wnnna$aHereditary Motor Neuronopathies
=450  \\$wnnna$aHereditary Motor Neuronopathy
=450  \\$wnnna$aMotor Neuronopathies, Hereditary
=450  \\$wnnna$aMotor Neuronopathy, Hereditary
=450  \\$wnnna$aMuscular Atrophies, Progressive
=450  \\$wnnna$aMuscular Atrophy, Adult Spinal
=450  \\$wnnna$aMuscular Atrophy, Myelopathic
=450  \\$wnnna$aMuscular Atrophy, Progressive
=450  \\$wnnna$aMyelopathic Muscular Atrophy
=450  \\$wnnna$aMyelopathic Muscular Atrophy, Progressive
=450  \\$wnnna$aNeuronopathies, Bulbospinal
=450  \\$wnnna$aNeuronopathies, Hereditary Motor
=450  \\$wnnna$aNeuronopathy, Bulbospinal
=450  \\$wnnna$aNeuronopathy, Hereditary Motor
=450  \\$aOculopharyngeal Spinal Muscular Atrophy
=450  \\$wnnna$aProgressive Muscular Atrophies
=450  \\$aProgressive Muscular Atrophy
=450  \\$wnnna$aProgressive Myelopathic Muscular Atrophy
=450  \\$wnnna$aProgressive Proximal Myelopathic Muscular Atrophy
=450  \\$wnnna$aProximal Myelopathic Muscular Atrophy, Progressive
=450  \\$aScapuloperoneal Form of Spinal Muscular Atrophy
=450  \\$wnnna$aScapuloperoneal Spinal Muscular Atrophy
=450  \\$wnnna$aSpinal Amyotrophies
=450  \\$wnnna$aSpinal Amyotrophy
=450  \\$aSpinal Muscular Atrophy
=450  \\$wnnna$aSpinal Muscular Atrophy, Distal
=450  \\$wnnna$aSpinal Muscular Atrophy, Oculopharyngeal
=450  \\$wnnna$aSpinal Muscular Atrophy, Scapuloperoneal
=450  \\$wnnna$aSpinal Muscular Atrophy, Scapuloperoneal Form
=550  \\$wg$aMotor Neuron Disease
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wh$aBulbo-Spinal Atrophy, X-Linked
=550  \\$wh$aSpinal Muscular Atrophies of Childhood
=667  \\$aMUSCULAR ATROPHY, SPINAL, INFANTILE see SPINAL MUSCULAR ATROPHIES OF CHILDHOOD is also available
=680  \\$iA group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. (Adams et al., Principles of Neurology, 6th ed, p1089)
=688  \\$a1988
=750  \0$aSpinal muscular atrophy$5IEN-M$0(DLC)sh 93009486

=LDR  01754cz  a2200457n  4500
=001  9880363604702441
=005  20141212203642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009133
=035  \\$aCBA2390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x612
=072  \\$aC23.$x300.$x70.$x500
=072  \\$aC23.$x888.$x592.$x608.$x612
=150  \\$aMuscular Atrophy
=450  \\$wnnna$aAtrophies, Muscle
=450  \\$wnnna$aAtrophies, Muscular
=450  \\$wnnna$aAtrophies, Neurogenic Muscular
=450  \\$wnnna$aAtrophies, Neurotrophic Muscular
=450  \\$aAtrophy, Muscle
=450  \\$wnnna$aAtrophy, Muscular
=450  \\$wnnna$aAtrophy, Neurogenic Muscular
=450  \\$wnnna$aAtrophy, Neurotrophic Muscular
=450  \\$wnnna$aMuscle Atrophies
=450  \\$wnnna$aMuscle Atrophy
=450  \\$wnnna$aMuscular Atrophies
=450  \\$wnnna$aMuscular Atrophies, Neurogenic
=450  \\$wnnna$aMuscular Atrophies, Neurotrophic
=450  \\$wnnna$aMuscular Atrophy, Neurogenic
=450  \\$wnnna$aMuscular Atrophy, Neurotrophic
=450  \\$wnnna$aNeurogenic Muscular Atrophies
=450  \\$aNeurogenic Muscular Atrophy
=450  \\$wnnna$aNeurotrophic Muscular Atrophies
=450  \\$wnnna$aNeurotrophic Muscular Atrophy
=550  \\$wg$aAtrophy
=550  \\$wg$aNeuromuscular Manifestations
=550  \\$wh$aSarcopenia
=550  \\$aMuscular Disorders, Atrophic
=667  \\$aMUSCULAR ATROPHY, SPINAL is also available
=680  \\$iDerangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
=750  \0$aMuscular atrophy$5IEN$0(DLC)sh 85009364

=LDR  01134cz  a2200277n  4500
=001  9880363604802441
=005  20141212203642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009132
=035  \\$aCBA2389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633
=072  \\$aA10.$x690
=150  \\$aMuscles
=360  \\$iconsider also terms at$aMYO-
=450  \\$wnnna$aMuscle
=550  \\$wg$aMusculoskeletal System
=550  \\$wg$aTissues
=550  \\$wh$aMuscle, Skeletal
=550  \\$wh$aMuscle, Smooth
=550  \\$wh$aMuscle, Striated
=550  \\$wh$aMyocardium
=667  \\$aManual 21.8; as tissue: Manual 21.9, 21.52; unspecified as smooth or striated; MUSCLES, SKELETAL and MUSCLE, SMOOTH and their indentions are available; /innerv: consider also NEUROMUSCULAR JUNCTION & MUSCLE DENERVATION; /surg: consider also SURGICAL FLAPS but see note there; /embryol: coord with MUSCLE DEVELOPMENT if pertinent; inflammation = MYOSITIS
=680  \\$iContractile tissue that produces movement in animals.
=688  \\$a/transplantation was MUSCLE TRANSPLANTATION 1963-65
=750  \0$aMuscles$5IEN$0(DLC)sh 85088687

=LDR  01112cz  a2200313n  4500
=001  9880363604902441
=005  20141212203641.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009131
=035  \\$aCBA2388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x570.$x491
=072  \\$aA7.$x231.$x491
=072  \\$aA10.$x690.$x467.$x491
=150  \\$aMuscle, Smooth, Vascular
=450  \\$wnnna$aMuscle, Vascular Smooth
=450  \\$wnnna$aMuscles, Vascular Smooth
=450  \\$wnnna$aSmooth Muscle, Vascular
=450  \\$wnnna$aSmooth Muscles, Vascular
=450  \\$aVascular Smooth Muscle
=450  \\$wnnna$aVascular Smooth Muscles
=550  \\$wg$aBlood Vessels
=550  \\$wg$aMuscle, Smooth
=550  \\$wh$aTunica Media
=550  \\$aVasomotor System
=667  \\$acoord IM with specific vein or artery (NIM & then only if pertinent); /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe nonstriated, involuntary muscle tissue of blood vessels.
=688  \\$a80
=750  \0$aVascular smooth muscle$5IEN$0(DLC)sh 85142361

=LDR  01329cz  a2200301n  4500
=001  9880363605002441
=005  20141212203641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009130
=035  \\$aCBA2387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x570
=072  \\$aA10.$x690.$x467
=150  \\$aMuscle, Smooth
=450  \\$wnnna$aInvoluntary Muscle
=450  \\$wnnna$aInvoluntary Muscles
=450  \\$aMuscle, Involuntary
=450  \\$wnnna$aMuscles, Involuntary
=450  \\$wnnna$aMuscles, Smooth
=450  \\$aSmooth Muscle
=450  \\$wnnna$aSmooth Muscles
=550  \\$wg$aMuscles
=550  \\$wh$aEsophageal Sphincter, Lower
=550  \\$wh$aMuscle, Smooth, Vascular
=550  \\$wh$aMyometrium
=667  \\$acoordinate with specific organ if pertinent; /growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent
=680  \\$iUnstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
=750  \0$aSmooth muscle$5IEN$0(DLC)sh 85123706

=LDR  00952cz  a2200265n  4500
=001  9880363605102441
=005  20141212203641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009129
=035  \\$aCBA2386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x565
=150  \\$aMuscle Tonus
=450  \\$aMuscle Tension
=450  \\$wnnna$aMuscle Tightness
=450  \\$aMuscle Tone$5IEN
=450  \\$wnnna$aMuscular Tension
=450  \\$wnnna$aTension, Muscle
=450  \\$wnnna$aTension, Muscular
=450  \\$wnnna$aTightness, Muscle
=450  \\$wnnna$aTonus, Muscle
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=680  \\$iThe state of activity or tension of a muscle beyond that related to its physical properties, that is, its active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation. (Stedman, 25th ed)
=688  \\$a72(70)
=750  \0$aMuscle tone$5IEN$0(DLC)sh 85088686

=LDR  01437cz  a2200289n  4500
=001  9880363605202441
=005  20141212203640.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009128
=035  \\$aCBA2385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x512
=072  \\$aC10.$x597.$x613.$x550.$x550
=072  \\$aC23.$x888.$x592.$x608.$x550.$x550
=150  \\$aMuscle Spasticity
=450  \\$aClasp-Knife Spasticity
=450  \\$wnnna$aClasp Knife Spasticity
=450  \\$wnnna$aSpastic
=450  \\$wnnna$aSpasticity, Clasp-Knife
=450  \\$wnnna$aSpasticity, Muscle
=550  \\$wg$aMuscle Hypertonia
=550  \\$wg$aMuscular Diseases
=550  \\$aSpasm
=667  \\$askeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS (IM); spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed
=680  \\$iA form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)
=688  \\$a1977
=750  \0$aSpasticity$5IEN$0(DLC)sh 85126342

=LDR  01595cz  a2200409n  4500
=001  9880363605302441
=005  20141212203640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009127
=035  \\$aCBA2384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x504
=072  \\$aC10.$x597.$x613.$x550.$x500
=072  \\$aC23.$x888.$x592.$x608.$x550.$x500
=150  \\$aMuscle Rigidity
=450  \\$wnnna$aCatatonic Rigidity
=450  \\$wnnna$aCogwheel Rigidities
=450  \\$aCogwheel Rigidity
=450  \\$wnnna$aExtensor Rigidity
=450  \\$aExtrapyramidal Rigidity
=450  \\$aGegenhalten
=450  \\$wnnna$aGegenhaltens
=450  \\$wnnna$aMuscular Rigidity
=450  \\$aNuchal Rigidity
=450  \\$wnnna$aRigidities, Cogwheel
=450  \\$wnnna$aRigidity, Catatonic
=450  \\$wnnna$aRigidity, Cogwheel
=450  \\$wnnna$aRigidity, Extensor
=450  \\$wnnna$aRigidity, Extrapyramidal
=450  \\$wnnna$aRigidity, Muscle
=450  \\$aRigidity, Muscular
=450  \\$wnnna$aRigidity, Nuchal
=550  \\$wg$aMuscle Hypertonia
=550  \\$wg$aMuscular Diseases
=680  \\$iContinuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)
=688  \\$a1973(1972)
=750  \0$aMuscle rigidity$5IEN$0(DLC)sh 85088684

=LDR  01658cz  a2200277n  4500
=001  9880363605402441
=005  20141212203639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009125
=035  \\$aCBA2382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x510
=072  \\$aD27.$x505.$x696.$x663.$x700.$x600
=072  \\$aD27.$x505.$x954.$x427.$x525
=150  \\$aMuscle Relaxants, Central
=450  \\$wnnna$aCentral Muscle Relaxants
=450  \\$aCentrally Acting Muscle Relaxants
=450  \\$wnnna$aRelaxants, Central Muscle
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aNeuromuscular Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$aParasympatholytics
=667  \\$arefers to skeletal muscle relaxants only: smooth muscle relaxants = PARASYMPATHOLYTICS
=680  \\$iA heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
=688  \\$a70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69
=750  \0$aMuscle relaxants$5IEN$0(DLC)sh 85088683

=LDR  01594cz  a2200457n  4500
=001  9880363605502441
=005  20200501152020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009124
=035  \\$aCBA2381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x210.$x500
=150  \\$aMuscle Proteins
=450  \\$wnnna$aMuscle Protein
=450  \\$wnnna$aProtein, Muscle
=450  \\$wnnna$aProteins, Muscle
=550  \\$wg$aContractile Proteins
=550  \\$wh$aActinin
=550  \\$wh$aActins
=550  \\$wh$aActomyosin
=550  \\$wh$aCalsequestrin
=550  \\$wh$aCapZ Actin Capping Protein
=550  \\$wh$aCaveolin 3
=550  \\$wh$aCofilin 2
=550  \\$wh$aConnectin
=550  \\$wh$aDysferlin
=550  \\$wh$aDystrophin
=550  \\$wh$aDystrophin-Associated Proteins
=550  \\$wh$aMyogenic Regulatory Factors
=550  \\$wh$aMyoglobin
=550  \\$wh$aMyosins
=550  \\$wh$aNAV1.4 Voltage-Gated Sodium Channel
=550  \\$wh$aParvalbumins
=550  \\$wh$aProfilins
=550  \\$wh$aRyanodine Receptor Calcium Release Channel
=550  \\$wh$aTropomodulin
=550  \\$wh$aTropomyosin
=550  \\$wh$aTroponin
=667  \\$a/biosyn /drug eff /physiol permitted; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics & not also under CONTRACTILE PROTEINS
=680  \\$iThe protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.
=750  \0$aMuscle proteins$5IEN$0(DLC)sh 85088681

=LDR  01899cz  a2200577n  4500
=001  9880363605602441
=005  20141212203638.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009123
=035  \\$aCBA2380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x575
=072  \\$aC23.$x888.$x592.$x608.$x575
=150  \\$aMuscle Hypotonia
=450  \\$wnnna$aDecreased Muscle Tone
=450  \\$aFlaccid Muscle Tone
=450  \\$wnnna$aFlaccidity, Muscle
=450  \\$wnnna$aFlaccidity, Muscular
=450  \\$wnnna$aFloppy Muscle
=450  \\$wnnna$aFloppy Muscles
=450  \\$wnnna$aHypomyotonia
=450  \\$aHypotonia
=450  \\$wnnna$aHypotonia, Muscle
=450  \\$wnnna$aHypotonia, Muscular
=450  \\$wnnna$aHypotonia, Neonatal
=450  \\$wnnna$aHypotonia, Unilateral
=450  \\$wnnna$aHypotonias, Neonatal
=450  \\$wnnna$aHypotonias, Unilateral
=450  \\$wnnna$aHypotony, Muscle
=450  \\$wnnna$aMuscle Flaccidity
=450  \\$wnnna$aMuscle, Floppy
=450  \\$wnnna$aMuscle Hypotony
=450  \\$wnnna$aMuscle Tone Atonic
=450  \\$wnnna$aMuscle Tone Atonics
=450  \\$wnnna$aMuscle Tone, Decreased
=450  \\$wnnna$aMuscle Tone, Flaccid
=450  \\$wnnna$aMuscle Tone Poor
=450  \\$wnnna$aMuscles, Floppy
=450  \\$wnnna$aMuscular Flaccidities
=450  \\$wnnna$aMuscular Flaccidity
=450  \\$wnnna$aMuscular Hypotonia
=450  \\$wnnna$aNeonatal Hypotonia
=450  \\$wnnna$aNeonatal Hypotonias
=450  \\$wnnna$aTone Atonic, Muscle
=450  \\$wnnna$aTone Poor, Muscle
=450  \\$wnnna$aUnilateral Hypotonia
=550  \\$wg$aNeuromuscular Manifestations
=550  \\$aMuscle Tonus
=680  \\$iA diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.
=688  \\$a1977
=750  \0$aMuscle hypotonia$5IEN$0(DLC)sh 85088679

=LDR  01494cz  a2200397n  4500
=001  9880363605702441
=005  20141212203636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009119
=035  \\$aCBA2376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x540
=150  \\$aMuscle Contraction
=450  \\$wnnna$aContraction, Muscle
=450  \\$wnnna$aContraction, Muscular
=450  \\$wnnna$aContractions, Muscle
=450  \\$wnnna$aContractions, Muscular
=450  \\$aInotropism
=450  \\$wnnna$aInotropisms
=450  \\$wnnna$aMuscle Contractions
=450  \\$wnnna$aMuscular Contraction
=450  \\$wnnna$aMuscular Contractions
=550  \\$wg$aMusculoskeletal Physiological Processes
=550  \\$wh$aExcitation Contraction Coupling
=550  \\$wh$aIsometric Contraction
=550  \\$wh$aIsotonic Contraction
=550  \\$wh$aMuscle Relaxation
=550  \\$wh$aMyocardial Contraction
=550  \\$wh$aMyoelectric Complex, Migrating
=550  \\$wh$aUterine Contraction
=550  \\$aMuscle Strength
=550  \\$aMyofibrils
=667  \\$ado not use for HEART or MYOCARDIUM ( = MYOCARDIAL CONTRACTION) or UTERUS ( = UTERINE CONTRACTION)
=680  \\$iA process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
=688  \\$a65(64)
=750  \0$aMuscle contraction$5IEN$0(DLC)sh 85088677

=LDR  01712cz  a2200505n  4500
=001  9880363605802441
=005  20141212203635.0
=008  870502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009117
=035  \\$aCBA2374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x642
=150  \\$aMuscidae
=450  \\$wnnna$aautumnali, Musca
=450  \\$wnnna$aautumnalis, Musca
=450  \\$wnnna$acalcitran, Stomoxys
=450  \\$wnnna$acalcitrans, Stomoxys
=450  \\$wnnna$aFace Flies
=450  \\$aFace Fly
=450  \\$aFannia
=450  \\$wnnna$aFannias
=450  \\$wnnna$aFlies, Face
=450  \\$wnnna$aFlies, Horn
=450  \\$wnnna$aFlies, Stable
=450  \\$wnnna$aFly, Face
=450  \\$wnnna$aFly, Horn
=450  \\$wnnna$aFly, Stable
=450  \\$wnnna$aHaematobia irritan
=450  \\$aHaematobia irritans
=450  \\$wnnna$aHorn Flies
=450  \\$aHorn Fly
=450  \\$wnnna$airritan, Haematobia
=450  \\$wnnna$airritans, Haematobia
=450  \\$wnnna$aMusca autumnali
=450  \\$aMusca autumnalis
=450  \\$wnnna$aStable Flies
=450  \\$aStable Fly
=450  \\$wnnna$aStomoxys calcitran
=450  \\$aStomoxys calcitrans
=550  \\$wg$aDiptera
=550  \\$wh$aHouseflies
=667  \\$ado not use /drug eff for insecticides: TN 111; note MUSCA DOMESTICA see HOUSEFLIES
=680  \\$iA family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus (HOUSEFLIES), Musca autumnalis (face fly), Stomoxys calcitrans (stable fly), Haematobia irritans (horn fly) and Fannia spp.
=688  \\$a88
=750  \0$aMuscidae$5IEN$0(DLC)sh 85088674

=LDR  00976cz  a2200229n  4500
=001  9880363605902441
=005  20141212203635.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009116
=035  \\$aCBA2373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x883.$x777
=072  \\$aD2.$x675.$x276.$x580
=072  \\$aD3.$x132.$x545
=150  \\$aMuscarine
=550  \\$wg$aAlkaloids
=550  \\$wg$aQuaternary Ammonium Compounds
=550  \\$wg$aTrimethyl Ammonium Compounds
=667  \\$a/biosyn if permitted by plant; do not confuse with the dye muscarine
=680  \\$iA toxic alkaloid found in Amanita muscaria (fly fungus) and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.
=688  \\$a77; was see under PARASYMPATHOMIMETICS 1963-68
=750  \0$aMuscarine$5IEN$0(DLC)sh 85088669

=LDR  01139cz  a2200277n  4500
=001  9880363606002441
=005  20141212203634.0
=008  810514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009115
=035  \\$aCBA2372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635
=150  \\$aMuridae
=450  \\$wnnna$aMurid
=450  \\$aMurids
=550  \\$wg$aRodentia
=550  \\$wh$aArvicolinae
=550  \\$wh$aCricetinae
=550  \\$wh$aGerbillinae
=550  \\$wh$aMurinae
=550  \\$wh$aSigmodontinae
=550  \\$wh$aSpalax
=667  \\$ado not check tags MICE or RATS
=680  \\$iA family of the order Rodentia containing 250 genera including the two genera Mus (MICE) and Rattus (RATS), from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE (New World mice and rats), CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE (Old World mice and rats), and Hydromyinae.
=688  \\$a82
=750  \0$aMuridae$0(DLC) sh 85088629$5IEN

=LDR  01011cz  a2200229n  4500
=001  9880363606102441
=005  20141212203634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009113
=035  \\$aCBA2370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x642
=150  \\$aMuramidase
=450  \\$wnnna$aGlycanhydrolase, N-Acetylmuramide
=450  \\$wnnna$aLeftose
=450  \\$aLysozyme
=450  \\$wnnna$aN-Acetylmuramide Glycanhydrolase
=450  \\$wnnna$aN Acetylmuramide Glycanhydrolase
=550  \\$wg$aGlycoside Hydrolases
=667  \\$aan anti-infective glycoside hydrolase
=680  \\$iA basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.
=750  \0$aLysozyme$5IEN$0(DLC)sh 85079198

=LDR  00945cz  a2200289n  4500
=001  9880363606202441
=005  20141212203633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009111
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x409.$x700
=072  \\$aN3.$x540.$x348.$x750
=150  \\$aLocal Government
=450  \\$aCity Government
=450  \\$aCounty Government
=450  \\$wnnna$aGovernment, City
=450  \\$wnnna$aGovernment, County
=450  \\$aGovernment, Local
=450  \\$wnnna$aGovernment, Metropolitan
=450  \\$wnnna$aGovernment, Municipal
=450  \\$aMetropolitan Government
=450  \\$aMunicipal Government
=550  \\$wg$aGovernment
=667  \\$aspecify geography
=680  \\$iSmallest political subdivisions within a country at which general governmental functions are carried-out.
=688  \\$a99; was MUNICIPAL GOVERNMENT 1966-98
=750  \0$aLocal government$5IEN-M$0(DLC)sh 85077923

=LDR  01218cz  a2200301n  4500
=001  9880363606302441
=005  20141212203633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009110
=035  \\$aCBA2367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x400.$x600
=150  \\$aMunchausen Syndrome
=450  \\$aHospital-Addiction Syndrome
=450  \\$wnnna$aHospital Addiction Syndrome
=450  \\$wnnna$aHospital-Addiction Syndromes
=450  \\$wnnna$aMunchhausen Syndrome
=450  \\$wnnna$aSyndrome, Hospital-Addiction
=450  \\$wnnna$aSyndrome, Hospital Addiction
=450  \\$wnnna$aSyndrome, Munchausen
=450  \\$wnnna$aSyndrome, Munchhausen
=450  \\$wnnna$aSyndromes, Hospital-Addiction
=550  \\$wg$aFactitious Disorders
=550  \\$aHealth Services Misuse
=667  \\$adis symptoms fabricated by a person seeking hospitalization repeatedly; MUNCHAUSEN SYNDROME BY PROXY is available
=680  \\$iA factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false.
=688  \\$a68(64)
=750  \0$aMunchausen syndrome$5IEN$0(DLC)sh 93000061

=LDR  00974cz  a2200241n  4500
=001  9880363606402441
=005  20141212203632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009107
=035  \\$aCBA2364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x680.$x500
=072  \\$aC7.$x465.$x815.$x470.$x800.$x630
=150  \\$aMumps
=450  \\$wnnna$aEpidemic Parotitides
=450  \\$wnnna$aEpidemic Parotitis
=450  \\$wnnna$aParotitides, Epidemic
=450  \\$aParotitis, Epidemic
=550  \\$wg$aParotitis
=550  \\$wg$aRubulavirus Infections
=667  \\$acaused by the MUMPS VIRUS, a rubulavirus
=680  \\$iAn acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)
=750  \0$aMumps$5IEN$0(DLC)sh 85088403

=LDR  00871cz  a2200205n  4500
=001  9880363606502441
=005  20141212203632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009106
=035  \\$aCBA2363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x584.$x500
=150  \\$aMummies
=450  \\$wnnna$aMummy
=550  \\$wg$aPaleontology
=550  \\$aEmbalming
=550  \\$aPaleontology
=667  \\$ado not routinely check the tag ANCIENT HISTORY unless the historical & ancient medical aspects are particularly discussed; /pathol: do not coordinate with PALEOPATHOLOGY; FETAL MUMMIFICATION see FETAL DEATH and PULP MUMMIFICATION see DENTAL PULP NECROSIS are also available
=680  \\$iBodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions.
=750  \0$aMummies$5IEN$0(DLC)sh 85088398

=LDR  01709cz  a2200301n  4500
=001  9880363606702441
=005  20141212203631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009103
=035  \\$aCBA2360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x375.$x500
=072  \\$aC10.$x314.$x350.$x500
=072  \\$aC20.$x111.$x258.$x250.$x500
=150  \\$aMultiple Sclerosis
=450  \\$wnnna$aDisseminated Sclerosis
=450  \\$aMS (Multiple Sclerosis)
=450  \\$aMultiple Sclerosis, Acute Fulminating
=450  \\$aSclerosis, Disseminated
=450  \\$wnnna$aSclerosis, Multiple
=550  \\$wg$aDemyelinating Autoimmune Diseases, CNS
=550  \\$wh$aMultiple Sclerosis, Chronic Progressive
=550  \\$wh$aMultiple Sclerosis, Relapsing-Remitting
=550  \\$wh$aNeuromyelitis Optica
=550  \\$aMyelin-Oligodendrocyte Glycoprotein
=550  \\$aMyelitis, Transverse
=680  \\$iAn autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
=750  \0$aMultiple sclerosis$5IEN$0(DLC)sh 85088374

=LDR  00955cz  a2200265n  4500
=001  9880363606802441
=005  20141212203630.0
=008  820426\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009102
=035  \\$aCBA2359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x835.$x525
=150  \\$aMultiple Organ Failure
=450  \\$wnnna$aFailure, Multiple Organ
=450  \\$aMODS
=450  \\$aMultiple Organ Dysfunction Syndrome
=450  \\$wnnna$aMultiple Organ Failures
=450  \\$aOrgan Dysfunction Syndrome, Multiple
=450  \\$aOrgan Failure, Multiple
=550  \\$wg$aShock
=550  \\$aCapillary Leak Syndrome
=550  \\$aOrgan Dysfunction Scores
=680  \\$iA progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
=688  \\$a83
=750  \0$aMultiple organ failure$5IEN$0(DLC)sh 89005207

=LDR  02052cz  a2200529n  4500
=001  9880363606902441
=005  20141212203630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009101
=035  \\$aCBA2358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x595.$x500
=072  \\$aC14.$x907.$x454.$x460
=072  \\$aC15.$x378.$x147.$x780.$x650
=072  \\$aC15.$x378.$x463.$x515.$x460
=072  \\$aC20.$x683.$x515.$x845
=072  \\$aC20.$x683.$x780.$x650
=150  \\$aMultiple Myeloma
=450  \\$wnnna$aCell Myeloma, Plasma
=450  \\$wnnna$aCell Myelomas, Plasma
=450  \\$wnnna$aDisease, Kahler
=450  \\$wnnna$aKahler Disease
=450  \\$wnnna$aMultiple Myelomas
=450  \\$wnnna$aMyeloma, Multiple
=450  \\$wnnna$aMyeloma-Multiple
=450  \\$wnnna$aMyeloma Multiple
=450  \\$wnnna$aMyeloma-Multiples
=450  \\$aMyeloma, Plasma-Cell
=450  \\$wnnna$aMyeloma, Plasma Cell
=450  \\$wnnna$aMyelomas, Multiple
=450  \\$wnnna$aMyelomas, Plasma Cell
=450  \\$wnnna$aMyelomas, Plasma-Cell
=450  \\$wnnna$aMyelomatoses
=450  \\$wnnna$aMyelomatosis
=450  \\$wnnna$aPlasma Cell Myeloma
=450  \\$wnnna$aPlasma-Cell Myeloma
=450  \\$wnnna$aPlasma Cell Myelomas
=450  \\$wnnna$aPlasma-Cell Myelomas
=550  \\$wg$aHemostatic Disorders
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wg$aNeoplasms, Plasma Cell
=550  \\$wg$aParaproteinemias
=550  \\$wh$aLeukemia, Plasma Cell
=550  \\$aMyeloma Proteins
=667  \\$amyeloma unspecified is probably MULTIPLE MYELOMA; solitary myeloma = PLASMACYTOMA
=680  \\$iA malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
=750  \0$aMultiple myeloma$5IEN$0(DLC)sh 85088367

=LDR  01009cz  a2200313n  4500
=001  9880363607002441
=005  20141212203629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009099
=035  \\$aCBA2356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x438
=150  \\$aMultiple Birth Offspring
=450  \\$wnnna$aBirth, Multiple
=450  \\$wnnna$aBirth Offspring, Multiple
=450  \\$wnnna$aMultiple Birth
=450  \\$wnnna$aMultiple Births
=450  \\$wnnna$aOffspring, Multiple Birth
=450  \\$wnnna$aSextuplet
=450  \\$aSextuplets
=550  \\$wg$aPersons
=550  \\$wh$aQuadruplets
=550  \\$wh$aQuintuplets
=550  \\$wh$aTriplets
=550  \\$wh$aTwins
=667  \\$anote specifics; human & animal; for animals, consider also LITTER SIZE
=680  \\$iThe offspring in multiple pregnancies (PREGNANCY, MULTIPLE): TWINS; TRIPLETS; QUADRUPLETS; QUINTUPLETS; etc.
=688  \\$a98; use explode 1975-97
=750  \0$aMultiple birth$5IEN-M$0(DLC)sh 85014361

=LDR  01075cz  a2200289n  4500
=001  9880363607102441
=005  20141212203629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009098
=035  \\$aCBA2355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x500.$x540
=072  \\$aE5.$x318.$x308.$x250.$x580.$x560
=072  \\$aN2.$x421.$x143.$x827.$x233.$x443.$x633
=072  \\$aN2.$x421.$x726.$x233.$x443.$x633
=072  \\$aN5.$x715.$x360.$x300.$x375.$x500.$x540
=072  \\$aN6.$x850.$x520.$x308.$x250.$x580.$x560
=072  \\$aN6.$x850.$x780.$x500.$x560
=150  \\$aMultiphasic Screening
=450  \\$aAutomated Multiphasic Health Testing
=450  \\$wnnna$aMultiphasic Screenings
=450  \\$wnnna$aScreening, Multiphasic
=450  \\$wnnna$aScreenings, Multiphasic
=550  \\$wg$aMass Screening
=680  \\$iThe simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.
=688  \\$a68
=750  \0$aMultiphasic health screening$5IEN$0(DLC)sh 85088357

=LDR  02073cz  a2200481n  4500
=001  9880363607202441
=005  20141212203628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009097
=035  \\$aCBA2354HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x562
=072  \\$aD8.$x811.$x600
=150  \\$aMultienzyme Complexes
=450  \\$wnnna$aComplexes, Multienzyme
=550  \\$wg$aEnzymes
=550  \\$wg$aMultiprotein Complexes
=550  \\$wh$aAnthranilate Phosphoribosyltransferase
=550  \\$wh$aAnthranilate Synthase
=550  \\$wh$aElectron Transport Chain Complex Proteins
=550  \\$wh$aElectron Transport Complex I
=550  \\$wh$aElectron Transport Complex IV
=550  \\$wh$aExosome Multienzyme Ribonuclease Complex
=550  \\$wh$aFatty Acid Synthase, Type II
=550  \\$wh$aGlycine Decarboxylase Complex
=550  \\$wh$aKetoglutarate Dehydrogenase Complex
=550  \\$wh$aLactose Synthase
=550  \\$wh$aMi-2 Nucleosome Remodeling and Deacetylase Complex
=550  \\$wh$aPhosphoenolpyruvate Sugar Phosphotransferase System
=550  \\$wh$aPhotosynthetic Reaction Center Complex Proteins
=550  \\$wh$aPolyketide Synthases
=550  \\$wh$aProstaglandin-Endoperoxide Synthases
=550  \\$wh$aProteasome Endopeptidase Complex
=550  \\$wh$aPyruvate Dehydrogenase Complex
=550  \\$wh$aSin3 Histone Deacetylase and Corepressor Complex
=550  \\$wh$aSuccinate Cytochrome c Oxidoreductase
=550  \\$wh$aSucrase-Isomaltase Complex
=550  \\$wh$aTryptophan Synthase
=550  \\$aMultifunctional Enzymes
=667  \\$aMULTIPROTEIN COMPLEXES and MULTIFUNCTIONAL ENZYMES are also available
=680  \\$iSystems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES.
=688  \\$a73
=750  \0$aMultienzyme complexes$5IEN$0(DLC)sh 89006397

=LDR  01550cz  a2200397n  4500
=001  9880363607302441
=005  20141212203627.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009096
=035  \\$aCBA2352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x540
=150  \\$aMulti-Institutional Systems
=450  \\$wnnna$aMulti-Hospital System
=450  \\$aMulti-Hospital Systems
=450  \\$wnnna$aMulti Hospital Systems
=450  \\$wnnna$aMulti-Institutional System
=450  \\$wnnna$aMulti Institutional System
=450  \\$wnnna$aMulti Institutional Systems
=450  \\$wnnna$aMultihospital System
=450  \\$wnnna$aMultihospital Systems
=450  \\$wnnna$aSystem, Multi-Hospital
=450  \\$wnnna$aSystem, Multi Hospital
=450  \\$wnnna$aSystem, Multi-Institutional
=450  \\$wnnna$aSystem, Multi Institutional
=450  \\$wnnna$aSystem, Multihospital
=450  \\$wnnna$aSystems, Multi-Hospital
=450  \\$wnnna$aSystems, Multi-Institutional
=450  \\$wnnna$aSystems, Multi Institutional
=450  \\$wnnna$aSystems, Multihospital
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aHospital Shared Services
=667  \\$aIM; coord with institutions or specialty (IM); specify geog
=680  \\$iInstitutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures.
=688  \\$a80
=750  \0$aMultihospital systems$5IEN$0(DLC)sh 85088347

=LDR  01134cz  a2200361n  4500
=001  9880363607402441
=005  20141212203627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009094
=035  \\$aCBA2350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x56.$x610
=072  \\$aE2.$x779.$x249.$x610
=150  \\$aMud Therapy
=450  \\$wnnna$aBath, Mud
=450  \\$aEarths, Medical and Surgical Uses of$5IEN
=450  \\$aFangotherapy
=450  \\$wnnna$aMud Bath
=450  \\$aMud Baths
=450  \\$wnnna$aMud Pack
=450  \\$wnnna$aMud Packs
=450  \\$wnnna$aPack, Mud
=450  \\$wnnna$aPacks, Mud
=450  \\$aPeat Therapy
=450  \\$aPeloid Therapy
=450  \\$aPelotherapy
=450  \\$wnnna$aTherapy, Mud
=450  \\$wnnna$aTherapy, Peat
=450  \\$wnnna$aTherapy, Peloid
=550  \\$wg$aBalneology
=667  \\$aincludes earth & clay
=680  \\$iThe therapeutic use of mud in packs or baths taking advantage of the absorptive qualities of the mud. It has been used for rheumatism and skin problems.
=750  \0$aEarths, Medical and surgical uses of$5IEN$0(DLC)sh 85040501

=LDR  00629cz  a2200193n  4500
=001  9880363607502441
=005  20141212203626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009093
=035  \\$aCBA2349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x503
=150  \\$aMucus
=550  \\$wg$aBodily Secretions
=550  \\$wh$aCervix Mucus
=667  \\$amucus glands: index MUCUS (IM) + EXOCRINE GLANDS (IM)
=680  \\$iThe viscous secretion of mucous membranes. It contains mucin, white blood cells, water, inorganic salts, and exfoliated cells.
=688  \\$a66(63)
=750  \0$aMucus$5IEN$0(DLC)sh 85088241

=LDR  01587cz  a2200397n  4500
=001  9880363607602441
=005  20180702111247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009092
=035  \\$aCBA2348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x550
=150  \\$aMucous Membrane
=450  \\$aLamina Propria
=450  \\$wnnna$aMembrane, Mucous
=450  \\$wnnna$aMembranes, Mucous
=450  \\$aMucosa
=450  \\$wnnna$aMucosae, Muscularis
=450  \\$aMucosal Tissue
=450  \\$wnnna$aMucosal Tissues
=450  \\$wnnna$aMucous Membranes
=450  \\$aMuscularis Mucosae
=450  \\$wnnna$aPropria, Lamina
=450  \\$wnnna$aTissue, Mucosal
=450  \\$wnnna$aTissues, Mucosal
=550  \\$wg$aMembranes
=550  \\$wg$aEsophageal Mucosa
=550  \\$wh$aGastric Mucosa
=550  \\$wh$aHymen
=550  \\$wh$aIntestinal Mucosa
=550  \\$wh$aMouth Mucosa
=550  \\$wh$aRespiratory Mucosa
=550  \\$aAdministration, Mucosal
=667  \\$ageneral or unspecified; prefer specifics; coordinate NIM with specific organ (IM)
=680  \\$iAn EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.
=750  \0$aMucous membrane$5IEN$0(DLC)sh 85088237

=LDR  00961cz  a2200181n  4500
=001  9880363607702441
=005  20141212203625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009091
=035  \\$aCBA2347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x980.$x600
=150  \\$aMucormycosis
=450  \\$wnnna$aMucormycoses
=550  \\$wg$aZygomycosis
=667  \\$afungus dis caused by various MUCORALES
=680  \\$iInfection in humans and animals caused by any fungus in the order Mucorales (e.g., Absidia, Mucor, Rhizopus etc.) There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. (From Dorland, 28th ed)
=750  \0$aMucormycosis$5IEN$0(DLC)sh 85088235

=LDR  00908cz  a2200277n  4500
=001  9880363607802441
=005  20141212203625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009090
=035  \\$aCBA2346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x500
=150  \\$aMucorales
=450  \\$wnnna$aMucorale
=550  \\$wg$aFungi, Unclassified
=550  \\$wh$aAbsidia
=550  \\$wh$aCunninghamella
=550  \\$wh$aMortierella
=550  \\$wh$aMucor
=550  \\$wh$aPhycomyces
=550  \\$wh$aRhizomucor
=550  \\$wh$aRhizopus
=667  \\$ainfection = MUCORMYCOSIS
=680  \\$iAn order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases.
=688  \\$a79; use FUNGI 1963-78
=750  \0$aMucorales$5IEN$0(DLC)sh 85088234

=LDR  00638cz  a2200181n  4500
=001  9880363607902441
=005  20141212203624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009089
=035  \\$aCBA2345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x500.$x500
=150  \\$aMucor
=450  \\$wnnna$aMucors
=550  \\$wg$aMucorales
=667  \\$aa zygomycete; infection = MUCORMYCOSIS
=680  \\$iA genus of zygomycetous fungi of the family Mucoraceae, order Mucorales. It is primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs.
=750  \0$aMucor$5IEN$0(DLC)sh 88021897

=LDR  00940cz  a2200277n  4500
=001  9880363608002441
=005  20141212203624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009088
=035  \\$aCBA2344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x560
=150  \\$aMucoproteins
=550  \\$wg$aGlycoproteins
=550  \\$wh$aCell Wall Skeleton
=550  \\$wh$aHaptoglobins
=550  \\$wh$aIntrinsic Factor
=550  \\$wh$aMucins
=550  \\$wh$aOrosomucoid
=550  \\$wh$aOvomucin
=550  \\$wh$aPeptidoglycan
=550  \\$wh$aPhytohemagglutinins
=550  \\$wh$aUromodulin
=667  \\$aincludes mucoids & mucopeptides
=680  \\$iConjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.
=750  \0$aMucoproteins$5IEN-M$0(DLC)sh 93006657

=LDR  01549cz  a2200337n  4500
=001  9880363608102441
=005  20200821165906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009083
=035  \\$aCBA2339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x202.$x715
=072  \\$aC16.$x320.$x565.$x595.$x600
=072  \\$aC17.$x300.$x550.$x575
=072  \\$aC18.$x452.$x648.$x202.$x715
=072  \\$aC18.$x452.$x648.$x595.$x600
=150  \\$aMucopolysaccharidoses
=450  \\$wnnna$aMucopolysaccharidosis
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wg$aLysosomal Storage Diseases
=550  \\$wg$aMucinoses
=550  \\$wh$aMucopolysaccharidosis I
=550  \\$wh$aMucopolysaccharidosis II
=550  \\$wh$aMucopolysaccharidosis III
=550  \\$wh$aMucopolysaccharidosis IV
=550  \\$wh$aMucopolysaccharidosis VI
=550  \\$wh$aMucopolysaccharidosis VII
=667  \\$alysosomal storage dis; types I through VII except V are available as main headings: V = MUCOPOLYSACCHARIDOSIS V see MUCOPOLYSACCHARIDOSIS I; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iGroup of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.
=688  \\$a92; was MUCOPOLYSACCHARIDOSIS 1974-91
=750  \0$aMucopolysaccharidoses$5IEN-M$0(DLC)sh 85088232

=LDR  04939cz  a2201225n  4500
=001  9880363608202441
=005  20141212203619.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x371
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x590
=072  \\$aC16.$x320.$x565.$x189.$x435.$x590
=072  \\$aC16.$x320.$x565.$x202.$x670
=072  \\$aC16.$x320.$x565.$x595.$x554.$x590
=072  \\$aC18.$x452.$x132.$x100.$x435.$x590
=072  \\$aC18.$x452.$x648.$x189.$x435.$x590
=072  \\$aC18.$x452.$x648.$x202.$x670
=072  \\$aC18.$x452.$x648.$x595.$x554.$x590
=150  \\$aMucolipidoses
=450  \\$wnnna$aAlpha/Beta, Ml III
=450  \\$wnnna$aAlpha/Beta, Mucolipidosis III
=450  \\$wnnna$aAlpha/Betas, Mucolipidosis III
=450  \\$wnnna$aCell Disease, Inclusion
=450  \\$wnnna$aCell Diseases, Inclusion
=450  \\$wnnna$aCherry Red Spot-Myoclonus Syndrome
=450  \\$aCherry Red Spot Myoclonus Syndrome
=450  \\$wnnna$aDeficiencies, Glycoprotein Neuraminidase
=450  \\$wnnna$aDeficiency Disease, Ganglioside Sialidase
=450  \\$wnnna$aDeficiency, Glycoprotein Neuraminidase
=450  \\$wnnna$aDisease, I-Cell
=450  \\$wnnna$aDisease, Inclusion Cell
=450  \\$wnnna$aDisease, Psuedo-Hurler
=450  \\$wnnna$aDiseases, I-Cell
=450  \\$wnnna$aDiseases, Inclusion Cell
=450  \\$wnnna$aDiseases, Psuedo-Hurler
=450  \\$aGanglioside Sialidase Deficiency Disease
=450  \\$wnnna$aGlycoprotein Neuraminidase Deficiencies
=450  \\$wnnna$aGlycoprotein Neuraminidase Deficiency
=450  \\$aI-Cell Disease
=450  \\$wnnna$aI Cell Disease
=450  \\$wnnna$aI-Cell Diseases
=450  \\$wnnna$aIII Alpha/Beta, Mucolipidosis
=450  \\$wnnna$aIII Alpha/Betas, Mucolipidosis
=450  \\$wnnna$aIIIa, Mucolipidosis
=450  \\$wnnna$aInclusion Cell Disease
=450  \\$wnnna$aInclusion Cell Diseases
=450  \\$wnnna$aLipomucopolysaccharidoses
=450  \\$aLipomucopolysaccharidosis
=450  \\$wnnna$aMl III Alpha/Beta
=450  \\$wnnna$aMucolipidoses, Type I
=450  \\$wnnna$aMucolipidoses, Type II
=450  \\$wnnna$aMucolipidoses, Type III
=450  \\$wnnna$aMucolipidoses, Type IV
=450  \\$aMucolipidosis
=450  \\$wnnna$aMucolipidosis I
=450  \\$wnnna$aMucolipidosis II
=450  \\$wnnna$aMucolipidosis II Alpha/Beta
=450  \\$wnnna$aMucolipidosis III
=450  \\$wnnna$aMucolipidosis III Alpha/Beta
=450  \\$wnnna$aMucolipidosis IIIa
=450  \\$wnnna$aMucolipidosis IIIs
=450  \\$wnnna$aMucolipidosis Is
=450  \\$wnnna$aMucolipidosis IV
=450  \\$wnnna$aMucolipidosis Type 1
=450  \\$wnnna$aMucolipidosis Type 1s
=450  \\$wnnna$aMucolipidosis Type I
=450  \\$wnnna$aMucolipidosis, Type I
=450  \\$wnnna$aMucolipidosis Type II
=450  \\$wnnna$aMucolipidosis, Type II
=450  \\$wnnna$aMucolipidosis Type III
=450  \\$wnnna$aMucolipidosis, Type III
=450  \\$wnnna$aMucolipidosis Type Is
=450  \\$wnnna$aMucolipidosis Type IV
=450  \\$wnnna$aMucolipidosis, Type IV
=450  \\$wnnna$aMucolipidosis Type IVs
=450  \\$wnnna$aMyoclonus-Cherry Red Spot Syndrome
=450  \\$aMyoclonus Cherry Red Spot Syndrome
=450  \\$wnnna$aNeuraminidase Deficiencies, Glycoprotein
=450  \\$wnnna$aNeuraminidase Deficiency, Glycoprotein
=450  \\$wnnna$aPolydystrophy, Pseudo-Hurler
=450  \\$aPseudo-Hurler Polydystrophy
=450  \\$wnnna$aPseudo Hurler Polydystrophy
=450  \\$wnnna$aPsuedo-Hurler Disease
=450  \\$wnnna$aPsuedo Hurler Disease
=450  \\$wnnna$aPsuedo-Hurler Diseases
=450  \\$wnnna$aSialidoses
=450  \\$aSialidosis
=450  \\$wnnna$aSialolipidoses
=450  \\$wnnna$aSialolipidosis
=450  \\$wnnna$aType I Mucolipidoses
=450  \\$wnnna$aType I Mucolipidosis
=450  \\$wnnna$aType II Mucolipidoses
=450  \\$wnnna$aType II Mucolipidosis
=450  \\$wnnna$aType III Mucolipidoses
=450  \\$wnnna$aType III Mucolipidosis
=450  \\$wnnna$aType IV Mucolipidoses
=450  \\$wnnna$aType IV Mucolipidosis
=550  \\$wg$aBone Diseases, Metabolic
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wg$aLysosomal Storage Diseases, Nervous System
=550  \\$aGangliosidoses
=680  \\$iA group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7)
=688  \\$a2000(1977)
=750  \0$aSialidoses$5IEN-M$0(DLC)sh 93004739

=LDR  01173cz  a2200277n  4500
=001  9880363608302441
=005  20141212203617.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009080
=035  \\$aCBA2336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x940.$x560
=072  \\$aC15.$x604.$x560
=072  \\$aC17.$x800.$x862.$x560
=150  \\$aMucocutaneous Lymph Node Syndrome
=450  \\$aKawasaki Disease
=450  \\$wnnna$aKawasaki Syndrome
=450  \\$aLymph Node Syndrome, Mucocutaneous
=550  \\$wg$aLymphatic Diseases
=550  \\$wg$aSkin Diseases, Vascular
=550  \\$wg$aVasculitis
=667  \\$aDF: MLNS or MCLS
=680  \\$iAn acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
=688  \\$a1984(77); use LYMPHATIC DISEASES 1977-1983
=688  \\$a84(77); was see under LYMPHATIC DISEASES 1977-83
=750  \0$aMucocutaneous lymph node syndrome$5IEN$0(DLC)sh 87004913

=LDR  00980cz  a2200277n  4500
=001  9880363608402441
=005  20141212203617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009077
=035  \\$aCBA2333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x560.$x631
=150  \\$aMucins
=450  \\$wnnna$aMucin
=550  \\$wg$aMucoproteins
=550  \\$wh$aGastric Mucins
=550  \\$wh$aMucin-1
=550  \\$wh$aMucin-2
=550  \\$wh$aMucin-3
=550  \\$wh$aMucin-4
=550  \\$wh$aMucin-5B
=550  \\$wh$aSialomucins
=667  \\$acoordinate with MEMBRANE GLYCOPROTEINS if membrane-bound
=680  \\$iHigh molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface.
=688  \\$a79; was MUCIN 1963-78
=750  \0$aMucins$0(DLC) sh 85088227$5IEN

=LDR  01785cz  a2200385n  4500
=001  9880363608502441
=005  20141212192338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009074
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x935.$x531.$x750
=072  \\$aD6.$x472.$x699.$x631.$x525.$x600.$x531.$x750
=072  \\$aD12.$x644.$x400.$x400.$x935.$x531.$x750
=072  \\$aD12.$x644.$x400.$x460
=072  \\$aD12.$x644.$x548.$x365.$x935.$x531.$x750
=072  \\$aD12.$x644.$x548.$x691.$x525.$x690.$x531.$x750
=072  \\$aD12.$x776.$x641.$x650.$x405.$x935.$x531.$x750
=072  \\$aD12.$x776.$x641.$x650.$x460
=150  \\$aMelanocyte-Stimulating Hormones
=450  \\$wnnna$aMelanocyte Stimulating Hormones
=450  \\$wnnna$aMelanophore-Stimulating Hormone
=450  \\$wnnna$aMelanophore Stimulating Hormone
=450  \\$aMelanotropin
=450  \\$aMSH
=450  \\$wnnna$aMSH (Melanocyte-Stimulating Hormones)
=550  \\$wg$aMelanocortins
=550  \\$wg$aNeuropeptides
=550  \\$wh$aalpha-MSH
=550  \\$wh$abeta-MSH
=550  \\$wh$agamma-MSH
=680  \\$iPeptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS.
=688  \\$a2006(1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a MSH
=688  \\$a68; was INTERMEDIN 1963-67
=750  \0$aMSH (Hormone)$0sh 85067305$5IEN

=LDR  01916cz  a2200433n  4500
=001  9880363608602441
=005  20141212203616.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009072
=035  \\$aCBA2328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x200.$x600
=072  \\$aC10.$x228.$x140.$x300.$x510.$x200.$x737
=072  \\$aC14.$x907.$x137.$x615
=072  \\$aC14.$x907.$x253.$x123.$x620
=072  \\$aC14.$x907.$x253.$x560.$x200.$x737
=150  \\$aMoyamoya Disease
=450  \\$aCerebrovascular Moyamoya Disease
=450  \\$wnnna$aClassic Moyamoya Disease
=450  \\$wnnna$aDisease, Classic Moyamoya
=450  \\$wnnna$aDisease, Moya-Moya
=450  \\$wnnna$aDisease, Primary Moyamoya
=450  \\$wnnna$aMoya-Moya Disease
=450  \\$wnnna$aMoya Moya Disease
=450  \\$wnnna$aMoyamoya Disease, Classic
=450  \\$wnnna$aMoyamoya Disease, Primary
=450  \\$wnnna$aMoyamoya Disease, Secondary
=450  \\$wnnna$aMoyamoya Diseases, Primary
=450  \\$wnnna$aMoyamoya Syndrome
=450  \\$wnnna$aPrimary Moyamoya Disease
=450  \\$wnnna$aPrimary Moyamoya Diseases
=450  \\$aProgressive Intracranial Occlusive Arteropathy (Moyamoya)
=450  \\$wnnna$aSecondary Moyamoya Disease
=550  \\$wg$aArterial Occlusive Diseases
=550  \\$wg$aCarotid Artery Diseases
=550  \\$wg$aCerebral Arterial Diseases
=680  \\$iA noninflammatory, progressive occlusion of the intracranial CAROTID ARTERIES and the formation of netlike collateral arteries arising from the CIRCLE OF WILLIS. Cerebral angiogram shows the puff-of-smoke (moyamoya) collaterals at the base of the brain. It is characterized by endothelial HYPERPLASIA and FIBROSIS with thickening of arterial walls. This disease primarily affects children but can also occur in adults.
=688  \\$a1991(1978)
=750  \0$aMoyamoya disease$5IEN$0(DLC)sh 85088178

=LDR  00716cz  a2200205n  4500
=001  9880363608702441
=005  20141212203615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009071
=035  \\$aCBA2327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x44.$x588
=150  \\$aMoxibustion
=450  \\$aMoxa$5IEN
=450  \\$wnnna$aMoxabustion
=550  \\$wg$aAcupuncture Therapy
=667  \\$acoordinate with disease /ther, not disease /drug ther
=680  \\$iThe burning of a small, thimble sized, smoldering plug of dried leaves on the SKIN at an ACUPUNCTURE point. Usually the plugs contain leaves of MUGWORT or moxa.
=688  \\$a67; was MOXA 1963-66
=750  \0$aMoxa$5IEN$0(DLC)sh 85088173

=LDR  03134cz  a2200805n  4500
=001  9880363608802441
=005  20141212203614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009069
=035  \\$aCBA2325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662
=150  \\$aMovement Disorders
=450  \\$wnnna$aDyskinesia, Lingual-Facial-Buccal
=450  \\$wnnna$aDyskinesia, Linguofacial
=450  \\$wnnna$aDyskinesia, Oral
=450  \\$wnnna$aDyskinesia, Oral-facial
=450  \\$wnnna$aDyskinesia, Orofacial
=450  \\$wnnna$aDyskinesia Syndrome
=450  \\$aDyskinesia Syndromes
=450  \\$wnnna$aDyskinesia, Tardive
=450  \\$wnnna$aDyskinesias, Lingual-Facial-Buccal
=450  \\$wnnna$aDyskinesias, Linguofacial
=450  \\$wnnna$aDyskinesias, Oral
=450  \\$wnnna$aDyskinesias, Oral-facial
=450  \\$wnnna$aDyskinesias, Orofacial
=450  \\$wnnna$aDyskinesias, Tardive
=450  \\$wnnna$aDystonia, Tardive
=450  \\$wnnna$aDystonias, Tardive
=450  \\$aEtat Marbre
=450  \\$aLingual-Facial-Buccal Dyskinesia
=450  \\$wnnna$aLingual Facial Buccal Dyskinesia
=450  \\$wnnna$aLingual-Facial-Buccal Dyskinesias
=450  \\$wnnna$aLinguofacial Dyskinesia
=450  \\$wnnna$aLinguofacial Dyskinesias
=450  \\$wnnna$aMovement Disorder
=450  \\$wnnna$aMovement Disorder Syndrome
=450  \\$wnnna$aMovement Disorder Syndromes
=450  \\$wnnna$aOral Dyskinesia
=450  \\$wnnna$aOral Dyskinesias
=450  \\$wnnna$aOral-facial Dyskinesia
=450  \\$wnnna$aOral facial Dyskinesia
=450  \\$wnnna$aOral-facial Dyskinesias
=450  \\$aOrofacial Dyskinesia
=450  \\$wnnna$aOrofacial Dyskinesias
=450  \\$aStatus Marmoratus
=450  \\$wnnna$aTardive Dyskinesia
=450  \\$wnnna$aTardive Dyskinesias
=450  \\$wnnna$aTardive Dystonia
=450  \\$wnnna$aTardive Dystonias
=450  \\$wnnna$aTardive Oral Dyskinesia
=450  \\$wnnna$aTardive Oral Dyskinesias
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wh$aAkathisia, Drug-Induced
=550  \\$wh$aAngelman Syndrome
=550  \\$wh$aDyskinesias
=550  \\$wh$aDystonic Disorders
=550  \\$wh$aEssential Tremor
=550  \\$wh$aHepatolenticular Degeneration
=550  \\$wh$aMultiple System Atrophy
=550  \\$wh$aPantothenate Kinase-Associated Neurodegeneration
=550  \\$wh$aParkinsonian Disorders
=550  \\$wh$aSupranuclear Palsy, Progressive
=550  \\$wh$aTic Disorders
=550  \\$aDyskinesias
=550  \\$aPsychomotor Disorders
=667  \\$aconsider DYSKINESIAS for abnormal involuntary movements as a manifestation of an underlying disease
=680  \\$iSyndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
=688  \\$a1963; for ORAL DYSKINESIA & LINGUAL-FACIAL-BUCCAL DYSKINESIA use DYSKINESIA, DRUG-INDUCED 2000-2007
=750  \0$aMovement disorders$5IEN$0(DLC)sh 85088017

=LDR  01604cz  a2200325n  4500
=001  9880363608902441
=005  20200610121854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009068
=035  \\$aCBA2324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x568.$x750
=072  \\$aG11.$x427.$x410.$x849
=150  \\$aMovement
=450  \\$aAnimal Mechanics$5IEN
=450  \\$aHuman Mechanics$5IEN
=450  \\$wnnna$aMovements
=550  \\$wg$aMusculoskeletal Physiological Processes
=550  \\$wg$aPhysiological Processes
=550  \\$wh$aEye Movements
=550  \\$wh$aGait
=550  \\$wh$aHead Movements
=550  \\$wh$aLocomotion
=550  \\$wh$aMotor Activity
=550  \\$wh$aOrgan Movement
=550  \\$aMotion
=667  \\$aLOCOMOTION; MOTION ( a concept of physics); and MOTOR ACTIVITY are also available; animal running in exercise wheel is probably MOTOR ACTIVITY or PHYSICAL EXERTION; NIM for microorganisms; movement of cells = CELL MOVEMENT
=680  \\$iThe act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.
=750  \0$aHuman mechanics$5IEN-M$0(DLC)sh 85062883
=750  \0$aAnimal mechanics$5IEN-HS$0(DLC)sh 85005209

=LDR  00832cz  a2200265n  4500
=001  9880363609002441
=005  20141212203613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009067
=035  \\$aCBA2323HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x583
=072  \\$aD27.$x720.$x102.$x583
=072  \\$aD27.$x720.$x269.$x583
=072  \\$aJ1.$x637.$x51.$x583
=150  \\$aMouthwashes
=450  \\$wnnna$aMouthwashe
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aCosmetics
=550  \\$wh$aSaliva, Artificial
=550  \\$aDentifrices
=667  \\$aD25-26 qualif
=680  \\$iSolutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher's Clinical Dental Terminology, 4th ed)
=688  \\$a65
=750  \0$aMouthwashes$5IEN$0(DLC)sh 85088010

=LDR  00966cz  a2200265n  4500
=001  9880363609102441
=005  20141212203612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009066
=035  \\$aCBA2322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x550
=072  \\$aC7.$x793.$x597
=150  \\$aMouth, Edentulous
=450  \\$wnnna$aEdentulous Mouth
=450  \\$wnnna$aEdentulous Mouths
=450  \\$wnnna$aMouth, Toothless
=450  \\$wnnna$aToothless Mouth
=550  \\$wg$aMouth Diseases
=550  \\$wg$aTooth Diseases
=550  \\$wh$aJaw, Edentulous
=667  \\$ado not confuse with ANODONTIA (congenital absence of one or more teeth); differentiate from JAW, EDENTULOUS & JAW, EDENTULOUS, PARTIALLY (see definitions under JAW, EDENTULOUS)
=680  \\$iTotal lack of teeth through disease or extraction.
=688  \\$a65; included total & partial edentulous state 1965-79
=750  \0$aEdentulous mouth$5IEN$0(DLC)sh 85040953

=LDR  01483cz  a2200421n  4500
=001  9880363609202441
=005  20141212203612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009064
=035  \\$aCBA2320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x761.$x599
=072  \\$aE7.$x700.$x520
=072  \\$aJ1.$x637.$x708.$x520
=150  \\$aMouth Protectors
=450  \\$wnnna$aGuard, Mouth
=450  \\$wnnna$aGuards, Mouth
=450  \\$wnnna$aMouth Guard
=450  \\$aMouth Guards
=450  \\$wnnna$aMouth Piece, Protective
=450  \\$wnnna$aMouth Pieces, Protective
=450  \\$wnnna$aMouth Protector
=450  \\$wnnna$aMouthpiece, Protective
=450  \\$aMouthpieces, Protective
=450  \\$wnnna$aPiece, Protective Mouth
=450  \\$wnnna$aPieces, Protective Mouth
=450  \\$wnnna$aProtective Mouth Piece
=450  \\$wnnna$aProtective Mouth Pieces
=450  \\$wnnna$aProtective Mouthpiece
=450  \\$wnnna$aProtective Mouthpieces
=450  \\$wnnna$aProtector, Mouth
=450  \\$wnnna$aProtectors, Mouth
=550  \\$wg$aPreventive Dentistry
=550  \\$wg$aProtective Devices
=667  \\$acoord IM with specific instrum of relevant subject area (IM) or procedure (IM)
=680  \\$iDevices or pieces of equipment placed in or around the mouth or attached to instruments to protect the external or internal tissues of the mouth and the teeth.
=688  \\$a65
=750  \0$aMouth protectors$5IEN$0(DLC)sh 85088009

=LDR  01443cz  a2200481n  4500
=001  9880363609302441
=005  20141212203611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009062
=035  \\$aCBA2318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591
=072  \\$aC7.$x465.$x565
=150  \\$aMouth Neoplasms
=450  \\$wnnna$aCancer, Mouth
=450  \\$aCancer of Mouth
=450  \\$wnnna$aCancer of the Mouth
=450  \\$wnnna$aCancer, Oral
=450  \\$wnnna$aCancers, Mouth
=450  \\$wnnna$aCancers, Oral
=450  \\$aMouth Cancer
=450  \\$wnnna$aMouth Cancers
=450  \\$wnnna$aMouth Neoplasm
=450  \\$wnnna$aNeoplasm, Mouth
=450  \\$wnnna$aNeoplasm, Oral
=450  \\$wnnna$aNeoplasms, Mouth
=450  \\$wnnna$aNeoplasms, Oral
=450  \\$aOral Cancer
=450  \\$wnnna$aOral Cancers
=450  \\$wnnna$aOral Neoplasm
=450  \\$aOral Neoplasms
=550  \\$wg$aHead and Neck Neoplasms
=550  \\$wg$aMouth Diseases
=550  \\$wh$aGingival Neoplasms
=550  \\$wh$aLeukoplakia, Oral
=550  \\$wh$aLip Neoplasms
=550  \\$wh$aPalatal Neoplasms
=550  \\$wh$aSalivary Gland Neoplasms
=550  \\$wh$aTongue Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the MOUTH.
=750  \0$aMouth$xTumors$5IEN-M$0(DLC)sh 85088004
=750  \0$aMouth$xCancer$5IEN-HS$0(DLC)sh 92005236

=LDR  01005cz  a2200253n  4500
=001  9880363609402441
=005  20141212203610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009061
=035  \\$aCBA2317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x550.$x599
=072  \\$aA14.$x549.$x512
=150  \\$aMouth Mucosa
=450  \\$aBuccal Mucosa
=450  \\$wnnna$aMucosa, Mouth
=450  \\$wnnna$aMucosa, Oral
=450  \\$aOral Mucosa
=550  \\$wg$aMouth
=550  \\$wg$aMucous Membrane
=667  \\$a/surg: consider also VESTIBULOPLASTY; mucositis: coordinate NIM with STOMATITIS (IM)
=680  \\$iLining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations.
=688  \\$a65
=750  \0$aOral mucosa$5IEN$0(DLC)sh 85095245

=LDR  00756cz  a2200265n  4500
=001  9880363609502441
=005  20141212203610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009060
=035  \\$aCBA2316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x441
=150  \\$aMouth Floor
=450  \\$wnnna$aFloor, Mouth
=450  \\$aFloor of Mouth
=450  \\$wnnna$aFloors, Mouth
=450  \\$wnnna$aMouth Floors
=450  \\$wnnna$aRegion, Sublingual
=450  \\$wnnna$aRegions, Sublingual
=450  \\$aSublingual Region
=450  \\$wnnna$aSublingual Regions
=550  \\$wg$aMouth
=667  \\$aNIM when merely locational
=688  \\$a74; was SUBLINGUAL REGION 1972-73 (Prov)
=750  \0$aMouth floor$5IEN$0(DLC)sh 85088007

=LDR  01959cz  a2200625n  4500
=001  9880363609602441
=005  20141212203610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009059
=035  \\$aCBA2315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465
=150  \\$aMouth Diseases
=450  \\$wnnna$aDisease, Mouth
=450  \\$wnnna$aDiseases, Mouth
=450  \\$wnnna$aMouth Disease
=550  \\$wg$aStomatognathic Diseases
=550  \\$wh$aBehcet Syndrome
=550  \\$wh$aBell Palsy
=550  \\$wh$aBurning Mouth Syndrome
=550  \\$wh$aCandidiasis, Oral
=550  \\$wh$aDry Socket
=550  \\$wh$aFacial Hemiatrophy
=550  \\$wh$aFacial Neuralgia
=550  \\$wh$aFacial Paralysis
=550  \\$wh$aFocal Epithelial Hyperplasia
=550  \\$wh$aGranulomatosis, Orofacial
=550  \\$wh$aHemifacial Spasm
=550  \\$wh$aLeukoedema, Oral
=550  \\$wh$aLichen Planus, Oral
=550  \\$wh$aLip Diseases
=550  \\$wh$aLudwig's Angina
=550  \\$wh$aMelkersson-Rosenthal Syndrome
=550  \\$wh$aMouth Abnormalities
=550  \\$wh$aMouth, Edentulous
=550  \\$wh$aMouth Neoplasms
=550  \\$wh$aMucositis
=550  \\$wh$aNoma
=550  \\$wh$aOral Fistula
=550  \\$wh$aOral Hemorrhage
=550  \\$wh$aOral Manifestations
=550  \\$wh$aOral Submucous Fibrosis
=550  \\$wh$aOral Ulcer
=550  \\$wh$aPeri-Implantitis
=550  \\$wh$aPeriodontal Diseases
=550  \\$wh$aRanula
=550  \\$wh$aSalivary Gland Diseases
=550  \\$wh$aStomatitis
=550  \\$wh$aTongue Diseases
=550  \\$wh$aTuberculosis, Oral
=550  \\$aOral Health
=550  \\$aOral Medicine
=667  \\$aGEN only: prefer specifics; inflamm dis = STOMATITIS; mucositis: index under STOMATITIS (IM) + MOUTH MUCOSA (NIM)
=688  \\$a65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67
=750  \0$aMouth$xDiseases$5IEN$0(DLC)sh 85087993

=LDR  00821cz  a2200253n  4500
=001  9880363609702441
=005  20141212203609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009058
=035  \\$aCBA2314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x659
=072  \\$aC23.$x888.$x852.$x761
=150  \\$aMouth Breathing
=450  \\$wnnna$aBreathing, Mouth
=450  \\$wnnna$aBreathings, Mouth
=450  \\$wnnna$aMouth Breathings
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$aRespiration
=667  \\$anote category: use all pertinent qualif
=680  \\$iAbnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.
=688  \\$a72(68)
=750  \0$aMouth breathing$5IEN$0(DLC)sh 85088006

=LDR  01061cz  a2200337n  4500
=001  9880363609802441
=005  20141212203608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009056
=035  \\$aCBA2313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x525
=072  \\$aC7.$x650.$x525
=072  \\$aC16.$x131.$x850.$x525
=150  \\$aMouth Abnormalities
=450  \\$wnnna$aAbnormalities, Mouth
=450  \\$wnnna$aAbnormality, Mouth
=450  \\$aMouth$xabnormalities
=450  \\$wnnna$aMouth Abnormality
=550  \\$wg$aMouth Diseases
=550  \\$wg$aStomatognathic System Abnormalities
=550  \\$wh$aCleft Lip
=550  \\$wh$aCleft Palate
=550  \\$wh$aFibromatosis, Gingival
=550  \\$wh$aMacrostomia
=550  \\$wh$aMicrostomia
=550  \\$wh$aVelopharyngeal Insufficiency
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iCongenital absence of or defects in structures of the mouth.
=688  \\$a65
=750  \0$aMouth$xAbnormalities$5IEN$0(DLC)sh 85087989

=LDR  01345cz  a2200409n  4500
=001  9880363609902441
=005  20141212203608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009055
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x631
=072  \\$aA3.$x556.$x500
=072  \\$aA14.$x549
=150  \\$aMouth
=360  \\$iconsider also terms at$aORAL$aORO-$aSTOMAT-
=450  \\$wnnna$aCavitas Oris
=450  \\$wnnna$aCavitas oris propria
=450  \\$wnnna$aCavity, Oral
=450  \\$wnnna$aMouth Cavity Proper
=450  \\$aOral Cavity
=450  \\$wnnna$aOral Cavity Proper
=450  \\$wnnna$aVestibule of the Mouth
=450  \\$wnnna$aVestibule Oris
=550  \\$wg$aFace
=550  \\$wg$aGastrointestinal Tract
=550  \\$wg$aStomatognathic System
=550  \\$wh$aDentition
=550  \\$wh$aLip
=550  \\$wh$aMouth Floor
=550  \\$wh$aMouth Mucosa
=550  \\$wh$aPalate
=550  \\$wh$aSalivary Glands
=550  \\$wh$aTongue
=667  \\$a/surg: consider also ORAL SURGICAL PROCEDURES; inflammation = STOMATITIS
=680  \\$iThe oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.
=688  \\$a/microbiology was MOUTH MICROORGANISMS 1965-67
=750  \0$aMouth$5IEN$0(DLC)sh 85087988

=LDR  01637cz  a2200361n  4500
=001  9880363610002441
=005  20141212203608.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009053
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x265.$x600
=072  \\$aB4.$x820.$x650.$x375.$x860
=072  \\$aB4.$x909.$x574.$x807.$x375.$x860
=072  \\$aB4.$x909.$x777.$x731.$x375.$x860
=150  \\$aSarcoma Viruses, Murine
=450  \\$wnnna$aFBJ-MSV
=450  \\$wnnna$aFBR-MSV
=450  \\$aFinkel-Biskis-Jinkins murine sarcoma virus
=450  \\$wnnna$aFinkel Biskis Jinkins murine sarcoma virus
=450  \\$wnnna$aFinkel-Biskis-Reilly murine sarcoma virus
=450  \\$wnnna$aFinkel Biskis Reilly murine sarcoma virus
=450  \\$aMouse Sarcoma Viruses
=450  \\$wnnna$aMurine Sarcoma Viruses
=450  \\$wnnna$aSarcoma Viruses, Mouse
=550  \\$wg$aDefective Viruses
=550  \\$wg$aGammaretrovirus
=550  \\$wh$aHarvey murine sarcoma virus
=550  \\$wh$aKirsten murine sarcoma virus
=550  \\$wh$aMoloney murine sarcoma virus
=667  \\$ainfection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM); add SARCOMA, EXPERIMENTAL (IM) if pertinent
=680  \\$iA group of replication-defective viruses, in the genus GAMMARETROVIRUS, which are capable of transforming cells, but which replicate and produce tumors only in the presence of Murine leukemia viruses (LEUKEMIA VIRUS, MURINE).
=688  \\$a94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79
=750  \0$aMurine sarcoma viruses$5IEN$0(DLC)sh 85088634

=LDR  01782cz  a2200397n  4500
=001  9880363610102441
=005  20141212203607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009052
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x375.$x525
=072  \\$aB4.$x909.$x574.$x807.$x375.$x525
=072  \\$aB4.$x909.$x777.$x731.$x375.$x525
=150  \\$aLeukemia Virus, Murine
=450  \\$wnnna$aGraffi Chloroleukemic Strain
=450  \\$aGraffi Virus
=450  \\$aGraffi's Chloroleukemic Strain
=450  \\$wnnna$aGraffis Chloroleukemic Strain
=450  \\$wnnna$aLeukemia Viruses, Mouse
=450  \\$wnnna$aLeukemia Viruses, Murine
=450  \\$wnnna$aMouse Leukemia Viruses
=450  \\$aMurine leukemia virus
=450  \\$wnnna$aMurine Leukemia Viruses
=550  \\$wg$aGammaretrovirus
=550  \\$wh$aAbelson murine leukemia virus
=550  \\$wh$aAKR murine leukemia virus
=550  \\$wh$aFriend murine leukemia virus
=550  \\$wh$aMink Cell Focus-Inducing Viruses
=550  \\$wh$aMoloney murine leukemia virus
=550  \\$wh$aRadiation Leukemia Virus
=550  \\$wh$aRauscher Virus
=550  \\$wh$aSpleen Focus-Forming Viruses
=667  \\$ainfection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM)
=680  \\$iSpecies of GAMMARETROVIRUS, containing many well-defined strains, producing leukemia in mice. Disease is commonly induced by injecting filtrates of propagable tumors into newborn mice.
=688  \\$a2002 (1966); was MOUSE LEUKEMIA VIRUSES 1966-93; for GRAFFI VIRUS use GRAFFI VIRUS 1991, use MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI'S CHLOROLEUKEMIC STRAIN use GRAFFI VIRUS 1975-1991
=750  \0$aMouse leukemia viruses$5IEN$0(DLC)sh 85087984

=LDR  00596cz  a2200193n  4500
=001  9880363610202441
=005  20141212203607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009051
=035  \\$aCBA2308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x582
=150  \\$aMountaineering
=450  \\$wnnna$aMountaineerings
=550  \\$wg$aSports
=550  \\$aAltitude
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA sport involving mountain climbing techniques.
=750  \0$aMountaineering$5IEN$0(DLC)sh 85087816

=LDR  01194cz  a2200277n  4500
=001  9880363610302441
=005  20141212203606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009050
=035  \\$aCBA2307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x330
=150  \\$aFluorosis, Dental
=450  \\$wnnna$aDental Fluoroses
=450  \\$aDental Fluorosis
=450  \\$wnnna$aEnamel, Mottled
=450  \\$wnnna$aEnamels, Mottled
=450  \\$wnnna$aFluoroses, Dental
=450  \\$aMottled Enamel
=450  \\$wnnna$aMottled Enamels
=550  \\$wg$aTooth Diseases
=550  \\$aFluorides
=667  \\$ado not confuse with TOOTH DISCOLORATION; DF: FLUOROSIS DENT
=680  \\$iA chronic endemic form of hypoplasia of the dental enamel caused by drinking water with a high fluorine content during the time of tooth formation, and characterized by defective calcification that gives a white chalky appearance to the enamel, which gradually undergoes brown discoloration. (Jablonski's Dictionary of Dentistry, 1992, p286)
=688  \\$a97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96
=750  \0$aMottled enamel$0(DLC) sh 85087700$5IEN

=LDR  00925cz  a2200205n  4500
=001  9880364436302441
=005  20141212193158.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059206
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x369
=072  \\$aN6.$x230.$x132.$x258.$x369
=150  \\$aNatural Gas
=450  \\$aGas, Natural
=550  \\$wg$aFossil Fuels
=550  \\$aOil and Gas Fields
=680  \\$iA combustible, gaseous mixture of low-molecular weight PARAFFIN hydrocarbons, generated below the surface of the earth. It contains mostly METHANE and ETHANE with small amounts of PROPANE; BUTANES; and higher hydrocarbons, and sometimes NITROGEN; CARBON DIOXIDE; HYDROGEN SULFIDE; and HELIUM. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2012
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Gas, Natural
=750  \0$aNatural gas$0(DLC) sh 85053223$5IEN-M

=LDR  01062cz  a2200301n  4500
=001  9880364436402441
=005  20141212222217.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059205
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x132.$x644
=150  \\$aRenewable Energy
=450  \\$wnnna$aEnergies, Renewable
=450  \\$wnnna$aEnergies, Sustainable
=450  \\$wnnna$aEnergy, Renewable
=450  \\$wnnna$aEnergy, Sustainable
=450  \\$wnnna$aRenewable Energies
=450  \\$wnnna$aSustainable Energies
=450  \\$wnnna$aSustainable Energy
=550  \\$wg$aEnergy-Generating Resources
=550  \\$wh$aBiofuels
=550  \\$wh$aGeothermal Energy
=550  \\$wh$aSolar Energy
=550  \\$wh$aWater Movements
=550  \\$wh$aWind
=680  \\$iForms of energy that are constantly and rapidly renewed by natural processes such as solar, ocean wave, and wind energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2012
=750  \0$aRenewable energy sources$0(DLC) sh 85112837$5IEN-M

=LDR  00869cz  a2200205n  4500
=001  9880364436502441
=005  20141212193157.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059167
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x500
=072  \\$aA11.$x671.$x487
=150  \\$aMirror Neurons
=450  \\$wnnna$aMirror Neuron
=450  \\$wnnna$aNeuron, Mirror
=450  \\$wnnna$aNeurons, Mirror
=550  \\$wg$aNeurons
=680  \\$iNeurons that fire when an animal acts or observes the same action of another thus coding the motor response. They were originally discovered in the premotor and parietal cortex of the monkey and studies have shown that neurons that have a similar mechanism are present in humans. Mirror neurons are theorized to be related to social cognition.
=688  \\$a2012
=750  \0$aMirror neurons$0(DLC)sh2006009040$5IEN-M

=LDR  00895cz  a2200229n  4500
=001  9880364436602441
=005  20141212193157.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059165
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x220.$x500
=150  \\$aHormesis
=450  \\$wnnna$aDose-Response, Hormetic
=450  \\$wnnna$aDose-Responses, Hormetic
=450  \\$wnnna$aHormeses
=450  \\$wnnna$aHormetic Dose-Response
=450  \\$wnnna$aHormetic Dose Response
=450  \\$wnnna$aHormetic Dose-Responses
=550  \\$wg$aDose-Response Relationship, Drug
=680  \\$iBiphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.
=688  \\$a2012
=750  \0$aHormesis$0(DLC) sh 94005580$5IEN-M

=LDR  02531cz  a2200625n  4500
=001  9880364436702441
=005  20141212193157.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x110.$x110.$x850
=072  \\$aE4.$x650.$x110.$x850
=072  \\$aE4.$x680.$x101.$x110.$x850
=150  \\$aTotal Disc Replacement
=450  \\$wnnna$aArthroplasties, Total Disc
=450  \\$wnnna$aArthroplasties, Total Disk
=450  \\$wnnna$aArthroplasty, Replacement, Disc
=450  \\$wnnna$aArthroplasty, Replacement, Disk
=450  \\$wnnna$aArthroplasty, Total Disc
=450  \\$wnnna$aArthroplasty, Total Disk
=450  \\$wnnna$aArtificial Disc Replacement
=450  \\$wnnna$aArtificial Disc Replacements
=450  \\$wnnna$aArtificial Disk Replacement
=450  \\$wnnna$aArtificial Disk Replacements
=450  \\$wnnna$aDisc Arthroplasties, Total
=450  \\$wnnna$aDisc Arthroplasty, Total
=450  \\$wnnna$aDisc Replacement, Artificial
=450  \\$wnnna$aDisc Replacement, Total
=450  \\$wnnna$aDisc Replacements, Artificial
=450  \\$wnnna$aDisc Replacements, Total
=450  \\$wnnna$aDisk Arthroplasties, Total
=450  \\$wnnna$aDisk Arthroplasty, Total
=450  \\$wnnna$aDisk Replacement, Artificial
=450  \\$wnnna$aDisk Replacement, Total
=450  \\$wnnna$aDisk Replacements, Artificial
=450  \\$wnnna$aDisk Replacements, Total
=450  \\$wnnna$aReplacement, Artificial Disc
=450  \\$wnnna$aReplacement, Artificial Disk
=450  \\$wnnna$aReplacement, Total Disc
=450  \\$wnnna$aReplacement, Total Disk
=450  \\$wnnna$aReplacements, Artificial Disc
=450  \\$wnnna$aReplacements, Artificial Disk
=450  \\$wnnna$aReplacements, Total Disc
=450  \\$wnnna$aReplacements, Total Disk
=450  \\$wnnna$aTotal Disc Arthroplasties
=450  \\$wnnna$aTotal Disc Arthroplasty
=450  \\$wnnna$aTotal Disc Replacements
=450  \\$wnnna$aTotal Disk Arthroplasties
=450  \\$wnnna$aTotal Disk Arthroplasty
=450  \\$wnnna$aTotal Disk Replacement
=450  \\$wnnna$aTotal Disk Replacements
=550  \\$wg$aArthroplasty, Replacement
=680  \\$iThe replacement of intervertebral discs in the spinal column with artificial devices. The procedure is done in the lumbar or cervical spine to relieve severe pain resulting from INTERVERTEBRAL DISC DEGENERATION.
=688  \\$a2012
=750  \0$aIntervertebral disk prostheses$0(DLC) sh 90005147$5IEN-M

=LDR  00846cz  a2200229n  4500
=001  9880364436802441
=005  20141212222215.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059125
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x550
=150  \\$aNeanderthals
=450  \\$aHomo neanderthalensis
=450  \\$wnnna$aHomo sapiens neanderthalensis
=450  \\$wnnna$aNeandertal
=450  \\$wnnna$aNeandertals
=450  \\$wnnna$aNeanderthal
=550  \\$wg$aHominidae
=667  \\$acheck the tag ANIMAL
=680  \\$iCommon name for an extinct species of the Homo genus. Fossils have been found in Europe and Asia. Genetic evidence suggests that limited interbreeding with modern HUMANS (Homo sapiens) took place.
=688  \\$a2012
=750  \0$aNeanderthals$0(DLC) sh 85090493$5IEN-M

=LDR  00564cz  a2200181n  4500
=001  9880364436902441
=005  20141212222215.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059066
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x587
=150  \\$aGross Domestic Product
=450  \\$wnnna$aGross Domestic Products
=450  \\$wnnna$aGross National Product
=550  \\$wg$aEconomics
=680  \\$iValue of all final goods and services produced in a country in one year.
=688  \\$a2011
=750  \0$aGross domestic product$0(DLC) sh 93006719$5IEN-M

=LDR  00696cz  a2200217n  4500
=001  9880364437002441
=005  20141212193156.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059037
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x345
=150  \\$aDoulas
=450  \\$wnnna$aCoach, Labor
=450  \\$wnnna$aCoaches, Labor
=450  \\$wnnna$aDoula
=450  \\$wnnna$aLabor Coach
=450  \\$wnnna$aLabor Coaches
=550  \\$wg$aHealth Personnel
=680  \\$iTrained lay women who provide emotional and/or physical support during obstetric labor and the postpartum period for mothers and their partners.
=688  \\$a2011
=750  \0$aDoulas$0(DLC) sh 92005410$5IEN-M

=LDR  00589cz  a2200181n  4500
=001  9880364437102441
=005  20141212222212.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059032
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x529.$x274
=150  \\$aLearning Curve
=450  \\$wnnna$aCurve, Learning
=450  \\$wnnna$aLearning Curves
=550  \\$wg$aLearning
=680  \\$iThe course of learning of an individual or a group. It is a measure of performance plotted over time.
=688  \\$a2011
=750  \0$aLearning curve (Psychometrics)$0(DLC)sh2006007157$5IEN-M

=LDR  00582cz  a2200169n  4500
=001  9880364437202441
=005  20141212222212.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059031
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x93
=150  \\$aAnticipation, Psychological
=450  \\$wnnna$aPsychological Anticipation
=550  \\$wg$aMental Processes
=680  \\$iThe ability to foresee what is likely to happen on the basis of past experience. It is largely a frontal lobe function.
=688  \\$a2011
=750  \0$aExpectation (Psychology)$0(DLC) sh 85046420$5IEN-M

=LDR  00791cz  a2200205n  4500
=001  9880364437302441
=005  20171219153153.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059029
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x710.$x189
=150  \\$aElectronic Waste
=450  \\$wnnna$aElectronic Wastes
=450  \\$wnnna$aWaste, Electronic
=450  \\$wnnna$aWastes, Electronic
=550  \\$wg$aRefuse and refuse disposal
=550  \\$wg$aWaste Products
=680  \\$iDiscarded electronic devices containing valuable and sometimes hazardous materials such as LEAD, NICKEL, CADMIUM, and MERCURY. (from http://www.epa.gov/osw/conserve/materials/ecycling/faq.htm#impact accessed 4/25/2010)
=688  \\$a2011
=750  \0$aElectronic waste$0(DLC) sh 96003263$5IEN-M

=LDR  00639cz  a2200181n  4500
=001  9880364437402441
=005  20190130104327.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059028
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x34
=072  \\$aN6.$x850.$x860.$x410.$x54
=150  \\$aAirports
=450  \\$aAirport
=550  \\$wg$aTransportation Facilities
=680  \\$iTerminal facilities used for aircraft takeoff and landing and including facilities for handling passengers. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)
=688  \\$a2011
=750  \0$aAirports$0(DLC) sh 85002960$5IEN-M

=LDR  00772cz  a2200193n  4500
=001  9880364437502441
=005  20141212222211.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059027
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x256.$x675
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x525
=072  \\$aN6.$x850.$x860.$x510.$x244
=150  \\$aRecycling
=550  \\$wg$aConservation of Natural Resources
=550  \\$wg$aSanitary Engineering
=680  \\$iThe extraction and recovery of usable or valuable material from scrap or other discarded materials. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)
=688  \\$a2011; use CONSERVATION OF NATURAL RESOURCES 1996-2010
=750  \0$aRecycling (Waste, etc.)$0(DLC) sh 85112020$5IEN-M

=LDR  00786cz  a2200229n  4500
=001  9880364437602441
=005  20141212222210.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500
=072  \\$aN6.$x850.$x601.$x500
=150  \\$aFood Safety
=450  \\$wnnna$aSafety, Food
=550  \\$wg$aFood Quality
=550  \\$wh$aFood Contamination
=550  \\$wh$aFood Inspection
=550  \\$wh$aHazard Analysis and Critical Control Points
=550  \\$aHazard Analysis and Critical Control Points
=680  \\$iActivities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination.
=688  \\$a2011
=750  \0$aFood$xSafety measures$0(DLC)sh2001007789$5IEN-M

=LDR  00750cz  a2200193n  4500
=001  9880364437702441
=005  20141212222208.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059015
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x950
=150  \\$aWireless Technology
=450  \\$wnnna$aTechnologies, Wireless
=450  \\$wnnna$aTechnology, Wireless
=450  \\$wnnna$aWireless Technologies
=550  \\$wg$aTelecommunications
=680  \\$iTechniques using energy such as radio frequency, infrared light, laser light, visible light, or acoustic energy to transfer information without the use of wires, over both short and long distances.
=688  \\$a2011
=750  \0$aWireless communication systems$0(DLC) sh 92006740$5IEN-M

=LDR  00999cz  a2200289n  4500
=001  9880364437802441
=005  20141212222206.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059007
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x440.$x500
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x580
=072  \\$aG5.$x360.$x162.$x440.$x500
=150  \\$aPolytene Chromosomes
=450  \\$wnnna$aChromosome, Polytene
=450  \\$wnnna$aChromosomes, Polytene
=450  \\$aPolytene Chromosome
=550  \\$wg$aChromosomes
=550  \\$wg$aChromosomes, Insect
=550  \\$wh$aChromosomal Puffs
=550  \\$aEndoreduplication
=550  \\$aPolyploidy
=680  \\$iExtra large CHROMOSOMES, each consisting of many identical copies of a chromosome lying next to each other in parallel.
=688  \\$a2013 (2011)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Polytene Chromosome
=688  \\$a2011
=750  \0$aGiant chromosomes$0(DLC) sh 85054834$5IEN-M

=LDR  00985cz  a2200337n  4500
=001  9880364437902441
=005  20200611171843.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80
=072  \\$aG16.$x500.$x275.$x810.$x650.$x75
=150  \\$aAquatic Organisms
=450  \\$wnnna$aAquatic Organism
=450  \\$wnnna$aMarine Organism
=450  \\$wnnna$aMarine Organisms
=450  \\$wnnna$aOrganism, Aquatic
=450  \\$wnnna$aOrganism, Marine
=450  \\$wnnna$aOrganisms, Aquatic
=450  \\$wnnna$aOrganisms, Marine
=550  \\$wg$aOceans and Seas
=550  \\$wg$aOrganism Forms
=550  \\$wh$aPeriphyton
=550  \\$wh$aPlankton
=550  \\$wh$aSeaweed
=550  \\$aMarine Biology
=550  \\$aPlankton
=667  \\$ageneral or unspecified; prefer specific organisms
=680  \\$iOrganisms that live in water.
=688  \\$a2011
=750  \0$aAquatic organisms$0(DLC) sh 85006238$5IEN-M

=LDR  00954cz  a2200253n  4500
=001  9880364438002441
=005  20141212222204.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058998
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x750.$x500
=072  \\$aE5.$x925.$x500
=072  \\$aL1.$x178.$x847.$x675.$x500
=150  \\$aRemote Sensing Technology
=450  \\$wnnna$aRemote Sensing Technologies
=450  \\$wnnna$aTechnologies, Remote Sensing
=450  \\$wnnna$aTechnology, Remote Sensing
=550  \\$wg$aTelemetry
=550  \\$wh$aSatellite Imagery
=550  \\$aGeographic Information Systems
=550  \\$aRadio Frequency Identification Device
=680  \\$iObservation and aquisition of physical data from a distance by viewing and making measurements from a distance or receiving transmitted data from observations made at distant location.
=688  \\$a2011
=750  \0$aRemote sensing$0(DLC) sh 85112798$5IEN-M

=LDR  00505cz  a2200169n  4500
=001  9880364438102441
=005  20141212222202.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058992
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x50.$x750
=150  \\$aSocial Participation
=450  \\$wnnna$aParticipation, Social
=550  \\$wg$aActivities of Daily Living
=680  \\$iInvolvement in community activities or programs.
=688  \\$a2011
=750  \0$aSocial participation$0(DLC) sh 85123981$5IEN-M

=LDR  00725cz  a2200217n  4500
=001  9880364438202441
=005  20141212222159.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058980
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x450
=150  \\$aInformation Literacy
=450  \\$wnnna$aInformation Literacies
=450  \\$wnnna$aLiteracies, Information
=450  \\$wnnna$aLiteracy, Information
=550  \\$wg$aCommunication
=550  \\$wh$aHealth Literacy
=550  \\$aComputer Literacy
=680  \\$iThe ability to recognize when information is needed and to locate, evaluate, and use the needed information effectively.
=688  \\$a2011
=750  \0$aInformation literacy$0(DLC) sh 00007046$5IEN-M

=LDR  01044cz  a2200241n  4500
=001  9880364438302441
=005  20141212222157.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058974
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x335.$x500
=072  \\$aH1.$x277.$x500.$x589
=150  \\$aPhylogeography
=450  \\$wnnna$aBiogeography, Phylogenetic
=450  \\$wnnna$aPhylogenetic Biogeography
=550  \\$wg$aGenetics, Population
=550  \\$wg$aGeography
=550  \\$aPaleontology
=550  \\$aPhylogeny
=667  \\$aIM for the discipline (education, history, etc); NIM as a coordinate for phylogeographic studies of populations
=680  \\$iA field of study concerned with the principles and processes governing the geographic distributions of genealogical lineages, especially those within and among closely related species. (Avise, J.C., Phylogeography: The History and Formation of Species. Harvard University Press, 2000)
=688  \\$a2011
=750  \0$aPhylogeography$0(DLC) sh 99000800$5IEN-M

=LDR  01216cz  a2200325n  4500
=001  9880364438402441
=005  20141212222156.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058971
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x712
=150  \\$aTenotomy
=450  \\$wnnna$aHeel-Cord Release
=450  \\$wnnna$aHeel Cord Release
=450  \\$wnnna$aHeel-Cord Releases
=450  \\$wnnna$aLengthening, Tendon
=450  \\$wnnna$aLengthenings, Tendon
=450  \\$wnnna$aRelease, Heel-Cord
=450  \\$wnnna$aRelease, Tendon
=450  \\$wnnna$aReleases, Heel-Cord
=450  \\$wnnna$aReleases, Tendon
=450  \\$wnnna$aTendon Lengthening
=450  \\$wnnna$aTendon Lengthenings
=450  \\$wnnna$aTendon Release
=450  \\$wnnna$aTendon Releases
=450  \\$wnnna$aTenotomies
=550  \\$wg$aOrthopedic Procedures
=680  \\$iSurgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.
=688  \\$a2011
=750  \0$aTenotomy$0(DLC) sh 85133922$5IEN-M

=LDR  00812cz  a2200289n  4500
=001  9880364438502441
=005  20141212222153.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058955
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x513
=150  \\$aMetalloids
=450  \\$wnnna$aIntermediate Metals
=450  \\$wnnna$aMetals, Intermediate
=450  \\$wnnna$aSemi-Metals
=450  \\$wnnna$aSemi Metals
=550  \\$wg$aElements
=550  \\$wh$aAntimony
=550  \\$wh$aArsenic
=550  \\$wh$aBoron
=550  \\$wh$aGermanium
=550  \\$wh$aPolonium
=550  \\$wh$aSilicon
=550  \\$wh$aTellurium
=680  \\$iA class of nonmetals such as arsenic that have some of the chemical properties of a metal.
=688  \\$a2011
=750  \0$aSemimetals$0(DLC) sh 85119926$5IEN-M

=LDR  00814cz  a2200229n  4500
=001  9880364438602441
=005  20200609125538.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058953
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x872.$x653
=150  \\$aNeural Stem Cells
=450  \\$wnnna$aCell, Neural Stem
=450  \\$wnnna$aCells, Neural Stem
=450  \\$wnnna$aNeural Stem Cell
=450  \\$wnnna$aStem Cell, Neural
=450  \\$wnnna$aStem Cells, Neural
=550  \\$wg$aStem Cells
=550  \\$wh$aOligodendrocyte Precursor Cells
=680  \\$iSelf-renewing cells that generate the main phenotypes of the nervous system in both the embryo and adult. Neural stem cells are precursors to both NEURONS and NEUROGLIA.
=688  \\$a2011
=750  \0$aNeural stem cells$0(DLC)sh2003001310$5IEN-M

=LDR  00741cz  a2200217n  4500
=001  9880364438702441
=005  20141212222149.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058945
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x416.$x583
=072  \\$aD12.$x776.$x556.$x579.$x374.$x568
=150  \\$aLipoxygenases
=550  \\$wg$aDioxygenases
=550  \\$wg$aNonheme Iron Proteins
=550  \\$wh$aArachidonate Lipoxygenases
=550  \\$wh$aLipoxygenase
=667  \\$aLIPOXYGENASE is also available
=680  \\$iDioxygenases that catalyze the peroxidation of methylene-interrupted UNSATURATED FATTY ACIDS.
=688  \\$a2011; use LIPOXYGENASE 1992-2010
=750  \0$aLipoxygenases$0(DLC) sh 85077316$5IEN-M

=LDR  01034cz  a2200241n  4500
=001  9880364438802441
=005  20141212222149.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058928
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x544.$x427
=072  \\$aD13.$x444.$x735.$x790.$x878.$x942.$x500
=072  \\$aG2.$x111.$x570.$x80.$x689.$x687.$x124
=072  \\$aG5.$x360.$x80.$x689.$x687.$x124
=150  \\$aRiboswitch
=450  \\$wnnna$aRibosensor
=450  \\$wnnna$aRibosensors
=450  \\$aRiboswitches
=550  \\$wg$aRegulatory Sequences, Ribonucleic Acid
=550  \\$wg$aRNA, Messenger
=680  \\$iPart of a MESSENGER RNA molecule that undergoes a conformation change upon binding a specific metabolite or other small molecule thereby regulating the messenger RNA's transcription, post-transcriptional processing, transport, translation, or stability in response to varying levels of the metabolite or other small molecule.
=688  \\$a2011
=750  \0$aRiboswitches$0(DLC)sh2010013135$5IEN-M

=LDR  00683cz  a2200181n  4500
=001  9880364438902441
=005  20141212222141.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058894
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x655
=150  \\$aNematocyst
=450  \\$wnnna$aNematocysts
=550  \\$wg$aAnimal Structures
=550  \\$aCnidarian Venoms
=680  \\$iA double-walled capsule found in jellyfish and other CNIDARIA whose functions include prey capture, defense, locomotion, and attachment. Nematocysts contain toxic CNIDARIAN VENOMS which are injected into the victim via a barbed tubule.
=688  \\$a2011
=750  \0$aNematocysts$0(DLC) sh 85090701$5IEN-M

=LDR  00903cz  a2200241n  4500
=001  9880364439002441
=005  20141212222138.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058874
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x830.$x666.$x500
=150  \\$aElectrowetting
=450  \\$wnnna$aEffect, Electrocapillary
=450  \\$wnnna$aEffects, Electrocapillary
=450  \\$wnnna$aElectrocapillary Effect
=450  \\$wnnna$aElectrocapillary Effects
=450  \\$wnnna$aElectrowettings
=550  \\$wg$aMicrofluidics
=550  \\$aWettability
=667  \\$afor electrowetting agents coordinate with WETTING AGENTS
=680  \\$iReducing the SURFACE TENSION at a liquid/solid interface by the application of an electric current across the interface thereby enhancing the WETTABILITY of the surface.
=688  \\$a2011
=750  \0$aElectrocapillary phenomena$0(DLC) sh 85042096$5IEN-M

=LDR  00920cz  a2200193n  4500
=001  9880364439102441
=005  20141212222137.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058872
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x290.$x200
=150  \\$aEpidemics
=450  \\$wnnna$aEpidemic
=550  \\$wg$aDisease Outbreaks
=550  \\$wh$aPandemics
=667  \\$acoordinate IM with specific disease / epidemiol (IM) & specify geographic location if pertinent; differentiate from DISEASE OUTBREAKS, follow terminology in text
=680  \\$iSudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease. Epidemics can also refer to outbreaks of disease in animal or plant populations.
=688  \\$a2011; use DISEASE OUTBREAKS 1968-2010
=750  \0$aEpidemics$0(DLC) sh 85044370$5IEN-M

=LDR  01143cz  a2200325n  4500
=001  9880364439202441
=005  20141212222137.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058871
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x895
=150  \\$aOrganic Agriculture
=450  \\$wnnna$aAgriculture, Organic
=450  \\$wnnna$aFarm, Organic
=450  \\$wnnna$aFarming, Organic
=450  \\$wnnna$aFarms, Organic
=450  \\$wnnna$aGarden, Organic
=450  \\$wnnna$aGardening, Organic
=450  \\$wnnna$aGardens, Organic
=450  \\$wnnna$aOrganic Farm
=450  \\$wnnna$aOrganic Farming
=450  \\$wnnna$aOrganic Farms
=450  \\$wnnna$aOrganic Garden
=450  \\$wnnna$aOrganic Gardening
=450  \\$wnnna$aOrganic Gardens
=550  \\$wg$aAgriculture
=550  \\$aFood, Organic
=680  \\$iSystems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.
=688  \\$a2011
=750  \0$aOrganic farming$0(DLC) sh 85095504$5IEN-M

=LDR  01010cz  a2200265n  4500
=001  9880364439302441
=005  20160914172727.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058870
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x300.$x519
=072  \\$aJ2.$x500.$x519
=150  \\$aFood, Organic
=450  \\$wnnna$aFoods, Organic
=450  \\$wnno$aHealth Food$5IEN-M
=450  \\$aOrganic Food
=450  \\$wnnna$aOrganic Foods
=450  \\$wnnna$aOrganic Produce
=450  \\$wnnna$aProduce, Organic
=550  \\$wg$aFood
=550  \\$aOrganic Agriculture
=667  \\$aHEALTH FOOD is also available
=680  \\$iFood that is grown or manufactured in accordance with nationally regulated production standards that include restrictions on the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ingredients.
=688  \\$a2011; use HEALTH FOOD (1996-2010)
=750  \0$aNatural foods$0(DLC) sh 85050247$5IEN-M

=LDR  01524cz  a2200433n  4500
=001  9880364439402441
=005  20141212222136.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x293
=150  \\$aGynecological Examination
=450  \\$wnnna$aExam, Gynecological
=450  \\$wnnna$aExam, Pelvic
=450  \\$wnnna$aExam, Vaginal
=450  \\$wnnna$aExamination, Gynecological
=450  \\$wnnna$aExamination, Pelvic
=450  \\$wnnna$aExamination, Vaginal
=450  \\$wnnna$aExaminations, Gynecological
=450  \\$wnnna$aExaminations, Pelvic
=450  \\$wnnna$aExaminations, Vaginal
=450  \\$wnnna$aExams, Gynecological
=450  \\$wnnna$aExams, Pelvic
=450  \\$wnnna$aExams, Vaginal
=450  \\$wnnna$aGynecological Exam
=450  \\$wnnna$aGynecological Examinations
=450  \\$wnnna$aGynecological Exams
=450  \\$wnnna$aPelvic Exam
=450  \\$wnnna$aPelvic Examination
=450  \\$wnnna$aPelvic Examinations
=450  \\$wnnna$aPelvic Exams
=450  \\$wnnna$aVaginal Exam
=450  \\$wnnna$aVaginal Examination
=450  \\$wnnna$aVaginal Examinations
=450  \\$wnnna$aVaginal Exams
=550  \\$wg$aPhysical Examination
=680  \\$iInspection and PALPATATION of female breasts, abdomen, and GENITALIA, as well as obtaining a gynecological history. (from Dictionary of Obstetrics and Gynecology)
=688  \\$a2011
=750  \0$aGynecologic examination$0(DLC) sh 85058086$5IEN-M

=LDR  00826cz  a2200277n  4500
=001  9880364439502441
=005  20141212222136.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058868
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x161
=072  \\$aG16.$x500.$x275.$x63.$x150.$x500
=072  \\$aN6.$x230.$x300.$x100.$x150.$x592
=150  \\$aCompressed Air
=450  \\$wnnna$aAir, Compressed
=450  \\$wnnna$aAir, Pressurized
=450  \\$wnnna$aAirs, Compressed
=450  \\$wnnna$aAirs, Pressurized
=450  \\$wnnna$aCompressed Airs
=450  \\$wnnna$aPressurized Air
=450  \\$wnnna$aPressurized Airs
=550  \\$wg$aAir
=550  \\$wg$aEquipment and Supplies
=680  \\$iAir that is reduced in volume by pressure.
=688  \\$a2011
=750  \0$aCompressed air$0(DLC) sh 85029430$5IEN-M

=LDR  00736cz  a2200229n  4500
=001  9880364439602441
=005  20141212222135.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x580
=072  \\$aG16.$x500.$x275.$x157.$x49.$x400
=072  \\$aN6.$x230.$x124.$x49.$x400
=150  \\$aIntroduced Species
=450  \\$aInvasive Species
=450  \\$wnnna$aSpecies, Introduced
=450  \\$wnnna$aSpecies, Invasive
=550  \\$wg$aAnimal Population Groups
=550  \\$wg$aBiodiversity
=680  \\$iNon-native organisms brought into a region, habitat, or ECOSYSTEM by human activity.
=688  \\$a2011
=750  \0$aIntroduced organisms$0(DLC)sh2002000268$5IEN-M

=LDR  00769cz  a2200229n  4500
=001  9880364439702441
=005  20141212222124.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058753
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x371
=150  \\$aLaryngoplasty
=450  \\$wnnna$aLaryngoplasties
=450  \\$wnnna$aLaryngoplasties, Medialization
=450  \\$wnnna$aLaryngoplasty, Medialization
=450  \\$wnnna$aMedialization Laryngoplasties
=450  \\$wnnna$aMedialization Laryngoplasty
=450  \\$wnnna$aThyroplasty
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=680  \\$iRestoration, reconstruction, or improvement of a defective or damaged LARYNX.
=688  \\$a2011
=750  \0$aLaryngoplasty$0(DLC) sh 85074742$5IEN-M

=LDR  01206cz  a2200361n  4500
=001  9880364439802441
=005  20141212222123.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x850.$x710.$x500
=072  \\$aE7.$x862.$x710.$x500
=150  \\$aFree Tissue Flaps
=450  \\$wnnna$aFlap, Free
=450  \\$wnnna$aFlap, Free Tissue
=450  \\$wnnna$aFlap, Microsurgical Free
=450  \\$wnnna$aFlaps, Free
=450  \\$wnnna$aFlaps, Free Tissue
=450  \\$wnnna$aFlaps, Microsurgical Free
=450  \\$wnnna$aFree Flap
=450  \\$wnnna$aFree Flap, Microsurgical
=450  \\$aFree Flaps
=450  \\$wnnna$aFree Flaps, Microsurgical
=450  \\$wnnna$aFree Tissue Flap
=450  \\$wnnna$aFree Tissue Transfer Flaps
=450  \\$wnnna$aMicrosurgical Free Flap
=450  \\$wnnna$aMicrosurgical Free Flaps
=450  \\$wnnna$aTissue Flap, Free
=450  \\$wnnna$aTissue Flaps, Free
=550  \\$wg$aSurgical Flaps
=680  \\$iA mass of tissue that has been cut away from its surrounding areas to be used in TISSUE TRANSPLANTATION.
=688  \\$a2011
=750  \0$aFree flaps (Surgery)$0(DLC) sh 89000954$5IEN-M

=LDR  00715cz  a2200181n  4500
=001  9880364439902441
=005  20141212222123.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058751
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x500
=150  \\$aLivestock
=450  \\$wnnna$aLivestocks
=550  \\$wg$aAnimals, Domestic
=667  \\$aprefer specific domestic animals like CATTLE; SHEEP; HORSES; etc.; excludes POULTRY
=680  \\$iDomesticated farm animals raised for home use or profit but excluding POULTRY. Typically livestock includes CATTLE; SHEEP; HORSES; SWINE; GOATS; and others.
=688  \\$a2011; use ANIMALS, DOMESTIC 1993-2010
=750  \0$aLivestock$0(DLC) sh 85077784$5IEN-M

=LDR  00821cz  a2200265n  4500
=001  9880364440002441
=005  20141212222122.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058749
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x445
=150  \\$aMilitary Facilities
=450  \\$wnnna$aBase, Military
=450  \\$wnnna$aBases, Military
=450  \\$wnnna$aFacilities, Military
=450  \\$wnnna$aFacility, Military
=450  \\$wnnna$aMilitary Base
=450  \\$wnnna$aMilitary Bases
=450  \\$wnnna$aMilitary Facility
=450  \\$wnnna$aMilitary Forts
=550  \\$wg$aFacility Design and Construction
=550  \\$wh$aHospitals, Military
=680  \\$iAreas designated for use by the armed forces personnel.
=688  \\$a2011
=750  \0$aMilitary bases$0(DLC) sh 85085159$5IEN-M

=LDR  00694cz  a2200217n  4500
=001  9880364440102441
=005  20141212222122.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058748
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x504
=150  \\$aPain Perception
=450  \\$wnnna$aPain Perceptions
=450  \\$wnnna$aPerception, Pain
=450  \\$wnnna$aPerceptions, Pain
=550  \\$wg$aPerception
=550  \\$wh$aNociception
=667  \\$adifferentiate from PAIN; PAIN PERCEPTION takes place in the brain
=680  \\$iThe process by which PAIN is recognized and interpreted by the brain.
=688  \\$a2011
=750  \0$aPain perception$0(DLC)sh2003008336$5IEN-M

=LDR  00896cz  a2200241n  4500
=001  9880364440202441
=005  20141212222120.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058735
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x180
=072  \\$aI1.$x880.$x604.$x825.$x608.$x180
=072  \\$aN3.$x623.$x500.$x608.$x180
=072  \\$aN6.$x230.$x204
=150  \\$aEnvironmental Policy
=450  \\$wnnna$aEnvironmental Policies
=450  \\$wnnna$aPolicies, Environmental
=450  \\$wnnna$aPolicy, Environmental
=550  \\$wg$aEnvironment
=550  \\$wg$aPublic Policy
=680  \\$iA course of action or principle adopted or proposed by a government, party, business, or individual that concerns human interactions with nature and natural resources.
=688  \\$a2011; use ENVIRONMENT 1996-2010
=750  \0$aEnvironmental policy$0(DLC) sh 85044197$5IEN-M

=LDR  00635cz  a2200229n  4500
=001  9880364440302441
=005  20141212222118.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x947
=150  \\$aWeed Control
=450  \\$wnnna$aControl, Weed
=450  \\$wnnna$aControls, Weed
=450  \\$wnnna$aWeed Controls
=550  \\$wg$aAgriculture
=550  \\$aHerbicides
=550  \\$aPest Control
=550  \\$aPlant Weeds
=680  \\$iThe prevention of growth and or spread of unwanted plants.
=688  \\$a2011
=750  \0$aWeeds$xControl$0(DLC) sh 85145922$5IEN-M

=LDR  00685cz  a2200205n  4500
=001  9880364440402441
=005  20141212222110.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058643
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x600
=150  \\$aPlanococcus Insect
=450  \\$wnnna$aInsect, Planococcus
=450  \\$wnnna$aInsects, Planococcus
=450  \\$wnnna$aPlanococcus Insects
=550  \\$wg$aHemiptera
=667  \\$ado not confuse with the bacteria genus Planococcus: see PLANOCOCCUS BACTERIA
=680  \\$iA genus of insect in the mealybug family Pseudococcidae.
=688  \\$a2011
=750  \0$aPlanococcus$0(DLC)sh2007005060$5IEN-M

=LDR  00730cz  a2200217n  4500
=001  9880364440502441
=005  20141212222109.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058636
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x137.$x750
=072  \\$aE7.$x858.$x642
=150  \\$aSurgical Drapes
=450  \\$wnnna$aDrape, Surgical
=450  \\$wnnna$aDrapes, Surgical
=450  \\$wnnna$aSurgical Drape
=550  \\$wg$aBedding and Linens
=550  \\$wg$aSurgical Equipment
=680  \\$iSterile fabric or fabric-like material used to isolate the surgical site from the rest of the body and other possible sources of contamination.
=688  \\$a2011
=750  \0$aDraping (Surgery)$0(DLC) sh 85039393$5IEN-M

=LDR  00836cz  a2200253n  4500
=001  9880364440602441
=005  20141212222108.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058633
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x68
=150  \\$aAntipyretics
=450  \\$wnnna$aAgents, Antifebrile
=450  \\$wnnna$aAgents, Antipyretic
=450  \\$wnnna$aAntifebrile Agents
=450  \\$wnnna$aAntipyretic Agents
=450  \\$wnnna$aAntipyretic Effect
=450  \\$wnnna$aAntipyretic Effects
=450  \\$wnnna$aEffect, Antipyretic
=450  \\$wnnna$aEffects, Antipyretic
=550  \\$wg$aPhysiological Effects of Drugs
=680  \\$iDrugs that are used to reduce body temperature in fever.
=688  \\$a2011; use ANALGESICS, NON-NARCOTIC 1995-2010
=750  \0$aAntipyretics$0(DLC) sh 85005739$5IEN

=LDR  01091cz  a2200313n  4500
=001  9880364440702441
=005  20141212222107.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x615.$x500
=072  \\$aG16.$x100.$x856.$x611.$x500
=150  \\$aSpinal Cord Regeneration
=450  \\$wnnna$aCord Regeneration, Spinal
=450  \\$wnnna$aCord Regenerations, Spinal
=450  \\$wnnna$aCord Repair, Spinal
=450  \\$wnnna$aCord Repairs, Spinal
=450  \\$wnnna$aRegeneration, Spinal Cord
=450  \\$wnnna$aRegenerations, Spinal Cord
=450  \\$wnnna$aRepair, Spinal Cord
=450  \\$wnnna$aRepairs, Spinal Cord
=450  \\$wnnna$aSpinal Cord Regenerations
=450  \\$wnnna$aSpinal Cord Repair
=450  \\$wnnna$aSpinal Cord Repairs
=550  \\$wg$aNerve Regeneration
=550  \\$aSpinal Cord Injuries
=680  \\$iRepair of the damaged neuron function after SPINAL CORD INJURY or SPINAL CORD DISEASES.
=688  \\$a2011
=750  \0$aSpinal cord$xRegeneration$0(DLC) sh 85126676$5IEN-M

=LDR  00719cz  a2200193n  4500
=001  9880364440802441
=005  20141212222106.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058628
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x228.$x975
=072  \\$aA11.$x620.$x520.$x500
=150  \\$aMyofibroblasts
=450  \\$wnnna$aMyofibroblast
=550  \\$wg$aFibroblasts
=550  \\$wg$aMyocytes, Smooth Muscle
=680  \\$iSpindle-shaped cells with characteristic CONTRACTILE PROTEINS and structures that contribute to the WOUND HEALING process. They occur in GRANULATION TISSUE and also in pathological processes such as FIBROSIS.
=688  \\$a2011
=750  \0$aMyofibroblasts$0(DLC) sh 99001909$5IEN-M

=LDR  01095cz  a2200253n  4500
=001  9880364440902441
=005  20141212222106.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058626
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x740
=150  \\$aPlasma Gases
=450  \\$wnnna$aCold Plasma
=450  \\$wnnna$aGases, Plasma
=450  \\$wnnna$aNon-Thermal Atmospheric Pressure Plasma
=450  \\$wnnna$aNon Thermal Atmospheric Pressure Plasma
=450  \\$wnnna$aPlasma, Cold
=450  \\$wnnna$aPlasma, Thermal
=450  \\$wnnna$aThermal Plasma
=550  \\$wg$aGases
=667  \\$ado not use for blood gases or blood plasma
=680  \\$iIonized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. Plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., PLASMA ARC DENTAL CURING LIGHTS); and in other treatments (e.g., ARGON PLASMA COAGULATION).
=688  \\$a2011
=750  \0$aPlasma (Ionized gases)$0(DLC) sh 85103050$5IEN-M

=LDR  00756cz  a2200193n  4500
=001  9880364441002441
=005  20141212222105.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x145.$x229.$x93
=150  \\$aBlood Buffy Coat
=450  \\$wnnna$aBlood Buffy Coats
=450  \\$wnnna$aBuffy Coat, Blood
=450  \\$wnnna$aBuffy Coats, Blood
=550  \\$wg$aBlood Cells
=680  \\$iThe fraction of a blood sample, following CENTRIFUGATION, that is distinguished as a thin light-colored layer between the RED BLOOD CELLS, underneath it, and the PLASMA, above it. It is composed mostly of WHITE BLOOD CELLS and PLATELETS.
=688  \\$a2011
=750  \0$aBlood$xBuffy coat$0(DLC) sh 85014930$5IEN-M

=LDR  01029cz  a2200265n  4500
=001  9880364441102441
=005  20141212222105.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058620
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x315
=150  \\$aElder Nutritional Physiological Phenomena
=450  \\$wnnna$aAged Nutrition Physiological Phenomena
=450  \\$wnnna$aAged Nutrition Physiology
=450  \\$wnnna$aAged Nutritional Physiological Phenomena
=450  \\$wnnna$aElder Nutrition Physiological Phenomena
=450  \\$wnnna$aElder Nutritional Physiological Phenomenon
=450  \\$wnnna$aElder Nutritional Physiology
=450  \\$wnnna$aElderly Nutrition Physiological Phenomena
=450  \\$wnnna$aNutritional Physiology, Elder
=450  \\$wnnna$aPhysiology, Elder Nutritional
=550  \\$wg$aNutritional Physiological Phenomena
=680  \\$iNutritional physiology of adults aged 65 years of age and older.
=688  \\$a2011
=750  \0$aOlder people$xNutrition$0(DLC) sh 85002116$5IEN-M

=LDR  00912cz  a2200229n  4500
=001  9880364441202441
=005  20141212222104.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x904
=072  \\$aJ1.$x293.$x69.$x500
=150  \\$aSynthetic Biology
=450  \\$wnnna$aBiologies, Synthetic
=450  \\$wnnna$aBiology, Synthetic
=450  \\$wnnna$aSynthetic Biologies
=550  \\$wg$aBioengineering
=550  \\$wg$aBiology
=667  \\$aIM for the discipline (education, history, etc); NIM as a coordinate for studies involving specific synthetic biology concepts and applications
=680  \\$iA field of biological research combining engineering in the formulation, design, and building (synthesis) of novel biological structures, functions, and systems.
=688  \\$a2011
=750  \0$aSynthetic biology$0(DLC)sh2010006918$5IEN-M

=LDR  00806cz  a2200241n  4500
=001  9880364441302441
=005  20170609112452.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058614
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x154.$x767
=072  \\$aG15.$x620.$x500
=072  \\$aG15.$x808
=150  \\$aSeed Dispersal
=450  \\$wnnna$aDispersal, Seed
=450  \\$wnnna$aDispersals, Seed
=450  \\$wnnna$aSeed Dispersals
=550  \\$wg$aBiophysical Phenomena
=550  \\$wg$aPlant Dispersal
=550  \\$wg$aPlant Physiological Phenomena
=680  \\$iThe various physical methods which include wind, insects, animals, tension, and water, by which a plant scatters its seeds away from the parent plant.
=688  \\$a2011
=750  \0$aSeeds$xDispersal$0(DLC) sh 85119551$5IEN-M

=LDR  00752cz  a2200193n  4500
=001  9880364441402441
=005  20141212222103.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058612
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x200.$x550
=072  \\$aJ1.$x637.$x512.$x600.$x580
=150  \\$aNanodiamonds
=450  \\$wnnna$aNanodiamond
=550  \\$wg$aDiamond
=550  \\$wg$aNanoparticles
=680  \\$iDiamond nanoparticles that exhibit unique biological, thermal, mechanical, and optoelectronic properties. They have important NANOMEDICINE applications including DRUG DELIVERY SYSTEMS; DIAGNOSTIC IMAGING; protein separation; and BIOSENSING TECHNIQUES.
=688  \\$a2011
=750  \0$aNanodiamonds$0(DLC)sh2005003924$5IEN-M

=LDR  00789cz  a2200217n  4500
=001  9880364441502441
=005  20141212222103.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058611
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x438
=072  \\$aF4.$x754.$x392
=150  \\$aHorticultural Therapy
=450  \\$wnnna$aHorticultural Therapies
=450  \\$wnnna$aTherapies, Horticultural
=450  \\$wnnna$aTherapy, Horticultural
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aPsychotherapy
=680  \\$iA therapeutic approach in which horticultural artefacts are utilized in improving an individual's social, emotional, educational, psychological, and physical well-being.
=688  \\$a2011
=750  \0$aGardening$xTherapeutic use$0(DLC) sh 85053096$5IEN-M

=LDR  01815cz  a2200517n  4500
=001  9880364441602441
=005  20141212222102.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058609
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850.$x962
=150  \\$aVisual Field Tests
=450  \\$wnnna$aAutomated Perimetry Exam
=450  \\$wnnna$aAutomated Perimetry Exams
=450  \\$wnnna$aCampimetries
=450  \\$wnnna$aCampimetry
=450  \\$wnnna$aExam, Automated Perimetry
=450  \\$wnnna$aExam, Tangent Screen
=450  \\$wnnna$aExam, Visual Field
=450  \\$wnnna$aExams, Automated Perimetry
=450  \\$wnnna$aExams, Tangent Screen
=450  \\$wnnna$aExams, Visual Field
=450  \\$wnnna$aField Exam, Visual
=450  \\$wnnna$aField Exams, Visual
=450  \\$wnnna$aField Test, Visual
=450  \\$wnnna$aField Tests, Visual
=450  \\$wnnna$aPerimetries
=450  \\$wnnna$aPerimetry
=450  \\$wnnna$aPerimetry Exam, Automated
=450  \\$wnnna$aPerimetry Exams, Automated
=450  \\$wnnna$aScreen Exam, Tangent
=450  \\$wnnna$aScreen Exams, Tangent
=450  \\$wnnna$aTangent Screen Exam
=450  \\$wnnna$aTangent Screen Exams
=450  \\$wnnna$aTest, Visual Field
=450  \\$wnnna$aTests, Visual Field
=450  \\$wnnna$aVisual Field Exam
=450  \\$wnnna$aVisual Field Exams
=450  \\$wnnna$aVisual Field Test
=550  \\$wg$aVision Tests
=550  \\$aVisual Fields
=667  \\$aVISUAL FIELDS is also available
=680  \\$iMethod of measuring and mapping the scope of vision, from central to peripheral of each eye.
=688  \\$a2011
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20110909: 150:##:_{dollar}a Perimetry
=750  \0$aVisual fields$xMeasurement$0(DLC)sh2004006007$5IEN-M

=LDR  00556cz  a2200169n  4500
=001  9880364441702441
=005  20141212222101.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x650
=150  \\$aNanopores
=450  \\$wnnna$aNanopore
=550  \\$wg$aNanostructures
=680  \\$iSmall holes of nanometer dimensions in a membrane, that can be used as single molecule detectors. The pores can be biological or synthetic.
=688  \\$a2011
=750  \0$aNanopores$5IEN-M$0(DLC)sh2012002342

=LDR  01099cz  a2200277n  4500
=001  9880364441802441
=005  20141212222053.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x467
=072  \\$aF3.$x900.$x467
=150  \\$aInhalant Abuse
=450  \\$wnnna$aAbuse, Glue
=450  \\$wnnna$aAbuse, Inhalant
=450  \\$wnnna$aAbuses, Glue
=450  \\$wnnna$aAbuses, Inhalant
=450  \\$wnnna$aGlue Abuse
=450  \\$wnnna$aGlue Abuses
=450  \\$aGlue Sniffing
=450  \\$wnnna$aGlue Sniffings
=450  \\$wnnna$aInhalant Abuses
=550  \\$wg$aSubstance-Related Disorders
=680  \\$iIllicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. Inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.
=688  \\$a2011; for Glue Sniffing, use Substance-Related Disorders 1981-2010; Glue Sniffing was a heading 1969-1980
=750  \0$aInhalant abuse$0(DLC) sh 85124743$5IEN-M

=LDR  01133cz  a2200253n  4500
=001  9880364441902441
=005  20141212222044.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x778
=072  \\$aE5.$x978.$x673
=150  \\$aQuartz Crystal Microbalance Techniques
=450  \\$wnnna$aElectrochemical Quartz Crystal Impedance Analysis
=450  \\$wnnna$aMicrobalance, Quartz Crystal
=450  \\$wnnna$aMicrobalances, Quartz Crystal
=450  \\$wnnna$aQuartz Crystal Microbalance
=450  \\$wnnna$aQuartz Crystal Microbalance with Dissipation Monitoring
=450  \\$wnnna$aQuartz Crystal Microbalances
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aWeights and Measures
=680  \\$iThe use of a quartz crystal microbalance for measuring weights and forces in the micro- to nanogram range. It is used to study the chemical and mechanical properties of thin layers, such as polymer coatings and lipid membranes; and interactions between molecues.
=688  \\$a2011
=750  \0$aQuartz crystal microbalances$0(DLC) sh 85109734$5IEN-M

=LDR  00593cz  a2200181n  4500
=001  9880364442002441
=005  20141212222043.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058506
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x875.$x875.$x500
=072  \\$aA18.$x400.$x500.$x299
=150  \\$aCambium
=450  \\$wnnna$aCambiums
=550  \\$wg$aMeristem
=680  \\$iA layer of living cells between the bark and hardwood that each year produces additional wood and bark cells, forming concentric growth rings.
=688  \\$a2011
=750  \0$aCambium$0(DLC) sh 85019078$5IEN-M

=LDR  00574cz  a2200193n  4500
=001  9880364442102441
=005  20141212222041.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058500
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x77
=150  \\$aAnimal Fins
=450  \\$wnnna$aAnimal Fin
=450  \\$wnnna$aFin, Animal
=450  \\$wnnna$aFins, Animal
=550  \\$wg$aAnimal Structures
=680  \\$iMembranous appendage of fish and other aquatic organisms used for locomotion or balance.
=688  \\$a2011
=750  \0$aFins (Anatomy)$0(DLC) sh 85048438$5IEN-M

=LDR  01323cz  a2200277n  4500
=001  9880364442202441
=005  20141212222040.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058496
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x281.$x900
=072  \\$aC16.$x131.$x77.$x879
=072  \\$aC16.$x131.$x260.$x887
=072  \\$aC16.$x320.$x180.$x887
=150  \\$aSmith-Magenis Syndrome
=450  \\$wnnna$a17p11.2 Monosomy
=450  \\$wnnna$aChromosome 17p11.2 Deletion Syndrome
=450  \\$wnnna$aSmith Magenis Syndrome
=450  \\$wnnna$aSyndrome, Smith-Magenis
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aChronobiology Disorders
=550  \\$aChronobiology Disorders
=680  \\$iComplex neurobehavioral disorder characterized by distinctive facial features (FACIES), developmental delay and INTELLECTUAL DISABILITY. Behavioral phenotypes include sleep disturbance, maladaptive, self-injurious and attention-seeking behaviors. The sleep disturbance is linked to an abnormal circadian secretion pattern of MELATONIN. The syndrome is associated with de novo deletion or mutation and HAPLOINSUFFICIENCY of the retinoic acid-induced 1 protein on chromosome 17p11.2.
=688  \\$a2011
=750  \0$aSmith-Magenis syndrome$0(DLC) sh2005007971$5IEN-M

=LDR  00846cz  a2200253n  4500
=001  9880364442302441
=005  20141212222039.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058493
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x797
=150  \\$aSarcophagidae
=450  \\$wnnna$aFlesh Flies
=450  \\$wnnna$aFlesh Fly
=450  \\$wnnna$aFleshflies
=450  \\$wnnna$aFleshfly
=450  \\$wnnna$aFlies, Flesh
=450  \\$wnnna$aFly, Flesh
=450  \\$aSarcophaga
=550  \\$wg$aDiptera
=667  \\$afor killing Sarcophagidae with insecticides, see note at INSECTICIDES
=680  \\$iFamily of flies in the order DIPTERA, commonly known as flesh flies. They lay their eggs in dead or decaying matter or open wounds.
=688  \\$a2011
=750  \0$aSarcophagidae$0(DLC) sh 85117515$5IEN-M

=LDR  00641cz  a2200181n  4500
=001  9880364442402441
=005  20141212222038.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x500.$x500.$x150.$x500
=072  \\$aG7.$x700.$x320.$x500.$x550.$x500.$x500.$x150.$x500
=150  \\$aMetacercariae
=550  \\$wg$aCercaria
=667  \\$ado not use / embryol with reference to metacercariae
=680  \\$iEncysted cercaria which house the intermediate stages of trematode parasites in tissues of an intermediate host.
=688  \\$a2011
=750  \0$aMetacercaria$0(DLC) sh 89001176$5IEN-M

=LDR  00608cz  a2200193n  4500
=001  9880364442502441
=005  20141212222037.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058487
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x500.$x500.$x150
=072  \\$aG7.$x700.$x320.$x500.$x550.$x500.$x500.$x150
=150  \\$aCercaria
=550  \\$wg$aLarva
=550  \\$wh$aMetacercariae
=667  \\$ado not use / embryol with reference to cercaria
=680  \\$iThe free-swimming larval forms of parasites found in an intermediate host.
=688  \\$a2011
=750  \0$aCercariae$0(DLC) sh 85022050$5IEN-M

=LDR  00896cz  a2200229n  4500
=001  9880364442602441
=005  20141212222033.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058467
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x901
=150  \\$aTardigrada
=450  \\$wnnna$aBear, Water
=450  \\$wnnna$aBears, Water
=450  \\$wnnna$aTartigrade
=450  \\$wnnna$aTartigrades
=450  \\$wnnna$aWater Bear
=450  \\$wnnna$aWater Bears
=550  \\$wg$aInvertebrates
=680  \\$iA phylum of microscopic ecdysozoan invertebrates, closely related to ARTHROPODS. Members exhibit anabiosis and cryptobiosis, dormant states where metabolic activity is reduced or absent, thus making them tolerant to extreme environmental conditions. They are distributed worldwide and most are semi-aquatic.
=688  \\$a2011
=750  \0$aTardigrada$0(DLC) sh 85132477$5IEN-M

=LDR  00543cz  a2200169n  4500
=001  9880364442702441
=005  20141212222032.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058465
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x465.$x500
=150  \\$aNitrification
=450  \\$wnnna$aNitrifications
=550  \\$wg$aNitrogen Cycle
=680  \\$iA process facilitated by specialized bacteria involving the oxidation of ammonium to nitrite and nitrate.
=688  \\$a2011
=750  \0$aNitrification$0(DLC) sh 85092051$5IEN-M

=LDR  01110cz  a2200277n  4500
=001  9880364442802441
=005  20170608152332.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058458
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x587
=072  \\$aG2.$x607.$x560
=072  \\$aG16.$x500.$x768
=150  \\$aNitrogen Cycle
=450  \\$wnnna$aCycle, Nitrogen
=450  \\$wnnna$aCycles, Nitrogen
=450  \\$wnnna$aNitrogen Cycles
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$wh$aDenitrification
=550  \\$wh$aNitrification
=550  \\$wh$aNitrogen Fixation
=680  \\$iThe circulation of nitrogen in nature, consisting of a cycle of biochemical reactions in which atmospheric nitrogen is compounded, dissolved in rain, and deposited in the soil, where it is assimilated and metabolized by bacteria and plants, eventually returning to the atmosphere by bacterial decomposition of organic matter.
=688  \\$a2011
=750  \0$aNitrogen cycle$0(DLC) sh 85092071$5IEN-M

=LDR  01661cz  a2200457n  4500
=001  9880364442902441
=005  20141212222030.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058448
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x49.$x100
=072  \\$aN6.$x230.$x124.$x49.$x100
=150  \\$aBiota
=450  \\$wnnna$aBiocenose
=450  \\$wnnna$aBiocenoses
=450  \\$wnnna$aBiological Communities
=450  \\$wnnna$aBiological Community
=450  \\$wnnna$aBiotic Communities
=450  \\$wnnna$aBiotic Community
=450  \\$wnnna$aCommunities, Biological
=450  \\$wnnna$aCommunities, Biotic
=450  \\$wnnna$aCommunities, Ecological
=450  \\$wnnna$aCommunity, Biological
=450  \\$wnnna$aCommunity, Biotic
=450  \\$aCommunity Composition, Ecological
=450  \\$wnnna$aCommunity Compositions, Ecological
=450  \\$wnnna$aCommunity, Ecological
=450  \\$aCommunity Structure, Ecological
=450  \\$wnnna$aCommunity Structures, Ecological
=450  \\$wnnna$aEcological Communities
=450  \\$wnnna$aEcological Community
=450  \\$wnnna$aEcological Community Composition
=450  \\$wnnna$aEcological Community Compositions
=450  \\$wnnna$aEcological Community Structure
=450  \\$wnnna$aEcological Community Structures
=450  \\$wnnna$aStructure, Ecological Community
=550  \\$wg$aBiodiversity
=550  \\$wh$aMicrobiota
=680  \\$iThe spectrum of different living organisms inhabiting a particular region, habitat, or biotope.
=688  \\$a2011; use BIODIVERSITY 2004-2010
=750  \0$aBiotic communities$0(DLC) sh 85014266$5IEN-M

=LDR  00667cz  a2200181n  4500
=001  9880364443002441
=005  20141212222028.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x125.$x550
=150  \\$aBullying
=450  \\$wnnna$aCyberbullying
=550  \\$wg$aAggression
=680  \\$iAggressive behavior intended to cause harm or distress. The behavior may be physical or verbal. There is typically an imbalance of power, strength, or status between the target and the aggressor.
=688  \\$a2011
=750  \0$aBullying$0(DLC) sh 89006054$5IEN-M
=750  \0$aBullies$0(DLC)sh2013002695$5IEN-M

=LDR  00812cz  a2200241n  4500
=001  9880364443102441
=005  20141212222028.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x100.$x575
=072  \\$aF1.$x470.$x132.$x225
=150  \\$aCatastrophization
=450  \\$aCatastrophizing
=450  \\$wnnna$aCatastrophizing, Pain
=450  \\$wnnna$aCatastrophizings, Pain
=450  \\$wnnna$aPain Catastrophizing
=450  \\$wnnna$aPain Catastrophizings
=550  \\$wg$aAnxiety
=550  \\$wg$aAttitude
=680  \\$iCognitive and emotional processes encompassing magnification of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation.
=688  \\$a2011
=750  \0$aCatastrophizing$0(DLC)sh2010015276$5IEN-M

=LDR  00768cz  a2200205n  4500
=001  9880364443202441
=005  20141212222028.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x630
=072  \\$aG16.$x500.$x275.$x157.$x625
=072  \\$aN6.$x230.$x124.$x437
=150  \\$aRhizosphere
=450  \\$wnnna$aRhizospheres
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aEcosystem
=680  \\$iThe immediate physical zone surrounding plant roots that include the plant roots. It is an area of intense and complex biological activity involving plants, microorganisms, other soil organisms, and the soil.
=688  \\$a2011
=750  \0$aRhizosphere$0(DLC) sh 85113717$5IEN-M

=LDR  00723cz  a2200193n  4500
=001  9880364443302441
=005  20170609104300.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058440
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x587.$x250
=072  \\$aG2.$x607.$x560.$x225
=072  \\$aG16.$x500.$x768.$x249
=150  \\$aDenitrification
=450  \\$wnnna$aDenitrifications
=550  \\$wg$aNitrogen Cycle
=680  \\$iNitrate reduction process generally mediated by anaerobic bacteria by which nitrogen available to plants is converted to a gaseous form and lost from the soil or water column. It is a part of the nitrogen cycle.
=688  \\$a2011
=750  \0$aDenitrification$0(DLC) sh 86001979$5IEN-M

=LDR  00926cz  a2200253n  4500
=001  9880364443402441
=005  20141212193142.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058439
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500.$x550
=072  \\$aG15.$x744.$x749
=150  \\$aPlant Somatic Embryogenesis Techniques
=450  \\$wnnna$aEmbryogeneses, Plant Somatic
=450  \\$wnnna$aEmbryogenesis, Plant Somatic
=450  \\$wnnna$aPlant Somatic Embryogeneses
=450  \\$wnnna$aPlant Somatic Embryogenesis
=450  \\$wnnna$aSomatic Embryogeneses, Plant
=450  \\$wnnna$aSomatic Embryogenesis, Plant
=550  \\$wg$aCulture Techniques
=550  \\$wg$aPlant Physiological Processes
=680  \\$iThe process of embryo initiation in culture from vegetative, non-gametic, sporophytic, or somatic plant cells.
=688  \\$a2011
=750  \0$aSomatic embryogenesis$0(DLC) sh 94004932$5IEN-M

=LDR  00883cz  a2200265n  4500
=001  9880364443502441
=005  20141212222027.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058438
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x340.$x950
=072  \\$aG16.$x500.$x240.$x795
=150  \\$aWater Cycle
=450  \\$wnnna$aCycle, Hydrologic
=450  \\$wnnna$aCycle, Water
=450  \\$wnnna$aCycles, Hydrologic
=450  \\$wnnna$aCycles, Water
=450  \\$wnnna$aHydrologic Cycle
=450  \\$wnnna$aHydrologic Cycles
=450  \\$wnnna$aWater Cycles
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aGeological Processes
=680  \\$iCirculation of water among various ecological systems, in various states, on, above, and below the surface of the earth.
=688  \\$a2011
=750  \0$aHydrologic cycle$0(DLC) sh 85063450$5IEN-M

=LDR  00578cz  a2200169n  4500
=001  9880364443602441
=005  20141212222026.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058436
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x480
=150  \\$aKnowledge Management
=450  \\$wnnna$aManagement, Knowledge
=550  \\$wg$aOrganization and Administration
=680  \\$iThe leveraging of collective wisdom within an organization as a catalyst to increase responsiveness and innovation.
=688  \\$a2011
=750  \0$aKnowledge management$0(DLC) sh 97007353$5IEN-M

=LDR  00549cz  a2200193n  4500
=001  9880364443702441
=005  20141212222026.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058432
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x560
=072  \\$aA19.$x800
=150  \\$aSporangia
=450  \\$aSporangium
=550  \\$wg$aFungal Structures
=550  \\$wg$aPlant Structures
=680  \\$iA structure found in plants, fungi, and algae, that produces and contains spores.
=688  \\$a2011
=750  \0$aSporangium$0(DLC) sh 85126867$5IEN-M

=LDR  00855cz  a2200181n  4500
=001  9880364443802441
=005  20141212222026.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058431
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x72
=150  \\$aBrachypodium
=450  \\$wnnna$aBrachypodium distachyon
=550  \\$wg$aPoaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family POACEAE. Brachypodium distachyon is a model species for functional genomics studies.
=688  \\$a2011
=750  \0$aBrachypodium$0(DLC) sh 88022606$5IEN-M

=LDR  00667cz  a2200193n  4500
=001  9880364443902441
=005  20141212221609.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x715.$x600
=150  \\$aPhytophthora infestans
=450  \\$wnnna$ainfestan, Phytophthora
=450  \\$wnnna$ainfestans, Phytophthora
=450  \\$wnnna$aPhytophthora infestan
=550  \\$wg$aPhytophthora
=680  \\$iA species of parasitic OOMYCETES in the family Peronosporaceae that is the causative agent of late blight of potato.
=688  \\$a2009
=750  \0$aPhytophthora infestans$0(DLC) sh 85101700$5IEN-M

=LDR  01051cz  a2200277n  4500
=001  9880364444002441
=005  20141212221607.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055745
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x411.$x125.$x500
=150  \\$aBronchioles
=450  \\$wnnna$aBronchiole
=450  \\$wnnna$aBronchiole, Respiratory
=450  \\$wnnna$aBronchiole, Terminal
=450  \\$wnnna$aBronchioles, Respiratory
=450  \\$wnnna$aBronchioles, Terminal
=450  \\$wnnna$aRespiratory Bronchiole
=450  \\$wnnna$aRespiratory Bronchioles
=450  \\$wnnna$aTerminal Bronchiole
=450  \\$wnnna$aTerminal Bronchioles
=550  \\$wg$aBronchi
=667  \\$ainflammation = BRONCHIOLITIS or specifics
=680  \\$iThe small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.
=688  \\$a2009; use BRONCHI 1984-2008
=750  \0$aBronchioles$0(DLC) sh 93006340$5IEN-M

=LDR  01455cz  a2200313n  4500
=001  9880364444102441
=005  20141212221606.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055732
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x472.$x850
=150  \\$aPulmonary Aspergillosis
=450  \\$wnnna$aAspergillose, Bronchopulmonary
=450  \\$wnnna$aAspergilloses, Bronchopulmonary
=450  \\$wnnna$aAspergilloses, Lung
=450  \\$wnnna$aAspergillosis, Bronchopulmonary
=450  \\$wnnna$aAspergillosis, Lung
=450  \\$wnnna$aAspergillosis, Pulmonary
=450  \\$wnnna$aBronchopulmonary Aspergillose
=450  \\$wnnna$aBronchopulmonary Aspergilloses
=450  \\$aBronchopulmonary Aspergillosis
=450  \\$wnnna$aLung Aspergillosis
=450  \\$wnnna$aPulmonary Aspergilloses
=550  \\$wg$aLung Diseases, Fungal
=550  \\$wh$aAspergillosis, Allergic Bronchopulmonary
=550  \\$wh$aInvasive Pulmonary Aspergillosis
=680  \\$iInfections of the respiratory tract with fungi of the genus ASPERGILLUS. Infections may result in allergic reaction (ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS), colonization in pulmonary cavities as fungus balls (MYCETOMA), or lead to invasion of the lung parenchyma (INVASIVE PULMONARY ASPERGILLOSIS).
=688  \\$a2009; for BRONCHOPULMONARY ASPERGILLOSIS use ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY 1992-2008
=750  \0$aPulmonary aspergillosis$0(DLC) sh 85108999$5IEN-M

=LDR  01202cz  a2200313n  4500
=001  9880364444202441
=005  20141212221706.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056448
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277
=150  \\$aEarth Sciences
=450  \\$wnnna$aEarth Science
=450  \\$wnnna$aGeoscience
=450  \\$wnnna$aGeosciences
=450  \\$wnnna$aScience, Earth
=450  \\$wnnna$aSciences, Earth
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aEcology
=550  \\$wh$aGeography
=550  \\$wh$aGeology
=550  \\$wh$aLimnology
=550  \\$wh$aMeteorology
=550  \\$wh$aOceanography
=550  \\$wh$aPaleontology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iFields of science encompassing studies and research from the disciplines of PHYSICS; CHEMISTRY; BIOLOGICAL SCIENCES; and MATHEMATICS; that are related to the planet EARTH. Subfields include atmospheric chemistry; CLIMATOLOGY; ENVIRONMENTAL SCIENCES; GEOGRAPHY; GEOLOGY; geophysics; METEOROLOGY; OCEANOGRAPHY; PALEONTOLOGY; mineralogy; and seismology.
=688  \\$a2010
=750  \0$aEarth sciences$0(DLC) sh 85040468$5IEN-M

=LDR  01904cz  a2200493n  4500
=001  9880364444302441
=005  20141212221605.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x190.$x636.$x765
=150  \\$aPrimary Myelofibrosis
=450  \\$wnnna$aAgnogenic Myeloid Metaplasia
=450  \\$wnnna$aAgnogenic Myeloid Metaplasias
=450  \\$wnnna$aBone Marrow Fibroses
=450  \\$wnnna$aBone Marrow Fibrosis
=450  \\$wnnna$aChronic Idiopathic Myelofibrosis
=450  \\$wnnna$aFibroses, Bone Marrow
=450  \\$wnnna$aFibrosis, Bone Marrow
=450  \\$wnnna$aIdiopathic Myelofibrosis
=450  \\$wnnna$aMetaplasia, Agnogenic Myeloid
=450  \\$wnnna$aMetaplasia, Myeloid
=450  \\$wnnna$aMetaplasias, Agnogenic Myeloid
=450  \\$wnnna$aMetaplasias, Myeloid
=450  \\$wnnna$aMyelofibroses
=450  \\$wnnna$aMyelofibroses, Primary
=450  \\$wnnna$aMyelofibrosis
=450  \\$wnnna$aMyelofibrosis, Primary
=450  \\$wnnna$aMyelofibrosis With Myeloid Metaplasia
=450  \\$wnnna$aMyeloid Metaplasia
=450  \\$wnnna$aMyeloid Metaplasia, Agnogenic
=450  \\$wnnna$aMyeloid Metaplasias
=450  \\$wnnna$aMyeloid Metaplasias, Agnogenic
=450  \\$wnnna$aMyeloscleroses
=450  \\$wnnna$aMyelosclerosis
=450  \\$wnnna$aMyeloses, Nonleukemic
=450  \\$wnnna$aMyelosis, Nonleukemic
=450  \\$wnnna$aNonleukemic Myeloses
=450  \\$wnnna$aNonleukemic Myelosis
=450  \\$wnnna$aPrimary Myelofibroses
=550  \\$wg$aMyeloproliferative Disorders
=680  \\$iA de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
=688  \\$a2009
=750  \0$aMyelofibrosis$0(DLC) sh 85089220$5IEN-M

=LDR  01593cz  a2200469n  4500
=001  9880364444402441
=005  20141212221706.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056447
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x124
=072  \\$aE2.$x831.$x83
=072  \\$aF4.$x754.$x17
=150  \\$aAnimal Assisted Therapy
=450  \\$wnnna$aAnimal Assisted Therapies
=450  \\$wnnna$aAnimal Facilitated Therapies
=450  \\$wnnna$aAnimal Facilitated Therapy
=450  \\$wnnna$aAssisted Therapies, Animal
=450  \\$wnnna$aAssisted Therapy, Animal
=450  \\$wnnna$aFacilitated Therapies, Animal
=450  \\$wnnna$aFacilitated Therapies, Pet
=450  \\$wnnna$aFacilitated Therapy, Animal
=450  \\$wnnna$aFacilitated Therapy, Pet
=450  \\$wnnna$aPet Facilitated Therapies
=450  \\$aPet Facilitated Therapy
=450  \\$wnnna$aPet Therapies
=450  \\$aPet Therapy
=450  \\$wnnna$aTherapies, Animal Assisted
=450  \\$wnnna$aTherapies, Animal Facilitated
=450  \\$wnnna$aTherapies, Pet
=450  \\$wnnna$aTherapies, Pet Facilitated
=450  \\$wnnna$aTherapy, Animal Assisted
=450  \\$wnnna$aTherapy, Animal Facilitated
=450  \\$wnnna$aTherapy, Pet
=450  \\$wnnna$aTherapy, Pet Facilitated
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aPsychotherapy
=550  \\$wg$aRehabilitation
=550  \\$wh$aEquine-Assisted Therapy
=680  \\$iThe use of live animal as a means of therapy
=688  \\$a2010
=750  \0$aPets$xTherapeutic use$0(DLC) sh 97007316$5IEN-M

=LDR  00518cz  a2200169n  4500
=001  9880364444502441
=005  20141212221702.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056352
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x72
=150  \\$aAthletes
=450  \\$wnnna$aAthlete
=550  \\$wg$aPersons
=680  \\$iIndividuals who have developed skills, physical stamina and strength or participants in SPORTS or other physical activities.
=688  \\$a2010
=750  \0$aAthletes$0(DLC) sh 85009135$5IEN-M

=LDR  00544cz  a2200181n  4500
=001  9880364444602441
=005  20141212221601.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055700
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x550.$x175
=150  \\$aCremation
=450  \\$aCremains
=450  \\$wnnna$aCremations
=550  \\$wg$aFuneral Rites
=680  \\$iReducing a dead body to ashes by burning or incineration.
=688  \\$a2009; use MORTUARY PRACTICE 1979-2008
=750  \0$aCremation$0(DLC) sh 85033903$5IEN-M

=LDR  01153cz  a2200277n  4500
=001  9880364444702441
=005  20141212221701.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056348
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x543.$x500
=150  \\$aEmotional Intelligence
=450  \\$wnnna$aEmotional Intelligences
=450  \\$wnnna$aIntelligence, Emotional
=450  \\$wnnna$aIntelligence, Social
=450  \\$wnnna$aIntelligences, Emotional
=450  \\$wnnna$aIntelligences, Social
=450  \\$aSocial Intelligence
=450  \\$wnnna$aSocial Intelligences
=550  \\$wg$aIntelligence
=550  \\$wh$aEmpathy
=550  \\$wh$aMotivation
=550  \\$aInterpersonal Relations
=680  \\$iThe ability to understand and manage emotions and to use emotional knowledge to enhance thought and deal effectively with tasks. Components of emotional intelligence include empathy, self-motivation, self-awareness, self-regulation, and social skill. Emotional intelligence is a measurement of one's ability to socialize or relate to others.
=688  \\$a2010
=750  \0$aEmotional intelligence$0(DLC) sh 99002928$5IEN-M

=LDR  00495cz  a2200169n  4500
=001  9880364444802441
=005  20141212221601.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055699
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x550.$x150.$x500
=150  \\$aCemeteries
=450  \\$wnnna$aCemetery
=550  \\$wg$aBurial
=680  \\$iAreas set apart as burial grounds.
=688  \\$a2009; use MORTUARY PRACTICE 1963-2008
=750  \0$aCemeteries$0(DLC) sh 85021756$5IEN-M

=LDR  00791cz  a2200217n  4500
=001  9880364444902441
=005  20141212193133.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x750
=072  \\$aE1.$x370.$x376.$x537.$x500
=072  \\$aE5.$x629.$x750
=150  \\$aDiffusion Tensor Imaging
=450  \\$aDiffusion Tractography
=450  \\$wnnna$aImaging, Diffusion Tensor
=450  \\$wnnna$aTractography, Diffusion
=550  \\$wg$aNeuroimaging
=680  \\$iThe use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules.
=688  \\$a2010
=750  \0$aDiffusion tensor imaging$0(DLC)sh2005006795$5IEN-M

=LDR  00930cz  a2200217n  4500
=001  9880364445002441
=005  20141212221656.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056246
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x309
=150  \\$aChemistry, Analytic
=450  \\$wnnna$aAnalytic Chemistry
=450  \\$aAnalytical Chemistry$5IEN-M
=450  \\$wnnoa$aChemistry, Analytical$5IEN-M
=550  \\$wg$aChemistry
=667  \\$athe discipline (education, history, etc) only; use CHEMISTRY TECHNIQUES, ANALYTICAL or specifics treed under it for techniques in analytical chemistry
=680  \\$iThe branch of chemistry dealing with detection (qualitative) and determination (quantitative) of substances. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a2010
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Chemistry, Analytical
=750  \0$aChemistry, Analytic$0(DLC) sh 85023011$5IEN

=LDR  00993cz  a2200313n  4500
=001  9880364445102441
=005  20141212221653.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x350.$x261
=150  \\$aMetagenomics
=450  \\$wnnna$aCommunity Genomic
=450  \\$wnnna$aCommunity Genomics
=450  \\$wnnna$aEnvironmental Genomic
=450  \\$wnnna$aEnvironmental Genomics
=450  \\$wnnna$aGenomic, Community
=450  \\$wnnna$aGenomic, Environmental
=450  \\$wnnna$aGenomic, Population
=450  \\$wnnna$aGenomics, Community
=450  \\$wnnna$aGenomics, Environmental
=450  \\$wnnna$aGenomics, Population
=450  \\$wnnna$aMetagenomic
=450  \\$wnnna$aPopulation Genomic
=450  \\$wnnna$aPopulation Genomics
=550  \\$wg$aGenomics
=680  \\$iThe genomic analysis of assemblages of organisms.
=688  \\$a2010
=750  \0$aMetagenomics$0(DLC)sh2012000572$5IEN-M

=LDR  00703cz  a2200193n  4500
=001  9880364445202441
=005  20141212221557.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x723
=150  \\$aPyricularia grisea
=450  \\$wnnna$agrisea, Pyricularia
=450  \\$wnnna$agriseas, Pyricularia
=450  \\$wnnna$aPyricularia griseas
=550  \\$wg$aMitosporic Fungi
=680  \\$iThe anamorphic form of the fungus MAGNAPORTHE GRISEA and the most important pathogen of rice worldwide. It causes rice blast which prevents maturation of the rice grains.
=688  \\$a2009
=750  \0$aPyricularia grisea$0(DLC) sh 98004804$5IEN-M

=LDR  00855cz  a2200229n  4500
=001  9880364445302441
=005  20141212221557.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055682
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x944
=150  \\$aViscoelastic Substances
=450  \\$wnnna$aFoams, Viscoelastic
=450  \\$wnnna$aSolutions, Viscoelastic
=450  \\$wnnna$aSubstances, Viscoelastic
=450  \\$wnnna$aViscoelastic Foams
=450  \\$wnnna$aViscoelastic Solutions
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aViscosupplements
=680  \\$iSubstances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner.
=688  \\$a2009
=750  \0$aViscoelastic materials$0(DLC) sh 88002557$5IEN-M

=LDR  01493cz  a2200397n  4500
=001  9880364445402441
=005  20141212221650.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x124.$x500
=072  \\$aE2.$x831.$x83.$x500
=072  \\$aF4.$x754.$x17.$x500
=150  \\$aEquine-Assisted Therapy
=450  \\$wnnna$aEquine-Assisted Psychotherapies
=450  \\$aEquine-Assisted Psychotherapy
=450  \\$wnnna$aEquine Assisted Psychotherapy
=450  \\$wnnna$aEquine-Assisted Therapies
=450  \\$wnnna$aEquine Assisted Therapy
=450  \\$wnnna$aHippotherapies
=450  \\$aHippotherapy
=450  \\$wnnna$aHorseback Riding Therapies
=450  \\$aHorseback Riding Therapy
=450  \\$wnnna$aPsychotherapies, Equine-Assisted
=450  \\$wnnna$aPsychotherapy, Equine-Assisted
=450  \\$aRecreational Horseback Riding Therapy
=450  \\$wnnna$aRiding Therapies, Horseback
=450  \\$wnnna$aRiding Therapy, Horseback
=450  \\$wnnna$aTherapies, Equine-Assisted
=450  \\$wnnna$aTherapies, Horseback Riding
=450  \\$wnnna$aTherapy, Equine-Assisted
=450  \\$wnnna$aTherapy, Horseback Riding
=550  \\$wg$aAnimal Assisted Therapy
=680  \\$iTherapy assisted by the use of a horse and/or its movement, including equine-assisted psychotherapy, horseback riding, and hippotherapy.
=688  \\$a2010
=750  \0$aHorsemanship$xTherapeutic use$0(DLC) sh 85062149$5IEN-M

=LDR  00674cz  a2200229n  4500
=001  9880364445502441
=005  20141212221555.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x249.$x820
=150  \\$aStatic Electricity
=450  \\$wnnna$aCharge, Static
=450  \\$wnnna$aCharges, Static
=450  \\$wnnna$aElectricity, Static
=450  \\$wnnna$aElectrostatics
=450  \\$wnnna$aStatic Charge
=450  \\$wnnna$aStatic Charges
=550  \\$wg$aElectricity
=680  \\$iThe accumulation of an electric charge on a object
=688  \\$a2009
=750  \0$aElectrostatics$0sh 85042463$5IEN-M

=LDR  00936cz  a2200289n  4500
=001  9880364445602441
=005  20141212221649.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056146
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x224.$x200
=072  \\$aC26.$x986.$x111
=072  \\$aI1.$x198.$x240.$x194
=150  \\$aCorpse Dismemberment
=450  \\$wnnna$aCadaver Dismemberment
=450  \\$wnnna$aCadaver Dismemberments
=450  \\$wnnna$aCorpse Dismemberments
=450  \\$wnnna$aDismemberment, Cadaver
=450  \\$wnnna$aDismemberment, Corpse
=450  \\$wnnna$aDismemberments, Cadaver
=450  \\$wnnna$aDismemberments, Corpse
=550  \\$wg$aCadaver
=550  \\$wg$aCrime
=550  \\$wg$aWounds, Penetrating
=680  \\$iDisjoining the limbs or other parts of a corpse, often in association with criminal acts.
=688  \\$a2010
=750  \0$aDismemberment$0(DLC)sh2003011358$5IEN-M

=LDR  00783cz  a2200241n  4500
=001  9880364445702441
=005  20141212221649.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x750.$x249
=072  \\$aH1.$x277.$x249.$x750.$x249
=072  \\$aH1.$x277.$x625.$x500
=150  \\$aFreshwater Biology
=450  \\$wnnna$aBiology, Fresh Water
=450  \\$wnnna$aBiology, Freshwater
=450  \\$wnnna$aFresh Water Biology
=550  \\$wg$aHydrobiology
=550  \\$wg$aLimnology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of life and ECOLOGIC SYSTEMS in bodies of FRESHWATER.
=688  \\$a2010
=750  \0$aFreshwater biology$0(DLC) sh 85051943$5IEN-M

=LDR  00993cz  a2200241n  4500
=001  9880364445802441
=005  20141212221554.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055670
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x585.$x700
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x700
=150  \\$aMedicine, Korean Traditional
=450  \\$wnnna$aKorea Traditional Medicine
=450  \\$wnnna$aKorean Traditional Medicine
=450  \\$wnnna$aMedicine, Korea Traditional
=450  \\$aTraditional Medicine, Korea
=450  \\$wnnna$aTraditional Medicine, Korean
=550  \\$wg$aMedicine, East Asian Traditional
=667  \\$afor hand acupuncture (Koryo Sooji Chim) in Korean traditional medicine index ACUPUNCTURE THERAPY + HAND + MEDICINE, KOREAN TRADITIONAL
=680  \\$iMedical practice or discipline that is based on the knowledge, cultures, and beliefs of the people of KOREA.
=688  \\$a2009
=750  \0$aMedicine, Korean$0(DLC) sh 85083149$5IEN-M

=LDR  00919cz  a2200265n  4500
=001  9880364445902441
=005  20141212221649.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056130
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x650.$x240
=072  \\$aG8.$x686.$x785.$x760.$x310.$x249
=072  \\$aG15.$x744.$x149
=150  \\$aGametogenesis, Plant
=450  \\$wnnna$aAntheridiogenesis
=450  \\$wnnna$aMegasporogenesis
=450  \\$wnnna$aMicrosporogenesis
=450  \\$wnnna$aPlant Gametogenesis
=450  \\$wnnna$aPlant Spermatogenesis
=450  \\$wnnna$aSpermatogenesis, Plant
=550  \\$wg$aGametogenesis
=550  \\$wg$aPlant Physiological Processes
=680  \\$iThe process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.
=688  \\$a2010
=750  \0$aSpermatogenesis in plants$0(DLC) sh 85126543$5IEN-M

=LDR  01114cz  a2200301n  4500
=001  9880364446002441
=005  20141212221552.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055656
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x668.$x778
=150  \\$aPrescriptions
=450  \\$wnnna$aNon-Drug Prescription
=450  \\$wnnna$aNon-Drug Prescriptions
=450  \\$wnnna$aNondrug Prescription
=450  \\$wnnna$aNondrug Prescriptions
=450  \\$wnnna$aPrescription
=450  \\$wnnna$aPrescription, Non-Drug
=450  \\$wnnna$aPrescription, Nondrug
=450  \\$wnnna$aPrescriptions, Non-Drug
=450  \\$wnnna$aPrescriptions, Non Drug
=450  \\$wnnna$aPrescriptions, Nondrug
=550  \\$wg$aPharmaceutical Services
=550  \\$wh$aDrug Prescriptions
=550  \\$wh$aElectronic Prescribing
=680  \\$iDirections written for the obtaining and use of PHARMACEUTICAL PREPARATIONS; MEDICAL DEVICES; corrective LENSES; and a variety of other medical remedies.
=688  \\$a2009, 1963-1977
=750  \0$aMedicine$vFormulae, receipts, prescriptions$0(DLC) sh 85083077$5IEN-M

=LDR  00992cz  a2200277n  4500
=001  9880364446102441
=005  20141212221648.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056127
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x750
=072  \\$aH1.$x277.$x249.$x750
=150  \\$aHydrobiology
=450  \\$wnnna$aAquatic Biology
=450  \\$wnnna$aAquatic Ecology
=450  \\$wnnna$aBiology, Aquatic
=450  \\$wnnna$aEcology, Aquatic
=550  \\$wg$aEcology
=550  \\$wh$aFreshwater Biology
=550  \\$wh$aMarine Biology
=550  \\$aAquaculture
=550  \\$aLimnology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of aquatic life inhabiting bodies of water, including growth, morphology, physiology, genetics, distribution, and interactions with other organisms and the environment. It includes MARINE HYDROBIOLOGY.
=688  \\$a2010
=750  \0$aAquatic biology$0(DLC) sh 85006231$5IEN-M

=LDR  00999cz  a2200265n  4500
=001  9880364446202441
=005  20141212221647.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x774.$x860.$x619
=150  \\$aOrchiopexy
=450  \\$wnnna$aLaparoscopic Orchiopexies
=450  \\$aLaparoscopic Orchiopexy
=450  \\$wnnna$aOrchidopexies
=450  \\$aOrchidopexy
=450  \\$wnnna$aOrchiopexies
=450  \\$wnnna$aOrchiopexies, Laparoscopic
=450  \\$wnnna$aOrchiopexy, Laparoscopic
=550  \\$wg$aUrologic Surgical Procedures, Male
=550  \\$aOrchiectomy
=667  \\$acheck tags MALE & ANIMALS or HUMAN.
=680  \\$iA surgical procedure in which an undescended testicle is sutured inside the SCROTUM in male infants or children to correct CRYPTORCHIDISM. Orchiopexy is also performed to treat TESTICULAR TORSION in adults and adolescents.
=688  \\$a2010
=750  \0$aOrchiopexy$0(DLC) sh 85095340$5IEN-M

=LDR  00899cz  a2200217n  4500
=001  9880364084702441
=005  20141212212643.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x625.$x249
=072  \\$aG15.$x744.$x300
=150  \\$aGermination
=450  \\$wnnna$aGerminations
=550  \\$wg$aPlant Development
=550  \\$wg$aPlant Physiological Processes
=550  \\$wh$aPlant Dormancy
=550  \\$aSeedling
=680  \\$iThe initial stages of the growth of SEEDS into a SEEDLING. The embryonic shoot (plumule) and embryonic PLANT ROOTS (radicle) emerge and grow upwards and downwards respectively. Food reserves for germination come from endosperm tissue within the seed and/or from the seed leaves (COTYLEDON). (Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aGermination$5IEN-M$0(DLC)sh 85054682

=LDR  00801cz  a2200241n  4500
=001  9880364084802441
=005  20141212212629.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018478
=035  \\$aCSK5623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285.$x850.$x400
=150  \\$aExtravehicular Activity
=450  \\$wnnna$aActivity, Extravehicular
=450  \\$aEVA
=450  \\$aSpace-Walk
=450  \\$wnnna$aSpace Walk
=450  \\$wnnna$aSpace-Walks
=550  \\$wg$aSpace Flight
=667  \\$aactivity of crew members outside a spacecraft; /adv eff /physiol permitted; DF: note short X ref
=680  \\$iActivities by crew members conducted outside the pressurized hull of a spacecraft.
=688  \\$a95
=750  \2$aExtravehicular activity (Manned space flight)$5IEN-M

=LDR  00967cz  a2200217n  4500
=001  9880364084902441
=005  20141212212651.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018553
=035  \\$aCSK5620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x188.$x666
=072  \\$aJ2.$x500.$x850.$x250
=150  \\$aCucumis sativus
=450  \\$aCucumbers
=550  \\$wg$aCucumis
=550  \\$wg$aVegetables
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA creeping annual plant species of the CUCURBITACEAE family. It has a rough succulent, trailing stem and hairy leaves with three to five pointed lobes.
=688  \\$a2002(1995)
=750  \0$aCucumbers$5IEN-M$0(DLC)sh 85034673

=LDR  00696cz  a2200229n  4500
=001  9880364085002441
=005  20141212212652.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018556
=035  \\$aCSK5619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x510.$x344
=072  \\$aJ2.$x500.$x300
=150  \\$aCrops, Agricultural
=450  \\$wnnna$aAgricultural Crop
=450  \\$aAgricultural Crops
=550  \\$wg$aFood
=550  \\$wg$aPlants, Edible
=550  \\$wh$aAnimal Feed
=680  \\$iCultivated plants or agricultural produce such as grain, vegetables, or fruit. (From American Heritage Dictionary, 1982)
=688  \\$a95
=750  \0$aCrops$5IEN-M$0(DLC)sh 85034249

=LDR  00777cz  a2200181n  4500
=001  9880364085102441
=005  20141212212630.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018481
=035  \\$aCSK5617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x230
=150  \\$aConvection
=550  \\$wg$aThermodynamics
=667  \\$aa principle of thermodynamics; no qualif
=680  \\$iTransmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed)
=688  \\$a95
=750  \0$aHeat$xConvection$5IEN-M$0(DLC)sh 85059761

=LDR  01066cz  a2200229n  4500
=001  9880364085202441
=005  20141212212651.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018552
=035  \\$aCSK5616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x288
=072  \\$aJ2.$x500.$x850.$x311
=150  \\$aDaucus carota
=450  \\$wnnna$aCarrot
=450  \\$aCarrots
=550  \\$wg$aApiaceae
=550  \\$wg$aVegetables
=667  \\$aX ref SOLANUM LYCOPERSICUM: SOLANUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family APIACEAE that is widely cultivated for the edible yellow-orange root. The plant has finely divided leaves and flat clusters of small white flowers.
=688  \\$a2003(1995)
=750  \0$aCarrots$5IEN-M$0(DLC)sh 85020481

=LDR  00686cz  a2200193n  4500
=001  9880364085302441
=005  20141212212646.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018533
=035  \\$aCSK5614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x100
=072  \\$aN6.$x230.$x124.$x100
=150  \\$aBiomass
=450  \\$wnnna$aBiomasses
=550  \\$wg$aEcosystem
=680  \\$iTotal mass of all the organisms of a given type and/or in a given area. (From Concise Dictionary of Biology, 1990) It includes the yield of vegetative mass produced from any given crop.
=688  \\$a95; was see ECOLOGY 1982-94
=750  \0$aBiomass$5IEN-M$0(DLC)sh 90000612

=LDR  00666cz  a2200205n  4500
=001  9880364085402441
=005  20141212212629.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018480
=035  \\$aCSK5613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x770.$x100
=150  \\$aAstronauts
=450  \\$aCosmonauts
=550  \\$wg$aResearch Personnel
=550  \\$aSpace Flight
=667  \\$afor crew or travelers
=680  \\$iMembers of spacecraft crew including those who travel in space, and those in training for space flight. (From Webster, 10th ed; Jane's Aerospace Dictionary, 3d ed)
=688  \\$a95
=750  \0$aAstronauts$5IEN-M$0(DLC)sh 85008988

=LDR  01269cz  a2200349n  4500
=001  9880364085502441
=005  20141212212746.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018718
=035  \\$aCSK5612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x444
=072  \\$aN2.$x421.$x143.$x524.$x436
=150  \\$aHome Infusion Therapy
=450  \\$wnnna$aHome Infusion Therapies
=450  \\$wnnna$aInfusion Therapies, Home
=450  \\$wnnna$aInfusion Therapies, Outpatient
=450  \\$aInfusion Therapy, Home
=450  \\$wnnna$aInfusion Therapy, Outpatient
=450  \\$wnnna$aOutpatient Infusion Therapies
=450  \\$aOutpatient Infusion Therapy
=450  \\$wnnna$aTherapies, Home Infusion
=450  \\$wnnna$aTherapies, Outpatient Infusion
=450  \\$aTherapy, Home Infusion
=450  \\$wnnna$aTherapy, Outpatient Infusion
=550  \\$wg$aDrug Therapy
=550  \\$wg$aHome Care Services
=550  \\$aInfusions, Parenteral
=667  \\$aIM; coord with specific type of infusion or infusion ther (IM); DF: HOME INFUSION THER
=680  \\$iUse of any infusion therapy on an ambulatory, outpatient, or other non-institutionalized basis.
=688  \\$a95
=750  \0$aHome drug infusion therapy$5IEN-M$0(DLC)sh 94001175

=LDR  01151cz  a2200265n  4500
=001  9880364085602441
=005  20141212212822.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018846
=035  \\$aCSK5610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x427
=150  \\$aExcitatory Amino Acids
=450  \\$wnnna$aAcid, Excitatory Amino
=450  \\$wnnna$aAcids, Excitatory Amino
=450  \\$wnnna$aAmino Acid, Excitatory
=450  \\$aAmino Acids, Excitatory
=450  \\$wnnna$aExcitatory Amino Acid
=550  \\$wg$aAmino Acids
=550  \\$wh$aAspartic Acid
=550  \\$wh$aGlutamic Acid
=667  \\$aendogenous: do not confuse with EXCITATORY AMINO ACID AGENTS which are exogenous; GEN or unspecified; prefer specifics; DF: EXCITATORY AA
=680  \\$iEndogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.
=688  \\$a95
=750  \0$aExcitatory amino acids$0(DLC) sh 88004079$5IEN-M

=LDR  01590cz  a2200373n  4500
=001  9880364085702441
=005  20190419105815.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018691
=035  \\$aCSK5605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x190.$x300
=072  \\$aD27.$x505.$x696.$x577.$x190.$x300
=150  \\$aExcitatory Amino Acid Antagonists
=450  \\$wnnna$aAmino Acid Antagonists, Excitatory
=450  \\$aAmino Acids, Excitatory, Antagonists
=450  \\$wnnna$aAntagonists, EAA
=450  \\$wnnna$aAntagonists, Excitatory Amino Acid
=450  \\$wnnna$aAntagonists, Glutamate
=450  \\$wnnna$aAntagonists, Glutamate Receptor
=450  \\$wnnna$aEAA Antagonists
=450  \\$aGlutamate Antagonists
=450  \\$wnnna$aGlutamate Receptor Antagonists
=450  \\$aGlutamates$xantagonists & inhibitors
=450  \\$aGlutamic Acid$xantagonists & inhibitors
=450  \\$wnnna$aReceptor Antagonists, Glutamate
=450  \\$aReceptors, Glutamate$xantagonists & inhibitors
=550  \\$wg$aExcitatory Amino Acid Agents
=667  \\$aGEN or unspecified; prefer specifics; DF: EAA ANTAG
=680  \\$iDrugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aExcitatory amino acids$0(DLC)sh 88004079$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAntagonists$0(DLC)sh 99002348$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aExcitatory amino acids--Antagonists$5IEN-M

=LDR  01615cz  a2200409n  4500
=001  9880364085802441
=005  20190419105750.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018690
=035  \\$aCSK5604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x190.$x200
=072  \\$aD27.$x505.$x696.$x577.$x190.$x200
=150  \\$aExcitatory Amino Acid Agonists
=450  \\$wnnna$aAgonist, EAA
=450  \\$wnnna$aAgonist, Glutamate
=450  \\$wnnna$aAgonists, EAA
=450  \\$wnnna$aAgonists, Excitatory Amino Acid
=450  \\$wnnna$aAgonists, Glutamate
=450  \\$wnnna$aAmino Acid Agonist, Excitatory
=450  \\$wnnna$aAmino Acid Agonists, Excitatory
=450  \\$aAmino Acids, Excitatory, Agonists
=450  \\$wnnna$aEAA Agonist
=450  \\$wnnna$aEAA Agonists
=450  \\$wnnna$aExcitatory Amino Acid Agonist
=450  \\$wnnna$aGlutamate Agonist
=450  \\$aGlutamate Agonists
=450  \\$aGlutamates$xagonists
=450  \\$aGlutamic Acid$xagonists
=450  \\$aReceptors, Glutamate$xagonists
=550  \\$wg$aExcitatory Amino Acid Agents
=667  \\$anote X ref GLUTAMATE AGONISTS: do not coord with GLUTAMATES; GEN or unspecified; prefer specifics; DF: EAA AG
=680  \\$iDrugs that bind to and activate excitatory amino acid receptors.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aExcitatory amino acids$0(DLC)sh 88004079$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAgonists$0(DLC)sh 99002380$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aExcitatory amino acids--Agonists$5IEN-M

=LDR  01271cz  a2200373n  4500
=001  9880364085902441
=005  20141212212805.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018794
=035  \\$aCSK5602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x720
=072  \\$aI2.$x158.$x660
=072  \\$aI2.$x903.$x565
=150  \\$aProblem-Based Learning
=450  \\$aActive Learning
=450  \\$wnnna$aCurricula, Problem-Based
=450  \\$aCurriculum, Problem-Based
=450  \\$wnnna$aCurriculum, Problem Based
=450  \\$aExperiential Learning
=450  \\$wnnna$aLearning, Active
=450  \\$wnnna$aLearning, Experiential
=450  \\$wnnna$aLearning, Problem-Based
=450  \\$wnnna$aProblem-Based Curricula
=450  \\$wnnna$aProblem Based Curricula
=450  \\$wnnna$aProblem-Based Curriculum
=450  \\$wnnna$aProblem Based Learning
=550  \\$wg$aCurriculum
=550  \\$wg$aLearning
=550  \\$wg$aTeaching
=667  \\$aa teaching method in the curriculum: do not confuse with PROBLEM SOLVING, a type of learning
=680  \\$iInstructional use of examples or cases to teach using problem-solving skills and critical thinking.
=688  \\$a95
=750  \0$aActive learning$5IEN-M$0(DLC)sh 92000622

=LDR  01323cz  a2200373n  4500
=001  9880364086002441
=005  20141212212739.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018698
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x67.$x625.$x349
=072  \\$aD12.$x125.$x119.$x409.$x349
=072  \\$aD12.$x125.$x427.$x300
=150  \\$aGlutamic Acid
=450  \\$aAluminum L-Glutamate
=450  \\$wnnna$aAluminum L Glutamate
=450  \\$wnnna$aD-Glutamate
=450  \\$wnnna$aD Glutamate
=450  \\$aGlutamate
=450  \\$wnnna$aGlutamate, Potassium
=450  \\$wnnna$aGlutamic Acid, (D)-Isomer
=450  \\$wnnna$aL-Glutamate
=450  \\$wnnna$aL Glutamate
=450  \\$wnnna$aL-Glutamate, Aluminum
=450  \\$wnnna$aL-Glutamic Acid
=450  \\$wnnna$aL Glutamic Acid
=450  \\$aPotassium Glutamate
=550  \\$wg$aExcitatory Amino Acids
=550  \\$wg$aGlutamates
=550  \\$wh$aSodium Glutamate
=680  \\$iA non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.
=688  \\$a1995; for POTASSIUM GLUTAMATE and ALUMINUM L-GLUTAMATE use GLUTAMATES 1995-2013
=688  \\$a95; was GLUTAMIC ACID (NM) 1981-94
=750  \0$aGlutamic acid$5IEN-M$0(DLC)sh 85055379

=LDR  01704cz  a2200337n  4500
=001  9880364086102441
=005  20141212212634.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018492
=035  \\$aCSK5595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x150.$x175
=072  \\$aD27.$x505.$x696.$x577.$x150.$x175
=150  \\$aDopamine Antagonists
=450  \\$wnnna$aAntagonists, Dopamine
=450  \\$wnnna$aAntagonists, Dopamine Receptor
=450  \\$wnnna$aAntagonists, Dopaminergic
=450  \\$wnnna$aBlockers, Dopamine
=450  \\$aDopamine$xantagonists & inhibitors
=450  \\$wnnna$aDopamine Blockers
=450  \\$aDopamine Receptor Antagonists
=450  \\$aDopaminergic Antagonists
=450  \\$wnnna$aReceptor Antagonists, Dopamine
=450  \\$aReceptors, Dopamine$xantagonists & inhibitors
=550  \\$wg$aDopamine Agents
=550  \\$wh$aDopamine D2 Receptor Antagonists
=550  \\$aAntipsychotic Agents
=667  \\$aDF: DOPAMINE ANTAG
=680  \\$iDrugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.
=688  \\$a95
=750  \0$aDopamine$xAntagonists$5IEN$0(DLC)sh 90004348

=LDR  01283cz  a2200265n  4500
=001  9880364086202441
=005  20190419141514.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018733
=035  \\$aCSK5593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x200.$x700
=072  \\$aD27.$x505.$x696.$x577.$x120.$x200.$x700
=150  \\$aNicotinic Antagonists
=450  \\$wnnna$aAntagonists, Nicotinic
=450  \\$aReceptors, Nicotinic$xantagonists & inhibitors
=550  \\$wg$aCholinergic Antagonists
=550  \\$aGanglionic Blockers
=550  \\$aNeuromuscular Nondepolarizing Agents
=667  \\$aGEN or unspecified; prefer specifics; DF: NICOTINIC ANTAG
=680  \\$iDrugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aNicotine$0(DLC)sh 85091817$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAntagonists$0(DLC)sh 99002348$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNicotine--Antagonists$5IEN-M

=LDR  01025cz  a2200301n  4500
=001  9880364086302441
=005  20141212212801.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018784
=035  \\$aCSK5592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x25.$x20
=150  \\$aAbdominal Abscess
=450  \\$wnnna$aAbdominal Abscesses
=450  \\$aAbscess, Abdominal
=450  \\$aAbscess, Intra-Abdominal
=450  \\$wnnna$aAbscess, Intra Abdominal
=450  \\$wnnna$aAbscesses, Abdominal
=450  \\$wnnna$aAbscesses, Intra-Abdominal
=450  \\$wnnna$aIntra-Abdominal Abscess
=450  \\$wnnna$aIntra-Abdominal Abscesses
=550  \\$wg$aAbscess
=550  \\$wh$aLiver Abscess
=550  \\$wh$aSubphrenic Abscess
=667  \\$afor coord read note on ABSCESS
=680  \\$iAn abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed)
=688  \\$a95
=750  \0$aAbdomen$xAbscess$0(DLC) sh 85000092$5IEN-M

=LDR  01101cz  a2200253n  4500
=001  9880364086402441
=005  20141212212739.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018697
=035  \\$aCSK5591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x637
=150  \\$aNootropic Agents
=450  \\$wnnna$aAgents, Nootropic
=450  \\$aCognitive Enhancers
=450  \\$wnnna$aDrugs, Nootropic
=450  \\$wnnna$aEnhancers, Cognitive
=450  \\$wnnna$aNootropic Drugs
=450  \\$wnnna$aNootropics
=550  \\$wg$aCentral Nervous System Agents
=667  \\$aCNS agents; from Greek nous, mind; GEN or unspecified: prefer specifics
=680  \\$iDrugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.
=688  \\$a95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94
=750  \0$aNootropic agents$5IEN-M$0(DLC)sh 91003114

=LDR  01354cz  a2200301n  4500
=001  9880364086502441
=005  20141212212739.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018696
=035  \\$aCSK5590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x706.$x548
=072  \\$aD27.$x505.$x954.$x427.$x575
=150  \\$aNeuroprotective Agents
=450  \\$wnnna$aAgents, Neuroprotective
=450  \\$wnnna$aDrugs, Neuroprotective
=450  \\$wnnna$aEffect, Neuroprotective
=450  \\$wnnna$aEffects, Neuroprotective
=450  \\$wnnna$aNeuroprotectants
=450  \\$wnnna$aNeuroprotective Drugs
=450  \\$wnnna$aNeuroprotective Effect
=450  \\$wnnna$aNeuroprotective Effects
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aProtective Agents
=667  \\$anote entry term NEUROPROTECTIVE EFFECT: use only for the neuroprotective effect of a chemical substance
=680  \\$iDrugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
=688  \\$a95
=750  \0$aNeuroprotective agents$0(DLC)sh2007004834$5IEN-M

=LDR  02492cz  a2200625n  4500
=001  9880364086602441
=005  20141212212724.0
=008  940527\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018653
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x188.$x500
=150  \\$aJuniperus
=450  \\$aCade
=450  \\$wnnna$aCades
=450  \\$wnnna$aCedar, Eastern Red
=450  \\$aCedar, Red Eastern
=450  \\$aCedar, Western
=450  \\$wnnna$aCedars, Eastern Red
=450  \\$wnnna$aCedars, Red Eastern
=450  \\$wnnna$aCedars, Western
=450  \\$wnnna$aCommon Juniper
=450  \\$wnnna$aCommon Junipers
=450  \\$wnnna$acommuni, Juniperus
=450  \\$wnnna$acommunis, Juniperus
=450  \\$wnnna$aEastern Cedar, Red
=450  \\$wnnna$aEastern Cedars, Red
=450  \\$wnnna$aEastern Red Cedar
=450  \\$wnnna$aEastern Red Cedars
=450  \\$aJuniper
=450  \\$wnnna$aJuniper, Common
=450  \\$wnnna$aJunipers
=450  \\$wnnna$aJunipers, Common
=450  \\$wnnna$aJuniperus communi
=450  \\$wnnna$aJuniperus communis
=450  \\$wnnna$aJuniperus occidentali
=450  \\$wnnna$aJuniperus occidentalis
=450  \\$wnnna$aJuniperus oxycedrus
=450  \\$wnnna$aJuniperus virginiana
=450  \\$wnnna$aJuniperus virginianas
=450  \\$wnnna$aoccidentali, Juniperus
=450  \\$wnnna$aoccidentalis, Juniperus
=450  \\$wnnna$aoxycedrus, Juniperus
=450  \\$wnnna$aRed Cedar, Eastern
=450  \\$wnnna$aRed Cedars, Eastern
=450  \\$wnnna$aRed Eastern Cedar
=450  \\$wnnna$aRed Eastern Cedars
=450  \\$wnnna$avirginiana, Juniperus
=450  \\$wnnna$avirginianas, Juniperus
=450  \\$wnnna$aWestern Cedar
=450  \\$wnnna$aWestern Cedars
=550  \\$wg$aCupressaceae
=667  \\$anote X refs WESTERN CEDAR and EASTERN RED CEDAR: check text to distinguish from other cedar terms in MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUPRESSACEAE. The species are slow growing coniferous evergreen trees or shrubs.
=688  \\$a1995, 1963-1985; use TREES 1986-1994; for JUNIPERUS OXYCEDRUS use JUNIPERUS OXYCEDRUS (NM) 1998-2001
=750  \0$aJunipers$5IEN-M$0(DLC)sh 85071044

=LDR  01399cz  a2200361n  4500
=001  9880364086802441
=005  20141212212659.0
=008  940527\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018578
=035  \\$aCSK5587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x458
=072  \\$aN4.$x452.$x442.$x530
=072  \\$aN4.$x452.$x758.$x275
=072  \\$aN4.$x452.$x822.$x379
=150  \\$aHospital-Physician Relations
=450  \\$wnnna$aHospital-Physician Relation
=450  \\$wnnna$aHospital Physician Relations
=450  \\$wnnna$aPhysician-Hospital Relation
=450  \\$aPhysician-Hospital Relations
=450  \\$wnnna$aPhysician Hospital Relations
=450  \\$wnnna$aRelation, Hospital-Physician
=450  \\$wnnna$aRelation, Physician-Hospital
=450  \\$wnnna$aRelations, Hospital-Physician
=450  \\$wnnna$aRelations, Physician-Hospital
=550  \\$wg$aHospital Administration
=550  \\$wg$aProfessional Practice
=550  \\$wg$aPublic Relations
=550  \\$wh$aMedical Staff Privileges
=667  \\$ano qualif; DF: HOSP PHYSICIAN RELAT
=680  \\$iIncludes relationships between hospitals, their governing boards, and administrators in regard to physicians, whether or not the physicians are members of the medical staff or have medical staff privileges.
=688  \\$a95
=750  \0$aHospital-physician relations$5IEN-M$0(DLC)sh 90003577

=LDR  01292cz  a2200385n  4500
=001  9880364086902441
=005  20141212212731.0
=008  940531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018673
=035  \\$aCSK5586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x400.$x650
=072  \\$aI1.$x880.$x604.$x825.$x608.$x400.$x650
=072  \\$aN3.$x623.$x500.$x608.$x428.$x650
=150  \\$aNutrition Policy
=450  \\$wnnna$aDietary Guideline
=450  \\$wnnna$aDietary Guidelines
=450  \\$wnnna$aFood Policies
=450  \\$aFood Policy
=450  \\$wnnna$aGuideline, Dietary
=450  \\$wnnna$aGuideline, Nutrition
=450  \\$wnnna$aGuidelines, Dietary
=450  \\$wnnna$aGuidelines, Nutrition
=450  \\$wnnna$aNutrition Guideline
=450  \\$wnnna$aNutrition Guidelines
=450  \\$wnnna$aNutrition Policies
=450  \\$wnnna$aPolicies, Food
=450  \\$wnnna$aPolicies, Nutrition
=450  \\$wnnna$aPolicy, Food
=450  \\$wnnna$aPolicy, Nutrition
=550  \\$wg$aHealth Policy
=550  \\$wh$aRecommended Dietary Allowances
=680  \\$iGuidelines and objectives pertaining to food supply and nutrition including recommendations for healthy diet.
=688  \\$a95
=750  \0$aNutrition policy$5IEN-M$0(DLC)sh 85093473

=LDR  01633cz  a2200481n  4500
=001  9880364087002441
=005  20180829110538.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018805
=035  \\$aCSK5580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x757
=072  \\$aC16.$x614
=072  \\$aC23.$x550.$x470.$x790.$x500
=150  \\$aSepsis
=450  \\$wnnna$aBlood Poisoning
=450  \\$wnnna$aBlood Poisonings
=450  \\$wnnna$aPoisoning, Blood
=450  \\$wnnna$aPoisonings, Blood
=450  \\$aPyaemia
=450  \\$wnnna$aPyaemias
=450  \\$aPyemia
=450  \\$wnnna$aPyemias
=450  \\$aPyohemia
=450  \\$wnnna$aPyohemias
=450  \\$wnnna$aSepsis, Severe
=450  \\$wnnna$aSepticemia
=450  \\$wnnna$aSepticemias
=450  \\$wnnna$aSevere Sepsis
=550  \\$wg$aInfection
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aSystemic Inflammatory Response Syndrome
=550  \\$wh$aBacteremia
=550  \\$wh$aFungemia
=550  \\$wh$aNeonatal Sepsis
=550  \\$wh$aParasitemia
=550  \\$wh$aShock, Septic
=550  \\$wh$aViremia
=667  \\$aSEPSIS SYNDROME see SYSTEMIC INFLAMMATORY RESPONSE SYNDROME is also available
=680  \\$iSystemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
=688  \\$a1995
=688  \\$a95
=750  \0$aSepticemia$0(DLC) sh 85120119$5IEN-M

=LDR  01535cz  a2200277n  4500
=001  9880364087102441
=005  20141212212748.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018732
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x400
=072  \\$aI1.$x198.$x780.$x750
=150  \\$aForensic Anthropology
=450  \\$aAnthropology, Forensic
=450  \\$aHuman Identification
=450  \\$wnnna$aHuman Identifications
=450  \\$wnnna$aIdentification, Human
=450  \\$wnnna$aIdentifications, Human
=550  \\$wg$aAnthropology, Physical
=550  \\$wg$aForensic Sciences
=550  \\$aBiometric Identification
=550  \\$aExhumation
=667  \\$arestrict to identif of skeletal remains; SPEC; NIM as coord; human identif by teeth: coord FORENSIC DENTISTRY (IM) + specific dent heading (IM); DF: FORENSIC ANTHROPOL
=680  \\$iScientific study of human skeletal remains with the express purpose of identification. This includes establishing individual identity, trauma analysis, facial reconstruction, photographic superimposition, determination of time interval since death, and crime-scene recovery. Forensic anthropologists do not certify cause of death but provide data to assist in determination of probable cause. This is a branch of the field of physical anthropology and qualified individuals are certified by the American Board of Forensic Anthropology. (From Am J Forensic Med Pathol 1992 Jun;13(2):146)
=688  \\$a95
=750  \0$aForensic anthropology$5IEN-M$0(DLC)sh 85050537

=LDR  01366cz  a2200397n  4500
=001  9880364087202441
=005  20141212212753.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018753
=035  \\$aCSK5573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x280
=072  \\$aG7.$x610.$x240.$x280
=150  \\$aDiet, Protein-Restricted
=450  \\$aDiet, Low-Protein
=450  \\$wnnna$aDiet, Low Protein
=450  \\$aDiet, Protein-Free
=450  \\$wnnna$aDiet, Protein Free
=450  \\$wnnna$aDiet, Protein Restricted
=450  \\$wnnna$aDiets, Low-Protein
=450  \\$wnnna$aDiets, Protein-Free
=450  \\$wnnna$aDiets, Protein-Restricted
=450  \\$aLow-Protein Diet
=450  \\$wnnna$aLow Protein Diet
=450  \\$wnnna$aLow-Protein Diets
=450  \\$wnnna$aProtein-Free Diet
=450  \\$wnnna$aProtein-Free Diets
=450  \\$aProtein-Restricted Diet
=450  \\$wnnna$aProtein Restricted Diet
=450  \\$wnnna$aProtein-Restricted Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=667  \\$aIM; coord with dis /diet ther (IM)
=680  \\$iA diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a95
=750  \0$aLow-protein diet$5IEN-M$0(DLC)sh 85078648

=LDR  01621cz  a2200433n  4500
=001  9880364087302441
=005  20141212212754.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x240.$x200
=072  \\$aD27.$x505.$x696.$x577.$x240.$x200
=150  \\$aGABA Agonists
=450  \\$wnnna$aAcid Agonist, gamma-Aminobutyric
=450  \\$wnnna$aAcid Agonists, gamma-Aminobutyric
=450  \\$wnnna$aAgonist, GABA
=450  \\$wnnna$aAgonist, GABA Receptor
=450  \\$wnnna$aAgonist, gamma-Aminobutyric Acid
=450  \\$wnnna$aAgonists, GABA
=450  \\$wnnna$aAgonists, GABA Receptor
=450  \\$wnnna$aAgonists, gamma-Aminobutyric Acid
=450  \\$wnnna$aGABA Agonist
=450  \\$wnnna$aGABA Receptor Agonist
=450  \\$wnnna$aGABA Receptor Agonists
=450  \\$wnnna$agamma-Aminobutyric Acid Agonist
=450  \\$wnnna$agamma Aminobutyric Acid Agonist
=450  \\$agamma-Aminobutyric Acid Agonists
=450  \\$wnnna$agamma Aminobutyric Acid Agonists
=450  \\$agamma-Aminobutyric Acid$xagonists
=450  \\$wnnna$aReceptor Agonist, GABA
=450  \\$wnnna$aReceptor Agonists, GABA
=450  \\$aReceptors, GABA$xagonists
=550  \\$wg$aGABA Agents
=550  \\$wh$aGABA-A Receptor Agonists
=550  \\$wh$aGABA-B Receptor Agonists
=667  \\$anote specifics; do not confuse with GABA ANTAGONISTS
=680  \\$iEndogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA).
=688  \\$a95
=750  \0$aGABA$xAgonists$5IEN$0(DLC)sh 85052648

=LDR  01373cz  a2200373n  4500
=001  9880364087402441
=005  20141212212633.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018491
=035  \\$aCSK5566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x150.$x151
=072  \\$aD27.$x505.$x696.$x577.$x150.$x151
=150  \\$aDopamine Agonists
=450  \\$wnnna$aAgonist, Dopamine
=450  \\$wnnna$aAgonist, Dopamine Receptor
=450  \\$wnnna$aAgonist, Dopaminergic
=450  \\$wnnna$aAgonists, Dopamine
=450  \\$wnnna$aAgonists, Dopamine Receptor
=450  \\$wnnna$aAgonists, Dopaminergic
=450  \\$wnnna$aDopamine Agonist
=450  \\$aDopamine$xagonists
=450  \\$wnnna$aDopamine Receptor Agonist
=450  \\$aDopamine Receptor Agonists
=450  \\$wnnna$aDopaminergic Agonist
=450  \\$aDopaminergic Agonists
=450  \\$wnnna$aReceptor Agonist, Dopamine
=450  \\$wnnna$aReceptor Agonists, Dopamine
=450  \\$aReceptors, Dopamine$xagonists
=550  \\$wg$aDopamine Agents
=667  \\$aGEN or unspecified; prefer specifics; DF: DOPAMINE AGON or DOPAMINE AG
=680  \\$iDrugs that bind to and activate dopamine receptors.
=688  \\$a95; DOPAMINE AGONISTS & DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94
=750  \0$aDopamine$xAgonists$5IEN-M$0(DLC)sh 85039076

=LDR  01278cz  a2200337n  4500
=001  9880364087502441
=005  20190422141721.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018679
=035  \\$aCSK5565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x140
=072  \\$aD27.$x505.$x696.$x577.$x120.$x140
=150  \\$aCholinergic Agonists
=450  \\$wnnna$aAcetylcholine Agonist
=450  \\$aAcetylcholine Agonists
=450  \\$wnnna$aAgonist, Acetylcholine
=450  \\$wnnna$aAgonist, Cholinergic
=450  \\$wnnna$aAgonists, Acetylcholine
=450  \\$wnnna$aAgonists, Cholinergic
=450  \\$wnnna$aCholinergic Agonist
=450  \\$aReceptors, Cholinergic$xagonists
=550  \\$wg$aCholinergic Agents
=550  \\$wh$aMuscarinic Agonists
=550  \\$wh$aNicotinic Agonists
=667  \\$aGEN or unspecified; prefer specifics; DF: CHOLINERGIC AGON or CHOLINERGIC AG
=680  \\$iDrugs that bind to and activate cholinergic receptors.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aAcetylcholine$0(DLC)sh 85000467$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAgonists$0(DLC)sh 99002380$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAcetylcholine--Agonists$5IEN-M

=LDR  01115cz  a2200277n  4500
=001  9880364087602441
=005  20141212212555.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018376
=035  \\$aCSK5564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240
=072  \\$aC16.$x131.$x240
=150  \\$aCardiovascular Abnormalities
=450  \\$wnnna$aAbnormalities, Cardiovascular
=450  \\$wnnna$aAbnormality, Cardiovascular
=450  \\$wnnna$aCardiovascular Abnormality
=450  \\$aCardiovascular System$xabnormalities
=550  \\$wg$aCardiovascular Diseases
=550  \\$wg$aCongenital Abnormalities
=550  \\$wh$aHeart Defects, Congenital
=550  \\$wh$aVascular Malformations
=667  \\$ageneral or unspecified; prefer specifics, particularly HEART DEFECTS, CONGENITAL, or specific cardiovascular term /abnorm; DF: CARDIOVASC ABNORM
=680  \\$iCongenital, inherited, or acquired anomalies of the CARDIOVASCULAR SYSTEM, including the HEART and BLOOD VESSELS.
=688  \\$a98; use explode 1995-97
=750  \0$aCardiovascular system$xAbnormalities$5IEN-M$0(DLC)sh 85020227

=LDR  01074cz  a2200241n  4500
=001  9880364087702441
=005  20141212212806.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018796
=035  \\$aCSK5562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x580
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x580
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x580
=150  \\$aImmunoconjugates
=450  \\$wnnna$aImmunoconjugate
=450  \\$wnnna$aRadioimmunoconjugate
=450  \\$aRadioimmunoconjugates
=550  \\$wg$aAntibodies
=550  \\$wh$aImmunotoxins
=680  \\$iCombinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.
=688  \\$a95
=750  \0$aAntibody-toxin conjugates$5IEN-M$0(DLC)sh 87005963

=LDR  00760cz  a2200193n  4500
=001  9880364087802441
=005  20141212212706.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018597
=035  \\$aCSK5448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x188.$x715
=150  \\$aSaints
=450  \\$wnnna$aSaint
=550  \\$wg$aChristianity
=667  \\$aIM; coord with RELIGION AND MEDICINE (IM) if pertinent + specific med aspect (IM); TN H: form of Saint names as subject name
=680  \\$iPersons officially recognized or acknowledged as pre-eminent for consecration, holiness, and piety, especially through canonization by a branch of the Christian church. (From Webster, 3d ed)
=688  \\$a95
=750  \0$aSaints$5IEN-M$0(DLC)sh 85116629

=LDR  00910cz  a2200181n  4500
=001  9880364087902441
=005  20141212212705.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018595
=035  \\$aCSK5447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696.$x116
=150  \\$aColonialism
=550  \\$wg$aPolitical Systems
=667  \\$aIM; specify geog & hist period
=680  \\$iThe aggregate of various economic, political, and social policies by which an imperial power maintains or extends its control over other areas or peoples. It includes the practice of or belief in acquiring and retaining colonies. The emphasis is less on its identity as an ideological political system than on its designation in a period of history. (Webster, 3d ed; from Dr. J. Cassedy, NLM History of Medicine Division)
=688  \\$a95; was see POLITICAL SYSTEMS 1990-94
=750  \0$aColonies$5IEN-M$0(DLC)sh 85028562

=LDR  01465cz  a2200409n  4500
=001  9880364088002441
=005  20141212212642.0
=008  940524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018521
=035  \\$aCSK5444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15
=150  \\$aPlant Physiological Phenomena
=450  \\$wnnna$aPhenomena, Plant Physiologic
=450  \\$wnnna$aPhenomena, Plant Physiological
=450  \\$wnnna$aPhenomenon, Plant Physiologic
=450  \\$wnnna$aPhysiologic Phenomena, Plant
=450  \\$wnnna$aPhysiologic Phenomenon, Plant
=450  \\$wnnna$aPhysiological Phenomena, Plant
=450  \\$wnnna$aPhysiology, Plant
=450  \\$wnnna$aPlant Physiologic Phenomena
=450  \\$wnnna$aPlant Physiologic Phenomenon
=450  \\$wnnna$aPlant Physiological Phenomenon
=450  \\$aPlant Physiology
=450  \\$aPlants$xphysiology
=550  \\$wh$aOrganogenesis, Plant
=550  \\$wh$aPlant Diseases
=550  \\$wh$aPlant Immunity
=550  \\$wh$aPlant Infertility
=550  \\$wh$aPlant Physiological Processes
=550  \\$wh$aSeed Dispersal
=667  \\$ageneral or unspecified; prefer specifics; DF: PLANT PHYSIOL
=680  \\$iThe physiological processes, properties, and states characteristic of plants.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Plant Physiology
=688  \\$a98; use explode 1995-97
=750  \0$aPlant physiology$0(DLC) sh 85102796$5IEN-M

=LDR  00678cz  a2200229n  4500
=001  9880364088102441
=005  20141212212751.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018745
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x365
=150  \\$aGenome, Plant
=450  \\$wnnna$aGenomes, Plant
=450  \\$aPlant Genome
=450  \\$wnnna$aPlant Genomes
=550  \\$wg$aGenome
=550  \\$wh$aGenes, Plant
=550  \\$aGenes, Plant
=667  \\$acoordinate IM with specific plant /genet (IM)
=680  \\$iThe genetic complement of a plant (PLANTS) as represented in its DNA.
=688  \\$a95
=750  \0$aPlant genomes$5IEN-M$0(DLC)sh2003004669

=LDR  00710cz  a2200217n  4500
=001  9880364088202441
=005  20141212212746.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018724
=035  \\$aCSK5432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x800
=072  \\$aJ2.$x500.$x850.$x800
=150  \\$aSpinacia oleracea
=450  \\$aSpinach
=550  \\$wg$aChenopodiaceae
=550  \\$wg$aVegetables
=667  \\$aas plant & food;
=680  \\$iA widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. (From American Heritage Dictionary, 1982)
=688  \\$a2005(1995)
=750  \0$aSpinach$0(DLC) sh 85126659$5IEN-M

=LDR  01277cz  a2200277n  4500
=001  9880364088302441
=005  20141212212717.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018631
=035  \\$aCSK5422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x330.$x300.$x400.$x500
=072  \\$aD12.$x644.$x360.$x525.$x500
=072  \\$aD12.$x776.$x157.$x325.$x515.$x500
=072  \\$aD12.$x776.$x476.$x525.$x500
=150  \\$aras Proteins
=450  \\$aGene Products, ras
=450  \\$wnnna$aras Gene Products
=550  \\$wg$aMonomeric GTP-Binding Proteins
=550  \\$wh$aOncogene Protein p21(ras)
=550  \\$wh$aProto-Oncogene Proteins p21(ras)
=550  \\$aGenes, ras
=667  \\$aras derived from "Rat Sarcoma"
=680  \\$iSmall, monomeric GTP-binding proteins encoded by ras genes (GENES, RAS). The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21(RAS), plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein (ONCOGENE PROTEIN P21(RAS)) can play a role in aberrant cellular regulation during neoplastic cell transformation (CELL TRANSFORMATION, NEOPLASTIC). This enzyme was formerly listed as EC 3.6.1.47.
=688  \\$a95
=750  \0$aRas proteins$5IEN-M$0(DLC)sh 93000043

=LDR  01036cz  a2200205n  4500
=001  9880364088402441
=005  20141212212723.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018652
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x388
=150  \\$aHemlock
=450  \\$wnnna$aHemlocks
=550  \\$wg$aApiaceae
=550  \\$wh$aCicuta
=550  \\$wh$aConium
=667  \\$afor hemlock tree use TSUGA; GEN or unspecified; prefer specifics: CONIUM or CICUTA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAny of several poisonous plants, commonly called poison hemlock, of the CICUTA or CONIUM genus. The hemlock tree (TSUGA) is completely unrelated being a coniferous tree of the pine family.
=688  \\$a95
=750  \0$aPoison hemlock$0(DLC)sh2007000033$5IEN-M

=LDR  00927cz  a2200217n  4500
=001  9880364088502441
=005  20141212212711.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018614
=035  \\$aCSK5418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x119.$x344.$x672
=150  \\$aSweating Sickness
=450  \\$aEnglish Sweating Sickness
=450  \\$wnnna$aSickness, Sweating
=450  \\$aSudor Anglicus
=550  \\$wg$aFever
=667  \\$aa hist epidemic dis
=680  \\$iA clinical condition characterized by fever and profuse sweating and associated with high mortality. It occurred in epidemic form five times in the fifteenth and sixteenth centuries in England, first in 1485 and last in 1551, specially during the summer and early autumn, attacking the relatively affluent adult male population. The etiology was unknown.
=688  \\$a95
=750  \0$aSweating-sickness$5IEN-M$0(DLC)sh 85131030

=LDR  00993cz  a2200193n  4500
=001  9880364088602441
=005  20141212212707.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018602
=035  \\$aCSK5416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x756.$x600
=150  \\$aMilk Sickness
=450  \\$wnnna$aSickness, Milk
=550  \\$wg$aPlant Poisoning
=667  \\$aa form of plant pois: see MeSH definition
=680  \\$iAn acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot (Eupatorium rugosum) and the rayless goldenrod (Haplopappus heterophyllus). (From Dorland, 27th ed)
=688  \\$a95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67
=750  \0$aMilk sickness$5IEN-M$0(DLC)sh 85085364

=LDR  01166cz  a2200313n  4500
=001  9880364088702441
=005  20141212212705.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018594
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x560
=072  \\$aK1.$x93.$x378
=150  \\$aHuman Body
=450  \\$wnnna$aBodies, Human
=450  \\$aBody, Human
=450  \\$wnnna$aBody Parts
=450  \\$wnnna$aBody Parts and Fluids
=450  \\$wnnna$aFigure, Human
=450  \\$wnnna$aFigures, Human
=450  \\$wnnna$aHuman Bodies
=450  \\$aHuman Figure
=450  \\$wnnna$aHuman Figures
=450  \\$wnnna$aParts, Body
=550  \\$wg$aArt
=550  \\$wg$aCulture
=667  \\$athe human body as a whole, viewed from an artistic, cultural, historical, or social perspective; no qualif
=680  \\$iThe human being as a non-anatomical and non-zoological entity. The emphasis is on the philosophical or artistic treatment of the human being, and includes lay and social attitudes toward the body in history. (From J. Cassedy, NLM History of Medicine Division)
=688  \\$a95
=750  \0$aHuman body$5IEN-M$0(DLC)sh 85015222

=LDR  00920cz  a2200205n  4500
=001  9880364088802441
=005  20141212212705.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018596
=035  \\$aCSK5414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x231
=150  \\$aHinduism
=450  \\$wnnna$aEthics, Hindu
=450  \\$wnnna$aHindu Ethics
=550  \\$wg$aReligion
=667  \\$aIM; specify geog if pertinent
=680  \\$iA complex body of social, cultural, and religious beliefs and practices evolved in and largely confined to the Indian subcontinent and marked by a caste system, an outlook tending to view all forms and theories as aspects of one eternal being and truth, and the practice of the way of works, the way of knowledge, or the way of devotion as a means of release from the round of rebirths. (From Webster, 3d ed)
=688  \\$a95
=750  \0$aHinduism$5IEN-M$0(DLC)sh 85060932

=LDR  01450cz  a2200361n  4500
=001  9880364088902441
=005  20190520161157.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018528
=035  \\$aCSK5413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x100
=072  \\$aD12.$x776.$x395.$x550.$x20
=072  \\$aD12.$x776.$x543.$x550.$x192
=072  \\$aD12.$x776.$x543.$x585.$x100
=150  \\$aATP-Binding Cassette Transporters
=450  \\$aABC Transporters
=450  \\$wnnna$aATP Binding Cassette Transporters
=450  \\$wnnna$aTransporters, ABC
=450  \\$wnnna$aTransporters, ATP-Binding Cassette
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wg$aMembrane Transport Proteins
=550  \\$wh$aATP Binding Cassette Transporter 1
=550  \\$wh$aATP Binding Cassette Transporter, Sub-Family B
=550  \\$wh$aATP Binding Cassette Transporter, Sub-Family G
=550  \\$wh$aMultidrug Resistance-Associated Proteins
=550  \\$wh$aSulfonylurea Receptors
=550  \\$aAdrenoleukodystrophy
=550  \\$aCongenital Hyperinsulinism
=550  \\$aNesidioblastosis
=680  \\$iA family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.
=688  \\$a2002(1995)
=750  \0$aATP-binding cassette transporters$0(DLC) sh2004000512$5IEN-M

=LDR  00852cz  a2200241n  4500
=001  9880364089002441
=005  20141212212753.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018754
=035  \\$aCSK5411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x945
=150  \\$aVentricular Dysfunction
=450  \\$wnnna$aDysfunction, Ventricular
=450  \\$wnnna$aDysfunctions, Ventricular
=450  \\$wnnna$aVentricular Dysfunctions
=550  \\$wg$aHeart Diseases
=550  \\$wh$aVentricular Dysfunction, Left
=550  \\$wh$aVentricular Dysfunction, Right
=667  \\$ageneral or unspecified: prefer VENTRICULAR DYSFUNCTION, LEFT or VENTRICULAR DYSFUNCTION, RIGHT
=680  \\$iA condition in which HEART VENTRICLES exhibit impaired function.
=688  \\$a95
=750  \0$aHeart$xVentricles$xDiseases$5IEN-M$0(DLC)sh 85059732

=LDR  01027cz  a2200229n  4500
=001  9880364089102441
=005  20141212212635.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018497
=035  \\$aCSK5410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x945.$x910
=150  \\$aVentricular Dysfunction, Right
=450  \\$wnnna$aDysfunction, Right Ventricular
=450  \\$wnnna$aDysfunctions, Right Ventricular
=450  \\$aRight Ventricular Dysfunction
=450  \\$wnnna$aRight Ventricular Dysfunctions
=450  \\$wnnna$aVentricular Dysfunctions, Right
=550  \\$wg$aVentricular Dysfunction
=680  \\$iA condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.
=688  \\$a95
=750  \0$aHeart$xRight ventricle$xDiseases$5IEN-HS

=LDR  01059cz  a2200241n  4500
=001  9880364089202441
=005  20141212212632.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018487
=035  \\$aCSK5409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x945.$x900
=150  \\$aVentricular Dysfunction, Left
=450  \\$wnnna$aDysfunction, Left Ventricular
=450  \\$wnnna$aDysfunctions, Left Ventricular
=450  \\$aLeft Ventricular Dysfunction
=450  \\$wnnna$aLeft Ventricular Dysfunctions
=450  \\$wnnna$aVentricular Dysfunctions, Left
=550  \\$wg$aVentricular Dysfunction
=550  \\$wh$aTakotsubo Cardiomyopathy
=680  \\$iA condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
=688  \\$a95
=750  \0$aHeart$xLeft ventricle$xDiseases$5IEN-M

=LDR  00847cz  a2200241n  4500
=001  9880364089302441
=005  20141212212620.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018452
=035  \\$aCSK5402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x975.$x500.$x400
=072  \\$aG8.$x686.$x867.$x500.$x400
=150  \\$aHomosexuality, Female
=450  \\$wnnna$aFemale Homosexuality
=450  \\$wnnna$aLesbian
=450  \\$aLesbianism
=450  \\$wnnna$aLesbians
=550  \\$wg$aHomosexuality
=667  \\$acheck tag FEMALE
=680  \\$iSexual attraction or relationship between females.
=688  \\$a95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, & was see under HOMOSEXUALITY 1968-75
=750  \0$aLesbianism$5IEN-M$0(DLC)sh 85076157

=LDR  00600cz  a2200205n  4500
=001  9880364089402441
=005  20141212212702.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018586
=035  \\$aCSK5401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65.$x900.$x205
=150  \\$aBone Banks
=450  \\$wnnna$aBank, Bone
=450  \\$wnnna$aBanks, Bone
=450  \\$wnnna$aBone Bank
=550  \\$wg$aTissue Banks
=680  \\$iCenters for acquiring, characterizing, and storing bones or bone tissue for future use.
=688  \\$a95
=750  \0$aBone banks$5IEN-M$0(DLC)sh 85015515

=LDR  01531cz  a2200313n  4500
=001  9880364089502441
=005  20141212212717.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018630
=035  \\$aCSK5400HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x890
=072  \\$aC11.$x975
=150  \\$aVitreoretinopathy, Proliferative
=450  \\$wnnna$aInflammatories, Vitreoretinopathy Neovascular
=450  \\$wnnna$aInflammatory, Vitreoretinopathy Neovascular
=450  \\$wnnna$aNeovascular Inflammatories, Vitreoretinopathy
=450  \\$wnnna$aNeovascular Inflammatory, Vitreoretinopathy
=450  \\$wnnna$aProliferative Vitreoretinopathies
=450  \\$wnnna$aProliferative Vitreoretinopathy
=450  \\$wnnna$aVitreoretinopathies, Proliferative
=450  \\$wnnna$aVitreoretinopathy Neovascular Inflammatories
=450  \\$wnnna$aVitreoretinopathy Neovascular Inflammatory
=550  \\$wg$aEye Diseases
=550  \\$wg$aRetinal Diseases
=667  \\$ashrinkage of vitreoretinal membrane after prolif of retinal pigment cells
=680  \\$iVitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
=688  \\$a95
=750  \0$aProliferative vitreoretinopathy$5IEN-M$0(DLC)sh 88004091

=LDR  00848cz  a2200265n  4500
=001  9880364089602441
=005  20141212212611.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018420
=035  \\$aCSK5399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x735.$x50
=150  \\$aApe Diseases
=450  \\$wnnna$aApe Disease
=450  \\$wnnna$aDisease, Ape
=450  \\$wnnna$aDisease, Pongidae
=450  \\$wnnna$aDiseases, Ape
=450  \\$wnnna$aDiseases, Pongidae
=450  \\$wnnna$aPongidae Disease
=450  \\$wnnna$aPongidae Diseases
=550  \\$wg$aPrimate Diseases
=667  \\$acoordinate IM with specific ape (IM) or with HOMINIDAE (NIM) if ape is not specified + specific disease /vet; DF: APE DIS
=680  \\$iDiseases of chimpanzees, gorillas, and orangutans.
=688  \\$a95
=750  \0$aApes$xDiseases$5IEN-M

=LDR  00802cz  a2200193n  4500
=001  9880364089702441
=005  20141212212719.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018635
=035  \\$aCSK5398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x100.$x350
=150  \\$aRescue Work
=450  \\$wnnna$aWork, Rescue
=550  \\$wg$aDisasters
=667  \\$anot restricted to med emerg; not restricted to organized services
=680  \\$iActivities devoted to freeing persons or animals from danger to life or well-being in accidents, fires, bombings, floods, earthquakes, other disasters and life-threatening conditions. While usually performed by team efforts, rescue work is not restricted to organized services.
=688  \\$a95
=750  \0$aRescue work$5IEN-M$0(DLC)sh 85113019

=LDR  00602cz  a2200205n  4500
=001  9880364089802441
=005  20161115140431.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018451
=035  \\$aCSK5395HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x975.$x500.$x600
=072  \\$aG8.$x686.$x867.$x500.$x600
=150  \\$aHomosexuality, Male
=450  \\$wnnna$aMale Homosexuality
=550  \\$wg$aHomosexuality
=667  \\$acheck tag MALE
=680  \\$iSexual attraction or relationship between males.
=688  \\$a95
=750  \0$aMale homosexuality$5IEN-M$0(DLC)sh 85061786

=LDR  00757cz  a2200217n  4500
=001  9880364089902441
=005  20141212212624.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018460
=035  \\$aCSK5394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x186
=150  \\$aFractures, Comminuted
=450  \\$wnnna$aComminuted Fracture
=450  \\$wnnna$aComminuted Fractures
=450  \\$wnnna$aFracture, Comminuted
=550  \\$wg$aFractures, Bone
=667  \\$afract where bone is splintered or crushed; IM; coord with specific organ/inj or precoord organ/fract term (IM)
=680  \\$iA fracture in which the bone is splintered or crushed. (Dorland, 27th ed)
=688  \\$a95
=750  \0$aComminuted fractures$0(DLC)sh2008009877$5IEN-M

=LDR  01302cz  a2200241n  4500
=001  9880364090002441
=005  20141212212556.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018380
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x225.$x687.$x500
=150  \\$aHematopoietic Stem Cell Transplantation
=450  \\$aHematopoietic Stem Cells$xtransplantation
=450  \\$aStem Cell Transplantation, Hematopoietic
=450  \\$wnnna$aTransplantation, Hematopoietic Stem Cell
=550  \\$wg$aStem Cell Transplantation
=550  \\$aBone Marrow Purging
=550  \\$aBone Marrow Transplantation
=550  \\$aHematopoietic Stem Cell Mobilization
=667  \\$aconditioning before transpl of hematopoietic stem cells: coord IM with TRANSPLANTATION CONDITIONING (IM)
=680  \\$iTransfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
=688  \\$a95; was HEMATOPOIETIC STEM CELLS/transplantation 1971-94
=750  \0$aHematopoietic stem cells$xTransplantation$5IEN-M$0(DLC)sh2008121541

=LDR  00884cz  a2200241n  4500
=001  9880364090102441
=005  20141212212609.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018411
=035  \\$aCSK5392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x561.$x650.$x700
=150  \\$aSpodoptera
=450  \\$wnnna$afrugiperda, Spodoptera
=450  \\$wnnna$afrugiperdas, Spodoptera
=450  \\$aSpodoptera frugiperda
=450  \\$wnnna$aSpodoptera frugiperdas
=450  \\$wnnna$aSpodopteras
=550  \\$wg$aMoths
=667  \\$aa genus of moths; /microbiol /parasitol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle.
=688  \\$a95
=750  \0$aSpodoptera$5IEN-M$0(DLC)sh 85126838

=LDR  00852cz  a2200277n  4500
=001  9880364090202441
=005  20141212212605.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018397
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x709.$x235
=150  \\$aEquidae
=450  \\$wnnna$aAss
=450  \\$aAsses
=450  \\$wnnna$aDonkey
=450  \\$aDonkeys
=450  \\$wnnna$aEquus asinus
=450  \\$wnnna$aMule
=450  \\$aMules
=450  \\$wnnna$aZebra
=450  \\$aZebras
=550  \\$wg$aPerissodactyla
=550  \\$wh$aHorses
=680  \\$iA family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.
=688  \\$a95
=750  \0$aEquidae$5IEN-M$0(DLC)sh 85044536

=LDR  00964cz  a2200205n  4500
=001  9880364090402441
=005  20141212212637.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018502
=035  \\$aCSK5385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x225
=072  \\$aB3.$x510.$x550.$x737.$x872.$x225
=150  \\$aStreptococcus equi
=450  \\$aStreptococcus zooepidemicus
=550  \\$wg$aStreptococcus
=667  \\$ainfection: coord IM with STREPTOCOCCAL INFECTIONS (IM); DF: STREP EQUI
=680  \\$iA species of gram-positive, coccoid bacteria isolated from abscesses in submaxillary glands and mucopurulent discharges of the upper respiratory tract of horses. This organism belongs to Group C streptococci with regards to antigen response and is known to cause strangles. The subspecies S. zooepidemicus is also considered a pathogen of horses.
=688  \\$a95
=750  \0$aStreptococcus equi$5IEN-M$0(DLC)sh 85128681

=LDR  01378cz  a2200313n  4500
=001  9880364090502441
=005  20141212212709.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018608
=035  \\$aCSK5380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x850
=150  \\$aUltrasonography, Doppler
=450  \\$aDoppler Ultrasonography
=450  \\$wnnna$aDoppler Ultrasound Imaging
=450  \\$wnnna$aDoppler Ultrasound Imagings
=450  \\$wnnna$aImaging, Doppler Ultrasound
=450  \\$wnnna$aImagings, Doppler Ultrasound
=450  \\$wnnna$aUltrasound Imaging, Doppler
=450  \\$wnnna$aUltrasound Imagings, Doppler
=550  \\$wg$aUltrasonography
=550  \\$wh$aEchocardiography, Doppler
=550  \\$wh$aUltrasonography, Doppler, Duplex
=550  \\$wh$aUltrasonography, Doppler, Pulsed
=550  \\$wh$aUltrasonography, Doppler, Transcranial
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iUltrasonography applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. (Stedman, 25th ed)
=688  \\$a95
=750  \0$aDoppler ultrasonography$5IEN-M$0(DLC)sh 86006173

=LDR  00818cz  a2200205n  4500
=001  9880364090602441
=005  20141212212638.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018506
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x375
=150  \\$aGene Expression Regulation, Plant
=450  \\$aPlant Gene Expression Regulation
=450  \\$wnnna$aRegulation, Gene Expression, Plant
=450  \\$aRegulation of Gene Expression, Plant
=550  \\$wg$aGene Expression Regulation
=667  \\$acoord IM with specific plant /genet (IM); DF: GENE EXPRESSION REG PLANT
=680  \\$iAny of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants.
=688  \\$a95
=750  \0$aPlant genetic regulation$5IEN-M$0(DLC)sh 90005025

=LDR  01225cz  a2200265n  4500
=001  9880364090702441
=005  20141212212612.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018421
=035  \\$aCSK5376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x125
=072  \\$aE4.$x928.$x220.$x220
=150  \\$aCardiomyoplasty
=450  \\$wnnna$aCardiomyoplasties
=450  \\$wnnna$aCardiomyoplasties, Dynamic
=450  \\$aCardiomyoplasty, Dynamic
=450  \\$wnnna$aDynamic Cardiomyoplasties
=450  \\$aDynamic Cardiomyoplasty
=550  \\$wg$aCardiac Surgical Procedures
=550  \\$aSkeletal Muscle Ventricle
=667  \\$aa technique in heart surg using autol skeletal muscle
=680  \\$iAn operation that uses stimulated latissimus dorsi muscle (SKELETAL MUSCLE VENTRICLE) to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. (Stedman, 26th ed)
=688  \\$a95
=750  \0$aCardiomyoplasty$5IEN-M$0(DLC)sh 86006014

=LDR  01472cz  a2200289n  4500
=001  9880364090802441
=005  20141212212615.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018434
=035  \\$aCSK5375HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x475.$x730
=072  \\$aN5.$x715.$x360.$x300.$x375.$x375.$x730
=072  \\$aN6.$x850.$x520.$x308.$x250.$x475.$x730
=150  \\$aSickness Impact Profile
=450  \\$wnnna$aImpact Profile, Sickness
=450  \\$wnnna$aImpact Profiles, Sickness
=450  \\$wnnna$aProfile, Sickness Impact
=450  \\$wnnna$aProfiles, Sickness Impact
=450  \\$wnnna$aSickness Impact Profiles
=550  \\$wg$aHealth Status Indicators
=550  \\$aActivities of Daily Living
=550  \\$aQuality of Life
=667  \\$aa health status indicator
=680  \\$iA quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient's perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. (From Medical Care, vol.xix, no.8, August 1981, p.787-805)
=688  \\$a95
=750  \0$aSickness Impact Profile$5IEN-M$0(DLC)sh 86002094

=LDR  01152cz  a2200277n  4500
=001  9880364090902441
=005  20141212212558.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018385
=035  \\$aCSK5372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x585.$x160
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x820.$x500.$x500
=150  \\$aCentrosome
=450  \\$wnnna$aCentrosomes
=450  \\$aPericentriolar Region
=450  \\$wnnna$aPericentriolar Regions
=450  \\$wnnna$aRegion, Pericentriolar
=450  \\$wnnna$aRegions, Pericentriolar
=550  \\$wg$aMicrotubule-Organizing Center
=550  \\$wg$aSpindle Poles
=550  \\$wh$aCentrioles
=550  \\$aSpindle Apparatus
=680  \\$iThe cell center, consisting of a pair of CENTRIOLES surrounded by a cloud of amorphous material called the pericentriolar region. During interphase, the centrosome nucleates microtubule outgrowth. The centrosome duplicates and, during mitosis, separates to form the two poles of the mitotic spindle (MITOTIC SPINDLE APPARATUS).
=688  \\$a95
=750  \0$aCentrosomes$5IEN-M$0(DLC)sh 85021958

=LDR  01691cz  a2200469n  4500
=001  9880364091002441
=005  20170607114825.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018407
=035  \\$aCSK5366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x99
=150  \\$aBacterial Physiological Phenomena
=450  \\$aBacteria$xphysiology
=450  \\$wnnoa$aBacterial Phenomena$5IEN
=450  \\$wnnna$aBacterial Physiological Concept
=450  \\$wnnna$aBacterial Physiological Concepts
=450  \\$wnnna$aBacterial Physiological Phenomenon
=450  \\$aBacterial Physiology
=450  \\$wnnna$aBacterial Process
=450  \\$wnno$aBacterial Processes
=450  \\$wnnna$aConcept, Bacterial Physiological
=450  \\$wnnna$aConcepts, Bacterial Physiological
=450  \\$wnnna$aPhenomena, Bacterial Physiological
=450  \\$wnnna$aPhenomenon, Bacterial Physiological
=450  \\$wnnna$aPhysiology, Bacterial
=450  \\$wnnna$aProcess, Bacterial
=450  \\$wnnna$aProcesses, Bacterial
=550  \\$wg$aMicrobiological Phenomena
=550  \\$wh$aBacterial Adhesion
=550  \\$wh$aBacterial Load
=550  \\$wh$aBacterial Translocation
=550  \\$wh$aBacteriolysis
=550  \\$wh$aDrug Resistance, Bacterial
=550  \\$wh$aTransformation, Bacterial
=550  \\$wh$aViral Tropism
=667  \\$ageneral or unspecified; prefer specifics; DF: BACT PHYSIOL
=680  \\$iPhysiological processes and properties of BACTERIA.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Bacterial Physiology
=688  \\$a98; use explode 1995-97
=750  \0$aBacteria$xPhysiology$0(DLC) sh 85010820$5IEN-M

=LDR  00898cz  a2200217n  4500
=001  9880364091102441
=005  20141212212603.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018392
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x203.$x500
=150  \\$aGenomic Imprinting
=450  \\$aGenetic Imprinting
=450  \\$wnnna$aImprinting, Genetic
=450  \\$wnnna$aImprinting, Genomic
=450  \\$wnnna$aImprinting, Parental
=450  \\$aParental Imprinting
=550  \\$wg$aEpigenesis, Genetic
=680  \\$iThe variable phenotypic expression of a GENE depending on whether it is of paternal or maternal origin, which is a function of the DNA METHYLATION pattern. Imprinted regions are observed to be more methylated and less transcriptionally active. (Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a95
=750  \0$aGenomic imprinting$5IEN-M$0(DLC)sh 95000173

=LDR  00852cz  a2200241n  4500
=001  9880364091202441
=005  20141212212602.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018390
=035  \\$aCSK5363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x335
=150  \\$aGene Targeting
=450  \\$wnnna$aGene Targetings
=450  \\$wnnna$aTargeting, Gene
=450  \\$wnnna$aTargetings, Gene
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aGene Knock-In Techniques
=550  \\$wh$aGene Knockdown Techniques
=550  \\$wh$aGene Knockout Techniques
=680  \\$iThe integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination.
=688  \\$a95
=750  \0$aGene targeting$0(DLC) sh 97003192$5IEN-M

=LDR  01041cz  a2200253n  4500
=001  9880364091302441
=005  20141212212611.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018419
=035  \\$aCSK5360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x735
=150  \\$aPrimate Diseases
=450  \\$wnnna$aDisease, Primate
=450  \\$wnnna$aDiseases, Primate
=450  \\$wnnna$aPrimate Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aApe Diseases
=550  \\$wh$aMonkey Diseases
=550  \\$wh$aMonkeypox
=667  \\$aanimal only, not man; GEN or unspecified; prefer specifics; coord IM with specific dis /vet (IM); for abnormalities or injuries, index under specific primate heading /abnorm or /inj; don't forget also PRIMATES (NIM) if no specific primate is indexed; also check tag ANIMALS; DF: PRIMATE DIS
=680  \\$iDiseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.
=688  \\$a95
=750  \0$aPrimates$xDiseases$5IEN-M$0(DLC)sh 85106671

=LDR  01003cz  a2200265n  4500
=001  9880364091402441
=005  20141212212618.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018448
=035  \\$aCSK5358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395.$x500
=150  \\$aModels, Immunological
=450  \\$wnnna$aImmunologic Model
=450  \\$wnnna$aImmunologic Models
=450  \\$wnnna$aImmunological Model
=450  \\$aImmunological Models
=450  \\$wnnna$aModel, Immunologic
=450  \\$wnnna$aModel, Immunological
=450  \\$wnnna$aModels, Immunologic
=550  \\$wg$aModels, Biological
=667  \\$ano qualif; TN 128: definition of MODELS, BIOLOGICAL; DF: MODELS IMMUNOL
=680  \\$iTheoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
=688  \\$a95
=750  \0$aImmunology$xMathematical models$5IEN-M

=LDR  00974cz  a2200265n  4500
=001  9880364091502441
=005  20141212212552.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018360
=035  \\$aCRE7270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x309.$x742.$x225
=150  \\$aCrystallography, X-Ray
=450  \\$wnnna$aCrystallographies, X Ray
=450  \\$wnnna$aCrystallography, X Ray
=450  \\$wnnna$aCrystallography, Xray
=450  \\$wnnna$aX Ray Crystallographies
=450  \\$wnnna$aX Ray Crystallography
=450  \\$aX-Ray Crystallography
=450  \\$wnnna$aXray Crystallography
=550  \\$wg$aX-Ray Diffraction
=667  \\$astudy of crystal struct using x-ray diffraction; NIM; DF: CRYSTALLOGR XRAY
=680  \\$iThe study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a94
=750  \0$aX-ray crystallography$5IEN-M$0(DLC)sh 85148730

=LDR  01406cz  a2200337n  4500
=001  9880364091602441
=005  20141212212552.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018358
=035  \\$aCRE7269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650
=072  \\$aC4.$x557.$x580.$x625.$x650
=150  \\$aNeuroendocrine Tumors
=450  \\$wnnna$aNeuroendocrine Tumor
=450  \\$wnnna$aTumor, Neuroendocrine
=450  \\$wnnna$aTumors, Neuroendocrine
=550  \\$wg$aNeuroectodermal Tumors
=550  \\$wh$aAdenoma, Acidophil
=550  \\$wh$aAdenoma, Basophil
=550  \\$wh$aAdenoma, Chromophobe
=550  \\$wh$aApudoma
=550  \\$wh$aCarcinoid Tumor
=550  \\$wh$aCarcinoma, Neuroendocrine
=550  \\$wh$aMelanoma
=550  \\$wh$aNeurilemmoma
=550  \\$wh$aParaganglioma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iTumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
=688  \\$a94
=750  \0$aNeuroendocrine tumors$0(DLC) sh 94005134$5IEN-M

=LDR  01377cz  a2200289n  4500
=001  9880364091702441
=005  20141212192812.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018352
=035  \\$aCRE7264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x600.$x550.$x200
=150  \\$aCoronavirus Infections
=450  \\$wnnna$aCoronavirus Infection
=450  \\$wnnna$aInfection, Coronavirus
=450  \\$wnnna$aInfections, Coronavirus
=450  \\$wnnna$aMERS (Middle East Respiratory Syndrome)
=450  \\$wnnna$aMiddle East Respiratory Syndrome
=550  \\$wg$aCoronaviridae Infections
=550  \\$wh$aEnteritis, Transmissible, of Turkeys
=550  \\$wh$aFeline Infectious Peritonitis
=550  \\$wh$aGastroenteritis, Transmissible, of Swine
=550  \\$wh$aSevere Acute Respiratory Syndrome
=667  \\$ado not confuse with CORONAVIRIDAE INFECTIONS; coordinate IM with specific coronavirus (IM) but note some specific coronavirus infection terms are available
=680  \\$iVirus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
=688  \\$a94; was heading 1977-93
=750  \0$aCoronavirus Infections$5IEN-M$0(DLC)sh 90004313

=LDR  00920cz  a2200229n  4500
=001  9880364091802441
=005  20141212212521.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018274
=035  \\$aCRE7191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x242.$x448
=072  \\$aE5.$x301.$x500
=150  \\$aElectroporation
=450  \\$wnnna$aElectropermeabilisation
=550  \\$wg$aCytological Techniques
=550  \\$wg$aElectrochemical Techniques
=550  \\$wh$aElectrochemotherapy
=550  \\$aTransfection
=680  \\$iA technique in which electric pulses of intensity in kilovolts per centimeter and of microsecond-to-millisecond duration cause a temporary loss of the semipermeability of CELL MEMBRANES, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA.
=688  \\$a94
=750  \0$aElectroporation$0(DLC) sh 89001422$5IEN-M

=LDR  01282cz  a2200349n  4500
=001  9880364091902441
=005  20141212212521.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018273
=035  \\$aCRE7190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25.$x290
=072  \\$aC4.$x588.$x274.$x761.$x500
=072  \\$aC4.$x588.$x322.$x475.$x500
=072  \\$aC6.$x301.$x761.$x500
=072  \\$aC6.$x689.$x667.$x500
=072  \\$aC19.$x344.$x421.$x500
=150  \\$aCarcinoma, Islet Cell
=450  \\$wnnna$aCarcinomas, Islet Cell
=450  \\$wnnna$aIslet Cell Carcinoma
=450  \\$wnnna$aIslet Cell Carcinomas
=450  \\$aIslet Cell Tumor, Malignant
=550  \\$wg$aAdenocarcinoma
=550  \\$wg$aPancreatic Neoplasms
=550  \\$wh$aGastrinoma
=550  \\$wh$aGlucagonoma
=550  \\$wh$aSomatostatinoma
=550  \\$wh$aVipoma
=667  \\$acoord IM with PANCREATIC NEOPLASMS (IM)
=680  \\$iA primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells (SOMATOSTATIN-SECRETING CELLS) in GLUCAGONOMA and SOMATOSTATINOMA, respectively.
=688  \\$a94
=750  \0$aIslands of Langerhans$xCancer$5IEN-M

=LDR  01368cz  a2200349n  4500
=001  9880364092002441
=005  20141212212514.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018257
=035  \\$aCRE7175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x790.$x709.$x600.$x40.$x360
=150  \\$aHelix-Loop-Helix Motifs
=450  \\$wnnna$aHelix-Loop-Helix Motif
=450  \\$wnnna$aHelix Loop Helix Motifs
=450  \\$wnnna$aHLH Motif
=450  \\$aHLH Motifs
=450  \\$wnnna$aMotif, Helix-Loop-Helix
=450  \\$wnnna$aMotif, HLH
=450  \\$wnnna$aMotifs, Helix-Loop-Helix
=450  \\$wnnna$aMotifs, Helix Loop Helix
=450  \\$wnnna$aMotifs, HLH
=550  \\$wg$aAmino Acid Motifs
=550  \\$wh$aEF Hand Motifs
=550  \\$wh$aHelix-Turn-Helix Motifs
=550  \\$aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors
=550  \\$aBasic Helix-Loop-Helix Transcription Factors
=550  \\$aDNA-Binding Proteins
=667  \\$ado not confuse with HELIX-TURN-HELIX MOTIFS
=680  \\$iRecurring supersecondary structures characterized by 20 amino acids folding into two alpha helices connected by a non-helical "loop" segment. They are found in many sequence-specific DNA-BINDING PROTEINS and in CALCIUM-BINDING PROTEINS.
=688  \\$a94
=750  \0$aHelix-loop-helix motifs$0(DLC) sh 96001120$5IEN-M

=LDR  00957cz  a2200217n  4500
=001  9880364092102441
=005  20141212212514.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018255
=035  \\$aCRE7173HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x35.$x210
=150  \\$aAdenomatosis, Pulmonary
=450  \\$wnnna$aAdenomatoses, Pulmonary
=450  \\$wnnna$aPulmonary Adenomatoses
=450  \\$aPulmonary Adenomatosis
=550  \\$wg$aAdenoma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS (IM); DF: ADENOMATOSIS PULM
=680  \\$iA neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. (Stedman, 25th ed)
=688  \\$a94
=750  \0$aPulmonary adenomatosis$5IEN-M$0(DLC)sh 85108994

=LDR  00768cz  a2200193n  4500
=001  9880364092202441
=005  20141212212509.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018243
=035  \\$aCRE7161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x900
=150  \\$aTeratocarcinoma
=450  \\$wnnna$aTeratocarcinomas
=550  \\$wg$aNeoplasms, Germ Cell and Embryonal
=667  \\$a/blood supply /chem /second /secret /ultrastruct; coord IM with probably TESTICULAR NEOPLASMS (IM)
=680  \\$iA malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
=688  \\$a94
=750  \0$aTeratocarcinoma$5IEN-M$0(DLC)sh 85133982

=LDR  00972cz  a2200229n  4500
=001  9880364092302441
=005  20141212212507.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018237
=035  \\$aCRE7155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x330
=150  \\$aGerminoma
=450  \\$wnnna$aGerminomas
=550  \\$wg$aNeoplasms, Germ Cell and Embryonal
=550  \\$wh$aDysgerminoma
=550  \\$wh$aSeminoma
=550  \\$aTesticular Neoplasms
=667  \\$acoordinate IM with precoordinated organ/neoplasm term (IM)
=680  \\$iA malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. (Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1642-3)
=688  \\$a94
=750  \0$aGerm cells$xTumors$5IEN-M

=LDR  01052cz  a2200241n  4500
=001  9880364092402441
=005  20141212212506.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018235
=035  \\$aCRE7153M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x590.$x800
=150  \\$aSmooth Muscle Tumor
=450  \\$wnnna$aMuscle Tumor, Smooth
=450  \\$wnnna$aMuscle Tumors, Smooth
=450  \\$wnnna$aSmooth Muscle Tumors
=450  \\$wnnna$aTumor, Smooth Muscle
=450  \\$wnnna$aTumors, Smooth Muscle
=550  \\$wg$aNeoplasms, Muscle Tissue
=667  \\$aa specific histol type: do not confuse with NEOPLASMS, MUSCLE TISSUE, a group histol term, or with LEIOMYOMA (see MeSH definition); /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); restricted use: Manual 24.2.2.5
=680  \\$iA tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle.
=688  \\$a94
=750  \0$aSmooth muscle$xTumors$5IEN-M$0(DLC)sh 86005515

=LDR  02103cz  a2200493n  4500
=001  9880364092502441
=005  20141212212501.0
=008  930625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018219
=035  \\$aCRE7137M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x590.$x425.$x350
=150  \\$aHistiocytoma, Benign Fibrous
=450  \\$wnnna$aAngioma, Sclerosing
=450  \\$wnnna$aAngiomas, Sclerosing
=450  \\$wnnna$aBenign Fibrous Histiocytoma
=450  \\$wnnna$aBenign Fibrous Histiocytomas
=450  \\$wnnna$aCutaneous Histiocytoma
=450  \\$wnnna$aCutaneous Histiocytomas
=450  \\$aDermatofibroma
=450  \\$wnnna$aDermatofibromas
=450  \\$wnnna$aFibrous Histiocytoma
=450  \\$wnnna$aFibrous Histiocytoma, Benign
=450  \\$wnnna$aFibrous Histiocytomas
=450  \\$wnnna$aFibrous Histiocytomas, Benign
=450  \\$aHemangioma, Sclerosing
=450  \\$wnnna$aHemangiomas, Sclerosing
=450  \\$aHistiocytoma, Cutaneous
=450  \\$aHistiocytoma, Fibrous
=450  \\$wnnna$aHistiocytomas, Benign Fibrous
=450  \\$wnnna$aHistiocytomas, Cutaneous
=450  \\$wnnna$aHistiocytomas, Fibrous
=450  \\$wnnna$aSclerosing Angioma
=450  \\$wnnna$aSclerosing Angiomas
=450  \\$wnnna$aSclerosing Hemangioma
=450  \\$wnnna$aSclerosing Hemangiomas
=550  \\$wg$aHistiocytoma
=550  \\$aHemangioma
=667  \\$abenign only; malignant = HISTIOCYTOMA, MALIGNANT FIBROUS; coordinate IM with precoordinated organ/neoplasm term (IM)
=680  \\$iA benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
=688  \\$a2006 (1994)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Histiocytoma, Fibrous
=688  \\$a94
=750  \0$aDermatofibroma$0(DLC) sh 89006247$5IEN-M

=LDR  01306cz  a2200289n  4500
=001  9880364092602441
=005  20141212212453.0
=008  930624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018192
=035  \\$aCRE7110M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x375.$x460.$x465
=072  \\$aC4.$x557.$x450.$x692.$x500
=072  \\$aC15.$x604.$x515.$x562.$x465
=072  \\$aC20.$x683.$x515.$x710.$x465
=150  \\$aLymphangioleiomyomatosis
=450  \\$wnnna$aLymphangioleiomyomatoses
=450  \\$wnnna$aLymphangiomyomatoses
=450  \\$wnnna$aLymphangiomyomatosis
=550  \\$wg$aLymphangiomyoma
=550  \\$wg$aPerivascular Epithelioid Cell Neoplasms
=667  \\$adifferentiate from LYMPHANGIOMYOMA; coordinate IM with precoordinated organ/neoplasm terms (IM) if relevant
=680  \\$iA disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).
=688  \\$a2006 (1994)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Lymphangiomyomatosis
=688  \\$a94
=750  \0$aLymphangiomyomatosis$0(DLC) sh 99000736$5IEN-M

=LDR  01085cz  a2200253n  4500
=001  9880364092702441
=005  20141212212452.0
=008  930624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018190
=035  \\$aCRE7108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x375
=150  \\$aLymphatic Vessel Tumors
=450  \\$wnnna$aLymphatic Vessel Tumor
=450  \\$wnnna$aTumor, Lymphatic Vessel
=450  \\$wnnna$aTumors, Lymphatic Vessel
=550  \\$wg$aNeoplasms by Histologic Type
=550  \\$wh$aLymphangioma
=550  \\$wh$aLymphangiomyoma
=550  \\$wh$aLymphangiosarcoma
=667  \\$aneoplasms composed of lymphatic tissue, not located in lymphatic tissue: TN 135; /blood supply /chem /second /secret /ultrastruct permitted; coord with precoord organ/neopl term; restricted use: Manual 24.2.2.5
=680  \\$iNeoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels.
=688  \\$a94
=750  \0$aLymphoid tissue$xTumors$5IEN-M

=LDR  01345cz  a2200241n  4500
=001  9880364092802441
=005  20141212212451.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018187
=035  \\$aCRE7105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x660
=150  \\$aPersonal Construct Theory
=450  \\$wnnna$aConstruct Theories, Personal
=450  \\$wnnna$aConstruct Theory, Personal
=450  \\$wnnna$aPersonal Construct Theories
=450  \\$wnnna$aTheories, Personal Construct
=450  \\$wnnna$aTheory, Personal Construct
=550  \\$wg$aPsychological Theory
=667  \\$ano qualif; includes personal construct, personal construct method, personal construct organization, etc.; for personal construct ther, coord IM with PSYCHOTHERAPY (IM)
=680  \\$iA psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. (From Stuart Sutherland, The International Dictionary of Psychology, 1989)
=688  \\$a94
=750  \0$aPersonal construct theory$5IEN-M$0(DLC)sh 85100093

=LDR  00901cz  a2200265n  4500
=001  9880364092902441
=005  20141212212449.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018182
=035  \\$aCRE7100M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350.$x675
=150  \\$aPestivirus Infections
=450  \\$wnnna$aInfection, Pestivirus
=450  \\$wnnna$aInfections, Pestivirus
=450  \\$wnnna$aPestivirus Infection
=550  \\$wg$aFlaviviridae Infections
=550  \\$wh$aBorder Disease
=550  \\$wh$aBovine Virus Diarrhea-Mucosal Disease
=550  \\$wh$aClassical Swine Fever
=550  \\$wh$aHemorrhagic Syndrome, Bovine
=667  \\$acaused by a flavivirus; GEN or unspecified; prefer specifics
=680  \\$iInfections with viruses of the genus PESTIVIRUS, family FLAVIVIRIDAE.
=688  \\$a94
=750  \0$aPestivirus infections$0(DLC)sh2007000823$5IEN-M

=LDR  00813cz  a2200205n  4500
=001  9880364093002441
=005  20141212212448.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018180
=035  \\$aCRE7098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x625.$x800.$x800
=072  \\$aD12.$x776.$x543.$x550.$x625.$x800.$x800
=072  \\$aD12.$x776.$x543.$x750.$x750.$x850.$x800
=150  \\$aThrombomodulin
=550  \\$wg$aReceptors, Thrombin
=667  \\$aa thrombin receptor
=680  \\$iA cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.
=688  \\$a94; THROMBOMODULIN was SY to THROMBIN RECEPTOR (NM) 1981-93
=750  \0$aThrombomodulin$5IEN-M$0(DLC)sh 94002869

=LDR  02193cz  a2200421n  4500
=001  9880364093102441
=005  20190507152606.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018179
=035  \\$aCRE7097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x625.$x800
=072  \\$aD12.$x776.$x543.$x550.$x625.$x800
=072  \\$aD12.$x776.$x543.$x750.$x695.$x875
=072  \\$aD12.$x776.$x543.$x750.x705.$x675.$x892
=072  \\$aD12.$x776.$x543.$x750.$x750.$x850
=072  \\$aD12.$x776.$x543.$x750.$x792.$x500
=150  \\$aReceptors, Thrombin
=450  \\$wnnna$aPeptide, TRAP
=450  \\$wnnna$aReceptor, Thrombin
=450  \\$wnnna$aThrombin Receptor
=450  \\$wnnna$aThrombin Receptor Activating Peptide Ligand
=450  \\$wnnna$aThrombin Receptor Activating Peptides
=450  \\$wnnna$aThrombin Receptor Activator Peptide
=450  \\$aThrombin Receptors
=450  \\$wnnna$aTRAP Peptide
=550  \\$wg$aPlatelet Membrane Glycoproteins
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$wg$aReceptors, Proteinase-Activated
=550  \\$wh$aReceptor, PAR-1
=550  \\$wh$aThrombomodulin
=667  \\$aDF: RECEPT THROMBIN
=680  \\$iA family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.
=688  \\$a1994; use THROMBIN RECEPTOR (NM) 1981-1993; for TRAP PEPTIDE use RECEPTORS, THROMBIN (NM) 2000-2003
=750  \0$81$wb$iBroader mapping$aThrombin$0(DLC)sh 85135066$4BM$5IEN-M
=780  \\$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThrombin--Receptors$5IEN-M

=LDR  00920cz  a2200253n  4500
=001  9880364093202441
=005  20141212212448.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018178
=035  \\$aCRE7096M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350
=150  \\$aFlaviviridae Infections
=450  \\$wnnna$aFlaviviridae Infection
=450  \\$wnnna$aInfection, Flaviviridae
=450  \\$wnnna$aInfections, Flaviviridae
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aFlavivirus Infections
=550  \\$wh$aHepatitis C
=550  \\$wh$aPestivirus Infections
=667  \\$acaused by members of the Flaviviridae family: do not confuse with FLAVIVIRUS INFECTIONS caused by members of the Flavivirus genus; GEN or unspecified; prefer specifics
=680  \\$iInfections with viruses of the family FLAVIVIRIDAE.
=688  \\$a94
=750  \0$aFlaviviral diseases$0(DLC)sh2007004836$5IEN-M

=LDR  01117cz  a2200325n  4500
=001  9880364093302441
=005  20141212212445.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018170
=035  \\$aCRE7088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x750
=072  \\$aD2.$x886.$x590.$x700.$x750
=072  \\$aD3.$x438.$x473.$x914.$x907
=150  \\$aSumatriptan
=450  \\$wnnna$a3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide
=450  \\$wnnna$aGlaxo Wellcome Brand of Sumatriptan
=450  \\$wnnna$aGR-43175
=450  \\$wnnna$aGR 43175
=450  \\$wnnna$aGR43175
=450  \\$wnnna$aGSK Brand of Sumatriptan
=450  \\$wnnna$aImigran
=450  \\$wnnna$aSuccinate, Sumatriptan
=450  \\$wnnna$aSumatriptan GSK Brand
=450  \\$wnnna$aSumatriptan Succinate
=550  \\$wg$aSulfonamides
=550  \\$wg$aTryptamines
=680  \\$iA serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
=688  \\$a94; was SUMATRIPTAN (NM) 1988-93
=750  \0$aSumatriptan$5IEN-M$0(DLC)sh 96010267

=LDR  01288cz  a2200313n  4500
=001  9880364093402441
=005  20181206104835.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018168
=035  \\$aCRE7086M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x826.$x701
=072  \\$aD12.$x776.$x930.$x7775
=150  \\$aReceptors, Retinoic Acid
=450  \\$wnnna$aProteins, Retinoic Acid-Binding
=450  \\$wnnna$aReceptor, Retinoic Acid
=450  \\$aRetinoic Acid-Binding Proteins
=450  \\$wnnna$aRetinoic Acid Binding Proteins
=450  \\$wnnna$aRetinoic Acid Receptor
=450  \\$aRetinoic Acid Receptors
=550  \\$wg$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aRetinoic Acid Receptor alpha
=550  \\$wh$aRetinoid X Receptors
=550  \\$aRetinol-Binding Proteins
=550  \\$aTretinoin
=667  \\$aDF: RECEPT RETINOIC ACID
=680  \\$iProteins in the nucleus or cytoplasm that specifically bind RETINOIC ACID or RETINOL and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized.
=688  \\$a94; was RETINOIC ACID-BINDING PROTEINS (NM) 1976-93
=750  \0$aTretinoin$xReceptors$0(DLC)sh2011003190$5IEN-M

=LDR  01663cz  a2200361n  4500
=001  9880364093502441
=005  20141212212443.0
=008  930528\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018166
=035  \\$aCRE7084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x400.$x285
=072  \\$aI1.$x880.$x604.$x825.$x608.$x400.$x285
=072  \\$aN3.$x349.$x285
=072  \\$aN3.$x623.$x500.$x608.$x428.$x285
=072  \\$aN4.$x590.$x374.$x285
=072  \\$aN5.$x300.$x380
=150  \\$aHealth Care Reform
=450  \\$wnnna$aHealth Care Reforms
=450  \\$wnnna$aHealthcare Reform
=450  \\$wnnna$aHealthcare Reforms
=450  \\$wnnna$aReform, Health Care
=450  \\$wnnna$aReform, Healthcare
=450  \\$wnnna$aReforms, Health Care
=450  \\$wnnna$aReforms, Healthcare
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aHealth Planning
=550  \\$wg$aHealth Policy
=550  \\$wh$aAccountable Care Organizations
=667  \\$anot restricted to US; specify state or country
=680  \\$iInnovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services.
=688  \\$a94
=750  \0$aHealth care reform$0(DLC) sh 93007525$5IEN-M

=LDR  01035cz  a2200277n  4500
=001  9880364093602441
=005  20141212212443.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018165
=035  \\$aCRE7083M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630.$x590
=072  \\$aB4.$x909.$x777.$x714.$x590
=150  \\$aOrthoreovirus
=450  \\$aBaboon orthoreovirus
=450  \\$aNelson Bay orthoreovirus
=450  \\$aOrthoreovirus, Baboon
=450  \\$aOrthoreovirus, Nelson Bay
=450  \\$wnnna$aOrthoreoviruses
=550  \\$wg$aReoviridae
=550  \\$wh$aOrthoreovirus, Avian
=550  \\$wh$aOrthoreovirus, Mammalian
=667  \\$ainfection: coord IM with REOVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of the family REOVIRIDAE infecting vertebrates only. Transmission is horizontal and infected species include humans, birds, cattle, monkeys, sheep, swine, baboons, and bats. MAMMALIAN ORTHOREOVIRUS is the type species.
=688  \\$a1994
=750  \0$aOrthoreoviruses$0(DLC) sh 99005850$5IEN-M

=LDR  01189cz  a2200289n  4500
=001  9880364093702441
=005  20160826090134.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018163
=035  \\$aCRE7081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630.$x550
=072  \\$aB4.$x909.$x777.$x714.$x550
=150  \\$aOrbivirus
=450  \\$aChanguinola Virus
=450  \\$wnnna$aChenuda Virus
=450  \\$wnnna$aKemerovo Virus
=450  \\$wnnna$aOrbiviruses
=550  \\$wg$aReoviridae
=550  \\$wh$aAfrican Horse Sickness Virus
=550  \\$wh$aBluetongue virus
=550  \\$wh$aHemorrhagic Disease Virus, Epizootic
=550  \\$wh$aPalyam Virus
=667  \\$ainfection: coordinate IM with REOVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least 21 serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks.
=688  \\$a1994; for CHANGUINOLA VIRUS use REOVIRIDAE 1976-1993; for CHENUDA VIRUS see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS, REOVIRIDAE 1981-1990
=750  \0$aOrbiviruses$5IEN-M$0(DLC)sh 85095320

=LDR  01810cz  a2200421n  4500
=001  9880364093802441
=005  20190429162216.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018161
=035  \\$aCRE7079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x826.$x750.$x530
=150  \\$aReceptors, Mineralocorticoid
=450  \\$wnnna$aAldosterone Receptor
=450  \\$wnnna$aAldosterone Receptors
=450  \\$wnnna$aCorticoid I Receptor
=450  \\$wnnna$aCorticoid I Receptors
=450  \\$wnnna$aCorticoid Type I Receptors
=450  \\$wnnna$aMineralocorticoid Receptor
=450  \\$aMineralocorticoid Receptors
=450  \\$wnnna$aMineralocorticoids Receptors
=450  \\$wnnna$aReceptor, Aldosterone
=450  \\$wnnna$aReceptor, Corticoid I
=450  \\$wnnna$aReceptor, Mineralocorticoid
=450  \\$wnno$aReceptors, Aldosterone
=450  \\$wnnna$aReceptors, Corticoid I
=450  \\$wnnna$aReceptors, Corticoid Type I
=450  \\$wnnna$aReceptors, Mineralocorticoids
=550  \\$wg$aReceptors, Steroid
=550  \\$aAldosterone
=550  \\$aPseudohypoaldosteronism
=680  \\$iCytoplasmic proteins that specifically bind MINERALOCORTICOIDS and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA.
=688  \\$a1994
=688  \\$a94; was MINERALOCORTICOID RECEPTOR (NM) 1980-93
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Receptors, Aldosterone
=750  \0$81$wb$iBroader mapping$aMineralocorticoids$0(DLC)sh 85085585$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMineralocorticoids--Receptors$5IEN-M

=LDR  02771cz  a2200613n  4500
=001  9880364093902441
=005  20200618165340.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018160
=035  \\$aCRE7078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x826
=150  \\$aReceptors, Cytoplasmic and Nuclear
=450  \\$aCytoplasmic and Nuclear Receptors
=450  \\$wnnna$aCytoplasmic Hormone Receptors
=450  \\$wnnna$aCytoplasmic Receptors
=450  \\$wnnna$aCytosol and Nuclear Receptors
=450  \\$aCytosolic and Nuclear Receptors
=450  \\$aHormone Receptors, Cytoplasmic
=450  \\$aHormone Receptors, Nuclear
=450  \\$wnnna$aIntracellular Membrane Receptors
=450  \\$wnnna$aMembrane Receptors, Intracellular
=450  \\$aNuclear and Cytoplasmic Receptors
=450  \\$wnnna$aNuclear Hormone Receptors
=450  \\$wnnna$aNuclear Receptors
=450  \\$wnnna$aReceptors, Cytoplasmic
=450  \\$wnnna$aReceptors, Cytoplasmic Hormone
=450  \\$wnnna$aReceptors, Cytosol and Nuclear
=450  \\$wnnna$aReceptors, Cytosolic and Nuclear
=450  \\$wnnna$aReceptors, Intracellular Membrane
=450  \\$wnnna$aReceptors, Nuclear
=450  \\$wnnna$aReceptors, Nuclear and Cytoplasmic
=450  \\$wnnna$aReceptors, Nuclear Hormone
=550  \\$wg$aDNA-Binding Proteins
=550  \\$wg$aProteins
=550  \\$wg$aTranscription Factors
=550  \\$wh$aHepatocyte Nuclear Factor 4
=550  \\$wh$aInositol 1,4,5-Trisphosphate Receptors
=550  \\$wh$aLiver X Receptors
=550  \\$wh$aOrphan Nuclear Receptors
=550  \\$wh$aPeroxisome Proliferator-Activated Receptors
=550  \\$wh$aReceptors, Artificial
=550  \\$wh$aReceptors, Calcitriol
=550  \\$wh$aReceptors for Activated C Kinase
=550  \\$wh$aReceptors, Melatonin
=550  \\$wh$aReceptors, Retinoic Acid
=550  \\$wh$aReceptors, Steroid
=550  \\$wh$aReceptors, Thyroid Hormone
=550  \\$wh$aSteroidogenic Factor 1
=550  \\$aHormones
=667  \\$ageneral or unspecified; prefer specifics; for hormone receptors, see note at RECEPTORS, CELL SURFACE
=680  \\$iIntracellular receptors that can be found in the cytoplasm or in the nucleus. They bind to extracellular signaling molecules that migrate through or are transported across the CELL MEMBRANE. Many members of this class of receptors occur in the cytoplasm and are transported to the CELL NUCLEUS upon ligand-binding where they signal via DNA-binding and transcription regulation. Also included in this category are receptors found on INTRACELLULAR MEMBRANES that act via mechanisms similar to CELL SURFACE RECEPTORS.
=688  \\$a94
=750  \0$aNuclear receptors (Biochemistry)$0(DLC) sh 96008334$5IEN-M

=LDR  00772cz  a2200193n  4500
=001  9880364094002441
=005  20141212212440.0
=008  930602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018156
=035  \\$aCRE7074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x498.$x550
=150  \\$aJournalism, Medical
=450  \\$aMedical Journalism
=550  \\$wg$aJournalism
=667  \\$aIM; JOURNALISM, DENTAL is also available
=680  \\$iThe collection, writing, and editing of current interest material on topics related to biomedicine for presentation through the mass media, including newspapers, magazines, radio, or television, usually for a public audience such as health care consumers.
=688  \\$a98
=750  \0$aJournalism, Medical$5IEN-M$0(DLC)sh 85070771

=LDR  01128cz  a2200313n  4500
=001  9880364094102441
=005  20141212212440.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018155
=035  \\$aCRE7073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x650.$x160.$x650
=072  \\$aB4.$x909.$x204.$x783.$x160.$x650
=150  \\$aOrthopoxvirus
=450  \\$wnnna$aCamelpox virus
=450  \\$wnnna$aCamelpox viruses
=450  \\$wnnna$aOrthopoxviruses
=450  \\$wnnna$avirus, Camelpox
=450  \\$wnnna$aviruses, Camelpox
=550  \\$wg$aChordopoxvirinae
=550  \\$wh$aCowpox virus
=550  \\$wh$aEctromelia virus
=550  \\$wh$aMonkeypox virus
=550  \\$wh$aVaccinia virus
=550  \\$wh$aVariola virus
=667  \\$ainfection: coordinate IM with POXVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.
=688  \\$a94
=750  \0$aOrthopoxviruses$5IEN-M$0(DLC)sh 88001450

=LDR  00930cz  a2200217n  4500
=001  9880364094202441
=005  20141212212438.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018149
=035  \\$aCRE7067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x952.$x500
=150  \\$aGlucose Intolerance
=450  \\$wnnna$aGlucose Intolerances
=450  \\$wnnna$aIntolerance, Glucose
=450  \\$wnnna$aIntolerances, Glucose
=550  \\$wg$aHyperglycemia
=550  \\$aDiabetes Mellitus
=680  \\$iA pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
=688  \\$a94
=750  \0$aCarbohydrate intolerance$5IEN-M$0(DLC)sh 88002748

=LDR  02345cz  a2200517n  4500
=001  9880364094302441
=005  20141212212435.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018139
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x100.$x750
=072  \\$aB4.$x909.$x204.$x382.$x100.$x750
=150  \\$aSimplexvirus
=450  \\$aCercopithecine herpesvirus 16
=450  \\$aHerpes labialis Virus
=450  \\$wnnna$aHerpes labialis Viruses
=450  \\$aHerpes Simplex Virus
=450  \\$wnnna$aHerpes Simplex Viruses
=450  \\$wnnna$aHerpes-T Virus
=450  \\$wnnna$aHerpes T Virus
=450  \\$wnnna$aHerpes-T Viruses
=450  \\$wnnna$aHerpesvirus 1 (alpha), Saimirine
=450  \\$aHerpesvirus 1, Saimiriine
=450  \\$aHerpesvirus 1, Saimirine
=450  \\$aHerpesvirus 16, Cercopithecine
=450  \\$aHerpesvirus hominis
=450  \\$wnnna$aHerpesvirus, Marmoset
=450  \\$aHerpesvirus papio 2
=450  \\$aHerpesvirus platyrhinae
=450  \\$wnnna$aHerpesviruses, Marmoset
=450  \\$wnnna$aMarmoset Herpesvirus
=450  \\$wnnna$aMarmoset Herpesviruses
=450  \\$aMarmoset Virus
=450  \\$wnnna$aMarmoset Viruses
=450  \\$aSaimiriine herpesvirus 1
=450  \\$wnnna$aSaimirine Herpesvirus 1
=450  \\$wnnna$aSimplexviruses
=550  \\$wg$aAlphaherpesvirinae
=550  \\$wh$aHerpesvirus 1, Cercopithecine
=550  \\$wh$aHerpesvirus 1, Human
=550  \\$wh$aHerpesvirus 2, Bovine
=550  \\$wh$aHerpesvirus 2, Human
=667  \\$anote X ref HERPES SIMPLEX VIRUS: HERPES SIMPLEX VIRUS 1 and HERPES SIMPLEX VIRUS 2 are also available; do not confuse X ref HERPESVIRUS 1, SAIMIRINE with HERPESVIRUS 2, SAIMIRINE; infection = HERPES SIMPLEX or its indentions
=680  \\$iA genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN.
=688  \\$a94; MARMOSET VIRUS was heading 1975-93 (see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80); HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS & HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93
=750  \0$aHerpes simplex virus$5IEN-M$0(DLC)sh 85060455

=LDR  00760cz  a2200205n  4500
=001  9880364094402441
=005  20141212212433.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018130
=035  \\$aCRE7053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x200
=150  \\$aDiamond
=450  \\$wnnna$aDiamonds
=550  \\$wg$aCarbon
=550  \\$wh$aNanodiamonds
=667  \\$aa form of carbon
=680  \\$iDiamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a94; was DIAMOND (NM) 1980-93
=750  \0$aDiamonds$5IEN-M$0(DLC)sh 85037566

=LDR  01473cz  a2200325n  4500
=001  9880364094502441
=005  20141212212432.0
=008  930603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018126
=035  \\$aCRE7050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x650.$x800.$x600
=072  \\$aC7.$x793.$x700.$x600
=072  \\$aC16.$x131.$x850.$x800.$x600
=150  \\$aOdontodysplasia
=450  \\$wnnna$aDysplasia, Odontogenic
=450  \\$wnnna$aDysplasias, Odontogenic
=450  \\$aGhost Teeth
=450  \\$wnnna$aGhost Tooth
=450  \\$wnnna$aOdontodysplasias
=450  \\$aOdontogenesis Imperfecta
=450  \\$aOdontogenic Dysplasia
=450  \\$wnnna$aOdontogenic Dysplasias
=450  \\$wnnna$aTeeth, Ghost
=450  \\$wnnna$aTooth, Ghost
=550  \\$wg$aTooth Abnormalities
=667  \\$aan abnorm of tooth develop; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. (Jablonski, Illustrated Dictionary of Dentistry, 1982)
=688  \\$a94; ODONTOGENESIS IMPERFECTA was heading 1965-93
=750  \0$aDentinogenesis imperfecta$5IEN-M$0(DLC)sh 85036951

=LDR  01808cz  a2200373n  4500
=001  9880364094602441
=005  20190507162725.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018125
=035  \\$aCRE7049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x720
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x820
=150  \\$aReceptors, Transforming Growth Factor beta
=450  \\$wnnna$aReceptor, TGF-beta
=450  \\$aReceptors, TGF-beta
=450  \\$wnnna$aReceptors, TGF beta
=450  \\$wnnna$aTGF-beta Receptor
=450  \\$wnnna$aTGF beta Receptor
=450  \\$aTGF-beta Receptors
=450  \\$wnnna$aTGF beta Receptors
=450  \\$wnnna$aTransforming Growth Factor beta Receptor
=450  \\$aTransforming Growth Factor beta Receptors
=550  \\$wg$aReceptors, Cytokine
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aActivin Receptors
=550  \\$wh$aReceptor, Transforming Growth Factor-beta Type I
=550  \\$wh$aReceptor, Transforming Growth Factor-beta Type II
=667  \\$aDF: RECEPT TGF BETA
=680  \\$iCell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.
=688  \\$a94; was TRANSFORMING GROWTH FACTOR RECEPTOR, BETA (NM) 1986-93
=750  \0$81$wb$iBroader mapping$aTransforming growth factors-beta$0(DLC)sh 90001874$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aTransforming growth factors-beta--Receptors$5IEN-M

=LDR  02176cz  a2200553n  4500
=001  9880364094702441
=005  20190521131919.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018124
=035  \\$aCRE7048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x760
=150  \\$aReceptors, Tumor Necrosis Factor
=450  \\$aCachectin Receptors
=450  \\$wnnna$aReceptor, TNF
=450  \\$wnnna$aReceptors, Cachectin
=450  \\$wnnna$aReceptors, TNF
=450  \\$wnnna$aTNF Receptor
=450  \\$aTNF Receptors
=450  \\$wnnna$aTumor Necrosis Factor Receptor
=450  \\$aTumor Necrosis Factor Receptors
=550  \\$wg$aReceptors, Cytokine
=550  \\$wh$aAntigens, CD137
=550  \\$wh$aAntigens, CD30
=550  \\$wh$aCD40 Antigens
=550  \\$wh$aK-1 Antigen
=550  \\$wh$aB-Cell Activation Factor Receptor
=550  \\$wh$aB-Cell Maturation Antigen
=550  \\$wh$aEtanercept
=550  \\$wh$aGlucocorticoid-Induced TNFR-Related Protein
=550  \\$wh$aLymphotoxin beta Receptor
=550  \\$wh$aReceptor Activator of Nuclear Factor-kappa B
=550  \\$wh$aReceptors, Ectodysplasin
=550  \\$wh$aReceptors, OX40
=550  \\$wh$aReceptors, TNF-Related Apoptosis-Inducing Ligand
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Member 14
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Member 25
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Type I
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Type II
=550  \\$wh$aTransmembrane Activator and CAML Interactor Protein
=550  \\$wh$aTumor Necrosis Factor Decoy Receptors
=550  \\$wh$aTumor Necrosis Factor Receptor Superfamily, Member 7
=550  \\$wh$aTumor Necrosis Factor Receptor Superfamily, Member 9
=550  \\$wh$aTWEAK receptor
=550  \\$aReceptors, Death Domain
=667  \\$ageneral; prefer specifics
=680  \\$iCell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.
=688  \\$a94; was TUMOR NECROSIS FACTOR RECEPTOR (NM) 1985-93
=750  \0$aTumor necrosis factor$xReceptors$0(DLC)sh2009010985$5IEN-M

=LDR  01271cz  a2200373n  4500
=001  9880363984002441
=005  20141212212311.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017859
=035  \\$aCRE6802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x385.$x300
=150  \\$aEsocidae
=450  \\$wnnna$aAmur Pike
=450  \\$wnnna$aChain Pickerel
=450  \\$aEsox
=450  \\$wnnna$aEsox americanus
=450  \\$wnnna$aEsox lucius
=450  \\$wnnna$aEsox masquinongy
=450  \\$wnnna$aEsox niger
=450  \\$wnnna$aEsox reicherti
=450  \\$wnnna$aGrass Pickerel
=450  \\$wnnna$aMuskellunge
=450  \\$wnnna$aMuskellunges
=450  \\$aNorthern Pike
=450  \\$wnnna$aPickerel, Chain
=450  \\$wnnna$aPickerel, Grass
=450  \\$aPike
=450  \\$wnnna$aPike, Amur
=450  \\$wnnna$aPike, Northern
=550  \\$wg$aEsociformes
=680  \\$iA family of freshwater fish of the order ESOCIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with five species: northern pike, grass pickerel, chain pickerel, muskellunge, and Amur pike.
=688  \\$a94; ESOX was see SALMONIDAE 1987-93
=750  \0$aEsocidae$5IEN$0(DLC)sh 85044844

=LDR  00773cz  a2200193n  4500
=001  9880363984102441
=005  20141212212310.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017858
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817
=150  \\$aSalmoniformes
=450  \\$wnnna$aSalmoniforme
=550  \\$wg$aFishes
=550  \\$wh$aSalmonidae
=667  \\$aGEN or unspecified: prefer specific families or specific genera
=680  \\$iAn order of fish comprising salmons, trouts, whitefish, graylings, and other families. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. (From Nelson: Fishes of the World)
=688  \\$a94
=750  \0$aSalmoniformes$5IEN-M$0(DLC)sh 85116836

=LDR  01159cz  a2200229n  4500
=001  9880363984202441
=005  20141212212307.0
=008  930527\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017850
=035  \\$aCRE6793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x390
=150  \\$aEconomics, Pharmaceutical
=450  \\$aPharmaceutical Economics
=450  \\$aPharmacoeconomics
=450  \\$aPharmacy$xeconomics
=550  \\$wg$aEconomics
=667  \\$aGEN or unspecified only: pref /econ with specific drugs or specific pharmaceutical subject; Manual 19.8.27; DF: ECON PHARM
=680  \\$iEconomic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1))
=688  \\$a94
=750  \0$aPharmacology$xEconomic aspects$5IEN-M
=750  \0$aPharmacy$xEconomic aspects$5IEN-HS

=LDR  02217cz  a2200529n  4500
=001  9880363984302441
=005  20141212212307.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017849
=035  \\$aCRE6792HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x157
=072  \\$aB1.$x50.$x50.$x199.$x520
=150  \\$aAnimals, Inbred Strains
=450  \\$wnnna$aAnimal Inbred Strain
=450  \\$wnnna$aAnimal Inbred Strains
=450  \\$wnnna$aAnimal, Inbred Strains
=450  \\$wnnna$aAnimal Strain, Inbred
=450  \\$wnnna$aAnimal Strains, Inbred
=450  \\$wnnna$aAnimals Inbred Strain
=450  \\$wnnna$aAnimals Inbred Strains
=450  \\$wnnna$aInbred Animal Strain
=450  \\$wnnna$aInbred Animal Strains
=450  \\$wnnna$aInbred Strain, Animal
=450  \\$wnnna$aInbred Strain of Animal
=450  \\$wnnna$aInbred Strains, Animal
=450  \\$wnnna$aInbred Strains Animal
=450  \\$wnnna$aInbred Strains Animals
=450  \\$wnnna$aInbred Strains of Animals
=450  \\$wnnna$aStrain, Animal Inbred
=450  \\$wnnna$aStrain, Inbred Animal
=450  \\$wnnna$aStrains Animal, Inbred
=450  \\$wnnna$aStrains, Animal Inbred
=450  \\$wnnna$aStrains Animals, Inbred
=450  \\$wnnna$aStrains, Inbred Animal
=550  \\$wg$aAnimal Population Groups
=550  \\$wg$aAnimals, Laboratory
=550  \\$wh$aAnimals, Congenic
=550  \\$wh$aMice, Inbred Strains
=550  \\$wh$aRats, Inbred Strains
=550  \\$aInbreeding
=667  \\$aIM GEN or unspecified; coord NIM with specific exper animal (NIM); when IM, qualif permitted; do not forget also to check tag ANIMALS
=680  \\$iAnimals produced by the mating of littermates or siblings over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. (Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a94
=750  \0$81$wb$aAnimals$5IEN-M$0(DLC)sh 85005249
=750  \0$81$wb$aInbreeding$5IEN-HS$0(DLC)sh 85064709
=788  \0$iSearch also under the following headings used together in the same record:$aAnimals$iand$aInbreeding$5IEN-M

=LDR  02055cz  a2200421n  4500
=001  9880363984402441
=005  20160912153403.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017848
=035  \\$aCRE6791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x248
=072  \\$aB2.$x50
=072  \\$aB3.$x165
=072  \\$aB4.$x194
=150  \\$aBlood-Borne Pathogens
=450  \\$wnnna$aBlood-Borne Pathogen
=450  \\$wnnna$aBlood Borne Pathogens
=450  \\$wnnna$aBloodborne Pathogen
=450  \\$wnnna$aBloodborne Pathogens
=450  \\$wnnna$aPathogen, Blood-Borne
=450  \\$wnnna$aPathogen, Bloodborne
=450  \\$aPathogens, Blood-Borne
=450  \\$wnnna$aPathogens, Blood Borne
=450  \\$wnnna$aPathogens, Bloodborne
=550  \\$wg$aArchaea
=550  \\$wg$aBacteria
=550  \\$wg$aFungi
=550  \\$wg$aViruses
=550  \\$aInfectious Disease Transmission, Patient-to-Professional
=550  \\$aInfectious Disease Transmission, Professional-to-Patient
=550  \\$aMedical Waste
=667  \\$acoordinate with specific pathogen (IM) if pertinent; do not routinely add as a coordinate for infections in the blood (VIREMIA; BACTEREMIA; FUNGEMIA; PARASITEMIA)
=680  \\$iInfectious organisms in the BLOOD, of which the predominant medical interest is their contamination of blood-soiled linens, towels, gowns, BANDAGES, other items from individuals in risk categories, NEEDLES and other sharp objects, MEDICAL WASTE and DENTAL WASTE, all of which health workers are exposed to. This concept is differentiated from the clinical conditions of BACTEREMIA; VIREMIA; and FUNGEMIA where the organism is present in the blood of a patient as the result of a natural infectious process.
=688  \\$a94
=750  \0$81$wb$aBloodborne infections$5IEN-M$0(DLC)sh 90003346
=750  \0$81$wb$aPathogenic microorganisms$5IEN-HS$0(DLC)sh 85084744
=788  \0$iSearch also under the following headings used together in the same record:$aBloodborne infections$iand$aPathogenic microorganisms$5IEN-M

=LDR  00925cz  a2200205n  4500
=001  9880363984502441
=005  20200427180411.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017841
=035  \\$aCRE6785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937.$x750
=150  \\$aTrimeresurus
=450  \\$aHabu
=450  \\$wnnna$aHabus
=550  \\$wg$aCrotalinae
=667  \\$aa genus of vipers; its venom: coord IM with CROTALID VENOMS (IM)
=680  \\$iA genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. (Moore: Poisonous Snakes of the World, 1980, p136)
=688  \\$a94
=750  \0$aTrimeresurus$5IEN-M$0(DLC)sh 85137537

=LDR  01114cz  a2200205n  4500
=001  9880363984602441
=005  20200427175545.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017839
=035  \\$aCRE6783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937.$x240.$x500
=150  \\$aCrotalus
=450  \\$aRattlesnake
=450  \\$wnnna$aRattlesnakes
=550  \\$wg$aCrotalinae
=667  \\$aa genus of pit vipers; note X ref; its venom: coord IM with CROTALID VENOMS (IM)
=680  \\$iA genus of snakes of the subfamily Crotalinae, having a hollowed out pit in the maxillary bone between the eye and nostril. Most of the recognized species are found in the southwestern United States and northern Mexico. Several species are found as far north as Canada and east of the Mississippi, including southern Appalachia. They are named for the jointed rattle (Greek krotalon) at the tip of their tail.. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980, p335)
=688  \\$a94
=750  \0$aCrotalus$5IEN$0(DLC)sh 85034306

=LDR  00959cz  a2200241n  4500
=001  9880363984702441
=005  20200427180009.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017837
=035  \\$aCRE6781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937.$x240.$x375
=150  \\$aBothrops
=450  \\$aBothrops jararaca
=450  \\$aFer-de-Lance
=450  \\$wnnna$aFer de Lance
=450  \\$wnnna$aFer-de-Lances
=450  \\$wnnna$aJararaca
=550  \\$wg$aCrotalinae
=667  \\$aa genus of vipers; its venom: coord IM with CROTALID VENOMS (IM)
=680  \\$iA genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336)
=688  \\$a94
=750  \0$aBothrops$5IEN$0(DLC)sh 85016019

=LDR  01213cz  a2200277n  4500
=001  9880363984802441
=005  20200427172320.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017836
=035  \\$aCRE6780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937.$x240.$x250
=150  \\$aAgkistrodon
=450  \\$wnnna$aAncistrodon
=450  \\$aBlack Moccasin
=450  \\$aCopperhead
=450  \\$wnnna$aCopperheads
=450  \\$aCottonmouth
=450  \\$wnnna$aCottonmouths
=450  \\$aSwamp Moccasin
=450  \\$aWater Moccasin
=550  \\$wg$aCrotalinae
=667  \\$aa genus of vipers; note X refs; its venom: coord IM with CROTALID VENOMS (IM)
=680  \\$iA genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75)
=688  \\$a94
=750  \0$aAgkistrodon$5IEN$0(DLC)sh 85002214

=LDR  01712cz  a2200409n  4500
=001  9880363984902441
=005  20141212212302.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017831
=035  \\$aCRE6777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x190
=150  \\$aDiagnosis, Dual (Psychiatry)
=450  \\$wnnna$aDiagnoses, Dual
=450  \\$wnnna$aDiagnoses, Dual Psychiatric
=450  \\$wnnna$aDiagnoses, Dual (Psychiatry)
=450  \\$wnnna$aDiagnoses, Psychiatric Dual
=450  \\$wnnna$aDiagnosis, Dual
=450  \\$wnnna$aDiagnosis, Dual Psychiatric
=450  \\$wnnna$aDiagnosis, Psychiatric Dual
=450  \\$wnnna$aDual Diagnoses
=450  \\$wnnna$aDual Diagnoses, Psychiatric
=450  \\$wnnna$aDual Diagnoses (Psychiatry)
=450  \\$wnnna$aDual Diagnosis
=450  \\$aDual Diagnosis, Psychiatric
=450  \\$wnnna$aDual Diagnosis (Psychiatry)
=450  \\$wnnna$aDual Psychiatric Diagnoses
=450  \\$wnnna$aDual Psychiatric Diagnosis
=450  \\$wnnna$aPsychiatric Diagnoses, Dual
=450  \\$wnnna$aPsychiatric Diagnosis, Dual
=450  \\$wnnna$aPsychiatric Dual Diagnoses
=450  \\$wnnna$aPsychiatric Dual Diagnosis
=550  \\$wg$aDiagnosis
=667  \\$arestrict to substance abuse with ment disord; IM GEN only; coord NIM with specific addiction (IM) + specific ment disord (IM); DF: DUAL DIAG
=680  \\$iThe co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity.
=688  \\$a94
=750  \0$aDual diagnosis$5IEN-M$0(DLC)sh 92003958

=LDR  03941cz  a2200769n  4500
=001  9880363985002441
=005  20141212212259.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017825
=035  \\$aCRE6772M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x362.$x375
=072  \\$aC10.$x228.$x140.$x695.$x625.$x375
=072  \\$aC10.$x314.$x400.$x375
=072  \\$aC10.$x574.$x500.$x300
=072  \\$aC16.$x320.$x400.$x150
=072  \\$aC16.$x320.$x565.$x189.$x362.$x375
=072  \\$aC18.$x452.$x132.$x100.$x362.$x375
=072  \\$aC18.$x452.$x648.$x189.$x362.$x375
=150  \\$aCanavan Disease
=450  \\$wnnna$aACY2 Deficiency
=450  \\$wnnna$aAminoacylase 2 Deficiency
=450  \\$wnnna$aASP Deficiency
=450  \\$wnnna$aASPA Deficiency
=450  \\$wnnna$aAspartoacylase Deficiency
=450  \\$wnnna$aCanavan Disease, Familial Form
=450  \\$wnnna$aCanavan Disease, Infantile
=450  \\$wnnna$aCanavan Disease, Juvenile
=450  \\$wnnna$aCanavan Disease, Neonatal
=450  \\$wnnna$aCanavan Disease, Sporadic Form
=450  \\$wnnna$aCanavan Disease, Type I
=450  \\$wnnna$aCanavan Disease, Type II
=450  \\$wnnna$aCanavan Disease, Type III
=450  \\$wnnna$aCanavan-van Bogaert-Bertrand Disease
=450  \\$wnnna$aCanavan van Bogaert Bertrand Disease
=450  \\$wnnna$aDeficiency Disease, Aspartoacylase
=450  \\$wnnna$aDisease, Canavan
=450  \\$wnnna$aDisease, Canavan-van Bogaert-Bertrand
=450  \\$wnnna$aDisease, Von Bogaert-Bertrand
=450  \\$wnnna$aFamilial Form of Canavan Disease
=450  \\$wnnna$aInfantile Canavan Disease
=450  \\$wnnna$aJuvenile Canavan Disease
=450  \\$wnnna$aLeukodystrophy, Spongiform
=450  \\$wnnna$aNeonatal Canavan Disease
=450  \\$wnnna$aSpongiform Leukodystrophy
=450  \\$wnnna$aSpongy Degeneration Of Central Nervous System
=450  \\$wnnna$aSpongy Degeneration of Infancy
=450  \\$wnnna$aSpongy Degeneration of the Brain
=450  \\$wnnna$aSpongy Degeneration of the Central Nervous System
=450  \\$wnnna$aSpongy Degeneration of White Matter In Infancy
=450  \\$wnnna$aSpongy Disease of Central Nervous System
=450  \\$wnnna$aSpongy Disease of White Matter
=450  \\$wnnna$aSporadic Form of Canavan Disease
=450  \\$wnnna$aSyndrome, Van Bogaert-Bertrand
=450  \\$wnnna$aType I Canavan Disease
=450  \\$wnnna$aType II Canavan Disease
=450  \\$wnnna$aType III Canavan Disease
=450  \\$wnnna$aVan Bogaert-Bertrand Syndrome
=450  \\$wnnna$aVan Bogaert Bertrand Syndrome
=450  \\$wnnna$aVon Bogaert-Bertrand Disease
=450  \\$wnnna$aVon Bogaert Bertrand Disease
=550  \\$wg$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=667  \\$ado not confuse X ref CANAVAN-VAN BOGAERT-BERTRAND DISEASE with VAN BOGAERT'S LEUKOENCEPHALITIS see SUBACUTE SCLEROSING PANENCEPHALITIS; DF: CANAVAN DIS
=680  \\$iA rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. (From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29(2):463-71)
=688  \\$a94
=750  \0$aCanavan disease$0(DLC)sh2006008479$5IEN-M

=LDR  00815cz  a2200217n  4500
=001  9880363985102441
=005  20141212212257.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017823
=035  \\$aCRE6770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x204
=150  \\$aFurcation Defects
=450  \\$wnnna$aDefect, Furcation
=450  \\$wnnna$aDefects, Furcation
=450  \\$wnnna$aFurcation Defect
=550  \\$wg$aPeriodontal Diseases
=667  \\$aa periodontal dis
=680  \\$iConditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.
=688  \\$a94
=750  \0$aTeeth$xRoots$xFurcation$5IEN-M$0(DLC)sh 85133230

=LDR  01157cz  a2200253n  4500
=001  9880363985202441
=005  20141212212257.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017821
=035  \\$aCRE6769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x250
=150  \\$aBoidae
=450  \\$aAnaconda
=450  \\$wnnna$aAnacondas
=450  \\$aBoa
=450  \\$wnnna$aBoas
=450  \\$aPython
=450  \\$wnnna$aPythons
=550  \\$wg$aSnakes
=667  \\$aa family of snakes; note X refs
=680  \\$iA family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial (burrowing). Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey's breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p315-320)
=688  \\$a94
=750  \0$aBoidae$5IEN$0(DLC)sh 85015337

=LDR  01857cz  a2200517n  4500
=001  9880363985302441
=005  20200427174941.0
=008  930507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017819
=035  \\$aCRE6768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x937
=150  \\$aViperidae
=450  \\$wnnna$aAdder, European
=450  \\$wnnna$aAdders, European
=450  \\$aAsp
=450  \\$wnnna$aAsps
=450  \\$wnnna$aAzemiopinae
=450  \\$aBitis
=450  \\$aBushmaster
=450  \\$wnnna$aBushmasters
=450  \\$aCerastes
=450  \\$wnnna$aCrotalid
=450  \\$aCrotalids
=450  \\$wnnna$aEuropean Adder
=450  \\$wnnna$aEuropean Adders
=450  \\$aEuropean Viper
=450  \\$wnnna$aEuropean Vipers
=450  \\$aGaboon Viper
=450  \\$wnnna$aGaboon Vipers
=450  \\$aLachesis
=450  \\$wnnna$aTrue Viper
=450  \\$wnnna$aTrue Vipers
=450  \\$wnnna$aViper, European
=450  \\$wnnna$aViper, Gaboon
=450  \\$wnnna$aViper, True
=450  \\$aViperinae
=450  \\$wnnna$aVipers, European
=450  \\$wnnna$aVipers, Gaboon
=450  \\$wnnna$aVipers, True
=550  \\$wg$aSnakes
=550  \\$wh$aCrotalinae
=550  \\$wh$aRussell's Viper
=680  \\$iA family of snakes comprising four subfamilies: Azemiopinae (the mountain viper, the sole member of this subfamily), Viperinae (true vipers), Crotalinae (pit vipers) and Causinae. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood (hemotoxic) as compared to the venom of elapids which act on the nervous system (neurotoxic). (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36)
=688  \\$a94
=750  \0$aViperidae$5IEN-M$0(DLC)sh 85143723

=LDR  02544cz  a2200673n  4500
=001  9880363985402441
=005  20200609144225.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017815
=035  \\$aCRE6766HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875
=150  \\$aElapidae
=450  \\$wnnna$aAsiatic Cobra
=450  \\$wnnna$aAsiatic Cobras
=450  \\$wnnna$aBoulengerina
=450  \\$wnnna$aCobra
=450  \\$wnnna$aCobra, Asiatic
=450  \\$wnnna$aCobra, Egyptian
=450  \\$wnnna$aCobra, Water
=450  \\$wnnna$aCobras
=450  \\$wnnna$aCobras, Asiatic
=450  \\$wnnna$aCobras, Egyptian
=450  \\$wnnna$aCobras, Water
=450  \\$wnnna$aEgyptian Cobra
=450  \\$wnnna$aEgyptian Cobras
=450  \\$wnnna$aHydrophidae
=450  \\$wnnna$aHydrophiinae
=450  \\$wnnna$aLauticaudinae
=450  \\$wnnna$aLauticaudus
=450  \\$aMamba
=450  \\$wnnna$aMambas
=450  \\$aMicrurus
=450  \\$wnnna$aNaja
=450  \\$wnnna$aNaja haje
=450  \\$wnnna$aNaja naja
=450  \\$wnnna$aRinghals
=450  \\$wnnna$aSea Snake
=450  \\$wnnna$aSea Snakes
=450  \\$wnnna$aSnake, Coral
=450  \\$wnnna$aSnake, Sea
=450  \\$wnnna$aSnakes, Coral
=450  \\$wnnna$aSnakes, Sea
=450  \\$wnnna$aWater Cobra
=450  \\$wnnna$aWater Cobras
=550  \\$wg$aAlethinophidia
=550  \\$wh$aBungarus
=550  \\$wh$aCoral Snakes
=550  \\$wh$aDendroaspis
=550  \\$wh$aHemachatus
=550  \\$wh$aHydrophiidae
=550  \\$wh$aLaticauda
=550  \\$wh$aOphiophagus hannah
=667  \\$aa family of very venomous snakes
=680  \\$iA family of extremely venomous snakes, comprising coral snakes, cobras, mambas, kraits, and sea snakes. They are widely distributed, being found in the southern United States, South America, Africa, southern Asia, Australia, and the Pacific Islands. The elapids include three subfamilies: Elapinae, Hydrophiinae, and Lauticaudinae. Like the viperids, they have venom fangs in the front part of the upper jaw. The mambas of Africa are the most dangerous of all snakes by virtue of their size, speed, and highly toxic venom. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p329-33)
=688  \\$a94
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Cobra
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Hydrophidae
=750  \0$aElapidae$5IEN$0(DLC)sh 85041501

=LDR  01974cz   2200481n  4500
=001  9880363985502441
=005  20220926163653.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017812
=035  \\$aCRE6765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x280
=150  \\$aColubridae
=450  \\$aGarter Snake
=450  \\$wnnna$aGarter Snakes
=450  \\$wnnna$aKing Snake
=450  \\$wnnna$aKing Snakes
=450  \\$wnnna$aLampropeltis
=450  \\$wnnna$aMocassin, Water
=450  \\$wnnna$aMocassins, Water
=450  \\$wnnna$aMoccasin, Water
=450  \\$wnnna$aMoccasins, Water
=450  \\$aNatrix
=450  \\$wnnna$aSnake, Garter
=450  \\$wnnna$aSnake, King
=450  \\$wnnna$aSnake, Water
=450  \\$wnnna$aSnakes, Garter
=450  \\$wnnna$aSnakes, King
=450  \\$wnnna$aSnakes, Water
=450  \\$aThamnophis
=450  \\$wnnna$aWater Mocassin
=450  \\$wnnna$aWater Mocassins
=450  \\$aWater Moccasin
=450  \\$wnnna$aWater Moccasins
=450  \\$aWater Snake
=450  \\$wnnna$aWater Snakes
=550  \\$wg$aSnakes
=667  \\$athe largest family of snakes; its venom: coord IM with SNAKE VENOMS (IM)
=680  \\$iThe largest family of snakes, comprising five subfamilies: Colubrinae, Natricinae, Homalopsinae, Lycodontinae, and Xenodontinae. They show a great diversity of eating habits, some eating almost anything, others having a specialized diet. They can be oviparous, ovoviviparous, or viviparous. The majority of North American snakes are colubrines. Among the colubrids are king snakes, water moccasins, water snakes, and garter snakes. Some genera are poisonous. (Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp321-29)
=688  \\$a94
=750  \0$aColubridae$5IEN$0(DLC)sh 85028731
=750  \0$iNarrower mapping$aBoomslang$0(DLC)sh2021008307$4NM$5IEN-M
=750  \0$iNarrower mapping$aDispholidus$0(DLC)sh2021008308$4NM$5IEN-M

=LDR  00762cz  a2200229n  4500
=001  9880363985602441
=005  20141212192755.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017806
=035  \\$aCRE6763M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x464.$x750
=072  \\$aB4.$x715.$x850.$x860
=072  \\$aB4.$x820.$x900.$x850
=150  \\$aTymovirus
=450  \\$aTurnip yellow mosaic virus
=450  \\$wnnna$aTymoviruses
=550  \\$wg$aMosaic Viruses
=550  \\$wg$aTymoviridae
=680  \\$iA genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation.
=688  \\$a94
=750  \0$aTymoviruses$0(DLC)sh2005000076$5IEN-M

=LDR  01071cz  a2200301n  4500
=001  9880363985702441
=005  20141212192755.0
=008  930216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017805
=035  \\$aCRE6762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500.$x862
=072  \\$aI1.$x240.$x361.$x500.$x862
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500.$x862
=072  \\$aN1.$x224.$x361.$x500.$x862
=072  \\$aN1.$x824.$x308.$x500.$x862
=150  \\$aWidowhood
=450  \\$wnnna$aWidow
=450  \\$wnnna$aWidowed
=450  \\$wnnna$aWidower
=450  \\$aWidowers
=450  \\$aWidows
=550  \\$wg$aMarital Status
=550  \\$aSingle Person
=667  \\$awoman or man: note X refs; spousal bereavement: coord IM with BEREAVEMENT (IM); coping behavior, coping strategy, coping style: coord IM with ADAPTATION, PSYCHOLOGICAL
=680  \\$iThe state of having lost a marital partner by death.
=688  \\$a94; WIDOWERS & WIDOWS were WIDOWER & WIDOW see SINGLE PERSON 1983-93
=750  \0$aWidowhood$5IEN$0(DLC)sh 88006252

=LDR  01093cz  a2200289n  4500
=001  9880363985802441
=005  20141212192754.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017800
=035  \\$aCRE6760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x464.$x600
=072  \\$aB4.$x715.$x635.$x600
=072  \\$aB4.$x820.$x590.$x600
=150  \\$aPotyvirus
=450  \\$aPotato Virus Y
=450  \\$wnnna$aPotato Virus Ys
=450  \\$wnnna$aPotyviruses
=450  \\$wnnna$aVirus Ys, Potato
=450  \\$wnnna$aYs, Potato Virus
=550  \\$wg$aMosaic Viruses
=550  \\$wg$aPotyviridae
=550  \\$wh$aPlum Pox Virus
=667  \\$aa genus of mosaic viruses; from POTato virus Y (Y is one of a series, e.g., A, M, S, V, etc.); coord IM with specific plant /virol (IM or NIM)
=680  \\$iA large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y.
=688  \\$a94
=750  \0$aPotyviruses$0(DLC) sh 92003570$5IEN-M

=LDR  01102cz  a2200265n  4500
=001  9880363985902441
=005  20141212192753.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017799
=035  \\$aCRE6759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x81.$x180
=072  \\$aB4.$x715.$x464.$x180
=072  \\$aB4.$x820.$x81.$x180
=150  \\$aCucumovirus
=450  \\$aCucumber mosaic virus
=450  \\$wnnna$aCucumber mosaic viruses
=450  \\$wnnna$aCucumoviruses
=450  \\$wnnna$amosaic virus, Cucumber
=550  \\$wg$aBromoviridae
=550  \\$wg$aMosaic Viruses
=667  \\$acoord IM with specific plant /virol
=680  \\$iA genus of plant viruses of the family BROMOVIRIDAE, which infect cucurbits and solanaceous plants. Transmission occurs via aphids in a non-persistent manner, and also via seeds. The type species Cucumber mosaic virus, a CUCUMOVIRUS, should not be confused with Cucumber green mottle mosaic virus, a TOBAMOVIRUS.
=688  \\$a94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96
=750  \0$aCucumoviruses$0(DLC)sh2007002838$5IEN-M

=LDR  01062cz  a2200265n  4500
=001  9880363986002441
=005  20141212192753.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017798
=035  \\$aCRE6758M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x150.$x150
=072  \\$aB4.$x715.$x464.$x150
=072  \\$aB4.$x820.$x150.$x150
=150  \\$aComovirus
=450  \\$aCowpea Mosaic Virus
=450  \\$wnnna$aCowpea Mosaic Viruses
=450  \\$wnnna$aMosaic Virus, Cowpea
=450  \\$wnnna$aMosaic Viruses, Cowpea
=550  \\$wg$aComoviridae
=550  \\$wg$aMosaic Viruses
=667  \\$acoord IM with specific plant /virol
=680  \\$iA genus of plant viruses of the family COMOVIRIDAE in which the bipartite genome is encapsidated in separate icosahedral particles. Mosaic and mottle symptoms are characteristic, and transmission is exclusively by leaf-feeding beetles. Cowpea mosaic virus is the type species.
=688  \\$a94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96
=750  \0$aComoviruses$0(DLC)sh2007002893$5IEN-M

=LDR  01115cz  a2200289n  4500
=001  9880363986102441
=005  20141212212254.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017796
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x92.$x150
=072  \\$aB4.$x715.$x102.$x150
=072  \\$aB4.$x715.$x464.$x100
=150  \\$aCaulimovirus
=450  \\$aCauliflower Mosaic Virus
=450  \\$wnnna$aCauliflower Mosaic Viruses
=450  \\$wnnna$aCaulimoviruses
=450  \\$wnnna$aMosaic Virus, Cauliflower
=450  \\$wnnna$aMosaic Viruses, Cauliflower
=450  \\$wnnna$aVirus, Cauliflower Mosaic
=450  \\$wnnna$aViruses, Cauliflower Mosaic
=550  \\$wg$aCaulimoviridae
=550  \\$wg$aMosaic Viruses
=667  \\$acoord IM with specific plant /virol (IM or NIM)
=680  \\$iA genus of PLANT VIRUSES, in the family CAULIMOVIRIDAE, that are transmitted by APHIDS in a semipersistent manner. Aphid-borne transmission of some caulimoviruses requires certain virus-coded proteins termed transmission factors.
=688  \\$a94
=750  \0$aCaulimoviruses$0(DLC)sh2007002851$5IEN-M

=LDR  00744cz  a2200229n  4500
=001  9880363986202441
=005  20141212192752.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017794
=035  \\$aCRE6754M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x81.$x50.$x50
=072  \\$aB4.$x715.$x464.$x40.$x50
=072  \\$aB4.$x820.$x81.$x50.$x50
=150  \\$aAlfalfa mosaic virus
=450  \\$wnnna$aAlfalfa mosaic viruses
=450  \\$wnnna$amosaic virus, Alfalfa
=550  \\$wg$aAlfamovirus
=667  \\$acoord IM with specific plant /virol
=680  \\$iThe type species of the genus ALFAMOVIRUS that is non-persistently transmitted by aphids.
=688  \\$a94
=750  \0$aAlfalfa mosaic virus$0(DLC) sh2003001493$5IEN-M

=LDR  00822cz  a2200229n  4500
=001  9880363986302441
=005  20141212212253.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017793
=035  \\$aCRE6753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x435.$x500
=072  \\$aB4.$x820.$x420.$x500
=150  \\$aLuteovirus
=450  \\$aBarley Yellow Dwarf Viruses
=450  \\$aBeet Western Yellows Virus
=450  \\$wnnna$aLuteoviruses
=550  \\$wg$aLuteoviridae
=667  \\$acoord IM with specific plant /virol (IM or NIM)
=680  \\$iA genus of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection.
=688  \\$a94
=750  \2$aLuteoviruses$0(DLC) sh 00000070$5IEN-M

=LDR  00831cz  a2200217n  4500
=001  9880363986502441
=005  20141212212253.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017790
=035  \\$aCRE6750M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x110.$x150
=072  \\$aB4.$x820.$x110.$x150
=150  \\$aClosterovirus
=450  \\$aBeet yellow stunt virus
=450  \\$aBeet yellows virus
=550  \\$wg$aClosteroviridae
=667  \\$acoord IM with specific plant /virol
=680  \\$iA genus of plant viruses in the family CLOSTEROVIRIDAE containing highly flexuous filaments. Some members are important pathogens of crop plants. Natural vectors include APHIDS, whiteflies, and mealybugs. The type species is Beet yellows virus.
=688  \\$a1994
=750  \0$aClosteroviruses$0(DLC)sh2005004621$5IEN-M

=LDR  00719cz  a2200205n  4500
=001  9880363986602441
=005  20141212212252.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017788
=035  \\$aCRE6748M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x260.$x150
=072  \\$aB4.$x820.$x260.$x150
=150  \\$aCarlavirus
=450  \\$wnnna$aCarlaviruses
=450  \\$aCarnation latent virus
=550  \\$wg$aFlexiviridae
=680  \\$iA genus of RNA plant viruses in the family FLEXIVIRIDAE, containing slightly flexuous filaments, often transmitted by aphids in a non-persistent manner. Carnation latent virus is the type species.
=688  \\$a94
=750  \0$aCarlaviruses$0(DLC)sh2007002845$5IEN-M

=LDR  00967cz  a2200241n  4500
=001  9880363986702441
=005  20141212212252.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017785
=035  \\$aCRE6747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x705
=072  \\$aG1.$x358.$x500.$x505.$x650.$x782
=072  \\$aG1.$x590.$x540.$x782
=072  \\$aG1.$x750.$x250.$x650.$x782
=072  \\$aG1.$x750.$x770.$x578.$x782
=150  \\$aPhotons
=550  \\$wg$aElementary Particles
=550  \\$wg$aLight
=667  \\$aelementary particles; IM
=680  \\$iDiscrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=688  \\$a94; was see RADIATION 1985-1993
=750  \0$aPhotons$5IEN$0(DLC)sh 85101398

=LDR  00762cz  a2200217n  4500
=001  9880363986802441
=005  20141212212251.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017780
=035  \\$aCRE6743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x582.$x500
=150  \\$aMalaria Vaccines
=450  \\$wnnna$aMalarial Vaccines
=450  \\$wnnna$aVaccines, Malaria
=450  \\$wnnna$aVaccines, Malarial
=550  \\$wg$aProtozoan Vaccines
=667  \\$acoord IM with specific Plasmodium /immunol (IM)
=680  \\$iVaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.
=688  \\$a94
=750  \0$aMalaria vaccines$5IEN-M

=LDR  00865cz  a2200265n  4500
=001  9880363986902441
=005  20141212212250.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017778
=035  \\$aCRE6741M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x815
=150  \\$aVaccines, Combined
=450  \\$wnnna$aCombination Vaccines
=450  \\$wnnna$aCombined Vaccines
=450  \\$wnnna$aVaccines, Combination
=550  \\$wg$aVaccines
=550  \\$wh$aDiphtheria-Tetanus-acellular Pertussis Vaccines
=550  \\$wh$aDiphtheria-Tetanus-Pertussis Vaccine
=550  \\$wh$aDiphtheria-Tetanus Vaccine
=550  \\$wh$aMeasles-Mumps-Rubella Vaccine
=667  \\$acoord NIM with specific vaccines (IM)
=680  \\$iTwo or more vaccines in a single dosage form.
=688  \\$a94
=750  \0$aCombined vaccines$5IEN-M$0(DLC)sh 98008106

=LDR  01008cz  a2200253n  4500
=001  9880363987002441
=005  20141212212249.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017773
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x600.$x600
=072  \\$aA2.$x633.$x567.$x50.$x750
=150  \\$aPelvic Floor
=450  \\$wnnna$aDiaphragm, Pelvic
=450  \\$wnnna$aDiaphragms, Pelvic
=450  \\$wnnna$aFloor, Pelvic
=450  \\$wnnna$aPelvic Diaphragm
=450  \\$wnnna$aPelvic Diaphragms
=550  \\$wg$aAbdominal Muscles
=550  \\$wg$aPelvis
=667  \\$aNIM when merely locational
=680  \\$iSoft tissue formed mainly by the pelvic diaphragm, which is composed of the two levator ani and two coccygeus muscles. The pelvic diaphragm lies just below the pelvic aperture (outlet) and separates the pelvic cavity from the PERINEUM. It extends between the PUBIC BONE anteriorly and the COCCYX posteriorly.
=688  \\$a94
=750  \0$aPelvic floor$0(DLC) sh 95007753$5IEN-M

=LDR  00854cz  a2200205n  4500
=001  9880363987102441
=005  20141212212249.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017770
=035  \\$aCRE6735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x676.$x530
=072  \\$aG1.$x595.$x540.$x530
=150  \\$aLifting
=450  \\$wnnna$aCarrying
=550  \\$wg$aMechanical Processes
=667  \\$aby machines or humans; PATIENT LIFTING see PATIENT MOVING AND LIFTING is available
=680  \\$iMoving or bringing something from a lower level to a higher one. The concept encompasses biomechanic stresses resulting from work done in transferring objects from one plane to another as well as the effects of varying techniques of patient handling and transfer.
=688  \\$a94
=750  \0$aLifting and carrying$5IEN-M$0(DLC)sh 85076860

=LDR  00841cz  a2200217n  4500
=001  9880363987202441
=005  20141212212247.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017767
=035  \\$aCRE6732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x903.$x149.$x500
=072  \\$aI1.$x880.$x735.$x944.$x903.$x149.$x500
=150  \\$aHolocaust
=450  \\$wnnna$aHolocausts
=550  \\$wg$aGenocide
=550  \\$aNational Socialism
=667  \\$awhen used in reference to the extermination of Jews by Nazis, spell with uppercase H: Holocaust in titles and translations
=680  \\$iA massive slaughter, especially the systematic mass extermination of European Jews in Nazi concentration camps prior to and during World War II.
=688  \\$a94
=750  \0$aHolocaust, Jewish (1939-1945)$5IEN-M$0(DLC)sh 85061515

=LDR  00725cz  a2200241n  4500
=001  9880363987302441
=005  20141212212243.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017756
=035  \\$aCRE6723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x168
=150  \\$aAquaculture
=450  \\$wnnna$aAquacultures
=450  \\$wnnna$aAquiculture
=450  \\$wnnna$aAquicultures
=550  \\$wg$aAgriculture
=550  \\$wh$aFisheries
=550  \\$aHydrobiology
=667  \\$arestrict to fauna in waters
=680  \\$iCultivation of natural faunal resources of water. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a94
=750  \0$aAquaculture$5IEN-M$0(DLC)sh 85006210

=LDR  00898cz  a2200277n  4500
=001  9880363987402441
=005  20141212212243.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017755
=035  \\$aCRE6722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x794
=150  \\$aProsthesis Fitting
=450  \\$wnnna$aAdjustment, Prosthesis
=450  \\$wnnna$aAdjustments, Prosthesis
=450  \\$wnnna$aFitting, Prosthesis
=450  \\$wnnna$aFittings, Prosthesis
=450  \\$wnnna$aProsthesis Adjustment
=450  \\$wnnna$aProsthesis Adjustments
=450  \\$wnnna$aProsthesis Fittings
=550  \\$wg$aTherapeutics
=550  \\$wh$aProsthesis Retention
=667  \\$acoordinate with specific prosthesis with no qualifiers
=680  \\$iThe fitting and adjusting of artificial parts of the body. (From Stedman's, 26th ed)
=688  \\$a94
=750  \0$aProsthesis$xFitting$5IEN-M

=LDR  00947cz  a2200253n  4500
=001  9880363987502441
=005  20141212212242.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017752
=035  \\$aCRE6719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x374.$x750
=072  \\$aG16.$x500.$x240.$x135.$x827
=072  \\$aN6.$x230.$x265
=150  \\$aGreenhouse Effect
=450  \\$wnnna$aEffect, Greenhouse
=550  \\$wg$aClimate Change
=550  \\$wg$aClimatic Processes
=550  \\$wg$aEnvironment
=550  \\$aCarbon Footprint
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe effect of GLOBAL WARMING and the resulting increase in world temperatures. The predicted health effects of such long-term climatic change include increased incidence of respiratory, water-borne, and vector-borne diseases.
=688  \\$a94
=750  \0$aGreenhouse effect, Atmospheric$5IEN-M$0(DLC)sh 85057237

=LDR  02481cz  a2200625n  4500
=001  9880363987602441
=005  20141212212241.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017750
=035  \\$aCRE6717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x40
=072  \\$aN2.$x360.$x67.$x40
=150  \\$aAnimal Technicians
=450  \\$wnnna$aAnimal Care Assistant
=450  \\$wnnna$aAnimal Care Assistants
=450  \\$wnnna$aAnimal Care Technician
=450  \\$wnnna$aAnimal Care Technicians
=450  \\$wnnna$aAnimal Technician
=450  \\$wnnna$aAnimal Technologist, Laboratory
=450  \\$wnnna$aAnimal Technologists, Laboratory
=450  \\$wnnna$aAssistant, Animal Care
=450  \\$wnnna$aAssistant, Veterinary
=450  \\$wnnna$aAssistants, Animal Care
=450  \\$wnnna$aAssistants, Veterinary
=450  \\$wnnna$aCare Assistant, Animal
=450  \\$wnnna$aCare Assistants, Animal
=450  \\$wnnna$aCare Technician, Animal
=450  \\$wnnna$aCare Technicians, Animal
=450  \\$wnnna$aLaboratory Animal Technologist
=450  \\$aLaboratory Animal Technologists
=450  \\$wnnna$aNurse, Veterinary
=450  \\$aNurses, Veterinary
=450  \\$wnnna$aTechnician, Animal
=450  \\$wnnna$aTechnician, Animal Care
=450  \\$wnnna$aTechnician, Veterinary
=450  \\$wnnna$aTechnicians, Animal
=450  \\$wnnna$aTechnicians, Animal Care
=450  \\$wnnna$aTechnicians, Veterinary
=450  \\$wnnna$aTechnologist, Laboratory Animal
=450  \\$wnnna$aTechnologists, Laboratory Animal
=450  \\$wnnna$aVeterinary Assistant
=450  \\$aVeterinary Assistants
=450  \\$wnnna$aVeterinary Nurse
=450  \\$aVeterinary Nurses
=450  \\$wnnna$aVeterinary Technician
=450  \\$wnnna$aVeterinary Technicians
=550  \\$wg$aAllied Health Personnel
=550  \\$aVeterinarians
=550  \\$aVeterinary Medicine
=667  \\$aX ref VETERINARY NURSES is British
=680  \\$iAssistants to a veterinarian, biological or biomedical researcher, or other scientist who are engaged in the care and management of animals, and who are trained in basic principles of animal life processes and routine laboratory and animal health care procedures. (Facts on File Dictionary of Health Care Management, 1988)
=688  \\$a94
=750  \0$aAnimal health technicians$5IEN-M$0(DLC)sh 85005192
=750  \0$aLaboratory animal technicians$5IEN-HS$0(DLC)sh 85073745

=LDR  01007cz  a2200265n  4500
=001  9880363987702441
=005  20141212212240.0
=008  930505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017749
=035  \\$aCRE6716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x955
=072  \\$aN4.$x761.$x700.$x675
=072  \\$aN5.$x700.$x792
=150  \\$aTotal Quality Management
=450  \\$aContinuous Quality Management
=450  \\$wnnna$aManagement, Continuous Quality
=450  \\$wnnna$aManagement, Total Quality
=550  \\$wg$aOrganization and Administration
=550  \\$wg$aQuality Assurance, Health Care
=550  \\$aQuality Control
=667  \\$anot restricted to health care; DF: TQM
=680  \\$iThe application of industrial management practice to systematically maintain and improve organization-wide performance. Effectiveness and success are determined and assessed by quantitative quality measures.
=688  \\$a94
=750  \0$aTotal quality management$5IEN$0(DLC)sh 91000952

=LDR  00812cz  a2200265n  4500
=001  9880363987802441
=005  20141212212240.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017748
=035  \\$aCRE6715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x412.$x923
=072  \\$aF2.$x784.$x692.$x816
=072  \\$aF4.$x96.$x628.$x779.$x900
=072  \\$aN4.$x452.$x932
=150  \\$aTime Management
=450  \\$wnnna$aManagement, Time
=450  \\$wnnna$aManagements, Time
=450  \\$wnnna$aTime Managements
=550  \\$wg$aHuman Engineering
=550  \\$wg$aOrganization and Administration
=550  \\$wg$aPsychology, Industrial
=680  \\$iPlanning and control of time to improve efficiency and effectiveness.
=688  \\$a94
=750  \0$aTime management$5IEN$0(DLC)sh 85135416

=LDR  00823cz  a2200253n  4500
=001  9880363987902441
=005  20141212212240.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017747
=035  \\$aCRE6714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x600.$x875
=150  \\$aSeafood
=450  \\$wnnna$aSea-Food
=450  \\$wnnna$aSea Food
=450  \\$wnnna$aSea-Foods
=450  \\$wnnna$aSeafoods
=550  \\$wg$aMeat
=550  \\$wh$aFish Products
=550  \\$wh$aShellfish
=667  \\$a"marine fish & shellfish used as food"; coord IM with specific fish or shellfish (IM)
=680  \\$iMarine fish and shellfish used as food or suitable for food. (Webster, 3d ed) SHELLFISH and FISH PRODUCTS are more specific types of SEAFOOD.
=688  \\$a94
=750  \0$aSeafood$5IEN$0(DLC)sh 85119293

=LDR  00800cz  a2200241n  4500
=001  9880363988002441
=005  20141212212239.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017745
=035  \\$aCRE6712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x510.$x900.$x600.$x500
=150  \\$aIncineration
=450  \\$wnnna$aDestruction, Thermal
=450  \\$wnnna$aDestructions, Thermal
=450  \\$wnnna$aIncinerations
=450  \\$wnnna$aThermal Destruction
=450  \\$wnnna$aThermal Destructions
=550  \\$wg$aRefuse Disposal
=667  \\$arestrict to waste disposal
=680  \\$iHigh temperature destruction of waste by burning with subsequent reduction to ashes or conversion to an inert mass.
=688  \\$a94
=750  \0$aIncineration$5IEN-M$0(DLC)sh 85064747

=LDR  01097cz  a2200289n  4500
=001  9880363988102441
=005  20141212212238.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017743
=035  \\$aCRE6710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x328
=072  \\$aN6.$x850.$x585
=150  \\$aEquipment Reuse
=450  \\$wnnna$aEquipment Recycling
=450  \\$wnnna$aEquipment Reusability
=450  \\$aProduct Recycling
=450  \\$aRecycling, Equipment
=450  \\$wnnna$aRecycling, Product
=450  \\$wnnna$aReusability, Equipment
=450  \\$wnnna$aReuse, Equipment
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aPublic Health
=667  \\$aNIM; coord with specific equip (IM) or specific techn /instrum (IM)
=680  \\$iFurther or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.
=688  \\$a94
=750  \0$aRecycled products$5IEN-M$0(DLC)sh 94005746

=LDR  01066cz  a2200253n  4500
=001  9880363988202441
=005  20141212212238.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017742
=035  \\$aCRE6709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x170.$x205
=072  \\$aN2.$x421.$x240.$x190.$x220
=150  \\$aDental Care for Chronically Ill
=450  \\$wnnna$aChronically Ill, Dental Care
=450  \\$wnnna$aChronically Ill, Dentistry
=450  \\$wnnna$aDentistry Chronically Ill
=450  \\$aDentistry for Chronically Ill
=550  \\$wg$aDental Care
=550  \\$aDental Care for Disabled
=667  \\$a= professional care by a professional; DF: DENT CARE CHRONIC ILL
=680  \\$iDental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED.
=688  \\$a94
=750  \0$aChronically ill$xDental care$5IEN-M

=LDR  01104cz  a2200301n  4500
=001  9880363988302441
=005  20141212212237.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017736
=035  \\$aCRE6703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x471
=150  \\$aIon-Selective Electrodes
=450  \\$wnnna$aElectrode, Ion-Selective
=450  \\$wnnna$aElectrode, Ion-Sensitive
=450  \\$aElectrodes, Ion-Selective
=450  \\$wnnna$aElectrodes, Ion Selective
=450  \\$wnnna$aElectrodes, Ion-Sensitive
=450  \\$wnnna$aIon-Selective Electrode
=450  \\$wnnna$aIon Selective Electrodes
=450  \\$wnnna$aIon-Sensitive Electrode
=450  \\$wnnna$aIon-Sensitive Electrodes
=450  \\$wnnna$aIon Sensitive Electrodes
=550  \\$wg$aElectrodes
=667  \\$adesigned to measure specific ion concentrations in cells, tissue or solutions
=680  \\$iElectrodes which can be used to measure the concentration of particular ions in cells, tissues, or solutions.
=688  \\$a94
=750  \0$aElectrodes, Ion selective$5IEN-M$0(DLC)sh 85042120

=LDR  01078cz  a2200265n  4500
=001  9880363988402441
=005  20141212212236.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017735
=035  \\$aCRE6702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x920.$x900
=150  \\$aVirus Latency
=450  \\$wnnna$aLatencies, Viral
=450  \\$wnnna$aLatencies, Virus
=450  \\$wnnna$aLatency, Viral
=450  \\$wnnna$aLatency, Virus
=450  \\$wnnna$aViral Latencies
=450  \\$wnnna$aViral Latency
=450  \\$wnnna$aVirus Latencies
=550  \\$wg$aVirus Physiological Phenomena
=667  \\$acoord with specific virus /physiol (IM or NIM)
=680  \\$iThe ability of a pathogenic virus to lie dormant within a cell (latent infection). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors.
=688  \\$a94
=750  \0$aLatent virus diseases$5IEN-M$0(DLC)sh 90002264

=LDR  01068cz  a2200337n  4500
=001  9880363988502441
=005  20141212212235.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017732
=035  \\$aCRE6699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285.$x100.$x100
=072  \\$aN2.$x421.$x297.$x879.$x100.$x100
=150  \\$aAir Ambulances
=450  \\$wnnna$aAir Ambulance
=450  \\$wnnna$aAmbulance, Air
=450  \\$wnnna$aAmbulance, Helicopter
=450  \\$aAmbulances, Air
=450  \\$wnnna$aAmbulances, Helicopter
=450  \\$wnnna$aEmergency Helicopter
=450  \\$wnnna$aEmergency Helicopters
=450  \\$wnnna$aHelicopter Ambulance
=450  \\$aHelicopter Ambulances
=450  \\$wnnna$aHelicopter, Emergency
=450  \\$wnnna$aHelicopters, Emergency
=550  \\$wg$aAircraft
=550  \\$wg$aAmbulances
=667  \\$aairplanes & helicopters
=680  \\$iFixed-wing aircraft or helicopters equipped for air transport of patients.
=688  \\$a94
=750  \0$aAirplane ambulances$5IEN-M$0(DLC)sh 85002777

=LDR  01871cz  a2200421n  4500
=001  9880363988602441
=005  20141212212232.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017723
=035  \\$aCRE6691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x706.$x477.$x400
=072  \\$aN4.$x761.$x879.$x300
=072  \\$aN5.$x700.$x900.$x300
=150  \\$aDrug Utilization Review
=450  \\$wnnna$aDrug-Use Review
=450  \\$wnnna$aDrug Use Review
=450  \\$wnnna$aDrug-Use Reviews
=450  \\$wnnna$aDrug Utilization Evaluation
=450  \\$wnnna$aDrug Utilization Evaluations
=450  \\$wnnna$aDrug Utilization Reviews
=450  \\$wnnna$aEvaluation, Drug Utilization
=450  \\$wnnna$aEvaluations, Drug Utilization
=450  \\$wnnna$aReview, Drug-Use
=450  \\$wnnna$aReview, Drug Use
=450  \\$wnnna$aReview, Drug Utilization
=450  \\$wnnna$aReviews, Drug-Use
=450  \\$wnnna$aReviews, Drug Utilization
=450  \\$wnnna$aUtilization Evaluation, Drug
=450  \\$wnnna$aUtilization Evaluations, Drug
=450  \\$aUtilization Review, Drug
=450  \\$wnnna$aUtilization Reviews, Drug
=550  \\$wg$aDrug Utilization
=550  \\$wg$aUtilization Review
=667  \\$aGEN or unspecified, IM; coord IM with specific drug with no qualif (IM); DF: DRUG UTIL REV
=680  \\$iFormal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
=688  \\$a94
=750  \0$aDrug utilization$xEvaluation$5IEN-M$0(DLC)sh 85039717

=LDR  01085cz  a2200241n  4500
=001  9880363988702441
=005  20141212212232.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017722
=035  \\$aCRE6690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x262.$x300
=072  \\$aN3.$x219.$x442.$x613
=150  \\$aHospital Charges
=450  \\$wnnna$aCharge, Hospital
=450  \\$wnnna$aCharges, Hospital
=450  \\$wnnna$aHospital Charge
=550  \\$wg$aEconomics, Hospital
=550  \\$wg$aFees and Charges
=667  \\$aprices for services: do not confuse with HOSPITAL COSTS, expenses incurred by hosp in providing services; DF: HOSP CHARGES
=680  \\$iThe prices a hospital sets for its services. HOSPITAL COSTS (the direct and indirect expenses incurred by the hospital in providing the services) are one factor in the determination of hospital charges. Other factors may include, for example, profits, competition, and the necessity of recouping the costs of uncompensated care.
=688  \\$a94
=750  \0$aHospitals$xRates$5IEN-M$0(DLC)sh 85062358

=LDR  01186cz  a2200253n  4500
=001  9880363988802441
=005  20141212212231.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017721
=035  \\$aCRE6689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x400.$x687
=072  \\$aN3.$x219.$x262.$x500
=072  \\$aN5.$x300.$x375.$x500
=150  \\$aHospital Costs
=450  \\$wnnna$aCost, Hospital
=450  \\$wnnna$aCosts, Hospital
=450  \\$wnnna$aHospital Cost
=550  \\$wg$aEconomics, Hospital
=550  \\$wg$aHealth Care Costs
=667  \\$aexpenses incurred by hosp in providing services: do not confuse with HOSPITAL CHARGES, prices for services; DF: HOSP COSTS
=680  \\$iThe expenses incurred by a hospital in providing care. The hospital costs attributed to a particular patient care episode include the direct costs plus an appropriate proportion of the overhead for administration, personnel, building maintenance, equipment, etc. Hospital costs are one of the factors which determine HOSPITAL CHARGES (the price the hospital sets for its services).
=688  \\$a94
=750  \0$aHospitals$xCost of operation$5IEN-M$0(DLC)sh 85062311

=LDR  01544cz  a2200325n  4500
=001  9880363988902441
=005  20190423152816.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017466
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x220
=072  \\$aD12.$x776.$x543.$x750.$x750.$x320
=150  \\$aReceptors, Endothelin
=450  \\$wnnna$aEndothelin Receptor
=450  \\$aEndothelin Receptors
=450  \\$wnnna$aEndothelium Derived Vasoconstrictor Factor Receptors
=450  \\$wnnna$aReceptor, Endothelin
=450  \\$wnnna$aReceptors, Endothelins
=450  \\$aReceptors, Endothelium-Derived Vasoconstrictor Factor
=450  \\$wnnna$aReceptors, Endothelium Derived Vasoconstrictor Factor
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aReceptor, Endothelin A
=550  \\$wh$aReceptor, Endothelin B
=550  \\$aEndothelins
=680  \\$iCell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells.
=688  \\$a93; was ENDOTHELIN RECEPTOR (NM) 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS & RECEPTORS, ENDOTHELIUM-DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993
=750  \0$81$wb$iBroader mapping$aEndothelins$0(DLC)sh 90000772$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aEndothelins--Receptors$5IEN-M

=LDR  01697cz  a2200397n  4500
=001  9880363989002441
=005  20190422120838.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017461
=035  \\$aCRE2624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8,$x811.$x520.$x650.$x600.$x500.$x500
=072  \\$aD12.$x776.$x543.$x750.$x700.$x500
=072  \\$aD12.$x776.$x543.$x750.$x750.$x160
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x170
=150  \\$aReceptors, Atrial Natriuretic Factor
=450  \\$aANF Receptors
=450  \\$aANP Receptors
=450  \\$wnnna$aAtrial Natriuretic Factor Receptor
=450  \\$aAtrial Natriuretic Factor Receptors
=450  \\$wnnna$aAtrial Natriuretic Peptides Receptor
=450  \\$aAtrial Natriuretic Peptides Receptors
=450  \\$aAtriopeptin Receptors
=450  \\$aReceptors, ANF
=450  \\$wnnna$aReceptors, ANP
=450  \\$wnnna$aReceptors, Atrial Natriuretic Peptides
=450  \\$aReceptors, Atriopeptin
=550  \\$wg$aReceptors, Guanylate Cyclase-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Peptide
=550  \\$aAtrial Natriuretic Factor
=680  \\$iCell surface proteins that bind ATRIAL NATRIURETIC FACTOR with high affinity and trigger intracellular changes influencing the behavior of cells. They contain intrinsic guanylyl cyclase activity.
=688  \\$a93; was ATRIAL NATRIURETIC FACTOR RECEPTOR (NM) 1984-92
=750  \0$81$wb$iBroader mapping$0(DLC)sh 86008139$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAtrial natriuretic peptides$5IEN-M

=LDR  01458cz  a2200313n  4500
=001  9880363989102441
=005  20190422112128.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017459
=035  \\$aCRE2623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200
=150  \\$aReceptors, Amino Acid
=450  \\$wnnna$aAmino Acid Receptor
=450  \\$aAmino Acid Receptors
=450  \\$wnnna$aAmino Acids Receptors
=450  \\$wnnna$aReceptor, Amino Acid
=450  \\$wnnna$aReceptors, Amino Acids
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wh$aReceptors, GABA
=550  \\$wh$aReceptors, Glutamate
=550  \\$wh$aReceptors, Glycine
=550  \\$aAmino Acids
=667  \\$acoord IM with specific amino acid (IM); DF: RECEPT AA
=680  \\$iCell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.
=688  \\$a93; was AMINO ACID RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aAmino acids$0(DLC)sh 85004486$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAmino acids--Receptors$5IEN-M

=LDR  01041cz  a2200265n  4500
=001  9880363989202441
=005  20190422142438.0
=008  920526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017457
=035  \\$aCRE2621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x100
=150  \\$aReceptors, Albumin
=450  \\$wnnna$aAlbumin Receptor
=450  \\$aAlbumin Receptors
=450  \\$wnnna$aReceptor, Albumin
=550  \\$wg$aReceptors, Peptide
=550  \\$aAlbumins
=550  \\$aSerum Albumin
=667  \\$acoord IM with specific albumin (IM); DF; RECEPT ALBUMIN
=680  \\$iCell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behavior of cells.
=688  \\$a93; was ALBUMIN RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aAlbumins$0(DLC)sh 85003246$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAlbumins--Receptors$5IEN-M

=LDR  01582cz  a2200457n  4500
=001  9880363989302441
=005  20141212212113.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017455
=035  \\$aCRE2619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x871.$x280
=072  \\$aD23.$x50.$x301.$x264.$x35.$x690
=072  \\$aD23.$x101.$x100.$x110.$x690
=150  \\$aReceptors, IgE
=450  \\$wnnna$aAntigen, CD23
=450  \\$wnnna$aAntigens, CD 23
=450  \\$aAntigens, CD23
=450  \\$wnnna$aCD 23 Antigens
=450  \\$wnnna$aCD23 Antigen
=450  \\$aCD23 Antigens
=450  \\$aepsilon Fc Receptors
=450  \\$wnnna$aepsilon Receptors, Fc
=450  \\$wnnna$aepsilon RI, Fc
=450  \\$wnnna$aepsilon RII, Fc
=450  \\$aFc epsilon Receptors
=450  \\$wnnna$aFc epsilon RI
=450  \\$wnnna$aFc epsilon RII
=450  \\$aFc Receptors, epsilon
=450  \\$aIgE Receptors
=450  \\$wnnna$aImmunoglobulin E Receptor
=450  \\$wnnna$aReceptor, Immunoglobulin E
=450  \\$wnnna$aReceptors, epsilon Fc
=450  \\$aReceptors, Fc epsilon
=550  \\$wg$aAntigens, CD
=550  \\$wg$aReceptors, Fc
=550  \\$aImmunoglobulin E
=667  \\$aDF: RECEPT IGE
=680  \\$iSpecific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).
=688  \\$a93; was IMMUNOGLOBULIN E RECEPTOR (NM) 1981-92
=750  \0$aCD23 antigen$5IEN-M$0(DLC)sh 91001904

=LDR  01866cz  a2200349n  4500
=001  9880363989402441
=005  20190507142337.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017451
=035  \\$aCRE2615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x780
=150  \\$aReceptors, Somatomedin
=450  \\$wnnna$aInsulin-Like Growth Factor Receptor
=450  \\$wnnna$aInsulin Like Growth Factor Receptor
=450  \\$wnnna$aInsulin-Like Growth Factor Receptors
=450  \\$wnnna$aInsulin Like Growth Factor Receptors
=450  \\$wnnna$aReceptor, Somatomedin
=450  \\$aReceptors, Insulin-Like Growth Factors
=450  \\$wnnna$aReceptors, Insulin Like Growth Factors
=450  \\$wnnna$aSomatomedin Receptor
=450  \\$aSomatomedin Receptors
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aReceptor, IGF Type 1
=550  \\$wh$aReceptor, IGF Type 2
=550  \\$aSomatomedins
=667  \\$aspecifics are also available; DF: RECEPT SOMATOMEDIN
=680  \\$iCell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes.
=688  \\$a93; was INSULIN-LIKE GROWTH FACTOR RECEPTOR (NM) 1980-92; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993
=750  \0$81$wb$iBroader mapping$aSomatomedin$0(DLC)sh 85124781$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSomatomedin--Receptors$5IEN-M

=LDR  03119cz  a2200781n  4500
=001  9880363989502441
=005  20190422141929.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017442
=035  \\$aCRE2606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x375.$x400
=072  \\$aD27.$x505.$x696.$x577.$x375.$x400
=150  \\$aHistamine Agonists
=450  \\$wnnna$aAgonist, H1
=450  \\$wnnna$aAgonist, H2
=450  \\$wnnna$aAgonist, H3
=450  \\$wnnna$aAgonist, Histamine
=450  \\$wnnna$aAgonist, Histamine H1
=450  \\$wnnna$aAgonist, Histamine H2
=450  \\$wnnna$aAgonist, Histamine H3
=450  \\$wnnna$aAgonist, Histaminergic
=450  \\$wnnna$aAgonists, H1
=450  \\$wnnna$aAgonists, H2
=450  \\$wnnna$aAgonists, H3
=450  \\$wnnna$aAgonists, Histamine
=450  \\$wnnna$aAgonists, Histamine H1
=450  \\$wnnna$aAgonists, Histamine H2
=450  \\$wnnna$aAgonists, Histamine H3
=450  \\$wnnna$aAgonists, Histaminergic
=450  \\$wnnna$aH1 Agonist
=450  \\$wnnna$aH1 Agonist, Histamine
=450  \\$wnnna$aH1 Agonists
=450  \\$wnnna$aH1 Agonists, Histamine
=450  \\$wnnna$aH2 Agonist
=450  \\$wnnna$aH2 Agonist, Histamine
=450  \\$wnnna$aH2 Agonists
=450  \\$wnnna$aH2 Agonists, Histamine
=450  \\$wnnna$aH3 Agonist
=450  \\$wnnna$aH3 Agonist, Histamine
=450  \\$wnnna$aH3 Agonists
=450  \\$wnnna$aH3 Agonists, Histamine
=450  \\$wnnna$aHistamine Agonist
=450  \\$aHistamine$xagonists
=450  \\$wnnna$aHistamine H1 Agonist
=450  \\$aHistamine H1 Agonists
=450  \\$wnnna$aHistamine H1 Receptor Agonist
=450  \\$wnnna$aHistamine H1 Receptor Agonists
=450  \\$wnnna$aHistamine H2 Agonist
=450  \\$aHistamine H2 Agonists
=450  \\$wnnna$aHistamine H2 Receptor Agonist
=450  \\$wnnna$aHistamine H2 Receptor Agonists
=450  \\$wnnna$aHistamine H3 Agonist
=450  \\$aHistamine H3 Agonists
=450  \\$wnnna$aHistamine H3 Receptor Agonists
=450  \\$wnnna$aHistaminergic Agonist
=450  \\$wnnna$aHistaminergic Agonists
=450  \\$aReceptors, Histamine$xagonists
=450  \\$aReceptors, Histamine H1$xagonists
=450  \\$aReceptors, Histamine H2$xagonists
=450  \\$aReceptors, Histamine H3$xagonists
=550  \\$wg$aHistamine Agents
=667  \\$aGEN or unspecified; prefer specifics; do not confuse with HISTAMINE ANTAGONISTS; DF: HISTAMINE AGON or HISTAMINE AG
=680  \\$iDrugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.
=688  \\$a93; HISTAMINE H1 RECEPTOR AGONISTS & HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94
=750  \0$81$wb$iBroader mapping$aHistamine$0(DLC)sh 85061073$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAgonists$0(DLC)sh 99002380$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aHistamine--Agonists$5IEN-M

=LDR  01344cz  a2200409n  4500
=001  9880363989602441
=005  20141212212106.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017440
=035  \\$aCRE2604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910.$x675
=150  \\$aPhotoperiod
=450  \\$wnnna$aCycle, Dark-Light
=450  \\$wnnna$aCycle, Daylight
=450  \\$wnnna$aCycle, Light
=450  \\$wnnna$aCycle, Light-Dark
=450  \\$wnnna$aCycles, Dark-Light
=450  \\$wnnna$aCycles, Daylight
=450  \\$wnnna$aCycles, Light
=450  \\$wnnna$aCycles, Light-Dark
=450  \\$wnnna$aDark-Light Cycle
=450  \\$wnnna$aDark Light Cycle
=450  \\$wnnna$aDark-Light Cycles
=450  \\$wnnna$aDaylight Cycle
=450  \\$wnnna$aDaylight Cycles
=450  \\$wnnna$aLight Cycle
=450  \\$wnnna$aLight Cycles
=450  \\$wnnna$aLight-Dark Cycle
=450  \\$wnnna$aLight Dark Cycle
=450  \\$wnnna$aLight-Dark Cycles
=450  \\$wnnna$aPhotoperiods
=550  \\$wg$aTime
=550  \\$aCircadian Rhythm
=680  \\$iThe time period of daily exposure that an organism receives from daylight or artificial light. It is believed that photoperiodic responses may affect the control of energy balance and thermoregulation.
=688  \\$a93
=750  \0$aPhotoperiodiodism$5IEN-M

=LDR  01095cz  a2200289n  4500
=001  9880363989702441
=005  20141212212106.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017439
=035  \\$aCRE2603M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x450.$x300.$x125
=072  \\$aC23.$x550.$x355.$x274.$x505
=150  \\$aCicatrix, Hypertrophic
=450  \\$wnnna$aCicatrices, Hypertrophic
=450  \\$wnnna$aHypertrophic Cicatrices
=450  \\$wnnna$aHypertrophic Cicatrix
=450  \\$wnnna$aHypertrophic Scar
=450  \\$wnnna$aHypertrophic Scars
=450  \\$wnnna$aScar, Hypertrophic
=450  \\$aScars, Hypertrophic
=550  \\$wg$aCicatrix
=550  \\$aKeloid
=667  \\$adoes not spread to surrounding tissue: do not confuse with KELOID which does; follow text of author
=680  \\$iAn elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously.
=688  \\$a93
=750  \0$aHypertrophic scars$5IEN-M$0(DLC)sh2001008803

=LDR  01519cz  a2200385n  4500
=001  9880363989802441
=005  20160425095509.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017430
=035  \\$aCRE2595M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x442.$x750
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x442.$x750
=072  \\$aD12.$x776.$x866.$x249.$x500
=072  \\$aD23.$x50.$x285.$x625
=072  \\$aD23.$x101.$x840.$x625
=150  \\$aProstate-Specific Antigen
=450  \\$agamma-Seminoprotein
=450  \\$wnnna$agamma Seminoprotein
=450  \\$ahK3 Kallikrein
=450  \\$aKallikrein hK3
=450  \\$wnnna$aKallikrein, hK3
=450  \\$wnnna$aProstate Specific Antigen
=450  \\$aPSA$5IEN-M
=450  \\$wnnna$aSemenogelase
=450  \\$wnnna$aSeminin
=550  \\$wg$aAntigens, Neoplasm
=550  \\$wg$aKallikreins
=550  \\$wg$aProstatic Secretory Proteins
=550  \\$wg$aBiomarkers, Tumor
=550  \\$aProstatic Neoplasms
=667  \\$ado not confuse with prostate-specific acid phosphatase ( = PROSTATE + ACID PHOSPHATASE)
=680  \\$iA glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
=688  \\$a93; was PROSTATE CANCER SPECIFIC ANTIGENS (NM) 1982-92; SEMENOGELASE was NM 1976-95
=750  \0$aProstate-specific antigen$5IEN-M$0(DLC)sh2001002935

=LDR  00633cz  a2200193n  4500
=001  9880363989902441
=005  20141212212057.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017419
=035  \\$aCRE2591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x745.$x660
=150  \\$aPotassium, Dietary
=450  \\$aDietary Potassium
=550  \\$wg$aPotassium Compounds
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther
=680  \\$iPotassium or potassium compounds used in foods or as foods.
=688  \\$a93
=750  \0$aFood$xPotassium content$5IEN-M$0(DLC)sh 85050211

=LDR  01622cz  a2200265n  4500
=001  9880363990002441
=005  20141212212053.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017406
=035  \\$aCRE2581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x950
=150  \\$aSexual Harassment
=450  \\$aHarassment, Sexual
=450  \\$wnnna$aHarassments, Sexual
=450  \\$wnnna$aHarrassment, Sexual
=450  \\$wnnna$aHarrassments, Sexual
=450  \\$wnnna$aSexual Harassments
=450  \\$wnnna$aSexual Harrassment
=450  \\$wnnna$aSexual Harrassments
=550  \\$wg$aSexual Behavior
=667  \\$aHARASSMENT, NONSEXUAL see SOCIAL BEHAVIOR is also available
=680  \\$iA form of discrimination in the workplace which violates the Civil Rights Act of 1964. Sexual harassment takes two forms: quid pro quo, where the employee must submit to sexual advances in exchange for job benefits or be penalized for refusing; or a hostile environment, where the atmosphere of the workplace is offensive and affects the employee's well-being. Offensive sexual conduct may include unwelcome advances, comments, touching, questions about marital status and sex practices, etc. Both men and women may be aggressors or victims. (Slee and Slee, Health Care Terms, 2d ed, p.404). While civil rights legislation deals with sexual harassment in the workplace, the behavior is not restricted to this; it may take place outside the work environment: in schools and colleges, athletics, and other social milieus and activities.
=688  \\$a93
=750  \0$aSexual Harassment$5IEN-M$0(DLC)sh 85120735

=LDR  01685cz  a2200409n  4500
=001  9880363990102441
=005  20141212212052.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017404
=035  \\$aCRE2579M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670.$x325.$x350
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670.$x325.$x350
=072  \\$aE5.$x200.$x500.$x620.$x670.$x325.$x350
=072  \\$aE5.$x200.$x750.$x600.$x670.$x325.$x350
=072  \\$aE5.$x393.$x285.$x350
=072  \\$aE5.$x393.$x661.$x475.$x350
=150  \\$aIn Situ Hybridization, Fluorescence
=450  \\$wnnna$aFISH Technic
=450  \\$wnnna$aFISH Technics
=450  \\$aFISH Technique
=450  \\$wnnna$aFISH Techniques
=450  \\$aFluorescence in situ hybridization$5IEN-HS
=450  \\$aFluorescent in Situ Hybridization
=450  \\$aHybridization in Situ, Fluorescence
=450  \\$wnnna$aHybridization in Situ, Fluorescent
=450  \\$wnnna$aIn Situ Hybridization, Fluorescent
=450  \\$wnnna$aTechnic, FISH
=450  \\$wnnna$aTechnics, FISH
=450  \\$wnnna$aTechnique, FISH
=450  \\$wnnna$aTechniques, FISH
=550  \\$wg$aCytogenetic Analysis
=550  \\$wg$aIn Situ Hybridization
=550  \\$wh$aChromosome Painting
=680  \\$iA type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.
=688  \\$a93
=750  \0$aFluorescence in situ hybridization$5IEN-M$0(DLC)sh 98005669

=LDR  01197cz  a2200313n  4500
=001  9880363990202441
=005  20141212212051.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017403
=035  \\$aCRE2578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670.$x325
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670.$x325
=072  \\$aE5.$x200.$x500.$x620.$x670.$x325
=072  \\$aE5.$x200.$x750.$x600.$x670.$x325
=072  \\$aE5.$x393.$x661.$x475
=150  \\$aIn Situ Hybridization
=450  \\$aHybridization in Situ
=450  \\$wnnna$aHybridization, In Situ
=450  \\$wnnna$aHybridizations, In Situ
=450  \\$wnnna$aIn Situ Hybridizations
=550  \\$wg$aNucleic Acid Hybridization
=550  \\$wg$aStaining and Labeling
=550  \\$wh$aIn Situ Hybridization, Fluorescence
=550  \\$wh$aPrimed In Situ Labeling
=667  \\$ato locate specific nucleic acid seq
=680  \\$iA technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
=688  \\$a93
=750  \0$aIn situ hybridization$5IEN-M$0(DLC)sh 90000762

=LDR  01288cz  a2200301n  4500
=001  9880363990302441
=005  20141212212051.0
=008  920513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017402
=035  \\$aCRE2577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x220
=072  \\$aD2.$x455.$x526.$x510.$x140
=150  \\$aChlorofluorocarbons
=450  \\$wnnna$aChlorofluorocarbon Derivatives
=450  \\$wnnna$aDerivatives, Chlorofluorocarbon
=450  \\$wnnna$aFreon
=450  \\$aFreons
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wg$aHydrocarbons, Fluorinated
=550  \\$wh$aBromochlorofluorocarbons
=550  \\$wh$aChlorofluorocarbons, Ethane
=550  \\$wh$aChlorofluorocarbons, Methane
=667  \\$ado not confuse with FLUOROCARBONS or HYDROCARBONS, CHLORINATED or HYDROCARBONS, FLUORINATED
=680  \\$iA series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.
=688  \\$a1993; for FREONS and FREON use CHLOROFLUORCARBONS, METHANE
=688  \\$a93
=750  \0$aChlorofluorocarbons$5IEN-M$0(DLC)sh 85024561

=LDR  04756cz  a2201249n  4500
=001  9880363990402441
=005  20141212192736.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017397
=035  \\$aCRE2573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x270.$x700
=150  \\$aPrefrontal Cortex
=450  \\$wnnna$aArea, Orbital
=450  \\$wnnna$aArea, Subcallosal
=450  \\$wnnna$aAreas, Orbital
=450  \\$wnnna$aAreas, Subcallosal
=450  \\$wnnna$aConvolution, Superior Frontal
=450  \\$wnnna$aConvolutions, Superior Frontal
=450  \\$wnnna$aCortex, Lateral Orbitofrontal
=450  \\$wnnna$aCortex, Orbital
=450  \\$wnnna$aCortex, Orbitofrontal
=450  \\$wnnna$aCortex, Prefrontal
=450  \\$wnnna$aCortex, Ventromedial Prefrontal
=450  \\$wnnna$aCortices, Lateral Orbitofrontal
=450  \\$wnnna$aCortices, Orbital
=450  \\$wnnna$aCortices, Orbitofrontal
=450  \\$wnnna$aCortices, Ventromedial Prefrontal
=450  \\$wnnna$aFrontal Convolution, Superior
=450  \\$wnnna$aFrontal Convolutions, Superior
=450  \\$wnnna$aFrontal Gyrus, Inferior
=450  \\$wnnna$aFrontal Gyrus, Medial
=450  \\$wnnna$aFrontal Gyrus, Superior
=450  \\$wnnna$aFrontal Sulcus
=450  \\$wnnna$aFrontalis Inferior, Gyrus
=450  \\$wnnna$aFrontalis Inferiors, Gyrus
=450  \\$wnnna$aFrontalis Superior, Gyrus
=450  \\$wnnna$aFrontalis Superiors, Gyrus
=450  \\$wnnna$aGyri, Orbital
=450  \\$wnnna$aGyri, Orbitofrontal
=450  \\$wnnna$aGyrus Frontalis Inferior
=450  \\$wnnna$aGyrus Frontalis Inferiors
=450  \\$wnnna$aGyrus Frontalis Superior
=450  \\$wnnna$aGyrus Frontalis Superiors
=450  \\$wnnna$aGyrus, Inferior Frontal
=450  \\$wnnna$aGyrus, Marginal
=450  \\$wnnna$aGyrus, Medial Frontal
=450  \\$wnnna$aGyrus, Orbital
=450  \\$wnnna$aGyrus Orbitali
=450  \\$wnnna$aGyrus Orbitalis
=450  \\$wnnna$aGyrus, Orbitofrontal
=450  \\$wnnna$aGyrus, Rectal
=450  \\$wnnna$aGyrus Rectus
=450  \\$wnnna$aGyrus, Rectus
=450  \\$wnnna$aGyrus, Straight
=450  \\$wnnna$aGyrus, Superior Frontal
=450  \\$wnnna$aInferior Frontal Gyrus
=450  \\$wnnna$aInferior, Gyrus Frontalis
=450  \\$wnnna$aInferiors, Gyrus Frontalis
=450  \\$wnnna$aLateral Orbitofrontal Cortex
=450  \\$wnnna$aLateral Orbitofrontal Cortices
=450  \\$wnnna$aMarginal Gyrus
=450  \\$wnnna$aMedial Frontal Gyrus
=450  \\$wnnna$aOlfactory Sulci
=450  \\$wnnna$aOlfactory Sulcus
=450  \\$wnnna$aOrbital Area
=450  \\$wnnna$aOrbital Areas
=450  \\$wnnna$aOrbital Cortex
=450  \\$wnnna$aOrbital Cortices
=450  \\$wnnna$aOrbital Gyri
=450  \\$wnnna$aOrbital Gyrus
=450  \\$wnnna$aOrbitali, Gyrus
=450  \\$wnnna$aOrbitalis, Gyrus
=450  \\$wnnna$aOrbitofrontal Cortex
=450  \\$wnnna$aOrbitofrontal Cortex, Lateral
=450  \\$wnnna$aOrbitofrontal Cortices
=450  \\$wnnna$aOrbitofrontal Cortices, Lateral
=450  \\$wnnna$aOrbitofrontal Gyri
=450  \\$wnnna$aOrbitofrontal Gyrus
=450  \\$wnnna$aOrbitofrontal Region
=450  \\$wnnna$aOrbitofrontal Regions
=450  \\$wnnna$aPrefrontal Cortex, Ventromedial
=450  \\$wnnna$aPrefrontal Cortices, Ventromedial
=450  \\$wnnna$aRectal Gyrus
=450  \\$wnnna$aRectus Gyrus
=450  \\$wnnna$aRectus, Gyrus
=450  \\$wnnna$aRegion, Orbitofrontal
=450  \\$wnnna$aRegions, Orbitofrontal
=450  \\$wnnna$aStraight Gyrus
=450  \\$wnnna$aSubcallosal Area
=450  \\$wnnna$aSubcallosal Areas
=450  \\$wnnna$aSulci, Olfactory
=450  \\$wnnna$aSulcus, Frontal
=450  \\$wnnna$aSulcus, Olfactory
=450  \\$wnnna$aSuperior Frontal Convolution
=450  \\$wnnna$aSuperior Frontal Convolutions
=450  \\$wnnna$aSuperior Frontal Gyrus
=450  \\$wnnna$aSuperior, Gyrus Frontalis
=450  \\$wnnna$aSuperiors, Gyrus Frontalis
=450  \\$wnnna$aVentral Medial Prefrontal Cortex
=450  \\$wnnna$aVentromedial Prefrontal Cortex
=450  \\$wnnna$aVentromedial Prefrontal Cortices
=550  \\$wg$aFrontal Lobe
=550  \\$wh$aBroca Area
=680  \\$iThe rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The prefrontal cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin.
=688  \\$a93
=750  \0$aPrefrontal cortex$5IEN-M$0(DLC)sh 90005125

=LDR  01123cz  a2200265n  4500
=001  9880363990502441
=005  20141212212048.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017393
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x750.$x250
=072  \\$aG2.$x149.$x115.$x750.$x250
=072  \\$aG3.$x495.$x839.$x250
=072  \\$aG5.$x355.$x315.$x700.$x250
=150  \\$aRNA Editing
=450  \\$wnnna$aEditing, RNA
=450  \\$wnnna$aEditings, RNA
=450  \\$wnnna$aRNA Editings
=450  \\$aRNA, Messenger, Editing
=550  \\$wg$aRNA Processing, Post-Transcriptional
=550  \\$aRNA, Guide
=667  \\$aa type of post-transcriptional RNA processing
=680  \\$iA process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE).
=688  \\$a93
=750  \0$aRNA editing$5IEN-M$0(DLC)sh 93000171

=LDR  00930cz  a2200241n  4500
=001  9880363990602441
=005  20141212212045.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017380
=035  \\$aCRE2559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x195.$x410
=072  \\$aC23.$x300.$x775.$x250.$x401
=150  \\$aHypertrophy, Right Ventricular
=450  \\$wnnna$aHypertrophies, Right Ventricular
=450  \\$wnnna$aRight Ventricular Hypertrophies
=450  \\$aRight Ventricular Hypertrophy
=450  \\$wnnna$aVentricular Hypertrophies, Right
=450  \\$aVentricular Hypertrophy, Right
=550  \\$wg$aCardiomegaly
=680  \\$iEnlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
=688  \\$a93
=750  \0$aHeart$xRight ventricle$xHypertrophy$5IEN-M

=LDR  00937cz  a2200241n  4500
=001  9880363990702441
=005  20141212212045.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017379
=035  \\$aCRE2558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x195.$x400
=072  \\$aC23.$x300.$x775.$x250.$x400
=150  \\$aHypertrophy, Left Ventricular
=450  \\$wnnna$aHypertrophies, Left Ventricular
=450  \\$wnnna$aLeft Ventricular Hypertrophies
=450  \\$aLeft Ventricular Hypertrophy
=450  \\$wnnna$aVentricular Hypertrophies, Left
=450  \\$aVentricular Hypertrophy, Left
=550  \\$wg$aCardiomegaly
=680  \\$iEnlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
=688  \\$a93
=750  \0$aHeart$xLeft ventricle$xHypertrophy$5IEN-M

=LDR  00862cz  a2200217n  4500
=001  9880363990802441
=005  20141212212044.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017378
=035  \\$aCRE2557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x822.$x700
=150  \\$aQuinolinic Acid
=450  \\$aQuinolinate
=450  \\$wnnna$aQuinolinic Acid, Copper(2+) Salt
=450  \\$wnnna$aQuinolinic Acid, Disodium Salt
=450  \\$wnnna$aQuinolinic Acid, Strontium Salt
=550  \\$wg$aQuinolinic Acids
=680  \\$iA metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
=688  \\$a93; was QUINOLINIC ACID (NM) 1981-92
=750  \0$aQuinolinic Acid$5IEN-M$0(DLC)sh 88006235

=LDR  00797cz  a2200205n  4500
=001  9880363990902441
=005  20141212212044.0
=008  920514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017377
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x875
=150  \\$aDiatoms
=450  \\$aBacillariophyta
=450  \\$wnnna$aBacillariophytas
=450  \\$wnnna$aDiatom
=550  \\$wg$aStramenopiles
=550  \\$aPhytoplankton
=680  \\$iThe common name for the phylum of microscopic unicellular STRAMENOPILES. Most are aquatic, being found in fresh, brackish, and salt water. Diatoms are noted for the symmetry and sculpturing of their siliceous cell walls. They account for 40% of PHYTOPLANKTON, but not all diatoms are planktonic.
=688  \\$a93
=750  \0$aDiatoms$5IEN-M$0(DLC)sh 85037628

=LDR  01728cz  a2200493n  4500
=001  9880363991002441
=005  20141212212043.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017374
=035  \\$aCRE2553M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x600
=150  \\$aParoxetine
=450  \\$wnnna$aAcetate, Paroxetine
=450  \\$wnnna$aAnhydrous, Paroxetine Hydrochloride
=450  \\$wnnna$aAropax
=450  \\$wnnna$aBRL-29060
=450  \\$wnnna$aBRL 29060
=450  \\$wnnna$aBRL29060
=450  \\$wnnna$aFG-7051
=450  \\$wnnna$aFG 7051
=450  \\$wnnna$aFG7051
=450  \\$wnnna$aHemihydrate Paroxetine Hydrochloride
=450  \\$wnnna$aHemihydrate, Paroxetine Hydrochloride
=450  \\$wnnna$aHydrochloride Anhydrous, Paroxetine
=450  \\$wnnna$aHydrochloride Hemihydrate, Paroxetine
=450  \\$wnnna$aHydrochloride, Hemihydrate Paroxetine
=450  \\$wnnna$aHydrochloride, Paroxetine
=450  \\$wnnna$aMaleate, Paroxetine
=450  \\$wnnna$aParoxetine Acetate
=450  \\$wnnna$aParoxetine, cis-(+)-Isomer
=450  \\$wnnna$aParoxetine, cis-(-)-Isomer
=450  \\$wnnna$aParoxetine Hydrochloride
=450  \\$wnnna$aParoxetine Hydrochloride Anhydrous
=450  \\$wnnna$aParoxetine Hydrochloride Hemihydrate
=450  \\$wnnna$aParoxetine Hydrochloride, Hemihydrate
=450  \\$wnnna$aParoxetine Maleate
=450  \\$wnnna$aParoxetine, trans-(+)-Isomer
=450  \\$wnnna$aPaxil
=450  \\$wnnna$aSeroxat
=550  \\$wg$aPiperidines
=680  \\$iA serotonin uptake inhibitor that is effective in the treatment of depression.
=688  \\$a93; was PAROXETINE (NM) 1978-92
=750  \0$aParoxetine$0(DLC)sh2008001313$5IEN-M

=LDR  02388nz  a2200601n  4500
=001  9882549679202441
=005  20250214144351.0
=008  920522\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017367
=035  \\$a(DNLM)D017367
=035  \\$a(NLM)98198605550000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 77.5
=072  \\$aD27.$x505.$x519.$x562.$x437.$x850
=072  \\$aD27.$x505.$x519.$x625.$x600.$x850
=072  \\$aD27.$x505.$x519.$x625.$x850.$x900
=072  \\$aD27.$x505.$x696.$x577.$x600.$x850
=072  \\$aD27.$x505.$x696.$x577.$x850.$x900
=150  \\$aSelective Serotonin Reuptake Inhibitors
=450  \\$wnnna$aInhibitors, 5-HT Uptake
=450  \\$wnnna$aInhibitors, 5-Hydroxytryptamine Uptake
=450  \\$wnnna$aInhibitors, Serotonin Reuptake
=450  \\$wnnna$aInhibitors, Serotonin Uptake
=450  \\$wnnna$aReuptake Inhibitors, Serotonin
=450  \\$wnnna$aUptake Inhibitors, 5-HT
=450  \\$wnnna$aUptake Inhibitors, 5-Hydroxytryptamine
=450  \\$wnnna$aUptake Inhibitors, Serotonin
=450  \\$a5-HT Uptake Inhibitor
=450  \\$a5-HT Uptake Inhibitors
=450  \\$a5-Hydroxytryptamine Uptake Inhibitor
=450  \\$a5-Hydroxytryptamine Uptake Inhibitors
=450  \\$aSelective Serotonin Reuptake Inhibitor
=450  \\$aSerotonin Reuptake Inhibitor
=450  \\$aSerotonin Reuptake Inhibitors
=450  \\$aSerotonin Uptake Inhibitor
=450  \\$aSerotonin Uptake Inhibitors
=450  \\$aSSRIs
=450  \\$wnnna$aInhibitor, 5-HT Uptake
=450  \\$wnnna$aInhibitor, 5-Hydroxytryptamine Uptake
=450  \\$wnnna$aInhibitor, Serotonin Reuptake
=450  \\$wnnna$aInhibitor, Serotonin Uptake
=450  \\$wnnna$aReuptake Inhibitor, Serotonin
=450  \\$wnnna$aUptake Inhibitor, 5-HT
=450  \\$wnnna$aUptake Inhibitor, 5-Hydroxytryptamine
=450  \\$wnnna$aUptake Inhibitor, Serotonin
=450  \\$aSerotonin Plasma Membrane Transport Proteins$xantagonists & inhibitors
=550  \\$aSerotonin Antagonists
=550  \\$aSerotonin Syndrome
=667  \\$ado not confuse with SEROTONIN ANTAGONISTS
=680  \\$iCompounds that specifically inhibit the reuptake of serotonin in the brain.
=680  \\$iCompounds that specifically inhibit the reuptake of serotonin in the brain.
=688  \\$a2023(1993)
=750  \0$aSerotonin uptake inhibitors$5IEN-M$0(DLC)sh 94000398

=LDR  02324cz  a2200589n  4500
=001  9880363991202441
=005  20141212212041.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017366
=035  \\$aCRE2546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x850.$x800
=072  \\$aD27.$x505.$x696.$x577.$x850.$x800
=150  \\$aSerotonin Receptor Agonists
=450  \\$wnnna$a5-HT Agonist
=450  \\$wnnna$a5 HT Agonist
=450  \\$a5-HT Agonists
=450  \\$wnnna$a5 HT Agonists
=450  \\$a5-Hydroxytryptamine Agonists
=450  \\$wnnna$a5 Hydroxytryptamine Agonists
=450  \\$wnnna$a5-Hydroxytrytamine Agonist
=450  \\$wnnna$a5 Hydroxytrytamine Agonist
=450  \\$wnnna$aAgonist, 5-HT
=450  \\$wnnna$aAgonist, 5-Hydroxytrytamine
=450  \\$wnnna$aAgonist, Serotonergic
=450  \\$wnnna$aAgonist, Serotonin
=450  \\$wnnna$aAgonist, Serotonin Receptor
=450  \\$wnnna$aAgonists, 5-HT
=450  \\$wnnna$aAgonists, 5-Hydroxytryptamine
=450  \\$wnnna$aAgonists, Serotonergic
=450  \\$wnnna$aAgonists, Serotonin
=450  \\$wnnna$aAgonists, Serotonin Receptor
=450  \\$wnnna$aReceptor Agonist, Serotonin
=450  \\$wnnna$aReceptor Agonists, Serotonin
=450  \\$aReceptors, Serotonin$xagonists
=450  \\$wnnna$aSerotonergic Agonist
=450  \\$wnnna$aSerotonergic Agonists
=450  \\$wnnna$aSerotonin Agonist
=450  \\$aSerotonin Agonists
=450  \\$aSerotonin$xagonists
=450  \\$wnnna$aSerotonin Receptor Agonist
=550  \\$wg$aSerotonin Agents
=550  \\$wh$aSerotonin 5-HT1 Receptor Agonists
=550  \\$wh$aSerotonin 5-HT2 Receptor Agonists
=550  \\$wh$aSerotonin 5-HT3 Receptor Agonists
=550  \\$wh$aSerotonin 5-HT4 Receptor Agonists
=667  \\$ageneral or unspecified; prefer specifics; note entry term SEROTONIN AGONISTS: do not confuse with SEROTONIN ANTAGONISTS
=680  \\$iEndogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.
=688  \\$a2011(1993)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Serotonin Agonists
=688  \\$a93
=750  \0$aSerotonin$xAgonists$0(DLC) sh 96010269$5IEN-M

=LDR  00790cz  a2200205n  4500
=001  9880363991302441
=005  20160914180011.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017365
=035  \\$aCRE2545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x300.$x250.$x725
=072  \\$aJ2.$x500.$x250.$x725
=150  \\$aSpices
=450  \\$wnnna$aSpice
=550  \\$wg$aCondiments
=667  \\$acoord with specific plant + specific plant component (if pertinent); for use in therapy coord with PHYTOTHERAPY (IM) + disease /*drug ther (IM)
=680  \\$iThe dried seeds, bark, root, stems, buds, leaves, or fruit of aromatic plants used to season food.
=688  \\$a93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82
=750  \0$aSpices$5IEN-M$0(DLC)sh 85126619

=LDR  01185cz  a2200325n  4500
=001  9880363991402441
=005  20141212212040.0
=008  920513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017364
=035  \\$aCRE2544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x480.$x205
=072  \\$aD8.$x811.$x277.$x656.$x675.$x374.$x205
=150  \\$aCollagenases
=450  \\$wnnna$aCollagen-Degrading Enzyme
=450  \\$wnnna$aCollagen Degrading Enzyme
=450  \\$wnnna$aCollagen Peptidase
=450  \\$wnnna$aCollagenase
=450  \\$wnnna$aPeptidase, Collagen
=550  \\$wg$aMetalloendopeptidases
=550  \\$wh$aMatrix Metalloproteinase 1
=550  \\$wh$aMatrix Metalloproteinase 13
=550  \\$wh$aMatrix Metalloproteinase 2
=550  \\$wh$aMatrix Metalloproteinase 8
=550  \\$wh$aMatrix Metalloproteinase 9
=550  \\$wh$aMicrobial Collagenase
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iEnzymes that catalyze the degradation of collagen by acting on the peptide bonds.
=688  \\$a93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92
=750  \0$aCollagenases$0(DLC) sh 85097972$5IEN-M

=LDR  01386cz  a2200301n  4500
=001  9880363991502441
=005  20141212212039.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017360
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x100
=150  \\$aArabidopsis
=450  \\$wnnna$aArabidopses
=450  \\$aArabidopsis thaliana
=450  \\$wnnna$aArabidopsis thalianas
=450  \\$aCress, Mouse-ear
=450  \\$wnnna$aCress, Mouse ear
=450  \\$wnnna$aCresses, Mouse-ear
=450  \\$wnnna$aMouse-ear Cress
=450  \\$wnnna$aMouse-ear Cresses
=450  \\$wnnna$athaliana, Arabidopsis
=450  \\$wnnna$athalianas, Arabidopsis
=550  \\$wg$aBrassicaceae
=550  \\$aArabidopsis Proteins
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE that contains ARABIDOPSIS PROTEINS and MADS DOMAIN PROTEINS. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development.
=688  \\$a93
=750  \0$aArabidopsis$0(DLC) sh 88022561$5IEN-M

=LDR  00927cz  a2200217n  4500
=001  9880363991602441
=005  20141212212038.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017357
=035  \\$aCRE2538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x710.$x680.$x250
=150  \\$aCyclotrons
=450  \\$wnnna$aCyclotron
=450  \\$wnnna$aSynchrocyclotron
=450  \\$aSynchrocyclotrons
=550  \\$wg$aParticle Accelerators
=667  \\$aparticle accelerators; do not confuse X ref SYNCHROCYCLOTRONS with SYNCHROTRONS
=680  \\$iDevices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field.
=688  \\$a93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92
=750  \0$aCyclotrons$5IEN-M$0(DLC)sh 85035113

=LDR  00817cz  a2200193n  4500
=001  9880363991702441
=005  20141212212037.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017356
=035  \\$aCRE2537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x710.$x680.$x700
=150  \\$aSynchrotrons
=450  \\$wnnna$aSynchrotron
=550  \\$wg$aParticle Accelerators
=667  \\$aparticle accelerators; do not confuse with SYNCHROCYCLOTRONS see CYCLOTRONS
=680  \\$iDevices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies (the accelerating voltage is held constant for electrons) in order to keep the orbit radius constant.
=688  \\$a93; was see PARTICLE ACCELERATORS 1978-92
=750  \0$aSynchrotrons$5IEN-M$0(DLC)sh 85131613

=LDR  02214cz  a2200517n  4500
=001  9880363991802441
=005  20150406101615.0
=008  920508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017352
=035  \\$aCRE2533M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x825.$x500.$x200
=150  \\$aEcho-Planar Imaging
=450  \\$wnnna$aEcho Planar Imaging
=450  \\$wnnna$aEcho-Planar Imagings
=450  \\$wnnna$aEcho-Planar Magnetic Resonance Imaging
=450  \\$wnnna$aEcho Planar Magnetic Resonance Imaging
=450  \\$wnnna$aEcho-Planar MR Tomographies
=450  \\$wnnna$aEcho-Planar MR Tomography
=450  \\$wnnna$aEcho Planar MR Tomography
=450  \\$wnnna$aEchoplanar Imaging
=450  \\$wnnna$aEchoplanar Imagings
=450  \\$wnnna$aEchoplanar Magnetic Resonance Imaging
=450  \\$wnnna$aEchoplanar MR Tomographies
=450  \\$wnnna$aEchoplanar MR Tomography
=450  \\$wnnna$aImaging, Echo-Planar
=450  \\$wnnna$aImaging, Echoplanar
=450  \\$wnnna$aImagings, Echo-Planar
=450  \\$wnnna$aImagings, Echoplanar
=450  \\$aMagnetic Resonance Imaging, Echo-Planar
=450  \\$wnnna$aMagnetic Resonance Imaging, Echo Planar
=450  \\$wnnna$aMagnetic Resonance Imaging, Echoplanar
=450  \\$wnnna$aMR Tomographies, Echo-Planar
=450  \\$wnnna$aMR Tomographies, Echoplanar
=450  \\$aMR Tomography, Echo-Planar
=450  \\$wnnna$aMR Tomography, Echo Planar
=450  \\$wnnna$aMR Tomography, Echoplanar
=450  \\$wnnna$aTomographies, Echo-Planar MR
=450  \\$wnnna$aTomographies, Echoplanar MR
=450  \\$wnnna$aTomography, Echo-Planar MR
=450  \\$wnnna$aTomography, Echoplanar MR
=550  \\$wg$aMagnetic Resonance Imaging
=667  \\$aa type of magnetic resonance imaging; for coord see note on MAGNETIC RESONANCE IMAGING
=680  \\$iA type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications.
=688  \\$a93
=750  \0$aEcho-planar imaging$0(DLC)sh2008007025$5IEN-M

=LDR  01229cz  a2200229n  4500
=001  9880363991902441
=005  20141212212034.0
=008  920518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017348
=035  \\$aCRE2529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402.$x580.$x480
=072  \\$aE5.$x595.$x402.$x580.$x480
=150  \\$aMicroscopy, Electron, Scanning Transmission
=450  \\$aElectron Microscopy, Scanning Transmission
=450  \\$aScanning Transmission Electron Microscopy
=450  \\$aSTEM
=550  \\$wg$aMicroscopy, Electron, Transmission
=667  \\$ado not confuse with MICROSCOPY, ELECTRON, SCANNING nor with MICROSCOPY, ELECTRON, TRANSMISSION; since the techniques have different applications, do not interpret: if in doubt, use words of author
=680  \\$iA type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.
=688  \\$a93
=750  \0$aScanning transmission electron microscopy$5IEN-M$0(DLC)sh 97007332

=LDR  00849cz  a2200193n  4500
=001  9880363992002441
=005  20141212212034.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017347
=035  \\$aCRE2528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x215.$x500.$x500
=072  \\$aB3.$x660.$x50.$x70.$x100.$x500
=150  \\$aBrucella melitensis
=550  \\$wg$aBrucella
=667  \\$anote specific biovars are X refs to other species; infection: coord IM with BRUCELLOSIS (IM)
=680  \\$iA species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including humans, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.
=688  \\$a93
=750  \0$aBrucella melitensis$5IEN-M$0(DLC)sh 85017286

=LDR  00784cz  a2200205n  4500
=001  9880363992102441
=005  20141212212028.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017325
=035  \\$aCRE2508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x955.$x400
=150  \\$aHepatitis B Vaccines
=450  \\$wnnna$aHepatitis B Vaccine
=450  \\$wnnna$aVaccine, Hepatitis B
=450  \\$wnnna$aVaccines, Hepatitis B
=550  \\$wg$aViral Hepatitis Vaccines
=680  \\$iVaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced.
=688  \\$a93; was HEPATITIS B VACCINE (NM) 1982-92
=750  \0$aHepatitis B vaccines$5IEN-M

=LDR  01282cz  a2200277n  4500
=001  9880363992202441
=005  20141212212025.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017319
=035  \\$aCRE2502HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x444.$x600
=072  \\$aD27.$x505.$x954.$x600.$x710
=150  \\$aPhotosensitizing Agents
=450  \\$wnnna$aAgents, Photosensitizing
=450  \\$wnnna$aEffect, Photosensitizing
=450  \\$wnnna$aEffects, Photosensitizing
=450  \\$aPhotosensitizers
=450  \\$wnnna$aPhotosensitizing Effect
=450  \\$wnnna$aPhotosensitizing Effects
=550  \\$wg$aDermatologic Agents
=550  \\$wg$aRadiation-Sensitizing Agents
=667  \\$anote entry term PHOTOSENSITIZING EFFECT: use only for the photosensitizing effect of a chemical substance
=680  \\$iDrugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
=688  \\$a93
=750  \0$aPhotosensitizing compounds$5IEN-M$0(DLC)sh 89004157

=LDR  01431cz  a2200385n  4500
=001  9880363992302441
=005  20161205104034.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017311
=035  \\$aCRE2494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203.$x65
=150  \\$aAmlodipine
=450  \\$wnnna$aAlmirall Brand of Amlodipine Besilate
=450  \\$wnnna$aAmlodipine, (+-)-Isomer
=450  \\$wnnna$aAmlodipine, (+-)-Isomer, Maleate (1:1)
=450  \\$wnnna$aAmlodipine Besylate
=450  \\$wnnna$aAmlodipine Maleate
=450  \\$wnnna$aAmlodipine Maleate (1:1)
=450  \\$wnnna$aAmlodipine, (R)-Isomer
=450  \\$wnnna$aAmlodipine, (S)-Isomer, Maleate (1:1)
=450  \\$wnnna$aAmlodis
=450  \\$wnnna$aAmlor
=450  \\$wnnna$aAstudal
=450  \\$wnnna$aEczacibasi Brand of Amlodipine besilate
=450  \\$wnnna$aIstin
=450  \\$wnnna$aMack Brand of Amlodipine Besilate
=450  \\$wnnna$aNorvasc
=450  \\$wnnna$aPfizer Brand of Amlodipine Besilate
=550  \\$wg$aDihydropyridines
=550  \\$wh$aAmlodipine Besylate, Olmesartan Medoxomil Drug Combination
=550  \\$wh$aAmlodipine, Valsartan Drug Combination
=680  \\$iA long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
=688  \\$a93; was AMLODIPINE (NM) 1986-92
=750  \0$aAmlodipine$5IEN-M$0(DLC)sh 93005977

=LDR  01443cz  a2200445n  4500
=001  9880363992402441
=005  20141212212020.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017302
=035  \\$aCRE2487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x125.$x50
=150  \\$aAnnexins
=450  \\$aAnnexin A11
=450  \\$aAnnexin A8
=450  \\$aAnnexin B10
=450  \\$aAnnexin B9
=450  \\$aAnnexin IX
=450  \\$aAnnexin VIII
=450  \\$aAnnexin X
=450  \\$aAnnexin XI
=450  \\$aCalcimedins
=450  \\$wnnna$aCalelectrin
=450  \\$aCalelectrins
=450  \\$wnnna$aCalpactin
=450  \\$aCalpactins
=450  \\$wnnna$aChromobindins
=450  \\$wnnna$aLipocortin
=450  \\$aLipocortins
=550  \\$wg$aCalcium-Binding Proteins
=550  \\$wh$aAnnexin A1
=550  \\$wh$aAnnexin A2
=550  \\$wh$aAnnexin A3
=550  \\$wh$aAnnexin A4
=550  \\$wh$aAnnexin A5
=550  \\$wh$aAnnexin A6
=550  \\$wh$aAnnexin A7
=680  \\$iFamily of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70-kDa repeats. The annexins are differentially distributed in vertebrate tissues (and lower eukaryotes) and appear to be involved in MEMBRANE FUSION and SIGNAL TRANSDUCTION.
=688  \\$a1993
=750  \0$aLipocortins$5IEN-M$0(DLC)sh 90001214

=LDR  01507cz  a2200421n  4500
=001  9880363992502441
=005  20141212212019.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017298
=035  \\$aCRE2483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x85
=072  \\$aD2.$x33.$x755.$x624.$x698.$x85
=072  \\$aD2.$x92.$x63.$x624.$x698.$x85
=150  \\$aBisoprolol
=450  \\$wnnna$aBisoprolol, (+-)-Isomer
=450  \\$wnnna$aBisoprolol Fumarate
=450  \\$wnnna$aBisoprolol, Fumarate (1:1) Salt
=450  \\$wnnna$aBisoprolol Fumarate (1:1) Salt, (+-)-Isomer
=450  \\$wnnna$aBisoprolol, Fumarate (2:1) Salt
=450  \\$wnnna$aBisoprolol Fumarate (2:1) Salt, (+-)-Isomer
=450  \\$wnnna$aBisoprolol Hydrochloride
=450  \\$wnnna$aBisoprolol, (-)-Isomer
=450  \\$wnnna$aBisoprolol Methanesulfonate Salt
=450  \\$wnnna$aCL-297939
=450  \\$wnnna$aCL 297939
=450  \\$wnnna$aCL297939
=450  \\$wnnna$aConcor
=450  \\$wnnna$aEMD-33512
=450  \\$wnnna$aEMD 33512
=450  \\$wnnna$aEMD33512
=450  \\$wnnna$aFumarate, Bisoprolol
=450  \\$wnnna$aHydrochloride, Bisoprolol
=450  \\$wnnna$aMerck Brand of Bisoprolol Fumarate
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
=688  \\$a93; was BISOPROLOL (NM) 1984-92
=750  \0$aBisoprolol$5IEN-M$0(DLC)sh 89004755

=LDR  01189cz  a2200301n  4500
=001  9880363992602441
=005  20141212212018.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017293
=035  \\$aCRE2481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x670
=072  \\$aD12.$x776.$x395.$x642
=072  \\$aD23.$x113.$x725
=150  \\$aProtein S
=450  \\$wnnna$aCofactor Protein S
=450  \\$wnnna$aProtein S, Cofactor
=450  \\$wnnna$aProtein S, Vitamin K-Dependent
=450  \\$wnnna$aProtein S, Vitamin K Dependent
=450  \\$aVitamin K-Dependent Protein S
=450  \\$wnnna$aVitamin K Dependent Protein S
=550  \\$wg$aBlood Coagulation Factor Inhibitors
=550  \\$wg$aBlood Proteins
=550  \\$wg$aGlycoproteins
=667  \\$aa blood protein; an anticoagulant
=680  \\$iThe vitamin K-dependent cofactor of activated PROTEIN C. Together with protein C, it inhibits the action of factors VIIIa and Va. A deficiency in protein S; (PROTEIN S DEFICIENCY); can lead to recurrent venous and arterial thrombosis.
=688  \\$a93; was PROTEIN S, VITAMIN K-DEPENDENT (NM) 1979-92
=750  \0$aProtein S$0(DLC) sh 87007325$5IEN-M

=LDR  04967cz  a2201333n  4500
=001  9880363992702441
=005  20141212192728.0
=008  920513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017292
=035  \\$aCRE2480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x786.$x750.$x200
=150  \\$aDoxazosin
=450  \\$wnnna$a1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
=450  \\$wnnna$aAlfamedin
=450  \\$wnnna$aAliud Brand of Doxazosin Mesylate
=450  \\$wnnna$aAlmirall Brand of Doxazosin Mesylate
=450  \\$wnnna$aAlpharma Brand of Doxazosin Mesylate
=450  \\$wnnna$aAlter Brand of Doxazosin Mesylate
=450  \\$wnnna$aApo-Doxazosin
=450  \\$wnnna$aApo Doxazosin
=450  \\$wnnna$aApogepha Brand of Doxazosin Mesylate
=450  \\$wnnna$aApotex Brand of Doxazosin Mesylate
=450  \\$wnnna$aAstraZeneca Brand of Doxazosin Mesylate
=450  \\$wnnna$aAzupharma Brand of Doxazosin Mesylate
=450  \\$wnnna$abetapharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aCantabria Brand of Doxazosin Mesylate
=450  \\$wnnna$aCardular
=450  \\$wnnna$aCardura
=450  \\$wnnna$aCarduran
=450  \\$wnnna$aCarduran Neo
=450  \\$wnnna$aCiclum Brand of Doxazosin Mesylate
=450  \\$wnnna$aCinfa Brand of Doxazosin Mesylate
=450  \\$wnnna$aCombino Brand of Doxazosin Mesylate
=450  \\$wnnna$act-Arzneimittel Brand of Doxazosin Mesylate
=450  \\$wnnna$act Arzneimittel Brand of Doxazosin Mesylate
=450  \\$wnnna$aDiblocin
=450  \\$wnnna$aDoxa-Puren
=450  \\$wnnna$aDoxa Puren
=450  \\$wnnna$aDoxacor
=450  \\$wnnna$aDoxagamma
=450  \\$wnnna$aDoxamax
=450  \\$wnnna$aDoxatensa
=450  \\$wnnna$aDoxaUro
=450  \\$wnnna$aDoxazomerck
=450  \\$wnnna$aDoxazosin AL
=450  \\$wnnna$aDoxazosin Apogepha
=450  \\$wnnna$aDoxazosin AZU
=450  \\$wnnna$aDoxazosin beta
=450  \\$wnnna$aDoxazosin findusFit
=450  \\$wnnna$aDoxazosin Heumann
=450  \\$wnnna$aDoxazosin Klast
=450  \\$aDoxazosin Mesylate
=450  \\$wnnna$aDoxazosin Monohydrochloride
=450  \\$wnnna$aDoxazosin-ratiopharm
=450  \\$wnnna$aDoxazosin ratiopharm
=450  \\$wnnna$aDoxazosin Stada
=450  \\$wnnna$adoxazosin von ct
=450  \\$wnnna$aDoxazosin-Wolff
=450  \\$wnnna$aDoxazosin Wolff
=450  \\$wnnna$aDoxazosina Alter
=450  \\$wnnna$aDoxazosina Cinfa
=450  \\$wnnna$aDoxazosina Combino Pharm
=450  \\$wnnna$aDoxazosina Geminis
=450  \\$wnnna$aDoxazosina Normon
=450  \\$wnnna$aDoxazosina Pharmagenus
=450  \\$wnnna$aDoxazosina Ratiopharm
=450  \\$wnnna$aDoxazosina Ur
=450  \\$wnnna$aesparma Brand of Doxazosin Mesylate
=450  \\$wnnna$afindusFit Brand of Doxazosin Mesylate
=450  \\$wnnna$aGeminis Brand of Doxazosin Mesylate
=450  \\$wnnna$aGen-Doxazosin
=450  \\$wnnna$aGen Doxazosin
=450  \\$wnnna$aGenpharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aHeumann Brand of Doxazosin Mesylate
=450  \\$wnnna$aHexal Brand of Doxazosin Mesylate
=450  \\$wnnna$aJuta Brand of Doxazosin Mesylate
=450  \\$wnnna$aJutalar
=450  \\$wnnna$aKade Brand of Doxazosin Mesylate
=450  \\$wnnna$aLinden Brand of Doxazosin Mesylate
=450  \\$wnnna$aMerck dura Brand of Doxazosin Mesylate
=450  \\$wnnna$aMesylate, Doxazosin
=450  \\$wnnna$aMonohydrochloride, Doxazosin
=450  \\$wnnna$aMTW Brand of Doxazosin Mesylate
=450  \\$wnnna$aMTW-Doxazosin
=450  \\$wnnna$aMTW Doxazosin
=450  \\$wnnna$aNeo, Carduran
=450  \\$wnnna$aNormon Brand of Doxazosin Mesylate
=450  \\$wnnna$aNovo-Doxazosin
=450  \\$wnnna$aNovo Doxazosin
=450  \\$wnnna$aNovopharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aPfizer Brand of Doxazosin Mesylate
=450  \\$wnnna$aPharmagenus Brand of Doxazosin Mesylate
=450  \\$wnnna$aProgandol Neo
=450  \\$wnnna$aQ-Pharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aQ Pharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aratio-Doxazosin
=450  \\$wnnna$aratio Doxazosin
=450  \\$wnnna$aRatiopharm Brand of Doxazosin Mesylate
=450  \\$wnnna$aRatiopharm, Doxazosina
=450  \\$wnnna$aSolvay Brand of Doxazosin Mesylate
=450  \\$wnnna$aStadapharm Brand of Doxazosin
=450  \\$wnnna$aTAD Brand of Doxazosin Mesylate
=450  \\$wnnna$aUK-33274
=450  \\$wnnna$aUK 33274
=450  \\$wnnna$aUK33274
=450  \\$wnnna$aUriduct
=450  \\$wnnna$aWörwag Brand of Doxazosin Mesylate
=450  \\$wnnna$aWolff Brand of Doxazosin Mesylate
=450  \\$wnnna$aZoxan
=550  \\$wg$aPrazosin
=680  \\$iA prazosin-related compound that is a selective alpha-1-adrenergic blocker.
=688  \\$a93; was UK 33274 (NM) 1980-92
=750  \0$aDoxazosin$5IEN-M$0(DLC)sh 97002232

=LDR  00986cz  a2200253n  4500
=001  9880363992802441
=005  20141212212016.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017286
=035  \\$aCRE2474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x625
=150  \\$aPolysomnography
=450  \\$aMonitoring, Sleep
=450  \\$wnnna$aPolysomnographies
=450  \\$wnnna$aSleep Monitoring
=450  \\$wnnna$aSomnographies
=450  \\$aSomnography
=550  \\$wg$aMonitoring, Physiologic
=550  \\$aActigraphy
=550  \\$aSleep
=680  \\$iSimultaneous and continuous monitoring of several parameters during sleep to study normal and abnormal sleep. The study includes monitoring of brain waves, to assess sleep stages, and other physiological variables such as breathing, eye movements, and blood oxygen levels which exhibit a disrupted pattern with sleep disturbances.
=688  \\$a93
=750  \0$aPolysomnography$5IEN-M$0(DLC)sh 00005379

=LDR  01770cz  a2200313n  4500
=001  9880363992902441
=005  20141212212015.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017285
=035  \\$aCRE2473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x594.$x819
=072  \\$aC10.$x668.$x491.$x562.$x575
=150  \\$aPolymyositis
=450  \\$wnnna$aIdiopathic Polymyositides
=450  \\$wnnna$aIdiopathic Polymyositis
=450  \\$wnnna$aMultiple Myositis
=450  \\$wnnna$aMyositides, Multiple
=450  \\$aMyositis, Multiple
=450  \\$wnnna$aOssificans, Polymyositis
=450  \\$wnnna$aPolymyositides
=450  \\$wnnna$aPolymyositides, Idiopathic
=450  \\$wnnna$aPolymyositis, Idiopathic
=450  \\$wnnna$aPolymyositis Ossificans
=550  \\$wg$aMyositis
=550  \\$wh$aDermatomyositis
=680  \\$iDiseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)
=688  \\$a93
=750  \0$aPolymyositis$5IEN-M$0(DLC)sh 85104685

=LDR  00969cz  a2200265n  4500
=001  9880363993002441
=005  20141212212015.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017283
=035  \\$aCRE2472M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x390.$x600
=072  \\$aH2.$x478.$x676.$x631.$x600
=072  \\$aN2.$x421.$x533.$x460.$x600
=072  \\$aN2.$x421.$x533.$x691.$x600
=150  \\$aNeonatal Nursing
=450  \\$wnnna$aNursing, Neonatal
=450  \\$wnnna$aNursing, Perinatal
=450  \\$aPerinatal Nursing
=550  \\$wg$aMaternal-Child Nursing
=550  \\$wg$aPediatric Nursing
=667  \\$aSPEC; SPEC qualif; check also tag INFANT, NEWBORN
=680  \\$iThe nursing specialty that deals with the care of newborn infants during the first four weeks after birth.
=688  \\$a93; NEONATAL NURSING & PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92
=750  \2$aNeonatal nursing$0(DLC)sh2005006764$5IEN-M

=LDR  02366cz  a2200565n  4500
=001  9880363993102441
=005  20200706135345.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017282
=035  \\$aCRE2471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x825
=072  \\$aC2.$x81.$x885
=072  \\$aC3.$x752.$x875
=150  \\$aTick-Borne Diseases
=450  \\$wnnna$aDisease, Tick-Borne
=450  \\$wnnna$aDiseases, Tick-Borne
=450  \\$wnnna$aInfection, Tick-Borne
=450  \\$wnnna$aInfections, Tick-Borne
=450  \\$wnnna$aInfections, Tick Borne
=450  \\$wnnna$aTick-Borne Disease
=450  \\$wnnna$aTick Borne Diseases
=450  \\$wnnna$aTick-Borne Infection
=450  \\$wnnna$aTick-Borne Infections
=450  \\$wnnna$aTick Borne Infections
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aAfrican Swine Fever
=550  \\$wh$aAnaplasmosis
=550  \\$wh$aBabesiosis
=550  \\$wh$aBoutonneuse Fever
=550  \\$wh$aColorado Tick Fever
=550  \\$wh$aEhrlichiosis
=550  \\$wh$aEncephalitis, Tick-Borne
=550  \\$wh$aHeartwater Disease
=550  \\$wh$aHemorrhagic Fever, Crimean
=550  \\$wh$aHemorrhagic Fever, Omsk
=550  \\$wh$aKyasanur Forest Disease
=550  \\$wh$aLyme Disease
=550  \\$wh$aNairobi Sheep Disease
=550  \\$wh$aRelapsing Fever
=550  \\$wh$aRocky Mountain Spotted Fever
=550  \\$wh$aSpotted Fever Fever Group Ricketssiosis
=550  \\$wh$aTheileriasis
=550  \\$wh$aTularemia
=667  \\$acan be bacterial, viral or protozoan; GEN or unspecified; prefer specifics; for GEN articles specifying type, coord IM with GEN organism/infect term (IM), as "tick-borne arbovirus diseases" = TICK-BORNE DISEASES (IM) + ARBOVIRUS INFECTIONS (IM)
=680  \\$iBacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.
=688  \\$a93
=750  \0$aTick-Borne Diseases$5IEN-M$0(DLC)sh 86002246

=LDR  00800cz  a2200217n  4500
=001  9880363993202441
=005  20141212212014.0
=008  920513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017280
=035  \\$aCRE2469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x270.$x150
=150  \\$aCondoms
=450  \\$wnnna$aCondom
=450  \\$wnnna$aCondom Manufacture
=450  \\$wnnna$aManufacture, Condom
=550  \\$wg$aContraceptive Devices, Male
=667  \\$aGEN or unspecified but probably for males; CONDOMS, FEMALE is also available
=680  \\$iA sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.
=688  \\$a93; was see CONTRACEPTIVE DEVICES, MALE 1988-92
=750  \0$aCondoms$5IEN-M$0(DLC)sh 85030795

=LDR  00864cz  a2200277n  4500
=001  9880363993302441
=005  20141212212013.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017278
=035  \\$aCRE2467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x100
=072  \\$aJ1.$x637.$x708.$x100
=150  \\$aAir Bags
=450  \\$wnnna$aAir Bag
=450  \\$wnnna$aAirbag
=450  \\$wnnna$aAirbags
=450  \\$wnnna$aBag, Air
=450  \\$wnnna$aBags, Air
=550  \\$wg$aProtective Devices
=550  \\$aAccidents, Traffic
=550  \\$aAutomobiles
=550  \\$aSeat Belts
=680  \\$iAutomotive safety devices consisting of a bag designed to inflate upon collision and prevent passengers from pitching forward. (American Heritage Dictionary, 1982)
=688  \\$a93
=750  \0$aAir bag restraint systems$5IEN-M$0(DLC)sh 85002595

=LDR  01862cz  a2200469n  4500
=001  9880363993402441
=005  20141212212013.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017277
=035  \\$aCRE2466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x337.$x300
=072  \\$aI1.$x880.$x604.$x605.$x250.$x250
=150  \\$aDrug Approval
=450  \\$wnnna$aApproval, Drug
=450  \\$wnnna$aApproval, New Drug
=450  \\$wnnna$aApproval Process, Drug
=450  \\$wnnna$aApproval Processes, Drug
=450  \\$wnnna$aApprovals, Drug
=450  \\$wnnna$aApprovals, New Drug
=450  \\$wnnna$aDrug Approval, New
=450  \\$aDrug Approval Process
=450  \\$wnnna$aDrug Approval Processes
=450  \\$wnnna$aDrug Approvals
=450  \\$wnnna$aDrug Approvals, New
=450  \\$wnnna$aFood and Drug Administration Drug Approval
=450  \\$wnnna$aFood and Drug Administration Drug Approval Process
=450  \\$aNew Drug Approval
=450  \\$wnnna$aNew Drug Approval Process
=450  \\$wnnna$aNew Drug Approvals
=450  \\$wnnna$aProcess, Drug Approval
=450  \\$wnnna$aProcesses, Drug Approval
=550  \\$wg$aDrug and Narcotic Control
=550  \\$wg$aEvaluation Studies as Topic
=550  \\$wh$aCompassionate Use Trials
=550  \\$wh$aInvestigational New Drug Application
=550  \\$aClinical Trials as Topic
=550  \\$aOff-Label Use
=667  \\$aby govt regulatory agency, U.S. (not restricted to FDA) or foreign
=680  \\$iProcess that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.
=688  \\$a93
=750  \0$aDrug approval$5IEN-M$0(DLC)sh2002008777

=LDR  00608cz  a2200181n  4500
=001  9880363993502441
=005  20141212212013.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017276
=035  \\$aCRE2465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x618
=150  \\$aFriction
=550  \\$wg$aMechanical Phenomena
=667  \\$abiological and non-biological application
=680  \\$iSurface resistance to the relative motion of one body against the rubbing, sliding, rolling, or flowing of another with which it is in contact.
=688  \\$a93
=750  \0$aFriction$5IEN-M$0(DLC)sh 85051971

=LDR  01085cz  a2200289n  4500
=001  9880363993602441
=005  20141212212012.0
=008  920519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017273
=035  \\$aCRE2462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x740.$x320.$x340
=072  \\$aD12.$x644.$x400.$x400.$x740.$x320.$x340
=072  \\$aD12.$x644.$x456.$x460.$x315
=072  \\$aD12.$x644.$x548.$x365.$x740.$x320.$x340
=072  \\$aD12.$x776.$x641.$x650.$x405.$x740.$x320.$x340
=150  \\$aGoserelin
=450  \\$wnnna$aAcetate, Goserelin
=450  \\$wnnna$aGoserelin Acetate
=450  \\$wnnna$aICI-118630
=450  \\$wnnna$aICI 118630
=450  \\$wnnna$aICI118630
=450  \\$wnnna$aZoladex
=550  \\$wg$aGonadotropin-Releasing Hormone
=680  \\$iA synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.
=688  \\$a93; was ICI 118630 (NM) 1979-92
=750  \0$aGoserelin$5IEN-M$0(DLC)sh 93001443

=LDR  01304cz  a2200313n  4500
=001  9880363993702441
=005  20141212212011.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017271
=035  \\$aCRE2460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x607.$x221
=072  \\$aC5.$x651.$x243
=072  \\$aC7.$x320.$x610.$x291
=150  \\$aCraniomandibular Disorders
=450  \\$wnnna$aCraniomandibular Disease
=450  \\$wnnna$aCraniomandibular Diseases
=450  \\$wnnna$aCraniomandibular Disorder
=450  \\$wnnna$aDisease, Craniomandibular
=450  \\$wnnna$aDiseases, Craniomandibular
=450  \\$wnnna$aDisorder, Craniomandibular
=450  \\$wnnna$aDisorders, Craniomandibular
=550  \\$wg$aMandibular Diseases
=550  \\$wg$aMuscular Diseases
=550  \\$wh$aTemporomandibular Joint Disorders
=667  \\$aGEN or unspecified; prefer specifics; usually called this or CMD by authors; DF: CMD
=680  \\$iDiseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISORDERS and TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.
=688  \\$a93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92
=750  \0$aMasticatory muscles$xDiseases$5IEN-M

=LDR  00999cz  a2200241n  4500
=001  9880363993802441
=005  20141212212010.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017270
=035  \\$aCRE2459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x350
=072  \\$aD12.$x776.$x521.$x400
=150  \\$aLipoprotein(a)
=450  \\$wnnna$aLipoprotein (a)
=450  \\$wnnna$aLipoprotein (a-)
=450  \\$wnnna$aLipoprotein a
=450  \\$wnnna$aLipoprotein Lp(a)
=550  \\$wg$aLipoproteins
=550  \\$wh$aApoprotein(a)
=680  \\$iA lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease.
=688  \\$a93; was LIPOPROTEIN LP(A) (NM) 1977-92
=750  \0$aLipoprotein A$0(DLC) sh 89006043$5IEN-M

=LDR  00760cz  a2200205n  4500
=001  9880363993902441
=005  20141212212007.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017262
=035  \\$aCRE2452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x914.$x500.$x410.$x750
=072  \\$aD27.$x720.$x832.$x500.$x410.$x750
=150  \\$aSiderophores
=450  \\$wnnna$aSiderochromes
=550  \\$wg$aIron Chelating Agents
=550  \\$aIron Chelating Agents
=680  \\$iLow-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994)
=688  \\$a93; was SIDEROCHROMES (NM) 1972-92
=750  \0$aSiderophores$5IEN-M$0(DLC)sh 87000619

=LDR  00810cz  a2200229n  4500
=001  9880363822702441
=005  20181206093714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011871
=035  \\$aCBA5172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x740
=150  \\$aRadiology
=450  \\$aRadiologists$5IEN
=550  \\$wg$aMedicine
=550  \\$wh$aNuclear Medicine
=550  \\$wh$aRadiation Oncology
=550  \\$wh$aRadiology, Interventional
=667  \\$aSPEC: SPEC qualif; /methods: probably better is TECHNOLOGY, RADIOLOGIC; DF: RADIOL
=680  \\$iA specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease.
=750  \0$aRadiology$5IEN-M$0(DLC)sh 85110774
=750  \0$aMedical radiology$5IEN-HS$0(DLC)sh 85110777

=LDR  01130cz  a2200337n  4500
=001  9880363822802441
=005  20141212205128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011870
=035  \\$aCBA5171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x810
=150  \\$aRadiologic Health
=450  \\$wnnna$aHealth, Radiologic
=450  \\$wnnna$aHealth, Radiological
=450  \\$wnnna$aRadiological Health
=550  \\$wg$aPublic Health
=550  \\$wh$aAir Pollution, Radioactive
=550  \\$wh$aFood Contamination, Radioactive
=550  \\$wh$aRadiation Dosage
=550  \\$wh$aRadiation Effects
=550  \\$wh$aRadiation Genetics
=550  \\$wh$aRadiation Monitoring
=550  \\$wh$aRadiation Protection
=550  \\$wh$aRadioactive Fallout
=550  \\$wh$aRadioactive Waste
=550  \\$wh$aWater Pollution, Radioactive
=667  \\$aSPEC: SPEC qualif
=680  \\$iHealth concerns associated with the effects of radiation on the environment and on public and personal health.
=688  \\$a98; use explode 1970-97
=750  \0$aRadiation$xHealth aspects$5IEN-M$0(DLC)sh2010109293

=LDR  01553cz  a2200409n  4500
=001  9880363822902441
=005  20141212205127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011869
=035  \\$aCBA5170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x985
=072  \\$aE1.$x370.$x374.$x650
=072  \\$aE1.$x370.$x384.$x720
=072  \\$aE5.$x200.$x985
=150  \\$aRadioligand Assay
=450  \\$wnnna$aAssay, Radioligand
=450  \\$wnnna$aAssay, Radioreceptor
=450  \\$wnnna$aAssays, Radioligand
=450  \\$wnnna$aAssays, Radioreceptor
=450  \\$aProtein-Binding Radioassay
=450  \\$wnnna$aProtein Binding Radioassay
=450  \\$wnnna$aProtein-Binding Radioassays
=450  \\$wnnna$aRadioassay, Protein-Binding
=450  \\$wnnna$aRadioassays, Protein-Binding
=450  \\$wnnna$aRadioligand Assays
=450  \\$aRadioreceptor Assay
=450  \\$wnnna$aRadioreceptor Assays
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aDiagnostic Techniques, Endocrine
=550  \\$wg$aDiagnostic Techniques, Radioisotope
=550  \\$aLigands
=550  \\$aProtein Binding
=667  \\$ado not use /util except by MeSH definition; coord with substance /anal or body fluid qualif but not /immunol
=680  \\$iQuantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).
=688  \\$a73
=750  \0$aRadioligand assay$5IEN$0(DLC)sh 85110769

=LDR  02973cz  a2200697n  4500
=001  9880363823002441
=005  20141212205127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011868
=035  \\$aCBA5169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749
=150  \\$aRadioisotopes
=450  \\$wnnna$aIsotopes, Radioactive
=450  \\$aRadioactive Isotopes
=450  \\$aRadionuclides
=550  \\$wg$aIsotopes
=550  \\$wh$aBarium Radioisotopes
=550  \\$wh$aBromine Radioisotopes
=550  \\$wh$aCadmium Radioisotopes
=550  \\$wh$aCalcium Radioisotopes
=550  \\$wh$aCarbon Radioisotopes
=550  \\$wh$aCerium Radioisotopes
=550  \\$wh$aCesium Radioisotopes
=550  \\$wh$aChromium Radioisotopes
=550  \\$wh$aCobalt Radioisotopes
=550  \\$wh$aCopper Radioisotopes
=550  \\$wh$aFluorine Radioisotopes
=550  \\$wh$aGallium Radioisotopes
=550  \\$wh$aGold Radioisotopes
=550  \\$wh$aIndium Radioisotopes
=550  \\$wh$aIodine Radioisotopes
=550  \\$wh$aIridium Radioisotopes
=550  \\$wh$aIron Radioisotopes
=550  \\$wh$aKrypton Radioisotopes
=550  \\$wh$aLead Radioisotopes
=550  \\$wh$aMercury Radioisotopes
=550  \\$wh$aNitrogen Radioisotopes
=550  \\$wh$aOxygen Radioisotopes
=550  \\$wh$aPhosphorus Radioisotopes
=550  \\$wh$aPotassium Radioisotopes
=550  \\$wh$aRadioactive Tracers
=550  \\$wh$aRubidium Radioisotopes
=550  \\$wh$aRuthenium Radioisotopes
=550  \\$wh$aSelenium Radioisotopes
=550  \\$wh$aSodium Radioisotopes
=550  \\$wh$aStrontium Radioisotopes
=550  \\$wh$aSulfur Radioisotopes
=550  \\$wh$aThallium Radioisotopes
=550  \\$wh$aTin Radioisotopes
=550  \\$wh$aTritium
=550  \\$wh$aXenon Radioisotopes
=550  \\$wh$aYttrium Radioisotopes
=550  \\$wh$aZinc Radioisotopes
=550  \\$aElements
=550  \\$aElements, Radioactive
=550  \\$aIsotopes
=550  \\$aNuclear Medicine
=667  \\$aIM for general or unspecified or as coord for a specific radioisotope not in MeSH; when IM, qualif permitted; indexing policy: Manual 25.20-25.20.8; /blood-csf-urine /metab permitted but use with caution & not for tracer studies ( = /diag use); diag use = DIAGNOSTIC TECHNIQUES, RADIOISOTOPE but /diag use permitted with specific radioisotopes: Manual 25.15.1; relation to /rad eff: Manual 28.11.3; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope; decay: coord RADIOISOTOPES or specific radioisotope (IM) with RADIOACTIVITY (NIM) & do not add RADIOMETRY; radioisotope implants = RADIOISOTOPES or specific /admin or BRACHYTHERAPY (see X refs there)
=680  \\$iIsotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aRadioisotopes$5IEN-M$0(DLC)sh 85110713

=LDR  00827cz  a2200205n  4500
=001  9880363823102441
=005  20141212205126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011867
=035  \\$aCBA5168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x722.$x820
=150  \\$aRadioisotope Teletherapy
=450  \\$aTeleradioisotope Therapy
=450  \\$wnnna$aTeletherapy, Radioisotope
=450  \\$wnnna$aTherapy, Teleradioisotope
=550  \\$wg$aRadiotherapy, High-Energy
=667  \\$aionizing; do not use /util except by MeSH definition; coord IM with specific radioisotope /ther use (IM)
=680  \\$iA type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit.
=750  \0$aRadioisotope teletherapy$5IEN$0(DLC)sh 85110712

=LDR  01549cz  a2200349n  4500
=001  9880363823202441
=005  20141212205125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011865
=035  \\$aCBA5166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x384.$x710
=072  \\$aE5.$x484.$x650
=150  \\$aRadioisotope Dilution Technique
=450  \\$wnnna$aDilution Technic, Radioisotope
=450  \\$wnnna$aDilution Technics, Radioisotope
=450  \\$wnnna$aDilution Technique, Radioisotope
=450  \\$wnnna$aDilution Techniques, Radioisotope
=450  \\$wnnna$aRadioisotope Dilution Technic
=450  \\$wnnna$aRadioisotope Dilution Technics
=450  \\$wnnna$aRadioisotope Dilution Techniques
=450  \\$wnnna$aTechnic, Radioisotope Dilution
=450  \\$wnnna$aTechnics, Radioisotope Dilution
=450  \\$wnnna$aTechnique, Radioisotope Dilution
=450  \\$wnnna$aTechniques, Radioisotope Dilution
=550  \\$wg$aDiagnostic Techniques, Radioisotope
=550  \\$wg$aIndicator Dilution Techniques
=550  \\$aBody Fluids
=667  \\$aNIM; do not use /util except by MeSH definition; coord with specific radioisotope /diag use
=680  \\$iMethod for assessing flow through a system by injection of a known quantity of radionuclide into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed)
=688  \\$a91(64); was RADIOISOTOPE DILUTION TECHNIC 1964-90 (Prov 1964-66)
=750  \0$aIsotope dilution analysis$5IEN$0(DLC)sh 85068677

=LDR  01341cz  a2200277n  4500
=001  9880363823302441
=005  20141212205124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011863
=035  \\$aCBA5164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x384.$x700
=072  \\$aE5.$x478.$x566.$x639
=072  \\$aE5.$x601.$x495.$x639
=150  \\$aRadioimmunoassay
=450  \\$wnnna$aRadioimmunoassays
=550  \\$wg$aDiagnostic Techniques, Radioisotope
=550  \\$wg$aImmunoassay
=550  \\$wh$aImmunoradiometric Assay
=550  \\$wh$aRadioallergosorbent Test
=550  \\$wh$aRadioimmunoprecipitation Assay
=550  \\$wh$aRadioimmunosorbent Test
=667  \\$aNIM; coord with substance /anal or body fluid qualif but not /immunol; do not confuse with IMMUNORADIOMETRIC ASSAY
=680  \\$iClassic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation.
=688  \\$a68
=750  \0$aRadioimmunoassay$5IEN$0(DLC)sh 85110708

=LDR  00957cz  a2200277n  4500
=001  9880363823402441
=005  20141212205124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011862
=035  \\$aCBA5163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x720.$x750
=072  \\$aE6.$x342.$x764.$x750
=150  \\$aRadiography, Panoramic
=450  \\$wnnna$aOrthopantomographies
=450  \\$aOrthopantomography
=450  \\$wnnna$aPanoramic Radiographies
=450  \\$aPanoramic Radiography
=450  \\$wnnna$aPantomographies
=450  \\$aPantomography
=450  \\$wnnna$aRadiographies, Panoramic
=550  \\$wg$aRadiography, Dental
=667  \\$ado not use /util except by MeSH definition; DF: RADIOGR PANORAMIC
=680  \\$iExtraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film.
=688  \\$a74
=750  \0$aRadiography, Panoramic$5IEN$0(DLC)sh 85110699

=LDR  00916cz  a2200277n  4500
=001  9880363823502441
=005  20141212205124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011861
=035  \\$aCBA5162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x720
=072  \\$aE6.$x342.$x764
=150  \\$aRadiography, Dental
=450  \\$aDental Radiography
=550  \\$wg$aDiagnosis, Oral
=550  \\$wg$aRadiography
=550  \\$wh$aAge Determination by Teeth
=550  \\$wh$aRadiography, Bitewing
=550  \\$wh$aRadiography, Dental, Digital
=550  \\$wh$aRadiography, Panoramic
=550  \\$wh$aSialography
=550  \\$aDiagnosis, Oral
=667  \\$aGEN; prefer /radiogr with dental organ terms; do not use /util except by MeSH definition; DF: RADIOGR DENT
=680  \\$iRadiographic techniques used in dentistry.
=750  \0$aTeeth$xRadiography$5IEN$0(DLC)sh 85133226

=LDR  00977cz  a2200277n  4500
=001  9880363823602441
=005  20141212205123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011860
=035  \\$aCBA5161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x715
=150  \\$aRadiography, Abdominal
=450  \\$aAbdomen$xradiography
=450  \\$wnnna$aAbdominal Radiographies
=450  \\$wnnna$aAbdominal Radiography
=450  \\$wnnna$aRadiographies, Abdominal
=550  \\$wg$aRadiography
=550  \\$wh$aCholangiography
=550  \\$wh$aCholecystography
=550  \\$wh$aDefecography
=550  \\$wh$aPortography
=667  \\$aGEN or unspecified; prefer specifics or specific organ /radiogr; DF: RADIOGR ABDOMINAL
=680  \\$iRadiographic visualization of the body between the thorax and the pelvis, i.e., within the peritoneal cavity.
=688  \\$a98; use explode 1975-97
=750  \0$aAbdomen$xRadiography$5IEN-M$0(DLC)sh 85000100

=LDR  02504cz  a2200637n  4500
=001  9880363823702441
=005  20141212205123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011859
=035  \\$aCBA5160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700
=150  \\$aRadiography
=450  \\$wnnna$aDiagnostic X-Ray
=450  \\$wnnna$aDiagnostic X Ray
=450  \\$wnnna$aDiagnostic X-Ray Radiology
=450  \\$wnnna$aDiagnostic X Ray Radiology
=450  \\$wnnna$aDiagnostic X-Rays
=450  \\$aRadiology, Diagnostic X-Ray
=450  \\$wnnna$aRadiology, Diagnostic X Ray
=450  \\$aRoentgenography
=450  \\$aX-Ray, Diagnostic
=450  \\$wnnna$aX Ray, Diagnostic
=450  \\$wnnna$aX-Ray Radiology, Diagnostic
=450  \\$wnnna$aX Ray Radiology, Diagnostic
=450  \\$wnnna$aX-Rays, Diagnostic
=450  \\$aX-Rays$xdiagnostic use
=550  \\$wg$aDiagnostic Imaging
=550  \\$wh$aAbsorptiometry, Photon
=550  \\$wh$aAge Determination by Skeleton
=550  \\$wh$aAngiography
=550  \\$wh$aArthrography
=550  \\$wh$aCineradiography
=550  \\$wh$aElectrokymography
=550  \\$wh$aFluoroscopy
=550  \\$wh$aHysterosalpingography
=550  \\$wh$aLymphography
=550  \\$wh$aMammography
=550  \\$wh$aMicroradiography
=550  \\$wh$aNeuroradiography
=550  \\$wh$aPneumoradiography
=550  \\$wh$aRadiographic Image Enhancement
=550  \\$wh$aRadiographic Image Interpretation, Computer-Assisted
=550  \\$wh$aRadiographic Magnification
=550  \\$wh$aRadiography, Abdominal
=550  \\$wh$aRadiography, Dental
=550  \\$wh$aRadiography, Interventional
=550  \\$wh$aRadiography, Thoracic
=550  \\$wh$aRadiostereometric Analysis
=550  \\$wh$aSex Determination by Skeleton
=550  \\$wh$aTomography, X-Ray
=550  \\$wh$aUrography
=550  \\$wh$aXeroradiography
=667  \\$ageneral only: prefer /radiogr with organs & diseases: Manual 19.7+, 19.8.61; prefer also specific indentions under RADIOGRAPHY; Manual 26.4+; /educ = RADIOGRAPHY (IM) + RADIOLOGY /educ; /man = RADIOGRAPHY (IM) + RADIOLOGY /man or TECHNOLOGY, RADIOLOGIC /man (NIM); /methods: consider also TECHNOLOGY, RADIOLOGIC; DF: RADIOGR
=680  \\$iExamination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film).
=750  \0$aRadiography$5IEN-M$0(DLC)sh 85110685

=LDR  00834cz  a2200217n  4500
=001  9880363823802441
=005  20141212205122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011858
=035  \\$aCBA5159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x710
=150  \\$aRadiographic Magnification
=450  \\$wnnna$aMagnification, Radiographic
=450  \\$wnnna$aMagnifications, Radiographic
=450  \\$wnnna$aRadiographic Magnifications
=550  \\$wg$aRadiography
=667  \\$ado not use /util except by MeSH definition
=680  \\$iUse of optic and geometric techniques to enhance radiographic image quality and interpretation. It includes use of microfocal X-ray tubes and intensifying fluoroscopic screens.
=688  \\$a73(72)
=750  \0$aRadiographic magnification$5IEN$0(DLC)sh 85110684

=LDR  01416cz  a2200397n  4500
=001  9880363823902441
=005  20141212205121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011855
=035  \\$aCBA5156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x826
=072  \\$aC26.$x733.$x804
=150  \\$aRadiodermatitis
=450  \\$wnnna$aDermatitides, Radiation-Induced
=450  \\$wnnna$aDermatitides, Radiation Recall
=450  \\$aDermatitis, Radiation-Induced
=450  \\$wnnna$aDermatitis, Radiation Induced
=450  \\$wnnna$aDermatitis, Radiation Recall
=450  \\$wnnna$aRadiation-Induced Dermatitides
=450  \\$aRadiation-Induced Dermatitis
=450  \\$wnnna$aRadiation Induced Dermatitis
=450  \\$wnnna$aRadiation Recall Dermatitides
=450  \\$aRadiation Recall Dermatitis
=450  \\$wnnna$aRadiation Recall Reaction
=450  \\$wnnna$aRadiation Recall Reactions
=450  \\$wnnna$aRadiodermatitides
=450  \\$wnnna$aReaction, Radiation Recall
=450  \\$wnnna$aReactions, Radiation Recall
=450  \\$wnnna$aRecall Reaction, Radiation
=450  \\$wnnna$aRecall Reactions, Radiation
=550  \\$wg$aDermatitis
=550  \\$wg$aRadiation Injuries
=680  \\$iA cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.
=688  \\$a66(64)
=750  \0$aRadiodermatitis$5IEN$0(DLC)sh 85110680

=LDR  00606cz  a2200193n  4500
=001  9880363824002441
=005  20141212205121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011854
=035  \\$aCBA5155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x529.$x776
=150  \\$aRadiochemistry
=450  \\$wnnna$aRadiochemistries
=550  \\$wg$aChemistry, Physical
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the chemical and physical phenomena of radioactive substances.
=688  \\$a66
=750  \0$aRadiochemistry$5IEN$0(DLC)sh 85110675

=LDR  00717cz  a2200205n  4500
=001  9880363824102441
=005  20141212205120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011853
=035  \\$aCBA5154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x789
=150  \\$aRadiobiology
=450  \\$wnnna$aBiology, Radiation
=450  \\$aRadiation Biology
=550  \\$wg$aBiology
=667  \\$aSPEC: SPEC qualif; DF: RADIOBIOL
=680  \\$iStudy of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a66
=750  \0$aRadiobiology$5IEN$0(DLC)sh 85110669

=LDR  01473cz  a2200361n  4500
=001  9880363824202441
=005  20141212205120.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011852
=035  \\$aCBA5153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x830
=072  \\$aE5.$x200.$x812.$x735.$x830
=072  \\$aE5.$x478.$x566.$x380.$x810
=072  \\$aE5.$x478.$x566.$x639.$x810
=072  \\$aE5.$x478.$x594.$x760.$x830
=072  \\$aE5.$x601.$x495.$x380.$x810
=072  \\$aE5.$x601.$x495.$x639.$x810
=150  \\$aRadioallergosorbent Test
=450  \\$wnnna$aAllergens Radioimmunosorbent Assay
=450  \\$wnnna$aAllergens Radioimmunosorbent Assays
=450  \\$wnnna$aRadioallergosorbent Tests
=450  \\$aRadioimmunosorbent Assay of Allergens
=450  \\$wnnna$aTest, Radioallergosorbent
=450  \\$wnnna$aTests, Radioallergosorbent
=550  \\$wg$aImmunosorbent Techniques
=550  \\$wg$aRadioimmunoassay
=550  \\$wg$aSerologic Tests
=550  \\$aRadioimmunosorbent Test
=667  \\$aNIM; IMMUNOSORBENTS is also available; DF: RAST
=680  \\$iAn in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies.
=688  \\$a89(77); was see under RADIOIMMUNOASSAY 1977-88
=750  \0$aRadioallergosorbent test$5IEN$0(DLC)sh 85110668

=LDR  01383cz  a2200265n  4500
=001  9880363824302441
=005  20141212205120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011851
=035  \\$aCBA5152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x815
=150  \\$aRadioactivity
=450  \\$wnnna$aDecay, Nuclear
=450  \\$wnnna$aDisintegration, Radioactive
=450  \\$wnnna$aDisintegrations, Radioactive
=450  \\$aNuclear Decay
=450  \\$wnnna$aRadioactive Disintegration
=450  \\$wnnna$aRadioactive Disintegrations
=450  \\$wnnna$aRadioactivities
=550  \\$wg$aPhysical Processes
=550  \\$aRadiation
=667  \\$aIM general only for principle of emission of radiations; NIM as coordinate for degree of radioactivity of specific radioelements or radioisotopes (IM); do not use as routine coordinate for amount of radiation or degree of radioactivity of radioisotope tracers; entry term NUCLEAR DECAY: coordinate NIM with specific radioactive substance (IM) & do not add RADIOMETRY
=680  \\$iThe spontaneous transformation of a nuclide into one or more different nuclides, accompanied by either the emission of particles from the nucleus, nuclear capture or ejection of orbital electrons, or fission. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aRadioactivity$5IEN$0(DLC)sh 85110661

=LDR  01686cz  a2200421n  4500
=001  9880363824402441
=005  20141212205119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011850
=035  \\$aCBA5151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x693.$x638
=072  \\$aD20.$x944.$x380.$x638
=072  \\$aD27.$x888.$x426.$x500.$x638
=072  \\$aN6.$x850.$x460.$x710.$x380.$x638
=072  \\$aN6.$x850.$x810.$x485
=150  \\$aRadioactive Waste
=450  \\$aHazardous Waste, Radioactive
=450  \\$wnnna$aHazardous Wastes, Radioactive
=450  \\$aNuclear Waste
=450  \\$wnnna$aNuclear Wastes
=450  \\$wnnna$aRadioactive Hazardous Waste
=450  \\$wnnna$aRadioactive Hazardous Wastes
=450  \\$wnnna$aRadioactive Wastes
=450  \\$wnnna$aWaste, Nuclear
=450  \\$wnnna$aWaste, Radioactive
=450  \\$wnnna$aWaste, Radioactive Hazardous
=450  \\$wnnna$aWastes, Nuclear
=450  \\$wnnna$aWastes, Radioactive
=450  \\$wnnna$aWastes, Radioactive Hazardous
=550  \\$wg$aHazardous Waste
=550  \\$wg$aRadioactive Pollutants
=550  \\$wg$aRadiologic Health
=550  \\$aNuclear Energy
=667  \\$aspecify geog if pertinent
=680  \\$iLiquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, and related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$aNUCLEAR WASTE was see HAZARDOUS WASTE 1988-89
=750  \0$aRadioactive wastes$5IEN$0(DLC)sh 85110658

=LDR  00869cz  a2200193n  4500
=001  9880363824502441
=005  20141212205119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011849
=035  \\$aCBA5150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x731
=150  \\$aRadioactive Tracers
=450  \\$wnnna$aTracers, Radioactive
=550  \\$wg$aRadioisotopes
=667  \\$aIM for general only; no qualif
=680  \\$iRadioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. (Hawley's Condensed Chemical Dictionary, 12th ed)
=688  \\$a91(75); was see under RADIOISOTOPES 1975-90
=750  \0$aRadioactive tracers$5IEN$0(DLC)sh 85110620

=LDR  00983cz  a2200265n  4500
=001  9880363824602441
=005  20141212205119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011848
=035  \\$aCBA5149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x693
=150  \\$aRadioactive Pollutants
=450  \\$wnnna$aPollutants, Radioactive
=450  \\$aRadioactive Pollution$5IEN
=550  \\$wg$aComplex Mixtures
=550  \\$wh$aAir Pollutants, Radioactive
=550  \\$wh$aRadioactive Fallout
=550  \\$wh$aRadioactive Waste
=550  \\$wh$aSoil Pollutants, Radioactive
=550  \\$wh$aWater Pollutants, Radioactive
=667  \\$aspecify radiopollutant if pertinent (IM or NIM)
=680  \\$iRadioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like.
=688  \\$a75
=750  \0$aRadioactive pollution$5IEN$0(DLC)sh 85110601

=LDR  00873cz  a2200241n  4500
=001  9880363824702441
=005  20141212205118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011847
=035  \\$aCBA5148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x693.$x555
=072  \\$aN6.$x850.$x810.$x460
=150  \\$aRadioactive Fallout
=450  \\$wnnna$aFallout, Radioactive
=450  \\$wnnna$aFallouts, Radioactive
=450  \\$wnnna$aRadioactive Fallouts
=550  \\$wg$aRadioactive Pollutants
=550  \\$wg$aRadiologic Health
=550  \\$aNuclear Warfare
=667  \\$aIM; specify geog if pertinent
=680  \\$iThe material that descends to the earth or water well beyond the site of a surface or subsurface nuclear explosion. (McGraw-Hill Dictionary of Chemical and Technical Terms, 4th ed)
=750  \0$aRadioactive fallout$5IEN$0(DLC)sh 85110599

=LDR  01577cz  a2200409n  4500
=001  9880363824802441
=005  20141212205118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011846
=035  \\$aCBA5147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x810
=072  \\$aG1.$x750.$x250.$x810
=072  \\$aG1.$x750.$x770.$x721
=150  \\$aRadio Waves
=450  \\$wnnna$aFrequency Wave, High
=450  \\$wnnna$aFrequency Waves, High
=450  \\$aHertzian Waves
=450  \\$wnnna$aHigh Frequency Wave
=450  \\$aHigh Frequency Waves
=450  \\$wnnna$aRadio Wave
=450  \\$wnnna$aShort Wave
=450  \\$aShort Waves
=450  \\$aVery High Frequency Waves
=450  \\$wnnna$aWave, High Frequency
=450  \\$wnnna$aWave, Radio
=450  \\$wnnna$aWave, Short
=450  \\$wnnna$aWaves, Hertzian
=450  \\$wnnna$aWaves, High Frequency
=450  \\$wnnna$aWaves, Radio
=450  \\$wnnna$aWaves, Short
=550  \\$wg$aElectromagnetic Radiation
=550  \\$wg$aRadiation, Nonionizing
=550  \\$wh$aMicrowaves
=667  \\$aradiation policy: see Manual index under RADIATION & entries following
=680  \\$iElectromagnetic waves with frequencies between about 3 kilohertz (very low frequency - VLF) and 300,000 megahertz (extremely high frequency - EHF). They are used in television and radio broadcasting, land and satellite communications systems, radionavigation, radiolocation, and DIATHERMY. The highest frequency radio waves are MICROWAVES.
=750  \0$aRadio waves$5IEN$0(DLC)sh 85110586

=LDR  00845cz  a2200229n  4500
=001  9880363824902441
=005  20141212205117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011845
=035  \\$aCBA5146HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x739
=072  \\$aL1.$x178.$x590.$x700
=072  \\$aL1.$x178.$x820.$x90.$x739
=072  \\$aL1.$x178.$x847.$x514
=150  \\$aRadio
=450  \\$wnnna$aRadios
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aMass Media
=550  \\$wg$aTelecommunications
=680  \\$iThe transmission and reception of electric impulses or signals by means of electric waves without a connecting wire, or the use of these waves for the wireless transmission of electric impulses into which sound is converted. (From Webster's 3d)
=750  \0$aRadio$5IEN$0(DLC)sh 85110385

=LDR  00698cz  a2200181n  4500
=001  9880363825002441
=005  20141212205117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011844
=035  \\$aCBA5145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x901.$x740
=150  \\$aRadiesthesia
=550  \\$wg$aSpiritual Therapies
=667  \\$ado not use /util except by MeSH definition
=680  \\$iTherapeutic cult concerned with intangible energies surrounding the living body and based on the detection of these intrinsic radiations by dowsing, or divining, or the use of more elaborate instruments (radionics).
=688  \\$a67,63-65
=750  \0$aRadiesthesia$5IEN$0(DLC)sh 85110382

=LDR  01890cz  a2200433n  4500
=001  9880363825102441
=005  20141212205117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011843
=035  \\$aCBA5144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x820
=150  \\$aRadiculopathy
=450  \\$wnnna$aAvulsion, Nerve Root
=450  \\$wnnna$aAvulsions, Nerve Root
=450  \\$wnnna$aCervical Radiculopathies
=450  \\$wnnna$aCervical Radiculopathy
=450  \\$wnnna$aCompression, Nerve Root
=450  \\$wnnna$aCompressions, Nerve Root
=450  \\$wnnna$aInflammation, Nerve Root
=450  \\$aNerve Root Avulsion
=450  \\$wnnna$aNerve Root Avulsions
=450  \\$aNerve Root Compression
=450  \\$wnnna$aNerve Root Compressions
=450  \\$aNerve Root Disorder
=450  \\$wnnna$aNerve Root Disorders
=450  \\$wnnna$aNerve Root Inflammation
=450  \\$wnnna$aNerve Root Inflammations
=450  \\$wnnna$aRadiculitides
=450  \\$aRadiculitis
=450  \\$wnnna$aRadiculopathies
=450  \\$wnnna$aRadiculopathies, Cervical
=450  \\$wnnna$aRadiculopathy, Cervical
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$aSpinal Nerve Roots
=667  \\$adisease of a single spinal nerve root; do not confuse with POLYRADICULOPATHY (disease of several spinal nerve roots) nor with POLYRADICULONEUROPATHY (disease of both spinal nerve roots & peripheral nerves)
=680  \\$iDisease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.
=688  \\$a2000(1971)
=750  \0$aRadiculitis$5IEN$0(DLC)sh 85110381

=LDR  01459cz  a2200397n  4500
=001  9880363825202441
=005  20141212205116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011842
=035  \\$aCBA5143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530.$x690.$x790.$x820
=072  \\$aC5.$x500.$x470.$x690.$x790.$x820
=072  \\$aC7.$x320.$x450.$x670.$x513.$x811
=072  \\$aC7.$x320.$x830.$x820
=072  \\$aC7.$x465.$x714.$x306.$x820
=150  \\$aRadicular Cyst
=450  \\$wnnna$aApical Periodontal Cyst
=450  \\$wnnna$aApical Periodontal Cysts
=450  \\$wnnna$aCyst, Apical Periodontal
=450  \\$wnnna$aCyst, Periapical
=450  \\$wnnna$aCyst, Radicular
=450  \\$wnnna$aCysts, Apical Periodontal
=450  \\$wnnna$aCysts, Periapical
=450  \\$wnnna$aCysts, Radicular
=450  \\$aPeriapical Cyst
=450  \\$wnnna$aPeriapical Cysts
=450  \\$aPeriodontal Cyst, Apical
=450  \\$wnnna$aPeriodontal Cysts, Apical
=450  \\$wnnna$aRadicular Cysts
=550  \\$wg$aPeriapical Diseases
=550  \\$wg$aPeriodontal Cyst
=667  \\$anon-neoplastic periodontal cyst; /blood supply /chem /secret /ultrastruct permitted; coord IM with organ/dis (IM), not organ/neopl
=680  \\$iSlow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling.
=688  \\$a65
=750  \0$aRadicular cyst$5IEN$0(DLC)sh 85110380

=LDR  01319cz  a2200325n  4500
=001  9880363825302441
=005  20141212205116.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011840
=035  \\$aCBA5141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x770
=150  \\$aRadiation, Nonionizing
=450  \\$wnnna$aNon-Ionizing Radiation
=450  \\$wnnna$aNon Ionizing Radiation
=450  \\$wnnna$aNon-Ionizing Radiations
=450  \\$wnnna$aNonionizing Radiation
=450  \\$wnnna$aNonionizing Radiations
=450  \\$wnnna$aRadiation, Non-Ionizing
=450  \\$wnnna$aRadiations, Non-Ionizing
=450  \\$wnnna$aRadiations, Nonionizing
=550  \\$wg$aRadiation
=550  \\$wh$aLight
=550  \\$wh$aRadio Waves
=550  \\$wh$aSound
=550  \\$wh$aTerahertz Radiation
=667  \\$apolicy: Manual 19.8.60, 21.16, 28.11.1; /adv eff = RADIATION INJURIES but see note there
=680  \\$iELECTROMAGNETIC RADIATION or sonic radiation (SOUND WAVES) which does not produce IONS in matter through which it passes. The wavelengths of non-ionizing electromagentic radiation are generally longer than those of far ultraviolet radiation and range through the longest RADIO WAVES.
=688  \\$a76; was NON MESH before 1976
=750  \0$aNonionizing radiation$5IEN$0(DLC)sh 86008067

=LDR  01227cz  a2200301n  4500
=001  9880363825402441
=005  20141212205116.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011839
=035  \\$aCBA5140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x750
=150  \\$aRadiation, Ionizing
=450  \\$wnnna$aIonizing Radiation
=450  \\$wnnna$aIonizing Radiations
=450  \\$wnnna$aRadiations, Ionizing
=550  \\$wg$aRadiation
=550  \\$wh$aAlpha Particles
=550  \\$wh$aBackground Radiation
=550  \\$wh$aBeta Particles
=550  \\$wh$aCosmic Radiation
=550  \\$wh$aGamma Rays
=550  \\$wh$aUltraviolet Rays
=550  \\$wh$aX-Rays
=667  \\$apolicy: Manual 19.8.60, 21.16, 28.11.1; /adv eff = RADIATION INJURIES but see note there
=680  \\$iELECTROMAGNETIC RADIATION or particle radiation (high energy ELEMENTARY PARTICLES) capable of directly or indirectly producing IONS in its passage through matter. The wavelengths of ionizing electromagnetic radiation are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays.
=688  \\$a76; was NON MESH before 1976
=750  \0$aIonizing radiation$5IEN$0(DLC)sh 85067827

=LDR  01880cz  a2200481n  4500
=001  9880363825502441
=005  20141212205115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011838
=035  \\$aCBA5139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x600
=150  \\$aRadiation-Sensitizing Agents
=450  \\$wnnna$aAgents, Radiation-Sensitizing
=450  \\$wnnna$aAgents, Radiation Sensitizing
=450  \\$wnnna$aAgents, Radiosensitizing
=450  \\$wnnna$aDrugs, Radiation-Sensitizing
=450  \\$wnnna$aDrugs, Radiosensitizing
=450  \\$wnnna$aEffect, Radiation-Sensitizing
=450  \\$wnnna$aEffect, Radiosensitizing
=450  \\$wnnna$aEffects, Radiation-Sensitizing
=450  \\$wnnna$aEffects, Radiosensitizing
=450  \\$wnnna$aRadiation Sensitizers
=450  \\$wnnna$aRadiation Sensitizing Agents
=450  \\$wnnna$aRadiation-Sensitizing Drugs
=450  \\$wnnna$aRadiation Sensitizing Drugs
=450  \\$wnnna$aRadiation-Sensitizing Effect
=450  \\$wnnna$aRadiation Sensitizing Effect
=450  \\$wnnna$aRadiation-Sensitizing Effects
=450  \\$wnnna$aRadiation Sensitizing Effects
=450  \\$aRadiosensitizing Agents
=450  \\$wnnna$aRadiosensitizing Drugs
=450  \\$wnnna$aRadiosensitizing Effect
=450  \\$wnnna$aRadiosensitizing Effects
=450  \\$wnnna$aSensitizers, Radiation
=450  \\$wnnna$aSensitizing Agents, Radiation
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aPhotosensitizing Agents
=550  \\$aRadiation Tolerance
=667  \\$anote entry term RADIATION-SENSITIZING EFFECT: use only for the radiation sensitizing effect of a chemical substance
=680  \\$iDrugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
=688  \\$a66(65)
=750  \0$aRadiation-sensitizing agents$5IEN$0(DLC)sh 85110359

=LDR  01901cz  a2200445n  4500
=001  9880363825602441
=005  20141212205114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011837
=035  \\$aCBA5138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x706.$x776
=072  \\$aD27.$x720.$x799.$x763
=150  \\$aRadiation-Protective Agents
=450  \\$wnnna$aAgents, Radiation-Protective
=450  \\$wnnna$aAgents, Radiation Protective
=450  \\$wnnna$aAgents, Radioprotective
=450  \\$wnnna$aDrugs, Radiation-Protective
=450  \\$wnnna$aDrugs, Radioprotective
=450  \\$wnnna$aEffect, Radiation-Protective
=450  \\$wnnna$aEffects, Radiation-Protective
=450  \\$wnnna$aProtectants, Radiation
=450  \\$wnnna$aProtective Agents, Radiation
=450  \\$wnnna$aRadiation Protectants
=450  \\$wnnna$aRadiation Protective Agents
=450  \\$wnnna$aRadiation-Protective Drugs
=450  \\$wnnna$aRadiation Protective Drugs
=450  \\$wnnna$aRadiation-Protective Effect
=450  \\$wnnna$aRadiation Protective Effect
=450  \\$wnnna$aRadiation-Protective Effects
=450  \\$wnnna$aRadiation Protective Effects
=450  \\$aRadioprotective Agents
=450  \\$wnnna$aRadioprotective Drugs
=550  \\$wg$aProtective Agents
=550  \\$wh$aSunscreening Agents
=550  \\$aRadiation Injuries
=550  \\$aRadiation Tolerance
=667  \\$aSUNSCREENING AGENTS is also available; use RADIATION PROTECTION for shielding from diagnostic x-rays; note entry term RADIATION-PROTECTIVE EFFECT: use only for the radiation protective effect of a chemical substance
=680  \\$iDrugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.
=750  \0$aRadiation-protective agents$5IEN$0(DLC)sh 85110357

=LDR  01205cz  a2200325n  4500
=001  9880363825702441
=005  20170620115015.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011836
=035  \\$aCBA5137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x712
=072  \\$aG7.$x738
=150  \\$aRadiation Tolerance
=450  \\$wnnna$aRadiation Sensitivities
=450  \\$aRadiation Sensitivity
=450  \\$wnnna$aRadiation Tolerances
=450  \\$wnnna$aRadiosensitivities
=450  \\$aRadiosensitivity
=450  \\$wnnna$aSensitivities, Radiation
=450  \\$wnnna$aSensitivity, Radiation
=450  \\$wnnna$aTolerance, Radiation
=450  \\$wnnna$aTolerances, Radiation
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wg$aPhysiological Processes
=550  \\$wh$aDose-Response Relationship, Radiation
=550  \\$aRadiation Effects
=680  \\$iThe ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.
=688  \\$a77
=750  \0$aRadiation tolerance$5IEN$0(DLC)sh 89004270

=LDR  00669cz  a2200229n  4500
=001  9880363825802441
=005  20141212205113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011835
=035  \\$aCBA5136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x810.$x425
=150  \\$aRadiation Protection
=450  \\$wnnna$aProtection, Radiation
=450  \\$wnnna$aProtections, Radiation
=450  \\$wnnna$aRadiation Protections
=550  \\$wg$aRadiologic Health
=550  \\$aHealth Physics
=550  \\$aNuclear Energy
=550  \\$aRadiation Injuries
=667  \\$aincludes "shielding"
=750  \0$aRadiation$xSafety measures$5IEN$0(DLC)sh 85110347

=LDR  01224cz  a2200301n  4500
=001  9880363825902441
=005  20180719092750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011834
=035  \\$aCBA5135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x638
=072  \\$aN6.$x850.$x780.$x375.$x700
=072  \\$aN6.$x850.$x810.$x370
=150  \\$aRadiation Monitoring
=450  \\$wnnna$aMonitoring, Radiation
=550  \\$wg$aEnvironmental Monitoring
=550  \\$wg$aRadiologic Health
=550  \\$wg$aRadiometry
=550  \\$wh$aBody Burden
=550  \\$wh$aFilm Dosimetry
=550  \\$wh$aIn Vivo Dosimetry
=550  \\$wh$aOptically Stimulated Luminescence Dosimetry
=550  \\$wh$aThermoluminescent Dosimetry
=550  \\$aHealth Physics
=680  \\$iThe observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.
=688  \\$a64; was see under RADIOMETRY 1963
=750  \0$aRadiation$xMeasurement$5IEN-HS$0(DLC)sh 85110345

=LDR  01936cz  a2200469n  4500
=001  9880363826002441
=005  20141212205112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011832
=035  \\$aCBA5133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x733
=072  \\$aN6.$x850.$x810.$x300.$x360
=150  \\$aRadiation Injuries
=450  \\$wnnna$aInjuries, Radiation
=450  \\$wnnna$aInjury, Radiation
=450  \\$wnnna$aRadiation Injury
=450  \\$wnno$aRadiation, Ionizing$xadverse effects$5IEN-M
=450  \\$aRadiation Sickness
=450  \\$wnnna$aRadiation Sicknesses
=450  \\$aRadiation Syndrome
=450  \\$wnnna$aRadiation Syndromes
=450  \\$wnnna$aSickness, Radiation
=450  \\$wnnna$aSicknesses, Radiation
=450  \\$wnnna$aSyndrome, Radiation
=450  \\$wnnna$aSyndromes, Radiation
=550  \\$wg$aRadiation Effects
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aAbnormalities, Radiation-Induced
=550  \\$wh$aAcute Radiation Syndrome
=550  \\$wh$aCardiotoxicity
=550  \\$wh$aLeukemia, Radiation-Induced
=550  \\$wh$aNeoplasms, Radiation-Induced
=550  \\$wh$aOsteoradionecrosis
=550  \\$wh$aRadiation Injuries, Experimental
=550  \\$wh$aRadiation Pneumonitis
=550  \\$wh$aRadiodermatitis
=550  \\$aRadioactive Hazard Release
=667  \\$ahuman & veterinary animals only; radiation injuries in experimental vertebrate animals = RADIATION INJURIES, EXPERIMENTAL: see note there; Manual 28.12; radiations causing neoplasms = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED; radiations causing abnormalities = ABNORMALITIES, RADIATION-INDUCED; OSTEORADIONECROSIS is available
=680  \\$iHarmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
=688  \\$a73; was RADIATION INJURY 1963-72
=750  \0$aRadiation injuries$0(DLC) sh 86007210$5IEN

=LDR  00698cz  a2200205n  4500
=001  9880363826102441
=005  20141212205112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011831
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x800
=072  \\$aN6.$x850.$x810.$x335
=150  \\$aRadiation Genetics
=450  \\$aGenetics, Radiation
=550  \\$wg$aGenetics
=550  \\$wg$aRadiologic Health
=550  \\$aRadiation Effects
=667  \\$aSPEC or GEN; prefer specifics: Manual 28.22.5
=680  \\$iA subdiscipline of genetics that studies RADIATION EFFECTS on the components and processes of biological inheritance.
=750  \0$aRadiogenetics$5IEN$0(DLC)sh 85110683

=LDR  01234cz  a2200265n  4500
=001  9880363826202441
=005  20141212205112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011830
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x745
=072  \\$aN6.$x850.$x810.$x300
=150  \\$aRadiation Effects
=450  \\$wnnna$aEffect, Radiation
=450  \\$wnnna$aEffects, Radiation
=450  \\$wnnna$aRadiation Effect
=550  \\$wg$aRadiation
=550  \\$wg$aRadiologic Health
=550  \\$wh$aRadiation Injuries
=550  \\$aRadiation Genetics
=550  \\$aRadiation Tolerance
=667  \\$ageneral only: prefer the qualifier / rad eff: Manual 19.7+, 19.8.60; indexing policy: Manual 28.10+ ; radiation causing neoplasms = NEOPLASMS, RADIATION-INDUCED or LEUKEMIA, RADIATION-INDUCED, radiation causing abnormalities = ABNORMALITIES, RADIATION-INDUCED
=680  \\$iThe effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on food, drugs, and chemicals.
=688  \\$aRADIATION IMMUNOLOGY was heading 1964-66
=750  \0$aRadiation$xPhysiological effect$5IEN$0(DLC)sh 85110346

=LDR  01382cz  a2200349n  4500
=001  9880363826302441
=005  20141212205111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011829
=035  \\$aCBA5130HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x513
=072  \\$aG1.$x750.$x740
=072  \\$aN6.$x850.$x810.$x250
=150  \\$aRadiation Dosage
=450  \\$wnnna$aDosage, Radiation
=450  \\$wnnna$aDosages, Radiation
=450  \\$wnnna$aGray Units
=450  \\$wnnna$aGy Radiation
=450  \\$wnnna$aRadiation Dosages
=450  \\$aSievert Units
=450  \\$wnnna$aSv Radiation Dose Equivalent
=450  \\$wnnna$aUnits, Gray
=450  \\$wnnna$aUnits, Sievert
=550  \\$wg$aRadiation
=550  \\$wg$aRadiologic Health
=550  \\$wg$aRadiometry
=550  \\$wh$aDose-Response Relationship, Radiation
=550  \\$wh$aRelative Biological Effectiveness
=680  \\$iThe amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).
=688  \\$a72
=750  \0$aRadiation$xDosage$5IEN$0(DLC)sh 85110341

=LDR  01184cz  a2200289n  4500
=001  9880363826402441
=005  20170927154206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011827
=035  \\$aCBA5128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750
=150  \\$aRadiation
=450  \\$wnnna$aRadiations
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aAbsorption, Radiation
=550  \\$wh$aElectromagnetic Radiation
=550  \\$wh$aRadiation Dosage
=550  \\$wh$aRadiation Effects
=550  \\$wh$aRadiation Exposure
=550  \\$wh$aRadiation, Ionizing
=550  \\$wh$aRadiation, Nonionizing
=550  \\$wh$aSolar Energy
=667  \\$ageneral or unspecified; prefer specifics; /adv eff = RADIATION INJURIES but see note there; /diag use consider RADIOGRAPHY or RADIONUCLIDE IMAGING; Manual 29.12
=680  \\$iEmission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES).
=688  \\$aRADIATION IMMUNOLOGY was heading 1964-66
=750  \0$aRadiation$5IEN$0(DLC)sh 85110340

=LDR  00994cz  a2200205n  4500
=001  9880363826502441
=005  20141212205110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011826
=035  \\$aCBA5127HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x50.$x700
=150  \\$aRadial Nerve
=450  \\$wnnna$aNerve, Radial
=450  \\$wnnna$aNerves, Radial
=450  \\$wnnna$aRadial Nerves
=550  \\$wg$aBrachial Plexus
=667  \\$adis = RADIAL NEUROPATHY; neopl = RADIAL NEUROPATHY (IM) + PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iA major nerve of the upper extremity. In humans the fibers of the radial nerve originate in the lower cervical and upper thoracic spinal cord (usually C5 to T1), travel via the posterior cord of the brachial plexus, and supply motor innervation to extensor muscles of the arm and cutaneous sensory fibers to extensor regions of the arm and hand.
=750  \0$aRadial nerve$5IEN$0(DLC)sh 85110336

=LDR  00606cz  a2200181n  4500
=001  9880363826602441
=005  20141212205110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011825
=035  \\$aCBA5126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x500
=150  \\$aRadar
=550  \\$wg$aTelecommunications
=550  \\$aRadio Waves
=667  \\$anon-ionizing
=680  \\$iA system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined.
=750  \0$aRadar$5IEN$0(DLC)sh 85110293

=LDR  00732cz  a2200241n  4500
=001  9880363826702441
=005  20180406111534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011822
=035  \\$aCBA5123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x820.$x500
=150  \\$aRace Relations
=450  \\$wnnna$aRelations, Race
=550  \\$wg$aSocial Segregation
=550  \\$wh$aApartheid
=550  \\$wh$aDesegregation
=550  \\$wh$aRacism
=550  \\$aPsychology, Social
=667  \\$acoord IM with specific races (IM) & and locale if pertinent; DF: RACE RELAT
=680  \\$iCultural contacts between people of different races.
=688  \\$a68
=750  \0$aRace relations$5IEN$0(DLC)sh 85110249

=LDR  00768cz  a2200217n  4500
=001  9880363826802441
=005  20141212205109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011821
=035  \\$aCBA5122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x650.$x700
=150  \\$aRaccoons
=450  \\$aProcyon
=450  \\$wnnna$aProcyons
=450  \\$wnnna$aRaccoon
=550  \\$wg$aProcyonidae
=667  \\$ado not confuse with RACCOON DOGS
=680  \\$iCarnivores of the genus Procyon of the family PROCYONIDAE. Two subgenera and seven species are currently recognized. They range from southern Canada to Panama and are found in several of the Caribbean Islands.
=688  \\$a68
=750  \0$aProcyon$0(DLC) sh 86008018$5IEN

=LDR  00735cz  a2200193n  4500
=001  9880363826902441
=005  20141212205109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011820
=035  \\$aCBA5121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x750.$x500.$x700
=072  \\$aB4.$x909.$x777.$x455.$x750.$x500.$x700
=150  \\$aRabies virus
=450  \\$wnnna$aRabies viruses
=550  \\$wg$aLyssavirus
=667  \\$ainfection = RABIES
=680  \\$iThe type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.
=750  \0$aRabies virus$5IEN$0(DLC)sh 88003397

=LDR  00850cz  a2200217n  4500
=001  9880363827002441
=005  20141212205109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011819
=035  \\$aCBA5120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x700
=150  \\$aRabies Vaccines
=450  \\$wnnna$aRabies Human Diploid Cell Vaccine
=450  \\$wnnna$aRabies Vaccine
=450  \\$wnnna$aVaccine, Rabies
=450  \\$wnnna$aVaccines, Rabies
=550  \\$wg$aViral Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.
=688  \\$a2001 (1963)
=750  \0$aRabies vaccines$5IEN$0(DLC)sh 85110221

=LDR  00834cz  a2200205n  4500
=001  9880363827102441
=005  20141212205109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011818
=035  \\$aCBA5119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x830.$x750
=150  \\$aRabies
=450  \\$aHydrophobia
=450  \\$wnnna$aLyssa
=450  \\$wnnna$aLyssas
=550  \\$wg$aRhabdoviridae Infections
=667  \\$ahuman & animal; coordinate with NEGLECTED DISEASES if pertinent
=680  \\$iAcute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf.
=750  \0$aRabies$5IEN$0(DLC)sh 85110217

=LDR  01440cz  a2200397n  4500
=001  9880363827202441
=005  20141212205108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x521.$x700
=150  \\$aRabbits
=450  \\$aBelgian Hare
=450  \\$wnnna$aChinchilla Rabbit
=450  \\$wnnna$aChinchilla Rabbits
=450  \\$wnnna$aDomestic Rabbit
=450  \\$wnnna$aDomestic Rabbits
=450  \\$wnnna$aHare, Belgian
=450  \\$wnnna$aNew Zealand Rabbit
=450  \\$aNew Zealand Rabbits
=450  \\$wnnna$aNew Zealand White Rabbits
=450  \\$wnnna$aNZW Rabbit
=450  \\$wnnna$aNZW Rabbits
=450  \\$wnnna$aOryctolagus cuniculus
=450  \\$wnnna$aRabbit, Chinchilla
=450  \\$aRabbit, Domestic
=450  \\$wnnna$aRabbit, New Zealand
=450  \\$wnnna$aRabbit, NZW
=450  \\$wnnna$aRabbits, Chinchilla
=450  \\$wnnna$aRabbits, Domestic
=450  \\$wnnna$aRabbits, New Zealand
=450  \\$wnnna$aRabbits, NZW
=550  \\$wg$aLagomorpha
=667  \\$acheck tag: NIM no qualifiers; do not confuse entry term BELGIAN HARE with HARES
=680  \\$iThe species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
=750  \0$aRabbits$5IEN$0(DLC)sh 85110203

=LDR  00796cz  a2200253n  4500
=001  9880363827302441
=005  20141212205108.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011815
=035  \\$aCBA5116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x600.$x600
=150  \\$aR Factors
=450  \\$wnnna$aFactors, R
=450  \\$wnnna$aFactors, Resistance
=450  \\$wnnna$aPlasmids, R
=450  \\$aR Plasmids
=450  \\$aResistance Factors
=550  \\$wg$aPlasmids
=550  \\$aDrug Resistance, Microbial
=667  \\$abacterial
=680  \\$iA class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.
=688  \\$a78(75); was see under DRUG RESISTANCE, MICROBIAL 1975-77
=750  \0$aR factors$5IEN$0(DLC)sh 85110175

=LDR  00685cz  a2200181n  4500
=001  9880363827402441
=005  20141212205107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011811
=035  \\$aCBA5112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x438.$x587
=150  \\$aQuintuplets
=450  \\$wnnna$aQuintuplet
=550  \\$wg$aMultiple Birth Offspring
=667  \\$ahuman only: for animals use LITTER SIZE; PREGNANCY, QUINTUPLET is also available
=680  \\$iFive individuals derived from five FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
=750  \0$aQuintuplets$5IEN$0(DLC)sh 85110107

=LDR  00587cz  a2200217n  4500
=001  9880363827502441
=005  20171215155433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011810
=035  \\$aCBA5111M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x857
=150  \\$aQuinoxalines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$a6-Cyano-7-nitroquinoxaline-2,3-dione
=550  \\$wh$aCarbadox
=550  \\$wh$aEchinomycin
=550  \\$wh$aTyrphostins
=550  \\$wh$aVarenicline
=688  \\$a66
=750  \0$aQuinoxalines$0(DLC) sh2004007285$5IEN-M

=LDR  00720cz  a2200217n  4500
=001  9880363827602441
=005  20141212205107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011809
=035  \\$aCBA5110HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x806
=150  \\$aQuinones
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAnthraquinones
=550  \\$wh$aBenzoquinones
=550  \\$wh$aIndolequinones
=550  \\$wh$aNaphthoquinones
=667  \\$acoord with specific hydrocarbon structure if pertinent
=680  \\$iHydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
=750  \0$aQuinone$5IEN$0(DLC)sh 85109891

=LDR  00862cz  a2200265n  4500
=001  9880363827702441
=005  20141212211015.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015363
=035  \\$aCBA5107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x835
=150  \\$aQuinolones
=450  \\$aKetoquinolines
=450  \\$aOxoquinolines
=450  \\$aQuinolinones
=550  \\$wg$aQuinolines
=550  \\$wh$a4-Quinolones
=550  \\$wh$aCarteolol
=550  \\$wh$aFluoroquinolones
=550  \\$wh$aPQQ Cofactor
=667  \\$ado not confuse with QUINOLINES
=680  \\$iA group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
=688  \\$a94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93
=750  \0$aQuinolone antibacterial agents$0(DLC)sh 88006460$5IEN-M

=LDR  01029cz  a2200361n  4500
=001  9880363827802441
=005  20141212205105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011804
=035  \\$aCBA5104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810
=150  \\$aQuinolines
=450  \\$aCinchophen$5IEN
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aAminoquinolines
=550  \\$wh$aDiarylquinolines
=550  \\$wh$aDibucaine
=550  \\$wh$aEthoxyquin
=550  \\$wh$aHydroxyquinolines
=550  \\$wh$aMefloquine
=550  \\$wh$aNitroquinolines
=550  \\$wh$aPyrroloiminoquinones
=550  \\$wh$aQuinaldines
=550  \\$wh$aQuinidine
=550  \\$wh$aQuinine
=550  \\$wh$aQuinolinium Compounds
=550  \\$wh$aQuinolones
=550  \\$wh$aQuinpirole
=550  \\$wh$aQuipazine
=550  \\$wh$aSaquinavir
=667  \\$ado not confuse with QUINOLIZINES nor with QUINOLONES nor its X ref QUINOLINONES
=750  \0$aQuinoline$5IEN$0(DLC)sh 85109889

=LDR  02676cz  a2200625n  4500
=001  9880363827902441
=005  20141212205105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011803
=035  \\$aCBA5103HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x206.$x719
=072  \\$aD3.$x438.$x810.$x762
=072  \\$aD3.$x605.$x687.$x762
=150  \\$aQuinine
=450  \\$wnnna$aAlphapharm Brand of Quinine Sulfate
=450  \\$wnnna$aAventis Brand of Quinine Bisulfate
=450  \\$wnnna$aBiquinate
=450  \\$wnnna$aBisulfate, Quinine
=450  \\$wnnna$aFawns & McAllan Brand of Quinine Bisulfate
=450  \\$wnnna$aFawns & McAllan Brand of Quinine Sulfate
=450  \\$wnnna$aFoy Brand of Quinine Sulfate
=450  \\$wnnna$aHoechst Brand of Quinine Sulfate
=450  \\$wnnna$aHydrochloride, Quinine
=450  \\$wnnna$aInnotech Brand of Quinine Hydrochloride
=450  \\$wnnna$aLafran Brand of Quinine Hydrochloride
=450  \\$wnnna$aLegatrim
=450  \\$wnnna$aMyoquin
=450  \\$wnnna$aOdan Brand of Quinine Sulfate
=450  \\$wnnna$aPlough Brand of Quinine Sulfate
=450  \\$wnnna$aProsana Brand of Quinine Bisulfate
=450  \\$wnnna$aQuinamm
=450  \\$wnnna$aQuinbisan
=450  \\$wnnna$aQuinbisul
=450  \\$wnnna$aQuindan
=450  \\$wnnna$aQuinimax
=450  \\$wnnna$aQuinine Bisulfate
=450  \\$wnnna$aQuinine Hydrochloride
=450  \\$wnnna$aQuinine Lafran
=450  \\$wnnna$aQuinine-Odan
=450  \\$wnnna$aQuinine Sulfate
=450  \\$wnnna$aQuinine Sulphate
=450  \\$wnnna$aQuinoctal
=450  \\$wnnna$aQuinson
=450  \\$wnnna$aQuinsul
=450  \\$wnnna$aStrema
=450  \\$wnnna$aSulfate, Quinine
=450  \\$wnnna$aSulphate, Quinine
=450  \\$wnnna$aSurquina
=550  \\$wg$aCinchona Alkaloids
=550  \\$wg$aQuinolines
=550  \\$wg$aQuinuclidines
=667  \\$a/biosyn permitted if by plant
=680  \\$iAn alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.
=750  \0$aQuinine$5IEN$0(DLC)sh 85109880

=LDR  01454cz  a2200361n  4500
=001  9880363828002441
=005  20141212192456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011802
=035  \\$aCBA5102HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x206.$x636
=072  \\$aD3.$x438.$x810.$x699
=072  \\$aD3.$x605.$x687.$x637
=150  \\$aQuinidine
=450  \\$wnnna$aAdaquin
=450  \\$wnnna$aApo-Quinidine
=450  \\$wnnna$aApo Quinidine
=450  \\$wnnna$aApotex Brand of Quinidine Sulfate
=450  \\$wnnna$aChinidin
=450  \\$wnnna$aFawns & McAllan Brand of Quinidine Sulfate
=450  \\$wnnna$aNelson Brand of Quinidine Sulfate
=450  \\$wnnna$aQuincardine
=450  \\$wnnna$aQuinidex
=450  \\$wnnna$aQuinidine Sulfate
=450  \\$wnnna$aQuinora
=450  \\$wnnna$aRobins Brand of Quinidine Sulfate
=450  \\$wnnna$aSulfate, Quinidine
=550  \\$wg$aCinchona Alkaloids
=550  \\$wg$aQuinolines
=550  \\$wg$aQuinuclidines
=680  \\$iAn optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.
=750  \0$aQuinidine$5IEN$0(DLC)sh 85109879

=LDR  00616cz  a2200229n  4500
=001  9880363828102441
=005  20170705104243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011799
=035  \\$aCBA5099HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100.$x786
=150  \\$aQuinazolines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aErlotinib Hydrochloride
=550  \\$wh$aLinagliptin
=550  \\$wh$aPrazosin
=550  \\$wh$aQuinazolinones
=550  \\$wh$aTetrodotoxin
=550  \\$wh$aTrimetrexate
=688  \\$a66(65)
=750  \0$aQuinazoline$0(DLC) sh 85109873$5IEN

=LDR  01780cz  a2200445n  4500
=001  9880363828202441
=005  20141212205103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011796
=035  \\$aCBA5096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x46.$x250.$x760
=150  \\$aQuinacrine
=450  \\$wnnna$aAcrichine
=450  \\$wnnna$aAtabrine
=450  \\$wnnna$aAtebrin
=450  \\$wnnna$aDihydrochloride, Quinacrine
=450  \\$wnnna$aDimesylate, Quinacrine
=450  \\$wnnna$aHydrochloride, Quinacrine
=450  \\$aMepacrine
=450  \\$wnnna$aMonoacetate, Quinacrine
=450  \\$wnnna$aMonohydrochloride, Quinacrine
=450  \\$wnnna$aMonomesylate, Quinacrine
=450  \\$wnnna$aQuinacrine, (+-)-Isomer
=450  \\$wnnna$aQuinacrine Dihydrochloride
=450  \\$wnnna$aQuinacrine Dihydrochloride, Dihydrate
=450  \\$wnnna$aQuinacrine Dihyrochloride, (R)-Isomer
=450  \\$wnnna$aQuinacrine Dihyrochloride, (S)-Isomer
=450  \\$wnnna$aQuinacrine Dimesylate
=450  \\$wnnna$aQuinacrine Hydrochloride
=450  \\$wnnna$aQuinacrine Monoacetate
=450  \\$wnnna$aQuinacrine Monohydrochloride
=450  \\$wnnna$aQuinacrine Monomesylate
=450  \\$wnnna$aQuinacrine, (R)-Isomer
=450  \\$wnnna$aQuinacrine, (S)-Isomer
=550  \\$wg$aAminoacridines
=550  \\$wh$aQuinacrine Mustard
=680  \\$iAn acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
=688  \\$aCHINACRIN was see QUINACRINE 1977-93
=750  \0$aQuinacrine$5IEN$0(DLC)sh 85109867

=LDR  02603cz  a2200685n  4500
=001  9880363828302441
=005  20200611124801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011795
=035  \\$aCBA5095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x980
=072  \\$aL1.$x280.$x960
=072  \\$aN5.$x715.$x360.$x300.$x800
=072  \\$aN6.$x850.$x520.$x308.$x980
=150  \\$aSurveys and Questionnaires
=450  \\$wnno$aQuestionnaires
=450  \\$wnnna$aBaseline Survey
=450  \\$wnnna$aBaseline Surveys
=450  \\$wnnna$aCommunity Survey
=450  \\$wnnna$aCommunity Surveys
=450  \\$wnnna$aDesign, Questionnaire
=450  \\$wnnna$aDesigns, Questionnaire
=450  \\$wnnna$aMethods, Survey
=450  \\$wnnna$aMethodology, Survey
=450  \\$wnnna$aNonrespondent
=450  \\$wnnna$aNonrespondents
=450  \\$wnnna$aQuestionnaire
=450  \\$wnnna$aQuestionnaire Design
=450  \\$wnnna$aQuestionnaire Designs
=450  \\$wnnna$aQuestionnaires and Surveys
=450  \\$wnnna$aRandomized Response Technique
=450  \\$wnnna$aRandomized Response Techniques
=450  \\$wnnna$aRepeated Rounds of Survey
=450  \\$wnnna$aRespondent
=450  \\$wnnna$aRespondents
=450  \\$wnnna$aResponse Technique, Randomized
=450  \\$wnnna$aResponse Techniques, Randomized
=450  \\$wnnna$aSurvey
=450  \\$wnnna$aSurvey, Baseline
=450  \\$wnnna$aSurvey, Community
=450  \\$wnnna$aSurvey Methodology
=450  \\$wnnna$aSurvey Method
=450  \\$aSurvey Methods
=450  \\$aSurveys
=450  \\$wnnna$aSurveys, Baseline
=450  \\$wnnna$aSurveys, Community
=450  \\$wnnna$aTechniques, Randomized Response
=550  \\$wg$aData Collection
=550  \\$wh$aContraceptive Prevalence Surveys
=550  \\$wh$aDelphi Technique
=550  \\$wh$aHealth Care Surveys
=550  \\$wh$aHealth Surveys
=550  \\$wh$aNutrition Surveys
=550  \\$wh$aPatient Health Questionnaire
=550  \\$wh$aSelf Report
=680  \\$iCollections of data obstained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions.
=688  \\$a2016(1973); was QUESTIONNAIRE 1967-1972; for BASELINE SURVEY use DATA COLLECTION 1996-2015; for Community Surveys use DATA COLLECTION 1980-2015; for NONRESPONDENTS use DATA COLLECTION 1992-2015; for RESPONDENTS use DATA COLLECTION 1992-2015; for SURVEY METHODS use DATA COLLECTION 1992-2015
=750  \0$aQuestionnaires$5IEN$0(DLC)sh 85109824
=750  \0$aSurveys$0(DLC)sh 85130875$5IEN-M

=LDR  00796cz  a2200205n  4500
=001  9880363828402441
=005  20141212205102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011794
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x284.$x777
=072  \\$aD3.$x830.$x219.$x266.$x450.$x284.$x777
=150  \\$aQuercetin
=450  \\$wnnna$a3,3',4',5,7-Pentahydroxyflavone
=450  \\$wnnna$aDikvertin
=550  \\$wg$aFlavonols
=680  \\$iA flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
=688  \\$a1991(1975);
=688  \\$a91(75); was see under FLAVONES 1975-90; was see under BIOFLAVONOIDS 1963-74
=750  \0$aQuercetin$5IEN$0(DLC)sh 85109812

=LDR  00746cz  a2200205n  4500
=001  9880363828502441
=005  20141212205101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011791
=035  \\$aCBA5091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x750.$x600
=072  \\$aD1.$x650.$x550.$x825.$x600
=072  \\$aD1.$x837.$x725.$x600
=150  \\$aQuartz
=550  \\$wg$aSilicon Dioxide
=667  \\$aa form of silicon dioxide
=680  \\$iQuartz (SiO2). A glassy or crystalline form of silicon dioxide. Many colored varieties are semiprecious stones. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a91(75)63-64; was see under SILICA 1965-90; was heading 1963-64
=750  \0$aQuartz$5IEN$0(DLC)sh 85109732

=LDR  01064cz  a2200181n  4500
=001  9880363828602441
=005  20141212205101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011790
=035  \\$aCBA5090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x450.$x700
=150  \\$aQuarantine
=450  \\$wnnna$aQuarantines
=550  \\$wg$aInfection Control
=667  \\$ahuman or animal; /vet permitted
=680  \\$iRestriction of freedom of movement of individuals who have been exposed to infectious or communicable disease in order to prevent its spread; a period of detention of vessels, vehicles, or travelers coming from infected or suspected places; and detention or isolation on account of suspected contagion. It includes government regulations on the detention of animals at frontiers or ports of entrance for the prevention of infectious disease, through a period of isolation before being allowed to enter a country. (From Dorland, 28th ed & Black's Veterinary Dictionary, 17th ed)
=750  \0$aQuarantine$5IEN$0(DLC)sh 85109473

=LDR  00852cz   2200217n  4500
=001  9880363828702441
=005  20230901094011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011789
=035  \\$aCBA5089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x579.$x800
=150  \\$aQuantum Theory
=450  \\$wnnna$aQuantum Theories
=450  \\$wnnna$aTheories, Quantum
=450  \\$wnnna$aTheory, Quantum
=550  \\$wg$aNuclear Physics
=680  \\$iThe theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E=hv in which h is Planck's constant and v is the frequency of the radiation.
=688  \\$a67(64)
=750  \0$aQuantum theory$5IEN$0(DLC)sh 85109469
=750  \0$iNarrower mapping$aQuantum jumps$0(DLC)sh2022007581$4NM$5IEN-M

=LDR  00869cz  a2200265n  4500
=001  9880363828802441
=005  20141212205100.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011788
=035  \\$aCBA5088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x800
=072  \\$aK1.$x752.$x400.$x750
=150  \\$aQuality of Life
=450  \\$wnnna$aLife Qualities
=450  \\$wnnna$aLife Quality
=550  \\$wg$aLife
=550  \\$wg$aSocial Sciences
=550  \\$aCost of Illness
=550  \\$aKarnofsky Performance Status
=550  \\$aLife Style
=550  \\$aValue of Life
=680  \\$iA generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
=688  \\$a77(75)
=750  \0$aQuality of life$5IEN$0(DLC)sh 85109445

=LDR  00653cz  a2200193n  4500
=001  9880363828902441
=005  20141212205026.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011675
=035  \\$aCBA4972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x660
=150  \\$aPulse Radiolysis
=450  \\$wnnna$aRadiolysis, Pulse
=550  \\$wg$aSpectrum Analysis
=667  \\$aa type of spectrum anal; NIM
=680  \\$iUse of a pulse of X-rays or fast electrons to generate free radicals for spectroscopic examination.
=688  \\$a91(75); was see under SPECTRUM ANALYSIS 1975-90
=750  \0$aPulse radiolysis$5IEN$0(DLC)sh 85109041

=LDR  00997cz  a2200241n  4500
=001  9880363829002441
=005  20141212205026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011674
=035  \\$aCBA4971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x650
=072  \\$aE1.$x370.$x600.$x650
=072  \\$aG9.$x330.$x380.$x750
=150  \\$aPulse
=450  \\$wnnna$aPulses
=550  \\$wg$aHeart Function Tests
=550  \\$wg$aHemodynamics
=550  \\$wg$aPhysical Examination
=550  \\$aHeart Rate
=667  \\$ado not add PULSE (NIM) for PULSE PRESSURE see BLOOD PRESSURE unless particularly discussed; taking of pulse in traditional East Asian medicine = PULSE + appropriate acupuncture or traditional East Asian medicine terms
=680  \\$iThe rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts.
=750  \0$aPulse$5IEN$0(DLC)sh 85109028

=LDR  00943cz  a2200241n  4500
=001  9880363829102441
=005  20141212205025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011671
=035  \\$aCBA4968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x237.$x820
=150  \\$aPulpitis
=450  \\$wnnna$aEndodontic Inflammation
=450  \\$wnnna$aEndodontic Inflammations
=450  \\$aInflammation, Endodontic
=450  \\$wnnna$aInflammations, Endodontic
=450  \\$wnnna$aPulpitides
=550  \\$wg$aDental Pulp Diseases
=550  \\$aPeriapical Periodontitis
=680  \\$iInflammation of the DENTAL PULP, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may also cause pulpitis.
=688  \\$a65(63)
=750  \0$aPulpitis$5IEN$0(DLC)sh 85109019

=LDR  00626cz  a2200205n  4500
=001  9880363829202441
=005  20141212205024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011667
=035  \\$aCBA4964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x713
=150  \\$aPulmonary Veins
=450  \\$wnnna$aPulmonary Vein
=450  \\$wnnna$aVein, Pulmonary
=450  \\$wnnna$aVeins, Pulmonary
=550  \\$wg$aVeins
=667  \\$aDF: PULM VEINS
=680  \\$iThe veins that return the oxygenated blood from the lungs to the left atrium of the heart.
=750  \0$aPulmonary veins$5IEN$0(DLC)sh 85109013

=LDR  01731cz  a2200433n  4500
=001  9880363829302441
=005  20141212205023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011666
=035  \\$aCBA4963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x716
=072  \\$aC14.$x280.$x955.$x750
=150  \\$aPulmonary Valve Stenosis
=450  \\$wnnna$aPulmonary Stenose
=450  \\$wnnna$aPulmonary Stenoses
=450  \\$aPulmonary Stenosis
=450  \\$wnnna$aPulmonary Valve Stenoses
=450  \\$wnnna$aPulmonic Stenoses
=450  \\$wnnna$aPulmonic Stenoses, Valvular
=450  \\$wnnna$aPulmonic Stenosis
=450  \\$wnnna$aPulmonic Stenosis, Valvular
=450  \\$wnnna$aStenose, Pulmonary
=450  \\$wnnna$aStenoses, Pulmonary
=450  \\$wnnna$aStenoses, Pulmonary Valve
=450  \\$wnnna$aStenoses, Pulmonic
=450  \\$wnnna$aStenosis, Pulmonary
=450  \\$wnnna$aStenosis, Pulmonary Valve
=450  \\$wnnna$aStenosis, Pulmonic
=450  \\$wnnna$aValvular Pulmonic Stenoses
=450  \\$wnnna$aValvular Pulmonic Stenosis
=550  \\$wg$aHeart Valve Diseases
=550  \\$wg$aVentricular Outflow Obstruction
=550  \\$wh$aLEOPARD Syndrome
=550  \\$wh$aPulmonary Subvalvular Stenosis
=667  \\$ado not confuse with PULMONARY SUBVALVULAR STENOSIS; DF: PULM VALVE STENOSIS
=680  \\$iThe pathologic narrowing of the orifice of the PULMONARY VALVE. This lesion restricts blood outflow from the RIGHT VENTRICLE to the PULMONARY ARTERY. When the trileaflet valve is fused into an imperforate membrane, the blockage is complete.
=688  \\$a67; was PULMONARY STENOSIS 1963-66
=750  \0$aPulmonary valve$xStenosis$0(DLC) sh 85109010$5IEN-M

=LDR  00711cz  a2200205n  4500
=001  9880363829402441
=005  20141212205023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011664
=035  \\$aCBA4961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510.$x738
=150  \\$aPulmonary Valve
=450  \\$wnnna$aPulmonary Valves
=450  \\$wnnna$aValve, Pulmonary
=450  \\$wnnna$aValves, Pulmonary
=550  \\$wg$aHeart Valves
=667  \\$adis: coord IM with HEART VALVE DISEASES (NIM) but note specific pulm valve dis; DF: PULM VALVE
=680  \\$iA valve situated at the entrance to the pulmonary trunk from the right ventricle.
=750  \0$aPulmonary valve$0(DLC)sh2006001316$5IEN-M

=LDR  00773cz  a2200217n  4500
=001  9880363829502441
=005  20141212205022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x796.$x600
=150  \\$aPulmonary Surfactants
=450  \\$wnnna$aPulmonary Surfactant
=450  \\$wnnna$aSurfactant, Pulmonary
=450  \\$aSurfactants, Pulmonary
=550  \\$wg$aRespiratory System Agents
=550  \\$aSurface-Active Agents
=667  \\$aDF: PULM SURFACTANTS
=680  \\$iSubstances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
=688  \\$a87; was PULMONARY SURFACTANT 1971-86 (Prov 1971-72)
=750  \0$aPulmonary surfactant$5IEN$0(DLC)sh 85109012

=LDR  01029cz  a2200265n  4500
=001  9880363829602441
=005  20141212205021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011660
=035  \\$aCBA4957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x832
=150  \\$aPulmonary Heart Disease
=450  \\$aCor Pulmonale
=450  \\$wnnna$aDisease, Pulmonary Heart
=450  \\$wnnna$aDiseases, Pulmonary Heart
=450  \\$wnnna$aHeart Disease, Pulmonary
=450  \\$wnnna$aHeart Diseases, Pulmonary
=450  \\$wnnna$aPulmonary Heart Diseases
=550  \\$wg$aHeart Diseases
=550  \\$aHypertension, Pulmonary
=550  \\$aLung Diseases
=667  \\$aDF: PULM HEART DIS
=680  \\$iHypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.
=750  \0$aCor pulmonale$5IEN$0(DLC)sh 85032504

=LDR  01051cz  a2200277n  4500
=001  9880363829702441
=005  20141212205021.0
=008  820426\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011659
=035  \\$aCBA4956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x650
=072  \\$aG3.$x495.$x166.$x775.$x602
=072  \\$aG9.$x772.$x770.$x755.$x760.$x602
=150  \\$aPulmonary Gas Exchange
=450  \\$wnnna$aExchange, Pulmonary Gas
=450  \\$wnnna$aGas Exchange, Pulmonary
=550  \\$wg$aRespiratory Function Tests
=550  \\$wg$aRespiratory Transport
=550  \\$wh$aPulmonary Diffusing Capacity
=550  \\$wh$aVentilation-Perfusion Ratio
=550  \\$aBlood-Air Barrier
=667  \\$ado not coord with OXYGEN or CARBON DIOXIDE unless particularly discussed; DF: PULM GAS EXCHANGE
=680  \\$iThe exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER.
=688  \\$a83
=750  \0$aPulmonary gas exchange$5IEN$0(DLC)sh 85109007

=LDR  01274cz  a2200301n  4500
=001  9880363829802441
=005  20141212205021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011658
=035  \\$aCBA4955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x765
=150  \\$aPulmonary Fibrosis
=450  \\$wnnna$aAlveolitides, Fibrosing
=450  \\$aAlveolitis, Fibrosing
=450  \\$wnnna$aFibroses, Pulmonary
=450  \\$wnnna$aFibrosing Alveolitides
=450  \\$wnnna$aFibrosing Alveolitis
=450  \\$wnnna$aFibrosis, Pulmonary
=450  \\$aHamman-Rich Syndrome
=450  \\$wnnna$aHamman Rich Syndrome
=450  \\$wnnna$aPulmonary Fibroses
=450  \\$wnnna$aSyndrome, Hamman-Rich
=550  \\$wg$aLung Diseases
=550  \\$wh$aIdiopathic Pulmonary Fibrosis
=667  \\$ausually chronic so do not coordinate with CHRONIC DISEASE; IDIOPATHIC PULMONARY FIBROSIS is also available; DF: PULM FIBROSIS
=680  \\$iA process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
=750  \0$aPulmonary fibrosis$0(DLC) sh 85109004$5IEN

=LDR  01828cz  a2200457n  4500
=001  9880363829902441
=005  20141212205020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011656
=035  \\$aCBA4953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x495.$x389.$x750
=150  \\$aPulmonary Emphysema
=450  \\$wnnna$aCentriacinar Emphysema
=450  \\$wnnna$aCentriacinar Emphysemas
=450  \\$wnnna$aCentrilobular Emphysema
=450  \\$wnnna$aCentrilobular Emphysemas
=450  \\$wnnna$aEmphysema, Centriacinar
=450  \\$wnnna$aEmphysema, Centrilobular
=450  \\$wnnna$aEmphysema, Focal
=450  \\$wnnna$aEmphysema, Panacinar
=450  \\$wnnna$aEmphysema, Panlobular
=450  \\$aEmphysema, Pulmonary
=450  \\$wnnna$aEmphysemas, Centriacinar
=450  \\$wnnna$aEmphysemas, Centrilobular
=450  \\$wnnna$aEmphysemas, Focal
=450  \\$wnnna$aEmphysemas, Panacinar
=450  \\$wnnna$aEmphysemas, Panlobular
=450  \\$wnnna$aEmphysemas, Pulmonary
=450  \\$wnnna$aFocal Emphysema
=450  \\$wnnna$aFocal Emphysemas
=450  \\$wnnna$aPanacinar Emphysema
=450  \\$wnnna$aPanacinar Emphysemas
=450  \\$wnnna$aPanlobular Emphysema
=450  \\$wnnna$aPanlobular Emphysemas
=450  \\$wnnna$aPulmonary Emphysemas
=550  \\$wg$aPulmonary Disease, Chronic Obstructive
=550  \\$aEmphysema
=667  \\$ain cattle, probably EMPHYSEMA, ACUTE BOVINE PULMONARY see PNEUMONIA, ATYPICAL INTERSTITIAL, OF CATTLE
=680  \\$iEnlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.
=750  \0$aEmphysema, Pulmonary$5IEN$0(DLC)sh 85042841

=LDR  00954cz  a2200301n  4500
=001  9880363830002441
=005  20141212205019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011655
=035  \\$aCBA4952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x746
=072  \\$aC14.$x907.$x355.$x350.$x700
=150  \\$aPulmonary Embolism
=450  \\$wnnna$aEmbolism, Pulmonary
=450  \\$wnnna$aEmbolisms, Pulmonary
=450  \\$wnnna$aPulmonary Embolisms
=450  \\$aPulmonary Thromboembolism
=450  \\$wnnna$aPulmonary Thromboembolisms
=450  \\$aThromboembolism, Pulmonary
=450  \\$wnnna$aThromboembolisms, Pulmonary
=550  \\$wg$aEmbolism
=550  \\$wg$aLung Diseases
=550  \\$wh$aPulmonary Infarction
=550  \\$aInfarction
=667  \\$aDF: PULM EMBOLISM
=680  \\$iBlocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
=750  \0$aPulmonary embolism$0(DLC) sh 85109002$5IEN

=LDR  01143cz  a2200277n  4500
=001  9880363830102441
=005  20141212205019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011654
=035  \\$aCBA4951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x742
=150  \\$aPulmonary Edema
=450  \\$wnnna$aEdema, Pulmonary
=450  \\$wnnna$aEdemas, Pulmonary
=450  \\$wnnna$aLung, Wet
=450  \\$wnnna$aLungs, Wet
=450  \\$wnnna$aPulmonary Edemas
=450  \\$aWet Lung
=450  \\$wnnna$aWet Lungs
=550  \\$wg$aLung Diseases
=550  \\$aEdema
=667  \\$aentry term WET LUNG: in shock, consider also SHOCK LUNG see RESPIRATORY DISTRESS SYNDROME, ADULT; DF: PULM EDEMA
=680  \\$iExcessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
=688  \\$aWET LUNG was see RESPIRATORY DISTRESS SYNDROME, ADULT 1977-91; was WET LUNG SYNDROME see PULMONARY EDEMA 1975-76
=750  \0$aPulmonary edema$5IEN$0(DLC)sh 85109001

=LDR  00892cz  a2200265n  4500
=001  9880363830202441
=005  20170609124257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011652
=035  \\$aCBA4948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x100.$x770
=072  \\$aG9.$x772.$x593
=150  \\$aPulmonary Circulation
=450  \\$wnnna$aCirculation, Pulmonary
=450  \\$wnnna$aCirculation, Respiratory
=450  \\$aRespiratory Circulation
=550  \\$wg$aBlood Circulation
=550  \\$wg$aRespiratory Physiological Phenomena
=550  \\$aLung
=550  \\$aPulmonary Wedge Pressure
=667  \\$aconsider also LUNG /blood supply; DF: PULM CIRC
=680  \\$iThe circulation of the BLOOD through the LUNGS.
=688  \\$a1963; for RESPIRATORY CIRCULATION use PULMONARY CIRCULATION 1990-1999
=750  \0$aPulmonary circulation$5IEN$0(DLC)sh 85109000

=LDR  00674cz  a2200205n  4500
=001  9880363830302441
=005  20141212205018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011651
=035  \\$aCBA4947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x715
=150  \\$aPulmonary Artery
=450  \\$wnnna$aArteries, Pulmonary
=450  \\$wnnna$aArtery, Pulmonary
=450  \\$wnnna$aPulmonary Arteries
=550  \\$wg$aArteries
=667  \\$aDF: PULM ARTERY
=680  \\$iThe short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs.
=750  \0$aPulmonary artery$0(DLC) sh 85108996$5IEN

=LDR  00861cz  a2200241n  4500
=001  9880363830402441
=005  20180117155341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011650
=035  \\$aCBA4946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x411.$x715
=150  \\$aPulmonary Alveoli
=450  \\$wnnna$aAlveoli, Pulmonary
=450  \\$wnnna$aAlveolus, Pulmonary
=450  \\$wnnna$aPulmonary Alveolus
=550  \\$wg$aLung
=550  \\$wh$aBlood-Air Barrier
=550  \\$wh$aAlveolar Epithelial Cells
=667  \\$aDF: PULM ALVEOLI
=680  \\$iSmall polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.
=688  \\$a66(64)
=750  \0$aPulmonary alveoli$5IEN$0(DLC)sh 85108995

=LDR  00903cz  a2200253n  4500
=001  9880363830502441
=005  20141212205016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011645
=035  \\$aCBA4941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x674.$x715
=072  \\$aC13.$x703.$x700.$x715
=072  \\$aC13.$x703.$x844.$x757
=150  \\$aPuerperal Infection
=450  \\$wnnna$aInfection, Puerperal
=450  \\$wnnna$aInfections, Puerperal
=450  \\$wnnna$aPuerperal Infections
=450  \\$aPuerperal Septicemia$5IEN
=550  \\$wg$aPregnancy Complications, Infectious
=550  \\$wg$aPuerperal Disorders
=667  \\$ageneral or unspecified; coordinate IM with specific infection (IM); check the tag FEMALE
=680  \\$iAn infection occurring in PUERPERIUM, the period of 6-8 weeks after giving birth.
=750  \0$aPuerperal septicemia$5IEN$0(DLC)sh 85108918

=LDR  01010cz  a2200277n  4500
=001  9880363830602441
=005  20141212205016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011644
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x844
=150  \\$aPuerperal Disorders
=450  \\$wnnna$aDisorder, Puerperal
=450  \\$wnnna$aDisorders, Puerperal
=450  \\$wnnna$aPuerperal Disorder
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aDepression, Postpartum
=550  \\$wh$aLactation Disorders
=550  \\$wh$aMastitis
=550  \\$wh$aPostpartum Hemorrhage
=550  \\$wh$aPostpartum Thyroiditis
=550  \\$wh$aPubic Symphysis Diastasis
=550  \\$wh$aPuerperal Infection
=667  \\$acheck the tag FEMALE; puerperal psychoses: coordinate IM with PSYCHOTIC DISORDERS (IM)
=680  \\$iDisorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
=750  \0$aPuerperal disorders$5IEN$0(DLC)sh 85108916

=LDR  01548cz  a2200349n  4500
=001  9880363830702441
=005  20201123173354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011643
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737
=150  \\$aPublishing
=450  \\$aElectronic Publishing
=450  \\$wnnna$aElectronic Publishings
=450  \\$aPublishing, Electronic
=450  \\$wnnna$aPublishings, Electronic
=550  \\$wg$aInformation Science
=550  \\$wh$aAccess to Information
=550  \\$wh$aBook Industry
=550  \\$wh$aCopyright
=550  \\$wh$aDuplicate Publications as Topic
=550  \\$wh$aEditorial Policies
=550  \\$wh$aJournalism
=550  \\$wh$aPeer Review, Research
=550  \\$wh$aPlagiarism
=550  \\$wh$aPrinting
=550  \\$wh$aPublication Bias
=550  \\$wh$aRetraction of Publication as Topic
=550  \\$aBook Industry
=667  \\$athe industry & the dissemination of knowledge & research; printing & disseminating textual material: do not confuse with WRITING (the act, profession or product) or with AUTHORSHIP (identity as author); med publishing: do not coord with MEDICINE; RETRACTION OF PUBLICATION AS TOPIC is also available
=680  \\$i"The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.
=750  \0$aPublishers and publishing$5IEN$0(DLC)sh 85108871

=LDR  01231cz  a2200337n  4500
=001  9880363830802441
=005  20141212205015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011642
=035  \\$aCBA4938M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682
=150  \\$aPublications
=450  \\$wnnna$aPublication
=550  \\$wg$aCommunications Media
=550  \\$wh$aBibliography as Topic
=550  \\$wh$aBook Reviews as Topic
=550  \\$wh$aBooks
=550  \\$wh$aBroadsides as Topic
=550  \\$wh$aCatalogs as Topic
=550  \\$wh$aDissertations, Academic as Topic
=550  \\$wh$aGovernment Publications as Topic
=550  \\$wh$aManuscripts as Topic
=550  \\$wh$aPamphlets
=550  \\$wh$aReview Literature as Topic
=550  \\$wh$aSerial Publications
=550  \\$wh$aTranslations
=667  \\$aavoid: too general; prefer specifics; the published material itself: differentiate from PUBLISHING, the industry
=680  \\$iCopies of a work or document distributed to the public by sale, rental, lease, or lending. (From ALA Glossary of Library and Information Science, 1983, p181)
=688  \\$a98; use explode 1975-97
=750  \0$aPublications$0(DLC) sh2004003366$5IEN-M

=LDR  01402cz  a2200349n  4500
=001  9880363830902441
=005  20141212205015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011641
=035  \\$aCBA4937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x822
=150  \\$aPublic Relations
=450  \\$wnnna$aClient-Staff Relation
=450  \\$wnnna$aClient-Staff Relations
=450  \\$wnnna$aClient Staff Relations
=450  \\$wnnna$aRelation, Client-Staff
=450  \\$wnnna$aRelations, Client-Staff
=450  \\$wnnna$aRelations, Client Staff
=450  \\$wnnna$aRelations, Public
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aAnniversaries and Special Events
=550  \\$wh$aCommunity-Institutional Relations
=550  \\$wh$aHospital-Patient Relations
=550  \\$wh$aHospital-Physician Relations
=550  \\$wh$aInterdepartmental Relations
=550  \\$wh$aInterinstitutional Relations
=550  \\$wh$aPatient Satisfaction
=667  \\$aDF: PUBLIC RELAT
=680  \\$iRelations of an individual, association, organization, hospital, or corporation with the publics which it must take into consideration in carrying out its functions. Publics may include consumers, patients, pressure groups, departments, etc.
=688  \\$aNEWS MEDIA RELATIONS was see PUBLIC RELATIONS 1978-93
=750  \0$aPublic relations$5IEN$0(DLC)sh 85108753

=LDR  01367cz  a2200385n  4500
=001  9880363831002441
=005  20141212205014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011639
=035  \\$aCBA4935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x630.$x548
=150  \\$aPublic Opinion
=450  \\$wnnna$aGroup, Interest
=450  \\$wnnna$aGroup, Pro-Choice
=450  \\$wnnna$aGroups, Interest
=450  \\$wnnna$aGroups, Pro-Choice
=450  \\$wnnna$aInterest Group
=450  \\$wnnna$aInterest Groups
=450  \\$wnnna$aOpinion Poll, Public
=450  \\$wnnna$aOpinion Polls, Public
=450  \\$wnnna$aOpinion, Public
=450  \\$wnnna$aPoll, Public Opinion
=450  \\$wnnna$aPolls, Public Opinion
=450  \\$wnnna$aPro-Choice Group
=450  \\$wnnna$aPro-Choice Groups
=450  \\$wnnna$aPro Choice Groups
=450  \\$wnnna$aPublic Opinion Poll
=450  \\$wnnna$aPublic Opinion Polls
=550  \\$wg$aSocial Control, Informal
=550  \\$aAttitude
=680  \\$iThe attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis, and reasoning.
=688  \\$a68
=750  \0$aPublic opinion polls$5IEN-M$0(DLC)sh 85108738
=750  \0$aPublic opinion$5IEN-HS$0(DLC)sh 85108736

=LDR  00624cz  a2200205n  4500
=001  9880363831102441
=005  20141212205013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011638
=035  \\$aCBA4934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x224.$x791.$x400.$x650
=072  \\$aN6.$x230.$x150.$x360.$x650
=150  \\$aPublic Housing
=450  \\$wnnna$aHousing, Public
=550  \\$wg$aHousing
=667  \\$aspecify geog if pertinent
=680  \\$iHousing subsidized by tax funds, usually intended for low income persons or families.
=688  \\$a68
=750  \0$aPublic housing$5IEN$0(DLC)sh 85108673

=LDR  00910cz  a2200181n  4500
=001  9880363831202441
=005  20141212205013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011637
=035  \\$aCBA4933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x755
=150  \\$aPublic Health Nursing
=450  \\$wnnna$aNursing, Public Health
=550  \\$wg$aSpecialties, Nursing
=667  \\$ado not confuse with COMMUNITY HEALTH NURSING
=680  \\$iA nursing specialty concerned with promoting and protecting the health of populations, using knowledge from nursing, social, and public health sciences to develop local, regional, state, and national health policy and research. It is population-focused and community-oriented, aimed at health promotion and disease prevention through educational, diagnostic, and preventive programs.
=750  \0$aPublic health nursing$5IEN-HS$0(DLC)sh 85108662

=LDR  00939cz  a2200253n  4500
=001  9880363831302441
=005  20141212205013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011636
=035  \\$aCBA4932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x876.$x770
=072  \\$aN6.$x890
=150  \\$aPublic Health Dentistry
=450  \\$wnnna$aDentistry, Public Health
=550  \\$wg$aEnvironment and Public Health
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aCommunity Dentistry
=550  \\$wh$aDental Health Surveys
=550  \\$wh$aFluoridation
=550  \\$wh$aHealth Education, Dental
=667  \\$aSPEC: SPEC qualif; DF: PUBLIC HEALTH DENT
=680  \\$iA dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level.
=750  \0$aDental public health$5IEN$0(DLC)sh 85036920

=LDR  00663cz  a2200193n  4500
=001  9880363831402441
=005  20141212205012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011635
=035  \\$aCBA4931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x794
=150  \\$aPublic Health Administration
=450  \\$wnnna$aAdministration, Public Health
=450  \\$aPublic Health$xorganization & administration
=550  \\$wg$aOrganization and Administration
=667  \\$aSPEC: SPEC qualif; DF: PUBLIC HEALTH ADMIN
=680  \\$iManagement of public health organizations or agencies.
=750  \0$aPublic health administration$5IEN$0(DLC)sh 85108653

=LDR  02156cz  a2200589n  4500
=001  9880363831502441
=005  20141212205012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011634
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x720
=072  \\$aN1.$x400.$x550
=072  \\$aN6.$x850
=150  \\$aPublic Health
=450  \\$wnnna$aEnvironment, Preventive Medicine & Public Health
=450  \\$wnnna$aEnvironment, Preventive Medicine and Public Health
=450  \\$wnnna$aHealth, Public
=550  \\$wg$aEnvironment and Public Health
=550  \\$wg$aHealth
=550  \\$wg$aMedicine
=550  \\$wh$aAccidents
=550  \\$wh$aCarrier State
=550  \\$wh$aConsumer Product Safety
=550  \\$wh$aDisease Eradication
=550  \\$wh$aDisease Outbreaks
=550  \\$wh$aDisease Reservoirs
=550  \\$wh$aDisease Transmission, Infectious
=550  \\$wh$aDrug Contamination
=550  \\$wh$aEmergencies
=550  \\$wh$aEndemic Diseases
=550  \\$wh$aEnvironmental Medicine
=550  \\$wh$aEnvironmental Microbiology
=550  \\$wh$aEnvironmental Pollution
=550  \\$wh$aEpidemiologic Factors
=550  \\$wh$aEpidemiologic Measurements
=550  \\$wh$aEpidemiologic Methods
=550  \\$wh$aEpidemiology
=550  \\$wh$aEquipment Contamination
=550  \\$wh$aEquipment Reuse
=550  \\$wh$aFood Quality
=550  \\$wh$aHealth Transition
=550  \\$wh$aHygiene
=550  \\$wh$aPatient Harm
=550  \\$wh$aPreventive Medicine
=550  \\$wh$aPublic Health Practice
=550  \\$wh$aRadiologic Health
=550  \\$wh$aSanitation
=550  \\$aEducation, Public Health Professional
=550  \\$aPreventive Medicine
=667  \\$aSPEC; SPEC qualif; a venerable hist & modern concept of the health & health problems of "the public": do not confuse with NATIONAL HEALTH PROGRAMS
=680  \\$iBranch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.
=750  \0$aPublic health$5IEN$0(DLC)sh 85108638

=LDR  00814cz  a2200253n  4500
=001  9880363831602441
=005  20141212205011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011632
=035  \\$aCBA4928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506
=150  \\$aPublic Assistance
=450  \\$wnnna$aAssistance, Public
=450  \\$aPublic Welfare$5IEN-HS
=550  \\$wg$aFinancing, Government
=550  \\$wh$aFood Assistance
=550  \\$wh$aMedical Assistance
=550  \\$wh$aOld Age Assistance
=550  \\$wh$aSocial Security
=667  \\$aspecify geog
=680  \\$iFinancial assistance to impoverished persons for the essentials of living through federal, state or local government programs.
=688  \\$a68
=750  \0$aPublic welfare$5IEN$0(DLC)sh 85108846

=LDR  00491cz  a2200181n  4500
=001  9880363831702441
=005  20141212205011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011631
=035  \\$aCBA4927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x656
=150  \\$aPubic Symphysis
=450  \\$wnnna$aPubic Symphyses
=450  \\$wnnna$aSymphyses, Pubic
=450  \\$wnnna$aSymphysis, Pubic
=550  \\$wg$aJoints
=750  \0$aPubic symphysis$5IEN$0(DLC)sh 85108608

=LDR  00882cz  a2200193n  4500
=001  9880363831802441
=005  20141212205010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011629
=035  \\$aCBA4925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x391.$x693
=150  \\$aPuberty, Precocious
=450  \\$wnnna$aPrecocious Puberty
=550  \\$wg$aGonadal Disorders
=550  \\$aAdrenal Hyperplasia, Congenital
=667  \\$ahuman only
=680  \\$iDevelopment of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE.
=750  \0$aPrecocious puberty$5IEN$0(DLC)sh 89003319

=LDR  01016cz  a2200241n  4500
=001  9880363831902441
=005  20141212205010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011627
=035  \\$aCBA4923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x760
=072  \\$aG8.$x686.$x785.$x880.$x374
=150  \\$aPuberty
=450  \\$wnnna$aPuberties
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wg$aSexual Development
=550  \\$wh$aAdrenarche
=550  \\$wh$aMenarche
=550  \\$aSexual Maturation
=667  \\$ahuman only: for animal use AGING; GROWTH or SEX MATURATION
=680  \\$iA period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.
=750  \0$aPuberty$5IEN$0(DLC)sh 85108606

=LDR  01012cz  a2200229n  4500
=001  9880363832002441
=005  20141212205010.0
=008  790312\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011626
=035  \\$aCBA4922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x600.$x700
=072  \\$aA14.$x530.$x790
=150  \\$aPterygoid Muscles
=450  \\$wnnna$aMuscle, Pterygoid
=450  \\$wnnna$aMuscles, Pterygoid
=450  \\$wnnna$aPterygoid Muscle
=550  \\$wg$aMasticatory Muscles
=667  \\$a/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iTwo of the masticatory muscles: the internal, or medial, pterygoid muscle and external, or lateral, pterygoid muscle. Action of the former is closing the jaws and that of the latter is opening the jaws, protruding the mandible, and moving the mandible from side to side.
=688  \\$a91(80); was see under MASTICATORY MUSCLES 1980-90
=750  \0$aPterygoid muscles$5IEN$0(DLC)sh 85108577

=LDR  00829cz  a2200181n  4500
=001  9880363832102441
=005  20141212205009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011625
=035  \\$aCBA4921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187.$x781
=150  \\$aPterygium
=450  \\$wnnna$aPterygiums
=550  \\$wg$aConjunctival Diseases
=667  \\$aa conjunctival dis, not a structure; pterygium of other organs: index under specific organ /abnorm
=680  \\$iAn abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed)
=750  \0$aPterygium$5IEN$0(DLC)sh 85108576

=LDR  00694cz  a2200229n  4500
=001  9880363832202441
=005  20141212205008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011621
=035  \\$aCBA4917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733
=150  \\$aPteridines
=450  \\$wnnna$aPteridinones
=450  \\$aPyrazinopyrimidines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aFlavins
=550  \\$wh$aPterins
=550  \\$wh$aTriamterene
=680  \\$iCompounds based on pyrazino[2,3-d]pyrimidine which is a pyrimidine fused to a pyrazine, containing four NITROGEN atoms.
=688  \\$a66
=750  \0$aPteridines$5IEN$0(DLC)sh 85108545

=LDR  00979cz  a2200301n  4500
=001  9880363832302441
=005  20141212205008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011620
=035  \\$aCBA4916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x720
=150  \\$aPsyllium
=450  \\$wnnna$aGum, Ispaghule
=450  \\$wnnna$aIsogel
=450  \\$aIspaghula
=450  \\$wnnna$aIspaghule Gum
=450  \\$wnnna$aMetamucil
=450  \\$wnnna$aPlantaglucide
=450  \\$wnnna$aPlantago Seed
=450  \\$wnnna$aReguval
=450  \\$wnnna$aSeed, Plantago
=550  \\$wg$aPlant Extracts
=550  \\$aPlantago
=667  \\$adrug only; plant source is PLANTAGO
=680  \\$iDried, ripe seeds of Plantago psyllium, P. indica, and P. ovata (Plantaginaceae). Plantain seeds swell in water and are used as demulcents and bulk laxatives.
=688  \\$awas in Cat B & D 1963-77
=750  \0$aPsyllium products$5IEN-M$0(DLC)sh 97005949

=LDR  01266cz  a2200301n  4500
=001  9880363832402441
=005  20141212205008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011619
=035  \\$aCBA4915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x700
=150  \\$aPsychotropic Drugs
=450  \\$wnnna$aAgents, Psychoactive
=450  \\$wnnna$aDrugs, Psychoactive
=450  \\$wnnna$aDrugs, Psychotropic
=450  \\$aPsychoactive Agents
=450  \\$wnnna$aPsychoactive Drugs
=450  \\$aPsychopharmaceuticals
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wh$aAntidepressive Agents
=550  \\$wh$aHallucinogens
=550  \\$wh$aTranquilizing Agents
=550  \\$aPsychopharmacology
=667  \\$aGEN or unspecified; prefer specific groups or specific drugs; relation to PSYCHOPHARMACOLOGY: Manual 27.13
=680  \\$iA loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
=688  \\$a75; was see under ANTIDEPRESSIVE AGENTS & TRANQUILIZING AGENTS 1974
=750  \0$aPsychotropic drugs$5IEN$0(DLC)sh 85108528

=LDR  01606cz  a2200421n  4500
=001  9880363832502441
=005  20141212205007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011618
=035  \\$aCBA4914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x675
=150  \\$aPsychotic Disorders
=450  \\$wnnna$aBrief Reactive Psychoses
=450  \\$wnnna$aBrief Reactive Psychosis
=450  \\$wnnna$aDisorder, Psychotic
=450  \\$wnnna$aDisorder, Schizoaffective
=450  \\$wnnna$aDisorder, Schizophreniform
=450  \\$wnnna$aDisorders, Psychotic
=450  \\$wnnna$aDisorders, Schizoaffective
=450  \\$wnnna$aDisorders, Schizophreniform
=450  \\$aPsychoses
=450  \\$wnnna$aPsychoses, Brief Reactive
=450  \\$wnnna$aPsychosis
=450  \\$aPsychosis, Brief Reactive
=450  \\$wnnna$aPsychotic Disorder
=450  \\$wnnna$aReactive Psychoses, Brief
=450  \\$wnnna$aReactive Psychosis, Brief
=450  \\$aSchizoaffective Disorder
=450  \\$wnnna$aSchizoaffective Disorders
=450  \\$wnnna$aSchizophreniform Disorder
=450  \\$aSchizophreniform Disorders
=550  \\$wg$aSchizophrenia and Disorders with Psychotic Features
=550  \\$wh$aPsychoses, Substance-Induced
=667  \\$apuerperal psychoses = PSYCHOTIC DISORDERS (IM) + PUERPERAL DISORDERS (IM)
=680  \\$iDisorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
=688  \\$a81; was PSYCHOSES 1963-80
=750  \0$aPsychoses$5IEN$0(DLC)sh 85108502

=LDR  01124cz  a2200289n  4500
=001  9880363832602441
=005  20141212205007.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011617
=035  \\$aCBA4913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x785
=150  \\$aPsychotherapy, Rational-Emotive
=450  \\$wnnna$aPsychotherapies, Rational
=450  \\$wnnna$aPsychotherapies, Rational-Emotive
=450  \\$aPsychotherapy, Rational
=450  \\$wnnna$aPsychotherapy, Rational Emotive
=450  \\$wnnna$aRational-Emotive Psychotherapies
=450  \\$aRational-Emotive Psychotherapy
=450  \\$wnnna$aRational Emotive Psychotherapy
=450  \\$wnnna$aRational Psychotherapies
=450  \\$wnnna$aRational Psychotherapy
=550  \\$wg$aPsychotherapy
=667  \\$aDF: PSYCHOTHER RATIONAL
=680  \\$iThe replacement of illogical and unrealistic ideas with more realistic and adaptive ones through direct intervention and confrontation by the therapist.
=688  \\$a91(77); was see under PSYCHOTHERAPY 1977-90
=750  \0$aRational emotive behavior therapy$5IEN$0(DLC)sh 85111516

=LDR  01007cz  a2200289n  4500
=001  9880363368302441
=005  20141212194405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000138
=035  \\$aCAZ3285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x76.$x176
=150  \\$aAcidosis
=450  \\$wnnna$aAcidoses
=450  \\$wnnna$aAcidoses, Metabolic
=450  \\$wnnna$aAcidosis, Metabolic
=450  \\$wnnna$aMetabolic Acidoses
=450  \\$wnnna$aMetabolic Acidosis
=550  \\$wg$aAcid-Base Imbalance
=550  \\$wh$aAcidosis, Lactic
=550  \\$wh$aAcidosis, Renal Tubular
=550  \\$wh$aAcidosis, Respiratory
=550  \\$wh$aKetosis
=550  \\$aAcid-Base Equilibrium
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up.
=750  \0$aAcidosis$5IEN$0(DLC)sh 85000531

=LDR  01687cz  a2200409n  4500
=001  9880363368402441
=005  20141212191910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000055
=035  \\$aCAZ3201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x60
=150  \\$aAccessory Nerve
=450  \\$wnnna$aAccessorius, Nervus
=450  \\$wnnna$aAccessory Nerve, Spinal
=450  \\$wnnna$aAccessory Nerves
=450  \\$wnnna$aAccessory Nerves, Spinal
=450  \\$wnnna$aCranial Nerve, Eleventh
=450  \\$aCranial Nerve XI
=450  \\$wnnna$aCranial Nerves, Eleventh
=450  \\$aEleventh Cranial Nerve
=450  \\$wnnna$aEleventh Cranial Nerves
=450  \\$wnnna$aNerve, Accessory
=450  \\$wnnna$aNerve, Eleventh Cranial
=450  \\$wnnna$aNerve, Spinal Accessory
=450  \\$wnnna$aNerve XI
=450  \\$wnnna$aNerve XIs
=450  \\$wnnna$aNerves, Accessory
=450  \\$wnnna$aNerves, Eleventh Cranial
=450  \\$wnnna$aNerves, Spinal Accessory
=450  \\$wnnna$aNervus Accessorius
=450  \\$aSpinal Accessory Nerve
=450  \\$wnnna$aSpinal Accessory Nerves
=550  \\$wg$aCranial Nerves
=667  \\$aneoplasm = ACCESSORY NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe 11th cranial nerve which originates from NEURONS in the MEDULLA and in the CERVICAL SPINAL CORD. It has a cranial root, which joins the VAGUS NERVE (10th cranial) and sends motor fibers to the muscles of the LARYNX, and a spinal root, which sends motor fibers to the TRAPEZIUS and the sternocleidomastoid muscles.
=750  \0$aAccessory nerve$0(DLC) sh 85000364$5IEN

=LDR  00586cz  a2200205n  4500
=001  9880363368502441
=005  20141212194341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000054
=035  \\$aCAZ3200HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x560.$x107
=150  \\$aAcceleration
=450  \\$wnnna$aAccelerations
=550  \\$wg$aMotion
=550  \\$wh$aDeceleration
=667  \\$aIM
=680  \\$iAn increase in the rate of speed.
=750  \0$aAcceleration (Mechanics)$5IEN$0(DLC)sh 85000344
=750  \0$aAcceleration (Physiology)$5IEN-HS$0(DLC)sh 85000345

=LDR  00767cz  a2200253n  4500
=001  9880363368602441
=005  20141212194404.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000137
=035  \\$aCAZ3284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x76
=150  \\$aAcid-Base Imbalance
=450  \\$wnnna$aAcid Base Imbalance
=450  \\$wnnna$aAcid-Base Imbalances
=450  \\$wnnna$aImbalance, Acid-Base
=450  \\$wnnna$aImbalances, Acid-Base
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aAchlorhydria
=550  \\$wh$aAcidosis
=550  \\$wh$aAlkalosis
=680  \\$iDisturbances in the ACID-BASE EQUILIBRIUM of the body.
=688  \\$a76; was NON MESH before 1976
=750  \0$aAcid-base imbalances$5IEN$0(DLC)sh 85000517

=LDR  00867cz  a2200205n  4500
=001  9880363368702441
=005  20141212194341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000052
=035  \\$aCAZ3198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x621.$x430.$x530.$x100
=150  \\$aAcanthosis Nigricans
=450  \\$wnnna$aAcanthosis Nigrican
=450  \\$wnnna$aNigrican, Acanthosis
=450  \\$wnnna$aNigricans, Acanthosis
=550  \\$wg$aMelanosis
=667  \\$aa type of melanosis
=680  \\$iA circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.
=750  \0$aAcanthosis nigricans$5IEN$0(DLC)sh 85000328

=LDR  01240cz  a2200373n  4500
=001  9880363368802441
=005  20180109094640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000136
=035  \\$aCAZ3283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x007
=072  \\$aG2.$x300.$x176
=072  \\$aG3.$x30
=072  \\$aG7.$x410.$x110
=072  \\$aG9.$x188.$x50
=150  \\$aAcid-Base Equilibrium
=450  \\$wnnna$aAcid-Base Balance
=450  \\$wnnna$aAcid Base Balance
=450  \\$wnnna$aAcid Base Equilibrium
=450  \\$aAnion Gap
=450  \\$wnnna$aAnion Gaps
=450  \\$wnnna$aBalance, Acid-Base
=450  \\$wnnna$aEquilibrium, Acid-Base
=450  \\$wnnna$aGap, Anion
=450  \\$wnnna$aGaps, Anion
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aHomeostasis
=550  \\$wg$aHydrogen-Ion Concentration
=550  \\$wg$aMetabolism
=667  \\$aconsider also ACID-BASE IMBALANCE
=680  \\$iThe balance between acids and bases in the BODY FLUIDS. The pH (HYDROGEN-ION CONCENTRATION) of the arterial BLOOD provides an index for the total body acid-base balance.
=750  \0$aAcid-base equilibrium$5IEN$0(DLC)sh 85000516

=LDR  01051cz  a2200265n  4500
=001  9880363368902441
=005  20141212194340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000049
=035  \\$aCAZ3195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x132
=150  \\$aAcanthocephala
=450  \\$wnnna$aAcanthocephalas
=450  \\$wnnna$aThorny-Headed Worm
=450  \\$aThorny-Headed Worms
=450  \\$wnnna$aThorny Headed Worms
=450  \\$wnnna$aWorm, Thorny-Headed
=450  \\$wnnna$aWorms, Thorny-Headed
=550  \\$wg$aHelminths
=550  \\$wh$aMoniliformis
=667  \\$ainfection: coord IM with HELMINTHIASIS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.
=688  \\$a74; was see under HELMINTHS 1963-73
=750  \0$aAcanthocephala$5IEN$0(DLC)sh 85000314

=LDR  01172cz  a2200313n  4500
=001  9880363369002441
=005  20141212210938.0
=008  880517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015258
=035  \\$aCAZ3282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x50
=072  \\$aG16.$x500.$x240.$x135.$x859.$x50
=072  \\$aG16.$x500.$x275.$x63.$x725.$x395.$x50
=072  \\$aG16.$x500.$x750.$x775.$x450.$x50
=072  \\$aN6.$x230.$x300.$x100.$x725.$x450.$x50
=072  \\$aN6.$x230.$x520.$x50
=072  \\$aN6.$x850.$x460.$x790.$x410.$x50
=150  \\$aAcid Rain
=450  \\$wnnna$aAcid Rains
=450  \\$aRain, Acid
=450  \\$wnnna$aRains, Acid
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aRain
=550  \\$wg$aWater Pollution, Chemical
=667  \\$aspecify geog if pertinent
=680  \\$iAcidic water usually pH 2.5 to 4.5, which poisons the ecosystem and adversely affects plants, fishes, and mammals. It is caused by industrial pollutants, mainly sulfur oxides and nitrogen oxides, emitted into the atmosphere and returning to earth in the form of acidic rain water.
=688  \\$a89
=750  \0$aAcid rain$5IEN$0(DLC)sh 85000526

=LDR  00843cz  a2200205n  4500
=001  9880363369102441
=005  20141212194340.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000048
=035  \\$aCAZ3194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100.$x75.$x80
=150  \\$aAcanthamoeba
=450  \\$wnnna$aAcanthamoebas
=550  \\$wg$aAcanthopodina
=550  \\$wh$aAcanthamoeba castellanii
=667  \\$ainfection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.
=688  \\$a88
=750  \0$aAcanthamoeba$5IEN$0(DLC)sh 88021265

=LDR  00947cz  a2200217n  4500
=001  9880363369202441
=005  20190124113609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000135
=035  \\$aCAZ3281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x25
=150  \\$aAcid Phosphatase
=450  \\$wnnna$aAcid beta-Glycerophosphatase
=450  \\$wnnna$aAcid beta Glycerophosphatase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=550  \\$wh$aTartrate-Resistant Acid Phosphatase
=667  \\$a/defic permitted: TN 222; prostate-specific acid phosphatase (PROSTATE + ACID PHOSPHATASE): do not confuse with PROSTATE-SPECIFIC ANTIGEN, a serine proteinase
=680  \\$iAn enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.
=688  \\$a/blood was BLOOD ACID PHOSPHATASE 1963-67
=750  \0$aAcid phosphatase$5IEN$0(DLC)sh 85000523

=LDR  00995cz  a2200205n  4500
=001  9880363369302441
=005  20141212194403.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000134
=035  \\$aCAZ3280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x931.$x475.$x111
=150  \\$aAcid Etching, Dental
=450  \\$aDental Acid Etching
=450  \\$wnnna$aEtching, Dental Acid
=550  \\$wg$aDental Etching
=667  \\$aetching of tooth surface to increase adhesion of resins; do not use for etching of metal appliances for better adhesion ( = specific appliance (IM) + METALLURGY (NIM) ); do not use for etching of veneers or resins ( = specific dent restoration); DF: ACID ETCHING DENT
=680  \\$iPreparation of TOOTH surfaces and DENTAL MATERIALS with etching agents, usually phosphoric acid, to roughen the surface to increase adhesion or osteointegration.
=688  \\$a91(77); was see under BONDING, DENTAL 1977-90
=750  \0$aDental acid etching$5IEN$0(DLC)sh 85036855

=LDR  01250cz  a2200301n  4500
=001  9880363369402441
=005  20141212194340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000047
=035  \\$aCAZ3193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x52
=150  \\$aAcademies and Institutes
=450  \\$wnnna$aAcademies
=450  \\$wnnna$aAcademy
=450  \\$wnnna$aAcademy and Institute
=450  \\$wnnna$aInstitute and Academy
=450  \\$wnnna$aInstitute, Research
=450  \\$aInstitutes
=450  \\$wnnna$aInstitutes and Academies
=450  \\$wnnna$aInstitutes, Research
=450  \\$wnnna$aResearch Institute
=450  \\$aResearch Institutes
=550  \\$wg$aOrganizations
=667  \\$anot for educ acad & institutes ( = SCHOOLS or its indentions); Acad of Med: do not index also under MEDICINE; NY Acad of Med: when geog coord needed use NEW YORK CITY; DF: ACADEMIES
=680  \\$iOrganizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc.
=688  \\$a70(65)
=750  \0$aLearned institutions and societies$5IEN$0(DLC)sh 85075516

=LDR  01752cz  a2200385n  4500
=001  9880363369502441
=005  20141212194403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000130
=035  \\$aCAZ3276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x343.$x110
=072  \\$aC5.$x116.$x99.$x708.$x17
=072  \\$aC16.$x320.$x240.$x500
=150  \\$aAchondroplasia
=450  \\$wnnna$aAchondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans
=450  \\$wnnna$aAchondroplasias
=450  \\$wnnna$aDysplasia, SADDAN
=450  \\$wnnna$aDysplasias, SADDAN
=450  \\$wnnna$aSADDAN
=450  \\$wnnna$aSADDAN Dysplasia
=450  \\$wnnna$aSADDAN Dysplasias
=450  \\$wnnna$aSADDANs
=450  \\$aSevere Achondroplasia with Developmental Delay and Acanthosis Nigricans
=450  \\$wnnna$aSkeleton-Skin-Brain Syndrome
=450  \\$wnnna$aSkeleton Skin Brain Syndrome
=450  \\$wnnna$aSkeleton-Skin-Brain Syndromes
=450  \\$wnnna$aSyndrome, Skeleton-Skin-Brain
=450  \\$wnnna$aSyndromes, Skeleton-Skin-Brain
=550  \\$wg$aDwarfism
=550  \\$wg$aOsteochondrodysplasias
=550  \\$wh$aThanatophoric Dysplasia
=550  \\$aReceptor, Fibroblast Growth Factor, Type 3
=680  \\$iAn autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, GENU VARUM, and trident hand. (Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM#100800, April 20, 2001)
=750  \0$aAchondroplasia$5IEN$0(DLC)sh 85000510

=LDR  00748cz  a2200241n  4500
=001  9880363369602441
=005  20141212194402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000126
=035  \\$aCAZ3272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x45
=072  \\$aC18.$x452.$x76.$x87
=150  \\$aAchlorhydria
=450  \\$aAchylia Gastrica
=450  \\$aHypochlorhydria
=550  \\$wg$aAcid-Base Imbalance
=550  \\$wg$aStomach Diseases
=550  \\$aGastric Acid
=550  \\$aGastric Juice
=680  \\$iA lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.
=688  \\$aACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78
=750  \0$aAchlorhydria$5IEN$0(DLC)sh 85000507

=LDR  00687cz  a2200217n  4500
=001  9880363369702441
=005  20141212194401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000124
=035  \\$aCAZ3270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x59
=072  \\$aF2.$x784.$x629.$x54
=150  \\$aAchievement
=450  \\$wnnna$aAchievements
=550  \\$wg$aMotivation
=550  \\$wg$aPsychology, Educational
=667  \\$ano qualif
=680  \\$iSuccess in bringing an effort to the desired end; the degree or level of success attained in some specified area (esp. scholastic) or in general.
=688  \\$a65(64)
=750  \0$aSuccess$5IEN-M$0(DLC)sh 85129587

=LDR  01256cz  a2200349n  4500
=001  9880363369802441
=005  20141212194339.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000046
=035  \\$aCAZ3192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x20
=150  \\$aAcademic Medical Centers
=450  \\$wnnna$aAcademic Medical Center
=450  \\$wnnna$aCenter, Academic Medical
=450  \\$wnnna$aCenter, University Medical
=450  \\$wnnna$aCenters, Academic Medical
=450  \\$wnnna$aCenters, University Medical
=450  \\$wnnna$aMedical Center, Academic
=450  \\$wnnna$aMedical Center, University
=450  \\$aMedical Centers, Academic
=450  \\$aMedical Centers, University
=450  \\$wnnna$aUniversity Medical Center
=450  \\$aUniversity Medical Centers
=550  \\$wg$aHealth Facilities
=550  \\$wh$aHospitals, Teaching
=550  \\$wh$aSchools, Medical
=550  \\$aTertiary Care Centers
=667  \\$aspecify geog; DF: ACAD MED CENTERS
=680  \\$iMedical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.
=688  \\$a80; was see HOSPITALS, UNIVERSITY 1979
=750  \0$aAcademic medical centers$5IEN$0(DLC)sh 92006454

=LDR  01325cz  a2200349n  4500
=001  9880363369902441
=005  20180815130550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000123
=035  \\$aCAZ3269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x50.$x134
=150  \\$aAcetyltransferases
=550  \\$wg$aAcyltransferases
=550  \\$wh$aAcetyl-CoA C-Acetyltransferase
=550  \\$wh$aAcyl-Carrier Protein S-Acetyltransferase
=550  \\$wh$aAmino-Acid N-Acetyltransferase
=550  \\$wh$aArylalkylamine N-Acetyltransferase
=550  \\$wh$aArylamine N-Acetyltransferase
=550  \\$wh$aCarnitine O-Acetyltransferase
=550  \\$wh$aChloramphenicol O-Acetyltransferase
=550  \\$wh$aCholine O-Acetyltransferase
=550  \\$wh$aDihydrolipoyllysine-Residue Acetyltransferase
=550  \\$wh$aGlucosamine 6-Phosphate N-Acetyltransferase
=550  \\$wh$aLysine Acetyltransferases
=550  \\$wh$aN-Terminal Acetyltransferases
=550  \\$wh$ap300-CBP Transcription Factors
=550  \\$wh$aPhosphate Acetyltransferase
=550  \\$wh$aSerine O-Acetyltransferase
=680  \\$iEnzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1.
=688  \\$a73
=750  \0$aAcetyltransferases$5IEN$0(DLC)sh 87001829

=LDR  00372cz  a2200145n  4500
=001  9880363370002441
=005  20141212194358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000114
=035  \\$aCAZ3260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x397.$x259
=150  \\$aAcetylene
=550  \\$wg$aAlkynes
=750  \0$aAcetylene$5IEN-M$0(DLC)sh 85000470

=LDR  01408cz  a2200325n  4500
=001  9880363370102441
=005  20141212194339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x25
=150  \\$aAcacia
=450  \\$wnnna$aAcacia catechu
=450  \\$wnnna$aAcacia catechus
=450  \\$wnnna$aAcacias
=450  \\$wnnna$acatechu, Acacia
=450  \\$wnnna$acatechus, Acacia
=450  \\$aLocust Tree
=450  \\$wnnna$aLocust Trees
=450  \\$wnnna$aTree, Locust
=450  \\$wnnna$aTree, Wattle
=450  \\$wnnna$aTrees, Locust
=450  \\$wnnna$aTrees, Wattle
=450  \\$aWattle Tree
=450  \\$wnnna$aWattle Trees
=550  \\$wg$aFabaceae
=667  \\$aacacia pharmaceut agents are probably GUM ARABIC; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name of catechu is more often used for Areca catechu (ARECA).
=688  \\$a91(86)63; was see under TREES 1986-90; was heading 1963-85
=750  \0$aAcacia$5IEN$0(DLC)sh 85000291

=LDR  00864cz  a2200205n  4500
=001  9880363370202441
=005  20141212194356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000110
=035  \\$aCAZ3256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x170.$x176
=150  \\$aAcetylcholinesterase
=450  \\$wnnna$aAcetylcholine Hydrolase
=450  \\$wnnna$aAcetylthiocholinesterase
=450  \\$wnnna$aHydrolase, Acetylcholine
=550  \\$wg$aCholinesterases
=667  \\$areactivation or reactivators: coord NIM (with no qualif) with CHOLINESTERASE REACTIVATORS (IM)
=680  \\$iAn enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.
=750  \0$aAcetylcholinesterase$5IEN$0(DLC)sh 92004641

=LDR  00843cz  a2200229n  4500
=001  9880363370302441
=005  20141212194338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000044
=035  \\$aCAZ3190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x500
=072  \\$aE7.$x695.$x190.$x175
=150  \\$aDental Abutments
=450  \\$wnnna$aAbutment, Dental
=450  \\$aAbutments, Dental
=450  \\$wnnna$aDental Abutment
=550  \\$wg$aDental Prosthesis
=667  \\$atooth or root used as anchor for denture or implant, etc.; DF: DENT ABUTMENTS
=680  \\$iNatural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis (such as an implant) serving the same purpose.
=688  \\$a91; was ABUTMENTS, DENTAL 1970-90
=750  \0$aDental abutments$5IEN$0(DLC)sh 85036854

=LDR  00952cz  a2200289n  4500
=001  9880363370502441
=005  20170628104054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000042
=035  \\$aCAZ3188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x15
=072  \\$aG2.$x10
=072  \\$aG2.$x842.$x750.$x19
=072  \\$aG3.$x15
=072  \\$aG3.$x787.$x24
=072  \\$aG7.$x690.$x725.$x15
=150  \\$aAbsorption
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aPharmacokinetics
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aAbsorption, Physicochemical
=550  \\$wh$aAbsorption, Physiological
=667  \\$abeginning in 2015: used for searching; indexers and catalogers apply specifics
=680  \\$iThe physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
=750  \0$aAbsorption$5IEN-HS$0(DLC)sh 85000245

=LDR  02077cz  a2200493n  4500
=001  9880363370602441
=005  20141212194356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000109
=035  \\$aCAZ3255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x111
=150  \\$aAcetylcholine
=450  \\$wnnna$a2-(Acetyloxy)-N,N,N-trimethylethanaminium
=450  \\$wnnna$aAcetilcolina Cusi
=450  \\$wnnna$aAcetylcholine Bromide
=450  \\$wnnna$aAcetylcholine Chloride
=450  \\$wnnna$aAcetylcholine Fluoride
=450  \\$wnnna$aAcetylcholine Hydroxide
=450  \\$wnnna$aAcetylcholine Iodide
=450  \\$wnnna$aAcetylcholine L-Tartrate
=450  \\$wnnna$aAcetylcholine L Tartrate
=450  \\$wnnna$aAcetylcholine Perchlorate
=450  \\$wnnna$aAcetylcholine Picrate
=450  \\$wnnna$aAcetylcholine Picrate (1:1)
=450  \\$wnnna$aAcetylcholine Sulfate (1:1)
=450  \\$wnnna$aAlcon Brand of Acetylcholine Chloride
=450  \\$wnnna$aBournonville Brand of Acetylcholine Chloride
=450  \\$wnnna$aBromide, Acetylcholine
=450  \\$wnnna$aBromoacetylcholine
=450  \\$wnnna$aChloroacetylcholine
=450  \\$wnnna$aCiba Vision Brand of Acetylcholine Chloride
=450  \\$wnnna$aCusi, Acetilcolina
=450  \\$wnnna$aFluoride, Acetylcholine
=450  \\$wnnna$aHydroxide, Acetylcholine
=450  \\$wnnna$aIodide, Acetylcholine
=450  \\$wnnna$aIolab Brand of Acetylcholine Chloride
=450  \\$wnnna$aL-Tartrate, Acetylcholine
=450  \\$wnnna$aMiochol
=450  \\$wnnna$aPerchlorate, Acetylcholine
=550  \\$wg$aBiogenic Amines
=680  \\$iA neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system.
=688  \\$a1998; for MIOCHOL use ACETYLCHOLINE (NM) 1981-1997; for CHLOROACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000; for BROMOACETYLCHOLINE use ACETYLCHOLINE (NM) 1969-2000
=750  \0$aAcetylcholine$5IEN$0(DLC)sh 85000467

=LDR  00545cz  a2200181n  4500
=001  9880363370702441
=005  20141212194338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000041
=035  \\$aCAZ3187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x692.$x107
=150  \\$aAbsenteeism
=550  \\$wg$aPsychology, Industrial
=667  \\$aIM; no qualif
=680  \\$iChronic absence from work or other duty.
=688  \\$awas in Cat F & J 1967-82, was in Cat F & I 1963-66
=750  \0$aAbsenteeism (Labor)$5IEN$0(DLC)sh 85000235

=LDR  01257cz  a2200325n  4500
=001  9880363370802441
=005  20141212194337.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000040
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x268.$x34
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x61
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x24
=072  \\$aD2.$x455.$x849.$x131.$x61
=072  \\$aD2.$x455.$x849.$x765.$x33
=150  \\$aAbscisic Acid
=450  \\$wnnna$aAbscisic Acid, (+,-)-Isomer
=450  \\$wnnna$aAbscisic Acid, (E,E)-(+-)-Isomer
=450  \\$wnnna$aAbscisic Acid, (E,Z)-(+,-)-Isomer
=450  \\$wnnna$aAbscisic Acid Monoammonium Salt, (R)-Isomer
=450  \\$wnnna$aAbscisic Acid, (R)-Isomer
=450  \\$wnnna$aAbscisic Acid, (Z,E)-Isomer
=450  \\$wnnna$aAbscissic Acid
=450  \\$wnnna$aAbscissins
=550  \\$wg$aCarotenoids
=550  \\$wg$aCyclohexanecarboxylic Acids
=550  \\$wg$aSesquiterpenes
=680  \\$iAbscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.
=688  \\$a93(75)
=750  \0$aAbscisic acid$5IEN-M$0(DLC)sh 85000226

=LDR  01228cz  a2200313n  4500
=001  9880363370902441
=005  20141212194337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000038
=035  \\$aCAZ3185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x25
=072  \\$aC23.$x550.$x470.$x756.$x100
=150  \\$aAbscess
=450  \\$wnnna$aAbscesses
=550  \\$wg$aSuppuration
=550  \\$wh$aAbdominal Abscess
=550  \\$wh$aBrain Abscess
=550  \\$wh$aEpidural Abscess
=550  \\$wh$aLung Abscess
=550  \\$wh$aPeriapical Abscess
=550  \\$wh$aPeriodontal Abscess
=550  \\$wh$aPeritonsillar Abscess
=550  \\$wh$aPsoas Abscess
=550  \\$wh$aRetropharyngeal Abscess
=550  \\$aEmpyema
=667  \\$aIM; coord IM with site (organ/dis term) (IM) + precoord organism/infect term (IM); if unspecified bacterial abscess do not coord with BACTERIAL INFECTIONS (since most abscesses are bact) but coord with specific bact infect term if given (as ABSCESS + STAPHYLOCOCCAL INFECTIONS)
=680  \\$iAccumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.
=750  \0$aAbscess$5IEN$0(DLC)sh 85000225

=LDR  00792cz  a2200217n  4500
=001  9880363371002441
=005  20141212194335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000032
=035  \\$aCAZ3179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x50.$x60
=150  \\$aAbortion, Therapeutic
=450  \\$wnnna$aAbortions, Therapeutic
=450  \\$wnnna$aTherapeutic Abortion
=450  \\$wnnna$aTherapeutic Abortions
=550  \\$wg$aAbortion, Induced
=550  \\$wh$aPregnancy Reduction, Multifetal
=667  \\$ado not use /util except by MeSH definition; don't forget also check tags FEMALE & PREGNANCY
=680  \\$iAbortion induced to save the life or health of a pregnant woman. (From Dorland, 28th ed)
=750  \0$aAbortion, Therapeutic$5IEN$0(DLC)sh 85000206

=LDR  01036cz  a2200241n  4500
=001  9880363371102441
=005  20141212194335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000031
=035  \\$aCAZ3178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x674.$x173
=072  \\$aC13.$x703.$x39.$x256
=072  \\$aC13.$x703.$x700.$x173
=150  \\$aAbortion, Septic
=450  \\$wnnna$aAbortions, Septic
=450  \\$wnnna$aSeptic Abortion
=450  \\$wnnna$aSeptic Abortions
=550  \\$wg$aAbortion, Spontaneous
=550  \\$wg$aPregnancy Complications, Infectious
=667  \\$a/vet permitted only if discussed as "septic" abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE & PREGNANCY
=680  \\$iAny type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.
=750  \0$aSeptic abortion$5IEN$0(DLC)sh 85000205

=LDR  01245cz  a2200325n  4500
=001  9880363371202441
=005  20141212194355.0
=008  770517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000108
=035  \\$aCAZ3254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x883.$x99.$x90
=150  \\$aAcetylcarnitine
=450  \\$aAcetyl Carnitine
=450  \\$wnnna$aAcetyl-L-Carnitine
=450  \\$wnnna$aAcetyl L Carnitine
=450  \\$wnnna$aAcetylcarnitine, (R)-Isomer
=450  \\$wnnna$aAlcar
=450  \\$wnnna$aBranigen
=450  \\$wnnna$aCarnitine, Acetyl
=450  \\$wnnna$aGlaxo Brand of Acetyl L-Carnitine
=450  \\$wnnna$aGlaxo Brand of Acetyl L Carnitine
=450  \\$wnnna$aLevocarnitine Acetyl
=450  \\$aMedosan
=450  \\$wnnna$aSigma-Tau brand of Acetyl L-Carnitine
=450  \\$wnnna$aSigma Tau brand of Acetyl L Carnitine
=550  \\$wg$aCarnitine
=680  \\$iAn acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
=688  \\$a1991(1978); use CARNITINE 1978-1990; for MEDOSAN use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL (NM) 1988-2003
=750  \0$aAcetylcarnitine$5IEN$0(DLC)sh 89002719

=LDR  03514cz  a2200913n  4500
=001  9880363371302441
=005  20141212194334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000028
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x50
=150  \\$aAbortion, Induced
=450  \\$wnnna$aAbortion, Drug-Induced
=450  \\$wnnna$aAbortion, Drug Induced
=450  \\$wnnna$aAbortion Failure
=450  \\$wnnna$aAbortion Failures
=450  \\$wnnna$aAbortion Histories
=450  \\$wnnna$aAbortion History
=450  \\$wnnna$aAbortion (Induced)
=450  \\$wnnna$aAbortion, Previous
=450  \\$wnnna$aAbortion Rate
=450  \\$wnnna$aAbortion Rates
=450  \\$wnnna$aAbortion, Rivanol
=450  \\$wnnna$aAbortion, Saline-Solution
=450  \\$wnnna$aAbortion, Saline Solution
=450  \\$wnnna$aAbortion, Soap-Solution
=450  \\$wnnna$aAbortion, Soap Solution
=450  \\$wnnna$aAbortion Technic
=450  \\$wnnna$aAbortion Technics
=450  \\$wnnna$aAbortion Technique
=450  \\$wnnna$aAbortion Techniques
=450  \\$wnnna$aAbortions, Drug-Induced
=450  \\$wnnna$aAbortions (Induced)
=450  \\$wnnna$aAbortions, Induced
=450  \\$wnnna$aAbortions, Previous
=450  \\$wnnna$aAbortions, Rivanol
=450  \\$wnnna$aAbortions, Saline-Solution
=450  \\$wnnna$aAbortions, Soap-Solution
=450  \\$wnnna$aAnti-Abortion Group
=450  \\$wnnna$aAnti-Abortion Groups
=450  \\$wnnna$aAnti Abortion Groups
=450  \\$wnnna$aDrug-Induced Abortion
=450  \\$wnnna$aDrug-Induced Abortions
=450  \\$wnnna$aEmbryotomies
=450  \\$aEmbryotomy
=450  \\$wnnna$aFailure, Abortion
=450  \\$wnnna$aFailures, Abortion
=450  \\$wnnna$aFertility Control, Postconception
=450  \\$wnnna$aGroup, Anti-Abortion
=450  \\$wnnna$aGroups, Anti-Abortion
=450  \\$wnnna$aHistories, Abortion
=450  \\$wnnna$aHistory, Abortion
=450  \\$wnnna$aInduced Abortion
=450  \\$wnnna$aInduced Abortions
=450  \\$wnnna$aPostconception Fertility Control
=450  \\$wnnna$aPrevious Abortion
=450  \\$wnnna$aPrevious Abortions
=450  \\$wnnna$aRate, Abortion
=450  \\$wnnna$aRates, Abortion
=450  \\$wnnna$aRivanol Abortion
=450  \\$wnnna$aRivanol Abortions
=450  \\$wnnna$aSaline-Solution Abortion
=450  \\$wnnna$aSaline-Solution Abortions
=450  \\$wnnna$aSoap-Solution Abortion
=450  \\$wnnna$aSoap-Solution Abortions
=450  \\$wnnna$aTechnic, Abortion
=450  \\$wnnna$aTechnics, Abortion
=450  \\$wnnna$aTechnique, Abortion
=450  \\$wnnna$aTechniques, Abortion
=550  \\$wg$aObstetric Surgical Procedures
=550  \\$wh$aAbortion, Eugenic
=550  \\$wh$aAbortion, Legal
=550  \\$wh$aAbortion, Therapeutic
=550  \\$wh$aPregnancy Reduction, Multifetal
=550  \\$aAborted Fetus
=667  \\$ado not use /util except by MeSH definition; for use of an abortifacient here or in ABORTION, CRIMINAL, coord IM with abortifacient agent (IM with no qualif, not /adv eff unless text specifically discusses adverse eff); don't forget also check tags FEMALE & PREGNANCY
=680  \\$iIntentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978)
=688  \\$a71; was see under ABORTION, CRIMINAL & ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85
=750  \0$aAbortion$5IEN$0(DLC)sh 85000196

=LDR  00849cz  a2200241n  4500
=001  9880363371402441
=005  20141212194355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000107
=035  \\$aCAZ3253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x19.$x52
=072  \\$aG2.$x149.$x115.$x19.$x52
=072  \\$aG2.$x149.$x465.$x30.$x52
=072  \\$aG2.$x607.$x750.$x30.$x52
=072  \\$aG3.$x495.$x95.$x52
=150  \\$aAcetylation
=450  \\$wnnna$aAcetylations
=550  \\$wg$aAcylation
=667  \\$aalmost never IM; enzymatic acetylation: coord NIM with ACETYLTRANSFERASES (IM) + substrate (NIM) or specific acetyltransferase (IM)
=680  \\$iFormation of an acetyl derivative. (Stedman, 25th ed)
=688  \\$a91(73); was see under CHEMISTRY, ORGANIC 1973-90
=750  \0$aAcetylation$5IEN$0(DLC)sh 87001826

=LDR  00440cz  a2200169n  4500
=001  9880363371502441
=005  20141212194351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000098
=035  \\$aCAZ3244M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x120
=150  \\$aAcetophenones
=550  \\$wg$aKetones
=550  \\$wh$aBenzoin
=550  \\$wh$aomega-Chloroacetophenone
=750  \0$aAcetophenone$0(DLC) sh2005002607$5IEN-M

=LDR  00676cz  a2200241n  4500
=001  9880363371602441
=005  20141212194351.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000097
=035  \\$aCAZ3243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x626.$x80
=150  \\$aAcetonitriles
=450  \\$wnnna$aCyanides, Methyl
=450  \\$aCyanomethanes
=450  \\$aEthane Nitriles
=450  \\$aMethyl Cyanides
=450  \\$wnnna$aNitriles, Ethane
=550  \\$wg$aNitriles
=550  \\$wh$aAminoacetonitrile
=680  \\$iCompounds in which a methyl group is attached to the cyano moiety.
=688  \\$a75
=750  \0$aAcetonitrile$5IEN$0(DLC)sh 85000464

=LDR  01402cz  a2200409n  4500
=001  9880363371702441
=005  20141212194331.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000023
=035  \\$aCAZ3170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x50
=150  \\$aAbortion Applicants
=450  \\$wnnna$aAbortion Applicant
=450  \\$wnnna$aAbortion Seeker
=450  \\$wnnna$aAbortion Seeker, Refused
=450  \\$wnnna$aAbortion Seeker, Repeated
=450  \\$aAbortion Seekers
=450  \\$wnnna$aAbortion Seekers, Refused
=450  \\$wnnna$aAbortion Seekers, Repeated
=450  \\$wnnna$aApplicant, Abortion
=450  \\$wnnna$aApplicants, Abortion
=450  \\$wnnna$aRefused Abortion Seeker
=450  \\$wnnna$aRefused Abortion Seekers
=450  \\$wnnna$aRepeated Abortion Seeker
=450  \\$wnnna$aRepeated Abortion Seekers
=450  \\$wnnna$aSeeker, Abortion
=450  \\$wnnna$aSeeker, Refused Abortion
=450  \\$wnnna$aSeeker, Repeated Abortion
=450  \\$wnnna$aSeekers, Abortion
=450  \\$wnnna$aSeekers, Refused Abortion
=450  \\$wnnna$aSeekers, Repeated Abortion
=550  \\$wg$aPersons
=667  \\$adon't forget also check tags HUMANS & FEMALE & PREGNANCY
=680  \\$iIndividuals requesting induced abortions.
=688  \\$a76(75); was see under ABORTION 1975
=750  \0$aAbortion applicants$5IEN$0(DLC)sh 92002018

=LDR  00619cz  a2200193n  4500
=001  9880363371802441
=005  20141212194351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000096
=035  \\$aCAZ3242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x64
=072  \\$aD2.$x522.$x585.$x342
=150  \\$aAcetone
=550  \\$wg$aKetone Bodies
=550  \\$wg$aKetones
=667  \\$aacetonemia & acetonuria go under KETONE BODIES
=680  \\$iA colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.
=750  \0$aAcetone$5IEN$0(DLC)sh 85000462

=LDR  01282cz  a2200373n  4500
=001  9880363371902441
=005  20141212194331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x39
=150  \\$aAbortion, Spontaneous
=450  \\$wnnna$aAbortion, Tubal
=450  \\$wnnna$aAbortions, Spontaneous
=450  \\$wnnna$aAbortions, Tubal
=450  \\$aMiscarriage
=450  \\$wnnna$aMiscarriages
=450  \\$wnnna$aSpontaneous Abortion
=450  \\$wnnna$aSpontaneous Abortions
=450  \\$wnnna$aTubal Abortion
=450  \\$wnnna$aTubal Abortions
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aAbortion, Habitual
=550  \\$wh$aAbortion, Incomplete
=550  \\$wh$aAbortion, Missed
=550  \\$wh$aAbortion, Septic
=550  \\$wh$aAbortion, Threatened
=550  \\$wh$aAbortion, Veterinary
=550  \\$wh$aEmbryo Loss
=550  \\$aAborted Fetus
=667  \\$a/chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS & FEMALE & PREGNANCY
=680  \\$iExpulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.
=688  \\$a99(63)
=750  \0$aMiscarriage$5IEN-M$0(DLC)sh 85085974

=LDR  01314cz  a2200337n  4500
=001  9880363372002441
=005  20141212194330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000019
=035  \\$aCAZ3166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x131
=072  \\$aD27.$x505.$x954.$x705.$x131
=150  \\$aAbortifacient Agents
=450  \\$wnnna$aAbortifacient Effect
=450  \\$wnnna$aAbortifacient Effects
=450  \\$wnnna$aAbortifacients
=450  \\$wnnna$aAgents, Abortifacient
=450  \\$wnnna$aAgents, Postconception Contraceptive
=450  \\$wnnna$aContraceptive Agents, Postconception
=450  \\$wnnna$aEffect, Abortifacient
=450  \\$wnnna$aEffects, Abortifacient
=450  \\$wnnna$aPostconception Contraceptive Agents
=550  \\$wg$aReproductive Control Agents
=550  \\$wh$aAbortifacient Agents, Nonsteroidal
=550  \\$wh$aAbortifacient Agents, Steroidal
=550  \\$aAbortion, Spontaneous
=667  \\$ause no qualifiers for abortifacients when used to interrupt pregnancy; note entry term ABORTIFACIENT EFFECT: use only for the abortifacient effect of a chemical substance
=680  \\$iChemical substances that interrupt pregnancy after implantation.
=688  \\$a75
=750  \0$aAbortifacients$5IEN$0(DLC)sh 85000195

=LDR  01487cz  a2200349n  4500
=001  9880363372102441
=005  20141212194351.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000095
=035  \\$aCAZ3241HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x200.$x324
=072  \\$aD12.$x776.$x331.$x49
=150  \\$aAcetolactate Synthase
=450  \\$aAcetohydroxy Acid Synthase
=450  \\$aAcetohydroxy Acid Synthetase
=450  \\$wnnna$aAcetohydroxyacid Synthetase I
=450  \\$aAcetolactate Synthetase
=450  \\$wnnna$aAcetoxyhydroxyacid Synthase III
=450  \\$wnnna$aAcid Synthase, Acetohydroxy
=450  \\$wnnna$aAcid Synthetase, Acetohydroxy
=450  \\$wnnna$aSynthase, Acetohydroxy Acid
=450  \\$wnnna$aSynthase, Acetolactate
=450  \\$wnnna$aSynthase III, Acetoxyhydroxyacid
=450  \\$wnnna$aSynthetase, Acetohydroxy Acid
=450  \\$wnnna$aSynthetase, Acetolactate
=450  \\$wnnna$aSynthetase I, Acetohydroxyacid
=550  \\$wg$aAldehyde-Ketone Transferases
=550  \\$wg$aFlavoproteins
=680  \\$iA flavoprotein enzyme that catalyzes the formation of acetolactate from 2 moles of PYRUVATE in the biosynthesis of VALINE and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of ISOLEUCINE. This enzyme was formerly listed as EC 4.1.3.18.
=688  \\$a91(75); was see under KETOACID-LYASES 1975-90
=750  \0$aAcetolactate synthase$5IEN-M$0(DLC)sh 96009481

=LDR  00661cz  a2200181n  4500
=001  9880363372202441
=005  20141212194349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x100.$x100
=072  \\$aB3.$x660.$x50.$x663.$x50.$x10
=150  \\$aAcetobacter
=550  \\$wg$aAcetobacteraceae
=667  \\$ado not confuse with ACETOBACTERIUM
=680  \\$iA species of gram-negative bacteria of the family ACETOBACTERACEAE found in FLOWERS and FRUIT. Cells are ellipsoidal to rod-shaped and straight or slightly curved.
=688  \\$a1966
=750  \0$aAcetobacter$5IEN$0(DLC)sh 88023203

=LDR  01714cz  a2200433n  4500
=001  9880363372302441
=005  20141212194329.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000017
=035  \\$aCAZ3164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x31
=072  \\$aD23.$x50.$x705.$x230.$x31
=150  \\$aABO Blood-Group System
=450  \\$aABH Blood Group
=450  \\$wnnna$aABH Blood Groups
=450  \\$wnnna$aABO Blood Group System
=450  \\$wnnna$aABO Blood-Group Systems
=450  \\$wnnna$aABO Factor
=450  \\$aABO Factors
=450  \\$wnnna$aBlood Group, ABH
=450  \\$wnnna$aBlood Group, H
=450  \\$wnnna$aBlood Group H Type 1 Antigen
=450  \\$wnnna$aBlood-Group System, ABO
=450  \\$wnnna$aBlood-Group Systems, ABO
=450  \\$wnnna$aBlood Groups, ABH
=450  \\$wnnna$aBlood Groups, H
=450  \\$wnnna$aFactor, ABO
=450  \\$wnnna$aFactors, ABO
=450  \\$wnnna$aH Blood Group
=450  \\$wnnna$aH Blood Group System
=450  \\$wnnna$aH Blood Groups
=450  \\$wnnna$aSystem, ABO Blood-Group
=450  \\$wnnna$aSystems, ABO Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iThe major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane.
=688  \\$a76; was ABO FACTORS 1963-75
=750  \0$aBlood groups$xABO system$5IEN$0(DLC)sh 85014986

=LDR  02336cz  a2200649n  4500
=001  9880363372402441
=005  20141212194326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000013
=035  \\$aCAZ3160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131
=150  \\$aCongenital Abnormalities
=450  \\$wnno$aAbnormalities$5IEN-M
=450  \\$wnnna$aAbnormalities, Congenital
=450  \\$aAbnormalities, Human$5IEN
=450  \\$wnnna$aAbnormality, Congenital
=450  \\$wnnna$aBirth Defect
=450  \\$aBirth Defects
=450  \\$wnnna$aCongenital Abnormality
=450  \\$wnnna$aCongenital Defect
=450  \\$aCongenital Defects
=450  \\$wnnna$aDefect, Birth
=450  \\$wnnna$aDefect, Congenital
=450  \\$wnnna$aDefects, Birth
=450  \\$wnnna$aDefects, Congenital
=450  \\$aDeformities
=450  \\$wnnna$aDeformity
=550  \\$wg$aCongenital, Hereditary, and Neonatal Diseases and Abnormalities
=550  \\$wh$aAbnormalities, Drug-Induced
=550  \\$wh$aAbnormalities, Multiple
=550  \\$wh$aAbnormalities, Radiation-Induced
=550  \\$wh$aAbnormalities, Severe Teratoid
=550  \\$wh$aAicardi Syndrome
=550  \\$wh$aCardiovascular Abnormalities
=550  \\$wh$aChromosome Disorders
=550  \\$wh$aCongenital Microtia
=550  \\$wh$aDigestive System Abnormalities
=550  \\$wh$aEye Abnormalities
=550  \\$wh$aHernias, Diaphragmatic, Congenital
=550  \\$wh$aLymphatic Abnormalities
=550  \\$wh$aMusculoskeletal Abnormalities
=550  \\$wh$aNervous System Malformations
=550  \\$wh$aRespiratory System Abnormalities
=550  \\$wh$aSitus Inversus
=550  \\$wh$aSkin Abnormalities
=550  \\$wh$aStomatognathic System Abnormalities
=550  \\$wh$aThyroid Dysgenesis
=550  \\$wh$aUrogenital Abnormalities
=550  \\$aFetal Diseases
=550  \\$aInfant, Newborn, Diseases
=550  \\$aTeratogenesis
=667  \\$ageneral only: prefer /abnorm with specific anatomical term or specific animal: Manual 19.7+, 19.8.1; policy: Manual 23.20+
=680  \\$iMalformations of organs or body parts during development in utero.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Abnormalities
=750  \0$aAbnormalties, Human$0(DLC) sh 85000182$5IEN

=LDR  01682cz  a2200457n  4500
=001  9880363372502441
=005  20180130162346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000009
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x50
=150  \\$aAbdominal Muscles
=450  \\$wnnna$aAbdominal Muscle
=450  \\$wnnna$aAbdominal, Transverse
=450  \\$wnnna$aAbdominals, Transverse
=450  \\$wnnna$aAbdomini, Quadratus
=450  \\$wnnna$aAbdominis, Quadratus
=450  \\$wnnna$aCremaster Muscle
=450  \\$wnnna$aCremaster Muscles
=450  \\$wnnna$aMuscle, Abdominal
=450  \\$wnnna$aMuscle, Cremaster
=450  \\$wnnna$aMuscle, Pyramidalis
=450  \\$wnnna$aMuscles, Abdominal
=450  \\$wnnna$aMuscles, Cremaster
=450  \\$wnnna$aMuscles, Pyramidalis
=450  \\$wnnna$aPyramidalis Muscle
=450  \\$wnnna$aPyramidalis Muscles
=450  \\$wnnna$aQuadratus Abdomini
=450  \\$wnnna$aQuadratus Abdominis
=450  \\$wnnna$aTransverse Abdominal
=450  \\$wnnna$aTransverse Abdominals
=450  \\$wnnna$aTransversus Abdominis
=550  \\$wg$aMuscle, Skeletal
=550  \\$wh$aAbdominal Oblique Muscles
=550  \\$wh$aPelvic Floor
=550  \\$wh$aRectus Abdominis
=550  \\$aAbdominal Wall
=667  \\$a/growth: coordinate with MUSCLE DEVELOPMENT; /embyol: coordinate with MUSCLE DEVELOPMENT if pertinent
=680  \\$iMuscles forming the ABDOMINAL WALL including RECTUS ABDOMINIS; ABDOMINAL OBLIQUE MUSCLES, transversus abdominis, pyramidalis muscles and quadratus abdominis.
=688  \\$a93; was ABDOMINAL WALL 1966-92
=750  \0$aAbdomen$xMuscles$0(DLC)sh 85000098$5IEN-M

=LDR  00913cz  a2200241n  4500
=001  9880363372602441
=005  20141212194324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000008
=035  \\$aCAZ3155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x33
=150  \\$aAbdominal Neoplasms
=450  \\$wnnna$aAbdominal Neoplasm
=450  \\$wnnna$aNeoplasm, Abdominal
=450  \\$wnnna$aNeoplasms, Abdominal
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aPeritoneal Neoplasms
=550  \\$wh$aRetroperitoneal Neoplasms
=550  \\$wh$aSister Mary Joseph's Nodule
=667  \\$ageneral term for neopl of organs in the abdom cavity; prefer specific organ/neopl terms; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl if given (IM)
=750  \0$aAbdomen$xCancer$5IEN$0(DLC)sh 85000095
=750  \0$aAbdomen$xTumors$5IEN-HS$0(DLC)sh 85000102

=LDR  00872cz  a2200253n  4500
=001  9880363372702441
=005  20141212194324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000007
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x17
=150  \\$aAbdominal Injuries
=450  \\$aAbdomen$xinjuries
=450  \\$aAbdominal Cavity$xinjuries
=450  \\$wnnna$aAbdominal Injury
=450  \\$wnnna$aInjuries, Abdominal
=450  \\$wnnna$aInjury, Abdominal
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aHernia, Diaphragmatic, Traumatic
=550  \\$wh$aSplenic Rupture
=550  \\$wh$aStomach Rupture
=667  \\$ageneral term for inj of organs in the abdom cavity; prefer specific organs /inj
=680  \\$iGeneral or unspecified injuries involving organs in the abdominal cavity.
=750  \0$aAbdomen$xWounds and injuries$5IEN$0(DLC)sh 85000103

=LDR  03427cz  a2200769n  4500
=001  9880363372802441
=005  20141212191914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000086
=035  \\$aCAZ3232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x867.$x60
=072  \\$aD3.$x383.$x129.$x708.$x867.$x60
=150  \\$aAcetazolamide
=450  \\$wnnna$aAcetadiazol
=450  \\$wnnna$aAcetazolam
=450  \\$wnnna$aAcetazolamide Apotex Brand
=450  \\$wnnna$aAcetazolamide Chiesi Brand
=450  \\$wnnna$aAcetazolamide Dioptic Brand
=450  \\$wnnna$aAcetazolamide Grin Brand
=450  \\$wnnna$aAcetazolamide ICN Brand
=450  \\$wnnna$aAcetazolamide Jumer Brand
=450  \\$wnnna$aAcetazolamide Llorens Brand
=450  \\$wnnna$aAcetazolamide Medphano Brand
=450  \\$wnnna$aAcetazolamide, Monosodium Salt
=450  \\$wnnna$aAcetazolamide Novopharm Brand
=450  \\$wnnna$aAcetazolamide Orion Brand
=450  \\$wnnna$aAcetazolamide Sodium, (Sterile)
=450  \\$wnnna$aAcetazolamide Wassermann Brand
=450  \\$wnnna$aAk-Zol
=450  \\$wnnna$aAk Zol
=450  \\$wnnna$aAkZol
=450  \\$wnnna$aApo-Acetazolamide
=450  \\$wnnna$aApo Acetazolamide
=450  \\$wnnna$aApoAcetazolamide
=450  \\$wnnna$aApotex Brand of Acetazolamide
=450  \\$wnnna$aChiesi Brand of Acetazolamide
=450  \\$wnnna$aCiba Vision Brand of Acetazolamide
=450  \\$wnnna$aCyanamid Brand of Acetazolamide Preparation
=450  \\$wnnna$aDéfiltran
=450  \\$wnnna$aDiacarb
=450  \\$wnnna$aDiamox
=450  \\$wnnna$aDioptic Brand of Acetazolamide
=450  \\$wnnna$aDiuramide
=450  \\$wnnna$aEdemox
=450  \\$wnnna$aGlauconox
=450  \\$wnnna$aGlaupax
=450  \\$wnnna$aGrin Brand of Acetazolamide
=450  \\$wnnna$aHuma-Zolamide
=450  \\$wnnna$aHuma Zolamide
=450  \\$wnnna$aHumaZolamide
=450  \\$wnnna$aICN Brand of Acetazolamide
=450  \\$wnnna$aJumer Brand of Acetazolamide
=450  \\$wnnna$aLederle Brand of Acetazolamide Preparation
=450  \\$wnnna$aLlorens Brand of Acetazolamide
=450  \\$wnnna$aMedphano Brand of Acetazolamide
=450  \\$wnnna$aMonosodium Salt Acetazolamide
=450  \\$wnnna$aNovopharm Brand of Acetazolamide
=450  \\$wnnna$aOrion Brand of Acetazolamide
=450  \\$wnnna$aStorz Brand of Acetazolamide Preparation
=450  \\$wnnna$aThéraplix Brand of Acetazolamide Preparation
=450  \\$wnnna$aWassermann Brand of Acetazolamide
=450  \\$wnnna$aWhelehan Brand of Acetazolamide Preparation
=450  \\$wnnna$aWyeth Brand of Acetazolamide Preparation
=550  \\$wg$aThiadiazoles
=680  \\$iOne of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
=750  \0$aAcetazolamide$5IEN$0(DLC)sh 85000458

=LDR  00725cz  a2200205n  4500
=001  9880363372902441
=005  20141212194324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000006
=035  \\$aCAZ3153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x646.$x100.$x200
=072  \\$aC23.$x888.$x821.$x30.$x249
=150  \\$aAbdomen, Acute
=450  \\$wnnna$aAbdomens, Acute
=450  \\$wnnna$aAcute Abdomen
=450  \\$wnnna$aAcute Abdomens
=550  \\$wg$aAbdominal Pain
=680  \\$iA clinical syndrome with acute abdominal pain that is severe, localized, and rapid onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.
=750  \0$aAcute abdomen$5IEN$0(DLC)sh 85000767

=LDR  00790cz  a2200229n  4500
=001  9880363373002441
=005  20141212194324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47
=150  \\$aAbdomen
=450  \\$wnnna$aAbdomens
=550  \\$wg$aTorso
=550  \\$wh$aAbdominal Cavity
=550  \\$wh$aAbdominal Wall
=550  \\$wh$aGroin
=550  \\$wh$aInguinal Canal
=550  \\$wh$aUmbilicus
=667  \\$aGEN: prefer specifics; abdom muscles = ABDOMINAL MUSCLES but RECTUS ABDOMINIS is available; abdominal pain = ABDOMINAL PAIN; abrupt dis requiring emerg surg = ABDOMEN, ACUTE
=680  \\$iThat portion of the body that lies between the THORAX and the PELVIS.
=750  \0$aAbdomen$5IEN$0(DLC)sh 85000091

=LDR  00701cz  a2200205n  4500
=001  9880363373102441
=005  20141212194323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000004
=035  \\$aCAZ3151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x400.$x556.$x131
=150  \\$aAbbreviations as Topic
=450  \\$wnnna$aAcronyms as Topic
=550  \\$wg$aNames
=667  \\$aincludes acronyms; do not confuse with Publication Type ABBREVIATIONS
=680  \\$iShortened forms of written words or phrases used for brevity.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Abbreviations
=750  \0$aAbbreviations$0(DLC) sh 85000072$5IEN

=LDR  01661cz  a2200493n  4500
=001  9880363373202441
=005  20141212194348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000085
=035  \\$aCAZ3231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18
=072  \\$aD10.$x251.$x400.$x45
=150  \\$aAcetates
=450  \\$aAcetic Acid$xanalogs & derivatives
=450  \\$aAcetic Acid Esters
=450  \\$wnnna$aAcetic Acids
=450  \\$wnnna$aAcids, Acetic
=450  \\$wnnna$aEsters, Acetic Acid
=450  \\$aPotassium Acetate$xanalogs & derivatives
=450  \\$aSodium Acetate$xanalogs & derivatives
=450  \\$aZinc Acetate$xanalogs & derivatives
=550  \\$wg$aAcids, Acyclic
=550  \\$wg$aFatty Acids, Volatile
=550  \\$wh$aAcetamides
=550  \\$wh$aAcetic Acid
=550  \\$wh$aAcetic Anhydrides
=550  \\$wh$aAminooxyacetic Acid
=550  \\$wh$aChloroacetates
=550  \\$wh$aEdetic Acid
=550  \\$wh$aEgtazic Acid
=550  \\$wh$aFluoroacetates
=550  \\$wh$aGlycolates
=550  \\$wh$aIodoacetates
=550  \\$wh$aNitrilotriacetic Acid
=550  \\$wh$aPentetic Acid
=550  \\$wh$aPeracetic Acid
=550  \\$wh$aPhosphonoacetic Acid
=550  \\$wh$aThioglycolates
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iDerivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
=688  \\$a1966
=688  \\$aACETIC ACID ESTERS was heading 1975-96 (see under ACETIC ACIDS 1975-90)
=750  \0$aAcetates$5IEN$0(DLC)sh 85000457

=LDR  00650cz  a2200205n  4500
=001  9880363373302441
=005  20180816120954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000003
=035  \\$aCAZ3150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x700.$x100
=150  \\$aAbattoirs
=450  \\$wnnna$aAbattoir
=450  \\$wnnna$aSlaughterhouse
=450  \\$aSlaughterhouses
=550  \\$wg$aManufacturing and Industrial Facilities
=550  \\$wg$aMeat-Packing Industry
=680  \\$iPlaces where animals are slaughtered and dressed for market.
=750  \0$aSlaughtering and slaughter houses$5IEN$0(DLC)sh 85123301

=LDR  00999cz  a2200229n  4500
=001  9880363373402441
=005  20141212194323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x800
=072  \\$aD2.$x705.$x539.$x345.$x800
=072  \\$aD2.$x886.$x300.$x692.$x800
=150  \\$aTemefos
=450  \\$wnnna$aAbate
=450  \\$wnnna$aDifos
=450  \\$wnnna$aTemephos
=550  \\$wg$aOrganothiophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organothiophosphate insecticide.
=688  \\$a96; was ABATE 1972-95 (see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90)
=750  \0$aTemephos$5IEN$0(DLC)sh 85133687

=LDR  01078cz  a2200313n  4500
=001  9880363373502441
=005  20170927161702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000083
=035  \\$aCAZ3229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x92
=150  \\$aAcetanilides
=450  \\$wnnna$aAcetylanilines
=450  \\$wnnna$aN-Phenylacetamides
=550  \\$wg$aAnilides
=550  \\$wh$aAcetaminophen
=550  \\$wh$aDiamfenetide
=550  \\$wh$aEtidocaine
=550  \\$wh$aInosine Pranobex
=550  \\$wh$aLidocaine
=550  \\$wh$aPhenacetin
=550  \\$wh$aPractolol
=550  \\$wh$aRanolazine
=550  \\$wh$aTrimecaine
=550  \\$aBenzeneacetamides
=680  \\$iCompounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.
=688  \\$a79; was ACETANILIDE 1968-78, was ACETANILID 1963-67
=750  \0$aAcetanilide$5IEN$0(DLC)sh 85000455

=LDR  00331cz  a2200121n  4500
=001  9880363373602441
=005  20120717142040.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCAZ2962HS
=035  \\$a(DNLM)D014570Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aUrologic Diseases$xveterinary
=750  \0$aVeterinary urology$5IEN$0(DLC)sh 85143085

=LDR  00324cz  a2200121n  4500
=001  9880363373702441
=005  20120717142039.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCAZ2961HS
=035  \\$a(DNLM)D007668Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aKidney$xdrug effects
=750  \0$aRenal pharmacology$5IEN-M$0(DLC)sh 85112821

=LDR  00797cz  a2200229n  4500
=001  9880363373802441
=005  20141212211935.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017157
=035  \\$aBZK0751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100
=150  \\$aAdenophorea
=450  \\$wnnna$aAdenophoreas
=450  \\$aAphasmidia
=450  \\$wnnna$aAphasmidias
=550  \\$wg$aNematoda
=550  \\$wh$aEnoplida
=667  \\$aa subclass of nematodes; infection = ADENOPHOREA INFECTIONS
=680  \\$iA subclass of nematodes characterized by reduced or absent caudal papillae and an excretory system lacking lateral canals. Its organisms are usually infective to their final host.
=688  \\$a93
=750  \0$aAdenophorea$5IEN-M$0(DLC)sh 85000845

=LDR  01306cz  a2200349n  4500
=001  9880363374402441
=005  20200629180016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006266
=035  \\$aCAZ9437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x332
=072  \\$aN2.$x421.$x143.$x827.$x407
=072  \\$aN2.$x421.$x726.$x407
=150  \\$aHealth Education
=450  \\$aCommunity Health Education
=450  \\$wnnna$aEducation, Community Health
=450  \\$aEducation, Health
=450  \\$aHealth$xeducation
=450  \\$wnnna$aHealth Education, Community
=550  \\$wg$aEducation, Nonprofessional
=550  \\$wg$aPreventive Health Services
=550  \\$wh$aConsumer Health Information
=550  \\$wh$aHealth Education, Dental
=550  \\$wh$aHealth Fairs
=550  \\$wh$aPatient Education as Topic
=550  \\$wh$aSex Education
=550  \\$wh$aSmoking Prevention
=550  \\$wh$aTeach-Back Communication
=667  \\$aeduc of general public or individuals; educ of patients in & outside hosp = PATIENT EDUCATION AS TOPIC
=680  \\$iEducation that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.
=750  \0$aHealth education$0sh 85059537$5IEN

=LDR  00855cz  a2200265n  4500
=001  9880363374502441
=005  20141212210944.0
=008  880519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015276
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x750.$x500
=072  \\$aN3.$x349.$x270
=072  \\$aN5.$x300.$x430.$x375
=150  \\$aHealth Care Rationing
=450  \\$wnnna$aHealthcare Rationing
=450  \\$aRationing, Health Care
=450  \\$wnnna$aRationing, Healthcare
=550  \\$wg$aHealth Planning
=550  \\$wg$aHealth Services Accessibility
=550  \\$wg$aResource Allocation
=550  \\$aHealth Resources
=550  \\$aPatient Selection
=680  \\$iPlanning for the equitable allocation, apportionment, or distribution of available health resources.
=688  \\$a89
=750  \0$aHealth care rationing$5IEN$0(DLC)sh 92002909

=LDR  01165cz  a2200301n  4500
=001  9880363374602441
=005  20200717113133.0
=008  880608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015438
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x488
=150  \\$aHealth Behavior
=450  \\$wnnna$aBehavior, Health
=450  \\$wnnna$aBehaviors, Health
=450  \\$wnnna$aHealth Behaviors
=550  \\$wg$aBehavior
=550  \\$wh$aHealth Risk Behaviors
=550  \\$wh$aPatient Compliance
=550  \\$wh$aSelf-Examination
=550  \\$wh$aSleep Hygiene
=550  \\$wh$aSmoking Reduction
=550  \\$wh$aTobacco Use Cessation
=550  \\$wh$aTreatment Adherence and Compliance
=550  \\$aHealth Promotion
=550  \\$aLife Style
=680  \\$iBehaviors expressed by individuals to protect, maintain or promote their health status. For example, proper diet, and appropriate exercise are activities perceived to influence health status. Life style is closely associated with health behavior and factors influencing life style are socioeconomic, educational, and cultural.
=688  \\$a89
=750  \0$aHealth behavior$5IEN$0(DLC)sh 85059530

=LDR  01379cz  a2200469n  4500
=001  9880363374702441
=005  20200626123517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400
=150  \\$aHealth
=450  \\$wnnna$aNormalcy
=450  \\$wnnna$aNormalities
=450  \\$wnnna$aNormality
=550  \\$wg$aPopulation Characteristics
=550  \\$wh$aAdolescent Health
=550  \\$wh$aCardiorespiratory Fitness
=550  \\$wh$aChild Health
=550  \\$wh$aFamily Health
=550  \\$wh$aGlobal Health
=550  \\$wh$aHolistic Health
=550  \\$wh$aInfant Health
=550  \\$wh$aMen's Health
=550  \\$wh$aMental Health
=550  \\$wh$aMinority Health
=550  \\$wh$aOccupational Health
=550  \\$wh$aOne Health
=550  \\$wh$aOral Health
=550  \\$wh$aPhysical Fitness
=550  \\$wh$aPopulation Health
=550  \\$wh$aPublic Health
=550  \\$wh$aReproductive Health
=550  \\$wh$aRural Health
=550  \\$wh$aSexual Health
=550  \\$wh$aSocial Determinants of Health
=550  \\$wh$aSuburban Health
=550  \\$wh$aUrban Health
=550  \\$wh$aVeterans Health
=550  \\$wh$aWomen's Health
=680  \\$iThe state of the organism when it functions optimally without evidence of disease.
=750  \0$aHealth$0(DLC) sh 85059518$5IEN

=LDR  03108cz  a2200913n  4500
=001  9880363374802441
=005  20141212201930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006261
=035  \\$aCAZ9430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x470
=072  \\$aC23.$x888.$x592.$x612.$x441
=072  \\$aC23.$x888.$x646.$x487
=150  \\$aHeadache
=450  \\$wnnna$aBilateral Headache
=450  \\$wnnna$aBilateral Headaches
=450  \\$wnnna$aCephalalgia
=450  \\$wnnna$aCephalalgias
=450  \\$aCephalgia
=450  \\$wnnna$aCephalgias
=450  \\$wnnna$aCephalodynia
=450  \\$wnnna$aCephalodynias
=450  \\$wnnna$aCranial Pain
=450  \\$wnnna$aCranial Pains
=450  \\$wnnna$aGeneralized Headache
=450  \\$wnnna$aGeneralized Headaches
=450  \\$wnnna$aHead Pain
=450  \\$wnnna$aHead Pains
=450  \\$wnnna$aHeadache, Bilateral
=450  \\$wnnna$aHeadache, Generalized
=450  \\$wnnna$aHeadache, Ocular
=450  \\$wnnna$aHeadache, Orthostatic
=450  \\$wnnna$aHeadache, Periorbital
=450  \\$wnnna$aHeadache, Retro-Ocular
=450  \\$wnnna$aHeadache, Sharp
=450  \\$wnnna$aHeadache, Throbbing
=450  \\$wnnna$aHeadache, Unilateral
=450  \\$wnnna$aHeadache, Vertex
=450  \\$wnnna$aHeadaches
=450  \\$wnnna$aHeadaches, Bilateral
=450  \\$wnnna$aHeadaches, Generalized
=450  \\$wnnna$aHeadaches, Ocular
=450  \\$wnnna$aHeadaches, Orthostatic
=450  \\$wnnna$aHeadaches, Periorbital
=450  \\$wnnna$aHeadaches, Retro-Ocular
=450  \\$wnnna$aHeadaches, Sharp
=450  \\$wnnna$aHeadaches, Throbbing
=450  \\$wnnna$aHeadaches, Unilateral
=450  \\$wnnna$aHeadaches, Vertex
=450  \\$aHemicrania
=450  \\$wnnna$aOcular Headache
=450  \\$wnnna$aOcular Headaches
=450  \\$wnnna$aOrthostatic Headache
=450  \\$wnnna$aOrthostatic Headaches
=450  \\$wnnna$aPain, Cranial
=450  \\$wnnna$aPain, Head
=450  \\$wnnna$aPains, Cranial
=450  \\$wnnna$aPains, Head
=450  \\$wnnna$aPeriorbital Headache
=450  \\$wnnna$aPeriorbital Headaches
=450  \\$wnnna$aRetro-Ocular Headache
=450  \\$wnnna$aRetro Ocular Headache
=450  \\$wnnna$aRetro-Ocular Headaches
=450  \\$wnnna$aSharp Headache
=450  \\$wnnna$aSharp Headaches
=450  \\$wnnna$aThrobbing Headache
=450  \\$wnnna$aThrobbing Headaches
=450  \\$wnnna$aUnilateral Headache
=450  \\$wnnna$aUnilateral Headaches
=450  \\$wnnna$aVertex Headache
=450  \\$wnnna$aVertex Headaches
=550  \\$wg$aPain
=550  \\$wh$aSlit Ventricle Syndrome
=550  \\$aHeadache Disorders
=667  \\$aHEADACHE DISORDERS and specifics are also available but do not diagnose: use word of text
=680  \\$iThe symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
=688  \\$a2006 (1963); for HEMICRANIA use MIGRAINE 1963-2005
=750  \0$aHeadache$5IEN$0(DLC)sh 85059488

=LDR  00882cz  a2200265n  4500
=001  9880363374902441
=005  20141212201928.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006260
=035  \\$aCAZ9429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x380
=072  \\$aJ1.$x637.$x708.$x380
=150  \\$aHead Protective Devices
=450  \\$wnnna$aDevice, Head Protective
=450  \\$wnnna$aDevices, Head Protective
=450  \\$wnnna$aHead Protective Device
=450  \\$wnnna$aHelmet
=450  \\$aHelmets
=450  \\$wnnna$aProtective Device, Head
=450  \\$wnnna$aProtective Devices, Head
=550  \\$wg$aProtective Devices
=680  \\$iPersonal devices for protection of heads from impact, penetration from falling and flying objects, and from limited electric shock and burn.
=688  \\$a91(75)
=750  \0$aHelmets$5IEN$0(DLC)sh 85060069

=LDR  04612cz  a2201237n  4500
=001  9880363375002441
=005  20141212201928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006259
=035  \\$aCAZ9428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x900.$x300
=072  \\$aC26.$x260
=072  \\$aC26.$x915.$x300
=150  \\$aCraniocerebral Trauma
=450  \\$wnnna$aCraniocerebral Injuries
=450  \\$wnnna$aCraniocerebral Injury
=450  \\$wnnna$aCraniocerebral Traumas
=450  \\$wnnna$aCrushing Skull Injuries
=450  \\$wnnna$aCrushing Skull Injury
=450  \\$wnnna$aForehead Trauma
=450  \\$wnnna$aForehead Traumas
=450  \\$aFrontal Region Trauma
=450  \\$wnnna$aFrontal Region Traumas
=450  \\$aHead Injuries
=450  \\$aHead$xinjuries
=450  \\$wnnna$aHead Injuries, Minor
=450  \\$wnnna$aHead Injuries, Multiple
=450  \\$wnnna$aHead Injuries, Open
=450  \\$wnnna$aHead Injuries, Superficial
=450  \\$wnnna$aHead Injury
=450  \\$wnnna$aHead Injury, Minor
=450  \\$wnnna$aHead Injury, Multiple
=450  \\$wnnna$aHead Injury, Open
=450  \\$wnnna$aHead Injury, Superficial
=450  \\$aHead Trauma
=450  \\$wnnna$aHead Traumas
=450  \\$wnnna$aInjuries, Craniocerebral
=450  \\$wnnna$aInjuries, Head
=450  \\$wnnna$aInjuries, Minor Head
=450  \\$wnnna$aInjuries, Multiple Head
=450  \\$wnnna$aInjuries, Open Head
=450  \\$wnnna$aInjuries, Superficial Head
=450  \\$wnnna$aInjury, Craniocerebral
=450  \\$wnnna$aInjury, Head
=450  \\$wnnna$aInjury, Minor Head
=450  \\$wnnna$aInjury, Multiple Head
=450  \\$wnnna$aInjury, Open Head
=450  \\$wnnna$aInjury, Superficial Head
=450  \\$wnnna$aMinor Head Injuries
=450  \\$wnnna$aMinor Head Injury
=450  \\$wnnna$aMultiple Head Injuries
=450  \\$wnnna$aMultiple Head Injury
=450  \\$aOccipital Region Trauma
=450  \\$wnnna$aOccipital Region Traumas
=450  \\$wnnna$aOccipital Trauma
=450  \\$wnnna$aOccipital Traumas
=450  \\$wnnna$aOpen Head Injuries
=450  \\$wnnna$aOpen Head Injury
=450  \\$aParietal Region Trauma
=450  \\$wnnna$aParietal Region Traumas
=450  \\$wnnna$aRegion Trauma, Frontal
=450  \\$wnnna$aRegion Trauma, Occipital
=450  \\$wnnna$aRegion Trauma, Parietal
=450  \\$wnnna$aRegion Traumas, Frontal
=450  \\$wnnna$aRegion Traumas, Occipital
=450  \\$wnnna$aRegion Traumas, Parietal
=450  \\$wnnna$aSkull Injuries, Crushing
=450  \\$wnnna$aSkull Injury, Crushing
=450  \\$wnnna$aSuperficial Head Injuries
=450  \\$wnnna$aSuperficial Head Injury
=450  \\$aTemporal Region Trauma
=450  \\$wnnna$aTemporal Region Traumas
=450  \\$wnnna$aTrauma, Craniocerebral
=450  \\$wnnna$aTrauma, Forehead
=450  \\$wnnna$aTrauma, Frontal Region
=450  \\$wnnna$aTrauma, Head
=450  \\$wnnna$aTrauma, Occipital
=450  \\$wnnna$aTrauma, Occipital Region
=450  \\$wnnna$aTrauma, Parietal Region
=450  \\$wnnna$aTrauma, Temporal Region
=450  \\$wnnna$aTraumas, Craniocerebral
=450  \\$wnnna$aTraumas, Forehead
=450  \\$wnnna$aTraumas, Frontal Region
=450  \\$wnnna$aTraumas, Head
=450  \\$wnnna$aTraumas, Occipital
=450  \\$wnnna$aTraumas, Occipital Region
=450  \\$wnnna$aTraumas, Parietal Region
=450  \\$wnnna$aTraumas, Temporal Region
=550  \\$wg$aTrauma, Nervous System
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBrain Injuries
=550  \\$wh$aCerebrospinal Fluid Leak
=550  \\$wh$aComa, Post-Head Injury
=550  \\$wh$aCranial Nerve Injuries
=550  \\$wh$aFacial Injuries
=550  \\$wh$aHead Injuries, Closed
=550  \\$wh$aHead Injuries, Penetrating
=550  \\$wh$aIntracranial Hemorrhage, Traumatic
=550  \\$wh$aSkull Fractures
=550  \\$aOlfactory Nerve Diseases
=550  \\$aOptic Nerve Injuries
=667  \\$ageneral or unspecified; do not consider a substitute for /inj with various bones or other portions of the head; do not confuse with BRAIN INJURIES; DF: HEAD INJ
=680  \\$iTraumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
=688  \\$a2000(1966)
=750  \0$aHead$xWounds and injuries$5IEN$0(DLC)sh 85059478

=LDR  02323cz  a2200553n  4500
=001  9880363375102441
=005  20141212201926.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006258
=035  \\$aCAZ9427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443
=150  \\$aHead and Neck Neoplasms
=450  \\$wnnna$aCancer of Head
=450  \\$aCancer of Head and Neck
=450  \\$wnnna$aCancer of Neck
=450  \\$wnnna$aCancer of the Head
=450  \\$wnnna$aCancer of the Head and Neck
=450  \\$wnnna$aCancer of the Neck
=450  \\$aHead and Neck Cancer
=450  \\$aHead Cancer
=450  \\$wnnna$aHead, Neck Neoplasms
=450  \\$wnnna$aHead Neoplasms
=450  \\$aNeck Cancer
=450  \\$aNeck Neoplasms
=450  \\$wnnna$aNeoplasm, UADT
=450  \\$wnnna$aNeoplasms, Head
=450  \\$wnnna$aNeoplasms, Head and Neck
=450  \\$wnnna$aNeoplasms, Neck
=450  \\$wnnna$aNeoplasms, UADT
=450  \\$aNeoplasms, Upper Aerodigestive Tract
=450  \\$wnnna$aUADT Neoplasm
=450  \\$wnnna$aUADT Neoplasms
=450  \\$aUpper Aerodigestive Tract Neoplasms
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aEsophageal Neoplasms
=550  \\$wh$aFacial Neoplasms
=550  \\$wh$aMouth Neoplasms
=550  \\$wh$aOtorhinolaryngologic Neoplasms
=550  \\$wh$aParathyroid Neoplasms
=550  \\$wh$aThyroid Neoplasms
=550  \\$wh$aTracheal Neoplasms
=667  \\$asoft tissue neopls only; GEN: prefer FACIAL NEOPLASMS, & other specific organ/neopl terms pertinent to the soft tissues of the head & neck; coord IM with histol type of neopl if possible; DF: HEAD NEOPLASMS or HEAD NEOPL
=680  \\$iSoft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
=688  \\$a76; NECK NEOPLASMS was heading 1963-75
=750  \0$aHead$xTumors$5IEN-M$0(DLC)sh 85059477
=750  \0$aNeck$xCancer$5IEN-HS$0(DLC)sh 85090556
=750  \0$aNeck$xTumors$5IEN-HS$0(DLC)sh 85090560
=750  \0$aHead$xCancer$5IEN-HS$0(DLC)sh 85059470

=LDR  00761cz  a2200217n  4500
=001  9880363375202441
=005  20141212201926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006257
=035  \\$aCAZ9426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456
=150  \\$aHead
=450  \\$wnnna$aHeads
=550  \\$wg$aBody Regions
=550  \\$wh$aEar
=550  \\$wh$aFace
=550  \\$wh$aScalp
=550  \\$wh$aSkull Base
=667  \\$ausually NIM as site; soft parts = FACE, bony parts = SKULL; /anat: consider also CEPHALOMETRY; /inj = CRANIOCEREBRAL TRAUMA but consider also SKULL & FACIAL BONES & specifics under each with /inj; HEAD-DOWN TILT is available for physiological aspects of this position
=750  \0$aHead$5IEN$0(DLC)sh 85059468

=LDR  00889cz  a2200265n  4500
=001  9880363375302441
=005  20141212201925.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006256
=035  \\$aCAZ9425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944.$x380
=072  \\$aD27.$x888.$x426.$x500
=072  \\$aN6.$x850.$x460.$x710.$x380
=150  \\$aHazardous Waste
=450  \\$wnnna$aHazardous Wastes
=450  \\$wnnna$aWaste, Hazardous
=450  \\$wnnna$aWastes, Hazardous
=550  \\$wg$aHazardous Substances
=550  \\$wg$aWaste Products
=550  \\$wh$aRadioactive Waste
=667  \\$aHAZARDOUS SUBSTANCES is also available
=680  \\$iWaste products which threaten life, health, or the environment when improperly treated, stored, transported, disposed of, or otherwise managed.
=688  \\$a88
=750  \0$aHazardous wastes$5IEN$0(DLC)sh 85059459

=LDR  01252cz  a2200337n  4500
=001  9880363375402441
=005  20141212211020.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015386
=035  \\$aCAZ9424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x426
=150  \\$aHazardous Substances
=450  \\$wnnna$aBiohazards
=450  \\$wnnna$aChemicals, Hazardous
=450  \\$wnnna$aEnvironmental Substances, Toxic
=450  \\$wnnna$aEnvironmental Toxic Substances
=450  \\$aHazardous Chemicals
=450  \\$aHazardous Materials
=450  \\$wnnna$aMaterials, Hazardous
=450  \\$wnnna$aSubstances, Environmental Toxic
=450  \\$wnnna$aSubstances, Hazardous
=450  \\$wnnna$aSubstances, Toxic Environmental
=450  \\$wnnna$aToxic Environmental Substances
=450  \\$aToxic Substances, Environmental
=550  \\$wg$aToxic Actions
=550  \\$wh$aHazardous Waste
=667  \\$aHAZARDOUS WASTE is also available
=680  \\$iElements, compounds, mixtures, or solutions that are considered severely harmful to human health and the environment. They include substances that are toxic, corrosive, flammable, or explosive.
=688  \\$a89
=750  \0$aHazardous substances$5IEN$0(DLC)sh 85059440

=LDR  01595cz  a2200433n  4500
=001  9880363375502441
=005  20141212192230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006255
=035  \\$aCAZ9423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x799.$x315.$x750
=072  \\$aC8.$x674.$x453.$x750
=072  \\$aC9.$x603.$x799.$x315.$x750
=072  \\$aC20.$x543.$x480.$x680.$x443.$x750
=150  \\$aRhinitis, Allergic, Seasonal
=450  \\$wnnna$aAllergic Rhinitides, Seasonal
=450  \\$wnnna$aAllergic Rhinitis, Seasonal
=450  \\$wnnna$aAllergies, Pollen
=450  \\$wnnna$aAllergy, Pollen
=450  \\$wnnna$aFever, Hay
=450  \\$aHay Fever
=450  \\$wnnna$aHayfever
=450  \\$wnnna$aPollen Allergies
=450  \\$aPollen Allergy
=450  \\$wnnna$aPollinoses
=450  \\$aPollinosis
=450  \\$wnnna$aRhinitides, Seasonal Allergic
=450  \\$wnnna$aRhinitis, Seasonal Allergic
=450  \\$wnnna$aSeasonal Allergic Rhinitides
=450  \\$aSeasonal Allergic Rhinitis
=550  \\$wg$aRhinitis, Allergic
=550  \\$aPollen
=667  \\$ado not confuse with RHINITIS, ALLERGIC, NONSEASONAL
=680  \\$iAllergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Hay Fever
=688  \\$aRHINITIS, ALLERGIC was see HAY FEVER 1963-79
=750  \0$aHay-fever$0(DLC) sh 85059408$5IEN

=LDR  00550cz  a2200181n  4500
=001  9880363375602441
=005  20141212201924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006252
=035  \\$aCAZ9420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x548
=150  \\$aHate
=450  \\$wnnna$aHates
=550  \\$wg$aEmotions
=667  \\$ano qualif
=680  \\$iAn enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others.
=750  \0$aHate$5IEN$0(DLC)sh 85059272

=LDR  00838cz  a2200229n  4500
=001  9880363375702441
=005  20141212201922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006245
=035  \\$aCAZ9413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x417
=072  \\$aG1.$x374.$x647.$x457
=150  \\$aHardness Tests
=450  \\$wnnna$aHardness Test
=450  \\$wnnna$aTest, Hardness
=450  \\$wnnna$aTests, Hardness
=550  \\$wg$aHardness
=550  \\$wg$aInvestigative Techniques
=680  \\$iA test to determine the relative hardness of a metal, mineral, or other material according to one of several scales, such as Brinell, Mohs, Rockwell, Vickers, or Shore. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a72(64)
=750  \0$aHardness$xTesting$5IEN$0(DLC)sh 85058887

=LDR  00586cz  a2200193n  4500
=001  9880363375802441
=005  20141212201922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006244
=035  \\$aCAZ9412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x647
=150  \\$aHardness
=450  \\$wnnna$aHardnesses
=550  \\$wg$aMechanical Phenomena
=550  \\$wh$aHardness Tests
=680  \\$iThe mechanical property of material that determines its resistance to force. HARDNESS TESTS measure this property.
=688  \\$a65
=750  \0$aHardness$5IEN$0(DLC)sh 85058886

=LDR  00716cz  a2200193n  4500
=001  9880363375902441
=005  20141212201922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006243
=035  \\$aCAZ9411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x445
=150  \\$aHarderian Gland
=450  \\$wnnna$aGland, Harderian
=550  \\$wg$aAnimal Structures
=667  \\$aanimal only; accessory lacrimal gland
=680  \\$iA sebaceous gland that, in some animals, acts as an accessory to the lacrimal gland. The harderian gland excretes fluid that facilitates movement of the third eyelid.
=688  \\$a91(75); was see under LACRIMAL APPARATUS 1975-90
=750  \0$aHarderian gland$5IEN$0(DLC)sh 91005220

=LDR  00871cz  a2200241n  4500
=001  9880363376002441
=005  20141212201921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006242
=035  \\$aCAZ9410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x50.$x300
=072  \\$aD12.$x776.$x124.$x790.$x106.$x394
=072  \\$aD12.$x776.$x377.$x715.$x85.$x394
=072  \\$aD12.$x776.$x395.$x560.$x373
=150  \\$aHaptoglobins
=450  \\$wnnna$aHaptoglobin
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aMucoproteins
=667  \\$aalpha-globulins; acute phase proteins
=680  \\$iPlasma glycoproteins that form a stable complex with hemoglobin to aid the recycling of heme iron. They are encoded in man by a gene on the short arm of chromosome 16.
=750  \0$aHaptoglobins$5IEN$0(DLC)sh 85058816

=LDR  00926cz  a2200265n  4500
=001  9880363376102441
=005  20141212201921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006241
=035  \\$aCAZ9409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x550.$x480
=150  \\$aHaptens
=450  \\$wnnna$aAgents, Contact-Sensitizing
=450  \\$wnnna$aContact-Sensitizing Agents
=450  \\$wnnna$aContact Sensitizing Agents
=550  \\$wg$aEpitopes
=550  \\$wh$aCardiolipins
=550  \\$wh$aDinitrochlorobenzene
=550  \\$wh$aNitrohydroxyiodophenylacetate
=550  \\$wh$ap-Azobenzenearsonate
=550  \\$wh$aPicryl Chloride
=680  \\$iSmall antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response.
=688  \\$a65(64)
=750  \0$aHaptens$5IEN$0(DLC)sh 85058815

=LDR  00561cz  a2200193n  4500
=001  9880363376202441
=005  20141212201921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006240
=035  \\$aCAZ9408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x516
=150  \\$aHappiness
=450  \\$wnnna$aHappinesses
=550  \\$wg$aEmotions
=667  \\$ano qualif; includes "joy"
=680  \\$iHighly pleasant emotion characterized by outward manifestations of gratification; joy.
=688  \\$a74(70)
=750  \0$aHappiness$5IEN$0(DLC)sh 85058807

=LDR  00734cz  a2200253n  4500
=001  9880363376302441
=005  20141212201920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006238
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x700.$x456
=150  \\$aHaploidy
=450  \\$wnnna$aCell, Haploid
=450  \\$wnnna$aCells, Haploid
=450  \\$wnnna$aHaploid
=450  \\$wnnna$aHaploid Cell
=450  \\$wnnna$aHaploid Cells
=450  \\$wnnna$aHaploidies
=450  \\$wnnna$aHaploids
=550  \\$wg$aPloidies
=667  \\$ano qualif
=680  \\$iThe chromosomal constitution of cells, in which each type of CHROMOSOME is represented once. Symbol: N.
=688  \\$a68
=750  \0$aHaploidy$5IEN$0(DLC)sh 85058795

=LDR  00764cz  a2200253n  4500
=001  9880363376402441
=005  20141212201920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006236
=035  \\$aCAZ9404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x539
=150  \\$aHandwriting
=450  \\$aAutographs$5IEN
=450  \\$aGraphology$5IEN
=450  \\$wnnna$aHandwritings
=450  \\$aPenmanship$5IEN
=550  \\$wg$aWriting
=550  \\$wh$aPaleography
=550  \\$wh$aShorthand
=667  \\$ano qualif; handwriting "disorders" goes here with no coord for disord
=750  \0$aPenmanship$5IEN-M$0(DLC)sh 85099491
=750  \0$aAutographs$5IEN-HS$0(DLC)sh 85010068
=750  \0$aGraphology$5IEN-HS$0(DLC)sh 85056495

=LDR  01102cz  a2200325n  4500
=001  9880363376502441
=005  20141212201920.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006235
=035  \\$aCAZ9403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x412.$x500
=150  \\$aHand Disinfection
=450  \\$aDisinfection, Hand
=450  \\$wnnna$aHand Sanitization
=450  \\$wnnna$aHand Washing
=450  \\$wnnna$aHand Washings
=450  \\$aHandwashing
=450  \\$wnnna$aSanitization, Hand
=450  \\$wnnna$aScrubbing, Surgical
=450  \\$wnnna$aSurgical Scrubbing
=450  \\$wnnna$aWashing, Hand
=450  \\$wnnna$aWashings, Hand
=550  \\$wg$aHand Hygiene
=550  \\$aHand Sanitizers
=680  \\$iThe act of cleansing the hands with water or other liquid, with or without the inclusion of soap or other detergent, for the purpose of destroying infectious microorganisms.
=688  \\$a2013 (1982)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Handwashing
=688  \\$a82
=750  \0$aHand washing$5IEN$0(DLC)sh 85058646

=LDR  02020cz   2200493n  4500
=001  9880363376602441
=005  20220303085154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006233
=035  \\$aCAZ9401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150
=150  \\$aDisabled Persons
=450  \\$wnnna$aDisabilities, People with
=450  \\$wnnna$aDisabilities, Persons with
=450  \\$wnnna$aDisability, Persons with
=450  \\$wnnoa$aDisabled$5IEN
=450  \\$wnnna$aDisabled Person
=450  \\$wnnna$aDisabled, Physically
=450  \\$aHandicapped
=450  \\$wnnna$aHandicapped, Physically
=450  \\$aPeople with Disabilities
=450  \\$wnnna$aPeople with Disability
=450  \\$wnnna$aPerson, Disabled
=450  \\$wnnna$aPersons, Disabled
=450  \\$aPersons with Disabilities
=450  \\$wnnna$aPersons with Disability
=450  \\$aPhysically Challenged
=450  \\$wnnna$aPhysically Disabled
=450  \\$aPhysically Handicapped
=550  \\$wg$aPersons
=550  \\$wh$aAmputees
=550  \\$wh$aDisabled Children
=550  \\$wh$aPersons with Mental Disabilities
=550  \\$wh$aMentally Ill Persons
=550  \\$wh$aPersons With Hearing Impairments
=550  \\$wh$aVisually Impaired Persons
=550  \\$aHealth Services for Persons with Disabilities
=550  \\$aImmobilization
=550  \\$aSports for Persons with Disabilities
=667  \\$aas GEN or unspecified includes both physical & mental disability; prefer specifics (VISUALLY IMPAIRED PERSONS; HEARING IMPAIRED PERSONS; PERSON WITH MENTAL DISABILITIES) emotionally disabled = MENTAL DISORDERS or specific; /educ permitted but is probably EDUCATION, SPECIAL or MAINSTREAMING (EDUCATION); /rehabil permitted; DF: DISABLED
=680  \\$iPersons with physical or mental disabilities that affect or limit their activities of daily living and that may require special accommodations.
=688  \\$a98(63)
=750  \0$aPeople with disabilities$5IEN-HS$0(DLC)sh 85058663
=LDR  00699cz  a2200229n  4500
=001  9880363376702441
=005  20141212201919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006230
=035  \\$aCAZ9398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x448
=150  \\$aHand Injuries
=450  \\$aHand$xinjuries
=450  \\$wnnna$aHand Injury
=450  \\$wnnna$aInjuries, Hand
=450  \\$wnnna$aInjury, Hand
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aFinger Injuries
=667  \\$aconsider also METACARPUS /inj; FINGER INJURIES is also available
=680  \\$iGeneral or unspecified injuries to the hand.
=750  \0$aHand$xWounds and injuries$5IEN$0(DLC)sh 85058628

=LDR  01134cz  a2200301n  4500
=001  9880363376802441
=005  20141212201918.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006228
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x390.$x408
=072  \\$aC5.$x660.$x585.$x988.$x425
=072  \\$aC16.$x131.$x621.$x585.$x425
=150  \\$aHand Deformities, Congenital
=450  \\$wnnna$aCongenital Hand Deformities
=450  \\$wnnna$aCongenital Hand Deformity
=450  \\$wnnna$aDeformities, Congenital Hand
=450  \\$wnnna$aDeformity, Congenital Hand
=450  \\$aHand$xabnormalities
=450  \\$aHand Deformities$xcongenital
=450  \\$wnnna$aHand Deformity, Congenital
=550  \\$wg$aHand Deformities
=550  \\$wg$aLimb Deformities, Congenital
=550  \\$wg$aUpper Extremity Deformities, Congenital
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iAlterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth.
=688  \\$a88
=750  \0$aHand$xAbnormalities$5IEN$0(DLC)sh 85058616

=LDR  00603cz  a2200205n  4500
=001  9880363376902441
=005  20141212201918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006225
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x667
=150  \\$aHand
=450  \\$wnnna$aHands
=550  \\$wg$aUpper Extremity
=550  \\$wh$aFingers
=550  \\$wh$aMetacarpus
=550  \\$wh$aWrist
=667  \\$aprimates only; /inj = HAND INJURIES; skin dis of hand = HAND DERMATOSES: see note there
=688  \\$aHAND DEFORMITIES was heading 1966-70
=750  \0$aHand$5IEN$0(DLC)sh 85058615

=LDR  00961cz  a2200277n  4500
=001  9880363377002441
=005  20190225141730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006224
=035  \\$aCAZ9392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992.$x635.$x75.$x250
=150  \\$aCricetinae
=450  \\$aCricetus
=450  \\$wnnna$aHamster
=450  \\$aHamsters
=550  \\$wg$aArvicolinae
=550  \\$wh$aCricetulus
=550  \\$wh$aMesocricetus
=550  \\$wh$aPhodopus
=667  \\$acheck tag: NIM no qualifiers for HAMSTERS or any CRICETINAE
=680  \\$iA subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Hamsters
=688  \\$aCRICETUS was see under HAMSTERS 1963-81
=750  \0$aHamsters$0(DLC) sh 85058603$5IEN

=LDR  02687cz  a2200613n  4500
=001  9880363377102441
=005  20141212201917.0
=008  860623\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006223
=035  \\$aCAZ9391M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x445.$x435
=072  \\$aC4.$x651.$x435
=072  \\$aC4.$x700.$x435
=072  \\$aC16.$x320.$x700.$x435
=150  \\$aHamartoma Syndrome, Multiple
=450  \\$aBannayan-Riley-Ruvalcaba Syndrome
=450  \\$wnnna$aBannayan Riley Ruvalcaba Syndrome
=450  \\$wnnna$aBannayan-Ruvalcaba-Riley Syndrome
=450  \\$wnnna$aBannayan-Zonana Syndrome
=450  \\$wnnna$aBannayan Zonana Syndrome
=450  \\$wnnna$aCerebellum Dysplastic Gangliocytoma
=450  \\$wnnna$aCerebellum Dysplastic Gangliocytomas
=450  \\$aCowden Disease
=450  \\$wnnna$aCowden Syndrome
=450  \\$aCowden's Disease
=450  \\$wnnna$aCowdens Disease
=450  \\$wnnna$aCowden's Syndrome
=450  \\$wnnna$aCowdens Syndrome
=450  \\$wnnna$aDysplastic Gangliocytoma of Cerebellum
=450  \\$wnnna$aDysplastic Gangliocytoma of the Cerebellum
=450  \\$wnnna$aHamartoma Syndromes, Multiple
=450  \\$aLhermitte-Duclos Disease
=450  \\$wnnna$aLhermitte Duclos Disease
=450  \\$wnnna$aMacrocephaly, Multiple Lipomas, and Hemangiomata
=450  \\$wnnna$aMacrocephaly, Pseudopapilledema, and Multiple Hemangiomas
=450  \\$wnnna$aMacrocephaly, Pseudopapilledema, and Multiple Hemangiomata
=450  \\$aMultiple Hamartoma Syndrome
=450  \\$wnnna$aMultiple Hamartoma Syndromes
=450  \\$wnnna$aMyhre-Riley-Smith Syndrome
=450  \\$wnnna$aMyhre Riley Smith Syndrome
=450  \\$aPTEN Hamartoma Tumor Syndrome
=450  \\$wnnna$aRiley-Smith Syndrome
=450  \\$wnnna$aRiley Smith Syndrome
=450  \\$wnnna$aRuvalcaba-Myhre-Smith Syndrome
=450  \\$wnnna$aRuvalcaba Myhre Smith Syndrome
=450  \\$wnnna$aRuvalcaba-Myhre Syndrome
=550  \\$wg$aHamartoma
=550  \\$wg$aNeoplasms, Multiple Primary
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wh$aProteus Syndrome
=680  \\$iA hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Facial trichilemmomas and papillomatous papules of the oral mucosa are the most characteristic lesions. Individuals with this syndrome have a high risk of BREAST CANCER; THYROID CANCER; and ENDOMETRIAL CANCER. This syndrome is associated with mutations in the gene for PTEN PHOSPHATASE.
=688  \\$a91(87); was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90
=750  \0$aCowden syndrome$0(DLC)sh2008009754$5IEN-M

=LDR  00755cz  a2200217n  4500
=001  9880363377202441
=005  20141212201916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006222
=035  \\$aCAZ9390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x445
=150  \\$aHamartoma
=450  \\$wnnna$aHamartomas
=550  \\$wg$aNeoplasms
=550  \\$wh$aHamartoma Syndrome, Multiple
=550  \\$wh$aPallister-Hall Syndrome
=550  \\$wh$aTuberous Sclerosis
=667  \\$anon-neoplastic; coord IM with precoord organ/diseases term (IM)
=680  \\$iA focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
=750  \0$aHamartoma$0(DLC)sh2008009753$5IEN-M

=LDR  00988cz  a2200217n  4500
=001  9880363377302441
=005  20141212201916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006221
=035  \\$aCAZ9389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x340
=150  \\$aHalothane
=450  \\$wnnna$a1,1,1-Trifluoro-2-Chloro-2-Bromoethane
=450  \\$wnnna$aFluothane
=450  \\$wnnna$aFtorotan
=450  \\$wnnna$aNarcotan
=550  \\$wg$aHydrocarbons, Halogenated
=680  \\$iA nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)
=688  \\$aBROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94
=750  \0$aHalothane$5IEN$0(DLC)sh 85058513

=LDR  00823cz  a2200265n  4500
=001  9880363377402441
=005  20141212201915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006219
=035  \\$aCAZ9387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x380
=150  \\$aHalogens
=450  \\$wnnna$aElements, Group 17
=450  \\$wnnna$aGroup 17 Elements
=450  \\$aOrganohalogen Compounds$5IEN
=550  \\$wg$aElements
=550  \\$wh$aAstatine
=550  \\$wh$aBromine
=550  \\$wh$aChlorine
=550  \\$wh$aFluorine
=550  \\$wh$aIodine
=680  \\$iA family of nonmetallic, generally electronegative, elements that form group 17 (formerly group VIIa) of the periodic table.
=750  \0$aHalogens$5IEN-M$0(DLC)sh 85058508
=750  \0$aHalogen compounds$5IEN-HS$0(DLC)sh 90006057

=LDR  00649cz  a2200181n  4500
=001  9880363377502441
=005  20141212201915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006217
=035  \\$aCAZ9385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2.$x200.$x400.$x400.$x410
=150  \\$aHalobacterium
=550  \\$wg$aHalobacteriaceae
=550  \\$wh$aHalobacterium salinarum
=667  \\$aa genus of Halobacteriaceae found in salt waters & brines; DF: HALOBACT
=680  \\$iA genus of HALOBACTERIACEAE whose growth requires a high concentration of salt. Binary fission is by constriction.
=750  \0$aHalobacterium$5IEN$0(DLC)sh 85058501

=LDR  00931cz  a2200277n  4500
=001  9880363377602441
=005  20141212201914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006215
=035  \\$aCAZ9383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x610
=150  \\$aHallux Valgus
=450  \\$aBunion
=450  \\$wnnna$aBunions
=450  \\$aHallux Abductovalgus
=450  \\$aMetatarsus Primus Varus
=450  \\$wnnna$aPrimus Varus, Metatarsus
=450  \\$wnnna$aVarus, Metatarsus Primus
=550  \\$wg$aFoot Deformities
=550  \\$aBunion, Tailor's
=667  \\$ado not confuse BUNION with TAILOR'S BUNION
=680  \\$iLateral displacement of the great toe (HALLUX), producing deformity of the first METATARSOPHALANGEAL JOINT with callous, bursa, or bunion formation over the bony prominence.
=688  \\$a1967(1963)
=688  \\$a67(63)
=750  \0$aHallux valgus$5IEN$0(DLC)sh 85058496

=LDR  01572cz  a2200373n  4500
=001  9880363377702441
=005  20141212201914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006213
=035  \\$aCAZ9381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x388
=072  \\$aD27.$x505.$x954.$x427.$x300
=072  \\$aD27.$x505.$x954.$x427.$x700.$x372
=150  \\$aHallucinogens
=450  \\$wnnna$aAgents, Hallucinogenic
=450  \\$wnnna$aAgents, Psychedelic
=450  \\$wnnna$aAgents, Psychotomimetic
=450  \\$wnnna$aDrugs, Hallucinogenic
=450  \\$wnnna$aHallucinogenic Agents
=450  \\$wnnna$aHallucinogenic Drugs
=450  \\$aHallucinogenic Plants$5IEN
=450  \\$wnnna$aHallucinogenic Substances
=450  \\$aPsychedelic Agents
=450  \\$wnnna$aPsychedelics
=450  \\$aPsychotomimetic Agents
=450  \\$wnnna$aSubstances, Hallucinogenic
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wg$aPsychotropic Drugs
=550  \\$aHallucinations
=667  \\$aGEN or unspecified; prefer specifics; consider also HALLUCINATIONS /chem ind
=680  \\$iDrugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
=750  \0$aHallucinogenic drugs$5IEN-M$0(DLC)sh 85058490

=LDR  04605cz  a2201153n  4500
=001  9880363377802441
=005  20200423114132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006212
=035  \\$aCAZ9380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762.$x300
=072  \\$aC23.$x888.$x592.$x604.$x764.$x300
=072  \\$aF1.$x700.$x750.$x300
=150  \\$aHallucinations
=450  \\$wnnna$aAuditory Hallucination
=450  \\$wnnna$aAuditory Hallucination, Verbal
=450  \\$wnnna$aAuditory Hallucinations
=450  \\$wnnna$aAuditory Hallucinations, Verbal
=450  \\$wnnna$aBody Sensation Hallucination
=450  \\$wnnna$aBody Sensation Hallucinations
=450  \\$wnnna$aDissociative Hallucination
=450  \\$wnnna$aDissociative Hallucinations
=450  \\$wnnna$aElementary Hallucination
=450  \\$wnnna$aElementary Hallucinations
=450  \\$wnnna$aGustatory Hallucination
=450  \\$wnnna$aGustatory Hallucinations
=450  \\$wnnna$aHallucination
=450  \\$wnnna$aHallucination, Auditory
=450  \\$wnnna$aHallucination, Dissociative
=450  \\$wnnna$aHallucination, Elementary
=450  \\$wnnna$aHallucination, Gustatory
=450  \\$wnnna$aHallucination, Hypnagogic
=450  \\$wnnna$aHallucination, Hypnapompic
=450  \\$wnnna$aHallucination, Kinesthetic
=450  \\$wnnna$aHallucination, Mood Congruent
=450  \\$wnnna$aHallucination, Mood Incongruent
=450  \\$wnnna$aHallucination of Body Sensation
=450  \\$wnnna$aHallucination, Olfactory
=450  \\$wnnna$aHallucination, Organic
=450  \\$wnnna$aHallucination, Reflex
=450  \\$wnnna$aHallucination, Sensory
=450  \\$wnnna$aHallucination, Somatic
=450  \\$wnnna$aHallucination, Tactile
=450  \\$wnnna$aHallucination, Verbal Auditory
=450  \\$wnnna$aHallucination, Visual
=450  \\$wnnna$aHallucinations, Auditory
=450  \\$wnnna$aHallucinations, Dissociative
=450  \\$wnnna$aHallucinations, Elementary
=450  \\$wnnna$aHallucinations, Formed, of People
=450  \\$wnnna$aHallucinations, Gustatory
=450  \\$wnnna$aHallucinations, Hypnagogic
=450  \\$wnnna$aHallucinations, Hypnapompic
=450  \\$wnnna$aHallucinations, Internal Body Sensation
=450  \\$wnnna$aHallucinations, Kinesthetic
=450  \\$wnnna$aHallucinations, Mood Congruent
=450  \\$wnnna$aHallucinations, Mood Incongruent
=450  \\$wnnna$aHallucinations, Olfactory
=450  \\$wnnna$aHallucinations, Organic
=450  \\$wnnna$aHallucinations, Reflex
=450  \\$wnnna$aHallucinations, Sensory
=450  \\$wnnna$aHallucinations, Somatic
=450  \\$wnnna$aHallucinations, Tactile
=450  \\$wnnna$aHallucinations, Verbal Auditory
=450  \\$wnnna$aHallucinations, Visual
=450  \\$wnnna$aHallucinations, Visual, Formed
=450  \\$wnnna$aHallucinations, Visual, Unformed
=450  \\$wnnna$aHypnagogic Hallucination
=450  \\$wnnna$aHypnagogic Hallucinations
=450  \\$wnnna$aHypnapompic Hallucination
=450  \\$wnnna$aHypnapompic Hallucinations
=450  \\$wnnna$aKinesthetic Hallucination
=450  \\$wnnna$aKinesthetic Hallucinations
=450  \\$wnnna$aMood Congruent Hallucination
=450  \\$wnnna$aMood Congruent Hallucinations
=450  \\$wnnna$aMood Incongruent Hallucination
=450  \\$wnnna$aMood Incongruent Hallucinations
=450  \\$wnnna$aOlfactory Hallucination
=450  \\$wnnna$aOlfactory Hallucinations
=450  \\$wnnna$aOrganic Hallucination
=450  \\$wnnna$aOrganic Hallucinations
=450  \\$wnnna$aReflex Hallucination
=450  \\$wnnna$aReflex Hallucinations
=450  \\$wnnna$aSensory Hallucination
=450  \\$wnnna$aSensory Hallucinations
=450  \\$wnnna$aSomatic Hallucination
=450  \\$wnnna$aSomatic Hallucinations
=450  \\$wnnna$aTactile Hallucination
=450  \\$wnnna$aTactile Hallucinations
=450  \\$wnnna$aVerbal Auditory Hallucination
=450  \\$wnnna$aVerbal Auditory Hallucinations
=450  \\$wnnna$aVisual Hallucination
=450  \\$wnnna$aVisual Hallucinations
=550  \\$wg$aPerceptual Disorders
=550  \\$wh$aCharles Bonnet Syndrome
=550  \\$aHallucinogens
=667  \\$a/chem ind: consider also HALLUCINOGENS
=680  \\$iSubjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
=750  \0$aHallucinations and illusions$5IEN$0(DLC)sh 85058489

=LDR  00622cz  a2200181n  4500
=001  9880363377902441
=005  20141212201910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006209
=035  \\$aCAZ9377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x475
=150  \\$aHalitosis
=450  \\$wnnna$aHalitoses
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$aMouth Diseases
=680  \\$iAn offensive, foul breath odor resulting from a variety of causes such as poor oral hygiene, dental or oral infections, or the ingestion of certain foods.
=750  \0$aBad breath$5IEN$0(DLC)sh 85016699

=LDR  00817cz  a2200241n  4500
=001  9880363378002441
=005  20141212201910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006208
=035  \\$aCAZ9376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x408
=150  \\$aHalfway Houses
=450  \\$wnnna$aHalfway House
=450  \\$wnnna$aHouse, Halfway
=450  \\$wnnna$aHouses, Halfway
=550  \\$wg$aResidential Facilities
=550  \\$aAftercare
=550  \\$aRehabilitation
=667  \\$aIM
=680  \\$iSpecialized residences for persons who do not require full hospitalization, and are not well enough to function completely within the community without professional supervision, protection and support.
=688  \\$a67(65)
=750  \0$aHalfway houses$5IEN$0(DLC)sh 85058432

=LDR  00788cz  a2200229n  4500
=001  9880363378102441
=005  20141212201910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006207
=035  \\$aCAZ9375HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910.$x405
=150  \\$aHalf-Life
=450  \\$wnnna$aHalf Life
=450  \\$wnnna$aHalf-Lifes
=450  \\$wnnna$aHalflife
=450  \\$wnnna$aHalflifes
=550  \\$wg$aTime
=667  \\$aalmost never IM; no qualif; may refer to radioactivity, metabolized substances or cells
=680  \\$iThe time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.
=688  \\$a74(71)
=750  \0$aHalf-life (Nuclear physics)$5IEN$0(DLC)sh 85058421

=LDR  00847cz  a2200289n  4500
=001  9880363378202441
=005  20141212201909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006204
=035  \\$aCAZ9372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x372
=150  \\$aHair Removal
=450  \\$aDepilation
=450  \\$wnnna$aDepilation, Electrolytic
=450  \\$wnnna$aDepilations
=450  \\$wnnna$aDepilations, Electrolytic
=450  \\$aElectrolytic Depilation
=450  \\$wnnna$aElectrolytic Depilations
=450  \\$aEpilation
=450  \\$wnnna$aEpilations
=450  \\$wnnna$aHair Removals
=450  \\$wnnna$aRemoval, Hair
=450  \\$wnnna$aRemovals, Hair
=550  \\$wg$aCosmetic Techniques
=667  \\$ado not use /util except by MeSH definition
=750  \0$aHair$xRemoval$5IEN$0(DLC)sh 85058312

=LDR  00863cz  a2200241n  4500
=001  9880363378302441
=005  20141212201909.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006203
=035  \\$aCAZ9371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x430
=150  \\$aHair Preparations
=450  \\$aCosmetics, Hair
=450  \\$wnnna$aHair Cosmetics
=450  \\$wnnna$aPreparations, Hair
=550  \\$wg$aCosmetics
=550  \\$wh$aHair Bleaching Agents
=550  \\$wh$aHair Dyes
=667  \\$aHAIR DYES and HAIR BLEACHING AGENTS are also available
=680  \\$iHair grooming, cleansing and modifying products meant for topical application to hair, usually human. They include sprays, bleaches, dyes, conditioners, rinses, shampoos, nutrient lotions, etc.
=688  \\$a80
=750  \0$aHair preparations$5IEN$0(DLC)sh 85058324

=LDR  00864cz  a2200265n  4500
=001  9880363378402441
=005  20141212201909.0
=008  780501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006202
=035  \\$aCAZ9370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x233.$x688
=072  \\$aD27.$x720.$x269.$x430.$x430
=150  \\$aHair Dyes
=450  \\$wnnna$aAgents, Hair Coloring
=450  \\$wnnna$aColorants, Hair
=450  \\$aColoring Agents, Hair
=450  \\$aDyes, Hair
=450  \\$aHair Colorants
=450  \\$wnnna$aHair Coloring Agents
=550  \\$wg$aColoring Agents
=550  \\$wg$aHair Preparations
=680  \\$iDyes used as cosmetics to change hair color either permanently or temporarily.
=688  \\$a91(79); was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979
=750  \0$aHair dyes$5IEN$0(DLC)sh 85058317

=LDR  00989cz  a2200277n  4500
=001  9880363378502441
=005  20141212201908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006201
=035  \\$aCAZ9369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x329
=150  \\$aHair Diseases
=450  \\$wnnna$aHair Disease
=550  \\$wg$aSkin Diseases
=550  \\$wh$aFolliculitis
=550  \\$wh$aHirsutism
=550  \\$wh$aHypertrichosis
=550  \\$wh$aHypotrichosis
=550  \\$wh$aMenkes Kinky Hair Syndrome
=550  \\$wh$aMonilethrix
=550  \\$wh$aPiedra
=667  \\$aGEN or unspecified; prefer specifics; dis of hair follicles: coord IM with HAIR FOLLICLES (IM) but FOLLICULITIS is also available
=680  \\$iDiseases affecting the orderly growth and persistence of hair.
=688  \\$a80; was HAIR FOLLICLE DISEASES (NON MESH) before 1980; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95
=750  \0$aHair$xDiseases$5IEN$0(DLC)sh 85058308

=LDR  01587cz  a2200361n  4500
=001  9880363378602441
=005  20141212192228.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006198
=035  \\$aCAZ9366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x250
=072  \\$aA8.$x675.$x650.$x915.$x750.$x600.$x350
=072  \\$aA8.$x800.$x950.$x750.$x600.$x350
=072  \\$aA9.$x246.$x631.$x246.$x577.$x325
=072  \\$aA11.$x671.$x650.$x250
=072  \\$aA11.$x671.$x650.$x915.$x750.$x600.$x350
=150  \\$aHair Cells, Auditory
=450  \\$wnnna$aAuditory Hair Cell
=450  \\$wnnna$aAuditory Hair Cells
=450  \\$wnnna$aHair Cell, Auditory
=450  \\$wnnoa$aHair Cells$5IEN-M
=550  \\$wg$aNeuroepithelial Cells
=550  \\$wg$aNeurons, Afferent
=550  \\$wg$aOrgan of Corti
=550  \\$wh$aHair Cells, Auditory, Inner
=550  \\$wh$aHair Cells, Auditory, Outer
=550  \\$aStereocilia
=680  \\$iSensory cells in the organ of Corti, characterized by their apical stereocilia (hair-like projections). The inner and outer hair cells, as defined by their proximity to the core of spongy bone (the modiolus), change morphologically along the COCHLEA. Towards the cochlear apex, the length of hair cell bodies and their apical STEREOCILIA increase, allowing differential responses to various frequencies of sound.
=688  \\$a2008 (1977)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Hair Cells
=688  \\$a80(77); was see under MECHANORECEPTORS 1977-79
=750  \0$aHair cells$0(DLC) sh 95005808$5IEN-M

=LDR  01065cz  a2200313n  4500
=001  9880363378702441
=005  20200409145056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006197
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA17.$x360
=150  \\$aHair
=450  \\$aFetal Hair
=450  \\$wnnna$aFetal Hairs
=450  \\$wnnna$aFur, Animal
=450  \\$aHair, Fetal
=450  \\$wnnna$aHairs
=450  \\$wnnna$aHairs, Fetal
=450  \\$aLanugo
=550  \\$wg$aIntegumentary System
=550  \\$wh$aAnimal Fur
=550  \\$wh$aEyebrows
=550  \\$wh$aEyelashes
=550  \\$wh$aHair Follicle
=550  \\$wh$aWool
=667  \\$aabnormally pulling at one's hair = TRICHOTILLOMANIA; HAIR FOLLICLE is available
=680  \\$iA filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.
=688  \\$aLANUGO was see under HAIR 1963-78
=750  \0$aHair$5IEN$0(DLC)sh 85058305

=LDR  00849cz  a2200265n  4500
=001  9880363378802441
=005  20141212201907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006196
=035  \\$aCAZ9364M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x400.$x380
=072  \\$aB1.$x50.$x150.$x900.$x493.$x516
=072  \\$aB1.$x50.$x500.$x272.$x400.$x380
=150  \\$aHagfishes
=450  \\$wnnna$aHagfish
=450  \\$wnnna$aHagfishe
=450  \\$wnnna$aHagfishs
=450  \\$wnnna$aMyxiniforme
=450  \\$wnnna$aMyxiniformes
=550  \\$wg$aFishes
=550  \\$wg$aHyperotreti
=680  \\$iCommon name for a family of eel-shaped jawless fishes (Myxinidae), the only family in the order MYXINIFORMES. They are not true vertebrates.
=688  \\$a2002 (1975)
=750  \0$aHagfishes$5IEN-M$0(DLC)sh 85058255

=LDR  01110cz  a2200373n  4500
=001  9880363194402441
=005  20141212195342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001862
=035  \\$aCAZ5027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x264
=072  \\$aG11.$x427.$x590.$x195.$x150
=150  \\$aBone Resorption
=450  \\$aBone Loss, Osteoclastic
=450  \\$wnnna$aBone Losses, Osteoclastic
=450  \\$wnnna$aBone Resorptions
=450  \\$wnnna$aLoss, Osteoclastic Bone
=450  \\$wnnna$aLosses, Osteoclastic Bone
=450  \\$aOsteoclastic Bone Loss
=450  \\$wnnna$aOsteoclastic Bone Losses
=450  \\$wnnna$aResorption, Bone
=450  \\$wnnna$aResorptions, Bone
=550  \\$wg$aBone Diseases
=550  \\$wg$aBone Remodeling
=550  \\$wh$aAinhum
=550  \\$wh$aAlveolar Bone Loss
=550  \\$wh$aOsteolysis
=550  \\$aAlveolar Bone Loss
=550  \\$aOsteoclasts
=667  \\$ause Cat C qualif
=680  \\$iBone loss due to osteoclastic activity.
=688  \\$a65(64)
=750  \0$aBone resorption$5IEN$0(DLC)sh 85015529

=LDR  01029cz  a2200265n  4500
=001  9880363194502441
=005  20141212195342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001861
=035  \\$aCAZ5026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x195.$x140
=072  \\$aG16.$x100.$x856.$x150.$x150
=150  \\$aBone Regeneration
=450  \\$wnnna$aBone Regenerations
=450  \\$wnnna$aOsteoconduction
=450  \\$wnnna$aRegeneration, Bone
=450  \\$wnnna$aRegenerations, Bone
=550  \\$wg$aBone Remodeling
=550  \\$wh$aOsseointegration
=550  \\$aBone Density Conservation Agents
=667  \\$anot for callus formation (= BONY CALLUS with required qualifiers); not for fracture healing (= FRACTURE HEALING); do not confuse OSTEOCONDUCTION with BONE CONDUCTION
=680  \\$iRenewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone.
=688  \\$a65
=750  \0$aBone regeneration$5IEN$0(DLC)sh 85015528

=LDR  00805cz  a2200229n  4500
=001  9880363194602441
=005  20141212192027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001860
=035  \\$aCAZ5025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x370.$x374
=072  \\$aE7.$x858.$x442.$x660.$x460.$x374
=072  \\$aE7.$x858.$x690.$x725.$x460.$x374
=150  \\$aBone Plates
=450  \\$wnnna$aBone Plate
=450  \\$wnnna$aPlate, Bone
=450  \\$wnnna$aPlates, Bone
=550  \\$wg$aInternal Fixators
=680  \\$iImplantable fracture fixation devices attached to bone fragments with screws to bridge the fracture gap and shield the fracture site from stress as bone heals. (UMDNS, 1999)
=688  \\$a74(71)
=750  \0$aBone plates (Orthopedics)$5IEN$0(DLC)sh 85015526

=LDR  01109cz  a2200325n  4500
=001  9880363194702441
=005  20141212195341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001859
=035  \\$aCAZ5024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149
=072  \\$aC5.$x116.$x231
=150  \\$aBone Neoplasms
=450  \\$aBone Cancer
=450  \\$wnnna$aBone Neoplasm
=450  \\$aCancer of Bone
=450  \\$wnnna$aCancer of the Bone
=450  \\$wnnna$aNeoplasm, Bone
=450  \\$wnnna$aNeoplasms, Bone
=550  \\$wg$aBone Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aAdamantinoma
=550  \\$wh$aFemoral Neoplasms
=550  \\$wh$aSkull Neoplasms
=550  \\$wh$aSpinal Neoplasms
=667  \\$aGEN: prefer specific precoord; do not confuse with NEOPLASMS, BONE TISSUE (neopl composed of bone tissue); coord IM with specific bone (IM) + histol type of neopl (IM)
=680  \\$iTumors or cancer located in bone tissue or specific BONES.
=750  \0$aBones$xCancer$5IEN-M$0(DLC)sh 85015544
=750  \0$aBones$xTumors$5IEN-HS$0(DLC)sh 85015553

=LDR  00942cz  a2200313n  4500
=001  9880363194802441
=005  20141212192027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001858
=035  \\$aCAZ5023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x370.$x249
=072  \\$aE7.$x858.$x442.$x660.$x460.$x249
=072  \\$aE7.$x858.$x690.$x725.$x460.$x249
=150  \\$aBone Nails
=450  \\$wnnna$aBone Nail
=450  \\$wnnna$aBone Pin
=450  \\$aBone Pins
=450  \\$wnnna$aNail, Bone
=450  \\$wnnna$aNails, Bone
=450  \\$wnnna$aPin, Bone
=450  \\$wnnna$aPins, Bone
=550  \\$wg$aInternal Fixators
=550  \\$aBone Screws
=550  \\$aBone Wires
=667  \\$anote X ref BONE PINS
=680  \\$iRods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.
=688  \\$a74(71)
=750  \0$aBone nails (Orthopedics)$5IEN$0(DLC)sh 85015525

=LDR  00745cz  a2200229n  4500
=001  9880363194902441
=005  20141212195341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001856
=035  \\$aCAZ5021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x135
=072  \\$aE5.$x200.$x625.$x135
=150  \\$aBone Marrow Examination
=450  \\$wnnna$aBone Marrow Examinations
=450  \\$wnnna$aExamination, Bone Marrow
=450  \\$wnnna$aExaminations, Bone Marrow
=550  \\$wg$aHematologic Tests
=550  \\$aBone Marrow Cells
=667  \\$aNIM; DF: BONE MARROW EXAM
=680  \\$iRemoval of bone marrow and evaluation of its histologic picture.
=750  \0$aBone marrow$xExamination$5IEN$0(DLC)sh 85081541

=LDR  00888cz  a2200277n  4500
=001  9880363195002441
=005  20141212195341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001855
=035  \\$aCAZ5020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x190
=150  \\$aBone Marrow Diseases
=450  \\$wnnna$aBone Marrow Disease
=450  \\$wnnna$aDisease, Bone Marrow
=450  \\$wnnna$aDiseases, Bone Marrow
=450  \\$wnnna$aMarrow Disease, Bone
=450  \\$wnnna$aMarrow Diseases, Bone
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aAnemia, Aplastic
=550  \\$wh$aBone Marrow Neoplasms
=550  \\$wh$aMyelodysplastic-Myeloproliferative Diseases
=550  \\$wh$aMyelodysplastic Syndromes
=550  \\$wh$aMyeloproliferative Disorders
=667  \\$ainflamm dis = OSTEOMYELITIS
=750  \0$aBone marrow$xDiseases$5IEN$0(DLC)sh 85081540

=LDR  01117cz  a2200337n  4500
=001  9880363195102441
=005  20141212195340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001854
=035  \\$aCAZ5019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x148
=072  \\$aA15.$x378.$x316
=150  \\$aBone Marrow Cells
=450  \\$wnnna$aBone Marrow Cell
=450  \\$aBone Marrow$xcytology
=450  \\$wnnna$aCell, Bone Marrow
=450  \\$wnnna$aCells, Bone Marrow
=450  \\$wnnna$aMarrow Cell, Bone
=450  \\$wnnna$aMarrow Cells, Bone
=550  \\$wg$aCells
=550  \\$wg$aHematopoietic System
=550  \\$wh$aEndothelial Progenitor Cells
=550  \\$wh$aGranulocytes
=550  \\$wh$aHematopoietic Stem Cells
=550  \\$wh$aMegakaryocytes
=550  \\$wh$aMonocytes
=550  \\$wh$aReticulocytes
=680  \\$iCells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
=688  \\$a98; 65-77, use explode 1978-97
=750  \0$aBone marrow cells$5IEN-M$0(DLC)sh 85081545

=LDR  01510cz  a2200265n  4500
=001  9880363195202441
=005  20141212195340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001853
=035  \\$aCAZ5018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x382.$x216
=150  \\$aBone Marrow
=360  \\$iconsider also terms at$aMYEL-
=450  \\$aMarrow
=450  \\$wnnna$aMarrow, Bone
=450  \\$wnnna$aMarrow, Red
=450  \\$wnnna$aMarrow, Yellow
=450  \\$aRed Marrow
=450  \\$aYellow Marrow
=550  \\$wg$aImmune System
=667  \\$a/cytol = BONE MARROW CELLS; /transpl = BONE MARROW TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS; inflammation = OSTEOMYELITIS; fibrosis = MYELOFIBROSIS; do not confuse words containing "myel-" for spinal cord with "myel-" for bone marrow
=680  \\$iThe soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
=688  \\$a65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89
=750  \0$aBone marrow$5IEN$0(DLC)sh 85081538

=LDR  01047cz  a2200241n  4500
=001  9880363195302441
=005  20141212195339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001852
=035  \\$aCAZ5017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x120
=150  \\$aBone Lengthening
=450  \\$wnnna$aLengthening, Bone
=550  \\$wg$aOrthopedic Procedures
=550  \\$wh$aIlizarov Technique
=550  \\$wh$aOsteogenesis, Distraction
=550  \\$aLeg Length Inequality
=550  \\$aTissue Expansion
=667  \\$anot restricted to long bones; coordinate IM with specific bone /surg (IM) or specific disease /surg (IM)
=680  \\$iIncrease in the longest dimension of a bone to correct anatomical deficiencies, congenital, traumatic, or as a result of disease. The lengthening is not restricted to long bones. The usual surgical methods are internal fixation and distraction.
=688  \\$a72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66)
=750  \0$aBone lengthening (Orthopedics)$5IEN$0(DLC)sh 90003762

=LDR  01018cz  a2200325n  4500
=001  9880363195402441
=005  20141212195339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001851
=035  \\$aCAZ5016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198
=150  \\$aBone Diseases, Metabolic
=450  \\$wnnna$aBone Disease, Metabolic
=450  \\$wnnna$aDisease, Metabolic Bone
=450  \\$wnnna$aDiseases, Metabolic Bone
=450  \\$wnnna$aMetabolic Bone Disease
=450  \\$wnnna$aMetabolic Bone Diseases
=450  \\$aOsteopenia
=450  \\$wnnna$aOsteopenias
=550  \\$wg$aBone Diseases
=550  \\$wh$aBone Demineralization, Pathologic
=550  \\$wh$aMucolipidoses
=550  \\$wh$aOsteoporosis
=550  \\$wh$aPseudohypoparathyroidism
=550  \\$wh$aRenal Osteodystrophy
=550  \\$wh$aRickets
=688  \\$a80; was NON MESH before 1980
=750  \0$aOsteopenia$5IEN-M$0(DLC)sh 85095982
=750  \0$aBones$xMetabolism$xDisorders$5IEN-HS$0(DLC)sh 89004874

=LDR  01412cz  a2200469n  4500
=001  9880363195502441
=005  20141212195337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001847
=035  \\$aCAZ5012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116
=150  \\$aBone Diseases
=450  \\$wnnna$aBone Disease
=450  \\$wnnna$aDisease, Bone
=450  \\$wnnna$aDiseases, Bone
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aBone Cysts
=550  \\$wh$aBone Diseases, Developmental
=550  \\$wh$aBone Diseases, Endocrine
=550  \\$wh$aBone Diseases, Infectious
=550  \\$wh$aBone Diseases, Metabolic
=550  \\$wh$aBone Malalignment
=550  \\$wh$aBone Neoplasms
=550  \\$wh$aBone Resorption
=550  \\$wh$aCoxa Valga
=550  \\$wh$aEosinophilic Granuloma
=550  \\$wh$aEpiphyses, Slipped
=550  \\$wh$aGenu Valgum
=550  \\$wh$aGenu Varum
=550  \\$wh$aHyperostosis
=550  \\$wh$aOsteitis
=550  \\$wh$aOsteitis Deformans
=550  \\$wh$aOsteoarthropathy, Primary Hypertrophic
=550  \\$wh$aOsteoarthropathy, Secondary Hypertrophic
=550  \\$wh$aOsteochondritis
=550  \\$wh$aOsteochondrosis
=550  \\$wh$aOsteonecrosis
=550  \\$wh$aSpinal Diseases
=667  \\$ainflammatory disease = OSTEITIS
=680  \\$iDiseases of BONES.
=750  \0$aBones$xDiseases$5IEN$0(DLC)sh 85015545

=LDR  01108cz  a2200277n  4500
=001  9880363195602441
=005  20141212195337.0
=008  780621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001846
=035  \\$aCAZ5011HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625.$x100
=072  \\$aG11.$x427.$x590.$x560.$x100
=150  \\$aBone Development
=450  \\$aBone and Bones$xgrowth & development
=450  \\$wnnna$aBone Growth
=550  \\$wg$aMusculoskeletal Development
=550  \\$wh$aCalcification, Physiologic
=550  \\$wh$aMaxillofacial Development
=550  \\$wh$aOsteogenesis
=550  \\$aCalcification, Physiologic
=550  \\$aGrowth Plate
=667  \\$aOSTEOGENESIS is also available
=680  \\$iThe growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
=688  \\$a65
=750  \0$aBones$xGrowth$5IEN$0(DLC)sh 85015514

=LDR  01114cz  a2200253n  4500
=001  9880363195702441
=005  20141212195336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001844
=035  \\$aCAZ5009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x263.$x500
=072  \\$aG11.$x561.$x600.$x810.$x263.$x398
=150  \\$aBone Conduction
=450  \\$wnnna$aBone Conduction Hearing
=450  \\$wnnna$aConduction, Bone
=450  \\$wnnna$aConduction Hearing, Bone
=450  \\$wnnna$aHearing, Bone Conduction
=550  \\$wg$aHearing
=550  \\$aHearing
=667  \\$ado not confuse with OSTEOCONDUCTION
=680  \\$iTransmission of sound waves through vibration of bones in the SKULL to the inner ear (COCHLEA). By using bone conduction stimulation and by bypassing any OUTER EAR or MIDDLE EAR abnormalities, hearing thresholds of the cochlea can be determined. Bone conduction hearing differs from normal hearing which is based on air conduction stimulation via the EAR CANAL and the TYMPANIC MEMBRANE.
=688  \\$a67(64)
=750  \0$aBone conduction$5IEN$0(DLC)sh 85015519

=LDR  01323cz  a2200349n  4500
=001  9880363195802441
=005  20141212195335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001843
=035  \\$aCAZ5008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x822.$x300
=072  \\$aD25.$x720.$x716.$x822.$x300
=072  \\$aD27.$x720.$x102.$x158
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x300
=150  \\$aBone Cements
=450  \\$wnnna$aBone Glue
=450  \\$aBone Glues
=450  \\$wnnna$aBone Paste
=450  \\$aBone Pastes
=450  \\$wnnna$aCements, Bone
=450  \\$wnnna$aGlue, Bone
=450  \\$wnnna$aGlues, Bone
=450  \\$wnnna$aPaste, Bone
=450  \\$wnnna$aPastes, Bone
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aResins, Synthetic
=550  \\$aTissue Adhesives
=667  \\$aIM; coord with specific material if relevant (IM); D25-26 qualif
=680  \\$iAdhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.
=688  \\$a72
=750  \0$aBone cements$5IEN$0(DLC)sh 85015518

=LDR  02092cz  a2200505n  4500
=001  9880363195902441
=005  20180323102838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001842
=035  \\$aCAZ5007HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232
=072  \\$aA10.$x165.$x265
=150  \\$aBone and Bones
=360  \\$iconsider also terms at$aOSSI-$aOSTE-
=450  \\$wnnna$aBone
=450  \\$aBone Tissue
=450  \\$wnnna$aBone Tissues
=450  \\$wnnna$aBones
=450  \\$wnnna$aBones and Bone
=450  \\$wnnna$aBones and Bone Tissue
=450  \\$wnnna$aTissue, Bone
=450  \\$wnnna$aTissues, Bone
=550  \\$wg$aConnective Tissue
=550  \\$wg$aSkeleton
=550  \\$wh$aBone-Implant Interface
=550  \\$wh$aBone Matrix
=550  \\$wh$aBones of Lower Extremity
=550  \\$wh$aBones of Upper Extremity
=550  \\$wh$aBony Callus
=550  \\$wh$aCancellous Bone
=550  \\$wh$aCortical Bone
=550  \\$wh$aDiaphyses
=550  \\$wh$aEpiphyses
=550  \\$wh$aHyoid Bone
=550  \\$wh$aPeriosteum
=550  \\$wh$aRib Cage
=550  \\$wh$aSesamoid Bones
=550  \\$wh$aSkull
=550  \\$wh$aSpine
=667  \\$a/cytol: consider also OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; /embryol: consider also OSTEOGENESIS; /surg: consider also OSTEOTOMY or ARTHRODESIS or FRACTURE FIXATION & its specifics; differentiate from SKELETON which is almost never used: restrict SKELETON to bone arrangement as a whole & not for "skeletal" which usually means "bone" (= BONE AND BONES); inflammation = OSTEITIS; necrosis = OSTEONECROSIS;
=680  \\$iA specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
=688  \\$a/transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89
=750  \0$aBone$5IEN-M$0(DLC)sh 85015512
=750  \0$aBones$5IEN-HS$0(DLC)sh 85015539

=LDR  01148cz  a2200301n  4500
=001  9880363196002441
=005  20141212195334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001840
=035  \\$aCAZ5005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x95
=150  \\$aDental Bonding
=450  \\$aBonding, Dental
=450  \\$aCure of Orthodontic Adhesives
=450  \\$wnnna$aCuring, Dental Cement
=450  \\$wnnna$aDental Cement Curing
=450  \\$wnnna$aOrthodontic Adhesives Cure
=550  \\$wg$aDentistry
=550  \\$wh$aCementation
=550  \\$wh$aLight-Curing of Dental Adhesives
=550  \\$wh$aSelf-Curing of Dental Resins
=550  \\$aDental Materials
=550  \\$aOrthodontic Appliances
=667  \\$ageneral; note specifics; DF: DENT BONDING
=680  \\$iAn adhesion procedure for orthodontic attachments, such as plastic DENTAL CROWNS. This process usually includes the application of an adhesive material (DENTAL CEMENTS) and letting it harden in-place by light or chemical curing.
=688  \\$a91(71); was BONDING, DENTAL 1971-90 (Prov 1971)
=750  \0$aDental bonding$0(DLC) sh 85036867$5IEN

=LDR  01092cz  a2200277n  4500
=001  9880363196102441
=005  20141212195334.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001839
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x100
=072  \\$aD12.$x644.$x400.$x85
=072  \\$aD12.$x644.$x548.$x100
=072  \\$aD12.$x776.$x641.$x650.$x85
=072  \\$aD20.$x888.$x33.$x137
=072  \\$aD23.$x946.$x833.$x33.$x137
=150  \\$aBombesin
=450  \\$wnnna$aBombesin 14
=450  \\$wnnna$aBombesin Dihydrochloride
=450  \\$wnnna$aDihydrochloride, Bombesin
=550  \\$wg$aAmphibian Venoms
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=680  \\$iA tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function.
=688  \\$a86(75); was see under PEPTIDES 1975-85
=750  \0$aBombesin$5IEN$0(DLC)sh 88007757

=LDR  01037cz  a2200337n  4500
=001  9880363196202441
=005  20141212195332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001835
=035  \\$aCAZ5000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120
=072  \\$aE5.$x41.$x124.$x160.$x750
=072  \\$aG7.$x100.$x100.$x160.$x120
=072  \\$aG7.$x700.$x320.$x249.$x314.$x120
=150  \\$aBody Weight
=450  \\$wnnna$aBody Weights
=450  \\$wnnna$aWeight, Body
=450  \\$wnnna$aWeights, Body
=550  \\$wg$aBody Size
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aBirth Weight
=550  \\$wh$aBody Weight Changes
=550  \\$wh$aFetal Weight
=550  \\$wh$aIdeal Body Weight
=550  \\$wh$aOverweight
=550  \\$wh$aThinness
=550  \\$aObesity
=680  \\$iThe mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
=750  \0$aBody weight$5IEN$0(DLC)sh 85015259

=LDR  00600cz  a2200217n  4500
=001  9880363196302441
=005  20141212195332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001834
=035  \\$aCAZ4999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x200
=150  \\$aBody Water
=450  \\$wnnna$aBody Waters
=450  \\$wnnna$aWater, Body
=450  \\$wnnna$aWaters, Body
=550  \\$wg$aBody Fluids
=550  \\$aWater
=667  \\$ado not confuse with EXTRACELLULAR FLUID see EXTRACELLULAR SPACE
=688  \\$a74(72)
=750  \0$aWater in the body$5IEN$0(DLC)sh 85145573

=LDR  01240cz  a2200385n  4500
=001  9880363196402441
=005  20141212195332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001833
=035  \\$aCAZ4998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x110.$x232
=072  \\$aG7.$x700.$x345.$x421
=072  \\$aG16.$x100.$x57.$x500.$x535
=150  \\$aBody Temperature Regulation
=450  \\$wnnna$aBody Temperature Regulations
=450  \\$aHeat Loss
=450  \\$wnnna$aHeat Losses
=450  \\$wnnna$aLoss, Heat
=450  \\$wnnna$aLosses, Heat
=450  \\$wnnna$aRegulation, Body Temperature
=450  \\$wnnna$aRegulations, Body Temperature
=450  \\$wnnna$aTemperature Regulation, Body
=450  \\$wnnna$aTemperature Regulations, Body
=450  \\$aThermoregulation
=450  \\$wnnna$aThermoregulations
=550  \\$wg$aAdaptation, Physiological
=550  \\$wg$aBody Temperature
=550  \\$wg$aHomeostasis
=550  \\$wh$aSweating
=550  \\$wh$aThermogenesis
=550  \\$wh$aTorpor
=550  \\$aThermoreceptors
=680  \\$iThe processes of heating and cooling that an organism uses to control its temperature.
=750  \0$aBody temperature$xRegulation$5IEN$0(DLC)sh 85015258

=LDR  00917cz  a2200301n  4500
=001  9880363196502441
=005  20141212195331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001831
=035  \\$aCAZ4996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x875.$x374
=072  \\$aG7.$x110
=150  \\$aBody Temperature
=450  \\$wnnna$aBody Temperatures
=450  \\$aOrgan Temperature
=450  \\$wnnna$aOrgan Temperatures
=450  \\$wnnna$aTemperature, Body
=450  \\$wnnna$aTemperature, Organ
=450  \\$wnnna$aTemperatures, Body
=450  \\$wnnna$aTemperatures, Organ
=550  \\$wg$aPhysiological Phenomena
=550  \\$wg$aVital Signs
=550  \\$wh$aBody Temperature Regulation
=550  \\$wh$aSkin Temperature
=550  \\$aTemperature
=680  \\$iThe measure of the level of heat of a human or animal.
=750  \0$aBody temperature$5IEN$0(DLC)sh 85015255

=LDR  00792cz  a2200253n  4500
=001  9880363196602441
=005  20141212195331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001830
=035  \\$aCAZ4995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x231
=072  \\$aE5.$x41.$x124.$x231
=072  \\$aG7.$x100.$x100.$x231
=150  \\$aBody Surface Area
=450  \\$wnnna$aArea, Body Surface
=450  \\$wnnna$aAreas, Body Surface
=450  \\$wnnna$aBody Surface Areas
=450  \\$wnnna$aSurface Area, Body
=450  \\$wnnna$aSurface Areas, Body
=550  \\$wg$aBody Weights and Measures
=680  \\$iThe two dimensional measure of the outer layer of the body.
=688  \\$a70(67)
=750  \0$aBody surface mapping$5IEN$0(DLC)sh 85015254

=LDR  00871cz  a2200301n  4500
=001  9880363196702441
=005  20141212195330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001828
=035  \\$aCAZ4993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x112
=150  \\$aBody Image
=450  \\$wnnna$aBody Images
=450  \\$wnnna$aBody Representation
=450  \\$wnnna$aBody Representations
=450  \\$wnnna$aBody Schema
=450  \\$wnnna$aBody Schemas
=450  \\$wnnna$aImage, Body
=450  \\$wnnna$aImages, Body
=450  \\$wnnna$aRepresentation, Body
=450  \\$wnnna$aRepresentations, Body
=450  \\$wnnna$aSchema, Body
=450  \\$wnnna$aSchemas, Body
=550  \\$wg$aPerception
=550  \\$aSelf Concept
=680  \\$iIndividuals' concept of their own bodies.
=750  \0$aBody image$5IEN$0(DLC)sh 85015249

=LDR  00916cz  a2200265n  4500
=001  9880363196802441
=005  20141212195330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001827
=035  \\$aCAZ4992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x100
=072  \\$aE5.$x41.$x124.$x160.$x500
=072  \\$aG7.$x100.$x100.$x160.$x100
=072  \\$aG7.$x700.$x320.$x249.$x314.$x100
=150  \\$aBody Height
=450  \\$wnnna$aBody Heights
=450  \\$wnnna$aHeight, Body
=450  \\$wnnna$aHeights, Body
=450  \\$aStature$5IEN
=550  \\$wg$aBody Size
=550  \\$wh$aCrown-Rump Length
=667  \\$ahuman only; for height or length of animals use animal /anat (IM) + BIOMETRY (NIM)
=680  \\$iThe distance from the sole to the crown of the head with body standing on a flat surface and fully extended.
=750  \0$aStature$5IEN-M$0(DLC)sh 85127601

=LDR  00798cz  a2200289n  4500
=001  9880363196902441
=005  20180904121339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001826
=035  \\$aCAZ4991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207
=150  \\$aBody Fluids
=450  \\$wnnna$aBody Fluid
=450  \\$wnnna$aFluid, Body
=450  \\$wnnna$aFluids, Body
=550  \\$wg$aFluids and Secretions
=550  \\$wh$aAscitic Fluid
=550  \\$wh$aBlood
=550  \\$wh$aBody Fluid Compartments
=550  \\$wh$aBody Water
=550  \\$wh$aExtracellular Fluid
=550  \\$wh$aIntracellular Fluid
=550  \\$wh$aNipple Discharge
=550  \\$wh$aUrine
=680  \\$iLiquid components of living organisms.
=750  \0$aBody fluids$5IEN$0(DLC)sh 85015244

=LDR  01083cz  a2200289n  4500
=001  9880363197002441
=005  20180316112533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001824
=035  \\$aCAZ4989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115
=072  \\$aG7.$x100
=150  \\$aBody Constitution
=450  \\$wnnna$aBody Constitutions
=450  \\$wnnna$aConstitution, Body
=450  \\$wnnna$aConstitutions, Body
=550  \\$wg$aPhysical Examination
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aBody Composition
=550  \\$wh$aBreast Density
=550  \\$wh$aPhysical Appearance, Body
=550  \\$wh$aBody Weights and Measures
=550  \\$wh$aDisease Susceptibility
=550  \\$wh$aSomatotypes
=680  \\$iThe physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms.
=750  \0$aHuman beings$xConstitution$0(DLC) sh 85080296$5IEN-M

=LDR  00804cz  a2200265n  4500
=001  9880363197102441
=005  20180109095037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001823
=035  \\$aCAZ4988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x130
=072  \\$aG3.$x180
=072  \\$aG7.$x100.$x49
=150  \\$aBody Composition
=450  \\$wnnna$aBody Compositions
=450  \\$wnnna$aComposition, Body
=450  \\$wnnna$aCompositions, Body
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aBody Constitution
=550  \\$wg$aMetabolism
=550  \\$wh$aBody Fat Distribution
=550  \\$aAnthropometry
=680  \\$iThe relative amounts of various components in the body, such as percentage of body fat.
=750  \0$aBody composition$5IEN$0(DLC)sh 85015239

=LDR  00694cz  a2200217n  4500
=001  9880363197202441
=005  20141212195328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001821
=035  \\$aCAZ4986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530.$x136
=072  \\$aF2.$x830.$x158
=150  \\$aBlushing
=450  \\$wnnna$aBlushings
=550  \\$wg$aNonverbal Communication
=550  \\$wg$aPsychophysiology
=550  \\$aFlushing
=667  \\$anote category: do not confuse with FLUSHING
=680  \\$iInvoluntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame.
=750  \0$aBlushing$5IEN$0(DLC)sh 85015124

=LDR  00930cz  a2200241n  4500
=001  9880363197302441
=005  20141212195328.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001820
=035  \\$aCAZ4985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630.$x550.$x100
=072  \\$aB4.$x909.$x777.$x714.$x550.$x100
=150  \\$aBluetongue virus
=450  \\$wnnna$aBlue Tongue Virus
=450  \\$wnnna$aBlue Tongue Viruses
=450  \\$wnnna$aBluetongue Viruses
=450  \\$aOvine Catarrhal Fever Virus
=550  \\$wg$aOrbivirus
=667  \\$ainfection = BLUETONGUE: see note there
=680  \\$iThe type species of ORBIVIRUS causing a serious disease in sheep, especially lambs. It may also infect wild ruminants and other domestic animals.
=688  \\$a94; was BLUE TONGUE VIRUS 1975-93 (see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80)
=750  \0$aBluetongue virus$5IEN$0(DLC)sh 85015118

=LDR  01026cz  a2200253n  4500
=001  9880363197402441
=005  20141212195327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001819
=035  \\$aCAZ4984HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x125
=072  \\$aC2.$x782.$x791.$x315
=072  \\$aC22.$x836.$x120
=150  \\$aBluetongue
=450  \\$wnnna$aBlue Tongue
=450  \\$wnnna$aTongue, Blue
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aReoviridae Infections
=550  \\$wg$aSheep Diseases
=667  \\$acaused by a reovirus; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
=680  \\$iA reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet.
=688  \\$a94; was BLUE TONGUE 1968-93 (Prov 1968-73)
=750  \0$aBluetongue$5IEN$0(DLC)sh 85015117

=LDR  01589cz  a2200445n  4500
=001  9880363197502441
=005  20141212210857.0
=008  880322\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015153
=035  \\$aCAZ4981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x143
=072  \\$aE5.$x301.$x300.$x96
=072  \\$aE5.$x393.$x525.$x262
=072  \\$aE5.$x478.$x566.$x320.$x200
=072  \\$aE5.$x601.$x495.$x320.$x200
=150  \\$aBlotting, Western
=450  \\$wnnna$aBlot, Western
=450  \\$wnnna$aBlots, Western
=450  \\$wnnna$aBlottings, Western
=450  \\$wnnna$aImmunoblot, Western
=450  \\$wnnna$aImmunoblots, Western
=450  \\$aImmunoblotting, Western
=450  \\$wnnna$aImmunoblottings, Western
=450  \\$wnnna$aWestern Blot
=450  \\$wnnna$aWestern Blots
=450  \\$aWestern Blotting
=450  \\$wnnna$aWestern Blottings
=450  \\$wnnna$aWestern Immunoblot
=450  \\$wnnna$aWestern Immunoblots
=450  \\$aWestern Immunoblotting
=450  \\$wnnna$aWestern Immunoblottings
=550  \\$wg$aElectrophoresis
=550  \\$wg$aImmunoblotting
=550  \\$wg$aMolecular Probe Techniques
=550  \\$wh$aBlotting, Far-Western
=667  \\$a"western" is not capitalized in titles or translations
=680  \\$iIdentification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
=688  \\$a89
=750  \0$aWestern immunoblotting$5IEN$0(DLC)sh 88007495

=LDR  00846cz  a2200217n  4500
=001  9880363197602441
=005  20141212195327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001815
=035  \\$aCAZ4977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x800.$x558.$x500
=150  \\$aBloodletting
=450  \\$aBlood-letting$5IEN
=550  \\$wg$aPhlebotomy
=550  \\$aHemorrhage
=550  \\$aLeeching
=550  \\$aPhlebotomy
=667  \\$arestrict to hist articles or hist contexts: modern counterpart is PHLEBOTOMY
=680  \\$iPuncture of a vein to draw blood for therapeutic purposes. Bloodletting therapy has been used in Talmudic and Indian medicine since the medieval time, and was still practiced widely in the 18th and 19th centuries. Its modern counterpart is PHLEBOTOMY.
=750  \0$aPhlebotomy$5IEN$0(DLC)sh 85015033

=LDR  01534cz  a2200409n  4500
=001  9880363197702441
=005  20141212195326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001812
=035  \\$aCAZ4974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x35
=072  \\$aA8.$x186.$x211.$x35
=150  \\$aBlood-Brain Barrier
=450  \\$wnnna$aBarrier, Blood-Brain
=450  \\$wnnna$aBarrier, Brain-Blood
=450  \\$wnnna$aBarrier, Hemato-Encephalic
=450  \\$wnnna$aBarriers, Blood-Brain
=450  \\$wnnna$aBarriers, Brain-Blood
=450  \\$wnnna$aBarriers, Hemato-Encephalic
=450  \\$wnnna$aBlood Brain Barrier
=450  \\$wnnna$aBlood-Brain Barriers
=450  \\$aBrain-Blood Barrier
=450  \\$wnnna$aBrain Blood Barrier
=450  \\$wnnna$aBrain-Blood Barriers
=450  \\$aHemato-Encephalic Barrier
=450  \\$wnnna$aHemato Encephalic Barrier
=450  \\$wnnna$aHemato-Encephalic Barriers
=550  \\$wg$aBrain
=550  \\$wg$aCardiovascular System
=550  \\$aAstrocytes
=550  \\$aCapillary Permeability
=550  \\$aCerebrospinal Fluid
=667  \\$acoord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
=680  \\$iSpecialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.
=688  \\$a66; was HEMATO-ENCEPHALIC BARRIER 1963-65
=750  \0$aBlood-brain barrier$5IEN$0(DLC)sh 85014964

=LDR  01752cz  a2200397n  4500
=001  9880363197802441
=005  20141212195237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001682
=035  \\$aCAZ4841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x787.$x151
=072  \\$aG7.$x690.$x725.$x129
=150  \\$aBiological Availability
=450  \\$wnnna$aAvailabilities, Biologic
=450  \\$wnnna$aAvailabilities, Biological
=450  \\$wnnna$aAvailabilities, Physiologic
=450  \\$wnnna$aAvailability, Biologic
=450  \\$wnnna$aAvailability, Biological
=450  \\$wnnna$aAvailability Equivalencies
=450  \\$aAvailability Equivalency
=450  \\$wnnna$aAvailability, Physiologic
=450  \\$wnnna$aBioavailabilities
=450  \\$aBioavailability
=450  \\$wnnna$aBiologic Availabilities
=450  \\$wnnna$aBiologic Availability
=450  \\$wnnna$aBiological Availabilities
=450  \\$wnnna$aEquivalencies, Availability
=450  \\$wnnna$aEquivalency, Availability
=450  \\$wnnna$aPhysiologic Availabilities
=450  \\$aPhysiologic Availability
=550  \\$wg$aPharmacokinetics
=667  \\$aNIM with specific drug /pharmacokin (IM); no qualif; DF: BIOL AVAILABILITY
=680  \\$iThe extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.
=688  \\$a79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86
=750  \0$aBioavailability$5IEN$0(DLC)sh 88003406

=LDR  01336cz  a2200289n  4500
=001  9880363197902441
=005  20141212195237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001681
=035  \\$aCAZ4840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x91
=150  \\$aBiological Assay
=450  \\$wnnna$aAssay, Biologic
=450  \\$wnnna$aAssay, Biological
=450  \\$wnnna$aAssays, Biologic
=450  \\$wnnna$aAssays, Biological
=450  \\$aBioassay
=450  \\$wnnna$aBioassays
=450  \\$wnnna$aBiologic Assay
=450  \\$wnnna$aBiologic Assays
=450  \\$wnnna$aBiological Assays
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aLimulus Test
=667  \\$aassays using living-matter intermediate; check text: not all "bioassays" are MeSH term BIOLOGICAL ASSAY; Manual 22.27; DF: BIOL ASSAY
=680  \\$iA method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.
=750  \0$aBiological assay$5IEN$0(DLC)sh 85014169

=LDR  01071cz  a2200253n  4500
=001  9880363198102441
=005  20141212195236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001679
=035  \\$aCAZ4836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211
=150  \\$aBiogenic Amines
=450  \\$wnnna$aAmine, Biogenic
=450  \\$aAmines, Biogenic
=450  \\$wnnna$aBiogenic Amine
=550  \\$wg$aAmines
=550  \\$wh$aAcetylcholine
=550  \\$wh$aBiogenic Monoamines
=550  \\$wh$aBiogenic Polyamines
=667  \\$aGEN or unspecified: prefer specific biogenic amine group term or specific biogenic amine indented under each
=680  \\$iA group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.
=688  \\$a73(71)
=750  \0$aBiogenic amines$5IEN$0(DLC)sh 85014143

=LDR  01022cz  a2200289n  4500
=001  9880363198202441
=005  20170609105740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001678
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x618
=072  \\$aG16.$x645
=150  \\$aOrganelle Biogenesis
=450  \\$wnnna$aBiogenesis, Mitochondrial
=450  \\$wnnna$aBiogeneses, Organelle
=450  \\$wnnna$aBiogenesis, Organelle
=450  \\$wnnna$aMitochondrial Biogenesis
=450  \\$wnnna$aOrganelle Biogeneses
=450  \\$wnnna$aOrganelle Biogenesis
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aCell Physiological Phenomena
=550  \\$aEvolution, Chemical
=550  \\$aOrigin of Life
=667  \\$adistinguish from biogenesis in the context of ORIGIN OF LIFE
=680  \\$iThe natural growth and development within living CELLS
=688  \\$a2016(1979); for BIOGENESIS, MITOCHONDRIAL use MITOCHONDRIAL TURNOVER 2013-2015
=750  \2$aCell organelles$xFormation$0(DLC)sh 88004690$5IEN-M

=LDR  02326cz  a2200601n  4500
=001  9880363198302441
=005  20141212195235.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001676
=035  \\$aCAZ4833HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x123
=072  \\$aF2.$x830.$x131
=072  \\$aF4.$x754.$x137.$x301
=072  \\$aF4.$x754.$x308.$x500
=072  \\$aL1.$x143.$x283.$x425.$x624.$x500
=150  \\$aBiofeedback, Psychology
=450  \\$wnnna$aBiofeedback
=450  \\$aBiofeedback (Psychology)
=450  \\$wnnna$aBiofeedbacks
=450  \\$wnnna$aBiofeedbacks (Psychology)
=450  \\$wnnna$aBiofeedbacks, Psychology
=450  \\$aBogus Physiological Feedback
=450  \\$wnnna$aBogus Physiological Feedbacks
=450  \\$aFalse Physiological Feedback
=450  \\$wnnna$aFalse Physiological Feedbacks
=450  \\$wnnna$aFeedback, Bogus Physiological
=450  \\$wnnna$aFeedback, False Physiological
=450  \\$aFeedback, Psychophysiologic
=450  \\$wnnna$aFeedback, Psychophysiological
=450  \\$wnnna$aFeedbacks, Bogus Physiological
=450  \\$wnnna$aFeedbacks, False Physiological
=450  \\$wnnna$aMyofeedback
=450  \\$wnnna$aMyofeedbacks
=450  \\$wnnna$aPhysiological Feedback, Bogus
=450  \\$wnnna$aPhysiological Feedback, False
=450  \\$wnnna$aPhysiological Feedbacks, Bogus
=450  \\$wnnna$aPhysiological Feedbacks, False
=450  \\$wnnna$aPsychology Biofeedback
=450  \\$wnnna$aPsychology Biofeedbacks
=450  \\$wnnna$aPsychophysiologic Feedback
=550  \\$wg$aBehavior Therapy
=550  \\$wg$aFeedback, Psychological
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPsychophysiology
=550  \\$wh$aFeedback, Sensory
=550  \\$wh$aNeurofeedback
=550  \\$aFeedback
=667  \\$aFEEDBACK, PSYCHOLOGICAL is also available
=680  \\$iThe therapy technique of providing the status of one's own AUTONOMIC NERVOUS SYSTEM function (e.g., skin temperature, heartbeats, brain waves) as visual or auditory feedback in order to self-control related conditions (e.g., hypertension, migraine headaches).
=688  \\$a77
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Biofeedback (Psychology)
=750  \0$aBiofeedback training$0(DLC) sh 85014139$5IEN

=LDR  00917cz  a2200265n  4500
=001  9880363198402441
=005  20141212195234.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001675
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x70
=072  \\$aN5.$x350.$x200
=150  \\$aBioethics
=450  \\$wnnna$aBiomedical Ethics
=450  \\$wnnna$aEthics, Biomedical
=450  \\$wnnna$aEthics, Health Care
=450  \\$wnnna$aHealth Care Ethics
=550  \\$wg$aEthics
=550  \\$wh$aEthics, Clinical
=550  \\$aEthicists
=550  \\$aEthics, Medical
=667  \\$aSPEC only; for issues in bioethics use BIOETHICAL ISSUES or its specifics; ETHICISTS is also available
=680  \\$iA branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.
=688  \\$a78
=750  \0$aBioethics$5IEN$0(DLC)sh 85014136

=LDR  01190cz  a2200277n  4500
=001  9880363198502441
=005  20141212192023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001673
=035  \\$aCAZ4830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x80.$x600.$x500
=072  \\$aN6.$x850.$x460.$x375.$x500
=150  \\$aBiodegradation, Environmental
=450  \\$aBioremediation
=450  \\$wnnna$aEnvironmental Biodegradation
=450  \\$wnnna$aNatural Attenuation, Pollution
=450  \\$aPhytoremediation
=450  \\$wnnna$aPollution Natural Attenuation
=550  \\$wg$aEnvironmental Restoration and Remediation
=667  \\$aNIM when specific substance is IM; do not confuse with BIOTRANSFORMATION: see note there; for PHYTOREMEDIATION coordinate with PLANTS
=680  \\$iElimination of ENVIRONMENTAL POLLUTANTS; PESTICIDES and other waste using living organisms, usually involving intervention of environmental or sanitation engineers.
=688  \\$a2007(1969)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Biodegradation
=688  \\$a78(69); was see under SANITARY ENGINEERING 1975-77
=750  \0$aBioremediation$0(DLC) sh 89005627$5IEN

=LDR  01010cz  a2200301n  4500
=001  9880363198602441
=005  20141212195233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x130
=072  \\$aD27.$x720.$x102.$x130
=072  \\$aJ1.$x637.$x51.$x130
=150  \\$aBiocompatible Materials
=450  \\$aBiomaterials
=450  \\$wnnna$aHemocompatible Materials
=450  \\$wnnna$aMaterials, Biocompatible
=450  \\$wnnna$aMaterials, Hemocompatible
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wh$aBone Substitutes
=550  \\$wh$aCoated Materials, Biocompatible
=550  \\$wh$aPolydioxanone
=550  \\$aBiomimetic Materials
=550  \\$aMaterials Testing
=550  \\$aRegenerative Medicine
=680  \\$iSynthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.
=688  \\$a73(72)
=750  \0$aBiocompatibility$5IEN-HS$0(DLC)sh 86004343

=LDR  01111cz  a2200313n  4500
=001  9880363198702441
=005  20141212195233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001671
=035  \\$aCAZ4828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201
=072  \\$aH1.$x181.$x122
=150  \\$aBiochemistry
=550  \\$wg$aBiological Science Disciplines
=550  \\$wg$aChemistry
=550  \\$wh$aCarbohydrate Biochemistry
=550  \\$wh$aChemistry, Bioinorganic
=550  \\$wh$aGlycomics
=550  \\$wh$aHistocytochemistry
=550  \\$wh$aImmunochemistry
=550  \\$wh$aMetabolomics
=550  \\$wh$aMolecular Biology
=550  \\$wh$aNeurochemistry
=550  \\$wh$aProteomics
=667  \\$athe discipline (education, history, etc) only; use BIOCHEMICAL PHENOMENA or specifics treed under it for chemical processes and reactions of biological systems
=680  \\$iThe study of the composition, chemical structures, and chemical reactions of living things.
=750  \0$aBiochemistry$5IEN-HS$0(DLC)sh 85014171
=750  \0$aBiochemists$5IEN-HS$0(DLC)sh 85014126

=LDR  00819cz  a2200205n  4500
=001  9880363198802441
=005  20141212195232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001668
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x99.$x434
=072  \\$aL1.$x453.$x183.$x392
=150  \\$aBiobibliography as Topic
=450  \\$wnnna$aBiobibliography as Topics
=550  \\$wg$aBibliography as Topic
=667  \\$afor biobibliography of a biographee coordinate NIM with the Publication Type BIBLIOGRAPHY; do not confuse with the Publication Type BIOBIBLIOGRAPHY
=680  \\$iA biography which includes a list of the writings of the subject person.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Biobibliography
=750  \0$aBio-bibliography$0(DLC) sh 85014117$5IEN

=LDR  01259cz  a2200349n  4500
=001  9880363198902441
=005  20141212195231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001665
=035  \\$aCAZ4822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x120
=150  \\$aBinding Sites
=450  \\$wnnna$aBinding Site
=450  \\$aCombining Site
=450  \\$wnnna$aCombining Sites
=450  \\$wnnna$aSite, Binding
=450  \\$wnnna$aSite, Combining
=450  \\$wnnna$aSites, Binding
=450  \\$wnnna$aSites, Combining
=550  \\$wg$aMolecular Structure
=550  \\$wh$aAllosteric Site
=550  \\$wh$aBay-Region, Polycyclic Aromatic Hydrocarbon
=550  \\$wh$aBinding, Competitive
=550  \\$wh$aBinding Sites, Antibody
=550  \\$wh$aCatalytic Domain
=550  \\$aProtein Binding
=550  \\$aProtein Interaction Mapping
=667  \\$ausually NIM; do not use as substitute for chemistry or metabolic mechanism of binding; do not coordinate with receptors terms unless specifically discussed
=680  \\$iThe parts of a macromolecule that directly participate in its specific combination with another molecule.
=688  \\$a68
=750  \0$aBinding sites (Biochemistry)$5IEN$0(DLC)sh 85014090

=LDR  01387cz  a2200409n  4500
=001  9880363199002441
=005  20141212195230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001663
=035  \\$aCAZ4820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x249.$x184
=072  \\$aD3.$x549.$x909.$x249.$x184
=072  \\$aD4.$x345.$x783.$x249.$x184
=072  \\$aD23.$x767.$x193.$x184
=150  \\$aBilirubin
=450  \\$wnnna$aBilirubin, (15E)-Isomer
=450  \\$wnnna$aBilirubin, (4E,15E)-Isomer
=450  \\$wnnna$aBilirubin, (4E)-Isomer
=450  \\$wnnna$aBilirubin, Calcium Salt
=450  \\$wnnna$aBilirubin, Disodium Salt
=450  \\$wnnna$aBilirubin IX alpha
=450  \\$wnnna$aBilirubin, Monosodium Salt
=450  \\$wnnna$aBilirubinate, Calcium
=450  \\$wnnna$aCalcium Bilirubinate
=450  \\$wnnna$aCalcium Salt Bilirubin
=450  \\$wnnna$adelta-Bilirubin
=450  \\$wnnna$adelta Bilirubin
=450  \\$wnnna$aDisodium Salt Bilirubin
=450  \\$wnnna$aHematoidin
=450  \\$wnnna$aMonosodium Salt Bilirubin
=450  \\$wnnna$aSalt Bilirubin, Calcium
=550  \\$wg$aBile Pigments
=550  \\$wh$aBiliverdine
=667  \\$aBILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available
=680  \\$iA bile pigment that is a degradation product of HEME.
=750  \0$aBilirubin$5IEN$0(DLC)sh 85014033

=LDR  01396cz  a2200373n  4500
=001  9880363199102441
=005  20141212195230.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001662
=035  \\$aCAZ4819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x120
=150  \\$aBiliary Tract Surgical Procedures
=450  \\$wnnna$aBiliary Surgical Procedure
=450  \\$aBiliary Surgical Procedures
=450  \\$aBiliary Tract$xsurgery
=450  \\$wnnoa$aBiliary Tract Surgery$5IEN
=450  \\$wnnna$aBiliary Tract Surgical Procedure
=450  \\$wnnna$aSurgical Procedure, Biliary
=450  \\$wnnna$aSurgical Procedure, Biliary Tract
=450  \\$wnnna$aSurgical Procedures, Biliary
=450  \\$wnnna$aSurgical Procedures, Biliary Tract
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wh$aBiliopancreatic Diversion
=550  \\$wh$aCholecystectomy
=550  \\$wh$aCholecystostomy
=550  \\$wh$aCholedochostomy
=550  \\$wh$aPortoenterostomy, Hepatic
=550  \\$wh$aSphincterotomy, Endoscopic
=550  \\$wh$aSphincterotomy, Transhepatic
=667  \\$aGEN only: prefer specific organ with /surg or specific biliary surg technique; do not use /util except by MeSH definition.
=680  \\$iAny surgical procedure performed on the biliary tract.
=688  \\$a98(88)
=750  \0$aBiliary tract$xSurgery$5IEN$0(DLC)sh 85014025

=LDR  01238cz  a2200361n  4500
=001  9880363199202441
=005  20141212195230.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001661
=035  \\$aCAZ4818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x120
=072  \\$aC6.$x130.$x320
=072  \\$aC6.$x301.$x120
=150  \\$aBiliary Tract Neoplasms
=450  \\$aBiliary Tract Cancer
=450  \\$wnnna$aBiliary Tract Cancers
=450  \\$wnnna$aBiliary Tract Neoplasm
=450  \\$wnnna$aCancer, Biliary Tract
=450  \\$aCancer of Biliary Tract
=450  \\$wnnna$aCancer of the Biliary Tract
=450  \\$wnnna$aCancers, Biliary Tract
=450  \\$wnnna$aNeoplasm, Biliary Tract
=450  \\$wnnna$aNeoplasms, Biliary Tract
=550  \\$wg$aBiliary Tract Diseases
=550  \\$wg$aDigestive System Neoplasms
=550  \\$wh$aBile Duct Neoplasms
=550  \\$wh$aGallbladder Neoplasms
=667  \\$aGEN: prefer specifics; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
=688  \\$a80
=750  \0$aBiliary tract$xTumors$5IEN-M
=750  \0$aBiliary tract$xCancer$5IEN-HS$0(DLC)sh2010008259

=LDR  01260cz  a2200313n  4500
=001  9880363199302441
=005  20141212195229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001660
=035  \\$aCAZ4817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130
=150  \\$aBiliary Tract Diseases
=450  \\$wnnna$aBiliary Tract Disease
=450  \\$wnnna$aDisease, Biliary Tract
=450  \\$wnnna$aDiseases, Biliary Tract
=450  \\$wnnna$aTract Disease, Biliary
=450  \\$wnnna$aTract Diseases, Biliary
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aBile Duct Diseases
=550  \\$wh$aBile Reflux
=550  \\$wh$aBiliary Tract Neoplasms
=550  \\$wh$aCholelithiasis
=550  \\$wh$aGallbladder Diseases
=550  \\$wh$aPostcholecystectomy Syndrome
=667  \\$aGEN: prefer specifics; biliary empyema = EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) or if of gallbladder, EMPYEMA, GALLBLADDER see CHOLECYSTITIS; inflamm dis = CHOLECYSTITIS or CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS
=680  \\$iDiseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
=688  \\$a66
=750  \0$aBiliary tract$xDiseases$5IEN$0(DLC)sh 85014022

=LDR  01077cz  a2200253n  4500
=001  9880363199402441
=005  20141212195229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001659
=035  \\$aCAZ4816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159
=150  \\$aBiliary Tract
=450  \\$wnnna$aBiliary System
=450  \\$wnnna$aBiliary Tree
=450  \\$wnnna$aSystem, Biliary
=450  \\$wnnna$aTract, Biliary
=450  \\$wnnna$aTree, Biliary
=550  \\$wg$aDigestive System
=550  \\$wh$aBile Ducts
=550  \\$wh$aGallbladder
=667  \\$a/abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray & CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS; empyema = EMPYEMA, GALLBLADDER see CHOLECYSTITIS or EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) if not of gallbladder; inflammation = CHOLECYSTITIS or CHOLANGITIS
=680  \\$iThe BILE DUCTS and the GALLBLADDER.
=750  \0$aBiliary tract$5IEN$0(DLC)sh 85014021

=LDR  00771cz  a2200217n  4500
=001  9880363199502441
=005  20141212195228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001658
=035  \\$aCAZ4815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x150
=072  \\$aC23.$x300.$x575.$x185.$x150
=150  \\$aBiliary Fistula
=450  \\$wnnna$aBiliary Fistulas
=450  \\$wnnna$aFistula, Biliary
=450  \\$wnnna$aFistulas, Biliary
=550  \\$wg$aDigestive System Fistula
=667  \\$acoord IM with specific precoord biliary tract/dis heading (IM); fistula policy: Manual 23.19+
=680  \\$iAbnormal passage in any organ of the biliary tract or between biliary organs and other organs.
=750  \0$aFistula, Biliary$5IEN$0(DLC)sh 85048895

=LDR  01317cz  a2200325n  4500
=001  9880363199602441
=005  20141212195228.0
=008  860403\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001656
=035  \\$aCAZ4813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x120.$x123
=072  \\$aC6.$x198.$x125
=072  \\$aC16.$x131.$x314.$x125
=150  \\$aBiliary Atresia
=450  \\$aAtresia, Biliary
=450  \\$wnnna$aAtresia, Extrahepatic Biliary
=450  \\$wnnna$aAtresias, Extrahepatic Biliary
=450  \\$wnnna$aBiliary Atresia, Extrahepatic
=450  \\$wnnna$aBiliary Atresias, Extrahepatic
=450  \\$wnnna$aExtrahepatic Biliary Atresia
=450  \\$wnnna$aExtrahepatic Biliary Atresias
=450  \\$wnnna$aFamilial Extrahepatic Biliary Atresia
=450  \\$wnnna$aIdiopathic Extrahepatic Biliary Atresia
=550  \\$wg$aBile Duct Diseases
=550  \\$wg$aDigestive System Abnormalities
=667  \\$ado not coord with INFANT, NEWBORN, DISEASES
=680  \\$iProgressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
=688  \\$a87
=750  \0$aBiliary atresia$5IEN$0(DLC)sh 85014020

=LDR  00889cz  a2200289n  4500
=001  9880363199702441
=005  20141212195227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001654
=035  \\$aCAZ4811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x249
=072  \\$aD3.$x549.$x909.$x249
=072  \\$aD4.$x345.$x783.$x249
=072  \\$aD23.$x767.$x193
=150  \\$aBile Pigments
=450  \\$wnnna$aBile Pigment
=450  \\$wnnna$aBilin
=450  \\$wnnna$aPigment, Bile
=450  \\$wnnna$aPigments, Bile
=550  \\$wg$aPigments, Biological
=550  \\$wg$aTetrapyrroles
=550  \\$wh$aBilirubin
=550  \\$wh$aUrobilin
=550  \\$wh$aUrobilinogen
=680  \\$iLinear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.
=750  \0$aBile pigments$5IEN$0(DLC)sh 85014017

=LDR  01273cz  a2200265n  4500
=001  9880363199802441
=005  20141212195227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001653
=035  \\$aCAZ4810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159.$x183.$x158
=072  \\$aA3.$x620.$x150
=150  \\$aBile Ducts, Intrahepatic
=450  \\$wnnna$aBile Duct, Intrahepatic
=450  \\$wnnna$aDuct, Intrahepatic Bile
=450  \\$wnnna$aDucts, Intrahepatic Bile
=450  \\$wnnna$aIntrahepatic Bile Duct
=450  \\$wnnna$aIntrahepatic Bile Ducts
=550  \\$wg$aBile Ducts
=550  \\$wg$aLiver
=550  \\$wh$aBile Canaliculi
=667  \\$ado not confuse with BILE DUCTS, EXTRAHEPATIC; do not confuse with HEPATIC DUCT, COMMON, the external junction of right & left hepatic ducts; diseases: coord IM with BILE DUCT DISEASES (IM); neopl: coord IM with BILE DUCT NEOPLASMS (IM); inflammation: coord IM with CHOLANGITIS (IM); BILE DUCT OBSTRUCTION, INTRAHEPATIC see CHOLESTASIS, INTRAHEPATIC is also available
=680  \\$iPassages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
=750  \0$aBile ducts$5IEN$0(DLC)sh 85014009

=LDR  00995cz  a2200229n  4500
=001  9880363199902441
=005  20141212195227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001652
=035  \\$aCAZ4809HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159.$x183
=150  \\$aBile Ducts
=450  \\$wnnna$aBile Duct
=450  \\$wnnna$aDuct, Bile
=450  \\$wnnna$aDucts, Bile
=550  \\$wg$aBiliary Tract
=550  \\$wh$aBile Ducts, Extrahepatic
=550  \\$wh$aBile Ducts, Intrahepatic
=667  \\$a/abnorm: BILIARY ATRESIA is also available; inflammation = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS (IM) + BILE DUCT DISEASES (IM)
=680  \\$iThe channels that collect and transport the bile secretion from the BILE CANALICULI, the smallest branch of the BILIARY TRACT in the LIVER, through the bile ductules, the bile ducts out the liver, and to the GALLBLADDER for storage.
=750  \0$aBile ducts$5IEN$0(DLC)sh 85014009

=LDR  01141cz  a2200349n  4500
=001  9880363200002441
=005  20141212195226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001650
=035  \\$aCAZ4807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x120.$x250
=072  \\$aC6.$x130.$x120.$x120
=072  \\$aC6.$x130.$x320.$x120
=072  \\$aC6.$x301.$x120.$x250
=150  \\$aBile Duct Neoplasms
=450  \\$aBile Duct Cancer
=450  \\$wnnna$aBile Duct Cancers
=450  \\$wnnna$aBile Duct Neoplasm
=450  \\$wnnna$aCancer, Bile Duct
=450  \\$aCancer of Bile Duct
=450  \\$wnnna$aCancer of the Bile Duct
=450  \\$wnnna$aCancers, Bile Duct
=450  \\$wnnna$aNeoplasm, Bile Duct
=450  \\$wnnna$aNeoplasms, Bile Duct
=550  \\$wg$aBile Duct Diseases
=550  \\$wg$aBiliary Tract Neoplasms
=550  \\$wh$aCommon Bile Duct Neoplasms
=667  \\$acoord IM with specific bile duct (IM) + histol type of neopl (IM)
=680  \\$iTumors or cancer of the BILE DUCTS.
=750  \0$aBile ducts$xCancer$5IEN-M$0(DLC)sh2003005952
=750  \0$aBile ducts$xTumors$5IEN-M

=LDR  01119cz  a2200313n  4500
=001  9880363200102441
=005  20141212195226.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001649
=035  \\$aCAZ4806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x120
=150  \\$aBile Duct Diseases
=450  \\$wnnna$aBile Duct Disease
=450  \\$wnnna$aDisease, Bile Duct
=450  \\$wnnna$aDiseases, Bile Duct
=450  \\$wnnna$aDuct Disease, Bile
=450  \\$wnnna$aDuct Diseases, Bile
=550  \\$wg$aBiliary Tract Diseases
=550  \\$wh$aBile Duct Neoplasms
=550  \\$wh$aBiliary Atresia
=550  \\$wh$aCholangitis
=550  \\$wh$aCholedochal Cyst
=550  \\$wh$aCholestasis
=550  \\$wh$aCommon Bile Duct Diseases
=667  \\$ainflamm dis = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS + BILE DUCT DISEASES
=680  \\$iDiseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.
=688  \\$a80
=750  \0$aBile ducts$xdiseases$5IEN$0(DLC)sh 85014012

=LDR  00971cz  a2200229n  4500
=001  9880363200202441
=005  20141212195225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001647
=035  \\$aCAZ4804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x105
=150  \\$aBile Acids and Salts
=450  \\$wnnna$aAcids, Bile
=450  \\$wnnna$aBile Acids
=450  \\$aBile Salts
=450  \\$wnnna$aSalts, Bile
=550  \\$wg$aSteroids
=550  \\$wh$aCholic Acids
=680  \\$iSteroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones.
=750  \0$aBile acids$5IEN-M$0(DLC)sh 85014008
=750  \0$aBile salts$5IEN-HS$0(DLC)sh 85014018

=LDR  00746cz  a2200193n  4500
=001  9880363200302441
=005  20141212195224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001646
=035  \\$aCAZ4803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x87
=150  \\$aBile
=450  \\$aBiliary Sludge
=450  \\$aSludge, Biliary
=550  \\$wg$aBodily Secretions
=667  \\$astasis = CHOLESTASIS; drugs stimulating or increasing flow of bile = CHOLAGOGUES AND CHOLERETICS
=680  \\$iAn emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.
=750  \0$aBile$5IEN$0(DLC)sh 85014007

=LDR  00570cz  a2200229n  4500
=001  9880363200402441
=005  20141212195224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001645
=035  \\$aCAZ4802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x141
=150  \\$aBiguanides
=450  \\$aBiguanide$5IEN
=550  \\$wg$aGuanidines
=550  \\$wh$aBuformin
=550  \\$wh$aChlorhexidine
=550  \\$wh$aMetformin
=550  \\$wh$aPhenformin
=550  \\$wh$aProguanil
=688  \\$a66(65)
=750  \0$aBiguanide$5IEN$0(DLC)sh 85013986

=LDR  01064cz  a2200253n  4500
=001  9880363200502441
=005  20180314110502.0
=008  830310\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001644
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x100
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x100
=150  \\$aBifidobacterium
=550  \\$wg$aActinobacteria
=550  \\$wh$aBifidobacterium adolescents
=550  \\$wh$aBifidobacterium animalis
=550  \\$wh$aBifidobacterium bifidum
=550  \\$wh$aBifidobacterium breve
=550  \\$wh$aBifidobacterium longum
=550  \\$wh$aBifidobacterium pseudocatenulation
=667  \\$ainfection: coord IM with BIFIDOBACTERIALES INFECTIONS (IM); DF: BIFIDOBACT
=680  \\$iA rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.
=688  \\$a84
=750  \0$aBifidobacterium$5IEN$0(DLC)sh 85013939

=LDR  00863cz  a2200193n  4500
=001  9880363200602441
=005  20141212195223.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001642
=035  \\$aCAZ4799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x140
=150  \\$aBicycling
=450  \\$aCycling$5IEN
=550  \\$wg$aSports
=667  \\$afor transport or recreation: not for test of phys exertion ( = probably BICYCLE ERGOMETRY TEST see EXERCISE TEST); /inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iThe use of a bicycle for transportation or recreation. It does not include the use of a bicycle in studying the body's response to physical exertion (BICYCLE ERGOMETRY TEST see EXERCISE TEST).
=688  \\$a90(83); was see under SPORTS 1983-89
=750  \0$aCycling$5IEN$0(DLC)sh 85035070

=LDR  00846cz  a2200217n  4500
=001  9880363200702441
=005  20141212195223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001641
=035  \\$aCAZ4798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x150
=150  \\$aBicuspid
=450  \\$wnnna$aBicuspids
=450  \\$aPremolar
=450  \\$wnnna$aPremolars
=550  \\$wg$aTooth
=667  \\$abetween the canine & molar teeth; NIM when merely locational
=680  \\$iOne of the eight permanent teeth, two on either side in each jaw, between the canines (CUSPID) and the molars (MOLAR), serving for grinding and crushing food. The upper have two cusps (bicuspid) but the lower have one to three. (Jablonski, Dictionary of Dentistry, 1992, p822)
=688  \\$a65
=750  \0$aBicuspids$5IEN$0(DLC)sh 85013891

=LDR  00769cz  a2200241n  4500
=001  9880363200802441
=005  20141212195222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001638
=035  \\$aCAZ4795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x169
=072  \\$aF4.$x754.$x168
=150  \\$aBibliotherapy
=450  \\$wnnna$aBibliotherapies
=450  \\$aBibliotherapists$5IEN
=550  \\$wg$aPsychotherapy
=550  \\$wg$aRehabilitation
=550  \\$aBooks
=667  \\$aa psychother technique; DF: BIBLIOTHER
=680  \\$iA form of supportive psychotherapy in which the patient is given carefully selected material to read.
=750  \0$aBibliotherapists$5IEN-M$0(DLC)sh 85013877
=750  \0$aBibliotherapy$5IEN-HS$0(DLC)sh 85013878

=LDR  01217cz  a2200205n  4500
=001  9880363200902441
=005  20141212195222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001637
=035  \\$aCAZ4794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x99.$x183
=150  \\$aBibliography, National
=450  \\$wnnna$aBibliographies, National
=450  \\$wnnna$aNational Bibliographies
=450  \\$wnnna$aNational Bibliography
=550  \\$wg$aBibliography as Topic
=667  \\$acataloging term: no qualif; DF: BIBLIOG NATIONAL or BIBLIOGR NATIONAL
=680  \\$iA bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country (whether written by its nationals or not) and those written in the language of the country as well as those published in it. (Harrod's Librarians' Glossary, 7th ed)
=750  \0$aBibliography, National$5IEN$0(DLC)sh 85013867

=LDR  01195cz  a2200289n  4500
=001  9880363201002441
=005  20201106173059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001635
=035  \\$aCAZ4792HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x99.$x308
=072  \\$aL1.$x453.$x183.$x224
=150  \\$aBibliography of Medicine
=450  \\$wnnna$aBibliographies, Medical
=450  \\$wnnna$aBibliography, Medical
=450  \\$wnnna$aMedical Bibliographies
=450  \\$wnnna$aMedical Bibliography
=450  \\$wnnna$aMedicine, Bibliographies
=450  \\$wnnna$aMedicine Bibliographies
=450  \\$wnnna$aMedicine, Bibliography
=450  \\$wnnna$aMedicine Bibliography
=450  \\$aMedicine,$xbibliography$5IEN
=550  \\$wg$aBibliographies as Topic
=667  \\$aIM for bibliog of med as a subject; do not use for specific medical subjects: use BIBLIOGRAPHY AS TOPIC instead but see note there; no qualif; Manual 33.9; DF: BIBLIOG MED or BIBLIOGR MED
=680  \\$iA list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.
=750  \0$aMedicine$xBibliography$5IEN$0(DLC)sh 85083070

=LDR  00824cz  a2200253n  4500
=001  9880363201202441
=005  20141212195219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001630
=035  \\$aCAZ4787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x392.$x183
=150  \\$aBezoars
=450  \\$wnnna$aBall, Hair
=450  \\$wnnna$aBalls, Hair
=450  \\$wnnna$aBezoar
=450  \\$wnnna$aHair Ball
=450  \\$aHair Balls
=450  \\$wnnna$aTrichobezoar
=450  \\$aTrichobezoars
=550  \\$wg$aForeign Bodies
=667  \\$aconcretions from ingested foreign matter; coord IM with organ (IM), not organ/dis: Manual 21.39
=680  \\$iConcretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.
=750  \0$aBezoars$5IEN-HS$0(DLC)sh 85013521

=LDR  01036cz  a2200313n  4500
=001  9880363201302441
=005  20161018112819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001628
=035  \\$aCAZ4785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x100
=072  \\$aJ2.$x200
=150  \\$aBeverages
=450  \\$wnnna$aBeverage
=550  \\$wg$aFood and Beverages
=550  \\$wh$aAlcoholic Beverages
=550  \\$wh$aCarbonated Beverages
=550  \\$wh$aCoffee
=550  \\$wh$aDrinking Water
=550  \\$wh$aEnergy Drinks
=550  \\$wh$aMilk
=550  \\$wh$aMilk Substitutes
=550  \\$wh$aTea
=550  \\$wh$aTeas, Herbal
=550  \\$wh$aTeas, Medicinal
=667  \\$afruit or vegetable juices: coordinate IM specific fruit (IM) or specific vegetable (IM); ALCOHOLIC BEVERAGES & specifics & CARBONATED BEVERAGES are also available
=680  \\$iLiquids that are suitable for drinking. (From Merriam Webster Collegiate Dictionary, 10th ed)
=750  \0$aBeverages$5IEN$0(DLC)sh 85013504

=LDR  02120cz  a2200529n  4500
=001  9880363201402441
=005  20141212195217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001622
=035  \\$aCAZ4779M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x883.$x77
=072  \\$aD2.$x675.$x276.$x125
=150  \\$aBetaine
=450  \\$wnnna$aAcidin-Pepsin
=450  \\$wnnna$aAcidin Pepsin
=450  \\$wnnna$aAcidinPepsin
=450  \\$wnnna$aBeaufour Brand of Betaine Citrate
=450  \\$wnnna$aBetaine, Glycine
=450  \\$wnnna$aBetaine Hydrochloride
=450  \\$wnnna$aBetaine Orphan Brand
=450  \\$wnnna$aBoizot Brand of Betaine Aspartate
=450  \\$wnnna$aByk Brand of Betaine Phosphate
=450  \\$wnnna$aC.B.B.
=450  \\$wnnna$aCitrate de Béta� (Sa (Bne Beaufour
=450  \\$wnnna$aCitrate de Béta� (Sa (Bne UPSA
=450  \\$wnnna$aCystadane
=450  \\$wnnna$aFournier Brand of Betaine Ascorbate and Hydrate
=450  \\$wnnna$aGlycine Betaine
=450  \\$wnnna$aHepastyl
=450  \\$wnnna$aHydrochloride, Betaine
=450  \\$wnnna$aLogeais Brand of Betaine Cyclobutyrate
=450  \\$aLycine
=450  \\$wnnna$aNovobetaine
=450  \\$wnnna$aOrphan Brand of Betaine
=450  \\$aOxyneurine
=450  \\$wnnna$aScorbo-béta� (Sa (Bne
=450  \\$wnnna$aScorbo béta� (Sa (Bne
=450  \\$wnnna$aScorbobéta� (Sa (Bne
=450  \\$wnnna$aStea-16
=450  \\$wnnna$aStea16
=450  \\$wnnna$aUPSA Brand of Betaine Citrate
=550  \\$wg$aQuaternary Ammonium Compounds
=550  \\$wg$aTrimethyl Ammonium Compounds
=680  \\$iA naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341)
=688  \\$a68(64)
=750  \0$aBetaine$0(DLC)sh2005007337$5IEN-M

=LDR  00795cz  a2200229n  4500
=001  9880363201502441
=005  20141212195214.0
=008  780516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001618
=035  \\$aCAZ4775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x180
=150  \\$abeta-Lactamases
=450  \\$wnnna$abeta-Lactamase
=450  \\$wnnna$abeta Lactamase
=450  \\$wnnna$abeta Lactamases
=550  \\$wg$aAmidohydrolases
=550  \\$wh$aCephalosporinase
=550  \\$wh$aPenicillinase
=680  \\$iEnzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
=688  \\$a79
=750  \0$aBeta lactamases$5IEN$0(DLC)sh 85013446

=LDR  02053cz  a2200529n  4500
=001  9880363201602441
=005  20141212195214.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001616
=035  \\$aCAZ4773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x410.$x100
=150  \\$abeta-Galactosidase
=450  \\$wnnna$abeta-D-Galactosidase
=450  \\$wnnna$abeta D Galactosidase
=450  \\$wnnna$abeta Galactosidase
=450  \\$wnnna$abeta-Galactosidase A1
=450  \\$wnnna$abeta Galactosidase A1
=450  \\$wnnna$abeta-Galactosidase A2
=450  \\$wnnna$abeta Galactosidase A2
=450  \\$wnnna$abeta-Galactosidase A3
=450  \\$wnnna$abeta Galactosidase A3
=450  \\$wnnna$abeta-Galactosidases
=450  \\$wnnna$abeta Galactosidases
=450  \\$wnnna$aDairyaid
=450  \\$wnnna$alac Z Protein
=450  \\$wnnna$aLactaid
=450  \\$aLactases
=450  \\$wnnna$aLactogest
=450  \\$wnnna$aLactrase
=450  \\$wnnna$aMcNeil Brand of beta-Galactosidase
=450  \\$wnnna$aProtein, lac Z
=450  \\$wnnna$aRivex Brand of beta-Galactosidase
=450  \\$wnnna$aRivex Brand of beta Galactosidase
=450  \\$wnnna$aSunrise Brand of beta-Galactosidase
=450  \\$wnnna$aSunrise Brand of beta Galactosidase
=450  \\$wnnna$aTanta Brand of beta-Galactosidase
=450  \\$wnnna$aTanta Brand of beta Galactosidase
=450  \\$wnnna$aThompson Brand of beta-Galactosidase
=450  \\$wnnna$aThompson Brand of beta Galactosidase
=550  \\$wg$aGalactosidases
=550  \\$wh$aLactase
=550  \\$aGangliosidosis, GM1
=667  \\$a/defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS, GM1
=680  \\$iA group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.
=688  \\$a92; was BETA-GALACTOSIDASES 1978-91 (see under GALACTOSIDASES 1978-90)
=750  \0$aBeta-galactosidase$5IEN-M$0(DLC)sh 85073860

=LDR  00797cz  a2200241n  4500
=001  9880363201702441
=005  20150406103211.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001611
=035  \\$aCAZ4768M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x300.$x150.$x750
=072  \\$aE1.$x370.$x405.$x245.$x287.$x750
=072  \\$aG7.$x265.$x87.$x750
=072  \\$aG11.$x561.$x127.$x750
=150  \\$aBeta Rhythm
=450  \\$wnnna$aBeta Rhythms
=450  \\$wnnna$aRhythm, Beta
=450  \\$wnnna$aRhythms, Beta
=550  \\$wg$aBrain Waves
=680  \\$iBrain waves with frequency between 15-30 Hz seen on EEG during wakefulness and mental activity.
=688  \\$a91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90
=750  \0$aBeta rhythm$0(DLC)sh2005008617$5IEN-M

=LDR  01094cz  a2200337n  4500
=001  9880363201802441
=005  20141212195212.0
=008  840224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001610
=035  \\$aCAZ4767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x750.$x125
=150  \\$aBeta Particles
=450  \\$wnnna$aBeta Particle
=450  \\$wnnna$aBeta Radiation
=450  \\$wnnna$aBeta Radiations
=450  \\$wnnna$aBeta Ray
=450  \\$aBeta Rays
=450  \\$wnnna$aParticle, Beta
=450  \\$wnnna$aParticles, Beta
=450  \\$wnnna$aRadiation, Beta
=450  \\$wnnna$aRadiations, Beta
=450  \\$wnnna$aRay, Beta
=450  \\$wnnna$aRays, Beta
=550  \\$wg$aRadiation, Ionizing
=550  \\$aElectrons
=680  \\$iHigh energy POSITRONS or ELECTRONS ejected from a disintegrating atomic nucleus.
=688  \\$a2010 (1985)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Beta Rays
=688  \\$a85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75
=750  \0$aBeta rays$0(DLC) sh 85013449$5IEN

=LDR  00851cz  a2200217n  4500
=001  9880363201902441
=005  20141212195211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001608
=035  \\$aCAZ4765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552.$x75
=072  \\$aD1.$x268.$x557.$x80
=072  \\$aD1.$x552.$x547.$x80
=150  \\$aBeryllium
=450  \\$aOrganoberyllium Compounds$5IEN
=550  \\$wg$aMetals, Alkaline Earth
=550  \\$wg$aMetals, Light
=667  \\$aBe-9; Be-6-8, 10, 11 = BERYLLIUM (IM) + RADIOISOTOPES (IM); /adv eff /tox permitted but /pois = BERYLLIOSIS
=680  \\$iBeryllium. An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.
=750  \0$aBeryllium$5IEN-HS$0(DLC)sh 85013403

=LDR  00830cz  a2200229n  4500
=001  9880363202002441
=005  20141212195209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001603
=035  \\$aCAZ4760M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x100
=072  \\$aD1.$x268.$x271.$x100.$x100
=072  \\$aD1.$x268.$x556.$x75
=072  \\$aD1.$x552.$x20.$x150
=072  \\$aD1.$x552.$x544.$x75
=150  \\$aBerkelium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$aman-made radioactive element; IM
=680  \\$iBerkelium. A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.
=750  \0$aBerkelium$0(DLC)sh2012004283$5IEN-M

=LDR  00632cz  a2200217n  4500
=001  9880363202102441
=005  20141212195209.0
=008  870314\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001601
=035  \\$aCAZ4758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x142
=150  \\$aBereavement
=450  \\$wnnna$aBereavements
=550  \\$wg$aEmotions
=550  \\$wh$aGrief
=550  \\$aDeath
=667  \\$ahuman & animal; no qualif
=680  \\$iRefers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness.
=688  \\$a88
=750  \0$aBereavement$5IEN$0(DLC)sh 85013296

=LDR  00746cz  a2200193n  4500
=001  9880363202202441
=005  20141212195209.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001599
=035  \\$aCAZ4756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x98.$x57.$x100
=072  \\$aD3.$x549.$x168.$x100
=150  \\$aBerberine
=450  \\$wnnna$aUmbellatine
=550  \\$wg$aBerberine Alkaloids
=680  \\$iAn alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.
=688  \\$a91(76); was see under BERBINES 1976-90
=750  \0$aBerberine$5IEN$0(DLC)sh 85013289

=LDR  00885cz  a2200325n  4500
=001  9880363202302441
=005  20190304141829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001578
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x663.$x283
=072  \\$aD3.$x663.$x100.$x150
=150  \\$aBenzopyrans
=450  \\$aChromenes
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wg$aPyrans
=550  \\$wh$aAflatoxins
=550  \\$wh$aChromans
=550  \\$wh$aChromones
=550  \\$wh$aCitrinin
=550  \\$wh$aCoumarins
=550  \\$wh$aCromakalim
=550  \\$wh$aEllagic Acid
=550  \\$wh$aHematoxylin
=550  \\$wh$aNebivolol
=550  \\$wh$aVitamin E
=667  \\$ado not confuse with BENZOPYRENES
=680  \\$iCompounds with a core of fused benzo-pyran rings.
=688  \\$a66
=750  \0$aBenzopyrans$0(DLC)sh 85013246$5IEN-M

=LDR  00708cz  a2200181n  4500
=001  9880363202402441
=005  20141212195201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001573
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x120.$x100
=150  \\$aBenzoin
=450  \\$wnnna$a2-hydroxy-1,2-diphenylethanone
=450  \\$wnnna$a2 hydroxy 1,2 diphenylethanone
=550  \\$wg$aAcetophenones
=667  \\$aD25-26 qualif; benzoin gum (NM) is also available
=680  \\$iA white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses. This should not be confused with benzoin gum from STYRAX.
=750  \0$aBenzoin$5IEN$0(DLC)sh 85013244

=LDR  00873cz  a2200313n  4500
=001  9880363202502441
=005  20171219113534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001572
=035  \\$aCAZ4729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x127
=150  \\$aBenzofurans
=450  \\$aCoumarones
=450  \\$wnnna$aDiphenylbenzofuran
=450  \\$aUsnic Acid$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aAmiodarone
=550  \\$wh$aBenzbromarone
=550  \\$wh$aCantharidin
=550  \\$wh$aCitalopram
=550  \\$wh$aFluorescamine
=550  \\$wh$aFura-2
=550  \\$wh$aGriseofulvin
=550  \\$wh$aPterocarpans
=550  \\$wh$aVilazodone Hydrochloride
=680  \\$iCompounds that contain a BENZENE ring fused to a furan ring.
=688  \\$a66
=750  \0$aBenzofuran$5IEN$0(DLC)sh 85013243

=LDR  00913cz  a2200301n  4500
=001  9880363202602441
=005  20141212195200.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001569
=035  \\$aCAZ4726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80
=150  \\$aBenzodiazepines
=450  \\$wnnna$aBenzodiazepine
=450  \\$wnnna$aBenzodiazepine Compounds
=550  \\$wg$aBenzazepines
=550  \\$wh$aAlprazolam
=550  \\$wh$aBenzodiazepinones
=550  \\$wh$aChlordiazepoxide
=550  \\$wh$aClorazepate Dipotassium
=550  \\$wh$aEstazolam
=550  \\$wh$aMedazepam
=550  \\$wh$aMidazolam
=550  \\$wh$aTriazolam
=667  \\$ado not confuse with BENZODIAZEPINONES
=680  \\$iA group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.
=688  \\$a75
=750  \0$aBenzodiazepines$5IEN$0(DLC)sh 85013239

=LDR  01534cz  a2200433n  4500
=001  9880363202702441
=005  20141212195159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001565
=035  \\$aCAZ4722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127
=150  \\$aBenzoates
=450  \\$wnnna$aAcids, Benzoic
=450  \\$aBenzoate
=450  \\$aBenzoic Acid$xanalogs & derivatives
=450  \\$wnnna$aBenzoic Acids
=450  \\$aSodium Benzoate$xanalogs & derivatives
=550  \\$wg$aAcids, Carbocyclic
=550  \\$wg$aBenzene Derivatives
=550  \\$wh$aAminobenzoates
=550  \\$wh$aBenzamides
=550  \\$wh$aBenzoic Acid
=550  \\$wh$aBenzoyl Peroxide
=550  \\$wh$aBenzoylcholine
=550  \\$wh$aBromobenzoates
=550  \\$wh$aChlorobenzoates
=550  \\$wh$aHydroxybenzoates
=550  \\$wh$aIodobenzoates
=550  \\$wh$aMercuribenzoates
=550  \\$wh$aNitrobenzoates
=550  \\$aChalcones
=680  \\$iDerivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure.
=688  \\$a1963
=688  \\$a1963; for BENZOATE & POTASSIUM BENZOATE use BENZOIC ACID (NM) 1980-98
=688  \\$a99; for BENZOATE & POTASSIUM BENZOATE use BENZOIC ACID (NM) 1980-98
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Benzoic Acids
=750  \0$aBenzoates$5IEN$0(DLC)sh 85013237

=LDR  01006cz  a2200361n  4500
=001  9880363202802441
=005  20210218091712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001562
=035  \\$aCAZ4719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x103
=150  \\$aBenzimidazoles
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$a2-Pyridinylmethylsulfinylbenzimidazoles
=550  \\$wh$aAlbendazole
=550  \\$wh$aAstemizole
=550  \\$wh$aBenomyl
=550  \\$wh$aBisbenzimidazole
=550  \\$wh$aCambendazole
=550  \\$wh$aDomperidone
=550  \\$wh$aDroperidol
=550  \\$wh$aFenbendazole
=550  \\$wh$aMebendazole
=550  \\$wh$aMibefradil
=550  \\$wh$aNocodazole
=550  \\$wh$aPimozide
=550  \\$wh$aThiabendazole
=550  \\$wh$aTelmisartan
=550  \\$wh$aTriclabendazole
=550  \\$aImidazoles
=680  \\$iCompounds with a BENZENE fused to IMIDAZOLES.
=750  \0$aBenzimidazoles$5IEN$0(DLC)sh 85013236

=LDR  00786cz  a2200193n  4500
=001  9880363202902441
=005  20141212195158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001560
=035  \\$aCAZ4717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x185.$x100
=150  \\$aBenzidines
=450  \\$aBianilines
=450  \\$aBiphenyldiamines
=550  \\$wg$aBiphenyl Compounds
=680  \\$iVery toxic industrial chemicals. They are absorbed through the skin, causing lethal blood, bladder, liver, and kidney damage and are potent, broad-spectrum carcinogens in most species.
=688  \\$a77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74
=750  \0$aBenzidine$0(DLC)sh2009009562$5IEN-M

=LDR  00859cz  a2200205n  4500
=001  9880363203102441
=005  20141212195155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001554
=035  \\$aCAZ4711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x23
=150  \\$aBenzene
=450  \\$aBenzol
=450  \\$wnnna$aBenzole
=450  \\$wnnna$aCyclohexatriene
=550  \\$wg$aBenzene Derivatives
=667  \\$ado not confuse with benzil or benzal
=680  \\$iToxic, volatile, flammable liquid hydrocarbon byproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide.
=750  \0$aBenzene$5IEN$0(DLC)sh 85013229

=LDR  00897cz  a2200253n  4500
=001  9880363203202441
=005  20141212195154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001551
=035  \\$aCAZ4708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x149
=072  \\$aD4.$x615.$x149
=150  \\$aBenz(a)Anthracenes
=450  \\$wnnna$aBenz(b)Phenanthrenes
=450  \\$wnno$aBenzanthracenes$5IEN-M
=450  \\$wnnna$aNaphthanthracenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$a9,10-Dimethyl-1,2-benzanthracene
=550  \\$wh$aMethylcholanthrene
=550  \\$wh$aPerylene
=680  \\$iFour fused benzyl rings with three linear and one angular, that can be viewed as a benzyl-phenanthrenes. Compare with NAPHTHACENES which are four linear rings.
=688  \\$a2005(1963)
=750  \0$aBenzanthracenes$0(DLC) sh 87002942$5IEN

=LDR  01119cz  a2200409n  4500
=001  9880363203302441
=005  20170404152236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001549
=035  \\$aCAZ4706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x277
=072  \\$aD2.$x241.$x223.$x100.$x100
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x85
=150  \\$aBenzamides
=550  \\$wg$aAmides
=550  \\$wg$aBenzoates
=550  \\$wh$aAcecainide
=550  \\$wh$aAminohippuric Acids
=550  \\$wh$aBezafibrate
=550  \\$wh$aCisapride
=550  \\$wh$aDEET
=550  \\$wh$aDinitolmide
=550  \\$wh$aHippurates
=550  \\$wh$aImatinib Mesylate
=550  \\$wh$aIndoramin
=550  \\$wh$aMetoclopramide
=550  \\$wh$aMoclobemide
=550  \\$wh$aProcainamide
=550  \\$wh$aProcarbazine
=550  \\$wh$aRaclopride
=550  \\$wh$aRemoxipride
=550  \\$wh$aSulpiride
=550  \\$wh$aTiapride Hydrochloride
=680  \\$iBENZOIC ACID amides.
=688  \\$a73; TRIMETHOBENZAMIDE was heading 1963-84
=750  \0$aBenzamide$5IEN$0(DLC)sh 85013227

=LDR  00389cz  a2200157n  4500
=001  9880363203402441
=005  20141212195153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001547
=035  \\$aCAZ4704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x222
=150  \\$aBenzaldehydes
=550  \\$wg$aAldehydes
=688  \\$a74(72)
=750  \0$aBenzaldehyde$5IEN$0(DLC)sh 85013226

=LDR  00807cz  a2200229n  4500
=001  9880363203502441
=005  20141212195153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001546
=035  \\$aCAZ4703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x50.$x75.$x100
=072  \\$aD1.$x578.$x725.$x25.$x100
=072  \\$aD1.$x650.$x550.$x50.$x75.$x100
=072  \\$aD1.$x837.$x725.$x700.$x760.$x50.$x100
=150  \\$aBentonite
=450  \\$aMontmorillonite
=450  \\$wnnna$aMontmorrillonite
=550  \\$wg$aAluminum Silicates
=680  \\$iA colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.
=688  \\$a73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93
=750  \0$aBentonite$5IEN-HS$0(DLC)sh 85013218

=LDR  00698cz  a2200229n  4500
=001  9880363203602441
=005  20141212195152.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001542
=035  \\$aCAZ4699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x125
=072  \\$aD3.$x438.$x103.$x140
=150  \\$aBenomyl
=450  \\$wnnna$aBenlate
=450  \\$wnnna$aFundasol
=450  \\$wnnna$aFundazol
=550  \\$wg$aBenzimidazoles
=550  \\$wg$aCarbamates
=680  \\$iA systemic agricultural fungicide used for control of certain fungal diseases of stone fruit.
=688  \\$a91(75); was see under CARBAMATES 1975-90
=750  \0$aBenomyl$5IEN$0(DLC)sh 85013207

=LDR  00833cz  a2200229n  4500
=001  9880363203702441
=005  20141212195151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001538
=035  \\$aCAZ4695HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x513.$x180
=072  \\$aF4.$x711.$x647.$x138
=150  \\$aBender-Gestalt Test
=450  \\$wnnna$aBender Gestalt Test
=450  \\$wnnna$aBender Visual Motor Gestalt Test
=450  \\$aGestalt Test, Bender$5IEN-M
=450  \\$wnnna$aTest, Bender-Gestalt
=550  \\$wg$aNeuropsychological Tests
=550  \\$wg$aPersonality Tests
=680  \\$iA psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually.
=750  \0$aBender-Gestalt Test$5IEN$0(DLC)sh 85013109

=LDR  00951cz  a2200229n  4500
=001  9880363203802441
=005  20201023150125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001533
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x760.$x180
=072  \\$aD3.$x132.$x889.$x180
=150  \\$aBelladonna Alkaloids
=450  \\$wnnna$aAlkaloids, Belladonna
=550  \\$wg$aSolanaceous Alkaloids
=550  \\$wg$aTropanes
=550  \\$wh$aAtropine Derivatives
=550  \\$wh$aScopolamine
=550  \\$aAtropa belladonna
=680  \\$iAlkaloids obtained from various plants, especially the deadly nightshade (Atropa belladonna), variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics.
=688  \\$a76(75); was see under BELLADONNA 1975-76, was see under TROPANES 1969-74
=750  \0$aBelladonna (Drug)$5IEN$0(DLC)sh 95007340

=LDR  01213cz  a2200241n  4500
=001  9880363203902441
=005  20141212195149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001532
=035  \\$aCAZ4689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x49.$x222
=150  \\$aAtropa belladonna
=450  \\$wnnna$aAtropa belladonnas
=450  \\$aBelladonna
=450  \\$wnnna$abelladonna, Atropa
=450  \\$wnnna$aBelladonnas
=450  \\$wnnna$abelladonnas, Atropa
=550  \\$wg$aAtropa
=667  \\$aBLACK NIGHTSHADE see SOLANUM NIGRUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE; SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.
=688  \\$a2003(1963)
=750  \0$aBelladonna (Plant)$5IEN$0(DLC)sh 95007338

=LDR  01502cz  a2200373n  4500
=001  9880363204002441
=005  20141212192020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001528
=035  \\$aCAZ4685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x75
=072  \\$aC11.$x941.$x879.$x780.$x880.$x200
=072  \\$aC14.$x907.$x940.$x100
=072  \\$aC17.$x800.$x862.$x150
=150  \\$aBehcet Syndrome
=450  \\$wnnna$aAdamantiades-Behcet Disease
=450  \\$wnnna$aBehçet Disease
=450  \\$aBehcet Disease
=450  \\$wnnna$aBehcet Triple Symptom Complex
=450  \\$aBehcet's Disease$5IEN
=450  \\$aBehcet's Syndrome
=450  \\$wnnna$aBehcets Syndrome
=450  \\$wnnna$aOld Silk Route Disease
=450  \\$wnnna$aTriple Symptom Complex
=450  \\$aTriple-Symptom Complex
=550  \\$wg$aMouth Diseases
=550  \\$wg$aSkin Diseases, Vascular
=550  \\$wg$aUveitis, Anterior
=550  \\$wg$aVasculitis
=667  \\$ain translations spell Behçet's, not Behcet's
=680  \\$iRare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
=688  \\$a2003 (1963)
=750  \0$aBeh�cet's disease$5IEN$0(DLC)sh 85012908

=LDR  00633cz  a2200181n  4500
=001  9880363204102441
=005  20141212195149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001527
=035  \\$aCAZ4684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x138
=150  \\$aBehaviorism
=450  \\$wnnna$aBehaviorisms
=550  \\$wg$aPsychological Theory
=667  \\$aa school of psychology: do not confuse with BEHAVIOR
=680  \\$iA psychologic theory, developed by John Broadus Watson, concerned with studying and measuring behaviors that are observable.
=750  \0$aBehaviorism (Psychology)$5IEN$0(DLC)sh 85012905

=LDR  01022cz  a2200265n  4500
=001  9880363204202441
=005  20141212195148.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001524
=035  \\$aCAZ4681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x80
=072  \\$aH2.$x403.$x90
=150  \\$aBehavioral Medicine
=450  \\$wnnna$aHealth Psychologies
=450  \\$aHealth Psychology
=450  \\$wnnna$aMedicine, Behavioral
=450  \\$wnnna$aPsychologies, Health
=450  \\$aPsychology, Health
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aMedicine
=667  \\$aSPEC: SPEC qualif; DF: BEHAVIORAL MED
=680  \\$iThe interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation.
=688  \\$a83
=750  \0$aMedicine and psychology$5IEN$0(DLC)sh 85083185

=LDR  01843cz  a2200493n  4500
=001  9880363204302441
=005  20171212102806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001523
=035  \\$aCAZ4680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3
=150  \\$aMental Disorders
=450  \\$wnnna$aBehavior Disorders
=450  \\$wnnna$aDiagnosis, Psychiatric
=450  \\$wnnna$aDisorder, Mental
=450  \\$wnnna$aDisorders, Behavior
=450  \\$wnnna$aDisorders, Mental
=450  \\$wnnna$aMental Disorder
=450  \\$wnnna$aPsychiatric Diagnosis
=450  \\$wh$aDisruptive, Impulse Control, and Conduct Disorders
=550  \\$wh$aAnxiety Disorders
=550  \\$wh$aBipolar and Related Disorders
=550  \\$wh$aDissociative Disorders
=550  \\$wh$aElimination Disorders
=550  \\$wh$aFeeding and Eating Disorders
=550  \\$wh$aFactitious Disorders
=550  \\$wh$aMood Disorders
=550  \\$wh$aMotor Disorders
=550  \\$wh$aNeurocognitive Disorders
=550  \\$wh$aNeurodevelopmental Disorders
=550  \\$wh$aNeurotic Disorders
=550  \\$wh$aParaphilic Disorders
=550  \\$wh$aPersonality Disorders
=550  \\$wh$aSchizophrenic Spectrum and Other Psychotic Disorders
=550  \\$wh$aSexual Dysfunctions, Psychological
=550  \\$wh$aSleep Wake Disorders
=550  \\$wh$aSomatoform Disorders
=550  \\$wh$aSubstance-Related Disorders
=550  \\$wh$aTrauma and Stressor Related Disorders
=550  \\$aMentally Ill Persons
=680  \\$iPsychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
=688  \\$ause pre-explosion 1974-97
=750  \0$aMental illness$5IEN-M$0(DLC)sh 85083643

=LDR  01113cz  a2200373n  4500
=001  9880363204402441
=005  20180928115217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001522
=035  \\$aCAZ4679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113
=150  \\$aBehavior, Animal
=450  \\$wnnna$aAnimal Behavior
=450  \\$wnnna$aAnimal Behaviors
=450  \\$wnnna$aBehaviors, Animal
=550  \\$wg$aBehavior
=550  \\$wh$aAnimal Communication
=550  \\$wh$aAnimal Distribution
=550  \\$wh$aAppetitive Behavior
=550  \\$wh$aConsummatory Behavior
=550  \\$wh$aEliminative Behavior, Animal
=550  \\$wh$aEscape Reaction
=550  \\$wh$aFeeding Behavior
=550  \\$wh$aFreezing Reaction, Cataleptic
=550  \\$wh$aHoming Behavior
=550  \\$wh$aImmobility Response, Tonic
=550  \\$wh$aKinesis
=550  \\$wh$aTaxis Response
=550  \\$wh$aTool Use Behavior
=550  \\$aEthology
=680  \\$iThe observable response an animal makes to any situation.
=688  \\$a64
=750  \0$aAnimal behavior$5IEN$0(DLC)sh 85005162

=LDR  01601cz  a2200433n  4500
=001  9880363204502441
=005  20201008104315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137
=150  \\$aBehavior Therapy
=450  \\$aBehavior Modification
=450  \\$wnnna$aBehavior Modifications
=450  \\$wnnna$aBehavior Therapies
=450  \\$wnnna$aConditioning Therapies
=450  \\$aConditioning Therapy
=450  \\$wnnna$aModification, Behavior
=450  \\$wnnna$aModifications, Behavior
=450  \\$wnnna$aTherapies, Behavior
=450  \\$wnnna$aTherapies, Conditioning
=450  \\$wnnna$aTherapy, Behavior
=450  \\$wnnna$aTherapy, Conditioning
=550  \\$wg$aPsychotherapy
=550  \\$wh$aAnger Management Therapy
=550  \\$wh$aApplied Behavior Analysis
=550  \\$wh$aAversive Therapy
=550  \\$wh$aBiofeedback, Psychology
=550  \\$wh$aCognitive Remediation
=550  \\$wh$aCognitive Behavioral Therapy
=550  \\$wh$aDesensitization, Psychologic
=550  \\$wh$aRelaxation Therapy
=550  \\$wh$aSleep Phase Chronotherapy
=550  \\$aBehavior Control
=550  \\$aMind-Body Therapies
=667  \\$aa psychother technique; assertiveness training: coord IM with ASSERTIVENESS (IM); DF: BEHAVIOR THER
=680  \\$iThe application of modern theories of learning and conditioning in the treatment of behavior disorders.
=688  \\$a66(64); BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78
=750  \0$aBehavior therapy$5IEN-M$0(DLC)sh 85012900

=LDR  02092cz  a2200673n  4500
=001  9880363204602441
=005  20201202114445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001519
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145
=150  \\$aBehavior
=450  \\$wnnna$aAcceptance Process
=450  \\$wnnna$aAcceptance Processes
=450  \\$wnnna$aBehaviors
=450  \\$wnnna$aProcess, Acceptance
=450  \\$wnnna$aProcesses, Acceptance
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aAccident Proneness
=550  \\$wh$aAdolescent Behavior
=550  \\$wh$aBehavior, Animal
=550  \\$wh$aBehavioral Symptoms
=550  \\$wh$aChild Behavior
=550  \\$wh$aCodependency, Psychological
=550  \\$wh$aCommunication
=550  \\$wh$aConsumer Behavior
=550  \\$wh$aCriminal Behavior
=550  \\$wh$aDangerous Behavior
=550  \\$wh$aDrinking Behavior
=550  \\$wh$aDrug-Seeking Behavior
=550  \\$wh$aEscape Reaction
=550  \\$wh$aExploratory Behavior
=550  \\$wh$aFeeding Behavior
=550  \\$wh$aHabits
=550  \\$wh$aHarm Reduction
=550  \\$wh$aHealth Behavior
=550  \\$wh$aHoarding
=550  \\$wh$aIllness Behavior
=550  \\$wh$aImitative Behavior
=550  \\$wh$aImpulsive Behavior
=550  \\$wh$aInformation Seeking Behavior
=550  \\$wh$aInhibition, Psychological
=550  \\$wh$aMarijuana Use
=550  \\$wh$aMotor Activity
=550  \\$wh$aMultitasking Behavior
=550  \\$wh$aPersonal Satisfaction
=550  \\$wh$aReproductive Behavior
=550  \\$wh$aRisk Reduction Behavior
=550  \\$wh$aRisk-Taking
=550  \\$wh$aSelf Stimulation
=550  \\$wh$aSexual Behavior
=550  \\$wh$aSocial Behavior
=550  \\$wh$aSpatial Behavior
=550  \\$wh$aStereotyped Behavior
=550  \\$wh$aSucking Behavior
=550  \\$wh$aTobacco Use
=667  \\$ahuman only; GEN; prefer specifics
=680  \\$iThe observable response of a man or animal to a situation.
=750  \0$aHuman behavior$5IEN-M$0(DLC)sh 85062839

=LDR  00798cz  a2200181n  4500
=001  9880364225902441
=005  20141212214607.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x901
=150  \\$aSmilacaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aSmilax
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledon).
=688  \\$a2002
=750  \0$aSmilacaceae$5IEN-M$0(DLC)sh 92005321

=LDR  01439cz  a2200337n  4500
=001  9880364226002441
=005  20190705100453.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x750.$x200
=150  \\$aBetulaceae
=450  \\$wnnna$aCarpinus
=450  \\$wnnna$aHop Hornbeam
=450  \\$wnnna$aHop Hornbeams
=450  \\$aHornbeam
=450  \\$aHornbeam, Hop
=450  \\$wnnna$aHornbeams
=450  \\$wnnna$aHornbeams, Hop
=450  \\$aOstrya
=450  \\$wnnna$aOstryas
=450  \\$wnnna$aOstryopses
=450  \\$wnnna$aOstryopsis
=550  \\$wg$aFagales
=550  \\$wh$aAlnus
=550  \\$wh$aBetula
=550  \\$wh$aCorylus
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Fagales, subclass Hamamelidae, class Magnoliopsida. They have simple, serrate, alternate leaves. Male flowers are borne in long, pendulous catkins; the female in shorter, pendulous or erect catkins. The fruit is usually a small nut or a short-winged samara.
=688  \\$a2002
=750  \0$aBetulaceae$5IEN-M$0(DLC)sh 85013490

=LDR  01334cz  a2200337n  4500
=001  9880364226102441
=005  20141212214606.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x898
=150  \\$aSimaroubaceae
=450  \\$aCastela
=450  \\$wnnna$aCastelas
=450  \\$aHarrisonia
=450  \\$wnnna$aHarrisonias
=450  \\$wnnna$aPicrolemma
=450  \\$wnnna$aPicrolemmas
=450  \\$aSimaba
=450  \\$wnnna$aSimabas
=550  \\$wg$aAngiosperms
=550  \\$wh$aAilanthus
=550  \\$wh$aBrucea
=550  \\$wh$aEurycoma
=550  \\$wh$aPicrasma
=550  \\$wh$aQuassia
=550  \\$wh$aSimarouba
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are alternate and compound. Most have small flowers, bitter bark, and fleshy fruits that are sometimes winged. Members contain QUASSINS.
=688  \\$a2002
=750  \0$aSimaroubaceae$5IEN-M$0(DLC)sh 85122706

=LDR  00731cz  a2200217n  4500
=001  9880364226202441
=005  20141212214536.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x110
=072  \\$aB4.$x820.$x110
=150  \\$aClosteroviridae
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aClosterovirus
=550  \\$wh$aCrinivirus
=667  \\$acoord IM with specific plant /virol
=680  \\$iA family of plant viruses containing the largest single-stranded RNA genomes. Infections typically involve yellowing and necrosis, particularly affecting the phloem.
=688  \\$a2002
=750  \0$aClosteroviridae$0(DLC)sh2007002926$5IEN

=LDR  00827cz  a2200193n  4500
=001  9880364226302441
=005  20141212214606.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029633
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x889
=150  \\$aSchisandraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aKadsura
=550  \\$wh$aSchisandra
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Illiciales, subclass Magnoliidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aSchisandraceae$5IEN-M$0(DLC)sh 88023095

=LDR  00814cz  a2200229n  4500
=001  9880364226402441
=005  20141212214535.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029364
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x780
=072  \\$aB4.$x820.$x800
=072  \\$aB4.$x909.$x777.$x827
=150  \\$aTenuivirus
=450  \\$aRice stripe virus
=450  \\$wnnna$aTenuiviruses
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=667  \\$acoord IM with specific plant /virol
=680  \\$iA genus of RNA plant viruses as yet unassigned to any family. Plant hosts are all in the family Poaceae. Each species is transmitted by a particular species of planthopper. The type species is Rice stripe virus.
=688  \\$a2002
=750  \0$aTenuiviruses$0(DLC)sh2008008674$5IEN-M

=LDR  01273cz  a2200313n  4500
=001  9880364226502441
=005  20141212214605.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029632
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x886
=150  \\$aSapotaceae
=450  \\$wnnna$aArgania
=450  \\$wnnna$aArganias
=450  \\$aSideroxylon
=450  \\$wnnna$aSideroxylons
=450  \\$aTieghemella
=450  \\$wnnna$aTieghemellas
=550  \\$wg$aAngiosperms
=550  \\$wh$aMadhuca
=550  \\$wh$aManilkara
=550  \\$wh$aMimusops
=550  \\$wh$aPalaquium
=550  \\$wh$aPouteria
=550  \\$wh$aSynsepalum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida that are tropical trees which have elongate latex cells. Several members bear sweet edible fruits and produce triterpenoid saponins.
=688  \\$a2002
=750  \0$aSapotaceae$5IEN-M$0(DLC)sh 88023082

=LDR  01205cz  a2200265n  4500
=001  9880364226602441
=005  20160914175514.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812.$x666.$x500
=150  \\$aPiper nigrum
=450  \\$wnno$aBlack Pepper
=450  \\$aWhite Pepper
=450  \\$wnnna$anigrum, Piper
=450  \\$wnnna$anigrums, Piper
=450  \\$wnnna$aPiper nigrums
=450  \\$wnnna$aPepper, Black
=450  \\$wnnna$aPepper, White
=550  \\$wg$aPiper
=667  \\$asee entry terms at CAPSICUM for other types of pepper.
=680  \\$iA plant species in the PIPERACEAE plant family. It is a common spice on foods and is used medicinally to increase gastrointestinal assimilation of other supplements and drugs. Piperine is a key component. Black pepper is picked unripe and heaped for a few days to ferment. White Pepper is the ripe fruit dehulled by maceration in water.
=688  \\$a2002; for BLACK PEPPER use SPICES 1993-2001; for WHITE PEPPER use SPICES 1998-2001
=750  \0$aPepper (Spice)$5IEN-M$0(DLC)sh 85099662
=750  \0$aBlack pepper (Plant)$5IEN-M$0(DLC)sh 85102395

=LDR  00780cz  a2200193n  4500
=001  9880364226702441
=005  20141212214529.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x475
=150  \\$aHamamelidaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aHamamelis
=550  \\$wh$aLiquidambar
=667  \\$aGEN or unspecified; prefer specifics; specify Plant Components; for /Chem coord with D tree compound and/or Preparation; for therap. coordinate with PLANT PREPARATION or children and Diseases and PHYTOTHERAPY
=680  \\$iA plant family of the order Hamamelidales, subclass Hamamelidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aHamamelidaceae$5IEN-M$0(DLC)sh 85058532

=LDR  01149cz  a2200301n  4500
=001  9880364226802441
=005  20190619095820.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029631
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x885
=150  \\$aSapindaceae
=450  \\$aCardiospermum
=450  \\$wnnna$aCardiospermums
=450  \\$aHarpullia
=450  \\$wnnna$aHarpullias
=450  \\$wnnna$aXanthocera
=450  \\$aXanthoceras
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAcer
=550  \\$wh$aBlighia
=550  \\$wh$aLitchi
=550  \\$wh$aPaullinia
=550  \\$wh$aSapindus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe soapberry plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Some members contain SAPONINS.
=688  \\$a2002
=750  \0$aSapindaceae$5IEN-M$0(DLC)sh 85117446

=LDR  00717cz  a2200193n  4500
=001  9880364226902441
=005  20141212214529.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029181
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x880.$x705
=072  \\$aK1.$x844.$x664.$x500
=150  \\$aSpirituality
=450  \\$wnnna$aSpiritualities
=550  \\$wg$aReligion and Psychology
=550  \\$aSpiritual Therapies
=680  \\$iSensitivity or attachment to religious values, or to things of the spirit as opposed to material or worldly interests. (from Merriam-Webster's Collegiate Dictionary, 10th ed, and Oxford English Dictionary, 2nd ed)
=688  \\$a2002
=750  \0$aSpirituality$5IEN-M$0(DLC)sh 85126779

=LDR  01273cz  a2200265n  4500
=001  9880364227002441
=005  20141212214604.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x884
=150  \\$aSantalaceae
=450  \\$wnnna$aBastard Toadflax
=450  \\$wnnna$aBastard Toadflaxs
=450  \\$aComandra
=450  \\$wnnna$aComandras
=450  \\$aToadflax, Bastard
=450  \\$wnnna$aToadflaxs, Bastard
=550  \\$wg$aAngiosperms
=550  \\$wh$aPyrularia
=550  \\$wh$aSantalum
=667  \\$aX ref Toadflax, Bastard: Toadflax see LINARIA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections (haustoria) to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.
=688  \\$a2002
=750  \0$aSantalaceae$5IEN-M$0(DLC)sh 85117390

=LDR  00807cz  a2200193n  4500
=001  9880364227102441
=005  20141212214528.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029142
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x750.$x600.$x400
=072  \\$aB4.$x909.$x777.$x455.$x750.$x600.$x400
=150  \\$aInfectious hematopoietic necrosis virus
=450  \\$aIHNV
=550  \\$wg$aNovirhabdovirus
=667  \\$ado not confuse with INFECTIOUS HYPODERMAL AND HEMATOPOIETIC NECROSIS VIRUS see DENSOVIRINAE; infection: coord IM with RHABDOVIRIDAE INFECTIONS (IM)
=680  \\$iThe type species of NOVIRHABDOVIRUS, in the family RHABDOVIRIDAE. It is a major pathogen of TROUT and SALMON.
=688  \\$a2002
=750  \0$aInfectious hematopoietic necrosis virus$5IEN-M$0(DLC)sh 98004076

=LDR  01295cz  a2200217n  4500
=001  9880364227302441
=005  20141212214527.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x700.$x800
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x700.$x800
=150  \\$aSendai virus
=450  \\$aHemagglutinating Virus of Japan
=450  \\$wnnna$aJapan Hemagglutinating Virus
=550  \\$wg$aRespirovirus
=667  \\$ainfection: coordinate IM with RESPIROVIRUS INFECTIONS (IM)
=680  \\$iThe type species of RESPIROVIRUS in the subfamily PARAMYXOVIRINAE. It is the murine version of HUMAN PARAINFLUENZA VIRUS 1, distinguished by host range.
=688  \\$a2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 1 1977-1996, use SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996
=688  \\$a2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 1 1977-1996, use SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996; for INFLUENZA D VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996
=750  \0$aSendai virus$5IEN-M$0(DLC)sh 85119988

=LDR  01100cz  a2200253n  4500
=001  9880364227402441
=005  20141212214603.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029627
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x249
=150  \\$aCrassulaceae
=450  \\$aSempervivum
=450  \\$wnnna$aSempervivums
=450  \\$aTylecodon
=450  \\$wnnna$aTylecodons
=550  \\$wg$aRosales
=550  \\$wh$aKalanchoe
=550  \\$wh$aRhodiola
=550  \\$wh$aSedum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe stonecrop plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that grow in warm, dry regions. The leaves are thick. The flower clusters are red, yellow, or white.
=688  \\$a2002
=750  \0$aCrassulaceae$5IEN-M$0(DLC)sh 85033774

=LDR  01577cz  a2200397n  4500
=001  9880364227502441
=005  20190627102158.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029061
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x065
=150  \\$aAnnonaceae
=450  \\$wnnna$aArtabotry
=450  \\$aArtabotrys
=450  \\$wnnna$aArtabotrys uncinatus
=450  \\$wnnna$aFissistigma
=450  \\$wnnna$aFissistigmas
=450  \\$aPorcelia
=450  \\$wnnna$aPorcelias
=450  \\$wnnna$auncinatus, Artabotrys
=450  \\$wnnna$aYingzhao
=450  \\$wnnna$aYingzhaos
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAnnona
=550  \\$wh$aAsimina
=550  \\$wh$aCananga
=550  \\$wh$aGoniothalamus
=550  \\$wh$aGuatteria
=550  \\$wh$aPolyalthia
=550  \\$wh$aRollinia
=550  \\$wh$aUvaria
=550  \\$wh$aXylopia
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe custard-apple plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. Some members provide large pulpy fruits and commercial timber. Leaves and wood are often fragrant. Leaves are simple, with smooth margins, and alternately arranged in two rows along the stems.
=688  \\$a2002
=750  \0$aAnnonaceae$5IEN-M$0(DLC)sh 85005359

=LDR  01150cz  a2200289n  4500
=001  9880364227602441
=005  20141212214526.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x112.$x500
=150  \\$aImpatiens
=450  \\$wnnna$abalsamina, Impatiens
=450  \\$wnnna$abalsaminas, Impatiens
=450  \\$wnnna$aImpatien
=450  \\$wnnna$aImpatiens balsamina
=450  \\$wnnna$aImpatiens balsaminas
=450  \\$aJewelweed
=450  \\$wnnna$aJewelweeds
=450  \\$aTouch-me-not
=450  \\$wnnna$aTouch me not
=450  \\$wnnna$aTouch-me-nots
=550  \\$wg$aBalsaminaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of subsucculent annual or perennial plants in the family BALSAMINACEAE, order Geraniales.
=688  \\$a2002
=750  \0$aImpatiens$5IEN-M$0(DLC)sh 85064606

=LDR  00840cz  a2200181n  4500
=001  9880364227702441
=005  20190702103805.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029068
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x112
=150  \\$aBalsaminaceae
=550  \\$wg$aEricales
=550  \\$wh$aImpatiens
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Geraniales (or Ericales in APG system), subclass Rosidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aBalsaminaceae$5IEN-M$0(DLC)sh 85011350

=LDR  00997cz  a2200193n  4500
=001  9880364227802441
=005  20141212214522.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x44.$x666
=150  \\$aRhus
=450  \\$aSumac
=450  \\$wnnna$aSumacs
=550  \\$wg$aAnacardiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Anacardiaceae, order Sapindales, subclass Rosidae. It is a source of gallotannin (TANNIC ACID) and of somewhat edible fruit. Do not confuse with TOXICODENDRON which used to be part of this genus.
=688  \\$a2002; use TOXICODENDRON 1993-2001, use RHUS 1963-1992
=750  \0$aRhus$5IEN-M$0(DLC)sh 85113796

=LDR  01656cz  a2200469n  4500
=001  9880364227902441
=005  20190319100130.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029626
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x836.750.$x33
=150  \\$aRanunculaceae
=450  \\$aBeesia
=450  \\$wnnna$aBeesias
=450  \\$aConsolida
=450  \\$wnnna$aConsolidas
=450  \\$aHepatica
=450  \\$wnnna$aHepaticas
=450  \\$aIsopyrum
=450  \\$wnnna$aIsopyrums
=550  \\$wg$aAngiosperms
=550  \\$wh$aAconitum
=550  \\$wh$aActaea
=550  \\$wh$aAdonis
=550  \\$wh$aAnemone
=550  \\$wh$aAquilegia
=550  \\$wh$aCimicifuga
=550  \\$wh$aClematis
=550  \\$wh$aCoptis
=550  \\$wh$aDelphinium
=550  \\$wh$aHelleborus
=550  \\$wh$aHydrastis
=550  \\$wh$aNigella
=550  \\$wh$aPulsatilla
=550  \\$wh$aRanunculus
=550  \\$wh$aSemiaquilegia
=550  \\$wh$aThalictrum
=550  \\$wh$aXanthorhiza
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe buttercup plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.
=688  \\$a2002
=750  \0$aRanunculaceae$5IEN-M$0(DLC)sh 85111388

=LDR  00882cz  a2200217n  4500
=001  9880364228002441
=005  20141212214601.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029625
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x750
=150  \\$aPteridaceae
=450  \\$wnnna$aCheilanthe
=450  \\$aCheilanthes
=550  \\$wg$aFerns
=550  \\$wh$aAdiantum
=550  \\$wh$aPteris
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Polypodiales, class Filicopsida, division Pteridophyta (FERNS).
=688  \\$a2002
=750  \0$aAdiantaceae$5IEN-M$0(DLC)sh 85000871

=LDR  01085cz  a2200277n  4500
=001  9880364228102441
=005  20141212214521.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x124.$x500
=150  \\$aActinidia
=450  \\$wnnna$aActinidia deliciosa
=450  \\$wnnna$aActinidia deliciosas
=450  \\$wnnna$aActinidias
=450  \\$wnnna$adeliciosa, Actinidia
=450  \\$wnnna$adeliciosas, Actinidia
=450  \\$aKiwi Plant
=450  \\$wnnna$aKiwi Plants
=450  \\$wnnna$aPlant, Kiwi
=450  \\$wnnna$aPlants, Kiwi
=550  \\$wg$aActinidiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family ACTINIDIACEAE, order Theales.
=688  \\$a2002
=750  \0$aActinidia$5IEN-M$0(DLC)sh 85000702

=LDR  01363cz  a2200265n  4500
=001  9880364228302441
=005  20141212214601.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029624
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750
=150  \\$aFerns
=450  \\$aBlechnum
=450  \\$wnnna$aBlechnums
=450  \\$wnnna$aFern
=550  \\$wg$aPteridophyta
=550  \\$wh$aDennstaedtiaceae
=550  \\$wh$aDryopteridaceae
=550  \\$wh$aMarsileaceae
=550  \\$wh$aPolypodiaceae
=550  \\$wh$aPteridaceae
=667  \\$aprefer specific plant; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific pIant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iSeedless nonflowering plants of the class Filicinae. They reproduce by spores that appear as dots on the underside of feathery fronds. In earlier classifications the Pteridophyta included the club mosses, horsetails, ferns, and various fossil groups. In more recent classifications, pteridophytes and spermatophytes (seed-bearing plants) are classified in the Subkingdom Tracheobionta (also known as Tracheophyta).
=688  \\$a2002
=750  \0$aFerns$5IEN-M$0(DLC)sh 85047836

=LDR  00870cz  a2200181n  4500
=001  9880364228402441
=005  20190702122308.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341.$x500
=150  \\$aActinidiaceae
=550  \\$wg$aEricales
=550  \\$wh$aActinidia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Theales, subclass Dilleniidae, class Magnoliopsida. It is best known for Kiwi fruit (ACTINIDIA).
=688  \\$a2002
=750  \0$aActinidiaceae$5IEN-M$0(DLC)sh 85000703

=LDR  01029cz  a2200193n  4500
=001  9880364228502441
=005  20190628101404.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x096
=150  \\$aAristolochiaceae
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAristolochia
=550  \\$wh$aAsarum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.
=688  \\$a2002
=750  \0$aAristolochiaceae$5IEN-M$0(DLC)sh 88022572

=LDR  01297cz  a2200349n  4500
=001  9880364228602441
=005  20190702132202.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341.$x984
=150  \\$aPrimulaceae
=450  \\$aAegiceras
=450  \\$wnnna$aLoosestrife, Yellow
=450  \\$wnnna$aLoosestrifes, Yellow
=450  \\$aLysimachia
=450  \\$wnnna$aLysimachias
=450  \\$aMyrsinaceae
=450  \\$aOncostemon
=450  \\$wnnna$aYellow Loosestrife
=450  \\$wnnna$aYellow Loosestrifes
=550  \\$wg$aEricales
=550  \\$wh$aAnagallis
=550  \\$wh$aArdisia
=550  \\$wh$aCyclamen
=550  \\$wh$aEmbelia
=550  \\$wh$aMaesa
=550  \\$wh$aMyrsine
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ERICALES, class MAGNOLIOPSIDA, with flowers having both stamens and pistil, producing encapsulated fruits
=688  \\$a2002
=750  \0$aPrimulaceae$5IEN-M$0(DLC)sh 85106709

=LDR  01070cz  a2200229n  4500
=001  9880364228702441
=005  20200422111247.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x984
=150  \\$aPortulacaceae
=450  \\$aClaytonia
=450  \\$wnnna$aClaytonias
=450  \\$aMontia
=450  \\$wnnna$aMontias
=550  \\$wg$aCaryophyllales
=550  \\$wh$aPortulaca
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. There are no true petals; each flower has two to six sepals. They produce betacyanin and betaxanthin pigments and lack anthocyanins.
=688  \\$a2002
=750  \0$aPortulacaceae$5IEN-M$0(DLC)sh 85105373

=LDR  01581cz  a2200349n  4500
=001  9880364228802441
=005  20141212214521.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029024
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x300.$x650
=072  \\$aB4.$x909.$x777.$x455.$x300.$x650
=150  \\$aMarburgvirus
=450  \\$wnnna$aFrankfurt-Marburg Syndrome Virus
=450  \\$wnnna$aFrankfurt Marburg Syndrome Virus
=450  \\$aLake Victoria marburgvirus
=450  \\$wnnna$aMarburg-like Virus
=450  \\$wnnna$aMarburg-like Viruses
=450  \\$wnnna$aMarburg like Viruses
=450  \\$wnnna$aMarburg Virus
=450  \\$wnnna$aMarburg Viruses
=450  \\$wnnna$amarburgvirus, Lake Victoria
=450  \\$wnnna$aMarburgviruses
=450  \\$wnnna$aVirus, Marburg
=450  \\$wnnna$aViruses, Marburg
=550  \\$wg$aFiloviridae
=667  \\$ainfection = MARBURG VIRUS DISEASE
=680  \\$iA genus in the family FILOVIRIDAE consisting of one species (Lake Victoria marburgvirus) with several strains. The genus shows no antigenic cross-reactivity with EBOLAVIRUS.
=688  \\$a2007 (2002); for LAKE VICTORIA MARBURGVIRUS use MARBURG-LIKE VIRUSES 1991-2001, use RHABDOVIRIDAE 1981-1990, use RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Marburg-like Viruses
=688  \\$a2002; for MARBURG VIRUS use MARBURG-LIKE VIRUSES 1991-2001, use RHABDOVIRIDAE 1981-1990, use RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977
=750  \0$aMarburg virus$0(DLC) sh 85080961$5IEN

=LDR  00826cz  a2200205n  4500
=001  9880364228902441
=005  20141212214520.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x500.$x600
=072  \\$aC22.$x706
=150  \\$aPeste-des-Petits-Ruminants
=450  \\$wnnna$aPeste des Petits Ruminants
=450  \\$wnnna$aPseudorinderpest
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aMorbillivirus Infections
=680  \\$iA highly fatal contagious disease of goats and sheep caused by PESTE-DES-PETITS-RUMINANTS VIRUS. The disease may be acute or subacute and is characterized by stomatitis, conjunctivitis, diarrhea, and pneumonia.
=688  \\$a2002; use RINDERPEST 1998-2001
=750  \0$aPeste des petits ruminants$5IEN-M$0(DLC)sh 89003899

=LDR  00970cz  a2200241n  4500
=001  9880364229002441
=005  20141212214600.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x700
=150  \\$aPolypodiaceae
=450  \\$aDrynaria
=450  \\$wnnna$aDrynariae
=450  \\$wnnna$aDrynarias
=450  \\$aGusuibu
=450  \\$wnnna$aGusuibus
=550  \\$wg$aFerns
=550  \\$wh$aPolypodium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta, subkingdom Tracheobionta.
=688  \\$a2002
=750  \0$aPolypodiaceae$5IEN-M$0(DLC)sh 85104713

=LDR  02160cz  a2200661n  4500
=001  9880364229102441
=005  20190628095029.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029064
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x050.$x750
=150  \\$aAraceae
=450  \\$wnnna$aAroid
=450  \\$wnnna$aAroideae
=450  \\$wnnna$aAroids
=450  \\$aCabbage, Skunk
=450  \\$wnnna$aCabbages, Skunk
=450  \\$aDracunculus Plant
=450  \\$wnnna$aDracunculus Plants
=450  \\$aLettuce, Water
=450  \\$wnnna$aLettuces, Water
=450  \\$aLysichiton
=450  \\$wnnna$aLysichitons
=450  \\$aMonstera
=450  \\$wnnna$aMonsteras
=450  \\$aOrontium
=450  \\$wnnna$aOrontiums
=450  \\$aPistia
=450  \\$wnnna$aPistia stratiote
=450  \\$wnnna$aPistia stratiotes
=450  \\$wnnna$aPistias
=450  \\$wnnna$aPlant, Dracunculus
=450  \\$wnnna$aPlants, Dracunculus
=450  \\$wnnna$aRhaphidophora
=450  \\$wnnna$aRhaphidophoras
=450  \\$aSkunk Cabbage
=450  \\$wnnna$aSkunk Cabbages
=450  \\$wnnna$astratiote, Pistia
=450  \\$wnnna$astratiotes, Pistia
=450  \\$aSymplocarpus
=450  \\$wnnna$aWater Lettuce
=450  \\$wnnna$aWater Lettuces
=550  \\$wg$aAlismatales
=550  \\$wh$aAlocasia
=550  \\$wh$aAmorphophallus
=550  \\$wh$aArisaema
=550  \\$wh$aArum
=550  \\$wh$aCalla Plant
=550  \\$wh$aColocasia
=550  \\$wh$aCyrtosperma
=550  \\$wh$aPhilodendron
=550  \\$wh$aPinellia
=550  \\$wh$aXanthosoma
=550  \\$wh$aZantedeschia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ALISMATALES. Many members contain OXALIC ACID and calcium oxalate (OXALATES).
=688  \\$a2002
=750  \0$aAraceae$5IEN-M$0(DLC)sh 85006362

=LDR  00900cz  a2200313n  4500
=001  9880364229202441
=005  20141212214520.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x56.$x902
=072  \\$aE2.$x565.$x640
=072  \\$aE2.$x779.$x249.$x902
=072  \\$aE2.$x779.$x496.$x640
=150  \\$aSteam Bath
=450  \\$wnnna$aBath, Finnish
=450  \\$wnnna$aBath, Steam
=450  \\$aBaths, Finnish
=450  \\$wnnna$aFinnish Bath
=450  \\$wnnna$aFinnish Sauna
=450  \\$wnnna$aLodge, Sweat
=450  \\$aSauna
=450  \\$aSweat Lodge
=550  \\$wg$aBalneology
=550  \\$wg$aHyperthermia, Induced
=550  \\$aSteam
=680  \\$iTherapy of sitting in a hot steamy room followed by a cool bath or shower.
=688  \\$a2002; see Baths, Finnish (1963-2001)
=750  \0$aSauna$5IEN$0(DLC)sh 85117721

=LDR  00827cz  a2200181n  4500
=001  9880364229302441
=005  20190628093637.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029063
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x084
=150  \\$aAquifoliaceae
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aIlex
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe holly plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aAquifoliaceae$5IEN-M$0(DLC)sh 88022558

=LDR  00766cz  a2200205n  4500
=001  9880364229402441
=005  20141212214516.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x165
=072  \\$aK1.$x752.$x566.$x479.$x116
=150  \\$aEthical Relativism
=450  \\$wnnna$aRelativism, Ethical
=550  \\$wg$aEthics
=550  \\$aCultural Diversity
=550  \\$aRetrospective Moral Judgment
=680  \\$iThe philosophical view that conceptions of truth and moral values are not absolute but are relative to the persons or groups holding them. (from American Heritage Dictionary of the English Language, 4th ed)
=688  \\$a2002
=750  \0$aEthical relativism$5IEN-M$0(DLC)sh 85045094

=LDR  01719cz  a2200601n  4500
=001  9880364229502441
=005  20180711151246.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x456.$x500
=150  \\$aApocynaceae
=450  \\$aAcokanthera
=450  \\$wnno$aAsclepiadaceae
=450  \\$wnnna$aCaralluma
=450  \\$aCarissa
=450  \\$wnnna$aGongronema
=450  \\$aCerbera
=450  \\$aChonemorpha
=450  \\$aCryptostegia
=450  \\$aHimatanthus
=450  \\$aPlumeria
=450  \\$aGomphocarpus
=450  \\$aRhazya
=550  \\$wg$aGentianales
=550  \\$wh$aAlstonia
=550  \\$wh$aAmsonia
=550  \\$wh$aApocynum
=550  \\$wh$aAsclepias
=550  \\$wh$aAspidosperma
=550  \\$wh$aCalotropis
=550  \\$wh$aCatharanthus
=550  \\$wh$aCryptolepis
=550  \\$wh$aCynanchum
=550  \\$wh$aGymnema
=550  \\$wh$aHemidesmus
=550  \\$wh$aHolarrhena
=550  \\$wh$aHoodia
=550  \\$wh$aMarsdenia
=550  \\$wh$aNerium
=550  \\$wh$aOchrosia
=550  \\$wh$aPeiploca
=550  \\$wh$aRauwolfia
=550  \\$wh$aStrophanthus
=550  \\$wh$aTabernaemontana
=550  \\$wh$aThevetia
=550  \\$wh$aTylophora
=550  \\$wh$aVinca
=550  \\$wh$aVincetoxicum
=550  \\$wh$aVoacanga
=680  \\$iThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters. Asclepiadaceae (formerly the milkweed family) has been included since 1999 and before 1810.
=688  \\$a2002
=750  \0$aApocynaceae$5IEN-M$0(DLC)sh 85006011

=LDR  01464cz  a2200349n  4500
=001  9880364229602441
=005  20141212214514.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x173.$x500
=072  \\$aN4.$x452.$x758.$x788.$x300.$x500
=072  \\$aN5.$x350.$x268.$x500
=072  \\$aN5.$x700.$x685.$x300.$x500
=150  \\$aEthics Committees, Clinical
=450  \\$wnnna$aClinical Ethics Committee
=450  \\$wnnna$aClinical Ethics Committees
=450  \\$wnnna$aCommittee, Clinical Ethics
=450  \\$wnnna$aCommittee, Hospital Ethics
=450  \\$wnnna$aCommittees, Clinical Ethics
=450  \\$wnnna$aCommittees, Hospital Ethics
=450  \\$wnnna$aEthics Committee, Clinical
=450  \\$wnnna$aEthics Committee, Hospital
=450  \\$wnnna$aEthics Committees, Hospital
=450  \\$wnnna$aHospital Ethics Committee
=450  \\$wnnna$aHospital Ethics Committees
=550  \\$wg$aEthics Committees
=550  \\$aEthics, Clinical
=667  \\$adistinguish from ETHICS COMMITTEES, RESEARCH
=680  \\$iHospital or other institutional ethics committees established to consider the ethical dimensions of patient care. Distinguish from ETHICS COMMITTEES, RESEARCH, which are established to monitor the welfare of patients or healthy volunteers participating in research studies.
=688  \\$a2002
=750  \0$aMedical ethics committees$5IEN-M$0(DLC)sh 97006646

=LDR  00617cz  a2200157n  4500
=001  9880364229702441
=005  20141212214514.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028725
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x949
=150  \\$aTheology
=550  \\$wg$aReligion
=680  \\$iThe study of religion and religious belief, or a particular system or school of religious beliefs and teachings (from online Cambridge Dictionary of American English, 2000 and WordNet: An Electronic Lexical Database, 1997)
=688  \\$a2002; use RELIGION 1978-2001
=750  \0$aTheology$5IEN-M$0(DLC)sh 85134665

=LDR  00821cz  a2200193n  4500
=001  9880364229802441
=005  20141212214559.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x823
=150  \\$aPolygalaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aPolygala
=550  \\$wh$aSecuridaca
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aPolygalaceae$5IEN-M$0(DLC)sh 88023015

=LDR  00683cz  a2200217n  4500
=001  9880364229902441
=005  20141212214513.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x500.$x840
=072  \\$aK1.$x559.$x840
=072  \\$aK1.$x752.$x566.$x840
=150  \\$aVirtues
=450  \\$wnnna$aVirtue
=550  \\$wg$aMorals
=550  \\$aSocial Values
=667  \\$afor "virtue theory," coordinate with ETHICAL THEORY
=680  \\$iCharacter traits that are considered to be morally praiseworthy. (Bioethics Thesaurus)
=688  \\$a2002; use SOCIAL VALUES 1987-2001
=750  \0$aVirtues$5IEN-M$0(DLC)sh 85143810

=LDR  01880cz  a2200493n  4500
=001  9880364230002441
=005  20141212214513.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x650
=072  \\$aN3.$x706.$x437.$x650
=150  \\$aPatient Rights
=450  \\$wnnna$aPatient Right
=450  \\$wnnna$aPatient's Right
=450  \\$wnnna$aPatients' Right
=450  \\$wnnna$aPatient's Rights
=450  \\$wnnna$aPatients' Rights
=450  \\$wnnna$aPatients Rights
=450  \\$wnnna$aRight, Patient
=450  \\$wnnna$aRight, Patient's
=450  \\$wnnna$aRight, Patients'
=450  \\$aRight to Treatment
=450  \\$wnnna$aRight to Treatments
=450  \\$wnnna$aRights, Patient
=450  \\$wnnna$aRights, Patient's
=450  \\$wnnna$aRights, Patients'
=450  \\$wnnna$aTreatment, Right to
=450  \\$wnnna$aTreatments, Right to
=550  \\$wg$aHuman Rights
=550  \\$wh$aConfidentiality
=550  \\$wh$aInformed Consent
=550  \\$wh$aPatient Access to Records
=550  \\$wh$aRight to Die
=550  \\$wh$aTherapeutic Misconception
=550  \\$wh$aTreatment Refusal
=550  \\$aBioethical Issues
=550  \\$aPatient Advocacy
=550  \\$aTruth Disclosure
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iFundamental claims of patients, as expressed in statutes, declarations, or generally accepted moral principles. (Bioethics Thesaurus) The term is used for discussions of patient rights as a group of many rights, as in a hospital's posting of a list of patient rights.
=688  \\$a2002; use PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT use PATIENT ADVOCACY 1978-2001
=750  \0$aPatients$xCivil rights$5IEN-M$0(DLC)sh 98005010
=750  \0$aPatients$xLegal status, laws, etc.$5IEN-M$0(DLC)sh 88006248

=LDR  00957cz  a2200229n  4500
=001  9880364230102441
=005  20141212214513.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028683
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696.$x586
=150  \\$aNational Socialism
=450  \\$wnnna$aNazi
=450  \\$wnnna$aNazis
=450  \\$wnnna$aNazism
=450  \\$wnnna$aSocialism, National
=550  \\$wg$aPolitical Systems
=550  \\$aHolocaust
=667  \\$aspecify geog
=680  \\$iThe doctrines and policies of the Nazis or the National Social German Workers party, which ruled Germany under Adolf Hitler from 1933-1945. These doctrines and policies included racist nationalism, expansionism, and state control of the economy. (from Columbia Encyclopedia, 6th ed. and American Heritage College Dictionary, 3d ed.)
=688  \\$a2002; for NAZISM use POLITICAL SYSTEMS 1990-2001
=750  \0$aNational socialism$5IEN-M$0(DLC)sh 85090131

=LDR  00800cz  a2200253n  4500
=001  9880364230202441
=005  20141212214511.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150.$x725
=150  \\$aMentally Ill Persons
=450  \\$wnnna$aIll, Mentally
=450  \\$aMental Patients
=450  \\$wnnna$aMentally Ill
=450  \\$wnnna$aMentally Ill Person
=450  \\$wnnna$aPerson, Mentally Ill
=450  \\$wnnna$aPersons, Mentally Ill
=550  \\$wg$aDisabled Persons
=550  \\$aCommitment of Mentally Ill
=550  \\$aMental Disorders
=680  \\$iPersons with psychiatric illnesses or diseases, particularly psychotic and severe mood disorders.
=688  \\$a2002
=750  \0$aMentally ill$5IEN-M$0(DLC)sh 85083699

=LDR  01440cz  a2200553n  4500
=001  9880364230302441
=005  20141212214510.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x956
=150  \\$aTransition Elements
=450  \\$wnnna$aElements, Transition
=550  \\$wg$aElements
=550  \\$wh$aCadmium
=550  \\$wh$aChromium
=550  \\$wh$aCobalt
=550  \\$wh$aCopper
=550  \\$wh$aGold
=550  \\$wh$aHafnium
=550  \\$wh$aIridium
=550  \\$wh$aIron
=550  \\$wh$aLawrencium
=550  \\$wh$aLutetium
=550  \\$wh$aManganese
=550  \\$wh$aMercury
=550  \\$wh$aMolybdenum
=550  \\$wh$aNickel
=550  \\$wh$aNiobium
=550  \\$wh$aOsmium
=550  \\$wh$aPalladium
=550  \\$wh$aPlatinum
=550  \\$wh$aRhenium
=550  \\$wh$aRhodium
=550  \\$wh$aRuthenium
=550  \\$wh$aScandium
=550  \\$wh$aSilver
=550  \\$wh$aTantalum
=550  \\$wh$aTechnetium
=550  \\$wh$aTitanium
=550  \\$wh$aTungsten
=550  \\$wh$aVanadium
=550  \\$wh$aYttrium
=550  \\$wh$aZinc
=550  \\$wh$aZirconium
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iElements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements.
=688  \\$a2002
=750  \0$aTransition metals$5IEN-M$0(DLC)sh 85136954

=LDR  01028cz  a2200253n  4500
=001  9880364230402441
=005  20141212214509.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028529
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x625
=150  \\$aPastinaca
=450  \\$wnnna$aParsnip
=450  \\$aParsnips
=450  \\$wnnna$aPastinaca sativa
=450  \\$wnnna$aPastinaca sativas
=450  \\$wnnna$aPastinacas
=450  \\$wnnna$asativa, Pastinaca
=450  \\$wnnna$asativas, Pastinaca
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. The roots are used as food.
=688  \\$a2002; for PARSNIPS use APIACEAE 1998-2001
=750  \0$aPastinaca$0(DLC)sh2006002487$5IEN

=LDR  01050cz  a2200253n  4500
=001  9880364230502441
=005  20141212214509.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028528
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x750
=150  \\$aPetroselinum
=450  \\$wnnna$acrispum, Petroselinum
=450  \\$wnnna$acrispums, Petroselinum
=450  \\$aParsley
=450  \\$wnnna$aParsleys
=450  \\$wnnna$aPetroselinum crispum
=450  \\$wnnna$aPetroselinum crispums
=450  \\$wnnna$aPetroselinums
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE used for flavoring food.
=688  \\$a2002; for PARSLEY use APIACEAE 1998-2001
=750  \0$aPetroselinum$0(DLC)sh2007004509$5IEN-M

=LDR  01013cz  a2200253n  4500
=001  9880364230602441
=005  20141212214509.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028527
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x233
=150  \\$aCuminum
=450  \\$aCumin
=450  \\$wnnna$aCumins
=450  \\$wnnna$aCuminum cyminum
=450  \\$wnnna$aCuminum cyminums
=450  \\$wnnna$aCuminums
=450  \\$wnnna$acyminum, Cuminum
=450  \\$wnnna$acyminums, Cuminum
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. The seed is used in SPICES.
=688  \\$a2002; for CUMIN use APIACEAE 1998-2001
=750  \0$aCuminum$0(DLC)sh2006006419$5IEN-M

=LDR  01175cz  a2200277n  4500
=001  9880364230702441
=005  20141212214508.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028526
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x211
=150  \\$aCoriandrum
=450  \\$aCilantro
=450  \\$wnnna$aCilantros
=450  \\$aCoriander
=450  \\$wnnna$aCorianders
=450  \\$wnnna$aCoriandrum sativum
=450  \\$wnnna$aCoriandrum sativums
=450  \\$wnnna$aCoriandrums
=450  \\$wnnna$asativum, Coriandrum
=450  \\$wnnna$asativums, Coriandrum
=550  \\$wg$aApiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. The leaves are the source of cilantro and the seeds are the source of coriander, both of which are used in SPICES.
=688  \\$a2002; use APIACEAE 1998-2001
=750  \0$aCoriandrum$5IEN-M$0(DLC)sh 85032600

=LDR  01287cz  a2200313n  4500
=001  9880364230902441
=005  20141212214508.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028524
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x77
=150  \\$aAnethum graveolens
=450  \\$wnnna$aAnethum graveolen
=450  \\$wnnna$aDill Plant
=450  \\$wnnna$aDill Plants
=450  \\$wnnna$aDill Weed
=450  \\$wnnna$aDill Weeds
=450  \\$wnnna$agraveolen, Anethum
=450  \\$wnnna$agraveolens, Anethum
=450  \\$wnnna$aPlant, Dill
=450  \\$wnnna$aPlants, Dill
=450  \\$wnnna$aWeed, Dill
=450  \\$wnnna$aWeeds, Dill
=550  \\$wg$aApiaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAnethum graveolens L. is a plant species of the family APIACEAE. The leaves are considered as a spice (SPICES).
=688  \\$a2002; for DILL PLANT use APIACEAE 1998-2001
=688  \\$a2002; for DILL use APIACEAE 1998-2001
=750  \0$aDill$5IEN-M$0(DLC)sh 85038016

=LDR  01423cz  a2200325n  4500
=001  9880364231002441
=005  20141212214508.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x900.$x333
=150  \\$aElettaria
=450  \\$aAmomum cardamomum
=450  \\$wnnna$aAmomum cardamomums
=450  \\$aCardamom
=450  \\$wnnna$aCardamoms
=450  \\$wnnna$acardamomum, Amomum
=450  \\$wnnna$acardamomum, Elettaria
=450  \\$wnnna$acardamomums, Amomum
=450  \\$wnnna$acardamomums, Elettaria
=450  \\$aCardamon
=450  \\$wnnna$aCardamons
=450  \\$wnnna$aElettaria cardamomum
=450  \\$wnnna$aElettaria cardamomums
=450  \\$wnnna$aElettarias
=550  \\$wg$aZingiberaceae
=667  \\$aX ref AMOMUM CARDAMOMUM: AMOMUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZINGIBERACEAE, order Zingiberales, subclass Zingiberidae. Elettaria cardamomum (L.) Maton is the source of Cardamom used in SPICES.
=688  \\$a2002; for CARDAMON use ZINGIBERALES 1998-2001
=750  \0$aElettaria$5IEN-M$0(DLC)sh 88022764

=LDR  01000cz  a2200181n  4500
=001  9880364231102441
=005  20141212214507.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028522
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x555
=150  \\$aMusaceae
=550  \\$wg$aZingiberales
=550  \\$wh$aMusa
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida best known for banana (MUSA). The slender false trunk, formed by leaf sheaths of the spirally arranged leaves, may rise to 15 meters (50 feet). There is a crown of large leaves at the top.
=688  \\$a2002
=750  \0$aMusaceae$5IEN-M$0(DLC)sh 85088661

=LDR  01211cz  a2200253n  4500
=001  9880364231202441
=005  20141212214507.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x555.$x500
=150  \\$aMusa
=450  \\$aBanana
=450  \\$aBanana Plant
=450  \\$wnnna$aBanana Plants
=450  \\$wnnna$aBananas
=450  \\$wnnna$aMusas
=450  \\$wnnna$aPlant, Banana
=450  \\$wnnna$aPlants, Banana
=550  \\$wg$aMusaceae
=667  \\$aPlantain, the banana-like fruit and green plantain flour go here; the medicinal herb referred to by the common name plantain probably goes under PLANTAGO; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Musaceae, order Zingiberales, subclass Zingiberidae, class Liliopsida.
=688  \\$a2002; for BANANA use ZINGIBERALES 1998-2001; use FRUIT 1983-1997
=750  \0$aBananas$5IEN-M$0(DLC)sh 85011450

=LDR  01387cz  a2200313n  4500
=001  9880364231302441
=005  20141212214507.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028503
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x200
=150  \\$aCephaelis
=450  \\$wnnna$aCephaeli
=450  \\$wnnna$aCephaelis ipecacuanha
=450  \\$wnnna$aCephaelis ipecacuanhas
=450  \\$wnnna$aipecacuanha, Cephaelis
=450  \\$wnnna$aipecacuanha, Psychotria
=450  \\$wnnna$aipecacuanhas, Cephaelis
=450  \\$wnnna$aipecacuanhas, Psychotria
=450  \\$wnnna$aPsychotria ipecacuanha
=450  \\$wnnna$aPsychotria ipecacuanhas
=450  \\$wnnna$aUragoga
=450  \\$wnnna$aUragogas
=550  \\$wg$aRubiaceae
=550  \\$aIpecac
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE, order Rubiales, subclass Asteridae. Cephaelis ipecacuanha is the source of IPECAC.
=688  \\$a2002; use RUBIACEAE 1999-2001; use IPECAC 1977-1998; for URAGOGA use RUBIACEAE 1999-2001, use IPECAC 1977-1998
=750  \0$aCephaelis$5IEN-M$0(DLC)sh 85021965

=LDR  01370cz  a2200313n  4500
=001  9880364231402441
=005  20141212214506.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028502
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x437
=150  \\$aPolygonum
=450  \\$aBistort
=450  \\$wnnna$aBistorts
=450  \\$aBuckwheat, False
=450  \\$wnnna$aBuckwheats, False
=450  \\$wnnna$aFalse Buckwheat
=450  \\$wnnna$aFalse Buckwheats
=450  \\$aKnotweed
=450  \\$wnnna$aKnotweeds
=450  \\$wnnna$aPolygonums
=450  \\$aSmartweed
=450  \\$wnnna$aSmartweeds
=550  \\$wg$aPolygonaceae
=550  \\$wh$aPolygonum cuspidatum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYGONACEAE that is an ingredient of Shou-Wu-Pian, a Chinese herbal preparation (DRUGS, CHINESE HERBAL). The common name of black bindweed also refers to TAMUS or Fallopia (use POLYGONACEAE).
=688  \\$a2002, 1963-1985; use POLYGONACEAE 1998-2001, use PLANTS, MEDICINAL 1986-1997
=750  \0$aPolygonum$5IEN-M$0(DLC)sh 85104638

=LDR  00876cz  a2200181n  4500
=001  9880364231502441
=005  20141212214506.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x700.$x555
=150  \\$aMalva
=450  \\$wnnna$aMalvas
=550  \\$wg$aMalvaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MALVACEAE, order Malvales, subclass Dilleniida. The common name of 'Mallow' may sometimes get confused with other plants.
=688  \\$a2002; use MALVACEAE 1996-2001
=750  \0$aMalva$5IEN-M$0(DLC)sh 85080230

=LDR  00958cz  a2200217n  4500
=001  9880364231602441
=005  20141212214505.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x700.$x100
=150  \\$aAbelmoschus
=450  \\$aAbelmoschus esculentus
=450  \\$wnnna$aesculentus, Abelmoschus
=450  \\$aOkra
=450  \\$wnnna$aOkras
=550  \\$wg$aMalvaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MALVACEAE, order Malvales, subclass Dilleniidae best known for okra.
=688  \\$a2002; for OKRA use MALVACEAE 1996-2001
=750  \0$aAbelmoschus$0(DLC)sh2007005915$5IEN

=LDR  01315cz  a2200289n  4500
=001  9880364231702441
=005  20141212214505.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x399
=150  \\$aHevea
=450  \\$wnnna$abrasilienses, Hevea
=450  \\$wnnna$abrasiliensis, Hevea
=450  \\$wnnna$aHevea brasilienses
=450  \\$aHevea brasiliensis
=450  \\$wnnna$aHeveas
=450  \\$aRubber Tree
=450  \\$wnnna$aRubber Trees
=450  \\$wnnna$aTree, Rubber
=450  \\$wnnna$aTrees, Rubber
=550  \\$wg$aEuphorbiaceae
=550  \\$aRubber
=667  \\$ado not confuse with FICUS which is sometimes called rubberplant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. Commercial natural RUBBER is mainly obtained from Hevea brasiliensis but also from some other plants.
=688  \\$a2002; for RUBBER TREE use EUPHORBIACEAE 1998-2001
=750  \0$aHevea$5IEN-M$0(DLC)sh 85060560

=LDR  01287cz  a2200229n  4500
=001  9880364231802441
=005  20141212193014.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028481
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x333
=150  \\$aEuphorbia
=450  \\$wnnna$aChamaesyce hirta
=450  \\$wnnna$aEuphorbia hirta
=450  \\$wnnna$aEuphorbias
=450  \\$aSpurge
=450  \\$wnnna$aSpurges
=550  \\$wg$aEuphorbiaceae
=667  \\$anote entry term SPURGE: restrict to EUPHORBIA; SPURGE, JAPANESE see PACHYSANDRA is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil, surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.
=688  \\$a2002; for SPURGE use EUPHORBIACEAE 1998-2001
=750  \0$aEuphorbia$5IEN-M$0(DLC)sh 85045600

=LDR  01195cz  a2200277n  4500
=001  9880364231902441
=005  20141212214505.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028464
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x222
=150  \\$aCucurbita
=450  \\$wnnna$aCucurbitas
=450  \\$wnnna$aPlant, Squash
=450  \\$wnnna$aPlants, Squash
=450  \\$wnnna$aPumpkin
=450  \\$aPumpkins
=450  \\$aSquash Plant
=450  \\$wnnna$aSquash Plants
=450  \\$wnnna$aSquashe
=450  \\$aSquashes
=550  \\$wg$aCucurbitaceae
=667  \\$ado not confuse with Squash (Sport) = RACQUET SPORTS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae, which includes pumpkin, gourd and squash.
=688  \\$a2002; for PUMPKINS & SQUASHES use CUCURBITACEAE 1998-2001
=750  \0$aCucurbita$5IEN-M$0(DLC)sh 85034677

=LDR  01058cz  a2200229n  4500
=001  9880364232002441
=005  20141212214504.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028463
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x188.$x444
=150  \\$aCucumis melo
=450  \\$wnnna$aCantaloupe
=450  \\$aCantaloupes
=450  \\$wnnna$aCucumis melos
=450  \\$wnnna$amelo, Cucumis
=450  \\$wnnna$amelos, Cucumis
=550  \\$wg$aCucumis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family CUCURBITACEAE, order Violales, subclass Dilleniidae known for the melon fruits with reticulated (net) surface including cantaloupes, honeydew, casaba, and Persian melons.
=688  \\$a2002
=750  \0$aMuskmelon$5IEN-M$0(DLC)sh 85089059

=LDR  01076cz  a2200205n  4500
=001  9880364232102441
=005  20141212214504.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028462
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300.$x188
=150  \\$aCucumis
=450  \\$wnnna$aCucumi
=550  \\$wg$aCucurbitaceae
=550  \\$wh$aCucumis melo
=550  \\$wh$aCucumis sativus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae best known for cucumber (CUCUMIS SATIVUS) and cantaloupe (CUCUMIS MELO). Watermelon is a different genus, CITRULLUS. Bitter melon may refer to MOMORDICA or this genus.
=688  \\$a2002; use CUCURBITACEAE 1996-2001
=750  \0$aCucumis$5IEN-M$0(DLC)sh 85034676

=LDR  01040cz  a2200241n  4500
=001  9880364232202441
=005  20141212214504.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x987
=150  \\$aZygophyllaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aBalanites
=550  \\$wh$aGuaiacum
=550  \\$wh$aLarrea
=550  \\$wh$aPeganum
=550  \\$wh$aTribulus
=550  \\$wh$aZygophyllum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida which is a small family of small trees and shrubs growing in arid and warm regions.
=688  \\$a2002
=750  \0$aZygophyllaceae$5IEN-M$0(DLC)sh 85150086

=LDR  01084cz  a2200217n  4500
=001  9880364232302441
=005  20141212214503.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x100.$x375
=072  \\$aD10.$x251.$x355.$x411
=150  \\$aIsoprostanes
=450  \\$wnnna$aIsoprostane
=550  \\$wg$aArachidonic Acids
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wh$aF2-Isoprostanes
=550  \\$wh$aNeuroprostanes
=680  \\$iA series of prostaglandin-like compounds that are produced by the attack of free-radical species on unsaturated fatty acids, especially ARACHIDONIC ACID, of cellular MEMBRANES. Once cleaved from the lipid membrane by the action of phospholipases they can circulate into various bodily fluids and eventually be excreted. Although these compounds resemble enzymatically synthesized prostaglandins their stereoisometric arrangement is usually different than the "naturally occurring" compounds.
=688  \\$a2002
=750  \0$aIsoprostanes$0(DLC)sh2006004544$5IEN-M

=LDR  00807cz  a2200241n  4500
=001  9880364232402441
=005  20141212214502.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x504
=072  \\$aB4.$x909.$x777.$x500
=150  \\$aNidovirales
=450  \\$wnnna$aNidovirus
=450  \\$aNidoviruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aArteriviridae
=550  \\$wh$aCoronaviridae
=550  \\$wh$aRoniviridae
=667  \\$ainfection = NIDOVIRALES INFECTIONS
=680  \\$iAn order comprising three families of eukaryotic viruses possessing linear, nonsegmented, positive sense RNA genomes. The families are CORONAVIRIDAE; ARTERIVIRIDAE; and RONIVIRIDAE.
=688  \\$a2002
=750  \0$aNidoviruses$0(DLC)sh2007005762$5IEN-M

=LDR  02476cz  a2200529n  4500
=001  9880364232502441
=005  20141212214502.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x660
=150  \\$aMitochondrial Diseases
=450  \\$wnnna$aDeficiencies, Oxidative Phosphorylation
=450  \\$wnnna$aDeficiencies, Respiratory Chain
=450  \\$wnnna$aDeficiency, Oxidative Phosphorylation
=450  \\$wnnna$aDeficiency, Respiratory Chain
=450  \\$wnnna$aDisease, Mitochondrial
=450  \\$wnnna$aDisorder, Mitochondrial
=450  \\$wnnna$aDisorders, Mitochondrial
=450  \\$aElectron Transport Chain Deficiencies, Mitochondrial
=450  \\$wnnna$aMitochondrial Disease
=450  \\$wnnna$aMitochondrial Disorder
=450  \\$wnnna$aMitochondrial Disorders
=450  \\$wnnna$aMitochondrial Electron Transport Chain Deficiencies
=450  \\$wnnna$aMitochondrial Respiratory Chain Deficiencies
=450  \\$aOxidative Phosphorylation Deficiencies
=450  \\$wnnna$aOxidative Phosphorylation Deficiency
=450  \\$wnnna$aPhosphorylation Deficiencies, Oxidative
=450  \\$wnnna$aPhosphorylation Deficiency, Oxidative
=450  \\$aRespiratory Chain Deficiencies, Mitochondrial
=450  \\$wnnna$aRespiratory Chain Deficiency
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aCarbamoyl-Phosphate Synthase I Deficiency Disease
=550  \\$wh$aCytochrome-c Oxidase Deficiency
=550  \\$wh$aFriedreich Ataxia
=550  \\$wh$aKearns-Sayre Syndrome
=550  \\$wh$aLeigh Disease
=550  \\$wh$aMitochondrial Myopathies
=550  \\$wh$aMultiple Acyl Coenzyme A Dehydrogenase Deficiency
=550  \\$wh$aOptic Atrophy, Autosomal Dominant
=550  \\$wh$aOptic Atrophy, Hereditary, Leber
=550  \\$wh$aPyruvate Carboxylase Deficiency Disease
=550  \\$wh$aPyruvate Dehydrogenase Complex Deficiency Disease
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iDiseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
=688  \\$a2002; use MITOCHONDRIAL MYOPATHIES 2000-2001
=750  \0$aMitochondrial pathology$5IEN-M$0(DLC)sh 90003586

=LDR  01078cz  a2200277n  4500
=001  9880364232602441
=005  20141212214501.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x500
=072  \\$aD6.$x472.$x699.$x9
=072  \\$aD12.$x644.$x548.$x9
=072  \\$aD12.$x776.$x395.$x22
=150  \\$aActivins
=450  \\$wnnna$aActivin
=450  \\$wnnna$aFSH-Releasing Protein
=450  \\$wnnna$aFSH Releasing Protein
=450  \\$wnnna$aProtein, FSH-Releasing
=550  \\$wg$aGlycoproteins
=550  \\$wg$aGonadal Hormones
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aInhibin-beta Subunits
=680  \\$iActivins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
=688  \\$a2002; use ACTIVINS (NM) 1987-2001
=750  \0$aActivin$5IEN-M$0(DLC)sh 97005108

=LDR  00920cz  a2200205n  4500
=001  9880364232702441
=005  20141212214500.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795.$x249
=150  \\$aChelidonium
=450  \\$aCelandine
=450  \\$wnnna$aCelandines
=450  \\$wnnna$aChelidoniums
=550  \\$wg$aPapaveraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PAPAVERACEAE, order Papaverales, subclass Magnoliidae.
=688  \\$a2002; use PAPAVER 1998-2001, use PLANTS, MEDICINAL 1986-1997
=750  \0$aChelidonium$5IEN-M$0(DLC)sh 96009458

=LDR  00986cz  a2200217n  4500
=001  9880364232802441
=005  20141212214459.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028244
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x500.$x500
=150  \\$aCamellia
=450  \\$wnnna$aCamellias
=450  \\$aThea
=450  \\$wnnna$aTheas
=550  \\$wg$aTheaceae
=550  \\$wh$aCamellia sinensis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family THEACEAE, order THEALES best known for CAMELLIA SINENSIS which is the source of Oriental TEA.
=688  \\$a2002; for CAMELLIA & THEA use Theales 1999-2001, use TEA 1986-1998
=750  \0$aCamellias$5IEN-M$0(DLC)sh 85019114

=LDR  01048cz  a2200229n  4500
=001  9880364232902441
=005  20190702133636.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x500
=150  \\$aTheaceae
=450  \\$aGordonia Plant
=450  \\$wnnna$aGordonia Plants
=450  \\$wnnna$aPlant, Gordonia
=450  \\$wnnna$aPlants, Gordonia
=550  \\$wg$aEricales
=550  \\$wh$aCamellia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida, best known for CAMELLIA SINENSIS, which is the source of Oriental TEA.
=688  \\$a2002; use Theales 1999-2001
=750  \0$aTheaceae$5IEN-M$0(DLC)sh 85134520

=LDR  01094cz  a2200229n  4500
=001  9880364233002441
=005  20141212214455.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028225
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x992
=150  \\$aTsuga
=450  \\$aHemlock Tree
=450  \\$wnnna$aHemlock Trees
=450  \\$wnnna$aTree, Hemlock
=450  \\$wnnna$aTrees, Hemlock
=450  \\$wnnna$aTsugas
=550  \\$wg$aPinaceae
=667  \\$adistinguish from hemlock plants (CICUTA or CONIUM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees and should not be confused with hemlock plants (CICUTA and CONIUM).
=688  \\$a2002
=750  \0$aTsuga$5IEN-M$0(DLC)sh 85138338

=LDR  01111cz  a2200229n  4500
=001  9880364233102441
=005  20141212214455.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028224
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x984
=150  \\$aPseudotsuga
=450  \\$aDouglas Fir
=450  \\$wnnna$aDouglas Firs
=450  \\$aFir, Douglas
=450  \\$wnnna$aFirs, Douglas
=450  \\$wnnna$aPseudotsugas
=550  \\$wg$aPinaceae
=667  \\$anote X ref: FIR TREE see ABIES is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees with long, flat, spirally arranged needles that grow directly from the branch.
=688  \\$a2002
=750  \0$aPseudotsuga$5IEN-M$0(DLC)sh 85108310

=LDR  01787cz  a2200493n  4500
=001  9880364233202441
=005  20141212214454.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x777
=150  \\$aPinus
=450  \\$wnnna$aabies, Pinus
=450  \\$wnnna$aaby, Pinus
=450  \\$wnnna$amaritima, Pinus
=450  \\$wnnna$amaritimas, Pinus
=450  \\$wnnna$apinaster, Pinus
=450  \\$wnnna$apinasters, Pinus
=450  \\$aPine Tree
=450  \\$wnnna$aPine Trees
=450  \\$wnnna$aPinus abies
=450  \\$wnnna$aPinus aby
=450  \\$wnnna$aPinus maritima
=450  \\$wnnna$aPinus maritimas
=450  \\$wnnna$aPinus pinaster
=450  \\$wnnna$aPinus pinasters
=450  \\$wnnna$aPinus radiata
=450  \\$wnnna$aPinus radiatas
=450  \\$wnnna$aPinus tremula
=450  \\$wnnna$aPinus tremulas
=450  \\$wnnna$aradiata, Pinus
=450  \\$wnnna$aradiatas, Pinus
=450  \\$wnnna$aTree, Pine
=450  \\$wnnna$aTrees, Pine
=450  \\$wnnna$atremula, Pinus
=450  \\$wnnna$atremulas, Pinus
=550  \\$wg$aPinaceae
=550  \\$wh$aPinus ponderosa
=550  \\$wh$aPinus sylvestris
=550  \\$wh$aPinus taeda
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen trees mainly in temperate climates.
=688  \\$a2002
=750  \0$aPine$5IEN-M$0(DLC)sh 85102199

=LDR  01111cz  a2200229n  4500
=001  9880364233302441
=005  20141212214454.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x755
=150  \\$aPicea
=450  \\$wnnna$aPiceas
=450  \\$aSpruce Tree
=450  \\$wnnna$aSpruce Trees
=450  \\$wnnna$aTree, Spruce
=450  \\$wnnna$aTrees, Spruce
=550  \\$wg$aPinaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves is jointed near the stem on a separate woody base.
=688  \\$a2002
=750  \0$aSpruce$5IEN-M$0(DLC)sh 85127037

=LDR  00891cz  a2200229n  4500
=001  9880364233402441
=005  20141212214453.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x444
=150  \\$aLarix
=450  \\$aLarch
=450  \\$wnnna$aLarchs
=450  \\$wnnna$aLarices
=450  \\$aTamarack
=450  \\$wnnna$aTamaracks
=550  \\$wg$aPinaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.
=688  \\$a2002
=750  \0$aLarix$5IEN-M

=LDR  01187cz  a2200217n  4500
=001  9880364233502441
=005  20141212214453.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028203
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x222
=150  \\$aCedrus
=450  \\$aCedar Tree
=450  \\$wnnna$aCedar Trees
=450  \\$wnnna$aTree, Cedar
=450  \\$wnnna$aTrees, Cedar
=550  \\$wg$aPinaceae
=667  \\$aX ref CEDAR TREE: check text; restrict to genus CEDRUS; do not use for other genera referred to as cedar in the literature; check MeSH for other cedar terms; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. It is the source of cedarwood oil. Cedar ordinarily refers to this but also forms part of the name of plants in other genera.
=688  \\$a2002
=750  \0$aCedrus$5IEN-M$0(DLC)sh 85021602

=LDR  00997cz  a2200253n  4500
=001  9880364233602441
=005  20141212214452.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666
=150  \\$aPinaceae
=550  \\$wg$aConiferophyta
=550  \\$wh$aAbies
=550  \\$wh$aCedrus
=550  \\$wh$aLarix
=550  \\$wh$aPicea
=550  \\$wh$aPinus
=550  \\$wh$aPseudotsuga
=550  \\$wh$aTsuga
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Pinales, class Pinopsida, division Coniferophyta, known for the various conifers.
=688  \\$a2002
=750  \0$aPinaceae$5IEN-M$0(DLC)sh 85102188

=LDR  01393cz  a2200313n  4500
=001  9880364233702441
=005  20141212214452.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028184
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735.$x888.$x699
=150  \\$aPhoradendron
=450  \\$wnnna$aAmerican Mistletoe
=450  \\$wnnna$aleucarpum, Phoradendron
=450  \\$wnnna$aleucarpum, Viscum
=450  \\$wnnna$aleucarpums, Phoradendron
=450  \\$wnnna$aleucarpums, Viscum
=450  \\$aMistletoe, American
=450  \\$wnnna$aPhoradendron leucarpum
=450  \\$wnnna$aPhoradendron leucarpums
=450  \\$wnnna$aPhoradendrons
=450  \\$wnnna$aViscum leucarpum
=450  \\$wnnna$aViscum leucarpums
=550  \\$wg$aViscaceae
=550  \\$aLoranthaceae
=667  \\$aX ref MISTLETOE, AMERICAN: several mistletoe terms are available, check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family VISCACEAE, order Santalales, subclass Rosidae. Members contain phoratoxin and oleanane TRITERPENES.
=688  \\$a2002
=750  \0$aPhoradendron$5IEN-M$0(DLC)sh 88022989

=LDR  01544cz  a2200325n  4500
=001  9880364233802441
=005  20141212214451.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028183
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735.$x249
=150  \\$aLoranthaceae
=450  \\$wnnna$aAfrican Mistletoe
=450  \\$wnnna$aArgentine Mistletoe
=450  \\$wnnna$acuneifolia, Ligaria
=450  \\$wnnna$acuneifolias, Ligaria
=450  \\$aDendrophtora
=450  \\$wnnna$aDendrophtoras
=450  \\$aLigaria cuneifolia
=450  \\$wnnna$aLigaria cuneifolias
=450  \\$wnnna$aMistletoe, African
=450  \\$wnnna$aMistletoe, Argentine
=450  \\$aTapinanthus
=450  \\$aTaxillus
=550  \\$wg$aMistletoe
=550  \\$aPhoradendron
=667  \\$aX ref MISTLETOE, ARGENTINE: several mistletoe terms are available, check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe showy mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. This includes parasitic tropical plants with haustoria connecting to the hosts. The leaves are opposite and thick. The flowers (4-7) have both calyx and corolla. The fruit is a berry with one seed.
=688  \\$a2002
=750  \0$aLoranthaceae$5IEN-M$0(DLC)sh 85078345

=LDR  01503cz  a2200229n  4500
=001  9880364233902441
=005  20141212214451.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028182
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735.$x888.$x750.$x500
=150  \\$aViscum album
=450  \\$wnnna$aalbum, Viscum
=450  \\$wnnna$aalbums, Viscum
=450  \\$wnnna$aEuropean Mistletoe
=450  \\$aMistletoe, European
=450  \\$wnnna$aViscum albums
=550  \\$wg$aViscum
=667  \\$aX ref MISTLETOE, EUROPEAN: several mistletoe terms are available, check text and MeSH; Christmas mistletoe goes here; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family VISCACEAE, order Santalales, subclass Rosidae. This is the traditional mistletoe of literature and Christmas. Members contain viscotoxin (5 kDa basic polypeptides related to thionins), beta-galactoside- and N-acetyl-D-galactosamine-specific lectin II (60 kDa), and polysaccharides. Mistletoe lectin I is a type 2 ribosome-inactivating protein. Commercial extracts include Plenosol, Eurixor, Helixor Isorel, Iscador, and NSC 635089 (ANTINEOPLASTIC AGENTS, PHYTOGENIC).
=688  \\$a2002
=750  \0$aEuropean mistletoe$5IEN-M$0(DLC)sh 85045837

=LDR  01056cz  a2200193n  4500
=001  9880364234002441
=005  20141212214450.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028181
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735.$x888.$x750
=150  \\$aViscum
=450  \\$wnnna$aViscums
=550  \\$wg$aViscaceae
=550  \\$wh$aViscum album
=667  \\$aVISCUM LEUCARPUM see PHORADENDRON is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family VISCACEAE, order Santalales, subclass Rosidae, class Magnoliopsida. Species of this genus contain cytotoxic LECTINS. The common name of MISTLETOE is used for many species of this and the LORANTHACEAE families.
=688  \\$a2002; use MISTLETOE 1963-2001
=750  \0$aViscum$5IEN$0(DLC)sh 88001093

=LDR  01147cz  a2200241n  4500
=001  9880364234102441
=005  20141212214450.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735.$x888
=150  \\$aViscaceae
=450  \\$aArceuthobium
=450  \\$wnnna$aArceuthobiums
=450  \\$aKorthalsella
=450  \\$wnnna$aKorthalsellas
=550  \\$wg$aMistletoe
=550  \\$wh$aPhoradendron
=550  \\$wh$aViscum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe Christmas Mistletoe plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasitic primarily on coniferous trees forming a drooping evergreen bush of leathery leaves on tree branches. The berries are sticky and toxic.
=688  \\$a2002
=750  \0$aViscaceae$5IEN-M$0(DLC)sh2001000580

=LDR  01000cz  a2200229n  4500
=001  9880364234202441
=005  20141212214450.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x444
=150  \\$aHeliotropium
=450  \\$aHeliotrope, True
=450  \\$wnnna$aHeliotropes, True
=450  \\$wnnna$aHeliotropiums
=450  \\$wnnna$aTrue Heliotrope
=450  \\$wnnna$aTrue Heliotropes
=550  \\$wg$aBoraginaceae
=667  \\$adistinguish from PHOTOTROPISM and VALERIAN; specify Plant Components; for /Chem coord with D tree compound and/or Preparation; for therap. coordinate with Diseases and PHYTOTHERAPY
=680  \\$iA plant genus in the family Boraginaceae, order Lamiales, subclass Asteridae. This is the True Heliotrope that should not be confused with an unrelated plant sometimes called Garden Heliotrope (VALERIAN).
=688  \\$a2002
=750  \0$aHeliotropium$5IEN-M$0(DLC)sh 88022825

=LDR  01065cz  a2200229n  4500
=001  9880364234302441
=005  20200430134012.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x937
=150  \\$aValerianaceae
=450  \\$aCentranthus
=550  \\$wg$aDipsacales
=550  \\$wh$aNardostachys
=550  \\$wh$aPatrinia
=550  \\$wh$aValerian
=550  \\$wh$aValerianella
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe Valerian plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida that is characterized by 3-5-lobed tubular flowers, often spurred at the base and clustered in tight heads.
=688  \\$a2002
=750  \0$aValerianaceae$5IEN-M$0(DLC)sh 85141837

=LDR  01517cz  a2200301n  4500
=001  9880364234402441
=005  20141212214448.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028144
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x125.$x500.$x500
=150  \\$aPodophyllum peltatum
=450  \\$wnnna$aAmerican Mandrake
=450  \\$wnnna$aAmerican Mandrakes
=450  \\$wnnna$aApple, May
=450  \\$wnnna$aApples, May
=450  \\$aMandrake, American
=450  \\$wnnna$aMandrakes, American
=450  \\$wnnna$aMay Apple
=450  \\$wnnna$aMay Apples
=450  \\$wnnna$apeltatum, Podophyllum
=450  \\$wnnna$apeltatums, Podophyllum
=450  \\$wnnna$aPodophyllum peltatums
=550  \\$wg$aPodophyllum
=667  \\$ado not confuse X refs MANDRAKE, AMERICAN with MANDRAKE, EUROPEAN see MANDRAGORA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant of the genus PODOPHYLLUM, family BERBERIDACEAE (sometimes classified as Podophyllaceae) which is the source of PODOPHYLLIN and of PODOPHYLLOTOXIN that inhibits DNA TOPOISOMERASES, TYPE II. It is different from the European mandrake, MANDRAGORA.
=688  \\$a2002; for MANDRAKE, AMERICAN use Podophyllum 1985-2001
=750  \0$aPodophyllum peltatum$5IEN-M$0(DLC)sh 85103689

=LDR  01359cz  a2200277n  4500
=001  9880364234502441
=005  20141212214448.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028143
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x125.$x374
=150  \\$aMahonia
=450  \\$wnnna$aaquifolium, Mahonia
=450  \\$wnnna$aaquifoliums, Mahonia
=450  \\$wnnna$aBarberries, Hollyleaved
=450  \\$aBarberry, Hollyleaved
=450  \\$wnnna$aHollyleaved Barberries
=450  \\$wnnna$aHollyleaved Barberry
=450  \\$wnnna$aMahonia aquifolium
=450  \\$wnnna$aMahonia aquifoliums
=450  \\$wnnna$aMahonias
=550  \\$wg$aBerberidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family BERBERIDACEAE. Oregon Grape was discovered in North America and classified by Pursh as a BERBERIS but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Now botanists insist on Berberis while horticulturists stay with this genus. It is a source of BERBERINE.
=688  \\$a2002
=750  \0$aMahonia$5IEN-M$0(DLC)sh 85079859

=LDR  01445cz  a2200205n  4500
=001  9880364234602441
=005  20141212214448.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028142
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x125.$x249
=150  \\$aBerberis
=450  \\$wnnna$aBarberries
=450  \\$aBarberry
=450  \\$wnnna$aBerberi
=550  \\$wg$aBerberidaceae
=667  \\$aX ref BARBERRY: HOLLYLEAVED BARBERRY see MAHONIA is also available; BAYBERRY see MYRICA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family BERBERIDACEAE. The common names of Barberry or Oregon Grape are also used for MAHONIA. The similar-named Bayberry is the unrelated MYRICA. Oregon Grape was classified by Pursh as a Berberis but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Botanists insist on this name while horticulturists stay with Mahonia. They are shrubs with yellow wood and usually three-branched spines at the base of leafstalks. Flowers are yellow, six-petaled and fruit is a berry with one to several seeds. Members contain BERBERINE.
=688  \\$a2002
=750  \0$aBarberries$5IEN-M$0(DLC)sh 85011795

=LDR  00988cz  a2200229n  4500
=001  9880364234702441
=005  20190702134757.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028141
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x125
=150  \\$aBerberidaceae
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aBerberis
=550  \\$wh$aCaulophyllum
=550  \\$wh$aEpimedium
=550  \\$wh$aMahonia
=550  \\$wh$aPodophyllum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe Barberry plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. The shrubs have spiny leaves.
=688  \\$a2002
=750  \0$aBerberidaceae$5IEN-M$0(DLC)sh 85013288

=LDR  01210cz  a2200229n  4500
=001  9880364234802441
=005  20141212214447.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795
=150  \\$aPapaveraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aArgemone
=550  \\$wh$aChelidonium
=550  \\$wh$aEschscholzia
=550  \\$wh$aPapaver
=550  \\$wh$aSanguinaria
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe poppy plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. These have bisexual, regular, cup-shaped flowers with one superior pistil and many stamens; 2 or 3 conspicuous, separate sepals and a number of separate petals. The fruit is a capsule. Leaves are usually deeply cut or divided into leaflets.
=688  \\$a2002; use Papaver 1998-2001
=750  \0$aPapaveraceae$5IEN-M$0(DLC)sh 85097570

=LDR  01591cz  a2200385n  4500
=001  9880364234902441
=005  20141212214446.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028084
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249
=150  \\$aClusiaceae
=450  \\$aAllanblackia
=450  \\$wnnna$aAllanblackias
=450  \\$aCratoxylum
=450  \\$wnnna$aCratoxylums
=450  \\$aHypericaceae
=450  \\$aPlum, Waika
=450  \\$wnnna$aPlums, Waika
=450  \\$aPsorospermum
=450  \\$wnnna$aPsorospermums
=450  \\$aRheedia
=450  \\$wnnna$aRheedias
=450  \\$wnnna$aWaika Plum
=450  \\$wnnna$aWaika Plums
=550  \\$wg$aTheales
=550  \\$wh$aCalophyllum
=550  \\$wh$aClusia
=550  \\$wh$aGarcinia
=550  \\$wh$aHypericum
=550  \\$wh$aMammea
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe mangosteen plant family (sometimes classified as Guttiferae; also known as Hypericaceae) of the order THEALES, subclass Dilleniidae, class Magnoliopsida. It includes trees and shrubs with resinous, sticky sap, usually with broad-ended, oblong, leathery leaves with a strong, central vein, flowers with many stamens.
=688  \\$a2002; use Theales 1999-2001
=750  \0$aGuttiferae$5IEN-M$0(DLC)sh 85058003

=LDR  01047cz  a2200205n  4500
=001  9880364235002441
=005  20161122163337.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028083
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x800
=150  \\$aScrophulariaceae
=550  \\$wg$aLamiales
=550  \\$wh$aBuddleja
=550  \\$wh$aScrophularia
=550  \\$wh$aVerbascum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe figwort plant family of the order Lamiales. The family is characterized by bisexual flowers with tubular corollas (fused petals) that are bilaterally symmetrical (two-lips) and have four stamens in most, two of which are usually shorter.
=688  \\$a2002
=750  \0$aScrophulariaceae$5IEN-M$0(DLC)sh 85118989

=LDR  01591cz  a2200433n  4500
=001  9880364235102441
=005  20141212214445.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150
=150  \\$aBoraginaceae
=450  \\$aAlkanna
=450  \\$wnnna$aAlkannas
=450  \\$aAnchusa
=450  \\$wnnna$aAnchusas
=450  \\$wnnna$aArnebia
=450  \\$wnnna$aArnebias
=450  \\$aCynoglossum
=450  \\$wnnna$aCynoglossums
=450  \\$aEhretia
=450  \\$wnnna$aEhretias
=450  \\$aOnosma
=450  \\$wnnna$aOnosmas
=450  \\$aTournefortia
=450  \\$wnnna$aTournefortias
=550  \\$wg$aAngiosperms
=550  \\$wh$aAmsinckia
=550  \\$wh$aBorago
=550  \\$wh$aComfrey
=550  \\$wh$aCordia
=550  \\$wh$aEchium
=550  \\$wh$aHeliotropium
=550  \\$wh$aLithospermum
=550  \\$wh$aPulmonaria
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe Borage plant family is in the class Magnoliopsida, subclass Asteridae, order Lamiales. It is characterized by hairy foliage, usually alternate and simple; flowers are funnel-shaped or tubular. Some of the species contain PYRROLIZIDINE ALKALOIDS.
=688  \\$a2002
=750  \0$aBoraginaceae$0(DLC) sh 85015798$5IEN-M

=LDR  01091cz  a2200253n  4500
=001  9880364235202441
=005  20141212214443.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x798
=150  \\$aPimpinella
=450  \\$aAnise
=450  \\$wnnna$aAnises
=450  \\$wnnna$aanisum, Pimpinella
=450  \\$wnnna$aanisums, Pimpinella
=450  \\$aPimpinella anisum
=450  \\$wnnna$aPimpinella anisums
=450  \\$wnnna$aPimpinellas
=550  \\$wg$aApiaceae
=667  \\$adistinguish from Star Anise (ILLICIUM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family APIACEAE (Umbelliferae) that is used in SPICES and is a source of anethole.
=688  \\$a2003; use APIACEAE 1998-2001
=750  \0$aPimpinella$5IEN-M$0(DLC)sh 85102183

=LDR  01558cz  a2200373n  4500
=001  9880364235302441
=005  20141212193014.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x180
=150  \\$aCentella
=450  \\$wnnna$aasiatica, Centella
=450  \\$wnnna$aasiatica, Hydrocotyle
=450  \\$wnnna$aasiaticas, Centella
=450  \\$wnnna$aasiaticas, Hydrocotyle
=450  \\$wnnna$aCentella asiatica
=450  \\$wnnna$aCentella asiaticas
=450  \\$wnnna$aCentellas
=450  \\$aGotu kola
=450  \\$wnnna$aGotu kolas
=450  \\$aHydrocotyle
=450  \\$aHydrocotyle asiatica
=450  \\$wnnna$aHydrocotyle asiaticas
=450  \\$wnnna$aHydrocotyles
=450  \\$wnnna$akola, Gotu
=450  \\$wnnna$akolas, Gotu
=450  \\$aMandukaparni
=450  \\$wnnna$aMandukaparnus
=550  \\$wg$aApiaceae
=667  \\$afor Cola or Kola see COLA; BITTER KOLA see GARCINIA KOLA is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant of the family APIACEAE which is the source of asiatic acid and asiaticoside. Centella asiatica (L.) Urb. = Hydrocotyle asiatica L. is known for effect on peripheral circulation.
=688  \\$a2002
=750  \0$aHydrocotyle$5IEN-M$0(DLC)sh 96004548

=LDR  01371cz  a2200349n  4500
=001  9880364235402441
=005  20141212214443.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028024
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x750
=150  \\$aSerenoa
=450  \\$wnnna$arepen, Serenoa
=450  \\$wnnna$arepens, Serenoa
=450  \\$aSabal
=450  \\$wnnna$aSabal serrulata
=450  \\$wnnna$aSabal serrulatas
=450  \\$wnnna$aSabals
=450  \\$wnnna$aSerenoa repen
=450  \\$wnnna$aSerenoa repens
=450  \\$wnnna$aSerenoa serrulata
=450  \\$wnnna$aSerenoa serrulatas
=450  \\$wnnna$aSerenoas
=450  \\$wnnna$aserrulata, Sabal
=450  \\$wnnna$aserrulata, Serenoa
=450  \\$wnnna$aserrulatas, Sabal
=450  \\$wnnna$aserrulatas, Serenoa
=550  \\$wg$aArecaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract (Permixon) is used for PROSTATIC HYPERPLASIA.
=688  \\$a2002
=750  \0$aSerenoa$5IEN-M$0(DLC)sh 99005028

=LDR  01274cz  a2200385n  4500
=001  9880364235502441
=005  20190628101006.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028023
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x093
=150  \\$aArecaceae
=450  \\$wnnna$aBactri
=450  \\$aBactris
=450  \\$aMetroxylon
=450  \\$wnnna$aMetroxylons
=450  \\$aPalm, Peach
=450  \\$wnnna$aPalms, Peach
=450  \\$aPeach Palm
=450  \\$wnnna$aPeach Palms
=450  \\$aPejibaye
=450  \\$wnnna$aPejibayes
=450  \\$aPijiguao
=450  \\$wnnna$aPijiguaos
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAreca
=550  \\$wh$aCalamus
=550  \\$wh$aCocos
=550  \\$wh$aEuterpe
=550  \\$wh$aPhoeniceae
=550  \\$wh$aSerenoa
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iThe palm family of order Arecales, subclass Arecidae, class Liliopsida.
=688  \\$a2002
=750  \0$aPalms$5IEN-M$0(DLC)sh 85097246

=LDR  00911cz  a2200253n  4500
=001  9880364235602441
=005  20160930102141.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D028001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x87.$x374
=150  \\$aEleutherococcus
=450  \\$wnno$aAcanthopanax
=450  \\$aCiwujia
=450  \\$aEleuthero
=450  \\$aGinseng, Siberian
=450  \\$wnnna$aGinsengs, Siberian
=450  \\$aSiberian Ginseng
=450  \\$wnnna$aSiberian Ginsengs
=550  \\$wg$aAraliaceae
=667  \\$anote entry term SIBERIAN GINSENG; do not confuse with GINSENG see PANAX
=680  \\$iA plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is best known as an adaptogen and a substitute for PANAX GINSENG.
=688  \\$a2002; use ELEUTHEROCOCC (NM) 1987-2001
=750  \0$aEleutherococcus$5IEN-M$0(DLC)sh 85042538

=LDR  01206cz  a2200253n  4500
=001  9880364235702441
=005  20141212214440.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027983
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x87.$x249
=150  \\$aAralia
=450  \\$wnnna$aAralias
=450  \\$aSarsaparilla, Wild
=450  \\$wnnna$aSarsaparillas, Wild
=450  \\$aSpikenard
=450  \\$wnnna$aSpikenards
=450  \\$aWild Sarsaparilla
=450  \\$wnnna$aWild Sarsaparillas
=550  \\$wg$aAraliaceae
=667  \\$ado not confuse with Sarsaparilla = Smilax (use SMILACACEAE) or with East Indian Sarsaparilla = Hemidesmus (use ASCLEPIADACEAE); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It includes Aralia californica S. Watson, Aralia nudicaulis L., and Aralia racemosa L.
=688  \\$a2002
=750  \0$aSpikenard$5IEN-M$0(DLC)sh 85126639

=LDR  01072cz  a2200277n  4500
=001  9880364235802441
=005  20141212214435.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x44.$x555
=150  \\$aPistacia
=450  \\$aMastictree
=450  \\$wnnna$aMastictrees
=450  \\$wnnna$aNut, Pistachio
=450  \\$wnnna$aNuts, Pistachio
=450  \\$aPistachio
=450  \\$wnnna$aPistachio Nut
=450  \\$wnnna$aPistachio Nuts
=450  \\$wnnna$aPistachios
=450  \\$wnnna$aPistacias
=550  \\$wg$aAnacardiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the ANACARDIACEAE family known for the Pistachio nuts and for gum Mastic.
=688  \\$a2002
=750  \0$aPistacia$5IEN-M$0(DLC)sh 85102466

=LDR  01625cz  a2200433n  4500
=001  9880364235902441
=005  20190626124239.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.x250.$x044
=150  \\$aAnacardiaceae
=450  \\$wnnna$aBrazilian Peppertree
=450  \\$wnnna$aCalifornia Peppertree
=450  \\$aCotinus
=450  \\$aLannea
=450  \\$wnnna$aLanneas
=450  \\$aLithrea
=450  \\$wnnna$aLithreas
=450  \\$aMarula
=450  \\$wnnna$aMarulas
=450  \\$aPeppertree, Brazilian
=450  \\$aPeppertree, California
=450  \\$aSchinus
=450  \\$aSclerocarya
=450  \\$wnnna$aSclerocaryas
=450  \\$wnnna$aSpondia
=450  \\$aSpondias
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAnacardium
=550  \\$wh$aMangifera
=550  \\$wh$aPistacia
=550  \\$wh$aRhus
=550  \\$wh$aSemecarpus
=550  \\$wh$aToxicodendron
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe sumac plant family in the order Sapindales, subclass Rosidae, class Magnoliopsida. They are tropical and subtropical trees, shrubs, and woody vines that have resin ducts in the bark. The sap of many of the species is irritating to the skin.
=688  \\$a2002
=750  \0$aAnacardiaceae$0(DLC) sh 85004740$5IEN-M

=LDR  01310cz  a2200277n  4500
=001  9880364236002441
=005  20190624105152.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027925
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x500.$x750
=150  \\$aViburnum
=450  \\$wnnna$aBark, Cramp
=450  \\$wnnna$aBarks, Cramp
=450  \\$aCramp Bark
=450  \\$wnnna$aCramp Barks
=450  \\$wnnna$aCranberries, Highbush
=450  \\$aCranberry, Highbush
=450  \\$wnnna$aHighbush Cranberries
=450  \\$aHighbush Cranberry
=450  \\$wnnna$aViburnums
=550  \\$wg$aAdoxaceae
=667  \\$ado not confuse with true cranberry = VACCINIUM MACROCARPON; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family CAPRIFOLIACEAE. The common name derives from its traditional use for menstrual cramps. It is a source of viburnine, valerianic acid, vibsanin, and ursolic acid. Note that true cranberry is VACCINIUM MACROCARPON.
=688  \\$a2002
=750  \0$aViburnum$5IEN-M$0(DLC)sh 85143143

=LDR  01303cz  a2200301n  4500
=001  9880364236102441
=005  20141212214434.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027924
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x180.$x500.$x500
=150  \\$aSambucus nigra
=450  \\$aBlack Elder
=450  \\$wnnna$aBlack Elders
=450  \\$aElder, Black
=450  \\$aElder, European
=450  \\$wnnna$aElders, Black
=450  \\$wnnna$aElders, European
=450  \\$wnnna$aEuropean Elder
=450  \\$wnnna$aEuropean Elders
=450  \\$wnnna$anigra, Sambucus
=450  \\$wnnna$anigras, Sambucus
=450  \\$wnnna$aSambucus nigras
=550  \\$wg$aSambucus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species in the genus SAMBUCUS, known for the elderberry fruit. The plant is also a source of Sambucus nigra lectins and ribosome-inactivating protein.
=688  \\$a2002; use SAMBUCUS RIBOSOME-INACTIVATING PROTEIN (NM) 1999-2001
=750  \0$aEuropean elder$5IEN-M$0(DLC)sh 96010723

=LDR  00957cz  a2200265n  4500
=001  9880363923302441
=005  20141212205448.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012458
=035  \\$aCBA5766M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x860
=072  \\$aD2.$x65.$x793.$x650
=150  \\$aSalicylanilides
=450  \\$aN-Phenylsalicylamides
=450  \\$wnnna$aN Phenylsalicylamides
=550  \\$wg$aAnilides
=550  \\$wg$aSalicylamides
=550  \\$wh$aNiclosamide
=550  \\$wh$aOxyclozanide
=550  \\$wh$aRafoxanide
=667  \\$aantifungals
=680  \\$i2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes.
=688  \\$a91(77); was see under SALICYLAMIDES 1977-90
=750  \0$aSalicylanilides$0(DLC)sh2006001589$5IEN-M

=LDR  01384cz  a2200469n  4500
=001  9880363923402441
=005  20141212205448.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012456
=035  \\$aCBA5764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417.$x700
=072  \\$aN4.$x452.$x677.$x800
=150  \\$aSalaries and Fringe Benefits
=450  \\$wnnna$aBenefit, Fringe
=450  \\$wnnna$aBenefit, Paternity
=450  \\$wnnna$aBenefits, Fringe
=450  \\$wnnna$aBenefits, Paternity
=450  \\$aEmployee Fringe Benefits$5IEN
=450  \\$wnnna$aEquities, Pay
=450  \\$wnnna$aEquity, Pay
=450  \\$wnnna$aFringe Benefit
=450  \\$aFringe Benefits
=450  \\$wnnna$aPaternity Benefit
=450  \\$wnnna$aPaternity Benefits
=450  \\$wnnna$aPay Equities
=450  \\$wnnna$aPay Equity
=450  \\$wnnna$aSalaries
=450  \\$wnnna$aSalary
=450  \\$wnnna$aWage
=450  \\$aWages
=550  \\$wg$aIncome
=550  \\$wg$aPersonnel Management
=550  \\$wh$aFamily Leave
=550  \\$wh$aHealth Benefit Plans, Employee
=550  \\$wh$aSick Leave
=550  \\$aIncome
=667  \\$aDF: SALARIES
=680  \\$iThe remuneration paid or benefits granted to an employee.
=688  \\$a78
=750  \0$aEmployee fringe benefits$5IEN-M$0(DLC)sh 85042858
=750  \0$aWages$5IEN-HS$0(DLC)sh 85144526

=LDR  00925cz  a2200277n  4500
=001  9880363923502441
=005  20141212205447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012455
=035  \\$aCBA5763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x700
=150  \\$aSalamandridae
=450  \\$wnnna$aNewt
=450  \\$aNewts
=450  \\$aTaricha
=450  \\$wnnna$aTarichas
=550  \\$wg$aUrodela
=550  \\$wh$aNotophthalmus
=550  \\$wh$aPleurodeles
=550  \\$wh$aSalamandra
=550  \\$wh$aTriturus
=667  \\$aGEN: prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa.
=688  \\$a81; was NEWTS see under SALAMANDERS 1972-80
=750  \0$aSalamandridae$5IEN$0(DLC)sh 85116691

=LDR  00729cz  a2200193n  4500
=001  9880363923602441
=005  20141212205447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012454
=035  \\$aCBA5762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x700.$x610
=150  \\$aSalamandra
=450  \\$wnnna$aSalamandras
=550  \\$wg$aSalamandridae
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra (European "fire" salamander) and Salamandra atra (European alpine salamander).
=688  \\$a72
=750  \0$aSalamandra$5IEN$0(DLC)sh 85116689

=LDR  01132cz  a2200241n  4500
=001  9880363923702441
=005  20141212205447.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012453
=035  \\$aCBA5761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x710.$x710
=150  \\$aSaimiri
=450  \\$aMonkey, Squirrel
=450  \\$wnnna$aMonkeys, Squirrel
=450  \\$wnnna$aSaimirus
=450  \\$aSquirrel Monkey
=450  \\$wnnna$aSquirrel Monkeys
=550  \\$wg$aSaimirinae
=667  \\$aNew World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii (red-backed squirrel monkey), S. sciureus (common squirrel monkey), and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies.
=688  \\$a91(81); was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80
=750  \0$aSquirrel monkeys$5IEN$0(DLC)sh 85127114

=LDR  01514cz  a2200373n  4500
=001  9880363923802441
=005  20141212205446.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012452
=035  \\$aCBA5760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x150.$x710
=150  \\$aSaguinus
=450  \\$wnnna$aCotton-Top Marmoset
=450  \\$wnnna$aCotton-Top Marmosets
=450  \\$wnnna$aLong-Tusked Marmoset
=450  \\$wnnna$aLong-Tusked Marmosets
=450  \\$wnnna$aLong-tusked Tamarin
=450  \\$wnnna$aLong-tusked Tamarins
=450  \\$aMarmoset, Cotton-Top
=450  \\$wnnna$aMarmoset, Cotton Top
=450  \\$aMarmoset, Long-Tusked
=450  \\$wnnna$aMarmoset, Long Tusked
=450  \\$wnnna$aMarmosets, Cotton-Top
=450  \\$wnnna$aMarmosets, Long-Tusked
=450  \\$wnnna$aSaguinus oedipus
=450  \\$wnnna$aTamarin, Long-tusked
=450  \\$aTamarins, Long-tusked
=450  \\$wnnna$aTamarins, Long tusked
=550  \\$wg$aCallitrichinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA genus in the subfamily CALLITRICHINAE consisting of 12 species and found in Panama as well as South America. Species seen most frequently in the literature are S. oedipus (cotton-top marmoset), S. nigricollis, and S. fusicollis.
=688  \\$a91(81); was see under CALLITHRICIDAE 1981-90
=750  \0$aSaguinus$5IEN$0(DLC)sh 85116497

=LDR  01214cz  a2200289n  4500
=001  9880363923902441
=005  20141212205446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012450
=035  \\$aCBA5758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x750
=072  \\$aD10.$x212.$x507.$x750
=072  \\$aD10.$x627.$x700.$x840
=072  \\$aD20.$x215.$x784.$x750.$x840
=072  \\$aJ2.$x500.$x375.$x400.$x700
=150  \\$aSafflower Oil
=450  \\$wnnna$aOil, Safflower
=450  \\$wnnna$aOils, Safflower
=450  \\$wnnna$aSafflower Oils
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=667  \\$aan unsaturated fat
=680  \\$iAn oily liquid extracted from the seeds of the safflower, Carthamus tinctorius. It is used as a dietary supplement in the management of HYPERCHOLESTEROLEMIA. It is used also in cooking, as a salad oil, and as a vehicle for medicines, paints, varnishes, etc. (Dorland, 28th ed & Random House Unabridged Dictionary, 2d ed)
=688  \\$a91(75); was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74
=750  \0$aSafflower oil$5IEN$0(DLC)sh 88006607

=LDR  00774cz  a2200217n  4500
=001  9880363924002441
=005  20160609131227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012448
=035  \\$aCBA5756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x700
=150  \\$aSadism
=450  \\$wnnna$aSadism, Sexual
=450  \\$wnnna$aSadisms
=450  \\$wnnna$aSadisms, Sexual
=450  \\$aSexual Sadism
=450  \\$wnnna$aSexual Sadisms
=550  \\$wg$aParaphilic Disorders
=680  \\$iA condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious.
=750  \0$aSadism$5IEN$0(DLC)sh 85116425

=LDR  00569cz  a2200169n  4500
=001  9880363924102441
=005  20141212205445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012447
=035  \\$aCBA5755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x717
=150  \\$aSacrum
=450  \\$wnnna$aSacrums
=550  \\$wg$aSpine
=667  \\$aa bone of the spine; do not confuse with LUMBOSACRAL REGION or SACROCOCCYGEAL REGION, both locational: use term in the text; coord IM with specific disease (IM)
=750  \0$aSacrum$5IEN$0(DLC)sh 85116403

=LDR  00663cz  a2200217n  4500
=001  9880363924202441
=005  20141212205444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012446
=035  \\$aCBA5754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x707
=150  \\$aSacroiliac Joint
=450  \\$wnnna$aJoint, Sacroiliac
=450  \\$wnnna$aJoints, Sacroiliac
=450  \\$wnnna$aSacroiliac Joints
=550  \\$wg$aJoints
=550  \\$aSacroiliitis
=667  \\$ainflammation = Sacroiliitis
=680  \\$iThe immovable joint formed by the lateral surfaces of the SACRUM and ILIUM.
=750  \0$aSacroiliac joint$5IEN$0(DLC)sh 85116401

=LDR  00921cz  a2200289n  4500
=001  9880363924302441
=005  20141212205444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012445
=035  \\$aCBA5753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x176.$x780
=150  \\$aSacrococcygeal Region
=450  \\$aCoccygeal Region
=450  \\$wnnna$aCoccygeal Regions
=450  \\$wnnna$aRegion, Coccygeal
=450  \\$wnnna$aRegion, Sacral
=450  \\$wnnna$aRegion, Sacrococcygeal
=450  \\$wnnna$aRegions, Coccygeal
=450  \\$wnnna$aRegions, Sacral
=450  \\$wnnna$aRegions, Sacrococcygeal
=450  \\$aSacral Region
=450  \\$wnnna$aSacral Regions
=450  \\$wnnna$aSacrococcygeal Regions
=550  \\$wg$aBack
=667  \\$anot a substitute for the bones SACRUM & COCCYX; this is merely locational & usually NIM
=750  \0$aSacrococcygeal region$5IEN$0(DLC)sh 85116398

=LDR  01593cz  a2200457n  4500
=001  9880363924402441
=005  20141212205443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012441
=035  \\$aCBA5749HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x785.$x800
=072  \\$aB1.$x300.$x930.$x705.$x655
=150  \\$aSaccharomyces cerevisiae
=450  \\$wnnna$aBaker Yeast
=450  \\$wnnna$aBaker Yeasts
=450  \\$aBaker's Yeast
=450  \\$wnnna$aBakers Yeast
=450  \\$wnnna$aBaker's Yeasts
=450  \\$wnnna$aBrewer Yeast
=450  \\$aBrewer's Yeast
=450  \\$wnnna$aBrewers Yeast
=450  \\$wnnna$aBrewer's Yeasts
=450  \\$wnnna$acerevisiae, S
=450  \\$wnnna$acerevisiae, Saccharomyces
=450  \\$wnnna$aS cerevisiae
=450  \\$wnnna$aYeast, Baker
=450  \\$aYeast, Baker's
=450  \\$wnnna$aYeast, Bakers
=450  \\$wnnna$aYeast, Brewer
=450  \\$aYeast, Brewer's
=450  \\$wnnna$aYeast, Brewers
=450  \\$wnnna$aYeasts, Baker
=450  \\$wnnna$aYeasts, Baker's
=450  \\$wnnna$aYeasts, Brewer's
=550  \\$wg$aSaccharomyces
=550  \\$aSaccharomyces cerevisiae Proteins
=667  \\$ause YEAST, DRIED for brewer's yeast or baker's yeast used as a nutritional supplement or therapeutically
=680  \\$iA species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
=688  \\$a73(72)
=750  \0$aSaccharomyces cerevisiae$5IEN$0(DLC)sh 87002577

=LDR  00820cz  a2200241n  4500
=001  9880363924502441
=005  20181213105908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012440
=035  \\$aCBA5748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x785
=072  \\$aB1.$x300.$x930.$x705
=150  \\$aSaccharomyces
=450  \\$wnnna$aSaccharomyce
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=550  \\$wh$aSaccharomyces boulardii
=550  \\$wh$aSaccharomyces cerevisiae
=667  \\$athere are many species but check Dorland for those wrongly called Saccharomyces
=680  \\$iA genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.
=688  \\$a64; was see under YEASTS 1963
=750  \0$aSaccharomyces$5IEN$0(DLC)sh 85116225

=LDR  00760cz  a2200253n  4500
=001  9880363924602441
=005  20141212205442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012439
=035  \\$aCBA5747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x687
=072  \\$aD3.$x383.$x129.$x708.$x89.$x708
=072  \\$aD3.$x438.$x185.$x708
=150  \\$aSaccharin
=450  \\$wnnna$aCalcium, Saccharin
=450  \\$wnnna$aSaccharin Calcium
=450  \\$wnnna$aSaccharin Sodium
=550  \\$wg$aBenzothiazoles
=550  \\$wg$aThiazoles
=667  \\$aD25-26 qualif
=680  \\$iFlavoring agent and non-nutritive sweetener.
=688  \\$a71(70); was see under SWEETENING AGENTS 1963-70
=750  \0$aSaccharin$5IEN$0(DLC)sh 85116223

=LDR  01002cz  a2200301n  4500
=001  9880363924702441
=005  20141212205442.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012438
=035  \\$aCBA5746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x640.$x260.$x500
=150  \\$aSaccades
=450  \\$wnnna$aEye Movement, Saccadic
=450  \\$wnnna$aEye Movements, Saccadic
=450  \\$wnnna$aMovement, Saccadic Eye
=450  \\$wnnna$aMovements, Saccadic Eye
=450  \\$aPursuit, Saccadic
=450  \\$wnnna$aPursuits, Saccadic
=450  \\$wnnna$aSaccade
=450  \\$wnnna$aSaccadic Eye Movement
=450  \\$aSaccadic Eye Movements
=450  \\$wnnna$aSaccadic Pursuit
=450  \\$wnnna$aSaccadic Pursuits
=550  \\$wg$aEye Movements
=680  \\$iAn abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading.
=688  \\$a91(75); was see under EYE MOVEMENTS 1975-90
=750  \0$aSaccadic eye movements$5IEN$0(DLC)sh 85116218

=LDR  01753cz  a2200457n  4500
=001  9880363924802441
=005  20141212205441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012436
=035  \\$aCBA5744HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x676.$x180
=072  \\$aD3.$x438.$x759.$x590.$x138.$x264
=072  \\$aD12.$x125.$x166.$x676.$x180
=072  \\$aD13.$x570.$x583.$x138.$x264
=072  \\$aD13.$x570.$x800.$x96.$x264
=150  \\$aS-Adenosylmethionine
=450  \\$wnnna$aAdemetionine
=450  \\$wnnna$aAdemetionine Europharma Brand
=450  \\$aAdoMet
=450  \\$wnnna$aAmet, S
=450  \\$wnnna$aASTA Medica Brand of Ademetionine Tosilate Disulfate
=450  \\$wnnna$aEuropharma Brand of Ademetionine
=450  \\$wnnna$aFO-1561
=450  \\$wnnna$aFO 1561
=450  \\$wnnna$aFO1561
=450  \\$wnnna$aGumbaral
=450  \\$wnnna$aKnoll Brand of Brand of Ademetionine Tosilate Disulfate
=450  \\$wnnna$aS Adenosylmethionine
=450  \\$wnnna$aS-Adenosylmethionine Sulfate Tosylate
=450  \\$wnnna$aS Adenosylmethionine Sulfate Tosylate
=450  \\$wnnna$aS Amet
=450  \\$wnnna$aSamyr
=450  \\$wnnna$aSulfate Tosylate, S-Adenosylmethionine
=450  \\$wnnna$aTosylate, S-Adenosylmethionine Sulfate
=550  \\$wg$aAdenosine
=550  \\$wg$aMethionine
=667  \\$a/biosyn /physiol permitted; DF: note short X ref
=680  \\$iPhysiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)
=688  \\$a73(71)
=750  \0$aAdenosylmethionine$5IEN$0(DLC)sh 85000852

=LDR  00788cz  a2200217n  4500
=001  9880363924902441
=005  20160801104935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012434
=035  \\$aCBA5742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x857
=150  \\$aSecale
=450  \\$wnno$aSecale cereale
=450  \\$aRye
=450  \\$wnnna$aRyes
=550  \\$wg$aPoaceae
=667  \\$ado not confuse X ref SECALE with Secale cornutum ( = ERGOT FUNGUS see CLAVICEPS) nor entry term RYE with RYE GRASS see LOLIUM; the rye-wheat hybrid TRITICALE is also available.
=680  \\$iGenus in the grass family (Poaceae) including well known species Secale cereale (rye).
=688  \\$a2016(1963)
=750  \0$aRye$5IEN-HS$0(DLC)sh 85116118

=LDR  00965cz  a2200217n  4500
=001  9880363925002441
=005  20141212205440.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012433
=035  \\$aCBA5741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291.$x686
=072  \\$aD3.$x132.$x740
=072  \\$aD3.$x383.$x129.$x578.$x805
=150  \\$aRyanodine
=550  \\$wg$aAlkaloids
=550  \\$wg$aDiterpenes
=550  \\$wg$aPyrroles
=680  \\$iA methylpyrrole-carboxylate from RYANIA that disrupts the RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL to modify CALCIUM release from SARCOPLASMIC RETICULUM resulting in alteration of MUSCLE CONTRACTION. It was previously used in INSECTICIDES. It is used experimentally in conjunction with THAPSIGARGIN and other inhibitors of CALCIUM ATPASE uptake of calcium into SARCOPLASMIC RETICULUM.
=688  \\$a91(75); was see under ALKALOIDS 1975-90
=750  \0$aRyanodine$5IEN-M$0(DLC)sh 95002586

=LDR  00938cz  a2200241n  4500
=001  9880363925102441
=005  20141212205440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012431
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x284.$x888
=072  \\$aD3.$x830.$x219.$x266.$x450.$x284.$x888
=150  \\$aRutin
=450  \\$wnnna$a3-Rhamnosyl-Glucosyl Quercetin
=450  \\$wnnna$aQuercetin, 3-Rhamnosyl-Glucosyl
=450  \\$wnnna$aQuercetin-3-Rutinoside
=450  \\$wnnna$aQuercetin 3 Rutinoside
=450  \\$wnnna$aRutoside
=550  \\$wg$aFlavonols
=550  \\$wh$aHydroxyethylrutoside
=680  \\$iA flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility.
=688  \\$a2007(1963); for RUTINOSIDE use RUTIN SULFATE (NM) 1988-2006
=750  \0$aRutin$5IEN$0(DLC)sh 85116098

=LDR  00767cz  a2200193n  4500
=001  9880363925202441
=005  20141212205439.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012429
=035  \\$aCBA5737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x745
=150  \\$aRuthenium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Ruthenium
=550  \\$wg$aRadioisotopes
=667  \\$aRu-93-95, 97, 103, 105-108; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of ruthenium that decay or disintegrate emitting radiation. Ru atoms with atomic weights 93-95, 97, 103, and 105-108 are radioactive ruthenium isotopes.
=688  \\$a88
=750  \0$aRuthenium$xIsotopes$5IEN$0(DLC)sh 85116087

=LDR  00821cz  a2200205n  4500
=001  9880363925302441
=005  20141212205439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012428
=035  \\$aCBA5736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x805
=072  \\$aD1.$x268.$x956.$x812
=072  \\$aD1.$x552.$x544.$x805
=150  \\$aRuthenium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aRu-102; Ru-96, 98-101, 104 = RUTHENIUM (IM) + ISOTOPES (NIM); Ru-93-95, 97, 103, 105-108 = RUTHENIUM RADIOISOTOPES (IM)
=680  \\$iA hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.
=750  \0$aRuthenium$5IEN-M$0(DLC)sh 85116086

=LDR  01049cz  a2200313n  4500
=001  9880363925402441
=005  20141212205438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012424
=035  \\$aCBA5732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x600.$x725
=150  \\$aRural Population
=450  \\$wnnna$aCommunities, Rural
=450  \\$wnnna$aCommunity, Rural
=450  \\$wnnna$aDistribution, Rural Spatial
=450  \\$wnnna$aDistributions, Rural Spatial
=450  \\$wnnna$aPopulation, Rural
=450  \\$wnnna$aPopulations, Rural
=450  \\$wnnna$aRural Communities
=450  \\$wnnna$aRural Community
=450  \\$wnnna$aRural Populations
=450  \\$wnnna$aRural Spatial Distribution
=450  \\$wnnna$aRural Spatial Distributions
=550  \\$wg$aPopulation
=667  \\$aspecify geog; RURAL HEALTH & RURAL HEALTH SERVICES are also available
=680  \\$iThe inhabitants of rural areas or of small towns classified as rural.
=688  \\$a68(65)
=750  \0$aRural population$5IEN$0(DLC)sh 85115926

=LDR  00489cz  a2200181n  4500
=001  9880363925502441
=005  20141212205437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012423
=035  \\$aCBA5731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x650
=150  \\$aRural Health
=450  \\$wnnna$aHealth, Rural
=550  \\$wg$aHealth
=667  \\$aspecify geog
=680  \\$iThe status of health in rural populations.
=750  \0$aRural health$5IEN-M$0(DLC)sh 85115915

=LDR  01161cz  a2200289n  4500
=001  9880363925602441
=005  20141212192507.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012420
=035  \\$aCBA5728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x568.$x610
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x750
=072  \\$aI3.$x350.$x750
=072  \\$aI3.$x450.$x642.$x845.$x610
=150  \\$aRunning
=450  \\$wnnna$aRunnings
=550  \\$wg$aExercise
=550  \\$wg$aLocomotion
=550  \\$wg$aSports
=550  \\$wh$aJogging
=550  \\$aTrack and Field
=667  \\$ahuman & animal; / inj: coordinate IM with specific injury (IM); JOGGING and TRACK AND FIELD are also available; animals running in exercise wheel is probably MOTOR ACTIVITY or PHYSICAL EXERTION
=680  \\$iAn activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace.
=688  \\$a76
=750  \0$aRunners (Sports)$5IEN-M$0(DLC)sh 85115856
=750  \0$aRunning$5IEN-HS$0(DLC)sh 85115858

=LDR  01195cz  a2200385n  4500
=001  9880363925702441
=005  20170329094725.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012418
=035  \\$aCBA5726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380
=150  \\$aRuminants
=450  \\$wnnna$aGoat, Mountain
=450  \\$aGoats, Mountain
=450  \\$wnnna$aMountain Goat
=450  \\$wnnna$aMountain Goats
=450  \\$wnnna$aOreamnos americanus
=450  \\$wnnna$aRuminant
=450  \\$aRuminantia
=550  \\$wg$aArtiodactyla
=550  \\$wh$aAntelopes
=550  \\$wh$aBison
=550  \\$wh$aBuffaloes
=550  \\$wh$aCamelids, New World
=550  \\$wh$aCamels
=550  \\$wh$aCattle
=550  \\$wh$aDeer
=550  \\$wh$aGiraffes
=550  \\$wh$aGoats
=550  \\$wh$aSheep
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach, including the capacious RUMEN. Horns or antlers are usually present, at least in males.
=688  \\$a87
=750  \0$aRuminants$5IEN$0(DLC)sh 85115827

=LDR  01445cz  a2200181n  4500
=001  9880363925802441
=005  20141212205436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012417
=035  \\$aCBA5725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x869.$x804
=150  \\$aRumen
=450  \\$wnnna$aRumens
=550  \\$wg$aStomach, Ruminant
=667  \\$aa ruminant's 1st stomach; dis: coord IM with STOMACH DISEASES /vet (IM); neopl: coord IM with STOMACH NEOPLASMS /vet (IM) + histol type /vet (IM); ulcer: coord IM with STOMACH ULCER /vet (IM)
=680  \\$iThe first stomach of ruminants. It lies on the left side of the body, occupying the whole of the left side of the abdomen and even stretching across the median plane of the body to the right side. It is capacious, divided into an upper and a lower sac, each of which has a blind sac at its posterior extremity. The rumen is lined by mucous membrane containing no digestive glands, but mucus-secreting glands are present in large numbers. Coarse, partially chewed food is stored and churned in the rumen until the animal finds circumstances convenient for rumination. When this occurs, little balls of food are regurgitated through the esophagus into the mouth, and are subjected to a second more thorough mastication, swallowed, and passed on into other parts of the compound stomach. (From Black's Veterinary Dictionary, 17th ed)
=750  \0$aRumen$5IEN$0(DLC)sh 85115819

=LDR  00765cz  a2200205n  4500
=001  9880363925902441
=005  20141212205435.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012414
=035  \\$aCBA5722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x740
=150  \\$aRubidium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Rubidium
=550  \\$wg$aRadioisotopes
=550  \\$aRubidium
=667  \\$aRb-79-84, 86-95; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of rubidium that decay or disintegrate emitting radiation. Rb atoms with atomic weights 79-84, and 86-95 are radioactive rubidium isotopes.
=688  \\$a88
=750  \0$aRubidium$xIsotopes$5IEN$0(DLC)sh 85115685

=LDR  00802cz  a2200217n  4500
=001  9880363926002441
=005  20141212205435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012413
=035  \\$aCBA5721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549.$x650
=072  \\$aD1.$x268.$x556.$x800
=072  \\$aD1.$x552.$x528.$x759
=072  \\$aD1.$x552.$x544.$x800
=150  \\$aRubidium
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Heavy
=667  \\$aan alkali metal; Rb-85; Rb-79-84, 86-95 = RUBIDIUM RADIOISOTOPES (IM)
=680  \\$iAn element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.
=750  \0$aRubidium$5IEN$0(DLC)sh 85115684

=LDR  00834cz  a2200217n  4500
=001  9880363926102441
=005  20141212205434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012412
=035  \\$aCBA5720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x850.$x700.$x700
=072  \\$aB4.$x909.$x777.$x923.$x700.$x700
=150  \\$aRubella virus
=450  \\$wnnna$aGerman Measles Virus
=450  \\$aMeasles Virus, German
=550  \\$wg$aRubivirus
=667  \\$ado not confuse with RUBULAVIRUS, a RESPIROVIRUS; infection = RUBELLA
=680  \\$iThe type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis.
=688  \\$a66
=750  \0$aRubella virus$5IEN$0(DLC)sh 85115675

=LDR  00900cz  a2200193n  4500
=001  9880363926202441
=005  20141212205434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012411
=035  \\$aCBA5719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x779
=150  \\$aRubella Vaccine
=450  \\$wnnna$aVaccine, Rubella
=550  \\$wg$aViral Vaccines
=550  \\$wh$aMeasles-Mumps-Rubella Vaccine
=680  \\$iA live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed)
=688  \\$a73(69)
=750  \0$aRubella vaccines$5IEN$0(DLC)sh 85115674

=LDR  01164cz  a2200265n  4500
=001  9880363926302441
=005  20141212192506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012409
=035  \\$aCBA5717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x930.$x700.$x700
=150  \\$aRubella
=450  \\$wnnna$aGerman Measles
=450  \\$wnnna$aMeasle, Three Day
=450  \\$aMeasles, German
=450  \\$wnnna$aMeasles, Three Day
=450  \\$wnnna$aRubellas
=450  \\$wnnna$aThree Day Measle
=450  \\$wnnna$aThree Day Measles
=550  \\$wg$aRubivirus Infections
=550  \\$wh$aRubella Syndrome, Congenital
=667  \\$acaused by a rubivirus, RUBELLA VIRUS: do not confuse with RUBULAVIRUS, a paramyxovirus; do not confuse with RUBEOLA see MEASLES; French for rubella = rubéole, Ital for rubella = rubeola, Span for rubella = rubéola or roséola epidemica; /congen: consider also RUBELLA SYNDROME, CONGENITAL
=680  \\$iAn acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM.
=750  \0$aRubella$5IEN$0(DLC)sh 85115670

=LDR  01525cz  a2200433n  4500
=001  9880363926402441
=005  20141212205433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012408
=035  \\$aCBA5716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x720.$x99.$x750
=072  \\$aD25.$x720.$x327.$x840
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x750
=072  \\$aJ1.$x637.$x51.$x720.$x327.$x840
=072  \\$aJ1.$x637.$x412.$x767
=150  \\$aRubber
=450  \\$wnnna$aElastica
=450  \\$wnnna$aIndia Rubber
=450  \\$aLatex Rubber
=450  \\$wnnna$aNatural Rubber
=450  \\$wnnna$aNatural Rubbers
=450  \\$wnnna$aPlant Rubber
=450  \\$wnnna$aPlant Rubbers
=450  \\$wnnna$aRubber, Natural
=450  \\$wnnna$aRubber, Plant
=450  \\$wnnna$aRubbers, Natural
=450  \\$wnnna$aRubbers, Plant
=450  \\$wnnna$aVulcanite
=550  \\$wg$aBiopolymers
=550  \\$wg$aElastomers
=550  \\$wh$aGutta-Percha
=550  \\$wh$aLatex
=550  \\$wh$aNeoprene
=550  \\$aHevea
=550  \\$aLatex Hypersensitivity
=680  \\$iA high-molecular-weight polymeric elastomer derived from the milk juice (LATEX) of HEVEA brasiliensis and other trees and plants. It is a substance that can be stretched at room temperature to at least twice its original length and after releasing the stress, retract rapidly, and recover its original dimensions fully.
=688  \\$aLATEX RUBBER was see under RUBBER 1968-80
=750  \0$aRubber$5IEN$0(DLC)sh 85115631

=LDR  00522cz  a2200193n  4500
=001  9880363926502441
=005  20141212205432.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012403
=035  \\$aCBA5711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x770
=150  \\$aRotifera
=450  \\$wnnna$aRotiferas
=550  \\$wg$aHelminths
=667  \\$aan aschelminth
=680  \\$iA class of minute animals of the phylum Aschelminthes.
=688  \\$a77
=750  \0$aRotifera$5IEN$0(DLC)sh 85115501

=LDR  00673cz  a2200205n  4500
=001  9880363926602441
=005  20141212205432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012402
=035  \\$aCBA5710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x400.$x843
=072  \\$aD3.$x549.$x825
=072  \\$aD3.$x830.$x219.$x266.$x450.$x400.$x843
=150  \\$aRotenone
=550  \\$wg$aHeterocyclic Compounds with 4 or More Rings
=550  \\$wg$aIsoflavones
=667  \\$aTN 111 for eff on insects
=680  \\$iA botanical insecticide that is an inhibitor of mitochondrial electron transport.
=750  \0$aRotenone$5IEN$0(DLC)sh 88005659

=LDR  00884cz  a2200217n  4500
=001  9880363926702441
=005  20141212205431.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012401
=035  \\$aCBA5709M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630.$x790
=072  \\$aB4.$x909.$x777.$x714.$x790
=150  \\$aRotavirus
=450  \\$aNeonatal Calf Diarrhea Virus
=450  \\$wnnna$aRotaviruses
=550  \\$wg$aReoviridae
=667  \\$ainfection = ROTAVIRUS INFECTIONS
=680  \\$iA genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species (Rotaviruses A thru G) are recognized.
=688  \\$a94, 78-80; was ROTAVIRUSES 1981-93 (see under REOVIRIDAE 1981-82); was see under RNA VIRUSES 1978-80
=750  \0$aRotaviruses$5IEN-M$0(DLC)sh 99003533

=LDR  00758cz  a2200217n  4500
=001  9880363926802441
=005  20141212205431.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012400
=035  \\$aCBA5708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x791.$x814
=150  \\$aRotavirus Infections
=450  \\$wnnna$aInfection, Rotavirus
=450  \\$wnnna$aInfections, Rotavirus
=450  \\$wnnna$aRotavirus Infection
=550  \\$wg$aReoviridae Infections
=667  \\$acaused by a reovirus
=680  \\$iInfection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
=688  \\$a83
=750  \0$aRotavirus infections$5IEN-M$0(DLC)sh 99003534

=LDR  00738cz  a2200229n  4500
=001  9880363926902441
=005  20141212192506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012395
=035  \\$aCBA5703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x779.$x347.$x700
=072  \\$aD3.$x494.$x953.$x275.$x700
=072  \\$aD4.$x711.$x347.$x700
=150  \\$aRose Bengal
=450  \\$wnnna$aBengal, Rose
=450  \\$wnnna$aRose Bengal Sodium I 125
=450  \\$wnnna$aRose Bengal Sodium I 131
=550  \\$wg$aFluoresceins
=667  \\$aD25-26n qualif
=680  \\$iA bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.
=750  \0$aRose bengal$5IEN$0(DLC)sh 85115412

=LDR  01418cz  a2200313n  4500
=001  9880363927002441
=005  20141212205430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012393
=035  \\$aCBA5701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x716
=150  \\$aRosacea
=450  \\$wnnna$aAcne Rosacea
=450  \\$wnnna$aErythematotelangiectatic Rosacea
=450  \\$wnnna$aGranulomatous Rosacea
=450  \\$wnnna$aOcular Rosacea
=450  \\$wnnna$aPapulopustular Rosacea
=450  \\$wnnna$aPhymatous Rosacea
=450  \\$wnnna$aRosacea, Erythematotelangiectatic
=450  \\$wnnna$aRosacea, Granulomatous
=450  \\$wnnna$aRosacea, Ocular
=450  \\$wnnna$aRosacea, Papulopustular
=450  \\$wnnna$aRosacea, Phymatous
=550  \\$wg$aSkin Diseases
=550  \\$wh$aRhinophyma
=680  \\$iA cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
=688  \\$a2005, 1963-1992
=750  \0$aRosacea$0(DLC) sh 85115399$5IEN-M

=LDR  00685cz  a2200169n  4500
=001  9880363927102441
=005  20141212205429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012392
=035  \\$aCBA5700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x622.$x341.$x736
=150  \\$aRorschach Test
=450  \\$wnnna$aTest, Rorschach
=550  \\$wg$aInk Blot Tests
=680  \\$iA projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject's responses to inkblot prints are scored along with subjective interpretation by the test administrator.
=750  \0$aRorschach Test$5IEN$0(DLC)sh 85115396

=LDR  01159cz  a2200301n  4500
=001  9880363927202441
=005  20141212205429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012390
=035  \\$aCBA5698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x397.$x778
=150  \\$aRoot Canal Therapy
=450  \\$wnnna$aCanal Therapies, Root
=450  \\$wnnna$aCanal Therapy, Root
=450  \\$wnnna$aRoot Canal Therapies
=450  \\$wnnna$aTherapies, Root Canal
=450  \\$wnnna$aTherapy, Root Canal
=550  \\$wg$aEndodontics
=550  \\$wh$aApexification
=550  \\$wh$aDental Pulp Devitalization
=550  \\$wh$aRoot Canal Obturation
=550  \\$wh$aRoot Canal Preparation
=667  \\$athe corresponding specialty is ENDODONTICS; reamers & broaches: index under ROOT CANAL PREPARATION /instrum
=680  \\$iA treatment modality in endodontics concerned with the therapy of diseases of the dental pulp. For preparatory procedures, ROOT CANAL PREPARATION is available.
=688  \\$a1965; use ENDODONTICS 1963-1964
=688  \\$a65; was see under ENDODONTICS 1963-64
=750  \0$aRoot canal therapy$5IEN$0(DLC)sh 85115359

=LDR  00767cz  a2200229n  4500
=001  9880363927302441
=005  20141212205426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012381
=035  \\$aCBA5689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x781.$x653
=072  \\$aF4.$x754.$x864.$x581.$x679.$x653
=150  \\$aRole Playing
=450  \\$wnnna$aPlaying, Role
=450  \\$wnnna$aPlayings, Role
=450  \\$wnnna$aRole Playings
=550  \\$wg$aPsychodrama
=667  \\$ano qualif
=680  \\$iThe adopting or performing the role of another significant individual in order to gain insight into the behavior of that person.
=688  \\$a91(75); was see under PSYCHODRAMA 1975-90
=750  \0$aRole playing$5IEN$0(DLC)sh 85114860

=LDR  00852cz  a2200253n  4500
=001  9880363927402441
=005  20141212205426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012380
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x616
=150  \\$aRole
=450  \\$wnnna$aConcept, Role
=450  \\$wnnna$aConcepts, Role
=450  \\$aRole Concept
=450  \\$wnnna$aRole Concepts
=450  \\$wnnna$aRoles
=550  \\$wg$aGroup Processes
=550  \\$wh$aProfessional Role
=550  \\$wh$aSick Role
=667  \\$aGEN; prefer specifics
=680  \\$iThe expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group.
=688  \\$a69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68
=750  \0$aSocial role$5IEN$0(DLC)sh 85123999

=LDR  00651cz  a2200205n  4500
=001  9880363927502441
=005  20141212205426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012378
=035  \\$aCBA5686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700.$x853
=072  \\$aD27.$x720.$x723.$x853
=072  \\$aD27.$x888.$x723.$x853
=150  \\$aRodenticides
=550  \\$wg$aPesticides
=550  \\$aRodent Control
=667  \\$aspecify rodent if pertinent but not with /drug eff
=680  \\$iSubstances used to destroy or inhibit the action of rats, mice, or other rodents.
=750  \0$aRodenticides$5IEN$0(DLC)sh 85114802

=LDR  01281cz  a2200481n  4500
=001  9880363927602441
=005  20200508133620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012377
=035  \\$aCBA5685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992
=150  \\$aRodentia
=450  \\$wnnna$aBeaver
=450  \\$aBeavers
=450  \\$wnnna$aCapybara
=450  \\$aCapybaras
=450  \\$aCastor Beaver
=450  \\$aDipodidae
=450  \\$wnnna$aHydrochaeri
=450  \\$aHydrochaeris
=450  \\$wnnna$aJerboa
=450  \\$aJerboas
=450  \\$wnnna$aRodent
=450  \\$wnnna$aRodentias
=450  \\$wnnna$aRodents
=550  \\$wg$aEutheria
=550  \\$wh$aChinchilla
=550  \\$wh$aCuniculidae
=550  \\$wh$aDasyproctidae
=550  \\$wh$aDipodomys
=550  \\$wh$aGophers
=550  \\$wh$aGuinea Pigs
=550  \\$wh$aMole Rats
=550  \\$wh$aMuridae
=550  \\$wh$aMyoxidae
=550  \\$wh$aOctodon
=550  \\$wh$aPorcupines
=550  \\$wh$aSciuridae
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA mammalian order which consists of 29 families and many genera.
=688  \\$a1982; use RODENTS 1963-1981
=750  \0$aRodents$5IEN$0(DLC)sh 85114803

=LDR  01136cz  a2200241n  4500
=001  9880363927702441
=005  20141212205425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012376
=035  \\$aCBA5684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x795
=150  \\$aRodent Diseases
=450  \\$wnnna$aDisease, Rodent
=450  \\$wnnna$aDiseases, Rodent
=450  \\$wnnna$aRodent Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aEctromelia, Infectious
=550  \\$wh$aMonkeypox
=550  \\$wh$aMurine Acquired Immunodeficiency Syndrome
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific rodent dis (IM); coord IM with specific rodent (IM); don't forget also RODENTIA (NIM) & check tag ANIMALS; DF: RODENT DIS
=680  \\$iDiseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs).
=750  \0$aRodents$xDiseases$5IEN$0(DLC)sh 85114805

=LDR  00632cz  a2200205n  4500
=001  9880363927802441
=005  20141212205345.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012245
=035  \\$aCBA5550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x660.$x50.$x663
=150  \\$aRhodospirillales
=550  \\$wg$aAlphaproteobacteria
=550  \\$wh$aAcetobacteraceae
=550  \\$wh$aRhodospirillaceae
=667  \\$ain water
=680  \\$iAn order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria.
=688  \\$a76
=750  \0$aRhodospirillales$5IEN$0(DLC)sh 88023318

=LDR  00844cz  a2200253n  4500
=001  9880363927902441
=005  20141212205345.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012244
=035  \\$aCBA5549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x708
=072  \\$aB3.$x660.$x50.$x663.$x750
=150  \\$aRhodospirillaceae
=450  \\$aBacteria, Purple Nonsulfur
=450  \\$aPurple Nonsulfur Bacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wg$aRhodospirillales
=550  \\$wh$aAzospirillum
=550  \\$wh$aMagnetospirillum
=550  \\$wh$aRhodospirillum
=680  \\$iA family of phototrophic bacteria, in the order Rhodospirillales, isolated from stagnant water and mud.
=688  \\$a76; was ATHIORHODACEAE 1975
=750  \0$aRhodospirillaceae$5IEN$0(DLC)sh 85113780

=LDR  00934cz  a2200217n  4500
=001  9880363928002441
=005  20141212205345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012243
=035  \\$aCBA5548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x955
=072  \\$aD23.$x767.$x930.$x750.$x500.$x500
=150  \\$aRhodopsin
=450  \\$aVisual Purple
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aRod Opsins
=667  \\$ado not confuse with ROD OPSINS or microbial rhodopsins (BACTERIORHODOPSINS)
=680  \\$iA purplish-red, light-sensitive pigment found in RETINAL ROD CELLS of most vertebrates. It is a complex consisting of a molecule of ROD OPSIN and a molecule of 11-cis retinal (RETINALDEHYDE). Rhodopsin exhibits peak absorption wavelength at about 500 nm.
=688  \\$a91(75); was see under RETINAL PIGMENTS 1975-90
=750  \0$aRhodopsin$5IEN$0(DLC)sh 85113779

=LDR  00683cz  a2200181n  4500
=001  9880363928102441
=005  20141212205344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012241
=035  \\$aCBA5546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x200.$x700
=072  \\$aB3.$x660.$x50.$x35.$x700
=150  \\$aRhodopseudomonas
=550  \\$wg$aBradyrhizobiaceae
=667  \\$ain mud & stagnant water
=680  \\$iA genus of gram-negative, rod-shaped, phototrophic bacteria found in aquatic environments. Internal photosynthetic membranes are present as lamellae underlying the cytoplasmic membrane.
=750  \0$aRhodopseudomonas$5IEN$0(DLC)sh 85113777

=LDR  00552cz  a2200181n  4500
=001  9880363928202441
=005  20141212205344.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012240
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x537.$x775
=150  \\$aRhodococcus
=550  \\$wg$aNocardiaceae
=550  \\$wh$aRhodococcus equi
=667  \\$ainfection: coord IM with ACTINOMYCETALES INFECTIONS (IM)
=680  \\$iA bacterial genus of the order ACTINOMYCETALES.
=688  \\$a87
=750  \0$aRhodococcus$0(DLC)sh2005002565$5IEN-M

=LDR  00694cz  a2200181n  4500
=001  9880363928302441
=005  20141212205344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012239
=035  \\$aCBA5544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x700.$x850.$x700
=150  \\$aRhodnius
=550  \\$wg$aTriatominae
=667  \\$avectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111;
=680  \\$iA genus of the subfamily TRIATOMINAE. Rhodnius prolixus is a vector for TRYPANOSOMA CRUZI.
=688  \\$a91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78
=750  \0$aRhodnius$5IEN$0(DLC)sh 85113762

=LDR  00761cz  a2200217n  4500
=001  9880363928402441
=005  20141212205344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012238
=035  \\$aCBA5543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x793
=072  \\$aD1.$x268.$x956.$x781
=072  \\$aD1.$x552.$x544.$x793
=150  \\$aRhodium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aRh-103; Rh-97-102, 104-110 = RHODIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iRhodium. A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh. (Dorland, 28th ed)
=750  \0$aRhodium$5IEN-M$0(DLC)sh 85113755
=750  \0$aRhodium compounds$5IEN-HS$0(DLC)sh 96003630

=LDR  00785cz  a2200205n  4500
=001  9880363928502441
=005  20141212205343.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012235
=035  \\$aCBA5540M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x953.$x600
=150  \\$aRhodamines
=450  \\$wnnna$aRhodamine
=550  \\$wg$aXanthenes
=550  \\$wh$aRhodamine 123
=667  \\$aRHODAMINE 123 is available
=680  \\$iA family of 3,6-di(substituted-amino)-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry.
=688  \\$a91(75); was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93
=750  \0$aRhodamine B$0(DLC)sh2006020034$5IEN-M

=LDR  00600cz  a2200181n  4500
=001  9880363928602441
=005  20141212205342.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012232
=035  \\$aCBA5537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x740
=150  \\$aRhizoctonia
=450  \\$wnnna$aRhizoctonias
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic Ceratobasidiaceae fungal genus that is an important plant pathogen affecting potatoes and other plants. There are numerous teleomorphs.
=688  \\$a91(75)
=750  \0$aRhizoctonia$5IEN$0(DLC)sh 88022090

=LDR  00936cz  a2200277n  4500
=001  9880363928702441
=005  20180912111533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012231
=035  \\$aCBA5536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700.$x800
=072  \\$aB3.$x585.900
=072  \\$aB3.$x660.$x50.$x730.$x670
=150  \\$aRhizobium
=450  \\$aRhizobium galegae
=450  \\$aRhizobium lupini
=550  \\$wg$aNitrogen-Fixing Bacteria
=550  \\$wg$aRhizobiaceae
=550  \\$wh$aRhizobium etli
=550  \\$wh$aRhizobium leguminosarum
=550  \\$wh$aRhizobium phaseoli
=550  \\$wh$aRhizobium tropici
=680  \\$iA genus of gram-negative, aerobic, rod-shaped bacteria that activate PLANT ROOT NODULATION in leguminous plants. Members of this genus are nitrogen-fixing and common soil inhabitants.
=688  \\$a1963
=750  \0$aRhizobium$5IEN$0(DLC)sh 85113711

=LDR  00739cz  a2200241n  4500
=001  9880363928802441
=005  20141212205342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012230
=035  \\$aCBA5535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700
=072  \\$aB3.$x660.$x50.$x730
=150  \\$aRhizobiaceae
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aAgrobacterium
=550  \\$wh$aRhizobium
=550  \\$wh$aSinorhizobium
=667  \\$ain soil, water & plants
=680  \\$iA family of gram-negative bacteria which are saprophytes, symbionts, or plant pathogens.
=688  \\$a75
=750  \0$aRhizobiaceae$5IEN$0(DLC)sh 85113710

=LDR  01114cz  a2200277n  4500
=001  9880363928902441
=005  20141212205342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012229
=035  \\$aCBA5534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x775
=072  \\$aB4.$x909.$x777.$x618.$x775
=150  \\$aRhinovirus
=450  \\$wnnna$aCold Virus, Common
=450  \\$wnnna$aCold Viruses, Common
=450  \\$aCommon Cold Virus
=450  \\$wnnna$aCommon Cold Viruses
=450  \\$wnnna$aCoryza Virus
=450  \\$aCoryza Viruses
=450  \\$wnnna$aRhinoviruses
=550  \\$wg$aPicornaviridae
=667  \\$ainfection: coord IM with PICORNAVIRIDAE INFECTIONS (IM) but consider also COMMON COLD
=680  \\$iA genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes over 100 human serotypes associated with the COMMON COLD.
=688  \\$a94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963
=750  \0$aRhinoviruses$5IEN$0(DLC)sh 85113701

=LDR  00709cz  a2200169n  4500
=001  9880363929002441
=005  20141212205341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012227
=035  \\$aCBA5532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x600.$x700
=150  \\$aRhinosporidiosis
=450  \\$wnnna$aRhinosporidioses
=550  \\$wg$aMesomycetozoea Infections
=680  \\$iChronic, localized granulomatous infection of mucocutaneous tissues, especially the NOSE, and characterized by HYPERPLASIA and the development of POLYPS. It is found in humans and other animals and is caused by the mesomycetozoean organism RHINOSPORIDIUM SEEBERI.
=750  \0$aRhinosporidiosis$5IEN$0(DLC)sh 85113698

=LDR  01186cz  a2200325n  4500
=001  9880363929102441
=005  20141212205341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012226
=035  \\$aCBA5531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x503.$x650
=072  \\$aC1.$x252.$x825.$x705
=072  \\$aC1.$x539.$x800.$x720.$x705
=072  \\$aC8.$x460.$x850
=072  \\$aC8.$x730.$x702
=072  \\$aC9.$x603.$x850
=072  \\$aC17.$x800.$x838.$x765.$x705
=150  \\$aRhinoscleroma
=450  \\$wnnna$aNasal Scleroma
=450  \\$wnnna$aNasal Scleromas
=450  \\$wnnna$aRhinoscleromas
=450  \\$aScleroma, Nasal
=450  \\$wnnna$aScleromas, Nasal
=550  \\$wg$aKlebsiella Infections
=550  \\$wg$aNose Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wg$aSkin Diseases, Bacterial
=680  \\$iA granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.
=750  \0$aRhinoscleroma$5IEN$0(DLC)sh 85113697

=LDR  00810cz  a2200253n  4500
=001  9880363929202441
=005  20141212205341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012225
=035  \\$aCBA5530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x755
=072  \\$aE4.$x580.$x392.$x500
=072  \\$aE4.$x680.$x650
=150  \\$aRhinoplasty
=450  \\$wnnna$aRhinoplasties
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aNasal Surgical Procedures
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$aNasal Bone
=550  \\$aNose
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA plastic surgical operation on the nose, either reconstructive, restorative, or cosmetic. (Dorland, 28th ed)
=750  \0$aRhinoplasty$5IEN$0(DLC)sh 85113696

=LDR  00900cz  a2200241n  4500
=001  9880363929302441
=005  20141212205340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012222
=035  \\$aCBA5527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x799.$x649
=072  \\$aC9.$x603.$x799.$x649
=150  \\$aRhinitis, Atrophic
=450  \\$wnnna$aAtrophic Rhinitides
=450  \\$wnnna$aAtrophic Rhinitis
=450  \\$aOzaena$5IEN
=450  \\$aOzena
=450  \\$wnnna$aOzenas
=450  \\$wnnna$aRhinitides, Atrophic
=550  \\$wg$aRhinitis
=680  \\$iA chronic inflammation in which the NASAL MUCOSA gradually changes from a functional to a non-functional lining without mucociliary clearance. It is often accompanied by degradation of the bony TURBINATES, and the foul-smelling mucus which forms a greenish crust (ozena).
=750  \0$aOzaena$5IEN$0(DLC)sh 85096384

=LDR  01003cz  a2200301n  4500
=001  9880363929402441
=005  20141212205339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012220
=035  \\$aCBA5525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x799
=072  \\$aC8.$x730.$x674
=072  \\$aC9.$x603.$x799
=150  \\$aRhinitis
=450  \\$wnnna$aCatarrh, Nasal
=450  \\$wnnna$aCatarrhs, Nasal
=450  \\$aNasal Catarrh
=450  \\$wnnna$aNasal Catarrhs
=450  \\$wnnna$aRhinitides
=550  \\$wg$aNose Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aRhinitis, Allergic
=550  \\$wh$aRhinitis, Atrophic
=550  \\$wh$aRhinitis, Vasomotor
=667  \\$ageneral or unspecified; prefer specifics; do not confuse NASAL CATARRH with CATARRH; rhinosinusitis: index RHINITIS + SINUSITIS
=680  \\$iInflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
=750  \0$aRhinitis$5IEN$0(DLC)sh 85113675

=LDR  00759cz  a2200181n  4500
=001  9880363929502441
=005  20181206130145.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012219
=035  \\$aCBA5524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x730
=150  \\$aRheumatology
=550  \\$wg$aInternal Medicine
=667  \\$aSPEC only; SPEC qualif; field covers collagen dis, rheum dis & arthritis; DF: RHEUMATOL
=680  \\$iA subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.
=688  \\$a80
=750  \0$aRheumatology$0(DLC) sh 88000877$5IEN-M

=LDR  00704cz  a2200193n  4500
=001  9880363929602441
=005  20141212205339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012217
=035  \\$aCBA5522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x323.$x732
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x323.$x732
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x323.$x732
=150  \\$aRheumatoid Factor
=450  \\$wnnna$aFactor, Rheumatoid
=550  \\$wg$aAutoantibodies
=680  \\$iAntibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS.
=750  \0$aRheumatoid factor$5IEN$0(DLC)sh 85113651

=LDR  01258cz  a2200361n  4500
=001  9880363929702441
=005  20180626122904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012216
=035  \\$aCBA5521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x799
=072  \\$aC17.$x300.$x775
=150  \\$aRheumatic Diseases
=450  \\$wnnna$aDisease, Rheumatic
=450  \\$wnnna$aDiseases, Rheumatic
=450  \\$wnnna$aRheumatic Disease
=450  \\$aRheumatism
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aArthritis, Juvenile
=550  \\$wh$aArthritis, Rheumatoid
=550  \\$wh$aFibromyalgia
=550  \\$wh$aGout
=550  \\$wh$aHyperostosis, Sternocostoclavicular
=550  \\$wh$aOsteoarthritis
=550  \\$wh$aPolymyalgia Rheumatica
=550  \\$wh$aRheumatic Fever
=550  \\$aRheumatology
=667  \\$ado not confuse with the specialty RHEUMATOLOGY; /drug ther: consider also ANTIRHEUMATIC AGENTS
=680  \\$iDisorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
=688  \\$a90; was RHEUMATISM 1966-89
=750  \0$aRheumatism$0(DLC) sh 85113643$5IEN

=LDR  01336cz  a2200337n  4500
=001  9880363929802441
=005  20141212205338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012214
=035  \\$aCBA5519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890.$x731.$x649
=072  \\$aC14.$x280.$x874
=150  \\$aRheumatic Heart Disease
=450  \\$wnnna$aBouillaud Disease
=450  \\$wnnna$aBouillaud's Disease
=450  \\$wnnna$aBouillauds Disease
=450  \\$wnnna$aDisease, Bouillaud
=450  \\$wnnna$aDisease, Bouillaud's
=450  \\$wnnna$aDisease, Rheumatic Heart
=450  \\$wnnna$aDiseases, Rheumatic Heart
=450  \\$wnnna$aHeart Disease, Rheumatic
=450  \\$wnnna$aHeart Diseases, Rheumatic
=450  \\$wnnna$aRheumatic Heart Diseases
=550  \\$wg$aHeart Diseases
=550  \\$wg$aRheumatic Fever
=667  \\$acoordinate with specific disease of the heart
=680  \\$iCardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.
=688  \\$a1963; for BOUILLAUD'S DISEASE use RHEUMATIC FEVER 1964-1991
=688  \\$aBOUILLAUD'S DISEASE was see RHEUMATIC FEVER 1964-91
=750  \0$aRheumatic heart disease$5IEN$0(DLC)sh 85113641

=LDR  02421cz  a2200577n  4500
=001  9880363929902441
=005  20141212205337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012213
=035  \\$aCBA5518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890.$x731
=072  \\$aC5.$x550.$x114.$x843
=072  \\$aC5.$x799.$x825
=150  \\$aRheumatic Fever
=450  \\$wnnna$aAcute Articular Rheumatism
=450  \\$wnnna$aAcute Articular Rheumatisms
=450  \\$wnnna$aAcute Rheumatic Arthritides
=450  \\$wnnna$aAcute Rheumatic Arthritis
=450  \\$aAcute Rheumatic Fever
=450  \\$wnnna$aAcute Rheumatic Fevers
=450  \\$wnnna$aArthritides, Acute Rheumatic
=450  \\$wnnna$aArthritis, Acute Rheumatic
=450  \\$aArthritis, Rheumatic, Acute
=450  \\$wnnna$aArticular Rheumatism, Acute
=450  \\$wnnna$aArticular Rheumatisms, Acute
=450  \\$wnnna$aFever, Acute Rheumatic
=450  \\$wnnna$aFever, Rheumatic
=450  \\$wnnna$aFevers, Acute Rheumatic
=450  \\$wnnna$aFevers, Rheumatic
=450  \\$wnnna$aInflammatory Rheumatism
=450  \\$wnnna$aPolyarthritis Rheumatica
=450  \\$wnnna$aPolyarthritis Rheumaticas
=450  \\$wnnna$aRheumatic Arthritides, Acute
=450  \\$wnnna$aRheumatic Arthritis
=450  \\$wnnna$aRheumatic Arthritis, Acute
=450  \\$wnnna$aRheumatic Fever, Acute
=450  \\$wnnna$aRheumatic Fevers
=450  \\$wnnna$aRheumatic Fevers, Acute
=450  \\$wnnna$aRheumatism, Acute Articular
=450  \\$aRheumatism, Articular, Acute
=450  \\$wnnna$aRheumatisms, Acute Articular
=550  \\$wg$aArthritis
=550  \\$wg$aRheumatic Diseases
=550  \\$wg$aStreptococcal Infections
=550  \\$wh$aRheumatic Heart Disease
=550  \\$wh$aRheumatic Nodule
=550  \\$wh$aWissler's Syndrome
=667  \\$aStrep infect; rheum fever with heart dis, unspecified or specific = RHEUMATIC HEART DISEASE (IM) + the specific heart dis (IM or NIM), but not HEART DISEASES
=680  \\$iA febrile disease occurring as a delayed sequela of infections with STREPTOCOCCUS PYOGENES. It is characterized by multiple focal inflammatory lesions of the connective tissue structures, such as the heart, blood vessels, and joints (POLYARTHRITIS) and brain, and by the presence of ASCHOFF BODIES in the myocardium and skin.
=750  \0$aRheumatic fever$5IEN$0(DLC)sh 85113639

=LDR  01115cz  a2200301n  4500
=001  9880363930002441
=005  20141212205336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012212
=035  \\$aCBA5517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x830
=072  \\$aH1.$x671.$x808
=150  \\$aRheology
=450  \\$aFlowmetry
=450  \\$wnnna$aVelocimetries
=450  \\$aVelocimetry
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aPhysics
=550  \\$wh$aHemorheology
=550  \\$wh$aLaser-Doppler Flowmetry
=550  \\$wh$aLubrication
=550  \\$wh$aMicrofluidics
=667  \\$afor non-plethysmographic rheography: for plethysmographic rheology, index under PLETHYSMOGRAPHY or its specifics
=680  \\$iThe study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY.
=688  \\$a1966(1964)
=750  \0$aRheology (Biology)$5IEN-M$0(DLC)sh 85113620
=750  \0$aRheology$5IEN-HS$0(DLC)sh 85113619

=LDR  00808cz  a2200229n  4500
=001  9880363930102441
=005  20141212205336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012211
=035  \\$aCBA5516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x787
=072  \\$aD1.$x268.$x956.$x750
=072  \\$aD1.$x552.$x544.$x787
=150  \\$aRhenium
=450  \\$aRhenium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aRe-187; Re-185 = RHENIUM (IM) + ISOTOPES (NIM); Re-177-184, 186, 188-192 = RHENIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iRhenium. A metal, atomic number 75, atomic weight 186.2, symbol Re. (Dorland, 28th ed)
=750  \0$aRhenium$5IEN-M$0(DLC)sh 85113607
=750  \0$aRhenium compounds$5IEN-HS$0(DLC)sh 85113613

=LDR  00974cz  a2200265n  4500
=001  9880363930202441
=005  20141212205335.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012209
=035  \\$aCBA5514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x750
=072  \\$aB4.$x909.$x777.$x455.$x750
=150  \\$aRhabdoviridae
=450  \\$wnnna$aRhabdovirus
=450  \\$wnnna$aRhabdoviruses
=550  \\$wg$aMononegavirales
=550  \\$wh$aEphemerovirus
=550  \\$wh$aLyssavirus
=550  \\$wh$aNovirhabdovirus
=550  \\$wh$aVesiculovirus
=667  \\$ainfection = RHABDOVIRIDAE INFECTIONS
=680  \\$iA family of bullet-shaped viruses of the order MONONEGAVIRALES, infecting vertebrates, arthropods, protozoa, and plants. Genera include VESICULOVIRUS; LYSSAVIRUS; EPHEMEROVIRUS; NOVIRHABDOVIRUS; Cytorhabdovirus; and Nucleorhabdovirus.
=688  \\$a81; was RHABDOVIRUSES 1978-80
=750  \0$aRhabdoviruses$5IEN$0(DLC)sh 85113571

=LDR  01424cz  a2200217n  4500
=001  9880363930302441
=005  20141212205335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012208
=035  \\$aCBA5513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x590.$x550.$x660
=072  \\$aC4.$x557.$x450.$x795.$x550.$x660
=150  \\$aRhabdomyosarcoma
=450  \\$wnnna$aRhabdomyosarcomas
=550  \\$wg$aMyosarcoma
=550  \\$wh$aRhabdomyosarcoma, Alveolar
=550  \\$wh$aRhabdomyosarcoma, Embryonal
=667  \\$aGEN; prefer specifics; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
=750  \0$aRhabdomyosarcoma$5IEN$0(DLC)sh 85113568

=LDR  00750cz  a2200205n  4500
=001  9880363930402441
=005  20141212205335.0
=008  830421\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012206
=035  \\$aCBA5511HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x807
=150  \\$aRhabdomyolysis
=450  \\$wnnna$aRhabdomyolyses
=550  \\$wg$aMuscular Diseases
=550  \\$wh$aMyoglobinuria
=667  \\$a"necrosis or disintegration of skeletal muscle often followed by myoglobinuria": do not index under MYOGLOBINURIA unless this is particularly discussed & then probably NIM
=680  \\$iNecrosis or disintegration of skeletal muscle often followed by myoglobinuria.
=688  \\$a84
=750  \0$aRhabdomyolysis$5IEN$0(DLC)sh 87007562

=LDR  01567cz  a2200409n  4500
=001  9880363930502441
=005  20141212205334.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012204
=035  \\$aCBA5509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x775
=072  \\$aD23.$x50.$x705.$x230.$x775
=150  \\$aRh-Hr Blood-Group System
=450  \\$wnnna$aAntigen D, Rh Blood Group
=450  \\$wnnna$aBlood-Group System, Rh-Hr
=450  \\$wnnna$aBlood-Group System, Rhesus
=450  \\$wnnna$aBlood-Group Systems, Rh-Hr
=450  \\$wnnna$aBlood-Group Systems, Rhesus
=450  \\$wnnna$aFactor, Rh
=450  \\$wnnna$aFactors, Rh
=450  \\$wnnna$aRh Factor
=450  \\$aRh Factors
=450  \\$wnnna$aRh Hr Blood Group System
=450  \\$wnnna$aRh-Hr Blood-Group Systems
=450  \\$aRhesus Blood-Group System
=450  \\$wnnna$aRhesus Blood Group System
=450  \\$wnnna$aRhesus Blood-Group Systems
=450  \\$wnnna$aSystem, Rh-Hr Blood-Group
=450  \\$wnnna$aSystem, Rhesus Blood-Group
=450  \\$wnnna$aSystems, Rh-Hr Blood-Group
=450  \\$wnnna$aSystems, Rhesus Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$acoordinate IM with disease /blood (IM), not /immunol nor /genet
=680  \\$iErythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.
=688  \\$a76; was RH FACTORS 1963-75
=750  \0$aRh factor$5IEN$0(DLC)sh 85113562

=LDR  01356cz  a2200349n  4500
=001  9880363930602441
=005  20141212205334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012202
=035  \\$aCBA5507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x241.$x649
=072  \\$aC10.$x228.$x140.$x163.$x780
=072  \\$aC18.$x452.$x132.$x780
=150  \\$aReye Syndrome
=450  \\$wnnna$aAdult Reye Syndrome
=450  \\$wnnna$aAdult Reye's Syndrome
=450  \\$wnnna$aFatty Liver with Encephalopathy
=450  \\$wnnna$aReye-Johnson Syndrome
=450  \\$wnnna$aReye Johnson Syndrome
=450  \\$wnnna$aReye-Like Syndrome
=450  \\$wnnna$aReye Like Syndrome
=450  \\$wnnna$aReye Syndrome, Adult
=450  \\$wnnna$aReye's-Like Syndrome
=450  \\$wnnna$aReye's Like Syndrome
=450  \\$wnnna$aReye's Syndrome
=450  \\$wnnna$aReye's Syndrome, Adult
=550  \\$wg$aBrain Diseases, Metabolic
=550  \\$wg$aFatty Liver
=680  \\$iA form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism.
=688  \\$a1998(1977)
=750  \0$aReye's syndrome$5IEN$0(DLC)sh 85113551

=LDR  00731cz  a2200217n  4500
=001  9880363930702441
=005  20141212192503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012201
=035  \\$aCBA5506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x770.$x836
=150  \\$aReward
=450  \\$wnnna$aRewards
=550  \\$wg$aReinforcement (Psychology)
=550  \\$wh$aToken Economy
=550  \\$aDelay Discounting
=667  \\$ahuman & animal
=680  \\$iAn object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.
=688  \\$a65(64); was see under MOTIVATION & REINFORCEMENT LEARNING 1963-64
=750  \0$aReward (Psychology)$5IEN$0(DLC)sh 85113522

=LDR  01438cz  a2200373n  4500
=001  9880363930802441
=005  20141212205333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012194
=035  \\$aCBA5499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x445.$x308.$x300.$x750
=072  \\$aD12.$x776.$x964.$x775.$x375.$x750
=072  \\$aD12.$x776.$x964.$x970.$x600.$x850.$x375.$x750
=150  \\$aRNA-Directed DNA Polymerase
=450  \\$wnnna$aDNA Polymerase, RNA-Dependent
=450  \\$aDNA Polymerase, RNA-Directed
=450  \\$wnnna$aDNA Polymerase, RNA Directed
=450  \\$aReverse Transcriptase
=450  \\$wnnna$aRevertase
=450  \\$aRNA-Dependent DNA Polymerase
=450  \\$wnnna$aRNA Dependent DNA Polymerase
=450  \\$wnnna$aRNA Directed DNA Polymerase
=450  \\$wnnna$aRNA Transcriptase
=550  \\$wg$aDNA-Directed DNA Polymerase
=550  \\$wg$aGene Products, pol
=550  \\$wh$aHIV Reverse Transcriptase
=550  \\$wh$aTelomerase
=550  \\$aGene Products, pol
=550  \\$aReverse Transcriptase Polymerase Chain Reaction
=550  \\$aReverse Transcription
=680  \\$iAn enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49.
=688  \\$a96; was REVERSE TRANSCRIPTASE 1972-95 (Prov 1972)
=750  \0$aReverse transcriptase$0(DLC) sh 92004219$5IEN

=LDR  01172cz  a2200349n  4500
=001  9880363930902441
=005  20141212205332.0
=008  800513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012192
=035  \\$aCBA5497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815
=150  \\$aRetroviridae Infections
=450  \\$wnnna$aInfection, Retroviridae
=450  \\$wnnna$aInfection, Retrovirus
=450  \\$wnnna$aInfections, Retroviridae
=450  \\$wnnna$aInfections, Retrovirus
=450  \\$wnnna$aRetroviridae Infection
=450  \\$wnnna$aRetrovirus Infection
=450  \\$aRetrovirus Infections
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aAvian Leukosis
=550  \\$wh$aDeltaretrovirus Infections
=550  \\$wh$aLentivirus Infections
=550  \\$wh$aLeukemia, Feline
=550  \\$wh$aMurine Acquired Immunodeficiency Syndrome
=550  \\$wh$aPulmonary Adenomatosis, Ovine
=550  \\$wh$aSarcoma, Avian
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the RETROVIRIDAE.
=688  \\$a94; was RETROVIRUS INFECTIONS 1981-93
=750  \0$aRetrovirus infections$5IEN$0(DLC)sh 87006115

=LDR  03420cz  a2200637n  4500
=001  9880363931002441
=005  20141212205331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012190
=035  \\$aCBA5495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650
=072  \\$aB4.$x909.$x574.$x807
=072  \\$aB4.$x909.$x777.$x731
=150  \\$aRetroviridae
=450  \\$wnnna$aC Oncovirus, Type
=450  \\$wnnna$aC Oncoviruses, Type
=450  \\$wnnna$aLeukemogenic Virus
=450  \\$aLeukemogenic Viruses
=450  \\$wnnna$aLeukovirus
=450  \\$aLeukoviruses
=450  \\$wnnna$aOncornavirus
=450  \\$aOncornaviruses
=450  \\$aOncovirinae
=450  \\$wnnna$aOncovirus
=450  \\$wnnna$aOncovirus, Type C
=450  \\$aOncoviruses
=450  \\$aOncoviruses, Type C
=450  \\$wnnna$aRetrovirus
=450  \\$aRetroviruses
=450  \\$aRetroviruses, MLV-Related$5IEN-M
=450  \\$wnnna$aRNA Tumor Virus
=450  \\$aRNA Tumor Viruses
=450  \\$wnnna$aTumor Virus, RNA
=450  \\$wnnna$aTumor Viruses, RNA
=450  \\$wnnna$aType C Oncovirus
=450  \\$aType C Oncoviruses
=450  \\$wnnna$aVirus, Leukemogenic
=450  \\$wnnna$aVirus, RNA Tumor
=450  \\$wnnna$aViruses, Leukemogenic
=450  \\$wnnna$aViruses, RNA Tumor
=550  \\$wg$aOncogenic Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aAlpharetrovirus
=550  \\$wh$aBetaretrovirus
=550  \\$wh$aDeltaretrovirus
=550  \\$wh$aEndogenous Retroviruses
=550  \\$wh$aEpsilonretrovirus
=550  \\$wh$aGammaretrovirus
=550  \\$wh$aLentivirus
=550  \\$wh$aRetroviruses, Simian
=550  \\$wh$aSpumavirus
=667  \\$ainfection = RETROVIRIDAE INFECTIONS; if discussed as tumor viruses, add TUMOR VIRUS INFECTIONS (IM); antiretroviral agents is likely to be ANTI-HIV AGENTS, otherwise index under ANTIVIRAL AGENTS
=680  \\$iFamily of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES).
=688  \\$a81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES & RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-3, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, & was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90 (Prov 1972-73); C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES & TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93
=750  \0$aRetroviruses$5IEN$0(DLC)sh 85113381

=LDR  01027cz  a2200193n  4500
=001  9880363931102441
=005  20141212205330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012187
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x25.$x750
=150  \\$aRetroperitoneal Space
=450  \\$wnnna$aRetroperitoneal Spaces
=450  \\$wnnna$aSpace, Retroperitoneal
=450  \\$wnnna$aSpaces, Retroperitoneal
=550  \\$wg$aAbdominal Cavity
=667  \\$aNIM: usually locational so few qualif apply; diagnostic retropneumoperitoneum or pneumoretroperitoneum: index under RETROPERITONEAL SPACE /radiogr (IM) + PNEUMORADIOGRAPHY (NIM): do not confuse with RETROPNEUMOPERITONEUM (Cat C)
=680  \\$iAn area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.
=750  \0$aRetroperitoneum$5IEN$0(DLC)sh 85113377

=LDR  00728cz  a2200205n  4500
=001  9880363931202441
=005  20141212205329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012186
=035  \\$aCBA5491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x33.$x731
=150  \\$aRetroperitoneal Neoplasms
=450  \\$wnnna$aNeoplasm, Retroperitoneal
=450  \\$wnnna$aNeoplasms, Retroperitoneal
=450  \\$wnnna$aRetroperitoneal Neoplasm
=550  \\$wg$aAbdominal Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=750  \0$aRetroperitoneum$xCancer$5IEN-M$0(DLC)sh2010010285
=750  \0$aRetroperitoneum$xTumors$5IEN-M$0(IEN)380267

=LDR  01671cz  a2200397n  4500
=001  9880363931302441
=005  20141212205329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012185
=035  \\$aCBA5490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x355.$x700
=150  \\$aRetroperitoneal Fibrosis
=450  \\$wnnna$aChronic Periaortitides
=450  \\$wnnna$aChronic Periaortitis
=450  \\$wnnna$aDisease, Ormond
=450  \\$wnnna$aDisease, Ormond's
=450  \\$wnnna$aFibroses, Retroperitoneal
=450  \\$wnnna$aFibrosis, Inflammatory Perianeurysmal
=450  \\$wnnna$aFibrosis, Perianeurysmal Inflammatory
=450  \\$wnnna$aFibrosis, Retroperitoneal
=450  \\$wnnna$aIdiopathic Retroperitoneal Fibrosis
=450  \\$wnnna$aInflammatory Fibrosis, Perianeurysmal
=450  \\$wnnna$aInflammatory Perianeurysmal Fibrosis
=450  \\$aOrmond Disease
=450  \\$wnnna$aOrmond's Disease
=450  \\$aPerianeurysmal Fibrosis, Inflammatory
=450  \\$wnnna$aPerianeurysmal Inflammatory Fibrosis
=450  \\$wnnna$aPeriaortitides, Chronic
=450  \\$aPeriaortitis, Chronic
=450  \\$wnnna$aRetroperitoneal Fibroses
=550  \\$wg$aFibrosis
=550  \\$aPeritoneal Fibrosis
=680  \\$iA slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.
=688  \\$a66(64)
=750  \0$aRetroperitoneal fibrosis$5IEN$0(DLC)sh 85113376

=LDR  00579cz  a2200205n  4500
=001  9880363931402441
=005  20141212205327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012179
=035  \\$aCBA5483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x702
=150  \\$aRetirement
=450  \\$aRetirees$5IEN
=450  \\$wnnna$aRetirements
=550  \\$wg$aHuman Activities
=550  \\$aAged
=680  \\$iThe state of being retired from one's position or occupation.
=750  \0$aRetirees$5IEN-M$0(DLC)sh 88002484
=750  \0$aRetirement$5IEN-HS$0(DLC)sh 85113347

=LDR  01507cz  a2200277n  4500
=001  9880363931502441
=005  20141212205327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012178
=035  \\$aCBA5482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x836
=072  \\$aC16.$x614.$x521.$x731
=150  \\$aRetinopathy of Prematurity
=450  \\$wnnna$aFibroplasia, Retrolental
=450  \\$wnnna$aFibroplasias, Retrolental
=450  \\$wnnna$aPrematurity Retinopathies
=450  \\$wnnna$aPrematurity Retinopathy
=450  \\$aRetrolental Fibroplasia
=450  \\$wnnna$aRetrolental Fibroplasias
=550  \\$wg$aInfant, Premature, Diseases
=550  \\$wg$aRetinal Diseases
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; caused by oxygen ther of premature inf but for this etiol, do not use /chem ind: use /etiol if this etiol is discussed at all (& then probably NIM): TN 167
=680  \\$iA bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
=688  \\$a87; was RETROLENTAL FIBROPLASIA 1963-86
=750  \0$aRetrolental fibroplasia$5IEN$0(DLC)sh 85113373

=LDR  01005cz  a2200289n  4500
=001  9880363931602441
=005  20141212205326.0
=008  830616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012176
=035  \\$aCBA5480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700
=072  \\$aD2.$x455.$x849.$x131.$x495
=072  \\$aD23.$x767.$x261.$x700
=150  \\$aRetinoids
=550  \\$wg$aCarotenoids
=550  \\$wh$aAcitretin
=550  \\$wh$aEtretinate
=550  \\$wh$aFenretinide
=550  \\$wh$aIsotretinoin
=550  \\$wh$aRetinaldehyde
=550  \\$wh$aTretinoin
=550  \\$wh$aVitamin A
=680  \\$iA group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.
=688  \\$a84
=750  \0$aRetinoids$5IEN$0(DLC)sh 85113339

=LDR  02651cz  a2200577n  4500
=001  9880363931702441
=005  20141212205326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012175
=035  \\$aCBA5479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x725
=072  \\$aC4.$x557.$x470.$x670.$x725
=072  \\$aC4.$x557.$x580.$x625.$x600.$x725
=072  \\$aC4.$x588.$x364.$x818.$x760
=072  \\$aC11.$x319.$x475.$x760
=072  \\$aC11.$x768.$x717.$x760
=150  \\$aRetinoblastoma
=450  \\$wnnna$aEye Cancer, Retinoblastoma
=450  \\$wnnna$aFamilial Retinoblastoma
=450  \\$wnnna$aFamilial Retinoblastomas
=450  \\$aGlioblastoma, Retinal
=450  \\$wnnna$aGlioblastomas, Retinal
=450  \\$aGlioma, Retinal
=450  \\$wnnna$aGliomas, Retinal
=450  \\$wnnna$aHereditary Retinoblastoma
=450  \\$wnnna$aHereditary Retinoblastomas
=450  \\$aNeuroblastoma, Retinal
=450  \\$wnnna$aNeuroblastomas, Retinal
=450  \\$wnnna$aRetinal Glioblastoma
=450  \\$wnnna$aRetinal Glioblastomas
=450  \\$wnnna$aRetinal Glioma
=450  \\$wnnna$aRetinal Gliomas
=450  \\$wnnna$aRetinal Neuroblastoma
=450  \\$wnnna$aRetinal Neuroblastomas
=450  \\$wnnna$aRetinoblastoma, Familial
=450  \\$wnnna$aRetinoblastoma, Hereditary
=450  \\$wnnna$aRetinoblastoma, Sporadic
=450  \\$wnnna$aRetinoblastomas
=450  \\$wnnna$aRetinoblastomas, Familial
=450  \\$wnnna$aRetinoblastomas, Hereditary
=450  \\$wnnna$aRetinoblastomas, Sporadic
=450  \\$wnnna$aSporadic Retinoblastoma
=450  \\$wnnna$aSporadic Retinoblastomas
=550  \\$wg$aNeoplasms, Neuroepithelial
=550  \\$wg$aRetinal Neoplasms
=550  \\$aGenes, Retinoblastoma
=550  \\$aRetinal Neoplasms
=667  \\$acoordinate IM with RETINAL NEOPLASMS (IM); /genetics: consider also GENES, RETINOBLASTOMA
=680  \\$iA malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)
=750  \0$aRetinoblastoma$0(DLC) sh 85113337$5IEN

=LDR  02728cz  a2200733n  4500
=001  9880363931802441
=005  20141212205325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012174
=035  \\$aCBA5478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x270.$x684
=072  \\$aC11.$x768.$x585.$x658.$x500
=072  \\$aC16.$x320.$x290.$x684
=150  \\$aRetinitis Pigmentosa
=450  \\$wnnna$aCone-Rod Degeneration
=450  \\$wnnna$aCone-Rod Degenerations
=450  \\$wnnna$aCone Rod Degenerations
=450  \\$wnnna$aCone-Rod Dystrophies
=450  \\$wnnna$aCone-Rod Dystrophies, Retinal
=450  \\$wnnna$aCone-Rod Dystrophy
=450  \\$wnnna$aCone Rod Dystrophy
=450  \\$wnnna$aCone-Rod Dystrophy 2
=450  \\$wnnna$aCone-Rod Dystrophy, Retinal
=450  \\$wnnna$aCone-Rod Retinal Dystrophies
=450  \\$wnnna$aCone-Rod Retinal Dystrophy
=450  \\$wnnna$aCone Rod Retinal Dystrophy
=450  \\$wnnna$aDegeneration, Cone-Rod
=450  \\$wnnna$aDegeneration, Tapetoretinal
=450  \\$wnnna$aDegenerations, Cone-Rod
=450  \\$wnnna$aDegenerations, Tapetoretinal
=450  \\$wnnna$aDystrophies, Cone-Rod
=450  \\$wnnna$aDystrophies, Cone-Rod Retinal
=450  \\$wnnna$aDystrophies, Retinal Cone-Rod
=450  \\$wnnna$aDystrophies, Rod Cone
=450  \\$wnnna$aDystrophies, Rod-Cone
=450  \\$wnnna$aDystrophy, Cone-Rod
=450  \\$wnnna$aDystrophy, Cone-Rod Retinal
=450  \\$wnnna$aDystrophy, Retinal Cone-Rod
=450  \\$wnnna$aDystrophy, Rod Cone
=450  \\$wnnna$aDystrophy, Rod-Cone
=450  \\$wnnna$aPigmentary Retinopathies
=450  \\$aPigmentary Retinopathy
=450  \\$wnnna$aRetinal Cone-Rod Dystrophies
=450  \\$wnnna$aRetinal Cone-Rod Dystrophy
=450  \\$wnnna$aRetinal Cone Rod Dystrophy
=450  \\$wnnna$aRetinal Dystrophies, Cone-Rod
=450  \\$wnnna$aRetinal Dystrophy, Cone-Rod
=450  \\$wnnna$aRetinopathies, Pigmentary
=450  \\$wnnna$aRetinopathy, Pigmentary
=450  \\$wnnna$aRod Cone Dystrophies
=450  \\$wnnna$aRod-Cone Dystrophies
=450  \\$aRod-Cone Dystrophy
=450  \\$wnnna$aRod Cone Dystrophy
=450  \\$aTapetoretinal Degeneration
=450  \\$wnnna$aTapetoretinal Degenerations
=550  \\$wg$aEye Diseases, Hereditary
=550  \\$wg$aRetinal Dystrophies
=550  \\$wh$aAlstrom Syndrome
=550  \\$wh$aKearns-Sayre Syndrome
=550  \\$wh$aUsher Syndromes
=550  \\$aTangier Disease
=680  \\$iHereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field.
=750  \0$aRetinitis pigmentosa$5IEN$0(DLC)sh 85113336

=LDR  01457cz  a2200325n  4500
=001  9880363931902441
=005  20141212205324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012172
=035  \\$aCBA5476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x850
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x690
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700.$x690
=072  \\$aD2.$x455.$x849.$x131.$x495.$x690
=072  \\$aD23.$x767.$x261.$x700.$x690
=150  \\$aRetinaldehyde
=450  \\$wnnna$a11-cis-Retinal
=450  \\$wnnna$a11 cis Retinal
=450  \\$wnnna$aAldehyde, Vitamin A
=450  \\$aAxerophthal
=450  \\$aRetinal
=450  \\$aRetinene
=450  \\$aVitamin A Aldehyde
=550  \\$wg$aAldehydes
=550  \\$wg$aRetinoids
=667  \\$a/biosyn /physiol permitted
=680  \\$iA carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in "dark" reactions to return to the native trans-configuration.
=688  \\$a91(75); was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83
=750  \0$aRetinal (Visual pigment)$5IEN$0(DLC)sh 85113331

=LDR  01158cz  a2200325n  4500
=001  9880363932002441
=005  20141212205323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012171
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x611
=150  \\$aRetinal Vessels
=450  \\$wnnna$aBlood Vessel, Retinal
=450  \\$wnnna$aBlood Vessels, Retinal
=450  \\$aPecten Oculi
=450  \\$wnnna$aRetinal Blood Vessel
=450  \\$wnnna$aRetinal Blood Vessels
=450  \\$wnnna$aRetinal Vessel
=450  \\$wnnna$aVessel, Retinal
=450  \\$wnnna$aVessel, Retinal Blood
=450  \\$wnnna$aVessels, Retinal
=450  \\$wnnna$aVessels, Retinal Blood
=550  \\$wg$aBlood Vessels
=550  \\$wh$aRetinal Artery
=550  \\$wh$aRetinal Vein
=550  \\$aRetinal Vasculitis
=667  \\$aGEN & unspecified: prefer RETINAL ARTERY or RETINAL VEIN; dis of retinal vessels: coord IM with RETINAL DISEASES (IM), not VASCULAR DISEASES
=680  \\$iThe blood vessels which supply and drain the RETINA.
=688  \\$aPECTEN OCULI was see under RETINAL VESSELS 1969-83
=750  \0$aRetina$xBlood-vessels$5IEN$0(DLC)sh 85113324

=LDR  01152cz  a2200265n  4500
=001  9880363932102441
=005  20141212205322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012168
=035  \\$aCBA5472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x767.$x930
=150  \\$aRetinal Pigments
=450  \\$wnnna$aPhotoreceptor Pigments, Retinal
=450  \\$wnnna$aPigments, Retinal
=450  \\$wnnna$aPigments, Retinal Photoreceptor
=450  \\$wnnna$aPigments, Visual
=450  \\$wnnna$aRetinal Photoreceptor Pigments
=450  \\$aVisual Pigments
=550  \\$wg$aPigments, Biological
=550  \\$wh$aOpsins
=550  \\$aPhotoreceptor Cells
=667  \\$anot for deposition of pigments in the retina (= RETINITIS PIGMENTOSA)
=680  \\$iPhotosensitive protein complexes of varied light absorption properties which are expressed in the PHOTORECEPTOR CELLS. They are OPSINS conjugated with VITAMIN A-based chromophores. Chromophores capture photons of light, leading to the activation of opsins and a biochemical cascade that ultimately excites the photoreceptor cells.
=750  \0$aVisual pigments$5IEN$0(DLC)sh 85143930

=LDR  00626cz  a2200217n  4500
=001  9880363932202441
=005  20141212205321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012166
=035  \\$aCBA5470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x290.$x807
=072  \\$aC11.$x768.$x710
=072  \\$aC23.$x550.$x414.$x756.$x775
=150  \\$aRetinal Hemorrhage
=450  \\$aHemorrhage, Retinal
=450  \\$wnnna$aRetinal Hemorrhages
=550  \\$wg$aEye Hemorrhage
=550  \\$wg$aRetinal Diseases
=680  \\$iBleeding from the vessels of the retina.
=750  \0$aRetina$xHemorrhage$5IEN$0(IEN)377559

=LDR  01078cz  a2200241n  4500
=001  9880363932302441
=005  20141212192503.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012165
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x850.$x875
=072  \\$aA9.$x371.$x729.$x831.$x875
=072  \\$aA11.$x671.$x650.$x850.$x875
=150  \\$aRetinal Ganglion Cells
=450  \\$wnnna$aCell, Retinal Ganglion
=450  \\$wnnna$aCells, Retinal Ganglion
=450  \\$wnnna$aGanglion Cell, Retinal
=450  \\$wnnna$aGanglion Cells, Retinal
=450  \\$wnnna$aRetinal Ganglion Cell
=550  \\$wg$aRetinal Neurons
=680  \\$iNeurons of the innermost layer of the retina, the internal plexiform layer. They are of variable sizes and shapes, and their axons project via the OPTIC NERVE to the brain. A small subset of these cells act as photoreceptors with projections to the SUPRACHIASMATIC NUCLEUS, the center for regulating CIRCADIAN RHYTHM.
=688  \\$a91(83); was see under RETINA 1983-90
=750  \0$aRetinal ganglion cells$5IEN$0(DLC)sh 85113334

=LDR  01432cz  a2200457n  4500
=001  9880363932402441
=005  20141212205321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012164
=035  \\$aCBA5468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768
=150  \\$aRetinal Diseases
=450  \\$wnnna$aDisease, Retinal
=450  \\$wnnna$aDiseases, Retinal
=450  \\$wnnna$aRetinal Disease
=550  \\$wg$aEye Diseases
=550  \\$wh$aAngioid Streaks
=550  \\$wh$aCentral Serous Chorioretinopathy
=550  \\$wh$aDiabetic Retinopathy
=550  \\$wh$aEpiretinal Membrane
=550  \\$wh$aHypertensive Retinopathy
=550  \\$wh$aLeber Congenital Amaurosis
=550  \\$wh$aRetinal Artery Occlusion
=550  \\$wh$aRetinal Degeneration
=550  \\$wh$aRetinal Detachment
=550  \\$wh$aRetinal Dysplasia
=550  \\$wh$aRetinal Hemorrhage
=550  \\$wh$aRetinal Neoplasms
=550  \\$wh$aRetinal Neovascularization
=550  \\$wh$aRetinal Perforations
=550  \\$wh$aRetinal Telangiectasis
=550  \\$wh$aRetinal Vasculitis
=550  \\$wh$aRetinal Vein Occlusion
=550  \\$wh$aRetinitis
=550  \\$wh$aRetinopathy of Prematurity
=550  \\$wh$aVitreoretinopathy, Proliferative
=550  \\$aColor Vision Defects
=667  \\$ainflammatory disease = RETINITIS or specifics
=688  \\$a72
=750  \0$aRetina$xDiseases$5IEN$0(DLC)sh 85113328

=LDR  01101cz  a2200229n  4500
=001  9880363932502441
=005  20141212205320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x648
=150  \\$aRetinal Detachment
=450  \\$wnnna$aDetachment, Retinal
=450  \\$wnnna$aDetachments, Retinal
=450  \\$wnnna$aRetinal Detachments
=450  \\$aRetinal Pigment Epithelial Detachment
=550  \\$wg$aRetinal Diseases
=550  \\$aRetinoschisis
=550  \\$aScleral Buckling
=667  \\$a/surg: consider also SCLERAL BUCKLING
=680  \\$iSeparation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
=750  \0$aRetinal detachment$5IEN$0(DLC)sh 85113333

=LDR  01014cz  a2200253n  4500
=001  9880363932602441
=005  20141212205320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012162
=035  \\$aCBA5466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x768.$x585
=150  \\$aRetinal Degeneration
=450  \\$wnnna$aDegeneration, Retinal
=450  \\$wnnna$aDegenerations, Retinal
=450  \\$wnnna$aRetinal Degenerations
=550  \\$wg$aRetinal Diseases
=550  \\$wh$aMacular Degeneration
=550  \\$wh$aRetinal Drusen
=550  \\$wh$aRetinal Dystrophies
=550  \\$wh$aRetinoschisis
=680  \\$iA retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
=688  \\$a70(68)
=750  \0$aRetinal degeneration$5IEN$0(DLC)sh 85113332

=LDR  01150cz  a2200277n  4500
=001  9880363932702441
=005  20141212205319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012160
=035  \\$aCBA5463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x729
=150  \\$aRetina
=450  \\$wnnna$aRetinas
=550  \\$wg$aEye
=550  \\$wh$aBlood-Retinal Barrier
=550  \\$wh$aFundus Oculi
=550  \\$wh$aMacula Lutea
=550  \\$wh$aOptic Disk
=550  \\$wh$aRetinal Neurons
=550  \\$wh$aRetinal Pigment Epithelium
=550  \\$aAngioid Streaks
=550  \\$aElectroretinography
=667  \\$a/blood supply = RETINAL VESSELS or RETINAL ARTERY or RETINAL VEIN; inflammation = RETINITIS or specifics
=680  \\$iThe ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
=750  \0$aRetina$5IEN$0(DLC)sh 85113322

=LDR  01253cz  a2200277n  4500
=001  9880363932802441
=005  20141212205224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012011
=035  \\$aCBA5312M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x514.$x642
=072  \\$aN3.$x540.$x630.$x780.$x608
=150  \\$aRed Cross
=450  \\$wnnna$aAmerican Red Cross
=450  \\$wnnna$aInternational Committee of the Red Cross
=450  \\$wnnna$aInternational Federation of Red Cross and Red Crescent Societies
=450  \\$wnnna$aInternational Red Cross and Red Crescent Movement
=450  \\$wnnna$aMagen David Adom
=450  \\$wnnna$aRed Crescent
=550  \\$wg$aInternational Agencies
=550  \\$wg$aVoluntary Health Agencies
=667  \\$aspecify geographic location; CATALOG: coordinate with specific NAF entry if applicable
=680  \\$iInternational collective of humanitarian organizations led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, to provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies.
=688  \\$a66
=750  \0$aRed Cross and Red Crescent$5IEN-M$0(DLC)sh 85112043

=LDR  01110cz  a2200325n  4500
=001  9880363932902441
=005  20141212205223.0
=008  840529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012010
=035  \\$aCBA5311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x750
=150  \\$aRed-Cell Aplasia, Pure
=450  \\$wnnna$aAplasia, Erythrocyte
=450  \\$wnnna$aAplasia, Pure Red-Cell
=450  \\$wnnna$aAplasias, Erythrocyte
=450  \\$wnnna$aAplasias, Pure Red-Cell
=450  \\$aErythrocyte Aplasia
=450  \\$wnnna$aErythrocyte Aplasias
=450  \\$aPure Red-Cell Aplasia
=450  \\$wnnna$aPure Red Cell Aplasia
=450  \\$wnnna$aPure Red-Cell Aplasias
=450  \\$wnnna$aRed Cell Aplasia, Pure
=450  \\$wnnna$aRed-Cell Aplasias, Pure
=550  \\$wg$aAnemia
=550  \\$wh$aAnemia, Diamond-Blackfan
=667  \\$aa form of anemia
=680  \\$iSuppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
=688  \\$a92; was RED CELL APLASIA, PURE 1985-91
=750  \0$aPure red cell aplasia$5IEN-M$0(DLC)sh 87006060

=LDR  00763cz  a2200253n  4500
=001  9880363933002441
=005  20171102151754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012008
=035  \\$aCBA5309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x937
=150  \\$aRecurrence
=450  \\$aRecrudescence
=450  \\$wnnna$aRecrudescences
=450  \\$wnnna$aRecurrences
=450  \\$aRelapse
=450  \\$wnnna$aRelapses
=550  \\$wg$aDisease Attributes
=550  \\$wh$aSymptom Flare Up
=667  \\$acoordinate NIM with specific disease
=680  \\$iThe return of a sign, symptom, or disease after a remission.
=688  \\$a91(71); was see under DISEASE 1971-90
=750  \0$aDiseases$xRelapse$5IEN-M$0(DLC)sh 98007420

=LDR  00880cz  a2200205n  4500
=001  9880363933102441
=005  20141212205222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012007
=035  \\$aCBA5308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526.$x767
=072  \\$aA3.$x556.$x249.$x249.$x767
=150  \\$aRectum
=360  \\$iconsider also terms at$aPROCT-
=450  \\$wnnna$aRectums
=550  \\$wg$aIntestine, Large
=667  \\$a/surg: do not confuse with the specialty COLORECTAL SURGERY; rectal bleeding: RECTUM (NIM) + HEMORRHAGE, GASTROINTESTINAL (IM) for bleeding through the rectum; hemorrhaging rectum is RECTAL DISEASES (IM) + HEMORRHAGE, GASTROINTESTINAL (IM); inflammation = PROCTITIS
=680  \\$iThe distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
=750  \0$aRectum$5IEN$0(DLC)sh 85112003

=LDR  01145cz  a2200265n  4500
=001  9880363933202441
=005  20141212205222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012005
=035  \\$aCBA5306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x860.$x800
=072  \\$aC23.$x300.$x842.$x624.$x500
=150  \\$aRectal Prolapse
=450  \\$aAnus Prolapse
=450  \\$wnnna$aAnus Prolapses
=450  \\$wnnna$aProlapse, Anus
=450  \\$wnnna$aProlapse, Rectal
=450  \\$wnnna$aProlapses, Anus
=450  \\$wnnna$aProlapses, Rectal
=450  \\$wnnna$aRectal Prolapses
=550  \\$wg$aPelvic Organ Prolapse
=550  \\$wg$aRectal Diseases
=680  \\$iProtrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum.
=750  \0$aRectum$xProlapse$5IEN$0(DLC)sh 85112007

=LDR  00972cz  a2200205n  4500
=001  9880364195402441
=005  20141212215222.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x33
=150  \\$aAlismataceae
=450  \\$aEchinodorus
=550  \\$wg$aAlismatidae
=550  \\$wh$aAlisma
=550  \\$wh$aSagittaria
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the subclass ALISMATIDAE, class Liliopsida (monocotyledons) of aquatic plants. The flower parts are in threes with 3 green sepals and 3 white or yellow petals.
=688  \\$a2003
=750  \0$aAlismataceae$5IEN-M$0(DLC)sh 85003577

=LDR  00812cz  a2200181n  4500
=001  9880364195502441
=005  20141212215222.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x50
=150  \\$aAbdominal Wall
=450  \\$wnnna$aWall, Abdominal
=550  \\$wg$aAbdomen
=550  \\$aAbdominal Muscles
=680  \\$iThe outer margins of the ABDOMEN, extending from the osteocartilaginous thoracic cage to the PELVIS. Though its major part is muscular, the abdominal wall consists of at least seven layers: the SKIN, subcutaneous fat, deep FASCIA; ABDOMINAL MUSCLES, transversalis fascia, extraperitoneal fat, and the parietal PERITONEUM.
=688  \\$a2003; use ABDOMINAL MUSCLES 1966-1992
=750  \0$aAbdominal wall$5IEN-M$0(DLC)sh 85000113

=LDR  00867cz  a2200205n  4500
=001  9880364195602441
=005  20141212215221.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034823
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x233.$x611
=150  \\$aTradescantia
=450  \\$aSpiderwort
=450  \\$wnnna$aSpiderworts
=450  \\$wnnna$aTradescantias
=550  \\$wg$aCommelinaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family COMMELINACEAE that is used in genotoxic bioassays.
=688  \\$a2003
=750  \0$aTradescantia$5IEN-M$0(DLC)sh 85136745

=LDR  00858cz  a2200205n  4500
=001  9880364195702441
=005  20141212215221.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x233.$x222
=150  \\$aCommelina
=450  \\$wnnna$aCommelinas
=450  \\$aDayflower
=450  \\$wnnna$aDayflowers
=550  \\$wg$aCommelinaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family COMMELINACEAE of perennial herbs with blue flowers.
=688  \\$a2003
=750  \0$aDayflowers$5IEN-M$0(DLC)sh 85035967

=LDR  01059cz  a2200193n  4500
=001  9880364195802441
=005  20141212215220.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x233
=150  \\$aCommelinaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCommelina
=550  \\$wh$aTradescantia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Commelinales, subclass Commelinidae, class Liliopsida (monocotyledons) that are often somewhat succulent. The leaves are alternate, simple, parallel-veined, and usually with a closed sheathing base. The flowers are often in cymes and have 3 petals and 3 sepals.
=688  \\$a2003
=750  \0$aCommelinaceae$5IEN-M$0(DLC)sh 85028890

=LDR  01253cz  a2200277n  4500
=001  9880364195902441
=005  20141212215219.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x37.$x333
=150  \\$aCelosia
=450  \\$wnnna$aCelosia cristata
=450  \\$wnnna$aCelosia cristatas
=450  \\$wnnna$aCelosias
=450  \\$aCockscomb, Common
=450  \\$wnnna$aCockscombs, Common
=450  \\$wnnna$aCommon Cockscomb
=450  \\$wnnna$aCommon Cockscombs
=450  \\$wnnna$acristata, Celosia
=450  \\$wnnna$acristatas, Celosia
=550  \\$wg$aAmaranthaceae
=667  \\$aX ref COCKSCOMB, COMMON: COCKSCOMB, GREEN see SEDUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family AMARANTHACEAE. Young leaves are used as vegetables in Asia. Members contain betacyanins, celogentins, betaxanthin, and celosian.
=688  \\$a2003
=750  \0$aCelosia$5IEN-M$0(DLC)sh 85021713

=LDR  01065cz  a2200253n  4500
=001  9880364196002441
=005  20141212215217.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x377.$x333
=072  \\$aL1.$x178.$x847.$x249
=150  \\$aElectronic Mail
=450  \\$aE-Mail
=450  \\$wnnna$aE Mail
=450  \\$wnnna$aE-Mails
=450  \\$aEmail
=450  \\$wnnna$aEmails
=450  \\$wnnna$aMail, Electronic
=550  \\$wg$aCorrespondence as Topic
=550  \\$wg$aTelecommunications
=680  \\$iMessages between computer users via COMPUTER COMMUNICATION NETWORKS. This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.
=688  \\$a2003; use COMPUTER COMMUNICATION NETWORKS 1996-2002; use OFFICE AUTOMATION 1987-1995
=750  \0$aElectronic mail messages$5IEN-M$0(DLC)sh 96007226

=LDR  02675cz  a2200637n  4500
=001  9880364196102441
=005  20190304142256.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x150.$x650.$x700
=072  \\$aD13.$x444.$x735.$x150.$x700
=072  \\$aD13.$x444.$x735.$x790.$x552.$x875
=150  \\$aRNA, Small Interfering
=450  \\$wnnna$aHairpin RNA, Short
=450  \\$wnnna$aHairpin RNA, Small
=450  \\$wnnna$aInterfering RNA, Short
=450  \\$wnnna$aInterfering RNA, Small
=450  \\$wnnna$apiRNA
=450  \\$aPiwi-Interacting RNA
=450  \\$wnnna$aPiwi Interacting RNA
=450  \\$aRepeat-Associated siRNA
=450  \\$wnnna$aRepeat Associated siRNA
=450  \\$aRNA, Piwi-Interacting
=450  \\$wnnna$aRNA, Piwi Interacting
=450  \\$aRNA, Scan
=450  \\$wnnna$aRNA, Short Hairpin
=450  \\$wnnna$aRNA, Short Interfering
=450  \\$wnnna$aRNA, Small Hairpin
=450  \\$wnnna$aRNA, Small Scan
=450  \\$aScan RNA
=450  \\$wnnna$aScan RNA, Small
=450  \\$wnnna$ascnRNA
=450  \\$wnnna$aShort Hairpin RNA
=450  \\$wnnna$aShort Interfering RNA
=450  \\$wnnna$ashRNA
=450  \\$asiRNA
=450  \\$asiRNA, Repeat-Associated
=450  \\$wnnna$asiRNA, Repeat Associated
=450  \\$asiRNA, Trans-Acting
=450  \\$wnnna$asiRNA, Trans Acting
=450  \\$wnnna$aSmall Hairpin RNA
=450  \\$wnnna$aSmall Interfering RNA
=450  \\$aSmall Scan RNA
=450  \\$wnnna$atasiRNA
=450  \\$aTrans-Acting siRNA
=450  \\$wnnna$aTrans Acting siRNA
=550  \\$wg$aRNA, Antisense
=550  \\$wg$aRNA, Small Untranslated
=550  \\$aMicroRNAs
=550  \\$aRNA-Induced Silencing Complex
=550  \\$aRNA Interference
=667  \\$aDo not confuse with defective interfering RNA (diRNA), a viral RNA of DEFECTIVE VIRUSES.
=680  \\$iSmall double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.
=688  \\$a2003; use RNA, SMALL INTERFERING (NM) 2001-2002
=750  \0$aSmall interfering RNA$0(DLC)sh2003008503$5IEN-M

=LDR  01769cz  a2200361n  4500
=001  9880364196202441
=005  20141212215216.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x566.$x479.$x101
=150  \\$aDouble Effect Principle
=450  \\$wnnna$aDoctrine, Double Effect
=450  \\$wnnna$aDoctrine of Double Effect
=450  \\$wnnoa$aDouble Effect$5IEN-M
=450  \\$wnnna$aDouble Effect Doctrine
=450  \\$wnnna$aDouble Effect Rule
=450  \\$wnnna$aEffect Doctrine, Double
=450  \\$wnnna$aEffect Principle, Double
=450  \\$wnnna$aEffect Rule, Double
=450  \\$wnnna$aPrinciple, Double Effect
=450  \\$wnnna$aPrinciple of Double Effect
=450  \\$wnnna$aPrinciples, Double Effect
=450  \\$wnnna$aRule, Double Effect
=450  \\$wnnna$aRule of Double Effect
=550  \\$wg$aEthics
=550  \\$aIntention
=667  \\$anote category; use only in the context of ethics
=680  \\$iGuideline for determining when it is morally permissible to perform an action to pursue a good end with knowledge that the action will also bring about bad results. It generally states that, in cases where a contemplated action has such double effect, the action is permissible only if: it is not wrong in itself; the bad result is not intended; the good result is not a direct causal result of the bad result; and the good result is "proportionate to" the bad result. (from Solomon, "Double Effect," in Becker, The Encyclopedia of Ethics, 1992)
=688  \\$a2009 (2003); use ETHICS 2002
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Double Effect
=688  \\$a2003; use ETHICS 2002
=750  \0$aDouble effect (Ethics)$0(DLC) sh 00002291$5IEN-M

=LDR  00756cz  a2200217n  4500
=001  9880364196302441
=005  20141212215212.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x521.$x400
=150  \\$aHares
=450  \\$wnnna$aHare
=450  \\$wnnna$aJackrabbit
=450  \\$aJackrabbits
=450  \\$aLepus
=550  \\$wg$aLagomorpha
=667  \\$ado not confuse with BELGIAN HARE see RABBITS
=680  \\$iThe genus Lepus, in the family Leporidae, order LAGOMORPHA. Hares are born above ground, fully furred, and with their eyes and ears open. In contrast with RABBITS, hares have 24 chromosome pairs.
=688  \\$a2003
=750  \0$aHares$5IEN-M$0(DLC)sh 85058912

=LDR  00769cz  a2200229n  4500
=001  9880364196402441
=005  20200409151331.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA17
=150  \\$aIntegumentary System
=450  \\$wnnna$aIntegumentary Systems
=450  \\$wnnna$aSystem, Integumentary
=450  \\$wnnna$aSystems, Integumentary
=550  \\$wh$aAnimal Scales
=550  \\$wh$aHair
=550  \\$wh$aNails
=550  \\$wh$aSkin
=680  \\$iThe outer covering of the body composed of the SKIN and the skin appendages, which are the HAIR, the NAILS; and the SEBACEOUS GLANDS and the SWEAT GLANDS and their ducts.
=688  \\$a2003
=750  \2$aBody covering (Anatomy)$0(DLC) sh 85015240$5IEN-M

=LDR  00684cz  a2200193n  4500
=001  9880364196502441
=005  20141212215211.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x791.$x100
=150  \\$aSheep, Bighorn
=450  \\$wnnna$aBighorn Sheep
=450  \\$wnnna$aOvis canadensis
=450  \\$aRocky Mountain Bighorn Sheep
=550  \\$wg$aSheep
=680  \\$iA species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.
=688  \\$a2003
=750  \0$aBighorn sheep$5IEN-M$0(DLC)sh 85013981

=LDR  00832cz  a2200253n  4500
=001  9880364196602441
=005  20141212215211.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x791.$x150
=150  \\$aSheep, Domestic
=450  \\$wnnna$aDomestic Sheep
=450  \\$aMouflon
=450  \\$wnnna$aMouflons
=450  \\$wnnna$aOvis ammon aries
=450  \\$wnnna$aOvis aries
=450  \\$wnnna$aOvis aries musimon
=450  \\$wnnna$aOvis gmelini musimon
=550  \\$wg$aSheep
=667  \\$asheep unspecified goes under SHEEP; SHEEP, BIGHORN is also available
=680  \\$iA species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.
=688  \\$a2003
=750  \0$aMouflon$5IEN-M$0(DLC)sh 85087707

=LDR  00942cz  a2200289n  4500
=001  9880364196702441
=005  20141212215204.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x880.$x399
=150  \\$aSus scrofa
=450  \\$wnnna$aBoar, Wild
=450  \\$wnnna$aBoars, Wild
=450  \\$wnnna$aDomestic Pig
=450  \\$wnnna$aDomestic Pigs
=450  \\$aPig, Domestic
=450  \\$wnnna$aPigs, Domestic
=450  \\$wnnna$aSus scrofa domestica
=450  \\$aWild Boar
=450  \\$wnnna$aWild Boars
=550  \\$wg$aSwine
=550  \\$wh$aSwine, Miniature
=667  \\$aonly Sus scrofa; index other species or unspecified swine or pigs under SWINE
=680  \\$iA species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.
=688  \\$a2003
=750  \2$aWild boar$5IEN-M

=LDR  00924cz  a2200217n  4500
=001  9880364196802441
=005  20141212215204.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034403
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x949.$x888
=150  \\$aUlmus
=450  \\$aElm Tree
=450  \\$wnnna$aElm Trees
=450  \\$wnnna$aTree, Elm
=450  \\$wnnna$aTrees, Elm
=550  \\$wg$aUlmaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma.
=688  \\$a2003
=750  \0$aElm$5IEN-M$0(DLC)sh 85042618

=LDR  00921cz  a2200205n  4500
=001  9880364197002441
=005  20141212215201.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x877
=150  \\$aStriga
=450  \\$wnnna$aStrigas
=450  \\$aWitchweed
=450  \\$wnnna$aWitchweeds
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE that is parasitic on the roots of other plants. Members contain the flavones, apigenin and luteolin.
=688  \\$a2003
=750  \0$aWitchweeds$5IEN-M$0(DLC)sh 85128725

=LDR  00636cz  a2200169n  4500
=001  9880364197102441
=005  20141212215200.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x200
=150  \\$aDeinococcus
=450  \\$wnnna$aDeinococcus radiodurans
=550  \\$wg$aGram-Positive Cocci
=680  \\$iA genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation (RADIATION, IONIZING). Deinococcus radiodurans is the type species.
=688  \\$a2003
=750  \0$aDeinococcus$0(DLC) sh2004001432$5IEN-M

=LDR  01762cz  a2200493n  4500
=001  9880364197202441
=005  20161021160135.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x550.$x500
=150  \\$aComputers, Handheld
=450  \\$wnnna$aComputer, Handheld
=450  \\$wnnna$aComputer, Palm-Top
=450  \\$wnnna$aComputer, Palmtop
=450  \\$wnnna$aComputer, PDA
=450  \\$wnnna$aComputers, Palm-Top
=450  \\$wnnna$aComputers, Palm Top
=450  \\$wnnna$aComputers, Palmtop
=450  \\$wnnna$aComputers, PDA
=450  \\$wnnna$aDigital Assistant, Personal
=450  \\$wnnna$aHandheld Computer
=450  \\$wnnna$aHandheld Computers
=450  \\$wnnna$aPalm Pilot
=450  \\$wnnna$aPalm Pilots
=450  \\$wnnna$aPalm-Top Computer
=450  \\$wnnna$aPalm-Top Computers
=450  \\$wnnna$aPalmtop Computer
=450  \\$wnnna$aPalmtop Computers
=450  \\$wnnna$aPC, Pocket
=450  \\$wnnna$aPCs, Pocket
=450  \\$wnnna$aPDA Computer
=450  \\$wnnna$aPDA Computers
=450  \\$aPersonal Digital Assistant
=450  \\$wnnna$aPilot, Palm
=450  \\$wnnna$aPilots, Palm
=450  \\$wnnna$aPocket PC
=450  \\$wnnna$aPocket PCs
=550  \\$wg$aMicrocomputers
=550  \\$wh$aSmartphone
=550  \\$aCell Phones
=680  \\$iMICROCOMPUTERS, sometimes called PDA, that are very small and portable, fitting in a hand, and that have much more function than a calculator. They are convenient to use in clinical and other field situations for quick data management. They usually require docking with MICROCOMPUTERS for updates.
=688  \\$a2003
=750  \0$aPocket computers$5IEN-M$0(DLC)sh 93005979

=LDR  00880cz  a2200205n  4500
=001  9880364197302441
=005  20141212215157.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034182
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x306
=150  \\$aCuscuta
=450  \\$wnnna$aCuscutas
=450  \\$aDodder
=450  \\$wnnna$aDodders
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Cuscutaceae. It is a threadlike climbing parasitic plant that is used in DRUGS, CHINESE HERBAL.
=688  \\$a2003
=750  \0$aDodder$5IEN-M$0(DLC)sh 85038739

=LDR  00882cz  a2200181n  4500
=001  9880364197402441
=005  20141212215157.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034181
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x125.$x342
=150  \\$aEpimedium
=450  \\$wnnna$aEpimediums
=550  \\$wg$aBerberidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BERBERIDACEAE which is used in DRUGS, CHINESE HERBAL. Members contain flavonol glycosides including epimedins, icariin and noricariin.
=688  \\$a2003
=750  \0$aEpimedium$5IEN-M$0(DLC)sh2002004573

=LDR  00644cz  a2200217n  4500
=001  9880364197502441
=005  20141212215156.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x635
=150  \\$aPelvic Infection
=450  \\$wnnna$aInfection, Pelvic
=450  \\$wnnna$aInfections, Pelvic
=450  \\$wnnna$aPelvic Infections
=550  \\$wg$aInfection
=550  \\$wh$aPelvic Inflammatory Disease
=550  \\$aPelvis
=680  \\$iInfection involving the tissues or organs in the PELVIS.
=688  \\$a2003; use ADNEXITIS 1990-2002
=750  \0$aPelvis$xInfections$5IEN-M

=LDR  01044cz  a2200241n  4500
=001  9880364197602441
=005  20141212215156.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034121
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x800
=150  \\$aReproductive Health Services
=450  \\$wnnna$aHealth Service, Reproductive
=450  \\$wnnna$aHealth Services, Reproductive
=450  \\$wnnna$aReproductive Health Service
=450  \\$wnnna$aService, Reproductive Health
=450  \\$wnnna$aServices, Reproductive Health
=550  \\$wg$aHealth Services
=550  \\$wh$aFamily Planning Services
=550  \\$wh$aMaternal Health Services
=680  \\$iHealth care services related to human REPRODUCTION and diseases of the reproductive system. Services are provided to both sexes and usually by physicians in the medical or the surgical specialities such as REPRODUCTIVE MEDICINE; ANDROLOGY; GYNECOLOGY; OBSTETRICS; and PERINATOLOGY.
=688  \\$a2003
=750  \0$aReproductive health services$0(DLC)sh2009007251$5IEN-M

=LDR  00819cz  a2200205n  4500
=001  9880364197702441
=005  20141212215155.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800.$x858
=072  \\$aC10.$x574.$x843.$x925
=072  \\$aC22.$x955
=150  \\$aWasting Disease, Chronic
=450  \\$aChronic Wasting Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aPrion Diseases
=680  \\$iA transmissible spongiform encephalopathy (prion disease) of DEER and elk characterized by chronic weight loss leading to death. It is thought to spread by direct contact between animals or through environmental contamination with the prion protein (PRIONS).
=688  \\$a2003
=750  \0$aChronic wasting disease$5IEN-M$0(DLC)sh2003001228

=LDR  01462cz  a2200373n  4500
=001  9880364197802441
=005  20141212215155.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800.$x392
=072  \\$aC10.$x574.$x843.$x512
=072  \\$aC10.$x886.$x425.$x800.$x800.$x400
=150  \\$aInsomnia, Fatal Familial
=450  \\$wnnna$aFamilial Fatal Insomnia
=450  \\$wnnna$aFamilial Fatal, Insomnia
=450  \\$wnnna$aFamilial Fatal Insomnias
=450  \\$wnnna$aFamilial Fatals, Insomnia
=450  \\$aFatal Familial Insomnia
=450  \\$wnnna$aFatal Familial Insomnias
=450  \\$wnnna$aFatal Insomnia, Familial
=450  \\$wnnna$aFatal, Insomnia Familial
=450  \\$wnnna$aFatal Insomnias, Familial
=450  \\$wnnna$aFatals, Insomnia Familial
=450  \\$wnnna$aInsomnia Familial Fatal
=450  \\$wnnna$aInsomnia, Familial Fatal
=450  \\$wnnna$aInsomnia Familial Fatals
=450  \\$wnnna$aInsomnias, Familial Fatal
=450  \\$wnnna$aInsomnias, Fatal Familial
=550  \\$wg$aPrion Diseases
=550  \\$wg$aSleep Initiation and Maintenance Disorders
=680  \\$iAn autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).
=688  \\$a2003; use PRION DISEASES 1993-2002
=750  \0$aFatal familial insomnia$5IEN-M$0(DLC)sh 93006259

=LDR  01333cz  a2200277n  4500
=001  9880364197902441
=005  20141212215142.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x594
=150  \\$aMillettia
=450  \\$wnnna$aMillettia pinnata
=450  \\$wnnna$aMillettia pinnatas
=450  \\$wnnna$aMillettias
=450  \\$wnnna$apinnata, Millettia
=450  \\$wnnna$apinnata, Pongamia
=450  \\$wnnna$apinnatas, Millettia
=450  \\$wnnna$apinnatas, Pongamia
=450  \\$wnnna$aPongamia pinnata
=450  \\$wnnna$aPongamia pinnatas
=550  \\$wg$aFabaceae
=667  \\$aX ref PONGAMIA PINNATA: Pongamia unspecified: PONGAMIA see FABACEAE is available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain ISOFLAVONES, some of which show molluscicidal and schistosomicidal activity. Some species of Pongamia have been reclassified to this genus and some to DERRIS.
=688  \\$a2003
=750  \0$aMillettia$0(DLC)sh2010005590$5IEN-M

=LDR  01088cz  a2200289n  4500
=001  9880364198002441
=005  20141212215142.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x850.$x150
=150  \\$aCeratitis capitata
=450  \\$wnnna$acapitata, Ceratitis
=450  \\$wnnna$acapitatas, Ceratitis
=450  \\$wnnna$aCeratitis capitatas
=450  \\$wnnna$aFlies, Mediterranean Fruit
=450  \\$wnnna$aFly, Mediterranean Fruit
=450  \\$wnnna$aFruit Flies, Mediterranean
=450  \\$aFruit Fly, Mediterranean
=450  \\$wnnna$aMedflies
=450  \\$aMedfly
=450  \\$wnnna$aMediterranean Fruit Flies
=450  \\$aMediterranean Fruit Fly
=550  \\$wg$aTephritidae
=680  \\$iA species of fruit fly originating in sub-Saharan Africa but widely distributed worldwide. One of the most destructive fruit pests, its larvae feed and develop on many different fruits and some vegetables.
=688  \\$a2003
=750  \0$aMediterranean fruit-fly$5IEN-M$0(DLC)sh 85083227

=LDR  02250cz  a2200637n  4500
=001  9880364198102441
=005  20250501163405.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x850
=150  \\$aTephritidae
=450  \\$aAnastrepha
=450  \\$wnnna$aAnastrepha luden
=450  \\$wnnna$aAnastrepha ludens
=450  \\$wnnna$aAnastrepha suspensa
=450  \\$wnnna$aAnastrepha suspensas
=450  \\$wnnna$aAnastrephas
=450  \\$aBactrocera
=450  \\$wnnna$aBactrocera tryoni
=450  \\$wnnna$aBactrocera tryonus
=450  \\$wnnna$aBactroceras
=450  \\$wnnna$aCaribbean Fruit Flies
=450  \\$wnnna$aCaribbean Fruit Fly
=450  \\$wnnna$aFlies, Caribbean Fruit
=450  \\$wnnna$aFlies, Mexican Fruit
=450  \\$wnnna$aFlies, Queensland Fruit
=450  \\$wnnna$aFly, Caribbean Fruit
=450  \\$wnnna$aFly, Mexican Fruit
=450  \\$wnnna$aFly, Queensland Fruit
=450  \\$wnnna$aFruit Flies, Caribbean
=450  \\$wnnna$aFruit Flies, Mexican
=450  \\$wnnna$aFruit Flies, Queensland
=450  \\$aFruit Fly, Caribbean
=450  \\$aFruit Fly, Mexican
=450  \\$aFruit Fly, Queensland
=450  \\$wnnna$aluden, Anastrepha
=450  \\$wnnna$aludens, Anastrepha
=450  \\$wnnna$aMexican Fruit Flies
=450  \\$wnnna$aMexican Fruit Fly
=450  \\$wnnna$aQueensland Fruit Flies
=450  \\$wnnna$aQueensland Fruit Fly
=450  \\$wnnna$aRhagoleti
=450  \\$aRhagoletis
=450  \\$wnnna$asuspensa, Anastrepha
=450  \\$wnnna$asuspensas, Anastrepha
=450  \\$wnnna$atryoni, Bactrocera
=450  \\$wnnna$atryonus, Bactrocera
=450  \\$wnnna$aTrypetidae
=550  \\$wg$aDiptera
=550  \\$wh$aCeratitis capitata
=680  \\$iA large family of fruit flies in the order DIPTERA, comprising over 4,500 species in about 100 genera. They have patterned wings and brightly colored bodies and are found predominantly in the tropical latitudes.
=688  \\$a2003
=750  \0$aTephritidae$5IEN-M$0(DLC)sh 85133969
=750  \0$iNarrower mapping$aPacific fruit fly    $0(DLC)sh2023001871$4NM$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01356cz  a2200265n  4500
=001  9880364198202441
=005  20141212215140.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x225.$x687
=150  \\$aStem Cell Transplantation
=450  \\$wnnna$aStem Cell Transplantations
=450  \\$aStem Cells$xtransplantation
=450  \\$aTransplantation, Stem Cell
=450  \\$wnnna$aTransplantations, Stem Cell
=550  \\$wg$aCell Transplantation
=550  \\$wh$aCord Blood Stem Cell Transplantation
=550  \\$wh$aHematopoietic Stem Cell Transplantation
=550  \\$wh$aMesenchymal Stem Cell Transplantation
=550  \\$wh$aPeripheral Blood Stem Cell Transplantation
=667  \\$ageneral or unspecified only: prefer specifics or /transpl with specific type of stem cell
=680  \\$iThe transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.
=688  \\$a2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002
=750  \0$aStem cells$xTransplantation$0(DLC) sh2003001456$5IEN-M

=LDR  00917cz  a2200241n  4500
=001  9880364198302441
=005  20201118174505.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x660
=150  \\$aPenaeidae
=450  \\$aMetapenaeus
=450  \\$wnnna$aPenaeid Shrimp
=450  \\$wnnna$aPenaeid Shrimps
=450  \\$aPenaeus
=450  \\$aShrimp, Penaeid
=450  \\$wnnna$aShrimps, Penaeid
=550  \\$wg$aDecapoda
=667  \\$aas animal & food; as food coord IM with SHELLFISH (IM); unspecified shrimp as food probably goes here but note several other shrimp terms in MeSH
=680  \\$iA family of CRUSTACEA, order DECAPODA, comprising the penaeid shrimp. Species of the genus Penaeus are the most important commercial shrimp throughout the world.
=688  \\$a2003
=750  \0$aPenaeidae$5IEN-M$0(DLC)sh 85099348

=LDR  00945cz  a2200229n  4500
=001  9880364198402441
=005  20201118174444.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x635
=150  \\$aPandalidae
=450  \\$wnnna$aPandalid Shrimp
=450  \\$wnnna$aPandalid Shrimps
=450  \\$aPandalus
=450  \\$aShrimp, Pandalid
=450  \\$wnnna$aShrimps, Pandalid
=550  \\$wg$aDecapoda
=667  \\$anote X ref PANDALID SHRIMP: several other shrimp termsare available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE
=680  \\$iA family of CRUSTACEA, order DECAPODA, comprising the pandalid shrimp. They are protandric hermaphrodites and can breed in both male and female stages. Many species are commercially harvested in the Pacific Northwest.
=688  \\$a2003
=750  \0$aPandalidae$5IEN-M$0(DLC)sh 85097389

=LDR  01169cz   2200301n  4500
=001  9880364198502441
=005  20220926164935.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x615
=150  \\$aPalaemonidae
=450  \\$aMacrobrachium
=450  \\$wnnna$aMacrobrachiums
=450  \\$aPalaemon
=450  \\$wnnna$aPalaemonete
=450  \\$aPalaemonetes
=450  \\$wnnna$aPalaemonid Shrimp
=450  \\$wnnna$aPalaemonid Shrimps
=450  \\$wnnna$aPalaemons
=450  \\$aShrimp, Palaemonid
=450  \\$wnnna$aShrimps, Palaemonid
=550  \\$wg$aDecapoda
=667  \\$anote X ref PALAEMONID SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE
=680  \\$iA family of CRUSTACEA, order DECAPODA, comprising the palaemonid shrimp. Genera include Macrobrachium, Palaemon, and Palaemonetes. Palaemonidae osmoregulate by means of gills.
=688  \\$a2003
=750  \0$aPalaemonidae$5IEN-M$0(DLC)sh 85096949
=750  \0$iNarrower mapping$aPalaemonetes kadiakensis$0(DLC)sh2021008653$4NM$5IEN-M

=LDR  00774cz  a2200217n  4500
=001  9880364198602441
=005  20201118174420.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x625
=150  \\$aPalinuridae
=450  \\$wnnna$aLobster, Spiny
=450  \\$aLobsters, Spiny
=450  \\$aPanulirus
=450  \\$wnnna$aSpiny Lobster
=450  \\$aSpiny Lobsters
=550  \\$wg$aDecapoda
=680  \\$iA family of marine CRUSTACEA, in the order DECAPODA, comprising the clawless lobsters. They are found in tropical and subtropical waters and characterized by short spines along the length of the tail and body.
=688  \\$a2003
=750  \0$aSpiny lobsters$5IEN-M$0(DLC)sh 85126723

=LDR  00572cz  a2200181n  4500
=001  9880364198702441
=005  20201118174108.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x150
=150  \\$aCrangonidae
=450  \\$aCrangon
=450  \\$wnnna$aCrangons
=550  \\$wg$aDecapoda
=680  \\$iA family of shrimp in the class CRUSTACEA, order DECAPODA, containing a single genus, Crangon, with multiple species.
=688  \\$a2003
=750  \0$aCrangonidae$5IEN-M$0(DLC)sh 88000379

=LDR  00804cz  a2200157n  4500
=001  9880364198802441
=005  20141212215138.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x449
=150  \\$aHyperuricemia
=550  \\$wg$aPathologic Processes
=680  \\$iExcessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
=688  \\$a2003
=750  \0$aHyperuricemia$5IEN-M$0(DLC)sh 85063735

=LDR  00716cz  a2200181n  4500
=001  9880364198902441
=005  20141212215137.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x59
=150  \\$aAndrology
=550  \\$wg$aMedicine
=550  \\$aUrology
=667  \\$aSPEC
=680  \\$iA scientific or medical discipline concerning the study of male reproductive biology, diseases of the male genital organs, and male infertility. Major areas of interest include ENDOCRINOLOGY; SPERMATOGENESIS; semen analysis; FERTILIZATION; CONTRACEPTION; and CRYOPRESERVATION.
=688  \\$a2003; use UROLOGY 1992-2002
=750  \0$aAndrology$5IEN-M$0(DLC)sh 85004922

=LDR  01870cz  a2200445n  4500
=001  9880364199002441
=005  20141212215137.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x370
=072  \\$aE1.$x370.$x350.$x850.$x565
=072  \\$aE5.$x595.$x370
=150  \\$aMicroscopy, Acoustic
=450  \\$wnnna$aAcoustic Microscopies
=450  \\$wnnna$aAcoustic Microscopies, Scanning
=450  \\$aAcoustic Microscopy
=450  \\$wnnna$aAcoustic Microscopy, Scanning
=450  \\$wnnna$aBiomicroscopies, Ultrasonic
=450  \\$wnnna$aBiomicroscopies, Ultrasonographic
=450  \\$wnnna$aBiomicroscopies, Ultrasound
=450  \\$wnnna$aBiomicroscopy, Ultrasonic
=450  \\$wnnna$aBiomicroscopy, Ultrasonographic
=450  \\$wnnna$aBiomicroscopy, Ultrasound
=450  \\$wnnna$aMicroscopies, Acoustic
=450  \\$wnnna$aMicroscopies, Scanning Acoustic
=450  \\$wnnna$aMicroscopy, Scanning Acoustic
=450  \\$wnnna$aScanning Acoustic Microscopies
=450  \\$wnnna$aScanning Acoustic Microscopy
=450  \\$wnnna$aUltrasonic Biomicroscopies
=450  \\$wnnna$aUltrasonic Biomicroscopy
=450  \\$wnnna$aUltrasonographic Biomicroscopies
=450  \\$wnnna$aUltrasonographic Biomicroscopy
=450  \\$wnnna$aUltrasound Biomicroscopies
=450  \\$wnnna$aUltrasound Biomicroscopy
=550  \\$wg$aMicroscopy
=550  \\$wg$aUltrasonography
=680  \\$iA scientific tool based on ULTRASONOGRAPHY and used not only for the observation of microstructure in metalwork but also in living tissue. In biomedical application, the acoustic propagation speed in normal and abnormal tissues can be quantified to distinguish their tissue elasticity and other properties.
=688  \\$a2003
=750  \0$aAcoustic microscopy$5IEN-M$0(DLC)sh 92003371

=LDR  00774cz  a2200253n  4500
=001  9880364199102441
=005  20201118173810.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x50
=150  \\$aAnomura
=450  \\$wnnna$aAnomuras
=450  \\$wnnna$aCrab, Hermit
=450  \\$wnnna$aCrabs, Hermit
=450  \\$aHermit Crab
=450  \\$wnnna$aHermit Crabs
=450  \\$aPagurus
=450  \\$wnnna$aParalithode
=450  \\$aParalithodes
=550  \\$wg$aDecapoda
=680  \\$iAn infraorder of CRUSTACEA, in the order DECAPODA comprising the hermit crabs and characterized by a small fifth pair of legs.
=688  \\$a2003
=750  \0$aHermit crabs$5IEN-M$0(DLC)sh 85060411

=LDR  00992cz  a2200265n  4500
=001  9880364199302441
=005  20170629131553.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033363
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x309.$x555
=072  \\$aE5.$x196.$x822.$x650
=072  \\$aG1.$x867.$x650
=072  \\$aG2.$x551
=150  \\$aNeutron Diffraction
=450  \\$wnnna$aDiffraction, Neutron
=450  \\$wnnna$aDiffractions, Neutron
=450  \\$wnnna$aNeutron Diffractions
=550  \\$wg$aCrystallography
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aScattering, Radiation
=667  \\$afor SANS (small angle neutron scattering) coordinate with SCATTERING, SMALL ANGLE
=680  \\$iThe scattering of NEUTRONS by matter, especially crystals, with accompanying variation in intensity due to interference effects. It is useful in CRYSTALLOGRAPHY and POWDER DIFFRACTION.
=688  \\$a2003
=750  \0$aNeutrons$xDiffraction$5IEN-M$0(DLC)sh 85091224

=LDR  00811cz  a2200229n  4500
=001  9880364199402441
=005  20141212215135.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x150
=150  \\$aCladocera
=450  \\$wnnna$aCladoceras
=450  \\$wnnna$aFlea, Water
=450  \\$wnnna$aFleas, Water
=450  \\$aWater Flea
=450  \\$wnnna$aWater Fleas
=550  \\$wg$aCrustacea
=550  \\$wh$aDaphnia
=680  \\$iA suborder of CRUSTACEA, order Diplostraca, comprising the water fleas. They are benthic filter feeders that consume PHYTOPLANKTON. The body is laterally compressed and enclosed in a bivalved carapace, from which the head extends.
=688  \\$a2003
=750  \0$aCladocera$5IEN-M$0(DLC)sh 85026514

=LDR  01431cz  a2200409n  4500
=001  9880364199502441
=005  20141212215134.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x160
=150  \\$aCopepoda
=450  \\$aCalanoida
=450  \\$wnnna$aCalanoidas
=450  \\$wnnna$aCopepod
=450  \\$wnnna$aCopepodas
=450  \\$wnnna$aCopepods
=450  \\$aCyclopoida
=450  \\$wnnna$aCyclopoidas
=450  \\$aHarpacticoida
=450  \\$wnnna$aHarpacticoidas
=450  \\$wnnna$aLepeophtheirus salmoni
=450  \\$aLepeophtheirus salmonis
=450  \\$wnnna$aLouse, Salmon
=450  \\$wnnna$aLouses, Salmon
=450  \\$wnnna$aMesocyclop
=450  \\$aMesocyclops
=450  \\$aSalmon Louse
=450  \\$wnnna$aSalmon Louses
=450  \\$wnnna$asalmoni, Lepeophtheirus
=450  \\$wnnna$asalmonis, Lepeophtheirus
=450  \\$aSiphonostomatoida
=450  \\$wnnna$aSiphonostomatoidas
=550  \\$wg$aCrustacea
=680  \\$iA huge subclass of mostly marine CRUSTACEA, containing over 14,000 species. The 10 orders comprise both planktonic and benthic organisms, and include both free-living and parasitic forms. Planktonic copepods form the principle link between PHYTOPLANKTON and the higher trophic levels of the marine food chains.
=688  \\$a2003
=750  \0$aCopepoda$5IEN-M$0(DLC)sh 85032264

=LDR  00830cz  a2200265n  4500
=001  9880364199602441
=005  20141212215134.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x70
=150  \\$aArguloida
=450  \\$wnnna$aArguloidas
=450  \\$aArgulus
=450  \\$aBranchiura (Crustacea)
=450  \\$wnnna$aBranchiuras (Crustacea)
=450  \\$wnnna$aFish Lice
=450  \\$wnnna$aFish Lices
=450  \\$wnnna$aLice, Fish
=450  \\$wnnna$aLices, Fish
=550  \\$wg$aCrustacea
=667  \\$ado not confuse Branchiura the subclass of CRUSTACEA, with Branchiura a genus of ANNELIDA.
=680  \\$iAn order of CRUSTACEA that are parasitic on freshwater fish.
=688  \\$a2003
=750  \0$aArguloida$5IEN-M$0(DLC)sh 87020472

=LDR  00835cz  a2200193n  4500
=001  9880364199702441
=005  20141212215134.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x400
=150  \\$aIsopoda
=450  \\$wnnna$aIsopod
=450  \\$wnnna$aIsopodas
=450  \\$wnnna$aIsopods
=550  \\$wg$aCrustacea
=680  \\$iOne of the largest orders of mostly marine CRUSTACEA, containing over 10,000 species. Like AMPHIPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Amphipoda, they possess abdominal pleopods (modified as gills) and their bodies are dorsoventrally flattened.
=688  \\$a2003
=750  \0$aIsopoda$5IEN-M$0(DLC)sh 85068661

=LDR  00818cz  a2200193n  4500
=001  9880364199802441
=005  20141212215133.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x55
=150  \\$aAmphipoda
=450  \\$wnnna$aAmphipod
=450  \\$wnnna$aAmphipodas
=450  \\$wnnna$aAmphipods
=550  \\$wg$aCrustacea
=680  \\$iAn order of mostly marine CRUSTACEA containing more than 5500 species in over 100 families. Like ISOPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Isopoda, they possess thoracic gills and their bodies are laterally compressed.
=688  \\$a2003
=750  \0$aAmphipoda$5IEN-M$0(DLC)sh 85004624

=LDR  02266cz  a2200637n  4500
=001  9880364199902441
=005  20141212215133.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033303
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x188.$x644
=150  \\$aProtestantism
=450  \\$wnnna$aAdventist, Seventh-Day
=450  \\$wnnna$aAdventists, Seventh-Day
=450  \\$wnnna$aAnglican
=450  \\$wnnna$aAnglican Church
=450  \\$wnnna$aAnglicans
=450  \\$wnnna$aBaptist
=450  \\$wnnna$aBaptist Church
=450  \\$wnnna$aBaptists
=450  \\$wnnna$aChurch, Anglican
=450  \\$wnnna$aChurch, Baptist
=450  \\$wnnna$aChurch, Episcopal
=450  \\$wnnna$aChurch, Lutheran
=450  \\$wnnna$aChurch, Methodist
=450  \\$wnnna$aChurch, Presbyterian
=450  \\$wnnna$aEpiscopal Church
=450  \\$wnnna$aEpiscopalian
=450  \\$wnnna$aEpiscopalians
=450  \\$wnnna$aEthic, Protestant
=450  \\$wnnna$aEthics, Protestant
=450  \\$wnnna$aFriends Society
=450  \\$wnnna$aLutheran
=450  \\$wnnna$aLutheran Church
=450  \\$wnnna$aLutherans
=450  \\$wnnna$aMethodist
=450  \\$wnnna$aMethodist Church
=450  \\$wnnna$aMethodists
=450  \\$wnnna$aPresbyterian
=450  \\$wnnna$aPresbyterian Church
=450  \\$wnnna$aPresbyterians
=450  \\$wnnna$aProtestant
=450  \\$wnnna$aProtestant Ethic
=450  \\$wnnna$aProtestant Ethics
=450  \\$wnnna$aProtestants
=450  \\$wnnna$aQuaker
=450  \\$wnnna$aQuakers
=450  \\$wnnna$aSeventh-Day Adventist
=450  \\$aSeventh-Day Adventists
=450  \\$wnnna$aSeventh Day Adventists
=450  \\$wnnna$aSociety of Friends
=550  \\$wg$aChristianity
=667  \\$aspecify geog if pertinent
=680  \\$iThe name given to all Christian denominations, sects, or groups rising out of the Reformation. Protestant churches generally agree that the principle of authority should be the Scriptures rather than the institutional church or the pope. (from W.L. Reese, Dictionary of Philosophy and Religion, 1999)
=688  \\$a2003; use CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS use CHRISTIANITY 1994-2002
=750  \0$aProtestantism$5IEN-M$0(DLC)sh 85107718

=LDR  00711cz  a2200157n  4500
=001  9880364200002441
=005  20141212215132.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x720
=150  \\$aPostmodernism
=550  \\$wg$aPhilosophy
=680  \\$iA late 20th-century philosophical approach or style of cultural analysis that seeks to reveal the cultural or social construction of concepts conventionally assumed to be natural or universal. (from E.R. DuBose, The Illusion of Trust: Toward a Medical Theological Ethics in the Postmodern Age, Kluwer, 1995)
=688  \\$a2003; use PHILOSOPHY 2002
=750  \0$aPostmodernism$5IEN-M$0(DLC)sh 85105557

=LDR  00657cz  a2200205n  4500
=001  9880364200202441
=005  20141212215130.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x416
=150  \\$aMinors
=450  \\$wnnna$aMinor
=550  \\$wg$aPersons
=550  \\$aAdolescent
=550  \\$aChild
=667  \\$acheck appropriate age check tag; do not routinely add this term; use only when specified by author
=680  \\$iA person who has not attained the age at which full civil rights are accorded.
=688  \\$a2003; use ADOLESCENCE 1982-2002
=750  \0$aMinors$5IEN-M$0(DLC)sh 87006936

=LDR  00836cz  a2200253n  4500
=001  9880364200302441
=005  20141212215130.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x520
=150  \\$aLawyers
=450  \\$wnnna$aAttorney
=450  \\$wnnna$aAttorneys
=450  \\$wnnna$aDefender, Public
=450  \\$wnnna$aDefenders, Public
=450  \\$wnnna$aLawyer
=450  \\$wnnna$aPublic Defender
=450  \\$wnnna$aPublic Defenders
=550  \\$wg$aOccupational Groups
=550  \\$aJurisprudence
=680  \\$iPersons whose profession is to give legal advice and assistance to clients and represent them in legal matters. (American Heritage Dictionary, 3d ed)
=688  \\$a2003; use JURISPRUDENCE 1992-2002
=750  \0$aLawyers$5IEN-M$0(DLC)sh 85075351

=LDR  01228cz  a2200349n  4500
=001  9880364200402441
=005  20141212215129.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x474
=150  \\$aJudicial Role
=450  \\$wnnna$aAction, Court
=450  \\$wnnna$aAction, Judicial
=450  \\$wnnna$aActions, Court
=450  \\$wnnna$aActions, Judicial
=450  \\$wnnna$aBypass, Judicial
=450  \\$wnnna$aConsent, Judicial
=450  \\$wnnna$aCourt Action
=450  \\$wnnna$aCourt Actions
=450  \\$aJudicial Action
=450  \\$wnnna$aJudicial Actions
=450  \\$aJudicial Bypass
=450  \\$wnnna$aJudicial Consent
=450  \\$wnnna$aJudicial Roles
=450  \\$wnnna$aRole, Judicial
=450  \\$wnnna$aRoles, Judicial
=550  \\$wg$aJurisprudence
=667  \\$ause only for discussions of the role of judges or courts in decision making, not routinely for individual court cases
=680  \\$iThe kind of action or activity proper to the judiciary, particularly its responsibility for decision making.
=688  \\$a2003; use JURISPRUDENCE 1978-2002
=750  \0$aJudicial process$5IEN-M$0(DLC)sh 85070959

=LDR  01202cz  a2200241n  4500
=001  9880364200502441
=005  20141212215129.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x188.$x573
=072  \\$aM1.$x352
=150  \\$aJehovah's Witnesses
=450  \\$wnnna$aJehovah Witnesses
=450  \\$wnnna$aJehovahs Witnesses
=450  \\$wnnna$aWatchtower Bible and Tract Society
=450  \\$wnnna$aWitnesses, Jehovah's
=550  \\$wg$aChristianity
=550  \\$wg$aPersons
=667  \\$aspecify geographic term if pertinent; CATALOG: use NAF entry
=680  \\$iMembers of a religious denomination founded in the United States during the late 19th century in which active evangelism is practiced, the imminent approach of the millennium is preached, and war and organized government authority in matters of conscience are strongly opposed (from American Heritage Dictionary of the English Language, 4th ed). Jehovah's Witnesses generally refuse blood transfusions and other blood-based treatments based on religious belief.
=688  \\$a2003; use CHRISTIANITY 1978-2002
=750  \0$aJehovah's Witnesses$5IEN-M$0(DLC)sh 85069870

=LDR  00942cz  a2200241n  4500
=001  9880364200602441
=005  20141212215129.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x60
=150  \\$aAnostraca
=450  \\$wnnna$aAnostracas
=450  \\$aFairy Shrimp
=450  \\$wnnna$aFairy Shrimps
=450  \\$aShrimp, Fairy
=450  \\$wnnna$aShrimps, Fairy
=550  \\$wg$aCrustacea
=550  \\$wh$aArtemia
=667  \\$anote X ref FAIRY SHRIMP: several other shrimp terms are available; check text and MeSH; as animal & food; as food, coord IM with SHELLFISH (IM); unspecified shrimp as food is probably PENAEIDAE
=680  \\$iAn order of CRUSTACEA comprised of shrimp-like organisms containing body trunks with at least 20 segments. The are commonly used as aquarium food.
=688  \\$a2003
=750  \0$aFairy shrimps$5IEN-M$0(DLC)sh 85005458

=LDR  00790cz  a2200205n  4500
=001  9880364200702441
=005  20141212193031.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x250
=150  \\$aEuphausiacea
=450  \\$aEuphausia
=450  \\$aKrill
=450  \\$aNyctiphanes
=550  \\$wg$aCrustacea
=667  \\$aas food, coordinate with SHELLFISH
=680  \\$iAn order of pelagic, shrimplike CRUSTACEA. Many consume ZOOPLANKTON and a few are predacious. Many antarctic species, such as Euphausia superba, constitute the chief food of other animals.
=688  \\$a2003; use CRUSTACEA 1990-2002; for EUPHAUSIA & NYCTIPHANES use CRUSTACEA 1986-2002
=750  \0$aEuphausiacea$5IEN-M$0(DLC)sh 85045588

=LDR  00662cz  a2200241n  4500
=001  9880364200802441
=005  20141212215128.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033182
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x650
=072  \\$aF2.$x463.$x306
=150  \\$aIntention
=450  \\$wnnna$aIntentions
=550  \\$wg$aMental Processes
=550  \\$wg$aMotivation
=550  \\$aAttitude
=550  \\$aDouble Effect Principle
=550  \\$aGoals
=550  \\$aMotivation
=680  \\$iWhat a person has in mind to do or bring about.
=688  \\$a2003; use MOTIVATION 1993-2002
=750  \0$aIntention$5IEN-M$0(DLC)sh 85067189

=LDR  00752cz  a2200169n  4500
=001  9880364200902441
=005  20141212215126.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x820
=150  \\$aShear Strength
=450  \\$wnnna$aStrength, Shear
=550  \\$wg$aMechanical Phenomena
=680  \\$iThe internal resistance of a material to moving some parts of it parallel to a fixed plane, in contrast to stretching (TENSILE STRENGTH) or compression (COMPRESSIVE STRENGTH). Ionic crystals are brittle because, when subjected to shear, ions of the same charge are brought next to each other, which causes repulsion.
=688  \\$a2003
=750  \0$aShear (Mechanics)$5IEN-M$0(DLC)sh 85121188

=LDR  00747cz  a2200253n  4500
=001  9880364201002441
=005  20141212215125.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x252
=150  \\$aFriends
=450  \\$wnnna$aAcquaintances
=450  \\$wnnna$aCompanion
=450  \\$wnnna$aCompanions
=450  \\$wnnna$aFriend
=450  \\$aFriendship
=450  \\$wnnna$aFriendships
=550  \\$wg$aPersons
=550  \\$aInterpersonal Relations
=667  \\$afor Society of Friends, or Quakers, use PROTESTANTISM
=680  \\$iPersons whom one knows, likes, and trusts.
=688  \\$a2003; use INTERPERSONAL RELATIONS 1980-2002
=750  \0$aFriendship$5IEN-M$0(DLC)sh 85051992

=LDR  01056cz  a2200241n  4500
=001  9880364201102441
=005  20141212215125.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033061
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x167.$x200
=072  \\$aN4.$x452.$x758.$x849.$x174
=072  \\$aN5.$x350.$x250.$x200
=150  \\$aEthics Consultation
=450  \\$wnnna$aConsultation, Ethics
=450  \\$wnnna$aConsultations, Ethics
=450  \\$wnnna$aEthics Consultations
=550  \\$wg$aEthical Review
=550  \\$wg$aReferral and Consultation
=550  \\$aEthics, Clinical
=680  \\$iServices provided by an individual ethicist (ETHICISTS) or an ethics team or committee (ETHICS COMMITTEES, CLINICAL) to address the ethical issues involved in a specific clinical case. The central purpose is to improve the process and outcomes of patients' care by helping to identify, analyze, and resolve ethical problems.
=688  \\$a2003; use ETHICAL REVIEW 2002
=750  \0$aMedical ethics consultation$5IEN-M$0(DLC)sh 94002524

=LDR  01513cz  a2200337n  4500
=001  9880364201202441
=005  20141212215125.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x349
=072  \\$aH1.$x770.$x644.$x145.$x300
=150  \\$aFetal Research
=450  \\$wnnna$aCell Research, Fetal
=450  \\$wnnna$aExperimentation, Fetal
=450  \\$aFetal Cell Research
=450  \\$wnnna$aFetal Experimentation
=450  \\$aFetal Tissue Research
=450  \\$wnnna$aResearch, Fetal
=450  \\$wnnna$aResearch, Fetal Cell
=450  \\$wnnna$aResearch, Fetal Tissue
=550  \\$wg$aBiomedical Research
=550  \\$wg$aInvestigative Techniques
=550  \\$aEthics, Research
=550  \\$aFetal Tissue Transplantation
=550  \\$aFetus
=550  \\$aHuman Experimentation
=667  \\$amammalian only; IM for ethical, legal, moral, social, or religious aspects of research on fetuses; do not routinely add for research involving fetuses; X ref Fetal Cell Research: coord with specific type of cell
=680  \\$iExperimentation on, or using the organs or tissues from, a human or other mammalian conceptus in the postembryonic period, after the major structures have been outlined. In humans, this corresponds to the period from the third month after fertilization until birth.
=688  \\$a2003; use RESEARCH 1996-2002; for FETAL TISSUE RESEARCH use RESEARCH 1995-2002
=750  \0$aFetus$xResearch$5IEN-M$0(DLC)sh 85047978

=LDR  01088cz  a2200277n  4500
=001  9880364201302441
=005  20141212215123.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D033021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x606
=150  \\$aOxytropis
=450  \\$aLocoweed, White
=450  \\$wnnna$aLocoweeds, White
=450  \\$wnnna$aOxytropi
=450  \\$wnnna$aOxytropis sericea
=450  \\$wnnna$aOxytropis sericeas
=450  \\$wnnna$asericea, Oxytropis
=450  \\$wnnna$asericeas, Oxytropis
=450  \\$wnnna$aWhite Locoweed
=450  \\$wnnna$aWhite Locoweeds
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain SWAINSONINE.
=688  \\$a2003
=750  \0$aOxytropis$5IEN-M$0(DLC)sh 88022964

=LDR  01104cz  a2200301n  4500
=001  9880364201402441
=005  20141212215121.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032984
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x366
=072  \\$aN5.$x350.$x670
=150  \\$aEthics, Research
=450  \\$aResearch Ethics
=450  \\$aResearch$xethics
=550  \\$wg$aEthics
=550  \\$wh$aHelsinki Declaration
=550  \\$wh$aTherapeutic Equipoise
=550  \\$wh$aTherapeutic Misconception
=550  \\$aAnimal Experimentation
=550  \\$aEmbryo Research
=550  \\$aFetal Research
=550  \\$aHuman Experimentation
=550  \\$aResearch
=667  \\$ado not use routinely for ethical issues in research, for which prefer specific topics; reserve for discussions of research ethics as a topic in its own right
=680  \\$iThe moral obligations governing the conduct of research. Used for discussions of research ethics as a general topic.
=688  \\$a2003; use ETHICS 2002
=750  \0$aResearch$xMoral and ethical aspects$5IEN-M$0(DLC)sh 85113041

=LDR  01724cz  a2200421n  4500
=001  9880364201502441
=005  20141212215121.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032983
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x871
=150  \\$aSetaria Plant
=450  \\$aBristlegrass
=450  \\$wnnna$aBristlegrasses
=450  \\$wnnna$aChaetochloa italica
=450  \\$wnnna$aChaetochloa italicas
=450  \\$wnnna$aFoxtail Millet
=450  \\$wnnna$aFoxtail Millets
=450  \\$wnnna$aGerman Millet
=450  \\$aItalian Millet
=450  \\$wnnna$aitalica, Chaetochloa
=450  \\$wnnna$aitalica, Setaria
=450  \\$wnnna$aitalicas, Chaetochloa
=450  \\$wnnna$aitalicas, Setaria
=450  \\$aMillet, Foxtail
=450  \\$aMillet, German
=450  \\$aMillet, Italian
=450  \\$wnnna$aMillets, Foxtail
=450  \\$wnnna$aPlant, Setaria
=450  \\$wnnna$aPlants, Setaria
=450  \\$aSetaria italica
=450  \\$wnnna$aSetaria italicas
=450  \\$wnnna$aSetaria Plants
=550  \\$wg$aPoaceae
=667  \\$anote X refs: other millet terms are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The small pointed seeds are grown for hay in North America and western Europe and important as food in China and other Asian countries.
=688  \\$a2003; for ITALIAN MILLET use PANICUM 1990-2002
=750  \0$aSetaria$5IEN-M$0(DLC)sh 88023104

=LDR  00793cz  a2200205n  4500
=001  9880364201602441
=005  20141212215120.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x90
=072  \\$aN3.$x706.$x535.$x241
=150  \\$aContracts
=450  \\$wnnna$aContract
=550  \\$wg$aJurisprudence
=550  \\$aContract Services
=667  \\$aCONTRACT SERVICES is also available
=680  \\$iAgreements between two or more parties, especially those that are written and enforceable by law (American Heritage Dictionary of the English Language, 4th ed). It is sometimes used to characterize the nature of the professional-patient relationship.
=688  \\$a2003
=750  \0$aContracts$5IEN-M$0(DLC)sh 85031620

=LDR  00834cz  a2200241n  4500
=001  9880364201702441
=005  20141212215119.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x68
=072  \\$aF2.$x463.$x785.$x373.$x433
=150  \\$aConsensus
=450  \\$wnnna$aConsensus Development
=450  \\$wnnna$aDevelopment, Consensus
=550  \\$wg$aDecision Making
=550  \\$wg$aGroup Processes
=550  \\$aConsensus Development Conferences as Topic
=550  \\$aDissent and Disputes
=550  \\$aPractice Guidelines as Topic
=680  \\$iGeneral agreement or collective opinion; the judgment arrived at by most of those concerned.
=688  \\$a2003; use DECISION MAKING 1997-2002
=750  \0$aConsensus (Social sciences)$5IEN-M$0(DLC)sh 85031242

=LDR  00627cz  a2200157n  4500
=001  9880364201802441
=005  20141212215119.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x799.$x214
=150  \\$aConfucianism
=550  \\$wg$aReligious Philosophies
=680  \\$iA school of thought and set of moral, ethical, and political teachings usually considered to be founded by Confucius in 6th-5th century B.C. China. (from Cambridge Dictionary of Philosophy, 1995)
=688  \\$a2003; use RELIGIOUS PHILOSOPHIES 2002
=750  \0$aConfucianism$5IEN-M$0(DLC)sh 85031069

=LDR  00698cz  a2200181n  4500
=001  9880364201902441
=005  20141212215118.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x379
=150  \\$aGanoderma
=450  \\$wnnna$aGanodermas
=550  \\$wg$aPolyporales
=550  \\$wh$aReishi
=680  \\$iA genus of fungi in the family Ganodermataceae, order POLYPORALES, containing a dimitic hyphal system. It causes a white rot, and is a wood decomposer. Ganoderma lucidum (REISHI) is used in traditional Chinese medicine (MEDICINE, CHINESE TRADITIONAL).
=688  \\$a2003
=750  \0$aGanoderma$5IEN-M$0(DLC)sh 85053036

=LDR  00607cz  a2200169n  4500
=001  9880364202002441
=005  20141212215118.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x320.$x800
=150  \\$aTalaromyces
=450  \\$wnnna$aTalaromyce
=550  \\$wg$aEurotiales
=680  \\$iA fungal genus in the family Trichocomaceae, order EUROTIALES, characterized by loose hyphal fruiting bodies containing spherical asci. Anamorphs include PENICILLIUM and PAECILOMYCES.
=688  \\$a2003
=750  \0$aTalaromyces$5IEN-M$0(DLC)sh 85132068

=LDR  00758cz  a2200205n  4500
=001  9880364202102441
=005  20141212215118.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x357
=150  \\$aComprehension
=450  \\$aReadability
=450  \\$aUnderstanding
=550  \\$wg$aCognition
=550  \\$aMental Competency
=550  \\$aMental Recall
=680  \\$iThe act or fact of grasping the meaning, nature, or importance of; understanding. (American Heritage Dictionary, 4th ed) Includes understanding by a patient or research subject of information disclosed orally or in writing.
=688  \\$a2003; use COGNITION 1993-2002
=750  \0$aComprehension$5IEN-M$0(DLC)sh 85029421

=LDR  00839cz  a2200181n  4500
=001  9880364202202441
=005  20141212215117.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x124
=150  \\$aBuddleja
=450  \\$wnnna$aBuddlejas
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain mimengoside B, verbascoside, and phenylethanoids.
=688  \\$a2003
=750  \0$aButterfly bushes$0(DLC)sh2005002187$5IEN-M

=LDR  00839cz  a2200253n  4500
=001  9880364202302441
=005  20141212215116.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x122
=150  \\$aCommittee Membership
=450  \\$wnnna$aCommittee Member
=450  \\$wnnna$aCommittee Members
=450  \\$wnnna$aCommittee Memberships
=450  \\$wnnna$aMember, Committee
=450  \\$wnnna$aMembers, Committee
=450  \\$wnnna$aMembership, Committee
=450  \\$wnnna$aMemberships, Committee
=550  \\$wg$aOrganization and Administration
=667  \\$acoord with specific committee if pertinent
=680  \\$iThe composition of a committee; the state or status of being a member of a committee.
=688  \\$a2003
=750  \0$aCommittees$xMembership$5IEN-M

=LDR  00538cz  a2200193n  4500
=001  9880364202402441
=005  20141212215116.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x480
=150  \\$aIridectomy
=450  \\$wnnna$aCorectomies
=450  \\$aCorectomy
=450  \\$wnnna$aIridectomies
=550  \\$wg$aOphthalmologic Surgical Procedures
=680  \\$iSurgical removal of a section of the iris.
=688  \\$a2003
=750  \0$aIridectomy$5IEN-M$0(DLC)sh 85068065

=LDR  00900cz  a2200181n  4500
=001  9880364202502441
=005  20141212215115.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032764
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x163.$x150
=072  \\$aK1.$x752.$x566.$x479.$x113.$x150
=150  \\$aCasuistry
=550  \\$wg$aEthical Analysis
=667  \\$ado not confuse with "casuistics," the recording and study of cases of disease, or with CAUSALITY
=680  \\$iA method of ETHICAL ANALYSIS that emphasizes practical problem solving through examining individual cases that are considered to be representative; sometimes used to denote specious argument or rationalization. Differentiate from casuistics, which is the recording and study of cases and disease.
=688  \\$a2003; use ETHICAL ANALYSIS 2002; use ETHICS 1992-2001
=750  \0$aCasuistry$5IEN-M$0(DLC)sh 85020764

=LDR  00678cz  a2200205n  4500
=001  9880364202602441
=005  20141212215114.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x445.$x100
=072  \\$aH1.$x770.$x644.$x145.$x365.$x100
=072  \\$aH1.$x770.$x644.$x302.$x100
=150  \\$aAutoexperimentation
=450  \\$aSelf-Experimentation
=450  \\$wnnna$aSelf Experimentation
=550  \\$wg$aHuman Experimentation
=680  \\$iIntentionally using oneself as a research subject.
=688  \\$a2003; use HUMAN EXPERIMENTATION 1999-2002
=750  \0$aSelf-experimentation in medicine$5IEN-M$0(DLC)sh 85119746

=LDR  01498cz  a2200409n  4500
=001  9880364202702441
=005  20141212215114.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x17
=072  \\$aH1.$x770.$x644.$x53
=150  \\$aAnimal Experimentation
=450  \\$wnnna$aAnimal Experiment
=450  \\$wnnna$aAnimal Experimental Use
=450  \\$wnnna$aAnimal Experimental Uses
=450  \\$wnnna$aAnimal Experiments
=450  \\$wnnna$aAnimal Research
=450  \\$wnnna$aExperiment, Animal
=450  \\$wnnna$aExperimental Use, Animal
=450  \\$wnnna$aExperimental Uses, Animal
=450  \\$wnnna$aExperimentation, Animal
=450  \\$wnnna$aExperiments, Animal
=450  \\$wnnna$aResearch, Animal
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aResearch
=550  \\$wh$aAnimal Use Alternatives
=550  \\$wh$aRotarod Performance Test
=550  \\$wh$aVivisection
=550  \\$aAnimal Use Alternatives
=550  \\$aBioethical Issues
=550  \\$aEthics, Research
=550  \\$aModels, Animal
=667  \\$aIM for moral, legal, ethical, social, and religious aspects of experiments on animals; do not routinely add for specific research studies involving animals
=680  \\$iThe use of animals as investigational subjects.
=688  \\$a2003; use ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS use ANIMALS 1978-2003
=750  \0$aAnimal experimentation$5IEN-M$0(DLC)sh 85005173

=LDR  00636cz  a2200181n  4500
=001  9880364202802441
=005  20141212215113.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x320.$x500
=150  \\$aMonascus
=450  \\$wnnna$aMonascus purpureus
=450  \\$wnnna$apurpureus, Monascus
=550  \\$wg$aEurotiales
=680  \\$iA genus in the family Monascaceae, order EUROTIALES. One species, Monascus purpureus, has multiple uses in traditional Chinese medicine (MEDICINE, CHINESE TRADITIONAL).
=688  \\$a2003
=750  \0$aMonascus$5IEN-M$0(DLC)sh 85086689

=LDR  01029cz  a2200337n  4500
=001  9880364202902441
=005  20141212193029.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032721
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x65
=072  \\$aI1.$x880.$x853.$x150.$x281
=072  \\$aM1.$x55
=150  \\$aAdult Children
=450  \\$wnnna$aAdult Daughter
=450  \\$wnnna$aAdult Daughters
=450  \\$aAdult Offspring
=450  \\$wnnna$aAdult Son
=450  \\$wnnna$aAdult Sons
=450  \\$aChildren, Adult
=450  \\$wnnna$aDaughter, Adult
=450  \\$wnnna$aDaughters, Adult
=450  \\$aOffspring, Adult
=450  \\$wnnna$aSon, Adult
=450  \\$wnnna$aSons, Adult
=550  \\$wg$aFamily
=550  \\$wg$aPersons
=667  \\$aHUMAN only; use only when the subject of discussion, not as a checktag
=680  \\$iChildren who have reached maturity or the legal age of majority.
=688  \\$a2003; use FAMILY 2002
=750  \0$aAdult children$5IEN-M$0(DLC)sh 85001027

=LDR  00845cz  a2200241n  4500
=001  9880364203002441
=005  20141212215113.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x550.$x100
=072  \\$aJ1.$x897.$x120.$x100
=150  \\$aBiomimetics
=450  \\$wnnna$aBiological Mimetic
=450  \\$wnnna$aBiological Mimetics
=450  \\$wnnna$aBiomimetic
=450  \\$wnnna$aMimetic, Biological
=450  \\$aMimetics, Biological
=550  \\$wg$aBiotechnology
=667  \\$aBIOMIMETIC MATERIALS is also available
=680  \\$iAn interdisciplinary field in materials science, ENGINEERING, and BIOLOGY, studying the use of biological principles for synthesis or fabrication of BIOMIMETIC MATERIALS.
=688  \\$a2003
=750  \0$aBiomimetics$5IEN-M$0(DLC)sh 89000711

=LDR  00957cz  a2200265n  4500
=001  9880364203102441
=005  20141212215112.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501.$x220
=150  \\$aCordyceps
=450  \\$wnnna$aCordycep
=450  \\$wnnna$aCordyceps militari
=450  \\$wnnna$aCordyceps militaris
=450  \\$wnnna$aCordyceps sinenses
=450  \\$wnnna$aCordyceps sinensis
=450  \\$wnnna$amilitari, Cordyceps
=450  \\$wnnna$amilitaris, Cordyceps
=450  \\$wnnna$asinenses, Cordyceps
=450  \\$wnnna$asinensis, Cordyceps
=550  \\$wg$aHypocreales
=680  \\$iA genus of ascomycetous fungi (ASCOMYCOTA), family Clavicipitaceae, order HYPOCREALES, that grows by infecting insect larvae or mature insects with spores that germinate often before the cocoon is formed.
=688  \\$a2003
=750  \0$aCordyceps$5IEN-M$0(DLC)sh 85032574

=LDR  00869cz  a2200265n  4500
=001  9880364203202441
=005  20141212215112.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x320
=150  \\$aEurotiales
=450  \\$wnnna$aEurotiale
=550  \\$wg$aAscomycota
=550  \\$wh$aByssochlamys
=550  \\$wh$aEmericella
=550  \\$wh$aEupenicillium
=550  \\$wh$aEurotium
=550  \\$wh$aMonascus
=550  \\$wh$aNeosartorya
=550  \\$wh$aTalaromyces
=550  \\$wh$aThermoascus
=680  \\$iAn order of fungi in the phylum ASCOMYCOTA characterized by the presence of well defined peridia and cleistothecial asci. Notable anamorphs (mitosporic forms) of Eurotiales include PENICILLIUM and ASPERGILLUS.
=688  \\$a2003
=750  \0$aEurotiales$0(DLC) sh 85045867$5IEN-M

=LDR  00990cz  a2200193n  4500
=001  9880364203302441
=005  20190626113652.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x22
=150  \\$aAlangiaceae
=450  \\$aAlangium
=450  \\$wnnna$aAlangiums
=550  \\$wg$aMagnoliopsida
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Cornales, subclass Rosidae, class Magnoliopsida, consisting of slow-growing evergreen trees common in tropical forests of south India and Burma. Members contain tetrahydroisoquinoline-monoterpene and iridoid glycosides.
=688  \\$a2003
=750  \0$aAlangium$5IEN-M$0(DLC)sh 88022534

=LDR  00831cz  a2200205n  4500
=001  9880364203402441
=005  20141212215110.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032602
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x98
=150  \\$aCaragana
=450  \\$wnnna$aCaraganas
=450  \\$aPeashrub
=450  \\$wnnna$aPeashrubs
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain STILBENES.
=688  \\$a2003
=750  \0$aCaragana$5IEN-M$0(DLC)sh 88003413

=LDR  00859cz  a2200205n  4500
=001  9880364203502441
=005  20141212215110.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x357
=150  \\$aErysimum
=450  \\$wnnna$aErysimums
=450  \\$aWallflower
=450  \\$wnnna$aWallflowers
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE. Some members contain CARDIAC GLYCOSIDES.
=688  \\$a2003
=750  \0$aErysimum$0(DLC) sh 88022786$5IEN-M

=LDR  00603cz  a2200181n  4500
=001  9880364203602441
=005  20141212215110.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x825
=150  \\$aTuberculosis Vaccines
=450  \\$wnnna$aVaccines, Tuberculosis
=550  \\$wg$aBacterial Vaccines
=550  \\$wh$aBCG Vaccine
=680  \\$iVaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.
=688  \\$a2003, 1965-1978; use BCG VACCINE 1965-2002
=750  \0$aTuberculosis vaccines$5IEN-M$0(DLC)sh 85138448

=LDR  01311cz  a2200313n  4500
=001  9880364203702441
=005  20141212215109.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032503
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x825
=150  \\$aSelaginellaceae
=450  \\$aFern, Rainbow
=450  \\$wnnna$aFerns, Rainbow
=450  \\$aMoss, Spike
=450  \\$wnnna$aMosses, Spike
=450  \\$wnnna$aRainbow Fern
=450  \\$wnnna$aRainbow Ferns
=450  \\$wnnna$aSelaginella
=450  \\$wnnna$aSelaginellas
=450  \\$wnnna$aSpike Moss
=450  \\$wnnna$aSpike Mosses
=450  \\$aSpikemoss
=450  \\$wnnna$aSpikemosses
=550  \\$wg$aEmbryophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Selaginellales, class Lycopodiopsida, division Lycopodiophyta, subkingdom Tracheobionta. Members contain bilobetin. The rarely used common name of resurrection plant is mainly used with CRATEROSTIGMA.
=688  \\$a2003
=750  \0$aSelaginellaceae$5IEN-M$0(DLC)sh 85119663

=LDR  00831cz  a2200181n  4500
=001  9880364203802441
=005  20141212215108.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032502
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x525.$x666
=150  \\$aLycopodium
=450  \\$wnnna$aLycopodiums
=550  \\$wg$aLycopodiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LYCOPODIACEAE. Members contain ALKALOIDS. Lycopodium oil is obtained from L. clavatum.
=688  \\$a2003
=750  \0$aClub mosses$5IEN-M$0(DLC)sh 85027226

=LDR  01235cz  a2200277n  4500
=001  9880364203902441
=005  20141212215042.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032323
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x725.$x666
=150  \\$aSolanum melongena
=450  \\$aAubergine
=450  \\$wnnna$aAubergines
=450  \\$aBrinjal
=450  \\$wnnna$aBrinjals
=450  \\$aEggplant
=450  \\$wnnna$aEggplants
=450  \\$wnnna$amelongena, Solanum
=450  \\$wnnna$amelongenas, Solanum
=450  \\$wnnna$aSolanum melongenas
=550  \\$wg$aSolanum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus SOLANUM, family SOLANACEAE. The fruit is a large, egg-shaped berry, varying in color from dark purple to red, yellowish, or white. The leaves are large and ovate. The flowers are pendant, violet, and two inches across.
=688  \\$a2003
=750  \0$aEggplant$5IEN-M$0(DLC)sh 85041224

=LDR  02149cz  a2200565n  4500
=001  9880364204002441
=005  20141212215042.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x725
=150  \\$aSolanum
=450  \\$wnnna$aBitter Nightshade
=450  \\$wnnna$aBitter Nightshades
=450  \\$wnnna$adulcamara, Solanum
=450  \\$wnnna$adulcamaras, Solanum
=450  \\$wnnna$aHorse Nettle
=450  \\$wnnna$aHorse Nettles
=450  \\$aHorsenettle
=450  \\$wnnna$aHorsenettles
=450  \\$wnnna$aLaciniate Nightshade
=450  \\$wnnna$aLaciniate Nightshades
=450  \\$wnnna$alaciniatum, Solanum
=450  \\$wnnna$alaciniatums, Solanum
=450  \\$aNettle, Horse
=450  \\$wnnna$aNettles, Horse
=450  \\$aNightshade
=450  \\$aNightshade, Bitter
=450  \\$aNightshade, Laciniate
=450  \\$wnnna$aNightshades
=450  \\$wnnna$aNightshades, Bitter
=450  \\$wnnna$aNightshades, Laciniate
=450  \\$aPoroporo
=450  \\$wnnna$aPoroporos
=450  \\$wnnna$aSolanum dulcamara
=450  \\$wnnna$aSolanum dulcamaras
=450  \\$wnnna$aSolanum laciniatum
=450  \\$wnnna$aSolanum laciniatums
=450  \\$wnnna$aSolanums
=450  \\$aTrompillo
=450  \\$wnnna$aTrompillos
=550  \\$wg$aSolanaceae
=550  \\$wh$aSolanum glaucophyllum
=550  \\$wh$aSolanum melongena
=550  \\$wh$aSolanum nigrum
=550  \\$wh$aSolanum tuberosum
=667  \\$aseveral specific Solanum terms are available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for ATROPA BELLADONNA.
=688  \\$a2003
=750  \0$aSolanum$5IEN-M$0(DLC)sh 85124479

=LDR  00998cz  a2200253n  4500
=001  9880364204102441
=005  20141212215041.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x499
=150  \\$aPhysalis
=450  \\$wnnna$aCherries, Ground
=450  \\$wnnna$aCherry, Ground
=450  \\$wnnna$aGround Cherries
=450  \\$aGround Cherry
=450  \\$wnnna$aPhysali
=450  \\$aTomatillo
=450  \\$wnnna$aTomatillos
=550  \\$wg$aSolanaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain physalin and withangulatin.
=688  \\$a2003
=750  \0$aPhysalis$0(DLC) sh 88022996$5IEN-M

=LDR  00797cz  a2200193n  4500
=001  9880364204202441
=005  20141212215041.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x448
=150  \\$aPetunia
=450  \\$wnnna$aPetunias
=550  \\$wg$aSolanaceae
=550  \\$aAcanthaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain steroidal glycosides.
=688  \\$a2003
=750  \0$aPetunia$5IEN-M

=LDR  00803cz  a2200193n  4500
=001  9880364204302441
=005  20141212215040.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x274
=150  \\$aHyoscyamus
=450  \\$aHenbane
=450  \\$wnnna$aHenbanes
=550  \\$wg$aSolanaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE which contains TROPANES.
=688  \\$a2003
=750  \0$aHyoscyamus$5IEN-M$0(DLC)sh 85063657

=LDR  00946cz  a2200205n  4500
=001  9880364204402441
=005  20190304141905.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x905.$x188
=150  \\$aDatura
=450  \\$wnnna$aDaturas
=550  \\$wg$aSolanaceae
=550  \\$wh$aDatura metel
=550  \\$wh$aDatura stramonium
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain TROPANES. The common name of trumpet flower is also sometimes used for GELSEMIUM.
=688  \\$a2003(1974)
=750  \0$aDatura$0(DLC)sh 85035892$5IEN

=LDR  00953cz  a2200193n  4500
=001  9880364204502441
=005  20141212215039.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x49
=150  \\$aAtropa
=450  \\$wnnna$aAtropas
=550  \\$wg$aSolanaceae
=550  \\$wh$aAtropa belladonna
=667  \\$aprefer specific plant; ATROPA MANDRAGORA see MANDRAGORA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE which contain SOLANACEOUS ALKALOIDS including ATROPINE which is named after this genus.
=688  \\$a2003
=750  \0$aAtropa (Plants)$5IEN-M$0(DLC)sh 88022585

=LDR  01173cz  a2200229n  4500
=001  9880364204602441
=005  20141212215039.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x901.$x500
=150  \\$aSmilax
=450  \\$aSarsaparilla
=450  \\$wnnna$aSarsaparillas
=450  \\$wnnna$aSmilaxs
=450  \\$aZarzaparilla
=450  \\$wnnna$aZarzaparillas
=550  \\$wg$aSmilacaceae
=667  \\$aX ref SARSAPARILLA: SARSAPARILLA, WILD see ARALIA and SARSAPARILLA, EAST INDIAN see HEMIDESMUS are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SMILACACEAE. Members contain smiglasides (phenylpropanoid glycosides) and steroidal saponins. Commercially it is sometimes adulterated with HEMIDESMUS, which would affect experimental results.
=688  \\$a2003
=750  \0$aSmilax$5IEN-M$0(DLC)sh 85123642

=LDR  01037cz  a2200229n  4500
=001  9880364204702441
=005  20141212215038.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032271
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x898.$x599
=150  \\$aQuassia
=450  \\$wnnna$aamara, Quassia
=450  \\$wnnna$aamaras, Quassia
=450  \\$wnnna$aQuassia amara
=450  \\$wnnna$aQuassia amaras
=450  \\$wnnna$aQuassias
=550  \\$wg$aSimaroubaceae
=667  \\$aQUASSIA SIMAROUBA see SIMAROUBA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SIMAROUBACEAE. Members contain quassinoids. Quassia simarouba has been reclassified as SIMAROUBA.
=688  \\$a2003
=750  \0$aQuassia$5IEN-M$0(DLC)sh 85109752

=LDR  01264cz  a2200325n  4500
=001  9880364204802441
=005  20141212215037.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032268
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x898.$x44
=150  \\$aAilanthus
=450  \\$wnnna$aAilanthus altissima
=450  \\$wnnna$aAilanthus altissimas
=450  \\$wnnna$aaltissima, Ailanthus
=450  \\$wnnna$aaltissimas, Ailanthus
=450  \\$aChina-Sumac
=450  \\$wnnna$aChina Sumac
=450  \\$wnnna$aHeaven, Tree Of
=450  \\$wnnna$aHeavens, Tree Of
=450  \\$wnnna$aOf Heaven, Tree
=450  \\$wnnna$aOf Heavens, Tree
=450  \\$aSumac, China
=450  \\$aTree Of Heaven
=450  \\$wnnna$aTree Of Heavens
=550  \\$wg$aSimaroubaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SIMAROUBACEAE. Members contain ailantinols and other quassinoids.
=688  \\$a2003
=750  \0$aAilanthus$5IEN-M$0(DLC)sh 88022533

=LDR  00947cz  a2200229n  4500
=001  9880364204902441
=005  20141212215036.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032266
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x855
=150  \\$aScrophularia
=450  \\$wnnna$aBetonies, Figwort
=450  \\$wnnna$aBetony, Figwort
=450  \\$wnnna$aFigwort Betonies
=450  \\$aFigwort Betony
=450  \\$wnnna$aScrophularias
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain iridoids.
=688  \\$a2003
=750  \0$aFigworts$0(DLC) sh 93008226$5IEN-M

=LDR  00821cz  a2200205n  4500
=001  9880364205002441
=005  20141212215036.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032265
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x899
=150  \\$aVerbascum
=450  \\$aMullein
=450  \\$wnnna$aMulleins
=450  \\$wnnna$aVerbascums
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE.
=688  \\$a2003
=750  \0$aMulleins$5IEN-M$0(DLC)sh 94007232

=LDR  00881cz  a2200205n  4500
=001  9880364205102441
=005  20141212215035.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032264
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x905
=150  \\$aVeronica
=450  \\$aSpeedwell
=450  \\$wnnna$aSpeedwells
=450  \\$wnnna$aVeronicas
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain bis-sesquiterpene and iridoid glucosides.
=688  \\$a2003
=750  \0$aVeronica$5IEN-M$0(DLC)sh 85142854

=LDR  00828cz  a2200181n  4500
=001  9880364205302441
=005  20141212215035.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x705
=150  \\$aPedicularis
=450  \\$wnnna$aPediculari
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain phenylpropanoid glycosides and iridoids.
=688  \\$a2003
=750  \0$aPedicularis$5IEN-M$0(DLC)sh 85099195

=LDR  00559cz  a2200181n  4500
=001  9880364205402441
=005  20161117133617.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x580
=150  \\$aMimulus
=450  \\$aMonkeyflower
=450  \\$wnnna$aMonkeyflowers
=550  \\$wg$aLamiales
=680  \\$iA plant genus of the family Phrymaceae. Members contain 6-geranylflavanones and mimulone.
=688  \\$a2003
=750  \0$aMonkeyflowers$5IEN-M$0(DLC)sh 00003573

=LDR  00998cz  a2200193n  4500
=001  9880364266802441
=005  20141212213157.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019369
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x400
=150  \\$aLife
=550  \\$wg$aPhilosophy
=550  \\$wh$aBeginning of Human Life
=550  \\$wh$aQuality of Life
=550  \\$wh$aValue of Life
=680  \\$iThe state that distinguishes organisms from inorganic matter, manifested by growth, metabolism, reproduction, and adaptation. It includes the course of existence, the sum of experiences, the mode of existing, or the fact of being. Over the centuries inquiries into the nature of life have crossed the boundaries from philosophy to biology, forensic medicine, anthropology, etc., in creative as well as scientific literature. (Random House Unabridged Dictionary, 2d ed; Dr. James H. Cassedy, NLM History of Medicine Division)
=688  \\$a97
=750  \0$aLife$5IEN-M$0(DLC)sh 85076807

=LDR  01283cz  a2200289n  4500
=001  9880364266902441
=005  20141212212825.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018857
=035  \\$aCSK5995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x375
=072  \\$aJ1.$x576.$x423.$x850.$x600
=072  \\$aJ1.$x576.$x761.$x400
=150  \\$aFood Packaging
=450  \\$wnnna$aFood Container
=450  \\$aFood Containers
=450  \\$aPackaging, Food
=550  \\$wg$aFood Handling
=550  \\$wg$aFood Technology
=550  \\$wg$aProduct Packaging
=550  \\$wh$aFood Labeling
=550  \\$aFood Storage
=667  \\$aincludes containers, packaging methods, packaging materials; IM; coord with specific food (IM); FOOD LABELING is also available
=680  \\$iContainers, packaging, and packaging materials for processed and raw foods and beverages. It includes packaging intended to be used for storage and also used for preparation of foods such as microwave food containers versus COOKING AND EATING UTENSILS. Packaging materials may be intended for food contact or designated non-contact, for example, shipping containers. FOOD LABELING is also available.
=688  \\$a96
=750  \0$aFood$xPackaging$5IEN-M$0(DLC)sh 85050207

=LDR  01289cz  a2200169n  4500
=001  9880364267002441
=005  20141212213158.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019370
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x581.$x249
=150  \\$aObservation
=550  \\$wg$aMethods
=667  \\$ado not confuse with the Publication Type OBSERVATIONAL STUDY or with OBSERVATIONAL STUDY AS TOPIC; use only as a scientific method, as "Langerhans, a genius at observation", "the father of clinical observation"; not for "electron microscopy observations on Pleistocene tissues" or "historical observations on dental care" or "observations on difficult children" or "diagnostic observations on hypertension"
=680  \\$iThe act of regarding attentively and studying facts and occurrences, gathering data through analyzing, measuring, and drawing conclusions, with the purpose of applying the observed information to theoretical assumptions. Observation as a scientific method in the acquisition of knowledge began in classical antiquity; in modern science and medicine its greatest application is facilitated by modern technology. Observation is one of the components of the research process.
=688  \\$a97
=750  \0$aObservation (Scientific method)$5IEN-M$0(DLC)sh 87001905

=LDR  00897cz  a2200253n  4500
=001  9880364267102441
=005  20141212212820.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018836
=035  \\$aCSK5993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x469
=150  \\$aInflammation Mediators
=450  \\$wnnna$aMediators, Inflammation
=450  \\$aMediators of Inflammation
=550  \\$wg$aBiological Factors
=550  \\$wh$aAutacoids
=550  \\$wh$aChemokines
=550  \\$wh$aProstaglandins, Synthetic
=550  \\$aInflammasomes
=667  \\$ado not confuse with ANTI-INFLAMMATORY AGENTS; DF: INFLAMM MEDIATORS
=680  \\$iThe endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).
=688  \\$a95
=750  \0$aInflammation$xMediators$5IEN-M$0(DLC)sh 85066109

=LDR  00926cz  a2200277n  4500
=001  9880364267202441
=005  20141212213208.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019422
=035  \\$aCTL9159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x301.$x325
=072  \\$aD9.$x698.$x629.$x305.$x770.$x200
=072  \\$aJ2.$x500.$x362.$x325
=150  \\$aDietary Sucrose
=450  \\$aDietary Sugars
=450  \\$aSucrose, Dietary
=450  \\$aSugars, Dietary
=450  \\$wnnna$aTable Sugar
=550  \\$wg$aDietary Carbohydrates
=550  \\$wg$aSucrose
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther
=680  \\$iSucrose present in the diet. It is added to food and drinks as a sweetener.
=688  \\$a97
=750  \0$aFood$xSugar content$5IEN-M$0(DLC)sh 85050227
=750  \0$aSugars in human nutrition$5IEN-HS$0(DLC)sh 85129733

=LDR  00865cz  a2200217n  4500
=001  9880364267302441
=005  20141212212927.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019022
=035  \\$aCSK5992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x190.$x500
=150  \\$aAlmshouses
=450  \\$wnnna$aAlmshouse
=450  \\$wnnna$aPoorhouse
=450  \\$aPoorhouses
=550  \\$wg$aCharities
=667  \\$ain hist contexts only; check hist tags
=680  \\$iPrivately endowed or public charities or institutions receiving and supporting the aged or infirm poor. They sometimes functioned as centers of health care before the establishment of formal hospitals. (From Random House Unabridged Dictionary, 2d ed & Dr. James H. Cassedy, NLM History of Medicine Division)
=688  \\$a96
=750  \0$aAlmshouses$5IEN-M$0(DLC)sh 85003781

=LDR  00935cz  a2200229n  4500
=001  9880364267402441
=005  20141212192904.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019398
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x249.$x100
=072  \\$aG5.$x360.$x340.$x24.$x340.$x415.$x400.$x100
=150  \\$aGenes, BRCA1
=450  \\$aBRCA1 Gene
=450  \\$wnnna$aBRCA1 Genes
=450  \\$wnnna$aGene, BRCA1
=550  \\$wg$aGenes, Tumor Suppressor
=550  \\$aBRCA1 Protein
=667  \\$aBRCA stands for "BReast CAncer"
=680  \\$iA tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human CHROMOSOME 17 at locus 17q21. Mutations of this gene are associated with the formation of HEREDITARY BREAST AND OVARIAN CANCER SYNDROME. It encodes a large nuclear protein that is a component of DNA repair pathways.
=688  \\$a97
=750  \0$aBRCA genes$0(DLC)sh2006006447$5IEN-M

=LDR  00667cz  a2200205n  4500
=001  9880364267502441
=005  20141212212943.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019051
=035  \\$aCSK5991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x210.$x700
=150  \\$aRhizotomy
=450  \\$wnnna$aRhizotomies
=550  \\$wg$aDenervation
=550  \\$aSpinal Nerve Roots
=667  \\$asurg interruption of spinal and cranial nerve roots; do not use /util except by MeSH definition
=680  \\$iSurgical interruption of a spinal or cranial nerve root. (From Dorland, 28th ed)
=688  \\$a96
=750  \0$aRhizotomy$5IEN-M$0(DLC)sh 92005146

=LDR  00791cz  a2200229n  4500
=001  9880364267602441
=005  20141212213145.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019327
=035  \\$aCTL9156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x875.$x800.$x800.$x850.$x150
=150  \\$aCopper Sulfate
=450  \\$wnnna$aBlue Vitriol
=450  \\$aCupric Sulfate
=450  \\$wnnna$aSulfate, Copper
=450  \\$wnnna$aSulfate, Cupric
=450  \\$wnnna$aVitriol, Blue
=550  \\$wg$aSulfates
=680  \\$iA sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.
=688  \\$a97; was COPPER SULFATE (NM) 1969-96
=750  \0$aCopper sulfate$5IEN-M$0(DLC)sh 85032394

=LDR  01461cz  a2200469n  4500
=001  9880364267702441
=005  20141212212854.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018942
=035  \\$aCSK5980M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505
=072  \\$aD2.$x540.$x576.$x500
=072  \\$aD4.$x345.$x674.$x500
=150  \\$aMacrolides
=550  \\$wg$aLactones
=550  \\$wg$aPolyketides
=550  \\$wh$aAmphotericin B
=550  \\$wh$aAntimycin A
=550  \\$wh$aBrefeldin A
=550  \\$wh$aBryostatins
=550  \\$wh$aCandicidin
=550  \\$wh$aEpothilones
=550  \\$wh$aErythromycin
=550  \\$wh$aFilipin
=550  \\$wh$aIvermectin
=550  \\$wh$aJosamycin
=550  \\$wh$aLeucomycins
=550  \\$wh$aLucensomycin
=550  \\$wh$aMaytansine
=550  \\$wh$aMepartricin
=550  \\$wh$aMiocamycin
=550  \\$wh$aNatamycin
=550  \\$wh$aNystatin
=550  \\$wh$aOleandomycin
=550  \\$wh$aOligomycins
=550  \\$wh$aSirolimus
=550  \\$wh$aTacrolimus
=550  \\$wh$aTylosin
=680  \\$iA group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.
=688  \\$a96
=750  \0$aMacrolide antibiotics$0(DLC) sh 85079448$5IEN-M

=LDR  00953cz  a2200229n  4500
=001  9880364267802441
=005  20141212213126.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019275
=035  \\$aCTL9153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x259.$x843
=072  \\$aD27.$x505.$x519.$x871
=072  \\$aD27.$x720.$x470.$x410.$x650
=150  \\$aRadiopharmaceuticals
=550  \\$wg$aDiagnostic Uses of Chemicals
=550  \\$wg$aIndicators and Reagents
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=667  \\$apharmaceuticals as source of radiation in radiother & radioisotope scanning; D25-26 qualif
=680  \\$iCompounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)
=688  \\$a97
=750  \0$aRadiopharmaceuticals$5IEN-M$0(DLC)sh 85110790

=LDR  00939cz  a2200277n  4500
=001  9880364267902441
=005  20180309111711.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019390
=035  \\$aCTL9139M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x360.$x24.$x98
=072  \\$aD12.$x776.$x157.$x57.$x5
=072  \\$aD12.$x776.$x306.$x90
=072  \\$aD12.$x776.$x476.$x24.$x104
=072  \\$aD12.$x776.$x543.$x90
=150  \\$aArrestins
=550  \\$wg$aAdaptor Proteins, Signal Transducing
=550  \\$wg$aEye Proteins
=550  \\$wg$aMembrane Proteins
=550  \\$wh$aArrestin
=550  \\$wh$abeta-Arrestins
=667  \\$aregulatory proteins; do not confuse with ARRESTIN
=680  \\$iRegulatory proteins that down-regulate phosphorylated G-protein membrane receptors, including rod and cone photoreceptors and adrenergic receptors.
=688  \\$a97
=750  \0$aArrestins$0(DLC)sh2012002723$5IEN-M

=LDR  01349cz  a2200241n  4500
=001  9880364268002441
=005  20141212213155.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019356
=035  \\$aCTL9136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x552.$x169
=150  \\$aGrave Robbing
=450  \\$wnnna$aGrave Robberies
=450  \\$wnnna$aGrave Robbery
=450  \\$wnnna$aRobberies, Grave
=450  \\$wnnna$aRobbery, Grave
=450  \\$wnnna$aRobbing, Grave
=550  \\$wg$aHistory of Medicine
=667  \\$astealing of corpses, espec for med dissection; usually in hist contexts; check hist tags
=680  \\$iThe stealing of corpses after burial, especially for medical dissection. In the late 18th and early 19th centuries, in the absence of laws governing the acquisition of dissecting material for the study of anatomy, the needs of anatomy classes were met by surreptitious methods: body-snatching and grave robbing. The infamous practice of "burking", murder to procure bodies for dissection, was given the name of a rascal named W. Burke, hanged in Edinburgh in 1829. (Random House Unabridged Dictionary, 2d ed; from Garrison, An Introduction to the History of Medicine, 4th ed, p447; from Castiglioni, A History of Medicine, 2d ed, p676)
=688  \\$a97
=750  \0$aGrave robbing$5IEN-M$0(DLC)sh 97006928

=LDR  01191cz  a2200337n  4500
=001  9880364268102441
=005  20141212212931.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019035
=035  \\$aCSK5977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x816
=150  \\$aRural Health Services
=450  \\$wnnna$aCenter, Rural Health
=450  \\$wnnna$aCenters, Rural Health
=450  \\$wnnna$aHealth Center, Rural
=450  \\$wnnna$aHealth Centers, Rural
=450  \\$wnnna$aHealth Service, Rural
=450  \\$wnnna$aHealth Services, Rural
=450  \\$wnnna$aRural Health Center
=450  \\$wnnna$aRural Health Centers
=450  \\$wnnna$aRural Health Service
=450  \\$wnnna$aService, Rural Health
=450  \\$wnnna$aServices, Rural Health
=550  \\$wg$aHealth Services
=550  \\$wh$aRural Nursing
=550  \\$aSuburban Health Services
=667  \\$aIM; coord with specific health serv (IM); DF: RURAL HEALTH SERV
=680  \\$iHealth services, public or private, in rural areas. The services include the promotion of health and the delivery of health care.
=688  \\$a96
=750  \0$aRural health services$5IEN-M$0(DLC)sh 85115918

=LDR  01043cz  a2200277n  4500
=001  9880364268202441
=005  20141212213155.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019358
=035  \\$aCTL9128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x368.$x350
=072  \\$aJ2.$x500.$x512.$x350
=150  \\$aFat Substitutes
=450  \\$wnnna$aArtificial Fat
=450  \\$aArtificial Fats
=450  \\$wnnna$aFat, Artificial
=450  \\$wnnna$aFat Substitute
=450  \\$wnnna$aFats, Artificial
=450  \\$wnnna$aSubstitute, Fat
=450  \\$wnnna$aSubstitutes, Fat
=550  \\$wg$aFood Additives
=667  \\$aIM; coord with specific substitute (IM) if pertinent; D25-26 qualif
=680  \\$iCompounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats.
=688  \\$a97; was FAT SUBSTITUTES (NM) 1990-96
=750  \0$aFat substitutes$0(DLC) sh 91001908$5IEN-M

=LDR  00923cz  a2200229n  4500
=001  9880364268302441
=005  20141212212949.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019063
=035  \\$aCSK5969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x860.$x300.$x850
=150  \\$aTenascin
=450  \\$aCytotactin
=450  \\$aHexabrachion
=450  \\$wnnna$aJ1-200-220
=450  \\$aTenascin-C
=450  \\$wnnna$aTenascin C
=550  \\$wg$aExtracellular Matrix Proteins
=680  \\$iHexameric extracellular matrix glycoprotein transiently expressed in many developing organs and often re-expressed in tumors. It is present in the central and peripheral nervous systems as well as in smooth muscle and tendons. (From Kreis & Vale, Guidebook to the Extracellular Matrix and Adhesion Proteins, 1993, p93)
=688  \\$a96; was TENASCIN (NM) 1986-95
=750  \0$aTenascin$5IEN-M$0(DLC)sh 97005031

=LDR  00792cz  a2200205n  4500
=001  9880364268402441
=005  20141212213130.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019289
=035  \\$aCTL9127HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x755.$x812.$x800
=150  \\$aPyruvic Acid
=450  \\$wnnna$aAcid, Pyruvic
=450  \\$aPyruvate
=550  \\$wg$aPyruvates
=667  \\$ado not confuse X ref PYRUVATE with PYRUVATES
=680  \\$iAn intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
=688  \\$a97; was PYRUVIC ACID (NM) 1981-96
=750  \0$aPyruvic acid$5IEN-M$0(DLC)sh 85109371

=LDR  00769cz  a2200241n  4500
=001  9880364268502441
=005  20141212212854.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018943
=035  \\$aCSK5965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x50
=072  \\$aD4.$x615.$x562.$x50
=072  \\$aD9.$x408.$x51.$x59
=150  \\$aAnthracyclines
=550  \\$wg$aAminoglycosides
=550  \\$wg$aNaphthacenes
=550  \\$wh$aAclarubicin
=550  \\$wh$aDaunorubicin
=550  \\$wh$aPlicamycin
=680  \\$iOrganic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.
=688  \\$a96
=750  \0$aAnthracyclines$5IEN-M$0(DLC)sh 85005559

=LDR  01266cz  a2200349n  4500
=001  9880364268602441
=005  20141212213151.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019344
=035  \\$aCTL9126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x511.$x459.$x450
=150  \\$aLactic Acid
=450  \\$wnnna$a2-Hydroxypropanoic Acid
=450  \\$wnnna$a2 Hydroxypropanoic Acid
=450  \\$wnnna$a2-Hydroxypropionic Acid
=450  \\$wnnna$a2 Hydroxypropionic Acid
=450  \\$wnnna$aAmmonium Lactate
=450  \\$wnnna$aD-Lactic Acid
=450  \\$wnnna$aD Lactic Acid
=450  \\$wnnna$aL-Lactic Acid
=450  \\$wnnna$aL Lactic Acid
=450  \\$aLactate
=450  \\$wnnna$aLactate, Ammonium
=450  \\$wnnna$aPropanoic Acid, 2-Hydroxy-, (2R)-
=450  \\$wnnna$aPropanoic Acid, 2-Hydroxy-, (2S)-
=450  \\$wnnna$aSarcolactic Acid
=550  \\$wg$aLactates
=667  \\$ado not confuse X ref LACTATE with LACTATES
=680  \\$iA normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
=688  \\$a97; was LACTIC ACID (NM) 1981-96
=750  \0$aLactic acid$5IEN-M$0(DLC)sh 85073866

=LDR  02128cz  a2200469n  4500
=001  9880364268702441
=005  20141212212907.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018980
=035  \\$aCSK5963M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x970
=072  \\$aC14.$x280.$x484.$x150.$x535.$x960
=072  \\$aC16.$x131.$x260.$x970
=072  \\$aC16.$x320.$x180.$x970
=150  \\$aWilliams Syndrome
=450  \\$wnnna$aAortic Stenoses, Hypercalcemia-Supravalvar
=450  \\$wnnna$aAortic Stenosis, Hypercalcemia-Supravalvar
=450  \\$wnnna$aBeuren Syndrome
=450  \\$wnnna$aChromosome 7q11.23 Deletion Syndrome
=450  \\$aContiguous Gene Syndrome, Williams
=450  \\$wnnna$aHypercalcemia-Supravalvar Aortic Stenoses
=450  \\$wnnna$aHypercalcemia-Supravalvar Aortic Stenosis
=450  \\$wnnna$aHypercalcemia Supravalvar Aortic Stenosis
=450  \\$wnnna$aStenoses, Hypercalcemia-Supravalvar Aortic
=450  \\$wnnna$aStenosis, Hypercalcemia-Supravalvar Aortic
=450  \\$wnnna$aSupravalvar Aortic Stenosis Syndrome
=450  \\$wnnna$aSyndrome, Beuren
=450  \\$wnnna$aSyndrome, Williams
=450  \\$wnnna$aSyndrome, Williams-Beuren
=450  \\$wnnna$aWilliams-Beuren Syndrome
=450  \\$wnnna$aWilliams Beuren Syndrome
=450  \\$wnnna$aWilliams Contiguous Gene Syndrome
=550  \\$wg$aAortic Stenosis, Supravalvular
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aIntellectual Disability
=550  \\$aElastin
=550  \\$aIntellectual Disability
=667  \\$ado not confuse with Williams-Campbell syndrome, a congenital cartilage deficiency
=680  \\$iA disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.
=688  \\$a96
=750  \0$aWilliams syndrome$5IEN-M$0(DLC)sh 98004230

=LDR  00942cz  a2200229n  4500
=001  9880364268802441
=005  20141212213130.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019287
=035  \\$aCTL9121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x875.$x800.$x800.$x850.$x950
=072  \\$aD1.$x975.$x987
=150  \\$aZinc Sulfate
=450  \\$wnnna$aSulfate, Zinc
=450  \\$wnnna$aZinc Sulfate, Heptahydrate
=450  \\$wnnna$aZincteral
=550  \\$wg$aSulfates
=550  \\$wg$aZinc Compounds
=680  \\$iA compound given in the treatment of conditions associated with zinc deficiency such as acrodermatitis enteropathica. Externally, zinc sulfate is used as an astringent in lotions and eye drops. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
=688  \\$a97; was ZINC SULFATE (NM) 1979-96
=750  \0$aZinc sulfate$5IEN-M$0(DLC)sh 85149871

=LDR  01032cz  a2200229n  4500
=001  9880364268902441
=005  20141212213019.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019140
=035  \\$aCSK5954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x170.$x152
=072  \\$aN2.$x421.$x240.$x190.$x215
=150  \\$aDental Care for Children
=450  \\$wnnna$aChildren, Dentistry for
=450  \\$aDentistry for Children
=550  \\$wg$aDental Care
=550  \\$aPediatric Dentistry
=667  \\$a= professional care by a professional; do not confuse with PEDIATRIC DENTISTRY, the specialty; check tag CHILD; DF: DENT CARE CHILDREN
=680  \\$iThe giving of attention to the special dental needs of children, including the prevention of tooth diseases and instruction in dental hygiene and dental health. The dental care may include the services provided by dental specialists.
=688  \\$a96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995
=750  \0$aChildren$xDental care$5IEN-M$0(DLC)sh 85023432

=LDR  02161cz  a2200601n  4500
=001  9880364269002441
=005  20200617174813.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019411
=035  \\$aCTL9119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225
=072  \\$aE5.$x200
=150  \\$aClinical Laboratory Techniques
=450  \\$wnnna$aClinical Laboratory Technique
=450  \\$wnnna$aDiagnoses and Laboratory Examinations
=450  \\$wnnna$aDiagnoses, Laboratory
=450  \\$wnnna$aDiagnosis, Laboratory
=450  \\$wnnna$aLaboratory Diagnoses
=450  \\$wnnna$aLaboratory Diagnosis
=450  \\$wnnna$aLaboratory Examinations and Diagnoses
=450  \\$wnnna$aLaboratory Technique, Clinical
=450  \\$wnno$aLaboratory Techniques and Procedures$5IEN-M
=450  \\$wnnna$aLaboratory Techniques, Clinical
=450  \\$wnnna$aTechnique, Clinical Laboratory
=450  \\$wnnna$aTechniques, Clinical Laboratory
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aClinical Chemistry Tests
=550  \\$wh$aCytological Techniques
=550  \\$wh$aGenetic Testing
=550  \\$wh$aHematologic Tests
=550  \\$wh$aHistological Techniques
=550  \\$wh$aImmunologic Tests
=550  \\$wh$aLaboratory Critical Values
=550  \\$wh$aMolecular Diagnostic Techniques
=550  \\$wh$aNeonatal Screening
=550  \\$wh$aOccult Blood
=550  \\$wh$aParasite Load
=550  \\$wh$aParasitic Sensitivity Tests
=550  \\$wh$aPre-Analytical Phase
=550  \\$wh$aPregnancy Tests
=550  \\$wh$aRadioligand Assay
=550  \\$wh$aSemen Analysis
=550  \\$wh$aSex Determination Analysis
=550  \\$wh$aSpecimen Handling
=550  \\$aClinical Laboratory Services
=550  \\$aLaboratories
=550  \\$aMedical Laboratory Science
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iTechniques used to carry out clinical investigative procedures in the diagnosis and therapy of disease.
=688  \\$a2000 (1997)
=750  \0$aMedical laboratory technology$0(DLC) sh 86002225$5IEN-M

=LDR  01343cz  a2200349n  4500
=001  9880364269102441
=005  20250501092315.0
=008  950607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019093
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x85.$x165
=072  \\$aE4.$x85.$x165
=072  \\$aE4.$x950.$x300.$x200
=072  \\$aI1.$x76.$x201.$x450.$x199
=150  \\$aCircumcision, Female
=450  \\$wnnna$aCircumcisions, Female
=450  \\$wnnna$aClitorectomies
=450  \\$wnnna$aClitorectomy
=450  \\$wnnna$aClitoridectomies
=450  \\$aClitoridectomy
=450  \\$aFemale Circumcision
=450  \\$wnnna$aFemale Circumcisions
=450  \\$aGenital Mutilation, Female
=450  \\$aInfibulation
=450  \\$wnnna$aInfibulations
=550  \\$wg$aBody Modification, Non-Therapeutic
=550  \\$wg$aCulture
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$aBody Modification, Non-Therapeutic
=680  \\$iA general term encompassing three types of excision of the external female genitalia - Sunna, clitoridectomy, and infibulation. It is associated with severe health risks and has been declared illegal in many places, but continues to be widely practiced in a number of countries, particularly in Africa.
=688  \\$a96
=750  \0$aFemale genital mutilation$0(DLC) sh 93002781$5IEN-M

=LDR  00812cz  a2200193n  4500
=001  9880364269202441
=005  20141212213129.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019283
=035  \\$aCTL9116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x689.$x750.$x650
=150  \\$aPancreatitis, Acute Necrotizing
=450  \\$aAcute Necrotizing Pancreatitis
=450  \\$aNecrotizing Pancreatitis, Acute
=550  \\$wg$aPancreatitis
=680  \\$iA severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.
=688  \\$a97
=750  \0$aNecrotizing pancreatitis$0(DLC) sh 90004218$5IEN-M

=LDR  01034cz  a2200301n  4500
=001  9880364269302441
=005  20141212213101.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x80.$x134.$x300
=072  \\$aI1.$x880.$x604.$x583.$x527
=072  \\$aI1.$x880.$x604.$x622.$x249
=072  \\$aN3.$x706.$x535.$x615
=072  \\$aN3.$x706.$x657.$x249
=150  \\$aMandatory Reporting
=450  \\$aAbuse Reporting
=450  \\$wnnna$aReporting, Abuse
=450  \\$wnnna$aReporting, Mandatory
=550  \\$wg$aDisclosure
=550  \\$wg$aJurisprudence
=550  \\$wg$aMandatory Programs
=550  \\$aDisease Notification
=550  \\$aDuty to Warn
=550  \\$aParental Notification
=680  \\$iA legal requirement that designated types of information acquired by professionals or institutions in the course of their work be reported to appropriate authorities.
=688  \\$a97
=750  \0$aChild abuse$xReporting$5IEN-M$0(DLC)sh 89004795

=LDR  01360cz  a2200385n  4500
=001  9880364269402441
=005  20141212213037.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019183
=035  \\$aCTL9114M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x810
=072  \\$aB4.$x820.$x860
=150  \\$aTombusviridae
=450  \\$aAureusvirus
=450  \\$wnnna$aAureusviruses
=450  \\$aAvenavirus
=450  \\$wnnna$aAvenaviruses
=450  \\$aDianthovirus
=450  \\$wnnna$aDianthoviruses
=450  \\$aMachlomovirus
=450  \\$wnnna$aMachlomoviruses
=450  \\$aNecrovirus
=450  \\$wnnna$aNecroviruses
=450  \\$aOlive Latent Virus 1
=450  \\$aPanicovirus
=450  \\$wnnna$aPanicoviruses
=450  \\$wnnna$aRed clover necrotic mosaic virus
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aCarmovirus
=550  \\$wh$aTombusvirus
=680  \\$iA family of RNA plant viruses infecting dicotyledons. Transmission is mainly by mechanical inoculation and through propagative plant material. All species elicit formation of multivesicular inclusion bodies. There are at least eight genera: Aureusvirus, Avenavirus, CARMOVIRUS, Dianthovirus, Machlomovirus, Necrovirus, Panicovirus, and TOMBUSVIRUS.
=688  \\$a97
=750  \0$aTombusviridae$0(DLC)sh2007002973$5IEN-M

=LDR  02318cz  a2200577n  4500
=001  9880364269502441
=005  20141212212743.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018710
=035  \\$aCSK5952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x380.$x600
=072  \\$aN2.$x278.$x35.$x516
=072  \\$aN2.$x278.$x354.$x422.$x527.$x600
=072  \\$aN4.$x452.$x442.$x422.$x527.$x600
=150  \\$aPain Clinics
=450  \\$aAcute Pain Service
=450  \\$wnnna$aAcute Pain Services
=450  \\$wnnna$aCenter, Multidisciplinary Pain
=450  \\$wnnna$aCenter, Pain
=450  \\$wnnna$aCenters, Multidisciplinary Pain
=450  \\$wnnna$aCenters, Pain
=450  \\$wnnna$aClinic, Multidisciplinary Pain
=450  \\$wnnna$aClinic, Pain
=450  \\$wnnna$aClinics, Multidisciplinary Pain
=450  \\$wnnna$aClinics, Pain
=450  \\$wnnna$aMultidisciplinary Pain Center
=450  \\$aMultidisciplinary Pain Centers
=450  \\$wnnna$aMultidisciplinary Pain Clinic
=450  \\$wnnna$aMultidisciplinary Pain Clinics
=450  \\$wnnna$aPain Center
=450  \\$wnnna$aPain Center, Multidisciplinary
=450  \\$aPain Centers
=450  \\$wnnna$aPain Centers, Multidisciplinary
=450  \\$wnnna$aPain Clinic
=450  \\$wnnna$aPain Clinic, Multidisciplinary
=450  \\$wnnna$aPain Clinics, Multidisciplinary
=450  \\$wnnna$aPain Relief Unit
=450  \\$aPain Relief Units
=450  \\$wnnna$aPain Service, Acute
=450  \\$wnnna$aPain Services, Acute
=450  \\$wnnna$aService, Acute Pain
=450  \\$wnnna$aServices, Acute Pain
=450  \\$wnnna$aUnit, Pain Relief
=450  \\$wnnna$aUnits, Pain Relief
=550  \\$wg$aAmbulatory Care Facilities
=550  \\$wg$aOutpatient Clinics, Hospital
=667  \\$afor diag & ther; coord IM with specific dis (IM) if pertinent
=680  \\$iFacilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as "acute pain services". (From Br Med Bull 1991 Jul;47(3):762-85)
=688  \\$a95
=750  \0$aPain clinics$5IEN-M$0(DLC)sh 87006969

=LDR  00932cz  a2200253n  4500
=001  9880364269602441
=005  20141212213032.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019167
=035  \\$aCTL9112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x282.$x50
=072  \\$aD27.$x505.$x954.$x427.$x220.$x50
=150  \\$aAppetite Stimulants
=450  \\$wnnna$aAppetite-Stimulating Drugs
=450  \\$wnnna$aAppetite Stimulating Drugs
=450  \\$wnnna$aDrugs, Appetite-Stimulating
=450  \\$wnnna$aStimulants, Appetite
=550  \\$wg$aCentral Nervous System Stimulants
=550  \\$aAppetite
=667  \\$aGEN or unspecified; prefer specifics; consider also APPETITE /drug eff
=680  \\$iAgents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.
=688  \\$a97
=750  \0$aAppetite stimulants$5IEN-M$0(DLC)sh 85006103

=LDR  01075cz  a2200325n  4500
=001  9880364269702441
=005  20141212213035.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019176
=035  \\$aCTL9111M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x635
=072  \\$aB4.$x820.$x590
=150  \\$aPotyviridae
=450  \\$aBymovirus
=450  \\$wnnna$aBymoviruses
=450  \\$aIpomovirus
=450  \\$wnnna$aIpomoviruses
=450  \\$aMacluravirus
=450  \\$wnnna$aMacluraviruses
=450  \\$aRymovirus
=450  \\$wnnna$aRymoviruses
=450  \\$aTritimovirus
=450  \\$wnnna$aTritimoviruses
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aPotyvirus
=680  \\$iA family of RNA plant viruses with flexuous, filamentous particles and consisting of six genera: POTYVIRUS; Ipomovirus; Macluravirus; Rymovirus; Tritimovirus; and Bymovirus. All members of the family form cytoplasmic cylindrical inclusion bodies during infection.
=688  \\$a97
=750  \0$aPotyviridae$0(DLC)sh2007002916$5IEN-M

=LDR  00795cz  a2200217n  4500
=001  9880364269802441
=005  20141212213054.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019210
=035  \\$aCTL9108M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x730.$x825.$x925
=072  \\$aD12.$x776.$x210.$x500.$x910.$x925
=072  \\$aD12.$x776.$x220.$x525.$x825.$x925
=150  \\$aTroponin I
=450  \\$wnnna$aTroponin-I
=550  \\$wg$aTroponin
=667  \\$aa muscle protein; /biosyn /physiol permitted; TROPONIN C & TROPONIN T are also available
=680  \\$iOne of the three polypeptide chains that make up the TROPONIN complex. It inhibits F-actin-myosin interactions.
=688  \\$a97; was TROPONIN I (NM) 1975-96
=750  \0$aTroponin I$0(DLC)sh2011005434$5IEN-M

=LDR  02063cz  a2200361n  4500
=001  9880364269902441
=005  20141212213029.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019160
=035  \\$aCTL9105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x280
=150  \\$aEndosonography
=450  \\$wnnna$aEcho Endoscopies
=450  \\$wnnna$aEcho-Endoscopies
=450  \\$aEcho-Endoscopy
=450  \\$wnnna$aEcho Endoscopy
=450  \\$wnnna$aEndoscopic Ultrasonographies
=450  \\$aEndoscopic Ultrasonography
=450  \\$wnnna$aEndoscopies, Echo
=450  \\$wnnna$aEndoscopies, Ultrasonic
=450  \\$aEndoscopy, Echo
=450  \\$aEndoscopy, Ultrasonic
=450  \\$wnnna$aEndosonographies
=450  \\$wnnna$aUltrasonic Endoscopies
=450  \\$aUltrasonic Endoscopy
=450  \\$wnnna$aUltrasonographies, Endoscopic
=450  \\$aUltrasonography, Endoscopic
=550  \\$wg$aUltrasonography
=667  \\$aultrasonogr of hollow organs: endo- = within, not with endoscopy; coord IM with organ or dis /ultrasonogr; do not index under ENDOSCOPY or specific endoscopic technique unless also discussed in article; DF: ENDOSONOGR
=680  \\$iUltrasonography of internal organs using an ultrasound transducer sometimes mounted on a fiberoptic endoscope. In endosonography the transducer converts electronic signals into acoustic pulses or continuous waves and acts also as a receiver to detect reflected pulses from within the organ. An audiovisual-electronic interface converts the detected or processed echo signals, which pass through the electronics of the instrument, into a form that the technologist can evaluate. The procedure should not be confused with ENDOSCOPY which employs a special instrument called an endoscope. The "endo-" of endosonography refers to the examination of tissue within hollow organs, with reference to the usual ultrasonography procedure which is performed externally or transcutaneously.
=688  \\$a97
=750  \0$aEndoscopic ultrasonography$5IEN-M$0(DLC)sh 88005425

=LDR  03396cz  a2200829n  4500
=001  9880364270002441
=005  20160425095402.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018719
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x9.$x400
=072  \\$aD12.$x776.$x543.$x750.$x60.$x9.$x400
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x74.$x400
=072  \\$aD12.$x776.$x624.$x664.$x700.$x642
=072  \\$aD23.$x50.$x301.$x264.$x35.$x596
=072  \\$aD23.$x101.$x100.$x110.$x596
=072  \\$aD23.$x101.$x840.$x642
=150  \\$aReceptor, ErbB-2
=450  \\$wnnna$aAntigen, CD340
=450  \\$wnnna$aAntigens, CD340
=450  \\$ac-erbB-2 Protein
=450  \\$wnnna$ac erbB 2 Protein
=450  \\$wnnna$ac-ErbB-2, Proto-oncogene
=450  \\$wnnna$aCD340 Antigen
=450  \\$wnnna$aCD340 Antigens
=450  \\$aerbB-2 Proto-Oncogene Protein
=450  \\$wnnna$aerbB 2 Proto Oncogene Protein
=450  \\$wnnna$aErbB-2 Receptor
=450  \\$aerbB-2 Receptor Protein-Tyrosine Kinase
=450  \\$wnnna$aerbB 2 Receptor Protein Tyrosine Kinase
=450  \\$wnnna$aerbB-2 Receptors
=450  \\$aHER-2 Proto-Oncogene Protein
=450  \\$wnnna$aHER 2 Proto Oncogene Protein
=450  \\$wnnna$aMetastatic Lymph Node Gene 19 Protein
=450  \\$aneu Proto-Oncogene Protein
=450  \\$wnnna$aNeu, Proto-oncogene Protein
=450  \\$wnnna$aneu Proto Oncogene Protein
=450  \\$wnnna$aNeu Receptor
=450  \\$wnnna$aOncogene Protein HER-2
=450  \\$wnnna$aOncogene Protein HER 2
=450  \\$wnnna$ap185(c-neu)
=450  \\$wnnna$ap185erbB2 Protein
=450  \\$wnnna$aProtein Neu, Proto-oncogene
=450  \\$wnnna$aProtein, p185erbB2
=450  \\$wnnna$aProto-oncogene c-ErbB-2
=450  \\$wnnna$aProto oncogene c ErbB 2
=450  \\$wnnna$aProto-Oncogene Protein, erbB-2
=450  \\$aProto-Oncogene Protein HER-2
=450  \\$wnnna$aProto Oncogene Protein HER 2
=450  \\$wnnna$aProto-Oncogene Protein, HER-2
=450  \\$wnnna$aProto-oncogene Protein Neu
=450  \\$wnnna$aProto oncogene Protein Neu
=450  \\$wnnna$aProto-Oncogene Protein, neu
=450  \\$aProto-Oncogene Protein p185(neu)
=450  \\$wnnna$aProto-Oncogene Proteins c-erbB-2
=450  \\$wnnna$aProto Oncogene Proteins c erbB 2
=450  \\$wnnna$aReceptor, ErbB 2
=450  \\$wnnna$aReceptor, Neu
=450  \\$wnnna$aReceptors, erbB-2
=450  \\$wnnna$aReceptors, erbB 2
=450  \\$wnnna$aTyrosine Kinase-type Cell Surface Receptor HER2
=450  \\$wnnna$aTyrosine Kinase type Cell Surface Receptor HER2
=550  \\$wg$aAntigens, CD
=550  \\$wg$aErbB Receptors
=550  \\$wg$aProto-Oncogene Proteins
=550  \\$wg$aBiomarkers, Tumor
=550  \\$aGenes, erbB-2
=550  \\$aNeuregulins
=680  \\$iA cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and  heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.
=688  \\$a2000(1995); use RECEPTOR, ERBB-2 (NM) 1985-1994
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Receptor, erbB-2
=750  \0$aHER-2 protein$5IEN-M$0(DLC)sh 98002671

=LDR  01177cz  a2200241n  4500
=001  9880364270102441
=005  20141212213026.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019155
=035  \\$aCTL9104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x939
=150  \\$aVeterinary Drugs
=450  \\$wnnna$aDrug, Veterinary
=450  \\$aDrugs, Veterinary
=450  \\$wnnna$aPharmaceuticals, Veterinary
=450  \\$wnnna$aVeterinary Drug
=450  \\$wnnna$aVeterinary Pharmaceuticals
=550  \\$wg$aPharmaceutical Preparations
=667  \\$aGEN or unspecified; prefer specific drug /ther use with required animal dis precoords with /drug ther
=680  \\$iDrugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the United States most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.
=688  \\$a97
=750  \0$aVeterinary drugs$5IEN-M$0(DLC)sh 85143020

=LDR  00941cz  a2200313n  4500
=001  9880364270202441
=005  20161206110059.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019152
=035  \\$aCTL9101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x329
=072  \\$aE2.$x800.$x550
=072  \\$aE4.$x665.$x600
=072  \\$aE5.$x200.$x998.$x329
=150  \\$aParacentesis
=450  \\$wnnna$aParacenteses
=550  \\$wg$aDrainage
=550  \\$wg$aPunctures
=550  \\$wg$aSpecimen Handling
=550  \\$wh$aAmniocentesis
=550  \\$wh$aArthrocentesis
=550  \\$wh$aCordocentesis
=550  \\$wh$aPericardiocentesis
=550  \\$wh$aThoracentesis
=550  \\$wh$aTympanocentesis
=680  \\$iA procedure in which fluid is withdrawn from a body cavity via a trocar and cannula, needle, or other hollow instrument.
=688  \\$a97
=750  \0$aParacentesis$5IEN-M$0(DLC)sh 85097729

=LDR  00826cz  a2200181n  4500
=001  9880364270302441
=005  20141212213157.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019368
=035  \\$aCTL9086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x637
=150  \\$aNature
=550  \\$wg$aHumanities
=667  \\$arestrict to Nature as an abstract or philosophical concept, as "von Humboldt's Views of Nature" or "the laws of nature"; not for "the nature of science" or "the nature of psychoanalytic theory"
=680  \\$iThe system of all phenomena in space and time; the totality of physical reality. It is both a scientific and philosophic concept appearing in all historic eras. (Webster 2d; Dr. James H. Cassedy, NLM History of Medicine Division)
=688  \\$a97
=750  \0$aNature$5IEN-M$0(DLC)sh 85090277

=LDR  01101cz  a2200349n  4500
=001  9880364270402441
=005  20141212212849.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018927
=035  \\$aCSK5947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x796.$x50
=150  \\$aAnti-Asthmatic Agents
=450  \\$wnnna$aAgents, Anti-Asthmatic
=450  \\$wnnna$aAgents, Antiasthmatic
=450  \\$wnnna$aAnti Asthmatic Agents
=450  \\$wnnna$aAnti-Asthmatic Drugs
=450  \\$wnnna$aAnti Asthmatic Drugs
=450  \\$wnnna$aAnti-Asthmatics
=450  \\$wnnna$aAnti Asthmatics
=450  \\$wnnna$aAntiasthmatic Agents
=450  \\$wnnna$aAntiasthmatic Drugs
=450  \\$wnnna$aAntiasthmatics
=450  \\$wnnna$aDrugs, Anti-Asthmatic
=450  \\$wnnna$aDrugs, Antiasthmatic
=550  \\$wg$aRespiratory System Agents
=550  \\$wh$aBronchodilator Agents
=550  \\$aAsthma
=667  \\$aconsider also ASTHMA /drug ther
=680  \\$iDrugs that are used to treat asthma.
=688  \\$a96
=750  \0$aAntiasthmatic agents$5IEN-M$0(DLC)sh 85005633

=LDR  00694cz  a2200193n  4500
=001  9880364270502441
=005  20141212213158.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019372
=035  \\$aCTL9085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x700
=150  \\$aOrphanages
=450  \\$wnnna$aOrphanage
=550  \\$wg$aResidential Facilities
=667  \\$ahist or modern usage
=680  \\$iInstitutions for the housing and care of orphans, foundlings, and abandoned children. They have existed as such since the medieval period but the heading is applicable to such usage also in modern parlance.
=688  \\$a97
=750  \0$aOrphanages$5IEN-M$0(DLC)sh 85095748

=LDR  00920cz  a2200205n  4500
=001  9880364270602441
=005  20141212213156.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019365
=035  \\$aCTL9084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x899.$x500
=072  \\$aK1.$x752.$x798.$x500
=150  \\$aMetaphor
=450  \\$wnnna$aMetaphors
=550  \\$wg$aSymbolism
=667  \\$aIM; coord with object of comparison (IM)
=680  \\$iThe application of a concept to that which it is not literally the same but which suggests a resemblance and comparison. Medical metaphors were widespread in ancient literature; the description of a sick body was often used by ancient writers to define a critical condition of the State, in which one corrupt part can ruin the entire system. (From Med Secoli Arte Sci, 1990;2(3):abstract 331)
=688  \\$a97
=750  \0$aMetaphor$5IEN-M$0(DLC)sh 85084283

=LDR  00892cz  a2200289n  4500
=001  9880364270702441
=005  20141212213019.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019141
=035  \\$aCSK5946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x796
=150  \\$aRespiratory System Agents
=450  \\$wnnna$aAgents, Respiratory System
=450  \\$aRespiratory Stimulants
=450  \\$wnnna$aStimulants, Respiratory
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnti-Asthmatic Agents
=550  \\$wh$aAntitussive Agents
=550  \\$wh$aBronchoconstrictor Agents
=550  \\$wh$aDemulcents
=550  \\$wh$aExpectorants
=550  \\$wh$aNasal Decongestants
=550  \\$wh$aPulmonary Surfactants
=680  \\$iDrugs used for their effects on the respiratory system.
=688  \\$a96
=750  \0$aRespiratory agents$5IEN-M$0(DLC)sh 85113187

=LDR  00995cz  a2200217n  4500
=001  9880364270802441
=005  20141212213156.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019359
=035  \\$aCTL9083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x468
=072  \\$aL1.$x535
=150  \\$aKnowledge
=450  \\$aEpistemology
=550  \\$wg$aHumanities
=550  \\$wg$aInformation Science
=667  \\$arestrict to knowledge as an abstract or philosophical concept, as "transmission of knowledge"; do not use as coordinate for knowledge of specific subjects as "fuller use of our knowledge about children"; will figure largely in historical articles & historical contexts; "medical knowledge" is probably MEDICINE & not here
=680  \\$iThe body of truths or facts accumulated in the course of time, the cumulated sum of information, its volume and nature, in any civilization, period, or country.
=688  \\$a97
=750  \0$aKnowledge, Theory of$5IEN-M$0(DLC)sh 85072732

=LDR  01123cz  a2200229n  4500
=001  9880364270902441
=005  20141212212736.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018686
=035  \\$aCSK5942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x100.$x35.$x75
=072  \\$aD27.$x505.$x954.$x427.$x210.$x100.$x35.$x75
=150  \\$aAnesthetics, Intravenous
=450  \\$aIntravenous Anesthetics
=550  \\$wg$aAnesthetics, General
=550  \\$wh$aAnesthetics, Dissociative
=550  \\$aBarbiturates
=667  \\$asee note at ANESTHETICS
=680  \\$iUltrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174)
=688  \\$a95
=750  \0$aIntravenous anesthetics$5IEN-M$0(DLC)sh 91006267

=LDR  00755cz  a2200193n  4500
=001  9880364271002441
=005  20141212213126.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019277
=035  \\$aCTL9073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x345
=150  \\$aEntropy
=450  \\$wnnna$aEntropies
=550  \\$wg$aThermodynamics
=667  \\$aa principle of thermodynamics wherein "heat or energy of a system is not available to perform work"; no qualif
=680  \\$iThe measure of that part of the heat or energy of a system which is not available to perform work. Entropy increases in all natural (spontaneous and irreversible) processes. (From Dorland, 28th ed)
=688  \\$a97
=750  \0$aEntropy$5IEN-M$0(DLC)sh 85044150

=LDR  00819cz  a2200205n  4500
=001  9880364271102441
=005  20141212213135.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019303
=035  \\$aCTL9072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x452
=150  \\$aMultilingualism
=450  \\$aBilingualism
=550  \\$wg$aLanguage Arts
=550  \\$aLanguage
=667  \\$aIM; do not coord with a Cat Z term to specify the languages, i.e., French-Italian bilingualism = MULTILINGUALISM only & not also FRANCE & ITALY
=680  \\$iThe ability to speak, read, or write several languages or many languages with some facility. Bilingualism is the most common form. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a97
=750  \0$aMultilingualism$5IEN-M$0(DLC)sh 85088352

=LDR  00888cz  a2200229n  4500
=001  9880364271202441
=005  20161219102113.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019336
=035  \\$aCTL9070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x255
=150  \\$aCognitive Science
=450  \\$wnnna$aCognitive Sciences
=450  \\$wnnna$aScience, Cognitive
=450  \\$wnnna$aSciences, Cognitive
=550  \\$wg$aPsychology
=550  \\$wh$aCognitive Neuroscience
=667  \\$aa branch of psychol; SPEC; SPEC qualif
=680  \\$iThe study of the precise nature of different mental tasks and the operations of the brain that enable them to be performed, engaging branches of psychology, computer science, philosophy, and linguistics. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a97
=750  \0$aCognitive science$5IEN-M$0(DLC)sh 88006179

=LDR  01347cz  a2200325n  4500
=001  9880364271302441
=005  20141212212653.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018561
=035  \\$aCSK5933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x440
=150  \\$aSpace Simulation
=450  \\$wnnna$aModel, Space
=450  \\$aModels, Space
=450  \\$aOrbital Simulation
=450  \\$wnnna$aOrbital Simulations
=450  \\$wnnna$aSimulation, Orbital
=450  \\$wnnna$aSimulation, Space
=450  \\$wnnna$aSimulations, Orbital
=450  \\$wnnna$aSimulations, Space
=450  \\$wnnna$aSpace Model
=450  \\$wnnna$aSpace Models
=450  \\$wnnna$aSpace Simulations
=550  \\$wg$aEnvironment, Controlled
=550  \\$wh$aWeightlessness Simulation
=667  \\$ato test space systems or components by approximating the space environment
=680  \\$iAn environment simulating one or more parameters of the space environment, applied in testing space systems or components. Often, a closed chamber is used, capable of approximating the vacuum and normal environments of space. (From NASA Thesaurus, 1988) This also includes simulated EXTRAVEHICULAR ACTIVITY studies in atmosphere exposure chambers or water tanks.
=688  \\$a95
=750  \0$aSpace simulators$5IEN-M$0(DLC)sh 85125960

=LDR  00667cz  a2200193n  4500
=001  9880364271402441
=005  20141212213038.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019185
=035  \\$aCTL9065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x700.$x500
=150  \\$aNotophthalmus
=550  \\$wg$aSalamandridae
=550  \\$wh$aNotophthalmus viridescens
=667  \\$aa genus of newts
=680  \\$iA genus of newts of the Salamandridae family found in North America in areas east of the 100th meridian. A common species is NOTOPHTHALMUS VIRIDESCENS.
=688  \\$a97
=750  \0$aNotophthalmus$5IEN-M$0(DLC)sh 85092816

=LDR  00917cz  a2200289n  4500
=001  9880364271502441
=005  20170608114658.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019175
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x35.$x538.$x161
=072  \\$aG2.$x111.$x218
=072  \\$aG3.$x59.$x538.191
=072  \\$aG5.$x206
=150  \\$aDNA Methylation
=450  \\$wnnna$aDNA Methylations
=450  \\$wnnna$aMethylation, DNA
=450  \\$wnnna$aMethylations, DNA
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aGenetic Phenomena
=550  \\$wg$aMethylation
=550  \\$aEpigenesis, Genetic
=550  \\$aGene Silencing
=550  \\$aGenomic Imprinting
=680  \\$iAddition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.
=688  \\$a97
=750  \0$aDNA$xMethylation$5IEN-M

=LDR  01848cz  a2200277n  4500
=001  9880364271602441
=005  20141212212952.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019068
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x137.$x500
=150  \\$aBryopsida
=450  \\$wnnna$aBryopsidas
=450  \\$aCeratodon
=450  \\$wnnna$aCeratodons
=450  \\$wnnna$aMosse, True
=450  \\$aMosses, True
=450  \\$aPhyscomitrella
=450  \\$wnnna$aPhyscomitrellas
=450  \\$wnnna$aTrue Mosse
=450  \\$wnnna$aTrue Mosses
=550  \\$wg$aBryophyta
=667  \\$aentry term MOSSES, TRUE: check MeSH for other moss terms; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA class of plants within the Bryophyta comprising the mosses, which are found in both damp (including freshwater) and drier situations. Mosses possess erect or prostrate leafless stems, which give rise to leafless stalks bearing capsules. Spores formed in the capsules are released and grow to produce new plants. (Concise Dictionary of Biology, 1990). Many small plants bearing the name moss are in fact not mosses. The "moss" found on the north side of trees is actually a green alga (CHLOROPHYTA). Irish moss is really a red alga (RHODOPHYTA). Beard lichen (beard moss), Iceland moss, oak moss, and reindeer moss are actually LICHENS. Spanish moss is a common name for both LICHENS and an air plant (TILLANDSIA usneoides) of the pineapple family. Club moss is an evergreen herb of the family LYCOPODIACEAE.
=688  \\$a2004(1996)
=750  \0$aMosses$0(DLC) sh 85087489$5IEN-M

=LDR  00932cz  a2200265n  4500
=001  9880364271702441
=005  20141212213036.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019177
=035  \\$aCTL9056M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x81
=072  \\$aB4.$x820.$x81
=150  \\$aBromoviridae
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aAlfamovirus
=550  \\$wh$aBromovirus
=550  \\$wh$aCucumovirus
=550  \\$wh$aIlarvirus
=550  \\$wh$aOleavirus
=667  \\$acoord IM with specific plant /virol
=680  \\$iA family of RNA plant viruses with a wide host range in crops and horticultural species. All viruses are readily transmitted by mechanical means and some by insects and pollen. The genera include: ALFAMOVIRUS; BROMOVIRUS; CUCUMOVIRUS; ILARVIRUS; and OLEAVIRUS.
=688  \\$a97
=750  \0$aBromoviridae$0(DLC) sh2004003306$5IEN-M

=LDR  01250cz  a2200277n  4500
=001  9880364271802441
=005  20141212212905.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018973
=035  \\$aCSK5930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x458
=072  \\$aN3.$x706.$x535.$x518
=150  \\$aIntellectual Property
=450  \\$wnnna$aIntellectual Properties
=450  \\$wnnna$aProperties, Intellectual
=450  \\$wnnna$aProperty, Intellectual
=550  \\$wg$aJurisprudence
=550  \\$wh$aCopyright
=550  \\$wh$aPatents as Topic
=550  \\$aInventions
=550  \\$aOwnership
=667  \\$arefers to PATENTS, trademarks, COPYRIGHT, espec under US Constitution; no qualif; specify geog
=680  \\$iProperty, such as patents, trademarks, and copyright, that results from creative effort. The Patent and Copyright Clause (Art. 1, Sec. 8, cl. 8) of the United States Constitution provides for promoting the progress of science and useful arts by securing for limited times to authors and inventors, the exclusive right to their respective writings and discoveries. (From Black's Law Dictionary, 5th ed, p1014)
=688  \\$a96
=750  \0$aIntellectual property$5IEN-M$0(DLC)sh 85067167

=LDR  01261cz  a2200313n  4500
=001  9880364272002441
=005  20141212212914.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019001
=035  \\$aCSK5928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x664.$x500.$x772
=150  \\$aNitric Oxide Synthase
=450  \\$wnnna$aNitric-Oxide Synthase
=450  \\$wnnna$aNitric-Oxide Synthetase
=450  \\$wnnna$aNitric Oxide Synthetase
=450  \\$aNO Synthase
=450  \\$wnnna$aOxide Synthase, Nitric
=450  \\$wnnna$aSynthase, Nitric Oxide
=550  \\$wg$aAmino Acid Oxidoreductases
=550  \\$wh$aNitric Oxide Synthase Type I
=550  \\$wh$aNitric Oxide Synthase Type II
=550  \\$wh$aNitric Oxide Synthase Type III
=667  \\$ageneral; prefer specifics
=680  \\$iAn NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE.
=688  \\$a2006(1990)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Nitric-Oxide Synthase
=688  \\$a1996; use NITRIC-OXIDE SYNTHASE (NM) 1990-1995; for ENDOTHELIUM-DERIVED GROWTH FACTOR SYNTHASE use NITRIC-OXIDE SYNTHASE (NM) 1991-2000
=750  \0$aNitric-oxide synthase$0(DLC) sh 98004697$5IEN-M

=LDR  01088cz  a2200277n  4500
=001  9880364272102441
=005  20141212213038.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019184
=035  \\$aCTL9051M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x810.$x150
=072  \\$aB4.$x820.$x860.$x150
=150  \\$aCarmovirus
=450  \\$wnnna$aCarmoviruses
=450  \\$aCarnation mottle virus
=450  \\$wnnna$aCarnation mottle viruses
=450  \\$wnnna$acrinkle virus, Turnip
=450  \\$wnnna$acrinkle viruses, Turnip
=450  \\$aTurnip crinkle virus
=450  \\$wnnna$aTurnip crinkle viruses
=450  \\$wnnna$aviruses, Turnip crinkle
=550  \\$wg$aTombusviridae
=680  \\$iA genus in the family TOMBUSVIRIDAE mostly found in temperate regions. Some species infecting legumes (FABACEAE) are reported from tropical areas. Most viruses are soil-borne, but some are transmitted by the fungus Olpidium radicale and others by beetles. Carnation mottle virus is the type species.
=688  \\$a97
=750  \0$aCarmoviruses$0(DLC)sh2007002972$5IEN-M

=LDR  00830cz  a2200229n  4500
=001  9880364272202441
=005  20141212213008.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019096
=035  \\$aCSK5922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x920
=072  \\$aD12.$x776.$x395.$x970
=072  \\$aD12.$x776.$x860.$x300.$x920
=150  \\$aVitronectin
=550  \\$wg$aBlood Proteins
=550  \\$wg$aExtracellular Matrix Proteins
=550  \\$wg$aGlycoproteins
=667  \\$aa glycoprotein
=680  \\$iA blood plasma glycoprotein that mediates cell adhesion and interacts with proteins of the complement, coagulation, and fibrinolytic cascade. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a96; was VITRONECTIN (NM) 1978-95
=750  \0$aVitronectin$5IEN-M$0(DLC)sh 93007496

=LDR  01070cz  a2200217n  4500
=001  9880364272302441
=005  20190507170013.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019030
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x408.$x460.$x870
=150  \\$aReceptors, Vitronectin
=450  \\$wnnna$aVitronectin Receptors
=550  \\$wg$aReceptors, Cytoadhesin
=550  \\$wh$aIntegrin alphaVbeta3
=667  \\$ado not confuse with VITRONECTIN RECEPTOR see INTEGRIN ALPHAVBETA3, DF: RECEPT VITRONECTIN
=680  \\$iReceptors such as INTEGRIN ALPHAVBETA3 that bind VITRONECTIN with high affinity and play a role in cell migration. They also bind FIBRINOGEN; VON WILLEBRAND FACTOR; osteopontin; and THROMBOSPONDINS.
=688  \\$a96; was VITRONECTIN RECEPTOR (NM) 1985-95
=750  \0$81$wb$iBroader mapping$aVitronectin$0(DLC)sh 93007496$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aVitronectin--Receptors$5IEN-M

=LDR  01798cz  a2200373n  4500
=001  9880364272402441
=005  20141212212934.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019039
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x625.$x785
=072  \\$aD12.$x776.$x543.$x550.$x625.$x785
=072  \\$aD12.$x776.$x543.$x750.$x705.$x408.$x460.$x700
=072  \\$aD12.$x776.$x543.$x750.$x705.$x675.$x784
=150  \\$aPlatelet Glycoprotein GPIIb-IIIa Complex
=450  \\$wnnna$aalphaIIbbeta3, Integrin
=450  \\$wnnna$abeta-3, Integrin alpha-IIb
=450  \\$wnnna$aGlycoproteins IIb-IIIa
=450  \\$wnnna$aGlycoproteins IIb IIIa
=450  \\$aGPIIb-IIIa Receptors
=450  \\$wnnna$aGPIIb IIIa Receptors
=450  \\$wnnna$aIntegrin alpha-IIb beta-3
=450  \\$wnnna$aIntegrin alpha IIb beta 3
=450  \\$aIntegrin alphaIIbbeta3
=450  \\$wnnna$aPlatelet Glycoprotein GPIIb IIIa Complex
=450  \\$wnnna$aReceptors, GPIIb-IIIa
=550  \\$wg$aPlatelet Membrane Glycoproteins
=550  \\$wg$aReceptors, Cytoadhesin
=550  \\$aIntegrin beta3
=550  \\$aPlatelet Membrane Glycoprotein IIb
=550  \\$aThrombasthenia
=680  \\$iPlatelet membrane glycoprotein complex important for platelet adhesion and aggregation. It is an integrin complex containing INTEGRIN ALPHAIIB and INTEGRIN BETA3 which recognizes the arginine-glycine-aspartic acid (RGD) sequence present on several adhesive proteins. As such, it is a receptor for FIBRINOGEN; VON WILLEBRAND FACTOR; FIBRONECTIN; VITRONECTIN; and THROMBOSPONDINS. A deficiency of GPIIb-IIIa results in GLANZMANN THROMBASTHENIA.
=688  \\$a1996(1987); use INTEGRIN ALPHAIIBBETA3 (NM) 1992-1995
=750  \0$aPlatelet glycoprotein GPIIb-IIIa complex$5IEN-M$0(DLC)sh 99003277

=LDR  00766cz  a2200229n  4500
=001  9880364272502441
=005  20141212213043.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019191
=035  \\$aCTL9050M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x750
=072  \\$aB4.$x820.$x750
=150  \\$aSequiviridae
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aSequivirus
=550  \\$wh$aWaikavirus
=667  \\$aa family of plant viruses
=680  \\$iA family of monopartite RNA plant viruses resembling picornaviruses and containing two genera: SEQUIVIRUS and WAIKAVIRUS. Transmission is by aphids or leafhoppers and requires a helper protein.
=688  \\$a97
=750  \0$aSequiviridae$0(DLC)sh2007002925$5IEN-M

=LDR  01844cz  a2200385n  4500
=001  9880364272602441
=005  20190416160526.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018960
=035  \\$aCSK5919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x200.$x625.$x144
=072  \\$aD12.$x776.$x395.$x650.$x750.$x281
=072  \\$aD12.$x776.$x543.$x550.$x200.$x625.$x144
=072  \\$aD12.$x776.$x543.$x750.$x705.$x877.$x144
=072  \\$aD23.$x50.$x301.$x350.$x625.$x144
=150  \\$aHyaluronan Receptors
=450  \\$wnno$aAntigens, CD44
=450  \\$wnnna$aAntigen, CD44
=450  \\$wnnna$aCD44 Antigen
=450  \\$aCD44 Antigens
=450  \\$wnnna$aChondroitin Sulfate Proteoglycan 8
=450  \\$aHyaluronan-Binding Protein
=450  \\$wnnna$aHyaluronan Binding Protein
=450  \\$wnnna$aHyaluronan Receptor
=450  \\$wnnna$aHyaluronic Acid Binding Protein
=450  \\$wnnna$aReceptor, Hyaluronan
=450  \\$aReceptors, Hyaluronan
=550  \\$wg$aChondroitin Sulfate Proteoglycans
=550  \\$wg$aReceptors, Lymphocyte Homing
=680  \\$iAcidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. Their interaction with HYAURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.
=688  \\$a2018 (1996); for CD44 ANTIGENS use RECEPTORS, LYMPHOCYTE HOMING 1991-93
=750  \0$81$wb$iBroader mapping$aHyaluronic acid$0(DLC)sh 85063257$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC) sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading:$aHyaluronic acid--Receptors.

=LDR  01039cz  a2200265n  4500
=001  9880364272702441
=005  20141212213023.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019149
=035  \\$aCTL9048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x115
=072  \\$aJ1.$x897.$x120.$x115
=150  \\$aBioreactors
=450  \\$wnnna$aBioreactor
=450  \\$wnnna$aFermentor
=450  \\$wnnna$aFermentors
=550  \\$wg$aBiotechnology
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aPhotobioreactors
=550  \\$aBatch Cell Culture Techniques
=550  \\$aFermentation
=680  \\$iTools or devices for generating products using the synthetic or chemical conversion capacity of a biological system. They can be classical fermentors, cell culture perfusion systems, or enzyme bioreactors. For production of proteins or enzymes, recombinant microorganisms such as bacteria, mammalian cells, or insect or plant cells are usually chosen.
=688  \\$a97
=750  \0$aBioreactors$5IEN-M$0(DLC)sh 87005835

=LDR  00716cz  a2200181n  4500
=001  9880364272802441
=005  20141212213033.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019170
=035  \\$aCTL9046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x504.$x660.$x750
=150  \\$aSomites
=450  \\$wnnna$aSomite
=550  \\$wg$aMesoderm
=680  \\$iPaired, segmented masses of MESENCHYME located on either side of the developing spinal cord (neural tube). Somites derive from PARAXIAL MESODERM and continue to increase in number during ORGANOGENESIS. Somites give rise to SKELETON (sclerotome); MUSCLES (myotome); and DERMIS (dermatome).
=688  \\$a97
=750  \0$aSomite$5IEN-M$0(DLC)sh 85124799

=LDR  01130cz  a2200289n  4500
=001  9880364272902441
=005  20141212213014.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019115
=035  \\$aCSK5917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x825.$x340
=072  \\$aC5.$x321.$x550
=150  \\$aFasciitis, Necrotizing
=450  \\$wnnna$aFasciitides, Necrotizing
=450  \\$wnnna$aFascitides, Necrotizing
=450  \\$wnnna$aFascitis, Necrotizing
=450  \\$wnnna$aNecrotizing Fasciitides
=450  \\$wnnna$aNecrotizing Fasciitis
=450  \\$wnnna$aNecrotizing Fascitides
=450  \\$wnnna$aNecrotizing Fascitis
=550  \\$wg$aFasciitis
=550  \\$wg$aSkin Diseases, Bacterial
=667  \\$acoordinate IM with specific bacterial infection term (IM), often Streptococcal infection caused by Streptococcus pyogenes
=680  \\$iA fulminating bacterial infection of the deep layers of the skin and FASCIA. It can be caused by many different organisms, with STREPTOCOCCUS PYOGENES being the most common.
=688  \\$a96
=750  \0$aNecrotizing fasciitis$5IEN-M$0(DLC)sh 96010132

=LDR  01001cz  a2200265n  4500
=001  9880364273002441
=005  20141212213040.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019189
=035  \\$aCTL9044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x565
=150  \\$aIron Metabolism Disorders
=450  \\$wnnna$aDisorder, Iron Metabolism
=450  \\$wnnna$aDisorders, Iron Metabolism
=450  \\$wnnna$aIron Metabolism Disorder
=450  \\$wnnna$aMetabolism Disorder, Iron
=450  \\$wnnna$aMetabolism Disorders, Iron
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aAnemia, Iron-Deficiency
=550  \\$wh$aIron Overload
=667  \\$aGEN or unspecified; prefer specifics; DF: IRON METAB DIS
=680  \\$iDisorders in the processing of iron in the body: its absorption, transport, storage, and utilization. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed)
=688  \\$a97
=750  \0$aIron$xMetabolism$xDisorders$5IEN-M$0(DLC)sh 85068203

=LDR  00974cz  a2200253n  4500
=001  9880364273102441
=005  20201223122745.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018940
=035  \\$aCSK5916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370
=150  \\$aElasmobranchii
=450  \\$wnnna$aElasmobranch
=450  \\$wnnna$aElasmobranchius
=450  \\$aElasmobranchs
=550  \\$wg$aFishes
=550  \\$wh$aSharks
=550  \\$wh$aSkates, Fish
=550  \\$wh$aTorpedo
=667  \\$aGEN or unspecified; SHARKS; DOGFISH; SKATES (FISH) are also available
=680  \\$iA subclass of cartilaginous fish comprising the SHARKS; rays; skates (SKATES (FISH);), and sawfish. Elasmobranchs are typically predaceous, relying more on smell (the olfactory capsules are relatively large) than sight (the eyes are relatively small) for obtaining their food.
=688  \\$a1996
=750  \0$aChondrichthyes$5IEN-M$0(DLC)sh 85024672

=LDR  00838cz  a2200253n  4500
=001  9880364273202441
=005  20141212213032.0
=008  960212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019164
=035  \\$aCTL9043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x82.$x620
=150  \\$aLiver, Artificial
=450  \\$aArtificial Liver
=450  \\$wnnna$aArtificial Livers
=450  \\$aBioartificial Liver
=450  \\$wnnna$aBioartificial Livers
=450  \\$wnnna$aLiver, Bioartificial
=450  \\$wnnna$aLivers, Artificial
=450  \\$wnnna$aLivers, Bioartificial
=550  \\$wg$aArtificial Organs
=680  \\$iDevices for simulating the activities of the liver. They often consist of a hybrid between both biological and artificial materials.
=688  \\$a97
=750  \0$aArtificial liver$5IEN-M$0(DLC)sh 85008193

=LDR  00346cz  a2200121n  4500
=001  9880364273302441
=005  20120717143611.0
=008  690101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTG5298HS
=035  \\$a(DNLM)D013315Q000517
=040  \\$aDNLM$cDNLM
=150  \\$aStress, Psychological$xprevention & control
=750  \0$aStress management$5IEN-M$0(DLC)sh 88004681

=LDR  00961cz  a2200277n  4500
=001  9880364273402441
=005  20141212212902.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018967
=035  \\$aCSK5914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x685
=150  \\$aRisperidone
=450  \\$wnnna$aConsta, Risperdal
=450  \\$wnnna$aR-64,766
=450  \\$wnnna$aR 64,766
=450  \\$wnnna$aR-64766
=450  \\$wnnna$aR 64766
=450  \\$wnnna$aR64,766
=450  \\$wnnna$aR64766
=450  \\$wnnna$aRisperdal Consta
=450  \\$wnnna$aRisperidal
=550  \\$wg$aPyrimidinones
=680  \\$iA selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
=688  \\$a96; was RISPERIDONE (NM) 1988-95
=750  \0$aRisperidone$5IEN-M$0(DLC)sh 94008150

=LDR  00329cz  a2200121n  4500
=001  9880364273502441
=005  20120717143611.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTG1193HS
=035  \\$a(DNLM)D008579Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aMeningioma$xveterinary
=750  \0$aMeningioma in animals$5IEN-M$0(DLC)sh 94002477

=LDR  00328cz  a2200121n  4500
=001  9880364273602441
=005  20010320231501.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTG1177HS
=035  \\$a(DNLM)D011182Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aPostoperative Care$xveterinary
=750  \0$aPostoperative care for animals$5IEN-M

=LDR  00324cz  a2200121n  4500
=001  9880364273702441
=005  20120717143611.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTG0812HS
=035  \\$a(DNLM)D008405Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aMassage$xveterinary
=750  \0$aMassage for animals$5IEN-M$0(DLC)sh 93007509

=LDR  01224cz  a2200325n  4500
=001  9880364273802441
=005  20141212192839.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018864
=035  \\$aCSK5910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x350
=072  \\$aI1.$x880.$x853.$x100.$x450
=150  \\$aCultural Diversity
=450  \\$wnnna$aCultural Diversities
=450  \\$wnnna$aCultural Pluralism
=450  \\$wnnna$aDiversities, Cultural
=450  \\$wnnna$aDiversity, Cultural
=450  \\$aMulticulturalism
=450  \\$wnnna$aMulticulturalisms
=450  \\$aPluralism
=450  \\$wnnna$aPluralism, Cultural
=450  \\$wnnna$aPluralisms
=550  \\$wg$aCulture
=550  \\$aEthical Relativism
=667  \\$aIM; coord with specific ethnic, racial, religious or other cultural aspect (IM); specify geog if pertinent
=680  \\$iCoexistence of numerous distinct ethnic, racial, religious, or cultural groups within one social unit, organization, or population. (From American Heritage Dictionary, 2d college ed., 1982, p955)
=688  \\$a96
=750  \0$aCultural pluralism$5IEN-M$0(DLC)sh 85103571
=750  \0$aMulticulturalism$5IEN-HS$0(DLC)sh 93001610

=LDR  01382cz  a2200349n  4500
=001  9880364273902441
=005  20141212212754.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018756
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x240.$x300
=072  \\$aD27.$x505.$x696.$x577.$x240.$x300
=150  \\$aGABA Antagonists
=450  \\$wnnna$aAcid Antagonists, gamma-Aminobutyric
=450  \\$wnnna$aAntagonist, GABA
=450  \\$wnnna$aAntagonists, GABA
=450  \\$wnnna$aAntagonists, GABA Receptor
=450  \\$wnnna$aAntagonists, gamma-Aminobutyric Acid
=450  \\$wnnna$aGABA Antagonist
=450  \\$wnnna$aGABA Receptor Antagonists
=450  \\$agamma-Aminobutyric Acid Antagonists
=450  \\$wnnna$agamma Aminobutyric Acid Antagonists
=450  \\$agamma-Aminobutyric Acid$xantagonists & inhibitors
=450  \\$wnnna$aReceptor Antagonists, GABA
=450  \\$aReceptors, GABA$xantagonists & inhibitors
=550  \\$wg$aGABA Agents
=550  \\$wh$aGABA-A Receptor Antagonists
=550  \\$wh$aGABA-B Receptor Antagonists
=667  \\$anote specifics; do not confuse with GABA AGONISTS
=680  \\$iDrugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS.
=688  \\$a95
=750  \0$aGABA$xAntagonists$5IEN-M$0(DLC)sh 85052649

=LDR  01688cz  a2200337n  4500
=001  9880364274002441
=005  20190422142112.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018722
=035  \\$aCSK5558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x140.$x700
=072  \\$aD27.$x505.$x696.$x577.$x120.$x140.$x700
=150  \\$aNicotinic Agonists
=450  \\$wnnna$aAgonist, Nicotinic
=450  \\$wnnna$aAgonist, Nicotinic Cholinergic
=450  \\$wnnna$aAgonists, Nicotinic
=450  \\$wnnna$aAgonists, Nicotinic Cholinergic
=450  \\$wnnna$aCholinergic Agonist, Nicotinic
=450  \\$aCholinergic Agonists, Nicotinic
=450  \\$wnnna$aNicotinic Agonist
=450  \\$wnnna$aNicotinic Cholinergic Agonist
=450  \\$wnnna$aNicotinic Cholinergic Agonists
=450  \\$aReceptors, Nicotinic$xagonists
=550  \\$wg$aCholinergic Agonists
=550  \\$aGanglionic Stimulants
=680  \\$iDrugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aNicotine$0(DLC)sh 85091817$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAgonists$0(DLC)sh 99002380$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNicotine--Agonists$5IEN-M

=LDR  02013cz  a2200469n  4500
=001  9880364274102441
=005  20190419105717.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018680
=035  \\$aCSK5557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x200
=072  \\$aD27.$x505.$x696.$x577.$x120.$x200
=150  \\$aCholinergic Antagonists
=450  \\$aAcetylcholine Antagonists
=450  \\$wnnna$aAgents, Anticholinergic
=450  \\$wnnna$aAgents, Cholinergic-Blocking
=450  \\$wnnna$aAntagonist, Cholinergic
=450  \\$wnnna$aAntagonists, Acetylcholine
=450  \\$wnnna$aAntagonists, Cholinergic
=450  \\$wnnna$aAntagonists, Cholinergic Receptor
=450  \\$wnnna$aAnti-Cholinergics
=450  \\$wnnna$aAnti Cholinergics
=450  \\$aAnticholinergic Agents
=450  \\$wnnna$aAnticholinergics
=450  \\$wnnna$aCholinergic Antagonist
=450  \\$aCholinergic-Blocking Agents
=450  \\$wnnna$aCholinergic Blocking Agents
=450  \\$wnnna$aCholinergic Receptor Antagonists
=450  \\$aCholinolytics
=450  \\$wnnna$aReceptor Antagonists, Cholinergic
=450  \\$aReceptors, Cholinergic$xantagonists & inhibitors
=550  \\$wg$aCholinergic Agents
=550  \\$wh$aMuscarinic Antagonists
=550  \\$wh$aNicotinic Antagonists
=550  \\$aAnticholinergic Syndrome
=667  \\$a/adv eff: consider also ANTICHOLINERGIC SYNDROME
=680  \\$iDrugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
=688  \\$a95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS & ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94
=750  \0$81$wb$iBroader mapping$aAcetylcholine$0(DLC)sh 85000467$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAntagonists$0(DLC) sh 99002348$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAcetylcholine--Antagonists$5IEN-M

=LDR  01631cz  a2200313n  4500
=001  9880364274202441
=005  20190419135817.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018727
=035  \\$aCSK5556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x200.$x500
=072  \\$aD27.$x505.$x696.$x577.$x120.$x200.$x500
=150  \\$aMuscarinic Antagonists
=450  \\$wnnna$aAgents, Antimuscarinic
=450  \\$wnnna$aAntagonists, Cholinergic Muscarinic
=450  \\$wnnna$aAntagonists, Muscarinic
=450  \\$aAntimuscarinic Agents
=450  \\$wnnna$aAntimuscarinics
=450  \\$wnnna$aCholinergic Muscarinic Antagonists
=450  \\$wnnna$aMuscarinic Antagonists, Cholinergic
=450  \\$aReceptors, Muscarinic$xantagonists & inhibitors
=550  \\$wg$aCholinergic Antagonists
=550  \\$aParasympatholytics
=680  \\$iDrugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
=688  \\$a95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94
=750  \0$81$wb$iBroader mapping$aMuscarine$0(DLC) sh 99002348$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aAntagonists$0(DLC) sh 99002348$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMuscarine--Antagonists$5IEN-M

=LDR  01716cz  a2200445n  4500
=001  9880364274302441
=005  20141212212637.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018501
=035  \\$aCSK5555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x329
=150  \\$aAntirheumatic Agents
=450  \\$wnnna$aAgents, Anti-Rheumatic
=450  \\$wnnna$aAgents, Antirheumatic
=450  \\$wnnna$aAnti-Rheumatic Agents
=450  \\$wnnna$aAnti Rheumatic Agents
=450  \\$wnnna$aAnti-Rheumatic Drugs
=450  \\$wnnna$aAnti Rheumatic Drugs
=450  \\$wnnna$aAntirheumatic Disease-Modifying Second-Line Drugs
=450  \\$wnnna$aAntirheumatic Disease Modifying Second Line Drugs
=450  \\$wnnna$aAntirheumatic Drugs
=450  \\$wnnna$aAntirheumatic Drugs, Disease-Modifying
=450  \\$wnnna$aAntirheumatic Drugs, Disease Modifying
=450  \\$aDisease-Modifying Antirheumatic Drugs
=450  \\$wnnna$aDisease Modifying Antirheumatic Drugs
=450  \\$wnnna$aDisease-Modifying, Antirheumatic Second-Line Drugs
=450  \\$wnnna$aDisease Modifying, Antirheumatic Second Line Drugs
=450  \\$aDMARD
=450  \\$wnnna$aDrugs, Anti-Rheumatic
=450  \\$wnnna$aDrugs, Antirheumatic
=450  \\$wnnna$aDrugs, Disease-Modifying Antirheumatic
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnti-Inflammatory Agents, Non-Steroidal
=550  \\$wh$aGout Suppressants
=550  \\$aAntimalarials
=550  \\$aImmunosuppressive Agents
=680  \\$iDrugs that are used to treat RHEUMATOID ARTHRITIS.
=688  \\$a95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94
=750  \0$aAntirheumatic agents$5IEN-M$0(DLC)sh 85005763

=LDR  01042cz  a2200337n  4500
=001  9880364274402441
=005  20141212220557.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x700
=150  \\$aRats
=450  \\$wnnna$aLaboratory Rat
=450  \\$wnnna$aLaboratory Rats
=450  \\$wnnna$aRat
=450  \\$wnnna$aRat, Laboratory
=450  \\$wnnna$aRats, Laboratory
=450  \\$wnnna$aRats, Norway
=450  \\$aRattus
=450  \\$wnnna$aRattus norvegicus
=550  \\$wg$aMurinae
=550  \\$wh$aRats, Inbred Strains
=550  \\$wh$aRats, Long-Evans
=550  \\$wh$aRats, Mutant Strains
=550  \\$wh$aRats, Sprague-Dawley
=550  \\$wh$aRats, Transgenic
=550  \\$wh$aRats, Wistar
=667  \\$acheck tag: NIM no qualifiers for RATS, the genus RATTUS unspecified, or any RATTUS species
=680  \\$iThe common name for the genus Rattus.
=688  \\$a2006
=750  \0$aRats$0(DLC) sh 85111538$5IEN-M

=LDR  01397cz  a2200457n  4500
=001  9880364274502441
=005  20141212220557.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051379
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x500
=150  \\$aMice
=450  \\$wnnna$adomesticus, Mus
=450  \\$wnnna$adomesticus, Mus musculus
=450  \\$wnnna$aHouse Mice
=450  \\$wnnna$aHouse Mouse
=450  \\$wnnna$aLaboratory Mice
=450  \\$wnnna$aLaboratory Mouse
=450  \\$aMice, House
=450  \\$wnnna$aMice, Laboratory
=450  \\$wnnna$aMice, Swiss
=450  \\$wnnna$aMouse
=450  \\$wnnna$aMouse, House
=450  \\$wnnna$aMouse, Laboratory
=450  \\$wnnna$aMouse, Swiss
=450  \\$aMus
=450  \\$wnnna$aMus domesticus
=450  \\$aMus musculus
=450  \\$wnnna$aMus musculus domesticus
=450  \\$wnnna$amusculus domesticus, Mus
=450  \\$wnnna$aSwiss Mice
=450  \\$wnnna$aSwiss Mouse
=550  \\$wg$aMurinae
=550  \\$wh$aMice, Congenic
=550  \\$wh$aMice, Inbred Strains
=550  \\$wh$aMice, Mutant Strains
=550  \\$wh$aMice, Transgenic
=667  \\$acheck tag: NIM no qualifiers for MICE, the genus MUS unspecified, or any MUS species
=680  \\$iThe common name for the genus Mus.
=688  \\$a2006
=750  \0$aMice$0(DLC) sh 85084671$5IEN-M

=LDR  00736cz  a2200205n  4500
=001  9880364274602441
=005  20141212220549.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051337
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x800.$x325
=072  \\$aI1.$x880.$x735.$x900.$x800.$x150
=072  \\$aI1.$x880.$x735.$x944.$x340.$x150
=150  \\$aChemical Terrorism
=450  \\$wnnna$aTerrorism, Chemical
=550  \\$wg$aChemical Warfare
=550  \\$wg$aTerrorism
=680  \\$iThe use of chemical agents in TERRORISM. This includes the malevolent use of nerve agents, blood agents, blister agents, and choking agents (NOXAE).
=688  \\$a2006
=750  \0$aChemical terrorism$0(DLC) sh2001002061$5IEN-M

=LDR  01586cz  a2200349n  4500
=001  9880364274702441
=005  20141212220549.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051336
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x450.$x349
=072  \\$aA11.$x284.$x835.$x514.$x349
=150  \\$aMitochondrial Membranes
=450  \\$wnnna$aInner Mitochondrial Membrane
=450  \\$wnnna$aInner Mitochondrial Membranes
=450  \\$wnnna$aMembrane, Inner Mitochondrial
=450  \\$wnnna$aMembrane, Mitochondrial
=450  \\$wnnna$aMembrane, Outer Mitochondrial
=450  \\$wnnna$aMembranes, Inner Mitochondrial
=450  \\$wnnna$aMembranes, Mitochondrial
=450  \\$wnnna$aMembranes, Outer Mitochondrial
=450  \\$wnnna$aMitochondrial Membrane
=450  \\$wnnna$aMitochondrial Membrane, Inner
=450  \\$wnnna$aMitochondrial Membrane, Outer
=450  \\$wnnna$aMitochondrial Membranes, Inner
=450  \\$wnnna$aMitochondrial Membranes, Outer
=450  \\$wnnna$aOuter Mitochondrial Membrane
=450  \\$wnnna$aOuter Mitochondrial Membranes
=550  \\$wg$aIntracellular Membranes
=680  \\$iThe two lipoprotein layers in the MITOCHONDRION. The outer membrane encloses the entire mitochondrion and contains channels with TRANSPORT PROTEINS to move molecules and ions in and out of the organelle. The inner membrane folds into cristae and contains many ENZYMES important to cell METABOLISM and energy production (MITOCHONDRIAL ATP SYNTHASE).
=688  \\$a2006
=750  \0$aMitochondrial membranes$0(DLC) sh 85086281$5IEN-M

=LDR  00611cz  a2200205n  4500
=001  9880364274802441
=005  20141212220528.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x319.$x150.$x800
=150  \\$aTrapezium Bone
=450  \\$wnnna$aBone, Trapezium
=450  \\$wnnna$aBones, Trapezium
=450  \\$wnnna$aOs Trapezium
=450  \\$wnnna$aTrapezium Bones
=550  \\$wg$aCarpal Bones
=680  \\$iA carpal bone adjacent to the TRAPEZOID BONE.
=688  \\$a2006
=750  \0$aTrapezium (Anatomy)$0(DLC) sh 85137114$5IEN-M

=LDR  00692cz  a2200205n  4500
=001  9880364274902441
=005  20141212220519.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051177
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x220.$x145
=150  \\$aCatenins
=450  \\$wnnna$aCatenin Proteins
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wh$aalpha Catenin
=550  \\$wh$abeta Catenin
=550  \\$wh$agamma Catenin
=680  \\$iA family of cytoskeletal proteins that play essential roles in CELL ADHESION at ADHERENS JUNCTIONS by linking CADHERINS to the ACTIN FILAMENTS of the CYTOSKELETON.
=688  \\$a2006
=750  \0$aCatenins$0(DLC)sh2012000199$5IEN-M

=LDR  01096cz  a2200265n  4500
=001  9880364275002441
=005  20190204131658.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051153
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x467.$x984
=072  \\$aD23.$x529.$x984
=150  \\$aWnt Proteins
=450  \\$wnnna$aWingless Type Proteins
=450  \\$wnnna$aWnt Factors
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aWnt-5a Protein
=550  \\$wh$aWnt1 Protein
=550  \\$wh$aWnt2 Protein
=550  \\$wh$aWnt3 Protein
=550  \\$wh$aWnt3A Protein
=550  \\$wh$aWnt4 Protein
=680  \\$iWnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.
=688  \\$a2006(1987)
=750  \0$aWnt proteins$0(DLC)sh2003001148$5IEN-M

=LDR  01872cz  a2200457n  4500
=001  9880364275102441
=005  20141212220517.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051152
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x207
=072  \\$aD12.$x776.$x580.$x215
=150  \\$aClusterin
=450  \\$wnnna$a40,40 Protein, SP
=450  \\$wnnna$aApoJ Protein
=450  \\$wnnna$aApolipoprotein J
=450  \\$wnnna$aComplement-Associated Protein SP-40,40
=450  \\$wnnna$aComplement Associated Protein SP 40,40
=450  \\$wnnna$aComplement Lysis Inhibitor
=450  \\$wnnna$aIonizing Radiation-Induced Protein-8
=450  \\$wnnna$aIonizing Radiation Induced Protein 8
=450  \\$wnnna$aMAC393 Antigen
=450  \\$wnnna$aRadiation-Induced Protein-8, Ionizing
=450  \\$wnnna$aSGP-2 Protein
=450  \\$wnnna$aSGP 2 Protein
=450  \\$wnnna$aSP-40,40, Complement-Associated Protein
=450  \\$wnnna$aSP 40,40 Protein
=450  \\$wnnna$aSulfated Glycoprotein 2
=450  \\$wnnna$aSulfated Glycoprotein-2
=450  \\$wnnna$aTestosterone-Repressed Prostate Message-2 Protein
=450  \\$wnnna$aTestosterone Repressed Prostate Message 2 Protein
=450  \\$wnnna$aTRPM-2 Protein
=450  \\$wnnna$aTRPM 2 Protein
=450  \\$wnnna$aX-Ray-Inducible Protein 8
=450  \\$wnnna$aX Ray Inducible Protein 8
=450  \\$wnnna$aXIP8 Protein
=550  \\$wg$aGlycoproteins
=550  \\$wg$aMolecular Chaperones
=680  \\$iA highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as CANCER; APOPTOSIS; and various NEUROLOGICAL DISORDERS. Clusterin is ubiquitously expressed and appears to function as a secreted MOLECULAR CHAPERONE.
=688  \\$a2006(1980)
=750  \0$aClusterin$0(DLC) sh 95004987$5IEN-M

=LDR  00844cz  a2200229n  4500
=001  9880364275202441
=005  20141212220514.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051140
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x864
=150  \\$aSelenoproteins
=450  \\$wnnna$aSelenoprotein
=450  \\$wnnna$aSelenoprotein P1
=550  \\$wg$aProteins
=550  \\$wh$aMethionine Sulfoxide Reductases
=550  \\$wh$aSelenoprotein P
=550  \\$wh$aSelenoprotein W
=667  \\$ageneral; prefer specifics
=680  \\$iSelenoproteins are proteins that specifically incorporate SELENOCYSTEINE into their amino acid chain. Most selenoproteins are enzymes with the selenocysteine residues being responsible for their catalytic functions.
=688  \\$a2006(1982)
=750  \0$aSelenoproteins$0(DLC)sh2004014372$5IEN-M

=LDR  01083cz  a2200289n  4500
=001  9880364275302441
=005  20141212220505.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051078
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600
=150  \\$aPlatyrrhini
=450  \\$wnnna$aMonkey, New World
=450  \\$aMonkeys, New World
=450  \\$wnnna$aNew World Monkey
=450  \\$wnnna$aNew World Monkeys
=450  \\$wnnna$aWorld Monkey, New
=450  \\$wnnna$aWorld Monkeys, New
=550  \\$wg$aHaplorhini
=550  \\$wh$aAotidae
=550  \\$wh$aAtelidae
=550  \\$wh$aCebidae
=550  \\$wh$aPitheciidae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iAn infraorder of New World monkeys, comprised of the families AOTIDAE; ATELIDAE; CEBIDAE; and PITHECIIDAE. They are found exclusively in the Americas.
=688  \\$a2006; for MONKEYS, NEW WORLD use CEBIDAE 1981-2005
=750  \0$aNew World monkeys$0(DLC)sh2006001552$5IEN-M

=LDR  00707cz  a2200193n  4500
=001  9880364275402441
=005  20141212220505.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051077
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x75
=150  \\$aAtelidae
=550  \\$wg$aPlatyrrhini
=550  \\$wh$aAlouattinae
=550  \\$wh$aAtelinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA family of New World Monkeys in the infraorder PLATYRRHINI, comprising two subfamilies: ALOUATTINAE and ATELINAE.
=688  \\$a2006
=750  \0$aAtelidae$0(DLC) sh2006001561$5IEN-M

=LDR  01019cz  a2200277n  4500
=001  9880364275502441
=005  20141212220458.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051039
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x150.$x450
=150  \\$aLeontopithecus
=450  \\$wnnna$aGolden Tamarin
=450  \\$wnnna$aGolden Tamarins
=450  \\$wnnna$aLeontideus
=450  \\$wnnna$aLion Tamarin
=450  \\$wnnna$aLion Tamarins
=450  \\$aTamarin, Golden
=450  \\$aTamarin, Lion
=450  \\$wnnna$aTamarins, Golden
=450  \\$wnnna$aTamarins, Lion
=550  \\$wg$aCallitrichinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iThe genus of lion tamarins in the subfamily CALLITRICHINAE. The common name refers to the mane on the shoulders.
=688  \\$a2006; use CALLITRICHIDAE 1990-2005
=750  \0$aLion tamarins$0(DLC) sh 85076027$5IEN-M

=LDR  00876cz  a2200205n  4500
=001  9880364275602441
=005  20171102163207.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050997
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x603.$x600
=072  \\$aJ1.$x897.$x115.$x625
=072  \\$aJ1.$x897.$x520.$x600.$x600
=150  \\$aNanomedicine
=550  \\$wg$aBiomedical Technology
=550  \\$wg$aNanotechnology
=550  \\$wh$aTheranostic Nanomedicine
=680  \\$iThe branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
=688  \\$a2006
=750  \0$aNanomedicine$0(DLC)sh2007008651$5IEN-M

=LDR  01061cz  a2200229n  4500
=001  9880364275702441
=005  20141212220441.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050939
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x385
=150  \\$aGene Fusion
=450  \\$wnnna$aFusion, Gene
=450  \\$wnnna$aFusions, Gene
=450  \\$wnnna$aGene Fusions
=550  \\$wg$aRecombination, Genetic
=550  \\$wh$aOncogene Fusion
=550  \\$aArtificial Gene Fusion
=667  \\$aARTIFICIAL GENE FUSION is also available
=680  \\$iThe GENETIC RECOMBINATION of the parts of two or more GENES resulting in a gene with different or additional regulatory regions, or a new chimeric gene product. ONCOGENE FUSION includes an ONCOGENE as at least one of the fusion partners and such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS. ARTIFICIAL GENE FUSION is carried out in vitro by RECOMBINANT DNA technology.
=688  \\$a2006
=750  \0$aGene fusion$0(DLC) sh 85053736$5IEN-M

=LDR  01155cz  a2200253n  4500
=001  9880364275802441
=005  20190510162918.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050916
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x901.$x888
=150  \\$aTRPV Cation Channels
=450  \\$wnnna$aCapsaicin Receptors
=450  \\$wnnna$aCation Channels, TRPV
=450  \\$wnnna$aChannels, TRPV Cation
=450  \\$wnnna$aReceptors, Capsaicin
=450  \\$wnnna$aReceptors, Vanilloid
=450  \\$wnnna$aVanilloid Receptors
=550  \\$wg$aTransient Receptor Potential Channels
=680  \\$iA subgroup of TRP cation channels named after vanilloid receptor. They are very sensitive to TEMPERATURE and hot spicy food and CAPSAICIN. They have the TRP domain and ANKYRIN repeats. Selectivity for CALCIUM over SODIUM ranges from 3 to 100 fold.
=688  \\$a2006(1991)
=750  \0$81$wb$iBroader mapping$aCapsaicin$0(DLC)sh 85020016$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCapsaicin--Receptors$5IEN-M

=LDR  00826cz  a2200253n  4500
=001  9880364275902441
=005  20141212220430.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x506
=150  \\$aLiquid Crystals
=450  \\$wnnna$aCrystal, Liquid
=450  \\$wnnna$aCrystals, Liquid
=450  \\$wnnna$aLiquid Crystal
=450  \\$wnnna$aLiquid Crystalline Materials
=450  \\$wnnna$aMaterial, Mesomorphous Phase
=450  \\$wnnna$aMaterials, Mesomorphous Phase
=450  \\$wnnna$aMesomorphous Phase Material
=450  \\$wnnna$aMesomorphous Phase Materials
=550  \\$wg$aManufactured Materials
=680  \\$iMaterials in intermediate state between solid and liquid.
=688  \\$a2006
=750  \0$aLiquid crystals$0(DLC) sh 85077357$5IEN-M

=LDR  00850cz  a2200229n  4500
=001  9880364276002441
=005  20141212220415.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050812
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x770
=150  \\$aSplit-Brain Procedure
=450  \\$wnnna$aProcedures, Split-Brain
=450  \\$wnnna$aSplit-Brain
=450  \\$wnnna$aSplit Brain
=450  \\$wnnna$aSplit Brain Procedure
=450  \\$wnnna$aSplit-Brain Procedures
=550  \\$wg$aNeurosurgical Procedures
=550  \\$aFunctional Laterality
=680  \\$iComplete severing of the CORPUS CALLOSUM. In humans it is usually performed to treat medically intractable, multifocal EPILEPSY. EXPERIMENTAL ANIMAL MODELS of split brain preparations are used in research.
=688  \\$a2006
=750  \0$aSplit brain$0(DLC) sh 85126835$5IEN-M

=LDR  00631cz  a2200181n  4500
=001  9880364276102441
=005  20141212220405.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x441
=150  \\$aCryoanesthesia
=450  \\$aAnesthesia, Refrigeration
=450  \\$wnnna$aRefrigeration Anesthesia
=550  \\$wg$aAnesthesia
=680  \\$iANESTHESIA achieved by lowering either BODY TEMPERATURE (core cooling) or SKIN TEMPERATURE (external cooling).
=688  \\$a2006; use HYPOTHERMIA, INDUCED 1984-2005
=750  \0$aRefrigeration anesthesia$0(DLC) sh 85112288$5IEN-M

=LDR  01496cz  a2200277n  4500
=001  9880364276202441
=005  20141212193104.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x621.$x820
=150  \\$aTranscranial Magnetic Stimulation
=450  \\$wnnna$aMagnetic Stimulation, Transcranial
=450  \\$wnnna$aMagnetic Stimulations, Transcranial
=450  \\$wnnna$aStimulation, Transcranial Magnetic
=450  \\$wnnna$aStimulations, Transcranial Magnetic
=450  \\$wnnna$aTranscranial Magnetic Stimulation, Paired Pulse
=450  \\$wnnna$aTranscranial Magnetic Stimulation, Repetitive
=450  \\$wnnna$aTranscranial Magnetic Stimulation, Single Pulse
=450  \\$wnnna$aTranscranial Magnetic Stimulations
=550  \\$wg$aMagnetic Field Therapy
=550  \\$aMagnetoencephalography
=550  \\$aTranscranial Direct Current Stimulation
=680  \\$iA technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX. It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.
=688  \\$a2006
=750  \0$aMagnetic brain stimulation$0(DLC) sh 99002394$5IEN-M

=LDR  01090cz  a2200313n  4500
=001  9880364276302441
=005  20141212220352.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x566.$x600
=150  \\$aPhocoena
=450  \\$wnnna$aCommon Porpoise
=450  \\$wnnna$aCommon Porpoises
=450  \\$aHarbor Porpoise
=450  \\$wnnna$aHarbor Porpoises
=450  \\$wnnna$aHarbour Porpoise
=450  \\$wnnna$aHarbour Porpoises
=450  \\$wnnna$aPhocoena phocoena
=450  \\$wnnna$aPorpoise, Common
=450  \\$wnnna$aPorpoise, Harbor
=450  \\$wnnna$aPorpoise, Harbour
=450  \\$wnnna$aPorpoises, Common
=450  \\$wnnna$aPorpoises, Harbor
=450  \\$wnnna$aPorpoises, Harbour
=550  \\$wg$aPorpoises
=680  \\$iA genus of PORPOISES, in the family Phocoenidae, comprised of several species. They frequent coastal waters, bays, estuaries, and the mouths of large rivers.
=688  \\$a2006; use PORPOISES 1998-2005
=750  \0$aPhocoena$0(DLC) sh 95000559$5IEN-M

=LDR  00831cz  a2200229n  4500
=001  9880364276402441
=005  20141212220349.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050724
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x411
=150  \\$aFractures, Cartilage
=450  \\$wnnna$aCartilage Fracture
=450  \\$wnnna$aCartilage Fractures
=450  \\$wnnna$aFracture, Cartilage
=550  \\$wg$aWounds and Injuries
=667  \\$acoordinate IM with specific type of cartilage /inj (IM)
=680  \\$iBreaks in CARTILAGE.
=688  \\$a2006
=750  \0$81$wb$aFractures$0(DLC) sh 85051155$5IEN-M$0(DLC)sh 85051155
=750  \0$81$wb$aCartilage$0(DLC) sh 85020509$5IEN-M$0(DLC)sh 85020509
=788  \0$iSearch also under the following headings used together in the same record:$aFractures$iand$aCartilage$5IEN

=LDR  00308cz  a2200109n  4500
=001  9880364276502441
=005  20060508145806.0
=008  050630\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D050723Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aFractures, Bone$xveterinary
=750  \0$aFractures in animals$0(DLC) sh 85051160$5IEN-M

=LDR  01939cz  a2200601n  4500
=001  9880364276602441
=005  20180709152627.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404
=150  \\$aFractures, Bone
=450  \\$wnnna$aBone, Broken
=450  \\$wnnna$aBone Fracture
=450  \\$aBone Fractures
=450  \\$wnnna$aBones, Broken
=450  \\$wnnna$aBroken Bone
=450  \\$wnnna$aBroken Bones
=450  \\$wnnna$aFracture, Bone
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aAnkle Fractures
=550  \\$wh$aFemoral Fractures
=550  \\$wh$aFracture Dislocation
=550  \\$wh$aFractures, Avulsion
=550  \\$wh$aFractures, Closed
=550  \\$wh$aFractures, Comminuted
=550  \\$wh$aFractures, Compression
=550  \\$wh$aFractures, Malunited
=550  \\$wh$aFractures, Multiple
=550  \\$wh$aFractures, Open
=550  \\$wh$aFractures, Spontaneous
=550  \\$wh$aFractures, Stress
=550  \\$wh$aFractures, Ununited
=550  \\$wh$aHip Fractures
=550  \\$wh$aHumeral Fractures
=550  \\$wh$aIntra-Articular Fractures
=550  \\$wh$aOsteoporotic Fractures
=550  \\$wh$aPeriprosthetic Fractures
=550  \\$wh$aRadius Fractures
=550  \\$wh$aRib Fractures
=550  \\$wh$aShoulder Fractures
=550  \\$wh$aSkull Fractures
=550  \\$wh$aSpinal Fractures
=550  \\$wh$aTibial Fractures
=550  \\$wh$aUlna Fractures
=550  \\$aBone Density Conservation Agents
=550  \\$aBone Diseases
=550  \\$aBony Callus
=667  \\$acoord IM with specific bone /inj (IM) but note many precoordinated Bone/Fracture terms and many specific types of fractures
=680  \\$iBreaks in bones.
=688  \\$a2006
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20061114: 150:##:_{dollar}a Fractures
=750  \0$aFractures$0(DLC) sh 85051155$5IEN-M

=LDR  01244cz  a2200337n  4500
=001  9880364276702441
=005  20141212220345.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050706
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267.$x750
=150  \\$aStenella
=450  \\$wnnna$aDolphin, Spinner
=450  \\$wnnna$aDolphin, Spotted
=450  \\$wnnna$aDolphin, Striped
=450  \\$wnnna$aDolphins, Spinner
=450  \\$wnnna$aDolphins, Spotted
=450  \\$wnnna$aDolphins, Striped
=450  \\$wnnna$aSpinner Dolphin
=450  \\$aSpinner Dolphins
=450  \\$wnnna$aSpotted Dolphin
=450  \\$aSpotted Dolphins
=450  \\$wnnna$aStenella coeruleoalba
=450  \\$wnnna$aStenella frontalis
=450  \\$wnnna$aStenella longirostris
=450  \\$aStriped Dolphin
=450  \\$wnnna$aStriped Dolphins
=550  \\$wg$aDolphins
=680  \\$iA genus comprised of spinner, spotted, and striped DOLPHINS, in the family Delphinidae. Schools of Stenella, that may number in the thousands, often associate with schools of TUNA, and are thus vulnerable to accidental harvesting.
=688  \\$a2006; use DOLPHINS 1998-2005
=750  \0$aStenella (Mammals)$0(DLC) sh 85127938$5IEN-M

=LDR  01520cz  a2200397n  4500
=001  9880364276802441
=005  20141212220342.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050696
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x267.$x150
=150  \\$aCommon Dolphins
=450  \\$wnnna$aCommon Dolphin
=450  \\$wnnna$aCommon Dolphin, Long-Beaked
=450  \\$wnnna$aCommon Dolphin, Short-Beaked
=450  \\$wnnna$aCommon Dolphins, Long-Beaked
=450  \\$wnnna$aCommon Dolphins, Short-Beaked
=450  \\$wnnna$aDelphinus
=450  \\$wnnna$aDelphinus capensis
=450  \\$wnnna$aDelphinus delphis
=450  \\$wnnna$aDolphin, Common
=450  \\$wnnna$aDolphin, Saddleback
=450  \\$wnnna$aDolphins, Common
=450  \\$wnnna$aDolphins, Saddleback
=450  \\$wnnna$aLong-Beaked Common Dolphin
=450  \\$wnnna$aLong Beaked Common Dolphin
=450  \\$wnnna$aLong-Beaked Common Dolphins
=450  \\$wnnna$aSaddleback Dolphin
=450  \\$wnnna$aSaddleback Dolphins
=450  \\$wnnna$aShort-Beaked Common Dolphin
=450  \\$wnnna$aShort Beaked Common Dolphin
=450  \\$wnnna$aShort-Beaked Common Dolphins
=550  \\$wg$aDolphins
=680  \\$iThe genus Delphinus, in the family Delphinidae, consisting of two species of DOLPHINS. They are multicolored, with a characteristic yellow-tan criss-cross hourglass pattern behind the eyes.
=688  \\$a2006; use DOLPHINS 1998-2005
=750  \0$aDelphinus$0(DLC) sh 95002716$5IEN-M

=LDR  01410cz  a2200289n  4500
=001  9880363539502441
=005  20141212201222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004931
=035  \\$aCAZ8071HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x119.$x500.$x432
=150  \\$aEsophageal Achalasia
=450  \\$wnnna$aAchalasia
=450  \\$aAchalasia, Esophageal
=450  \\$wnnna$aAchalasias
=450  \\$wnnna$aAchalasias, Esophageal
=450  \\$aCardiospasm
=450  \\$wnnna$aCardiospasms
=450  \\$wnnna$aEsophageal Achalasias
=450  \\$aMegaesophagus
=550  \\$wg$aEsophageal Motility Disorders
=667  \\$aCARDIOSPASM refers to spasm of the CARDIA, not the heart; not for esophageal spasm ( = ESOPHAGEAL SPASM, DIFFUSE)
=680  \\$iA motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
=688  \\$a1985; for ACHALASIA OF ESOPHAGUS use CARDIOSPASM 1974-1984; for ACHALASIA use CARDIOSPASM 1963-1973; CARDIOSPASM was heading 1963-1984
=688  \\$a85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84
=750  \0$aCardiospasm$5IEN$0(DLC)sh 85020220

=LDR  01227nz  a2200361n  4500
=001  9882549679402441
=005  20250214143839.0
=008  990101\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004930
=035  \\$a(DNLM)D004930
=035  \\$a(NLM)98195929280000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x968.$x500.$x600.$x375.$x500
=072  \\$aM1.$x686.$x477.$x250.$x600.$x375.$x500
=150  \\$aInuit
=450  \\$aAleuts
=450  \\$aEskimos
=450  \\$aInuits
=450  \\$aInuk
=450  \\$aInupiats
=450  \\$aKalaallits
=450  \\$wnnna$aAleut
=450  \\$wnnna$aEskimo
=450  \\$wnnna$aInupiat
=450  \\$wnnna$aKalaallit
=550  \\$aAlaska Natives
=667  \\$aspecify geographic location if pertinent
=680  \\$iAn ethnic group inhabiting primarily arctic areas.
=680  \\$iInuktitut-speakers generally associated with the northern polar region.
=680  \\$iAn Inuit ethnic group geographically associated with GREENLAND; (KALAALLIT NUNAAT).
=680  \\$iMembers of the INUIT ethnic group geographically associated with northern ALASKA.
=688  \\$a2023; use ESKIMOS 1965-2003, INUITS 2004-2022
=750  \0$aInuit$5IEN$0(DLC)sh 93001720

=LDR  00948cz  a2200265n  4500
=001  9880363539702441
=005  20141212201220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004927
=035  \\$aCAZ8067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x330
=150  \\$aEscherichia coli Infections
=450  \\$wnnna$aE coli Infection
=450  \\$wnnna$aE coli Infections
=450  \\$wnnna$aEscherichia coli Infection
=450  \\$wnnna$aInfection, E coli
=450  \\$wnnna$aInfection, Escherichia coli
=450  \\$wnnna$aInfections, E coli
=450  \\$wnnna$aInfections, Escherichia coli
=550  \\$wg$aEnterobacteriaceae Infections
=550  \\$wh$aMeningitis, Escherichia coli
=667  \\$acoordinate IM with specific strain (IM) if pertinent; DF: E COLI INFECT
=680  \\$iInfections with bacteria of the species ESCHERICHIA COLI.
=750  \0$aEscherichia coli infections$5IEN$0(DLC)sh 85044800

=LDR  01915cz  a2200373n  4500
=001  9880363539802441
=005  20180702114311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004926
=035  \\$aCAZ8066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x325.$x300
=072  \\$aB3.$x660.$x250.$x150.$x180.$x100
=150  \\$aEscherichia coli
=450  \\$aAlkalescens-Dispar Group
=450  \\$wnnna$aDiffusely Adherent E. coli
=450  \\$aDiffusely Adherent Escherichia coli
=450  \\$aE coli
=450  \\$aEAggEC
=450  \\$wnnna$aEnteroaggregative E. coli
=450  \\$aEnteroaggregative Escherichia coli
=450  \\$wnnna$aEnteroinvasive E. coli
=450  \\$wnnna$aEnteroinvasive Escherichia coli
=550  \\$wg$aEscherichia
=550  \\$wh$aEnteropathogenic Escherichia coli
=550  \\$wh$aEnterotoxigenic Escherichia coli
=550  \\$wh$aEscherichia coli K12
=550  \\$wh$aExtraintestinal Pathogenic Escherichia coli
=550  \\$wh$aShiga-Toxigenic Escherichia coli
=550  \\$aEscherichia coli Proteins
=667  \\$anot for "coliform bacillus" ( = COLIFORM BACILLI see ENTEROBACTERIACEAE); note specific strains; infection = ESCHERICHIA COLI INFECTIONS
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
=688  \\$aALKALESCENS-DISPAR GROUP was heading 1975-96 (see under ESCHERICHIA 1975-90); was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1963-73 (Prov 1963-67)
=750  \0$aEscherichia coli$5IEN$0(DLC)sh 85044799

=LDR  00774cz  a2200193n  4500
=001  9880363539902441
=005  20141212201220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004925
=035  \\$aCAZ8065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x325
=072  \\$aB3.$x660.$x250.$x150.$x180
=150  \\$aEscherichia
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aEscherichia coli
=667  \\$ainfection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.
=750  \0$aEscherichia$5IEN$0(DLC)sh 85044798

=LDR  01094cz  a2200325n  4500
=001  9880363540002441
=005  20181121123640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004924
=035  \\$aCAZ8064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x780.$x688
=072  \\$aF1.$x145.$x367
=072  \\$aF1.$x875.$x439.500.$x688
=072  \\$aG7.$x568.$x500.$x590.688
=072  \\$aG11.$x427.$x410.$x568.$x850.$x688
=150  \\$aEscape Reaction
=450  \\$wnnna$aEscape Reactions
=450  \\$aFlight Reaction
=450  \\$wnnna$aFlight Reactions
=450  \\$wnnna$aReaction, Escape
=450  \\$wnnna$aReaction, Flight
=450  \\$wnnna$aReactions, Escape
=450  \\$wnnna$aReactions, Flight
=550  \\$wg$aBehavior
=550  \\$wg$aTaxis Response
=667  \\$ahuman & animal
=680  \\$iInnate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy.
=688  \\$a68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78
=750  \0$aStartle reaction$5IEN$0(DLC)sh 85127470

=LDR  01060cz  a2200265n  4500
=001  9880363540102441
=005  20170103104451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004921
=035  \\$aCAZ8061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x150
=072  \\$aD12.$x776.$x395.$x240.$x150
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x150
=072  \\$aD23.$x529.$x374.$x410.$x240.$x150
=150  \\$aErythropoietin
=450  \\$aEpoetin$5IEN-M
=450  \\$wnnna$aEpoetins$5IEN-M
=450  \\$wnnoa$aErythropoietin, Recombinant$5IEN-M
=550  \\$wg$aColony-Stimulating Factors
=550  \\$wh$aDarbepoetin alfa
=550  \\$wh$aEpoetin Alfa
=680  \\$iGlycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20120905: 150:##:_{dollar}a Epoetin
=750  \0$aErythropoietin$0(DLC) sh 85044756$5IEN

=LDR  00864cz  a2200169n  4500
=001  9880363540202441
=005  20141212201219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004920
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x825.$x414
=072  \\$aG9.$x188.$x124.$x544.$x414
=150  \\$aErythropoiesis
=450  \\$wnnna$aErythropoieses
=550  \\$wg$aHematopoiesis
=680  \\$iThe production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.
=750  \0$aErythropoiesis$5IEN$0(DLC)sh 85044755

=LDR  01449cz  a2200385n  4500
=001  9880363540302441
=005  20141212201218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004917
=035  \\$aCAZ8057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x250
=150  \\$aErythromycin
=450  \\$wnnna$aC, Erythromycin
=450  \\$wnnna$aErycette
=450  \\$wnnna$aErymax
=450  \\$wnnna$aErythromycin A
=450  \\$wnnna$aErythromycin C
=450  \\$wnnna$aErythromycin Lactate
=450  \\$wnnna$aErythromycin Phosphate
=450  \\$wnnna$aIlotycin
=450  \\$wnnna$aLactate, Erythromycin
=450  \\$wnnna$aPhosphate, Erythromycin
=450  \\$wnnna$aT-Stat
=450  \\$wnnna$aT Stat
=450  \\$wnnna$aTStat
=550  \\$wg$aMacrolides
=550  \\$wh$aAzithromycin
=550  \\$wh$aClarithromycin
=550  \\$wh$aErythromycin Estolate
=550  \\$wh$aErythromycin Ethylsuccinate
=550  \\$wh$aKetolides
=550  \\$wh$aRoxithromycin
=680  \\$iA bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
=750  \0$aErythromycin$5IEN$0(DLC)sh 85044753

=LDR  01408cz  a2200325n  4500
=001  9880363540402441
=005  20141212201217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004916
=035  \\$aCAZ8056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x617.$x500
=150  \\$aErythromelalgia
=450  \\$aErythermalgia
=450  \\$wnnna$aErythermalgia, Primary
=450  \\$wnnna$aErythermalgias
=450  \\$wnnna$aErythermalgias, Primary
=450  \\$wnnna$aErythromelalgia, Familial
=450  \\$wnnna$aErythromelalgia, Primary
=450  \\$wnnna$aErythromelalgias
=450  \\$wnnna$aFamilial Erythromelalgia
=450  \\$wnnna$aPrimary Erythermalgia
=450  \\$wnnna$aPrimary Erythermalgias
=450  \\$wnnna$aPrimary Erythromelalgia
=450  \\$wnnna$aSmall Fiber Neuropathy
=450  \\$wnnna$aSmall Nerve Fiber Neuropathy
=550  \\$wg$aPeripheral Vascular Diseases
=550  \\$aNAV1.7 Voltage-Gated Sodium Channel
=680  \\$iA peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.
=750  \0$aErythromelalgia$5IEN$0(DLC)sh 85044752

=LDR  01109cz  a2200289n  4500
=001  9880363540502441
=005  20141212201216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004913
=035  \\$aCAZ8054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x290.$x330
=072  \\$aA11.$x443.$x240.$x330
=072  \\$aA15.$x145.$x229.$x334.$x330
=150  \\$aErythrocytes, Abnormal
=450  \\$wnnna$aAbnormal Erythrocyte
=450  \\$wnnna$aAbnormal Erythrocytes
=450  \\$wnnna$aErythrocyte, Abnormal
=450  \\$aErythrocytes$xabnormalities
=550  \\$wg$aErythrocytes
=550  \\$wh$aAcanthocytes
=550  \\$wh$aErythrocyte Inclusions
=550  \\$wh$aMegaloblasts
=550  \\$wh$aSpherocytes
=667  \\$a= abnorm of size & shape; do not equate with ERYTHROCYTES /pathol; do not confuse with ERYTHROCYTE DEFORMABILITY which is the "ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature"; A 11 qualif; coord with disease /blood, not /compl
=688  \\$a68
=750  \0$aErythrocyte disorders$5IEN$0(DLC)sh 85044746

=LDR  01489cz  a2200385n  4500
=001  9880363540602441
=005  20141212201216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004912
=035  \\$aCAZ8053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x290
=072  \\$aA11.$x443.$x240
=072  \\$aA15.$x145.$x229.$x334
=150  \\$aErythrocytes
=450  \\$wnnna$aBlood Cell, Red
=450  \\$aBlood Cells, Red
=450  \\$wnnna$aBlood Corpuscle, Red
=450  \\$aBlood Corpuscles, Red
=450  \\$wnnna$aCorpuscle, Red Blood
=450  \\$wnnna$aCorpuscles, Red Blood
=450  \\$wnnna$aErythrocyte
=450  \\$wnnna$aRed Blood Cell
=450  \\$aRed Blood Cells
=450  \\$wnnna$aRed Blood Corpuscle
=450  \\$wnnna$aRed Blood Corpuscles
=550  \\$wg$aBlood Cells
=550  \\$wg$aErythroid Cells
=550  \\$wh$aErythrocyte Membrane
=550  \\$wh$aErythrocytes, Abnormal
=550  \\$wh$aErythroid Precursor Cells
=550  \\$wh$aReticulocytes
=667  \\$avertebrates only; for invertebrates index under HEMOCYTES; /cytol: consider also ERYTHROCYTE INDICES; do not equate /pathol with ERYTHROCYTES, ABNORMAL; erythrocyte antibodies: index BLOOD GROUP ANTIGENS /immunol + ISOANTIBODIES & do not index under ERYTHROCYTES
=680  \\$iRed blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.
=750  \0$aErythrocytes$5IEN$0(DLC)sh 85044747

=LDR  01319cz  a2200385n  4500
=001  9880363540702441
=005  20141212201215.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004910
=035  \\$aCAZ8051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x290.$x270
=072  \\$aA11.$x284.$x149.$x356
=072  \\$aA15.$x145.$x229.$x334.$x270
=150  \\$aErythrocyte Membrane
=450  \\$wnnna$aCytoskeleton, Erythrocyte
=450  \\$wnnna$aCytoskeletons, Erythrocyte
=450  \\$wnnna$aErythrocyte Cytoskeleton
=450  \\$wnnna$aErythrocyte Cytoskeletons
=450  \\$aErythrocyte Ghost
=450  \\$wnnna$aErythrocyte Ghosts
=450  \\$wnnna$aErythrocyte Membranes
=450  \\$wnnna$aGhost, Erythrocyte
=450  \\$wnnna$aGhost, Red Cell
=450  \\$wnnna$aGhosts, Erythrocyte
=450  \\$wnnna$aGhosts, Red Cell
=450  \\$wnnna$aMembrane, Erythrocyte
=450  \\$wnnna$aMembranes, Erythrocyte
=450  \\$aRed Cell Ghost
=450  \\$wnnna$aRed Cell Ghosts
=550  \\$wg$aCell Membrane
=550  \\$wg$aErythrocytes
=680  \\$iThe semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS.
=688  \\$a84(77); was see under ERYTHROCYTES 1977-83
=750  \0$aErythrocyte membranes$5IEN$0(DLC)sh 89006625

=LDR  00901cz  a2200229n  4500
=001  9880363540802441
=005  20141212201214.0
=008  840530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004907
=035  \\$aCAZ8048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x370.$x249
=150  \\$aErythrocyte Deformability
=450  \\$wnnna$aDeformability, Erythrocyte
=450  \\$aErythrocyte Filterability
=450  \\$wnnna$aFilterability, Erythrocyte
=550  \\$wg$aHemorheology
=550  \\$aHemorheology
=667  \\$anote category: do not confuse with ERYTHROCYTES, ABNORMAL: deformability is a normal desirable characteristic of erythrocytes; coord with disease /blood, not /physiopathol
=680  \\$iAbility of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature.
=688  \\$a85
=750  \0$aErythrocytes$xDeformability$5IEN$0(DLC)sh 85044749

=LDR  00968cz  a2200241n  4500
=001  9880363540902441
=005  20170609114603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004905
=035  \\$aCAZ8046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x43.$x260
=072  \\$aG9.$x188.$x230
=150  \\$aErythrocyte Aging
=450  \\$wnnna$aAging, Erythrocyte
=450  \\$aErythrocyte Survival
=450  \\$wnnna$aSurvival, Erythrocyte
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aCell Aging
=667  \\$acoord with disease /blood, not /physiopathol
=680  \\$iThe senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
=688  \\$a67(65)
=750  \0$aErythrocytes$xAging$5IEN$0(DLC)sh 85044748

=LDR  01817cz  a2200433n  4500
=001  9880363541002441
=005  20141212192156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004899
=035  \\$aCAZ8040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277.$x60
=072  \\$aC15.$x378.$x295
=072  \\$aC16.$x300.$x60
=072  \\$aC16.$x614.$x304
=072  \\$aC20.$x306
=150  \\$aErythroblastosis, Fetal
=450  \\$wnnna$aErythroblastoses, Fetal
=450  \\$wnnna$aErythroblastosis Fetali
=450  \\$wnnna$aErythroblastosis Fetalis
=450  \\$wnnna$aFetal Erythroblastoses
=450  \\$wnnna$aFetal Erythroblastosis
=450  \\$wnnna$aFetali, Erythroblastosis
=450  \\$wnnna$aFetalis, Erythroblastosis
=450  \\$aHemolytic Disease of Newborn
=450  \\$wnnna$aNewborn Hemolytic Disease
=450  \\$wnnna$aNewborn Hemolytic Diseases
=550  \\$wg$aFetal Diseases
=550  \\$wg$aHematologic Diseases
=550  \\$wg$aImmune System Diseases
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wh$aHydrops Fetalis
=550  \\$wh$aKernicterus
=550  \\$aJaundice, Neonatal
=550  \\$aRh-Hr Blood-Group System
=550  \\$aRh Isoimmunization
=667  \\$aerythroblastosis, non-fetal may be ERYTHREMIC MYELOSIS but be careful; do not confuse with VITAMIN K DEFICIENCY BLEEDING
=680  \\$iA condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.
=750  \0$aErythroblastosis fetalis$5IEN$0(DLC)sh 85044745

=LDR  01103cz  a2200241n  4500
=001  9880363541102441
=005  20141212201211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004895
=035  \\$aCAZ8036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x200
=150  \\$aErythrina
=450  \\$wnnna$acristagalli, Erythrina
=450  \\$wnnna$acristagallus, Erythrina
=450  \\$wnnna$aErythrina cristagalli
=450  \\$wnnna$aErythrina cristagallus
=450  \\$wnnna$aErythrinas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of leguminous shrubs or trees, mainly tropical, yielding certain alkaloids, lectins, and other useful compounds.
=688  \\$a91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
=750  \0$aErythrina$5IEN$0(DLC)sh 85044742

=LDR  00759cz  a2200193n  4500
=001  9880363541202441
=005  20141212201210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004892
=035  \\$aCAZ8033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x229.$x400
=072  \\$aC17.$x800.$x865.$x475
=150  \\$aErythema Multiforme
=550  \\$wg$aErythema
=550  \\$wg$aSkin Diseases, Vesiculobullous
=550  \\$wh$aStevens-Johnson Syndrome
=680  \\$iA skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic "bull's-eye" lesions usually occurring on the dorsal aspect of the hands and forearms.
=750  \0$aErythema multiforme$5IEN$0(DLC)sh 85044741

=LDR  01051cz  a2200265n  4500
=001  9880363541302441
=005  20141212201209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004890
=035  \\$aCAZ8031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x229
=150  \\$aErythema
=450  \\$wnnna$aErythemas
=550  \\$wg$aSkin Diseases
=550  \\$wh$aErythema Chronicum Migrans
=550  \\$wh$aErythema Induratum
=550  \\$wh$aErythema Infectiosum
=550  \\$wh$aErythema Multiforme
=550  \\$wh$aErythema Nodosum
=550  \\$wh$aErythrokeratodermia Variabilis
=550  \\$wh$aSweet Syndrome
=667  \\$aGEN or unspecified; prefer specifics; redness of the skin from various causes: do not confuse with ERYTHRODERMA see DERMATITIS, EXFOLIATIVE & do not make diagnoses: use the word of the text; prickly heat: index under MILIARIA
=680  \\$iRedness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.
=750  \0$aErythema$5IEN$0(DLC)sh 85044740

=LDR  00874cz  a2200205n  4500
=001  9880363541402441
=005  20170317161932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004888
=035  \\$aCAZ8029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x353.$x668
=072  \\$aB3.$x510.$x460.$x400.$x410.$x350
=150  \\$aErysipelothrix
=450  \\$aErysipelothrix rhusiopathiae
=550  \\$wg$aFirmicutes
=550  \\$wg$aGram-Positive Asporogenous Rods, Regular
=667  \\$ainfection = ERYSIPELOTHRIX INFECTIONS
=680  \\$iA genus of gram-positive, facultatively anaerobic, rod-shaped bacteria that has a tendency to form long filaments. Its organisms are widely distributed in nature and are found in MAMMALS; BIRDS; and FISHES. Erysipelothrix may appear gram-negative because they decolorize easily.
=750  \0$aErysipelothrix$5IEN$0(DLC)sh 88023256

=LDR  01019cz  a2200217n  4500
=001  9880363541502441
=005  20141212201208.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004886
=035  \\$aCAZ8027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890.$x328
=072  \\$aC1.$x252.$x825.$x260
=072  \\$aC1.$x539.$x800.$x720.$x260
=072  \\$aC17.$x800.$x838.$x765.$x260
=150  \\$aErysipelas
=550  \\$wg$aSkin Diseases, Bacterial
=550  \\$wg$aStreptococcal Infections
=667  \\$aStrep skin dis; do not confuse with ERYSIPELOID, caused by Erysipelothrix; do not confuse with SWINE ERYSIPELAS, also an Erysipelothrix infection
=680  \\$iAn acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
=750  \0$aErysipelas$5IEN$0(DLC)sh 85044737

=LDR  00766cz  a2200193n  4500
=001  9880363541602441
=005  20141212201207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004885
=035  \\$aCAZ8026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x300
=072  \\$aB3.$x660.$x250.$x150.$x175
=150  \\$aErwinia
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aErwinia amylovora
=667  \\$ain plants; rarely infects humans but if so, coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.
=750  \0$aErwinia$5IEN$0(DLC)sh 88023252

=LDR  00559cz  a2200193n  4500
=001  9880363541702441
=005  20141212201207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004884
=035  \\$aCAZ8025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x297
=150  \\$aEructation
=450  \\$aBelching
=450  \\$wnnna$aBelchings
=450  \\$wnnna$aEructations
=550  \\$wg$aSigns and Symptoms, Digestive
=680  \\$iThe ejection of gas or air through the mouth from the stomach.
=750  \0$aBelching$5IEN-M$0(DLC)sh 96008472

=LDR  00641cz  a2200193n  4500
=001  9880363541802441
=005  20141212201207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004882
=035  \\$aCAZ8023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x362
=150  \\$aErotica
=450  \\$wnnna$aEroticism
=450  \\$aPornography
=550  \\$wg$aCommunications Media
=667  \\$aonly /hist /legis /psychol
=680  \\$iLiterary or artistic items having an erotic theme. It refers especially to books treating sexual love in a sensuous or voluptuous manner. (Webster, 3d ed)
=750  \0$aErotica$5IEN$0(DLC)sh 85044718

=LDR  01211cz  a2200373n  4500
=001  9880363541902441
=005  20141212201207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x327
=072  \\$aC25.$x723.$x680.$x262
=072  \\$aC25.$x723.$x756.$x262
=150  \\$aErgotism
=450  \\$aErgot Alkaloids$xpoisoning
=450  \\$aErgot Poisoning
=450  \\$wnnna$aErgot Poisonings
=450  \\$wnnna$aErgotisms
=450  \\$wnnna$aFire, St. Anthonys
=450  \\$wnnna$aPoisoning, Ergot
=450  \\$wnnna$aPoisonings, Ergot
=450  \\$wnnna$aSaint Anthony Fire
=450  \\$wnnna$aSaint Anthony's Fire
=450  \\$aSaint Anthonys Fire
=450  \\$wnnna$aSt. Anthony Fire
=450  \\$wnnna$aSt. Anthony's Fire
=450  \\$aSt. Anthonys Fire
=550  \\$wg$aMycotoxicosis
=550  \\$wg$aPlant Poisoning
=550  \\$wg$aPoisoning
=550  \\$aMycotoxins
=667  \\$apois from eating ergot-tainted grain or ergot admin as ther agent
=680  \\$iPoisoning caused by ingesting ergotized grain or by the misdirected or excessive use of ergot as a medicine.
=750  \0$aErgotism$5IEN$0(DLC)sh 85044604

=LDR  01847cz  a2200409n  4500
=001  9880363542002441
=005  20141212201205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004877
=035  \\$aCAZ8018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327.$x412.$x250.$x500
=072  \\$aD3.$x549.$x562.$x400.$x500
=150  \\$aErgoloid Mesylates
=450  \\$wnnna$aCircanol
=450  \\$wnnna$aCo-Dergine Mesylate
=450  \\$wnnna$aCo Dergine Mesylate
=450  \\$wnnna$aCo-Dergocrine Mesilate
=450  \\$wnnna$aCo Dergocrine Mesilate
=450  \\$aCo-Dergocrine Mesylate
=450  \\$wnnna$aCo Dergocrine Mesylate
=450  \\$aDihydroergotoxine Mesylate
=450  \\$wnnna$aDihydroergotoxine Methanesulfonate
=450  \\$wnnna$aDihydroergotoxine Monomethanesulfonate
=450  \\$wnnna$aErgodesit
=450  \\$wnnna$aErgoloid Mesylate
=450  \\$wnnna$aErgotoxin, Dihydro-, Monomethasulfonate
=450  \\$wnnna$aHydergine
=450  \\$wnnna$aMethanesulfonate, Dihydroergotoxine
=450  \\$wnnna$aMonomethanesulfonate, Dihydroergotoxine
=450  \\$wnnna$aRedergam
=450  \\$wnnna$aRedergin
=450  \\$wnnna$aRedergine
=550  \\$wg$aDihydroergotoxine
=680  \\$iA mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.
=688  \\$a92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76
=750  \0$aErgoloid mesylates$5IEN-M$0(DLC)sh 88003112

=LDR  00830cz  a2200217n  4500
=001  9880363542102441
=005  20141212201205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004876
=035  \\$aCAZ8017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327
=150  \\$aErgot Alkaloids
=450  \\$wnnna$aAlkaloids, Clavine
=450  \\$wnnna$aAlkaloids, Ergot
=450  \\$wnnna$aClavine Alkaloids
=550  \\$wg$aAlkaloids
=550  \\$wh$aErgolines
=550  \\$wh$aErgotamines
=680  \\$iAlkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.
=750  \0$aErgot alkaloids$0(DLC) sh 89004729$5IEN-M

=LDR  00999cz  a2200265n  4500
=001  9880363542202441
=005  20141212201204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004875
=035  \\$aCAZ8016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x222.$x537
=072  \\$aD4.$x808.$x247.$x808.$x756.$x287
=150  \\$aErgosterol
=450  \\$wnnna$aD2, Pro-Vitamin
=450  \\$wnnna$aLumisterol
=450  \\$wnnna$aPro-Vitamin D2
=450  \\$wnnna$aPro Vitamin D2
=450  \\$wnnna$aProvitamin D 2
=550  \\$wg$aCholestenes
=550  \\$wg$aPhytosterols
=550  \\$wh$aWithanolides
=680  \\$iA steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS break a bond to result in ERGOCALCIFEROL.
=688  \\$a74(72); was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66
=750  \0$aErgosterol$5IEN$0(DLC)sh 85044602

=LDR  00781cz  a2200193n  4500
=001  9880363542302441
=005  20141212201203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004871
=035  \\$aCAZ8012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x437
=072  \\$aD1.$x268.$x558.$x362.$x437
=072  \\$aD1.$x552.$x550.$x399.$x437
=150  \\$aErbium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Er-166; Er-162, 164, 167, 168, 170 = ERBIUM (IM) + ISOTOPES (NIM); Er-158-161, 163, 165, 169, 171, 172 = ERBIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iErbium. An element of the rare earth family of metals. It has the atomic symbol Er, atomic number 68, and atomic weight 167.26.
=750  \0$aErbium$5IEN$0(DLC)sh 85044573

=LDR  01369cz  a2200409n  4500
=001  9880363542402441
=005  20141212201201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004865
=035  \\$aCAZ8006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325
=150  \\$aEquipment and Supplies, Hospital
=450  \\$wnnna$aEquipment, Hospital
=450  \\$wnnna$aHospital Equipment
=450  \\$aHospital Equipment and Supplies
=450  \\$wnnna$aHospital Supplies
=450  \\$wnnna$aHospital Supply
=450  \\$aHospitals$xinstrumentation
=450  \\$wnnna$aSupplies, Hospital
=450  \\$wnnna$aSupply, Hospital
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aAbsorbent Pads
=550  \\$wh$aBedding and Linens
=550  \\$wh$aBeds
=550  \\$wh$aExamination Tables
=550  \\$wh$aHospitals, Packaged
=550  \\$wh$aIncubators, Infant
=550  \\$wh$aOperating Tables
=550  \\$wh$aPatient Isolators
=550  \\$wh$aSurgical Attire
=550  \\$aHospitals
=550  \\$aPurchasing, Hospital
=667  \\$acovers wide range from furnaces to surgical dressings; DF: EQUIPMENT HOSP
=680  \\$iAny materials used in providing care specifically in the hospital.
=688  \\$a78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77
=750  \0$aHospitals$xFurniture, equipment, etc.$5IEN$0(DLC)sh 85062331

=LDR  03362cz  a2201009n  4500
=001  9880363542502441
=005  20180306113840.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004864
=035  \\$aCAZ8005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7
=150  \\$aEquipment and Supplies
=450  \\$aApparatus and Instruments
=450  \\$wnnna$aDevice
=450  \\$wnnna$aDevice, Medical
=450  \\$aDevices
=450  \\$wnnna$aDevices, Medical
=450  \\$wnnna$aEquipment
=450  \\$wnnna$aInstruments and Apparatus
=450  \\$wnnna$aInventories
=450  \\$wnnna$aInventory
=450  \\$wnnna$aMedical Device
=450  \\$aMedical Devices
=450  \\$wnnna$aSupplies
=450  \\$wnnna$aSupplies and Equipment
=550  \\$wh$aAir Filters
=550  \\$wh$aAtmosphere Exposure Chambers
=550  \\$wh$aBandages
=550  \\$wh$aBathroom Equipment
=550  \\$wh$aBioreactors
=550  \\$wh$aCapillary Tubing
=550  \\$wh$aCatheters
=550  \\$wh$aCompressed Air
=550  \\$wh$aContraceptive Devices
=550  \\$wh$aCulture Media
=550  \\$wh$aDental Equipment
=550  \\$wh$aDiagnostic Equipment
=550  \\$wh$aDiffusion Chambers, Culture
=550  \\$wh$aDisposable Equipment
=550  \\$wh$aDurable Medical Equipment
=550  \\$wh$aElectrical Equipment and Supplies
=550  \\$wh$aEmergency Medical Tags
=550  \\$wh$aEquipment and Supplies, Hospital
=550  \\$wh$aExoskeleton Device
=550  \\$wh$aFeminine Hygiene Products
=550  \\$wh$aGamma Cameras
=550  \\$wh$aGas Scavengers
=550  \\$wh$aGastric Balloon
=550  \\$wh$aGravity Suits
=550  \\$wh$aHumidifiers
=550  \\$wh$aIncubators
=550  \\$wh$aInfant Equipment
=550  \\$wh$aInfusion Pumps
=550  \\$wh$aIntermittent Pneumatic Compression Devices
=550  \\$wh$aMedicine Chests
=550  \\$wh$aMicrobubbles
=550  \\$wh$aMicropore Filters
=550  \\$wh$aMicrospheres
=550  \\$wh$aNanospheres
=550  \\$wh$aNebulizers and Vaporizers
=550  \\$wh$aNeedles
=550  \\$wh$aOptical Devices
=550  \\$wh$aOxygenators
=550  \\$wh$aPhantoms, Imaging
=550  \\$wh$aProstheses and Implants
=550  \\$wh$aProtective Devices
=550  \\$wh$aQuantum Dots
=550  \\$wh$aRadiation Equipment and Supplies
=550  \\$wh$aRadio Frequency Identification Device
=550  \\$wh$aReagent Kits, Diagnostic
=550  \\$wh$aSelf-Help Devices
=550  \\$wh$aSensory Aids
=550  \\$wh$aSurgical Equipment
=550  \\$wh$aSurgically-Created Structures
=550  \\$wh$aSyringes
=550  \\$wh$aThermometers
=550  \\$wh$aTomography Scanners, X-Ray Computed
=550  \\$wh$aTourniquets
=550  \\$wh$aTransdermal Patch
=550  \\$wh$aVentilators, Mechanical
=550  \\$wh$aX-Ray Film
=550  \\$wh$aX-Ray Intensifying Screens
=667  \\$aGEN only: prefer /instrum: Manual 19.7+, 19.8.40; when GEN & IM, Manual 26.24+; DF: EQUIPMENT
=680  \\$iExpendable and nonexpendable equipment, supplies, apparatus, and instruments that are used in diagnostic, surgical, therapeutic, scientific, and experimental procedures.
=750  \0$aMedical instruments and apparatus$0(DLC) sh 85082949$5IEN-M
=750  \0$aEquipment and supplies$0(DLC) sh 87002492$5IEN

=LDR  01311cz  a2200337n  4500
=001  9880363542602441
=005  20141212201158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004859
=035  \\$aCAZ8000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x300
=072  \\$aC2.$x839.$x375
=072  \\$aC22.$x488.$x304
=150  \\$aEquine Infectious Anemia
=450  \\$wnnna$aAnemia, Equine Infectious
=450  \\$wnnna$aAnemias, Equine Infectious
=450  \\$wnnna$aEquine Infectious Anemias
=450  \\$wnnna$aFever, Swamp
=450  \\$wnnna$aFevers, Swamp
=450  \\$wnnna$aInfectious Anemia, Equine
=450  \\$wnnna$aInfectious Anemias, Equine
=450  \\$aSwamp Fever
=450  \\$wnnna$aSwamp Fevers
=550  \\$wg$aHorse Diseases
=550  \\$wg$aLentivirus Infections
=550  \\$wg$aSlow Virus Diseases
=667  \\$acaused by a lentivirus; don't forget also HORSES (NIM) & check tag ANIMALS; DF: note short X ref
=680  \\$iViral disease of horses caused by the equine infectious anemia virus (EIAV; INFECTIOUS ANEMIA VIRUS, EQUINE). It is characterized by intermittent fever, weakness, and anemia. Chronic infection consists of acute episodes with remissions.
=688  \\$a70
=750  \0$aEquine infectious anemia$5IEN$0(DLC)sh 85044544

=LDR  01241cz  a2200301n  4500
=001  9880363542702441
=005  20141212201157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004856
=035  \\$aCAZ7997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x690
=072  \\$aG11.$x561.$x600.$x810.$x541.$x595
=150  \\$aPostural Balance
=450  \\$wnnna$aBalance, Postural
=450  \\$wnnoa$aEquilibrium$5IEN-HS
=450  \\$wnnna$aEquilibrium, Musculoskeletal
=450  \\$wnnna$aEquilibrium, Postural
=450  \\$wnnna$aMusculoskeletal Equilibrium
=450  \\$wnnna$aPostural Equilibrium
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wg$aProprioception
=667  \\$adisorders of equilibrium: coordinate IM with SENSATION DISORDERS (IM)
=680  \\$iA POSTURE in which an ideal body mass distribution is achieved. Postural balance provides the body carriage stability and conditions for normal functions in stationary position or in movement, such as sitting, standing, or walking.
=688  \\$a2009(1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Musculoskeletal Equilibrium
=688  \\$a2004(1966)
=750  \0$aEquilibrium (Physiology)$5IEN$0(DLC)sh 85044539

=LDR  01825cz  a2200445n  4500
=001  9880363542802441
=005  20141212201157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004854
=035  \\$aCAZ7995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x400.$x500.$x450
=072  \\$aB4.$x909.$x204.$x210.$x400.$x500.$x400
=072  \\$aB4.$x909.$x204.$x382.$x400.$x500.$x400
=072  \\$aB4.$x909.$x574.$x204.$x500.$x500.$x400
=150  \\$aHerpesvirus 4, Human
=450  \\$aBurkitt Herpesvirus
=450  \\$aBurkitt Lymphoma Virus
=450  \\$wnnna$aBurkitt's Lymphoma Virus
=450  \\$wnnna$aBurkitts Lymphoma Virus
=450  \\$aE-B Virus
=450  \\$wnnna$aE B Virus
=450  \\$wnnna$aE-B Viruses
=450  \\$aEBV
=450  \\$aEpstein-Barr Virus
=450  \\$wnnna$aEpstein Barr Virus
=450  \\$wnnna$aHerpesvirus 4 (gamma), Human
=450  \\$wnnna$aHerpesvirus, Burkitt
=450  \\$wnnna$aHHV-4
=450  \\$aHuman Herpesvirus 4
=450  \\$aInfectious Mononucleosis Virus
=450  \\$wnnna$aInfectious Mononucleosis Viruses
=450  \\$wnnna$aLymphoma Virus, Burkitt
=450  \\$wnnna$aMononucleosis Virus, Infectious
=450  \\$wnnna$aMononucleosis Viruses, Infectious
=550  \\$wg$aLymphocryptovirus
=667  \\$ainfection = EPSTEIN-BARR VIRUS INFECTIONS or its indentions
=680  \\$iThe type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.
=688  \\$a94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT'S LYMPHOMA VIRUS 1969-77 (Prov 1969-72)
=750  \0$aEpstein-Barr virus$5IEN$0(DLC)sh 85044491

=LDR  00742cz  a2200217n  4500
=001  9880363542902441
=005  20141212201156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004853
=035  \\$aCAZ7994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x822.$x461
=072  \\$aD25.$x720.$x716.$x822.$x461
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x461
=150  \\$aEpoxy Resins
=450  \\$wnnna$aResins, Epoxy
=550  \\$wg$aResins, Synthetic
=550  \\$wh$aSilorane Resins
=680  \\$iPolymeric resins derived from OXIRANES and characterized by strength and thermosetting properties. Epoxy resins are often used as dental materials.
=688  \\$a68(66)
=750  \0$aEpoxy resins$5IEN$0(DLC)sh 85044477

=LDR  00884cz  a2200265n  4500
=001  9880363543002441
=005  20141212201156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004852
=035  \\$aCAZ7993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x411
=150  \\$aEpoxy Compounds
=450  \\$wnnna$aCompounds, Epoxy
=450  \\$aEpoxides
=450  \\$wnnna$aOxiranes
=550  \\$wg$aEthers, Cyclic
=550  \\$wh$aEpichlorohydrin
=550  \\$wh$aEthoglucid
=550  \\$wh$aEthylene Oxide
=550  \\$wh$aMupirocin
=550  \\$wh$aTrichloroepoxypropane
=680  \\$iOrganic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS.
=688  \\$a91(75); was see under ETHERS, CYCLIC 1975-90
=750  \0$aEpoxy compounds$5IEN$0(DLC)sh 85044476

=LDR  00435cz  a2200169n  4500
=001  9880363543102441
=005  20141212201155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004850
=035  \\$aCAZ7991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x400.$x556.$x536
=150  \\$aEponyms
=450  \\$wnnna$aEponym
=550  \\$wg$aNames
=667  \\$aIM; no qualif
=750  \0$aEponyms$5IEN$0(DLC)sh 85044474

=LDR  00851cz  a2200277n  4500
=001  9880363543202441
=005  20141212201155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004848
=035  \\$aCAZ7989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x272
=150  \\$aEpithelium
=450  \\$aMesothelium
=550  \\$wg$aTissues
=550  \\$wh$aBasement Membrane
=550  \\$wh$aEndothelium
=550  \\$wh$aEpidermis
=550  \\$wh$aEpithelium, Corneal
=550  \\$wh$aPigment Epithelium of Eye
=550  \\$wh$aSeminiferous Epithelium
=550  \\$wh$aUrothelium
=550  \\$aCilia
=667  \\$ausually NIM with specific organ IM
=680  \\$iOne or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
=750  \0$aEpithelium$5IEN$0(DLC)sh 85044466

=LDR  04032cz  a2201057n  4500
=001  9880363543302441
=005  20180130111126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004847
=035  \\$aCAZ7988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436
=150  \\$aEpithelial Cells
=450  \\$wnnna$aAdenomatous Epithelial Cell
=450  \\$wnnna$aAdenomatous Epithelial Cells
=450  \\$wnnna$aCell, Adenomatous Epithelial
=450  \\$wnnna$aCell, Epithelial
=450  \\$wnnna$aCell, Glandular Epithelial
=450  \\$wnnna$aCell, Squamous
=450  \\$wnnna$aCell, Squamous Epithelial
=450  \\$wnnna$aCell, Transitional Epithelial
=450  \\$wnnna$aCells, Adenomatous Epithelial
=450  \\$wnnna$aCells, Epithelial
=450  \\$wnnna$aCells, Glandular Epithelial
=450  \\$wnnna$aCells, Squamous
=450  \\$wnnna$aCells, Squamous Epithelial
=450  \\$wnnna$aCells, Transitional Epithelial
=450  \\$wnnna$aColumnar Glandular Epithelial Cells
=450  \\$wnnna$aCuboidal Glandular Epithelial Cells
=450  \\$wnnna$aEpithelial Cell
=450  \\$wnnna$aEpithelial Cell, Adenomatous
=450  \\$wnnna$aEpithelial Cell, Glandular
=450  \\$wnnna$aEpithelial Cell, Squamous
=450  \\$wnnna$aEpithelial Cell, Transitional
=450  \\$wnnna$aEpithelial Cells, Adenomatous
=450  \\$wnnna$aEpithelial Cells, Glandular
=450  \\$wnnna$aEpithelial Cells, Squamous
=450  \\$wnnna$aEpithelial Cells, Transitional
=450  \\$aEpithelium$xcytology
=450  \\$wnnna$aGlandular Epithelial Cell
=450  \\$wnnna$aGlandular Epithelial Cells
=450  \\$wnnna$aSquamous Cell
=450  \\$wnnna$aSquamous Cells
=450  \\$wnnna$aSquamous Epithelial Cell
=450  \\$wnnna$aSquamous Epithelial Cells
=450  \\$wnnna$aTransitional Epithelial Cell
=450  \\$wnnna$aTransitional Epithelial Cells
=550  \\$wg$aCells
=550  \\$wh$aA549 Cells
=550  \\$wh$aAlveolar Epithelial Cells
=550  \\$wh$aAmeloblasts
=550  \\$wh$aAtypical Squamous Cells of the Cervix
=550  \\$wh$aCaco-2 Cells
=550  \\$wh$aChief Cells, Gastric
=550  \\$wh$aCHO Cells
=550  \\$wh$aChromatophores
=550  \\$wh$aCorticotrophs
=550  \\$wh$aDendritic Cells
=550  \\$wh$aEndothelial Cells
=550  \\$wh$aEnterocytes
=550  \\$wh$aEnteroendocrine Cells
=550  \\$wh$aGoblet Cells
=550  \\$wh$aGonadotrophs
=550  \\$wh$aGranulosa Cells
=550  \\$wh$aHEK293 Cells
=550  \\$wh$aHeLa Cells
=550  \\$wh$aHepatocytes
=550  \\$wh$aHT29 Cells
=550  \\$wh$aKeratinocytes
=550  \\$wh$aLabyrinth Supporting Cells
=550  \\$wh$aLactotrophs
=550  \\$wh$aLeydig Cells
=550  \\$wh$aLLC-PK1 Cells
=550  \\$wh$aLuteal Cells
=550  \\$wh$aMadin Darby Canine Kidney Cells
=550  \\$wh$aMelanocytes
=550  \\$wh$aMelanotrophs
=550  \\$wh$aMerkel Cells
=550  \\$wh$aNeuroepithelial Cells
=550  \\$wh$aPaneth Cells
=550  \\$wh$aParietal Cells, Gastric
=550  \\$wh$aPodocytes
=550  \\$wh$aSertoli Cells
=550  \\$wh$aSomatotrophs
=550  \\$wh$aThyroid Epithelial Cells
=550  \\$wh$aThyrotrophs
=550  \\$wh$aVero Cells
=667  \\$acoordinate with specific tissue type if pertinent; do not confuse with EPITHELIOID CELLS (type of macrophage)
=680  \\$iCells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
=688  \\$a98, 65-77; use explode 1978-97
=750  \0$aEpithelial cells$0(DLC) sh 85044464$5IEN

=LDR  00742cz  a2200277n  4500
=001  9880363543402441
=005  20141212201154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004844
=035  \\$aCAZ7985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x261
=072  \\$aC9.$x603.$x261
=072  \\$aC23.$x550.$x414.$x712
=150  \\$aEpistaxis
=450  \\$wnnna$aBleeding, Nasal
=450  \\$wnnna$aBleedings, Nasal
=450  \\$wnnna$aNasal Bleeding
=450  \\$wnnna$aNasal Bleedings
=450  \\$aNose Bleed
=450  \\$wnnna$aNose Bleeds
=450  \\$aNosebleed
=550  \\$wg$aHemorrhage
=550  \\$wg$aNose Diseases
=680  \\$iBleeding from the nose.
=750  \0$aNosebleed$5IEN$0(DLC)sh 85092762

=LDR  02181cz  a2200529n  4500
=001  9880363543502441
=005  20141212201153.0
=008  780127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x207
=150  \\$aEpistasis, Genetic
=450  \\$aDeviation, Epistatic
=450  \\$wnnna$aEpistases, Genetic
=450  \\$aEpistatic Deviation
=450  \\$wnnna$aEpistatic Gene
=450  \\$wnnna$aEpistatic Gene-Gene Interaction
=450  \\$wnnna$aEpistatic Gene-Gene Interactions
=450  \\$wnnna$aEpistatic Genes
=450  \\$wnnna$aGene, Epistatic
=450  \\$wnnna$aGene-Gene Interaction, Epistatic
=450  \\$wnnna$aGene Gene Interaction, Epistatic
=450  \\$wnnna$aGene-Gene Interactions, Epistatic
=450  \\$wnnna$aGene Gene Interactions, Epistatic
=450  \\$wnnna$aGene, Hypostatic
=450  \\$wnnna$aGene Interaction, Non-Allelic
=450  \\$wnnna$aGene Interactions, Non-Allelic
=450  \\$aGenes, Epistatic
=450  \\$aGenes, Hypostatic
=450  \\$wnnna$aGenetic Epistases
=450  \\$wnnna$aGenetic Epistasis
=450  \\$wnnna$aHypostatic Gene
=450  \\$wnnna$aHypostatic Genes
=450  \\$wnnna$aInteraction Deviation
=450  \\$wnnna$aInteraction, Epistatic Gene-Gene
=450  \\$wnnna$aInteraction, Non-Allelic Gene
=450  \\$wnnna$aInteractions, Epistatic Gene-Gene
=450  \\$wnnna$aInteractions, Non-Allelic Gene
=450  \\$wnnna$aNon-Allelic Gene Interaction
=450  \\$wnnna$aNon-Allelic Gene Interactions
=450  \\$wnnna$aNon Allelic Gene Interactions
=550  \\$wg$aGene Expression Regulation
=550  \\$aGenes, Modifier
=550  \\$aMultifactorial Inheritance
=680  \\$iA form of gene interaction whereby the expression of one gene interferes with or masks the expression of a different gene or genes. Genes whose expression interferes with or masks the effects of other genes are said to be epistatic to the effected genes. Genes whose expression is affected (blocked or masked) are hypostatic to the interfering genes.
=688  \\$a79
=750  \0$aEpistasis (Genetics)$5IEN-M$0(DLC)sh 99011759

=LDR  00994cz  a2200229n  4500
=001  9880363543602441
=005  20141212201153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004842
=035  \\$aCAZ7983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x374
=072  \\$aC12.$x777.$x767.$x374
=072  \\$aC13.$x351.$x875.$x374
=072  \\$aC13.$x351.$x968.$x767.$x374
=072  \\$aC16.$x131.$x939.$x374
=150  \\$aEpispadias
=450  \\$wnnna$aEpispadia
=550  \\$wg$aUrethral Diseases
=550  \\$wg$aUrogenital Abnormalities
=680  \\$iA birth defect due to malformation of the URETHRA in which the urethral opening is above its normal location. In the male, the malformed urethra generally opens on the top or the side of the PENIS, but the urethra can also be open the entire length of the penis. In the female, the malformed urethral opening is often between the CLITORIS and the labia, or in the ABDOMEN.
=750  \0$aEpispadias$5IEN$0(DLC)sh 85044450

=LDR  00618cz  a2200169n  4500
=001  9880363543702441
=005  20141212201152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x750
=150  \\$aEpisiotomy
=450  \\$wnnna$aEpisiotomies
=550  \\$wg$aDelivery, Obstetric
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAn incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations.
=750  \0$aEpisiotomy$5IEN$0(DLC)sh 85044448

=LDR  00750cz  a2200193n  4500
=001  9880363543802441
=005  20141212201152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004838
=035  \\$aCAZ7978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x251
=150  \\$aEpiphyses
=450  \\$wnnna$aEpiphysis
=550  \\$wg$aBone and Bones
=550  \\$wh$aGrowth Plate
=667  \\$aIM GEN or unspecified; NIM with specific long bone IM; DIAPHYSES (shaft of long bones) is also available
=680  \\$iThe head of a long bone that is separated from the shaft by the epiphyseal plate until bone growth stops. At that time, the plate disappears and the head and shaft are united.
=750  \0$aEpiphysis$5IEN-M$0(DLC)sh 85044429

=LDR  01723cz  a2200445n  4500
=001  9880363543902441
=005  20141212201152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004837
=035  \\$aCAZ7977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x310
=072  \\$aD2.$x92.$x63.$x291.$x310
=072  \\$aD2.$x92.$x211.$x215.$x311.$x461
=072  \\$aD2.$x92.$x311.$x461
=150  \\$aEpinephrine
=450  \\$wnnna$a4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
=450  \\$wnnna$aAcetate, Epinephrine
=450  \\$aAdrenaline
=450  \\$wnnna$aAdrenaline Acid Tartrate
=450  \\$wnnna$aAdrenaline Bitartrate
=450  \\$wnnna$aAdrenaline Hydrochloride
=450  \\$wnnna$aAllergan Brand of Adrenaline Hydrochloride
=450  \\$wnnna$aEpifrin
=450  \\$wnnna$aEpinephrine Acetate
=450  \\$wnnna$aEpinephrine Bitartrate
=450  \\$wnnna$aEpinephrine Hydrochloride
=450  \\$wnnna$aEpinephrine Hydrogen Tartrate
=450  \\$wnnna$aEpitrate
=450  \\$wnnna$aLyophrin
=450  \\$wnnna$aMedihaler-Epi
=550  \\$wg$aCatecholamines
=550  \\$wg$aEthanolamines
=550  \\$wh$aDeoxyepinephrine
=550  \\$wh$aMetanephrine
=550  \\$wh$aNorepinephrine
=550  \\$wh$aNormetanephrine
=550  \\$wh$aRacepinephrine
=680  \\$iThe active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
=750  \0$aAdrenaline$5IEN$0(DLC)sh 85001007

=LDR  03207cz  a2200673n  4500
=001  9880363544002441
=005  20141212201151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004834
=035  \\$aCAZ7974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x199.$x650
=072  \\$aC10.$x228.$x140.$x490.$x380
=072  \\$aC10.$x900.$x300.$x87.$x600
=072  \\$aC26.$x260.$x118.$x475
=072  \\$aC26.$x915.$x300.$x200.$x475
=150  \\$aEpilepsy, Post-Traumatic
=450  \\$aConcussive Convulsion
=450  \\$wnnna$aConcussive Convulsions
=450  \\$wnnna$aConvulsion, Concussive
=450  \\$wnnna$aConvulsions, Concussive
=450  \\$wnnna$aDisorder, Post-Traumatic Seizure
=450  \\$wnnna$aDisorders, Post-Traumatic Seizure
=450  \\$wnnna$aEarly Post-Traumatic Seizure
=450  \\$wnnna$aEarly Post-Traumatic Seizures
=450  \\$wnnna$aEarly Post Traumatic Seizures
=450  \\$wnnna$aEpilepsies, Post-Traumatic
=450  \\$wnnna$aEpilepsies, Traumatic
=450  \\$wnnna$aEpilepsy, Post Traumatic
=450  \\$aEpilepsy, Traumatic
=450  \\$aImpact Seizure
=450  \\$wnnna$aImpact Seizures
=450  \\$wnnna$aLate Post-Traumatic Seizure
=450  \\$wnnna$aLate Post-Traumatic Seizures
=450  \\$wnnna$aLate Post Traumatic Seizures
=450  \\$wnnna$aPost-Traumatic Epilepsies
=450  \\$wnnna$aPost-Traumatic Epilepsy
=450  \\$wnnna$aPost-Traumatic Seizure Disorder
=450  \\$wnnna$aPost Traumatic Seizure Disorder
=450  \\$wnnna$aPost-Traumatic Seizure Disorders
=450  \\$wnnna$aPost-Traumatic Seizure, Early
=450  \\$wnnna$aPost-Traumatic Seizure, Late
=450  \\$wnnna$aPost-Traumatic Seizures, Early
=450  \\$wnnna$aPost-Traumatic Seizures, Late
=450  \\$aSeizure Disorder, Post-Traumatic
=450  \\$wnnna$aSeizure Disorder, Post Traumatic
=450  \\$wnnna$aSeizure Disorders, Post-Traumatic
=450  \\$wnnna$aSeizure, Early Post-Traumatic
=450  \\$wnnna$aSeizure, Late Post-Traumatic
=450  \\$wnnna$aSeizures, Early Post-Traumatic
=450  \\$wnnna$aSeizures, Late Post-Traumatic
=450  \\$wnnna$aTraumatic Epilepsies
=450  \\$wnnna$aTraumatic Epilepsy
=550  \\$wg$aBrain Injuries
=550  \\$wg$aEpilepsy
=667  \\$acoord IM with specific type of epilepsy (IM or NIM)
=680  \\$iRecurrent seizures causally related to CRANIOCEREBRAL TRAUMA. Seizure onset may be immediate but is typically delayed for several days after the injury and may not occur for up to two years. The majority of seizures have a focal onset that correlates clinically with the site of brain injury. Cerebral cortex injuries caused by a penetrating foreign object (CRANIOCEREBRAL TRAUMA, PENETRATING) are more likely than closed head injuries (HEAD INJURIES, CLOSED) to be associated with epilepsy. Concussive convulsions are nonepileptic phenomena that occur immediately after head injury and are characterized by tonic and clonic movements. (From Rev Neurol 1998 Feb;26(150):256-261; Sports Med 1998 Feb;25(2):131-6)
=688  \\$a1992; was EPILEPSY, TRAUMATIC 1963-1991
=750  \0$aTraumatic epilepsy$5IEN-M$0(DLC)sh 85137136

=LDR  01813cz  a2200361n  4500
=001  9880363544102441
=005  20200506120129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004833
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x360.$x290
=072  \\$aC10.$x228.$x140.$x490.$x493.$x375
=150  \\$aEpilepsy, Temporal Lobe
=450  \\$wnnna$aBenign Psychomotor Epilepsy, Childhood
=450  \\$wnnna$aChildhood Benign Psychomotor Epilepsy
=450  \\$wnnna$aEpilepsies, Lateral Temporal
=450  \\$wnnna$aEpilepsies, Temporal Lobe
=450  \\$wnnna$aEpilepsies, Uncinate
=450  \\$aEpilepsy, Benign Psychomotor, Childhood
=450  \\$wnnna$aEpilepsy, Lateral Temporal
=450  \\$wnnna$aEpilepsy, Uncinate
=450  \\$wnnna$aLateral Temporal Epilepsies
=450  \\$wnnna$aLateral Temporal Epilepsy
=450  \\$wnnna$aTemporal Lobe Epilepsies
=450  \\$wnnna$aTemporal Lobe Epilepsy
=450  \\$wnnna$aUncinate Epilepsies
=450  \\$wnnna$aUncinate Epilepsy
=550  \\$wg$aEpilepsies, Partial
=550  \\$wg$aEpileptic Syndromes
=550  \\$aAnterior Temporal Lobectomy
=680  \\$iA localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321).
=688  \\$a1964
=750  \0$aTemporal lobe epilepsy$5IEN$0(DLC)sh 85133785

=LDR  03286cz  a2200757n  4500
=001  9880363544202441
=005  20200506103453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004832
=035  \\$aCAZ7972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x375.$x260
=072  \\$aC10.$x228.$x140.$x490.$x493.$x125
=150  \\$aEpilepsy, Absence
=450  \\$wnnna$aAbsence Epilepsies, Childhood
=450  \\$wnnna$aAbsence Epilepsies, Juvenile
=450  \\$wnnna$aAbsence Epilepsy
=450  \\$wnnna$aAbsence Epilepsy, Childhood
=450  \\$wnnna$aAbsence Epilepsy, Juvenile
=450  \\$wnnna$aAbsence Seizure
=450  \\$wnnna$aAbsence Seizure, Atonic
=450  \\$wnnna$aAbsence Seizure Disorder
=450  \\$wnnna$aAbsence Seizure Disorders
=450  \\$aAbsence Seizures
=450  \\$wnnna$aAbsence Seizures, Atonic
=450  \\$aAkinetic Petit Mal
=450  \\$wnnna$aAtonic Absence Seizure
=450  \\$wnnna$aAtonic Absence Seizures
=450  \\$wnnna$aChildhood Absence Epilepsies
=450  \\$wnnna$aChildhood Absence Epilepsy
=450  \\$wnnna$aConvulsion, Petit Mal
=450  \\$wnnna$aEpilepsies, Childhood Absence
=450  \\$wnnna$aEpilepsies, Juvenile Absence
=450  \\$wnnna$aEpilepsy, Absence, Atypical
=450  \\$wnnna$aEpilepsy, Childhood Absence
=450  \\$wnnna$aEpilepsy Juvenile Absence
=450  \\$wnnna$aEpilepsy, Juvenile Absence
=450  \\$wnnna$aEpilepsy Juvenile Absences
=450  \\$aEpilepsy, Minor
=450  \\$wnnna$aEpilepsy, Petit Mal
=450  \\$wnnna$aJuvenile Absence Epilepsies
=450  \\$wnnna$aJuvenile Absence Epilepsy
=450  \\$wnnna$aJuvenile Absence, Epilepsy
=450  \\$wnnna$aJuvenile Absences, Epilepsy
=450  \\$wnnna$aMinor Epilepsies
=450  \\$wnnna$aMinor Epilepsy
=450  \\$wnnna$aPetit Mal, Akinetic
=450  \\$wnnna$aPetit Mal Convulsion
=450  \\$wnnna$aPetit Mal Epilepsies
=450  \\$aPetit Mal Epilepsy
=450  \\$wnnna$aPykno-Epilepsies
=450  \\$wnnna$aPykno-Epilepsy
=450  \\$wnnna$aPykno Epilepsy
=450  \\$wnnna$aPyknolepsies
=450  \\$aPyknolepsy
=450  \\$wnnna$aSeizure, Absence
=450  \\$wnnna$aSeizure, Atonic Absence
=450  \\$wnnna$aSeizure Disorder, Absence
=450  \\$wnnna$aSeizure Disorders, Absence
=450  \\$wnnna$aSeizures, Atonic Absence
=550  \\$wg$aEpilepsy, Generalized
=550  \\$wh$aEpileptiic Syndromes
=667  \\$anote X ref PETIT MAL EPILEPSY: do not confuse with PETIT MAL STATUS see STATUS EPILEPTICUS
=680  \\$iA childhood seizure disorder characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)
=688  \\$a1992; was EPILEPSY, PETIT MAL 1963-1991
=750  \0$aPetit mal epilepsy$5IEN-M$0(DLC)sh 87006114

=LDR  04814cz  a2201117n  4500
=001  9880363544302441
=005  20200506105233.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004831
=035  \\$aCAZ7971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x130
=072  \\$aC10.$x228.$x140.$x490.$x063
=150  \\$aEpilepsies, Myoclonic
=450  \\$wnnna$aAbsence Epilepsies, Myoclonic
=450  \\$wnnna$aAbsence Epilepsy, Myoclonic
=450  \\$wnnna$aAstatic Epilepsies, Myoclonic
=450  \\$wnnna$aAstatic Epilepsy, Myoclonic
=450  \\$wnnna$aBenign Infantile Myoclonic Epilepsy
=450  \\$wnnna$aCryptogenic Myoclonic Epilepsies
=450  \\$wnnna$aCryptogenic Myoclonic Epilepsy
=450  \\$wnnna$aDisorder, Myoclonic Seizure
=450  \\$wnnna$aDisorders, Myoclonic Seizure
=450  \\$wnnna$aDravet Syndrome
=450  \\$wnnna$aDravet Syndromes
=450  \\$wnnna$aEarly Childhood Epilepsy, Myoclonic
=450  \\$wnnna$aEarly Childhood, Myoclonic Epilepsy
=450  \\$wnnna$aEncephalopathies, Myoclonic
=450  \\$wnnna$aEncephalopathy, Myoclonic
=450  \\$wnnna$aEpilepsies, Cryptogenic Myoclonic
=450  \\$wnnna$aEpilepsies, Idiopathic Myoclonic
=450  \\$wnnna$aEpilepsies, Infantile Myoclonic
=450  \\$wnnna$aEpilepsies, Myoclonic Absence
=450  \\$wnnna$aEpilepsies, Myoclonic Astatic
=450  \\$wnnna$aEpilepsies, Symptomatic Myoclonic
=450  \\$wnnna$aEpilepsy, Cryptogenic Myoclonic
=450  \\$wnnna$aEpilepsy, Early Childhood, Myoclonic
=450  \\$wnnna$aEpilepsy, Idiopathic Myoclonic
=450  \\$wnnna$aEpilepsy, Infantile Myoclonic
=450  \\$wnnna$aEpilepsy, Myoclonic
=450  \\$wnnna$aEpilepsy, Myoclonic Absence
=450  \\$wnnna$aEpilepsy, Myoclonic Astatic
=450  \\$wnnna$aEpilepsy, Myoclonic, Early Childhood
=450  \\$wnnna$aEpilepsy, Myoclonic, Infantile
=450  \\$wnnna$aEpilepsy, Myoclonic, Infantile, Benign
=450  \\$wnnna$aEpilepsy, Myoclonic, Infantile, Severe
=450  \\$wnnna$aEpilepsy, Myoclonus
=450  \\$wnnna$aEpilepsy, Symptomatic Myoclonic
=450  \\$wnnna$aIdiopathic Myoclonic Epilepsies
=450  \\$aIdiopathic Myoclonic Epilepsy
=450  \\$wnnna$aInfantile Myoclonic Epilepsies
=450  \\$wnnna$aInfantile Myoclonic Epilepsy
=450  \\$wnnna$aInfantile Severe Myoclonic Epilepsy
=450  \\$wnnna$aMyoclonic Absence Epilepsies
=450  \\$aMyoclonic Absence Epilepsy
=450  \\$wnnna$aMyoclonic Astatic Epilepsies
=450  \\$wnnna$aMyoclonic Astatic Epilepsy
=450  \\$wnnna$aMyoclonic Encephalopathies
=450  \\$aMyoclonic Encephalopathy
=450  \\$wnnna$aMyoclonic Epilepsies
=450  \\$wnnna$aMyoclonic Epilepsies, Cryptogenic
=450  \\$wnnna$aMyoclonic Epilepsies, Idiopathic
=450  \\$wnnna$aMyoclonic Epilepsies, Infantile
=450  \\$wnnna$aMyoclonic Epilepsies, Symptomatic
=450  \\$aMyoclonic Epilepsy
=450  \\$wnnna$aMyoclonic Epilepsy, Benign Infantile
=450  \\$wnnna$aMyoclonic Epilepsy, Cryptogenic
=450  \\$wnnna$aMyoclonic Epilepsy, Early Childhood
=450  \\$wnnna$aMyoclonic Epilepsy, Idiopathic
=450  \\$wnnna$aMyoclonic Epilepsy, Infantile
=450  \\$wnnna$aMyoclonic Epilepsy, Infantile, Benign
=450  \\$wnnna$aMyoclonic Epilepsy, Infantile, Severe
=450  \\$wnnna$aMyoclonic Epilepsy, Severe Infantile
=450  \\$wnnna$aMyoclonic Epilepsy, Severe, Of Infancy
=450  \\$wnnna$aMyoclonic Epilepsy, Symptomatic
=450  \\$wnnna$aMyoclonic Seizure Disorder
=450  \\$wnnna$aMyoclonic Seizure Disorders
=450  \\$wnnna$aMyoclonus Epilepsies
=450  \\$wnnna$aMyoclonus Epilepsy
=450  \\$wnnna$aSeizure Disorder, Myoclonic
=450  \\$wnnna$aSeizure Disorders, Myoclonic
=450  \\$wnnna$aSevere Infantile Myoclonic Epilepsy
=450  \\$wnnna$aSevere Myoclonic Epilepsy, Infantile
=450  \\$wnnna$aSevere Myoclonic Epilepsy Of Infancy
=450  \\$wnnna$aSymptomatic Myoclonic Epilepsies
=450  \\$aSymptomatic Myoclonic Epilepsy
=450  \\$wnnna$aSyndrome, Dravet
=450  \\$wnnna$aSyndromes, Dravet
=550  \\$wg$aEpilepsy, Generalized
=550  \\$wg$aEpileptic Syndromes
=550  \\$wh$aMyoclonic Epilepsies, Progressive
=550  \\$wh$aMyoclonic Epilepsy, Juvenile
=550  \\$aNAV1.1 Voltage-Gated Sodium Channel
=680  \\$iA clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.
=688  \\$a2000(1992) was EPILEPSY, MYOCLONUS 1977-1991
=750  \0$aMyoclonus$5IEN-M$0(DLC)sh 85089250

=LDR  02290cz  a2200577n  4500
=001  9880363544402441
=005  20200506105434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004827
=035  \\$aCAZ7967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490
=150  \\$aEpilepsy
=450  \\$aAura
=450  \\$wnnna$aAuras
=450  \\$aAwakening Epilepsy
=450  \\$wnnna$aCryptogenic Epilepsies
=450  \\$wnnna$aCryptogenic Epilepsy
=450  \\$wnnna$aEpilepsies
=450  \\$wnnna$aEpilepsies, Cryptogenic
=450  \\$wnnna$aEpilepsy, Awakening
=450  \\$wnnna$aEpilepsy, Cryptogenic
=450  \\$wnnna$aEpileptic Seizure
=450  \\$aEpileptic Seizures
=450  \\$aEpileptics$5IEN
=450  \\$aSeizure Disorder
=450  \\$wnnna$aSeizure Disorders
=450  \\$wnnna$aSeizure, Epileptic
=450  \\$wnnna$aSeizure, Single
=450  \\$wnnna$aSeizures, Epileptic
=450  \\$wnnna$aSeizures, Single
=450  \\$wnnna$aSingle Seizure
=450  \\$wnnna$aSingle Seizures
=550  \\$wg$aBrain Diseases
=550  \\$wh$aDrug Resistant Epilepsy
=550  \\$wh$aEpilepsies, Partial
=550  \\$wh$aEpilepsy, Benign Neonatal
=550  \\$wh$aEpilepsy, Generalized
=550  \\$wh$aEpilepsy, Post-Traumatic
=550  \\$wh$aEpilepsy, Reflex
=550  \\$wh$aEpileptic Syndromes
=550  \\$wh$aLandau-Kleffner Syndrome
=550  \\$wh$aLennox Gastaut Syndrome
=550  \\$wh$aSeizures
=550  \\$wh$aSeizures, Febrile
=550  \\$wh$aStatus Epilepticus
=550  \\$aSeizures
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
=750  \0$aEpilepsy$5IEN-M$0(DLC)sh 85044401
=750  \0$aEpileptics$5IEN-HS$0(DLC)sh 85044409

=LDR  00921cz  a2200229n  4500
=001  9880363544502441
=005  20141212201141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004825
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x165.$x257.$x625.$x411
=072  \\$aA2.$x165.$x407.$x500.$x411
=072  \\$aA4.$x329.$x591.$x411
=150  \\$aEpiglottis
=450  \\$wnnna$aCartilage, Epiglottic
=450  \\$wnnna$aCartilages, Epiglottic
=450  \\$wnnna$aEpiglottic Cartilage
=450  \\$wnnna$aEpiglottic Cartilages
=550  \\$wg$aLaryngeal Cartilages
=667  \\$ainflammation = EPIGLOTTITIS
=680  \\$iA thin leaf-shaped cartilage that is covered with LARYNGEAL MUCOSA and situated posterior to the root of the tongue and HYOID BONE. During swallowing, the epiglottis folds back over the larynx inlet thus prevents foods from entering the airway.
=750  \0$aEpiglottis$0(DLC) sh 85044383$5IEN

=LDR  00817cz  a2200157n  4500
=001  9880363544602441
=005  20141212201140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x371
=150  \\$aEpididymis
=550  \\$wg$aGenitalia, Male
=667  \\$aNIM when used in fat-pad tissue studies; diseases: coordinate IM with GENITAL DISEASES, MALE (IM); inflammation = EPIDIDYMITIS
=680  \\$iThe convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head (caput), the body (corpus), and the tail (cauda). A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.
=750  \0$aEpididymis$5IEN$0(DLC)sh 85044379

=LDR  00597cz  a2200193n  4500
=001  9880363544702441
=005  20141212201140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004821
=035  \\$aCAZ7960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x340
=150  \\$aEpidermophyton
=450  \\$wnnna$aEpidermophytons
=550  \\$wg$aMitosporic Fungi
=550  \\$aArthrodermataceae
=667  \\$ainfection = EPIDERMOPHYTOSIS see TINEA
=680  \\$iA fungal genus which grows in the epidermis and is the cause of TINEA.
=750  \0$aEpidermophyton$5IEN$0(DLC)sh 88022045

=LDR  01255cz  a2200301n  4500
=001  9880363544802441
=005  20141212201140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004820
=035  \\$aCAZ7959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x831.$x493
=072  \\$aC16.$x320.$x850.$x275
=072  \\$aC17.$x800.$x804.$x493
=072  \\$aC17.$x800.$x827.$x275
=072  \\$aC17.$x800.$x865.$x410
=150  \\$aEpidermolysis Bullosa
=450  \\$aAcantholysis Bullosa
=550  \\$wg$aSkin Abnormalities
=550  \\$wg$aSkin Diseases, Genetic
=550  \\$wg$aSkin Diseases, Vesiculobullous
=550  \\$wh$aEpidermolysis Bullosa Acquisita
=550  \\$wh$aEpidermolysis Bullosa Dystrophica
=550  \\$wh$aEpidermolysis Bullosa, Junctional
=550  \\$wh$aEpidermolysis Bullosa Simplex
=667  \\$avesiculobullous skin dis; GEN only: prefer specifics; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iGroup of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
=750  \0$aEpidermolysis bullosa$5IEN$0(DLC)sh 85044376

=LDR  00818cz  a2200193n  4500
=001  9880363544902441
=005  20141212201139.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x272.$x497
=072  \\$aA17.$x815.$x250
=150  \\$aEpidermis
=550  \\$wg$aEpithelium
=550  \\$wg$aSkin
=550  \\$wh$aHair Follicle
=680  \\$iThe external, nonvascular layer of the skin. It is made up, from within outward, of five layers of EPITHELIUM: (1) basal layer (stratum basale epidermidis); (2) spinous layer (stratum spinosum epidermidis); (3) granular layer (stratum granulosum epidermidis); (4) clear layer (stratum lucidum epidermidis); and (5) horny layer (stratum corneum epidermidis).
=688  \\$a78
=750  \0$aEpidermis$5IEN$0(DLC)sh 85044375

=LDR  01504cz  a2200301n  4500
=001  9880363545002441
=005  20141212192153.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004815
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x350
=072  \\$aD12.$x644.$x276.$x382.$x500
=072  \\$aD12.$x776.$x467.$x382.$x500
=072  \\$aD23.$x529.$x382.$x500
=150  \\$aEpidermal Growth Factor
=450  \\$wnnna$abeta-Urogastrone
=450  \\$wnnna$abeta Urogastrone
=450  \\$aEGF
=450  \\$aEpidermal Growth Factor-Urogastrone
=450  \\$wnnna$aGrowth Factor, Epidermal
=450  \\$wnnna$aGrowth Factor-Urogastrone, Epidermal
=450  \\$wnnna$aHuman Urinary Gastric Inhibitor
=450  \\$aUrogastrone
=550  \\$wg$aEGF Family of Proteins
=550  \\$wg$aGastrointestinal Hormones
=680  \\$iA 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form.
=688  \\$a2000(1982); use PEPTIDES 1977-1981; for UROGASTRONE use GASTROINTESTINAL HORMONES 1963-1981
=750  \0$aEpidermal growth factor$5IEN$0(DLC)sh 89005597

=LDR  01055cz  a2200205n  4500
=001  9880363545102441
=005  20180626160302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004813
=035  \\$aCAZ7952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x720.$x500
=150  \\$aEpidemiology
=450  \\$aDisease$xepidemiology
=550  \\$wg$aPublic Health
=550  \\$wh$aMolecular Epidemiology
=550  \\$wh$aPharmacoepidemiology
=667  \\$aSPEC only: SPEC qualif; prefer /epidemiol with diseases: Manual 19.7+, 19.8.31; do not confuse with TOPOGRAPHY, MEDICAL: epidemiol emphasizes disease outbreaks & disease-related conditions, topography emphasizes geography-related events; DF: EPIDEMIOL
=680  \\$iField of medicine concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease.
=750  \0$aEpidemiology$5IEN-M$0(DLC)sh 85044373

=LDR  01377cz  a2200409n  4500
=001  9880363545202441
=005  20190530122111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004812
=035  \\$aCAZ7951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318
=072  \\$aN6.$x850.$x520
=150  \\$aEpidemiologic Methods
=450  \\$wnnna$aEpidemiologic Method
=450  \\$wnnna$aEpidemiological Method
=450  \\$wnnna$aEpidemiological Methods
=450  \\$aEpidemiology$xmethods
=450  \\$wnnna$aMethod, Epidemiologic
=450  \\$wnnna$aMethod, Epidemiological
=450  \\$wnnna$aMethods, Epidemiologic
=450  \\$wnnna$aMethods, Epidemiological
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aPublic Health
=550  \\$wh$aContact Tracing
=550  \\$wh$aData Collection
=550  \\$wh$aDisease Notification
=550  \\$wh$aEpidemiologic Research Design
=550  \\$wh$aEpidemiologic Study Characteristics
=550  \\$wh$aEpidemiological Monitoring
=550  \\$wh$aGeographic Mapping
=550  \\$wh$aMolecular Epidemiology
=550  \\$wh$aSentinel Surveillance
=550  \\$wh$aStatistics as Topic
=667  \\$aIM GEN only; coord NIM with disease /epidemiol (IM); specify geog if pertinent; DF: EPIDEMIOL METHODS
=688  \\$a67(65)
=750  \0$aEpidemiology$xMethodology$5IEN$0(DLC)sh2009125069

=LDR  00709cz  a2200205n  4500
=001  9880363545302441
=005  20141212201137.0
=008  741114\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004811
=035  \\$aCAZ7950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x411.$x400
=150  \\$aEpichlorohydrin
=450  \\$wnnna$aEpichlorhydrin
=450  \\$wnnna$aEpichlorohydrin, (+-)-Isomer
=450  \\$wnnna$aEpichlorohydrin, (S)-Isomer
=550  \\$wg$aEpoxy Compounds
=680  \\$iA chlorinated epoxy compound used as an industrial solvent. It is a strong skin irritant and carcinogen.
=688  \\$a91(75); was see under CHLOROHYDRINS 1975-90
=750  \0$aEpichlorohydrin$5IEN$0(DLC)sh 85044363

=LDR  01530cz  a2200349n  4500
=001  9880363545402441
=005  20141212201136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004809
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x302
=072  \\$aD2.$x33.$x755.$x624.$x302
=072  \\$aD2.$x92.$x63.$x624.$x302
=072  \\$aD2.$x92.$x471.$x683.$x430
=150  \\$aEphedrine
=450  \\$wnnna$aEphedrine Erythro Isomer
=450  \\$wnnna$aEphedrine Hydrochloride
=450  \\$wnnna$aEphedrine Renaudin
=450  \\$wnnna$aEphedrine Sulfate
=450  \\$wnnna$aErythro Isomer of Ephedrine
=450  \\$wnnna$aHydrochloride, Ephedrine
=450  \\$wnnna$aRenaudin Brand of Ephedrine Hydrochloride
=450  \\$wnnna$aRenaudin, Ephedrine
=450  \\$wnnna$aSal-Phedrine
=450  \\$wnnna$aSal Phedrine
=450  \\$wnnna$aSalPhedrine
=450  \\$wnnna$aSulfate, Ephedrine
=450  \\$wnnna$aWendt Brand of Ephedrine Sulfate
=550  \\$wg$aPhenethylamines
=550  \\$wg$aPropanolamines
=680  \\$iA phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.
=750  \0$aEphedrine$5IEN$0(DLC)sh 85044255

=LDR  00720cz  a2200229n  4500
=001  9880363545502441
=005  20141212201135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004805
=035  \\$aCAZ7944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x276.$x460
=072  \\$aA8.$x561.$x326
=072  \\$aA10.$x755.$x260
=150  \\$aEpendyma
=450  \\$wnnna$aEpendymas
=550  \\$wg$aCerebral Ventricles
=550  \\$wg$aNerve Tissue
=550  \\$aEpendymoglial Cells
=667  \\$a/radiogr: coordinate with CEREBRAL VENTRICULOGRAPHY
=680  \\$iA thin membrane that lines the CEREBRAL VENTRICLES and the central canal of the SPINAL CORD.
=750  \0$aEpendyma$5IEN$0(DLC)sh 85044249

=LDR  00983cz  a2200217n  4500
=001  9880363545602441
=005  20141212201135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004804
=035  \\$aCAZ7943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x415.$x345
=072  \\$aA11.$x627.$x340.$x345
=072  \\$aA15.$x145.$x229.$x637.$x415.$x345
=072  \\$aA15.$x382.$x490.$x315.$x251
=150  \\$aEosinophils
=450  \\$wnnna$aEosinophil
=550  \\$wg$aGranulocytes
=667  \\$arestrict to leukocytes: not for "eosinophilic", stainable with eosin ( = STAINING AND LABELING + EOSIN); eosinophilic states: see note under EOSINOPHILIA; eosinophil count: coord with LEUKOCYTE COUNT
=680  \\$iGranular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.
=750  \0$aEosinophils$0(DLC) sh 85044242$5IEN-M

=LDR  01051cz  a2200277n  4500
=001  9880363545702441
=005  20141212201135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004803
=035  \\$aCAZ7942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x391
=072  \\$aC8.$x381.$x483.$x375.$x500
=072  \\$aC15.$x378.$x553.$x231.$x348
=072  \\$aC15.$x604.$x250.$x400.$x360
=072  \\$aC23.$x550.$x382.$x250
=150  \\$aEosinophilic Granuloma
=450  \\$wnnna$aEosinophilic Granulomas
=450  \\$aGranuloma, Eosinophilic
=450  \\$wnnna$aGranulomas, Eosinophilic
=550  \\$wg$aBone Diseases
=550  \\$wg$aEosinophilia
=550  \\$wg$aGranuloma
=550  \\$wg$aHistiocytosis, Langerhans-Cell
=680  \\$iThe most benign and common form of Langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by EOSINOPHILS.
=750  \0$aEosinophilic granuloma$5IEN$0(DLC)sh 85044244

=LDR  01274cz  a2200301n  4500
=001  9880363545802441
=005  20141212201135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004802
=035  \\$aCAZ7941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x553.$x231
=150  \\$aEosinophilia
=450  \\$aEosinophilia, Tropical
=450  \\$wnnna$aEosinophilias
=450  \\$wnnna$aEosinophilias, Tropical
=450  \\$wnnna$aTropical Eosinophilia
=450  \\$wnnna$aTropical Eosinophilias
=550  \\$wg$aLeukocyte Disorders
=550  \\$wh$aAngiolymphoid Hyperplasia with Eosinophilia
=550  \\$wh$aEosinophilia-Myalgia Syndrome
=550  \\$wh$aEosinophilic Esophagitis
=550  \\$wh$aEosinophilic Granuloma
=550  \\$wh$aHypereosinophilic Syndrome
=667  \\$ageneral or unspecified; prefer specifics; for eosinophilic states (as eosinophilic gastritis, eosinophilic meningitis) coordinate IM with disease (IM); /chem ind: consider also EOSINOPHILIA-MYALGIA SYNDROME; HYPEREOSINOPHILIC SYNDROME is also available
=680  \\$iAbnormal increase of EOSINOPHILS in the blood, tissues or organs.
=688  \\$a1963; for EOSINOPHILIA, TROPICAL use PULMONARY EOSINOPHILIA 1982-2008
=750  \0$aEosinophilia$5IEN$0(DLC)sh 85044243

=LDR  01207cz  a2200337n  4500
=001  9880363545902441
=005  20141212192153.0
=008  780207\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004801
=035  \\$aCAZ7940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x779.$x347.$x325
=072  \\$aD3.$x494.$x953.$x275.$x325
=072  \\$aD4.$x711.$x347.$x325
=150  \\$aEosine Yellowish-(YS)
=450  \\$wnnna$aAcid Red 87
=450  \\$wnnna$aC.I. Acid Red 87
=450  \\$aEosin
=450  \\$wnnna$aEosin Y
=450  \\$wnnna$aEosin (yellowish) (free acid)
=450  \\$wnnna$aEosine
=450  \\$aEosine Yellowish
=450  \\$wnnna$aEosine Yellowish-(YS), Dipotassium Salt
=450  \\$wnnna$aEosine Yellowish-(YS), Potassium, Sodium Salt
=450  \\$aTetrabromofluorescein
=550  \\$wg$aFluoresceins
=667  \\$aD25-26 qualif; DF: note short X ref
=680  \\$iA versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.
=688  \\$a1994; was EOSIN 1979-1993
=688  \\$a94; was EOSIN 1979-93
=750  \0$aEosin$5IEN$0(DLC)sh 85044241

=LDR  00921cz  a2200241n  4500
=001  9880363546002441
=005  20141212201134.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004800
=035  \\$aCAZ7939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x180
=072  \\$aD12.$x776.$x463.$x500
=150  \\$aEnzymes, Immobilized
=450  \\$wnnna$aEnzyme, Immobilized
=450  \\$wnnna$aImmobilized Enzyme
=450  \\$aImmobilized Enzymes
=550  \\$wg$aEnzymes
=550  \\$wg$aImmobilized Proteins
=550  \\$aMicrospheres
=680  \\$iEnzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields.
=688  \\$a77
=750  \0$aImmobilized enzymes$5IEN$0(DLC)sh 85064525

=LDR  01827cz  a2200421n  4500
=001  9880363546102441
=005  20180409082820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004798
=035  \\$aCAZ7937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811
=150  \\$aEnzymes
=450  \\$wnnna$aBiocatalysts
=550  \\$wg$aEnzymes and Coenzymes
=550  \\$wh$aDeubiquitinating Enzymes
=550  \\$wh$aDNA, Catalytic
=550  \\$wh$aDNA Repair Enzymes
=550  \\$wh$aDNA Restriction-Modification Enzymes
=550  \\$wh$aEnzymes, Immobilized
=550  \\$wh$aHoloenzymes
=550  \\$wh$aHydrolases
=550  \\$wh$aIsoenzymes
=550  \\$wh$aIsomerases
=550  \\$wh$aLigases
=550  \\$wh$aLyases
=550  \\$wh$aMultienzyme Complexes
=550  \\$wh$aMultifunctional Enzymes
=550  \\$wh$aOxidoreductases
=550  \\$wh$aPenicillin-Binding Proteins
=550  \\$wh$aRecombinases
=550  \\$wh$aRNA, Catalytic
=550  \\$wh$aTransferases
=550  \\$aMolecular Mechanisms of Pharmacological Action
=667  \\$ageneral only: avoid; prefer specific enzyme or / enzymol: Manual 19.7+, 19.8.30; policy: Manual 25.18+; SUBSTRATE SPECIFICITY, restricted to enzymes, is available; ENZYME TESTS, CLINICAL is available for measuring the level of a specific enzyme in the diagnosis of a disease; ENZYME ACTIVATION; ENZYME REPRESSION; ENZYME STABILITY are also available; ENZYME INDUCTION: coordinate with specific enzyme / biosyn
=680  \\$iBiological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.
=750  \0$aEnzyme kinetics$5IEN-M$0(DLC)sh 87003634
=750  \0$aEnzymes$5IEN-HS$0(DLC)sh 85044229

=LDR  01708cz  a2200349n  4500
=001  9880363546202441
=005  20141212201133.0
=008  760419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004797
=035  \\$aCAZ7936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x478.$x566.$x350.$x170
=072  \\$aE5.$x478.$x566.$x380.$x360
=072  \\$aE5.$x478.$x583.$x400.$x170
=072  \\$aE5.$x601.$x495.$x350.$x170
=072  \\$aE5.$x601.$x495.$x380.$x360
=150  \\$aEnzyme-Linked Immunosorbent Assay
=450  \\$wnnna$aAssay, Enzyme-Linked Immunosorbent
=450  \\$wnnna$aAssays, Enzyme-Linked Immunosorbent
=450  \\$aELISA
=450  \\$wnnna$aEnzyme Linked Immunosorbent Assay
=450  \\$wnnna$aEnzyme-Linked Immunosorbent Assays
=450  \\$wnnna$aImmunosorbent Assay, Enzyme-Linked
=450  \\$wnnna$aImmunosorbent Assays, Enzyme-Linked
=550  \\$wg$aImmunoenzyme Techniques
=550  \\$wg$aImmunosorbent Techniques
=550  \\$wh$aEnzyme-Linked Immunospot Assay
=550  \\$aImmunosorbents
=667  \\$aNIM; IMMUNOSORBENTS is also available
=680  \\$iAn immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
=688  \\$a86(77); was see under IMMUNOENZYME TECHNIQUES 1977-85
=750  \0$aEnzyme-linked immunosorbent assay$5IEN$0(DLC)sh 85044227

=LDR  01202cz  a2200289n  4500
=001  9880363546302441
=005  20141212201133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004796
=035  \\$aCAZ7935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x200
=072  \\$aE5.$x196.$x427.$x200
=072  \\$aE5.$x200.$x124.$x200
=150  \\$aClinical Enzyme Tests
=450  \\$wnnna$aClinical Enzyme Test
=450  \\$wnnna$aEnzyme Test, Clinical
=450  \\$aEnzyme Tests, Clinical
=450  \\$wnnna$aTest, Clinical Enzyme
=450  \\$wnnna$aTests, Clinical Enzyme
=550  \\$wg$aClinical Chemistry Tests
=550  \\$wg$aEnzyme Assays
=667  \\$acoordinate with specific enzyme with pertinent qualifiers + disease /diag, not disease /enzymol; Manual 25.19.4 & 26.8
=680  \\$iAnalyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Enzyme Tests
=750  \0$aClinical enzymology$5IEN$0(DLC)sh 85027065

=LDR  02350cz  a2200601n  4500
=001  9880363546402441
=005  20170925100355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004791
=035  \\$aCAZ7930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389
=150  \\$aEnzyme Inhibitors
=450  \\$aEnzymes$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, Enzyme
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wh$a5-Lipoxygenase-Activating Protein Inhibitors
=550  \\$wh$aAcetaldehyde Dehydrogenase Inhibitors
=550  \\$wh$aAdenosine Deaminase Inhibitors
=550  \\$wh$aAdenylyl Cyclase Inhibitors
=550  \\$wh$aAromatic Amino Acid Decarboxylase Inhibitors
=550  \\$wh$abeta-Lactamase Inhibitors
=550  \\$wh$aCalcineurin Inhibitors
=550  \\$wh$aCarbonic Anhydrase Inhibitors
=550  \\$wh$aCatechol O-Methyltransferase Inhibitors
=550  \\$wh$aCholinesterase Inhibitors
=550  \\$wh$aCyclooxygenase Inhibitors
=550  \\$wh$aCytochrome P-450 Enzyme Inhibitors
=550  \\$wh$aFolic Acid Antagonists
=550  \\$wh$aGlycoside Hydrolase Inhibitors
=550  \\$wh$aHistone Deacetylase Inhibitors
=550  \\$wh$aHydroxymethylglutaryl-CoA Reductase Inhibitors
=550  \\$wh$aIntegrase Inhibitors
=550  \\$wh$aLipoxygenase Inhibitors
=550  \\$wh$aMonoamine Oxidase Inhibitors
=550  \\$wh$aNucleic Acid Synthesis Inhibitors
=550  \\$wh$aOrnithine Decarboxylase Inhibitors
=550  \\$wh$aPhosphodiesterase Inhibitors
=550  \\$wh$aPhospholipase A2 Inhibitors
=550  \\$wh$aPoly(ADP-ribose) Polymerase Inhibitors
=550  \\$wh$aProlyl-Hydroxylase Inhibitors
=550  \\$wh$aProtease Inhibitors
=550  \\$wh$aProtein Kinase Inhibitors
=550  \\$wh$aProtein Synthesis Inhibitors
=550  \\$wh$aProton Pump Inhibitors
=550  \\$wh$aSteroid Synthesis Inhibitors
=550  \\$wh$aTopoisomerase Inhibitors
=550  \\$wh$aUncoupling Agents
=550  \\$aSulfhydryl Reagents
=667  \\$aGEN only; prefer specifics
=680  \\$iCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
=688  \\$a75,64-67
=750  \0$aEnzyme inhibitors$5IEN$0(DLC)sh 85044226

=LDR  00733cz  a2200193n  4500
=001  9880363546502441
=005  20141212201130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004790
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x320.$x200
=150  \\$aEnzyme Induction
=450  \\$wnnna$aInduction, Enzyme
=550  \\$wg$aGene Expression Regulation, Enzymologic
=550  \\$aStimulation, Chemical
=667  \\$aIM for general only; NIM with specific enzyme /biosyn (IM)
=680  \\$iAn increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.
=688  \\$a68(66)
=750  \0$aEnzyme induction$5IEN$0(DLC)sh 85044225

=LDR  01118cz  a2200253n  4500
=001  9880363546602441
=005  20170608142836.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004789
=035  \\$aCAZ7928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x263
=072  \\$aG3.$x328
=150  \\$aEnzyme Activation
=450  \\$wnnna$aActivation, Enzyme
=450  \\$wnnna$aActivations, Enzyme
=450  \\$wnnna$aEnzyme Activations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$aEnzyme Activators
=667  \\$aIM for general only; NIM with specific enzyme (IM); "enzyme reactivation": coord IM with specific enzyme /metab (IM) + ENZYME REACTIVATORS (IM) if discussed (see note there)
=680  \\$iConversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme.
=688  \\$a76(69); was see under BIOCHEMISTRY 1975
=750  \0$aEnzyme activation$5IEN$0(DLC)sh 85044224

=LDR  01217cz  a2200361n  4500
=001  9880363546702441
=005  20210219093705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004787
=035  \\$aCAZ7926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460
=150  \\$aEnvironmental Pollution
=450  \\$wnnna$aPollution, Environmental
=450  \\$wnnna$aPollution, Soil
=450  \\$wnnna$aSoil Pollution
=550  \\$wg$aPublic Health
=550  \\$wh$aAir Pollution
=550  \\$wh$aBiofouling
=550  \\$wh$aBody Burden
=550  \\$wh$aEnvironmental Exposure
=550  \\$wh$aEnvironmental Restoration and Remediation
=550  \\$wh$aFood Contamination
=550  \\$wh$aNoise
=550  \\$wh$aPetroleum Pollution
=550  \\$wh$aWaste Products
=550  \\$wh$aWater Pollution
=550  \\$wh$aTraffic-Related Pollution
=550  \\$aEnvironmental Pollutants
=667  \\$acoordinate IM with source of pollution (IM); specify geographic location if pertinent
=680  \\$iContamination of the air, bodies of water, or land with substances that are harmful to human health and the environment.
=688  \\$a74(71)
=750  \0$aPollution$0(DLC) sh 85104530$5IEN

=LDR  01040cz  a2200253n  4500
=001  9880363546802441
=005  20141212201129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004785
=035  \\$aCAZ7924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x284
=150  \\$aEnvironmental Pollutants
=450  \\$wnnna$aPollutants, Environmental
=550  \\$wg$aToxic Actions
=550  \\$wh$aAir Pollutants
=550  \\$wh$aSoil Pollutants
=550  \\$wh$aWater Pollutants
=550  \\$aEnvironmental Exposure
=550  \\$aEnvironmental Pollution
=667  \\$aspecify pollutant if pertinent (IM or NIM); in addition to AIR POLLUTANTS; RADIOACTIVE POLLUTANTS; SOIL POLLUTANTS & WATER POLLUTANTS & their specifics, CARCINOGENS, ENVIRONMENTAL is also available; DF: ENVIR POLLUTANTS
=680  \\$iSubstances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS.
=688  \\$a75
=750  \0$aPollutants$5IEN$0(DLC)sh 85104528

=LDR  01586cz  a2200409n  4500
=001  9880363546902441
=005  20200504112409.0
=008  850618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004784
=035  \\$aCAZ7923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x80
=072  \\$aN6.$x850.$x780.$x375
=150  \\$aEnvironmental Monitoring
=450  \\$wnnna$aBio-Monitoring
=450  \\$wnnna$aBio Monitoring
=450  \\$wnnna$aBiologic Monitoring
=450  \\$aBiological Monitoring
=450  \\$wnnna$aBiomonitoring
=450  \\$wnnna$aEnvironmental Surveillance
=450  \\$wnnna$aMonitoring, Biologic
=450  \\$wnnna$aMonitoring, Biological
=450  \\$aMonitoring, Environmental
=450  \\$wnnna$aSurveillance, Environmental
=550  \\$wg$aEnvironmental Exposure
=550  \\$wg$aPublic Health Practice
=550  \\$wh$aBiological Oxygen Demand Analysis
=550  \\$wh$aEnvironmental Biomarkers
=550  \\$wh$aRadiation Monitoring
=550  \\$wh$aWater Quality
=550  \\$aEcological Parameter Monitoring
=550  \\$aEnvironmental Restoration and Remediation
=667  \\$ado not confuse with EPIDEMIOLOGICAL MONITORING
=680  \\$iThe monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment.
=688  \\$a86
=750  \0$aEnvironmental monitoring$5IEN-M$0(DLC)sh 85044194
=750  \0$aBiological monitoring$5IEN-HS$0(DLC)sh 86001972

=LDR  01034cz  a2200277n  4500
=001  9880363547002441
=005  20141212201129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004783
=035  \\$aCAZ7922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x274
=072  \\$aN6.$x850.$x425
=150  \\$aEnvironmental Microbiology
=450  \\$aEnvironment$xmicrobiology
=450  \\$wnnna$aMicrobiology, Environmental
=550  \\$wg$aMicrobiology
=550  \\$wg$aPublic Health
=550  \\$wh$aAir Microbiology
=550  \\$wh$aFood Microbiology
=550  \\$wh$aSoil Microbiology
=550  \\$wh$aWater Microbiology
=667  \\$aGEN or unspecified; prefer specifics; IM; coord with specific microbe (IM); DF: ENVIR MICROBIOL
=680  \\$iThe study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man.
=688  \\$a85; was NON MESH before 1985
=750  \0$aMicrobial ecology$5IEN$0(DLC)sh 85084757

=LDR  01187cz  a2200325n  4500
=001  9880363547102441
=005  20141212201128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004782
=035  \\$aCAZ7921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x229
=150  \\$aEnvironmental Health
=450  \\$wnnna$aEnvironmental Health Science
=450  \\$wnnna$aEnvironmental Health Sciences
=450  \\$wnnna$aEnvironmental Healths
=450  \\$wnnna$aHealth, Environmental
=450  \\$wnnna$aHealth Science, Environmental
=450  \\$wnnna$aHealth Sciences, Environmental
=450  \\$wnnna$aHealths, Environmental
=450  \\$wnnna$aScience, Environmental Health
=450  \\$wnnna$aSciences, Environmental Health
=550  \\$wg$aHealth Occupations
=550  \\$wh$aHealth Physics
=550  \\$wh$aSanitary Engineering
=550  \\$wh$aSanitation
=550  \\$aEcology
=667  \\$aindex geographic term if pertinent
=680  \\$iThe science of controlling or modifying those conditions, influences, or forces surrounding man which relate to promoting, establishing, and maintaining health.
=750  \0$aEnvironmental health$5IEN$0(DLC)sh 85044173

=LDR  00805cz  a2200265n  4500
=001  9880363547202441
=005  20141212201127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004779
=035  \\$aCAZ7918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x283
=072  \\$aI1.$x880.$x709.$x359
=072  \\$aN6.$x230.$x200
=150  \\$aEnvironment Design
=450  \\$wnnna$aDesign, Environment
=450  \\$wnnna$aDesigns, Environment
=450  \\$wnnna$aEnvironment Designs
=550  \\$wg$aEnvironment
=550  \\$wg$aSocial Planning
=550  \\$wg$aSocial Sciences
=667  \\$aDF: ENVIR DESIGN
=680  \\$iThe structuring of the environment to permit or promote specific patterns of behavior.
=688  \\$a74(72)
=750  \0$aEnvironmental engineering$5IEN$0(DLC)sh 85044170

=LDR  01939cz  a2200649n  4500
=001  9880363547302441
=005  20180702115123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004777
=035  \\$aCAZ7916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275
=072  \\$aN6.$x230
=150  \\$aEnvironment
=450  \\$wnnna$aEnvironmental Impact
=450  \\$wnnna$aEnvironmental Impacts
=450  \\$wnnna$aEnvironments
=450  \\$wnnna$aImpact, Environmental
=450  \\$wnnna$aImpacts, Environmental
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aEnvironment and Public Health
=550  \\$wh$aAltitude
=550  \\$wh$aAtmosphere
=550  \\$wh$aCarbon Footprint
=550  \\$wh$aCaves
=550  \\$wh$aCities
=550  \\$wh$aClimate
=550  \\$wh$aConfined Spaces
=550  \\$wh$aConservation of Natural Resources
=550  \\$wh$aDisasters
=550  \\$wh$aEcosystem
=550  \\$wh$aEnergy-Generating Resources
=550  \\$wh$aEnvironment, Controlled
=550  \\$wh$aEnvironment Design
=550  \\$wh$aEnvironmental Policy
=550  \\$wh$aExplosions
=550  \\$wh$aExtraterrestrial Environment
=550  \\$wh$aExtreme Environments
=550  \\$wh$aFires
=550  \\$wh$aFresh Water
=550  \\$wh$aGreenhouse Effect
=550  \\$wh$aIce
=550  \\$wh$aIslands
=550  \\$wh$aMeteorological Concepts
=550  \\$wh$aNoise
=550  \\$wh$aOdorants
=550  \\$wh$aRain
=550  \\$wh$aRefugium
=550  \\$wh$aSaline Waters
=550  \\$wh$aSoil
=550  \\$wh$aSteam
=550  \\$wh$aStructure Collapse
=550  \\$wh$aWater Movements
=550  \\$wh$aWilderness
=550  \\$aEnvironmental Health
=680  \\$iThe external elements and conditions which surround, influence, and affect the life and development of an organism or population.
=750  \0$aEcology$0(DLC) sh 85040752$5IEN

=LDR  01022cz  a2200253n  4500
=001  9880363547402441
=005  20141212201126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004775
=035  \\$aCAZ7914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x284
=072  \\$aC13.$x351.$x968.$x934.$x252
=072  \\$aF1.$x145.$x126.$x856
=072  \\$aF3.$x550.$x375.$x400
=150  \\$aEnuresis
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aElimination Disorders
=550  \\$wg$aUrination Disorders
=550  \\$wh$aDiurnal Enuresis
=550  \\$wh$aNocturnal Enuresis
=667  \\$ageneral; prefer specifics
=680  \\$iInvoluntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).
=750  \0$aEnuresis$0(DLC) sh 85044157$5IEN

=LDR  00728cz  a2200193n  4500
=001  9880363547502441
=005  20141212201125.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004773
=035  \\$aCAZ7912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x300.$x300
=150  \\$aEntomophthora
=450  \\$wnnna$aEntomophthoras
=550  \\$wg$aEntomophthorales
=667  \\$ainfection: coord IM with ZYGOMYCOSIS (IM)
=680  \\$iA genus of fungi in the family Entomophthoraceae, order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses.
=688  \\$a91(75)
=750  \0$aEntomophthora$5IEN$0(DLC)sh 88021889

=LDR  00642cz  a2200193n  4500
=001  9880363547602441
=005  20141212201125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004772
=035  \\$aCAZ7911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x943.$x409
=150  \\$aEntomology
=450  \\$aEntomologists$5IEN
=550  \\$wg$aZoology
=667  \\$aSPEC: SPEC qualif; DF: ENTOMOL
=680  \\$iA discipline or occupation concerned with the study of INSECTS, including the biology and the control of insects.
=750  \0$aEntomology$5IEN-M$0(DLC)sh 85044125
=750  \0$aEntomologists$5IEN-HS$0(DLC)sh 85044124

=LDR  01287cz  a2200301n  4500
=001  9880363547702441
=005  20141212201124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004770
=035  \\$aCAZ7909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x284
=072  \\$aB4.$x909.$x777.$x618.$x284
=150  \\$aEnterovirus
=450  \\$wnnna$aCoxsackie Viruses
=450  \\$wnnna$aCoxsackieviruses
=550  \\$wg$aPicornaviridae
=550  \\$wh$aEnterovirus A, Human
=550  \\$wh$aEnterovirus B, Human
=550  \\$wh$aEnterovirus, Bovine
=550  \\$wh$aEnterovirus C, Human
=550  \\$wh$aEnterovirus D, Human
=550  \\$wh$aEnteroviruses, Porcine
=550  \\$wh$aPoliovirus
=667  \\$anote X ref COXSACKIEVIRUSES: GEN only, prefer specific Coxsackievirus terms; infection = ENTEROVIRUS INFECTIONS or COXSACKIEVIRUS INFECTIONS, follow text
=680  \\$iA genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus".
=688  \\$a94,63-74; was ENTEROVIRUSES 1975-93
=750  \0$aEnteroviruses$5IEN$0(DLC)sh 85044093

=LDR  00882cz  a2200277n  4500
=001  9880363547802441
=005  20141212201124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004769
=035  \\$aCAZ7908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x359
=150  \\$aEnterovirus Infections
=450  \\$wnnna$aEnterovirus Infection
=450  \\$wnnna$aInfection, Enterovirus
=450  \\$wnnna$aInfections, Enterovirus
=550  \\$wg$aPicornaviridae Infections
=550  \\$wh$aConjunctivitis, Acute Hemorrhagic
=550  \\$wh$aCoxsackievirus Infections
=550  \\$wh$aEchovirus Infections
=550  \\$wh$aEncephalomyelitis, Enzootic Porcine
=550  \\$wh$aHepatitis A
=550  \\$wh$aPoliomyelitis
=550  \\$wh$aSwine Vesicular Disease
=667  \\$acaused by a picornavirus
=750  \0$aEnterovirus diseases$5IEN$0(DLC)sh 85044092

=LDR  00785cz  a2200217n  4500
=001  9880363547902441
=005  20141212201124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004768
=035  \\$aCAZ7907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946.$x330
=150  \\$aEnterotoxins
=450  \\$wnnna$aEnterotoxin
=550  \\$wg$aToxins, Biological
=550  \\$wh$aCholera Toxin
=550  \\$wh$aShiga Toxins
=667  \\$a/antag permitted but consider also ANTITOXINS; coord IM with specific bacterium (IM or NIM)
=680  \\$iSubstances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.
=688  \\$a68; was ENTEROTOXIN 1964-67 (Prov)
=750  \0$aEnterotoxins$5IEN$0(DLC)sh 85044091

=LDR  01162cz  a2200217n  4500
=001  9880363548002441
=005  20141212201123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004767
=035  \\$aCAZ7906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x222.$x325
=072  \\$aC22.$x313
=150  \\$aEnterotoxemia
=450  \\$wnnna$aEnterotoxemias
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aClostridium Infections
=667  \\$aClostridium infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord
=680  \\$iDisease caused by the liberation of exotoxins of CLOSTRIDIUM PERFRINGENS in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces "struck", and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease.
=688  \\$a91(69); was see under CLOSTRIDIUM INFECTIONS 1969-90
=750  \0$aType D enterotoxemia of sheep$5IEN$0(DLC)sh 85044090

=LDR  00875cz  a2200289n  4500
=001  9880363548102441
=005  20141212201123.0
=008  870318\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004766
=035  \\$aCAZ7905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x338
=072  \\$aE4.$x579.$x338
=150  \\$aEnterostomy
=450  \\$wnnna$aEnterostomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wg$aOstomy
=550  \\$wh$aCecostomy
=550  \\$wh$aColostomy
=550  \\$wh$aDuodenostomy
=550  \\$wh$aIleostomy
=550  \\$wh$aJejunostomy
=550  \\$aIntestines
=667  \\$aGEN only: prefer specific intestinal -ostomy; do not use /util except by MeSH definition
=680  \\$iCreation of an artificial external opening or fistula in the intestines.
=688  \\$a88
=750  \0$aEnterostomy$0(DLC) sh 85044086$5IEN

=LDR  00744cz  a2200193n  4500
=001  9880363548202441
=005  20141212201123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004765
=035  \\$aCAZ7904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x284
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x284
=150  \\$aEnteropeptidase
=450  \\$wnnna$aEnterokinase
=550  \\$wg$aSerine Endopeptidases
=680  \\$iA specialized proteolytic enzyme secreted by intestinal cells. It converts TRYPSINOGEN into its active form TRYPSIN by removing the N-terminal peptide. EC 3.4.21.9.
=688  \\$a91(73); was see under SERINE ENDOPEPTIDASES 1973-90
=750  \0$aEnterokinase$5IEN$0(DLC)sh 85044083

=LDR  01219cz  a2200301n  4500
=001  9880363548302441
=005  20141212192152.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004764
=035  \\$aCAZ7903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x355
=150  \\$aEnterohepatic Circulation
=450  \\$wnnna$aCirculation, Entero-Hepatic
=450  \\$wnnna$aCirculation, Enterohepatic
=450  \\$wnnna$aCirculations, Entero-Hepatic
=450  \\$wnnna$aCirculations, Enterohepatic
=450  \\$wnnna$aEntero-Hepatic Circulation
=450  \\$wnnna$aEntero Hepatic Circulation
=450  \\$wnnna$aEntero-Hepatic Circulations
=450  \\$wnnna$aEnterohepatic Circulations
=550  \\$wg$aMetabolism
=550  \\$wh$aIntestinal Reabsorption
=550  \\$aLiver Circulation
=667  \\$aa metab concept, not a hemodynamic circ concept; bile-to-intestines-to-portal circ-to-liver-to-bile; DF: ENTEROHEPATIC CIRC
=680  \\$iRecycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile.
=688  \\$a75
=750  \0$aEnterohepatic circulation$5IEN$0(DLC)sh 85044082

=LDR  00869cz  a2200217n  4500
=001  9880363548402441
=005  20141212201119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004754
=035  \\$aCAZ7893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x275
=072  \\$aB3.$x660.$x250.$x150.$x170
=150  \\$aEnterobacter
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aEnterobacter aerogenes
=550  \\$wh$aEnterobacter cloacae
=667  \\$ainfection: coordinate IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iGram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
=688  \\$a91(78); was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75
=750  \0$aEnterobacter$5IEN$0(DLC)sh 88023249

=LDR  00699cz  a2200229n  4500
=001  9880363548502441
=005  20141212201118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004751
=035  \\$aCAZ7890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x462
=072  \\$aC6.$x405.$x469.$x326
=150  \\$aEnteritis
=450  \\$wnnna$aEnteritides
=550  \\$wg$aGastroenteritis
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aDuodenitis
=550  \\$wh$aIleitis
=667  \\$aGEN or unspecified; jejunitis: coord JEJUNAL DISEASES (IM) + ENTERITIS (IM)
=680  \\$iInflammation of any segment of the SMALL INTESTINE.
=750  \0$aEnteritis$5IEN$0(DLC)sh 85044076

=LDR  01723cz  a2200385n  4500
=001  9880363548602441
=005  20141212201118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004750
=035  \\$aCAZ7889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x421.$x360
=072  \\$aE2.$x642.$x500.$x360
=150  \\$aEnteral Nutrition
=450  \\$aEnteral Feeding
=450  \\$wnnna$aFeeding, Enteral
=450  \\$wnnna$aFeeding, Force
=450  \\$wnnna$aFeeding, Tube
=450  \\$wnnna$aFeeding Tube, Gastric
=450  \\$wnnna$aFeeding Tubes, Gastric
=450  \\$wnnna$aFeedings, Force
=450  \\$aForce Feeding
=450  \\$wnnna$aForce Feedings
=450  \\$wnnna$aGastric Feeding Tube
=450  \\$wnnna$aGastric Feeding Tubes
=450  \\$aNutrition, Enteral
=450  \\$aTube Feeding
=450  \\$wnnna$aTube, Gastric Feeding
=450  \\$wnnna$aTubes, Gastric Feeding
=550  \\$wg$aFeeding Methods
=550  \\$wg$aNutritional Support
=667  \\$ado not use /util except by MeSH definition; coord IM with dis /ther (IM), not dis /diet ther; do not confuse with PARENTERAL NUTRITION or PARENTERAL NUTRITION, TOTAL; "includes oral feeding, sip feeding & tube feeding using nasogastric, gastrostomy & jejunostomy tubes"
=680  \\$iNutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes.
=688  \\$a92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1964-79 (Prov 1964-65); ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91
=750  \0$aEnteral feeding$5IEN-M$0(DLC)sh 85044071

=LDR  01187cz  a2200253n  4500
=001  9880363548702441
=005  20190726140358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004748
=035  \\$aCAZ7887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100.$x700.$x335.$x330
=150  \\$aEntamoeba histolytica
=450  \\$aEndamoeba histolytica
=450  \\$wnnna$aEndamoeba histolyticas
=450  \\$wnnna$aEntamoeba histolyticas
=450  \\$wnnna$ahistolytica, Endamoeba
=450  \\$wnnna$ahistolytica, Entamoeba
=450  \\$wnnna$ahistolyticas, Endamoeba
=450  \\$wnnna$ahistolyticas, Entamoeba
=550  \\$wg$aEntamoeba
=667  \\$ainfection: coordinate with ENTAMOEBIASIS and, if pertinent, coordinate with  DYSENTERY, AMEBIC or LIVER ABSCESS, AMEBIC; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery (DYSENTERY, AMEBIC). Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded.
=750  \0$aEntamoeba histolytica$5IEN$0(DLC)sh 86001988

=LDR  00813cz  a2200193n  4500
=001  9880363548802441
=005  20141212201117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004747
=035  \\$aCAZ7886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100.$x700.$x335
=150  \\$aEntamoeba
=450  \\$wnnna$aEntamoebas
=550  \\$wg$aTubulina
=550  \\$wh$aEntamoeba histolytica
=667  \\$ainfection = ENTAMOEBIASIS but see note there; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans.
=750  \0$aEntamoeba$5IEN$0(DLC)sh 86001986

=LDR  02270cz  a2200493n  4500
=001  9880363548902441
=005  20141212201014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004577
=035  \\$aCAZ7714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402.$x250
=072  \\$aE5.$x196.$x867.$x800.$x360
=072  \\$aE5.$x595.$x402.$x250
=072  \\$aE5.$x799.$x830.$x360
=150  \\$aElectron Probe Microanalysis
=450  \\$wnnna$aElectron Probe Microanalyses
=450  \\$wnnna$aMicroanalyses, Electron Probe
=450  \\$wnnna$aMicroanalysis, Electron Probe
=450  \\$wnnna$aMicroanalysis, X-Ray
=450  \\$aMicroscopy, Electron, X-Ray Microanalysis
=450  \\$wnnna$aProbe Microanalyses, Electron
=450  \\$wnnna$aProbe Microanalysis, Electron
=450  \\$wnnna$aSpectrometry, X Ray Emission, Electron Microscopic
=450  \\$aSpectrometry, X-Ray Emission, Electron Microscopic
=450  \\$wnnna$aSpectrometry, X Ray Emission, Electron Probe
=450  \\$aSpectrometry, X-Ray Emission, Electron Probe
=450  \\$wnnna$aX Ray Emission Spectrometry, Electron Microscopic
=450  \\$aX-Ray Emission Spectrometry, Electron Microscopic
=450  \\$wnnna$aX Ray Emission Spectrometry, Electron Probe
=450  \\$aX-Ray Emission Spectrometry, Electron Probe
=450  \\$wnnna$aX-Ray Microanalysis
=450  \\$wnnna$aX Ray Microanalysis
=450  \\$aX-Ray Microanalysis, Electron Microscopic
=450  \\$wnnna$aX Ray Microanalysis, Electron Microscopic
=450  \\$aX-Ray Microanalysis, Electron Probe
=450  \\$wnnna$aX Ray Microanalysis, Electron Probe
=550  \\$wg$aMicroscopy, Electron
=550  \\$wg$aSpectrometry, X-Ray Emission
=550  \\$aNuclear Microscopy
=667  \\$aDF: ELECTRON PROBE MICROANAL
=680  \\$iIdentification and measurement of ELEMENTS and their location based on the fact that X-RAYS emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It is performed with an electron microscope fitted with an x-ray spectrometer, in scanning or transmission mode.
=688  \\$a70(67)
=750  \0$aElectron probe microanalysis$5IEN$0(DLC)sh 85042233

=LDR  00803cz  a2200241n  4500
=001  9880363549002441
=005  20141212201013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004576
=035  \\$aCAZ7713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x405.$x255
=072  \\$aE1.$x370.$x530.$x255
=150  \\$aElectromyography
=450  \\$wnnna$aElectromyographies
=450  \\$wnnna$aElectromyographies, Surface
=450  \\$wnnna$aElectromyography, Surface
=450  \\$wnnna$aSurface Electromyographies
=450  \\$wnnna$aSurface Electromyography
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aMyography
=680  \\$iRecording of the changes in electric potential of muscle by means of surface or needle electrodes.
=750  \0$aElectromyography$5IEN$0(DLC)sh 85042194

=LDR  00767cz  a2200229n  4500
=001  9880363549102441
=005  20141212201013.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004574
=035  \\$aCAZ7711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x260
=072  \\$aG1.$x358.$x750.$x500
=150  \\$aElectromagnetic Fields
=450  \\$wnnna$aElectromagnetic Field
=450  \\$wnnna$aField, Electromagnetic
=450  \\$wnnna$aFields, Electromagnetic
=550  \\$wg$aElectromagnetic Phenomena
=550  \\$wg$aMagnetic Fields
=680  \\$iFields representing the joint interplay of electric and magnetic forces.
=688  \\$a91(75); was see under ELECTROMAGNETICS 1975-90
=750  \0$aElectromagnetic fields$5IEN$0(DLC)sh 85042168

=LDR  00852cz  a2200205n  4500
=001  9880363549202441
=005  20181126103517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004573
=035  \\$aCAZ7710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248
=150  \\$aElectrolytes
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aPolyelectrolytes
=550  \\$wh$aIons
=550  \\$aPotassium Magnesium Aspartate
=667  \\$aGEN: prefer specifics but use for more than three; /ther use: consider also ORAL REHYDRATION THERAPY see FLUID THERAPY
=680  \\$iSubstances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aElectrolytes$5IEN$0(DLC)sh 85042157

=LDR  00581cz  a2200181n  4500
=001  9880363549302441
=005  20141212201012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004572
=035  \\$aCAZ7709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x301.$x250
=150  \\$aElectrolysis
=450  \\$wnnna$aElectrolyses
=550  \\$wg$aElectrochemical Techniques
=550  \\$wh$aElectroplating
=680  \\$iDestruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution.
=750  \0$aElectrolysis$0(DLC) sh 85042152$5IEN

=LDR  01189cz  a2200325n  4500
=001  9880363549402441
=005  20141212201012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004571
=035  \\$aCAZ7708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x200
=072  \\$aE1.$x370.$x405.$x250
=072  \\$aE1.$x370.$x475.$x200
=150  \\$aElectrokymography
=450  \\$wnnna$aElectrokymographies
=450  \\$wnnna$aKymographies, Radiographic
=450  \\$aKymography, Radiographic
=450  \\$wnnna$aPhotokymographies
=450  \\$aPhotokymography
=450  \\$wnnna$aRadiographic Kymographies
=450  \\$wnnna$aRadiographic Kymography
=450  \\$wnnna$aRoentgenkymographies
=450  \\$aRoentgenkymography
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aKymography
=550  \\$wg$aRadiography
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTROKYMOGR
=680  \\$iRadiographic technique combining a photoelectric recording system with fluoroscopy. It is used especially with electrocardiography to study heart motion.
=750  \0$aElectrokymography$5IEN$0(DLC)sh 85042148

=LDR  03593cz  a2200781n  4500
=001  9880364246402441
=005  20141212213747.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x600
=150  \\$aPeroneal Neuropathies
=450  \\$wnnna$aCommon Peroneal Neuropathies
=450  \\$wnnna$aCommon Peroneal Neuropathy
=450  \\$wnnna$aDeep Peroneal Neuropathies
=450  \\$wnnna$aDeep Peroneal Neuropathy
=450  \\$wnnna$aExternal Popliteal Neuropathies
=450  \\$wnnna$aExternal Popliteal Neuropathy
=450  \\$wnnna$aFibular Nerve Disease
=450  \\$wnnna$aFibular Nerve Diseases
=450  \\$wnnna$aFibular Neuropathies
=450  \\$wnnna$aFibular Neuropathy
=450  \\$wnnna$aLateral Popliteal Neuropathies
=450  \\$wnnna$aLateral Popliteal Neuropathy
=450  \\$wnnna$aNerve Disease, Fibular
=450  \\$wnnna$aNerve Disease, Peroneal
=450  \\$wnnna$aNerve Diseases, Fibular
=450  \\$wnnna$aNerve Diseases, Peroneal
=450  \\$wnnna$aNerve Paralyses, Peroneal
=450  \\$wnnna$aNerve Paralysis, Peroneal
=450  \\$wnnna$aNeuropathies, Common Peroneal
=450  \\$wnnna$aNeuropathies, Deep Peroneal
=450  \\$wnnna$aNeuropathies, External Popliteal
=450  \\$wnnna$aNeuropathies, Fibular
=450  \\$wnnna$aNeuropathies, Lateral Popliteal
=450  \\$wnnna$aNeuropathies, Peroneal
=450  \\$wnnna$aNeuropathies, Superficial Peroneal
=450  \\$aNeuropathy, Common Peroneal
=450  \\$aNeuropathy, Deep Peroneal
=450  \\$wnnna$aNeuropathy, External Popliteal
=450  \\$wnnna$aNeuropathy, Fibular
=450  \\$wnnna$aNeuropathy, Lateral Popliteal
=450  \\$wnnna$aNeuropathy, Peroneal
=450  \\$aNeuropathy, Superficial Peroneal
=450  \\$wnnna$aParalyses, Peroneal Nerve
=450  \\$wnnna$aParalysis, Peroneal Nerve
=450  \\$wnnna$aPeroneal Nerve Disease
=450  \\$wnnna$aPeroneal Nerve Diseases
=450  \\$wnnna$aPeroneal Nerve Paralyses
=450  \\$wnnna$aPeroneal Nerve Paralysis
=450  \\$wnnna$aPeroneal Neuropathies, Common
=450  \\$wnnna$aPeroneal Neuropathies, Deep
=450  \\$wnnna$aPeroneal Neuropathies, Superficial
=450  \\$wnnna$aPeroneal Neuropathy
=450  \\$wnnna$aPeroneal Neuropathy, Common
=450  \\$wnnna$aPeroneal Neuropathy, Deep
=450  \\$wnnna$aPeroneal Neuropathy, Superficial
=450  \\$wnnna$aPopliteal Neuropathies, External
=450  \\$wnnna$aPopliteal Neuropathies, Lateral
=450  \\$wnnna$aPopliteal Neuropathy, External
=450  \\$wnnna$aPopliteal Neuropathy, Lateral
=450  \\$wnnna$aSuperficial Peroneal Neuropathies
=450  \\$wnnna$aSuperficial Peroneal Neuropathy
=550  \\$wg$aMononeuropathies
=550  \\$aLeg Injuries
=680  \\$iDisease involving the common PERONEAL NERVE or its branches, the deep and superficial peroneal nerves. Lesions of the deep peroneal nerve are associated with PARALYSIS of dorsiflexion of the ankle and toes and loss of sensation from the web space between the first and second toe. Lesions of the superficial peroneal nerve result in weakness or paralysis of the peroneal muscles (which evert the foot) and loss of sensation over the dorsal and lateral surface of the leg. Traumatic injury to the common peroneal nerve near the head of the FIBULA is a relatively common cause of this condition. (From Joynt, Clinical Neurology, 1995, Ch51, p31)
=688  \\$a2000
=750  \0$aPeroneal nerve$xDiseases$5IEN-M$0(DLC)sh 85100023

=LDR  00818cz  a2200253n  4500
=001  9880364246502441
=005  20141212192957.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x802.$x100
=150  \\$aAcarbose
=450  \\$wnnna$aBay g 5421
=450  \\$wnnna$aBayer Brand of Acarbose
=450  \\$wnnna$aGlucobay
=450  \\$wnnna$aGlucor
=450  \\$wnnna$aGlumida
=450  \\$wnnna$aLasa Brand of Acarbose
=450  \\$wnnna$aPrandase
=450  \\$wnnna$aPrecose
=550  \\$wg$aTrisaccharides
=680  \\$iAn inhibitor of ALPHA-GLUCOSIDASES that retards the digestion and absorption of DIETARY CARBOHYDRATES in the SMALL INTESTINE.
=688  \\$a2000; use ACARBOSE (NM) 1979-1999
=750  \0$aAcarbose$5IEN-M$0(DLC)sh 85000330

=LDR  02096cz  a2200457n  4500
=001  9880364246602441
=005  20141212213744.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x500
=150  \\$aMedian Neuropathy
=450  \\$wnnna$aDistal Medial Neuropathies
=450  \\$wnnna$aDistal Medial Neuropathy
=450  \\$wnnna$aMedial Neuropathies, Distal
=450  \\$wnnna$aMedial Neuropathy, Distal
=450  \\$wnnna$aMedian Nerve Disease
=450  \\$aMedian Nerve Diseases
=450  \\$wnnna$aMedian Nerve Neuralgia
=450  \\$wnnna$aMedian Nerve Neuralgias
=450  \\$wnnna$aMedian Neuropathies
=450  \\$wnnna$aMedian Neuropathies, Proximal
=450  \\$wnnna$aMedian Neuropathy, Proximal
=450  \\$wnnna$aNerve Disease, Median
=450  \\$wnnna$aNerve Diseases, Median
=450  \\$wnnna$aNeuralgia, Median Nerve
=450  \\$wnnna$aNeuralgias, Median Nerve
=450  \\$wnnna$aNeuropathies, Distal Medial
=450  \\$wnnna$aNeuropathies, Median
=450  \\$wnnna$aNeuropathies, Proximal Median
=450  \\$wnnna$aNeuropathy, Distal Medial
=450  \\$wnnna$aNeuropathy, Median
=450  \\$wnnna$aNeuropathy, Proximal Median
=450  \\$wnnna$aProximal Median Neuropathies
=450  \\$wnnna$aProximal Median Neuropathy
=550  \\$wg$aMononeuropathies
=550  \\$wh$aCarpal Tunnel Syndrome
=667  \\$apronator nerve syndrome: coord (IM) with NERVE COMPRESSION SYNDROMES
=680  \\$iDisease involving the median nerve, from its origin at the BRACHIAL PLEXUS to its termination in the hand. Clinical features include weakness of wrist and finger flexion, forearm pronation, thenar abduction, and loss of sensation over the lateral palm, first three fingers, and radial half of the ring finger. Common sites of injury include the elbow, where the nerve passes through the two heads of the pronator teres muscle (pronator syndrome) and in the carpal tunnel (CARPAL TUNNEL SYNDROME).
=688  \\$a2000
=750  \0$aMedian nerve$xDiseases$5IEN-M

=LDR  01470cz  a2200277n  4500
=001  9880364246702441
=005  20141212213631.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020236
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x60
=072  \\$aC10.$x597.$x606.$x525.$x100.$x800
=072  \\$aC23.$x888.$x592.$x604.$x529.$x100.$x800
=072  \\$aF1.$x700.$x625.$x100.$x800
=072  \\$aF3.$x87.$x200.$x800
=150  \\$aAmnesia, Transient Global
=450  \\$wnnna$aGlobal Amnesia, Transient
=450  \\$wnnna$aTGA (Transient Global Amnesia)
=450  \\$wnnna$aTGAs (Transient Global Amnesia)
=450  \\$aTransient Global Amnesia
=550  \\$wg$aAmnesia
=550  \\$wg$aBrain Diseases
=667  \\$aAMNESIA, GLOBAL see AMNESIA is also available
=680  \\$iA syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. (From Adams et al., Principles of Neurology, 6th ed, pp429-30)
=688  \\$a2000
=750  \0$aTransient global amnesia$5IEN-M$0(DLC)sh 90002241

=LDR  00754cz  a2200205n  4500
=001  9880364246802441
=005  20141212214045.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020946
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x833.$x500
=150  \\$aTaxus
=450  \\$wnnna$abrevifolia, Taxus
=450  \\$wnnna$abrevifolias, Taxus
=450  \\$aTaxus brevifolia
=450  \\$wnnna$aTaxus brevifolias
=550  \\$wg$aTaxaceae
=680  \\$iGenus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).
=688  \\$a2000
=750  \0$aTaxus$5IEN-M$0(DLC)sh 85132900

=LDR  00939cz  a2200289n  4500
=001  9880364246902441
=005  20141212214043.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x515.$x810
=150  \\$aShiitake Mushrooms
=450  \\$wnnna$aedode, Lentinula
=450  \\$wnnna$aedode, Lentinus
=450  \\$wnnna$aedodes, Lentinula
=450  \\$wnnna$aedodes, Lentinus
=450  \\$wnnna$aLentinula edode
=450  \\$aLentinula edodes
=450  \\$wnnna$aLentinus edode
=450  \\$aLentinus edodes
=450  \\$wnnna$aMushroom, Shiitake
=450  \\$wnnna$aMushrooms, Shiitake
=450  \\$wnnna$aShiitake Mushroom
=550  \\$wg$aLentinula
=680  \\$iMushrooms in the order AGARICALES containing B vitamins, cortinelin, and the polysaccharide LENTINAN.
=688  \\$a2000; use LENTINUS 1999
=750  \0$aShiitake$5IEN-M$0(DLC)sh 85076013

=LDR  00813cz  a2200217n  4500
=001  9880364247002441
=005  20141212214041.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020940
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x379.$x700
=150  \\$aReishi
=450  \\$aGanoderma lucidum
=450  \\$wnnna$aGanoderma lucidums
=450  \\$wnnna$alucidum, Ganoderma
=450  \\$wnnna$alucidums, Ganoderma
=450  \\$wnnna$aReishus
=550  \\$wg$aGanoderma
=680  \\$iA mushroom, Ganoderma lucidum, of the POLYPORALES order of basidiomycetous fungi. It has long been used in traditional Chinese medicine in various forms. Contains STEROLS; COUMARINS; MANNITOL; POLYSACCHARIDES; and triterpenoids.
=688  \\$a2000
=750  \0$aGanoderma lucidum$5IEN-M$0(DLC)sh 85053037

=LDR  01324cz  a2200313n  4500
=001  9880364247102441
=005  20141212213542.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x127.$x500
=072  \\$aC10.$x228.$x140.$x300.$x100.$x200
=072  \\$aC10.$x228.$x140.$x300.$x535.$x200.$x150
=072  \\$aC14.$x907.$x253.$x61.$x200
=072  \\$aC14.$x907.$x253.$x573.$x200.$x150
=072  \\$aC23.$x550.$x414.$x913.$x100.$x200
=150  \\$aBasal Ganglia Hemorrhage
=450  \\$wnnna$aBasal Ganglionic Hemorrhage
=450  \\$wnnna$aGanglionic Hemorrhage, Basal
=450  \\$wnnna$aHematoma, Basal Ganglia
=450  \\$aHemorrhage, Basal Ganglia
=450  \\$wnnna$aHemorrhage, Basal Ganglionic
=550  \\$wg$aBasal Ganglia Cerebrovascular Disease
=550  \\$wg$aCerebral Hemorrhage
=550  \\$wh$aPutaminal Hemorrhage
=667  \\$acoordinate IM with site (IM) if given; PUTAMINAL HEMORRHAGE is also available
=680  \\$iBleeding within the subcortical regions of cerebral hemispheres (BASAL GANGLIA). It is often associated with HYPERTENSION or ARTERIOVENOUS MALFORMATIONS. Clinical manifestations may include HEADACHE; DYSKINESIAS; and HEMIPARESIS.
=688  \\$a2000
=750  \0$aBasal ganglia$xHemorrhage$5IEN-M

=LDR  00994cz  a2200229n  4500
=001  9880364247202441
=005  20170516152319.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020678
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x560
=150  \\$aMicroscopic Angioscopy
=450  \\$wnnna$aAngioscopies, Microscopic
=450  \\$wnnna$aAngioscopy, Microscopic
=450  \\$wnnna$aCapillaroscopies
=450  \\$aCapillaroscopy
=450  \\$wnnna$aMicroscopic Angioscopies
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aIntravital Microscopy
=680  \\$iThe noninvasive microscopic examination of the microcirculation, commonly done in the nailbed or conjunctiva. In addition to the capillaries themselves, observations can be made of passing blood cells or intravenously injected substances. This is not the same as endoscopic examination of blood vessels (ANGIOSCOPY).
=688  \\$a2000
=750  \0$aCapillaroscopy$5IEN-M$0(DLC)sh 90003387

=LDR  01014cz  a2200289n  4500
=001  9880364247302441
=005  20141212213900.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020690
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x360.$x325.$x150
=072  \\$aD12.$x776.$x402.$x150
=072  \\$aD12.$x776.$x476.$x325.$x150
=150  \\$aGTPase-Activating Proteins
=450  \\$wnnna$aGAP Protein
=450  \\$aGAP Proteins
=450  \\$wnnna$aGTPase-Activating Protein
=450  \\$wnnna$aGTPase Activating Protein
=450  \\$wnnna$aGTPase Activating Proteins
=550  \\$wg$aGTP-Binding Protein Regulators
=550  \\$wh$aChimerin Proteins
=550  \\$wh$aEukaryotic Initiation Factor-5
=550  \\$wh$aras GTPase-Activating Proteins
=550  \\$wh$aRGS Proteins
=680  \\$iProteins that activate the GTPase of specific GTP-BINDING PROTEINS.
=688  \\$a2000; use GTPASE-ACTIVATING PROTEINS (NM) 1988-1999
=750  \0$aGTPase-activating protein$5IEN-M$0(DLC)sh 93000039

=LDR  02297cz  a2200505n  4500
=001  9880364247402441
=005  20141212213710.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020325
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x546.$x399.$x750.$x250
=150  \\$aMigraine with Aura
=450  \\$wnnna$aAcute Onset Aura Migraine
=450  \\$wnnna$aBasilar Artery Migraine
=450  \\$wnnna$aBasilar Migraine
=450  \\$wnnna$aBasilar Migraines
=450  \\$aBasilar-Type Migraine
=450  \\$wnnna$aBasilar Type Migraine
=450  \\$aClassic Migraine
=450  \\$wnnna$aClassical Migraine
=450  \\$aComplicated Migraine
=450  \\$aFamilial Hemiplegic Migraine
=450  \\$wnnna$aFamilial Hemiplegic Migraines
=450  \\$wnnna$aHemiplegic Migraine, Familial
=450  \\$wnnna$aHemiplegic-Ophthalmoplegic Migraine
=450  \\$wnnna$aMigraine Aura without Headache
=450  \\$wnnna$aMigraine, Basilar
=450  \\$wnnna$aMigraine, Basilar Artery
=450  \\$wnnna$aMigraine, Basilar-Type
=450  \\$aMigraine, Classic
=450  \\$wnnna$aMigraine, Classical
=450  \\$wnnna$aMigraine, Complicated
=450  \\$wnnna$aMigraine, Prolonged Aura
=450  \\$wnnna$aMigraine with Acute Onset Aura
=450  \\$wnnna$aMigraine with Auras
=450  \\$wnnna$aMigraine with Prolonged Aura
=450  \\$wnnna$aMigraine with Typical Aura
=450  \\$wnnna$aProlonged Aura Migraine
=450  \\$wnnna$aTypical Aura without Headache
=550  \\$wg$aMigraine Disorders
=680  \\$iA subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
=688  \\$a2006 (2000); for COMPLICATED MIGRAINE use MIGRAINE 2000-2005
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Classic Migraine
=688  \\$a2000
=750  \0$aMigraine aura$0(DLC)sh2006002065$5IEN-M

=LDR  00968cz  a2200253n  4500
=001  9880364247502441
=005  20141212213559.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020179
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x281.$x440
=072  \\$aC10.$x886.$x425.$x200.$x500
=072  \\$aF3.$x870.$x400.$x200.$x500
=150  \\$aJet Lag Syndrome
=450  \\$wnnna$aJet Lag Syndromes
=450  \\$aTime Zone Change Syndrome
=450  \\$wnnna$aTime Zone Syndrome
=450  \\$wnnna$aTime Zone Syndromes
=550  \\$wg$aChronobiology Disorders
=550  \\$wg$aSleep Disorders, Circadian Rhythm
=550  \\$aAir Travel
=680  \\$iA chronobiologic disorder resulting from rapid travel across a number of time zones, characterized by insomnia or hypersomnolence, fatigue, behavioral symptoms, headaches, and gastrointestinal disturbances. (From Cooper, Sleep, 1994, pp593-8)
=688  \\$a2000
=750  \0$aJet lag$5IEN-M$0(DLC)sh 85070158

=LDR  01731cz  a2200445n  4500
=001  9880364247602441
=005  20200622113458.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x330.$x300.$x400.$x700
=072  \\$aD12.$x644.$x360.$x525.$x700
=072  \\$aD12.$x776.$x157.$x325.$x515.$x700
=072  \\$aD12.$x776.$x476.$x525.$x700
=150  \\$arho GTP-Binding Proteins
=450  \\$wnnna$aG-Proteins, rho
=450  \\$wnnna$aGTP-Binding Protein, rho
=450  \\$wnnna$aGTP-Binding Proteins, rho
=450  \\$wnnna$aGTPases, rho
=450  \\$wnnna$aP21 (rho)Protein
=450  \\$wnnna$aP21, rho Protein
=450  \\$arho G-Proteins
=450  \\$wnnna$arho G Proteins
=450  \\$wnnna$arho GTP-Binding Protein
=450  \\$wnnna$arho GTP Binding Protein
=450  \\$wnnna$arho GTP Binding Proteins
=450  \\$arho GTPases
=450  \\$wnnna$arho Protein P21
=450  \\$arho Small GTP-Binding Proteins
=450  \\$wnnna$arho Small GTP Binding Proteins
=550  \\$wg$aMonomeric GTP-Binding Proteins
=550  \\$wh$acdc42 GTP-Binding Protein
=550  \\$wh$acdc42 GTP-Binding Protein, Saccharomyces cerevisiae
=550  \\$wh$arac GTP-Binding Proteins
=550  \\$wh$arhoA GTP-Binding Protein
=550  \\$wh$arhoB GTP-Binding Protein
=550  \\$wh$arhoC GTP-Binding Protein
=680  \\$iA large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.
=688  \\$a2000; use RHO GTP-BINDING PROTEINS (NM) 1992-1999
=750  \0$aRho GTPases$5IEN-M$0(DLC)sh2003008350

=LDR  02044cz  a2200409n  4500
=001  9880364247702441
=005  20141212213750.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020433
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x775
=150  \\$aTrigeminal Nerve Diseases
=450  \\$aCranial Nerve V Diseases
=450  \\$aFifth Cranial Nerve Diseases
=450  \\$wnnna$aIdiopathic Trigeminal Neuropathies
=450  \\$wnnna$aIdiopathic Trigeminal Neuropathy
=450  \\$wnnna$aNeuropathies, Idiopathic Trigeminal
=450  \\$wnnna$aNeuropathies, Trigeminal
=450  \\$wnnna$aNeuropathy, Idiopathic Trigeminal
=450  \\$wnnna$aNeuropathy, Trigeminal
=450  \\$aRaeder Paratrigeminal Syndrome
=450  \\$wnnna$aSyndrome, Raeder Paratrigeminal
=450  \\$wnnna$aTrigeminal Nerve Disease
=450  \\$wnnna$aTrigeminal Nerve Disorder
=450  \\$wnnna$aTrigeminal Nerve Disorders
=450  \\$wnnna$aTrigeminal Neuropathies
=450  \\$wnnna$aTrigeminal Neuropathies, Idiopathic
=450  \\$wnnna$aTrigeminal Neuropathy
=450  \\$wnnna$aTrigeminal Neuropathy, Idiopathic
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aTrigeminal Nerve Injuries
=550  \\$wh$aTrigeminal Neuralgia
=550  \\$aCranial Nerve Injuries
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.
=688  \\$a2000
=750  \0$aTrigeminal nerve$xDiseases$0(DLC) sh 93006396$5IEN-M

=LDR  01293cz  a2200361n  4500
=001  9880364247802441
=005  20141212214009.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x387
=072  \\$aC10.$x500.$x142
=072  \\$aC10.$x551.$x240.$x375
=072  \\$aC16.$x131.$x666.$x142
=150  \\$aCentral Nervous System Cysts
=450  \\$wnnna$aCleft Cysts, Rathke's
=450  \\$wnnna$aCyst, Suprasellar
=450  \\$aCysts, Central Nervous System
=450  \\$wnnna$aCysts, Rathke Cleft
=450  \\$wnnna$aCysts, Suprasellar
=450  \\$aRathke Cleft Cysts
=450  \\$wnnna$aRathke's Cleft Cysts
=450  \\$wnnna$aRathkes Cleft Cysts
=450  \\$aSuprasellar Cyst
=450  \\$wnnna$aSuprasellar Cysts
=550  \\$wg$aCentral Nervous System Neoplasms
=550  \\$wg$aNervous System Malformations
=550  \\$wh$aArachnoid Cysts
=550  \\$wh$aColloid Cysts
=667  \\$acoord with organ neopl site
=680  \\$iCongenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.
=688  \\$a2000; for SUPRASELLAR CYST use CRANIOPHARYNGIOMA 1966-1999
=750  \0$aCentral nervous system$xCysts$5IEN-M

=LDR  01233cz  a2200337n  4500
=001  9880364247902441
=005  20141212213909.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020724
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x720.$x327
=072  \\$aJ1.$x637.$x51.$x720.$x327
=072  \\$aJ1.$x637.$x412
=150  \\$aElastomers
=450  \\$wnnna$aElastomer
=450  \\$wnnna$aRubber, Synthetic
=450  \\$wnnna$aRubbers, Synthetic
=450  \\$aSynthetic Rubber
=450  \\$wnnna$aSynthetic Rubbers
=550  \\$wg$aManufactured Materials
=550  \\$wg$aPolymers
=550  \\$wh$aNeoprene
=550  \\$wh$aPolyurethanes
=550  \\$wh$aPolyvinyl Chloride
=550  \\$wh$aRubber
=550  \\$wh$aSilicone Elastomers
=667  \\$aSILICONE ELASTOMERS is available
=680  \\$iA generic term for all substances having the properties of stretching under tension, high tensile strength, retracting rapidly, and recovering their original dimensions fully. They are generally POLYMERS.
=688  \\$a2000; for SYNTHETIC RUBBER use RUBBER 2000-2006; for ELASTOMERS use RUBBER 1981-1999
=688  \\$a2000; for ELASTOMERS use RUBBER 1981-1999
=750  \0$aElastomers$0(DLC) sh 85041520$5IEN-M

=LDR  01321cz  a2200313n  4500
=001  9880364248002441
=005  20141212214004.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x195
=150  \\$aChamomile
=450  \\$wnnna$aCamomile
=450  \\$wnnna$aCamomiles
=450  \\$wnnna$aChamomile Oil
=450  \\$wnnna$aChamomile Oils
=450  \\$wnnna$aChamomiles
=450  \\$wnnna$aOil, Chamomile
=450  \\$wnnna$aOils, Chamomile
=550  \\$wg$aAsteraceae
=550  \\$wh$aAnthemis
=550  \\$wh$aChamaemelum
=550  \\$wh$aMatricaria
=550  \\$wh$aTripleurospermum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iCommon name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.
=688  \\$a2000
=750  \0$aRoman chamomile$5IEN-M$0(DLC)sh 99005120
=750  \0$aGerman chamomile$5IEN-M$0(DLC)sh 85082209

=LDR  01025cz  a2200217n  4500
=001  9880364248102441
=005  20141212213959.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020829
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x175
=150  \\$aEquisetum
=450  \\$wnnna$aEquisetaceae
=450  \\$wnnna$aEquisetums
=450  \\$aHorsetail
=450  \\$wnnna$aHorsetails
=550  \\$wg$aEmbryophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe only living genus of the order Equisetales, class Equisetopsida (Sphenopsida), division Equisetophyta (Sphenophyta); distantly related to ferns. It grows in moist places. The hollow, jointed, ridged stems contain SILICATES.
=688  \\$a2000
=750  \0$aEquisetum$5IEN-M$0(DLC)sh 85044551

=LDR  00600cz  a2200193n  4500
=001  9880364248202441
=005  20141212213902.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020699
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x260.$x320
=072  \\$aE7.$x858.$x240.$x260.$x320
=150  \\$aGastroscopes
=450  \\$wnnna$aGastroscope
=550  \\$wg$aEndoscopes, Gastrointestinal
=550  \\$aGastroscopy
=680  \\$iEndoscopes used for examining the interior of the stomach.
=688  \\$a2000; use ENDOSCOPES 1998-1999
=750  \0$aGastroscopes$5IEN-M$0(DLC)sh 87003090

=LDR  01223cz  a2200265n  4500
=001  9880364248302441
=005  20141212213749.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020431
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x650
=150  \\$aOlfactory Nerve Diseases
=450  \\$aCranial Nerve I Diseases
=450  \\$wnnna$aCranial Nerve I Disorders
=450  \\$aFirst Cranial Nerve Diseases
=450  \\$wnnna$aOlfactory Nerve Disease
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aEsthesioneuroblastoma, Olfactory
=550  \\$wh$aOlfactory Nerve Injuries
=550  \\$aCranial Nerve Injuries
=550  \\$aOlfaction Disorders
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the first cranial (olfactory) nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. (Adams et al., Principles of Neurology, 6th ed, pp229-31)
=688  \\$a2000
=750  \0$aOlfactory nerve$xDiseases$5IEN-M

=LDR  01334cz  a2200301n  4500
=001  9880364248502441
=005  20141212213747.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020428
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x200
=150  \\$aFemoral Neuropathy
=450  \\$wnnna$aFemoral Mononeuropathies
=450  \\$aFemoral Mononeuropathy
=450  \\$wnnna$aFemoral Nerve Disease
=450  \\$aFemoral Nerve Diseases
=450  \\$wnnna$aFemoral Neuritis
=450  \\$wnnna$aFemoral Neuropathies
=450  \\$wnnna$aMononeuropathies, Femoral
=450  \\$aMononeuropathy, Femoral
=450  \\$wnnna$aNerve Disease, Femoral
=450  \\$wnnna$aNerve Diseases, Femoral
=450  \\$wnnna$aNeuropathies, Femoral
=450  \\$aNeuropathy, Femoral
=550  \\$wg$aMononeuropathies
=680  \\$iDisease involving the femoral nerve. The femoral nerve may be injured by ISCHEMIA (e.g., in association with DIABETIC NEUROPATHIES), nerve compression, trauma, COLLAGEN DISEASES, and other disease processes. Clinical features include MUSCLE WEAKNESS or PARALYSIS of hip flexion and knee extension, ATROPHY of the QUADRICEPS MUSCLE, reduced or absent patellar reflex, and impaired sensation over the anterior and medial thigh.
=688  \\$a2000
=750  \0$aFemoral nerve$xDiseases$5IEN-M

=LDR  01199cz  a2200349n  4500
=001  9880364248602441
=005  20141212213832.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020567
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144.$x300
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x300
=072  \\$aE5.$x41.$x124.$x160.$x750.$x300
=072  \\$aG7.$x100.$x100.$x160.$x120.$x300
=072  \\$aG7.$x700.$x320.$x249.$x314.$x120.$x300
=072  \\$aG7.$x700.$x320.$x500.$x325.$x235.$x937
=072  \\$aG8.$x686.$x280
=150  \\$aFetal Weight
=450  \\$aBody Weight, Fetal
=450  \\$wnnna$aBody Weights, Fetal
=450  \\$wnnna$aFetal Body Weight
=450  \\$wnnna$aFetal Body Weights
=450  \\$wnnna$aFetal Weights
=450  \\$wnnna$aWeight, Fetal
=450  \\$wnnna$aWeights, Fetal
=550  \\$wg$aBody Weight
=550  \\$wg$aFetal Development
=550  \\$wg$aReproductive Physiological Phenomena
=667  \\$amammalian only
=680  \\$iThe weight of the FETUS in utero. It is usually estimated by various formulas based on measurements made during PRENATAL ULTRASONOGRAPHY.
=688  \\$a2000
=750  \0$aFetus$xWeight$5IEN-M

=LDR  00911cz  a2200241n  4500
=001  9880364248702441
=005  20141212213851.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365.$x795.$x598
=150  \\$aPolymorphism, Single Nucleotide
=450  \\$wnnna$aNucleotide Polymorphism, Single
=450  \\$wnnna$aNucleotide Polymorphisms, Single
=450  \\$wnnna$aPolymorphisms, Single Nucleotide
=450  \\$aSingle Nucleotide Polymorphism
=450  \\$wnnna$aSingle Nucleotide Polymorphisms
=450  \\$aSNPs
=550  \\$wg$aPolymorphism, Genetic
=667  \\$ado not confuse with POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL
=680  \\$iA single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.
=688  \\$a2000
=750  \0$aSingle nucleotide polymorphisms$5(DLC)sh2013002602$5IEN-M

=LDR  03146cz  a2200793n  4500
=001  9880364248802441
=005  20141212213658.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020295
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195.$x411.$x100
=072  \\$aC10.$x228.$x140.$x211.$x500.$x100
=072  \\$aC10.$x551.$x240.$x250.$x400.$x200
=150  \\$aBrain Stem Neoplasms
=450  \\$wnnna$aBrain Stem Neoplasm
=450  \\$wnnna$aBrain Stem Neoplasms, Primary
=450  \\$wnnna$aBrain Stem Tumor
=450  \\$wnnna$aBrain Stem Tumors
=450  \\$wnnna$aBrainstem Neoplasm
=450  \\$wnnna$aBrainstem Neoplasm, Primary
=450  \\$wnnna$aBrainstem Neoplasms
=450  \\$wnnna$aBrainstem Neoplasms, Primary
=450  \\$wnnna$aBrainstem Tumor
=450  \\$wnnna$aBrainstem Tumors
=450  \\$wnnna$aMedullary Neoplasm
=450  \\$aMedullary Neoplasms
=450  \\$wnnna$aMedullary Tumor
=450  \\$wnnna$aMedullary Tumors
=450  \\$wnnna$aMesencephalic Neoplasm
=450  \\$aMesencephalic Neoplasms
=450  \\$wnnna$aMidbrain Neoplasm
=450  \\$aMidbrain Neoplasms
=450  \\$wnnna$aMidbrain Tumor
=450  \\$wnnna$aMidbrain Tumors
=450  \\$wnnna$aNeoplasm, Brain Stem
=450  \\$wnnna$aNeoplasm, Brainstem
=450  \\$wnnna$aNeoplasm, Medullary
=450  \\$wnnna$aNeoplasm, Mesencephalic
=450  \\$wnnna$aNeoplasm, Midbrain
=450  \\$wnnna$aNeoplasm, Pontine
=450  \\$wnnna$aNeoplasm, Primary Brainstem
=450  \\$wnnna$aNeoplasms, Brain Stem
=450  \\$wnnna$aNeoplasms, Brainstem
=450  \\$wnnna$aNeoplasms, Brainstem, Primary
=450  \\$wnnna$aNeoplasms, Medullary
=450  \\$wnnna$aNeoplasms, Mesencephalic
=450  \\$wnnna$aNeoplasms, Midbrain
=450  \\$wnnna$aNeoplasms, Pontine
=450  \\$wnnna$aNeoplasms, Primary Brainstem
=450  \\$wnno$aPontine Glioma$5IEN-M
=450  \\$wnnna$aPontine Neoplasm
=450  \\$aPontine Neoplasms
=450  \\$wnnna$aPontine Tumor
=450  \\$wnnna$aPontine Tumors
=450  \\$wnnna$aPrimary Brain Stem Neoplasms
=450  \\$wnnna$aPrimary Brainstem Neoplasm
=450  \\$wnnna$aPrimary Brainstem Neoplasms
=450  \\$wnnna$aTumor, Brain Stem
=450  \\$wnnna$aTumor, Medullary
=450  \\$wnnna$aTumor, Midbrain
=450  \\$wnnna$aTumor, Pontine
=450  \\$wnnna$aTumors, Medullary
=450  \\$wnnna$aTumors, Midbrain
=450  \\$wnnna$aTumors, Pontine
=550  \\$wg$aInfratentorial Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iBenign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.
=688  \\$a2000
=750  \0$aBrain stem$xCancer$0(DLC) sh2010008347$5IEN-M

=LDR  01903cz  a2200409n  4500
=001  9880364248902441
=005  20141212213420.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019859
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x75
=072  \\$aD12.$x776.$x543.$x750.$x60.$x186
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x100
=072  \\$aD12.$x776.$x624.$x664.$x700.$x186
=150  \\$aProto-Oncogene Proteins c-met
=450  \\$ac-met Proteins
=450  \\$wnnna$ac met Proteins
=450  \\$aHepatocyte Growth Factor Receptor
=450  \\$aHGF Receptor
=450  \\$amet Proto-Oncogene Proteins
=450  \\$wnnna$amet Proto Oncogene Proteins
=450  \\$wnnna$aProto Oncogene Proteins c met
=450  \\$wnnna$aProto-Oncogene Proteins, met
=450  \\$wnnna$aReceptor, Hepatocyte Growth Factor
=450  \\$wnnna$aReceptor, HGF
=450  \\$wnnna$aReceptor, Scatter Factor
=450  \\$wnnna$aScatter Factor Receptor
=550  \\$wg$aProto-Oncogene Proteins
=550  \\$wg$aReceptor Protein-Tyrosine Kinases
=550  \\$wg$aReceptors, Growth Factor
=667  \\$aDF: C MET PROTEINS
=680  \\$iCell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations of the gene for PROTO-ONCOGENE PROTEINS C-MET are associated with papillary renal carcinoma and other neoplasia.
=688  \\$a2006, 1998-1999
=688  \\$a2006(1998)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Proto-Oncogene Protein c-met
=688  \\$a2000(1998); use PROTO-ONCOGENE PROTEIN C-MET (NM) 1989-1997
=750  \0$aHepatocyte growth factor$xReceptors$0(DLC) sh 92004250$5IEN-M

=LDR  01137cz  a2200265n  4500
=001  9880364249002441
=005  20141212213418.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019855
=035  \\$aCVE6162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250.$x268
=150  \\$aEthylene Glycol
=450  \\$wnnna$a1,2-Ethanediol
=450  \\$wnnna$a1,2 Ethanediol
=450  \\$wnnna$a2-Hydroxyethanol
=450  \\$wnnna$a2 Hydroxyethanol
=450  \\$wnnna$aGlycol, Ethylene
=450  \\$wnnna$aGlycol, Monoethylene
=450  \\$wnnna$aMonoethylene Glycol
=550  \\$wg$aEthylene Glycols
=667  \\$aETHYLENE GLYCOLS also available
=680  \\$iA colorless, odorless, viscous dihydroxy alcohol. It has a sweet taste, but is poisonous if ingested. Ethylene glycol is the most important glycol commercially available and is manufactured on a large scale in the United States. It is used as an antifreeze and coolant, in hydraulic fluids, and in the manufacture of low-freezing dynamites and resins.
=688  \\$a98; use ETHYLENE GLYCOL (NM) 1982-97
=750  \0$aEthylene glycol$5IEN-M$0(DLC)sh 98000445

=LDR  01117cz  a2200229n  4500
=001  9880364249102441
=005  20170717165359.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019962
=035  \\$aCVE6154M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x937
=150  \\$aReactive Attachment Disorder
=450  \\$wnnna$aAttachment Disorder, Reactive
=450  \\$wnnna$aAttachment Disorders, Reactive
=450  \\$wnnna$aDisorder, Reactive Attachment
=450  \\$wnnna$aDisorders, Reactive Attachment
=450  \\$wnnna$aReactive Attachment Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=680  \\$iMarkedly disturbed and developmentally inappropriate social relatedness that begins before age 5 and is associated with grossly pathological child care. The child may persistently fail to initiate and respond to social interactions in a developmentally appropriate way (inhibited type) or there may be a pattern of diffuse attachments with nondiscriminate sociability (disinhibited type). (From DSM-IV, 1994)
=688  \\$a98
=750  \0$aAttachment disorder$0(DLC)sh2005001291$5IEN-M

=LDR  01331cz  a2200337n  4500
=001  9880364249202441
=005  20141212192924.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019999
=035  \\$aCVE6153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776.$x708
=072  \\$aD27.$x505.$x954.$x578
=072  \\$aD27.$x720.$x752
=150  \\$aPharmaceutical Solutions
=450  \\$wnnna$aPharmaceutic Solutions
=450  \\$wnnna$aSolutions, Pharmaceutic
=450  \\$wnnna$aSolutions, Pharmaceutical
=550  \\$wg$aSolutions
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aCardioplegic Solutions
=550  \\$wh$aDialysis Solutions
=550  \\$wh$aOphthalmic Solutions
=550  \\$wh$aParenteral Nutrition Solutions
=550  \\$wh$aSclerosing Solutions
=550  \\$aSolutions
=667  \\$aIM general only; coordinate NIM with specific drug in solution (IM)
=680  \\$iHomogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.
=688  \\$a98
=750  \0$aSolutions (Pharmacy)$5IEN-M$0(DLC)sh 85124736

=LDR  00918cz  a2200193n  4500
=001  9880364249302441
=005  20141212213446.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019936
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x456.$x500
=150  \\$aProbiotics
=450  \\$wnnna$aProbiotic
=550  \\$wg$aDietary Supplements
=550  \\$aPrebiotics
=667  \\$aDo not confuse with PREBIOTICS
=680  \\$iLive microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)
=688  \\$a98
=750  \0$aProbiotics$0(DLC)sh2006003499$5IEN-M

=LDR  01462cz  a2200361n  4500
=001  9880364249402441
=005  20141212213253.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019576
=035  \\$aCVE6149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x566
=150  \\$aPorpoises
=450  \\$wnnna$aAustralophocaena dioptrica
=450  \\$aDall Porpoise
=450  \\$aFinless Porpoise
=450  \\$wnnna$aFinless Porpoises
=450  \\$wnnna$aNeophocaena phocaenoides
=450  \\$aPhocoenidae
=450  \\$wnnna$aPhocoenoides dalli
=450  \\$wnnna$aPorpoise
=450  \\$wnnna$aPorpoise, Dall
=450  \\$wnnna$aPorpoise, Finless
=450  \\$wnnna$aPorpoise, Spectacled
=450  \\$wnnna$aPorpoises, Finless
=450  \\$wnnna$aPorpoises, Spectacled
=450  \\$aSpectacled Porpoise
=450  \\$wnnna$aSpectacled Porpoises
=550  \\$wg$aCetacea
=550  \\$wh$aPhocoena
=680  \\$iMammals of the family Phocoenidae comprising four genera found in the North Pacific Ocean and both sides of the North Atlantic Ocean and in various other seas. They differ from DOLPHINS in that porpoises have a blunt snout and a rather stocky body while dolphins have a beak-like snout and a slender, streamlined body. They usually travel in small groups. (From Walker's Mammals of the World, 5th ed, pp1003-4)
=688  \\$a98; use DOLPHINS 1968-97
=750  \0$aPorpoises$5IEN-M$0(DLC)sh 85105031

=LDR  01819cz  a2200433n  4500
=001  9880364249502441
=005  20141212192914.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019587
=035  \\$aCVE6148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x456
=150  \\$aDietary Supplements
=450  \\$wnnna$aDietary Supplement
=450  \\$wnnna$aDietary Supplementations
=450  \\$wnnna$aFood Supplement
=450  \\$wnnna$aFood Supplementations
=450  \\$aFood Supplements
=450  \\$wnnna$aNeutraceutical
=450  \\$aNeutraceuticals
=450  \\$wnnna$aNutraceutical
=450  \\$wnnna$aNutraceuticals
=450  \\$wnnna$aNutriceutical
=450  \\$wnnna$aNutriceuticals
=450  \\$wnnna$aSupplement, Dietary
=450  \\$wnnna$aSupplement, Food
=450  \\$wnnna$aSupplementations, Dietary
=450  \\$wnnna$aSupplements, Dietary
=450  \\$wnnna$aSupplements, Food
=550  \\$wg$aFood
=550  \\$wh$aPrebiotics
=550  \\$wh$aProbiotics
=550  \\$wh$aSynbiotics
=550  \\$wh$aYeast, Dried
=550  \\$aFunctional Food
=667  \\$ado not confuse with FOOD, FORTIFIED or FOOD, FORMULATED or FOOD ADDITIVES or FUNCTIONAL FOOD; coordinate IM with specific nutrient if relevant (IM)
=680  \\$iProducts in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients.  Dietary supplements can include macronutrients, such as protein, carbohydrates, and fats; and/or MICRONUTRIENTS, such as vitamins, minerals, PHYTOCHEMICALS, or similar nutritional substances.
=688  \\$a98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97
=750  \0$aDietary supplements$5IEN-M$0(DLC)sh 85037861

=LDR  01126cz  a2200277n  4500
=001  9880364249602441
=005  20141212213401.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019798
=035  \\$aCVE6141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x631.$x202.$x500
=072  \\$aD8.$x211.$x90.$x500
=150  \\$aNeopterin
=450  \\$a2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone
=450  \\$wnnna$aMonapterin
=450  \\$wnnna$aNeopterin, (erythro-D)-Isomer
=450  \\$wnnna$aNeopterin, (erythro-L)-Isomer
=450  \\$wnnna$aNeopterin, (R*, R*)-Isomer
=450  \\$wnnna$aNeopterin, (threo-D)-Isomer
=450  \\$wnnna$aNeopterin, (threo-L)-Isomer
=450  \\$wnnna$aUmanopterin
=550  \\$wg$aBiopterin
=680  \\$iA pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.
=688  \\$a98; use NEOPTERIN (NM) 1979-97
=750  \0$aNeopterin$5IEN-M$0(DLC)sh 91004709

=LDR  01344cz  a2200385n  4500
=001  9880364249702441
=005  20141212213302.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019616
=035  \\$aCVE6140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928
=150  \\$aThoracic Surgical Procedures
=450  \\$wnnna$aProcedure, Thoracic Surgical
=450  \\$wnnna$aProcedures, Thoracic Surgical
=450  \\$wnnna$aSurgical Procedure, Thoracic
=450  \\$wnnna$aSurgical Procedures, Thoracic
=450  \\$wnnna$aThoracic Surgical Procedure
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aCardiac Surgical Procedures
=550  \\$wh$aMediastinoscopy
=550  \\$wh$aPulmonary Surgical Procedures
=550  \\$wh$aSternotomy
=550  \\$wh$aThoracoplasty
=550  \\$wh$aThoracoscopy
=550  \\$wh$aThoracostomy
=550  \\$wh$aThoracotomy
=550  \\$wh$aThymectomy
=550  \\$wh$aTracheostomy
=550  \\$wh$aTracheotomy
=550  \\$aThoracic Surgery
=667  \\$anote category: do not confuse with THORACIC SURGERY, the surg specialty; GEN or unspecified; prefer specifics; DF: THORACIC SURG PROCEDURES
=680  \\$iSurgery performed on the thoracic organs, most commonly the lungs and the heart.
=688  \\$a98
=750  \0$aChest$xSurgery$5IEN-M$0(DLC)sh 85023143

=LDR  01331cz  a2200373n  4500
=001  9880364249802441
=005  20141212213502.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019986
=035  \\$aCVE6138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150.$x750
=150  \\$aPersons With Hearing Impairments
=450  \\$wnnna$aDeaf Person
=450  \\$aDeaf Persons
=450  \\$wnnna$aDisabled Persons, Hearing
=450  \\$aHard of Hearing Persons
=450  \\$wnnna$aHearing Disabled Person
=450  \\$wnnna$aHearing Disabled Persons
=450  \\$wnnna$aHearing Impaired Person
=450  \\$aHearing Impaired Persons
=450  \\$wnnna$aPerson, Deaf
=450  \\$wnnna$aPerson, Hearing Disabled
=450  \\$wnnna$aPerson, Hearing Impaired
=450  \\$wnnna$aPersons, Deaf
=450  \\$wnnna$aPersons, Hearing Disabled
=450  \\$wnnna$aPersons, Hearing Impaired
=550  \\$wg$aDisabled Persons
=550  \\$aDeaf-Blind Disorders
=550  \\$aHearing Disorders
=680  \\$iPersons with any degree of loss of hearing that has an impact on their activities of daily living or that requires special assistance or intervention.
=688  \\$a98
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Hearing Impaired Persons
=750  \0$aHearing impaired$5IEN-M$0(DLC)sh 85059626

=LDR  01270nz  a2200325n  4500
=001  9881821164702441
=005  20220303084548.0
=008  970620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D019989
=035  \\$a(DNLM)D019989
=035  \\$a(NLM)98197037760000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x150.$x600
=150  \\$aPersons with Mental Disabilities
=450  \\$wnnna$aMentally Retarded
=450  \\$aIntellectually Disabled Persons
=450  \\$aMentally Disabled
=450  \\$aMentally Disabled Persons
=450  \\$aMentally Handicapped
=450  \\$aPersons with Intellectual Disability
=450  \\$wnnna$aDisabled Persons, Intellectually
=450  \\$wnnna$aDisabled, Mentally
=450  \\$wnnna$aIntellectually Disabled Person
=450  \\$wnnna$aMentally Disabled Person
=450  \\$wnnna$aPerson, Mentally Disabled
=450  \\$wnnna$aPersons, Intellectually Disabled
=450  \\$wnnna$aPersons, Mentally Disabled
=680  \\$iPersons diagnosed as having significantly lower than average intelligence and considerable problems in adapting to everyday life or lacking independence in regard to activities of daily living.
=688  \\$a98
=750  \0$aPeople with mental disabilities$0(DLC) sh 85083667$5IEN-M

=LDR  01226cz  a2200337n  4500
=001  9880364250002441
=005  20180829124819.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019696
=035  \\$aCVE6133M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x325.$x500
=150  \\$aPeptidylprolyl Isomerase
=450  \\$wnnna$acis-trans-Isomerase, Peptidyl-Prolyl
=450  \\$wnnna$aIsomerase, Peptidylprolyl
=450  \\$wnnna$aIsomerase, Proline
=450  \\$wnnna$aIsomerase, Prolyl
=450  \\$aPeptidyl-Prolyl cis-trans-Isomerase
=450  \\$wnnna$aPeptidyl Prolyl cis trans Isomerase
=450  \\$aPPIase
=450  \\$wnnna$aProline Isomerase
=450  \\$wnnna$aProline Rotamase
=450  \\$aProlyl Isomerase
=450  \\$wnnna$aRotamase, Proline
=550  \\$wg$acis-trans-Isomerases
=550  \\$wh$aImmunophilins
=550  \\$wh$aNIMA-Interacting Peptidylprolyl Isomerase
=550  \\$wh$aPeptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4
=680  \\$iAn enzyme that catalyzes the isomerization of proline residues within proteins. EC 5.2.1.8.
=688  \\$a98; use PEPTIDYLPROLYL ISOMERASE (NM) 1984-97
=750  \0$aPeptidylprolyl Isomerase$5IEN-M$0(DLC)sh 98002861

=LDR  01170cz  a2200265n  4500
=001  9880364250102441
=005  20141212213421.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019862
=035  \\$aCVE6122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975
=150  \\$aZingiberales
=450  \\$wnnna$aZingiberale
=550  \\$wg$aAngiosperms
=550  \\$wh$aCostus
=550  \\$wh$aHeliconiaceae
=550  \\$wh$aMarantaceae
=550  \\$wh$aMusaceae
=550  \\$wh$aStrelitziaceae
=550  \\$wh$aZingiberaceae
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThis plant order includes 8 families, 66 genera, and about 1,800 species. These herbaceous perennials are mainly found in the wet tropics. Members include the banana family (MUSACEAE) and GINGER family (ZINGIBERACEAE).
=688  \\$a1998
=750  \0$aZingiberales$5IEN-M$0(DLC)sh 85118722

=LDR  01990cz  a2200589n  4500
=001  9880364250202441
=005  20180712121139.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019666
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x456.$x937
=150  \\$aRubiaceae
=450  \\$aBouvardia
=450  \\$wnnna$aBouvardias
=450  \\$aChiococca
=450  \\$wnnna$aChiococcas
=450  \\$aCruciata
=450  \\$wnnna$aCruciatas
=450  \\$aIsertia
=450  \\$wnnna$aIsertias
=450  \\$aNauclea
=450  \\$wnnna$aNaucleas
=450  \\$aPalicourea
=450  \\$wnnna$aPalicoureas
=450  \\$aPentanisia
=450  \\$wnnna$aPentanisias
=450  \\$aPentas
=450  \\$aRandia
=450  \\$wnnna$aRandias
=450  \\$aSaprosma
=450  \\$wnnna$aSaprosmas
=450  \\$aSchumanniophyton
=450  \\$wnnna$aSchumanniophytons
=550  \\$wg$aGentianales
=550  \\$wh$aCephaelis
=550  \\$wh$aCinchona
=550  \\$wh$aCoffea
=550  \\$wh$aGalium
=550  \\$wh$aGardenia
=550  \\$wh$aHamelia
=550  \\$wh$aHedyotis
=550  \\$wh$aMitragyna
=550  \\$wh$aMorinda
=550  \\$wh$aOldenlandia
=550  \\$wh$aPausinystalia
=550  \\$wh$aPsychotria
=550  \\$wh$aRubia
=550  \\$wh$aUncaria
=667  \\$ado not confuse X ref CRUCIATA with crucifers (CRUCIFERAE); prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe Madder plant family of the order Rubiales, subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.
=688  \\$a1998
=750  \0$aRubiaceae$5IEN-M$0(DLC)sh 85115683

=LDR  01232cz  a2200301n  4500
=001  9880364250302441
=005  20141212213328.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842
=150  \\$aRosales
=450  \\$aPittosporaceae
=450  \\$aPittosporum
=450  \\$wnnna$aPittosporums
=450  \\$wnnna$aRosale
=550  \\$wg$aAngiosperms
=550  \\$wh$aChrysobalanaceae
=550  \\$wh$aConnaraceae
=550  \\$wh$aCrassulaceae
=550  \\$wh$aGrossulariaceae
=550  \\$wh$aHydrangeaceae
=550  \\$wh$aRosaceae
=550  \\$wh$aSaxifragaceae
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAn order of the ANGIOSPERMS, subclass Rosidae. Its members include some of the most known ornamental and edible plants of temperate zones including roses, apples, cherries, and peaches.
=688  \\$a1998
=750  \0$aRosales$5IEN-M$0(DLC)sh 85115401

=LDR  01069cz  a2200253n  4500
=001  9880364250402441
=005  20170226162435.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019664
=035  \\$aCVE6118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825
=150  \\$aPolygonaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aEriogonum
=550  \\$wh$aFagopyrum
=550  \\$wh$aFallopia
=550  \\$wh$aPolygonum
=550  \\$wh$aRheum
=550  \\$wh$aRumex
=667  \\$aFAGOPYRUM & RHEUM are also available; prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.
=688  \\$a1998
=750  \0$aPolygonaceae$5IEN-M$0(DLC)sh 85104634

=LDR  00710cz  a2200241n  4500
=001  9880364250502441
=005  20141212213332.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019697
=035  \\$aCVE6117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x100.$x600
=072  \\$aJ2.$x500.$x850.$x100.$x500
=150  \\$aOnions
=450  \\$aAllium cepa
=450  \\$aAllium porrum
=450  \\$aLeeks
=450  \\$wnnna$aOnion
=550  \\$wg$aAllium
=667  \\$aas plant & food
=680  \\$iHerbaceous biennial plants and their edible bulbs, belonging to the Liliaceae.
=688  \\$a98; was see ALLIUM 1986-97
=750  \0$aOnions$5IEN-M$0(DLC)sh 85094798

=LDR  00906cz  a2200193n  4500
=001  9880364250702441
=005  20141212213312.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019658
=035  \\$aCVE6115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x620
=150  \\$aLinaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aFlax
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family in the order Linales. These plants have simple leaves and regular flowers housing a compound ovary. Stamens are usually fused by their filaments.
=688  \\$a98
=750  \0$aLinaceae$5IEN-M$0(DLC)sh 85077073

=LDR  00633cz  a2200229n  4500
=001  9880364250802441
=005  20180212103827.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019668
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x875.$x500
=150  \\$aLiliaceae
=450  \\$aLily Family
=450  \\$wnnna$aFamily, Lily
=550  \\$wg$aLilales
=550  \\$wh$aFritillaria
=550  \\$wh$aLilium
=550  \\$wh$aOrnithogalum
=550  \\$wh$aTulipa
=680  \\$iA monocot family within the order Liliales.
=688  \\$a98
=750  \0$aLiliaceae$5IEN-M$0(DLC)sh 85076962

=LDR  01189cz  a2200289n  4500
=001  9880364250902441
=005  20141212213351.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019770
=035  \\$aCVE6113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590
=150  \\$aLauraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCinnamomum
=550  \\$wh$aCryptocarya
=550  \\$wh$aLaurus
=550  \\$wh$aLindera
=550  \\$wh$aLitsea
=550  \\$wh$aOcotea
=550  \\$wh$aPersea
=550  \\$wh$aSassafras
=550  \\$wh$aUmbellularia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.
=688  \\$a98
=750  \0$aLauraceae$5IEN-M$0(DLC)sh 85075080

=LDR  02031cz  a2200733n  4500
=001  9880364251002441
=005  20181126095031.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x520
=150  \\$aLamiaceae
=450  \\$aGlechoma
=450  \\$wnnna$aGlechomas
=450  \\$aLabiatae
=450  \\$wnnna$aLeonoti
=450  \\$aLeonotis
=450  \\$aMesona
=450  \\$wnnna$aMesonas
=450  \\$aMicromeria
=450  \\$wnnna$aMicromerias
=450  \\$aSchizonepeta
=450  \\$wnnna$aSchizonepetas
=450  \\$aTetradenia
=450  \\$wnnna$aTetradenias
=550  \\$wg$aLamiales
=550  \\$wh$aAgastache
=550  \\$wh$aAjuga
=550  \\$wh$aBallota
=550  \\$wh$aCallicarpa
=550  \\$wh$aClerodendrum
=550  \\$wh$aColeus
=550  \\$wh$aHedeoma
=550  \\$wh$aHyptis
=550  \\$wh$aHyssopus Plant
=550  \\$wh$aIsodon
=550  \\$wh$aLavandula
=550  \\$wh$aLeonurus
=550  \\$wh$aLycopus
=550  \\$wh$aMarrubium
=550  \\$wh$aMelissa
=550  \\$wh$aMentha
=550  \\$wh$aMonarda
=550  \\$wh$aNepeta
=550  \\$wh$aOcimum
=550  \\$wh$aOriganum
=550  \\$wh$aOrthosiphon
=550  \\$wh$aPerilla
=550  \\$wh$aPhlomis
=550  \\$wh$aPlectranthus
=550  \\$wh$aPogostemon
=550  \\$wh$aPrunella
=550  \\$wh$aRosmarinus
=550  \\$wh$aSalvia
=550  \\$wh$aSatureja
=550  \\$wh$aScutellaria
=550  \\$wh$aSideritis
=550  \\$wh$aStachys
=550  \\$wh$aTeucrium
=550  \\$wh$aThymus Plant
=550  \\$wh$aVitex
=680  \\$iThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).
=688  \\$a1998
=750  \0$aLamiaceae$5IEN-M$0(DLC)sh 85074201

=LDR  01656cz  a2200481n  4500
=001  9880364251202441
=005  20141212213318.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350
=150  \\$aEuphorbiaceae
=450  \\$aAlchornea
=450  \\$wnnna$aAlchorneas
=450  \\$aExcoecaria
=450  \\$wnnna$aExcoecarias
=450  \\$aMacaranga
=450  \\$wnnna$aMacarangas
=450  \\$aMaprounea
=450  \\$wnnna$aMaprouneas
=450  \\$aSebastiania
=450  \\$wnnna$aSebastianias
=450  \\$wnnna$aSecurinega
=450  \\$wnnna$aSecurinegas
=450  \\$aSpondianthus
=550  \\$wg$aAngiosperms
=550  \\$wh$aAcalypha
=550  \\$wh$aAleurites
=550  \\$wh$aCroton
=550  \\$wh$aEuphorbia
=550  \\$wh$aHevea
=550  \\$wh$aHippomane
=550  \\$wh$aJatropha
=550  \\$wh$aMallotus Plant
=550  \\$wh$aManihot
=550  \\$wh$aPhyllanthus
=550  \\$wh$aRicinus
=550  \\$wh$aSapium
=550  \\$wh$aSuregada
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe spurge family of flowering plants, in the order Euphorbiales, contains some 7,500 species in 275 genera. The family consists of annual and perennial herbs and woody shrubs or trees.
=688  \\$a98
=750  \0$aEuphorbiaceae$0(DLC) sh 85045604$5IEN-M

=LDR  01526cz  a2200409n  4500
=001  9880364251302441
=005  20141212213316.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019662
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x300
=150  \\$aCucurbitaceae
=450  \\$aCoccinia
=450  \\$wnnna$aCoccinias
=450  \\$wnnna$aFevillea
=450  \\$wnnna$aFevilleas
=450  \\$aGourd, Ivy
=450  \\$wnnna$aGourds, Ivy
=450  \\$aIvy Gourd
=450  \\$wnnna$aIvy Gourds
=450  \\$wnnna$aMelon
=450  \\$aMelons
=450  \\$aMelothria
=450  \\$wnnna$aMelothrias
=550  \\$wg$aAngiosperms
=550  \\$wh$aBryonia
=550  \\$wh$aCitrullus
=550  \\$wh$aCucumis
=550  \\$wh$aCucurbita
=550  \\$wh$aGynostemma
=550  \\$wh$aLuffa
=550  \\$wh$aMomordica
=550  \\$wh$aTrichosanthes
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe gourd plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. It is sometimes placed in its own order, Cucurbitales. 'Melon' generally refers to CUCUMIS; CITRULLUS; or MOMORDICA.
=688  \\$a1998; for MELONS use CUCUMIS 2002-2004
=750  \0$aCucurbitaceae$5IEN-M$0(DLC)sh 85034679

=LDR  02070cz  a2200445n  4500
=001  9880364251402441
=005  20141212213300.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019607
=035  \\$aCVE6105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157
=150  \\$aBrassicaceae
=450  \\$aCress
=450  \\$wnnna$aCresses
=450  \\$aCruciferae
=450  \\$wnnna$aMoricandia
=450  \\$wnnna$aMoricandias
=550  \\$wg$aAngiosperms
=550  \\$wh$aArabidopsis
=550  \\$wh$aArabis
=550  \\$wh$aArmoracia
=550  \\$wh$aBarbarea
=550  \\$wh$aBrassica
=550  \\$wh$aCapsella
=550  \\$wh$aCardamine
=550  \\$wh$aCrambe Plant
=550  \\$wh$aErysimum
=550  \\$wh$aIsatis
=550  \\$wh$aLepidium
=550  \\$wh$aNasturtium
=550  \\$wh$aRaphanus
=550  \\$wh$aRorippa
=550  \\$wh$aSinapis
=550  \\$wh$aThlaspi
=550  \\$wh$aWasabia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. They are mostly herbaceous plants with peppery-flavored leaves, due to gluconapin (GLUCOSINOLATES) and its hydrolysis product butenylisotrhiocyanate. The family includes many plants of economic importance that have been extensively altered and domesticated by humans. Flowers have 4 petals. Podlike fruits contain a number of seeds. Cress is a general term used for many in the Brassicacea family. Rockcress is usually ARABIS; Bittercress is usually CARDAMINE; Yellowcress is usually RORIPPA; Pennycress is usually THLASPI; Watercress refers to NASTURTIUM; or RORIPPA or TROPAEOLUM; Gardencress refers to LEPIDIUM; Indiancress refers to TROPAEOLUM.
=688  \\$a2003(1998)
=750  \0$aCruciferae$5IEN-M$0(DLC)sh 85034360

=LDR  01317cz  a2200337n  4500
=001  9880364251502441
=005  20141212213317.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200
=150  \\$aChenopodiaceae
=450  \\$aHalogeton
=450  \\$wnnna$aHalogetons
=450  \\$aKochia
=450  \\$wnnna$aKochias
=450  \\$aSalicornia
=450  \\$wnnna$aSalicornias
=450  \\$aSuaeda
=450  \\$wnnna$aSuaedas
=550  \\$wg$aAngiosperms
=550  \\$wh$aAtriplex
=550  \\$wh$aBassia scoparia
=550  \\$wh$aBeta vulgaris
=550  \\$wh$aChenopodium
=550  \\$wh$aSalsola
=550  \\$wh$aSpinacia oleracea
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe goosefoot plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. It includes beets and chard (BETA VULGARIS), as well as SPINACH, and salt tolerant plants.
=688  \\$a98
=750  \0$aChenopodiaceae$5IEN-M$0(DLC)sh 85023057

=LDR  01227cz  a2200289n  4500
=001  9880364251602441
=005  20160422111951.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019612
=035  \\$aCVE6103HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x333
=072  \\$aJ2.$x500.$x200.$x175
=072  \\$aJ2.$x500.$x300.$x100.$x175
=150  \\$aFagopyrum
=450  \\$aBuckwheat
=450  \\$aFagopyrum esculentum
=450  \\$aFagopyrum sagittatum
=450  \\$aFagopyrum tataricum
=550  \\$wg$aAnimal Feed
=550  \\$wg$aPolygonaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYGONACEAE that is used as a cereal grain. Although the seeds are used as cereal, the plant is not one of the cereal grasses (POACEAE).
=688  \\$a2006(1998)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Buckwheat
=688  \\$a98
=750  \0$aFagopyrum$0(DLC) sh 85046874$5IEN-M

=LDR  02150cz  a2200577n  4500
=001  9880364251802441
=005  20190628093243.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x075
=150  \\$aApiaceae
=450  \\$wnnna$aAzorella
=450  \\$wnnna$aAzorellas
=450  \\$aFangfeng
=450  \\$wnnna$aFangfengs
=450  \\$aGlehnia
=450  \\$wnnna$aGlehnias
=450  \\$aSaposhnikovia
=450  \\$wnnna$aSaposhnikovias
=450  \\$aSmyrnium
=450  \\$wnnna$aSmyrniums
=450  \\$aUmbelliferae
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAnethum graveolens
=550  \\$wh$aAngelica
=550  \\$wh$aApium graveolens
=550  \\$wh$aBupleurum
=550  \\$wh$aCarum
=550  \\$wh$aCentella
=550  \\$wh$aCnidium
=550  \\$wh$aCoriandrum
=550  \\$wh$aCuminum
=550  \\$wh$aDaucus carota
=550  \\$wh$aEryngium
=550  \\$wh$aFerula
=550  \\$wh$aFoeniculum
=550  \\$wh$aHemlock
=550  \\$wh$aHeracleum
=550  \\$wh$aLevisticum
=550  \\$wh$aLigusticum
=550  \\$wh$aOenanthe
=550  \\$wh$aPastinaca
=550  \\$wh$aPetroselinum
=550  \\$wh$aPimpinella
=550  \\$wh$aSanicula
=550  \\$wh$aThapsia
=667  \\$aprefer specific plant; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.
=688  \\$a98
=750  \0$aUmbelliferae$5IEN-M$0(DLC)sh 85139518

=LDR  00745cz  a2200181n  4500
=001  9880364251902441
=005  20141212213441.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019920
=035  \\$aCVE6095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x410.$x80.$x600
=150  \\$aPhotoaffinity Labels
=450  \\$wnnna$aLabels, Photoaffinity
=550  \\$wg$aAffinity Labels
=680  \\$iBiologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins.
=688  \\$a98
=750  \0$aPhotoaffinity labeling$5IEN-M$0(DLC)sh 89001028

=LDR  00673cz  a2200181n  4500
=001  9880364252002441
=005  20141212213404.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019809
=035  \\$aCVE6094M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97.$x835
=150  \\$aStreptavidin
=450  \\$wnnna$aStrepavidin
=550  \\$wg$aBacterial Proteins
=680  \\$iA 60-kDa extracellular protein of Streptomyces avidinii with four high-affinity biotin binding sites. Unlike AVIDIN, streptavidin has a near neutral isoelectric point and is free of carbohydrate side chains.
=688  \\$a98; use STREPTAVIDIN (NM) 1980-97
=750  \2$aStreptavidin$5IEN-M

=LDR  01676cz  a2200385n  4500
=001  9880364252102441
=005  20141212213400.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019797
=035  \\$aCVE6091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x510
=072  \\$aD2.$x455.$x426.$x559.$x389.$x454.$x300
=072  \\$aD2.$x455.$x526.$x581.$x496.$x300
=150  \\$a3-Iodobenzylguanidine
=450  \\$wnnna$a123I Labeled 3-Iodobenzylguanidine
=450  \\$wnnna$a125I Labeled 3-Iodobenzylguanidine
=450  \\$a(3-Iodo-(131I)benzyl)guanidine
=450  \\$wnnna$a3 Iodobenzylguanidine
=450  \\$wnnna$a3-Iodobenzylguanidine, 123I Labeled
=450  \\$wnnna$a3 Iodobenzylguanidine, 123I Labeled
=450  \\$wnnna$a3-Iodobenzylguanidine, 125I Labeled
=450  \\$wnnna$a3 Iodobenzylguanidine, 125I Labeled
=450  \\$aIobenguane
=450  \\$wnnna$aIobenguane (131I)
=450  \\$wnnna$am-Iodobenzylguanidine
=450  \\$wnnna$am Iodobenzylguanidine
=450  \\$wnnna$ameta-Iodobenzylguanidine
=450  \\$wnnna$ameta Iodobenzylguanidine
=450  \\$aMIBG
=550  \\$wg$aGuanidines
=550  \\$wg$aIodobenzenes
=680  \\$iA guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
=688  \\$a98; use 3-IODOBENZYLGUANIDINE (NM) 1980-97
=750  \0$aMIBG (Chemical)$5IEN-M$0(DLC)sh 88007119

=LDR  01020cz  a2200337n  4500
=001  9880364252202441
=005  20180711121026.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019719
=035  \\$aCVE6089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230
=150  \\$aDiagnostic Equipment
=450  \\$wnnna$aDiagnostic Equipments
=450  \\$wnnna$aEquipment, Diagnostic
=450  \\$wnnna$aEquipments, Diagnostic
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aClinical Alarms
=550  \\$wh$aElectronic Nose
=550  \\$wh$aEndoscopes
=550  \\$wh$aFitness Trackers
=550  \\$wh$aFlowmeters
=550  \\$wh$aMuscle Strength Dynamometer
=550  \\$wh$aOphthalmoscopes
=550  \\$wh$aOtoscopes
=550  \\$wh$aSphygmomanometers
=550  \\$wh$aStethoscopes
=667  \\$ado not use /util except by MeSH definition; DF: DIAG EQUIPMENT
=680  \\$iNonexpendable items used in examination.
=688  \\$a98
=750  \0$aDiagnosis$xEquipment and supplies$5IEN-M

=LDR  00665cz  a2200193n  4500
=001  9880364252302441
=005  20141212213339.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019722
=035  \\$aCVE6088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x740
=150  \\$aSphygmomanometers
=450  \\$wnnna$aSphygmomanometer
=550  \\$wg$aDiagnostic Equipment
=550  \\$wh$aBlood Pressure Monitors
=680  \\$iInstruments for measuring arterial blood pressure consisting of an inflatable cuff, inflating bulb, and a gauge showing the blood pressure. (Stedman, 26th ed)
=688  \\$a98
=750  \0$aSphygmomanometers$5IEN-M$0(DLC)sh 85126612

=LDR  00711cz  a2200193n  4500
=001  9880364252402441
=005  20141212213339.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019720
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x550
=150  \\$aOtoscopes
=450  \\$wnnna$aOtoscope
=450  \\$aOtoscopy$xinstrumentation
=550  \\$wg$aDiagnostic Equipment
=550  \\$aOtoscopy
=680  \\$iInstruments designed to inspect or auscultate the ear. They are designed primarily to examine the outer ear canal and tympanic membrane by means of light and air under moderate pressure, as with a pneumatic otoscope. (UMDNS, 1999)
=688  \\$a98
=750  \0$aOtoscopes$5IEN-M$0(DLC)sh 85096076

=LDR  00766cz  a2200241n  4500
=001  9880364252502441
=005  20181221102549.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019721
=035  \\$aCVE6086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x540
=150  \\$aOphthalmoscopes
=450  \\$wnnna$aFunduscope
=450  \\$aFunduscopes
=450  \\$wnnna$aOphthalmoscope
=450  \\$aOphthalmoscopy$xinstrumentation
=550  \\$wg$aDiagnostic Equipment
=550  \\$wh$aRetinoscopes
=550  \\$wh$aSlit Lamp
=680  \\$iDevices for examining the interior of the eye, permitting the clear visualization of the structures of the eye at any depth. (UMDNS, 1999)
=688  \\$a98
=750  \0$aOphthalmoscopes$5IEN-M$0(DLC)sh 91002043

=LDR  01231cz  a2200397n  4500
=001  9880364252602441
=005  20141212213340.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220
=072  \\$aE7.$x858.$x240
=150  \\$aEndoscopes
=450  \\$wnnna$aEndoscope
=550  \\$wg$aDiagnostic Equipment
=550  \\$wg$aSurgical Equipment
=550  \\$wh$aAngioscopes
=550  \\$wh$aArthroscopes
=550  \\$wh$aBronchoscopes
=550  \\$wh$aColposcopes
=550  \\$wh$aCuldoscopes
=550  \\$wh$aCystoscopes
=550  \\$wh$aEndoscopes, Gastrointestinal
=550  \\$wh$aFetoscopes
=550  \\$wh$aHysteroscopes
=550  \\$wh$aLaparoscopes
=550  \\$wh$aLaryngoscopes
=550  \\$wh$aMediastinoscopes
=550  \\$wh$aNeuroendoscopes
=550  \\$wh$aThoracoscopes
=550  \\$wh$aUreteroscopes
=550  \\$aEndoscopy
=667  \\$aGEN: prefer specifics
=680  \\$iInstruments for the visual examination of interior structures of the body. There are rigid endoscopes and flexible fiberoptic endoscopes for various types of viewing in ENDOSCOPY.
=688  \\$a98
=750  \0$aEndoscopes$5IEN-M$0(DLC)sh 87003022

=LDR  00999cz  a2200253n  4500
=001  9880364252702441
=005  20141212213434.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019899
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x122.$x600
=150  \\$aParacrine Communication
=450  \\$wnnna$aCommunication, Paracrine
=450  \\$wnnna$aCommunications, Paracrine
=450  \\$wnnna$aParacrine Communications
=450  \\$aParacrine Signaling
=450  \\$wnnna$aParacrine Signalings
=450  \\$wnnna$aSignaling, Paracrine
=450  \\$wnnna$aSignalings, Paracrine
=550  \\$wg$aCell Communication
=550  \\$aIntercellular Signaling Peptides and Proteins
=680  \\$iCellular signaling in which a factor secreted by a cell affects other cells in the local environment. This term is often used to denote the action of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS on surrounding cells.
=688  \\$a98
=750  \0$aParacrine mechanisms$5IEN-M$0(DLC)sh 90000023

=LDR  00856cz  a2200253n  4500
=001  9880364252802441
=005  20141212213433.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019898
=035  \\$aCVE6076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x122.$x100
=150  \\$aAutocrine Communication
=450  \\$wnnna$aAutocrine Communications
=450  \\$aAutocrine Signaling
=450  \\$wnnna$aAutocrine Signalings
=450  \\$wnnna$aCommunication, Autocrine
=450  \\$wnnna$aCommunications, Autocrine
=450  \\$wnnna$aSignaling, Autocrine
=450  \\$wnnna$aSignalings, Autocrine
=550  \\$wg$aCell Communication
=680  \\$iMode of communication wherein a bound hormone affects the function of the cell type that produced the hormone.
=688  \\$a98
=750  \0$aAutocrine mechanisms$5IEN-M$0(DLC)sh 90000024

=LDR  02177cz  a2200553n  4500
=001  9880364252902441
=005  20141212192918.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019645
=035  \\$aCVE6068M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x110.$x110.$x115
=072  \\$aE4.$x650.$x110.$x115
=072  \\$aE4.$x680.$x101.$x110.$x115
=150  \\$aArthroplasty, Replacement, Knee
=450  \\$wnnna$aArthroplasties, Knee Replacement
=450  \\$wnnna$aArthroplasties, Replacement, Knee
=450  \\$wnnna$aArthroplasty, Knee
=450  \\$wnnna$aArthroplasty, Knee Replacement
=450  \\$wnnna$aArthroplasty, Partial Knee
=450  \\$wnnna$aArthroplasty, Replacement, Partial Knee
=450  \\$wnnna$aArthroplasty, Unicompartmental Knee
=450  \\$wnnna$aArthroplasty, Unicondylar Knee
=450  \\$wnnna$aKnee Arthroplasty
=450  \\$wnnna$aKnee Arthroplasty, Partial
=450  \\$wnnna$aKnee Arthroplasty, Total
=450  \\$wnnna$aKnee Arthroplasty, Unicompartmental
=450  \\$wnnna$aKnee Arthroplasty, Unicondylar
=450  \\$wnnna$aKnee Replacement Arthroplasties
=450  \\$wnnna$aKnee Replacement Arthroplasty
=450  \\$wnnna$aKnee Replacement, Partial
=450  \\$aKnee Replacement, Total
=450  \\$wnnna$aKnee Replacement, Unicompartmental
=450  \\$wnnna$aKnee Replacement, Unicondylar
=450  \\$wnnna$aPartial Knee Arthroplasty
=450  \\$wnnna$aPartial Knee Replacement
=450  \\$wnnna$aReplacement Arthroplasties, Knee
=450  \\$wnnna$aReplacement Arthroplasty, Knee
=450  \\$wnnna$aReplacement, Total Knee
=450  \\$wnnna$aTotal Knee Replacement
=450  \\$wnnna$aUnicompartmental Knee Arthroplasty
=450  \\$wnnna$aUnicompartmental Knee Replacement
=450  \\$wnnna$aUnicondylar Knee Arthroplasty
=450  \\$wnnna$aUnicondylar Knee Replacement
=550  \\$wg$aArthroplasty, Replacement
=550  \\$aKnee Prosthesis
=680  \\$iReplacement of the knee joint.
=688  \\$a98; use KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL use KNEE PROSTHESIS 1992-97
=750  \0$aTotal knee replacement$0(DLC) sh 91001877$5IEN-M

=LDR  00825cz  a2200181n  4500
=001  9880364253002441
=005  20141212213438.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019910
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x720.$x500
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x720.$x500
=150  \\$aMycobacterium marinum
=550  \\$wg$aNontuberculous Mycobacteria
=667  \\$ainfection: coord IM with MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS (IM); DF: MYCOBACT MARINUM
=680  \\$iA moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas (swimming pool granuloma) in humans. (Dorland, 28th ed)
=688  \\$a98
=750  \0$aMycobacterium marinum$5IEN-M$0(DLC)sh 85089184

=LDR  00831cz  a2200229n  4500
=001  9880364253102441
=005  20141212213405.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019811
=035  \\$aCVE6057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x62.$x437
=150  \\$aHydroxylamine
=450  \\$wnnna$aChloride, Hydroxylammonium
=450  \\$wnnna$aHydrochloride, Hydroxylamine
=450  \\$wnnna$aHydroxylamine Hydrochloride
=450  \\$wnnna$aHydroxylammonium Chloride
=550  \\$wg$aAmmonium Compounds
=667  \\$aHYDROXYLAMINES is also available
=680  \\$iA colorless inorganic compound (HONH2) used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide.
=688  \\$a98; use HYDROXYLAMINE (NM) 1980-97
=750  \0$aHydroxylamine$5IEN-M$0(DLC)sh 85063506

=LDR  00943cz  a2200193n  4500
=001  9880364253202441
=005  20141212213408.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019820
=035  \\$aCVE6047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x960.$x938
=072  \\$aD3.$x438.$x759.$x758.$x824.$x938
=150  \\$aXanthine
=550  \\$wg$aXanthines
=667  \\$aa specific chem: do not confuse with XANTHINES or XANTHENES
=680  \\$iA purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed)
=688  \\$a98; use XANTHINE (NM) 1980-97
=750  \0$aXanthine$5IEN-M$0(DLC)sh 85148764

=LDR  01361cz  a2200385n  4500
=001  9880364253302441
=005  20141212213500.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019976
=035  \\$aCVE6043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x240
=072  \\$aE5.$x820.$x180
=150  \\$aCloning, Organism
=450  \\$wnnna$aCloning
=450  \\$aCloning, Embryo
=450  \\$aCloning, Human
=450  \\$wnnna$aClonings, Embryo
=450  \\$wnnna$aClonings, Human
=450  \\$wnnna$aClonings, Organism
=450  \\$aEmbryo Cloning
=450  \\$wnnna$aEmbryo Clonings
=450  \\$aHuman Cloning
=450  \\$wnnna$aHuman Clonings
=450  \\$wnnna$aOrganism Cloning
=450  \\$wnnna$aOrganism Clonings
=550  \\$wg$aGenetic Techniques
=550  \\$wg$aReproductive Techniques
=550  \\$aCloning, Molecular
=550  \\$aNuclear Transfer Techniques
=550  \\$aReproduction, Asexual
=667  \\$acheck tags HUMANS or ANIMALS; differentiate from CLONING, MOLECULAR and CLONE CELLS; DF: CLONING
=680  \\$iThe formation of one or more genetically identical organisms derived by vegetative reproduction from a single cell. The source nuclear material can be embryo-derived, fetus-derived, or taken from an adult somatic cell.
=688  \\$a98
=750  \0$aCloning$5IEN-M$0(DLC)sh 85027122

=LDR  00770cz  a2200265n  4500
=001  9880364253402441
=005  20141212213401.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019800
=035  \\$aCVE6035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x595
=150  \\$aPhenol
=450  \\$wnnna$aCarbol
=450  \\$wnnna$aCarbolic Acid
=450  \\$wnnna$aHydroxybenzene
=450  \\$wnnna$aPhenol, Sodium Salt
=450  \\$wnnna$aPhenolate Sodium
=450  \\$wnnna$aPhenolate, Sodium
=450  \\$wnnna$aSodium Phenolate
=550  \\$wg$aPhenols
=680  \\$iAn antiseptic and disinfectant aromatic alcohol.
=688  \\$a1998
=688  \\$a98; use PHENOL (NM) 1979-97
=750  \0$aPhenol$5IEN-M$0(DLC)sh 85020087

=LDR  00711cz  a2200253n  4500
=001  9880364253502441
=005  20141212213506.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020005
=035  \\$aCVE6034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x755
=150  \\$aPropanols
=450  \\$a1-Propanol$xanalogs & derivatives
=450  \\$a2-Propanol$xanalogs & derivatives
=450  \\$aAlcohols, Propyl
=450  \\$wnnna$aPropyl Alcohols
=550  \\$wg$aAlcohols
=550  \\$wh$a1-Propanol
=550  \\$wh$a2-Propanol
=550  \\$wh$aPropanolamines
=680  \\$iIsomeric forms and derivatives of PROPANOL (C3H7OH).
=688  \\$a98
=750  \0$aPropanols$5IEN$0(DLC)sh 85107481

=LDR  00887cz  a2200241n  4500
=001  9880364253602441
=005  20141212213413.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019838
=035  \\$aCVE6019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x700
=150  \\$aNeck Injuries
=450  \\$wnnna$aInjuries, Neck
=450  \\$wnnna$aInjury, Neck
=450  \\$aNeck$xinjuries
=450  \\$wnnna$aNeck Injury
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aWhiplash Injuries
=667  \\$aGEN or unspecified; restrict to inj of soft tissue; inj of cervical vertebrae = CERVICAL VERTEBRAE /inj; coord IM with specific inj (IM); DF: NECK INJ
=680  \\$iGeneral or unspecified injuries to the neck. It includes injuries to the skin, muscles, and other soft tissues of the neck.
=688  \\$a98
=750  \0$aNeck$xWounds and injuries$5IEN-M$0(DLC)sh 85090561

=LDR  01524cz  a2200373n  4500
=001  9880364253702441
=005  20141212192922.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019818
=035  \\$aCVE6017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x374.$x160
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x374.$x160
=150  \\$aClavulanic Acid
=450  \\$wnnna$aBRL-14151
=450  \\$wnnna$aBRL 14151
=450  \\$wnnna$aBRL14151
=450  \\$aClavulanate
=450  \\$wnnna$aClavulanate Potassium
=450  \\$wnnna$aClavulanate, Potassium
=450  \\$wnnna$aClavulanate, Sodium
=450  \\$wnnna$aClavulanic Acid, Monopotassium Salt
=450  \\$wnnna$aClavulanic Acid, Monosodium Salt
=450  \\$wnnna$aMM-14151
=450  \\$wnnna$aMM 14151
=450  \\$wnnna$aMM14151
=450  \\$wnnna$aPotassium Clavulanate
=450  \\$wnnna$aPotassium, Clavulanate
=450  \\$wnnna$aSodium Clavulanate
=550  \\$wg$aClavulanic Acids
=550  \\$wh$aAmoxicillin-Potassium Clavulanate Combination
=680  \\$iClavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
=688  \\$a98; use CLAVULANIC ACID (NM) 1980-97
=750  \0$aClavulanic acid$5IEN-M$0(DLC)sh 85026861

=LDR  00903cz  a2200241n  4500
=001  9880364253802441
=005  20141212213249.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019567
=035  \\$aCVE6016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x117
=150  \\$aBack Injuries
=450  \\$aBack$xinjuries
=450  \\$wnnna$aBack Injury
=450  \\$wnnna$aInjuries, Back
=450  \\$wnnna$aInjury, Back
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aSpinal Injuries
=667  \\$aGEN or unspecified; coord IM with specific inj (IM) or specific region (NIM); do not confuse with SPINAL INJURIES which refers to vertebrae only: see note there; DF: BACK INJ
=680  \\$iGeneral or unspecified injuries to the posterior part of the trunk. It includes injuries to the muscles of the back.
=688  \\$a98
=750  \0$aBack$xWounds and injuries$5IEN-M$0(DLC)sh2009116574

=LDR  01853cz  a2200457n  4500
=001  9880364253902441
=005  20141212213358.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019791
=035  \\$aCVE6015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x472
=150  \\$aGuanidine
=450  \\$wnnna$aChloride, Guanidinium
=450  \\$wnnna$aChloride, Guanidium
=450  \\$aGuanidine Hydrochloride
=450  \\$wnnna$aGuanidine Monohydrate
=450  \\$wnnna$aGuanidine Monohydrobromide
=450  \\$wnnna$aGuanidine Monohydrochloride
=450  \\$wnnna$aGuanidine Monohydroiodine
=450  \\$wnnna$aGuanidine Nitrate
=450  \\$wnnna$aGuanidine Phosphate
=450  \\$wnnna$aGuanidine Sulfate
=450  \\$wnnna$aGuanidine Sulfate (1:1)
=450  \\$wnnna$aGuanidine Sulfate (2:1)
=450  \\$wnnna$aGuanidine Sulfite (1:1)
=450  \\$aGuanidinium
=450  \\$aGuanidinium Chloride
=450  \\$wnnna$aGuanidium Chloride
=450  \\$wnnna$aHydrochloride, Guanidine
=450  \\$wnnna$aMonohydrate, Guanidine
=450  \\$wnnna$aMonohydrobromide, Guanidine
=450  \\$wnnna$aMonohydrochloride, Guanidine
=450  \\$wnnna$aMonohydroiodine, Guanidine
=450  \\$wnnna$aNitrate, Guanidine
=450  \\$wnnna$aPhosphate, Guanidine
=450  \\$wnnna$aSulfate, Guanidine
=550  \\$wg$aGuanidines
=680  \\$iA strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.
=688  \\$a98; use GUANIDINE (NM) 1974-97
=750  \0$aGuanidine$5IEN-M$0(DLC)sh 85057589

=LDR  01096cz  a2200265n  4500
=001  9880364254002441
=005  20141212213459.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019974
=035  \\$aCVE6001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x600
=150  \\$aPan paniscus
=450  \\$aBonobo
=450  \\$wnnna$aBonobos
=450  \\$aChimpanzee, Pygmy
=450  \\$wnnna$aChimpanzees, Pygmy
=450  \\$wnnna$apaniscus, Pan
=450  \\$aPygmy Chimpanzee
=450  \\$wnnna$aPygmy Chimpanzees
=550  \\$wg$aHominidae
=667  \\$adiseases: coordinate IM with APE DISEASES (IM) + specific disease /vet (IM)
=680  \\$iThe pygmy chimpanzee, a species of the genus Pan, family HOMINIDAE. Its common name is Bonobo, which was once considered a separate genus by some; others considered it a subspecies of PAN TROGLODYTES. Its range is confined to the forests of the central Zaire basin. Despite its name, it is often of equal size to P. troglodytes.
=688  \\$a98
=750  \0$aBonobo$5IEN-M$0(DLC)sh 85109278

=LDR  01598cz  a2200409n  4500
=001  9880364254102441
=005  20190321173244.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019849
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x813
=072  \\$aG7.$x345.$x500.$x325.$x377.$x812
=072  \\$aG7.$x345.$x750.$x437
=072  \\$aG8.$x686.$x841.$x437
=150  \\$aSex Determination Processes
=450  \\$wnnna$aDetermination Process, Sex
=450  \\$wnnna$aDetermination Processes, Sex
=450  \\$wnnna$aGenetics, Sex Determination
=450  \\$wnnna$aProcess, Sex Determination
=450  \\$wnnna$aProcesses, Sex Determination
=450  \\$wnnna$aProtandry
=450  \\$wnnna$aProtogyny
=450  \\$wnnna$aSex Determination Genetic Processes
=450  \\$aSex Determination Genetics
=450  \\$wnnna$aSex Determination Process
=550  \\$wg$aGenetic Phenomena
=550  \\$wg$aOrganogenesis
=550  \\$wg$aSexual Development
=550  \\$aGenes, sry
=550  \\$aSex Differentiation
=550  \\$aSex Preselection
=667  \\$ado not confuse with SEX DETERMINATION ANALYSIS which is validation of sex by examination of gonads or genetic tests; natural sex reversal processes go here (note entry terms PROTANDRY and PROTOGYNY); HERMAPHRODITIC ORGANISMS is also available
=680  \\$iThe mechanisms by which the SEX of an individual's GONADS are fixed.
=688  \\$a2011 (1998)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Sex Determination (Genetics)
=688  \\$a1998
=750  \0$aSex determination$0(DLC)sh2017003164$5IEN-M

=LDR  01269cz  a2200265n  4500
=001  9880364254202441
=005  20190422165916.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019707
=035  \\$aCVE5998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x160.$x160
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x125
=150  \\$aReceptors, Chemokine
=450  \\$aChemokine Receptors
=550  \\$wg$aReceptors, Cytokine
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, CCR
=550  \\$wh$aReceptors, CXCR
=667  \\$aDF: RECEPT CHEMOKINE
=680  \\$iCell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif.
=688  \\$a98
=750  \0$81$wb$iBroader mapping$aChemokines$0(DLC)sh 94002232$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aChemokines--Receptors$5IEN-M

=LDR  01549cz  a2200361n  4500
=001  9880364254302441
=005  20141212213412.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019836
=035  \\$aCVE5997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x625
=150  \\$aPreimplantation Diagnosis
=450  \\$wnnna$aDiagnoses, Preimplantation
=450  \\$wnnna$aDiagnoses, Preimplantation Genetic
=450  \\$aDiagnosis, Preimplantation
=450  \\$wnnna$aDiagnosis, Preimplantation Genetic
=450  \\$wnnna$aGenetic Diagnoses, Preimplantation
=450  \\$wnnna$aGenetic Diagnosis, Preimplantation
=450  \\$wnnna$aPreimplantation Diagnoses
=450  \\$wnnna$aPreimplantation Genetic Diagnoses
=450  \\$aPreimplantation Genetic Diagnosis
=450  \\$wnnna$aPreimplantation Screening
=450  \\$wnnna$aPreimplantation Screenings
=450  \\$wnnna$aScreening, Preimplantation
=450  \\$wnnna$aScreenings, Preimplantation
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$aGenetic Testing
=550  \\$aPrenatal Diagnosis
=667  \\$apreimplanation refers to ovum implantation; check tags HUMANS or ANIMALS & FEMALE & PREGNANCY
=680  \\$iDetermination of the nature of a pathological condition or disease in the OVUM; ZYGOTE; or BLASTOCYST prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.
=688  \\$a98
=750  \0$aPreimplantation genetic diagnosis$5IEN-M$0(DLC)sh 91002847

=LDR  01094cz  a2200241n  4500
=001  9880364254402441
=005  20141212213354.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019781
=035  \\$aCVE5994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x150
=150  \\$aCorneal Topography
=450  \\$wnnna$aCorneal Topographies
=450  \\$wnnna$aTopographies, Corneal
=450  \\$aTopography, Corneal
=450  \\$wnnna$aVideokeratographies
=450  \\$aVideokeratography
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$aAberrometry
=680  \\$iThe measurement of curvature and shape of the anterior surface of the cornea using techniques such as keratometry, keratoscopy, photokeratoscopy, profile photography, computer-assisted image processing and videokeratography. This measurement is often applied in the fitting of contact lenses and in diagnosing corneal diseases or corneal changes including keratoconus, which occur after keratotomy and keratoplasty.
=688  \\$a98
=750  \0$aCorneal topography$5IEN-M$0(DLC)sh 92004383

=LDR  00978cz  a2200217n  4500
=001  9880364254502441
=005  20141212213333.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019700
=035  \\$aCVE5989M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x895.$x800
=072  \\$aD12.$x776.$x543.$x550.$x895.$x800
=150  \\$aThrombospondin 1
=450  \\$wnnna$a1, Thrombospondin
=450  \\$aTSP-1
=550  \\$wg$aThrombospondins
=667  \\$aa membrane glycoprotein
=680  \\$iAn extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.
=688  \\$a98; see THROMBOSPONDIN (NM) 1991-97
=750  \0$aThrombospondin-1$0(DLC)sh2011005387$5IEN-M

=LDR  01263cz  a2200217n  4500
=001  9880364254602441
=005  20141212213333.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019699
=035  \\$aCVE5988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x895
=072  \\$aD12.$x776.$x543.$x550.$x895
=150  \\$aThrombospondins
=450  \\$wnnna$aThrombospondin
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wh$aThrombospondin 1
=667  \\$amembrane glycoproteins; THROMBOSPONDIN 1 is also available
=680  \\$iA family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein (COMP). They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, VASCULAR SMOOTH MUSCLE growth, and tissue repair.
=688  \\$a98; see THROMBOSPONDINS (NM) 1981-97
=750  \0$aThrombospondins$5IEN-M$0(DLC)sh 92006106

=LDR  00676cz  a2200217n  4500
=001  9880364254702441
=005  20141212213414.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019841
=035  \\$aCVE5987HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x715.$x250
=150  \\$aDefecography
=450  \\$wnnna$aDefecographies
=550  \\$wg$aRadiography, Abdominal
=550  \\$aDefecation
=550  \\$aFecal Incontinence
=667  \\$aDF: DEFECOGR
=680  \\$iRadiographic examination of the process of defecation after the instillation of a CONTRAST MEDIA into the rectum.
=688  \\$a98
=750  \0$aDefecography$5IEN-M$0(DLC)sh 92003947

=LDR  02577cz  a2200601n  4500
=001  9880364254802441
=005  20180329095538.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019636
=035  \\$aCVE5974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x574
=150  \\$aNeurodegenerative Diseases
=450  \\$wnnna$aDegenerative Condition, Neurologic
=450  \\$wnnna$aDegenerative Conditions, Neurologic
=450  \\$wnnna$aDegenerative Diseases, Central Nervous System
=450  \\$aDegenerative Diseases, Nervous System
=450  \\$wnnna$aDegenerative Diseases, Neurologic
=450  \\$wnnna$aDegenerative Diseases, Spinal Cord
=450  \\$wnnna$aDegenerative Neurologic Disease
=450  \\$wnnna$aDegenerative Neurologic Diseases
=450  \\$wnnna$aDegenerative Neurologic Disorder
=450  \\$wnnna$aDegenerative Neurologic Disorders
=450  \\$wnnna$aNervous System Degenerative Diseases
=450  \\$wnnna$aNeurodegenerative Disease
=450  \\$wnnna$aNeurodegenerative Disorder
=450  \\$wnnna$aNeurodegenerative Disorders
=450  \\$wnnna$aNeurologic Degenerative Condition
=450  \\$wnnna$aNeurologic Degenerative Conditions
=450  \\$wnnna$aNeurologic Degenerative Disease
=450  \\$wnnna$aNeurologic Degenerative Diseases
=450  \\$wnnna$aNeurologic Disease, Degenerative
=450  \\$wnnna$aNeurologic Diseases, Degenerative
=450  \\$wnnna$aNeurologic Disorder, Degenerative
=450  \\$wnnna$aNeurologic Disorders, Degenerative
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aChronic Traumatic Encephalopathy
=550  \\$wh$aHeredodegenerative Disorders, Nervous System
=550  \\$wh$aLewy Body Disease
=550  \\$wh$aMotor Neuron Disease
=550  \\$wh$aMultiple System Atrophy
=550  \\$wh$aParaneoplastic Syndromes, Nervous System
=550  \\$wh$aParkinson Disease
=550  \\$wh$aPostpoliomyelitis Syndrome
=550  \\$wh$aPrion Diseases
=550  \\$wh$aShy-Drager Syndrome
=550  \\$wh$aSubacute Combined Degeneration
=550  \\$wh$aTauopathies
=550  \\$wh$aTDP-43 Proteinopathies
=667  \\$aGEN or unspecified; prefer specifics; /genet: consider also HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM
=680  \\$iHereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
=688  \\$a98
=750  \0$aNervous system$xDegeneration$5IEN-M$0(DLC)sh 85090923

=LDR  00853cz  a2200265n  4500
=001  9880364254902441
=005  20141212213309.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019649
=035  \\$aCVE5971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423
=150  \\$aFood Industry
=450  \\$wnnna$aFood Industries
=450  \\$wnnna$aIndustries, Food
=450  \\$wnnna$aIndustry, Food
=550  \\$wg$aIndustry
=550  \\$wh$aFood Handling
=550  \\$wh$aFood Services
=550  \\$wh$aFood Supply
=550  \\$wh$aFood Technology
=667  \\$aGEN or unspecified; prefer specific activities; DF: FOOD INDUST
=680  \\$iThe industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.
=688  \\$a98
=750  \0$aFood industry and trade$5IEN-M$0(DLC)sh 85050282

=LDR  00806cz  a2200229n  4500
=001  9880364255002441
=005  20161219093301.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019652
=035  \\$aCVE5970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x875
=150  \\$aExtraction and Processing Industry
=550  \\$wg$aManufacturing Industry
=550  \\$wh$aCoal Industry
=550  \\$wh$aMetallurgy
=550  \\$wh$aMining
=550  \\$wh$aOil and Gas Industry
=667  \\$aindust removal of raw materials from the earth & conversion into refined products
=680  \\$iThe industry concerned with the removal of raw materials from the Earth's crust and with their conversion into refined products.
=688  \\$a98
=750  \0$aMineral industries$5IEN-M$0(DLC)sh 85085548

=LDR  01430cz  a2200361n  4500
=001  9880364255102441
=005  20141212213320.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x475
=150  \\$aGenes, T-Cell Receptor
=450  \\$wnnna$aGene, T-Cell Receptor
=450  \\$wnnna$aGene, TcR
=450  \\$wnnna$aGenes, T Cell Receptor
=450  \\$wnnna$aGenes, TcR
=450  \\$wnnna$aT-Cell Receptor Gene
=450  \\$aT-Cell Receptor Genes
=450  \\$wnnna$aT Cell Receptor Genes
=450  \\$wnnna$aTcR Gene
=450  \\$aTcR Genes
=550  \\$wg$aGenes
=550  \\$wh$aGenes, T-Cell Receptor alpha
=550  \\$wh$aGenes, T-Cell Receptor beta
=550  \\$wh$aGenes, T-Cell Receptor delta
=550  \\$wh$aGenes, T-Cell Receptor gamma
=550  \\$aGene Rearrangement, T-Lymphocyte
=550  \\$aReceptors, Antigen, T-Cell
=550  \\$aVDJ Exons
=667  \\$aGEN or unspecified; prefer specifics; DF: note short X ref
=680  \\$iDNA sequences, in cells of the T-lymphocyte lineage, that code for T-cell receptors. The TcR genes are formed by somatic rearrangement (see GENE REARRANGEMENT, T-LYMPHOCYTE and its children) of germline gene segments, and resemble Ig genes in their mechanisms of diversity generation and expression.
=688  \\$a98
=750  \0$aT-cell receptor genes$5IEN-M$0(DLC)sh2001010951

=LDR  01509cz   2200421n  4500
=001  9880364255202441
=005  20220922155509.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019657
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905
=150  \\$aSolanaceae
=450  \\$aAcnistus
=450  \\$aBrugmansia
=450  \\$wnnna$aBrugmansias
=450  \\$aDunalia
=450  \\$wnnna$aDunalias
=550  \\$wg$aAngiosperms
=550  \\$wh$aAtropa
=550  \\$wh$aCapsicum
=550  \\$wh$aCestrum
=550  \\$wh$aDatura
=550  \\$wh$aDuboisia
=550  \\$wh$aHyoscyamus
=550  \\$wh$aLycium
=550  \\$wh$aLycopersicon esculentum
=550  \\$wh$aMandragora
=550  \\$wh$aPetunia
=550  \\$wh$aPhysalis
=550  \\$wh$aScopolia
=550  \\$wh$aSolanum
=550  \\$wh$aTobacco
=550  \\$wh$aWithania
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Solanales, subclass Asteridae. Among the most important are POTATOES; TOMATOES; CAPSICUM (green and red peppers); TOBACCO; and BELLADONNA.
=688  \\$a98
=750  \0$aSolanaceae$5IEN-M$0(DLC)sh 85124477
=750  \0$iNarrower mapping$aSolandra$0(DLC)sh2021006834$4NM$5IEN-M

=LDR  01542cz  a2200361n  4500
=001  9880364255402441
=005  20141212213256.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019586
=035  \\$aCVE5948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x631
=150  \\$aIntracranial Hypertension
=450  \\$wnnna$aElevated ICP (Intracranial Pressure)
=450  \\$wnnna$aElevated Intracranial Pressure
=450  \\$wnnna$aHypertension, Intracranial
=450  \\$wnnna$aICP, Elevated (Intracranial Pressure)
=450  \\$wnnna$aICP (Intracranial Pressure) Elevation
=450  \\$wnnna$aICP (Intracranial Pressure) Increase
=450  \\$wnnna$aIntracranial Pressure, Elevated
=450  \\$wnnna$aIntracranial Pressure Increase
=450  \\$wnnna$aPressure, Elevated Intracranial
=450  \\$wnnna$aPressure Increase, Intracranial
=550  \\$wg$aBrain Diseases
=550  \\$wh$aHydrocephalus
=550  \\$wh$aHypertensive Encephalopathy
=550  \\$wh$aPseudotumor Cerebri
=550  \\$aBrain Edema
=550  \\$aHydrocephalus
=667  \\$ado not confuse with INTRACRANIAL HYPOTENSION; coord IM with disease /physiopathol (IM) causing or caused by intracranial hypertension
=680  \\$iIncreased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
=688  \\$a1998
=750  \0$aIntracranial hypertension$5IEN-M$0(DLC)sh 85067614

=LDR  01259cz  a2200301n  4500
=001  9880364255502441
=005  20141212213258.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x620.$x500
=150  \\$aFlax
=450  \\$wnnna$aFlaxs
=450  \\$aFlaxseed
=450  \\$wnnna$aFlaxseeds
=450  \\$aLinseed
=450  \\$wnnna$aLinseeds
=450  \\$aLinum
=450  \\$wnnna$aLinum usitatissimum
=450  \\$wnnna$aLinum usitatissimums
=450  \\$wnnna$aLinums
=450  \\$wnnna$ausitatissimum, Linum
=450  \\$wnnna$ausitatissimums, Linum
=550  \\$wg$aLinaceae
=667  \\$adespite X ref FLAXSEED, coord IM with SEEDS (IM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LINACEAE that is cultivated for its fiber (manufactured into linen cloth). It contains a trypsin inhibitor and the seed is the source of LINSEED OIL.
=688  \\$a98
=750  \0$aFlax$5IEN-M$0(DLC)sh 85049037

=LDR  00826cz  a2200289n  4500
=001  9880364255602441
=005  20141212213257.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019596
=035  \\$aCVE5942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x900
=150  \\$aWolves
=450  \\$aCanis lupus
=450  \\$aCanis rufus
=450  \\$aCanis simensis
=450  \\$wnnna$aEthiopian Wolf
=450  \\$wnnna$aGray Wolf
=450  \\$wnnna$aRed Wolf
=450  \\$wnnna$aWolf
=450  \\$wnnna$aWolf, Ethiopian
=450  \\$wnnna$aWolf, Gray
=450  \\$wnnna$aWolf, Red
=550  \\$wg$aCanidae
=680  \\$iAny of several large carnivorous mammals of the family CANIDAE that usually hunt in packs.
=688  \\$a98
=750  \0$aWolves$5IEN-M$0(DLC)sh 85147257

=LDR  02118cz  a2200445n  4500
=001  9880364255702441
=005  20141212213254.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019578
=035  \\$aCVE5940M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177.$x575.$x550
=072  \\$aC10.$x228.$x140.$x79.$x612
=072  \\$aC10.$x228.$x662.$x550
=072  \\$aC10.$x574.$x625
=150  \\$aMultiple System Atrophy
=450  \\$wnnna$aAtrophies, Multisystem
=450  \\$wnnna$aAtrophies, Multisystemic
=450  \\$wnnna$aAtrophy, Multiple System
=450  \\$wnnna$aAtrophy, Multisystem
=450  \\$wnnna$aAtrophy, Multisystemic
=450  \\$wnnna$aMultiple System Atrophies
=450  \\$wnnna$aMultiple System Atrophy Syndrome
=450  \\$wnnna$aMultisystem Atrophies
=450  \\$wnnna$aMultisystem Atrophy
=450  \\$wnnna$aMultisystemic Atrophies
=450  \\$wnnna$aMultisystemic Atrophy
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aMovement Disorders
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wg$aPrimary Dysautonomias
=550  \\$wh$aOlivopontocerebellar Atrophies
=550  \\$wh$aShy-Drager Syndrome
=550  \\$wh$aStriatonigral Degeneration
=550  \\$aOlivopontocerebellar Atrophies
=550  \\$aShy-Drager Syndrome
=667  \\$aa specific neurodegenerative syndrome complex; not for atrophy in other systems
=680  \\$iA syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
=688  \\$a1998
=750  \0$aMultiple system atrophy$0(DLC)sh2014001105$5IEN-M

=LDR  02468cz  a2200637n  4500
=001  9880364255802441
=005  20141212192913.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019579
=035  \\$aCVE5939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x420
=150  \\$aNeocortex
=450  \\$wnnna$aCerebral Neocortex
=450  \\$wnnna$aCerebral Neocortices
=450  \\$wnnna$aCortex, Neopallial
=450  \\$wnnna$aCorticali, Substantia
=450  \\$wnnna$aCorticalis, Substantia
=450  \\$wnnna$aCortices, Neopallial
=450  \\$wnnna$aExternal Granular Layer
=450  \\$wnnna$aExternal Granular Layers
=450  \\$wnnna$aGranular Layer, External
=450  \\$wnnna$aGranular Layers, External
=450  \\$wnnna$aIsocortex
=450  \\$wnnna$aIsocortices
=450  \\$wnnna$aLayer, External Granular
=450  \\$wnnna$aLayer, Neocortical Molecular
=450  \\$wnnna$aLayer, Neocortical Multiform
=450  \\$wnnna$aLayers, External Granular
=450  \\$wnnna$aLayers, Neocortical Molecular
=450  \\$wnnna$aLayers, Neocortical Multiform
=450  \\$wnnna$aMolecular Layer, Neocortical
=450  \\$wnnna$aMolecular Layers, Neocortical
=450  \\$wnnna$aMultiform Layer, Neocortical
=450  \\$wnnna$aMultiform Layers, Neocortical
=450  \\$wnnna$aNeocortex, Cerebral
=450  \\$wnnna$aNeocortical External Granular Layer
=450  \\$wnnna$aNeocortical External Pyramidal Layer
=450  \\$wnnna$aNeocortical Internal Granular Layer
=450  \\$wnnna$aNeocortical Internal Pyramidal Layer
=450  \\$wnnna$aNeocortical Molecular Layer
=450  \\$wnnna$aNeocortical Molecular Layers
=450  \\$wnnna$aNeocortical Multiform Layer
=450  \\$wnnna$aNeocortical Multiform Layers
=450  \\$wnnna$aNeocortices
=450  \\$wnnna$aNeocortices, Cerebral
=450  \\$wnnna$aNeopallial Cortex
=450  \\$wnnna$aNeopallial Cortices
=450  \\$wnnna$aNeopallium
=450  \\$wnnna$aNeopalliums
=450  \\$wnnna$aSubstantia Corticali
=450  \\$wnnna$aSubstantia Corticalis
=550  \\$wg$aCerebral Cortex
=680  \\$iThe largest portion of the CEREBRAL CORTEX in which the NEURONS are arranged in six layers in the mammalian brain: molecular, external granular, external pyramidal, internal granular, internal pyramidal and multiform layers.
=688  \\$a98
=750  \0$aNeocortex$5IEN-M$0(DLC)sh 85090802

=LDR  01174cz  a2200385n  4500
=001  9880364255902441
=005  20141212213251.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019572
=035  \\$aCVE5938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x364.$x818
=072  \\$aC11.$x319.$x475
=072  \\$aC11.$x768.$x717
=150  \\$aRetinal Neoplasms
=450  \\$wnnna$aCancer of the Retina
=450  \\$wnnna$aCancer, Retinal
=450  \\$wnnna$aCancers, Retinal
=450  \\$wnnna$aNeoplasm, Retinal
=450  \\$wnnna$aNeoplasms, Retinal
=450  \\$wnnna$aRetinal Cancer
=450  \\$wnnna$aRetinal Cancers
=450  \\$wnnna$aRetinal Neoplasm
=450  \\$wnnna$aRetinal Tumor
=450  \\$wnnna$aRetinal Tumors
=450  \\$wnnna$aTumor, Retinal
=450  \\$wnnna$aTumors, Retinal
=550  \\$wg$aEye Neoplasms
=550  \\$wg$aRetinal Diseases
=550  \\$wh$aRetinoblastoma
=667  \\$acoordinate IM with histologic type of neoplasm (IM) but majority will be RETINOBLASTOMA
=680  \\$iTumors or cancer of the RETINA.
=688  \\$a1998
=688  \\$a98
=750  \0$aRetina$xCancer$5IEN-M$0(DLC)sh 85113326

=LDR  02301cz  a2200553n  4500
=001  9880364256002441
=005  20141212213252.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019574
=035  \\$aCVE5933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x300.$x600
=072  \\$aC4.$x588.$x614.$x596.$x240.$x240
=072  \\$aC10.$x292.$x225.$x800
=072  \\$aC10.$x292.$x700.$x500
=072  \\$aC10.$x551.$x360.$x500
=072  \\$aC11.$x640.$x544
=150  \\$aOptic Nerve Neoplasms
=450  \\$wnnna$aBenign Optic Nerve Neoplasm
=450  \\$wnnna$aBenign Optic Nerve Sheath Neoplasms
=450  \\$wnnna$aBenign Optic Nerve Sheath Tumors
=450  \\$wnnna$aBenign Optic Nerve Tumor
=450  \\$wnnna$aMalignant Optic Nerve Neoplasm
=450  \\$wnnna$aMalignant Optic Nerve Sheath Neoplasms
=450  \\$wnnna$aMalignant Optic Nerve Sheath Tumors
=450  \\$wnnna$aMalignant Optic Nerve Tumor
=450  \\$wnnna$aNeoplasm, Benign, Optic Nerve
=450  \\$wnnna$aNeoplasm, Optic Nerve
=450  \\$wnnna$aNeoplasm, Optic Nerve, Benign
=450  \\$wnnna$aNeoplasms, Optic Nerve
=450  \\$wnnna$aOptic Nerve Neoplasm
=450  \\$wnnna$aOptic Nerve Neoplasm, Benign
=450  \\$wnnna$aOptic Nerve Sheath Neoplasm
=450  \\$wnnna$aOptic Nerve Sheath Neoplasms, Malignant
=450  \\$aOptic Nerve Sheath Tumors
=450  \\$wnnna$aOptic Nerve Sheath Tumors, Benign
=450  \\$wnnna$aOptic Nerve Sheath Tumors, Malignant
=450  \\$wnnna$aOptic Nerve Tumor, Malignant
=450  \\$wnnna$aTumor, Benign, Optic Nerve
=450  \\$wnnna$aTumor, Malignant, Optic Nerve
=450  \\$wnnna$aTumor, Optic Nerve, Benign
=450  \\$wnnna$aTumor, Optic Nerve, Malignant
=550  \\$wg$aCranial Nerve Neoplasms
=550  \\$wg$aOptic Nerve Diseases
=550  \\$wh$aOptic Nerve Glioma
=667  \\$acoordinate IM with histologic type of neoplasm (IM)
=680  \\$iBenign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.
=688  \\$a98
=750  \0$aOptic nerve$xTumors$5IEN-M$0(DLC)sh 85095133

=LDR  00757cz  a2200217n  4500
=001  9880364256102441
=005  20141212213250.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019570
=035  \\$aCVE5930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x112
=150  \\$aInhalation Exposure
=450  \\$wnnna$aExposure, Inhalation
=450  \\$wnnna$aExposures, Inhalation
=450  \\$wnnna$aInhalation Exposures
=550  \\$wg$aEnvironmental Exposure
=667  \\$amay or may not result in a disease; coord IM with specific inhalant (IM)
=680  \\$iThe exposure to potentially harmful chemical, physical, or biological agents by inhaling them.
=688  \\$a98
=750  \0$aPulmonary toxicology$5IEN-M$0(DLC)sh 89003786

=LDR  00339cz  a2200121n  4500
=001  9880364256202441
=005  20120717143620.0
=008  670901\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCUX7256HS
=035  \\$a(DNLM)D004452Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEchocardiography$xveterinary
=750  \0$aVeterinary echocardiography$5IEN$0(DLC)sh 97008064

=LDR  00347cz  a2200121n  4500
=001  9880364256302441
=005  20120717143620.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCUB1423HS
=035  \\$a(DNLM)D009748Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aNutrition Disorders$xveterinary
=750  \0$aNutrition disorders in animals$5IEN-M$0(DLC)sh 88004393

=LDR  00337cz  a2200121n  4500
=001  9880364256402441
=005  20120717143620.0
=008  920522\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCUA2208HS
=035  \\$a(DNLM)D017096Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aPrion Diseases$xveterinary
=750  \0$aPrion diseases in animals$5IEN-M$0(DLC)sh 92003844

=LDR  00359cz  a2200133n  4500
=001  9880364256502441
=005  20120717143620.0
=008  900617\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCTQ2096HS
=035  \\$a(DNLM)D016189Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aDystrophin$xgenetics
=450  \\$aDystrophin Gene$5IEN
=750  \0$aDystrophin genes$5IEN-M$0(DLC)sh 96011007

=LDR  00354cz  a2200133n  4500
=001  9880364256602441
=005  20120717143620.0
=008  960610\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCTQ2071HS
=035  \\$a(DNLM)D019344Q000097
=040  \\$aDNLM$cDNLM
=150  \\$aLactic Acid$xblood
=450  \\$aBlood Lactate$5IEN-M
=750  \0$aBlood lactate$5IEN-M$0(DLC)sh 94005185

=LDR  01970cz  a2200445n  4500
=001  9880364256702441
=005  20141212213030.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186.$x71.$x202.$x370
=072  \\$aD27.$x505.$x519.$x389.$x370
=072  \\$aD27.$x505.$x954.$x557.$x500.$x202.$x370
=150  \\$aHydroxymethylglutaryl-CoA Reductase Inhibitors
=450  \\$aHMG-CoA Reductase Inhibitors
=450  \\$wnnna$aHMG CoA Reductase Inhibitors
=450  \\$wnnna$aHMG-CoA Statins
=450  \\$wnnna$aHydroxymethylglutaryl-CoA Inhibitors
=450  \\$wnnna$aHydroxymethylglutaryl CoA Reductase Inhibitors
=450  \\$aHydroxymethylglutaryl CoA Reductases$xantagonists & inhibitors
=450  \\$aHydroxymethylglutaryl-CoA-Reductases, NADP-dependent$xantagonists & inhibitors
=450  \\$wnnna$aHydroxymethylglutaryl-Coenzyme A Inhibitors
=450  \\$wnnna$aInhibitors, HMG-CoA Reductase
=450  \\$wnnna$aInhibitors, HMG CoA Reductase
=450  \\$wnnna$aInhibitors, Hydroxymethylglutaryl-CoA
=450  \\$wnnna$aInhibitors, Hydroxymethylglutaryl CoA
=450  \\$wnnna$aInhibitors, Hydroxymethylglutaryl-CoA Reductase
=450  \\$wnnna$aInhibitors, Hydroxymethylglutaryl-Coenzyme A
=450  \\$wnnna$aInhibitors, Hydroxymethylglutaryl Coenzyme A
=450  \\$wnnna$aReductase Inhibitors, HMG-CoA
=450  \\$wnnna$aReductase Inhibitors, Hydroxymethylglutaryl-CoA
=450  \\$aStatins, HMG-CoA
=450  \\$wnnna$aStatins, HMG CoA
=550  \\$wg$aAnticholesteremic Agents
=550  \\$wg$aEnzyme Inhibitors
=550  \\$aHydroxymethylglutaryl CoA Reductases
=667  \\$aX ref STATINS, HMG-COA: do not confuse with statin protein in SCR
=680  \\$iCompounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.
=688  \\$a98
=750  \0$aStatins (Cardiovascular agents)$5IEN-M$0(DLC)sh 00001691

=LDR  00661cz  a2200205n  4500
=001  9880363459102441
=005  20141212200112.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002938
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x727.$x300
=072  \\$aB1.$x50.$x500.$x272.$x727.$x300
=150  \\$aCiona intestinalis
=450  \\$wnnna$aCiona intestinali
=450  \\$wnnna$aintestinali, Ciona
=450  \\$wnnna$aintestinalis, Ciona
=550  \\$wg$aUrochordata
=680  \\$iThe only species of a cosmopolitan ascidian.
=688  \\$a91(75); was see under UROCHORDATA 1975-90
=750  \0$aCiona intestinalis$5IEN$0(DLC)sh 87020404

=LDR  02101cz  a2200589n  4500
=001  9880363459202441
=005  20141212192110.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002936
=035  \\$aCAZ6093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x606.$x290
=150  \\$aCinnarizine
=450  \\$wnnna$a1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine
=450  \\$wnnna$aAliud Brand of Cinnarizine
=450  \\$wnnna$aAlpharma Brand of Cinnarizine
=450  \\$wnnna$aArtu Brand of Cinnarizine
=450  \\$wnnna$aAshbourne Brand of Cinnarizine
=450  \\$wnnna$aCinarizina Inkey
=450  \\$wnnna$aCinarizina Ratiopharm
=450  \\$wnnna$aCinarizine
=450  \\$wnnna$aCinazière
=450  \\$wnnna$aCinna
=450  \\$wnnna$aCinnarizin AL
=450  \\$wnnna$aCinnarizin-ratiopharm
=450  \\$wnnna$aCinnarizin Siegfried
=450  \\$wnnna$acinnarizin von ct
=450  \\$wnnna$aCinnarizine, Dihydrochloride
=450  \\$wnnna$aCinnarizine, (E)-Isomer
=450  \\$wnnna$aCinnarizine L-Tartrate
=450  \\$wnnna$aCinnarizine L Tartrate
=450  \\$wnnna$aCinnarizine L-Tartrate (1:1)
=450  \\$wnnna$aCinnipirine
=450  \\$wnnna$aCisaken
=450  \\$wnnna$act-Arzneimittel Brand of Cinnarizine
=450  \\$wnnna$aDihydrochloride Cinnarizine
=450  \\$wnnna$aDimitronal
=450  \\$wnnna$aEsteve Brand of Cinnarizine
=450  \\$wnnna$aInkeysa Brand of Cinnarizine
=450  \\$wnnna$aJanssen Brand of Cinnarizine
=450  \\$wnnna$aKendrick Brand of Cinnarizine
=450  \\$wnnna$aL-Tartrate, Cinnarizine
=450  \\$wnnna$aR-516
=450  \\$wnnna$aR 516
=450  \\$wnnna$aR516
=450  \\$wnnna$aratiopharm Brand of Cinnarizine
=450  \\$wnnna$aStugeron
=450  \\$wnnna$aStugeron Forte
=550  \\$wg$aPiperazines
=680  \\$iA piperazine derivative having histamine H1-receptor and calcium-channel blocking activity with vasodilating and antiemetic properties but it induces PARKINSONIAN DISORDERS.
=688  \\$a86(75)
=750  \0$aCinnarizine$5IEN$0(DLC)sh 85026036

=LDR  00945cz  a2200205n  4500
=001  9880363459302441
=005  20141212192109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002935
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x149.$x500
=150  \\$aCinnamomum zeylanicum
=450  \\$wnnna$aCinnamomum verum
=450  \\$aCinnamon
=450  \\$wnnna$aCinnamons
=550  \\$wg$aCinnamomum
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iThe tree which is known for its bark which is sold as cinnamon. The oil contains about 65-80% cinnamaldehyde and 10% EUGENOL and many TERPENES.
=688  \\$a2002(1975)
=750  \0$aCinnamon tree$5IEN$0(DLC)sh 85026035

=LDR  00540cz  a2200205n  4500
=001  9880363459402441
=005  20141212200112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002934
=035  \\$aCAZ6091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x200
=150  \\$aCinnamates
=550  \\$wg$aAcids, Carbocyclic
=550  \\$wh$aCaffeic Acids
=550  \\$wh$aChlorogenic Acid
=550  \\$wh$aCinanserin
=550  \\$wh$aCoumaric Acids
=550  \\$wh$aPuromycin
=750  \0$aCinnamates$0(DLC) sh 86006849$5IEN

=LDR  00936cz  a2200277n  4500
=001  9880363459502441
=005  20141212200112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002933
=035  \\$aCAZ6090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x150
=150  \\$aCineradiography
=450  \\$wnnna$aCinefluorographies
=450  \\$aCinefluorography
=450  \\$wnnna$aCineradiographies
=450  \\$wnnna$aRadiocinematographies
=450  \\$aRadiocinematography
=550  \\$wg$aRadiography
=550  \\$wh$aCineangiography
=550  \\$aMotion Pictures as Topic
=667  \\$ado not use /util except by MeSH definition; DF: CINERADIOGR
=680  \\$iMotion picture study of successive images appearing on a fluoroscopic screen.
=688  \\$a73; was CINEFLUOROGRAPHY 1963-72
=750  \0$aCinefluorography$5IEN-M$0(DLC)sh 85026012
=750  \0$aCineradiography$5IEN-HS$0(DLC)sh 85026030

=LDR  00816cz  a2200241n  4500
=001  9880363459602441
=005  20141212200111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002932
=035  \\$aCAZ6089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x60.$x190
=072  \\$aE1.$x370.$x350.$x700.$x150.$x190
=072  \\$aE1.$x370.$x370.$x50.$x190
=150  \\$aCineangiography
=450  \\$wnnna$aCineangiographies
=550  \\$wg$aAngiography
=550  \\$wg$aCineradiography
=550  \\$aMotion Pictures as Topic
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CINEANGIOGR
=680  \\$iMotion pictures of the passage of contrast medium through blood vessels.
=688  \\$a66(64)
=750  \0$aCineangiography$5IEN$0(DLC)sh 85026011

=LDR  00657cz  a2200229n  4500
=001  9880363459702441
=005  20141212200111.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002930
=035  \\$aCAZ6087M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x206
=150  \\$aCinchona Alkaloids
=450  \\$wnnna$aAlkaloids, Cinchona
=550  \\$wg$aAlkaloids
=550  \\$wh$aQuinidine
=550  \\$wh$aQuinine
=550  \\$aCinchona
=667  \\$aGEN or unspecified: prefer specific indentions
=680  \\$iAlkaloids extracted from various species of Cinchona.
=688  \\$a77
=750  \0$aCinchona alkaloids$0(DLC) sh2004009967$5IEN-M

=LDR  01255cz  a2200277n  4500
=001  9880363459802441
=005  20141212192108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002929
=035  \\$aCAZ6086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x250
=150  \\$aCinchona
=450  \\$wnnna$aBark, Peruvian
=450  \\$wnnna$aCinchona pubescens
=450  \\$wnnna$aCinchona, Red
=450  \\$wnnna$aCinchonas
=450  \\$wnnna$aCinchonas, Red
=450  \\$aPeruvian Bark
=450  \\$wnnna$aRed Cinchona
=450  \\$wnnna$aRed Cinchonas
=550  \\$wg$aRubiaceae
=667  \\$aplant only: alkaloids = CINCHONA ALKALOIDS; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE; QUINIDINE; chinconine, cinchonidine and others are used to treat MALARIA and CARDIAC ARRHYTHMIAS.
=688  \\$awas in Cat B & D 1963-76
=750  \0$aCinchona$5IEN$0(DLC)sh 85026000

=LDR  01359cz  a2200385n  4500
=001  9880363459902441
=005  20141212192108.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x200
=072  \\$aD3.$x383.$x129.$x308.$x130
=150  \\$aCimetidine
=450  \\$wnnna$aAltramet
=450  \\$wnnna$aBiomet
=450  \\$wnnna$aBiomet400
=450  \\$wnnna$aCimetidine HCl
=450  \\$wnnna$aCimetidine Hydrochloride
=450  \\$wnnna$aEureceptor
=450  \\$wnnna$aHCl, Cimetidine
=450  \\$wnnna$aHistodil
=450  \\$wnnna$aHydrochloride, Cimetidine
=450  \\$wnnna$aN-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine
=450  \\$wnnna$aSK&F-92334
=450  \\$wnnna$aSK&F 92334
=450  \\$wnnna$aSK&F92334
=450  \\$wnnna$aSKF-92334
=450  \\$wnnna$aSKF 92334
=450  \\$wnnna$aSKF92334
=450  \\$wnnna$aTagamet
=550  \\$wg$aGuanidines
=550  \\$wg$aImidazoles
=680  \\$iA histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
=688  \\$a84(78); was see under GUANIDINES 1978-83
=750  \0$aCimetidine$5IEN$0(DLC)sh 85025995

=LDR  01492cz  a2200325n  4500
=001  9880363460002441
=005  20141212192107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002924
=035  \\$aCAZ6081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x160
=072  \\$aA9.$x371.$x894.$x280
=150  \\$aCiliary Body
=450  \\$wnnna$aBodies, Ciliary
=450  \\$wnnna$aBody, Ciliary
=450  \\$wnnna$aCiliare, Corpus
=450  \\$wnnna$aCiliares, Corpus
=450  \\$wnnna$aCiliari, Corpus
=450  \\$wnnna$aCiliaris, Corpus
=450  \\$wnnna$aCiliary Bodies
=450  \\$wnnna$aCorpus Ciliare
=450  \\$wnnna$aCorpus Ciliares
=450  \\$wnnna$aCorpus Ciliari
=450  \\$wnnna$aCorpus Ciliaris
=550  \\$wg$aAnterior Eye Segment
=550  \\$wg$aUvea
=667  \\$ainflammation: consider CILIARY BODY (IM) + UVEITIS (IM) or UVEITIS, ANTERIOR (IM); diseases = CILIARY BODY (IM) + UVEAL DISEASES (IM); neoplasms = CILIARY BODY (IM) + UVEAL NEOPLASMS (IM) + histological type of neoplasm (IM); / blood supply consider also CILIARY ARTERIES; pigmented ciliary epithelium: coordinate CILIARY BODY with PIGMENT EPITHELIUM OF EYE
=680  \\$iA ring of tissue extending from the scleral spur to the ora serrata of the RETINA. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.
=750  \0$aCiliary body$5IEN$0(DLC)sh 85025974

=LDR  01060cz  a2200301n  4500
=001  9880363460102441
=005  20141212200109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x450.$x300
=072  \\$aC23.$x550.$x355.$x274
=072  \\$aG16.$x100.$x856.$x891.$x249
=150  \\$aCicatrix
=450  \\$wnnna$aCicatrization
=450  \\$wnnna$aScar
=450  \\$wnnna$aScarring
=450  \\$aScars
=550  \\$wg$aFibrosis
=550  \\$wg$aGranulation Tissue
=550  \\$wg$aWound Healing
=550  \\$wh$aCicatrix, Hypertrophic
=550  \\$wh$aKeloid
=550  \\$wh$aTissue Adhesions
=550  \\$aWound Healing
=667  \\$aCICATRIX, HYPERTROPHIC is also available; do not confuse entry term SCARRING with scarification (scratching open the surface of the skin purposely for VACCINATION; BODY MODIFICATION, NON-THERAPEUTIC; etc.)
=680  \\$iThe fibrous tissue that replaces normal tissue during the process of WOUND HEALING.
=750  \0$aScars$5IEN$0(DLC)sh 85025918

=LDR  01137cz  a2200277n  4500
=001  9880363460202441
=005  20141212192107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002918
=035  \\$aCAZ6075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x176
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x176
=150  \\$aChymotrypsin
=450  \\$wnnna$aAlpha-Chymotrypsin Choay
=450  \\$wnnna$aAlphacutanée
=450  \\$wnnna$aAvazyme
=450  \\$wnnna$aDelalande Brand of Chymotrypsin
=450  \\$wnnna$aLeurquin Brand of Chymotrypsin
=450  \\$wnnna$aSanofi Synthelabo Brand of Chymotrypsin
=450  \\$wnnna$aWampole Brand of Chymotrypsin
=550  \\$wg$aSerine Endopeptidases
=550  \\$aPancreatic Juice
=667  \\$a/antag: consider also ALPHA 1-ANTICHYMOTRYPSIN
=680  \\$iA serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side.
=750  \0$aChymotrypsin$0(DLC) sh 85025904$5IEN

=LDR  00989cz  a2200277n  4500
=001  9880363460302441
=005  20141212200109.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002917
=035  \\$aCAZ6074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x262.$x500.$x160
=072  \\$aD8.$x811.$x277.$x656.$x300.$x200.$x160
=150  \\$aChymopapain
=450  \\$wnnna$aChemolase
=450  \\$wnnna$aChymodiactin
=450  \\$wnnna$aChymopapain A
=450  \\$wnnna$aChymopapain B
=450  \\$wnnna$aDiscase
=450  \\$wnnna$aFarmamed Brand of Chymopapain
=450  \\$wnnna$aLink Brand of Chymopapain
=550  \\$wg$aCysteine Endopeptidases
=550  \\$aIntervertebral Disc Chemolysis
=680  \\$iA cysteine endopeptidase isolated from papaya latex. Preferential cleavage at glutamic and aspartic acid residues. EC 3.4.22.6.
=688  \\$a86(75); was see under PEPTIDE PEPTIDOHYDROLASES 1975-85
=750  \0$aChymopapain$5IEN$0(DLC)sh 85025903

=LDR  00528cz  a2200181n  4500
=001  9880363460402441
=005  20141212200108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002916
=035  \\$aCAZ6073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x142
=150  \\$aChylothorax
=550  \\$wg$aPleural Diseases
=550  \\$aLymphatic Diseases
=667  \\$achyle in thoracic cavity
=680  \\$iThe presence of chyle in the thoracic cavity. (Dorland, 27th ed)
=750  \0$aChylothorax$5IEN$0(DLC)sh 85025902

=LDR  00657cz  a2200193n  4500
=001  9880363460502441
=005  20141212200108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002913
=035  \\$aCAZ6070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x270.$x606.$x350
=072  \\$aA15.$x382.$x520.$x150.$x350
=150  \\$aChyle
=450  \\$wnnna$aChyles
=550  \\$wg$aLymph
=667  \\$achyluria: index CHYLE (IM) + URINE (NIM)
=680  \\$iAn opaque, milky-white fluid consisting mainly of emulsified fats that passes through the lacteals of the small intestines into the lymphatic system.
=750  \0$aChyle$5IEN$0(DLC)sh 85025901

=LDR  00739cz  a2200241n  4500
=001  9880363460602441
=005  20141212200107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002910
=035  \\$aCAZ6066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910.$x200
=072  \\$aL1.$x80
=150  \\$aChronology as Topic
=450  \\$wnnna$aChronology as Topics
=450  \\$wnnna$aDates
=550  \\$wg$aInformation Science
=550  \\$wg$aTime
=667  \\$ado not confuse with TIME; TIME FACTORS or TIME PERCEPTION
=680  \\$iThe temporal sequence of events that have occurred.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Chronology
=750  \0$aChronology$0(DLC) sh 85025406$5IEN

=LDR  01292cz  a2200337n  4500
=001  9880363460702441
=005  20141212200107.0
=008  850619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002909
=035  \\$aCAZ6065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x180
=150  \\$aChronobiology Phenomena
=450  \\$wnno$aChronobiology$5IEN-M
=450  \\$wnnna$aChronobiology Concept
=450  \\$wnnna$aChronobiology Concepts
=450  \\$wnnna$aChronobiology Phenomenon
=450  \\$wnnna$aConcept, Chronobiology
=450  \\$wnnna$aConcepts, Chronobiology
=450  \\$wnnna$aPhenomena, Chronobiology
=450  \\$wnnna$aPhenomenon, Chronobiology
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aPeriodicity
=550  \\$aChronobiology Discipline
=550  \\$aChronotherapy
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iBiological systems as affected by time. Aging, biological rhythms, and cyclic phenomena are included. Statistical, computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time.
=688  \\$a2009 (1986)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Chronobiology
=688  \\$a86
=750  \0$aChronobiology$0(DLC) sh 87003347$5IEN-M

=LDR  01307cz  a2200301n  4500
=001  9880363460802441
=005  20180822120333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002908
=035  \\$aCAZ6064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x500
=150  \\$aChronic Disease
=450  \\$wnnna$aChronic Diseases
=450  \\$aChronic Illness
=450  \\$wnnna$aChronic Illnesses
=450  \\$wnnna$aChronically Ill
=450  \\$wnnna$aDisease, Chronic
=450  \\$wnnna$aDiseases, Chronic
=450  \\$wnnna$aIllness, Chronic
=450  \\$wnnna$aIllnesses, Chronic
=550  \\$wg$aDisease Attributes
=550  \\$wh$aMultiple Chronic Conditions
=550  \\$aPain Management
=667  \\$aIM GEN only; usually NIM with specific dis IM; no qualif when NIM; Manual 23.16+
=680  \\$iDiseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
=750  \0$aChronically ill$5IEN-M$0(DLC)sh 85025397
=750  \0$aChronic diseases$5IEN-HS$0(DLC)sh 85025392

=LDR  00635cz  a2200181n  4500
=001  9880363460902441
=005  20141212200102.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002889
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x520.$x300.$x235.$x245
=072  \\$aG5.$x360.$x162.$x520.$x300.$x235.$x245
=150  \\$aChromosomes, Human, Pair 2
=450  \\$aChromosome 2
=550  \\$wg$aChromosomes, Human, 1-3
=680  \\$iA specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification.
=688  \\$a87
=750  \0$aHuman chromosome 2$0(DLC)sh2005005112$5IEN-M

=LDR  00602cz  a2200181n  4500
=001  9880363461002441
=005  20141212200101.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002884
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x520.$x300.$x370.$x385
=072  \\$aG5.$x360.$x162.$x520.$x300.$x370.$x385
=150  \\$aChromosomes, Human, Pair 15
=450  \\$aChromosome 15
=550  \\$wg$aChromosomes, Human, 13-15
=680  \\$iA specific pair of GROUP D CHROMOSOMES of the human chromosome classification.
=688  \\$a87
=750  \0$aHuman chromosome 15$5IEN$0(DLC)sh 92000323

=LDR  00609cz  a2200181n  4500
=001  9880363461102441
=005  20141212200100.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x520.$x300.$x325.$x360
=072  \\$aG5.$x360.$x162.$x520.$x300.$x325.$x360
=150  \\$aChromosomes, Human, Pair 12
=450  \\$aChromosome 12
=550  \\$wg$aChromosomes, Human, 6-12 and X
=680  \\$iA specific pair of GROUP C CHROMOSOMES of the human chromosome classification.
=688  \\$a87
=750  \0$aHuman chromosome 12$5IEN-M$0(DLC)sh 94003715

=LDR  01433cz  a2200313n  4500
=001  9880363461202441
=005  20141212200100.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002877
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x520.$x300
=072  \\$aG5.$x360.$x162.$x520.$x300
=150  \\$aChromosomes, Human
=450  \\$wnnna$aChromosome, Human
=450  \\$wnnna$aHuman Chromosome
=450  \\$wnnna$aHuman Chromosomes
=550  \\$wg$aChromosomes, Mammalian
=550  \\$wh$aChromosomes, Artificial, Human
=550  \\$wh$aChromosomes, Human, 1-3
=550  \\$wh$aChromosomes, Human, 13-15
=550  \\$wh$aChromosomes, Human, 16-18
=550  \\$wh$aChromosomes, Human, 19-20
=550  \\$wh$aChromosomes, Human, 21-22 and Y
=550  \\$wh$aChromosomes, Human, 4-5
=550  \\$wh$aChromosomes, Human, 6-12 and X
=667  \\$aGEN only: prefer specifics; do not coord with pre-coord chromosome terms, such as CHROMOSOME ABERRATIONS; CHROMOSOMAL PROTEINS, NON-HISTONE; etc.: check tag HUMANS will serve for these
=680  \\$iVery long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual.
=688  \\$a78
=750  \0$aHuman chromosomes$5IEN$0(DLC)sh 85062851

=LDR  00988cz  a2200265n  4500
=001  9880363461302441
=005  20141212200059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002876
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x190
=072  \\$aA20.$x812
=072  \\$aG5.$x360.$x162.$x190
=150  \\$aChromosomes, Bacterial
=450  \\$wnnna$aBacterial Chromosome
=450  \\$wnnna$aBacterial Chromosomes
=450  \\$wnnna$aChromosome, Bacterial
=550  \\$wg$aBacterial Structures
=550  \\$wg$aChromosomes
=550  \\$wh$aChromosomes, Artificial, Bacterial
=550  \\$aGenetics, Microbial
=667  \\$aA 11 qualif except /cytol; /genet permitted; coord IM with specific bact /genet (IM); DF: CHROMOSOMES BACT
=680  \\$iStructures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.
=688  \\$a68
=750  \0$aBacterial chromosomes$0(DLC) sh 89006409$5IEN

=LDR  01382cz  a2200433n  4500
=001  9880363461402441
=005  20141212200058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002874
=035  \\$aCAZ6031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x183
=150  \\$aChromosome Mapping
=450  \\$wnnna$aChromosome Mappings
=450  \\$aGene Mapping
=450  \\$wnnna$aGene Mappings
=450  \\$wnnna$aGenome Mapping
=450  \\$wnnna$aGenome Mappings
=450  \\$aLinkage Mapping
=450  \\$wnnna$aLinkage Mappings
=450  \\$wnnna$aMapping, Chromosome
=450  \\$wnnna$aMapping, Gene
=450  \\$wnnna$aMapping, Genome
=450  \\$wnnna$aMapping, Linkage
=450  \\$wnnna$aMappings, Chromosome
=450  \\$wnnna$aMappings, Gene
=450  \\$wnnna$aMappings, Genome
=450  \\$wnnna$aMappings, Linkage
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aChromosome Walking
=550  \\$wh$aPhysical Chromosome Mapping
=550  \\$aCytogenetic Analysis
=550  \\$aCytogenetics
=550  \\$aGene Order
=550  \\$aGenetic Markers
=550  \\$aSynteny
=680  \\$iAny method used for determining the location of and relative distances between genes on a chromosome.
=688  \\$a1967(1965); for GENOME MAPPING use HUMAN GENOME PROJECT 1990-2001
=750  \0$aGene mapping$5IEN$0(DLC)sh 85025386

=LDR  01313cz  a2200301n  4500
=001  9880363461502441
=005  20141212200057.0
=008  780313\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002871
=035  \\$aCAZ6028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x385.$x130
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670.$x130
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670.$x130
=072  \\$aE5.$x200.$x500.$x385.$x130
=072  \\$aE5.$x200.$x500.$x620.$x670.$x130
=072  \\$aE5.$x200.$x750.$x600.$x670.$x130
=072  \\$aE5.$x242.$x385.$x130
=072  \\$aE5.$x393.$x285.$x130
=150  \\$aChromosome Banding
=450  \\$aBanding, Chromosome
=450  \\$wnnna$aBandings, Chromosome
=450  \\$wnnna$aChromosome Bandings
=550  \\$wg$aCytogenetic Analysis
=550  \\$wg$aStaining and Labeling
=680  \\$iStaining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping.
=688  \\$a79
=750  \0$aChromosome banding$5IEN$0(DLC)sh 90001545

=LDR  02923cz  a2200769n  4500
=001  9880363461602441
=005  20180328114023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210
=072  \\$aG5.$x365.$x590.$x175
=150  \\$aChromosome Aberrations
=450  \\$wnnna$aAberration, Chromosomal
=450  \\$wnnna$aAberration, Chromosome
=450  \\$wnnna$aAberration, Cytogenetic
=450  \\$wnnna$aAberrations, Chromosomal
=450  \\$wnnna$aAberrations, Chromosome
=450  \\$wnnna$aAberrations, Cytogenetic
=450  \\$wnnna$aAbnormalities, Autosome
=450  \\$wnnna$aAbnormalities, Chromosomal
=450  \\$wnnna$aAbnormalities, Chromosome
=450  \\$wnnna$aAbnormalities, Cytogenetic
=450  \\$wnnna$aAbnormality, Autosome
=450  \\$wnnna$aAbnormality, Chromosomal
=450  \\$wnnna$aAbnormality, Chromosome
=450  \\$wnnna$aAbnormality, Cytogenetic
=450  \\$aAutosome Abnormalities
=450  \\$wnnna$aAutosome Abnormality
=450  \\$wnnna$aChromosomal Aberration
=450  \\$wnnna$aChromosomal Aberrations
=450  \\$wnnna$aChromosomal Abnormalities
=450  \\$wnnna$aChromosomal Abnormality
=450  \\$wnnna$aChromosome Aberration
=450  \\$wnnna$aChromosome Abnormalities
=450  \\$wnnna$aChromosome Abnormality
=450  \\$aChromosomes$xabnormalities
=450  \\$wnnna$aCytogenetic Aberration
=450  \\$aCytogenetic Aberrations
=450  \\$wnnna$aCytogenetic Abnormalities
=450  \\$wnnna$aCytogenetic Abnormality
=550  \\$wg$aMutation
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAbnormal Karyotype
=550  \\$wh$aAneuploidy
=550  \\$wh$aChimerism
=550  \\$wh$aChromosomal Instability
=550  \\$wh$aChromosome Breakage
=550  \\$wh$aChromosome Duplication
=550  \\$wh$aChromosome Inversion
=550  \\$wh$aChromothripsis
=550  \\$wh$aIsochromosomes
=550  \\$wh$aMicronuclei, Chromosome-Defective
=550  \\$wh$aMosaicism
=550  \\$wh$aNondisjunction, Genetic
=550  \\$wh$aPolyploidy
=550  \\$wh$aRing Chromosomes
=550  \\$wh$aSex Chromosome Aberrations
=550  \\$wh$aTranslocation, Genetic
=550  \\$wh$aUniparental Disomy
=550  \\$aCytogenetic Analysis
=550  \\$aCytogenetics
=550  \\$aGenetics, Medical
=667  \\$acoordinate IM with specific numbered chromosome or sex chromosome (IM) but not with CHROMOSOMES, HUMAN
=680  \\$iAbnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS.
=688  \\$a1968; for CHROMOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001; for AUTOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001
=750  \0$aChromosome abnormalities$5IEN$0(DLC)sh 85025385

=LDR  01746cz  a2200409n  4500
=001  9880363461702441
=005  20190131095215.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002868
=035  \\$aCAZ6025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x660.$x235
=072  \\$aD12.$x776.$x664.$x235
=150  \\$aChromosomal Proteins, Non-Histone
=450  \\$wnnna$aChromosomal Phosphoproteins, Non-Histone
=450  \\$wnnna$aChromosomal Proteins, Non Histone
=450  \\$wnnna$aChromosomal Proteins, Nonhistone
=450  \\$wnnna$aNon-Histone Chromosomal Phosphoproteins
=450  \\$wnnna$aNon Histone Chromosomal Phosphoproteins
=450  \\$aNon-Histone Chromosomal Proteins
=450  \\$wnnna$aNon Histone Chromosomal Proteins
=450  \\$wnnna$aNonhistone Chromosomal Proteins
=450  \\$wnnna$aProteins, Non-Histone Chromosomal
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aNucleoproteins
=550  \\$wh$aCentromere Protein B
=550  \\$wh$aHigh Mobility Group Proteins
=550  \\$wh$aMethyl-CpG-Binding Protein 2
=550  \\$wh$aMinichromosome Maintenance Proteins
=550  \\$wh$aPolycomb-Group Proteins
=550  \\$wh$aSMARCB1 Protein
=550  \\$wh$aTelomere-Binding Proteins
=550  \\$wh$aTumor Suppressor p53-Binding Protein 1
=550  \\$aGene Expression Regulation
=680  \\$iNucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens.
=688  \\$a77
=750  \0$aNonhistone chromosomal proteins$5IEN$0(DLC)sh 85092315

=LDR  01113cz  a2200265n  4500
=001  9880363461802441
=005  20141212200054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002864
=035  \\$aCAZ6021M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x641.$x199
=072  \\$aD12.$x776.$x811.$x185
=150  \\$aChromogranins
=450  \\$wnnna$aGranins
=450  \\$aSecretogranins
=550  \\$wg$aNerve Tissue Proteins
=550  \\$wg$aProtein Precursors
=550  \\$wh$aChromogranin A
=550  \\$wh$aChromogranin B
=550  \\$wh$aSecretogranin II
=680  \\$iA group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources.
=688  \\$a1991(1973)
=688  \\$a91(73); was see under NERVE TISSUE PROTEINS 1973-90
=750  \0$aChromogranins$0(DLC) sh 00000068$5IEN-M

=LDR  01185cz  a2200253n  4500
=001  9880363461902441
=005  20141212200054.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002863
=035  \\$aCAZ6020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x233.$x173
=072  \\$aD27.$x720.$x470.$x410.$x200
=150  \\$aChromogenic Compounds
=450  \\$aChromogenic Substrates
=450  \\$wnnna$aCompounds, Chromogenic
=450  \\$wnnna$aSubstrates, Chromogenic
=550  \\$wg$aColoring Agents
=550  \\$wg$aIndicators and Reagents
=550  \\$aLuminescent Agents
=667  \\$a"colorless ... precursors that may be transformed ... into colored cpds; used in biochem assays & ... as indicators"; D25-26 qualif; DF: CHROMOGENIC CPDS
=680  \\$iColorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens).
=688  \\$a81
=750  \0$aChromogenic compounds$5IEN$0(DLC)sh 85025382

=LDR  00744cz  a2200193n  4500
=001  9880363462002441
=005  20141212200053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002861
=035  \\$aCAZ6018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x360
=072  \\$aB3.$x660.$x75.$x525.$x100
=150  \\$aChromobacterium
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wg$aNeisseriaceae
=667  \\$ain soil & water
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria occurring in soil and water. Its organisms are generally nonpathogenic, but some species do cause infections of mammals, including humans.
=750  \0$aChromobacterium$5IEN$0(DLC)sh 88023228

=LDR  00694cz  a2200205n  4500
=001  9880363462102441
=005  20141212200053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002859
=035  \\$aCAZ6016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x212
=150  \\$aChromium Isotopes
=450  \\$wnnna$aIsotopes, Chromium
=550  \\$wg$aIsotopes
=550  \\$wh$aChromium Radioisotopes
=550  \\$aChromium
=667  \\$aCr-50, 53, 54; NIM
=680  \\$iStable chromium atoms that have the same atomic number as the element chromium, but differ in atomic weight. Cr-50, 53, and 54 are stable chromium isotopes.
=750  \0$aChromium$xIsotopes$5IEN-M$0(DLC)sh 85025351

=LDR  01559cz  a2200433n  4500
=001  9880363462202441
=005  20141212200052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002858
=035  \\$aCAZ6015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x220.$x175
=072  \\$aD1.$x552.$x33.$x182
=072  \\$aD25.$x58.$x224
=072  \\$aD25.$x339.$x208.$x224
=072  \\$aJ1.$x637.$x51.$x58.$x224
=072  \\$aJ1.$x637.$x51.$x339.$x208.$x224
=150  \\$aChromium Alloys
=450  \\$wnnna$aAlloys, Chromium
=450  \\$wnnna$aAlloys, Chromium-Cobalt
=450  \\$wnnna$aAlloys, Chromium-Nickel
=450  \\$wnnna$aAlloys, Cobalt-Chromium
=450  \\$wnnna$aAlloys, Nickel-Chromium
=450  \\$aChromium-Cobalt Alloys
=450  \\$wnnna$aChromium Cobalt Alloys
=450  \\$aChromium-Nickel Alloys
=450  \\$wnnna$aChromium Nickel Alloys
=450  \\$aCobalt-Chromium Alloys
=450  \\$wnnna$aCobalt Chromium Alloys
=450  \\$aNickel-Chromium Alloys
=450  \\$wnnna$aNickel Chromium Alloys
=550  \\$wg$aAlloys
=550  \\$wg$aChromium Compounds
=550  \\$wg$aDental Alloys
=550  \\$wh$aVitallium
=667  \\$aused in dent technol & orthopedics; D25-26 qualif
=680  \\$iSpecific alloys not less than 85% chromium and nickel or cobalt, with traces of either nickel or cobalt, molybdenum, and other substances. They are used in partial dentures, orthopedic implants, etc.
=688  \\$a82; was CHROMIUM-COBALT ALLOYS 1965-81
=750  \0$aChromium alloys$5IEN$0(DLC)sh 85025354

=LDR  00838cz  a2200217n  4500
=001  9880363462302441
=005  20141212200052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002857
=035  \\$aCAZ6014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x175
=072  \\$aD1.$x268.$x956.$x124
=072  \\$aD1.$x552.$x544.$x175
=150  \\$aChromium
=450  \\$aOrganochromium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aCr-52
=680  \\$iA trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.
=750  \0$aChromium$5IEN-M$0(DLC)sh 85025350

=LDR  00972cz  a2200193n  4500
=001  9880363462402441
=005  20141212200052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002856
=035  \\$aCAZ6013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x265
=150  \\$aChromatophores
=450  \\$wnnna$aChromatophore
=550  \\$wg$aEpithelial Cells
=550  \\$wh$aMelanophores
=667  \\$ado not confuse with chromophores (chemical groups imparting color to a cpd); BACTERIAL CHROMATOPHORES is available
=680  \\$iThe large pigment cells of fish, amphibia, reptiles and many invertebrates which actively disperse and aggregate their pigment granules. These cells include MELANOPHORES, erythrophores, xanthophores, leucophores and iridiophores. (In algae, chromatophores refer to CHLOROPLASTS. In phototrophic bacteria chromatophores refer to membranous organelles (BACTERIAL CHROMATOPHORES).)
=750  \0$aChromatophores$5IEN$0(DLC)sh 85025337

=LDR  01089cz  a2200265n  4500
=001  9880363462502441
=005  20141212200051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002855
=035  \\$aCAZ6012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x537
=150  \\$aChromatography, Thin Layer
=450  \\$wnnna$aChromatographies, Thin Layer
=450  \\$wnnna$aChromatographies, Thin-Layer
=450  \\$wnnna$aChromatography, Thin-Layer
=450  \\$wnnna$aThin Layer Chromatographies
=450  \\$wnnna$aThin-Layer Chromatographies
=450  \\$wnnna$aThin Layer Chromatography
=450  \\$wnnna$aThin-Layer Chromatography
=550  \\$wg$aChromatography, Liquid
=667  \\$aa type of liquid chromatogr; NIM; DF: CHROMATOGR THIN LAYER
=680  \\$iChromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a66
=750  \0$aThin layer chromatography$5IEN$0(DLC)sh 85134870

=LDR  00902cz  a2200229n  4500
=001  9880363462602441
=005  20141212200051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002854
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x454
=150  \\$aChromatography, Paper
=450  \\$wnnna$aChromatographies, Paper
=450  \\$wnnna$aPaper Chromatographies
=450  \\$wnnna$aPaper Chromatography
=550  \\$wg$aChromatography, Liquid
=550  \\$wh$aNucleotide Mapping
=550  \\$wh$aPeptide Mapping
=667  \\$aDF: CHROMATOGR PAPER
=680  \\$iAn analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase).
=688  \\$a66
=750  \0$aPaper chromatography$5IEN$0(DLC)sh 85097605

=LDR  01029cz  a2200301n  4500
=001  9880363462702441
=005  20141212200051.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002853
=035  \\$aCAZ6010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400
=150  \\$aChromatography, Liquid
=450  \\$wnnna$aLiquid Chromatography
=550  \\$wg$aChromatography
=550  \\$wh$aCapillary Electrochromatography
=550  \\$wh$aChromatography, Affinity
=550  \\$wh$aChromatography, Gel
=550  \\$wh$aChromatography, High Pressure Liquid
=550  \\$wh$aChromatography, Ion Exchange
=550  \\$wh$aChromatography, Paper
=550  \\$wh$aChromatography, Reverse-Phase
=550  \\$wh$aChromatography, Thin Layer
=550  \\$wh$aCountercurrent Distribution
=667  \\$aan anal chem technique; NIM; DF: CHROMATOGR LIQUID
=680  \\$iChromatographic techniques in which the mobile phase is a liquid.
=688  \\$a76
=750  \0$aLiquid chromatography$5IEN$0(DLC)sh 85077354

=LDR  01060cz  a2200289n  4500
=001  9880363462802441
=005  20141212200015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002747
=035  \\$aCAZ5902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x795.$x283
=072  \\$aD2.$x948.$x828.$x283
=150  \\$aChlorpropamide
=450  \\$wnnna$aApo-Chlorpropamide
=450  \\$wnnna$aApotex Brand of Chlorpropamide
=450  \\$wnnna$aByk Gulden Brand of Chlorpropamide
=450  \\$aClorpropamid
=450  \\$wnnna$aDiabinese
=450  \\$wnnna$aFarmasierra Brand of Chlorpropamide
=450  \\$wnnna$aGlucamide
=450  \\$wnnna$aInsogen
=450  \\$wnnna$aMeldian
=450  \\$wnnna$aPfizer Brand of Chlorpropamide
=550  \\$wg$aSulfonylurea Compounds
=680  \\$iA sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
=750  \0$aChlorpropamide$5IEN$0(DLC)sh 85024592

=LDR  01220cz  a2200301n  4500
=001  9880363462902441
=005  20141212200015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002746
=035  \\$aCAZ5901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x369.$x198
=072  \\$aD3.$x494.$x741.$x198
=150  \\$aChlorpromazine
=450  \\$wnnna$aAminazine
=450  \\$wnnna$aChlorazine
=450  \\$wnnna$aChlordelazine
=450  \\$wnnna$aChlorpromazine Hydrochloride
=450  \\$wnnna$aContomin
=450  \\$wnnna$aFenactil
=450  \\$wnnna$aHydrochloride, Chlorpromazine
=450  \\$wnnna$aLargactil
=450  \\$wnnna$aPropaphenin
=450  \\$wnnna$aThorazine
=550  \\$wg$aPhenothiazines
=680  \\$iThe prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
=688  \\$a/adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65
=750  \0$aChlorpromazine$5IEN$0(DLC)sh 85024591

=LDR  00789cz  a2200205n  4500
=001  9880363463002441
=005  20141212200012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002740
=035  \\$aCAZ5895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x700.$x135.$x261
=072  \\$aD2.$x886.$x655.$x500.$x261
=072  \\$aD3.$x438.$x174.$x261
=150  \\$aChlorothiazide
=550  \\$wg$aBenzothiadiazines
=550  \\$wh$aHydrochlorothiazide
=680  \\$iA thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
=688  \\$aCHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65
=750  \0$aChlorothiazide$5IEN$0(DLC)sh 85024590

=LDR  01048cz  a2200301n  4500
=001  9880363463102441
=005  20141212200012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002738
=035  \\$aCAZ5893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x50.$x180
=150  \\$aChloroquine
=450  \\$wnnna$aAralen
=450  \\$wnnna$aArechine
=450  \\$wnnna$aArequin
=450  \\$wnnna$aChingamin
=450  \\$wnnna$aChlorochin
=450  \\$wnnna$aChloroquine Sulfate
=450  \\$wnnna$aChloroquine Sulphate
=450  \\$wnnna$aKhingamin
=450  \\$wnnna$aNivaquine
=450  \\$wnnna$aSulfate, Chloroquine
=450  \\$wnnna$aSulphate, Chloroquine
=550  \\$wg$aAminoquinolines
=550  \\$wh$aHydroxychloroquine
=680  \\$iThe prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
=750  \0$aChloroquine$5IEN-M$0(DLC)sh 93001667

=LDR  00639cz  a2200169n  4500
=001  9880363463202441
=005  20141212200011.0
=008  780501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002737
=035  \\$aCAZ5892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x146.$x280
=150  \\$aChloroprene
=550  \\$wg$aAlkadienes
=680  \\$iToxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene.
=688  \\$a91(79); was see under BUTADIENES 1979-90
=750  \0$aChloroprene$5IEN-M$0(DLC)sh 94008140

=LDR  00725cz  a2200241n  4500
=001  9880363463302441
=005  20141212200010.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002733
=035  \\$aCAZ5890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x261.$x190
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x190
=150  \\$aChlorophenols
=450  \\$aHydroxychlorobenzenes
=550  \\$wg$aChlorobenzenes
=550  \\$wg$aPhenols
=550  \\$wh$aDichlorophen
=550  \\$wh$aHexachlorophene
=550  \\$wh$aPentachlorophenol
=680  \\$iPhenols substituted with one or more chlorine atoms in any position.
=688  \\$a77
=750  \0$aChlorophenols$5IEN$0(DLC)sh 85024575

=LDR  00901cz  a2200229n  4500
=001  9880363463402441
=005  20141212200008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002726
=035  \\$aCAZ5883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x200.$x185
=072  \\$aD2.$x241.$x223.$x268.$x220
=150  \\$aChlorogenic Acid
=450  \\$wnnna$a3-Caffeoylquinic Acid
=450  \\$wnnna$a3 Caffeoylquinic Acid
=450  \\$wnnna$aAcid, 3-Caffeoylquinic
=450  \\$wnnna$aAcid, Chlorogenic
=550  \\$wg$aCinnamates
=550  \\$wg$aCyclohexanecarboxylic Acids
=680  \\$iA naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68).
=750  \0$aChlorogenic acid$5IEN$0(DLC)sh 85024566

=LDR  00715cz  a2200205n  4500
=001  9880363463502441
=005  20141212200008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002725
=035  \\$aCAZ5882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x224
=072  \\$aD2.$x455.$x526.$x913.$x810
=150  \\$aChloroform
=450  \\$wnnna$aTrichloromethane
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wg$aTrihalomethanes
=550  \\$wh$aBromotrichloromethane
=680  \\$iA commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.
=750  \0$aChloroform$5IEN$0(DLC)sh 85024563

=LDR  00678cz  a2200241n  4500
=001  9880363463602441
=005  20141212200007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002722
=035  \\$aCAZ5879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x261
=072  \\$aD2.$x455.$x526.$x439.$x202
=150  \\$aChlorobenzenes
=450  \\$aChrlorobenzene$5IEN
=550  \\$wg$aBenzene Derivatives
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wh$aChlorophenols
=550  \\$wh$aDicofol
=550  \\$wh$aDinitrochlorobenzene
=550  \\$wh$aHexachlorobenzene
=688  \\$a74
=750  \0$aChlorobenzene$0(DLC) sh 85024555$5IEN

=LDR  00990cz  a2200289n  4500
=001  9880363463702441
=005  20141212200006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002715
=035  \\$aCAZ5872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x144
=072  \\$aD4.$x808.$x883.$x294
=150  \\$aChlormadinone Acetate
=450  \\$wnnna$aAcetate, Chlormadinon
=450  \\$wnnna$aAcetate, Chlormadinone
=450  \\$wnnna$aChlormadinon Acetate
=450  \\$wnnna$aChlormadinone
=450  \\$wnnna$aChlormadinone Acetate, (9 beta,10 alpha)-Isomer
=450  \\$wnnna$aNeo-Eunomin
=450  \\$wnnna$aNeo Eunomin
=450  \\$wnnna$aNeoEunomin
=550  \\$wg$aPregnadienes
=550  \\$wg$aSteroids, Chlorinated
=680  \\$iAn orally active synthetic progestational hormone used often in combinations as an oral contraceptive.
=688  \\$a96; was CHLORMADINONE 1964-1995 (Prov 1964-65)
=750  \0$aChlormadinone$5IEN$0(DLC)sh 85024553

=LDR  00949cz  a2200193n  4500
=001  9880363463802441
=005  20141212200005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002713
=035  \\$aCAZ5870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x380.$x150
=072  \\$aD1.$x362.$x225
=150  \\$aChlorine
=550  \\$wg$aGases
=550  \\$wg$aHalogens
=667  \\$aCl-35; Cl-37 = CHLORINE (IM) + ISOTOPES (NIM); Cl-34, 36, 38-40 = CHLORINE (IM) + RADIOISOTOPES (IM)
=680  \\$iA greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching.
=750  \0$aChlorine$5IEN-M$0(DLC)sh 85024541

=LDR  01096cz  a2200337n  4500
=001  9880363463902441
=005  20141212200005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002712
=035  \\$aCAZ5869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150
=072  \\$aD1.$x248.$x497.$x158.$x215
=150  \\$aChlorides
=450  \\$wnnna$aChloride Ion Level
=450  \\$wnnna$aIon Level, Chloride
=450  \\$wnnna$aLevel, Chloride Ion
=550  \\$wg$aAnions
=550  \\$wg$aHydrochloric Acid
=550  \\$wh$aAmmonium Chloride
=550  \\$wh$aCadmium Chloride
=550  \\$wh$aCalcium Chloride
=550  \\$wh$aLithium Chloride
=550  \\$wh$aMagnesium Chloride
=550  \\$wh$aMercuric Chloride
=550  \\$wh$aPotassium Chloride
=550  \\$wh$aSodium Chloride
=667  \\$aonly for inorganic cpds or chloride ion; /physiol permitted
=680  \\$iInorganic compounds derived from hydrochloric acid that contain the Cl- ion.
=750  \0$aChlorides$5IEN-M$0(DLC)sh 85024536
=750  \0$aChlorides in the body$5IEN-HS$0(DLC)sh 85024539

=LDR  00955cz  a2200301n  4500
=001  9880363464002441
=005  20141212200004.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002710
=035  \\$aCAZ5867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x141.$x100
=150  \\$aChlorhexidine
=450  \\$wnnna$aA, Sebidin
=450  \\$wnnna$aAcetate, Chlorhexidine
=450  \\$wnnna$aChlorhexidine Acetate
=450  \\$wnnna$aChlorhexidine Hydrochloride
=450  \\$wnnna$aHydrochloride, Chlorhexidine
=450  \\$wnnna$aMK-412A
=450  \\$wnnna$aMK 412A
=450  \\$wnnna$aMK412A
=450  \\$wnnna$aNovalsan
=450  \\$wnnna$aSebidin A
=450  \\$wnnna$aTubulicid
=550  \\$wg$aBiguanides
=680  \\$iA disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.
=688  \\$a80(75); was see under BIGUANIDES 1975-79
=750  \0$aChlorhexidine$5IEN$0(DLC)sh 85024534

=LDR  01036cz  a2200229n  4500
=001  9880363464102441
=005  20141212200004.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002709
=035  \\$aCAZ5866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x120
=150  \\$aChlorfenvinphos
=450  \\$wnnna$aBirlane
=450  \\$wnnna$aChlorphenvinphos
=450  \\$wnnna$aClofenvinfos
=450  \\$wnnna$aDermaton
=550  \\$wg$aOrganophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.
=688  \\$a91(80); was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90
=750  \0$aChlorfenvinphos$5IEN-M$0(DLC)sh 94007512

=LDR  00886cz  a2200205n  4500
=001  9880363464202441
=005  20141212200004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002708
=035  \\$aCAZ5865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x469
=150  \\$aChlorella
=450  \\$wnnna$aChlorellas
=550  \\$wg$aChlorophyta
=550  \\$wh$aChlorella vulgaris
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iNonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins.
=688  \\$a74(72)
=750  \0$aChlorella$5IEN$0(DLC)sh 85024529

=LDR  00841cz  a2200205n  4500
=001  9880363464302441
=005  20141212200003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002706
=035  \\$aCAZ5863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x180
=150  \\$aChlordan
=450  \\$wnnna$aChlordane
=450  \\$wnnna$agamma-Chlordane
=450  \\$wnnna$agamma Chlordane
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iA highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. (From Merck Index, 11th ed)
=750  \0$aChlordan$5IEN$0(DLC)sh 85024527

=LDR  00537cz  a2200193n  4500
=001  9880363464402441
=005  20141212200003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002704
=035  \\$aCAZ5861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x300
=072  \\$aD1.$x248.$x497.$x158.$x190
=150  \\$aChlorates
=550  \\$wg$aAnions
=550  \\$wg$aChlorine Compounds
=680  \\$iInorganic salts of chloric acid that contain the ClO3- ion.
=688  \\$a73(71)
=750  \0$aChlorates$5IEN$0(DLC)sh 85024526

=LDR  00786cz  a2200253n  4500
=001  9880363464502441
=005  20141212200003.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002703
=035  \\$aCAZ5860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x806.$x250.$x210
=150  \\$aChloranil
=450  \\$wnnna$a2,3,5,6-Tetrachloro-1,4-benzoquinone
=450  \\$wnnna$aCoversan
=450  \\$wnnna$aReranil
=450  \\$wnnna$aSpergon
=450  \\$wnnna$aTetrachloro-1,4-benzoquinone
=450  \\$wnnna$aTetrachloro 1,4 benzoquinone
=450  \\$wnnna$aVulklor
=550  \\$wg$aBenzoquinones
=680  \\$iA quinone fungicide used for treatment of seeds and foliage.
=688  \\$a91(76); was see under QUINONES 1976-90
=750  \0$aChloranil$5IEN-M$0(DLC)sh 93007807

=LDR  01243cz  a2200325n  4500
=001  9880363464602441
=005  20141212200002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002701
=035  \\$aCAZ5857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x706.$x300
=072  \\$aD2.$x455.$x426.$x559.$x389.$x565.$x175
=072  \\$aD2.$x640.$x529.$x175
=150  \\$aChloramphenicol
=450  \\$wnnna$aChlornitromycin
=450  \\$wnnna$aChlorocid
=450  \\$wnnna$aChloromycetin
=450  \\$aCloranfenicol
=450  \\$wnnna$aDetreomycin
=450  \\$aKloramfenikol
=450  \\$aLevomycetin
=450  \\$wnnna$aOphthochlor
=450  \\$wnnna$aSyntomycin
=550  \\$wg$aNitrobenzenes
=550  \\$wg$aPropylene Glycols
=550  \\$wh$aThiamphenicol
=667  \\$aan antibiotic
=680  \\$iAn antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
=750  \0$aChloramphenicol$5IEN$0(DLC)sh 85024570

=LDR  00450cz  a2200169n  4500
=001  9880363464702441
=005  20141212200002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002700
=035  \\$aCAZ5856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x344
=072  \\$aD2.$x886.$x590.$x700.$x344
=150  \\$aChloramines
=450  \\$wnnna$aChloroamines
=550  \\$wg$aSulfonamides
=750  \0$aChloramines$5IEN$0(DLC)sh 85024524

=LDR  00555cz  a2200193n  4500
=001  9880363464802441
=005  20141212200001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002697
=035  \\$aCAZ5853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250.$x130
=150  \\$aChloral Hydrate
=450  \\$wnnna$aHydrate, Chloral
=450  \\$wnnna$aNoctec
=550  \\$wg$aEthylene Glycols
=550  \\$wh$aChloralose
=680  \\$iA hypnotic and sedative used in the treatment of INSOMNIA.
=750  \0$aChloral$5IEN$0(DLC)sh 85024522

=LDR  00924cz  a2200205n  4500
=001  9880363464902441
=005  20141212200001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002696
=035  \\$aCAZ5852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x925.$x344
=150  \\$aChlamydomonas
=450  \\$wnnna$aChlamydomona
=550  \\$wg$aVolvocida
=550  \\$wh$aChlamydomonas reinhardtii
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus GREEN ALGAE in the order VOLVOCIDA. It consists of solitary biflagellated organisms common in fresh water and damp soil.
=688  \\$a74(72)
=750  \0$aChlamydomonas$0(DLC) sh 88022327$5IEN

=LDR  01117cz  a2200253n  4500
=001  9880363465002441
=005  20141212200000.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002695
=035  \\$aCAZ5851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190
=150  \\$aChlamydiales
=450  \\$aCriblamydiaceae
=450  \\$wnnna$aMicroorganism Z
=450  \\$aParachlamydiaceae
=450  \\$aRhabdochlamydia
=450  \\$aSimkaniaceae
=450  \\$aWaddliaceae
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aChlamydiaceae
=680  \\$iAn order of obligately intracellular, gram-negative bacteria that have the chlamydia-like developmental cycle of replication. This is a two-stage cycle that includes a metabolically inactive infectious form, and a vegetative form that replicates by binary fission. Members of Chlamydiales are disseminated by aerosol or by contact. There are at least six recognized families: CHLAMYDIACEAE, Criblamydiaceae, Parachlamydiaceae, Rhabdochlamydia, Simkaniaceae, and Waddliaceae.
=688  \\$a1976
=750  \0$aChlamydiales$5IEN$0(DLC)sh 85024516

=LDR  00762cz  a2200205n  4500
=001  9880363465102441
=005  20141212200000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002693
=035  \\$aCAZ5849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190.$x190
=150  \\$aChlamydiaceae
=550  \\$wg$aChlamydiales
=550  \\$wh$aChlamydia
=550  \\$wh$aChlamydophila
=667  \\$ainfection = CHLAMYDIACEAE INFECTIONS
=680  \\$iA family of gram-negative, coccoid microorganisms, in the order CHLAMYDIALES, pathogenic for vertebrates. Genera include CHLAMYDIA and CHLAMYDOPHILA.
=688  \\$a76(64); was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91
=750  \0$aChlamydiaceae$5IEN$0(DLC)sh 87005335

=LDR  00759cz  a2200181n  4500
=001  9880363465202441
=005  20141212195959.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002692
=035  \\$aCAZ5848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190.$x190.$x190.$x750
=150  \\$aChlamydia trachomatis
=550  \\$wg$aChlamydia
=667  \\$ainfection: coord IM with CHLAMYDIA INFECTIONS (IM) or index TRACHOMA; LYMPHOGRANULOMA VENEREUM; or CONJUNCTIVITIS, INCLUSION if specified in text
=680  \\$iType species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
=688  \\$a76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74
=750  \0$aChlamydia trachomatis$5IEN$0(DLC)sh 85024515

=LDR  01342cz  a2200337n  4500
=001  9880363465302441
=005  20141212195959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002690
=035  \\$aCAZ5846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x210.$x210
=072  \\$aC1.$x252.$x810.$x301
=072  \\$aC1.$x539.$x778.$x281.$x301
=072  \\$aC12.$x294.$x668.$x281.$x301
=072  \\$aC13.$x351.$x500.$x711.$x281.$x301
=150  \\$aChlamydia Infections
=450  \\$wnnna$aChlamydia Infection
=450  \\$wnnna$aInfection, Chlamydia
=450  \\$wnnna$aInfections, Chlamydia
=550  \\$wg$aChlamydiaceae Infections
=550  \\$wg$aSexually Transmitted Diseases, Bacterial
=550  \\$wh$aChlamydial Pneumonia
=550  \\$wh$aConjunctivitis, Inclusion
=550  \\$wh$aLymphogranuloma Venereum
=550  \\$wh$aTrachoma
=667  \\$ado not confuse with CHLAMYDIACEAE INFECTIONS; Chlamydophila psittaci infection = PSITTACOSIS; Chlamydia trachomatis infection: see note at CHLAMYDIA TRACHOMATIS
=680  \\$iInfections with bacteria of the genus CHLAMYDIA.
=688  \\$a1967; for CHLAMYDIAL PNEUMONIA use PSITTACOSIS 2011
=688  \\$a67; MIYAGAWANELLA INFECTIONS was see CHLAMYDIA INFECTIONS 1977-91; was heading 1967-76
=750  \0$aChlamydia infections$5IEN$0(DLC)sh 85024513

=LDR  00795cz  a2200193n  4500
=001  9880363465402441
=005  20141212195959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002689
=035  \\$aCAZ5845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190.$x190.$x190
=150  \\$aChlamydia
=550  \\$wg$aChlamydiaceae
=550  \\$wh$aChlamydia muridarum
=550  \\$wh$aChlamydia trachomatis
=667  \\$aGEN or unspecified; prefer specific species; infection = CHLAMYDIA INFECTIONS
=680  \\$iA genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.
=750  \0$aChlamydia$5IEN$0(DLC)sh 87005330

=LDR  00744cz  a2200193n  4500
=001  9880363465502441
=005  20180328101044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002688
=035  \\$aCAZ5844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x207
=150  \\$aChitinases
=450  \\$wnno$aChitinase
=450  \\$wnnna$aEndochitinase
=550  \\$wg$aGlycoside Hydrolases
=550  \\$wh$aChitinase-3-Like Protein 1
=680  \\$iGlycoside hydrolases that break down glycosidic bonds in CHITIN. They are important for insect and worm morphogenesis and plant defense against pathogens. Human chitinases may play a role in the etiology of allergies and asthma.
=750  \0$aChitinase$5IEN-M$0(DLC)sh 97006222

=LDR  00698cz  a2200205n  4500
=001  9880363465602441
=005  20141212195958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002686
=035  \\$aCAZ5842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x139
=072  \\$aD9.$x698.$x211
=150  \\$aChitin
=550  \\$wg$aBiopolymers
=550  \\$wg$aPolysaccharides
=550  \\$wh$aChitosan
=680  \\$iA linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.
=688  \\$a72(67)
=750  \0$aChitin$5IEN$0(DLC)sh 85024494

=LDR  00832cz  a2200289n  4500
=001  9880363465702441
=005  20200508120155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002685
=035  \\$aCAZ5841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$937
=150  \\$aChiroptera
=450  \\$wnnna$aBat, Horseshoe
=450  \\$aBats
=450  \\$wnnna$aBats, Horseshoe
=450  \\$aFlying Foxes
=450  \\$wnnna$aFoxes, Flying
=450  \\$wnnna$aHorseshoe Bat
=450  \\$aHorseshoe Bats
=450  \\$aPteropodidae
=450  \\$aPteropus
=450  \\$aRhinolophus
=450  \\$aRousettus
=550  \\$wg$aEutheria
=680  \\$iOrder of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats.
=750  \0$aBats$5IEN$0(DLC)sh 85012393

=LDR  00810cz  a2200217n  4500
=001  9880363465802441
=005  20141212195957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002684
=035  \\$aCAZ5840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x110
=150  \\$aChiropractic
=450  \\$aChiropractors$5IEN
=550  \\$wg$aHealth Occupations
=550  \\$aManipulation, Chiropractic
=550  \\$aManipulation, Orthopedic
=667  \\$athe discipline only (education, history, etc); use MANIPULATION, CHIROPRACTIC for chiropractic procedures
=680  \\$iAn occupational discipline founded by D.D. Palmer in the 1890's based on the relationship of the spine to health and disease.
=750  \0$aChiropractors$5IEN-M$0(DLC)sh 85024472
=750  \0$aChiropractic$5IEN-HS$0(DLC)sh 85024464

=LDR  00905cz  a2200253n  4500
=001  9880363465902441
=005  20141212195957.0
=008  800519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002683
=035  \\$aCAZ5839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x260
=150  \\$aChironomidae
=450  \\$aChironomus
=450  \\$wnnna$aMidge, Nonbiting
=450  \\$aMidges, Nonbiting
=450  \\$wnnna$aNonbiting Midge
=450  \\$wnnna$aNonbiting Midges
=550  \\$wg$aDiptera
=667  \\$ado not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA
=680  \\$iA family of nonbiting midges, in the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry.
=688  \\$a91(81)
=750  \0$aChironomus$5IEN-M$0(DLC)sh 85024461
=750  \0$aChironomidae$5IEN-HS$0(DLC)sh 85024460

=LDR  00646cz  a2200181n  4500
=001  9880363466002441
=005  20141212195957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002682
=035  \\$aCAZ5838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x328
=150  \\$aChinchilla
=450  \\$wnnna$aChinchillas
=550  \\$wg$aRodentia
=680  \\$iA genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.
=688  \\$a82; was CHINCHILLAS 1968-81
=750  \0$aChinchillas$5IEN$0(DLC)sh 85024228

=LDR  01162cz  a2200229n  4500
=001  9880363466102441
=005  20141212195956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002680
=035  \\$aCAZ5836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x259
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x632.$x130
=072  \\$aA14.$x521.$x632.$x300
=150  \\$aChin
=450  \\$wnnna$aMentum
=550  \\$wg$aFace
=550  \\$wg$aMandible
=550  \\$aMandible
=667  \\$abone or site; usually NIM as site: submental (beneath the chin) refers to skin, fat & other tissue below the chin as in "submental lipectomy for double chin"; /growth: consider also MAXILLOFACIAL DEVELOPMENT
=680  \\$iThe anatomical frontal portion of the mandible, also known as the mentum, that contains the line of fusion of the two separate halves of the mandible (symphysis menti). This line of fusion divides inferiorly to enclose a triangular area called the mental protuberance. On each side, inferior to the second premolar tooth, is the mental foramen for the passage of blood vessels and a nerve.
=750  \0$aChin$5IEN$0(DLC)sh 85023977

=LDR  01180cz  a2200313n  4500
=001  9880363466202441
=005  20141212195956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002679
=035  \\$aCAZ5835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x620
=150  \\$aPan troglodytes
=450  \\$wnnoa$aChimpansee troglodytes$5IEN
=450  \\$aChimpanzee
=450  \\$wnnna$aChimpanzee troglodyte
=450  \\$wnnna$aChimpanzee troglodytes
=450  \\$wnnna$aChimpanzees
=450  \\$wnnna$aPan troglodyte
=450  \\$wnnna$atroglodyte, Chimpanzee
=450  \\$wnnna$atroglodyte, Pan
=450  \\$wnnna$atroglodytes, Chimpanzee
=450  \\$wnnna$atroglodytes, Pan
=550  \\$wg$aHominidae
=667  \\$adiseases: coordinate IM with APE DISEASES (IM) + specific disease/vet (IM)
=680  \\$iThe common chimpanzee, a species of the genus Pan, family HOMINIDAE. It lives in Africa, primarily in the tropical rainforests. There are a number of recognized subspecies.
=688  \\$a1998 (1972)
=750  \0$aPan (Mammals)$5IEN-M$0(DLC)sh 85097303
=750  \0$aChimpanzees$5IEN-HS$0(DLC)sh 85023971

=LDR  00625cz  a2200205n  4500
=001  9880363466302441
=005  20141212192104.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002675
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x406.$x448
=150  \\$aChild, Preschool
=450  \\$wnnna$aChildren, Preschool
=450  \\$wnnna$aPreschool Child
=450  \\$wnnna$aPreschool Children
=550  \\$wg$aChild
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9
=680  \\$iA child between the ages of 2 and 5.
=688  \\$a66
=750  \0$aPreschool children$5IEN$0(DLC)sh 87008036

=LDR  00730cz  a2200217n  4500
=001  9880363466402441
=005  20141212195955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002674
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x643.$x364
=150  \\$aChild, Institutionalized
=450  \\$wnnna$aChildren, Institutionalized
=450  \\$aInstitutionalized Child
=450  \\$wnnna$aInstitutionalized Children
=550  \\$wg$aPatients
=550  \\$aInstitutionalization
=667  \\$acheck also tag CHILD or specific
=680  \\$iA child who is receiving long-term in-patient services or who resides in an institutional setting.
=688  \\$a67(65)
=750  \0$aChildren$xInstitutional care$5IEN$0(DLC)sh 85023452

=LDR  00759cz  a2200217n  4500
=001  9880363466502441
=005  20141212195954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002673
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x643.$x259
=150  \\$aChild, Hospitalized
=450  \\$wnnna$aChildren, Hospitalized
=450  \\$aHospitalized Child
=450  \\$wnnna$aHospitalized Children
=550  \\$wg$aPatients
=550  \\$aHospitalization
=667  \\$anot for dis in child in hosp for diag or ther: use only for hospitalized child as a psychol, sociol or social entity; check also tag CHILD or specific
=680  \\$iChild hospitalized for short term care.
=688  \\$a67(65)
=750  \0$aChildren$xHospital care$5IEN$0(DLC)sh 85023449

=LDR  01044cz  a2200265n  4500
=001  9880363466602441
=005  20141212195954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x228.$x350
=072  \\$aM1.$x102.$x350
=150  \\$aChild, Gifted
=450  \\$wnnna$aAdolescent, Gifted
=450  \\$wnnna$aAdolescents, Gifted
=450  \\$wnnna$aChildren, Gifted
=450  \\$wnnna$aGifted Adolescent
=450  \\$wnnna$aGifted Adolescents
=450  \\$aGifted Child
=450  \\$wnnna$aGifted Children
=550  \\$wg$aChild, Exceptional
=667  \\$acheck also tag CHILD or specific
=680  \\$iA child or adolescent who, when compared to others of the same age or experience, exhibits capability of high performance in intellectual, creative, or artistic areas, possesses an unusual capacity for leadership or excels in specific academic fields. (From PL 100-297, Sec. 4103, Definitions)
=688  \\$a66
=750  \0$aGifted children$5IEN$0(DLC)sh 85054887

=LDR  01182cz  a2200241n  4500
=001  9880363466702441
=005  20141212195954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002671
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x228
=072  \\$aM1.$x102
=150  \\$aChild, Exceptional
=450  \\$wnnna$aChildren, Exceptional
=450  \\$aExceptional Child
=450  \\$wnnna$aExceptional Children
=550  \\$wg$aPersons
=550  \\$wg$aPsychology, Educational
=550  \\$wh$aChild, Gifted
=667  \\$aconsider also CHILD, GIFTED & MENTALLY DISABLED PERSONS; check also tag CHILD or specific
=680  \\$iA child whose needs, abilities, or other characteristics vary so much from the average in mental, physical, or social areas that a greater than usual level of services is needed to facilitate the child's maximum potential development.
=688  \\$a75; was see under CHILD, GIFTED & MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION (but EXCEPTIONAL CHILD was see under CHILD, GIFTED) 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966
=750  \0$aExceptional children$5IEN$0(DLC)sh 85046210

=LDR  00833cz  a2200253n  4500
=001  9880363466802441
=005  20141212195953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002670
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x97
=150  \\$aChild, Abandoned
=450  \\$wnnna$aAbandoned Adolescent
=450  \\$wnnna$aAbandoned Adolescents
=450  \\$wnnna$aAbandoned Child
=450  \\$wnnna$aAbandoned Children
=450  \\$wnnna$aAdolescent, Abandoned
=450  \\$wnnna$aAdolescents, Abandoned
=450  \\$wnnna$aChildren, Abandoned
=550  \\$wg$aPersons
=667  \\$acheck also tag CHILD or specific
=680  \\$iA child or adolescent who is deserted by parents or parent substitutes without regard for its future care.
=688  \\$a72(69)
=750  \0$aAbandoned children$5IEN$0(DLC)sh 85000048

=LDR  01073cz  a2200301n  4500
=001  9880363466902441
=005  20141212192101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002666
=035  \\$aCAZ5824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x193
=150  \\$aPsychology, Child
=450  \\$aChild Psychology
=450  \\$aChild$xpsychology
=450  \\$aInfant Psychology
=450  \\$aInfant$xpsychology
=450  \\$aPediatric Psychology
=450  \\$wnnna$aPsychology, Infant
=450  \\$wnnna$aPsychology, Pediatric
=550  \\$wg$aPsychology
=550  \\$aPsychology, Developmental
=667  \\$ause for the specialty and also for articles on the way a normal child thinks & acts
=680  \\$iBranch of psychology involving the study of normal and abnormal behavior of children.
=688  \\$a1966; use CHILD PSYCHOLOGY 1966-2014
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Child Psychology
=750  \0$aInfant psychology$5IEN-M$0(DLC)sh 85066009
=750  \0$aChild psychology$5IEN-HS$0(DLC)sh 85023380

=LDR  00850cz  a2200217n  4500
=001  9880363467002441
=005  20141212195952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002665
=035  \\$aCAZ5823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x193
=072  \\$aH2.$x403.$x690.$x130
=150  \\$aChild Psychiatry
=450  \\$aChild Psychopathology$5IEN
=450  \\$wnnna$aPsychiatry, Child
=550  \\$wg$aPsychiatry
=667  \\$aSPEC: SPEC qualif; not for mental disord in children ( = MENTAL DISORDERS (IM) + CHILD or other child check tag (NIM) ): Manual 27.9
=680  \\$iThe medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in children.
=750  \0$aChild psychiatry$0(DLC) sh 85023378$5IEN-HS
=750  \0$aChild psychiatrists$0(DLC) sh2004000702$5IEN-M

=LDR  01040cz  a2200289n  4500
=001  9880363467102441
=005  20141212211015.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015362
=035  \\$aCAZ5822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x180
=150  \\$aChild Nutrition Disorders
=450  \\$aChild Malnutrition
=450  \\$wnnna$aChild Nutrition Disorder
=450  \\$wnnna$aChild Overnutrition
=450  \\$wnnna$aMalnutrition, Child
=450  \\$wnnna$aMalnutrition in Children
=450  \\$wnnna$aNutrition Disorder, Child
=450  \\$aNutrition Disorders, Child
=450  \\$wnnna$aOvernutrition, Child
=550  \\$wg$aNutrition Disorders
=550  \\$aInfant Nutrition Disorders
=667  \\$aGEN only; prefer specific dis with appropriate age check tag
=680  \\$iDisorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in children ages 2 to 12 years.
=688  \\$a1989
=750  \0$aNutrition disorders in children$5IEN-M$0(DLC)sh 85093470

=LDR  01544cz  a2200397n  4500
=001  9880363467202441
=005  20141212195952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002664
=035  \\$aCAZ5821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x220
=150  \\$aChild Nutritional Physiological Phenomena
=450  \\$wnno$aChild Nutrition$5IEN-M
=450  \\$aChild Nutrition Physiology
=450  \\$wnnna$aChild Nutritional Physiology
=450  \\$aChild Nutritional Physiology Phenomena
=450  \\$wnnna$aChild Nutritional Physiology Phenomenon
=450  \\$aNutrition Physiology, Child
=450  \\$wnnna$aNutritional Physiology, Child
=450  \\$wnnna$aPhysiology, Child Nutrition
=450  \\$wnnna$aPhysiology, Child Nutritional
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aAdolescent Nutritional Physiological Phenomena
=550  \\$wh$aInfant Nutritional Physiological Phenomena
=550  \\$aInfant Nutritional Physiological Phenomena
=667  \\$acheck also tag CHILD or specific
=680  \\$iNutritional physiology of children aged 2-12 years.
=688  \\$a2010 (1967)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Child Nutritional Physiology Phenomena
=688  \\$a2009 (1967)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Child Nutrition Physiology
=688  \\$a2007(1967)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Child Nutrition
=688  \\$a67
=750  \0$aChildren$xNutrition$0(DLC) sh 85023463$5IEN

=LDR  01796cz  a2200469n  4500
=001  9880363467302441
=005  20201123173925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002662
=035  \\$aCAZ5819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x130
=150  \\$aChild Health Services
=450  \\$wnnna$aChild Health Service
=450  \\$wnnna$aChild Service, Health
=450  \\$wnnna$aChild Services, Health
=450  \\$wnnna$aHealth Child Service
=450  \\$wnnna$aHealth Child Services
=450  \\$wnnna$aHealth Infant Service
=450  \\$wnnna$aHealth Infant Services
=450  \\$wnnna$aHealth Service, Child
=450  \\$wnnna$aHealth Service, Infant
=450  \\$wnnna$aHealth Services, Child
=450  \\$wnnna$aHealth Services, Infant
=450  \\$wnnna$aInfant Health Service
=450  \\$aInfant Health Services
=450  \\$wnnna$aInfant Service, Health
=450  \\$wnnna$aInfant Services, Health
=450  \\$wnnna$aService, Child Health
=450  \\$wnnna$aService, Health Child
=450  \\$wnnna$aService, Health Infant
=450  \\$wnnna$aService, Infant Health
=450  \\$wnnna$aServices, Child Health
=450  \\$wnnna$aServices, Health Child
=450  \\$wnnna$aServices, Health Infant
=450  \\$wnnna$aServices, Infant Health
=550  \\$wg$aCommunity Health Services
=550  \\$wh$aEarly Intervention, Educational
=667  \\$acheck also tag CHILD or specific
=680  \\$iOrganized services to provide health care for children.
=688  \\$a68; INFANT HEALTH SERVICES was see under CHILD HEALTH SERVICES 1968-78; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92
=750  \0$aChild health services$5IEN-HS$0(DLC)sh 85023366

=LDR  00935cz  a2200241n  4500
=001  9880363467402441
=005  20141212195950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002661
=035  \\$aCAZ5818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x158.$x300
=150  \\$aChild Guidance Clinics
=450  \\$wnnna$aChild Guidance Clinic
=450  \\$wnnna$aClinic, Child Guidance
=450  \\$wnnna$aClinics, Child Guidance
=450  \\$wnnna$aGuidance Clinic, Child
=450  \\$wnnna$aGuidance Clinics, Child
=550  \\$wg$aCommunity Mental Health Centers
=667  \\$acheck also tag CHILD or specific
=680  \\$iFacilities which administer the delivery of mental health counseling services to children.
=688  \\$a91(75); was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78
=750  \0$aChild guidance clinics$5IEN$0(DLC)sh 85023365

=LDR  01297cz  a2200301n  4500
=001  9880363467502441
=005  20170717162739.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002659
=035  \\$aCAZ5816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x141
=150  \\$aChild Development Disorders, Pervasive
=450  \\$wnnna$aDevelopment Disorder, Pervasive
=450  \\$wnnna$aDevelopment Disorders, Pervasive
=450  \\$wnnna$aDisorder, Pervasive Development
=450  \\$wnnna$aDisorders, Pervasive Development
=450  \\$aPervasive Child Development Disorders
=450  \\$wnnna$aPervasive Development Disorder
=450  \\$aPervasive Development Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=550  \\$wh$aAsperger Syndrome
=550  \\$wh$aAutistic Disorder
=550  \\$wh$aAutism Spectrum Disorder
=667  \\$a"pervasive" is a psychiatric diagnosis: follow text; check the tag CHILD or specific
=680  \\$iSevere distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements.
=688  \\$a81
=750  \0$aAutism spectrum disorders$o(DLC)sh2008009581$5IEN-M

=LDR  01645cz  a2200349n  4500
=001  9880363467602441
=005  20170717163511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002658
=035  \\$aCAZ5815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x421
=150  \\$aDevelopmental Disabilities
=450  \\$wnnna$aChild Development Deviation
=450  \\$aChild Development Deviations
=450  \\$wnnna$aChild Development Disorder
=450  \\$aChild Development Disorders
=450  \\$aChild Development Disorders, Specific
=450  \\$wnnna$aDevelopment Deviation, Child
=450  \\$wnnna$aDevelopment Deviations, Child
=450  \\$wnnna$aDevelopment Disorder, Child
=450  \\$wnnna$aDevelopment Disorders, Child
=450  \\$wnnna$aDevelopmental Delay Disorder
=450  \\$aDevelopmental Delay Disorders
=450  \\$wnnna$aDevelopmental Disability
=450  \\$wnnna$aDeviation, Child Development
=450  \\$aDisabilities, Developmental
=450  \\$wnnna$aDisability, Developmental
=550  \\$wg$aNeurodevelopmental Disorders
=680  \\$iDisorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
=688  \\$a96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80
=750  \0$aDevelopmental disabilities$0(DLC) sh 85037355$5IEN-M

=LDR  00753cz  a2200241n  4500
=001  9880363467702441
=005  20161021162655.0
=008  870227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002655
=035  \\$aCAZ5814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x293.$x370
=150  \\$aChild Custody
=450  \\$wnnna$aChild Support
=450  \\$wnnna$aChild Custodies
=450  \\$wnnna$aCustodies, Child
=450  \\$aCustody, Child
=450  \\$wnnna$aSupport, Child
=550  \\$wg$aChild Welfare
=667  \\$acheck also tag CHILD or specific
=680  \\$iThe formally authorized guardianship or care of a child.
=688  \\$a91(88); was see under CHILD WELFARE 1988-90
=750  \0$aCustody of children$5IEN$0(DLC)sh 85034952

=LDR  00732cz  a2200229n  4500
=001  9880363467802441
=005  20161021162723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002654
=035  \\$aCAZ5813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x88
=150  \\$aChild Care
=450  \\$wnnna$aCare, Child
=450  \\$aPuericulture
=550  \\$wg$aHealth Services
=550  \\$wh$aInfant Care
=667  \\$ain home or institution; check also tag CHILD or specific
=680  \\$iCare of children in the home or institution.
=750  \0$aChildren$xHealth and hygiene$5IEN-M$0(DLC)sh 85023425
=750  \0$aSchool-age child care$5IEN-HS$0(DLC)sh 87001693
=750  \0$aChild care$5IEN-HS$0(DLC)sh 85023354

=LDR  00861cz  a2200205n  4500
=001  9880363467902441
=005  20170717162339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002653
=035  \\$aCAZ5812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x141
=150  \\$aChild Behavior Disorders
=450  \\$wnnna$aBehavior Disorders, Child
=450  \\$aChild Psychopathology$5IEN
=450  \\$wnnna$aDisorders, Child Behavior
=550  \\$wg$aNeurodevelopmental Disorders
=667  \\$acheck also tag CHILD or specific
=680  \\$iDisturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.
=750  \0$aBehavior disorders in children$5IEN-HS$0(DLC)sh 86005717

=LDR  00826cz  a2200229n  4500
=001  9880363468002441
=005  20170927122716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002652
=035  \\$aCAZ5811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x179
=150  \\$aChild Behavior
=450  \\$aBehavior, Child
=550  \\$wg$aBehavior
=550  \\$wh$aInfant Behavior
=550  \\$wh$aProblem Behavior
=667  \\$acheck also tag CHILD or specific; INFANT BEHAVIOR is also available
=680  \\$iAny observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available.
=688  \\$a68
=750  \0$aChild psychology$5IEN-M$0(DLC)sh 85023380
=750  \0$aChildren$xConduct of life$5IEN-M$0(DLC)sh 85023426

=LDR  00889cz  a2200265n  4500
=001  9880363468102441
=005  20141212195948.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002651
=035  \\$aCAZ5810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x300
=072  \\$aI1.$x880.$x787.$x293.$x350
=072  \\$aN3.$x706.$x437.$x300
=150  \\$aChild Advocacy
=450  \\$wnnna$aAdvocacies, Child
=450  \\$wnnna$aAdvocacy, Child
=450  \\$wnnna$aChild Advocacies
=550  \\$wg$aChild Welfare
=550  \\$wg$aHuman Rights
=667  \\$arights of children; check also tag CHILD or specific
=680  \\$iPromotion and protection of the rights of children; frequently through a legal process.
=688  \\$a75
=750  \0$aChildren$xLegal status, laws, etc.$5IEN-M$0(DLC)sh 85023456
=750  \0$aChildren's rights$5IEN-HS$0(DLC)sh 85023773

=LDR  01176cz  a2200349n  4500
=001  9880363468302441
=005  20141212192100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x350.$x250
=072  \\$aI1.$x880.$x735.$x900.$x350.$x250
=150  \\$aChild Abuse
=450  \\$wnnna$aAbuse, Child
=450  \\$wnnna$aAbuses, Child
=450  \\$wnnna$aChild Abuses
=450  \\$wnnna$aChild Maltreatment
=450  \\$wnnna$aChild Mistreatment
=450  \\$aChild Neglect
=450  \\$wnnna$aMaltreatment, Child
=450  \\$wnnna$aMistreatment, Child
=450  \\$wnnna$aNeglect, Child
=550  \\$wg$aDomestic Violence
=550  \\$wh$aChild Abuse, Sexual
=550  \\$aBattered Child Syndrome
=550  \\$aMunchausen Syndrome by Proxy
=550  \\$aShaken Baby Syndrome
=667  \\$acheck the tag CHILD or specific
=680  \\$iAbuse of children in a family, institutional, or other setting. (APA, Thesaurus of Psychological Index Terms, 1994)
=688  \\$a65(64)
=750  \0$aAbused children$5IEN-M$0(DLC)sh 85000277
=750  \0$aChild abuse$5IEN-HS$0(DLC)sh 85023348

=LDR  00653cz  a2200205n  4500
=001  9880363468402441
=005  20141212192100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002648
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x406
=150  \\$aChild
=450  \\$wnnna$aChildren
=550  \\$wg$aAge Groups
=550  \\$wh$aChild, Preschool
=550  \\$aMinors
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9
=680  \\$iA person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.
=750  \0$aChildren$5IEN-M$0(DLC)sh 85023418
=750  \0$aDaughters$5IEN-HS$0(DLC)sh 85035899

=LDR  00883cz  a2200277n  4500
=001  9880363468502441
=005  20141212192059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002647
=035  \\$aCAZ5806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x417.$x217
=150  \\$aChilblains
=450  \\$wnnna$aChilblain
=450  \\$wnnna$aIdiopathic Pernioses
=450  \\$wnnna$aIdiopathic Perniosis
=450  \\$wnnna$aPernio
=450  \\$wnnna$aPernios
=450  \\$wnnna$aPernioses
=450  \\$wnnna$aPernioses, Idiopathic
=450  \\$wnnna$aPerniosis
=450  \\$wnnna$aPerniosis, Idiopathic
=550  \\$wg$aFrostbite
=680  \\$iRecurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold.
=688  \\$a91(75); was see under FROSTBITE 1975-90
=750  \0$aChilblains$5IEN$0(DLC)sh 85023346

=LDR  00925cz  a2200253n  4500
=001  9880363468602441
=005  20141212195947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002645
=035  \\$aCAZ5804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350.$x150
=072  \\$aB1.$x50.$x150.$x900.$x248.$x617.$x192
=150  \\$aChickens
=450  \\$wnnna$aChicken
=450  \\$wnnna$aGallus domesticus
=450  \\$aGallus gallus
=450  \\$wnnna$aGallus gallus domesticus
=550  \\$wg$aGalliformes
=550  \\$wg$aPoultry
=667  \\$adiseases: coord IM with POULTRY DISEASES (IM); canned chicken: coord IM with FOOD PRESERVATION
=680  \\$iCommon name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.
=688  \\$a68
=750  \0$aChickens$5IEN$0(DLC)sh 85023298

=LDR  01003cz  a2200193n  4500
=001  9880363468702441
=005  20141212195947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002644
=035  \\$aCAZ5803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x175
=150  \\$aChickenpox
=450  \\$wnnna$aChicken Pox
=450  \\$aVaricella
=550  \\$wg$aHerpesviridae Infections
=667  \\$acaused by a herpesvirus
=680  \\$iA highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)
=750  \0$aChickenpox$5IEN$0(DLC)sh 85023295

=LDR  01053cz  a2200241n  4500
=001  9880363468802441
=005  20141212195947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002642
=035  \\$aCAZ5801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x350.$x150
=072  \\$aA16.$x331.$x200
=150  \\$aChick Embryo
=450  \\$wnnna$aChick Embryos
=450  \\$aChickens$xembryology
=450  \\$aEmbryo, Chick
=450  \\$wnnna$aEmbryos, Chick
=550  \\$wg$aEmbryo, Nonmammalian
=667  \\$acheck tag: NIM no qualifiers; chick embryo heart = CHICK EMBRYO + HEART /embryol (not FETAL HEART); transfer of chick embryo = CHICK EMBRYO /transpl not EMBRYO TRANSFER
=680  \\$iThe developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.
=688  \\$a64
=750  \0$aChickens$xEmbryos$5IEN$0(DLC)sh 85023277

=LDR  01022cz  a2200277n  4500
=001  9880363468902441
=005  20200605174849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002638
=035  \\$aCAZ5797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x739.$x249
=072  \\$aD9.$x698.$x700.$x249
=072  \\$aD20.$x215.$x721.$x249.$x249
=072  \\$aG7.$x500.$x140.$x200
=072  \\$aJ2.$x500.$x140.$x200
=150  \\$aChewing Gum
=450  \\$wnnna$aChewing Gums
=450  \\$wnnna$aGum, Chewing
=450  \\$wnnna$aGums, Chewing
=550  \\$wg$aCandy
=550  \\$wg$aPlant Gums
=550  \\$wh$aNicotine Chewing Gum
=667  \\$aas a confection or as vehicle for admin of med substances
=680  \\$iA preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.
=750  \0$aChewing gum$0(DLC) sh 85023185$5IEN

=LDR  00633cz  a2200229n  4500
=001  9880363469002441
=005  20141212195750.0
=008  860326\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002637
=035  \\$aCAZ5796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x646.$x215
=150  \\$aChest Pain
=450  \\$wnnna$aChest Pains
=450  \\$wnnna$aPain, Chest
=450  \\$wnnna$aPains, Chest
=550  \\$wg$aPain
=550  \\$wh$aAngina Pectoris
=667  \\$acardiac = probably ANGINA PECTORIS
=680  \\$iPressure, burning, or numbness in the chest.
=688  \\$a87
=750  \0$aChest pain$5IEN$0(DLC)sh 85023146

=LDR  00825cz  a2200217n  4500
=001  9880364114802441
=005  20141212211746.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016792
=035  \\$aCBM5678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x600.$x580
=150  \\$aPiroplasmida
=450  \\$wnnna$aPiroplasmidas
=550  \\$wg$aPiroplasmia
=550  \\$wh$aBabesia
=550  \\$wh$aTheileria
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; do not confuse with subclass PIROPLASMIA
=680  \\$iAn order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA.
=688  \\$a92
=750  \0$aPrioplasmida$5IEN-M

=LDR  00964cz  a2200217n  4500
=001  9880364114902441
=005  20141212211745.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016789
=035  \\$aCBM5675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611.$x505
=150  \\$aPlasmodium cynomolgi
=450  \\$wnnna$acynomolgi, Plasmodium
=450  \\$wnnna$acynomolgus, Plasmodium
=450  \\$wnnna$aPlasmodium cynomolgus
=550  \\$wg$aPlasmodium
=667  \\$ainfection: coord IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria (MALARIA, VIVAX). This species has been found to give rise to both natural and experimental human infections.
=688  \\$a92
=750  \0$aPlasmodium cynomolgi$5IEN-M$0(DLC)sh 88021417

=LDR  00951cz  a2200217n  4500
=001  9880364115002441
=005  20141212211744.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016785
=035  \\$aCBM5671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x150.$x160.$x170
=150  \\$aCryptosporidium parvum
=450  \\$wnnna$aCryptosporidium parvums
=450  \\$wnnna$aparvum, Cryptosporidium
=450  \\$wnnna$aparvums, Cryptosporidium
=550  \\$wg$aCryptosporidium
=667  \\$ainfection: coordinate IM with CRYPTOSPORIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.
=688  \\$a92
=750  \0$aCryptosporidium parvum$5IEN-M$0(DLC)sh 91004855

=LDR  01129cz  a2200277n  4500
=001  9880364115102441
=005  20141212211744.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016782
=035  \\$aCBM5668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75
=150  \\$aApicomplexa
=450  \\$wnnna$aApicomplexas
=450  \\$wnnna$aSporozoa
=450  \\$wnnna$aSporozoas
=450  \\$wnnna$aSporozoea
=450  \\$wnnna$aSporozoeas
=550  \\$wg$aAlveolata
=550  \\$wh$aCoccidia
=550  \\$wh$aHaemosporida
=550  \\$wh$aPiroplasmia
=667  \\$ageneral; prefer specifics; infection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
=680  \\$iA phylum of unicellular parasitic EUKARYOTES characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility.
=688  \\$a1992
=750  \0$aApicomplexa$5IEN-M$0(DLC)sh 87001229

=LDR  00804cz  a2200217n  4500
=001  9880364115202441
=005  20141212211743.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016780
=035  \\$aCBM5666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x530.$x700
=150  \\$aMalaria, Vivax
=450  \\$wnnna$aMalaria, Plasmodium vivax
=450  \\$aPlasmodium vivax Malaria
=450  \\$wnnna$aVivax Malaria
=550  \\$wg$aMalaria
=680  \\$iMalaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.
=688  \\$a1992
=750  \0$81$wb$aPlasmodium vivax$5IEN-M$0(DLC)sh 88021423
=750  \0$81$wb$aMalaria$5IEN-HS$0(DLC)sh 85080038

=LDR  01378cz  a2200277n  4500
=001  9880364115302441
=005  20141212211742.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016779
=035  \\$aCBM5665M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x105.$x300.$x500
=072  \\$aC3.$x752.$x530.$x620
=072  \\$aC3.$x752.$x530.$x650.$x675
=072  \\$aC10.$x228.$x228.$x205.$x300.$x500
=150  \\$aMalaria, Cerebral
=450  \\$aCerebral Malaria
=450  \\$aMalaria Meningitis
=450  \\$wnnna$aMeningitis, Malaria
=550  \\$wg$aCentral Nervous System Protozoal Infections
=550  \\$wg$aMalaria
=550  \\$wg$aMalaria, Falciparum
=667  \\$acoord IM with Plasmodium species (IM) but do not coord with PLASMODIUM FALCIPARUM unless particularly discussed
=680  \\$iA condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM (and rarely other Plasmodium species). Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. (From Adams et al., Principles of Neurology, 6th ed, p136)
=688  \\$a1992
=750  \0$aCerebral malaria$5IEN-M$0(DLC)sh 99003425

=LDR  00971cz  a2200229n  4500
=001  9880364115402441
=005  20141212211742.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016778
=035  \\$aCBM5664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x530.$x650
=150  \\$aMalaria, Falciparum
=450  \\$wnnna$aMalaria, Plasmodium falciparum
=450  \\$aPlasmodium falciparum Malaria
=550  \\$wg$aMalaria
=550  \\$wh$aBlackwater Fever
=550  \\$wh$aMalaria, Cerebral
=680  \\$iMalaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
=688  \\$a1992
=750  \0$81$wb$aPlasmodium falciparum$5IEN-M$0(DLC)sh 85103100
=750  \0$81$wb$aMalaria$5IEN-HS$0(DLC)sh 85080038

=LDR  02130cz  a2200373n  4500
=001  9880364115502441
=005  20141212211741.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016773
=035  \\$aCBM5659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x500.$x400
=072  \\$aC3.$x858.$x560.$x400
=072  \\$aC17.$x800.$x838.$x775.$x560.$x400
=150  \\$aLeishmaniasis, Cutaneous
=450  \\$wnnna$aAmerican Leishmaniasis
=450  \\$wnnna$aCutaneous Leishmaniases
=450  \\$wnnna$aCutaneous Leishmaniasis
=450  \\$wnnna$aLeishmaniases, Cutaneous
=450  \\$aLeishmaniasis, American
=450  \\$aLeishmaniasis, New World
=450  \\$aLeishmaniasis, Old World
=450  \\$wnnna$aNew World Leishmaniasis
=450  \\$wnnna$aOld World Leishmaniasis
=450  \\$aOriental Sore
=450  \\$wnnna$aSore, Oriental
=550  \\$wg$aLeishmaniasis
=550  \\$wh$aLeishmaniasis, Diffuse Cutaneous
=550  \\$wh$aLeishmaniasis, Mucocutaneous
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; LEISHMANIASIS, DIFFUSE CUTANEOUS & LEISHMANIASIS, MUCOCUTANEOUS are also available; tegumentary leishmaniasis goes here
=680  \\$iAn endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
=688  \\$a1992; use LEISHMANIASIS 1979-1991; for ORIENTAL SORE use LEISHMANIASIS 1979-1991, use LEISHMANIASIS 1963-78
=688  \\$a92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91, was see under LEISHMANIASIS 1963-78
=750  \0$aLeishmaniasis, Cutaneous$5IEN-M$0(DLC)sh 85075923

=LDR  01417cz  a2200337n  4500
=001  9880364115602441
=005  20141212211739.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791.$x330
=150  \\$aGenes, fos
=450  \\$wnnna$ac-fos Gene
=450  \\$ac-fos Genes
=450  \\$wnnna$ac fos Genes
=450  \\$wnnna$ac-fos Proto-Oncogene
=450  \\$wnnna$ac-fos Proto-Oncogenes
=450  \\$wnnna$ac fos Proto Oncogenes
=450  \\$wnnna$afos Gene
=450  \\$afos Genes
=450  \\$wnnna$av-fos Gene
=450  \\$av-fos Genes
=450  \\$wnnna$av fos Genes
=450  \\$wnnna$av-fos Oncogene
=450  \\$wnnna$av-fos Oncogenes
=450  \\$wnnna$av fos Oncogenes
=550  \\$wg$aProto-Oncogenes
=667  \\$afos stands for "Finkel" & "Osteogenic Sarcoma"
=680  \\$iRetrovirus-associated DNA sequences (fos) originally isolated from the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses. The proto-oncogene protein c-fos codes for a nuclear protein which is involved in growth-related transcriptional control. The insertion of c-fos into FBJ-MSV or FBR-MSV induces osteogenic sarcomas in mice. The human c-fos gene is located at 14q21-31 on the long arm of chromosome 14.
=688  \\$a92
=750  \0$aFos oncogenes$5IEN-M$0(DLC)sh 94003461

=LDR  01752cz  a2200445n  4500
=001  9880364115702441
=005  20141212211736.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016758
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791.$x365
=150  \\$aGenes, jun
=450  \\$wnnna$ac-jun Gene
=450  \\$ac-jun Genes
=450  \\$wnnna$ac jun Genes
=450  \\$wnnna$ac-jun Proto-Oncogene
=450  \\$wnnna$ac-jun Proto-Oncogenes
=450  \\$wnnna$ac jun Proto Oncogenes
=450  \\$wnnna$ajun Gene
=450  \\$ajun Genes
=450  \\$wnnna$ajun Oncogene
=450  \\$wnnna$ajun Oncogenes
=450  \\$wnnna$ajun Proto-Oncogene
=450  \\$wnnna$ajun Proto Oncogene
=450  \\$wnnna$ajun Proto-Oncogenes
=450  \\$wnnna$aOncogene, jun
=450  \\$wnnna$aOncogenes, jun
=450  \\$wnnna$aProto-Oncogene, jun
=450  \\$wnnna$aProto-Oncogenes, jun
=450  \\$wnnna$av-jun Gene
=450  \\$av-jun Genes
=450  \\$wnnna$av jun Genes
=450  \\$wnnna$av-jun Oncogene
=450  \\$wnnna$av-jun Oncogenes
=450  \\$wnnna$av jun Oncogenes
=550  \\$wg$aProto-Oncogenes
=667  \\$ajun stands for "JU-Nana", Japanese for 17 (avian sarcoma virus 17)
=680  \\$iRetrovirus-associated DNA sequences (jun) originally isolated from the avian sarcoma virus 17 (ASV 17). The proto-oncogene jun (c-jun) codes for a nuclear protein which is involved in growth-related transcriptional control. Insertion of c-jun into ASV-17 or the constitutive expression of the c-jun protein produces tumorgenicity. The human c-jun gene is located at 1p31-32 on the short arm of chromosome 1.
=688  \\$a92
=750  \0$aJun oncogenes$5IEN-M$0(DLC)sh 94003462

=LDR  03355cz  a2200781n  4500
=001  9880364115802441
=005  20141212211735.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016756
=035  \\$aCBM5645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x393.$x536
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x632
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x632
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x632
=150  \\$aImmunoglobulins, Intravenous
=450  \\$wnnna$aAlphaglobin
=450  \\$aAntibodies, Intravenous
=450  \\$wnnna$aBaxter Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aBayer Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aBiotest Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aCSL Behring Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aEndobulin
=450  \\$wnnna$aFlebogamma DIF
=450  \\$wnnna$aGamimmune
=450  \\$wnnna$aGamimmune N
=450  \\$wnnna$aGamimune
=450  \\$wnnna$aGamimune N
=450  \\$wnnna$aGammagard
=450  \\$wnnna$aGammonativ
=450  \\$wnnna$aGamunex
=450  \\$wnnna$aGlobulin-N
=450  \\$wnnna$aGlobulin N
=450  \\$wnnna$aGlobulinN
=450  \\$wnnna$aGrifols Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aHuman Intravenous Immunoglobulins
=450  \\$wnnna$aImmune Globulin, Intravenous
=450  \\$wnnna$aImmune Globulin Intravenous (Human)
=450  \\$wnnna$aImmunoglobulins, Human Intravenous
=450  \\$wnnna$aImmunoglobulins, Intravenous, Human
=450  \\$wnnna$aImmunoglobulins, IV
=450  \\$wnnna$aIntraglobin
=450  \\$wnnna$aIntraglobin F
=450  \\$aIntravenous Antibodies
=450  \\$wnnna$aIntravenous IG
=450  \\$wnnna$aIntravenous Immune Globulin
=450  \\$aIntravenous Immunoglobulins
=450  \\$wnnna$aIntravenous Immunoglobulins, Human
=450  \\$wnnna$aIV Immunoglobulins
=450  \\$wnnna$aIveegam
=450  \\$aIVIG
=450  \\$wnnna$aModified Immune Globulin (Anti-Echovirus Antibody)
=450  \\$wnnna$aOctapharma Brand of Intravenous Immunoglobulins, Human
=450  \\$wnnna$aPrivigen
=450  \\$wnnna$aSandoglobulin
=450  \\$wnnna$aVenimmune
=450  \\$wnnna$aVenoglobulin
=450  \\$wnnna$aVenoglobulin-I
=450  \\$wnnna$aVenoglobulin I
=450  \\$wnnna$aVenoglobulinI
=550  \\$wg$aAntibodies
=550  \\$wg$aImmunoglobulin G
=550  \\$aInfusions, Intravenous
=680  \\$iImmunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
=688  \\$a1992
=688  \\$a92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV & INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN & MODIFIED IMMUNE GLOBULIN (ANTI-ECHOVIRUS ANTIBODY) were NM 1981-91
=750  \0$81$wb$aImmunoglobulins$5IEN-M$0(DLC)sh 85064568
=750  \0$81$wb$aIntravenous therapy$5IEN-HS$0(DLC)sh 85067634

=LDR  01079cz  a2200265n  4500
=001  9880364115902441
=005  20141212211733.0
=008  910627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016753
=035  \\$aCBM5643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x510
=072  \\$aD12.$x776.$x467.$x374.$x465.$x510
=072  \\$aD23.$x529.$x374.$x465.$x510
=150  \\$aInterleukin-10
=450  \\$wnnna$aCSIF-10
=450  \\$wnnna$aCytokine Synthesis Inhibitory Factor
=450  \\$aIL-10
=450  \\$wnnna$aIL10
=450  \\$wnnna$aInterleukin 10
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 10 or IL10
=680  \\$iA cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.
=688  \\$a92; was INTERLEUKIN-10 (NM) 1990-91
=750  \0$aInterleukin-10$0(DLC) sh 94007678$5IEN-M

=LDR  01329cz  a2200337n  4500
=001  9880364116002441
=005  20141212211733.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016751
=035  \\$aCBM5641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x440.$x470
=072  \\$aC2.$x782.$x455
=072  \\$aC6.$x552.$x380.$x705.$x470
=150  \\$aHepatitis E
=450  \\$aEnterically-Transmitted Non-A, Non-B Hepatitis
=450  \\$wnnna$aEnterically Transmitted Non A, Non B Hepatitis
=450  \\$aEpidemic Non-A, Non-B Hepatitis
=450  \\$wnnna$aEpidemic Non A, Non B Hepatitis
=450  \\$wnnna$aET-NANBH
=450  \\$wnnna$aHepatitides, Water-Borne
=450  \\$aHepatitis, Viral, Non-A, Non-B, Enterically-Transmitted
=450  \\$aHepatitis, Water-Borne
=450  \\$wnnna$aHepatitis, Water Borne
=450  \\$wnnna$aWater-Borne Hepatitides
=450  \\$wnnna$aWater-Borne Hepatitis
=550  \\$wg$aHepatitis, Viral, Human
=550  \\$wg$aRNA Virus Infections
=680  \\$iAcute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
=688  \\$a92
=750  \0$aHepatitis E$0(DLC) sh 92000217$5IEN

=LDR  01951cz  a2200433n  4500
=001  9880364116102441
=005  20141212211732.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x812
=072  \\$aC10.$x228.$x854.$x790
=072  \\$aC10.$x668.$x900
=072  \\$aC20.$x111.$x258.$x850
=150  \\$aStiff-Person Syndrome
=450  \\$wnnna$aCongenital Stiff-Man Syndrome
=450  \\$wnnna$aCongenital Stiff-Person Syndrome
=450  \\$wnnna$aFamilial Hyperekplexia
=450  \\$wnnna$aHereditary Hyperekplexia
=450  \\$wnnna$aHyperekplexia
=450  \\$aMoersch-Woltmann Syndrome
=450  \\$wnnna$aMoersch Woltmann Syndrome
=450  \\$wnnna$aStartle Syndrome
=450  \\$wnnna$aStiff-Baby Syndrome
=450  \\$aStiff-Man Syndrome
=450  \\$wnnna$aStiff Man Syndrome
=450  \\$wnnna$aStiff Person Syndrome
=450  \\$wnnna$aStiff-Trunk Syndrome
=450  \\$wnnna$aStiffman Syndrome
=450  \\$wnnna$aSyndrome, Moersch-Woltmann
=450  \\$wnnna$aSyndrome, Stiff-Man
=450  \\$wnnna$aSyndrome, Stiff-Person
=450  \\$wnnna$aSyndrome, Stiffman
=550  \\$wg$aAutoimmune Diseases of the Nervous System
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wg$aSpinal Cord Diseases
=680  \\$iA condition characterized by persistent spasms (SPASM) involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. (Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51(1):85-93)
=688  \\$a2000(1992)
=750  \0$aStiff-man syndrome$5IEN-M$0(DLC)sh 93001826

=LDR  01149cz  a2200313n  4500
=001  9880364116202441
=005  20141212211731.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016748
=035  \\$aCBM5638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x895
=150  \\$aVenous Cutdown
=450  \\$wnnna$aCutdown, Vein
=450  \\$aCutdown, Venous
=450  \\$wnnna$aCutdowns, Vein
=450  \\$wnnna$aCutdowns, Venous
=450  \\$aVein Cutdown
=450  \\$wnnna$aVein Cutdowns
=450  \\$wnnna$aVenostomies
=450  \\$aVenostomy
=450  \\$wnnna$aVenous Cutdowns
=550  \\$wg$aVascular Surgical Procedures
=550  \\$aCatheterization
=550  \\$aCatheterization, Central Venous
=667  \\$ausually for insertion of a catheter; do not use /util except by MeSH definition
=680  \\$iCreation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. (Dorland, 28th ed.; Stedman, 26th ed.)
=688  \\$a92
=750  \0$aVeins$xCutdown$5IEN-M$0(DLC)sh 87000122

=LDR  01194cz  a2200205n  4500
=001  9880364116302441
=005  20141212211730.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016746
=035  \\$aCBM5636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x920
=150  \\$aTranscultural Nursing
=450  \\$aNursing, Transcultural
=550  \\$wg$aSpecialties, Nursing
=550  \\$aCultural Competency
=667  \\$aspecialty; on an international or cultural level only; coordinate IM with nursing specialty (IM) if pertinent + culture or ethnic group (IM) if pertinent; specify geography; consider also CULTURAL COMPETENCY; DF: TRANSCULTURAL NURS
=680  \\$iA nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example.
=688  \\$a92
=750  \0$aTranscultural nursing$5IEN-M$0(DLC)sh 90002303

=LDR  01005cz  a2200265n  4500
=001  9880364116402441
=005  20141212211730.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016745
=035  \\$aCBM5635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x189.$x350.$x650
=072  \\$aE6.$x721.$x874.$x650
=072  \\$aE6.$x761.$x227.$x350.$x650
=150  \\$aRoot Planing
=450  \\$wnnna$aPlaning, Root
=450  \\$wnnna$aPlanings, Root
=450  \\$wnnna$aRoot Planings
=550  \\$wg$aDental Scaling
=550  \\$wg$aSubgingival Curettage
=550  \\$aTooth Root
=667  \\$ain periodontal ther to smooth root surface or cementum; do not use /util except by MeSH definition; do not confuse with ROOT SCALING see DENTAL SCALING
=680  \\$iA procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy.
=688  \\$a92
=750  \0$aTeeth$xRoots$xPlaning$5IEN-M$0(DLC)sh 85133231

=LDR  01256cz  a2200265n  4500
=001  9880364116502441
=005  20141212211729.0
=008  910507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016742
=035  \\$aCBM5632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x775
=072  \\$aN2.$x421.$x143.$x620.$x620
=072  \\$aN2.$x421.$x585.$x775
=072  \\$aN2.$x421.$x920.$x660
=150  \\$aPreconception Care
=450  \\$wnnna$aCare, Preconception
=550  \\$wg$aMaternal Health Services
=550  \\$wg$aPatient Care
=550  \\$wg$aWomen's Health Services
=550  \\$aGenetic Counseling
=667  \\$amay refer to prospective mother or father
=680  \\$iAn organized and comprehensive program of health care that identifies and reduces a woman's reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy.
=688  \\$a92
=750  \0$aPreconception care$5IEN-M$0(DLC)sh 94006774

=LDR  01070cz  a2200253n  4500
=001  9880364116602441
=005  20141212211726.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016737
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x219.$x620
=150  \\$aProctocolectomy, Restorative
=450  \\$wnnna$aColoproctectomies, Restorative
=450  \\$aColoproctectomy, Restorative
=450  \\$wnnna$aProctocolectomies, Restorative
=450  \\$wnnna$aRestorative Coloproctectomies
=450  \\$wnnna$aRestorative Coloproctectomy
=450  \\$wnnna$aRestorative Proctocolectomies
=450  \\$wnnna$aRestorative Proctocolectomy
=550  \\$wg$aColectomy
=550  \\$aColonic Pouches
=680  \\$iA surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.
=688  \\$a92
=750  \0$aRestorative Proctocolectomy$5IEN-M$0(DLC)sh 92005596

=LDR  00802cz  a2200169n  4500
=001  9880364116702441
=005  20141212192712.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016735
=035  \\$aCBM5625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x400.$x800
=150  \\$aMunchausen Syndrome by Proxy
=550  \\$wg$aFactitious Disorders
=680  \\$iA phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care.
=688  \\$a92
=750  \0$aMunchausen syndrome by proxy$5IEN$0(DLC)sh 93000062

=LDR  01025cz  a2200253n  4500
=001  9880364116802441
=005  20141212211726.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016733
=035  \\$aCBM5623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186.$x670
=072  \\$aE7.$x222.$x670
=150  \\$aRubber Dams
=450  \\$wnnna$aDam, Rubber
=450  \\$wnnna$aDams, Rubber
=450  \\$wnnna$aRubber Dam
=450  \\$wnnna$aRubberdam
=450  \\$wnnna$aRubberdams
=550  \\$wg$aDental Equipment
=667  \\$ato isolate operative field during dent proced; do not use /util except by MeSH definition
=680  \\$iSheets of latex rubber punched and placed over the teeth during dental procedures to isolate the field of operation from the rest of the oral cavity (Jablonski; Illustrated Dictionary of Dentistry, 1982). Rubber dams are useful in preventing the swallowing of instruments or restorations during dental work.
=688  \\$a92
=750  \0$aDams (Dentistry)$5IEN-M$0(DLC)sh 85035617

=LDR  01008cz  a2200265n  4500
=001  9880364116902441
=005  20141212211725.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016731
=035  \\$aCBM5621M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x700.$x300
=072  \\$aC2.$x825.$x260
=072  \\$aC17.$x800.$x229.$x335
=072  \\$aC17.$x800.$x838.$x790.$x260
=150  \\$aErythema Infectiosum
=450  \\$aFifth Disease
=550  \\$wg$aErythema
=550  \\$wg$aParvoviridae Infections
=550  \\$wg$aSkin Diseases, Viral
=550  \\$aParvovirus B19, Human
=667  \\$acaused by Parvovirus B19 but do not index under PARVOVIRUS B19, HUMAN unless particularly discussed
=680  \\$iContagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with rubella.
=688  \\$a92
=750  \0$aFifth disease$5IEN-M$0(DLC)sh2002000804

=LDR  01184cz  a2200337n  4500
=001  9880364117002441
=005  20141212211724.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016728
=035  \\$aCBM5618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x980
=150  \\$aSelf-Injurious Behavior
=450  \\$wnnna$aBehavior, Self-Destructive
=450  \\$wnnna$aBehavior, Self-Injurious
=450  \\$wnnna$aDeliberate Self-Harm
=450  \\$wnnna$aDeliberate Self Harm
=450  \\$aParasuicide
=450  \\$aSelf-Destructive Behavior
=450  \\$wnnna$aSelf Destructive Behavior
=450  \\$wnnna$aSelf-Harm, Deliberate
=450  \\$wnnna$aSelf Injurious Behavior
=550  \\$wg$aBehavioral Symptoms
=550  \\$wh$aSelf Mutilation
=550  \\$wh$aSuicide
=550  \\$aBody Modification, Non-Therapeutic
=667  \\$aSELF MUTILATION is also available; DF: SELF INJ BEHAVIOR
=680  \\$iBehavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.
=688  \\$a92
=750  \0$aSelf-Injurious Behavior$0sh 91001773$5IEN-M
=750  \0$aSelf-destructive behavior$0(DLC) sh 85119733$5IEN-M

=LDR  01260cz  a2200241n  4500
=001  9880364117102441
=005  20141212211723.0
=008  910429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016723
=035  \\$aCBM5614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x195
=072  \\$aG16.$x100.$x856.$x150
=150  \\$aBone Remodeling
=450  \\$wnnna$aRemodeling, Bone
=550  \\$wg$aMusculoskeletal Physiological Processes
=550  \\$wg$aRegeneration
=550  \\$wh$aBone Regeneration
=550  \\$wh$aBone Resorption
=667  \\$anote category: an aspect of bone physiol
=680  \\$iThe continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS.
=688  \\$a92
=750  \0$aBone remodeling$5IEN-M$0(DLC)sh 93001828

=LDR  01715cz  a2200373n  4500
=001  9880364117202441
=005  20141212211721.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016719
=035  \\$aCBM5610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x710.$x710
=072  \\$aE1.$x370.$x384.$x730.$x710
=072  \\$aE5.$x478.$x805
=150  \\$aRadioimmunodetection
=450  \\$wnnna$aImmunoscintigraphies, Radiolabeled
=450  \\$wnnna$aImmunoscintigraphies, Radiolabelled
=450  \\$aImmunoscintigraphy, Radiolabeled
=450  \\$wnnna$aImmunoscintigraphy, Radiolabelled
=450  \\$wnnna$aRadioimmunodetections
=450  \\$aRadioimmunoimaging
=450  \\$wnnna$aRadioimmunoimagings
=450  \\$wnnna$aRadioimmunoscintigraphies
=450  \\$aRadioimmunoscintigraphy
=450  \\$wnnna$aRadiolabeled Immunoscintigraphies
=450  \\$wnnna$aRadiolabeled Immunoscintigraphy
=450  \\$wnnna$aRadiolabelled Immunoscintigraphies
=450  \\$wnnna$aRadiolabelled Immunoscintigraphy
=550  \\$wg$aImmunologic Techniques
=550  \\$wg$aRadionuclide Imaging
=667  \\$auses radiolabeled antibodies for diag imaging; do not use /util except by MeSH definition; coord IM or NIM with dis /radionuclide (IM), not /diag, not /radiogr & not /immunol, + specific radioisotope /diag use (IM or NIM)
=680  \\$iUse of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.
=688  \\$a92
=750  \0$aRadioimmunoimaging$5IEN-M$0(DLC)sh 87004417

=LDR  01764cz  a2200361n  4500
=001  9880364117302441
=005  20141212211721.0
=008  910208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016718
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x96.$x100
=072  \\$aD10.$x251.$x355.$x255.$x100.$x100
=072  \\$aD10.$x251.$x355.$x310.$x166.$x100
=150  \\$aArachidonic Acid
=450  \\$wnnna$a(all-Z)-5,8,11,14-Eicosatetraenoic acid
=450  \\$wnnna$aArachidonate, Sodium
=450  \\$wnnna$aArachidonic Acid, (all-Z)-Isomer, 1-(14)C-Labeled
=450  \\$wnnna$aArachidonic Acid, (all-Z)-isomer, 3H-Labeled
=450  \\$wnnna$aArachidonic Acid, Ammonium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Cerium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Cesium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Lithium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Potassium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Sodium Salt
=450  \\$wnnna$aArachidonic Acid, Sodium Salt, (all-Z)-Isomer
=450  \\$wnnna$aArachidonic Acid, Zinc Salt, (all-Z)-Isomer
=450  \\$wnnna$aSodium Arachidonate
=450  \\$wnnna$aVitamin F
=550  \\$wg$aArachidonic Acids
=667  \\$ado not confuse with ARACHIDONIC ACIDS
=680  \\$iAn unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.
=688  \\$a92; was ARACHIDONIC ACID (NM) 1981-91
=750  \0$aArachidonic Acid$5IEN-M$0(DLC)sh 85006365

=LDR  01600cz  a2200325n  4500
=001  9880364117402441
=005  20141212211720.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016715
=035  \\$aCBM5606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x445.$x435.$x500
=072  \\$aC4.$x651.$x435.$x500
=072  \\$aC5.$x116.$x99.$x750
=072  \\$aC5.$x660.$x585.$x620
=072  \\$aC16.$x131.$x77.$x740
=072  \\$aC16.$x131.$x621.$x585.$x620
=150  \\$aProteus Syndrome
=450  \\$aElephant Man Disease
=450  \\$wnnna$aProteus-Like Syndrome
=450  \\$wnnna$aProteus Like Syndrome
=450  \\$wnnna$aSyndrome, Proteus-Like
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aHamartoma Syndrome, Multiple
=550  \\$wg$aLimb Deformities, Congenital
=667  \\$ahamartomas & multiple abnorm; "Proteus" refers to the sea god in Greek mythol who could assume many forms; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iHamartoneoplastic malformation syndrome of uncertain etiology characterized by partial GIGANTISM of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas (HEMANGIOMA), lipomas (LIPOMA), lymphangiomas (LYMPHANGIOMA), epidermal NEVI; MACROCEPHALY; cranial HYPEROSTOSIS, and long-bone overgrowth. Joseph Merrick, the so-called "elephant man", apparently suffered from Proteus syndrome and not NEUROFIBROMATOSIS, a disorder with similar characteristics.
=688  \\$a92
=750  \0$aProteus syndrome$5IEN-M$0(DLC)sh 93003272

=LDR  01447cz  a2200385n  4500
=001  9880364117502441
=005  20141212211719.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016712
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x411.$x658
=072  \\$aD3.$x383.$x663.$x555
=072  \\$aD3.$x830.$x555
=072  \\$aD10.$x251.$x536
=150  \\$aMupirocin
=450  \\$wnnna$a14C-Labeled Mupirocin
=450  \\$wnnna$aAcid, Pseudomonic
=450  \\$wnnna$aBactroban
=450  \\$wnnna$aBRL-4910A
=450  \\$wnnna$aBRL 4910A
=450  \\$wnnna$aBRL4910A
=450  \\$wnnna$aMupirocin, 14C-Labeled
=450  \\$wnnna$aMupirocin, 14C Labeled
=450  \\$wnnna$aMupirocin, Calcium Salt (2:1)
=450  \\$wnnna$aMupirocin, Calcium Salt (2:1), Dihydrate
=450  \\$wnnna$aMupirocin, Lithium Salt
=450  \\$wnnna$aMupirocin, Sodium Salt
=450  \\$aPseudomonic Acid
=450  \\$wnnna$aPseudomonic Acid A
=550  \\$wg$aEpoxy Compounds
=550  \\$wg$aFatty Acids
=550  \\$wg$aPyrans
=680  \\$iA topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.
=688  \\$a92; was PSEUDOMONIC ACID (NM) 1977-91
=750  \0$aMupirocin$5IEN-M$0(DLC)sh 85088527

=LDR  01419cz  a2200241n  4500
=001  9880364117602441
=005  20141212211718.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x520.$x967
=072  \\$aK1.$x752.$x967
=150  \\$aYin-Yang
=450  \\$wnnna$aYin Yang
=550  \\$wg$aMedicine, Chinese Traditional
=550  \\$wg$aPhilosophy
=550  \\$aQi
=550  \\$aYang Deficiency
=550  \\$aYin Deficiency
=667  \\$ayang exuberance syndrome can go here, defic syndromes: index YIN DEFICIENCY or YANG DEFICIENCY: see notes there
=680  \\$iIn Chinese philosophy and religion, two principles, one negative, dark, and feminine (yin) and one positive, bright, and masculine (yang), from whose interaction all things are produced and all things are dissolved. As a concept the two polar elements referred originally to the shady and sunny sides of a valley or a hill but it developed into the relationship of any contrasting pair: those specified above (female-male, etc.) as well as cold-hot, wet-dry, weak-strong, etc. It is not a distinct system of thought by itself but permeates Chinese life and thought. A balance of yin and yang is essential to health. A deficiency of either principle can manifest as disease. (Encyclopedia Americana)
=688  \\$a92
=750  \0$aYin-yang$5IEN-M$0(DLC)sh 85149161

=LDR  00832cz  a2200217n  4500
=001  9880364117702441
=005  20141212211717.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016707
=035  \\$aCBM5599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x760.$x720
=072  \\$aE1.$x370.$x225.$x750.$x600.$x760.$x720
=072  \\$aE5.$x200.$x500.$x620.$x760.$x720
=072  \\$aE5.$x200.$x750.$x600.$x760.$x720
=150  \\$aTissue Fixation
=450  \\$aFixation, Tissue
=550  \\$wg$aTissue Preservation
=680  \\$iThe technique of using FIXATIVES in the preparation of cytologic, histologic, or pathologic specimens for the purpose of maintaining the existing form and structure of all the constituent elements.
=688  \\$a92
=750  \0$aFixation (Histology)$5IEN-M$0(DLC)sh 85048932

=LDR  00852cz  a2200217n  4500
=001  9880364117802441
=005  20171024145116.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016544
=035  \\$aCBM5462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x903.$x847.$x500
=150  \\$aPatient Simulation
=450  \\$wnnna$aPatient Simulations
=450  \\$wnnna$aSimulation, Patient
=450  \\$wnnna$aSimulations, Patient
=550  \\$wg$aSimulation Training
=667  \\$aactual persons (sometimes actors) "coached to feign symptoms or conditions of real diseases" as a technique in med educ; no qualif
=680  \\$iThe use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel.
=688  \\$a92
=750  \0$aSimulated patients$5IEN-M$0(DLC)sh 85122759

=LDR  01166cz  a2200301n  4500
=001  9880364117902441
=005  20141212211626.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016543
=035  \\$aCBM5461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250
=072  \\$aC10.$x551.$x240
=150  \\$aCentral Nervous System Neoplasms
=450  \\$wnnna$aCentral Nervous System Neoplasms, Primary
=450  \\$wnnna$aCentral Nervous System Tumors
=450  \\$aNeoplasms, Central Nervous System
=450  \\$wnnna$aPrimary Central Nervous System Neoplasms
=450  \\$wnnna$aTumors, Central Nervous System
=550  \\$wg$aNervous System Neoplasms
=550  \\$wh$aBrain Neoplasms
=550  \\$wh$aCentral Nervous System Cysts
=550  \\$wh$aMeningeal Neoplasms
=550  \\$wh$aSpinal Cord Neoplasms
=667  \\$aGEN or unspecified, prefer specifics; coord IM with histol type of neopl (IM); DF: CNS NEOPL
=680  \\$iBenign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
=688  \\$a92
=750  \0$aCentral nervous system$xCancer$5IEN-M$0(DLC)sh 85021908

=LDR  00766cz  a2200241n  4500
=001  9880364118002441
=005  20210211142430.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016540
=035  \\$aCBM5459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x488.$x750.$x700
=150  \\$aSmoking Cessation
=450  \\$wnnna$aCessation, Smoking
=450  \\$wnnna$aCessations, Smoking
=450  \\$wnnna$aSmoking Cessations
=550  \\$wg$aTobacco Use Cessation
=550  \\$aBupropion
=550  \\$aTobacco Use Disorder
=667  \\$aTOBACCO USE CESSATION is also available
=680  \\$iDiscontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.
=688  \\$a92
=750  \0$aSmoking cessation$0(DLC) sh 88006409$5IEN-M

=LDR  00690cz  a2200229n  4500
=001  9880364118102441
=005  20141212211620.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016530
=035  \\$aCBM5450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x615
=072  \\$aN2.$x421.$x533.$x635
=150  \\$aOrthopedic Nursing
=450  \\$wnnna$aNursing, Orthopedic
=450  \\$aOrthopedics$xnursing
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe specialty or practice of nursing in the care of the orthopedic patient.
=688  \\$a92
=750  \0$aOrthopedic nursing$5IEN-M$0(DLC)sh 85095809

=LDR  00762cz  a2200241n  4500
=001  9880364118202441
=005  20141212211620.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016529
=035  \\$aCBM5449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x200
=072  \\$aN2.$x421.$x533.$x200
=150  \\$aEmergency Nursing
=450  \\$wnnna$aEmergency Room Nursing
=450  \\$wnnna$aNursing, Emergency
=450  \\$wnnna$aNursing, Emergency Room
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe specialty or practice of nursing in the care of patients admitted to the emergency department.
=688  \\$a92
=750  \0$aEmergency nursing$5IEN$0(DLC)sh 85042756

=LDR  01240cz  a2200349n  4500
=001  9880364118302441
=005  20141212211620.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016528
=035  \\$aCBM5448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x650.$x650
=072  \\$aN2.$x421.$x533.$x710.$x650
=150  \\$aPostanesthesia Nursing
=450  \\$wnnna$aNursing, Post-Anesthesia
=450  \\$wnnna$aNursing, Post Anesthesia
=450  \\$wnnna$aNursing, Post-Surgical
=450  \\$wnnna$aNursing, Post Surgical
=450  \\$wnnna$aNursing, Postanesthesia
=450  \\$wnnna$aNursing, Recovery Room
=450  \\$aPost-Anesthesia Nursing
=450  \\$wnnna$aPost Anesthesia Nursing
=450  \\$aPost-Surgical Nursing
=450  \\$wnnna$aPost Surgical Nursing
=450  \\$aRecovery Room Nursing
=550  \\$wg$aPerioperative Nursing
=550  \\$aAnesthesia Recovery Period
=550  \\$aPerioperative Nursing
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe specialty or practice of nursing in the care of patients in the recovery room following surgery and/or anesthesia.
=688  \\$a93; was POST-ANESTHESIA NURSING 1992
=750  \0$aPost anesthesia nursing$5IEN-M$0(DLC)sh 91000751

=LDR  00993cz  a2200301n  4500
=001  9880364118402441
=005  20141212211618.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016523
=035  \\$aCBM5443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x321.$x250
=072  \\$aC17.$x800.$x893.$x592.$x450
=150  \\$aFoot Ulcer
=450  \\$wnnna$aFoot Ulcers
=450  \\$aPlantar Ulcer
=450  \\$wnnna$aPlantar Ulcers
=450  \\$wnnna$aUlcer, Foot
=450  \\$wnnna$aUlcer, Plantar
=450  \\$wnnna$aUlcers, Foot
=450  \\$wnnna$aUlcers, Plantar
=550  \\$wg$aFoot Diseases
=550  \\$wg$aLeg Ulcer
=550  \\$wh$aDiabetic Foot
=667  \\$aDIABETIC FOOT is also available
=680  \\$iLesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy.
=688  \\$a92
=750  \0$aFoot$xUlcers$5IEN-M$0(DLC)sh 85050395

=LDR  01958cz  a2200385n  4500
=001  9880364118502441
=005  20141212211617.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016521
=035  \\$aCBM5441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x220
=072  \\$aE5.$x301.$x300.$x220
=150  \\$aElectrophoresis, Gel, Pulsed-Field
=450  \\$wnnna$aAlternation-Gel Electrophoresis, Orthogonal-Field
=450  \\$wnnna$aContour-Clamped Homogeneous-Field Gel Electrophoresis
=450  \\$wnnna$aContour Clamped Homogeneous Field Gel Electrophoresis
=450  \\$wnnna$aElectrophoresis, Gel, Pulsed Field
=450  \\$aElectrophoresis, Gel, Pulsed-Field Gradient
=450  \\$wnnna$aElectrophoresis, Orthogonal-Field Alternation-Gel
=450  \\$wnnna$aElectrophoresis, Pulsed Field Gel
=450  \\$wnnna$aElectrophoresis, Pulsed-Field Gel
=450  \\$wnnna$aField Inversion Gel Electrophoresis
=450  \\$aGel Electrophoresis, Pulsed-Field
=450  \\$wnnna$aGel Electrophoresis, Pulsed Field
=450  \\$wnnna$aOrthogonal Field Alternation Gel Electrophoresis
=450  \\$wnnna$aOrthogonal-Field Alternation-Gel Electrophoresis
=450  \\$wnnna$aPulsed-Field Gel Electrophoresis
=450  \\$wnnna$aPulsed Field Gel Electrophoresis
=450  \\$wnnna$aPulsed Field Gradient Gel Electrophoresis
=450  \\$wnnna$aPulsed-Field Gradient Gel Electrophoresis
=550  \\$wg$aElectrophoresis
=680  \\$iGel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.
=688  \\$a92
=750  \0$aPulsed-field gel electrophoresis$5IEN-M$0(DLC)sh 92000993

=LDR  00687cz  a2200205n  4500
=001  9880364118602441
=005  20141212211617.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016520
=035  \\$aCBM5440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x375
=072  \\$aN4.$x452.$x610.$x250
=150  \\$aEntrepreneurship
=550  \\$wg$aCommerce
=550  \\$wg$aOrganizational Innovation
=667  \\$ause qualif discreetly
=680  \\$iThe organization, management, and assumption of risks of a business or enterprise, usually implying an element of change or challenge and a new opportunity.
=688  \\$a92
=750  \0$aEntrepreneurship$5IEN-M$0(DLC)sh 85044149

=LDR  01074cz  a2200337n  4500
=001  9880364118702441
=005  20141212211613.0
=008  910531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016512
=035  \\$aCBM5433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x558.$x100
=150  \\$aAnkle Injuries
=450  \\$aAnkle$xinjuries
=450  \\$wnnna$aAnkle Injury
=450  \\$aAnkle Joint$xinjuries
=450  \\$wnnna$aAnkle Sprain
=450  \\$wnnna$aAnkle Sprains
=450  \\$wnnna$aInjuries, Ankle
=450  \\$wnnna$aInjuries, Syndesmotic
=450  \\$wnnna$aInjury, Ankle
=450  \\$wnnna$aInjury, Syndesmotic
=450  \\$wnnna$aSprain, Ankle
=450  \\$wnnna$aSprains, Ankle
=450  \\$wnnna$aSyndesmotic Injuries
=450  \\$wnnna$aSyndesmotic Injury
=550  \\$wg$aLeg Injuries
=667  \\$aconsider also TARSAL BONES /inj
=680  \\$iHarm or hurt to the ankle or ankle joint usually inflicted by an external source.
=688  \\$a92; was ANKLE/injuries 1966-91
=750  \0$aAnkle$xWounds and injuries$5IEN-M$0(DLC)sh 85005321

=LDR  02301cz  a2200541n  4500
=001  9880364118802441
=005  20141212192704.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016511
=035  \\$aCBM5432M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x815
=072  \\$aC18.$x452.$x284.$x800
=072  \\$aC20.$x673.$x815
=150  \\$aSevere Combined Immunodeficiency
=450  \\$aBare Lymphocyte Syndrome
=450  \\$wnnna$aBare Lymphocyte Syndromes
=450  \\$wnnna$aCombined Immunodeficiencies, Severe
=450  \\$wnnna$aCombined Immunodeficiency, Severe
=450  \\$wnnna$aFamilial Reticuloendothelioses
=450  \\$wnnna$aFamilial Reticuloendotheliosis
=450  \\$wnnna$aImmunodeficiencies, Severe Combined
=450  \\$aImmunodeficiency, Severe Combined
=450  \\$wnnna$aImmunodeficiency Syndrome, Severe Combined
=450  \\$wnnna$aImmunologic Deficiency, Severe Combined
=450  \\$wnnna$aLymphocyte Syndrome, Bare
=450  \\$wnnna$aLymphocyte Syndromes, Bare
=450  \\$aOmenn Syndrome
=450  \\$wnnna$aOmenn's Syndrome
=450  \\$wnnna$aOmenns Syndrome
=450  \\$wnnna$aReticuloendothelioses, Familial
=450  \\$wnnna$aReticuloendotheliosis, Familial
=450  \\$wnnna$aSevere Combined Immune Deficiency
=450  \\$wnnna$aSevere Combined Immunodeficiencies
=450  \\$wnnna$aSevere Combined Immunodeficiency Syndrome
=450  \\$wnnna$aSevere Combined Immunologic Deficiency
=450  \\$wnnna$aSyndrome, Bare Lymphocyte
=450  \\$wnnna$aSyndrome, Omenn
=450  \\$wnnna$aSyndrome, Omenn's
=450  \\$wnnna$aSyndromes, Bare Lymphocyte
=550  \\$wg$aDNA Repair-Deficiency Disorders
=550  \\$wg$aImmunologic Deficiency Syndromes
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wh$aX-Linked Combined Immunodeficiency Diseases
=680  \\$iGroup of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).
=688  \\$a1992
=688  \\$a92
=750  \0$aSevere combined immunodeficiency$0(DLC)sh2006003643$5IEN-M

=LDR  01239cz  a2200325n  4500
=001  9880364118902441
=005  20141212211612.0
=008  910208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016507
=035  \\$aCBM5429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x215
=072  \\$aN4.$x452.$x442.$x422.$x215
=150  \\$aCardiology Service, Hospital
=450  \\$wnnna$aCardiology Hospital Service
=450  \\$wnnna$aCardiology Hospital Services
=450  \\$wnnna$aCardiology Services, Hospital
=450  \\$aHospital Cardiology Service
=450  \\$wnnna$aHospital Cardiology Services
=450  \\$wnnna$aHospital Service, Cardiology
=450  \\$wnnna$aHospital Services, Cardiology
=450  \\$wnnna$aService, Cardiology Hospital
=450  \\$wnnna$aService, Hospital Cardiology
=450  \\$wnnna$aServices, Cardiology Hospital
=450  \\$wnnna$aServices, Hospital Cardiology
=550  \\$wg$aHospital Departments
=667  \\$aDF: CARDIOL SERV HOSP
=680  \\$iThe hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cardiac patient.
=688  \\$a92
=750  \0$aHospitals$xCardiovascular services$5IEN-M$0(DLC)sh 85062303

=LDR  00905cz  a2200253n  4500
=001  9880364119002441
=005  20141212211611.0
=008  910208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016504
=035  \\$aCBM5427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x750.$x100
=072  \\$aF1.$x145.$x488.$x700.$x100
=150  \\$aBreast Self-Examination
=450  \\$wnnna$aBreast Self Examination
=450  \\$wnnna$aBreast Self-Examinations
=450  \\$aSelf-Examination, Breast
=450  \\$wnnna$aSelf Examination, Breast
=450  \\$wnnna$aSelf-Examinations, Breast
=550  \\$wg$aSelf-Examination
=667  \\$acoord IM with no qualif with disease /diag (IM) if discussed; DF: BREAST SELF EXAM
=680  \\$iThe inspection of one's breasts, usually for signs of disease, especially neoplastic disease.
=688  \\$a92
=750  \0$aBreast$xExamination$5IEN-M$0(DLC)sh 85016685

=LDR  01430cz  a2200349n  4500
=001  9880364119102441
=005  20141212211611.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016503
=035  \\$aCBM5426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x300
=150  \\$aDrug Delivery Systems
=450  \\$wnnna$aDelivery System, Drug
=450  \\$wnnna$aDelivery Systems, Drug
=450  \\$wnnna$aDrug Delivery System
=450  \\$aDrug Targeting
=450  \\$wnnna$aDrug Targetings
=450  \\$wnnna$aSystem, Drug Delivery
=450  \\$wnnna$aSystems, Drug Delivery
=450  \\$wnnna$aTargeting, Drug
=450  \\$wnnna$aTargetings, Drug
=550  \\$wg$aDrug Therapy
=550  \\$wh$aDelayed-Action Preparations
=550  \\$wh$aDrug Carriers
=550  \\$wh$aInsulin Infusion Systems
=550  \\$wh$aPharmaceutical Vehicles
=550  \\$aDosage Forms
=667  \\$acoordinate with drug / admin; do not confuse with MEDICATION SYSTEMS, an organizational concept in patient care for providing medication; note entry term DRUG TARGETING: do not confuse with MOLECULAR TARGETED THERAPY
=680  \\$iSystems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
=688  \\$a92
=750  \0$aDrug delivery systems$5IEN-M$0(DLC)sh 88007108

=LDR  00994cz  a2200265n  4500
=001  9880364119202441
=005  20141212211610.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016500
=035  \\$aCBM5424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x888.$x249
=072  \\$aE2.$x774.$x215
=072  \\$aF4.$x754.$x215
=150  \\$aColor Therapy
=450  \\$wnnna$aChromatotherapy
=450  \\$aChromotherapy
=450  \\$wnnna$aTherapy, Color
=550  \\$wg$aPhototherapy
=550  \\$wg$aPsychotherapy
=550  \\$wg$aSensory Art Therapies
=667  \\$atreatment of dis with color; coord IM with disease /ther (IM)
=680  \\$iA form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.
=688  \\$a92
=750  \0$aColor$xTherapeutic use$5IEN-M$0(DLC)sh 85028582

=LDR  01424cz  a2200277n  4500
=001  9880364119302441
=005  20141212211610.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016499
=035  \\$aCBM5423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465.$x425.$x750
=072  \\$aE2.$x186.$x750
=072  \\$aE2.$x815.$x520
=150  \\$aRadioimmunotherapy
=450  \\$wnnna$aImmunoradiotherapies
=450  \\$wnnna$aImmunoradiotherapy
=450  \\$wnnna$aRadioimmunotherapies
=550  \\$wg$aCombined Modality Therapy
=550  \\$wg$aImmunotherapy
=550  \\$wg$aRadiotherapy
=550  \\$aAntibodies, Bispecific
=667  \\$aradiother by cytotoxic radioisotopes linked to antibodies: read MeSH definition; do not use /util except by MeSH definition; coord IM with disease /radiother (IM)
=680  \\$iRadiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
=688  \\$a92
=750  \0$aRadioimmunotherapy$5IEN-M$0(DLC)sh 87004418

=LDR  00851cz  a2200241n  4500
=001  9880364119402441
=005  20141212211610.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016497
=035  \\$aCBM5422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x44
=150  \\$aAdolescent Health Services
=450  \\$wnnna$aAdolescent Health Service
=450  \\$wnnna$aHealth Service, Adolescent
=450  \\$aHealth Services, Adolescent
=450  \\$wnnna$aService, Adolescent Health
=450  \\$wnnna$aServices, Adolescent Health
=550  \\$wg$aHealth Services
=667  \\$acheck also tags HUMANS & ADOLESCENCE; DF: ADOLESCENT HEALTH SERV
=680  \\$iOrganized services to provide health care to adolescents, ages ranging from 13 through 18 years.
=688  \\$a92
=750  \0$aTeenagers$xMedical care$5IEN-M$0(DLC)sh 88005813

=LDR  01905cz  a2200469n  4500
=001  9880364119602441
=005  20170103141135.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016494
=035  \\$aCBM5419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x209
=072  \\$aN4.$x452.$x910.$x200
=150  \\$aComputer Security
=450  \\$wnnna$aCompromising of Data
=450  \\$wnnna$aComputer Hacker
=450  \\$wnnna$aComputer Hackers
=450  \\$wnnna$aComputer Virus
=450  \\$aComputer Viruses
=450  \\$wnnna$aComputer Worm
=450  \\$wnnna$aComputer Worms
=450  \\$wnnna$aData Compromising
=450  \\$aData Protection
=450  \\$aData Security
=450  \\$wnnna$aHacker, Computer
=450  \\$wnnna$aHackers, Computer
=450  \\$wnnna$aInformation Protection
=450  \\$wnnna$aProtection, Data
=450  \\$wnnna$aProtection, Information
=450  \\$wnnna$aSecurity, Computer
=450  \\$wnnna$aSecurity, Data
=450  \\$wnnna$aVirus, Computer
=450  \\$wnnna$aViruses, Computer
=450  \\$wnnna$aWorm, Computer
=450  \\$wnnna$aWorms, Computer
=550  \\$wg$aInformation Science
=550  \\$wg$aSecurity Measures
=550  \\$wh$aData Anonymization
=667  \\$aagainst unauthorized access to computers & databases: read MeSH definition & note X refs; do not use for confidentiality of records ( = CONFIDENTIALITY + RECORDS AS TOPIC or specific records term)
=680  \\$iProtective measures against unauthorized access to or interference with computer operating systems, telecommunications, or data structures, especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or so-called computer hackers aiming to compromise stored data.
=688  \\$a92
=750  \0$aComputer security$5IEN-M$0(DLC)sh 90001862

=LDR  01428cz  a2200373n  4500
=001  9880364119702441
=005  20141212211608.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016491
=035  \\$aCBM5418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x617
=150  \\$aPeripheral Vascular Diseases
=450  \\$wnnna$aAngiopathies, Peripheral
=450  \\$wnnna$aAngiopathy, Peripheral
=450  \\$wnnna$aDisease, Peripheral Vascular
=450  \\$wnnna$aDiseases, Peripheral Vascular
=450  \\$aPeripheral Angiopathies
=450  \\$wnnna$aPeripheral Angiopathy
=450  \\$wnnna$aPeripheral Vascular Disease
=450  \\$wnnna$aVascular Disease, Peripheral
=450  \\$aVascular Diseases, Peripheral
=550  \\$wg$aVascular Diseases
=550  \\$wh$aBlue Toe Syndrome
=550  \\$wh$aErythromelalgia
=550  \\$wh$aLivedo Reticularis
=550  \\$wh$aMay-Thurner Syndrome
=550  \\$wh$aPeripheral Arterial Disease
=550  \\$wh$aPhlebitis
=550  \\$wh$aRaynaud Disease
=667  \\$acoordinate IM with specific blood vessel (IM) and specific disease (IM) if pertinent; note PERIPHERAL ARTERIAL DISEASE is also available; inflammatory disease = probably VASCULITIS
=680  \\$iPathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
=688  \\$a92
=750  \0$aPeripheral vascular diseases$5IEN-M$0(DLC)sh 85099933

=LDR  01647cz  a2200373n  4500
=001  9880364119802441
=005  20141212211607.0
=008  910703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016488
=035  \\$aCBM5415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x505
=072  \\$aE2.$x190.$x901.$x433
=072  \\$aI1.$x76.$x201.$x450.$x654.$x505
=150  \\$aMedicine, African Traditional
=450  \\$wnnna$aAfrican Medicine
=450  \\$aAfrican Medicine, Traditional
=450  \\$wnnna$aAfrican Traditional Medicine
=450  \\$aAfrican Witch Doctor
=450  \\$wnnna$aAfrican Witch Doctors
=450  \\$wnnna$aDoctor, African Witch
=450  \\$wnnna$aDoctors, African Witch
=450  \\$wnnna$aMedicine, African
=450  \\$wnnna$aMedicine, Traditional African
=450  \\$wnnna$aTraditional African Medicine
=450  \\$aTraditional Medicine, African
=450  \\$aWitch Doctor, African
=450  \\$wnnna$aWitch Doctors, African
=550  \\$wg$aMedicine, Traditional
=550  \\$wg$aSpiritual Therapies
=667  \\$aIM; not medicine in Africa ( = MEDICINE + AFRICA); apply policy of Manual 32.13 to this term; apply TN J/29-36 on Chinese plants to indexing of African plants where applicable; specify geog; DF: MED AFRICAN TRADITIONAL
=680  \\$iA system of traditional medicine which is based on the beliefs and practices of the African peoples. It includes treatment by medicinal plants and other materia medica as well as by the ministrations of diviners, medicine men, witch doctors, and sorcerers.
=688  \\$a92
=750  \0$aTraditional medicine$zAfrica$5IEN$0(DLC)sh2010116794

=LDR  01076cz  a2200193n  4500
=001  9880364119902441
=005  20141212211606.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016487
=035  \\$aCBM5414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x310
=150  \\$aParenting
=550  \\$wg$aFamily Relations
=550  \\$aChild Rearing
=667  \\$aparenting education: coordinate IM with EDUCATION, NONPROFESSIONAL (IM)
=680  \\$iPerforming the role of a parent by care-giving, nurturance, and protection of the child by a natural or substitute parent. The parent supports the child by exercising authority and through consistent, empathic, appropriate behavior in response to the child's needs. PARENTING differs from CHILD REARING in that in child rearing the emphasis is on the act of training or bringing up the children and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.
=688  \\$a92
=750  \0$aParenting$5IEN-M$0(DLC)sh 85098009

=LDR  00832cz  a2200253n  4500
=001  9880364120002441
=005  20141212211606.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016485
=035  \\$aCBM5413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x580
=150  \\$aNeedle Sharing
=450  \\$wnnna$aNeedle-Sharing
=450  \\$wnnna$aNeedlesharing
=450  \\$wnnna$aSharing, Needle
=450  \\$wnnna$aSharing, Syringe
=450  \\$aSyringe Sharing
=550  \\$wg$aSocial Problems
=550  \\$aSubstance Abuse, Intravenous
=667  \\$aby intravenous drug users
=680  \\$iUsage of a single needle among two or more people for injecting drugs. Needle sharing is a high-risk behavior for contracting infectious disease.
=688  \\$a92
=750  \0$aNeedle sharing$5IEN$0(DLC)sh 92006704

=LDR  02517cz  a2200541n  4500
=001  9880364120102441
=005  20141212211602.0
=008  910621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016472
=035  \\$aCBM5405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x574.$x562
=072  \\$aC10.$x668.$x467
=150  \\$aMotor Neuron Disease
=450  \\$aAnterior Horn Cell Disease
=450  \\$aFamilial Motor Neuron Disease
=450  \\$wnnna$aLateral Scleroses
=450  \\$wnnna$aLateral Scleroses, Primary
=450  \\$aLateral Sclerosis
=450  \\$wnnna$aLateral Sclerosis, Primary
=450  \\$wnnna$aLower Motor Neuron Disease
=450  \\$wnnna$aMotor Neuron Disease, Familial
=450  \\$aMotor Neuron Disease, Lower
=450  \\$wnnna$aMotor Neuron Disease, Secondary
=450  \\$aMotor Neuron Disease, Upper
=450  \\$wnnna$aMotor Neuron Diseases
=450  \\$wnnna$aMotor System Disease
=450  \\$wnnna$aMotor System Diseases
=450  \\$wnnna$aNeuron Disease, Motor
=450  \\$wnnna$aNeuron Diseases, Motor
=450  \\$wnnna$aPrimary Lateral Scleroses
=450  \\$wnnna$aPrimary Lateral Sclerosis
=450  \\$wnnna$aScleroses, Lateral
=450  \\$wnnna$aScleroses, Primary Lateral
=450  \\$wnnna$aSclerosis, Lateral
=450  \\$wnnna$aSclerosis, Primary Lateral
=450  \\$wnnna$aSecondary Motor Neuron Disease
=450  \\$wnnna$aUpper Motor Neuron Disease
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wh$aAmyotrophic Lateral Sclerosis
=550  \\$wh$aBulbar Palsy, Progressive
=550  \\$wh$aMuscular Atrophy, Spinal
=550  \\$aMotor Neurons
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iDiseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)
=688  \\$a92
=750  \0$aMotor neurons$xDiseases$5IEN-M$0(DLC)sh 91000013

=LDR  01134cz  a2200253n  4500
=001  9880364120202441
=005  20141212211601.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016470
=035  \\$aCBM5403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x100
=072  \\$aC1.$x539.$x757.$x100
=072  \\$aC23.$x550.$x470.$x790.$x500.$x100
=150  \\$aBacteremia
=450  \\$wnnna$aBacteremias
=550  \\$wg$aBacterial Infections
=550  \\$wg$aSepsis
=550  \\$wh$aEndotoxemia
=550  \\$wh$aHemorrhagic Septicemia
=667  \\$acoord with specific bact/infect heading or specific bacterium if specific bact infect is not in MeSH (do not use /blood to indicate -emia)
=680  \\$iThe presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
=688  \\$a92; was see SEPTICEMIA 1975-91
=750  \0$aBacteremia$5IEN-M$0(DLC)sh 85010812

=LDR  00555cz  a2200193n  4500
=001  9880364120302441
=005  20141212211601.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016468
=035  \\$aCBM5401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x430
=150  \\$aForestry
=550  \\$wg$aIndustry
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe science of developing, caring for, or cultivating forests.
=688  \\$a92
=750  \0$aForesters$5IEN-M$0(DLC)sh 85050686
=750  \0$aForests and forestry$5IEN-HS$0(DLC)sh 85050707

=LDR  01127cz  a2200241n  4500
=001  9880364120402441
=005  20141212211600.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016465
=035  \\$aCBM5399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x120.$x142
=150  \\$aBone Marrow Purging
=450  \\$aHematopoietic Stem Cell Purging
=450  \\$wnnna$aPurging, Bone Marrow
=550  \\$wg$aBlood Component Removal
=550  \\$aBone Marrow Transplantation
=550  \\$aHematopoietic Stem Cell Transplantation
=550  \\$aImmunomagnetic Separation
=667  \\$acoord IM with purging agent or method (IM with no qualif)
=680  \\$iTechniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.
=688  \\$a92
=750  \0$aBone marrow purging$5IEN$0(DLC)sh 92002451

=LDR  01507cz  a2200385n  4500
=001  9880364120502441
=005  20141212211559.0
=008  910102\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016464
=035  \\$aCBM5398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x595
=072  \\$aC18.$x452.$x648.$x595
=150  \\$aLysosomal Storage Diseases
=450  \\$wnnna$aDisease, Lysosomal Storage
=450  \\$wnnna$aDiseases, Lysosomal Storage
=450  \\$wnnna$aDisorder, Lysosomal Enzyme
=450  \\$wnnna$aDisorders, Lysosomal Enzyme
=450  \\$wnnna$aEnzyme Disorder, Lysosomal
=450  \\$wnnna$aEnzyme Disorders, Lysosomal
=450  \\$wnnna$aLysosomal Enzyme Disorder
=450  \\$aLysosomal Enzyme Disorders
=450  \\$wnnna$aLysosomal Storage Disease
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aAspartylglucosaminuria
=550  \\$wh$aCholesterol Ester Storage Disease
=550  \\$wh$aCystinosis
=550  \\$wh$aLysosomal Storage Diseases, Nervous System
=550  \\$wh$aMannosidase Deficiency Diseases
=550  \\$wh$aMucopolysaccharidoses
=550  \\$wh$aPycnodysostosis
=667  \\$aan inborn error of metab; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iInborn errors of metabolism characterized by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolized substrates.
=688  \\$a92
=750  \0$aLysosomal storage diseases$0(DLC) sh 85079196$5IEN

=LDR  01048cz  a2200313n  4500
=001  9880364120602441
=005  20141212211558.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016462
=035  \\$aCBM5396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x565
=072  \\$aE4.$x680.$x500
=150  \\$aMammaplasty
=450  \\$aBreast Reconstruction
=450  \\$wnnna$aBreast Reconstructions
=450  \\$wnnna$aMammaplasties
=450  \\$wnnna$aMammoplasties
=450  \\$wnnna$aMammoplasty
=450  \\$wnnna$aReconstruction, Breast
=450  \\$wnnna$aReconstructions, Breast
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wh$aBreast Implantation
=550  \\$aBreast
=667  \\$aincludes augmentation & reduction; do not use /util except by MeSH definition; BREAST IMPLANTS is also available
=680  \\$iSurgical reconstruction of the breast including both augmentation and reduction.
=688  \\$a92
=750  \0$aMammaplasty$5IEN-M$0(DLC)sh 85080274

=LDR  01306cz  a2200277n  4500
=001  9880364120702441
=005  20141212211557.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016459
=035  \\$aCBM5393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x685
=072  \\$aC23.$x550.$x767.$x868
=150  \\$aProsthesis-Related Infections
=450  \\$wnnna$aInfections, Prosthesis-Related
=450  \\$wnnna$aProsthesis-Related Infection
=450  \\$wnnna$aProsthesis Related Infections
=550  \\$wg$aInfection
=550  \\$wg$aPostoperative Complications
=550  \\$aBiofilms
=667  \\$acoord IM with specific infect (IM) + specific prosthesis /adv eff (IM), as EYE, ARTIFICIAL /adv eff; infect by biofilm: coord IM with BIOFILMS (IM) but see note there; DF: PROSTHESIS RELAT INFECT
=680  \\$iInfections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination (early) or hematogenously acquired from other sites (late).
=688  \\$a92
=750  \0$81$wb$aInfection$5IEN-M$0(DLC)sh 85066076
=750  \0$81$wb$aProsthesis$xComplications$5IEN-M$0(DLC)sh 85107616
=788  \0$iSearch also under the following headings used together in the same record:$aProsthesis--Complications$iand$aInfection$5IEN-M

=LDR  01015cz  a2200289n  4500
=001  9880364120802441
=005  20141212211539.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016382
=035  \\$aCBM5392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x320.$x274
=072  \\$aE6.$x658.$x450
=072  \\$aE6.$x912.$x675
=150  \\$aOrthodontic Appliance Design
=450  \\$wnnna$aAppliance Design, Orthodontic
=450  \\$wnnna$aAppliance Designs, Orthodontic
=450  \\$wnnna$aDesign, Orthodontic Appliance
=450  \\$wnnna$aDesigns, Orthodontic Appliance
=450  \\$wnnna$aOrthodontic Appliance Designs
=550  \\$wg$aEquipment Design
=550  \\$wg$aOrthodontics
=550  \\$wg$aTechnology, Dental
=667  \\$acoordinate with specific appliance
=680  \\$iThe planning, calculation, and creation of an apparatus for the purpose of correcting the placement or straightening of teeth.
=688  \\$a92
=750  \0$aOrthodontic appliances$xDesign and construction$5IEN-M

=LDR  00335cz  a2200121n  4500
=001  9880364120902441
=005  20120717143504.0
=008  771128\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBM2730HS
=035  \\$a(DNLM)D005440Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aFluid Therapy$xveterinary
=750  \0$aVeterinary fluid therapy$5IEN-M$0(DLC)sh 91004923

=LDR  00329cz  a2200121n  4500
=001  9880364121002441
=005  20120717143503.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBM2729HS
=035  \\$a(DNLM)D004210Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDissection$xveterinary
=750  \0$aVeterinary dissection$5IEN-M$0(DLC)sh 85143018

=LDR  00317cz  a2200121n  4500
=001  9880364121102441
=005  20120717143503.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBM2643HS
=035  \\$a(DNLM)D010146Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aPain$xveterinary
=750  \0$aPain in animals$5IEN-M$0(DLC)sh 91004130

=LDR  00321cz  a2200121n  4500
=001  9880364121202441
=005  20120717143503.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBM2625HS
=035  \\$a(DNLM)D008099Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aLiver$xdrug effects
=750  \0$aHepatotoxicology$5IEN-M$0(DLC)sh 91002831

=LDR  01372cz  a2200301n  4500
=001  9880364121302441
=005  20141212211510.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016298
=035  \\$aCBK1716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410
=072  \\$aD12.$x776.$x467.$x374.$x410
=072  \\$aD23.$x529.$x374.$x410
=150  \\$aHematopoietic Cell Growth Factors
=450  \\$wnnna$aHematopoietic Cell Growth Factor
=450  \\$wnnna$aHematopoietic-CGF
=450  \\$wnnna$aHematopoietic CGF
=450  \\$wnnna$aHematopoietic Stem Cell-Activating Factors
=450  \\$wnnna$aHematopoietic Stem Cell Stimulators
=450  \\$aHematopoietins
=550  \\$wg$aCytokines
=550  \\$wh$aColony-Stimulating Factors
=550  \\$wh$aStem Cell Factor
=667  \\$aDF: HCGF
=680  \\$iThese growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
=688  \\$a91
=750  \0$aHematopoietic growth factors$5IEN$0(DLC)sh 89007108

=LDR  00371cz  a2200133n  4500
=001  9880364121402441
=005  20120717143503.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBJ9526HS
=035  \\$a(DNLM)D002802Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aCholinesterases$xgenetics
=450  \0$aCholinesterase Genes$5IEN
=750  \0$aCholinesterase genes$5IEN$0(DLC)sh 90000852

=LDR  00325cz  a2200121n  4500
=001  9880364121602441
=005  20120717143503.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBH6636HS
=035  \\$a(DNLM)D001168Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aArthritis$xveterinary
=750  \0$aArthritis in animals$5IEN$0(DLC)sh 98000091

=LDR  01227cz  a2200217n  4500
=001  9880364121702441
=005  20141212211605.0
=008  900803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016481
=035  \\$aCBG6743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x466
=150  \\$aHelicobacter Infections
=450  \\$wnnna$aHelicobacter Infection
=450  \\$wnnna$aInfection, Helicobacter
=450  \\$wnnna$aInfections, Helicobacter
=550  \\$wg$aGram-Negative Bacterial Infections
=667  \\$agram-neg bact infect; check text for genus & species: Campylobacter pylori = HELICOBACTER PYLORI; Campylobacter pylori infect = HELICOBACTER INFECTIONS (IM) + HELICOBACTER PYLORI (IM) but Campylobacter jejuni infect = CAMPYLOBACTER INFECTIONS (IM) + CAMPYLOBACTER JEJUNI (IM); DF: HELICOBACTER INFECT
=680  \\$iInfections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
=688  \\$a91
=750  \0$aHelicobacter infections$5IEN$0(DLC)sh 90002593

=LDR  01179cz  a2200205n  4500
=001  9880364121802441
=005  20141212211604.0
=008  900803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016480
=035  \\$aCBG6742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x500.$x550
=072  \\$aB3.$x660.$x150.$x280.$x550
=150  \\$aHelicobacter pylori
=450  \\$aCampylobacter pylori
=550  \\$wg$aHelicobacter
=667  \\$ainfection: coord IM with HELICOBACTER INFECTIONS (IM)
=680  \\$iA spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).
=688  \\$a91
=750  \0$aHelicobacter pylori$0(DLC) sh 88002440$5IEN

=LDR  01348cz  a2200289n  4500
=001  9880364121902441
=005  20141212211546.0
=008  900601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016415
=035  \\$aCBG6741M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x751
=150  \\$aSequence Alignment
=450  \\$wnnna$aAlignment, Sequence
=450  \\$wnnna$aAlignments, Sequence
=450  \\$wnnna$aDetermination, Sequence Homology
=450  \\$wnnna$aDeterminations, Sequence Homology
=450  \\$wnnna$aSequence Alignments
=450  \\$aSequence Homology Determination
=450  \\$wnnna$aSequence Homology Determinations
=550  \\$wg$aGenetic Techniques
=550  \\$aMolecular Sequence Data
=550  \\$aSequence Homology, Nucleic Acid
=667  \\$aDF: SEQ ALIGNMENT
=680  \\$iThe arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
=688  \\$a91
=750  \0$aSequence alignment (Bioinformatics)$0(DLC)sh2008009623$5IEN-M

=LDR  01927cz  a2200529n  4500
=001  9880364122002441
=005  20141212211546.0
=008  900601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016414
=035  \\$aCBG6740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x647.$x740
=072  \\$aE2.$x760.$x905.$x700
=072  \\$aI1.$x880.$x604.$x583.$x789
=072  \\$aN2.$x421.$x585.$x905.$x700
=072  \\$aN3.$x706.$x535.$x704
=150  \\$aResuscitation Orders
=450  \\$wnnna$aDecision, Resuscitation
=450  \\$wnnna$aDecisions, Resuscitation
=450  \\$wnnna$aDo-Not-Resuscitate Order
=450  \\$aDo-Not-Resuscitate Orders
=450  \\$wnnna$aDo Not Resuscitate Orders
=450  \\$wnnna$aOrder, Do-Not-Resuscitate
=450  \\$wnnna$aOrder, Resuscitation
=450  \\$wnnna$aOrders, Do-Not-Resuscitate
=450  \\$wnnna$aOrders, Resuscitation
=450  \\$wnnna$aPolicies, Resuscitation
=450  \\$wnnna$aPolicy, Resuscitation
=450  \\$wnnna$aResuscitation Decision
=450  \\$aResuscitation Decisions
=450  \\$wnnna$aResuscitation Order
=450  \\$wnnna$aResuscitation Policies
=450  \\$wnnna$aResuscitation Policy
=450  \\$wnnna$aWithholding Resuscitation
=550  \\$wg$aJurisprudence
=550  \\$wg$aResuscitation
=550  \\$wg$aTerminal Care
=550  \\$aAdvance Directive Adherence
=550  \\$aAdvance Directives
=550  \\$aEuthanasia, Passive
=550  \\$aLife Support Care
=550  \\$aMedical Futility
=550  \\$aWithholding Treatment
=667  \\$aDF: DNR ORDERS
=680  \\$iInstructions issued by a physician pertaining to the institution, continuation, or withdrawal of life support measures. The concept includes policies, laws, statutes, decisions, guidelines, and discussions that may affect the issuance of such orders.
=688  \\$a91
=750  \0$aDo-not-resuscitate orders$5IEN$0(DLC)sh 90003925

=LDR  01175cz  a2200325n  4500
=001  9880364122102441
=005  20141212211543.0
=008  900601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016399
=035  \\$aCBG6726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386.$x480.$x750
=072  \\$aC15.$x604.$x515.$x569.$x480.$x750
=072  \\$aC20.$x683.$x515.$x761.$x480.$x750
=150  \\$aLymphoma, T-Cell
=450  \\$wnnna$aLymphoma, T Cell
=450  \\$wnnna$aLymphomas, T-Cell
=450  \\$aT-Cell Lymphoma
=450  \\$wnnna$aT Cell Lymphoma
=450  \\$wnnna$aT-Cell Lymphomas
=550  \\$wg$aLymphoma, Non-Hodgkin
=550  \\$wh$aEnteropathy-Associated T-Cell Lymphoma
=550  \\$wh$aLymphoma, Extranodal NK-T-Cell
=550  \\$wh$aLymphoma, Large-Cell, Anaplastic
=550  \\$wh$aLymphoma, T-Cell, Cutaneous
=550  \\$wh$aLymphoma, T-Cell, Peripheral
=667  \\$aa non-Hodgkin's lymphoma; LYMPHOMA, T-CELL, CUTANEOUS & LYMPHOMA, T-CELL, PERIPHERAL are also available
=680  \\$iA group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
=688  \\$a91
=750  \0$aT cells$xTumors$5IEN

=LDR  01220cz  a2200337n  4500
=001  9880364122202441
=005  20141212211543.0
=008  900601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016393
=035  \\$aCBG6720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386.$x480.$x150
=072  \\$aC15.$x604.$x515.$x569.$x480.$x150
=072  \\$aC20.$x683.$x515.$x761.$x480.$x150
=150  \\$aLymphoma, B-Cell
=450  \\$aB-Cell Lymphoma
=450  \\$wnnna$aB Cell Lymphoma
=450  \\$wnnna$aB-Cell Lymphomas
=450  \\$wnnna$aLymphoma, B Cell
=450  \\$wnnna$aLymphomas, B-Cell
=550  \\$wg$aLymphoma, Non-Hodgkin
=550  \\$wh$aBurkitt Lymphoma
=550  \\$wh$aLymphoma, AIDS-Related
=550  \\$wh$aLymphoma, B-Cell, Marginal Zone
=550  \\$wh$aLymphoma, Large B-Cell, Diffuse
=550  \\$wh$aLymphoma, Primary Effusion
=550  \\$wh$aLymphomatoid Granulomatosis
=667  \\$aa non-Hodgkin's lymphoma; LYMPHOMA, T-CELL is also available
=680  \\$iA group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
=688  \\$a91
=750  \0$aB cells$xTumors$5IEN$0(DLC)sh 90004484

=LDR  01221cz  a2200301n  4500
=001  9880364122302441
=005  20141212211541.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016389
=035  \\$aCBG6716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x390
=072  \\$aN2.$x421.$x533.$x460
=150  \\$aMaternal-Child Nursing
=450  \\$wnnna$aMaternal Child Nursing
=450  \\$aMaternity Nursing
=450  \\$aNursing, Maternal-Child
=450  \\$wnnna$aNursing, Maternal Child
=450  \\$wnnna$aNursing, Maternity
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=550  \\$wh$aNeonatal Nursing
=550  \\$aPediatric Nursing
=550  \\$aPerinatology
=667  \\$aSPEC: SPEC qualif; nurs of pregnant women & their newborn infants: do not confuse with PEDIATRIC NURSING, nurs of only infants & children; NEONATAL NURSING & OBSTETRIC NURSING are available; check also tags PREGNANCY & INFANT, NEWBORN; DF: MATERNAL CHILD NURS
=680  \\$iThe nursing specialty that deals with the care of women throughout their pregnancy and childbirth and the care of their newborn children.
=688  \\$a91
=750  \0$aMaternity nursing$5IEN$0(DLC)sh 85093760

=LDR  00699cz  a2200241n  4500
=001  9880364122402441
=005  20161116115129.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016387
=035  \\$aCBG6714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x900
=150  \\$aWomen's Health
=450  \\$wnnna$aHealth, Woman's
=450  \\$wnnna$aHealth, Women's
=450  \\$wnnna$aWoman's Health
=450  \\$wnnna$aWomen Health
=450  \\$wnnna$aWomens Health
=550  \\$wg$aHealth
=550  \\$wh$aMaternal Health
=680  \\$iThe concept covering the physical and mental conditions of women.
=688  \\$a91
=750  \0$aWomen$xHealth and hygiene$0(DLC) sh 85147301$5IEN

=LDR  00793cz  a2200217n  4500
=001  9880364122502441
=005  20141212211540.0
=008  900529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016385
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x689.$x675.$x850
=072  \\$aG5.$x360.$x80.$x689.$x675.$x850
=072  \\$aG5.$x360.$x340.$x24.$x340.$x137.$x750.$x680.$x850
=150  \\$aTATA Box
=450  \\$wnnna$aBox, Hogness
=450  \\$wnnna$aBox, TATA
=450  \\$aHogness Box
=550  \\$wg$aPromoter Regions, Genetic
=680  \\$iA conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA.
=688  \\$a91
=750  \0$aTATA Box$0(DLC)sh2007010065$5IEN-M

=LDR  01584cz  a2200349n  4500
=001  9880364122602441
=005  20141212211538.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016380
=035  \\$aCBG6709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x90
=072  \\$aE4.$x936.$x580.$x90
=150  \\$aBrain Tissue Transplantation
=450  \\$wnnna$aBrain Tissue Grafting
=450  \\$wnnna$aBrain Tissue Graftings
=450  \\$wnnna$aBrain Tissue Transplantations
=450  \\$aBrain$xtransplantation
=450  \\$aGrafting, Brain Tissue
=450  \\$wnnna$aGraftings, Brain Tissue
=450  \\$wnnna$aTissue Grafting, Brain
=450  \\$wnnna$aTissue Graftings, Brain
=450  \\$wnnna$aTissue Transplantation, Brain
=450  \\$wnnna$aTissue Transplantations, Brain
=450  \\$aTransplantation, Brain Tissue
=450  \\$wnnna$aTransplantations, Brain Tissue
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wg$aTissue Transplantation
=667  \\$acoordinate IM with specific tissue / transpl (IM or NIM); do not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; transplantation of fetal or embryonic brain tissue: coordinate IM with FETAL TISSUE TRANSPLANTATION (IM) + specific tissue / transpl + / embryol if pertinent (IM or NIM)
=680  \\$iTransference of brain tissue, either from a fetus or from a born individual, between individuals of the same species or between individuals of different species.
=688  \\$a91; was BRAIN/transplantation 1966-90
=750  \0$aBrain$xTransplantation$5IEN

=LDR  01137cz  a2200277n  4500
=001  9880364122702441
=005  20141212211535.0
=008  900525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016373
=035  \\$aCBG6703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x150.$x200
=072  \\$aD13.$x444.$x308.$x150
=072  \\$aD13.$x444.$x600.$x150.$x200
=072  \\$aD27.$x720.$x470.$x530.$x600.$x150.$x200
=150  \\$aDNA, Antisense
=450  \\$wnnna$aAnti-Sense DNA
=450  \\$wnnna$aAnti Sense DNA
=450  \\$aAntisense DNA
=450  \\$wnnna$aDNA, Anti-Sense
=550  \\$wg$aAntisense Elements (Genetics)
=550  \\$wg$aDNA
=550  \\$wh$aOligodeoxyribonucleotides, Antisense
=680  \\$iDNA that is complementary to the sense strand. (The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.) Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.
=688  \\$a91
=750  \0$aAntisense DNA$5IEN$0(DLC)sh 89003558

=LDR  00323cz  a2200121n  4500
=001  9880364122802441
=005  20120717143443.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4315HS
=035  \\$a(DNLM)D005131Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aEye Injuries$xnursing
=750  \0$aOphthalmic nursing$5IEN$0(DLC)sh 85095066

=LDR  00332cz  a2200121n  4500
=001  9880364122902441
=005  20120717143442.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4312HS
=035  \\$a(DNLM)D005128Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEye Diseases$xveterinary
=750  \0$aVeterinary ophthalmology$5IEN$0(DLC)sh 85143062

=LDR  00337cz  a2200121n  4500
=001  9880364123002441
=005  20120717143442.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4311HS
=035  \\$a(DNLM)D005128Q000628
=040  \\$aDNLM$cDNLM
=150  \\$aEye Diseases$xtherapy
=750  \0$aTherapeutics, Ophthalmological$5IEN-M$0(DLC)sh 85134728

=LDR  00323cz  a2200121n  4500
=001  9880364123102441
=005  20120717143442.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4308HS
=035  \\$a(DNLM)D005128Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aEye Diseases$xnursing
=750  \0$aOphthalmic nursing$5IEN$0(DLC)sh 85095066

=LDR  00329cz  a2200121n  4500
=001  9880364123202441
=005  20120717143442.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4305HS
=035  \\$a(DNLM)D005128Q000188
=040  \\$aDNLM$cDNLM
=150  \\$aEye Diseases$xdrug therapy
=750  \0$aOcular pharmacology$5IEN$0(DLC)sh 85094053

=LDR  00355cz  a2200133n  4500
=001  9880364123302441
=005  20120717143442.0
=008  720101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD4304HS
=035  \\$a(DNLM)D002477Q000378
=040  \\$aDNLM$cDNLM
=150  \\$aCells$xmetabolism
=450  \\$aCell Metabolism$5IEN-M
=750  \0$aCell metabolism$5IEN$0(DLC)sh 85021656

=LDR  00320cz  a2200121n  4500
=001  9880364123402441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4303HS
=035  \\$a(DNLM)D005123Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aEye$xdrug effects
=750  \0$aOcular pharmacology$5IEN$0(DLC)sh 85094053

=LDR  00325cz  a2200121n  4500
=001  9880364123502441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4204HS
=035  \\$a(DNLM)D004724Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEndoscopy$xveterinary
=750  \0$aVeterinary endoscopy$5IEN$0(DLC)sh 89005962

=LDR  00453cz  a2200145n  4500
=001  9880364123602441
=005  20050202125117.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$a(DNLM)D004700Q000662
=035  \\$aCBD4194HS
=040  \\$aDNLM$cDNLM
=150  \\$aEndocrine System Diseases$xveterinary
=450  \\$wnnoa$aEndocrine Diseases$xveterinary$5IEN-HS
=450  \\$aVeterinary Endocrinology$5IEN
=750  \0$aVeterinary endocrinology$0(DLC) sh 85143027$5IEN

=LDR  00315cz  a2200121n  4500
=001  9880364123702441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4187HS
=035  \\$a(DNLM)D002245Q000652
=040  \\$aDNLM$cDNLM
=150  \\$aCarbon Dioxide$xurine
=750  \0$aCarbonuria$5IEN$0(DLC)sh 85020142

=LDR  00329cz  a2200121n  4500
=001  9880364123802441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4148HS
=035  \\$a(DNLM)D004630Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEmergencies$xveterinary
=750  \0$aVeterinary emergencies$5IEN$0(DLC)sh 85143026

=LDR  00364cz  a2200133n  4500
=001  9880364123902441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD4146HS
=035  \\$a(DNLM)D004630Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aEmergencies$xnursing
=550  \\$aEmergency Nursing$5IEN-M
=750  \0$aEmergency nursing$5IEN-M$0(DLC)sh 85042756

=LDR  00334cz  a2200121n  4500
=001  9880364124002441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4118HS
=035  \\$a(DNLM)D004581Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aElectronics$xinstrumentation
=750  \0$aElectronic instruments$5IEN$0(DLC)sh 85042343

=LDR  00332cz  a2200121n  4500
=001  9880364124102441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4111HS
=035  \\$a(DNLM)D004573Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aElectrolytes$xtherapeutic use
=750  \0$aElectrolyte therapy$5IEN$0(DLC)sh 85042156

=LDR  00351cz  a2200121n  4500
=001  9880364124202441
=005  20120717143442.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4109HS
=035  \\$a(DNLM)D004569Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aElectroencephalography$xveterinary
=750  \0$aVeterinary electroencephalography$5IEN$0(DLC)sh 85143024

=LDR  00345cz  a2200121n  4500
=001  9880364124302441
=005  20120717143441.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4102HS
=035  \\$a(DNLM)D004562Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aElectrocardiography$xveterinary
=750  \0$aVeterinary electrocardiography$5IEN$0(DLC)sh 85143023

=LDR  00327cz  a2200121n  4500
=001  9880364124402441
=005  20120717143441.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4031HS
=035  \\$a(DNLM)D004298Q000502
=040  \\$aDNLM$cDNLM
=150  \\$aDopamine$xphysiology
=750  \0$aDopaminergic mechanisms$5IEN$0(DLC)sh 88004890

=LDR  00345cz  a2200133n  4500
=001  9880364124502441
=005  20120717143441.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3992HS
=035  \\$a(DNLM)D004194Q000145
=040  \\$aDNLM$cDNLM
=150  \\$aDisease$xclassification
=450  \\$aNosology$5IEN
=750  \0$aNosology$5IEN$0(DLC)sh 85092771

=LDR  00323cz  a2200121n  4500
=001  9880364124602441
=005  20120717143441.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3965HS
=035  \\$a(DNLM)D003967Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDiarrhea$xveterinary
=750  \0$aDiarrhea in animals$5IEN$0(DLC)sh 85037607

=LDR  00377cz  a2200133n  4500
=001  9880364124702441
=005  20120717143441.0
=008  670101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3933HS
=035  \\$a(DNLM)D003879Q000494
=040  \\$aDNLM$cDNLM
=150  \\$aDermatologic Agents$xpharmacology
=450  \\$aDermatopharmacology$5IEN
=750  \0$aDermatopharmacology$5IEN$0(DLC)sh 85037098

=LDR  00340cz  a2200121n  4500
=001  9880364124802441
=005  20120717143441.0
=008  780101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3857HS
=035  \\$a(DNLM)D003727Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aDental Auxiliaries$xeducation
=750  \0$aDental auxiliary teachers$5IEN-M$0(DLC)sh 85036866

=LDR  01389cz  a2200313n  4500
=001  9880364297002441
=005  20141212215729.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044127
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x203
=150  \\$aEpigenesis, Genetic
=450  \\$wnnna$aEpigenetic Process
=450  \\$aEpigenetic Processes
=450  \\$wnnna$aEpigenetics Processes
=450  \\$wnnna$aGenetic Epigenesis
=450  \\$wnnna$aProcess, Epigenetic
=450  \\$wnnna$aProcesses, Epigenetic
=450  \\$wnnna$aProcesses, Epigenetics
=550  \\$wg$aGene Expression Regulation
=550  \\$wh$aChromosomal Position Effects
=550  \\$wh$aDosage Compensation, Genetic
=550  \\$wh$aEpigenetic Repression
=550  \\$wh$aGene Silencing
=550  \\$wh$aGenomic Imprinting
=550  \\$aDNA Methylation
=680  \\$iA genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression.
=688  \\$a2004
=750  \0$aEpigenesis$0(DLC) sh 85044382$5IEN-M

=LDR  01681cz  a2200397n  4500
=001  9880364297102441
=005  20190429160918.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044094
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x826.$x590
=072  \\$aD12.$x776.$x543.$x750.$x695.$x440
=150  \\$aReceptors, Melatonin
=450  \\$wnnna$aMel(1c) Receptor
=450  \\$wnnna$aMel1c Receptor
=450  \\$wnnna$aMelatonin MT3 Receptor
=450  \\$wnnna$aMelatonin Receptor
=450  \\$aMelatonin Receptors
=450  \\$wnnna$aMT3 Receptor
=450  \\$wnnna$aMT3 Receptor, Melatonin
=450  \\$wnnna$aReceptor, Mel1c
=450  \\$wnnna$aReceptor, Melatonin
=450  \\$wnnna$aReceptor, Melatonin, 1C
=450  \\$wnnna$aReceptor, Melatonin, MT3
=450  \\$wnnna$aReceptor, Melatonin MT3
=450  \\$wnnna$aReceptor, MT3
=550  \\$wg$aReceptors, Cytoplasmic and Nuclear
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptor, Melatonin, MT1
=550  \\$wh$aReceptor, Melatonin, MT2
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.
=688  \\$a2004; use RECEPTORS, MELATONIN (NM) 1981-2003
=750  \0$81$wb$iBroader mapping$aMelatonin$0(DLC)sh 85083394$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMelatonin--Receptors$5IEN-M

=LDR  01523cz  a2200313n  4500
=001  9880364297202441
=005  20190423170933.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044088
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x315
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x410
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x410
=150  \\$aReceptors, Galanin
=450  \\$wnnna$aGalanin Receptor
=450  \\$wnnna$aGalanin Receptors
=450  \\$wnnna$aReceptor, Galanin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptor, Galanin, Type 1
=550  \\$wh$aReceptor, Galanin, Type 2
=550  \\$wh$aReceptor, Galanin, Type 3
=550  \\$aGalanin
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA family of G-protein-coupled receptors that are specific for GALANIN and galanin peptides. They are generally considered to be coupled to the GI, INHIBITORY G-PROTEIN to meditate the neurological effects of galanin. Several subtypes of galanin receptors occur with differing specificities for the full length galanin, galanin peptide fragments, and galanin-like peptide.
=688  \\$a2004; use RECEPTORS, GALANIN (NM) 1999-2003
=750  \0$81$wb$iBroader mapping$aGalanin$0(DLC)sh 98007595$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGalanin--Receptors$5IEN-M

=LDR  00886cz  a2200241n  4500
=001  9880364297302441
=005  20141212215721.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044085
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x830.$x666
=072  \\$aH1.$x671.$x808.$x500
=072  \\$aJ1.$x897.$x520.$x500.$x500
=150  \\$aMicrofluidics
=450  \\$wnnna$aMicrofluidic
=550  \\$wg$aMicrotechnology
=550  \\$wg$aRheology
=550  \\$wh$aElectrowetting
=550  \\$aMicrofluidic Analytical Techniques
=550  \\$aRheology
=680  \\$iThe study of fluid channels and chambers of tiny dimensions of tens to hundreds of micrometers and volumes of nanoliters or picoliters. This is of interest in biological MICROCIRCULATION and used in MICROCHEMISTRY and INVESTIGATIVE TECHNIQUES.
=688  \\$a2004
=750  \0$aMicrofluidics$0(DLC) sh2005000678$5IEN-M

=LDR  00549cz  a2200169n  4500
=001  9880364297402441
=005  20141212215720.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044084
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x300.$x50
=072  \\$aB3.$x660.$x250.$x150.$x175.$x50
=150  \\$aErwinia amylovora
=550  \\$wg$aErwinia
=680  \\$iA species of gram-negative bacteria, in the genus ERWINIA, causing a necrotic disease of plants.
=688  \\$a2004
=750  \0$aErwinia amylovora$5IEN-M$0(DLC)sh 88023253

=LDR  00798cz  a2200217n  4500
=001  9880364297502441
=005  20141212215720.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044083
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x198.$x150
=072  \\$aB3.$x660.$x250.$x150.$x98.$x150
=150  \\$aCronobacter sakazakii
=450  \\$aEnterobacter sakazakii
=550  \\$wg$aCronobacter
=667  \\$ainfection: coordinate IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA species of gram-negative bacteria in the genus CHRONOBACTER, found in the environment and in foods.
=688  \\$a2012 (2004)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Enterobacter sakazakii
=688  \\$a2004
=750  \0$aEnterobacter sakazakii$0(DLC)sh2007004205$5IEN-M

=LDR  00767cz  a2200193n  4500
=001  9880364297602441
=005  20190429152651.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044067
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x200.$x575
=150  \\$aReceptors, Lipoxin
=450  \\$aLipoxin Receptors
=550  \\$wg$aReceptors, Eicosanoid
=680  \\$iCell surface proteins that bind LIPOXINS with high affinity and trigger intracellular changes influencing the behavior of cells.
=688  \\$a2004
=750  \0$81$wb$iBroader mapping$aLipoxins$0(DLC)sh 88000578$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLipoxins--Receptors$5IEN-M

=LDR  00633cz  a2200169n  4500
=001  9880364297702441
=005  20141212215718.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x375
=150  \\$aLipoxins
=450  \\$wnnna$aLipoxin
=550  \\$wg$aEicosanoids
=680  \\$iTrihydroxy derivatives of eicosanoic acids. They are primarily derived from arachidonic acid, however eicosapentaenoic acid derivatives also exist. Many of them are naturally occurring mediators of immune regulation.
=688  \\$a2004
=750  \0$aLipoxins$5IEN-M$0(DLC)sh 88000578

=LDR  00677cz  a2200181n  4500
=001  9880364297802441
=005  20141212215545.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041883
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x250.$x140
=072  \\$aB3.$x440.$x425.$x410.$x275
=150  \\$aChlorobium
=550  \\$wg$aChlorobi
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=680  \\$iA genus of phototrophic, obligately anaerobic bacteria in the family Chlorobiaceae. They are found in hydrogen sulfide-containing mud and water environments.
=688  \\$a2004; use CHLOROBI 1997-2003
=750  \0$aChlorobium$5IEN-M$0(DLC)sh 88023226

=LDR  00684cz  a2200205n  4500
=001  9880364297902441
=005  20141212215543.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x365.$x500
=072  \\$aB3.$x660.$x50.$x663.$x50.$x400.$x500
=150  \\$aGluconacetobacter xylinus
=450  \\$aAcetobacter xylinum
=450  \\$wnnna$aAcetobacter xylinus
=450  \\$wnnna$aGluconacetobacter xylinum
=550  \\$wg$aGluconacetobacter
=680  \\$iA species of acetate-oxidizing bacteria, formerly known as Acetobacter xylinum.
=688  \\$a2004
=750  \0$aAcetobacter xylinum$5IEN-M$0(DLC)sh 88023204

=LDR  01029cz  a2200277n  4500
=001  9880364298002441
=005  20141212215542.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x429.$x500.$x755
=072  \\$aC23.$x888.$x885.$x375.$x500
=150  \\$aJaundice, Obstructive
=450  \\$wnnna$aCholestatic Jaundice
=450  \\$aJaundice, Cholestatic
=450  \\$aJaundice, Mechanical
=450  \\$wnnna$aMechanical Jaundice
=450  \\$wnnna$aObstructive Jaundice
=550  \\$wg$aJaundice
=550  \\$aCholestasis
=550  \\$aCholestasis, Extrahepatic
=550  \\$aCholestasis, Intrahepatic
=550  \\$aMirizzi Syndrome
=680  \\$iJaundice, the condition with yellowish staining of the skin and mucous membranes, that is due to impaired BILE flow in the BILIARY TRACT, such as INTRAHEPATIC CHOLESTASIS, or EXTRAHEPATIC CHOLESTASIS.
=688  \\$a2004; use CHOLESTASIS 1980-2003
=750  \0$aJaundice, Obstructive$5IEN-M$0(DLC)sh 85069785

=LDR  01870cz  a2200493n  4500
=001  9880364298102441
=005  20141212193042.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041743
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x240.$x755
=072  \\$aG7.$x700.$x680.$x240.$x755
=150  \\$aHerb-Drug Interactions
=450  \\$wnnna$aDrug-Herb Interaction
=450  \\$wnnna$aDrug-Herb Interactions
=450  \\$wnnna$aDrug Herb Interactions
=450  \\$wnnna$aDrug Interaction, Herbal
=450  \\$wnnna$aDrug Interactions, Herbal
=450  \\$wnnna$aDrug-Plant Interaction
=450  \\$wnnna$aDrug-Plant Interactions
=450  \\$wnnna$aDrug Plant Interactions
=450  \\$wnnna$aHerb-Drug Interaction
=450  \\$wnnna$aHerb Drug Interactions
=450  \\$wnnna$aHerbal Drug Interaction
=450  \\$wnnna$aHerbal Drug Interactions
=450  \\$wnnna$aInteraction, Drug-Herb
=450  \\$wnnna$aInteraction, Drug-Plant
=450  \\$wnnna$aInteraction, Herb-Drug
=450  \\$wnnna$aInteraction, Herbal Drug
=450  \\$wnnna$aInteraction, Plant-Drug
=450  \\$wnnna$aInteractions, Drug-Herb
=450  \\$wnnna$aInteractions, Drug-Plant
=450  \\$wnnna$aInteractions, Herb-Drug
=450  \\$wnnna$aInteractions, Herbal Drug
=450  \\$wnnna$aInteractions, Plant-Drug
=450  \\$wnnna$aPlant-Drug Interaction
=450  \\$wnnna$aPlant-Drug Interactions
=450  \\$wnnna$aPlant Drug Interactions
=550  \\$wg$aDrug Interactions
=550  \\$aMetabolic Side Effects of Drugs and Substances
=667  \\$acoord IM with specific plant (IM) + specific drug (IM) with pertinent qualif
=680  \\$iThe effect of herbs, other PLANTS, or PLANT EXTRACTS on the activity, metabolism, or toxicity of drugs.
=688  \\$a2004
=750  \0$aDrug-herb interactions$5IEN-M$0(DLC)sh 98000190

=LDR  01185cz  a2200301n  4500
=001  9880364298202441
=005  20141212215538.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625
=072  \\$aG11.$x427.$x590.$x560
=150  \\$aMusculoskeletal Development
=450  \\$wnnna$aDevelopment, Musculoskeletal
=450  \\$wnnna$aDevelopment, Musculoskeletal System
=450  \\$wnnna$aMusculoskeletal System Development
=450  \\$aMusculoskeletal System$xgrowth & development
=450  \\$wnnna$aSystem Development, Musculoskeletal
=550  \\$wg$aMusculoskeletal Physiological Processes
=550  \\$wg$aOrganogenesis
=550  \\$wh$aBone Development
=550  \\$wh$aChondrogenesis
=550  \\$wh$aMuscle Development
=550  \\$aMusculoskeletal System
=667  \\$aGEN: prefer specifics
=680  \\$iThe morphologic and physiological changes of the MUSCLES, bones (BONE AND BONES), and CARTILAGE of the body, i.e., MUSCULOSKELETAL SYSTEM, during the prenatal and postnatal stages of development.
=688  \\$a2004
=750  \0$aMusculoskeletal system$xGrowth$5IEN-M

=LDR  00936cz  a2200229n  4500
=001  9880364298302441
=005  20141212215538.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x589.$x249.$x500
=072  \\$aE1.$x370.$x350.$x825.$x805.$x500
=072  \\$aE5.$x642.$x249.$x500
=150  \\$aTomography, Optical Coherence
=450  \\$wnnna$aCoherence Tomography, Optical
=450  \\$wnnna$aOCT Tomography
=450  \\$wnnna$aOptical Coherence Tomography
=450  \\$wnnna$aTomography, OCT
=550  \\$wg$aTomography, Optical
=680  \\$iAn imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.
=688  \\$a2004
=750  \0$aOptical coherence tomography$0(DLC)sh2006001524$5IEN-M

=LDR  01005cz  a2200217n  4500
=001  9880364298402441
=005  20141212215538.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x589.$x249
=072  \\$aE1.$x370.$x350.$x825.$x805
=072  \\$aE5.$x642.$x249
=150  \\$aTomography, Optical
=450  \\$wnnna$aOptical Tomography
=550  \\$wg$aOptical Imaging
=550  \\$wg$aTomography
=550  \\$wh$aTomography, Optical Coherence
=680  \\$iProjection of near-IR light (INFRARED RAYS), in the 700-1000 nm region, across an object in parallel beams to an array of sensitive photodetectors. This is repeated at various angles and a mathematical reconstruction provides three dimensional MEDICAL IMAGING of tissues. Based on the relative transparency of tissues to this spectra, it has been used to monitor local oxygenation, brain and joints.
=688  \\$a2004
=750  \0$aOptical tomography$0(DLC) sh 89007004$5IEN-M

=LDR  01043cz  a2200205n  4500
=001  9880364298502441
=005  20141212215537.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x756.$x249
=150  \\$aEremophila Plant
=450  \\$wnnna$aEremophila Plants
=450  \\$wnnna$aPlant, Eremophila
=450  \\$wnnna$aPlants, Eremophila
=550  \\$wg$aMyoporaceae
=667  \\$aEREMOPHILA ALPESTRIS see SONGBIRDS and EREMOPHILUS MUTISII see CATFISHES are also available; eremophilane compounds (NM) is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYOPORACEAE. Members have been used in FOLK MEDICINE.
=688  \\$a2004
=750  \0$aEremophila (Plants)$5IEN-M$0(DLC)sh 85044593

=LDR  00995cz  a2200205n  4500
=001  9880364298602441
=005  20141212215537.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041605
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x777.$x744
=150  \\$aPinus sylvestris
=450  \\$wnnna$aPinus sylvestri
=450  \\$wnnna$asylvestri, Pinus
=450  \\$wnnna$asylvestris, Pinus
=550  \\$wg$aPinus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus PINUS which is the source of pinosylvin. It is sometimes called Scotch pine or Scots pine, which is also a common name for other species of this genus.
=688  \\$a2004
=750  \0$aScots pine$0(DLC)sh 85118798$5IEN-M

=LDR  01032cz  a2200253n  4500
=001  9880364298702441
=005  20141212215537.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x777.$x600
=150  \\$aPinus ponderosa
=450  \\$wnnna$aPine, Ponderosa
=450  \\$wnnna$aPines, Ponderosa
=450  \\$wnnna$aPinus ponderosas
=450  \\$aPonderosa Pine
=450  \\$wnnna$aPonderosa Pines
=450  \\$wnnna$aponderosa, Pinus
=450  \\$wnnna$aponderosas, Pinus
=550  \\$wg$aPinus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus PINUS that contains isocupressic acid.
=688  \\$a2004
=750  \0$aPonderosa pine$0(DLC)sh 85104789$5IEN-M

=LDR  01011cz  a2200253n  4500
=001  9880364298802441
=005  20141212215536.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041603
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x666.$x777.$x888
=150  \\$aPinus taeda
=450  \\$aLoblolly Pine
=450  \\$wnnna$aLoblolly Pines
=450  \\$aPine, Loblolly
=450  \\$wnnna$aPines, Loblolly
=450  \\$wnnna$aPinus taedas
=450  \\$wnnna$ataeda, Pinus
=450  \\$wnnna$ataedas, Pinus
=550  \\$wg$aPinus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus PINUS which is the subject of genetic study.
=688  \\$a2004
=750  \0$aLoblolly pine$0(DLC)sh 85077898$5IEN-M

=LDR  01024cz  a2200241n  4500
=001  9880364298902441
=005  20141212193053.0
=008  030324\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045169
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x600.$x550.$x200.$x750
=072  \\$aC8.$x730.$x730
=150  \\$aSevere Acute Respiratory Syndrome
=450  \\$wnnna$aRespiratory Syndrome, Acute, Severe
=450  \\$aRespiratory Syndrome, Severe Acute
=450  \\$aSARS$5IEN-HS
=450  \\$wnnna$aSARS (Severe Acute Respiratory Syndrome)
=550  \\$wg$aCoronavirus Infections
=550  \\$wg$aRespiratory Tract Infections
=667  \\$ado not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN or RESPIRATORY DISTRESS SYNDROME, ADULT
=680  \\$iA viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
=688  \\$a2003
=750  \0$aSARS (Disease)$5IEN-M$0(DLC)sh2003006472

=LDR  00725cz  a2200241n  4500
=001  9880364299002441
=005  20141212215532.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x68.$x249
=150  \\$aDiapers, Infant
=450  \\$wnnna$aDiaper, Infant
=450  \\$wnnna$aDiaper Pin
=450  \\$aDiaper Pins
=450  \\$wnnna$aInfant Diaper
=450  \\$wnnna$aInfant Diapers
=450  \\$wnnna$aPin, Diaper
=450  \\$wnnna$aPins, Diaper
=550  \\$wg$aAbsorbent Pads
=680  \\$iAbsorbent pads designed to be worn by infants and very young children.
=688  \\$a2003; use INFANT CARE 1989-2002
=750  \0$aDiapers$5IEN-M$0(DLC)sh 85037582

=LDR  00699cz  a2200169n  4500
=001  9880364299102441
=005  20141212215531.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x490.$x500
=150  \\$aPacifiers
=450  \\$wnnna$aPacifier
=550  \\$wg$aInfant Equipment
=680  \\$iDevices that babies can suck on when they are not feeding. The extra sucking can be comforting to the babies and pacify them. Pacifiers usually are used as a substitute for the thumb in babies who suck on their thumb or fingers almost constantly.
=688  \\$a2003; use INFANT CARE 1989-2002
=750  \0$aPacifiers (Infant care)$5IEN-M$0(DLC)sh 85096500

=LDR  00708cz  a2200181n  4500
=001  9880364299202441
=005  20141212215529.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041261
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x859.$x900
=072  \\$aB3.$x660.$x250.$x830.$x830.$x900
=150  \\$aVibrio vulnificus
=550  \\$wg$aVibrio
=667  \\$ainfection: coord IM with VIBRIO INFECTIONS (IM)
=680  \\$iA species of halophilic bacteria in the genus VIBRIO, which lives in warm SEAWATER. It can cause infections in those who eat raw contaminated seafood or have open wounds exposed to seawater.
=688  \\$a2003
=750  \0$aVibrio vulnificus$5IEN-M$0(DLC)sh 97001503

=LDR  00889cz  a2200217n  4500
=001  9880364299302441
=005  20141212215525.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041102
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x40.$x525
=072  \\$aB3.$x660.$x50.$x20.$x525
=150  \\$aNeorickettsia
=450  \\$aNeorickettsia helminthoeca
=550  \\$wg$aAnaplasmataceae
=550  \\$wh$aNeorickettsia risticii
=550  \\$wh$aNeorickettsia sennetsu
=667  \\$ainfection: coord IM with ANAPLASMATACEAE INFECTIONS (IM)
=680  \\$iGenus of gram-negative, intracytoplasmic bacteria that are found primarily in VACUOLES of MONOCYTES in the BLOOD and MACROPHAGES of lymphoid or other tissues of DOGS; HORSES, and humans. (From Int. J. Syst. Evol. Microbiol. (2001) 51:2145-2165)
=688  \\$a2003, 1963-1981
=750  \0$aNeorickettsia$5IEN-M$0(DLC)sh 88023295

=LDR  00878cz  a2200217n  4500
=001  9880364299402441
=005  20141212215524.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x147.$x800
=072  \\$aB1.$x300.$x930.$x176.$x800
=150  \\$aCandida tropicalis
=450  \\$wnnna$aCandida tropicali
=450  \\$wnnna$atropicali, Candida
=450  \\$wnnna$atropicalis, Candida
=550  \\$wg$aCandida
=667  \\$ainfection: coord with CANDIDIASIS (IM) or its indentions (IM)
=680  \\$iA species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.
=688  \\$a2003
=750  \0$aCandida tropicalis$5IEN-M$0(DLC)sh 88022025

=LDR  00675cz  a2200193n  4500
=001  9880364299502441
=005  20141212215524.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x215.$x500.$x750
=072  \\$aB3.$x660.$x50.$x70.$x100.$x750
=150  \\$aBrucella suis
=450  \\$wnnna$aBrucella melitensis biovar suis
=550  \\$wg$aBrucella
=667  \\$ainfection: coord IM with BRUCELLOSIS (IM)
=680  \\$iA species of gram-negative bacteria, primarily infecting SWINE, but it can also infect humans, DOGS, and HARES.
=688  \\$a2003
=750  \0$aBrucella suis$5IEN-M$0(DLC)sh 88023223

=LDR  00515cz  a2200169n  4500
=001  9880364299602441
=005  20141212215522.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x380
=150  \\$aHeredity
=550  \\$wg$aGenetic Processes
=667  \\$ado not confuse with INHERITANCE see WILLS
=680  \\$iThe transmission of traits encoded in GENES from parent to offspring.
=688  \\$a2003; use GENETICS (1974-2002)
=750  \2$aHeredity$5IEN-M

=LDR  00692cz  a2200229n  4500
=001  9880364299702441
=005  20181129145047.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x843
=072  \\$aH1.$x158.$x273.$x180.$x350.$x700
=072  \\$aH1.$x158.$x273.$x343.$x350.$x700
=072  \\$aH1.$x181.$x122.$x738
=150  \\$aProteomics
=550  \\$wg$aBiochemistry
=550  \\$wg$aGenomics
=550  \\$wh$aProteogenomics
=550  \\$aGenomics
=680  \\$iThe systematic study of the complete complement of proteins (PROTEOME) of organisms.
=688  \\$a2003
=750  \0$aProteomics$5IEN-M$0(DLC)sh2002000814

=LDR  00673cz  a2200229n  4500
=001  9880364299802441
=005  20141212215521.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x181
=150  \\$aEthics, Business
=450  \\$wnnna$aBusiness Ethics
=450  \\$wnnna$aCorporate Ethics
=450  \\$aEthics, Corporate
=550  \\$wg$aEthics
=550  \\$aCommerce
=550  \\$aEthics, Institutional
=550  \\$aIndustry
=680  \\$iThe moral obligations governing the conduct of commercial or industrial enterprises.
=688  \\$a2003
=750  \0$aBusiness ethics$5IEN-M$0(DLC)sh 85018297

=LDR  01087cz  a2200265n  4500
=001  9880364299902441
=005  20141212193042.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x261.$x750
=150  \\$aResource Allocation
=450  \\$aAllocation of Resources
=450  \\$wnnna$aAllocation, Resource
=450  \\$wnnna$aAllocations, Resource
=450  \\$aAllocative Efficiency
=450  \\$wnnna$aEfficiency, Allocative
=450  \\$wnnna$aResource Allocations
=450  \\$wnnna$aResources Allocation
=550  \\$wg$aEconomics
=550  \\$wh$aHealth Care Rationing
=667  \\$afor health care resource allocation, use HEALTH CARE RATIONING; use both terms only when a discussion of health care resource allocation is accompanied by a more theoretical discussion of the concept of equity in the distribution of limited resources
=680  \\$iSocietal or individual decisions about the equitable distribution of available resources.
=688  \\$a2003
=750  \0$aResource allocation$5IEN-M$0(DLC)sh 85113168

=LDR  01041cz  a2200301n  4500
=001  9880364300002441
=005  20141212215520.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x87
=150  \\$aBiomimetic Materials
=450  \\$wnnna$aBiomimetic Device
=450  \\$aBiomimetic Devices
=450  \\$wnnna$aBiomimetic Material
=450  \\$wnnna$aDevice, Biomimetic
=450  \\$wnnna$aDevices, Biomimetic
=450  \\$wnnna$aMaterial, Biomimetic
=450  \\$wnnna$aMaterials, Biomimetic
=550  \\$wg$aManufactured Materials
=550  \\$wh$aBlood Substitutes
=550  \\$wh$aMembranes, Artificial
=550  \\$wh$aReceptors, Artificial
=550  \\$aBiocompatible Materials
=667  \\$ado not confuse with BIOMATERIALS see BIOCOMPATIBLE MATERIALS
=680  \\$iMaterials fabricated by BIOMIMETICS techniques, i.e., based on natural processes found in biological systems.
=688  \\$a2003
=750  \0$aBiomimetic materials$0(DLC)sh2009009164$5IEN-M

=LDR  00746cz  a2200181n  4500
=001  9880364300102441
=005  20141212215520.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x350
=150  \\$aGenetic Load
=450  \\$wnnna$aLoad, Genetic
=550  \\$wg$aGenetic Phenomena
=550  \\$aHybrid Vigor
=680  \\$iThe relative amount by which the average fitness of a POPULATION is lowered, due to the presence of GENES that decrease survival, compared to the GENOTYPE with maximum or optimal fitness. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
=688  \\$a2003; use GENETICS, POPULATION 1998-2002
=750  \0$aGenetic load$5IEN-M$0(DLC)sh 85053864

=LDR  00862cz  a2200193n  4500
=001  9880364300202441
=005  20141212215517.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x187
=150  \\$aAssisted Living Facilities
=450  \\$wnnna$aAssisted Living Facility
=450  \\$wnnna$aFacilities, Assisted Living
=450  \\$wnnna$aFacility, Assisted Living
=550  \\$wg$aResidential Facilities
=680  \\$iA housing and health care alternative combining independence with personal care. It provides a combination of housing, personalized supportive services and health care designed to meet the needs, both scheduled and unscheduled, of those who need help with activities of daily living. (www.alfa.org)
=688  \\$a2003
=750  \0$aCongregate housing$5IEN-M$0(DLC)sh 85031107

=LDR  00880cz  a2200253n  4500
=001  9880364300302441
=005  20141212215517.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x687
=150  \\$aMarketing
=450  \\$wnnna$aAudience Research
=450  \\$wnnna$aMarket Research
=450  \\$wnnna$aResearch, Audience
=450  \\$wnnna$aResearch, Market
=550  \\$wg$aCommerce
=550  \\$wh$aAdvertising as Topic
=550  \\$wh$aMarketing of Health Services
=550  \\$wh$aSocial Marketing
=667  \\$aMARKETING OF HEALTH SERVICES and SOCIAL MARKETING are also available
=680  \\$iActivity involved in transfer of goods from producer to consumer or in the exchange of services.
=688  \\$a2003; use MARKETING OF HEALTH SERVICES 1979-2002
=750  \0$aMarketing$5IEN-M$0(DLC)sh 85081333

=LDR  01615cz  a2200409n  4500
=001  9880364300502441
=005  20141212215512.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750.$x750.$x462
=072  \\$aL1.$x700.$x508.$x300.$x314
=150  \\$aGeographic Information Systems
=450  \\$wnnna$aGeographic Information System
=450  \\$wnnna$aGeographical Information System
=450  \\$wnnna$aGeographical Information Systems
=450  \\$wnnna$aGlobal Positioning System
=450  \\$wnnna$aGlobal Positioning Systems
=450  \\$wnnna$aInformation System, Geographic
=450  \\$wnnna$aInformation System, Geographical
=450  \\$wnnna$aInformation Systems, Geographic
=450  \\$wnnna$aInformation Systems, Geographical
=450  \\$wnnna$aPositioning System, Global
=450  \\$wnnna$aPositioning Systems, Global
=450  \\$wnnna$aSystem, Geographical Information
=450  \\$wnnna$aSystem, Global Positioning
=450  \\$wnnna$aSystems, Geographical Information
=450  \\$wnnna$aSystems, Global Positioning
=550  \\$wg$aDatabases, Factual
=550  \\$wg$aInformation Systems
=550  \\$aGeographic Mapping
=550  \\$aRemote Sensing Technology
=550  \\$aSatellite Imagery
=550  \\$aSpatial Analysis
=680  \\$iComputer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.
=688  \\$a2003
=750  \0$aGeographic information systems$5IEN-M$0(DLC)sh 90001880

=LDR  02284cz  a2200397n  4500
=001  9880364300602441
=005  20190507161840.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x950
=072  \\$aD12.$x776.$x543.$x750.$x630.$x750
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x910
=150  \\$aReceptors, Vascular Endothelial Growth Factor
=450  \\$wnnna$aEndothelial Growth Factor Receptor
=450  \\$wnnna$aReceptor, Endothelial Growth Factors
=450  \\$wnnna$aReceptor, Vascular Endothelial Cell Growth Factor
=450  \\$wnnna$aReceptor, Vascular Permeability Factor
=450  \\$wnnna$aReceptors, VEGF
=450  \\$wnnna$aVascular Endothelial Cell Growth Factor Receptor
=450  \\$wnnna$aVascular Endothelial Growth Factor Receptor
=450  \\$wnnna$aVascular Permeability Factor Receptor
=450  \\$wnnna$aVEGF Receptor
=450  \\$wnnna$aVEGF Receptors
=450  \\$wnnna$aVPF Receptor
=550  \\$wg$aReceptor Protein-Tyrosine Kinases
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aVascular Endothelial Growth Factor Receptor-1
=550  \\$wh$aVascular Endothelial Growth Factor Receptor-2
=550  \\$wh$aVascular Endothelial Growth Factor Receptor-3
=667  \\$aGEN; prefer specifics, DF: VEGF RECEPT
=680  \\$iA family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular Ig-like domains which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.
=688  \\$a2003; use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1991-2002; for ENDOTHELIAL GROWTH FACTOR RECEPTOR use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR (NM) 1985-2003
=750  \0$81$wb$iBroader mapping$aVascular endothelial growth factors$0(DLC)sh2004000517$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aVascular endothelial growth factors--Receptors$5IEN-M

=LDR  00885cz  a2200193n  4500
=001  9880364300702441
=005  20141212215507.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x219.$x687.$x750
=072  \\$aN5.$x300.$x430.$x500.$x500
=150  \\$aSocial Marketing
=450  \\$wnnna$aMarketing, Social
=550  \\$wg$aMarketing
=550  \\$wg$aMarketing of Health Services
=680  \\$iUse of marketing principles also used to sell products to consumers to promote ideas, attitudes and behaviors. Design and use of programs seeking to increase the acceptance of a social idea or practice by target groups, not for the benefit of the marketer, but to benefit the target audience and the general society.
=688  \\$a2003; use Marketing of Health Services 1980-2002
=750  \0$aSocial marketing$5IEN-M$0(DLC)sh 89002650

=LDR  00600cz  a2200181n  4500
=001  9880364300802441
=005  20180911163105.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x250
=072  \\$aB3.$x585.$x420
=150  \\$aFrankia
=550  \\$wg$aActinomycetales
=550  \\$wg$aNitrogen-Fixing Bacteria
=680  \\$iGenus of BACTERIA in the family Frankiaceae. They are nitrogen-fixing root-nodule symbionts of many species of woody dicotyledonous plants.
=688  \\$a2003
=750  \0$aFrankia$5IEN-M$0(DLC)sh 85051577

=LDR  00546cz  a2200157n  4500
=001  9880364300902441
=005  20141212215505.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040143
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x150
=150  \\$aCellulomonas
=550  \\$wg$aActinomycetales
=680  \\$iA genus of aerobic or facultatively anaerobic BACTERIA, in the family Cellulomonadaceae. It is found in the SOIL and capable of hydrolyzing CELLULOSE.
=688  \\$a2003
=750  \0$aCellulomonas$5IEN-M$0(DLC)sh 85021704

=LDR  00617cz  a2200205n  4500
=001  9880364301002441
=005  20141212215503.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040102
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x850
=150  \\$aTetranychidae
=450  \\$wnnna$aMite, Spider
=450  \\$aMites, Spider
=450  \\$wnnna$aSpider Mite
=450  \\$aSpider Mites
=550  \\$wg$aMites
=680  \\$iFamily of spider MITES, in the superfamily Tetranychoidea, suborder Trombidiformes.
=688  \\$a2003
=750  \0$aSpider mites$5IEN-M$0(DLC)sh 85134205

=LDR  03396cz  a2200901n  4500
=001  9880364301102441
=005  20141212215503.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x630.$x570.$x700
=072  \\$aE5.$x393.$x525.$x680
=072  \\$aE5.$x588.$x570.$x700
=072  \\$aE5.$x601.$x680
=150  \\$aProtein Array Analysis
=450  \\$wnnna$aAnalyses, Protein Array
=450  \\$wnnna$aAnalyses, Protein Microarray
=450  \\$wnnna$aAnalysis, Protein Array
=450  \\$wnnna$aAnalysis, Protein Microarray
=450  \\$wnnna$aArray Analyses, Protein
=450  \\$wnnna$aArray Analysis, Protein
=450  \\$wnnna$aArray Assay, Protein
=450  \\$wnnna$aArray Assays, Protein
=450  \\$wnnna$aArray, Protein
=450  \\$wnnna$aArrays, Protein
=450  \\$wnnna$aAssay, Protein Array
=450  \\$wnnna$aAssay, Protein Microarray
=450  \\$wnnna$aAssays, Protein Array
=450  \\$wnnna$aAssays, Protein Microarray
=450  \\$wnnna$aBiochip, Protein
=450  \\$wnnna$aBiochips, Protein
=450  \\$wnnna$aChip, Protein
=450  \\$wnnna$aChip, Protein Profiling
=450  \\$wnnna$aChips, Protein
=450  \\$wnnna$aChips, Protein Profiling
=450  \\$wnnna$aMicroarray Analyses, Protein
=450  \\$wnnna$aMicroarray Analysis, Protein
=450  \\$wnnna$aMicroarray Assay, Protein
=450  \\$wnnna$aMicroarray Assays, Protein
=450  \\$wnnna$aMicroarray, Protein
=450  \\$wnnna$aMicroarray, Protein Profiling
=450  \\$wnnna$aMicroarrays, Protein
=450  \\$wnnna$aMicroarrays, Protein Profiling
=450  \\$wnnna$aMicrochip, Protein
=450  \\$wnnna$aMicrochips, Protein
=450  \\$wnnna$aProfiling Chip, Protein
=450  \\$wnnna$aProfiling Chips, Protein
=450  \\$wnnna$aProfiling Microarray, Protein
=450  \\$wnnna$aProfiling Microarrays, Protein
=450  \\$wnnna$aProtein Array
=450  \\$wnnna$aProtein Array Analyses
=450  \\$wnnna$aProtein Array Assay
=450  \\$wnnna$aProtein Array Assays
=450  \\$wnnna$aProtein Arrays
=450  \\$wnnna$aProtein Biochip
=450  \\$wnnna$aProtein Biochips
=450  \\$wnnna$aProtein Chip
=450  \\$aProtein Chips
=450  \\$wnnna$aProtein Microarray
=450  \\$wnnna$aProtein Microarray Analyses
=450  \\$wnnna$aProtein Microarray Analysis
=450  \\$wnnna$aProtein Microarray Assay
=450  \\$wnnna$aProtein Microarray Assays
=450  \\$aProtein Microarrays
=450  \\$wnnna$aProtein Microchip
=450  \\$aProtein Microchips
=450  \\$wnnna$aProtein Profiling Chip
=450  \\$aProtein Profiling Chips
=450  \\$wnnna$aProtein Profiling Microarray
=450  \\$wnnna$aProtein Profiling Microarrays
=450  \\$wnnna$aProteinChip
=450  \\$wnnna$aProteinChips
=550  \\$wg$aMicroarray Analysis
=550  \\$wg$aMolecular Probe Techniques
=550  \\$aProtein Interaction Mapping
=680  \\$iLigand-binding assays that measure protein-protein, protein-small molecule, or protein-nucleic acid interactions using a very large set of capturing molecules, i.e., those attached separately on a solid support, to measure the presence or interaction of target molecules in the sample.
=688  \\$a2003
=750  \0$aProtein microarrays$5IEN-M$0(DLC)sh2001002930

=LDR  00918cz  a2200277n  4500
=001  9880364301202441
=005  20141212215501.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x50
=150  \\$aAcaridae
=450  \\$wnnna$aMite, Storage
=450  \\$wnnna$aMite, Store Product
=450  \\$aMites, Storage
=450  \\$aMites, Store Product
=450  \\$wnnna$aProduct Mite, Store
=450  \\$wnnna$aProduct Mites, Store
=450  \\$wnnna$aStorage Mite
=450  \\$aStorage Mites
=450  \\$wnnna$aStore Product Mite
=450  \\$wnnna$aStore Product Mites
=550  \\$wg$aMites
=680  \\$iFamily of MITES, in the superfamily Acaroidea, order Astigmata. They are frequently found in cereal-based foodstuffs including GRAIN and FLOUR.
=688  \\$a2003
=750  \0$aAcaridae$5IEN-M$0(DLC)sh 85000333

=LDR  00690cz  a2200181n  4500
=001  9880364301302441
=005  20141212215500.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x750
=150  \\$aSarcoptidae
=550  \\$wg$aMites
=550  \\$wh$aSarcoptes scabiei
=667  \\$ainfestation: coord IM with MITE INFESTATIONS (IM)
=680  \\$iFamily of MITES, in the superfamily Sarcoptoidea, order Astigmata. They are slow moving, obligate PARASITES that infect MAMMALS and BIRDS. The species SARCOPTES SCABIEI causes SCABIES.
=688  \\$a2003
=750  \0$aSarcoptidae$5IEN-M$0(DLC)sh 85117518

=LDR  00716cz  a2200193n  4500
=001  9880364301402441
=005  20141212215500.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D040002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x600.$x215
=150  \\$aDermatophagoides pteronyssinus
=450  \\$wnnna$aEuropean House Dust Mite
=450  \\$wnnna$aHouse Dust Mite, European
=450  \\$wnnna$apteronyssinus, Dermatophagoides
=550  \\$wg$aPyroglyphidae
=680  \\$iSpecies of European house dust mite, in the family PYROGLYPHIDAE. It is the most commonly found house dust mite.
=688  \\$a2003
=750  \0$aDermatophagoides pteronyssinus$5IEN-M$0(DLC)sh 85062546

=LDR  01129cz  a2200349n  4500
=001  9880364301502441
=005  20141212215500.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x600
=150  \\$aPyroglyphidae
=450  \\$wnnna$aDermatophagoide
=450  \\$aDermatophagoides
=450  \\$wnnna$aDust Mite, House
=450  \\$aDust Mites, House
=450  \\$wnnna$aEuroglyphus
=450  \\$wnnna$aHouse Dust Mite
=450  \\$aHouse Dust Mites
=450  \\$wnnna$aHousedust Mite
=450  \\$wnnna$aHousedust Mites
=450  \\$wnnna$aMite, House Dust
=450  \\$wnnna$aMite, Housedust
=450  \\$aMites, House Dust
=450  \\$wnnna$aMites, Housedust
=550  \\$wg$aMites
=550  \\$wh$aDermatophagoides farinae
=550  \\$wh$aDermatophagoides pteronyssinus
=550  \\$aDust
=680  \\$iFamily of house dust mites, in the superfamily Analgoidea, order Astigmata. They include the genera Dermatophagoides and Euroglyphus.
=688  \\$a2003
=750  \0$aPyroglyphidae$5IEN-M$0(DLC)sh 85109344

=LDR  02631cz  a2200589n  4500
=001  9880364301602441
=005  20141212215459.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039961
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x923
=072  \\$aD12.$x776.$x467.$x923
=072  \\$aD23.$x529.$x923
=150  \\$aSemaphorins
=450  \\$wnnna$aClass 1 Semaphorins
=450  \\$wnnna$aClass 2 Semaphorins
=450  \\$wnnna$aClass 3 Semaphorins
=450  \\$wnnna$aClass 4 Semaphorins
=450  \\$wnnna$aClass 5 Semaphorins
=450  \\$wnnna$aClass 6 Semaphorins
=450  \\$wnnna$aClass 7 Semaphorins
=450  \\$wnnna$aClass V Semaphorins
=450  \\$wnnna$aSema 1
=450  \\$wnnna$aSemaphorin
=450  \\$wnnna$aSemaphorin-1
=450  \\$wnnna$aSemaphorin 1
=450  \\$wnnna$aSemaphorin-2
=450  \\$wnnna$aSemaphorin 2
=450  \\$wnnna$aSemaphorin-3
=450  \\$wnnna$aSemaphorin 3
=450  \\$wnnna$aSemaphorin-4
=450  \\$wnnna$aSemaphorin 4
=450  \\$wnnna$aSemaphorin-5
=450  \\$wnnna$aSemaphorin-6
=450  \\$wnnna$aSemaphorin 6
=450  \\$wnnna$aSemaphorin-7
=450  \\$wnnna$aSemaphorin 7
=450  \\$wnnna$aSemaphorin-V
=450  \\$wnnna$aSemaphorins, Class 1
=450  \\$wnnna$aSemaphorins, Class 2
=450  \\$wnnna$aSemaphorins, Class 3
=450  \\$wnnna$aSemaphorins, Class 4
=450  \\$wnnna$aSemaphorins, Class 5
=450  \\$wnnna$aSemaphorins, Class 6
=450  \\$wnnna$aSemaphorins, Class 7
=450  \\$wnnna$aSemaphorins, Class V
=450  \\$wnnna$aV Semaphorins, Class
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aSemaphorin-3A
=680  \\$iA family of proteins that mediate axonal guidance. Semaphorins act as repulsive cues for neuronal GROWTH CONES and bind to receptors on their filopodia. At least 20 different molecules have been described and divided into eight classes based on domain organization and species of origin. Classes 1 and 2 are invertebrate, classes 3-7 are vertebrate, and class V are viral. Semaphorins may be secreted (classes 2, 3, and V), transmembrane (classes 1, 4, 5, and 6), or membrane-anchored (class 7). All semaphorins possess a common 500-amino acid extracellular domain which is critical for receptor binding and specificity, and is also found in plexins and scatter factor receptors. Their C termini are class-specific and may contain additional sequence motifs.
=688  \\$a2003; for SEMA 1 & SEMAPHORIN-1 use SEMAPHORIN 1A, GRASSHOPPER (NM) 1994-2002
=750  \0$aSemaphorins$0(DLC)sh2007001873$5IEN-M

=LDR  01363cz  a2200193n  4500
=001  9880364301702441
=005  20141212215457.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x55
=150  \\$aNeuropilins
=450  \\$aNeuropilin
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aNeuropilin-1
=550  \\$wh$aNeuropilin-2
=680  \\$iNeuropilins are 140-kDa vertebrate cell surface receptors that bind neuronal guidance molecules during neural development and axonal outgrowth, and modulate VEGF-mediated angiogenesis. NEUROPILIN-1 and NEUROPILIN-2 differ in their binding specificities, and are distributed complementarily in regions of the developing nervous system. Neuropilins are receptors for secreted CLASS 3 SEMAPHORINS as well as for vascular endothelial growth factors, and may form hetero- or homodimers. They may also interact synergistically with plexins and with VEGF RECEPTORS to form receptor complexes with distinct affinities and specificities. Neuropilin binding specificity is determined by CUB and coagulation-factor-like domains in the extracellular portion of the molecule, while a MAM domain is essential for SIGNAL TRANSDUCTION.
=688  \\$a2003; for NEUROPILIN use NEUROPILIN-1 (NM) 1998-2002
=750  \0$aNeuropilins$5IEN-M$0(DLC)sh2002008705

=LDR  01233cz  a2200301n  4500
=001  9880364301802441
=005  20141212215456.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49
=150  \\$aActinobacteria
=450  \\$wnno$aActinobacteria Group$5IEN-HS
=450  \\$aActinomycetes
=450  \\$aGram-Positive Bacteria, High G+C
=450  \\$wnnna$aHigh G+C Gram-Positive Bacteria
=550  \\$wg$aGram-Positive Asporogenous Rods, Irregular
=550  \\$wg$aGram-Positive Bacteria
=550  \\$wh$aActinomycetaceae
=550  \\$wh$aActinomycetales
=550  \\$wh$aArthrobacter
=550  \\$wh$aBifidobacterium
=550  \\$wh$aBrevibacterium
=550  \\$wh$aGardnerella
=680  \\$iClass of BACTERIA with diverse morphological properties. Strains of Actinobacteria show greater than 80% 16S rDNA/rRNA sequence similarity among each other and also the presence of certain signature nucleotides. (Stackebrandt E. et al, Int. J. Syst. Bacteriol. (1997) 47:479-491)
=688  \\$a2003; for ACTINOMYCETES use ACTINOMYCETALES 1997-2002 & 1963-1966
=750  \0$aActinobacteria$0(DLC)sh2007000158$5IEN-M

=LDR  01000cz  a2200217n  4500
=001  9880364301902441
=005  20201019121720.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x872.$x590
=150  \\$aMultipotent Stem Cells
=450  \\$wnnna$aMultipotent Stem Cell
=450  \\$wnnna$aStem Cell, Multipotent
=450  \\$aStem Cells, Multipotent
=550  \\$wg$aStem Cells
=550  \\$wh$aMesenchymal Stem Cells
=667  \\$aTOTIPOTENT STEM CELLS and PLURIPOTENT STEM CELLS are also available
=680  \\$iSpecialized stem cells that are committed to give rise to cells that have a particular function; examples are MYOBLASTS; MYELOID PROGENITOR CELLS; and skin stem cells. (Stem Cells: A Primer [Internet]. Bethesda (MD): National Institutes of Health (US); 2000 May [cited 2002 Apr 5]. Available from: http://www.nih.gov/news/stemcell/primer.htm)
=688  \\$a2003
=750  \0$aMultipotent stem cells$0(DLC)sh2010012755$5IEN-M

=LDR  00882cz  a2200229n  4500
=001  9880364302002441
=005  20141212215452.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x575
=150  \\$aMonoterpenes
=450  \\$wnnna$aMonoterpenoids
=550  \\$wg$aTerpenes
=550  \\$wh$aIridoids
=550  \\$wh$aMenthol
=550  \\$wh$aNorbornanes
=550  \\$wh$aPyrethrins
=550  \\$wh$aThymol
=680  \\$iCompounds with a core of 10 carbons generally formed via the mevalonate pathway from the combination of 3,3-dimethylallyl pyrophosphate and isopentenyl pyrophosphate. They are cyclized and oxidized in a variety of ways. Due to the low molecular weight many of them exist in the form of essential oils (OILS, VOLATILE).
=688  \\$a2003
=750  \0$aMonoterpenes$5IEN-M$0(DLC)sh 85086975

=LDR  02045cz  a2200589n  4500
=001  9880364302102441
=005  20141212215452.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x952
=150  \\$aUlex
=450  \\$wnnna$aCommon Gorse
=450  \\$wnnna$aCommon Gorses
=450  \\$wnnna$aeulopeus, Ulex
=450  \\$wnnna$aeuroapaeus, Ulex
=450  \\$wnnna$aeuropae, Ulex
=450  \\$wnnna$aeuropaes, Ulex
=450  \\$wnnna$aeuropaeus, Ulex
=450  \\$wnnna$aEuropean Gorse
=450  \\$wnnna$aeuropean, Ulex
=450  \\$wnnna$aeuropeans, Ulex
=450  \\$wnnna$aeuropeaus, Ulex
=450  \\$wnnna$aeuropeus, Ulex
=450  \\$wnnna$aeurophaeus, Ulex
=450  \\$wnnna$aeuropoeus, Ulex
=450  \\$wnnna$aeuropus, Ulex
=450  \\$aGorse, Common
=450  \\$aGorse, European
=450  \\$wnnna$aGorses, Common
=450  \\$wnnna$ajussiaei, Ulex
=450  \\$wnnna$ajussiaeus, Ulex
=450  \\$wnnna$aUlex eulopeus
=450  \\$wnnna$aUlex euroapaeus
=450  \\$wnnna$aUlex europae
=450  \\$wnnna$aUlex europaes
=450  \\$wnnna$aUlex europaeus
=450  \\$wnnna$aUlex european
=450  \\$wnnna$aUlex europeans
=450  \\$wnnna$aUlex europeaus
=450  \\$wnnna$aUlex europeus
=450  \\$wnnna$aUlex europhaeus
=450  \\$wnnna$aUlex europoeus
=450  \\$wnnna$aUlex europus
=450  \\$wnnna$aUlex jussiaei
=450  \\$wnnna$aUlex jussiaeus
=450  \\$wnnna$aUlices
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE (sometimes classified as Papilionaceae). Members contain LECTINS.
=688  \\$a2003
=750  \0$aUlex$5IEN-M$0(DLC)sh 85139431

=LDR  01356cz  a2200313n  4500
=001  9880364302202441
=005  20141212215449.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039682
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x400.$x400
=072  \\$aC2.$x800.$x801.$x400.$x400
=072  \\$aC17.$x800.$x849.$x391.$x400
=072  \\$aC18.$x452.$x584.$x625.$x400
=072  \\$aC18.$x452.$x880.$x391.$x400
=072  \\$aC20.$x673.$x480.$x400
=150  \\$aHIV-Associated Lipodystrophy Syndrome
=450  \\$wnnna$aHIV-Associated Lipodystrophy
=450  \\$wnnna$aHIV Associated Lipodystrophy
=450  \\$wnnna$aHIV Associated Lipodystrophy Syndrome
=450  \\$wnnna$aHIV Lipodystrophy Syndrome
=450  \\$wnnna$aLipodystrophy, HIV-Associated
=450  \\$wnnna$aLipodystrophy Syndrome, HIV
=450  \\$wnnna$aLipodystrophy Syndrome, HIV-Associated
=550  \\$wg$aHIV Infections
=550  \\$wg$aLipodystrophy
=680  \\$iDefective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
=688  \\$a2003
=750  \0$aHIV-associated lipodystrophy syndrome$5IEN-M$0(DLC)sh2003008360

=LDR  00737cz  a2200229n  4500
=001  9880364302302441
=005  20141212215444.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x140
=072  \\$aL1.$x178.$x847.$x698.$x249
=072  \\$aN4.$x590.$x374.$x34.$x500
=072  \\$aN5.$x300.$x49.$x500
=150  \\$aAnswering Services
=450  \\$wnnna$aAnswering Service
=550  \\$wg$aAfter-Hours Care
=550  \\$wg$aCommunication
=550  \\$wg$aTelephone
=680  \\$iCommunication services provided by a person or a machine to record and relay the message from the caller.
=688  \\$a2003
=750  \0$aTelephone answering services$5IEN-M$0(DLC)sh 85133406

=LDR  01413cz  a2200373n  4500
=001  9880364302402441
=005  20141212215436.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x566.$x624
=072  \\$aG8.$x686.$x785.$x760.$x769.$x600
=150  \\$aPrenatal Nutritional Physiological Phenomena
=450  \\$wnnna$aNutrition During Pregnancy
=450  \\$wnnna$aNutrition Physiology, Prenatal
=450  \\$wnnna$aNutrition, Pregnancy
=450  \\$wnnna$aNutritional Physiology, Prenatal
=450  \\$wnnna$aPhysiology, Prenatal Nutrition
=450  \\$wnnna$aPhysiology, Prenatal Nutritional
=450  \\$aPregnancy Nutrition
=450  \\$wnno$aPrenatal Nutrition$5IEN-M
=450  \\$aPrenatal Nutrition Physiology
=450  \\$wnnna$aPrenatal Nutritional Physiological Phenomenon
=450  \\$wnnna$aPrenatal Nutritional Physiology
=550  \\$wg$aMaternal Nutritional Physiological Phenomena
=550  \\$wg$aPregnancy
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iNutrition of FEMALE during PREGNANCY.
=688  \\$a2009 (2003)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Prenatal Nutrition Physiology
=688  \\$a2007 (2003)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Prenatal Nutrition
=688  \\$a2003
=750  \0$aPregnancy$xNutritional aspects$0(DLC) sh 85106279$5IEN-M

=LDR  01405cz  a2200325n  4500
=001  9880364302502441
=005  20141212215436.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039382
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x566
=150  \\$aMaternal Nutritional Physiological Phenomena
=450  \\$wnnoa$aMaternal Nutrition$5IEN-M
=450  \\$aMaternal Nutrition Physiology
=450  \\$wnnna$aMaternal Nutritional Physiological Phenomenon
=450  \\$wnnna$aMaternal Nutritional Physiology
=450  \\$wnnna$aNutrition Physiology, Maternal
=450  \\$wnnna$aNutritional Physiology, Maternal
=450  \\$wnnna$aPhysiology, Maternal Nutrition
=450  \\$wnnna$aPhysiology, Maternal Nutritional
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aPrenatal Nutritional Physiological Phenomena
=667  \\$aPRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA is also available
=680  \\$iNutrition of a mother which affects the health of the FETUS and INFANT as well as herself.
=688  \\$a2009 (2003); use NUTRITION 1979-2002
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Maternal Nutrition Physiology
=688  \\$a2007(2003); use NUTRITION 1979-2002
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Maternal Nutrition
=688  \\$a2003; use NUTRITION 1979-2002
=750  \0$aMothers$xNutrition$0(DLC) sh 85087531$5IEN-M

=LDR  01063cz  a2200205n  4500
=001  9880364302602441
=005  20190423162234.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x408.$x495
=150  \\$aReceptors, Fibrinogen
=450  \\$aFibrinogen Receptors
=550  \\$wg$aIntegrins
=550  \\$wh$aMacrophage-1 Antigen
=680  \\$iReceptors that bind FIBRINOGEN through distinct adhesive sequences on the fibrinogen molecule. Although MACROPHAGE-1 ANTIGEN is considered an important signaling molecule for fibrinogen interaction, a variety of INTEGRINS from all three major families, (beta1, beta2, and beta3) have been shown to bind fibrinogen.
=688  \\$a2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002
=750  \0$81$wb$iBroader mapping$aFibrinogen$0(DLC)sh 85048030$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aFibrinogen--Receptors

=LDR  00797cz  a2200181n  4500
=001  9880364302702441
=005  20141212215434.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x205
=150  \\$aClematis
=450  \\$wnnna$aClemati
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain SCOPOLETIN and SAPONINS.
=688  \\$a2003
=750  \0$aClematis$5IEN-N$0(DLC)sh 85026933

=LDR  00836cz  a2200181n  4500
=001  9880364302802441
=005  20141212215107.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032497
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x199
=150  \\$aDennstaedtiaceae
=550  \\$wg$aFerns
=550  \\$wh$aPteridium
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe bracken fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.
=688  \\$a2003
=750  \0$aDennstaedtiaceae$5IEN-M$0(DLC)sh 85036839

=LDR  01082cz  a2200277n  4500
=001  9880364302902441
=005  20141212215106.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032494
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x700.$x666
=150  \\$aPolypodium
=450  \\$wnnna$aCalaguala Fern
=450  \\$wnnna$aCalaguala Ferns
=450  \\$aFern, Calaguala
=450  \\$aFern, Licorice
=450  \\$wnnna$aFerns, Calaguala
=450  \\$wnnna$aFerns, Licorice
=450  \\$wnnna$aLicorice Fern
=450  \\$wnnna$aLicorice Ferns
=450  \\$wnnna$aPolypodiums
=550  \\$wg$aPolypodiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYPODIACEAE. Members contain polypodoside.
=688  \\$a2003
=750  \0$aPolypodium$5IEN-M$0(DLC)sh 85104714

=LDR  01006cz  a2200253n  4500
=001  9880364303002441
=005  20141212215106.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032493
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x222.$x611
=150  \\$aPolystichum
=450  \\$aFern, Giant Holly
=450  \\$wnnna$aFerns, Giant Holly
=450  \\$wnnna$aGiant Holly Fern
=450  \\$wnnna$aGiant Holly Ferns
=450  \\$wnnna$aHolly Fern, Giant
=450  \\$wnnna$aHolly Ferns, Giant
=450  \\$wnnna$aPolystichums
=550  \\$wg$aDryopteridaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family DRYOPTERIDACEAE.
=688  \\$a2003
=750  \0$aPolystichum$5IEN-M$0(DLC)sh 85104733

=LDR  01348cz  a2200349n  4500
=001  9880364303102441
=005  20141212215105.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032492
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x222.$x222
=150  \\$aDryopteris
=450  \\$wnnna$aAspidium filix-ma
=450  \\$wnnna$aAspidium filix-mas
=450  \\$wnnna$aAspidium filix mas
=450  \\$wnnna$aDryopteri
=450  \\$wnnna$aDryopteris filix-ma
=450  \\$wnnna$aDryopteris filix-mas
=450  \\$wnnna$aDryopteris filix mas
=450  \\$aFern, Male
=450  \\$wnnna$aFerns, Male
=450  \\$wnnna$afilix-ma, Aspidium
=450  \\$wnnna$afilix-ma, Dryopteris
=450  \\$wnnna$afilix-mas, Aspidium
=450  \\$wnnna$afilix-mas, Dryopteris
=450  \\$aMale Fern
=450  \\$wnnna$aMale Ferns
=550  \\$wg$aDryopteridaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family DRYOPTERIDACEAE. Members contain aspidin and filicic acid.
=688  \\$a2003
=750  \0$aDryopteris$5IEN-M$0(DLC)sh 85039827

=LDR  00918cz  a2200217n  4500
=001  9880364303202441
=005  20141212215105.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032491
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x222
=150  \\$aDryopteridaceae
=450  \\$aOnoclea
=450  \\$wnnna$aOnocleas
=550  \\$wg$aFerns
=550  \\$wh$aDryopteris
=550  \\$wh$aPolystichum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe wood fern plant family of the order Polypodiales, class Filicopsida, division Pteridophyta.
=688  \\$a2003
=750  \0$aDryopteridaceae$5IEN-M$0(DLC)sh 96000954

=LDR  00864cz  a2200205n  4500
=001  9880364303302441
=005  20141212215105.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032490
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x833
=150  \\$aTaxaceae
=450  \\$aTorreya
=450  \\$wnnna$aTorreyas
=550  \\$wg$aConiferophyta
=550  \\$wh$aTaxus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Taxales, class Pinopsida, division CONIFEROPHYTA.
=688  \\$a2003
=750  \0$aTaxaceae$5IEN-M$0(DLC)sh 85132844

=LDR  00959cz  a2200217n  4500
=001  9880364303402441
=005  20201102113828.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032489
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x855.$x833
=150  \\$aTaxodium
=450  \\$aBald Cypress
=450  \\$wnnna$aBald Cypresses
=450  \\$aCypress, Bald
=450  \\$wnnna$aCypresses, Bald
=450  \\$wnnna$aTaxodiums
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TAXODIACEAE. Members contain taxodione and taxodone, which are diterpenoid quinone methide tumor inhibitors.
=688  \\$a2003
=750  \0$aTaxodium$5IEN-M$0(DLC)sh 88023145

=LDR  00969cz  a2200217n  4500
=001  9880364303502441
=005  20201102113751.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x855.$x788
=150  \\$aSequoiadendron
=450  \\$wnnna$aGiant Sequoia
=450  \\$wnnna$aGiant Sequoias
=450  \\$aSequoia, Giant
=450  \\$wnnna$aSequoiadendrons
=450  \\$wnnna$aSequoias, Giant
=667  \\$aSEQUOIA genus is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TAXODIACEAE known for tall trees like the SEQUOIA redwoods.
=688  \\$a2003
=750  \0$aSequoiadendron$5IEN-M$0(DLC)sh 00003489

=LDR  00870cz  a2200193n  4500
=001  9880364303602441
=005  20201102113726.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032487
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x855.$x777
=150  \\$aSequoia
=450  \\$aRedwood
=450  \\$wnnna$aRedwoods
=450  \\$wnnna$aSequoias
=667  \\$aSEQUOIA, GIANT see SEQUOIADENDRON is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TAXODIACEAE known for including some of the tallest trees.
=688  \\$a2003
=750  \2$aSequoia (Genus)$5IEN-M

=LDR  01020cz  a2200241n  4500
=001  9880364303702441
=005  20201102113634.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032486
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x855.$x177
=150  \\$aCunninghamia
=450  \\$wnnna$aChinese Fir
=450  \\$wnnna$aCunninghamia lanceolata
=450  \\$wnnna$aCunninghamia lanceolatas
=450  \\$wnnna$aCunninghamias
=450  \\$aFir, Chinese
=450  \\$wnnna$alanceolata, Cunninghamia
=450  \\$wnnna$alanceolatas, Cunninghamia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TAXODIACEAE. Members contain DITERPENES.
=688  \\$a2003
=750  \0$aCunninghamia$5IEN-M$0(DLC)sh 85034813

=LDR  00831cz  a2200193n  4500
=001  9880364303802441
=005  20201102113609.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032485
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x122.$x855.$x166
=150  \\$aCryptomeria
=450  \\$aCedar, Japanese
=450  \\$wnnna$aCryptomerias
=450  \\$wnnna$aJapanese Cedar
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TAXODIACEAE. Its POLLEN is one of the major ALLERGENS.
=688  \\$a2003
=750  \2$aCryptomeria$5IEN-M

=LDR  01206cz  a2200337n  4500
=001  9880364304102441
=005  20190528150745.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032481
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x186.$x955
=150  \\$aZamiaceae
=450  \\$wnnna$aCeratozamia
=450  \\$wnnna$aCeratozamias
=450  \\$wnnna$aDioon
=450  \\$wnnna$aDioons
=450  \\$wnnna$aEncephalarto
=450  \\$wnnna$aEncephalartos
=450  \\$aLepidozamia
=450  \\$wnnna$aLepidozamias
=450  \\$wnnna$aMacrozamia
=450  \\$wnnna$aMacrozamias
=450  \\$wnnna$aMicrocyca
=450  \\$wnnna$aMicrocycas
=450  \\$aZamia
=450  \\$wnnna$aZamias
=550  \\$wg$aCycadopsida
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Cycadales, class Cycadopsida, division CYCADOPHYTA.
=688  \\$a2003
=750  \0$aZamiaceae$5IEN-M$0(DLC)sh 86003275

=LDR  00722cz  a2200229n  4500
=001  9880364304202441
=005  20141212215101.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x560
=072  \\$aA18.$x5
=072  \\$aG5.$x360.$x162.$x560
=150  \\$aChromosomes, Plant
=450  \\$wnnna$aChromosome, Plant
=450  \\$wnnna$aPlant Chromosome
=450  \\$wnnna$aPlant Chromosomes
=550  \\$wg$aChromosomes
=550  \\$wg$aPlant Structures
=680  \\$iComplex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of PLANTS.
=688  \\$a2003
=750  \0$aPlant chromosomes$5IEN-M$0(DLC)sh 87005149

=LDR  00804cz  a2200181n  4500
=001  9880364304302441
=005  20141212215100.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032449
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x96
=150  \\$aCanavalia
=450  \\$wnnna$aCanavalias
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Canavalia ensiformis is the source of CONCANAVALIN A.
=688  \\$a2003
=750  \0$aCanavalia$5IEN-M$0(DLC)sh 88022632

=LDR  01056cz  a2200253n  4500
=001  9880364304402441
=005  20141212215100.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032447
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x984
=150  \\$aWisteria
=450  \\$wnnna$afloribunda, Wisteria
=450  \\$wnnna$afloribundas, Wisteria
=450  \\$wnnna$aWistaria
=450  \\$wnnna$aWistarias
=450  \\$wnnna$aWisteria floribunda
=450  \\$wnnna$aWisteria floribundas
=450  \\$wnnna$aWisterias
=550  \\$wg$aFabaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain wistarin, wisteria lectin and wistariasaponin.
=688  \\$a2003
=750  \0$aWisteria$5IEN-M$0(DLC)sh 85147122

=LDR  01265cz  a2200349n  4500
=001  9880364304502441
=005  20141212215059.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x635
=072  \\$aA11.$x872.$x645
=150  \\$aMyoblasts
=450  \\$wnnna$aEmbryonic Muscle Cell
=450  \\$wnnna$aEmbryonic Muscle Cells
=450  \\$wnnna$aMuscle Cell, Embryonic
=450  \\$wnnna$aMuscle Cell, Precursor
=450  \\$aMuscle Cells, Embryonic
=450  \\$wnnna$aMuscle Cells, Precursor
=450  \\$wnnna$aMyoblast
=450  \\$wnnna$aPrecursor Muscle Cell
=450  \\$wnnna$aPrecursor Muscle Cells
=550  \\$wg$aCells
=550  \\$wg$aStem Cells
=550  \\$wh$aMyoblasts, Cardiac
=550  \\$wh$aMyoblasts, Skeletal
=550  \\$wh$aMyoblasts, Smooth Muscle
=550  \\$aMuscle Cells
=667  \\$aprefer specifics
=680  \\$iEmbryonic (precursor) cells of the myogenic lineage that develop from the MESODERM. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes (MYOCYTES, SKELETAL; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE).
=688  \\$a2003
=750  \0$aMyoblasts$5IEN-M$0(DLC)sh 90003813

=LDR  01249cz  a2200289n  4500
=001  9880364304602441
=005  20141212215059.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x987.$x849
=150  \\$aTribulus
=450  \\$aGoathead
=450  \\$wnnna$aGoatheads
=450  \\$aPuncture Vine
=450  \\$wnnna$aPuncture Vines
=450  \\$wnnna$aterrestri, Tribulus
=450  \\$wnnna$aterrestris, Tribulus
=450  \\$wnnna$aTribulus terrestri
=450  \\$wnnna$aTribulus terrestris
=450  \\$wnnna$aVine, Puncture
=450  \\$wnnna$aVines, Puncture
=550  \\$wg$aZygophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZYGOPHYLLACEAE. Members contain steroidal saponins. Ingestion by grazing animals causes PHOTOSENSITIVITY DISORDERS called geeldikkop (yellow thick head) in South Africa.
=688  \\$a2003
=750  \0$aTribulus$5IEN-M$0(DLC)sh 85137433

=LDR  00861cz  a2200181n  4500
=001  9880364304702441
=005  20141212215058.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x987.$x699
=150  \\$aPeganum
=450  \\$wnnna$aPeganums
=550  \\$wg$aZygophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZYGOPHYLLACEAE. Harmala and other ALKALOIDS, phenylpropanoids, and TRITERPENES have been found in plants of this genus.
=688  \\$a2003
=750  \0$aPeganum$5IEN-M$0(DLC)sh 85099231

=LDR  01105cz  a2200253n  4500
=001  9880364304802441
=005  20141212215058.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032442
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x987.$x399
=150  \\$aLarrea
=450  \\$wnnna$aBush, Creosote
=450  \\$wnnna$aBushs, Creosote
=450  \\$aCreosote Bush
=450  \\$wnnna$aCreosote Bushs
=450  \\$aGobernadora
=450  \\$wnnna$aGobernadoras
=450  \\$wnnna$aLarreas
=550  \\$wg$aZygophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZYGOPHYLLACEAE. It is sometimes called chaparral but that is a generic word which is used with a number of other plants. Members contain NORDIHYDROGUAIARETIC ACID.
=688  \\$a2003
=750  \0$aLarrea$5IEN$0(DLC)sh 85074725

=LDR  00972cz  a2200181n  4500
=001  9880364304902441
=005  20150529162752.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032430
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x987.$x88
=150  \\$aBalanites
=450  \\$wnnna$aBalanite
=550  \\$wg$aZygophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZYGOPHYLLACEAE. Feruloyltyramine, balanitoside (a furostanol glycoside), and cytostatic steroidal saponins have been found in this genus. B. aegyptiaca fruit water extract is traditionally used as an anthelmintic in the Sudan.
=688  \\$a2003
=750  \0$aBalanites$0(DLC)sh2014002179$5IEN-M

=LDR  01036cz  a2200253n  4500
=001  9880364305002441
=005  20141212215057.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x900.$x33
=150  \\$aAlpinia
=450  \\$wnnna$aAlpinia galanga
=450  \\$wnnna$aAlpinia galangas
=450  \\$wnnna$aAlpinias
=450  \\$aGalanga
=450  \\$wnnna$agalanga, Alpinia
=450  \\$wnnna$aGalangas
=450  \\$wnnna$agalangas, Alpinia
=550  \\$wg$aZingiberaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.
=688  \\$a2003
=750  \0$aAlpinia$0(DLC) sh2004004524$5IEN-M

=LDR  00969cz  a2200193n  4500
=001  9880364305102441
=005  20141212215056.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032428
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x727
=150  \\$aStrelitziaceae
=450  \\$aStrelitzia
=450  \\$wnnna$aStrelitzias
=550  \\$wg$aZingiberales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida. Some species in this genus are called bird-of-paradise which is also a common name for CAESALPINIA and Heliconia (HELICONIACEAE).
=688  \\$a2003
=750  \0$aStrelitziaceae$0(DLC)sh2008006474$5IEN-M

=LDR  00830cz  a2200193n  4500
=001  9880364305202441
=005  20141212215056.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x323
=150  \\$aHeliconiaceae
=450  \\$aHeliconia
=450  \\$wnnna$aHeliconias
=550  \\$wg$aZingiberales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.
=688  \\$a2003
=750  \0$aHeliconia$5IEN-M$0(DLC)sh 85059996

=LDR  01063cz  a2200265n  4500
=001  9880364305302441
=005  20141212215056.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032426
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x522
=150  \\$aMarantaceae
=450  \\$aArrowroot
=450  \\$wnnna$aArrowroots
=450  \\$aCalathea
=450  \\$wnnna$aCalatheas
=450  \\$aMaranta
=450  \\$wnnna$aMarantas
=450  \\$aThalia
=450  \\$wnnna$aThalias
=550  \\$wg$aZingiberales
=667  \\$aX ref ARROWROOT: BRAZILIAN ARROWROOT see MANIHOT is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.
=688  \\$a2003
=750  \0$aMarantaceae$5IEN-M$0(DLC)sh 85080901

=LDR  00908cz  a2200181n  4500
=001  9880364305402441
=005  20141212215055.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032424
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x970.$x199
=150  \\$aDrimys
=450  \\$wnnna$aDrimy
=550  \\$wg$aWinteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family WINTERACEAE. They have leathery, elliptic-shaped leaves; red-tinged shoots; and jasmine-scented, cream-colored, 8- to 12-petaled, 2.5-centimeter (1-inch) flowers in clusters.
=688  \\$a2003
=750  \0$aDrimys$5IEN-M$0(DLC)sh 85039570

=LDR  01099cz  a2200193n  4500
=001  9880364305502441
=005  20141212215055.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x970
=150  \\$aWinteraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aDrimys
=550  \\$wh$aPseudowintera
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. The wood lacks water-conducting cells but has acrid sap. The leaves are gland-dotted, leathery, and smooth-margined. The flowers are small, in clusters, with two to six sepals, petals in two or more series, several stamens, and one to several carpels.
=688  \\$a2003
=750  \0$aWinteraceae$5IEN-M$0(DLC)sh 85147047

=LDR  00775cz  a2200169n  4500
=001  9880364305602441
=005  20141212215055.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x965.$x272
=150  \\$aCissus
=550  \\$wg$aVitaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VITACEAE. Cissus rufescence gum is considered comparable to TRAGACANTH.
=688  \\$a2003
=750  \0$aCissus$5IEN-M$0(DLC)sh2001004282

=LDR  01252cz  a2200301n  4500
=001  9880364305702441
=005  20141212215054.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x965.$x44
=150  \\$aAmpelopsis
=450  \\$wnnna$aAmpelopses
=450  \\$wnnna$aBerry Plant, Porcelain
=450  \\$wnnna$aBerry Plants, Porcelain
=450  \\$wnnna$aPlant, Porcelain Berry
=450  \\$wnnna$aPlant, Porcelainberry
=450  \\$wnnna$aPlants, Porcelain Berry
=450  \\$wnnna$aPlants, Porcelainberry
=450  \\$wnnna$aPorcelain Berry Plant
=450  \\$wnnna$aPorcelain Berry Plants
=450  \\$wnnna$aPorcelainberry Plant
=450  \\$wnnna$aPorcelainberry Plants
=550  \\$wg$aVitaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VITACEAE. Members contain momordin and SITOSTEROLS.
=688  \\$a2003
=750  \0$aAmpelopsis$5IEN-M$0(DLC)sh2001004283

=LDR  01004cz  a2200229n  4500
=001  9880364305802441
=005  20141212215054.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032413
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x962.$x888
=150  \\$aViola
=450  \\$wnnna$aPansies
=450  \\$aPansy
=450  \\$wnnna$aViolas
=450  \\$aViolet
=450  \\$wnnna$aViolets
=550  \\$wg$aViolaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.
=688  \\$a2003
=750  \0$aViolets$5IEN-M$0(DLC)sh 85143541

=LDR  00896cz  a2200205n  4500
=001  9880364305902441
=005  20141212215053.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032412
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x960.$x855
=150  \\$aVerbena
=450  \\$wnnna$aVerbenas
=450  \\$aVervain
=450  \\$wnnna$aVervains
=550  \\$wg$aVerbenaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VERBENACEAE. Members contain verbenachalcone (dimeric dihydrochalcone), iridoids, and phenylethanoids.
=688  \\$a2003
=750  \0$aVerbena$5IEN-M$0(DLC)sh 85142801

=LDR  00974cz  a2200181n  4500
=001  9880364306002441
=005  20141212215053.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032411
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x960.$x433
=150  \\$aLippia
=450  \\$wnnna$aLippias
=550  \\$wg$aVerbenaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VERBENACEAE. Lippsidoquinone; TRITERPENES; SESQUITERPENES; and THYMOL have been found in this genus. Plant extracts have cytotoxic activity. It is sometimes called Mexican oregano but that confuses it with real oregano (ORIGANUM).
=688  \\$a2003
=750  \0$aLippia (Genus)$5IEN-M$0(DLC)sh 88022887

=LDR  00800cz  a2200181n  4500
=001  9880364306102441
=005  20141212215053.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x960.$x411
=150  \\$aLantana
=450  \\$wnnna$aLantanas
=550  \\$wg$aVerbenaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VERBENACEAE. Members contain lantadene and other TRITERPENES.
=688  \\$a2003
=750  \0$aLantana$5IEN-M$0(DLC)sh 85074627

=LDR  01053cz  a2200241n  4500
=001  9880364306202441
=005  20141212215052.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x960.$x66
=150  \\$aAvicennia
=450  \\$wnnna$aAvicennias
=450  \\$wnnna$aGrey Mangrove
=450  \\$wnnna$aGrey Mangroves
=450  \\$aMangrove, Grey
=450  \\$wnnna$aMangroves, Grey
=550  \\$wg$aVerbenaceae
=550  \\$aWetlands
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29; note entry term MANGROVE, GREY: MANGROVE SWAMPS see WETLANDS is also available
=680  \\$iA plant genus of the family VERBENACEAE. Members contain NAPHTHOQUINONES.
=688  \\$a2003
=750  \0$aMangrove plants$5IEN-M$0(DLC)sh 85080527

=LDR  00896cz  a2200181n  4500
=001  9880364306302441
=005  20141212215051.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032405
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x955.$x665
=150  \\$aPatrinia
=450  \\$wnnna$aPatrinias
=550  \\$wg$aValerianaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VALERIANACEAE. Members contain ursolic acid and oleanolic acid glycosides, sulfapatrinosides (triterpenoid glycosides), and patriscabrol (iridolactone).
=688  \\$a2003
=750  \0$aPatrinia$5IEN-M$0(DLC)sh 88022973

=LDR  00900cz  a2200205n  4500
=001  9880364306402441
=005  20141212215050.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032402
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x950.$x77
=150  \\$aBoehmeria
=450  \\$wnnna$aBoehmerias
=450  \\$aRamie
=450  \\$wnnna$aRamies
=550  \\$wg$aUrticaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family URTICACEAE. Members contain cryptopleurine, beta-sitosterol, daucosterol and 19 alpha-hydroxyursolic acid.
=688  \\$a2003
=750  \0$aBoehmeria$5IEN-M$0(DLC)sh 88022600

=LDR  00937cz  a2200217n  4500
=001  9880364306502441
=005  20141212215050.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x948
=150  \\$aTyphaceae
=450  \\$aCattail
=450  \\$wnnna$aCattails
=450  \\$aTypha
=450  \\$wnnna$aTyphas
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Typhales, subclass Commelinidae, class Liliopsida (monocotyledons) that contains a single genus, Typha, that grows worldwide.
=688  \\$a2003
=750  \0$aTyphaceae$5IEN-M$0(DLC)sh 85139145

=LDR  01445cz  a2200277n  4500
=001  9880364306602441
=005  20141212215049.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x942.$x500
=150  \\$aTropaeolum
=450  \\$aCress, Indian
=450  \\$wnnna$aGarden Nasturtium
=450  \\$wnnna$aGarden Nasturtiums
=450  \\$wnnna$aIndian Cress
=450  \\$wnnna$amajus, Tropaeolum
=450  \\$aNasturtium, Garden
=450  \\$wnnna$aNasturtiums, Garden
=450  \\$wnnna$aTropaeolum majus
=450  \\$wnnna$aTropaeolums
=550  \\$wg$aTropaeolaceae
=667  \\$aX ref NASTURTIUM, GARDEN: the genus NASTURTIUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TROPAEOLACEAE. The common nasturtium is a plant that grows 2.4-3.6 m (8-12 feet) tall and has funnel-shaped flowers that are commonly yellow-orange with red spots or stripes and have a long spur that contains sweet nectar. Some species in this genus are called watercress which is also a common name for RORIPPA and NASTURTIUM.
=688  \\$a2003
=750  \0$aTropaeolum$5IEN-M$0(DLC)sh 85138042

=LDR  00817cz  a2200181n  4500
=001  9880364306702441
=005  20141212215048.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032387
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x942
=150  \\$aTropaeolaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aTropaeolum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aTropaeolaceae$5IEN-M$0(DLC)sh 85138041

=LDR  01079cz  a2200229n  4500
=001  9880364306802441
=005  20141212215046.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032384
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x938.$x777
=150  \\$aTilia
=450  \\$aBasswood
=450  \\$wnnna$aBasswoods
=450  \\$aLinden
=450  \\$wnnna$aLindens
=450  \\$wnnna$aTilias
=550  \\$wg$aTiliaceae
=667  \\$aLime citrus fruit see CITRUS AURANTIIFOLIA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime (CITRUS AURANTIIFOLIA). Some people are allergic to the POLLEN.
=688  \\$a2003
=750  \0$aLindens$5IEN-M$0(DLC)sh 85077148

=LDR  00775cz  a2200169n  4500
=001  9880364306902441
=005  20141212215045.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x938.$x144
=150  \\$aCorchorus
=550  \\$wg$aTiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family TILIACEAE. Members contain cycloartane saponins and CARDENOLIDES.
=688  \\$a2003
=750  \0$aCorchorus$5IEN-M$0(DLC)sh 88004900

=LDR  00844cz  a2200181n  4500
=001  9880364307002441
=005  20141212215045.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x932.$x909
=150  \\$aWikstroemia
=450  \\$wnnna$aWikstroemias
=550  \\$wg$aThymelaeaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family THYMELAEACEAE. Members contain daphnoretin and wikstroelides and daphnane-type DITERPENES.
=688  \\$a2003
=750  \0$aWikstroemia$0(DLC) sh 85146649$5IEN-M

=LDR  00932cz  a2200181n  4500
=001  9880364307102441
=005  20141212215045.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032364
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x932.$x500
=150  \\$aDaphne
=450  \\$wnnna$aDaphnes
=550  \\$wg$aThymelaeaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family THYMELAEACEAE. They are evergreen shrubs much cultivated in garden borders and rock gardens in mild climates. Members contain mezerein, flavonoids, and COUMARINS such as daphnetin and daphnin.
=688  \\$a2003
=750  \0$aDaphnes$0(DLC) sh 88022736$5IEN-M

=LDR  00898cz  a2200217n  4500
=001  9880364307202441
=005  20200422111921.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032363
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x992
=150  \\$aTamaricaceae
=450  \\$wnnna$aTamarices
=450  \\$aTamarisk
=450  \\$wnnna$aTamarisks
=450  \\$aTamarix
=550  \\$wg$aCaryophyllales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aTamaricaceae$5IEN-M$0(DLC)sh 87005363

=LDR  02390cz  a2200565n  4500
=001  9880364466502441
=005  20141212220226.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049970
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x270.$x842
=072  \\$aC11.$x675.$x349.$x500.$x500
=072  \\$aC19.$x874.$x283.$x605.$x500
=072  \\$aC19.$x874.$x397.$x370.$x500
=072  \\$aC20.$x111.$x555.$x500
=150  \\$aGraves Ophthalmopathy
=450  \\$wnnna$aCongestive Ophthalmopathies
=450  \\$wnnna$aCongestive Ophthalmopathy
=450  \\$wnnna$aDysthyroid Ophthalmopathies
=450  \\$wnnna$aDysthyroid Ophthalmopathy
=450  \\$wnnna$aEdematous Ophthalmopathies
=450  \\$wnnna$aEdematous Ophthalmopathy
=450  \\$wnnna$aInfiltrative Ophthalmopathies
=450  \\$wnnna$aInfiltrative Ophthalmopathy
=450  \\$wnnna$aMyopathic Ophthalmopathies
=450  \\$wnnna$aMyopathic Ophthalmopathy
=450  \\$wnnna$aOphthalmopathies, Congestive
=450  \\$wnnna$aOphthalmopathies, Dysthyroid
=450  \\$wnnna$aOphthalmopathies, Edematous
=450  \\$wnnna$aOphthalmopathies, Infiltrative
=450  \\$wnnna$aOphthalmopathies, Myopathic
=450  \\$wnnna$aOphthalmopathies, Thyroid-Associated
=450  \\$wnnna$aOphthalmopathies, Thyroid Associated
=450  \\$wnnna$aOphthalmopathy, Congestive
=450  \\$wnnna$aOphthalmopathy, Dysthyroid
=450  \\$wnnna$aOphthalmopathy, Edematous
=450  \\$wnnna$aOphthalmopathy, Graves
=450  \\$aOphthalmopathy, Infiltrative
=450  \\$wnnna$aOphthalmopathy, Myopathic
=450  \\$aOphthalmopathy, Thyroid-Associated
=450  \\$wnnna$aOphthalmopathy, Thyroid Associated
=450  \\$wnnna$aThyroid-Associated Ophthalmopathies
=450  \\$wnnna$aThyroid Associated Ophthalmopathies
=450  \\$aThyroid-Associated Ophthalmopathy
=450  \\$wnnna$aThyroid Associated Ophthalmopathy
=550  \\$wg$aEye Diseases, Hereditary
=550  \\$wg$aGraves Disease
=680  \\$iAn autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
=688  \\$a2006; use GRAVES DISEASE 1997-2005
=750  \0$aThyroid eye disease$0(DLC) sh 85135162$5IEN-M

=LDR  00980cz  a2200229n  4500
=001  9880364466602441
=005  20141212220224.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049936
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x118
=150  \\$aAnthocerotophyta
=450  \\$wnnna$aAnthocero
=450  \\$wnnna$aAnthoceros
=450  \\$wnnna$aAnthocerotophytas
=450  \\$wnnna$aHornwort
=450  \\$wnnna$aHornworts
=550  \\$wg$aEmbryophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant division that includes hornworts, named for the horn-like appearance of the spore-producing plant (sporophyte).
=688  \\$a2006
=750  \0$aHornworts (Bryophytes)$0(DLC) sh 85005529$5IEN-M

=LDR  00904cz  a2200193n  4500
=001  9880364466702441
=005  20141212220224.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049935
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x489
=150  \\$aHernandiaceae
=450  \\$wnnna$aHernandia
=450  \\$wnnna$aHernandias
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida. Members contain cytotoxic furofuran LIGNANS and isoquinoline ALKALOIDS.
=688  \\$a2006
=750  \0$aHernandiaceae$0(DLC) sh 85060422$5IEN-M

=LDR  00801cz  a2200181n  4500
=001  9880364466802441
=005  20141212220223.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049931
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x726
=150  \\$aSesbania
=450  \\$wnnna$aSesbanias
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain piperidine alkaloids (PIPERIDINES).
=688  \\$a2006
=750  \0$aSesbania$0(DLC) sh 85120374$5IEN-M

=LDR  00874cz  a2200205n  4500
=001  9880364467002441
=005  20141212220222.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049919
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x342
=150  \\$aErigeron
=450  \\$wnnna$aErigerons
=450  \\$wnnna$aFleabane
=450  \\$wnnna$aFleabanes
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that is similar to CONYZA. Members contain SESQUITERPENES.
=688  \\$a2006
=750  \0$aErigeron$0(DLC) sh 94000354$5IEN-M

=LDR  01158cz  a2200301n  4500
=001  9880364467102441
=005  20200430133223.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049917
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x875
=150  \\$aDipsacaceae
=450  \\$wnnna$aCephalaria
=450  \\$wnnna$aCephalarias
=450  \\$wnnna$aDipsacus
=450  \\$wnnna$aKnautia
=450  \\$wnnna$aKnautias
=450  \\$wnnna$aScabiosa
=450  \\$wnnna$aScabiosas
=450  \\$wnnna$aSuccisa
=450  \\$wnnna$aSuccisas
=450  \\$wnnna$aTeasel
=450  \\$wnnna$aTeasels
=550  \\$wg$aDipsacales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. It is sometimes called the teasel family.
=688  \\$a2006
=750  \0$aDipsacaceae$0(DLC) sh 85038233$5IEN-M

=LDR  00660cz  a2200193n  4500
=001  9880364467202441
=005  20141212220221.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049916
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x600
=150  \\$aPolyplacophora
=450  \\$wnnna$aChiton
=450  \\$aChitons
=450  \\$wnnna$aPolyplacophoras
=550  \\$wg$aMollusca
=680  \\$iA class in the phylum MOLLUSCA comprised of flattened, elongated marine mollusks, commonly called chitons. They are unique in that they possess seven or eight separate shell plates.
=688  \\$a2006
=750  \0$aChitons$0(DLC) sh 85024496$5IEN-M

=LDR  01241cz  a2200289n  4500
=001  9880364467302441
=005  20141212220220.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049915
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238.$x500.$x750
=150  \\$aIpomoea nil
=450  \\$wnnna$aGlory, Japanese Morning
=450  \\$wnnna$aIpomoea nils
=450  \\$wnnna$aJapanese Morning Glory
=450  \\$wnnna$aMorning Glory, Japanese
=450  \\$wnnna$anil, Ipomoea
=450  \\$wnnna$anil, Pharbitis
=450  \\$wnnna$anils, Ipomoea
=450  \\$wnnna$anils, Pharbitis
=450  \\$wnnna$aPharbitis nil
=450  \\$wnnna$aPharbitis nils
=550  \\$wg$aIpomoea
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus IPOMOEA, family CONVOLVULACEAE. An abundance of spontaneous mutants makes it useful in study of PLANT DNA and GENETICS.
=688  \\$a2006
=750  \0$aJapanese morning glory$0(DLC) sh 85069687$5IEN-M

=LDR  00787cz  a2200217n  4500
=001  9880364467402441
=005  20141212220218.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049911
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x670
=150  \\$aPinctada
=450  \\$wnnna$aOyster, Pearl
=450  \\$aOysters, Pearl
=450  \\$wnnna$aPearl Oyster
=450  \\$wnnna$aPearl Oysters
=450  \\$wnnna$aPinctadas
=550  \\$wg$aBivalvia
=680  \\$iA genus of pearl oysters in the family Pteriidae, class BIVALVIA. Both cultured and natural pearls are obtained from species in the genus. They are distinct from the distantly related, edible true oysters of the family OSTREIDAE.
=688  \\$a2006
=750  \0$aPinctada$0(DLC) sh 93000102$5IEN-M

=LDR  00715cz  a2200205n  4500
=001  9880364467502441
=005  20141212220218.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049910
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x660.$x600
=150  \\$aPecten
=450  \\$wnnna$amaximus, Pecten
=450  \\$wnnna$aPecten maximus
=450  \\$wnnna$aPectens
=550  \\$wg$aPectinidae
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA genus of scallops in the family PECTINIDAE, class BIVALVIA. The shell is usually radially ribbed.
=688  \\$a2006
=750  \0$aPecten$0(DLC) sh 95004855$5IEN-M

=LDR  00889cz  a2200253n  4500
=001  9880364467602441
=005  20141212220218.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049897
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x660
=150  \\$aPectinidae
=450  \\$wnnna$aChlamy
=450  \\$aChlamys
=450  \\$aPatinopecten
=450  \\$wnnna$aPatinopectens
=450  \\$wnnna$aScallop
=450  \\$aScallops
=550  \\$wg$aBivalvia
=550  \\$wh$aPecten
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA large family of mollusks in the class BIVALVIA, known commonly as scallops. They possess flat, almost circular shells and are found in all seas from shallow water to great depths.
=688  \\$a2006
=750  \0$aScallops$0(DLC) sh 85117923$5IEN-M

=LDR  01100cz  a2200325n  4500
=001  9880364467702441
=005  20141212220217.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049896
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x643.$x150
=150  \\$aCrassostrea
=450  \\$wnnna$aCrassostrea giga
=450  \\$wnnna$aCrassostrea gigas
=450  \\$wnnna$aCrassostrea virginica
=450  \\$wnnna$aCrassostrea virginicas
=450  \\$wnnna$aCrassostreas
=450  \\$wnnna$aEastern Oyster
=450  \\$wnnna$aEastern Oysters
=450  \\$wnnna$agiga, Crassostrea
=450  \\$wnnna$agigas, Crassostrea
=450  \\$wnnna$aOyster, Eastern
=450  \\$aOysters, Eastern
=450  \\$wnnna$avirginica, Crassostrea
=450  \\$wnnna$avirginicas, Crassostrea
=550  \\$wg$aOstreidae
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA genus of oysters in the family OSTREIDAE, class BIVALVIA.
=688  \\$a2006
=750  \0$aCrassostrea$0(DLC) sh 85033771$5IEN-M

=LDR  00967cz  a2200277n  4500
=001  9880364467802441
=005  20141212220217.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049895
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x643.$x600
=150  \\$aOstrea
=450  \\$wnnna$aeduli, Ostrea
=450  \\$wnnna$aedulis, Ostrea
=450  \\$wnnna$aOstrea eduli
=450  \\$wnnna$aOstrea edulis
=450  \\$wnnna$aOstreas
=450  \\$wnnna$aOyster, True
=450  \\$aOysters, True
=450  \\$wnnna$aTrue Oyster
=450  \\$wnnna$aTrue Oysters
=550  \\$wg$aOstreidae
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM); index oysters unspecified at OYSTERS see OSTREIDAE
=680  \\$iA genus of oysters in the family OSTREIDAE, which includes the edible true oyster, Ostrea edulis.
=688  \\$a2006
=750  \0$aOstrea$0(DLC) sh 85096006$5IEN-M

=LDR  00742cz  a2200241n  4500
=001  9880364467902441
=005  20141212220217.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049893
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x50
=150  \\$aArcidae
=450  \\$aAnadara
=450  \\$wnnna$aAnadaras
=450  \\$wnnna$aArk Shell
=450  \\$wnnna$aArk Shells
=450  \\$wnnna$aShell, Ark
=450  \\$wnnna$aShells, Ark
=550  \\$wg$aBivalvia
=550  \\$wh$aScapharca
=680  \\$iA family of ark shell mollusks, in the class BIVALVIA. They have soft bodies with platelike GILLS enclosed within two shells hinged together.
=688  \\$a2006
=750  \0$aArcidae$0(DLC)sh2010012277$5IEN-M

=LDR  00879cz  a2200277n  4500
=001  9880364468002441
=005  20141212220216.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049892
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x535
=150  \\$aMya
=450  \\$wnnna$aarenaria, Mya
=450  \\$wnnna$aarenarias, Mya
=450  \\$wnnna$aClam, Softshell
=450  \\$aClams, Softshell
=450  \\$wnnna$aMya arenaria
=450  \\$wnnna$aMya arenarias
=450  \\$wnnna$aMyas
=450  \\$wnnna$aSoftshell Clam
=450  \\$wnnna$aSoftshell Clams
=550  \\$wg$aBivalvia
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA genus of soft-shell clams in the family Myidae, class BIVALVIA.
=688  \\$a2006
=750  \0$aMya$0(DLC) sh 85089169$5IEN-M

=LDR  00783cz  a2200205n  4500
=001  9880364468102441
=005  20141212220216.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049891
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x500
=150  \\$aMercenaria
=450  \\$wnnna$aMercenarias
=450  \\$wnnna$aQuahog
=450  \\$aQuahogs
=550  \\$wg$aBivalvia
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA genus of hard-shelled clams in the family Veneridae, class BIVALVIA, commonly called quahogs. They are found just below the surface in the subtidal or lower intertidal coastal waters.
=688  \\$a2006
=750  \0$aMercenaria$0(DLC) sh 88001043$5IEN-M

=LDR  00485cz  a2200169n  4500
=001  9880364468302441
=005  20141212220215.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x850.$x850
=150  \\$aUnio
=450  \\$wnnna$aUnios
=550  \\$wg$aUnionidae
=680  \\$iA genus of freshwater mussels in the family UNIONIDAE, class BIVALVIA.
=688  \\$a2006
=750  \0$aUnio$0(DLC) sh 88021252$5IEN-M

=LDR  01070cz  a2200301n  4500
=001  9880364468402441
=005  20141212220215.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049880
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x537.$x500.$x500
=150  \\$aMytilus edulis
=450  \\$wnnna$aBlue Mussel
=450  \\$wnnna$aBlue Mussels
=450  \\$wnnna$aCommon Mussel
=450  \\$wnnna$aCommon Mussels
=450  \\$wnnna$aeduli, Mytilus
=450  \\$wnnna$aedulis, Mytilus
=450  \\$wnnna$aMussel, Blue
=450  \\$wnnna$aMussel, Common
=450  \\$aMussels, Blue
=450  \\$aMussels, Common
=450  \\$wnnna$aMytilus eduli
=550  \\$wg$aMytilus
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA species of mussel in the genus MYTILUS, family MYTILIDAE, class BIVALVIA, known as the common mussel. It has a bluish-black shell and is highly edible.
=688  \\$a2006
=750  \0$aMytilus edulis$0(DLC) sh 85089445$5IEN-M

=LDR  00491cz  a2200181n  4500
=001  9880364468502441
=005  20141212220215.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049879
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x537
=150  \\$aMytilidae
=550  \\$wg$aBivalvia
=550  \\$wh$aMytilus
=550  \\$wh$aPerna
=680  \\$iA family of marine MUSSELS in the class BIVALVIA.
=688  \\$a2006
=750  \0$aMytilidae$0(DLC) sh 85089441$5IEN-M

=LDR  00580cz  a2200169n  4500
=001  9880364468602441
=005  20141212220215.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049878
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x537.$x500
=150  \\$aMytilus
=550  \\$wg$aMytilidae
=550  \\$wh$aMytilus edulis
=680  \\$iA genus of marine mussels in the family MYTILIDAE, class BIVALVIA. The species MYTILUS EDULIS is the highly edible common mussel.
=688  \\$a2006; use BIVALVIA 1979-2005
=750  \0$aMytilus$0(DLC) sh 85089443$5IEN-M

=LDR  00509cz  a2200169n  4500
=001  9880364468702441
=005  20141212220214.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D049877
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x850.$x50
=150  \\$aAnodonta
=450  \\$wnnna$aAnodontas
=550  \\$wg$aUnionidae
=680  \\$iA genus of thin-shelled freshwater mussels in the family UNIONIDAE, class BIVALVIA.
=688  \\$a2006
=750  \0$aAnodonta$0(DLC) sh 88021172$5IEN-M

=LDR  00746cz  a2200217n  4500
=001  9880364468902441
=005  20141212220132.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048790
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x237.$x700
=150  \\$aRenilla
=450  \\$wnnna$aPansies, Sea
=450  \\$wnnna$aPansy, Sea
=450  \\$wnnna$aRenillas
=450  \\$wnnna$aSea Pansies
=450  \\$aSea Pansy
=550  \\$wg$aAnthozoa
=680  \\$iA genus of bioluminescent marine invertebrates in the family Renillidae, order Pennatulacea, class ANTHOZOA. It contains Renilla LUCIFERASE which oxidizes coelenterazine resulting in LUMINESCENCE.
=688  \\$a2005
=750  \0$aSea pansies$0(DLC)sh2007005937$5IEN-M

=LDR  00686cz  a2200193n  4500
=001  9880364469002441
=005  20141212220132.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048789
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x277.$x540.$x500
=150  \\$aPhytoestrogens
=450  \\$wnnna$aPhyto-Estrogen
=450  \\$wnnna$aPhyto Estrogen
=450  \\$wnnna$aPhytoestrogen
=550  \\$wg$aEstrogens, Non-Steroidal
=680  \\$iPLANT EXTRACTS and compounds, primarily ISOFLAVONES, that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.
=688  \\$a2005(1978)
=750  \0$aPhytoestrogens$0(DLC) sh 00009583$5IEN-M

=LDR  00315cz  a2200109n  4500
=001  9880364469102441
=005  20071019102642.0
=008  040707\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D048788Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aGrowth and Development$xgenetics
=750  \0$aDevelopmental genetics$0(DLC) sh 85037356$5IEN-M

=LDR  01334cz  a2200409n  4500
=001  9880364469202441
=005  20141212220131.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x134.$x220.$x220
=072  \\$aG5.$x355.$x105.$x220
=150  \\$aCell Nucleus Division
=450  \\$aCell Nucleus Division Phases
=450  \\$wnnna$aCell Nucleus Divisions
=450  \\$wnnna$aDivision, Cell Nucleus
=450  \\$wnnna$aDivision, Nuclear
=450  \\$wnnna$aDivisions, Cell Nucleus
=450  \\$wnnna$aDivisions, Nuclear
=450  \\$aKaryokinesis
=450  \\$aNuclear Division
=450  \\$wnnna$aNuclear Divisions
=450  \\$wnnna$aNucleus Division, Cell
=450  \\$wnnna$aNucleus Divisions, Cell
=550  \\$wg$aCell Division
=550  \\$wh$aAnaphase
=550  \\$wh$aChromosome Segregation
=550  \\$wh$aMeiosis
=550  \\$wh$aMetaphase
=550  \\$wh$aMitosis
=550  \\$wh$aPrometaphase
=550  \\$wh$aProphase
=550  \\$wh$aTelophase
=667  \\$a1st phase = PROPHASE, 2d phase = METAPHASE, 3d phase = ANAPHASE, final phase = TELOPHASE
=680  \\$iThe process by which the CELL NUCLEUS is divided.
=688  \\$a2005; for KARYOKINESIS use MITOSIS 1981-2004
=750  \0$aKaryokinesis$0(DLC) sh 85071684$5IEN-M

=LDR  00808cz  a2200229n  4500
=001  9880364469302441
=005  20141212220130.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048749
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x134.$x220.$x250
=150  \\$aCytokinesis
=450  \\$wnnna$aCytokineses
=450  \\$wnnna$aCytoplasmic Division
=450  \\$wnnna$aCytoplasmic Divisions
=450  \\$wnnna$aDivision, Cytoplasmic
=450  \\$wnnna$aDivisions, Cytoplasmic
=550  \\$wg$aCell Division
=667  \\$apermitted with microorganisms; do not confuse CYTOKINESIS with CELL MOVEMENT or CYTOPLASMIC STREAMING
=680  \\$iThe process by which the CYTOPLASM of a cell is divided.
=688  \\$a2005; use CELL DIVISION 1985-2004
=750  \0$aCytokinesis$0(DLC) sh 85035237$5IEN-M

=LDR  00712cz  a2200229n  4500
=001  9880364469402441
=005  20170620110923.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048708
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x233
=072  \\$aG7.$x345.$x249.$x410
=150  \\$aCell Growth Processes
=450  \\$wnnna$aProcesses, Cell Growth
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wg$aGrowth
=550  \\$wh$aCell Enlargement
=550  \\$wh$aCell Proliferation
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iProcesses required for CELL ENLARGEMENT and CELL PROLIFERATION.
=688  \\$a2005
=750  \0$aCells$xGrowth$0(DLC) sh 85021686$5IEN-M

=LDR  00690cz  a2200241n  4500
=001  9880364469502441
=005  20141212220128.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048691
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x350
=150  \\$aGrifola
=450  \\$wnnna$afrondosa, Grifola
=450  \\$wnnna$afrondosas, Grifola
=450  \\$wnnna$aGrifola frondosa
=450  \\$wnnna$aGrifola frondosas
=450  \\$wnnna$aGrifolas
=450  \\$wnnna$aMaitake
=450  \\$wnnna$aMaitakes
=550  \\$wg$aAgaricales
=680  \\$iA member of the AGARICALES known for edible MUSHROOMS.
=688  \\$a2005
=750  \0$aGrifola$0(DLC) sh 99001491$5IEN-M

=LDR  00661cz  a2200169n  4500
=001  9880364469602441
=005  20141212220126.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048668
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x475.$x250
=072  \\$aB3.$x510.$x550.$x450.$x475.$x250
=150  \\$aLactobacillus delbrueckii
=550  \\$wg$aLactobacillus
=680  \\$iA species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing LACTIC ACID. It is important in the manufacture of fermented dairy products.
=688  \\$a2005
=750  \0$aLactobacillus delbrueckii$0(DLC) sh 88023273$5IEN-M

=LDR  00743cz  a2200217n  4500
=001  9880364469702441
=005  20141212220124.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048628
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x250.$x445
=150  \\$aKetolides
=450  \\$wnnna$a3-Keto-Erythromycins
=450  \\$wnnna$a3 Keto Erythromycins
=450  \\$wnnna$a3-Keto Erythromycins
=450  \\$wnnna$aErythromycins, 3-Keto
=450  \\$wnnna$aErythromycins, 3 Keto
=550  \\$wg$aErythromycin
=680  \\$iCompounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.
=688  \\$a2005
=750  \0$aKetolide antibiotics$0(DLC)sh2009006392$5IEN-M

=LDR  00835cz  a2200229n  4500
=001  9880364469802441
=005  20141212220123.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x513.$x500
=150  \\$aRupicapra
=450  \\$aChamois
=450  \\$aChamois, Pyrenean
=450  \\$wnnna$aPyrenean Chamois
=450  \\$wnnna$aRupicapra pyrenaica
=450  \\$wnnna$aRupicapra rupicapra
=450  \\$wnnna$aRupicapras
=550  \\$wg$aGoats
=680  \\$iA genus of ruminants in the family Bovidae. The common name chamois usually refers to the species Rupicapra rupicapra. Rupicapra pyrenaica, found in the Pyrenees, is more properly referred to as the Pyrenean chamois.
=688  \\$a2005
=750  \0$aRupicapra$0(DLC) sh 85115879$5IEN-M

=LDR  00709cz  a2200205n  4500
=001  9880364469902441
=005  20141212220123.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048549
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610.$x800
=150  \\$aPapio ursinus
=450  \\$wnnna$aBaboon, Chacma
=450  \\$wnnna$aBaboons, Chacma
=450  \\$aChacma Baboon
=450  \\$wnnna$aChacma Baboons
=550  \\$wg$aPapio
=680  \\$iA species of baboon in the family CERCOPITHECIDAE found in southern Africa. They are dark colored and have a variable social structure.
=688  \\$a2005
=750  \0$aChacma baboon$0(DLC) sh 85022240$5IEN-M

=LDR  00734cz  a2200205n  4500
=001  9880364470002441
=005  20141212220122.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048548
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610.$x150
=150  \\$aPapio cynocephalus
=450  \\$wnnna$aBaboon, Yellow
=450  \\$wnnna$aBaboons, Yellow
=450  \\$aYellow Baboon
=450  \\$wnnna$aYellow Baboons
=550  \\$wg$aPapio
=680  \\$iA species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.
=688  \\$a2005
=750  \0$aYellow baboon$0(DLC) sh 85149079$5IEN-M

=LDR  00606cz  a2200181n  4500
=001  9880364470102441
=005  20141212220122.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048531
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610.$x600
=150  \\$aPapio papio
=450  \\$wnnna$aBaboon, Guinea
=450  \\$wnnna$aGuinea Baboon
=550  \\$wg$aPapio
=680  \\$iA species of baboon in the family CERCOPITHECIDAE, often used as an animal model for cognitive studies.
=688  \\$a2005
=750  \0$aGuinea baboon$0(DLC) sh 96000424$5IEN-M

=LDR  00739cz  a2200205n  4500
=001  9880364470202441
=005  20141212220122.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048530
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610.$x50
=150  \\$aPapio anubis
=450  \\$wnnna$aBaboon, Olive
=450  \\$wnnna$aBaboons, Olive
=450  \\$aOlive Baboon
=450  \\$wnnna$aOlive Baboons
=550  \\$wg$aPapio
=680  \\$iA species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.
=688  \\$a2005
=750  \0$aOlive baboon$0(DLC) sh 85094615$5IEN-M

=LDR  00824cz  a2200229n  4500
=001  9880364470302441
=005  20141212220122.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048529
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610.$x400
=150  \\$aPapio hamadryas
=450  \\$wnnna$aBaboon, Hamadryas
=450  \\$wnnna$aBaboons, Hamadryas
=450  \\$wnnna$aHamadryas
=450  \\$aHamadryas Baboon
=450  \\$wnnna$aHamadryas Baboons
=450  \\$wnnna$ahamadryas, Papio
=550  \\$wg$aPapio
=680  \\$iA species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.
=688  \\$a2005; use PAPIO 1975-2004
=750  \0$aHamadryas baboon$0(DLC) sh 85058530$5IEN-M

=LDR  00997cz  a2200229n  4500
=001  9880364470402441
=005  20141212220121.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048528
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x530
=150  \\$aMandrillus
=450  \\$aDrill
=450  \\$wnnna$aDrills
=450  \\$aMandrill
=450  \\$wnnna$aMandrills
=450  \\$wnnna$aMandrillus leucophaeus
=450  \\$wnnna$aMandrillus sphinx
=550  \\$wg$aCercopithecinae
=680  \\$iA genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, comprising two species: the drill (M. leucophaeus) and the mandrill (M. sphinx). They are usually found in thick rainforest and have a gentle disposition despite their ferocious reputation. Some authors consider Mandrillus a subgenus of PAPIO.
=688  \\$a2005; use PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004
=750  \0$aMandrillus$0(DLC)sh2012003498$5IEN-M

=LDR  01025cz  a2200241n  4500
=001  9880364470502441
=005  20141212220121.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048508
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400.$x712.$x700
=150  \\$aRhipicephalus sanguineus
=450  \\$aBrown Dog Tick
=450  \\$wnnna$aBrown Dog Ticks
=450  \\$wnnna$aDog Tick, Brown
=450  \\$wnnna$aDog Ticks, Brown
=450  \\$wnnna$asanguineus, Rhipicephalus
=450  \\$wnnna$aTick, Brown Dog
=450  \\$wnnna$aTicks, Brown Dog
=550  \\$wg$aRhipicephalus
=680  \\$iA species of tick (TICKS) in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.
=688  \\$a2005
=750  \0$aBrown dog tick$0(DLC)sh2003006400$5IEN-M

=LDR  00607cz  a2200169n  4500
=001  9880364470602441
=005  20141212220121.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048494
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400.$x712
=150  \\$aRhipicephalus
=550  \\$wg$aIxodidae
=550  \\$wh$aRhipicephalus sanguineus
=680  \\$iA genus of TICKS, in the family IXODIDAE, widespread in Africa. Members of the genus include many important vectors of animal and human pathogens.
=688  \\$a2005
=750  \0$aRhipicephalus$0(DLC) sh 85113702$5IEN-M

=LDR  00764cz  a2200205n  4500
=001  9880364470702441
=005  20141212220119.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048489
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375.$x550.$x637.$x74
=150  \\$aParamecium aurelia
=450  \\$wnnna$aaurelia, Paramecium
=450  \\$wnnna$aaurelias, Paramecium
=450  \\$wnnna$aParamecium aurelias
=550  \\$wg$aParamecium
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of ciliated PARAMECIUM possessing two micronuclei.
=688  \\$a2005
=750  \0$aParamecium aurelia$0(DLC) sh 88021402$5IEN-M

=LDR  00819cz  a2200205n  4500
=001  9880364470802441
=005  20141212220119.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048488
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375.$x550.$x637.$x150
=150  \\$aParamecium caudatum
=450  \\$wnnna$acaudatum, Paramecium
=450  \\$wnnna$acaudatums, Paramecium
=450  \\$wnnna$aParamecium caudatums
=550  \\$wg$aParamecium
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iThe most widely distributed species of PARAMECIUM. It is elongated and possesses a bluntly pointed posterior.
=688  \\$a2005
=750  \0$aParamecium caudatum$0(DLC) sh 88021403$5IEN-M

=LDR  00694cz  a2200217n  4500
=001  9880364470902441
=005  20141212220118.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048468
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x800.$x700
=150  \\$aPodospora
=450  \\$wnnna$aanserina, Podospora
=450  \\$wnnna$aanserinas, Podospora
=450  \\$wnnna$aPodospora anserina
=450  \\$wnnna$aPodospora anserinas
=450  \\$wnnna$aPodosporas
=550  \\$wg$aSordariales
=680  \\$iA genus of ascomycete FUNGI in the order SORDARIALES, which is found on SOIL and herbivore dung (FECES).
=688  \\$a2005
=750  \0$aPodospora$0(DLC) sh 85103690$5IEN-M

=LDR  00686cz  a2200205n  4500
=001  9880364471002441
=005  20141212220118.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048430
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x320
=150  \\$aCell Shape
=450  \\$wnnna$aCell Shapes
=450  \\$wnnna$aShape, Cell
=450  \\$wnnna$aShapes, Cell
=550  \\$wg$aCell Physiological Phenomena
=667  \\$anot for microorganisms; coordinate with organ /cytol or /pathol or specific cell /cytol or /pathol
=680  \\$iThe quality of surface form or outline of CELLS.
=688  \\$a2005; use CELL SIZE 1993-2004
=750  \0$aCells$xMorphology$0(DLC) sh 85021688$5IEN

=LDR  00748cz  a2200217n  4500
=001  9880364471102441
=005  20141212220117.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048428
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x559.$x600
=150  \\$aPetromyzon
=450  \\$wnnna$aLamprey, Sea
=450  \\$wnnna$aLampreys, Sea
=450  \\$aPetromyzon marinus
=450  \\$aSea Lamprey
=450  \\$wnnna$aSea Lampreys
=550  \\$wg$aLampreys
=680  \\$iA genus of primitive fish in the family Petromyzontidae. The sole species is Petromyzon marinus, known as the sea lamprey. The adult form feeds parasitically on other fish species.
=688  \\$a2005
=750  \0$aPetromyzon$0(DLC) sh 85100475$5IEN-M

=LDR  00761cz  a2200181n  4500
=001  9880364471202441
=005  20141212220117.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048409
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x19.$x25.$x690
=072  \\$aB3.$x660.$x250.$x17.$x25.$x690
=150  \\$aAeromonas salmonicida
=550  \\$wg$aAeromonas
=667  \\$ainfection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) and FURUNCULOSIS (IM) if pertinent
=680  \\$iA species of gram-negative bacteria, in the family Aeromonadaceae. It is strictly parasitic and often pathogenic causing FURUNCULOSIS in SALMONIDS and ulcer disease in GOLDFISH.
=688  \\$a2005
=750  \0$aAeromonas salmonicida$0(DLC) sh2005020183$5IEN-M

=LDR  00592cz  a2200181n  4500
=001  9880364471302441
=005  20141212220117.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048389
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x467.$x400
=150  \\$aGadus morhua
=450  \\$aAtlantic Cod
=450  \\$wnnna$aCod, Atlantic
=550  \\$wg$aGadiformes
=680  \\$iA species of fish in the cod family GADIDAE, known as the Atlantic cod. It is one of the most important commercial FISHES.
=688  \\$a2005
=750  \0$aAtlantic cod$0(DLC) sh 85009191$5IEN-M

=LDR  00784cz  a2200253n  4500
=001  9880364471402441
=005  20141212220116.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x467
=150  \\$aGadiformes
=450  \\$wnnna$aCods
=450  \\$aGadidae
=450  \\$wnnna$aGrenadier
=450  \\$wnnna$aGrenadiers
=450  \\$wnnna$aHake
=450  \\$aHakes
=450  \\$wnnna$aMacrouridae
=550  \\$wg$aFishes
=550  \\$wh$aGadus morhua
=680  \\$iAn order of fish including the families Gadidae (cods), Macrouridae (grenadiers), and hakes. The large Gadidae family includes cod, haddock, whiting, and pollock.
=688  \\$a2005
=750  \0$aGadiformes$0(DLC) sh 85052684$5IEN-M

=LDR  00826cz  a2200205n  4500
=001  9880364471502441
=005  20141212220116.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048372
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x810.$x768.$x200
=072  \\$aB3.$x510.$x24.$x49.$x775.$x775.$x200
=072  \\$aB3.$x510.$x415.$x400.$x810.$x768.$x200
=072  \\$aB3.$x510.$x460.$x410.$x810.$x768.$x200
=150  \\$aStreptomyces coelicolor
=450  \\$wnnna$aStreptomyces coelicolor A3(2)
=550  \\$wg$aStreptomyces
=680  \\$iA soil-dwelling actinomycete with a complex lifecycle involving mycelial growth and spore formation. It is involved in the production of a number of medically important ANTIBIOTICS.
=688  \\$a2005
=750  \0$aStreptomyces coelicolor$0(DLC) sh 88023344$5IEN-M

=LDR  00683cz  a2200193n  4500
=001  9880364471602441
=005  20141212220114.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x590
=150  \\$aPhascolarctidae
=450  \\$aKoala
=450  \\$wnnna$aKoalas
=450  \\$aPhascolarctos cinereus
=550  \\$wg$aMarsupialia
=680  \\$iA family of marsupials in the order Diprotodontia, native to Australia and possessing vestigial tails. There is a single living genus and species: Phascolarctos cinereus, the koala.
=688  \\$a2005
=750  \0$aPhascolarctidae$0(DLC) sh 95004611$5IEN-M

=LDR  00835cz  a2200229n  4500
=001  9880364471702441
=005  20141212220114.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x587.$x800
=150  \\$aTrichosurus
=450  \\$wnnna$aBrush-Tailed Possum
=450  \\$wnnna$aBrush-Tailed Possums
=450  \\$wnnna$aPossum, Brush-Tailed
=450  \\$aPossums, Brush-Tailed
=450  \\$wnnna$aPossums, Brush Tailed
=450  \\$wnnna$aTrichosurus vulpecula
=550  \\$wg$aPhalangeridae
=680  \\$iA genus of brush-tailed possums found chiefly in Australia and New Zealand. Secretions from their ANAL GLAND function both in defense and demarcating territory.
=688  \\$a2005
=750  \0$aBrush-tailed possums$0(DLC) sh 85017352$5IEN-M

=LDR  00687cz  a2200217n  4500
=001  9880364471802441
=005  20141212220114.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048329
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x587
=150  \\$aPhalangeridae
=450  \\$aCuscuses
=450  \\$aPhalanger
=450  \\$wnnna$aPhalangers
=550  \\$wg$aMarsupialia
=550  \\$wh$aTrichosurus
=667  \\$apossums unspecified go here; OPOSSUMS is also available
=680  \\$iA family of possums and cuscuses found in Australia, Tasmania, New Guinea and other islands.
=688  \\$a2005
=750  \0$aPhalangeridae$0(DLC) sh 85100559$5IEN-M

=LDR  01301cz  a2200385n  4500
=001  9880364471902441
=005  20141212220113.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x600
=150  \\$aPotoroidae
=450  \\$aBettongia
=450  \\$wnnna$aKangaroo, Rat
=450  \\$wnnna$aKangaroos, Rat
=450  \\$aLong-Nosed Potoroo
=450  \\$wnnna$aLong Nosed Potoroo
=450  \\$wnnna$aLong-Nosed Potoroos
=450  \\$aLong-Nosed Rat Kangaroo
=450  \\$wnnna$aLong Nosed Rat Kangaroo
=450  \\$wnnna$aLong-Nosed Rat Kangaroos
=450  \\$wnnna$aPotoroo
=450  \\$wnnna$aPotoroo, Long-Nosed
=450  \\$wnnna$aPotoroos
=450  \\$wnnna$aPotoroos, Long-Nosed
=450  \\$wnnna$aPotorous tridactylus
=450  \\$aRat Kangaroo
=450  \\$wnnna$aRat Kangaroo, Long-Nosed
=450  \\$wnnna$aRat Kangaroos
=450  \\$wnnna$aRat Kangaroos, Long-Nosed
=550  \\$wg$aMarsupialia
=667  \\$ado not confuse rat kangaroo with KANGAROO RATS see DIPODOMYS
=680  \\$iA family of rat kangaroos found in and around Australia. Genera include Potorous and Bettongia.
=688  \\$a2005; use MACROPODIDAE 2001-2004
=750  \0$aPotoroidae$0(DLC) sh 88003411$5IEN-M

=LDR  00854cz  a2200229n  4500
=001  9880364472002441
=005  20141212220113.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048309
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x575.$x500
=150  \\$aMonodelphis
=450  \\$wnnna$aMonodelphis domestica
=450  \\$wnnna$aOpossum, Short-Tailed
=450  \\$aOpossums, Short-Tailed
=450  \\$wnnna$aOpossums, Short Tailed
=450  \\$wnnna$aShort-Tailed Opossum
=450  \\$wnnna$aShort-Tailed Opossums
=550  \\$wg$aOpossums
=680  \\$iA genus of short-tailed OPOSSUMS in the family Didelphidae found in South American, chiefly Brazil. They are opossums least well-adapted to arboreal life.
=688  \\$a2005; use OPOSSUMS 1995-2004
=750  \0$aShort-tailed opossums$0(DLC)sh2007000579$5IEN-M

=LDR  00787cz  a2200217n  4500
=001  9880364472102441
=005  20141212220112.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048293
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x573.$x575.$x150
=150  \\$aDidelphis
=450  \\$wnnna$aDidelphis virginiana
=450  \\$wnnna$aNorth American Opossum
=450  \\$wnnna$aNorth American Opossums
=450  \\$aOpossum, North American
=450  \\$wnnna$aOpossums, North American
=550  \\$wg$aOpossums
=680  \\$iA genus of large OPOSSUMS in the family Didelphidae, found in the Americas. The species Didelphis virginiana is prominent in North America.
=688  \\$a2005; use OPOSSUMS 1968-2004
=750  \0$aDidelphis$0(DLC) sh 85037748$5IEN-M

=LDR  00523cz  a2200181n  4500
=001  9880364472202441
=005  20141212220110.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048288
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x436
=150  \\$aImidazolines
=550  \\$wg$aImidazoles
=550  \\$wh$aClonidine
=550  \\$wh$aTolazoline
=680  \\$iCompounds based on reduced IMIDAZOLES containing a single double bond.
=688  \\$a2005
=750  \0$aImidazolines$0(DLC) sh 85064492$5IEN-M

=LDR  00585cz  a2200181n  4500
=001  9880364472302441
=005  20141212220110.0
=008  040708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048271
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x139.$x500
=072  \\$aD9.$x698.$x211.$x500
=150  \\$aChitosan
=450  \\$wnnna$aPoliglusam
=550  \\$wg$aChitin
=680  \\$iDeacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS.
=688  \\$a2005(2004)
=750  \0$aChitosan$0(DLC) sh 85024498$5IEN-M

=LDR  00717cz  a2200181n  4500
=001  9880364472402441
=005  20141212220110.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048251
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x853.$x392.$x800.$x500
=150  \\$aSqualus acanthias
=450  \\$aDogfish, Spiny
=450  \\$wnnna$aSpiny Dogfish
=550  \\$wg$aSqualus
=680  \\$iA species of shark in the family SQUALIDAE, used for its oil (SQUALENE) and as fish meal. It also figures heavily in biological research, especially with reference to its RECTAL GLAND in studies of WATER-ELECTROLYTE BALANCE.
=688  \\$a2005
=750  \0$aSpiny dogfish$0(DLC) sh 85127081$5IEN-M

=LDR  00628cz  a2200169n  4500
=001  9880364472502441
=005  20141212220110.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x853.$x392.$x800
=150  \\$aSqualus
=550  \\$wg$aDogfish
=550  \\$wh$aSqualus acanthias
=680  \\$iA genus of SHARKS in the family SQUALIDAE, comprised of many different species. They travel in large groups and are bottom dwellers that feed mostly on bony fishes.
=688  \\$a2005; use DOGFISH 1994-2004
=750  \0$aSqualus$0(DLC) sh 85127080$5IEN-M

=LDR  00562cz  a2200169n  4500
=001  9880364472602441
=005  20141212220110.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048249
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x800
=072  \\$aB3.$x510.$x550.$x737.$x872.$x800
=150  \\$aStreptococcus thermophilus
=550  \\$wg$aStreptococcus
=680  \\$iA species of thermophilic, gram-positive bacteria found in MILK and milk products.
=688  \\$a2005
=750  \0$aStreptococcus thermophilus$0(DLC) sh 85128688$5IEN-M

=LDR  00836cz  a2200205n  4500
=001  9880364472702441
=005  20141212220109.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048248
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100.$x75.$x80.$x150
=150  \\$aAcanthamoeba castellanii
=450  \\$wnnna$aAcanthamoeba castellanius
=450  \\$wnnna$acastellanii, Acanthamoeba
=450  \\$wnnna$acastellanius, Acanthamoeba
=550  \\$wg$aAcanthamoeba
=667  \\$ainfection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of free-living soil amoebae in the family Acanthamoebidae. It can cause ENCEPHALITIS and KERATITIS in humans.
=688  \\$a2005
=750  \0$aAcanthamoeba castellanii$0(DLC) sh 90004976$5IEN-M

=LDR  00586cz  a2200169n  4500
=001  9880364472802441
=005  20141212220109.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048230
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x180.$x300
=072  \\$aB3.$x510.$x460.$x400.$x400.$x200.$x300
=150  \\$aCorynebacterium glutamicum
=550  \\$wg$aCorynebacterium
=680  \\$iA species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.
=688  \\$a2005
=750  \0$aCorynebacterium glutamicum$0(DLC)sh2004000516$5IEN-M

=LDR  00887cz  a2200181n  4500
=001  9880364472902441
=005  20141212220108.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048209
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x327.$x400
=150  \\$aEchinococcus granulosus
=450  \\$wnnna$agranulosus, Echinococcus
=550  \\$wg$aEchinococcus
=667  \\$ainfection: coordinate (IM) with ECHINOCOCCOSIS (IM) or specifics (IM); Taenia echinococcus goes here
=680  \\$iA species of hydatid tapeworm (class CESTODA) in the family Taeniidae, whose adult form infects the DIGESTIVE TRACT of DOGS, other canines, and CATS. The larval form infects SHEEP; PIGS; HORSES; and may infect humans, where it migrates to various organs and forms permanent HYDATID CYSTS.
=688  \\$a2005
=750  \0$aEchinococcus granulosus$0(DLC) sh 85040695$5IEN-M

=LDR  00573cz  a2200169n  4500
=001  9880364473002441
=005  20141212220107.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048191
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x475.$x612
=072  \\$aB3.$x510.$x550.$x450.$x475.$x612
=150  \\$aLactobacillus plantarum
=550  \\$wg$aLactobacillus
=680  \\$iA species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.
=688  \\$a2005
=750  \0$aLactobacillus plantarum$0(DLC) sh 88023275$5IEN-M

=LDR  00955cz  a2200253n  4500
=001  9880364473102441
=005  20141212220107.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048190
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x454.$x400
=150  \\$aHymenolepis diminuta
=450  \\$wnnna$adiminuta, Hymenolepis
=450  \\$wnnna$adiminutas, Hymenolepis
=450  \\$wnnna$aHymenolepis diminutas
=450  \\$aRat Tapeworm
=450  \\$wnnna$aRat Tapeworms
=450  \\$wnnna$aTapeworm, Rat
=450  \\$wnnna$aTapeworms, Rat
=550  \\$wg$aHymenolepis
=667  \\$ainfection: coordinate (IM) with HYMENOLEPIASIS (IM)
=680  \\$iA species of tapeworm (TAPEWORMS) infecting RATS and MICE but rarely causing disease in humans. Its life cycle involves RODENTS as the definitive host and BEETLES as the intermediate host.
=688  \\$a2005
=750  \0$aHymenolepis diminuta$0(DLC) sh 85063587$5IEN-M

=LDR  00661cz  a2200193n  4500
=001  9880364473202441
=005  20141212220106.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x678.$x369.$x500
=150  \\$aLocusta migratoria
=450  \\$wnnna$aLocusta migratorias
=450  \\$wnnna$amigratoria, Locusta
=450  \\$wnnna$amigratorias, Locusta
=550  \\$wg$aGrasshoppers
=680  \\$iA species of migratory Old World locusts, in the family ACRIDIDAE, that are important pests in Africa and Asia.
=688  \\$a2005
=750  \0$aMigratory locust$0(DLC) sh 85055073$5IEN-M

=LDR  00596cz  a2200169n  4500
=001  9880364473402441
=005  20141212220105.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x313.$x650
=150  \\$aNursing Informatics
=450  \\$wnnna$aInformatics, Nursing
=550  \\$wg$aInformatics
=680  \\$iThe field of information science concerned with the analysis and dissemination of data through the application of computers applied to the field of nursing.
=688  \\$a2005
=750  \0$aNursing informatics$0(DLC) sh 91005164$5IEN-M

=LDR  01172cz  a2200229n  4500
=001  9880364473502441
=005  20141212220104.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x680.$x300
=150  \\$aGuided Tissue Regeneration
=450  \\$wnnna$aRegeneration, Guided Tissue
=450  \\$wnnna$aTissue Regeneration, Guided
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wh$aGuided Tissue Regeneration, Periodontal
=550  \\$aBioprinting
=550  \\$aCell- and Tissue-Based Therapy
=550  \\$aTissue Engineering
=680  \\$iProcedures for enhancing and directing tissue repair and renewal processes, such as BONE REGENERATION; NERVE REGENERATION; etc. They involve surgically implanting growth conducive tracks or conduits (TISSUE SCAFFOLDING) at the damaged site to stimulate and control the location of cell repopulation. The tracks or conduits are made from synthetic and/or natural materials and may include support cells and induction factors for CELL GROWTH PROCESSES; or CELL MIGRATION.
=688  \\$a2005
=750  \0$aGuided tissue regeneration$0(DLC) sh 94001282$5IEN-M

=LDR  00838cz  a2200253n  4500
=001  9880364473602441
=005  20200424130451.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048088
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x313
=150  \\$aInformatics
=550  \\$wg$aInformation Science
=550  \\$wh$aCheminformatics
=550  \\$wh$aComputational Biology
=550  \\$wh$aConsumer Health Informatics
=550  \\$wh$aDental Informatics
=550  \\$wh$aMedical Informatics
=550  \\$wh$aNursing Informatics
=550  \\$wh$aPublic Health Informatics
=667  \\$ageneral; prefer specifics
=680  \\$iThe field of information science concerned with the analysis and dissemination of data through the application of computers.
=688  \\$a2005
=750  \0$aComputer science$0(DLC) sh 89003285$5IEN-M

=LDR  00840cz  a2200241n  4500
=001  9880364473702441
=005  20141212220103.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277.$x677
=072  \\$aC18.$x654.$x521.$x625
=150  \\$aFetal Nutrition Disorders
=450  \\$aFetal Malnutrition
=450  \\$wnnna$aFetal Nutrition Disorder
=450  \\$aMalnutrition, Fetal
=450  \\$wnnna$aNutrition Disorder, Fetal
=450  \\$wnnna$aNutrition Disorders, Fetal
=550  \\$wg$aFetal Diseases
=550  \\$wg$aMalnutrition
=680  \\$iDisorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.
=688  \\$a2005; use PLACENTA INSUFFICIENCY 1998-2004
=750  \0$aFetal malnutrition$0(DLC) sh 85047952$5IEN-M

=LDR  01856cz  a2200493n  4500
=001  9880364473802441
=005  20200428125120.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x750
=072  \\$aD12.$x644.$x276.$x972
=072  \\$aD12.$x776.$x467.$x374.$x750
=072  \\$aD12.$x776.$x467.$x972
=072  \\$aD23.$x529.$x374.$x750
=072  \\$aD23.$x529.$x972
=150  \\$aTumor Necrosis Factors
=450  \\$wnnna$aNecrosis Factors, Tumor
=450  \\$wnnna$aReceptor Ligands, TNF
=450  \\$wnnna$aTNF Receptor Ligands
=450  \\$wnnna$aTumor Necrosis Factor Superfamily Ligands
=550  \\$wg$aCytokines
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$a4-1BB Ligand
=550  \\$wh$aAntigens, CD70
=550  \\$wh$aB-Cell Activating Factor
=550  \\$wh$aCD30 Ligand
=550  \\$wh$aCD40 Ligand
=550  \\$wh$aCytokine TWEAK
=550  \\$wh$aEctodysplasins
=550  \\$wh$aFas Ligand Protein
=550  \\$wh$aLymphotoxin-alpha
=550  \\$wh$aLymphotoxin alpha1, beta2 Heterotrimer
=550  \\$wh$aLymphotoxin-beta
=550  \\$wh$aOX40 Ligand
=550  \\$wh$aRANK Ligand
=550  \\$wh$aTNF-Related Apoptosis-Inducing Ligand
=550  \\$wh$aTumor Necrosis Factor-alpha
=550  \\$wh$aTumor Necrosis Factor Ligand Superfamily Member 13
=550  \\$wh$aTumor Necrosis Factor Ligand Superfamily Member 14
=550  \\$wh$aTumor Necrosis Factor Ligand Superfamily Member 15
=680  \\$iA family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.
=688  \\$a2005
=750  \0$aTumor necrosis factor$0(DLC) sh 87004016$5IEN

=LDR  00553cz  a2200169n  4500
=001  9880364473902441
=005  20141212220058.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048048
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x313.$x249
=150  \\$aDental Informatics
=450  \\$wnnna$aInformatics, Dental
=550  \\$wg$aInformatics
=680  \\$iThe application of computer and information sciences to improve dental practice, research, education and management.
=688  \\$a2005
=750  \0$aDental informatics$0(DLC)sh2003009008$5IEN-M

=LDR  01639cz  a2200373n  4500
=001  9880364474002441
=005  20141212220058.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D048031
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x567.$x513
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x646.$x750.$x374
=072  \\$aD12.$x644.$x360.$x450.$x340
=072  \\$aD12.$x776.$x476.$x450.$x340
=150  \\$aJNK Mitogen-Activated Protein Kinases
=450  \\$wnnna$aAmino-Terminal Kinase, c-jun
=450  \\$wnnna$ac-jun Amino-Terminal Kinase
=450  \\$wnnna$ac jun Amino Terminal Kinase
=450  \\$wnnna$ac-jun N-Terminal Kinase
=450  \\$wnnna$ac jun N Terminal Kinase
=450  \\$wnnna$aJNK Mitogen Activated Protein Kinases
=450  \\$wnnna$ajun-NH2-Terminal Kinase
=450  \\$wnnna$ajun NH2 Terminal Kinase
=450  \\$wnnna$ajun-NH2-Terminal Kinases
=450  \\$wnnna$ajun NH2 Terminal Kinases
=450  \\$wnnna$aN-Terminal Kinase, c-jun
=550  \\$wg$aMitogen-Activated Protein Kinases
=550  \\$wh$aMitogen-Activated Protein Kinase 10
=550  \\$wh$aMitogen-Activated Protein Kinase 8
=550  \\$wh$aMitogen-Activated Protein Kinase 9
=667  \\$anote specifics
=680  \\$iA subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.
=688  \\$a2005
=750  \0$aJNK mitogen-activated protein kinases$0(DLC)sh2005006730$5IEN-M

=LDR  01002cz  a2200253n  4500
=001  9880364474102441
=005  20160826165953.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x813
=072  \\$aK1.$x400.$x504.$x968.$x500
=150  \\$aKorean War
=450  \\$wnnna$a1950-1953 Korean War
=450  \\$wnnna$aConflict, Korean
=450  \\$wnnna$aKorean Conflict
=450  \\$aKorean War, 1950-1953
=450  \\$wnnna$aKorean War, 1950 1953
=450  \\$wnnna$aWar, Korean
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iAn armed conflict between Communist and non-Communist forces in Korea from June 25, 1950, to July 27, 1953. The parties included United Nations forces from 15 member nations under United States command against military from North Korea and the Peoples Republic of China.
=688  \\$a2005
=750  \0$aKorean War, 1950-1953$0(DLC) sh 85073117$5IEN-M

=LDR  01640cz  a2200409n  4500
=001  9880364474202441
=005  20141212220048.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047852
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x968.$x150
=072  \\$aN6.$x850.$x135.$x848.$x500
=150  \\$aChernobyl Nuclear Accident
=450  \\$wnnna$aAccident, Chernobyl Nuclear
=450  \\$wnnna$aAccident, Chornobyl Nuclear
=450  \\$wnnna$aAccidents, Chernobyl Nuclear
=450  \\$wnnna$aAccidents, Chornobyl Nuclear
=450  \\$wnnna$aChernobyl Nuclear Accident, Chornobyl, Ukraine, 1986
=450  \\$wnnna$aChernobyl Nuclear Accidents
=450  \\$aChornobyl Nuclear Accident
=450  \\$wnnna$aChornobyl Nuclear Accidents
=450  \\$wnnna$aChornobyl Nuclear Disaster
=450  \\$wnnna$aChornobyl Nuclear Disasters
=450  \\$wnnna$aDisaster, Chornobyl Nuclear
=450  \\$wnnna$aDisasters, Chornobyl Nuclear
=450  \\$wnnna$aNuclear Accident, Chernobyl
=450  \\$wnnna$aNuclear Accident, Chornobyl
=450  \\$wnnna$aNuclear Accidents, Chernobyl
=450  \\$wnnna$aNuclear Accidents, Chornobyl
=450  \\$wnnna$aNuclear Disaster, Chornobyl
=450  \\$wnnna$aNuclear Disasters, Chornobyl
=550  \\$wg$aHistory, 20th Century
=550  \\$wg$aRadioactive Hazard Release
=550  \\$aNuclear Reactors
=680  \\$iApril 25th -26th, 1986 nuclear power accident that occurred at Chernobyl in the former USSR (Ukraine) located 80 miles north of Kiev.
=688  \\$a2005
=750  \0$aChernobyl Nuclear Accident, Chornobyl�, Ukraine, 1986$0(DLC) sh 87003900$5IEN-M

=LDR  01057cz  a2200289n  4500
=001  9880364474302441
=005  20160826171913.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047851
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x800.$x750
=072  \\$aI1.$x880.$x735.$x950.$x250.$x860
=072  \\$aK1.$x400.$x504.$x984.$x500
=150  \\$aSeptember 11 Terrorist Attacks
=450  \\$wnnna$a9-11-2001 Attack
=450  \\$wnnna$a9 11 2001 Attack
=450  \\$wnnna$a9-11-2001 Attacks
=450  \\$wnnna$aAttack, 9-11-2001
=450  \\$wnnna$aAttacks, 9-11-2001
=450  \\$wnnna$aSeptember 11 Terrorist Attacks, 2001
=450  \\$wnnna$aWorld Trade Center Attack, 2001
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 21st Century
=550  \\$wg$aTerrorism
=680  \\$iTerrorism on September 11, 2001 against targets in New York, the Pentagon in Virginia, and an aborted attack that ended in Pennsylvania.
=688  \\$a2005
=750  \0$aSeptember 11 Terrorist Attacks, 2001$0(DLC)sh2001000147$5IEN-M

=LDR  01141cz  a2200313n  4500
=001  9880364527802441
=005  20181221103337.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066167
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x230.$x540.$x750
=150  \\$aSlit Lamp
=450  \\$wnnna$aBiomicroscope, Slit Lamp
=450  \\$wnnna$aBiomicroscopes, Slit Lamp
=450  \\$wnnna$aGullstrand Slit Lamp
=450  \\$wnnna$aGullstrand's Slit Lamp
=450  \\$wnnna$aGullstrands Slit Lamp
=450  \\$wnnna$aLamp Biomicroscope, Slit
=450  \\$wnnna$aLamp Biomicroscopes, Slit
=450  \\$wnnna$aLamp, Gullstrand's Slit
=450  \\$wnnna$aLamp, Slit
=450  \\$wnnna$aLamps, Slit
=450  \\$wnnna$aSlit Lamp Biomicroscope
=450  \\$wnnna$aSlit Lamp Biomicroscopes
=450  \\$wnnna$aSlit Lamp, Gullstrand's
=450  \\$wnnna$aSlit Lamps
=550  \\$wg$aOphthalmoscopes
=680  \\$iA microscope with a light source that can be projected into a linear beam. It allows cross-sectional viewing of the AQUEOUS HUMOR; CONJUNCTEIVA; CORNEA; EYELIDS; IRIS; and lens (see LENS, EYE) of the eye.
=688  \\$a2015

=LDR  01164cz  a2200337n  4500
=001  9880364527902441
=005  20150501105045.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066107
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x828
=072  \\$aF1.$x829.$x401.$x737
=150  \\$aSocial Skills
=450  \\$wnnna$aAbilities, Social
=450  \\$wnnna$aAbility, Social
=450  \\$wnnna$aCompetence, Social
=450  \\$wnnna$aInterpersonal Skill
=450  \\$wnnna$aInterpersonal Skills
=450  \\$wnnna$aSkill, Interpersonal
=450  \\$wnnna$aSkill, Social
=450  \\$wnnna$aSkills, Interpersonal
=450  \\$wnnna$aSkills, Social
=450  \\$wnnna$aSocial Abilities
=450  \\$wnnna$aSocial Ability
=450  \\$wnnna$aSocial Competence
=450  \\$wnnna$aSocial Skill
=550  \\$wg$aInterpersonal Relations
=550  \\$wg$aSocial Behavior
=680  \\$iThe personal set of abilities required to successfully interact and communicate with others, both verbally and non-verbally through gestures, body language and personal appearance.
=688  \\$a2015
=750  \0$aSocial skills$0(DLC)sh 85124073$5IEN-M

=LDR  00831cz  a2200253n  4500
=001  9880364528002441
=005  20150415171224.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066088
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x260.$x657
=150  \\$aInfant Death
=450  \\$wnnna$aDeath, Infant
=450  \\$wnnna$aDeaths, Infant
=450  \\$wnnna$aInfant Deaths
=550  \\$wg$aDeath
=550  \\$wh$aSudden Infant Death
=550  \\$aInfant Mortality
=550  \\$aPerinatal Death
=550  \\$aPerinatal Mortality
=667  \\$ause PERINATAL DEATH for death of an infant less than 28 days of age; do not confuse with INFANT MORTALITY, a statistical concept
=680  \\$iThe death of a live-born INFANT within its first year of life.
=688  \\$a2015
=750  \0$aInfants$xDeath$0sh 85066030$5IEN-M

=LDR  01012cz  a2200313n  4500
=001  9880364528102441
=005  20150423104845.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066087
=040  \\$aDNLM$cDNLM
=072  \\$aC13.$x703.$x572
=072  \\$aC23.$x550.$x260.$x865
=150  \\$aPerinatal Death
=450  \\$wnnna$aDeath, Neonatal
=450  \\$wnnna$aDeath, Perinatal
=450  \\$wnnna$aDeaths, Neonatal
=450  \\$wnnna$aDeaths, Perinatal
=450  \\$wnnna$aNeonatal Death
=450  \\$wnnna$aNeonatal Deaths
=450  \\$wnnna$aPerinatal Deaths
=550  \\$wg$aDeath
=550  \\$wg$aPregnancy Complications
=550  \\$aFetal Death
=550  \\$aInfant Death
=550  \\$aPerinatal Mortality
=667  \\$aDo not confuse with PERINATAL MORTALITY, a statistical concept
=680  \\$iThe death of a FETUS of GESTATIONAL AGE 28 weeks or more, or the death of a live-born INFANT less than 28 days of age.
=688  \\$a2015
=750  \0$aPerinatal death$0(DLC)sh 85099874

=LDR  00867cz  a2200193n  4500
=001  9880364528202441
=005  20150413135346.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066086
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x421.$x314
=150  \\$aHealth Services for Persons with Disabilities
=450  \\$wnnna$aHealth Services for Disabled Persons
=450  \\$wnnna$aHealth Services for People with Disabilities
=450  \\$wnnna$aHealth Services for the Disabled
=550  \\$wg$aHealth Services
=680  \\$iHealth services and access for DISABLED PERSONS. Disabilities include impairments, activity limitations, or participation restrictions, and reflect the interaction between the individual with the disability and personal and environmental factors.
=688  \\$a2015
=750  \0$aPeople with disabilities$xMedical care$0(DLC)sh 95003823$5IEN-M

=LDR  00976cz  a2200277n  4500
=001  9880364528302441
=005  20150417125430.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066067
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x435
=072  \\$aI1.$x880.$x853.$x150.$x482
=150  \\$aMilitary Family
=450  \\$wnnna$aFamilies, Military
=450  \\$wnnna$aFamilies of Military Personnel
=450  \\$wnnna$aFamilies of Veterans
=450  \\$wnnna$aFamily, Military
=450  \\$aMilitary Families
=450  \\$wnnna$aVeterans Families
=450  \\$wnnna$aVeterans Family
=550  \\$wg$aFamily
=550  \\$aVeterans
=667  \\$afor families of veterans, coordinate with VETERANS
=680  \\$iMen and women serving on active duty in the military, or in a reserve military force, and their immediate family including spouses, children, and parents.
=688  \\$a2015
=750  \0$aFamilies of military personnel$0(DLC)sh 99004254$5IEN-M

=LDR  00738cz  a2200277n  4500
=001  9880364528402441
=005  20150406105108.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065948
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x531
=072  \\$aN6.$x230.$x124.$x390
=150  \\$aGrassland
=450  \\$wnnna$aGrasslands
=450  \\$wnnna$aMeadow
=450  \\$aMeadows
=450  \\$aPrairie
=450  \\$wnnna$aPrairies
=450  \\$aSavanna
=450  \\$wnnna$aSavannas
=450  \\$aSteppe
=450  \\$wnnna$aSteppes
=550  \\$wg$aEcosystem
=680  \\$iAn ecosystem dominated by grasses (POACEAE) with few trees or shrubs.
=688  \\$a2015
=750  \0$aGrasslands$0(DLC)sh 85056528$5IEN-M

=LDR  00990cz  a2200325n  4500
=001  9880364528502441
=005  20150430145913.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065947
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x437.$x500
=072  \\$aN6.$x230.$x124.$x343.$x500
=150  \\$aRainforest
=450  \\$wnnna$aForest, Rain
=450  \\$wnnna$aForests, Rain
=450  \\$wnnna$aRain Forest
=450  \\$wnnna$aRain Forests
=450  \\$wnnna$aRainforest, Temperate
=450  \\$wnnna$aRainforest, Tropical
=450  \\$wnnna$aRainforests
=450  \\$wnnna$aRainforests, Temperate
=450  \\$wnnna$aRainforests, Tropical
=450  \\$wnnna$aTemperate Rainforest
=450  \\$wnnna$aTemperate Rainforests
=450  \\$wnnna$aTropical Rainforest
=450  \\$wnnna$aTropical Rainforests
=550  \\$wg$aForests
=680  \\$iForests with high average annual rainfall.
=688  \\$a2015
=750  \0$aRain forests$0(DLC)sh 85111193

=LDR  00902cz  a2200301n  4500
=001  9880364528602441
=005  20150429143406.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065946
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x820.$x500
=072  \\$aG16.$x500.$x275.$x157.$x718.$x500
=072  \\$aG16.$x500.$x275.$x815.$x500
=072  \\$aN6.$x230.$x124.$x531.$x500
=072  \\$aN6.$x230.$x600.$x500
=150  \\$aPermafrost
=450  \\$wnnna$aPermafrost Region
=450  \\$wnnna$aPermafrost Soil
=450  \\$wnnna$aPermafrost Soils
=450  \\$wnnna$aPermafrost Zone
=450  \\$wnnna$aPermafrosts
=450  \\$wnnna$aSoil, Permafrost
=450  \\$wnnna$aSoils, Permafrost
=550  \\$wg$aSoil
=550  \\$wg$aTundra
=680  \\$iPerennially frozen layer of soil below the surface in tundra.
=688  \\$a2015
=750  \0$aPermafrost$0(DLC)sh2005001377$5IEN-M

=LDR  01102cz  a2200337n  4500
=001  9880364528702441
=005  20150518165724.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065929
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x718
=072  \\$aN6.$x230.$x124.$x531
=150  \\$aTundra
=450  \\$wnnna$aAlpine Tundra
=450  \\$wnnna$aAlpine Tundras
=450  \\$wnnna$aAntarctic Tundra
=450  \\$wnnna$aAntarctic Tundras
=450  \\$wnnna$aArtcic Tundra
=450  \\$wnnna$aArtcic Tundras
=450  \\$wnnna$aTundra, Alpine
=450  \\$wnnna$aTundra, Antarctic
=450  \\$wnnna$aTundra, Artcic
=450  \\$wnnna$aTundras
=450  \\$wnnna$aTundras, Alpine
=450  \\$wnnna$aTundras, Antarctic
=450  \\$wnnna$aTundras, Artcic
=550  \\$wg$aEcosystem
=550  \\$wh$aPermafrost
=680  \\$iAn ecosystem dominated by grasses, lichens, mosses, sedges and shrubs in cold landscapes or at high elevations where a layer of the ground remains perennially frozen (PERMAFROST).
=688  \\$a2015
=750  \0$aTundras$0(DLC)sh 85138590

=LDR  00913cz  a2200325n  4500
=001  9880364528802441
=005  20150406102049.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065928
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x437
=072  \\$aN6.$x230.$x124.$x343
=150  \\$aForests
=450  \\$wnnna$aArea, Forested
=450  \\$wnnna$aAreas, Forested
=450  \\$wnnna$aForest
=450  \\$wnnna$aForested Area
=450  \\$wnnna$aForested Areas
=450  \\$wnnna$aForestland
=450  \\$wnnna$aForestlands
=450  \\$wnnna$aWoodland
=450  \\$wnnna$aWoodlands
=550  \\$wg$aEcosystem
=550  \\$wh$aRainforest
=550  \\$wh$aTaiga
=550  \\$aTrees
=550  \\$aWood
=680  \\$iAn ecosystem dominated by trees and other woody vegetation.
=688  \\$a2015; use Trees 1983-2014
=750  \0$aForests and forestry$0(DLC)sh 85050707$5IEN-M

=LDR  00820cz  a2200265n  4500
=001  9880364528902441
=005  20150501095430.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065856
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x764
=150  \\$aRubus
=450  \\$wnnna$aAndean Blackberries
=450  \\$wnnna$aAndean Blackberry
=450  \\$wnnna$aBlackberries
=450  \\$wnnna$aBlackberries, Andean
=450  \\$wnnna$aBlackberry
=450  \\$wnnna$aBlackberry, Andean
=450  \\$wnnna$aRaspberries
=450  \\$wnnna$aRaspberry
=450  \\$wnnna$aRubus glaucus
=550  \\$wg$aRosaceae
=680  \\$iA plant genus of the family Rosaceae whose members include blackberries and raspberries.
=688  \\$a2015
=750  \0$aRubus$0(DLC)sh 85115696$5IEN-M

=LDR  01058cz  a2200313n  4500
=001  9880364529002441
=005  20150511165258.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065854
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x875.$x797
=072  \\$aF2.$x463.$x641
=150  \\$aSpatial Navigation
=450  \\$wnnna$aAbilities, Spatial
=450  \\$wnnna$aAbility, Spatial
=450  \\$wnnna$aNavigation, Spatial
=450  \\$wnnna$aNavigations, Spatial
=450  \\$wnnna$aSpatial Abilities
=450  \\$wnnna$aSpatial Ability
=450  \\$wnnna$aSpatial Navigations
=450  \\$wnnna$aSpatial Visualization
=450  \\$wnnna$aSpatial Visualizations
=450  \\$wnnna$aVisualization, Spatial
=450  \\$wnnna$aVisualizations, Spatial
=550  \\$wg$aMental Processes
=550  \\$wg$aSpatial Behavior
=680  \\$iProcess by which organisms use various cues to develop a route to a destination and their ability to travel such a planned route.
=688  \\$a2015
=750  \0$aSpatial ability$0(DLC)sh 97008210$5IEN-M

=LDR  01488cz  a2200409n  4500
=001  9880364529102441
=005  20150311132406.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065850
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x413
=072  \\$aA8.$x186.$x211.$x653.$x413
=150  \\$aCerebral Peduncle
=450  \\$wnnna$aBasis Pedunculi
=450  \\$wnnna$aBasis Pedunculi Cerebri
=450  \\$wnnna$aBasis Pedunculi Cerebrus
=450  \\$wnnna$aBasis Pedunculus
=450  \\$aCerebral Peduncles
=450  \\$wnnna$aCerebri, Basis Pedunculi
=450  \\$wnnna$aCerebri, Pedunculus
=450  \\$wnnna$aCerebrus, Basis Pedunculi
=450  \\$wnnna$aCerebrus, Pedunculus
=450  \\$wnnna$aPeduncle, Cerebral
=450  \\$wnnna$aPeduncles, Cerebral
=450  \\$wnnna$aPedunculi, Basis
=450  \\$wnnna$aPedunculi Cerebri, Basis
=450  \\$wnnna$aPedunculi Cerebrus, Basis
=450  \\$wnnna$aPedunculus, Basis
=450  \\$wnnna$aPedunculus Cerebri
=450  \\$wnnna$aPedunculus Cerebrus
=550  \\$wg$aMesencephalon
=550  \\$wh$aCerebral Crus
=550  \\$wh$aSubstantia Nigra
=550  \\$wh$aTegmentum Mesencephali
=680  \\$iVentral portion of the mesencephalon including the MIDBRAIN TEGMENTUM; CRUS CEREBRI; and the PRETECTUM. It does not include tectum mesencephali and TROCHLEAR NERVE.
=688  \\$a2015; use Tegmentum Mesencephali 2008-2014
=750  \0$aCerebral peduncle$0(DLC)sh 85022107$5IEN-M

=LDR  01084cz  a2200277n  4500
=001  9880364529202441
=005  20150417111934.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065837
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x521
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x521
=150  \\$aMiddle Cerebellar Peduncle
=450  \\$wnnna$aBrachia Pontis
=450  \\$wnnna$aBrachium Pontis
=450  \\$wnnna$aCerebellar Peduncle, Middle
=450  \\$wnnna$aCerebellar Peduncles, Middle
=450  \\$wnnna$aMiddle Cerebellar Peduncles
=450  \\$wnnna$aPeduncle, Middle Cerebellar
=450  \\$wnnna$aPeduncles, Middle Cerebellar
=450  \\$wnnna$aPontis, Brachia
=450  \\$wnnna$aPontis, Brachium
=550  \\$wg$aPons
=680  \\$iWHITE MATTER consisting of a large bundle of paired fibers originating in the pontine nuclei in the pre pontis and the nucleus reticularis tegmenti pontis projecting to the contralateral cerebral cortex.
=688  \\$a2015
=750  \0$aCerebellar peduncles$0(DLC)sh 85022076$5IEN-M

=LDR  00826cz  a2200277n  4500
=001  9880364529302441
=005  20150420163756.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065831
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x799.$x875
=150  \\$aNuns
=450  \\$wnnna$aAbbess
=450  \\$wnnna$aAbbesses
=450  \\$wnnna$aNun
=450  \\$wnnna$aPrioress
=450  \\$wnnna$aPrioresses
=450  \\$wnnna$aReligious Sister
=450  \\$wnnna$aReligious Sisters
=450  \\$wnnna$aSister, Religious
=450  \\$wnnna$aSisters, Religious
=550  \\$wg$aReligious Personnel
=550  \\$aReligious Missions
=680  \\$iMembers of a religious community of women typically living under vows of poverty, chastity, and obedience.
=688  \\$a2015
=750  \0$aNuns$0(DLC)sh 85093287$5IEN-M

=LDR  00810cz  a2200265n  4500
=001  9880364529402441
=005  20150417125710.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065830
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x799.$x750
=150  \\$aMonks
=450  \\$wnnna$aBrother, Religious
=450  \\$wnnna$aBrothers, Religious
=450  \\$wnnna$aFriar
=450  \\$wnnna$aFriars
=450  \\$wnnna$aMonk
=450  \\$wnnna$aReligious Brother
=450  \\$wnnna$aReligious Brothers
=550  \\$wg$aReligious Personnel
=550  \\$aReligious Missions
=667  \\$aspecify religion if pertinent
=680  \\$iMembers of a religious community of men typically living under vows of poverty, chastity, and obedience.
=688  \\$a2015
=750  \2$aMonks$0(DLC)sh 85086875$5IEN-M

=LDR  01189cz  a2200349n  4500
=001  9880364529502441
=005  20150406094510.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065828
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x650.$x374
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x650.$x374
=150  \\$aFacial Nucleus
=450  \\$wnnna$aFacial Motor Nucleus
=450  \\$wnnna$aFaciali, Nucleus
=450  \\$wnnna$aFaciali, Nucleus Nervi
=450  \\$wnnna$aFacialis, Nucleus
=450  \\$wnnna$aFacialis, Nucleus Nervi
=450  \\$wnnna$aMotor Nucleus, Facial
=450  \\$wnnna$aNervi Faciali, Nucleus
=450  \\$wnnna$aNervi Facialis, Nucleus
=450  \\$wnnna$aNucleus, Facial
=450  \\$wnnna$aNucleus, Facial Motor
=450  \\$wnnna$aNucleus Faciali
=450  \\$wnnna$aNucleus Facialis
=450  \\$wnnna$aNucleus Nervi Faciali
=450  \\$wnnna$aNucleus Nervi Facialis
=550  \\$wg$aPontine Tegmentum
=550  \\$aFacial Nerve
=680  \\$iA region in the pontine tegmentum that is the nucleus of the FACIAL NERVE.
=688  \\$a2015
=750  \0$aFacial motor nucleus$0(DLC)sh 93006882$5IEN-M

=LDR  01278cz  a2200349n  4500
=001  9880364529602441
=005  20150305095955.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065826
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x789.$x500
=150  \\$aAverrhoa
=450  \\$wnnna$aAverrhoa bilimbi
=450  \\$wnnna$aAverrhoa carambola
=450  \\$wnnna$aAverrhoas
=450  \\$wnnna$aCarambola Tree
=450  \\$wnnna$aCarambola Trees
=450  \\$wnnna$aCucumber Tree
=450  \\$wnnna$aCucumber Trees
=450  \\$wnnna$aStarfruit Tree
=450  \\$wnnna$aStarfruit Trees
=450  \\$wnnna$aTree, Carambola
=450  \\$wnnna$aTree, Cucumber
=450  \\$wnnna$aTree, Starfruit
=450  \\$wnnna$aTrees, Carambola
=450  \\$wnnna$aTrees, Cucumber
=450  \\$wnnna$aTrees, Starfruit
=550  \\$wg$aOxalidaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iTropical trees in the family Oxalidaceae
=688  \\$a2015
=750  \0$aAverrhoa$0(DLC)sh 94004376$5IEN-M

=LDR  00873cz  a2200289n  4500
=001  9880364529702441
=005  20150422111745.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065825
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x789
=150  \\$aOxalidaceae
=450  \\$wnnna$acorniculata, Oxalis
=450  \\$wnnna$acorniculatas, Oxalis
=450  \\$wnnna$aCreping Wood Sorrel
=450  \\$wnnna$aCreping Wood Sorrels
=450  \\$wnnna$aOxalis corniculata
=450  \\$wnnna$aOxalis corniculatas
=450  \\$wnnna$aSorrel, Creping Wood
=450  \\$wnnna$aSorrels, Creping Wood
=450  \\$wnnna$aWood Sorrel, Creping
=450  \\$wnnna$aWood Sorrels, Creping
=550  \\$wg$aAngiosperms
=550  \\$wh$aAverrhoa
=680  \\$iWood-sorrel family.
=688  \\$a2015
=750  \0$aOxalidaceae$0(DLC)sh 88022962$5IEN-M

=LDR  02085cz  a2200553n  4500
=001  9880364529802441
=005  20150312104115.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065822
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x540.$x162
=150  \\$aCollege Fraternities and Sororities
=450  \\$wnnna$aCollege Fraternities
=450  \\$wnnna$aCollege Fraternity
=450  \\$wnnna$aCollege Sororities
=450  \\$wnnna$aCollege Sorority
=450  \\$wnnna$aCollegiate Fraternities
=450  \\$wnnna$aCollegiate Fraternities and Sororities
=450  \\$wnnna$aCollegiate Fraternity
=450  \\$wnnna$aCollegiate Sororities
=450  \\$wnnna$aCollegiate Sorority
=450  \\$wnnna$aFraternities, College
=450  \\$wnnna$aFraternities, Collegiate
=450  \\$wnnna$aFraternity, College
=450  \\$wnnna$aFraternity, Collegiate
=450  \\$wnnna$aGreek Letter Organization
=450  \\$wnnna$aGreek-Letter Organization
=450  \\$wnnna$aGreek Letter Organizations
=450  \\$wnnna$aGreek-Letter Organizations
=450  \\$wnnna$aGreek Letter Societies
=450  \\$wnnna$aGreek-Letter Societies
=450  \\$wnnna$aGreek Letter Society
=450  \\$wnnna$aGreek-Letter Society
=450  \\$wnnna$aOrganization, Greek Letter
=450  \\$wnnna$aOrganization, Greek-Letter
=450  \\$wnnna$aOrganizations, Greek Letter
=450  \\$wnnna$aOrganizations, Greek-Letter
=450  \\$wnnna$aSocieties, Greek Letter
=450  \\$wnnna$aSocieties, Greek-Letter
=450  \\$wnnna$aSociety, Greek Letter
=450  \\$wnnna$aSociety, Greek-Letter
=450  \\$wnnna$aSororities, College
=450  \\$wnnna$aSororities, Collegiate
=450  \\$wnnna$aSorority, College
=450  \\$wnnna$aSorority, Collegiate
=550  \\$wg$aOrganizations
=680  \\$iLocal or national organizations of college students, primarily for social purposes, usually with secret initiations and rites and a name composed of two or three Greek letters.
=688  \\$a2015
=750  \0$aGreek letter societies$0(DLC)sh 85057168$5IEN-M

=LDR  00701cz  a2200217n  4500
=001  9880364529902441
=005  20150420160322.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065816
=040  \\$aDNLM$cDNLM
=072  \\$aH2.$x478.$x676.$x542
=072  \\$aN2.$x421.$x533.$x505
=150  \\$aNeuroscience Nursing
=450  \\$wnnna$aNeurological Nursing
=450  \\$wnnna$aNursing, Neurological
=450  \\$wnnna$aNursing, Neuroscience
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=680  \\$iThe nursing specialty focusing on the needs of patients with dysfunction of the NERVOUS SYSTEM.
=688  \\$a2015
=750  \0$aNeurological nursing$5IEN$0(DLC)sh 85091134

=LDR  00709cz  a2200193n  4500
=001  9880364530002441
=005  20150415171840.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065812
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x593.$x465
=150  \\$aInteroception
=450  \\$wnnna$aAlliesthesia
=450  \\$wnnna$aAlliesthesias
=550  \\$wg$aPerception
=667  \\$ado not confuse with enteroception; note entry term ALLIESTHESIA: do not confuse with ALLESTHESIA
=680  \\$iThe perception of and sensitivity to stimuli originating inside of the body. It is a sense of the physiological condition of the entire body.
=688  \\$a2015
=750  \0$aInteroception$0(DLC)sh 85067476$5IEN-M

=LDR  00924cz  a2200193n  4500
=001  9880364530102441
=005  20150520103118.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065806
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x875
=072  \\$aF1.$x145.$x813.$x629.$x875
=072  \\$aF1.$x829.$x595.$x875
=150  \\$aXenophobia
=550  \\$wg$aPrejudice
=550  \\$wg$aSocial Discrimination
=680  \\$iIntense or irrational dislike or fear of anything that is strange or foreign, particularly of people who are strangers or foreigners. It is an attitudinal orientation of hostility against non-natives in a given population that includes attitudes, prejudices and behavior that reject, exclude or vilify persons, based on the perception that they are outsiders or foreigners to the community, society or national identity.
=688  \\$a2015
=750  \0$aXenophobia$0(DLC)sh 85148799$5IEN-M

=LDR  01648cz  a2200493n  4500
=001  9880363933302441
=005  20141212205222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012004
=035  \\$aCBA5305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411.$x307.$x790
=072  \\$aC6.$x301.$x371.$x411.$x307.$x790
=072  \\$aC6.$x405.$x249.$x411.$x307.$x790
=072  \\$aC6.$x405.$x469.$x491.$x307.$x790
=072  \\$aC6.$x405.$x469.$x860.$x180.$x500
=150  \\$aRectal Neoplasms
=450  \\$aCancer of Rectum
=450  \\$wnnna$aCancer of the Rectum
=450  \\$wnnna$aCancer, Rectal
=450  \\$wnnna$aCancer, Rectum
=450  \\$wnnna$aCancers, Rectal
=450  \\$wnnna$aCancers, Rectum
=450  \\$wnnna$aNeoplasm, Rectal
=450  \\$wnnna$aNeoplasm, Rectum
=450  \\$wnnna$aNeoplasms, Rectal
=450  \\$wnnna$aNeoplasms, Rectum
=450  \\$aRectal Cancer
=450  \\$wnnna$aRectal Cancers
=450  \\$wnnna$aRectal Neoplasm
=450  \\$wnnna$aRectal Tumor
=450  \\$aRectal Tumors
=450  \\$wnnna$aRectum Cancer
=450  \\$wnnna$aRectum Cancers
=450  \\$wnnna$aRectum Neoplasm
=450  \\$wnnna$aRectum Neoplasms
=450  \\$wnnna$aTumor, Rectal
=450  \\$wnnna$aTumors, Rectal
=550  \\$wg$aColorectal Neoplasms
=550  \\$wh$aAnus Neoplasms
=667  \\$acoord IM with histol type of neopl (IM); familial: consider also COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS
=680  \\$iTumors or cancer of the RECTUM.
=750  \0$aRectum$xCancer$5IEN-M$0(DLC)sh 90003388
=750  \0$aRectum$xTumors$5IEN-HS$0(DLC)sh 85112009

=LDR  00994cz  a2200265n  4500
=001  9880363933402441
=005  20141212205221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012003
=035  \\$aCBA5304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x550.$x600
=072  \\$aC6.$x405.$x469.$x471.$x600
=072  \\$aC6.$x405.$x469.$x860.$x752
=072  \\$aC23.$x300.$x575.$x185.$x550.$x600
=150  \\$aRectal Fistula
=450  \\$aAnal Fistula
=450  \\$wnnna$aFistula, Rectal
=550  \\$wg$aIntestinal Fistula
=550  \\$wg$aRectal Diseases
=550  \\$wh$aRectovaginal Fistula
=667  \\$afistula policy: Manual 23.19+; do not confuse X ref ANAL FISTULA with FISSURE IN ANO; RECTOVAGINAL FISTULA is also available
=680  \\$iAn abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.
=750  \0$aFistula, Recto-urethral$5IEN$0(DLC)sh 85048902
=750  \0$aAnal fistula$5IEN-HS$0(DLC)sh 85048893

=LDR  00937cz  a2200313n  4500
=001  9880363933502441
=005  20141212205221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012002
=035  \\$aCBA5303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x860
=150  \\$aRectal Diseases
=450  \\$wnnna$aDisease, Rectal
=450  \\$wnnna$aDiseases, Rectal
=450  \\$wnnna$aRectal Disease
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aAnus Diseases
=550  \\$wh$aColorectal Neoplasms
=550  \\$wh$aFecal Incontinence
=550  \\$wh$aHemorrhoids
=550  \\$wh$aProctitis
=550  \\$wh$aRectal Fistula
=550  \\$wh$aRectal Prolapse
=550  \\$wh$aRectocele
=667  \\$ainflamm dis = PROCTITIS
=680  \\$iPathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
=688  \\$a66
=750  \0$aRectum$xDiseases$5IEN$0(DLC)sh 85112006

=LDR  01561cz  a2200397n  4500
=001  9880363933602441
=005  20141212205221.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x505
=072  \\$aC10.$x597.$x751.$x418.$x505
=072  \\$aC23.$x888.$x592.$x763.$x393.$x505
=150  \\$aHyperacusis
=450  \\$aAuditory Hyperesthesia
=450  \\$wnnna$aAuditory Hyperesthesias
=450  \\$wnnna$aDisturbance, Loudness Perception
=450  \\$wnnna$aDisturbances, Loudness Perception
=450  \\$wnnna$aHyperacuses
=450  \\$wnnna$aHyperacusia
=450  \\$wnnna$aHyperacusias
=450  \\$wnnna$aHyperesthesia, Auditory
=450  \\$wnnna$aHyperesthesias, Auditory
=450  \\$wnnna$aLoudness Perception Disturbance
=450  \\$wnnna$aLoudness Perception Disturbances
=450  \\$aLoudness Recruitment
=450  \\$wnnna$aLoudness Recruitments
=450  \\$wnnna$aPerception Disturbance, Loudness
=450  \\$wnnna$aPerception Disturbances, Loudness
=450  \\$wnnna$aPhonophobia
=450  \\$wnnna$aPhonophobias
=450  \\$aRecruitment, Loudness
=550  \\$wg$aHearing Disorders
=680  \\$iAn abnormally disproportionate increase in the sensation of loudness in response to auditory stimuli of normal volume. COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; FACIAL NERVE DISEASES; STAPES SURGERY; and other disorders may be associated with this condition.
=688  \\$a2000(1979)
=750  \0$aHyperacusis$5IEN-M$0(DLC)sh 96006735

=LDR  00660cz  a2200253n  4500
=001  9880363933702441
=005  20141212205219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011998
=035  \\$aCBA5299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642
=150  \\$aRecreation
=450  \\$wnnna$aRecreations
=550  \\$wg$aLeisure Activities
=550  \\$wh$aCamping
=550  \\$wh$aDancing
=550  \\$wh$aGardening
=550  \\$wh$aHobbies
=550  \\$wh$aPlay and Playthings
=550  \\$wh$aSports
=550  \\$wh$aSunbathing
=680  \\$iActivity engaged in for pleasure.
=750  \0$aRecreation$5IEN$0(DLC)sh 85111945

=LDR  00935cz  a2200277n  4500
=001  9880363933802441
=005  20141212205219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011997
=035  \\$aCBA5298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x493.$x592
=150  \\$aRecovery Room
=450  \\$aHospital Recovery Room
=450  \\$aHospital Recovery Rooms
=450  \\$wnnna$aRecovery Room, Hospital
=450  \\$wnnna$aRecovery Rooms
=450  \\$wnnna$aRecovery Rooms, Hospital
=450  \\$wnnna$aRoom, Hospital Recovery
=450  \\$wnnna$aRoom, Recovery
=450  \\$wnnna$aRooms, Hospital Recovery
=450  \\$wnnna$aRooms, Recovery
=550  \\$wg$aIntensive Care Units
=680  \\$iHospital unit providing continuous monitoring of the patient following anesthesia.
=688  \\$a79(75); was see under INTENSIVE CARE UNITS 1966-78
=750  \0$aRecovery rooms$5IEN$0(DLC)sh 85111943

=LDR  01145cz  a2200313n  4500
=001  9880363934002441
=005  20141212205218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011995
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760
=150  \\$aRecombination, Genetic
=450  \\$aGenetic Recombination
=450  \\$wnnna$aGenetic Recombinations
=450  \\$wnnna$aRecombination
=450  \\$wnnna$aRecombinations
=450  \\$wnnna$aRecombinations, Genetic
=550  \\$wg$aGenetic Processes
=550  \\$wh$aConjugation, Genetic
=550  \\$wh$aGene Fusion
=550  \\$wh$aGene Transfer, Horizontal
=550  \\$wh$aHomologous Recombination
=550  \\$wh$aTransduction, Genetic
=550  \\$wh$aTransfection
=550  \\$wh$aTransformation, Genetic
=550  \\$wh$aV(D)J Recombination
=680  \\$iProduction of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses.
=688  \\$a68
=750  \0$aGenetic recombination$5IEN$0(DLC)sh 85053867

=LDR  01087cz  a2200337n  4500
=001  9880363934102441
=005  20141212205218.0
=008  850308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011994
=035  \\$aCBA5295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x828
=150  \\$aRecombinant Proteins
=450  \\$aBiosynthetic Proteins
=450  \\$wnnna$aDNA Proteins, Recombinant
=450  \\$aDNA Recombinant Proteins
=450  \\$wnnna$aProteins, Biosynthetic
=450  \\$wnnna$aProteins, DNA Recombinant
=450  \\$wnnna$aProteins, Recombinant
=450  \\$wnnna$aProteins, Recombinant DNA
=450  \\$wnnna$aRecombinant DNA Proteins
=450  \\$wnnna$aRecombinant Proteins, DNA
=550  \\$wg$aProteins
=550  \\$wh$aRecombinant Fusion Proteins
=550  \\$wh$aVaccines, Synthetic
=550  \\$aBioreactors
=550  \\$aBiotechnology
=667  \\$aIM general only; coordinate NIM with specific protein
=680  \\$iProteins prepared by recombinant DNA technology.
=688  \\$a86
=750  \0$aRecombinant proteins$5IEN$0(DLC)sh 90005744

=LDR  00810cz  a2200241n  4500
=001  9880363934202441
=005  20141212205217.0
=008  820419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011992
=035  \\$aCBA5293M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x880.$x337
=150  \\$aEndosomes
=450  \\$wnnna$aEndosome
=450  \\$wnnna$aReceptosome
=450  \\$aReceptosomes
=550  \\$wg$aTransport Vesicles
=550  \\$wh$aMultivesicular Bodies
=550  \\$aEndocytosis
=550  \\$aExosomes
=680  \\$iCytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface.
=688  \\$a95; was RECEPTOSOMES 1983-94
=750  \0$aEndosomes$0(DLC)sh2006004529$5IEN-M

=LDR  01351cz  a2200313n  4500
=001  9880363934302441
=005  20200618171229.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011991
=035  \\$aCBA5292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x830
=150  \\$aReceptors, Virus
=450  \\$aPhage Receptors
=450  \\$wnnna$aReceptors, Phage
=450  \\$aVirus Receptors
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aCoxsackie and Adenovirus Receptor-Like Membrane Protein
=550  \\$wh$aHepatitis A Virus Cellular Receptor 1
=550  \\$wh$aHepatitis A Virus Cellular Receptor 2
=550  \\$wh$aReceptors, Complement 3d
=550  \\$wh$aReceptors, CXCR6
=550  \\$wh$aReceptors, HIV
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Member 14
=550  \\$aViruses
=667  \\$areceptor on or within the cell binding the virus; do not confuse X ref PHAGE RECEPTORS with PHAGE ATTACHMENT SITES see ATTACHMENT SITES (MICROBIOLOGY); DF: RECEPT VIRUS
=680  \\$iSpecific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
=688  \\$a79
=750  \0$aViruses$xReceptors$0(DLC)sh 85143839$5IEN-M

=LDR  01207cz  a2200277n  4500
=001  9880363934402441
=005  20190507160041.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011990
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x905.$x500
=072  \\$aD12.$x776.$x543.$x750.$x800
=150  \\$aReceptors, Transferrin
=450  \\$wnnna$aReceptor, Transferrin
=450  \\$wnnna$aTransferrin Receptor
=450  \\$aTransferrin Receptors
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aTransferrin-Binding Proteins
=550  \\$wh$aBacterial Transferrin Receptor Complex
=550  \\$aTransferrin
=667  \\$aDF: RECEPT TRANSFERRIN
=680  \\$iMembrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.
=688  \\$a87
=750  \0$81$wb$iBroader mapping$aTransferrin$0(DLC)sh 85136915$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aTransferrin--Receptors$5IEN-M

=LDR  02444cz  a2200577n  4500
=001  9880363934502441
=005  20190507154750.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011988
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x624.$x664.$x700.$x830
=072  \\$aD12.$x776.$x826.$x850
=150  \\$aReceptors, Thyroid Hormone
=450  \\$wnnna$aDiiodotyrosine Receptor
=450  \\$aDiiodotyrosine Receptors
=450  \\$wnnna$aDIT Receptors
=450  \\$wnnna$aMIT Receptors
=450  \\$wnnna$aMonoiodotyrosine Receptors
=450  \\$aReceptors, Diiodotyrosine
=450  \\$wnnna$aReceptors, DIT
=450  \\$wnnna$aReceptors, MIT
=450  \\$wnnna$aReceptors, Monoiodotyrosine
=450  \\$wnnna$aReceptors, T3
=450  \\$wnnna$aReceptors, T4
=450  \\$aReceptors, Thyroxine
=450  \\$aReceptors, Triiodothyronine
=450  \\$wnnna$aT3 Receptor
=450  \\$aT3 Receptors
=450  \\$wnnna$aT4 Receptor
=450  \\$aT4 Receptors
=450  \\$wnnna$aThyroid Hormone Receptor
=450  \\$aThyroid Hormone Receptors
=450  \\$wnnna$aThyroxine Receptor
=450  \\$aThyroxine Receptors
=450  \\$aTriiodothyronine Receptors
=550  \\$wg$aProto-Oncogene Proteins
=550  \\$wg$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aThyroid Hormone Receptors alpha
=550  \\$wh$aThyroid Hormone Receptors beta
=550  \\$aDiiodotyrosine
=550  \\$aGenes, erbA
=550  \\$aLong-Acting Thyroid Stimulator
=550  \\$aThyroid Hormones
=550  \\$aThyroxine
=550  \\$aTriiodothyronine
=667  \\$acoord IM with specific thyroid hormone (IM); DF: RECEPT THYROID HORMONE
=680  \\$iSpecific high affinity binding proteins for THYROID HORMONES in target cells. They are usually found in the nucleus and regulate DNA transcription. These receptors are activated by hormones that leads to transcription, cell differentiation, and growth suppression. Thyroid hormone receptors are encoded by two genes (GENES, ERBA): erbA-alpha and erbA-beta for alpha and beta thyroid hormone receptors, respectively.
=688  \\$a87; PROTO-ONCOGENE PROTEIN ERBA was (NM) 1987-93
=750  \0$81$wb$iBroader mapping$aThyroid hormones$0(DLC)sh 85135174$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThyroid hormones--Receptors$5IEN-M

=LDR  01622cz  a2200385n  4500
=001  9880363934602441
=005  20190506135257.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011987
=035  \\$aCBA5288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x698.$x750
=072  \\$aD12.$x776.$x826.$x750
=072  \\$aD12.$x776.$x930.$x669.$x750
=150  \\$aReceptors, Steroid
=450  \\$wnnna$aCorticosteroid Receptor
=450  \\$aCorticosteroid Receptors
=450  \\$wnnna$aReceptor, Corticosteroid
=450  \\$wnnna$aReceptor, Steroid
=450  \\$aReceptors, Corticosteroid
=450  \\$wnnna$aReceptors, Steroids
=450  \\$wnnna$aSteroid Receptor
=450  \\$aSteroid Receptors
=450  \\$wnnna$aSteroids Receptors
=550  \\$wg$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aReceptors, Androgen
=550  \\$wh$aReceptors, Estrogen
=550  \\$wh$aReceptors, Glucocorticoid
=550  \\$wh$aReceptors, Mineralocorticoid
=550  \\$wh$aReceptors, Progesterone
=550  \\$aSteroids
=667  \\$aGEN; prefer specifics; coord IM with specific steroid (IM); DF: RECEPT STEROID
=680  \\$iProteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes.
=688  \\$a77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993
=750  \0$aSteroid hormones$xReceptors$0(DLC)sh 85128054$5IEN-M

=LDR  01757cz  a2200373n  4500
=001  9880363934702441
=005  20190507143419.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011986
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x770
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x750
=150  \\$aReceptors, Somatotropin
=450  \\$wnnna$aGrowth Hormone Receptor
=450  \\$aGrowth Hormone Receptors
=450  \\$wnnna$aHormone Receptor, Growth
=450  \\$wnnna$aHormone Receptors, Growth
=450  \\$wnnna$aReceptor, Growth Hormone
=450  \\$aReceptors, Growth Hormone
=450  \\$wnnna$aReceptors, Somatomammotropin
=450  \\$wnnna$aSomatomammotropin Receptor
=450  \\$aSomatomammotropin Receptors
=450  \\$wnnna$aSomatotropin Receptor
=450  \\$aSomatotropin Receptors
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aGrowth Hormone
=550  \\$aPlacental Lactogen
=667  \\$aDF: RECEPT SOMATOTROPIN
=680  \\$iCell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins.
=688  \\$a87
=750  \0$aSomatotropin$0(DLC)sh 85124783$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSomatotropin--Receptors$5IEN-M

=LDR  01876cz  a2200457n  4500
=001  9880363934802441
=005  20190507140752.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011985
=035  \\$aCBA5286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x70.$x800
=072  \\$aD12.$x776.$x543.$x750.$x100.$x800
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.$x800
=150  \\$aReceptors, Serotonin
=450  \\$a5-HT Receptors
=450  \\$wnnna$a5 HT Receptors
=450  \\$a5-Hydroxytryptamine Receptors
=450  \\$wnnna$a5 Hydroxytryptamine Receptors
=450  \\$wnnna$aReceptors, 5-HT
=450  \\$wnnna$aReceptors, 5 HT
=450  \\$wnnna$aReceptors, 5-Hydroxytryptamine
=450  \\$wnnna$aReceptors, 5 Hydroxytryptamine
=450  \\$aReceptors, Tryptamine
=450  \\$aSerotonin Receptors
=450  \\$aTryptamine Receptors
=550  \\$wg$aReceptors, Biogenic Amine
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, Serotonin, 5-HT1
=550  \\$wh$aReceptors, Serotonin, 5-HT2
=550  \\$wh$aReceptors, Serotonin, 5-HT3
=550  \\$wh$aReceptors, Serotonin, 5-HT4
=550  \\$aSerotonin
=550  \\$aSerotonin Plasma Membrane Transport Proteins
=550  \\$aTryptamines
=667  \\$aGEN; prefer specifics; DF: RECEPT SEROTONIN
=680  \\$iCell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.
=688  \\$a77
=750  \0$81$wb$iBroader mapping$aSerotonin$0(DLC)sh 85120301$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSerotonin--Receptors$5IEN-M

=LDR  02086cz  a2200565n  4500
=001  9880363934902441
=005  20141212192500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011984
=035  \\$aCBA5285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915
=072  \\$aA8.$x800.$x950
=072  \\$aA11.$x671.$x650.$x915
=150  \\$aSensory Receptor Cells
=450  \\$wnnna$aNerve Ending, Sensory
=450  \\$aNerve Endings, Sensory
=450  \\$wnnna$aNeural Receptor
=450  \\$wnnna$aNeural Receptors
=450  \\$wnnna$aNeuron, Sensory
=450  \\$aNeurons, Sensory
=450  \\$wnnna$aNeuroreceptor
=450  \\$aNeuroreceptors
=450  \\$wnnna$aReceptor Cell, Sensory
=450  \\$wnnna$aReceptor Cells, Sensory
=450  \\$wnnna$aReceptor, Neural
=450  \\$wnnna$aReceptor, Sensory
=450  \\$aReceptors, Neural
=450  \\$wnnna$aReceptors, Sensory
=450  \\$wnnna$aSensory Nerve Ending
=450  \\$wnnna$aSensory Nerve Endings
=450  \\$wnnna$aSensory Neuron
=450  \\$wnnna$aSensory Neurons
=450  \\$wnnna$aSensory Receptor
=450  \\$wnnna$aSensory Receptor Cell
=450  \\$wnnna$aSensory Receptors
=550  \\$wg$aNeurons, Afferent
=550  \\$wg$aPeripheral Nervous System
=550  \\$wh$aChemoreceptor Cells
=550  \\$wh$aMechanoreceptors
=550  \\$wh$aNociceptors
=550  \\$wh$aPhotoreceptor Cells
=550  \\$wh$aThermoreceptors
=550  \\$aNeurons, Afferent
=550  \\$aSense Organs
=680  \\$iSpecialized afferent neurons capable of transducing sensory stimuli into NERVE IMPULSES to be transmitted to the CENTRAL NERVOUS SYSTEM. Sometimes sensory receptors for external stimuli are called exteroceptors; for internal stimuli are called interoceptors and proprioceptors.
=688  \\$a2009 (1963); for SENSORY NEURONS use NEURONS, AFFERENT 2007-2008
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Receptors, Sensory
=688  \\$a77; was RECEPTORS, NEURAL 1963-76
=750  \0$aSensory receptors$0(DLC) sh 88002450$5IEN-HS

=LDR  01648cz  a2200373n  4500
=001  9880363935002441
=005  20141212205213.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011983
=035  \\$aCBA5284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x700
=072  \\$aD12.$x776.$x543.$x750.$x720.$x700
=072  \\$aD12.$x776.$x543.$x750.$x810
=150  \\$aReceptors, Purinergic
=450  \\$aMethyladenine Receptors
=450  \\$wnnna$aPurine Receptor
=450  \\$aPurine Receptors
=450  \\$aPurinergic Receptors
=450  \\$wnnna$aPurinoceptor
=450  \\$aPurinoceptors
=450  \\$wnnna$aReceptor, Purine
=450  \\$wnnna$aReceptors, Methyladenine
=450  \\$wnnna$aReceptors, Purine
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wh$aReceptors, Cyclic AMP
=550  \\$wh$aReceptors, Purinergic P1
=550  \\$wh$aReceptors, Purinergic P2
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iCell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.
=688  \\$a87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, & THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE & RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993
=750  \0$aPurines$xReceptors$5IEN$0(DLC)sh 85109191

=LDR  01198cz  a2200277n  4500
=001  9880363935102441
=005  20190502110507.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011980
=035  \\$aCBA5281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x698.$x750.$x765
=072  \\$aD12.$x776.$x826.$x750.$x765
=072  \\$aD12.$x776.$x930.$x669.$x750.$x765
=150  \\$aReceptors, Progesterone
=450  \\$wnnna$aProgesterone Receptor
=450  \\$aProgesterone Receptors
=450  \\$aProgestin Receptors
=450  \\$wnnna$aReceptor, Progesterone
=450  \\$aReceptors, Progestin
=550  \\$wg$aReceptors, Steroid
=550  \\$aProgesterone
=667  \\$acoord IM with specific progesterone (IM); DF: RECEPT PROGESTERONE
=680  \\$iSpecific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.
=688  \\$a77
=750  \0$aProgesterone$xReceptors$0(DLC)sh 85107296$5IEN-M

=LDR  01695cz  a2200373n  4500
=001  9880363935202441
=005  20190430153226.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011978
=035  \\$aCBA5279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x400.$x100.$x500
=072  \\$aD12.$x776.$x543.$x550.$x425.$x500.$x100.$x500
=072  \\$aD12.$x776.$x543.$x585.$x400.$x500.$x100.$x500
=072  \\$aD12.$x776.$x543.$x750.$x51.$x687
=072  \\$aD12.$x776.$x543.$x750.$x720.$x360.$x550
=150  \\$aReceptors, Nicotinic
=450  \\$wnnna$aAcetylcholine Receptor, Nicotinic
=450  \\$wnnna$aAcetylcholine Receptors, Nicotinic
=450  \\$wnnna$aNicotinic Acetylcholine Receptor
=450  \\$aNicotinic Acetylcholine Receptors
=450  \\$wnnna$aNicotinic Receptor
=450  \\$aNicotinic Receptors
=450  \\$wnnna$aReceptor, Nicotinic
=450  \\$wnnna$aReceptor, Nicotinic Acetylcholine
=450  \\$wnnna$aReceptors, Nicotinic Acetylcholine
=550  \\$wg$aCysteine Loop Ligand-Gated Ion Channel Receptors
=550  \\$wg$aReceptors, Cholinergic
=550  \\$wh$aalpha7 Nicotinic Acetylcholine Receptor
=550  \\$aGanglionic Blockers
=550  \\$aGanglionic Stimulants
=680  \\$iOne of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.
=688  \\$a84(77); was see under RECEPTORS, CHOLINERGIC 1977-83
=750  \0$aNicotinic receptors$0(DLC)sh 88007070$5IEN

=LDR  01619cz  a2200373n  4500
=001  9880363935302441
=005  20141212205210.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011976
=035  \\$aCBA5277HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x475
=072  \\$aD12.$x776.$x543.$x750.$x720.$x360.$x500
=150  \\$aReceptors, Muscarinic
=450  \\$wnnna$aAcetylcholine Receptor, Muscarinic
=450  \\$wnnna$aAcetylcholine Receptors, Muscarinic
=450  \\$wnnna$aMuscarinic Acetylcholine Receptor
=450  \\$aMuscarinic Acetylcholine Receptors
=450  \\$wnnna$aMuscarinic Receptor
=450  \\$aMuscarinic Receptors
=450  \\$wnnna$aReceptor, Muscarinic
=450  \\$wnnna$aReceptor, Muscarinic Acetylcholine
=450  \\$wnnna$aReceptors, Muscarinic Acetylcholine
=550  \\$wg$aReceptors, Cholinergic
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptor, Muscarinic M1
=550  \\$wh$aReceptor, Muscarinic M2
=550  \\$wh$aReceptor, Muscarinic M3
=550  \\$wh$aReceptor, Muscarinic M4
=550  \\$wh$aReceptor, Muscarinic M5
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iOne of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology.
=688  \\$a84(77); was see under RECEPTORS, CHOLINERGIC 1977-83
=750  \0$aMuscarinic receptors$5IEN$0(DLC)sh 85088670

=LDR  01692cz  a2200349n  4500
=001  9880363935402441
=005  20141212205209.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011973
=035  \\$aCBA5275HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x710.$x450
=150  \\$aReceptors, LDL
=450  \\$wnnna$aLDL Receptor
=450  \\$aLDL Receptors
=450  \\$wnnna$aLDL Receptors, Lipoprotein
=450  \\$aLipoprotein LDL Receptors
=450  \\$wnnna$aLow Density Lipoprotein Receptor
=450  \\$wnnna$aLow Density Lipoprotein Receptors
=450  \\$wnnna$aReceptor, LDL
=450  \\$wnnna$aReceptors, Lipoprotein, LDL
=450  \\$wnnna$aReceptors, Lipoprotein LDL
=450  \\$aReceptors, Low Density Lipoprotein
=550  \\$wg$aReceptors, Lipoprotein
=550  \\$wh$aLDL-Receptor Related Proteins
=550  \\$wh$aReceptors, Oxidized LDL
=550  \\$wh$aReceptors, Scavenger
=550  \\$aLipoproteins, LDL
=667  \\$aDF: RECEPT LDL
=680  \\$iReceptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.
=688  \\$a85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92
=750  \0$aLow density lipoproteins$xReceptors$5IEN$0(IEN)377070

=LDR  02452cz  a2200577n  4500
=001  9880363935502441
=005  20190426133651.0
=008  880603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015375
=035  \\$aCBA5274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x320
=150  \\$aReceptors, Interleukin-2
=450  \\$wnnna$aIL-2 Receptor
=450  \\$wnnna$aIL 2 Receptor
=450  \\$aIL-2 Receptors
=450  \\$wnnna$aIL 2 Receptors
=450  \\$wnnna$aIL2 Receptor
=450  \\$wnnna$aIL2 Receptors
=450  \\$wnnna$aInterleukin 2 Receptor
=450  \\$aInterleukin-2 Receptors
=450  \\$wnnna$aInterleukin 2 Receptors
=450  \\$wnnna$aReceptor, IL-2
=450  \\$wnnna$aReceptor, IL2
=450  \\$wnnna$aReceptor, Interleukin 2
=450  \\$wnnna$aReceptor, TCGF
=450  \\$aReceptors, IL-2
=450  \\$wnnna$aReceptors, IL 2
=450  \\$wnnna$aReceptors, IL2
=450  \\$wnnna$aReceptors, Interleukin 2
=450  \\$aReceptors, T-Cell Growth Factor
=450  \\$wnnna$aReceptors, T Cell Growth Factor
=450  \\$wnnna$aReceptors, TCGF
=450  \\$wnnna$aT-Cell Growth Factor Receptor
=450  \\$wnnna$aT Cell Growth Factor Receptor
=450  \\$aT-Cell Growth Factor Receptors
=450  \\$wnnna$aT Cell Growth Factor Receptors
=450  \\$wnnna$aTCGF Receptor
=450  \\$wnnna$aTCGF Receptors
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aInterleukin-2 Receptor alpha Subunit
=550  \\$wh$aInterleukin-2 Receptor beta Subunit
=550  \\$wh$aInterleukin Receptor Common gamma Subunit
=550  \\$aInterleukin-2
=667  \\$aDF: RECEPT IL 2 or RECEPT IL2
=680  \\$iReceptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
=688  \\$a1990(1989)
=688  \\$a90; was RECEPTORS, INTERLEUKIN 2 1989; CD25 ANTIGENS was CD25 ANTIGEN see RECEPTORS, INTERLEUKIN-2 1989-92
=750  \0$81$wb$iBroader mapping$aInterleukin-2$0(DLC) sh 87006638$4BM$5IEN
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-2--Receptors$5IEN-M

=LDR  01853cz  a2200361n  4500
=001  9880363935602441
=005  20190419143643.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x200
=072  \\$aD12.$x776.$x543.$x750.$x60.$x484
=072  \\$aD12.$x776.$x543.$x750.$x750.$x580.$x300
=150  \\$aReceptor, Insulin
=450  \\$wnnna$aInsulin-Dependent Tyrosine Protein Kinase
=450  \\$aInsulin Receptor
=450  \\$wnnna$aInsulin Receptor alpha Chain
=450  \\$aInsulin Receptor alpha Subunit
=450  \\$wnnna$aInsulin Receptor beta Chain
=450  \\$aInsulin Receptor beta Subunit
=450  \\$aInsulin Receptor Protein-Tyrosine Kinase
=450  \\$wnnna$aInsulin Receptor Protein Tyrosine Kinase
=450  \\$wnnna$aInsulin Receptors
=450  \\$wnnna$aReceptors, Insulin
=550  \\$wg$aReceptor Protein-Tyrosine Kinases
=550  \\$wg$aReceptors, Pancreatic Hormone
=550  \\$aDonohue Syndrome
=550  \\$aInsulin
=680  \\$iA cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE.
=688  \\$a2000(1977); for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, INSULIN (NM) 1983-1993
=750  \0$81$wb$iBroader mapping$aInsulin$0(DLC)sh 85066794$4BM$5IEN
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInsulin--Receptors$5IEN-M

=LDR  01407cz  a2200325n  4500
=001  9880363935702441
=005  20200619113930.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011968
=035  \\$aCBA5269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x670.$x450
=072  \\$aD12.$x776.$x543.$x750.$x720.$x720.$x480
=150  \\$aReceptors, Histamine
=450  \\$wnnna$aBinding Sites, Histamine
=450  \\$aHistamine Binding Sites
=450  \\$wnnna$aHistamine Receptor
=450  \\$aHistamine Receptors
=450  \\$wnnna$aReceptor, Histamine
=450  \\$wnnna$aSites, Histamine Binding
=550  \\$wg$aReceptors, Biogenic Amine
=550  \\$wh$aReceptors, Histamine H1
=550  \\$wh$aReceptors, Histamine H2
=550  \\$wh$aReceptors, Histamine H3
=550  \\$wh$aReceptors, Histamine H4
=550  \\$aHistamine
=667  \\$aGEN or unspecified; prefer specifics; coord IM with specific histamine cpd (IM); DF: RECEPT HISTAMINE
=680  \\$iCell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action.
=688  \\$a77
=750  \0$aHistamine$xReceptors$5IEN$0(DLC)sh 85061074

=LDR  03205cz  a2200637n  4500
=001  9880363935802441
=005  20190429153509.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x410
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x460
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x460
=072  \\$aD12.$x776.$x543.$x750.$x750.$x700.$x460
=150  \\$aReceptors, LHRH
=450  \\$wnnna$aFollicle Stimulating Hormone-Releasing Hormone Receptors
=450  \\$wnnna$aFollicle Stimulating Hormone Releasing Hormone Receptors
=450  \\$wnnna$aGnRH Receptor
=450  \\$aGnRH Receptors
=450  \\$aGonadoliberin Receptors
=450  \\$wnnna$aGonadorelin Receptor
=450  \\$aGonadorelin Receptors
=450  \\$wnnna$aGonadotropin-Releasing Hormone Receptor
=450  \\$wnnna$aGonadotropin Releasing Hormone Receptor
=450  \\$aGonadotropin Releasing-Hormone Receptors
=450  \\$wnnna$aGonadotropin Releasing Hormone Receptors
=450  \\$wnnna$aHormone Receptor, Gonadotropin-Releasing
=450  \\$aLHFSHRH Receptors
=450  \\$wnnna$aLHRH Receptor
=450  \\$aLHRH Receptors
=450  \\$aLuliberin Receptors
=450  \\$wnnna$aLuteinizing Hormone Releasing-Hormone Receptor
=450  \\$wnnna$aLuteinizing Hormone Releasing Hormone Receptor
=450  \\$wnnna$aLuteinizing Hormone Releasing Hormone Receptors
=450  \\$wnnna$aReceptor, GnRH
=450  \\$wnnna$aReceptor, Gonadorelin
=450  \\$wnnna$aReceptor, Gonadotropin-Releasing Hormone
=450  \\$wnnna$aReceptor, LHRH
=450  \\$aReceptors, GnRH
=450  \\$aReceptors, Gonadoliberin
=450  \\$aReceptors, Gonadorelin
=450  \\$wnnna$aReceptors, Gonadotropin Releasing-Hormone
=450  \\$wnnna$aReceptors, Gonadotropin Releasing Hormone
=450  \\$wnnna$aReceptors, LHFSHRH
=450  \\$aReceptors, Luliberin
=450  \\$wnnna$aReleasing-Hormone Receptors, Gonadotropin
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone-Regulating Hormone
=550  \\$aGonadotropin-Releasing Hormone
=667  \\$aDF: RECEPT LHRH
=680  \\$iReceptors with a 6-kDa protein on the surfaces of cells that secrete LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE, usually in the adenohypophysis. LUTEINIZING HORMONE-RELEASING HORMONE binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LUTEINIZING HORMONE or FOLLICLE STIMULATING HORMONE by the cell. These receptors are also found in rat gonads. INHIBINS prevent the binding of GnRH to its receptors.
=688  \\$a94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91
=750  \0$81$wb$iBroader mapping$5IEN-M$aLuteinizing hormone releasing hormone$0(DLC)sh 85078987$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLuteinizing hormone releasing hormone--Receptor$5IEN-M

=LDR  01653cz  a2200361n  4500
=001  9880363935902441
=005  20141212205205.0
=008  760505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011965
=035  \\$aCBA5266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x698.$x750.$x430
=072  \\$aD12.$x776.$x826.$x750.$x430
=072  \\$aD12.$x776.$x930.$x669.$x750.$x430
=150  \\$aReceptors, Glucocorticoid
=450  \\$wnnna$aCorticoid II Receptor
=450  \\$wnnna$aCorticoid II Receptors
=450  \\$wnnna$aCorticoid Type II Receptors
=450  \\$wnnna$aGlucocorticoid Receptor
=450  \\$aGlucocorticoid Receptors
=450  \\$wnnna$aGlucocorticoids Receptors
=450  \\$wnnna$aReceptor, Corticoid II
=450  \\$wnnna$aReceptor, Glucocorticoid
=450  \\$wnnna$aReceptors, Corticoid II
=450  \\$wnnna$aReceptors, Corticoid Type II
=450  \\$wnnna$aReceptors, Glucocorticoids
=550  \\$wg$aReceptors, Steroid
=550  \\$aAdrenal Cortex Hormones
=550  \\$aGlucocorticoids
=667  \\$acoord IM with specific glucocorticoid (IM); DF: RECEPT GLUCOCORTICOID
=680  \\$iCytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.
=688  \\$a86(77); was see under RECEPTORS, STEROID 1977-85
=750  \0$aGlucocorticoids$xReceptors$5IEN$0(DLC)sh 85055359

=LDR  02214cz  a2200457n  4500
=001  9880363936002441
=005  20190503154002.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011964
=035  \\$aCBA5265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x360
=150  \\$aReceptors, Gastrointestinal Hormone
=450  \\$wnnna$aGastrointestinal Hormone Receptor
=450  \\$aGastrointestinal Hormone Receptors
=450  \\$wnnna$aGastrointestinal Hormones Receptors
=450  \\$wnnna$aGastrointestinal Peptides Receptors
=450  \\$wnnna$aHormone Receptor, Gastrointestinal
=450  \\$wnnna$aHormone Receptor, Intestinal
=450  \\$wnnna$aHormone Receptors, Gastrointestinal
=450  \\$wnnna$aHormone Receptors, Intestinal
=450  \\$wnnna$aHormones Receptors, Gastrointestinal
=450  \\$wnnna$aIntestinal Hormone Receptor
=450  \\$aIntestinal Hormone Receptors
=450  \\$wnnna$aPeptides Receptors, Gastrointestinal
=450  \\$wnnna$aReceptor, Gastrointestinal Hormone
=450  \\$wnnna$aReceptor, Intestinal Hormone
=450  \\$wnnna$aReceptors, Gastrointestinal Hormones
=450  \\$aReceptors, Gastrointestinal Peptides
=450  \\$wnnna$aReceptors, Intestinal Hormone
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aGlucagon-Like Peptide Receptors
=550  \\$wh$aReceptors, Cholecystokinin
=550  \\$wh$aReceptors, Vasoactive Intestinal Peptide
=550  \\$aGastrointestinal Hormones
=667  \\$aGEN: prefer specifics; coord IM with specific hormone (IM); DF: RECEPT GASTROINTESTINAL HORMONE
=680  \\$iCell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.
=688  \\$a87
=750  \0$81$wb$iBroader mapping$aGastrointestinal hormones$0(DLC)sh 85053486$5IEN
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGastrointestinal hormones--Receptors$5IEN-M

=LDR  03881cz  a2200937n  4500
=001  9880363936102441
=005  20190423165629.0
=008  840531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011963
=035  \\$aCBA5264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x175.$x562
=072  \\$aD12.$x776.$x157.$x530.$x400.$x400.$x100.$x100
=072  \\$aD12.$x776.$x543.$x550.$x425.$x175.$x562
=072  \\$aD12.$x776.$x543.$x550.$x425.$x500.$x100.$x100
=072  \\$aD12.$x776.$x543.$x585.$x400.$x175.$x562
=072  \\$aD12.$x776.$x543.$x585.$x400.$x500.$x100.$x100
=072  \\$aD12.$x776.$x543.$x750.$x51.$x500
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x300.$x300
=150  \\$aReceptors, GABA-A
=450  \\$wnnna$aBenzodiazepine-GABA Receptor
=450  \\$wnnna$aBenzodiazepine GABA Receptor
=450  \\$aBenzodiazepine-Gaba Receptors
=450  \\$wnnna$aBenzodiazepine Gaba Receptors
=450  \\$wnnna$aBenzodiazepine Receptor
=450  \\$wnnna$aBenzodiazepine Receptors
=450  \\$wnnna$adelta Subunit, GABA-A Receptor
=450  \\$wnnna$adelta Subunit, GABA A Receptor
=450  \\$wnnna$aDiazepam Receptor
=450  \\$wnnna$aDiazepam Receptors
=450  \\$wnnna$aepsilon Subunit, GABA-A Receptor
=450  \\$wnnna$aepsilon Subunit, GABA A Receptor
=450  \\$wnnna$aGABA(A) Receptor
=450  \\$wnnna$aGABA-A Receptor
=450  \\$wnnna$aGABA A Receptor
=450  \\$wnnna$aGABA-A Receptor alpha Subunit
=450  \\$wnnna$aGABA A Receptor alpha Subunit
=450  \\$wnnna$aGABA-A Receptor beta Subunit
=450  \\$wnnna$aGABA A Receptor beta Subunit
=450  \\$wnnna$aGABA-A Receptor delta Subunit
=450  \\$wnnna$aGABA A Receptor delta Subunit
=450  \\$wnnna$aGABA-A Receptor epsilon Subunit
=450  \\$wnnna$aGABA A Receptor epsilon Subunit
=450  \\$wnnna$aGABA-A Receptor gamma Subunit
=450  \\$wnnna$aGABA A Receptor gamma Subunit
=450  \\$wnnna$aGABA-A Receptor rho Subunit
=450  \\$wnnna$aGABA A Receptor rho Subunit
=450  \\$aGABA-A Receptors
=450  \\$wnnna$aGABA A Receptors
=450  \\$wnnna$aGABA-Benzodiazepine Receptor
=450  \\$wnnna$aGABA Benzodiazepine Receptor
=450  \\$wnnna$aGABA-Benzodiazepine Receptors
=450  \\$wnnna$aGABA Benzodiazepine Receptors
=450  \\$wnnna$agamma-Aminobutyric Acid Subtype A Receptors
=450  \\$wnnna$agamma Aminobutyric Acid Subtype A Receptors
=450  \\$wnnna$aMuscimol Receptor
=450  \\$wnnna$aMuscimol Receptors
=450  \\$wnnna$aReceptor, Benzodiazepine
=450  \\$wnnna$aReceptor, Benzodiazepine-GABA
=450  \\$wnnna$aReceptor, Diazepam
=450  \\$wnnna$aReceptor, GABA-A
=450  \\$wnnna$aReceptor, GABA-Benzodiazepine
=450  \\$wnnna$aReceptor, Muscimol
=450  \\$aReceptors, Benzodiazepine
=450  \\$aReceptors, Benzodiazepine-GABA
=450  \\$wnnna$aReceptors, Benzodiazepine GABA
=450  \\$aReceptors, Diazepam
=450  \\$wnnna$aReceptors, GABA A
=450  \\$aReceptors, GABA-Benzodiazepine
=450  \\$wnnna$aReceptors, GABA Benzodiazepine
=450  \\$aReceptors, Muscimol
=550  \\$wg$aChloride Channels
=550  \\$wg$aCysteine Loop Ligand-Gated Ion Channel Receptors
=550  \\$wg$aReceptors, GABA
=550  \\$aAminobutyrates
=550  \\$aDiazepam
=550  \\$aMuscimol
=680  \\$iCell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop.
=688  \\$a1994; was RECEPTORS, GABA-BENZODIAZEPINE 1985-1993
=688  \\$a94; was RECEPTORS, GABA-BENZODIAZEPINE 1985-93
=750  \0$aBenzodiazepines$xReceptors$0(DLC)sh 85013242$5IEN-M

=LDR  00923cz  a2200265n  4500
=001  9880363936202441
=005  20141212205201.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011961
=035  \\$aCBA5262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x871
=150  \\$aReceptors, Fc
=450  \\$wnnna$aFc Receptor
=450  \\$aFc Receptors
=450  \\$wnnna$aReceptor, Fc
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aReceptors, IgE
=550  \\$wh$aReceptors, IgG
=550  \\$wh$aReceptors, Polymeric Immunoglobulin
=550  \\$aImmunoglobulin Fc Fragments
=667  \\$aDF: RECEPT FC
=680  \\$iMolecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules.
=688  \\$a80
=750  \0$aFc receptors$5IEN$0(DLC)sh 85047511

=LDR  01448cz  a2200373n  4500
=001  9880363936302441
=005  20141212205201.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011960
=035  \\$aCBA5261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x698.$x750.$x350
=072  \\$aD12.$x776.$x826.$x750.$x350
=072  \\$aD12.$x776.$x930.$x669.$x750.$x350
=150  \\$aReceptors, Estrogen
=450  \\$wnnna$aEstrogen Nuclear Receptor
=450  \\$wnnna$aEstrogen Receptor Type I
=450  \\$wnnna$aEstrogen Receptor Type II
=450  \\$aEstrogen Receptors
=450  \\$wnnna$aEstrogen Receptors Type I
=450  \\$wnnna$aEstrogen Receptors Type II
=450  \\$wnnna$aNuclear Receptor, Estrogen
=450  \\$wnnna$aReceptor, Estrogen Nuclear
=450  \\$wnnna$aReceptors, Estrogen, Type I
=450  \\$wnnna$aReceptors, Estrogen, Type II
=550  \\$wg$aReceptors, Steroid
=550  \\$wh$aEstrogen Receptor alpha
=550  \\$wh$aEstrogen Receptor beta
=550  \\$wh$aReceptors, Estradiol
=550  \\$aEstrogens
=667  \\$acoord IM with specific estrogen (IM); DF: RECEPT ESTROGEN
=680  \\$iCytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
=688  \\$a77
=750  \0$aEstrogen$xReceptors$5IEN$0(DLC)sh 85045014

=LDR  00974cz  a2200253n  4500
=001  9880363936402441
=005  20190423160052.0
=008  840524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011959
=035  \\$aCBA5260M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x826.$x750.$x350.$x350
=150  \\$aReceptors, Estradiol
=450  \\$wnnna$aEstradiol Receptor
=450  \\$aEstradiol Receptors
=450  \\$wnnna$aReceptor, Estradiol
=550  \\$wg$aReceptors, Estrogen
=550  \\$aEstradiol
=667  \\$aDF: RECEPT ESTRADIOL
=680  \\$iCytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.
=688  \\$a89(85); was see under RECEPTORS, ESTROGEN 1985-88
=750  \0$81$wb$iBroader mapping$aEstradiol$0(DLC)sh 85045006$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aEstradiol--Receptors$5IEN-M

=LDR  02429cz  a2200613n  4500
=001  9880363936602441
=005  20141212192458.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011957
=035  \\$aCBA5258HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x620
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x610
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x610
=150  \\$aReceptors, Opioid
=450  \\$wnnna$abeta-Endorphin Receptor
=450  \\$wnnna$abeta Endorphin Receptor
=450  \\$wnnna$abeta-Endorphin Receptors
=450  \\$wnnna$aEndorphin Receptor
=450  \\$aEndorphin Receptors
=450  \\$wnnna$aEnkephalin Receptor
=450  \\$aEnkephalin Receptors
=450  \\$aNarcotic Receptors
=450  \\$wnnna$aNormorphine Receptors
=450  \\$wnnna$aOpiate Receptor
=450  \\$wnnna$aOpiate Receptors
=450  \\$wnnna$aOpioid Receptor
=450  \\$aOpioid Receptors
=450  \\$wnnna$aReceptor, beta-Endorphin
=450  \\$wnnna$aReceptor, Endorphin
=450  \\$wnnna$aReceptor, Enkephalin
=450  \\$wnnna$aReceptor, Opiate
=450  \\$wnnna$aReceptor, Opioid
=450  \\$wnnna$aReceptors, beta-Endorphin
=450  \\$wnnna$aReceptors, beta Endorphin
=450  \\$aReceptors, Endorphin
=450  \\$aReceptors, Enkephalin
=450  \\$aReceptors, Narcotic
=450  \\$wnnna$aReceptors, Normorphine
=450  \\$aReceptors, Opiate
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptors, Opioid, delta
=550  \\$wh$aReceptors, Opioid, kappa
=550  \\$wh$aReceptors, Opioid, mu
=550  \\$wh$aReceptors, sigma
=550  \\$aEndorphins
=550  \\$aEnkephalins
=550  \\$aMorphine
=550  \\$aNarcotics
=550  \\$aOpioid Peptides
=680  \\$iCell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
=688  \\$a94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79
=750  \0$aOpioids$xReceptors$5IEN$0(DLC)sh 85095086

=LDR  03551cz  a2200757n  4500
=001  9880363936702441
=005  20200504104507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011956
=035  \\$aCBA5257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750
=150  \\$aReceptors, Cell Surface
=450  \\$aCell Receptors$5IEN-M
=450  \\$wnnna$aCell Surface Hormone Receptors
=450  \\$aCell Surface Receptors
=450  \\$wnnna$aEndogenous Substances Receptors
=450  \\$aHormone Receptors, Cell Surface
=450  \\$aReceptors, Endogenous Substances
=550  \\$wg$aMembrane Proteins
=550  \\$wh$aAntigens, CD36
=550  \\$wh$aAsialoglycoprotein Receptor
=550  \\$wh$aAutoreceptors
=550  \\$wh$aCysteine Loop Ligand-Gated Ion Channel Receptors
=550  \\$wh$aEndoglin
=550  \\$wh$aEndothelial Protein C Receptor
=550  \\$wh$aFolate Receptors, GPI-Anchored
=550  \\$wh$aJunctional Adhesion Molecule A
=550  \\$wh$aMethyl-Accepting Chemotaxis Proteins
=550  \\$wh$aNeuropilins
=550  \\$wh$aNogo Receptors
=550  \\$wh$aPatched Receptors
=550  \\$wh$aReceptor Protein-Tyrosine Kinases
=550  \\$wh$aReceptors, Adipokine
=550  \\$wh$aReceptors, Artificial
=550  \\$wh$aReceptors, Autocrine Motility Factor
=550  \\$wh$aReceptors, Biogenic Amine
=550  \\$wh$aReceptors, Collagen
=550  \\$wh$aReceptors, Death Domain
=550  \\$wh$aReceptors, Eicosanoid
=550  \\$wh$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, Guanylate Cyclase-Coupled
=550  \\$wh$aReceptors, Immunologic
=550  \\$wh$aReceptors, Lipoprotein
=550  \\$wh$aReceptors, N-Acetylglucosamine
=550  \\$wh$aReceptors, Neurotransmitter
=550  \\$wh$aReceptors, Notch
=550  \\$wh$aReceptors, Odorant
=550  \\$wh$aReceptors, Peptide
=550  \\$wh$aReceptors, Pheromone
=550  \\$wh$aReceptors, Phospholipase A2
=550  \\$wh$aReceptors, Proteinase-Activated
=550  \\$wh$aReceptors, Purinergic
=550  \\$wh$aReceptors, Transferrin
=550  \\$wh$aReceptors, Urokinase Plasminogen Activator
=550  \\$wh$aReceptors, Virus
=550  \\$wh$aReceptors, Wnt
=550  \\$wh$aZona Pellucida Glycoproteins
=550  \\$aBinding Sites
=550  \\$aHormones
=550  \\$aLigands
=550  \\$aReceptor Cross-Talk
=667  \\$aGEN: prefer specifics; coord IM with specific endogenous substance (IM); for hormone receptors in general coord HORMONES (IM) + RECEPTORS, CELL SURFACE (IM) or RECEPTORS, CYTOPLASMIC AND NUCLEAR (IM), for receptors of specific hormones, coord specific hormone or hormone group (IM) + precoord hormone receptor (e.g., RECEPTORS, ALDOSTERONE) (IM) or precoord hormone-group receptor (e.g., RECEPTORS, GLUCOCORTICOID) (IM); DF: RECEPT CELL SURFACE
=680  \\$iCell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
=688  \\$a94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS & RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93
=750  \0$aCell receptors$5IEN-M$0(DLC)sh 85021665

=LDR  01071cz  a2200277n  4500
=001  9880363936802441
=005  20141212205159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011955
=035  \\$aCBA5256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x827
=150  \\$aReceptors, Drug
=450  \\$wnnna$aDrug Receptor
=450  \\$aDrug Receptors
=450  \\$wnnna$aReceptor, Drug
=550  \\$wg$aProteins
=550  \\$wh$aImidazoline Receptors
=550  \\$wh$aImmunophilins
=550  \\$wh$aReceptors, Phencyclidine
=550  \\$wh$aSulfonylurea Receptors
=550  \\$aPharmaceutical Preparations
=667  \\$ado not confuse with CHEMORECEPTOR CELLS: TN 160; coord IM with specific drug or chemical (IM); DF: RECEPT DRUG
=680  \\$iProteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified.
=688  \\$a68
=750  \0$aDrug receptors$5IEN$0(DLC)sh 85039707

=LDR  01007cz  a2200277n  4500
=001  9880363936902441
=005  20141212205159.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011954
=035  \\$aCBA5255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x70.$x300.$x400
=072  \\$aD12.$x776.$x543.$x750.$x100.$x150.$x400
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.$x300.$x400
=150  \\$aReceptors, Dopamine
=450  \\$wnnna$aDopamine Receptor
=450  \\$aDopamine Receptors
=450  \\$wnnna$aReceptor, Dopamine
=550  \\$wg$aReceptors, Catecholamine
=550  \\$wh$aReceptors, Dopamine D1
=550  \\$wh$aReceptors, Dopamine D2
=550  \\$aDopamine
=667  \\$acoord IM with specific dopamine agent (IM); DF: RECEPT DOPAMINE
=680  \\$iCell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.
=688  \\$a77
=750  \0$aDopamine$xReceptors$0(DLC) sh 85039077$5IEN

=LDR  01395cz  a2200349n  4500
=001  9880363937002441
=005  20190423092212.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011951
=035  \\$aCBA5252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x833
=150  \\$aReceptors, Complement
=450  \\$wnnna$aComplement Receptor
=450  \\$wnnna$aComplement Receptor Type 1
=450  \\$aComplement Receptors
=450  \\$wnnna$aReceptor, Complement
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aCD11b Antigen
=550  \\$wh$aIntegrin alphaXbeta2
=550  \\$wh$aMacrophage-1 Antigen
=550  \\$wh$aMembrane Cofactor Protein
=550  \\$wh$aReceptor, Anaphylatoxin C5a
=550  \\$wh$aReceptors, Complement 3b
=550  \\$wh$aReceptors, Complement 3d
=550  \\$aComplement System Proteins
=667  \\$aGEN; prefer specific; DF: RECEPT COMPLEMENT
=680  \\$iMolecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement.
=688  \\$a80
=750  \0$81$wb$iBroader mapping$aComplement (Immunology)$0(DLC)sh 85029354$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aComplement (Immunology)--Receptors$5IEN-M

=LDR  01470cz  a2200325n  4500
=001  9880363937102441
=005  20141212205157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011950
=035  \\$aCBA5251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x360
=150  \\$aReceptors, Cholinergic
=450  \\$aAcetylcholine Receptors
=450  \\$wnnna$aACh Receptors
=450  \\$aCholinergic Receptors
=450  \\$aCholinoceptive Sites
=450  \\$aCholinoceptors
=450  \\$aReceptors, Acetylcholine
=450  \\$wnnna$aReceptors, ACh
=450  \\$wnnna$aSites, Cholinoceptive
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wh$aReceptors, Muscarinic
=550  \\$wh$aReceptors, Nicotinic
=550  \\$aAcetylcholine
=550  \\$aNeuromuscular Junction
=667  \\$a/antag = NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; coord IM with specific cholinergic agent (IM); DF: RECEPT CHOLINERGIC
=680  \\$iCell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.
=688  \\$a74(71)
=750  \0$aAcetylcholine$xReceptors$5IEN$0(DLC)sh 85000468

=LDR  02578cz  a2200589n  4500
=001  9880363937202441
=005  20190422170943.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011949
=035  \\$aCBA5250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x170
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x270
=072  \\$aD12.$x776.$x543.$x750.$x750.$x360.$x200
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x270
=150  \\$aReceptors, Cholecystokinin
=450  \\$aCaerulein Receptors
=450  \\$wnnna$aCCK-4 Receptors
=450  \\$wnnna$aCCK 4 Receptors
=450  \\$wnnna$aCCK-8 Receptors
=450  \\$wnnna$aCCK 8 Receptors
=450  \\$wnnna$aCCK Receptor
=450  \\$aCCK Receptors
=450  \\$aCholecystokinin Octapeptide Receptors
=450  \\$wnnna$aCholecystokinin Receptor
=450  \\$aCholecystokinin Receptors
=450  \\$wnnna$aOctapeptide Receptors, Cholecystokinin
=450  \\$aPancreozymin Receptors
=450  \\$wnnna$aReceptor, CCK
=450  \\$wnnna$aReceptor, Cholecystokinin
=450  \\$aReceptors, Caerulein
=450  \\$aReceptors, CCK
=450  \\$wnnna$aReceptors, CCK-4
=450  \\$wnnna$aReceptors, CCK 4
=450  \\$wnnna$aReceptors, CCK-8
=450  \\$wnnna$aReceptors, CCK 8
=450  \\$wnnna$aReceptors, Cholecystokinin Octapeptide
=450  \\$aReceptors, Pancreozymin
=450  \\$aReceptors, Sincalide
=450  \\$aSincalide Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Gastrointestinal Hormone
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wh$aReceptor, Cholecystokinin A
=550  \\$wh$aReceptor, Cholecystokinin B
=550  \\$aCholecystokinin
=667  \\$aDF: RECEPT CCK
=680  \\$iCell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood.
=688  \\$a87
=750  \0$81$wb$iBroader mapping$aCholecystokinin$0(DLCsh 85024642$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCholecystokinin--Receptors$5IEN-M

=LDR  02141cz  a2200445n  4500
=001  9880363937302441
=005  20141212205156.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011948
=035  \\$aCBA5249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x816.$x824
=150  \\$aReceptors, Antigen, T-Cell
=450  \\$wnnna$aAntigen Receptor, T-Cell
=450  \\$aAntigen Receptors, T-Cell
=450  \\$wnnna$aAntigen Receptors, T Cell
=450  \\$wnnna$aReceptor, T-Cell
=450  \\$wnnna$aReceptor, T-Cell Antigen
=450  \\$wnnna$aReceptors, T-Cell
=450  \\$wnnna$aReceptors, T-Cell Antigen
=450  \\$wnnna$aReceptors, T Cell Antigen
=450  \\$wnnna$aT-Cell Antigen Receptor
=450  \\$wnnna$aT Cell Antigen Receptor
=450  \\$wnnna$aT-Cell Antigen Receptors
=450  \\$wnnna$aT-Cell Receptor
=450  \\$wnnna$aT Cell Receptor
=450  \\$aT-Cell Receptors
=450  \\$wnnna$aT Cell Receptors
=550  \\$wg$aReceptors, Antigen
=550  \\$wh$aComplementarity Determining Regions
=550  \\$wh$aReceptor-CD3 Complex, Antigen, T-Cell
=550  \\$wh$aReceptors, Antigen, T-Cell, alpha-beta
=550  \\$wh$aReceptors, Antigen, T-Cell, gamma-delta
=550  \\$aAntigens, CD3
=550  \\$aComplementarity Determining Regions
=550  \\$aGenes, T-Cell Receptor
=667  \\$aGEN; prefer specifics; do not confuse their gamma-delta chains with gamma & delta chains which are subunits of CD3 antigens (index under ANTIGENS, CD3); DF: RECEPT ANTIGEN T CELL
=680  \\$iMolecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (ANTIGENS, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
=688  \\$a80
=750  \0$aT cells$xReceptors$5IEN$0(DLC)sh 87006116

=LDR  01033cz  a2200277n  4500
=001  9880363937402441
=005  20190422114626.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011946
=035  \\$aCBA5247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x816
=150  \\$aReceptors, Antigen
=450  \\$wnnna$aAntigen Receptor
=450  \\$aAntigen Receptors
=450  \\$wnnna$aReceptor, Antigen
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aReceptors, Antigen, B-Cell
=550  \\$wh$aReceptors, Antigen, T-Cell
=550  \\$aAntigens
=667  \\$aGEN; prefer specific; DF: RECEPT ANTIGEN
=680  \\$iMolecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens.
=688  \\$a80
=750  \0$81$wb$iBroader mapping$aAntigens$0(DLC)sh 85005675$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAntigens--Receptors$5IEN-M

=LDR  01433cz  a2200325n  4500
=001  9880363937502441
=005  20190422142536.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011945
=035  \\$aCBA5246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x47
=072  \\$aD12.$x776.$x543.$x750.$x750.$x130
=150  \\$aReceptors, Angiotensin
=450  \\$wnnna$aAngiotensin II Receptor
=450  \\$wnnna$aAngiotensin III Receptor
=450  \\$aAngiotensin Receptors
=450  \\$wnnna$aReceptor, Angiotensin II
=450  \\$wnnna$aReceptor, Angiotensin III
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aReceptor, Angiotensin, Type 1
=550  \\$wh$aReceptor, Angiotensin, Type 2
=550  \\$aAngiotensins
=667  \\$anote specific subtypes; do not confuse receptors that bind to ANGIOTENSIN II and ANGIOTENSIN III with specific angiotensin receptor subtypes
=680  \\$iCell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells.
=688  \\$a87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86
=750  \0$81$wb$iBroader mapping$aAngiotensins$0(DLC)sh 85005038$4BM$5IEN
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAngiotensins--Receptors$5IEN-M

=LDR  01379cz  a2200325n  4500
=001  9880363937602441
=005  20141212205154.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011943
=035  \\$aCBA5244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x70.$x300.$x300.$x340
=072  \\$aD12.$x776.$x543.$x750.$x100.$x150.$x300.$x340
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.$x300.$x300.$x340
=150  \\$aReceptors, Adrenergic, beta
=450  \\$aAdrenergic beta-Receptors
=450  \\$wnnna$aAdrenergic beta Receptors
=450  \\$abeta-Adrenergic Receptors
=450  \\$wnnna$abeta Adrenergic Receptors
=450  \\$wnnna$abeta-Receptors, Adrenergic
=450  \\$wnnna$aReceptor, Adrenergic, beta
=450  \\$aReceptors, beta-Adrenergic
=450  \\$wnnna$aReceptors, beta Adrenergic
=550  \\$wg$aReceptors, Adrenergic
=550  \\$wh$aReceptors, Adrenergic, beta-1
=550  \\$wh$aReceptors, Adrenergic, beta-2
=550  \\$wh$aReceptors, Adrenergic, beta-3
=680  \\$iOne of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS.
=688  \\$a84(77); was see under RECEPTORS, ADRENERGIC 1977-83
=750  \0$aBeta adrenoceptors$5IEN-M$0(DLC)sh 89006891

=LDR  01564cz  a2200313n  4500
=001  9880363937702441
=005  20141212205153.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011942
=035  \\$aCBA5243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x70.$x300.$x300.$x300
=072  \\$aD12.$x776.$x543.$x750.$x100.$x150.$x300.$x300
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.$x300.$x300.$x300
=150  \\$aReceptors, Adrenergic, alpha
=450  \\$aAdrenergic alpha-Receptors
=450  \\$wnnna$aAdrenergic alpha Receptors
=450  \\$aalpha-Adrenergic Receptors
=450  \\$wnnna$aalpha Adrenergic Receptors
=450  \\$wnnna$aalpha-Receptors, Adrenergic
=450  \\$wnnna$aReceptor, Adrenergic, alpha
=450  \\$aReceptors, alpha-Adrenergic
=450  \\$wnnna$aReceptors, alpha Adrenergic
=550  \\$wg$aReceptors, Adrenergic
=550  \\$wh$aReceptors, Adrenergic, alpha-1
=550  \\$wh$aReceptors, Adrenergic, alpha-2
=680  \\$iOne of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation.
=688  \\$a84(77); was see under RECEPTORS, ADRENERGIC 1977-83
=750  \0$aAlpha adrenoceptors$5IEN$0(DLC)sh 91003714

=LDR  01473cz  a2200421n  4500
=001  9880363937802441
=005  20201217121020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011787
=035  \\$aCBA5087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761
=072  \\$aN5.$x715
=150  \\$aQuality of Health Care
=450  \\$wnnna$aHealth Care Quality
=450  \\$wnnna$aHealthcare Quality
=450  \\$wnnna$aQuality of Healthcare
=550  \\$wg$aHealth Care Quality, Access, and Evaluation
=550  \\$wg$aHealth Services Administration
=550  \\$wh$aAdvance Directive Adherence
=550  \\$wh$aClinical Competence
=550  \\$wh$aEpidemiologic Factors
=550  \\$wh$aGuideline Adherence
=550  \\$wh$aHealth Care Evaluation Mechanisms
=550  \\$wh$aNarrative Medicine
=550  \\$wh$aOutcome and Process Assessment, Health Care
=550  \\$wh$aPeer Review, Health Care
=550  \\$wh$aProfessional Review Organizations
=550  \\$wh$aProgram Evaluation
=550  \\$wh$aQuality Assurance, Health Care
=550  \\$wh$aQuality Improvement
=550  \\$wh$aQuality Indicators, Health Care
=550  \\$wh$aStandard of Care
=550  \\$wh$aUtilization Review
=667  \\$aIM
=680  \\$iThe levels of excellence which characterize the health service or health care provided based on accepted standards of quality.
=688  \\$a68
=750  \0$aMedical care$xQuality control$5IEN$0(DLC)sh 85082880

=LDR  00889cz  a2200241n  4500
=001  9880363937902441
=005  20141212205100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011786
=035  \\$aCBA5086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x608
=150  \\$aQuality Control
=450  \\$wnnna$aControl, Quality
=450  \\$wnnna$aControls, Quality
=450  \\$wnnna$aQuality Controls
=550  \\$wg$aTechnology
=550  \\$wh$aLaboratory Proficiency Testing
=550  \\$aTotal Quality Management
=667  \\$aNIM; no qualif
=680  \\$iA system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a74(71)
=750  \0$aQuality control$5IEN$0(DLC)sh 85109440

=LDR  02424cz  a2200553n  4500
=001  9880363938002441
=005  20180208142940.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011785
=035  \\$aCBA5085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761.$x700
=072  \\$aN5.$x700
=150  \\$aQuality Assurance, Health Care
=450  \\$wnnna$aAssessment, Healthcare Quality
=450  \\$wnnna$aAssessments, Healthcare Quality
=450  \\$wnnna$aAssurance, Healthcare Quality
=450  \\$wnnna$aAssurances, Healthcare Quality
=450  \\$wnnna$aHealth Care Quality Assessment
=450  \\$wnnna$aHealth Care Quality Assurance
=450  \\$wnnna$aHealthcare Quality Assessment
=450  \\$wnnna$aHealthcare Quality Assessments
=450  \\$wnnna$aHealthcare Quality Assurance
=450  \\$wnnna$aHealthcare Quality Assurances
=450  \\$aQuality Assessment, Health Care
=450  \\$wnnna$aQuality Assessment, Healthcare
=450  \\$wnnna$aQuality Assessments, Healthcare
=450  \\$wnnna$aQuality Assurance, Healthcare
=450  \\$wnnna$aQuality Assurances, Healthcare
=550  \\$wg$aHealth Care Quality, Access, and Evaluation
=550  \\$wg$aQuality of Health Care
=550  \\$wh$aAlert Fatigue, Health Personnel
=550  \\$wh$aBenchmarking
=550  \\$wh$aClinical Audit
=550  \\$wh$aCredentialing
=550  \\$wh$aFacility Regulation and Control
=550  \\$wh$aGuidelines as Topic
=550  \\$wh$aLaboratory Proficiency Testing
=550  \\$wh$aNear Miss, Healthcare
=550  \\$wh$aPotentially Inappropriate Medication List
=550  \\$wh$aProfessional Review Organizations
=550  \\$wh$aProfessional Staff Committees
=550  \\$wh$aTime Out, Healthcare
=550  \\$wh$aTotal Quality Management
=550  \\$wh$aUtilization Review
=667  \\$aDF: QUAL ASSUR
=680  \\$iActivities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.
=688  \\$a80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79
=750  \0$aMedical care$xQuality control$5IEN$0(DLC)sh 85082880

=LDR  00838cz  a2200217n  4500
=001  9880363938102441
=005  20141212205059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011784
=035  \\$aCBA5084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350.$x650
=150  \\$aQuail
=450  \\$wnnna$aQuails
=550  \\$wg$aGalliformes
=550  \\$wh$aColinus
=550  \\$wh$aCoturnix
=667  \\$aGEN or unspecified; prefer COLINUS & COTURNIX; note JAPANESE QUAIL see COTURNIX; diseases: coord IM with BIRD DISEASES (IM)
=680  \\$iCommon name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae.
=688  \\$a73
=750  \0$aQuails$5IEN$0(DLC)sh 85109431

=LDR  00685cz  a2200181n  4500
=001  9880363938202441
=005  20141212205058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011783
=035  \\$aCBA5083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x438.$x486
=150  \\$aQuadruplets
=450  \\$wnnna$aQuadruplet
=550  \\$wg$aMultiple Birth Offspring
=667  \\$ahuman only: for animals use LITTER SIZE; PREGNANCY, QUADRUPLET is also available
=680  \\$iFour individuals derived from four FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
=750  \0$aQuadruplets$5IEN$0(DLC)sh 85109426

=LDR  02217cz  a2200529n  4500
=001  9880363938302441
=005  20141212205058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011782
=035  \\$aCBA5082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x622.$x760
=072  \\$aC23.$x888.$x592.$x636.$x786
=150  \\$aQuadriplegia
=450  \\$wnnna$aFlaccid Quadriplegia
=450  \\$wnnna$aFlaccid Quadriplegias
=450  \\$wnnna$aFlaccid Tetraplegia
=450  \\$wnnna$aFlaccid Tetraplegias
=450  \\$aLocked-In Syndrome
=450  \\$wnnna$aLocked In Syndrome
=450  \\$wnnna$aLocked-In Syndromes
=450  \\$wnnna$aParalysis, Spinal, Quadriplegic
=450  \\$wnnna$aQuadripareses
=450  \\$aQuadriparesis
=450  \\$wnnna$aQuadriplegia, Flaccid
=450  \\$wnnna$aQuadriplegia, Spastic
=450  \\$wnnna$aQuadriplegias
=450  \\$wnnna$aQuadriplegias, Flaccid
=450  \\$wnnna$aQuadriplegias, Spastic
=450  \\$aQuadriplegics$5IEN
=450  \\$aSpastic Quadriplegia
=450  \\$wnnna$aSpastic Quadriplegias
=450  \\$wnnna$aSpastic Tetraplegia
=450  \\$wnnna$aSpastic Tetraplegias
=450  \\$wnnna$aSyndrome, Locked-In
=450  \\$wnnna$aSyndromes, Locked-In
=450  \\$aTetraplegia
=450  \\$wnnna$aTetraplegia, Flaccid
=450  \\$wnnna$aTetraplegia, Spastic
=450  \\$wnnna$aTetraplegias
=450  \\$wnnna$aTetraplegias, Flaccid
=450  \\$wnnna$aTetraplegias, Spastic
=550  \\$wg$aParalysis
=680  \\$iSevere or complete loss of motor function in all four limbs which may result from BRAIN DISEASES; SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or rarely MUSCULAR DISEASES. The locked-in syndrome is characterized by quadriplegia in combination with cranial muscle paralysis. Consciousness is spared and the only retained voluntary motor activity may be limited eye movements. This condition is usually caused by a lesion in the upper BRAIN STEM which injures the descending cortico-spinal and cortico-bulbar tracts.
=688  \\$a1967(1964)
=750  \0$aQuadriplegia$5IEN-M$0(DLC)sh 85109421
=750  \0$aQuadriplegics$5IEN-HS$0(DLC)sh 85109422

=LDR  00594cz  a2200205n  4500
=001  9880363938402441
=005  20141212205057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011781
=035  \\$aCBA5081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x728
=150  \\$aQuackery
=450  \\$wnnna$aQuackeries
=450  \\$aQuacks and Quackery$5IEN
=550  \\$wg$aSocial Problems
=550  \\$aFraud
=550  \\$aNostrums
=680  \\$iThe fraudulent misrepresentation of the diagnosis and treatment of disease.
=750  \0$aQuacks and quackery$5IEN$0(DLC)sh 85109407

=LDR  01838cz  a2200493n  4500
=001  9880363938502441
=005  20141212205057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011778
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x755
=150  \\$aQ Fever
=450  \\$wnnna$aAcute Q Fever
=450  \\$wnnna$aAcute Q Fevers
=450  \\$wnnna$aChronic Q Fever
=450  \\$wnnna$aChronic Q Fevers
=450  \\$aCoxiella burnetii Fever
=450  \\$wnnna$aCoxiella burnetii Fevers
=450  \\$wnnna$aCoxiella burnetii Infection
=450  \\$wnnna$aCoxiella burnetii Infections
=450  \\$wnnna$aCoxiella burnetii Vector-Borne Disease
=450  \\$wnnna$aCoxiella burnetii Vector Borne Disease
=450  \\$wnnna$aFever, Acute Q
=450  \\$wnnna$aFever, Chronic Q
=450  \\$wnnna$aFever, Coxiella burnetii
=450  \\$wnnna$aFever, Q
=450  \\$wnnna$aFever, Query
=450  \\$wnnna$aFevers, Acute Q
=450  \\$wnnna$aFevers, Chronic Q
=450  \\$wnnna$aFevers, Coxiella burnetii
=450  \\$wnnna$aFevers, Q
=450  \\$wnnna$aFevers, Query
=450  \\$wnnna$aInfection, Coxiella burnetii
=450  \\$wnnna$aInfections, Coxiella burnetii
=450  \\$wnnna$aQ Fever, Acute
=450  \\$wnnna$aQ Fever, Chronic
=450  \\$wnnna$aQ Fevers
=450  \\$wnnna$aQ Fevers, Acute
=450  \\$wnnna$aQ Fevers, Chronic
=450  \\$aQuery Fever
=450  \\$wnnna$aQuery Fevers
=550  \\$wg$aGram-Negative Bacterial Infections
=680  \\$iAn acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals (ANIMALS, DOMESTIC).
=750  \0$aQ fever$5IEN$0(DLC)sh 85109385

=LDR  00676cz  a2200193n  4500
=001  9880363938602441
=005  20141212205055.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011775
=035  \\$aCBA5075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x750
=150  \\$aPythium
=450  \\$wnnna$aPythiums
=550  \\$wg$aOomycetes
=667  \\$ainfection = PYTHIOSIS
=680  \\$iA genus of destructive root-parasitic OOMYCETES in the family Pythiaceae, order Peronosporales, commonly found in cultivated soils all over the world. Differentiation of zoospores takes place in a vesicle.
=688  \\$a91(75)
=750  \0$aPythium$5IEN$0(DLC)sh 85109376

=LDR  00500cz  a2200181n  4500
=001  9880363938702441
=005  20141212205055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011773
=035  \\$aCBA5073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x755.$x812
=150  \\$aPyruvates
=550  \\$wg$aKeto Acids
=550  \\$wh$aPhenylpyruvic Acids
=550  \\$wh$aPyruvic Acid
=667  \\$ado not confuse with PYRUVATE see PYRUVIC ACID
=750  \0$aPyruvates$5IEN$0(DLC)sh 85109370

=LDR  01547cz  a2200373n  4500
=001  9880363938802441
=005  20141212205054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011770
=035  \\$aCBA5069HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x695
=150  \\$aPyruvate Kinase
=450  \\$wnnna$aL-Type Pyruvate Kinase
=450  \\$wnnna$aL Type Pyruvate Kinase
=450  \\$wnnna$aM-Type Pyruvate Kinase
=450  \\$wnnna$aM Type Pyruvate Kinase
=450  \\$wnnna$aM1-Type Pyruvate Kinase
=450  \\$wnnna$aM1 Type Pyruvate Kinase
=450  \\$wnnna$aM2-Type Pyruvate Kinase
=450  \\$wnnna$aM2 Type Pyruvate Kinase
=450  \\$wnnna$aPyruvate Kinase L
=450  \\$wnnna$aPyruvate Kinase, L-Type
=450  \\$wnnna$aPyruvate Kinase, M-Type
=450  \\$wnnna$aPyruvate Kinase, M1-Type
=450  \\$wnnna$aPyruvate Kinase, M2-Type
=450  \\$wnnna$aPyruvate Kinase, R-Type
=450  \\$wnnna$aR-Type Pyruvate Kinase
=450  \\$wnnna$aR Type Pyruvate Kinase
=550  \\$wg$aPhosphotransferases (Alcohol Group Acceptor)
=667  \\$ado not coord L-, R-, M-, M1- or M2-type pyruvate kinase with ISOENZYMES
=680  \\$iATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.
=688  \\$a65
=750  \0$aPyruvate kinase$5IEN-M$0(DLC)sh 97002386

=LDR  00807cz  a2200193n  4500
=001  9880363938902441
=005  20141212205053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011766
=035  \\$aCBA5063HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464.$x257.$x500
=150  \\$aPyruvate Carboxylase
=450  \\$wnnna$aCarboxylase, Pyruvate
=550  \\$wg$aCarbon-Carbon Ligases
=550  \\$aPyruvate Carboxylase Deficiency Disease
=680  \\$iA biotin-dependent enzyme belonging to the ligase family that catalyzes the addition of CARBON DIOXIDE to pyruvate. It is occurs in both plants and animals. Deficiency of this enzyme causes severe psychomotor retardation and ACIDOSIS, LACTIC in infants. EC 6.4.1.1.
=688  \\$a74
=750  \0$aPyruvate carboxylase$5IEN$0(DLC)sh 85109369

=LDR  00984cz  a2200253n  4500
=001  9880363939002441
=005  20141212205052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011763
=035  \\$aCBA5060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x716
=072  \\$aD3.$x438.$x772
=150  \\$aPyrrolizidine Alkaloids
=450  \\$wnnna$aAlkaloids, Pyrrolizidine
=450  \\$wnnna$aAlkaloids, Senecio
=450  \\$aSenecio Alkaloids
=550  \\$wg$aAlkaloids
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aMonocrotaline
=550  \\$aSenecio
=680  \\$iA group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS.
=688  \\$a73(71)
=750  \0$aPyrrolizidines$5IEN$0(DLC)sh 85109367

=LDR  01068cz  a2200361n  4500
=001  9880363939102441
=005  20141212205051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011759
=035  \\$aCBA5056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x773
=150  \\$aPyrrolidines
=450  \\$aProfadol$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
=550  \\$wh$aAnisomycin
=550  \\$wh$aBepridil
=550  \\$wh$aClemastine
=550  \\$wh$aGlycopyrrolate
=550  \\$wh$aImino Furanoses
=550  \\$wh$aKainic Acid
=550  \\$wh$aLincosamides
=550  \\$wh$aN-Nitrosopyrrolidine
=550  \\$wh$aNafoxidine
=550  \\$wh$aNitromifene
=550  \\$wh$aPentolinium Tartrate
=550  \\$wh$aProcyclidine
=550  \\$wh$aPyrrolidinones
=550  \\$wh$aTremorine
=667  \\$ado not confuse with PYRROLIDONES or PYRROLIDINONES
=688  \\$a66
=750  \0$aPyrrolidine$5IEN$0(DLC)sh 85109366

=LDR  00709cz  a2200253n  4500
=001  9880363939202441
=005  20141212205050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011758
=035  \\$aCBA5055HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578
=150  \\$aPyrroles
=550  \\$wg$aAzoles
=550  \\$wh$aCromakalim
=550  \\$wh$aMaleimides
=550  \\$wh$aPorphobilinogen
=550  \\$wh$aProdigiosin
=550  \\$wh$aPyrrolnitrin
=550  \\$wh$aRyanodine
=550  \\$wh$aTetrapyrroles
=550  \\$wh$aTolmetin
=680  \\$iAzoles of one NITROGEN and two double bonds that have aromatic chemical properties.
=750  \0$aPyrroles$5IEN$0(DLC)sh 85109365

=LDR  00768cz  a2200229n  4500
=001  9880363939302441
=005  20141212205050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011756
=035  \\$aCBA5053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374.$x775.$x150
=072  \\$aD1.$x248.$x497.$x158.$x730.$x650.$x200
=072  \\$aD1.$x695.$x625.$x675.$x650.$x775.$x150
=150  \\$aDiphosphates
=450  \\$aPyrophosphates
=550  \\$wg$aPolyphosphates
=550  \\$wh$aCalcium Pyrophosphate
=550  \\$wh$aTechnetium Tc 99m Pyrophosphate
=680  \\$iInorganic salts of phosphoric acid that contain two phosphate groups.
=688  \\$a94; was PYROPHOSPHATES 1963-93
=750  \0$aPyrophosphates$5IEN$0(DLC)sh 87001973

=LDR  00593cz  a2200169n  4500
=001  9880363939402441
=005  20141212205048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011749
=035  \\$aCBA5046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x673
=150  \\$aPyrogens
=550  \\$wg$aNoxae
=550  \\$aFever
=680  \\$iSubstances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water.
=750  \0$aPyrogens$5IEN$0(DLC)sh 85109343

=LDR  00613cz  a2200193n  4500
=001  9880363939502441
=005  20141212205048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011748
=035  \\$aCBA5045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x800
=150  \\$aPyrogallol
=450  \\$wnnna$a1,2,3-Trihydroxybenzene
=450  \\$wnnna$aacid, Pyrogallic
=450  \\$wnnna$aPyrogallic acid
=550  \\$wg$aPhenols
=680  \\$iA trihydroxybenzene or dihydroxy phenol that can be prepared by heating GALLIC ACID.
=750  \0$aPyrogallic acid$5IEN$0(DLC)sh 85109342

=LDR  01429cz  a2200445n  4500
=001  9880363939602441
=005  20171012142316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011743
=035  \\$aCBA5040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742
=150  \\$aPyrimidines
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aBuspirone
=550  \\$wh$aDasatinib
=550  \\$wh$aDipyridamole
=550  \\$wh$aEpirizole
=550  \\$wh$aFursultiamin
=550  \\$wh$aHexetidine
=550  \\$wh$aImatinib Mesylate
=550  \\$wh$aMinoxidil
=550  \\$wh$aMopidamol
=550  \\$wh$aMorantel
=550  \\$wh$aNicarbazin
=550  \\$wh$aOxypurinol
=550  \\$wh$aPaliperidone Palmitate
=550  \\$wh$aPyrantel
=550  \\$wh$aPyrimethamine
=550  \\$wh$aPyrimidine Nucleosides
=550  \\$wh$aPyrimidine Nucleotides
=550  \\$wh$aPyrimidinones
=550  \\$wh$aPyrithiamine
=550  \\$hw$aRosuvastatin Calcium
=550  \\$wh$aThiamine
=550  \\$wh$aTrapidil
=550  \\$wh$aTrimethoprim
=680  \\$iA family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
=688  \\$aTHONZYLAMINE was heading 1972-84 (Prov 1972)
=750  \0$aPyrimidines$5IEN$0(DLC)sh 85109338

=LDR  00819cz  a2200265n  4500
=001  9880363939702441
=005  20141212205047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011742
=035  \\$aCBA5039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x686
=072  \\$aD13.$x695.$x740
=150  \\$aPyrimidine Nucleotides
=450  \\$wnnna$aNucleotides, Pyrimidine
=550  \\$wg$aNucleotides
=550  \\$wg$aPyrimidines
=550  \\$wh$aApurinic Acid
=550  \\$wh$aCytosine Nucleotides
=550  \\$wh$aPyrimidine Dimers
=550  \\$wh$aThymine Nucleotides
=550  \\$wh$aUracil Nucleotides
=680  \\$iPyrimidines with a RIBOSE and phosphate attached that can polymerize to form DNA and RNA.
=688  \\$a74(72)
=750  \0$aPyrimidine nucleotides$5IEN$0(DLC)sh 85109337

=LDR  00843cz  a2200217n  4500
=001  9880363939802441
=005  20141212205043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011729
=035  \\$aCBA5026M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x762.$x740
=150  \\$aPyridostigmine Bromide
=450  \\$wnnna$aBromide, Pyridostigmine
=450  \\$wnnna$aMestinon
=450  \\$wnnna$aPyridostigmine
=550  \\$wg$aPyridinium Compounds
=667  \\$aa cholinesterase inhib
=680  \\$iA cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
=688  \\$a65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64
=750  \0$aPyridostigmine bromide$5IEN-M$0(DLC)sh2002009521

=LDR  00635cz  a2200229n  4500
=001  9880363939902441
=005  20141212205043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011728
=035  \\$aCBA5025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x791
=150  \\$aPyridones
=450  \\$aPyridinones
=550  \\$wg$aPyridines
=550  \\$wh$aBemegride
=550  \\$wh$aIodopyridones
=550  \\$wh$aMimosine
=550  \\$wh$aTrazodone
=680  \\$iPyridine derivatives with one or more keto groups on the ring.
=688  \\$a68; was PYRIDINONES 1966-67
=750  \0$aPyridone$5IEN$0(DLC)sh 85109336

=LDR  00902cz  a2200325n  4500
=001  9880363940002441
=005  20141212205042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011726
=035  \\$aCBA5023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x762
=150  \\$aPyridinium Compounds
=450  \\$wnnna$aCompounds, Pyridinium
=550  \\$wg$aPyridines
=550  \\$wh$a1-Methyl-4-phenylpyridinium
=550  \\$wh$aCetylpyridinium
=550  \\$wh$aDesmosine
=550  \\$wh$aDiquat
=550  \\$wh$aIsodesmosine
=550  \\$wh$aObidoxime Chloride
=550  \\$wh$aParaquat
=550  \\$wh$aPyridostigmine Bromide
=550  \\$wh$aPyrithiamine
=550  \\$wh$aTrimedoxime
=550  \\$wh$aViologens
=550  \\$aQuaternary Ammonium Compounds
=667  \\$aDF: PYRIDINIUM CPDS
=688  \\$a68
=750  \0$aPyridinium compounds$5IEN$0(DLC)sh 85109335

=LDR  01800cz  a2200601n  4500
=001  9880363940102441
=005  20210217153045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011725
=035  \\$aCBA5022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725
=150  \\$aPyridines
=450  \\$aZolimidine$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
=550  \\$wh$a2,2'-Dipyridyl
=550  \\$wh$a2-Pyridinylmethylsulfinylbenzimidazoles
=550  \\$wh$aAminopyridines
=550  \\$wh$aBetahistine
=550  \\$wh$aCarbolines
=550  \\$wh$aClopidol
=550  \\$wh$aDabigatran
=550  \\$wh$aDihydropyridines
=550  \\$wh$aDimethindene
=550  \\$wh$aDisopyramide
=550  \\$wh$aDoxylamine
=550  \\$wh$aEszopiclone
=550  \\$wh$aIndinavir
=550  \\$wh$aIsonicotinic Acids
=550  \\$wh$aMetyrapone
=550  \\$wh$aNaphthylvinylpyridine
=550  \\$wh$aNevirapine
=550  \\$wh$aNicotine
=550  \\$wh$aNicotinic Acids
=550  \\$wh$aNicotinyl Alcohol
=550  \\$wh$aPheniramine
=550  \\$wh$aPicolines
=550  \\$wh$aPicolinic Acids
=550  \\$wh$aPolyvinylpyridine N-Oxide
=550  \\$wh$aPyridinium Compounds
=550  \\$wh$aPyridones
=550  \\$wh$aPyrithioxin
=550  \\$wh$aQuinolinic Acids
=550  \\$wh$aThienopyridines
=550  \\$wh$aTolperisone
=550  \\$wh$aTriprolidine
=550  \\$wh$aTropicamide
=550  \\$wh$aTorsemide
=550  \\$aPiperidines
=667  \\$apyridine nucleotides will probably be NAD or NADP
=680  \\$iCompounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
=750  \0$aPyridine$5IEN$0(DLC)sh 85109332

=LDR  00556cz  a2200205n  4500
=001  9880363940202441
=005  20141212205041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011724
=035  \\$aCBA5021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x710
=150  \\$aPyridazines
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aCilazapril
=550  \\$wh$aLuminol
=550  \\$wh$aMaleic Hydrazide
=550  \\$wh$aPhthalazines
=667  \\$ado not confuse with PYRAZINES
=750  \0$aPyridazines$5IEN$0(DLC)sh 85109330

=LDR  01986cz  a2200433n  4500
=001  9880363940302441
=005  20141212205041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011723
=035  \\$aCBA5020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x206.$x222
=150  \\$aChrysanthemum cinerariifolium
=450  \\$wnnna$aChrysanthemum cinerariifoliums
=450  \\$wnnna$aChrysanthemum coccineum
=450  \\$wnnna$aChrysanthemum coccineums
=450  \\$wnnna$acinerariifolium, Chrysanthemum
=450  \\$wnnna$acinerariifolium, Tanacetum
=450  \\$wnnna$acinerariifoliums, Chrysanthemum
=450  \\$wnnna$acinerariifoliums, Tanacetum
=450  \\$wnnna$acoccineum, Chrysanthemum
=450  \\$wnnna$acoccineum, Tanacetum
=450  \\$wnnna$acoccineums, Chrysanthemum
=450  \\$wnnna$acoccineums, Tanacetum
=450  \\$wnnna$aDaisies, Pyrethum
=450  \\$wnnna$aDaisy, Pyrethum
=450  \\$aPyrethrum
=450  \\$wnnna$aPyrethrums
=450  \\$wnnna$aPyrethum Daisies
=450  \\$aPyrethum Daisy
=450  \\$wnnna$aTanacetum cinerariifolium
=450  \\$wnnna$aTanacetum cinerariifoliums
=450  \\$wnnna$aTanacetum coccineum
=450  \\$wnnna$aTanacetum coccineums
=550  \\$wg$aChrysanthemum
=667  \\$afor insecticides from this plant use PYRETHRINS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus CHRYSANTHEMUM, family ASTERACEAE. The flowers contain PYRETHRINS, cinerolones, and chrysanthemines which are powerful contact insecticides. Most in the old Pyrethrum genus are reclassified to TANACETUM; some to other ASTERACEAE genera.
=688  \\$a2003(1963)
=750  \0$aPyrethrum (Plant)$5IEN$0(DLC)sh 85109321

=LDR  00839cz  a2200217n  4500
=001  9880363940402441
=005  20201105102229.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x575.$x812
=150  \\$aPyrethrins
=450  \\$wnnna$aPyrethroids
=550  \\$wg$aMonoterpenes
=550  \\$wh$aAllethrins
=550  \\$wh$aPermethrin
=550  \\$aChrysanthemum cinerariifolium
=667  \\$afor use as an insecticide, see note at INSECTICIDES
=680  \\$iThe active insecticidal constituent of CHRYSANTHEMUM CINERARIIFOLIUM flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester.
=688  \\$a77
=750  \0$aPyrethrins$5IEN$0(DLC)sh 85109318

=LDR  00603cz  a2200205n  4500
=001  9880363940502441
=005  20141212205040.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011721
=035  \\$aCBA5018M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x799
=072  \\$aD4.$x615.$x799
=150  \\$aPyrenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$aBenzopyrenes
=667  \\$ado not confuse with PYRANS or PYRONES
=680  \\$iA group of condensed ring hydrocarbons.
=688  \\$a74
=750  \0$aPyrene (Chemical)$5IEN-M$0(DLC)sh2002005321

=LDR  00886cz  a2200277n  4500
=001  9880363940602441
=005  20161216091058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011720
=035  \\$aCBA5017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539
=150  \\$aPyrazoles
=550  \\$wg$aAzoles
=550  \\$wh$a4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
=550  \\$wh$aBetazole
=550  \\$wh$aCelecoxib
=550  \\$wh$aEpirizole
=550  \\$wh$aIndazoles
=550  \\$wh$aMuzolimine
=550  \\$wh$aOxypurinol
=550  \\$wh$aPyrazolones
=550  \\$wh$aSulfaphenazole
=667  \\$aincludes pyrazolines & pyrazolidines
=680  \\$iAzoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
=750  \0$aPyrazoles$5IEN$0(DLC)sh 85109308

=LDR  00565cz  a2200205n  4500
=001  9880363940702441
=005  20171024154742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011719
=035  \\$aCBA5016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x679
=150  \\$aPyrazines
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aAmiloride
=550  \\$wh$aEszopiclone
=550  \\$wh$aPyrazinamide
=550  \\$wh$aSitagliptin Phosphate
=667  \\$ado not confuse with PYRIDAZINES
=750  \0$aPyrazines$0(DLC)sh2007003956$5IEN-M

=LDR  00489cz  a2200169n  4500
=001  9880363940802441
=005  20141212205039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011718
=035  \\$aCBA5015M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x679.$x750
=150  \\$aPyrazinamide
=450  \\$wnnna$aTisamid
=550  \\$wg$aPyrazines
=680  \\$iA pyrazine that is used therapeutically as an antitubercular agent.
=750  \0$aPyrazinamide$0(DLC)sh2007003976$5IEN-M

=LDR  00828cz  a2200313n  4500
=001  9880363940902441
=005  20141212205039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011714
=035  \\$aCBA5011HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x663
=072  \\$aD3.$x830
=150  \\$aPyrans
=550  \\$wg$aHeterocyclic Compounds
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aAurovertins
=550  \\$wh$aBenzopyrans
=550  \\$wh$aGlaucarubin
=550  \\$wh$aIridoids
=550  \\$wh$aMupirocin
=550  \\$wh$aNigericin
=550  \\$wh$aPatulin
=550  \\$wh$aPyran Copolymer
=550  \\$wh$aPyranocoumarins
=550  \\$wh$aPyrones
=550  \\$wh$aZanamivir
=667  \\$ado not confuse with PYRENES or PYRONES
=750  \0$aPyran$5IEN$0(DLC)sh 85109306

=LDR  01227cz  a2200337n  4500
=001  9880363941002441
=005  20141212205038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011712
=035  \\$aCBA5009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x854.$x633
=072  \\$aA8.$x612.$x380.$x730
=150  \\$aPyramidal Tracts
=450  \\$wnnna$aCorticobulbar Tract
=450  \\$aCorticobulbar Tracts
=450  \\$wnnna$aCorticospinal Tract
=450  \\$aCorticospinal Tracts
=450  \\$aDecussation, Pyramidal
=450  \\$wnnna$aPyramidal Decussation
=450  \\$wnnna$aPyramidal Tract
=450  \\$wnnna$aTract, Corticobulbar
=450  \\$wnnna$aTract, Corticospinal
=450  \\$wnnna$aTract, Pyramidal
=450  \\$wnnna$aTracts, Corticobulbar
=450  \\$wnnna$aTracts, Corticospinal
=450  \\$wnnna$aTracts, Pyramidal
=550  \\$wg$aEfferent Pathways
=550  \\$wg$aSpinal Cord
=680  \\$iFibers that arise from cells within the cerebral cortex, pass through the medullary pyramid, and descend in the spinal cord. Many authorities say the pyramidal tracts include both the corticospinal and corticobulbar tracts.
=750  \0$aPyramidal tract$5IEN$0(DLC)sh 85109299

=LDR  00608cz  a2200205n  4500
=001  9880363941102441
=005  20141212205037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011711
=035  \\$aCBA5008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x695
=150  \\$aPyoderma
=450  \\$wnnna$aPyodermas
=550  \\$wg$aSkin Diseases
=550  \\$wh$aEcthyma
=550  \\$wh$aPyoderma Gangrenosum
=667  \\$a"any purulent skin dis" but do not make diagnoses: use term of text
=680  \\$iAny purulent skin disease (Dorland, 27th ed).
=750  \0$aPyoderma$5IEN$0(DLC)sh 85109291

=LDR  00743cz  a2200205n  4500
=001  9880363941202441
=005  20141212205037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011708
=035  \\$aCBA5005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x875.$x799
=150  \\$aPylorus
=450  \\$wnnna$aPyloric Sphincter
=450  \\$wnnna$aPyloric Sphincters
=450  \\$wnnna$aSphincter, Pyloric
=450  \\$wnnna$aSphincters, Pyloric
=550  \\$wg$aStomach
=680  \\$iThe region of the STOMACH at the junction with the DUODENUM. It is marked by the thickening of circular muscle layers forming the pyloric sphincter to control the opening and closure of the lumen.
=750  \0$aPylorus$5IEN$0(DLC)sh 85109287

=LDR  00657cz  a2200181n  4500
=001  9880363941302441
=005  20141212205036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011707
=035  \\$aCBA5004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x340.$x690
=150  \\$aPyloric Stenosis
=450  \\$wnnna$aStenosis, Pyloric
=550  \\$wg$aGastric Outlet Obstruction
=550  \\$wh$aPyloric Stenosis, Hypertrophic
=680  \\$iNarrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.
=750  \0$aPylorus$xStenosis$0(DLC) sh 85109286$5IEN

=LDR  01145cz  a2200265n  4500
=001  9880363941402441
=005  20141212205036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011704
=035  \\$aCBA5001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570.$x643.$x790
=072  \\$aC12.$x777.$x419.$x570.$x821.$x717
=072  \\$aC13.$x351.$x968.$x419.$x570.$x643.$x790
=072  \\$aC13.$x351.$x968.$x419.$x570.$x821.$x717
=150  \\$aPyelonephritis
=450  \\$aNecrotizing Pyelonephritis
=450  \\$wnnna$aPyelonephritides
=450  \\$aPyelonephritis, Acute Necrotizing
=550  \\$wg$aNephritis, Interstitial
=550  \\$wg$aPyelitis
=550  \\$wh$aPyelonephritis, Xanthogranulomatous
=680  \\$iInflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.
=688  \\$a1963; for PYELONEPHRITIS, ACUTE NECROTIZING use KIDNEY PAPILLARY NECROSIS 1967-2006, use PYELONEPHRITIS, ACUTE NECROTIZING 1963-1966
=750  \0$aPyelonephritis$5IEN$0(DLC)sh 85109270

=LDR  00817cz  a2200265n  4500
=001  9880363941502441
=005  20141212205035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011700
=035  \\$aCBA4997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x415.$x701
=072  \\$aD2.$x92.$x782.$x258.$x784
=150  \\$aPutrescine
=450  \\$wnnna$a1,4-Butanediamine
=450  \\$wnnna$a1,4 Butanediamine
=450  \\$wnnna$a1,4-Diaminobutane
=450  \\$wnnna$a1,4 Diaminobutane
=450  \\$wnnna$aTetramethylenediamine
=550  \\$wg$aBiogenic Polyamines
=550  \\$wg$aDiamines
=550  \\$wh$aSpermidine
=680  \\$iA toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine.
=688  \\$a73(72)
=750  \0$aPutrescine$5IEN$0(DLC)sh 85109251

=LDR  02519cz  a2200541n  4500
=001  9880363941602441
=005  20141212205035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011697
=035  \\$aCBA4994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x802.$x687.$x680
=072  \\$aC15.$x378.$x140.$x855.$x925.$x750.$x680
=072  \\$aC15.$x378.$x925.$x850
=072  \\$aC23.$x550.$x414.$x950.$x687.$x680
=072  \\$aC23.$x888.$x885.$x687.$x687.$x680
=150  \\$aPurpura, Thrombotic Thrombocytopenic
=450  \\$wnnna$aCongenital Thrombotic Thrombocytopenic Purpura
=450  \\$wnnna$aDisease, Moschcowitz
=450  \\$wnnna$aDisease, Moschkowitz
=450  \\$wnnna$aFamilial Thrombotic Microangiopathy
=450  \\$wnnna$aFamilial Thrombotic Thrombocytopenia Purpura
=450  \\$wnnna$aFamilial Thrombotic Thrombocytopenic Purpura
=450  \\$wnnna$aMicroangiopathic Hemolytic Anemia, Congenital
=450  \\$wnnna$aMicroangiopathy, Familial Thrombotic
=450  \\$wnnna$aMoschcowitz Disease
=450  \\$aMoschkowitz Disease
=450  \\$aPurpura, Thrombotic Thrombopenic
=450  \\$wnnna$aSchulman-Upshaw Syndrome
=450  \\$wnnna$aSchulman Upshaw Syndrome
=450  \\$wnnna$aSyndrome, Schulman-Upshaw
=450  \\$wnnna$aSyndrome, Upshaw-Schulman
=450  \\$wnnna$aThrombocytopenic Purpura, Thrombotic
=450  \\$wnnna$aThrombopenic Purpura, Thrombotic
=450  \\$wnnna$aThrombotic Microangiopathy, Familial
=450  \\$wnnna$aThrombotic Thrombocytopenic Purpura
=450  \\$aThrombotic Thrombocytopenic Purpura, Congenital
=450  \\$aThrombotic Thrombocytopenic Purpura, Familial
=450  \\$wnnna$aThrombotic Thrombopenic Purpura
=450  \\$wnnna$aUpshaw Factor, Deficiency of
=450  \\$wnnna$aUpshaw-Schulman Syndrome
=450  \\$wnnna$aUpshaw Schulman Syndrome
=550  \\$wg$aPurpura, Thrombocytopenic
=550  \\$wg$aThrombophilia
=680  \\$iAn acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE.
=688  \\$a1986; use PURPURA, THROMBOTIC THROMBOPENIC 1965-1985
=688  \\$a86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85
=750  \0$aThrombotic thrombocytopenic purpura$0(DLC) sh 92002901$5IEN-M

=LDR  01439cz  a2200361n  4500
=001  9880363941702441
=005  20141212205034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011696
=035  \\$aCBA4993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x802.$x687
=072  \\$aC15.$x378.$x140.$x855.$x925.$x750
=072  \\$aC20.$x841
=072  \\$aC23.$x550.$x414.$x950.$x687
=072  \\$aC23.$x888.$x885.$x687.$x687
=150  \\$aPurpura, Thrombocytopenic
=450  \\$aPurpura, Thrombopenic
=450  \\$wnnna$aPurpuras, Thrombocytopenic
=450  \\$wnnna$aPurpuras, Thrombopenic
=450  \\$wnnna$aThrombocytopenic Purpura
=450  \\$wnnna$aThrombocytopenic Purpuras
=450  \\$wnnna$aThrombopenic Purpura
=450  \\$wnnna$aThrombopenic Purpuras
=550  \\$wg$aImmune System Diseases
=550  \\$wg$aPurpura
=550  \\$wg$aThrombotic Microangiopathies
=550  \\$wh$aPurpura, Thrombocytopenic, Idiopathic
=550  \\$wh$aPurpura, Thrombotic Thrombocytopenic
=667  \\$aPURPURA, THROMBOCYTOPENIC, IDIOPATHIC & PURPURA, THROMBOTIC THROMBOCYTOPENIC are also available; nonthrombocytopenic = PURPURA, SCHOENLEIN-HENOCH
=680  \\$iAny form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.
=688  \\$a86; was PURPURA, THROMBOPENIC 1963-85
=750  \0$aThrombopenic purpura$0(DLC) sh 85135074$5IEN

=LDR  01171cz  a2200349n  4500
=001  9880363941802441
=005  20141212205032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011691
=035  \\$aCBA4988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x200.$x380
=072  \\$aD3.$x438.$x759.$x590.$x138.$x711
=072  \\$aD9.$x408.$x51.$x788
=072  \\$aD13.$x570.$x583.$x138.$x711
=150  \\$aPuromycin
=450  \\$wnnna$aCL-13900
=450  \\$wnnna$aCL 13900
=450  \\$wnnna$aCL13900
=450  \\$wnnna$aP-638
=450  \\$wnnna$aP 638
=450  \\$wnnna$aP638
=450  \\$wnnna$aPuromycin Dihydrochloride
=450  \\$wnnna$aPuromycin Hydrochloride
=450  \\$wnnna$aStylomycin
=550  \\$wg$aAdenosine
=550  \\$wg$aAminoglycosides
=550  \\$wg$aCinnamates
=550  \\$wh$aPuromycin Aminonucleoside
=680  \\$iA cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.
=688  \\$a65(63)
=750  \0$aPuromycin$5IEN$0(DLC)sh 85109203

=LDR  00762cz  a2200241n  4500
=001  9880363941902441
=005  20141212192454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011689
=035  \\$aCBA4986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x200.$x212.$x600
=072  \\$aA8.$x186.$x211.$x865.$x428.$x200.$x212.$x600
=072  \\$aA8.$x675.$x784
=072  \\$aA11.$x671.$x784
=150  \\$aPurkinje Cells
=450  \\$wnnna$aCells, Purkinje
=550  \\$wg$aCerebellar Cortex
=550  \\$wg$aNeurons
=667  \\$ain cerebellum: do not confuse with PURKINJE FIBERS (heart)
=680  \\$iThe output neurons of the cerebellar cortex.
=688  \\$a65(64)
=750  \0$aPurkinje cells$5IEN$0(DLC)sh 85109202

=LDR  01026cz  a2200277n  4500
=001  9880363942002441
=005  20170705104029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011687
=035  \\$aCBA4984HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100.$x759
=150  \\$aPurines
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$a6-Mercaptopurine
=550  \\$wh$aAdenine
=550  \\$wh$aAllopurinol
=550  \\$wh$aLinagliptin
=550  \\$wh$aPurine Nucleosides
=550  \\$wh$aPurine Nucleotides
=550  \\$wh$aPurinones
=550  \\$wh$aSaxitoxin
=550  \\$wh$aSildenafil Citrate
=550  \\$wh$aThioguanine
=680  \\$iA series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
=750  \0$aPurines$5IEN$0(DLC)sh 85109190

=LDR  00916cz  a2200241n  4500
=001  9880363942102441
=005  20141212205031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011686
=035  \\$aCBA4983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x798
=072  \\$aC18.$x452.$x648.$x798
=150  \\$aPurine-Pyrimidine Metabolism, Inborn Errors
=450  \\$wnnna$aPurine Pyrimidine Metabolism, Inborn Errors
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aDihydropyrimidine Dehydrogenase Deficiency
=550  \\$wh$aGout
=550  \\$wh$aLesch-Nyhan Syndrome
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific purine /metab (IM) or pyrimidine /metab (IM); DF: PP METAB INBORN ERR
=688  \\$a65
=750  \0$81$wb$aPyrimindines$xMetabolism$xDisorders$5IEN
=750  \0$81$wb$aPurines$xMetabolism$xDisorders$5IEN-HS

=LDR  00729cz  a2200241n  4500
=001  9880363942202441
=005  20141212205030.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011685
=035  \\$aCBA4982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646
=072  \\$aD13.$x695.$x667
=150  \\$aPurine Nucleotides
=450  \\$wnnna$aNucleotides, Purine
=550  \\$wg$aNucleotides
=550  \\$wg$aPurines
=550  \\$wh$aAdenine Nucleotides
=550  \\$wh$aGuanine Nucleotides
=550  \\$wh$aInosine Nucleotides
=680  \\$iPurines attached to a RIBOSE and a phosphate that can polymerize to form DNA and RNA.
=688  \\$a74(72)
=750  \0$aPurine nucleotides$5IEN$0(DLC)sh 85109188

=LDR  00815cz  a2200253n  4500
=001  9880363942302441
=005  20141212205029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011682
=035  \\$aCBA4979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x679
=072  \\$aN4.$x452.$x442.$x422.$x679
=150  \\$aPurchasing, Hospital
=450  \\$aHospital Purchasing
=450  \\$aHospital Purchasings
=450  \\$wnnna$aPurchasings, Hospital
=550  \\$wg$aHospital Departments
=550  \\$wh$aGroup Purchasing
=550  \\$aEconomics, Hospital
=550  \\$aGroup Purchasing
=680  \\$iHospital department responsible for the purchasing of supplies and equipment.
=688  \\$a78; was HOSPITAL PURCHASING 1963-77
=750  \0$aHospital purchasing$5IEN$0(DLC)sh 85062355

=LDR  04476cz  a2201237n  4500
=001  9880363942402441
=005  20141212205029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011681
=035  \\$aCBA4978M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x690
=072  \\$aC11.$x710
=072  \\$aC23.$x888.$x592.$x708
=150  \\$aPupil Disorders
=450  \\$wnnna$aAbnormal Pupillary Function
=450  \\$wnnna$aAbnormal Pupillary Functions
=450  \\$aAfferent Pupillary Defect
=450  \\$wnnna$aAfferent Pupillary Defects
=450  \\$wnnna$aAnomalies, Pupillary
=450  \\$wnnna$aAnomaly, Pupillary
=450  \\$wnnna$aArgyll-Robertson Pupil, Non-Syphilitic
=450  \\$wnnna$aDeformed Pupil
=450  \\$wnnna$aDeformed Pupils
=450  \\$wnnna$aEctopic Pupil
=450  \\$wnnna$aEctopic Pupils
=450  \\$aEfferent Pupillary Defect
=450  \\$wnnna$aEfferent Pupillary Defects
=450  \\$wnnna$aFixed Pupil
=450  \\$wnnna$aFixed Pupils
=450  \\$wnnna$aHemianopic Pupil, Wernicke
=450  \\$wnnna$aHemianopic Pupil, Wernicke's
=450  \\$wnnna$aKeyhole Pupil
=450  \\$wnnna$aKeyhole Pupils
=450  \\$wnnna$aMalformation, Pupil
=450  \\$wnnna$aMalformations, Pupil
=450  \\$aMarcus-Gunn Pupil
=450  \\$wnnna$aMarcus Gunn Pupil
=450  \\$wnnna$aNon-Syphilitic Argyll-Robertson Pupil
=450  \\$wnnna$aNon Syphilitic Argyll Robertson Pupil
=450  \\$wnnna$aOccluded Pupil
=450  \\$wnnna$aOccluded Pupils
=450  \\$wnnna$aOcclusion, Pupillary
=450  \\$wnnna$aOcclusions, Pupillary
=450  \\$wnnna$aParalyses, Pupillary
=450  \\$wnnna$aParalyses, Pupillary Sector
=450  \\$wnnna$aParalysis, Pupillary
=450  \\$wnnna$aParalysis, Pupillary Sector
=450  \\$wnnna$aPupil, Deformed
=450  \\$wnnna$aPupil Disorder
=450  \\$wnnna$aPupil, Ectopic
=450  \\$wnnna$aPupil, Fixed
=450  \\$wnnna$aPupil, Keyhole
=450  \\$wnnna$aPupil Malformation
=450  \\$wnnna$aPupil Malformations
=450  \\$wnnna$aPupil, Marcus-Gunn
=450  \\$wnnna$aPupil, Non-Syphilitic Argyll-Robertson
=450  \\$wnnna$aPupil, Occluded
=450  \\$aPupil Reaction Absent
=450  \\$wnnna$aPupil, Wernicke Hemianopic
=450  \\$wnnna$aPupil, Wernicke's Hemianopic
=450  \\$wnnna$aPupillary Anomalies
=450  \\$wnnna$aPupillary Anomaly
=450  \\$wnnna$aPupillary Defect, Afferent
=450  \\$wnnna$aPupillary Defect, Efferent
=450  \\$wnnna$aPupillary Defects, Afferent
=450  \\$wnnna$aPupillary Defects, Efferent
=450  \\$wnnna$aPupillary Disorder
=450  \\$wnnna$aPupillary Disorders
=450  \\$wnnna$aPupillary Function, Abnormal
=450  \\$aPupillary Functions, Abnormal
=450  \\$wnnna$aPupillary Occlusion
=450  \\$wnnna$aPupillary Occlusions
=450  \\$wnnna$aPupillary Paralyses
=450  \\$wnnna$aPupillary Paralysis
=450  \\$wnnna$aPupillary Sector Paralyses
=450  \\$wnnna$aPupillary Sector Paralysis
=450  \\$wnnna$aPupillary Sphincter Rupture
=450  \\$wnnna$aPupillary Sphincter Ruptures
=450  \\$wnnna$aPupils, Deformed
=450  \\$wnnna$aPupils, Ectopic
=450  \\$wnnna$aPupils, Fixed
=450  \\$wnnna$aPupils, Keyhole
=450  \\$wnnna$aPupils, Occluded
=450  \\$wnnna$aReaction Absent, Pupil
=450  \\$wnnna$aReaction Absents, Pupil
=450  \\$wnnna$aRupture, Pupillary Sphincter
=450  \\$wnnna$aRuptures, Pupillary Sphincter
=450  \\$wnnna$aSector Paralyses, Pupillary
=450  \\$wnnna$aSector Paralysis, Pupillary
=450  \\$wnnna$aSector Pupil Palsy
=450  \\$wnnna$aSphincter Rupture, Pupillary
=450  \\$wnnna$aSphincter Ruptures, Pupillary
=450  \\$wnnna$aWernicke Hemianopic Pupil
=450  \\$wnnna$aWernicke's Hemianopic Pupil
=450  \\$wnnna$aWernickes Hemianopic Pupil
=550  \\$wg$aEye Diseases
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aAnisocoria
=550  \\$wh$aMiosis
=550  \\$wh$aMydriasis
=550  \\$wh$aTonic Pupil
=667  \\$asee also IRIS DISEASES
=680  \\$iConditions which affect the structure or function of the pupil of the eye, including disorders of innervation to the pupillary constrictor or dilator muscles, and disorders of pupillary reflexes.
=688  \\$a2000(1974)
=750  \0$aPupil (Eye)$xDiseases$5IEN-M$0(IEN)5665335

=LDR  00659cz  a2200205n  4500
=001  9880363942502441
=005  20141212205027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011679
=035  \\$aCBA4976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x500.$x700
=072  \\$aG7.$x700.$x320.$x500.$x550.$x500.$x700
=150  \\$aPupa
=450  \\$wnnna$aPupae
=550  \\$wg$aLife Cycle Stages
=667  \\$aNIM; for metamorphosing insects only: do not use /embryol with ref to pupae
=680  \\$iAn inactive stage between the larval and adult stages in the life cycle of insects.
=688  \\$a74(70)
=750  \0$aPupae$5IEN-M$0(DLC)sh 85109135

=LDR  00740cz  a2200217n  4500
=001  9880363942602441
=005  20201221175424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011678
=035  \\$aCBA4975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x770.$x571
=072  \\$aI1.$x880.$x630.$x716
=150  \\$aPunishment
=450  \\$wnnna$aPunishments
=550  \\$wg$aReinforcement, Psychology
=550  \\$wg$aSocial Control, Informal
=667  \\$ahuman & animal
=680  \\$iThe application of an unpleasant stimulus or penalty for the purpose of eliminating or correcting undesirable behavior.
=750  \0$aPunishment$5IEN-M$0(DLC)sh 85109115
=750  \0$aPunishment (Psychology)$5IEN-HS$0(DLC)sh 85109120

=LDR  00576cz  a2200193n  4500
=001  9880363942702441
=005  20201006123625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011676
=035  \\$aCBA4973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x85.$x800
=150  \\$aPunched-Card Systems
=450  \\$wnnna$aPunched-Card System
=450  \\$wnnna$aPunched Card Systems
=450  \\$wnnna$aSystem, Punched-Card
=450  \\$wnnna$aSystems, Punched-Card
=550  \\$wg$aElectronic Data Processing
=750  \0$aPunched card systems$5IEN$0(DLC)sh 85109085

=LDR  01023cz  a2200265n  4500
=001  9880363942802441
=005  20141212205002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011601
=035  \\$aCBA4897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x685
=072  \\$aF4.$x96.$x753
=072  \\$aF4.$x732
=150  \\$aPsychophysics
=450  \\$wnnna$aPsychophysic
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aPsychoacoustics
=550  \\$wh$aSignal Detection, Psychological
=667  \\$aSPEC: IM, SPEC qualif; NIM coord, no qualif; PSYCHOACOUSTICS is also available
=680  \\$iThe science dealing with the correlation of the physical characteristics of a stimulus, e.g., frequency or intensity, with the response to the stimulus, in order to assess the psychologic factors involved in the relationship.
=688  \\$a70
=750  \0$aPsychophysics$5IEN$0(DLC)sh 85108501

=LDR  00924cz  a2200265n  4500
=001  9880363942902441
=005  20141212205002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011600
=035  \\$aCBA4896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x712
=072  \\$aF4.$x570.$x505
=072  \\$aH1.$x158.$x703.$x546
=072  \\$aH2.$x628.$x546
=150  \\$aPsychopharmacology
=450  \\$aNeuropsychopharmacology$5IEN
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aPharmacology
=550  \\$wg$aPsychiatric Somatic Therapies
=550  \\$wh$aNarcotherapy
=667  \\$aSPEC: IM, SPEC qualif; NIM coord, no qualif; Manual 27.13: relation to PSYCHOTROPIC DRUGS; DF: PSYCHOPHARMACOL
=680  \\$iThe study of the effects of drugs on mental and behavioral activity.
=750  \0$aPsychopharmacology$5IEN-M$0(DLC)sh 85108498
=750  \0$aNeuropsychopharmacology$5IEN-HS$0(DLC)sh 85091165

=LDR  00666cz  a2200181n  4500
=001  9880363943002441
=005  20141212205001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011599
=035  \\$aCBA4895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x670
=150  \\$aPsychopathology
=450  \\$aPsychology, Pathological$5IEN
=550  \\$wg$aBehavioral Sciences
=667  \\$aSPEC: IM, SPEC qualif; NIM coord, no qualif; do not confuse with MENTAL DISORDERS: Manual 27.14; DF: PSYCHOPATHOL
=680  \\$iThe study of significant causes and processes in the development of mental illness.
=750  \0$aPsychology, Pathological$5IEN$0(DLC)sh 85108479

=LDR  00941cz  a2200205n  4500
=001  9880363943102441
=005  20141212205001.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011598
=035  \\$aCBA4894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x795.$x650
=072  \\$aH1.$x158.$x782.$x795.$x180
=150  \\$aPsychoneuroimmunology
=450  \\$aPsychoimmunology
=550  \\$wg$aPsychophysiology
=667  \\$aSPEC: IM; SPEC qualif; relation of brain, behavior & immune system; prefer specific terms with /physiol or /immunol; avoid as NIM coord & use no qualif; DF: PSYCHONEUROIMMUNOL
=680  \\$iThe field concerned with the interrelationship between the brain, behavior and the immune system. Neuropsychologic, neuroanatomic and psychosocial studies have demonstrated their role in accentuating or diminishing immune/allergic responses.
=688  \\$a88
=750  \0$aPsychoneuroimmunology$5IEN$0(DLC)sh 86001417

=LDR  01863cz  a2200505n  4500
=001  9880363943202441
=005  20141212205001.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x808
=072  \\$aG11.$x427.$x700
=072  \\$aG11.$x561.$x623
=150  \\$aPsychomotor Performance
=450  \\$wnnna$aCoordination, Visual Motor
=450  \\$wnnna$aCoordinations, Visual Motor
=450  \\$wnnna$aMotor Coordination, Visual
=450  \\$wnnna$aMotor Coordinations, Visual
=450  \\$wnnna$aMotor Performance, Perceptual
=450  \\$wnnna$aMotor Performance, Sensory
=450  \\$wnnna$aMotor Performances, Perceptual
=450  \\$wnnna$aMotor Performances, Sensory
=450  \\$aPerceptual Motor Performance
=450  \\$wnnna$aPerceptual Motor Performances
=450  \\$wnnna$aPerformance, Perceptual Motor
=450  \\$wnnna$aPerformance, Psychomotor
=450  \\$wnnna$aPerformance, Sensory Motor
=450  \\$wnnna$aPerformances, Perceptual Motor
=450  \\$wnnna$aPerformances, Psychomotor
=450  \\$wnnna$aPerformances, Sensory Motor
=450  \\$wnnna$aPsychomotor Performances
=450  \\$aSensory Motor Performance
=450  \\$wnnna$aSensory Motor Performances
=450  \\$aVisual Motor Coordination
=450  \\$wnnna$aVisual Motor Coordinations
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aMotor Skills
=550  \\$wh$aTask Performance and Analysis
=550  \\$aAthletic Performance
=550  \\$aMotor Activity
=680  \\$iThe coordination of a sensory or ideational (cognitive) process and a motor activity.
=688  \\$a83
=750  \0$aSensorimotor integration$5IEN$0(DLC)sh 85120056

=LDR  01140cz  a2200325n  4500
=001  9880363943302441
=005  20141212205000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011596
=035  \\$aCBA4892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x881
=072  \\$aC23.$x888.$x592.$x604.$x882
=072  \\$aF1.$x700.$x875
=150  \\$aPsychomotor Disorders
=450  \\$wnnna$aDevelopmental Psychomotor Disorder
=450  \\$wnnna$aDevelopmental Psychomotor Disorders
=450  \\$wnnna$aImpairment, Psychomotor
=450  \\$wnnna$aImpairments, Psychomotor
=450  \\$wnnna$aPsychomotor Disorder, Developmental
=450  \\$wnnna$aPsychomotor Disorders, Developmental
=450  \\$aPsychomotor Impairment
=450  \\$wnnna$aPsychomotor Impairments
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wh$aApraxias
=550  \\$wh$aPsychomotor Agitation
=550  \\$aMovement Disorders
=680  \\$iAbnormalities of motor function that are associated with organic and non-organic cognitive disorders.
=688  \\$a1969
=750  \0$aPsychomotor disorders$5IEN$0(DLC)sh 85108493

=LDR  00711cz  a2200193n  4500
=001  9880363943402441
=005  20141212204959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011594
=035  \\$aCBA4890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x780
=150  \\$aPsychometrics
=450  \\$wnnna$aPsychometric
=550  \\$wg$aPsychological Tests
=550  \\$aStatistics as Topic
=667  \\$aSPEC: SPEC qualif; NIM coord: no qualif; includes statist analysis of psychol tests, validation, applic of statist theory or formulae to psychol
=680  \\$iAssessment of psychological variables by the application of mathematical procedures.
=750  \0$aPsychometrics$5IEN$0(DLC)sh 85108490

=LDR  01019cz  a2200301n  4500
=001  9880363479202441
=005  20141212202337.0
=008  840529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007012
=035  \\$aCBA0199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x710.$x485
=072  \\$aC7.$x550.$x745.$x436
=072  \\$aC9.$x647.$x710.$x485
=072  \\$aC9.$x775.$x549.$x485
=150  \\$aHypopharyngeal Neoplasms
=450  \\$wnnna$aCancer, Hypopharyngeal
=450  \\$wnnna$aCancers, Hypopharyngeal
=450  \\$aHypopharyngeal Cancer
=450  \\$wnnna$aHypopharyngeal Cancers
=450  \\$wnnna$aHypopharyngeal Neoplasm
=450  \\$wnnna$aNeoplasm, Hypopharyngeal
=450  \\$wnnna$aNeoplasms, Hypopharyngeal
=550  \\$wg$aPharyngeal Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the HYPOPHARYNX.
=688  \\$a91(85); was see under PHARYNGEAL NEOPLASMS 1985-90
=750  \0$aHypopharynx$xCancer$5IEN-M$0(DLC)sh2010009369

=LDR  00988cz  a2200205n  4500
=001  9880363479302441
=005  20141212202337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007011
=035  \\$aCBA0198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x642.$x482
=150  \\$aHypoparathyroidism
=450  \\$wnnna$aHypoparathyroidism, Idiopathic
=450  \\$wnnna$aIdiopathic Hypoparathyroidism
=550  \\$wg$aParathyroid Diseases
=550  \\$wh$a22q11 Deletion Syndrome
=550  \\$aParathyroid Hormone
=680  \\$iA condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
=750  \0$aHypoparathyroidism$5IEN$0(DLC)sh 85063800

=LDR  00611cz  a2200193n  4500
=001  9880363479402441
=005  20141212202337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007010
=035  \\$aCBA0197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950.$x620
=150  \\$aHyponatremia
=450  \\$wnnna$aHyponatremias
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$aSodium
=667  \\$alow blood sodium levels; do not confuse with HYPERNATREMIA
=680  \\$iDeficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
=750  \0$aHyponatremia$5IEN$0(DLC)sh 85063797

=LDR  01436cz  a2200301n  4500
=001  9880363479502441
=005  20141212202337.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007009
=035  \\$aCBA0196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x398.$x500
=072  \\$aC18.$x452.$x584.$x500.$x875
=072  \\$aC18.$x452.$x648.$x398.$x500
=150  \\$aHypolipoproteinemias
=450  \\$wnnna$aHypolipoproteinemia
=450  \\$wnnna$aHypoprebetalipoproteinemia
=550  \\$wg$aDyslipidemias
=550  \\$wg$aLipid Metabolism, Inborn Errors
=550  \\$wh$aHypoalphalipoproteinemias
=550  \\$wh$aHypobetalipoproteinemias
=550  \\$aLipoproteins
=667  \\$ado not confuse with HYPERLIPOPROTEINEMIA; hypoprebetalipoproteinemia: coordinate IM with LIPOPROTEINS, VLDL /blood (IM); HYPOALPHALIPOPROTEINEMIA; HYPOBETALIPOPROTEINEMIA; & ABETALIPOPROTEINEMIA are also available
=680  \\$iConditions with abnormally low levels of LIPOPROTEINS in the blood. This may involve any of the lipoprotein subclasses, including ALPHA-LIPOPROTEINS (high-density lipoproteins); BETA-LIPOPROTEINS (low-density lipoproteins); and PREBETA-LIPOPROTEINS (very-low-density lipoproteins).
=688  \\$a2007 (1978)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Hypolipoproteinemia
=688  \\$a80; was HYPOLIPOPROTEINEMIAS 1978-79
=750  \0$aHypolipoproteinemia$0(DLC) sh 86004097$5IEN-M

=LDR  01078cz  a2200229n  4500
=001  9880363479602441
=005  20141212202336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007008
=035  \\$aCBA0195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950.$x565
=150  \\$aHypokalemia
=450  \\$wnnna$aHypokalemias
=450  \\$aHypopotassemia
=450  \\$wnnna$aHypopotassemias
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$aPotassium
=550  \\$aPotassium Deficiency
=667  \\$alow blood potassium levels; do not confuse with HYPERKALEMIA
=680  \\$iAbnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
=750  \0$aHypokalemia$5IEN$0(DLC)sh 85063791

=LDR  00793cz  a2200205n  4500
=001  9880363479702441
=005  20141212202336.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007007
=035  \\$aCBA0194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x946.$x370
=150  \\$aHypohidrosis
=450  \\$aAnhidrosis
=550  \\$wg$aSweat Gland Diseases
=550  \\$aSweating
=667  \\$adiminished sweating; do not confuse with HYPERHIDROSIS, excessive sweating
=680  \\$iAbnormally diminished or absent perspiration. Both generalized and segmented (reduced or absent sweating in circumscribed locations) forms of the disease are usually associated with other underlying conditions.
=688  \\$a76; was ANHIDROSIS 1975
=750  \0$aAnhidrosis$0(DLC) sh 85005149$5IEN

=LDR  01439cz  a2200301n  4500
=001  9880363479802441
=005  20141212202336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007006
=035  \\$aCBA0193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x391.$x482
=150  \\$aHypogonadism
=450  \\$wnnna$aHypergonadotropic Hypogonadism
=450  \\$wnnna$aHypogonadism, Hypergonadotropic
=450  \\$wnnna$aHypogonadism, Hypogonadotropic
=450  \\$wnnna$aHypogonadism, Isolated Hypogonadotropic
=450  \\$wnnna$aHypogonadotropic Hypogonadism
=550  \\$wg$aGonadal Disorders
=550  \\$wh$aEunuchism
=550  \\$wh$aKallmann Syndrome
=550  \\$wh$aKlinefelter Syndrome
=550  \\$wh$aSexual Infantilism
=667  \\$afor male or female; do not routinely interpret hypogonadism in male as EUNUCHISM: use terminology of author
=680  \\$iCondition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
=688  \\$a1966
=688  \\$aINFANTILISM, GENITAL & INFANTILISM, SEXUAL were heading INFANTILISM 1963-83
=750  \0$aHypogonadism$5IEN$0(DLC)sh 85063790

=LDR  01509cz  a2200409n  4500
=001  9880363479902441
=005  20141212202335.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007004
=035  \\$aCBA0191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x422
=150  \\$aHypoglycemic Agents
=450  \\$wnnna$aAgents, Antidiabetic
=450  \\$wnnna$aAgents, Antihyperglycemic
=450  \\$wnnna$aAgents, Hypoglycemic
=450  \\$wnnna$aAntidiabetic Agents
=450  \\$wnnna$aAntidiabetic Drugs
=450  \\$aAntidiabetics
=450  \\$wnnna$aAntihyperglycemic Agents
=450  \\$wnnna$aAntihyperglycemics
=450  \\$wnnna$aDrugs, Antidiabetic
=450  \\$wnnna$aDrugs, Hypoglycemic
=450  \\$wnnna$aEffect, Hypoglycemic
=450  \\$wnnna$aEffects, Hypoglycemic
=450  \\$wnnna$aHypoglycemic Drugs
=450  \\$wnnna$aHypoglycemic Effect
=450  \\$wnnna$aHypoglycemic Effects
=450  \\$wnnna$aHypoglycemics
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAmylin Receptor Agonists
=550  \\$wh$aDipeptidyl-Peptidase IV Inhibitors
=550  \\$wh$aGlycoside Hydrolase Inhibitors
=667  \\$anote entry term HYPOGLYCEMIC EFFECT: use only for the hypoglycemic effect of a chemical substance
=680  \\$iSubstances which lower blood glucose levels.
=688  \\$a76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75
=750  \0$aHypoglycemic agents$5IEN$0(DLC)sh 85063785

=LDR  01295cz  a2200313n  4500
=001  9880363480002441
=005  20141212202334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007003
=035  \\$aCBA0190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x984
=150  \\$aHypoglycemia
=450  \\$wnnna$aFasting Hypoglycemia
=450  \\$wnnna$aHypoglycemia, Fasting
=450  \\$wnnna$aHypoglycemia, Postabsorptive
=450  \\$wnnna$aHypoglycemia, Postprandial
=450  \\$wnnna$aHypoglycemia, Reactive
=450  \\$wnnna$aPostabsorptive Hypoglycemia
=450  \\$wnnna$aPostprandial Hypoglycemia
=450  \\$wnnna$aReactive Hypoglycemia
=550  \\$wg$aGlucose Metabolism Disorders
=550  \\$wh$aCongenital Hyperinsulinism
=550  \\$wh$aInsulin Coma
=550  \\$aBlood Glucose
=550  \\$aGlucose
=667  \\$afor hypoglycemic effects caused by plants or extracts use HYPOGLYCEMIC AGENTS
=680  \\$iA syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
=750  \0$aHypoglycemia$5IEN$0(DLC)sh 85063783

=LDR  01599cz  a2200397n  4500
=001  9880363480102441
=005  20141212192239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007002
=035  \\$aCBA0189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x330
=150  \\$aHypoglossal Nerve
=450  \\$wnnna$aCranial Nerve, Twelfth
=450  \\$aCranial Nerve XII
=450  \\$wnnna$aCranial Nerve XIIs
=450  \\$wnnna$aCranial Nerves, Twelfth
=450  \\$wnnna$aHypoglossal Nerves
=450  \\$wnnna$aHypoglossus, Nervus
=450  \\$wnnna$aNerve, Hypoglossal
=450  \\$wnnna$aNerve, Twelfth Cranial
=450  \\$wnnna$aNerve XII
=450  \\$wnnna$aNerve XII, Cranial
=450  \\$wnnna$aNerve XIIs
=450  \\$wnnna$aNerve XIIs, Cranial
=450  \\$wnnna$aNerves, Hypoglossal
=450  \\$wnnna$aNerves, Twelfth Cranial
=450  \\$wnnna$aNervus Hypoglossus
=450  \\$aTwelfth Cranial Nerve
=450  \\$wnnna$aTwelfth Cranial Nerves
=450  \\$wnnna$aXII, Nerve
=450  \\$wnnna$aXIIs, Nerve
=550  \\$wg$aCranial Nerves
=667  \\$aneoplasm = HYPOGLOSSAL NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe 12th cranial nerve. The hypoglossal nerve originates in the hypoglossal nucleus of the medulla and supplies motor innervation to all of the muscles of the tongue except the palatoglossus (which is supplied by the vagus). This nerve also contains proprioceptive afferents from the tongue muscles.
=750  \0$aHypoglossal nerve$0(DLC) sh 85063782$5IEN

=LDR  00932cz  a2200217n  4500
=001  9880363480202441
=005  20141212202334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007001
=035  \\$aCBA0188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x400
=072  \\$aA8.$x800.$x800.$x60.$x400
=150  \\$aHypogastric Plexus
=450  \\$aPelvic Plexus
=450  \\$wnnna$aPlexus, Hypogastric
=450  \\$wnnna$aPlexus, Pelvic
=550  \\$wg$aAutonomic Pathways
=667  \\$aa network of autonomic nerve fibers in the pelvic region
=680  \\$iA complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent.
=750  \0$aHypogastric plexus$5IEN$0(DLC)sh 85063779

=LDR  00780cz  a2200253n  4500
=001  9880363480302441
=005  20141212202333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006999
=035  \\$aCBA0186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501
=150  \\$aHypocreales
=450  \\$wnnna$aHypocreale
=550  \\$wg$aAscomycota
=550  \\$wh$aClaviceps
=550  \\$wh$aCordyceps
=550  \\$wh$aEpichloe
=550  \\$wh$aGibberella
=550  \\$wh$aHypocrea
=550  \\$wh$aNectria
=680  \\$iAn order of fungi in the phylum ASCOMYCOTA that includes a number of species which are parasitic on higher plants, insects, or fungi. Other species are saprotrophic.
=688  \\$a75(63)
=750  \0$aHypocreales$5IEN$0(DLC)sh 85063767

=LDR  00898cz   2200217n  4500
=001  9880363480402441
=005  20220926171432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006998
=035  \\$aCBA0185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x875.$x450
=150  \\$aHypochondriasis
=450  \\$aHypochondria$5IEN
=450  \\$wnnna$aHypochondriacal Neuroses
=450  \\$wnnna$aHypochondriacal Neurosis
=450  \\$aNeurosis, Hypochondriacal
=550  \\$wg$aSomatoform Disorders
=680  \\$iPreoccupation with the fear of having, or the idea that one has, a serious disease based on the person's misinterpretation of bodily symptoms. (APA, DSM-IV)
=688  \\$aNEUROSIS, HYPOCHONDRIACAL was HYPOCHONDRIACAL NEUROSES see HYPOCHONDRIASIS 1979-80, was HYPOCHONDRIACAL NEUROSES see under HYPOCHONDRIASIS 1969-78
=750  \0$aIllness anxiety disorder$5IEN$0(DLC)sh 85063763

=LDR  00844cz  a2200229n  4500
=001  9880363480502441
=005  20141212202333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006996
=035  \\$aCBA0183HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174.$x509
=072  \\$aC18.$x452.$x950.$x509
=150  \\$aHypocalcemia
=450  \\$wnnna$aHypocalcemias
=550  \\$wg$aCalcium Metabolism Disorders
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$wh$aTetany
=550  \\$aCalcium
=667  \\$alow blood calcium levels; do not confuse with HYPERCALCEMIA
=680  \\$iReduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
=750  \0$aHypocalcemia$5IEN$0(DLC)sh 85063761

=LDR  01512cz  a2200409n  4500
=001  9880363480602441
=005  20171026100838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006993
=035  \\$aCBA0180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x350
=072  \\$aD27.$x505.$x696.$x410
=072  \\$aD27.$x505.$x954.$x427.$x210.$x350
=150  \\$aHypnotics and Sedatives
=450  \\$wnnna$aEffect, Hypnotic
=450  \\$wnnna$aEffect, Sedative
=450  \\$wnnna$aEffects, Hypnotic
=450  \\$wnnna$aEffects, Sedative
=450  \\$wnnna$aHypnotic Effect
=450  \\$wnnna$aHypnotic Effects
=450  \\$wnnna$aHypnotics
=450  \\$wnnna$aSedative Effect
=450  \\$wnnna$aSedative Effects
=450  \\$aSedatives
=450  \\$wnnna$aSedatives and Hypnotics
=450  \\$wnno$aSedatives, Barbiturate$5IEN-M
=450  \\$wnno$aSedatives, Nonbarbiturate$5IEN-M
=550  \\$wg$aCentral Nervous System Depressants
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$aBarbiturates
=550  \\$aGABA Modulators
=550  \\$aTranquilizing Agents
=667  \\$anote entry terms HYPNOTIC EFFECT and SEDATIVE EFFECT: use only for the hypnotic or sedative effect of a chemical substance
=680  \\$iDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
=750  \0$iNarrower mapping$aHypnotics$0(DLC)sh 85063749$4NM$5IEN-M
=750  \0$iNarrower mapping$aSedatives$0(DLC)sh 85119490$4NM$5IEN-M

=LDR  00714cz  a2200241n  4500
=001  9880363480702441
=005  20141212202331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006992
=035  \\$aCBA0179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x141.$x481
=072  \\$aE3.$x155.$x675.$x481
=072  \\$aE6.$x45.$x481
=150  \\$aHypnosis, Dental
=450  \\$wnnna$aDental Hypnoses
=450  \\$wnnna$aDental Hypnosis
=450  \\$wnnna$aHypnoses, Dental
=550  \\$wg$aAnesthesia, Dental
=550  \\$wg$aHypnosis, Anesthetic
=667  \\$ado not use /util except by MeSH definition; DF: HYPNOSIS DENT
=688  \\$a65
=750  \0$aHypnotism in dentistry$5IEN$0(DLC)sh 85063757

=LDR  00624cz  a2200217n  4500
=001  9880363480802441
=005  20141212202331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006991
=035  \\$aCBA0178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x675
=150  \\$aHypnosis, Anesthetic
=450  \\$wnnna$aAnesthetic Hypnoses
=450  \\$wnnna$aAnesthetic Hypnosis
=450  \\$wnnna$aHypnoses, Anesthetic
=550  \\$wg$aAnesthesia
=550  \\$wh$aHypnosis, Dental
=667  \\$ado not use /util except by MeSH definition
=688  \\$a65
=750  \0$aHypnotism in surgery$5IEN$0(DLC)sh 85063760

=LDR  00877cz  a2200265n  4500
=001  9880363480902441
=005  20141212202331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006990
=035  \\$aCBA0177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x217
=072  \\$aF4.$x754.$x424
=150  \\$aHypnosis
=450  \\$wnnna$aHypnoses
=450  \\$aHypnotism$5IEN
=450  \\$aMesmerism
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPsychotherapy
=550  \\$wh$aAutogenic Training
=550  \\$wh$aSuggestion
=667  \\$ahuman only; for animals use ANIMAL HYPNOSIS see IMMOBILITY RESPONSE, TONIC
=680  \\$iA state of increased receptivity to suggestion and direction, initially induced by the influence of another person.
=688  \\$aMESMERISM was see under HYPNOSIS 1963-78
=750  \0$aHypnotism$5IEN-M$0(DLC)sh 85063752

=LDR  01002cz  a2200229n  4500
=001  9880363481002441
=005  20141212202330.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006985
=035  \\$aCBA0172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x501
=072  \\$aC23.$x888.$x852.$x591
=150  \\$aHyperventilation
=450  \\$wnnna$aHyperventilations
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wh$aAlkalosis, Respiratory
=667  \\$arespiratory, not environmental; hyperventilation syndrome: coord IM with /psychol + emotional aspect (IM or NIM)
=680  \\$iA pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.
=688  \\$a64
=750  \0$aHyperventilation$5IEN$0(DLC)sh 85063737

=LDR  01003cz  a2200241n  4500
=001  9880363481102441
=005  20141212202329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006984
=035  \\$aCBA0171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x775
=150  \\$aHypertrophy
=450  \\$wnnna$aHypertrophies
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aCardiomegaly
=550  \\$wh$aHepatomegaly
=550  \\$wh$aSplenomegaly
=550  \\$aCell Enlargement
=667  \\$aNIM; general or unspecified: many precoordinated organ/hypertrophy terms are available; do not confuse with HYPERPLASIA; coord with organ /pathol (IM)
=680  \\$iGeneral increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
=688  \\$a65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64
=750  \0$aHypertrophy$5IEN$0(DLC)sh 85063734

=LDR  00808cz  a2200229n  4500
=001  9880363481202441
=005  20141212210925.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015228
=035  \\$aCBA0170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584.$x500.$x500.$x851
=150  \\$aHypertriglyceridemia
=450  \\$wnnna$aHypertriglyceridemias
=550  \\$wg$aHyperlipidemias
=550  \\$wh$aHyperlipoproteinemia Type IV
=550  \\$wh$aHyperlipoproteinemia Type V
=550  \\$wh$aHypertriglyceridemic Waist
=667  \\$aconsider also HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV; & HYPERLIPOPROTEINEMIA TYPE V
=680  \\$iA condition of elevated levels of TRIGLYCERIDES in the blood.
=688  \\$a89
=750  \0$aHypertriglyceridemia$5IEN$0(DLC)sh 91000712

=LDR  00760cz  a2200181n  4500
=001  9880363481302441
=005  20141212202329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006983
=035  \\$aCBA0169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x329.$x875
=150  \\$aHypertrichosis
=450  \\$wnnna$aHypertrichoses
=550  \\$wg$aHair Diseases
=550  \\$aHirsutism
=680  \\$iExcessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.
=750  \0$aHypertrichosis$5IEN$0(DLC)sh 85063732

=LDR  00802cz  a2200205n  4500
=001  9880363481402441
=005  20141212202329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006982
=035  \\$aCBA0168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776.$x314
=150  \\$aHypertonic Solutions
=450  \\$wnnna$aSolutions, Hypertonic
=550  \\$wg$aSolutions
=550  \\$wh$aGlucose Solution, Hypertonic
=550  \\$wh$aSaline Solution, Hypertonic
=667  \\$aGEN; NIM; no qualif when NIM coord; SALINE SOLUTION, HYPERTONIC & GLUCOSE SOLUTION, HYPERTONIC are available; DF: HYPERTONIC SOL
=680  \\$iSolutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.
=750  \0$aHypertonic solutions$5IEN$0(DLC)sh 85063729

=LDR  00952cz  a2200265n  4500
=001  9880363481502441
=005  20141212202328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006980
=035  \\$aCBA0166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x397
=150  \\$aHyperthyroidism
=450  \\$wnnna$aHyperthyroidism, Primary
=450  \\$wnnna$aPrimary Hyperthyroidism
=450  \\$wnnna$aPrimary Hyperthyroidisms
=550  \\$wg$aThyroid Diseases
=550  \\$wh$aGraves Disease
=550  \\$wh$aThyrotoxicosis
=550  \\$aAntithyroid Agents
=550  \\$aLong-Acting Thyroid Stimulator
=550  \\$aThyroid Hormones
=667  \\$aTHYROTOXICOSIS & THYROID CRISIS are available: do not make a diagnosis: use term of author
=680  \\$iHypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
=750  \0$aHyperthyroidism$5IEN$0(DLC)sh 85063728

=LDR  01372cz  a2200361n  4500
=001  9880363481602441
=005  20141212202328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006979
=035  \\$aCBA0165HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x565
=072  \\$aE2.$x779.$x496
=150  \\$aHyperthermia, Induced
=450  \\$aFever Therapy
=450  \\$aHyperthermia, Local
=450  \\$aHyperthermia, Therapeutic
=450  \\$wnnna$aInduced Hyperthermia
=450  \\$wnnna$aLocal Hyperthermia
=450  \\$wnnna$aTherapeutic Hyperthermia
=450  \\$wnnna$aTherapy, Fever
=450  \\$aThermotherapy
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aTherapeutics
=550  \\$wh$aAmmotherapy
=550  \\$wh$aDiathermy
=550  \\$wh$aSteam Bath
=550  \\$aFever
=550  \\$aHot Temperature
=667  \\$adifferentiate X ref FEVER THERAPY from FEVER /ther ( = treatment of fever); coord IM with disease /ther (IM); do not index under specific type of induction unless the point of the article & then probably only NIM
=680  \\$iAbnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.
=688  \\$a84; was FEVER THERAPY 1963-83
=750  \0$aFever therapy$5IEN-M$0(DLC)sh 85047998

=LDR  01001cz  a2200277n  4500
=001  9880363481702441
=005  20141212202328.0
=008  771206\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006978
=035  \\$aCBA0164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x331.$x490
=072  \\$aC13.$x351.$x968.$x419.$x331.$x490
=072  \\$aC14.$x907.$x489.$x631.$x485
=150  \\$aHypertension, Renovascular
=450  \\$wnnna$aGoldblatt Hypertension
=450  \\$wnnna$aGoldblatt Syndrome
=450  \\$aHypertension, Goldblatt
=450  \\$wnnna$aRenovascular Hypertension
=450  \\$wnnna$aSyndrome, Goldblatt
=550  \\$wg$aHypertension, Renal
=550  \\$aRenal Artery Obstruction
=667  \\$ado not routinely index also under RENAL ARTERY or RENAL ARTERY OBSTRUCTION
=680  \\$iHypertension due to RENAL ARTERY OBSTRUCTION or compression.
=688  \\$a84(79); was see under HYPERTENSION, RENAL 1979-83
=750  \0$aRenovascular hypertension$5IEN$0(DLC)sh 87001175

=LDR  01018cz  a2200253n  4500
=001  9880363481802441
=005  20141212202327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006977
=035  \\$aCBA0163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x331
=072  \\$aC13.$x351.$x968.$x419.$x331
=072  \\$aC14.$x907.$x489.$x631
=150  \\$aHypertension, Renal
=450  \\$wnnna$aHypertensions, Renal
=450  \\$wnnna$aRenal Hypertension
=450  \\$wnnna$aRenal Hypertensions
=550  \\$wg$aHypertension
=550  \\$wg$aKidney Diseases
=550  \\$wh$aHypertension, Renovascular
=667  \\$acoord IM with specific kidney dis (IM) if pertinent; Goldblatt hypertension or Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR
=680  \\$iPersistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
=750  \0$aRenal hypertension$5IEN$0(DLC)sh 85112813

=LDR  00730cz  a2200205n  4500
=001  9880363481902441
=005  20141212202327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006976
=035  \\$aCBA0162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x423
=150  \\$aHypertension, Pulmonary
=450  \\$aPulmonary Hypertension
=550  \\$wg$aLung Diseases
=550  \\$wh$aFamilial Primary Pulmonary Hypertension
=550  \\$wh$aPersistent Fetal Circulation Syndrome
=680  \\$iIncreased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
=688  \\$aAYERZA'S SYNDROME was heading 1963-83
=750  \0$aPulmonary hypertension$5IEN$0(DLC)sh 85109008

=LDR  01088cz  a2200253n  4500
=001  9880363482002441
=005  20141212202327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006975
=035  \\$aCBA0161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x494
=150  \\$aHypertension, Portal
=450  \\$aCruveilhier-Baumgarten Syndrome
=450  \\$wnnna$aCruveilhier Baumgarten Syndrome
=450  \\$wnnna$aHypertensions, Portal
=450  \\$wnnna$aPortal Hypertension
=450  \\$wnnna$aPortal Hypertensions
=450  \\$wnnna$aSyndrome, Cruveilhier-Baumgarten
=550  \\$wg$aLiver Diseases
=550  \\$wh$aEsophageal and Gastric Varices
=680  \\$iAbnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
=688  \\$aCRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 (see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78); was see under LIVER CIRRHOSIS 1963-74
=750  \0$aPortal hypertension$5IEN$0(DLC)sh 85105065

=LDR  01555cz  a2200313n  4500
=001  9880363482102441
=005  20200506174722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006973
=035  \\$aCBA0159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x489
=150  \\$aHypertension
=450  \\$aBlood Pressure, High
=450  \\$wnnna$aBlood Pressures, High
=450  \\$wnnna$aHigh Blood Pressure
=450  \\$wnnna$aHigh Blood Pressures
=550  \\$wg$aVascular Diseases
=550  \\$wh$aEssential Hypertension
=550  \\$wh$aHypertension, Malignant
=550  \\$wh$aHypertension, Pregnancy-Induced
=550  \\$wh$aHypertension, Renal
=550  \\$wh$aHypertensive Retinopathy
=550  \\$wh$aMasked Hypertension
=550  \\$wh$aWhite Coat Hypertension
=550  \\$aBlood Pressure
=667  \\$anot for intracranial or intraocular pressure; relation to BLOOD PRESSURE: Manual 23.27; Goldblatt kidney is HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; hypertension with kidney disease is probably HYPERTENSION, RENAL, not HYPERTENSION; venous hypertension: index under VENOUS PRESSURE (IM) & do not coordinate with HYPERTENSION; PREHYPERTENSION is also available
=680  \\$iPersistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
=750  \0$aHypertension$0(DLC) sh 85063723$5IEN-HS

=LDR  00980cz  a2200241n  4500
=001  9880363482202441
=005  20141212202325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006971
=035  \\$aCBA0157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x744.$x293
=150  \\$aHypersplenism
=450  \\$aAnemia, Splenic
=450  \\$wnnna$aAnemias, Splenic
=450  \\$wnnna$aSplenic Anemia
=450  \\$wnnna$aSplenic Anemias
=550  \\$wg$aSplenic Diseases
=550  \\$aSplenomegaly
=667  \\$aincrease in splenic hemolytic function: do not confuse with SPLENOMEGALY, increase in spleen size
=680  \\$iCondition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.
=688  \\$a66; ANEMIA, SPLENIC was heading 1963-83, was see under HYPERSPLENISM 1982-83
=750  \0$aHypersplenism$5IEN$0(DLC)sh 85063721

=LDR  02288cz  a2200493n  4500
=001  9880363482302441
=005  20201125164908.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006970
=035  \\$aCBA0156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x425.$x800.$x200
=072  \\$aF3.$x870.$x400.$x800.$x200
=150  \\$aDisorders of Excessive Somnolence
=450  \\$wnnna$aDOES (Disorders of Excessive Somnolence)
=450  \\$wnnna$aDOESs (Disorders of Excessive Somnolence)
=450  \\$wnnna$aExcessive Somnolence Disorder
=450  \\$wnnna$aExcessive Somnolence Disorders
=450  \\$aHypersomnia
=450  \\$wnnna$aHypersomnia, Recurrent
=450  \\$wnnna$aHypersomnias
=450  \\$wnnna$aHypersomnias, Recurrent
=450  \\$aHypersomnolence
=450  \\$wnnna$aHypersomnolence Disorder
=450  \\$wnnna$aHypersomnolence Disorder, Primary
=450  \\$wnnna$aHypersomnolence Disorder, Secondary
=450  \\$wnnna$aHypersomnolence Disorders
=450  \\$wnnna$aHypersomnolence Disorders, Primary
=450  \\$wnnna$aHypersomnolence Disorders, Secondary
=450  \\$wnnna$aPrimary Hypersomnolence Disorder
=450  \\$wnnna$aPrimary Hypersomnolence Disorders
=450  \\$wnnna$aRecurrent Hypersomnia
=450  \\$wnnna$aRecurrent Hypersomnias
=450  \\$wnnna$aSecondary Hypersomnolence Disorder
=450  \\$wnnna$aSecondary Hypersomnolence Disorders
=450  \\$wnnna$aSomnolence Disorder, Excessive
=450  \\$wnnna$aSomnolence Disorders, Excessive
=550  \\$wg$aSleep Disorders, Intrinsic
=550  \\$wh$aIdiopathic Hypersomnolence
=550  \\$wh$aKleine-Levin Syndrome
=550  \\$wh$aNarcolepsy
=680  \\$iDisorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)
=688  \\$a2000(1975)
=750  \0$aHypersomnia$5IEN$0(DLC)sh 85063717

=LDR  01970cz  a2200517n  4500
=001  9880363482402441
=005  20141212202324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006969
=035  \\$aCBA0155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x480
=150  \\$aHypersensitivity, Immediate
=450  \\$wnnna$aAtopic Hypersensitivities
=450  \\$aAtopic Hypersensitivity
=450  \\$wnnna$aHypersensitivities, Atopic
=450  \\$wnnna$aHypersensitivities, IgE-Mediated
=450  \\$wnnna$aHypersensitivities, Immediate
=450  \\$wnnna$aHypersensitivities, Type I
=450  \\$aHypersensitivity, Atopic
=450  \\$wnnna$aHypersensitivity, IgE-Mediated
=450  \\$aHypersensitivity, Type I
=450  \\$wnnna$aIgE-Mediated Hypersensitivities
=450  \\$aIgE-Mediated Hypersensitivity
=450  \\$wnnna$aIgE Mediated Hypersensitivity
=450  \\$wnnna$aImmediate Hypersensitivities
=450  \\$wnnna$aImmediate Hypersensitivity
=450  \\$wnnna$aType I Hypersensitivities
=450  \\$aType I Hypersensitivity
=550  \\$wg$aHypersensitivity
=550  \\$wh$aAnaphylaxis
=550  \\$wh$aAsthma, Aspirin-Induced
=550  \\$wh$aConjunctivitis, Allergic
=550  \\$wh$aDermatitis, Atopic
=550  \\$wh$aEosinophilic Esophagitis
=550  \\$wh$aFood Hypersensitivity
=550  \\$wh$aRespiratory Hypersensitivity
=550  \\$wh$aUrticaria
=550  \\$aAntigen-Antibody Reactions
=550  \\$aHistamine
=550  \\$aHistamine H1 Antagonists
=550  \\$aLatex Hypersensitivity
=667  \\$a/chem ind: coord with DRUG HYPERSENSITIVITY or specifics
=680  \\$iHypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.
=688  \\$a66(65)
=750  \0$aAllergy$5IEN$0(DLC)sh 85003662

=LDR  01370cz  a2200361n  4500
=001  9880363482502441
=005  20141212202324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006968
=035  \\$aCBA0154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x418
=150  \\$aHypersensitivity, Delayed
=450  \\$wnnna$aDelayed Hypersensitivities
=450  \\$wnnna$aDelayed Hypersensitivity
=450  \\$wnnna$aHypersensitivities, Delayed
=450  \\$wnnna$aHypersensitivities, Tuberculin-Type
=450  \\$wnnna$aHypersensitivities, Type IV
=450  \\$aHypersensitivity, Tuberculin-Type
=450  \\$wnnna$aHypersensitivity, Tuberculin Type
=450  \\$aHypersensitivity, Type IV
=450  \\$wnnna$aTuberculin-Type Hypersensitivities
=450  \\$aTuberculin-Type Hypersensitivity
=450  \\$wnnna$aTuberculin Type Hypersensitivity
=450  \\$wnnna$aType IV Hypersensitivities
=450  \\$aType IV Hypersensitivity
=550  \\$wg$aHypersensitivity
=550  \\$wh$aDermatitis, Allergic Contact
=550  \\$aImmunity, Cellular
=667  \\$aIM; use qualif with caution; /chem ind: coord IM with DRUG HYPERSENSITIVITY or specifics (IM)
=680  \\$iAn increased reactivity to specific antigens mediated not by antibodies but by cells.
=688  \\$a66(65)
=750  \0$aDelayed hypersensitivity$5IEN$0(DLC)sh 85036557

=LDR  01478cz  a2200361n  4500
=001  9880363482602441
=005  20200522120110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006967
=035  \\$aCBA0153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543
=150  \\$aHypersensitivity
=450  \\$wnnna$aAllergic Reaction
=450  \\$wnnna$aAllergic Reactions
=450  \\$wnnna$aAllergies
=450  \\$aAllergy
=450  \\$wnnna$aHypersensitivities
=450  \\$wnnna$aReaction, Allergic
=450  \\$wnnna$aReactions, Allergic
=550  \\$wg$aImmune System Diseases
=550  \\$wh$aDrug Hypersensitivity
=550  \\$wh$aEnvironmental Illness
=550  \\$wh$aHypersensitivity, Delayed
=550  \\$wh$aHypersensitivity, Immediate
=550  \\$wh$aImmune Complex Diseases
=550  \\$wh$aKounis Syndrome
=550  \\$wh$aLatex Hypersensitivity
=550  \\$wh$aWissler's Syndrome
=667  \\$aIM; use qualif with caution; /drug ther: consider also ANTI-ALLERGIC AGENTS; atopic = HYPERSENSITIVITY, IMMEDIATE; to food = FOOD HYPERSENSITIVITY; to light = PHOTOSENSITIVITY DISORDERS; RESPIRATORY HYPERSENSITIVITY is also available; in occup or environ exposure MULTIPLE CHEMICAL SENSITIVITY is also available
=680  \\$iAltered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
=688  \\$a66; was ALLERGY 1963-65
=750  \0$aAllergy$5IEN$0(DLC)sh 85003662

=LDR  01624cz  a2200349n  4500
=001  9880363482702441
=005  20141212202323.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006966
=035  \\$aCBA0152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x617.$x738.$x250.$x450
=072  \\$aC19.$x700.$x355.$x600
=150  \\$aHyperprolactinemia
=450  \\$wnnna$aHyperprolactinaemia
=450  \\$wnnna$aHyperprolactinemias
=450  \\$wnnna$aHypersecretion Syndrome, Prolactin
=450  \\$wnnna$aInappropriate Prolactin Secretion
=450  \\$wnnna$aInappropriate Prolactin Secretion Syndrome
=450  \\$wnnna$aInappropriate Secretion Prolactin
=450  \\$aProlactin Hypersecretion Syndrome
=450  \\$aProlactin, Inappropriate Secretion
=450  \\$wnnna$aProlactin Secretion, Inappropriate
=450  \\$wnnna$aSecretion, Inappropriate Prolactin
=450  \\$wnnna$aSecretion Prolactin, Inappropriate
=450  \\$wnnna$aSyndrome, Prolactin Hypersecretion
=550  \\$wg$aHyperpituitarism
=550  \\$aProlactin
=550  \\$aProlactinoma
=680  \\$iIncreased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
=688  \\$a1986
=750  \0$aHyperprolactinemia$5IEN$0(DLC)sh 91000369

=LDR  00933cz  a2200193n  4500
=001  9880363482802441
=005  20141212202322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x444
=150  \\$aHyperplasia
=450  \\$wnnna$aHyperplasias
=550  \\$wg$aPathologic Processes
=550  \\$aCell Proliferation
=667  \\$ageneral or unspecified; coordinate NIM with organ /pathol (IM); many specific precoordinated hyperplasia terms are available; congen adrenal hyperplasia = ADRENAL HYPERPLASIA, CONGENITAL but non-congenital adrenal hyperplasia = ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM)
=680  \\$iAn increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
=688  \\$a1965
=750  \0$aHyperplasia$0(DLC) sh 85063716$5IEN

=LDR  00680cz  a2200229n  4500
=001  9880363482902441
=005  20141212192239.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006963
=035  \\$aCBA0149M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x645
=150  \\$aHyperphagia
=450  \\$aOvereating
=450  \\$wnnna$aPolyphagia
=450  \\$wnnna$aPolyphagias
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$wh$aBulimia
=550  \\$aOvernutrition
=680  \\$iIngestion of a greater than optimal quantity of food.
=688  \\$a89(81); was see under APPETITE DISORDERS 1981-88
=750  \0$aHyperphagia$0(DLC)sh2012003178$5IEN-M

=LDR  01002cz  a2200193n  4500
=001  9880363483002441
=005  20141212202321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006961
=035  \\$aCBA0147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x642.$x355
=150  \\$aHyperparathyroidism
=550  \\$wg$aParathyroid Diseases
=550  \\$wh$aHyperparathyroidism, Primary
=550  \\$wh$aHyperparathyroidism, Secondary
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
=750  \0$aHyperparathyroidism$5IEN$0(DLC)sh 85063715

=LDR  00694cz  a2200241n  4500
=001  9880363483102441
=005  20141212202320.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006959
=035  \\$aCBA0145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x313
=072  \\$aC13.$x351.$x968.$x419.$x313
=150  \\$aHyperoxaluria
=450  \\$wnnna$aOxalosis
=450  \\$aOxaluria
=550  \\$wg$aKidney Diseases
=550  \\$wh$aHyperoxaluria, Primary
=550  \\$aOxalates
=667  \\$aHYPEROXALURIA, PRIMARY is also available
=680  \\$iExcretion of an excessive amount of OXALATES in the urine.
=688  \\$a87
=750  \0$aOxaluria$5IEN$0(DLC)sh 85096292

=LDR  02553cz  a2200589n  4500
=001  9880363483202441
=005  20141212202320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006958
=035  \\$aCBA0144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x479
=072  \\$aC5.$x116.$x540.$x400
=072  \\$aC16.$x614.$x465
=150  \\$aHyperostosis, Cortical, Congenital
=450  \\$aCaffey-De Toni-Silvermann Syndrome
=450  \\$wnnna$aCaffey De Toni Silvermann Syndrome
=450  \\$wnnna$aCaffey Disease
=450  \\$wnnna$aCaffey's Disease, Familial
=450  \\$wnnna$aCongenital Cortical Hyperostoses
=450  \\$wnnna$aCongenital Cortical Hyperostosis
=450  \\$wnnna$aCongenital Hyperostoses, Cortical
=450  \\$wnnna$aCongenital Hyperostosis, Cortical
=450  \\$wnnna$aCortical Congenital Hyperostoses
=450  \\$wnnna$aCortical Congenital Hyperostosis
=450  \\$wnnna$aCortical Hyperostoses, Congenital
=450  \\$wnnna$aCortical Hyperostoses, Infantile
=450  \\$aCortical Hyperostosis, Congenital
=450  \\$wnnna$aCortical Hyperostosis, Infantile
=450  \\$wnnna$aDisease, Caffey
=450  \\$wnnna$aDisease, Familial Caffey's
=450  \\$wnnna$aFamilial Caffey Disease
=450  \\$wnnna$aFamilial Caffey's Disease
=450  \\$wnnna$aFamilial Caffeys Disease
=450  \\$wnnna$aFamilial Infantile Cortical Hyperostosis
=450  \\$wnnna$aHyperostoses, Congenital Cortical
=450  \\$wnnna$aHyperostoses, Cortical Congenital
=450  \\$wnnna$aHyperostoses, Infantile Cortical
=450  \\$wnnna$aHyperostosis, Congenital Cortical
=450  \\$wnnna$aHyperostosis, Cortical Congenital
=450  \\$aHyperostosis Corticalis Generalisata$5IEN
=450  \\$wnnna$aHyperostosis, Infantile Cortical
=450  \\$wnnna$aInfantile Cortical Hyperostoses
=450  \\$aInfantile Cortical Hyperostosis
=450  \\$wnnna$aSyndrome, Caffey-De Toni-Silvermann
=550  \\$wg$aHyperostosis
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aOsteochondrodysplasias
=667  \\$acortical refers to cortex of bone; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA disease of young infants characterized by soft tissue swellings over the affected bones, fever, and irritability, and marked by periods of remission and exacerbation. (Dorland, 27th ed)
=688  \\$a91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90
=750  \0$aHyperostosis corticalis generalisata$5IEN$0(DLC)sh 85063713

=LDR  00969cz  a2200253n  4500
=001  9880363483302441
=005  20141212202319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006957
=035  \\$aCBA0143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x486
=072  \\$aC5.$x116.$x540.$x420
=150  \\$aHyperostosis Frontalis Interna
=450  \\$aLeontiasis Ossium
=450  \\$aMorgagni-Stewart-Morel Syndrome
=450  \\$wnnna$aMorgagni Stewart Morel Syndrome
=450  \\$wnnna$aSyndrome, Morgagni-Stewart-Morel
=550  \\$wg$aHyperostosis
=550  \\$wg$aOsteochondrodysplasias
=667  \\$afrontalis refers to frontal bone of skull
=680  \\$iThickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.
=688  \\$aLEONTIASIS OSSIUM was heading 1963-84
=750  \0$aHyperostosis frontalis interna$5IEN$0(DLC)sh 85063714

=LDR  00840cz  a2200193n  4500
=001  9880363483402441
=005  20141212202319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006956
=035  \\$aCBA0142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744.$x479
=150  \\$aHyperopia
=450  \\$aFarsightedness
=450  \\$aHypermetropia
=550  \\$wg$aRefractive Errors
=667  \\$arefractive error; note X ref
=680  \\$iA refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed)
=750  \0$aHyperopia$5IEN$0(DLC)sh 85063712

=LDR  00604cz  a2200193n  4500
=001  9880363483502441
=005  20141212202319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006955
=035  \\$aCBA0141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950.$x452
=150  \\$aHypernatremia
=450  \\$wnnna$aHypernatremias
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$aSodium
=667  \\$ahigh blood sodium levels; do not confuse with HYPONATREMIA
=680  \\$iExcessive amount of sodium in the blood. (Dorland, 27th ed)
=750  \0$aHypernatremia$5IEN$0(DLC)sh 85063709

=LDR  01400cz  a2200289n  4500
=001  9880363483602441
=005  20141212202317.0
=008  790423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006951
=035  \\$aCBA0137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584.$x500.$x500.$x644
=150  \\$aHyperlipoproteinemias
=450  \\$wnnna$aHyperlipoproteinemia
=550  \\$wg$aHyperlipidemias
=550  \\$wh$aHyperlipoproteinemia Type I
=550  \\$wh$aHyperlipoproteinemia Type II
=550  \\$wh$aHyperlipoproteinemia Type III
=550  \\$wh$aHyperlipoproteinemia Type IV
=550  \\$wh$aHyperlipoproteinemia Type V
=550  \\$aLipoproteins
=667  \\$ado not confuse with HYPOLIPOPROTEINEMIA; general or unspecified: specific Types I-V are available
=680  \\$iConditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
=688  \\$a2007 (1980); use HYPERLIPEMIA 1975-1979
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Hyperlipoproteinemia
=688  \\$a80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)
=750  \0$aHyperlipoproteinemia$0(DLC) sh 85063707$5IEN-M

=LDR  01264cz  a2200337n  4500
=001  9880363483702441
=005  20141212202316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006949
=035  \\$aCBA0135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584.$x500.$x500
=150  \\$aHyperlipidemias
=450  \\$aHyperlipemia
=450  \\$wnnna$aHyperlipemias
=450  \\$wnnna$aHyperlipidemia
=450  \\$wnnna$aLipemia
=450  \\$wnnna$aLipemias
=450  \\$wnnna$aLipidemia
=450  \\$wnnna$aLipidemias
=550  \\$wg$aDyslipidemias
=550  \\$wh$aHypercholesterolemia
=550  \\$wh$aHyperlipidemia, Familial Combined
=550  \\$wh$aHyperlipoproteinemias
=550  \\$wh$aHypertriglyceridemia
=550  \\$aLipids
=667  \\$ageneral; prefer specifics
=680  \\$iConditions with excess LIPIDS in the blood.
=688  \\$a80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Hyperlipidemia
=750  \0$aHyperlipidemia$0(DLC) sh 85063704$5IEN

=LDR  01275cz  a2200337n  4500
=001  9880363483802441
=005  20141212202315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006948
=035  \\$aCBA0134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x350
=072  \\$aC23.$x888.$x592.$x350.$x350
=150  \\$aHyperkinesis
=450  \\$wnnna$aGeneralized Hyperkinesia
=450  \\$wnnna$aGeneralized Hyperkinesias
=450  \\$aHyperactivity, Motor
=450  \\$wnnna$aHyperkinesia
=450  \\$wnnna$aHyperkinesia, Generalized
=450  \\$wnnna$aHyperkinesias, Generalized
=450  \\$wnnna$aHyperkinetic Movement
=450  \\$wnnna$aHyperkinetic Movements
=450  \\$wnnna$aMotor Hyperactivity
=450  \\$wnnna$aMovement, Hyperkinetic
=450  \\$wnnna$aMovements, Hyperkinetic
=550  \\$wg$aDyskinesias
=550  \\$aMotor Activity
=667  \\$ahuman & animal; MOTOR ACTIVITY is also available: see note there; do not confuse with MYOKYMIA or ISAACS SYNDROME
=680  \\$iExcessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.
=688  \\$a69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68
=750  \0$aHyperkinesia$5IEN$0(DLC)sh 85063703

=LDR  00513cz  a2200181n  4500
=001  9880363483902441
=005  20141212202156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006686
=035  \\$aCAZ9862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x469
=150  \\$aHobbies
=450  \\$wnnna$aHobby
=550  \\$wg$aRecreation
=667  \\$aIM; coord with person pursuing the hobby (IM)
=680  \\$iLeisure activities engaged in for pleasure.
=750  \0$aHobbies$5IEN$0(DLC)sh 85061308

=LDR  01188cz  a2200361n  4500
=001  9880363484002441
=005  20141212202156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006685
=035  \\$aCAZ9861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x940.$x490
=072  \\$aC8.$x618.$x490
=072  \\$aC9.$x400.$x940.$x490
=072  \\$aC10.$x597.$x975.$x550
=072  \\$aC23.$x888.$x592.$x979.$x550
=072  \\$aC23.$x888.$x852.$x490
=150  \\$aHoarseness
=450  \\$wnnna$aHoarseness, Neurogenic
=450  \\$wnnna$aHoarseness of Voice
=450  \\$wnnna$aHoarseness, Voice
=450  \\$wnnna$aHoarsenesses
=450  \\$wnnna$aNeurogenic Hoarseness
=450  \\$wnnna$aNeurogenic Hoarsenesses
=450  \\$wnnna$aVoice Hoarseness
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wg$aVoice Disorders
=550  \\$wh$aLipoid Proteinosis of Urbach and Wiethe
=550  \\$aVoice Quality
=667  \\$afor other qualities of voice VOICE QUALITY & VOICE DISORDERS are available
=680  \\$iAn unnaturally deep or rough quality of voice.
=750  \0$aHoarseness$5IEN$0(DLC)sh 85061307

=LDR  01563cz  a2200361n  4500
=001  9880363484102441
=005  20141212202154.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006680
=035  \\$aCAZ9853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x500.$x450
=072  \\$aD23.$x50.$x705.$x552.$x450
=150  \\$aHLA Antigens
=450  \\$wnnna$aAntigens, HL-A
=450  \\$wnnna$aAntigens, HLA
=450  \\$wnnna$aAntigens, Human Leukocyte
=450  \\$wnnna$aAntigens, Leukocyte
=450  \\$wnnna$aHL-A Antigens
=450  \\$wnnna$aHL A Antigens
=450  \\$aHuman Leukocyte Antigens
=450  \\$aLeukocyte Antigens
=450  \\$wnnna$aLeukocyte Antigens, Human
=550  \\$wg$aHistocompatibility Antigens
=550  \\$wh$aHLA-A Antigens
=550  \\$wh$aHLA-B Antigens
=550  \\$wh$aHLA-C Antigens
=550  \\$wh$aHLA-D Antigens
=550  \\$wh$aHLA-G Antigens
=667  \\$ahuman only, standing for Human Leukocyte Antigen; assoc with tissue types in transpl & with various dis; GEN or unspecified; prefer specifics; HLA goes here; DF: HLA
=680  \\$iAntigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
=688  \\$a82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77
=750  \0$aHLA histocompatibility antigens$5IEN$0(DLC)sh 85061292

=LDR  02496cz  a2200529n  4500
=001  9880363484202441
=005  20141212202152.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006678
=035  \\$aCAZ9849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x589.$x650.$x350
=072  \\$aB4.$x909.$x777.$x731.$x589.$x650.$x350
=150  \\$aHIV
=450  \\$wnnna$aAcquired Immune Deficiency Syndrome Virus
=450  \\$wnnna$aAcquired Immunodeficiency Syndrome Virus
=450  \\$aAIDS Virus
=450  \\$wnnna$aAIDS Viruses
=450  \\$aHTLV-III
=450  \\$wnnna$aHuman Immunodeficiency Virus
=450  \\$aHuman Immunodeficiency Viruses
=450  \\$wnnna$aHuman T-Cell Leukemia Virus Type III
=450  \\$wnnna$aHuman T Cell Leukemia Virus Type III
=450  \\$wnnna$aHuman T Cell Lymphotropic Virus Type III
=450  \\$aHuman T-Cell Lymphotropic Virus Type III
=450  \\$wnnna$aHuman T Lymphotropic Virus Type III
=450  \\$aHuman T-Lymphotropic Virus Type III
=450  \\$wnnna$aImmunodeficiency Virus, Human
=450  \\$wnnna$aImmunodeficiency Viruses, Human
=450  \\$aLAV-HTLV-III
=450  \\$aLymphadenopathy-Associated Virus
=450  \\$wnnna$aLymphadenopathy Associated Virus
=450  \\$wnnna$aLymphadenopathy-Associated Viruses
=450  \\$wnnna$aVirus, AIDS
=450  \\$wnnna$aVirus, Human Immunodeficiency
=450  \\$wnnna$aVirus, Lymphadenopathy-Associated
=450  \\$wnnna$aViruses, AIDS
=450  \\$wnnna$aViruses, Human Immunodeficiency
=450  \\$wnnna$aViruses, Lymphadenopathy-Associated
=550  \\$wg$aLentiviruses, Primate
=550  \\$wh$aHIV-1
=550  \\$wh$aHIV-2
=550  \\$aHuman Immunodeficiency Virus Proteins
=667  \\$ainfection = HIV INFECTIONS but note specifics; do not confuse the old name HTLV-III with the Deltaretrovirus HTLV-3
=680  \\$iHuman immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
=688  \\$a1988; use HTLV-III 1987; for AIDS VIRUS use HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991
=750  \0$aHIV (Viruses)$5IEN$0(DLC)sh 86004391

=LDR  00897cz  a2200289n  4500
=001  9880363484302441
=005  20141212202151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006676
=035  \\$aCAZ9847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x608
=150  \\$aHistory of Nursing
=450  \\$wnnna$aHistory Nursing
=450  \\$wnnna$aHistory Nursings
=450  \\$aNurses$xhistory
=450  \\$aNursing Care$xhistory
=450  \\$wnnna$aNursing Histories
=450  \\$wnnna$aNursing, History
=450  \\$wnnna$aNursing History
=450  \\$aNursing$xhistory
=450  \\$wnnna$aNursings, History
=550  \\$wg$aHistory
=550  \\$aNursing
=667  \\$ageneral; prefer /hist with specific nursing term and do not coordinate here or with NURSING; Manual 18.14+, 32.7-.8; DF: HIST NURS
=688  \\$a66
=750  \0$aNursing$xHistory$0sh2008108528$5IEN

=LDR  01357cz  a2200349n  4500
=001  9880363484402441
=005  20141212202151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006666
=035  \\$aCAZ9837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x552
=150  \\$aHistory of Medicine
=450  \\$wnno$aHistory of Medicine, 15th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 16th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 17th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 18th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 19th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 20th Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, 21st Cent.$5IEN-M
=450  \\$wnno$aHistory of Medicine, Ancient$5IEN-M
=450  \\$wnno$aHistory of Medicine, Medieval$5IEN-M
=450  \\$wnno$aHistory of Medicine, Modern$5IEN-M
=450  \\$wnnna$aMedicine, History
=450  \\$aMedicine$xhistory
=550  \\$wg$aHistory
=550  \\$wh$aBarber Surgeons
=550  \\$wh$aGrave Robbing
=550  \\$wh$aMedicine, Arabic
=550  \\$aMedicine
=667  \\$ageneral; prefer /hist with specific medical concept and do not coordinate here; Manual 18.14+; 32.4-.6; Avicenna (Ibn Sina): see note under MEDICINE, ARABIC; DF: HIST MED
=750  \0$aMedicine$xHistory$5IEN$0(DLC)sh 85083080

=LDR  00849cz  a2200265n  4500
=001  9880363484502441
=005  20141212202150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006665
=035  \\$aCAZ9836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x551
=150  \\$aHistory of Dentistry
=450  \\$wnnna$aDentistries, History
=450  \\$wnnna$aDentistry Histories
=450  \\$wnnna$aDentistry, History
=450  \\$wnnna$aDentistry History
=450  \\$aDentistry$xhistory
=450  \\$wnnna$aHistory Dentistries
=450  \\$wnnna$aHistory Dentistry
=550  \\$wg$aHistory
=550  \\$aDentistry
=667  \\$ageneral; prefer /hist with specific dentistry term & do not coordinate here or wth DENTISTRY; Manual 32.7, 32.8; DF: HIST DENT
=688  \\$a65
=750  \0$aDentistry$xHistory$5IEN$0(DLC)sh 85036957

=LDR  01414cz  a2200445n  4500
=001  9880363484602441
=005  20141212202150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006664
=035  \\$aCAZ9835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400
=150  \\$aHistory
=450  \\$wnnna$aAspect, Historical
=450  \\$wnnna$aAspects, Historical
=450  \\$aHistorians$5IEN
=450  \\$wnnna$aHistorical Aspect
=450  \\$wnnna$aHistorical Aspects
=450  \\$wnnna$aHistories
=550  \\$wg$aHumanities
=550  \\$wh$aAlchemy
=550  \\$wh$aAnniversaries and Special Events
=550  \\$wh$aArchives
=550  \\$wh$aEmblems and Insignia
=550  \\$wh$aEugenics
=550  \\$wh$aGenealogy and Heraldry
=550  \\$wh$aHistoriography
=550  \\$wh$aHistory, Ancient
=550  \\$wh$aHistory, Early Modern 1451-1600
=550  \\$wh$aHistory, Medieval
=550  \\$wh$aHistory, Modern 1601-
=550  \\$wh$aHistory of Dentistry
=550  \\$wh$aHistory of Medicine
=550  \\$wh$aHistory of Nursing
=550  \\$wh$aNatural History
=550  \\$wh$aPhrenology
=550  \\$wh$aSymbolism
=667  \\$aIM for specialty or general articles on history: Mnual 32.3; prefer /hist with specific subjects: Manual 19.7+, 19.8.36; Saints: 32.18.3
=750  \0$aHistory$5IEN-M$0(DLC)sh 85061212
=750  \0$aHistorians$5IEN-HS$0(DLC)sh 85061091

=LDR  00714cz   2200193n  4500
=001  9880363484702441
=005  20230831152108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006663
=035  \\$aCAZ9834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x441
=150  \\$aHistoriography
=450  \\$wnnna$aHistoriographies
=550  \\$wg$aHistory
=667  \\$a= the writing of histories; no qualif; DF: HISTORIOGR
=680  \\$iThe writing of history; the principles, theory, and history of historical writing; the product of historical writing. (Webster, 3d ed)
=750  \0$aHistoriography$5IEN$0(DLC)sh 85061211
=750  \0$iNarrower mapping$aTransnational history$0(DLC)sh2022007058$4NM$5IEN-M

=LDR  00683cz  a2200181n  4500
=001  9880363484802441
=005  20141212202149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006660
=035  \\$aCAZ9831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x450
=150  \\$aHistoplasmosis
=450  \\$wnnna$aHistoplasmoses
=550  \\$wg$aMycoses
=667  \\$afungus dis
=680  \\$iInfection resulting from inhalation or ingestion of spores of the fungus of the genus HISTOPLASMA, species H. capsulatum. It is worldwide in distribution and particularly common in the midwestern United States. (From Dorland, 27th ed)
=750  \0$aHistoplasmosis$5IEN$0(DLC)sh 85061088

=LDR  01127cz  a2200313n  4500
=001  9880363484902441
=005  20141212202149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006657
=035  \\$aCAZ9828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x660.$x470
=072  \\$aD12.$x776.$x664.$x469
=150  \\$aHistones
=450  \\$wnnna$aHistone
=450  \\$wnnna$aHistone H1
=450  \\$wnnna$aHistone H1(s)
=450  \\$wnnna$aHistone H2a
=450  \\$wnnna$aHistone H2b
=450  \\$wnnna$aHistone H3
=450  \\$wnnna$aHistone H3.3
=450  \\$wnnna$aHistone H4
=450  \\$wnnna$aHistone H5
=450  \\$wnnna$aHistone H7
=550  \\$wg$aNuclear Proteins
=550  \\$wg$aNucleoproteins
=667  \\$aH1, H2a, H2b, H3, etc. go here
=680  \\$iSmall chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.
=750  \0$aHistones$5IEN$0(DLC)sh 85061087

=LDR  01459cz  a2200325n  4500
=001  9880363485002441
=005  20200515130936.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006655
=035  \\$aCAZ9826M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x520
=150  \\$aHistone Deacetylases
=450  \\$wnnna$aClass I Histone Deacetylases
=450  \\$wnnna$aClass II Histone Deacetylases
=450  \\$wnnna$aComplexes, Histone Deacetylase
=450  \\$wnnna$aDeacetylase Complexes, Histone
=450  \\$wnnna$aDeacetylase, Histone
=450  \\$wnnna$aDeacetylases, Histone
=450  \\$wnnna$aHDAC Proteins
=450  \\$wnnna$aHistone Deacetylase
=450  \\$wnnna$aHistone Deacetylase Complexes
=550  \\$wg$aAmidohydrolases
=550  \\$wh$aGroup III Histone Deacetylases
=550  \\$wh$aHistone Deacetylase 6
=550  \\$wh$aMi-2 Nucleosome Remodeling and Deacetylase Complex
=550  \\$wh$aSin3 Histone Deacetylase and Corepressor Complex
=680  \\$iDeacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes.
=688  \\$a2003; use AMIDOHYDROLASES 1975-1990
=750  \0$aHistone deacetylase$5IEN-M$0(DLC)sh 00007235

=LDR  00758cz  a2200205n  4500
=001  9880363485102441
=005  20141212202147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006653
=035  \\$aCAZ9824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x656
=150  \\$aHistology
=550  \\$wg$aAnatomy
=550  \\$wh$aHistocytochemistry
=550  \\$wh$aHistology, Comparative
=667  \\$athe discipline only (education, history, etc); for histological structures, use the qualifier /anat with specific anatomical term or organism
=680  \\$iThe study of the structure of various TISSUES of organisms on a microscopic level.
=750  \0$aHistologists$5IEN-M$0(DLC)sh 85061083
=750  \0$aHistology$5IEN-HS$0(DLC)sh 85061084

=LDR  01487cz  a2200421n  4500
=001  9880363485202441
=005  20141212202147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006652
=035  \\$aCAZ9823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x750
=072  \\$aE5.$x200.$x750
=150  \\$aHistological Techniques
=450  \\$wnnna$aHistologic Technic
=450  \\$wnnna$aHistologic Technics
=450  \\$wnnna$aHistologic Technique
=450  \\$wnnna$aHistologic Techniques
=450  \\$wnnna$aHistological Technic
=450  \\$wnnna$aHistological Technics
=450  \\$wnnna$aHistological Technique
=450  \\$aHistology$xmethods
=450  \\$wnnna$aTechnic, Histologic
=450  \\$wnnna$aTechnic, Histological
=450  \\$wnnna$aTechnics, Histologic
=450  \\$wnnna$aTechnics, Histological
=450  \\$wnnna$aTechnique, Histologic
=450  \\$wnnna$aTechnique, Histological
=450  \\$wnnna$aTechniques, Histologic
=450  \\$wnnna$aTechniques, Histological
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wh$aAutoradiography
=550  \\$wh$aDecalcification Technique
=550  \\$wh$aHistocytochemistry
=550  \\$wh$aHistocytological Preparation Techniques
=680  \\$iMethods of preparing tissue for examination and study of the origin, structure, function, or pathology.
=688  \\$a91; was HISTOLOGICAL TECHNICS 1963-90
=750  \0$aHistology$xTechnique$5IEN$0(DLC)sh 85061085

=LDR  01389cz  a2200361n  4500
=001  9880363485302441
=005  20141212202147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006651
=035  \\$aCAZ9822HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x607
=072  \\$aE1.$x370.$x225.$x750.$x551
=072  \\$aE5.$x200.$x500.$x607
=072  \\$aE5.$x200.$x750.$x551
=072  \\$aH1.$x158.$x100.$x656.$x234
=072  \\$aH1.$x158.$x201.$x344
=072  \\$aH1.$x181.$x122.$x573
=150  \\$aHistocytochemistry
=450  \\$aCytochemistry
=450  \\$aHistochemistry$5IEN
=550  \\$wg$aBiochemistry
=550  \\$wg$aCytological Techniques
=550  \\$wg$aHistological Techniques
=550  \\$wg$aHistology
=550  \\$wh$aImmunohistochemistry
=550  \\$wh$aPeriodic Acid-Schiff Reaction
=550  \\$wh$aPrussian Blue Reaction
=667  \\$ahistocytochemistry of disease is disease / metab; Manual 26.11.3+
=680  \\$iStudy of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods.
=688  \\$a67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66
=750  \0$aCytochemistry$5IEN-M$0(DLC)sh 85035228
=750  \0$aHistochemistry$5IEN-HS$0(DLC)sh 85061077

=LDR  01810cz  a2200445n  4500
=001  9880363485402441
=005  20141212202146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006650
=035  \\$aCAZ9821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x385
=072  \\$aE5.$x200.$x812.$x385
=072  \\$aE5.$x478.$x594.$x385
=150  \\$aHistocompatibility Testing
=450  \\$aCrossmatching, Tissue
=450  \\$wnnna$aCrossmatchings, Tissue
=450  \\$wnnna$aHistocompatibility Testings
=450  \\$aHLA Typing
=450  \\$wnnna$aHLA Typings
=450  \\$wnnna$aTesting, Histocompatibility
=450  \\$wnnna$aTestings, Histocompatibility
=450  \\$wnnna$aTissue Crossmatching
=450  \\$wnnna$aTissue Crossmatchings
=450  \\$aTissue Typing
=450  \\$wnnna$aTissue Typings
=450  \\$wnnna$aTyping, HLA
=450  \\$wnnna$aTyping, Tissue
=450  \\$wnnna$aTypings, HLA
=450  \\$wnnna$aTypings, Tissue
=550  \\$wg$aImmunologic Tests
=550  \\$wh$aBlood Grouping and Crossmatching
=550  \\$wh$aLymphocyte Culture Test, Mixed
=550  \\$aGenetics
=550  \\$aTransplantation
=550  \\$aTransplantation Immunology
=667  \\$ahuman or animal; do not confuse with HEMOCOMPATIBILITY TESTING see MATERIALS TESTING
=680  \\$iIdentification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
=688  \\$a70(68)
=750  \0$aHistocompatibility testing$5IEN$0(DLC)sh 85061081

=LDR  01581cz  a2200361n  4500
=001  9880363485502441
=005  20141212202146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006649
=035  \\$aCAZ9820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x500
=072  \\$aD23.$x50.$x705.$x552
=150  \\$aHistocompatibility Antigens
=450  \\$wnnna$aAntigen, Histocompatibility
=450  \\$wnnna$aAntigens, Histocompatibility
=450  \\$wnnna$aAntigens, LD
=450  \\$wnnna$aAntigens, SD
=450  \\$wnnna$aAntigens, Transplantation
=450  \\$wnnna$aHistocompatibility Antigen
=450  \\$wnnna$aLD Antigens
=450  \\$wnnna$aSD Antigens
=450  \\$aTransplantation Antigens
=550  \\$wg$aAntigens, Surface
=550  \\$wg$aIsoantigens
=550  \\$wh$aHistocompatibility Antigens Class I
=550  \\$wh$aHistocompatibility Antigens Class II
=550  \\$wh$aHLA Antigens
=550  \\$wh$aMinor Histocompatibility Antigens
=667  \\$aGEN or unspecified only; prefer specifics but for humans, use HLA ANTIGENS; /genet permitted but consider also MAJOR HISTOCOMPATIBILITY COMPLEX
=680  \\$iA group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection.
=688  \\$a73
=750  \0$aHistocompatibility antigens$5IEN$0(DLC)sh 85061079

=LDR  00934cz  a2200265n  4500
=001  9880363485602441
=005  20141212202145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006648
=035  \\$aCAZ9819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x901.$x519
=150  \\$aHistocompatibility
=450  \\$wnnna$aCompatibilities, Tissue
=450  \\$wnnna$aCompatibility, Tissue
=450  \\$wnnna$aHistocompatibilities
=450  \\$wnnna$aImmunocompatibilities
=450  \\$aImmunocompatibility
=450  \\$wnnna$aTissue Compatibilities
=450  \\$aTissue Compatibility
=550  \\$wg$aTransplantation Immunology
=550  \\$wh$aHistocompatibility, Maternal-Fetal
=680  \\$iThe degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts.
=688  \\$a70(68)
=750  \0$aHistocompatibility$0(DLC) sh 85061078$5IEN-M

=LDR  04166cz  a2200925n  4500
=001  9880363485702441
=005  20141212192235.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006646
=035  \\$aCAZ9817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x375
=072  \\$aC15.$x604.$x250.$x400
=150  \\$aHistiocytosis, Langerhans-Cell
=450  \\$wnnna$aAleukemic Reticuloendothelioses, Systemic
=450  \\$wnnna$aAleukemic Reticuloendotheliosis, Systemic
=450  \\$wnnna$aCell Granulomatoses, Langerhans
=450  \\$wnnna$aCell Granulomatosis, Langerhans
=450  \\$wnnna$aCell Histiocytoses, Langerhans
=450  \\$wnnna$aCell Histiocytosis, Langerhans
=450  \\$wnnna$aDisease, Hand-Schüller-Christian
=450  \\$wnnna$aDisease, Hand-Schueller-Christian
=450  \\$wnnna$aDisease, Letterer-Siwe
=450  \\$wnnna$aDisease, Schueller-Christian
=450  \\$wnnna$aGeneralized Histiocytoses
=450  \\$wnnna$aGeneralized Histiocytosis
=450  \\$wnnna$aGranulomatoses, Langerhans Cell
=450  \\$wnnna$aGranulomatosis, Langerhans Cell
=450  \\$wnnna$aGranulomatosis, Langerhans-Cell
=450  \\$wnnna$aHand-Schüller-Christian Disease
=450  \\$wnnna$aHand Schüller Christian Disease
=450  \\$wnnna$aHand-Schüller-Christian Syndrome
=450  \\$wnnna$aHand Schüller Christian Syndrome
=450  \\$wnnna$aHand-Schueller-Christian Disease
=450  \\$wnnna$aHand Schueller Christian Disease
=450  \\$wnnna$aHand-Schueller-Christian Syndrome
=450  \\$wnnna$aHand Schueller Christian Syndrome
=450  \\$wnnna$aHashimoto-Pritzger Disease
=450  \\$wnnna$aHistiocytoses, Generalized
=450  \\$wnnna$aHistiocytoses, Langerhans Cell
=450  \\$wnnna$aHistiocytoses, Type 2
=450  \\$wnnna$aHistiocytosis, Generalized
=450  \\$wnnna$aHistiocytosis, Langerhans Cell
=450  \\$wnnna$aHistiocytosis, Type 2
=450  \\$wnnna$aHistiocytosis-X
=450  \\$aHistiocytosis X
=450  \\$wnnna$aHistiocytosis X, Pulmonary
=450  \\$wnnna$aLangerhans Cell Granulomatoses
=450  \\$wnnna$aLangerhans Cell Granulomatosis
=450  \\$aLangerhans-Cell Granulomatosis
=450  \\$wnnna$aLangerhans Cell Granulomatosis, Pulmonary
=450  \\$wnnna$aLangerhans Cell Histiocytoses
=450  \\$wnnna$aLangerhans Cell Histiocytosis
=450  \\$aLangerhans-Cell Histiocytosis
=450  \\$wnnna$aLetterer-Siwe Disease
=450  \\$wnnna$aLetterer Siwe Disease
=450  \\$wnnna$aNon-Lipid Reticuloendothelioses
=450  \\$wnnna$aNon-Lipid Reticuloendotheliosis
=450  \\$wnnna$aNon Lipid Reticuloendotheliosis
=450  \\$wnnna$aPulmonary Histiocytosis X
=450  \\$wnnna$aPulmonary Langerhans Cell Granulomatosis
=450  \\$wnnna$aReticuloendothelioses, Non-Lipid
=450  \\$wnnna$aReticuloendothelioses, Systemic Aleukemic
=450  \\$wnnna$aReticuloendotheliosis, Non-Lipid
=450  \\$wnnna$aReticuloendotheliosis, Systemic Aleukemic
=450  \\$wnnna$aSchueller-Christian Disease
=450  \\$wnnna$aSchueller Christian Disease
=450  \\$wnnna$aSyndrome, Hand-Schüller-Christian
=450  \\$wnnna$aSyndrome, Hand-Schueller-Christian
=450  \\$wnnna$aSystemic Aleukemic Reticuloendothelioses
=450  \\$wnnna$aSystemic Aleukemic Reticuloendotheliosis
=450  \\$wnnna$aType 2 Histiocytoses
=450  \\$wnnna$aType 2 Histiocytosis
=550  \\$wg$aHistiocytosis
=550  \\$wg$aLung Diseases, Interstitial
=550  \\$wh$aEosinophilic Granuloma
=680  \\$iA group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.
=688  \\$a90(75); was see under RETICULOENDOTHELIOSIS 1966-75; was HISTIOCYTOSIS X 1975-89
=750  \0$aHand-Schueller-Christian syndrome$5IEN-M$0(DLC)sh 85058638
=750  \0$aLetterer-Siwe disease$0(DLC)sh 85076237$5IEN-M

=LDR  01296cz  a2200301n  4500
=001  9880363485802441
=005  20141212202141.0
=008  760505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006633
=035  \\$aCAZ9804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x375.$x425
=072  \\$aD27.$x505.$x696.$x577.$x375.$x425
=150  \\$aHistamine Antagonists
=450  \\$wnnna$aAntagonists, Histamine
=450  \\$aAntihistamines
=450  \\$aHistamine$xantagonists & inhibitors
=450  \\$aReceptors, Histamine$xantagonists & inhibitors
=450  \\$aReceptors, Histamine H3$xantagonists & inhibitors
=550  \\$wg$aHistamine Agents
=550  \\$wh$aHistamine H1 Antagonists
=550  \\$wh$aHistamine H2 Antagonists
=550  \\$wh$aHistamine H3 Antagonists
=667  \\$aGEN or unspecified; prefer specifics; do not confuse with HISTAMINE AGONISTS; DF: HISTAMINE ANTAG
=680  \\$iDrugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.
=688  \\$a1977; for ANTIHISTAMINES use HISTAMINE H1 ANTAGONISTS 1997-2008
=688  \\$a77; was see ANTIHISTAMINICS 1963-76
=750  \0$aAntihistamines$5IEN-M$0(DLC)sh 85005683

=LDR  01171cz  a2200325n  4500
=001  9880363485902441
=005  20141212202141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006632
=035  \\$aCAZ9803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x501
=072  \\$aD2.$x92.$x471.$x440
=072  \\$aD3.$x383.$x129.$x308.$x373
=072  \\$aD23.$x469.$x50.$x300
=150  \\$aHistamine
=450  \\$wnnna$aCeplene
=450  \\$wnnna$aDihydrochloride, Histamine
=450  \\$wnnna$aHistamine Dihydrochloride
=450  \\$wnnna$aHistamine Hydrochloride
=450  \\$wnnna$aHydrochloride, Histamine
=450  \\$wnnna$aPeremin
=550  \\$wg$aAutacoids
=550  \\$wg$aBiogenic Monoamines
=550  \\$wg$aEthylamines
=550  \\$wg$aImidazoles
=550  \\$wh$aMethylhistamines
=680  \\$iAn amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
=688  \\$a/antagonists & inhibitors was ANTIHISTAMINICS 1963-76
=750  \0$aHistamine$5IEN$0(DLC)sh 85061073

=LDR  01662cz  a2200385n  4500
=001  9880363486002441
=005  20141212202140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006631
=035  \\$aCAZ9802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x664.$x249
=150  \\$aAmine Oxidase (Copper-Containing)
=450  \\$wnnna$aAmine Oxidase, Copper
=450  \\$wnnna$aAmine Oxidase, Copper-Containing
=450  \\$wnnna$aAmine Oxidase, Copper Containing
=450  \\$wnnna$aAmine Oxidase, Semicarbazide-Sensitive
=450  \\$wnnna$aCopper Amine Oxidase
=450  \\$wnnna$aCopper-Containing Amine Oxidase
=450  \\$aDiamine Oxidase
=450  \\$wnnna$aDiamine Oxidase, Xylylene
=450  \\$wnnna$aDiaminobenzidine Oxidase
=450  \\$aHistaminase
=450  \\$wnnna$aOxidase, Copper Amine
=450  \\$wnnna$aOxidase, Copper-Containing Amine
=450  \\$wnnna$aOxidase, Diaminobenzidine
=450  \\$wnnna$aOxidase, Semicarbazide-Sensitive Amine
=450  \\$wnnna$aOxidase, Xylylene Diamine
=450  \\$wnnna$aSemicarbazide-Sensitive Amine Oxidase
=450  \\$wnnna$aSemicarbazide Sensitive Amine Oxidase
=450  \\$wnnna$aXylylene Diamine Oxidase
=550  \\$wg$aOxidoreductases Acting on CH-NH2 Group Donors
=680  \\$iA group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide.
=688  \\$a92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was SY to AMINE OXIDASE (NM) 1978-91
=750  \0$aHistaminase$5IEN-M$0(DLC)sh 85061072

=LDR  01844cz  a2200433n  4500
=001  9882116472102441
=005  20230127144254.0
=008  770301\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006630
=035  \\$a(DNLM)D006630
=035  \\$a(NLM)98199621180000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x953
=072  \\$aM1.$x686.$x477.$x625.$x188.$x441
=150  \\$aHispanic or Latino
=450  \\$wnnna$aHispanics
=450  \\$aCuban Americans
=450  \\$aHispanic Americans
=450  \\$aLatin Americans, US
=450  \\$aLatinas
=450  \\$aLatinos
=450  \\$aLatinx
=450  \\$aPuerto Ricans
=450  \\$aSpanish Americans
=450  \\$wnnna$aAmerican, Hispanic
=450  \\$wnnna$aAmerican, US Latin
=450  \\$wnnna$aCuban American
=450  \\$wnnna$aHispanic American
=450  \\$wnnna$aHispanic or Latinos
=450  \\$wnnna$aLatin American, US
=450  \\$wnnna$aLatina
=450  \\$wnnna$aLatino
=450  \\$wnnna$aPuerto Rican
=450  \\$wnnna$aSpanish American
=450  \\$wnnna$aUS Latin American
=450  \\$wnnna$aUS Latin Americans
=680  \\$iA person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2022(1978)
=750  \0$aHispanic Americans$5IEN-M$0(DLC)sh 85061051

=LDR  00935cz  a2200217n  4500
=001  9880363486202441
=005  20141212202139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006628
=035  \\$aCAZ9799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x329.$x750
=072  \\$aC23.$x888.$x971.$x468
=150  \\$aHirsutism
=550  \\$wg$aHair Diseases
=550  \\$wg$aVirilism
=550  \\$aHyperandrogenism
=550  \\$aHypertrichosis
=680  \\$iA condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.
=688  \\$a66(64); was see under HYPERTRICHOSIS 1963-65
=750  \0$aHypertrichosis$5IEN$0(DLC)sh 85063732

=LDR  01781cz  a2200433n  4500
=001  9880363486302441
=005  20141212202139.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006627
=035  \\$aCAZ9798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x198.$x439
=072  \\$aC6.$x405.$x469.$x158.$x701.$x439
=072  \\$aC16.$x131.$x314.$x439
=150  \\$aHirschsprung Disease
=450  \\$wnnna$aAganglionic Megacolon
=450  \\$aAganglionosis, Colonic
=450  \\$wnnna$aAganglionosis, Rectosigmoid
=450  \\$wnnna$aAganglionosis, Rectosigmoid Colon
=450  \\$wnnna$aAganglionosis, Total Colonic
=450  \\$aColonic Aganglionosis
=450  \\$wnnna$aCongenital Intestinal Aganglionosis
=450  \\$wnnna$aCongenital Megacolon
=450  \\$wnnna$aDisease, Hirschsprung
=450  \\$wnnna$aDisease, Hirschsprung's
=450  \\$wnnna$aHirschsprung's Disease
=450  \\$wnnna$aHirschsprungs Disease
=450  \\$wnnna$aMegacolon, Aganglionic
=450  \\$aMegacolon, Congenital
=450  \\$aMegacolon$xcongenital
=450  \\$wnnna$aRectosigmoid Aganglionosis
=450  \\$wnnna$aRectosigmoid Colon Aganglionosis
=450  \\$wnnna$aTotal Colonic Aganglionosis
=550  \\$wg$aDigestive System Abnormalities
=550  \\$wg$aMegacolon
=667  \\$aacquired megacolon = MEGACOLON
=680  \\$iCongenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.
=688  \\$a83; was HIRSCHSPRUNG'S DISEASE see MEGACOLON 1963-82
=750  \0$aHirschsprung's disease$5IEN$0(DLC)sh 85061021

=LDR  01817cz  a2200493n  4500
=001  9880363486402441
=005  20141212192233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006624
=035  \\$aCAZ9795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x405
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x345
=150  \\$aHippocampus
=450  \\$aAmmon Horn
=450  \\$wnnna$aAmmon's Horn
=450  \\$wnnna$aAmmons Horn
=450  \\$wnnna$aCollaterals, Schaffer
=450  \\$aCornu Ammonis
=450  \\$wnnna$aFormation, Hippocampal
=450  \\$wnnna$aFormations, Hippocampal
=450  \\$aHippocampal Formation
=450  \\$wnnna$aHippocampal Formations
=450  \\$wnnna$aHippocampus Proper
=450  \\$wnnna$aHippocampus Propers
=450  \\$wnnna$aHorn, Ammon
=450  \\$wnnna$aHorn, Ammon's
=450  \\$wnnna$aProper, Hippocampus
=450  \\$wnnna$aPropers, Hippocampus
=450  \\$wnnna$aSchaffer Collaterals
=450  \\$aSubiculum
=450  \\$wnnna$aSubiculums
=550  \\$wg$aCerebral Cortex
=550  \\$wg$aLimbic System
=550  \\$wh$aCA1 Region, Hippocampal
=550  \\$wh$aCA2 Region, Hippocampal
=550  \\$wh$aCA3 Region, Hippocampal
=550  \\$wh$aDentate Gyrus
=550  \\$wh$aFornix, Brain
=550  \\$aEntorhinal Cortex
=550  \\$aPerforant Pathway
=680  \\$iA curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
=688  \\$a2015; use under HIPPOCAMPUS1966-2014
=750  \0$aHippocampus (Brain)$0(DLC) sh 85060982$5IEN

=LDR  00936cz  a2200301n  4500
=001  9880363486502441
=005  20141212202137.0
=008  781219\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006622
=035  \\$aCAZ9793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x400.$x400
=150  \\$aHip Prosthesis
=450  \\$aArtificial Hip Joints$5IEN
=450  \\$wnnna$aFemoral Head Prostheses
=450  \\$aFemoral Head Prosthesis
=450  \\$wnnna$aHip Prostheses
=450  \\$wnnna$aProstheses, Femoral Head
=450  \\$wnnna$aProstheses, Hip
=450  \\$wnnna$aProsthesis, Femoral Head
=450  \\$wnnna$aProsthesis, Hip
=550  \\$wg$aJoint Prosthesis
=550  \\$aArthroplasty, Replacement, Hip
=550  \\$aOsseointegration
=680  \\$iReplacement for a hip joint.
=688  \\$a80
=750  \0$aTotal hip replacement$5IEN-M$0(DLC)sh 90001569
=750  \0$aArtificial hip joints$5IEN-HS$0(DLC)sh 85008171

=LDR  00965cz  a2200277n  4500
=001  9880363486602441
=005  20171012143410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006621
=035  \\$aCAZ9792HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x411
=150  \\$aHip Joint
=450  \\$wnnna$aAcetabulofemoral Joint
=450  \\$wnnna$aAcetabulofemoral Joints
=450  \\$wnnna$aHip Joints
=450  \\$wnnna$aJoint, Acetabulofemoral
=450  \\$wnnna$aJoint, Hip
=450  \\$wnnna$aJoints, Acetabulofemoral
=450  \\$wnnna$aJoints, Hip
=550  \\$wg$aJoints
=550  \\$wh$aRound Ligament of Femur
=667  \\$ainjury is probably HIP DISLOCATION or HIP FRACTURES, otherwise coordinate IM with HIP INJURIES (IM); differentiate from HIP
=680  \\$iThe joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS.
=688  \\$a65
=750  \0$aHip joint$5IEN$0(DLC)sh 85060970

=LDR  01449cz  a2200337n  4500
=001  9880363486702441
=005  20141212202136.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006620
=035  \\$aCAZ9791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x61.$x425
=072  \\$aC26.$x404.$x484
=072  \\$aC26.$x531.$x750
=072  \\$aC26.$x558.$x276.$x425
=150  \\$aHip Fractures
=450  \\$wnnna$aFractures, Hip
=450  \\$wnnna$aFractures, Intertrochanteric
=450  \\$wnnna$aFractures, Subtrochanteric
=450  \\$wnnna$aFractures, Trochanteric
=450  \\$aIntertrochanteric Fractures
=450  \\$aSubtrochanteric Fractures
=450  \\$aTrochanteric Fractures
=550  \\$wg$aFemoral Fractures
=550  \\$wg$aFractures, Bone
=550  \\$wg$aHip Injuries
=550  \\$wh$aFemoral Neck Fractures
=667  \\$aGEN or unspecified; note X refs: fract below subtrochant = FEMORAL FRACTURES; FEMORAL NECK FRACTURES is available; femur head fract = FEMUR HEAD /inj (IM) + HIP FRACTURES (IM); acetabular fract = ACETABULUM /inj (IM) + FRACTURES, BONE (IM)
=680  \\$iFractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).
=688  \\$a78
=750  \0$aHip joint$xFractures$5IEN$0(IEN)368620

=LDR  00761cz  a2200205n  4500
=001  9880363486802441
=005  20141212202136.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006619
=035  \\$aCAZ9790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x268.$x485
=150  \\$aHip Dysplasia, Canine
=450  \\$aCanine Hip Dysplasia
=450  \\$wnnna$aDysplasia, Canine Hip
=550  \\$wg$aDog Diseases
=667  \\$acongen hip disloc in dogs; don't forget check tags ANIMALS & DOGS (NIM)
=680  \\$iA hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age.
=688  \\$a91(76); was see under HIP DISLOCATION, CONGENITAL 1976-90
=750  \0$aCanine hip dysplasia$5IEN$0(DLC)sh 85019599

=LDR  02037cz  a2200445n  4500
=001  9880363486902441
=005  20141212202136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006618
=035  \\$aCAZ9789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x660.$x449
=072  \\$aC16.$x131.$x621.$x449
=150  \\$aHip Dislocation, Congenital
=450  \\$wnnna$aCongenital Dysplasia Of The Hip
=450  \\$wnnna$aCongenital Hip Dislocation
=450  \\$wnnna$aCongenital Hip Dislocations
=450  \\$wnnna$aCongenital Hip Displacement
=450  \\$wnnna$aCongenital Hip Displacements
=450  \\$wnnna$aCongenital Hip Dysplasia
=450  \\$wnnna$aCongenital Hip Dysplasias
=450  \\$wnnna$aDislocation, Congenital Hip
=450  \\$wnnna$aDislocation Of Hip, Congenital
=450  \\$wnnna$aDislocations, Congenital Hip
=450  \\$wnnna$aDisplacement, Congenital Hip
=450  \\$wnnna$aDisplacements, Congenital Hip
=450  \\$wnnna$aDysplasia, Congenital Hip
=450  \\$wnnna$aDysplasias, Congenital Hip
=450  \\$aHip Dislocation$xcongenital
=450  \\$wnnna$aHip, Dislocation Of, Congenital
=450  \\$wnnna$aHip Dislocations, Congenital
=450  \\$wnnna$aHip Displacement, Congenital
=450  \\$wnnna$aHip Displacements, Congenital
=450  \\$aHip Dysplasia, Congenital
=450  \\$wnnna$aHip Dysplasia, Congenital, Nonsyndromic
=450  \\$wnnna$aHip Dysplasias, Congenital
=550  \\$wg$aMusculoskeletal Abnormalities
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; /vet permitted but congen hip disloc in dogs = HIP DYSPLASIA, CANINE: see note there
=680  \\$iCongenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males.
=750  \0$aHip joint$xDislocation, Congenital$5IEN$0(DLC)sh 85060974

=LDR  00938cz  a2200289n  4500
=001  9880363487002441
=005  20141212202135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006617
=035  \\$aCAZ9788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x289.$x384
=072  \\$aC26.$x531.$x500
=150  \\$aHip Dislocation
=450  \\$wnnna$aDislocation, Hip
=450  \\$wnnna$aDislocations, Hip
=450  \\$wnnna$aDisplacement, Hip
=450  \\$wnnna$aDisplacements, Hip
=450  \\$wnnna$aHip Dislocations
=450  \\$wnnna$aHip Displacement
=450  \\$wnnna$aHip Displacements
=450  \\$wnnna$aHip Dysplasia
=550  \\$wg$aDislocations
=550  \\$wg$aHip Injuries
=667  \\$anote entry term HIP DYSPLASIA: HIP DYSPLASIA, CANINE is also available
=680  \\$iDisplacement of the femur bone from its normal position at the HIP JOINT.
=750  \0$aHip joint$xDislocation$5IEN$0(DLC)sh 85060973

=LDR  00746cz  a2200205n  4500
=001  9880363487102441
=005  20141212202134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x400
=150  \\$aHip
=360  \\$iconsider also terms at$aCOX-
=450  \\$aCoxa
=450  \\$wnnna$aCoxas
=450  \\$wnnna$aHips
=550  \\$wg$aLower Extremity
=667  \\$ado not confuse with HIP JOINT or PELVIC BONES (os coxae); aseptic or avascular necrosis = FEMUR HEAD NECROSIS; differentiate from HIP JOINT
=680  \\$iThe projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur.
=750  \0$aHip joint$5IEN$0(DLC)sh 85060970

=LDR  00780cz  a2200229n  4500
=001  9880363487202441
=005  20141212202134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006614
=035  \\$aCAZ9785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x473
=150  \\$aHindlimb
=450  \\$wnnna$aHindlimbs
=550  \\$wg$aAnimal Structures
=550  \\$wh$aStifle
=550  \\$wh$aTarsus, Animal
=550  \\$aLeg
=667  \\$anon-primate vertebrates only; for primates use LEG
=680  \\$iEither of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73)
=688  \\$a1968
=750  \0$aHindlimb$5IEN-M$0(DLC)sh 85046601

=LDR  01188cz  a2200265n  4500
=001  9880363487302441
=005  20141212202134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006613
=035  \\$aCAZ9784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x247
=072  \\$aG11.$x561.$x600.$x370
=150  \\$aHigher Nervous Activity
=450  \\$wnnna$aActivities, Higher Nervous
=450  \\$wnnna$aActivity, Higher Nervous
=450  \\$wnnna$aHigher Nervous Activities
=450  \\$wnnna$aNervous Activities, Higher
=450  \\$wnnna$aNervous Activity, Higher
=550  \\$wg$aMental Processes
=550  \\$wg$aNervous System Physiological Processes
=667  \\$athis expression is found intact as "vysshaia nervnaia deiatel'nost" in Russian neurophysiol literature
=680  \\$iA term used in Eastern European research literature on brain and behavior physiology for cortical functions. It refers to the highest level of integrative function of the brain, centered in the CEREBRAL CORTEX, regulating language, thought, and behavior via sensory, motor, and cognitive processes.
=688  \\$a65(64)
=750  \0$aHigher nervous activity$5IEN$0(DLC)sh 85060758

=LDR  00613cz  a2200193n  4500
=001  9880363487402441
=005  20141212202132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006606
=035  \\$aCAZ9777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x578
=150  \\$aHiccup
=450  \\$wnnna$aHiccough
=450  \\$wnnna$aHiccoughs
=450  \\$wnnna$aHiccups
=550  \\$wg$aSigns and Symptoms, Digestive
=680  \\$iA spasm of the diaphragm that causes a sudden inhalation followed by rapid closure of the glottis which produces a sound.
=750  \0$aHiccups$5IEN$0(DLC)sh 85060608

=LDR  01142cz  a2200289n  4500
=001  9880363487502441
=005  20141212202131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006605
=035  \\$aCAZ9776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x110.$x232.$x889.$x500
=072  \\$aG7.$x700.$x345.$x421.$x889.$x500
=072  \\$aG16.$x100.$x57.$x500.$x535.$x889.$x500
=150  \\$aHibernation
=450  \\$wnnna$aArtificial Hibernation
=450  \\$wnnna$aArtificial Hibernations
=450  \\$aHibernation, Artificial
=450  \\$wnnna$aHibernation, Induced
=450  \\$wnnna$aHibernations
=450  \\$wnnna$aInduced Hibernation
=450  \\$wnnna$aInduced Hibernations
=550  \\$wg$aTorpor
=667  \\$aanimal only; summer dormancy = HIBERNATION
=680  \\$iThe dormant state in which some warm-blooded animal species pass the winter. It is characterized by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs.
=688  \\$a1963; for HIBERNATION, ARTIFICIAL use HYPOTHERMIA, INDUCED 1983-2008
=750  \0$aHibernation$5IEN$0(DLC)sh 85060601

=LDR  00610cz  a2200217n  4500
=001  9880363487602441
=005  20141212202130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006600
=035  \\$aCAZ9771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x894.$x417
=150  \\$aHexosephosphates
=450  \\$aHexose Phosphates$5IEN
=550  \\$wg$aSugar Phosphates
=550  \\$wh$aFructosephosphates
=550  \\$wh$aGalactosephosphates
=550  \\$wh$aGlucosephosphates
=550  \\$wh$aHexosediphosphates
=550  \\$wh$aMannosephosphates
=750  \0$aHexose phosphates$5IEN$0(DLC)sh 85060587

=LDR  00494cz  a2200193n  4500
=001  9880363487702441
=005  20141212202129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006595
=035  \\$aCAZ9767M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x67.$x342
=150  \\$aHexosamines
=550  \\$wg$aAmino Sugars
=550  \\$wh$aFructosamine
=550  \\$wh$aGalactosamine
=550  \\$wh$aGlucosamine
=550  \\$wh$aMeglumine
=750  \0$aHexosamines$0(DLC) sh 93006663$5IEN-M

=LDR  00723cz  a2200193n  4500
=001  9880363487802441
=005  20141212202127.0
=008  770520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006586
=035  \\$aCAZ9758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x500
=150  \\$aHexanes
=450  \\$aIsohexanes
=550  \\$wg$aAlkanes
=667  \\$adoes not include hexenes ( = ALKENES), hexadienes ( = ALKADIENES), or hexatrienes ( = POLYENES); CYCLOHEXANES is also available
=680  \\$iSix-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Various polyneuropathies are caused by hexane poisoning.
=688  \\$a78
=750  \0$aHexane$5IEN$0(DLC)sh 85060586

=LDR  00694cz  a2200205n  4500
=001  9880363487902441
=005  20141212202126.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006581
=035  \\$aCAZ9753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x261.$x400
=072  \\$aD2.$x455.$x526.$x439.$x202.$x400
=150  \\$aHexachlorobenzene
=450  \\$aHCB
=550  \\$wg$aChlorobenzenes
=667  \\$ado not confuse with BENZENE HEXACHLORIDE see LINDANE; DF: note short X ref
=680  \\$iAn agricultural fungicide and seed treatment agent.
=688  \\$a91(75); was see under CHLOROBENZENES 1975-90
=750  \0$aHexachlorobenzene$5IEN$0(DLC)sh 88000662

=LDR  00976cz  a2200277n  4500
=001  9880363488002441
=005  20180718095947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006571
=035  \\$aCAZ9743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3
=150  \\$aHeterocyclic Compounds
=450  \\$wnnna$aCompounds, Heterocyclic
=550  \\$wh$aAcids, Heterocyclic
=550  \\$wh$aAlkaloids
=550  \\$wh$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aHeterocyclic Compounds, Bridged-Ring
=550  \\$wh$aHeterocyclic Compounds, Fused-Ring
=550  \\$wh$aHeterocyclic Oxides
=550  \\$wh$aPhytochemicals
=550  \\$wh$aPyrans
=550  \\$wh$aSpiro Compounds
=667  \\$aGEN or unspecified; prefer specific groups or specific cpd; DF: HETEROCYCLIC CPDS
=680  \\$iRing compounds having atoms other than carbon in their nuclei. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aHeterocyclic compounds$5IEN$0(DLC)sh 85060525

=LDR  00699cz  a2200205n  4500
=001  9880363488102441
=005  20141212202121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006570
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x180.$x383
=072  \\$aD12.$x776.$x664.$x224.$x466
=072  \\$aG5.$x360.$x160.$x180.$x383
=150  \\$aHeterochromatin
=450  \\$wnnna$aHeterochromatins
=550  \\$wg$aChromatin
=550  \\$wh$aSex Chromatin
=680  \\$iThe portion of chromosome material that remains condensed and is transcriptionally inactive during INTERPHASE.
=688  \\$a72(68)
=750  \0$aHeterochromatin$0(DLC) sh 85060524$5IEN

=LDR  00816cz  a2200241n  4500
=001  9880363488202441
=005  20141212202121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006569
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x252.$x500
=072  \\$aD3.$x830.$x219.$x266.$x450.$x252.$x500
=150  \\$aHesperidin
=450  \\$wnnna$a7-Rhamnoglucoside, Hesperetin
=450  \\$wnnna$aHesperetin 7-Rhamnoglucoside
=450  \\$wnnna$aHesperetin 7 Rhamnoglucoside
=450  \\$wnnna$aHesperetin-7-Rutinoside
=450  \\$wnnna$aHesperetin 7 Rutinoside
=550  \\$wg$aFlavanones
=680  \\$iA flavanone glycoside found in CITRUS fruit peels.
=688  \\$a1991(1975)
=688  \\$a91(75); was see under BIOFLAVONOIDS 1975-90
=750  \0$aHesperidin$5IEN$0(DLC)sh 85060491

=LDR  01433cz  a2200433n  4500
=001  9880363488302441
=005  20141212202120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006566
=035  \\$aCAZ9738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466
=150  \\$aHerpesviridae Infections
=450  \\$wnnna$aHerpesviridae Infection
=450  \\$wnnna$aHerpesvirus Infection
=450  \\$aHerpesvirus Infections
=450  \\$wnnna$aInfection, Herpesviridae
=450  \\$wnnna$aInfection, Herpesvirus
=450  \\$wnnna$aInfections, Herpesviridae
=450  \\$wnnna$aInfections, Herpesvirus
=550  \\$wg$aDNA Virus Infections
=550  \\$wh$aBell Palsy
=550  \\$wh$aChickenpox
=550  \\$wh$aCytomegalovirus Infections
=550  \\$wh$aEncephalitis, Herpes Simplex
=550  \\$wh$aEncephalitis, Varicella Zoster
=550  \\$wh$aEpstein-Barr Virus Infections
=550  \\$wh$aHerpes Simplex
=550  \\$wh$aHerpes Zoster
=550  \\$wh$aInfectious Bovine Rhinotracheitis
=550  \\$wh$aMalignant Catarrh
=550  \\$wh$aMarek Disease
=550  \\$wh$aPseudorabies
=550  \\$wh$aRoseolovirus Infections
=550  \\$wh$aSarcoma, Kaposi
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the HERPESVIRIDAE.
=688  \\$a94; was HERPESVIRUS INFECTIONS 1963-93
=750  \0$aHerpesvirus diseases$5IEN$0(DLC)sh 85060459

=LDR  01351cz  a2200349n  4500
=001  9880363488402441
=005  20141212202120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006564
=035  \\$aCAZ9736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382
=072  \\$aB4.$x909.$x204.$x382
=150  \\$aHerpesviridae
=450  \\$wnnna$aherpesvirus 3, Murid
=450  \\$wnnna$aHerpesviruses
=450  \\$aMouse Thymic Virus
=450  \\$wnnna$aMouse Thymic Viruses
=450  \\$aMurid herpesvirus 3
=450  \\$aThymic Group Viruses
=450  \\$wnnna$aThymic Virus, Mouse
=450  \\$wnnna$aThymic Viruses, Mouse
=550  \\$wg$aDNA Viruses
=550  \\$wh$aAlphaherpesvirinae
=550  \\$wh$aBetaherpesvirinae
=550  \\$wh$aGammaherpesvirinae
=550  \\$wh$aHerpesvirus 1, Ranid
=550  \\$wh$aIctalurivirus
=667  \\$aGEN: prefer specifics; infection = HERPESVIRIDAE INFECTIONS
=680  \\$iA family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE.
=688  \\$a81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91
=750  \0$aHerpesviruses$5IEN$0(DLC)sh 85060462

=LDR  01021cz  a2200241n  4500
=001  9880363488502441
=005  20141212202119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006563
=035  \\$aCAZ9735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x423.$x466
=072  \\$aC2.$x325.$x450
=072  \\$aC11.$x294.$x800.$x450
=150  \\$aHerpes Zoster Ophthalmicus
=450  \\$aHerpes Zoster, Ocular
=450  \\$wnnna$aOcular Herpes Zoster
=550  \\$wg$aEye Infections, Viral
=550  \\$wg$aHerpes Zoster
=667  \\$acaused by human herpesvirus 3 (OCULAR HERPES ZOSTER VIRUS see HERPESVIRUS 3, HUMAN)
=680  \\$iVirus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve.
=688  \\$a90; was HERPES ZOSTER, OCULAR 1963-89
=750  \0$aOphthalmic zoster$5IEN-M$0(DLC)sh 97006035

=LDR  01097cz  a2200241n  4500
=001  9880363488602441
=005  20141212202119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006562
=035  \\$aCAZ9734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x423
=150  \\$aHerpes Zoster
=450  \\$aShingles
=450  \\$aZona
=450  \\$aZoster
=550  \\$wg$aHerpesviridae Infections
=550  \\$wh$aHerpes Zoster Ophthalmicus
=550  \\$wh$aHerpes Zoster Oticus
=550  \\$wh$aZoster Sine Herpete
=550  \\$aNeuralgia, Postherpetic
=680  \\$iAn acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
=750  \0$aShingles (Disease)$5IEN$0(DLC)sh 85060456

=LDR  01161cz  a2200265n  4500
=001  9880363488702441
=005  20141212202119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006561
=035  \\$aCAZ9733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x382
=072  \\$aC2.$x825.$x320
=072  \\$aC17.$x800.$x838.$x790.$x320
=150  \\$aHerpes Simplex
=550  \\$wg$aHerpesviridae Infections
=550  \\$wg$aSkin Diseases, Viral
=550  \\$wh$aHerpes Genitalis
=550  \\$wh$aHerpes Labialis
=550  \\$wh$aKaposi Varicelliform Eruption
=550  \\$wh$aKeratitis, Herpetic
=550  \\$wh$aStomatitis, Herpetic
=667  \\$anote Cat C; caused by Simplexvirus (also called Herpes simplex virus & Herpesvirus hominis)
=680  \\$iA group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)
=750  \0$aHerpes simplex$5IEN$0(DLC)sh 85060454

=LDR  00990cz  a2200301n  4500
=001  9880363488802441
=005  20141212202117.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006558
=035  \\$aCAZ9730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x382.$x290
=072  \\$aC2.$x800.$x801.$x350
=072  \\$aC12.$x294.$x329
=072  \\$aC13.$x351.$x500.$x342
=150  \\$aHerpes Genitalis
=450  \\$aGenital Herpes
=450  \\$wnnna$aGenital Herpes Simplex
=450  \\$wnnna$aHerpes, Genital
=450  \\$aHerpes Simplex, Genital
=450  \\$wnnna$aHerpes Simplex Virus Genital Infection
=550  \\$wg$aGenital Diseases, Female
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aHerpes Simplex
=550  \\$wg$aSexually Transmitted Diseases, Viral
=680  \\$iInfection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females.
=688  \\$a82
=750  \0$aHerpes genitalis$5IEN$0(DLC)sh 85060453

=LDR  00752cz  a2200241n  4500
=001  9880363488902441
=005  20141212202117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006556
=035  \\$aCAZ9728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x675.$x400
=072  \\$aF3.$x900.$x675.$x400
=150  \\$aHeroin Dependence
=450  \\$wnnna$aAbuse, Heroin
=450  \\$wnnna$aAddiction, Heroin
=450  \\$wnnna$aDependence, Heroin
=450  \\$aHeroin Abuse
=450  \\$aHeroin Addiction
=550  \\$wg$aOpioid-Related Disorders
=680  \\$iStrong dependence, both physiological and emotional, upon heroin.
=688  \\$a81; was HEROIN ADDICTION 1973-80 (Prov 1973)
=750  \0$aHeroin abuse$5IEN$0(DLC)sh 85060445

=LDR  00831cz  a2200217n  4500
=001  9880363489002441
=005  20141212202117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006555
=035  \\$aCAZ9727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707.$x374.$x937
=150  \\$aHernia, Ventral
=450  \\$wnnna$aHernias, Ventral
=450  \\$aVentral Hernia
=450  \\$wnnna$aVentral Hernias
=550  \\$wg$aHernia, Abdominal
=550  \\$wh$aHernia, Umbilical
=680  \\$iA hernia caused by weakness of the anterior ABDOMINAL WALL due to midline defects, previous incisions, or increased intra-abdominal pressure. Ventral hernias include UMBILICAL HERNIA, incisional, epigastric, and spigelian hernias.
=688  \\$a80; was VENTRAL HERNIA 1963-79
=750  \0$aVentral hernia$5IEN$0(DLC)sh 85142751

=LDR  01521cz  a2200349n  4500
=001  9880363489102441
=005  20141212202116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006552
=035  \\$aCAZ9724HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707.$x374.$x875
=150  \\$aHernia, Inguinal
=450  \\$wnnna$aDirect Inguinal Hernia
=450  \\$wnnna$aDirect Inguinal Hernias
=450  \\$wnnna$aHernia, Direct Inguinal
=450  \\$wnnna$aHernia, Indirect Inguinal
=450  \\$wnnna$aHernias, Direct Inguinal
=450  \\$wnnna$aHernias, Indirect Inguinal
=450  \\$wnnna$aHernias, Inguinal
=450  \\$wnnna$aIndirect Inguinal Hernia
=450  \\$wnnna$aIndirect Inguinal Hernias
=450  \\$aInguinal Hernia
=450  \\$wnnna$aInguinal Hernia, Direct
=450  \\$wnnna$aInguinal Hernia, Indirect
=450  \\$wnnna$aInguinal Hernias
=450  \\$wnnna$aInguinal Hernias, Direct
=450  \\$wnnna$aInguinal Hernias, Indirect
=550  \\$wg$aHernia, Abdominal
=680  \\$iAn abdominal hernia with an external bulge in the GROIN region. It can be classified by the location of herniation. Indirect inguinal hernias occur through the internal inguinal ring. Direct inguinal hernias occur through defects in the ABDOMINAL WALL (transversalis fascia) in Hesselbach's triangle. The former type is commonly seen in children and young adults; the latter in adults.
=688  \\$a80; was INGUINAL HERNIA 1963-79
=750  \0$aInguinal hernia$5IEN$0(DLC)sh 85066363

=LDR  00781cz  a2200241n  4500
=001  9880364570502441
=005  20141212220811.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052679
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x435
=072  \\$aB4.$x820.$x420
=150  \\$aLuteoviridae
=450  \\$aEnamovirus
=450  \\$wnnna$aEnamoviruses
=450  \\$aPolerovirus
=450  \\$wnnna$aPoleroviruses
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aLuteovirus
=680  \\$iA family of RNA plant viruses infecting disparate plant families. They are transmitted by specific aphid vectors. There are three genera: LUTEOVIRUS; Polerovirus; and Enamovirus.
=688  \\$a2007
=750  \0$aLuteoviridae$0(DLC)sh2007002895$5IEN-M

=LDR  00958cz  a2200289n  4500
=001  9880364570602441
=005  20141212220808.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052639
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x92
=072  \\$aB4.$x715.$x102
=150  \\$aCaulimoviridae
=450  \\$aCavemovirus
=450  \\$wnnna$aCavemoviruses
=450  \\$aPetuvirus
=450  \\$wnnna$aPetuviruses
=450  \\$aSoymovirus
=450  \\$wnnna$aSoymoviruses
=550  \\$wg$aDNA Viruses
=550  \\$wg$aPlant Viruses
=550  \\$wh$aBadnavirus
=550  \\$wh$aCaulimovirus
=550  \\$wh$aTungrovirus
=680  \\$iA family of DNA plant viruses with isometric or bacilliform virions and no envelope. The host ranges of most species are narrow. There are six genera: CAULIMOVIRUS; BADNAVIRUS; Cavemovirus; Soymovirus; Petuvirus; and TUNGROVIRUS.
=688  \\$a2007
=750  \0$aCaulimoviridae$0(DLC)sh2007002891$5IEN-M

=LDR  01132cz  a2200301n  4500
=001  9880364570702441
=005  20141212220808.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052638
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633
=150  \\$aParticulate Matter
=450  \\$wnnna$aAir Pollutants, Particulate
=450  \\$wnnna$aAirborne Particulate Matter
=450  \\$wnnna$aAmbient Particulate Matter
=450  \\$wnnna$aParticulate Air Pollutants
=450  \\$wnnna$aParticulate Matter, Airborne
=450  \\$wnnna$aParticulate Matter, Ambient
=450  \\$wnnna$aPollutants, Particulate Air
=550  \\$wg$aComplex Mixtures
=550  \\$wh$aCoal Ash
=550  \\$wh$aDust
=550  \\$wh$aSmog
=550  \\$wh$aSmoke
=550  \\$aParticle Size
=680  \\$iParticles of any solid substance, generally under 30 microns in size, often noted as PM30. There is special concern with PM1 which can get down to PULMONARY ALVEOLI and induce MACROPHAGE ACTIVATION and PHAGOCYTOSIS leading to FOREIGN BODY REACTION and LUNG DISEASES.
=688  \\$a2007
=750  \0$aParticles$0(DLC) sh 85098370$5IEN-M

=LDR  00930cz  a2200217n  4500
=001  9880364570802441
=005  20141212220808.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052636
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x100.$x57.$x500.$x274
=150  \\$aAllostasis
=450  \\$wnnna$aAllostases
=450  \\$aAllostatic Load
=450  \\$wnnna$aAllostatic Loads
=450  \\$wnnna$aLoad, Allostatic
=450  \\$wnnna$aLoads, Allostatic
=550  \\$wg$aAdaptation, Physiological
=680  \\$iBiological adaptation, such as the rise of EPINEPHRINE in response to exercise, stress or perceived danger, followed by a fall of epinephrine during RELAXATION. Allostasis is the achievement of stability by turning on and turning off the allostatic systems including the IMMUNE SYSTEM; the AUTONOMIC NERVOUS SYSTEM and NEUROENDOCRINE SYSTEMS.
=688  \\$a2007
=750  \0$aAllostasis$0(DLC)sh2003008301$5IEN-M

=LDR  00794cz  a2200205n  4500
=001  9880364570902441
=005  20141212220807.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052616
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x155.$x800
=150  \\$aSolid Phase Extraction
=450  \\$wnnna$aExtraction, Solid Phase
=450  \\$wnnna$aExtractions, Solid Phase
=450  \\$wnnna$aSolid Phase Extractions
=550  \\$wg$aChemical Fractionation
=550  \\$wh$aSolid Phase Microextraction
=680  \\$iAn extraction method that separates analytes using a solid phase and a liquid phase. It is used for preparative sample cleanup before analysis by CHROMATOGRAPHY and other analytical methods.
=688  \\$a2007
=750  \0$aSolid-phase analysis$0(DLC) sh 93001640$5IEN-M

=LDR  00811cz  a2200181n  4500
=001  9880364571002441
=005  20141212220806.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x327
=150  \\$aHymenaea
=450  \\$wnnna$aHymenaeas
=550  \\$wg$aFabaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain resins (RESINS, PLANT) and GLUCANS.
=688  \\$a2007
=750  \0$aHymenaea$0(DLC) sh 85063582$5IEN-M

=LDR  00867cz  a2200193n  4500
=001  9880364571102441
=005  20141212220806.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052586
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x252.$x748.$x300
=150  \\$aMating Preference, Animal
=450  \\$wnnna$aAnimal Mating Preference
=450  \\$wnnna$aAnimal Sexual Selection
=450  \\$wnnna$aSexual Selection, Animal
=550  \\$wg$aSexual Behavior, Animal
=680  \\$iThe selection or choice of sexual partner in animals. Often this reproductive preference is based on traits in the potential mate, such as coloration, size, or behavioral boldness. If the chosen ones are genetically different from the rejected ones, then NATURAL SELECTION is occurring.
=688  \\$a2007
=750  \0$aSexual selection in animals$0(DLC) sh 85120741$5IEN-M

=LDR  00790cz  a2200193n  4500
=001  9880364571202441
=005  20141212220805.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x11
=072  \\$aA18.$x450.$x249
=150  \\$aPhloem
=450  \\$wnnna$aPhloems
=550  \\$wg$aPlant Structures
=550  \\$wg$aPlant Vascular Bundle
=680  \\$iPlant tissue that carries nutrients, especially sucrose, by turgor pressure. Movement is bidirectional, in contrast to XYLEM where it is only upward. Phloem originates and grows outwards from meristematic cells (MERISTEM) in the vascular cambium. P-proteins, a type of LECTINS, are characteristically found in phloem.
=688  \\$a2007
=750  \0$aPhloem$0(DLC) sh 85101014$5IEN-M

=LDR  00723cz  a2200205n  4500
=001  9880364571302441
=005  20141212220805.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052584
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x450.$x500
=072  \\$aA18.$x700
=150  \\$aXylem
=450  \\$wnnna$aXylems
=550  \\$wg$aPlant Structures
=550  \\$wg$aPlant Vascular Bundle
=550  \\$wh$aWood
=680  \\$iPlant tissue that carries water up the root and stem. Xylem cell walls derive most of their strength from LIGNIN. The vessels are similar to PHLOEM sieve tubes but lack companion cells and do not have perforated sides and pores.
=688  \\$a2007
=750  \0$aXylem$0(DLC) sh 85148852$5IEN-M

=LDR  01055cz  a2200265n  4500
=001  9880364571402441
=005  20141212220805.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052583
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x887
=150  \\$aSarraceniaceae
=450  \\$wnnna$aDarlingtonia
=450  \\$wnnna$aDarlingtonias
=450  \\$aFlytrap
=450  \\$wnnna$aFlytraps
=450  \\$aPitcherplant
=450  \\$wnnna$aPitcherplants
=450  \\$aSarracenia
=450  \\$wnnna$aSarracenias
=550  \\$wg$aAngiosperms
=667  \\$aX ref FLYTRAP: VENUS FLYTRAP see DROSERACEAE is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Nepenthales.
=688  \\$a2007
=750  \0$aSarraceniaceae$0(DLC) sh 85117585$5IEN-M

=LDR  02015cz  a2200505n  4500
=001  9880364571502441
=005  20141212220804.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052580
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x483.$x750
=072  \\$aE2.$x831.$x387.$x750
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x249
=072  \\$aI3.$x350.$x249
=150  \\$aMuscle Stretching Exercises
=450  \\$wnnna$aActive Stretching
=450  \\$wnnna$aBallistic Stretching
=450  \\$wnnna$aDynamic Stretching
=450  \\$wnnna$aExercise, Muscle Stretching
=450  \\$wnnna$aExercises, Muscle Stretching
=450  \\$wnnna$aIsometric Stretching
=450  \\$wnnna$aMuscle Stretching Exercise
=450  \\$wnnna$aPassive Stretching
=450  \\$wnnna$aProprioceptive Neuromuscular Facilitation (PNF) Stretching
=450  \\$wnnna$aRelaxed Stretching
=450  \\$wnnna$aStatic-Active Stretching
=450  \\$wnnna$aStatic Active Stretching
=450  \\$wnnna$aStatic-Passive Stretching
=450  \\$wnnna$aStatic Passive Stretching
=450  \\$wnnna$aStatic Stretching
=450  \\$wnnna$aStretching, Active
=450  \\$wnnna$aStretching, Ballistic
=450  \\$wnnna$aStretching, Dynamic
=450  \\$wnnna$aStretching, Isometric
=450  \\$wnnna$aStretching, Passive
=450  \\$wnnna$aStretching, Relaxed
=450  \\$wnnna$aStretching, Static
=450  \\$wnnna$aStretching, Static-Active
=450  \\$wnnna$aStretching, Static-Passive
=550  \\$wg$aExercise
=550  \\$wg$aExercise Therapy
=550  \\$aYoga
=680  \\$iExercises that stretch the muscle fibers with the aim to increase muscle-tendon FLEXIBILITY, improve RANGE OF MOTION or musculoskeletal function, and prevent injuries. There are various types of stretching techniques including active, passive (relaxed), static, dynamic (gentle), ballistic (forced), isometric, and others.
=688  \\$a2007
=750  \0$aStretching exercises$0(DLC) sh 88003016$5IEN-M

=LDR  01611cz  a2200481n  4500
=001  9880364571602441
=005  20141212220803.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052576
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x357.$x500
=150  \\$aMenstrual Hygiene Products
=450  \\$wnnna$aFeminine Napkin
=450  \\$wnnna$aFeminine Napkins
=450  \\$wnnna$aHygiene Product, Menstrual
=450  \\$wnnna$aHygiene Products, Menstrual
=450  \\$wnnna$aMenstrual Hygiene Product
=450  \\$wnnna$aMenstrual Napkin
=450  \\$wnnna$aMenstrual Napkins
=450  \\$wnnna$aMenstrual Pad
=450  \\$wnnna$aMenstrual Pads
=450  \\$wnnna$aMenstrual Product
=450  \\$wnnna$aMenstrual Products
=450  \\$wnnna$aMenstrual Tampon
=450  \\$wnnna$aMenstrual Tampons
=450  \\$wnnna$aNapkin, Feminine
=450  \\$wnnna$aNapkin, Menstrual
=450  \\$wnnna$aNapkins, Feminine
=450  \\$wnnna$aNapkins, Menstrual
=450  \\$wnnna$aPad, Menstrual
=450  \\$wnnna$aPads, Menstrual
=450  \\$wnnna$aTampon, Menstrual
=450  \\$wnnna$aTampon, Vaginal
=450  \\$wnno$aTampons$5IEN-M
=450  \\$aTampons, Menstrual
=450  \\$wnnna$aTampons, Vaginal
=450  \\$wnnna$aVaginal Tampon
=450  \\$wnnna$aVaginal Tampons
=550  \\$wg$aFeminine Hygiene Products
=667  \\$anote entry term VAGINAL TAMPON: TAMPONS, SURGICAL is also available
=680  \\$iPersonal care items used during MENSTRUATION.
=688  \\$a2007; for VAGINAL TAMPON use TAMPONS 1978-2006
=750  \0$aTampons$0(DLC) sh 85132223$5IEN-M

=LDR  00913cz  a2200277n  4500
=001  9880364571702441
=005  20141212220755.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052439
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584
=150  \\$aLipid Metabolism Disorders
=450  \\$wnnna$aLipid Metabolism Disorder
=450  \\$wnnna$aMetabolism Disorder, Lipid
=450  \\$wnnna$aMetabolism Disorders, Lipid
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aDyslipidemias
=550  \\$wh$aLipid Metabolism, Inborn Errors
=550  \\$wh$aLipidoses
=550  \\$wh$aLipodystrophy
=550  \\$wh$aLipomatosis
=550  \\$wh$aXanthomatosis
=667  \\$ageneral; prefer specifics
=680  \\$iPathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.
=688  \\$a2007
=750  \0$aLipids$xMetabolism$xDisorders$0(DLC) sh 85077298$5IEN

=LDR  00670cz  a2200181n  4500
=001  9880364571802441
=005  20141212220752.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x655
=150  \\$aOvoviviparity
=450  \\$wnnna$aOvoviviparous
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$aClutch Size
=680  \\$iThe capability of producing yolk-filled eggs that hatch within the body, so that the young are born alive, but without placental attachment. This applies to certain species of REPTILES and FISHES.
=688  \\$a2006
=750  \0$aOvoviviparity$0(DLC) sh 85096285$5IEN-M

=LDR  01232cz  a2200349n  4500
=001  9880364571902441
=005  20180626122615.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052256
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x869
=072  \\$aC26.$x874.$x800
=150  \\$aTendinopathy
=450  \\$wnnna$aTendinitides
=450  \\$aTendinitis
=450  \\$wnnna$aTendinopathies
=450  \\$wnnna$aTendinoses
=450  \\$aTendinosis
=450  \\$wnnna$aTendonitides
=450  \\$wnnna$aTendonitis
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aTendon Injuries
=550  \\$wh$aElbow Tendinopathy
=550  \\$wh$aEnthesopathy
=550  \\$wh$aGiant Cell Tumor of Tendon Sheath
=550  \\$wh$aEnthesopathy
=550  \\$wh$aGiant Cell Tumor of Tendon Sheath
=550  \\$wh$aTendon Entrapment
=550  \\$wh$aTenosynovitis
=680  \\$iClinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance. Distinguishing tendinosis from tendinitis is clinically difficult and can be made only after histopathological examination.
=688  \\$a2006
=750  \0$aTendinitis$0(DLC) sh 85133838$5IEN-M

=LDR  01130cz  a2200313n  4500
=001  9880364572002441
=005  20141212220749.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052246
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x310.$x500
=072  \\$aD27.$x505.$x696.$x663.$x850.$x14.$x40.$x500.$x500.$x500
=072  \\$aD27.$x505.$x954.$x158.$x30.$x500.$x500
=072  \\$aD27.$x505.$x954.$x329.$x30.$x500.$x500
=150  \\$aCyclooxygenase 2 Inhibitors
=450  \\$wnnna$aCOX-2 Inhibitors
=450  \\$wnnna$aCOX 2 Inhibitors
=450  \\$wnnna$aCOX2 Inhibitors
=450  \\$wnnna$aCoxibs
=450  \\$aCyclooxygenase 2$xantagonists & inhibitors
=450  \\$wnnna$aCyclooxygenase-2 Inhibitors
=450  \\$wnnna$aInhibitors, COX-2
=450  \\$wnnna$aInhibitors, COX2
=450  \\$wnnna$aInhibitors, Cyclooxygenase 2
=450  \\$wnnna$aInhibitors, Cyclooxygenase-2
=550  \\$wg$aCyclooxygenase Inhibitors
=680  \\$iA subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2.
=688  \\$a2006
=750  \0$aCyclooxygenase 2$xInhibitors$0(IEN)7622225

=LDR  03026cz  a2200685n  4500
=001  9880364572102441
=005  20141212220748.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052245
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x341.$x186.$x500.$x500
=072  \\$aC9.$x218.$x458.$x341.$x887.$x886
=072  \\$aC10.$x597.$x751.$x418.$x341.$x186.$x500.$x500
=072  \\$aC10.$x597.$x751.$x418.$x341.$x887.$x886
=072  \\$aC10.$x597.$x751.$x941.$x162.$x625.$x500
=072  \\$aC11.$x768.$x585.$x658.$x500.$x813
=072  \\$aC11.$x966.$x75.$x375.$x500
=072  \\$aC16.$x131.$x77.$x299.$x500
=072  \\$aC16.$x320.$x290.$x684.$x500
=072  \\$aC23.$x888.$x592.$x763.$x393.$x341.$x887.$x886
=150  \\$aUsher Syndromes
=450  \\$wnnna$aDeafness-Retinitis Pigmentosa Syndrome
=450  \\$wnnna$aDeafness Retinitis Pigmentosa Syndrome
=450  \\$wnnna$aDeafness-Retinitis Pigmentosa Syndromes
=450  \\$wnnna$aDystrophia Retinae Pigmentosa-Dysostosis Syndrome
=450  \\$wnnna$aDystrophia Retinae Pigmentosa Dysostosis Syndrome
=450  \\$wnnna$aGraefe-Usher Syndrome
=450  \\$wnnna$aGraefe Usher Syndrome
=450  \\$wnnna$aHallgren Syndrome
=450  \\$wnnna$aPigmentosa Syndromes, Deafness-Retinitis
=450  \\$wnnna$aRetinitis Pigmentosa And Congenital Deafness
=450  \\$wnnna$aRetinitis Pigmentosa-Deafness Syndrome
=450  \\$wnnna$aRetinitis Pigmentosa Deafness Syndrome
=450  \\$wnnna$aRetinitis Pigmentosa-Deafness Syndromes
=450  \\$wnnna$aSyndrome, Deafness-Retinitis Pigmentosa
=450  \\$wnnna$aSyndrome, Graefe-Usher
=450  \\$wnnna$aSyndrome, Hallgren
=450  \\$wnnna$aSyndrome, Retinitis Pigmentosa-Deafness
=450  \\$wnnna$aSyndrome, Usher
=450  \\$wnnna$aSyndrome, Usher's
=450  \\$wnnna$aSyndromes, Deafness-Retinitis Pigmentosa
=450  \\$wnnna$aSyndromes, Retinitis Pigmentosa-Deafness
=450  \\$wnnna$aSyndromes, Usher
=450  \\$wnnna$aUsher Syndrome
=450  \\$wnnna$aUsher Syndrome, Type 1
=450  \\$wnnna$aUsher Syndrome, Type 1A
=450  \\$wnnna$aUsher Syndrome, Type 3
=450  \\$wnnna$aUsher Syndrome, Type I
=450  \\$wnnna$aUsher Syndrome, Type I, French Variety
=450  \\$wnnna$aUsher Syndrome, Type II
=450  \\$wnnna$aUsher Syndrome, Type IId
=450  \\$wnnna$aUsher Syndrome, Type III
=450  \\$wnnna$aUsher's Syndrome
=450  \\$wnnna$aUshers Syndrome
=550  \\$wg$aDeaf-Blind Disorders
=550  \\$wg$aHearing Loss, Sensorineural
=550  \\$wg$aRetinitis Pigmentosa
=680  \\$iAutosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.
=688  \\$a2006
=750  \0$aUsher's syndrome$0(DLC) sh 85141557$5IEN-M

=LDR  01582cz  a2200313n  4500
=001  9880364572202441
=005  20141212220747.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052244
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x353
=072  \\$aD27.$x888.$x141
=150  \\$aEndocrine Disruptors
=450  \\$wnnna$aChemicals, Endocrine Disrupting
=450  \\$wnnna$aDisruptor Effect, Endocrine
=450  \\$wnnna$aDisruptor Effects, Endocrine
=450  \\$wnnna$aDisruptors, Endocrine
=450  \\$wnnna$aEffect, Endocrine Disruptor
=450  \\$wnnna$aEffects, Endocrine Disruptor
=450  \\$aEndocrine Disrupting Chemicals
=450  \\$wnnna$aEndocrine Disruptor Effect
=450  \\$wnnna$aEndocrine Disruptor Effects
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wg$aToxic Actions
=550  \\$aHormones, Hormone Substitutes, and Hormone Antagonists
=667  \\$anote entry term ENDOCRINE DISRUPTOR EFFECT: use only for the endocrine disruptor effect of a chemical substance
=680  \\$iExogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism.
=688  \\$a2006
=750  \0$aEndocrine disrupting chemicals$0(DLC)sh2008020233$5IEN-M

=LDR  00983cz  a2200205n  4500
=001  9880364572302441
=005  20141212220744.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052216
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x469.$x500.$x500
=150  \\$aGlucagon-Like Peptide 1
=450  \\$wnnna$aGLP-1
=450  \\$wnnna$aGLP 1
=450  \\$wnnna$aGlucagon-Like Peptide-1
=450  \\$wnnna$aGlucagon Like Peptide 1
=550  \\$wg$aGlucagon-Like Peptides
=680  \\$iA peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.
=688  \\$a2006
=750  \0$aGlucagon-like peptide 1$0(DLC) sh 97000516$5IEN-M

=LDR  01185cz  a2200349n  4500
=001  9880364572402441
=005  20141212220744.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052203
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x490.$x100.$x375
=072  \\$aD1.$x490.$x200.$x350
=072  \\$aD1.$x578.$x285
=150  \\$aFerrosoferric Oxide
=450  \\$wnnna$aAMAG Pharmaceuticals Brand of Ferumoxytol
=450  \\$wnnna$aFeraheme
=450  \\$wnnna$aFerriferrous Oxide
=450  \\$aFerumoxytol
=450  \\$wnnna$aMagnetite
=450  \\$wnnna$aOxide, Ferriferrous
=450  \\$wnnna$aOxide, Ferrosoferric
=550  \\$wg$aFerric Compounds
=550  \\$wg$aFerrous Compounds
=550  \\$wg$aMinerals
=550  \\$wh$aMagnetite Nanoparticles
=550  \\$aMagnetosomes
=550  \\$aMetal Nanoparticles
=680  \\$iIron (II,III) oxide (Fe3O4). It is a black ore of IRON that forms opaque crystals and exerts strong magnetism.
=688  \\$a2006 (1981)
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Ferumoxytol
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Ferrosoferric Oxide
=750  \0$aMagnetite$0(DLC) sh 85079771$5IEN-M

=LDR  00575cz  a2200169n  4500
=001  9880364572502441
=005  20141212220743.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052199
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x475.$x506
=072  \\$aB3.$x510.$x550.$x450.$x475.$x506
=150  \\$aLactobacillus leichmannii
=550  \\$wg$aLactobacillus
=680  \\$iA species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.
=688  \\$a2006
=750  \0$aLactobacillus leichmannii$0(DLC) sh 88023274$5IEN-M

=LDR  01409cz  a2200397n  4500
=001  9880364572602441
=005  20141212220739.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052177
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x403
=072  \\$aC13.$x351.$x968.$x419.$x403
=150  \\$aKidney Diseases, Cystic
=450  \\$wnnna$aCystic Kidney
=450  \\$wnnna$aCystic Kidney Disease
=450  \\$wnnna$aCystic Kidney Diseases
=450  \\$wnnna$aCystic Kidneys
=450  \\$wnnna$aCystic Renal Disease
=450  \\$wnnna$aCystic Renal Diseases
=450  \\$wnnna$aDisease, Cystic Kidney
=450  \\$wnnna$aDisease, Cystic Renal
=450  \\$wnnna$aDiseases, Cystic Kidney
=450  \\$wnnna$aDiseases, Cystic Renal
=450  \\$wnnna$aKidney, Cystic
=450  \\$wnnna$aKidney Disease, Cystic
=450  \\$wnnna$aKidneys, Cystic
=450  \\$wnnna$aRenal Disease, Cystic
=450  \\$wnnna$aRenal Diseases, Cystic
=550  \\$wg$aKidney Diseases
=550  \\$wh$aMedullary Sponge Kidney
=550  \\$wh$aMulticystic Dysplastic Kidney
=550  \\$wh$aPolycystic Kidney Diseases
=667  \\$anote specifics
=680  \\$iA heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally (KIDNEY, CYSTIC).
=688  \\$a2006
=750  \0$aKidney, Cystic$0(DLC) sh 85072247$5IEN-M

=LDR  00994cz  a2200277n  4500
=001  9880364572702441
=005  20141212220735.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052138
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375
=150  \\$aGenes, Neoplasm
=450  \\$wnnna$aCancer Gene
=450  \\$aCancer Genes
=450  \\$wnnna$aGene, Cancer
=450  \\$wnnna$aGene, Neoplasm
=450  \\$wnnna$aGenes, Cancer
=450  \\$wnnna$aNeoplasm Gene
=450  \\$wnnna$aNeoplasm Genes
=550  \\$wg$aGenes
=550  \\$wh$aGenes, Tumor Suppressor
=550  \\$wh$aOncogenes
=667  \\$ageneral; prefer specifics; coordinate with specific neoplasm terms /genet; do not confuse with ONCOGENES
=680  \\$iGenes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS.
=688  \\$a2006; for CANCER GENES use ONCOGENES 1985-2005
=750  \0$aCancer genes$0(DLC)sh2006006635$5IEN-M

=LDR  00906cz  a2200253n  4500
=001  9880364572802441
=005  20141212220733.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052097
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x850
=150  \\$aQuadriceps Muscle
=450  \\$wnnna$aMuscle, Quadriceps
=450  \\$wnnna$aMuscles, Quadriceps
=450  \\$wnnna$aQuadriceps Femoris
=450  \\$wnnna$aQuadriceps Muscles
=450  \\$wnnna$aRectus Femoris
=450  \\$wnnna$aVastus Intermedius
=450  \\$wnnna$aVastus Lateralis
=450  \\$wnnna$aVastus Medialis
=550  \\$wg$aMuscle, Skeletal
=680  \\$iThe quadriceps femoris. A collective name of the four-headed skeletal muscle of the thigh, comprised of the rectus femoris, vastus intermedius, vastus lateralis, and vastus medialis.
=688  \\$a2006
=750  \0$aQuadriceps muscle$0(DLC)sh2003011478$5IEN-M

=LDR  00722cz  a2200205n  4500
=001  9880364572902441
=005  20141212220732.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052078
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x275
=150  \\$aConus Snail
=450  \\$wnnna$aConus
=450  \\$wnnna$aConus Snails
=450  \\$wnnna$aSnail, Conus
=450  \\$wnnna$aSnails, Conus
=550  \\$wg$aGastropoda
=680  \\$iA genus of cone-shaped marine snails in the family Conidae, class GASTROPODA. It comprises more than 600 species, many containing unique venoms (CONUS VENOMS) with which they immobilize their prey.
=688  \\$a2006
=750  \0$aConus$0(DLC) sh 85031671$5IEN-M

=LDR  00750cz  a2200205n  4500
=001  9880364573002441
=005  20141212220730.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x665.$x656
=072  \\$aC13.$x351.$x500.$x894.$x870
=072  \\$aF3.$x800.$x800.$x900
=150  \\$aVaginismus
=550  \\$wg$aSexual Dysfunction, Physiological
=550  \\$wg$aSexual Dysfunctions, Psychological
=550  \\$wg$aVaginal Diseases
=680  \\$iRecurrent or persistent involuntary SPASM of the outer muscles of the VAGINA, occurring during vaginal penetration.
=688  \\$a2006; use SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005
=750  \0$aVaginismus$0(DLC) sh 85141761$5IEN-M

=LDR  01259cz  a2200277n  4500
=001  9880364573102441
=005  20190419105431.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052004
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x109
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x49
=150  \\$aBone Morphogenetic Protein Receptors
=450  \\$wnnna$aBMP Receptor
=450  \\$wnnna$aBMP Receptors
=450  \\$wnnna$aReceptor, BMP
=450  \\$wnnna$aReceptors, BMP
=550  \\$wg$aProtein-Serine-Threonine Kinases
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aBone Morphogenetic Protein Receptors, Type I
=550  \\$wh$aBone Morphogenetic Protein Receptors, Type II
=680  \\$iA family of CELL SURFACE RECEPTORS that bind BONE MORPHOGENETIC PROTEINS. They are PROTEIN-SERINE-THREONINE KINASES that mediate SIGNAL TRANSDUCTION PATHWAYS through SMAD PROTEINS.
=688  \\$a2006(1994)
=750  \0$81$wb$iBroader mapping$aBone morphogenetic proteins$0(DLC)sh 96003251$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC) sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aBone morphogenetic proteins--Receptors$5IEN-M

=LDR  01031cz  a2200253n  4500
=001  9880364573202441
=005  20181206095104.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051880
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x725
=072  \\$aD12.$x776.$x930.$x770
=150  \\$aReceptors, Notch
=450  \\$wnnna$aNotch Proteins
=450  \\$aNotch Receptors
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aTranscription Factors
=550  \\$wh$aReceptor, Notch1
=550  \\$wh$aReceptor, Notch2
=550  \\$wh$aReceptor, Notch3
=550  \\$wh$aReceptor, Notch4
=680  \\$iA family of conserved cell surface receptors that contain EPIDERMAL GROWTH FACTOR repeats in their extracellular domain and ANKYRIN repeats in their cytoplasmic domains. The cytoplasmic domain of notch receptors is released upon ligand binding and translocates to the CELL NUCLEUS where it acts as transcription factor.
=688  \\$a2006(1990)
=750  \0$aNotch proteins$0(DLC) sh 94005822$5IEN-M

=LDR  00679cz  a2200193n  4500
=001  9880364573302441
=005  20141212220705.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x641.$x860.$x500
=150  \\$aalpha-Synuclein
=450  \\$wnnna$aalpha Synuclein
=450  \\$wnnna$aNon-AB Component of AD Amyloid Protein
=450  \\$wnnna$aNon AB Component of AD Amyloid Protein
=550  \\$wg$aSynucleins
=680  \\$iA synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.
=688  \\$a2006(1988)
=750  \0$aAlpha-synuclein$0(DLC)sh2013001905$5IEN-M

=LDR  00767cz  a2200205n  4500
=001  9880364573402441
=005  20141212220705.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x641.$x860
=150  \\$aSynucleins
=450  \\$wnnna$aSynuclein
=550  \\$wg$aNerve Tissue Proteins
=550  \\$wh$aalpha-Synuclein
=550  \\$wh$abeta-Synuclein
=550  \\$wh$agamma-Synuclein
=680  \\$iA family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.
=688  \\$a2006(1988)
=750  \0$aSynucleins$0(DLC)sh2013001906$5IEN-M

=LDR  00826cz  a2200217n  4500
=001  9880364573502441
=005  20141212220654.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x260.$x536
=072  \\$aD12.$x776.$x660.$x235.$x550
=072  \\$aD12.$x776.$x664.$x235.$x700
=150  \\$aMethyl-CpG-Binding Protein 2
=450  \\$wnnna$aMeCP2 Protein
=450  \\$wnnna$aMethyl CpG Binding Protein 2
=550  \\$wg$aChromosomal Proteins, Non-Histone
=550  \\$wg$aDNA-Binding Proteins
=680  \\$iA DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.
=688  \\$a2006(1992)
=750  \0$aMethyl-CpG-binding protein 2$0(DLC)sh2013002599$5IEN-M

=LDR  00545cz  a2200181n  4500
=001  9880364573602441
=005  20141212220631.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051639
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x378
=072  \\$aJ1.$x40.$x413
=150  \\$aGardening
=550  \\$wg$aAgriculture
=550  \\$wg$aRecreation
=680  \\$iCultivation of PLANTS; (FRUIT; VEGETABLES; MEDICINAL HERBS) on small plots of ground or in containers.
=688  \\$a2006
=750  \0$aGardening$0(DLC) sh 85053089$5IEN-M

=LDR  01163cz  a2200313n  4500
=001  9880364573702441
=005  20141212220626.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051598
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x925
=072  \\$aE5.$x979
=150  \\$aWhole Body Imaging
=450  \\$wnnna$aImaging, Whole Body
=450  \\$wnnna$aImagings, Whole Body
=450  \\$wnnna$aScan, Whole Body
=450  \\$wnnna$aScans, Whole Body
=450  \\$wnnna$aScreening, Whole Body
=450  \\$wnnna$aScreenings, Whole Body
=450  \\$wnnna$aWhole Body Imagings
=450  \\$wnnna$aWhole Body Scan
=450  \\$aWhole Body Scanning
=450  \\$wnnna$aWhole Body Screening
=450  \\$wnnna$aWhole Body Screenings
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aInvestigative Techniques
=680  \\$iThe creation of a visual display of the inside of the entire body of a human or animal for the purposes of diagnostic evaluation. This is most commonly achieved by using MAGNETIC RESONANCE IMAGING; or POSITRON EMISSION TOMOGRAPHY.
=688  \\$a2006
=750  \0$aWhole body imaging$0(DLC)sh2007003457$5IEN-M

=LDR  01095cz  a2200289n  4500
=001  9880364573802441
=005  20141212220614.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051546
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x600.$x720.$x750
=150  \\$aCyclooxygenase 2
=450  \\$wnnna$aCOX-2 Prostaglandin Synthase
=450  \\$wnnna$aCOX 2 Prostaglandin Synthase
=450  \\$wnnna$aCyclo-Oxygenase II
=450  \\$wnnna$aCyclo Oxygenase II
=450  \\$wnnna$aCyclooxygenase-2
=450  \\$wnnna$aPGHS-2
=450  \\$wnnna$aProstaglandin H Synthase-2
=450  \\$wnnna$aProstaglandin H Synthase 2
=450  \\$wnnna$aProstaglandin Synthase, COX-2
=450  \\$wnnna$aPTGS2
=450  \\$wnnna$aSynthase, COX-2 Prostaglandin
=550  \\$wg$aProstaglandin-Endoperoxide Synthases
=680  \\$iAn inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS.
=688  \\$a2006(1996)
=750  \0$aCyclooxygenase 2$0(DLC) sh 00000065$5IEN-M

=LDR  00525cz  a2200169n  4500
=001  9880364573902441
=005  20141212220609.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051520
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x189
=150  \\$aAntiperspirants
=450  \\$wnnna$aAntiperspirant
=550  \\$wg$aCosmetics
=680  \\$iAgents that are put on the SKIN to reduce SWEATING or prevent excess sweating (HYPERHIDROSIS).
=688  \\$a2006
=750  \0$aAntiperspirants$0(DLC) sh 88002616$5IEN-M

=LDR  01225cz  a2200265n  4500
=001  9880364574002441
=005  20141212220608.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051517
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x600.$x500
=150  \\$aDigital Rectal Examination
=450  \\$wnnna$aDigital Rectal Examinations
=450  \\$wnnna$aExamination, Digital Rectal
=450  \\$wnnna$aExaminations, Digital Rectal
=450  \\$wnnna$aPalpation, Rectal
=450  \\$wnnna$aPalpations, Rectal
=450  \\$wnnna$aRectal Examination, Digital
=450  \\$wnnna$aRectal Examinations, Digital
=450  \\$wnnna$aRectal Palpation
=450  \\$wnnna$aRectal Palpations
=550  \\$wg$aPalpation
=680  \\$iA physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area to palpate for abnormalities in the lower rectum, and nearby organs or tissues. The method is commonly used to check the lower rectum, the PROSTATE gland in men, and the UTERUS and OVARIES in women.
=688  \\$a2006
=750  \0$aRectum$xExamination$0(DLC) sh 87003083$5IEN-M

=LDR  00786cz  a2200205n  4500
=001  9880364574102441
=005  20141212220605.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051479
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x649
=150  \\$aPlant Infertility
=450  \\$aInfertility, Plant
=450  \\$wnnna$aReproductive Sterility in Plants
=450  \\$wnnna$aReproductive Sterility, Plants
=450  \\$wnnna$aSterility, Reproductive, Plants
=550  \\$wg$aPlant Physiological Phenomena
=680  \\$iThe failure of PLANTS to complete fertilization and obtain seed (SEEDS) as a result of defective POLLEN or ovules, or other aberrations. (Dict. of Plant Genet. and Mol. Biol., 1998)
=688  \\$a2006
=750  \0$aSterility in plants$0(DLC) sh 85128025$5IEN-M

=LDR  00664cz  a2200169n  4500
=001  9880364574202441
=005  20141212220604.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051456
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x330.$x159
=150  \\$aGene Flow
=450  \\$wnnna$aFlow, Gene
=550  \\$wg$aGene Frequency
=680  \\$iThe change in gene frequency in a population due to migration of gametes or individuals (ANIMAL MIGRATION) across population barriers. In contrast, in GENETIC DRIFT the cause of gene frequency changes are not a result of population or gamete movement.
=688  \\$a2006
=750  \0$aGene flow$0(DLC)sh2014000857$5IEN-M

=LDR  01055cz  a2200277n  4500
=001  9880364574302441
=005  20141212220601.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D051416
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x49
=072  \\$aD12.$x644.$x360.$x287
=072  \\$aD12.$x776.$x476.$x287
=150  \\$aFocal Adhesion Protein-Tyrosine Kinases
=450  \\$wnnna$aFocal Adhesion Kinase
=450  \\$wnnna$aFocal Adhesion Protein-Tyrosine Kinase
=450  \\$aFocal Adhesion Protein-Tyrosine Kinase Family
=450  \\$wnnna$aFocal Adhesion Protein Tyrosine Kinase Family
=450  \\$wnnna$aFocal Adhesion Protein Tyrosine Kinases
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aProtein-Tyrosine Kinases
=550  \\$wh$aFocal Adhesion Kinase 1
=550  \\$wh$aFocal Adhesion Kinase 2
=680  \\$iA family of non-receptor, PROLINE-rich protein-tyrosine kinases.
=688  \\$a2006(1999)
=750  \0$aFocal adhesion kinase$0(DLC)sh2002000232$5IEN-M

=LDR  00681nz  a2200193n  4500
=001  9880443950102441
=005  20160412131250.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069537
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x421.$x143.$x65
=150  \\$aAdult Day Care Centers
=450  \\$wnnna$aAdult Day Care Center
=450  \\$wnnna$aDay Care Center, Adult
=450  \\$wnnna$aDay Care Centers, Adult
=550  \\$aSenior Centers
=680  \\$iNon-residential facilities that are designed to provide care and companionship for seniors who need assistance or supervision during the day.
=688  \\$a2016
=750  \2$aAdult day care centers$0(DLC)sh 85035959$5IEN-M

=LDR  00528nz  a2200157n  4500
=001  9880444390602441
=005  20160422093510.0
=008  160421\aeazcnnaabn||||||||||\a|ana||||\d
=016  7\$a0200771$2DNLM
=035  \\$a(DNLM)0200771
=040  \\$aDNLM$beng$erda$dDNLM$dDNLM$dIEN-M
=046  \\$q1893
=111  2\$aInternational Dental Congress$n(2nd :$d1893 :$nChicago, Ill.)
=370  \\$eChicago (Ill.)
=411  2\$aWorld's Columbian Dental Congress$d(1893 :$nChicago, Ill.)
=670  \\$aTransactions of the World's Columbian Dental Congress, 1893

=LDR  00686nz  a2200205n  4500
=001  9880444415902441
=005  20171219133843.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067796
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x700.$x750
=072  \\$aG7.$x203.$x300.$x350.$x525.$x760
=072  \\$aJ2.$x200.$x700.$x750
=072  \\$aJ2.$x500.$x350.$x525.$x760
=150  \\$aWhey
=550  \\$wg$aMilk
=550  \\$wh$aWhey Proteins
=680  \\$iThe liquid components of milk that remain after the CASEIN, fat, and fat soluble components have been removed. It is also a byproduct of cheese production.
=688  \\$a2016
=750  \0$aWhey$0(DLC)sh 85146422$5IEN-M

=LDR  00776cz  a2200229n  4500
=001  9880445235102441
=005  20160429150952.0
=008  970620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019959
=040  \\$aDNLM$cDNLM
=060  \0$aWM 175
=072  \\$aF3.$x400.$x500
=150  \\$aFeeding and Eating Disorders of Childhood
=450  \\$aChildhood Eating and Feeding Disorders
=450  \\$aRumination Disorders
=450  \\$wnnna$aDisorder, Rumination
=450  \\$wnnna$aDisorders, Rumination
=450  \\$wnnna$aRumination Disorder
=550  \\$wg$aFeeding and Eating Disorders
=680  \\$iMental disorders related to feeding and eating usually diagnosed in infancy or early childhood.
=688  \\$a98
=750  \0$aEating disorders in children$0(DLC)sh 86004212$5IEN-M

=LDR  00853cz  a2200229n  4500
=001  9880445237602441
=005  20160429141125.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065811
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x903.$x74
=072  \\$aI1.$x880.$x735.$x900.$x575.$x500
=072  \\$aI1.$x880.$x735.$x950.$x500.$x903.$x74
=150  \\$aEthnic Cleansing
=450  \\$wnnna$aCleansing, Ethnic
=450  \\$wnnna$aCleansings, Ethnic
=450  \\$wnnna$aEthnic Cleansings
=550  \\$wg$aEthnic Violence
=550  \\$wg$aWar Crimes
=680  \\$iExpulsion of a population from a given territory due to religious or ethnic discrimination, political, strategic or ideological considerations, or a combination of these.
=688  \\$a2015; use under GENOCIDE 2014
=750  \0$aPopulation transfers$0(DLC)sh 85104929$5IEN-M

=LDR  00690cz  a2200229n  4500
=001  9880447813702441
=005  20160516161009.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D027902
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x40.$x22
=150  \\$aJusticia
=450  \\$wnnna$aAdhatoda vasica
=450  \\$aAdhatoda
=450  \\$aJusticia adhatoda
=450  \\$aMalabar-nut
=450  \\$wnnna$aMalabar nut
=450  \\$wnnna$aMalabar-nuts
=550  \\$wg$aAcanthaceae
=680  \\$iA plant genus in the family ACANTHACEAE. Adhatoda vasica Nees is a source of vasicine.
=688  \\$a2016 (2002)
=750  \0$aJusticia$0(DLC)sh 85071143$5IEN-M

=LDR  00765nz  a2200265n  4500
=001  9880449369302441
=005  20170609111628.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069497
=040  \\$aDNLM$cDNLM
=060  \0$aQH 325
=072  \\$aG16.$x650
=072  \\$aI1.$x76.$x368.$x584.$x542
=150  \\$aOrigin of Life
=450  \\$wnnna$aGenesis of Life
=450  \\$wnnna$aLife Geneses
=450  \\$wnnna$aLife Genesis
=450  \\$wnnna$aLife Origin
=450  \\$wnnna$aLife Origins
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aPaleontology
=550  \\$aOrganelle Biogenesis
=680  \\$iThe process by which life began.
=688  \\$a2016; use ORGANELLE BIOGENESIS 1979-2015
=750  \0$aLife$xOrigin$0(DLC)sh 85076809$5IEN-M

=LDR  00976cz  a2200289n  4500
=001  9880463864302441
=005  20240216145517.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D057285
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x574
=072  \\$aH2.$x403.$x200.$x700
=150  \\$aPrecision Medicine
=450  \\$wnnna$aPersonalized Medicine
=450  \\$wnnna$aPrecision-Medicine
=450  \\$aIndividualized Medicine
=450  \\$wnnna$aMedicine, Individualized
=450  \\$wnnna$aMedicine, Personalized
=450  \\$wnnna$aMedicine, Precision
=450  \\$wnnna$aMedicines, Precision
=550  \\$wg$aClinical Medicine
=550  \\$wg$aTherapeutics
=550  \\$aPharmacogenetics
=550  \\$aPatient-Specific Modeling
=680  \\$iClinical, therapeutic and diagnostic approaches to optimal disease management based on individual variations in a patient's genetic profile.
=688  \\$a2010
=750  \0$aPrecision medicine$0(DLC)sh2013003324$5IEN-M

=LDR  01731cz  a2200433n  4500
=001  9880463865202441
=005  20160729123757.0
=008  860530\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010818
=040  \\$aDNLM$cDNLM
=060  \0$aW 87
=072  \\$aN4.$x590.$x374.$x577
=072  \\$aN5.$x300.$x625
=150  \\$aPractice Patterns, Physicians'
=450  \\$wnnna$aClinical Practice Pattern
=450  \\$wnnna$aPattern, Clinical Practice
=450  \\$wnnna$aPatterns, Clinical Practice
=450  \\$wnnna$aPractice Pattern, Clinical
=450  \\$wnnna$aPractice Patterns, Clinical
=450  \\$wnnna$aPractice Patterns, Physician's
=450  \\$wnnna$aPrescribing Patterns, Physician
=450  \\$aClinical Practice Patterns
=450  \\$wnno$aPhysician's Practice Patterns
=450  \\$wnnna$aPhysician Practice Patterns
=450  \\$wnnna$aPhysician Prescribing Pattern
=450  \\$wnnna$aPhysician Prescribing Patterns
=450  \\$wnnna$aPhysician's Practice Pattern
=450  \\$wnnna$aPhysicians' Practice Pattern
=450  \\$wnnna$aPhysicians' Practice Patterns
=450  \\$wnnna$aPractice Pattern, Physician's
=450  \\$wnnna$aPractice Pattern, Physicians'
=450  \\$wnnna$aPractice Patterns, Physician
=450  \\$wnnna$aPrescribing Pattern, Physician
=550  \\$wg$aDelivery of Health Care
=550  \\$aInsurance, Health
=667  \\$ado not confuse with PROFESSIONAL PRACTICE where emphasis is on individual physicians & their practices
=680  \\$iPatterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.
=688  \\$a2016 (1987)
=750  \0$aPhysician practice patterns$0(DLC)sh 99001213$5IEN-M

=LDR  01281nz  a2200349n  4500
=001  9880466966502441
=005  20160815125605.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068856
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x374
=150  \\$aEugenia
=450  \\$wnnna$aBrazilian Cherry Tree
=450  \\$wnnna$aEuginia uniflora
=450  \\$wnnna$aPitanga
=450  \\$wnnna$aSurinam Cherry Tree
=450  \\$wnnna$aBrazilian Cherry Trees
=450  \\$wnnna$aCherry Tree, Brazilian
=450  \\$wnnna$aCherry Tree, Surinam
=450  \\$wnnna$aCherry Trees, Brazilian
=450  \\$wnnna$aCherry Trees, Surinam
=450  \\$wnnna$aEugenias
=450  \\$wnnna$aPitangas
=450  \\$wnnna$aSurinam Cherry Trees
=450  \\$wnnna$aTree, Brazilian Cherry
=450  \\$wnnna$aTree, Surinam Cherry
=450  \\$wnnna$aTrees, Brazilian Cherry
=450  \\$wnnna$aTrees, Surinam Cherry
=550  \\$wg$aMyrtaceae
=680  \\$iA genus in the family Myrtaceae sometimes known as "stoppers" in FOLK MEDICINE. Many species of the genus SYZYGIUM have synonymous names that begin with the Eugenia genus name.
=688  \\$a2016; see SYZYGIUM 2005-2015; see CLOVE 2002-2004
=750  \0$aEugenia$0(DLC)sh2011000737$5IEN-M

=LDR  00809cz  a2200229n  4500
=001  9880468203902441
=005  20160826164856.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D047850
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x563
=072  \\$aK1.$x400.$x504.$x875.$x374
=150  \\$aFrench Revolution
=450  \\$wnnna$aFrance Revolution, 1789-1799
=450  \\$wnnna$aFrance Revolution, 1789 1799
=450  \\$wnnna$aRevolution, 1789-1799 France
=450  \\$wnnna$aRevolution, French
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 19th Century
=680  \\$iConflict during which traditional monarchy was ended and modern government functions were instituted.
=688  \\$a2005
=751  \0$aFrance$xHistory$yRevolution, 1789-1799$0(DLC)sh 85051319$5IEN-M

=LDR  01001cz  a2200277n  4500
=001  9880468204202441
=005  20160826163229.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D047788
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x375
=072  \\$aK1.$x400.$x504.$x875.$x100
=150  \\$aAmerican Revolution
=450  \\$wnnna$aAmerican Revolution, 1775-1783
=450  \\$aAmerican War of Independence
=450  \\$aRevolutionary War
=450  \\$wnnna$aAmerican Revolution, 1775 1783
=450  \\$wnnna$aAmerican Revolutions
=450  \\$wnnna$aRevolution, American
=450  \\$wnnna$aRevolutions, American
=450  \\$wnnna$aWar, Revolutionary
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 18th Century
=680  \\$iArmed conflict that resulted in separation of American colonies from Britain and established the United States of America.
=688  \\$a2005
=751  \0$aUnited States$xHistory$yRevolution, 1775-1783$0(DLC)sh 85140139$5IEN-M

=LDR  01103cz  a2200301n  4500
=001  9880468204402441
=005  20160826163254.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D047831
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x188
=072  \\$aK1.$x400.$x504.$x937.$x100
=150  \\$aAmerican Civil War
=450  \\$wnnna$aU. S. Civil War, 1861-1865
=450  \\$wnnna$aWar of Secession
=450  \\$wnnna$aWar of the Rebellion
=450  \\$aWar Between the States
=450  \\$wnnna$aAmerican Civil Wars
=450  \\$wnnna$aCivil War, American
=450  \\$wnnna$aCivil Wars, American
=450  \\$wnnna$aU. S. Civil War, 1861 1865
=450  \\$wnnna$aWar, American Civil
=450  \\$wnnna$aWars, American Civil
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 19th Century
=680  \\$i1861-1865 conflict between the Union (Northern states) and the 11 Southern states that seceded and were organized as the Confederate States of America.
=688  \\$a2005
=751  \0$aUnited States$xHistory$yCivil War, 1861-1865$0(DLC)sh 85140205$5IEN-M

=LDR  01136nz  a2200361n  4500
=001  9880468205202441
=005  20160826160612.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068337
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250
=150  \\$aArmed Conflicts
=450  \\$wnnna$aArmed Conflict
=450  \\$wnnna$aConflict, Armed
=450  \\$wnnna$aConflicts, Armed
=550  \\$wg$aWarfare and Armed Conflicts
=550  \\$wh$aAfghan Campaign 2001-
=550  \\$wh$aAmerican Civil War
=550  \\$wh$aAmerican Revolution
=550  \\$wh$aCrimean War
=550  \\$wh$aFrench Revolution
=550  \\$wh$aGulf War
=550  \\$wh$aIraq War, 2003-2011
=550  \\$wh$aKorean War
=550  \\$wh$aRussian-Japanese War
=550  \\$wh$aSeptember 11 Terrorist Attacks
=550  \\$wh$aSpanish-American War, 1898
=550  \\$wh$aVietnam Conflict
=550  \\$wh$aWorld War I
=550  \\$wh$aWorld War II
=680  \\$iAny differences arising between two nations or groups and leading to the intervention of armed forces.
=688  \\$a2016
=750  \0$aWar$0(DLC)sh 85145114$5IEN-M

=LDR  00725cz  a2200229n  4500
=001  9880471062302441
=005  20160913124056.0
=008  130708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D064648
=040  \\$aDNLM$cDNLM
=060  \0$aWY 154
=072  \\$aH2.$x478.$x676.$x175
=072  \\$aN2.$x421.$x533.$x149
=150  \\$aCritical Care Nursing
=450  \\$wnnna$aIntensive Care Nursing
=450  \\$wnnna$aNursing, Critical Care
=450  \\$wnnna$aNursing, Intensive Care
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=680  \\$iA nursing specialty that deals specifically with the care of patients who are critically ill.
=688  \\$a2014
=750  \0$aIntensive care nursing$0(DLC)sh 85067185

=LDR  00545nz  a2200169n  4500
=001  9880472500802441
=005  20160928162705.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068798
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x389
=150  \\$aHoodia
=450  \\$wnnna$aHoodia gordonii
=550  \\$wg$aApocynaceae
=680  \\$iA genus in the dogbane family (Apocynaceae) used in TRADITIONAL MEDICINE for appetite-suppressant properties.
=688  \\$a2016
=750  \0$aHoodia$0(DLC)sh2001007922$5IEN-M

=LDR  00867nz  a2200181n  4500
=001  9880473584202441
=005  20161024094413.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067877
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x625.$x164.$x113
=150  \\$aAutism Spectrum Disorder
=450  \\$wnnna$aAutism Spectrum Disorders
=450  \\$wnnna$aSpectrum Disorders, Autism
=550  \\$wg$aChild Development Disorders, Pervasive
=680  \\$iWide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
=688  \\$a2016; use CHILD DEVELOPMENT DISORDERS, PERVASIVE 2010-2015
=750  \0$aAutism spectrum disorders$0(DLC)sh2008009581$5IEN-M

=LDR  00584nz  a2200181n  4500
=001  9880473585402441
=005  20161021161610.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066889
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x906
=150  \\$aTriticale
=450  \\$wnnna$aTriticosecale
=450  \\$wnnna$aTriticum x Secale
=550  \\$wg$aPoaceae
=680  \\$iA CEREAL GRAIN plant resulting from a cross between TRITICUM and SECALE CEREALE.
=688  \\$a2016; use EDIBLE GRAIN 1998-2015
=750  \0$aTriticale$0(DLC)sh 85137934$5IEN-M

=LDR  00753nz  a2200229n  4500
=001  9880473585902441
=005  20190528143302.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068997
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x847.$x698.$x300.$x250
=072  \\$aL1.$x224.$x230.$x260.$x550.$x500.$x500
=150  \\$aSmartphone
=450  \\$wnnna$aSmart Phone
=450  \\$wnnna$aSmart Phones
=450  \\$wnnna$aPhone, Smart
=450  \\$wnnna$aPhones, Smart
=450  \\$wnnna$aSmartphones
=550  \\$wg$aComputers, Handheld
=680  \\$iA cellular phone with advanced computing and connectivity capability built on an operating system.
=688  \\$a2016; use CELL PHONES 2015
=750  \0$aSmartphones$0(DLC)sh2007006251$5IEN-M

=LDR  00684nz  a2200241n  4500
=001  9880473620102441
=005  20161018112058.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069459
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x215.$x784.$x937
=072  \\$aG7.$x203.$x100.$x950
=072  \\$aJ2.$x200.$x950
=150  \\$aTeas, Herbal
=450  \\$wnnna$aTisanes
=450  \\$aHerbal Teas
=450  \\$wnnna$aHerbal Tea
=450  \\$wnnna$aTea, Herbal
=450  \\$wnnna$aTisane
=550  \\$wg$aBeverages
=680  \\$iBeverages prepared from an infusion of plant tissues.
=688  \\$a2016; use BEVERAGES 1986-2015
=750  \0$aHerbal teas$0(DLC)sh 85060334$5IEN-M

=LDR  01193nz  a2200313n  4500
=001  9880473622002441
=005  20161017164031.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067936
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x553
=072  \\$aJ1.$x728
=072  \\$aN6.$x230.$x350
=150  \\$aNatural Resources
=450  \\$wnnna$aLand Supply
=450  \\$wnnna$aLand Supplies
=450  \\$wnnna$aNatural Resource
=450  \\$wnnna$aResource, Natural
=450  \\$wnnna$aResources, Natural
=450  \\$wnnna$aSupplies, Land
=450  \\$wnnna$aSupply, Land
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wg$aEnvironment
=550  \\$wh$aWater Resources
=550  \\$aConservation of Natural Resources
=667  \\$acoordinate with  specific natural resource if pertinent
=680  \\$iMaterials or substances such as land, timber, fresh water, fossil fuels, or mineral deposits that occur in a natural state and have economic value or usefulness to humans.
=688  \\$a2016;  use CONSERVATION OF NATURAL RESOURCES 1991-2015; for LAND SUPPLY use AGRICULTURE 1978-2015
=750  \0$aNatural resources$0(DLC)sh 85090254$5IEN-M

=LDR  00955nz  a2200313n  4500
=001  9880473622402441
=005  20161017162826.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067565
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x390
=150  \\$aFarmers
=450  \\$wnnna$aAgricultural Workers
=450  \\$wnnna$aFarm Workers
=450  \\$wnnna$aFarmworkers
=450  \\$wnnna$aRanchers
=450  \\$wnnna$aAgricultural Worker
=450  \\$wnnna$aFarm Worker
=450  \\$wnnna$aFarmer
=450  \\$wnnna$aFarmworker
=450  \\$wnnna$aRancher
=450  \\$wnnna$aWorker, Agricultural
=450  \\$wnnna$aWorker, Farm
=450  \\$wnnna$aWorkers, Agricultural
=450  \\$wnnna$aWorkers, Farm
=550  \\$wg$aOccupational Groups
=680  \\$iPersons who cultivate land or crops, or raise LIVESTOCK.
=688  \\$a2016; for AGRICULTURAL WORKERS use AGRICULTURE 1981-2015
=750  \2$aFarmers$0(DLC)sh 85047270$5IEN-M

=LDR  00795nz  a2200217n  4500
=001  9880478663802441
=005  20161109161126.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068216
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x409.$x418.$x500
=072  \\$aN3.$x540.$x400.$x500
=150  \\$aChild Protective Services
=450  \\$wnnna$aChild Welfare Agencies
=450  \\$wnnna$aChild Protective Service
=450  \\$wnnna$aChild Welfare Agency
=450  \\$wnnna$aWelfare Agency, Child
=550  \\$wg$aGovernment Agencies
=680  \\$iLocal governmental offices which investigate reports of abuse and neglect of children, and act to assure a safe environment for minors.
=688  \\$a2016 (2010); use CHILD WELFARE 2010-2015
=750  \0$aChild welfare$0(DLC)sh 85023396$5IEN-M

=LDR  00752nz  a2200241n  4500
=001  9880478663902441
=005  20161110093254.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067576
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x400.$x225
=150  \\$aChild Health
=450  \\$wnnna$aChildren's Health
=450  \\$wnnna$aChildrens Health
=450  \\$wnnna$aHealth, Child
=450  \\$wnnna$aHealth, Children's
=450  \\$wnnna$aHealth, Childrens
=550  \\$wg$aHealth
=550  \\$aChild Health Services
=550  \\$aChild Welfare
=680  \\$iThe concept covering the physical and mental conditions of CHILDREN.
=688  \\$a2016; use CHILD WELFARE 1978-2015
=750  \0$aChildren$xHealth and hygiene$0(DLC)sh 85023425$5IEN-M

=LDR  00849nz  a2200193n  4500
=001  9880479466002441
=005  20161110134122.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066308
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x805
=150  \\$aPublic Service Announcements as Topic
=450  \\$wnnna$aPublic Service Ads as Topic
=450  \\$wnnna$aPublic Service Advertising as Topic
=550  \\$wg$aCommunication
=667  \\$ado not confuse with the Publication Type PUBLIC SERVICE ANNOUNCEMENTS
=680  \\$iAnnouncements for which no charge is made and which promote programs, activities, or services of federal, state, or local governments or those of non-profit organizations and other announcements regarded as serving community interests.
=688  \\$a2015
=750  \0$aAdvertising, Public service$0(DLC) sh 85001190$5IEN-M

=LDR  00591nz  a2200205n  4500
=001  9880479472302441
=005  20161110104021.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067010
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x209.$x429
=072  \\$aL1.$x143.$x563
=072  \\$aN1.$x824.$x196.$x500
=150  \\$aLiteracy
=450  \\$aIlliteracy
=550  \\$wg$aCommunication
=550  \\$wg$aEducational Status
=680  \\$iAbility to read and write.
=688  \\$a2016; for ILLITERACY use EDUCATIONAL STATUS (1968-2015)
=750  \0$aLiteracy$0(DLC) sh 85077482$5IEN-M

=LDR  01233nz  a2200361n  4500
=001  9880479473602441
=005  20161110102058.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067048
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x212.$x302.$x199.$x500
=072  \\$aG7.$x203.$x300.$x350.$x100.$x500
=072  \\$aG7.$x203.$x300.$x375.$x200.$x500
=072  \\$aJ2.$x500.$x350.$x100.$x500
=072  \\$aJ2.$x500.$x375.$x200.$x500
=150  \\$aGhee
=450  \\$wnnna$aAnhydrous Butterfat
=450  \\$wnnna$aButter Oil
=450  \\$wnnna$aClarified Butter
=450  \\$wnnna$aAnhydrous Butterfats
=450  \\$wnnna$aButter Oils
=450  \\$wnnna$aButter, Clarified
=450  \\$wnnna$aButterfat, Anhydrous
=450  \\$wnnna$aButterfats, Anhydrous
=450  \\$wnnna$aButters, Clarified
=450  \\$wnnna$aClarified Butters
=450  \\$wnnna$aGhees
=450  \\$wnnna$aOil, Butter
=450  \\$wnnna$aOils, Butter
=550  \\$wg$aButter
=680  \\$iThe clarified portion of milk, cream, or butter obtained by the removal of the nonfat constituents. (from Dictionary of Food Ingredients, 4th ed., 2001)
=688  \\$a2016; use DIETARY FATS 1982-2015
=750  \0$aGhee$0(DLC) sh 85054798$5IEN-M

=LDR  00665nz  a2200181n  4500
=001  9880479473802441
=005  20161110094124.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066989
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x928.$x500
=150  \\$aVegans
=450  \\$wnnna$aVegan
=550  \\$wg$aVegetarians
=550  \\$aDiet, Vegan
=680  \\$iPersons who avoid consuming animal products or animal-derived substances, such as MEAT; EGGS; or HONEY.  Some vegans also refrain from using animals or animal products in any form or for any purpose, such as in CLOTHING or household goods.
=688  \\$a2016
=750  \0$aVegans$0(DLC) sh2003011014$5IEN-M

=LDR  00928nz  a2200313n  4500
=001  9880479474002441
=005  20161110093839.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066988
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x928
=150  \\$aVegetarians
=450  \\$wnnna$aLacto-Ovo Vegetarians
=450  \\$wnnna$aOvo-Lacto Vegetarians
=450  \\$wnnna$aLacto Ovo Vegetarians
=450  \\$wnnna$aLacto-Ovo Vegetarian
=450  \\$wnnna$aOvo Lacto Vegetarians
=450  \\$wnnna$aOvo-Lacto Vegetarian
=450  \\$wnnna$aVegetarian
=450  \\$wnnna$aVegetarian, Lacto-Ovo
=450  \\$wnnna$aVegetarian, Ovo-Lacto
=450  \\$wnnna$aVegetarians, Lacto-Ovo
=450  \\$wnnna$aVegetarians, Ovo-Lacto
=550  \\$wg$aPersons
=550  \\$wh$aVegans
=550  \\$aDiet, Vegetarian
=680  \\$iPersons who do not eat MEAT.
=688  \\$a2016
=750  \0$aVegetarians$5IEN-M$0(DLC)sh 85142523

=LDR  00680nz  a2200229n  4500
=001  9880479474302441
=005  20161110092040.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067269
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x642.$x249.$x300.$x750
=072  \\$aG7.$x203.$x650.$x240.$x300.$x750
=150  \\$aDiet, Vegan
=450  \\$wnnna$aVeganism
=450  \\$aVegan Diet
=450  \\$wnnna$aDiets, Vegan
=450  \\$wnnna$aVegan Diets
=550  \\$wg$aDiet, Vegetarian
=550  \\$aVegans
=680  \\$iDietary practice of avoiding animal products in any form.
=688  \\$a2016; use DIET, VEGETARIAN 2003-2015
=750  \0$aVeganism$0(DLC)sh 96001788$5IEN-M

=LDR  00934cz  a2200205n  4500
=001  9880364205502441
=005  20141212215034.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x555
=150  \\$aLinaria
=450  \\$wnnna$aLinarias
=450  \\$aToadflax
=450  \\$wnnna$aToadflaxs
=550  \\$wg$aScrophulariaceae
=667  \\$aX ref TOADFLAX: TOADFLAX, BASTARD see SANTALACEAE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain linarin (also called acaciin).
=688  \\$a2003
=750  \0$aLinaria$5IEN-M$0(DLC)sh 85077074

=LDR  00868cz  a2200205n  4500
=001  9880364205602441
=005  20141212215033.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x55
=150  \\$aAntirrhinum
=450  \\$wnnna$aAntirrhinums
=450  \\$aSnapdragon
=450  \\$wnnna$aSnapdragons
=550  \\$wg$aScrophulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCROPHULARIACEAE. Members contain DEFICIENS PROTEIN.
=688  \\$a2003
=750  \0$aSnapdragons$5IEN-M$0(DLC)sh 85123735

=LDR  01389cz  a2200325n  4500
=001  9880364205702441
=005  20141212215033.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032141
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x889.$x750
=150  \\$aSchisandra
=450  \\$aGomisi
=450  \\$wnnna$aGomisus
=450  \\$wnnna$aSchisandras
=450  \\$aSchizandra
=450  \\$wnnna$aSchizandras
=450  \\$wnnna$awei zi, Wu
=450  \\$wnnna$awei zus, Wu
=450  \\$aWu wei zi
=450  \\$wnnna$aWu wei zus
=450  \\$aWuweizi
=450  \\$wnnna$aWuweizus
=450  \\$wnnna$azi, Wu wei
=450  \\$wnnna$azus, Wu wei
=550  \\$wg$aSchisandraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCHISANDRACEAE. Members contain schisandrins (Russian) which are also called gomisins (Japanese) or wuweizins (Chinese). The compounds in this genus are very similar to those in the related KADSURA and medicinal usage is very similar. It is sometimes adulterated with KADSURA.
=688  \\$a2003
=750  \0$aSchisandra$5IEN-M$0(DLC)sh 88023093

=LDR  00851cz  a2200181n  4500
=001  9880364205802441
=005  20141212215032.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032135
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x889.$x500
=150  \\$aKadsura
=450  \\$wnnna$aKadsuras
=550  \\$wg$aSchisandraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SCHISANDRACEAE that is used in folk medicine much like SCHISANDRA. Members contain kadsurenone and kadsurin.
=688  \\$a2003
=750  \0$aKadsura$5IEN-M$0(DLC)sh2001000379

=LDR  00875cz  a2200193n  4500
=001  9880364205902441
=005  20190617141456.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032134
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x888
=150  \\$aSaururaceae
=450  \\$aSaururus
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aHouttuynia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Piperales, subclass Magnoliidae class Magnoliopsida. Members contain sauristolactam, and aristololactam BII.
=688  \\$a2003
=750  \0$aSaururaceae$5IEN-M$0(DLC)sh 85117735

=LDR  01164cz  a2200277n  4500
=001  9880364206002441
=005  20141212215031.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032132
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x886.$x699
=150  \\$aPouteria
=450  \\$wnnna$aPouteria sapota
=450  \\$wnnna$aPouteria sapotas
=450  \\$wnnna$aPouterias
=450  \\$wnnna$asapota, Pouteria
=450  \\$wnnna$asapotas, Pouteria
=450  \\$aSapote, Yellow
=450  \\$wnnna$aSapotes, Yellow
=450  \\$wnnna$aYellow Sapote
=450  \\$wnnna$aYellow Sapotes
=550  \\$wg$aSapotaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPOTACEAE. Members contain triterpenes. Some species in this genus are called mamey which is also a common name for MAMMEA.
=688  \\$a2003
=750  \0$aPouteria$0(DLC)sh2005003650$5IEN-M

=LDR  01576cz  a2200445n  4500
=001  9880364206102441
=005  20141212215030.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032129
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x886.$x555
=150  \\$aManilkara
=450  \\$wnnna$aAchras zapotilla
=450  \\$wnnna$aAchras zapotillas
=450  \\$wnnna$aLucuma mammosa
=450  \\$wnnna$aLucuma mammosas
=450  \\$wnnna$amammosa, Lucuma
=450  \\$wnnna$amammosas, Lucuma
=450  \\$wnnna$aManilkara zapota
=450  \\$wnnna$aManilkara zapotas
=450  \\$wnnna$aManilkaras
=450  \\$aSapodilla
=450  \\$wnnna$aSapodillas
=450  \\$wnnna$aSapota zapotilla
=450  \\$wnnna$aSapota zapotillas
=450  \\$aSapote
=450  \\$wnnna$aSapotes
=450  \\$wnnna$azapota, Manilkara
=450  \\$wnnna$azapotas, Manilkara
=450  \\$aZapote
=450  \\$wnnna$aZapotes
=450  \\$wnnna$azapotilla, Achras
=450  \\$wnnna$azapotilla, Sapota
=450  \\$wnnna$azapotillas, Achras
=450  \\$wnnna$azapotillas, Sapota
=550  \\$wg$aSapotaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPOTACEAE that bears sweet fruit.
=688  \\$a2003
=750  \0$aManilkara$0(DLC)sh2008009542$5IEN-M

=LDR  00829cz  a2200181n  4500
=001  9880364206202441
=005  20141212215030.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032128
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x886.$x500
=150  \\$aMadhuca
=450  \\$wnnna$aMadhucas
=550  \\$wg$aSapotaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPOTACEAE that is the source of mahua oil. Members contain oleanene triterpenoid saponins.
=688  \\$a2003
=750  \0$aMadhuca$5IEN-M$0(DLC)sh 97004875

=LDR  01275cz  a2200325n  4500
=001  9880364206302441
=005  20141212215029.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x885.$x722
=150  \\$aPaullinia
=450  \\$aBarbasco
=450  \\$wnnna$aBarbascos
=450  \\$wnnna$acupana, Paullinia
=450  \\$wnnna$acupanas, Paullinia
=450  \\$aGuarana
=450  \\$wnnna$aGuaranas
=450  \\$wnnna$aPaullinia cupana
=450  \\$wnnna$aPaullinia cupanas
=450  \\$wnnna$aPaullinia pinnata
=450  \\$wnnna$aPaullinia pinnatas
=450  \\$wnnna$aPaullinias
=450  \\$wnnna$apinnata, Paullinia
=450  \\$wnnna$apinnatas, Paullinia
=550  \\$wg$aSapindaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPINDACEAE. The seed of P. cupana is the source of guarana powder which contains 4% CAFFEINE.
=688  \\$a2003
=750  \0$aPaullinia$5IEN-M$0(DLC)sh 85098820

=LDR  01128cz  a2200277n  4500
=001  9880364206402441
=005  20141212215029.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032125
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x885.$x444
=150  \\$aLitchi
=450  \\$wnnna$achinenses, Litchi
=450  \\$wnnna$achinensis, Litchi
=450  \\$aLeechee
=450  \\$wnnna$aLeechees
=450  \\$wnnna$aLitchi chinenses
=450  \\$wnnna$aLitchi chinensis
=450  \\$wnnna$aLitchus
=450  \\$aLychee
=450  \\$wnnna$aLychees
=550  \\$wg$aSapindaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPINDACEAE that bears sweet fruits. Unusual fatty acids such as cyclopropanoic fatty acids have been identified in the seeds.
=688  \\$a2003
=750  \0$aLitchi$5IEN-M$0(DLC)sh 85077479

=LDR  01046cz  a2200277n  4500
=001  9880364206502441
=005  20141212215028.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032124
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x885.$x111
=150  \\$aBlighia
=450  \\$aAckee
=450  \\$wnnna$aAckees
=450  \\$aAkee
=450  \\$wnnna$aAkees
=450  \\$wnnna$aBlighia sapida
=450  \\$wnnna$aBlighia sapidas
=450  \\$wnnna$aBlighias
=450  \\$wnnna$asapida, Blighia
=450  \\$wnnna$asapidas, Blighia
=550  \\$wg$aSapindaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAPINDACEAE. Members contain hypoglycins and ackee oil.
=688  \\$a2003
=750  \0$aBlighia$5IEN-M$0(DLC)sh 85014854

=LDR  00853cz  a2200205n  4500
=001  9880364206602441
=005  20141212215028.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032123
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x884.$x833
=150  \\$aSantalum
=450  \\$aSandalwood
=450  \\$wnnna$aSandalwoods
=450  \\$wnnna$aSantalums
=550  \\$wg$aSantalaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SANTALACEAE which is the source of sandalwood oil.
=688  \\$a2003
=750  \0$aSantalum$5IEN-M$0(DLC)sh 85117397

=LDR  01826cz  a2200481n  4500
=001  9880364206802441
=005  20141212215027.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032107
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x881.$x666
=150  \\$aPopulus
=450  \\$wnnna$aBalsam Poplar
=450  \\$wnnna$aBalsam Poplars
=450  \\$wnnna$abalsamifera, Populus
=450  \\$wnnna$abalsamiferas, Populus
=450  \\$wnnna$aBlack Poplar
=450  \\$wnnna$aBlack Poplars
=450  \\$aCottonwood
=450  \\$wnnna$aCottonwoods
=450  \\$wnnna$afremontii, Populus
=450  \\$wnnna$afremontius, Populus
=450  \\$wnnna$anigra, Populus
=450  \\$wnnna$anigras, Populus
=450  \\$aPoplar, Balsam
=450  \\$aPoplar, Black
=450  \\$aPoplar, True
=450  \\$wnnna$aPoplars, Balsam
=450  \\$wnnna$aPoplars, Black
=450  \\$wnnna$aPoplars, True
=450  \\$wnnna$aPopulus balsamifera
=450  \\$wnnna$aPopulus balsamiferas
=450  \\$wnnna$aPopulus fremontii
=450  \\$wnnna$aPopulus fremontius
=450  \\$wnnna$aPopulus nigra
=450  \\$wnnna$aPopulus nigras
=450  \\$wnnna$aTrue Poplar
=450  \\$wnnna$aTrue Poplars
=550  \\$wg$aSalicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SALICACEAE. Balm of Gilead is a common name used for P. candicans, or P. gileadensis, or P. jackii, and sometimes also used for ABIES BALSAMEA or for COMMIPHORA.
=688  \\$a2003
=750  \0$aPoplar$5IEN-M$0(DLC)sh 85104888

=LDR  05929cz  a2201549n  4500
=001  9880364206902441
=005  20141212193028.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x922
=150  \\$aZanthoxylum
=450  \\$wnnna$aailanthoide, Fagara
=450  \\$wnnna$aailanthoide, Zanthoxylum
=450  \\$wnnna$aailanthoides, Fagara
=450  \\$wnnna$aailanthoides, Zanthoxylum
=450  \\$wnnna$aboninenses, Fagara
=450  \\$wnnna$aboninensis, Fagara
=450  \\$wnnna$acoco, Fagara
=450  \\$wnnna$acoco, Zanthoxylum
=450  \\$wnnna$acocos, Fagara
=450  \\$wnnna$acocos, Zanthoxylum
=450  \\$wnnna$acuspidata, Fagara
=450  \\$wnnna$acuspidatas, Fagara
=450  \\$wnnna$acuspidatum, Xanthoxylum
=450  \\$wnnna$acuspidatums, Xanthoxylum
=450  \\$wnnna$aFagara ailanthoide
=450  \\$wnnna$aFagara ailanthoides
=450  \\$wnnna$aFagara boninenses
=450  \\$wnnna$aFagara boninensis
=450  \\$wnnna$aFagara coco
=450  \\$wnnna$aFagara cocos
=450  \\$wnnna$aFagara cuspidata
=450  \\$wnnna$aFagara cuspidatas
=450  \\$wnnna$aFagara heitzii
=450  \\$wnnna$aFagara heitzius
=450  \\$wnnna$aFagara leprieurii
=450  \\$wnnna$aFagara leprieurius
=450  \\$wnnna$aFagara macrophylla
=450  \\$wnnna$aFagara macrophyllas
=450  \\$wnnna$aFagara mayu
=450  \\$wnnna$aFagara mayus
=450  \\$wnnna$aFagara monophyllum
=450  \\$wnnna$aFagara monophyllums
=450  \\$wnnna$aFagara nitidum
=450  \\$wnnna$aFagara nitidums
=450  \\$wnnna$aFagara rhetza
=450  \\$wnnna$aFagara rhetzas
=450  \\$wnnna$aFagara rubescen
=450  \\$wnnna$aFagara rubescens
=450  \\$wnnna$aFagara tessmannii
=450  \\$wnnna$aFagara tessmannius
=450  \\$wnnna$aFagara xanthoxyloide
=450  \\$wnnna$aFagara xanthoxyloides
=450  \\$wnnna$aFagara zanthoxyloide
=450  \\$wnnna$aFagara zanthoxyloides
=450  \\$wnnna$afagara, Zanthoxylum
=450  \\$wnnna$afagaras, Zanthoxylum
=450  \\$wnnna$agilletii, Zanthoxylum
=450  \\$wnnna$agilletius, Zanthoxylum
=450  \\$wnnna$aheitzii, Fagara
=450  \\$wnnna$aheitzii, Zanthoxylum
=450  \\$wnnna$aheitzius, Fagara
=450  \\$wnnna$aheitzius, Zanthoxylum
=450  \\$wnnna$ainerme, Xanthoxylum
=450  \\$wnnna$ainermes, Xanthoxylum
=450  \\$wnnna$aleprieurii, Fagara
=450  \\$wnnna$aleprieurii, Zanthoxylum
=450  \\$wnnna$aleprieurius, Fagara
=450  \\$wnnna$aleprieurius, Zanthoxylum
=450  \\$wnnna$amacrophylla, Fagara
=450  \\$wnnna$amacrophyllas, Fagara
=450  \\$wnnna$amayu, Fagara
=450  \\$wnnna$amayu, Zanthoxylum
=450  \\$wnnna$amayus, Fagara
=450  \\$wnnna$amayus, Zanthoxylum
=450  \\$wnnna$amonophyllum, Fagara
=450  \\$wnnna$amonophyllum, Zanthoxylum
=450  \\$wnnna$amonophyllums, Fagara
=450  \\$wnnna$amonophyllums, Zanthoxylum
=450  \\$wnnna$anitidum, Fagara
=450  \\$wnnna$anitidum, Zanthoxylum
=450  \\$wnnna$anitidums, Fagara
=450  \\$wnnna$anitidums, Zanthoxylum
=450  \\$wnnna$arhetza, Fagara
=450  \\$wnnna$arhetza, Zanthoxylum
=450  \\$wnnna$arhetzas, Fagara
=450  \\$wnnna$arhetzas, Zanthoxylum
=450  \\$wnnna$arubescen, Fagara
=450  \\$wnnna$arubescen, Zanthoxylum
=450  \\$wnnna$arubescens, Fagara
=450  \\$wnnna$arubescens, Zanthoxylum
=450  \\$wnnna$atessmannii, Fagara
=450  \\$wnnna$atessmannius, Fagara
=450  \\$wnnna$axanthoxyloide, Fagara
=450  \\$wnnna$axanthoxyloides, Fagara
=450  \\$aXanthoxylum
=450  \\$wnnna$aXanthoxylum cuspidatum
=450  \\$wnnna$aXanthoxylum cuspidatums
=450  \\$wnnna$aXanthoxylum inerme
=450  \\$wnnna$aXanthoxylum inermes
=450  \\$wnnna$aXanthoxylums
=450  \\$wnnna$azanthoxyloide, Fagara
=450  \\$wnnna$azanthoxyloides, Fagara
=450  \\$wnnna$aZanthoxylum ailanthoide
=450  \\$wnnna$aZanthoxylum ailanthoides
=450  \\$wnnna$aZanthoxylum coco
=450  \\$wnnna$aZanthoxylum cocos
=450  \\$wnnna$aZanthoxylum fagara
=450  \\$wnnna$aZanthoxylum fagaras
=450  \\$wnnna$aZanthoxylum gilletii
=450  \\$wnnna$aZanthoxylum gilletius
=450  \\$wnnna$aZanthoxylum heitzii
=450  \\$wnnna$aZanthoxylum heitzius
=450  \\$wnnna$aZanthoxylum leprieurii
=450  \\$wnnna$aZanthoxylum leprieurius
=450  \\$wnnna$aZanthoxylum mayu
=450  \\$wnnna$aZanthoxylum mayus
=450  \\$wnnna$aZanthoxylum monophyllum
=450  \\$wnnna$aZanthoxylum monophyllums
=450  \\$wnnna$aZanthoxylum nitidum
=450  \\$wnnna$aZanthoxylum nitidums
=450  \\$wnnna$aZanthoxylum rhetza
=450  \\$wnnna$aZanthoxylum rhetzas
=450  \\$wnnna$aZanthoxylum rubescen
=450  \\$wnnna$aZanthoxylum rubescens
=450  \\$wnnna$aZanthoxylums
=550  \\$wg$aRutaceae
=667  \\$anote FAGARA entry terms: FAGARA see RUTACEAE and FAGARA HORRIDA see GLEDITSIA are also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family RUTACEAE. Some members of Zanthoxylum are reclassified from ELEUTHEROCOCCUS, Melicope, and EVODIA. The twigs are used as dental brushing sticks (TOOTHBRUSHING).  Most plants that are called Fagara have been reclassified as Zanthoxylum, however some Fagara were reclassified  to MELICOPE (also in the Rutacea family) or to GLEDITSIA (a genus in the FABACEAE family).
=688  \\$a2003
=750  \0$aZanthoxylum$5IEN-M$0(DLC)sh 87000390

=LDR  01139cz  a2200301n  4500
=001  9880364207002441
=005  20141212215026.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x788
=150  \\$aRuta
=450  \\$wnnna$achalepenses, Ruta
=450  \\$wnnna$achalepensis, Ruta
=450  \\$wnnna$agraveolen, Ruta
=450  \\$wnnna$agraveolens, Ruta
=450  \\$aRue
=450  \\$wnnna$aRues
=450  \\$wnnna$aRuta chalepenses
=450  \\$wnnna$aRuta chalepensis
=450  \\$wnnna$aRuta graveolen
=450  \\$wnnna$aRuta graveolens
=450  \\$wnnna$aRutas
=550  \\$wg$aRutaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE. Members contain quinoline alkaloids.
=688  \\$a2003
=750  \0$aRues (Plants)$5IEN-M$0(DLC)sh 99003104

=LDR  00906cz  a2200205n  4500
=001  9880364207102441
=005  20141212215025.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032102
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x717
=150  \\$aPhellodendron
=450  \\$aCorktree
=450  \\$wnnna$aCorktrees
=450  \\$wnnna$aPhellodendrons
=550  \\$wg$aRutaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE. Members contain BERBERINE, indolopyridoquinazoline and other ALKALOIDS and limonoids.
=688  \\$a2003
=750  \0$aPhellodendron$5IEN-M$0(DLC)sh 85100656

=LDR  00891cz  a2200181n  4500
=001  9880364207202441
=005  20141212215025.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x666
=150  \\$aMurraya
=450  \\$wnnna$aMurrayas
=550  \\$wg$aRutaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.
=688  \\$a2003
=750  \0$aMurraya$0(DLC)sh2007003875$5IEN-M

=LDR  01721cz  a2200445n  4500
=001  9880364207302441
=005  20141212215025.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032086
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x333
=150  \\$aEvodia
=450  \\$aEuodia
=450  \\$wnnna$aEuodia ruticarpa
=450  \\$wnnna$aEuodia ruticarpas
=450  \\$wnnna$aEuodias
=450  \\$wnnna$aEvodia rutaecarpa
=450  \\$wnnna$aEvodia rutaecarpas
=450  \\$aEvodiae Fructus
=450  \\$wnnna$aEvodias
=450  \\$wnnna$aFructus, Evodiae
=450  \\$wnnna$arutaecarpa, Evodia
=450  \\$wnnna$arutaecarpas, Evodia
=450  \\$wnnna$aruticarpa, Euodia
=450  \\$wnnna$aruticarpas, Euodia
=450  \\$wnnna$aruticarpum, Tetradium
=450  \\$wnnna$aruticarpums, Tetradium
=450  \\$wnnna$aTetradium ruticarpum
=450  \\$wnnna$aTetradium ruticarpums
=450  \\$aWu Zhu Yu
=450  \\$wnnna$aWu Zhu Yus
=450  \\$wnnna$aYu, Wu Zhu
=450  \\$wnnna$aYus, Wu Zhu
=450  \\$wnnna$aZhu Yu, Wu
=450  \\$wnnna$aZhu Yus, Wu
=550  \\$wg$aRutaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE which is used in Chinese medicine (DRUGS, CHINESE HERBAL). Evodiamine and other quinazoline alkaloids (QUINAZOLINES) are obtained from the fruit of E. ruticarpa.
=688  \\$a2003
=750  \0$aEuodia$5IEN-M$0(DLC)sh2001005971

=LDR  01137cz  a2200277n  4500
=001  9880364207402441
=005  20141212215024.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032084
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177.$x769
=150  \\$aCitrus sinensis
=450  \\$wnnna$aCitrus sinenses
=450  \\$wnnna$aOrange
=450  \\$aOrange Tree
=450  \\$wnnna$aOrange Trees
=450  \\$aOranges
=450  \\$wnnna$asinenses, Citrus
=450  \\$wnnna$asinensis, Citrus
=450  \\$wnnna$aTree, Orange
=450  \\$wnnna$aTrees, Orange
=550  \\$wg$aCitrus
=667  \\$anot the color; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus CITRUS, family RUTACEAE that provides the familiar orange fruit which is also a source of orange oil.
=688  \\$a2003
=750  \0$aOranges$5IEN-M$0(DLC)sh 85095257

=LDR  01143cz  a2200229n  4500
=001  9880364207502441
=005  20141212193026.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032083
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177.$x538
=150  \\$aCitrus paradisi
=450  \\$wnnna$aCitrus x paradisi
=450  \\$aGrapefruit
=450  \\$wnnna$aGrapefruits
=450  \\$aToronja
=450  \\$wnnna$aToronjas
=550  \\$wg$aCitrus
=667  \\$aas plant & fruit; juice: coordinate IM with BEVERAGES (IM); coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant species of the genus CITRUS, family RUTACEAE that produces the familiar grapefruit. There is evidence that grapefruit inhibits CYTOCHROME P-450 CYP3A4, resulting in delayed metabolism and higher blood levels of a variety of drugs.
=688  \\$a2003
=750  \0$aGrapefruit$5IEN-M$0(DLC)sh 85056457

=LDR  01097cz  a2200217n  4500
=001  9880364207602441
=005  20141212215024.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x177.$x77
=150  \\$aCitrus aurantiifolia
=450  \\$wnnna$aaurantiifolia, Citrus
=450  \\$wnnna$aaurantiifolias, Citrus
=450  \\$wnnna$aCitrus aurantiifolias
=450  \\$aLimes
=550  \\$wg$aCitrus
=667  \\$aas plant & fruit; juice: coord IM with BEVERAGES (IM); do not confuse with Limetree = TILIA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus CITRUS, family RUTACEAE that provides the familiar lime fruit. Its common name of lime is similar to the limetree (TILIA).
=688  \\$a2003
=750  \0$aMexican lime$5IEN-M$0(DLC)sh 96008907

=LDR  00915cz  a2200193n  4500
=001  9880364207702441
=005  20141212215023.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x909
=150  \\$aUncaria
=450  \\$wnnna$aUncarias
=550  \\$wg$aRubiaceae
=550  \\$wh$aCat's Claw
=667  \\$aUNCARIA PROCUMBENS see HARPAGOPHYTUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Members contain uncarine and other cytotoxic and hypotensive oxindole alkaloids.
=688  \\$a2003
=750  \0$aUncaria$5IEN-M$0(DLC)sh2001006255

=LDR  00894cz  a2200181n  4500
=001  9880364207802441
=005  20141212215022.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032067
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x611
=150  \\$aOldenlandia
=450  \\$wnnna$aOldenlandias
=550  \\$wg$aRubiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Some species are used as an ingredient in Chinese and African traditional medicines. Members contain kalata B1, a macrocyclic peptide.
=688  \\$a2003
=750  \0$aOldenlandia$5IEN-M$0(DLC)sh 88022949

=LDR  01019cz  a2200253n  4500
=001  9880364207902441
=005  20141212215022.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032066
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x566
=150  \\$aMorinda
=450  \\$wnnna$acitrifolia, Morinda
=450  \\$wnnna$acitrifolias, Morinda
=450  \\$wnnna$aMorinda citrifolia
=450  \\$wnnna$aMorinda citrifolias
=450  \\$wnnna$aMorindas
=450  \\$aNoni
=450  \\$wnnna$aNonus
=550  \\$wg$aRubiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.
=688  \\$a2003
=750  \0$aMorinda$5IEN-M$0(DLC)sh 98003964

=LDR  00844cz  a2200181n  4500
=001  9880364208002441
=005  20150623155447.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x555
=150  \\$aMitragyna
=450  \\$wnnna$aMitragynas
=550  \\$wg$aRubiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Members contain antimalarial (ANTIMALARIALS) and analgesic (ANALGESICS) indole alkaloids.
=688  \\$a2003
=750  \0$aMitragyna$0(DLC)sh2015000611$5IEN-M

=LDR  00838cz  a2200181n  4500
=001  9880364208102441
=005  20141212215021.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032064
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x422
=150  \\$aHedyotis
=450  \\$wnnna$aHedyoti
=550  \\$wg$aRubiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Members contain anthraquinones and iridoids. H. diffusa is used in DRUGS, CHINESE HERBAL.
=688  \\$a2003
=750  \0$aHedyotis$5IEN-M$0(DLC)sh 88022823

=LDR  00925cz  a2200193n  4500
=001  9880364208202441
=005  20141212215021.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x388
=150  \\$aGardenia
=450  \\$wnnna$aGardeniae
=450  \\$wnnna$aGardenias
=550  \\$wg$aRubiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE. Members contain genepin, from which geniposide is obtained for use as a crosslinking agent in ADHESIVES, and 3-caffeoyl-4-sinapoylquinic acid.
=688  \\$a2003
=750  \0$aGardenia$5IEN-M$0(DLC)sh 85053088

=LDR  01027cz  a2200229n  4500
=001  9880364208302441
=005  20141212215020.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032061
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x850.$x377
=150  \\$aGalium
=450  \\$aBedstraw
=450  \\$wnnna$aBedstraws
=450  \\$wnnna$aCleaver
=450  \\$aCleavers
=450  \\$wnnna$aGaliums
=550  \\$wg$aRubiaceae
=667  \\$athe element GALLIUM is also available; X ref BEDSTRAW: for "smooth bedstraw" refering to the Cruciata genus use RUBIACEAE; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUBIACEAE with a name very similar to the element GALLIUM.
=688  \\$a2003
=750  \0$aGalium$5IEN-M$0(DLC)sh 85052802

=LDR  00883cz  a2200205n  4500
=001  9880364208402441
=005  20141212215019.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031996
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x750.$x500
=150  \\$aHeuchera
=450  \\$aAlumroot
=450  \\$wnnna$aAlumroots
=450  \\$wnnna$aHeucheras
=550  \\$wg$aSaxifragaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SAXIFRAGACEAE with dark green round or heart-shaped leaves and tiny flowers.
=688  \\$a2003
=750  \0$aHeuchera$5IEN-M$0(DLC)sh 85060553

=LDR  01167cz  a2200229n  4500
=001  9880364208502441
=005  20141212215019.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031995
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x750
=150  \\$aSaxifragaceae
=450  \\$aSaxifraga
=450  \\$wnnna$aSaxifragas
=450  \\$aSaxifrage
=450  \\$wnnna$aSaxifrages
=550  \\$wg$aRosales
=550  \\$wh$aHeuchera
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe saxifrage plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. The leaves are alternate and sometimes deeply lobed or form rosettes. The flowers have both male and female parts and 4 or 5 sepals and petals; they are usually in branched clusters. The fruit is a capsule with many seeds.
=688  \\$a2003
=750  \0$aSaxifragaceae$5IEN-M$0(DLC)sh 85117811

=LDR  00901cz  a2200241n  4500
=001  9880364208602441
=005  20141212215018.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031994
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x793
=150  \\$aSorbus
=450  \\$aAsh, Mountain
=450  \\$wnnna$aAshs, Mountain
=450  \\$aMountain Ash
=450  \\$wnnna$aMountain Ashs
=450  \\$aRowan
=450  \\$wnnna$aRowans
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE.
=688  \\$a2003
=750  \0$aSorbus$5IEN-M$0(DLC)sh 87002988

=LDR  00842cz  a2200205n  4500
=001  9880364208702441
=005  20141212215018.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031993
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x779
=150  \\$aSanguisorba
=450  \\$aBurnet
=450  \\$wnnna$aBurnets
=450  \\$wnnna$aSanguisorbas
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. Members contain sanguiin.
=688  \\$a2003
=750  \0$aSanguisorba$5IEN-M$0(DLC)sh 88023081

=LDR  00820cz  a2200181n  4500
=001  9880364208802441
=005  20141212215018.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031992
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x808
=150  \\$aSpiraea
=450  \\$wnnna$aSpiraeas
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. Members contain prunioside, spiramine and other diterpene alkaloids.
=688  \\$a2003
=750  \0$aSpireas$5IEN-M$0(DLC)sh 88023124

=LDR  00792cz  a2200193n  4500
=001  9880364208902441
=005  20141212215017.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031989
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x699
=150  \\$aPyrus
=450  \\$wnnna$aPear
=450  \\$aPears
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE known for the edible fruit.
=688  \\$a2003
=750  \0$aPears$5IEN-M$0(DLC)sh 85099008

=LDR  00753cz  a2200229n  4500
=001  9880364209002441
=005  20160930135725.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000068218
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x250
=150  \\$aPrunus africana
=450  \\$wnnoa$aPygeum$5IEN-M
=450  \\$aAfrican Prune
=450  \\$wnnna$aAfrican Prunes
=450  \\$aPrune, African
=450  \\$wnnna$aPrunes, African
=450  \\$wnnna$aPygeum africanum
=550  \\$wg$aPrunus
=680  \\$iA plant genus of the family ROSACEAE. The bark extract known as pygeum is an ingredient in FOLK REMEDIES..
=688  \\$a2016 (2002)
=750  \0$aPrunus africana$0(DLC)sh2006002677$5IEN-M

=LDR  00925cz  a2200229n  4500
=001  9880364209102441
=005  20141212215016.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031987
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x601
=150  \\$aPotentilla
=450  \\$aCinquefoil
=450  \\$wnnna$aCinquefoils
=450  \\$wnnna$aPotentillas
=450  \\$aSilverweed
=450  \\$wnnna$aSilverweeds
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. Members contain procyanidins and TANNINS.
=688  \\$a2003
=750  \0$aCinquefoils$5IEN-M$0(DLC)sh 85105674

=LDR  00820cz  a2200205n  4500
=001  9880364209202441
=005  20141212215016.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031986
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x288
=150  \\$aGeum
=450  \\$wnnna$aAven
=450  \\$aAvens
=450  \\$wnnna$aGeums
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. Members contain TRITERPENES.
=688  \\$a2003
=750  \0$aGeum$5IEN-M$0(DLC)sh 88022802

=LDR  00847cz  a2200205n  4500
=001  9880364209302441
=005  20141212215016.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031985
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x266
=150  \\$aFragaria
=450  \\$wnnna$aFragarias
=450  \\$aStrawberries
=450  \\$wnnna$aStrawberry
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE known for the edible fruit.
=688  \\$a2003
=750  \0$aStrawberries$5IEN-M$0(DLC)sh 85128547

=LDR  01015cz  a2200253n  4500
=001  9880364209402441
=005  20141212215015.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031983
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x222
=150  \\$aEriobotrya
=450  \\$wnnna$aEriobotryas
=450  \\$wnnna$aLoquat
=450  \\$aLoquat Tree
=450  \\$wnnna$aLoquat Trees
=450  \\$aLoquats
=450  \\$wnnna$aTree, Loquat
=450  \\$wnnna$aTrees, Loquat
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE that is the source of an edible fruit. Members contain TRITERPENES.
=688  \\$a2003
=750  \0$aEriobotrya$0(DLC) sh 89023395$5IEN-M

=LDR  01011cz  a2200253n  4500
=001  9880364209502441
=005  20141212215015.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x55
=150  \\$aAlchemilla
=450  \\$wnnna$aAlchemillas
=450  \\$wnnna$aLady Mantle
=450  \\$aLady's Mantle
=450  \\$wnnna$aLadys Mantle
=450  \\$wnnna$aLady's Mantles
=450  \\$wnnna$aMantle, Lady's
=450  \\$wnnna$aMantles, Lady's
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.
=688  \\$a2003
=750  \0$aAlchemilla$5IEN-M$0(DLC)sh 85003262

=LDR  00898cz  a2200193n  4500
=001  9880364209602441
=005  20141212215014.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x374.$x500
=150  \\$aHydrangea
=450  \\$wnnna$aHydrangeae
=450  \\$wnnna$aHydrangeas
=550  \\$wg$aHydrangeaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family HYDRANGEACEAE. Members contain hydrangenol, thunberginols, hydramacrosides A and B, and secoiridoid glucosides.
=688  \\$a2003
=750  \0$aHydrangeas$5IEN-M$0(DLC)sh 85063290

=LDR  01029cz  a2200253n  4500
=001  9880364209702441
=005  20141212215014.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x311.$x500
=150  \\$aRibes
=450  \\$aBlack Currant
=450  \\$wnnna$aBlack Currants
=450  \\$aCurrant, Black
=450  \\$wnnna$aCurrants, Black
=450  \\$wnnna$aGooseberries
=450  \\$aGooseberry
=450  \\$wnnna$aRibe
=550  \\$wg$aGrossulariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family GROSSULARIACEAE. GAMMA-LINOLENIC ACID is obtained from the black currant oil of the seeds.
=688  \\$a2003
=750  \0$aRibes$5IEN-M$0(DLC)sh 86000041

=LDR  00937cz  a2200181n  4500
=001  9880364209802441
=005  20141212215013.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031964
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x311
=150  \\$aGrossulariaceae
=550  \\$wg$aRosales
=550  \\$wh$aRibes
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. They are deciduous woody shrubs with alternate leaves. The flowers are in terminal racemes with 5 petals and 5 stamens.
=688  \\$a2003
=750  \0$aGrossulariaceae$0(DLC) sh2004008818$5IEN-M

=LDR  01149cz  a2200277n  4500
=001  9880364209902441
=005  20141212215013.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031963
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x249.$x750
=150  \\$aSedum
=450  \\$aCockscomb, Green
=450  \\$wnnna$aCockscombs, Green
=450  \\$wnnna$aGreen Cockscomb
=450  \\$wnnna$aGreen Cockscombs
=450  \\$wnnna$apraealtum, Sedum
=450  \\$wnnna$apraealtums, Sedum
=450  \\$wnnna$aSedum praealtum
=450  \\$wnnna$aSedum praealtums
=450  \\$wnnna$aSedums
=550  \\$wg$aCrassulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CRASSULACEAE. Some species in this genus are called stonecrop which is also a common name for RHODIOLA.
=688  \\$a2003
=750  \0$aSedum$5IEN-M$0(DLC)sh 85119520

=LDR  00896cz  a2200181n  4500
=001  9880364210002441
=005  20141212215012.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031962
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x249.$x249
=150  \\$aKalanchoe
=450  \\$aBryophyllum
=550  \\$wg$aCrassulaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CRASSULACEAE. Members contain bryophyllins (also called bryotoxins) which are bufadienolides (BUFANOLIDES) that have insecticidal activity.
=688  \\$a2003
=750  \0$aKalanchoe$5IEN-M$0(DLC)sh 96005383

=LDR  01141cz  a2200253n  4500
=001  9880364210102441
=005  20141212215012.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031961
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x222
=150  \\$aConnaraceae
=450  \\$aAgelaea
=450  \\$wnnna$aAgelaeas
=450  \\$wnnna$aCnesti
=450  \\$aCnestis
=450  \\$aConnarus
=450  \\$aRourea
=450  \\$wnnna$aRoureas
=550  \\$wg$aRosales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that are tropical plants. The flowers are usually bisexual and have 5 sepals and petals; 5 or 10 stamens; and 1, 4, or usually 5 separate, one-chambered, female ovule-bearing structures (carpels).
=688  \\$a2003
=750  \0$aConnaraceae$5IEN-M$0(DLC)sh 85031153

=LDR  00882cz  a2200205n  4500
=001  9880364210202441
=005  20141212215012.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031957
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x840.$x833
=150  \\$aZiziphus
=450  \\$aJujube
=450  \\$wnnna$aJujubes
=450  \\$aZizyphus
=550  \\$wg$aRhamnaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RHAMNACEAE. Members contain nummularogenin (a spirostane) and is the source of an edible fruit.
=688  \\$a2003
=750  \0$aZiziphus$5IEN-M$0(DLC)sh 94000428

=LDR  01287cz  a2200277n  4500
=001  9880364210302441
=005  20141212215011.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031956
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x840.$x408
=150  \\$aKarwinskia
=450  \\$aCoyotillo
=450  \\$wnnna$aCoyotillos
=450  \\$wnnna$ahumboldtiana, Karwinskia
=450  \\$wnnna$ahumboldtianas, Karwinskia
=450  \\$wnnna$aKarwinskia humboldtiana
=450  \\$wnnna$aKarwinskia humboldtianas
=450  \\$wnnna$aKarwinskias
=450  \\$aTullidora
=450  \\$wnnna$aTullidoras
=550  \\$wg$aRhamnaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RHAMNACEAE that contains tullidinol (toxin T-544) and peroxisomicine (toxin T-514). It is sometimes called buckthorn but should not be confused with other plants called that.
=688  \\$a2003; use RHAMNUS 1985-2002; for Tullidora use RHAMNUS 1986-2002
=750  \0$aKarwinskia$5IEN-M$0(DLC)sh 85071681

=LDR  00794cz  a2200169n  4500
=001  9880364210502441
=005  20141212215010.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031952
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x840.$x111
=150  \\$aCeanothus
=550  \\$wg$aRhamnaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RHAMNACEAE. Root nodules host the Frankia (ACTINOMYCETES) nitrogen-fixing bacteria.
=688  \\$a2003
=750  \0$aCeanothus$5IEN-M$0(DLC)sh 88022654

=LDR  00913cz  a2200205n  4500
=001  9880364210602441
=005  20141212215010.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031951
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x839
=150  \\$aResedaceae
=450  \\$aOchradenus
=450  \\$aReseda
=450  \\$wnnna$aResedas
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. It is a small family of herbs and shrubs. Some produce GLUCOSINOLATES.
=688  \\$a2003
=750  \0$aResedaceae$5IEN-M$0(DLC)sh 88023062

=LDR  00954cz  a2200229n  4500
=001  9880364210702441
=005  20141212215009.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031949
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x883
=150  \\$aThalictrum
=450  \\$aMeadow Rue
=450  \\$wnnna$aMeadow Rues
=450  \\$aRue, Meadow
=450  \\$wnnna$aRues, Meadow
=450  \\$wnnna$aThalictrums
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids and triterpene glycosides.
=688  \\$a2003
=750  \0$aThalictrum$5IEN-M$0(DLC)sh 88023149

=LDR  00785cz  a2200169n  4500
=001  9880364210802441
=005  20141212215008.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x733
=150  \\$aRanunculus
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE that contains protoanemonin, anemonin, and ranunculin.
=688  \\$a2003
=750  \0$aRanunculus$0(DLC) sh 85111390$5IEN-M

=LDR  01015cz  a2200253n  4500
=001  9880364210902441
=005  20141212215008.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031945
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x248
=150  \\$aCoreopsis
=450  \\$wnnna$aCoreopses
=450  \\$aDahlia, Sea
=450  \\$wnnna$aDahlias, Sea
=450  \\$wnnna$aSea Dahlia
=450  \\$wnnna$aSea Dahlias
=450  \\$aTickseed
=450  \\$wnnna$aTickseeds
=550  \\$wg$aAsteraceae
=667  \\$aX ref DAHLIA, SEA: DAHLIA also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that contains phenyl propanoids.
=688  \\$a2003
=750  \0$aCoreopsis$5IEN-M$0(DLC)sh 85032589

=LDR  00832cz  a2200181n  4500
=001  9880364211002441
=005  20141212215007.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031944
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x289
=150  \\$aDahlia
=450  \\$wnnna$aDahlias
=550  \\$wg$aAsteraceae
=667  \\$aDAHLIA, SEA see COREOPSIS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that contains antifungal plant defensin.
=688  \\$a2003
=750  \0$aDahlias$5IEN-M$0(DLC)sh 85035416

=LDR  00942cz  a2200205n  4500
=001  9880364211102441
=005  20141212215007.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031943
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x269.$x500
=150  \\$aCynara scolymus
=450  \\$aArtichoke
=450  \\$wnnna$aArtichokes
=450  \\$wnnna$ascolymus, Cynara
=550  \\$wg$aCynara
=667  \\$aSCOLYMUS genus is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus CYNARA, family ASTERACEAE. The flower bud is the familiar artichoke eaten as a vegetable.
=688  \\$a2003
=750  \0$aArtichokes$5IEN-M$0(DLC)sh 85008150

=LDR  00919cz  a2200241n  4500
=001  9880364211202441
=005  20141212215007.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x269
=150  \\$aCynara
=450  \\$aCardoon
=450  \\$wnnna$aCardoons
=450  \\$wnnna$acardunculus, Cynara
=450  \\$wnnna$aCynara cardunculus
=450  \\$wnnna$aCynaras
=550  \\$wg$aAsteraceae
=550  \\$wh$aCynara scolymus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE.
=688  \\$a2003
=750  \0$aCynara$5IEN-M$0(DLC)sh 85035149

=LDR  01028cz  a2200277n  4500
=001  9880364211302441
=005  20141212215006.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x830.$x450
=072  \\$aC22.$x362.$x450
=072  \\$aC23.$x550.$x470.$x790.$x500.$x900.$x400
=150  \\$aHemorrhagic Septicemia, Viral
=450  \\$wnnna$aHaemorrhagic Septicaemia, Viral
=450  \\$wnnna$aSepticaemia, Viral Haemorrhagic
=450  \\$wnnna$aSepticemia, Viral Hemorrhagic
=450  \\$wnnna$aViral Haemorrhagic Septicaemia
=450  \\$wnnna$aViral Hemorrhagic Septicemia
=550  \\$wg$aFish Diseases
=550  \\$wg$aRhabdoviridae Infections
=550  \\$wg$aViremia
=550  \\$aHemorrhagic Septicemia
=680  \\$iA systemic infection of various salmonid and a few nonsalmonid fishes caused by Viral hemorrhagic septicemia virus (see NOVIRHABDOVIRUS),
=688  \\$a2003
=750  \0$aViral hemorrhagic septicemia$5IEN-M$0(DLC)sh 85143731

=LDR  01933cz  a2200397n  4500
=001  9880364211402441
=005  20141212215006.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x955.$x416
=072  \\$aC4.$x850.$x908.$x416
=072  \\$aC13.$x703.$x720.$x949.$x416
=150  \\$aGestational Trophoblastic Disease
=450  \\$wnnna$aDisease, Gestational Trophoblastic
=450  \\$wnnna$aDiseases, Gestational Trophoblastic
=450  \\$wnnna$aGestational Trophoblastic Diseases
=450  \\$wnnna$aGestational Trophoblastic Neoplasia
=450  \\$wnnna$aGestational Trophoblastic Neoplasm
=450  \\$aGestational Trophoblastic Neoplasms
=450  \\$wnnna$aNeoplasia, Gestational Trophoblastic
=450  \\$wnnna$aNeoplasm, Gestational Trophoblastic
=450  \\$wnnna$aNeoplasms, Gestational Trophoblastic
=450  \\$wnnna$aTrophoblastic Disease, Gestational
=450  \\$wnnna$aTrophoblastic Diseases, Gestational
=450  \\$wnnna$aTrophoblastic Neoplasia, Gestational
=450  \\$wnnna$aTrophoblastic Neoplasm, Gestational
=450  \\$aTrophoblastic Neoplasms, Gestational
=550  \\$wg$aTrophoblastic Neoplasms
=550  \\$wh$aChoriocarcinoma
=550  \\$wh$aHydatidiform Mole
=680  \\$iA group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.
=688  \\$a2012 (2003)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Gestational Trophoblastic Neoplasms
=688  \\$a2003
=750  \0$aGestational trophoblastic disease$5IEN-M$0(DLC)sh2012001931

=LDR  01579cz  a2200373n  4500
=001  9880364211502441
=005  20141212215005.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031885
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x182
=150  \\$aCimicifuga
=450  \\$wnnna$aActaea racemosa
=450  \\$wnnna$aActaea racemosas
=450  \\$wnnna$aBlack Bugbane
=450  \\$wnnna$aBlack Bugbanes
=450  \\$aBlack Cohosh
=450  \\$wnnna$aBlack Cohoshs
=450  \\$aBugbane, Black
=450  \\$wnnna$aBugbanes, Black
=450  \\$wnnna$aCimicifuga racemosa
=450  \\$wnnna$aCimicifuga racemosas
=450  \\$wnnna$aCimicifugas
=450  \\$aCohosh, Black
=450  \\$wnnna$aCohoshs, Black
=450  \\$wnnna$aracemosa, Actaea
=450  \\$wnnna$aracemosa, Cimicifuga
=450  \\$wnnna$aracemosas, Actaea
=450  \\$wnnna$aracemosas, Cimicifuga
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE that contains triterpenoid saponins. Remifemin from C. racemosa is used to suppress LUTEINIZING HORMONE. It is reclassified by some to ACTAEA. The common name of black snakeroot is also used with ASARUM and SANICULA.
=688  \\$a2003
=750  \0$aBugbane$5IEN-M$0(DLC)sh 85017668

=LDR  00979cz  a2200217n  4500
=001  9880364211602441
=005  20141212215005.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031884
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x88
=150  \\$aAquilegia
=450  \\$wnnna$aAquilegias
=450  \\$aColumbine
=450  \\$wnnna$aColumbines
=550  \\$wg$aRanunculaceae
=550  \\$aSemiaquilegia
=667  \\$aAQUILEGIA ADOXOIDES see SEMIAQUILEGIA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE that contains aquiledine, isoaquiledine and cycloartane-type glycosides.
=688  \\$a2003
=750  \0$aColumbines$5IEN-M$0(DLC)sh 88022559

=LDR  01356cz  a2200277n  4500
=001  9880364211702441
=005  20141212215004.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031883
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x77
=150  \\$aAnemone
=450  \\$wnnna$aAnemone hepatica
=450  \\$wnnna$aAnemone hepaticas
=450  \\$wnnna$aAnemone raddeana
=450  \\$wnnna$aAnemone raddeanas
=450  \\$wnnna$aAnemones
=450  \\$wnnna$ahepatica, Anemone
=450  \\$wnnna$ahepaticas, Anemone
=450  \\$wnnna$araddeana, Anemone
=450  \\$wnnna$araddeanas, Anemone
=550  \\$wg$aRanunculaceae
=667  \\$aX ref ANEMONE: venom of Conus anemone use MOLLUSK VENOMS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE that contains triterpene saponins. The root of Anemone raddeana is the source of a Chinese folk medicine, zhu jie xian fu. The common name of liverwort is also used with other plants. This genus is unrelated to SEA ANEMONES.
=688  \\$a2003
=750  \0$aAnemone$5IEN-M

=LDR  00880cz  a2200205n  4500
=001  9880364211802441
=005  20141212215004.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x277
=150  \\$aDelphinium
=450  \\$wnnna$aDelphiniums
=450  \\$aLarkspur
=450  \\$wnnna$aLarkspurs
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain ACONITINE and other diterpenoid alkaloids.
=688  \\$a2003
=750  \0$aDelphinium$5IEN-M$0(DLC)sh 85036604

=LDR  01133cz  a2200277n  4500
=001  9880364211902441
=005  20141212215004.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x518.$x750
=150  \\$aNigella sativa
=450  \\$aBlack Cumin
=450  \\$wnnna$aBlack Cumins
=450  \\$aCumin, Black
=450  \\$wnnna$aCumins, Black
=450  \\$aKalonji
=450  \\$wnnna$aKalonjus
=450  \\$wnnna$aNigella sativas
=450  \\$wnnna$asativa, Nigella
=450  \\$wnnna$asativas, Nigella
=550  \\$wg$aNigella
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE that contains alpha-hederin, a triterpene saponin in the seeds, and is the source of black seed oil.
=688  \\$a2003
=750  \0$aBlack cumin$5IEN-M$0(DLC)sh 99000721

=LDR  01178cz  a2200253n  4500
=001  9880364212002441
=005  20141212215003.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x518.$x500
=150  \\$aNigella damascena
=450  \\$wnnna$adamascena, Nigella
=450  \\$wnnna$adamascenas, Nigella
=450  \\$aFennel, Wild
=450  \\$wnnna$aFennels, Wild
=450  \\$wnnna$aNigella damascenas
=450  \\$wnnna$aWild Fennel
=450  \\$wnnna$aWild Fennels
=550  \\$wg$aNigella
=667  \\$aX ref Fennel, Wild: other fennel terms are also available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. The name is similar to giant fennel (FERULA), true fennel (FOENICULUM), and dog fennel (ANTHEMIS).
=688  \\$a2003
=750  \0$aLove-in-a-mist$5IEN-M$0(DLC)sh 99000718

=LDR  00826cz  a2200205n  4500
=001  9880364212102441
=005  20141212215002.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x518
=150  \\$aNigella
=450  \\$wnnna$aNigellas
=550  \\$wg$aRanunculaceae
=550  \\$wh$aNigella damascena
=550  \\$wh$aNigella sativa
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE.
=688  \\$a2003
=750  \0$aNigella$5IEN-M$0(DLC)sh 99000704

=LDR  01129cz  a2200277n  4500
=001  9880364212202441
=005  20141212215002.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x36
=150  \\$aAdonis
=450  \\$wnnna$aAdoni
=450  \\$wnnna$aAdonis vernali
=450  \\$wnnna$aAdonis vernalis
=450  \\$wnnna$aDaisies, Oxeye
=450  \\$aDaisy, Oxeye
=450  \\$wnnna$aOxeye Daisies
=450  \\$aOxeye Daisy
=450  \\$wnnna$avernali, Adonis
=450  \\$wnnna$avernalis, Adonis
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain cardenolide oligoglycosides such as adoniside, adonisidum and alepposide.
=688  \\$a2003
=750  \0$aAdonis (Plant)$5IEN-M$0(DLC)sh 88022524

=LDR  01420cz  a2200313n  4500
=001  9880364212302441
=005  20141212215001.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x22
=150  \\$aAconitum
=450  \\$wnnna$aAconite
=450  \\$wnnna$aAconites
=450  \\$wnnna$aAconiti, Radix
=450  \\$wnnna$aAconitum napellus
=450  \\$wnnna$aAconitums
=450  \\$wnnna$aAconitus, Radix
=450  \\$aMonkshood
=450  \\$wnnna$aMonkshoods
=450  \\$wnnna$anapellus, Aconitum
=450  \\$wnnna$aRadix Aconiti
=450  \\$wnnna$aRadix Aconitus
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.
=688  \\$a2003
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Aconite
=750  \0$aMonkshoods$5IEN-M$0(DLC)sh 87001925

=LDR  01088cz  a2200277n  4500
=001  9880364212402441
=005  20141212193025.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031825
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x829.$x774
=150  \\$aPrimula
=450  \\$wnnna$aCowslip
=450  \\$wnnna$aCowslips
=450  \\$aPrimrose
=450  \\$wnnna$aPrimroses
=450  \\$wnnna$aPrimula veri
=450  \\$wnnna$aPrimula veris
=450  \\$wnnna$aPrimulas
=450  \\$wnnna$averi, Primula
=450  \\$wnnna$averis, Primula
=550  \\$wg$aPrimulaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family PRIMULACEAE. It can cause CONTACT DERMATITIS. SAPONINS have been identified in the root.
=688  \\$a2003
=750  \0$aPrimroses$5IEN-M$0(DLC)sh 85106708

=LDR  00790cz  a2200181n  4500
=001  9880364212502441
=005  20141212215000.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031824
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x829.$x549
=150  \\$aCyclamen
=450  \\$wnnna$aCyclamens
=550  \\$wg$aPrimulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PRIMULACEAE that contains triterpenoid saponins.
=688  \\$a2003
=750  \0$aCyclamen$5IEN-M$0(DLC)sh 85035058

=LDR  01087cz  a2200277n  4500
=001  9880364212602441
=005  20200422111604.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x984.$x500
=150  \\$aPortulaca
=450  \\$wnnna$aoleracae, Portulaca
=450  \\$wnnna$aoleracea, Portulaca
=450  \\$wnnna$aoleraceas, Portulaca
=450  \\$wnnna$aPortulaca oleracae
=450  \\$wnnna$aPortulaca oleracea
=450  \\$wnnna$aPortulaca oleraceas
=450  \\$wnnna$aPortulacas
=450  \\$aPurslane
=450  \\$wnnna$aPurslanes
=550  \\$wg$aPortulacaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PORTULACACEAE.
=688  \\$a2003
=750  \0$aPortulaca$5IEN-M$0(DLC)sh 88023027

=LDR  00855cz  a2200193n  4500
=001  9880364212702441
=005  20141212214959.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x699
=150  \\$aPotamogetonaceae
=450  \\$aPotamogeton
=450  \\$wnnna$aPotamogetons
=550  \\$wg$aAlismatidae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Najadales, subclass Alismatidae, class Liliopsida (monocotyledons).
=688  \\$a2003
=750  \0$aPotamogetonaceae$5IEN-M$0(DLC)sh 88023034

=LDR  01031cz  a2200229n  4500
=001  9880364212802441
=005  20141212214959.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031806
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x826.$x500
=150  \\$aEichhornia
=450  \\$wnnna$aEichhornias
=450  \\$aHyacinth, Water
=450  \\$wnnna$aHyacinths, Water
=450  \\$aWater Hyacinth
=450  \\$wnnna$aWater Hyacinths
=550  \\$wg$aPontederiaceae
=667  \\$aX ref WATER HYACINTH: HYACINTH see HYACINTHUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PONTEDERIACEAE that is used as a biological filter for treating wastewater.
=688  \\$a2003
=750  \0$aEichhornia$5IEN-M$0(DLC)sh 86006838

=LDR  01139cz  a2200205n  4500
=001  9880364212902441
=005  20141212214958.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x826
=150  \\$aPontederiaceae
=450  \\$aPontederia
=450  \\$wnnna$aPontederias
=550  \\$wg$aAngiosperms
=550  \\$wh$aEichhornia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledons). Most species are perennials, native primarily to tropical America. They have creeping rootstocks, fibrous roots, and leaves in clusters at the base of the plant or borne on branched stems. The fruit is a capsule containing many seeds, or a one-seeded winged structure.
=688  \\$a2003
=750  \0$aPontederiaceae$5IEN-M$0(DLC)sh 86006839

=LDR  01038cz  a2200277n  4500
=001  9880364213002441
=005  20141212214958.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031804
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x850
=150  \\$aRumex
=450  \\$aCanaigre
=450  \\$wnnna$aCanaigres
=450  \\$aDock, Yellow
=450  \\$wnnna$aDocks, Yellow
=450  \\$wnnna$aRumices
=450  \\$aSorrel
=450  \\$wnnna$aSorrels
=450  \\$aYellow Dock
=450  \\$wnnna$aYellow Docks
=550  \\$wg$aPolygonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYGONACEAE that contains patientosides and other naphthalene glycosides.
=688  \\$a2003
=750  \2$aDocks (Plants)$5IEN-M

=LDR  01047cz  a2200277n  4500
=001  9880364213102441
=005  20141212214958.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031803
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x306
=150  \\$aEriogonum
=450  \\$aBuckwheat, Red
=450  \\$aBuckwheat, Wild
=450  \\$wnnna$aBuckwheats, Red
=450  \\$wnnna$aBuckwheats, Wild
=450  \\$wnnna$aEriogonums
=450  \\$wnnna$aRed Buckwheat
=450  \\$wnnna$aRed Buckwheats
=450  \\$wnnna$aWild Buckwheat
=450  \\$wnnna$aWild Buckwheats
=550  \\$wg$aPolygonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYGONACEAE.
=688  \\$a2003
=750  \0$aEriogonum$5IEN-M$0(DLC)sh 88022777

=LDR  01161cz  a2200229n  4500
=001  9880364213202441
=005  20141212214957.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x823.$x500
=150  \\$aPolygala
=450  \\$wnnna$aPolygalas
=450  \\$wnnna$aSeneca Snakeroot
=450  \\$wnnna$aSeneca Snakeroots
=450  \\$aSnakeroot, Seneca
=450  \\$wnnna$aSnakeroots, Seneca
=550  \\$wg$aPolygalaceae
=667  \\$aother snakeroots are available such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POLYGALACEAE that contains onjisaponins, xanthones, pyrones, and benzophenones. The name is similar to other snakeroots such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; and others.
=688  \\$a2003
=750  \0$aPolygala$5IEN-M$0(DLC)sh 88023014

=LDR  01404cz  a2200349n  4500
=001  9880364213302441
=005  20141212214957.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031787
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x844
=150  \\$aSasa
=450  \\$wnnna$aalbomarginata, Sasa
=450  \\$wnnna$aalbomarginatas, Sasa
=450  \\$aBamboo Grass
=450  \\$wnnna$aBamboo Grasses
=450  \\$aGrass, Bamboo
=450  \\$wnnna$aGrasses, Bamboo
=450  \\$aKumazasa
=450  \\$wnnna$aKumazasas
=450  \\$wnnna$akurinenses, Sasa
=450  \\$wnnna$akurinensis, Sasa
=450  \\$wnnna$aSasa albomarginata
=450  \\$wnnna$aSasa albomarginatas
=450  \\$wnnna$aSasa kurinenses
=450  \\$wnnna$aSasa kurinensis
=450  \\$wnnna$aSasas
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. Folin is the water-soluble extract from Sasa albomarginata. Sasa kurinensis is an ingredient of Sho-ju-sen, a Japanese herbal medicine.
=688  \\$a2003
=750  \0$aHymenachne amplexicaulis$0(DLC)sh2008020156$5IEN-M

=LDR  00889cz  a2200205n  4500
=001  9880364213402441
=005  20141212214956.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031786
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x835
=150  \\$aSaccharum
=450  \\$wnnna$aSaccharums
=450  \\$aSugarcane
=450  \\$wnnna$aSugarcanes
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.
=688  \\$a2003
=750  \0$aSaccharum$5IEN-M$0(DLC)sh 85116227

=LDR  01117cz  a2200289n  4500
=001  9880364213502441
=005  20141212214956.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x793
=150  \\$aPoa
=450  \\$wnnna$aBlue Grass, Kentucky
=450  \\$aBluegrass
=450  \\$wnnna$aBluegrasses
=450  \\$aGrass, Kentucky Blue
=450  \\$aKentucky Blue Grass
=450  \\$wnnna$aPoa pratenses
=450  \\$wnnna$aPoa pratensis
=450  \\$wnnna$aPoas
=450  \\$wnnna$apratenses, Poa
=450  \\$wnnna$apratensis, Poa
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that contains the Poa p Ia allergen and allergen C KBGP.
=688  \\$a2003
=750  \0$aBluegrasses$5IEN-M$0(DLC)sh 85015065

=LDR  00913cz  a2200229n  4500
=001  9880364213602441
=005  20141212214955.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031784
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x788
=150  \\$aPhleum
=450  \\$aGrass, Timothy
=450  \\$wnnna$aGrasses, Timothy
=450  \\$wnnna$aPhleums
=450  \\$aTimothy Grass
=450  \\$wnnna$aTimothy Grasses
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that contains the Phl p 4 allergen.
=688  \\$a2003
=750  \0$aPhleum$5IEN-M$0(DLC)sh 88022987

=LDR  00948cz  a2200253n  4500
=001  9880364213702441
=005  20141212214955.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x777
=150  \\$aPhalaris
=450  \\$wnnna$aCanary Grass
=450  \\$wnnna$aCanary Grasses
=450  \\$aCanarygrass
=450  \\$wnnna$aCanarygrasses
=450  \\$aGrass, Canary
=450  \\$wnnna$aGrasses, Canary
=450  \\$wnnna$aPhalari
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE.
=688  \\$a2003
=750  \0$aPhalaris$5IEN-M$0(DLC)sh 88022981

=LDR  01284cz  a2200325n  4500
=001  9880364213802441
=005  20141212214955.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x755
=150  \\$aPennisetum
=450  \\$aBajra
=450  \\$wnnna$aBajras
=450  \\$wnnna$aFountain Grass
=450  \\$wnnna$aFountain Grasses
=450  \\$aFountaingrass
=450  \\$wnnna$aFountaingrasses
=450  \\$aGrass, Fountain
=450  \\$wnnna$aGrasses, Fountain
=450  \\$aMillet, Pearl
=450  \\$wnnna$aMillets, Pearl
=450  \\$wnnna$aPearl Millet
=450  \\$wnnna$aPearl Millets
=450  \\$wnnna$aPennisetums
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The seed is one of the millets used in CEREALS. It contains vitexin. The common name of buffelgrass is also used for CENCHRUS.
=688  \\$a2003
=750  \0$aPennisetum$5IEN-M$0(DLC)sh 85099509

=LDR  00869cz  a2200205n  4500
=001  9880364213902441
=005  20141212214912.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x945
=150  \\$aSideritis
=450  \\$aIronwort
=450  \\$wnnna$aIronworts
=450  \\$wnnna$aSideritides
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains isoscutellarein-7-O-(allosyl(1-2)glucoside).
=688  \\$a2003
=750  \0$aSideritis$5IEN-M$0(DLC)sh 97003259

=LDR  00837cz  a2200193n  4500
=001  9880364214002441
=005  20141212214911.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031363
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x942
=150  \\$aScutellaria
=450  \\$wnnna$aScutellarias
=550  \\$wg$aLamiaceae
=550  \\$wh$aScutellaria baicalensis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE used in folk medicine as a nervine.
=688  \\$a2003
=750  \0$aScutellaria$5IEN-M$0(DLC)sh 96008797

=LDR  00961cz  a2200253n  4500
=001  9880364214102441
=005  20141212214911.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x935
=150  \\$aSatureja
=450  \\$wnnna$aPlant, Savory
=450  \\$wnnna$aPlants, Savory
=450  \\$wnnna$aSaturejas
=450  \\$wnnna$aSavories
=450  \\$aSavory
=450  \\$aSavory Plant
=450  \\$wnnna$aSavory Plants
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE used to flavor food.
=688  \\$a2003
=750  \0$aSavory$5IEN-M$0(DLC)sh2003004917

=LDR  01029cz  a2200253n  4500
=001  9880364214202441
=005  20141212214910.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031347
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x755
=150  \\$aPrunella
=450  \\$wnnna$aPrunella vulgari
=450  \\$wnnna$aPrunella vulgaris
=450  \\$wnnna$aPrunellas
=450  \\$wnnna$avulgari, Prunella
=450  \\$wnnna$avulgaris, Prunella
=450  \\$aXiakucao
=450  \\$wnnna$aXiakucaos
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE. Members contain TRITERPENES. Heal all is another common name.
=688  \\$a2003
=750  \0$aPrunella$5IEN-M$0(DLC)sh 85108038

=LDR  01123cz  a2200265n  4500
=001  9880364214302441
=005  20161109162521.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031346
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x520.$x753
=150  \\$aPlectranthus
=450  \\$wnnna$aColeus barbatus
=450  \\$wnnna$aColeus forskohli
=450  \\$wnnna$aColeus forskohlii
=450  \\$wnnna$aForskohli
=450  \\$wnnna$aForskohlius
=450  \\$wnnna$aPlectranthus barbatus
=450  \\$wnnna$abarbatus, Coleus
=450  \\$wnnna$abarbatus, Plectranthus
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains eudesmane sesquiterpenes and antimicrobial abietane diterpenoids.
=688  \\$a2003
=750  \0$aPlectranthus$0(DLC)sh2007002827$5IEN-M

=LDR  00823cz  a2200181n  4500
=001  9880364214402441
=005  20141212214910.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031345
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x750
=150  \\$aPhlomis
=450  \\$wnnna$aPhlomi
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains phlorigidosides, iridoid glucosides and megastigmane glycosides.
=688  \\$a2003
=750  \0$aPhlomis$5IEN-M$0(DLC)sh 98007963

=LDR  00901cz  a2200193n  4500
=001  9880364214502441
=005  20141212214909.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031343
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x743
=150  \\$aPerilla
=450  \\$wnnna$aPerillas
=550  \\$wg$aLamiaceae
=550  \\$wh$aPerilla frutescens
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that is a source of perilla alcohol and the oil is rich in alpha-linolenic acid (alpha-18:3).
=688  \\$a2003
=750  \0$aPerilla$5IEN-M$0(DLC)sh 98003959

=LDR  01522cz  a2200421n  4500
=001  9880364214602441
=005  20141212214909.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x702
=150  \\$aOriganum
=450  \\$wnnna$ahortenses, Majorana
=450  \\$wnnna$ahortensis, Majorana
=450  \\$wnnna$aMajorana hortenses
=450  \\$aMajorana hortensis
=450  \\$wnnna$amajorana, Origanum
=450  \\$wnnna$amajoranas, Origanum
=450  \\$aMarjoram
=450  \\$aMarjoram Plant
=450  \\$wnnna$aMarjoram Plants
=450  \\$wnnna$aMarjorams
=450  \\$aOregano
=450  \\$aOregano Plant
=450  \\$wnnna$aOregano Plants
=450  \\$wnnna$aOreganos
=450  \\$wnnna$aOriganum majorana
=450  \\$wnnna$aOriganum majoranas
=450  \\$wnnna$aOriganums
=450  \\$wnnna$aPlant, Marjoram
=450  \\$wnnna$aPlant, Oregano
=450  \\$wnnna$aPlants, Marjoram
=450  \\$wnnna$aPlants, Oregano
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that is the source of a familiar food seasoning.
=688  \\$a2003
=750  \0$aOriganum$5IEN-M$0(DLC)sh 85095644

=LDR  00886cz  a2200181n  4500
=001  9880364214702441
=005  20141212214908.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031338
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x510
=150  \\$aMonarda
=450  \\$wnnna$aMonardas
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MELISSA. The common name of bergamot is also used for Citrus bergamia (CITRUS).
=688  \\$a2003
=750  \0$aMonarda$5IEN-M$0(DLC)sh 96008780

=LDR  00931cz  a2200229n  4500
=001  9880364214802441
=005  20141212214908.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031337
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x483.$x750
=150  \\$aMentha spicata
=450  \\$wnnna$aMentha spicatas
=450  \\$aSpearmint
=450  \\$wnnna$aSpearmints
=450  \\$wnnna$aspicata, Mentha
=450  \\$wnnna$aspicatas, Mentha
=550  \\$wg$aMentha
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE having characteristic flavor.
=688  \\$a2003
=750  \0$aSpearmint$5IEN-M$0(DLC)sh 00003443

=LDR  00992cz  a2200229n  4500
=001  9880364214902441
=005  20141212214906.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031334
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x474
=150  \\$aMelissa
=450  \\$wnnna$aMelissa officinali
=450  \\$wnnna$aMelissa officinalis
=450  \\$wnnna$aMelissas
=450  \\$wnnna$aofficinali, Melissa
=450  \\$wnnna$aofficinalis, Melissa
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MONARDA.
=688  \\$a2003
=750  \0$aMelissa (Plants)$5IEN-M$0(DLC)sh 00005576

=LDR  00803cz  a2200193n  4500
=001  9880364215002441
=005  20141212214906.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031332
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x446
=150  \\$aLeonurus
=450  \\$aMotherwort
=450  \\$wnnna$aMotherworts
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains leonurine.
=688  \\$a2003
=750  \0$aLeonurus$5IEN-M$0(DLC)sh 85076030

=LDR  00761cz  a2200169n  4500
=001  9880364215102441
=005  20161021164416.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x520.$x166
=150  \\$aColeus
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE which is the natural source of COLFORSIN.
=688  \\$a2003
=750  \0$aColeus$5IEN-M$0(DLC)sh 88022690

=LDR  00893cz  a2200205n  4500
=001  9880364215202441
=005  20141212214904.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x51
=150  \\$aAjuga
=450  \\$wnnna$aAjugas
=450  \\$aBugle
=450  \\$wnnna$aBugles
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains cyasterone, ajugasterone, 20-hydroxyecdysone, 8-acetylharpagide (an iridoid glycoside).
=688  \\$a2003
=750  \0$aAjuga$0(DLC)sh2008003159$5IEN-M

=LDR  00977cz  a2200229n  4500
=001  9880364215302441
=005  20141212214904.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031327
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x49
=150  \\$aAgastache
=450  \\$wnnna$aAgastaches
=450  \\$wnnna$aGiant Hyssop
=450  \\$wnnna$aGiant Hyssops
=450  \\$aHyssop, Giant
=450  \\$wnnna$aHyssops, Giant
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that contains tilianin, agastanol, and agastaquinone (a cytotoxic diterpenoid quinone).
=688  \\$a2003
=750  \0$aAgastache$5IEN-M$0(DLC)sh 86006000

=LDR  00970cz  a2200241n  4500
=001  9880364215402441
=005  20141212214904.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031326
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x572
=150  \\$aKrameriaceae
=450  \\$aKrameria
=450  \\$wnnna$aKramerias
=450  \\$wnnna$aRatanies
=450  \\$aRatany
=450  \\$wnnna$aRhatanies
=450  \\$aRhatany
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2003; for RHATANY use KRAMERIACEAE 1992-2002
=750  \0$aKrameriaceae$5IEN-M$0(DLC)sh 90000388

=LDR  01389cz  a2200397n  4500
=001  9880364215502441
=005  20141212214903.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031325
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x569.$x249
=150  \\$aCarya
=450  \\$wnnna$aCarya illinoenses
=450  \\$wnnna$aCarya illinoensis
=450  \\$wnnna$aCaryas
=450  \\$wnnna$aHickory Nut
=450  \\$aHickory Nuts
=450  \\$aHickory Tree
=450  \\$wnnna$aHickory Trees
=450  \\$wnnna$aillinoenses, Carya
=450  \\$wnnna$aillinoensis, Carya
=450  \\$wnnna$aNut, Hickory
=450  \\$wnnna$aNuts, Hickory
=450  \\$wnnna$aPecan
=450  \\$aPecan Tree
=450  \\$wnnna$aPecan Trees
=450  \\$aPecans
=450  \\$wnnna$aTree, Hickory
=450  \\$wnnna$aTree, Pecan
=450  \\$wnnna$aTrees, Hickory
=450  \\$wnnna$aTrees, Pecan
=550  \\$wg$aJuglandaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family JUGLANDACEAE that bears edible nuts.
=688  \\$a2003
=750  \0$aHickories$5IEN-M$0(DLC)sh 85060616

=LDR  00954cz  a2200241n  4500
=001  9880363671402441
=005  20141212202024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006394
=035  \\$aCAZ9565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x795.$x390
=072  \\$aC4.$x557.$x645.$x390
=150  \\$aHemangiosarcoma
=450  \\$aAngiosarcoma
=450  \\$wnnna$aAngiosarcomas
=450  \\$wnnna$aHemangiosarcomas
=550  \\$wg$aNeoplasms, Vascular Tissue
=550  \\$wg$aSarcoma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
=688  \\$a86; was ANGIOSARCOMA 1963-85
=750  \0$aAngiosarcoma$5IEN$0(DLC)sh 85005032

=LDR  01742cz  a2200433n  4500
=001  9880363671502441
=005  20141212202023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006391
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x645.$x375
=150  \\$aHemangioma
=450  \\$aAngioma
=450  \\$wnnna$aChorangioma
=450  \\$wnnna$aChorangiomas
=450  \\$aChorioangioma
=450  \\$wnnna$aChorioangiomas
=450  \\$aHemangioma, Histiocytoid
=450  \\$aHemangioma, Intramuscular
=450  \\$wnnna$aHemangiomas
=450  \\$wnnna$aHemangiomas, Histiocytoid
=450  \\$wnnna$aHemangiomas, Intramuscular
=450  \\$wnnna$aHistiocytoid Hemangioma
=450  \\$wnnna$aHistiocytoid Hemangiomas
=450  \\$wnnna$aIntramuscular Hemangioma
=450  \\$wnnna$aIntramuscular Hemangiomas
=550  \\$wg$aNeoplasms, Vascular Tissue
=550  \\$wh$aCentral Nervous System Venous Angioma
=550  \\$wh$aHemangioendothelioma
=550  \\$wh$aHemangioma, Capillary
=550  \\$wh$aHemangioma, Cavernous
=550  \\$wh$aKasabach-Merritt Syndrome
=550  \\$wh$aSturge-Weber Syndrome
=550  \\$aArteriovenous Malformations
=550  \\$aPulmonary Sclerosing Hemangioma
=667  \\$acoordinate IM with pre-coordinated organ/neoplasm term (IM); note specific hemangioma terms are also available
=680  \\$iA vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
=750  \0$aHemangiomas$5IEN-M$0(DLC)sh 85060117
=750  \0$aAngiomas$5IEN-HS$0(DLC)sh 85005028

=LDR  00931cz  a2200205n  4500
=001  9880363671602441
=005  20141212202021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x136.$x377
=150  \\$aHemagglutinins
=450  \\$wnnna$aExohemagglutinins
=450  \\$wnnna$aHemagglutinin
=450  \\$aIsohemagglutinins
=550  \\$wg$aAgglutinins
=667  \\$arestrict to erythrocytes: leukoagglutinins are indexed under AGGLUTININS (IM) + LEUKOCYTES or specific with /immunol (IM)
=680  \\$iAgents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.
=688  \\$a81(75); was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67
=750  \0$aHemagglutinin$5IEN$0(DLC)sh 85060116

=LDR  00939cz  a2200265n  4500
=001  9880363671702441
=005  20141212202020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006386
=035  \\$aCAZ9557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x50.$x375
=072  \\$aE5.$x200.$x812.$x735.$x50.$x375
=072  \\$aE5.$x478.$x594.$x760.$x50.$x375
=150  \\$aHemagglutination Tests
=450  \\$wnnna$aHemagglutination Test
=450  \\$wnnna$aTest, Hemagglutination
=450  \\$wnnna$aTests, Hemagglutination
=550  \\$wg$aAgglutination Tests
=550  \\$wh$aCoombs Test
=550  \\$aHemagglutination
=550  \\$aHemagglutination, Viral
=680  \\$iSensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)
=688  \\$a66
=750  \0$aHemagglutination tests$5IEN$0(DLC)sh 85060115

=LDR  00829cz  a2200229n  4500
=001  9880363671802441
=005  20141212202019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006384
=035  \\$aCAZ9555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x26.$x500
=072  \\$aG2.$x149.$x115.$x26.$x500
=072  \\$aG12.$x425.$x143.$x100.$x200
=150  \\$aHemagglutination
=450  \\$wnnna$aHemagglutinations
=550  \\$wg$aAgglutination
=550  \\$wh$aHemagglutination, Viral
=550  \\$aHemagglutination Tests
=667  \\$aintravascular hemagglutination = ERYTHROCYTE AGGREGATION, INTRAVASCULAR
=680  \\$iThe aggregation of ERYTHROCYTES by AGGLUTININS, including antibodies, lectins, and viral proteins (HEMAGGLUTINATION, VIRAL).
=750  \0$aBlood$xAgglutination$5IEN$0(DLC)sh 85014928

=LDR  00685cz  a2200217n  4500
=001  9880363671902441
=005  20141212202018.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006379
=035  \\$aCAZ9550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x225
=150  \\$aHelping Behavior
=450  \\$wnnna$aBehavior, Helping
=450  \\$wnnna$aBehaviors, Helping
=450  \\$wnnna$aHelping Behaviors
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iBehaviors associated with the giving of assistance or aid to individuals.
=688  \\$a79(75); was see under SOCIAL BEHAVIOR 1975-78
=750  \0$aHelping behavior$5IEN$0(DLC)sh 85060103

=LDR  01320cz  a2200361n  4500
=001  9880363672002441
=005  20141212202016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006376
=035  \\$aCAZ9547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500
=150  \\$aHelminths
=450  \\$wnnna$aAschelminthe
=450  \\$aAschelminthes
=450  \\$aGordius
=450  \\$wnnna$aHelminth
=450  \\$aNematomorpha
=450  \\$wnnna$aNematomorphas
=450  \\$wnnna$aParasitic Worm
=450  \\$aParasitic Worms
=450  \\$wnnna$aWorm, Parasitic
=450  \\$aWorms, Parasitic
=550  \\$wg$aInvertebrates
=550  \\$wh$aAcanthocephala
=550  \\$wh$aNematoda
=550  \\$wh$aPlatyhelminths
=550  \\$wh$aRotifera
=667  \\$aGEN or unspecified; prefer specifics; infection = HELMINTHIASIS; coord with specific precoord helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent
=680  \\$iCommonly known as parasitic worms, this group includes the ACANTHOCEPHALA; NEMATODA; and PLATYHELMINTHS. Some authors consider certain species of LEECHES that can become temporarily parasitic as helminths.
=688  \\$aASCHELMINTHES was heading 1976-85
=750  \0$aMedical helminthology$5IEN-M$0(DLC)sh 85082941
=750  \0$aHelminths$5IEN-M$0(DLC)sh 85060076

=LDR  00540cz  a2200181n  4500
=001  9880363672102441
=005  20141212202016.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006375
=035  \\$aCAZ9546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x420
=150  \\$aHelminthosporium
=450  \\$wnnna$aHelminthosporiums
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic fungal genus including both saprophytes and plant parasites.
=688  \\$a91(75)
=750  \0$aHelminthosporium$5IEN$0(DLC)sh 88022063

=LDR  01203cz  a2200349n  4500
=001  9880363672202441
=005  20141212202016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006374
=035  \\$aCAZ9545M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x349
=072  \\$aC3.$x701.$x377
=072  \\$aC22.$x674.$x377
=150  \\$aHelminthiasis, Animal
=450  \\$wnnna$aAnimal Helminthiases
=450  \\$wnnna$aAnimal Helminthiasis
=450  \\$wnnna$aHelminthiases, Animal
=450  \\$aHelminthiasis$xveterinary
=550  \\$wg$aHelminthiasis
=550  \\$wg$aParasitic Diseases, Animal
=550  \\$wh$aDictyocaulus Infections
=550  \\$wh$aDirofilariasis
=550  \\$wh$aFascioloidiasis
=550  \\$wh$aMonieziasis
=550  \\$wh$aSetariasis
=550  \\$wh$aStrongyle Infections, Equine
=550  \\$wh$aToxocariasis
=667  \\$aexper or vet; GEN or unspecified; prefer specifics; don't forget to check tag ANIMALS
=680  \\$iInfestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary.
=688  \\$a98; use explode 1975-97
=750  \0$aVeterinary helminthology$5IEN-M$0(DLC)sh 85143034

=LDR  01103cz  a2200289n  4500
=001  9880363672302441
=005  20141212202015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006373
=035  \\$aCAZ9544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335
=150  \\$aHelminthiasis
=450  \\$wnnna$aHelminthiases
=450  \\$wnnna$aInfection, Nematomorpha
=450  \\$wnnna$aInfections, Nematomorpha
=450  \\$wnnna$aNematomorpha Infection
=450  \\$aNematomorpha Infections
=550  \\$wg$aParasitic Diseases
=550  \\$wh$aCestode Infections
=550  \\$wh$aHelminthiasis, Animal
=550  \\$wh$aNematode Infections
=550  \\$wh$aTrematode Infections
=667  \\$ageneral or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent; infections in the intestines: coordinate IM with INTESTINAL DISEASES, PARASITIC (IM)
=680  \\$iInfestation with parasitic worms of the helminth class.
=688  \\$aNEMATOMORPHA INFECTIONS was heading 1975-91 (see under HELMINTHIASIS 1975-90)
=750  \0$aHelminthiasis$5IEN-M$0(DLC)sh 85060073

=LDR  01002cz  a2200181n  4500
=001  9880363672502441
=005  20141212202015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006371
=035  \\$aCAZ9542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613.$x350
=072  \\$aD1.$x362.$x641.$x352
=150  \\$aHelium
=550  \\$wg$aNoble Gases
=667  \\$aa rare gas; He-4; He-3 = HELIUM (IM) + ISOTOPES (NIM); He-5, 6, 8 = HELIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iHelium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. (Dorland, 27th ed)
=750  \0$aHelium$5IEN$0(DLC)sh 85060043

=LDR  00956cz  a2200241n  4500
=001  9880363672602441
=005  20141212202014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006368
=035  \\$aCAZ9539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x400
=072  \\$aJ2.$x500.$x300.$x100.$x287
=150  \\$aHelianthus
=450  \\$wnnna$aArtichoke, Jerusalem
=450  \\$aJerusalem Artichoke
=450  \\$aSunflower
=450  \\$wnnna$aSunflowers
=550  \\$wg$aAnimal Feed
=550  \\$wg$aAsteraceae
=667  \\$afor sunflower seeds coord IM with SEEDS (IM); do not confuse X ref JERUSALEM ARTICHOKE with plain artichoke (index probably VEGETABLES)
=680  \\$iA genus of tall, erect American herbs of the Compositae. The seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum (Jerusalem artichoke) are edible.
=750  \0$aSunflowers$5IEN$0(DLC)sh 85130542

=LDR  01194cz  a2200337n  4500
=001  9880363672702441
=005  20141212202013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006367
=035  \\$aCAZ9538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x251.$x210.$x190.$x400
=072  \\$aA11.$x251.$x860.$x180.$x400
=072  \\$aA11.$x436.$x340
=150  \\$aHeLa Cells
=450  \\$wnnna$aCell, HeLa
=450  \\$wnnna$aCell, Hela
=450  \\$wnnna$aCells, HeLa
=450  \\$wnnna$aCells, Hela
=450  \\$wnnna$aHeLa Cell
=450  \\$wnnna$aHela Cell
=450  \\$aHela Cells
=550  \\$wg$aCell Line, Tumor
=550  \\$wg$aEpithelial Cells
=550  \\$wh$aKB Cells
=667  \\$aalmost always NIM with no subheadings; check HUMAN; do not routinely add UTERINE CERVICAL NEOPLASMS
=680  \\$iThe first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for VIRUS CULTIVATION and antitumor drug screening assays.
=688  \\$a2011 (1965)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Hela Cells
=688  \\$a68(65)
=750  \0$aHeLa cells$5IEN$0(DLC)sh 85059978

=LDR  00697cz  a2200229n  4500
=001  9880363672802441
=005  20141212201943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006294
=035  \\$aCAZ9465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x410.$x250
=150  \\$aHealth Resorts
=450  \\$wnnna$aHealth Resort
=450  \\$wnnna$aResort
=450  \\$wnnna$aResort, Health
=450  \\$aResorts
=450  \\$wnnna$aResorts, Health
=550  \\$wg$aPublic Facilities
=550  \\$aBalneology
=667  \\$asanatoria & sanitaria (often used interchangeably) can go here but consider also HOSPITALS, SPECIAL
=750  \0$aHealth resorts$5IEN$0(DLC)sh 85059593

=LDR  01536cz  a2200457n  4500
=001  9880363672902441
=005  20141212201943.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006293
=035  \\$aCAZ9464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x370
=072  \\$aN2.$x421.$x726.$x507
=150  \\$aHealth Promotion
=450  \\$wnnna$aCampaign, Health
=450  \\$wnnna$aCampaigns, Health
=450  \\$wnnna$aHealth Campaign
=450  \\$aHealth Campaigns
=450  \\$wnnna$aHealth Promotions
=450  \\$wnnna$aItem, Promotional
=450  \\$wnnna$aItems, Promotional
=450  \\$wnnna$aProgram, Wellness
=450  \\$wnnna$aPrograms, Wellness
=450  \\$wnnna$aPromotion, Health
=450  \\$aPromotion of Health
=450  \\$wnnna$aPromotional Item
=450  \\$wnnna$aPromotional Items
=450  \\$wnnna$aPromotions, Health
=450  \\$wnnna$aWellness Program
=450  \\$aWellness Programs
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=550  \\$wg$aPreventive Health Services
=550  \\$wh$aHealthy People Programs
=550  \\$wh$aWeight Reduction Programs
=550  \\$aHealth Education
=550  \\$aPreventive Health Services
=550  \\$aPreventive Medicine
=667  \\$aIM
=680  \\$iEncouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care.
=688  \\$a80
=750  \0$aHealth promotion$0sh 85059591$5IEN

=LDR  01249cz  a2200361n  4500
=001  9880363673002441
=005  20141212201942.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006291
=035  \\$aCAZ9462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x400
=072  \\$aI1.$x880.$x604.$x825.$x608.$x400
=072  \\$aN3.$x623.$x500.$x608.$x428
=150  \\$aHealth Policy
=450  \\$wnnna$aHealth Policies
=450  \\$wnnna$aHealth Policies, National
=450  \\$wnnna$aHealth Policy, National
=450  \\$aMedical Policy$5IEN
=450  \\$wnnna$aNational Health Policies
=450  \\$aNational Health Policy
=450  \\$wnnna$aPolicies, Health
=450  \\$wnnna$aPolicies, National Health
=450  \\$wnnna$aPolicy, Health
=450  \\$wnnna$aPolicy, National Health
=550  \\$wg$aPublic Policy
=550  \\$wh$aHealth Care Reform
=550  \\$wh$aNutrition Policy
=550  \\$aPolicy Making
=667  \\$aspecify state or country or other body if pertinent
=680  \\$iDecisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system.
=688  \\$a80
=750  \0$aMedical policy$5IEN$0(DLC)sh 85083002

=LDR  01851cz  a2200433n  4500
=001  9880363673102441
=005  20141212201940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006285
=035  \\$aCAZ9456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349
=072  \\$aN3.$x706.$x615.$x302
=150  \\$aHealth Planning
=450  \\$aHealth and Welfare Planning
=450  \\$aNational Health Planning and Resources Development Act of 1974
=450  \\$wnnna$aPL93-641
=450  \\$wnnna$aPlanning, Health
=450  \\$aPlanning, Health and Welfare
=450  \\$wnnna$aPublic Law 93-641
=450  \\$wnnna$aPublic Law 93 641
=450  \\$aState Health Planning, United States
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wg$aLegislation as Topic
=550  \\$wh$aHealth Care Rationing
=550  \\$wh$aHealth Care Reform
=550  \\$wh$aHealth Plan Implementation
=550  \\$wh$aHealth Planning Guidelines
=550  \\$wh$aHealth Planning Technical Assistance
=550  \\$wh$aHealth Priorities
=550  \\$wh$aHealth Resources
=550  \\$wh$aHealth Services Research
=550  \\$wh$aNational Health Programs
=550  \\$wh$aRegional Health Planning
=550  \\$aPlanning Techniques
=667  \\$aspecify geog & add UNITED STATES (NIM) for X ref STATE HEALTH PLANNING, UNITED STATES
=680  \\$iPlanning for needed health and/or welfare services and facilities.
=688  \\$a79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; & PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95
=750  \0$aHealth planning$5IEN$0(DLC)sh 85059584

=LDR  01007cz  a2200241n  4500
=001  9880363673202441
=005  20141212201939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006283
=035  \\$aCAZ9454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x368
=072  \\$aH2.$x229.$x333
=150  \\$aHealth Physics
=450  \\$wnnna$aPhysics, Health
=450  \\$wnnna$aPhysics, Radiologic
=450  \\$aRadiologic Physics
=550  \\$wg$aEnvironmental Health
=550  \\$wg$aPhysics
=667  \\$aSPEC: SPEC qualif; physics or phys principles in the field of med = specific med term (IM) + PHYSICS (NIM) or specific phys principle (IM), as "The physics of brachytherapy" = BRACHYTHERAPY (IM) + PHYSICS (NIM)
=680  \\$iThe science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment.
=688  \\$a73(67)
=750  \0$aMedical physics$5IEN$0(DLC)sh 85083001

=LDR  02700cz  a2200757n  4500
=001  9880363673302441
=005  20180223110730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006282
=035  \\$aCAZ9453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485
=072  \\$aN2.$x360
=150  \\$aHealth Personnel
=450  \\$wnnna$aField Worker
=450  \\$wnnna$aField Workers
=450  \\$wnnna$aFieldworker
=450  \\$wnnna$aFieldworkers
=450  \\$wnnna$aHealth Care Provider
=450  \\$aHealth Care Providers
=450  \\$wnnna$aHealthcare Provider
=450  \\$wnnna$aHealthcare Providers
=450  \\$wnnna$aPersonnel, Health
=450  \\$wnnna$aProvider, Health Care
=450  \\$wnnna$aProvider, Healthcare
=450  \\$wnnna$aProviders, Health Care
=450  \\$wnnna$aProviders, Healthcare
=450  \\$wnnna$aWorker, Field
=450  \\$wnnna$aWorkers, Field
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=550  \\$wg$aOccupational Groups
=550  \\$wh$aAllied Health Personnel
=550  \\$wh$aAnatomists
=550  \\$wh$aAnesthetists
=550  \\$wh$aAudiologists
=550  \\$wh$aCaregivers
=550  \\$wh$aCase Managers
=550  \\$wh$aCoroners and Medical Examiners
=550  \\$wh$aDental Staff
=550  \\$wh$aDentists
=550  \\$wh$aDoulas
=550  \\$wh$aEmergency Medical Dispatcher
=550  \\$wh$aEpidemiologists
=550  \\$wh$aFaculty, Dental
=550  \\$wh$aFaculty, Medical
=550  \\$wh$aFaculty, Nursing
=550  \\$wh$aHealth Educators
=550  \\$wh$aHealth Facility Administrators
=550  \\$wh$aInfection Control Practitioners
=550  \\$wh$aMedical Chaperones
=550  \\$wh$aMedical Laboratory Personnel
=550  \\$wh$aMedical Staff
=550  \\$wh$aNurses
=550  \\$wh$aNursing Staff
=550  \\$wh$aNutritionists
=550  \\$wh$aOccupational Therapists
=550  \\$wh$aOptometrists
=550  \\$wh$aPersonnel, Hospital
=550  \\$wh$aPharmacists
=550  \\$wh$aPhysician Executives
=550  \\$wh$aPhysicians
=550  \\$wh$aVeterinarians
=667  \\$apersons working in the field of health: do not confuse with HEALTH MANPOWER, the availability of HEALTH PERSONNEL
=680  \\$iMen and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976)
=688  \\$a92; was NON MESH 1966-91; was see HEALTH MANPOWER 1989-91
=750  \0$aMedical personnel$5IEN-M$0(DLC)sh 85082982

=LDR  01637cz  a2200313n  4500
=001  9880363673502441
=005  20141212201936.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006279
=035  \\$aCAZ9450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x800.$x400
=072  \\$aN3.$x219.$x521.$x576.$x343.$x925.$x400
=072  \\$aN4.$x452.$x758.$x244.$x425
=072  \\$aN4.$x590.$x374.$x410.$x400
=150  \\$aHealth Maintenance Organizations
=450  \\$aGroup Health Organizations, Prepaid
=450  \\$wnnna$aHealth Maintenance Organization
=450  \\$aHMO
=450  \\$wnnna$aOrganization, Health Maintenance
=450  \\$wnnna$aOrganizations, Health Maintenance
=450  \\$aPrepaid Group Health Organizations
=550  \\$wg$aGroup Practice
=550  \\$wg$aManaged Care Programs
=550  \\$wg$aPrepaid Health Plans
=667  \\$aDF: note short X ref
=680  \\$iOrganized systems for providing comprehensive prepaid health care that have five basic attributes: (1) provide care in a defined geographic area; (2) provide or ensure delivery of an agreed-upon set of basic and supplemental health maintenance and treatment services; (3) provide care to a voluntarily enrolled group of persons; (4) require their enrollees to use the services of designated providers; and (5) receive reimbursement through a predetermined, fixed, periodic prepayment made by the enrollee without regard to the degree of services provided. (From Facts on File Dictionary of Health Care Management, 1988)
=688  \\$a74(71)
=750  \0$aHealth maintenance organization$0sh 85059571$5IEN-M

=LDR  01939cz  a2200337n  4500
=001  9880363673602441
=005  20141212201936.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006278
=035  \\$aCAZ9449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x564.$x663
=072  \\$aN3.$x219.$x521.$x576.$x343.$x840
=072  \\$aN3.$x706.$x615.$x696
=150  \\$aMedicare
=450  \\$aHealth Insurance for Aged and Disabled, Title 18
=450  \\$wnnna$aHealth Insurance for Aged, Disabled, Title 18
=450  \\$wnnna$aHealth Insurance for Aged, Title 18
=450  \\$aInsurance, Health, for Aged and Disabled
=550  \\$wg$aInsurance, Health
=550  \\$wg$aLegislation as Topic
=550  \\$wg$aMedical Assistance
=550  \\$wh$aMedicare Assignment
=550  \\$wh$aMedicare Part A
=550  \\$wh$aMedicare Part B
=550  \\$wh$aMedicare Part C
=550  \\$wh$aMedicare Part D
=667  \\$aU.S. only: for Canada & Australia index under NATIONAL HEALTH PROGRAMS + country; specify geog; Public Law 89-97
=680  \\$iFederal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance (MEDICARE PART A) and supplementary medical insurance (MEDICARE PART B). (Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976)
=688  \\$a91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 (PROV 1966); MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, & HEALTH INSURANCE FOR AGED, TITLE 18 1975-78 1966-78 (Prov 1966)
=750  \0$aMedicare$0(DLC) sh 85083053$5IEN

=LDR  01207cz  a2200337n  4500
=001  9880363673702441
=005  20141212201935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006275
=035  \\$aCAZ9446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x250
=150  \\$aHealth Facility Planning
=450  \\$wnnna$aConversion, Health Facility
=450  \\$wnnna$aConversions, Health Facility
=450  \\$wnnna$aFacility Conversion, Health
=450  \\$wnnna$aFacility Conversions, Health
=450  \\$wnnna$aFacility Planning, Health
=450  \\$wnnna$aFacility Plannings, Health
=450  \\$aHealth Facility Conversion
=450  \\$wnnna$aHealth Facility Conversions
=450  \\$wnnna$aHealth Facility Plannings
=450  \\$aPlanning, Health Facility
=450  \\$wnnna$aPlannings, Health Facility
=550  \\$wg$aRegional Health Planning
=550  \\$wh$aBed Conversion
=550  \\$wh$aHospital Planning
=667  \\$adifferentiate from FACILITY DESIGN AND CONSTRUCTION
=680  \\$iAreawide planning for health care institutions on the basis of projected consumer need.
=688  \\$a68
=750  \0$aHealth facilities$xPlanning$5IEN$0(DLC)sh 85059563

=LDR  01243cz  a2200349n  4500
=001  9880363673802441
=005  20141212201934.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006273
=035  \\$aCAZ9444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x235
=150  \\$aHealth Facility Merger
=450  \\$aAcquisition, Health Facility
=450  \\$wnnna$aAcquisitions, Health Facility
=450  \\$wnnna$aFacility Acquisition, Health
=450  \\$wnnna$aFacility Acquisitions, Health
=450  \\$wnnna$aFacility Merger, Health
=450  \\$wnnna$aFacility Mergers, Health
=450  \\$aHealth Facility Acquisition
=450  \\$wnnna$aHealth Facility Acquisitions
=450  \\$wnnna$aHealth Facility Mergers
=450  \\$aHospital Merger
=450  \\$wnnna$aHospital Mergers
=450  \\$aMerger, Health Facility
=450  \\$wnnna$aMerger, Hospital
=450  \\$wnnna$aMergers, Health Facility
=450  \\$wnnna$aMergers, Hospital
=550  \\$wg$aHealth Facilities
=680  \\$iThe combining of administrative and organizational resources of two or more health care facilities.
=688  \\$a91(Aug 77); was see under HEALTH FACILITIES 1977-90
=750  \0$aHospital mergers$5IEN$0(DLC)sh 85062248

=LDR  01106cz  a2200301n  4500
=001  9880363673902441
=005  20141212201933.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006271
=035  \\$aCAZ9442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x218
=072  \\$aN5.$x300.$x430.$x390
=150  \\$aHealth Facility Closure
=450  \\$wnnna$aClosure, Health Facility
=450  \\$wnnna$aClosure, Hospital
=450  \\$wnnna$aClosures, Health Facility
=450  \\$wnnna$aClosures, Hospital
=450  \\$wnnna$aFacility Closure, Health
=450  \\$wnnna$aFacility Closures, Health
=450  \\$wnnna$aHealth Facility Closures
=450  \\$aHospital Closure
=450  \\$aHospital Closures
=550  \\$wg$aHealth Facilities
=550  \\$wg$aHealth Services Accessibility
=680  \\$iThe closing of any health facility, e.g., health centers, residential facilities, and hospitals.
=688  \\$a91(83); was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82
=750  \0$aHospital closures$5IEN$0(DLC)sh 89005588

=LDR  01005cz  a2200277n  4500
=001  9880363674002441
=005  20141212201933.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006270
=035  \\$aCAZ9441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70.$x490
=072  \\$aM1.$x526.$x485.$x430
=072  \\$aN2.$x360.$x430
=150  \\$aHealth Facility Administrators
=450  \\$wnnna$aAdministrator, Health Facility
=450  \\$wnnna$aAdministrators, Health Facility
=450  \\$wnnna$aFacility Administrator, Health
=450  \\$wnnna$aFacility Administrators, Health
=450  \\$wnnna$aHealth Facility Administrator
=550  \\$wg$aAdministrative Personnel
=550  \\$wg$aHealth Personnel
=550  \\$wh$aHospital Administrators
=680  \\$iManagerial personnel responsible for implementing policy and directing the activities of health care facilities such as nursing homes.
=688  \\$a78
=750  \0$aHealth services administrators$5IEN$0(DLC)sh 85059601

=LDR  01153cz  a2200301n  4500
=001  9880363674102441
=005  20141212201933.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006269
=035  \\$aCAZ9440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x215
=150  \\$aHealth Facilities, Proprietary
=450  \\$wnnna$aFacilities, Proprietary Health
=450  \\$wnnna$aFacility, Proprietary Health
=450  \\$wnnna$aHealth Facility, Proprietary
=450  \\$wnnna$aPrivately Sponsored Program
=450  \\$wnnna$aPrivately Sponsored Programs
=450  \\$wnnna$aProgram, Privately Sponsored
=450  \\$wnnna$aPrograms, Privately Sponsored
=450  \\$wnnna$aProprietary Health Facilities
=450  \\$wnnna$aProprietary Health Facility
=550  \\$wg$aHealth Facilities
=550  \\$wh$aHospitals, Proprietary
=667  \\$a"operated by private groups or corporations for a profit"
=680  \\$iHealth care institutions operated by private groups or corporations for a profit.
=688  \\$a91(Aug 77); was see under HEALTH FACILITIES 1977-90
=750  \0$aHealth facilities, Proprietary$5IEN$0(DLC)sh 85059568

=LDR  01793cz  a2200565n  4500
=001  9880363674202441
=005  20201216180248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006268
=035  \\$aCAZ9439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278
=150  \\$aHealth Facilities
=450  \\$wnnna$aFacilities, Health
=450  \\$wnnna$aFacility, Health
=450  \\$wnnna$aHealth Facility
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=550  \\$wh$aAcademic Medical Centers
=550  \\$wh$aAmbulatory Care Facilities
=550  \\$wh$aBed Occupancy
=550  \\$wh$aBiological Specimen Banks
=550  \\$wh$aBirthing Centers
=550  \\$wh$aDental Facilities
=550  \\$wh$aFacility Design and Construction
=550  \\$wh$aFitness Centers
=550  \\$wh$aHealth Facilities, Proprietary
=550  \\$wh$aHealth Facility Administration
=550  \\$wh$aHealth Facility Closure
=550  \\$wh$aHealth Facility Environment
=550  \\$wh$aHealth Facility Merger
=550  \\$wh$aHealth Facility Moving
=550  \\$wh$aHealth Facility Size
=550  \\$wh$aHospital Administration
=550  \\$wh$aHospital Units
=550  \\$wh$aHospitals
=550  \\$wh$aLaboratories
=550  \\$wh$aLeper Colonies
=550  \\$wh$aMedical Office Buildings
=550  \\$wh$aMorgue
=550  \\$wh$aNurseries, Infant
=550  \\$wh$aPharmacies
=550  \\$wh$aPhysicians' Offices
=550  \\$wh$aPoison Control Centers
=550  \\$wh$aRehabilitation Centers
=550  \\$wh$aResidential Facilities
=550  \\$wh$aStudent Run Clinic
=667  \\$aIM
=680  \\$iInstitutions which provide medical or health-related services.
=688  \\$a1968
=750  \0$aHealth facilities$0sh 85059543$5IEN

=LDR  00970cz  a2200277n  4500
=001  9880363674302441
=005  20141212201932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006267
=035  \\$aCAZ9438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x332.$x374
=072  \\$aN2.$x421.$x143.$x827.$x407.$x457
=072  \\$aN2.$x421.$x726.$x407.$x457
=072  \\$aN6.$x890.$x410
=150  \\$aHealth Education, Dental
=450  \\$aDental Health Education
=450  \\$aEducation, Dental Health
=550  \\$wg$aHealth Education
=550  \\$wg$aPublic Health Dentistry
=550  \\$aPreventive Dentistry
=550  \\$aPublic Health Dentistry
=667  \\$aDF: HEALTH EDUC DENT
=680  \\$iEducation which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis.
=688  \\$a65
=750  \0$aDental health education$5IEN$0(DLC)sh 85036892

=LDR  01316cz  a2200385n  4500
=001  9880363674402441
=005  20201124150632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010262
=035  \\$aCBA3547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657
=150  \\$aParaphilic Disorders
=450  \\$wnno$aParaphilias
=450  \\$wnnna$aDeviation, Sex
=450  \\$wnnna$aDeviations, Sex
=450  \\$aDisorder, Paraphilic
=450  \\$aDisorders, Paraphilic
=450  \\$wnnna$aParaphilia
=450  \\$aParaphilic Disorder
=450  \\$wnnna$aSex Deviation
=450  \\$aSex Deviations
=550  \\$wg$aMental Disorders
=550  \\$wh$aExhibitionism
=550  \\$wh$aFetishism, Psychiatric
=550  \\$wh$aMasochism
=550  \\$wh$aPedophilia
=550  \\$wh$aSadism
=550  \\$wh$aTransvestism
=550  \\$wh$aVoyeurism
=550  \\$aDisruptive, Impulse Control, and Conduct Disorders
=550  \\$aSex Offenses$5IEN-M
=680  \\$iDisorders that include recurrent, intense sexually arousing fantasies, sexual urges, or behaviors generally involving nonhuman objects, suffering of oneself or partners, or children or other nonconsenting partners. (from DSM-IV, 1994)
=688  \\$a81; was SEX DEVIATION 1963-80
=750  \0$aParaphilias$5IEN-M$0(DLC)sh 85120724

=LDR  01261cz  a2200277n  4500
=001  9880363674502441
=005  20141212192412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010234
=035  \\$aCBA3518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x500.$x600
=072  \\$aA8.$x800.$x950.$x500.$x600
=072  \\$aA11.$x671.$x650.$x915.$x500.$x600
=150  \\$aParaganglia, Nonchromaffin
=450  \\$wnnna$aNon-Chromaffin Paraganglia
=450  \\$wnnna$aNonchromaffin Paraganglia
=450  \\$wnnna$aParaganglia, Non-Chromaffin
=450  \\$wnnna$aParaganglia, Non Chromaffin
=550  \\$wg$aChemoreceptor Cells
=550  \\$wh$aAortic Bodies
=550  \\$wh$aCarotid Body
=550  \\$wh$aGlomus Jugulare
=550  \\$wh$aGlomus Tympanicum
=680  \\$iSeveral clusters of chemoreceptive and supporting cells associated with blood vessels and nerves (especially the glossopharyngeal and vagus). The nonchromaffin paraganglia sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in respiratory, and perhaps circulatory, control. They include the CAROTID BODY; AORTIC BODIES; the GLOMUS JUGULARE; and the GLOMUS TYMPANICUM.
=750  \0$aNonchromaffin paraganglia$5IEN$0(DLC)sh 85092238

=LDR  00701cz  a2200181n  4500
=001  9880363674602441
=005  20141212204243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010232
=035  \\$aCBA3516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x612
=150  \\$aParaffin
=450  \\$wnnna$aParafilm
=550  \\$wg$aHydrocarbons
=680  \\$iA mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology.
=688  \\$awas in Cat D only 1963-82
=750  \0$aParaffin wax$5IEN$0(DLC)sh 90001517

=LDR  01025cz  a2200253n  4500
=001  9880363674702441
=005  20141212204251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010259
=035  \\$aCBA3543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x450
=150  \\$aParanoid Disorders
=450  \\$wnnna$aDisorder, Paranoid
=450  \\$wnnna$aDisorders, Paranoid
=450  \\$aParanoia
=450  \\$wnnna$aParanoias
=450  \\$wnnna$aParanoid Disorder
=450  \\$aParanoid Psychoses
=450  \\$aPsychoses, Paranoid
=550  \\$wg$aSchizophrenia and Disorders with Psychotic Features
=680  \\$iChronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.
=688  \\$a81; was PARANOIA 1963-80
=750  \0$aParanoia$5IEN$0(DLC)sh 85097873

=LDR  01211cz  a2200265n  4500
=001  9880363674802441
=005  20141212204243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010229
=035  \\$aCBA3513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x600
=072  \\$aC1.$x703.$x295.$x600
=072  \\$aC1.$x703.$x700
=072  \\$aC17.$x800.$x838.$x208.$x600
=150  \\$aParacoccidioidomycosis
=450  \\$aBlastomycosis, South American
=450  \\$wnnna$aParacoccidioidomycoses
=450  \\$wnnna$aSouth American Blastomycosis
=550  \\$wg$aDermatomycoses
=550  \\$wg$aMycoses
=667  \\$afungus dis of skin caused by Paracoccidioides; do not confuse X ref BLASTOMYCOSIS, SOUTH AMERICAN with BLASTOMYCOSIS, NORTH AMERICAN see BLASTOMYCOSIS
=680  \\$iA mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma. Superficial resemblance of P. brasiliensis to Blastomyces brasiliensis (BLASTOMYCES) may cause misdiagnosis.
=688  \\$a77(75); was see under BLASTOMYCOSIS 1963-76
=750  \0$aParacoccidioidomycosis$5IEN$0(DLC)sh 85097738

=LDR  00604cz  a2200193n  4500
=001  9880363674902441
=005  20141212204242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010227
=035  \\$aCBA3511HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x660
=150  \\$aParabiosis
=450  \\$wnnna$aParabioses
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aCross Circulation
=680  \\$iThe experimental joining of two individuals for the purpose of studying the effects of one on the other.
=688  \\$awas in Cat G only 1963-78
=750  \0$aParabiosis$5IEN$0(DLC)sh 85097713

=LDR  00967cz  a2200253n  4500
=001  9880363675002441
=005  20141212204251.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010257
=035  \\$aCBA3541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x730
=150  \\$aParaneoplastic Syndromes
=450  \\$wnnna$aParaneoplastic Syndrome
=450  \\$wnnna$aSyndrome, Paraneoplastic
=450  \\$wnnna$aSyndromes, Paraneoplastic
=550  \\$wg$aNeoplasms
=550  \\$wh$aParaneoplastic Endocrine Syndromes
=550  \\$wh$aParaneoplastic Syndromes, Nervous System
=550  \\$wh$aParaneoplastic Syndromes, Ocular
=667  \\$ado not use /blood supply /chem /secret /ultrastruct
=680  \\$iIn patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
=688  \\$a80
=750  \0$aParaneoplastic syndromes$5IEN$0(DLC)sh 85097872

=LDR  01511cz  a2200325n  4500
=001  9880363675102441
=005  20141212204240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010220
=035  \\$aCBA3504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x224.$x636
=150  \\$aPara-Aortic Bodies
=450  \\$wnnna$aBodies, Para-Aortic
=450  \\$wnnna$aBodies, Paraaortic
=450  \\$wnnna$aBody, Para-Aortic
=450  \\$wnnna$aBody, Paraaortic
=450  \\$wnnna$aOrgan of Zuckerkandl
=450  \\$aOrgans of Zuckerkandl
=450  \\$wnnna$aPara Aortic Bodies
=450  \\$wnnna$aPara-Aortic Body
=450  \\$wnnna$aParaaortic Bodies
=450  \\$wnnna$aParaaortic Body
=450  \\$wnnna$aZuckerkandl Organ
=450  \\$wnnna$aZuckerkandl Organs
=550  \\$wg$aChromaffin System
=667  \\$ado not confuse with AORTIC BODIES
=680  \\$iSmall masses of chromaffin cells found near the SYMPATHETIC GANGLIA along the ABDOMINAL AORTA, beginning cranial to the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) or renal arteries and extending to the level of the aortic bifurcation or just beyond. They are also called the organs of Zuckerkandl and sometimes called aortic bodies (not to be confused with AORTIC BODIES in the THORAX). The para-aortic bodies are the dominant source of CATECHOLAMINES in the FETUS and normally regress after BIRTH.
=688  \\$a91(75); was see under CHROMAFFIN SYSTEM 1975-90
=750  \0$aAortic paraganglia$5IEN$0(DLC)sh 85005866

=LDR  01072cz  a2200253n  4500
=001  9880363675202441
=005  20141212204251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010256
=035  \\$aCBA3540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x621
=150  \\$aParanasal Sinuses
=450  \\$aNasal Sinuses
=450  \\$wnnna$aSinuses, Nasal
=450  \\$wnnna$aSinuses, Paranasal
=550  \\$wg$aNose
=550  \\$wh$aEthmoid Sinus
=550  \\$wh$aFrontal Sinus
=550  \\$wh$aMaxillary Sinus
=550  \\$wh$aSphenoid Sinus
=667  \\$ageneral, prefer specifics; inflammation = SINUSITIS but do not add PARANASAL SINUSES for "paranasal" or "nasal" sinusitis
=680  \\$iAir-filled spaces located within the bones around the NASAL CAVITY. They are extensions of the nasal cavity and lined by the ciliated NASAL MUCOSA. Each sinus is named for the cranial bone in which it is located, such as the ETHMOID SINUS; the FRONTAL SINUS; the MAXILLARY SINUS; and the SPHENOID SINUS.
=750  \0$aParanasal sinuses$5IEN$0(DLC)sh 85097869

=LDR  00966cz  a2200265n  4500
=001  9880363675302441
=005  20141212204239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010217
=035  \\$aCBA3501M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x700
=072  \\$aC2.$x782.$x147.$x700
=150  \\$aPhlebotomus Fever
=450  \\$aPappataci Fever
=450  \\$wnnna$aPappataci Fevers
=450  \\$wnnna$aPhlebotomus Fevers
=450  \\$aSandfly Fever
=450  \\$wnnna$aSandfly Fevers
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aBunyaviridae Infections
=667  \\$acaused by a bunyavirus
=680  \\$iInfluenza-like febrile viral disease caused by several members of the BUNYAVIRIDAE family and transmitted mostly by the bloodsucking sandfly Phlebotomus papatasii.
=688  \\$a92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91
=750  \0$aPhlebotomus fever$0(DLC)sh2010001749$5IEN-M

=LDR  01442cz  a2200325n  4500
=001  9880363675402441
=005  20141212204239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010215
=035  \\$aCBA3499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x610
=150  \\$aPapio
=450  \\$wnnna$aBaboon
=450  \\$wnnna$aBaboon, Savanna
=450  \\$aBaboons
=450  \\$aBaboons, Savanna
=450  \\$wnnna$aPapios
=450  \\$wnnna$aSavanna Baboon
=450  \\$aSavanna Baboons
=550  \\$wg$aCercopithecinae
=550  \\$wh$aPapio anubis
=550  \\$wh$aPapio cynocephalus
=550  \\$wh$aPapio hamadryas
=550  \\$wh$aPapio papio
=550  \\$wh$aPapio ursinus
=667  \\$aNIM with no qualifiers when experimental animal; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.
=688  \\$a81(75); was see under BABOONS 1973-80; BABOONS was heading 1971-80 (Prov 1971-72)
=750  \0$aPapio$0(DLC) sh 85097681$5IEN-M

=LDR  01440cz  a2200301n  4500
=001  9880363675502441
=005  20141212204239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010214
=035  \\$aCBA3498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x850.$x475.$x600
=072  \\$aC17.$x800.$x428.$x435.$x600
=072  \\$aC17.$x800.$x827.$x475.$x600
=150  \\$aPapillon-Lefevre Disease
=450  \\$wnnna$aHaim-Monk Syndrome
=450  \\$wnnna$aHaim Monk Syndrome
=450  \\$wnnna$aKeratosis Palmoplantar Periodontopathies
=450  \\$wnnna$aKeratosis Palmoplantar Periodontopathy
=450  \\$wnnna$aKeratosis Palmoplantaris with Periodontopathia
=450  \\$wnnna$aPalmoplantar Periodontopathies, Keratosis
=450  \\$wnnna$aPapillon Lefevre Disease
=450  \\$wnnna$aPapillon-Lefevre Syndrome
=450  \\$wnnna$aPapillon Lefevre Syndrome
=550  \\$wg$aKeratoderma, Palmoplantar
=680  \\$iRare, autosomal recessive disorder occurring between the first and fifth years of life. It is characterized by palmoplantar keratoderma with periodontitis followed by the premature shedding of both deciduous and permanent teeth. Mutations in the gene for CATHEPSIN C have been associated with this disease.
=688  \\$a91(75); was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 (which became KERATODERMA, PALMOPLANTAR 1993)
=750  \0$aPapillon Lefevre syndrome$0(DLC)sh2008006402$5IEN-M

=LDR  01091cz  a2200265n  4500
=001  9880363675602441
=005  20141212204238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010212
=035  \\$aCBA3496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x700.$x600
=150  \\$aPapilloma
=450  \\$aPapilloma, Squamous Cell
=450  \\$wnnna$aPapillomas
=450  \\$wnnna$aPapillomas, Squamous Cell
=450  \\$wnnna$aPapillomatoses
=450  \\$aPapillomatosis
=450  \\$wnnna$aSquamous Cell Papilloma
=450  \\$wnnna$aSquamous Cell Papillomas
=550  \\$wg$aNeoplasms, Squamous Cell
=550  \\$wh$aPapilloma, Inverted
=667  \\$acoordinate IM with precoordinated organ/neoplasm term (IM); PAPILLOMA, CHOROID PLEXUS is also available
=680  \\$iA circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)
=750  \0$aPapilloma$5IEN$0(DLC)sh 85097677

=LDR  00940cz  a2200205n  4500
=001  9880363675802441
=005  20141212204237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010207
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795.$x500
=150  \\$aPapaver
=450  \\$wnnna$aPapavers
=450  \\$wnnna$aPoppies
=450  \\$aPoppy
=550  \\$wg$aPapaveraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of Eurasian herbaceous plants, the poppies (family PAPAVERACEAE of the dicotyledon class Magnoliopsida), that yield OPIUM from the latex of the unripe seed pods.
=688  \\$a1991(1986)1963
=750  \0$aPapaver$5IEN$0(DLC)sh 85097569

=LDR  00684cz  a2200181n  4500
=001  9880363675902441
=005  20141212204236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010206
=035  \\$aCBA3490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x262.$x500.$x585
=072  \\$aD8.$x811.$x277.$x656.$x300.$x200.$x585
=150  \\$aPapain
=450  \\$wnnna$aTromasin
=550  \\$wg$aCysteine Endopeptidases
=680  \\$iA proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2.
=750  \0$aPapain$5IEN$0(DLC)sh 85097551

=LDR  01165cz  a2200301n  4500
=001  9880363676002441
=005  20141212204236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010205
=035  \\$aCBA3489M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x478.$x520
=072  \\$aD12.$x125.$x42.$x70.$x500
=150  \\$aPantothenic Acid
=450  \\$wnnna$aB 5, Vitamin
=450  \\$wnnna$aB5, Vitamin
=450  \\$wnnna$aCalcium Pantothenate
=450  \\$wnnna$aDexol
=450  \\$wnnna$aPantothenate, Calcium
=450  \\$wnnna$aPantothenate, Zinc
=450  \\$aVitamin B 5
=450  \\$wnnna$aVitamin B5
=450  \\$wnnna$aZinc Pantothenate
=550  \\$wg$abeta-Alanine
=550  \\$wg$aImides
=667  \\$adeficiency: coordinate PANTOTHENIC ACID /defic (IM) with VITAMIN B DEFICIENCY (IM); ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA butyryl-beta-alanine that can also be viewed as pantoic acid complexed with BETA ALANINE. It is incorporated into COENZYME A and protects cells against peroxidative damage by increasing the level of GLUTATHIONE.
=750  \0$aPantothenic acid$5IEN-M$0(DLC)sh2001002934

=LDR  00685cz  a2200181n  4500
=001  9880363676102441
=005  20141212204235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010203
=035  \\$aCBA3487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x700.$x850.$x600
=150  \\$aPanstrongylus
=550  \\$wg$aTriatominae
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iA genus of cone-nosed bugs of the subfamily TRIATOMINAE. Its species are vectors of TRYPANOSOMA CRUZI.
=688  \\$a91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78
=750  \0$aPanstrongylus$5IEN$0(DLC)sh 87020118

=LDR  00645cz  a2200193n  4500
=001  9880363676202441
=005  20141212204235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010200
=035  \\$aCBA3481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x361.$x585
=150  \\$aPanic
=450  \\$wnnna$aPanics
=550  \\$wg$aFear
=667  \\$anote category: do not confuse with PANIC DISORDER (Cat F3)
=680  \\$iA state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.
=688  \\$a91(75); was see under FEAR 1975-90
=750  \0$aPanic$5IEN-M$0(DLC)sh 85097438

=LDR  00959cz  a2200217n  4500
=001  9880363676302441
=005  20141212204233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010195
=035  \\$aCBA3476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x689.$x750
=150  \\$aPancreatitis
=450  \\$wnnna$aPancreatitides
=550  \\$wg$aPancreatic Diseases
=550  \\$wh$aPancreatitis, Acute Necrotizing
=550  \\$wh$aPancreatitis, Alcoholic
=550  \\$wh$aPancreatitis, Chronic
=550  \\$wh$aPancreatitis, Graft
=680  \\$iINFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
=750  \0$aPancreatitis$0(DLC) sh 85097387$5IEN

=LDR  00735cz  a2200217n  4500
=001  9880363676402441
=005  20141212204233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010194
=035  \\$aCBA3475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x610
=072  \\$aD20.$x777.$x500.$x720
=150  \\$aPancreatin
=450  \\$wnnna$aPanteric
=450  \\$wnnna$aPanzytrat
=550  \\$wg$aHydrolases
=550  \\$wg$aPancreatic Extracts
=680  \\$iA mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.
=688  \\$a67(64); was see PANCREATIC EXTRACTS 1963-66
=750  \0$aPancreatin$5IEN$0(DLC)sh 85097386

=LDR  02026cz  a2200493n  4500
=001  9880363676502441
=005  20141212204232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010190
=035  \\$aCBA3471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x761
=072  \\$aC4.$x588.$x322.$x475
=072  \\$aC6.$x301.$x761
=072  \\$aC6.$x689.$x667
=072  \\$aC19.$x344.$x421
=150  \\$aPancreatic Neoplasms
=450  \\$aCancer of Pancreas
=450  \\$wnnna$aCancer of the Pancreas
=450  \\$wnnna$aCancer, Pancreas
=450  \\$wnnna$aCancer, Pancreatic
=450  \\$wnnna$aCancers, Pancreas
=450  \\$wnnna$aCancers, Pancreatic
=450  \\$wnnna$aNeoplasm, Pancreas
=450  \\$wnnna$aNeoplasm, Pancreatic
=450  \\$wnnna$aNeoplasms, Pancreas
=450  \\$wnnna$aNeoplasms, Pancreatic
=450  \\$wnnna$aPancreas Cancer
=450  \\$wnnna$aPancreas Cancers
=450  \\$wnnna$aPancreas Neoplasm
=450  \\$wnnna$aPancreas Neoplasms
=450  \\$aPancreatic Cancer
=450  \\$wnnna$aPancreatic Cancers
=450  \\$wnnna$aPancreatic Neoplasm
=550  \\$wg$aDigestive System Neoplasms
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aPancreatic Diseases
=550  \\$wh$aAdenoma, Islet Cell
=550  \\$wh$aCarcinoma, Islet Cell
=550  \\$wh$aCarcinoma, Pancreatic Ductal
=667  \\$acoord IM with histol type of neopl (IM); available are ALPHA-CELL TUMOR see GLUCAGONOMA; BETA-CELL TUMOR see INSULINOMA; and pancreatic delta-cell tumor see SOMATOSTATINOMA
=680  \\$iTumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
=750  \0$aPancreas$xTumors$5IEN-M$0(DLC)sh 85097380
=750  \0$aPancreas$xCancer$5IEN-HS$0(DLC)sh2010009939

=LDR  00702cz  a2200205n  4500
=001  9880363676602441
=005  20141212204231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010189
=035  \\$aCBA3470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x567
=150  \\$aPancreatic Juice
=450  \\$wnnna$aJuice, Pancreatic
=450  \\$wnnna$aJuices, Pancreatic
=450  \\$wnnna$aPancreatic Juices
=550  \\$wg$aBodily Secretions
=667  \\$a/secret permitted but consider PANCREAS /secret if pertinent
=680  \\$iThe fluid containing digestive enzymes secreted by the pancreas in response to food in the duodenum.
=750  \0$aPancreas$xSecretions$5IEN$0(DLC)sh 85097378

=LDR  00746cz  a2200241n  4500
=001  9880363676702441
=005  20141212204230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010185
=035  \\$aCBA3466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x775
=072  \\$aC6.$x689.$x583
=072  \\$aC23.$x300.$x575.$x185.$x775
=150  \\$aPancreatic Fistula
=450  \\$wnnna$aFistula, Pancreatic
=450  \\$wnnna$aFistulas, Pancreatic
=450  \\$wnnna$aPancreatic Fistulas
=550  \\$wg$aDigestive System Fistula
=550  \\$wg$aPancreatic Diseases
=667  \\$afistula policy: Manual 23.19+
=680  \\$iAbnormal passage communicating with the PANCREAS.
=750  \0$aPancreatic fistula$5IEN$0(DLC)sh 92005253

=LDR  01965cz  a2200541n  4500
=001  9880363676802441
=005  20141212204230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010183
=035  \\$aCBA3464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x734.$x667
=150  \\$aPancreatic Ducts
=450  \\$wnnna$aAccessory Pancreatic Duct
=450  \\$wnnna$aAccessory Pancreatic Ducts
=450  \\$wnnna$aDuct, Accessory Pancreatic
=450  \\$wnnna$aDuct, Main Pancreatic
=450  \\$aDuct of Santorini
=450  \\$aDuct of Wirsung
=450  \\$wnnna$aDuct, Pancreatic
=450  \\$wnnna$aDuct, Santorini's
=450  \\$wnnna$aDuct, Wirsung's
=450  \\$wnnna$aDucts, Accessory Pancreatic
=450  \\$wnnna$aDucts, Main Pancreatic
=450  \\$wnnna$aDucts, Pancreatic
=450  \\$aDuodenal Papilla, Minor
=450  \\$wnnna$aDuodenal Papillas, Minor
=450  \\$wnnna$aMain Pancreatic Duct
=450  \\$wnnna$aMain Pancreatic Ducts
=450  \\$wnnna$aMinor Duodenal Papilla
=450  \\$wnnna$aMinor Duodenal Papillas
=450  \\$wnnna$aPancreatic Duct
=450  \\$wnnna$aPancreatic Duct, Accessory
=450  \\$wnnna$aPancreatic Duct, Main
=450  \\$wnnna$aPancreatic Ducts, Accessory
=450  \\$wnnna$aPancreatic Ducts, Main
=450  \\$wnnna$aPapilla, Minor Duodenal
=450  \\$wnnna$aPapillas, Minor Duodenal
=450  \\$wnnna$aSantorini Duct
=450  \\$wnnna$aSantorini's Duct
=450  \\$wnnna$aSantorinis Duct
=450  \\$wnnna$aWirsung Duct
=450  \\$aWirsung's Duct
=450  \\$wnnna$aWirsungs Duct
=550  \\$wg$aPancreas
=667  \\$anote X ref DUODENAL PAPILLA, MINOR: do not confuse with DUODENAL PAPILLA, MAJOR see VATER'S AMPULLA; "duodenal papilla" unspecified is probably DUODENAL PAPILLA, MAJOR
=680  \\$iDucts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.
=750  \0$aPancreatic duct$5IEN$0(DLC)sh 85097385

=LDR  00913cz  a2200301n  4500
=001  9880363676902441
=005  20141212204229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010182
=035  \\$aCBA3463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x689
=150  \\$aPancreatic Diseases
=450  \\$wnnna$aDisease, Pancreatic
=450  \\$wnnna$aDiseases, Pancreatic
=450  \\$wnnna$aPancreatic Disease
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aCongenital Hyperinsulinism
=550  \\$wh$aCystic Fibrosis
=550  \\$wh$aExocrine Pancreatic Insufficiency
=550  \\$wh$aPancreatic Cyst
=550  \\$wh$aPancreatic Fistula
=550  \\$wh$aPancreatic Neoplasms
=550  \\$wh$aPancreatitis
=667  \\$ainflamm dis = PANCREATITIS
=680  \\$iPathological processes of the PANCREAS.
=688  \\$a66
=750  \0$aPancreas$xDiseases$0(DLC) sh 85097374$5IEN

=LDR  01151cz  a2200241n  4500
=001  9880363677002441
=005  20141212204229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010181
=035  \\$aCBA3462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x640
=072  \\$aC6.$x689.$x500
=150  \\$aPancreatic Cyst
=450  \\$wnnna$aCyst, Pancreatic
=450  \\$wnnna$aCysts, Pancreatic
=450  \\$wnnna$aPancreatic Cysts
=550  \\$wg$aCysts
=550  \\$wg$aPancreatic Diseases
=550  \\$wh$aPancreatic Pseudocyst
=667  \\$anon-neoplastic; pancreatic pseudocyst = PANCREATIC PSEUDOCYST
=680  \\$iA true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. (From Bockus Gastroenterology, 4th ed, p4145)
=750  \0$aPancreas$xCysts$5IEN$0(DLC)sh 85097384

=LDR  00612cz  a2200205n  4500
=001  9880363677102441
=005  20141212204228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010180
=035  \\$aCBA3461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x752
=150  \\$aPancreatectomy
=450  \\$wnnna$aPancreatectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aPancreas
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal of the pancreas. (Dorland, 28th ed)
=688  \\$a67(65)
=750  \0$aPancreatectomy$5IEN$0(DLC)sh 85097382

=LDR  01213cz  a2200205n  4500
=001  9880363677202441
=005  20141212204228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010179
=035  \\$aCBA3460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x734
=150  \\$aPancreas
=550  \\$wg$aDigestive System
=550  \\$wh$aIslets of Langerhans
=550  \\$wh$aPancreas, Exocrine
=550  \\$wh$aPancreatic Ducts
=667  \\$a/enzymol: consider also PANCREATIN for "pancreatic enzymes" particularly in ther; /surg: consider also PANCREATECTOMY; note that ISLETS OF LANGERHANS TRANSPLANTATION is also available; inflammation = PANCREATITIS; pancreatic A, B, C cells: index under ISLETS OF LANGERHANS; D cells = SOMATOSTATIN-SECRETING CELLS
=680  \\$iA nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
=750  \0$aPancreas$5IEN$0(DLC)sh 85097370

=LDR  01097cz  a2200289n  4500
=001  9880363677302441
=005  20141212204228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010178
=035  \\$aCBA3459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797.$x520.$x734
=072  \\$aC8.$x381.$x540.$x734
=072  \\$aC8.$x785.$x520.$x734
=150  \\$aPancoast Syndrome
=450  \\$wnnna$aPancoast Tumor
=450  \\$wnnna$aPancoast's Syndrome
=450  \\$wnnna$aPancoasts Syndrome
=450  \\$wnnna$aSyndrome, Pancoast
=450  \\$wnnna$aSyndrome, Pancoast's
=450  \\$wnnna$aTumor, Pancoast
=550  \\$wg$aLung Neoplasms
=667  \\$aan apicocostovertebral syndrome
=680  \\$iA condition caused by an apical lung tumor (Pancoast tumor) with involvement of the nearby vertebral column and the BRACHIAL PLEXUS. Symptoms include pain in the shoulder and the arm, and atrophy of the hand.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Pancoast's Syndrome
=750  \0$aPancoast's syndrome$0(DLC) sh 85097369$5IEN

=LDR  00694cz  a2200217n  4500
=001  9880363677402441
=005  20141212204227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010174
=035  \\$aCBA3455HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x707
=150  \\$aPamphlets
=450  \\$wnnna$aBooklet
=450  \\$aBooklets
=450  \\$wnnna$aBrochure
=450  \\$aBrochures
=450  \\$wnnna$aPamphlet
=550  \\$wg$aPublications
=680  \\$iPrinted publications usually having a format with no binding and no cover and having fewer than some set number of pages. They are often devoted to a single subject.
=750  \0$aPamphlets$5IEN$0(DLC)sh 85097292

=LDR  00777cz  a2200193n  4500
=001  9880363677502441
=005  20141212204227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010173
=035  \\$aCBA3454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x600
=150  \\$aPalpation
=450  \\$wnnna$aPalpations
=550  \\$wg$aPhysical Examination
=550  \\$wh$aDigital Rectal Examination
=667  \\$ado not confuse with "palpitation" ( = HEART RATE; ARRHYTHMIAS, CARDIAC or specific arrhythmia)
=680  \\$iApplication of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.
=750  \0$aPalpation$5IEN$0(DLC)sh 85097266

=LDR  01178cz  a2200349n  4500
=001  9880363677602441
=005  20141212192412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010166
=035  \\$aCBA3447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x666
=072  \\$aN2.$x421.$x585.$x666
=150  \\$aPalliative Care
=450  \\$wnnna$aCare, Palliative
=450  \\$wnnna$aPalliative Surgery
=450  \\$wnnna$aPalliative Therapy
=450  \\$aPalliative Treatment
=450  \\$wnnna$aPalliative Treatments
=450  \\$wnnna$aSurgery, Palliative
=450  \\$wnnna$aTherapy, Palliative
=450  \\$wnnna$aTreatment, Palliative
=450  \\$wnnna$aTreatments, Palliative
=550  \\$wg$aPatient Care
=550  \\$aHospice and Palliative Care Nursing
=550  \\$aPain
=550  \\$aPalliative Medicine
=550  \\$aTerminal Care
=667  \\$acoordinate IM with disease (IM); consider also PAIN MANAGEMENT
=680  \\$iCare alleviating symptoms without curing the underlying disease. (Stedman, 25th ed)
=688  \\$a96; was PALLIATIVE TREATMENT 1964-95 (Prov 1964-65)
=750  \0$aPalliative treatment$5IEN$0(DLC)sh 90001135

=LDR  00934cz  a2200205n  4500
=001  9880363677702441
=005  20141212204225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010165
=035  \\$aCBA3446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x680
=072  \\$aD1.$x268.$x956.$x718
=072  \\$aD1.$x552.$x544.$x680
=150  \\$aPalladium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aPd-106; Pd-102, 104, 105, 108, 110 = PALLADIUM (IM) + ISOTOPES (NIM); Pd-98-101, 103, 107, 109, 111-115 = PALLADIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.
=750  \0$aPalladium$5IEN$0(DLC)sh 85097207

=LDR  00812cz  a2200169n  4500
=001  9880363677802441
=005  20141212204224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010164
=035  \\$aCBA3445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x584.$x709
=150  \\$aPaleopathology
=550  \\$wg$aPaleontology
=667  \\$aIM; SPEC: SPEC qualif; as NIM coord, no qualif; check tags HISTORICAL ARTICLE & ANCIENT HISTORY or MEDIEVAL HISTORY; for prehist, ANCIENT HISTORY tag is all right; paleopathol is for pre-Columbian, nothing later; consider also MUMMIES /pathol & do not coord with PALEOPATHOLOGY; DF: PALEOPATHOL
=680  \\$iThe study of disease in prehistoric times as revealed in bones, mummies, and archaeologic artifacts.
=750  \0$aPaleopathology$5IEN$0(DLC)sh 85097153

=LDR  01154cz  a2200289n  4500
=001  9880363677902441
=005  20160520155911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010163
=035  \\$aCBA3444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x875
=072  \\$aI1.$x76.$x368.$x584
=150  \\$aPaleontology
=450  \\$aPaleontologists$5IEN
=550  \\$wg$aAnthropology, Physical
=550  \\$wg$aEarth Sciences
=550  \\$wh$aFossils
=550  \\$wh$aMummies
=550  \\$wh$aOrigin of Life
=550  \\$wh$aPaleodontology
=550  \\$wh$aPaleopathology
=550  \\$aPhylogeography
=667  \\$aIM; SPEC: SPEC qualif; as NIM coord, no qualif; do not routinely check tags HISTORICAL ARTICLE & ANCIENT HISTORY or MEDIEVAL HISTORY: check only when the hist & ancient or medieval med aspects are particularly discussed; for prehist, ANCIENT HISTORY tag is all right; paleontology is for pre-Columbian, nothing later; DF: PALEONTOL
=680  \\$iThe study of early forms of life through fossil remains.
=750  \0$aPaleontology$5IEN-M$0(DLC)sh 85097123
=750  \0$aPaleontologists$5IEN-HS$0(DLC)sh 85097121

=LDR  00724cz  a2200181n  4500
=001  9880363678002441
=005  20141212204224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010162
=035  \\$aCBA3443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x539.$x500
=150  \\$aPaleography
=550  \\$wg$aHandwriting
=550  \\$aArchaeology
=667  \\$astudy of manuscripts & inscriptions; IM; med paleography: do not coord with MEDICINE; DF: PALEOGR
=680  \\$iThe study of ancient inscriptions and modes of writing. It includes the deciphering of manuscripts and other forms to determine their date, provenance, etc. (Webster's 1st ed)
=750  \0$aPaleography$5IEN$0(DLC)sh 85097064

=LDR  00793cz  a2200181n  4500
=001  9880363678102441
=005  20141212204224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010161
=035  \\$aCBA3442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x584.$x583
=150  \\$aPaleodontology
=550  \\$wg$aPaleontology
=550  \\$aTooth
=667  \\$aIM for the discipline (education, history, etc); NIM as a coordinate for studies involving fossil remains of teeth; check tags HISTORICAL ARTICLE & ANCIENT HISTORY or MEDIEVAL HISTORY; for prehistory, ANCIENT HISTORY tag is all right; paleodontology is for pre-Columbian, nothing later
=680  \\$iThe study of the teeth of early forms of life through fossil remains.
=750  \0$aTeeth, Fossil$5IEN$0(DLC)sh 85133237

=LDR  00695cz  a2200229n  4500
=001  9880363678202441
=005  20141212204223.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010160
=035  \\$aCBA3441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x617.$x780
=150  \\$aPalate, Soft
=450  \\$wnnna$aPalates, Soft
=450  \\$wnnna$aPalatinum, Velum
=450  \\$wnnna$aSoft Palate
=450  \\$aVelum Palatinum
=550  \\$wg$aPalate
=550  \\$wh$aUvula
=680  \\$iA movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border.
=688  \\$a79
=750  \0$aPalate, Soft$5IEN$0(DLC)sh 85096969

=LDR  01025cz  a2200289n  4500
=001  9880363678302441
=005  20141212204223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010159
=035  \\$aCBA3440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x521.$x658
=072  \\$aA14.$x549.$x617
=150  \\$aPalate
=450  \\$aIncisive Papilla
=450  \\$wnnna$aIncisive Papillas
=450  \\$wnnna$aPalates
=450  \\$wnnna$aPapilla, Incisive
=450  \\$wnnna$aPapillas, Incisive
=550  \\$wg$aJaw
=550  \\$wg$aMouth
=550  \\$wh$aPalatal Muscles
=550  \\$wh$aPalate, Hard
=550  \\$wh$aPalate, Soft
=667  \\$aX ref INCISIVE PAPILLA, a projection on the palate posterior to the central incisors: do not add INCISOR; PALATE, HARD and PALATE, SOFT are also available
=680  \\$iThe structure that forms the roof of the mouth. It consists of the anterior hard palate (PALATE, HARD) and the posterior soft palate (PALATE, SOFT).
=750  \0$aPalate$5IEN$0(DLC)sh 85096966

=LDR  01045cz  a2200313n  4500
=001  9880363678402441
=005  20141212204223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010158
=035  \\$aCBA3439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x850
=072  \\$aE7.$x695.$x190.$x600
=150  \\$aPalatal Obturators
=450  \\$aArtificial Palate$5IEN
=450  \\$wnnna$aCleft Palate Prostheses
=450  \\$aCleft Palate Prosthesis
=450  \\$wnnna$aObturator, Palatal
=450  \\$aObturators, Palatal
=450  \\$wnnna$aPalatal Obturator
=450  \\$wnnna$aPalate Prostheses, Cleft
=450  \\$wnnna$aPalate Prosthesis, Cleft
=450  \\$wnnna$aProstheses, Cleft Palate
=450  \\$wnnna$aProsthesis, Cleft Palate
=550  \\$wg$aDental Prosthesis
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAppliances that close a cleft or fissure of the palate.
=688  \\$a83; was CLEFT PALATE PROSTHESIS 1966-82
=750  \0$aArtificial palate$5IEN$0(DLC)sh 85008197

=LDR  00978cz  a2200277n  4500
=001  9880363678502441
=005  20141212204222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010157
=035  \\$aCBA3438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721.$x450.$x692
=072  \\$aC4.$x588.$x443.$x591.$x692
=072  \\$aC5.$x116.$x231.$x754.$x450.$x692
=072  \\$aC5.$x500.$x499.$x692
=072  \\$aC7.$x320.$x515.$x692
=072  \\$aC7.$x465.$x565.$x692
=150  \\$aPalatal Neoplasms
=450  \\$wnnna$aNeoplasm, Palatal
=450  \\$wnnna$aNeoplasms, Palatal
=450  \\$wnnna$aPalatal Neoplasm
=550  \\$wg$aJaw Neoplasms
=550  \\$wg$aMouth Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.
=750  \0$aPalate$xTumors$5IEN-M$0(DLC)sh 85096968

=LDR  01162cz  a2200301n  4500
=001  9880363678602441
=005  20141212204222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010155
=035  \\$aCBA3436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x578.$x458
=150  \\$aPalatal Expansion Technique
=450  \\$wnnna$aExpansion, Maxillary
=450  \\$wnnna$aExpansion Technic, Palatal
=450  \\$wnnna$aExpansion Technics, Palatal
=450  \\$wnnna$aExpansion Technique, Palatal
=450  \\$wnnna$aExpansion Techniques, Palatal
=450  \\$aMaxillary Expansion
=450  \\$wnnna$aPalatal Expansion Technic
=450  \\$wnnna$aPalatal Expansion Technics
=450  \\$wnnna$aPalatal Expansion Techniques
=450  \\$wnnna$aTechnic, Palatal Expansion
=450  \\$wnnna$aTechnique, Palatal Expansion
=550  \\$wg$aOrthodontics, Corrective
=680  \\$iAn orthodontic method used for correcting narrow or collapsed maxillary arches and functional cross-bite. (From Jablonski's Dictionary of Dentistry),
=688  \\$a91; was PALATAL EXPANSION TECHNIC 1973-90
=750  \0$aMaxillary expansion$5IEN$0(DLC)sh 85082354

=LDR  00739cz  a2200205n  4500
=001  9880363678702441
=005  20141212204221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010153
=035  \\$aCBA3434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x952.$x500
=150  \\$aPaired-Associate Learning
=450  \\$wnnna$aLearning, Paired-Associate
=450  \\$wnnna$aLearnings, Paired-Associate
=450  \\$wnnna$aPaired Associate Learning
=450  \\$wnnna$aPaired-Associate Learnings
=550  \\$wg$aVerbal Learning
=680  \\$iLearning in which the subject must respond with one word or syllable when presented with another word or syllable.
=750  \0$aPaired-association learning$5IEN$0(DLC)sh 85096858

=LDR  00433cz  a2200169n  4500
=001  9880363678802441
=005  20141212204221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010151
=035  \\$aCBA3432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x646
=150  \\$aPaintings
=450  \\$wnnna$aPainting
=550  \\$wg$aArt
=688  \\$a91(75); was see under ART 1975-90
=750  \0$aPainting$5IEN$0(DLC)sh 85096661

=LDR  00497cz  a2200193n  4500
=001  9880363678902441
=005  20141212204221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010150
=035  \\$aCBA3431HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x597
=150  \\$aPaint
=450  \\$wnnna$aPaints
=450  \\$aVarnish
=550  \\$wg$aManufactured Materials
=550  \\$wh$aLacquer
=688  \\$aVARNISH was see under PAINT 1963-78
=750  \0$aPaint$5IEN$0(DLC)sh 85096623

=LDR  00701cz  a2200241n  4500
=001  9880363679002441
=005  20141212204221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010149
=035  \\$aCBA3430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x767.$x700
=072  \\$aC23.$x888.$x646.$x530
=150  \\$aPain, Postoperative
=450  \\$wnnna$aPostoperative Pain
=450  \\$wnnna$aPostoperative Pains
=550  \\$wg$aPain
=550  \\$wg$aPostoperative Complications
=550  \\$wh$aPhantom Limb
=667  \\$aDF: PAIN POSTOP or POSTOP PAIN
=680  \\$iPain during the period after surgery.
=688  \\$a74
=750  \0$aPostoperative pain$5IEN$0(DLC)sh 85096621

=LDR  00914cz  a2200289n  4500
=001  9880363679102441
=005  20141212204220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010148
=035  \\$aCBA3429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x788
=072  \\$aC23.$x888.$x592.$x612.$x776
=072  \\$aC23.$x888.$x646.$x515
=150  \\$aPain, Intractable
=450  \\$wnnna$aIntractable Pain
=450  \\$wnnna$aIntractable Pains
=450  \\$wnnna$aPain, Refractory
=450  \\$wnnna$aPains, Intractable
=450  \\$wnnna$aPains, Refractory
=450  \\$wnnna$aRefractory Pain
=450  \\$wnnna$aRefractory Pains
=550  \\$wg$aPain
=667  \\$ausually chronic, so do not coordinate with CHRONIC PAIN
=680  \\$iPersistent pain that is refractory to some or all forms of treatment.
=688  \\$a1974
=750  \0$aIntractable pain$5IEN$0(DLC)sh 85067618

=LDR  02439cz  a2200709n  4500
=001  9880363679202441
=005  20141212204220.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010147
=035  \\$aCBA3428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x550.$x324
=150  \\$aPain Measurement
=450  \\$wnnna$aAnalgesia Test
=450  \\$aAnalgesia Tests
=450  \\$wnnna$aAnalog Pain Scale
=450  \\$wnnna$aAnalog Pain Scales
=450  \\$aAnalogue Pain Scale
=450  \\$wnnna$aAnalogue Pain Scales
=450  \\$wnnna$aAssessment, Pain
=450  \\$wnnna$aAssessments, Pain
=450  \\$aFormalin Test
=450  \\$wnnna$aFormalin Tests
=450  \\$aMcGill Pain Questionnaire
=450  \\$wnnna$aMcGill Pain Scale
=450  \\$wnnna$aMeasurement, Pain
=450  \\$wnnna$aMeasurements, Pain
=450  \\$wnnna$aNociception Test
=450  \\$aNociception Tests
=450  \\$aPain Assessment
=450  \\$wnnna$aPain Assessments
=450  \\$wnnna$aPain Measurements
=450  \\$wnnna$aPain Questionnaire, McGill
=450  \\$wnnna$aPain Scale, Analog
=450  \\$wnnna$aPain Scale, Analogue
=450  \\$wnnna$aPain Scale, McGill
=450  \\$wnnna$aPain Scales, Analog
=450  \\$wnnna$aPain Scales, Analogue
=450  \\$wnnna$aPain Test, Tourniquet
=450  \\$wnnna$aPain Tests, Tourniquet
=450  \\$wnnna$aQuestionnaire, McGill Pain
=450  \\$wnnna$aScale, Analog Pain
=450  \\$wnnna$aScale, Analogue Pain
=450  \\$wnnna$aScale, McGill Pain
=450  \\$wnnna$aScales, Analog Pain
=450  \\$wnnna$aScales, Analogue Pain
=450  \\$wnnna$aTest, Analgesia
=450  \\$wnnna$aTest, Formalin
=450  \\$wnnna$aTest, Nociception
=450  \\$wnnna$aTest, Tourniquet Pain
=450  \\$wnnna$aTests, Analgesia
=450  \\$wnnna$aTests, Formalin
=450  \\$wnnna$aTests, Nociception
=450  \\$wnnna$aTests, Tourniquet Pain
=450  \\$aTourniquet Pain Test
=450  \\$wnnna$aTourniquet Pain Tests
=450  \\$wnnna$aVisual Analog Pain Scale
=450  \\$aVisual Analogue Pain Scale
=550  \\$wg$aNeurologic Examination
=680  \\$iScales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.
=688  \\$a87
=750  \0$aPain$xMeasurement$0sh2005004160$5IEN

=LDR  03164cz  a2200961n  4500
=001  9880363679302441
=005  20200611112342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010146
=035  \\$aCBA3427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617
=072  \\$aC23.$x888.$x592.$x612
=072  \\$aC23.$x888.$x646
=072  \\$aF2.$x830.$x816.$x444
=072  \\$aG11.$x561.$x600.$x810.$x444
=150  \\$aPain
=450  \\$wnnna$aAche
=450  \\$wnnna$aAches
=450  \\$wnnna$aBurning Pain
=450  \\$wnnna$aBurning Pains
=450  \\$wnnna$aCrushing Pain
=450  \\$wnnna$aCrushing Pains
=450  \\$wnnna$aMigratory Pain
=450  \\$wnnna$aMigratory Pains
=450  \\$wnnna$aPain, Burning
=450  \\$wnnna$aPain, Crushing
=450  \\$wnnna$aPain, Migratory
=450  \\$wnnna$aPain, Radiating
=450  \\$wnnna$aPain, Splitting
=450  \\$wnnna$aPains, Burning
=450  \\$wnnna$aPains, Crushing
=450  \\$wnnna$aPains, Migratory
=450  \\$wnnna$aPains, Radiating
=450  \\$wnnna$aPains, Splitting
=450  \\$wnnna$aPhysical Suffering
=450  \\$wnnna$aPhysical Sufferings
=450  \\$wnnna$aRadiating Pain
=450  \\$wnnna$aRadiating Pains
=450  \\$wnnna$aSplitting Pain
=450  \\$wnnna$aSplitting Pains
=450  \\$aSuffering, Physical
=450  \\$wnnna$aSufferings, Physical
=550  \\$wg$aNeurologic Manifestations
=550  \\$wg$aSensation
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aAbdominal Pain
=550  \\$wh$aAcute Pain
=550  \\$wh$aArthralgia
=550  \\$wh$aBack Pain
=550  \\$wh$aBreakthrough Pain
=550  \\$wh$aCancer Pain
=550  \\$wh$aChest Pain
=550  \\$wh$aChronic Pain
=550  \\$wh$aEarache
=550  \\$wh$aEye Pain
=550  \\$wh$aFacial Pain
=550  \\$wh$aFlank Pain
=550  \\$wh$aGlossalgia
=550  \\$wh$aHeadache
=550  \\$wh$aLabor Pain
=550  \\$wh$aMastodynia
=550  \\$wh$aMetatarsalgia
=550  \\$wh$aMusculoskeletal Pain
=550  \\$wh$aNeck Pain
=550  \\$wh$aNeuralgia
=550  \\$wh$aNociceptive Pain
=550  \\$wh$aPain, Intractable
=550  \\$wh$aPain, Postoperative
=550  \\$wh$aPain, Referred
=550  \\$wh$aPain Threshold
=550  \\$wh$aPelvic Pain
=550  \\$wh$aPain, Procedural
=550  \\$wh$aShoulder Pain
=550  \\$wh$aSlit Ventricle Syndrome
=550  \\$aAnalgesia
=550  \\$aAnalgesics
=550  \\$aHyperalgesia
=550  \\$aPain Insensitivity, Congenital
=550  \\$aPalliative Care
=667  \\$ageneral; note specifics including precoordinated locational pain terms like ABDOMINAL PAIN; CHEST PAIN, etc.; / diag: consider also PAIN MEASUREMENT but PAIN / diag is probably PAIN / etiol; / physiopathol: PAIN THRESHOLD is also available; congenital absence of pain = PAIN SENSITIVITY, CONGENITAL; differentiate from PAIN PERCEPTION which takes place in the brain
=680  \\$iAn unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
=750  \0$aPain$0(DLC) sh 85096617$5IEN-M

=LDR  00723cz  a2200193n  4500
=001  9880363679402441
=005  20141212204217.0
=008  850212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010143
=035  \\$aCBA3424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x640
=150  \\$aPaecilomyces
=450  \\$wnnna$aPaecilomyce
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)
=680  \\$iA mitosporic fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Its teleomorph is BYSSOCHLAMYS.
=688  \\$a91(86)
=750  \0$aPaecilomyces$5IEN$0(DLC)sh 88022082

=LDR  01260cz  a2200313n  4500
=001  9880363679502441
=005  20141212204216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010138
=035  \\$aCBA3419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x750
=150  \\$aPacemaker, Artificial
=450  \\$wnnna$aArtificial Cardiac Pacemaker
=450  \\$wnnna$aArtificial Cardiac Pacemakers
=450  \\$wnnna$aArtificial Pacemaker
=450  \\$wnnna$aArtificial Pacemakers
=450  \\$aCardiac Pacemaker, Artificial
=450  \\$wnnna$aCardiac Pacemakers, Artificial
=450  \\$aCardiac Pacing, Artificial$xinstrumentation
=450  \\$wnnna$aPacemaker, Artificial Cardiac
=450  \\$wnnna$aPacemakers, Artificial
=450  \\$wnnna$aPacemakers, Artificial Cardiac
=550  \\$wg$aElectrodes
=550  \\$wh$aCardiac Resynchronization Therapy Devices
=550  \\$aCardiac Pacing, Artificial
=667  \\$acoordinate disease with / ther, not / surg for treatment with pacemaker
=680  \\$iA device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).
=750  \0$aCardiac pacemakers$5IEN$0(DLC)sh 85096422

=LDR  01171cz  a2200313n  4500
=001  9880363679602441
=005  20141212204214.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010134
=035  \\$aCBA3415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x685.$x440
=150  \\$aFenclonine
=450  \\$wnnna$aCP-10,188
=450  \\$wnnna$aDL-3-(4-Chlorophenyl)alanine
=450  \\$wnnna$aFenclonin
=450  \\$wnnna$aFenclonine, (D)-Isomer
=450  \\$wnnna$aFenclonine Hydrobromide
=450  \\$wnnna$aFenclonine Hydrochloride
=450  \\$wnnna$aFenclonine (L)-Isomer
=450  \\$wnnna$aHydrobromide, Fenclonine
=450  \\$wnnna$aHydrochloride, Fenclonine
=450  \\$ap-Chlorophenylalanine
=450  \\$apara-Chlorophenylalanine
=450  \\$wnnna$apara Chlorophenylalanine
=550  \\$wg$aPhenylalanine
=680  \\$iA selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
=688  \\$a93(71)
=750  \0$aChlorophenylalanine$5IEN$0(DLC)sh 85024577

=LDR  01176cz  a2200277n  4500
=001  9880363679702441
=005  20141212204211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010126
=035  \\$aCBA3407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x670.$x600
=150  \\$aOzone
=450  \\$wnnna$aGround Level Ozone
=450  \\$wnnna$aLevel Ozone, Ground
=450  \\$wnnna$aLevel Ozone, Low
=450  \\$wnnna$aLow Level Ozone
=450  \\$wnnna$aOzone, Ground Level
=450  \\$wnnna$aOzone, Low Level
=450  \\$wnnna$aOzone, Tropospheric
=450  \\$wnnna$aTropospheric Ozone
=550  \\$wg$aOxygen
=550  \\$wh$aStratospheric Ozone
=667  \\$aOZONE DEPLETION is also available
=680  \\$iThe unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE).
=750  \0$aOzone$5IEN$0(DLC)sh 85096391

=LDR  00960cz  a2200253n  4500
=001  9880363679802441
=005  20141212204210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010125
=035  \\$aCBA3406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x643
=150  \\$aOstreidae
=450  \\$wnnna$aOyster
=450  \\$aOysters
=550  \\$wg$aBivalvia
=550  \\$wh$aCrassostrea
=550  \\$wh$aOstrea
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM); note entry term OYSTERS: oysters unspecified go here; OYSTERS, TRUE is also available
=680  \\$iA family of marine mollusks in the class BIVALVIA, commonly known as oysters. They have a rough irregular shell closed by a single adductor muscle.
=688  \\$a2006
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Oysters
=688  \\$a72
=750  \0$aOysters$0(DLC) sh 85096377$5IEN

=LDR  00862cz  a2200229n  4500
=001  9880363679902441
=005  20141212204210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010123
=035  \\$aCBA3404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x550.$x550
=150  \\$aOxyuriasis
=450  \\$wnnna$aAspiculariases
=450  \\$aAspiculariasis
=450  \\$wnnna$aOxyuriases
=550  \\$wg$aOxyurida Infections
=550  \\$wh$aEnterobiasis
=667  \\$anematode infect caused by genera of the superfamily OXYUROIDEA; infect by Oxyuris species goes here but note X ref OXYURIS VERMICULARIS INFECTION see ENTEROBIASIS
=680  \\$iInfection with nematodes of the superfamily OXYUROIDEA.
=688  \\$aASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85
=750  \0$aOxyuriasis$5IEN$0(DLC)sh 85096357

=LDR  01004cz  a2200289n  4500
=001  9880363680002441
=005  20141212204210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010122
=035  \\$aCBA3403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x100.$x235
=072  \\$aD8.$x811.$x277.$x656.$x350.$x555.$x400
=072  \\$aD8.$x811.$x277.$x656.$x675.$x555.$x400
=150  \\$aCystinyl Aminopeptidase
=450  \\$wnnna$aCystidyl Aminopeptidase
=450  \\$wnnna$aCystinaminopeptidase
=450  \\$wnnna$aCystine Aminopeptidase
=450  \\$aCystine Arylamidase
=450  \\$aCystyl Aminopeptidase
=450  \\$aOxytocinase
=450  \\$wnnna$aVasopressinase
=550  \\$wg$aAminopeptidases
=550  \\$wg$aMetalloexopeptidases
=680  \\$iA zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.
=688  \\$a2000(1973)
=750  \0$aOxytocinase$5IEN$0(DLC)sh 85096356

=LDR  00976cz  a2200205n  4500
=001  9880363680102441
=005  20141212204209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010121
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x692.$x433
=072  \\$aD12.$x644.$x548.$x691.$x692.$x433
=150  \\$aOxytocin
=450  \\$aOcytocin
=450  \\$wnnna$aPitocin
=450  \\$wnnna$aSyntocinon
=550  \\$wg$aPituitary Hormones, Posterior
=680  \\$iA nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION.
=688  \\$aALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, & 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93
=750  \0$aOxytocin$5IEN$0(DLC)sh 85096354

=LDR  01013cz  a2200241n  4500
=001  9880363680202441
=005  20141212204205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010108
=035  \\$aCBA3389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x400.$x707
=072  \\$aD12.$x776.$x422.$x316.$x762.$x687
=150  \\$aOxyhemoglobins
=450  \\$wnnna$aHemoglobin, Oxycobalt
=450  \\$wnnna$aOxycobalt Hemoglobin
=450  \\$wnnna$aOxycobalthemoglobin
=450  \\$wnnna$aOxyhemoglobin
=550  \\$wg$aHemoglobins
=667  \\$aBohr effect is indexed OXYHEMOGLOBINS /metab (IM) + PH (NIM)
=680  \\$iA compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state.
=688  \\$a79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76, was OXYHEMOGLOBIN 1973-74 (Prov)
=750  \0$aOxyhemoglobin$5IEN$0(DLC)sh 85096346

=LDR  01031cz  a2200217n  4500
=001  9880363680302441
=005  20141212204205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010107
=035  \\$aCBA3388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x652.$x582
=150  \\$aOxygenators, Membrane
=450  \\$wnnna$aMembrane Oxygenator
=450  \\$wnnna$aMembrane Oxygenators
=450  \\$wnnna$aOxygenator, Membrane
=550  \\$wg$aOxygenators
=550  \\$aExtracorporeal Membrane Oxygenation
=680  \\$iDevices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. (Dorland, 28th ed)
=688  \\$a74(72)
=750  \0$aMembrane oxygenators$5IEN$0(DLC)sh 85096343

=LDR  00810cz  a2200205n  4500
=001  9880363680402441
=005  20141212204205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010106
=035  \\$aCBA3387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x652
=150  \\$aOxygenators
=450  \\$wnnna$aOxygenator
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aOxygenators, Membrane
=550  \\$aHeart-Lung Machine
=680  \\$iDevices which mechanically oxygenate venous blood extracorporeally. They are used in combination with one or more pumps for maintaining circulation during open heart surgery and for assisting the circulation in patients seriously ill with some cardiac and pulmonary disorders. (UMDNS, 1999)
=688  \\$a74(72)
=750  \0$aOxygenators$5IEN$0(DLC)sh 85096342

=LDR  00609cz  a2200193n  4500
=001  9880363680502441
=005  20141212204205.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010105
=035  \\$aCBA3386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690
=150  \\$aOxygenases
=550  \\$wg$aOxidoreductases
=550  \\$wh$aDioxygenases
=550  \\$wh$aInositol Oxygenase
=550  \\$wh$aMixed Function Oxygenases
=680  \\$iOxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules.
=750  \0$aOxygenases$5IEN$0(DLC)sh 85096341

=LDR  00664cz  a2200205n  4500
=001  9880363680602441
=005  20141212204204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010103
=035  \\$aCBA3384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x625
=150  \\$aOxygen Isotopes
=450  \\$wnnna$aIsotopes, Oxygen
=550  \\$wg$aIsotopes
=550  \\$wh$aOxygen Radioisotopes
=550  \\$aOxygen
=667  \\$aO-17,18; NIM
=680  \\$iStable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes.
=750  \0$aOxygen$xIsotopes$5IEN$0(DLC)sh 85096331

=LDR  01084cz  a2200253n  4500
=001  9880363680702441
=005  20141212204204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010102
=035  \\$aCBA3383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x880.$x690
=150  \\$aOxygen Inhalation Therapy
=450  \\$wnnna$aInhalation Therapies, Oxygen
=450  \\$wnnna$aInhalation Therapy, Oxygen
=450  \\$wnnna$aOxygen Inhalation Therapies
=450  \\$aOxygen Therapy$5IEN
=450  \\$wnnna$aTherapies, Oxygen Inhalation
=450  \\$wnnna$aTherapy, Oxygen Inhalation
=550  \\$wg$aRespiratory Therapy
=550  \\$wh$aHyperbaric Oxygenation
=667  \\$acoord with dis /ther, not dis /drug ther; do not use /util except by MeSH definition
=680  \\$iInhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)
=750  \0$aOxygen therapy$5IEN$0(DLC)sh 85096338

=LDR  01084cz  a2200265n  4500
=001  9880363680802441
=005  20180109103615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010101
=035  \\$aCBA3382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x680
=150  \\$aOxygen Consumption
=450  \\$wnnna$aConsumption, Oxygen
=450  \\$wnnna$aConsumptions, Oxygen
=450  \\$wnnna$aOxygen Consumptions
=550  \\$wg$aMetabolism
=550  \\$wh$aAnaerobic Threshold
=550  \\$wh$aMetabolic Equivalent
=550  \\$aCell Respiration
=550  \\$aRespiration
=667  \\$aTN 145: oxygen metab
=680  \\$iThe rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)
=688  \\$a66; was see under ENERGY METABOLISM & TISSUE METABOLISM 1963-65
=750  \0$aOxygen consumption (Physiology)$0(DLC)sh2007000583$5IEN-M

=LDR  01054cz  a2200253n  4500
=001  9880363680902441
=005  20141212204203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010100
=035  \\$aCBA3381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185.$x550
=072  \\$aD1.$x362.$x670
=150  \\$aOxygen
=450  \\$aDioxygen
=450  \\$aLiquid Oxygen$5IEN
=550  \\$wg$aChalcogens
=550  \\$wg$aGases
=550  \\$wh$aOzone
=667  \\$aO-16; /metab; consider also OXYGEN CONSUMPTION; /physiol for O2 in pulm resp process but tissue resp = OXYGEN CONSUMPTION; /ther use; consider also OXYGEN INHALATION THERAPY or HYPERBARIC OXYGENATION; /tox & /pois; consider also HYPEROXIA
=680  \\$iAn element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration.
=688  \\$a1963; for DIOXYGEN use OXYGEN (NM) 1980-2001
=750  \0$aLiquid oxygen$5IEN-M$0(DLC)sh 85077387
=750  \0$aOxygen$5IEN-HS$0(DLC)sh 85096329

=LDR  01063cz  a2200349n  4500
=001  9880363681002441
=005  20141212204203.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010098
=035  \\$aCBA3379M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x562.$x149.$x575
=072  \\$aD3.$x549.$x686.$x607.$x204.$x650
=072  \\$aD3.$x605.$x497.$x607.$x204.$x650
=072  \\$aD4.$x615.$x723.$x795.$x576.$x149.$x575
=150  \\$aOxycodone
=450  \\$aDihydrohydroxycodeinone
=450  \\$wnnna$aDihydrone
=450  \\$wnnna$aDinarkon
=450  \\$wnnna$aEucodal
=450  \\$aOxiconum
=450  \\$aOxycodeinon
=450  \\$wnnna$aOxycodone Hydrochloride
=450  \\$wnnna$aOxycone
=450  \\$wnnna$aOxycontin
=450  \\$wnnna$aPancodine
=450  \\$wnnna$aPurdue Frederick Brand of Oxycodone
=450  \\$wnnna$aTheocodin
=550  \\$wg$aCodeine
=680  \\$iA semisynthetic derivative of CODEINE.
=688  \\$a91(76); was see under CODEINE 1976-90
=750  \0$aOxycodone$5IEN-M$0(DLC)sh2002006018

=LDR  01259cz  a2200289n  4500
=001  9880363681102441
=005  20141212204201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010092
=035  \\$aCBA3373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x100.$x600
=072  \\$aE1.$x370.$x370.$x380.$x600
=072  \\$aE1.$x370.$x386.$x700.$x100.$x600
=072  \\$aE5.$x200.$x124.$x100.$x100.$x600
=150  \\$aOximetry
=450  \\$wnnna$aOximetries
=450  \\$wnnna$aOximetries, Pulse
=450  \\$wnnna$aOximetry, Pulse
=450  \\$wnnna$aPulse Oximetries
=450  \\$aPulse Oximetry
=550  \\$wg$aBlood Gas Analysis
=550  \\$wg$aHeart Function Tests
=550  \\$wh$aBlood Gas Monitoring, Transcutaneous
=667  \\$afor measurement of blood oxygen using an oximeter: not a synonym for "oxygen measurement" ( = OXYGEN / anal)
=680  \\$iThe determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. It includes non-invasive oxygen monitoring by pulse oximetry.
=750  \0$aOximetry$5IEN$0(DLC)sh 85096318

=LDR  02480cz  a2200589n  4500
=001  9880363681202441
=005  20141212204200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010088
=035  \\$aCBA3369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682
=150  \\$aOxidoreductases
=450  \\$wnnna$aDehydrogenase
=450  \\$aDehydrogenases
=450  \\$wnnna$aOxidase
=450  \\$aOxidases
=450  \\$wnnna$aReductase
=450  \\$aReductases
=550  \\$wg$aEnzymes
=550  \\$wh$a5,10-Methylenetetrahydrofolate Reductase (FADH2)
=550  \\$wh$aAlcohol Oxidoreductases
=550  \\$wh$aArsenate Reductases
=550  \\$wh$aAscorbate Oxidase
=550  \\$wh$aCeruloplasmin
=550  \\$wh$aElectron Transport Complex IV
=550  \\$wh$aHydrogenase
=550  \\$wh$aLaccase
=550  \\$wh$aLuciferases
=550  \\$wh$aMethionine Sulfoxide Reductases
=550  \\$wh$aNADH, NADPH Oxidoreductases
=550  \\$wh$aNitrogenase
=550  \\$wh$aNitroreductases
=550  \\$wh$aOxidoreductases Acting on Aldehyde or Oxo Group Donors
=550  \\$wh$aOxidoreductases Acting on CH-CH Group Donors
=550  \\$wh$aOxidoreductases Acting on CH-NH Group Donors
=550  \\$wh$aOxidoreductases Acting on CH-NH2 Group Donors
=550  \\$wh$aOxidoreductases Acting on Sulfur Group Donors
=550  \\$wh$aOxidoreductases, O-Demethylating
=550  \\$wh$aOxygenases
=550  \\$wh$aPeroxidases
=550  \\$wh$aPlastoquinol-Plastocyanin Reductase
=550  \\$wh$aRibonucleotide Reductases
=550  \\$wh$aSuccinate Cytochrome c Oxidoreductase
=550  \\$wh$aSuperoxide Dismutase
=550  \\$wh$aUrate Oxidase
=667  \\$aX refs OXIDASES; REDUCTASES & DEHYDROGENASES are GEN only: see Tree D8 under OXIDOREDUCTASES for all indentions & choose the most specific
=680  \\$iThe class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)
=688  \\$aDEHYDROGENASES & OXIDASES were headings 1963
=750  \0$aOxidases$5IEN-M$0(DLC)sh 85096306
=750  \0$aOxidoreductases$5IEN-HS$0(DLC)sh 85096317
=750  \0$aDehydrogenases$5IEN-HS$0(DLC)sh 85036492

=LDR  01046cz  a2200349n  4500
=001  9880363681302441
=005  20141212204159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010087
=035  \\$aCBA3368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x685
=072  \\$aD1.$x650.$x550
=150  \\$aOxides
=550  \\$wg$aAnions
=550  \\$wg$aOxygen Compounds
=550  \\$wh$aAluminum Oxide
=550  \\$wh$aCarbon Dioxide
=550  \\$wh$aCarbon Monoxide
=550  \\$wh$aHypochlorous Acid
=550  \\$wh$aMagnesium Oxide
=550  \\$wh$aNitrogen Oxides
=550  \\$wh$aOsmium Tetroxide
=550  \\$wh$aPeroxides
=550  \\$wh$aSilicon Dioxide
=550  \\$wh$aSulfur Oxides
=550  \\$wh$aThorium Dioxide
=550  \\$wh$aWater
=550  \\$wh$aZinc Oxide
=680  \\$iBinary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides.
=688  \\$a66
=750  \0$aOxides$5IEN$0(DLC)sh 85096314

=LDR  01096cz  a2200253n  4500
=001  9880363681402441
=005  20170629132335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010084
=035  \\$aCBA3365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x700
=072  \\$aG3.$x295.$x531
=150  \\$aOxidation-Reduction
=450  \\$wnnna$aOxidation Reduction
=450  \\$aRedox
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aEnergy Metabolism
=550  \\$wh$aElectron Transport
=550  \\$wh$aLipid Peroxidation
=550  \\$wh$aOxidative Coupling
=667  \\$aIM for general only; NIM with no qualif with specific drug IM
=680  \\$iA chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471).
=750  \0$aOxidation-reduction reaction$5IEN$0(DLC)sh 85096311

=LDR  00717cz  a2200193n  4500
=001  9880363681502441
=005  20141212204158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010083
=035  \\$aCBA3364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x642.$x631
=072  \\$aD27.$x888.$x569.$x540.$x631
=150  \\$aOxidants, Photochemical
=450  \\$wnnna$aPhotochemical Oxidants
=550  \\$wg$aOxidants
=680  \\$iCompounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light.
=688  \\$a75
=750  \0$aPhotochemical oxidants$5IEN$0(DLC)sh 85101141

=LDR  01626cz  a2200385n  4500
=001  9880363559602441
=005  20141212192141.0
=008  760419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004259
=035  \\$aCAZ7386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x445.$x308.$x300
=150  \\$aDNA-Directed DNA Polymerase
=450  \\$aDNA-Dependent DNA Polymerases
=450  \\$wnnna$aDNA Dependent DNA Polymerases
=450  \\$wnnna$aDNA Directed DNA Polymerase
=450  \\$wnnna$aDNA Polymerase, DNA-Directed
=450  \\$wnnna$aDNA Polymerase N3
=450  \\$aDNA Polymerases
=450  \\$wnnna$aDNA Polymerases, DNA-Dependent
=450  \\$wnnna$aPolymerase, DNA-Directed DNA
=450  \\$wnnna$aPolymerase N3, DNA
=450  \\$wnnna$aPolymerases, DNA
=450  \\$wnnna$aPolymerases, DNA-Dependent DNA
=550  \\$wg$aDNA Nucleotidyltransferases
=550  \\$wh$aDNA Polymerase beta
=550  \\$wh$aDNA Polymerase I
=550  \\$wh$aDNA Polymerase II
=550  \\$wh$aDNA Polymerase III
=550  \\$wh$aRNA-Directed DNA Polymerase
=550  \\$wh$aTaq Polymerase
=667  \\$ageneral; prefer specifics
=680  \\$iDNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair.
=688  \\$a98(68); for DNA POLYMERASE use DNA NUCLEOTIDYLTRANSFERASES 1968-76
=750  \0$aDNA polymerases$5IEN$0(DLC)sh 85037007

=LDR  02611cz  a2200649n  4500
=001  9880363559702441
=005  20190304142020.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004251
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x520
=072  \\$aG2.$x111.$x570.$x80.$x708.$x330.$x200
=072  \\$aG5.$x360.$x80.$x708.$x330.$x200
=072  \\$aG5.$x360.$x340.$x24.$x425.$x200
=150  \\$aDNA Transposable Elements
=450  \\$wnnna$aDNA Insertion Element
=450  \\$aDNA Insertion Elements
=450  \\$wnnna$aDNA Transposable Element
=450  \\$wnnna$aDNA Transposon
=450  \\$aDNA Transposons
=450  \\$wnnna$aElement, DNA Insertion
=450  \\$wnnna$aElement, DNA Transposable
=450  \\$wnnna$aElement, Insertion Sequence
=450  \\$wnnna$aElement, IS
=450  \\$wnnna$aElement, Tn
=450  \\$wnnna$aElement, Transposable
=450  \\$wnnna$aElements, DNA Insertion
=450  \\$wnnna$aElements, DNA Transposable
=450  \\$wnnna$aElements, Insertion Sequence
=450  \\$wnnna$aElements, IS
=450  \\$wnnna$aElements, Tn
=450  \\$wnnna$aElements, Transposable
=450  \\$wnnna$aInsertion Element, DNA
=450  \\$wnnna$aInsertion Elements, DNA
=450  \\$wnnna$aInsertion Sequence Element
=450  \\$aInsertion Sequence Elements
=450  \\$wnnna$aIS Element
=450  \\$aIS Elements
=450  \\$wnnna$aSequence Element, Insertion
=450  \\$wnnna$aSequence Elements, Insertion
=450  \\$wnnna$aTn Element
=450  \\$aTn Elements
=450  \\$wnnna$aTransposable Element
=450  \\$wnnna$aTransposable Element, DNA
=450  \\$aTransposable Elements
=450  \\$wnnna$aTransposable Elements, DNA
=450  \\$wnnna$aTransposon, DNA
=450  \\$wnnna$aTransposons, DNA
=550  \\$wg$aDNA
=550  \\$wg$aInterspersed Repetitive Sequences
=550  \\$wh$aIntegrons
=550  \\$aMutagenesis, Insertional
=550  \\$aRetroelements
=667  \\$ado not use for retrotransposable elements (RETROELEMENTS)
=680  \\$iDiscrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.
=688  \\$a99(80)
=750  \0$aInsertion elements, DNA$0(DLC)sh 85066708$5IEN-M

=LDR  01228cz  a2200277n  4500
=001  9880363559802441
=005  20141212200814.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004250
=035  \\$aCAZ7374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x403.$x741
=150  \\$aDNA Topoisomerases, Type II
=450  \\$aDNA Topoisomerase (ATP-Hydrolysing)
=450  \\$aDNA Topoisomerase II
=450  \\$wnnna$aDNA Type 2 Topoisomerase
=450  \\$wnnna$aTopoisomerase II
=450  \\$wnnna$aType II DNA Topoisomerase
=550  \\$wg$aDNA Topoisomerases
=550  \\$wh$aDNA Gyrase
=550  \\$wh$aDNA Topoisomerase IV
=667  \\$acoordinate with BACTERIAL PROTEINS or ARCHAEAL PROTEINS if pertinent
=680  \\$iDNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.
=688  \\$a2002; use DNA GYRASE 1980-1993
=688  \\$a2002; use DNA TOPOISOMERASE (ATP-HYDROLYSING) 1994-2001, use DNA GYRASE 1980-1993
=750  \0$aDNA topoisomerase II$0(DLC) sh 88003832$5IEN

=LDR  01855cz  a2200397n  4500
=001  9880363559902441
=005  20141212200813.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004249
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x180
=150  \\$aDNA Damage
=450  \\$wnnna$aDamage, DNA
=450  \\$wnnna$aDamages, DNA
=450  \\$wnnna$aDNA Damages
=450  \\$wnnna$aDNA Injuries
=450  \\$aDNA Injury
=450  \\$aGenotoxic Stress
=450  \\$wnnna$aGenotoxic Stresses
=450  \\$wnnna$aInjuries, DNA
=450  \\$wnnna$aInjury, DNA
=450  \\$aStress, Genotoxic
=450  \\$wnnna$aStresses, Genotoxic
=550  \\$wg$aGenetic Processes
=550  \\$wh$aDNA Adducts
=550  \\$wh$aDNA Breaks
=550  \\$wh$aDNA Degradation, Necrotic
=550  \\$wh$aDNA Fragmentation
=550  \\$aComet Assay
=550  \\$aDNA Repair Enzymes
=550  \\$aMutation
=550  \\$aPyrimidine Dimers
=667  \\$ado not use /drug eff & /rad eff for DNA damage induced by drugs or radiation; do not confuse with DNA FRAGMENTATION: see note there
=680  \\$iInjuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.
=688  \\$a87
=750  \0$aDNA damage$0(DLC) sh 88006186$5IEN

=LDR  02251cz  a2200589n  4500
=001  9880363560002441
=005  20180416094842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004247
=035  \\$aCAZ7371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308
=150  \\$aDNA
=450  \\$aDeoxyribonucleic Acid
=450  \\$aDNA, Double-Stranded
=450  \\$wnnna$aDNA, Double Stranded
=450  \\$wnnna$aDouble-Stranded DNA
=450  \\$wnnna$ads-DNA
=450  \\$wnnna$ads DNA
=550  \\$wg$aNucleic Acids
=550  \\$wh$aDNA, Ancient
=550  \\$wh$aDNA, A-Form
=550  \\$wh$aDNA Adducts
=550  \\$wh$aDNA, Algal
=550  \\$wh$aDNA, Antisense
=550  \\$wh$aDNA, Archaeal
=550  \\$wh$aDNA, B-Form
=550  \\$wh$aDNA, Bacterial
=550  \\$wh$aDNA, C-Form
=550  \\$wh$aDNA, Catalytic
=550  \\$wh$aDNA, Circular
=550  \\$wh$aDNA, Concatenated
=550  \\$wh$aDNA, Cruciform
=550  \\$wh$aDNA, Fungal
=550  \\$wh$aDNA, Helminth
=550  \\$wh$aDNA, Intergenic
=550  \\$wh$aDNA, Neoplasm
=550  \\$wh$aDNA, Plant
=550  \\$wh$aDNA, Protozoan
=550  \\$wh$aDNA, Recombinant
=550  \\$wh$aDNA, Ribosomal
=550  \\$wh$aDNA, Satellite
=550  \\$wh$aDNA, Single-Stranded
=550  \\$wh$aDNA Transposable Elements
=550  \\$wh$aDNA, Viral
=550  \\$wh$aDNA, Z-Form
=550  \\$wh$aIsochores
=550  \\$wh$aRetroelements
=550  \\$aBiopolymers
=667  \\$ageneral; prefer specifics; /biosyn permitted but consider also DNA REPLICATION; structural DNA models = DNA (IM) + MOLECULAR MODELS (IM)
=680  \\$iA deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
=750  \0$aDNA$5IEN$0(DLC)sh 85037008

=LDR  00869cz  a2200265n  4500
=001  9880363560102441
=005  20141212200811.0
=008  780517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004244
=035  \\$aCAZ7368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x237
=072  \\$aC23.$x888.$x592.$x763.$x237
=150  \\$aDizziness
=450  \\$wnnna$aDizzyness
=450  \\$wnnna$aLight-Headedness
=450  \\$wnnna$aLight Headedness
=450  \\$aLightheadedness
=450  \\$aOrthostasis
=550  \\$wg$aSensation Disorders
=550  \\$aVertigo
=667  \\$adifferentiate from VERTIGO, illusion of revolution in space, but use word of text
=680  \\$iAn imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.
=688  \\$a1979
=750  \0$aDizziness$5IEN$0(DLC)sh 91003003

=LDR  00881cz  a2200289n  4500
=001  9880363560202441
=005  20141212192141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004243
=035  \\$aCAZ7367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500.$x300
=072  \\$aI1.$x240.$x361.$x500.$x300
=072  \\$aI1.$x880.$x735.$x255
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500.$x300
=072  \\$aN1.$x224.$x361.$x500.$x300
=072  \\$aN1.$x824.$x308.$x500.$x300
=150  \\$aDivorce
=450  \\$wnnna$aDivorced
=450  \\$wnnna$aDivorces
=450  \\$wnnna$aSeparated
=450  \\$wnnna$aSeparation
=450  \\$wnnna$aSeparations
=550  \\$wg$aMarital Status
=550  \\$wg$aSocial Problems
=680  \\$iLegal dissolution of an officially recognized marriage relationship.
=750  \0$aDivorce$5IEN$0(DLC)sh 85038616

=LDR  01185cz  a2200265n  4500
=001  9880363560302441
=005  20141212200811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004242
=035  \\$aCAZ7366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x869.$x110
=072  \\$aN6.$x230.$x150.$x150
=150  \\$aDiving
=450  \\$wnnna$aDivings
=550  \\$wg$aEnvironment, Controlled
=550  \\$wg$aSwimming
=550  \\$aHigh Pressure Neurological Syndrome
=550  \\$aImmersion
=550  \\$aNaval Medicine
=667  \\$ahuman & animal; /adv eff permitted for hazards of diving as a Cat G3 concept, /inj permitted for diving as a sport in Cat I: coord IM with specific inj (IM); /physiol permitted; includes scuba & bell diving
=680  \\$iAn activity in which the organism plunges into water. It includes scuba and bell diving. Diving as natural behavior of animals goes here, as well as diving in decompression experiments with humans or animals.
=688  \\$awas in Cat G only 1975-80; was in Cat E only 1968-74; was in Cat E & J 1963-67
=750  \0$aDivers$5IEN-HS$0(DLC)sh 85038575
=750  \0$aDiving$5IEN-HS$0(DLC)sh 85038594

=LDR  00890cz  a2200253n  4500
=001  9880363560402441
=005  20141212200810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004240
=035  \\$aCAZ7364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x415
=150  \\$aDiverticulum
=450  \\$wnnna$aDiverticula
=450  \\$aDiverticulosis
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aDiverticulum, Colon
=550  \\$wh$aDiverticulum, Esophageal
=550  \\$wh$aDiverticulum, Stomach
=550  \\$wh$aMeckel Diverticulum
=667  \\$acoordinate IM with precoordinated organ/disease term (IM) but note specifics are available
=680  \\$iA pouch or sac developed from a tubular or saccular organ, such as the GASTROINTESTINAL TRACT.
=688  \\$a92; was DIVERTICULOSIS 1963-91
=750  \0$aDiverticulosis$5IEN-M$0(DLC)sh 85038582

=LDR  00708cz  a2200193n  4500
=001  9880363560502441
=005  20141212200810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004239
=035  \\$aCAZ7363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x158.$x587.$x500
=150  \\$aDiverticulitis, Colonic
=450  \\$aColonic Diverticulitis
=550  \\$wg$aDiverticulosis, Colonic
=667  \\$ado not confuse with DIVERTICULOSIS, COLONIC
=680  \\$iInflammation of the COLONIC DIVERTICULA, generally with abscess formation and subsequent perforation.
=750  \0$81$wb$aDiverticulitis$5IEN$0(DLC)sh 85038581
=750  \0$81$wb$aColon (Anatomy)$xDiseases$5IEN-HS$0(DLC)sh 85028545

=LDR  00770cz  a2200229n  4500
=001  9880363560602441
=005  20200430180124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004238
=035  \\$aCAZ7362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x463.$x298
=072  \\$aC6.$x405.$x205.$x282.$x500
=150  \\$aDiverticulitis
=450  \\$wnnna$aDiverticulitides
=550  \\$wg$aDiverticular Diseases
=550  \\$wh$aDiverticulitis, Colonic
=550  \\$wh$aDiverticulosis, Esophageal
=550  \\$wh$aDiverticulosis, Stomach
=667  \\$acoordinate IM with precoordinated organ/disease terms (IM) or specific diverticulum (IM)
=680  \\$iInflammation of a DIVERTICULUM or diverticula.
=750  \0$aDiverticulitis$5IEN$0(DLC)sh 85038581

=LDR  00574cz  a2200205n  4500
=001  9880363560702441
=005  20141212200810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004237
=035  \\$aCAZ7361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x703.$x397
=072  \\$aD2.$x948.$x681.$x397
=150  \\$aDiuron
=450  \\$wnnna$a3-(3,4-Dichlorophenyl)-1,1-dimethylurea
=450  \\$aDCMU
=550  \\$wg$aPhenylurea Compounds
=680  \\$iA pre-emergent herbicide.
=688  \\$a74(72)
=750  \0$aDiuron$5IEN$0(DLC)sh 85038569

=LDR  01068cz  a2200301n  4500
=001  9880363560802441
=005  20141212200809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004232
=035  \\$aCAZ7356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x560.$x500
=150  \\$aDiuretics
=450  \\$wnnna$aDiuretic Effect
=450  \\$wnnna$aDiuretic Effects
=450  \\$wnnna$aDiuretics, Sulfamyl$5IEN-M
=450  \\$wnnna$aEffect, Diuretic
=450  \\$wnnna$aEffects, Diuretic
=550  \\$wg$aNatriuretic Agents
=550  \\$wh$aDiuretics, Osmotic
=550  \\$wh$aDiuretics, Potassium Sparing
=550  \\$wh$aSodium Chloride Symporter Inhibitors
=550  \\$wh$aSodium Potassium Chloride Symporter Inhibitors
=550  \\$aAntihypertensive Agents
=550  \\$aDiuresis
=667  \\$anote entry term DIURETIC EFFECT: use only for the diuretic effect of a chemical substance
=680  \\$iAgents that promote the excretion of urine through their effects on kidney function.
=750  \0$aDiuretics$0(DLC) sh 85038566$5IEN

=LDR  01247cz  a2200445n  4500
=001  9880363560902441
=005  20201123171240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004224
=035  \\$aCAZ7349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291
=150  \\$aDiterpenes
=450  \\$wnnna$aCembrane Diterpenes
=450  \\$wnnna$aCembranes
=450  \\$aDiterpenes, Cembrane
=450  \\$aDiterpenes, Labdane
=450  \\$wnnna$aDiterpenoids
=450  \\$wnnna$aLabdane Diterpenes
=450  \\$wnnna$aLabdanes
=450  \\$aNorditerpenes
=450  \\$wnnna$aNorditerpenoids
=550  \\$wg$aTerpenes
=550  \\$wh$aAbietanes
=550  \\$wh$aAconitine
=550  \\$wh$aAphidicolin
=550  \\$wh$aAtractyloside
=550  \\$wh$aColforsin
=550  \\$wh$aDiterpenes, Clerodane
=550  \\$wh$aDiterpenes, Kaurane
=550  \\$wh$aGinkgolides
=550  \\$wh$aPhorbols
=550  \\$wh$aPhytanic Acid
=550  \\$wh$aPhytol
=550  \\$wh$aRyanodine
=550  \\$wh$aTaxoids
=667  \\$aGEN; prefer specifics
=680  \\$iTwenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate.
=688  \\$a74
=750  \0$aDiterpenes$5IEN$0(DLC)sh 89005223

=LDR  01790cz  a2200409n  4500
=001  9880363561002441
=005  20141212192140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004221
=035  \\$aCAZ7346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x869.$x220.$x250
=072  \\$aD2.$x886.$x520.$x150.$x175
=072  \\$aD2.$x886.$x706.$x200.$x200
=150  \\$aDisulfiram
=450  \\$wnnna$aAlcophobin
=450  \\$wnnna$aAllphar Brand of Disulfiram
=450  \\$wnnna$aAltana Pharma Brand of Disulfiram
=450  \\$wnnna$aAntabus
=450  \\$wnnna$aAntabuse
=450  \\$wnnna$aAnticol
=450  \\$wnnna$aBis(diethylthiocarbamoyl) Disulfide
=450  \\$wnnna$aBohm Brand of Disulfiram
=450  \\$wnnna$aDicupral
=450  \\$wnnna$aDisulfide, Tetraethylthiuram
=450  \\$wnnna$aDumex Brand of Disulfiram
=450  \\$wnnna$aEsperal
=450  \\$wnnna$aOdyssey Brand of Disulfiram
=450  \\$wnnna$aOrphan Brand of Disulfiram
=450  \\$wnnna$aSanofi Synthelabo Brand of Disulfiram
=450  \\$wnnna$aTetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2
=450  \\$aTetraethylthiuram Disulfide
=450  \\$wnnna$aTeturam
=550  \\$wg$aDisulfides
=550  \\$wg$aDitiocarb
=680  \\$iA carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms (acetaldehyde syndrome). It acts by inhibiting aldehyde dehydrogenase.
=750  \0$aDisulfiram$5IEN$0(DLC)sh 87002283

=LDR  00965cz  a2200229n  4500
=001  9880363561102441
=005  20141212200806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004217
=035  \\$aCAZ7342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x500.$x280
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x500.$x280
=150  \\$aDistemper Virus, Canine
=450  \\$aCanine distemper virus
=450  \\$wnnna$aCanine Distemper Viruses
=450  \\$wnnna$aDistemper Viruses, Canine
=550  \\$wg$aMorbillivirus
=667  \\$ainfection: coord IM with DISTEMPER (IM); DISTEMPER VIRUS, PHOCINE is also available
=680  \\$iA species of MORBILLIVIRUS causing distemper in dogs, wolves, foxes, raccoons, and ferrets. Pinnipeds have also been known to contract Canine distemper virus from contact with domestic dogs.
=688  \\$a66; was DISTEMPER VIRUS 1963-65
=750  \0$aCanine distemper virus$5IEN$0(DLC)sh 85019597

=LDR  01165cz  a2200253n  4500
=001  9880363561202441
=005  20141212200806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004216
=035  \\$aCAZ7341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x600.$x500.$x285
=072  \\$aC22.$x268.$x265
=150  \\$aDistemper
=450  \\$aCanine Distemper
=450  \\$wnnna$aCanine Distempers
=450  \\$aDistemper, Canine
=450  \\$wnnna$aDistempers
=450  \\$wnnna$aDistempers, Canine
=550  \\$wg$aDog Diseases
=550  \\$wg$aMorbillivirus Infections
=667  \\$adon't forget also DOGS (NIM) or other animal + check tag ANIMALS but in cats = FELINE PANLEUKOPENIA (IM) + CATS (NIM) + check tag ANIMALS
=680  \\$iA name for several highly contagious viral diseases of animals, especially canine distemper. In dogs, it is caused by the canine distemper virus (DISTEMPER VIRUS, CANINE). It is characterized by a diphasic fever, leukopenia, gastrointestinal and respiratory inflammation and sometimes, neurologic complications. In cats it is known as FELINE PANLEUKOPENIA.
=750  \0$aDistemper$5IEN$0(DLC)sh 85038515

=LDR  00787cz  a2200217n  4500
=001  9880363561302441
=005  20141212200805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004215
=035  \\$aCAZ7340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x200.$x390
=072  \\$aF2.$x463.$x593.$x932.$x869.$x255.$x390
=150  \\$aDistance Perception
=450  \\$wnnna$aDistance Perceptions
=450  \\$wnnna$aPerception, Distance
=450  \\$wnnna$aPerceptions, Distance
=550  \\$wg$aDepth Perception
=680  \\$iThe act of knowing or the recognition of a distance by recollective thought, or by means of a sensory process which is under the influence of set and of prior experience.
=688  \\$a66
=750  \0$aDepth perception$5IEN$0(DLC)sh 85037070

=LDR  01319cz  a2200349n  4500
=001  9880363561402441
=005  20201019140128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004213
=035  \\$aCAZ7338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x300
=150  \\$aDissociative Disorders
=450  \\$wnnna$aDisorder, Dissociative
=450  \\$wnnna$aDisorders, Dissociative
=450  \\$aDissociation
=450  \\$wnnna$aDissociative Disorder
=450  \\$wnnna$aDissociative Hysteria
=450  \\$wnnna$aDissociative Reaction
=450  \\$wnnna$aDissociative Reactions
=450  \\$aFugue
=450  \\$aHysteria, Dissociative
=450  \\$wnnna$aHysterias, Dissociative
=450  \\$wnnna$aReaction, Dissociative
=450  \\$wnnna$aReactions, Dissociative
=550  \\$wg$aMental Disorders
=550  \\$wh$aDissociative Identity Disorder
=667  \\$ause Cat F3 qualif
=680  \\$iSudden temporary alterations in the normally integrative functions of consciousness.
=688  \\$a81; was DISSOCIATIVE REACTION 1968-80; DISSOCIATION was see under DISSOCIATIVE REACTION 1969-78; FUGUE was see under DISSOCIATIVE REACTION 1968-78, was heading 1963-67
=750  \0$aDissociation (Psychology)$5IEN$0(DLC)sh 85038501
=750  \0$aDissociative disorders$5IEN-HS$0(DLC)sh 92004916

=LDR  01941cz  a2200421n  4500
=001  9880363561602441
=005  20141212200804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004211
=035  \\$aCAZ7336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x220
=072  \\$aC15.$x378.$x463.$x250
=072  \\$aC15.$x378.$x925.$x220
=150  \\$aDisseminated Intravascular Coagulation
=450  \\$wnnna$aCoagulation, Disseminated Intravascular
=450  \\$wnnna$aCoagulation, Intravascular Disseminated
=450  \\$wnnna$aCoagulations, Disseminated Intravascular
=450  \\$wnnna$aCoagulations, Intravascular Disseminated
=450  \\$wnnna$aCoagulopathies, Consumption
=450  \\$wnnna$aCoagulopathy, Consumption
=450  \\$wnnna$aConsumption Coagulopathies
=450  \\$aConsumption Coagulopathy
=450  \\$wnnna$aDisseminated Coagulation, Intravascular
=450  \\$wnnna$aDisseminated Coagulations, Intravascular
=450  \\$wnnna$aDisseminated Intravascular Coagulations
=450  \\$wnnna$aIntravascular Coagulation, Disseminated
=450  \\$wnnna$aIntravascular Coagulations, Disseminated
=450  \\$wnnna$aIntravascular Disseminated Coagulation
=450  \\$wnnna$aIntravascular Disseminated Coagulations
=550  \\$wg$aBlood Coagulation Disorders
=550  \\$wg$aHemorrhagic Disorders
=550  \\$wg$aThrombophilia
=550  \\$aPurpura Fulminans
=667  \\$ado not confuse with ERYTHROCYTE AGGREGATION, INTRAVASCULAR; DF: DISSEM INTRAVASC COAG
=680  \\$iA disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
=688  \\$a72(70)
=750  \0$aDisseminated intravascular coagulation$5IEN$0(DLC)sh 85038487

=LDR  00766cz  a2200241n  4500
=001  9880363561702441
=005  20141212200803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004210
=035  \\$aCAZ7335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x221
=072  \\$aE4.$x221
=072  \\$aE5.$x200.$x998.$x221
=150  \\$aDissection
=450  \\$wnnna$aDissections
=550  \\$wg$aSpecimen Handling
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aMicrodissection
=550  \\$aAnatomy
=667  \\$aNECK DISSECTION is also available
=680  \\$iThe separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures.
=750  \0$aDissection$5IEN$0(DLC)sh 85038485

=LDR  00612cz  a2200193n  4500
=001  9880363561802441
=005  20141212200803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004209
=035  \\$aCAZ7334HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x252
=150  \\$aDisposable Equipment
=450  \\$aEquipment, Disposable
=550  \\$wg$aEquipment and Supplies
=680  \\$iApparatus, devices, or supplies intended for one-time or temporary use.
=688  \\$a66
=750  \0$aMedical supplies, Disposable$5IEN-M$0(DLC)sh 85083041
=750  \0$aDisposable medical devices$5IEN-M$0(DLC)sh 00005324

=LDR  01937cz  a2200469n  4500
=001  9880363562102441
=005  20141212200802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004206
=035  \\$aCAZ7331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x227
=150  \\$aDisopyramide
=450  \\$wnnna$aDiisopyramide
=450  \\$wnnna$aDisopyramide, (+-)-Isomer
=450  \\$wnnna$aDisopyramide, D-Tartrate (1:1), (S)-Isomer
=450  \\$wnnna$aDisopyramide, L-Tartrate (1:1), (R)-Isomer
=450  \\$wnnna$aDisopyramide, L-Tartrate (1:1), (S)-Isomer
=450  \\$wnnna$aDisopyramide, L-Tartrate (1:2), (+-)-Isomer
=450  \\$wnnna$aDisopyramide, L-Tartrate, (S)-isomer
=450  \\$wnnna$aDisopyramide Monohydrochloride
=450  \\$wnnna$aDisopyramide Phosphate
=450  \\$wnnna$aDisopyramide Phosphate (1:1)
=450  \\$wnnna$aDisopyramide Phosphate (1:1), (+-)-Isomer
=450  \\$wnnna$aDisopyramide Phosphate (1:1), (R)-Isomer
=450  \\$wnnna$aDisopyramide Phosphate (1:1), (S)-Isomer
=450  \\$wnnna$aDisopyramide, (R)-Isomer
=450  \\$wnnna$aDisopyramide, (S)-Isomer
=450  \\$wnnna$aNorpace
=450  \\$wnnna$aPalpitin
=450  \\$wnnna$aPalpitine
=450  \\$wnnna$aRhythmodan
=450  \\$wnnna$aRitmilen
=450  \\$wnnna$aRythmilen
=450  \\$wnnna$aSC-13957
=450  \\$wnnna$aSC 13957
=450  \\$wnnna$aSC13957
=450  \\$wnnna$aSearle Brand of Disopyramide Phosphate
=550  \\$wg$aPyridines
=680  \\$iA class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
=688  \\$a84(72); was see under PYRIDINES 1972-83 (Prov 1972-74)
=750  \0$aDisopyramide$5IEN$0(DLC)sh 85038445

=LDR  01455cz  a2200409n  4500
=001  9880363562202441
=005  20141212200802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004205
=035  \\$aCAZ7330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x300
=072  \\$aD3.$x830.$x219.$x266.$x300
=150  \\$aCromolyn Sodium
=450  \\$wnnna$aAarane
=450  \\$wnnna$aBicromat Spray
=450  \\$wnnna$aCromoglicic Acid
=450  \\$wnnna$aCromoglycate
=450  \\$wnnna$aCromoglycate, Disodium
=450  \\$wnnna$aCromoglycate, Sodium
=450  \\$wnnna$aCromoglycic Acid
=450  \\$wnnna$aCromolyn
=450  \\$aDisodium Cromoglycate
=450  \\$wnnna$aFPL-670
=450  \\$wnnna$aFPL 670
=450  \\$wnnna$aFPL670
=450  \\$wnnna$aIntal
=450  \\$wnnna$aLomudal
=450  \\$wnnna$aNalcrom
=450  \\$wnnna$aNasalcrom
=450  \\$wnnna$aOpticrom
=450  \\$aSodium Cromoglycate
=450  \\$wnnna$aVicrom
=550  \\$wg$aChromones
=680  \\$iA chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
=688  \\$a92; was DISODIUM CROMOGLYCATE 1971-91 (Prov 1971-72); CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91
=750  \0$aCromolyn sodium$5IEN-M$0(DLC)sh 88004855

=LDR  01281cz  a2200397n  4500
=001  9880363562302441
=005  20180409090016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004204
=035  \\$aCAZ7329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x116
=072  \\$aC26.$x289
=150  \\$aJoint Dislocations
=450  \\$wnnna$aDislocation, Joint
=450  \\$wnnna$aDislocations, Joint
=450  \\$wnnna$aInferior Dislocation
=450  \\$wnnna$aInferior Dislocations
=450  \\$wnnna$aJoint Dislocation
=450  \\$wnnna$aJoint Subluxation
=450  \\$wnnna$aJoint Subluxations
=450  \\$wnnna$aSubluxation, Joint
=450  \\$wnnna$aSubluxations, Joint
=450  \\$wnnna$aLuxatio, Erecta
=550  \\$wg$aJoint Diseases
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aDiastasis, Bone
=550  \\$wh$aDiastasis, Muscle
=550  \\$wh$aFracture Dislocation
=550  \\$wh$aHip Dislocation
=550  \\$wh$aKnee Dislocation
=550  \\$wh$aPatellar Dislocation
=550  \\$wh$aShoulder Dislocation
=667  \\$aluxation & subluxation go here; coordinate with with specific joint
=680  \\$iDisplacement of bones from their normal positions at a joint.
=750  \0$aDislocations$0(DLC)sh 85038438$5IEN-M

=LDR  00928cz  a2200181n  4500
=001  9880363562402441
=005  20141212200801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004203
=035  \\$aCAZ7328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x450.$x850.$x375
=150  \\$aDisinfection
=550  \\$wg$aSterilization
=667  \\$adifferentiate from STERILIZATION: DISINFECTION renders matter free of pathogens, STERILIZATION destroys all microbes; if in doubt, use the word of the text; disinfection of needles using household bleach Clorox, as by intravenous drug users, is indexed under DISINFECTION + NEEDLES + SODIUM HYPOCHLORITE
=680  \\$iRendering pathogens harmless through the use of heat, antiseptics, antibacterial agents, etc.
=688  \\$a91(75)63-66; was see under STERILIZATION 1967-90; was heading 1963-66
=750  \0$aDisinfection and disinfectants$5IEN$0(DLC)sh 85038429

=LDR  01281cz  a2200265n  4500
=001  9880363562502441
=005  20141212200801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004202
=035  \\$aCAZ7327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x425
=072  \\$aD27.$x720.$x274
=150  \\$aDisinfectants
=450  \\$wnnna$aBiocides
=550  \\$wg$aAnti-Infective Agents
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aContact Lens Solutions
=550  \\$wh$aDental Disinfectants
=550  \\$wh$aHand Sanitizers
=550  \\$aAnti-Infective Agents, Local
=667  \\$ado not confuse with ANTISEPTICS which are used against organisms in man & animal
=680  \\$iSubstances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=688  \\$a67; was see ANTISEPTICS 1963-66
=750  \0$aDisinfection and disinfectants$5IEN$0(DLC)sh 85038429

=LDR  00825cz  a2200253n  4500
=001  9880363562602441
=005  20141212200800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004200
=035  \\$aCAZ7325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x750
=150  \\$aDiseases in Twins
=450  \\$wnnna$aDiseases in Twin
=450  \\$wnnna$ain Twin, Diseases
=450  \\$wnnna$ain Twins, Diseases
=450  \\$wnnna$aTwin, Diseases in
=450  \\$wnnna$aTwins, Diseases in
=550  \\$wg$aDisease Attributes
=550  \\$aGenetics, Medical
=550  \\$aTwins
=667  \\$ahuman only; the disease may be in only one or in both twins; Manual 34.14; DF: DIS IN TWINS
=680  \\$iDisorders affecting TWINS, one or both, at any age.
=750  \0$aDiseases in twins$5IEN$0(DLC)sh 85038420

=LDR  01081cz  a2200313n  4500
=001  9880363562702441
=005  20141212200800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004199
=035  \\$aCAZ7324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x310.$x350
=150  \\$aDisease Vectors
=450  \\$wnnna$aDisease Vector
=450  \\$wnnna$aDisease Vector, Infectious
=450  \\$wnnna$aDisease Vectors, Infectious
=450  \\$wnnna$aInfectious Disease Vector
=450  \\$wnnna$aInfectious Disease Vectors
=450  \\$wnnna$aVector, Disease
=450  \\$wnnna$aVector, Infectious Disease
=450  \\$wnnna$aVectors, Disease
=450  \\$wnnna$aVectors, Infectious Disease
=550  \\$wg$aDisease Transmission, Infectious
=550  \\$wh$aArthropod Vectors
=550  \\$aCommunicable Disease Control
=550  \\$aDisease Reservoirs
=680  \\$iInvertebrates or non-human vertebrates which transmit infective organisms from one host to another.
=688  \\$a67(65)
=750  \0$aAnimals as carriers of disease$5IEN$0(DLC)sh 85005281

=LDR  01511cz  a2200361n  4500
=001  9880363562802441
=005  20141212200759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004195
=035  \\$aCAZ7322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x232
=072  \\$aE5.$x598.$x500
=072  \\$aE5.$x599.$x395.$x80
=150  \\$aDisease Models, Animal
=450  \\$wnnna$aAnimal Disease Model
=450  \\$wnnna$aAnimal Disease Models
=450  \\$wnnna$aDisease Model, Animal
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aModels, Animal
=550  \\$wg$aModels, Biological
=550  \\$wh$aArthritis, Experimental
=550  \\$wh$aDiabetes Mellitus, Experimental
=550  \\$wh$aLiver Cirrhosis, Experimental
=550  \\$wh$aNeoplasms, Experimental
=550  \\$wh$aNervous System Autoimmune Disease, Experimental
=550  \\$wh$aRadiation Injuries, Experimental
=550  \\$aAnimals, Laboratory
=550  \\$aModels, Biological
=667  \\$anot a routine coordinate with experimental animal diseases: index only when the text indicates a disease model; when the model is the point of the article, coordinate IM with the specific disease (IM) + specific animal (IM) if pertinent
=680  \\$iNaturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
=688  \\$a70
=750  \0$aDiseases$xAnimal models$5IEN$0(DLC)sh 85038412

=LDR  00945cz  a2200193n  4500
=001  9880363562902441
=005  20141212200758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004194
=035  \\$aCAZ7321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x288
=150  \\$aDisease
=450  \\$wnnna$aDiseases
=550  \\$wg$aPathologic Processes
=550  \\$wh$aSyndrome
=667  \\$ageneral only as a physiological, pathological, philosophical concept, opposite "health"; Manual 23.5+; / econ permitted but consider also economic aspects of disease as ECONOMICS, MEDICAL; / psychol permitted but consider also psychogenic origin of disease as PSYCHOPHYSIOLOGIC DISORDERS
=680  \\$iA definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
=750  \0$aDiseases$5IEN$0(DLC)sh 85038411

=LDR  00640cz  a2200193n  4500
=001  9880363563002441
=005  20141212200758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004193
=035  \\$aCAZ7320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x280
=150  \\$aDiscrimination Learning
=450  \\$wnnna$aDiscrimination Learnings
=450  \\$wnnna$aLearning, Discrimination
=450  \\$wnnna$aLearnings, Discrimination
=550  \\$wg$aLearning
=680  \\$iLearning that is manifested in the ability to respond differentially to various stimuli.
=750  \0$aDiscrimination learning$5IEN$0(DLC)sh 85038404

=LDR  01315cz  a2200337n  4500
=001  9880363563102441
=005  20200722124705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004190
=035  \\$aCAZ7316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x100
=150  \\$aDisasters
=450  \\$wnnna$aDisaster
=450  \\$wnnna$aDisaster, Natural
=450  \\$wnnna$aDisasters, Natural
=450  \\$wnnna$aNatural Disaster
=450  \\$wnnna$aNatural Disasters
=550  \\$wg$aEnvironment
=550  \\$wh$aDisaster Planning
=550  \\$wh$aEmergencies
=550  \\$wh$aEmergency Shelter
=550  \\$wh$aMass Casualty Incidents
=550  \\$wh$aNatural Disasters
=550  \\$wh$aRelief Work
=550  \\$wh$aRescue Work
=550  \\$aChernobyl Nuclear Accident
=667  \\$acoordinate with specific event causing the disaster; specify geographic location
=680  \\$iCalamities producing great damage, loss of life, and distress. They include results of natural phenomena and man-made phenomena. Normal conditions of existence are disrupted and the level of impact exceeds the capacity of the hazard-affected community.
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20090831: 150:##:_{dollar}a Natural Disasters
=750  \0$aDisasters$0(DLC) sh 85038303$5IEN-HS

=LDR  00959cz  a2200277n  4500
=001  9880363563202441
=005  20141212200756.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004189
=035  \\$aCAZ7315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x100.$x35
=150  \\$aDisaster Planning
=450  \\$wnnna$aDisaster Relief Planning
=450  \\$wnnna$aDisaster Relief Plannings
=450  \\$wnnna$aPlanning, Disaster
=450  \\$wnnna$aPlanning, Disaster Relief
=450  \\$wnnna$aPlannings, Disaster Relief
=450  \\$wnnna$aRelief Planning, Disaster
=450  \\$wnnna$aRelief Plannings, Disaster
=550  \\$wg$aDisasters
=550  \\$wh$aStrategic Stockpile
=667  \\$aspecify disaster (IM) if pertinent; specify geog if pertinent
=680  \\$iProcedures outlined for the care of casualties and the maintenance of services in disasters.
=688  \\$a78
=750  \0$aEmergency management$5IEN$0(DLC)sh 91000441

=LDR  00745cz  a2200265n  4500
=001  9880363563302441
=005  20141212200756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004187
=035  \\$aCAZ7313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x305
=150  \\$aDisaccharides
=550  \\$wg$aOligosaccharides
=550  \\$wh$aCellobiose
=550  \\$wh$aIsomaltose
=550  \\$wh$aLactose
=550  \\$wh$aLactulose
=550  \\$wh$aMaltose
=550  \\$wh$aMelibiose
=550  \\$wh$aSucrose
=550  \\$wh$aTrehalose
=667  \\$aGEN; prefer specifics
=680  \\$iOligosaccharides containing two monosaccharide units linked by a glycosidic bond.
=750  \0$aDisaccharides$5IEN$0(DLC)sh 88003123

=LDR  01076cz  a2200265n  4500
=001  9880363563402441
=005  20141212200755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004185
=035  \\$aCAZ7311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x400
=150  \\$aDisability Evaluation
=450  \\$wnnna$aDisability Evaluations
=450  \\$wnnna$aEvaluation, Disability
=450  \\$wnnna$aEvaluations, Disability
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aWork Capacity Evaluation
=550  \\$aEligibility Determination
=550  \\$aInternational Classification of Functioning, Disability and Health
=550  \\$aRehabilitation
=550  \\$aWorkers' Compensation
=667  \\$ano qualif
=680  \\$iDetermination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.
=750  \0$aDisability evaluation$5IEN$0(DLC)sh 85038283

=LDR  01060cz  a2200277n  4500
=001  9880363563502441
=005  20141212200755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004184
=035  \\$aCAZ7310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x349.$x320
=072  \\$aC3.$x335.$x508.$x700.$x750.$x361.$x290
=072  \\$aC3.$x701.$x377.$x320
=072  \\$aC22.$x674.$x377.$x320
=150  \\$aDirofilariasis
=450  \\$wnnna$aDirofilariases
=450  \\$wnnna$aDisease, Heartworm
=450  \\$aHeartworm Disease
=550  \\$wg$aFilariasis
=550  \\$wg$aHelminthiasis, Animal
=667  \\$ausually in animals, espec dogs; coord IM with precoord animal/dis term (IM) + specific animal (NIM); check also tag ANIMALS; drug ther: consider FILARICIDES
=680  \\$iInfection with nematodes of the genus DIROFILARIA, usually in animals, especially dogs, but occasionally in man.
=688  \\$a68
=750  \0$aFeline heartworm disease$5IEN-M$0(DLC)sh 85047698
=750  \0$aCanine heartworm disease$5IEN-HS$0(DLC)sh 85019598

=LDR  01057cz  a2200265n  4500
=001  9880363563602441
=005  20141212200755.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004183
=035  \\$aCAZ7309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300.$x230.$x300
=150  \\$aDirofilaria immitis
=450  \\$wnnna$aDirofilaria immitides
=450  \\$aDog Heartworm
=450  \\$wnnna$aDog Heartworms
=450  \\$wnnna$aHeartworm, Dog
=450  \\$wnnna$aHeartworms, Dog
=450  \\$wnnna$aimmitides, Dirofilaria
=450  \\$wnnna$aimmitis, Dirofilaria
=550  \\$wg$aDirofilaria
=667  \\$ainfection = DIROFILARIASIS; coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES
=680  \\$iA filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes.
=688  \\$a91(75); was see under FILARIOIDEA 1975-90
=750  \0$aDirofilaria Immitis$5IEN$0(DLC)sh 85038281

=LDR  00868cz  a2200217n  4500
=001  9880363563702441
=005  20141212200754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004182
=035  \\$aCAZ7308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300.$x230
=150  \\$aDirofilaria
=450  \\$wnnna$aDirofilarias
=550  \\$wg$aFilarioidea
=550  \\$wh$aDirofilaria immitis
=550  \\$wh$aDirofilaria repens
=667  \\$ainfection = DIROFILARIASIS; coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES
=680  \\$iA genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans.
=688  \\$a91(75); was see under FILARIOIDEA 1975-90
=750  \0$aDirofilaria$5IEN$0(DLC)sh 85038280

=LDR  00900cz  a2200205n  4500
=001  9880363563802441
=005  20141212200754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004181
=035  \\$aCAZ7307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x339
=150  \\$aDirectories as Topic
=450  \\$wnnna$aDirectories as Topics
=550  \\$wg$aReference Books
=667  \\$ado not confuse with Publication Type DIRECTORIES
=680  \\$iLists of persons or organizations, systematically arranged, usually in alphabetic or classed order, giving address, affiliations, etc., for individuals, and giving address, officers, functions, and similar data for organizations. (ALA Glossary of Library and Information Science, 1983)
=688  \\$a1966
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Directories
=750  \0$aDirectories$0(DLC) sh 85038267$5IEN

=LDR  00666cz  a2200205n  4500
=001  9880363563902441
=005  20141212200753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004178
=035  \\$aCAZ7304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x762.$x352
=150  \\$aDiquat
=450  \\$wnnna$aDibromide, Diquat
=450  \\$wnnna$aDiquat Dibromide
=550  \\$wg$aPyridinium Compounds
=667  \\$aan herbicide
=680  \\$iA contact herbicide used also to produce desiccation and defoliation. (From Merck Index, 11th ed)
=688  \\$a91(71); was see under PYRIDINIUM COMPOUNDS 1971-90
=750  \0$aDiquat$5IEN$0(DLC)sh 85038245

=LDR  01713cz  a2200445n  4500
=001  9880363564002441
=005  20141212200753.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004177
=035  \\$aCAZ7303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x850.$x77.$x150
=150  \\$aDipyrone
=450  \\$wnnna$aAlgopyrin
=450  \\$wnnna$aAnalgin
=450  \\$wnnna$aBiopyrin
=450  \\$wnnna$aDipyronium
=450  \\$wnnna$aMetamizol
=450  \\$aMetamizole
=450  \\$wnnna$aMethamizole
=450  \\$aMethampyrone
=450  \\$wnnna$aMethanesulfonate, Noramidopyrine
=450  \\$wnnna$aMethanesulfonate Sodium, Noramidopyrine
=450  \\$wnnna$aNarone
=450  \\$aNoramidopyrine Methanesulfonate
=450  \\$wnnna$aNoramidopyrine Methanesulfonate Sodium
=450  \\$wnnna$aNormelubrine
=450  \\$wnnna$aNovalgetol
=450  \\$wnnna$aNovalgin
=450  \\$wnnna$aNovamidazophen
=450  \\$wnnna$aNovaminsulfone
=450  \\$wnnna$aOptalgin
=450  \\$wnnna$aPyralgin
=450  \\$wnnna$aSulpyrin
=450  \\$wnnna$aSulpyrine
=550  \\$wg$aAminopyrine
=667  \\$aa non-steroidal anti-inflamm agent; do not confuse with DIPYRINE see AMINOPYRINE, also an non-steroidal anti-inflamm agent
=680  \\$iA drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE. Because of the risk of serious adverse effects its use is justified only in serious situations where no alternative is available or suitable. (From Martindale, The Extra Pharmacopoeia, 30th ed, p13)
=688  \\$a91(75); was see under AMINOPYRINE 1975-90
=750  \0$aDipyrone$5IEN$0(DLC)sh 85038244

=LDR  01753cz  a2200337n  4500
=001  9880363564102441
=005  20200515132534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004175
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x750
=150  \\$aDiptera
=450  \\$wnnna$aDipteras
=450  \\$wnnna$aFlies
=450  \\$aFlies, True
=450  \\$wnnna$aFly
=450  \\$wnnna$aFly, True
=450  \\$wnnna$aTrue Flies
=450  \\$wnnna$aTrue Fly
=550  \\$wg$aHolometabola
=550  \\$wh$aDrosophilidae
=550  \\$wh$aGlossinidae
=550  \\$wh$aMuscidae
=550  \\$wh$aNematocera
=550  \\$wh$aPsychodidae
=550  \\$wh$aSarcophagidae
=550  \\$wh$aTephritidae
=667  \\$afor killing Diptera with insecticides, see note at INSECTICIDES;  DRAGONFLIES & DAMSELFLIES see ODONATA ,  MAYFLIES see EPHEMEROPTERA & FIREFLIES are also available; index caddisfly & stonefly under INSECTS; index sawfly & ichneumon fly under HYMENOPTERA; infestation by fly maggots = MYIASIS
=680  \\$iAn order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, SARCOPHAGIDAE, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots (see LARVA).
=688  \\$a81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74
=750  \0$aDiptera$5IEN$0(DLC)sh 85038238

=LDR  01015cz  a2200217n  4500
=001  9880363564202441
=005  20141212200752.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004173
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x510
=150  \\$aDipodomys
=450  \\$wnnna$aKangaroo Rat
=450  \\$aKangaroo Rats
=450  \\$wnnna$aRat, Kangaroo
=450  \\$aRats, Kangaroo
=550  \\$wg$aRodentia
=667  \\$ado not confuse X ref KANGAROO RATS with rat kangaroos ( = MACROPODIDAE); NIM when exper animal: no qualif; when IM, qualif permitted; do not check tag RATS
=680  \\$iA genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs.
=688  \\$a91(82); was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81
=750  \0$aKangaroo rats$5IEN$0(DLC)sh 85071464

=LDR  02143cz  a2200577n  4500
=001  9880363564302441
=005  20141212200752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004172
=035  \\$aCAZ7298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x339
=072  \\$aC11.$x966.$x339
=072  \\$aC23.$x888.$x592.$x763.$x941.$x339
=150  \\$aDiplopia
=450  \\$wnnna$aCortical Diplopia
=450  \\$wnnna$aCortical Diplopias
=450  \\$wnnna$aDiplopia, Cortical
=450  \\$wnnna$aDiplopia, Horizontal
=450  \\$wnnna$aDiplopia, Intermittent
=450  \\$wnnna$aDiplopia, Monocular
=450  \\$wnnna$aDiplopia, Refractive
=450  \\$wnnna$aDiplopia, Unilateral
=450  \\$wnnna$aDiplopia, Vertical
=450  \\$wnnna$aDiplopias
=450  \\$wnnna$aDiplopias, Cortical
=450  \\$wnnna$aDiplopias, Horizontal
=450  \\$wnnna$aDiplopias, Intermittent
=450  \\$wnnna$aDiplopias, Monocular
=450  \\$wnnna$aDiplopias, Refractive
=450  \\$wnnna$aDiplopias, Unilateral
=450  \\$wnnna$aDiplopias, Vertical
=450  \\$aDouble Vision
=450  \\$wnnna$aHorizontal Diplopia
=450  \\$wnnna$aHorizontal Diplopias
=450  \\$wnnna$aIntermittent Diplopia
=450  \\$wnnna$aIntermittent Diplopias
=450  \\$wnnna$aMonocular Diplopia
=450  \\$wnnna$aMonocular Diplopias
=450  \\$aPolyopsia
=450  \\$wnnna$aPolyopsias
=450  \\$wnnna$aRefractive Diplopia
=450  \\$wnnna$aRefractive Diplopias
=450  \\$wnnna$aUnilateral Diplopia
=450  \\$wnnna$aUnilateral Diplopias
=450  \\$wnnna$aVertical Diplopia
=450  \\$wnnna$aVertical Diplopias
=450  \\$wnnna$aVision, Double
=550  \\$wg$aVision Disorders
=680  \\$iA visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.
=750  \0$aDiplopia$5IEN$0(DLC)sh 85038207

=LDR  00837cz  a2200193n  4500
=001  9880363564402441
=005  20141212200751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004170
=035  \\$aCAZ7296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x228
=150  \\$aDiphyllobothrium
=450  \\$wnnna$aDiphyllobothriums
=550  \\$wg$aCestoda
=550  \\$wh$aSparganum
=667  \\$ainfection = DIPHYLLOBOTHRIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM.
=750  \0$aDiphyllobothrium$5IEN$0(DLC)sh 85038160

=LDR  00671cz  a2200217n  4500
=001  9880363564502441
=005  20141212200750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004169
=035  \\$aCAZ7295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x304
=150  \\$aDiphyllobothriasis
=450  \\$wnnna$aDiphyllobothriases
=550  \\$wg$aCestode Infections
=550  \\$wh$aSparganosis
=550  \\$aSparganosis
=667  \\$atapeworm infect; consider also SPARGANOSIS (infection at larval stage)
=680  \\$iInfection with tapeworms of the genus Diphyllobothrium.
=688  \\$a68
=750  \0$aDiphyllobothriasis$5IEN$0(DLC)sh 85038159

=LDR  01151cz  a2200229n  4500
=001  9880363564602441
=005  20141212200750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004167
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x725.$x115.$x220
=072  \\$aD23.$x946.$x123.$x305
=150  \\$aDiphtheria Toxin
=450  \\$aCorynebacterium Diphtheriae Toxin
=450  \\$wnnna$aToxin, Corynebacterium Diphtheriae
=550  \\$wg$aADP Ribose Transferases
=550  \\$wg$aBacterial Toxins
=550  \\$aCorynebacterium diphtheriae
=550  \\$aDiphtheria Toxoid
=667  \\$a/antag permitted but consider also DIPHTHERIA ANTITOXIN
=680  \\$iAn ADP-ribosylating polypeptide produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains MONO(ADP-RIBOSE) TRANSFERASES which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells.
=750  \0$aDiphtheria toxin$5IEN$0(DLC)sh 85038155

=LDR  00821cz  a2200217n  4500
=001  9880363564702441
=005  20141212200750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004166
=035  \\$aCAZ7292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x301.$x438
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573.$x601.$x438
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x301.$x438
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x301.$x438
=072  \\$aD20.$x215.$x121.$x388
=150  \\$aDiphtheria Antitoxin
=450  \\$wnnna$aAntitoxin, Diphtheria
=550  \\$wg$aAntitoxins
=680  \\$iAn antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA.
=750  \0$aDiphtheria antitoxin$5IEN$0(DLC)sh 85038154

=LDR  00809cz  a2200181n  4500
=001  9880363564802441
=005  20141212200749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004165
=035  \\$aCAZ7291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x246.$x388
=150  \\$aDiphtheria
=450  \\$wnnna$aDiphtherias
=550  \\$wg$aCorynebacterium Infections
=667  \\$acaused by Corynebacterium diphtheriae
=680  \\$iA localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.
=750  \0$aDiphtheria$5IEN$0(DLC)sh 85038147

=LDR  00915cz  a2200229n  4500
=001  9880363564902441
=005  20141212200749.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004164
=035  \\$aCAZ7290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x429.$x500
=150  \\$aDiphosphonates
=450  \\$aBisphosphonates
=550  \\$wg$aOrganophosphonates
=550  \\$wh$aAlendronate
=550  \\$wh$aClodronic Acid
=550  \\$wh$aEtidronic Acid
=550  \\$wh$aTechnetium Tc 99m Medronate
=680  \\$iOrganic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.
=688  \\$a77
=750  \0$aDiphosphonates$5IEN$0(DLC)sh 85038146

=LDR  00734cz  a2200169n  4500
=001  9880363565002441
=005  20141212200748.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004159
=035  \\$aCAZ7285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146.$x350
=150  \\$aDiphenylamine
=550  \\$wg$aAniline Compounds
=680  \\$iIn humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning.
=688  \\$a91(75); was see under ANILINE COMPOUNDS 1975-90
=750  \0$aDiphenylamine$5IEN$0(DLC)sh 91004706

=LDR  01053cz  a2200265n  4500
=001  9880363565102441
=005  20141212200747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004156
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x708.$x125
=150  \\$aCatechol Oxidase
=450  \\$wnnna$aDiphenol Oxidase
=450  \\$aDiphenol Oxidases
=450  \\$wnnna$aOxidase, Catechol
=450  \\$wnnna$aOxidase, Diphenol
=450  \\$wnnna$aOxidase, Polyphenol
=450  \\$wnnna$aOxidases, Diphenol
=450  \\$wnnna$aPolyphenol Oxidase
=450  \\$wnnna$aPolyphenoloxidase
=550  \\$wg$aMixed Function Oxygenases
=550  \\$wh$aMonophenol Monooxygenase
=680  \\$iAn enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1.
=688  \\$a92; was DIPHENOL OXIDASES 1968-91
=750  \0$aPolyphenol oxidase$5IEN-M$0(DLC)sh 95004878

=LDR  00827cz  a2200193n  4500
=001  9880363565202441
=005  20141212200746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004153
=035  \\$aCAZ7279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300.$x208
=150  \\$aDipetalonema
=450  \\$wnnna$aDipetalonemas
=550  \\$wg$aFilarioidea
=667  \\$ainfection = DIPETALONEMA INFECTIONS but infection with DIPETALONEMA PERSTANS = DIPETALONEMA PERSTANS INFECTION see MANSONELLIASIS; coordinate with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent
=680  \\$iA filarial nematode parasite of mammalian blood with the vector being a tick or small fly.
=688  \\$a86; was ACANTHOCHEILONEMA 1963-85
=750  \0$aDipetalonema$5IEN$0(DLC)sh 88021617

=LDR  00453cz  a2200169n  4500
=001  9880363565302441
=005  20210217181900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004148
=035  \\$aCAZ7274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x246.$x238
=150  \\$aDioxolanes
=550  \\$wg$aDioxoles
=550  \\$wh$aTrabectedin
=688  \\$a91(75); was see under DIOXOLES 1975-90
=750  \0$aDioxolanes$5IEN$0(DLC)sh 90001419

=LDR  00692cz  a2200205n  4500
=001  9880363565402441
=005  20180119113412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004147
=035  \\$aCAZ7273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x309.$x500
=072  \\$aD3.$x383.$x231
=150  \\$aDioxins
=550  \\$wg$aDioxins and Dioxin-like Compounds
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aPolychlorinated Dibenzodioxins
=680  \\$iA family of compounds that contain the 1,4-dioxin structure. Many specific dioxin derivatives are listed as CARCINOGENS; TERATOGENS; or MUTAGENS.
=688  \\$a68
=750  \0$aDioxins$5IEN$0(DLC)sh 85038140

=LDR  00788cz  a2200217n  4500
=001  9880363565502441
=005  20141212200745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004146
=035  \\$aCAZ7272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x231.$x388
=150  \\$aDioxanes
=550  \\$wg$aDioxins
=550  \\$wh$aIdazoxan
=550  \\$wh$aPiperoxan
=550  \\$wh$aSpectinomycin
=667  \\$aindust solvents
=680  \\$i1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), dioxane itself may "reasonably be anticipated to be a carcinogen." (Merck Index, 11th ed)
=688  \\$a91(75)63-67; was see under DIOXINS 1968-90; was heading 1963-67
=750  \0$aDioxane$5IEN$0(DLC)sh 85038139

=LDR  00684cz  a2200229n  4500
=001  9880363565602441
=005  20141212200744.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x260.$x222
=072  \\$aD3.$x830.$x219.$x266.$x450.$x260.$x222
=150  \\$aDiosmin
=450  \\$aBarosmin
=450  \\$aBuchu Resin
=450  \\$wnnna$aDaflon
=450  \\$wnnna$aResin, Buchu
=450  \\$wnnna$aVenosmine
=550  \\$wg$aFlavones
=680  \\$iA bioflavonoid that strengthens vascular walls.
=688  \\$a91(75); was see under BIOFLAVONOIDS 1975-90
=750  \0$aDiosmin$0(DLC)sh2007000497$5IEN-M

=LDR  00681cz  a2200181n  4500
=001  9880363565702441
=005  20141212200744.0
=008  771216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004144
=035  \\$aCAZ7270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x515.$x500
=150  \\$aDiosgenin
=550  \\$wg$aSpirostans
=550  \\$wh$aSolanine
=680  \\$iA spirostan found in DIOSCOREA and other plants. The 25S isomer is called yamogenin. Solasodine is a natural derivative formed by replacing the spiro-ring with a nitrogen, which can rearrange to SOLANINE.
=688  \\$a91(79); was see under SAPOGENINS 1979-90
=750  \0$aDiosgenin$5IEN-M$0(DLC)sh 97005842

=LDR  01623cz  a2200337n  4500
=001  9880363565802441
=005  20141212200743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004141
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x214
=150  \\$aDinoflagellida
=450  \\$wnnna$aDinoflagellate
=450  \\$wnnna$aDinoflagellates
=450  \\$wnnna$aDinoflagellidas
=450  \\$aGambierdiscus toxicus
=450  \\$aGonyaulax
=450  \\$wnnna$aGonyaulaxs
=450  \\$aGymnodinium
=450  \\$wnnna$aGymnodiniums
=450  \\$aPeridinium
=450  \\$wnnna$aPeridiniums
=450  \\$wnnna$atoxicus, Gambierdiscus
=550  \\$wg$aAlveolata
=550  \\$wh$aPfiesteria piscicida
=550  \\$aPhytoplankton
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
=680  \\$iFlagellate EUKARYOTES, found mainly in the oceans. They are characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water. Dinoflagellida were formerly members of the class Phytomastigophorea under the old five kingdom paradigm.
=688  \\$a1986 (1969); use DINOFLAGELLATES 1979-1985; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-1985
=688  \\$a86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM & PERIDINIUM were see RED TIDE 1979-85
=750  \0$aDinoflagellates$0(DLC) sh 85038084$5IEN-M

=LDR  00639cz  a2200205n  4500
=001  9880363565902441
=005  20141212200743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004140
=035  \\$aCAZ7263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x566.$x304
=072  \\$aD2.$x640.$x743.$x304
=150  \\$aDinitrophenols
=550  \\$wg$aNitrophenols
=550  \\$wh$a2,4-Dinitrophenol
=667  \\$auncoupling agents & indust fungicides
=680  \\$iOrganic compounds that contain two nitro groups attached to a phenol.
=688  \\$a64(63)
=750  \0$aDinitrophenol$5IEN$0(DLC)sh 85038073

=LDR  01231cz  a2200313n  4500
=001  9880363566002441
=005  20141212200742.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004137
=035  \\$aCAZ7260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x261.$x250
=072  \\$aD2.$x455.$x426.$x559.$x389.$x565.$x250
=072  \\$aD2.$x455.$x526.$x439.$x202.$x200
=072  \\$aD2.$x640.$x529.$x240.$x250
=072  \\$aD23.$x50.$x550.$x480.$x350
=150  \\$aDinitrochlorobenzene
=450  \\$wnnna$a1-Chloro-2,4-Dinitrobenzene
=450  \\$wnnna$a1 Chloro 2,4 Dinitrobenzene
=450  \\$aChlorodinitrobenzene
=450  \\$aDNCB
=550  \\$wg$aChlorobenzenes
=550  \\$wg$aDinitrobenzenes
=550  \\$wg$aHaptens
=550  \\$wg$aNitrobenzenes
=667  \\$aD25-26 qualif; DF: note short X ref
=680  \\$iA skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
=688  \\$a87(75); was see under NITROBENZENES 1975-86
=750  \0$aDinitrochlorobenzene$5IEN$0(DLC)sh 91004699

=LDR  00846cz  a2200241n  4500
=001  9880363566102441
=005  20141212200742.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004136
=035  \\$aCAZ7259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x565.$x225
=072  \\$aD2.$x640.$x529.$x240
=150  \\$aDinitrobenzenes
=450  \\$wnnna$aCompounds, Dinitrophenyl
=450  \\$aDinitrophenyl Compounds
=550  \\$wg$aNitrobenzenes
=550  \\$wh$aDinitrochlorobenzene
=550  \\$wh$aDinitrofluorobenzene
=667  \\$aincludes ortho-, meta- & para-dinitrobenzenes
=680  \\$iBenzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.
=688  \\$a91(77); was see under NITROBENZENES 1977-90
=750  \0$aDinitrobenzenes$5IEN-M$0(DLC)sh 96010945

=LDR  01153cz  a2200277n  4500
=001  9880363566202441
=005  20141212200740.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004129
=035  \\$aCAZ7253M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x715.$x650.$x700.$x150
=072  \\$aD5.$x750.$x900.$x850.$x150
=072  \\$aD25.$x720.$x900.$x850.$x150
=072  \\$aJ1.$x637.$x51.$x720.$x900.$x850.$x150
=150  \\$aDimethylpolysiloxanes
=450  \\$wnnna$aDimethylpolysiloxane
=450  \\$wnnna$aDimethylsiloxane
=450  \\$aDimethylsiloxanes
=450  \\$aPolydimethylsiloxanes
=550  \\$wg$aSilicones
=550  \\$wh$aSimethicone
=667  \\$aorganosiloxane polymers; D25-26 qualif
=680  \\$iSilicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents.
=688  \\$a91(75); was see under SILICONES 1975-90
=750  \0$aPolydimethylsiloxane$0(DLC)sh2010013859$5IEN-M

=LDR  00866cz  a2200241n  4500
=001  9880363566302441
=005  20141212200740.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004128
=035  \\$aCAZ7252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x654.$x442.$x225
=150  \\$aDimethylnitrosamine
=450  \\$wnnna$aN-Nitrosodimethylamine
=450  \\$wnnna$aN Nitrosodimethylamine
=450  \\$wnnna$aNDMA Nitrosodimethylamine
=450  \\$aNitrosodimethylamine
=450  \\$wnnna$aNitrosodimethylamine, NDMA
=550  \\$wg$aNitrosamines
=680  \\$iA nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.
=688  \\$a1980(1975)
=688  \\$a80(75); was see under NITROSAMINES 1975-79
=750  \0$aDimethylnitrosamine$5IEN$0(DLC)sh 88001004

=LDR  00598cz  a2200217n  4500
=001  9880363566402441
=005  20141212200739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004126
=035  \\$aCAZ7250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x463.$x387
=072  \\$aD2.$x241.$x81.$x420.$x500.$x387
=150  \\$aDimethylformamide
=450  \\$wnnna$aN,N-Dimethylformamide
=450  \\$wnnna$aN,N Dimethylformamide
=550  \\$wg$aFormamides
=667  \\$aD25-26 qualif
=688  \\$a1966(1963)
=688  \\$a66(63)
=750  \0$aDimethylformamide$5IEN$0(DLC)sh 91005517

=LDR  01243cz  a2200289n  4500
=001  9880363566502441
=005  20141212200739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004124
=035  \\$aCAZ7248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146.$x325
=150  \\$ap-Dimethylaminoazobenzene
=450  \\$wnnna$a4-Dimethylaminoazobenzene
=450  \\$wnnna$a4 Dimethylaminoazobenzene
=450  \\$aButter Yellow
=450  \\$aDimethylaminoazobenzene
=450  \\$wnnna$aMethyl Yellow
=450  \\$wnnna$ap Dimethylaminoazobenzene
=450  \\$wnnna$ap-Dimethylaminoazobenzene, (E)-Isomer
=450  \\$wnnna$ap-Dimethylaminoazobenzene, (Z)-Isomer
=550  \\$wg$aAniline Compounds
=550  \\$wh$aMethyldimethylaminoazobenzene
=667  \\$ausually NIM in DAB-induced exper cancer: no qualif; when IM, D25-26 qualif; DF: note short X ref
=680  \\$iA reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed)
=688  \\$a92; was DIMETHYLAMINOAZOBENZENE 1963-91
=750  \0$aDimethylaminoazobenzene$5IEN-M$0(DLC)sh 85038043

=LDR  00458cz  a2200181n  4500
=001  9880363566602441
=005  20141212200738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004123
=035  \\$aCAZ7247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x668.$x387
=150  \\$aDimethylamines
=550  \\$wg$aMethylamines
=550  \\$wh$aMoxisylyte
=550  \\$wh$aTramadol
=688  \\$a74(72)
=750  \0$aDimethylamine$5IEN$0(DLC)sh 85038042

=LDR  01310cz  a2200265n  4500
=001  9880363566702441
=005  20141212192138.0
=008  780518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004122
=035  \\$aCAZ7246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x225.$x400
=150  \\$aDimethylallyltranstransferase
=450  \\$aDimethylallyltransferase
=450  \\$wnnna$aDolichyl Phosphate Synthetase
=450  \\$wnnna$aGeranylgeranyl Pyrophosphate Synthetase
=450  \\$aGeranylpyrophosphate Synthetase
=450  \\$wnnna$aNerylpyrophosphate Synthetase
=450  \\$aPrenyltransferase
=450  \\$wnnna$aSynthetase, Geranylpyrophosphate
=450  \\$wnnna$aSynthetase, Nerylpyrophosphate
=550  \\$wg$aAlkyl and Aryl Transferases
=680  \\$iAn enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.
=688  \\$a97; was DIMETHYLALLYLTRANSFERASE 1979-96 (see under TRANSFERASES 1979-90)
=750  \0$aDimethylallyltranstransferase$5IEN-M$0(DLC)sh 00000060

=LDR  01544cz  a2200385n  4500
=001  9880363566802441
=005  20141212200738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004121
=035  \\$aCAZ7245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x640.$x150
=150  \\$aDimethyl Sulfoxide
=450  \\$wnnna$aDimethyl Sulphoxide
=450  \\$wnnna$aDimethylsulfoxide
=450  \\$wnnna$aDimethylsulphinyl
=450  \\$wnnna$aDimethylsulphoxide
=450  \\$wnnna$aDimexide
=450  \\$aDMSO
=450  \\$wnnna$aMerckle Brand of Dimethyl Sulfoxide
=450  \\$wnnna$aResearch Ind. Corp. Brand 1 of Dimethyl Sulfoxide
=450  \\$wnnna$aResearch Ind. Corp. Brand 2 of Dimethyl Sulfoxide
=450  \\$wnnna$aRheumabene
=450  \\$wnnna$aRimso
=450  \\$wnnna$aRimso 100
=450  \\$wnnna$aRimso-50
=450  \\$wnnna$aSclerosol
=450  \\$wnnna$aShire Brand of Dimethyl Sulfoxide
=450  \\$wnnna$aSulfinylbis(methane)
=450  \\$wnnna$aSulfoxide, Dimethyl
=450  \\$wnnna$aSulphoxide, Dimethyl
=550  \\$wg$aSulfoxides
=680  \\$iA highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
=688  \\$a65(64)
=750  \0$aDimethyl sulfoxide$5IEN$0(DLC)sh 85038040

=LDR  00933cz  a2200289n  4500
=001  9880363566902441
=005  20141212200731.0
=008  870331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004095
=035  \\$aCAZ7219HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203
=150  \\$aDihydropyridines
=550  \\$wg$aPyridines
=550  \\$wh$a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
=550  \\$wh$aAmlodipine
=550  \\$wh$aDicarbethoxydihydrocollidine
=550  \\$wh$aFelodipine
=550  \\$wh$aIsradipine
=550  \\$wh$aNicardipine
=550  \\$wh$aNifedipine
=550  \\$wh$aNimodipine
=550  \\$wh$aNisoldipine
=550  \\$wh$aNitrendipine
=680  \\$iPyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
=688  \\$a88
=750  \0$aDihydropyridine$5IEN$0(DLC)sh 85037998

=LDR  02492cz  a2200625n  4500
=001  9880363567002441
=005  20141212200725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004077
=035  \\$aCAZ7202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x155.$x160.$x349
=072  \\$aD4.$x808.$x155.$x580.$x130.$x500.$x436
=072  \\$aD9.$x408.$x180.$x261.$x436
=150  \\$aDigoxin
=450  \\$wnnna$aAWD.pharma Brand of Digoxin
=450  \\$wnnna$aBertek Brand of Digoxin
=450  \\$wnnna$aBoehringer, Digoxina
=450  \\$wnnna$aDigacin
=450  \\$wnnna$aDigitek
=450  \\$wnnna$aDigoregen
=450  \\$wnnna$aDigoxina Boehringer
=450  \\$wnnna$aDigoxine Nativelle
=450  \\$wnnna$aDilanacin
=450  \\$wnnna$aGlaxo Wellcome Brand of Digoxin
=450  \\$wnnna$aGlaxoSmithKline Brand 1 of Digoxin
=450  \\$wnnna$aGlaxoSmithKline Brand 2 of Digoxin
=450  \\$wnnna$aHemigoxine Nativelle
=450  \\$wnnna$aKern Brand of Digoxin
=450  \\$wnnna$aLanacordin
=450  \\$wnnna$aLanicor
=450  \\$wnnna$aLanoxicaps
=450  \\$wnnna$aLanoxin
=450  \\$wnnna$aLanoxin-PG
=450  \\$wnnna$aLanoxin PG
=450  \\$wnnna$aLenoxin
=450  \\$wnnna$aLilly Brand of Digoxin
=450  \\$wnnna$aMapluxin
=450  \\$wnnna$aNativelle, Digoxine
=450  \\$wnnna$aNativelle, Hemigoxine
=450  \\$wnnna$aNovartis Brand of Digoxin
=450  \\$wnnna$aProctor & Gamble Brand of Digoxin
=450  \\$wnnna$aR.A.N. Brand of Digoxin
=450  \\$wnnna$aRoche Brand of Digoxin
=450  \\$wnnna$aTeofarma Brand of Digoxin
=450  \\$wnnna$aUDL Brand of Digoxin
=450  \\$wnnna$aVirco Brand of Digoxin
=550  \\$wg$aCardenolides
=550  \\$wg$aDigitalis Glycosides
=550  \\$wh$aAcetyldigoxins
=550  \\$wh$aDigoxigenin
=550  \\$wh$aMedigoxin
=667  \\$ado not confuse with DIGITOXIN
=680  \\$iA cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
=750  \0$aDigoxin$5IEN$0(DLC)sh 85037995

=LDR  00461cz  a2200169n  4500
=001  9880363567102441
=005  20141212200724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004075
=035  \\$aCAZ7200M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x351.$x303
=150  \\$aDiglycerides
=450  \\$aDiacylglycerols
=550  \\$wg$aGlycerides
=688  \\$a91(75); was see under GLYCERIDES 1975-90
=750  \0$aDiglycerides$0(DLC) sh2004000532$5IEN-M

=LDR  01067cz  a2200253n  4500
=001  9880363567202441
=005  20141212200724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004071
=035  \\$aCAZ7196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x155.$x580.$x130.$x500
=072  \\$aD9.$x408.$x180.$x261
=150  \\$aDigitalis Glycosides
=450  \\$wnnna$aGlycosides, Digitalis
=550  \\$wg$aCardenolides
=550  \\$wg$aCardiac Glycosides
=550  \\$wh$aDigitonin
=550  \\$wh$aDigitoxin
=550  \\$wh$aDigoxin
=550  \\$wh$aLanatosides
=667  \\$acardiotonics; the pharmacological principle in the plant Digitalis
=680  \\$iGlycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
=750  \0$aDigitalis (Drug)$5IEN$0(DLC)sh 85037986

=LDR  00993cz  a2200193n  4500
=001  9880363567302441
=005  20141212200723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x892.$x333
=150  \\$aDigitalis
=450  \\$wnnna$aDigitali
=450  \\$aFoxglove
=450  \\$wnnna$aFoxgloves
=550  \\$wg$aScrophulariaceae
=667  \\$athe plant, not the drug which is probably DIGITALIS GLYCOSIDES; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of toxic herbaceous Eurasian plants of the SCROPHULARIACEAE which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.
=750  \0$aFoxgloves$5IEN$0(DLC)sh 85051137

=LDR  01537cz  a2200397n  4500
=001  9880363567402441
=005  20141212200723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004068
=035  \\$aCAZ7193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261
=150  \\$aDigestive System Physiological Phenomena
=450  \\$aDigestive Physiology
=450  \\$wnnna$aDigestive System Phenomena
=450  \\$wnnna$aDigestive System Phenomenon
=450  \\$wnnna$aDigestive System Physiological Concepts
=450  \\$wnnna$aDigestive System Physiological Phenomenon
=450  \\$wnnna$aDigestive System Physiology
=450  \\$aDigestive System$xphysiology
=450  \\$wnnna$aPhenomena, Digestive System
=450  \\$wnnna$aPhenomenas, Digestive System
=450  \\$wnnna$aPhenomenon, Digestive System
=450  \\$wnnna$aPhysiology, Digestive
=450  \\$wnnna$aPhysiology, Digestive System
=550  \\$wg$aDigestive System and Oral Physiological Phenomena
=550  \\$wh$aDigestive System Processes
=550  \\$wh$aHunger
=550  \\$wh$aPostprandial Period
=550  \\$aNutritional Physiological Phenomena
=667  \\$ageneral or unspecified; prefer specifics; DF: DIGESTIVE PHYSIOL
=680  \\$iProperties and processes of the DIGESTIVE SYSTEM as a whole or of any of its parts.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Digestive Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aDigestive organs$xPhysiology$0(IEN)4674477$5IEN-M

=LDR  01523cz  a2200385n  4500
=001  9880363567502441
=005  20141212200722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004067
=035  \\$aCAZ7192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274
=072  \\$aC6.$x301
=150  \\$aDigestive System Neoplasms
=450  \\$wnnna$aCancer, Digestive System
=450  \\$aCancer of Digestive System
=450  \\$wnnna$aCancer of the Digestive System
=450  \\$wnnna$aCancers, Digestive System
=450  \\$aDigestive System Cancer
=450  \\$wnnna$aDigestive System Cancers
=450  \\$wnnna$aDigestive System Neoplasm
=450  \\$wnnna$aNeoplasm, Digestive System
=450  \\$wnnna$aNeoplasms, Digestive System
=550  \\$wg$aDigestive System Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aBiliary Tract Neoplasms
=550  \\$wh$aGastrointestinal Neoplasms
=550  \\$wh$aLiver Neoplasms
=550  \\$wh$aPancreatic Neoplasms
=550  \\$wh$aPeritoneal Neoplasms
=667  \\$aGEN or unspecified; refers to all organs and accessory organs (biliary, liver, & pancreas) of the DIGESTIVE TRACT: do not confuse with GASTROINTESTINAL NEOPLASMS (eosphagus, stomach & intestines only); coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the DIGESTIVE SYSTEM.
=688  \\$a80; was NON MESH before 1980
=750  \0$aDigestive organs$xTumors$5IEN-M$0(IEN)367362
=750  \0$aDigestive organs$xCancer$5IEN-M$0(DLC)sh 85037954

=LDR  01328cz  a2200325n  4500
=001  9880363567602441
=005  20141212200722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004066
=035  \\$aCAZ7191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6
=150  \\$aDigestive System Diseases
=450  \\$wnnna$aDigestive System Disease
=450  \\$wnnna$aDisease, Digestive System
=450  \\$wnnna$aDiseases, Digestive System
=450  \\$wnnna$aSystem Disease, Digestive
=450  \\$wnnna$aSystem Diseases, Digestive
=550  \\$wh$aBiliary Tract Diseases
=550  \\$wh$aDigestive System Abnormalities
=550  \\$wh$aDigestive System Fistula
=550  \\$wh$aDigestive System Neoplasms
=550  \\$wh$aGastrointestinal Diseases
=550  \\$wh$aLiver Diseases
=550  \\$wh$aPancreatic Diseases
=550  \\$wh$aPeritoneal Diseases
=667  \\$aGEN or unspecified; refers to all organs of digestive tract: do not confuse with GASTROINTESTINAL DISEASES (diseases of the GASTROINTESTINAL TRACT); /diag: consider also DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM
=680  \\$iDiseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).
=688  \\$a80; was NON MESH before 1980
=750  \0$aDigestive organs$xDiseases$5IEN$0(DLC)sh 85037956

=LDR  01369cz  a2200385n  4500
=001  9880363567702441
=005  20200526152711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004065
=035  \\$aCAZ7190M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x198
=072  \\$aC16.$x131.$x314
=150  \\$aDigestive System Abnormalities
=450  \\$wnnna$aAbnormalities, Digestive System
=450  \\$wnnna$aAbnormality, Digestive System
=450  \\$aDigestive System$xabnormalities
=450  \\$wnnna$aDigestive System Abnormality
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aAnorectal Malformations
=550  \\$wh$aAnus, Imperforate
=550  \\$wh$aBarrett Esophagus
=550  \\$wh$aBiliary Atresia
=550  \\$wh$aCholedochal Cyst
=550  \\$wh$aDiaphragmatic Eventration
=550  \\$wh$aEsophageal Atresia
=550  \\$wh$aHirschsprung Disease
=550  \\$wh$aIntestinal Atresia
=550  \\$wh$aMeckel Diverticulum
=550  \\$wh$aMedian Arcuate Ligament Syndrome
=667  \\$aGEN or unspecified; prefer specifics or specific organ /abnorm; DF: DIGESTIVE SYSTEM ABNORM
=680  \\$iCongenital structural abnormalities of the DIGESTIVE SYSTEM.
=688  \\$a98; use explode 1971-97
=750  \0$aGastrointestinal system$xAbnormalities$0(DLC)sh2007006041$5IEN-M

=LDR  01018cz  a2200241n  4500
=001  9880363567802441
=005  20141212200721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004064
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3
=150  \\$aDigestive System
=450  \\$wnnna$aAilmentary System
=450  \\$wnnna$aAlimentary System
=450  \\$wnno$aGastrointestinal System$5IEN-M
=550  \\$wh$aBiliary Tract
=550  \\$wh$aGastrointestinal Tract
=550  \\$wh$aLiver
=550  \\$wh$aPancreas
=667  \\$aGEN: prefer specifics; /abnorm = DIGESTIVE SYSTEM ABNORMALITIES but consider also specific part of digest syst with /abnorm or specific abnorm
=680  \\$iA group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands (LIVER; BILIARY TRACT; PANCREAS).
=688  \\$a1972
=750  \0$aDigestive organs$5IEN$0(DLC)sh 85037949

=LDR  00640cz  a2200205n  4500
=001  9880363567902441
=005  20190325120325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004063
=035  \\$aCAZ7188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x650.$x250
=072  \\$aG10.$x261.$x190
=150  \\$aDigestion
=550  \\$wg$aDigestive System Physiological Phenomena
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aRumination, Digestive
=550  \\$wh$aSalivation
=680  \\$iThe process of breakdown of food for metabolism and use by the body.
=750  \0$aDigestion$5IEN$0(DLC)sh 85037947

=LDR  01355cz  a2200385n  4500
=001  9880363568002441
=005  20141212200720.0
=008  790530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004061
=035  \\$aCAZ7186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x595.$x303
=150  \\$aDiflunisal
=450  \\$wnnna$aApo-Diflunisal
=450  \\$wnnna$aApotex Brand of Diflunisal
=450  \\$wnnna$aCahill May Roberts Brand of Diflunisal
=450  \\$wnnna$aDiflunisal Novopharm Brand
=450  \\$wnnna$aDolobid
=450  \\$wnnna$aDolobis
=450  \\$wnnna$aDolocid
=450  \\$wnnna$aFrosst SA Brand of Diflunisal
=450  \\$wnnna$aMerck Brand of Diflunisal
=450  \\$wnnna$aMerck Sharp & Dohme Brand of Diflunisal
=450  \\$wnnna$aMK-647
=450  \\$wnnna$aMK 647
=450  \\$wnnna$aMK647
=450  \\$wnnna$aNovo-Diflunisal
=450  \\$wnnna$aNovopharm Brand of Diflunisal
=450  \\$wnnna$aNu-Diflunisal
=450  \\$wnnna$aNu-Pharm Brand of Diflunisal
=450  \\$wnnna$aNu Pharm Brand of Diflunisal
=550  \\$wg$aSalicylates
=680  \\$iA salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
=688  \\$a90(80); was see under SALICYLIC ACIDS 1980-89
=750  \0$aDiflunisal$5IEN$0(DLC)sh 85037942

=LDR  00769cz  a2200217n  4500
=001  9880363568102441
=005  20141212200719.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004059
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x320
=150  \\$aDiffusion of Innovation
=450  \\$wnnna$aDiffusion, Innovation
=450  \\$aInnovation Diffusion
=550  \\$wg$aCommunication
=550  \\$wh$aTechnology Transfer
=550  \\$aInformation Dissemination
=667  \\$ano qualif
=680  \\$iThe broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used.
=688  \\$a91(80); was see under COMMUNICATION 1980-90
=750  \0$aDiffusion of innovations$5IEN$0(DLC)sh 85037940

=LDR  00896cz  a2200241n  4500
=001  9880363568202441
=005  20170609104745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004058
=035  \\$aCAZ7182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x202
=072  \\$aG2.$x196
=150  \\$aDiffusion
=450  \\$wnnna$aDiffusions
=550  \\$wg$aPhysical Phenomena
=550  \\$wg$aChemical Phenomena
=550  \\$wh$aFacilitated Diffusion
=550  \\$wh$aThermal Diffusion
=550  \\$aBiological Transport
=680  \\$iThe tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT.
=688  \\$a70(68)
=750  \0$aDiffusion$5IEN$0(DLC)sh 85037936

=LDR  01346cz  a2200397n  4500
=001  9880363568302441
=005  20141212200718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004056
=035  \\$aCAZ7180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x230
=072  \\$aF2.$x463.$x593.$x710.$x370
=150  \\$aDifferential Threshold
=450  \\$wnnna$aDifference, Just-Noticeable
=450  \\$aDifference Limen
=450  \\$wnnna$aDifference Limens
=450  \\$wnnna$aDifferences, Just-Noticeable
=450  \\$wnnna$aDifferential Thresholds
=450  \\$aJust-Noticeable Difference
=450  \\$wnnna$aJust Noticeable Difference
=450  \\$wnnna$aJust-Noticeable Differences
=450  \\$wnnna$aLaw, Weber-Fechner
=450  \\$wnnna$aLimen, Difference
=450  \\$wnnna$aLimens, Difference
=450  \\$wnnna$aThreshold, Differential
=450  \\$wnnna$aThresholds, Differential
=450  \\$aWeber-Fechner Law
=450  \\$wnnna$aWeber Fechner Law
=550  \\$wg$aPerception
=550  \\$wg$aSensory Thresholds
=550  \\$aPsychophysics
=667  \\$aNIM; DF: DIFFER THRESHOLD
=680  \\$iThe smallest difference which can be discriminated between two stimuli or one which is barely above the threshold.
=688  \\$a74(72)
=750  \0$aWeber-Fechner law$5IEN$0(DLC)sh 85145886

=LDR  00957cz  a2200253n  4500
=001  9880363568402441
=005  20141212200717.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004055
=035  \\$aCAZ7179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x370
=150  \\$aDifferential Thermal Analysis
=450  \\$wnnna$aAnalyses, Differential Thermal
=450  \\$wnnna$aAnalysis, Differential Thermal
=450  \\$wnnna$aDifferential Thermal Analyses
=450  \\$wnnna$aThermal Analyses, Differential
=450  \\$wnnna$aThermal Analysis, Differential
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aCalorimetry, Differential Scanning
=667  \\$aNIM
=680  \\$iTechnique by which phase transitions of chemical reactions can be followed by observation of the heat absorbed or liberated.
=688  \\$a91(77); was see under CHEMISTRY, ANALYTICAL 1977-90
=750  \0$aThermal analysis$5IEN$0(DLC)sh 85134751

=LDR  01361cz  a2200337n  4500
=001  9880363568502441
=005  20141212192136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004054
=035  \\$aCAZ7178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x700.$x175
=150  \\$aDiethylstilbestrol
=450  \\$wnnna$aAgostilben
=450  \\$wnnna$aAPS Brand of Diethylstilbestrol
=450  \\$wnnna$aApstil
=450  \\$wnnna$aCo-Pharma Brand of Diethylstilbestrol
=450  \\$wnnna$aCo Pharma Brand of Diethylstilbestrol
=450  \\$wnnna$aDiethylstilbestrol, Disodium Salt
=450  \\$wnnna$aDiethylstilbestrol, (Z)-Isomer
=450  \\$wnnna$aDistilbène
=450  \\$wnnna$aEstrogen, Stilbene
=450  \\$wnnna$aGerda Brand of Diethylstilbestrol
=450  \\$wnnna$aStilbene Estrogen
=450  \\$aStilbestrol
=450  \\$wnnna$aTampovagan
=550  \\$wg$aStilbenes
=550  \\$wh$aHexestrol
=667  \\$aDF: DES
=680  \\$iA synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed)
=750  \0$aDiethylstilbestrol$5IEN$0(DLC)sh 85037869

=LDR  00906cz  a2200253n  4500
=001  9880363568602441
=005  20141212200717.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004051
=035  \\$aCAZ7175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x805.$x250
=150  \\$aDiethylhexyl Phthalate
=450  \\$wnnna$aBis(2-ethylhexyl)phthalate
=450  \\$wnnna$aDEHP
=450  \\$wnnna$aDi-2-Ethylhexylphthalate
=450  \\$wnnna$aDi 2 Ethylhexylphthalate
=450  \\$aDioctyl Phthalate
=450  \\$wnnna$aPhthalate, Diethylhexyl
=450  \\$wnnna$aPhthalate, Dioctyl
=550  \\$wg$aPhthalic Acids
=680  \\$iAn ester of phthalic acid. It appears as a light-colored, odorless liquid and is used as a plasticizer for many resins and elastomers.
=688  \\$a91(75); was see under PHTHALIC ACIDS 1975-90
=750  \0$aDiethylhexyl phthalate$5IEN$0(DLC)sh 92004676

=LDR  01962cz  a2200517n  4500
=001  9880363568702441
=005  20141212200716.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004050
=035  \\$aCAZ7174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x869.$x220
=072  \\$aD2.$x886.$x706.$x200
=150  \\$aDitiocarb
=450  \\$wnnna$aAmmonium Salt Ditiocarb
=450  \\$wnnna$aBismuth Salt Ditiocarb
=450  \\$wnnna$aDiethylcarbamodithioic Acid
=450  \\$aDiethyldithiocarbamate
=450  \\$wnnna$aDiethyldithiocarbamate, Sodium
=450  \\$wnnna$aDiethyldithiocarbamate, Zinc
=450  \\$wnnna$aDiethyldithiocarbamic Acid
=450  \\$wnnna$aDithiocarb
=450  \\$wnnna$aDitiocarb, Ammonium Salt
=450  \\$wnnna$aDitiocarb, Bismuth Salt
=450  \\$wnnna$aDitiocarb, Lead Salt
=450  \\$wnnna$aDitiocarb, Potassium Salt
=450  \\$wnnna$aDitiocarb Sodium
=450  \\$wnnna$aDitiocarb, Sodium Salt
=450  \\$wnnna$aDitiocarb, Sodium Salt, Trihydrate
=450  \\$wnnna$aDitiocarb, Tin(4+) Salt
=450  \\$wnnna$aDitiocarb, Zinc Salt
=450  \\$wnnna$aImuthiol
=450  \\$wnnna$aLead Salt Ditiocarb
=450  \\$wnnna$aPotassium Salt Ditiocarb
=450  \\$wnnna$aSodium Diethyldithiocarbamate
=450  \\$wnnna$aSodium, Ditiocarb
=450  \\$wnnna$aSodium Salt Ditiocarb
=450  \\$wnnna$aThiocarb
=450  \\$wnnna$aZinc Diethyldithiocarbamate
=450  \\$wnnna$aZinc Salt Ditiocarb
=550  \\$wg$aThiocarbamates
=550  \\$wh$aDisulfiram
=667  \\$aD25-26 qualif
=680  \\$iA chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM.
=688  \\$a94; was DIETHYLDITHIOCARBAMATE 1973-93 (see under THIOCARBAMATES 1973-86); DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93
=750  \0$aDiethyldithiocarbamate$5IEN-M$0(DLC)sh 91002256

=LDR  00423cz  a2200169n  4500
=001  9880363568802441
=005  20141212200715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004048
=035  \\$aCAZ7172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x302
=150  \\$aDiethylamines
=550  \\$wg$aEthylamines
=550  \\$wh$aPropanidid
=688  \\$a74
=750  \0$aDiethylamine$5IEN$0(DLC)sh 85037867

=LDR  01055cz  a2200265n  4500
=001  9880363568902441
=005  20201028132241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004044
=035  \\$aCAZ7169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x256
=072  \\$aJ2.$x500.$x428
=150  \\$aDietary Proteins
=450  \\$wnnna$aDietary Protein
=450  \\$wnnna$aProtein, Dietary
=450  \\$aProteins, Dietary
=550  \\$wg$aFood
=550  \\$wg$aProteins
=550  \\$wh$aEgg Proteins, Dietary
=550  \\$wh$aMilk Proteins
=550  \\$wh$aPlant Proteins, Dietary
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; high-protein diet: use /admin; EGG PROTEINS; MILK PROTEINS; & VEGETABLE PROTEINS and specifics are also available; for dietary plant proteins see note on PLANT PROTEINS
=680  \\$iProteins obtained from foods. They are the main source of the ESSENTIAL AMINO ACIDS.
=750  \0$aProteins in human nutrition$5IEN-M$0(DLC)sh 85107679

=LDR  01179cz  a2200325n  4500
=001  9880363569002441
=005  20141212200714.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004043
=035  \\$aCAZ7168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x400
=150  \\$aDietary Fiber
=450  \\$wnnna$aBran, Wheat
=450  \\$wnnna$aBrans, Wheat
=450  \\$wnnna$aDietary Fibers
=450  \\$aFiber, Dietary
=450  \\$wnnna$aFibers, Dietary
=450  \\$aRoughage
=450  \\$wnnna$aRoughages
=450  \\$wnnna$aWheat Bran
=450  \\$wnnna$aWheat Brans
=550  \\$wg$aFood
=550  \\$wh$aPrebiotics
=550  \\$aLaxatives
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; /defic permitted; low- or high-fiber diet: use /admin
=680  \\$iThe remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It comprises various polysaccharides and lignins.
=688  \\$a82(77); was see under CELLULOSE 1977-81
=750  \0$aHigh-fiber diet$5IEN-M$0(DLC)sh 85060671
=750  \0$aFiber in human nutrition$5IEN-HS$0(DLC)sh 85048013

=LDR  01012cz  a2200301n  4500
=001  9880363569102441
=005  20161110101753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004041
=035  \\$aCAZ7166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302
=072  \\$aG7.$x203.$x300.$x375
=072  \\$aJ2.$x500.$x375
=150  \\$aDietary Fats
=450  \\$wnnna$aDietary Fat
=450  \\$wnnna$aFat, Dietary
=450  \\$aFats, Dietary
=550  \\$wg$aFats
=550  \\$wg$aFood
=550  \\$wh$aButter
=550  \\$wh$aCholesterol, Dietary
=550  \\$wh$aDietary Fats, Unsaturated
=550  \\$wh$aMargarine
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific disease /diet ther
=680  \\$iFats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.
=688  \\$a64
=750  \0$aFood$xFat content$5IEN-M$0(DLC)sh 85050195

=LDR  01356cz  a2200289n  4500
=001  9880363569202441
=005  20141212200713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004040
=035  \\$aCAZ7165HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x301
=072  \\$aJ2.$x500.$x362
=150  \\$aDietary Carbohydrates
=450  \\$wnnna$aCarbohydrate, Dietary
=450  \\$aCarbohydrates, Dietary
=450  \\$wnnna$aDietary Carbohydrate
=550  \\$wg$aCarbohydrates
=550  \\$wg$aFood
=550  \\$wh$aDietary Sucrose
=550  \\$wh$aHigh Fructose Corn Syrup
=550  \\$aCarbohydrates
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; low-carbohydrate diet: use /admin
=680  \\$iCarbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277)
=688  \\$a64
=750  \0$aFood$xCarbohydrate content$5IEN-HS$0(DLC)sh 85050189
=750  \0$aSugars in human nutrition$5IEN-HS$0(DLC)sh 85129733

=LDR  01484cz  a2200445n  4500
=001  9880363569302441
=005  20141212200713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004039
=035  \\$aCAZ7164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x290
=072  \\$aG7.$x610.$x240.$x290
=150  \\$aDiet, Sodium-Restricted
=450  \\$aDiet, Low-Salt
=450  \\$wnnna$aDiet, Low Salt
=450  \\$aDiet, Low-Sodium
=450  \\$wnnna$aDiet, Low Sodium
=450  \\$wnnna$aDiet, Salt-Free
=450  \\$wnnna$aDiet, Salt Free
=450  \\$wnnna$aDiet, Sodium Restricted
=450  \\$wnnna$aDiets, Low-Salt
=450  \\$wnnna$aDiets, Low-Sodium
=450  \\$wnnna$aDiets, Salt-Free
=450  \\$wnnna$aDiets, Sodium-Restricted
=450  \\$wnnna$aLow-Salt Diet
=450  \\$wnnna$aLow-Salt Diets
=450  \\$wnnna$aLow-Sodium Diet
=450  \\$wnnna$aLow-Sodium Diets
=450  \\$wnnna$aSalt-Free Diet
=450  \\$wnnna$aSalt-Free Diets
=450  \\$wnnna$aSodium-Restricted Diet
=450  \\$wnnna$aSodium-Restricted Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$aSodium Chloride
=667  \\$acoord IM with specific dis /diet ther (IM)
=680  \\$iA diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed)
=688  \\$a80; was DIET, SALT-FREE 1963-79
=750  \0$aSalt-free diet$5IEN$0(DLC)sh 85116867

=LDR  01110cz  a2200349n  4500
=001  9880363569402441
=005  20141212200712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004038
=035  \\$aCAZ7163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x285
=072  \\$aG7.$x610.$x240.$x285
=150  \\$aDiet, Reducing
=450  \\$wnnna$aDiet, Weight Loss
=450  \\$wnnna$aDiet, Weight Reduction
=450  \\$wnnna$aDiets, Reducing
=450  \\$wnnna$aDiets, Weight Loss
=450  \\$wnnna$aDiets, Weight Reduction
=450  \\$wnnna$aReducing Diet
=450  \\$wnnna$aReducing Diets
=450  \\$wnnna$aWeight Loss Diet
=450  \\$wnnna$aWeight Loss Diets
=450  \\$wnnna$aWeight Reduction Diet
=450  \\$wnnna$aWeight Reduction Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$aObesity
=550  \\$aWeight Reduction Programs
=667  \\$acoordinate IM with specific disease / diet ther (IM) if pertinent
=680  \\$iA diet designed to cause an individual to lose weight.
=750  \0$aReducing diets$5IEN$0(DLC)sh 85112139

=LDR  00756cz  a2200253n  4500
=001  9880363569502441
=005  20141212200712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004037
=035  \\$aCAZ7162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x270
=072  \\$aG7.$x610.$x240.$x255
=150  \\$aDiet, Cariogenic
=450  \\$wnnna$aCariogenic Diet
=450  \\$wnnna$aCariogenic Diets
=450  \\$wnnna$aDiets, Cariogenic
=550  \\$wg$aDiet
=550  \\$wg$aInvestigative Techniques
=550  \\$aCariogenic Agents
=550  \\$aDental Caries
=680  \\$iA diet that contributes to the development and advancement of DENTAL CARIES.
=688  \\$a73(72)
=750  \0$aDental caries$xNutritional aspects$5IEN-M$0(IEN)367352

=LDR  01421cz  a2200397n  4500
=001  9880363569602441
=005  20200430121407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004035
=035  \\$aCAZ7161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249
=150  \\$aDiet Therapy
=450  \\$aDiet$xtherapeutic use
=450  \\$wnnna$aDiet Therapies
=450  \\$aDisease$xdiet therapy
=450  \\$wnnna$aTherapies, Diet
=450  \\$wnnna$aTherapy, Diet
=550  \\$wg$aNutrition Therapy
=550  \\$wh$aCaloric Restriction
=550  \\$wh$aDiet, Carbohydrate Loading
=550  \\$wh$aDiet, Carbohydrate-Restricted
=550  \\$wh$aDiet, Diabetic
=550  \\$wh$aDiet, Fat-Restricted
=550  \\$wh$aDiet, Gluten-Free
=550  \\$wh$aDiet, High-Protein
=550  \\$wh$aDiet, Mediterranean
=550  \\$wh$aDiet, Paleolithic
=550  \\$wh$aDiet, Protein-Restricted
=550  \\$wh$aDiet, Reducing
=550  \\$wh$aDiet, Sodium-Restricted
=550  \\$wh$aDiet, Vegetarian
=550  \\$wh$aDietary Approaches to Hypertension
=667  \\$aGEN only: prefer /diet ther with disease term: Manual 19.7+, 19.8.24; DF: DIET THER
=680  \\$iBy adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).
=750  \0$aDiet therapy$0(DLC) sh 85037857$5IEN

=LDR  00780cz  a2200253n  4500
=001  9880363569702441
=005  20141212192134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004027
=035  \\$aCAZ7154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x317
=150  \\$aDiencephalon
=450  \\$wnnna$aInterbrain
=450  \\$wnnna$aInterbrains
=550  \\$wg$aProsencephalon
=550  \\$wh$aEpithalamus
=550  \\$wh$aHypothalamus
=550  \\$wh$aOptic Chiasm
=550  \\$wh$aOptic Tract
=550  \\$wh$aSubthalamus
=550  \\$wh$aThalamus
=680  \\$iThe paired caudal parts of the PROSENCEPHALON from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived.
=750  \0$aDiencephalon$5IEN-M$0(DLC)sh 85037801

=LDR  00789cz  a2200205n  4500
=001  9880363569802441
=005  20141212200709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004026
=035  \\$aCAZ7153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x371
=150  \\$aDieldrin
=450  \\$wnnna$aAlvit-55
=450  \\$wnnna$aAlvit 55
=450  \\$wnnna$aAlvit55
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iAn organochlorine insecticide whose use has been cancelled or suspended in the United States. It has been used to control locusts, tropical disease vectors, in termite control by direct soil injection, and non-food seed and plant treatment. (From HSDB)
=750  \0$aDieldrin$5IEN$0(DLC)sh 87007407

=LDR  01171cz  a2200217n  4500
=001  9880363742302441
=005  20141212203203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008275
=035  \\$aCBA1516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x439
=150  \\$aMagnesium Deficiency
=450  \\$wnnna$aDeficiencies, Magnesium
=450  \\$wnnna$aDeficiency, Magnesium
=450  \\$wnnna$aMagnesium Deficiencies
=450  \\$aMagnesium$xdeficiency
=550  \\$wg$aDeficiency Diseases
=667  \\$aDF: MAGNESIUM DEFIC
=680  \\$iA nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)
=750  \0$aMagnesium deficiency diseases$5IEN$0(DLC)sh 85079669

=LDR  00878cz  a2200217n  4500
=001  9880363742402441
=005  20141212203203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008274
=035  \\$aCBA1515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552.$x437
=072  \\$aD1.$x268.$x557.$x500
=072  \\$aD1.$x552.$x547.$x500
=150  \\$aMagnesium
=450  \\$aOrganomagnesium Compounds$5IEN
=550  \\$wg$aMetals, Alkaline Earth
=550  \\$wg$aMetals, Light
=667  \\$aMg-24; Mg-25, 26 = MAGNESIUM (IM) + ISOTOPES (NIM); Mg-20, 21, 23, 27, 28 = MAGNESIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
=750  \0$aMagnesium$5IEN-M$0(DLC)sh 85079651

=LDR  00721cz  a2200217n  4500
=001  9880363742502441
=005  20141212203203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008273
=035  \\$aCBA1514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x901.$x411
=072  \\$aI1.$x76.$x201.$x450.$x897.$x439
=150  \\$aMagic
=450  \\$wnnna$aMagics
=550  \\$wg$aSpiritual Therapies
=550  \\$wg$aSuperstitions
=550  \\$wh$aWitchcraft
=667  \\$aIM; consider also WITCHCRAFT
=680  \\$iBeliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals.
=750  \0$aMagic$5IEN-M$0(DLC)sh 85079604

=LDR  01549cz  a2200397n  4500
=001  9880363742602441
=005  20141212203202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008271
=035  \\$aCBA1512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x692.$x606
=072  \\$aC1.$x252.$x825.$x557
=072  \\$aC1.$x539.$x800.$x200.$x500
=072  \\$aC1.$x539.$x800.$x720.$x557
=072  \\$aC1.$x703.$x295.$x522
=072  \\$aC17.$x800.$x838.$x208.$x557
=072  \\$aC17.$x800.$x838.$x765.$x557
=150  \\$aMycetoma
=450  \\$wnnna$aActinomycetoma
=450  \\$wnnna$aActinomycetomas
=450  \\$wnnna$aEumycetoma
=450  \\$wnnna$aEumycetomas
=450  \\$wnnna$aFoot, Madura
=450  \\$aMadura Foot
=450  \\$wnnna$aMaduromycoses
=450  \\$aMaduromycosis
=450  \\$wnnna$aMycetomas
=550  \\$wg$aDermatomycoses
=550  \\$wg$aNocardia Infections
=550  \\$wg$aSkin Diseases, Bacterial
=667  \\$acoordinate with causative organism (IM) or precoordinate organism/dis (IM) if pertinent
=680  \\$iA chronic progressive subcutaneous infection caused by species of fungi (eumycetoma), or actinomycetes (actinomycetoma). It is characterized by tumefaction, abscesses, and tumor-like granules representing microcolonies of pathogens, such as MADURELLA fungi and bacteria ACTINOMYCETES, with different grain colors.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Maduromycosis
=750  \0$aMycetoma$0(DLC) sh 85089176$5IEN

=LDR  01156cz  a2200217n  4500
=001  9880363742702441
=005  20141212203200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008266
=035  \\$aCBA1507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x729.$x522
=150  \\$aMacula Lutea
=450  \\$wnnna$aLutea, Macula
=450  \\$wnnna$aLuteas, Macula
=450  \\$wnnna$aMacula Luteas
=550  \\$wg$aRetina
=550  \\$wh$aFovea Centralis
=667  \\$aa depression on the retina; macular dis: coord IM with RETINAL DISEASES (IM)
=680  \\$iAn oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aMacula lutea$5IEN$0(DLC)sh 85079484

=LDR  02182cz  a2200541n  4500
=001  9880363742802441
=005  20170927163236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008264
=035  \\$aCBA1505HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x372
=072  \\$aA11.$x627.$x482
=072  \\$aA11.$x733.$x397
=072  \\$aA15.$x382.$x680.$x397
=072  \\$aA15.$x382.$x812.$x522
=150  \\$aMacrophages
=450  \\$wnnna$aBone Marrow-Derived Macrophage
=450  \\$aBone Marrow-Derived Macrophages
=450  \\$wnnna$aBone Marrow Derived Macrophages
=450  \\$wnnna$aMacrophage
=450  \\$wnnna$aMacrophage, Bone Marrow-Derived
=450  \\$wnnna$aMacrophage, Monocyte-Derived
=450  \\$wnnna$aMacrophages, Bone Marrow-Derived
=450  \\$wnnna$aMacrophages, Monocyte-Derived
=450  \\$wnnna$aMacrophages, Monocyte Derived
=450  \\$wnnna$aMonocyte-Derived Macrophage
=450  \\$aMonocyte-Derived Macrophages
=450  \\$wnnna$aMonocyte Derived Macrophages
=550  \\$wg$aConnective Tissue Cells
=550  \\$wg$aMononuclear Phagocyte System
=550  \\$wg$aMyeloid Cells
=550  \\$wg$aPhagocytes
=550  \\$wh$aEpithelioid Cells
=550  \\$wh$aFoam Cells
=550  \\$wh$aGiant Cells, Foreign-Body
=550  \\$wh$aGiant Cells, Langhans
=550  \\$wh$aHistiocytes
=550  \\$wh$aKupffer Cells
=550  \\$wh$aMacrophages, Alveolar
=550  \\$wh$aMacrophages, Peritoneal
=550  \\$wh$aMonocyte-Macrophage Precursor Cells
=550  \\$wh$aOsteoclasts
=550  \\$wh$aRAW 264.7 Cells
=550  \\$aMononuclear Phagocyte System
=550  \\$aPhagocytosis
=680  \\$iThe relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
=750  \0$aMacrophages$5IEN$0(DLC)sh 85079451

=LDR  01384cz  a2200301n  4500
=001  9880363742902441
=005  20141212203159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008263
=035  \\$aCBA1504M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x480.$x625
=072  \\$aD12.$x776.$x467.$x374.$x480.$x625
=072  \\$aD23.$x125.$x477.$x500
=072  \\$aD23.$x529.$x374.$x480.$x625
=150  \\$aMacrophage Migration-Inhibitory Factors
=450  \\$wnnna$aMacrophage Migration Inhibition Factors
=450  \\$wnnna$aMacrophage Migration Inhibitory Factors
=450  \\$wnnna$aMigration Inhibition Factor, Macrophage
=450  \\$aMigration Inhibition Factors, Macrophage
=450  \\$wnnna$aMigration-Inhibitory Factors, Macrophage
=550  \\$wg$aLeukocyte Migration-Inhibitory Factors
=550  \\$wg$aLymphokines
=550  \\$aCell Migration Inhibition
=667  \\$a/biosyn /physiol permitted
=680  \\$iProteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell.
=688  \\$a91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79
=750  \0$aMacrophage migration inhibitory factor$0(DLC)sh2007002290$5IEN-M

=LDR  00923cz  a2200205n  4500
=001  9880363743002441
=005  20141212203158.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008262
=035  \\$aCBA1503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x270.$x500
=150  \\$aMacrophage Activation
=450  \\$wnnna$aActivation, Macrophage
=450  \\$wnnna$aActivations, Macrophage
=450  \\$wnnna$aMacrophage Activations
=550  \\$wg$aCytotoxicity, Immunologic
=680  \\$iThe process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants.
=688  \\$a82
=750  \0$aMacrophages$xActivation$0(DLC) sh 95003455$5IEN-M

=LDR  00643cz  a2200205n  4500
=001  9880363743102441
=005  20141212203158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008259
=035  \\$aCBA1500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x790.$x720
=072  \\$aD12.$x776.$x377.$x715.$x647
=150  \\$aMacroglobulins
=550  \\$wg$aSerum Globulins
=550  \\$wh$aalpha-Macroglobulins
=667  \\$aserum globulins; ALPHA MACROGLOBULINS is also available
=680  \\$iSerum globulins with high molecular weight. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aMacroglobulins$5IEN$0(DLC)sh 85079447

=LDR  01534cz  a2200409n  4500
=001  9880363743202441
=005  20141212203156.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008254
=035  \\$aCBA1495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x510.$x560
=150  \\$aMacaca nemestrina
=450  \\$wnnna$aMacaque, Pigtail
=450  \\$wnnna$aMacaques, Pigtail
=450  \\$aMonkey, Pig-Tailed
=450  \\$wnnna$aMonkey, Pig Tailed
=450  \\$wnnna$aMonkey, Pigtail
=450  \\$wnnna$aMonkey, Pigtailed
=450  \\$wnnna$aMonkeys, Pig-Tailed
=450  \\$wnnna$aMonkeys, Pigtail
=450  \\$wnnna$aMonkeys, Pigtailed
=450  \\$aPig-Tailed Macaque$5IEN
=450  \\$aPig-Tailed Monkey
=450  \\$wnnna$aPig Tailed Monkey
=450  \\$wnnna$aPig-Tailed Monkeys
=450  \\$wnnna$aPigtail Macaque
=450  \\$wnnna$aPigtail Macaques
=450  \\$wnnna$aPigtail Monkey
=450  \\$wnnna$aPigtail Monkeys
=450  \\$wnnna$aPigtailed Monkey
=450  \\$wnnna$aPigtailed Monkeys
=550  \\$wg$aMacaca
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted.
=688  \\$a91(81); was see under MACACA 1981-90
=750  \0$aPig-tailed macaque$5IEN$0(DLC)sh 85102077

=LDR  01255cz  a2200313n  4500
=001  9880363743302441
=005  20141212203156.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008253
=035  \\$aCBA1494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x510.$x550
=150  \\$aMacaca mulatta
=450  \\$wnnna$aMacaca mulattas
=450  \\$wnnna$aMacaque, Rhesus
=450  \\$wnnna$aMacaques, Rhesus
=450  \\$aMonkey, Rhesus
=450  \\$wnnna$aMonkeys, Rhesus
=450  \\$wnnna$amulatta, Macaca
=450  \\$wnnna$amulattas, Macaca
=450  \\$wnnna$aRhesus Macaque
=450  \\$wnnna$aRhesus Macaques
=450  \\$aRhesus Monkey
=450  \\$wnnna$aRhesus Monkeys
=550  \\$wg$aMacaca
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.
=688  \\$a91(81); was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80
=750  \0$aRhesus monkey$5IEN$0(DLC)sh 85113626

=LDR  01454cz  a2200373n  4500
=001  9880363743402441
=005  20141212203155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008252
=035  \\$aCBA1493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x510.$x520
=150  \\$aMacaca fascicularis
=450  \\$wnnna$aCrab-Eating Macaque
=450  \\$wnnna$aCrab Eating Macaque
=450  \\$wnnna$aCrab-Eating Macaques
=450  \\$aCrab-Eating Monkey
=450  \\$wnnna$aCrab Eating Monkey
=450  \\$wnnna$aCrab-Eating Monkeys
=450  \\$aCynomolgus Monkey
=450  \\$wnnna$aCynomolgus Monkeys
=450  \\$aKra$5IEN
=450  \\$wnnna$aMacaque, Crab-Eating
=450  \\$wnnna$aMacaques, Crab-Eating
=450  \\$aMonkey, Crab-Eating
=450  \\$wnnna$aMonkey, Crab Eating
=450  \\$aMonkey, Cynomolgus
=450  \\$wnnna$aMonkeys, Crab-Eating
=450  \\$wnnna$aMonkeys, Cynomolgus
=550  \\$wg$aMacaca
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.
=688  \\$a91(81); was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80
=750  \0$aKra$5IEN$0(DLC)sh 85073230

=LDR  01597cz  a2200457n  4500
=001  9880363743502441
=005  20141212203155.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008251
=035  \\$aCBA1492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x510
=150  \\$aMacaca
=450  \\$aApe, Barbary
=450  \\$aApe, Black
=450  \\$aApe, Celebes
=450  \\$wnnna$aApes, Barbary
=450  \\$wnnna$aApes, Black
=450  \\$wnnna$aApes, Celebes
=450  \\$aBarbary Ape
=450  \\$wnnna$aBarbary Apes
=450  \\$aBlack Ape
=450  \\$wnnna$aBlack Apes
=450  \\$aCelebes Ape
=450  \\$wnnna$aCelebes Apes
=450  \\$aJapanese Monkey
=450  \\$wnnna$aJapanese Monkeys
=450  \\$wnnna$aMacacas
=450  \\$aMacaque
=450  \\$wnnna$aMacaques
=450  \\$aMonkey, Japanese
=450  \\$wnnna$aMonkeys, Japanese
=550  \\$wg$aCercopithecinae
=550  \\$wh$aMacaca fascicularis
=550  \\$wh$aMacaca mulatta
=550  \\$wh$aMacaca nemestrina
=550  \\$wh$aMacaca radiata
=667  \\$aOld World monkey, not ape despite X refs; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.
=688  \\$a73(71); APE, BARBARY was BARBARY APES see under MACACA 1973-80
=750  \0$aMacaques$5IEN$0(DLC)sh 85079250

=LDR  00902cz  a2200277n  4500
=001  9880363743602441
=005  20141212203154.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008250
=035  \\$aCBA1491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464.$x263.$x200.$x550
=150  \\$aLysine-tRNA Ligase
=450  \\$wnnna$aLigase, Lys-tRNA
=450  \\$wnnna$aLigase, Lysine-tRNA
=450  \\$wnnna$aLys-tRNA Ligase
=450  \\$wnnna$aLys tRNA Ligase
=450  \\$wnnna$aLysine tRNA Ligase
=450  \\$aLysyl T RNA Synthetase
=450  \\$wnnna$aLysyl-tRNA Synthetase
=450  \\$wnnna$aLysyl tRNA Synthetase
=450  \\$wnnna$aSynthetase, Lysyl-tRNA
=550  \\$wg$aAmino Acyl-tRNA Synthetases
=680  \\$iAn enzyme that activates lysine with its specific transfer RNA. EC 6.1.1.6.
=688  \\$a98(75)
=750  \0$aLysyl-tRNA synthetase$5IEN$0(DLC)sh 85079199

=LDR  01232cz  a2200205n  4500
=001  9880363743702441
=005  20141212203154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008247
=035  \\$aCBA1488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x550
=150  \\$aLysosomes
=450  \\$wnnna$aLysosome
=550  \\$wg$aCytoplasmic Vesicles
=550  \\$wh$aAcrosome
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iA class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured. Such rupture is supposed to be under metabolic (hormonal) control. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
=688  \\$a65(64)
=750  \0$aLysosomes$5IEN$0(DLC)sh 85079197

=LDR  00674cz  a2200205n  4500
=001  9880363743802441
=005  20141212203153.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008246
=035  \\$aCBA1487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x550
=150  \\$aLysophospholipids
=450  \\$wnnna$aAcids, Lysophosphatidic
=450  \\$aLysophosphatidic Acids
=550  \\$wg$aPhosphatidic Acids
=550  \\$wh$aLysophosphatidylcholines
=680  \\$iDerivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.
=688  \\$a88
=750  \0$aLysophospholipids$5IEN-M$0(DLC)sh 95000704

=LDR  01160cz  a2200277n  4500
=001  9880363743902441
=005  20141212203116.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008142
=035  \\$aCBA1381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x700.$x572
=150  \\$aLorisidae
=450  \\$aLoris, Slow
=450  \\$aNycticebus
=450  \\$aPerodicticus potto
=450  \\$wnnna$aPerodicticus pottos
=450  \\$wnnna$aPotto
=450  \\$aPottos
=450  \\$wnnna$aSlow Loris
=550  \\$wg$aStrepsirhini
=550  \\$wh$aGalago
=667  \\$aprosimians; IM; qualif permitted
=680  \\$iA family of Primates of the suborder Strepsirhini containing six genera. The family is distributed in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus (golden potto), GALAGO (bush babies), Loris (slender loris), Nycticebus (slow loris), and Perodicticus (potto). Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal.
=688  \\$a81; NYCTICEBUS was NYCETIBUS 1981-92
=750  \0$aLorises$5IEN$0(DLC)sh 85078411

=LDR  03546cz  a2200997n  4500
=001  9880363744002441
=005  20141212192302.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008140
=035  \\$aCBA1379HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x450
=150  \\$aLorazepam
=450  \\$wnnna$aAHP Brand of Lorazepam
=450  \\$wnnna$aApo-Lorazepam
=450  \\$wnnna$aApo Lorazepam
=450  \\$wnnna$aApoLorazepam
=450  \\$wnnna$aApotex Brand of Lorazepam
=450  \\$wnnna$aAtivan
=450  \\$wnnna$aBaxter Brand of Lorazepam
=450  \\$wnnna$act-Arzneimittel Brand of Lorazepam
=450  \\$wnnna$act Arzneimittel Brand of Lorazepam
=450  \\$wnnna$aDesitin Brand of Lorazepam
=450  \\$wnnna$aDolorgiet Brand of Lorazepam
=450  \\$wnnna$aDonix
=450  \\$wnnna$aDuralozam
=450  \\$wnnna$aDurazolam
=450  \\$wnnna$aIdalprem
=450  \\$wnnna$aLaubeel
=450  \\$wnnna$aLlorens Brand of Lorazepam
=450  \\$wnnna$alorazep von ct
=450  \\$wnnna$aLorazepam AHP Brand
=450  \\$wnnna$aLorazepam Apotex Brand
=450  \\$wnnna$aLorazepam Baxter Brand
=450  \\$wnnna$aLorazepam ct-Arzneimittel Brand
=450  \\$wnnna$aLorazepam Desitin Brand
=450  \\$wnnna$aLorazepam Dolorgiet Brand
=450  \\$wnnna$aLorazepam Llorens Brand
=450  \\$wnnna$aLorazepam Medical
=450  \\$wnnna$aLorazepam Medical Brand
=450  \\$wnnna$aLorazepam Medix Brand
=450  \\$wnnna$aLorazepam-neuraxpharm
=450  \\$wnnna$aLorazepam neuraxpharm
=450  \\$wnnna$aLorazepam neuraxpharm Brand
=450  \\$wnnna$aLorazepam Novartis Brand
=450  \\$wnnna$aLorazepam Novopharm Brand
=450  \\$wnnna$aLorazepam Nu-Pharm Brand
=450  \\$wnnna$aLorazepam-ratiopharm
=450  \\$wnnna$aLorazepam ratiopharm
=450  \\$wnnna$aLorazepam ratiopharm Brand
=450  \\$wnnna$aLorazepam Riemser Brand
=450  \\$wnnna$aLorazepam Wyeth Brand
=450  \\$wnnna$aMedical Brand of Lorazepam
=450  \\$wnnna$aMedical, Lorazepam
=450  \\$wnnna$aMedix Brand of Lorazepam
=450  \\$wnnna$aMerck dura Brand of Lorazepam
=450  \\$wnnna$aneuraxpharm Brand of Lorazepam
=450  \\$wnnna$aNovartis Brand of Lorazepam
=450  \\$wnnna$aNovo-Lorazem
=450  \\$wnnna$aNovo Lorazem
=450  \\$wnnna$aNovoLorazem
=450  \\$wnnna$aNovopharm Brand of Lorazepam
=450  \\$wnnna$aNu-Loraz
=450  \\$wnnna$aNu Loraz
=450  \\$wnnna$aNu-Pharm Brand of Lorazepam
=450  \\$wnnna$aNu Pharm Brand of Lorazepam
=450  \\$wnnna$aNuLoraz
=450  \\$wnnna$aOrfidal Wyeth
=450  \\$wnnna$aratiopharm Brand of Lorazepam
=450  \\$wnnna$aRiemser Brand of Lorazepam
=450  \\$wnnna$aSedicepan
=450  \\$wnnna$aSerra Pamies Brand of Lorazepam
=450  \\$wnnna$aSinestron
=450  \\$wnnna$aSomagerol
=450  \\$wnnna$aTémesta
=450  \\$wnnna$aTemesta
=450  \\$wnnna$aTolid
=450  \\$wnnna$aWY-4036
=450  \\$wnnna$aWY 4036
=450  \\$wnnna$aWY4036
=450  \\$wnnna$aWyeth Brand of Lorazepam
=450  \\$wnnna$aWyeth, Orfidal
=550  \\$wg$aBenzodiazepinones
=680  \\$iA benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
=688  \\$a84(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-83
=750  \0$aLorazepam$5IEN$0(DLC)sh 85078346

=LDR  01006cz  a2200265n  4500
=001  9880363744102441
=005  20141212203115.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008139
=035  \\$aCBA1378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x440
=150  \\$aLoperamide
=450  \\$wnnna$aHydrochloride, Loperamide
=450  \\$wnnna$aImodium
=450  \\$wnnna$aLoperamide Hydrochloride
=450  \\$wnnna$aLoperamide Monohydrochloride
=450  \\$wnnna$aMonohydrochloride, Loperamide
=450  \\$wnnna$aR-18553
=450  \\$wnnna$aR 18553
=450  \\$wnnna$aR18553
=550  \\$wg$aPiperidines
=680  \\$iOne of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
=688  \\$a91(76); was see under PIPERIDINES 1976-90
=750  \0$aLoperamide$5IEN$0(DLC)sh 85078329

=LDR  01228cz  a2200313n  4500
=001  9880363744202441
=005  20141212192301.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008137
=035  \\$aCBA1376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x500.$x750.$x500
=072  \\$aN5.$x715.$x360.$x775.$x175.$x250.$x450
=072  \\$aN6.$x850.$x520.$x450.$x500.$x750.$x500
=150  \\$aLongitudinal Studies
=450  \\$aLongitudinal Method$5IEN
=450  \\$wnnna$aLongitudinal Study
=450  \\$wnnna$aLongitudinal Survey
=450  \\$wnnna$aLongitudinal Surveys
=450  \\$wnnna$aStudies, Longitudinal
=450  \\$wnnna$aStudy, Longitudinal
=450  \\$wnnna$aSurvey, Longitudinal
=450  \\$wnnna$aSurveys, Longitudinal
=550  \\$wg$aCohort Studies
=550  \\$wh$aNational Longitudinal Study of Adolescent Health
=667  \\$aIM general only; coordinate NIM with specific disease (IM); add geographic term if pertinent
=680  \\$iStudies in which variables relating to an individual or group of individuals are assessed over a period of time.
=688  \\$a79(75); was see under EPIDEMIOLOGIC METHODS 1975-78
=750  \0$aLongitudinal method$5IEN$0(DLC)sh 85078296

=LDR  00626cz  a2200217n  4500
=001  9880363744302441
=005  20141212203114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008136
=035  \\$aCBA1375HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x540
=072  \\$aG7.$x700.$x320.$x124.$x519
=150  \\$aLongevity
=450  \\$aLength of Life
=550  \\$wg$aAging
=550  \\$wg$aPhysiological Phenomena
=550  \\$aLife Expectancy
=667  \\$ahuman & animal; consider also LIFE EXPECTANCY
=680  \\$iThe normal length of time of an organism's life.
=750  \0$aLongevity$5IEN$0(DLC)sh 85078286

=LDR  00781cz  a2200229n  4500
=001  9880363744402441
=005  20141212203114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008134
=035  \\$aCBA1373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x476
=072  \\$aN2.$x421.$x585.$x476
=150  \\$aLong-Term Care
=450  \\$wnnna$aCare, Long-Term
=450  \\$wnnna$aLong Term Care
=550  \\$wg$aPatient Care
=667  \\$aNIM
=680  \\$iCare over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.
=688  \\$a92; was LONG TERM CARE 1968-91
=750  \0$aLong-term care of the sick$5IEN-M$0(DLC)sh 85078277
=750  \0$aLong-term care facilities$5IEN-HS$0(DLC)sh 85078270

=LDR  01161cz  a2200265n  4500
=001  9880363744502441
=005  20141212203113.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008133
=035  \\$aCBA1372M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x565
=072  \\$aC16.$x131.$x240.$x400.$x715
=072  \\$aC23.$x550.$x73.$x547
=150  \\$aLong QT Syndrome
=550  \\$wg$aArrhythmias, Cardiac
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wh$aAndersen Syndrome
=550  \\$wh$aJervell-Lange Nielsen Syndrome
=550  \\$wh$aRomano-Ward Syndrome
=550  \\$aVoltage-Gated Sodium Channel beta-4 Subunit
=680  \\$iA condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
=688  \\$a1991(1986); use ARRHYTHMIA 1986-1990
=688  \\$a91(86); was see under ARRHYTHMIA 1986-90
=750  \0$aLong QT syndrome$5IEN-M$0(DLC)sh2003008370

=LDR  00712cz  a2200205n  4500
=001  9880363744602441
=005  20141212192300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008132
=035  \\$aCBA1371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x713
=072  \\$aI1.$x880.$x853.$x748.$x435
=150  \\$aLoneliness
=450  \\$aHomesickness
=550  \\$wg$aEmotions
=550  \\$wg$aSocial Isolation
=680  \\$iThe state of feeling sad or dejected as a result of lack of companionship or being separated from others.
=688  \\$a91(73); see SOCIAL ISOLATION 1973-90; HOMESICKNESS see ANXIETY, SEPARATION 1975-78; see EMOTIONS 1963-74
=750  \0$aLoneliness$5IEN$0(DLC)sh 85078243

=LDR  00968cz  a2200229n  4500
=001  9880363744702441
=005  20141212202954.0
=008  850503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008129
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x500
=072  \\$aJ2.$x500.$x300.$x100.$x400
=150  \\$aLolium
=450  \\$wnnna$aGrass, Rye
=450  \\$wnnna$aRye Grass
=450  \\$aRyegrass
=550  \\$wg$aAnimal Feed
=550  \\$wg$aPoaceae
=667  \\$aused as cattle fodder; do not confuse X ref RYE GRASS with rye (SECALE CEREALE)
=680  \\$iCommon member of the Gramineae family used as cattle fodder. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum.
=688  \\$a91(86); was see under GRASSES 1986-90
=750  \0$aRyegrasses$5IEN$0(DLC)sh 88022897

=LDR  00957cz  a2200217n  4500
=001  9880363744802441
=005  20141212202952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008118
=035  \\$aCBA1367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x750.$x361.$x518
=150  \\$aLoiasis
=450  \\$wnnna$aLoaiases
=450  \\$aLoaiasis
=450  \\$wnnna$aLoiases
=550  \\$wg$aFilariasis
=667  \\$a/drug ther: consider FILARICIDES
=680  \\$iA parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly (Tabanus) or the deerfly or mango fly (Chrysops). The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless.
=688  \\$a91(75); was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88
=750  \0$aLoaiasis$5IEN$0(DLC)sh 85077859

=LDR  00873cz  a2200217n  4500
=001  9880363744902441
=005  20141212202954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008128
=035  \\$aCBA1366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x448
=150  \\$aLogic
=450  \\$wnnna$aLogics
=450  \\$aMedical Logic$5IEN
=550  \\$wg$aPhilosophy
=550  \\$wh$aFuzzy Logic
=667  \\$ano qualif
=680  \\$iThe science that investigates the principles governing correct or reliable inference and deals with the canons and criteria of validity in thought and demonstration. This system of reasoning is applicable to any branch of knowledge or study. (Random House Unabridged Dictionary, 2d ed & Sippl, Computer Dictionary, 4th ed)
=750  \0$aLogic$0(DLC) sh 85078106$5IEN-M
=750  \0$aMedical logic$0(DLC) sh 85082973$5IEN-HS

=LDR  01550cz  a2200409n  4500
=001  9880363745002441
=005  20141212192300.0
=008  770411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008125
=035  \\$aCBA1363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x473
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x650.$x437
=072  \\$aA8.$x186.$x211.$x653.$x473
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x650.$x437
=150  \\$aLocus Coeruleus
=450  \\$wnnna$aCeruleus Complex, Locus
=450  \\$wnnna$aCeruleus Complices, Locus
=450  \\$wnnna$aCoeruleus Complex, Locus
=450  \\$wnnna$aCoeruleus Complices, Locus
=450  \\$wnnna$aComplex, Locus Ceruleus
=450  \\$wnnna$aComplex, Locus Coeruleus
=450  \\$wnnna$aComplices, Locus Ceruleus
=450  \\$wnnna$aComplices, Locus Coeruleus
=450  \\$wnnna$aLocus Caeruleus
=450  \\$wnnna$aLocus Ceruleus
=450  \\$wnnna$aLocus Ceruleus Complex
=450  \\$wnnna$aLocus Ceruleus Complices
=450  \\$wnnna$aLocus Coeruleus Complex
=450  \\$wnnna$aLocus Coeruleus Complices
=450  \\$wnnna$aNucleus Pigmentosus Pontis
=450  \\$wnnna$aPontis, Nucleus Pigmentosus
=550  \\$wg$aMesencephalon
=550  \\$wg$aPontine Tegmentum
=680  \\$iBluish-colored region in the superior angle of the FOURTH VENTRICLE floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the PERIAQUEDUCTAL GRAY.
=688  \\$a78
=750  \0$aLocus coeruleus$5IEN$0(DLC)sh 85078037

=LDR  01127cz  a2200265n  4500
=001  9880363745102441
=005  20181121115133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008124
=035  \\$aCBA1362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x568.$x500
=072  \\$aG11.$x427.$x410.$x568
=150  \\$aLocomotion
=450  \\$wnnna$aLocomotions
=550  \\$wg$aMovement
=550  \\$wh$aCell Movement
=550  \\$wh$aFlight, Animal
=550  \\$wh$aRunning
=550  \\$wh$aSwimming
=550  \\$wh$aTaxis Response
=550  \\$wh$aWalking
=667  \\$adifferentiate LOCOMOTION (getting from one point to another) from GAIT (how a man or major animal gets there), MOVEMENT (without necessarily locomoting), MOTOR ACTIVITY (movement assoc with behavior), WALKING (purposeful locomotion to get somewhere or for recreation, fitness or competition); CELL LOCOMOTION see CELL MOVEMENT is available
=680  \\$iMovement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms.
=750  \0$aLocomotion$5IEN$0(DLC)sh 85077989

=LDR  01036cz  a2200277n  4500
=001  9880363745202441
=005  20201118174327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008121
=035  \\$aCBA1359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x550
=150  \\$aNephropidae
=450  \\$wnnna$aClawed Lobster
=450  \\$aClawed Lobsters
=450  \\$aHomaridae
=450  \\$aHomarus
=450  \\$wnnna$aLobster, Clawed
=450  \\$wnnoa$aLobsters$5IEN-HS
=450  \\$aLobsters, Clawed
=550  \\$wg$aDecapoda
=550  \\$aShellfish
=667  \\$aas animal & food; unspecified lobster as food probably goes here and is coord IM with SHELLFISH (IM)
=680  \\$iFamily of large marine CRUSTACEA, in the order DECAPODA. These are called clawed lobsters because they bear pincers on the first three pairs of legs. The American lobster and Cape lobster in the genus Homarus are commonly used for food.
=688  \\$a2003 (1972)
=750  \0$aLobsters$5IEN$0(DLC)sh 85077905

=LDR  00660cz  a2200193n  4500
=001  9880363745302441
=005  20141212202952.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008119
=035  \\$aCBA1357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x738.$x610
=150  \\$aLobbying
=450  \\$wnnna$aLobbyings
=550  \\$wg$aPolitics
=667  \\$ano qualif
=680  \\$iA process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.
=688  \\$a91(82); was see under POLITICS 1982-90
=750  \0$aLobbying$5IEN$0(DLC)sh 85077890

=LDR  00537cz  a2200193n  4500
=001  9880363745402441
=005  20141212202951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008116
=035  \\$aCBA1355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x393
=150  \\$aLizards
=450  \\$wnnna$aLizard
=550  \\$wg$aReptiles
=550  \\$wh$aIguanas
=667  \\$aincludes IGUANAS, geckos, chameleons, Gila monsters; IM; qualif permitted
=688  \\$a68
=750  \0$aLizards$5IEN$0(DLC)sh 85077831

=LDR  00719cz  a2200253n  4500
=001  9880363745502441
=005  20141212202951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008115
=035  \\$aCBA1354HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261.$x326.$x520
=072  \\$aG16.$x100.$x856.$x468
=150  \\$aLiver Regeneration
=450  \\$wnnna$aLiver Regenerations
=450  \\$wnnna$aRegeneration, Liver
=450  \\$wnnna$aRegenerations, Liver
=550  \\$wg$aDigestive System Processes
=550  \\$wg$aRegeneration
=550  \\$aHepatectomy
=667  \\$aIM
=680  \\$iRepair or renewal of hepatic tissue.
=688  \\$a64
=750  \0$aLiver$xRegeneration$5IEN$0(DLC)sh 85077765

=LDR  01850cz  a2200505n  4500
=001  9880363745602441
=005  20141212202950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008113
=035  \\$aCBA1352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x623
=072  \\$aC6.$x301.$x623
=072  \\$aC6.$x552.$x697
=150  \\$aLiver Neoplasms
=450  \\$wnnna$aCancer, Hepatic
=450  \\$wnnna$aCancer, Hepatocellular
=450  \\$wnnna$aCancer, Liver
=450  \\$aCancer of Liver
=450  \\$wnnna$aCancer of the Liver
=450  \\$wnnna$aCancers, Hepatic
=450  \\$wnnna$aCancers, Hepatocellular
=450  \\$wnnna$aCancers, Liver
=450  \\$aHepatic Cancer
=450  \\$wnnna$aHepatic Cancers
=450  \\$wnnna$aHepatic Neoplasm
=450  \\$wnnna$aHepatic Neoplasms
=450  \\$wnnna$aHepatocellular Cancer
=450  \\$wnnna$aHepatocellular Cancers
=450  \\$aLiver Cancer
=450  \\$wnnna$aLiver Cancers
=450  \\$wnnna$aLiver Neoplasm
=450  \\$wnnna$aNeoplasm, Hepatic
=450  \\$wnnna$aNeoplasm, Liver
=450  \\$wnnna$aNeoplasms, Hepatic
=450  \\$wnnna$aNeoplasms, Liver
=550  \\$wg$aDigestive System Neoplasms
=550  \\$wg$aLiver Diseases
=550  \\$wh$aAdenoma, Liver Cell
=550  \\$wh$aCarcinoma, Hepatocellular
=550  \\$wh$aLiver Neoplasms, Experimental
=667  \\$acoord IM with histol type of neopl (IM), including HEPATOMA (IM); LIVER NEOPLASMS, EXPERIMENTAL is available; be careful: do not confuse "hepatic neopl" with "intrahepatic neopl": "intrahepatic neopl" may refer to BILE DUCT NEOPLASMS with regard to BILE DUCTS, INTRAHEPATIC, not LIVER NEOPLASMS
=680  \\$iTumors or cancer of the LIVER.
=750  \0$aLiver$xTumors$5IEN-M$0(DLC)sh 85077769
=750  \0$aLiver$xCancer$5IEN-HS$0(DLC)sh 85077753

=LDR  00617cz  a2200205n  4500
=001  9880363745702441
=005  20141212202949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008112
=035  \\$aCBA1351HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x388.$x518
=072  \\$aD9.$x698.$x365.$x388.$x518
=150  \\$aLiver Glycogen
=450  \\$wnnna$aGlycogen, Hepatic
=450  \\$wnnna$aGlycogen, Liver
=450  \\$aHepatic Glycogen
=550  \\$wg$aGlycogen
=680  \\$iGlycogen stored in the liver. (Dorland, 28th ed)
=750  \0$aLiver$xGlycogenic function$5IEN$0(DLC)sh 85077760

=LDR  00654cz  a2200217n  4500
=001  9880363745802441
=005  20141212202949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008111
=035  \\$aCBA1350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x460
=150  \\$aLiver Function Tests
=450  \\$wnnna$aFunction Test, Liver
=450  \\$wnnna$aFunction Tests, Liver
=450  \\$wnnna$aLiver Function Test
=450  \\$wnnna$aTest, Liver Function
=450  \\$wnnna$aTests, Liver Function
=550  \\$wg$aDiagnostic Techniques, Digestive System
=667  \\$aNIM
=750  \0$aLiver function tests$5IEN$0(DLC)sh 85077776

=LDR  00890cz  a2200193n  4500
=001  9880363745902441
=005  20141212202949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008110
=035  \\$aCBA1349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x777.$x351
=150  \\$aLiver Extracts
=450  \\$wnnna$aExtracts, Liver
=450  \\$wnnna$aPerhepar
=550  \\$wg$aTissue Extracts
=667  \\$aextracts of liver or liver fractions containing uncharacterized factors; do not confuse with chemical substances "extracted" from the liver, as "peptides extracted from the mouse liver" ( = PEPTIDES /anal + LIVER /anal)
=680  \\$iExtracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.
=750  \0$aLiver extract$5IEN$0(DLC)sh 85077774

=LDR  00964cz  a2200265n  4500
=001  9880363746002441
=005  20141212202948.0
=008  780126\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008108
=035  \\$aCBA1347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x645
=072  \\$aC25.$x775.$x100.$x87.$x645
=150  \\$aLiver Diseases, Alcoholic
=450  \\$wnnna$aAlcoholic Liver Disease
=450  \\$aAlcoholic Liver Diseases
=450  \\$wnnna$aLiver Disease, Alcoholic
=550  \\$wg$aAlcohol-Induced Disorders
=550  \\$wg$aLiver Diseases
=550  \\$wh$aFatty Liver, Alcoholic
=550  \\$wh$aHepatitis, Alcoholic
=550  \\$wh$aLiver Cirrhosis, Alcoholic
=680  \\$iLiver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
=688  \\$a79
=750  \0$aAlcoholic liver diseases$5IEN$0(DLC)sh 91004141

=LDR  02022cz  a2200541n  4500
=001  9880363746102441
=005  20141212202948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008107
=035  \\$aCBA1346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552
=150  \\$aLiver Diseases
=450  \\$wnnna$aDisease, Liver
=450  \\$wnnna$aDiseases, Liver
=450  \\$wnnna$aDysfunction, Liver
=450  \\$wnnna$aDysfunctions, Liver
=450  \\$wnnna$aLiver Disease
=450  \\$wnnna$aLiver Dysfunction
=450  \\$wnnna$aLiver Dysfunctions
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aalpha 1-Antitrypsin Deficiency
=550  \\$wh$aBudd-Chiari Syndrome
=550  \\$wh$aCholestasis, Intrahepatic
=550  \\$wh$aDrug-Induced Liver Injury
=550  \\$wh$aFatty Liver
=550  \\$wh$aFocal Nodular Hyperplasia
=550  \\$wh$aHepatic Insufficiency
=550  \\$wh$aHepatic Veno-Occlusive Disease
=550  \\$wh$aHepatitis
=550  \\$wh$aHepatolenticular Degeneration
=550  \\$wh$aHepatomegaly
=550  \\$wh$aHepatopulmonary Syndrome
=550  \\$wh$aHepatorenal Syndrome
=550  \\$wh$aHypertension, Portal
=550  \\$wh$aLiver Abscess
=550  \\$wh$aLiver Cirrhosis
=550  \\$wh$aLiver Diseases, Alcoholic
=550  \\$wh$aLiver Diseases, Parasitic
=550  \\$wh$aLiver Neoplasms
=550  \\$wh$aPeliosis Hepatis
=550  \\$wh$aPorphyrias, Hepatic
=550  \\$wh$aTuberculosis, Hepatic
=550  \\$wh$aZellweger Syndrome
=667  \\$ageneral; prefer specifics; inflammatory disease = HEPATITIS & its specifics; specialty is HEPATOLOGY see GASTROENTEROLOGY; be careful: do not confuse "hepatic disease" with "intrahepatic disease": "intrahepatic disease" may refer to BILE DUCT DISEASES with regard to BILE DUCTS, INTRAHEPATIC, not LIVER DISEASES
=680  \\$iPathological processes of the LIVER.
=688  \\$aACUTE YELLOW ATROPHY was heading 1963-96
=750  \0$aLiver$xDiseases$5IEN$0(DLC)sh 85077755

=LDR  01233cz  a2200337n  4500
=001  9880363746202441
=005  20141212202946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008103
=035  \\$aCBA1342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x630
=150  \\$aLiver Cirrhosis
=450  \\$wnnna$aCirrhoses, Hepatic
=450  \\$wnnna$aCirrhoses, Liver
=450  \\$wnnna$aCirrhosis, Hepatic
=450  \\$aCirrhosis, Liver
=450  \\$wnnna$aFibroses, Liver
=450  \\$aFibrosis, Liver
=450  \\$wnnna$aHepatic Cirrhoses
=450  \\$aHepatic Cirrhosis
=450  \\$wnnna$aLiver Cirrhoses
=450  \\$wnnna$aLiver Fibroses
=450  \\$aLiver Fibrosis
=550  \\$wg$aLiver Diseases
=550  \\$wh$aLiver Cirrhosis, Alcoholic
=550  \\$wh$aLiver Cirrhosis, Biliary
=550  \\$wh$aLiver Cirrhosis, Experimental
=680  \\$iLiver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
=688  \\$aLIVER CIRRHOSIS, POSTNECROTIC was heading 1963-77
=750  \0$aLiver$xCirrhosis$5IEN$0(DLC)sh 85077754

=LDR  00811cz  a2200253n  4500
=001  9880363746302441
=005  20141212202946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008102
=035  \\$aCBA1341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x881.$x552
=150  \\$aLiver Circulation
=450  \\$wnnna$aCirculation, Hepatic
=450  \\$wnnna$aCirculation, Liver
=450  \\$aHepatic Circulation
=550  \\$wg$aSplanchnic Circulation
=550  \\$aHepatic Artery
=550  \\$aHepatic Veins
=550  \\$aPortal System
=667  \\$aconsider also LIVER /blood supply & ENTEROHEPATIC CIRCULATION (see note there); DF: LIVER CIRC
=680  \\$iThe circulation of BLOOD through the LIVER.
=688  \\$a64
=750  \0$aLiver$xBlood-vessels$5IEN$0(DLC)sh 85077751

=LDR  02075cz  a2200577n  4500
=001  9880363746402441
=005  20141212202946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008101
=035  \\$aCBA1340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x25.$x20.$x455.$x460
=072  \\$aC3.$x518.$x600
=072  \\$aC3.$x752.$x49.$x703
=072  \\$aC6.$x552.$x597.$x517
=072  \\$aC6.$x552.$x664.$x642
=150  \\$aLiver Abscess, Amebic
=450  \\$aAbscess, Amebic, Hepatic
=450  \\$wnnna$aAbscess, Amebic Liver
=450  \\$wnnna$aAbscess, Amoebic Hepatic
=450  \\$wnnna$aAbscess, Amoebic Liver
=450  \\$aAbscess, Hepatic, Amebic
=450  \\$aAbscess, Liver, Amebic
=450  \\$wnnna$aAbscesses, Amebic Liver
=450  \\$wnnna$aAbscesses, Amoebic Hepatic
=450  \\$wnnna$aAbscesses, Amoebic Liver
=450  \\$aAmebiasis, Hepatic
=450  \\$wnnna$aAmebic Liver Abscess
=450  \\$wnnna$aAmebic Liver Abscesses
=450  \\$wnnna$aAmoebiasis, Hepatic
=450  \\$wnnna$aAmoebic Hepatic Abscess
=450  \\$wnnna$aAmoebic Hepatic Abscesses
=450  \\$wnnna$aAmoebic Liver Abscess
=450  \\$wnnna$aAmoebic Liver Abscesses
=450  \\$wnnna$aEntamoebiases, Hepatic
=450  \\$aEntamoebiasis, Hepatic
=450  \\$wnnna$aHepatic Abscess, Amoebic
=450  \\$wnnna$aHepatic Abscesses, Amoebic
=450  \\$aHepatic Amebiasis
=450  \\$wnnna$aHepatic Amoebiasis
=450  \\$wnnna$aHepatic Entamoebiases
=450  \\$aHepatic Entamoebiasis
=450  \\$wnnna$aLiver Abscess, Amoebic
=450  \\$wnnna$aLiver Abscesses, Amebic
=450  \\$wnnna$aLiver Abscesses, Amoebic
=550  \\$wg$aAmebiasis
=550  \\$wg$aLiver Abscess
=550  \\$wg$aLiver Diseases, Parasitic
=667  \\$acoordinate IM with specific organism (IM)
=680  \\$iSingle or multiple areas of PUS due to infection by any ameboid protozoa (AMEBIASIS). A common form is caused by the ingestion of ENTAMOEBA HISTOLYTICA.
=750  \0$aLiver abscess, Amebic$5IEN$0(DLC)sh 85077771

=LDR  01126cz  a2200313n  4500
=001  9880363746502441
=005  20141212202945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008100
=035  \\$aCBA1339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x25.$x20.$x455
=072  \\$aC6.$x552.$x597
=150  \\$aLiver Abscess
=450  \\$aAbscess, Hepatic
=450  \\$wnnna$aAbscess, Liver
=450  \\$wnnna$aAbscesses, Hepatic
=450  \\$wnnna$aAbscesses, Liver
=450  \\$wnnna$aHepatic Abscess
=450  \\$wnnna$aHepatic Abscesses
=450  \\$aLiver,$xabscess$5IEN
=450  \\$wnnna$aLiver Abscesses
=550  \\$wg$aAbdominal Abscess
=550  \\$wg$aLiver Diseases
=550  \\$wh$aLiver Abscess, Amebic
=550  \\$wh$aLiver Abscess, Pyogenic
=667  \\$acoordinate IM with specific organism infection term (IM); LIVER ABSCESS, AMEBIC and LIVER ABSCESS, PYOGENIC are also available
=680  \\$iSolitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.
=750  \0$aLiver$xAbscess$5IEN$0(DLC)sh 85077749

=LDR  01030cz  a2200217n  4500
=001  9880363746602441
=005  20171012143849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008099
=035  \\$aCBA1338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x620
=150  \\$aLiver
=360  \\$iconsider also terms at$aHEPAT-
=450  \\$wnnna$aLivers
=550  \\$wg$aDigestive System
=550  \\$wh$aBile Ducts, Intrahepatic
=550  \\$wh$aRound Ligament of Liver
=667  \\$a/blood supply: consider also LIVER CIRCULATION; /cytol: consider also KUPFFER CELLS; /surg: consider also HEPATECTOMY & LIVER TRANSPLANTATION; inflammation = HEPATITIS & its specifics; specialty is HEPATOLOGY see GASTROENTEROLOGY; be careful: do not confuse "hepatic" with "intrahepatic": "intrahepatic" may refer to BILE DUCTS, INTRAHEPATIC & its dis, not LIVER
=688  \\$a/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65
=750  \0$aLiver$5IEN$0(DLC)sh 85077748

=LDR  02767cz  a2200613n  4500
=001  9880363746702441
=005  20141212202944.0
=008  850607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008096
=035  \\$aCBA1335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x600
=072  \\$aE4.$x943.$x500
=150  \\$aLithotripsy
=450  \\$wnnna$aElectrohydraulic Shockwave Lithotripsies
=450  \\$aElectrohydraulic Shockwave Lithotripsy
=450  \\$aESWL (Extracorporeal Shockwave Lithotripsy)
=450  \\$wnnna$aESWLs (Extracorporeal Shockwave Lithotripsy)
=450  \\$wnnna$aExtracorporeal Shockwave Lithotripsies
=450  \\$aExtracorporeal Shockwave Lithotripsy
=450  \\$wnnna$aLitholapaxies
=450  \\$wnnna$aLitholapaxies, Noninvasive
=450  \\$aLitholapaxy
=450  \\$wnnna$aLitholapaxy, Noninvasive
=450  \\$wnnna$aLithotripsies
=450  \\$wnnna$aLithotripsies, Electrohydraulic Shockwave
=450  \\$wnnna$aLithotripsies, Extracorporeal Shockwave
=450  \\$wnnna$aLithotripsies, Percutaneous Ultrasonic
=450  \\$wnnna$aLithotripsies, Ultrasonic
=450  \\$wnnna$aLithotripsy, Electrohydraulic Shockwave
=450  \\$wnnna$aLithotripsy, Extracorporeal Shockwave
=450  \\$wnnna$aLithotripsy, Percutaneous Ultrasonic
=450  \\$wnnna$aLithotripsy, Ultrasonic
=450  \\$wnnna$aNoninvasive Litholapaxies
=450  \\$aNoninvasive Litholapaxy
=450  \\$wnnna$aPercutaneous Ultrasonic Lithotripsies
=450  \\$aPercutaneous Ultrasonic Lithotripsy
=450  \\$wnnna$aShockwave Lithotripsies, Electrohydraulic
=450  \\$wnnna$aShockwave Lithotripsies, Extracorporeal
=450  \\$wnnna$aShockwave Lithotripsy, Electrohydraulic
=450  \\$wnnna$aShockwave Lithotripsy, Extracorporeal
=450  \\$wnnna$aUltrasonic Lithotripsies
=450  \\$wnnna$aUltrasonic Lithotripsies, Percutaneous
=450  \\$aUltrasonic Lithotripsy
=450  \\$wnnna$aUltrasonic Lithotripsy, Percutaneous
=550  \\$wg$aTherapeutics
=550  \\$wg$aUltrasonic Surgical Procedures
=550  \\$wh$aLithotripsy, Laser
=550  \\$aCalculi
=550  \\$aHigh-Energy Shock Waves
=667  \\$ado not use /util except by MeSH definition; litholysis (dissolving calculi by acid) is disease /ther, not LITHOTRIPSY; DF: ESWL
=680  \\$iThe destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER.
=688  \\$a86
=750  \0$aLithotripsy$5IEN$0(DLC)sh 85077618

=LDR  00955cz  a2200229n  4500
=001  9880363746802441
=005  20141212192259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008094
=035  \\$aCBA1333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549.$x450
=072  \\$aD1.$x268.$x557.$x290
=072  \\$aD1.$x552.$x528.$x480
=072  \\$aD1.$x552.$x547.$x290
=150  \\$aLithium
=450  \\$aOrganolithium Compounds$5IEN
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Light
=667  \\$aLi-7; Li-6 = LITHIUM (IM) + ISOTOPES (NIM); Li-5, 8, 9 = LITHIUM (IM) + RADIOISOTOPES (IM); therapeutic use of lithium = LITHIUM COMPOUNDS / ther use or specific lithium compound /ther use
=680  \\$iAn element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER.
=750  \0$aLithium$5IEN-M$0(DLC)sh 85077577

=LDR  00523cz  a2200169n  4500
=001  9880363746902441
=005  20141212202943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008093
=035  \\$aCBA1332HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x533
=150  \\$aLiterature, Modern
=450  \\$wnnna$aModern Literature
=550  \\$wg$aLiterature
=667  \\$astarts with 15th cent; coord IM with POETRY AS TOPIC (IM) or DRAMA (IM); DF: LIT MODERN
=750  \0$aLiterature, Modern$5IEN$0(DLC)sh 85077552

=LDR  00508cz  a2200169n  4500
=001  9880363747002441
=005  20141212202942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008092
=035  \\$aCBA1331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x495
=150  \\$aLiterature, Medieval
=450  \\$wnnna$aMedieval Literature
=550  \\$wg$aLiterature
=667  \\$acoord IM with POETRY AS TOPIC (IM) or DRAMA (IM); DF: LIT MEDIEVAL
=750  \0$aLiterature, Medieval$5IEN$0(DLC)sh 85077548

=LDR  01283cz   2200349n  4500
=001  9880363747102441
=005  20230831175052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008091
=035  \\$aCBA1330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517
=150  \\$aLiterature
=450  \\$wnnna$aLiteratures
=550  \\$wg$aHumanities
=550  \\$wh$aAnecdotes as Topic
=550  \\$wh$aAphorisms and Proverbs as Topic
=550  \\$wh$aBible
=550  \\$wh$aBiography as Topic
=550  \\$wh$aDrama
=550  \\$wh$aLiterature, Medieval
=550  \\$wh$aLiterature, Modern
=550  \\$wh$aMedicine in Literature
=550  \\$wh$aMythology
=550  \\$wh$aPhilology
=550  \\$wh$aPoetry as Topic
=550  \\$wh$aScience in Literature
=550  \\$wh$aWit and Humor as Topic
=667  \\$athe body of literary works; TN 121: differentiate from BIBLIOGRAPHY; relation to BOOKS: Manual 33.11
=680  \\$iWritings having excellence of form or expression and expressing ideas of permanent or universal interest. The body of written works produced in a particular language, country, or age. (Webster, 3d ed)
=750  \0$aLiterature$5IEN$0(DLC)sh 85077507
=750  \0$iNarrower mapping$aStevedores' writings$0(DLC)sh2022006851$4NM$5IEN-M

=LDR  01768cz  a2200481n  4500
=001  9880363747202441
=005  20141212202942.0
=008  780208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008090
=035  \\$aCBA1329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327.$x287.$x417
=072  \\$aD3.$x549.$x439.$x560
=150  \\$aLisuride
=450  \\$wnnna$aArolac
=450  \\$wnnna$aCarbamide, Methylergol
=450  \\$wnnna$aCuvalit
=450  \\$wnnna$aDopergin
=450  \\$wnnna$aDopergine
=450  \\$wnnna$aHydrochloride, Lisuride
=450  \\$wnnna$aHydrogen Maleate, Lysuride
=450  \\$wnnna$aIPRAD Brand of Lisuride Maleate
=450  \\$wnnna$aLisuride, (8alpha)-(+-)-Isomer
=450  \\$wnnna$aLisuride Hydrochloride
=450  \\$wnnna$aLisuride Maleate
=450  \\$wnnna$aLisuride Maleate (1:1)
=450  \\$wnnna$aLisuride Maleate, (8beta)-Isomer
=450  \\$wnnna$aLisuride Mesylate
=450  \\$wnnna$aLisuride Phosphate (1:1)
=450  \\$wnnna$aLysenyl
=450  \\$wnnna$aLysurid
=450  \\$aLysuride Hydrogen Maleate
=450  \\$wnnna$aMaleate, Lisuride
=450  \\$wnnna$aMesylate, Lisuride
=450  \\$aMethylergol Carbamide
=450  \\$wnnna$aRevanil
=450  \\$wnnna$aRoche Brand of Lisuride Maleate
=450  \\$wnnna$aSchering Brand 1 of Lisuride Maleate
=450  \\$wnnna$aSchering Brand 2 of Lisuride Maleate
=550  \\$wg$aErgolines
=680  \\$iAn ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS).
=688  \\$a91(79); was see under ERGOLINES 1979-90
=750  \0$aLisuride$5IEN$0(DLC)sh 85077474

=LDR  00817cz  a2200181n  4500
=001  9880363747302441
=005  20141212202941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008089
=035  \\$aCBA1328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x100.$x500.$x500
=072  \\$aB3.$x510.$x460.$x400.$x410.$x485.$x500
=150  \\$aListeria monocytogenes
=550  \\$wg$aListeria
=667  \\$ainfection = LISTERIOSIS & do not bother to coord with L. monocytogenes
=680  \\$iA species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.
=750  \0$aListeria monocytogenes$5IEN$0(DLC)sh 88023278

=LDR  00851cz  a2200265n  4500
=001  9880363747402441
=005  20141212202941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008088
=035  \\$aCBA1327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x514
=150  \\$aListeriosis
=450  \\$wnnna$aInfection, Listeria
=450  \\$wnnna$aInfections, Listeria
=450  \\$wnnna$aListeria Infection
=450  \\$aListeria Infections
=450  \\$wnnna$aListerioses
=550  \\$wg$aGram-Positive Bacterial Infections
=550  \\$wh$aMeningitis, Listeria
=667  \\$aMENINGITIS, LISTERIA is available
=680  \\$iInfections with bacteria of the genus LISTERIA.
=688  \\$a2011(1966)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Listeria Infections
=750  \0$aListeriosis$0(DLC) sh 85077461$5IEN

=LDR  00783cz  a2200217n  4500
=001  9880363747502441
=005  20141212202941.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008087
=035  \\$aCBA1326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x100.$x500
=072  \\$aB3.$x510.$x460.$x400.$x410.$x485
=150  \\$aListeria
=550  \\$wg$aBacillales
=550  \\$wg$aGram-Positive Asporogenous Rods, Regular
=550  \\$wh$aListeria monocytogenes
=667  \\$ain feces, on plants, in silage
=680  \\$iA genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage. Its species are parasitic on cold-blooded and warm-blooded animals, including man.
=688  \\$a76
=750  \0$aListeria$5IEN$0(DLC)sh 88023277

=LDR  00956cz  a2200301n  4500
=001  9880363747602441
=005  20141212202940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008085
=035  \\$aCBA1324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x200.$x432
=072  \\$aL1.$x143.$x506.$x423.$x348
=150  \\$aLipreading
=450  \\$wnnna$aLip Reading
=450  \\$wnnna$aLip Readings
=450  \\$wnnna$aLipreadings
=450  \\$wnnna$aReading, Lip
=450  \\$wnnna$aReadings, Lip
=450  \\$aSpeechreading
=450  \\$wnnna$aSpeechreadings
=550  \\$wg$aCorrection of Hearing Impairment
=550  \\$wg$aLanguage Arts
=550  \\$aDeafness
=667  \\$ano qualif
=680  \\$iThe process by which an observer comprehends speech by watching the movements of the speaker's lips without hearing the speaker's voice.
=688  \\$a77; was LIP READING 1963-76
=750  \0$aLipreading$5IEN$0(DLC)sh 85077319

=LDR  01423cz  a2200325n  4500
=001  9880363747702441
=005  20141212202940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008083
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x935.$x480
=072  \\$aD6.$x472.$x699.$x631.$x525.$x600.$x480
=072  \\$aD12.$x644.$x400.$x400.$x935.$x480
=072  \\$aD12.$x644.$x548.$x365.$x935.$x480
=072  \\$aD12.$x644.$x548.$x691.$x525.$x690.$x480
=072  \\$aD12.$x776.$x641.$x650.$x405.$x935.$x480
=150  \\$abeta-Lipotropin
=450  \\$wnnna$aAdipozin
=450  \\$wnnna$abeta-Lipotrophin
=450  \\$wnnna$abeta Lipotrophin
=450  \\$wnnna$abeta Lipotropin
=450  \\$wnnna$abeta-LPH
=450  \\$wnnna$abeta LPH
=450  \\$aLipotropin
=550  \\$wg$aPro-Opiomelanocortin
=680  \\$iA 90-amino acid peptide derived from post-translational processing of pro-opiomelanocortin (POMC) in the PITUITARY GLAND and the HYPOTHALAMUS. It is the C-terminal fragment of POMC with lipid-mobilizing activities, such as LIPOLYSIS and steroidogenesis. Depending on the species and the tissue sites, beta-LPH may be further processed to yield active peptides including GAMMA-LIPOTROPIN; BETA-MSH; and ENDORPHINS.
=688  \\$a2007(1965)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Lipotropin
=688  \\$a74(65)
=750  \0$aLipotropin$0(DLC) sh 85077315$5IEN

=LDR  01096cz  a2200301n  4500
=001  9880363747802441
=005  20141212202939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008082
=035  \\$aCBA1321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186.$x71.$x601
=072  \\$aD27.$x505.$x954.$x483.$x680
=072  \\$aD27.$x505.$x954.$x557.$x500.$x601
=150  \\$aLipotropic Agents
=450  \\$wnnna$aAgents, Lipotropic
=450  \\$wnnna$aDrugs, Lipotropic
=450  \\$wnnna$aFactors, Lipotropic
=450  \\$wnnna$aLipocaic
=450  \\$wnnna$aLipotropic Drugs
=450  \\$aLipotropic Factors
=450  \\$wnnna$aLipotropics
=550  \\$wg$aGastrointestinal Agents
=550  \\$wg$aHypolipidemic Agents
=550  \\$wh$aLipoprotein Lipase Activators
=680  \\$iEndogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues.
=688  \\$a96; was LIPOTROPIC FACTORS 1963-95
=750  \0$aLipotropic agents$5IEN$0(DLC)sh 85077314

=LDR  01690cz  a2200421n  4500
=001  9880363747902441
=005  20141212192259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008081
=035  \\$aCBA1320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x479.$x517
=072  \\$aD26.$x255.$x260.$x517
=072  \\$aJ1.$x637.$x51.$x479.$x517
=072  \\$aJ1.$x637.$x87.$x500.$x517
=150  \\$aLiposomes
=450  \\$wnnna$aLiposome
=450  \\$wnnna$aLiposome, Ultra-deformable
=450  \\$wnnna$aLiposome, Ultradeformable
=450  \\$wnnna$aLiposomes, Ultra-deformable
=450  \\$wnnna$aLiposomes, Ultra deformable
=450  \\$wnnna$aLiposomes, Ultradeformable
=450  \\$wnnna$aNiosome
=450  \\$aNiosomes
=450  \\$wnnna$aTransferosome
=450  \\$aTransferosomes
=450  \\$wnnna$aUltra-deformable Liposome
=450  \\$wnnna$aUltra-deformable Liposomes
=450  \\$wnnna$aUltradeformable Liposome
=450  \\$aUltradeformable Liposomes
=550  \\$wg$aDrug Carriers
=550  \\$wg$aMembranes, Artificial
=550  \\$wh$aUnilamellar Liposomes
=550  \\$aLipid Bilayers
=667  \\$awhen used as a vehicle in drug therapy, index specific drug / admin (IM) + LIPOSOMES (NIM without qualifiers); differentiate from LIPID DROPLETS which are organelles
=680  \\$iArtificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.
=688  \\$a73
=750  \0$aLiposomes$0(DLC) 85077311$5IEN

=LDR  01474cz  a2200313n  4500
=001  9880363748002441
=005  20141212202939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008080
=035  \\$aCBA1319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x550.$x420
=072  \\$aC4.$x557.$x450.$x795.$x465
=150  \\$aLiposarcoma
=450  \\$wnnna$aDedifferentiated Liposarcoma
=450  \\$wnnna$aDedifferentiated Liposarcomas
=450  \\$aLiposarcoma, Dedifferentiated
=450  \\$aLiposarcoma, Pleomorphic
=450  \\$wnnna$aLiposarcomas
=450  \\$wnnna$aLiposarcomas, Dedifferentiated
=450  \\$wnnna$aLiposarcomas, Pleomorphic
=450  \\$wnnna$aPleomorphic Liposarcoma
=450  \\$wnnna$aPleomorphic Liposarcomas
=550  \\$wg$aNeoplasms, Adipose Tissue
=550  \\$wg$aSarcoma
=550  \\$wh$aLiposarcoma, Myxoid
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)
=750  \0$aLiposarcoma$5IEN$0(DLC)sh 88002663

=LDR  01605cz  a2200409n  4500
=001  9880363748102441
=005  20141212202938.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008077
=035  \\$aCBA1315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x515
=072  \\$aD12.$x776.$x521.$x550
=150  \\$aLipoproteins, LDL
=450  \\$abeta-Lipoproteins
=450  \\$wnnna$abeta Lipoproteins
=450  \\$wnnna$aLDL(1)
=450  \\$wnnna$aLDL-1
=450  \\$wnnna$aLDL(2)
=450  \\$wnnna$aLDL-2
=450  \\$wnnna$aLDL Lipoproteins
=450  \\$wnnna$aLDL1
=450  \\$wnnna$aLDL2
=450  \\$wnnna$aLipoproteins, Low-Density
=450  \\$wnnna$aLow-Density Lipoprotein 1
=450  \\$wnnna$aLow Density Lipoprotein 1
=450  \\$wnnna$aLow-Density Lipoprotein 2
=450  \\$wnnna$aLow Density Lipoprotein 2
=450  \\$aLow-Density Lipoproteins
=450  \\$wnnna$aLow Density Lipoproteins
=550  \\$wg$aLipoproteins
=550  \\$wh$aCholesterol, LDL
=550  \\$aReceptors, LDL
=667  \\$a/defic: consider also HYPOBETALIPOPROTEINEMIAS
=680  \\$iA class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues.
=688  \\$a74(72)
=750  \0$aLow density lipoproteins$0(DLC) sh 89003534$5IEN

=LDR  01928cz  a2200361n  4500
=001  9880363748202441
=005  20141212202937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008075
=035  \\$aCBA1313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x432
=072  \\$aD12.$x776.$x521.$x479
=150  \\$aLipoproteins, HDL
=450  \\$wnnna$aalpha-1 Lipoprotein
=450  \\$aalpha-Lipoproteins
=450  \\$wnnna$aalpha Lipoproteins
=450  \\$wnnna$aHDL Lipoproteins
=450  \\$wnnna$aHeavy Lipoproteins
=450  \\$aHigh-Density Lipoproteins
=450  \\$wnnna$aHigh Density Lipoproteins
=450  \\$wnnna$aLipoproteins, Heavy
=450  \\$wnnna$aLipoproteins, High-Density
=550  \\$wg$aLipoproteins
=550  \\$wh$aCholesterol, HDL
=550  \\$wh$aHigh-Density Lipoproteins, Pre-beta
=550  \\$wh$aLipoproteins, HDL2
=550  \\$wh$aLipoproteins, HDL3
=550  \\$aTangier Disease
=667  \\$ahyperalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPERLIPOPROTEINEMIAS (IM); hypoalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPOLIPOPROTEINEMIAS (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; /defic: consider also HYPOLIPOPROTEINEMIAS
=680  \\$iA class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
=688  \\$a74(72)
=750  \0$aHigh density lipoproteins$0(DLC) sh 85060667$5IEN

=LDR  01715cz  a2200397n  4500
=001  9880363748302441
=005  20180223093739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008074
=035  \\$aCBA1312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532
=072  \\$aD12.$x776.$x521
=150  \\$aLipoproteins
=450  \\$wnnna$aCirculating Lipoproteins
=450  \\$wnnna$aLipoprotein
=450  \\$wnnna$aLipoproteins, Circulating
=550  \\$wg$aLipids
=550  \\$wg$aProteins
=550  \\$wh$aApolipoproteins
=550  \\$wh$aATP Binding Cassette Transporter, Sub-Family G, Member 5
=550  \\$wh$aATP Binding Cassette Transporter, Sub-Family G, Member 8
=550  \\$wh$aChylomicrons
=550  \\$wh$aLipoprotein(a)
=550  \\$wh$aLipoprotein-X
=550  \\$wh$aLipoproteins, HDL
=550  \\$wh$aLipoproteins, IDL
=550  \\$wh$aLipoproteins, LDL
=550  \\$wh$aLipoproteins, VLDL
=550  \\$aHyperlipoproteinemias
=550  \\$aHypolipoproteinemias
=550  \\$aLipid-Linked Proteins
=550  \\$aProteolipids
=667  \\$ageneral or unspecified; prefer specifics; /blood: consider also HYPERLIPOPROTEINEMIA; /defic: consider also HYPOLIPOPROTEINEMIAS & specifics; do not confuse with PROTEOLIPIDS or LIPID-LINKED PROTEINS
=680  \\$iLipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.
=750  \0$aLipoproteins$0(DLC) sh 85077309$5IEN

=LDR  01978cz  a2200421n  4500
=001  9880363748402441
=005  20141212202933.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008071
=035  \\$aCBA1309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x430
=150  \\$aLipoprotein Lipase
=450  \\$wnnna$aDiacylglycerol Lipase
=450  \\$wnnna$aDiglyceride Lipase
=450  \\$wnnna$aFactor, Heparin-Clearing
=450  \\$wnnna$aFactor, Lipemia-Clearing
=450  \\$aHeparin-Clearing Factor
=450  \\$wnnna$aHeparin Clearing Factor
=450  \\$wnnna$aLipase, Diacylglycerol
=450  \\$wnnna$aLipase, Diglyceride
=450  \\$wnnna$aLipase, Lipoprotein
=450  \\$wnnna$aLipase, Post-Heparin
=450  \\$wnnna$aLipase, Postheparin
=450  \\$wnnna$aLipase, Postheparin Lipoprotein
=450  \\$aLipemia-Clearing Factor
=450  \\$wnnna$aLipemia Clearing Factor
=450  \\$wnnna$aLipoprotein Lipase, Postheparin
=450  \\$wnnna$aPost-Heparin Lipase
=450  \\$wnnna$aPost Heparin Lipase
=450  \\$wnnna$aPostheparin Lipase
=450  \\$wnnna$aPostheparin Lipoprotein Lipase
=550  \\$wg$aCarboxylic Ester Hydrolases
=550  \\$aHyperlipoproteinemia Type I
=667  \\$a/defic: consider also HYPERLIPOPROTEINEMIA TYPE I
=680  \\$iAn enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34.
=688  \\$aHEPARIN-CLEARING FACTOR & LIPEMIA-CLEARING FACTOR were see under LIPOPROTEIN LIPASE 1963-80
=750  \0$aLipoprotein lipase$0(DLC) sh 85077308$5IEN

=LDR  01432cz  a2200409n  4500
=001  9880363748502441
=005  20141212202931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008067
=035  \\$aCBA1305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x550.$x400
=150  \\$aLipoma
=450  \\$wnnna$aAtypical Lipoma
=450  \\$wnnna$aAtypical Lipomas
=450  \\$aFatty Tumor
=450  \\$wnnna$aFatty Tumors
=450  \\$aHibernoma
=450  \\$wnnna$aHibernomas
=450  \\$wnnna$aLipoma, Atypical
=450  \\$aLipoma, Pleomorphic
=450  \\$wnnna$aLipomas
=450  \\$wnnna$aLipomas, Atypical
=450  \\$wnnna$aLipomas, Pleomorphic
=450  \\$wnnna$aLipomata
=450  \\$wnnna$aLipomatas
=450  \\$wnnna$aLipomatosis, Multiple
=450  \\$wnnna$aPleomorphic Lipoma
=450  \\$wnnna$aPleomorphic Lipomas
=450  \\$wnnna$aTumor, Fatty
=450  \\$wnnna$aTumors, Fatty
=550  \\$wg$aNeoplasms, Adipose Tissue
=550  \\$wh$aLipoblastoma
=667  \\$asolitary neoplastic; for non-neoplastic see LIPOMATOSIS; coordinate IM with precoordinated organ/neoplasm term (IM)
=680  \\$iA benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.
=688  \\$aFATTY TUMOR was heading 1963-67
=750  \0$aAdipose tissues$xTumors$5IEN$0(DLC)sh 85000880

=LDR  01041cz  a2200229n  4500
=001  9880363748602441
=005  20170608145209.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008066
=035  \\$aCBA1304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x534
=072  \\$aG3.$x458.$x500
=150  \\$aLipolysis
=450  \\$wnnna$aLipolyses
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aLipid Metabolism
=550  \\$wh$aLipid Mobilization
=667  \\$ametabolic only: not for "suction lipolysis" of adipose tissue ( = LIPOLYSIS, SUCTION see LIPECTOMY)
=680  \\$iThe metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues.
=688  \\$a80
=750  \0$aLipolysis$5IEN$0(DLC)sh 85077305

=LDR  01254cz  a2200313n  4500
=001  9880363748702441
=005  20141212202930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008064
=035  \\$aCBA1302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x398.$x641
=072  \\$aC18.$x452.$x584.$x687
=072  \\$aC18.$x452.$x648.$x398.$x641
=150  \\$aLipidoses
=450  \\$aLipidosis
=450  \\$aLipoidosis
=550  \\$wg$aLipid Metabolism Disorders
=550  \\$wg$aLipid Metabolism, Inborn Errors
=550  \\$wh$aCholesterol Ester Storage Disease
=550  \\$wh$aNeuronal Ceroid-Lipofuscinoses
=550  \\$wh$aSjogren-Larsson Syndrome
=550  \\$wh$aSphingolipidoses
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iConditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
=688  \\$a2007 (1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Lipoidosis
=688  \\$aAMAUROTIC FAMILIAL IDIOCY was heading 1963-84
=750  \0$aLipidoses$0(DLC) sh 85077295$5IEN

=LDR  04644cz  a2201273n  4500
=001  9880363748802441
=005  20141212202930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008063
=035  \\$aCBA1301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x803
=072  \\$aD2.$x886.$x778.$x827
=072  \\$aD8.$x211.$x906
=072  \\$aD10.$x251.$x941
=150  \\$aThioctic Acid
=450  \\$wnnna$aAcid, alpha-Lipoic
=450  \\$wnnna$aAliud Brand of Thioctic Acid
=450  \\$wnnna$aAlpha-Lipogamma
=450  \\$wnnna$aAlpha Lipogamma
=450  \\$wnnna$aalpha-Lipoic Acid
=450  \\$wnnna$aalpha Lipoic Acid
=450  \\$wnnna$aAlpha-Lipon Stada
=450  \\$wnnna$aAlpha Lipon Stada
=450  \\$wnnna$aalpha-Liponaure Heumann
=450  \\$wnnna$aalpha Liponaure Heumann
=450  \\$wnnna$aAlpha-Liponsaure Sofotec
=450  \\$wnnna$aAlpha Liponsaure Sofotec
=450  \\$wnnna$aalpha-Liponsaure von ct
=450  \\$wnnna$aalpha Liponsaure von ct
=450  \\$wnnna$aAlpha-Lippon AL
=450  \\$wnnna$aAlpha Lippon AL
=450  \\$wnnna$aalpha-Vibolex
=450  \\$wnnna$aalpha Vibolex
=450  \\$wnnna$aAlphaflam
=450  \\$wnnna$aAlphaLipogamma
=450  \\$wnnna$aAlphaLipon Stada
=450  \\$wnnna$aalphaLiponaure Heumann
=450  \\$wnnna$aAlphaLiponsaure Sofotec
=450  \\$wnnna$aalphaLiponsaure von ct
=450  \\$wnnna$aAlphaLippon AL
=450  \\$wnnna$aalphaVibolex
=450  \\$wnnna$aAzulipont
=450  \\$wnnna$aAzupharma Brand of Thioctic Acid
=450  \\$wnnna$abiomo Brand of Thioctic Acid
=450  \\$wnnna$abiomo-lipon
=450  \\$wnnna$abiomo lipon
=450  \\$wnnna$abiomolipon
=450  \\$wnnna$act-Arzneimittel Brand of Thioctic Acid
=450  \\$wnnna$act Arzneimittel Brand of Thioctic Acid
=450  \\$wnnna$aduralipon
=450  \\$wnnna$aespa-lipon
=450  \\$wnnna$aespa lipon
=450  \\$wnnna$aespalipon
=450  \\$wnnna$aesparma Brand of Thioctic Acid
=450  \\$wnnna$aFenint
=450  \\$wnnna$aGenerosan Brand of Thioctic Acid
=450  \\$wnnna$aHeumann Brand of Thioctic Acid
=450  \\$wnnna$aHexal Brand of Thioctic Acid
=450  \\$wnnna$aIlla Brand of Thioctic Acid
=450  \\$wnnna$aIlla Brand of Thioctic Acid Tromethamine
=450  \\$wnnna$aInjekt, Thiogamma
=450  \\$wnnna$aJuta Brand of Thioctic Acid
=450  \\$wnnna$aJuthiac
=450  \\$wnnna$aLichtenstein Brand of Thioctic Acid
=450  \\$aLipoic Acid
=450  \\$wnnna$aLiponsaure-ratiopharm
=450  \\$wnnna$aLiponsaure ratiopharm
=450  \\$wnnna$aLiponsaureratiopharm
=450  \\$wnnna$aMerck dura Brand of Thioctic Acid
=450  \\$wnnna$aMTW-Alphaliponsaure
=450  \\$wnnna$aMTW Alphaliponsaure
=450  \\$wnnna$aMTW Brand of Thioctic Acid
=450  \\$wnnna$aMTWAlphaliponsaure
=450  \\$wnnna$aNeurium
=450  \\$wnnna$aPharmacia Brand of Thioctic Acid
=450  \\$wnnna$aPleomix-Alpha
=450  \\$wnnna$aPleomix Alpha
=450  \\$wnnna$aPleomix-Alpha N
=450  \\$wnnna$aPleomix Alpha N
=450  \\$wnnna$aPleomixAlpha
=450  \\$wnnna$aPleomixAlpha N
=450  \\$wnnna$aQ-Pharm Brand of Thioctic Acid
=450  \\$wnnna$aQ Pharm Brand of Thioctic Acid
=450  \\$wnnna$aratiopharm Brand of Thioctic Acid
=450  \\$wnnna$aRosen Brand of Thioctic Acid
=450  \\$wnnna$aSofotec Brand of Thioctic Acid
=450  \\$wnnna$aStadapharm Brand of Thioctic Acid
=450  \\$wnnna$aThioctacid
=450  \\$wnnna$aThioctacide T
=450  \\$wnnna$aThiogamma Injekt
=450  \\$wnnna$aThiogamma oral
=450  \\$wnnna$aTromlipon
=450  \\$wnnna$aTrommsdorgg Brand of Thioctic Acid
=450  \\$wnnna$aVerla Brand of Thioctic Acid
=450  \\$wnnna$aVerla-Lipon
=450  \\$wnnna$aVerla Lipon
=450  \\$wnnna$aVerlaLipon
=450  \\$wnnna$aViatris Brand of Thioctic Acid
=450  \\$wnnna$aViatris Brand of Thioctic Acid Tromethamine
=450  \\$wnnna$aWorwag Brand of Thioctic Acid
=450  \\$wnnna$aWorwag Brand of Thioctic Acid Meglumine
=550  \\$wg$aCarboxylic Acids
=550  \\$wg$aCoenzymes
=550  \\$wg$aFatty Acids
=550  \\$wg$aThiophenes
=680  \\$iAn octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
=688  \\$a91; was LIPOIC ACID 1963-90
=750  \0$aLipoic acid$5IEN-M$0(DLC)sh 96009518

=LDR  00708cz  a2200205n  4500
=001  9880363748902441
=005  20141212202928.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008062
=035  \\$aCBA1300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x460
=072  \\$aD23.$x767.$x550
=150  \\$aLipofuscin
=550  \\$wg$aLipids
=550  \\$wg$aPigments, Biological
=667  \\$aa lipid pigment
=680  \\$iA naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age.
=688  \\$a91(75); was see under PIGMENTS 1975-90
=750  \0$aLipofuscins$5IEN$0(DLC)sh 85077304

=LDR  01199cz  a2200277n  4500
=001  9880363749002441
=005  20141212202928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008061
=035  \\$aCBA1299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x137.$x631
=072  \\$aC6.$x405.$x469.$x637.$x925
=072  \\$aC18.$x452.$x603.$x925
=150  \\$aWhipple Disease
=450  \\$wnnna$aDisease, Whipple
=450  \\$wnnna$aDisease, Whipple's
=450  \\$wnnna$aIntestinal Lipodystrophy
=450  \\$aLipodystrophy, Intestinal
=450  \\$aWhipple's Disease
=450  \\$wnnna$aWhipples Disease
=550  \\$wg$aActinomycosis
=550  \\$wg$aMalabsorption Syndromes
=680  \\$iA chronic systemic infection by a gram-positive bacterium, Tropheryma whippelii, mainly affecting the SMALL INTESTINE but also the JOINTS; CARDIOVASCULAR SYSTEM; and the CENTRAL NERVOUS SYSTEM. The disease is characterized by fat deposits in the INTESTINAL MUCOSA and LYMPH NODES, malabsorption, DIARRHEA with fatty stools, MALNUTRITION, and ARTHRITIS.
=688  \\$a2004 (1996); use LIPODYSTROPHY, INTESTINAL 1963-1995
=750  \0$aWhipple's disease$5IEN$0(DLC)sh 86008042

=LDR  01555cz  a2200373n  4500
=001  9880363749102441
=005  20141212202925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008055
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10
=150  \\$aLipids
=550  \\$wh$aCeroid
=550  \\$wh$aFats
=550  \\$wh$aFatty Acids
=550  \\$wh$aFatty Alcohols
=550  \\$wh$aGlycerides
=550  \\$wh$aGlycolipids
=550  \\$wh$aLipid Peroxides
=550  \\$wh$aLipofuscin
=550  \\$wh$aLipopeptides
=550  \\$wh$aLipopolysaccharides
=550  \\$wh$aLipoproteins
=550  \\$wh$aMembrane Lipids
=550  \\$wh$aOils
=550  \\$wh$aPhospholipids
=550  \\$wh$aPolyhydroxyalkanoates
=550  \\$wh$aSphingolipids
=550  \\$wh$aSterols
=550  \\$wh$aWaxes
=667  \\$aGEN or unspecified only: prefer specifics; differentiate from FATS ("outside the body"); /blood: consider also HYPERLIPIDEMIAS & specifics; dyslipidemia, especially in foreign lit, is probably HYPERLIPIDEMIAS or its specifics; DIETARY FATS is also available
=680  \\$iA generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65
=750  \0$aLipids$5IEN$0(DLC)sh 85077296

=LDR  00715cz  a2200229n  4500
=001  9880363749202441
=005  20170608144902.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015227
=035  \\$aCBA1291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x515
=072  \\$aG3.$x295.$x531.$x587
=150  \\$aLipid Peroxidation
=450  \\$wnnna$aLipid Peroxidations
=450  \\$wnnna$aPeroxidation, Lipid
=450  \\$wnnna$aPeroxidations, Lipid
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aOxidation-Reduction
=680  \\$iPeroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor.
=688  \\$a89
=750  \0$aLipids$xPeroxidation$5IEN$0(IEN)369023

=LDR  00842cz  a2200253n  4500
=001  9880363749302441
=005  20141212202923.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008051
=035  \\$aCBA1288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x510
=072  \\$aJ1.$x637.$x87.$x500.$x510
=150  \\$aLipid Bilayers
=450  \\$wnnna$aBilayer, Lipid
=450  \\$aBilayer Lipid Membranes$5IEN
=450  \\$aBilayers, Lipid
=450  \\$wnnna$aLipid Bilayer
=550  \\$wg$aMembrane Lipids
=550  \\$wg$aMembranes, Artificial
=667  \\$acoord IM with specific lipid (IM or NIM)
=680  \\$iLayers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes.
=688  \\$a80
=750  \0$aBilayer lipid membranes$5IEN$0(DLC)sh 85014002

=LDR  01528cz  a2200469n  4500
=001  9880363749402441
=005  20141212210908.0
=008  880419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015187
=035  \\$aCBA1286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x65.$x62.$x937
=072  \\$aE2.$x218.$x530
=072  \\$aE4.$x62.$x937
=072  \\$aE4.$x680.$x450
=150  \\$aLipectomy
=450  \\$wnnna$aAspiration Lipectomies
=450  \\$aAspiration Lipectomy
=450  \\$wnnna$aAspiration Lipolysis
=450  \\$wnnna$aLipectomies
=450  \\$wnnna$aLipectomies, Aspiration
=450  \\$wnnna$aLipectomies, Suction
=450  \\$wnnna$aLipectomy, Aspiration
=450  \\$wnnna$aLipectomy, Suction
=450  \\$wnnna$aLipolysis, Aspiration
=450  \\$aLipolysis, Suction
=450  \\$wnnna$aLipoplasties
=450  \\$wnnna$aLipoplasty
=450  \\$aLiposuction
=450  \\$wnnna$aLiposuctions
=450  \\$wnnna$aSuction Lipectomies
=450  \\$aSuction Lipectomy
=450  \\$wnnna$aSuction Lipolysis
=550  \\$wg$aBariatric Surgery
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$aAdipose Tissue
=550  \\$aObesity
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRemoval of localized SUBCUTANEOUS FAT deposits by SUCTION CURETTAGE or blunt CANNULATION in the cosmetic correction of OBESITY and other esthetic contour defects.
=688  \\$a89
=750  \0$aLipectomy$5IEN$0(DLC)sh 85077291

=LDR  01865cz  a2200493n  4500
=001  9880363749502441
=005  20141212202923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008049
=035  \\$aCBA1285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x400
=150  \\$aLipase
=450  \\$wnnna$aA, Acid Lipase
=450  \\$wnnna$aAcid Lipase
=450  \\$wnnna$aAcid Lipase A
=450  \\$wnnna$aAcid Lipase B
=450  \\$wnnna$aAcid Lipase I
=450  \\$wnnna$aAcid Lipase II
=450  \\$wnnna$aB, Acid Lipase
=450  \\$wnnna$aExolipase
=450  \\$wnnna$aHydrolase, Triacylglycerol
=450  \\$wnnna$aHydrolase, Triolean
=450  \\$wnnna$aI, Acid Lipase
=450  \\$wnnna$aII, Acid Lipase
=450  \\$wnnna$aLipase A, Acid
=450  \\$wnnna$aLipase, Acid
=450  \\$wnnna$aLipase B, Acid
=450  \\$wnnna$aLipase I, Acid
=450  \\$wnnna$aLipase II, Acid
=450  \\$wnnna$aLipase, Monoester
=450  \\$wnnna$aLipase, Triglyceride
=450  \\$wnnna$aMonoester Lipase
=450  \\$wnnna$aTriacylglycerol Hydrolase
=450  \\$aTriacylglycerol Lipase
=450  \\$aTributyrinase
=450  \\$wnnna$aTriglyceridase
=450  \\$aTriglyceride Lipase
=450  \\$wnnna$aTriolean Hydrolase
=550  \\$wg$aCarboxylic Ester Hydrolases
=550  \\$wh$aPancrelipase
=667  \\$a/defic: consider also LIPID METABOLISM, INBORN ERRORS & CHOLESTEROL ESTER STORAGE DISEASE & WOLMAN DISEASE; LIPOPROTEIN LIPASE is also available
=680  \\$iAn enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3.
=750  \0$aLipase$5IEN$0(DLC)sh 85077289

=LDR  00957cz  a2200325n  4500
=001  9880363749602441
=005  20141212202922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008048
=035  \\$aCBA1284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591.$x550
=072  \\$aC7.$x465.$x409.$x640
=072  \\$aC7.$x465.$x565.$x550
=150  \\$aLip Neoplasms
=450  \\$wnnna$aCancer, Lip
=450  \\$aCancer of Lip
=450  \\$wnnna$aCancer of the Lip
=450  \\$wnnna$aCancers, Lip
=450  \\$aLip Cancer
=450  \\$wnnna$aLip Cancers
=450  \\$wnnna$aLip Neoplasm
=450  \\$wnnna$aNeoplasm, Lip
=450  \\$wnnna$aNeoplasms, Lip
=550  \\$wg$aLip Diseases
=550  \\$wg$aMouth Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the LIP.
=750  \0$aLips$xCancer$5IEN-M$0(DLC)sh 85077322
=750  \0$aLips$xTumors$5IEN-HS$0(DLC)sh 85077324

=LDR  00661cz  a2200241n  4500
=001  9880363749702441
=005  20141212202922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008046
=035  \\$aCBA1282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x631.$x515
=072  \\$aA14.$x549.$x336
=150  \\$aLip
=450  \\$wnnna$aLips
=450  \\$aPhiltrum
=450  \\$wnnna$aPhiltrums
=550  \\$wg$aMouth
=550  \\$wh$aLabial Frenum
=667  \\$ainflammation = CHEILITIS
=680  \\$iEither of the two fleshy, full-blooded margins of the mouth.
=688  \\$a65; was LIPS 1963-64
=750  \0$aLips$5IEN$0(DLC)sh 85077320

=LDR  00676cz  a2200205n  4500
=001  9880363749802441
=005  20141212202922.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008045
=035  \\$aCBA1281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x600.$x500
=150  \\$aLions
=450  \\$wnnna$aLion
=450  \\$aPanthera leo
=550  \\$wg$aPanthera
=667  \\$aIM; qualif permitted
=680  \\$iLarge, chiefly nocturnal mammals of the cat family FELIDAE, species Panthera leo. They are found in Africa and southern Asia.
=688  \\$a91(75); was see under CARNIVORA 1975-90
=750  \0$aLion$5IEN$0(DLC)sh 85077276

=LDR  00935cz  a2200253n  4500
=001  9880363749902441
=005  20141212202921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008043
=035  \\$aCBA1279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x507.$x550
=072  \\$aD10.$x627.$x700.$x615
=072  \\$aD20.$x215.$x784.$x750.$x615
=150  \\$aLinseed Oil
=450  \\$aFlaxseed Oil
=450  \\$wnnna$aOil, Flaxseed
=450  \\$wnnna$aOil, Linseed
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=667  \\$aD25-26 qualif
=680  \\$iThe fixed oil obtained from the dried ripe seed of linseed, Linum usitatissimum (L. Linaceae). It is used as an emollient in liniments, pastes, and medicinal soaps, and in veterinary medicine as a laxative. It is also called flaxseed oil. (Dorland, 28th ed)
=688  \\$a87; was LINSEED 1963-86
=750  \0$aLinseed-oil$5IEN$0(DLC)sh 85077257

=LDR  00782cz  a2200217n  4500
=001  9880363750002441
=005  20141212202921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x310.$x640
=072  \\$aD10.$x251.$x355.$x450
=150  \\$aLinolenic Acids
=550  \\$wg$aFatty Acids, Essential
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wh$aalpha-Linolenic Acid
=550  \\$wh$agamma-Linolenic Acid
=667  \\$ado not confuse with LINOLEIC ACIDS
=680  \\$iEighteen-carbon essential fatty acids that contain three double bonds.
=688  \\$a75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72
=750  \0$aLinolenic acids$5IEN-M$0(DLC)sh 92003722

=LDR  01105cz  a2200325n  4500
=001  9880363750102441
=005  20141212202920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008040
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x540
=150  \\$aGenetic Linkage
=450  \\$wnnna$aAnalyses, Genetic Linkage
=450  \\$wnnna$aAnalysis, Genetic Linkage
=450  \\$wnnna$aGenetic Linkage Analyses
=450  \\$wnnna$aGenetic Linkage Analysis
=450  \\$wnnna$aLinkage Analyses, Genetic
=450  \\$wnnna$aLinkage Analysis, Genetic
=450  \\$wnnna$aLinkage, Genetic
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aLinkage Disequilibrium
=550  \\$wh$aLod Score
=550  \\$aGene Order
=550  \\$aGenotyping Techniques
=550  \\$aSynteny
=680  \\$iThe co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.
=688  \\$a2011 (1970)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Linkage (Genetics)
=688  \\$a73(70)
=750  \0$aLinkage (Genetics)$0(DLC) sh 85077241$5IEN

=LDR  01227cz  a2200253n  4500
=001  9880363750202441
=005  20141212202920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008037
=035  \\$aCBA1273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598
=150  \\$aLinguistics
=450  \\$wnnna$aLinguistic
=550  \\$wg$aLanguage
=550  \\$wh$aPhonetics
=550  \\$wh$aPsycholinguistics
=550  \\$wh$aSemantics
=550  \\$wh$aTerminology as Topic
=550  \\$wh$aVocabulary
=667  \\$a= science of LANGUAGE & SPEECH; do not confuse with LANGUAGE (what is spoken), SEMANTICS (hist or psychol study of language & meaning changes), NOMENCLATURE (names of things & etymology, the origin or words), PHONETICS (how words are sounded), LITERATURE (literary works), PHILOLOGY (study of literature or language as used in literature) or VOCABULARY (a person's stock of words); grammar, syntax, accent go here; SPEC: SPEC qualif
=680  \\$iThe science of language, including phonetics, phonology, morphology, syntax, semantics, pragmatics, and historical linguistics. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a67(65)
=750  \0$aLinguistics$5IEN$0(DLC)sh 85077222

=LDR  00545cz  a2200205n  4500
=001  9880363750302441
=005  20141212202919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008035
=035  \\$aCBA1271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x885.$x431
=072  \\$aA14.$x549.$x885.$x431
=150  \\$aLingual Frenum
=450  \\$aFrenum, Lingual
=450  \\$wnnna$aFrenums, Lingual
=450  \\$wnnna$aLingual Frenums
=550  \\$wg$aTongue
=688  \\$a65
=750  \0$aLingual frenum$5IEN$0(DLC)sh 85077212

=LDR  01248cz  a2200337n  4500
=001  9880363750402441
=005  20141212202919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008034
=035  \\$aCBA1270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x773.$x532.$x500
=072  \\$aD9.$x408.$x471.$x500
=150  \\$aLincomycin
=450  \\$wnnna$aEpilincomycin
=450  \\$wnnna$aHemihydrate Lincomycin Monohydrochloride
=450  \\$wnnna$aLincocin
=450  \\$aLincolnensin
=450  \\$aLincomycin, (2S-cis)-Isomer
=450  \\$wnnna$aLincomycin A
=450  \\$wnnna$aLincomycin Hydrochloride
=450  \\$wnnna$aLincomycin, (L-threo)-Isomer
=450  \\$wnnna$aLincomycin Monohydrochloride
=450  \\$wnnna$aLincomycin Monohydrochloride, (2S-cis)-Isomer
=450  \\$wnnna$aLincomycin Monohydrochloride, Hemihydrate
=450  \\$wnnna$aLincomycin Monohydrochloride, (L-threo)-Isomer
=550  \\$wg$aLincosamides
=550  \\$wh$aClindamycin
=680  \\$iAn antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
=688  \\$a66(64)
=750  \0$aLincomycin$5IEN$0(DLC)sh 85077140

=LDR  01260cz  a2200313n  4500
=001  9880363750502441
=005  20141212202918.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008033
=035  \\$aCBA1269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x470
=072  \\$aE1.$x370.$x225.$x875.$x150.$x570
=072  \\$aE5.$x91.$x570
=072  \\$aE5.$x200.$x124.$x470
=072  \\$aE5.$x200.$x875.$x150.$x570
=150  \\$aLimulus Test
=450  \\$wnnna$aLimulus Tests
=450  \\$wnnna$aTest, Limulus
=450  \\$wnnna$aTests, Limulus
=550  \\$wg$aBacteriological Techniques
=550  \\$wg$aBiological Assay
=550  \\$wg$aClinical Chemistry Tests
=550  \\$aEndotoxins
=550  \\$aHorseshoe Crabs
=667  \\$afor detection of bact endotoxins using horseshoe crab blood
=680  \\$iSensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate (LAL), prepared from the circulating blood (amebocytes) of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals.
=688  \\$a78
=750  \0$aLimulus test$5IEN$0(DLC)sh 85077070

=LDR  01517cz  a2200313n  4500
=001  9880363750602441
=005  20141212202918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008032
=035  \\$aCBA1268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464
=150  \\$aLimbic System
=450  \\$wnnna$aLimbic Systems
=450  \\$wnnna$aSystem, Limbic
=450  \\$wnnna$aSystems, Limbic
=550  \\$wg$aBrain
=550  \\$wh$aAmygdala
=550  \\$wh$aEpithalamus
=550  \\$wh$aHippocampus
=550  \\$wh$aHypothalamus
=550  \\$wh$aLimbic Lobe
=550  \\$wh$aOlfactory Pathways
=550  \\$wh$aParahippocampal Gyrus
=550  \\$wh$aPerforant Pathway
=550  \\$wh$aSeptum of Brain
=550  \\$wh$aSubstantia Innominata
=680  \\$iA set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors (feeding, mating, emotion). For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation (see HIPPOCAMPUS); HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. (Parent, Carpenter's Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html (September 2, 1998)).
=750  \0$aLimbic system$5IEN$0(DLC)sh 85076998

=LDR  01039cz  a2200253n  4500
=001  9880363750702441
=005  20141212202918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008031
=035  \\$aCBA1267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x180.$x515
=072  \\$aD5.$x750.$x78.$x687
=072  \\$aD20.$x538
=072  \\$aD25.$x720.$x99.$x687
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x687
=150  \\$aLignin
=450  \\$wnnna$aLignins
=550  \\$wg$aBiopolymers
=550  \\$wg$aCellulose
=550  \\$wg$aComplex Mixtures
=667  \\$ado not confuse with LIGNANS; D25-26 qualif
=680  \\$iThe most abundant natural aromatic organic polymer found in all vascular plants. Lignin together with cellulose and hemicellulose are the major cell wall components of the fibers of all wood and grass species. Lignin is composed of coniferyl, p-coumaryl, and sinapyl alcohols in varying ratios in different plant species. (From Merck Index, 11th ed)
=750  \0$aLignin$5IEN$0(DLC)sh 85076945

=LDR  00874cz  a2200229n  4500
=001  9880363750802441
=005  20141212202917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008030
=035  \\$aCBA1265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x843
=072  \\$aG16.$x500.$x750.$x775.$x375
=072  \\$aN6.$x230.$x300.$x100.$x725.$x375
=150  \\$aLightning
=450  \\$wnnna$aLightnings
=550  \\$wg$aClimatic Processes
=550  \\$wg$aWeather
=550  \\$aElectricity
=667  \\$aadverse effects of lightning is probably LIGHTNING INJURIES
=680  \\$iAn abrupt high-current electric discharge that occurs in the ATMOSPHERE and that has a path length ranging from hundreds of feet to tens of miles. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aLightning$5IEN$0(DLC)sh 85076931

=LDR  00793cz  a2200193n  4500
=001  9880363750902441
=005  20141212202917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008029
=035  \\$aCBA1264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x410
=150  \\$aLighting
=450  \\$aIllumination
=550  \\$wg$aEnvironment, Controlled
=550  \\$aLight
=667  \\$athe environment: differentiate from LIGHT, a principle of physics; /adv eff permitted but do not confuse with LIGHT /adv eff
=680  \\$iThe illumination of an environment and the arrangement of lights to achieve an effect or optimal visibility. Its application is in domestic or in public settings and in medical and non-medical environments.
=750  \0$aLighting$5IEN$0(DLC)sh 85076925

=LDR  01293cz  a2200289n  4500
=001  9880363751002441
=005  20141212202917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008028
=035  \\$aCBA1263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x520.$x745
=072  \\$aE4.$x350.$x750
=072  \\$aE4.$x540.$x630
=150  \\$aLight Coagulation
=450  \\$wnnna$aCoagulation, Light
=450  \\$wnnna$aCoagulations, Light
=450  \\$wnnna$aLight Coagulations
=450  \\$aPhotocoagulation
=450  \\$wnnna$aPhotocoagulations
=550  \\$wg$aHemostasis, Surgical
=550  \\$wg$aHemostatic Techniques
=550  \\$wg$aOphthalmologic Surgical Procedures
=550  \\$wh$aLaser Coagulation
=667  \\$anon-ionizing; used predominantly in eye surg; do not confuse with LASER COAGULATION also used in ophthalmol surg; do not use /util except by MeSH definition; coord IM with Cat A or C term with /surg; DF: LIGHT COAG
=680  \\$iThe coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed)
=750  \0$aLight coagulation$5IEN$0(DLC)sh 85076890

=LDR  01693cz  a2200457n  4500
=001  9880363751102441
=005  20141212202916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008027
=035  \\$aCBA1262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650
=072  \\$aG1.$x590.$x540
=072  \\$aG1.$x750.$x250.$x650
=072  \\$aG1.$x750.$x770.$x578
=150  \\$aLight
=360  \\$iconsider also terms at$aPHOTIC$aPHOTO-
=450  \\$aLight, Visible
=450  \\$aPhotoradiation
=450  \\$wnnna$aPhotoradiations
=450  \\$aRadiation, Visible
=450  \\$wnnna$aRadiations, Visible
=450  \\$wnnna$aVisible Light
=450  \\$wnnna$aVisible Radiation
=450  \\$wnnna$aVisible Radiations
=550  \\$wg$aElectromagnetic Radiation
=550  \\$wg$aOptical Phenomena
=550  \\$wg$aRadiation, Nonionizing
=550  \\$wh$aColor
=550  \\$wh$aDarkness
=550  \\$wh$aGlare
=550  \\$wh$aIncandescence
=550  \\$wh$aInfrared Rays
=550  \\$wh$aLuminescence
=550  \\$wh$aPhotons
=550  \\$wh$aSunlight
=550  \\$wh$aUltraviolet Rays
=550  \\$aPhotobiology
=667  \\$adifferentiate from LIGHTING (the environment); light scattering = SCATTERING, RADIATION (IM) + LIGHT; LIGHT + PERIODICITY is not necessarily CIRCADIAN RHYTHM; luminance goes here or under LIGHTING but not under LUMINESCENCE, PHYSICAL; black light: index under INFRARED RAYS or ULTRAVIOLET RAYS depending on text but unspecified, index under ULTRAVIOLET RAYS
=680  \\$iThat portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range.
=750  \0$aLight$5IEN$0(DLC)sh 85076871

=LDR  00988cz  a2200265n  4500
=001  9880363751202441
=005  20141212202916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008025
=035  \\$aCBA1260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464
=150  \\$aLigases
=450  \\$wnnna$aSynthetase
=450  \\$aSynthetases
=550  \\$wg$aEnzymes
=550  \\$wh$aCarbon-Carbon Ligases
=550  \\$wh$aCarbon-Nitrogen Ligases
=550  \\$wh$aCarbon-Oxygen Ligases
=550  \\$wh$aCarbon-Sulfur Ligases
=550  \\$wh$aPolynucleotide Ligases
=550  \\$wh$aUbiquitin-Protein Ligase Complexes
=680  \\$iA class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. (Dorland, 28th ed) EC 6.
=688  \\$aCARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963
=750  \0$aLigases$5IEN$0(DLC)sh 85076869

=LDR  00965cz  a2200181n  4500
=001  9880363751302441
=005  20141212202915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008024
=035  \\$aCBA1259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x480
=150  \\$aLigands
=550  \\$wg$aLaboratory Chemicals
=667  \\$aIM for general only; usually NIM with specific cpd IM; no qualif
=680  \\$iA molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed)
=688  \\$a74(73)
=750  \0$aLigands$5IEN$0(DLC)sh 85076868

=LDR  00737cz  a2200217n  4500
=001  9880363751402441
=005  20160801095059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008022
=035  \\$aCBA1257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x513
=150  \\$aLigaments
=450  \\$wnnna$aLigament
=550  \\$wg$aMusculoskeletal System
=550  \\$wh$aBroad Ligament
=550  \\$wh$aLigaments, Articular
=550  \\$wh$aRound Ligaments
=667  \\$aIM; coord with site (IM); joint ligaments = LIGAMENTS, ARTICULAR
=680  \\$iShiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile.
=750  \0$aLigaments$5IEN$0(DLC)sh 85076865

=LDR  01257cz  a2200253n  4500
=001  9880363751502441
=005  20141212202914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008021
=035  \\$aCBA1256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x391
=150  \\$aLife Support Systems
=450  \\$wnnna$aLife Support System
=450  \\$wnnna$aSupport System, Life
=450  \\$wnnna$aSupport Systems, Life
=450  \\$wnnna$aSystem, Life Support
=450  \\$wnnna$aSystems, Life Support
=550  \\$wg$aEnvironment, Controlled
=550  \\$aIncubators
=667  \\$ado not confuse with LIFE SUPPORT CARE: read MeSH definition
=680  \\$iSystems that provide all or most of the items necessary for maintaining life and health. Provisions are made for the supplying of oxygen, food, water, temperature and pressure control, disposition of carbon dioxide and body waste. The milieu may be a spacecraft, a submarine, or the surface of the moon. In medical care, usually under hospital conditions, LIFE SUPPORT CARE is available. (From Webster's New Collegiate Dictionary)
=688  \\$a91(66); was see under SEALED CABIN ECOLOGY 1966-90
=750  \0$aLife support systems (Space environment)$5IEN-M$0(DLC)sh 85076850

=LDR  01130cz  a2200313n  4500
=001  9880363751602441
=005  20141212202914.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008020
=035  \\$aCBA1255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x440
=072  \\$aN2.$x421.$x585.$x440
=150  \\$aLife Support Care
=450  \\$wnnna$aCare, Life Support
=450  \\$aExtraordinary Treatment
=450  \\$wnnna$aExtraordinary Treatments
=450  \\$wnnna$aLife Prolongation
=450  \\$wnnna$aProlongation of Life
=450  \\$wnnna$aTreatment, Extraordinary
=450  \\$wnnna$aTreatments, Extraordinary
=550  \\$wg$aPatient Care
=550  \\$wh$aAdvanced Cardiac Life Support
=550  \\$wh$aAdvanced Trauma Life Support Care
=550  \\$aTerminal Care
=667  \\$aextraordinary measures in patient care: do not confuse with LIFE SUPPORT SYSTEMS which is non-med
=680  \\$iCare provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life.
=688  \\$a78
=750  \0$aLife support systems (Critical care)$5IEN-M$0(DLC)sh 85076849

=LDR  00879cz  a2200277n  4500
=001  9880363751702441
=005  20201023150857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008019
=035  \\$aCBA1254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x458
=150  \\$aLife Style
=450  \\$wnnna$aLife Style Induced Illness
=450  \\$wnnna$aLife Styles
=450  \\$wnnna$aLifestyle
=450  \\$wnnna$aLifestyles
=550  \\$wg$aPsychology, Social
=550  \\$wh$aHealthy Lifestyle
=550  \\$wh$aLife Change Events
=550  \\$wh$aSedentary Behavior
=550  \\$aQuality of Life
=550  \\$aSocial Environment
=680  \\$iTypical way of life or manner of living characteristic of an individual or group. (From APA, Thesaurus of Psychological Index Terms, 8th ed)
=688  \\$a72(70)
=750  \0$aLifestyles$5IEN$0(DLC)sh 85076848

=LDR  01156cz  a2200313n  4500
=001  9880363751802441
=005  20141212202913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008017
=035  \\$aCBA1252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x450
=072  \\$aL1.$x280.$x975.$x450
=072  \\$aN1.$x224.$x935.$x464
=072  \\$aN6.$x850.$x505.$x400.$x975.$x450
=072  \\$aN6.$x850.$x520.$x308.$x985.$x450
=150  \\$aLife Expectancy
=450  \\$wnnna$aExpectancies, Life
=450  \\$wnnna$aExpectancy, Life
=450  \\$wnnna$aLife Expectancies
=450  \\$wnnna$aLife Extension
=450  \\$wnnna$aYears of Potential Life Lost
=550  \\$wg$aVital Statistics
=550  \\$aLongevity
=550  \\$aMortality, Premature
=667  \\$aIM for human, NIM for animal; consider also LONGEVITY
=680  \\$iBased on known statistical data, the number of years which any person of a given age may reasonably expected to live.
=688  \\$awas in Cat H & N 1979-81; was in Cat N only 1968-78; was in Cat G only 1967; was in Cat G & I 1963-66
=750  \0$aLife expectancy$5IEN$0(DLC)sh 85076821

=LDR  01469cz  a2200373n  4500
=001  9880363751902441
=005  20141212202913.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008016
=035  \\$aCBA1251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x458.$x410
=150  \\$aLife Change Events
=450  \\$wnnna$aAnalyses, Event History
=450  \\$wnnna$aAnalysis, Event History
=450  \\$wnnna$aEvent History Analyses
=450  \\$wnnna$aEvent History Analysis
=450  \\$wnnna$aEvent, Life Change
=450  \\$wnnna$aEvent, Stressful
=450  \\$wnnna$aEvents, Life Change
=450  \\$wnnna$aEvents, Stressful
=450  \\$wnnna$aExperience, Life
=450  \\$wnnna$aExperiences, Life
=450  \\$wnnna$aLife Change Event
=450  \\$wnnna$aLife Experience
=450  \\$aLife Experiences
=450  \\$wnnna$aStressful Event
=450  \\$aStressful Events
=550  \\$wg$aLife Style
=550  \\$aStress, Psychological
=667  \\$ahuman only: do not confuse with life cycles & life stages of animals & lower organisms; FAMILY LIFE CYCLES see FAMILY is also available for "transitional stages through which the family evolves...e.g., marriage, childbearing & death"
=680  \\$iThose occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living.
=688  \\$a77
=750  \0$aLife change events$5IEN$0(DLC)sh 85076819

=LDR  00845cz  a2200253n  4500
=001  9880363752002441
=005  20141212202912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008014
=035  \\$aCBA1249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x240.$x514
=072  \\$aF2.$x830.$x512
=072  \\$aI1.$x198.$x780.$x937.$x619
=150  \\$aLie Detection
=450  \\$wnnna$aDetection, Lie
=450  \\$wnnna$aDetections, Lie
=450  \\$wnnna$aLie Detections
=550  \\$wg$aCriminal Psychology
=550  \\$wg$aForensic Medicine
=550  \\$wg$aPsychophysiology
=550  \\$aDeception
=680  \\$iAscertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.
=750  \0$aLie detectors and detection$5IEN$0(DLC)sh 85076784

=LDR  00564cz  a2200193n  4500
=001  9880363752102441
=005  20141212202912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008013
=035  \\$aCBA1248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x606.$x596
=150  \\$aLidoflazine
=450  \\$wnnna$aClinium
=450  \\$wnnna$aOrdiflazine
=550  \\$wg$aPiperazines
=680  \\$iCoronary vasodilator with some antiarrhythmic action.
=688  \\$a91(73); was see under PIPERAZINES 1973-90
=750  \0$aLidoflazine$5IEN$0(DLC)sh 85076780

=LDR  01589cz  a2200409n  4500
=001  9880363752202441
=005  20141212202912.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008012
=035  \\$aCBA1247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x92.$x500
=150  \\$aLidocaine
=450  \\$wnnna$a2-2EtN-2MePhAcN
=450  \\$wnnna$a2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide
=450  \\$wnnna$aAstrazeneca Brand of Lidocaine
=450  \\$wnnna$aDalcaine
=450  \\$wnnna$aJenapharm Brand of Lidocanine Hydrochloride
=450  \\$wnnna$aLidocaine Carbonate
=450  \\$wnnna$aLidocaine Carbonate (2:1)
=450  \\$wnnna$aLidocaine Hydrocarbonate
=450  \\$wnnna$aLidocaine Hydrochloride
=450  \\$wnnna$aLidocaine Monoacetate
=450  \\$wnnna$aLidocaine Monohydrochloride
=450  \\$wnnna$aLidocaine Monohydrochloride, Monohydrate
=450  \\$wnnna$aLidocaine Sulfate (1:1)
=450  \\$aLignocaine
=450  \\$wnnna$aNovocol Brand of Lidocaine Hydrochloride
=450  \\$wnnna$aOctocaine
=450  \\$wnnna$aStrathmann Brand of Lidocaine Hydrochloride
=450  \\$wnnna$aXylesthesin
=450  \\$wnnna$aXylocaine
=450  \\$wnnna$aXylocitin
=450  \\$wnnna$aXyloneural
=550  \\$wg$aAcetanilides
=680  \\$iA local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
=750  \0$aLidocaine$5IEN$0(DLC)sh 85148855

=LDR  01219cz  a2200313n  4500
=001  9880364540302441
=005  20141212222533.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062406
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x984.$x186
=072  \\$aN6.$x850.$x135.$x848.$x750
=150  \\$aFukushima Nuclear Accident
=450  \\$wnnna$aAccidents, Fukushima Nuclear
=450  \\$wnnna$aDisaster, Fukushima Nuclear
=450  \\$wnnna$aDisasters, Fukushima Nuclear
=450  \\$wnnna$aFukushima Nuclear Accident, Japan
=450  \\$wnnna$aFukushima Nuclear Accidents
=450  \\$wnnna$aFukushima Nuclear Disaster
=450  \\$wnnna$aFukushima Nuclear Disasters
=450  \\$wnnna$aNuclear Accident, Fukushima
=450  \\$wnnna$aNuclear Accidents, Fukushima
=450  \\$wnnna$aNuclear Disaster, Fukushima
=450  \\$wnnna$aNuclear Disasters, Fukushima
=550  \\$wg$aHistory, 21st Century
=550  \\$wg$aRadioactive Hazard Release
=680  \\$iNuclear power accident that occurred following the Tohoku-Kanto earthquake of March 11, 2011 in the northern region of Japan.
=688  \\$a2013
=750  \0$aFukushima Nuclear Disaster, Japan, 2011$0(DLC)sh2011003738$5IEN-M

=LDR  00935cz  a2200193n  4500
=001  9880364540402441
=005  20141212222533.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062405
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x176.$x279.$x500
=072  \\$aF4.$x408.$x413.$x349.$x500
=072  \\$aN2.$x421.$x461.$x363.$x349.$x500
=150  \\$aMotivational Interviewing
=450  \\$wnnna$aInterviewing, Motivational
=550  \\$wg$aDirective Counseling
=680  \\$iIt is a client-centered, directive method for eliciting intrinsic motivation to change using open-ended questions, reflective listening, and decisional balancing. This nonjudgmental, nonconfrontational interviewing style is designed to minimize a patient's resistance to change by creating an interaction that supports open discussion of risky or problem behavior.
=688  \\$a2013
=750  \0$aMotivational interviewing$0(DLC)sh2006005865$5IEN-M

=LDR  00993cz  a2200241n  4500
=001  9880364540502441
=005  20141212222530.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x50
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x20
=150  \\$aAminobenzoates
=450  \\$wnnna$aAcids, Aminobenzoic
=450  \\$wnnna$aAminobenzoic Acids
=550  \\$wg$aBenzoates
=550  \\$wh$ameta-Aminobenzoates
=550  \\$wh$aortho-Aminobenzoates
=550  \\$wh$apara-Aminobenzoates
=680  \\$iDerivatives of BENZOIC ACID that contain one or more amino groups attached to the benzene ring structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobenzoate structure.
=688  \\$a2013
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Aminobenzoic Acids
=750  \0$aAminobenzoic acids$5IEN-M$0(DLC)sh 85004500

=LDR  01773cz  a2200493n  4500
=001  9880364540602441
=005  20141212193207.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062327
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x750
=072  \\$aJ1.$x516.$x213.$x500
=150  \\$aSkin Lightening Preparations
=450  \\$wnnna$aAgent, Depigmenting
=450  \\$wnnna$aAgent, Skin Bleaching
=450  \\$wnnna$aAgent, Skin Depigmenting
=450  \\$wnnna$aAgent, Skin Whitening
=450  \\$wnnna$aAgents, Depigmenting
=450  \\$wnnna$aAgents, Skin Bleaching
=450  \\$wnnna$aAgents, Skin Depigmenting
=450  \\$wnnna$aAgents, Skin Whitening
=450  \\$wnnna$aBleaching Agent, Skin
=450  \\$wnnna$aBleaching Agents, Skin
=450  \\$wnnna$aDepigmenting Agent
=450  \\$wnnna$aDepigmenting Agent, Skin
=450  \\$wnnna$aDepigmenting Agents
=450  \\$wnnna$aDepigmenting Agents, Skin
=450  \\$wnnna$aLightening Preparation, Skin
=450  \\$wnnna$aLightening Preparations, Skin
=450  \\$wnnna$aPreparation, Skin Lightening
=450  \\$wnnna$aPreparations, Skin Lightening
=450  \\$wnnna$aSkin Bleaching Agent
=450  \\$wnnna$aSkin Bleaching Agents
=450  \\$wnnna$aSkin Depigmenting Agent
=450  \\$wnnna$aSkin Depigmenting Agents
=450  \\$wnnna$aSkin Lightening Preparation
=450  \\$wnnna$aSkin Whitening Agent
=450  \\$wnnna$aSkin Whitening Agents
=450  \\$wnnna$aWhitening Agent, Skin
=450  \\$wnnna$aWhitening Agents, Skin
=550  \\$wg$aCosmetics
=680  \\$iSubstances used to obtain a lighter skin complexion or to treat HYPERPIGMENTATION disorders.
=688  \\$a2013
=750  \0$aSkin$xBleaching$0(DLC)sh2010009813$5IEN-M

=LDR  01173cz  a2200433n  4500
=001  9880364540702441
=005  20141212222528.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062312
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x505
=072  \\$aN6.$x230.$x295
=072  \\$aZ1.$x639
=150  \\$aIslands
=550  \\$wg$aEnvironment
=550  \\$wg$aGeographic Locations
=550  \\$wh$aAntarctic Regions
=550  \\$wh$aAtlantic Islands
=550  \\$wh$aAustralia
=550  \\$wh$aBorneo
=550  \\$wh$aGreat Britain
=550  \\$wh$aGreenland
=550  \\$wh$aIceland
=550  \\$wh$aIndian Ocean Islands
=550  \\$wh$aIndonesia
=550  \\$wh$aIreland
=550  \\$wh$aJapan
=550  \\$wh$aMacau
=550  \\$wh$aMediterranean Islands
=550  \\$wh$aPacific Islands
=550  \\$wh$aPhilippines
=550  \\$wh$aPrince Edward Island
=550  \\$wh$aSvalbard
=550  \\$wh$aTaiwan
=550  \\$wh$aWest Indies
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iTracts of land completely surrounded by water.
=688  \\$a2013
=750  \0$aIslands$0(DLC)sh 85068496$5IEN-M

=LDR  00712cz  a2200193n  4500
=001  9880364540802441
=005  20141212222528.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062309
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x354
=150  \\$aCommunity Integration
=450  \\$wnnna$aCommunity Integrations
=450  \\$wnnna$aIntegration, Community
=450  \\$wnnna$aIntegrations, Community
=550  \\$wg$aSocial Welfare
=680  \\$iPolicies and programs which ensure that DISPLACED PERSONS and chronic illnesses receive the support and SOCIAL SERVICES needed to live in their communities.
=688  \\$a2013
=750  \0$aCommunity-based social services$0(DLC)sh2003012320$5IEN-M

=LDR  00766cz  a2200217n  4500
=001  9880364540902441
=005  20141212222528.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062308
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x667
=150  \\$aOptogenetics
=450  \\$wnnna$aOptogenetic
=450  \\$wnnna$aOptogenetic Technique
=450  \\$wnnna$aOptogenetic Techniques
=450  \\$wnnna$aTechnique, Optogenetic
=450  \\$wnnna$aTechniques, Optogenetic
=550  \\$wg$aGenetic Techniques
=680  \\$iThe combination of genetic and optical methods in controlling specific events with temporal precision in targeted cells of a functioning intact biological system.
=688  \\$a2013
=750  \0$aOptogenetics$0(DLC)sh2013003595$5IEN-M

=LDR  01145cz  a2200289n  4500
=001  9880364541002441
=005  20141212222527.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062307
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x473.$x500
=150  \\$aMedical Device Legislation
=450  \\$wnnna$aDevice Legislation, Medical
=450  \\$wnnna$aDevice Legislations, Medical
=450  \\$wnnna$aEquipment Legislation, Medical
=450  \\$wnnna$aEquipment Legislations, Medical
=450  \\$wnnna$aLegislation, Medical Device
=450  \\$wnnna$aLegislation, Medical Equipment
=450  \\$wnnna$aLegislations, Medical Device
=450  \\$wnnna$aLegislations, Medical Equipment
=450  \\$wnnna$aMedical Device Legislations
=450  \\$wnnna$aMedical Equipment Legislation
=450  \\$wnnna$aMedical Equipment Legislations
=550  \\$wg$aLegislation, Medical
=680  \\$iLaws and regulations pertaining to devices used in medicine, proposed for enactment, or enacted by a legislative body.
=688  \\$a2013
=750  \0$aMedical instruments and apparatus$xLaw and legislation$0(IEN)10040599$5IEN-M

=LDR  00864cz  a2200241n  4500
=001  9880364541102441
=005  20141212222527.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x500.$x97
=072  \\$aH2.$x403.$x352
=150  \\$aGeography, Medical
=450  \\$wnnna$aGeomedicine
=450  \\$aMedical Geography
=450  \\$wnnna$aNosogeography
=550  \\$wg$aGeography
=550  \\$wg$aMedicine
=550  \\$wh$aTopography, Medical
=667  \\$aIM as the discipline (education, history, etc); NIM with no qualifiers as a coordinate
=680  \\$iThe area of medicine concerned with the effects on health and disease due to geographic factors such as CLIMATE, environmental conditions, and geographic location.
=688  \\$a2013
=750  \0$aMedical geography$0(DLC)sh 85082940$5IEN-M

=LDR  01206cz  a2200349n  4500
=001  9880364541202441
=005  20141212222527.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062305
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x389
=072  \\$aE5.$x318.$x740.$x933.$x249
=072  \\$aN5.$x715.$x360.$x750.$x746.$x249
=072  \\$aN6.$x850.$x520.$x830.$x933.$x249
=150  \\$aGeographic Mapping
=450  \\$wnnna$aCartography, Geographic
=450  \\$wnnna$aChoropleth Mapping
=450  \\$wnnna$aDasymetric Mapping
=450  \\$wnnna$aGeocoding
=450  \\$wnnna$aGeographic Cartography
=450  \\$wnnna$aGeoreferencing
=450  \\$wnnna$aMapping, Choropleth
=450  \\$wnnna$aMapping, Dasymetric
=450  \\$wnnna$aMapping, Geographic
=550  \\$wg$aEpidemiologic Methods
=550  \\$wg$aSpatial Analysis
=550  \\$aGeographic Information Systems
=550  \\$aMaps as Topic
=550  \\$aTopography, Medical
=680  \\$iCreating a representation of areas of the earth or other celestial bodies, for the purpose of visualizing spatial distributions of various information.
=688  \\$a2013
=750  \0$aCartography$0(DLC)sh 85020515$5IEN-M

=LDR  01135cz  a2200289n  4500
=001  9880364541302441
=005  20150527101313.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062265
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x918.$x500
=150  \\$aHealth Insurance Exchanges
=450  \\$wnnna$aExchange, Health Insurance
=450  \\$wnnna$aExchanges, Health Insurance
=450  \\$wnnna$aHealth Insurance Exchange
=450  \\$wnnna$aHealth Insurance Marketplace
=450  \\$wnnna$aHealth Insurance Marketplaces
=450  \\$wnnna$aInsurance Exchange, Health
=450  \\$wnnna$aInsurance Exchanges, Health
=450  \\$wnnna$aInsurance Marketplace, Health
=450  \\$wnnna$aInsurance Marketplaces, Health
=450  \\$wnnna$aMarketplace, Health Insurance
=450  \\$wnnna$aMarketplaces, Health Insurance
=550  \\$wg$aPatient Protection and Affordable Care Act
=680  \\$iState-provided health insurance marketplaces established under the PATIENT PROTECTION AND AFFORDABLE CARE ACT.
=688  \\$a2013
=750  \0$aHealth insurance exchanges$0(DLC)sh2014001324$5IEN-M

=LDR  01199cz  a2200277n  4500
=001  9880364541402441
=005  20141212222524.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062207
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x76
=150  \\$aBrain-Computer Interfaces
=450  \\$wnnna$aBrain-Computer Interface
=450  \\$wnnna$aBrain Computer Interface
=450  \\$wnnna$aBrain Computer Interfaces
=450  \\$wnnna$aBrain-Machine Interface
=450  \\$wnnna$aBrain-Machine Interfaces
=450  \\$wnnna$aBrain Machine Interfaces
=450  \\$wnnna$aInterface, Brain-Computer
=450  \\$wnnna$aInterface, Brain-Machine
=450  \\$wnnna$aInterfaces, Brain-Computer
=450  \\$wnnna$aInterfaces, Brain-Machine
=550  \\$wg$aElectrical Equipment and Supplies
=680  \\$iInstrumentation consisting of hardware and software that communicates with the BRAIN. The hardware component of the interface records brain signals, while the software component analyzes the signals and converts them into a command that controls a device or sends a feedback signal to the brain.
=688  \\$a2013
=750  \0$aBrain-computer interfaces$0(DLC)sh2007000197$5IEN-M

=LDR  01639cz  a2200481n  4500
=001  9880364541502441
=005  20171031092819.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062206
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x933
=072  \\$aN5.$x715.$x360.$x750.$x746
=072  \\$aN6.$x850.$x520.$x830.$x933
=150  \\$aSpatial Analysis
=450  \\$wnnna$aAnalyses, Spacial
=450  \\$wnnna$aAnalyses, Spatial
=450  \\$wnnna$aAnalysis, Spacial
=450  \\$wnnna$aAnalysis, Spatial
=450  \\$wnnna$aAutocorrelation, Spatial
=450  \\$wnnna$aAutocorrelations, Spatial
=450  \\$wnnna$aDependencies, Spatial
=450  \\$wnnna$aDependency, Spatial
=450  \\$wnnna$aInterpolation, Spatial
=450  \\$wnnna$aInterpolations, Spatial
=450  \\$wnnna$aKriging
=450  \\$wnnna$aKrigings
=450  \\$wnnna$aSpacial Analyses
=450  \\$wnnna$aSpacial Analysis
=450  \\$wnnna$aSpatial Analyses
=450  \\$wnnna$aSpatial Autocorrelation
=450  \\$wnnna$aSpatial Autocorrelations
=450  \\$wnnna$aSpatial Dependencies
=450  \\$wnnna$aSpatial Dependency
=450  \\$wnnna$aSpatial Interpolation
=450  \\$wnnna$aSpatial Interpolations
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aGeographic Mapping
=550  \\$wh$aSpatial Regression
=550  \\$wh$aSpatio-Temporal Analysis
=550  \\$aGeographic Information Systems
=680  \\$iTechniques which study entities using their topological, geometric, or geographic properties.
=688  \\$a2013
=750  \0$aSpatial analysis (Statistics)$0(DLC)sh 85126347$5IEN-M

=LDR  00756cz  a2200181n  4500
=001  9880364541602441
=005  20141212222520.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062125
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x933
=150  \\$aThermometry
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aThermography
=667  \\$acoordinate with specific measuring method or property measured
=680  \\$iMeasurement of the temperature of a material, or of the body or an organ by various temperature sensing devices which measure changes in properties of the material that vary with temperature, such as ELASTICITY; MAGNETIC FIELDS; or LUMINESCENCE.
=688  \\$a2013
=750  \0$aTemperature measurements$0(DLC)sh 89005773$5IEN-M

=LDR  01853cz  a2200541n  4500
=001  9880364541702441
=005  20141212222520.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x680.$x275
=150  \\$aDermatologic Surgical Procedures
=450  \\$wnnna$aCutaneous Surgeries
=450  \\$wnnna$aCutaneous Surgery
=450  \\$wnnna$aCutaneous Surgical Procedure
=450  \\$wnnna$aCutaneous Surgical Procedures
=450  \\$wnnna$aDermatologic Surgeries
=450  \\$wnnna$aDermatologic Surgery
=450  \\$wnnna$aDermatologic Surgical Procedure
=450  \\$wnnna$aProcedure, Cutaneous Surgical
=450  \\$wnnna$aProcedure, Dermatologic Surgical
=450  \\$wnnna$aProcedures, Cutaneous Surgical
=450  \\$wnnna$aProcedures, Dermatologic Surgical
=450  \\$wnnna$aSkin Surgeries
=450  \\$wnnna$aSkin Surgery
=450  \\$aSkin$xsurgery
=450  \\$wnnna$aSurgeries, Cutaneous
=450  \\$wnnna$aSurgeries, Dermatologic
=450  \\$wnnna$aSurgeries, Skin
=450  \\$wnnna$aSurgery, Cutaneous
=450  \\$wnnna$aSurgery, Dermatologic
=450  \\$wnnna$aSurgery, Skin
=450  \\$wnnna$aSurgical Procedure, Cutaneous
=450  \\$wnnna$aSurgical Procedure, Dermatologic
=450  \\$wnnna$aSurgical Procedures, Cutaneous
=450  \\$wnnna$aSurgical Procedures, Dermatologic
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wh$aBlepharoplasty
=550  \\$wh$aChemexfoliation
=550  \\$wh$aDermabrasion
=550  \\$wh$aMohs Surgery
=550  \\$wh$aRhytidoplasty
=550  \\$wh$aSkin Transplantation
=550  \\$aCosmetic Techniques
=550  \\$aSurgery, Plastic
=680  \\$iOperative procedures performed on the SKIN.
=688  \\$a2013
=750  \0$aSkin$xSurgery$0(DLC)sh 85123185$5IEN-M

=LDR  00808cz  a2200241n  4500
=001  9880364541802441
=005  20141212222516.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x875
=072  \\$aH1.$x277.$x249.$x875
=072  \\$aJ1.$x293.$x622
=150  \\$aHydrology
=450  \\$wnnna$aHydrologies
=550  \\$wg$aEcology
=550  \\$wg$aEngineering
=550  \\$wh$aWater Supply
=550  \\$aLimnology
=667  \\$aIM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate
=680  \\$iScience dealing with the properties, distribution, and circulation of water on and below the earth's surface, and atmosphere.
=688  \\$a2013
=750  \0$aHydrology$0(DLC)sh 85063458$5IEN-M

=LDR  00711cz  a2200217n  4500
=001  9880364541902441
=005  20141212222515.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x400
=150  \\$aInventions
=450  \\$wnnna$aInnovation, Technological
=450  \\$wnnna$aInnovations, Technological
=450  \\$wnnna$aInvention
=450  \\$wnnna$aTechnological Innovation
=450  \\$wnnna$aTechnological Innovations
=550  \\$wg$aTechnology
=680  \\$iA novel composition, device, or process, independently conceived de novo or derived from a pre-existing model.
=688  \\$a2013
=750  \0$aInventions$0(DLC)sh 85067667$5IEN-M

=LDR  00627cz  a2200205n  4500
=001  9880364542002441
=005  20141212222515.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062068
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x493
=150  \\$aInventors
=450  \\$wnnna$aCo-Inventor
=450  \\$wnnna$aCo-Inventors
=450  \\$wnnna$aCo Inventors
=450  \\$wnnna$aInventor
=550  \\$wg$aOccupational Groups
=680  \\$iPersons or entities that introduce a novel composition, device, or process, as well as improvements thereof.
=688  \\$a2013
=750  \0$aInventors$0(DLC)sh 85067676$5IEN-M

=LDR  00857cz  a2200253n  4500
=001  9880364542102441
=005  20141212222515.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062067
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x60.$x75.$x199
=150  \\$aChemical Safety
=450  \\$wnnna$aChemical Safety Measure
=450  \\$wnnna$aChemical Safety Measures
=450  \\$wnnna$aMeasure, Chemical Safety
=450  \\$wnnna$aMeasures, Chemical Safety
=450  \\$wnnna$aSafety, Chemical
=450  \\$wnnna$aSafety Measure, Chemical
=450  \\$wnnna$aSafety Measures, Chemical
=550  \\$wg$aSafety
=550  \\$aHazard Analysis and Critical Control Points
=680  \\$iRisk or hazard associated with the handling and use of chemicals.
=688  \\$a2013
=750  \0$aChemicals$xSafety measures$0(DLC)sh 85022970$5IEN-M

=LDR  00719cz  a2200205n  4500
=001  9880364542202441
=005  20141212222515.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062066
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x910
=150  \\$aWater Resources
=450  \\$wnnna$aResource, Water
=450  \\$wnnna$aResources, Water
=450  \\$wnnna$aWater Resource
=550  \\$wg$aGeological Phenomena
=550  \\$aGroundwater
=680  \\$iEnvironmental reservoirs of water related to natural WATER CYCLE by which water is obtained for various purposes. This includes but is not limited to watersheds, aquifers and springs.
=688  \\$a2013
=750  \0$aWater-supply$0(DLC)sh 85145648$5IEN-M

=LDR  02247cz  a2200493n  4500
=001  9880364542302441
=005  20141212222510.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x610
=150  \\$aMatrix Metalloproteinase Inhibitors
=450  \\$wnnna$aCollagenase Inhibitors
=450  \\$aCollagenases$xantagonists & inhibitors
=450  \\$wnnna$aGelatinase Inhibitors
=450  \\$wnnna$aInhibitors, Collagenase
=450  \\$wnnna$aInhibitors, Gelatinase
=450  \\$wnnna$aInhibitors, Matrix Metalloproteinase
=450  \\$wnnna$aInhibitors, MMP
=450  \\$wnnna$aInhibitors, Stromelysin
=450  \\$aMatrix Metalloproteinase 1$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 10$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 11$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 12$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 13$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 14$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 15$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 16$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 17$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 2$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 20$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 3$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 7$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 8$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinase 9$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinases$xantagonists & inhibitors
=450  \\$aMatrix Metalloproteinases, Membrane-Associated$xantagonists & inhibitors
=450  \\$wnnna$aMetalloproteinase Inhibitors, Matrix
=450  \\$wnnna$aMMP Inhibitors
=450  \\$wnnna$aStromelysin Inhibitors
=550  \\$wg$aProtease Inhibitors
=680  \\$iCompounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES.
=688  \\$a2013
=750  \0$aCollagenases$xInhibitors$0(IEN)10040591$5IEN-M

=LDR  00829cz  a2200253n  4500
=001  9880364542402441
=005  20141212222508.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061925
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x404
=150  \\$aImmobilized Nucleic Acids
=450  \\$wnnna$aAcids, Immobilized Nucleic
=450  \\$wnnna$aDNA, Immobilized
=450  \\$wnnna$aImmobilized DNA
=450  \\$wnnna$aImmobilized Oligonucleotides
=450  \\$wnnna$aImmobilized RNA
=450  \\$wnnna$aNucleic Acids, Immobilized
=450  \\$wnnna$aOligonucleotides, Immobilized
=450  \\$wnnna$aRNA, Immobilized
=550  \\$wg$aNucleic Acids
=680  \\$iDNA or RNA bound to a substrate thereby having fixed positions.
=688  \\$a2013
=750  \0$aImmobilized nucleic acids$0(DLC)sh 99000706$5IEN-M

=LDR  00685cz  a2200241n  4500
=001  9880364542502441
=005  20141212222507.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061895
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x416
=150  \\$aExternal Debt
=450  \\$wnnna$aDebt, External
=450  \\$wnnna$aDebt, Foreign
=450  \\$wnnna$aDebts, External
=450  \\$wnnna$aDebts, Foreign
=450  \\$wnnna$aExternal Debts
=450  \\$wnnna$aForeign Debt
=450  \\$wnnna$aForeign Debts
=550  \\$wg$aEconomics
=680  \\$iMoney owed to creditors outside of a country.
=688  \\$a2013
=750  \0$aDebts, External$0(DLC)sh 85036140$5IEN-M

=LDR  00785cz  a2200241n  4500
=001  9880364542602441
=005  20141212222507.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061889
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x483.$x500
=150  \\$aHealthcare Financing
=450  \\$wnnna$aFinancing, Health
=450  \\$wnnna$aFinancing, Healthcare
=450  \\$wnnna$aFinancings, Health
=450  \\$wnnna$aFinancings, Healthcare
=450  \\$aHealth Financing
=450  \\$wnnna$aHealth Financings
=450  \\$wnnna$aHealthcare Financings
=550  \\$wg$aFinancial Support
=680  \\$iMethods of generating, allocating, and using financial resources in healthcare systems.
=688  \\$a2013
=750  \0$aMedical care$xFinance$0(DLC)sh 85082877$5IEN-M

=LDR  01229cz  a2200277n  4500
=001  9880364542702441
=005  20141212222505.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061848
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x589
=072  \\$aE5.$x642
=150  \\$aOptical Imaging
=450  \\$wnnna$aAutofluorescence Imaging
=450  \\$wnnna$aFluorescence Imaging
=450  \\$wnnna$aImaging, Autofluorescence
=450  \\$wnnna$aImaging, Fluorescence
=450  \\$wnnna$aImaging, Optical
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aNarrow Band Imaging
=550  \\$wh$aTomography, Optical
=550  \\$wh$aTransillumination
=680  \\$iThe use of light interaction (scattering, absorption, and fluorescence) with biological tissue to obtain morphologically based information. It includes measuring inherent tissue optical properties such as scattering, absorption, and autofluorescence; or optical properties of exogenous targeted fluorescent molecular probes such as those used in optical MOLECULAR IMAGING, or nontargeted optical CONTRAST AGENTS.
=688  \\$a2013
=750  \0$aIntrinsic optical imaging$0(DLC)sh2011005252$5IEN-M

=LDR  00726cz  a2200205n  4500
=001  9880364542802441
=005  20200625124146.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060756
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x910
=150  \\$aSocial Networking
=450  \\$wnnna$aNetworking, Social
=550  \\$wg$aCommunication
=550  \\$wh$aOnline Social Networking
=550  \\$wh$aScholarly Communication
=667  \\$ado not confuse with SOCIAL NETWORKS see SOCIAL SUPPORT
=680  \\$iIndividuals connecting by family, work or other interests. It also includes connectivity facilitated by computer-based communications.
=688  \\$a2012
=750  \0$aSocial networks$0(DLC) sh 87002172$5IEN-M

=LDR  00654cz  a2200181n  4500
=001  9880364542902441
=005  20141212222358.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x667.$x555
=150  \\$aGerm Theory of Disease
=450  \\$wnnna$aDisease Germ Theories
=450  \\$wnnna$aDisease Germ Theory
=550  \\$wg$aPhilosophy, Medical
=680  \\$iThe fundamental tenet of modern medicine that certain diseases are caused by microorganisms. It was confirmed by the work of Pasteur, Lister, and Koch.
=688  \\$a2012
=750  \0$aGerm theory of disease$0(DLC) sh 85054323$5IEN-M

=LDR  00629cz  a2200193n  4500
=001  9880364543002441
=005  20141212222358.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060753
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x80.$x750
=072  \\$aN6.$x850.$x460.$x790.$x730
=150  \\$aWater Quality
=450  \\$wnnna$aQuality, Water
=550  \\$wg$aEnvironmental Monitoring
=550  \\$wg$aWater Pollution
=680  \\$iA rating of a body of water based on measurable physical, chemical, and biological characteristics.
=688  \\$a2012
=750  \0$aWater quality$0(DLC) sh 85145600$5IEN-M

=LDR  00846cz  a2200289n  4500
=001  9880364543102441
=005  20141212222355.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060739
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x675
=072  \\$aG1.$x750.$x770.$x776.$x783
=150  \\$aPhonons
=450  \\$wnnna$aAcoustic Phonon
=450  \\$wnnna$aAcoustic Phonons
=450  \\$wnnna$aOptical Phonon
=450  \\$wnnna$aOptical Phonons
=450  \\$wnnna$aPhonon
=450  \\$wnnna$aPhonon, Acoustic
=450  \\$wnnna$aPhonon, Optical
=450  \\$wnnna$aPhonons, Acoustic
=450  \\$wnnna$aPhonons, Optical
=550  \\$wg$aElementary Particles
=550  \\$wg$aSound
=680  \\$iQuanta of acoustic energy which move at the speed of sound.
=688  \\$a2012
=750  \0$aPhonons$0(DLC) sh 85101066$5IEN-M

=LDR  01048cz  a2200289n  4500
=001  9880364543202441
=005  20141212222354.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060737
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x730
=072  \\$aC12.$x294.$x604
=072  \\$aC13.$x351.$x500.$x630
=150  \\$aReproductive Tract Infections
=450  \\$wnnna$aGenital Tract Infection
=450  \\$wnnna$aGenital Tract Infections
=450  \\$wnnna$aInfection, Genital Tract
=450  \\$wnnna$aInfection, Reproductive Tract
=450  \\$wnnna$aInfections, Genital Tract
=450  \\$wnnna$aInfections, Reproductive Tract
=450  \\$wnnna$aReproductive Tract Infection
=550  \\$wg$aGenital Diseases, Female
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aInfection
=680  \\$iInfections of the genital tract in females or males. They can be caused by endogenous, iatrogenic, or sexually transmitted organisms.
=688  \\$a2012
=750  \0$aGenerative organs$xInfections$0(DLC) sh 90002384$5IEN-M

=LDR  00877cz  a2200205n  4500
=001  9880364543302441
=005  20141212222354.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060734
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x275.$x500
=072  \\$aD1.$x200.$x275.$x150.$x150.$x500
=072  \\$aD1.$x578.$x200.$x500
=150  \\$aNacre
=450  \\$wnnna$aMother of Pearl
=550  \\$wg$aCalcium Carbonate
=667  \\$aNACRE PROTEIN, ZEBRAFISH is also available
=680  \\$iA biomineral consisting of layers of crystalized ARAGONITE, separated by interlamellar layers of organic matrix containing beta-CHITIN, and surrounded by an intercrystalline organic membrane of silk fibroin. Nacre is the iridescent substance better known as mother-of-pearl that is secreted by MOLLUSCS.
=688  \\$a2012
=750  \0$aMother-of-pearl$0(DLC) sh 85087521$5IEN-M

=LDR  01232cz  a2200349n  4500
=001  9880364543402441
=005  20141212222353.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060733
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505
=072  \\$aG1.$x750.$x250
=150  \\$aElectromagnetic Radiation
=450  \\$wnnna$aElectromagnetic Energies
=450  \\$aElectromagnetic Energy
=450  \\$wnnna$aElectromagnetic Wave
=450  \\$aElectromagnetic Waves
=450  \\$wnnna$aEnergies, Electromagnetic
=450  \\$wnnna$aEnergy, Electromagnetic
=450  \\$wnnna$aRadiation, Electromagnetic
=450  \\$wnnna$aWave, Electromagnetic
=450  \\$wnnna$aWaves, Electromagnetic
=550  \\$wg$aElectromagnetic Phenomena
=550  \\$wg$aRadiation
=550  \\$wh$aGamma Rays
=550  \\$wh$aLight
=550  \\$wh$aRadio Waves
=550  \\$wh$aTerahertz Radiation
=550  \\$wh$aX-Rays
=680  \\$iWaves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.
=688  \\$a2012; for ELECTROMAGNETIC ENERGY and ELECTROMAGNETIC WAVES use RADIATION 1988-2011
=750  \0$aElectromagnetic waves$0(DLC) sh 85042179$5IEN-M

=LDR  00976cz  a2200289n  4500
=001  9880364543502441
=005  20141212222353.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060731
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x373
=150  \\$aEmergency Responders
=450  \\$wnnna$aEmergency First Responder
=450  \\$wnnna$aEmergency First Responders
=450  \\$wnnna$aEmergency Responder
=450  \\$wnnna$aFirst Responder, Emergency
=450  \\$wnnna$aFirst Responders, Emergency
=450  \\$wnnna$aResponder, Emergency
=450  \\$wnnna$aResponders, Emergency
=550  \\$wg$aOccupational Groups
=550  \\$wh$aEmergency Medical Technicians
=550  \\$wh$aFirefighters
=550  \\$wh$aPolice
=550  \\$aEmergency Service, Hospital
=680  \\$iPersonnel trained to provide the initial services, care, and support in EMERGENCIES or DISASTERS.
=688  \\$a2012
=750  \0$aFirst responders$0(DLC)sh2007008878$5IEN-M

=LDR  00817cz  a2200289n  4500
=001  9880364543602441
=005  20141212222352.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060729
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x110
=150  \\$aCoal Ash
=450  \\$wnnna$aAsh, Bottom
=450  \\$wnnna$aAsh, Coal
=450  \\$wnnna$aAsh, Fly
=450  \\$wnnna$aAsh, Oil Fly
=450  \\$wnnna$aBottom Ash
=450  \\$wnnna$aFly Ash
=450  \\$wnnna$aFly Ash, Oil
=450  \\$wnnna$aOil Fly Ash
=450  \\$wnnna$aPollutant, ROFA
=450  \\$wnnna$aROFA Pollutant
=450  \\$wnnna$aSoft Coal Fly Ash
=550  \\$wg$aParticulate Matter
=680  \\$iResidue generated from combustion of coal or petroleum.
=688  \\$a2012
=750  \0$aCoal ash$0(DLC) sh 85027337$5IEN-M

=LDR  00666cz  a2200217n  4500
=001  9880364543702441
=005  20141212222352.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x625
=150  \\$aReproductive Health
=450  \\$wnnna$aHealth, Reproductive
=450  \\$wnnna$aHealth, Sexual
=450  \\$wnnna$aSexual Health
=550  \\$wg$aHealth
=550  \\$aReproductive Medicine
=550  \\$aSex Education
=680  \\$iThe physical condition of human reproductive systems.
=688  \\$a2012; use Reproductive Medicine 1995-2011
=750  \0$aReproductive health$0(DLC) sh 98006709$5IEN-M

=LDR  01759cz  a2200421n  4500
=001  9880364543802441
=005  20141212222351.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060725
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x952
=072  \\$aC23.$x300.$x970.$x750
=150  \\$aUterine Retroversion
=450  \\$wnnna$aGravid Uterus, Retroverted
=450  \\$wnnna$aIncarcerated Retroverted Uterus
=450  \\$wnnna$aRetroflexed Uterus
=450  \\$wnnna$aRetroflexion, Uterine
=450  \\$wnnna$aRetroflexions, Uterine
=450  \\$wnnna$aRetroversion, Uterine
=450  \\$wnnna$aRetroversions, Uterine
=450  \\$wnnna$aRetroverted Gravid Uterus
=450  \\$wnnna$aRetroverted Uterus
=450  \\$wnnna$aRetroverted Uterus, Incarcerated
=450  \\$wnnna$aTipped Uterus
=450  \\$wnnna$aUterine Retroflexion
=450  \\$wnnna$aUterine Retroflexions
=450  \\$wnnna$aUterine Retroversions
=450  \\$wnnna$aUterus, Incarcerated Retroverted
=450  \\$wnnna$aUterus, Retroflexed
=450  \\$wnnna$aUterus, Retroverted
=450  \\$wnnna$aUterus, Retroverted Gravid
=450  \\$wnnna$aUterus, Tipped
=550  \\$wg$aTorsion Abnormality
=550  \\$wg$aUterine Diseases
=667  \\$acoordinate with OBSTETRIC LABOR COMPLICATIONS if pertinent
=680  \\$iA condition in which the UTERUS is found tilted backward toward the spine. The uterus is more commonly found in a straight vertical or anteverted (tipped forward) position. Although retroverted uterus is a normal variant position without symptoms, it is sometimes associated with pain, discomfort and other pregnancy complications.
=688  \\$a2012
=750  \0$aUterus$xDisplacements$0(DLC) sh 85141613$5IEN-M

=LDR  01571cz  a2200433n  4500
=001  9880364543902441
=005  20141212222351.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060705
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x550.$x99
=072  \\$aC23.$x888.$x592.$x604.$x150.$x550.$x99
=072  \\$aF3.$x550.$x350.$x500.$x99
=072  \\$aF3.$x550.$x450.$x199
=150  \\$aDyscalculia
=450  \\$wnnna$aAcalculia
=450  \\$wnnna$aAcalculia, Secondary
=450  \\$wnnna$aAcalculias
=450  \\$wnnna$aAcalculias, Secondary
=450  \\$wnnna$aAcquired Dyscalculia
=450  \\$wnnna$aAcquired Dyscalculias
=450  \\$wnnna$aDevelopmental Dyscalculia
=450  \\$wnnna$aDevelopmental Dyscalculias
=450  \\$wnnna$aDyscalculia, Acquired
=450  \\$wnnna$aDyscalculia, Developmental
=450  \\$wnnna$aDyscalculia, Primary
=450  \\$wnnna$aDyscalculias
=450  \\$wnnna$aDyscalculias, Acquired
=450  \\$wnnna$aDyscalculias, Developmental
=450  \\$wnnna$aDyscalculias, Primary
=450  \\$wnnna$aPrimary Dyscalculia
=450  \\$wnnna$aPrimary Dyscalculias
=450  \\$wnnna$aSecondary Acalculia
=450  \\$wnnna$aSecondary Acalculias
=550  \\$wg$aLearning Disorders
=550  \\$aGerstmann Syndrome
=680  \\$iImpaired ability in numerical concepts. These inabilities arise as a result of primary neurological lesion, are syndromic (e.g., GERSTMANN SYNDROME ) or acquired due to brain damage.
=688  \\$a2012
=750  \0$aAcalculia$0(DLC) sh 85000308$5IEN-M

=LDR  00708cz  a2200193n  4500
=001  9880364544002441
=005  20141212222350.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x58.$x788
=072  \\$aF1.$x752.$x747.$x792.$x925
=150  \\$aSense of Coherence
=450  \\$wnnna$aCoherence Sense
=550  \\$wg$aAdaptation, Psychological
=550  \\$wg$aSelf Concept
=680  \\$iA view of the world and the individual's environment as comprehensible, manageable, and meaningful, claiming that the way people view their life has a positive influence on their health.
=688  \\$a2012
=750  \0$aSense of coherence$0(DLC) sh2009008282$5IEN-M

=LDR  01190cz  a2200361n  4500
=001  9880364544102441
=005  20141212222350.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060666
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x249
=072  \\$aE5.$x8
=150  \\$aAirway Extubation
=450  \\$wnnna$aAirway Extubations
=450  \\$wnnna$aEndotracheal Extubation
=450  \\$wnnna$aEndotracheal Extubations
=450  \\$wnnna$aExtubation, Airway
=450  \\$wnnna$aExtubation, Endotracheal
=450  \\$wnnna$aExtubation, Intratracheal
=450  \\$wnnna$aExtubation, Tracheal
=450  \\$wnnna$aExtubations, Airway
=450  \\$wnnna$aExtubations, Endotracheal
=450  \\$wnnna$aExtubations, Intratracheal
=450  \\$wnnna$aExtubations, Tracheal
=450  \\$wnnna$aIntratracheal Extubation
=450  \\$wnnna$aIntratracheal Extubations
=450  \\$wnnna$aTracheal Extubation
=450  \\$wnnna$aTracheal Extubations
=550  \\$wg$aAirway Management
=550  \\$wg$aInvestigative Techniques
=680  \\$iRemoval of an endotracheal tube from the patient.
=688  \\$a2012
=750  \0$aAirway extubation$5IEN-M$0(DLC)sh2012001526

=LDR  00762cz  a2200217n  4500
=001  9880364544202441
=005  20141212222349.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060589
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x220.$x995
=072  \\$aD12.$x776.$x512.$x500
=072  \\$aD12.$x776.$x744.$x962
=150  \\$aZyxin
=450  \\$wnnna$aZyxin Protein
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wg$aLIM Domain Proteins
=550  \\$wg$aPhosphoproteins
=680  \\$iA zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half.
=688  \\$a2012
=750  \0$aZyxin$0(DLC)sh2006002969$5IEN-M

=LDR  01605cz  a2200529n  4500
=001  9880364544302441
=005  20141212222348.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060587
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x355
=150  \\$aGroundwater
=450  \\$wnnna$aAquifer
=450  \\$wnnna$aAquifers
=450  \\$wnnna$aGround Water
=450  \\$wnnna$aGround-Water
=450  \\$wnnna$aGround Waters
=450  \\$wnnna$aGround-Waters
=450  \\$wnnna$aGroundwaters
=450  \\$wnnna$aLake, Subterranean
=450  \\$wnnna$aLake, Underground
=450  \\$wnnna$aLakes, Subterranean
=450  \\$wnnna$aLakes, Underground
=450  \\$wnnna$aStream, Underground
=450  \\$wnnna$aStreams, Underground
=450  \\$wnnna$aSubterranean Lake
=450  \\$wnnna$aSubterranean Lakes
=450  \\$wnnna$aTable, Water
=450  \\$wnnna$aTables, Water
=450  \\$wnnna$aUnderground Lake
=450  \\$wnnna$aUnderground Lakes
=450  \\$wnnna$aUnderground Stream
=450  \\$wnnna$aUnderground Streams
=450  \\$wnnna$aUnderground Water
=450  \\$wnnna$aUnderground Waters
=450  \\$wnnna$aWater Table
=450  \\$wnnna$aWater Tables
=450  \\$wnnna$aWater, Underground
=450  \\$wnnna$aWaters, Underground
=550  \\$wg$aGeological Phenomena
=550  \\$wh$aNatural Springs
=550  \\$wh$aWater Wells
=550  \\$aWater Resources
=550  \\$aWater Supply
=680  \\$iLiquid water present beneath the surface of the earth.
=688  \\$a2012
=750  \0$aGroundwater$0(DLC) sh 85145514$5IEN-M

=LDR  01796cz  a2200445n  4500
=001  9880364544402441
=005  20141212222347.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x383.$x500
=072  \\$aC1.$x703.$x295.$x328.$x500
=072  \\$aC1.$x703.$x513.$x500
=072  \\$aC17.$x800.$x838.$x208.$x416.$x500
=150  \\$aFusariosis
=450  \\$wnnna$aDisseminated Fusarioses
=450  \\$wnnna$aDisseminated Fusariosis
=450  \\$wnnna$aFusarioses
=450  \\$wnnna$aFusarioses, Disseminated
=450  \\$wnnna$aFusarioses, Invasive
=450  \\$wnnna$aFusarioses, Invasive Pulmonary
=450  \\$wnnna$aFusarioses, Pulmonary
=450  \\$wnnna$aFusariosis, Disseminated
=450  \\$wnnna$aFusariosis, Invasive
=450  \\$wnnna$aFusariosis, Invasive Pulmonary
=450  \\$wnnna$aFusariosis, Pulmonary
=450  \\$wnnna$aFusarium Infection
=450  \\$wnnna$aFusarium Infections
=450  \\$wnnna$aInfection, Fusarium
=450  \\$wnnna$aInfections, Fusarium
=450  \\$wnnna$aInvasive Fusarioses
=450  \\$wnnna$aInvasive Fusariosis
=450  \\$wnnna$aInvasive Pulmonary Fusarioses
=450  \\$wnnna$aInvasive Pulmonary Fusariosis
=450  \\$wnnna$aPulmonary Fusarioses
=450  \\$wnnna$aPulmonary Fusariosis
=550  \\$wg$aHyalohyphomycosis
=680  \\$iOPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.
=688  \\$a2012
=750  \2$aFusariosis$0(DLC)sh2005007520$5IEN-M

=LDR  00611cz  a2200205n  4500
=001  9880364544502441
=005  20141212222345.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060526
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x750
=150  \\$aMagnetic Fields
=450  \\$wnnna$aField, Magnetic
=450  \\$wnnna$aFields, Magnetic
=450  \\$wnnna$aMagnetic Field
=550  \\$wg$aMagnetic Phenomena
=550  \\$wh$aElectromagnetic Fields
=680  \\$iAreas of attractive or repulsive force surrounding MAGNETS.
=688  \\$a2012
=750  \0$aMagnetic fields$0(DLC) sh 85079703$5IEN-M

=LDR  02413cz  a2200625n  4500
=001  9880364544602441
=005  20141212222345.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x450.$x680
=150  \\$aPudendal Nerve
=450  \\$wnnna$aAnal Nerve, Inferior
=450  \\$wnnna$aAnal Nerves, Inferior
=450  \\$wnnna$aClitoris Dorsal Nerve
=450  \\$wnnna$aClitoris Dorsal Nerves
=450  \\$wnnna$aClitoris Nerve, Dorsal
=450  \\$wnnna$aClitoris Nerves, Dorsal
=450  \\$wnnna$aDorsal Clitoris Nerve
=450  \\$wnnna$aDorsal Clitoris Nerves
=450  \\$wnnna$aDorsal Nerve of Clitoris
=450  \\$wnnna$aDorsal Nerve of Penis
=450  \\$wnnna$aDorsal Penile Nerve
=450  \\$wnnna$aDorsal Penile Nerves
=450  \\$wnnna$aHemorrhoidal Nerve, Inferior
=450  \\$wnnna$aHemorrhoidal Nerves, Inferior
=450  \\$wnnna$aInferior Anal Nerve
=450  \\$wnnna$aInferior Anal Nerves
=450  \\$wnnna$aInferior Hemorrhoidal Nerve
=450  \\$wnnna$aInferior Hemorrhoidal Nerves
=450  \\$wnnna$aNerve, Dorsal Clitoris
=450  \\$wnnna$aNerve, Dorsal Penile
=450  \\$wnnna$aNerve, Inferior Anal
=450  \\$wnnna$aNerve, Inferior Hemorrhoidal
=450  \\$wnnna$aNerve, Perineal
=450  \\$wnnna$aNerve, Pudendal
=450  \\$wnnna$aNerves, Dorsal Clitoris
=450  \\$wnnna$aNerves, Dorsal Penile
=450  \\$wnnna$aNerves, Inferior Anal
=450  \\$wnnna$aNerves, Inferior Hemorrhoidal
=450  \\$wnnna$aNerves, Perineal
=450  \\$wnnna$aNerves, Pudendal
=450  \\$wnnna$aPenile Nerve, Dorsal
=450  \\$wnnna$aPenile Nerves, Dorsal
=450  \\$wnnna$aPenis Dorsal Nerve
=450  \\$wnnna$aPenis Dorsal Nerves
=450  \\$wnnna$aPerineal Nerve
=450  \\$wnnna$aPerineal Nerves
=450  \\$wnnna$aPudendal Nerves
=550  \\$wg$aLumbosacral Plexus
=550  \\$aPeroneal Nerve
=667  \\$ado not confuse with PERONEAL NERVE
=680  \\$iA nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.
=688  \\$a2012
=750  \0$aPudendal nerve$0(DLC) sh 85108898$5IEN-M

=LDR  00678cz  a2200217n  4500
=001  9880364544702441
=005  20141212222339.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060447
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x100.$x121
=150  \\$aEmergency Shelter
=450  \\$wnnna$aEmergency Shelters
=450  \\$wnnna$aEvacuation Shelter
=450  \\$wnnna$aEvacuation Shelters
=450  \\$wnnna$aShelters, Emergency
=450  \\$wnnna$aShelters, Evacuation
=550  \\$wg$aDisasters
=680  \\$iTemporary shelter provided in response to a major disaster or emergency.
=688  \\$a2012
=750  \0$aEmergency housing$0(DLC) sh 85042742$5IEN-M

=LDR  00920cz  a2200229n  4500
=001  9880364544802441
=005  20141212222338.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060436
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x744.$x875
=150  \\$aSelf-Incompatibility in Flowering Plants
=450  \\$wnnna$aGametophytic Self-Incompatibilties
=450  \\$wnnna$aGametophytic Self-Incompatibilty
=450  \\$wnnna$aGametophytic Self Incompatibilty
=450  \\$wnnna$aSelf Incompatibility in Flowering Plants
=450  \\$wnnna$aSelf-Incompatibilties, Gametophytic
=450  \\$wnnna$aSelf-Incompatibilty, Gametophytic
=550  \\$wg$aPlant Physiological Processes
=680  \\$iOne of many different processes which occur in ANGIOSPERMS by which genetic diversity is maintained while INBREEDING is prevented.
=688  \\$a2012
=750  \0$aPlants$xSelf-incompatibility$0(DLC) sh 86007202$5IEN-M

=LDR  00723cz  a2200253n  4500
=001  9880364544902441
=005  20141212222338.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060434
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x547.$x600
=072  \\$aF1.$x145.$x407.$x758
=150  \\$aHerbivory
=450  \\$wnnna$aAnimal Grazing
=450  \\$wnnna$aAnimal Grazings
=450  \\$wnnna$aGrazing, Animal
=450  \\$wnnna$aGrazings, Animal
=450  \\$wnnna$aHerbivore
=450  \\$wnnna$aHerbivores
=450  \\$wnnna$aHerbivories
=550  \\$wg$aFeeding Behavior
=680  \\$iThe act of feeding on plants by animals.
=688  \\$a2012
=750  \0$aHerbivores$0(DLC) sh 85060349$5IEN-M

=LDR  00707cz  a2200193n  4500
=001  9880364545002441
=005  20141212222338.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060432
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x879.$x201.$x500
=072  \\$aI1.$x76.$x284
=150  \\$aAnthropology, Medical
=450  \\$aMedical Anthropology
=550  \\$wg$aAnthropology
=667  \\$aIM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate
=680  \\$iField of social science that is concerned with differences between human groups as related to health status and beliefs.
=688  \\$a2012
=750  \0$aMedical anthropology$0(DLC) sh 85082859$5IEN-M

=LDR  00597cz  a2200157n  4500
=001  9880364545102441
=005  20141212222335.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060406
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x808.$x756.$x71
=150  \\$aBrassinosteroids
=550  \\$wg$aPhytosterols
=680  \\$iPlant steroids ubiquitously distributed throughout the plant kingdom. They play essential roles in modulating growth and differentiation of cells at nanomolar to micromolar concentrations.
=688  \\$a2012
=750  \0$aBrassinosteroids$0(DLC) sh 91005031$5IEN-M

=LDR  01176cz  a2200361n  4500
=001  9880364545202441
=005  20141212193203.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060389
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x125
=150  \\$aConstruction Industry
=450  \\$wnnna$aBuilding Industries
=450  \\$wnnna$aBuilding Industry
=450  \\$wnnna$aBuilding Trade
=450  \\$wnnna$aBuilding Trades
=450  \\$wnnna$aConstruction Industries
=450  \\$wnnna$aConstruction Trade
=450  \\$wnnna$aConstruction Trades
=450  \\$wnnna$aIndustries, Building
=450  \\$wnnna$aIndustries, Construction
=450  \\$wnnna$aIndustry, Building
=450  \\$wnnna$aIndustry, Construction
=450  \\$wnnna$aTrade, Building
=450  \\$wnnna$aTrade, Construction
=450  \\$wnnna$aTrades, Building
=450  \\$wnnna$aTrades, Construction
=550  \\$wg$aManufacturing Industry
=550  \\$aConstruction Materials
=550  \\$aFacility Design and Construction
=680  \\$iThe aggregate business enterprise of building.
=688  \\$a2012
=750  \0$aConstruction industry$0(DLC) sh 85031360$5IEN-M

=LDR  01509cz  a2200325n  4500
=001  9880364545302441
=005  20160803131350.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG17.$x35.$x250.$x500.$x500.$x500
=072  \\$aL1.$x224.$x50.$x375.$x530.$x500.$x500
=072  \\$aL1.$x725.$x750
=150  \\$aSupport Vector Machine
=450  \\$wnnoa$aSupport Vector Machines
=450  \\$wnnna$aSupport Vector Network
=450  \\$wnnna$aSupport Vector Networks
=450  \\$wnnna$aMachine, Support Vector
=450  \\$wnnna$aMachines, Support Vector
=450  \\$wa Network, Support Vector
=450  \\$wa Networks, Support Vector
=450  \\$wnnna$aVector Machine, Support
=450  \\$wnnna$aVector Machines, Support
=450  \\$wnnna$aVector Network, Support
=450  \\$wnnna$aVector Networks, Support
=550  \\$wg$aSupervised Machine Learning
=550  \\$wg$aPattern Recognition, Automated
=680  \\$iSUPERVISED MACHINE LEARNING algorithm which learns to assign labels to objects from a set of training examples. Examples are learning to recognize fraudulent credit card activity by examing hundreds or thousands of fraudulent and non-fraudulent credit card activity, or learning to make disease diagnosis or prognosis based on automatic classification of microarray gene expression profiles drawn from hundreds or thousands of samples.
=688  \\$a2012
=750  \0$aSupport vector machines$0(DLC)sh2008009003$5IEN-M

=LDR  00666cz   2200205n  4500
=001  9880364545402441
=005  20230901102824.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060386
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x776
=150  \\$aSex Workers
=450  \\$wnnna$aProstitute
=450  \\$wnnna$aProstitutes
=450  \\$wnnna$aSex Worker
=550  \\$wg$aPersons
=680  \\$iPeople who engage in occupational sexual behavior in exchange for economic rewards or other extrinsic considerations.
=688  \\$a2012
=750  \0$aSex workers$0(DLC)sh2017000417$5IEN-M
=750  \0$iNarrower mapping$aWebcam models$0(DLC)sh2022006806$4NM$5IEN-M

=LDR  00743cz  a2200205n  4500
=001  9880364545502441
=005  20141212222332.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060345
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x213.$x199
=150  \\$aEducation of Hearing Disabled
=450  \\$wnnna$aDisabled Education, Hearing
=450  \\$wnnna$aEducation of Persons with Hearing Impairments
=450  \\$aPersons With Hearing Impairments$xeducation
=550  \\$wg$aEducation, Special
=680  \\$iThe teaching or training of those individuals with hearing disability or impairment.
=688  \\$a2012
=750  \0$aHearing impaired$xEducation$0(IEN)9729695$5IEN-M
=750  \0$aDeaf$xEducation$0(DLC) sh 85036048$5IEN-M

=LDR  00775cz  a2200217n  4500
=001  9880364545602441
=005  20141212222332.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060329
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x213.$x500
=150  \\$aEducation of Visually Disabled
=450  \\$wnnna$aEducation of Blind
=450  \\$wnnna$aEducation of Persons With Impaired Vision
=450  \\$wnnna$aVisually Disabled Education
=450  \\$aVisually Impaired Persons$xeducation
=550  \\$wg$aEducation, Special
=680  \\$iThe teaching or training of those individuals with visual disability.
=688  \\$a2012
=750  \0$aPeople with visual disabilities$xEducation$0(IEN)9729712$5IEN-M
=750  \0$aBlind$xEducation$0(DLC) sh 85014857$5IEN-M

=LDR  00788cz  a2200253n  4500
=001  9880364545702441
=005  20141212222332.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358
=150  \\$aMagnetic Phenomena
=450  \\$wnnna$aMagnetic Phenomenon
=450  \\$aMagnetism$5IEN
=450  \\$wnnna$aPhenomena, Magnetic
=450  \\$wnnna$aPhenomenon, Magnetic
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aElectromagnetic Phenomena
=550  \\$wh$aMagnetic Fields
=550  \\$aMagnets
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iCharacteristics, properties, and effects of magnetic substances and magnetic fields.
=688  \\$a2012
=750  \0$aMagnetism$0(DLC) sh 85079759$5IEN

=LDR  03087cz  a2200661n  4500
=001  9880364545802441
=005  20141212222331.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060327
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x39.$x500
=072  \\$aE5.$x916.$x840
=072  \\$aG2.$x607.$x750.$x155.$x500
=072  \\$aJ1.$x897.$x836.$x249.$x500
=150  \\$aSolid-Phase Synthesis Techniques
=450  \\$wnnna$aMethod, Solid-Phase Synthesis
=450  \\$wnnna$aMethods, Solid-Phase Synthesis
=450  \\$wnnna$aNucleotide Syntheses, Solid-Phase
=450  \\$wnnna$aNucleotide Synthesis, Solid-Phase
=450  \\$wnnna$aPeptide Syntheses, Solid-Phase
=450  \\$wnnna$aPeptide Synthesis, Solid-Phase
=450  \\$wnnna$aPeptide Synthesis, Solid Phase
=450  \\$wnnna$aSolid-Phase Nucleotide Syntheses
=450  \\$wnnna$aSolid-Phase Nucleotide Synthesis
=450  \\$wnnna$aSolid Phase Nucleotide Synthesis
=450  \\$wnnna$aSolid-Phase Nucleotide Synthesis Techniques
=450  \\$wnnna$aSolid Phase Nucleotide Synthesis Techniques
=450  \\$wnnna$aSolid-Phase Peptide Syntheses
=450  \\$wnnna$aSolid-Phase Peptide Synthesis
=450  \\$wnnna$aSolid Phase Peptide Synthesis
=450  \\$wnnna$aSolid-Phase Peptide Synthesis Techniques
=450  \\$wnnna$aSolid Phase Peptide Synthesis Techniques
=450  \\$wnnna$aSolid-Phase Syntheses
=450  \\$aSolid-Phase Synthesis
=450  \\$wnnna$aSolid Phase Synthesis
=450  \\$wnnna$aSolid-Phase Synthesis Method
=450  \\$wnnna$aSolid-Phase Synthesis Methods
=450  \\$wnnna$aSolid Phase Synthesis Methods
=450  \\$wnnna$aSolid-Phase Synthesis Technique
=450  \\$wnnna$aSolid Phase Synthesis Techniques
=450  \\$wnnna$aSyntheses, Solid-Phase
=450  \\$wnnna$aSyntheses, Solid-Phase Nucleotide
=450  \\$wnnna$aSyntheses, Solid-Phase Peptide
=450  \\$wnnna$aSynthesis Method, Solid-Phase
=450  \\$wnnna$aSynthesis Methods, Solid-Phase
=450  \\$wnnna$aSynthesis, Solid-Phase
=450  \\$wnnna$aSynthesis, Solid Phase
=450  \\$wnnna$aSynthesis, Solid-Phase Nucleotide
=450  \\$wnnna$aSynthesis, Solid-Phase Peptide
=450  \\$wnnna$aSynthesis Technique, Solid-Phase
=450  \\$wnnna$aSynthesis Techniques, Solid-Phase
=450  \\$wnnna$aTechnique, Solid-Phase Synthesis
=450  \\$wnnna$aTechniques, Solid-Phase Synthesis
=550  \\$wg$aChemistry Techniques, Synthetic
=550  \\$wg$aTechnology, Pharmaceutical
=680  \\$iTechniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.
=688  \\$a2012
=750  \0$aSolid-phase synthesis$0(DLC) sh 93001643$5IEN-M

=LDR  03674cz  a2200913n  4500
=001  9880364545902441
=005  20141212222330.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060326
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x39
=072  \\$aG2.$x607.$x750.$x155
=072  \\$aJ1.$x897.$x836.$x249
=150  \\$aChemistry Techniques, Synthetic
=450  \\$wnnna$aChemistry Technique, Synthetic
=450  \\$wnnna$aInorganic Syntheses
=450  \\$wnnna$aInorganic Synthesis
=450  \\$wnnna$aInorganic Synthesis Method
=450  \\$wnnna$aInorganic Synthesis Methods
=450  \\$wnnna$aInorganic Synthesis Technique
=450  \\$wnnna$aInorganic Synthesis Techniques
=450  \\$wnnna$aMethod, Inorganic Synthesis
=450  \\$wnnna$aMethod, Organic Synthesis
=450  \\$wnnna$aMethod, Peptide Synthesis
=450  \\$wnnna$aMethods, Inorganic Synthesis
=450  \\$wnnna$aMethods of Inorganic Synthesis
=450  \\$wnnna$aMethods of Organic Synthesis
=450  \\$wnnna$aMethods of Peptide Synthesis
=450  \\$wnnna$aMethods, Organic Synthesis
=450  \\$wnnna$aMethods, Peptide Synthesis
=450  \\$wnnna$aOrganic Syntheses
=450  \\$wnnna$aOrganic Synthesis
=450  \\$wnnna$aOrganic Synthesis Methods
=450  \\$wnnna$aOrganic Synthesis Technique
=450  \\$wnnna$aOrganic Synthesis Techniques
=450  \\$wnnna$aPeptide Syntheses, Synthetic
=450  \\$wnnna$aPeptide Synthesis Method
=450  \\$wnnna$aPeptide Synthesis Methods
=450  \\$wnnna$aPeptide Synthesis, Synthetic
=450  \\$wnnna$aPeptide Synthesis Technique
=450  \\$wnnna$aPeptide Synthesis Techniques
=450  \\$wnnna$aSyntheses, Inorganic
=450  \\$wnnna$aSyntheses, Organic
=450  \\$wnnna$aSyntheses, Synthetic Peptide
=450  \\$wnnna$aSynthesis, Inorganic
=450  \\$wnnna$aSynthesis Method, Inorganic
=450  \\$wnnna$aSynthesis Method, Peptide
=450  \\$wnnna$aSynthesis Methods, Inorganic
=450  \\$wnnna$aSynthesis Methods, Peptide
=450  \\$wnnna$aSynthesis, Organic
=450  \\$wnnna$aSynthesis, Synthetic Peptide
=450  \\$wnnna$aSynthesis Technique, Inorganic
=450  \\$wnnna$aSynthesis Technique, Organic
=450  \\$wnnna$aSynthesis Technique, Peptide
=450  \\$wnnna$aSynthesis Techniques, Inorganic
=450  \\$wnnna$aSynthesis Techniques, Organic
=450  \\$wnnna$aSynthesis Techniques, Peptide
=450  \\$wnnna$aSynthetic Chemistry Technique
=450  \\$wnnna$aSynthetic Chemistry Techniques
=450  \\$wnnna$aSynthetic Peptide Syntheses
=450  \\$wnnna$aSynthetic Peptide Synthesis
=450  \\$wnnna$aTechnique, Inorganic Synthesis
=450  \\$wnnna$aTechnique, Organic Synthesis
=450  \\$wnnna$aTechnique, Peptide Synthesis
=450  \\$wnnna$aTechnique, Synthetic Chemistry
=450  \\$wnnna$aTechniques, Inorganic Synthesis
=450  \\$wnnna$aTechniques, Organic Synthesis
=450  \\$wnnna$aTechniques, Peptide Synthesis
=450  \\$wnnna$aTechniques, Synthetic Chemistry
=550  \\$wg$aOrganic Chemistry Processes
=550  \\$wg$aTechnology, Pharmaceutical
=550  \\$wh$aClick Chemistry
=550  \\$wh$aCombinatorial Chemistry Techniques
=550  \\$wh$aCycloaddition Reaction
=550  \\$wh$aSolid-Phase Synthesis Techniques
=680  \\$iMethods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.
=688  \\$a2012
=750  \0$aInorganic compounds$xSynthesis$0sh 85023020$5IEN
=750  \0$aOrganic compounds$xSynthesis$0sh 85023025$5IEN

=LDR  00576cz  a2200193n  4500
=001  9880364546002441
=005  20141212222329.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x540
=150  \\$aMagnetometry
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aMagnetocardiography
=550  \\$wh$aMagnetoencephalography
=550  \\$aMagnetic Phenomena
=680  \\$iThe measurement of various aspects of MAGNETIC FIELDS.
=688  \\$a2012
=750  \0$aMagnetic fields$xMeasurement$0(DLC)sh2010100295$5IEN-M

=LDR  00769cz  a2200253n  4500
=001  9880364546102441
=005  20141212222327.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x518
=150  \\$aImaginal Discs
=450  \\$wnnna$aDisc, Imaginal
=450  \\$wnnna$aDiscs, Imaginal
=450  \\$wnnna$aDisk, Imaginal
=450  \\$wnnna$aDisks, Imaginal
=450  \\$wnnna$aImaginal Disc
=450  \\$wnnna$aImaginal Disk
=450  \\$wnnna$aImaginal Disks
=550  \\$wg$aAnimal Structures
=550  \\$aLarva
=680  \\$iHollow sacs of cells in LARVA that form adult structures in insects during BIOLOGICAL METAMORPHOSIS.
=688  \\$a2012
=750  \0$aImaginal disks$0(DLC) sh 85064455$5IEN-M

=LDR  00944cz  a2200277n  4500
=001  9880364546202441
=005  20141212222321.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060145
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x377.$x666
=072  \\$aL1.$x178.$x847.$x698.$x300.$x500
=150  \\$aText Messaging
=450  \\$wnnna$aMessage, Text
=450  \\$wnnna$aMessages, Text
=450  \\$wnnna$aMessaging, Text
=450  \\$wnnna$aShort Message Service
=450  \\$wnnna$aText Message
=450  \\$wnnna$aText Messages
=450  \\$wnnna$aTexting
=450  \\$wnnna$aTextings
=550  \\$wg$aCell Phones
=550  \\$wg$aCorrespondence as Topic
=680  \\$iCommunication between CELL PHONE users via the Short Message Service protocol which allows the interchange of short written messages.
=688  \\$a2012
=750  \0$aText messaging (Cell phone systems)$0(DLC)sh2012001654$5IEN-M

=LDR  00708cz  a2200241n  4500
=001  9880364546302441
=005  20141212222320.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x130.$x150
=150  \\$aCharacidae
=450  \\$wnnna$aCharacid
=450  \\$wnnna$aCharacids
=450  \\$wnnna$aCharacin
=450  \\$wnnna$aCharacins
=450  \\$wnnna$aTetra
=450  \\$wnnna$aTetragonopterus
=450  \\$wnnna$aTetras
=550  \\$wg$aCharaciformes
=680  \\$iA family of fresh water fish in the order CHARACIFORMES, which includes the Tetras.
=688  \\$a2012
=750  \0$aCharacidae$0(DLC) sh 85022613$5IEN-M

=LDR  00817cz  a2200229n  4500
=001  9880364546402441
=005  20250501163609.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060125
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x130
=150  \\$aCharaciformes
=450  \\$wnnna$aPiranha
=450  \\$wnnna$aPiranhas
=550  \\$wg$aFishes
=550  \\$wh$aCharacidae
=680  \\$iAn order of fresh water fish with 18 families and over 1600 species. The order includes CHARACINS, hatchetfish, piranhas, and TETRAS.
=688  \\$a2012
=750  \0$aCharaciformes$0(DLC) sh 85022614$5IEN-M
=750  \0$iNarrower mapping$aBryconidae$0(DLC)sh2023002710$4NM$5IEN-M
=750  \0$iNarrower mapping$aCynodontidae$0(DLC)sh2023002714$4NM$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  00706cz  a2200229n  4500
=001  9880364546502441
=005  20141212222320.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x580
=072  \\$aG16.$x500.$x275.$x280.$x500
=072  \\$aN6.$x230.$x232.$x500
=150  \\$aLakes
=450  \\$wnnna$aLake
=450  \\$wnnna$aLakes, Soda
=450  \\$wnnna$aSoda Lakes
=550  \\$wg$aFresh Water
=550  \\$wg$aGeological Phenomena
=680  \\$iInland bodies of still or slowly moving FRESH WATER or salt water, larger than a pond, and supplied by RIVERS and streams.
=688  \\$a2012
=750  \0$aLakes$0(DLC) sh 85074030$5IEN-M

=LDR  00963cz  a2200289n  4500
=001  9880364546602441
=005  20141212222320.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060086
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x355.$x750.$x500.$x400
=150  \\$aHydrothermal Vents
=450  \\$wnnna$aBlack Smoker Vent
=450  \\$wnnna$aBlack Smoker Vents
=450  \\$wnnna$aDeep Sea Vent
=450  \\$wnnna$aDeep Sea Vents
=450  \\$wnnna$aHydrothermal Vent
=450  \\$wnnna$aVent, Black Smoker
=450  \\$wnnna$aVent, Deep Sea
=450  \\$wnnna$aVent, Hydrothermal
=450  \\$wnnna$aVents, Black Smoker
=450  \\$wnnna$aVents, Deep Sea
=450  \\$wnnna$aVents, Hydrothermal
=550  \\$wg$aHot Springs
=680  \\$iHot springs on the ocean floor. They are commonly found near volcanically active places such as mid-oceanic ridges.
=688  \\$a2012
=750  \0$aHydrothermal vents$0(DLC) sh 85063499$5IEN-M

=LDR  01407cz  a2200409n  4500
=001  9880364546702441
=005  20141212222319.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060085
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x218
=072  \\$aC2.$x219
=072  \\$aC3.$x202
=150  \\$aCoinfection
=450  \\$wnnna$aCo-infection
=450  \\$wnnna$aCo infection
=450  \\$wnnna$aCo-infections
=450  \\$wnnna$aCoinfections
=450  \\$wnnna$aInfection, Mixed
=450  \\$wnnna$aInfection, Polymicrobial
=450  \\$wnnna$aInfection, Secondary
=450  \\$wnnna$aInfections, Mixed
=450  \\$wnnna$aInfections, Polymicrobial
=450  \\$wnnna$aInfections, Secondary
=450  \\$aMixed Infection
=450  \\$wnnna$aMixed Infections
=450  \\$wnnna$aPolymicrobial Infection
=450  \\$wnnna$aPolymicrobial Infections
=450  \\$wnnna$aSecondary Infection
=450  \\$wnnna$aSecondary Infections
=550  \\$wg$aInfection
=550  \\$wg$aParasitic Diseases
=550  \\$wg$aVirus Diseases
=667  \\$acoordinate with specific infections if pertinent
=680  \\$iSimultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.
=688  \\$a2012
=750  \0$aMixed infections$0(DLC) sh 90004047$5IEN-M

=LDR  00618cz  a2200181n  4500
=001  9880364546802441
=005  20141212222318.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060054
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x700.$x24
=072  \\$aB3.$x660.$x50.$x730.$x24
=150  \\$aAgrobacterium
=550  \\$wg$aRhizobiaceae
=550  \\$wh$aAgrobacterium tumefaciens
=680  \\$iA genus of gram negative, aerobic, rod-shaped bacteria found in soil, plants, and marine mud.
=688  \\$a2012, 1963-2003; use RHIZOBIUM 1963-2011
=750  \0$aAgrobacterium$0(DLC) sh 88023209$5IEN-M

=LDR  00984cz  a2200229n  4500
=001  9880364546902441
=005  20141212222316.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060047
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x44.$x675
=072  \\$aG16.$x100.$x178.$x802
=150  \\$aReproductive Isolation
=450  \\$wnnna$aHybridization Barriers
=450  \\$wnnna$aIsolation, Reproductive
=450  \\$wnnna$aIsolations, Reproductive
=450  \\$wnnna$aReproductive Isolations
=550  \\$wg$aBiological Evolution
=667  \\$apermitted with animals, plants and microorganisms
=680  \\$iMechanisms that prevent different populations from exchanging genes (GENE FLOW), resulting in or maintaining GENETIC SPECIATION. It can either prevent mating to take place or ensure that any offspring produced is either inviable or sterile, thereby preventing further REPRODUCTION.
=688  \\$a2012
=750  \0$aIsolating mechanisms$0(DLC) sh 85068639$5IEN-M

=LDR  00582cz  a2200169n  4500
=001  9880364547002441
=005  20141212222315.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060026
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x237
=150  \\$aEndophytes
=550  \\$wg$aOrganism Forms
=550  \\$aSymbiosis
=680  \\$iAn endosymbiont that is either a bacterium or fungus living part of its life in a plant. Endophytes can benefit host plants by preventing pathogenic organisms from colonizing them.
=688  \\$a2012
=750  \0$aEndophytes$0(DLC) sh 93003414$5IEN-M

=LDR  00983cz  a2200289n  4500
=001  9880364547102441
=005  20141212222314.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059952
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x483
=072  \\$aC13.$x351.$x625
=072  \\$aC13.$x703.$x565
=150  \\$aPelvic Floor Disorders
=450  \\$wnnna$aDisease, Pelvic Floor
=450  \\$wnnna$aDiseases, Pelvic Floor
=450  \\$wnnna$aDisorder, Pelvic Floor
=450  \\$wnnna$aDisorders, Pelvic Floor
=450  \\$wnnna$aPelvic Floor Disease
=450  \\$wnnna$aPelvic Floor Diseases
=450  \\$wnnna$aPelvic Floor Disorder
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wg$aPregnancy Complications
=680  \\$iInjury, weakening, or PROLAPSE of the pelvic muscles, surrounding connective tissues or ligaments (PELVIC FLOOR).
=688  \\$a2012
=750  \0$aPelvic floor$xDiseases$0(IEN)9795481$5IEN-M

=LDR  00944cz  a2200277n  4500
=001  9880364547202441
=005  20141212222308.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578
=072  \\$aE1.$x370.$x376.$x537
=072  \\$aE5.$x629
=150  \\$aNeuroimaging
=450  \\$wnnna$aBrain Imaging
=450  \\$wnnna$aImaging, Brain
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aDiffusion Tensor Imaging
=550  \\$wh$aFunctional Neuroimaging
=550  \\$wh$aNeuroradiography
=667  \\$acoordinate with specific imaging modality if appropriate
=680  \\$iNon-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.
=688  \\$a2012
=750  \0$aBrain$xImaging$0(DLC)sh2008117487$5IEN-M

=LDR  00624cz  a2200217n  4500
=001  9880364547302441
=005  20141212222304.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x750
=150  \\$aPlant Cells
=450  \\$wnnna$aCell, Plant
=450  \\$wnnna$aCells, Plant
=450  \\$wnnna$aPlant Cell
=450  \\$aPlants$xcytology
=550  \\$wg$aCells
=667  \\$aGeneral or unspecified. prefer specific plant with /cytol.
=680  \\$iBasic functional unit of plants.
=688  \\$a2012
=750  \0$aPlant cells and tissues$0(DLC) sh 85102712$5IEN-M

=LDR  01340cz  a2200385n  4500
=001  9880364547402441
=005  20141212193202.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059827
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x53
=072  \\$aB3.$x54
=150  \\$aAgricultural Inoculants
=450  \\$wnnna$aAgricultural Inoculant
=450  \\$wnnna$aBacterial Inoculant
=450  \\$wnnna$aBacterial Inoculants
=450  \\$wnnna$aFungal Inoculant
=450  \\$wnnna$aFungal Inoculants
=450  \\$wnnna$aInoculant, Agricultural
=450  \\$wnnna$aInoculant, Bacterial
=450  \\$wnnna$aInoculant, Fungal
=450  \\$wnnna$aInoculant, Microbial
=450  \\$wnnna$aInoculants, Agricultural
=450  \\$wnnna$aInoculants, Bacterial
=450  \\$wnnna$aInoculants, Fungal
=450  \\$wnnna$aInoculants, Microbial
=450  \\$wnnna$aMicrobial Inoculant
=450  \\$aMicrobial Inoculants
=550  \\$wg$aBacteria
=550  \\$wg$aFungi
=550  \\$aAgriculture
=550  \\$aEnvironmental Restoration and Remediation
=680  \\$iBeneficial microorganisms (bacteria or fungi) encapsulated in carrier material and applied to the environment for remediation and enhancement of agricultural productivity.
=688  \\$a2012
=750  \0$aMicrobial inoculants$0(DLC) sh 89001177$5IEN-M

=LDR  00891cz  a2200253n  4500
=001  9880364547502441
=005  20141212222303.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059825
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x739
=072  \\$aN2.$x360.$x67.$x735
=150  \\$aPhysical Therapists
=450  \\$wnnna$aPhysical Therapist
=450  \\$wnnna$aPhysiotherapist
=450  \\$wnnna$aPhysiotherapists
=450  \\$wnnna$aTherapist, Physical
=450  \\$wnnna$aTherapists, Physical
=550  \\$wg$aAllied Health Personnel
=550  \\$aPhysical Therapy Modalities
=550  \\$aPhysical Therapy Specialty
=680  \\$iPersons trained in PHYSICAL THERAPY SPECIALTY to make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction.
=688  \\$a2012
=750  \0$aPhysical therapists$0(DLC) sh 85101566$5IEN-M

=LDR  00592cz  a2200193n  4500
=001  9880364547602441
=005  20141212222302.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059808
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x715
=072  \\$aD3.$x438.$x150.$x266.$x450.$x260.$x777
=150  \\$aPolyphenols
=450  \\$wnnna$aProvinols
=550  \\$wg$aFlavones
=550  \\$wg$aPhenols
=680  \\$iA large class of organic compounds having more than one PHENOL group.
=688  \\$a2012 (2010)
=750  \0$aPolyphenols$0(DLC) sh 88004563$5IEN-M

=LDR  00734cz  a2200193n  4500
=001  9880364547702441
=005  20141212222300.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x162.$x679
=150  \\$aKaryotype
=450  \\$wnnna$aKaryotypes
=550  \\$wg$aChromosomes
=550  \\$wh$aAbnormal Karyotype
=550  \\$aKaryotyping
=680  \\$iThe full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed)
=688  \\$a2012
=750  \0$aKaryotypes$0(DLC) sh 85071686$5IEN

=LDR  00796cz  a2200217n  4500
=001  9880364547802441
=005  20141212222025.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x750.$x380
=150  \\$aGnathostomiasis
=450  \\$aGnathostoma Infection
=450  \\$wnnna$aGnathostoma Infections
=450  \\$wnnna$aGnathostomiases
=450  \\$wnnna$aInfection, Gnathostoma
=450  \\$wnnna$aInfections, Gnathostoma
=550  \\$wg$aSpirurida Infections
=680  \\$iInfections with nematodes of the genus GNATHOSTOMA, superfamily THELAZIOIDEA. Gnathostomiasis is a food-borne zoonosis caused by eating undercooked or raw fish or meat.
=688  \\$a2011
=750  \0$aGnathostomiasis$0(DLC) sh 87000738$5IEN-M

=LDR  00823cz  a2200217n  4500
=001  9880364547902441
=005  20141212222025.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058428
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x837.$x725.$x700.$x379
=072  \\$aD20.$x280.$x320.$x687
=072  \\$aD26.$x255.$x165.$x320.$x687
=150  \\$aSilica Gel
=450  \\$wnnna$aGel, Silica
=450  \\$wnnna$aSilochrome
=550  \\$wg$aGels
=550  \\$wg$aSilicic Acid
=680  \\$iA non-crystalline form of silicon oxide that has absorptive properties. It is commonly used as a desiccating agent and as a stationary phase for CHROMATOGRAPHY. The fully hydrated form of silica gel has distinct properties and is referred to as SILICIC ACID.
=688  \\$a2011
=750  \0$aSilica gel$0(DLC) sh 85122499$5IEN-M

=LDR  00686cz  a2200229n  4500
=001  9880364548002441
=005  20141212222025.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x369
=072  \\$aD27.$x720.$x470.$x370
=150  \\$aHygroscopic Agents
=450  \\$wnnna$aAgents, Hygroscopic
=450  \\$aDesiccants
=450  \\$wnnna$aDrying Agents
=450  \\$wnnna$aHumectants
=550  \\$wg$aLaboratory Chemicals
=550  \\$wg$aSpecialty Uses of Chemicals
=680  \\$iMaterials that readily absorb moisture from their surroundings.
=688  \\$a2011
=750  \0$aDrying agents$0(DLC) sh 85039817$5IEN-M

=LDR  00726cz  a2200193n  4500
=001  9880364548102441
=005  20141212222018.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058326
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x690.$x450
=150  \\$aIschnocera
=450  \\$wnnna$aBovicola
=450  \\$wnnna$aDamalinia
=550  \\$wg$aPhthiraptera
=667  \\$ainfestation: coordinate IM with LICE INFESTATIONS (IM); for killing Ischnocera with insecticides, see note at INSECTICIDES
=680  \\$iA suborder of chewing lice, in the order PHTHIRAPTERA, that are parasites of birds and mammals.
=688  \\$a2011; use PHTHIRAPTERA 1999-2010
=750  \0$aBovicola$0(DLC) sh 85016138$5IEN-M

=LDR  01339cz  a2200289n  4500
=001  9880364548202441
=005  20141212222015.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058266
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x335
=150  \\$aDielectric Spectroscopy
=450  \\$wnnna$aElectrochemical Impedance Spectroscopies
=450  \\$wnnna$aElectrochemical Impedance Spectroscopy
=450  \\$wnnna$aImpedance Spectroscopies
=450  \\$wnnna$aImpedance Spectroscopies, Electrochemical
=450  \\$wnnna$aImpedance Spectroscopy
=450  \\$wnnna$aImpedance Spectroscopy, Electrochemical
=450  \\$wnnna$aSpectroscopies, Electrochemical Impedance
=450  \\$wnnna$aSpectroscopies, Impedance
=450  \\$wnnna$aSpectroscopy, Dielectric
=450  \\$wnnna$aSpectroscopy, Electrochemical Impedance
=450  \\$wnnna$aSpectroscopy, Impedance
=550  \\$wg$aSpectrum Analysis
=680  \\$iA technique of measuring the dielectric properties of materials, which vary over a range of frequencies depending on the physical properties of the material. The technique involves measuring, over a range of frequencies, ELECTRICAL IMPEDANCE and phase shift of an electric field as it passes through the material.
=688  \\$a2011
=750  \0$aDielectric Spectroscopy$0(DLC)sh2002007143$5IEN-M

=LDR  00970cz  a2200253n  4500
=001  9880364548302441
=005  20141212222013.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058260
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x750.$x950
=150  \\$aXenopsylla
=450  \\$wnnna$aFlea, Oriental Rat
=450  \\$wnnna$aFleas, Oriental Rat
=450  \\$wnnna$aOriental Rat Flea
=450  \\$wnnna$aOriental Rat Fleas
=450  \\$wnnna$aRat Flea, Oriental
=450  \\$wnnna$aRat Fleas, Oriental
=450  \\$wnnna$aXenopsylla cheopis
=550  \\$wg$aSiphonaptera
=667  \\$ainfestation: coordinate IM with FLEA INFESTATIONS (IM); for killing Xenopsylla with insecticides, see note at INSECTICIDES
=680  \\$iA genus of fleas in the family Pulicidae which includes the species that serves as the primary vector of BUBONIC PLAGUE, Xenopsylla cheopis.
=688  \\$a2011
=750  \0$aXenopsylla$0(DLC) sh 85148801$5IEN-M

=LDR  01172cz  a2200361n  4500
=001  9880364548402441
=005  20141212222012.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058257
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x877
=072  \\$aE7.$x858.$x594
=150  \\$aSurgical Attire
=450  \\$wnnna$aAttire, Surgical
=450  \\$wnnna$aAttires, Surgical
=450  \\$wnnna$aCover, Surgical Shoe
=450  \\$wnnna$aCovers, Surgical Shoe
=450  \\$wnnna$aGown, Surgical
=450  \\$wnnna$aGowns, Surgical
=450  \\$wnnna$aShoe Cover, Surgical
=450  \\$wnnna$aShoe Covers, Surgical
=450  \\$wnnna$aSurgical Attires
=450  \\$wnnna$aSurgical Gown
=450  \\$wnnna$aSurgical Gowns
=450  \\$wnnna$aSurgical Shoe Cover
=450  \\$wnnna$aSurgical Shoe Covers
=550  \\$wg$aEquipment and Supplies, Hospital
=550  \\$wg$aSurgical Equipment
=550  \\$wh$aGloves, Surgical
=550  \\$wh$aMasks
=680  \\$iSterile clothing worn during surgical procedures to protect the surgical site from sources of contamination.
=688  \\$a2011
=750  \0$aSurgical gowns$0(DLC) sh 85130798$5IEN-M

=LDR  02017cz  a2200601n  4500
=001  9880364548502441
=005  20141212222011.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058254
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x220.$x500
=072  \\$aN2.$x421.$x297.$x879.$x550
=150  \\$aStretchers
=450  \\$wnnna$aAmbulance Stretcher
=450  \\$wnnna$aAmbulance Stretchers
=450  \\$wnnna$aEmergency Room Stretcher
=450  \\$wnnna$aEmergency Room Stretchers
=450  \\$wnnna$aGurney
=450  \\$wnnna$aGurneys
=450  \\$wnnna$aHolding Stretcher, Patient
=450  \\$wnnna$aHolding Stretchers, Patient
=450  \\$wnnna$aLitter, Patient
=450  \\$wnnna$aLitters, Patient
=450  \\$wnnna$aPatient Holding Stretcher
=450  \\$aPatient Holding Stretchers
=450  \\$wnnna$aPatient Litter
=450  \\$wnnna$aPatient Litters
=450  \\$wnnna$aPatient Trolley
=450  \\$wnnna$aPatient Trolleys
=450  \\$wnnna$aRescue Stretcher
=450  \\$wnnna$aRescue Stretchers
=450  \\$wnnna$aRoom Stretcher, Emergency
=450  \\$wnnna$aRoom Stretchers, Emergency
=450  \\$wnnna$aStretcher, Ambulance
=450  \\$wnnna$aStretcher, Emergency Room
=450  \\$wnnna$aStretcher, Patient Holding
=450  \\$wnnna$aStretcher, Rescue
=450  \\$wnnna$aStretcher, Wheeled
=450  \\$wnnna$aStretchers, Ambulance
=450  \\$wnnna$aStretchers, Emergency Room
=450  \\$wnnna$aStretchers, Patient Holding
=450  \\$wnnna$aStretchers, Rescue
=450  \\$wnnna$aStretchers, Wheeled
=450  \\$wnnna$aTrolley, Patient
=450  \\$wnnna$aTrolleys, Patient
=450  \\$wnnna$aWheeled Stretcher
=450  \\$wnnna$aWheeled Stretchers
=550  \\$wg$aBeds
=550  \\$wg$aTransportation of Patients
=550  \\$aTransportation of Patients
=680  \\$iBed-like structures for transporting or temporarily holding patients.
=688  \\$a2011
=750  \0$aLitters$0(DLC) sh 85077674$5IEN-M

=LDR  00954cz  a2200289n  4500
=001  9880364548602441
=005  20141212222010.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058253
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x750.$x800
=150  \\$aTunga
=450  \\$wnnna$aChigoe Flea
=450  \\$wnnna$aChigoe Fleas
=450  \\$wnnna$aFlea, Chigoe
=450  \\$wnnna$aFlea, Jigger
=450  \\$wnnna$aFleas, Chigoe
=450  \\$wnnna$aFleas, Jigger
=450  \\$wnnna$aJigger Flea
=450  \\$wnnna$aJigger Fleas
=450  \\$aSand Flea
=450  \\$aTunga penetrans
=550  \\$wg$aSiphonaptera
=667  \\$ainfestation = TUNGIASIS; for killing Tunga with insecticides, see note at INSECTICIDES
=680  \\$iA genus of parasitic fleas in the family Pulicidae. They are found mainly in Africa, South America, and Central America.
=688  \\$a2011
=750  \0$aTunga$0(DLC) sh 85138604$5IEN-M

=LDR  00861cz  a2200229n  4500
=001  9880364548702441
=005  20141212222010.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058251
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x750.$x200
=150  \\$aCtenocephalides
=450  \\$wnnna$aCat Flea
=450  \\$wnnna$aCat Fleas
=450  \\$wnnna$aCtenocephalides felis
=450  \\$wnnna$aFlea, Cat
=450  \\$wnnna$aFleas, Cat
=550  \\$wg$aSiphonaptera
=667  \\$ainfestation: coordinate IM with FLEA INFESTATIONS (IM); for killing Ctenocephalides with insecticides, see note at INSECTICIDES
=680  \\$iA genus of FLEAS in the family Pulicidae. It includes the cat flea (Ctenocephalides felis), one of the most common species on earth.
=688  \\$a2011
=750  \0$aCtenocephalides$0(DLC) sh 89005037$5IEN-M

=LDR  01476cz  a2200349n  4500
=001  9880364548802441
=005  20141212193142.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058228
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x587.$x334
=072  \\$aD12.$x644.$x548.$x586.$x234
=072  \\$aD12.$x776.$x49.$x407.$x500
=150  \\$aIslet Amyloid Polypeptide
=450  \\$wnnna$aAmlintide
=450  \\$wnnna$aAmylin
=450  \\$wnnna$aAmylin, Pancreatic
=450  \\$wnnna$aAmyloid Polypeptide, Insulinoma
=450  \\$wnnna$aAmyloid Polypeptide, Islet
=450  \\$wnnna$aIAPP Precursor
=450  \\$wnnna$aIAPP Protein
=450  \\$wnnna$aInsulinoma Amyloid Polypeptide
=450  \\$wnnna$aInsulinoma Amyloid Polypeptide Precursor
=450  \\$wnnna$aIslet Amyloid Polypeptide Precursor
=450  \\$wnnna$aPancreatic Amylin
=450  \\$wnnna$aPolypeptide, Insulinoma Amyloid
=450  \\$wnnna$aPolypeptide, Islet Amyloid
=550  \\$wg$aAmyloidogenic Proteins
=550  \\$wg$aPancreatic Hormones
=680  \\$iA pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.
=688  \\$a2011
=750  \0$aAmylin$0(DLC) sh 99004438$5IEN-M

=LDR  01389cz  a2200385n  4500
=001  9880364548902441
=005  20141212222008.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058226
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x823
=150  \\$aPlaque, Atherosclerotic
=450  \\$wnnna$aArterial Fatty Streak
=450  \\$wnnna$aArterial Fatty Streaks
=450  \\$wnnna$aAtheroma
=450  \\$wnnna$aAtheromas
=450  \\$wnnna$aAtheromatous Plaques
=450  \\$wnnna$aAtherosclerotic Plaque
=450  \\$wnnna$aAtherosclerotic Plaques
=450  \\$wnnna$aFatty Streak, Arterial
=450  \\$wnnna$aFatty Streaks, Arterial
=450  \\$wnnna$aFibroatheroma
=450  \\$wnnna$aFibroatheromas
=450  \\$wnnna$aFibroatheromatous Plaque
=450  \\$wnnna$aFibroatheromatous Plaques
=450  \\$wnnna$aPlaque, Fibroatheromatous
=450  \\$wnnna$aPlaques, Atherosclerotic
=450  \\$wnnna$aPlaques, Fibroatheromatous
=450  \\$wnnna$aStreak, Arterial Fatty
=450  \\$wnnna$aStreaks, Arterial Fatty
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$aAtherosclerosis
=680  \\$iLesions formed within the walls of ARTERIES.
=688  \\$a2011; for FATTY STREAK, ARTERIAL use ATHEROSCLEROSIS 1963-2010; for ATHEROMA use ATHEROSCLEROSIS 1984-2010
=750  \0$aAtherosclerotic plaque$0(DLC) (DNLM)D057685$5IEN-M

=LDR  00784cz  a2200241n  4500
=001  9880364549002441
=005  20141212222006.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058206
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x430.$x214
=072  \\$aD27.$x720.$x642.$x315.$x249
=150  \\$aHair Bleaching Agents
=450  \\$wnnna$aAgents, Hair Bleaching
=450  \\$wnnna$aAgents, Hair Lightening
=450  \\$wnnna$aBleaching Agents, Hair
=450  \\$wnnna$aHair Lightening Agents
=450  \\$wnnna$aLightening Agents, Hair
=550  \\$wg$aBleaching Agents
=550  \\$wg$aHair Preparations
=680  \\$iChemicals that are used to oxidize pigments in HAIR.
=688  \\$a2011
=750  \0$aHair$xDyeing and bleaching$0(DLC) sh 85058309$5IEN-M

=LDR  01932cz  a2200481n  4500
=001  9880364549102441
=005  20141212222006.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x780.$x50
=072  \\$aC13.$x351.$x968.$x419.$x780.$x50
=150  \\$aAcute Kidney Injury
=450  \\$wnnna$aAcute Kidney Failure
=450  \\$wnnna$aAcute Kidney Failures
=450  \\$wnnna$aAcute Kidney Injuries
=450  \\$wnnna$aAcute Kidney Insufficiencies
=450  \\$wnnna$aAcute Kidney Insufficiency
=450  \\$wnnna$aAcute Renal Failure
=450  \\$wnnna$aAcute Renal Failures
=450  \\$wnnna$aAcute Renal Injuries
=450  \\$wnnna$aAcute Renal Injury
=450  \\$wnnna$aAcute Renal Insufficiencies
=450  \\$wnnna$aAcute Renal Insufficiency
=450  \\$wnnna$aKidney Failure, Acute
=450  \\$wnnna$aKidney Failures, Acute
=450  \\$wnnna$aKidney Injuries, Acute
=450  \\$wnnna$aKidney Injury, Acute
=450  \\$wnnna$aKidney Insufficiencies, Acute
=450  \\$wnnna$aKidney Insufficiency, Acute
=450  \\$wnnna$aRenal Failure, Acute
=450  \\$wnnna$aRenal Failures, Acute
=450  \\$wnnna$aRenal Injuries, Acute
=450  \\$wnnna$aRenal Injury, Acute
=450  \\$wnnna$aRenal Insufficiencies, Acute
=450  \\$wnnna$aRenal Insufficiency, Acute
=550  \\$wg$aRenal Insufficiency
=550  \\$wh$aKidney Tubular Necrosis, Acute
=667  \\$atraumatic kidney injury: index KIDNEY/ inj
=680  \\$iAbrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
=688  \\$a2011
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20110909: 150:##:_{dollar}a Kidney Failure, Acute
=750  \0$aAcute renal failure$0(DLC) sh 85112815$5IEN-M

=LDR  00868cz  a2200169n  4500
=001  9880364549202441
=005  20141212222004.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058131
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x990.$x800
=150  \\$aSpirogyra
=550  \\$wg$aZygnematales
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of filamentous algae in the order ZYGNEMATALES, family Zygnemataceae, named for the helical arrangement of its CHLOROPLASTS. It is commonly found in freshwater habitats.
=688  \\$a2011
=750  \0$aSpirogyra$0(DLC) sh 88022473$5IEN-M

=LDR  00859cz  a2200193n  4500
=001  9880364549302441
=005  20141212222003.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058129
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x990
=150  \\$aZygnematales
=550  \\$wg$aCharophyceae
=550  \\$wh$aMougeotia
=550  \\$wh$aSpirogyra
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAn order of freshwater algae possessing unbranched filaments. Sexual reproduction takes place via conjugation.
=688  \\$a2011
=750  \0$aZygnematales$0(DLC) sh 85037220$5IEN-M

=LDR  00818cz  a2200181n  4500
=001  9880364549402441
=005  20141212222001.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058120
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x200.$x500
=150  \\$aMicrasterias
=450  \\$wnnna$aMicrasteria
=550  \\$wg$aDesmidiales
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of unicellular streptophyte algae in the family Desmidiaceae, order DESMIDIALES.
=688  \\$a2011
=750  \0$aMicrasterias$0(DLC) sh 85084720$5IEN-M

=LDR  00845cz  a2200229n  4500
=001  9880364549502441
=005  20141212222000.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058117
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x319.$x381.$x500
=072  \\$aE7.$x695.$x202.$x381.$x500
=150  \\$aNeural Prostheses
=450  \\$wnnna$aNeural Prosthesis
=450  \\$wnnna$aProstheses, Neural
=450  \\$wnnna$aProsthesis, Neural
=550  \\$wg$aImplantable Neurostimulators
=550  \\$wh$aAuditory Brain Stem Implants
=550  \\$wh$aCochlear Implants
=680  \\$iMedical devices which substitute for a nervous system function by electrically stimulating the nerves directly and monitoring the response to the electrical stimulation.
=688  \\$a2011
=750  \0$aNeuroprostheses$0(DLC)sh2008009942$5IEN-M

=LDR  00572cz  a2200193n  4500
=001  9880364549602441
=005  20141212222000.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058116
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x630
=072  \\$aD2.$x561
=150  \\$aLewis Acids
=450  \\$wnnna$aAcids, Lewis
=550  \\$wg$aAcids
=550  \\$wg$aOrganic Chemicals
=680  \\$iAny chemical species which accepts an electron-pair from a LEWIS BASE in a chemical bonding reaction.
=688  \\$a2011
=750  \0$aLewis acids$0(DLC) sh 89004433$5IEN-M

=LDR  00946cz  a2200193n  4500
=001  9880364549702441
=005  20141212221959.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058112
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x330.$x300.$x700
=072  \\$aD12.$x776.$x157.$x325.$x757
=072  \\$aD12.$x776.$x220.$x932
=150  \\$aSeptins
=550  \\$wg$aCytoskeletal Proteins
=550  \\$wg$aGTP-Binding Proteins
=680  \\$iA family of GTP-binding proteins that were initially identified in YEASTS where they were shown to initiate the process of septation and bud formation. Septins form into hetero-oligomeric complexes that are comprised of several distinct septin subunits. These complexes can act as cytoskeletal elements that play important roles in CYTOKINESIS, cytoskeletal reorganization, BIOLOGICAL TRANSPORT, and membrane dynamics.
=688  \\$a2011
=750  \0$aSeptins$0(DLC)sh2008004113$5IEN-M

=LDR  00541cz  a2200169n  4500
=001  9880364549802441
=005  20170628103043.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x149.$x883
=150  \\$aPolymerization
=450  \\$wnnna$aPolymerizations
=550  \\$wg$aChemical Phenomena
=680  \\$iChemical reaction in which monomeric components are combined to form POLYMERS (e.g., POLYMETHYLMETHACRYLATE).
=688  \\$a2011
=750  \0$aPolymerization$0(DLC) sh 89001625$5IEN-M

=LDR  00963cz  a2200325n  4500
=001  9880364549902441
=005  20141212221956.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058087
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x400
=150  \\$aHaptophyta
=450  \\$wnnna$aCoccolithophorid
=450  \\$wnnna$aCoccolithophorids
=450  \\$wnnna$aEmiliania
=450  \\$wnnna$aHaptophyceae
=450  \\$wnnna$aHaptophyte
=450  \\$wnnna$aHaptophytes
=450  \\$wnnna$aIsochrysis
=450  \\$wnnna$aPavlova
=450  \\$wnnna$aPhaeocystis
=450  \\$wnnna$aPleurochrysis
=450  \\$wnnna$aPrymnesiophyceae
=450  \\$wnnna$aPrymnesiophyte
=450  \\$wnnna$aPrymnesiophytes
=450  \\$wnnna$aPrymnesium
=550  \\$wg$aEukaryota
=680  \\$iA group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.
=688  \\$a2011
=750  \0$aPrymnesiophyceae$0(DLC) sh 88022391$5IEN-M

=LDR  00736cz  a2200181n  4500
=001  9880364550002441
=005  20141212221956.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058086
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80.$x500.$x600.$x500
=150  \\$aMicroalgae
=450  \\$wnnna$aMicrophytes
=550  \\$wg$aPhytoplankton
=667  \\$acoordinate with specific organism if pertinent
=680  \\$iA non-taxonomic term for unicellular microscopic algae which are found in both freshwater and marine environments. Some authors consider DIATOMS; CYANOBACTERIA; HAPTOPHYTA; and DINOFLAGELLATES as part of microalgae, even though they are not algae.
=688  \\$a2011
=750  \0$aMicroalgae$0(DLC) sh 92005993$5IEN-M

=LDR  00830cz  a2200265n  4500
=001  9880364550102441
=005  20141212221956.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058085
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x490
=072  \\$aD2.$x691.$x550
=150  \\$aIron Compounds
=450  \\$wnnna$aCompounds, Iron
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aFerric Compounds
=550  \\$wh$aFerrous Compounds
=550  \\$wh$aIron Carbonyl Compounds
=550  \\$wh$aIron, Dietary
=550  \\$wh$aSteel
=667  \\$aGEN or unspecified; prefer specifics; DF: IRON CPDS
=680  \\$iOrganic and inorganic compounds that contain iron as an integral part of the molecule.
=688  \\$a2011
=750  \0$aIron compounds$0(DLC) sh 85068181$5IEN-M

=LDR  01971cz  a2200445n  4500
=001  9880364550202441
=005  20141212221954.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D058067
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x959
=072  \\$aG17.$x915
=072  \\$aL1.$x224.$x800.$x750
=150  \\$aWavelet Analysis
=450  \\$wnnna$aAnalyses, Spatiotemporal Wavelet
=450  \\$wnnna$aAnalyses, Wavelet
=450  \\$wnnna$aAnalysis, Spatiotemporal Wavelet
=450  \\$wnnna$aAnalysis, Wavelet
=450  \\$wnnna$aProcessing, Wavelet Signal
=450  \\$wnnna$aProcessings, Wavelet Signal
=450  \\$wnnna$aSignal Processing, Wavelet
=450  \\$wnnna$aSignal Processings, Wavelet
=450  \\$wnnna$aSpatiotemporal Wavelet Analyses
=450  \\$wnnna$aSpatiotemporal Wavelet Analysis
=450  \\$wnnna$aTransform, Wavelet
=450  \\$wnnna$aTransforms, Wavelet
=450  \\$wnnna$aWavelet Analyses
=450  \\$wnnna$aWavelet Analyses, Spatiotemporal
=450  \\$wnnna$aWavelet Analysis, Spatiotemporal
=450  \\$wnnna$aWavelet Signal Processing
=450  \\$wnnna$aWavelet Signal Processings
=450  \\$wnnna$aWavelet Transform
=450  \\$wnnna$aWavelet Transforms
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aSignal Processing, Computer-Assisted
=550  \\$aFourier Analysis
=680  \\$iSignal and data processing method that uses decomposition of wavelets to approximate, estimate, or compress signals with finite time and frequency domains. It represents a signal or data in terms of a fast decaying wavelet series from the original prototype wavelet, called the mother wavelet. This mathematical algorithm has been adopted widely in biomedical disciplines for data and signal processing in noise removal and audio/image compression (e.g., EEG and MRI).
=688  \\$a2011
=750  \0$aWavelets (Mathematics)$0(DLC) sh 91006163$5IEN-M

=LDR  01129cz  a2200325n  4500
=001  9880363297302441
=005  20141212200025.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002780
=035  \\$aCAZ5936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x120.$x135.$x250
=072  \\$aC6.$x552.$x150
=150  \\$aCholestasis, Intrahepatic
=450  \\$aBile Duct Obstruction, Intrahepatic
=450  \\$wnnna$aBiliary Stases, Intrahepatic
=450  \\$aBiliary Stasis, Intrahepatic
=450  \\$wnnna$aCholestases, Intrahepatic
=450  \\$wnnna$aIntrahepatic Biliary Stases
=450  \\$wnnna$aIntrahepatic Biliary Stasis
=450  \\$wnnna$aIntrahepatic Cholestases
=450  \\$aIntrahepatic Cholestasis
=550  \\$wg$aCholestasis
=550  \\$wg$aLiver Diseases
=550  \\$wh$aAlagille Syndrome
=550  \\$wh$aLiver Cirrhosis, Biliary
=550  \\$aJaundice, Obstructive
=680  \\$iImpairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
=688  \\$a80
=750  \0$aCholestasis$5IEN$0(DLC)sh 85024651

=LDR  01186cz  a2200349n  4500
=001  9880363297402441
=005  20141212200025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002779
=035  \\$aCAZ5935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x120.$x135
=150  \\$aCholestasis
=450  \\$aBile Duct Obstruction
=450  \\$wnnna$aBile Duct Obstructions
=450  \\$wnnna$aBiliary Stases
=450  \\$aBiliary Stasis
=450  \\$wnnna$aCholestases
=450  \\$wnnna$aDuct Obstruction, Bile
=450  \\$wnnna$aDuct Obstructions, Bile
=450  \\$wnnna$aObstruction, Bile Duct
=450  \\$wnnna$aObstructions, Bile Duct
=450  \\$wnnna$aStases, Biliary
=450  \\$wnnna$aStasis, Biliary
=550  \\$wg$aBile Duct Diseases
=550  \\$wh$aCholestasis, Extrahepatic
=550  \\$wh$aCholestasis, Intrahepatic
=550  \\$wh$aMirizzi Syndrome
=550  \\$aJaundice, Obstructive
=680  \\$iImpairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
=688  \\$a1972 (1969)
=750  \0$aCholestasis$5IEN-HS$0(DLC)sh 85024651

=LDR  01834cz  a2200385n  4500
=001  9880363297502441
=005  20141212200023.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002772
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x725.$x115.$x180
=072  \\$aD23.$x946.$x123.$x194
=072  \\$aD23.$x946.$x330.$x150
=150  \\$aCholera Toxin
=450  \\$wnnna$aCholera Enterotoxin CT
=450  \\$wnnna$aCholera Exotoxin
=450  \\$wnnna$aCholera Toxin A Subunit
=450  \\$wnnna$aCholera Toxin B Subunit
=450  \\$aCholera Toxin Protomer A
=450  \\$aCholera Toxin Protomer B
=450  \\$aCholeragen
=450  \\$aCholeragenoid
=450  \\$wnnna$aCT, Cholera Enterotoxin
=450  \\$wnnna$aEnterotoxin CT, Cholera
=450  \\$wnnna$aExotoxin, Cholera
=450  \\$wnnna$aProcholeragenoid
=450  \\$wnnna$aToxin, Cholera
=550  \\$wg$aADP Ribose Transferases
=550  \\$wg$aBacterial Toxins
=550  \\$wg$aEnterotoxins
=550  \\$aVibrio cholerae
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iAn ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.
=688  \\$a78
=750  \0$aCholera toxin$0(DLC)sh2007004423$5IEN-M

=LDR  00650cz  a2200181n  4500
=001  9880363297602441
=005  20141212200022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002771
=035  \\$aCAZ5927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x959.$x347
=150  \\$aCholera
=450  \\$wnnna$aCholeras
=550  \\$wg$aVibrio Infections
=550  \\$aCholera Morbus
=680  \\$iAn acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
=750  \0$aCholera$5IEN$0(DLC)sh 85024645

=LDR  00805cz  a2200229n  4500
=001  9880363297702441
=005  20141212200021.0
=008  870320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002767
=035  \\$aCAZ5923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x195
=072  \\$aE4.$x210.$x120.$x195
=150  \\$aCholecystostomy
=450  \\$wnnna$aCholecystostomies
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aBiliary Tract Surgical Procedures
=550  \\$aGallbladder
=667  \\$ado not use /util except by MeSH definition
=680  \\$iEstablishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.
=688  \\$a88
=750  \0$aCholecystostomy$5IEN$0(DLC)sh 90004152

=LDR  01170cz  a2200289n  4500
=001  9880363297802441
=005  20141212200021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002766
=035  \\$aCAZ5922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x152
=072  \\$aD12.$x644.$x120
=072  \\$aD12.$x644.$x400.$x105
=072  \\$aD12.$x776.$x641.$x650.$x105
=150  \\$aCholecystokinin
=450  \\$wnnna$aCCK-33
=450  \\$wnnna$aCholecystokinin 33
=450  \\$aPancreozymin
=450  \\$wnnna$aUropancreozymin
=550  \\$wg$aGastrointestinal Hormones
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptides
=550  \\$wh$aSincalide
=680  \\$iA peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
=688  \\$aPANCREOZYMIN was heading 1963-76 (Prov 1963-66), was see under GASTROINTESTINAL HORMONES 1963-66
=750  \0$aCholecystokinin$5IEN$0(DLC)sh 85024642

=LDR  00811cz  a2200241n  4500
=001  9880363297902441
=005  20141212200021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002765
=035  \\$aCAZ5921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x715.$x210
=072  \\$aE1.$x370.$x372.$x210
=150  \\$aCholecystography
=450  \\$wnnna$aCholecystographies
=450  \\$aGallbladder$xradiography
=550  \\$wg$aDiagnostic Techniques, Digestive System
=550  \\$wg$aRadiography, Abdominal
=550  \\$aBiliary Tract
=550  \\$aGallbladder
=667  \\$ado not use /util except by MeSH definition; DF: CHOLECYSTOGR
=680  \\$iRadiography of the gallbladder after ingestion of a contrast medium.
=750  \0$aGallbladder$xRadiography$5IEN$0(DLC)sh 85052806

=LDR  01121cz  a2200277n  4500
=001  9880363298002441
=005  20141212200021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002764
=035  \\$aCAZ5920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x564.$x263
=150  \\$aCholecystitis
=450  \\$wnnna$aEmpyema, Gall Bladder
=450  \\$aEmpyema, Gallbladder
=450  \\$wnnna$aGall Bladder Empyema
=450  \\$wnnna$aGallbladder Empyema
=450  \\$aGallbladder Inflammation
=450  \\$wnnna$aInflammation, Gallbladder
=550  \\$wg$aGallbladder Diseases
=550  \\$wh$aAcalculous Cholecystitis
=550  \\$wh$aCholecystitis, Acute
=550  \\$aCholangitis
=667  \\$anote specifics; X ref EMPYEMA, GALLBLADDER: restrict to gallbladder; "biliary empyema": unless of gallbladder, index under EMPYEMA (IM) + BILIARY TRACT DISEASES (IM) or specific biliary precoord
=680  \\$iInflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.
=750  \0$aCholecystitis$5IEN$0(DLC)sh 85024641

=LDR  00617cz  a2200205n  4500
=001  9880363298102441
=005  20141212200020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002763
=035  \\$aCAZ5919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x120.$x172
=150  \\$aCholecystectomy
=450  \\$wnnna$aCholecystectomies
=550  \\$wg$aBiliary Tract Surgical Procedures
=550  \\$wh$aCholecystectomy, Laparoscopic
=550  \\$aGallbladder
=550  \\$aPostcholecystectomy Syndrome
=680  \\$iSurgical removal of the GALLBLADDER.
=750  \0$aCholecystectomy$5IEN$0(DLC)sh 85024639

=LDR  01247cz  a2200313n  4500
=001  9880363298202441
=005  20141212200020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002762
=035  \\$aCAZ5918M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x222.$x159
=072  \\$aD4.$x808.$x247.$x808.$x146
=072  \\$aD4.$x808.$x812.$x768.$x196
=072  \\$aD10.$x570.$x938.$x146
=150  \\$aCholecalciferol
=450  \\$wnnna$a(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
=450  \\$wnnna$aCalciol
=450  \\$wnnna$aCholecalciferols
=450  \\$aVitamin D 3
=450  \\$wnnna$aVitamin D3
=550  \\$wg$aCholestenes
=550  \\$wg$aSterols
=550  \\$wg$aVitamin D
=550  \\$wh$aHydroxycholecalciferols
=667  \\$adeficiency: coordinate CHOLECALCIFEROL /defic (IM) with VITAMIN D DEFICIENCY (IM)
=680  \\$iDerivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.
=688  \\$a94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66
=750  \0$aCholecalciferol$0(DLC) sh2004001239$5IEN-M

=LDR  01614cz  a2200373n  4500
=001  9880363298302441
=005  20141212192104.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002760
=035  \\$aCAZ5915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x715.$x200.$x200
=072  \\$aE1.$x370.$x372.$x200.$x200
=072  \\$aE1.$x370.$x372.$x250.$x200
=072  \\$aE1.$x370.$x388.$x250.$x250.$x160
=072  \\$aE4.$x210.$x240.$x160
=072  \\$aE4.$x502.$x250.$x250.$x160
=150  \\$aCholangiopancreatography, Endoscopic Retrograde
=450  \\$wnnna$aCholangiopancreatographies, Endoscopic Retrograde
=450  \\$wnnna$aEndoscopic Retrograde Cholangiopancreatographies
=450  \\$aEndoscopic Retrograde Cholangiopancreatography
=450  \\$aERCP
=450  \\$wnnna$aRetrograde Cholangiopancreatographies, Endoscopic
=450  \\$wnnna$aRetrograde Cholangiopancreatography, Endoscopic
=550  \\$wg$aCholangiography
=550  \\$wg$aEndoscopy, Digestive System
=550  \\$aAmpulla of Vater
=550  \\$aBile Ducts
=550  \\$aSphincter of Oddi
=550  \\$aSphincterotomy, Endoscopic
=667  \\$a/instrum is probably DUODENOSCOPES
=680  \\$iFiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure.
=688  \\$a81
=750  \0$aEndoscopic retrograde cholangiopancreatography$5IEN$0(DLC)sh 89001955

=LDR  00983cz  a2200265n  4500
=001  9880363298402441
=005  20141212200019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002758
=035  \\$aCAZ5913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x715.$x200
=072  \\$aE1.$x370.$x372.$x200
=150  \\$aCholangiography
=450  \\$aBile Ducts$xradiography
=450  \\$wnnna$aCholangiographies
=550  \\$wg$aDiagnostic Techniques, Digestive System
=550  \\$wg$aRadiography, Abdominal
=550  \\$wh$aCholangiopancreatography, Endoscopic Retrograde
=550  \\$aBile Ducts
=550  \\$aBiliary Tract
=550  \\$aBiliary Tract Diseases
=667  \\$ado not use /util except by MeSH definition; DF: CHOLANGIOGR
=680  \\$iAn imaging test of the BILIARY TRACT in which a contrast dye (RADIOPAQUE MEDIA) is injected into the BILE DUCT and x-ray pictures are taken.
=750  \0$aBile ducts$xRadiography$5IEN$0(DLC)sh 85014014

=LDR  00834cz  a2200241n  4500
=001  9880363298502441
=005  20141212200019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002756
=035  \\$aCAZ5911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x483.$x508
=150  \\$aCholagogues and Choleretics
=450  \\$wnnna$aCholagogues
=450  \\$wnnna$aCholagogues, Choleretics
=450  \\$aCholeretics
=450  \\$wnnna$aCholeretics and Cholagogues
=450  \\$wnnna$aHydrocholeretics
=550  \\$wg$aGastrointestinal Agents
=550  \\$aBiliary Tract
=667  \\$aDF: CHOLAGOGUES
=680  \\$iGastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
=750  \0$aCholagogues$5IEN$0(DLC)sh 85024637

=LDR  00762cz  a2200229n  4500
=001  9880363298602441
=005  20141212200018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002755
=035  \\$aCAZ5910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x373.$x346
=150  \\$aChoice Behavior
=450  \\$wnnna$aBehavior, Choice
=450  \\$wnnna$aBehaviors, Choice
=450  \\$wnnna$aChoice Behaviors
=550  \\$wg$aDecision Making
=550  \\$wh$aCareer Choice
=550  \\$wh$aDelay Discounting
=680  \\$iThe act of making a selection among two or more alternatives, usually after a period of deliberation.
=688  \\$a79(75); was see under DECISION MAKING 1974-78
=750  \0$aChoice (Psychology)$5IEN$0(DLC)sh 85024618

=LDR  00997cz  a2200313n  4500
=001  9880363298702441
=005  20141212200017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002752
=035  \\$aCAZ5907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x365
=072  \\$aD2.$x455.$x426.$x559.$x389.$x115.$x124.$x500
=072  \\$aD2.$x478.$x600.$x500
=072  \\$aD2.$x522.$x223.$x500
=072  \\$aD2.$x886.$x590.$x700.$x365
=072  \\$aD3.$x438.$x513.$x750.$x500
=150  \\$aChlorthalidone
=450  \\$aChlorphthalidolone
=450  \\$wnnna$aChlortalidone
=450  \\$wnnna$aHygroton
=450  \\$wnnna$aOxodoline
=450  \\$aPhthalamudine
=450  \\$wnnna$aThalitone
=550  \\$wg$aBenzophenones
=550  \\$wg$aPhthalimides
=550  \\$wg$aSulfonamides
=680  \\$iA benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.
=750  \0$aChlorthalidone$5IEN$0(DLC)sh 85024593

=LDR  01425cz  a2200397n  4500
=001  9880363298802441
=005  20141212200017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002751
=035  \\$aCAZ5906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x900.$x146
=072  \\$aD4.$x615.$x562.$x900.$x146
=150  \\$aChlortetracycline
=450  \\$wnnna$a4-Epimer Chlortetracycline
=450  \\$wnnna$aAureocyclin
=450  \\$wnnna$aAureomycin
=450  \\$wnnna$aAureomycine
=450  \\$wnnna$aBiomycin
=450  \\$wnnna$aBisulfate, Chlortetracycline
=450  \\$wnnna$aCalcium Salt Chlortetracycline
=450  \\$wnnna$aChlorotetracycline
=450  \\$wnnna$aChlortetracycline, 4-Epimer
=450  \\$wnnna$aChlortetracycline, 4 Epimer
=450  \\$wnnna$aChlortetracycline Bisulfate
=450  \\$wnnna$aChlortetracycline, Calcium Salt
=450  \\$wnnna$aChlortetracycline Hydrochloride
=450  \\$wnnna$aChlortetracycline Monohydrochloride
=450  \\$wnnna$aChlortetracycline Sulfate (1:1)
=450  \\$wnnna$aChlortetracycline Sulfate (2:1)
=450  \\$wnnna$aHydrochloride, Chlortetracycline
=450  \\$wnnna$aMonohydrochloride, Chlortetracycline
=450  \\$wnnna$aSalt Chlortetracycline, Calcium
=550  \\$wg$aTetracyclines
=680  \\$iA TETRACYCLINE with a 7-chloro substitution.
=750  \0$aAureomycin$5IEN$0(DLC)sh 85009544

=LDR  00952cz  a2200289n  4500
=001  9880363298902441
=005  20141212195609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002336
=035  \\$aCAZ5504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x100
=072  \\$aD12.$x644.$x456.$x345.$x331
=072  \\$aD12.$x776.$x641.$x650.$x100
=150  \\$aCarnosine
=450  \\$wnnna$abeta-Alanylhistidine
=450  \\$wnnna$abeta Alanylhistidine
=450  \\$wnnna$aCarnosine, (D-His)-Isomer
=450  \\$wnnna$aCarnosine Hydrochloride
=450  \\$wnnna$aHydrochloride, Carnosine
=450  \\$wnnna$aL-Carnosine
=450  \\$wnnna$aL Carnosine
=550  \\$wg$aDipeptides
=550  \\$wg$aNeuropeptides
=680  \\$iA naturally occurring dipeptide neuropeptide found in muscles.
=688  \\$a91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66
=750  \0$aCarnosine$5IEN$0(DLC)sh 85020385

=LDR  00676cz  a2200193n  4500
=001  9880363299002441
=005  20200508114132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002335
=035  \\$aCAZ5503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x750
=150  \\$aCarnivora
=550  \\$wg$aEutheria
=550  \\$wh$aCaniformia
=550  \\$wh$aFelifomia
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iAn order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores CANIFORMIA.
=750  \0$aCarnivora$0(DLC)sh 85020383$5IEN

=LDR  00876cz  a2200253n  4500
=001  9880363299102441
=005  20141212195607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002331
=035  \\$aCAZ5499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x883.$x99
=150  \\$aCarnitine
=450  \\$wnnna$aBicarnesine
=450  \\$wnnna$aL-Carnitine
=450  \\$wnnna$aL Carnitine
=450  \\$wnnna$aLevocarnitine
=450  \\$wnnna$aVitamin BT
=550  \\$wg$aTrimethyl Ammonium Compounds
=550  \\$wh$aAcetylcarnitine
=550  \\$wh$aPalmitoylcarnitine
=680  \\$iConstituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
=688  \\$a66(64); was see under VITAMIN B COMPLEX 1963-65
=750  \0$aCarnitine$5IEN$0(DLC)sh 85143975

=LDR  00951cz  a2200301n  4500
=001  9880363299202441
=005  20141212195634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002417
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x271
=150  \\$aCattle
=360  \\$iconsider also terms at$aBOVINE
=450  \\$aBos grunniens
=450  \\$aBos indicus
=450  \\$aBos taurus
=450  \\$aCow, Domestic
=450  \\$wnnna$aCows, Domestic
=450  \\$wnnna$aDomestic Cow
=450  \\$wnnna$aDomestic Cows
=450  \\$aYak
=450  \\$wnnna$aYaks
=450  \\$aZebu
=450  \\$wnnna$aZebus
=550  \\$wg$aRuminants
=667  \\$anot for all Bovidae: only cows, yaks & zebus
=680  \\$iDomesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
=750  \0$aCattle$5IEN$0(DLC)sh 85021286

=LDR  01210cz  a2200289n  4500
=001  9880363299302441
=005  20141212195633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002415
=035  \\$aCAZ5578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x250.$x125
=150  \\$aCats
=360  \\$iconsider also terms at$aFELINE
=450  \\$wnnna$aCat
=450  \\$wnnna$aCat, Domestic
=450  \\$wnnna$aCats, Domestic
=450  \\$wnnna$aDomestic Cat
=450  \\$wnnna$aDomestic Cats
=450  \\$aFelis catus
=450  \\$wnnna$aFelis domestica
=450  \\$aFelis domesticus
=450  \\$wnnna$aFelis sylvestris catus
=550  \\$wg$aFelis
=667  \\$acheck tag: no qualifiers; restrict to domestic cat
=680  \\$iThe domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801)
=750  \0$aCats$5IEN$0(DLC)sh 85021262

=LDR  01460cz  a2200373n  4500
=001  9880363299402441
=005  20141212195606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002328
=035  \\$aCAZ5496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x165
=150  \\$aCarisoprodol
=450  \\$wnnna$aBelmac Brand of Carisoprodol
=450  \\$wnnna$aCarisoma
=450  \\$aCarisoprodate
=450  \\$wnnna$aCarter Horner Brand of Carisoprodol
=450  \\$wnnna$aForest Brand of Carisoprodol
=450  \\$wnnna$aGM Pharmaceuticals Brand of Carisoprodol
=450  \\$aIsobamate
=450  \\$aIsomeprobamate
=450  \\$aIsopropylmeprobamate
=450  \\$wnnna$aMio Relax
=450  \\$wnnna$aSchein Brand of Carisoprodol
=450  \\$wnnna$aSoma
=450  \\$wnnna$aSomalgit
=450  \\$wnnna$aSoprodol
=450  \\$wnnna$aVanadom
=450  \\$wnnna$aWallace Brand 1 of Carisoprodol
=450  \\$wnnna$aWallace Brand 2 of Carisoprodol
=450  \\$wnnna$aWallace Brand 3 of Carisoprodol
=550  \\$wg$aCarbamates
=680  \\$iA centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
=750  \0$aCarisoprodol$5IEN$0(DLC)sh 85020330

=LDR  00747cz  a2200205n  4500
=001  9880363299502441
=005  20141212195633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002414
=035  \\$aCAZ5577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x300.$x459
=150  \\$aCations, Monovalent
=450  \\$wnnna$aMonovalent Cations
=550  \\$wg$aCations
=550  \\$wh$aProtons
=667  \\$aNIM: avoid as IM except when general only: prefer specifics; use qualif discreetly: few apply
=680  \\$iPositively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis.
=688  \\$a73
=750  \0$aMonovalent cations$5IEN$0(DLC)sh 89005469

=LDR  00637cz  a2200193n  4500
=001  9880363299602441
=005  20141212195633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002413
=035  \\$aCAZ5576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x300.$x333
=150  \\$aCations, Divalent
=450  \\$aDivalent Cations
=550  \\$wg$aCations
=667  \\$ageneral only: prefer specifics
=680  \\$iPositively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis.
=688  \\$a73
=750  \0$aCations$5IEN$0(DLC)sh 85021247

=LDR  01221cz  a2200253n  4500
=001  9880363299702441
=005  20141212195605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002325
=035  \\$aCAZ5494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x206
=150  \\$aCaricatures as Topic
=450  \\$wnnna$aCaricature as Topic
=450  \\$wnnna$aCaricature as Topics
=450  \\$wnnna$aCaricatures as Topics
=550  \\$wg$aArt
=550  \\$wh$aCartoons as Topic
=550  \\$aWit and Humor as Topic
=667  \\$aIM; coordinate with subject (IM) or person with required biography and history headings & check tags; do not confuse with Publication Type CARICATURES; CARTOONS AS TOPIC is also available
=680  \\$iPortraying in a critical or facetious way a real individual or group, or a figure representing a social, political, ethnic, or racial type. The effect is usually achieved through distortion or exaggeration of characteristics. (Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Caricatures
=750  \0$aCaricatures and cartoons$0(DLC) sh 85020312$5IEN-M

=LDR  00697cz  a2200205n  4500
=001  9880363299802441
=005  20141212195632.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002412
=035  \\$aCAZ5575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x300
=150  \\$aCations
=550  \\$wg$aIons
=550  \\$wh$aCations, Divalent
=550  \\$wh$aCations, Monovalent
=667  \\$aGEN or unspecified; avoid as too general: prefer specifics; use qualif discreetly: few apply
=680  \\$iPositively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis.
=688  \\$a78
=750  \0$aCations$5IEN$0(DLC)sh 85021247

=LDR  01225cz  a2200325n  4500
=001  9880363299902441
=005  20141212195604.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002323
=035  \\$aCAZ5492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x750.$x170.$x200
=072  \\$aD2.$x886.$x108.$x750.$x750.$x170.$x200
=072  \\$aD3.$x438.$x260.$x825.$x750.$x170.$x200
=072  \\$aD3.$x605.$x84.$x737.$x750.$x170.$x200
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x750.$x170.$x200
=150  \\$aCarfecillin
=450  \\$wnnna$aBRL-3475
=450  \\$wnnna$aBRL 3475
=450  \\$wnnna$aBRL3475
=450  \\$aCarbenicillin Phenyl Sodium
=450  \\$wnnna$aCarfecillin Sodium Salt
=450  \\$wnnna$aCarphecillin
=450  \\$wnnna$aSalt, Carfecillin Sodium
=450  \\$wnnna$aSodium Salt, Carfecillin
=450  \\$wnnna$aUticillin
=550  \\$wg$aCarbenicillin
=680  \\$iThe phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.
=688  \\$a91(78); was see under CARBENICILLIN 1978-90
=750  \0$aCarfecillin$5IEN$0(DLC)sh 85020262

=LDR  01896cz  a2200481n  4500
=001  9880363300002441
=005  20141212192045.0
=008  870509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002406
=035  \\$aCAZ5569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x224
=072  \\$aE4.$x100.$x814.$x529.$x937
=072  \\$aE4.$x502.$x382.$x937
=150  \\$aCatheterization, Peripheral
=450  \\$aArterial Catheterization, Peripheral
=450  \\$wnnna$aArterial Catheterizations, Peripheral
=450  \\$wnnna$aBronchial Catheterization
=450  \\$wnnna$aBronchial Catheterizations
=450  \\$aCatheterization, Bronchial
=450  \\$aCatheterization, Peripheral Arterial
=450  \\$aCatheterization, Peripheral Venous
=450  \\$wnnna$aCatheterizations, Bronchial
=450  \\$wnnna$aCatheterizations, Peripheral
=450  \\$wnnna$aCatheterizations, Peripheral Arterial
=450  \\$wnnna$aCatheterizations, Peripheral Venous
=450  \\$wnnna$aPeripheral Arterial Catheterization
=450  \\$wnnna$aPeripheral Arterial Catheterizations
=450  \\$aPeripheral Catheterization
=450  \\$wnnna$aPeripheral Catheterizations
=450  \\$wnnna$aPeripheral Venous Catheterization
=450  \\$wnnna$aPeripheral Venous Catheterizations
=450  \\$aVenous Catheterization, Peripheral
=450  \\$wnnna$aVenous Catheterizations, Peripheral
=550  \\$wg$aCatheterization
=550  \\$wg$aEndovascular Procedures
=550  \\$wh$aCatheterization, Swan-Ganz
=550  \\$aBronchoscopy
=667  \\$ado not use /util except by MeSH definition; DF: CATH PERIPHERAL
=680  \\$iInsertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes.
=688  \\$a88
=750  \0$aArterial catheterization$5IEN-M$0(DLC)sh 85008097
=750  \0$aBronchial catheterization$5IEN-HS$0(DLC)sh 85017077

=LDR  01280cz  a2200421n  4500
=001  9880363300102441
=005  20141212192043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002322
=035  \\$aCAZ5491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x200
=072  \\$aN1.$x824.$x175
=072  \\$aN1.$x824.$x547.$x330
=072  \\$aN4.$x452.$x677.$x300
=150  \\$aCareer Mobility
=450  \\$wnnna$aCareer Ladder
=450  \\$aCareer Ladders
=450  \\$wnnna$aCareer Mobilities
=450  \\$wnnna$aClinical Ladder
=450  \\$aClinical Ladders
=450  \\$wnnna$aJob Ladder
=450  \\$aJob Ladders
=450  \\$wnnna$aLadder, Career
=450  \\$wnnna$aLadder, Clinical
=450  \\$wnnna$aLadder, Job
=450  \\$wnnna$aLadders, Career
=450  \\$wnnna$aLadders, Clinical
=450  \\$wnnna$aLadders, Job
=450  \\$wnnna$aMobilities, Career
=450  \\$wnnna$aMobility, Career
=550  \\$wg$aOccupations
=550  \\$wg$aPersonnel Management
=550  \\$wg$aSocioeconomic Factors
=667  \\$ano qualif
=680  \\$iThe upward or downward mobility in an occupation or the change from one occupation to another.
=688  \\$a74(72)
=750  \0$aOccupational mobility$5IEN$0(DLC)sh 85093843

=LDR  00692cz  a2200217n  4500
=001  9880363300202441
=005  20141212195604.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002321
=035  \\$aCAZ5490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x373.$x346.$x400
=150  \\$aCareer Choice
=450  \\$wnnna$aCareer Choices
=450  \\$wnnna$aChoice, Career
=450  \\$wnnna$aChoices, Career
=550  \\$wg$aChoice Behavior
=667  \\$ano qualif
=680  \\$iSelection of a type of occupation or profession.
=688  \\$a83(75); was see under CHOICE BEHAVIOR 1981-82 & DECISION MAKING 1975-80
=750  \0$aVocational guidance$5IEN-HS$0(DLC)sh 85144186

=LDR  01189cz  a2200337n  4500
=001  9880363300302441
=005  20141212192044.0
=008  870509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002405
=035  \\$aCAZ5568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x167
=072  \\$aE4.$x100.$x814.$x529.$x875
=072  \\$aE4.$x502.$x382.$x875
=150  \\$aCatheterization, Central Venous
=450  \\$wnnna$aCatheterization, Central
=450  \\$wnnna$aCatheterizations, Central
=450  \\$wnnna$aCatheterizations, Central Venous
=450  \\$wnnna$aCentral Catheterization
=450  \\$wnnna$aCentral Catheterizations
=450  \\$aCentral Venous Catheterization
=450  \\$wnnna$aCentral Venous Catheterizations
=450  \\$aIntravenous Catheterization$5IEN
=450  \\$aVenous Catheterization, Central
=450  \\$wnnna$aVenous Catheterizations, Central
=550  \\$wg$aCatheterization
=550  \\$wg$aEndovascular Procedures
=550  \\$aCentral Venous Catheters
=680  \\$iPlacement of an intravenous CATHETER in the subclavian, jugular, or other central vein.
=688  \\$a88
=750  \0$aIntravenous catheterization$5IEN$0(DLC)sh 85067632

=LDR  01301cz  a2200349n  4500
=001  9880363300402441
=005  20141212195631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002404
=035  \\$aCAZ5567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148
=072  \\$aE5.$x157
=150  \\$aCatheterization
=450  \\$wnno$aBalloon Dilation$5IEN-M
=450  \\$aCannulation
=450  \\$wnnna$aCannulations
=450  \\$wnnna$aCatheterizations
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aTherapeutics
=550  \\$wh$aAngioplasty
=550  \\$wh$aBalloon Embolectomy
=550  \\$wh$aBalloon Occlusion
=550  \\$wh$aBalloon Valvuloplasty
=550  \\$wh$aCardiac Catheterization
=550  \\$wh$aCatheter Ablation
=550  \\$wh$aCatheterization, Central Venous
=550  \\$wh$aCatheterization, Peripheral
=550  \\$wh$aUrinary Catheterization
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iUse or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
=750  \0$aCatheterization$5IEN$0(DLC)sh 91006153

=LDR  03018cz  a2200709n  4500
=001  9880363300502441
=005  20170619091653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002320
=035  \\$aCAZ5489HS
=040  \\$aDNLM$beng$cDNLM
=060  \0$aWG 102
=072  \\$aG9.$x330
=150  \\$aCardiovascular Physiological Phenomena
=450  \\$wnnna$aCardiovascular Physiological Concept
=450  \\$wnnna$aCardiovascular Physiological Concepts
=450  \\$wnnna$aCardiovascular Physiological Phenomenas
=450  \\$wnnna$aCardiovascular Physiological Phenomenon
=450  \\$wnno$aCardiovascular Physiologic Process
=450  \\$wnno$aCardiovascular Physiologic Processes
=450  \\$wnno$aCardiovascular Physiological Process
=450  \\$wnno$aCardiovascular Physiological Processes
=450  \\$aCardiovascular Physiology
=450  \\$aCardiovascular System$xphysiology
=450  \\$wnnna$aConcept, Cardiovascular Physiological
=450  \\$wnnna$aConcepts, Cardiovascular Physiological
=450  \\$wnnna$aPhenomena, Cardiovascular Physiological
=450  \\$wnnna$aPhenomenon, Cardiovascular Physiological
=450  \\$wnnna$aPhysiologic Processes, Cardiovascular
=450  \\$wnnna$aPhysiological Concept, Cardiovascular
=450  \\$wnnna$aPhysiological Concepts, Cardiovascular
=450  \\$wnnna$aPhysiological Phenomena, Cardiovascular
=450  \\$wnnna$aPhysiological Phenomenon, Cardiovascular
=450  \\$wnnna$aPhysiological Process, Cardiovascular
=450  \\$wnnna$aPhysiological Processes, Cardiovascular
=450  \\$wnnna$aPhysiology, Cardiovascular
=450  \\$wnnna$aProcess, Cardiovascular Physiological
=450  \\$wnnna$aProcesses, Cardiovascular Physiologic
=450  \\$wnnna$aProcesses, Cardiovascular Physiological
=550  \\$wg$aCirculatory and Respiratory Physiological Phenomena
=550  \\$wh Atrial Function
=550  \\$wh$aBlood Circulation
=550  \\$wh$aCapillary Fragility
=550  \\$wh$aCapillary Permeability
=550  \\$wh$aCardiomegaly, Exercise-Induced
=550  \\$wh$aCardiovascular Deconditioning
=550  \\$wh$aCarotid Intima-Media Thickness
=550  \\$wh$aDiving Reflex
=550  \\$wh$aHemodynamics
=550  \\$wh$aMyocardial Contraction
=550  \\$wh$aNeovascularization, Physiologic
=550  \\$wh$aVascular Patency
=550  \\$wh$aVascular Remodeling
=550  \\$wh$aVascular Stiffness
=550  \\$wh$aVentricular Function
=667  \\$ageneral or unspecified; prefer specifics; DF: CARDIOVASC PHYSIOL
=680  \\$iProcesses and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Cardiovascular Physiology
=688  \\$a98; use explode 1970-97
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20090831: 150:##:_{dollar}a Cardiovascular Physiologic Phenomena
=750  \0$aCardiovascular System$xphysiology$0(DLC)sh2008117650$5IEN-M

=LDR  00654cz  a2200193n  4500
=001  9880363300602441
=005  20141212195629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002399
=035  \\$aCAZ5562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x720.$x107.$x333
=150  \\$aCatharsis
=450  \\$wnnna$aCatharses
=550  \\$wg$aAbreaction
=667  \\$ano qualif
=680  \\$iThe release of ideas, thoughts, and repressed material from the unconscious, accompanied by an emotional response and relief. (From Dorland, 28th ed)
=688  \\$a91(75); was see under ABREACTION 1975-90
=750  \0$aCatharsis$5IEN$0(DLC)sh 85021009

=LDR  00682cz  a2200181n  4500
=001  9880363300702441
=005  20141212195629.0
=008  780201\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002398
=035  \\$aCAZ5561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x690.$x820.$x250
=150  \\$aCatgut
=450  \\$wnnna$aCatguts
=550  \\$wg$aSutures
=680  \\$iSterile collagen strands obtained from healthy mammals. They are used as absorbable surgical ligatures and are frequently impregnated with chromium or silver for increased strength. They tend to cause tissue reaction.
=688  \\$a91(79); was see under SUTURES 1979-90
=750  \0$aCatgut$5IEN$0(DLC)sh 85021006

=LDR  01134cz  a2200313n  4500
=001  9880363300802441
=005  20141212195603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002319
=035  \\$aCAZ5488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7
=150  \\$aCardiovascular System
=450  \\$wnnna$aCardiovascular Systems
=450  \\$wnnna$aSystem, Cardiovascular
=450  \\$wnnna$aSystems, Cardiovascular
=550  \\$wh$aBlood-Air Barrier
=550  \\$wh$aBlood-Aqueous Barrier
=550  \\$wh$aBlood-Brain Barrier
=550  \\$wh$aBlood-Nerve Barrier
=550  \\$wh$aBlood-Retinal Barrier
=550  \\$wh$aBlood-Testis Barrier
=550  \\$wh$aBlood Vessels
=550  \\$wh$aGlomerular Filtration Barrier
=550  \\$wh$aHeart
=550  \\$aBlood Circulation
=667  \\$aGEN or unspecified; prefer specifics; /abnorm = CARDIOVASCULAR ABNORMALITIES but consider also specific artery or vein with /abnorm; DF: CARDIOVASC SYSTEM
=680  \\$iThe HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body.
=750  \0$aCardiovascular system$5IEN$0(DLC)sh 85020226

=LDR  01138cz  a2200289n  4500
=001  9880363300902441
=005  20141212195629.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002397
=035  \\$aCAZ5560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x80
=150  \\$aCatfishes
=450  \\$wnnna$aArius
=450  \\$wnnna$aCatfish
=450  \\$wnnna$aCatfish, Colombian
=450  \\$wnnna$aColombian Catfish
=450  \\$aEremophilus mutisii
=450  \\$aHeteropneustes
=450  \\$aPlotosus
=450  \\$aSiluriformes
=550  \\$wg$aFishes
=550  \\$wh$aIctaluridae
=667  \\$aBULLHEAD CATFISHES and CHANNEL CATFISH see ICTALURIDAE are also available; X ref EREMOPHILUS MUTISII: EREMOPHILA PLANT and EREMOPHILA ALPESTRIS see SONGBIRDS are also available
=680  \\$iCommon name of the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers.
=688  \\$a2002 (1987)
=750  \0$aCatfishes$5IEN$0(DLC)sh 85021003

=LDR  01003cz  a2200265n  4500
=001  9880363301002441
=005  20141212195602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002318
=035  \\$aCAZ5487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14
=150  \\$aCardiovascular Diseases
=450  \\$wnnna$aCardiovascular Disease
=450  \\$wnnna$aDisease, Cardiovascular
=450  \\$wnnna$aDiseases, Cardiovascular
=550  \\$wh$aCardiovascular Abnormalities
=550  \\$wh$aCardiovascular Infections
=550  \\$wh$aHeart Diseases
=550  \\$wh$aPregnancy Complications, Cardiovascular
=550  \\$wh$aVascular Diseases
=550  \\$aCardiology
=667  \\$ageneral, prefer specifics; /diag: consider also DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DF: CARDIOVASC DIS
=680  \\$iPathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
=750  \0$aCardiovascular system$xDiseases$0(DLC) sh 85020229$5IEN

=LDR  01013cz  a2200325n  4500
=001  9880363301102441
=005  20141212195629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002396
=035  \\$aCAZ5559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166
=150  \\$aCatechols
=450  \\$aCatechol$5IEN
=450  \\$ao-Dihydroxybenzenes
=450  \\$wnnna$ao Dihydroxybenzenes
=450  \\$aortho-Dihydroxybenzenes
=450  \\$wnnna$aortho Dihydroxybenzenes
=450  \\$aPyrocatechols
=550  \\$wg$aPhenols
=550  \\$wh$a1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
=550  \\$wh$a3-Methoxy-4-hydroxyphenylethanol
=550  \\$wh$aCapsaicin
=550  \\$wh$aCurcumin
=550  \\$wh$aEstrogens, Catechol
=550  \\$wh$aGuaiacol
=550  \\$wh$aMasoprocol
=680  \\$iA group of 1,2-benzenediols that contain the general formula R-C6H5O2.
=688  \\$a75; was CATECHOL 1963-74
=750  \0$aCatechol$5IEN$0(DLC)sh 85020984

=LDR  01263cz  a2200373n  4500
=001  9880363301202441
=005  20141212195602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002317
=035  \\$aCAZ5486HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411
=150  \\$aCardiovascular Agents
=450  \\$wnnna$aAgents, Cardiovascular
=450  \\$wnnna$aCardiovascular Drugs
=450  \\$wnnna$aDrugs, Cardiovascular
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnti-Arrhythmia Agents
=550  \\$wh$aAntihypertensive Agents
=550  \\$wh$aCalcium Channel Blockers
=550  \\$wh$aCardioplegic Solutions
=550  \\$wh$aCardiotonic Agents
=550  \\$wh$aFibrinolytic Agents
=550  \\$wh$aNatriuretic Agents
=550  \\$wh$aNitric Oxide Donors
=550  \\$wh$aPotassium Channel Blockers
=550  \\$wh$aSclerosing Solutions
=550  \\$wh$aSodium Channel Blockers
=550  \\$wh$aVasoconstrictor Agents
=550  \\$wh$aVasodilator Agents
=550  \\$aSympathomimetics
=680  \\$iAgents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
=688  \\$a79; was NON MESH before 1979
=750  \0$aCardiovascular agents$5IEN$0(DLC)sh 85020222

=LDR  00897cz  a2200289n  4500
=001  9880363301302441
=005  20141212195628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002395
=035  \\$aCAZ5558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x311
=072  \\$aD2.$x92.$x311
=150  \\$aCatecholamines
=450  \\$aSympathins
=550  \\$wg$aAmines
=550  \\$wg$aBiogenic Monoamines
=550  \\$wh$aDihydroxyphenylalanine
=550  \\$wh$aDobutamine
=550  \\$wh$aDopamine
=550  \\$wh$aEpinephrine
=550  \\$wh$aIsoproterenol
=550  \\$wh$aMetaproterenol
=550  \\$wh$aNorepinephrine
=667  \\$aif only EPINEPHRINE & NOREPINEPHRINE are discussed index under each & not also here
=680  \\$iA general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.
=750  \0$aCatecholamines$5IEN$0(DLC)sh 85020986

=LDR  01027cz  a2200241n  4500
=001  9880363301402441
=005  20141212195628.0
=008  810513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002393
=035  \\$aCAZ5556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166.$x350
=072  \\$aD6.$x472.$x334.$x851.$x437.$x984
=150  \\$aEstrogens, Catechol
=450  \\$aCatechol Estrogens
=450  \\$wnnna$aCatecholestrogens
=550  \\$wg$aCatechols
=550  \\$wg$aEstradiol Congeners
=550  \\$wh$aHydroxyestrones
=667  \\$a/biosyn /physiol permitted
=680  \\$i2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.
=688  \\$a94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93
=750  \0$aCatechol estrogens$5IEN$0(DLC)sh 85020985

=LDR  01177cz  a2200313n  4500
=001  9880363301502441
=005  20141212195602.0
=008  790228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002316
=035  \\$aCAZ5485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411.$x222
=072  \\$aD27.$x720.$x799.$x80
=150  \\$aCardiotonic Agents
=450  \\$aCardiac Stimulants
=450  \\$aCardioprotective Agents
=450  \\$wnnna$aCardiotonic Drugs
=450  \\$wnnna$aCardiotonics
=450  \\$aInotropic Agents, Positive Cardiac
=450  \\$aMyocardial Stimulants
=550  \\$wg$aCardiovascular Agents
=550  \\$wg$aProtective Agents
=550  \\$aHeart
=550  \\$aMyocardial Contraction
=550  \\$aSympathomimetics
=667  \\$ado not confuse with CARDIOTOXINS
=680  \\$iAgents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
=688  \\$a80
=750  \0$aCardiotonic agents$5IEN$0(DLC)sh 85020221

=LDR  01461cz  a2200445n  4500
=001  9880363301602441
=005  20141212195628.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002392
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x240.$x190
=072  \\$aD3.$x438.$x150.$x266.$x450.$x206
=072  \\$aD3.$x830.$x219.$x240.$x190
=072  \\$aD3.$x830.$x219.$x266.$x450.$x206
=150  \\$aCatechin
=450  \\$wnnna$a(+)-Catechin
=450  \\$wnnna$a(+)-Cyanidanol
=450  \\$wnnna$a(+)-Cyanidanol-3
=450  \\$wnnna$a2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-
=450  \\$wnnna$a3,3',4',5,7-Flavanpentol
=450  \\$wnnna$aAcid, Catechinic
=450  \\$wnnna$aAcid, Catechuic
=450  \\$aCatechinic Acid
=450  \\$aCatechuic Acid
=450  \\$wnnna$aCatergen
=450  \\$wnnna$aCianidanol
=450  \\$wnnna$aCyanidanol-3
=450  \\$wnnna$aCyanidanol 3
=450  \\$wnnna$aEpicatechin
=450  \\$wnnna$aKB-53
=450  \\$wnnna$aKB 53
=450  \\$wnnna$aKB53
=450  \\$wnnna$aZ 7300
=450  \\$wnnna$aZyma
=550  \\$wg$aChromans
=550  \\$wg$aFlavonoids
=680  \\$iAn antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms.
=688  \\$a87(77); was see under BENZOPYRANS 1977-86
=750  \0$aCatechin$5IEN-M$0(DLC)sh 85020980
=750  \0$aCatechu$5IEN-HS$0(DLC)sh 85020987

=LDR  01597cz  a2200433n  4500
=001  9880363301702441
=005  20141212192635.0
=008  880321\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015148
=035  \\$aCAZ5484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x170
=072  \\$aE1.$x370.$x378.$x230.$x150
=072  \\$aE1.$x370.$x520.$x230.$x150
=150  \\$aCardiotocography
=450  \\$wnnna$aAntepartum CTG
=450  \\$wnnna$aCardiotocogram
=450  \\$wnnna$aCardiotocograms
=450  \\$wnnna$aCardiotocography, External
=450  \\$wnnna$aCardiotocography, Internal
=450  \\$aCTG, Antepartum
=450  \\$wnnna$aElectronic Fetal Monitoring
=450  \\$wnnna$aExternal Cardiotocography
=450  \\$wnnna$aExternal Fetal Monitoring
=450  \\$aFetal Heart Rate Monitoring$5IEN
=450  \\$wnnna$aFetal Monitoring, Electronic
=450  \\$wnnna$aFetal Monitoring, External
=450  \\$wnnna$aFetal Monitoring, Internal
=450  \\$wnnna$aInternal Cardiotocography
=450  \\$wnnna$aInternal Fetal Monitoring
=450  \\$wnnna$aMonitoring, Electronic Fetal
=450  \\$wnnna$aMonitoring, External Fetal
=450  \\$wnnna$aMonitoring, Internal Fetal
=550  \\$wg$aFetal Monitoring
=550  \\$wg$aHeart Function Tests
=550  \\$aUterine Contraction
=680  \\$iMonitoring of FETAL HEART frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.
=688  \\$a89
=750  \0$aFetal heart rate monitoring$5IEN$0(DLC)sh 85047949

=LDR  01233cz  a2200277n  4500
=001  9880363301902441
=005  20141212195601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002315
=035  \\$aCAZ5483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x292.$x413
=150  \\$aCardiopulmonary Bypass
=450  \\$wnnna$aBypass, Cardiopulmonary
=450  \\$wnnna$aBypass, Heart-Lung
=450  \\$wnnna$aBypasses, Cardiopulmonary
=450  \\$wnnna$aBypasses, Heart-Lung
=450  \\$wnnna$aCardiopulmonary Bypasses
=450  \\$aHeart-Lung Bypass
=450  \\$wnnna$aHeart Lung Bypass
=450  \\$wnnna$aHeart-Lung Bypasses
=550  \\$wg$aExtracorporeal Circulation
=667  \\$adiverts blood from right atrium: consider also HEART BYPASS, LEFT which diverts blood from left atrium; /instrum: consider also HEART-LUNG MACHINE; do not use /util except by MeSH definition; DF: CARDIOPULM BYPASS
=680  \\$iDiversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
=688  \\$a77(75); was see under EXTRACORPOREAL CIRCULATION 1967-76
=750  \0$aCardiopulmonary bypass$5IEN$0(DLC)sh 85020219

=LDR  01006cz   2200265n  4500
=001  9880363302002441
=005  20230831155421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002309
=035  \\$aCAZ5477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x163
=150  \\$aCardiology
=450  \\$wnnna$aAngiology
=450  \\$wnnna$aCardiovascular Disease Specialty
=450  \\$wnnna$aDisease Specialty, Cardiovascular
=450  \\$wnnna$aMedicine, Vascular
=450  \\$wnnna$aSpecialty, Cardiovascular Disease
=450  \\$wnnna$aVascular Medicine
=550  \\$wg$aInternal Medicine
=550  \\$wh$aCardiac Electrophysiology
=667  \\$ause for the discipline (education, history, etc) only; corresponding disease term is CARDIOVASCULAR DISEASES or specifics
=680  \\$iThe study of the heart, its physiology, and its functions.
=750  \0$aCardiology$0(DLC)sh 85020214$5IEN-M
=750  \0$iNarrower mapping$aInterventional cardiology$0(DLC)sh2022006224$4NM$5IEN-M

=LDR  00976cz  a2200217n  4500
=001  9880363302102441
=005  20141212195559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002308
=035  \\$aCAZ5476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x885.$x185
=072  \\$aD23.$x50.$x550.$x480.$x330
=150  \\$aCardiolipins
=450  \\$aCardiolipin
=450  \\$aDiphosphatidylglycerols
=550  \\$wg$aHaptens
=550  \\$wg$aPhosphatidylglycerols
=680  \\$iAcidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.
=688  \\$a73(72); DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76
=750  \0$aCardiolipin$5IEN$0(DLC)sh 85020209

=LDR  02189cz  a2200493n  4500
=001  9880363302202441
=005  20141212195627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002389
=035  \\$aCAZ5552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x115
=072  \\$aC23.$x888.$x592.$x604.$x115
=072  \\$aF1.$x145.$x126.$x156
=072  \\$aF1.$x700.$x165
=150  \\$aCatatonia
=450  \\$wnnna$aCatatonia, Lethal
=450  \\$wnnna$aCatatonia, Malignant
=450  \\$wnnna$aCatatonia, Organic
=450  \\$wnnna$aCatatonia, Schizophreniform
=450  \\$wnnna$aCatatonias
=450  \\$wnnna$aCatatonias, Lethal
=450  \\$wnnna$aCatatonias, Malignant
=450  \\$wnnna$aCatatonias, Organic
=450  \\$wnnna$aCatatonias, Schizophreniform
=450  \\$wnnna$aCatatonic Disorder, Organic
=450  \\$wnnna$aCatatonic Disorders, Organic
=450  \\$wnnna$aLethal Catatonia
=450  \\$wnnna$aLethal Catatonias
=450  \\$wnnna$aMalignant Catatonia
=450  \\$wnnna$aMalignant Catatonias
=450  \\$wnnna$aOrganic Catatonia
=450  \\$wnnna$aOrganic Catatonias
=450  \\$wnnna$aOrganic Catatonic Disorder
=450  \\$wnnna$aOrganic Catatonic Disorders
=450  \\$wnnna$aSchizophreniform Catatonia
=450  \\$wnnna$aSchizophreniform Catatonias
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$aCatalepsy
=550  \\$aComa
=550  \\$aImmobility Response, Tonic
=680  \\$iA neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
=750  \0$aCatatonia$5IEN$0(DLC)sh 85020958

=LDR  00975cz  a2200253n  4500
=001  9880363302302441
=005  20141212195558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002305
=035  \\$aCAZ5473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x155
=150  \\$aCardiac Tamponade
=450  \\$wnnna$aCardiac Tamponades
=450  \\$aPericardial Tamponade
=450  \\$wnnna$aPericardial Tamponades
=450  \\$wnnna$aTamponade, Cardiac
=450  \\$wnnna$aTamponade, Pericardial
=450  \\$wnnna$aTamponades, Cardiac
=450  \\$wnnna$aTamponades, Pericardial
=550  \\$wg$aHeart Diseases
=550  \\$aPericardial Effusion
=680  \\$iCompression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
=750  \0$aCardiac tamponade$5IEN$0(DLC)sh 85020187

=LDR  00887cz  a2200229n  4500
=001  9880363302402441
=005  20141212195626.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002388
=035  \\$aCAZ5551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x250
=150  \\$aCatastrophic Illness
=450  \\$wnnna$aCatastrophic Illnesses
=450  \\$wnnna$aIllness, Catastrophic
=450  \\$wnnna$aIllnesses, Catastrophic
=550  \\$wg$aDisease Attributes
=550  \\$aInsurance, Major Medical
=667  \\$ausually GEN & IM; if a specific catastrophic illiness, coord NIM with specific dis (IM)
=680  \\$iAn acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.
=688  \\$a82
=750  \0$aCatastrophic illness$5IEN$0(DLC)sh 88004127

=LDR  00903cz  a2200265n  4500
=001  9880363302502441
=005  20141212195558.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002304
=035  \\$aCAZ5472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x342.$x124
=150  \\$aCardiac Pacing, Artificial
=450  \\$wnnna$aArtificial Cardiac Pacing
=450  \\$wnnna$aArtificial Cardiac Pacings
=450  \\$wnnna$aCardiac Pacings, Artificial
=450  \\$wnnna$aPacing, Artificial Cardiac
=450  \\$aPacing, Cardiac, Artificial
=450  \\$wnnna$aPacings, Artificial Cardiac
=550  \\$wg$aElectric Stimulation Therapy
=550  \\$wh$aCardiac Resynchronization Therapy
=550  \\$aElectric Stimulation
=680  \\$iRegulation of the rate of contraction of the heart muscles by an artificial pacemaker.
=688  \\$a78
=750  \0$aCardiac pacing$5IEN$0(DLC)sh 86003035

=LDR  01055cz  a2200325n  4500
=001  9880363302602441
=005  20141212195626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002387
=035  \\$aCAZ5550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x825.$x249
=150  \\$aCataract Extraction
=450  \\$wnnna$aCataract Extractions
=450  \\$aCataract$xsurgery
=450  \\$aCataract Surgery$5IEN-M
=450  \\$wnnna$aEnzymatic Zonulolyses
=450  \\$aEnzymatic Zonulolysis
=450  \\$wnnna$aExtraction, Cataract
=450  \\$wnnna$aExtractions, Cataract
=450  \\$wnnna$aPhakectomies
=450  \\$wnnna$aPhakectomy
=450  \\$wnnna$aZonulolyses, Enzymatic
=450  \\$wnnna$aZonulolysis, Enzymatic
=550  \\$wg$aRefractive Surgical Procedures
=550  \\$wh$aCapsulorhexis
=550  \\$wh$aPhacoemulsification
=680  \\$iThe removal of a cataractous CRYSTALLINE LENS from the eye.
=688  \\$aENZYMATIC ZONULOLYSIS was heading 1963-96
=750  \0$aCataract$xSurgery$5IEN$0(DLC)sh 85020949

=LDR  00946cz  a2200253n  4500
=001  9880363302702441
=005  20141212195557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002302
=035  \\$aCAZ5470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x150
=072  \\$aG9.$x330.$x380.$x124
=150  \\$aCardiac Output
=450  \\$wnnna$aCardiac Outputs
=450  \\$wnnna$aOutput, Cardiac
=450  \\$wnnna$aOutputs, Cardiac
=550  \\$wg$aHeart Function Tests
=550  \\$wg$aHemodynamics
=550  \\$wh$aStroke Volume
=667  \\$aa physiol concept: do not confuse with the C14 diseases CARDIAC OUTPUT, HIGH or CARDIAC OUTPUT, LOW
=680  \\$iThe volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).
=688  \\$a67(64)
=750  \0$aCardiac output$5IEN$0(DLC)sh 85020184

=LDR  01250cz  a2200277n  4500
=001  9880363302802441
=005  20141212195557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002301
=035  \\$aCAZ5469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x155.$x580
=072  \\$aD9.$x408.$x180
=150  \\$aCardiac Glycosides
=450  \\$aCardiotonic Steroids
=450  \\$wnnna$aGlycosides, Cardiac
=450  \\$wnnna$aSteroids, Cardiotonic
=550  \\$wg$aCardanolides
=550  \\$wg$aGlycosides
=550  \\$wh$aBufanolides
=550  \\$wh$aCardenolides
=550  \\$wh$aDigitalis Glycosides
=550  \\$wh$aProscillaridin
=550  \\$wh$aStrophanthins
=680  \\$iCyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.
=750  \0$aCardiac glycosides$5IEN$0(DLC)sh 85020182

=LDR  01273cz  a2200313n  4500
=001  9880363302902441
=005  20141212195625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002386
=035  \\$aCAZ5549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x510.$x245
=150  \\$aCataract
=450  \\$aCataract, Membranous
=450  \\$wnnna$aCataracts
=450  \\$wnnna$aCataracts, Membranous
=450  \\$aLens Opacities
=450  \\$wnnna$aLens Opacity
=450  \\$wnnna$aMembranous Cataract
=450  \\$wnnna$aMembranous Cataracts
=450  \\$wnnna$aOpacities, Lens
=450  \\$wnnna$aOpacity, Lens
=450  \\$aPseudoaphakia
=450  \\$wnnna$aPseudoaphakias
=550  \\$wg$aLens Diseases
=550  \\$wh$aCapsule Opacification
=667  \\$alens opacity; do not confuse X ref PSEUDOAPHAKIA (a synonym for membranous cataract) with PSEUDOPHAKIA, the presence of an intraocular lens after cataract extraction
=680  \\$iPartial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
=750  \0$aCataract$5IEN$0(DLC)sh 85020947

=LDR  00889cz  a2200181n  4500
=001  9880363303002441
=005  20141212195556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002299
=035  \\$aCAZ5467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x875.$x163
=150  \\$aCardia
=450  \\$wnnna$aCardias
=550  \\$wg$aStomach
=667  \\$aadjective form = "cardial": do not confuse with "cardiac" (heart); diseases: coord IM with STOMACH DISEASES (IM); neoplasms: coord IM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThat part of the STOMACH close to the opening from ESOPHAGUS into the stomach (cardiac orifice), the ESOPHAGOGASTRIC JUNCTION. The cardia is so named because of its closeness to the HEART. Cardia is characterized by the lack of acid-forming cells (GASTRIC PARIETAL CELLS).
=750  \0$aCardia$5IEN$0(DLC)sh 85020175

=LDR  00681cz  a2200217n  4500
=001  9880363303102441
=005  20170627163249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002384
=035  \\$aCAZ5547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x130
=150  \\$aCatalysis
=450  \\$wnnna$aCatalyses
=450  \\$aCatalysts$5IEN
=550  \\$wg$aChemical Phenomena
=550  \\$wh$aBiocatalysis
=667  \\$aNIM; BIOCATALYSIS is also available
=680  \\$iThe facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.
=750  \0$aCatalysts$5IEN-M$0(DLC)sh 85020940
=750  \0$aCatalysis$5IEN-HS$0(DLC)sh 85020938

=LDR  01051cz  a2200253n  4500
=001  9880363303202441
=005  20141212195556.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002298
=035  \\$aCAZ5466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x155.$x160
=072  \\$aD4.$x808.$x155.$x580.$x130
=150  \\$aCardenolides
=550  \\$wg$aCardanolides
=550  \\$wg$aCardiac Glycosides
=550  \\$wh$aDigitalis Glycosides
=550  \\$wh$aDigitoxin
=550  \\$wh$aDigoxin
=550  \\$wh$aStrophanthins
=667  \\$aincludes cardadienolides & cardatrienolides; do not confuse with CARDANOLIDES
=680  \\$iC(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.
=688  \\$a77
=750  \0$aCardenolides$5IEN$0(DLC)sh 85020174

=LDR  00527cz  a2200193n  4500
=001  9880363303302441
=005  20141212195624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002383
=035  \\$aCAZ5546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x290.$x483
=150  \\$aCatalogs, Union
=450  \\$wnnna$aCatalog, Union
=450  \\$wnnna$aUnion Catalog
=450  \\$wnnna$aUnion Catalogs
=550  \\$wg$aCatalogs as Topic
=667  \\$ano qualif
=750  \0$aUnion catalogs$5IEN$0(DLC)sh 85020922

=LDR  01545cz  a2200409n  4500
=001  9880363303502441
=005  20141212192040.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002294
=035  \\$aCAZ5462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x400
=072  \\$aC4.$x557.$x470.$x700.$x400
=150  \\$aCarcinoma, Squamous Cell
=450  \\$aCarcinoma, Epidermoid
=450  \\$aCarcinoma, Planocellular
=450  \\$aCarcinoma, Squamous
=450  \\$wnnna$aCarcinomas, Epidermoid
=450  \\$wnnna$aCarcinomas, Planocellular
=450  \\$wnnna$aCarcinomas, Squamous
=450  \\$wnnna$aCarcinomas, Squamous Cell
=450  \\$wnnna$aEpidermoid Carcinoma
=450  \\$wnnna$aEpidermoid Carcinomas
=450  \\$wnnna$aPlanocellular Carcinoma
=450  \\$wnnna$aPlanocellular Carcinomas
=450  \\$wnnna$aSquamous Carcinoma
=450  \\$wnnna$aSquamous Carcinomas
=450  \\$wnnna$aSquamous Cell Carcinoma
=450  \\$wnnna$aSquamous Cell Carcinomas
=550  \\$wg$aCarcinoma
=550  \\$wg$aNeoplasms, Squamous Cell
=550  \\$wh$aBowen's Disease
=550  \\$aCarcinoma, Non-Small-Cell Lung
=667  \\$acoordinate IM with precoordinated organ/neoplasm term (IM)
=680  \\$iA carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
=688  \\$a81; was CARCINOMA, EPIDERMOID 1963-80
=750  \0$aSquamous cell carcinoma$0(DLC) sh 88005247$5IEN

=LDR  00537cz  a2200193n  4500
=001  9880363303602441
=005  20141212195624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002381
=035  \\$aCAZ5544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x290.$x383
=150  \\$aCatalogs, Library
=450  \\$wnnna$aCatalog, Library
=450  \\$wnnna$aLibrary Catalog
=450  \\$wnnna$aLibrary Catalogs
=550  \\$wg$aCatalogs as Topic
=667  \\$ano qualif
=750  \0$aLibrary catalogs$5IEN$0(DLC)sh 85076668

=LDR  01039cz  a2200301n  4500
=001  9880363304002441
=005  20141212195623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002377
=035  \\$aCAZ5540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x290
=150  \\$aCatalogs as Topic
=450  \\$wnnna$aas Topic, Catalogs
=450  \\$wnnna$aas Topics, Catalogs
=450  \\$wnnna$aCatalogs as Topics
=450  \\$wnnna$aTopic, Catalogs as
=450  \\$wnnna$aTopics, Catalogs as
=550  \\$wg$aPublications
=550  \\$wh$aCatalogs, Commercial
=550  \\$wh$aCatalogs, Drug
=550  \\$wh$aCatalogs, Library
=550  \\$wh$aCatalogs, Union
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with Publication Type CATALOGS
=680  \\$iOrdered compilations of item descriptions and sufficient information to afford access to them.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Catalogs
=750  \0$aCatalogs$0(DLC) sh 85020898$5IEN

=LDR  00793cz   2200193n  4500
=001  9880363304102441
=005  20230831162639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002376
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x245.$x250
=072  \\$aL1.$x453.$x819.$x250
=150  \\$aCataloging
=550  \\$wg$aDocumentation
=550  \\$wg$aLibrary Technical Services
=550  \\$wh$aBook Classification
=680  \\$iActivities performed in the preparation of bibliographic records for CATALOGS. It is carried out according to a set of rules and contains information enabling the user to know what is available and where items can be found.
=750  \0$aCataloging$5IEN$0(DLC)sh 85020816
=750  \0$iNarrower mapping$aCataloging of realia$0(DLC)sh2022007138$4NM$5IEN-M

=LDR  03230cz  a2200805n  4500
=001  9880363304202441
=005  20141212195555.0
=008  840529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002292
=035  \\$aCAZ5460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25.$x390
=072  \\$aC4.$x588.$x945.$x947.$x535.$x160
=072  \\$aC12.$x758.$x820.$x750.$x160
=072  \\$aC12.$x777.$x419.$x473.$x160
=072  \\$aC13.$x351.$x937.$x820.$x535.$x160
=072  \\$aC13.$x351.$x968.$x419.$x473.$x160
=150  \\$aCarcinoma, Renal Cell
=450  \\$wnnna$aAdenocarcinoma Of Kidney
=450  \\$wnnna$aAdenocarcinoma, Renal
=450  \\$aAdenocarcinoma, Renal Cell
=450  \\$wnnna$aAdenocarcinomas, Renal Cell
=450  \\$wnnna$aCancer, Renal Cell
=450  \\$wnnna$aCancers, Renal Cell
=450  \\$wnnna$aCarcinoma, Collecting Duct
=450  \\$wnnna$aCarcinoma, Collecting Duct (Kidney)
=450  \\$aCarcinoma, Hypernephroid
=450  \\$wnnna$aCarcinoma, Nephroid
=450  \\$wnnna$aCarcinomas, Collecting Duct
=450  \\$wnnna$aCarcinomas, Collecting Duct (Kidney)
=450  \\$wnnna$aCarcinomas, Hypernephroid
=450  \\$wnnna$aCarcinomas, Nephroid
=450  \\$wnnna$aCarcinomas, Renal Cell
=450  \\$wnnna$aChromophil Renal Cell Carcinoma
=450  \\$wnnna$aChromophobe Renal Cell Carcinoma
=450  \\$wnnna$aClear Cell Renal Carcinoma
=450  \\$wnnna$aClear Cell Renal Cell Carcinoma
=450  \\$wnnna$aCollecting Duct Carcinoma
=450  \\$wnnna$aCollecting Duct Carcinoma (Kidney)
=450  \\$wnnna$aCollecting Duct Carcinoma of the Kidney
=450  \\$wnnna$aCollecting Duct Carcinomas
=450  \\$wnnna$aCollecting Duct Carcinomas (Kidney)
=450  \\$wnnna$aDuct Carcinoma, Collecting
=450  \\$wnnna$aDuct Carcinoma, Collecting (Kidney)
=450  \\$wnnna$aDuct Carcinomas, Collecting
=450  \\$wnnna$aDuct Carcinomas, Collecting (Kidney)
=450  \\$aGrawitz Tumor
=450  \\$wnnna$aHypernephroid Carcinoma
=450  \\$wnnna$aHypernephroid Carcinomas
=450  \\$aHypernephroma
=450  \\$wnnna$aHypernephromas
=450  \\$wnnna$aNephroid Carcinoma
=450  \\$wnnna$aNephroid Carcinomas
=450  \\$wnnna$aPapillary Renal Cell Carcinoma
=450  \\$wnnna$aRenal Cell Adenocarcinoma
=450  \\$wnnna$aRenal Cell Adenocarcinomas
=450  \\$wnnna$aRenal Cell Cancer
=450  \\$wnnna$aRenal Cell Cancers
=450  \\$wnnna$aRenal Cell Carcinoma
=450  \\$wnnna$aRenal Cell Carcinoma, Papillary
=450  \\$wnnna$aRenal Cell Carcinomas
=450  \\$wnnna$aRenal Collecting Duct Carcinoma
=450  \\$wnnna$aSarcomatoid Renal Cell Carcinoma
=450  \\$wnnna$aTumor, Grawitz
=550  \\$wg$aAdenocarcinoma
=550  \\$wg$aKidney Neoplasms
=667  \\$acoordinate IM with KIDNEY NEOPLASMS (IM)
=680  \\$iA heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
=688  \\$a85
=750  \0$aRenal cell carcinoma$5IEN-M$0(DLC)sh 93001433

=LDR  00709cz  a2200205n  4500
=001  9880363304302441
=005  20141212195622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002374
=035  \\$aCAZ5537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x732.$x332
=150  \\$aCatalase
=450  \\$wnnna$aCatalase A
=450  \\$wnnna$aCatalase T
=450  \\$wnnna$aManganese Catalase
=450  \\$wnnna$aMn Catalase
=550  \\$wg$aPeroxidases
=680  \\$iAn oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA.
=750  \0$aCatalase$5IEN-HS$0(DLC)sh 85020809

=LDR  01648cz  a2200373n  4500
=001  9880363304402441
=005  20141212210941.0
=008  880518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015266
=035  \\$aCAZ5455M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x721.$x150
=072  \\$aC2.$x928.$x216
=072  \\$aC4.$x557.$x465.$x625.$x650.$x240.$x325
=072  \\$aC4.$x557.$x470.$x200.$x25.$x370.$x325
=072  \\$aC4.$x557.$x580.$x625.$x650.$x240.$x325
=072  \\$aC4.$x925.$x216
=150  \\$aCarcinoma, Merkel Cell
=450  \\$wnnna$aCancer, Merkel Cell
=450  \\$wnnna$aCell Cancer, Merkel
=450  \\$wnnna$aMerkel Cell Cancer
=450  \\$wnnna$aMerkel Cell Carcinoma
=450  \\$aMerkel Cell Tumor
=450  \\$wnnna$aMerkle Tumors
=450  \\$wnnna$aTumor, Merkel Cell
=450  \\$wnnna$aTumors, Merkle
=550  \\$wg$aCarcinoma, Neuroendocrine
=550  \\$wg$aPolyomavirus Infections
=550  \\$wg$aTumor Virus Infections
=550  \\$aMerkel Cells
=667  \\$acoordinate IM with SKIN NEOPLASMS (IM)
=680  \\$iA carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)
=688  \\$a89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93
=750  \0$aMerkel cell carcinoma$5IEN-M$0(DLC)sh 00000069

=LDR  00991cz  a2200241n  4500
=001  9880363304502441
=005  20141212195552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002286
=035  \\$aCAZ5453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x200
=072  \\$aC4.$x619.$x169
=150  \\$aCarcinoma, Ehrlich Tumor
=450  \\$wnnna$aAscites Tumor, Ehrlich
=450  \\$aEhrlich Ascites Tumor
=450  \\$wnnna$aEhrlich Tumor Carcinoma
=450  \\$wnnna$aTumor, Ehrlich Ascites
=550  \\$wg$aCarcinoma
=550  \\$wg$aNeoplasms, Experimental
=667  \\$aexper neopl; /blood supply /chem /second /secret /ultrastruct permitted; note X ref: do not also index under ASCITES; don't forget check tag ANIMALS
=680  \\$iA transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
=750  \0$aAscites tumors$5IEN$0(DLC)sh 85008556

=LDR  01620cz  a2200361n  4500
=001  9880363304602441
=005  20141212195621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002372
=035  \\$aCAZ5535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x126.$x100.$x150
=072  \\$aC1.$x252.$x400.$x200
=072  \\$aC15.$x604.$x315.$x249
=150  \\$aCat-Scratch Disease
=450  \\$wnnna$aCat Scratch Disease
=450  \\$wnnna$aCatscratch Disease
=450  \\$wnnna$aDisease, Cat-Scratch
=450  \\$wnnna$aDisease, Catscratch
=450  \\$wnnna$aInoculation Lymphoreticuloses
=450  \\$aInoculation Lymphoreticulosis
=450  \\$wnnna$aInoculative Lymphoreticuloses
=450  \\$wnnna$aInoculative Lymphoreticulosis
=450  \\$wnnna$aLymphoreticuloses, Inoculation
=450  \\$wnnna$aLymphoreticuloses, Inoculative
=450  \\$wnnna$aLymphoreticulosis, Inoculation
=450  \\$wnnna$aLymphoreticulosis, Inoculative
=550  \\$wg$aBartonella Infections
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wg$aLymphadenitis
=667  \\$acoord IM with AFIPIA (IM) or BARTONELLA HENSELAE (IM) if appropriate
=680  \\$iA self-limiting bacterial infection of the regional lymph nodes caused by AFIPIA felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by BARTONELLA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom.
=750  \0$aCat-scratch disease$5IEN-M$0(DLC)sh 98002717

=LDR  01404cz  a2200301n  4500
=001  9880363304702441
=005  20141212195620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002371
=035  \\$aCAZ5534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x180
=150  \\$aCat Diseases
=450  \\$wnnna$aCat Disease
=450  \\$wnnna$aDisease, Cat
=450  \\$wnnna$aDisease, Feline
=450  \\$wnnna$aDiseases, Cat
=450  \\$wnnna$aDiseases, Feline
=450  \\$wnnna$aFeline Disease
=450  \\$wnnna$aFeline Diseases
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aFeline Acquired Immunodeficiency Syndrome
=550  \\$wh$aFeline Infectious Peritonitis
=550  \\$wh$aFeline Panleukopenia
=550  \\$wh$aLeukemia, Feline
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cat dis (IM); for abnormalities or injuries, index under CATS /abnorm or CATS /inj; does not include diseases of the so-called "big cats" (LIONS; CHEETAHS; tigers, panthers, etc.); don't forget also check tags CATS (NIM) & ANIMALS; DF: CAT DIS
=680  \\$iDiseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
=750  \0$aCats$xDiseases$5IEN$0(DLC)sh 85021264

=LDR  01560cz  a2200361n  4500
=001  9880363304802441
=005  20141212192043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002370
=035  \\$aCAZ5533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x660.$x430.$x500
=072  \\$aE7.$x858.$x690.$x725.$x430.$x500
=150  \\$aCasts, Surgical
=450  \\$wnnna$aCast, Fiberglass
=450  \\$wnnna$aCast, Plaster
=450  \\$wnnna$aCast, Plastic
=450  \\$wnnna$aCast, Surgical
=450  \\$wnnna$aCasts, Fiberglass
=450  \\$wnnna$aCasts, Plaster
=450  \\$wnnna$aCasts, Plastic
=450  \\$wnnna$aFiberglass Cast
=450  \\$aFiberglass Casts
=450  \\$wnnna$aPlaster Cast
=450  \\$aPlaster Casts
=450  \\$wnnna$aPlastic Cast
=450  \\$aPlastic Casts
=450  \\$wnnna$aSurgical Cast
=450  \\$wnnna$aSurgical Casts
=550  \\$wg$aExternal Fixators
=667  \\$a"cast syndrome" (duodenal compression caused by wearing a body cast) = SUPERIOR MESENTERIC ARTERY SYNDROME if confirmed by text but do not index under CASTS, SURGICAL /adv eff unless particularly discussed
=680  \\$iDressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid.
=750  \0$aSurgical casts$0(DLC)sh2008000131$5IEN

=LDR  00721cz  a2200241n  4500
=001  9880363304902441
=005  20141212195620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002368
=035  \\$aCAZ5532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x507.$x300
=072  \\$aD10.$x627.$x700.$x132
=072  \\$aD20.$x215.$x784.$x750.$x132
=150  \\$aCastor Oil
=450  \\$wnnna$aOil, Castor
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=550  \\$wh$aRicinoleic Acids
=550  \\$aCastor Bean
=550  \\$aRicinus
=680  \\$iOil obtained from seeds of Ricinus communis that is used as a cathartic and as a plasticizer.
=750  \0$aCastor oil$5IEN$0(DLC)sh 85020747

=LDR  00680cz  a2200205n  4500
=001  9880363305002441
=005  20141212195619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002367
=035  \\$aCAZ5531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x650.$x300
=150  \\$aCastor Bean
=450  \\$wnnna$aBean, Castor
=450  \\$wnnna$aBeans, Castor
=450  \\$wnnna$aCastor Beans
=550  \\$wg$aRicinus
=680  \\$iCommon name for Ricinus communis, a species in the family EUPHORBIACEAE. It is the source of CASTOR OIL.
=688  \\$a91(75); was see under RICINUS 1975-90
=750  \0$aCastor beans$5IEN$0(DLC)sh 85020745

=LDR  01353cz  a2200277n  4500
=001  9880363305102441
=005  20141212195619.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002366
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x100
=150  \\$aCassia
=450  \\$wnnna$aCassia fistula
=450  \\$wnnna$aCassia fistulas
=450  \\$wnnna$aCassias
=450  \\$wnnna$afistula, Cassia
=450  \\$wnnna$afistulas, Cassia
=450  \\$aIndian Laburnum
=450  \\$wnnna$aIndian Laburnums
=450  \\$wnnna$aLaburnum, Indian
=450  \\$wnnna$aLaburnums, Indian
=550  \\$wg$aFabaceae
=667  \\$aCASSIA SENNA; CASSIA ANGUSTIFOLIA and CASSIA OCCIDENTALIS see SENNA PLANT are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus (SENNA PLANT) and some to CHAMAECRISTA.
=688  \\$a91(78); was see under PLANTS, MEDICINAL 1978-90
=750  \0$aCassia (Genus)$5IEN$0(DLC)sh 85020625

=LDR  01655cz  a2200349n  4500
=001  9880363305202441
=005  20141212195550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002280
=035  \\$aCAZ5447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x165
=072  \\$aC4.$x557.$x470.$x565.$x165
=150  \\$aCarcinoma, Basal Cell
=450  \\$wnnna$aBasal Cell Carcinoma
=450  \\$wnnna$aBasal Cell Carcinomas
=450  \\$wnnna$aBasal Cell Epithelioma
=450  \\$wnnna$aBasal Cell Epitheliomas
=450  \\$aCarcinoma, Basal Cell, Pigmented
=450  \\$wnnna$aCarcinomas, Basal Cell
=450  \\$aEpithelioma, Basal Cell
=450  \\$wnnna$aEpitheliomas, Basal Cell
=450  \\$aRodent Ulcer
=450  \\$wnnna$aRodent Ulcers
=450  \\$aUlcer, Rodent
=450  \\$wnnna$aUlcers, Rodent
=550  \\$wg$aCarcinoma
=550  \\$wg$aNeoplasms, Basal Cell
=550  \\$wh$aBasal Cell Nevus Syndrome
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS (IM); X ref RODENT ULCER: do not coord with ULCER
=680  \\$iA malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
=750  \0$aBasal cell carcinoma$5IEN$0(DLC)sh 85114800

=LDR  01784cz  a2200361n  4500
=001  9880363305302441
=005  20141212195547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002276
=035  \\$aCAZ5443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x200
=072  \\$aC4.$x557.$x470.$x200.$x25.$x200
=072  \\$aC4.$x557.$x580.$x625.$x650.$x200
=150  \\$aCarcinoid Tumor
=450  \\$aArgentaffinoma
=450  \\$wnnna$aArgentaffinomas
=450  \\$aCarcinoid
=450  \\$aCarcinoid, Goblet Cell
=450  \\$wnnna$aCarcinoid Tumors
=450  \\$wnnna$aCarcinoids
=450  \\$wnnna$aCarcinoids, Goblet Cell
=450  \\$wnnna$aGoblet Cell Carcinoid
=450  \\$wnnna$aGoblet Cell Carcinoids
=450  \\$wnnna$aTumor, Carcinoid
=450  \\$wnnna$aTumors, Carcinoid
=550  \\$wg$aAdenocarcinoma
=550  \\$wg$aNeuroendocrine Tumors
=550  \\$wh$aMalignant Carcinoid Syndrome
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); consider also MALIGNANT CARCINOID SYNDROME or CARCINOID HEART DISEASE
=680  \\$iA usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
=688  \\$a68; was ARGENTAFFINOMA 1963-67
=750  \0$aCarcinoid$5IEN$0(DLC)sh 85020159

=LDR  01240cz  a2200253n  4500
=001  9880363305402441
=005  20141212195547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002275
=035  \\$aCAZ5442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x200.$x500.$x205
=072  \\$aC4.$x557.$x470.$x200.$x25.$x200.$x500.$x205
=072  \\$aC4.$x557.$x580.$x625.$x650.$x200.$x500.$x205
=072  \\$aC14.$x280.$x104
=150  \\$aCarcinoid Heart Disease
=450  \\$wnnna$aCarcinoid Heart Diseases
=450  \\$wnnna$aHeart Disease, Carcinoid
=450  \\$wnnna$aHeart Diseases, Carcinoid
=550  \\$wg$aHeart Diseases
=550  \\$wg$aMalignant Carcinoid Syndrome
=680  \\$iCardiac manifestation of gastrointestinal CARCINOID TUMOR that metastasizes to the liver. Substances secreted by the tumor cells, including SEROTONIN, promote fibrous plaque formation in ENDOCARDIUM and its underlying layers. These deposits cause distortion of the TRICUSPID VALVE and the PULMONARY VALVE eventually leading to STENOSIS and valve regurgitation.
=688  \\$a91(75)(64-72); was see under MALIGNANT CARCINOID SYNDROME 1964-90 (Prov 1964-72)
=750  \0$aCarcinoid heart disease$5IEN$0(DLC)sh 85020160

=LDR  01688cz  a2200385n  4500
=001  9880363305502441
=005  20141212195619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002365
=035  \\$aCAZ5529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x535
=150  \\$aManihot
=450  \\$aArrowroot, Brazilian
=450  \\$wnnna$aArrowroots, Brazilian
=450  \\$aBrazilian Arrowroot
=450  \\$wnnna$aBrazilian Arrowroots
=450  \\$aCassava
=450  \\$wnnna$aCassavas
=450  \\$wnnna$aesculenta, Manihot
=450  \\$wnnna$aesculentas, Manihot
=450  \\$aKasaba
=450  \\$wnnna$aKasabas
=450  \\$wnnna$aManihot esculenta
=450  \\$wnnna$aManihot esculentas
=450  \\$wnnna$aManihots
=450  \\$aManioc
=450  \\$wnnna$aManiocs
=450  \\$aTapioca
=450  \\$wnnna$aTapiocas
=550  \\$wg$aEuphorbiaceae
=667  \\$aARROWROOT see MARANTACEAE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE that is perennial with conspicuous, almost palmate leaves like those of RICINUS but more deeply parted into five to nine lobes. It is a source of a starch after removal of the cyanogenic glucosides. The common name of Arrowroot is also used with Maranta (MARANTACEAE). The common name of yuca is also used for YUCCA.
=688  \\$a2003(1963)
=750  \0$aManihot$5IEN-M$0(DLC)sh 87001932

=LDR  00696cz  a2200217n  4500
=001  9880363305602441
=005  20141212195547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002274
=035  \\$aCAZ5441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x100.$x125
=150  \\$aCarcinogens, Environmental
=450  \\$aEnvironmental Carcinogens
=550  \\$wg$aCarcinogens
=550  \\$aEnvironmental Pollutants
=667  \\$aDF: CARCINOGENS ENVIR
=680  \\$iCarcinogenic substances that are found in the environment.
=688  \\$a75
=750  \0$81$wb$aCarcinogens$5IEN$0(DLC)sh 85020157
=750  \0$81$wb$aEnvironmentally induced diseases$5IEN-HS$0(DLC)sh 85044215

=LDR  00938cz  a2200277n  4500
=001  9880363305702441
=005  20141212195546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002273
=035  \\$aCAZ5440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x569.$x100
=150  \\$aCarcinogens
=450  \\$wnnna$aInitiators, Tumor
=450  \\$aOncogens
=450  \\$wnnna$aPromoters, Tumor
=450  \\$aTumor Initiators
=450  \\$aTumor Promoters
=550  \\$wg$aNoxae
=550  \\$wh$aCarcinogens, Environmental
=550  \\$wh$aPeroxisome Proliferators
=550  \\$aBenzidines
=550  \\$aNeoplasms
=667  \\$aManual 24.5.6.2+
=680  \\$iSubstances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.
=750  \0$aCarcinogens$5IEN-HS$0(DLC)sh 85020157

=LDR  02163cz  a2200493n  4500
=001  9880363305802441
=005  20141212210912.0
=008  880423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015197
=035  \\$aCAZ5439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x940.$x150
=150  \\$aCarcinogenicity Tests
=450  \\$wnnna$aCarcinogen Test
=450  \\$wnnna$aCarcinogen Tests
=450  \\$wnnna$aCarcinogenesis Test
=450  \\$wnnna$aCarcinogenesis Tests
=450  \\$wnnna$aCarcinogenic Activity Test
=450  \\$wnnna$aCarcinogenic Activity Tests
=450  \\$wnnna$aCarcinogenic Potency Test
=450  \\$wnnna$aCarcinogenic Potency Tests
=450  \\$wnnna$aCarcinogenicity Test
=450  \\$wnnna$aPotency Test, Carcinogenic
=450  \\$wnnna$aPotency Tests, Carcinogenic
=450  \\$wnnna$aTest, Carcinogen
=450  \\$wnnna$aTest, Carcinogenesis
=450  \\$wnnna$aTest, Carcinogenic Activity
=450  \\$wnnna$aTest, Carcinogenic Potency
=450  \\$wnnna$aTest, Carcinogenicity
=450  \\$wnnna$aTest, Tumorigenicity
=450  \\$wnnna$aTests, Carcinogen
=450  \\$wnnna$aTests, Carcinogenesis
=450  \\$wnnna$aTests, Carcinogenic Activity
=450  \\$wnnna$aTests, Carcinogenic Potency
=450  \\$wnnna$aTests, Carcinogenicity
=450  \\$wnnna$aTests, Tumorigenicity
=450  \\$wnnna$aTumorigenicity Test
=450  \\$aTumorigenicity Tests
=550  \\$wg$aToxicity Tests
=550  \\$aMutagenicity Tests
=667  \\$aNIM; Manual 24.5.6.2+
=680  \\$iTests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.
=688  \\$a89
=750  \0$aCarcinogenicity testing$0(DLC) sh 85020156$5IEN

=LDR  01130cz  a2200313n  4500
=001  9880363305902441
=005  20160425095740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002272
=035  \\$aCAZ5438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x200.$x210
=072  \\$aD12.$x776.$x543.$x550.$x200.$x210
=072  \\$aD23.$x50.$x285.$x329
=072  \\$aD23.$x50.$x301.$x350.$x210
=072  \\$aD23.$x101.$x840.$x300
=150  \\$aCarcinoembryonic Antigen
=450  \\$wnnna$aAntigen, Carcinoembryonic
=450  \\$wnnna$aAntigen, CD66e
=450  \\$aAntigens, CD66e
=450  \\$aCD66e Antigen
=450  \\$wnnna$aCD66e Antigens
=550  \\$wg$aAntigens, Neoplasm
=550  \\$wg$aCell Adhesion Molecules
=550  \\$wg$aBiomarkers, Tumor
=667  \\$aDF: CEA
=680  \\$iA glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.
=688  \\$a74(73)
=750  \0$aCEA (Oncology)$5IEN$0(DLC)sh 85020154

=LDR  01849cz  a2200553n  4500
=001  9880363306002441
=005  20141212195618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002364
=035  \\$aCAZ5528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x256.$x626.$x207
=072  \\$aD12.$x776.$x744.$x150
=150  \\$aCaseins
=450  \\$wnnna$aAcetylated, Dephosphorylated beta-Casein
=450  \\$wnnna$aAD beta-Casein
=450  \\$wnnna$aAD beta Casein
=450  \\$wnnna$aalpha-Caseins
=450  \\$wnnna$aalpha Caseins
=450  \\$wnnna$aalpha(S1)-Casein
=450  \\$wnnna$aalpha(S1)-Casein A
=450  \\$wnnna$aalpha(S1)-Casein B
=450  \\$wnnna$aalpha(S1)-Casein C
=450  \\$wnnna$aalpha(S2)-Casein
=450  \\$wnnna$abeta-Casein
=450  \\$wnnna$abeta Casein
=450  \\$wnnna$abeta-Casein Acetylated, Dephosphorylated
=450  \\$wnnna$abeta-Casein, AD
=450  \\$wnnna$abeta-Caseins
=450  \\$wnnna$abeta Caseins
=450  \\$wnnna$aCasein
=450  \\$wnnna$aCasein A
=450  \\$wnnna$aCaseinate, Sodium
=450  \\$wnnna$aepsilon-Casein
=450  \\$wnnna$aepsilon Casein
=450  \\$wnnna$agamma-Caseins
=450  \\$wnnna$agamma Caseins
=450  \\$wnnna$aK-Casein
=450  \\$wnnna$aK Casein
=450  \\$wnnna$akappa-Casein
=450  \\$wnnna$akappa Casein
=450  \\$wnnna$akappa-Caseins
=450  \\$wnnna$akappa Caseins
=450  \\$wnnna$aSodium Caseinate
=550  \\$wg$aMilk Proteins
=550  \\$wg$aPhosphoproteins
=680  \\$iA mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.
=688  \\$a82; was CASEIN 1963-81
=750  \0$aCasein$5IEN$0(DLC)sh 85020578

=LDR  00910cz  a2200229n  4500
=001  9880363306102441
=005  20141212195545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002270
=035  \\$aCAZ5436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x868.$x820.$x270.$x200
=072  \\$aC1.$x252.$x825.$x770.$x270.$x200
=072  \\$aC1.$x539.$x800.$x720.$x770.$x270.$x200
=072  \\$aC17.$x800.$x838.$x765.$x770.$x270.$x200
=150  \\$aCarbuncle
=450  \\$wnnna$aCarbuncles
=550  \\$wg$aFurunculosis
=550  \\$aFurunculosis
=667  \\$ausually caused by Staph; malignant carbuncle = ANTHRAX
=680  \\$iAn infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.
=750  \0$aCarbuncle$5IEN$0(DLC)sh 85020146

=LDR  01036cz  a2200301n  4500
=001  9880363306302441
=005  20141212195545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002268
=035  \\$aCAZ5434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x245
=150  \\$aCarboxypeptidases
=550  \\$wg$aExopeptidases
=550  \\$wh$aCarboxypeptidase B
=550  \\$wh$aCarboxypeptidase B2
=550  \\$wh$aCarboxypeptidase H
=550  \\$wh$aCarboxypeptidases A
=550  \\$wh$aCathepsin A
=550  \\$wh$aCathepsin Z
=550  \\$wh$agamma-Glutamyl Hydrolase
=550  \\$wh$aGlutamate Carboxypeptidase II
=550  \\$wh$aLysine Carboxypeptidase
=550  \\$wh$aMuramoylpentapeptide Carboxypeptidase
=550  \\$wh$aSerine-Type D-Ala-D-Ala Carboxypeptidase
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iEnzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue.
=750  \0$aCarboxypeptidases$5IEN$0(DLC)sh 85020145

=LDR  00681cz  a2200229n  4500
=001  9880363306402441
=005  20141212195616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002358
=035  \\$aCAZ5522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x165.$x407.$x150
=072  \\$aA2.$x835.$x583.$x192
=150  \\$aCartilage, Articular
=450  \\$wnnna$aArticular Cartilage
=450  \\$wnnna$aArticular Cartilages
=450  \\$wnnna$aCartilages, Articular
=550  \\$wg$aHyaline Cartilage
=550  \\$wg$aJoints
=667  \\$ainflammation (chondritis) is likely to be OSTEOCHONDRITIS
=688  \\$a65
=750  \0$aArticular cartilage$0(DLC) sh 85008154$5IEN

=LDR  00977cz  a2200289n  4500
=001  9880363306502441
=005  20141212195544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002264
=035  \\$aCAZ5430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241
=150  \\$aCarboxylic Acids
=450  \\$wnnna$aAcids, Carboxylic
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcids, Acyclic
=550  \\$wh$aAcids, Aldehydic
=550  \\$wh$aAcids, Carbocyclic
=550  \\$wh$aEsters
=550  \\$wh$aHumic Substances
=550  \\$wh$aHydroxy Acids
=550  \\$wh$aKeto Acids
=550  \\$wh$aThioctic Acid
=667  \\$ado not confuse with CARBOCYCLIC ACIDS see ACIDS, CARBOCYCLIC
=680  \\$iOrganic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic.
=688  \\$a73(71)
=750  \0$aCarboxylic acids$5IEN$0(DLC)sh 85020144

=LDR  00875cz  a2200229n  4500
=001  9880363306602441
=005  20141212195615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002353
=035  \\$aCAZ5519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x160
=150  \\$aCarrier State
=450  \\$wnnna$aCarrier States
=450  \\$wnnna$aState, Carrier
=450  \\$wnnna$aStates, Carrier
=550  \\$wg$aPublic Health
=550  \\$aDisease Reservoirs
=667  \\$adisease carriers, not genetic carriers ( = CARRIERS, GENETIC see HETEROZYGOTE); coord with disease, not organism
=680  \\$iThe condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.
=688  \\$a65(63)
=750  \0$aCarrier state (Communicable diseases)$5IEN$0(DLC)sh 85020471

=LDR  01519cz  a2200373n  4500
=001  9880363306702441
=005  20141212195543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002262
=035  \\$aCAZ5428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x224.$x125
=150  \\$aCarboxy-Lyases
=450  \\$wnnna$aCarboxy Lyases
=450  \\$aDecarboxylases
=550  \\$wg$aCarbon-Carbon Lyases
=550  \\$wh$aAdenosylmethionine Decarboxylase
=550  \\$wh$aAromatic-L-Amino-Acid Decarboxylases
=550  \\$wh$aGlutamate Decarboxylase
=550  \\$wh$aHistidine Decarboxylase
=550  \\$wh$aIndole-3-Glycerol-Phosphate Synthase
=550  \\$wh$aMethylmalonyl-CoA Decarboxylase
=550  \\$wh$aOrnithine Decarboxylase
=550  \\$wh$aOrotidine-5'-Phosphate Decarboxylase
=550  \\$wh$aPhosphoenolpyruvate Carboxykinase (ATP)
=550  \\$wh$aPhosphoenolpyruvate Carboxykinase (GTP)
=550  \\$wh$aPhosphoenolpyruvate Carboxylase
=550  \\$wh$aPyruvate Decarboxylase
=550  \\$wh$aRibulose-Bisphosphate Carboxylase
=550  \\$wh$aTyrosine Decarboxylase
=550  \\$wh$aUroporphyrinogen Decarboxylase
=680  \\$iEnzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1.
=688  \\$a64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES & LIGASES 1964-74, was heading 1963
=750  \0$aDecarboxylases$5IEN$0(DLC)sh 85036166

=LDR  02597cz  a2200697n  4500
=001  9880363306802441
=005  20200616143823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002352
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157
=150  \\$aCarrier Proteins
=450  \\$wnnna$aBinding Protein
=450  \\$aBinding Proteins
=450  \\$wnnna$aProtein, Binding
=450  \\$wnnna$aProteins, Binding
=450  \\$wnnna$aProteins, Carrier
=450  \\$wnnna$aProteins, Transport
=450  \\$aTransport Proteins
=550  \\$wg$aProteins
=550  \\$wh$aAcyl Carrier Protein
=550  \\$wh$aAdaptor Proteins, Signal Transducing
=550  \\$wh$aAndrogen-Binding Protein
=550  \\$wh$aCalcium-Binding Proteins
=550  \\$wh$aCalmodulin-Binding Proteins
=550  \\$wh$aCeruloplasmin
=550  \\$wh$aCholesterol Ester Transfer Proteins
=550  \\$wh$aF-Box Proteins
=550  \\$wh$aFatty Acid-Binding Proteins
=550  \\$wh$aFollistatin
=550  \\$wh$aFollistatin-Related Proteins
=550  \\$wh$aGTP-Binding Proteins
=550  \\$wh$aInsulin-Like Growth Factor Binding Proteins
=550  \\$wh$aIron-Binding Proteins
=550  \\$wh$aLatent TGF-beta Binding Proteins
=550  \\$wh$aLipid Droplet Associated Proteins
=550  \\$wh$aLipocalins
=550  \\$wh$aLymphocyte Antigen 96
=550  \\$wh$aMembrane Transport Proteins
=550  \\$wh$aNeurophysins
=550  \\$wh$aPeriplasmic Binding Proteins
=550  \\$wh$aPeroxins
=550  \\$wh$aPhosphate-Binding Proteins
=550  \\$wh$aPhosphatidylethanolamine Binding Protein
=550  \\$wh$aPhospholipid Transfer Proteins
=550  \\$wh$aPoly-ADP-Ribose Binding Proteins
=550  \\$wh$aRetinol-Binding Proteins
=550  \\$wh$aRNA-Binding Proteins
=550  \\$wh$aS-Phase Kinase-Associated Proteins
=550  \\$wh$aSex Hormone-Binding Globulin
=550  \\$wh$aThyroxine-Binding Proteins
=550  \\$wh$aTranscobalamins
=550  \\$wh$aTranscortin
=550  \\$wh$aTransferrin-Binding Proteins
=550  \\$wh$aVitamin D-Binding Protein
=550  \\$aProtein Binding
=550  \\$aReceptors, Transferrin
=667  \\$ado not confuse BINDING PROTEINS (X ref) with PROTEIN BINDING; do not use CARRIER PROTEINS if the protein functions as a receptor: use instead the pertinent receptors term; not for antigenic carriers ( = ANTIGENS)
=680  \\$iTransport proteins that carry specific substances in the blood or across cell membranes.
=688  \\$a73(71)
=750  \0$aCarrier proteins$0(DLC) sh 85020470$5IEN

=LDR  01081cz  a2200301n  4500
=001  9880363306902441
=005  20180323140044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002256
=035  \\$aCAZ5422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x241.$x300.$x150
=150  \\$aCarbonic Anhydrases
=450  \\$wnnna$aAnhydrases, Carbonic
=450  \\$aCarbonate Dehydratase
=450  \\$aCarbonic Anhydrase
=450  \\$wnnna$aDehydratase, Carbonate
=550  \\$wg$aHydro-Lyases
=550  \\$wh$aCarbonic Anhydrase I
=550  \\$wh$aCarbonic Anhydrase II
=550  \\$wh$aCarbonic Anhydrase III
=550  \\$wh$aCarbonic Anhydrase IV
=550  \\$wh$aCarbonic Anhydrase IX
=550  \\$wh$aCarbonic Anhydrase V
=667  \\$anote specifics
=680  \\$iA family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1.
=688  \\$a2002(1963)
=750  \0$aCarbonic anhydrase$5IEN-M$0(DLC)sh 85020138

=LDR  00983cz  a2200229n  4500
=001  9880363307002441
=005  20141212195541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002255
=035  \\$aCAZ5421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x150
=072  \\$aD1.$x200.$x275
=150  \\$aCarbonic Acid
=450  \\$wnnna$aAcid, Carbonic
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aCarbon Compounds, Inorganic
=550  \\$wh$aCarbonates
=667  \\$a"the hypothetical acid of carbon dioxide & water"
=680  \\$iCarbonic acid (H2C03). The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts (carbonates), acid salts (hydrogen carbonates), amines (carbamic acid), and acid chlorides (carbonyl chloride). (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a91(75); was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74
=750  \0$aCarbonic acid$5IEN$0(DLC)sh 89006832

=LDR  00930cz  a2200253n  4500
=001  9880363307102441
=005  20141212195540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002254
=035  \\$aCAZ5420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45.$x125
=072  \\$aD1.$x200.$x275.$x150
=072  \\$aD1.$x248.$x497.$x158.$x165
=150  \\$aCarbonates
=550  \\$wg$aAlkalies
=550  \\$wg$aAnions
=550  \\$wg$aCarbonic Acid
=550  \\$wh$aBicarbonates
=550  \\$wh$aCalcium Carbonate
=550  \\$wh$aLithium Carbonate
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iSalts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aCarbonates$5IEN$0(DLC)sh 85020136

=LDR  01086cz  a2200313n  4500
=001  9880363307202441
=005  20141212195612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002348
=035  \\$aCAZ5515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x319.$x150
=150  \\$aCarpal Bones
=450  \\$wnnna$aBone, Carpal
=450  \\$wnnna$aBones, Carpal
=450  \\$wnnna$aCarpal Bone
=550  \\$wg$aHand Bones
=550  \\$wh$aCapitate Bone
=550  \\$wh$aHamate Bone
=550  \\$wh$aLunate Bone
=550  \\$wh$aPisiform Bone
=550  \\$wh$aScaphoid Bone
=550  \\$wh$aTrapezium Bone
=550  \\$wh$aTrapezoid Bone
=550  \\$wh$aTriquetrum Bone
=667  \\$ado not confuse with WRIST (the area) or WRIST JOINT; see note on CARPUS, ANIMAL; /inj permitted: not necessarily WRIST INJURIES
=680  \\$iThe eight bones of the wrist: SCAPHOID BONE; LUNATE BONE; TRIQUETRUM BONE; PISIFORM BONE; TRAPEZIUM BONE; TRAPEZOID BONE; CAPITATE BONE; and HAMATE BONE.
=688  \\$a72
=750  \0$aCarpal bones$5IEN$0(DLC)sh 90002819

=LDR  01369cz  a2200433n  4500
=001  9880363307302441
=005  20141212195612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002347
=035  \\$aCAZ5514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x200.$x244.$x248
=150  \\$aCarps
=450  \\$aCarassius carassius
=450  \\$wnnna$aCarp
=450  \\$wnnna$aCarp, Crucian
=450  \\$wnnna$aCarp, Grass
=450  \\$wnnna$aCarp, Koi
=450  \\$wnnna$aCarp, Silver
=450  \\$wnnna$aCarps, Crucian
=450  \\$wnnna$aCarps, Grass
=450  \\$wnnna$aCarps, Silver
=450  \\$aCrucian Carp
=450  \\$wnnna$aCrucian Carps
=450  \\$wnnna$aCtenopharyngodon idellus
=450  \\$aCyprinus
=450  \\$wnnna$aCyprinus carpio
=450  \\$aGrass Carp
=450  \\$wnnna$aGrass Carps
=450  \\$wnnna$aHypophthalmichthys molitrix
=450  \\$wnnna$aKoi Carp
=450  \\$wnnna$aSilver Carp
=450  \\$wnnna$aSilver Carps
=550  \\$wg$aCyprinidae
=550  \\$wh$aGoldfish
=680  \\$iCommon name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.
=688  \\$a2002 (1975)
=750  \0$aCarp$5IEN-M$0(DLC)sh 85020421
=750  \0$aCyprinus$5IEN-HS$0(DLC)sh 85035181

=LDR  01111cz  a2200361n  4500
=001  9880363307402441
=005  20141212195540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002253
=035  \\$aCAZ5419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x300
=150  \\$aCarbonated Beverages
=450  \\$wnnna$aBeverage, Carbonated
=450  \\$wnnna$aBeverages, Carbonated
=450  \\$wnnna$aCarbonated Beverage
=450  \\$wnnna$aCarbonated Drink
=450  \\$wnnna$aCarbonated Drinks
=450  \\$wnnna$aDrink, Carbonated
=450  \\$wnnna$aDrink, Soft
=450  \\$wnnna$aDrinks, Carbonated
=450  \\$wnnna$aDrinks, Soft
=450  \\$wnnna$aPop, Soda
=450  \\$wnnna$aPops, Soda
=450  \\$wnnna$aSoda Pop
=450  \\$wnnna$aSoda Pops
=450  \\$wnnna$aSoft Drink
=450  \\$wnnna$aSoft Drinks
=550  \\$wg$aBeverages
=550  \\$wh$aCarbonated Water
=680  \\$iDrinkable liquids combined with or impregnated with carbon dioxide.
=688  \\$a91(75); was see under BEVERAGES 1975-90
=750  \0$aCarbonated beverages$5IEN$0(DLC)sh 85020132

=LDR  01148cz  a2200277n  4500
=001  9880363307502441
=005  20141212195611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002345
=035  \\$aCAZ5513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x700.$x705.$x220
=072  \\$aC4.$x557.$x580.$x625.$x650.$x700.$x705.$x220
=150  \\$aCarotid Body Tumor
=450  \\$wnnna$aCarotid Body Paraganglioma
=450  \\$wnnna$aCarotid Body Paragangliomas
=450  \\$wnnna$aCarotid Body Tumors
=450  \\$aParaganglioma, Carotid Body
=450  \\$wnnna$aParagangliomas, Carotid Body
=450  \\$wnnna$aTumor, Carotid Body
=450  \\$wnnna$aTumors, Carotid Body
=550  \\$wg$aParaganglioma, Extra-Adrenal
=550  \\$aCarotid Body
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; organ/neopl & histol coords not necessary
=680  \\$iBenign paraganglioma at the bifurcation of the COMMON CAROTID ARTERIES. It can encroach on the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies.
=750  \0$aCarotid body$xTumors$5IEN-M$0(DLC)sh 85020417

=LDR  00848cz  a2200193n  4500
=001  9880363307602441
=005  20141212195539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002251
=035  \\$aCAZ5417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x150
=150  \\$aCarbon Tetrachloride
=450  \\$wnnna$aTetrachloride, Carbon
=450  \\$wnnna$aTetrachloromethane
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$a/tox permitted but consider also CARBON TETRACHLORIDE POISONING; DF: CCL4
=680  \\$iA solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
=750  \0$aCarbon tetrachloride$5IEN$0(DLC)sh 85020127

=LDR  01071cz  a2200253n  4500
=001  9880363307702441
=005  20141212192043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002344
=035  \\$aCAZ5512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x500.$x600.$x150
=072  \\$aA8.$x800.$x950.$x500.$x600.$x150
=072  \\$aA11.$x671.$x650.$x915.$x500.$x600.$x150
=150  \\$aCarotid Body
=450  \\$wnnna$aBodies, Carotid
=450  \\$wnnna$aBody, Carotid
=450  \\$wnnna$aCaroticum, Glomus
=450  \\$wnnna$aCarotid Bodies
=450  \\$aGlomus Caroticum
=550  \\$wg$aParaganglia, Nonchromaffin
=667  \\$aa nonchromaffin paraganglion
=680  \\$iA small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.
=750  \0$aCarotid body$5IEN$0(DLC)sh 85020416

=LDR  01190cz  a2200313n  4500
=001  9880363307802441
=005  20141212195539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002249
=035  \\$aCAZ5415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x455.$x245
=150  \\$aCarbon Monoxide Poisoning
=450  \\$aCarbon Monoxide$xpoisoning
=450  \\$wnnna$aCarbon Monoxide Poisonings
=450  \\$wnnna$aGas Poisoning, Illuminating
=450  \\$wnnna$aGas Poisonings, Illuminating
=450  \\$aIlluminating Gas Poisoning
=450  \\$wnnna$aIlluminating Gas Poisonings
=450  \\$wnnna$aMonoxide Poisoning, Carbon
=450  \\$wnnna$aMonoxide Poisonings, Carbon
=450  \\$wnnna$aPoisoning, Carbon Monoxide
=450  \\$wnnna$aPoisoning, Illuminating Gas
=450  \\$wnnna$aPoisonings, Carbon Monoxide
=450  \\$wnnna$aPoisonings, Illuminating Gas
=550  \\$wg$aGas Poisoning
=680  \\$iToxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide.
=688  \\$aILLUMINATING GAS POISONING was see under CARBON MONOXIDE POISONING 1969-78
=750  \0$aCarbon monoxide$xToxicology$5IEN$0(DLC)sh2009118397

=LDR  01517cz  a2200265n  4500
=001  9880363184402441
=005  20141212195500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002118
=035  \\$aCAZ5283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552.$x100
=072  \\$aD1.$x552.$x539.$x288
=072  \\$aD23.$x119.$x100
=150  \\$aCalcium
=450  \\$wnnna$aBlood Coagulation Factor IV
=450  \\$aCoagulation Factor IV
=450  \\$aFactor IV
=450  \\$wnnna$aFactor IV, Coagulation
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aMetals, Alkaline Earth
=667  \\$aCa-40; / antag permitted but consider also CALCIUM CHANNEL BLOCKERS; / blood: note HYPOCALCEMIA and HYPERCALCEMIA are available; / defic: consider also HYPOCALCEMIA & note that CALCIUM, DIETARY is also available; CALCIUM CHANNELS and CALCIUM SIGNALING are also available; metabolic disorders = CALCIUM METABOLISM DISORDERS
=680  \\$iA basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
=688  \\$a/metabolism was CALCIUM METABOLISM 1965
=750  \0$aCalcium$5IEN-HS$0(DLC)sh 85018768

=LDR  01214cz  a2200313n  4500
=001  9880363184502441
=005  20141212195458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002116
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x150
=072  \\$aD12.$x644.$x400.$x95
=072  \\$aD12.$x644.$x548.$x150
=072  \\$aD12.$x776.$x641.$x650.$x95
=150  \\$aCalcitonin
=450  \\$wnnna$aCalcitonin(1-32)
=450  \\$wnnna$aCalcitonin, Eel
=450  \\$wnnna$aCalcitrin
=450  \\$wnnna$aCiba 47175-BA
=450  \\$wnnna$aCiba 47175 BA
=450  \\$wnnna$aCiba 47175BA
=450  \\$wnnna$aEel Calcitonin
=450  \\$aThyrocalcitonin
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=550  \\$aUltimobranchial Body
=680  \\$iA peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.
=688  \\$a74,66-67; was THYROCALCITONIN 1968-73 & 1964-65 (Prov 1964-65)
=750  \0$aCalcitonin$5IEN$0(DLC)sh 85018767

=LDR  00794cz  a2200217n  4500
=001  9880363184602441
=005  20141212195458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002115
=035  \\$aCAZ5280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174.$x130.$x186
=150  \\$aCalciphylaxis
=450  \\$wnnna$aCalciphylaxes
=450  \\$wnnna$aCalciphylaxis, Idiopathic
=450  \\$wnnna$aIdiopathic Calciphylaxis
=550  \\$wg$aCalcinosis
=667  \\$ahypersensitivity with sudden local calcification
=680  \\$iCondition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
=688  \\$a91(84)63; was see under CALCINOSIS 1984-90
=750  \0$aCalciphylaxis$5IEN$0(DLC)sh 85018764

=LDR  01044cz  a2200301n  4500
=001  9880363184702441
=005  20141212195458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002114
=035  \\$aCAZ5279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174.$x130
=150  \\$aCalcinosis
=450  \\$aCalcification, Pathologic
=450  \\$wnnna$aCalcinoses
=450  \\$wnnna$aCalcinoses, Tumoral
=450  \\$wnnna$aCalcinosis, Tumoral
=450  \\$wnnna$aPathologic Calcification
=450  \\$wnnna$aTumoral Calcinoses
=450  \\$wnnna$aTumoral Calcinosis
=550  \\$wg$aCalcium Metabolism Disorders
=550  \\$wh$aCalciphylaxis
=550  \\$wh$aCREST Syndrome
=550  \\$wh$aNephrocalcinosis
=550  \\$wh$aVascular Calcification
=667  \\$acoordinate IM with organ/diseases term (IM); for calcinosis of the heart, coordinate IM with CARDIOMYOPATHIES (IM), not HEART DISEASES
=680  \\$iPathologic deposition of calcium salts in tissues.
=750  \0$aCalcification$5IEN-M$0(DLC)sh 85018762

=LDR  01088cz  a2200301n  4500
=001  9880363184802441
=005  20141212195457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002113
=035  \\$aCAZ5278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x186
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625.$x100.$x175
=072  \\$aG11.$x427.$x590.$x560.$x100.$x175
=150  \\$aCalcification, Physiologic
=450  \\$aBone Mineralization
=450  \\$wnnna$aCalcification, Physiological
=450  \\$wnnna$aMineralization, Bone
=450  \\$wnnna$aPhysiologic Calcification
=450  \\$wnnna$aPhysiological Calcification
=550  \\$wg$aBone Development
=550  \\$wg$aGrowth and Development
=550  \\$wh$aTooth Calcification
=550  \\$aBone and Bones
=667  \\$aTOOTH CALCIFICATION is also available; DF: CALCIFICATION PHYSIOL
=680  \\$iProcess by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
=688  \\$a65; was CALCIFICATION 1963-64
=750  \0$aCalcification$5IEN$0(DLC)sh 85018762

=LDR  00642cz  a2200205n  4500
=001  9880363184902441
=005  20141212195456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002111
=035  \\$aCAZ5276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x300.$x710.$x300
=150  \\$aCalcaneus
=450  \\$wnnna$aBone, Heel
=450  \\$aHeel Bone
=550  \\$wg$aTarsal Bones
=550  \\$aHeel
=667  \\$ado not confuse with HEEL, the area
=680  \\$iThe largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL.
=750  \0$aHeel bone$0(DLC) sh 85059922$5IEN

=LDR  02079cz  a2200445n  4500
=001  9880363185002441
=005  20141212192036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002110
=035  \\$aCAZ5275HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x960.$x175
=072  \\$aD3.$x438.$x759.$x758.$x824.$x175
=150  \\$aCaffeine
=450  \\$wnnna$a1,3,7-Trimethylxanthine
=450  \\$wnnna$aBerlin-Chemie Brand of Caffeine
=450  \\$wnnna$aBristol-Myers Squibb Brand of Caffeine
=450  \\$wnnna$aCaffedrine
=450  \\$aCaffeine Habit$5IEN
=450  \\$wnnna$aCoffeinum N
=450  \\$wnnna$aCoffeinum Purrum
=450  \\$wnnna$aDexitac
=450  \\$wnnna$aDurvitan
=450  \\$wnnna$aGlaxoSmithKline Brand of Caffeine
=450  \\$wnnna$aMerck dura Brand of Caffeine
=450  \\$wnnna$aNo Doz
=450  \\$wnnna$aPassauer Brand of Caffeine
=450  \\$wnnna$aPercoffedrinol N
=450  \\$wnnna$aPercutaféine
=450  \\$wnnna$aPierre Fabre Brand of Caffeine
=450  \\$wnnna$aQuick-Pep
=450  \\$wnnna$aRepublic Drug Brand of Caffeine
=450  \\$wnnna$aSeid Brand of Caffeine
=450  \\$wnnna$aThompson Brand 1 of Caffeine
=450  \\$wnnna$aThompson Brand 2 of Caffeine
=450  \\$wnnna$aVivarin
=550  \\$wg$aXanthines
=550  \\$aCoffee
=680  \\$iA methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
=750  \0$aCaffeine$5IEN-M$0(DLC)sh 85018686

=LDR  01114cz  a2200289n  4500
=001  9880363185102441
=005  20141212195456.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002108
=035  \\$aCAZ5273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x241
=150  \\$aCeruletide
=450  \\$aCaerulein
=450  \\$aCerulein
=450  \\$wnnna$aCeruletid
=450  \\$wnnna$aFI-6934
=450  \\$wnnna$aFI 6934
=450  \\$wnnna$aFI6934
=450  \\$wnnna$aTakus
=550  \\$wg$aOligopeptides
=667  \\$a/biosyn /physiol permitted; do not confuse X ref CERULEIN with CERULENIN
=680  \\$iA specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.
=688  \\$a2013(1972)
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Caerulein
=688  \\$a74(72)
=750  \0$aCerulein$5IEN$0(DLC)sh 85022173

=LDR  00761cz  a2200205n  4500
=001  9880363185202441
=005  20141212195455.0
=008  780302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002107
=035  \\$aCAZ5272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x700.$x660.$x250
=150  \\$aCaenorhabditis
=450  \\$wnnna$aCaenorhabditides
=550  \\$wg$aRhabditoidea
=550  \\$wh$aCaenorhabditis elegans
=667  \\$aa genus of nematodes used in exper
=680  \\$iA genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.
=688  \\$a79
=750  \0$aCaenorhabditis$5IEN$0(DLC)sh 85018674

=LDR  00799cz  a2200205n  4500
=001  9880363185302441
=005  20141212195455.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002106
=035  \\$aCAZ5271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x108
=150  \\$aCadmium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Cadmium
=550  \\$wg$aRadioisotopes
=550  \\$aCadmium
=667  \\$aCd-103-105, 107, 109, 115, 117-119; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of cadmium that decay or disintegrate emitting radiation. Cd atoms with atomic weights 103-105, 107, 109, 115, and 117-119 are radioactive cadmium isotopes.
=688  \\$a88
=750  \0$aCadmium$xIsotopes$5IEN-M$0(DLC)sh 85018637

=LDR  00924cz  a2200253n  4500
=001  9880363185402441
=005  20141212195455.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002105
=035  \\$aCAZ5270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x165
=150  \\$aCadmium Poisoning
=450  \\$aCadmium$xpoisoning
=450  \\$wnnna$aCadmium Poisonings
=450  \\$aItai-Itai
=450  \\$wnnna$aItai Itai
=450  \\$wnnna$aPoisoning, Cadmium
=450  \\$wnnna$aPoisonings, Cadmium
=550  \\$wg$aPoisoning
=667  \\$aoccup cadmium pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there)
=680  \\$iPoisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis.
=688  \\$a77; was CADMIUM/poisoning 1966-76
=750  \0$aCadmium$xToxicology$5IEN$0(DLC)sh2009118140

=LDR  00835cz  a2200217n  4500
=001  9880363185502441
=005  20141212195455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002104
=035  \\$aCAZ5269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x137
=072  \\$aD1.$x268.$x956.$x61
=072  \\$aD1.$x552.$x544.$x137
=150  \\$aCadmium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aCd-114; Cd-106, 108, 110-113, 116 = CADMIUM (IM) + ISOTOPES (NIM); Cd-103-105, 107, 109, 115, 117-119 = CADMIUM RADIOISOTOPES (IM)
=680  \\$iAn element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING.
=688  \\$a/poisoning was used for indexing 1966-76
=750  \0$aCadmium$5IEN-M$0(DLC)sh 85018635

=LDR  00723cz  a2200229n  4500
=001  9880363185602441
=005  20141212195454.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002101
=035  \\$aCAZ5266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x88.$x100
=150  \\$aCacodylic Acid
=450  \\$wnnna$aAcid, Cacodylic
=450  \\$wnnna$aAcid, Dimethylarsinic
=450  \\$wnnna$aCacodylate
=450  \\$wnnna$aDimethylarsinate
=450  \\$wnnna$aDimethylarsinic Acid
=550  \\$wg$aArsenicals
=680  \\$iAn arsenical that has been used as a dermatologic agent and as an herbicide.
=688  \\$a91(75); was see under ARSENICALS 1975-90
=750  \0$aCacodylic acid$5IEN$0(DLC)sh 87003500

=LDR  00872cz  a2200241n  4500
=001  9880363185702441
=005  20200929171809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002099
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x915.$x144
=150  \\$aCacao
=450  \\$wnnna$aCacaos
=450  \\$wnnna$aCocoa Plant
=450  \\$wnnna$aCocoa Plants
=450  \\$wnnna$aCocoas
=450  \\$wnnna$aPlant, Cocoa
=450  \\$wnnna$aPlants, Cocoa
=450  \\$aTheobroma cacao
=667  \\$aCHOCOLATE is also avaialble
=680  \\$iA tree of the family Sterculiaceae (or Byttneriaceae), usually Theobroma cacao, or its seeds, which after fermentation and roasting, yield cocoa and chocolate.
=688  \\$a1991(1986)1963; use PLANTS, EDIBLE 1986-1990; for COCOA use CACAO 1963-1984
=750  \0$aCacao$5IEN-HS$0(DLC)sh 85018593

=LDR  00815cz  a2200241n  4500
=001  9880363185802441
=005  20141212195453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002097
=035  \\$aCAZ5262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x34.$x145
=072  \\$aD12.$x776.$x124.$x50.$x120
=072  \\$aD12.$x776.$x124.$x486.$x157
=150  \\$aC-Reactive Protein
=450  \\$wnnna$aC Reactive Protein
=450  \\$wnnna$aProtein, C-Reactive
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlbumins
=550  \\$wg$aImmunoproteins
=667  \\$aan acute phase protein; /drug eff /ultrastruct permitted
=680  \\$iA plasma protein that circulates in increased amounts during inflammation and after tissue damage.
=750  \0$aC-reactive protein$5IEN$0(DLC)sh 85018543

=LDR  01317cz  a2200253n  4500
=001  9880363185902441
=005  20141212195453.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002096
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x587.$x200.$x500.$x250
=072  \\$aD12.$x644.$x548.$x586.$x200.$x500.$x250
=150  \\$aC-Peptide
=450  \\$wnnna$aC Peptide
=450  \\$wnnna$aC-Peptide, Proinsulin
=450  \\$wnnna$aC Peptide, Proinsulin
=450  \\$wnnna$aConnecting Peptide
=450  \\$aProinsulin C-Peptide
=450  \\$wnnna$aProinsulin C Peptide
=550  \\$wg$aProinsulin
=667  \\$afrom proinsulin only: not for peptide fragments from other proteins ( = PEPTIDE FRAGMENTS)
=680  \\$iThe middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
=688  \\$a84(77); was see under PEPTIDES 1977-83
=750  \0$aC-peptide$5IEN$0(DLC)sh 87002364

=LDR  00961cz  a2200265n  4500
=001  9880363186002441
=005  20141212195452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002095
=035  \\$aCAZ5260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x581.$x275
=072  \\$aC8.$x381.$x520.$x702.$x275
=072  \\$aC24.$x800.$x323
=150  \\$aByssinosis
=450  \\$wnnna$aBrown Lung
=450  \\$wnnna$aBrown Lung Disease
=450  \\$wnnna$aBrown Lung Diseases
=450  \\$wnnna$aBrown Lungs
=450  \\$wnnna$aByssinoses
=550  \\$wg$aPneumoconiosis
=667  \\$ado not coordinate with OCCUPATIONAL DISEASES
=680  \\$iA condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.
=688  \\$a74(69)
=750  \0$aByssinosis$5IEN$0(DLC)sh 85018467

=LDR  00767cz  a2200217n  4500
=001  9880363186102441
=005  20190801102942.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002091
=035  \\$aCAZ5256M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x170.$x250
=150  \\$aButyrylcholinesterase
=450  \\$aBenzoylcholinesterase
=450  \\$wnnna$aButyrylthiocholinesterase
=450  \\$wnno$aPseudocholinesterase
=550  \\$wg$aCholinesterases
=667  \\$a/antag = CHOLINESTERASE INHIBITORS (IM) + BUTYRYLCHOLINESTERASE (NIM with no qualif)
=680  \\$iAn aspect of cholinesterase (EC 3.1.1.8).
=688  \\$a91(75); was see under CHOLINESTERASES 1975-90
=750  \0$aButyrylcholinesterase$0(DLC) sh2004002178$5IEN-M

=LDR  01181cz  a2200325n  4500
=001  9880363186202441
=005  20141212195450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002084
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x239.$x216
=150  \\$aButylated Hydroxytoluene
=450  \\$wnnna$a2,6-Bis(1,1-dimethylethyl)-4-methylphenol
=450  \\$wnnna$a2,6-Di-t-butyl-4-methylphenol
=450  \\$wnnna$a2,6 Di t butyl 4 methylphenol
=450  \\$wnnna$a2,6-Di-tert-butyl-p-cresol
=450  \\$wnnna$a2,6 Di tert butyl p cresol
=450  \\$wnnna$a4-Methyl-2,6-ditertbutylphenol
=450  \\$wnnna$a4 Methyl 2,6 ditertbutylphenol
=450  \\$wnnna$aBHT
=450  \\$aButylhydroxytoluene
=450  \\$wnnna$aDibunol
=450  \\$wnnna$aHydroxytoluene, Butylated
=450  \\$wnnna$aIonol
=450  \\$wnnna$aIonol (BHT)
=550  \\$wg$aCresols
=667  \\$aconsider IONONES if C13-norisoprenoid or ionanes are discussed; DF: BHT;
=680  \\$iA di-tert-butyl PHENOL with antioxidant properties.
=688  \\$a80(75); was see under CRESOLS 1973-79
=750  \0$aButylated hydroxytoluene$0(DLC) sh2005001003$5IEN-M

=LDR  00574cz  a2200205n  4500
=001  9880363186302441
=005  20141212195449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x100
=150  \\$aButtocks
=450  \\$wnnna$aButtock
=450  \\$aGluteal Region
=450  \\$wnnna$aGluteal Regions
=450  \\$wnnna$aRegion, Gluteal
=450  \\$wnnna$aRegions, Gluteal
=550  \\$wg$aLower Extremity
=667  \\$afew qualif apply; usually NIM as site
=750  \0$aButtocks$5IEN$0(DLC)sh 85018392

=LDR  00647cz  a2200193n  4500
=001  9880363186402441
=005  20141212195448.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002080
=035  \\$aCAZ5245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x561.$x200
=150  \\$aButterflies
=450  \\$wnnna$aButterfly
=550  \\$wg$aLepidoptera
=667  \\$a/microbiol /parasitol /virol permitted
=680  \\$iSlender-bodies diurnal insects having large, broad wings often strikingly colored and patterned.
=688  \\$a91(75); was see under LEPIDOPTERA 1975-90
=750  \0$aButterflies$5IEN$0(DLC)sh 85018381

=LDR  00774cz  a2200217n  4500
=001  9880363186502441
=005  20141212195448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002079
=035  \\$aCAZ5244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x199
=072  \\$aJ2.$x500.$x350.$x100
=072  \\$aJ2.$x500.$x375.$x200
=150  \\$aButter
=450  \\$wnnna$aButters
=550  \\$wg$aDairy Products
=550  \\$wg$aDietary Fats
=667  \\$aa dairy product & dietary fat; MARGARINE is also available
=680  \\$iThe fatty portion of milk, separated as a soft yellowish solid when milk or cream is churned. It is processed for cooking and table use. (Random House Unabridged Dictionary, 2d ed)
=750  \0$aButter$5IEN$0(DLC)sh 85018371

=LDR  00497cz  a2200181n  4500
=001  9880363186602441
=005  20141212195447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002073
=035  \\$aCAZ5238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x216
=150  \\$aButanes
=450  \\$aIsobutanes
=550  \\$wg$aAlkanes
=667  \\$adoes not include butenes ( = ALKENES); CYCLOBUTANES is also available
=688  \\$a73
=750  \0$aButane$5IEN$0(DLC)sh 85018352

=LDR  00599cz  a2200193n  4500
=001  9880363186702441
=005  20141212195446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002070
=035  \\$aCAZ5235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x146.$x240
=150  \\$aButadienes
=450  \\$wnnna$aButadiene Derivatives
=450  \\$wnnna$aDerivatives, Butadiene
=550  \\$wg$aAlkadienes
=680  \\$iFour carbon unsaturated hydrocarbons containing two double bonds.
=688  \\$a78; was BUTADIENE 1963-77
=750  \0$aButadiene$5IEN$0(DLC)sh 85018350

=LDR  02838cz  a2200733n  4500
=001  9880363186802441
=005  20141212192035.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002065
=035  \\$aCAZ5230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x779.$x120
=072  \\$aD3.$x383.$x606.$x210
=072  \\$aD3.$x383.$x742.$x120
=072  \\$aD4.$x711.$x120
=150  \\$aBuspirone
=450  \\$wnnna$aAnxut
=450  \\$wnnna$aApo-Buspirone
=450  \\$wnnna$aApo Buspirone
=450  \\$wnnna$aApotex Brand of Buspirone Hydrochloride
=450  \\$wnnna$aArmstrong Brand of Buspirone Hydrochloride
=450  \\$wnnna$aBespar
=450  \\$wnnna$aBristol-Myers Brand of Buspirone Hydrochloride
=450  \\$wnnna$aBristol Myers Brand of Buspirone Hydrochloride
=450  \\$wnnna$aBristol-Myers Squibb Brand of Buspirone Hydrochloride
=450  \\$wnnna$aBristol Myers Squibb Brand of Buspirone Hydrochloride
=450  \\$wnnna$aBusp
=450  \\$wnnna$aBuspar
=450  \\$wnnna$aBuspirone Hydrochloride
=450  \\$wnnna$aEisai Brand of Buspirone Hydrochloride
=450  \\$wnnna$aGen-Buspirone
=450  \\$wnnna$aGen Buspirone
=450  \\$wnnna$aGenpharm Brand of Buspirone
=450  \\$wnnna$aHexal Brand of Buspirone Hydrochloride
=450  \\$wnnna$aHormosan Brand of Buspirone Hydrochloride
=450  \\$wnnna$aHydrochloride, Buspirone
=450  \\$wnnna$aLin-Buspirone
=450  \\$wnnna$aLin Buspirone
=450  \\$wnnna$aLinson Pharma Brand of Buspirone Hydrochloride
=450  \\$wnnna$aMJ-9022-1
=450  \\$wnnna$aMJ 9022 1
=450  \\$wnnna$aMJ90221
=450  \\$wnnna$aN-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
=450  \\$wnnna$aNeurosine
=450  \\$wnnna$aNovo-Buspirone
=450  \\$wnnna$aNovo Buspirone
=450  \\$wnnna$aNovopharm Brand of Buspirone Hydrochloride
=450  \\$wnnna$aNu-Buspirone
=450  \\$wnnna$aNu Buspirone
=450  \\$wnnna$aNu-Pharm Brand of Buspirone Hydrochloride
=450  \\$wnnna$aNu Pharm Brand of Buspirone Hydrochloride
=450  \\$wnnna$aPharmascience Brand of Buspirone Hydrochloride
=450  \\$wnnna$aPMS-Buspirone
=450  \\$wnnna$aPMS Buspirone
=450  \\$wnnna$aratio-Buspirone
=450  \\$wnnna$aratio Buspirone
=450  \\$wnnna$aRatiopharm Brand of Buspirone Hydrochloride
=450  \\$wnnna$aUPSA Brand of Buspirone Hydrochloride
=550  \\$wg$aPiperazines
=550  \\$wg$aPyrimidines
=550  \\$wg$aSpiro Compounds
=680  \\$iAn anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
=688  \\$a88
=750  \0$aBuspirone$5IEN$0(DLC)sh 90002754

=LDR  00832cz  a2200253n  4500
=001  9880363186902441
=005  20141212195445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002062
=035  \\$aCAZ5227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x251
=150  \\$aBursitis
=450  \\$wnnna$aAdhesive Capsulitides
=450  \\$aAdhesive Capsulitis
=450  \\$wnnna$aBursitides
=450  \\$wnnna$aCapsulitides, Adhesive
=450  \\$aCapsulitis, Adhesive
=450  \\$aFrozen Shoulder
=550  \\$wg$aJoint Diseases
=550  \\$wh$aPeriarthritis
=667  \\$acoordinate IM with specific joint IM
=680  \\$iInflammation or irritation of a bursa, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.
=750  \0$aBursitis$5IEN$0(DLC)sh 85018208

=LDR  00550cz  a2200205n  4500
=001  9880363187002441
=005  20141212195445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002061
=035  \\$aCAZ5226M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x156
=150  \\$aBursa, Synovial
=450  \\$wnnna$aBursas, Synovial
=450  \\$wnnna$aSynovial Bursa
=450  \\$wnnna$aSynovial Bursas
=550  \\$wg$aJoints
=667  \\$ainflammation = BURSITIS
=688  \\$a65
=750  \0$aBursae mucosae$0(DLC) sh 85018204$5IEN-M

=LDR  00900cz  a2200241n  4500
=001  9880363187102441
=005  20141212195445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002060
=035  \\$aCAZ5225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x549.$x175
=072  \\$aA13.$x163
=072  \\$aA15.$x382.$x520.$x604.$x114
=150  \\$aBursa of Fabricius
=450  \\$aBursa Fabricii$5IEN
=450  \\$wnnna$aFabricius Bursa
=550  \\$wg$aAnimal Structures
=550  \\$wg$aLymphoid Tissue
=550  \\$aThymus Gland
=680  \\$iAn epithelial outgrowth of the cloaca in birds similar to the thymus in mammals. It atrophies within 6 months after birth and remains as a fibrous remnant in adult birds. It is composed of lymphoid tissue and prior to involution, is the site of B-lymphocyte maturation.
=688  \\$a66(65)
=750  \0$aBursa Fabricii$5IEN$0(DLC)sh 85018202

=LDR  00650cz  a2200217n  4500
=001  9880363187202441
=005  20141212195444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002058
=035  \\$aCAZ5223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x200.$x239
=072  \\$aC26.$x324.$x323
=150  \\$aBurns, Electric
=450  \\$wnnna$aBurn, Electric
=450  \\$wnnna$aElectric Burn
=450  \\$aElectric Burns
=550  \\$wg$aBurns
=550  \\$wg$aElectric Injuries
=680  \\$iBurns produced by contact with electric current or from a sudden discharge of electricity.
=750  \0$aElectrical burns$5IEN$0(DLC)sh 85018163

=LDR  00601cz  a2200205n  4500
=001  9880363187302441
=005  20141212195444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002057
=035  \\$aCAZ5222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x200.$x156
=150  \\$aBurns, Chemical
=450  \\$wnnna$aBurn, Chemical
=450  \\$aBurns$xchemically induced
=450  \\$wnnna$aChemical Burn
=450  \\$wnnna$aChemical Burns
=550  \\$wg$aBurns
=667  \\$achem eye burns = BURNS, CHEMICAL (IM) + EYE BURNS /chem ind (IM)
=750  \0$aChemical burns$5IEN$0(DLC)sh 85018162

=LDR  00830cz  a2200241n  4500
=001  9880363187402441
=005  20141212195444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002056
=035  \\$aCAZ5221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x200
=150  \\$aBurns
=450  \\$wnnna$aBurn
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBurns, Chemical
=550  \\$wh$aBurns, Electric
=550  \\$wh$aBurns, Inhalation
=550  \\$wh$aEye Burns
=550  \\$wh$aSunburn
=667  \\$aGEN; "thermal injury"; EYE BURNS & SUNBURN are also available; burn shock: coord IM with SHOCK, TRAUMATIC (IM)
=680  \\$iInjuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like.
=750  \0$aBurns and scalds$5IEN$0(DLC)sh 85018164

=LDR  00828cz  a2200205n  4500
=001  9880363187502441
=005  20161219141511.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002055
=035  \\$aCAZ5220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x900.$x110
=150  \\$aBurnout, Professional
=450  \\$wnnna$aProfessional Burnout
=550  \\$wg$aStress, Psychological
=550  \\$wh$aCompassion Fatigue
=667  \\$ause Cat F3 qualif & even those with discretion
=680  \\$iAn excessive stress reaction to one's occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure.
=688  \\$a90(83); was see under STRESS, PSYCHOLOGICAL 1983-89
=750  \0$aBurn out (Psychology)$0(DLC) sh 85018150$5IEN-M

=LDR  00823cz  a2200265n  4500
=001  9880363187602441
=005  20141212195443.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002053
=035  \\$aCAZ5218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x493.$x160
=150  \\$aBurn Units
=450  \\$aBurn Care Units$5IEN
=450  \\$wnnna$aBurn Center
=450  \\$aBurn Centers
=450  \\$wnnna$aBurn Unit
=450  \\$wnnna$aCenter, Burn
=450  \\$wnnna$aCenters, Burn
=450  \\$wnnna$aUnit, Burn
=450  \\$wnnna$aUnits, Burn
=550  \\$wg$aIntensive Care Units
=680  \\$iSpecialized hospital facilities which provide intensive care for burn patients.
=688  \\$a91(82); was see under INTENSIVE CARE UNITS 1982-90
=750  \0$aBurn care units$5IEN$0(DLC)sh 85018148

=LDR  02654cz  a2200637n  4500
=001  9880363187702441
=005  20141212195442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002051
=035  \\$aCAZ5216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x313.$x165
=072  \\$aC2.$x928.$x313.$x165
=072  \\$aC4.$x557.$x386.$x480.$x100
=072  \\$aC4.$x557.$x386.$x480.$x150.$x165
=072  \\$aC4.$x619.$x935.$x313.$x165
=072  \\$aC4.$x925.$x313.$x165
=072  \\$aC15.$x604.$x515.$x569.$x480.$x100
=072  \\$aC15.$x604.$x515.$x569.$x480.$x150.$x165
=072  \\$aC20.$x683.$x515.$x761.$x480.$x100
=072  \\$aC20.$x683.$x515.$x761.$x480.$x150.$x165
=150  \\$aBurkitt Lymphoma
=450  \\$aAfrican Lymphoma
=450  \\$aBurkitt Cell Leukemia
=450  \\$wnnna$aBurkitt Leukemia
=450  \\$aBurkitt Tumor
=450  \\$wnnna$aBurkitt's Leukemia
=450  \\$wnnna$aBurkitts Leukemia
=450  \\$wnnna$aBurkitt's Lymphoma
=450  \\$wnnna$aBurkitts Lymphoma
=450  \\$wnnna$aBurkitt's Tumor
=450  \\$wnnna$aBurkitts Tumor
=450  \\$wnnna$aCell Leukemia, Burkitt
=450  \\$wnnna$aL3 Lymphocytic Leukemia
=450  \\$wnnna$aL3 Lymphocytic Leukemias
=450  \\$wnnna$aLeukemia, Burkitt
=450  \\$wnnna$aLeukemia, Burkitt Cell
=450  \\$wnnna$aLeukemia, Burkitt's
=450  \\$wnnna$aLeukemia, L3 Lymphocytic
=450  \\$wnnna$aLeukemia, Lymphoblastic, Burkitt-Type
=450  \\$wnnna$aLeukemia, Lymphocytic, L3
=450  \\$wnnna$aLeukemias, L3 Lymphocytic
=450  \\$wnnna$aLymphocytic Leukemia, L3
=450  \\$wnnna$aLymphocytic Leukemias, L3
=450  \\$wnnna$aLymphoma, African
=450  \\$aLymphoma, Burkitt
=450  \\$wnnna$aLymphoma, Burkitt's
=450  \\$wnnna$aTumor, Burkitt
=450  \\$wnnna$aTumor, Burkitt's
=550  \\$wg$aEpstein-Barr Virus Infections
=550  \\$wg$aLymphoma, B-Cell
=550  \\$wg$aLymphoma, Non-Hodgkin
=680  \\$iA form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
=688  \\$a1998 (1968)
=688  \\$a98(68)
=750  \0$aBurkitt's lymphoma$0(DLC) sh 85018105$5IEN

=LDR  00630cz  a2200193n  4500
=001  9880363187802441
=005  20141212195441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002048
=035  \\$aCAZ5213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x550.$x150
=150  \\$aBurial
=450  \\$wnnna$aBurials
=550  \\$wg$aFuneral Rites
=550  \\$wh$aCemeteries
=680  \\$iThe act or ceremony of putting a corpse into the ground or a vault, or into the sea; or the inurnment of CREMAINS.
=688  \\$a91(75); was see under MORTUARY PRACTICE 1975-90
=750  \0$aBurial$5IEN$0(DLC)sh 85018080

=LDR  02375cz  a2200541n  4500
=001  9880363187902441
=005  20161215115047.0
=008  780317\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002047
=035  \\$aCAZ5212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x150
=072  \\$aD3.$x549.$x686.$x150
=072  \\$aD3.$x605.$x497.$x150
=072  \\$aD4.$x615.$x723.$x795.$x150
=150  \\$aBuprenorphine
=450  \\$wnnna$a6029-M
=450  \\$wnnna$a6029 M
=450  \\$wnnna$a6029M
=450  \\$wnnna$aBuprenex
=450  \\$wnnna$aBuprenorphine Grünenthal Brand
=450  \\$wnnna$aBuprenorphine Hydrochloride
=450  \\$wnnna$aBuprex
=450  \\$wnnna$aEssex Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aGrünenthal Brand of Buprenorphine
=450  \\$wnnna$aGrünenthal Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aHydrochloride, Buprenorphine
=450  \\$wnnna$aKey Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aPrefin
=450  \\$wnnna$aReckitt & Colman Brand 1 of Buprenorphine Hydrochloride
=450  \\$wnnna$aReckitt & Colman Brand 2 of Buprenorphine Hydrochloride
=450  \\$wnnna$aReckitt Benckiser Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aReckitt Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aRX-6029-M
=450  \\$wnnna$aRX 6029 M
=450  \\$wnnna$aRX6029M
=450  \\$wnnna$aSchering-Plough Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aSchering Plough Brand of Buprenorphine Hydrochloride
=450  \\$wnnna$aSubutex
=450  \\$wnnna$aTemgésic
=450  \\$wnnna$aTemgesic
=550  \\$wg$aMorphinans
=550  \\$wh$aBuprenorphine, Naloxone Drug Combination
=550  \\$aOpiate Substitution Treatment
=667  \\$afor buprenorphine maintenance treatment, coordinate with OPIATE SUBSTITUTION TREATMENT
=680  \\$iA derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
=688  \\$a87(79); was see under MORPHINANS 1979-86
=750  \0$aBuprenorphine$5IEN$0(DLC)sh 85018028

=LDR  01021cz  a2200277n  4500
=001  9880363188002441
=005  20141212195440.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002043
=035  \\$aCAZ5208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x87
=072  \\$aB4.$x909.$x777.$x147
=150  \\$aBunyaviridae
=450  \\$aBunyaviruses$5IEN
=550  \\$wg$aRNA Viruses
=550  \\$wh$aHantavirus
=550  \\$wh$aNairovirus
=550  \\$wh$aOrthobunyavirus
=550  \\$wh$aPhlebovirus
=550  \\$wh$aTospovirus
=550  \\$aArboviruses
=667  \\$afrom BUNYAmwera, an African place name; infection = BUNYAVIRIDAE INFECTIONS
=680  \\$iA family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.
=688  \\$a81
=750  \0$aBunyaviruses$5IEN$0(DLC)sh 85018022

=LDR  01398cz  a2200301n  4500
=001  9880363188102441
=005  20141212195438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002038
=035  \\$aCAZ5203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x850.$x325.$x139
=072  \\$aD23.$x946.$x833.$x850.$x325.$x139
=150  \\$aBungarotoxins
=450  \\$wnnna$aalpha-Bungarotoxin
=450  \\$wnnna$aalpha Bungarotoxin
=450  \\$wnnna$abeta-Bungarotoxin
=450  \\$wnnna$abeta Bungarotoxin
=450  \\$aBungarotoxin$5IEN
=450  \\$wnnna$akappa-Bungarotoxin
=450  \\$wnnna$akappa Bungarotoxin
=550  \\$wg$aElapid Venoms
=550  \\$aBungarus
=550  \\$aCholinergic Agents
=667  \\$afrom the krait, a snake; /antag permitted but consider also ANTIVENINS; alpha-bungarotoxin & beta-bungarotoxin go here
=680  \\$iNeurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms.
=688  \\$a74(73)
=750  \0$aBungarotoxin$5IEN$0(DLC)sh 85018003

=LDR  02512cz  a2200649n  4500
=001  9880363188202441
=005  20141212195438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002037
=035  \\$aCAZ5202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x558.$x323
=072  \\$aC23.$x550.$x73.$x425.$x100
=150  \\$aBundle-Branch Block
=450  \\$wnnna$aAnterior Fascicular Block
=450  \\$wnnna$aAnterior Fascicular Blocks
=450  \\$wnnna$aBlock, Anterior Fascicular
=450  \\$wnnna$aBlock, Bundle Branch
=450  \\$wnnna$aBlock, Bundle-Branch
=450  \\$wnnna$aBlock, Fascicular
=450  \\$wnnna$aBlock, Left Bundle-Branch
=450  \\$wnnna$aBlock, Posterior Fascicular
=450  \\$wnnna$aBlock, Right Bundle-Branch
=450  \\$wnnna$aBlocks, Anterior Fascicular
=450  \\$wnnna$aBlocks, Bundle Branch
=450  \\$wnnna$aBlocks, Bundle-Branch
=450  \\$wnnna$aBlocks, Fascicular
=450  \\$wnnna$aBlocks, Left Bundle-Branch
=450  \\$wnnna$aBlocks, Posterior Fascicular
=450  \\$wnnna$aBlocks, Right Bundle-Branch
=450  \\$wnnna$aBranch Block, Bundle
=450  \\$wnnna$aBranch Blocks, Bundle
=450  \\$wnnna$aBundle Branch Block
=450  \\$wnnna$aBundle-Branch Block, Left
=450  \\$wnnna$aBundle-Branch Block, Right
=450  \\$wnnna$aBundle Branch Blocks
=450  \\$wnnna$aBundle-Branch Blocks
=450  \\$wnnna$aBundle-Branch Blocks, Left
=450  \\$wnnna$aBundle-Branch Blocks, Right
=450  \\$aFascicular Block
=450  \\$wnnna$aFascicular Block, Anterior
=450  \\$wnnna$aFascicular Block, Posterior
=450  \\$wnnna$aFascicular Blocks
=450  \\$wnnna$aFascicular Blocks, Anterior
=450  \\$wnnna$aFascicular Blocks, Posterior
=450  \\$wnnna$aLeft Bundle-Branch Block
=450  \\$wnnna$aLeft Bundle Branch Block
=450  \\$wnnna$aLeft Bundle-Branch Blocks
=450  \\$wnnna$aPosterior Fascicular Block
=450  \\$wnnna$aPosterior Fascicular Blocks
=450  \\$wnnna$aRight Bundle-Branch Block
=450  \\$wnnna$aRight Bundle Branch Block
=450  \\$wnnna$aRight Bundle-Branch Blocks
=550  \\$wg$aHeart Block
=550  \\$aBundle of His
=680  \\$iA form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BUNDLE OF HIS thus preventing the simultaneous depolarization of the two ventricles.
=750  \0$aBundle-branch block$5IEN$0(DLC)sh 85017997

=LDR  01432cz  a2200349n  4500
=001  9880363188302441
=005  20141212195437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002036
=035  \\$aCAZ5201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x409.$x273
=150  \\$aBundle of His
=450  \\$wnnna$aAnterior Fascicle
=450  \\$aAtrioventricular Bundle
=450  \\$wnnna$aAtrioventricular Bundles
=450  \\$wnnna$aBundle, Atrioventricular
=450  \\$wnnna$aBundle, Kent-His
=450  \\$wnnna$aBundles, Atrioventricular
=450  \\$wnnna$aFascicle, Anterior
=450  \\$wnnna$aFascicle, Posterior
=450  \\$wnnna$aHis Bundle
=450  \\$wnnna$aKent-His Bundle
=450  \\$wnnna$aKent His Bundle
=450  \\$wnnna$aLeft Bundle Branch of His
=450  \\$wnnna$aPosterior Fascicle
=450  \\$wnnna$aRight Bundle Branch of His
=550  \\$wg$aHeart Conduction System
=550  \\$aBundle-Branch Block
=680  \\$iSmall band of specialized CARDIAC MUSCLE fibers that originates in the ATRIOVENTRICULAR NODE and extends into the membranous part of the interventricular septum. The bundle of His, consisting of the left and the right bundle branches, conducts the electrical impulses to the HEART VENTRICLES in generation of MYOCARDIAL CONTRACTION.
=688  \\$a91(75); was see under HEART CONDUCTION SYSTEM 1975-90
=750  \0$aHis bundle$0(DLC) sh 85061030$5IEN

=LDR  01667cz  a2200505n  4500
=001  9880363188402441
=005  20141212195436.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002034
=035  \\$aCAZ5199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x150
=072  \\$aD2.$x241.$x223.$x100.$x50.$x300.$x200
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x20.$x452.$x500
=072  \\$aD2.$x886.$x590.$x700.$x150
=150  \\$aBumetanide
=450  \\$wnnna$aAstraZeneca Brand of Bumetanide
=450  \\$wnnna$aAtlantis Brand of Bumetanide
=450  \\$wnnna$aBumedyl
=450  \\$wnnna$aBumetanide AstraZeneca Brand
=450  \\$wnnna$aBumetanide Atlantis Brand
=450  \\$wnnna$aBumetanide Farmacusi Brand
=450  \\$wnnna$aBumetanide Grossmann Brand
=450  \\$wnnna$aBumetanide Leo Brand
=450  \\$wnnna$aBumetanide Roche Brand
=450  \\$wnnna$aBumetanide Senosiain Brand
=450  \\$wnnna$aBumethanide
=450  \\$wnnna$aBumex
=450  \\$wnnna$aBurinex
=450  \\$wnnna$aDrenural
=450  \\$wnnna$aFarmacusi Brand of Bumetanide
=450  \\$wnnna$aFordiuran
=450  \\$wnnna$aGrossmann Brand of Bumetanide
=450  \\$wnnna$aLeo Brand of Bumetanide
=450  \\$wnnna$aMiccil
=450  \\$wnnna$aPF-1593
=450  \\$wnnna$aPF 1593
=450  \\$wnnna$aPF1593
=450  \\$wnnna$aRoche Brand of Bumetanide
=450  \\$wnnna$aSenosiain Brand of Bumetanide
=550  \\$wg$ameta-Aminobenzoates
=550  \\$wg$aSulfonamides
=680  \\$iA sulfamyl diuretic.
=688  \\$a91(75); was see under DIURETICS, SULFAMYL 1975-90
=750  \0$aBumetanide$5IEN$0(DLC)sh 85017982

=LDR  00637cz  a2200181n  4500
=001  9880363188502441
=005  20141212195436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002033
=035  \\$aCAZ5198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x750.$x323
=150  \\$aBulinus
=550  \\$wg$aSnails
=667  \\$afreshwater snail; /microbiol /parasitol /virol permitted
=680  \\$iA genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.
=688  \\$a72
=750  \0$aBulinus$5IEN$0(DLC)sh 88020932

=LDR  00817cz  a2200229n  4500
=001  9880363188602441
=005  20141212195436.0
=008  860530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002032
=035  \\$aCAZ5197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x645.$x500
=150  \\$aBulimia
=450  \\$wnnna$aBinge Eating
=450  \\$wnnna$aBulimias
=450  \\$wnnna$aEating, Binge
=550  \\$wg$aHyperphagia
=550  \\$aBulimia Nervosa
=667  \\$aBULIMIA NERVOSA is also available
=680  \\$iEating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger".
=688  \\$a87; was see HYPERPHAGIA 1981-86
=750  \0$aBulimia$0(DLC) sh 85017926$5IEN

=LDR  00860cz  a2200265n  4500
=001  9880363188702441
=005  20141212195435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002030
=035  \\$aCAZ5195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x123
=072  \\$aA10.$x336.$x197
=150  \\$aBulbourethral Glands
=450  \\$wnnna$aBulbourethral Gland
=450  \\$wnnna$aCowper Glands
=450  \\$aCowper's Glands
=450  \\$wnnna$aCowpers Glands
=450  \\$wnnna$aGland, Bulbourethral
=450  \\$wnnna$aGlands, Bulbourethral
=450  \\$wnnna$aGlands, Cowper's
=550  \\$wg$aExocrine Glands
=550  \\$wg$aGenitalia, Male
=680  \\$iGlands situated on each side of the prostate that secrete a fluid component of the seminal fluid into the urethra.
=750  \0$aCowper's glands$5IEN$0(DLC)sh 85033663

=LDR  00858cz  a2200241n  4500
=001  9880363188802441
=005  20141212195435.0
=008  830606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002028
=035  \\$aCAZ5193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x200.$x100
=150  \\$aBuilding Codes
=450  \\$wnnna$aBuilding Code
=450  \\$aBuilding Laws$5IEN
=450  \\$wnnna$aCode, Building
=450  \\$wnnna$aCodes, Building
=550  \\$wg$aFacility Design and Construction
=550  \\$aFacility Design and Construction
=667  \\$acoord IM with type of facility (IM)
=680  \\$iStandards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc.
=688  \\$a91(84); was see under FACILITY DESIGN AND CONSTRUCTION 1984-90
=750  \0$aBuilding laws$5IEN$0(DLC)sh 85017734

=LDR  00962cz  a2200289n  4500
=001  9880363188902441
=005  20141212195434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002025
=035  \\$aCAZ5190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x210
=150  \\$aBufonidae
=450  \\$aBufo
=450  \\$wnnna$aBufos
=450  \\$wnnna$aToad, True
=450  \\$aToads, True
=450  \\$wnnna$aTrue Toad
=450  \\$wnnna$aTrue Toads
=550  \\$wg$aAnura
=550  \\$wh$aBufo arenarum
=550  \\$wh$aBufo bufo
=550  \\$wh$aBufo marinus
=667  \\$atoads including genera Bufo, Ansonia, Nectophrynoides & Atelopus; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iThe family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus.
=688  \\$a81; was BUFO 1972-80
=750  \0$aBufonidae$5IEN$0(DLC)sh 85017662

=LDR  01025cz  a2200301n  4500
=001  9880363189002441
=005  20141212195434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002024
=035  \\$aCAZ5189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x210.$x580
=150  \\$aBufo marinus
=450  \\$wnnna$aGiant Toad
=450  \\$wnnna$aGiant Toads
=450  \\$wnnna$amarinas, Rhinella
=450  \\$wnnna$aMarine Toad
=450  \\$wnnna$aMarine Toads
=450  \\$aRhinella marina
=450  \\$aToad, Giant
=450  \\$aToad, Marine
=450  \\$wnnna$aToads, Giant
=450  \\$wnnna$aToads, Marine
=550  \\$wg$aBufonidae
=667  \\$aNIM with no qualifiers when experimental animal
=680  \\$iA species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.
=688  \\$a72
=750  \0$aBufo marinus$5IEN$0(DLC)sh 85017659

=LDR  00754cz  a2200229n  4500
=001  9880363189102441
=005  20141212195433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002023
=035  \\$aCAZ5188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x210.$x108
=150  \\$aBufo bufo
=450  \\$wnnna$aCommon Toad
=450  \\$wnnna$aCommon Toads
=450  \\$aToad, Common
=450  \\$wnnna$aToads, Common
=550  \\$wg$aBufonidae
=667  \\$acommon U.S. & European toad; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of the true toads, Bufonidae, widely distributed in the United States and Europe.
=688  \\$a72
=750  \0$aBufo bufo$5IEN$0(DLC)sh 85017653

=LDR  00732cz  a2200229n  4500
=001  9880363189202441
=005  20141212195433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002022
=035  \\$aCAZ5187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x210.$x80
=150  \\$aBufo arenarum
=450  \\$wnnna$aArgentine Toad
=450  \\$wnnna$aArgentine Toads
=450  \\$aToad, Argentine
=450  \\$wnnna$aToads, Argentine
=550  \\$wg$aBufonidae
=667  \\$aSo. Amer. toad; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of the true toads, Bufonidae, found in South America.
=688  \\$a72
=750  \0$aBufo arenarum$5IEN$0(DLC)sh 85017652

=LDR  00819cz  a2200241n  4500
=001  9880363189302441
=005  20141212195433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002021
=035  \\$aCAZ5186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x280
=150  \\$aBuffers
=450  \\$wnnna$aAmpholytes
=550  \\$wg$aLaboratory Chemicals
=550  \\$wh$aAmpholyte Mixtures
=550  \\$aAcid-Base Equilibrium
=550  \\$aHydrogen-Ion Concentration
=550  \\$aSodium Bicarbonate
=667  \\$aalmost never IM
=680  \\$iA chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.
=688  \\$a67(64)
=750  \0$aBuffer solutions$5IEN-M$0(DLC)sh 85017645

=LDR  00864cz  a2200253n  4500
=001  9880363189402441
=005  20141212195432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002020
=035  \\$aCAZ5185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x135
=150  \\$aBuffaloes
=450  \\$aBubalus
=450  \\$wnnna$aBuffalo
=450  \\$wnnna$aBuffalo, Water
=450  \\$aSyncerus
=450  \\$wnnna$aWater Buffalo
=450  \\$aWater Buffaloes
=550  \\$wg$aRuminants
=667  \\$ado not confuse with BUFFALO, AMERICAN see BISON; IM; qualif permitted
=680  \\$iRuminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus.
=688  \\$a68
=750  \0$aBuffaloes$5IEN$0(DLC)sh 85017642

=LDR  00823cz  a2200241n  4500
=001  9880363189502441
=005  20141212195431.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002017
=035  \\$aCAZ5182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x60
=150  \\$aBudgets
=450  \\$wnnna$aBudget
=450  \\$aBudgetary Control
=450  \\$wnnna$aBudgetary Controls
=450  \\$wnnna$aControl, Budgetary
=450  \\$wnnna$aControls, Budgetary
=550  \\$wg$aFinancial Management
=550  \\$wh$aRate Setting and Review
=680  \\$iDetailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.
=688  \\$a90(78); was see under FINANCIAL MANAGEMENT 1978-89
=750  \0$aBudget$5IEN$0(DLC)sh 85017602

=LDR  00765cz  a2200217n  4500
=001  9880363189602441
=005  20141212195431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002016
=035  \\$aCAZ5181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x117
=150  \\$aBuddhism
=450  \\$wnnna$aBuddhist Ethic
=450  \\$wnnna$aBuddhist Ethics
=450  \\$wnnna$aEthic, Buddhist
=450  \\$wnnna$aEthics, Buddhist
=550  \\$wg$aReligion
=667  \\$aIM; specify geog if pertinent
=680  \\$iThe teaching ascribed to Gautama Buddha (ca. 483 B.C.) holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. (Webster, 3d ed)
=750  \0$aBuddhism$5IEN$0(DLC)sh 85017454

=LDR  00994cz  a2200253n  4500
=001  9880363189702441
=005  20141212195430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002013
=035  \\$aCAZ5178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x217
=150  \\$aBryozoa
=450  \\$wnnna$aAnimal, Moss
=450  \\$wnnna$aAnimals, Moss
=450  \\$wnnna$aBryozoas
=450  \\$wnnna$aMoss Animal
=450  \\$aMoss Animals
=450  \\$wnnna$aZoophyte
=450  \\$aZoophytes
=550  \\$wg$aInvertebrates
=667  \\$aa phylum of tiny aquatic colonial animals; /microbiol /parasitol /virol permitted
=680  \\$iA phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. (Storer & Stebbins, General Zoology, 6th ed, p443)
=750  \0$aBryozoa$0(DLC) sh 85017385$5IEN

=LDR  00853cz  a2200265n  4500
=001  9880363189802441
=005  20141212195430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002012
=035  \\$aCAZ5177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x99
=150  \\$aBruxism
=450  \\$wnnna$aDisorder, Teeth Grinding
=450  \\$wnnna$aDisorders, Teeth Grinding
=450  \\$wnnna$aGrinding Disorder, Teeth
=450  \\$wnnna$aGrinding Disorders, Teeth
=450  \\$aTeeth Grinding Disorder
=450  \\$wnnna$aTeeth Grinding Disorders
=550  \\$wg$aTooth Diseases
=550  \\$wh$aSleep Bruxism
=667  \\$aSLEEP BRUXISM is also available
=680  \\$iA disorder characterized by grinding and clenching of the teeth.
=688  \\$a65; was see under MASTICATION 1963-64
=750  \0$aBruxism$5IEN$0(DLC)sh 85017369

=LDR  00832cz  a2200253n  4500
=001  9880363189902441
=005  20141212195430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002011
=035  \\$aCAZ5176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x684.$x124.$x322
=072  \\$aA3.$x556.$x875.$x249.$x322
=150  \\$aBrunner Glands
=450  \\$wnnna$aBrunner Gland
=450  \\$wnnna$aBrunner's Glands
=450  \\$wnnna$aBrunners Glands
=450  \\$wnnna$aGland, Brunner
=450  \\$wnnna$aGlands, Brunner
=450  \\$wnnna$aGlands, Brunner's
=550  \\$wg$aDuodenum
=680  \\$iThe abundant submucosal mucous glands in the DUODENUM. These glands secrete BICARBONATE IONS; GLYCOPROTEINS; and PEPSINOGEN II.
=688  \\$a2004 (1991)
=750  \0$aBrunner's glands$5IEN$0(DLC)sh 85017336

=LDR  01136cz  a2200313n  4500
=001  9880363190002441
=005  20141212195429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002007
=035  \\$aCAZ5172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x167.$x322
=072  \\$aC22.$x21.$x322
=072  \\$aC22.$x196.$x148
=150  \\$aBrucellosis, Bovine
=450  \\$wnnna$aBang Disease
=450  \\$aBang's Disease
=450  \\$wnnna$aBangs Disease
=450  \\$wnnna$aBovine Brucelloses
=450  \\$wnnna$aBovine Brucellosis
=450  \\$wnnna$aBrucelloses, Bovine
=450  \\$wnnna$aDisease, Bang
=450  \\$wnnna$aDisease, Bang's
=550  \\$wg$aAbortion, Veterinary
=550  \\$wg$aBrucellosis
=550  \\$wg$aCattle Diseases
=667  \\$ain cattle only: if transmitted to man, use BRUCELLOSIS for the human; don't forget also CATTLE (NIM) & check tag ANIMALS
=680  \\$iA disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.
=750  \0$aBrucellosis in cattle$5IEN$0(DLC)sh 85017289

=LDR  01506cz  a2200433n  4500
=001  9880363190102441
=005  20141212195429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002006
=035  \\$aCAZ5171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x167
=150  \\$aBrucellosis
=450  \\$wnnna$aBrucelloses
=450  \\$wnnna$aBrucelloses, Pulmonary
=450  \\$wnnna$aBrucellosis, Pulmonary
=450  \\$wnnna$aCyprus Fever
=450  \\$wnnna$aCyprus Fevers
=450  \\$wnnna$aFever, Cyprus
=450  \\$wnnna$aFever, Gibraltar
=450  \\$wnnna$aFever, Malta
=450  \\$wnnna$aFever, Rock
=450  \\$wnnna$aFever, Undulant
=450  \\$wnnna$aFevers, Cyprus
=450  \\$wnnna$aFevers, Rock
=450  \\$wnnna$aFevers, Undulant
=450  \\$wnnna$aGibraltar Fever
=450  \\$aMalta Fever
=450  \\$wnnna$aPulmonary Brucelloses
=450  \\$wnnna$aPulmonary Brucellosis
=450  \\$wnnna$aRock Fever
=450  \\$wnnna$aRock Fevers
=450  \\$aUndulant Fever
=450  \\$wnnna$aUndulant Fevers
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wh$aBrucellosis, Bovine
=667  \\$afor entry term BRUCELLOSIS, PULMONARY, coordinate with LUNG DISEASES or specifics
=680  \\$iInfection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
=750  \0$aBrucellosis$5IEN$0(DLC)sh 85017288

=LDR  00839cz  a2200193n  4500
=001  9880363190202441
=005  20141212195428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002003
=035  \\$aCAZ5168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x215.$x500.$x100
=072  \\$aB3.$x660.$x50.$x70.$x100.$x100
=150  \\$aBrucella abortus
=450  \\$wnnna$aBrucella melitensis biovar abortus
=550  \\$wg$aBrucella
=667  \\$ainfection = probably BRUCELLOSIS, BOVINE but for man or other animals coord IM with BRUCELLOSIS (IM)
=680  \\$iA species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected.
=750  \0$aBrucella abortus$5IEN$0(DLC)sh 88023222

=LDR  00914cz  a2200253n  4500
=001  9880363190302441
=005  20141212195428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002002
=035  \\$aCAZ5167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x215.$x500
=072  \\$aB3.$x660.$x50.$x70.$x100
=150  \\$aBrucella
=550  \\$wg$aBrucellaceae
=550  \\$wh$aBrucella abortus
=550  \\$wh$aBrucella canis
=550  \\$wh$aBrucella melitensis
=550  \\$wh$aBrucella ovis
=550  \\$wh$aBrucella suis
=667  \\$ainfection = BRUCELLOSIS
=680  \\$iA genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.
=688  \\$a1963
=750  \0$aBrucella$5IEN$0(DLC)sh 85017285

=LDR  01004cz  a2200253n  4500
=001  9880363190402441
=005  20141212195427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002001
=035  \\$aCAZ5166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x114.$x322
=150  \\$aAdipose Tissue, Brown
=450  \\$wnnna$aBrown Adipose Tissue
=450  \\$aBrown Fat
=450  \\$wnnna$aFat, Brown
=450  \\$aHibernating Gland
=450  \\$wnnna$aTissue, Brown Adipose
=550  \\$wg$aAdipose Tissue
=680  \\$iA thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids.
=688  \\$a2007 (1968)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Brown Fat
=688  \\$a72(68)
=750  \0$aBrown adipose tissue$0(DLC) sh 85017245$5IEN

=LDR  00582cz  a2200181n  4500
=001  9880363190502441
=005  20141212195427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002000
=035  \\$aCAZ5165HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x750.$x100
=150  \\$aBronchospirometry
=450  \\$wnnna$aBronchospirometries
=550  \\$wg$aSpirometry
=667  \\$aNIM
=680  \\$iSpirometric technique in which the volume of air breathed in the right and left lung is recorded separately.
=750  \0$aBronchospirometry$5IEN$0(DLC)sh 85017088

=LDR  01226cz  a2200361n  4500
=001  9880363190602441
=005  20141212192033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001999
=035  \\$aCAZ5164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x105
=072  \\$aE1.$x370.$x388.$x250.$x100
=072  \\$aE4.$x502.$x250.$x100
=072  \\$aE4.$x928.$x600.$x80
=150  \\$aBronchoscopy
=450  \\$wnnna$aBronchoscopic Surgeries
=450  \\$wnnna$aBronchoscopic Surgery
=450  \\$wnnna$aBronchoscopic Surgical Procedure
=450  \\$aBronchoscopic Surgical Procedures
=450  \\$wnnna$aBronchoscopies
=450  \\$wnnna$aSurgeries, Bronchoscopic
=450  \\$wnnna$aSurgery, Bronchoscopic
=450  \\$wnnna$aSurgical Procedure, Bronchoscopic
=450  \\$aSurgical Procedures, Bronchoscopic
=550  \\$wg$aDiagnostic Techniques, Respiratory System
=550  \\$wg$aEndoscopy
=550  \\$wg$aPulmonary Surgical Procedures
=550  \\$aBronchi
=550  \\$aBronchoscopes
=667  \\$a/ instrum permitted but consider also BRONCHOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the bronchi.
=750  \0$aBronchoscopy$5IEN$0(DLC)sh 85017087

=LDR  01212cz  a2200217n  4500
=001  9880363190702441
=005  20141212195426.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001997
=035  \\$aCAZ5162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x520.$x750.$x500
=072  \\$aC16.$x614.$x521.$x125
=150  \\$aBronchopulmonary Dysplasia
=450  \\$wnnna$aDysplasia, Bronchopulmonary
=550  \\$wg$aInfant, Premature, Diseases
=550  \\$wg$aVentilator-Induced Lung Injury
=667  \\$arestrict to newborn infants; for lung injury caused by mechanical ventilation in other age groups, use VENTILATOR-INDUCED LUNG INJURY; DF: BRONCHOPULM DYSPLASIA
=680  \\$iA chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
=688  \\$a82
=750  \0$aBronchopulmonary dysplasia$5IEN$0(DLC)sh 87007528

=LDR  00949cz  a2200253n  4500
=001  9880363190802441
=005  20141212195426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001996
=035  \\$aCAZ5161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x509
=072  \\$aC8.$x381.$x677.$x127
=072  \\$aC8.$x730.$x610.$x127
=150  \\$aBronchopneumonia
=450  \\$wnnna$aBronchial Pneumonia
=450  \\$wnnna$aBronchial Pneumonias
=450  \\$wnnna$aBronchopneumonias
=450  \\$wnnna$aPneumonia, Bronchial
=450  \\$wnnna$aPneumonias, Bronchial
=550  \\$wg$aBronchial Diseases
=550  \\$wg$aPneumonia
=680  \\$iInflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches.
=750  \0$aBronchopneumonia$5IEN$0(DLC)sh 85017085

=LDR  00792cz  a2200241n  4500
=001  9880363190902441
=005  20141212195426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001995
=035  \\$aCAZ5160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x730.$x100
=072  \\$aE1.$x370.$x386.$x100
=150  \\$aBronchography
=450  \\$aBronchi$xradiography
=450  \\$wnnna$aBronchographies
=550  \\$wg$aDiagnostic Techniques, Respiratory System
=550  \\$wg$aRadiography, Thoracic
=550  \\$aBronchi
=667  \\$aNIM; do not use /util except by MeSH definition; DF: BRONCHOGR
=680  \\$iRadiography of the bronchial tree after injection of a contrast medium.
=688  \\$a64(63)
=750  \0$aBronchi$xRadiography$5IEN$0(DLC)sh 85017072

=LDR  01461cz  a2200409n  4500
=001  9880363191002441
=005  20141212195425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001993
=035  \\$aCAZ5158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x110
=072  \\$aD27.$x505.$x954.$x796.$x50.$x100
=150  \\$aBronchodilator Agents
=450  \\$wnnna$aAgents, Bronchial-Dilating
=450  \\$wnnna$aAgents, Bronchodilator
=450  \\$wnnna$aAgents, Broncholytic
=450  \\$aBronchial-Dilating Agents
=450  \\$wnnna$aBronchial Dilating Agents
=450  \\$wnnna$aBronchodilator Effect
=450  \\$wnnna$aBronchodilator Effects
=450  \\$wnnna$aBronchodilators
=450  \\$wnnna$aBroncholytic Agents
=450  \\$wnnna$aBroncholytic Effect
=450  \\$wnnna$aBroncholytic Effects
=450  \\$wnnna$aEffect, Bronchodilator
=450  \\$wnnna$aEffect, Broncholytic
=450  \\$wnnna$aEffects, Bronchodilator
=450  \\$wnnna$aEffects, Broncholytic
=550  \\$wg$aAnti-Asthmatic Agents
=550  \\$wg$aAutonomic Agents
=550  \\$aBronchi
=550  \\$aHistamine H1 Antagonists
=667  \\$anote entry term BRONCHODILATOR EFFECT: use only for the bronchodilator effect of a chemical substance
=680  \\$iAgents that cause an increase in the expansion of a bronchus or bronchial tubes.
=688  \\$a65(63)
=750  \0$aBronchodilator agents$5IEN$0(DLC)sh 85017084

=LDR  00953cz  a2200253n  4500
=001  9880363191102441
=005  20141212195424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001991
=035  \\$aCAZ5156HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x446
=072  \\$aC8.$x381.$x495.$x146
=072  \\$aC8.$x730.$x99
=150  \\$aBronchitis
=450  \\$wnnna$aBronchitides
=550  \\$wg$aBronchial Diseases
=550  \\$wg$aLung Diseases, Obstructive
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aBronchiolitis
=550  \\$wh$aBronchitis, Chronic
=667  \\$atuberculous bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHITIS unless particularly discussed; BRONCHIOLITIS is also available
=680  \\$iInflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
=750  \0$aBronchitis$5IEN$0(DLC)sh 85017081

=LDR  00555cz  a2200193n  4500
=001  9880363191202441
=005  20141212195423.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001987
=035  \\$aCAZ5152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x384
=150  \\$aBronchiectasis
=450  \\$wnnna$aBronchiectases
=550  \\$wg$aBronchial Diseases
=550  \\$wh$aKartagener Syndrome
=667  \\$abronchial dilatation
=680  \\$iPersistent abnormal dilatation of the bronchi.
=750  \0$aBronchiectasis$5IEN$0(DLC)sh 85017080

=LDR  00662cz  a2200229n  4500
=001  9880363191302441
=005  20141212195423.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001986
=035  \\$aCAZ5151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x321
=150  \\$aBronchial Spasm
=450  \\$wnnna$aBronchial Spasms
=450  \\$aBronchospasm
=450  \\$wnnna$aBronchospasms
=450  \\$wnnna$aSpasm, Bronchial
=450  \\$wnnna$aSpasms, Bronchial
=550  \\$wg$aBronchial Diseases
=680  \\$iSpasmodic contraction of the smooth muscle of the bronchi.
=688  \\$a64(63)
=750  \0$aBronchial spasm$5IEN$0(DLC)sh 85017079

=LDR  02676cz  a2200637n  4500
=001  9880363191402441
=005  20141212195422.0
=008  790308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001985
=035  \\$aCAZ5150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x125
=150  \\$aBronchial Provocation Tests
=450  \\$aAllergen Bronchial Provocation Tests
=450  \\$wnnna$aAllergen Challenge, Bronchial
=450  \\$aAllergen Challenge, Endobronchial
=450  \\$wnnna$aAllergen Challenges, Bronchial
=450  \\$wnnna$aAllergen Challenges, Endobronchial
=450  \\$aAntigen Bronchial Provocation Tests
=450  \\$aBronchial Allergen Challenge
=450  \\$wnnna$aBronchial Allergen Challenges
=450  \\$wnnna$aBronchial Challenge Test
=450  \\$aBronchial Challenge Tests
=450  \\$wnnna$aBronchial Provocation Test
=450  \\$wnnna$aChallenge, Bronchial Allergen
=450  \\$wnnna$aChallenge, Endobronchial Allergen
=450  \\$wnnna$aChallenge Test, Bronchial
=450  \\$wnnna$aChallenge Test, Endobronchial
=450  \\$wnnna$aChallenge Tests, Bronchial
=450  \\$wnnna$aChallenge Tests, Endobronchial
=450  \\$wnnna$aChallenges, Bronchial Allergen
=450  \\$wnnna$aChallenges, Endobronchial Allergen
=450  \\$wnnna$aEndobronchial Allergen Challenge
=450  \\$wnnna$aEndobronchial Allergen Challenges
=450  \\$wnnna$aEndobronchial Challenge Test
=450  \\$wnnna$aEndobronchial Challenge Tests
=450  \\$wnnna$aInhalation Provocation Test
=450  \\$aInhalation Provocation Tests
=450  \\$wnnna$aProvocation Test, Bronchial
=450  \\$wnnna$aProvocation Test, Inhalation
=450  \\$aProvocation Tests, Bronchial
=450  \\$wnnna$aProvocation Tests, Inhalation
=450  \\$wnnna$aTest, Bronchial Challenge
=450  \\$wnnna$aTest, Bronchial Provocation
=450  \\$wnnna$aTest, Endobronchial Challenge
=450  \\$wnnna$aTest, Inhalation Provocation
=450  \\$wnnna$aTests, Bronchial Challenge
=450  \\$wnnna$aTests, Bronchial Provocation
=450  \\$wnnna$aTests, Endobronchial Challenge
=450  \\$wnnna$aTests, Inhalation Provocation
=550  \\$wg$aRespiratory Function Tests
=550  \\$aBronchoconstriction
=667  \\$aDF: BP TESTS
=680  \\$iTests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.
=688  \\$a80
=750  \0$aBronchial provocation tests$5IEN$0(DLC)sh 85017078

=LDR  01095cz  a2200265n  4500
=001  9880363191502441
=005  20141212195422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001984
=035  \\$aCAZ5149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797.$x520.$x109
=072  \\$aC8.$x127.$x265
=072  \\$aC8.$x785.$x520.$x100
=150  \\$aBronchial Neoplasms
=450  \\$wnnna$aBronchial Neoplasm
=450  \\$wnnna$aNeoplasm, Bronchial
=450  \\$wnnna$aNeoplasms, Bronchial
=550  \\$wg$aBronchial Diseases
=550  \\$wg$aLung Neoplasms
=550  \\$wh$aCarcinoma, Bronchogenic
=667  \\$anot for bronchial carcinoma (= CARCINOMA, BRONCHIAL see CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS), nor bronchogenic carcinoma (= CARCINOMA, BRONCHOGENIC + LUNG NEOPLASMS) nor bronchiolar carcinoma (= CARCINOMA, BRONCHIOLAR + LUNG NEOPLASMS); coordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the BRONCHI.
=750  \0$aBronchi$xTumors$5IEN-M$0(DLC)sh 85017076
=750  \0$aBronchi$xCancer$5IEN-HS$0(DLC)sh 85017069

=LDR  00954cz  a2200325n  4500
=001  9880363191602441
=005  20141212195421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001982
=035  \\$aCAZ5147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127
=150  \\$aBronchial Diseases
=450  \\$wnnna$aBronchial Disease
=450  \\$wnnna$aDisease, Bronchial
=450  \\$wnnna$aDiseases, Bronchial
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aAsthma
=550  \\$wh$aBronchial Fistula
=550  \\$wh$aBronchial Hyperreactivity
=550  \\$wh$aBronchial Neoplasms
=550  \\$wh$aBronchial Spasm
=550  \\$wh$aBronchiectasis
=550  \\$wh$aBronchitis
=550  \\$wh$aBronchogenic Cyst
=550  \\$wh$aBronchopneumonia
=550  \\$wh$aTracheobronchomalacia
=550  \\$wh$aTracheobronchomegaly
=667  \\$ainflamm dis = BRONCHITIS
=750  \0$aBronchi$xDiseases$5IEN-M$0(DLC)sh 85017070

=LDR  01308cz  a2200313n  4500
=001  9880363191702441
=005  20141212195420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001980
=035  \\$aCAZ5145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x411.$x125
=150  \\$aBronchi
=450  \\$wnnna$aBronchi, Secondary
=450  \\$wnnna$aBronchi, Tertiary
=450  \\$wnnna$aBronchus
=450  \\$wnnna$aBronchus, Secondary
=450  \\$wnnna$aBronchus, Tertiary
=450  \\$wnnna$aPrimary Bronchi
=450  \\$wnnna$aPrimary Bronchus
=450  \\$wnnna$aSecondary Bronchi
=450  \\$wnnna$aSecondary Bronchus
=450  \\$wnnna$aTertiary Bronchi
=450  \\$wnnna$aTertiary Bronchus
=550  \\$wg$aLung
=550  \\$wh$aBronchioles
=667  \\$ainflammation = BRONCHITIS; dilatation = BRONCHIECTASIS; bronchial tuberculosis or tuberculous bronchitis: index under TUBERCULOSIS, PULMONARY & not also under BRONCHI or BRONCHITIS unless particularly discussed
=680  \\$iThe larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.
=750  \0$aBronchi$5IEN$0(DLC)sh 85017066

=LDR  00908cz  a2200217n  4500
=001  9880363191802441
=005  20141212195419.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001974
=035  \\$aCAZ5139M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x478.$x770.$x150
=072  \\$aD3.$x383.$x773.$x812.$x852.$x150
=150  \\$aBromosuccinimide
=450  \\$wnnna$aN-Bromosuccinimide
=450  \\$wnnna$aN Bromosuccinimide
=450  \\$aSuccinbromimide
=550  \\$wg$aSuccinimides
=680  \\$iA brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. (From Miall's Dictionary of Chemistry, 5th ed; Hawley's Condensed Chemical Dictionary, 12th ed,).
=688  \\$a91(75); was see under SUCCINIMIDES 1975-90
=750  \0$aBromosuccinimide$5IEN-M$0(DLC)sh 99005592

=LDR  01175cz  a2200313n  4500
=001  9880363191902441
=005  20141212195418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001973
=035  \\$aCAZ5138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x852.$x300.$x150
=072  \\$aD13.$x570.$x230.$x430.$x196
=072  \\$aD13.$x570.$x685.$x852.$x300.$x150
=150  \\$aBromodeoxyuridine
=450  \\$wnnna$a5-Bromo-2'-deoxyuridine
=450  \\$wnnna$a5 Bromo 2' deoxyuridine
=450  \\$wnnna$a5-Bromodeoxyuridine
=450  \\$wnnna$a5 Bromodeoxyuridine
=450  \\$aBrdU
=450  \\$aBromouracil Deoxyriboside
=450  \\$aBroxuridine
=450  \\$aBUdR
=450  \\$wnnna$aDeoxyriboside, Bromouracil
=450  \\$wnnna$aNSC-38297
=550  \\$wg$aDeoxyuridine
=680  \\$iA nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.
=688  \\$a66(65)
=750  \0$aBromodeoxyuridine$5IEN$0(DLC)sh 85017060

=LDR  01721cz  a2200469n  4500
=001  9880363192002441
=005  20141212195418.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001971
=035  \\$aCAZ5136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x327.$x412.$x100
=072  \\$aD3.$x549.$x439.$x131
=072  \\$aD3.$x549.$x562.$x100
=150  \\$aBromocriptine
=450  \\$wnnna$a2-Bromo-alpha-ergocryptine
=450  \\$wnnna$a2 Bromo alpha ergocryptine
=450  \\$wnnna$a2-Bromo-alpha-ergokryptine
=450  \\$wnnna$a2 Bromo alpha ergokryptine
=450  \\$a2-Bromoergocryptine
=450  \\$wnnna$a2 Bromoergocryptine
=450  \\$wnnna$a2-Bromoergocryptine Mesylate
=450  \\$wnnna$a2 Bromoergocryptine Mesylate
=450  \\$wnnna$a2-Bromoergocryptine Methanesulfonate
=450  \\$wnnna$a2 Bromoergocryptine Methanesulfonate
=450  \\$wnnna$a2-Bromoergokryptine
=450  \\$wnnna$a2 Bromoergokryptine
=450  \\$wnnna$aBromocriptin
=450  \\$wnnna$aBromocriptine Mesylate
=450  \\$aBromocryptin
=450  \\$wnnna$aCB-154
=450  \\$wnnna$aCB 154
=450  \\$wnnna$aCB154
=450  \\$wnnna$aMesylate, 2-Bromoergocryptine
=450  \\$wnnna$aMesylate, Bromocriptine
=450  \\$wnnna$aMethanesulfonate, 2-Bromoergocryptine
=450  \\$wnnna$aParlodel
=550  \\$wg$aErgolines
=550  \\$wg$aErgotamines
=680  \\$iA semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.
=688  \\$a81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76
=750  \0$aBromocriptine$5IEN$0(DLC)sh 85017059

=LDR  00766cz  a2200205n  4500
=001  9880363192102441
=005  20141212195416.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001967
=035  \\$aCAZ5132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x90
=150  \\$aBromine Radioisotopes
=450  \\$wnnna$aRadioisotopes, Bromine
=550  \\$wg$aRadioisotopes
=550  \\$aBromine
=667  \\$aBr-74-78, 80, 82-90; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of bromine that decay or disintegrate emitting radiation. Br atoms with atomic weights 74-78, 80, and 82-90 are radioactive bromine isotopes.
=688  \\$a88
=750  \0$aBromine$xIsotopes$5IEN$0(DLC)sh 85017054

=LDR  00785cz  a2200181n  4500
=001  9880363192202441
=005  20141212195416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001966
=035  \\$aCAZ5131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x380.$x112
=150  \\$aBromine
=550  \\$wg$aHalogens
=667  \\$aa halogen; Br-79; Br-81 = BROMINE (IM) + ISOTOPES (NIM); Br-74-78, 80, 82-90 = BROMINE RADIOISOTOPES (IM)
=680  \\$iA halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.
=750  \0$aBromination$5IEN-M$0(DLC)sh 85017052
=750  \0$aBromine$5IEN-HS$0(DLC)sh 85017053

=LDR  00820cz  a2200229n  4500
=001  9880363192302441
=005  20141212195416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001965
=035  \\$aCAZ5130HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x139.$x300.$x50
=072  \\$aD1.$x248.$x497.$x158.$x125
=150  \\$aBromides
=550  \\$wg$aAnions
=550  \\$wg$aHydrobromic Acid
=550  \\$wh$aCyanogen Bromide
=667  \\$aonly for inorganic cpds or bromide ion
=680  \\$iSalts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aBromides$5IEN-HS$0(DLC)sh 85017050
=750  \0$aBromide ions$5IEN-HS$0(DLC)sh 85017049
=750  \0$aBromides in the body$5IEN-HS$0(DLC)sh 85017051

=LDR  02255cz  a2200577n  4500
=001  9880363192402441
=005  20141212192032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001963
=035  \\$aCAZ5128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x262.$x500.$x96
=072  \\$aD8.$x811.$x277.$x656.$x300.$x200.$x96
=150  \\$aBromelains
=450  \\$wnnna$aAnanase
=450  \\$wnnna$aAventis Brand of Bromelains
=450  \\$wnnna$aBromelain
=450  \\$wnnna$aBromelain-POS
=450  \\$wnnna$aBromelain POS
=450  \\$wnnna$aBromelainPOS
=450  \\$wnnna$aBromelains Aventis Brand
=450  \\$wnnna$aBromelains Mucos Brand
=450  \\$wnnna$aBromelains Nattermann Brand
=450  \\$wnnna$aBromelains Rottapharm Brand
=450  \\$wnnna$aBromelains Ursapharm Brand
=450  \\$wnnna$aBromelains Wiedemann Brand
=450  \\$wnnna$aBromelin
=450  \\$aBromelins
=450  \\$wnnna$aDayto Anase
=450  \\$wnnna$aDebrase
=450  \\$wnnna$aDontisanin
=450  \\$wnnna$aExtranase
=450  \\$wnnna$aMucos Brand of Bromelains
=450  \\$wnnna$aMucozym
=450  \\$wnnna$aNattermann Brand of Bromelains
=450  \\$wnnna$aProteozym
=450  \\$wnnna$aRhône-Poulenc Rorer Brand 1 of Bromelains
=450  \\$wnnna$aRhône Poulenc Rorer Brand 1 of Bromelains
=450  \\$wnnna$aRhône-Poulenc Rorer Brand 2 of Bromelains
=450  \\$wnnna$aRhône Poulenc Rorer Brand 2 of Bromelains
=450  \\$wnnna$aRhône-Poulenc Rorer Brand 3 of Bromelains
=450  \\$wnnna$aRhône Poulenc Rorer Brand 3 of Bromelains
=450  \\$wnnna$aRottapharm Brand of Bromelains
=450  \\$wnnna$aTeva Pharmaceutical's Brand of Bromelain
=450  \\$wnnna$aTraumanase
=450  \\$wnnna$aUrsapharm Brand of Bromelains
=450  \\$wnnna$aWiedemann Brand of Bromelains
=550  \\$wg$aCysteine Endopeptidases
=680  \\$iProtein-digesting and milk-clotting enzymes found in PINEAPPLE fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. This enzyme was formerly listed as EC 3.4.22.4.
=688  \\$a67(65); was see under ENDOPEPTIDASES 1963-66
=750  \0$aBromelin$5IEN$0(DLC)sh 85017047

=LDR  02206cz  a2200637n  4500
=001  9880363192502441
=005  20141212195414.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001960
=035  \\$aCAZ5125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x110
=150  \\$aBromazepam
=450  \\$wnnna$a1A Brand of Bromazepam
=450  \\$wnnna$aAliud Brand of Bromazepam
=450  \\$wnnna$aAnxyrex
=450  \\$wnnna$aApo-Bromazepam
=450  \\$wnnna$aApo Bromazepam
=450  \\$wnnna$aApotex Brand of Bromazepam
=450  \\$wnnna$abetapharm Brand of Bromazepam
=450  \\$wnnna$aBromaLich
=450  \\$wnnna$aBromaz 1A Pharma
=450  \\$wnnna$aBromazanil
=450  \\$wnnna$abromazep von ct
=450  \\$wnnna$aBromazepam AL
=450  \\$wnnna$aBromazepam beta
=450  \\$wnnna$aBromazepam Heumann
=450  \\$wnnna$aBromazepam Lichtenstein Brand
=450  \\$wnnna$aBromazepam-neuraxpharm
=450  \\$wnnna$aBromazepam-ratiopharm
=450  \\$wnnna$aBromazepam ratiopharm
=450  \\$wnnna$aBromazepam Roche Brand
=450  \\$wnnna$act-Arzneimittel Brand of Bromazepam
=450  \\$wnnna$act Arzneimittel Brand of Bromazepam
=450  \\$wnnna$adurazanil
=450  \\$wnnna$aGen-Bromazepam
=450  \\$wnnna$aGen Bromazepam
=450  \\$wnnna$aGenpharm Brand of Bromazepam
=450  \\$wnnna$aHeumann Brand of Bromazepam
=450  \\$wnnna$aHexal Brand of Bromazepam
=450  \\$wnnna$aIrex Brand of Bromazepam
=450  \\$wnnna$aLexatin
=450  \\$wnnna$aLexomil
=450  \\$wnnna$aLexotan
=450  \\$wnnna$aLexotanil
=450  \\$wnnna$aLichtenstein Brand of Bromazepam
=450  \\$wnnna$aMerck dura Brand of Bromazepam
=450  \\$wnnna$aneuraxpharm Brand of Bromazepam
=450  \\$wnnna$aratiopharm Brand of Bromazepam
=450  \\$wnnna$aRo 5-3350
=450  \\$wnnna$aRo 53350
=450  \\$wnnna$aRoche Brand of Bromazepam
=550  \\$wg$aBenzodiazepinones
=680  \\$iOne of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.
=688  \\$a91(75); was see under BENZODIAZEPINE TRANQUILIZERS 1975-90
=750  \0$aBromazepam$5IEN$0(DLC)sh 85017043

=LDR  00560cz  a2200193n  4500
=001  9880363192602441
=005  20141212195413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001959
=035  \\$aCAZ5124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x139.$x100
=072  \\$aD1.$x248.$x497.$x158.$x100
=150  \\$aBromates
=550  \\$wg$aAnions
=550  \\$wg$aBromine Compounds
=680  \\$iNegative ions or salts derived from bromic acid, HBrO3.
=688  \\$a91(71); was see under BROMINE 1971-90
=750  \0$aBromate$5IEN$0(DLC)sh 85017042

=LDR  00917cz  a2200205n  4500
=001  9880363192702441
=005  20141212195413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001957
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x236
=150  \\$aBroadsides as Topic
=450  \\$wnnna$aBroadside as Topic
=450  \\$wnnna$aBroadsides as Topics
=550  \\$wg$aPublications
=667  \\$aIM; coordinate with subject (IM); do not confuse with Publication Type BROADSIDES
=680  \\$iPublished pieces of paper or other material, usually printed on one side and intended to be read unfolded and usually intended to be posted, publicly distributed, or sold. (From Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloguing, 2d ed)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Broadsides
=750  \0$aBroadsides$0(DLC) sh 85017011$5IEN

=LDR  00893cz  a2200229n  4500
=001  9880363192802441
=005  20141212195346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001880
=035  \\$aCAZ5045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x132.$x105
=072  \\$aD2.$x203.$x87
=150  \\$aBoranes
=450  \\$aBoron Hydrides
=450  \\$wnnna$aHydrides, Boron
=550  \\$wg$aBoron Compounds
=550  \\$wh$aBorohydrides
=667  \\$acollective name for boron hydrides (do not confuse with BOROHYDRIDES); do not confuse with BORATES or BORNANES
=680  \\$iThe collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a68
=750  \0$aBoranes$5IEN$0(DLC)sh 90001883

=LDR  00572cz  a2200205n  4500
=001  9880363192902441
=005  20141212195345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001879
=035  \\$aCAZ5044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x150.$x340
=150  \\$aBookselling
=450  \\$aAntiquarian Booksellers$5IEN
=450  \\$aBooksellers and Bookselling$5IEN
=450  \\$wnnna$aBooksellings
=550  \\$wg$aBook Industry
=550  \\$wh$aBook Prices
=667  \\$aIM
=750  \0$aBooksellers and bookselling$5IEN-HS$0(DLC)sh 85015765

=LDR  01181cz  a2200277n  4500
=001  9880363193002441
=005  20200513152621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001878
=035  \\$aCAZ5043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x117
=072  \\$aL1.$x178.$x682.$x192.$x289
=150  \\$aBooks, Illustrated
=450  \\$wnnna$aBook, Illustrated
=450  \\$aBook Illustration
=450  \\$wnnna$aIllustrated Book
=450  \\$aIllustrated Books
=450  \\$wnnna$aIllustration, Book
=450  \\$wnnna$aIllustrations, Book
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aBooks
=550  \\$wh$aGraphic Novels as Topic
=667  \\$aIM; coord with subject (IM) or type of illus (IM); do not confuse X ref BOOK ILLUSTRATION with Publication Type BOOK ILLUSTRATIONS
=680  \\$iBooks containing photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangement of data designed to elucidate or decorate its contents. (From The ALA Glossary of Library and Information Science, 1983, p114)
=750  \0$aIllustrated books$5IEN$0(DLC)sh 85064396

=LDR  01281cz  a2200349n  4500
=001  9880363193102441
=005  20141212195345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001877
=035  \\$aCAZ5042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192
=150  \\$aBooks
=450  \\$wnnna$aBook
=450  \\$wnnna$aBook Chapter
=450  \\$wnnna$aBook Chapters
=450  \\$wnnna$aChapter, Book
=450  \\$wnnna$aChapters, Book
=550  \\$wg$aPublications
=550  \\$wh$aBook Imprints
=550  \\$wh$aBook Ornamentation
=550  \\$wh$aBookplates as Topic
=550  \\$wh$aBooks, Illustrated
=550  \\$wh$aCookbooks as Topic
=550  \\$wh$aIncunabula as Topic
=550  \\$wh$aManuals as Topic
=550  \\$wh$aRare Books
=550  \\$wh$aReference Books
=550  \\$wh$aTextbooks as Topic
=667  \\$aNOT for specific books ( = LITERATURE or its indentions); NOT for lists of books ( = BIBLIOGRAPHY AS TOPIC or its indentions): for books as a means of communication or as a subject ("books as carriers of germs"): Manual 33.11; relation to LITERATURE: Manual 33.11, relation to MANUSCRIPTS: Manual 33.12;TEXTBOOKS & REFERENCE BOOKS are also available
=688  \\$a64
=750  \0$aBooks$5IEN$0(DLC)sh 85015738

=LDR  01321cz  a2200217n  4500
=001  9880363193202441
=005  20141212195344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001876
=035  \\$aCAZ5041HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x234
=150  \\$aBookplates as Topic
=450  \\$wnnna$aBook Plates as Topic
=450  \\$wnnna$aBookplates as Topics
=550  \\$wg$aBooks
=667  \\$adesigned labels showing ownership of a book; medical bookplates: do not coordinate with MEDICINE; coordinate IM with subject (IM) if relevant; bookplates of famous medical & non-medical figures: coordinate IM with required biographical and historical headings & check tags; do not confuse with Publication Type BOOKPLATES
=680  \\$iLabels pasted in books to mark their ownership and sometimes to indicate their location in a library. Private bookplates are often ornate or artistic: simpler and smaller ones bearing merely the owner's name are called "book labels." They are usually pasted on the front endpaper of books. (From Harrod, The Librarians' Glossary and Reference Book, 4th rev ed & Random House Unabridged Dictionary, 2d ed)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Bookplates
=750  \0$aBookplates$0(DLC) sh 85015646$5IEN

=LDR  00409cz  a2200157n  4500
=001  9880363193302441
=005  20141212195344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001875
=035  \\$aCAZ5040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x150.$x317
=150  \\$aBookbinding
=450  \\$wnnna$aBookbindings
=550  \\$wg$aBook Industry
=750  \0$aBookbinding$5IEN$0(DLC)sh 85015705

=LDR  00595cz  a2200193n  4500
=001  9880363193402441
=005  20141212195344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001874
=035  \\$aCAZ5039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x220
=150  \\$aBook Selection
=450  \\$wnnna$aBook Selections
=450  \\$wnnna$aSelection, Book
=450  \\$wnnna$aSelections, Book
=550  \\$wg$aInformation Services
=667  \\$ano qualif; lists of books probably go here but consider also BIBLIOGRAPHY AS TOPIC
=750  \0$aBook selection$5IEN$0(DLC)sh 85015693

=LDR  00645cz  a2200193n  4500
=001  9880363193502441
=005  20141212195344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001873
=035  \\$aCAZ5038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x150
=150  \\$aBook Reviews as Topic
=550  \\$wg$aPublications
=667  \\$ado not index book reviews; use for articles on book reviews as a subject
=680  \\$iCritical analyses of books or other monographic works.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Book Reviews
=750  \0$aBooks$xReviews$0(DLC) sh 85015752$5IEN

=LDR  00508cz  a2200193n  4500
=001  9880363193602441
=005  20141212195343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001872
=035  \\$aCAZ5037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x150.$x340.$x250
=150  \\$aBook Prices
=450  \\$wnnna$aBook Price
=450  \\$wnnna$aPrice, Book
=450  \\$wnnna$aPrices, Book
=550  \\$wg$aBookselling
=667  \\$ano qualif
=750  \0$aBooks$xPrices$5IEN$0(DLC)sh 85015750

=LDR  00513cz  a2200181n  4500
=001  9880363193702441
=005  20141212195343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001871
=035  \\$aCAZ5036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x178
=150  \\$aBook Ornamentation
=450  \\$wnnna$aBook Ornamentations
=450  \\$wnnna$aOrnamentation, Book
=450  \\$wnnna$aOrnamentations, Book
=550  \\$wg$aBooks
=750  \0$aBook ornamentation$5IEN$0(DLC)sh 85015644

=LDR  00862cz  a2200265n  4500
=001  9880363193802441
=005  20141212192028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001870
=035  \\$aCAZ5035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x374
=072  \\$aL1.$x737.$x150
=150  \\$aBook Industry
=450  \\$wnnna$aBook Industries
=450  \\$wnnna$aIndustries, Book
=450  \\$wnnna$aIndustry, Book
=550  \\$wg$aManufacturing Industry
=550  \\$wg$aPublishing
=550  \\$wh$aBookbinding
=550  \\$wh$aBookselling
=550  \\$aPublishing
=667  \\$aspecify geog if pertinent; DF: BOOK INDUST
=680  \\$iThe aggregate enterprise of manufacturing and technically producing books. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aBook industries and trade$5IEN$0(DLC)sh 85015617

=LDR  00553cz  a2200193n  4500
=001  9880363193902441
=005  20141212195343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001869
=035  \\$aCAZ5034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x122
=150  \\$aBook Imprints
=450  \\$wnnna$aBook Imprint
=450  \\$wnnna$aImprint, Book
=450  \\$wnnna$aImprints, Book
=550  \\$wg$aBooks
=550  \\$wh$aPrinters' Marks
=750  \0$aImprints (Publishers' and printers' statements)$5IEN$0(DLC)sh 85064672

=LDR  00493cz  a2200181n  4500
=001  9880363194002441
=005  20141212195343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001868
=035  \\$aCAZ5033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x40
=150  \\$aBook Collecting
=450  \\$wnnna$aBook Collectings
=450  \\$wnnna$aCollecting, Book
=450  \\$wnnna$aCollectings, Book
=550  \\$wg$aInformation Science
=750  \0$aBook collecting$5IEN$0(DLC)sh 85015610

=LDR  00813cz  a2200205n  4500
=001  9880363194102441
=005  20141212195343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001867
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x245.$x250.$x150
=072  \\$aL1.$x453.$x819.$x250.$x150
=150  \\$aBook Classification
=450  \\$wnnna$aBook Classifications
=450  \\$aBooks$xclassification
=450  \\$wnnna$aClassification, Book
=450  \\$wnnna$aClassifications, Book
=550  \\$wg$aCataloging
=680  \\$iA general term covering bibliographical and bibliothecal classifications. It mostly refers to library CLASSIFICATION for arrangement of books and documents on the shelves. (Harrod's Librarians' Glossary, 7th ed, p85)
=750  \0$aClassification$xBooks$5IEN$0(DLC)sh 85026721

=LDR  01072cz  a2200289n  4500
=001  9880363194202441
=005  20141212192028.0
=008  850607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001864
=035  \\$aCAZ5029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x370.$x468
=072  \\$aE7.$x858.$x442.$x660.$x460.$x468
=072  \\$aE7.$x858.$x690.$x725.$x460.$x468
=150  \\$aBone Wires
=450  \\$wnnna$aBone Wire
=450  \\$aKirschner Wires
=450  \\$wnnna$aWire, Bone
=450  \\$wnnna$aWires, Bone
=450  \\$wnnna$aWires, Kirschner
=550  \\$wg$aInternal Fixators
=550  \\$aBone Nails
=550  \\$aBone Screws
=667  \\$ado not confuse with BONE PINS see BONE NAILS
=680  \\$iSteel wires, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires.
=688  \\$a91(86); was see under ORTHOPEDIC FIXATION DEVICES 1986-90
=750  \0$aBone wiring (Orthopedics)$5IEN$0(DLC)sh 90003760

=LDR  00764cz  a2200265n  4500
=001  9880363194302441
=005  20141212192028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001863
=035  \\$aCAZ5028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x370.$x437
=072  \\$aE7.$x858.$x442.$x660.$x460.$x437
=072  \\$aE7.$x858.$x690.$x725.$x460.$x437
=150  \\$aBone Screws
=450  \\$wnnna$aBone Screw
=450  \\$wnnna$aScrew, Bone
=450  \\$wnnna$aScrews, Bone
=550  \\$wg$aInternal Fixators
=550  \\$wh$aPedicle Screws
=550  \\$aBone Nails
=550  \\$aBone Wires
=667  \\$ado not confuse with BONE PINS see BONE NAILS
=688  \\$a74(71)
=750  \0$aBone screws (Orthopedics)$5IEN$0(DLC)sh 85015531

=LDR  01731cz  a2200373n  4500
=001  9880363224902441
=005  20141212194729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000743
=035  \\$aCAZ3894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141
=150  \\$aAnemia, Hemolytic
=450  \\$wnnna$aAcquired Hemolytic Anemia
=450  \\$wnnna$aAnemia, Acquired Hemolytic
=450  \\$aAnemia, Hemolytic, Acquired
=450  \\$aAnemia, Microangiopathic
=450  \\$aHemolytic Anemia
=450  \\$wnnna$aHemolytic Anemia, Acquired
=450  \\$wnnna$aMicroangiopathic Anemia
=450  \\$wnnna$aMicroangiopathic Hemolytic Anemia
=550  \\$wg$aAnemia
=550  \\$wh$aAnemia, Hemolytic, Autoimmune
=550  \\$wh$aAnemia, Hemolytic, Congenital
=550  \\$wh$aFavism
=550  \\$wh$aHemoglobinuria, Paroxysmal
=550  \\$wh$aHemolytic-Uremic Syndrome
=550  \\$aHemolysis
=550  \\$aPyruvate Kinase
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iA condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
=688  \\$aANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67; for MICROANGIOPATHIC HEMOLYTIC ANEMIA use PURPURA, THROMBOTIC THROMBOCYTOPENIC 2012
=688  \\$aANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC & ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67
=750  \0$aHemolytic anemia$5IEN$0(DLC)sh 85060210

=LDR  00939cz  a2200289n  4500
=001  9880363225002441
=005  20141212194728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000741
=035  \\$aCAZ3892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x85
=072  \\$aC15.$x378.$x190.$x196
=150  \\$aAnemia, Aplastic
=450  \\$aAnemia, Hypoplastic
=450  \\$wnnna$aAnemias, Aplastic
=450  \\$wnnna$aAnemias, Hypoplastic
=450  \\$wnnna$aAplastic Anemia
=450  \\$wnnna$aAplastic Anemias
=450  \\$wnnna$aHypoplastic Anemia
=450  \\$wnnna$aHypoplastic Anemias
=550  \\$wg$aAnemia
=550  \\$wg$aBone Marrow Diseases
=550  \\$wh$aAnemia, Hypoplastic, Congenital
=667  \\$aa bone marrow dis
=680  \\$iA form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
=750  \0$aAplastic anemia$5IEN$0(DLC)sh 85005993

=LDR  00926cz  a2200301n  4500
=001  9880363225102441
=005  20141212194727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000740
=035  \\$aCAZ3891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71
=150  \\$aAnemia
=450  \\$wnnna$aAnemias
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aAnemia, Aplastic
=550  \\$wh$aAnemia, Hemolytic
=550  \\$wh$aAnemia, Hypochromic
=550  \\$wh$aAnemia, Macrocytic
=550  \\$wh$aAnemia, Myelophthisic
=550  \\$wh$aAnemia, Neonatal
=550  \\$wh$aAnemia, Refractory
=550  \\$wh$aAnemia, Sideroblastic
=550  \\$wh$aRed-Cell Aplasia, Pure
=550  \\$aHepcidins
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
=750  \0$aAnemia$5IEN$0(DLC)sh 85004940

=LDR  00642cz  a2200205n  4500
=001  9880363225202441
=005  20141212194727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000739
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x67
=150  \\$aAnecdotes as Topic
=450  \\$wnnna$aAnecdotes as Topics
=550  \\$wg$aLiterature
=550  \\$aNarration
=667  \\$ado not confuse with Publication Type ANECDOTES
=680  \\$iBrief accounts or narratives of an incident or event.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Anecdotes
=750  \0$aAnecdotes$0(DLC) sh 85004931$5IEN-M

=LDR  01050cz  a2200277n  4500
=001  9880363225302441
=005  20141212191952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000735
=035  \\$aCAZ3886M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54.$x79.$x329
=072  \\$aD4.$x808.$x578.$x502.$x112
=072  \\$aD6.$x472.$x40.$x502.$x112
=072  \\$aD6.$x472.$x334.$x851.$x968.$x875
=150  \\$aAndrostenedione
=450  \\$wnnna$a4-Androstene-3,17-dione
=450  \\$wnnna$a4 Androstene 3,17 dione
=450  \\$wnnna$adelta-4-Androstenedione
=450  \\$wnnna$adelta 4 Androstenedione
=550  \\$wg$a17-Ketosteroids
=550  \\$wg$aAndrostenes
=550  \\$wg$aTestosterone Congeners
=680  \\$iA delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
=688  \\$a74(73)
=750  \0$aAndrostenedione$5IEN-M$0(DLC)sh 99001784

=LDR  00568cz  a2200205n  4500
=001  9880363225402441
=005  20141212194725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000731
=035  \\$aCAZ3882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54
=150  \\$aAndrostanes
=550  \\$wg$aSteroids
=550  \\$wh$aAndrostanols
=550  \\$wh$aAndrostenes
=667  \\$ado not confuse with ANDROSTENES
=680  \\$iThe family of steroids from which the androgens are derived.
=688  \\$a68
=750  \0$aAndrostane$5IEN$0(DLC)sh 85004927

=LDR  01452cz  a2200325n  4500
=001  9880363225502441
=005  20141212194725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000728
=035  \\$aCAZ3879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x161
=150  \\$aAndrogens
=450  \\$wnnna$aAgents, Androgenic
=450  \\$wnnna$aAgonists, Androgen Receptor
=450  \\$wnnna$aAndrogen Effect
=450  \\$wnnna$aAndrogen Effects
=450  \\$wnnna$aAndrogen Receptor Agonists
=450  \\$wnnna$aAndrogenic Agents
=450  \\$wnnna$aAndrogenic Compounds
=450  \\$wnnna$aCompounds, Androgenic
=450  \\$wnnna$aEffect, Androgen
=450  \\$wnnna$aEffects, Androgen
=450  \\$wnnna$aReceptor Agonists, Androgen
=450  \\$aReceptors, Androgen$xagonists
=550  \\$wg$aHormones
=667  \\$adeficiency: consider also HYPOGONADISM & other gonadal disorders; note entry term ANDROGEN EFFECT: use only for the androgen effect of a chemical substance
=680  \\$iCompounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
=688  \\$a1963
=750  \0$aAndrogens$5IEN$0(DLC)sh 85004919

=LDR  01134cz  a2200241n  4500
=001  9880363225602441
=005  20141212194724.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000727
=035  \\$aCAZ3878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x65
=150  \\$aAndrogen-Binding Protein
=450  \\$wnnna$aAndrogen Binding Protein
=450  \\$wnnoa$aAndrogen-Binding Proteins$5IEN-HS
=450  \\$wnnna$aBinding Protein, Androgen
=450  \\$wnnna$aProtein, Androgen Binding
=450  \\$wnnna$aProtein, Androgen-Binding
=550  \\$wg$aCarrier Proteins
=550  \\$aSex Hormone-Binding Globulin
=680  \\$iCarrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as SEX HORMONE-BINDING GLOBULIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.
=688  \\$a2000(1980)
=750  \0$aAndrogen-binding proteins$5IEN-M$0(DLC)sh 95006342

=LDR  01346cz  a2200385n  4500
=001  9880363225702441
=005  20141212194724.0
=008  770517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000726
=035  \\$aCAZ3877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x65
=072  \\$aD27.$x505.$x696.$x399.$x450.$x65
=150  \\$aAndrogen Antagonists
=450  \\$aAndrogens$xantagonists & inhibitors
=450  \\$wnnna$aAntagonists, Androgen
=450  \\$wnnna$aAnti-Androgen Effect
=450  \\$wnnna$aAnti Androgen Effect
=450  \\$wnnna$aAnti-Androgen Effects
=450  \\$wnnna$aAnti Androgen Effects
=450  \\$wnnna$aAntiandrogen Effect
=450  \\$wnnna$aAntiandrogen Effects
=450  \\$aAntiandrogens
=450  \\$wnnna$aEffect, Anti-Androgen
=450  \\$wnnna$aEffect, Antiandrogen
=450  \\$wnnna$aEffects, Anti-Androgen
=450  \\$wnnna$aEffects, Antiandrogen
=550  \\$wg$aHormone Antagonists
=550  \\$wh$aAndrogen Receptor Antagonists
=550  \\$wh$aNonsteroidal Anti-Androgens
=550  \\$aAndrogens
=667  \\$anote entry term ANTI-ANDROGEN EFFECT: use only for the antiandrogen effect of a chemical substance
=680  \\$iCompounds which inhibit or antagonize the biosynthesis or actions of androgens.
=688  \\$a78
=750  \0$aAntiandrogens$5IEN$0(DLC)sh 85005628

=LDR  01407cz  a2200313n  4500
=001  9880363225802441
=005  20141212194723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000723
=035  \\$aCAZ3874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x100
=150  \\$aAncylostomatoidea
=450  \\$wnnna$aAncylostomatoideas
=450  \\$aBunostomum
=450  \\$wnnna$aBunostomums
=450  \\$wnnna$aHookworm
=450  \\$aHookworms
=450  \\$wnnna$astenocephala, Uncinaria
=450  \\$wnnna$astenocephalas, Uncinaria
=450  \\$aUncinaria stenocephala
=450  \\$wnnna$aUncinaria stenocephalas
=550  \\$wg$aStrongylida
=550  \\$wh$aAncylostoma
=550  \\$wh$aNecator
=667  \\$aa superfamily of nematodes (hookworms): HOOKWORM, NEW WORLD see NECATOR & HOOKWORM, OLD WORLD see ANCYLOSTOMA are available; infection = HOOKWORM INFECTIONS but see note under ANCYLOSTOMA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA; NECATOR; Bunostomum; and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs.
=688  \\$a86; was HOOKWORMS 1963-85
=750  \0$aHookworms$5IEN$0(DLC)sh 85061909

=LDR  01519cz  a2200361n  4500
=001  9880363225902441
=005  20141212194723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000722
=035  \\$aCAZ3873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x100.$x100
=150  \\$aAncylostoma
=450  \\$aAncylostoma caninum
=450  \\$wnnna$aAncylostoma caninums
=450  \\$aAncylostoma duodenale
=450  \\$wnnna$aAncylostoma duodenales
=450  \\$wnnna$aAncylostomas
=450  \\$wnnna$acaninum, Ancylostoma
=450  \\$wnnna$acaninums, Ancylostoma
=450  \\$wnnna$aduodenale, Ancylostoma
=450  \\$wnnna$aduodenales, Ancylostoma
=450  \\$aHookworm, Old World
=450  \\$wnnna$aHookworms, Old World
=450  \\$wnnna$aOld World Hookworm
=450  \\$wnnna$aOld World Hookworms
=450  \\$wnnna$aWorld Hookworm, Old
=450  \\$wnnna$aWorld Hookworms, Old
=550  \\$wg$aAncylostomatoidea
=667  \\$aa genus of nematodes; infection = ANCYLOSTOMIASIS; coord with specific pre-coordinated helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent
=680  \\$iA genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans.
=688  \\$aANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92
=750  \0$aAncylostoma$5IEN$0(DLC)sh 87020017

=LDR  00642cz  a2200205n  4500
=001  9880363226002441
=005  20141212194722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000719
=035  \\$aCAZ3870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x279
=150  \\$aAnatomy, Veterinary
=450  \\$wnnna$aAnatomies, Veterinary
=450  \\$wnnna$aVeterinary Anatomies
=450  \\$aVeterinary Anatomy
=550  \\$wg$aAnatomy
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the anatomical structures of animals.
=750  \0$aVeterinary anatomy$5IEN$0(DLC)sh 85143003

=LDR  00864cz  a2200205n  4500
=001  9880363226102441
=005  20141212194721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000718
=035  \\$aCAZ3869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x216
=150  \\$aAnatomy, Regional
=450  \\$wnnna$aAnatomies, Regional
=450  \\$wnnna$aRegional Anatomies
=450  \\$wnnna$aRegional Anatomy
=550  \\$wg$aAnatomy
=667  \\$athe discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific organ or organism
=680  \\$iThe anatomical study of specific regions or parts of organisms, emphasizing the relationship between the various structures (e.g. muscles, nerves, skeletal, cardiovascular, etc.).
=750  \0$aAnatomy, Surgical and topographical$0(DLC) sh 85004845$5IEN

=LDR  00873cz  a2200205n  4500
=001  9880363226202441
=005  20141212194721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000717
=035  \\$aCAZ3868HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x154
=150  \\$aAnatomy, Comparative
=450  \\$wnnna$aAnatomies, Comparative
=450  \\$wnnna$aComparative Anatomies
=450  \\$wnnna$aComparative Anatomy
=550  \\$wg$aAnatomy
=667  \\$aSPEC: IM, SPEC qualif; do not check COMPARATIVE STUDY for, as a field, it is not a substitute for a comparison of two or more anatomical concepts ( = COMPARATIVE STUDY tag); Manual 18.13.4: relation to COMPARATIVE STUDY
=680  \\$iThe comparative study of animal structure with regard to homologous organs or parts. (Stedman, 25th ed)
=750  \0$aAnatomy, Comparative$5IEN$0(DLC)sh 85004837

=LDR  00874cz  a2200241n  4500
=001  9880363226302441
=005  20141212194721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000716
=035  \\$aCAZ3867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x91
=072  \\$aK1.$x93.$x410.$x100
=150  \\$aAnatomy, Artistic
=450  \\$wnnna$aAnatomies, Artistic
=450  \\$wnnna$aArtistic Anatomies
=450  \\$wnnna$aArtistic Anatomy
=550  \\$wg$aAnatomy
=550  \\$wg$aMedical Illustration
=550  \\$aArt
=667  \\$ause for the discipline (education, history, etc) only; anatomical atlases go under ATLASES AS TOPIC (IM) + ANATOMY, ARTISTIC (IM)
=680  \\$iThe study of the structures of organisms for applications in art: drawing, painting, sculpture, illustration, etc.
=750  \0$aAnatomy, Artistic$5IEN$0(DLC)sh 85004836

=LDR  00997cz  a2200301n  4500
=001  9880363226402441
=005  20141212194720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000715
=035  \\$aCAZ3866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100
=150  \\$aAnatomy
=450  \\$wnnna$aAnatomies
=550  \\$wg$aBiological Science Disciplines
=550  \\$wh$aAnatomy, Artistic
=550  \\$wh$aAnatomy, Comparative
=550  \\$wh$aAnatomy, Cross-Sectional
=550  \\$wh$aAnatomy, Regional
=550  \\$wh$aAnatomy, Veterinary
=550  \\$wh$aCell Biology
=550  \\$wh$aEmbryology
=550  \\$wh$aHistology
=550  \\$wh$aNeuroanatomy
=550  \\$wh$aOsteology
=667  \\$athe discipline only (education, history, etc); for anatomical structures, use the qualifier / anat with specific anatomical terms or organisms
=680  \\$iA branch of biology dealing with the structure of organisms.
=750  \0$aAnatomy$0(DLC) sh 85004835$5IEN-M

=LDR  00778cz  a2200241n  4500
=001  9880363226502441
=005  20141212194719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000712
=035  \\$aCAZ3863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x54.$x50
=072  \\$aC1.$x252.$x400.$x825.$x50
=072  \\$aC22.$x85
=150  \\$aAnaplasmosis
=450  \\$wnnna$aAnaplasmoses
=550  \\$wg$aAnaplasmataceae Infections
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aTick-Borne Diseases
=667  \\$atick-borne dis; usually animal; check tag ANIMALS
=680  \\$iA disease of cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.
=688  \\$a68(66)
=750  \0$aAnaplasmosis$5IEN$0(DLC)sh 85004809

=LDR  00729cz  a2200241n  4500
=001  9880363226602441
=005  20141212194718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000710
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x40
=072  \\$aB3.$x660.$x50.$x20
=150  \\$aAnaplasmataceae
=450  \\$aEhrlichieae
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aAnaplasma
=550  \\$wh$aEhrlichia
=550  \\$wh$aNeorickettsia
=667  \\$ainfection = ANAPLASMATACEAE INFECTIONS
=680  \\$iA family of bacteria which inhabit RED BLOOD CELLS and cause several animal diseases.
=688  \\$a1975
=750  \0$aAnaplasmataceae$5IEN$0(DLC)sh 88023214

=LDR  00882cz  a2200217n  4500
=001  9880363226702441
=005  20141212194718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x40.$x50
=072  \\$aB3.$x660.$x50.$x20.$x50
=150  \\$aAnaplasma
=550  \\$wg$aAnaplasmataceae
=550  \\$wh$aAnaplasma centrale
=550  \\$wh$aAnaplasma marginale
=550  \\$wh$aAnaplasma ovis
=550  \\$wh$aAnaplasma phagocytophilum
=667  \\$ainfection = ANAPLASMOSIS
=680  \\$iA genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis.
=750  \0$aAnaplasma$5IEN$0(DLC)sh 88023213

=LDR  00867cz  a2200229n  4500
=001  9880363226802441
=005  20141212194718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000707
=035  \\$aCAZ3858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x480.$x99
=150  \\$aAnaphylaxis
=450  \\$aAnaphylactic Reaction
=450  \\$wnnna$aAnaphylactic Reactions
=450  \\$wnnna$aAnaphylactic Shock
=450  \\$wnnna$aReaction, Anaphylactic
=450  \\$wnnna$aReactions, Anaphylactic
=450  \\$aShock, Anaphylactic
=550  \\$wg$aHypersensitivity, Immediate
=680  \\$iAn acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
=750  \0$aAnaphylaxis$5IEN$0(DLC)sh 85004806

=LDR  01009cz  a2200277n  4500
=001  9880363226902441
=005  20141212194717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000704
=035  \\$aCAZ3855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x150
=072  \\$aN5.$x715.$x360.$x750.$x125
=072  \\$aN6.$x850.$x520.$x830.$x150
=150  \\$aAnalysis of Variance
=450  \\$wnnna$aAnalyses, Variance
=450  \\$wnnna$aAnalysis, Variance
=450  \\$aANOVA
=450  \\$wnnna$aVariance Analyses
=450  \\$wnnna$aVariance Analysis
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aMultivariate Analysis
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
=688  \\$a74(68)
=750  \0$aAnalysis of variance$5IEN$0(DLC)sh 85004782

=LDR  01135cz  a2200349n  4500
=001  9880363227002441
=005  20141212194716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000700
=035  \\$aCAZ3851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x850.$x14
=072  \\$aD27.$x505.$x954.$x427.$x40
=150  \\$aAnalgesics
=450  \\$wnnna$aAgents, Analgesic
=450  \\$wnnna$aAnalgesic Agents
=450  \\$wnnna$aAnalgesic Drugs
=450  \\$aAnodynes
=450  \\$aAntinociceptive Agents
=450  \\$wnnna$aDrugs, Analgesic
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aSensory System Agents
=550  \\$wh$aAnalgesics, Non-Narcotic
=550  \\$wh$aAnalgesics, Short-Acting
=550  \\$wh$aDentin Desensitizing Agents
=550  \\$wh$aNarcotics
=550  \\$aAnesthetics
=550  \\$aPain
=667  \\$ageneral or unspecified; prefer specific groups
=680  \\$iCompounds capable of relieving pain without the loss of CONSCIOUSNESS.
=688  \\$a78; ANALGESICS AND ANTIPYRETICS was heading 1963-77
=750  \0$aAnalgesics$5IEN$0(DLC)sh 85004764

=LDR  01836cz  a2200361n  4500
=001  9880363227102441
=005  20141212194716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000699
=035  \\$aCAZ3849M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x700
=072  \\$aC16.$x320.$x775
=150  \\$aPain Insensitivity, Congenital
=450  \\$aAnalgesia, Congenital
=450  \\$wnnna$aChannelopathy-Associated Insensitivity To Pain
=450  \\$wnnna$aCongenital Analgesia
=450  \\$wnnna$aCongenital Indifference to Pain
=450  \\$wnnna$aCongenital Insensitivity To Pain
=450  \\$wnnna$aCongenital Pain Indifference
=450  \\$wnnna$aCongenital Pain Indifferences
=450  \\$wnnna$aCongenital Pain Insensitivity
=450  \\$wnnna$aInsensitivity, Congenital Pain
=450  \\$wnnna$aInsensitivity To Pain, Congenital
=450  \\$aPain Indifference, Congenital
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$aHereditary Sensory and Autonomic Neuropathies
=550  \\$aPain
=667  \\$acongenital insensitivity to pain with anhidrosis = HSAN TYPE IV see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC; DF: PAIN INSENSITIVITY CONGEN
=680  \\$iA syndrome characterized by indifference to PAIN despite the ability to distinguish noxious from non-noxious stimuli. Absent corneal reflexes and INTELLECTUAL DISABILITY may be associated. Familial forms with autosomal recessive and autosomal dominant patterns of inheritance have been described. (Adams et al., Principles of Neurology, 6th ed, p1343)
=688  \\$a96; was ANALGESIA, CONGENITAL 1964-95 (Prov 1964-72); PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95
=750  \0$aCongenital insensitivity to pain$0(DLC)sh2008008364$5IEN-M

=LDR  00969cz  a2200301n  4500
=001  9880363227202441
=005  20141212194715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000698
=035  \\$aCAZ3848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x91
=150  \\$aAnalgesia
=450  \\$wnnna$aAnalgesias
=550  \\$wg$aAnesthesia and Analgesia
=550  \\$wh$aAcupuncture Analgesia
=550  \\$wh$aAnalgesia, Epidural
=550  \\$wh$aAnalgesia, Obstetrical
=550  \\$wh$aAnalgesia, Patient-Controlled
=550  \\$wh$aAudioanalgesia
=550  \\$wh$aDiffuse Noxious Inhibitory Control
=550  \\$wh$aInterpleural Analgesia
=550  \\$wh$aNeuroleptanalgesia
=550  \\$wh$aTranscutaneous Electric Nerve Stimulation
=550  \\$aPain
=667  \\$ado not use /util except by MeSH definition
=680  \\$iMethods of PAIN relief that may be used with or in place of ANALGESICS.
=750  \0$aAnalgesia$5IEN$0(DLC)sh 85004763

=LDR  01534cz  a2200349n  4500
=001  9880363227302441
=005  20141212194715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000697
=035  \\$aCAZ3847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x282
=072  \\$aD27.$x505.$x954.$x427.$x220
=150  \\$aCentral Nervous System Stimulants
=450  \\$wnnna$aAgents, Analeptic
=450  \\$wnnna$aAnaleptic Agents
=450  \\$wnnna$aAnaleptic Drugs
=450  \\$aAnaleptics
=450  \\$wnnna$aCentral Stimulants
=450  \\$wnnna$aDrugs, Analeptic
=450  \\$wnnna$aStimulants, Central
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAphrodisiacs
=550  \\$wh$aAppetite Stimulants
=550  \\$wh$aConvulsants
=550  \\$wh$aWakefulness-Promoting Agents
=550  \\$aAmphetamines
=667  \\$aGEN or unspecified; prefer specifics; consider also CENTRAL NERVOUS SYSTEM /drug eff & BRAIN /drug eff; DF: CNS STIMULANTS
=680  \\$iA loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
=688  \\$a95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94
=750  \0$aCentral nervous system stimulants$0(DLC)sh2007004820$5IEN-M

=LDR  00779cz  a2200217n  4500
=001  9880363227402441
=005  20170608115621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000693
=035  \\$aCAZ3843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x62
=072  \\$aG3.$x78
=150  \\$aAnaerobiosis
=450  \\$wnnna$aAnaerobioses
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=667  \\$aalmost never IM
=680  \\$iThe complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=688  \\$a91(71); was see under METABOLISM 1971-90
=750  \0$aAnaerobiosis$5IEN$0(DLC)sh 85004755

=LDR  02428cz  a2200469n  4500
=001  9880363227502441
=005  20141212194713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000690
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x854.$x139
=072  \\$aC10.$x574.$x562.$x250
=072  \\$aC10.$x574.$x950.$x50
=072  \\$aC10.$x668.$x467.$x250
=072  \\$aC18.$x452.$x845.$x800.$x50
=150  \\$aAmyotrophic Lateral Sclerosis
=450  \\$wnnna$aALS (Amyotrophic Lateral Sclerosis)
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis, Guam Form
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam
=450  \\$wnnna$aAmyotrophic Lateral Sclerosis With Dementia
=450  \\$wnnna$aCharcot Disease
=450  \\$wnnna$aDementia With Amyotrophic Lateral Sclerosis
=450  \\$wnnna$aDisease, Guam
=450  \\$wnnna$aDisease, Lou-Gehrigs
=450  \\$wnnna$aGehrig Disease
=450  \\$wnnna$aGehrig's Disease
=450  \\$wnnna$aGehrigs Disease
=450  \\$wnnna$aGuam Disease
=450  \\$wnnna$aGuam Form of Amyotrophic Lateral Sclerosis
=450  \\$aLou Gehrig Disease
=450  \\$wnnna$aLou Gehrig's Disease
=450  \\$wnnna$aLou-Gehrigs Disease
=450  \\$aMotor Neuron Disease, Amyotrophic Lateral Sclerosis
=450  \\$wnnna$aSclerosis, Amyotrophic Lateral
=550  \\$wg$aMotor Neuron Disease
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wg$aTDP-43 Proteinopathies
=680  \\$iA degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
=750  \0$aAmyotrophic lateral sclerosis$5IEN$0(DLC)sh 85004728

=LDR  01138cz  a2200253n  4500
=001  9880363227602441
=005  20200516141501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000686
=035  \\$aCAZ3835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x845.$x500
=150  \\$aAmyloidosis
=450  \\$wnnna$aAmyloidoses
=550  \\$wg$aProteostasis Deficiencies
=550  \\$wh$aAmyloid Neuropathies
=550  \\$wh$aAmyloidosis, Familial
=550  \\$wh$aCerebral Amyloid Angiopathy
=550  \\$wh$aImmunoglobulin Light-chain Amyloidosis
=550  \\$aAmyloid
=550  \\$aPlaque, Amyloid
=667  \\$acoord IM with organ/dis precoord (IM); /genet: consider also AMYLOIDOSIS, HEREDITARY
=680  \\$iA group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
=750  \0$aAmyloidosis$5IEN$0(DLC)sh 85004724

=LDR  01266cz  a2200277n  4500
=001  9880363227702441
=005  20141212194711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000682
=035  \\$aCAZ3831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x49
=072  \\$aD12.$x776.$x49
=150  \\$aAmyloid
=450  \\$wnnna$aAmyloid Fibrils
=450  \\$wnnna$aAmyloid Substance
=450  \\$wnnna$aFibrils, Amyloid
=450  \\$wnnna$aSubstance, Amyloid
=550  \\$wg$aMultiprotein Complexes
=550  \\$wg$aProteins
=550  \\$wh$aAmyloidogenic Proteins
=550  \\$aAmyloidosis
=667  \\$aPLAQUE, AMYLOID is also available
=680  \\$iA fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease.
=688  \\$a68; was AMYLOID SUBSTANCE 1963-67 (Cat C heading only 1966-67, Cat A heading only 1963-64)
=750  \0$aAmyloid$5IEN$0(DLC)sh 92004711

=LDR  00606cz  a2200193n  4500
=001  9880363227802441
=005  20141212191933.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000300
=035  \\$aCAZ3448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x150.$x140
=150  \\$aAdoption
=450  \\$aAdoptees$5IEN
=450  \\$wnnna$aAdoptions
=550  \\$wg$aFamily
=680  \\$iVoluntary acceptance of a child of other parents to be as one's own child, usually with legal confirmation.
=750  \0$aAdoption$5IEN-M$0(DLC)sh 85000978
=750  \0$aAdoptees$5IEN-HS$0(DLC)sh 85000976

=LDR  00911cz  a2200229n  4500
=001  9880363227902441
=005  20141212191929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000297
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x65
=150  \\$aPsychology, Adolescent
=450  \\$aAdolescent Psychology
=450  \\$aAdolescent$xpsychology
=550  \\$wg$aPsychology
=550  \\$aPsychology, Developmental
=667  \\$ause for the specialty and also for articles on the way a normal adolescent thinks & acts
=680  \\$iField of psychology involving the study of normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.
=688  \\$a1967; use ADOLESCENT PSYCHOLOGY 1967-2014
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Adolescent Psychology
=688  \\$a67
=750  \0$aAdolescent psychology$5IEN$0(DLC)sh 85000969

=LDR  00747cz  a2200193n  4500
=001  9880363228002441
=005  20141212194500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000296
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x65
=072  \\$aH2.$x403.$x690.$x80
=150  \\$aAdolescent Psychiatry
=450  \\$wnnna$aPsychiatry, Adolescent
=550  \\$wg$aPsychiatry
=667  \\$aSPEC: SPEC qualif; not for mental disorders in adolescents ( = MENTAL DISORDERS (IM) + ADOLESCENT (NIM) ): Manual 27.9
=680  \\$iThe medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.
=688  \\$a67
=750  \0$aAdolescent psychiatry$5IEN$0(DLC)sh 85000968

=LDR  00724cz  a2200193n  4500
=001  9880363228102441
=005  20141212194459.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000295
=035  \\$aCAZ3443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x14
=150  \\$aAdolescent Medicine
=450  \\$wnnna$aMedicine, Adolescent
=550  \\$wg$aMedicine
=667  \\$aspecialty; when permitted for "adolescent diseases": Manual 28.9.1; DF: ADOLESCENT MED
=680  \\$iA branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth.
=688  \\$a80
=750  \0$aAdolescent medicine$5IEN$0(DLC)sh 85000963

=LDR  01142cz  a2200385n  4500
=001  9880363228202441
=005  20141212191929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000293
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x57
=150  \\$aAdolescent
=450  \\$aAdolescence
=450  \\$wnnna$aAdolescent, Female
=450  \\$wnnna$aAdolescent, Male
=450  \\$wnnna$aAdolescents
=450  \\$wnnna$aAdolescents, Female
=450  \\$wnnna$aAdolescents, Male
=450  \\$wnnna$aFemale Adolescent
=450  \\$wnnna$aFemale Adolescents
=450  \\$wnnna$aMale Adolescent
=450  \\$wnnna$aMale Adolescents
=450  \\$wnnna$aTeen
=450  \\$wnnna$aTeenager
=450  \\$wnnna$aTeenagers
=450  \\$wnnna$aTeens
=450  \\$aYouth
=450  \\$wnnna$aYouths
=550  \\$wg$aAge Groups
=550  \\$aMinors
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9
=680  \\$iA person 13 to 18 years of age.
=750  \0$aTeenagers$5IEN-HS$0(DLC)sh 87006824
=750  \0$aYouth$5IEN-HS$0(DLC)sh 85149310
=750  \0$aAdolescence$5IEN-HS$0(DLC)sh 85000952

=LDR  01822cz  a2200397n  4500
=001  9880363228302441
=005  20141212194459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000292
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x635.$x500
=072  \\$aC13.$x351.$x500.$x56.$x750
=150  \\$aPelvic Inflammatory Disease
=450  \\$aAdnexitis
=450  \\$wnnna$aDisease, Inflammatory Pelvic
=450  \\$wnnna$aDisease, Pelvic Inflammatory
=450  \\$wnnna$aDiseases, Inflammatory Pelvic
=450  \\$wnnna$aDiseases, Pelvic Inflammatory
=450  \\$wnnna$aInflammatory Disease, Pelvic
=450  \\$wnnna$aInflammatory Diseases, Pelvic
=450  \\$wnnna$aInflammatory Pelvic Disease
=450  \\$wnnna$aInflammatory Pelvic Diseases
=450  \\$wnnna$aPelvic Disease, Inflammatory
=450  \\$wnnna$aPelvic Diseases, Inflammatory
=450  \\$wnnna$aPelvic Inflammatory Diseases
=550  \\$wg$aAdnexal Diseases
=550  \\$wg$aPelvic Infection
=550  \\$wh$aEndometritis
=550  \\$wh$aOophoritis
=550  \\$wh$aParametritis
=550  \\$wh$aSalpingitis
=550  \\$aPelvis
=667  \\$afemale only: note category; "male adnexitis": index under GENITAL DISEASES, MALE or PELVIC INFECTION
=680  \\$iA spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.
=688  \\$a2003 (1963)
=750  \0$aPelvic inflammatory disease$5IEN$0(DLC)sh 85000943

=LDR  00915cz  a2200253n  4500
=001  9880363228402441
=005  20160801095244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000290
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x114
=150  \\$aAdnexa Uteri
=450  \\$wnnna$aAppendage, Uterine
=450  \\$wnnna$aAppendages, Uterine
=450  \\$wnnna$aUterine Appendage
=450  \\$aUterine Appendages
=550  \\$wg$aGenitalia, Female
=550  \\$wh$aBroad Ligament
=550  \\$wh$aFallopian Tubes
=550  \\$wh$aOvary
=550  \\$wh$aRound Ligament of Uterus
=667  \\$aseen in titles more frequently in adjective form "adnexal"; inflammation = ADNEXITIS
=680  \\$iAppendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
=750  \0$aAdnexa uteri$5IEN$0(DLC)sh 85000941

=LDR  00954cz  a2200301n  4500
=001  9880363228502441
=005  20180326144540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000288
=035  \\$aCAZ3436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70
=150  \\$aAdministrative Personnel
=450  \\$wnnna$aAdministrator
=450  \\$aAdministrators
=450  \\$aExecutives$5IEN-M
=450  \\$wnnna$aPersonnel, Administrative
=450  \\$wnnna$aPolicy Maker
=450  \\$wnnna$aPolicy Makers
=550  \\$wg$aOccupational Groups
=550  \\$wh$aCase Managers
=550  \\$wh$aHealth Facility Administrators
=550  \\$wh$aNurse Administrators
=550  \\$wh$aPhysician Executives
=550  \\$wh$aTrustees
=680  \\$iIndividuals responsible for the development of policy and supervision of the execution of plans and functional operations.
=688  \\$a68
=750  \0$aExecutives$5IEN$0(DLC)sh 85046291

=LDR  01695cz  a2200445n  4500
=001  9880363228602441
=005  20141212191928.0
=008  860604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000285
=035  \\$aCAZ3433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x110
=072  \\$aE2.$x319.$x267.$x120.$x806
=150  \\$aAdministration, Rectal
=450  \\$wnnna$aAdministration, Anal Drug
=450  \\$wnnna$aAdministration, Rectal Drug
=450  \\$wnnna$aAdministrations, Anal Drug
=450  \\$wnnna$aAdministrations, Rectal
=450  \\$wnnna$aAdministrations, Rectal Drug
=450  \\$aAnal Drug Administration
=450  \\$wnnna$aAnal Drug Administrations
=450  \\$wnnna$aDrug Administration, Anal
=450  \\$aDrug Administration, Rectal
=450  \\$wnnna$aDrug Administrations, Anal
=450  \\$wnnna$aDrug Administrations, Rectal
=450  \\$aInstillation, Rectal
=450  \\$wnnna$aInstillations, Rectal
=450  \\$wnnna$aRectal Administration
=450  \\$wnnna$aRectal Administrations
=450  \\$aRectal Drug Administration
=450  \\$wnnna$aRectal Drug Administrations
=450  \\$wnnna$aRectal Instillation
=450  \\$wnnna$aRectal Instillations
=550  \\$wg$aAdministration, Topical
=550  \\$wg$aDrug Administration Routes
=550  \\$aRectal Absorption
=667  \\$aNIM but only if discussed: do not index here routinely for every rectally administered drug; no qualif
=680  \\$iThe insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose.
=688  \\$a87
=750  \0$aRectum, Medication by$5IEN$0(DLC)sh 85112010

=LDR  01239cz  a2200349n  4500
=001  9880363228702441
=005  20141212191928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000284
=035  \\$aCAZ3432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x100
=150  \\$aAdministration, Oral
=450  \\$wnnna$aAdministration, Oral Drug
=450  \\$wnnna$aAdministrations, Oral
=450  \\$wnnna$aAdministrations, Oral Drug
=450  \\$aDrug Administration, Oral
=450  \\$wnnna$aDrug Administrations, Oral
=450  \\$aMedication, Oral$5IEN-M
=450  \\$wnnna$aOral Administration
=450  \\$wnnna$aOral Administrations
=450  \\$wnnna$aOral Drug Administration
=450  \\$wnnna$aOral Drug Administrations
=450  \\$aOral Medication$5IEN
=550  \\$wg$aDrug Administration Routes
=550  \\$wh$aAdministration, Buccal
=550  \\$wh$aAdministration, Sublingual
=550  \\$aGastrointestinal Absorption
=667  \\$aNIM but only if discussed: do not index here routinely for every orally administered drug; no qualif
=680  \\$iThe giving of drugs, chemicals, or other substances by mouth.
=688  \\$a73(70)
=750  \0$aOral medication$5IEN$0(DLC)sh 85095244

=LDR  01341cz  a2200385n  4500
=001  9880363228802441
=005  20141212191927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000281
=035  \\$aCAZ3429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x80
=072  \\$aE2.$x319.$x267.$x120.$x80
=150  \\$aAdministration, Intranasal
=450  \\$wnnna$aAdministration, Intranasal Drug
=450  \\$wnnna$aAdministration, Nasal
=450  \\$wnnna$aAdministrations, Intranasal
=450  \\$wnnna$aAdministrations, Intranasal Drug
=450  \\$wnnna$aAdministrations, Nasal
=450  \\$aDrug Administration, Intranasal
=450  \\$wnnna$aDrug Administrations, Intranasal
=450  \\$wnnna$aIntranasal Administration
=450  \\$wnnna$aIntranasal Administrations
=450  \\$wnnna$aIntranasal Drug Administration
=450  \\$wnnna$aIntranasal Drug Administrations
=450  \\$wnnna$aNasal Administration
=450  \\$wnnna$aNasal Administrations
=550  \\$wg$aAdministration, Topical
=550  \\$wg$aDrug Administration Routes
=550  \\$aAdministration, Inhalation
=550  \\$aNasal Absorption
=550  \\$aNebulizers and Vaporizers
=680  \\$iDelivery of medications through the nasal mucosa.
=688  \\$a73
=750  \0$aIntranasal medication$5IEN$0(DLC)sh 85067621

=LDR  02609cz  a2200661n  4500
=001  9880363228902441
=005  20141212194456.0
=008  860625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000279
=035  \\$aCAZ3427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x120.$x60
=150  \\$aAdministration, Cutaneous
=450  \\$wnnna$aAdministration, Cutaneous Drug
=450  \\$wnnna$aAdministration, Dermal
=450  \\$wnnna$aAdministration, Dermal Drug
=450  \\$wnnna$aAdministration, Percutaneous
=450  \\$wnnna$aAdministration, Transcutaneous
=450  \\$wnnna$aAdministration, Transdermal
=450  \\$wnnna$aAdministrations, Cutaneous
=450  \\$wnnna$aAdministrations, Cutaneous Drug
=450  \\$wnnna$aAdministrations, Dermal
=450  \\$wnnna$aAdministrations, Dermal Drug
=450  \\$wnnna$aAdministrations, Percutaneous
=450  \\$wnnna$aAdministrations, Transcutaneous
=450  \\$wnnna$aAdministrations, Transdermal
=450  \\$wnnna$aCutaneous Administration
=450  \\$wnnna$aCutaneous Administration, Drug
=450  \\$wnnna$aCutaneous Administrations
=450  \\$wnnna$aCutaneous Administrations, Drug
=450  \\$aCutaneous Drug Administration
=450  \\$wnnna$aCutaneous Drug Administrations
=450  \\$wnnna$aDermal Administration
=450  \\$wnnna$aDermal Administrations
=450  \\$aDermal Drug Administration
=450  \\$wnnna$aDermal Drug Administrations
=450  \\$wnnna$aDrug Administration, Cutaneous
=450  \\$aDrug Administration, Dermal
=450  \\$wnnna$aDrug Administrations, Cutaneous
=450  \\$wnnna$aDrug Administrations, Dermal
=450  \\$wnnna$aDrug Skin Administrations
=450  \\$aPercutaneous Administration
=450  \\$wnnna$aPercutaneous Administrations
=450  \\$wnnna$aSkin Administration, Drug
=450  \\$wnnna$aSkin Administrations, Drug
=450  \\$aSkin Drug Administration
=450  \\$wnnna$aSkin Drug Administrations
=450  \\$aTranscutaneous Administration
=450  \\$wnnna$aTranscutaneous Administrations
=450  \\$aTransdermal Administration
=450  \\$wnnna$aTransdermal Administrations
=450  \\$aTransdermal Medication$5IEN
=550  \\$wg$aAdministration, Topical
=550  \\$aSkin Absorption
=667  \\$aNIM but only if discussed: do not index here routinely for every cutaneously administered drug; no qualif
=680  \\$iThe application of suitable drug dosage forms to the skin for either local or systemic effects.
=688  \\$a87
=750  \0$aTransdermal medication$0(DLC) sh 85043050$5IEN

=LDR  01646cz  a2200325n  4500
=001  9880363229002441
=005  20141212194454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000276
=035  \\$aCAZ3424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x67
=150  \\$aAdjuvants, Immunologic
=450  \\$wnnna$aAdjuvant, Immunologic
=450  \\$wnnna$aAdjuvant, Immunological
=450  \\$wnnna$aAdjuvants, Immunological
=450  \\$aImmunoactivators
=450  \\$aImmunoadjuvants
=450  \\$wnnna$aImmunologic Adjuvant
=450  \\$wnnna$aImmunologic Adjuvants
=450  \\$wnnna$aImmunological Adjuvant
=450  \\$wnnna$aImmunological Adjuvants
=450  \\$aImmunopotentiators
=450  \\$aImmunostimulants
=550  \\$wg$aImmunologic Factors
=550  \\$aAdjuvants, Pharmaceutic
=667  \\$aDF: ADJUVANTS IMMUNOL
=680  \\$iSubstances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
=688  \\$a65
=750  \0$aImmunological adjuvants$5IEN$0(DLC)sh 85000895

=LDR  01766cz  a2200421n  4500
=001  9880363229102441
=005  20171212103202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000275
=035  \\$aCAZ3423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x950.$x500
=150  \\$aAdjustment Disorders
=450  \\$wnnna$aAdjustment Disorder
=450  \\$aAnniversary Reaction
=450  \\$wnnna$aAnniversary Reactions
=450  \\$aDepression, Reactive
=450  \\$wnnna$aDepressions, Reactive
=450  \\$wnnna$aDisorder, Adjustment
=450  \\$wnnna$aDisorder, Reactive
=450  \\$wnnna$aDisorders, Adjustment
=450  \\$wnnna$aDisorders, Reactive
=450  \\$wnnna$aDisturbance, Transient Situational
=450  \\$wnnna$aDisturbances, Transient Situational
=450  \\$wnnna$aReaction, Anniversary
=450  \\$wnnna$aReactions, Anniversary
=450  \\$wnnna$aReactive Depression
=450  \\$wnnna$aReactive Depressions
=450  \\$wnnna$aReactive Disorder
=450  \\$aReactive Disorders
=450  \\$wnnna$aSituational Disturbance, Transient
=450  \\$wnnna$aSituational Disturbances, Transient
=450  \\$aTransient Situational Disturbance
=450  \\$wnnna$aTransient Situational Disturbances
=550  \\$wg$aTrauma and Stressor Related Disorders
=680  \\$iMaladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.
=688  \\$a81; was DEPRESSION, REACTIVE 1966-80 (Prov 1966-68)
=750  \0$aAdjustment disorders$5IEN$0(DLC)sh 89006058

=LDR  01195cz  a2200301n  4500
=001  9880363229202441
=005  20180205100434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000273
=035  \\$aCAZ3421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x114
=150  \\$aAdipose Tissue
=450  \\$wnnna$aBody Fat
=450  \\$wnnna$aFat Pad
=450  \\$wnnna$aFat Pads
=450  \\$aFatty Tissue
=450  \\$wnnna$aPad, Fat
=450  \\$wnnna$aPads, Fat
=450  \\$wnnna$aTissue, Adipose
=450  \\$wnnna$aTissue, Fatty
=550  \\$wg$aConnective Tissue
=550  \\$wh$aAdipose Tissue, Beige
=550  \\$wh$aAdipose Tissue, Brown
=550  \\$wh$aAdipose Tissue, White
=667  \\$ainflammation = PANNICULITIS; /surg: consider also LIPECTOMY; do not confuse with FAT BODY
=680  \\$iSpecialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white.
=750  \0$aAdipose tissues$5IEN$0(DLC)sh 85000877

=LDR  00941cz  a2200265n  4500
=001  9880363229302441
=005  20141212194453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000272
=035  \\$aCAZ3420M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x337.$x52
=150  \\$aAdipates
=450  \\$wnnna$aAcids, Adipic
=450  \\$wnnna$aAcids, Hexanedioic
=450  \\$aAdipic Acids
=450  \\$wnnna$aHexanedioic Acids
=550  \\$wg$aDicarboxylic Acids
=550  \\$wh$a2-Aminoadipic Acid
=550  \\$wh$aDimethyl Adipimidate
=680  \\$iDerivatives of adipic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain a 1,6-carboxy terminated aliphatic structure.
=688  \\$a2013(1975)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Adipic Acids
=688  \\$a75; was ADIPIC ACID 1963-74
=750  \0$aAdipic acid$0(DLC)sh2005000815$5IEN-M

=LDR  01347cz  a2200349n  4500
=001  9880363229402441
=005  20141212194452.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000269
=035  \\$aCAZ3417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x13
=072  \\$aJ1.$x637.$x16
=150  \\$aAdhesives
=450  \\$wnnna$aAdhesive
=450  \\$wnnna$aAdhesive Mucilage
=450  \\$wnnna$aAdhesive, Mucilage
=450  \\$wnnna$aAdhesive Mucilages
=450  \\$wnnna$aAdhesives, Mucilage
=450  \\$wnnna$aGlue
=450  \\$aGlues
=450  \\$wnnna$aMucilage Adhesive
=450  \\$wnnna$aMucilage, Adhesive
=450  \\$wnnna$aMucilage Adhesives
=450  \\$wnnna$aMucilages, Adhesive
=550  \\$wg$aManufactured Materials
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$aPlant Mucilage
=667  \\$acoordinate IM with DENTURE RETENTION (IM) for denture adhesives; spray adhesives: coordinate IM with AEROSOLS (NIM) if pertinent; BONE CEMENTS & DENTAL CEMENTS are also available; do not confuse entry term MUCILAGES, ADHESIVE with PLANT MUCILAGE
=680  \\$iSubstances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex.
=688  \\$a78
=750  \0$aAdhesives$5IEN$0(DLC)sh 85000865

=LDR  00584cz  a2200205n  4500
=001  9880363229502441
=005  20141212194451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000268
=035  \\$aCAZ3416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x850.$x139
=150  \\$aAdhesiveness
=450  \\$aAdhesion$5IEN-M
=450  \\$wnnna$aAdhesivenesses
=550  \\$wg$aSurface Properties
=667  \\$aNIM
=680  \\$iA property of the surface of an object that makes it stick to another surface.
=688  \\$a74(69)
=750  \0$aAdhesion$5IEN$0(DLC)sh 85000861

=LDR  01973cz  a2200505n  4500
=001  9880363229602441
=005  20141212194530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000381
=035  \\$aCAZ3529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x50
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x50
=150  \\$aAgraphia
=450  \\$wnnna$aAcquired Agraphia
=450  \\$wnnna$aAcquired Agraphias
=450  \\$wnnna$aAcquired Dysgraphia
=450  \\$wnnna$aAcquired Dysgraphias
=450  \\$wnnna$aAgraphia, Acquired
=450  \\$wnnna$aAgraphia, Constructional
=450  \\$wnnna$aAgraphia, Developmental
=450  \\$wnnna$aAgraphia, Pure
=450  \\$wnnna$aAgraphias
=450  \\$wnnna$aAgraphias, Acquired
=450  \\$wnnna$aAgraphias, Constructional
=450  \\$wnnna$aAgraphias, Developmental
=450  \\$wnnna$aAgraphias, Pure
=450  \\$wnnna$aConstructional Agraphia
=450  \\$wnnna$aConstructional Agraphias
=450  \\$wnnna$aDevelopmental Agraphia
=450  \\$wnnna$aDevelopmental Agraphias
=450  \\$wnnna$aDevelopmental Dysgraphia
=450  \\$wnnna$aDevelopmental Dysgraphias
=450  \\$aDysgraphia
=450  \\$wnnna$aDysgraphia, Acquired
=450  \\$wnnna$aDysgraphia, Developmental
=450  \\$wnnna$aDysgraphias
=450  \\$wnnna$aDysgraphias, Acquired
=450  \\$wnnna$aDysgraphias, Developmental
=450  \\$aPure Agraphia
=450  \\$wnnna$aPure Agraphias
=550  \\$wg$aLanguage Disorders
=550  \\$aHandwriting
=680  \\$iLoss or impairment of the ability to write (letters, syllables, words, or phrases) due to an injury to a specific cerebral area or occasionally due to emotional factors. This condition rarely occurs in isolation, and often accompanies APHASIA. (From Adams et al., Principles of Neurology, 6th ed, p485; APA, Thesaurus of Psychological Index Terms, 1994)
=750  \0$aAgraphia$5IEN$0(DLC)sh 85002254

=LDR  00629cz  a2200205n  4500
=001  9880363229702441
=005  20141212194529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000380
=035  \\$aCAZ3528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x553.$x546.$x184
=150  \\$aAgranulocytosis
=450  \\$wnnna$aAgranulocytoses
=450  \\$aGranulocytopenia
=450  \\$wnnna$aGranulocytopenias
=550  \\$wg$aLeukopenia
=550  \\$wh$aNeutropenia
=680  \\$iA decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
=750  \0$aAgranulocytosis$5IEN$0(DLC)sh 85002253

=LDR  01349cz  a2200373n  4500
=001  9880363229802441
=005  20141212194451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000267
=035  \\$aCAZ3415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x355.$x274.$x840
=150  \\$aTissue Adhesions
=450  \\$wnnna$aAdhesion, Surgery-Induced Tissue
=450  \\$wnnna$aAdhesion, Surgical
=450  \\$wnnna$aAdhesion, Tissue
=450  \\$wnno$aAdhesions$5IEN-M
=450  \\$wnnna$aAdhesions, Surgery-Induced Tissue
=450  \\$wnnna$aAdhesions, Surgical
=450  \\$wnnna$aAdhesions, Tissue
=450  \\$wnnna$aSurgery-Induced Tissue Adhesion
=450  \\$wnnna$aSurgery-Induced Tissue Adhesions
=450  \\$wnnna$aSurgery Induced Tissue Adhesions
=450  \\$wnnna$aSurgical Adhesion
=450  \\$wnnna$aSurgical Adhesions
=450  \\$wnnna$aTissue Adhesion
=450  \\$wnnna$aTissue Adhesion, Surgery-Induced
=450  \\$wnnna$aTissue Adhesions, Surgery-Induced
=550  \\$wg$aCicatrix
=667  \\$aIM GEN only; coordinate NIM with organ/disease term
=680  \\$iPathological processes consisting of the union of the opposing surfaces of a wound.
=688  \\$a2009 (1978)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Adhesions
=750  \0$aAdhesions$0(DLC) sh 85000862$5IEN

=LDR  00568cz  a2200181n  4500
=001  9880363229902441
=005  20141212194529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000379
=035  \\$aCAZ3527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x100
=150  \\$aAgoraphobia
=450  \\$wnnna$aAgoraphobias
=550  \\$wg$aAnxiety Disorders
=680  \\$iObsessive, persistent, intense fear of open places.
=688  \\$a90(75); was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80
=750  \0$aAgoraphobia$5IEN$0(DLC)sh 85002247

=LDR  00965cz  a2200289n  4500
=001  9880363230002441
=005  20160418090450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000262
=035  \\$aCAZ3410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x650.$x200
=072  \\$aD12.$x644.$x360.$x50
=072  \\$aD12.$x776.$x476.$x50
=150  \\$aAdenylyl Cyclases
=450  \\$wnno$aAdenylate Cyclase
=450  \\$aAdenylyl Cyclase
=450  \\$wnnna$aCyclase, Adenyl
=450  \\$wnnna$aCyclase, Adenylate
=450  \\$wnnna$aCyclase, Adenylyl
=450  \\$wnnna$aCyclases, Adenyl
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aPhosphorus-Oxygen Lyases
=550  \\$wh$aAdenylate Cyclase Toxin
=680  \\$iEnzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP. EC 4.6.1.1.
=688  \\$a2016(68)
=750  \0$aAdenylate cyclase$5IEN$0(DLC)sh 85000855

=LDR  01007cz  a2200289n  4500
=001  9880363230102441
=005  20141212194448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000257
=035  \\$aCAZ3405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x76
=150  \\$aAdenoviridae Infections
=450  \\$wnnna$aAdenoviridae Infection
=450  \\$wnnna$aAdenovirus Infection
=450  \\$aAdenovirus Infections
=450  \\$wnnna$aInfection, Adenoviridae
=450  \\$wnnna$aInfection, Adenovirus
=450  \\$wnnna$aInfections, Adenoviridae
=450  \\$wnnna$aInfections, Adenovirus
=550  \\$wg$aDNA Virus Infections
=550  \\$wh$aAdenovirus Infections, Human
=550  \\$wh$aHepatitis, Infectious Canine
=667  \\$aGEN or unspecified; prefer specifics; ADENOVIRUS INFECTIONS, HUMAN is available
=680  \\$iVirus diseases caused by the ADENOVIRIDAE.
=688  \\$a94; was ADENOVIRUS INFECTIONS 1963-93
=750  \0$aAdenovirus diseases$5IEN$0(DLC)sh 85000853

=LDR  00993cz  a2200265n  4500
=001  9880363230202441
=005  20141212194447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000256
=035  \\$aCAZ3404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x30
=072  \\$aB4.$x909.$x204.$x97
=150  \\$aAdenoviridae
=450  \\$wnnna$aAdenovirus
=450  \\$wnnna$aAdenoviruses
=550  \\$wg$aDNA Viruses
=550  \\$wh$aAtadenovirus
=550  \\$wh$aAviadenovirus
=550  \\$wh$aMastadenovirus
=550  \\$wh$aSiadenovirus
=667  \\$aa family of DNA viruses; adeno- refers to early isol from adenoids; infection = ADENOVIRIDAE INFECTIONS
=680  \\$iA family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.
=688  \\$a81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74
=750  \0$aAdenoviruses$5IEN$0(DLC)sh 85000854

=LDR  01767cz  a2200457n  4500
=001  9880363230302441
=005  20141212194447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000255
=035  \\$aCAZ3403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x138.$x236
=072  \\$aD13.$x695.$x667.$x138.$x236
=072  \\$aD13.$x695.$x827.$x68.$x236
=150  \\$aAdenosine Triphosphate
=450  \\$aAdenosine Triphosphate, Calcium Salt
=450  \\$wnnna$aAdenosine Triphosphate, Chromium Ammonium Salt
=450  \\$aAdenosine Triphosphate, Chromium Salt
=450  \\$wnnna$aAdenosine Triphosphate, Magnesium Chloride
=450  \\$aAdenosine Triphosphate, Magnesium Salt
=450  \\$aAdenosine Triphosphate, Manganese Salt
=450  \\$aAdenylpyrophosphate
=450  \\$aATP
=450  \\$wnnna$aATP-MgCl2
=450  \\$wnnna$aATP MgCl2
=450  \\$wnnna$aAtriphos
=450  \\$aCaATP
=450  \\$wnnna$aChromium Adenosine Triphosphate
=450  \\$wnnna$aCr(H2O)4 ATP
=450  \\$aCrATP
=450  \\$wnnna$aMagnesium Adenosine Triphosphate
=450  \\$aManganese Adenosine Triphosphate
=450  \\$aMgATP
=450  \\$aMnATP
=450  \\$wnnna$aStriadyne
=550  \\$wg$aAdenine Nucleotides
=550  \\$wh$aAdenylyl Imidodiphosphate
=550  \\$wh$aEthenoadenosine Triphosphate
=680  \\$iAn adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.
=688  \\$a1998; for CHROMIUM ADENOSINE TRIPHOSPHATE use ADENOSINE TRIPHOSPHATE (NM) 1974-1997; for MANGANESE ATP use ADENOSINE TRIPHOSPHATE (NM) 1981-2001
=750  \0$aAdenosine triphosphate$5IEN$0(DLC)sh 85000850

=LDR  02696cz  a2200541n  4500
=001  9880363230402441
=005  20141212194446.0
=008  780306\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000254
=035  \\$aCAZ3402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25.$x810
=072  \\$aD12.$x776.$x157.$x530.$x450.$x162.$x780
=072  \\$aD12.$x776.$x157.$x530.$x450.$x250.$x880
=072  \\$aD12.$x776.$x543.$x585.$x450.$x162.$x800
=072  \\$aD12.$x776.$x543.$x585.$x450.$x250.$x890
=150  \\$aSodium-Potassium-Exchanging ATPase
=450  \\$wnnna$aAdenosine Triphosphatase, Sodium, Potassium
=450  \\$aAdenosinetriphosphatase, Sodium, Potassium
=450  \\$wnnna$aAdenosinetriphosphatase Sodium, Potassium
=450  \\$aATPase, Sodium, Potassium
=450  \\$wnnna$aATPase Sodium, Potassium
=450  \\$wnnna$aATPase, Sodium-Potassium-Exchanging
=450  \\$aNa(+)-K(+)-Exchanging ATPase
=450  \\$wnnna$aNa(+) K(+)-Transporting ATPase
=450  \\$aNa(+)-K(+)-Transporting ATPase
=450  \\$aPotassium Pump
=450  \\$wnnna$aPump, Potassium
=450  \\$wnnna$aPump, Sodium
=450  \\$wnnna$aPump, Sodium-Potassium
=450  \\$wnnna$aSodium, Potassium Adenosine Triphosphatase
=450  \\$aSodium, Potassium Adenosinetriphosphatase
=450  \\$aSodium, Potassium ATPase
=450  \\$wnnna$aSodium Potassium Exchanging ATPase
=450  \\$aSodium-Potassium Pump
=450  \\$wnnna$aSodium Potassium Pump
=450  \\$aSodium Pump
=550  \\$wg$aAdenosine Triphosphatases
=550  \\$wg$aAntiporters
=550  \\$wg$aCation Transport Proteins
=550  \\$aPotassium Channels
=550  \\$aSodium Channels
=667  \\$aDF: NA K ATPASE
=680  \\$iAn enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients.
=688  \\$a2008(1978)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Na(+)-K(+)-Exchanging ATPase
=688  \\$a94; was NA(+) K(+)-TRANSPORTING ATPASE 1993; was ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM  1979-92; SODIUM-POTASSIUM PUMP was heading 1992-93; POTASSIUM PUMP & SODIUM PUMP were see SODIUM-POTASSIUM PUMP 1992-93; SODIUM POTASSIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, SODIUM POTSSIUM 1992; SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE was SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1989-92
=750  \0$aSodium potassium ATPase$0(DLC) sh 91005007$5IEN

=LDR  04281cz  a2201153n  4500
=001  9880363230502441
=005  20141212194529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000377
=035  \\$aCAZ3525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762.$x100
=072  \\$aC23.$x888.$x592.$x604.$x764.$x100
=072  \\$aF1.$x700.$x750.$x100
=150  \\$aAgnosia
=450  \\$wnnna$aAgnosia, Auditory
=450  \\$wnnna$aAgnosia, Body-Image
=450  \\$wnnna$aAgnosia, Congenital Auditory
=450  \\$wnnna$aAgnosia, Developmental
=450  \\$wnnna$aAgnosia, Finger
=450  \\$wnnna$aAgnosia for Pain
=450  \\$wnnna$aAgnosia for Smell
=450  \\$wnnna$aAgnosia for Taste
=450  \\$wnnna$aAgnosia for Tastes
=450  \\$wnnna$aAgnosia for Temperature
=450  \\$wnnna$aAgnosia, Gustatory
=450  \\$wnnna$aAgnosia, Ideational
=450  \\$wnnna$aAgnosia, Olfactory
=450  \\$wnnna$aAgnosia, Position
=450  \\$wnnna$aAgnosia, Sensory
=450  \\$wnnna$aAgnosia, Somatosensory
=450  \\$wnnna$aAgnosia, Tactile
=450  \\$wnnna$aAgnosia, Time
=450  \\$wnnna$aAgnosia, Topographical
=450  \\$wnnna$aAgnosia, Visual
=450  \\$wnnna$aAgnosia, Visuospatial
=450  \\$wnnna$aAgnosias
=450  \\$wnnna$aAgnosias, Auditory
=450  \\$wnnna$aAgnosias, Body-Image
=450  \\$wnnna$aAgnosias, Congenital Auditory
=450  \\$wnnna$aAgnosias, Developmental
=450  \\$wnnna$aAgnosias, Finger
=450  \\$wnnna$aAgnosias, Ideational
=450  \\$wnnna$aAgnosias, Olfactory
=450  \\$wnnna$aAgnosias, Position
=450  \\$wnnna$aAgnosias, Sensory
=450  \\$wnnna$aAgnosias, Somatosensory
=450  \\$wnnna$aAgnosias, Tactile
=450  \\$wnnna$aAgnosias, Time
=450  \\$wnnna$aAgnosias, Topographical
=450  \\$wnnna$aAgnosias, Visual
=450  \\$wnnna$aAgnosias, Visuospatial
=450  \\$wnnna$aAnosognosia
=450  \\$wnnna$aAnosognosias
=450  \\$aAuditory Agnosia
=450  \\$wnnna$aAuditory Agnosia, Congenital
=450  \\$wnnna$aAuditory Agnosias
=450  \\$wnnna$aAuditory Agnosias, Congenital
=450  \\$wnnna$aBody-Image Agnosia
=450  \\$wnnna$aBody Image Agnosia
=450  \\$wnnna$aBody-Image Agnosias
=450  \\$wnnna$aCongenital Auditory Agnosia
=450  \\$wnnna$aCongenital Auditory Agnosias
=450  \\$wnnna$aDevelopmental Agnosia
=450  \\$wnnna$aDevelopmental Agnosias
=450  \\$aFinger Agnosia
=450  \\$wnnna$aFinger Agnosias
=450  \\$wnnna$aGustatory Agnosia
=450  \\$wnnna$aIdeational Agnosia
=450  \\$wnnna$aIdeational Agnosias
=450  \\$wnnna$aOlfactory Agnosia
=450  \\$wnnna$aOlfactory Agnosias
=450  \\$wnnna$aPosition Agnosia
=450  \\$wnnna$aPosition Agnosias
=450  \\$aSensory Agnosia
=450  \\$wnnna$aSensory Agnosias
=450  \\$wnnna$aSomatosensory Agnosia
=450  \\$wnnna$aSomatosensory Agnosias
=450  \\$wnnna$aSyndrome, Visual Disorientation
=450  \\$wnnna$aSyndromes, Visual Disorientation
=450  \\$aTactile Agnosia
=450  \\$wnnna$aTactile Agnosias
=450  \\$wnnna$aTime Agnosia
=450  \\$wnnna$aTime Agnosias
=450  \\$wnnna$aTopographical Agnosia
=450  \\$wnnna$aTopographical Agnosias
=450  \\$aVisual Agnosia
=450  \\$wnnna$aVisual Agnosia for Objects
=450  \\$wnnna$aVisual Agnosias
=450  \\$wnnna$aVisual Disorientation Syndrome
=450  \\$wnnna$aVisual Disorientation Syndromes
=450  \\$wnnna$aVisuospatial Agnosia
=450  \\$wnnna$aVisuospatial Agnosias
=550  \\$wg$aPerceptual Disorders
=550  \\$wh$aGerstmann Syndrome
=550  \\$wh$aProsopagnosia
=667  \\$acoordinate IM with type of stimulus that is not recognized (IM)
=680  \\$iLoss of the ability to comprehend the meaning or recognize the importance of various forms of stimulation that cannot be attributed to impairment of a primary sensory modality. Tactile agnosia is characterized by an inability to perceive the shape and nature of an object by touch alone, despite unimpaired sensation to light touch, position, and other primary sensory modalities.
=750  \0$aAgnosia$5IEN$0(DLC)sh 85002229

=LDR  00699cz  a2200205n  4500
=001  9880363230602441
=005  20141212194527.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000376
=035  \\$aCAZ3524M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x60
=150  \\$aAgmatine
=450  \\$wnnna$a1-Amino-4-guanidinobutane
=450  \\$wnnna$a1 Amino 4 guanidinobutane
=450  \\$wnnna$a4-(Aminobutyl)guanidine
=550  \\$wg$aGuanidines
=680  \\$iDecarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
=688  \\$a91(75); was see under GUANIDINES 1975-90
=750  \0$aAgmatine$0(DLC)sh2003008321

=LDR  00976cz  a2200241n  4500
=001  9880363230702441
=005  20161219101139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000375
=035  \\$aCAZ3523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x124
=150  \\$aAging
=450  \\$wnnna$aAging, Biological
=450  \\$wnnna$aBiological Aging
=450  \\$aSenescence
=550  \\$wg$aGrowth and Development
=550  \\$wh$aCognitive Aging
=550  \\$wh$aImmunosenescence
=550  \\$wh$aLongevity
=667  \\$ahuman & animal; IM; aging process anywhere between birth & old age; differentiation from other age-related terms: Manual 28.16, 34.10; "aging" of lower organisms, cultures, drugs, etc. is probably TIME FACTORS; AGING, PREMATURE is also available
=680  \\$iThe gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
=750  \0$aAging$5IEN$0(DLC)sh 85002201

=LDR  01958cz  a2200493n  4500
=001  9880363230802441
=005  20200611111553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000251
=035  \\$aCAZ3398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25
=150  \\$aAdenosine Triphosphatases
=450  \\$wnnna$aAdenosine Triphosphatase
=450  \\$aAdenosinetriphosphatase
=450  \\$wnnna$aAdenosinetriphosphatases, DNA-Dependent
=450  \\$wnnna$aATPase
=450  \\$wnnna$aATPase, DNA-Dependent
=450  \\$wnnna$aATPase, DNA Dependent
=450  \\$aATPases
=450  \\$wnnna$aDNA-Dependent Adenosinetriphosphatases
=450  \\$wnnna$aDNA Dependent Adenosinetriphosphatases
=450  \\$wnnna$aDNA-Dependent ATPase
=450  \\$wnnna$aDNA Dependent ATPase
=450  \\$wnnna$aTriphosphatase, Adenosine
=550  \\$wg$aAcid Anhydride Hydrolases
=550  \\$wh$aArsenite Transporting ATPases
=550  \\$wh$aCa(2+) Mg(2+)-ATPase
=550  \\$wh$aCalcium-Transporting ATPases
=550  \\$wh$aChaperonins
=550  \\$wh$aDNA Helicases
=550  \\$wh$aMi-2 Nucleosome Remodeling and Deacetylase Complex
=550  \\$wh$aMolecular Motor Proteins
=550  \\$wh$aMutL Proteins
=550  \\$wh$aN-Ethylmaleimide-Sensitive Proteins
=550  \\$wh$aP-type ATPases
=550  \\$wh$aProton-Translocating ATPases
=550  \\$wh$aRecQ Helicases
=550  \\$wh$aSodium-Potassium-Exchanging ATPase
=680  \\$iA group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.
=688  \\$a2007(1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Adenosinetriphosphatase
=688  \\$a93; was ADENOSINE TRIPHOSPHATASE 1963-92
=750  \0$aAdenosine triphosphatase$0(DLC) sh 85000849$5IEN

=LDR  00889cz  a2200229n  4500
=001  9880363230902441
=005  20141212194526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000374
=035  \\$aCAZ3522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x125
=072  \\$aF1.$x145.$x813.$x45
=150  \\$aAggression
=450  \\$wnnna$aAggressions
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aSocial Behavior
=550  \\$wh$aAgonistic Behavior
=550  \\$wh$aBullying
=667  \\$ahuman & animal; "agression" in French is translated "stress" & indexed under STRESS, PHYSIOLOGICAL or specific; "agressologie" = STRESS, PHYSIOLOGICAL
=680  \\$iBehavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
=750  \0$aAggressiveness$5IEN$0(DLC)sh 85002193

=LDR  00663cz  a2200169n  4500
=001  9880363231002441
=005  20141212194526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000373
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x136
=150  \\$aAgglutinins
=550  \\$wg$aImmunologic Factors
=550  \\$wh$aHemagglutinins
=680  \\$iSubstances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They include those ANTIBODIES which cause aggregation or agglutination of particulate or insoluble ANTIGENS.
=688  \\$a73
=750  \0$aAgglutinins$5IEN$0(DLC)sh 85002186

=LDR  00900cz  a2200265n  4500
=001  9880363231102441
=005  20141212194526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000372
=035  \\$aCAZ3520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x50
=072  \\$aE5.$x200.$x812.$x735.$x50
=072  \\$aE5.$x478.$x594.$x760.$x50
=150  \\$aAgglutination Tests
=450  \\$wnnna$aAgglutination Test
=450  \\$wnnna$aTest, Agglutination
=450  \\$wnnna$aTests, Agglutination
=550  \\$wg$aSerologic Tests
=550  \\$wh$aHemagglutination Tests
=550  \\$wh$aLatex Fixation Tests
=550  \\$aAgglutination
=680  \\$iTests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
=688  \\$a66
=750  \0$aAgglutination tests$5IEN$0(DLC)sh 85002185

=LDR  00690cz  a2200229n  4500
=001  9880363231202441
=005  20170608110800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000371
=035  \\$aCAZ3519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x26
=072  \\$aG12.$x122.$x100
=150  \\$aAgglutination
=550  \\$wg$aAntigen-Antibody Reactions
=550  \\$wg$aBiochemical Phenomena
=550  \\$wh$aHemagglutination
=550  \\$wh$aSperm Agglutination
=550  \\$aAgglutination Tests
=667  \\$aNIM
=680  \\$iThe clumping together of suspended material resulting from the action of AGGLUTININS.
=750  \0$aAgglutination$5IEN$0(DLC)sh 85002184

=LDR  01893cz  a2200517n  4500
=001  9880363231302441
=005  20141212194444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000249
=035  \\$aCAZ3396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x138.$x180
=072  \\$aD13.$x695.$x667.$x138.$x180
=072  \\$aD13.$x695.$x827.$x68.$x180
=150  \\$aAdenosine Monophosphate
=450  \\$wnnna$a2'-Adenosine Monophosphate
=450  \\$wnnna$a2' Adenosine Monophosphate
=450  \\$wnnna$a2'-Adenylic Acid
=450  \\$wnnna$a2' Adenylic Acid
=450  \\$wnnna$a2'-AMP
=450  \\$wnnna$a5'-Adenylic Acid
=450  \\$wnnna$a5' Adenylic Acid
=450  \\$wnnna$a5'-Phosphate, Adenosine
=450  \\$wnnna$aAcid, 2'-Adenylic
=450  \\$wnnna$aAcid, 5'-Adenylic
=450  \\$wnnna$aAdenosine 2'-Phosphate
=450  \\$wnnna$aAdenosine 2' Phosphate
=450  \\$wnnna$aAdenosine 3'-Phosphate
=450  \\$wnnna$aAdenosine 3' Phosphate
=450  \\$wnnna$aAdenosine 5'-Phosphate
=450  \\$wnnna$aAdenosine 5' Phosphate
=450  \\$wnnna$aAdenosine Phosphate Dipotassium
=450  \\$wnnna$aAdenosine Phosphate Disodium
=450  \\$aAdenylic Acid
=450  \\$aAMP
=450  \\$wnnna$aDipotassium, Adenosine Phosphate
=450  \\$wnnna$aDisodium, Adenosine Phosphate
=450  \\$wnnna$aMonophosphate, 2'-Adenosine
=450  \\$wnnna$aPhosphaden
=450  \\$wnnna$aPhosphate Dipotassium, Adenosine
=450  \\$wnnna$aPhosphate Disodium, Adenosine
=550  \\$wg$aAdenine Nucleotides
=550  \\$wh$aAdenosine Phosphosulfate
=680  \\$iAdenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position.
=688  \\$a73(71); ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72
=750  \0$aAdenylic acid$5IEN$0(DLC)sh 85000857

=LDR  00866cz  a2200241n  4500
=001  9880363231402441
=005  20141212191935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000368
=035  \\$aCAZ3516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x116.$x100
=150  \\$aAged
=450  \\$aElderly
=550  \\$wg$aAdult
=550  \\$wh$aAged, 80 and over
=550  \\$wh$aFrail Elderly
=550  \\$aGeriatrics
=550  \\$aLongevity
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9; differentiate from AGING, a physiological process, & AGE FACTORS & AGE DISTRIBUTION, statistical concepts
=680  \\$iA person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
=688  \\$a66; was see under GERIATRICS 1963-65
=750  \0$aOlder people$5IEN$0(DLC)sh 85002087

=LDR  01303cz  a2200277n  4500
=001  9880363231502441
=005  20141212194525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000367
=035  \\$aCAZ3515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x350.$x75
=072  \\$aN6.$x850.$x490.$x250
=150  \\$aAge Factors
=450  \\$wnnna$aAge Factor
=450  \\$wnnna$aAge Reporting
=450  \\$wnnna$aFactor, Age
=450  \\$wnnna$aFactors, Age
=550  \\$wg$aEpidemiologic Factors
=550  \\$wh$aAge of Onset
=550  \\$wh$aMaternal Age
=667  \\$aNIM; no qualif; human & animal; related to cause & effect: do not confuse with AGE DISTRIBUTION which is largely statistical; differentiate from AGING, a physiol concept; policy: Manual 35.7
=680  \\$iAge as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
=688  \\$a68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92
=750  \0$aAge (Psychology)$5IEN-M$0(DLC)sh 85002070
=750  \0$aAge factors in disease$5IEN-HS$0(DLC)sh 85002082

=LDR  01120cz  a2200325n  4500
=001  9880363231602441
=005  20141212194442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000244
=035  \\$aCAZ3391HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x138.$x124
=072  \\$aD13.$x695.$x667.$x138.$x124
=072  \\$aD13.$x695.$x827.$x68.$x124
=150  \\$aAdenosine Diphosphate
=450  \\$wnnna$a5'-Pyrophosphate, Adenosine
=450  \\$wnnna$aAdenosine 5'-Pyrophosphate
=450  \\$wnnna$aAdenosine 5' Pyrophosphate
=450  \\$aAdenosine Pyrophosphate
=450  \\$aADP
=450  \\$wnnna$aADP, Magnesium
=450  \\$wnnna$aDiphosphate, Adenosine
=450  \\$aMagnesium ADP
=450  \\$aMgADP
=450  \\$wnnna$aPyrophosphate, Adenosine
=550  \\$wg$aAdenine Nucleotides
=550  \\$wh$aAdenosine Diphosphate Sugars
=680  \\$iAdenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position.
=688  \\$a73(71)
=750  \0$aAdenosine diphosphate$5IEN$0(DLC)sh 89006798

=LDR  00801cz  a2200217n  4500
=001  9880363231702441
=005  20141212194441.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000243
=035  \\$aCAZ3390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x151.$x486.$x75
=150  \\$aAdenosine Deaminase
=450  \\$aAdenosine Aminohydrolase
=450  \\$wnnna$aAminohydrolase, Adenosine
=450  \\$wnnna$aDeaminase, Adenosine
=550  \\$wg$aNucleoside Deaminases
=667  \\$a/defic: consider also SEVERE COMBINED IMMUNODEFICIENCY or SCID
=680  \\$iAn enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA.
=688  \\$a91(75); was see under NUCLEOSIDE DEAMINASES 1975-90
=750  \0$aAdenosine deaminase$5IEN$0(DLC)sh 85000847

=LDR  01525cz  a2200421n  4500
=001  9880363231802441
=005  20141212194524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000365
=035  \\$aCAZ3513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x49
=072  \\$aE1.$x370.$x350.$x700.$x50
=150  \\$aAge Determination by Skeleton
=450  \\$wnnna$aAge Measurement, Bone
=450  \\$wnnna$aAge Measurement, Skeletal
=450  \\$wnnna$aAge Measurements, Bone
=450  \\$wnnna$aAge Measurements, Skeletal
=450  \\$aBone Age Measurement
=450  \\$wnnna$aBone Age Measurements
=450  \\$wnnna$aIndex, Skeletal Maturation
=450  \\$wnnna$aIndices, Skeletal Maturation
=450  \\$wnnna$aMaturation Index, Skeletal
=450  \\$wnnna$aMaturation Indices, Skeletal
=450  \\$wnnna$aMeasurement, Bone Age
=450  \\$wnnna$aMeasurement, Skeletal Age
=450  \\$wnnna$aMeasurements, Bone Age
=450  \\$wnnna$aMeasurements, Skeletal Age
=450  \\$aSkeletal Age Measurement
=450  \\$wnnna$aSkeletal Age Measurements
=450  \\$wnnna$aSkeletal Maturation Index
=450  \\$wnnna$aSkeletal Maturation Indices
=450  \\$aSkeletal Maturity$5IEN
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aRadiography
=680  \\$iEstablishment of the age of an individual by examination of their skeletal structure.
=688  \\$a67; was SKELETAL AGE MEASUREMENT 1965-66
=750  \0$aSkeletal maturity$5IEN$0(DLC)sh 85123118

=LDR  00645cz  a2200181n  4500
=001  9880363231902441
=005  20141212194524.0
=008  850208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000364
=035  \\$aCAZ3512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x105
=150  \\$aAgaricus
=550  \\$wg$aAgaricales
=667  \\$aa basidiomycete
=680  \\$iA basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom (A. campestris) and the commercial mushroom (A. bisporus).
=688  \\$a91(86); was see under AGARICALES 1986-90
=750  \0$aAgaricus$5IEN$0(DLC)sh 88022139

=LDR  02368cz  a2200469n  4500
=001  9880363232002441
=005  20141212194441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000242
=035  \\$aCAZ3389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x138.$x395
=072  \\$aD13.$x695.$x462.$x200
=072  \\$aD13.$x695.$x667.$x138.$x395
=072  \\$aD13.$x695.$x827.$x68.$x395
=150  \\$aCyclic AMP
=450  \\$wnnna$a3',5'-Monophosphate, Adenosine Cyclic
=450  \\$wnnna$aAdenosine Cyclic 3,5 Monophosphate
=450  \\$wnnna$aAdenosine Cyclic-3',5'-Monophosphate
=450  \\$aAdenosine Cyclic 3',5'-Monophosphate
=450  \\$wnnna$aAdenosine Cyclic 3',5' Monophosphate
=450  \\$wnnna$aAdenosine Cyclic Monophosphate
=450  \\$wnnna$aAMP, Cyclic
=450  \\$wnnna$aCyclic 3',5'-Monophosphate, Adenosine
=450  \\$wnnna$aCyclic-3',5'-Monophosphate, Adenosine
=450  \\$aCyclic Adenylic Acid$5IEN
=450  \\$wnnna$aCyclic AMP, Disodium Salt
=450  \\$wnnna$aCyclic AMP, Monoammonium Salt
=450  \\$wnnna$aCyclic AMP, Monopotassium Salt
=450  \\$wnnna$aCyclic AMP, Monosodium Salt
=450  \\$wnnna$aCyclic AMP, (R)-Isomer
=450  \\$wnnna$aCyclic AMP, Sodium Salt
=450  \\$wnnna$aCyclic Monophosphate, Adenosine
=450  \\$wnnna$aMonophosphate, Adenosine Cyclic
=550  \\$wg$aAdenine Nucleotides
=550  \\$wg$aNucleotides, Cyclic
=550  \\$wh$a8-Bromo Cyclic Adenosine Monophosphate
=550  \\$wh$aBucladesine
=667  \\$a/biosyn /physiol permitted; cAMP receptor protein, cyclic AMP receptor protein: index under RECEPTORS, CYCLIC AMP; DF: CYCL AMP
=680  \\$iAn adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.
=688  \\$a94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3',5' MONOPHOSPHATE 1968-77 (Prov 1968-71); CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2',3'-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93
=750  \0$aCyclic adenylic acid$5IEN$0(DLC)sh 85035065

=LDR  01226cz  a2200349n  4500
=001  9880363232202441
=005  20210217131923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000241
=035  \\$aCAZ3388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100.$x759.$x590.$x138
=072  \\$aD13.$x570.$x583.$x138
=072  \\$aD13.$x570.$x800.$x96
=150  \\$aAdenosine
=450  \\$wnnna$aAdenocard
=450  \\$wnnna$aAdenoscan
=550  \\$wg$aPurine Nucleosides
=550  \\$wg$aRibonucleosides
=550  \\$wh$a2-Chloroadenosine
=550  \\$wh$aAdenosine-5'-(N-ethylcarboxamide)
=550  \\$wh$aDeoxyadenosines
=550  \\$wh$aIsopentenyladenosine
=550  \\$wh$aPhenylisopropyladenosine
=550  \\$wh$aPuromycin
=550  \\$wh$aS-Adenosylhomocysteine
=550  \\$wh$aS-Adenosylmethionine
=550  \\$wh$aVidarabine
=550  \\$wh$aTicagrelor
=680  \\$iA nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
=688  \\$a72; was see under NUCLEOSIDES 1963-71
=750  \0$aAdenosine$5IEN$0(DLC)sh 85000846

=LDR  00732cz  a2200169n  4500
=001  9880363232302441
=005  20141212194523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000362
=035  \\$aCAZ3510HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x360.$x41
=150  \\$aAgar
=550  \\$wg$aGalactans
=667  \\$aD25-26 qualif
=680  \\$iA complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.
=750  \0$aAgar$5IEN$0(DLC)sh 85002042

=LDR  00938cz  a2200265n  4500
=001  9880363232402441
=005  20141212194523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000361
=035  \\$aCAZ3509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x147.$x142
=072  \\$aC15.$x604.$x515.$x32
=072  \\$aC20.$x673.$x88
=150  \\$aAgammaglobulinemia
=450  \\$wnnna$aAgammaglobulinemias
=450  \\$aHypogammaglobulinemia
=450  \\$wnnna$aHypogammaglobulinemias
=550  \\$wg$aBlood Protein Disorders
=550  \\$wg$aImmunologic Deficiency Syndromes
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$aProtein-Losing Enteropathies
=667  \\$aDYSGAMMAGLOBULINEMIA is also available
=680  \\$iAn immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
=750  \0$aAgammaglobulinemia$5IEN$0(DLC)sh 85002037

=LDR  01129cz  a2200301n  4500
=001  9880363232502441
=005  20141212194522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000359
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x58
=072  \\$aN2.$x421.$x585.$x58
=150  \\$aAftercare
=450  \\$wnnna$aAfter Care
=450  \\$wnnna$aAfter-Treatment
=450  \\$wnnna$aAfter Treatment
=450  \\$wnnna$aAfter-Treatments
=450  \\$wnnna$aPostabortal Program
=450  \\$wnnna$aPostabortal Programs
=450  \\$wnnna$aPostabortion
=450  \\$wnnna$aProgram, Postabortal
=450  \\$wnnna$aPrograms, Postabortal
=550  \\$wg$aPatient Care
=550  \\$aPatient Care Planning
=667  \\$amed, nurs, psychiat care after discharge from a hosp or other health facil; differentiate from REHABILITATION which is for getting a person back to pre-illness work or other activity
=680  \\$iThe care and treatment of a convalescent patient, especially that of a patient after surgery.
=688  \\$a94; was AFTER CARE 1968-93
=750  \0$aHospitals$xAfter care$5IEN$0(DLC)sh 85062297

=LDR  01033cz  a2200229n  4500
=001  9880363232602441
=005  20141212194522.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000358
=035  \\$aCAZ3506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x49.$x35
=072  \\$aB4.$x909.$x204.$x102.$x35
=150  \\$aAfrican Swine Fever Virus
=450  \\$wnnna$aVirus, Wart-Hog Disease
=450  \\$aWart-Hog Disease Virus
=450  \\$wnnna$aWart Hog Disease Virus
=550  \\$wg$aAsfarviridae
=667  \\$ainfection = AFRICAN SWINE FEVER: see note there
=680  \\$iThe lone species of the genus Asfivirus. It infects domestic and wild pigs, warthogs, and bushpigs. Disease is endemic in domestic swine in many African countries and Sardinia. Soft ticks of the genus Ornithodoros are also infected and act as vectors.
=688  \\$a91(75); was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77
=750  \0$aAfrican swine fever virus$5IEN$0(DLC)sh 85001749

=LDR  02343cz  a2200709n  4500
=001  9880363232702441
=005  20141212194439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000236
=035  \\$aCAZ3383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x35
=150  \\$aAdenoma
=450  \\$aAdenoma, Basal Cell
=450  \\$aAdenoma, Follicular
=450  \\$aAdenoma, Microcystic
=450  \\$aAdenoma, Monomorphic
=450  \\$aAdenoma, Papillary
=450  \\$aAdenoma, Trabecular
=450  \\$wnnna$aAdenomas
=450  \\$wnnna$aAdenomas, Basal Cell
=450  \\$wnnna$aAdenomas, Follicular
=450  \\$wnnna$aAdenomas, Microcystic
=450  \\$wnnna$aAdenomas, Monomorphic
=450  \\$wnnna$aAdenomas, Papillary
=450  \\$wnnna$aAdenomas, Trabecular
=450  \\$wnnna$aBasal Cell Adenoma
=450  \\$wnnna$aBasal Cell Adenomas
=450  \\$wnnna$aFollicular Adenoma
=450  \\$wnnna$aFollicular Adenomas
=450  \\$wnnna$aMicrocystic Adenoma
=450  \\$wnnna$aMicrocystic Adenomas
=450  \\$wnnna$aMonomorphic Adenoma
=450  \\$wnnna$aMonomorphic Adenomas
=450  \\$wnnna$aPapillary Adenoma
=450  \\$wnnna$aPapillary Adenomas
=450  \\$wnnna$aTrabecular Adenoma
=450  \\$wnnna$aTrabecular Adenomas
=550  \\$wg$aNeoplasms, Glandular and Epithelial
=550  \\$wh$aACTH-Secreting Pituitary Adenoma
=550  \\$wh$aAdenoma, Acidophil
=550  \\$wh$aAdenoma, Basophil
=550  \\$wh$aAdenoma, Bile Duct
=550  \\$wh$aAdenoma, Chromophobe
=550  \\$wh$aAdenoma, Islet Cell
=550  \\$wh$aAdenoma, Liver Cell
=550  \\$wh$aAdenoma, Oxyphilic
=550  \\$wh$aAdenoma, Pleomorphic
=550  \\$wh$aAdenoma, Sweat Gland
=550  \\$wh$aAdenoma, Villous
=550  \\$wh$aAdenomatoid Tumor
=550  \\$wh$aAdenomatosis, Pulmonary
=550  \\$wh$aAdenomatous Polyps
=550  \\$wh$aAdrenal Rest Tumor
=550  \\$wh$aApudoma
=550  \\$wh$aCystadenoma
=550  \\$wh$aGrowth Hormone-Secreting Pituitary Adenoma
=550  \\$wh$aMesothelioma
=550  \\$wh$aProlactinoma
=667  \\$aGEN or unspecified; prefer specifics; coord IM with precoord organ/neopl term (IM)
=680  \\$iA benign epithelial tumor with a glandular organization.
=750  \0$aAdenoma$5IEN$0(DLC)sh 85000843

=LDR  01106cz  a2200277n  4500
=001  9880363232802441
=005  20141212194522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000357
=035  \\$aCAZ3505HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x885.$x125
=072  \\$aC2.$x256.$x142
=072  \\$aC22.$x905.$x72
=150  \\$aAfrican Swine Fever
=450  \\$aSwine Fever, African
=450  \\$wnnna$aWart-Hog Disease
=450  \\$wnnna$aWart Hog Disease
=450  \\$wnnna$aWart-Hog Diseases
=550  \\$wg$aDNA Virus Infections
=550  \\$wg$aSwine Diseases
=550  \\$wg$aTick-Borne Diseases
=667  \\$ado not confuse with SWINE FEVER see CLASSICAL SWINE FEVER
=680  \\$iA sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks (genus Ornithodoros).
=688  \\$a70
=750  \0$aAfrican swine fever$5IEN$0(DLC)sh 85001748

=LDR  00909cz  a2200229n  4500
=001  9880363232902441
=005  20141212194438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000235
=035  \\$aCAZ3382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x435.$x75
=150  \\$aAdenolymphoma
=450  \\$wnnna$aAdenolymphomas
=450  \\$aCystadenoma Lymphomatosum, Papillary
=450  \\$wnnna$aPapillary Cystadenoma Lymphomatosum
=450  \\$wnnna$aTumor, Warthin
=450  \\$aWarthin Tumor
=550  \\$wg$aNeoplasms, Complex and Mixed
=667  \\$a/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iA benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.
=750  \0$aAdenolymphoma$5IEN$0(DLC)sh 85000842

=LDR  00714cz  a2200181n  4500
=001  9880363233002441
=005  20160826085603.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000356
=035  \\$aCAZ3504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630.$x550.$x50
=150  \\$aAfrican Horsesickness Virus
=550  \\$wg$aOrbivirus
=667  \\$ainfection = AFRICAN HORSE SICKNESS
=680  \\$iA species of ORBIVIRUS that causes disease in horses, mules, and donkeys. Via its principal vector CULICOIDES, it can also infect dogs, elephants, camels, cattle, sheep, goats, and, in special circumstances, humans.
=688  \\$a98(75)
=750  \0$aAfrican horse sickness virus$5IEN$0(DLC)sh 92002399

=LDR  00797cz  a2200265n  4500
=001  9880363233102441
=005  20141212194438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000234
=035  \\$aCAZ3381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x623.$x557.$x500
=072  \\$aA10.$x549.$x100
=072  \\$aA14.$x724.$x557.$x500
=072  \\$aA15.$x382.$x520.$x604.$x100
=150  \\$aAdenoids
=450  \\$wnnna$aAdenoid
=450  \\$wnnna$aPharyngeal Tonsil
=450  \\$aPharyngeal Tonsils
=450  \\$aTonsil, Pharyngeal
=450  \\$wnnna$aTonsils, Pharyngeal
=550  \\$wg$aLymphoid Tissue
=550  \\$wg$aNasopharynx
=680  \\$iA collection of lymphoid nodules on the posterior wall and roof of the NASOPHARYNX.
=750  \0$aAdenoids$5IEN$0(DLC)sh 85000840

=LDR  01518cz  a2200385n  4500
=001  9880363233202441
=005  20141212194521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000355
=035  \\$aCAZ3503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x30
=072  \\$aC2.$x782.$x791.$x142
=072  \\$aC22.$x488.$x88
=150  \\$aAfrican Horse Sickness
=450  \\$wnnna$aAfrican Horse Sicknesses
=450  \\$wnnna$aAfrican Horsesickness
=450  \\$wnnna$aAfrican Horsesicknesses
=450  \\$aEquine Plague
=450  \\$wnnna$aEquine Plagues
=450  \\$wnnna$aHorse Sickness, African
=450  \\$wnnna$aHorse Sicknesses, African
=450  \\$wnnna$aHorsesickness, African
=450  \\$wnnna$aHorsesicknesses, African
=450  \\$wnnna$aPlague, Equine
=450  \\$wnnna$aPlagues, Equine
=450  \\$wnnna$aSickness, African Horse
=450  \\$wnnna$aSicknesses, African Horse
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aHorse Diseases
=550  \\$wg$aReoviridae Infections
=667  \\$acaused by an Orbivirus; in horses, mules & donkeys; if in horses don't forget also HORSES (NIM) & check tag ANIMALS; if in mules or donkeys, coord IM with EQUIDAE (IM) & check tag ANIMALS
=680  \\$iAn insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck.
=688  \\$a98
=750  \0$aAfrican horse sickness$5IEN$0(DLC)sh 85001728

=LDR  01051cz  a2200265n  4500
=001  9880363233302441
=005  20141212194517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000348
=035  \\$aCAZ3496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x119
=072  \\$aD3.$x830.$x219.$x119
=072  \\$aD23.$x946.$x587.$x142
=150  \\$aAflatoxins
=450  \\$wnnna$aAflatoxin
=550  \\$wg$aBenzopyrans
=550  \\$wg$aMycotoxins
=550  \\$wh$aAflatoxin B1
=550  \\$wh$aAflatoxin M1
=550  \\$aAspergillus flavus
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iFurano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2.
=688  \\$a75; was AFLATOXIN 1965-74 (Prov 1965-66)
=750  \0$aAflatoxins$5IEN$0(DLC)sh 85001527

=LDR  00991cz  a2200241n  4500
=001  9880363233402441
=005  20141212194516.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000345
=035  \\$aCAZ3493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x410.$x80
=150  \\$aAffinity Labels
=450  \\$aAffinity Labeling Reagents
=450  \\$wnnna$aLabeling Reagents, Affinity
=450  \\$wnnna$aLabels, Affinity
=450  \\$wnnna$aReagents, Affinity Labeling
=550  \\$wg$aIndicators and Reagents
=550  \\$wh$aPhotoaffinity Labels
=667  \\$aD25-26 qualif; use with caution: few apply
=680  \\$iAnalogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.
=688  \\$a75
=750  \0$aAffinity labeling$5IEN$0(DLC)sh 88000506

=LDR  00955cz  a2200289n  4500
=001  9880363233502441
=005  20141212194516.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000344
=035  \\$aCAZ3492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x612.$x220
=150  \\$aAfferent Pathways
=450  \\$wnnna$aAfferent Pathway
=450  \\$wnnna$aPathway, Afferent
=450  \\$wnnna$aPathways, Afferent
=550  \\$wg$aNeural Pathways
=550  \\$wh$aAuditory Pathways
=550  \\$wh$aOlfactory Pathways
=550  \\$wh$aSpinocerebellar Tracts
=550  \\$wh$aSpinothalamic Tracts
=550  \\$wh$aVisceral Afferents
=550  \\$wh$aVisual Pathways
=667  \\$acoord NIM with origin (IM) + termination (IM)
=680  \\$iNerve structures through which impulses are conducted from a peripheral part toward a nerve center.
=688  \\$a76; was NON MESH before 1976
=750  \0$aAfferent pathways$5IEN$0(DLC)sh 85001496

=LDR  03331cz  a2200937n  4500
=001  9880363233602441
=005  20141212194437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000230
=035  \\$aCAZ3377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25
=150  \\$aAdenocarcinoma
=450  \\$aAdenocarcinoma, Basal Cell
=450  \\$aAdenocarcinoma, Granular Cell
=450  \\$aAdenocarcinoma, Oxyphilic
=450  \\$aAdenocarcinoma, Tubular
=450  \\$wnnna$aAdenocarcinomas
=450  \\$wnnna$aAdenocarcinomas, Basal Cell
=450  \\$wnnna$aAdenocarcinomas, Granular Cell
=450  \\$wnnna$aAdenocarcinomas, Oxyphilic
=450  \\$wnnna$aAdenocarcinomas, Tubular
=450  \\$aAdenoma, Malignant
=450  \\$wnnna$aAdenomas, Malignant
=450  \\$wnnna$aBasal Cell Adenocarcinoma
=450  \\$wnnna$aBasal Cell Adenocarcinomas
=450  \\$aCarcinoma, Cribriform
=450  \\$aCarcinoma, Granular Cell
=450  \\$aCarcinoma, Tubular
=450  \\$wnnna$aCarcinomas, Cribriform
=450  \\$wnnna$aCarcinomas, Granular Cell
=450  \\$wnnna$aCarcinomas, Tubular
=450  \\$wnnna$aCribriform Carcinoma
=450  \\$wnnna$aCribriform Carcinomas
=450  \\$wnnna$aGranular Cell Adenocarcinoma
=450  \\$wnnna$aGranular Cell Adenocarcinomas
=450  \\$wnnna$aGranular Cell Carcinoma
=450  \\$wnnna$aGranular Cell Carcinomas
=450  \\$wnnna$aMalignant Adenoma
=450  \\$wnnna$aMalignant Adenomas
=450  \\$wnnna$aOxyphilic Adenocarcinoma
=450  \\$wnnna$aOxyphilic Adenocarcinomas
=450  \\$wnnna$aTubular Adenocarcinoma
=450  \\$wnnna$aTubular Adenocarcinomas
=450  \\$wnnna$aTubular Carcinoma
=450  \\$wnnna$aTubular Carcinomas
=550  \\$wg$aCarcinoma
=550  \\$wh$aAdenocarcinoma, Bronchiolo-Alveolar
=550  \\$wh$aAdenocarcinoma, Clear Cell
=550  \\$wh$aAdenocarcinoma, Follicular
=550  \\$wh$aAdenocarcinoma in Situ
=550  \\$wh$aAdenocarcinoma, Mucinous
=550  \\$wh$aAdenocarcinoma, Papillary
=550  \\$wh$aAdenocarcinoma, Scirrhous
=550  \\$wh$aAdenocarcinoma, Sebaceous
=550  \\$wh$aAdrenocortical Carcinoma
=550  \\$wh$aCarcinoid Tumor
=550  \\$wh$aCarcinoma, Acinar Cell
=550  \\$wh$aCarcinoma, Adenoid Cystic
=550  \\$wh$aCarcinoma, Ductal
=550  \\$wh$aCarcinoma, Endometrioid
=550  \\$wh$aCarcinoma, Hepatocellular
=550  \\$wh$aCarcinoma, Intraductal, Noninfiltrating
=550  \\$wh$aCarcinoma, Islet Cell
=550  \\$wh$aCarcinoma, Lobular
=550  \\$wh$aCarcinoma, Mucoepidermoid
=550  \\$wh$aCarcinoma, Neuroendocrine
=550  \\$wh$aCarcinoma, Renal Cell
=550  \\$wh$aCarcinoma, Signet Ring Cell
=550  \\$wh$aCarcinoma, Skin Appendage
=550  \\$wh$aCholangiocarcinoma
=550  \\$wh$aChoriocarcinoma
=550  \\$wh$aCystadenocarcinoma
=550  \\$wh$aEccrine Porocarcinoma
=550  \\$wh$aKlatskin's Tumor
=550  \\$wh$aPaget Disease, Extramammary
=550  \\$wh$aPulmonary Adenomatosis, Ovine
=550  \\$aCarcinoma, Non-Small-Cell Lung
=667  \\$acoord IM with precoord organ/neopl term (IM)
=680  \\$iA malignant epithelial tumor with a glandular organization.
=750  \0$aAdenocarcinoma$5IEN$0(DLC)sh 85000835

=LDR  01041cz  a2200301n  4500
=001  9880363233702441
=005  20141212194515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000342
=035  \\$aCAZ3490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x100
=150  \\$aAffective Symptoms
=450  \\$wnnna$aAffective Symptom
=450  \\$aAlexithymia
=450  \\$wnnna$aAlexithymias
=450  \\$wnnna$aDisturbance, Emotional
=450  \\$wnnna$aDisturbances, Emotional
=450  \\$wnnna$aEmotional Disturbance
=450  \\$aEmotional Disturbances
=450  \\$wnnna$aSymptom, Affective
=450  \\$wnnna$aSymptoms, Affective
=550  \\$wg$aBehavioral Symptoms
=550  \\$aEmotions
=667  \\$ahuman only; do not confuse with AFFECTIVE DISORDERS: read MeSH definitions & follow text
=680  \\$iMood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus.
=688  \\$a81; was AFFECTIVE DISTURBANCES 1969-80
=750  \0$aAlexithymia$5IEN$0(DLC)sh 87001669

=LDR  00669cz  a2200241n  4500
=001  9880363233802441
=005  20171102160553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000225
=035  \\$aCAZ3372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x138
=150  \\$aAdenine
=450  \\$wnnna$a4, Vitamin B
=450  \\$wnnna$aB 4, Vitamin
=450  \\$aVitamin B 4
=550  \\$wg$aPurines
=550  \\$wh$a2-Aminopurine
=550  \\$wh$aCytokinins
=550  \\$wh$aTenofovir
=667  \\$a/biosyn/physiol permitted
=680  \\$iA purine base and a fundamental unit of ADENINE NUCLEOTIDES.
=750  \0$aAdenine$5IEN$0(DLC)sh 85000834

=LDR  00842cz  a2200229n  4500
=001  9880363233902441
=005  20141212194514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000339
=035  \\$aCAZ3487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x47
=150  \\$aAffect
=450  \\$wnnna$aAffects
=450  \\$aMood
=450  \\$wnnna$aMoods
=550  \\$wg$aEmotions
=550  \\$wh$aIrritable Mood
=680  \\$iThe feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.
=688  \\$a65(64); was see under EMOTIONS 1963-64
=750  \0$aMood (Psychology)$5IEN-M$0(DLC)sh 85087104
=750  \0$aAffect (Psychology)$5IEN-HS$0(DLC)sh 85001493

=LDR  01260cz  a2200265n  4500
=001  9880363234002441
=005  20141212194513.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000337
=035  \\$aCAZ3485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x29
=150  \\$aAerospace Medicine
=450  \\$aAviation Medicine
=450  \\$wnnna$aMedicine, Aerospace
=450  \\$wnnna$aMedicine, Aviation
=450  \\$wnnna$aMedicine, Space
=450  \\$aSpace Medicine
=550  \\$wg$aMedicine
=550  \\$aAir Travel
=667  \\$aspecialty; med, physiol or psychol aspects of AVIATION go here but med, physiol or psychol aspects of space flight go under SPACE FLIGHT or other space related terms: Manual 28.8; DF: AEROSPACE MED
=680  \\$iThat branch of medicine dealing with the studies and effects of flight through the atmosphere or in space upon the human body and with the prevention or cure of physiological or psychological malfunctions arising from these effects. (from NASA Thesaurus)
=688  \\$a80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79
=750  \0$aAviation medicine$5IEN-M$0(DLC)sh 85010538
=750  \0$aSpace medicine$5IEN-HS$0(DLC)sh 85125942

=LDR  01050cz  a2200253n  4500
=001  9880363234102441
=005  20141212191935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000336
=035  \\$aCAZ3484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x280.$x55
=072  \\$aD26.$x255.$x165.$x55
=150  \\$aAerosols
=550  \\$wg$aColloids
=550  \\$wh$aAerosol Propellants
=550  \\$wh$aNasal Sprays
=550  \\$wh$aOral Sprays
=550  \\$aAdministration, Inhalation
=550  \\$aNebulizers and Vaporizers
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in aerosol form, not the aerosol
=680  \\$iColloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
=688  \\$awas in Cat D & J 1973-82, was in Cat D only 1963-72
=750  \0$aAerosols$5IEN$0(DLC)sh 85001419

=LDR  01642cz  a2200373n  4500
=001  9880363234202441
=005  20200515145925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000224
=035  \\$aCAZ3371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53.$x500.$x263
=072  \\$aC20.$x111.$x163
=150  \\$aAddison Disease
=450  \\$wnnna$aAddison's Disease
=450  \\$wnnna$aAddisons Disease
=450  \\$wnnna$aAdrenal Insufficiency, Primary
=450  \\$wnnna$aAdrenocortical Insufficiencies, Primary
=450  \\$wnnna$aAdrenocortical Insufficiency, Primary
=450  \\$wnnna$aDisease, Addison
=450  \\$wnnna$aHypoadrenalism, Primary
=450  \\$wnnna$aHypoadrenalisms, Primary
=450  \\$wnnna$aInsufficiencies, Primary Adrenocortical
=450  \\$wnnna$aInsufficiency, Primary Adrenocortical
=450  \\$wnnna$aPrimary Adrenal Insufficiency
=450  \\$wnnna$aPrimary Adrenocortical Insufficiencies
=450  \\$wnnna$aPrimary Adrenocortical Insufficiency
=450  \\$wnnna$aPrimary Hypoadrenalism
=550  \\$wg$aAdrenal Insufficiency
=550  \\$wg$aAutoimmune Diseases
=550  \\$wh$aHypoadrenocorticism, Familial
=680  \\$iAn adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.
=688  \\$a2005 (1963)
=750  \0$aAddison's disease$5IEN$0(DLC)sh 85000815

=LDR  00972cz  a2200193n  4500
=001  9880363234302441
=005  20141212191934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000335
=035  \\$aCAZ3483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x165.$x55.$x55
=150  \\$aAerosol Propellants
=450  \\$wnnna$aPropellants, Aerosol
=550  \\$wg$aAerosols
=667  \\$aIM; coord with propellant if relevant (IM); D25-26 qualif with discretion
=680  \\$iCompressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a91(73); was see under AEROSOLS 1973-90; was in Cat D & J 1973-82
=750  \0$aAerosol propellants$5IEN$0(DLC)sh 85001416

=LDR  00500cz  a2200181n  4500
=001  9880363234402441
=005  20141212194512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000334
=035  \\$aCAZ3482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x61
=150  \\$aAerophagy
=450  \\$aAir Swallowing
=450  \\$wnnna$aSwallowing, Air
=550  \\$wg$aSigns and Symptoms, Digestive
=680  \\$iSpasmodic swallowing of air.
=750  \0$aAerophagy$5IEN$0(DLC)sh 85001412

=LDR  00853cz  a2200217n  4500
=001  9880363234502441
=005  20180205110342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000333
=035  \\$aCAZ3481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x19.$x25
=150  \\$aAeromonas
=550  \\$wg$aAeromonadaceae
=550  \\$wh$aAeromonas caviae
=550  \\$wh$aAeromonas hydrophila
=550  \\$wh$aAeromonas salmonicida
=550  \\$wh$aAeromonas veronii
=667  \\$ain fish; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.
=750  \0$aAeromonas$5IEN$0(DLC)sh 85001304

=LDR  00696cz  a2200169n  4500
=001  9880363234602441
=005  20141212194511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x275.$x100
=150  \\$aAedes
=450  \\$wnnna$aAede
=550  \\$wg$aCulicidae
=667  \\$amosquito; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of mosquitoes (CULICIDAE) frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.
=750  \0$aAedes$5IEN$0(DLC)sh 85001226

=LDR  01517cz  a2200433n  4500
=001  9880363234702441
=005  20161017155619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000223
=035  \\$aCAZ3370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x58
=150  \\$aAdaptation, Psychological
=450  \\$wnnna$aAdaptation, Psychologic
=450  \\$wnnna$aAdaptive Behavior
=450  \\$wnnna$aAdaptive Behaviors
=450  \\$aAdjustment, Psychological
=450  \\$wnnna$aAdjustments, Psychological
=450  \\$aBehavior, Adaptive
=450  \\$wnnna$aBehavior, Coping
=450  \\$wnnna$aBehaviors, Adaptive
=450  \\$wnnna$aBehaviors, Coping
=450  \\$aCoping Behavior
=450  \\$wnnna$aCoping Behaviors
=450  \\$wnnna$aCoping Skill
=450  \\$wnnna$aCoping Skills
=450  \\$wnnna$aPsychologic Adaptation
=450  \\$wnnna$aPsychological Adaptation
=450  \\$wnnna$aSkill, Coping
=450  \\$wnnna$aSkills, Coping
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aFeedback, Psychological
=550  \\$wh$aOrientation
=550  \\$wh$aSense of Coherence
=550  \\$aAllostasis
=550  \\$aResilience, Psychological
=667  \\$ahuman & animal; DF: ADAPTATION PSYCHOL
=680  \\$iA state of harmony between internal needs and external demands and the processes used in achieving this condition. (From APA Thesaurus of Psychological Index Terms, 8th ed)
=750  \0$aAdaptability (Psychology)$5IEN-HS$0(DLC)sh 85000799

=LDR  00750cz  a2200229n  4500
=001  9880363234902441
=005  20141212191934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000328
=035  \\$aCAZ3476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x60.$x116
=150  \\$aAdult
=450  \\$wnnna$aAdults
=550  \\$wg$aAge Groups
=550  \\$wh$aAged
=550  \\$wh$aMiddle Aged
=550  \\$wh$aYoung Adult
=667  \\$aalmost always check tag: NIM no qualifiers; see Manual Chapter 9
=680  \\$iA person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
=688  \\$a66
=750  \0$aAdulthood$5IEN$0(DLC)sh 85001056

=LDR  00811cz  a2200229n  4500
=001  9880363681602441
=005  20141212204157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x852
=072  \\$aD3.$x383.$x564
=150  \\$aOxepins
=450  \\$wnnna$aOxepene
=450  \\$wnnna$aOxepenes
=450  \\$wnnna$aOxepin
=550  \\$wg$aEthers, Cyclic
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aDoxepin
=680  \\$iCompounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants.
=688  \\$a68
=750  \0$aOxepins$0(DLC)sh2007002601$5IEN-M

=LDR  01003cz  a2200313n  4500
=001  9880363681702441
=005  20141212204157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010080
=035  \\$aCBA3361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x462
=150  \\$aOxazoles
=450  \\$wnnna$a1,3-Oxazolium-5-Oxides
=450  \\$wnnna$a1,3 Oxazolium 5 Oxides
=450  \\$wnnna$aMunchnones
=550  \\$wg$aAzoles
=550  \\$wh$aAminorex
=550  \\$wh$aDimethadione
=550  \\$wh$aFura-2
=550  \\$wh$aMuscimol
=550  \\$wh$aOxadiazoles
=550  \\$wh$aOxazolidinones
=550  \\$wh$aOxazolone
=550  \\$wh$aPemoline
=550  \\$wh$aTrimethadione
=667  \\$aincludes oxazolines, oxazolidines
=680  \\$iFive-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions.
=750  \0$aOxazoles$5IEN$0(DLC)sh 85096293

=LDR  01087cz  a2200289n  4500
=001  9880363681802441
=005  20141212204154.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010070
=035  \\$aCBA3351HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x337.$x593
=150  \\$aOxalates
=450  \\$wnnna$aAcids, Ethanedioic
=450  \\$wnnna$aAcids, Oxalic
=450  \\$aCalcium Oxalate$xanalogs & derivatives
=450  \\$wnnna$aEthanedioic Acids
=450  \\$aOxalic Acid$xanalogs & derivatives
=450  \\$wnnna$aOxalic Acids
=550  \\$wg$aDicarboxylic Acids
=550  \\$wh$aOxalic Acid
=550  \\$wh$aOxaloacetates
=667  \\$a/urine: HYPEROXALURIA & HYPEROXALURIA, PRIMARY are also available
=680  \\$iDerivatives of OXALIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are derived from the ethanedioic acid structure.
=688  \\$a1966
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Oxalic Acids
=750  \0$aOxalates$5IEN$0(DLC)sh 87000414

=LDR  01246cz  a2200361n  4500
=001  9880363681902441
=005  20141212204152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010064
=035  \\$aCBA3345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x170.$x104.$x500
=150  \\$aEmbryo Implantation
=450  \\$aBlastocyst Implantation
=450  \\$wnnna$aBlastocyst Implantations
=450  \\$aDecidual Cell Reaction
=450  \\$wnnna$aDecidual Cell Reactions
=450  \\$wnnna$aEmbryo Implantations
=450  \\$aImplantation, Blastocyst
=450  \\$wnnna$aImplantation, Embryo
=450  \\$wnnna$aImplantation, Ovum
=450  \\$wnnna$aImplantations, Blastocyst
=450  \\$wnnna$aImplantations, Embryo
=450  \\$wnnna$aImplantations, Ovum
=450  \\$aNidation
=450  \\$wnnna$aNidations
=450  \\$aOvum Implantation
=450  \\$wnnna$aOvum Implantations
=550  \\$wg$aEmbryonic Development
=550  \\$wh$aEmbryo Implantation, Delayed
=680  \\$iEndometrial implantation of EMBRYO, MAMMALIAN at the BLASTOCYST stage.
=688  \\$a2003 (1985); for OVUM IMPLANTATION use NIDATION 1965-1984 (Prov 1965-1966)
=750  \0$aOvum implantation$5IEN$0(DLC)sh 85096272

=LDR  01082cz  a2200361n  4500
=001  9880363682002441
=005  20141212204151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010063
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490.$x690
=072  \\$aA11.$x497.$x497
=072  \\$aA16.$x690
=150  \\$aOvum
=360  \\$iconsider also terms at$aOO-
=450  \\$aEgg
=450  \\$wnnna$aEgg, Unfertilized
=450  \\$wnnna$aEggs, Unfertilized
=450  \\$wnnna$aOva
=450  \\$wnnna$aUnfertilized Egg
=450  \\$wnnna$aUnfertilized Eggs
=550  \\$wg$aEmbryonic Structures
=550  \\$wg$aGerm Cells
=550  \\$wh$aEgg Yolk
=550  \\$wh$aOocytes
=550  \\$wh$aOogonia
=550  \\$wh$aVitelline Membrane
=550  \\$wh$aZona Pellucida
=550  \\$wh$aZygote
=550  \\$aOvarian Follicle
=667  \\$adifferentiate from EGGS (Cat J2); /transpl is not implantation ( = OVUM IMPLANTATION)
=680  \\$iA mature haploid female germ cell extruded from the OVARY at OVULATION.
=750  \0$aOvum$5IEN$0(DLC)sh 85096271

=LDR  00841cz  a2200253n  4500
=001  9880363682102441
=005  20141212204151.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010062
=035  \\$aCBA3343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x800.$x984
=072  \\$aE5.$x820.$x800.$x984
=150  \\$aOvulation Induction
=450  \\$aOvarian Stimulation
=450  \\$wnnna$aOvarian Stimulations
=450  \\$wnnna$aStimulation, Ovarian
=450  \\$wnnna$aStimulations, Ovarian
=550  \\$wg$aReproductive Techniques, Assisted
=550  \\$wh$aSuperovulation
=550  \\$aOvarian Hyperstimulation Syndrome
=680  \\$iTechniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.
=688  \\$a1978
=750  \0$aOvulation$xInduction$5IEN$0(DLC)sh 85096268

=LDR  01267cz  a2200289n  4500
=001  9880363682202441
=005  20141212204151.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010061
=035  \\$aCBA3342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x530.$x550
=072  \\$aE2.$x875.$x690
=072  \\$aE5.$x820.$x690
=150  \\$aOvulation Detection
=450  \\$wnnna$aDetection, Ovulation
=450  \\$wnnna$aOvulation Detection, Basal Body Temperature Method
=450  \\$wnnna$aOvulation Detection, Cervical Mucus Method
=450  \\$wnnna$aOvulation Detection, Sympto-Thermal Method
=450  \\$wnnna$aOvulation Detection, Sympto Thermal Method
=450  \\$wnnna$aOvulation Detections
=550  \\$wg$aOvarian Function Tests
=550  \\$wg$aReproductive Techniques
=550  \\$aOvulation Prediction
=680  \\$iMethod to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus (CERVIX MUCUS), or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY.
=688  \\$a75
=750  \0$aOvulation$xDetection$5IEN$0(DLC)sh 85096267

=LDR  00631cz  a2200217n  4500
=001  9880363682302441
=005  20141212204150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010060
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x690
=150  \\$aOvulation
=450  \\$wnnna$aOvulations
=550  \\$wg$aReproduction
=550  \\$wh$aAnovulation
=550  \\$wh$aLuteinization
=550  \\$wh$aLuteolysis
=550  \\$wh$aOvulation Inhibition
=550  \\$wh$aSuperovulation
=680  \\$iThe discharge of an OVUM from a rupturing follicle in the OVARY.
=750  \0$aOvulation$5IEN$0(DLC)sh 85096266

=LDR  00822cz  a2200241n  4500
=001  9880363682402441
=005  20141212204150.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010059
=035  \\$aCBA3340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x256.$x317.$x675
=072  \\$aD12.$x776.$x290.$x675
=072  \\$aD12.$x776.$x395.$x560.$x760
=150  \\$aOvomucin
=450  \\$aOvomucoid
=550  \\$wg$aEgg Proteins
=550  \\$wg$aEgg Proteins, Dietary
=550  \\$wg$aMucoproteins
=667  \\$aa trypsin inhib; /drug eff /ultrastruct permitted
=680  \\$iA heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. It has trypsin-inhibiting activity.
=688  \\$a91(75); was see under EGG PROTEINS 1975-90
=750  \0$aOvomucoid$5IEN$0(DLC)sh 91000803

=LDR  00775cz  a2200193n  4500
=001  9880363682502441
=005  20141212204150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010057
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x706
=150  \\$aOviducts
=450  \\$wnnna$aOviduct
=550  \\$wg$aAnimal Structures
=550  \\$wh$aFallopian Tubes
=550  \\$aFallopian Tubes
=667  \\$anon-mammals only; mammals, use FALLOPIAN TUBES; disease probably GENITAL DISEASES, FEMALE + OVIDUCTS
=680  \\$iDucts that serve exclusively for the passage of eggs from the ovaries to the exterior of the body. In non-mammals, they are termed oviducts. In mammals, they are highly specialized and known as FALLOPIAN TUBES.
=750  \0$aOviduct$5IEN$0(DLC)sh 85096262

=LDR  01226cz  a2200241n  4500
=001  9880363682602441
=005  20141212204149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010053
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x114.$x630
=072  \\$aA5.$x360.$x576.$x497
=072  \\$aA6.$x407.$x312.$x497
=150  \\$aOvary
=360  \\$iconsider also terms at$aOOPHOR-$aTHEC-
=450  \\$wnnna$aOvaries
=550  \\$wg$aAdnexa Uteri
=550  \\$wg$aGonads
=550  \\$wh$aCorpus Luteum
=550  \\$wh$aOvarian Follicle
=667  \\$aOVARY, PLANT is also available; /surg permitted but is probably OVARIECTOMY; /abnorm: agenesis or dysgenesis: coord OVARY /abnorm (IM) with GONADAL DYSGENESIS (IM); /cytol: consider also THECA CELLS; inflammation = OOPHORITIS; polycystic ovary, sclerocystic ovary = POLYCYSTIC OVARY SYNDROME
=680  \\$iThe reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
=750  \0$aOvaries$5IEN$0(DLC)sh 85096184

=LDR  01083cz  a2200361n  4500
=001  9880363682702441
=005  20200623170955.0
=008  850607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010052
=035  \\$aCBA3333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x270.$x282.$x685
=072  \\$aE4.$x950.$x165.$x685
=072  \\$aE4.$x950.$x300.$x680
=150  \\$aOvariectomy
=450  \\$wnnna$aBilateral Ovariectomies
=450  \\$wnnna$aBilateral Ovariectomy
=450  \\$aCastration, Female
=450  \\$wnnna$aCastrations, Female
=450  \\$wnnna$aFemale Castration
=450  \\$wnnna$aFemale Castrations
=450  \\$wnnna$aOophorectomies
=450  \\$aOophorectomy
=450  \\$wnnna$aOvariectomies
=450  \\$wnnna$aOvariectomies, Bilateral
=450  \\$wnnna$aOvariectomy, Bilateral
=550  \\$wg$aCastration
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$wh$aSalpingo-oophorectomy
=550  \\$aOvary
=680  \\$iThe surgical removal of one or both ovaries.
=688  \\$a86
=750  \0$aOvariectomy$5IEN-M$0(DLC)sh 93001286

=LDR  01957cz  a2200553n  4500
=001  9880363682802441
=005  20141212204148.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010051
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x455
=072  \\$aC13.$x351.$x500.$x56.$x630.$x705
=072  \\$aC13.$x351.$x937.$x418.$x685
=072  \\$aC19.$x344.$x410
=072  \\$aC19.$x391.$x630.$x705
=150  \\$aOvarian Neoplasms
=450  \\$aCancer of Ovary
=450  \\$wnnna$aCancer of the Ovary
=450  \\$wnnna$aCancer, Ovarian
=450  \\$wnnna$aCancer, Ovary
=450  \\$wnnna$aCancers, Ovarian
=450  \\$wnnna$aCancers, Ovary
=450  \\$wnnna$aNeoplasm, Ovarian
=450  \\$wnnna$aNeoplasm, Ovary
=450  \\$wnnna$aNeoplasms, Ovarian
=450  \\$wnnna$aNeoplasms, Ovary
=450  \\$aOvarian Cancer
=450  \\$wnnna$aOvarian Cancers
=450  \\$wnnna$aOvarian Neoplasm
=450  \\$wnnna$aOvary Cancer
=450  \\$wnnna$aOvary Cancers
=450  \\$wnnna$aOvary Neoplasm
=450  \\$wnnna$aOvary Neoplasms
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aGenital Neoplasms, Female
=550  \\$wg$aOvarian Diseases
=550  \\$wh$aBrenner Tumor
=550  \\$wh$aCarcinoma, Endometrioid
=550  \\$wh$aGranulosa Cell Tumor
=550  \\$wh$aHereditary Breast and Ovarian Cancer Syndrome
=550  \\$wh$aLuteoma
=550  \\$wh$aMeigs Syndrome
=550  \\$wh$aSertoli-Leydig Cell Tumor
=550  \\$wh$aThecoma
=550  \\$aGerminoma
=667  \\$acoordinate IM with histologic type of neoplasm (IM)
=680  \\$iTumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
=750  \0$aOvaries$xCancer$5IEN-M$0(DLC)sh2010104661
=750  \0$aOvaries$xTumors$5IEN-HS$0(DLC)sh 85096187

=LDR  00949cz  a2200313n  4500
=001  9880363682902441
=005  20141212204147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010049
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x630
=072  \\$aC19.$x391.$x630
=150  \\$aOvarian Diseases
=450  \\$wnnna$aDisease, Ovarian
=450  \\$wnnna$aDiseases, Ovarian
=450  \\$wnnna$aOvarian Disease
=550  \\$wg$aAdnexal Diseases
=550  \\$wg$aGonadal Disorders
=550  \\$wh$aAnovulation
=550  \\$wh$aMenopause, Premature
=550  \\$wh$aOophoritis
=550  \\$wh$aOvarian Cysts
=550  \\$wh$aOvarian Hyperstimulation Syndrome
=550  \\$wh$aOvarian Neoplasms
=550  \\$wh$aPrimary Ovarian Insufficiency
=667  \\$ainflammatory disease = OOPHORITIS
=680  \\$iPathological processes of the OVARY.
=688  \\$a66
=750  \0$aOvaries$xDiseases$5IEN$0(DLC)sh 85096185

=LDR  01013cz  a2200313n  4500
=001  9880363683002441
=005  20141212204147.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010048
=035  \\$aCBA3329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x612
=072  \\$aC13.$x351.$x500.$x56.$x630.$x580
=072  \\$aC19.$x391.$x630.$x580
=150  \\$aOvarian Cysts
=450  \\$aCorpus Luteum Cyst
=450  \\$wnnna$aCorpus Luteum Cysts
=450  \\$wnnna$aCyst, Corpus Luteum
=450  \\$wnnna$aCyst, Ovarian
=450  \\$wnnna$aCysts, Corpus Luteum
=450  \\$wnnna$aCysts, Ovarian
=450  \\$wnnna$aOvarian Cyst
=550  \\$wg$aCysts
=550  \\$wg$aOvarian Diseases
=550  \\$wh$aPolycystic Ovary Syndrome
=667  \\$anon-neoplastic; POLYCYSTIC OVARY SYNDROME is also available
=680  \\$iGeneral term for CYSTS and cystic diseases of the OVARY.
=688  \\$a68; CORPUS LUTEUM CYST was heading 1963-84
=750  \0$aOvaries$xCysts$5IEN-M$0(DLC)sh 97002800

=LDR  01098cz  a2200301n  4500
=001  9880363683102441
=005  20141212204146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010044
=035  \\$aCBA3325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35.$x380
=072  \\$aN2.$x278.$x354.$x422.$x527
=072  \\$aN4.$x452.$x442.$x422.$x527
=150  \\$aOutpatient Clinics, Hospital
=450  \\$aAmbulatory Care Facilities, Hospital
=450  \\$wnnna$aClinic, Hospital Outpatient
=450  \\$wnnna$aClinics, Hospital Outpatient
=450  \\$wnnna$aHospital Outpatient Clinic
=450  \\$aHospital Outpatient Clinics
=450  \\$wnnna$aOutpatient Clinic, Hospital
=550  \\$wg$aAmbulatory Care Facilities
=550  \\$wg$aHospital Departments
=550  \\$wh$aPain Clinics
=667  \\$aIM
=680  \\$iOrganized services in a hospital which provide medical care on an outpatient basis.
=688  \\$a78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67
=750  \0$aHospitals$xOutpatient services$5IEN$0(DLC)sh 85062346

=LDR  01280cz  a2200421n  4500
=001  9880363683302441
=005  20141212204145.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010041
=035  \\$aCBA3322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x550.$x600
=150  \\$aOtters
=450  \\$aAonyx
=450  \\$wnnna$aClawless Otter
=450  \\$aClawless Otters
=450  \\$wnnna$aEnhydra lutris
=450  \\$wnnna$aGiant Otter
=450  \\$aGiant Otters
=450  \\$aLontra
=450  \\$wnnna$aLontra canadensis
=450  \\$aLutra
=450  \\$wnnna$aNorth American River Otter
=450  \\$wnnna$aOtter
=450  \\$wnnna$aOtter, Clawless
=450  \\$wnnna$aOtter, Giant
=450  \\$wnnna$aOtter, Sea
=450  \\$wnnna$aOtters, Clawless
=450  \\$wnnna$aOtters, Giant
=450  \\$wnnna$aOtters, Sea
=450  \\$aPteronura
=450  \\$wnnna$aSea Otter
=450  \\$aSea Otters
=550  \\$wg$aMustelidae
=667  \\$ado not confuse entry term ENHYDRA LUTRIS with ENHYDRA FLUCTUANS see ASTERACEAE
=680  \\$iFish-eating carnivores of the family MUSTELIDAE, found on both hemispheres.
=688  \\$a91(75); was see under CARNIVORA 1975-90
=750  \0$aOtters$5IEN$0(DLC)sh 85096097

=LDR  00772cz  a2200193n  4500
=001  9880363683402441
=005  20141212204144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010040
=035  \\$aCBA3321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x768
=150  \\$aOtosclerosis
=450  \\$wnnna$aOtoscleroses
=450  \\$wnnna$aOtospongioses
=450  \\$aOtospongiosis
=550  \\$wg$aEar Diseases
=680  \\$iFormation of spongy bone in the labyrinth capsule which can progress toward the STAPES (stapedial fixation) or anteriorly toward the COCHLEA leading to conductive, sensorineural, or mixed HEARING LOSS. Several genes are associated with familial otosclerosis with varied clinical signs.
=750  \0$aOtosclerosis$5IEN$0(DLC)sh 85096075

=LDR  01689cz  a2200481n  4500
=001  9880363683502441
=005  20141212204143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010038
=035  \\$aCBA3319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9
=150  \\$aOtorhinolaryngologic Diseases
=450  \\$wnnna$aDisease, ENT
=450  \\$wnnna$aDisease, Otolaryngologic
=450  \\$wnnna$aDisease, Otolaryngological
=450  \\$wnnna$aDisease, Otorhinolaryngologic
=450  \\$wnnna$aDisease, Otorhinolaryngological
=450  \\$wnnna$aDiseases, ENT
=450  \\$wnnna$aDiseases, Otolaryngologic
=450  \\$wnnna$aDiseases, Otolaryngological
=450  \\$wnnna$aDiseases, Otorhinolaryngologic
=450  \\$wnnna$aDiseases, Otorhinolaryngological
=450  \\$wnnna$aENT Disease
=450  \\$wnnna$aENT Diseases
=450  \\$wnnna$aOtolaryngologic Disease
=450  \\$aOtolaryngologic Diseases
=450  \\$wnnna$aOtolaryngological Disease
=450  \\$wnnna$aOtolaryngological Diseases
=450  \\$wnnna$aOtorhinolaryngologic Disease
=450  \\$wnnna$aOtorhinolaryngological Disease
=450  \\$wnnna$aOtorhinolaryngological Diseases
=550  \\$wh$aCiliary Motility Disorders
=550  \\$wh$aEar Diseases
=550  \\$wh$aLaryngeal Diseases
=550  \\$wh$aNose Diseases
=550  \\$wh$aOtorhinolaryngologic Neoplasms
=550  \\$wh$aPharyngeal Diseases
=550  \\$aOtolaryngology
=667  \\$ageneral; prefer specifics; DF: ORL DIS
=680  \\$iPathological processes of the ear, the nose, and the throat, also known as the ENT diseases.
=688  \\$a66
=750  \0$aOtolaryngology$5IEN-HS$0(DLC)sh 85096050

=LDR  01140cz  a2200277n  4500
=001  9880363683602441
=005  20141212204143.0
=008  820422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010037
=035  \\$aCBA3318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x909.$x625.$x125.$x680
=150  \\$aOtolithic Membrane
=450  \\$wnnna$aMembrane, Otolithic
=450  \\$wnnna$aMembranes, Otolithic
=450  \\$aOtoconia
=450  \\$wnnna$aOtoconias
=450  \\$wnnna$aOtolith
=450  \\$wnnna$aOtolithic Membranes
=450  \\$aOtoliths
=450  \\$aStatoconia
=450  \\$wnnna$aStatoconias
=550  \\$wg$aAcoustic Maculae
=680  \\$iA gelatinous membrane overlying the acoustic maculae of SACCULE AND UTRICLE. It contains minute crystalline particles (otoliths) of CALCIUM CARBONATE and protein on its outer surface. In response to head movement, the otoliths shift causing distortion of the vestibular hair cells which transduce nerve signals to the BRAIN for interpretation of equilibrium.
=688  \\$a91(83); was see under SACCULE AND UTRICLE 1983-90
=750  \0$aOtoliths$5IEN$0(DLC)sh 85096060

=LDR  00968cz  a2200277n  4500
=001  9880363683702441
=005  20180928121744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010036
=035  \\$aCBA3317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x526
=150  \\$aOtolaryngology
=450  \\$wnnna$aLaryngology
=450  \\$aOtology
=450  \\$aOtorhinolaryngology
=550  \\$wg$aSpecialties, Surgical
=550  \\$wh$aNeurotology
=550  \\$aAudiology
=550  \\$aNasal Surgical Procedures
=550  \\$aOtologic Surgical Procedures
=550  \\$aOtorhinolaryngologic Surgical Procedures
=667  \\$ause for the specialty only; corresponding disease term is OTOLARYNGOLOGIC DISEASES or specifics
=680  \\$iA surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat.
=688  \\$a80; was OTORHINOLARYNGOLOGY 1963-79
=750  \0$aOtolaryngology$0(DLC)sh 85096050$5IEN-M

=LDR  01038cz  a2200301n  4500
=001  9880363683802441
=005  20141212204142.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010034
=035  \\$aCBA3315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x705.$x663.$x683
=150  \\$aOtitis Media with Effusion
=450  \\$wnnna$aEar Effusion, Middle
=450  \\$wnnna$aEar Effusions, Middle
=450  \\$wnnna$aEffusion, Middle Ear
=450  \\$wnnna$aEffusions, Middle Ear
=450  \\$aMiddle Ear Effusion
=450  \\$wnnna$aMiddle Ear Effusions
=450  \\$aOtitis Media, Secretory
=450  \\$aOtitis Media, Serous
=450  \\$wnnna$aSecretory Otitis Media
=450  \\$wnnna$aSerous Otitis Media
=550  \\$wg$aOtitis Media
=667  \\$anonsuppurative otitis media
=680  \\$iInflammation of the middle ear with a clear pale yellow-colored transudate.
=688  \\$a86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85
=750  \0$aOtitis media with effusion$5IEN$0(DLC)sh 86005781

=LDR  01133cz  a2200289n  4500
=001  9880363683902441
=005  20141212204050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009874
=035  \\$aCBA3150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x333
=072  \\$aL1.$x906.$x575
=150  \\$aOperations Research
=450  \\$wnnna$aResearch, Operations
=550  \\$wg$aResearch
=550  \\$wg$aSystems Analysis
=550  \\$wh$aMonte Carlo Method
=550  \\$wh$aProbability Theory
=550  \\$wh$aProgramming, Linear
=550  \\$aDecision Theory
=550  \\$aGame Theory
=550  \\$aInformation Theory
=667  \\$ano qualif
=680  \\$iA group of techniques developed to apply scientific methods and tools to solve the problems of DECISION MAKING in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting GOALS and makes use of mathematical models from which solutions for actual problems may be derived. (From Psychiatric Dictionary, 6th ed)
=688  \\$a66
=750  \0$aOperations research$5IEN$0(DLC)sh 85095020

=LDR  00605cz  a2200205n  4500
=001  9880363684002441
=005  20141212204050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009873
=035  \\$aCBA3149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x700
=150  \\$aOperating Rooms
=450  \\$wnnna$aOperating Room
=450  \\$wnnna$aRoom, Operating
=450  \\$wnnna$aRooms, Operating
=550  \\$wg$aHospital Units
=550  \\$aSurgical Procedures, Operative
=680  \\$iFacilities equipped for performing surgery.
=750  \0$aOperating rooms$0(DLC) sh 85094979$5IEN

=LDR  00730cz  a2200217n  4500
=001  9880363684102441
=005  20141212204050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009872
=035  \\$aCBA3148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x700
=072  \\$aN2.$x360.$x67.$x700
=150  \\$aOperating Room Technicians
=450  \\$wnnna$aOperating Room Technician
=450  \\$wnnna$aTechnician, Operating Room
=450  \\$wnnna$aTechnicians, Operating Room
=550  \\$wg$aAllied Health Personnel
=680  \\$iSpecially trained personnel to assist in routine technical procedures in the operating room.
=688  \\$a71
=750  \0$aOperating room technicians$5IEN$0(DLC)sh 85094978

=LDR  00721cz  a2200217n  4500
=001  9880363684202441
=005  20141212204050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009871
=035  \\$aCBA3147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x650.$x625
=072  \\$aN2.$x421.$x533.$x710.$x625
=150  \\$aOperating Room Nursing
=450  \\$wnnna$aNursing, Operating Room
=550  \\$wg$aPerioperative Nursing
=550  \\$aPerioperative Nursing
=667  \\$aa nurs SPEC: a type of PERIOPERATIVE NURSING; DF: OPERATING ROOM NURS
=680  \\$iThe functions of the professional nurse in the operating room.
=688  \\$a74
=750  \0$aOperating room nursing$5IEN$0(DLC)sh 85094975

=LDR  00653cz  a2200193n  4500
=001  9880363684302441
=005  20141212204049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x56.$x630.$x450
=072  \\$aC13.$x351.$x500.$x56.$x750.$x500
=072  \\$aC19.$x391.$x630.$x450
=150  \\$aOophoritis
=450  \\$wnnna$aOophoritides
=550  \\$wg$aOvarian Diseases
=550  \\$wg$aPelvic Inflammatory Disease
=680  \\$iInflammation of the OVARY, generally caused by an ascending infection of organisms from the endocervix.
=750  \0$aOophoritis$0(DLC)sh2005006502$5IEN-M

=LDR  01446cz  a2200301n  4500
=001  9880363684402441
=005  20141212204049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009868
=035  \\$aCBA3144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937
=150  \\$aOomycetes
=450  \\$wnnna$aOomycete
=450  \\$aOomycota
=450  \\$wnnna$aOomycotas
=550  \\$wg$aStramenopiles
=550  \\$wh$aAchlya
=550  \\$wh$aAphanomyces
=550  \\$wh$aLagenidium
=550  \\$wh$aPeronospora
=550  \\$wh$aPhytophthora
=550  \\$wh$aPythium
=550  \\$wh$aSaprolegnia
=667  \\$ageneral or unspecified; prefer specifics; infection: coordinate IM with INFECTION (IM)
=680  \\$iEukaryotes in the group STRAMENOPILES, formerly considered FUNGI, whose exact taxonomic level is unsettled. Many consider Oomycetes (Oomycota) a phylum in the kingdom Stramenopila, or alternatively, as Pseudofungi in the phylum Heterokonta of the kingdom Chromista. They are morphologically similar to fungi but have no close phylogenetic relationship to them. Oomycetes are found in both fresh and salt water as well as in terrestrial environments. (Alexopoulos et al., Introductory Mycology, 4th ed, pp683-4). They produce flagellated, actively motile spores (zoospores) that are pathogenic to many crop plants and FISHES.
=688  \\$a91(75); use FUNGI 1972-74
=750  \0$aOomycetes$5IEN$0(DLC)sh 85094852

=LDR  00686cz  a2200205n  4500
=001  9880363684502441
=005  20141212204048.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x650.$x249
=072  \\$aG8.$x686.$x785.$x760.$x310.$x500
=150  \\$aOogenesis
=450  \\$wnnna$aOogeneses
=550  \\$wg$aGametogenesis
=550  \\$wh$aVitellogenesis
=550  \\$aIn Vitro Oocyte Maturation Techniques
=680  \\$iThe process of germ cell development in the female from the primordial germ cells through OOGONIA to the mature haploid ova (OVUM).
=688  \\$a75
=750  \0$aOogenesis$5IEN$0(DLC)sh 85094847

=LDR  00593cz  a2200217n  4500
=001  9880363684602441
=005  20141212192407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x500.$x280
=072  \\$aI1.$x880.$x853.$x150.$x500.$x280
=150  \\$aOnly Child
=450  \\$wnnna$aChild, Only
=450  \\$wnnna$aChildren, Only
=450  \\$wnnna$aOnly Children
=550  \\$wg$aNuclear Family
=550  \\$aChild
=680  \\$iChild who has no siblings.
=688  \\$a68
=750  \0$aOnly child$5IEN$0(DLC)sh 85094805

=LDR  01161cz  a2200301n  4500
=001  9880363684702441
=005  20141212204047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009862
=035  \\$aCBA3138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300.$x742
=150  \\$aOnline Systems
=450  \\$wnnna$aOn-Line System
=450  \\$aOn-Line Systems
=450  \\$wnnna$aOn Line Systems
=450  \\$wnnna$aOnline System
=450  \\$wnnna$aSystem, On-Line
=450  \\$wnnna$aSystem, Online
=450  \\$wnnna$aSystems, On-Line
=450  \\$wnnna$aSystems, Online
=550  \\$wg$aInformation Systems
=550  \\$wh$aLibraries, Digital
=550  \\$wh$aPubMed
=667  \\$aIM; coord with discipline, site or application where used (IM)
=680  \\$iSystems where the input data enter the computer directly from the point of origin (usually a terminal or workstation) and/or in which output data are transmitted directly to that terminal point of origin. (Sippl, Computer Dictionary, 4th ed)
=688  \\$a79; was ON LINE SYSTEMS 1971-78 (Prov 1971-73)
=750  \0$aOnline data processing$5IEN-M$0(DLC)sh 85094711

=LDR  00793cz  a2200217n  4500
=001  9880363684802441
=005  20141212204047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009861
=035  \\$aCBA3137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x675
=150  \\$aOnium Compounds
=450  \\$wnnna$aCompounds, Onium
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aQuaternary Ammonium Compounds
=550  \\$wh$aSulfonium Compounds
=667  \\$aDF: ONIUM CPDS
=680  \\$iIons with the suffix -onium, indicating cations with coordination number 4 of the type RxA+ which are analogous to QUATERNARY AMMONIUM COMPOUNDS (H4N+). Ions include phosphonium R4P+, oxonium R3O+, sulfonium R3S+, chloronium R2Cl+
=688  \\$a68
=750  \0$aOnium ions$5IEN$0(DLC)sh 97008022

=LDR  01099cz  a2200301n  4500
=001  9880363684902441
=005  20141212204047.0
=008  840411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009859
=035  \\$aCBA3135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x605
=072  \\$aN2.$x421.$x533.$x600
=150  \\$aOncology Nursing
=450  \\$wnnna$aCancer Nursing
=450  \\$wnnna$aNursing, Cancer
=450  \\$aNursing, Oncologic
=450  \\$wnnna$aNursing, Oncological
=450  \\$wnnna$aNursing, Oncology
=450  \\$aOncologic Nursing
=450  \\$wnnna$aOncological Nursing
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$ause ONCOLOGY NURSING for the nursing specialty; use NEOPLASMS/nurs for the patient
=680  \\$iA nursing specialty concerned with the care provided to cancer patients. It includes aspects of family functioning through education of both patient and family.
=688  \\$a85
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Oncologic Nursing
=750  \0$aCancer$xNursing$5IEN$0(DLC)sh 85019516

=LDR  00956cz  a2200313n  4500
=001  9880363685002441
=005  20160912153750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009858
=035  \\$aCBA3134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x613
=150  \\$aOncogenic Viruses
=450  \\$wnnna$aOncogenic Virus
=450  \\$wnnna$aTumor Virus
=450  \\$aTumor Viruses
=450  \\$wnnna$aVirus, Oncogenic
=450  \\$wnnna$aVirus, Tumor
=450  \\$wnnna$aViruses, Oncogenic
=450  \\$wnnna$aViruses, Tumor
=550  \\$wg$aViruses
=550  \\$wh$aDNA Tumor Viruses
=550  \\$wh$aRetroviridae
=550  \\$aCarcinogens
=550  \\$aNeoplasms
=667  \\$avertebrate viruses producing tumors; infection = TUMOR VIRUS INFECTIONS (IM) + neopl terms if pertinent
=680  \\$iViruses that produce tumors.
=688  \\$a66; was TUMOR VIRUSES 1963-65
=750  \0$aOncogenic viruses$5IEN$0(DLC)sh 85094722

=LDR  01339cz  a2200241n  4500
=001  9880363685102441
=005  20141212204046.0
=008  820422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009857
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500
=150  \\$aOncogenes
=450  \\$wnnna$aGene, Transforming
=450  \\$wnnna$aGenes, Transforming
=450  \\$wnnna$aOncogene
=450  \\$wnnna$aTransforming Gene
=450  \\$aTransforming Genes
=550  \\$wg$aGenes, Neoplasm
=550  \\$wh$aProto-Oncogenes
=667  \\$a"oncogene" used by author may refer to ONCOGENES or PROTO-ONCOGENES; do not confuse with ONCOGENS see CARCINOGENS; Manual 24.4.4.3; do not confuse with GENES, NEOPLASM
=680  \\$iGenes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene.
=688  \\$a83
=750  \0$aOncogenes$5IEN$0(DLC)sh 85094721

=LDR  00844cz  a2200229n  4500
=001  9880363685202441
=005  20141212204045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009855
=035  \\$aCBA3131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x750.$x361.$x699
=072  \\$aC3.$x858.$x650
=072  \\$aC17.$x800.$x838.$x775.$x690
=150  \\$aOnchocerciasis
=450  \\$wnnna$aOnchocerciases
=550  \\$wg$aFilariasis
=550  \\$wg$aSkin Diseases, Parasitic
=550  \\$wh$aOnchocerciasis, Ocular
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iInfection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.
=750  \0$aOnchocerciasis$5IEN$0(DLC)sh 85094719

=LDR  00816cz  a2200193n  4500
=001  9880363685302441
=005  20141212204045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009854
=035  \\$aCBA3130HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300.$x510
=150  \\$aOnchocerca
=450  \\$wnnna$aOnchocercas
=550  \\$wg$aFilarioidea
=550  \\$wh$aOnchocerca volvulus
=667  \\$ainfection = ONCHOCERCIASIS; coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent; /drug eff: consider FILARICIDES
=680  \\$iA genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum.
=750  \0$aOnchocerca$5IEN$0(DLC)sh 88021643

=LDR  01072cz  a2200289n  4500
=001  9880363685402441
=005  20141212204045.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009853
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x640.$x74.$x500
=072  \\$aD3.$x383.$x725.$x24.$x500
=072  \\$aD3.$x438.$x103.$x34.$x500
=150  \\$aOmeprazole
=450  \\$wnnna$aH 168-68
=450  \\$wnnna$aH 168 68
=450  \\$wnnna$aH 16868
=450  \\$wnnna$aMagnesium, Omeprazole
=450  \\$wnnna$aOmeprazole Magnesium
=450  \\$wnnna$aOmeprazole Sodium
=450  \\$wnnna$aPrilosec
=450  \\$wnnna$aSodium, Omeprazole
=550  \\$wg$a2-Pyridinylmethylsulfinylbenzimidazoles
=550  \\$wh$aEsomeprazole
=680  \\$iA 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
=688  \\$a87
=750  \0$aOmeprazole$5IEN-M$0(DLC)sh 95003436

=LDR  00633cz  a2200169n  4500
=001  9880363685502441
=005  20141212204044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009852
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x25.$x600.$x573
=150  \\$aOmentum
=450  \\$wnnna$aOmentums
=550  \\$wg$aPeritoneum
=667  \\$adis: coord IM with PERITONEAL DISEASES (IM); neopl: coord IM with PERITONEAL NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iA double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY.
=750  \0$aOmentum$5IEN$0(DLC)sh 85094688

=LDR  04036cz  a2200829n  4500
=001  9880363685602441
=005  20141212204044.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009849
=035  \\$aCBA3125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x612.$x600
=072  \\$aC10.$x228.$x140.$x252.$x700.$x650
=072  \\$aC10.$x228.$x662.$x550.$x600
=072  \\$aC10.$x228.$x854.$x787.$x750
=072  \\$aC10.$x574.$x500.$x825.$x650
=072  \\$aC10.$x574.$x625.$x600
=072  \\$aC10.$x574.$x750
=072  \\$aC16.$x320.$x400.$x780.$x750
=150  \\$aOlivopontocerebellar Atrophies
=450  \\$wnnna$aAtaxia, Presenile
=450  \\$wnnna$aAtaxias, Presenile
=450  \\$wnnna$aAtrophy, Familial Olivopontocerebellar
=450  \\$wnnna$aAtrophy, Idiopathic Olivopontocerebellar
=450  \\$wnnna$aAtrophy, Inherited Olivopontocerebellar
=450  \\$wnnna$aAtrophy, Nonfamilial Olivopontocerebellar
=450  \\$wnnna$aAtrophy, Olivo-Ponto-Cerebellar
=450  \\$wnnna$aAtrophy, Olivopontocerebellar
=450  \\$wnnna$aAtrophy, Pontoolivocerebellar
=450  \\$wnnna$aDegeneration, Olivo-Ponto-Cerebellar
=450  \\$wnnna$aDegeneration, Olivopontocerebellar
=450  \\$wnnna$aDegenerations, Olivo-Ponto-Cerebellar
=450  \\$wnnna$aDegenerations, Olivopontocerebellar
=450  \\$aDejerine-Thomas Syndrome
=450  \\$wnnna$aDejerine Thomas Syndrome
=450  \\$wnnna$aFamilial Olivopontocerebellar Atrophies
=450  \\$wnnna$aFamilial Olivopontocerebellar Atrophy
=450  \\$wnnna$aIdiopathic Olivopontocerebellar Atrophies
=450  \\$wnnna$aIdiopathic Olivopontocerebellar Atrophy
=450  \\$wnnna$aInherited Olivopontocerebellar Atrophies
=450  \\$wnnna$aInherited Olivopontocerebellar Atrophy
=450  \\$wnnna$aNonfamilial Olivopontocerebellar Atrophies
=450  \\$wnnna$aNonfamilial Olivopontocerebellar Atrophy
=450  \\$wnnna$aOlivo-Ponto-Cerebellar Atrophy
=450  \\$wnnna$aOlivo Ponto Cerebellar Atrophy
=450  \\$wnnna$aOlivo-Ponto-Cerebellar Degeneration
=450  \\$wnnna$aOlivo Ponto Cerebellar Degeneration
=450  \\$wnnna$aOlivo-Ponto-Cerebellar Degenerations
=450  \\$wnnna$aOlivopontocerebellar Atrophies, Familial
=450  \\$wnnna$aOlivopontocerebellar Atrophies, Idiopathic
=450  \\$wnnna$aOlivopontocerebellar Atrophies, Inherited
=450  \\$wnnna$aOlivopontocerebellar Atrophies, Nonfamilial
=450  \\$wnnna$aOlivopontocerebellar Atrophy
=450  \\$wnnna$aOlivopontocerebellar Atrophy, Familial
=450  \\$aOlivopontocerebellar Atrophy, Idiopathic
=450  \\$wnnna$aOlivopontocerebellar Atrophy, Inherited
=450  \\$wnnna$aOlivopontocerebellar Atrophy, Nonfamilial
=450  \\$wnnna$aOlivopontocerebellar Degeneration
=450  \\$wnnna$aOlivopontocerebellar Degenerations
=450  \\$wnnna$aPontoolivocerebellar Atrophies
=450  \\$wnnna$aPontoolivocerebellar Atrophy
=450  \\$wnnna$aPresenile Ataxia
=450  \\$wnnna$aPresenile Ataxias
=450  \\$wnnna$aSyndrome, Dejerine-Thomas
=550  \\$wg$aMultiple System Atrophy
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wg$aSpinocerebellar Degenerations
=550  \\$aMultiple System Atrophy
=667  \\$aDF: OPCA
=680  \\$iA group of inherited and sporadic disorders which share progressive ataxia in combination with atrophy of the CEREBELLUM; PONS; and inferior olivary nuclei. Additional clinical features may include MUSCLE RIGIDITY; NYSTAGMUS, PATHOLOGIC; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; and OPHTHALMOPLEGIA. The familial form has an earlier onset (second decade) and may feature spinal cord atrophy. The sporadic form tends to present in the fifth or sixth decade, and is considered a clinical subtype of MULTIPLE SYSTEM ATROPHY. (From Adams et al., Principles of Neurology, 6th ed, p1085)
=688  \\$a2000(1987)
=750  \0$aOlivopontocerebellar atrophies$5IEN$0(DLC)sh 85094630

=LDR  00755cz  a2200241n  4500
=001  9880363685702441
=005  20141212192406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009847
=035  \\$aCBA3123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x406.$x574
=072  \\$aA8.$x186.$x211.$x865.$x467.$x500.$x574
=150  \\$aOlivary Nucleus
=450  \\$aBasal Nucleus, Olivary
=450  \\$wnnna$aBasalis, Olivary Nucleus
=450  \\$aNucleus Basalis, Olivary
=450  \\$wnnna$aNucleus, Olivary
=450  \\$wnnna$aNucleus, Olivary Basal
=450  \\$wnnna$aOlivary Basal Nucleus
=550  \\$wg$aMedulla Oblongata
=550  \\$aSuperior Olivary Complex
=750  \0$aOlivary nucleus$5IEN$0(DLC)sh 85094610

=LDR  00806cz  a2200229n  4500
=001  9880363685802441
=005  20141212204042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009846
=035  \\$aCBA3122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x600
=072  \\$aC13.$x351.$x968.$x934.$x600
=072  \\$aC23.$x888.$x942.$x400
=150  \\$aOliguria
=450  \\$wnnna$aOligurias
=550  \\$wg$aUrination Disorders
=550  \\$wg$aUrological Manifestations
=667  \\$ado not confuse with ANURIA
=680  \\$iDecreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.
=688  \\$a91(75); was see under ANURIA 1975-90
=750  \0$aOliguria$5IEN$0(DLC)sh 85094607

=LDR  01004cz  a2200289n  4500
=001  9880363685902441
=005  20141212204042.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009845
=035  \\$aCBA3121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x365.$x700.$x508
=150  \\$aOligospermia
=450  \\$wnnna$aCount, Low Sperm
=450  \\$wnnna$aCounts, Low Sperm
=450  \\$wnnna$aHypospermatogenesis
=450  \\$aLow Sperm Count
=450  \\$wnnna$aLow Sperm Counts
=450  \\$wnnna$aOligozoospermia
=450  \\$wnnna$aSperm Count, Low
=450  \\$wnnna$aSperm Counts, Low
=550  \\$wg$aInfertility, Male
=550  \\$aSperm Count
=550  \\$aSpermatozoa
=680  \\$iA condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen.
=688  \\$a75
=750  \0$aOligospermia$5IEN$0(DLC)sh 85094606

=LDR  00754cz  a2200205n  4500
=001  9880363686002441
=005  20141212204041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009844
=035  \\$aCBA3120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629
=150  \\$aOligosaccharides
=550  \\$wg$aPolysaccharides
=550  \\$wh$aDisaccharides
=550  \\$wh$aOligosaccharides, Branched-Chain
=550  \\$wh$aTrisaccharides
=667  \\$aGEN; prefer specifics
=680  \\$iCarbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form.
=750  \0$aOligosaccharides$5IEN$0(DLC)sh 85094605

=LDR  01577cz  a2200493n  4500
=001  9880363686102441
=005  20141212204041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009842
=035  \\$aCBA3118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456
=150  \\$aOligopeptides
=550  \\$wg$aPeptides
=550  \\$wh$aAmanitins
=550  \\$wh$aAngiotensins
=550  \\$wh$aAntipain
=550  \\$wh$aBradykinin
=550  \\$wh$aCeruletide
=550  \\$wh$aChalones
=550  \\$wh$aDelta Sleep-Inducing Peptide
=550  \\$wh$aDipeptides
=550  \\$wh$aGlutathione
=550  \\$wh$aGonadotropin-Releasing Hormone
=550  \\$wh$aLeupeptins
=550  \\$wh$aN-Formylmethionine Leucyl-Phenylalanine
=550  \\$wh$aNetropsin
=550  \\$wh$aPentagastrin
=550  \\$wh$aPepstatins
=550  \\$wh$aPeptichemio
=550  \\$wh$aPeptide T
=550  \\$wh$aPhalloidine
=550  \\$wh$aTachykinins
=550  \\$wh$aTechnetium Tc 99m Mertiatide
=550  \\$wh$aTeprotide
=550  \\$wh$aTetragastrin
=550  \\$wh$aThymic Factor, Circulating
=550  \\$wh$aThyrotropin-Releasing Hormone
=550  \\$wh$aTuftsin
=550  \\$wh$aVasopressins
=667  \\$a2-12 amino acids (includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.); GEN; prefer specifics; conformation: coord OLIGOPEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM)
=680  \\$iPeptides composed of between two and twelve amino acids.
=688  \\$a73
=750  \0$aOligopeptides$5IEN$0(DLC)sh 85094603

=LDR  01060cz  a2200289n  4500
=001  9880363686202441
=005  20180212125850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009841
=035  \\$aCBA3117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x695.$x578.$x424
=150  \\$aOligonucleotides
=550  \\$wg$aPolynucleotides
=550  \\$wh$aAntagomirs
=550  \\$wh$aAptamers, Nucleotide
=550  \\$wh$aMorpholinos
=550  \\$wh$aOligodeoxyribonucleotides
=550  \\$wh$aOligonucleotides, Antisense
=550  \\$wh$aOligoribonucleotides
=550  \\$wh$aPeptide Nucleic Acids
=550  \\$wh$aPhosphorothioate Oligonucleotides
=550  \\$wh$aPyrimidine Dimers
=667  \\$a2-12 nucleotides
=680  \\$iPolymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed)
=688  \\$a74(72)
=750  \2$aOligonucleotides$0(DLC) sh 91002011$5IEN

=LDR  01725cz  a2200385n  4500
=001  9880363686302441
=005  20141212204038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009836
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637.$x600
=072  \\$aA11.$x650.$x600
=150  \\$aOligodendroglia
=450  \\$aInterfascicular Oligodendroglia
=450  \\$wnnna$aInterfascicular Oligodendroglias
=450  \\$wnnna$aOligodendrocyte
=450  \\$wnnna$aOligodendrocyte, Perineuronal Satellite
=450  \\$aOligodendrocytes
=450  \\$wnnna$aOligodendrocytes, Perineuronal Satellite
=450  \\$wnnna$aOligodendroglia, Interfascicular
=450  \\$wnnna$aOligodendroglia, Perineuronal
=450  \\$wnnna$aOligodendroglia, Perivascular
=450  \\$aPerineuronal Oligodendroglia
=450  \\$wnnna$aPerineuronal Satellite Oligodendrocyte
=450  \\$wnnna$aPerineuronal Satellite Oligodendrocytes
=450  \\$aPerineuronal Satellite Oligodendroglia Cells
=450  \\$aPerivascular Oligodendroglia
=450  \\$aSatellite Cells, Perineuronal, Oligodendroglia
=450  \\$wnnna$aSatellite Oligodendrocyte, Perineuronal
=450  \\$wnnna$aSatellite Oligodendrocytes, Perineuronal
=550  \\$wg$aNeuroglia
=550  \\$wh$aMyelin Sheath
=680  \\$iA class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.
=688  \\$a90(75); was see under NEUROGLIA 1966-89
=750  \0$aOligodendroglia$5IEN$0(DLC)sh 85094602

=LDR  01313cz  a2200409n  4500
=001  9880363686402441
=005  20141212204038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009835
=035  \\$aCBA3110HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x91.$x657
=150  \\$aOligochaeta
=450  \\$wnnna$aEarthworm
=450  \\$aEarthworms
=450  \\$wnnna$aEisenia fetida
=450  \\$wnnna$aEisenia fetidas
=450  \\$aEisenia foetida
=450  \\$wnnna$aEisenia foetidas
=450  \\$aEisenia worm
=450  \\$wnnna$aEisenia worms
=450  \\$wnnna$afetida, Eisenia
=450  \\$wnnna$afetidas, Eisenia
=450  \\$wnnna$afoetida, Eisenia
=450  \\$wnnna$afoetidas, Eisenia
=450  \\$aLumbricus
=450  \\$wnnna$aLumbricus terrestri
=450  \\$aLumbricus terrestris
=450  \\$wnnna$aOligochaetas
=450  \\$wnnna$aterrestri, Lumbricus
=450  \\$wnnna$aterrestris, Lumbricus
=450  \\$wnnna$aworm, Eisenia
=450  \\$wnnna$aworms, Eisenia
=550  \\$wg$aAnnelida
=680  \\$iA class of annelid worms with few setae per segment. It includes the earthworms such as Lumbricus and Eisenia.
=688  \\$a79(75); was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78
=750  \0$aOligochaeta$5IEN$0(DLC)sh 85094601

=LDR  01673cz  a2200445n  4500
=001  9880363686502441
=005  20141212192406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009832
=035  \\$aCBA3107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x640
=150  \\$aOlfactory Nerve
=450  \\$wnnna$aCranial Nerve, First
=450  \\$aCranial Nerve I
=450  \\$wnnna$aCranial Nerve Is
=450  \\$wnnna$aCranial Nerves, First
=450  \\$wnnna$aFila Olfactoria
=450  \\$wnnna$aFila Olfactorias
=450  \\$wnnna$aFila, Olfactory
=450  \\$wnnna$aFilas, Olfactory
=450  \\$aFirst Cranial Nerve
=450  \\$wnnna$aFirst Cranial Nerves
=450  \\$wnnna$aI, Cranial Nerve
=450  \\$wnnna$aIs, Cranial Nerve
=450  \\$wnnna$aNerve, First Cranial
=450  \\$wnnna$aNerve I, Cranial
=450  \\$wnnna$aNerve Is, Cranial
=450  \\$wnnna$aNerve, Olfactory
=450  \\$wnnna$aNerves, First Cranial
=450  \\$wnnna$aNerves, Olfactory
=450  \\$wnnna$aOlfactoria, Fila
=450  \\$wnnna$aOlfactorias, Fila
=450  \\$wnnna$aOlfactory Fila
=450  \\$wnnna$aOlfactory Filas
=450  \\$wnnna$aOlfactory Nerves
=550  \\$wg$aCranial Nerves
=667  \\$aneoplasms: coordinate IM with OLFACTORY NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS + histological type of neoplasm (IM)
=680  \\$iThe 1st cranial nerve. The olfactory nerve conveys the sense of smell. It is formed by the axons of OLFACTORY RECEPTOR NEURONS which project from the olfactory epithelium (in the nasal epithelium) to the OLFACTORY BULB.
=750  \0$aOlfactory nerve$0(DLC) sh 85094598$5IEN

=LDR  01199cz  a2200325n  4500
=001  9880363686602441
=005  20141212192405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009831
=035  \\$aCBA3106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x520.$x573
=072  \\$aA4.$x760.$x600.$x640
=072  \\$aA9.$x531.$x623
=072  \\$aA10.$x615.$x550.$x760.$x600.$x640
=150  \\$aOlfactory Mucosa
=450  \\$wnnna$aEpithelium, Olfactory
=450  \\$wnnna$aMembrane, Olfactory
=450  \\$wnnna$aMembranes, Olfactory
=450  \\$wnnna$aMucosa, Olfactory
=450  \\$aOlfactory Epithelium
=450  \\$wnnna$aOlfactory Membrane
=450  \\$wnnna$aOlfactory Membranes
=550  \\$wg$aNasal Mucosa
=550  \\$wg$aNose
=550  \\$wh$aOlfactory Receptor Neurons
=550  \\$aNeuroepithelial Cells
=680  \\$iThat portion of the nasal mucosa containing the sensory nerve endings for SMELL, located at the dome of each NASAL CAVITY. The yellow-brownish olfactory epithelium consists of OLFACTORY RECEPTOR NEURONS; brush cells; STEM CELLS; and the associated olfactory glands.
=688  \\$a72
=750  \0$aOlfactory mucosa$5IEN$0(DLC)sh 85094597

=LDR  00808cz  a2200229n  4500
=001  9880363686702441
=005  20141212204036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009826
=035  \\$aCBA3101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x678
=150  \\$aOld Age Assistance
=450  \\$wnnna$aAssistance, Old Age
=450  \\$wnnna$aAssistances, Old Age
=450  \\$wnnna$aOld Age Security
=450  \\$wnnna$aSecurity, Old Age
=550  \\$wg$aPublic Assistance
=667  \\$aspecify geog
=680  \\$iFinancial assistance for the impoverished elderly through public funding of programs, services, and individual income supplements.
=688  \\$a91(75); was see under PUBLIC ASSISTANCE 1975-90
=750  \0$aOld age assistance$5IEN$0(DLC)sh 85094509

=LDR  00879cz  a2200241n  4500
=001  9880363686802441
=005  20141212192404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009824
=035  \\$aCBA3099HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x640
=150  \\$aOintments
=450  \\$wnnna$aOintment, Skin
=450  \\$aPastes
=450  \\$wnnna$aSalves
=450  \\$wnnna$aSkin Ointment
=450  \\$wnnna$aUnguents
=550  \\$wg$aDosage Forms
=550  \\$aOintment Bases
=667  \\$aIM general only; NIM (no qualifiers) with specific drug IM
=680  \\$iSemisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons.
=750  \0$aOintments$5IEN$0(DLC)sh 85094424

=LDR  01159cz  a2200229n  4500
=001  9880363686902441
=005  20141212204036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009822
=035  \\$aCBA3097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627.$x675
=150  \\$aOils, Volatile
=450  \\$wnnna$aEssential Oils
=450  \\$aOils, Essential
=450  \\$wnnna$aVolatile Oils
=550  \\$wg$aOils
=550  \\$wh$aTea Tree Oil
=550  \\$wh$aTurpentine
=667  \\$aD25-26 qualif; coord IM with source of oil (IM or NIM); AROMATHERAPY (use of essential oils to treat dis in alternative med) is also available
=680  \\$iOils which evaporate readily. The volatile oils occur in aromatic plants, to which they give odor and other characteristics. Most volatile oils consist of a mixture of two or more TERPENES or of a mixture of an eleoptene (the more volatile constituent of a volatile oil) with a stearopten (the more solid constituent). The synonym essential oils refers to the essence of a plant, as its perfume or scent, and not to its indispensability.
=750  \0$aEssences and essential oils$5IEN$0(DLC)sh 85044920

=LDR  00946cz  a2200217n  4500
=001  9880363687002441
=005  20141212204035.0
=008  770509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009821
=035  \\$aCBA3096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627
=150  \\$aOils
=450  \\$aOils and Fats$5IEN
=550  \\$wg$aLipids
=550  \\$wh$aFish Oils
=550  \\$wh$aOils, Volatile
=550  \\$wh$aPlant Oils
=667  \\$aGEN or unspecified: prefer specific oil groups & specific oils; D25-26 qualif; coord IM with source of oil (IM or NIM)
=680  \\$iUnctuous combustible substances that are liquid or easily liquefiable on warming, and are soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. Depending on their behavior on heating, they are volatile or fixed. (Dorland, 28th ed)
=750  \0$aOils and fats$5IEN$0(DLC)sh 85094407

=LDR  00633cz  a2200217n  4500
=001  9880363687102441
=005  20141212204035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009818
=035  \\$aCBA3092HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x377.$x875
=150  \\$aOffice Nursing
=450  \\$aMedical Office Nursing$5IEN
=450  \\$wnnna$aNursing, Office
=450  \\$wnnna$aNursings, Office
=450  \\$wnnna$aOffice Nursings
=550  \\$wg$aNursing
=680  \\$iNursing practice limited to an office setting.
=688  \\$a73(66)
=750  \0$aMedical office nursing$5IEN$0(DLC)sh 85082977

=LDR  00751cz  a2200241n  4500
=001  9880363687202441
=005  20141212204034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009817
=035  \\$aCBA3091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x572
=072  \\$aN4.$x452.$x758.$x708.$x200
=150  \\$aOffice Management
=450  \\$wnnna$aManagement, Office
=550  \\$wg$aPractice Management
=550  \\$wg$aProfessional Practice
=550  \\$wh$aForms and Records Control
=550  \\$aEconomics, Dental
=550  \\$aEconomics, Medical
=667  \\$amed or non-med offices
=680  \\$iPlanning, organizing, and administering activities in an office.
=750  \0$aOffice management$5IEN$0(DLC)sh 85094189

=LDR  00766cz  a2200229n  4500
=001  9880363687302441
=005  20141212204034.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009816
=035  \\$aCBA3090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x515.$x708
=150  \\$aOffice Automation
=450  \\$aAutomation, Office
=450  \\$wnnna$aAutomations, Office
=450  \\$wnnna$aOffice Automations
=550  \\$wg$aManagement Information Systems
=550  \\$wh$aWord Processing
=667  \\$aIM
=680  \\$iUse of computers or computer systems for doing routine clerical work, e.g., billing, records pertaining to the administration of the office, etc.
=688  \\$a87
=750  \0$aOffice practice$xAutomation$5IEN$0(DLC)sh 85094193

=LDR  00680cz  a2200193n  4500
=001  9880363687402441
=005  20141212204033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009813
=035  \\$aCBA3087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794.$x653
=150  \\$aOedipus Complex
=450  \\$wnnna$aComplex, Oedipus
=550  \\$wg$aPsychoanalytic Theory
=667  \\$ano qualif
=680  \\$iAttachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex.
=688  \\$a91(75); was see under PSYCHOANALYTIC THEORY 1975-90
=750  \0$aOedipus complex$5IEN$0(DLC)sh 85094129

=LDR  00748cz  a2200229n  4500
=001  9880363687502441
=005  20180117101423.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009812
=035  \\$aCBA3086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x640
=072  \\$aN6.$x230.$x480
=150  \\$aOdorants
=450  \\$wnno$aOdors
=450  \\$wnnna$aOdorant
=450  \\$wnnna$aOdor
=550  \\$wg$aEnvironment
=550  \\$aSmell
=667  \\$anote entry term ODORS; mouth odors = HALITOSIS; AROMATHERAPY (use of essential oils to treat dis in alternative med) is also available
=680  \\$iThe volatile portions of chemical substances perceptible by the sense of smell.
=750  \0$aOdors$5IEN$0(DLC)sh 85094110

=LDR  01278cz  a2200349n  4500
=001  9880363687602441
=005  20141212204032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009808
=035  \\$aCBA3082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x695
=150  \\$aOdontogenic Tumors
=450  \\$wnnna$aDental Tissue Neoplasm
=450  \\$wnnna$aDental Tissue Neoplasms
=450  \\$wnnna$aNeoplasm, Dental Tissue
=450  \\$aNeoplasms, Dental Tissue
=450  \\$wnnna$aOdontogenic Tumor
=450  \\$wnnna$aTissue Neoplasm, Dental
=450  \\$wnnna$aTissue Neoplasms, Dental
=450  \\$wnnna$aTumor, Odontogenic
=450  \\$wnnna$aTumors, Odontogenic
=550  \\$wg$aNeoplasms by Histologic Type
=550  \\$wh$aAmeloblastoma
=550  \\$wh$aCementoma
=550  \\$wh$aOdontogenic Cyst, Calcifying
=550  \\$wh$aOdontogenic Tumor, Squamous
=550  \\$wh$aOdontoma
=667  \\$abenign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iNeoplasms produced from tooth-forming tissues.
=688  \\$a80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79
=750  \0$aOdontogenic tumors$0(DLC) sh 85094100$5IEN

=LDR  01443cz  a2200313n  4500
=001  9880363687702441
=005  20141212204032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009807
=035  \\$aCBA3081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530.$x690
=072  \\$aC5.$x500.$x470.$x690
=072  \\$aC7.$x320.$x450.$x670
=150  \\$aOdontogenic Cysts
=450  \\$wnnna$aCyst, Odontogenic
=450  \\$wnnna$aCysts, Odontogenic
=450  \\$wnnna$aKeratocyst
=450  \\$aKeratocysts
=450  \\$wnnna$aOdontogenic Cyst
=550  \\$wg$aJaw Cysts
=550  \\$wh$aBasal Cell Nevus Syndrome
=550  \\$wh$aDentigerous Cyst
=550  \\$wh$aOdontogenic Cyst, Calcifying
=550  \\$wh$aPeriodontal Cyst
=667  \\$anon-neoplastic but calcifying odontogenic cyst = ODONTOGENIC CYST, CALCIFYING (neoplastic); /blood supply /chem /secret /ultrastruct permitted; coord IM with MANDIBULAR DISEASES or MAXILLARY DISEASES (IM)
=680  \\$iCysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts (e.g., primordial cyst, dentigerous cyst, multilocular cyst), lateral periodontal cysts, and radicular cysts. They may become keratinized (odontogenic keratocysts). Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation.
=688  \\$a65
=750  \0$aOdontogenic cysts$0(DLC) sh 85094099$5IEN

=LDR  01023cz  a2200253n  4500
=001  9880363687802441
=005  20141212204031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009803
=035  \\$aCBA3077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159.$x183.$x79.$x300.$x950.$x600
=072  \\$aA3.$x556.$x124.$x684.$x124.$x236.$x572
=072  \\$aA3.$x556.$x875.$x249.$x160.$x572
=150  \\$aSphincter of Oddi
=450  \\$wnnna$aOddi Sphincter
=450  \\$aOddi's Sphincter
=450  \\$wnnna$aOddis Sphincter
=450  \\$wnnna$aSphincter, Oddi's
=550  \\$wg$aAmpulla of Vater
=667  \\$adiseases: coord IM with COMMON BILE DUCT DISEASES (IM); inflammation: coord IM with CHOLANGITIS (IM); neopl: coord IM with COMMON BILE DUCT NEOPLASMS (IM)
=680  \\$iThe sphincter of the hepatopancreatic ampulla within the duodenal papilla. The COMMON BILE DUCT and main pancreatic duct pass through this sphincter.
=688  \\$a2004 (1975)
=750  \0$aSphincter of Oddi$5IEN$0(DLC)sh 85126603

=LDR  00992cz  a2200205n  4500
=001  9880363687902441
=005  20180713162741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009801
=035  \\$aCBA3075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x700
=150  \\$aOculomotor Muscles
=450  \\$wnnna$aMuscle, Oculomotor
=450  \\$wnnna$aMuscles, Oculomotor
=450  \\$wnnna$aOculomotor Muscle
=550  \\$wg$aMuscle, Skeletal
=667  \\$a/innerv = probably OCULOMOTOR NERVE but consider also ABDUCENS NERVE & TROCHLEAR NERVE; paralysis = OCULOMOTOR PARALYSIS see OPHTHALMOPLEGIA; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe muscles that move the eye. Included in this group are the medial rectus, lateral rectus, superior rectus, inferior rectus, inferior oblique, superior oblique, musculus orbitalis, and levator palpebrae superioris.
=750  \0$aEye$xMuscles$5IEN$0(DLC)sh 85046669

=LDR  02811cz  a2200577n  4500
=001  9880363688002441
=005  20141212204030.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009800
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x640
=072  \\$aC12.$x777.$x419.$x815.$x720
=072  \\$aC13.$x351.$x968.$x419.$x815.$x720
=072  \\$aC16.$x131.$x77.$x661
=072  \\$aC16.$x320.$x322.$x750
=072  \\$aC16.$x320.$x565.$x151.$x600
=072  \\$aC16.$x320.$x565.$x189.$x640
=072  \\$aC16.$x320.$x565.$x861.$x750
=072  \\$aC18.$x452.$x132.$x100.$x640
=072  \\$aC18.$x452.$x648.$x151.$x600
=072  \\$aC18.$x452.$x648.$x189.$x640
=072  \\$aC18.$x452.$x648.$x861.$x750
=150  \\$aOculocerebrorenal Syndrome
=450  \\$wnnna$aCerebro-Oculo-Renal Syndrome
=450  \\$wnnna$aCerebro Oculo Renal Syndrome
=450  \\$aCerebrooculorenal Syndrome
=450  \\$wnnna$aDeficiency, Phosphatidylinositol-4,5-Bisphosphate-5-Phosphatase
=450  \\$wnnna$aDystrophy, Oculocerebrorenal
=450  \\$wnnna$aLowe-Bickel Syndrome
=450  \\$wnnna$aLowe Bickel Syndrome
=450  \\$wnnna$aLowe Disease
=450  \\$wnnna$aLowe Oculocerebrorenal Syndrome
=450  \\$aLowe Syndrome
=450  \\$wnnna$aLowe-Terrey-MacLachlan Syndrome
=450  \\$wnnna$aLowe Terrey MacLachlan Syndrome
=450  \\$wnnna$aOculocerebrorenal Dystrophy
=450  \\$wnnna$aOculocerebrorenal Syndrome of Lowe
=450  \\$wnnna$aPhosphatidylinositol 4,5-Bisphosphate 5-Phosphatase Deficiency
=450  \\$wnnna$aPhosphatidylinositol-4,5-Bisphosphate-5-Phosphatase Deficiency
=450  \\$wnnna$aPhosphatidylinositol 4,5 Bisphosphate 5 Phosphatase Deficiency
=450  \\$wnnna$aRenal-Oculocerebrodystrophy
=450  \\$wnnna$aRenal Oculocerebrodystrophy
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aAmino Acid Transport Disorders, Inborn
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wg$aGenetic Diseases, X-Linked
=550  \\$wg$aRenal Tubular Transport, Inborn Errors
=550  \\$aDent Disease
=680  \\$iA sex-linked recessive disorder affecting multiple systems including the EYE, the NERVOUS SYSTEM, and the KIDNEY. Clinical features include congenital CATARACT; MENTAL RETARDATION; and renal tubular dysfunction (FANCONI SYNDROME; RENAL TUBULAR ACIDOSIS; X-LINKED HYPOPHOSPHATEMIA or vitamin-D-resistant rickets) and SCOLIOSIS. This condition is due to a deficiency of phosphatidylinositol 4,5-bisphosphate-5-phosphatase leading to defects in PHOSPHATIDYLINOSITOL metabolism and INOSITOL signaling pathway. (from Menkes, Textbook of Child Neurology, 5th ed, p60; Am J Hum Genet 1997 Jun;60(6):1384-8)
=688  \\$a1991(1977)
=750  \0$aLowe's syndrome$5IEN$0(DLC)sh 87005152

=LDR  01993cz  a2200577n  4500
=001  9880363688102441
=005  20141212204029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009799
=035  \\$aCBA3073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14
=150  \\$aOcular Physiological Phenomena
=450  \\$wnnna$aConcept, Ocular Physiological
=450  \\$wnnna$aConcepts, Ocular Physiological
=450  \\$wnnna$aEye Physiology
=450  \\$aEye$xphysiology
=450  \\$wnnoa$aOcular Physiologic Phenomena$5IEN-M
=450  \\$wnnna$aOcular Physiological Concept
=450  \\$wnnna$aOcular Physiological Concepts
=450  \\$wnnna$aOcular Physiological Phenomenon
=450  \\$aOcular Physiology
=450  \\$wnnna$aPhenomena, Ocular Physiological
=450  \\$wnnna$aPhenomenon, Ocular Physiological
=450  \\$wnnna$aPhysiological Concept, Ocular
=450  \\$wnnna$aPhysiological Concepts, Ocular
=450  \\$wnnna$aPhysiology, Eye
=450  \\$wnnna$aPhysiology, Ocular
=450  \\$wnnna$aPhysiology of the Eye
=450  \\$wnnna$aPhysiology, Visual
=450  \\$wnnna$aVisual Physiology
=550  \\$wh$aAfterimage
=550  \\$wh$aDominance, Ocular
=550  \\$wh$aEvoked Potentials, Visual
=550  \\$wh$aEye Color
=550  \\$wh$aFigural Aftereffect
=550  \\$wh$aFlicker Fusion
=550  \\$wh$aGlare
=550  \\$wh$aIntraocular Pressure
=550  \\$wh$aOcular Physiological Processes
=550  \\$wh$aOptic Flow
=550  \\$wh$aRefraction, Ocular
=550  \\$wh$aVision Disparity
=550  \\$wh$aVisual Acuity
=550  \\$wh$aVisual Fields
=667  \\$ageneral or unspecified; prefer specifics; DF: OCULAR PHYSIOL
=680  \\$iProcesses and properties of the EYE as a whole or of any of its parts.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Ocular Physiology
=688  \\$a98; use explode 1975-97
=750  \0$aEye$xPhysiology$0(IEN)4729873$5IEN-M

=LDR  00747cz  a2200217n  4500
=001  9880363688202441
=005  20141212204027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009793
=035  \\$aCBA3066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x446.$x598.$x500
=072  \\$aD3.$x830.$x219.$x446.$x598.$x500
=072  \\$aD23.$x946.$x587.$x697
=150  \\$aOchratoxins
=550  \\$wg$aIsocoumarins
=550  \\$wg$aMycotoxins
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iIsocoumarins found in ASPERGILLUS OCHRACEUS and other FUNGI. Ochratoxin contaminated FOOD has been responsible for cases of FOODBORNE DISEASES.
=688  \\$a74(71)
=750  \0$aOchratoxins$5IEN$0(DLC)sh 91002914

=LDR  01060cz  a2200241n  4500
=001  9880363688402441
=005  20141212204026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009790
=035  \\$aCBA3063HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x547
=150  \\$aOccupations
=450  \\$wnnna$aOccupation
=450  \\$wnnna$aVocation
=450  \\$aVocations
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aCareer Mobility
=550  \\$aOccupational Groups
=667  \\$aSPEC: SPEC qualif; OCCUPATIONS are not necessarily "industrial"; differentiate from OCCUPATIONAL GROUPS: OCCUPATIONS is for the occup itself, OCCUPATIONAL GROUPS is for the collective members of an occup; relation to INDUSTRY; INDUSTRIAL MEDICINE (see OCCUPATIONAL MEDICINE) & OCCUPATIONAL DISEASES: Manual 31.13-31.16; BURNOUT, PROFESSIONAL is available; DF: OCCUP
=680  \\$iCrafts, trades, professions, or other means of earning a living.
=688  \\$a68; was OCCUPATIONS AND PROFESSIONS 1963-67
=750  \0$aOccupations$5IEN$0(DLC)sh 85093862

=LDR  00861cz  a2200229n  4500
=001  9880363688502441
=005  20141212204025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009788
=035  \\$aCBA3061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x489
=072  \\$aH2.$x10.$x500
=150  \\$aOccupational Therapy
=450  \\$wnnna$aOccupational Therapies
=450  \\$wnnna$aTherapies, Occupational
=450  \\$wnnna$aTherapy, Occupational
=550  \\$wg$aAllied Health Occupations
=550  \\$wg$aRehabilitation
=667  \\$acoordinate IM with disease/ rehabil (IM) not / ther; DF: OCCUP THER
=680  \\$iSkilled treatment that helps individuals achieve independence in all facets of their lives. It assists in the development of skills needed for independent living.
=750  \0$aOccupational therapy$0(DLC) sh 85093850$5IEN

=LDR  00976cz  a2200241n  4500
=001  9880363688602441
=005  20141212204025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009787
=035  \\$aCBA3060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x720.$x750.$x510
=150  \\$aOccupational Medicine
=450  \\$aIndustrial Hygiene$5IEN
=450  \\$aIndustrial Medicine
=450  \\$wnnna$aMedicine, Industrial
=450  \\$wnnna$aMedicine, Occupational
=550  \\$wg$aPreventive Medicine
=550  \\$aIndustry
=667  \\$aSPEC: SPEC qualif; do not confuse with OCCUPATIONAL HEALTH, the health of the worker; Manual 31.14: relation to INDUSTRY & OCCUPATIONAL DISEASES; DF: OCCUP MED
=680  \\$iMedical specialty concerned with the promotion and maintenance of the physical and mental health of employees in occupational settings.
=688  \\$a79; was INDUSTRIAL MEDICINE 1963-78
=750  \0$aMedicine, Industrial$5IEN-M$0(DLC)sh 85083146

=LDR  01828cz  a2200469n  4500
=001  9880363688702441
=005  20141212204024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009786
=035  \\$aCBA3059HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x740
=150  \\$aOccupational Health Services
=450  \\$wnnna$aAssistance Program, Employee (Health Care)
=450  \\$wnnna$aAssistance Programs, Employee (Health Care)
=450  \\$wnnna$aEmployee Assistance Program (Health Care)
=450  \\$aEmployee Assistance Programs (Health Care)
=450  \\$wnnna$aEmployee Health Service
=450  \\$aEmployee Health Services
=450  \\$wnnna$aEmployment-Based Service
=450  \\$wnnna$aEmployment-Based Services
=450  \\$wnnna$aEmployment Based Services
=450  \\$wnnna$aHealth Service, Employee
=450  \\$wnnna$aHealth Service, Occupational
=450  \\$wnnna$aHealth Services, Employee
=450  \\$wnnna$aHealth Services, Occupational
=450  \\$wnnna$aOccupational Health Service
=450  \\$wnnna$aProgram, Employee Assistance (Health Care)
=450  \\$wnnna$aPrograms, Employee Assistance (Health Care)
=450  \\$wnnna$aService, Employee Health
=450  \\$wnnna$aService, Employment-Based
=450  \\$wnnna$aService, Occupational Health
=450  \\$wnnna$aServices, Employee Health
=450  \\$wnnna$aServices, Employment-Based
=450  \\$wnnna$aServices, Employment Based
=450  \\$wnnna$aServices, Occupational Health
=550  \\$wg$aCommunity Health Services
=550  \\$aOccupational Medicine
=667  \\$aIM; DF: OCCUP HEALTH SERV
=680  \\$iHealth services for employees, usually provided by the employer at the place of work.
=688  \\$a68
=750  \0$aOccupational health services$5IEN$0(DLC)sh 85093842

=LDR  01065cz  a2200313n  4500
=001  9880363688802441
=005  20141212204024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009785
=035  \\$aCBA3058HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x590
=072  \\$aN2.$x421.$x533.$x585
=150  \\$aOccupational Health Nursing
=450  \\$wnnna$aHealth Nursing, Occupational
=450  \\$wnnna$aHealth Nursings, Occupational
=450  \\$aIndustrial Nursing
=450  \\$wnnna$aIndustrial Nursings
=450  \\$wnnna$aNursing, Industrial
=450  \\$wnnna$aNursing, Occupational Health
=450  \\$wnnna$aNursings, Industrial
=450  \\$wnnna$aNursings, Occupational Health
=450  \\$wnnna$aOccupational Health Nursings
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif; DF: OCCUP HEALTH NURS
=680  \\$iThe practice of nursing in the work environment.
=688  \\$a79; was INDUSTRIAL NURSING 1963-78
=750  \0$aIndustrial nursing$5IEN$0(DLC)sh 85065906

=LDR  01460cz  a2200433n  4500
=001  9880363688902441
=005  20200609120514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009784
=035  \\$aCBA3057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC24
=150  \\$aOccupational Diseases
=450  \\$wnnna$aDisease, Occupational
=450  \\$wnnna$aDiseases, Occupational
=450  \\$wnnna$aIllnesse, Occupational
=450  \\$wnnna$aIllnesses, Occupational
=450  \\$wnnna$aOccupational Disease
=450  \\$wnnna$aOccupational Illnesse
=450  \\$wnnna$aOccupational Illnesses
=550  \\$wh$aAgricultural Workers' Diseases
=550  \\$wh$aAsthma, Occupational
=550  \\$wh$aBird Fancier's Lung
=550  \\$wh$aDermatitis, Occupational
=550  \\$wh$aHand-Arm Vibration Syndrome
=550  \\$wh$aHigh Pressure Neurological Syndrome
=550  \\$wh$aInert Gas Narcosis
=550  \\$wh$aLaboratory Infection
=550  \\$wh$aOccupational Stress
=550  \\$wh$aPersian Gulf Syndrome
=550  \\$wh$aPneumoconiosis
=550  \\$wh$aSleep Disorders, Circadian Rhythm
=550  \\$aAccidents, Occupational
=550  \\$aIndustry
=550  \\$aKaroshi Death
=550  \\$aOccupational Medicine
=667  \\$acoordinate IM with specific disease (IM); Manual 31.14, 31.16
=680  \\$iDiseases caused by factors involved in one's employment.
=750  \0$aOccupational diseases$5IEN$0(DLC)sh 85093836

=LDR  01218cz  a2200313n  4500
=001  9880363689002441
=005  20141212204023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009783
=035  \\$aCBA3056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x255.$x700
=072  \\$aC17.$x800.$x815.$x255.$x700
=072  \\$aC24.$x270
=150  \\$aDermatitis, Occupational
=450  \\$wnnna$aDermatitides, Occupational
=450  \\$wnnna$aDermatoses, Industrial
=450  \\$wnnna$aDermatosis, Industrial
=450  \\$wnnna$aIndustrial Dermatoses
=450  \\$wnnna$aIndustrial Dermatosis
=450  \\$wnnna$aOccupational Dermatitides
=450  \\$aOccupational Dermatitis
=550  \\$wg$aDermatitis, Contact
=550  \\$wg$aOccupational Diseases
=550  \\$aDermatitis, Contact
=667  \\$ado not restrict to -itis: use as if "dermatoses"; coord with specific skin dis with /chem ind; includes housewives' dermatoses caused by housekeeping agents; DF: DERMATITIS OCCUP
=680  \\$iA recurrent contact dermatitis caused by substances found in the work place.
=688  \\$a93; was OCCUPATIONAL DERMATITIS 1963-92
=750  \0$aOccupational dermatitis$5IEN$0(DLC)sh 85093834

=LDR  00922cz  a2200265n  4500
=001  9880363689102441
=005  20141212204023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009782
=035  \\$aCBA3055HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x640
=150  \\$aOccupational Dentistry
=450  \\$wnnna$aDentistries, Industrial
=450  \\$wnnna$aDentistries, Occupational
=450  \\$wnnna$aDentistry, Industrial
=450  \\$wnnna$aDentistry, Occupational
=450  \\$wnnna$aIndustrial Dentistries
=450  \\$aIndustrial Dentistry
=450  \\$wnnna$aOccupational Dentistries
=550  \\$wg$aDentistry
=667  \\$aSPEC: SPEC qualif; DF: OCCUP DENT
=680  \\$iThe branch of dentistry concerned with maintaining oral health of employees in occupational environments.
=688  \\$a82; was INDUSTRIAL DENTISTRY 1965-81
=750  \0$aIndustrial dentistry$5IEN$0(DLC)sh 85065848

=LDR  01108cz  a2200325n  4500
=001  9880363689302441
=005  20141212204022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009779
=035  \\$aCBA3052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x101.$x650
=150  \\$aOcclusive Dressings
=450  \\$wnnna$aBandage, Occlusive
=450  \\$aBandages, Occlusive
=450  \\$wnnna$aDressing, Occlusive
=450  \\$wnnna$aDressing, Spray-On
=450  \\$aDressings, Occlusive
=450  \\$aDressings, Spray-On
=450  \\$wnnna$aDressings, Spray On
=450  \\$wnnna$aOcclusive Bandage
=450  \\$wnnna$aOcclusive Bandages
=450  \\$wnnna$aOcclusive Dressing
=450  \\$wnnna$aSpray-On Dressing
=450  \\$wnnna$aSpray-On Dressings
=550  \\$wg$aBandages
=667  \\$ato protect wounds from air or bact
=680  \\$iMaterial, usually gauze or absorbent cotton, used to cover and protect wounds, to seal them from contact with air or bacteria. (From Dorland, 27th ed)
=688  \\$a67(63)
=750  \0$aOcclusive surgical dressings$0(DLC) sh 85093816$5IEN

=LDR  02621cz  a2200745n  4500
=001  9880363689402441
=005  20141212192402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009778
=035  \\$aCBA3051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x571
=150  \\$aOccipital Lobe
=450  \\$wnnna$aAnnectant Gyrus
=450  \\$wnnna$aCalcarine Fissure
=450  \\$wnnna$aCalcarine Fissures
=450  \\$wnnna$aCalcarine Sulcus
=450  \\$wnnna$aCalcarinus, Sulcus
=450  \\$wnnna$aCortex, Cuneus
=450  \\$wnnna$aCortex, Occipital
=450  \\$wnnna$aCortices, Cuneus
=450  \\$wnnna$aCortices, Occipital
=450  \\$wnnna$aCuneate Lobule
=450  \\$wnnna$aCuneate Lobules
=450  \\$wnnna$aCuneus
=450  \\$wnnna$aCuneus Cortex
=450  \\$wnnna$aCuneus Cortices
=450  \\$wnnna$aCuneus Gyrus
=450  \\$wnnna$aFissure, Calcarine
=450  \\$wnnna$aFissures, Calcarine
=450  \\$wnnna$aGyrus, Annectant
=450  \\$wnnna$aGyrus, Cuneus
=450  \\$wnnna$aGyrus, Lingual
=450  \\$wnnna$aGyrus Linguali
=450  \\$wnnna$aGyrus Lingualis
=450  \\$wnnna$aGyrus, Medial Occipitotemporal
=450  \\$wnnna$aGyrus, Occipital
=450  \\$wnnna$aLingual Gyrus
=450  \\$wnnna$aLinguali, Gyrus
=450  \\$wnnna$aLingualis, Gyrus
=450  \\$wnnna$aLobe, Occipital
=450  \\$wnnna$aLobes, Occipital
=450  \\$wnnna$aLobule, Cuneate
=450  \\$wnnna$aLobules, Cuneate
=450  \\$wnnna$aLunate Sulcus
=450  \\$wnnna$aMedial Occipitotemporal Gyrus
=450  \\$wnnna$aOccipital Cortex
=450  \\$wnnna$aOccipital Cortices
=450  \\$wnnna$aOccipital Gyrus
=450  \\$wnnna$aOccipital Lobes
=450  \\$wnnna$aOccipital Region
=450  \\$wnnna$aOccipital Regions
=450  \\$wnnna$aOccipital Sulcus
=450  \\$wnnna$aOccipitotemporal Gyrus, Medial
=450  \\$wnnna$aRegion, Occipital
=450  \\$wnnna$aRegions, Occipital
=450  \\$wnnna$aSulcus, Calcarine
=450  \\$wnnna$aSulcus Calcarinus
=450  \\$wnnna$aSulcus, Lunate
=450  \\$wnnna$aSulcus, Occipital
=550  \\$wg$aCerebral Cortex
=550  \\$wh$aVisual Cortex
=667  \\$adiseases: coordinate IM with BRAIN DISEASES (IM); neoplasms: coordinate IM with BRAIN NEOPLASMS (IM)
=680  \\$iPosterior portion of the CEREBRAL HEMISPHERES responsible for processing visual sensory information. It is located posterior to the parieto-occipital sulcus and extends to the preoccipital notch.
=750  \0$aOccipital lobes$5IEN$0(DLC)sh 85093812

=LDR  00789cz  a2200253n  4500
=001  9880363689502441
=005  20141212204022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009777
=035  \\$aCBA3050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x572
=150  \\$aOccipital Bone
=450  \\$aBasilar Bone
=450  \\$wnnna$aBasilar Bones
=450  \\$wnnna$aBone, Basilar
=450  \\$wnnna$aBone, Occipital
=450  \\$wnnna$aBones, Basilar
=450  \\$wnnna$aBones, Occipital
=450  \\$wnnna$aOccipital Bones
=550  \\$wg$aSkull
=550  \\$wh$aForamen Magnum
=667  \\$afractures: coord OCCIPITAL BONE /inj (IM) + SKULL FRACTURES (IM); neopl: coord IM with SKULL NEOPLASMS (IM)
=750  \0$aOccipital bone$5IEN$0(DLC)sh 85093811

=LDR  00774cz  a2200205n  4500
=001  9880363689602441
=005  20141212204021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009774
=035  \\$aCBA3047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x450
=150  \\$aObstetrics
=450  \\$aObstetricians$5IEN
=550  \\$wg$aSpecialties, Surgical
=550  \\$aObstetric Surgical Procedures
=667  \\$aSPEC: SPEC qualif; do not use for "obstetric diseases" ( = probably PREGNANCY COMPLICATIONS, etc.)
=680  \\$iA medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium.
=750  \0$aObstetrics$5IEN-M$0(DLC)sh 85093768
=750  \0$aObstetricians$5IEN-HS$0(DLC)sh 85093764

=LDR  01031cz  a2200301n  4500
=001  9880363689702441
=005  20141212204021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009773
=035  \\$aCBA3046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x570
=072  \\$aN2.$x421.$x533.$x571
=150  \\$aObstetric Nursing
=450  \\$aNursing, Obstetric
=450  \\$wnnna$aNursing, Obstetrical
=450  \\$wnnna$aNursings, Obstetric
=450  \\$wnnna$aNursings, Obstetrical
=450  \\$wnnna$aObstetric Nursings
=450  \\$aObstetrical Nursing
=450  \\$wnnna$aObstetrical Nursings
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif; check also tag PREGNANCY
=680  \\$iA nursing specialty involving nursing care given to the pregnant patient before, after, or during childbirth.
=688  \\$a67
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Obstetrical Nursing
=750  \0$aMaternity nursing$5IEN-M$0(DLC)sh 85093760

=LDR  00866cz  a2200253n  4500
=001  9880363689802441
=005  20141212204020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009772
=035  \\$aCBA3045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x700.$x650
=150  \\$aObstetrical Forceps
=450  \\$wnnna$aForcep, Obstetric
=450  \\$wnnna$aForcep, Obstetrical
=450  \\$wnnna$aForceps, Obstetric
=450  \\$wnnna$aForceps, Obstetrical
=450  \\$wnnna$aObstetric Forcep
=450  \\$wnnna$aObstetric Forceps
=450  \\$wnnna$aObstetrical Forcep
=550  \\$wg$aSurgical Instruments
=550  \\$aExtraction, Obstetrical
=680  \\$iSurgical instrument designed to extract the newborn by the head from the maternal passages without injury to it or the mother.
=750  \0$aObstetrical forceps$5IEN$0(DLC)sh 85050457

=LDR  01747cz  a2200361n  4500
=001  9880363689902441
=005  20180111105647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009771
=035  \\$aCBA3044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x600
=150  \\$aObsessive-Compulsive Disorder
=450  \\$wnnna$aAnankastic Personalities
=450  \\$aAnankastic Personality
=450  \\$wnnna$aDisorder, Obsessive-Compulsive
=450  \\$wnnna$aDisorders, Obsessive-Compulsive
=450  \\$wnnna$aNeuroses, Obsessive-Compulsive
=450  \\$aNeurosis, Obsessive-Compulsive
=450  \\$wnnna$aNeurosis, Obsessive Compulsive
=450  \\$wnnna$aObsessive Compulsive Disorder
=450  \\$wnnna$aObsessive-Compulsive Disorders
=450  \\$wnnna$aObsessive-Compulsive Neuroses
=450  \\$wnnna$aObsessive-Compulsive Neurosis
=450  \\$wnnna$aPersonalities, Anankastic
=450  \\$wnnna$aPersonality, Anankastic
=550  \\$wg$aAnxiety Disorders
=550  \\$wh$aHoarding Disorder
=550  \\$aCompulsive Behavior
=667  \\$aCOMPULSIVE PERSONALITY DISORDER is also available
=680  \\$iAn anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
=688  \\$a81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78
=750  \0$aObsessive-compulsive disorder$5IEN$0(DLC)sh 85093751

=LDR  01581cz   2200469n  4500
=001  9880363690002441
=005  20220302163727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009769
=035  \\$aCBA3042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794.$x624
=150  \\$aObject Attachment
=450  \\$wnnna$aAttachment, Object
=450  \\$wnnna$aAttachments, Object
=450  \\$wnnna$aBond, Emotional
=450  \\$wnnna$aBonding, Psychological
=450  \\$aBonding (Psychology)
=450  \\$wnnna$aBondings (Psychology)
=450  \\$aBonds, Emotional
=450  \\$wnnna$aEmotional Bond
=450  \\$aEmotional Bonds
=450  \\$wnnna$aObject Attachments
=450  \\$wnnna$aObject Relation
=450  \\$aObject Relations
=450  \\$wnnna$aObject Relationship
=450  \\$wnnna$aObject Relationships
=450  \\$wnnna$aPsychological Bonding
=450  \\$wnnna$aRelation, Object
=450  \\$wnnna$aRelation, Symbiotic (Psychology)
=450  \\$wnnna$aRelations, Object
=450  \\$wnnna$aRelations, Symbiotic (Psychology)
=450  \\$wnnna$aRelationship, Object
=450  \\$wnnna$aRelationships, Object
=450  \\$wnnna$aSymbiotic Relation (Psychology)
=450  \\$aSymbiotic Relations (Psychology)
=550  \\$wg$aPsychoanalytic Theory
=550  \\$wh$aHuman-Animal Bond
=680  \\$iEmotional attachment to someone or something in the environment.
=688  \\$a69
=750  \0$aObject relations (Psychoanalysis)$5IEN-M$0(DLC)sh 85093655
=750  \0$aAttachment behavior$5IEN-HS$0(DLC)sh 85009379

=LDR  01169cz  a2200301n  4500
=001  9880363690102441
=005  20141212204018.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009767
=035  \\$aCBA3040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x726.$x500.$x700
=072  \\$aC23.$x888.$x144.$x699.$x500.$x500
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x699.$x500.$x500
=072  \\$aG7.$x100.$x100.$x160.$x120.$x699.$x500.$x500
=150  \\$aObesity, Morbid
=450  \\$wnnna$aMorbid Obesities
=450  \\$aMorbid Obesity
=450  \\$wnnna$aObesities, Morbid
=450  \\$wnnna$aObesities, Severe
=450  \\$wnnna$aObesity, Severe
=450  \\$wnnna$aSevere Obesities
=450  \\$wnnna$aSevere Obesity
=550  \\$wg$aObesity
=667  \\$a/surg: consider also BARIATRIC SURGERY
=680  \\$iThe condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
=688  \\$a87
=750  \0$aMorbid obesity$0(DLC)sh2004010669$5IEN-M

=LDR  01484cz  a2200337n  4500
=001  9880363690202441
=005  20170825173828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009765
=035  \\$aCBA3038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x726.$x500
=072  \\$aC23.$x888.$x144.$x699.$x500
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x699.$x500
=072  \\$aG7.$x100.$x100.$x160.$x120.$x699.$x500
=150  \\$aObesity
=550  \\$wg$aOvernutrition
=550  \\$wg$aOverweight
=550  \\$wh$aObesity, Abdominal
=550  \\$wh$aObesity Hypoventilation Syndrome
=550  \\$wh$aObesity, Metabolically Benign
=550  \\$wh$aObesity, Morbid
=550  \\$wh$aPediatric Obesity
=550  \\$wh$aPrader-Willi Syndrome
=550  \\$aBariatrics
=550  \\$aBody Weight
=550  \\$aHyperphagia
=550  \\$aWeight Gain
=667  \\$aOBESITY, MORBID is also available; obese hyperglycemic mice are indexed MICE, OBESE: do not add OBESITY or HYPERGLYCEMIA unless disease particularly discussed
=680  \\$iA status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
=750  \0$aObesity$0(DLC) sh 85093646$5IEN

=LDR  00870cz  a2200265n  4500
=001  9880363690302441
=005  20141212204016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009761
=035  \\$aCBA3034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x575
=150  \\$aNystatin
=450  \\$wnnna$aFungicidin
=450  \\$wnnna$aMycostatin
=450  \\$wnnna$aNilstat
=450  \\$wnnna$aNystatin A1
=450  \\$wnnna$aNystatin A2
=450  \\$wnnna$aNystatin A3
=450  \\$wnnna$aNystatin G
=450  \\$wnnna$aStamicin
=450  \\$wnnna$aStamycin
=550  \\$wg$aMacrolides
=680  \\$iMacrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.
=750  \0$aNystatin$5IEN$0(DLC)sh 85089200

=LDR  03355cz  a2200817n  4500
=001  9880363690402441
=005  20141212204016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009759
=035  \\$aCBA3032HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x562.$x675
=072  \\$aC11.$x590.$x400
=150  \\$aNystagmus, Pathologic
=450  \\$wnnna$aAlternating Nystagmus, Periodic
=450  \\$wnnna$aConjugate Nystagmus
=450  \\$aConvergence Nystagmus
=450  \\$wnnna$aDissociated Nystagmus
=450  \\$wnnna$aFatigable Positional Nystagmus
=450  \\$aHorizontal Nystagmus
=450  \\$aJerk Nystagmus
=450  \\$wnnna$aMultidirectional Nystagmus
=450  \\$wnnna$aNon-Fatigable Positional Nystagmus
=450  \\$wnnna$aNon Fatigable Positional Nystagmus
=450  \\$wnnna$aNystagmus, Conjugate
=450  \\$wnnna$aNystagmus, Convergence
=450  \\$wnnna$aNystagmus, Dissociated
=450  \\$wnnna$aNystagmus, Fatigable Positional
=450  \\$wnnna$aNystagmus, Horizontal
=450  \\$wnnna$aNystagmus, Jerk
=450  \\$wnnna$aNystagmus, Multidirectional
=450  \\$wnnna$aNystagmus, Non-Fatigable Positional
=450  \\$wnnna$aNystagmus, Pendular
=450  \\$wnnna$aNystagmus, Periodic Alternating
=450  \\$wnnna$aNystagmus, Permanent
=450  \\$wnnna$aNystagmus, Rebound
=450  \\$wnnna$aNystagmus, Retraction
=450  \\$wnnna$aNystagmus, Rotary
=450  \\$wnnna$aNystagmus, Rotational
=450  \\$wnnna$aNystagmus, See-Saw
=450  \\$wnnna$aNystagmus, Spontaneous Ocular
=450  \\$wnnna$aNystagmus, Symptomatic
=450  \\$wnnna$aNystagmus, Temporary
=450  \\$wnnna$aNystagmus, Unidirectional
=450  \\$wnnna$aNystagmus, Vertical
=450  \\$wnnna$aOcular Nystagmus, Spontaneous
=450  \\$wnnna$aPathologic Nystagmus
=450  \\$aPendular Nystagmus
=450  \\$aPeriodic Alternating Nystagmus
=450  \\$wnnna$aPermanent Nystagmus
=450  \\$wnnna$aPositional Nystagmus, Fatigable
=450  \\$wnnna$aPositional Nystagmus, Non-Fatigable
=450  \\$wnnna$aRebound Nystagmus
=450  \\$wnnna$aRetraction Nystagmus
=450  \\$aRotary Nystagmus
=450  \\$wnnna$aRotational Nystagmus
=450  \\$aSee-Saw Nystagmus
=450  \\$wnnna$aSee Saw Nystagmus
=450  \\$wnnna$aSpontaneous Ocular Nystagmus
=450  \\$wnnna$aSymptomatic Nystagmus
=450  \\$wnnna$aTemporary Nystagmus
=450  \\$wnnna$aUnidirectional Nystagmus
=450  \\$aVertical Nystagmus
=550  \\$wg$aOcular Motility Disorders
=550  \\$wh$aNystagmus, Congenital
=550  \\$aEye Movements
=550  \\$aNystagmus, Physiologic
=667  \\$ado not confuse with NYSTAGMUS, PHYSIOLOGIC; NYSTAGMUS, CONGENITAL is also available
=680  \\$iInvoluntary movements of the eye that are divided into two types, jerk and pendular. Jerk nystagmus has a slow phase in one direction followed by a corrective fast phase in the opposite direction, and is usually caused by central or peripheral vestibular dysfunction. Pendular nystagmus features oscillations that are of equal velocity in both directions and this condition is often associated with visual loss early in life. (Adams et al., Principles of Neurology, 6th ed, p272)
=688  \\$a2000
=750  \0$aNystagmus$5IEN$0(DLC)sh 85093547

=LDR  00877cz  a2200193n  4500
=001  9880363690502441
=005  20141212204014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009758
=035  \\$aCBA3031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x500.$x650
=072  \\$aG7.$x700.$x320.$x500.$x550.$x500.$x650
=150  \\$aNymph
=550  \\$wg$aLife Cycle Stages
=667  \\$aNIM; for metamorphosing arthropods only; do not use /embryol with ref to nymph
=680  \\$iThe immature stage in the life cycle of those orders of insects characterized by gradual metamorphosis, in which the young resemble the imago in general form of body, including compound eyes and external wings; also the 8-legged stage of mites and ticks that follows the first moult.
=688  \\$a91(73); was see under INSECTS 1973-90
=750  \0$aNymphs (Insects)$5IEN-M$0(DLC)sh 85093534

=LDR  01226cz  a2200349n  4500
=001  9880363690602441
=005  20141212192401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009757
=035  \\$aCBA3030HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x392
=072  \\$aD25.$x720.$x716.$x392
=072  \\$aJ1.$x576.$x655.$x937.$x800.$x600
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x392
=072  \\$aJ1.$x637.$x548
=150  \\$aNylons
=450  \\$wnnna$aDermalon
=450  \\$wnnna$aDermalons
=450  \\$wnnna$aEthilon
=450  \\$wnnna$aEthilons
=450  \\$wnnna$aNylon
=450  \\$wnnna$aPolyamide
=450  \\$aPolyamides
=450  \\$wnnna$aSupramid
=550  \\$wg$aManufactured Materials
=550  \\$wg$aPlastics
=550  \\$wg$aTextiles
=667  \\$aD25-26 qualif
=680  \\$iPolymers where the main polymer chain comprises recurring amide groups. These compounds are generally formed from combinations of diamines, diacids, and amino acids and yield fibers, sheeting, or extruded forms used in textiles, gels, filters, sutures, contact lenses, and other biomaterials.
=688  \\$a80; was NYLON in Cat D & J 1963-79
=750  \0$aNylon$5IEN$0(DLC)sh 85093523

=LDR  01018cz  a2200205n  4500
=001  9880363690702441
=005  20141212204014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009754
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x500.$x500
=072  \\$aJ2.$x500.$x700
=150  \\$aNuts
=450  \\$wnnna$aNut
=550  \\$wg$aFood
=550  \\$wg$aFruit
=550  \\$aSeeds
=667  \\$aas seed & food; /adv eff; consider also NUT HYPERSENSITIVITY; PEANUTS see ARACHIS HYPOGAEA is also available
=680  \\$iBotanically, a type of single-seeded fruit in which the pericarp enclosing the seed is a hard woody shell. In common usage the term is used loosely for any hard, oil-rich kernel. Of those commonly eaten, only hazel, filbert, and chestnut are strictly nuts. Walnuts, pecans, almonds, and coconuts are really drupes. Brazil nuts, pistachios, macadamias, and cashews are really seeds with a hard shell derived from the testa rather than the pericarp.
=750  \0$aNuts$5IEN$0(DLC)sh 85093481

=LDR  01274cz  a2200337n  4500
=001  9880363690802441
=005  20141212204012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009751
=035  \\$aCBA3024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x620
=150  \\$aNutritional Requirements
=450  \\$wnnna$aDietary Requirement
=450  \\$wnnna$aDietary Requirements
=450  \\$wnnna$aNutrition Requirement
=450  \\$wnnna$aNutrition Requirements
=450  \\$wnnna$aNutritional Requirement
=450  \\$wnnna$aRequirement, Dietary
=450  \\$wnnna$aRequirement, Nutrition
=450  \\$wnnna$aRequirement, Nutritional
=450  \\$wnnna$aRequirements, Dietary
=450  \\$wnnna$aRequirements, Nutrition
=450  \\$wnnna$aRequirements, Nutritional
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aRecommended Dietary Allowances
=550  \\$aFood
=667  \\$anot for nutritional requirements of microorganisms ( = microorganism /growth or /metab or /physiol)
=680  \\$iThe amounts of various substances in food needed by an organism to sustain healthy life.
=688  \\$a84(68); was see under NUTRITION 1975-83, was Prov 1968-74
=750  \0$aNutrition$xRequirements$5IEN$0(DLC)sh 85093463

=LDR  01507cz  a2200385n  4500
=001  9880363690902441
=005  20141212192401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009749
=035  \\$aCBA3022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x600
=072  \\$aE5.$x318.$x308.$x667
=072  \\$aN5.$x715.$x360.$x300.$x375.$x560
=072  \\$aN5.$x715.$x360.$x300.$x627
=072  \\$aN6.$x850.$x505.$x616
=072  \\$aN6.$x850.$x520.$x308.$x250.$x600
=072  \\$aN6.$x850.$x520.$x308.$x667
=150  \\$aNutrition Surveys
=450  \\$aNational Health and Nutrition Examination Survey
=450  \\$aNHANES
=450  \\$wnnna$aNutrition Survey
=450  \\$wnnna$aNutritional Survey
=450  \\$wnnna$aNutritional Surveys
=450  \\$wnnna$aSurvey, Nutrition
=450  \\$wnnna$aSurvey, Nutritional
=450  \\$wnnna$aSurveys, Nutrition
=450  \\$wnnna$aSurveys, Nutritional
=550  \\$wg$aData Collection
=550  \\$wg$aEpidemiologic Measurements
=550  \\$wg$aHealth Surveys
=550  \\$wh$aDiet Surveys
=667  \\$ado not confuse with NUTRITION ASSESSMENT: survey refers to a population in a given geographic area, assessment refers to an individual
=680  \\$iA systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTS.
=750  \0$aNutrition surveys$5IEN$0(DLC)sh 85093474

=LDR  01038cz  a2200289n  4500
=001  9880363691002441
=005  20141212204012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009748
=035  \\$aCBA3021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654
=150  \\$aNutrition Disorders
=450  \\$wnnna$aNutrition Disorder
=450  \\$wnnna$aNutritional Disorder
=450  \\$wnnna$aNutritional Disorders
=550  \\$wg$aNutritional and Metabolic Diseases
=550  \\$wh$aChild Nutrition Disorders
=550  \\$wh$aHypervitaminosis A
=550  \\$wh$aInfant Nutrition Disorders
=550  \\$wh$aMalnutrition
=550  \\$wh$aOvernutrition
=550  \\$wh$aWasting Syndrome
=667  \\$adifferentiate from DEFICIENCY DISEASES (results from deficient intake) & METABOLIC DISEASES
=680  \\$iDisorders caused by nutritional imbalance, either overnutrition or undernutrition.
=688  \\$aMALNUTRITION was see under DEFICIENCY DISEASES 1963-66
=750  \0$aNutrition disorders$5IEN-M$0(DLC)sh 85093469

=LDR  03785cz  a2200841n  4500
=001  9880363691102441
=005  20180102155529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009747
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x650
=150  \\$aNutritional Physiological Phenomena
=450  \\$wnnna$aConcept, Nutrition Physiological
=450  \\$wnnna$aConcept, Nutritional Physiology
=450  \\$wnnna$aConcepts, Nutrition Physiological
=450  \\$wnnna$aConcepts, Nutritional Physiology
=450  \\$wnno$aNutrition$5IEN-M
=450  \\$wnnna$aNutrition Phenomena
=450  \\$wnnna$aNutrition Physiological Concept
=450  \\$wnnna$aNutrition Physiological Concepts
=450  \\$aNutrition Physiological Phenomena
=450  \\$wnnna$aNutrition Physiological Phenomenon
=450  \\$aNutrition Physiology
=450  \\$wnnna$aNutritional Phenomena
=450  \\$wnnna$aNutritional Physiological Phenomenon
=450  \\$wnnna$aNutritional Physiology
=450  \\$wnnna$aNutritional Physiology Concept
=450  \\$wnnna$aNutritional Physiology Concepts
=450  \\$aNutritional Physiology Phenomena
=450  \\$wnnna$aNutritional Physiology Phenomenon
=450  \\$wnnna$aPhenomena, Nutrition
=450  \\$wnnna$aPhenomena, Nutrition Physiological
=450  \\$wnnna$aPhenomena, Nutritional
=450  \\$wnnna$aPhenomena, Nutritional Physiological
=450  \\$wnnna$aPhenomena, Nutritional Physiology
=450  \\$wnnna$aPhenomenon, Nutrition Physiological
=450  \\$wnnna$aPhenomenon, Nutritional Physiological
=450  \\$wnnna$aPhenomenon, Nutritional Physiology
=450  \\$wnnna$aPhysiological Concept, Nutrition
=450  \\$wnnna$aPhysiological Concepts, Nutrition
=450  \\$wnnna$aPhysiological Phenomena, Nutrition
=450  \\$wnnna$aPhysiological Phenomena, Nutritional
=450  \\$wnnna$aPhysiological Phenomenon, Nutrition
=450  \\$wnnna$aPhysiological Phenomenon, Nutritional
=450  \\$wnnna$aPhysiology Concept, Nutritional
=450  \\$wnnna$aPhysiology Concepts, Nutritional
=450  \\$wnnna$aPhysiology, Nutrition
=450  \\$wnnna$aPhysiology, Nutritional
=450  \\$wnnna$aPhysiology Phenomena, Nutritional
=450  \\$wnnna$aPhysiology Phenomenon, Nutritional
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aAnimal Nutritional Physiological Phenomena
=550  \\$wh$aChild Nutritional Physiological Phenomena
=550  \\$wh$aDiet
=550  \\$wh$aElder Nutritional Physiological Phenomena
=550  \\$wh$aFeeding Behavior
=550  \\$wh$aHunger
=550  \\$wh$aMaternal Nutritional Physiological Phenomena
=550  \\$wh$aNutrition Processes
=550  \\$wh$aNutritional Requirements
=550  \\$wh$aNutritional Status
=550  \\$wh$aNutritive Value
=550  \\$wh$aSports Nutritional Physiological Phenomena
=550  \\$aFood
=550  \\$aNutritional Sciences
=667  \\$ageneral or unspecified; prefer specifics; also available - NUTRIENTS (see FOOD) and DIET; clinical nutrition as a specialty goes to NUTRITIONAL SCIENCES; nutritional intervention use NUTRITION THERAPY or specifics
=680  \\$iThe processes and properties of living organisms by which they take in and balance the use of nutritive materials for energy, heat production, or building material for the growth, maintenance, or repair of tissues and the nutritive properties of FOOD.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Nutrition Physiology
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Nutrition
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20071115: 150:##:_{dollar}a Nutrition
=750  \0$aNutrition$0(DLC) sh 85093451$5IEN

=LDR  00721cz  a2200193n  4500
=001  9880363691202441
=005  20141212204010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009746
=035  \\$aCBA3019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x715.$x571
=150  \\$aNursing, Team
=450  \\$wnnna$aTeam Nursing
=550  \\$wg$aPatient Care Team
=667  \\$aIM; consider also PATIENT CARE TEAM; DF: NURS TEAM
=680  \\$iCoordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses' aides, and the practical nurse.
=688  \\$a67(65)
=750  \0$aTeam nursing$5IEN$0(DLC)sh 85133072

=LDR  00939cz  a2200289n  4500
=001  9880363691302441
=005  20141212204010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009745
=035  \\$aCBA3018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x377.$x750
=150  \\$aNursing, Supervisory
=450  \\$wnnna$aCharge Nurse
=450  \\$aCharge Nurses
=450  \\$wnnna$aHead Nurse
=450  \\$aHead Nurses
=450  \\$wnnna$aNurse, Charge
=450  \\$wnnna$aNurse, Head
=450  \\$wnnna$aNurses, Charge
=450  \\$aNurses, Head
=450  \\$wnnna$aSupervisory Nursing
=550  \\$wg$aNursing
=667  \\$aIM; in British jnls nursing "sisters" go here but "matron" goes under NURSE ADMINISTRATORS; DF: NURS SUPERVISORY
=680  \\$iAdministration of nursing services for one or more clinical units.
=688  \\$a66
=750  \0$aNursing services$xAdministration$5IEN$0(DLC)sh 85093433

=LDR  00775cz  a2200217n  4500
=001  9880363691402441
=005  20141212204009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009744
=035  \\$aCBA3017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x377.$x500
=150  \\$aNursing, Private Duty
=450  \\$wnnna$aNursing, Private Practice
=450  \\$wnnna$aPrivate Duty Nursing
=450  \\$wnnna$aPrivate Practice Nursing
=550  \\$wg$aNursing
=667  \\$aIM; coord with specific nurs specialty (IM); DF: NURS PRIVATE DUTY
=680  \\$iThe practice of nursing by a registered or licensed nurse to care for a specific patient in a health facility or in the home.
=688  \\$a67
=750  \0$aPrivate duty nursing$5IEN$0(DLC)sh 85107034

=LDR  00749cz  a2200229n  4500
=001  9880363691502441
=005  20141212204009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009743
=035  \\$aCBA3016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x495
=072  \\$aN2.$x421.$x533.$x520
=150  \\$aNursing, Practical
=450  \\$wnnna$aNursings, Practical
=450  \\$wnnna$aPractical Nursing
=450  \\$wnnna$aPractical Nursings
=550  \\$wg$aHealth Occupations
=550  \\$wg$aNursing Care
=667  \\$aSPEC: SPEC qualif; DF: NURS PRACTICAL
=680  \\$iThe practice of nursing by licensed, non-registered persons qualified to provide routine care to the sick.
=750  \0$aPractical nursing$5IEN$0(DLC)sh 85106046

=LDR  00697cz  a2200217n  4500
=001  9880363691602441
=005  20141212204009.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009742
=035  \\$aCBA3015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x408
=150  \\$aNursing Theory
=450  \\$wnnna$aNursing Theories
=450  \\$wnnna$aTheories, Nursing
=450  \\$wnnna$aTheory, Nursing
=550  \\$wg$aNursing
=667  \\$ano qualif; DF: NURS THEORY
=680  \\$iConcepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research.
=688  \\$a86
=750  \0$aNursing$xPhilosophy$5IEN$0(DLC)sh 90003890

=LDR  00731cz  a2200193n  4500
=001  9880363317902441
=005  20141212195349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001895
=035  \\$aCAZ5060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x108
=072  \\$aD1.$x268.$x513.$x500
=150  \\$aBoron
=550  \\$wg$aElements
=550  \\$wg$aMetalloids
=667  \\$aB-11; B-10 = BORON (IM) + ISOTOPES (NIM); B-8, 9, 12, 13 = BORON (IM) + RADIOISOTOPES (IM)
=680  \\$iA trace element with the atomic symbol B, atomic number 5, and atomic weight [10.806; 10.821]. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY.
=750  \0$aBoron$5IEN$0(DLC)sh 85015871

=LDR  01166cz  a2200229n  4500
=001  9880363318002441
=005  20141212195348.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001891
=035  \\$aCAZ5056M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x149.$x135
=072  \\$aB4.$x909.$x777.$x455.$x149.$x135
=150  \\$aBorna disease virus
=450  \\$wnnna$aEncephalomyelitis Virus, Enzootic
=450  \\$aEnzootic Encephalomyelitis Virus
=450  \\$aNear East Equine Encephalomyelitis Virus
=550  \\$wg$aBornaviridae
=667  \\$ainfection = BORNA DISEASE; DF: BORNA DIS VIRUS
=680  \\$iA species in the genus Bornavirus, family BORNAVIRIDAE, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East.
=688  \\$a91(75); was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76
=750  \0$aBorna disease virus$5IEN-M$0(DLC)sh2002000824

=LDR  00570cz  a2200193n  4500
=001  9880363318102441
=005  20141212195348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001890
=035  \\$aCAZ5055M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x124
=072  \\$aC22.$x152
=150  \\$aBorna Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aMononegavirales Infections
=680  \\$iAn encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.
=688  \\$a70
=750  \0$aBorna disease$5IEN-M$0(DLC)sh2002000829

=LDR  00688cz  a2200241n  4500
=001  9880363318202441
=005  20141212195348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001888
=035  \\$aCAZ5053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x93
=072  \\$aD1.$x132.$x250
=072  \\$aD2.$x203.$x130
=150  \\$aBoric Acids
=450  \\$wnnna$aAcids, Boric
=450  \\$aBoric Acid$5IEN
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aBoron Compounds
=550  \\$wh$aBorates
=680  \\$iInorganic and organic derivatives of boric acid either B(OH)3 or, preferably H3BO3.
=688  \\$a68
=750  \0$aBoric acid$5IEN$0(DLC)sh 85015848

=LDR  00580cz  a2200193n  4500
=001  9880363318302441
=005  20141212195347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001887
=035  \\$aCAZ5052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x192
=150  \\$aBoredom
=450  \\$wnnna$aBoredoms
=550  \\$wg$aEmotions
=667  \\$ano qualif
=680  \\$iA psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation.
=688  \\$a69
=750  \0$aBoredom$5IEN$0(DLC)sh 85015828

=LDR  00757cz  a2200205n  4500
=001  9880363318402441
=005  20141212195347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001886
=035  \\$aCAZ5051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x117.$x75.$x550
=072  \\$aB3.$x660.$x75.$x27.$x75.$x600
=150  \\$aBordetella pertussis
=450  \\$aHaemophilus pertussis
=450  \\$wnnna$aHemophilus pertussis
=550  \\$wg$aBordetella
=667  \\$ainfection = WHOOPING COUGH
=680  \\$iA species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath.
=750  \0$aBordetella pertussis$5IEN$0(DLC)sh 85015826

=LDR  00789cz  a2200229n  4500
=001  9880363318502441
=005  20141212195347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001884
=035  \\$aCAZ5049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x117.$x75
=072  \\$aB3.$x660.$x75.$x27.$x75
=150  \\$aBordetella
=550  \\$wg$aAlcaligenaceae
=550  \\$wh$aBordetella avium
=550  \\$wh$aBordetella bronchiseptica
=550  \\$wh$aBordetella parapertussis
=550  \\$wh$aBordetella pertussis
=667  \\$ainfection = BORDETELLA INFECTIONS
=680  \\$iA genus of gram-negative, aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species.
=750  \0$aBordetella$5IEN$0(DLC)sh 85015825

=LDR  01049cz  a2200241n  4500
=001  9880363318602441
=005  20141212195346.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001883
=035  \\$aCAZ5048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x100
=150  \\$aBorderline Personality Disorder
=450  \\$wnnna$aBorderline Personality Disorders
=450  \\$wnnna$aDisorder, Borderline Personality
=450  \\$wnnna$aDisorders, Borderline Personality
=450  \\$aPersonality Disorder, Borderline
=450  \\$wnnna$aPersonality Disorders, Borderline
=550  \\$wg$aPersonality Disorders
=667  \\$a"borderline" is a psychiatric diag: follow text
=680  \\$iA personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
=688  \\$a90(81); was see under PERSONALITY DISORDERS 1981-89
=750  \0$aBorderline personality disorder$5IEN$0(DLC)sh 85015821

=LDR  00950cz  a2200217n  4500
=001  9880363318702441
=005  20141212195346.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001882
=035  \\$aCAZ5047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350.$x675.$x100
=072  \\$aC22.$x836.$x160
=150  \\$aBorder Disease
=450  \\$wnnna$aBorder Diseases
=550  \\$wg$aPestivirus Infections
=550  \\$wg$aSheep Diseases
=667  \\$acaused by a pestivirus; border refers to the English-Welsh border where there is a high mortal among sheep from this dis; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
=680  \\$iCongenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus.
=688  \\$a91(85); was see under SHEEP DISEASES 1985-90
=750  \0$aBorder disease$5IEN-M$0(DLC)sh 92005730

=LDR  00580cz  a2200205n  4500
=001  9880363318802441
=005  20141212195346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001881
=035  \\$aCAZ5046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x132.$x250.$x75
=072  \\$aD1.$x248.$x497.$x158.$x76
=072  \\$aD2.$x203.$x130.$x75
=150  \\$aBorates
=550  \\$wg$aAnions
=550  \\$wg$aBoric Acids
=667  \\$ado not confuse with BORANES
=680  \\$iInorganic or organic salts and esters of boric acid.
=750  \0$aBorates$5IEN$0(DLC)sh 85015805

=LDR  01628cz  a2200481n  4500
=001  9880363318902441
=005  20141212195302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001749
=035  \\$aCAZ4910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x947.$x960
=072  \\$aC12.$x758.$x820.$x968
=072  \\$aC12.$x777.$x829.$x813
=072  \\$aC13.$x351.$x937.$x820.$x945
=072  \\$aC13.$x351.$x968.$x829.$x707
=150  \\$aUrinary Bladder Neoplasms
=450  \\$aBladder Cancer
=450  \\$wnnna$aBladder Cancers
=450  \\$wnnna$aBladder Neoplasm
=450  \\$aBladder Neoplasms
=450  \\$wnnna$aBladder Tumor
=450  \\$wnnna$aBladder Tumors
=450  \\$wnnna$aCancer, Bladder
=450  \\$aCancer of Bladder
=450  \\$wnnna$aCancer of the Bladder
=450  \\$wnnna$aCancer, Urinary Bladder
=450  \\$wnnna$aMalignant Tumor of Urinary Bladder
=450  \\$wnnna$aNeoplasm, Bladder
=450  \\$wnnna$aNeoplasm, Urinary Bladder
=450  \\$wnnna$aNeoplasms, Bladder
=450  \\$wnnna$aTumor, Bladder
=450  \\$wnnna$aTumors, Bladder
=450  \\$wnnna$aUrinary Bladder Cancer
=450  \\$wnnna$aUrinary Bladder Neoplasm
=550  \\$wg$aUrinary Bladder Diseases
=550  \\$wg$aUrologic Neoplasms
=667  \\$acoordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the URINARY BLADDER.
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder Neoplasms
=750  \0$aBladder$xCancer$0(IEN)366501$5IEN-M
=750  \0$aBladder$xTumors$0(DLC) sh 85014738$5IEN-HS

=LDR  01062cz  a2200253n  4500
=001  9880363319002441
=005  20141212195301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001748
=035  \\$aCAZ4909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x767.$x700.$x962
=072  \\$aC12.$x777.$x829.$x760
=072  \\$aC13.$x351.$x968.$x767.$x700.$x850
=072  \\$aC13.$x351.$x968.$x829.$x601
=150  \\$aUrinary Bladder Neck Obstruction
=450  \\$aBladder Neck Obstruction
=450  \\$wnnna$aBladder Outlet Obstruction
=550  \\$wg$aUrethral Obstruction
=550  \\$wg$aUrinary Bladder Diseases
=680  \\$iBlocked urine flow through the bladder neck, the narrow internal urethral opening at the base of the URINARY BLADDER. Narrowing or strictures of the URETHRA can be congenital or acquired. It is often observed in males with enlarged PROSTATE glands.
=688  \\$a2007 (1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder Neck Obstruction
=750  \0$aBladder$xObstructions$0(DLC) sh 93002060$5IEN

=LDR  00960cz  a2200277n  4500
=001  9880363319102441
=005  20180328093809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001810
=035  \\$aCAZ4972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x130
=072  \\$aG9.$x330.$x380.$x92
=150  \\$aBlood Volume
=450  \\$wnnna$aBlood Volumes
=450  \\$wnnna$aVolume, Blood
=450  \\$wnnna$aVolumes, Blood
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aHemodynamics
=550  \\$wh$aCerebral Blood Volume
=550  \\$wh$aErythrocyte Volume
=550  \\$wh$aPlasma Volume
=550  \\$aHypovolemia
=667  \\$aPLASMA VOLUME; ERYTHROCYTE VOLUME; & ERYTHROCYTE VOLUME, PACKED are also available; coord IM with disease /physiopathol (IM), not /blood
=680  \\$iVolume of circulating BLOOD. It is the sum of the PLASMA VOLUME and ERYTHROCYTE VOLUME.
=750  \0$aBlood volume$5IEN$0(DLC)sh 85015031

=LDR  01485cz  a2200385n  4500
=001  9880363319202441
=005  20141212195301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001746
=035  \\$aCAZ4907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x132
=072  \\$aC12.$x777.$x829.$x132
=072  \\$aC13.$x351.$x875.$x132
=072  \\$aC13.$x351.$x968.$x829.$x132
=072  \\$aC16.$x131.$x939.$x132
=150  \\$aBladder Exstrophy
=450  \\$wnnna$aBladder Exstrophies
=450  \\$wnnna$aBladder Extrophies
=450  \\$wnnna$aBladder Extrophy
=450  \\$wnnna$aExstrophies, Bladder
=450  \\$wnnna$aExstrophies, Urinary Bladder
=450  \\$wnnna$aExstrophy, Bladder
=450  \\$wnnna$aExstrophy Of Bladder
=450  \\$wnnna$aExstrophy of the Bladder
=450  \\$wnnna$aExstrophy, Urinary Bladder
=450  \\$wnnna$aExtrophies, Bladder
=450  \\$wnnna$aExtrophy, Bladder
=450  \\$wnnna$aUrinary Bladder Exstrophies
=450  \\$wnnna$aUrinary Bladder Exstrophy
=550  \\$wg$aUrinary Bladder Diseases
=550  \\$wg$aUrogenital Abnormalities
=680  \\$iA birth defect in which the URINARY BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.
=688  \\$a65(63)
=750  \0$aBladder exstrophy$5IEN$0(DLC)sh 85014741

=LDR  01065cz  a2200241n  4500
=001  9880363319302441
=005  20141212195325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001809
=035  \\$aCAZ4971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x370.$x124
=072  \\$aG9.$x330.$x380.$x630.$x110
=150  \\$aBlood Viscosity
=450  \\$wnnna$aBlood Viscosities
=450  \\$wnnna$aViscosities, Blood
=450  \\$wnnna$aViscosity, Blood
=550  \\$wg$aHemorheology
=550  \\$aHemorheology
=550  \\$aViscosity
=667  \\$acoord IM with disease /blood (IM), not /physiopathol
=680  \\$iThe internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA.
=750  \0$aBlood$xViscosity$5IEN$0(DLC)sh 85014956

=LDR  01202cz  a2200361n  4500
=001  9880363319402441
=005  20141212195300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001745
=035  \\$aCAZ4906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829
=072  \\$aC13.$x351.$x968.$x829
=150  \\$aUrinary Bladder Diseases
=450  \\$wnnna$aBladder Disease
=450  \\$aBladder Diseases
=450  \\$wnnna$aUrinary Bladder Disease
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aBladder Exstrophy
=550  \\$wh$aCystitis
=550  \\$wh$aCystocele
=550  \\$wh$aUrinary Bladder Calculi
=550  \\$wh$aUrinary Bladder Fistula
=550  \\$wh$aUrinary Bladder Neck Obstruction
=550  \\$wh$aUrinary Bladder Neoplasms
=550  \\$wh$aUrinary Bladder, Neurogenic
=550  \\$wh$aUrinary Bladder, Overactive
=550  \\$wh$aVesico-Ureteral Reflux
=667  \\$ageneral: prefer specifics; inflammatory disease = CYSTITIS
=680  \\$iPathological processes of the URINARY BLADDER.
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder Diseases
=750  \0$aBladder$xDiseases$0(DLC) sh 85014727$5IEN

=LDR  01261cz  a2200337n  4500
=001  9880363319502441
=005  20141212195324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001808
=035  \\$aCAZ4970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231
=150  \\$aBlood Vessels
=360  \\$iconsider also terms at$aANGI-$aVASA-$aVASC-$aVASO-
=450  \\$wnnna$aBlood Vessel
=450  \\$wnnna$aVessel, Blood
=450  \\$wnnna$aVessels, Blood
=550  \\$wg$aCardiovascular System
=550  \\$wh$aArteries
=550  \\$wh$aEndothelium, Vascular
=550  \\$wh$aMicrovessels
=550  \\$wh$aMuscle, Smooth, Vascular
=550  \\$wh$aRetinal Vessels
=550  \\$wh$aTunica Intima
=550  \\$wh$aVasa Nervorum
=550  \\$wh$aVasa Vasorum
=550  \\$wh$aVeins
=667  \\$ageneral only: prefer specifics; prefer /blood supply with anatomical terms: Manual 21.4+; permeability = VASCULAR PERMEABILITY see CAPILLARY PERMEABILITY; inflammation = VASCULITIS or its specifics
=680  \\$iAny of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins).
=688  \\$a/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65
=750  \0$aBlood-vessels$0(DLC) sh 85015021$5IEN

=LDR  01389cz  a2200361n  4500
=001  9880363319602441
=005  20141212195324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001807
=035  \\$aCAZ4969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x110
=150  \\$aBlood Vessel Prosthesis
=450  \\$wnnna$aBlood Vessel Prostheses
=450  \\$wnnna$aGraft, Tissue-Engineered Vascular
=450  \\$wnnna$aGrafts, Tissue-Engineered Vascular
=450  \\$wnnna$aProstheses, Blood Vessel
=450  \\$wnnna$aProstheses, Vascular
=450  \\$wnnna$aProsthesis, Blood Vessel
=450  \\$wnnna$aProsthesis, Vascular
=450  \\$wnnna$aTissue-Engineered Vascular Graft
=450  \\$wnnna$aTissue Engineered Vascular Graft
=450  \\$wnnna$aTissue-Engineered Vascular Grafts
=450  \\$wnnna$aVascular Graft, Tissue-Engineered
=450  \\$wnnna$aVascular Grafts, Tissue-Engineered
=450  \\$wnnna$aVascular Prostheses
=450  \\$aVascular Prosthesis
=450  \\$wnnna$aVessel Prostheses, Blood
=450  \\$wnnna$aVessel Prosthesis, Blood
=550  \\$wg$aProstheses and Implants
=550  \\$aBlood Vessel Prosthesis Implantation
=680  \\$iDevice constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels.
=750  \0$aBlood vessel prosthesis$5IEN$0(DLC)sh 85015020

=LDR  01985cz  a2200565n  4500
=001  9880363319702441
=005  20141212195300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001744
=035  \\$aCAZ4905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829.$x720
=072  \\$aC12.$x777.$x967.$x500.$x925
=072  \\$aC13.$x351.$x968.$x829.$x521
=072  \\$aC13.$x351.$x968.$x967.$x500.$x925
=072  \\$aC23.$x300.$x175.$x850.$x875
=150  \\$aUrinary Bladder Calculi
=450  \\$wnnna$aBladder Calculi
=450  \\$wnnna$aBladder Calculi, Urinary
=450  \\$wnnna$aBladder Calculus
=450  \\$wnnna$aBladder Calculus, Urinary
=450  \\$wnnna$aBladder Stone
=450  \\$wnnna$aBladder Stone, Urinary
=450  \\$wnnna$aBladder Stones
=450  \\$wnnna$aBladder Stones, Urinary
=450  \\$wnnna$aCalculi, Bladder
=450  \\$wnnna$aCalculi of Urinary Bladder
=450  \\$wnnna$aCalculi, Urinary Bladder
=450  \\$wnnna$aCalculi, Vesical
=450  \\$wnnna$aCalculus, Bladder
=450  \\$wnnna$aCalculus, Urinary Bladder
=450  \\$wnnna$aCalculus, Vesical
=450  \\$wnnna$aCystolith
=450  \\$wnnna$aCystoliths
=450  \\$wnnna$aStone, Bladder
=450  \\$wnnna$aStone, Urinary Bladder
=450  \\$wnnna$aStones, Bladder
=450  \\$wnnna$aStones, Urinary Bladder
=450  \\$wnnna$aUrinary Bladder Calculus
=450  \\$wnnna$aUrinary Bladder Stone
=450  \\$aUrinary Bladder Stones
=450  \\$aVesical Calculi
=450  \\$wnnna$aVesical Calculus
=550  \\$wg$aUrinary Bladder Diseases
=550  \\$wg$aUrinary Calculi
=667  \\$achemical composition of calculi: use /chem; /ultrastruct permitted
=680  \\$iStones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.
=688  \\$a2007 (1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder Calculi
=750  \0$aBladder$xCalculi$0(DLC) sh 85014726$5IEN

=LDR  00792cz  a2200229n  4500
=001  9880363319802441
=005  20141212195259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001743
=035  \\$aCAZ4904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x890
=150  \\$aUrinary Bladder
=360  \\$iconsider also terms at$aCYST-$aVESIC-
=450  \\$aBladder
=450  \\$wnnna$aBladder, Urinary
=550  \\$wg$aUrinary Tract
=667  \\$ainflammation = CYSTITIS
=680  \\$iA musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
=688  \\$a2007 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder
=750  \0$aBladder$0(DLC) sh 85014724$5IEN

=LDR  01352cz  a2200361n  4500
=001  9880363319902441
=005  20141212195323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001805
=035  \\$aCAZ4967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x264
=072  \\$aE2.$x467.$x500
=150  \\$aBlood Transfusion, Intrauterine
=450  \\$wnnna$aBlood Transfusions, Intrauterine
=450  \\$aFetal Transfusion
=450  \\$wnnna$aFetal Transfusions
=450  \\$wnnna$aIntrauterine Blood Transfusion
=450  \\$wnnna$aIntrauterine Blood Transfusions
=450  \\$aIntrauterine Transfusion
=450  \\$wnnna$aIntrauterine Transfusions
=450  \\$wnnna$aTransfusion, Fetal
=450  \\$wnnna$aTransfusion, Intrauterine
=450  \\$wnnna$aTransfusion, Intrauterine Blood
=450  \\$wnnna$aTransfusions, Fetal
=450  \\$wnnna$aTransfusions, Intrauterine
=450  \\$wnnna$aTransfusions, Intrauterine Blood
=550  \\$wg$aBlood Transfusion
=550  \\$wg$aFetal Therapies
=667  \\$acoordinate with specific type of transfusion if pertinent
=680  \\$iIn utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL).
=688  \\$a68(65)
=750  \0$aBlood$xTransfusion, Intrauterine$5IEN$0(DLC)sh 85014954

=LDR  01091cz  a2200313n  4500
=001  9880363320002441
=005  20141212195259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001742
=035  \\$aCAZ4903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x530.$x650.$x228
=150  \\$aBlackwater Fever
=450  \\$wnnna$aBlack Water Fever
=450  \\$wnnna$aBlack Water Fevers
=450  \\$wnnna$aBlackwater Fevers
=450  \\$wnnna$aFever, Black Water
=450  \\$wnnna$aFever, Blackwater
=450  \\$wnnna$aFevers, Black Water
=450  \\$wnnna$aFevers, Blackwater
=450  \\$wnnna$aHemolytic Malaria
=450  \\$wnnna$aHemolytic Malarias
=450  \\$aMalaria, Hemolytic
=450  \\$wnnna$aMalarias, Hemolytic
=550  \\$wg$aMalaria, Falciparum
=667  \\$ado not confuse with BLACK FEVER see LEISHMANIASIS, VISCERAL or AMAZON BLACK FEVER see HEPATITIS D
=680  \\$iA complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine.
=688  \\$a1991(1975)
=750  \0$aBlackwater fever$5IEN$0(DLC)sh 85014715

=LDR  01893nz  a2200397n  4500
=001  9882549680302441
=005  20250214135604.0
=008  750725\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001741
=035  \\$a(DNLM)D001741
=035  \\$a(NLM)98195841920000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x500
=072  \\$aM1.$x686.$x372.$x500
=072  \\$aM1.$x686.$x477.$x625.$x594.$x594
=150  \\$aBlack or African American
=450  \\$wnnna$aAfrican-Americans
=450  \\$wnnna$aNegro
=450  \\$aAfrican American
=450  \\$aAfrican-American
=450  \\$aAfrican Americans
=450  \\$aAfro-American
=450  \\$aAfro-Americans
=450  \\$aBlack Americans
=450  \\$aBlacks
=450  \\$aNegroes
=450  \\$wnnna$aAfro American
=450  \\$wnnna$aAfro Americans
=450  \\$wnnna$aAmerican, African
=450  \\$wnnna$aAmerican, Black
=450  \\$wnnna$aBlack American
=667  \\$ause only for the United States population groups. BLACK PEOPLE is also available
=680  \\$iPersons living in the United States having origins in any of the black racial groups of Africa, who identifies as having African ancestry.
=680  \\$iA person having origins in any of the black racial groups of Africa (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2023(2004); for BLACKS use BLACK PEOPLE 2004-2022
=750  \0$aAfrican Americans$5IEN-M$0(DLC)sh 85001932

=LDR  01050cz  a2200289n  4500
=001  9880363320202441
=005  20141212195323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001804
=035  \\$aCAZ4966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x164
=150  \\$aBlood Transfusion, Autologous
=450  \\$wnnna$aAutologous Blood Transfusion
=450  \\$wnnna$aAutologous Blood Transfusions
=450  \\$aAutotransfusion
=450  \\$wnnna$aAutotransfusions
=450  \\$aBlood Reinfusion$5IEN-M
=450  \\$wnnna$aBlood Transfusions, Autologous
=450  \\$wnnna$aTransfusion, Autologous Blood
=450  \\$wnnna$aTransfusions, Autologous Blood
=550  \\$wg$aBlood Transfusion
=550  \\$aOperative Blood Salvage
=667  \\$ado not use /util except by MeSH definition; DF: BLOOD TRANSFUSION AUTOL
=680  \\$iReinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed)
=688  \\$a71
=750  \0$aBlood$xTransfusion, Autologous$5IEN$0(DLC)sh 85014953

=LDR  01120cz  a2200265n  4500
=001  9880363320302441
=005  20141212195322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001803
=035  \\$aCAZ4965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135
=150  \\$aBlood Transfusion
=450  \\$wnnna$aBlood Transfusions
=450  \\$wnnna$aTransfusion, Blood
=450  \\$wnnna$aTransfusions, Blood
=550  \\$wg$aBiological Therapy
=550  \\$wh$aBlood Component Transfusion
=550  \\$wh$aBlood Transfusion, Autologous
=550  \\$wh$aBlood Transfusion, Intrauterine
=550  \\$wh$aExchange Transfusion, Whole Blood
=550  \\$wh$aPlasma Exchange
=667  \\$aTN 186: differentiate among various "transfusion" concepts; do not use /util except by MeSH definition; for whole blood or unspecified transfusion: note that BLOOD COMPONENT TRANSFUSION & BLOOD COMPONENT REMOVAL & its specifics are available
=680  \\$iThe introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)
=750  \0$aBlood$xTransfusion$5IEN$0(DLC)sh 85014949

=LDR  01015cz  a2200289n  4500
=001  9880363320402441
=005  20141212195258.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001740
=035  \\$aCAZ4901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x803.$x200
=150  \\$aBlack Widow Spider
=450  \\$wnnna$aBlack Widow Spiders
=450  \\$wnnna$aLatrodectus mactan
=450  \\$aLatrodectus mactans
=450  \\$wnnna$amactan, Latrodectus
=450  \\$wnnna$amactans, Latrodectus
=450  \\$wnnna$aSpider, Black Widow
=450  \\$wnnna$aSpiders, Black Widow
=450  \\$wnnna$aWidow Spider, Black
=450  \\$wnnna$aWidow Spiders, Black
=550  \\$wg$aSpiders
=667  \\$a/microbiol /parasitol /virol permitted; bite: coord IM with SPIDER BITES (IM)
=680  \\$iA venomous New World spider with an hourglass-shaped red mark on the abdomen.
=688  \\$a91(75); was see under SPIDERS 1975-90
=750  \0$aBlack widow spider$5IEN$0(DLC)sh 85014642

=LDR  00986cz  a2200217n  4500
=001  9880363320502441
=005  20141212195257.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001738
=035  \\$aCAZ4899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x85
=150  \\$aBiuret Reaction
=450  \\$wnnna$aBiuret Reactions
=450  \\$wnnna$aReaction, Biuret
=450  \\$wnnna$aReactions, Biuret
=550  \\$wg$aChemistry Techniques, Analytical
=667  \\$ado not confuse with BIURET: biuret reaction or method no longer uses BIURET as signif reagent
=680  \\$iA reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.
=688  \\$a91(75); was see under CHEMISTRY, ANALYTICAL 1975-90
=750  \0$aBiuret reaction$5IEN$0(DLC)sh 85014491

=LDR  02206cz  a2200601n  4500
=001  9880363320602441
=005  20141212195322.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001802
=035  \\$aCAZ4964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x140
=072  \\$aJ1.$x637.$x87.$x249
=150  \\$aBlood Substitutes
=450  \\$aArtificial Blood
=450  \\$wnnna$aArtificial Bloods
=450  \\$wnnna$aArtificial Erythrocyte
=450  \\$aArtificial Erythrocytes
=450  \\$aArtificial Hemoglobin
=450  \\$wnnna$aArtificial Hemoglobins
=450  \\$aBlood, Artificial
=450  \\$wnnna$aBlood Substitute
=450  \\$wnnna$aBloods, Artificial
=450  \\$wnnna$aCell Substitute, Red
=450  \\$wnnna$aCell Substitutes, Red
=450  \\$wnnna$aErythrocyte, Artificial
=450  \\$wnnna$aErythrocyte Substitute
=450  \\$aErythrocyte Substitutes
=450  \\$wnnna$aErythrocytes, Artificial
=450  \\$wnnna$aHemoglobin, Artificial
=450  \\$wnnna$aHemoglobin Substitute
=450  \\$aHemoglobin Substitutes
=450  \\$wnnna$aHemoglobins, Artificial
=450  \\$wnnna$aRed Cell Substitute
=450  \\$aRed Cell Substitutes
=450  \\$wnnna$aSubstitute, Blood
=450  \\$wnnna$aSubstitute, Erythrocyte
=450  \\$wnnna$aSubstitute, Hemoglobin
=450  \\$wnnna$aSubstitute, Red Cell
=450  \\$wnnna$aSubstitutes, Blood
=450  \\$wnnna$aSubstitutes, Erythrocyte
=450  \\$wnnna$aSubstitutes, Hemoglobin
=450  \\$wnnna$aSubstitutes, Red Cell
=550  \\$wg$aBiomimetic Materials
=550  \\$wg$aHematologic Agents
=550  \\$wh$aPlasma Substitutes
=550  \\$aArtificial Cells
=550  \\$aBloodless Medical and Surgical Procedures
=550  \\$aFluorocarbons
=667  \\$aPLASMA SUBSTITUTES is also available
=680  \\$iSubstances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs.
=688  \\$a81; was see PLASMA SUBSTITUTES 1963-80
=750  \0$aBlood substitutes$5IEN$0(DLC)sh 88004456

=LDR  00893cz  a2200325n  4500
=001  9880363320702441
=005  20141212195256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001733
=035  \\$aCAZ4894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x127
=072  \\$aC26.$x176
=150  \\$aBites and Stings
=450  \\$wnnna$aBite
=450  \\$wnnna$aBites
=450  \\$wnnna$aSting
=450  \\$aStings
=450  \\$wnnna$aStings and Bites
=550  \\$wg$aPoisoning
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBites, Human
=550  \\$wh$aInsect Bites and Stings
=550  \\$wh$aScorpion Stings
=550  \\$wh$aSnake Bites
=550  \\$wh$aSpider Bites
=550  \\$wh$aTick Bites
=550  \\$aAllergens
=667  \\$acoordinate IM with biter (IM) but note specifics are available
=750  \0$aBites and stings$5IEN$0(DLC)sh 85014468

=LDR  00693cz  a2200217n  4500
=001  9880363320802441
=005  20141212195321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001801
=035  \\$aCAZ4963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x780.$x937.$x206
=150  \\$aBlood Stains
=450  \\$wnnna$aBlood Stain
=450  \\$aBloodstains$5IEN
=450  \\$wnnna$aStain, Blood
=450  \\$wnnna$aStains, Blood
=550  \\$wg$aForensic Medicine
=667  \\$ano qualif
=680  \\$iAntigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases.
=750  \0$aBloodstains$0(DLC) sh 85015036$5IEN

=LDR  00710cz  a2200205n  4500
=001  9880363320902441
=005  20141212195255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001729
=035  \\$aCAZ4890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x100
=072  \\$aD1.$x552.$x544.$x100
=150  \\$aBismuth
=450  \\$wnno$aBismuth-Arsenic Compounds$5IEN-M
=550  \\$wg$aMetals, Heavy
=667  \\$aBi-209; Bi-199-208, 210-215 = BISMUTH (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.
=688  \\$aBISMUTH-ARSENIC COMPOUNDS was heading 1963-91
=750  \0$aBismuth$5IEN-M$0(DLC)sh 85014436

=LDR  00796cz  a2200217n  4500
=001  9880363321002441
=005  20141212195255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001728
=035  \\$aCAZ4889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x446.$x520.$x203
=072  \\$aD3.$x830.$x219.$x446.$x520.$x203
=150  \\$aDicumarol
=450  \\$aBishydroxycoumarin
=450  \\$wnnna$aDicoumarin
=450  \\$wnnna$aDicoumarol
=550  \\$wg$a4-Hydroxycoumarins
=680  \\$iAn oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.
=688  \\$a96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95
=750  \0$aDicumarol$5IEN$0(DLC)sh 85037708

=LDR  01117cz  a2200301n  4500
=001  9880363321102441
=005  20141212195321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001800
=035  \\$aCAZ4962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x110
=072  \\$aE4.$x665.$x150
=072  \\$aE5.$x200.$x998.$x110
=150  \\$aBlood Specimen Collection
=450  \\$wnnna$aBlood Specimen Collections
=450  \\$wnnna$aCollection, Blood Specimen
=450  \\$wnnna$aCollections, Blood Specimen
=450  \\$wnnna$aSpecimen Collection, Blood
=450  \\$wnnna$aSpecimen Collections, Blood
=550  \\$wg$aPunctures
=550  \\$wg$aSpecimen Handling
=550  \\$wh$aCordocentesis
=550  \\$wh$aPetrosal Sinus Sampling
=550  \\$wh$aPhlebotomy
=667  \\$aincludes "handling"
=680  \\$iThe taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc.
=750  \0$aBlood$xCollection and preservation$5IEN$0(DLC)sh 85014938

=LDR  00705cz  a2200217n  4500
=001  9880363321202441
=005  20141212195255.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001727
=035  \\$aCAZ4888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x975.$x200
=072  \\$aG8.$x686.$x867.$x200
=150  \\$aBisexuality
=450  \\$wnnna$aBisexual
=450  \\$wnnna$aBisexuals
=550  \\$wg$aSexuality
=667  \\$anote category: do not confuse with HERMAPHRODITISM see DISORDERS OF SEX DEVELOPMENT
=680  \\$iThe sexual attraction or relationship between members of both the same and the opposite SEX.
=688  \\$a88
=750  \0$aBisexuality$0(DLC) sh 85014412$5IEN

=LDR  00823cz  a2200229n  4500
=001  9880363321302441
=005  20141212195255.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001725
=035  \\$aCAZ4886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601.$x250
=150  \\$aBis(Chloromethyl) Ether
=450  \\$wnnna$aBis(Chloromethyl)Ether
=450  \\$aChloromethyl Ether
=450  \\$aDichloromethyl Ether
=450  \\$wnnna$aEther, Chloromethyl
=450  \\$wnnna$aEther, Dichloromethyl
=550  \\$wg$aMethyl Ethers
=680  \\$iA substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.
=688  \\$a91(79); was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78
=750  \0$aDichloromethyl ether$5IEN$0(DLC)sh 85037668

=LDR  01082cz  a2200289n  4500
=001  9880363321402441
=005  20141212195321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001799
=035  \\$aCAZ4961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x125
=072  \\$aE5.$x200.$x625.$x125
=150  \\$aBlood Sedimentation
=450  \\$aErythrocyte Sedimentation
=450  \\$wnnna$aErythrocyte Sedimentation Rate
=450  \\$wnnna$aErythrocyte Sedimentation Rates
=450  \\$wnnna$aRate, Erythrocyte Sedimentation
=450  \\$wnnna$aRates, Erythrocyte Sedimentation
=450  \\$wnnna$aSedimentation, Blood
=450  \\$wnnna$aSedimentation, Erythrocyte
=450  \\$wnnna$aSedimentation Rate, Erythrocyte
=450  \\$wnnna$aSedimentation Rates, Erythrocyte
=550  \\$wg$aHematologic Tests
=667  \\$aNIM; /drug eff /rad eff permitted; coord with disease /blood, not /physiopathol
=680  \\$iMeasurement of rate of settling of erythrocytes in anticoagulated blood.
=750  \0$aBlood$xSedimentation$5IEN$0(DLC)sh 85014948

=LDR  00907cz  a2200277n  4500
=001  9880363321502441
=005  20141212195254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001724
=035  \\$aCAZ4885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144.$x186
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x186
=072  \\$aE5.$x41.$x124.$x160.$x750.$x149
=072  \\$aG7.$x100.$x100.$x160.$x120.$x186
=072  \\$aG7.$x700.$x320.$x249.$x314.$x120.$x186
=150  \\$aBirth Weight
=450  \\$wnnna$aBirth Weights
=450  \\$wnnna$aWeight, Birth
=450  \\$wnnna$aWeights, Birth
=550  \\$wg$aBody Weight
=550  \\$wh$aFetal Macrosomia
=550  \\$aFetal Weight
=667  \\$aIM
=680  \\$iThe mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
=750  \0$aBirth weight$5IEN$0(DLC)sh 85014389

=LDR  01644cz  a2200505n  4500
=001  9880363321602441
=005  20201124172904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001798
=035  \\$aCAZ4960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124
=150  \\$aBlood Proteins
=450  \\$aPlasma Proteins
=450  \\$wnnna$aProteins, Blood
=450  \\$aProteins$xblood
=450  \\$wnnna$aProteins, Plasma
=450  \\$wnnna$aProteins, Serum
=450  \\$aSerum Proteins
=550  \\$wg$aProteins
=550  \\$wh$aAcute-Phase Proteins
=550  \\$wh$aAnion Exchange Protein 1, Erythrocyte
=550  \\$wh$aAnkyrins
=550  \\$wh$abeta 2-Glycoprotein I
=550  \\$wh$aBlood Coagulation Factors
=550  \\$wh$aCholesterol Ester Transfer Proteins
=550  \\$wh$aFibrin
=550  \\$wh$aGlycophorins
=550  \\$wh$aHemoglobins
=550  \\$wh$aImmunoproteins
=550  \\$wh$aPlatelet-Derived Growth Factor
=550  \\$wh$aProtein C
=550  \\$wh$aProtein S
=550  \\$wh$aRetinol-Binding Proteins, Plasma
=550  \\$wh$aSerum Albumin
=550  \\$wh$aSerum Globulins
=550  \\$wh$aSomatomedins
=550  \\$wh$aSpectrin
=550  \\$wh$aThyroxine-Binding Proteins
=550  \\$wh$aTumor Necrosis Factor-alpha
=550  \\$wh$aVitronectin
=550  \\$aProteins
=667  \\$aGEN: avoid: prefer specifics; electrophoresis = BLOOD PROTEIN ELECTROPHORESIS
=680  \\$iProteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
=750  \0$aBlood proteins$5IEN$0(DLC)sh 85015016

=LDR  01892cz  a2200493n  4500
=001  9880363321702441
=005  20141212195254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001723
=035  \\$aCAZ4884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x775.$x500
=072  \\$aL1.$x280.$x975.$x775.$x500
=072  \\$aN1.$x224.$x935.$x849.$x500
=072  \\$aN6.$x850.$x505.$x400.$x975.$x775.$x500
=072  \\$aN6.$x850.$x520.$x308.$x985.$x775.$x500
=150  \\$aBirth Rate
=450  \\$wnnna$aAge-Specific Birth Rate
=450  \\$wnnna$aAge Specific Birth Rate
=450  \\$wnnna$aAge-Specific Birth Rates
=450  \\$wnnna$aAge-Specific Fertility Rate
=450  \\$wnnna$aAge Specific Fertility Rate
=450  \\$wnnna$aAge-Specific Fertility Rates
=450  \\$wnnna$aBirth Rate, Age-Specific
=450  \\$wnnna$aBirth Rates
=450  \\$wnnna$aBirth Rates, Age-Specific
=450  \\$wnnna$aFertility Rate
=450  \\$wnnna$aFertility Rate, Age-Specific
=450  \\$wnnna$aFertility Rates
=450  \\$wnnna$aFertility Rates, Age-Specific
=450  \\$wnnna$aRate, Age-Specific Birth
=450  \\$wnnna$aRate, Age-Specific Fertility
=450  \\$wnnna$aRate, Birth
=450  \\$wnnna$aRate, Fertility
=450  \\$wnnna$aRates, Age-Specific Birth
=450  \\$wnnna$aRates, Age-Specific Fertility
=450  \\$wnnna$aRates, Birth
=450  \\$wnnna$aRates, Fertility
=550  \\$wg$aPregnancy Rate
=667  \\$aspecify geography if pertinent
=680  \\$iThe number of births in a given population per year or other unit of time.
=688  \\$a1967: use POPULATION & VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE & AGE-SPECIFIC FERTILITY RATE use MATERNAL AGE 1980
=750  \0$aFertility, Human$vStatistics$5IEN-M$0(DLC)sh 85047901
=750  \0$aChildbirth$vStatistics$5IEN-HS$0(DLC)sh 85023408

=LDR  01023cz  a2200289n  4500
=001  9880363321802441
=005  20141212195320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001797
=035  \\$aCAZ4959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x110
=072  \\$aE5.$x196.$x401.$x76
=072  \\$aE5.$x200.$x124.$x100.$x110
=072  \\$aE5.$x301.$x300.$x49
=150  \\$aBlood Protein Electrophoresis
=450  \\$wnnna$aBlood Protein Electrophoreses
=450  \\$wnnna$aElectrophoreses, Blood Protein
=450  \\$wnnna$aElectrophoresis, Blood Protein
=450  \\$wnnna$aProtein Electrophoreses, Blood
=450  \\$wnnna$aProtein Electrophoresis, Blood
=550  \\$wg$aBlood Chemical Analysis
=550  \\$wg$aElectrophoresis
=550  \\$aImmunoelectrophoresis
=667  \\$aelectrophoresis of hemoglobin goes here + HEMOGLOBINS /analysis
=680  \\$iElectrophoresis applied to BLOOD PROTEINS.
=750  \0$aBlood protein electrophoresis$5IEN$0(DLC)sh 85015015

=LDR  00799cz  a2200277n  4500
=001  9880363321902441
=005  20141212195254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001722
=035  \\$aCAZ4883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x132
=072  \\$aI1.$x240.$x361.$x160
=072  \\$aN1.$x224.$x361.$x160
=072  \\$aN6.$x850.$x505.$x400.$x400.$x160
=150  \\$aBirth Order
=450  \\$wnnna$aBirth, First
=450  \\$wnnna$aBirth Orders
=450  \\$wnnna$aBirths, First
=450  \\$wnnna$aFirst Birth
=450  \\$wnnna$aFirst Births
=550  \\$wg$aFamily
=550  \\$wg$aFamily Characteristics
=667  \\$aIM
=680  \\$iThe sequence in which children are born into the family.
=750  \0$aBirth order$5IEN$0(DLC)sh 85014387

=LDR  01033cz  a2200325n  4500
=001  9880363322002441
=005  20141212195319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001796
=035  \\$aCAZ4958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x147
=150  \\$aBlood Protein Disorders
=450  \\$wnnna$aBlood Protein Disorder
=450  \\$wnnna$aDisorder, Blood Protein
=450  \\$wnnna$aDisorders, Blood Protein
=450  \\$wnnna$aProtein Disorder, Blood
=450  \\$wnnna$aProtein Disorders, Blood
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aAgammaglobulinemia
=550  \\$wh$aAntithrombin III Deficiency
=550  \\$wh$aDysgammaglobulinemia
=550  \\$wh$aHypergammaglobulinemia
=550  \\$wh$aHypoproteinemia
=550  \\$wh$aParaproteinemias
=550  \\$wh$aProtein C Deficiency
=550  \\$wh$aProtein S Deficiency
=550  \\$aImmune System Diseases
=667  \\$aGEN: avoid: prefer specifics
=750  \0$aBlood protein disorders$5IEN$0(DLC)sh 85015013

=LDR  00930cz  a2200277n  4500
=001  9880363322102441
=005  20141212195253.0
=008  781219\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001721
=035  \\$aCAZ4882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x361.$x150
=072  \\$aN1.$x224.$x361.$x150
=150  \\$aBirth Intervals
=450  \\$wnnna$aBirth Interval
=450  \\$aBirth Spacing
=450  \\$wnnna$aBirth Spacings
=450  \\$wnnna$aFirst Birth Interval
=450  \\$wnnna$aFirst Birth Intervals
=450  \\$wnnna$aPregnancy Interval
=450  \\$wnnna$aPregnancy Intervals
=550  \\$wg$aFamily Characteristics
=667  \\$ahuman only; may be used in physiol or family planning context
=680  \\$iThe lengths of intervals between births to women in the population.
=688  \\$a80; CHILD SPACING was see BIRTH INTERVALS 1979-92
=750  \0$aBirth intervals$5IEN$0(DLC)sh 85014386

=LDR  00845cz  a2200253n  4500
=001  9880363322202441
=005  20141212195253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001720
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x131
=072  \\$aC26.$x141
=150  \\$aBirth Injuries
=450  \\$wnnna$aBirth Injury
=450  \\$wnnna$aInjuries, Birth
=450  \\$wnnna$aInjury, Birth
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aParalysis, Obstetric
=550  \\$aDelivery, Obstetric
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; DF: BIRTH INJ
=680  \\$iMechanical or anoxic trauma incurred by the infant during labor or delivery.
=688  \\$a73; was BIRTH INJURY 1963-72
=750  \0$aBirth injuries$5IEN$0(DLC)sh 85014384

=LDR  00867cz  a2200253n  4500
=001  9880363322302441
=005  20141212195319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001795
=035  \\$aCAZ4957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x140
=072  \\$aE1.$x370.$x600.$x100
=150  \\$aBlood Pressure Determination
=450  \\$wnnna$aBlood Pressure Determinations
=450  \\$wnnna$aDetermination, Blood Pressure
=450  \\$wnnna$aDeterminations, Blood Pressure
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aPhysical Examination
=550  \\$wh$aAnkle Brachial Index
=550  \\$wh$aBlood Pressure Monitoring, Ambulatory
=667  \\$aNIM; see note on BLOOD PRESSURE
=680  \\$iTechniques for measuring blood pressure.
=750  \0$aBlood pressure$xMeasurement$5IEN$0(DLC)sh 85015011

=LDR  01073cz  a2200301n  4500
=001  9880363322402441
=005  20141212195253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001719
=035  \\$aCAZ4880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x250
=072  \\$aL1.$x280.$x900.$x250
=072  \\$aN4.$x452.$x859.$x132
=072  \\$aN5.$x715.$x360.$x300.$x715.$x175
=072  \\$aN6.$x850.$x520.$x308.$x940.$x250
=150  \\$aBirth Certificates
=450  \\$wnnna$aBirth Certificate
=450  \\$wnnna$aBirth Record
=450  \\$wnnna$aBirth Records
=450  \\$wnnna$aCertificate, Birth
=450  \\$wnnna$aCertificates, Birth
=450  \\$wnnna$aRecord, Birth
=450  \\$wnnna$aRecords, Birth
=550  \\$wg$aRecords as Topic
=667  \\$aIM
=680  \\$iOfficial certifications by a physician recording the individual's birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics.
=750  \0$aBirth certificates$5IEN$0(DLC)sh 85014366

=LDR  01427cz  a2200337n  4500
=001  9880363322502441
=005  20141212195318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001794
=035  \\$aCAZ4956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x875.$x249
=072  \\$aG9.$x330.$x380.$x76
=150  \\$aBlood Pressure
=450  \\$wnnna$aDiastolic Pressure
=450  \\$wnnna$aPressure, Blood
=450  \\$wnnna$aPressure, Diastolic
=450  \\$wnnna$aPressure, Pulse
=450  \\$wnnna$aPressure, Systolic
=450  \\$wnnna$aPressures, Systolic
=450  \\$wnnna$aPulse Pressure
=450  \\$aSystolic Pressure
=550  \\$wg$aHemodynamics
=550  \\$wg$aVital Signs
=550  \\$wh$aArterial Pressure
=550  \\$wh$aPulmonary Wedge Pressure
=550  \\$wh$aVenous Pressure
=550  \\$aPressure
=667  \\$ageneral; note specifics; "arterial" pressure = BLOOD PRESSURE and not also ARTERIES unless a specific artery; pressure within a specific vessel: coordinate vessel / physiol (IM) + BLOOD PRESSURE (NIM); do not add SYSTOLE; DIASTOLE; or PULSE unless particularly discussed; with diseases coordinate IM with disease / physiopathol (IM), not / blood (IM): Manual 23.28; blood pressure vs HYPERTENSION & HYPOTENSION: Manual 23.27+
=680  \\$iPRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
=750  \0$aBlood pressure$5IEN$0(DLC)sh 85015010

=LDR  00985cz  a2200265n  4500
=001  9880363322602441
=005  20141212195252.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001718
=035  \\$aCAZ4879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x590.$x80
=150  \\$aBirefringence
=450  \\$aBirefraction
=450  \\$wnnna$aBirefractions
=450  \\$wnnna$aBirefringences
=450  \\$aDouble Refraction
=450  \\$wnnna$aDouble Refractions
=450  \\$wnnna$aRefraction, Double
=450  \\$wnnna$aRefractions, Double
=550  \\$wg$aOptical Phenomena
=667  \\$aa principle of optics; NIM; no qualif
=680  \\$iThe property of nonisotropic media, such as crystals, whereby a single incident beam of light traverses the medium as two beams, each plane-polarized, the planes being at right angles to each other. (Cline et al., Dictionary of Visual Science, 4th ed)
=688  \\$a68(64)
=750  \0$aRefraction, Double$5IEN$0(DLC)sh 85112259

=LDR  01085cz  a2200241n  4500
=001  9880363322702441
=005  20141212195318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001793
=035  \\$aCAZ4955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x792.$x833.$x230
=072  \\$aE5.$x760.$x833.$x230
=150  \\$aBlood Preservation
=450  \\$wnnna$aBlood Preservations
=450  \\$wnnna$aPreservation, Blood
=450  \\$wnnna$aPreservations, Blood
=550  \\$wg$aTissue Preservation
=550  \\$wh$aBlood Safety
=550  \\$aTissue and Organ Harvesting
=667  \\$apreserv of whole blood or specific cellular elements; coord IM with specific cell (IM); cryopreservation of blood: coord IM with CRYOPRESERVATION (IM)
=680  \\$iThe process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
=750  \0$aBlood$xCollection and preservation$5IEN-HS$0(DLC)sh 85014938

=LDR  01054cz  a2200361n  4500
=001  9880363322802441
=005  20141212195252.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001717
=035  \\$aCAZ4878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248
=150  \\$aBirds
=450  \\$aAves
=450  \\$wnnna$aBird
=450  \\$aOrnithology$5IEN
=550  \\$wg$aVertebrates
=550  \\$wh$aAnseriformes
=550  \\$wh$aCharadriiformes
=550  \\$wh$aColumbiformes
=550  \\$wh$aFalconiformes
=550  \\$wh$aGalliformes
=550  \\$wh$aPalaeognathae
=550  \\$wh$aPasseriformes
=550  \\$wh$aPoultry
=550  \\$wh$aPsittaciformes
=550  \\$wh$aRaptors
=550  \\$wh$aSpheniscidae
=550  \\$wh$aStrigiformes
=550  \\$aAvian Proteins
=667  \\$aGeneral or unspecified; prefer specifics; differentiate from POULTRY: Manual 22.29
=680  \\$iWarm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.
=750  \0$aBirds$5IEN-M$0(DLC)sh 85014310

=LDR  01009cz  a2200277n  4500
=001  9880363322902441
=005  20141212195318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001792
=035  \\$aCAZ4954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x188
=072  \\$aA15.$x145.$x229.$x188
=150  \\$aBlood Platelets
=360  \\$iconsider also terms at$aPLATELET$aTHROMBOCYT-
=450  \\$wnnna$aBlood Platelet
=450  \\$wnnna$aPlatelet
=450  \\$wnnna$aPlatelet, Blood
=450  \\$aPlatelets
=450  \\$wnnna$aPlatelets, Blood
=450  \\$wnnna$aThrombocyte
=450  \\$aThrombocytes
=550  \\$wg$aBlood Cells
=667  \\$aA 11 qualif; decrease in no. of platelets = THROMBOCYTOPENIA, increase = THROMBOCYTOSIS; platelet factors & defic: TN 228
=680  \\$iNon-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation.
=750  \0$aBlood platelets$5IEN$0(DLC)sh 85015006

=LDR  01688cz  a2200373n  4500
=001  9880363323002441
=005  20141212195251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001715
=035  \\$aCAZ4876HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x131
=150  \\$aBird Diseases
=450  \\$wnnna$aAvian Disease
=450  \\$wnnna$aAvian Diseases
=450  \\$wnnna$aBird Disease
=450  \\$wnnna$aDisease, Avian
=450  \\$wnnna$aDisease, Bird
=450  \\$wnnna$aDiseases, Avian
=450  \\$wnnna$aDiseases, Bird
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aAvian Leukosis
=550  \\$wh$aFowlpox
=550  \\$wh$aInfluenza in Birds
=550  \\$wh$aMalaria, Avian
=550  \\$wh$aMarek Disease
=550  \\$wh$aNewcastle Disease
=550  \\$wh$aPoultry Diseases
=550  \\$wh$aReticuloendotheliosis, Avian
=550  \\$wh$aSarcoma, Avian
=550  \\$wh$aTuberculosis, Avian
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific bird dis (IM); coord IM with specific bird (IM); for abnormalities or injuries, index under BIRDS /abnorm or BIRDS /inj; don't forget also BIRDS (NIM) if no specific bird is indexed; also check tag ANIMALS; differentiate from POULTRY DISEASES on basis of distinction between BIRDS & POULTRY shown under BIRDS; DF: BIRD DIS
=680  \\$iDiseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc.
=750  \0$aBirds$xdiseases$5IEN$0(DLC)sh 85014315

=LDR  01284cz  a2200349n  4500
=001  9880363323102441
=005  20141212195317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001791
=035  \\$aCAZ4953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x140
=150  \\$aBlood Platelet Disorders
=450  \\$wnnna$aBlood Platelet Disorder
=450  \\$wnnna$aDisorder, Blood Platelet
=450  \\$wnnna$aDisorders, Blood Platelet
=450  \\$wnnna$aPlatelet Disorder, Blood
=450  \\$wnnna$aPlatelet Disorders, Blood
=450  \\$wnnna$aThrombocytopathies
=450  \\$aThrombocytopathy
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aBernard-Soulier Syndrome
=550  \\$wh$aGray Platelet Syndrome
=550  \\$wh$aPlatelet Storage Pool Deficiency
=550  \\$wh$aThrombasthenia
=550  \\$wh$aThrombocytopenia
=550  \\$wh$aThrombocytosis
=550  \\$wh$avon Willebrand Diseases
=667  \\$ado not use as coord for platelet factor defic: use COAGULATION PROTEIN DISORDERS
=680  \\$iDisorders caused by abnormalities in platelet count or function.
=688  \\$a67(64); THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66
=750  \0$aBlood platelet disorders$5IEN$0(DLC)sh 85015004

=LDR  01483cz  a2200361n  4500
=001  9880363323202441
=005  20201207172621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001789
=035  \\$aCAZ4951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290
=072  \\$aD23.$x50.$x705.$x230
=150  \\$aBlood Group Antigens
=450  \\$wnnna$aAntigens, Blood Group
=450  \\$aBlood Groups
=450  \\$wnnna$aGroups, Blood
=550  \\$wg$aAntigens, Surface
=550  \\$wg$aIsoantigens
=550  \\$wh$aABO Blood-Group System
=550  \\$wh$aDuffy Blood-Group System
=550  \\$wh$aI Blood-Group System
=550  \\$wh$aKell Blood-Group System
=550  \\$wh$aKidd Blood-Group System
=550  \\$wh$aLewis Blood-Group Antigens
=550  \\$wh$aLutheran Blood-Group System
=550  \\$wh$aMNSs Blood-Group System
=550  \\$wh$aP Blood-Group System
=550  \\$wh$aRh-Hr Blood-Group System
=550  \\$aIsoantibodies
=667  \\$ahuman or animal; blood group of animal: coord animal /blood (not /immunol) (IM) + BLOOD GROUP ANTIGENS (IM); blood group in a disease: coord BLOOD GROUP ANTIGENS or specific blood group (IM) + disease /blood (IM), not /immunol nor /genet
=680  \\$iSets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.
=750  \0$aBlood group antigens$5IEN$0(DLC)sh 85014984

=LDR  01563cz   2200457n  4500
=001  9880363323302441
=005  20240216165124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001714
=035  \\$aCAZ4875HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x84.$x500.
=150  \\$aBipolar Disorder
=450  \\$aAffective Psychosis, Bipolar
=450  \\$wnnna$aBipolar Affective Psychosis
=450  \\$wnnna$aBipolar Depression
=450  \\$wnnna$aBipolar Disorders
=450  \\$aDepression, Bipolar
=450  \\$wnnna$aDisorder, Bipolar
=450  \\$wnnna$aDisorder, Manic
=450  \\$wnnna$aMania
=450  \\$wnnna$aManias
=450  \\$wnnna$aManic-Depressive Psychoses
=450  \\$aManic-Depressive Psychosis
=450  \\$wnnna$aManic Depressive Psychosis
=450  \\$aManic Disorder
=450  \\$wnnna$aManic Disorders
=450  \\$wnnna$aManic State
=450  \\$wnnna$aManic States
=450  \\$wnnna$aPsychoses, Bipolar Affective
=450  \\$wnnna$aPsychoses, Manic-Depressive
=450  \\$wnnna$aPsychoses, Manic Depressive
=450  \\$wnnna$aPsychosis, Bipolar Affective
=450  \\$aPsychosis, Manic-Depressive
=450  \\$wnnna$aPsychosis, Manic Depressive
=450  \\$wnnna$aState, Manic
=450  \\$wnnna$aStates, Manic
=550  \\$wg$aBipolar and Related Disorders
=680  \\$iA major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
=688  \\$a81(63)
=750  \0$aBipolar disorder$5IEN$0(DLC)sh 85080541

=LDR  01309cz  a2200325n  4500
=001  9880363323402441
=005  20141212195316.0
=008  790427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001788
=035  \\$aCAZ4950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x120
=072  \\$aE1.$x370.$x225.$x812.$x385.$x120
=072  \\$aE5.$x200.$x625.$x120
=072  \\$aE5.$x200.$x812.$x385.$x120
=072  \\$aE5.$x478.$x594.$x385.$x120
=150  \\$aBlood Grouping and Crossmatching
=450  \\$wnnna$aBlood Crossmatching
=450  \\$wnnna$aBlood Grouping
=450  \\$aBlood Typing
=450  \\$aCrossmatching, Blood
=450  \\$wnnna$aGrouping, Blood
=450  \\$wnnna$aTyping, Blood
=550  \\$wg$aHematologic Tests
=550  \\$wg$aHistocompatibility Testing
=550  \\$aBlood Transfusion
=667  \\$aDF: BLOOD GROUPING or short X ref
=680  \\$iTesting erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion.
=688  \\$a80
=750  \0$aCompatibility testing (Hematology)$5IEN$0(DLC)sh 85029316

=LDR  00910cz  a2200313n  4500
=001  9880363323502441
=005  20210212102824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001713
=035  \\$aCAZ4874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x185
=150  \\$aBiphenyl Compounds
=450  \\$wnnna$aCompounds, Biphenyl
=550  \\$wg$aBenzene Derivatives
=550  \\$wh$a3,3'-Diaminobenzidine
=550  \\$wh$a3,3'-Dichlorobenzidine
=550  \\$wh$aAminobiphenyl Compounds
=550  \\$wh$aBenzidines
=550  \\$wh$aClofenapate
=550  \\$wh$aDianisidine
=550  \\$wh$aFlurbiprofen
=550  \\$wh$aLosartan
=550  \\$wh$aNiclofolan
=550  \\$wh$aPolybrominated Biphenyls
=550  \\$wh$aPolychlorinated Biphenyls
=550  \\$wh$aTelmisartan
=667  \\$aDF: BIPHENYL CPDS
=750  \0$aBiphenyl compounds$5IEN$0(DLC)sh 85014271

=LDR  01246cz  a2200277n  4500
=001  9880363323602441
=005  20141212192026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001787
=035  \\$aCAZ4949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x114
=072  \\$aG12.$x186
=150  \\$aBlood Group Incompatibility
=450  \\$wnnna$aBlood Group Incompatibilities
=450  \\$wnnna$aGroup Incompatibilities, Blood
=450  \\$wnnna$aGroup Incompatibility, Blood
=450  \\$wnnna$aIncompatibilities, Blood Group
=450  \\$wnnna$aIncompatibility, Blood Group
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aImmune System Phenomena
=550  \\$wh$aRh Isoimmunization
=550  \\$aBlood Transfusion
=667  \\$acoordinate IM with specific blood group (IM)
=680  \\$iAn antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).
=750  \0$aCompatibility testing (Hematology)$5IEN$0(DLC)sh 85029316

=LDR  01138cz  a2200241n  4500
=001  9880363323702441
=005  20180109102401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001711
=035  \\$aCAZ4872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x171.$x244
=072  \\$aG3.$x787.$x225
=072  \\$aG7.$x690.$x725.$x225
=150  \\$aBiotransformation
=550  \\$wg$aMetabolism
=550  \\$wg$aPharmacokinetics
=550  \\$wh$aActivation, Metabolic
=550  \\$wh$aInactivation, Metabolic
=667  \\$arestrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab; do not confuse with BIODEGRADATION, ENVIRONMENTAL
=680  \\$iThe chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
=688  \\$a70(66)
=750  \0$aBiotransformation (Metabolism)$0(DLC) sh 85014269$5IEN

=LDR  01943cz   2200481n  4500
=001  9880363323802441
=005  20220926172005.0
=008  880420\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015190
=035  \\$aCAZ4948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x105
=072  \\$aE1.$x370.$x374.$x100
=072  \\$aE1.$x370.$x520.$x100
=072  \\$aE2.$x900.$x100
=072  \\$aE5.$x200.$x124.$x100.$x105
=150  \\$aBlood Glucose Self-Monitoring
=450  \\$wnnna$aBlood Glucose Self Monitoring
=450  \\$wnnna$aBlood Glucose Self-Monitorings
=450  \\$aBlood Sugar Self-Monitoring
=450  \\$wnnna$aBlood Sugar Self Monitoring
=450  \\$wnnna$aBlood Sugar Self-Monitorings
=450  \\$wnnna$aGlucose, Blood, Self Monitoring
=450  \\$wnnna$aGlucose, Blood, Self-Monitoring
=450  \\$wnnna$aGlucose Self-Monitoring, Blood
=450  \\$wnnna$aGlucose Self-Monitorings, Blood
=450  \\$aHome Blood Glucose Monitoring
=450  \\$aMonitoring, Home Blood Glucose
=450  \\$aSelf-Monitoring, Blood Glucose
=450  \\$wnnna$aSelf Monitoring, Blood Glucose
=450  \\$wnnna$aSelf-Monitoring, Blood Sugar
=450  \\$wnnna$aSelf-Monitorings, Blood Glucose
=450  \\$wnnna$aSelf-Monitorings, Blood Sugar
=450  \\$wnnna$aSugar Self-Monitoring, Blood
=450  \\$wnnna$aSugar Self-Monitorings, Blood
=550  \\$wg$aBlood Chemical Analysis
=550  \\$wg$aDiagnostic Techniques, Endocrine
=550  \\$wg$aMonitoring, Physiologic
=550  \\$wg$aSelf Care
=667  \\$aNIM; coord with dis /blood, not /physiopathol; DF: BGSM
=680  \\$iSelf evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
=688  \\$a89
=750  \0$aBlood glucose monitoring$0(DLC) sh 90000834$5IEN-M

=LDR  00610cz   2200229n  4500
=001  9880363323902441
=005  20220926171840.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001786
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x359.$x448.$x500
=150  \\$aBlood Glucose
=450  \\$aBlood Sugar
=450  \\$aGlucose, Blood
=450  \\$aGlucose$xblood
=450  \\$wnnna$aSugar, Blood
=550  \\$wg$aGlucose
=550  \\$aGlucose
=550  \\$aGlycemic Index
=680  \\$iGlucose in blood.
=688  \\$a80; was BLOOD SUGAR 1963-79
=750  \0$aBlood glucose$5IEN$0(DLC)sh 85015019

=LDR  02489cz  a2200697n  4500
=001  9880363324002441
=005  20141212195249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001710
=035  \\$aCAZ4871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x80
=072  \\$aD8.$x211.$x96
=150  \\$aBiotin
=450  \\$wnnna$aBiocur Brand of Biotin
=450  \\$wnnna$aBiodermatin
=450  \\$wnnna$aBiokur
=450  \\$wnnna$aBiotin Biocur Brand
=450  \\$wnnna$aBiotin Dermapharm Brand
=450  \\$wnnna$aBiotin Gelfert
=450  \\$wnnna$aBiotin Hermes
=450  \\$wnnna$aBiotin Hermes Brand
=450  \\$wnnna$aBiotin Medopharm Brand
=450  \\$wnnna$aBiotin-ratiopharm
=450  \\$wnnna$aBiotin ratiopharm
=450  \\$wnnna$aBiotin ratiopharm Brand
=450  \\$wnnna$aBiotin Roche Brand
=450  \\$wnnna$aBiotin Simons Brand
=450  \\$wnnna$aBiotin Strathmann Brand
=450  \\$wnnna$aBiotin Ziethen Brand
=450  \\$wnnna$aBiotine Roche
=450  \\$wnnna$aBiotinratiopharm
=450  \\$wnnna$aDeacura
=450  \\$wnnna$aDermapharm Brand of Biotin
=450  \\$wnnna$ae+b Pharma Brand of Biotin
=450  \\$wnnna$aGabunat
=450  \\$wnnna$aGelfert, Biotin
=450  \\$wnnna$aH, Vitamin
=450  \\$wnnna$aHermes, Biotin
=450  \\$wnnna$aHermes Brand of Biotin
=450  \\$wnnna$aMedea Brand of Biotin Sodium Salt
=450  \\$wnnna$aMedebiotin
=450  \\$wnnna$amedobiotin
=450  \\$wnnna$aMedopharm Brand of Biotin
=450  \\$wnnna$aratiopharm Brand of Biotin
=450  \\$wnnna$aRoche, Biotine
=450  \\$wnnna$aRoche Brand of Biotin
=450  \\$wnnna$aRombellin
=450  \\$wnnna$aSimons Brand of Biotin
=450  \\$wnnna$aStrathmann Brand of Biotin
=450  \\$aVitamin H
=450  \\$wnnna$aZiethen Brand of Biotin
=550  \\$wg$aCoenzymes
=550  \\$wg$aImidazoles
=550  \\$aAvidin
=550  \\$aBiotinidase Deficiency
=550  \\$aHolocarboxylase Synthetase Deficiency
=550  \\$aMultiple Carboxylase Deficiency
=667  \\$a/ther use: coordinate disease with /drug ther, not /diet ther; deficiency: coordinate BIOTIN /defic (IM) with VITAMIN B DEFICIENCY (IM)
=680  \\$iA water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.
=750  \0$aBiotin$5IEN$0(DLC)sh 85014267

=LDR  01167cz  a2200253n  4500
=001  9880363324102441
=005  20141212195248.0
=008  860327\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001709
=035  \\$aCAZ4870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x550
=072  \\$aJ1.$x897.$x120
=150  \\$aBiotechnology
=450  \\$wnnna$aBiotechnologies
=550  \\$wg$aBiological Science Disciplines
=550  \\$wg$aTechnology
=550  \\$wh$aBiomimetics
=550  \\$wh$aBioreactors
=550  \\$wh$aIndustrial Microbiology
=667  \\$aSPEC: SPEC qualif; DF: BIOTECHNOL
=680  \\$iBody of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.
=688  \\$a87
=750  \0$aBiotechnology$5IEN$0(DLC)sh 85014263

=LDR  01322cz  a2200361n  4500
=001  9880363324202441
=005  20141212211018.0
=008  880603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015374
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x601.$x123
=150  \\$aBiosensing Techniques
=450  \\$wnnna$aBioprobe
=450  \\$aBioprobes
=450  \\$wnnna$aBiosensing Technic
=450  \\$wnnna$aBiosensing Technics
=450  \\$wnnna$aBiosensing Technique
=450  \\$wnnna$aBiosensor
=450  \\$aBiosensors
=450  \\$wnnna$aElectrode, Enzyme
=450  \\$aElectrodes, Enzyme
=450  \\$wnnna$aEnzyme Electrode
=450  \\$wnnna$aEnzyme Electrodes
=450  \\$wnnna$aTechnic, Biosensing
=450  \\$wnnna$aTechnics, Biosensing
=450  \\$wnnna$aTechnique, Biosensing
=450  \\$wnnna$aTechniques, Biosensing
=550  \\$wg$aMolecular Probe Techniques
=550  \\$wh$aSurface Plasmon Resonance
=550  \\$aMicrochemistry
=680  \\$iAny of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal.
=688  \\$a99(89)
=750  \0$aBiosensors$5IEN-M$0(DLC)sh 85014260

=LDR  02000cz  a2200433n  4500
=001  9880363324302441
=005  20141212195315.0
=008  860620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001785
=035  \\$aCAZ4946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x100.$x600.$x100
=072  \\$aE1.$x370.$x370.$x380.$x600.$x100
=072  \\$aE1.$x370.$x386.$x700.$x100.$x600.$x100
=072  \\$aE5.$x200.$x124.$x100.$x100.$x600.$x100
=150  \\$aBlood Gas Monitoring, Transcutaneous
=450  \\$wnnna$aCapnometries, Transcutaneous
=450  \\$wnnna$aCapnometry, Transcutaneous
=450  \\$aCarbon Dioxide Partial Pressure Determination, Transcutaneous
=450  \\$wnnna$aCutaneous Oximetries
=450  \\$aCutaneous Oximetry
=450  \\$aMonitoring, Transcutaneous Blood Gas$5IEN-M
=450  \\$wnnna$aOximetries, Cutaneous
=450  \\$wnnna$aOximetries, Transcutaneous
=450  \\$wnnna$aOximetry, Cutaneous
=450  \\$aOximetry, Transcutaneous
=450  \\$aOxygen Partial Pressure Determination, Transcutaneous
=450  \\$wnnna$aPtcO2
=450  \\$wnnna$aTcPCO2
=450  \\$aTranscutaneous Blood Gas Monitoring
=450  \\$wnnna$aTranscutaneous Capnometries
=450  \\$aTranscutaneous Capnometry
=450  \\$wnnna$aTranscutaneous Oximetries
=450  \\$aTranscutaneous Oximetry
=550  \\$wg$aOximetry
=667  \\$aNIM; coord with disease /blood, not /physiopathol; when IM, do not coord with OXYGEN /blood or CARBON DIOXIDE /blood; DF: TCPO2
=680  \\$iThe noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin.
=688  \\$a87
=750  \0$aTranscutaneous blood gas monitoring$5IEN$0(DLC)sh 87003496

=LDR  00971cz  a2200277n  4500
=001  9880363324402441
=005  20141212195315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001784
=035  \\$aCAZ4945HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x100
=072  \\$aE1.$x370.$x386.$x700.$x100
=072  \\$aE5.$x200.$x124.$x100.$x100
=150  \\$aBlood Gas Analysis
=450  \\$wnnna$aAnalyses, Blood Gas
=450  \\$wnnna$aAnalysis, Blood Gas
=450  \\$wnnna$aBlood Gas Analyses
=450  \\$wnnna$aGas Analyses, Blood
=450  \\$wnnna$aGas Analysis, Blood
=550  \\$wg$aBlood Chemical Analysis
=550  \\$wg$aRespiratory Function Tests
=550  \\$wh$aOximetry
=667  \\$afor determ of oxygen & carbon dioxide in the blood; NIM; coord with disease /blood, not /physiopathol
=680  \\$iMeasurement of oxygen and carbon dioxide in the blood.
=750  \0$aBlood gases$xAnalysis$5IEN$0(DLC)sh 85014983

=LDR  01473cz  a2200433n  4500
=001  9880363324502441
=005  20141212195248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001707
=035  \\$aCAZ4867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100.$x119
=072  \\$aE1.$x370.$x225.$x998.$x54.$x119
=072  \\$aE1.$x370.$x388.$x100.$x100
=072  \\$aE4.$x74.$x119
=072  \\$aE4.$x665.$x100
=072  \\$aE5.$x200.$x500.$x384.$x100.$x119
=072  \\$aE5.$x200.$x998.$x54.$x119
=072  \\$aE5.$x242.$x384.$x100.$x119
=150  \\$aBiopsy, Needle
=450  \\$wnnna$aAspiration Biopsies
=450  \\$aAspiration Biopsy
=450  \\$wnnna$aBiopsies, Aspiration
=450  \\$wnnna$aBiopsies, Needle
=450  \\$wnnna$aBiopsies, Puncture
=450  \\$wnnna$aBiopsy, Aspiration
=450  \\$wnnna$aBiopsy, Puncture
=450  \\$wnnna$aNeedle Biopsies
=450  \\$wnnna$aNeedle Biopsy
=450  \\$wnnna$aPuncture Biopsies
=450  \\$aPuncture Biopsy
=550  \\$wg$aBiopsy
=550  \\$wg$aPunctures
=550  \\$wh$aBiopsy, Fine-Needle
=550  \\$wh$aBiopsy, Large-Core Needle
=667  \\$ausually NIM with specific organ /pathol (IM) + disease /pathol (IM)
=680  \\$iRemoval and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.
=688  \\$a73
=750  \0$aNeedle biopsy$5IEN$0(DLC)sh 85014258

=LDR  01000cz  a2200265n  4500
=001  9880363324602441
=005  20141212195314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001783
=035  \\$aCAZ4944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x130
=072  \\$aG9.$x330.$x380.$x630.$x80
=150  \\$aBlood Flow Velocity
=450  \\$wnnna$aBlood Flow Velocities
=450  \\$wnnna$aFlow Velocities, Blood
=450  \\$wnnna$aFlow Velocity, Blood
=450  \\$wnnna$aVelocities, Blood Flow
=450  \\$wnnna$aVelocity, Blood Flow
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aHemorheology
=667  \\$ausually NIM; coordinate with disease / physiopathol, not / blood; do not confuse with PULSE WAVE VELOCITY see PULSE WAVE ANASLYSIS
=680  \\$iA value equal to the total volume flow divided by the cross-sectional area of the vascular bed.
=688  \\$awas in Cat E only 1963-85
=750  \0$aBlood flow$5IEN$0(DLC)sh 85014980

=LDR  01292cz  a2200373n  4500
=001  9880363324702441
=005  20141212195247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001706
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100
=072  \\$aE1.$x370.$x225.$x998.$x54
=072  \\$aE1.$x370.$x388.$x100
=072  \\$aE4.$x74
=072  \\$aE5.$x200.$x500.$x384.$x100
=072  \\$aE5.$x200.$x998.$x54
=072  \\$aE5.$x242.$x384.$x100
=150  \\$aBiopsy
=450  \\$wnnna$aBiopsies
=550  \\$wg$aCytodiagnosis
=550  \\$wg$aDiagnostic Techniques, Surgical
=550  \\$wg$aSpecimen Handling
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aBiopsy, Needle
=550  \\$wh$aChorionic Villi Sampling
=550  \\$wh$aConization
=550  \\$wh$aImage-Guided Biopsy
=550  \\$wh$aPapanicolaou Test
=550  \\$wh$aSentinel Lymph Node Biopsy
=550  \\$wh$aSpinal Puncture
=550  \\$wh$aVaginal Smears
=667  \\$aIM GEN only; NIM with specific organ /pathol (IM) + dis /pathol (IM); coord with specific technique if appropriate
=680  \\$iRemoval and pathologic examination of specimens in the form of small pieces of tissue from the living body.
=750  \0$aBiopsy$5IEN$0(DLC)sh 85014257

=LDR  00646cz  a2200241n  4500
=001  9880363324802441
=005  20141212195314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001782
=035  \\$aCAZ4943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x898.$x313
=150  \\$aBlood Donors
=450  \\$wnnna$aBlood Donation
=450  \\$wnnna$aBlood Donations
=450  \\$wnnna$aBlood Donor
=450  \\$wnnna$aDonation, Blood
=450  \\$wnnna$aDonations, Blood
=450  \\$wnnna$aDonor, Blood
=450  \\$wnnna$aDonors, Blood
=550  \\$wg$aTissue Donors
=667  \\$aIM
=750  \0$aBlood donors$5IEN$0(DLC)sh 85014978

=LDR  01401cz  a2200445n  4500
=001  9880363324902441
=005  20141212195246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001704
=035  \\$aCAZ4864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78
=072  \\$aD25.$x720.$x99
=072  \\$aJ1.$x637.$x51.$x720.$x99
=150  \\$aBiopolymers
=450  \\$wnnna$aBiopolymer
=550  \\$wg$aPolymers
=550  \\$wh$aCellulose
=550  \\$wh$aChitin
=550  \\$wh$aCollagen
=550  \\$wh$aElastin
=550  \\$wh$aGlucans
=550  \\$wh$aIntermediate Filament Proteins
=550  \\$wh$aLatex
=550  \\$wh$aLignin
=550  \\$wh$aMicrofilament Proteins
=550  \\$wh$aMicrotubule Proteins
=550  \\$wh$aPectins
=550  \\$wh$aPlant Gums
=550  \\$wh$aPlant Mucilage
=550  \\$wh$aPolyhydroxyalkanoates
=550  \\$wh$aResins, Plant
=550  \\$wh$aReticulin
=550  \\$wh$aRubber
=550  \\$wh$aSilk
=550  \\$wh$aTannins
=667  \\$aIM GEN only
=680  \\$iPolymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES.
=688  \\$a1991(1975); use MACROMOLECULAR SUBSTANCES 1975-1990
=750  \0$aBiopolymers$5IEN$0(DLC)sh 85014255

=LDR  00801cz  a2200217n  4500
=001  9880363325002441
=005  20141212195246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x344
=072  \\$aH1.$x671.$x100
=150  \\$aBiophysics
=450  \\$wnnna$aMechanobiology
=550  \\$wg$aBiological Science Disciplines
=550  \\$wg$aPhysics
=550  \\$wh$aBionics
=550  \\$wh$aElectrophysiology
=667  \\$athe discipline (education, history, etc) only; use BIOPHYSICAL PHENOMENA or specifics treed under it for biophysical characteristics and processes of biological systems
=680  \\$iThe study of PHYSICAL PHENOMENA and PHYSICAL PROCESSES as applied to living things.
=750  \0$aBiophysics$5IEN$0(DLC)sh 85014253

=LDR  00669cz  a2200205n  4500
=001  9880363325102441
=005  20141212195245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001702
=035  \\$aCAZ4862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x3
=072  \\$aH2.$x628.$x49
=150  \\$aBiopharmaceutics
=550  \\$wg$aPharmacology
=550  \\$aChemistry, Pharmaceutical
=667  \\$ageneral or specialty
=680  \\$iThe study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.
=688  \\$a70
=750  \0$aBiopharmaceutics$5IEN$0(DLC)sh 85014252

=LDR  01158cz  a2200325n  4500
=001  9880363325202441
=005  20141212195313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001780
=035  \\$aCAZ4941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x115
=072  \\$aE5.$x200.$x625.$x115
=150  \\$aBlood Coagulation Tests
=450  \\$wnnna$aBlood Coagulation Test
=450  \\$wnnna$aCoagulation Test, Blood
=450  \\$wnnna$aCoagulation Tests, Blood
=450  \\$wnnna$aTest, Blood Coagulation
=450  \\$wnnna$aTests, Blood Coagulation
=550  \\$wg$aHematologic Tests
=550  \\$wh$aInternational Normalized Ratio
=550  \\$wh$aPartial Thromboplastin Time
=550  \\$wh$aProthrombin Time
=550  \\$wh$aThrombelastography
=550  \\$wh$aThrombin Time
=550  \\$wh$aWhole Blood Coagulation Time
=550  \\$aBlood Coagulation
=667  \\$aGEN: prefer specifics; NIM; coord with disease /blood, not /physiopathol; DF: BLOOD COAG TESTS
=680  \\$iLaboratory tests for evaluating the individual's clotting mechanism.
=750  \0$aBlood coagulation tests$5IEN$0(DLC)sh 85014976

=LDR  00925cz  a2200253n  4500
=001  9880363325302441
=005  20141212195245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001701
=035  \\$aCAZ4861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x344.$x310
=072  \\$aH1.$x671.$x100.$x202
=072  \\$aH1.$x671.$x293.$x159
=150  \\$aBionics
=450  \\$wnnna$aBionic
=550  \\$wg$aBiophysics
=550  \\$wg$aElectronics
=550  \\$aCybernetics
=550  \\$aModels, Biological
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of systems, particularly electronic systems, which function after the manner of, in a manner characteristic of, or resembling living systems. Also, the science of applying biological techniques and principles to the design of electronic systems.
=688  \\$a70(66)
=750  \0$aBionics$5IEN$0(DLC)sh 85014250

=LDR  00850cz  a2200241n  4500
=001  9880363325402441
=005  20141212195245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001700
=035  \\$aCAZ4860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x750.$x185
=150  \\$aBiomphalaria
=450  \\$wnnna$aAustralorbi
=450  \\$aAustralorbis
=450  \\$wnnna$aAustralorbis glabratus
=450  \\$wnnna$aBiomphalarias
=450  \\$wnnna$aglabratus, Australorbis
=550  \\$wg$aSnails
=667  \\$afreshwater snail; /microbiol /parasitol /virol permitted
=680  \\$iA genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.
=688  \\$a72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78
=750  \0$aBiomphalaria$5IEN-HS$0(DLC)sh 88020921

=LDR  02096cz  a2200649n  4500
=001  9880363325502441
=005  20141212195313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001779
=035  \\$aCAZ4940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125
=072  \\$aD23.$x119
=150  \\$aBlood Coagulation Factors
=450  \\$wnnna$aBlood Coagulation Factor
=450  \\$wnnna$aCoagulation Factor
=450  \\$wnnna$aCoagulation Factor, Blood
=450  \\$aCoagulation Factors
=450  \\$wnnna$aCoagulation Factors, Blood
=450  \\$wnnna$aFactor, Blood Coagulation
=450  \\$wnnna$aFactor, Coagulation
=450  \\$wnnna$aFactors, Blood Coagulation
=450  \\$wnnna$aFactors, Coagulation
=550  \\$wg$aBiological Factors
=550  \\$wg$aBlood Proteins
=550  \\$wh$abeta-Thromboglobulin
=550  \\$wh$aCalcium
=550  \\$wh$aFactor IX
=550  \\$wh$aFactor V
=550  \\$wh$aFactor VII
=550  \\$wh$aFactor VIII
=550  \\$wh$aFactor X
=550  \\$wh$aFactor XI
=550  \\$wh$aFactor XII
=550  \\$wh$aFactor XIII
=550  \\$wh$aFibrinogen
=550  \\$wh$aFibrinopeptide A
=550  \\$wh$aFibrinopeptide B
=550  \\$wh$aKallikreins
=550  \\$wh$aKininogens
=550  \\$wh$aPlasminogen Activator Inhibitor 1
=550  \\$wh$aPlasminogen Activator Inhibitor 2
=550  \\$wh$aPlasminogen Activators
=550  \\$wh$aPlasminogen Inactivators
=550  \\$wh$aPlatelet Activating Factor
=550  \\$wh$aPlatelet Factor 3
=550  \\$wh$aPlatelet Factor 4
=550  \\$wh$aProthrombin
=550  \\$wh$aThrombin
=550  \\$wh$aThromboplastin
=550  \\$wh$aTissue Plasminogen Activator
=550  \\$wh$avon Willebrand Factor
=550  \\$aBlood Coagulation Factor Inhibitors
=550  \\$aCoagulants
=667  \\$aGEN or unspecified; prefer specifics; DF: BLOOD COAG FACTORS
=680  \\$iEndogenous substances, usually proteins, that are involved in the blood coagulation process.
=750  \0$aBlood coagulation factors$5IEN$0(DLC)sh 85014975

=LDR  00724cz  a2200229n  4500
=001  9880363325602441
=005  20141212195245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001699
=035  \\$aCAZ4859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x225
=072  \\$aN6.$x850.$x505.$x200
=150  \\$aBiometry
=550  \\$wg$aEpidemiologic Measurements
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aAnthropometry
=550  \\$wh$aBiometric Identification
=550  \\$aAnthropology, Physical
=550  \\$aStatistics as Topic
=680  \\$iThe use of statistical and mathematical methods to analyze biological observations and phenomena.
=750  \0$aBiometry$0(DLC) sh 85014244$5IEN

=LDR  00808cz  a2200253n  4500
=001  9880363325702441
=005  20141212195244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001698
=035  \\$aCAZ4858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x70
=072  \\$aJ1.$x293.$x140
=150  \\$aBiomedical Engineering
=450  \\$aClinical Engineering
=450  \\$wnnna$aEngineering, Biomedical
=450  \\$aEngineering, Clinical
=550  \\$wg$aEngineering
=550  \\$wg$aHealth Occupations
=550  \\$aBiomedical Technology
=667  \\$aSPEC: SPEC qualif; DF: BIOMED ENGINEERING
=680  \\$iApplication of principles and practices of engineering science to biomedical research and health care.
=688  \\$a68
=750  \0$aBiomedical engineering$5IEN-HS$0(DLC)sh 85014237

=LDR  01554cz  a2200337n  4500
=001  9880363325802441
=005  20141212195312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001778
=035  \\$aCAZ4939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100
=150  \\$aBlood Coagulation Disorders
=450  \\$wnnna$aBlood Coagulation Disorder
=450  \\$wnnna$aCoagulation Disorder, Blood
=450  \\$wnnna$aCoagulation Disorders, Blood
=450  \\$wnnna$aDisorder, Blood Coagulation
=450  \\$wnnna$aDisorders, Blood Coagulation
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aBlood Coagulation Disorders, Inherited
=550  \\$wh$aCoagulation Protein Disorders
=550  \\$wh$aDisseminated Intravascular Coagulation
=550  \\$wh$aEcchymosis
=550  \\$wh$aPlatelet Storage Pool Deficiency
=550  \\$wh$aProtein S Deficiency
=550  \\$wh$aPurpura
=550  \\$wh$aThrombocythemia, Essential
=550  \\$wh$aVitamin K Deficiency
=667  \\$aGEN: prefer specifics; consider also COAGULATION PROTEIN DISORDERS and indentions; see also THROMBOSIS; EMBOLISM and specifics in C14; /genet: consider also BLOOD COAGULATION DISORDERS, INHERITED; DF: BLOOD COAG DIS
=680  \\$iHemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
=750  \0$aBlood coagulation disorders$5IEN$0(DLC)sh 85014937

=LDR  01292cz  a2200397n  4500
=001  9880363325902441
=005  20170104093653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001697
=035  \\$aCAZ4857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25
=072  \\$aD27.$x720.$x102
=072  \\$aJ1.$x637.$x51
=150  \\$aBiomedical and Dental Materials
=550  \\$wg$aManufactured Materials
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aAlloys
=550  \\$wh$aBiocompatible Materials
=550  \\$wh$aBone Cements
=550  \\$wh$aCariogenic Agents
=550  \\$wh$aCariostatic Agents
=550  \\$wh$aCeramics
=550  \\$wh$aDental Materials
=550  \\$wh$aDentifrices
=550  \\$wh$aDermal Fillers
=550  \\$wh$aMembranes, Artificial
=550  \\$wh$aMouthwashes
=550  \\$wh$aPharmaceutical Preparations, Dental
=550  \\$wh$aPolymers
=550  \\$wh$aRoot Canal Irrigants
=550  \\$wh$aTissue Adhesives
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iSubstances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties.
=688  \\$a98; use explode 1974-97
=750  \0$aBiomedical materials$5IEN-M$0(DLC)sh 85014239

=LDR  01115cz  a2200301n  4500
=001  9880363326002441
=005  20141212195312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001777
=035  \\$aCAZ4938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x124.$x560.$x150
=150  \\$aBlood Coagulation
=450  \\$aBlood Clotting
=450  \\$wnnna$aBlood Clottings
=450  \\$wnnna$aClotting, Blood
=450  \\$wnnna$aCoagulation, Blood
=550  \\$wg$aHemostasis
=550  \\$wh$aFibrinolysis
=550  \\$aBlood Coagulation Tests
=550  \\$aInternational Normalized Ratio
=550  \\$aPartial Thromboplastin Time
=550  \\$aProthrombin Time
=550  \\$aThrombin Time
=550  \\$aWhole Blood Coagulation Time
=667  \\$acoord BLOOD COAGULATION in diseases with disease /blood, not /physiopathol; "blood clot" if physiol goes here, if pathol, goes under THROMBOSIS or EMBOLISM; DF: BLOOD COAG
=680  \\$iThe process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.
=750  \0$aBlood$xCoagulation$5IEN$0(DLC)sh 85014936

=LDR  01107cz  a2200337n  4500
=001  9880363326102441
=005  20180928120357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001696
=035  \\$aCAZ4856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x154.$x90
=072  \\$aG1.$x374.$x89
=150  \\$aBiomechanical Phenomena
=450  \\$wnno$aBiomechanics$5IEN-M
=450  \\$aKinematics
=450  \\$wnnna$aMechanobiological Phenomena
=450  \\$wnnna$aPhenomena, Biomechanical
=450  \\$wnnna$aPhenomena, Mechanobiological
=550  \\$wg$aBiophysical Phenomena
=550  \\$wg$aMechanical Phenomena
=550  \\$wh$aMechanotransduction, Cellular
=550  \\$wh$aOrthodontic Friction
=550  \\$wh$aOsmosis
=550  \\$aMechanics
=550  \\$aPhysical and Rehabilitation Medicine
=667  \\$ausually NIM
=680  \\$iThe properties, processes, and behavior of biological systems under the action of mechanical forces.
=688  \\$a68
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Biomechanics
=750  \0$aBiomechanics$5IEN-HS$0(DLC)sh 85014236

=LDR  01217cz  a2200313n  4500
=001  9880363326202441
=005  20170609112814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001775
=035  \\$aCAZ4936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x100
=150  \\$aBlood Circulation
=450  \\$wnnna$aCirculation, Blood
=550  \\$wg$aCardiovascular Physiological Phenomena
=550  \\$wh$aCerebrovascular Circulation
=550  \\$wh$aCollateral Circulation
=550  \\$wh$aCoronary Circulation
=550  \\$wh$aMicrocirculation
=550  \\$wh$aPlacental Circulation
=550  \\$wh$aPulmonary Circulation
=550  \\$wh$aRegional Blood Flow
=550  \\$wh$aRenal Circulation
=550  \\$wh$aSplanchnic Circulation
=550  \\$aCardiovascular System
=550  \\$aPulsatile Flow
=667  \\$ageneral or unspecified, systemic; note specific indentions in tree; Manual 21.4.2-21.6; with diseases, coord IM with disease /physiopathol, not /blood (IM); circulatory failure or circulatory collapse = SHOCK; DF: BLOOD CIRC
=680  \\$iThe movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM.
=750  \0$aBlood$xCirculation$5IEN-M$0(DLC)sh 85014931

=LDR  01463cz  a2200385n  4500
=001  9880363326302441
=005  20200428112625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001695
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273
=150  \\$aBiology
=550  \\$wg$aBiological Science Disciplines
=550  \\$wh$aBotany
=550  \\$wh$aCell Biology
=550  \\$wh$aComputational Biology
=550  \\$wh$aBiology
=550  \\$wh$aDevelopmental Biology
=550  \\$wh$aEcology
=550  \\$wh$aExobiology
=550  \\$wh$aGenetics
=550  \\$wh$aLaboratory Animal Science
=550  \\$wh$aMicrobiology
=550  \\$wh$aNatural History
=550  \\$wh$aNeurobiology
=550  \\$wh$aParasitology
=550  \\$wh$aPhotobiology
=550  \\$wh$aRadiobiology
=550  \\$wh$aSociobiology
=550  \\$wh$aSynthetic Biology
=550  \\$wh$aZoology
=667  \\$athe discipline (education, history, etc) only; use BIOLOGICAL PHENOMENA or specifics treed under it for biological characteristics and processes of organisms and of the biosphere; note broader heading BIOLOGICAL SCIENCE DISCIPLINES is also available; DF:BIOL
=680  \\$iOne of the BIOLOGICAL SCIENCE DISCIPLINES concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms.
=750  \0$aBiology$5IEN-M$0(DLC)sh 85014203
=750  \0$aBiologists$5IEN-HS$0(DLC)sh 85014202

=LDR  00930cz  a2200277n  4500
=001  9880363326402441
=005  20160826102348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001694
=035  \\$aCAZ4854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x500.$x226
=150  \\$aBiological Warfare
=450  \\$aBacterial Warfare
=450  \\$wnnna$aBiologic Warfare
=450  \\$wnnna$aWarfare, Bacterial
=450  \\$wnnna$aWarfare, Biologic
=450  \\$wnnna$aWarfare, Biological
=550  \\$wg$aWarfare
=550  \\$wh$aBioterrorism
=550  \\$aBioterrorism
=550  \\$aViolence
=667  \\$aDF: BIOL WARFARE
=680  \\$iWarfare involving the use of living organisms or their products as disease etiologic agents against people, animals, or plants.
=688  \\$aBACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78
=750  \0$aBiological warfare$5IEN-M$0(DLC)sh 85014201

=LDR  01327cz  a2200361n  4500
=001  9880363326502441
=005  20141212195310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001774
=035  \\$aCAZ4935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100
=072  \\$aE5.$x200.$x124.$x100
=150  \\$aBlood Chemical Analysis
=450  \\$wnnna$aAnalyses, Blood Chemical
=450  \\$wnnna$aAnalysis, Blood Chemical
=450  \\$aBlood$xanalysis
=450  \\$wnnna$aBlood Chemical Analyses
=450  \\$aBlood$xchemistry
=450  \\$wnnna$aChemical Analyses, Blood
=450  \\$wnnna$aChemical Analysis, Blood
=550  \\$wg$aClinical Chemistry Tests
=550  \\$wh$aBlood Gas Analysis
=550  \\$wh$aBlood Glucose Self-Monitoring
=550  \\$wh$aBlood Protein Electrophoresis
=550  \\$wh$aBlood Urea Nitrogen
=550  \\$wh$aDried Blood Spot Testing
=550  \\$wh$aGlucose Clamp Technique
=550  \\$wh$aGlucose Tolerance Test
=550  \\$wh$aLactose Tolerance Test
=550  \\$wh$aPetrosal Sinus Sampling
=667  \\$aGEN only: prefer specific substance with /blood; emphasis is on technique: not for "blood chemistry"; when general & IM, qualif permitted; when not to use: Manual 25.14.3 & TN 25
=750  \0$aBlood$xAnalysis$5IEN$0(DLC)sh 85014929

=LDR  01192cz  a2200301n  4500
=001  9880363326602441
=005  20141212195242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001693
=035  \\$aCAZ4853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x166.$x310
=150  \\$aBiological Transport, Active
=450  \\$wnnna$aActive Biologic Transport
=450  \\$wnnna$aActive Biological Transport
=450  \\$aActive Transport
=450  \\$wnnna$aBiologic Transport, Active
=450  \\$wnnna$aTransport, Active
=450  \\$wnnna$aTransport, Active Biologic
=450  \\$wnnna$aTransport, Active Biological
=450  \\$wnnna$aTransport, Uphill
=450  \\$aUphill Transport
=550  \\$wg$aBiological Transport
=550  \\$wh$aActive Transport, Cell Nucleus
=667  \\$aalmost never IM; coord with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM); DF: BIOL TRANSPORT ACTIVE
=680  \\$iThe movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.
=688  \\$a66
=750  \0$aBiological transport, Active$5IEN$0(DLC)sh 85014199

=LDR  01062cz  a2200349n  4500
=001  9880363326702441
=005  20141212195310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001773
=035  \\$aCAZ4934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118
=072  \\$aA15.$x145.$x229
=150  \\$aBlood Cells
=450  \\$wnnna$aBlood Cell
=450  \\$wnnna$aBlood Corpuscle
=450  \\$aBlood Corpuscles
=450  \\$aBlood$xcytology
=450  \\$wnnna$aCell, Blood
=450  \\$wnnna$aCells, Blood
=450  \\$wnnna$aCorpuscle, Blood
=450  \\$wnnna$aCorpuscles, Blood
=550  \\$wg$aBlood
=550  \\$wg$aCells
=550  \\$wh$aBlood Buffy Coat
=550  \\$wh$aBlood Platelets
=550  \\$wh$aErythrocytes
=550  \\$wh$aHemocytes
=550  \\$wh$aLeukocytes
=667  \\$ageneral; prefer specifics; "blood picture" probably goes here or under BLOOD CELL COUNT
=680  \\$iThe cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM.
=750  \0$aBlood cells$5IEN$0(DLC)sh 85014968

=LDR  01467cz  a2200373n  4500
=001  9880363326802441
=005  20141212195242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001692
=035  \\$aCAZ4852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x166
=150  \\$aBiological Transport
=450  \\$wnnna$aBiologic Transport
=450  \\$wnnna$aTransport, Biologic
=450  \\$aTransport, Biological
=550  \\$wg$aMetabolism
=550  \\$wh$aBiological Transport, Active
=550  \\$wh$aCapillary Permeability
=550  \\$wh$aCell Membrane Permeability
=550  \\$wh$aCytoplasmic Streaming
=550  \\$wh$aFacilitated Diffusion
=550  \\$wh$aIon Transport
=550  \\$wh$aProtein Transport
=550  \\$wh$aRespiratory Transport
=550  \\$wh$aRNA Transport
=550  \\$wh$aSecretory Pathway
=550  \\$wh$aTranscytosis
=550  \\$aMembrane Transport Proteins
=550  \\$aTransport Vesicles
=667  \\$aalmost never IM; coord NIM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM); DF: BIOL TRANSPORT
=680  \\$iThe movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
=688  \\$a66(64)
=750  \0$aBiological transport$5IEN$0(DLC)sh 85014197

=LDR  01739cz  a2200469n  4500
=001  9880363326902441
=005  20141212195310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001772
=035  \\$aCAZ4933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x195.$x107
=072  \\$aE1.$x370.$x225.$x625.$x107
=072  \\$aE5.$x200.$x500.$x195.$x107
=072  \\$aE5.$x200.$x625.$x107
=072  \\$aE5.$x242.$x195.$x107
=072  \\$aG4.$x170.$x107
=072  \\$aG9.$x188.$x105
=150  \\$aBlood Cell Count
=450  \\$wnnna$aBlood Cell Counts
=450  \\$aBlood Cell Number
=450  \\$wnnna$aBlood Cell Numbers
=450  \\$aBlood Count, Complete
=450  \\$wnnna$aBlood Counts, Complete
=450  \\$wnnna$aComplete Blood Count
=450  \\$wnnna$aComplete Blood Counts
=450  \\$wnnna$aCount, Blood Cell
=450  \\$wnnna$aCount, Complete Blood
=450  \\$wnnna$aCounts, Blood Cell
=450  \\$wnnna$aCounts, Complete Blood
=450  \\$wnnna$aNumber, Blood Cell
=450  \\$wnnna$aNumbers, Blood Cell
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aCell Count
=550  \\$wg$aHematologic Tests
=550  \\$wh$aErythrocyte Count
=550  \\$wh$aLeukocyte Count
=550  \\$wh$aPlatelet Count
=550  \\$aCell Count
=667  \\$aGEN; prefer specifics; "blood picture" probably goes here or under specifics; usually NIM; coord with disease /blood, not /physiopathol
=680  \\$iThe number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.
=750  \0$aBlood cell count$0(DLC) sh 85014967$5IEN

=LDR  00567cz  a2200193n  4500
=001  9880363327002441
=005  20141212195309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001771
=035  \\$aCAZ4932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65.$x200
=150  \\$aBlood Banks
=450  \\$wnnna$aBank, Blood
=450  \\$wnnna$aBanks, Blood
=450  \\$wnnna$aBlood Bank
=550  \\$wg$aBiological Specimen Banks
=680  \\$iCenters for collecting, characterizing and storing human blood.
=750  \0$aBlood banks$5IEN$0(DLC)sh 85014961

=LDR  02144cz  a2200517n  4500
=001  9880363327102441
=005  20141212195241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001690
=035  \\$aCAZ4850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158
=150  \\$aBiological Science Disciplines
=450  \\$wnnna$aBiologic Science
=450  \\$wnnna$aBiologic Sciences
=450  \\$wnnna$aBiological Science
=450  \\$wnnna$aBiological Science Discipline
=450  \\$aBiological Sciences
=450  \\$wnnna$aDiscipline, Biological Science
=450  \\$wnnna$aDisciplines, Biological Science
=450  \\$wnnna$aLife Science
=450  \\$aLife Sciences
=450  \\$wnnna$aScience, Biologic
=450  \\$wnnna$aScience, Biological
=450  \\$wnnna$aScience Discipline, Biological
=450  \\$wnnna$aScience Disciplines, Biological
=450  \\$wnnna$aScience, Life
=450  \\$wnnna$aSciences, Biologic
=450  \\$wnnna$aSciences, Biological
=450  \\$wnnna$aSciences, Life
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aAnatomy
=550  \\$wh$aBiochemistry
=550  \\$wh$aBiology
=550  \\$wh$aBiophysics
=550  \\$wh$aBiotechnology
=550  \\$wh$aChronobiology Discipline
=550  \\$wh$aNeurosciences
=550  \\$wh$aPharmacology
=550  \\$wh$aPhysiology
=667  \\$aSPEC; SPEC qualif; do not confuse with BIOLOGY; DF: BIOL SCIENCES
=680  \\$iAll of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.
=688  \\$a2009 (1991); use BIOLOGY 1975-1990
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Biological Sciences
=688  \\$a91; was BIOLOGICAL SCIENCES (NON MESH) 1975-90; BIOLOGICAL SCIENCES was see BIOLOGY 1990
=750  \0$aLife sciences$0(DLC) sh 85076841$5IEN

=LDR  01347cz  a2200265n  4500
=001  9880363327202441
=005  20141212195308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001769
=035  \\$aCAZ4930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152
=072  \\$aA15.$x145
=150  \\$aBlood
=360  \\$iconsider also terms at$aHEM-
=450  \\$aWater$xblood
=550  \\$wg$aBody Fluids
=550  \\$wg$aHemic and Immune Systems
=550  \\$wh$aBlood Cells
=550  \\$wh$aFetal Blood
=550  \\$wh$aPlasma
=550  \\$wh$aSerum
=667  \\$ageneral only as a substance: prefer / blood with higher animals, substances & diseases: Manual 19.7+, 19.8.10; not for hemodynamics: Manual 23.28, 23.29; reinfusion = BLOOD TRANSFUSION, AUTOLOGOUS; venous blood: coordinate BLOOD + VEINS or specific vein but do not index here for routine blood samples; arterial blood: coordinate BLOOD + ARTERIES or specific artery but only if the arterial aspect is significant; "blood picture" = probably BLOOD CELLS or BLOOD CELL COUNT; "blood clot": physiol clot or clotting = BLOOD COAGULATION, pathologic clot or clotting = THROMBOSIS or EMBOLISM
=680  \\$iThe body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
=750  \0$aBlood$5IEN$0(DLC)sh 85014927

=LDR  00864cz  a2200229n  4500
=001  9880363327302441
=005  20141212195240.0
=008  830610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001689
=035  \\$aCAZ4849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x90
=072  \\$aH2.$x403.$x690.$x100
=150  \\$aBiological Psychiatry
=450  \\$wnnna$aBiologic Psychiatry
=450  \\$wnnna$aPsychiatry, Biologic
=450  \\$aPsychiatry, Biological
=550  \\$wg$aPsychiatry
=667  \\$aSPEC only: SPEC qualif; DF: BIOL PSYCHIATRY
=680  \\$iAn interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.
=688  \\$a84
=750  \0$aBiological psychiatry$5IEN$0(DLC)sh 85014185

=LDR  00970cz  a2200325n  4500
=001  9880363327402441
=005  20141212195308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001768
=035  \\$aCAZ4929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x865.$x187
=072  \\$aC23.$x300.$x122
=150  \\$aBlister
=450  \\$wnnna$aBleb
=450  \\$wnnna$aBlebs
=450  \\$wnnna$aBlisters
=450  \\$aBulla
=450  \\$wnnna$aBullae
=450  \\$wnnna$aBullous Lesion
=450  \\$wnnna$aBullous Lesions
=450  \\$wnnna$aLesion, Bullous
=450  \\$wnnna$aLesions, Bullous
=450  \\$aVesication
=450  \\$wnnna$aVesications
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wg$aSkin Diseases, Vesiculobullous
=667  \\$aFEVER BLISTER see HERPES LABIALIS is also available
=680  \\$iVisible accumulations of fluid within or beneath the epidermis.
=750  \0$aBlisters$5IEN$0(DLC)sh 85014896

=LDR  01600cz  a2200433n  4500
=001  9880363327502441
=005  20141212195240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001688
=035  \\$aCAZ4848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215
=150  \\$aBiological Products
=450  \\$wnnna$aBiologic Products
=450  \\$aBiologics
=450  \\$aNatural Products
=450  \\$wnnna$aProducts, Biologic
=450  \\$wnnna$aProducts, Biological
=450  \\$wnnna$aProducts, Natural
=550  \\$wg$aComplex Mixtures
=550  \\$wh$aAntitoxins
=550  \\$wh$aBiological Control Agents
=550  \\$wh$aBiological Warfare Agents
=550  \\$wh$aBiosimilar Pharmaceuticals
=550  \\$wh$aImmune Sera
=550  \\$wh$aMenotropins
=550  \\$wh$aPicibanil
=550  \\$wh$aPlant Exudates
=550  \\$wh$aPlant Nectar
=550  \\$wh$aPlant Preparations
=550  \\$wh$aVaccines
=550  \\$aBiological Factors
=667  \\$adifferentiate from BIOLOGICAL FACTORS; /ther use: coordinate with disease /drug ther
=680  \\$iComplex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
=688  \\$a2014(1966); for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Biological Agents
=688  \\$a1963; for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Biological Products
=750  \0$aBiological products$0(DLC) sh 85014183$5IEN

=LDR  01553cz  a2200433n  4500
=001  9880363327602441
=005  20141212195307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001766
=035  \\$aCAZ4927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x162
=072  \\$aC11.$x966.$x75
=072  \\$aC23.$x888.$x592.$x763.$x941.$x162
=150  \\$aBlindness
=450  \\$wnnna$aAcquired Blindness
=450  \\$wnnna$aAmauroses
=450  \\$aAmaurosis
=450  \\$aBlind$5IEN
=450  \\$wnnna$aBlindness, Acquired
=450  \\$wnnna$aBlindness, Complete
=450  \\$wnnna$aBlindness, Hysterical
=450  \\$aBlindness, Legal
=450  \\$aBlindness, Monocular
=450  \\$wnnna$aBlindness, Transient
=450  \\$wnnna$aComplete Blindness
=450  \\$wnnna$aHysterical Blindness
=450  \\$wnnna$aLegal Blindness
=450  \\$wnnna$aMonocular Blindness
=450  \\$wnnna$aTransient Blindness
=550  \\$wg$aVision Disorders
=550  \\$wh$aAmaurosis Fugax
=550  \\$wh$aBlindness, Cortical
=550  \\$wh$aDeaf-Blind Disorders
=550  \\$wh$aHemianopsia
=550  \\$aVisually Impaired Persons
=667  \\$afor Braille coord IM with SENSORY AIDS (IM) + READING (IM)
=680  \\$iThe inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
=750  \0$aBlindness$5IEN-M$0(DLC)sh 85014886

=LDR  01296cz  a2200289n  4500
=001  9880363327702441
=005  20141212195307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001765
=035  \\$aCAZ4926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637.$x145
=072  \\$aC18.$x452.$x603.$x145
=150  \\$aBlind Loop Syndrome
=450  \\$wnnna$aBacterial Overgrowth Syndrome
=450  \\$wnnna$aLoop Syndrome, Stagnant
=450  \\$wnnna$aLoop Syndromes, Stagnant
=450  \\$wnnna$aStagnant Loop Syndrome
=450  \\$wnnna$aStagnant Loop Syndromes
=450  \\$wnnna$aSyndrome, Bacterial Overgrowth
=450  \\$wnnna$aSyndrome, Blind Loop
=450  \\$wnnna$aSyndrome, Stagnant Loop
=450  \\$wnnna$aSyndromes, Stagnant Loop
=550  \\$wg$aMalabsorption Syndromes
=680  \\$iA malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.
=688  \\$a73(69)
=750  \0$aBlind loop syndrome$5IEN$0(DLC)sh 85014884

=LDR  00757cz  a2200253n  4500
=001  9880363327802441
=005  20141212195306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001763
=035  \\$aCAZ4924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x338.$x204
=150  \\$aBlepharoptosis
=450  \\$wnnna$aBlepharoptoses
=450  \\$wnnna$aEyelid Ptoses
=450  \\$wnnna$aEyelid Ptosis
=450  \\$wnnna$aPtoses, Eyelid
=450  \\$aPtosis, Eyelid
=550  \\$wg$aEyelid Diseases
=550  \\$aBlepharoplasty
=667  \\$adrooping eyelid
=680  \\$iDrooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.
=688  \\$a67(65)
=750  \0$aBlepharoptosis$5IEN$0(DLC)sh 85014843

=LDR  00637cz  a2200217n  4500
=001  9880363792402441
=005  20141212205616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012740
=035  \\$aCBA6051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x609.$x666
=072  \\$aL1.$x178.$x820.$x500.$x666
=150  \\$aSex Manuals
=450  \\$wnnna$aManual, Sex
=450  \\$wnnna$aManuals, Sex
=450  \\$wnnna$aSex Manual
=550  \\$wg$aManuals as Topic
=667  \\$ano qualif
=680  \\$iBooks used for sex education and procedural instruction.
=750  \0$aSex instruction$5IEN$0(DLC)sh 85120630

=LDR  01143cz  a2200289n  4500
=001  9880363792502441
=005  20141212205616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012739
=035  \\$aCBA6050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x851
=150  \\$aGonadal Steroid Hormones
=450  \\$wnnna$aHormones, Gonadal Steroid
=450  \\$wnnna$aHormones, Sex Steroid
=450  \\$wnnna$aSex Hormones
=450  \\$aSex Steroid Hormones
=450  \\$wnnna$aSteroid Hormones, Gonadal
=450  \\$wnnna$aSteroid Hormones, Sex
=550  \\$wg$aGonadal Hormones
=550  \\$wh$aEstradiol Congeners
=550  \\$wh$aProgesterone Congeners
=550  \\$wh$aTestosterone Congeners
=667  \\$aGEN or unspecified; prefer specific groups or specific hormone
=680  \\$iSteroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
=688  \\$a2004 (1963)
=750  \0$aHormones, Sex$5IEN$0(DLC)sh 85061983

=LDR  01082cz  a2200229n  4500
=001  9880363792602441
=005  20141212205615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012737
=035  \\$aCBA6048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x350.$x675
=072  \\$aN6.$x850.$x490.$x875
=150  \\$aSex Factors
=450  \\$wnnna$aFactor, Sex
=450  \\$wnnna$aFactors, Sex
=450  \\$wnnna$aSex Factor
=550  \\$wg$aEpidemiologic Factors
=667  \\$aNIM; human & animal; do not confuse with SEX DISTRIBUTION or SEX CHARACTERISTICS; Manual 35.6+
=680  \\$iMaleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances.
=688  \\$a68
=750  \0$aSex differences (Psychology)$5IEN$0(DLC)sh 85120581

=LDR  01132cz  a2200337n  4500
=001  9880363792702441
=005  20141212205615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012736
=035  \\$aCBA6047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x837.$x500
=072  \\$aI2.$x233.$x332.$x749
=150  \\$aSex Education
=450  \\$wnnna$aEducation, Family Planning
=450  \\$aEducation, Sex
=450  \\$wnnna$aFamily Planning Education
=450  \\$wnnna$aFamily Planning Instructor
=450  \\$wnnna$aFamily Planning Instructors
=450  \\$wnnna$aFamily Planning Training
=450  \\$wnnna$aInstructor, Family Planning
=450  \\$wnnna$aInstructors, Family Planning
=450  \\$aSex$xeducation
=450  \\$aSex Instruction$5IEN
=450  \\$wnnna$aTraining, Family Planning
=550  \\$wg$aHealth Education
=550  \\$wg$aSexology
=550  \\$aReproductive Health
=550  \\$aSafe Sex
=680  \\$iEducation which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.
=750  \0$aSex instruction$5IEN$0(DLC)sh 85120630

=LDR  01558cz  a2200409n  4500
=001  9880363792802441
=005  20141212205614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012735
=035  \\$aCBA6046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x644
=072  \\$aC13.$x351.$x500.$x665
=150  \\$aSexual Dysfunction, Physiological
=450  \\$wnnna$aPhysiological Sexual Disorder
=450  \\$wnnna$aPhysiological Sexual Disorders
=450  \\$wnnna$aPhysiological Sexual Dysfunction
=450  \\$wnnna$aPhysiological Sexual Dysfunctions
=450  \\$wnnna$aSex Disorders
=450  \\$wnnna$aSexual Disorder, Physiological
=450  \\$aSexual Disorders$5IEN
=450  \\$wnnna$aSexual Disorders, Physiological
=450  \\$wnnna$aSexual Dysfunctions, Physiological
=550  \\$wg$aGenital Diseases, Female
=550  \\$wg$aGenital Diseases, Male
=550  \\$wh$aDyspareunia
=550  \\$wh$aErectile Dysfunction
=550  \\$wh$aPremature Ejaculation
=550  \\$wh$aVaginismus
=550  \\$aReproductive Health
=667  \\$adifferentiate from DISORDERS OF SEX DEVELOPMENT
=680  \\$iPhysiological disturbances in normal sexual performance in either the male or the female.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Sex Disorders
=688  \\$awas in Cat C & F 1975-80, was in Cat C only 1963-74
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20061114: 150:##:_{dollar}a Sex Disorders
=750  \0$aSexual disorders$0(DLC) sh85120728$5IEN-HS

=LDR  03194cz  a2200733n  4500
=001  9880363792902441
=005  20141212205614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012734
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x316
=072  \\$aC13.$x351.$x875.$x253
=072  \\$aC16.$x131.$x939.$x316
=072  \\$aC19.$x391.$x119
=072  \\$aF3.$x800.$x399
=150  \\$aDisorders of Sex Development
=450  \\$wnnna$aAmbiguities, Genital
=450  \\$wnnna$aAmbiguity, Genital
=450  \\$wnnna$aAmbiguous Genitalia
=450  \\$wnnna$aCondition, Intersex
=450  \\$wnnna$aConditions, Intersex
=450  \\$wnnna$aDifferentiation Disorder, Sex
=450  \\$wnnna$aDifferentiation Disorder, Sexual
=450  \\$wnnna$aDifferentiation Disorders, Sex
=450  \\$wnnna$aDifferentiation Disorders, Sexual
=450  \\$wnnna$aDisorder, Sex Differentiation
=450  \\$wnnna$aDisorder, Sexual Differentiation
=450  \\$aDisorders of Sexual Development
=450  \\$wnnna$aDisorders, Sex Differentiation
=450  \\$wnnna$aDisorders, Sexual Differentiation
=450  \\$wnnna$aGenital Ambiguities
=450  \\$wnnna$aGenital Ambiguity
=450  \\$wnnna$aGenitalia, Ambiguous
=450  \\$wnnna$aHermaphroditism
=450  \\$wnnna$aIntersex Condition
=450  \\$wnnna$aIntersex Conditions
=450  \\$wnnna$aIntersexualities
=450  \\$wnnna$aIntersexuality
=450  \\$wnnna$aPseudohermaphroditism
=450  \\$wnnna$aSex Development Disorder
=450  \\$aSex Development Disorders
=450  \\$wnnna$aSex Differentiation Disorder
=450  \\$aSex Differentiation Disorders
=450  \\$wnnoa$aSex Reversal, Gonadal$5IEN-M
=450  \\$wnnna$aSexual Development Disorder
=450  \\$wnnna$aSexual Development Disorders
=450  \\$wnnna$aSexual Differentiation Disorder
=450  \\$wnnna$aSexual Differentiation Disorders
=550  \\$wg$aGonadal Disorders
=550  \\$wg$aSexual and Gender Disorders
=550  \\$wg$aUrogenital Abnormalities
=550  \\$wh$a46, XX Disorders of Sex Development
=550  \\$wh$a46, XY Disorders of Sex Development
=550  \\$wh$aAdrenogenital Syndrome
=550  \\$wh$aGonadal Dysgenesis
=550  \\$wh$aOvotesticular Disorders of Sex Development
=550  \\$wh$aSex Chromosome Disorders of Sex Development
=550  \\$aTransgendered Persons
=667  \\$adifferentiate from SEXUAL DYSFUNCTION, PHYSIOLOGICAL; note entry term HERMAPHRODITISM: HERMAPHRODITISM, TRUE see OVOTESTICULAR DISORDERS OF SEX DEVELOPMENT is also available
=680  \\$iIn gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.
=688  \\$a2011(1966)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Sex Differentiation Disorders
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20110909: 150:##:_{dollar}a Hermaphroditism
=750  \0$aSex differentiation disorders$0(DLC) sh 85120590$5IEN

=LDR  01080cz  a2200253n  4500
=001  9880363793002441
=005  20141212205613.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012733
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x843
=072  \\$aG7.$x700.$x320.$x750.$x500
=072  \\$aG8.$x686.$x785.$x880.$x500
=150  \\$aSex Differentiation
=450  \\$wnnna$aDifferentiation, Sex
=450  \\$wnnna$aDifferentiation, Sexual
=450  \\$wnnna$aSexual Differentiation
=550  \\$wg$aOrganogenesis
=550  \\$wg$aSexual Development
=550  \\$aSex Determination Processes
=667  \\$anote SEX DETERMINATION PROCESSES; SEX CHARACTERISTICS; SEX DISTRIBUTION; and SEX FACTORS are also available
=680  \\$iThe process in developing sex- or gender-specific tissue, organ, or function after SEX DETERMINATION PROCESSES have set the sex of the GONADS. Major areas of sex differentiation occur in the reproductive tract (GENITALIA) and the brain.
=688  \\$a75
=750  \0$aSex differentiation$5IEN$0(DLC)sh 85120585

=LDR  01711cz  a2200445n  4500
=001  9880363793102441
=005  20190321175007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012732
=035  \\$aCBA6043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x996
=072  \\$aE1.$x370.$x701
=072  \\$aE5.$x200.$x996
=072  \\$aE5.$x393.$x285.$x830
=150  \\$aSex Determination Analysis
=450  \\$wnnna$aAnalyses, Sex Determination
=450  \\$wnnna$aAnalysis, Sex Determination
=450  \\$wnnoa$aSex Determination$5IEN
=450  \\$wnnna$aSex Determination Analyses
=450  \\$wnnna$aSex Determination Technic
=450  \\$wnnna$aSex Determination Technics
=450  \\$wnnna$aSex Determination Technique
=450  \\$aSex Determination Techniques
=450  \\$wnnna$aTechnic, Sex Determination
=450  \\$wnnna$aTechnics, Sex Determination
=450  \\$wnnna$aTechnique, Sex Determination
=450  \\$wnnna$aTechniques, Sex Determination
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aCytogenetic Analysis
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aSex Determination by Skeleton
=550  \\$aSex
=550  \\$aSex Chromatin
=667  \\$ado not confuse with SEX DETERMINATION PROCESSES which is establishment of sex at fertilization; SEX DETERMINATION BY SKELETON is also available
=680  \\$iValidation of the SEX of an individual by inspection of the GONADS and/or by genetic tests.
=688  \\$a2011(1963)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Sex Determination (Analysis)
=688  \\$a98(63)
=750  \0$aDiagnostic sex determination$0(DLC) sh 85120578$5IEN

=LDR  00896cz  a2200265n  4500
=001  9880363793202441
=005  20141212205612.0
=008  870226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012731
=035  \\$aCBA6042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x176.$x700
=072  \\$aF4.$x96.$x837.$x249
=072  \\$aF4.$x408.$x413.$x700
=072  \\$aN2.$x421.$x143.$x303.$x700
=072  \\$aN2.$x421.$x461.$x363.$x700
=150  \\$aSex Counseling
=450  \\$aCounseling, Sex
=450  \\$wnnna$aCounselings, Sex
=450  \\$wnnna$aSex Counselings
=550  \\$wg$aCounseling
=550  \\$wg$aSexology
=680  \\$iAdvice and support given to individuals to help them understand and resolve their sexual adjustment problems. It excludes treatment for PSYCHOSEXUAL DISORDERS or PSYCHOSEXUAL DYSFUNCTION.
=688  \\$a88
=750  \0$aSex counseling$5IEN$0(DLC)sh 85120571

=LDR  01343cz  a2200289n  4500
=001  9880363793302441
=005  20181130122434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012730
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x865
=072  \\$aG5.$x360.$x162.$x865
=150  \\$aSex Chromosomes
=450  \\$wnnna$aChromosome, Sex
=450  \\$wnnna$aChromosomes, Sex
=450  \\$wnnna$aGonosome
=450  \\$aGonosomes
=450  \\$wnnna$aSex Chromosome
=550  \\$wg$aChromosomes
=550  \\$wh$aPseudoautosomal Regions
=550  \\$wh$aSex Chromatin
=550  \\$wh$aX Chromosome
=550  \\$wh$aY Chromosome
=667  \\$aX chromosome /abnorm = SEX CHROMOSOME ABERRATIONS (IM) + X CHROMOSOME (IM); Y chromosome /abnorm = SEX CHROMOSOME ABERRATIONS (IM) + Y CHROMOSOME (IM); A 11 qualif except /cytol /transpl; /genet permitted
=680  \\$iThe homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes (in animals in which the female is the heterogametic sex (the silkworm moth Bombyx mori, for example)). In such cases the W chromosome is the female-determining and the male is ZZ. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
=688  \\$a68
=750  \0$aSex chromosomes$5IEN$0(DLC)sh 85120570

=LDR  01478cz  a2200373n  4500
=001  9880363793402441
=005  20141212205611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012729
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x815
=072  \\$aG5.$x365.$x590.$x175.$x815
=150  \\$aSex Chromosome Aberrations
=450  \\$wnnna$aAberration, Sex Chromosome
=450  \\$wnnna$aAberrations, Sex Chromosome
=450  \\$wnnna$aAbnormalities, Sex Chromosome
=450  \\$wnnna$aAbnormality, Sex Chromosome
=450  \\$wnnna$aChromosome Aberration, Sex
=450  \\$wnnna$aChromosome Aberrations, Sex
=450  \\$wnnna$aChromosome Abnormalities, Sex
=450  \\$wnnna$aChromosome Abnormality, Sex
=450  \\$wnnna$aSex Chromosome Aberration
=450  \\$aSex Chromosome Abnormalities
=450  \\$wnnna$aSex Chromosome Abnormality
=450  \\$aSex Chromosomes$xabnormalities
=550  \\$wg$aChromosome Aberrations
=550  \\$wh$aXYY Karyotype
=550  \\$aGenetic Diseases, X-Linked
=550  \\$aSex Chromosome Disorders
=550  \\$aSex Chromosome Disorders of Sex Development
=667  \\$acoordinate with specific sex chromosome (IM)
=680  \\$iAbnormal number or structure of the SEX CHROMOSOMES. Some sex chromosome aberrations are associated with SEX CHROMOSOME DISORDERS and SEX CHROMOSOME DISORDERS OF SEX DEVELOPMENT.
=688  \\$a1968
=750  \0$aSex chromosome abnormalities$5IEN$0(DLC)sh 85120568

=LDR  01072cz  a2200265n  4500
=001  9880363793502441
=005  20141212205611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x865.$x800
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x180.$x383.$x800
=072  \\$aG5.$x360.$x160.$x180.$x383.$x800
=072  \\$aG5.$x360.$x162.$x865.$x800
=150  \\$aSex Chromatin
=450  \\$aBarr Bodies
=450  \\$wnnna$aBodies, Barr
=450  \\$aChromatin, Sex
=450  \\$wnnna$aChromatins, Sex
=450  \\$wnnna$aSex Chromatins
=550  \\$wg$aHeterochromatin
=550  \\$wg$aSex Chromosomes
=667  \\$aA 11 qualif except /cytol; /genet /isol permitted
=680  \\$iIn the interphase nucleus, a condensed mass of chromatin representing an inactivated X chromosome. Each X CHROMOSOME, in excess of one, forms sex chromatin (Barr body) in the mammalian nucleus. (from King & Stansfield, A Dictionary of Genetics, 4th ed)
=750  \0$aSex chromatin$5IEN$0(DLC)sh 85120567

=LDR  01246cz  a2200313n  4500
=001  9880363793602441
=005  20141212205611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012727
=035  \\$aCBA6038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x815
=150  \\$aSex Characteristics
=450  \\$wnnna$aCharacteristic, Sex
=450  \\$wnnna$aCharacteristics, Sex
=450  \\$wnnna$aDifference, Sex
=450  \\$wnnna$aDifferences, Sex
=450  \\$wnnna$aDimorphism, Sex
=450  \\$wnnna$aDimorphisms, Sex
=450  \\$wnnna$aSex Characteristic
=450  \\$wnnna$aSex Difference
=450  \\$aSex Differences
=450  \\$aSex Dimorphism
=450  \\$wnnna$aSex Dimorphisms
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$aSex
=667  \\$anote SEX DETERMINATION PROCESSES; SEX DIFFERENTIATION; SEX DISTRIBUTION; and SEX FACTORS are also available
=680  \\$iThose characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction.
=750  \0$aSex differences$0(DLC) sh 85120580$5IEN

=LDR  01180cz  a2200361n  4500
=001  9880363793702441
=005  20141212205610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012726
=035  \\$aCBA6037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x252.$x748
=150  \\$aSexual Behavior, Animal
=450  \\$wnnna$aAnimal Mating Behavior
=450  \\$wnnna$aAnimal Mating Behaviors
=450  \\$wnnna$aAnimal Sex Behavior
=450  \\$wnnna$aAnimal Sex Behaviors
=450  \\$wnnna$aAnimal Sexual Behavior
=450  \\$wnnna$aAnimal Sexual Behaviors
=450  \\$aMating Behavior, Animal
=450  \\$wnnna$aMating Behaviors, Animal
=450  \\$wnnna$aSex Behavior, Animal
=450  \\$wnnna$aSex Behaviors, Animal
=450  \\$wnnna$aSexual Behaviors, Animal
=550  \\$wg$aConsummatory Behavior
=550  \\$wh$aCopulation
=550  \\$wh$aMating Preference, Animal
=550  \\$wh$aPair Bond
=680  \\$iSexual activities of animals.
=688  \\$a2007 (1968)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Sex Behavior, Animal
=688  \\$a68
=750  \0$aSexual behavior in animals$0(DLC) sh 85120721$5IEN

=LDR  01354cz  a2200385n  4500
=001  9880363793902441
=005  20141212205541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012633
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x800
=072  \\$aD6.$x472.$x699.$x810
=072  \\$aD12.$x644.$x400.$x705
=072  \\$aD12.$x644.$x548.$x810
=072  \\$aD12.$x776.$x641.$x650.$x705
=150  \\$aSecretin
=450  \\$wnnna$aPig Secretin
=450  \\$wnnna$aPig Secretin Citrate
=450  \\$wnnna$aPig Secretin Maleate
=450  \\$wnnna$aPig Secretin Pentacetate
=450  \\$wnnna$aPig Secretin Sulfate
=450  \\$wnnna$aSecrepan
=450  \\$wnnna$aSecretin Citrate, Pig
=450  \\$wnnna$aSecretin-KABI
=450  \\$wnnna$aSecretin KABI
=450  \\$wnnna$aSecretin Maleate, Pig
=450  \\$wnnna$aSecretin Pentacetate, Pig
=450  \\$wnnna$aSecretin, Pig
=450  \\$wnnna$aSecretin Sulfate, Pig
=450  \\$wnnna$aSecretinKABI
=550  \\$wg$aGastrointestinal Hormones
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=680  \\$iA peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p597)
=750  \0$aSecretin$5IEN$0(DLC)sh 85119447

=LDR  01775cz  a2200373n  4500
=001  9880363794002441
=005  20141212210949.0
=008  880524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015290
=035  \\$aCBA5942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x800.$x800
=072  \\$aG2.$x149.$x115.$x800.$x800
=072  \\$aG4.$x299.$x880.$x800
=150  \\$aSecond Messenger Systems
=450  \\$wnnna$aIntracellular Second Messenger
=450  \\$aIntracellular Second Messengers
=450  \\$wnnna$aMessenger, Second
=450  \\$wnnna$aMessengers, Intracellular Second
=450  \\$wnnna$aMessengers, Second
=450  \\$wnnna$aSecond Messenger
=450  \\$wnnna$aSecond Messenger, Intracellular
=450  \\$wnnna$aSecond Messenger System
=450  \\$wnnna$aSecond Messengers
=450  \\$wnnna$aSecond Messengers, Intracellular
=450  \\$wnnna$aSystem, Second Messenger
=450  \\$wnnna$aSystems, Second Messenger
=550  \\$wg$aSignal Transduction
=550  \\$wh$aCalcium Signaling
=550  \\$aCell Communication
=667  \\$aa metab concept; IM; coord with substance acting as the second messenger (IM) with /physiol or /antag as applicable; DF: SECOND MESSENGERS
=680  \\$iSystems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.
=688  \\$a89
=750  \0$aSecond messengers (Biochemistry)$5IEN$0(DLC)sh 89000819

=LDR  00508cz  a2200169n  4500
=001  9880363794102441
=005  20141212205540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012629
=035  \\$aCBA5939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x702
=150  \\$aSebum
=450  \\$wnnna$aSebums
=550  \\$wg$aBodily Secretions
=680  \\$iThe oily substance secreted by SEBACEOUS GLANDS. It is composed of KERATIN, fat, and cellular debris.
=750  \0$aSebum$5IEN$0(DLC)sh 85119404

=LDR  00936cz  a2200217n  4500
=001  9880363794202441
=005  20141212205539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012627
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x336.$x827
=072  \\$aA17.$x815.$x805
=150  \\$aSebaceous Glands
=450  \\$wnnna$aGland, Sebaceous
=450  \\$wnnna$aGlands, Sebaceous
=450  \\$wnnna$aSebaceous Gland
=550  \\$wg$aExocrine Glands
=550  \\$wg$aSkin
=550  \\$wh$aMeibomian Glands
=680  \\$iSmall, sacculated organs found within the DERMIS. Each gland has a single duct that emerges from a cluster of oval alveoli. Each alveolus consists of a transparent BASEMENT MEMBRANE enclosing epithelial cells. The ducts from most sebaceous glands open into a HAIR FOLLICLE, but some open on the general surface of the SKIN. Sebaceous glands secrete SEBUM.
=750  \0$aSebaceous glands$5IEN$0(DLC)sh 85119389

=LDR  00842cz  a2200253n  4500
=001  9880363794302441
=005  20141212205539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012626
=035  \\$aCBA5936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x805.$x578
=072  \\$aC17.$x800.$x794.$x712
=072  \\$aC17.$x800.$x882.$x712
=150  \\$aSebaceous Gland Neoplasms
=450  \\$wnnna$aNeoplasm, Sebaceous Gland
=450  \\$wnnna$aNeoplasms, Sebaceous Gland
=450  \\$wnnna$aSebaceous Gland Neoplasm
=550  \\$wg$aSebaceous Gland Diseases
=550  \\$wg$aSkin Neoplasms
=550  \\$wh$aMuir-Torre Syndrome
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=688  \\$a68
=750  \0$aSebaceous glands$xTumors$5IEN-M$0(DLC)sh 85119391

=LDR  01081cz  a2200301n  4500
=001  9880363794402441
=005  20141212205539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012625
=035  \\$aCBA5935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x794
=150  \\$aSebaceous Gland Diseases
=450  \\$wnnna$aDisease, Sebaceous Gland
=450  \\$wnnna$aDiseases, Sebaceous Gland
=450  \\$wnnna$aGland Disease, Sebaceous
=450  \\$wnnna$aGland Diseases, Sebaceous
=450  \\$wnnna$aSebaceous Gland Disease
=550  \\$wg$aSkin Diseases
=550  \\$wh$aAcne Vulgaris
=550  \\$wh$aDermatitis, Seborrheic
=550  \\$wh$aMucinosis, Follicular
=550  \\$wh$aRhinophyma
=550  \\$wh$aSebaceous Gland Neoplasms
=667  \\$aGEN or unspecified; prefer specifics; DF: SEBACEOUS GLAND DIS
=680  \\$iDiseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma (SEBACEOUS GLAND NEOPLASMS).
=688  \\$a98; use explode 1976-97
=750  \0$aSebaceous glands$xDiseases$5IEN-M$0(DLC)sh 85119390

=LDR  01356cz  a2200217n  4500
=001  9880363794502441
=005  20141212205538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012624
=035  \\$aCBA5934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80.$x750
=150  \\$aSeaweed
=450  \\$aMacroalgae
=450  \\$aMarine Algae$5IEN
=550  \\$wg$aAquatic Organisms
=550  \\$wh$aKelp
=550  \\$aRhodophyta
=667  \\$acoordinate with specific alga if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iMulticellular marine macroalgae including some members of red (RHODOPHYTA), green (CHLOROPHYTA), and brown (PHAEOPHYTA) algae. They are widely distributed in the ocean, occurring from the tide level to considerable depths, free-floating (planktonic) or anchored to the substratum (benthic). They lack a specialized vascular system but take up fluids, nutrients, and gases directly from the water. They contain CHLOROPHYLL and are photosynthetic, but some also contain other light-absorbing pigments. Many are of economic importance as FOOD, fertilizer, AGAR, potash, or source of IODINE.
=750  \0$aMarine algae$5IEN$0(DLC)sh 85081114

=LDR  00750cz  a2200265n  4500
=001  9880363794602441
=005  20171012145701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012623
=035  \\$aCBA5933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x725.$x500
=150  \\$aSeawater
=450  \\$wnnna$aSea Water
=450  \\$wnnna$aSea Waters
=450  \\$wnnna$aSeawaters
=450  \\$wnnna$aWater, Sea
=450  \\$wnnna$aWaters, Sea
=550  \\$wg$aSaline Waters
=550  \\$wh$aOceans and Seas
=550  \\$aOceans and Seas
=550  \\$aWater
=680  \\$iThe salinated water of OCEANS AND SEAS that provides habitat for marine organisms.
=688  \\$a74(69)
=750  \0$aSeawater$5IEN$0(DLC)sh 85119275

=LDR  00872cz  a2200253n  4500
=001  9880363794702441
=005  20141212205537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012621
=035  \\$aCBA5931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910.$x645.$x661
=072  \\$aG16.$x500.$x275.$x71.$x590
=072  \\$aN6.$x230.$x300.$x100.$x250.$x525
=150  \\$aSeasons
=450  \\$wnnna$aSeason
=450  \\$wnnna$aSeasonal Variation
=450  \\$wnnna$aSeasonal Variations
=450  \\$wnnna$aVariation, Seasonal
=450  \\$wnnna$aVariations, Seasonal
=550  \\$wg$aClimate
=550  \\$wg$aPeriodicity
=680  \\$iDivisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aSeasons$5IEN$0(DLC)sh 85119377

=LDR  01330cz  a2200409n  4500
=001  9880363794802441
=005  20141212205536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012617
=035  \\$aCBA5927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x578
=150  \\$aSea Urchins
=450  \\$wnnna$aClypeasteroida
=450  \\$wnnna$aClypeasteroidas
=450  \\$wnnna$aDollar, Sand
=450  \\$wnnna$aDollars, Sand
=450  \\$aEchinoidea
=450  \\$wnnna$aEchinoideas
=450  \\$aSand-Dollar
=450  \\$wnnna$aSand Dollar
=450  \\$wnnna$aSand Dollars
=450  \\$wnnna$aSand-Dollars
=450  \\$wnnna$aSea Urchin
=450  \\$wnnna$aUrchin, Sea
=450  \\$wnnna$aUrchins, Sea
=550  \\$wg$aEchinodermata
=550  \\$wh$aAnthocidaris
=550  \\$wh$aArbacia
=550  \\$wh$aHemicentrotus
=550  \\$wh$aLytechinus
=550  \\$wh$aParacentrotus
=550  \\$wh$aStrongylocentrotus
=667  \\$ageneral; prefer specifics; sea urchin eggs = OVUM (IM) + SEA URCHINS (NIM) if merely test organism
=680  \\$iSomewhat flattened, globular echinoderms, having thin, brittle shells of calcareous plates. They are useful models for studying FERTILIZATION and EMBRYO DEVELOPMENT.
=688  \\$a72
=750  \0$aSea urchins$0(DLC) sh 85119269$5IEN

=LDR  00818cz  a2200277n  4500
=001  9880363794902441
=005  20141212205536.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012616
=035  \\$aCBA5926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x560
=150  \\$aSea Cucumbers
=450  \\$wnnna$aCucumber, Sea
=450  \\$wnnna$aCucumbers, Sea
=450  \\$aHolothuroidea
=450  \\$wnnna$aHolothuroideas
=450  \\$wnnna$aSea Cucumber
=550  \\$wg$aEchinodermata
=550  \\$wh$aCucumaria
=550  \\$wh$aHolothuria
=550  \\$wh$aStichopus
=667  \\$anote specifics
=680  \\$iA class of Echinodermata characterized by long, slender bodies.
=688  \\$a91(78); was see under ECHINODERMATA 1978-90
=750  \0$aSea cucumbers$0(DLC) sh 85061540$5IEN

=LDR  00708cz  a2200217n  4500
=001  9880363795002441
=005  20141212205536.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x237.$x750
=150  \\$aSea Anemones
=450  \\$aActiniaria
=450  \\$wnnna$aActiniarias
=450  \\$wnnna$aAnemone, Sea
=450  \\$wnnna$aAnemones, Sea
=450  \\$wnnna$aSea Anemone
=550  \\$wg$aAnthozoa
=680  \\$iThe order Actiniaria, in the class ANTHOZOA, comprised of large, solitary polyps. All species are carnivorous.
=688  \\$a91(75); was see under COELENTERATA 1975-90
=750  \0$aSea anemones$5IEN$0(DLC)sh 85119205

=LDR  01017cz  a2200253n  4500
=001  9880363795102441
=005  20141212205535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012614
=035  \\$aCBA5924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x454.$x800
=072  \\$aC15.$x378.$x463.$x515.$x800
=072  \\$aC18.$x654.$x521.$x500.$x133.$x115.$x661
=150  \\$aScurvy
=450  \\$wnnna$aHypoascorbemia
=450  \\$wnnna$aHypoascorbemias
=450  \\$aScorbutus
=450  \\$wnnna$aScurvies
=550  \\$wg$aAscorbic Acid Deficiency
=550  \\$wg$aHemostatic Disorders
=550  \\$aAscorbic Acid Deficiency
=680  \\$iAn acquired blood vessel disorder caused by severe deficiency of vitamin C (ASCORBIC ACID) in the diet leading to defective collagen formation in small blood vessels. Scurvy is characterized by bleeding in any tissue, weakness, ANEMIA, spongy gums, and a brawny induration of the muscles of the calves and legs.
=750  \0$aScurvy$5IEN$0(DLC)sh 85119180

=LDR  00436cz  a2200169n  4500
=001  9880363795202441
=005  20141212205535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012613
=035  \\$aCBA5923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x849
=150  \\$aSculpture
=450  \\$wnnna$aSculptures
=550  \\$wg$aArt
=688  \\$a91(75); was see under ART 1975-90
=750  \0$aSculpture$5IEN$0(DLC)sh 85119004

=LDR  01258cz  a2200289n  4500
=001  9880363795302441
=005  20141212205535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012612
=035  \\$aCBA5922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x850
=150  \\$aScrub Typhus
=450  \\$wnnna$aDisease, Tsutsugamushi
=450  \\$wnnna$aDiseases, Tsutsugamushi
=450  \\$wnnna$aFever, Tsutsugamushi
=450  \\$wnnna$aFevers, Tsutsugamushi
=450  \\$aTsutsugamushi Disease
=450  \\$wnnna$aTsutsugamushi Diseases
=450  \\$wnnna$aTsutsugamushi Fever
=450  \\$wnnna$aTsutsugamushi Fevers
=450  \\$aTyphus, Scrub
=550  \\$wg$aRickettsiaceae Infections
=667  \\$acaused by ORIENTIA TSUTSUGAMUSHI
=680  \\$iAn acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash.
=688  \\$aTSUTSUGAMUSHI DISEASE was TSUTSUGAMUSHI see SCRUB TYPHUS 1963-91
=750  \0$aTsutsugamushi disease$5IEN$0(DLC)sh 85138354

=LDR  00399cz  a2200157n  4500
=001  9880363795402441
=005  20141212205535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012611
=035  \\$aCBA5921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x661
=150  \\$aScrotum
=450  \\$wnnna$aScrotums
=550  \\$wg$aGenitalia, Male
=750  \0$aScrotum$5IEN$0(DLC)sh 85118990

=LDR  00930cz  a2200229n  4500
=001  9880363795502441
=005  20141212205534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012608
=035  \\$aCBA5918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800.$x717
=072  \\$aC10.$x574.$x843.$x850
=072  \\$aC22.$x836.$x799
=150  \\$aScrapie
=450  \\$aRida
=550  \\$wg$aPrion Diseases
=550  \\$wg$aSheep Diseases
=667  \\$aa prion dis; usually animal: check tag ANIMAL; if in sheep, coord IM with SHEEP (NIM) but do not index under SHEEP DISEASES; if in goats, coord IM with GOAT DISEASES (IM) & GOATS (NIM)
=680  \\$iA fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.
=688  \\$a68(66)
=750  \0$aScrapie$5IEN$0(DLC)sh 85118929

=LDR  02546cz  a2200733n  4500
=001  9880363795602441
=005  20141212205534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012607
=035  \\$aCBA5917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x811
=072  \\$aC11.$x966.$x811
=072  \\$aC23.$x888.$x592.$x763.$x941.$x811
=150  \\$aScotoma
=450  \\$wnnna$aAltitudinal Scotoma
=450  \\$wnnna$aAltitudinal Scotomas
=450  \\$wnnna$aArcuate Scotoma
=450  \\$wnnna$aArcuate Scotomas
=450  \\$wnnna$aBjerrum Scotoma
=450  \\$wnnna$aBjerrum Scotomas
=450  \\$wnnna$aCentral Scotoma
=450  \\$wnnna$aCentral Scotomas
=450  \\$wnnna$aCentrocecal Scotoma
=450  \\$wnnna$aCentrocecal Scotomas
=450  \\$wnnna$aParacecal Scotoma
=450  \\$wnnna$aParacecal Scotomas
=450  \\$wnnna$aParacentral Scotoma
=450  \\$wnnna$aParacentral Scotomas
=450  \\$wnnna$aPeripheral Scotoma
=450  \\$wnnna$aPeripheral Scotomas
=450  \\$wnnna$aRing Scotoma
=450  \\$wnnna$aRing Scotomas
=450  \\$wnnna$aScintillating Scotoma
=450  \\$wnnna$aScintillating Scotomas
=450  \\$wnnna$aScotoma, Altitudinal
=450  \\$aScotoma, Arcuate
=450  \\$aScotoma, Bjerrum
=450  \\$aScotoma, Central
=450  \\$aScotoma, Centrocecal
=450  \\$wnnna$aScotoma, Paracecal
=450  \\$wnnna$aScotoma, Paracentral
=450  \\$wnnna$aScotoma, Peripheral
=450  \\$wnnna$aScotoma, Ring
=450  \\$wnnna$aScotoma, Scintillating
=450  \\$wnnna$aScotoma, Sector
=450  \\$wnnna$aScotomas
=450  \\$wnnna$aScotomas, Altitudinal
=450  \\$wnnna$aScotomas, Arcuate
=450  \\$wnnna$aScotomas, Bjerrum
=450  \\$wnnna$aScotomas, Central
=450  \\$wnnna$aScotomas, Centrocecal
=450  \\$wnnna$aScotomas, Paracecal
=450  \\$wnnna$aScotomas, Paracentral
=450  \\$wnnna$aScotomas, Peripheral
=450  \\$wnnna$aScotomas, Ring
=450  \\$wnnna$aScotomas, Scintillating
=450  \\$wnnna$aScotomas, Sector
=450  \\$wnnna$aSector Scotoma
=450  \\$wnnna$aSector Scotomas
=550  \\$wg$aVision Disorders
=667  \\$adifferentiate from physiol blind spot ( = BLIND SPOT)
=680  \\$iA localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES (e.g., RETINAL DISEASES and GLAUCOMA); OPTIC NERVE DISEASES, and other conditions.
=750  \0$aScotoma$5IEN$0(DLC)sh 85118878

=LDR  01246cz  a2200181n  4500
=001  9880363795702441
=005  20141212205533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012605
=035  \\$aCBA5915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x661
=150  \\$aScorpions
=450  \\$wnnna$aScorpion
=550  \\$wg$aArachnida
=667  \\$aincludes the genera Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus; SCORPION STINGS is available
=680  \\$iArthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are nocturnal and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. (From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p417; Barnes, Invertebrate Zoology, 5th ed, p503)
=750  \0$aScorpions$5IEN$0(DLC)sh 85118793

=LDR  01374cz  a2200349n  4500
=001  9880363795802441
=005  20141212205532.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012604
=035  \\$aCBA5914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65.$x830
=072  \\$aD23.$x946.$x833.$x65.$x830
=150  \\$aScorpion Venoms
=450  \\$wnnna$aalpha-Scorpion Toxin
=450  \\$wnnna$aalpha Scorpion Toxin
=450  \\$wnnna$abeta-Scorpion Toxin
=450  \\$wnnna$abeta Scorpion Toxin
=450  \\$wnnna$agamma-Scorpion Toxin
=450  \\$wnnna$agamma Scorpion Toxin
=450  \\$wnnna$aScorpion Venom
=450  \\$wnnna$aToxin, alpha-Scorpion
=450  \\$wnnna$aToxin, beta-Scorpion
=450  \\$wnnna$aToxin, gamma-Scorpion
=450  \\$wnnna$aVenom, Scorpion
=450  \\$wnnna$aVenoms, Scorpion
=550  \\$wg$aArthropod Venoms
=550  \\$wh$aCharybdotoxin
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted
=680  \\$iVenoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic.
=688  \\$a78
=750  \0$aScorpions$xVenom$5IEN-M$0(DLC)sh 85118795

=LDR  02317cz  a2200565n  4500
=001  9880363795902441
=005  20141212205531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012601
=035  \\$aCBA5911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x74.$x722.$x822.$x775
=072  \\$aD3.$x132.$x760.$x180.$x848
=072  \\$aD3.$x132.$x889.$x601.$x775
=072  \\$aD3.$x605.$x869.$x822.$x775
=072  \\$aD4.$x75.$x80.$x875.$x99.$x722.$x822.$x775
=150  \\$aScopolamine Hydrobromide
=450  \\$wnnna$aAlcon Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aBoro-Scopol
=450  \\$wnnna$aBoro Scopol
=450  \\$wnnna$aBoroScopol
=450  \\$wnnna$aBull Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aCooper Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aHamilton Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aHope Brand of Scopolamine
=450  \\$wnnna$aHydrobromide, Scopolamine
=450  \\$aHyoscine
=450  \\$wnnna$aInibisa Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aIsopto Hyoscine
=450  \\$wnnna$aKwells
=450  \\$wnnna$aNovartis Brand of Scopolamine
=450  \\$wnnna$aNovartis Consumer Health Brand of Scopolamine
=450  \\$wnnna$aRenaudin Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aRoche Brand of Scopolamine Hydrobromide
=450  \\$wnnna$aScoburen
=450  \\$wnnna$aScopace
=450  \\$wnnna$aScopoderm TTS
=450  \\$aScopolamine
=450  \\$wnnna$aScopolamine Cooper
=450  \\$wnnna$aTransderm Scop
=450  \\$wnnna$aTransderm-V
=450  \\$wnnna$aTransderm V
=450  \\$wnnna$aTravacalm HO
=450  \\$wnnna$aVorigeno
=450  \\$wnnna$aWinzer Brand of Scopolamine Borate
=550  \\$wg$aBelladonna Alkaloids
=550  \\$wg$aScopolamine Derivatives
=680  \\$iAn alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in URINARY INCONTINENCE, in MOTION SICKNESS, as an antispasmodic, and as a mydriatic and cycloplegic.
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Scopolamine
=750  \0$aScopolamine$0(DLC) sh 85118772$5IEN

=LDR  00576cz  a2200181n  4500
=001  9880363796002441
=005  20141212205531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012600
=035  \\$aCBA5910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x800.$x875
=150  \\$aScoliosis
=450  \\$wnnna$aScolioses
=550  \\$wg$aSpinal Curvatures
=667  \\$aa type of spinal curvature
=680  \\$iAn appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed)
=750  \0$aScoliosis$5IEN$0(DLC)sh 85118750

=LDR  01223cz  a2200265n  4500
=001  9880363796102441
=005  20141212205530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012595
=035  \\$aCBA5905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x799
=072  \\$aC17.$x800.$x784
=150  \\$aScleroderma, Systemic
=450  \\$aSclerosis, Systemic
=450  \\$wnnna$aSystemic Scleroderma
=450  \\$wnnna$aSystemic Sclerosis
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aSkin Diseases
=550  \\$wh$aScleroderma, Diffuse
=550  \\$wh$aScleroderma, Limited
=667  \\$anote specific indentations and SCLERODERMA, LOCALIZED
=680  \\$iA chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
=688  \\$a1971
=750  \0$aSystemic scleroderma$5IEN$0(DLC)sh 85131748

=LDR  01329cz  a2200337n  4500
=001  9880363796202441
=005  20141212205529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012594
=035  \\$aCBA5904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x787
=072  \\$aC17.$x800.$x767
=150  \\$aScleroderma, Localized
=450  \\$wnnna$aCircumscribed Scleroderma
=450  \\$aDermatosclerosis
=450  \\$wnnna$aFrontal Linear Scleroderma en Coup de Sabre
=450  \\$wnnna$aLinear Scleroderma
=450  \\$wnnna$aLocalized Scleroderma
=450  \\$aMorphea
=450  \\$wnnna$aMorpheas
=450  \\$aScleroderma, Circumscribed
=450  \\$aScleroderma (Disease)$5IEN
=450  \\$wnnna$aScleroderma, Linear
=450  \\$wnnna$aSclerodermas, Localized
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aSkin Diseases
=667  \\$ado not confuse with SCLERODERMA, LIMITED
=680  \\$iA term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.
=688  \\$a2004 (1971)
=750  \0$aScleroderma (Disease)$5IEN$0(DLC)sh 85118731

=LDR  00956cz  a2200181n  4500
=001  9880363796302441
=005  20141212205528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012590
=035  \\$aCBA5898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x784
=150  \\$aSclera
=450  \\$wnnna$aScleras
=550  \\$wg$aEye
=667  \\$athe outer coat of the eyeball; inflammation = SCLERITIS; neopl = SCLERAL DISEASES (IM) + EYE NEOPLASMS (IM); blue sclera = SCLERA /abnorm
=680  \\$iThe white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aSclera$5IEN$0(DLC)sh 85118726

=LDR  00876cz  a2200241n  4500
=001  9880363796502441
=005  20141212205527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012588
=035  \\$aCBA5896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x700
=150  \\$aScintillation Counting
=450  \\$wnnna$aCounter, Scintillation
=450  \\$wnnna$aCounters, Scintillation
=450  \\$wnnna$aCounting, Scintillation
=450  \\$wnnna$aScintillation Counter
=450  \\$wnnna$aScintillation Counters
=550  \\$wg$aRadiometry
=550  \\$aRadionuclide Imaging
=680  \\$iDetection and counting of scintillations produced in a fluorescent material by ionizing radiation.
=688  \\$a79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72
=750  \0$aScintillation counters$5IEN$0(DLC)sh 85118711

=LDR  01547cz  a2200361n  4500
=001  9880363796602441
=005  20141212205526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012585
=035  \\$aCBA5893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x682.$x800
=072  \\$aC10.$x668.$x829.$x500.$x675.$x800
=072  \\$aC10.$x668.$x829.$x600.$x800
=072  \\$aC23.$x888.$x592.$x612.$x664.$x800
=072  \\$aC23.$x888.$x646.$x508.$x800
=150  \\$aSciatica
=450  \\$wnnna$aBilateral Sciatica
=450  \\$wnnna$aBilateral Sciaticas
=450  \\$aNeuralgia, Sciatic
=450  \\$wnnna$aNeuralgias, Sciatic
=450  \\$aSciatic Neuralgia
=450  \\$wnnna$aSciatic Neuralgias
=450  \\$wnnna$aSciatica, Bilateral
=550  \\$wg$aNeuralgia
=550  \\$wg$aSciatic Neuropathy
=550  \\$aIntervertebral Disc Degeneration
=550  \\$aIntervertebral Disc Displacement
=550  \\$aLow Back Pain
=550  \\$aSciatic Nerve
=667  \\$ado not confuse with BACK PAIN or LUMBAGO see LOW BACK PAIN: use term of text; "lombo-sciatique" in French texts is indexed here (IM) + LOW BACK PAIN (IM)
=680  \\$iA condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.
=750  \0$aSciatica$5IEN$0(DLC)sh 85118551

=LDR  01053cz  a2200229n  4500
=001  9880363796702441
=005  20141212205526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012584
=035  \\$aCBA5892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x450.$x760
=150  \\$aSciatic Nerve
=450  \\$wnnna$aNerve, Sciatic
=450  \\$wnnna$aNerves, Sciatic
=450  \\$wnnna$aSciatic Nerves
=550  \\$wg$aLumbosacral Plexus
=550  \\$wh$aPeroneal Nerve
=550  \\$wh$aTibial Nerve
=667  \\$adis = SCIATIC NEUROPATHY (IM); neopl = SCIATIC NEUROPATHY (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iA nerve which originates in the lumbar and sacral spinal cord (L4 to S3) and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE.
=750  \0$aSciatic nerve$5IEN$0(DLC)sh 85118547

=LDR  00748cz  a2200217n  4500
=001  9880363796802441
=005  20141212205525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012582
=035  \\$aCBA5890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x836
=150  \\$aSchools, Veterinary
=450  \\$wnnna$aSchool, Veterinary
=450  \\$aVeterinary Colleges$5IEN
=450  \\$wnnna$aVeterinary School
=450  \\$aVeterinary Schools
=550  \\$wg$aSchools, Health Occupations
=667  \\$aManual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS VET
=680  \\$iEducational institutions for individuals specializing in the field of veterinary medicine.
=750  \0$aVeterinary colleges$5IEN$0(DLC)sh 85143013

=LDR  00790cz  a2200229n  4500
=001  9880363796902441
=005  20141212205525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012581
=035  \\$aCBA5889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x765
=150  \\$aSchools, Public Health
=450  \\$wnnna$aHealth School, Public
=450  \\$wnnna$aHealth Schools, Public
=450  \\$wnnna$aPublic Health School
=450  \\$aPublic Health Schools
=450  \\$wnnna$aSchool, Public Health
=550  \\$wg$aSchools, Health Occupations
=667  \\$aManual 30.7.3, 30.8; specify geog if pertinent
=680  \\$iEducational institutions for individuals specializing in the field of public health.
=750  \0$aSchools of public health$5IEN$0(DLC)sh 85118474

=LDR  00746cz  a2200229n  4500
=001  9880363797002441
=005  20141212205525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012580
=035  \\$aCBA5888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x694
=150  \\$aSchools, Pharmacy
=450  \\$aPharmacy Colleges$5IEN
=450  \\$wnnna$aPharmacy School
=450  \\$aPharmacy Schools
=450  \\$wnnna$aSchool, Pharmacy
=550  \\$wg$aSchools, Health Occupations
=667  \\$aManual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS PHARM
=680  \\$iEducational institutions for individuals specializing in the field of pharmacy.
=688  \\$a68
=750  \0$aPharmacy colleges$5IEN$0(DLC)sh 85100618

=LDR  00981cz  a2200277n  4500
=001  9880363797102441
=005  20141212205525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012579
=035  \\$aCBA5887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x623
=150  \\$aSchools, Nursing
=450  \\$wnnna$aNurse Training School
=450  \\$aNurse Training Schools
=450  \\$wnnna$aNursing School
=450  \\$aNursing Schools
=450  \\$wnnna$aSchool, Nurse Training
=450  \\$wnnna$aSchool, Nursing
=450  \\$wnnna$aSchools, Nurse Training
=450  \\$wnnna$aTraining School, Nurse
=450  \\$wnnna$aTraining Schools, Nurse
=550  \\$wg$aSchools, Health Occupations
=667  \\$ado not confuse with SCHOOL NURSING; Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS NURS
=680  \\$iEducational institutions for individuals specializing in the field of nursing.
=750  \0$aNursing schools$5IEN$0(DLC)sh 85093422

=LDR  00573cz  a2200205n  4500
=001  9880363797202441
=005  20141212205524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012578
=035  \\$aCBA5886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x659.$x660
=150  \\$aSchools, Nursery
=450  \\$wnnna$aNursery School
=450  \\$aNursery Schools
=450  \\$wnnna$aSchool, Nursery
=550  \\$wg$aSchools
=667  \\$aIM
=680  \\$iSchools for children usually under five years of age.
=750  \0$aNursery schools$5IEN$0(DLC)sh 85093344

=LDR  01014cz  a2200241n  4500
=001  9880363797302441
=005  20141212192515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012577
=035  \\$aCBA5885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x552
=072  \\$aN2.$x278.$x20.$x578
=150  \\$aSchools, Medical
=450  \\$aMedical Colleges$5IEN
=450  \\$wnnna$aMedical School
=450  \\$aMedical Schools
=450  \\$wnnna$aSchool, Medical
=550  \\$wg$aAcademic Medical Centers
=550  \\$wg$aSchools, Health Occupations
=667  \\$aincludes Faculté de Médecine, Facultad de Medicina; "College of Physicians" = SOCIETIES, MEDICAL; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes here + UNITED STATES; Manual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS MED
=680  \\$iEducational institutions for individuals specializing in the field of medicine.
=750  \0$aMedical colleges$5IEN$0(DLC)sh 85082898

=LDR  01082cz  a2200325n  4500
=001  9880363797402441
=005  20141212205524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012576
=035  \\$aCBA5884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660
=150  \\$aSchools, Health Occupations
=450  \\$wnnna$aHealth Occupations School
=450  \\$aHealth Occupations Schools
=450  \\$wnnna$aOccupations School, Health
=450  \\$wnnna$aOccupations Schools, Health
=450  \\$wnnna$aSchool, Health Occupations
=550  \\$wg$aSchools
=550  \\$wh$aArea Health Education Centers
=550  \\$wh$aSchools, Dental
=550  \\$wh$aSchools, Medical
=550  \\$wh$aSchools, Nursing
=550  \\$wh$aSchools, Pharmacy
=550  \\$wh$aSchools, Public Health
=550  \\$wh$aSchools, Veterinary
=667  \\$aManual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS HEALTH OCCUP
=680  \\$iSchools which offer training in the area of health.
=688  \\$a68
=750  \0$aHealth occupations schools$5IEN$0(DLC)sh 85059578

=LDR  00677cz  a2200205n  4500
=001  9880363797502441
=005  20141212205524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012575
=035  \\$aCBA5883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x481
=150  \\$aSchools, Dental
=450  \\$wnnna$aDental School
=450  \\$aDental Schools
=450  \\$wnnna$aSchool, Dental
=550  \\$wg$aSchools, Health Occupations
=667  \\$aManual 30.7.3, 30.8; specify geog if pertinent; DF: SCHOOLS DENT
=680  \\$iEducational institutions for individuals specializing in the field of dentistry.
=750  \0$aDental schools$5IEN$0(DLC)sh 85036930

=LDR  00872cz  a2200253n  4500
=001  9880363797702441
=005  20141212205523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012573
=035  \\$aCBA5881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x824
=072  \\$aN2.$x421.$x143.$x827.$x809.$x742
=072  \\$aN2.$x421.$x726.$x809.$x742
=150  \\$aSchool Nursing
=450  \\$wnnna$aNursing, School
=450  \\$wnnna$aNursings, School
=450  \\$wnnna$aSchool Nursings
=550  \\$wg$aSchool Health Services
=550  \\$wg$aSpecialties, Nursing
=667  \\$ado not confuse with SCHOOLS, NURSING; SPEC: SPEC qualif
=680  \\$iA nursing specialty concerned with health and nursing care given to primary and secondary school students by a registered nurse.
=688  \\$a67
=750  \0$aSchool nursing$5IEN$0(DLC)sh 85118371

=LDR  01612cz  a2200433n  4500
=001  9880363797802441
=005  20141212205523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012572
=035  \\$aCBA5880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x827.$x809
=072  \\$aN2.$x421.$x726.$x809
=150  \\$aSchool Health Services
=450  \\$wnnna$aHealth Promotion, School
=450  \\$wnnna$aHealth Promotions, School
=450  \\$wnnna$aHealth, School
=450  \\$wnnna$aHealth Service, School
=450  \\$wnnna$aHealth Services, School
=450  \\$wnnna$aPromotion, School Health
=450  \\$wnnna$aPromotions, School Health
=450  \\$wnnna$aSchool-Based Service
=450  \\$wnnna$aSchool-Based Services
=450  \\$wnnna$aSchool Based Services
=450  \\$wnnna$aSchool Health
=450  \\$wnnna$aSchool Health Promotion
=450  \\$wnnna$aSchool Health Promotions
=450  \\$wnnna$aSchool Health Service
=450  \\$wnnna$aService, School-Based
=450  \\$wnnna$aService, School Health
=450  \\$wnnna$aServices, School-Based
=450  \\$wnnna$aServices, School Health
=550  \\$wg$aPreventive Health Services
=550  \\$wh$aSchool Dentistry
=550  \\$wh$aSchool Nursing
=667  \\$afor high school & under; do not confuse with STUDENT HEALTH SERVICES for univ; specify geog; DF: SCHOOL HEALTH SERV
=680  \\$iPreventive health services provided for students. It excludes college or university students.
=688  \\$a79; was SCHOOL HEALTH 1963-78
=750  \0$aSchool health services$5IEN$0(DLC)sh 91004799

=LDR  00799cz  a2200253n  4500
=001  9880363797902441
=005  20141212205522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012571
=035  \\$aCBA5879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x809
=072  \\$aN2.$x421.$x143.$x827.$x809.$x576
=072  \\$aN2.$x421.$x726.$x809.$x576
=150  \\$aSchool Dentistry
=450  \\$wnnna$aDentistries, School
=450  \\$wnnna$aDentistry, School
=450  \\$wnnna$aSchool Dentistries
=550  \\$wg$aDentistry
=550  \\$wg$aSchool Health Services
=667  \\$aSPEC; SPEC qualif
=680  \\$iPreventive dental services provided for students in primary and secondary schools.
=688  \\$a74(72)
=750  \0$aSchool children$xDental care$5IEN$0(DLC)sh 85118297

=LDR  02071cz  a2200469n  4500
=001  9880363798002441
=005  20141212205522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012569
=035  \\$aCBA5877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x725
=150  \\$aSchizotypal Personality Disorder
=450  \\$wnnna$aBorderline Schizophrenia
=450  \\$wnnna$aBorderline Schizophrenias
=450  \\$wnnna$aDisorder, Schizotypal Personality
=450  \\$wnnna$aDisorders, Schizotypal Personality
=450  \\$aIncipient Schizophrenia
=450  \\$wnnna$aIncipient Schizophrenias
=450  \\$aLatent Schizophrenia
=450  \\$wnnna$aLatent Schizophrenias
=450  \\$aPersonality Disorder, Schizotypal
=450  \\$wnnna$aPersonality Disorders, Schizotypal
=450  \\$aPseudoneurotic Schizophrenia
=450  \\$wnnna$aPseudoneurotic Schizophrenias
=450  \\$aPseudopsychopathic Schizophrenia
=450  \\$wnnna$aPseudopsychopathic Schizophrenias
=450  \\$aSchizophrenia, Borderline
=450  \\$wnnna$aSchizophrenia, Incipient
=450  \\$aSchizophrenia, Latent
=450  \\$aSchizophrenia, Pseudoneurotic
=450  \\$wnnna$aSchizophrenia, Pseudopsychopathic
=450  \\$wnnna$aSchizophrenias, Borderline
=450  \\$wnnna$aSchizophrenias, Incipient
=450  \\$wnnna$aSchizophrenias, Latent
=450  \\$wnnna$aSchizophrenias, Pseudoneurotic
=450  \\$wnnna$aSchizophrenias, Pseudopsychopathic
=450  \\$wnnna$aSchizotypal Personality Disorders
=550  \\$wg$aPersonality Disorders
=680  \\$iA personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia.
=688  \\$a81; was SCHIZOPHRENIA, LATENT 1972-80 (Prov 1972)
=750  \0$aSchizotypal personality disorder$5IEN$0(DLC)sh 85108286

=LDR  01081cz  a2200349n  4500
=001  9880363798102441
=005  20141212205521.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012568
=035  \\$aCBA5876HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x797
=072  \\$aB1.$x300.$x930.$x720
=150  \\$aSchizosaccharomyces
=450  \\$aFission Yeast
=450  \\$wnnna$aFission Yeasts
=450  \\$wnnna$apombe, S
=450  \\$wnnna$apombe, Schizosaccharomyces
=450  \\$wnnna$apombes, S
=450  \\$wnnna$apombes, Schizosaccharomyces
=450  \\$wnnna$aS pombe
=450  \\$wnnna$aS pombes
=450  \\$wnnna$aSchizosaccharomyce
=450  \\$aSchizosaccharomyces pombe
=450  \\$wnnna$aSchizosaccharomyces pombes
=450  \\$aYeast, Fission
=450  \\$wnnna$aYeasts, Fission
=550  \\$wg$aAscomycota
=550  \\$wg$aYeasts
=680  \\$iA genus of ascomycetous fungi of the family Schizosaccharomycetaceae, order Schizosaccharomycetales.
=688  \\$a91(75)
=750  \0$aSchizosaccharomyces$5IEN$0(DLC)sh 88022003

=LDR  00748cz  a2200193n  4500
=001  9880363798202441
=005  20141212205520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012565
=035  \\$aCBA5873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x824
=150  \\$aSchizophrenic Psychology
=450  \\$aPsychology, Schizophrenic
=450  \\$aSchizophrenia$xpsychology
=550  \\$wg$aBehavioral Disciplines and Activities
=667  \\$ano qualif; any mental process in schizophrenia; coord IM with specific psychol term (IM) + specific type of schizophrenia if relevant (IM or NIM); DF: SCHIZOPHRENIC PSYCHOL
=680  \\$iStudy of mental processes and behavior of schizophrenics.
=750  \0$aSchizophrenia$5IEN$0(DLC)sh 85118162

=LDR  00749cz  a2200181n  4500
=001  9880363798302441
=005  20141212205520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012564
=035  \\$aCBA5872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x975
=150  \\$aSchizophrenic Language
=450  \\$wnnna$aLanguage, Schizophrenic
=550  \\$wg$aBehavioral Symptoms
=667  \\$ano qualif; any language concept in schizophrenia; coord IM with specific language term (IM) + specific type of schizophrenia if relevant (IM or NIM)
=680  \\$iThe artificial language of schizophrenic patients - neologisms (words of the patient's own making with new meanings).
=750  \0$aSchizophrenics$xLanguage$5IEN$0(DLC)sh 85118172

=LDR  00998cz  a2200265n  4500
=001  9880363798402441
=005  20141212205520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012563
=035  \\$aCBA5871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x750.$x600
=150  \\$aSchizophrenia, Paranoid
=450  \\$aDelusional Disorder
=450  \\$wnnna$aDelusional Disorders
=450  \\$wnnna$aDisorder, Delusional
=450  \\$wnnna$aDisorders, Delusional
=450  \\$aParanoid Schizophrenia
=450  \\$wnnna$aParanoid Schizophrenias
=450  \\$wnnna$aSchizophrenias, Paranoid
=550  \\$wg$aSchizophrenia
=667  \\$a/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if paranoid aspect is less relevant (NIM)
=680  \\$iA chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.
=688  \\$a73
=750  \0$aParanoid schizophrenia$5IEN$0(DLC)sh 87001886

=LDR  00923cz  a2200217n  4500
=001  9880363798502441
=005  20170717165557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012561
=035  \\$aCBA5869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x968
=150  \\$aSchizophrenia, Childhood
=450  \\$wnnna$aChildhood-Onset Schizophrenia
=450  \\$wnnna$aChildhood Onset Schizophrenia
=450  \\$aChildhood Schizophrenia
=450  \\$wnnna$aSchizophrenia, Childhood-Onset
=550  \\$wg$aNeurodevelopmental Disorders
=667  \\$aobsolete concept, historical; do not use for schizophrenia in a child; /psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY (IM) if juvenile aspect is less relevant (NIM)
=680  \\$iAn obsolete concept, historically used for childhood mental disorders thought to be a form of schizophrenia.
=750  \0$aSchizophrenia in children$5IEN$0(DLC)sh 85118169

=LDR  01191cz  a2200313n  4500
=001  9880363798602441
=005  20141212205518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012559
=035  \\$aCBA5867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x750
=150  \\$aSchizophrenia
=450  \\$aDementia Praecox
=450  \\$wnnna$aDisorder, Schizophrenic
=450  \\$wnnna$aDisorders, Schizophrenic
=450  \\$wnnna$aSchizophrenias
=450  \\$wnnna$aSchizophrenic Disorder
=450  \\$aSchizophrenic Disorders
=450  \\$aSchizophrenics$5IEN
=550  \\$wg$aSchizophrenia and Disorders with Psychotic Features
=550  \\$wh$aSchizophrenia, Catatonic
=550  \\$wh$aSchizophrenia, Disorganized
=550  \\$wh$aSchizophrenia, Paranoid
=550  \\$wh$aShared Paranoid Disorder
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
=750  \0$aSchizophrenia$5IEN-M$0(DLC)sh 85118162
=750  \0$aSchizophrenics$5IEN-HS$0(DLC)sh 85118170

=LDR  01167cz  a2200277n  4500
=001  9880363798702441
=005  20141212205518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012557
=035  \\$aCBA5865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x700
=150  \\$aSchizoid Personality Disorder
=450  \\$wnnna$aDisorder, Schizoid Personality
=450  \\$wnnna$aDisorders, Schizoid Personality
=450  \\$wnnna$aPersonalities, Schizoid
=450  \\$aPersonality Disorder, Schizoid
=450  \\$wnnna$aPersonality Disorders, Schizoid
=450  \\$wnnna$aPersonality, Schizoid
=450  \\$wnnna$aSchizoid Personalities
=450  \\$wnnna$aSchizoid Personality
=450  \\$wnnna$aSchizoid Personality Disorders
=550  \\$wg$aPersonality Disorders
=680  \\$iA personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism.
=688  \\$a81; was SCHIZOID PERSONALITY 1972-80 (Prov 1972), was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72
=750  \0$aSchizoid personality$5IEN$0(DLC)sh 85118156

=LDR  01324cz  a2200277n  4500
=001  9880363798802441
=005  20141212205516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012552
=035  \\$aCBA5860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x859
=150  \\$aSchistosomiasis
=450  \\$wnnna$aBilharziases
=450  \\$aBilharziasis
=450  \\$wnnna$aFever, Katayama
=450  \\$wnnna$aKatayama Fever
=450  \\$wnnna$aSchistosomiases
=550  \\$wg$aTrematode Infections
=550  \\$wh$aNeuroschistosomiasis
=550  \\$wh$aSchistosomiasis haematobia
=550  \\$wh$aSchistosomiasis japonica
=550  \\$wh$aSchistosomiasis mansoni
=667  \\$ageneral or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent
=680  \\$iInfection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
=750  \0$aSchistosomiasis$0(DLC) sh 85118147$5IEN

=LDR  00888cz  a2200193n  4500
=001  9880363798902441
=005  20141212205516.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012551
=035  \\$aCBA5859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x770
=150  \\$aSchistosomatidae
=550  \\$wg$aTrematoda
=550  \\$wh$aSchistosoma
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of blood flukes of the class Trematoda which is found in animals and man. It Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Trichobilharzia, Pseudobilharzia, and Austrobilharzia.
=688  \\$a82
=750  \0$aSchistosomatidae$5IEN$0(DLC)sh 85118144

=LDR  00948cz  a2200217n  4500
=001  9880363799002441
=005  20141212205516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012550
=035  \\$aCBA5858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x770.$x680.$x700
=150  \\$aSchistosoma mansoni
=450  \\$wnnna$amansoni, Schistosoma
=450  \\$wnnna$amansonus, Schistosoma
=450  \\$wnnna$aSchistosoma mansonus
=550  \\$wg$aSchistosoma
=667  \\$ainfection = SCHISTOSOMIASIS MANSONI; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis.
=688  \\$a72
=750  \0$aSchistosoma mansoni$5IEN$0(DLC)sh 85118143

=LDR  00943cz  a2200217n  4500
=001  9880363799102441
=005  20141212205516.0
=008  780306\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012549
=035  \\$aCBA5857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x770.$x680.$x570
=150  \\$aSchistosoma japonicum
=450  \\$wnnna$ajaponicum, Schistosoma
=450  \\$wnnna$ajaponicums, Schistosoma
=450  \\$wnnna$aSchistosoma japonicums
=550  \\$wg$aSchistosoma
=667  \\$ainfection = SCHISTOSOMIASIS JAPONICA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals.
=688  \\$a79
=750  \0$aSchistosoma japonicum$5IEN$0(DLC)sh 85118142

=LDR  00988cz  a2200217n  4500
=001  9880363799202441
=005  20141212205515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012548
=035  \\$aCBA5856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x770.$x680.$x510
=150  \\$aSchistosoma haematobium
=450  \\$wnnna$ahaematobium, Schistosoma
=450  \\$wnnna$ahaematobiums, Schistosoma
=450  \\$wnnna$aSchistosoma haematobiums
=550  \\$wg$aSchistosoma
=667  \\$ainfection = SCHISTOSOMIASIS HAEMATOBIA; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis.
=688  \\$a72
=750  \0$aSchistosoma haematobium$5IEN$0(DLC)sh 85118140

=LDR  01041cz  a2200241n  4500
=001  9880363799302441
=005  20141212205515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012547
=035  \\$aCBA5855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x770.$x680
=150  \\$aSchistosoma
=450  \\$aBilharzia
=450  \\$wnnna$aBilharzias
=450  \\$wnnna$aSchistosomas
=550  \\$wg$aSchistosomatidae
=550  \\$wh$aSchistosoma haematobium
=550  \\$wh$aSchistosoma japonicum
=550  \\$wh$aSchistosoma mansoni
=667  \\$aGEN or unspecified; prefer specifics; /drug eff: consider also SCHISTOSOMICIDES; infection = SCHISTOSOMIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.
=750  \0$aSchistosoma$5IEN$0(DLC)sh 85118139

=LDR  00840cz  a2200217n  4500
=001  9880363799402441
=005  20141212205514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012545
=035  \\$aCBA5853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x491.$x784
=150  \\$aSchiff Bases
=450  \\$wnnna$aBase, Schiff
=450  \\$wnnna$aBases, Schiff
=450  \\$wnnna$aSchiff Base
=550  \\$wg$aImines
=667  \\$aIM general only; an imine: do not confuse with Schiff reagent nor PERIODIC ACID-SCHIFF REACTION
=680  \\$iCondensation products of aromatic amines and aldehydes forming azomethines substituted on the N atom, containing the general formula R-N:CHR. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a73; was SCHIFF BASE 1971-72 (Prov)
=750  \0$aSchiff bases$5IEN$0(DLC)sh 85118118

=LDR  02195cz  a2200565n  4500
=001  9880363799502441
=005  20141212205514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012544
=035  \\$aCBA5852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x821.$x500.$x500
=072  \\$aC5.$x116.$x900.$x800.$x500.$x500
=072  \\$aC5.$x116.$x900.$x808.$x500
=150  \\$aScheuermann Disease
=450  \\$wnnna$aAdolescent Kyphoses
=450  \\$wnnna$aAdolescent Kyphosis
=450  \\$wnnna$aJuvenile Kyphoses
=450  \\$wnnna$aJuvenile Kyphoses, Scheuermann
=450  \\$wnnna$aJuvenile Kyphosis
=450  \\$wnnna$aJuvenile Kyphosis, Scheuermann
=450  \\$wnnna$aJuvenile Osteochondrosis of Spine
=450  \\$wnnna$aKyphoses, Adolescent
=450  \\$wnnna$aKyphoses, Juvenile
=450  \\$wnnna$aKyphoses, Scheuermann
=450  \\$wnnna$aKyphoses, Scheuermann Juvenile
=450  \\$wnnna$aKyphoses, Scheuermann's
=450  \\$wnnna$aKyphosis, Adolescent
=450  \\$wnnna$aKyphosis, Juvenile
=450  \\$wnnna$aKyphosis, Scheuermann
=450  \\$wnnna$aKyphosis, Scheuermann Juvenile
=450  \\$wnnna$aKyphosis, Scheuermann's
=450  \\$wnnna$aScheuermann Juvenile Kyphoses
=450  \\$wnnna$aScheuermann Juvenile Kyphosis
=450  \\$wnnna$aScheuermann Kyphoses
=450  \\$wnnna$aScheuermann Kyphosis
=450  \\$wnnna$aScheuermann's Disease
=450  \\$wnnna$aScheuermanns Disease
=450  \\$wnnna$aScheuermann's Kyphoses
=450  \\$wnnna$aScheuermann's Kyphosis
=450  \\$wnnna$aScheuermanns Kyphosis
=450  \\$wnnna$aSpine Juvenile Osteochondroses
=450  \\$wnnna$aSpine Juvenile Osteochondrosis
=550  \\$wg$aKyphosis
=550  \\$wg$aSpinal Osteochondrosis
=680  \\$iA type of juvenile osteochondrosis affecting the fibrocartilaginous disc (INTERVERTEBRAL DISC) in the thoracic or thoracolumbar region of the SPINE. It is characterized by a forward concave SPINAL CURVATURE or KYPHOSIS.
=688  \\$a2009(1963)
=688  \\$a2009(1966)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Scheuermann's Disease
=750  \0$aScheuermann's disease$0(DLC) sh 85118115$5IEN

=LDR  00939cz  a2200217n  4500
=001  9880363799602441
=005  20141212205513.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012543
=035  \\$aCBA5851M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x820
=150  \\$aScent Glands
=450  \\$wnnna$aGland, Scent
=450  \\$wnnna$aGlands, Scent
=450  \\$wnnna$aScent Gland
=550  \\$wg$aAnimal Structures
=667  \\$aanimal only; includes skunk perianal glands, weasel anal glands, fox musk glands, wood rat ventral glands, peccary dorsal glands
=680  \\$iExocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries.
=688  \\$a91(75); was see under EXOCRINE GLANDS 1975-90
=750  \0$aGlands, Odoriferous$0(DLC) sh 85055093$5IEN-M

=LDR  01212cz  a2200301n  4500
=001  9880363799702441
=005  20170113102005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012542
=035  \\$aCBA5850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x822
=072  \\$aG1.$x595.$x861
=150  \\$aScattering, Radiation
=450  \\$wnnna$aRadiation Scattering
=450  \\$wnnna$aRadiation Scatterings
=450  \\$wnnna$aScatterings, Radiation
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aPhysical Processes
=550  \\$wh$aNeutron Diffraction
=550  \\$wh$aDynamic Light Scattering
=550  \\$wh$aScattering, Small Angle
=550  \\$wh$aSpectrum Analysis, Raman
=550  \\$wh$aX-Ray Diffraction
=667  \\$alight scattering: coordinate with LIGHT
=680  \\$iThe diversion of RADIATION (thermal, electromagnetic, or nuclear) from its original path as a result of interactions or collisions with atoms, molecules, or larger particles in the atmosphere or other media. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a74; was SCATTERING 1971-73 (Prov)
=750  \0$aScattering (Physics)$0(DLC) sh 85118047$5IEN

=LDR  00737cz  a2200217n  4500
=001  9880363799802441
=005  20141212205513.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012541
=035  \\$aCBA5849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890.$x823
=150  \\$aScarlet Fever
=450  \\$wnnna$aFever, Scarlet
=450  \\$wnnna$aFevers, Scarlet
=450  \\$aScarlatina$5IEN
=450  \\$wnnna$aScarlet Fevers
=550  \\$wg$aStreptococcal Infections
=667  \\$astrep infect; also called scarlatina
=680  \\$iInfection with group A streptococci that is characterized by tonsillitis and pharyngitis. An erythematous rash is commonly present.
=750  \0$aScarlatina$5IEN$0(DLC)sh 85118023

=LDR  00832cz  a2200241n  4500
=001  9880363799902441
=005  20180330105434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012540
=035  \\$aCBA5848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x783
=150  \\$aScapula
=450  \\$wnnna$aScapulae
=450  \\$aShoulder Blade$5IEN-M
=450  \\$wnnna$aShoulder Blades
=550  \\$wg$aBones of Upper Extremity
=550  \\$wh$aAcromion
=550  \\$wh$aCoracoid Process
=550  \\$wh$aGlenoid Cavity
=667  \\$afracture = SCAPULA /inj (IM) + FRACTURES, BONE (IM): do not confuse with SHOULDER FRACTURES
=680  \\$iAlso called the shoulder blade, it is a flat triangular bone, a pair of which form the back part of the shoulder girdle.
=750  \0$aScapula$5IEN$0(DLC)sh 85118011

=LDR  00724cz  a2200205n  4500
=001  9880363800002441
=005  20141212205512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012538
=035  \\$aCBA5846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x558.$x800
=072  \\$aD1.$x268.$x956.$x827
=072  \\$aD1.$x552.$x550.$x800
=150  \\$aScandium
=550  \\$wg$aMetals, Rare Earth
=550  \\$wg$aTransition Elements
=667  \\$aa rare earth metal; Sc-45; Sc-40-44, 46-50 = SCANDIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iScandium. An element of the rare earth family of metals. It has the atomic symbol Sc, atomic number 21, and atomic weight 45.
=750  \0$aScandium$5IEN$0(DLC)sh 85117977

=LDR  00743cz  a2200217n  4500
=001  9880363800102441
=005  20141212205512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012536
=035  \\$aCBA5844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x738
=150  \\$aScalp Dermatoses
=450  \\$wnnna$aDermatoses, Scalp
=450  \\$wnnna$aDermatosis, Scalp
=450  \\$wnnna$aScalp Dermatosis
=550  \\$wg$aSkin Diseases
=550  \\$wh$aDandruff
=550  \\$wh$aTinea Capitis
=667  \\$aconsider synonym for dermatitis of scalp & do not add DERMATITIS unless one of the specific DERMATITIS terms in MeSH; does not include neopl of scalp: see note on SCALP
=750  \0$aScalp$xDiseases$5IEN$0(DLC)sh 85117930

=LDR  00805cz  a2200169n  4500
=001  9880363800202441
=005  20141212205511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012535
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x810
=150  \\$aScalp
=450  \\$wnnna$aScalps
=550  \\$wg$aHead
=667  \\$adiseases of skin or hair of scalp = SCALP DERMATOSES; neopl of scalp = SKIN NEOPLASMS (IM) + SCALP (IM) + HEAD AND NECK NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
=750  \0$aScalp$5IEN$0(DLC)sh 85117928

=LDR  01255cz  a2200313n  4500
=001  9880363800302441
=005  20141212205511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012534
=035  \\$aCBA5842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x189.$x350
=072  \\$aE6.$x761.$x227.$x350
=150  \\$aDental Scaling
=450  \\$aRoot Scaling
=450  \\$wnnna$aRoot Scalings
=450  \\$aScaling, Dental
=450  \\$aScaling, Root
=450  \\$aScaling, Subgingival
=450  \\$aScaling, Supragingival
=450  \\$wnnna$aScalings, Root
=450  \\$wnnna$aSubgingival Scaling
=450  \\$wnnna$aSupragingival Scaling
=550  \\$wg$aDental Prophylaxis
=550  \\$wh$aRoot Planing
=667  \\$ado not use /util except by MeSH definition; do not confuse ROOT SCALING see DENTAL SCALING with ROOT PLANING; DF: DENT SCALING
=680  \\$iRemoval of dental plaque and dental calculus from the surface of a tooth, from the surface of a tooth apical to the gingival margin accumulated in periodontal pockets, or from the surface coronal to the gingival margin.
=688  \\$a91(72); was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1972-90 (Prov 1972-74)
=750  \0$aDental scaling$5IEN$0(DLC)sh 85036929

=LDR  00933cz  a2200229n  4500
=001  9880363800402441
=005  20141212205511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012532
=035  \\$aCBA5840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x858.$x211.$x480.$x708
=072  \\$aC17.$x800.$x838.$x775.$x800
=150  \\$aScabies
=450  \\$aMange, Sarcoptic
=450  \\$wnnna$aSarcoptic Mange
=550  \\$wg$aMite Infestations
=550  \\$wg$aSkin Diseases, Parasitic
=667  \\$amite infest caused by Sarcoptes scabiei
=680  \\$iA contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body.
=688  \\$aMANGE, SARCOPTIC was see under SCABIES 1968-76
=750  \0$aScabies$5IEN$0(DLC)sh 85117892

=LDR  01085cz  a2200265n  4500
=001  9880363800502441
=005  20141212205510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012530
=035  \\$aCBA5838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x794
=072  \\$aD23.$x946.$x580.$x830
=150  \\$aSaxitoxin
=450  \\$aGonyaulax Toxin
=450  \\$wnnna$aMitilotoxin
=450  \\$wnnna$aSaxitonin
=450  \\$wnnna$aToxin, Gonyaulax
=550  \\$wg$aMarine Toxins
=550  \\$wg$aPurines
=550  \\$aDinoflagellida
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iA compound that contains a reduced purine ring system but is not biosynthetically related to the purine alkaloids. It is a poison found in certain edible mollusks at certain times; elaborated by GONYAULAX and consumed by mollusks, fishes, etc. without ill effects. It is neurotoxic and causes RESPIRATORY PARALYSIS and other effects in MAMMALS, known as paralytic SHELLFISH poisoning.
=688  \\$a74
=750  \0$aSaxitoxin$5IEN$0(DLC)sh 85117812

=LDR  01014cz  a2200241n  4500
=001  9880363800602441
=005  20141212205509.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012524
=035  \\$aCBA5832M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x429.$x750.$x500
=150  \\$aSarin
=450  \\$wnnna$ao-Isopropylmethyl Phosphonofluoridate
=450  \\$wnnna$ao Isopropylmethyl Phosphonofluoridate
=450  \\$wnnna$aortho-Isopropylmethyl Phosphonofluoridate
=450  \\$wnnna$aortho Isopropylmethyl Phosphonofluoridate
=450  \\$wnnna$aPhosphonofluoridate, o-Isopropylmethyl
=450  \\$wnnna$aPhosphonofluoridate, ortho-Isopropylmethyl
=550  \\$wg$aOrganofluorophosphonates
=680  \\$iAn organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.
=688  \\$a91(72); was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90
=750  \0$aSarin$5IEN-M$0(DLC)sh 99011744

=LDR  00808cz  a2200217n  4500
=001  9880363800702441
=005  20141212205508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012523
=035  \\$aCBA5831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x250.$x634
=150  \\$aSarcocystosis
=450  \\$wnnna$aSarcocystoses
=450  \\$wnnna$aSarcosporidioses
=450  \\$aSarcosporidiosis
=550  \\$wg$aCoccidiosis
=667  \\$a/drug ther: consider also COCCIDIOSTATS
=680  \\$iInfection of the striated muscle of mammals by parasites of the genus SARCOCYSTIS. Disease symptoms such as vomiting, diarrhea, muscle weakness, and paralysis are produced by sarcocystin, a toxin produced by the organism.
=688  \\$a1992 (1963)
=750  \0$aSarcocystosis$5IEN-M$0(DLC)sh 88003023

=LDR  01024cz  a2200217n  4500
=001  9880363800802441
=005  20141212205508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012522
=035  \\$aCBA5830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x750.$x750
=150  \\$aSarcocystis
=450  \\$wnnna$aSarcocysti
=450  \\$aSarcosporidia
=450  \\$wnnna$aSarcosporidias
=550  \\$wg$aSarcocystidae
=667  \\$ainfection = SARCOCYSTOSIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa found in reptiles, birds, and mammals, including humans. This heteroxenous parasite produces muscle cysts in intermediate hosts such as domestic herbivores (cattle, sheep, pigs) and rodents. Final hosts are predators such as dogs, cats, and man.
=688  \\$a92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78
=750  \0$aSarcocystis$5IEN-M$0(DLC)sh 88003026

=LDR  00772cz  a2200193n  4500
=001  9880363800902441
=005  20141212205507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012520
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x750.$x800
=150  \\$aSarcoptes scabiei
=450  \\$wnnna$aSarcoptes scabieus
=450  \\$wnnna$ascabiei, Sarcoptes
=450  \\$wnnna$ascabieus, Sarcoptes
=550  \\$wg$aSarcoptidae
=667  \\$ainfestation = SCABIES
=680  \\$iA species of mite that causes SCABIES in humans and sarcoptic mange in other animals. Specific variants of S. scabiei exist for humans and animals, but many have the ability to cross species and cause disease.
=750  \0$aAcarus scabiei$5IEN$0(DLC)sh 85000339

=LDR  00898cz  a2200241n  4500
=001  9880363801002441
=005  20141212205507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012519
=035  \\$aCBA5827HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x690.$x552.$x500.$x500.$x850
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x248.$x310.$x800
=150  \\$aSarcoplasmic Reticulum
=450  \\$wnnna$aReticulum, Sarcoplasmic
=450  \\$wnnna$aReticulums, Sarcoplasmic
=450  \\$wnnna$aSarcoplasmic Reticulums
=550  \\$wg$aEndoplasmic Reticulum, Smooth
=550  \\$wg$aMuscle Fibers, Skeletal
=550  \\$aMuscles
=680  \\$iA network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.
=688  \\$a72
=750  \0$aSarcoplasmic reticulum$0(DLC) sh 85117517$5IEN

=LDR  01853cz  a2200289n  4500
=001  9880363801102441
=005  20141212205506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012514
=035  \\$aCBA5823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x860
=072  \\$aC4.$x557.$x450.$x795.$x850
=072  \\$aC4.$x557.$x645.$x750
=150  \\$aSarcoma, Kaposi
=450  \\$aKaposi Sarcoma
=450  \\$wnnna$aKaposi's Sarcoma
=450  \\$wnnna$aKaposis Sarcoma
=450  \\$wnnna$aMultiple Idiopathic Pigmented Hemangiosarcoma
=450  \\$wnnna$aSarcoma, Kaposi's
=550  \\$wg$aHerpesviridae Infections
=550  \\$wg$aNeoplasms, Vascular Tissue
=550  \\$wg$aSarcoma
=667  \\$acoordinate IM with precoordinated organ/ neoplasm term (IM)
=680  \\$iA multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
=688  \\$a98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97
=750  \0$aKaposi's sarcoma$5IEN$0(DLC)sh 85071562

=LDR  01332cz  a2200337n  4500
=001  9880363801202441
=005  20141212205505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012512
=035  \\$aCBA5821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x575.$x650.$x800
=072  \\$aC4.$x557.$x450.$x795.$x620.$x800
=150  \\$aSarcoma, Ewing
=450  \\$wnnna$aEwing Sarcoma
=450  \\$wnnna$aEwing Tumor
=450  \\$wnnna$aEwing's Sarcoma
=450  \\$wnnna$aEwings Sarcoma
=450  \\$aEwing's Tumor
=450  \\$wnnna$aEwings Tumor
=450  \\$aSarcoma, Ewing's
=450  \\$wnnna$aSarcoma, Ewings
=450  \\$wnnna$aTumor, Ewing
=450  \\$wnnna$aTumor, Ewing's
=550  \\$wg$aOsteosarcoma
=550  \\$aNeuroectodermal Tumors, Primitive, Peripheral
=667  \\$acoordinate IM with BONE NEOPLASMS (IM) or specific bone/neoplasm term (IM) or specific bone (IM) + BONE NEOPLASMS (IM)
=680  \\$iA malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
=688  \\$a2012 (1963)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Sarcoma, Ewing's
=750  \0$aEwing's sarcoma$0(DLC) sh 85046050$5IEN

=LDR  02073cz  a2200601n  4500
=001  9880363801302441
=005  20141212205504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012509
=035  \\$aCBA5818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x795
=150  \\$aSarcoma
=450  \\$wnnna$aEpithelioid Sarcoma
=450  \\$wnnna$aEpithelioid Sarcomas
=450  \\$aSarcoma, Epithelioid
=450  \\$aSarcoma, Soft Tissue
=450  \\$aSarcoma, Spindle Cell
=450  \\$wnnna$aSarcomas
=450  \\$wnnna$aSarcomas, Epithelioid
=450  \\$wnnna$aSarcomas, Soft Tissue
=450  \\$wnnna$aSarcomas, Spindle Cell
=450  \\$wnnna$aSoft Tissue Sarcoma
=450  \\$wnnna$aSoft Tissue Sarcomas
=450  \\$wnnna$aSpindle Cell Sarcoma
=450  \\$wnnna$aSpindle Cell Sarcomas
=550  \\$wg$aNeoplasms, Connective and Soft Tissue
=550  \\$wh$aAdenosarcoma
=550  \\$wh$aCarcinosarcoma
=550  \\$wh$aChondrosarcoma
=550  \\$wh$aDesmoplastic Small Round Cell Tumor
=550  \\$wh$aEndometrial Stromal Tumors
=550  \\$wh$aFibrosarcoma
=550  \\$wh$aHemangiosarcoma
=550  \\$wh$aHistiocytoma, Malignant Fibrous
=550  \\$wh$aLeiomyosarcoma
=550  \\$wh$aLiposarcoma
=550  \\$wh$aLymphangiosarcoma
=550  \\$wh$aMixed Tumor, Mesodermal
=550  \\$wh$aMyosarcoma
=550  \\$wh$aMyxosarcoma
=550  \\$wh$aOsteosarcoma
=550  \\$wh$aPhyllodes Tumor
=550  \\$wh$aSarcoma, Alveolar Soft Part
=550  \\$wh$aSarcoma, Clear Cell
=550  \\$wh$aSarcoma, Experimental
=550  \\$wh$aSarcoma, Kaposi
=550  \\$wh$aSarcoma, Myeloid
=550  \\$wh$aSarcoma, Small Cell
=550  \\$wh$aSarcoma, Synovial
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); SARCOMA, EXPERIMENTAL is also available
=680  \\$iA connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
=750  \0$aSarcoma$5IEN$0(DLC)sh 85117504

=LDR  00640cz  a2200205n  4500
=001  9880363801402441
=005  20141212205503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012508
=035  \\$aCBA5817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x707
=150  \\$aSarcolemma
=450  \\$wnnna$aSarcolemmas
=550  \\$wg$aCell Membrane
=550  \\$aMuscles
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iThe excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)
=688  \\$a72(67)
=750  \0$aSarcolemma$5IEN$0(DLC)sh 85117503

=LDR  01854cz  a2200457n  4500
=001  9880363801502441
=005  20141212205503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012507
=035  \\$aCBA5816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x515.$x827
=150  \\$aSarcoidosis
=450  \\$aBesnier-Boeck Disease
=450  \\$wnnna$aBesnier Boeck Disease
=450  \\$wnnna$aBesnier-Boeck-Schaumann Syndrome
=450  \\$wnnna$aBesnier Boeck Schaumann Syndrome
=450  \\$wnnna$aBoeck Disease
=450  \\$wnnna$aBoeck Sarcoid
=450  \\$wnnna$aBoeck's Disease
=450  \\$wnnna$aBoecks Disease
=450  \\$aBoeck's Sarcoid
=450  \\$wnnna$aBoecks Sarcoid
=450  \\$wnnna$aDisease, Schaumann
=450  \\$wnnna$aSarcoid, Boeck's
=450  \\$wnnna$aSarcoidoses
=450  \\$wnnna$aSchaumann Disease
=450  \\$wnnna$aSchaumann Syndrome
=450  \\$wnnna$aSchaumann's Syndrome
=450  \\$wnnna$aSchaumann's Syndromes
=450  \\$wnnna$aSyndrome, Besnier-Boeck-Schaumann
=450  \\$wnnna$aSyndrome, Schaumann
=450  \\$wnnna$aSyndrome, Schaumann's
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wh$aSarcoidosis, Pulmonary
=550  \\$wh$aUveoparotid Fever
=667  \\$acoord IM with organ/dis precoord (IM); sarcoidosis of heart: coord IM with CARDIOMYOPATHIES (IM), not HEART DISEASES
=680  \\$iAn idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
=688  \\$aPSEUDOTUBERCULOSIS use SARCOIDOSIS 1963-1992
=688  \\$aPSEUDOTUBERCULOSIS was see SARCOIDOSIS 1963-92
=750  \0$aSarcoidosis$5IEN$0(DLC)sh 85117502

=LDR  00636cz  a2200169n  4500
=001  9880363801602441
=005  20141212205502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012505
=035  \\$aCBA5814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x750
=150  \\$aSarcina
=550  \\$wg$aGram-Positive Cocci
=667  \\$ain air, water, soil, mud
=680  \\$iA genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens.
=750  \0$aSarcina$5IEN$0(DLC)sh 85117498

=LDR  01501cz  a2200361n  4500
=001  9880363801702441
=005  20141212192508.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012504
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x73.$x41.$x800
=072  \\$aD23.$x469.$x50.$x50.$x50.$x700
=150  \\$aSaralasin
=450  \\$a1-Sar-8-Ala Angiotensin II
=450  \\$wnnna$a1 Sar 8 Ala Angiotensin II
=450  \\$a1-Sarcosine-8-Alanine Angiotensin II
=450  \\$wnnna$a1 Sarcosine 8 Alanine Angiotensin II
=450  \\$wnnna$aAngiotensin II, 1-Sar-8-Ala
=450  \\$wnnna$aAngiotensin II, 1-Sarcosine-8-Alanine
=450  \\$wnnna$aAngiotensin II, Sar(1)-Ala(8)-
=450  \\$wnnna$aAngiotensin II, Sarcosyl(1)-Alanine(8)-
=450  \\$wnnna$aAnhydrous Saralasin Acetate
=450  \\$wnnna$aHydrated Saralasin Acetate
=450  \\$wnnna$a(Sar(1),Ala(8))ANGII
=450  \\$wnnna$aSar-Arg-Val-Tyr-Val-His-Pro-Ala
=450  \\$wnnna$a(Sar1,Val5,Ala8)Angiotensin II
=450  \\$wnnna$aSaralasin Acetate
=450  \\$wnnna$aSaralasin Acetate, Anhydrous
=450  \\$wnnna$aSaralasin Acetate, Hydrated
=550  \\$wg$aAngiotensin II
=680  \\$iAn octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.
=688  \\$a1984(1978)
=750  \0$aSaralasin$5IEN$0(DLC)sh 85117478

=LDR  00815cz  a2200241n  4500
=001  9880363801802441
=005  20141212205502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012503
=035  \\$aCBA5812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x782
=150  \\$aSaponins
=450  \\$wnnna$aSaponin
=550  \\$wg$aGlycosides
=550  \\$wh$aEscin
=550  \\$wh$aGinsenosides
=550  \\$wh$aHolothurin
=550  \\$wh$aQuillaja Saponins
=550  \\$wh$aSolanine
=550  \\$aISCOMs
=680  \\$iA type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose.
=750  \0$aSaponins$5IEN$0(DLC)sh 85117452

=LDR  00613cz  a2200205n  4500
=001  9880363801902441
=005  20141212205502.0
=008  771216\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012502
=035  \\$aCBA5811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x919.$x650
=072  \\$aD4.$x808.$x795
=150  \\$aSapogenins
=550  \\$wg$aSteroids
=550  \\$wg$aTriterpenes
=550  \\$wh$aOleanolic Acid
=680  \\$iThe aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature.
=688  \\$a79
=750  \0$aSapogenins$5IEN-M$0(DLC)sh 97005876

=LDR  00543cz  a2200193n  4500
=001  9880363802002441
=005  20141212205502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012501
=035  \\$aCBA5810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x819
=150  \\$aSaphenous Vein
=450  \\$wnnna$aSaphenous Veins
=450  \\$wnnna$aVein, Saphenous
=450  \\$wnnna$aVeins, Saphenous
=550  \\$wg$aVeins
=680  \\$iThe vein which drains the foot and leg.
=750  \0$aSaphenous vein$5IEN$0(DLC)sh 85117443

=LDR  00609cz  a2200157n  4500
=001  9880363802102441
=005  20141212205502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012500
=035  \\$aCBA5809HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x765.$x750
=150  \\$aSantonin
=550  \\$wg$aSesquiterpenes
=680  \\$iAnthelmintic isolated from the dried unexpanded flower heads of Artemisia maritima and other species of Artemisia found principally in Russian and Chinese Turkestan and the Southern Ural region. (From Merck, 11th ed.)
=750  \0$aSantonin$5IEN$0(DLC)sh 85117413

=LDR  00844cz  a2200265n  4500
=001  9880363802202441
=005  20141212205501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012499
=035  \\$aCBA5808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x229.$x782
=072  \\$aN6.$x850.$x780.$x200.$x800
=072  \\$aN6.$x850.$x860
=150  \\$aSanitation
=550  \\$wg$aCommunicable Disease Control
=550  \\$wg$aEnvironmental Health
=550  \\$wg$aPublic Health
=550  \\$wh$aFood Inspection
=550  \\$wh$aPublic Facilities
=550  \\$wh$aSanitary Engineering
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe development and establishment of environmental conditions favorable to the health of the public.
=688  \\$aSANITARY SURVEYS was heading 1963-66
=750  \0$aSanitation$5IEN$0(DLC)sh 85117296

=LDR  01222cz  a2200361n  4500
=001  9880363802302441
=005  20141212205501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012498
=035  \\$aCBA5807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x229.$x656
=072  \\$aJ1.$x293.$x821
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800
=072  \\$aN6.$x850.$x860.$x510
=150  \\$aSanitary Engineering
=450  \\$wnnna$aEngineering, Sanitary
=450  \\$aPlumbing
=450  \\$aSanitary Engineers$5IEN
=550  \\$wg$aEngineering
=550  \\$wg$aEnvironmental Health
=550  \\$wg$aSanitation
=550  \\$wh$aDrainage, Sanitary
=550  \\$wh$aRecycling
=550  \\$wh$aRefuse Disposal
=550  \\$wh$aToilet Facilities
=550  \\$wh$aWaste Disposal, Fluid
=550  \\$wh$aWaste Management
=550  \\$wh$aWater Softening
=667  \\$aSPEC; SPEC qualif
=680  \\$iA branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal.
=750  \0$aSanitary engineers$5IEN-M$0(DLC)sh 85117285
=750  \0$aSanitary engineering$5IEN-HS$0(DLC)sh 85117279

=LDR  01304cz  a2200433n  4500
=001  9880363519302441
=005  20141212201440.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005376
=035  \\$aCAZ8522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463
=150  \\$aFinancial Management
=450  \\$wnnna$aActivities, Financial
=450  \\$wnnna$aActivity, Financial
=450  \\$wnnna$aEndowment
=450  \\$aEndowments
=450  \\$aFinance$5IEN
=450  \\$wnnna$aFinancial Activities
=450  \\$wnnna$aFinancial Activity
=450  \\$wnnna$aFund
=450  \\$wnnna$aFunds
=450  \\$wnnna$aManagement, Financial
=550  \\$wg$aEconomics
=550  \\$wh$aAccounting
=550  \\$wh$aBankruptcy
=550  \\$wh$aBudgets
=550  \\$wh$aCapital Financing
=550  \\$wh$aContract Services
=550  \\$wh$aFinancial Management, Hospital
=550  \\$wh$aFinancing, Construction
=550  \\$wh$aFund Raising
=550  \\$wh$aGroup Purchasing
=550  \\$wh$aLeasing, Property
=550  \\$wh$aMarketing of Health Services
=550  \\$wh$aRisk Management
=680  \\$iThe obtaining and management of funds for institutional needs and responsibility for fiscal affairs.
=688  \\$a78
=750  \0$aFinance$5IEN$0(DLC)sh 85048256

=LDR  01194cz  a2200277n  4500
=001  9880363519402441
=005  20170628163537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005374
=035  \\$aCAZ8520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x454
=072  \\$aG1.$x280
=072  \\$aG2.$x263
=150  \\$aFiltration
=450  \\$wnnna$aFiltrations
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aAir Filters
=550  \\$wh$aMicropore Filters
=550  \\$wh$aUltrafiltration
=667  \\$aincludes filtration of fluids, gases & radiations; not for electrical or electronic filtering; filters: index FILTRATION / instrum but note MICROPORE FILTERS and AIR FILTERS are available
=680  \\$iA process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69
=750  \0$aFilters and filtration$5IEN$0(DLC)sh 85048252

=LDR  01249cz  a2200349n  4500
=001  9880363519502441
=005  20141212201439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005373
=035  \\$aCAZ8519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x638.$x420
=072  \\$aN6.$x850.$x810.$x370.$x310
=150  \\$aFilm Dosimetry
=450  \\$wnnna$aBadge Dosimetries, Film
=450  \\$wnnna$aBadge Dosimetry, Film
=450  \\$wnnna$aBadge, Film
=450  \\$wnnna$aBadges, Film
=450  \\$wnnna$aDosimetries, Film
=450  \\$wnnna$aDosimetries, Film Badge
=450  \\$wnnna$aDosimetry, Film
=450  \\$wnnna$aDosimetry, Film Badge
=450  \\$wnnna$aFilm Badge
=450  \\$wnnna$aFilm Badge Dosimetries
=450  \\$aFilm Badge Dosimetry
=450  \\$wnnna$aFilm Badges
=450  \\$wnnna$aFilm Dosimetries
=450  \\$aPhotographic Dosimetry$5IEN
=550  \\$wg$aRadiation Monitoring
=680  \\$iUse of a device (film badge) for measuring exposure of individuals to radiation. It is usually made of metal, plastic, or paper and loaded with one or more pieces of x-ray film.
=688  \\$a79; was FILM BADGE 1971-78 (Prov 1971-73)
=750  \0$aPhotographic dosimetry$5IEN$0(DLC)sh 85101183

=LDR  01153cz  a2200337n  4500
=001  9880363519602441
=005  20180103174041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005370
=035  \\$aCAZ8516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x300
=150  \\$aFilarioidea
=450  \\$aFilarial Worms$5IEN
=450  \\$wnnna$aFilarioideas
=450  \\$wnnna$aLitomosoide
=450  \\$aLitomosoides
=550  \\$wg$aSpirurina
=550  \\$wh$aAcanthocheilonema
=550  \\$wh$aBrugia
=550  \\$wh$aDipetalonema
=550  \\$wh$aDirofilaria
=550  \\$wh$aLoa
=550  \\$wh$aMansonella
=550  \\$wh$aMicrofilariae
=550  \\$wh$aOnchocerca
=550  \\$wh$aSetaria Nematode
=550  \\$wh$aWuchereria
=667  \\$ainfection = FILARIASIS but see note there; coord with specific helminth term (ANTIGENS, HELMINTH, etc) if pertinent: /drug eff: consider FILARICIDES
=680  \\$iA superfamily of nematodes of the suborder SPIRURINA. Its organisms possess a filiform body and a mouth surrounded by papillae.
=750  \0$aFilarial worms$5IEN$0(DLC)sh 85048191

=LDR  01480cz  a2200361n  4500
=001  9880363519702441
=005  20141212201437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005368
=035  \\$aCAZ8514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x750.$x361
=150  \\$aFilariasis
=450  \\$wnnna$aElaeophoriases
=450  \\$aElaeophoriasis
=450  \\$wnnna$aFilariases
=450  \\$wnnna$aFilarioidea Infection
=450  \\$aFilarioidea Infections
=450  \\$wnnna$aInfection, Filarioidea
=450  \\$wnnna$aInfections, Filarioidea
=550  \\$wg$aSpirurida Infections
=550  \\$wh$aAcanthocheilonemiasis
=550  \\$wh$aDipetalonema Infections
=550  \\$wh$aDirofilariasis
=550  \\$wh$aElephantiasis, Filarial
=550  \\$wh$aLoiasis
=550  \\$wh$aMansonelliasis
=550  \\$wh$aOnchocerciasis
=550  \\$wh$aSetariasis
=667  \\$aGEN: prefer specifics; drug ther: consider FILARICIDES
=680  \\$iInfections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.
=688  \\$aELAEOPHORIASIS was heading 1975-92 (see under FILARIASIS 1975-90)
=750  \0$aFilariasis$5IEN$0(DLC)sh 85048190

=LDR  01038cz  a2200229n  4500
=001  9880363519802441
=005  20141212201436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005366
=035  \\$aCAZ8512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932.$x401
=072  \\$aG14.$x360
=150  \\$aFigural Aftereffect
=450  \\$wnnna$aAftereffect, Figural
=450  \\$wnnna$aAftereffects, Figural
=450  \\$wnnna$aFigural Aftereffects
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aVisual Perception
=667  \\$ausually involves displacement of afterimage of geometric pattern in shape & space: differentiate from AFTERIMAGE; while both are in the field of perception, AFTERIMAGE is likely to be in ophthalmol jrnls, FIGURAL AFTEREFFECT, in psychol jrnls
=680  \\$iA perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may affect perception in another part.
=750  \0$aFigural aftereffects$5IEN$0(DLC)sh 85048168

=LDR  00850cz  a2200253n  4500
=001  9880363519902441
=005  20141212201436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005364
=035  \\$aCAZ8510HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x343
=072  \\$aF2.$x463.$x593.$x932.$x345
=150  \\$aField Dependence-Independence
=450  \\$wnnna$aDependence-Independence, Field
=450  \\$wnnna$aDependence-Independences, Field
=450  \\$wnnna$aField Dependence Independence
=450  \\$wnnna$aField Dependence-Independences
=550  \\$wg$aPerception
=550  \\$wg$aVisual Perception
=667  \\$ano qualif
=680  \\$iThe ability to respond to segments of the perceptual experience rather than to the whole.
=688  \\$a72
=750  \0$aField dependence (Psychology)$5IEN$0(DLC)sh 85048097

=LDR  00482cz  a2200169n  4500
=001  9880363520002441
=005  20141212201435.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005362
=035  \\$aCAZ8508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x330
=150  \\$aFicoll
=550  \\$wg$aPolysaccharides
=680  \\$iA sucrose polymer of high molecular weight.
=688  \\$a90(75); was see under POLYSACCHARIDES 1975-89
=750  \0$aFicoll$5IEN$0(DLC)sh 85048049

=LDR  00553cz  a2200169n  4500
=001  9880363520102441
=005  20141212201435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005360
=035  \\$aCAZ8506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x650.$x321
=150  \\$aFibula
=450  \\$wnnna$aFibulas
=550  \\$wg$aLeg Bones
=680  \\$iThe bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.
=750  \0$aFibula$5IEN$0(DLC)sh 85048041

=LDR  01306cz  a2200253n  4500
=001  9880363520202441
=005  20141212201434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005357
=035  \\$aCAZ8503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x375
=150  \\$aFibrous Dysplasia of Bone
=450  \\$wnnna$aBone Fibrous Dysplasia
=450  \\$wnnna$aBone Fibrous Dysplasias
=450  \\$aOsteitis Fibrosa Disseminata
=550  \\$wg$aOsteochondrodysplasias
=550  \\$wh$aCherubism
=550  \\$wh$aFibrous Dysplasia, Monostotic
=550  \\$wh$aFibrous Dysplasia, Polyostotic
=667  \\$aGEN or unspecified; prefer specifics; periapical fibrous dysplasia = CEMENTOMA; craniofacial fibrous dysplasia = FIBROUS DYSPLASIA, POLYOSTOTIC (IM) + SKULL (IM) + FACIAL BONES (IM)
=680  \\$iA disease of bone marked by thinning of the cortex by fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved (FIBROUS DYSPLASIA, MONOSTOTIC) or several (FIBROUS DYSPLASIA, POLYOSTOTIC).
=688  \\$a67; was FIBROUS DYSPLASIA 1963-66 (Prov); ALBRIGHT'S DISEASE & JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66
=750  \0$aFibrous dysplasia of bone$5IEN$0(DLC)sh 85048040

=LDR  00911cz  a2200253n  4500
=001  9880363520302441
=005  20141212201433.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005355
=035  \\$aCAZ8502M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x355
=150  \\$aFibrosis
=450  \\$aCirrhosis
=450  \\$wnnna$aFibroses
=550  \\$wg$aPathologic Processes
=550  \\$wh$aCicatrix
=550  \\$wh$aNephrogenic Fibrosing Dermopathy
=550  \\$wh$aPeritoneal Fibrosis
=550  \\$wh$aRetroperitoneal Fibrosis
=667  \\$aNIM only as pathol process with no qualif: coord with Cat A term /pathol (IM); several specific fibrosis terms are also available
=680  \\$iAny pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
=688  \\$a87
=750  \0$aFibrosis$0(DLC) sh2004000531$5IEN-M

=LDR  01561cz  a2200373n  4500
=001  9880363520402441
=005  20141212201432.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005353
=035  \\$aCAZ8500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x377.$x715.$x390
=072  \\$aD12.$x776.$x395.$x550.$x350
=072  \\$aD12.$x776.$x543.$x550.$x350
=072  \\$aD12.$x776.$x860.$x300.$x450
=150  \\$aFibronectins
=450  \\$wnnna$aalpha 2-Surface Binding Glycoprotein
=450  \\$wnnna$aalpha 2 Surface Binding Glycoprotein
=450  \\$aCold-Insoluble Globulins
=450  \\$wnnna$aCold Insoluble Globulins
=450  \\$wnnna$aFibronectin
=450  \\$wnnna$aGlobulins, Cold-Insoluble
=450  \\$wnnna$aGlycoprotein, Opsonic
=450  \\$aLETS Proteins
=450  \\$wnnna$aOpsonic alpha(2)SB Glycoprotein
=450  \\$wnnna$aOpsonic Glycoprotein
=450  \\$wnnna$aProteins, LETS
=550  \\$wg$aExtracellular Matrix Proteins
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wg$aSerum Globulins
=667  \\$aextracellular matrix proteins; /biosyn /physiol permitted
=680  \\$iGlycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins.
=688  \\$a80
=750  \0$aFibronectins$5IEN$0(DLC)sh 85048036

=LDR  02468cz  a2200517n  4500
=001  9880363520502441
=005  20141212201433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005356
=035  \\$aCAZ8499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x324
=072  \\$aC5.$x799.$x321
=072  \\$aC10.$x668.$x491.$x425
=150  \\$aFibromyalgia
=450  \\$aDiffuse Myofascial Pain Syndrome
=450  \\$wnnna$aFibromyalgia-Fibromyositis Syndrome
=450  \\$wnnna$aFibromyalgia Fibromyositis Syndrome
=450  \\$wnnna$aFibromyalgia-Fibromyositis Syndromes
=450  \\$wnnna$aFibromyalgia, Primary
=450  \\$wnnna$aFibromyalgia, Secondary
=450  \\$wnnna$aFibromyalgias
=450  \\$wnnna$aFibromyalgias, Primary
=450  \\$wnnna$aFibromyalgias, Secondary
=450  \\$wnnna$aFibromyositis-Fibromyalgia Syndrome
=450  \\$wnnna$aFibromyositis Fibromyalgia Syndrome
=450  \\$wnnna$aFibromyositis-Fibromyalgia Syndromes
=450  \\$wnnna$aFibrositides
=450  \\$aFibrositis
=450  \\$wnnna$aMuscular Rheumatism
=450  \\$wnnna$aMyofascial Pain Syndrome, Diffuse
=450  \\$wnnna$aPrimary Fibromyalgia
=450  \\$wnnna$aPrimary Fibromyalgias
=450  \\$aRheumatism, Muscular
=450  \\$wnnna$aSecondary Fibromyalgia
=450  \\$wnnna$aSecondary Fibromyalgias
=450  \\$wnnna$aSyndrome, Fibromyalgia-Fibromyositis
=450  \\$wnnna$aSyndrome, Fibromyositis-Fibromyalgia
=450  \\$wnnna$aSyndromes, Fibromyalgia-Fibromyositis
=450  \\$wnnna$aSyndromes, Fibromyositis-Fibromyalgia
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aRheumatic Diseases
=550  \\$aFatigue Syndrome, Chronic
=680  \\$iA common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
=688  \\$a89; was FIBROSITIS 1963-88
=750  \0$aFibromyalgia$5IEN-M$0(DLC)sh 88007812

=LDR  01180cz  a2200325n  4500
=001  9880363520602441
=005  20180709113642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005350
=035  \\$aCAZ8496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x590.$x340
=150  \\$aFibroma
=450  \\$wnnna$aFibromas
=450  \\$wnnna$aFibromatoses
=450  \\$aFibromatosis
=450  \\$aFibromyxoma
=450  \\$wnnna$aFibromyxomas
=450  \\$aMyxofibroma
=450  \\$wnnna$aMyxofibromas
=550  \\$wg$aNeoplasms, Fibrous Tissue
=550  \\$wh$aDupuytren Contracture
=550  \\$wh$aFibroma, Desmoplastic
=550  \\$wh$aFibroma, Ossifying
=550  \\$wh$aFibromatosis, Abdominal
=550  \\$wh$aFibromatosis, Aggressive
=550  \\$wh$aFibromatosis, Plantar
=667  \\$anot for uterine fibroma ( = LEIOMYOMA + UTERINE NEOPLASMS); note X ref FIBROMATOSIS but FIBROMATOSIS, ABDOMINAL; FIBROMATOSIS, AGGRESSIVE & FIBROMATOSIS, GINGIVAL are available; coord IM with precoord organ/neopl term (IM)
=680  \\$iA benign tumor of fibrous or fully developed connective tissue.
=750  \0$aFibromas$0(DLC) sh 85048035$5IEN

=LDR  02214cz  a2200517n  4500
=001  9880363520702441
=005  20141212201430.0
=008  781220\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005348
=035  \\$aCAZ8494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x90.$x750
=150  \\$aFibrocystic Breast Disease
=450  \\$wnnna$aAdenoses, Microglandular
=450  \\$wnnna$aAdenosis, Microglandular
=450  \\$wnnna$aAdenosis of Breast
=450  \\$wnnna$aBreast Adenosis
=450  \\$wnnna$aBreast Cystic Disease
=450  \\$wnnna$aBreast Cystic Diseases
=450  \\$wnnna$aBreast Disease, Cystic
=450  \\$wnnna$aBreast Disease, Fibrocystic
=450  \\$aBreast Dysplasia
=450  \\$wnnna$aBreast Fibrocystic Change
=450  \\$wnnna$aBreast Fibrocystic Changes
=450  \\$wnnna$aBreast Fibrocystic Disease
=450  \\$wnnna$aChronic Cystic Mastitis
=450  \\$wnnna$aCystic Breast Disease
=450  \\$wnnna$aCystic Disease of Breast
=450  \\$wnnna$aCystic Mastitis, Chronic
=450  \\$wnnna$aDisease, Cystic Breast
=450  \\$wnnna$aDisease, Fibrocystic Breast
=450  \\$wnnna$aDysplasia, Breast
=450  \\$wnnna$aDysplasia, Mammary
=450  \\$wnnna$aFibrocystic Changes of Breast
=450  \\$wnnna$aFibrocystic Disease of Breast
=450  \\$aFibrocystic Mastopathy
=450  \\$aMammary Dysplasia
=450  \\$wnnna$aMastopathy, Fibrocystic
=450  \\$wnnna$aMicroglandular Adenoses
=450  \\$wnnna$aMicroglandular Adenosis
=550  \\$wg$aBreast Diseases
=550  \\$aBreast Cyst
=667  \\$acommonly chronic so do not coordinate with CHRONIC DISEASE; breast cyst fluid in fibrocystic breast disease: coordinate IM with CYST FLUID (NIM); BREAST CYST is also available
=680  \\$iA common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.
=688  \\$a2005 (1980)
=750  \0$aBreast$xFibrocystic disease$0(DLC) sh 85016686$5IEN

=LDR  00810cz  a2200265n  4500
=001  9880363520802441
=005  20180323112049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005347
=035  \\$aCAZ8493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x228
=150  \\$aFibroblasts
=450  \\$wnnna$aFibroblast
=550  \\$wg$aConnective Tissue Cells
=550  \\$wh$a3T3 Cells
=550  \\$wh$aCancer-Associated Fibroblasts
=550  \\$wh$aCorneal Keratocytes
=550  \\$wh$aCOS Cells
=550  \\$wh$aL Cells (Cell Line)
=550  \\$wh$aMesangial Cells
=550  \\$wh$aMyofibroblasts
=680  \\$iConnective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.
=688  \\$a65(64)
=750  \0$aFibroblasts$5IEN$0(DLC)sh 85048034

=LDR  01639cz  a2200361n  4500
=001  9880363520902441
=005  20141212201429.0
=008  830531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005346
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x624
=072  \\$aD12.$x776.$x467.$x624
=072  \\$aD23.$x529.$x624
=150  \\$aFibroblast Growth Factors
=450  \\$wnnna$aDNA Synthesis Factor
=450  \\$wnnna$aFibroblast Growth Factor
=450  \\$wnnna$aFibroblast Growth Regulatory Factor
=450  \\$wnnna$aGrowth Factor, Fibroblast
=450  \\$wnnna$aGrowth Factors, Fibroblast
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aFibroblast Growth Factor 1
=550  \\$wh$aFibroblast Growth Factor 10
=550  \\$wh$aFibroblast Growth Factor 2
=550  \\$wh$aFibroblast Growth Factor 3
=550  \\$wh$aFibroblast Growth Factor 4
=550  \\$wh$aFibroblast Growth Factor 5
=550  \\$wh$aFibroblast Growth Factor 6
=550  \\$wh$aFibroblast Growth Factor 7
=550  \\$wh$aFibroblast Growth Factor 8
=550  \\$wh$aFibroblast Growth Factor 9
=680  \\$iA family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.
=688  \\$a2001(1984)
=750  \0$aFibroblast growth factors$0(DLC) sh 91005352$5IEN

=LDR  00872cz  a2200277n  4500
=001  9880363521002441
=005  20141212201428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005343
=035  \\$aCAZ8489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x421.$x750
=072  \\$aD27.$x505.$x954.$x411.$x320
=072  \\$aD27.$x505.$x954.$x502.$x427
=150  \\$aFibrinolytic Agents
=450  \\$wnnna$aAntithrombic Drugs
=450  \\$aAntithrombotic Agents
=450  \\$wnnna$aFibrinolytic Drugs
=450  \\$aThrombolytic Agents
=450  \\$wnnna$aThrombolytic Drugs
=550  \\$wg$aCardiovascular Agents
=550  \\$wg$aFibrin Modulating Agents
=550  \\$wg$aHematologic Agents
=680  \\$iFibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
=688  \\$a66
=750  \0$aFibrinolytic agents$5IEN$0(DLC)sh 85048033

=LDR  00527cz  a2200181n  4500
=001  9880363521102441
=005  20141212201428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005342
=035  \\$aCAZ8488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x124.$x560.$x150.$x390
=150  \\$aFibrinolysis
=450  \\$wnnna$aFibrinolyses
=550  \\$wg$aBlood Coagulation
=550  \\$aFibrin Clot Lysis Time
=680  \\$iThe natural enzymatic dissolution of FIBRIN.
=750  \0$aFibrinolysis$5IEN$0(DLC)sh 85048032

=LDR  01217cz  a2200289n  4500
=001  9880363521202441
=005  20141212201427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005341
=035  \\$aCAZ8487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x330
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x330
=150  \\$aFibrinolysin
=450  \\$wnnna$aAventis Pharma Brand of Plasmin
=450  \\$wnnna$aFibrogammin
=450  \\$wnnna$aGlu-Plasmin
=450  \\$wnnna$aGlu Plasmin
=450  \\$aPlasmin
=450  \\$wnnna$aProtease F
=450  \\$wnnna$aThrombolysin
=550  \\$wg$aSerine Endopeptidases
=680  \\$iA product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.
=688  \\$a2010, 1963-1992;
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Plasmin
=688  \\$a93; was FIBRINOLYSIN 1963-92; PLASMIN was see FIBRINOLYSIN 1963-92
=750  \0$aPlasmin$0(DLC) sh 85103094$5IEN

=LDR  01549cz  a2200361n  4500
=001  9880363521302441
=005  20141212201427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005340
=035  \\$aCAZ8485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x50.$x250
=072  \\$aD12.$x776.$x124.$x125.$x500
=072  \\$aD12.$x776.$x811.$x300
=072  \\$aD23.$x119.$x490
=150  \\$aFibrinogen
=450  \\$wnnna$aBlood Coagulation Factor I
=450  \\$aCoagulation Factor I
=450  \\$aFactor I
=450  \\$wnnna$aFactor I, Coagulation
=450  \\$wnnna$agamma-Fibrinogen
=450  \\$wnnna$agamma Fibrinogen
=450  \\$wnnna$aI, Coagulation Factor
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aProtein Precursors
=550  \\$wh$aFibrin Fibrinogen Degradation Products
=550  \\$wh$aFibrinogens, Abnormal
=550  \\$wh$aFibrinopeptide A
=550  \\$wh$aFibrinopeptide B
=667  \\$aa blood coag factor: do not confuse X ref FACTOR I with COMPLEMENT FACTOR I
=680  \\$iPlasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products.
=750  \0$aFibrinogen$5IEN$0(DLC)sh 85048030

=LDR  00753cz  a2200241n  4500
=001  9880363521402441
=005  20141212201426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005337
=035  \\$aCAZ8482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x270
=150  \\$aFibrin
=450  \\$aAntithrombin I
=450  \\$wnnna$aI, Antithrombin
=550  \\$wg$aBlood Proteins
=550  \\$wh$aFibrin Fibrinogen Degradation Products
=550  \\$wh$aFibrin Foam
=550  \\$wh$aFibrin Tissue Adhesive
=550  \\$wh$aFibrinopeptide A
=550  \\$wh$aFibrinopeptide B
=680  \\$iA protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.
=750  \0$aFibrin$5IEN$0(DLC)sh 85048029

=LDR  01021cz  a2200301n  4500
=001  9880363521502441
=005  20141212201426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005336
=035  \\$aCAZ8481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x617.$x249
=150  \\$aFiber Optic Technology
=450  \\$wnnna$aFiber Optic Technologies
=450  \\$wnno$aFiber Optics$5IEN-M
=450  \\$aFiberoptics$5IEN-M
=450  \\$wnnna$aOptic Technologies, Fiber
=450  \\$wnnna$aOptic Technology, Fiber
=450  \\$wnnna$aTechnologies, Fiber Optic
=450  \\$wnnna$aTechnology, Fiber Optic
=550  \\$wg$aOptics and Photonics
=550  \\$aOptical Fibers
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe technology of transmitting light over long distances through strands of glass or other transparent material.
=688  \\$a2009 (1970)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Fiber Optics
=688  \\$a73(70)
=750  \0$aFiber optics$0(DLC) sh 85048014$5IEN

=LDR  00983cz  a2200277n  4500
=001  9880363521602441
=005  20141212201425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005334
=035  \\$aCAZ8479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x119.$x344
=150  \\$aFever
=450  \\$wnnna$aFevers
=450  \\$aHyperthermia
=450  \\$wnnna$aHyperthermias
=450  \\$aPyrexia
=450  \\$wnnna$aPyrexias
=550  \\$wg$aBody Temperature Changes
=550  \\$wh$aFever of Unknown Origin
=550  \\$wh$aSweating Sickness
=550  \\$aBody Temperature
=550  \\$aMalignant Hyperthermia
=667  \\$a/ther = treatment of FEVER: differentiate from FEVER THERAPY see HYPERTHERMIA, INDUCED ( = high body temp induced to treat dis); /chem ind: consider also HYPERTHERMIA, INDUCED or PYROGENS
=680  \\$iAn abnormal elevation of body temperature, usually as a result of a pathologic process.
=750  \0$aFever$5IEN$0(DLC)sh 85047994

=LDR  01889cz  a2200445n  4500
=001  9880363521702441
=005  20141212201424.0
=008  780619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005333
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x378
=150  \\$aFetus
=450  \\$wnnna$aFetal Structure
=450  \\$aFetal Structures
=450  \\$wnnna$aFetal Tissue
=450  \\$wnnna$aFetal Tissues
=450  \\$wnnna$aFetus, Mummified
=450  \\$wnnna$aFetus, Retained
=450  \\$wnnna$aFetuses
=450  \\$wnnna$aMummified Fetus
=450  \\$wnnna$aRetained Fetus
=450  \\$wnnna$aStructure, Fetal
=450  \\$wnnna$aStructures, Fetal
=450  \\$wnnna$aTissue, Fetal
=450  \\$wnnna$aTissues, Fetal
=550  \\$wg$aEmbryonic Structures
=550  \\$wh$aAborted Fetus
=550  \\$wh$aAmniotic Fluid
=550  \\$wh$aFetal Blood
=550  \\$wh$aFetal Heart
=550  \\$wh$aMeconium
=550  \\$wh$aUmbilical Cord
=550  \\$wh$aVernix Caseosa
=550  \\$aEmbryo, Mammalian
=550  \\$aFetal Research
=667  \\$amammalian only; human: 3d month to term; fetus in fetu: index under FETUS /abnorm; FETUS and PREGNANCY: Manual 18.4.3, 21.55; specialty for fetus & newborn infant = PERINATOLOGY; lithopedion: coordinate FETUS (IM) + CALCINOSIS (IM); intrauterine surgery goes under FETUS /surg; fetal organs & tissues in tissue & cell cultures: coordinate FETUS + organ or tissue without qualifiers + culture term, all probably NIM
=680  \\$iThe unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN.
=688  \\$a1972 (1963)
=688  \\$aPRENATAL INFLUENCES was heading 1963-72
=750  \0$aFetus$5IEN$0(DLC)sh 85047965

=LDR  02580cz  a2200733n  4500
=001  9880363521802441
=005  20141212192212.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005332
=035  \\$aCAZ8477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x630.$x300
=072  \\$aE1.$x370.$x388.$x250.$x280
=072  \\$aE2.$x467.$x750
=072  \\$aE4.$x502.$x250.$x280
=072  \\$aE4.$x520.$x280
=150  \\$aFetoscopy
=450  \\$wnnna$aAmnioscopic Surgeries
=450  \\$wnnna$aAmnioscopic Surgery
=450  \\$wnnna$aAmnioscopic Surgical Procedure
=450  \\$aAmnioscopic Surgical Procedures
=450  \\$wnnna$aAmnioscopies
=450  \\$aAmnioscopy
=450  \\$wnnna$aEmbryoscopic Surgeries
=450  \\$wnnna$aEmbryoscopic Surgery
=450  \\$wnnna$aEmbryoscopic Surgical Procedure
=450  \\$aEmbryoscopic Surgical Procedures
=450  \\$wnnna$aEmbryoscopies
=450  \\$aEmbryoscopy
=450  \\$wnnna$aFetoscopic Surgeries
=450  \\$wnnna$aFetoscopic Surgery
=450  \\$wnnna$aFetoscopic Surgical Procedure
=450  \\$aFetoscopic Surgical Procedures
=450  \\$wnnna$aFetoscopies
=450  \\$wnnna$aProcedure, Amnioscopic Surgical
=450  \\$wnnna$aProcedure, Embryoscopic Surgical
=450  \\$wnnna$aProcedure, Fetoscopic Surgical
=450  \\$wnnna$aProcedures, Amnioscopic Surgical
=450  \\$wnnna$aProcedures, Embryoscopic Surgical
=450  \\$wnnna$aProcedures, Fetoscopic Surgical
=450  \\$wnnna$aSurgeries, Amnioscopic
=450  \\$wnnna$aSurgeries, Embryoscopic
=450  \\$wnnna$aSurgeries, Fetoscopic
=450  \\$wnnna$aSurgery, Amnioscopic
=450  \\$wnnna$aSurgery, Embryoscopic
=450  \\$wnnna$aSurgery, Fetoscopic
=450  \\$wnnna$aSurgical Procedure, Amnioscopic
=450  \\$wnnna$aSurgical Procedure, Embryoscopic
=450  \\$wnnna$aSurgical Procedure, Fetoscopic
=450  \\$aSurgical Procedures, Amnioscopic
=450  \\$aSurgical Procedures, Embryoscopic
=450  \\$aSurgical Procedures, Fetoscopic
=550  \\$wg$aEndoscopy
=550  \\$wg$aFetal Therapies
=550  \\$wg$aObstetric Surgical Procedures
=550  \\$wg$aPrenatal Diagnosis
=550  \\$aAmnion
=550  \\$aAmniotic Fluid
=550  \\$aFetoscopes
=550  \\$aFetus
=667  \\$a/ instrum permitted but consider also FETOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the fetus and amniotic cavity through abdominal or uterine entry.
=688  \\$a1991(1971)
=750  \0$aFetoscopy$5IEN$0(DLC)sh 85047961

=LDR  00720cz  a2200205n  4500
=001  9880363521902441
=005  20141212201421.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x235.$x374
=072  \\$aG8.$x686.$x785.$x760.$x170.$x157.$x374
=150  \\$aFetal Movement
=450  \\$wnnna$aFetal Activities
=450  \\$wnnna$aFetal Activity
=450  \\$wnnna$aFetal Movements
=550  \\$wg$aFetal Development
=680  \\$iPhysical activity of the FETUS in utero. Gross or fine fetal body movement can be monitored by the mother, PALPATION, or ULTRASONOGRAPHY.
=688  \\$a85
=750  \0$aFetus$xMovements$5IEN$0(DLC)sh 92006805

=LDR  01019cz  a2200253n  4500
=001  9880363522002441
=005  20141212201421.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005323
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x230
=072  \\$aE1.$x370.$x520.$x230
=150  \\$aFetal Monitoring
=450  \\$wnnna$aFetal Monitorings
=450  \\$aMonitoring, Fetal
=450  \\$wnnna$aMonitorings, Fetal
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wg$aMonitoring, Physiologic
=550  \\$wh$aCardiotocography
=550  \\$aLabor, Obstetric
=667  \\$aduring LABOR, OBSTETRIC or during prenatal maternal surg
=680  \\$iPhysiologic or biochemical monitoring of the fetus. It is usually done during LABOR, OBSTETRIC and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery.
=688  \\$a78
=750  \0$aFetal monitoring$5IEN$0(DLC)sh 87006888

=LDR  01729cz  a2200409n  4500
=001  9880363522102441
=005  20141212201420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005321
=035  \\$aCAZ8466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x284
=072  \\$aA16.$x254.$x750
=150  \\$aExtraembryonic Membranes
=450  \\$wnnna$aExtra-Embryonic Membrane
=450  \\$wnnna$aExtra-Embryonic Membranes
=450  \\$wnnna$aExtra Embryonic Membranes
=450  \\$wnnna$aExtraembryonic Membrane
=450  \\$wnnna$aFetal Membrane
=450  \\$aFetal Membranes
=450  \\$wnnna$aMembrane, Extra-Embryonic
=450  \\$wnnna$aMembrane, Extraembryonic
=450  \\$wnnna$aMembrane, Fetal
=450  \\$wnnna$aMembranes, Extra-Embryonic
=450  \\$wnnna$aMembranes, Extraembryonic
=450  \\$wnnna$aMembranes, Fetal
=550  \\$wg$aEmbryo, Mammalian
=550  \\$wg$aMembranes
=550  \\$wh$aAllantois
=550  \\$wh$aAmnion
=550  \\$wh$aChorioallantoic Membrane
=550  \\$wh$aChorion
=550  \\$wh$aYolk Sac
=667  \\$ainduced rupture = LABOR, INDUCED; premature rupture = FETAL MEMBRANES, PREMATURE RUPTURE; rupture in normal labor = EXTRAEMBRYONIC MEMBRANES (IM) + LABOR, OBSTETRIC (IM)
=680  \\$iThe thin layers of tissue that surround the developing embryo. There are four extra-embryonic membranes commonly found in VERTEBRATES, such as REPTILES; BIRDS; and MAMMALS. They are the YOLK SAC, the ALLANTOIS, the AMNION, and the CHORION. These membranes provide protection and means to transport nutrients and wastes.
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Fetal Membranes
=750  \0$aFetal membranes$0(DLC) sh 85047953$5IEN

=LDR  01054cz  a2200265n  4500
=001  9880363522202441
=005  20141212201419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005318
=035  \\$aCAZ8463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x278
=072  \\$aA16.$x378.$x303
=150  \\$aFetal Heart
=450  \\$wnnna$aFetal Hearts
=450  \\$wnnna$aHeart, Fetal
=450  \\$wnnna$aHearts, Fetal
=550  \\$wg$aFetus
=550  \\$wg$aHeart
=550  \\$wh$aDuctus Arteriosus
=550  \\$wh$aEndocardial Cushions
=550  \\$wh$aTruncus Arteriosus
=667  \\$amammals only; use all pertinent qualif (except /blood supply) & do not coord with MYOCARDIUM for HEART; MYOCARDIUM restrictions; not for chick embryo heart ( = CHICK EMBRYO + HEART /embryol)
=680  \\$iThe heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
=750  \0$aFetal heart$5IEN$0(DLC)sh 85047946

=LDR  00895cz  a2200277n  4500
=001  9880363522302441
=005  20141212201419.0
=008  770302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005317
=035  \\$aCAZ8462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277.$x370
=072  \\$aC16.$x300.$x390
=072  \\$aC23.$x550.$x393.$x450
=150  \\$aFetal Growth Retardation
=450  \\$wnnna$aGrowth Retardation, Fetal
=450  \\$aGrowth Retardation, Intrauterine
=450  \\$aIntrauterine Growth Retardation
=450  \\$aIUGR
=450  \\$wnnna$aRetardation, Fetal Growth
=450  \\$wnnna$aRetardation, Intrauterine Growth
=550  \\$wg$aFetal Diseases
=550  \\$wg$aGrowth Disorders
=680  \\$iThe failure of a FETUS to attain its expected FETAL GROWTH at any GESTATIONAL AGE.
=688  \\$a78
=750  \0$aFetal growth retardation$5IEN$0(DLC)sh 85047972

=LDR  00867cz  a2200217n  4500
=001  9880363522402441
=005  20141212201418.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005316
=035  \\$aCAZ8461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x380
=150  \\$aFetal Distress
=450  \\$wnnna$aFetal Status, Nonreassuring
=450  \\$aNonreassuring Fetal Status
=550  \\$wg$aSigns and Symptoms
=667  \\$ado not confuse with RESPIRATORY DISTRESS SYNDROME, NEWBORN (postnatal)
=680  \\$iA nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.
=688  \\$a1975
=688  \\$a75
=750  \0$aFetal distress$5IEN$0(DLC)sh 85047945

=LDR  01516cz  a2200421n  4500
=001  9880363522502441
=005  20141212201418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005315
=035  \\$aCAZ8460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277
=072  \\$aC16.$x300
=150  \\$aFetal Diseases
=450  \\$wnnna$aDisease, Fetal
=450  \\$wnnna$aDiseases, Fetal
=450  \\$aEmbryopathies
=450  \\$wnnna$aEmbryopathy
=450  \\$wnnna$aFetal Disease
=550  \\$wg$aCongenital, Hereditary, and Neonatal Diseases and Abnormalities
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aChorioamnionitis
=550  \\$wh$aEchogenic Bowel
=550  \\$wh$aErythroblastosis, Fetal
=550  \\$wh$aFetal Alcohol Spectrum Disorders
=550  \\$wh$aFetal Growth Retardation
=550  \\$wh$aFetal Hypoxia
=550  \\$wh$aFetal Macrosomia
=550  \\$wh$aFetal Nutrition Disorders
=550  \\$wh$aMeconium Aspiration Syndrome
=550  \\$wh$aNuchal Cord
=550  \\$wh$aPyelectasis
=550  \\$aPerinatology
=667  \\$aGEN: prefer specifics; FETAL DISTRESS is available; anoxia = FETAL ANOXIA: do not confuse with ASPHYXIA NEONATORUM
=680  \\$iPathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES.
=688  \\$aPRENATAL INFLUENCES was heading 1963-72
=750  \0$aHuman embryo$xDiseases$5IEN$0(DLC)sh 91005707
=750  \0$aFetus$xDiseases$5IEN-HS$0(DLC)sh 85047967

=LDR  01170cz  a2200361n  4500
=001  9880363522602441
=005  20141212192211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005313
=035  \\$aCAZ8458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x223
=072  \\$aC23.$x550.$x260.$x585
=150  \\$aFetal Death
=450  \\$wnnna$aDeath, Fetal
=450  \\$wnnna$aDeaths, Fetal
=450  \\$wnnna$aDemise, Fetal
=450  \\$wnnna$aFetal Deaths
=450  \\$wnnna$aFetal Demise
=450  \\$aFetal Mummification
=450  \\$wnnna$aMummification, Fetal
=550  \\$wg$aDeath
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aFetal Resorption
=550  \\$wh$aStillbirth
=550  \\$aAbortion, Habitual
=550  \\$aEmbryo Loss
=550  \\$aFetal Viability
=550  \\$aInfant Mortality
=550  \\$aPerinatal Death
=667  \\$ause PERINATAL DEATH for death of a fetus of gestational age 28 weeks or more; do not confuse with FETAL MORTALITY, a statistical concept
=680  \\$iDeath of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
=750  \0$aFetal death$5IEN$0(DLC)sh 85047944

=LDR  01252cz  a2200361n  4500
=001  9880363522702441
=005  20141212201417.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005312
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152.$x200
=072  \\$aA15.$x145.$x300
=072  \\$aA16.$x378.$x200
=150  \\$aFetal Blood
=450  \\$wnnna$aBlood, Cord
=450  \\$wnnna$aBlood, Fetal
=450  \\$wnnna$aBlood, Umbilical Cord
=450  \\$wnnna$aBloods, Cord
=450  \\$wnnna$aBloods, Fetal
=450  \\$wnnna$aBloods, Umbilical Cord
=450  \\$aCord Blood
=450  \\$wnnna$aCord Blood, Umbilical
=450  \\$wnnna$aCord Bloods
=450  \\$wnnna$aCord Bloods, Umbilical
=450  \\$wnnna$aFetal Bloods
=450  \\$aUmbilical Cord Blood
=450  \\$wnnna$aUmbilical Cord Bloods
=550  \\$wg$aBlood
=550  \\$wg$aFetus
=667  \\$a/transpl: consider also CORD BLOOD STEM CELL TRANSPLANTATION
=680  \\$iBlood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.
=688  \\$a75
=750  \0$aFetal blood$5IEN$0(DLC)sh 85047943

=LDR  00805cz  a2200277n  4500
=001  9880363522802441
=005  20141212201417.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005311
=035  \\$aCAZ8456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277.$x390
=072  \\$aC16.$x300.$x420
=072  \\$aC23.$x888.$x852.$x79.$x594
=150  \\$aFetal Hypoxia
=450  \\$aAnoxia, Fetal
=450  \\$aFetal Anoxia
=450  \\$wnnna$aHypoxia, Fetal
=550  \\$wg$aAnoxia
=550  \\$wg$aFetal Diseases
=667  \\$ado not confuse with ASPHYXIA NEONATORUM
=680  \\$iDeficient oxygenation of FETAL BLOOD.
=688  \\$a2006 (1975)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Fetal Anoxia
=688  \\$a75
=750  \0$aFetal anoxia$0(DLC) sh 85047942$5IEN

=LDR  01837cz  a2200445n  4500
=001  9880363522902441
=005  20141212201417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005309
=035  \\$aCAZ8454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x300
=150  \\$aFerula
=450  \\$wnnna$aAsa-foetida
=450  \\$wnnna$aAsa foetida
=450  \\$wnnna$aAsa-foetidas
=450  \\$wnnna$aAsafetida
=450  \\$wnnna$aAsafetidas
=450  \\$aAsafoetida
=450  \\$wnnna$aAsafoetidas
=450  \\$wnnna$aFerula foetida
=450  \\$wnnna$aFerula foetidas
=450  \\$wnnna$aFerula harmoni
=450  \\$wnnna$aFerula harmonis
=450  \\$wnnna$aFerula hermoni
=450  \\$wnnna$aFerula hermonis
=450  \\$wnnna$aFerulas
=450  \\$wnnna$afoetida, Ferula
=450  \\$wnnna$afoetidas, Ferula
=450  \\$wnnna$aharmoni, Ferula
=450  \\$wnnna$aharmonis, Ferula
=450  \\$wnnna$ahermoni, Ferula
=450  \\$wnnna$ahermonis, Ferula
=450  \\$wnnna$aZallouh
=450  \\$wnnna$aZallouhs
=550  \\$wg$aApiaceae
=667  \\$adistinguish from true Fennel = FOENICULUM; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of 'giant fennel' should not be confused with true fennel (FOENICULUM).
=688  \\$a91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85
=750  \0$aFerula$5IEN$0(DLC)sh 85047921

=LDR  00572cz  a2200157n  4500
=001  9880363523002441
=005  20141212201416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005308
=035  \\$aCAZ8453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x400
=150  \\$aFertilizers
=550  \\$wg$aAgrochemicals
=680  \\$iSubstances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity.
=750  \0$aFertilizers$5IEN$0(DLC)sh 85047919

=LDR  01625cz  a2200409n  4500
=001  9880363523102441
=005  20141212201416.0
=008  781122\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005307
=035  \\$aCAZ8452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x800.$x750
=072  \\$aE5.$x820.$x800.$x750
=150  \\$aFertilization in Vitro
=450  \\$wnnna$aBabies, Test-Tube
=450  \\$wnnna$aBaby, Test-Tube
=450  \\$wnnna$aFertilization, Test-Tube
=450  \\$wnnna$aFertilizations in Vitro
=450  \\$wnnna$aFertilizations, Test-Tube
=450  \\$wnnna$aIn Vitro Fertilization
=450  \\$wnnna$aIn Vitro Fertilizations
=450  \\$wnnna$aTest-Tube Babies
=450  \\$wnnna$aTest Tube Babies
=450  \\$wnnna$aTest-Tube Baby
=450  \\$aTest-Tube Fertilization
=450  \\$wnnna$aTest Tube Fertilization
=450  \\$wnnna$aTest-Tube Fertilizations
=550  \\$wg$aReproductive Techniques, Assisted
=550  \\$wh$aSperm Injections, Intracytoplasmic
=550  \\$aEctogenesis
=550  \\$aGenetic Engineering
=550  \\$aInsemination, Artificial
=667  \\$ado not check the tags IN VITRO; PREGNANCY; or FEMALE
=680  \\$iAn assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.
=688  \\$a79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79
=750  \0$aFertilization in vitro$5IEN-M$0(DLC)sh 85047905
=750  \0$aFertilization in vitro, Human$5IEN-M$0(DLC)sh 85047906

=LDR  01433cz  a2200385n  4500
=001  9880363523202441
=005  20141212201415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x277
=150  \\$aFertilization
=450  \\$aConception
=450  \\$wnnna$aConceptions
=450  \\$wnnna$aDelayed Fertilization
=450  \\$wnnna$aDelayed Fertilizations
=450  \\$aFertilization, Delayed
=450  \\$aFertilization, Polyspermic
=450  \\$wnnna$aFertilizations
=450  \\$wnnna$aFertilizations, Delayed
=450  \\$wnnna$aFertilizations, Polyspermic
=450  \\$wnnna$aPolyspermic Fertilization
=450  \\$wnnna$aPolyspermic Fertilizations
=550  \\$wg$aReproduction
=550  \\$wh$aOvum Transport
=550  \\$wh$aSelf-Fertilization
=550  \\$wh$aSperm Capacitation
=550  \\$wh$aSperm-Ovum Interactions
=550  \\$wh$aSperm Transport
=550  \\$aPosthumous Conception
=667  \\$aphysiol fertilization only: FERTILIZATION IN VITRO (Cat E2 and E5) is also available
=680  \\$iThe fusion of a spermatozoon (SPERMATOZOA) with an OVUM thus resulting in the formation of a ZYGOTE.
=688  \\$aFERTILIZATION, DELAYED & FERTILIZATION, POLYSPERMIC were see under FERTILIZATION 1975-84
=750  \0$aFertilization (Biology)$5IEN-M$0(DLC)sh 85047904
=750  \0$aConception$5IEN-HS$0(DLC)sh 85029616

=LDR  01958cz  a2200529n  4500
=001  9880363523302441
=005  20141212201414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005298
=035  \\$aCAZ8443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x210
=150  \\$aFertility
=450  \\$wnnna$aBelow Replacement Fertility
=450  \\$wnnna$aDeterminant, Fertility
=450  \\$wnnna$aDeterminants, Fertility
=450  \\$wnnna$aDifferential Fertility
=450  \\$wnnna$aFecundability
=450  \\$aFecundity
=450  \\$wnnna$aFertility, Below Replacement
=450  \\$wnnna$aFertility Determinant
=450  \\$wnnna$aFertility Determinants
=450  \\$wnnna$aFertility, Differential
=450  \\$wnnna$aFertility Incentive
=450  \\$wnnna$aFertility Incentives
=450  \\$wnnna$aFertility, Marital
=450  \\$wnnna$aFertility, Natural
=450  \\$wnnna$aFertility Preference
=450  \\$wnnna$aFertility Preferences
=450  \\$wnnna$aFertility Survey, World
=450  \\$wnnna$aFertility Surveys, World
=450  \\$wnnna$aMarital Fertility
=450  \\$wnnna$aNatural Fertility
=450  \\$wnnna$aPreference, Fertility
=450  \\$wnnna$aPreferences, Fertility
=450  \\$wnnna$aSubfecundity
=450  \\$wnnna$aSurvey, World Fertility
=450  \\$wnnna$aSurveys, World Fertility
=450  \\$wnnna$aWorld Fertility Survey
=450  \\$wnnna$aWorld Fertility Surveys
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wh$aOvarian Reserve
=550  \\$wh$aTime-to-Pregnancy
=667  \\$aIM for human, other mammals, birds & fish, NIM for animals lower than fish, plants & micro-organisms; /drug eff: consider also FERTILITY AGENTS
=680  \\$iThe capacity to conceive or to induce conception. It may refer to either the male or female.
=750  \0$aFertility, Human$5IEN-M$0(DLC)sh 85047898
=750  \0$aFertility$5IEN-HS$0(DLC)sh 85047895

=LDR  00658cz  a2200217n  4500
=001  9880363523402441
=005  20141212201413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005295
=035  \\$aCAZ8440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x291.$x370
=072  \\$aD1.$x490.$x200.$x250
=072  \\$aD1.$x625.$x400.$x100.$x350
=150  \\$aFerrocyanides
=550  \\$wg$aCyanides
=550  \\$wg$aFerrous Compounds
=667  \\$ado not confuse with FERRICYANIDES
=680  \\$iInorganic salts of the hypothetical acid ferrocyanic acid (H4Fe(CN)6).
=688  \\$a66
=750  \0$aFerrocyanides$5IEN$0(DLC)sh 85047876

=LDR  01094cz  a2200253n  4500
=001  9880363523502441
=005  20141212201412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005293
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x427.$x249
=072  \\$aD12.$x776.$x556.$x579.$x249
=150  \\$aFerritins
=450  \\$wnnna$aBasic Isoferritin
=450  \\$wnnna$aFerritin
=450  \\$wnnna$aIsoferritin
=450  \\$wnnna$aIsoferritin, Basic
=550  \\$wg$aIron-Binding Proteins
=550  \\$wh$aApoferritins
=550  \\$aIron
=680  \\$iIron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.
=688  \\$a2007 (1966); for ISOFERRITIN use FERRITIN (NM) 1972-2006
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Ferritin
=750  \0$aFerritin$0(DLC) sh 85047870$5IEN

=LDR  00958cz  a2200277n  4500
=001  9880363523602441
=005  20141212201411.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005289
=035  \\$aCAZ8434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x550.$x350
=150  \\$aFerrets
=450  \\$wnnna$aDomestic Polecat
=450  \\$aDomestic Polecats
=450  \\$aEuropean Polecats
=450  \\$wnnna$aFerret
=450  \\$aMustela putorius
=450  \\$aMustela putorius furo
=450  \\$wnnna$aPolecat, Domestic
=450  \\$wnnna$aPolecats, Domestic
=450  \\$wnnna$aPolecats, European
=550  \\$wg$aMustelidae
=680  \\$iSemidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.
=688  \\$a91(75); was see under CARNIVORA 1975-90
=750  \0$aFerret$5IEN$0(DLC)sh 85047848

=LDR  01233cz  a2200301n  4500
=001  9880363523702441
=005  20141212201410.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005287
=035  \\$aCAZ8432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x667.$x76
=150  \\$aFerredoxin-NADP Reductase
=450  \\$aAdrenodoxin Reductase
=450  \\$wnnna$aFerredoxin NADP Reductase
=450  \\$aIron-Sulfur Protein Reductase
=450  \\$wnnna$aIron Sulfur Protein Reductase
=450  \\$wnnna$aNADPH-Ferredoxin Reductase
=450  \\$wnnna$aNADPH Ferredoxin Reductase
=450  \\$wnnna$aProtein Reductase, Iron-Sulfur
=450  \\$wnnna$aReductase, Adrenodoxin
=450  \\$wnnna$aReductase, Ferredoxin-NADP
=450  \\$wnnna$aReductase, Iron-Sulfur Protein
=450  \\$wnnna$aReductase, NADPH-Ferredoxin
=550  \\$wg$aOxidoreductases Acting on Sulfur Group Donors
=680  \\$iAn enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.
=688  \\$a91(75); was see under NADH, NADPH OXIDOREDUCTASES 1975-90
=750  \0$aFerredoxin-NADP reductase$5IEN-M$0(DLC)sh 90004563

=LDR  00906cz  a2200229n  4500
=001  9880363523802441
=005  20141212201410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005286
=035  \\$aCAZ8431M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x275
=072  \\$aD1.$x268.$x271.$x100.$x275
=072  \\$aD1.$x268.$x556.$x266
=072  \\$aD1.$x552.$x20.$x394
=072  \\$aD1.$x552.$x544.$x266
=150  \\$aFermium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$aman-made radioactive element; IM
=680  \\$iFermium. A man-made radioactive actinide with atomic symbol Fm, atomic number 100, and atomic weight 257. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion.
=750  \0$aFermium$0(DLC)sh2012003995$5IEN-M

=LDR  00786cz  a2200205n  4500
=001  9880363523902441
=005  20141212201409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005285
=035  \\$aCAZ8430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x249
=072  \\$aG2.$x149.$x115.$x160.$x249
=072  \\$aG3.$x495.$x256.$x249
=150  \\$aFermentation
=450  \\$wnnna$aFermentations
=550  \\$wg$aCarbohydrate Metabolism
=550  \\$aBioreactors
=680  \\$iAnaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.
=750  \0$aFermentation$5IEN$0(DLC)sh 85047829

=LDR  01243cz  a2200349n  4500
=001  9880363524002441
=005  20141212192210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005283
=035  \\$aCAZ8428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x265
=150  \\$aFentanyl
=450  \\$wnnna$aCephalon Brand of Fentanyl Buccal OraVescent
=450  \\$wnnna$aDuragesic
=450  \\$wnnna$aDurogesic
=450  \\$wnnna$aFentanest
=450  \\$wnnna$aFentanyl Citrate
=450  \\$wnnna$aFentora
=450  \\$wnnna$aJanssen Pharmaceutica Brand of Fentanyl
=450  \\$aPhentanyl
=450  \\$wnnna$aR-4263
=450  \\$wnnna$aR 4263
=450  \\$wnnna$aR4263
=450  \\$wnnna$aSublimaze
=450  \\$wnnna$aTransmucosal Oral Fentanyl Citrate
=550  \\$wg$aPiperidines
=550  \\$wh$aAlfentanil
=550  \\$wh$aSufentanil
=680  \\$iA potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
=688  \\$a66
=750  \0$aFentanyl$5IEN$0(DLC)sh 85047807

=LDR  01241cz  a2200373n  4500
=001  9880363524102441
=005  20141212201409.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005280
=035  \\$aCAZ8425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x465.$x300
=072  \\$aD2.$x92.$x63.$x291.$x465.$x300
=072  \\$aD2.$x92.$x211.$x215.$x311.$x465.$x300
=072  \\$aD2.$x92.$x311.$x660.$x300
=150  \\$aFenoterol
=450  \\$wnnna$aBerotec
=450  \\$wnnna$aBerotek
=450  \\$wnnna$aFenoterol Hydrobromide
=450  \\$wnnna$aFenoterol Hydrochloride
=450  \\$wnnna$aHydrochloride, Fenoterol
=450  \\$wnnna$ap-Hydroxyphenyl-orciprenaline
=450  \\$wnnna$ap Hydroxyphenyl orciprenaline
=450  \\$wnnna$ap-Hydroxyphenylorciprenaline
=450  \\$wnnna$ap Hydroxyphenylorciprenaline
=450  \\$wnnna$aPartusisten
=450  \\$wnnna$aPhenoterol
=450  \\$wnnna$aTh-1165a
=450  \\$wnnna$aTh 1165a
=450  \\$wnnna$aTh1165a
=550  \\$wg$aMetaproterenol
=680  \\$iAn adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
=688  \\$a86(75); was see under ETHANOLAMINES 1975-85
=750  \0$aFenoterol$5IEN$0(DLC)sh 85047803

=LDR  01188cz  a2200301n  4500
=001  9880363524202441
=005  20141212201408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005278
=035  \\$aCAZ8423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x300
=072  \\$aD2.$x705.$x539.$x345.$x300
=072  \\$aD2.$x886.$x300.$x692.$x300
=150  \\$aFenitrothion
=450  \\$wnnna$a1050, Agria
=450  \\$wnnna$aAgria 1050
=450  \\$wnnna$aFolithion
=450  \\$wnnna$aMetathion
=450  \\$wnnna$aMethylnitrophos
=450  \\$wnnna$aNitrophos
=450  \\$wnnna$aSumithion
=450  \\$wnnna$aSumithione
=550  \\$wg$aOrganothiophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organothiophosphate cholinesterase inhibitor that is used as an insecticide.
=688  \\$a74(72)
=750  \0$aFenitrothion$5IEN$0(DLC)sh 85047797

=LDR  01124cz  a2200313n  4500
=001  9880363524302441
=005  20141212201408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005277
=035  \\$aCAZ8422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x467
=150  \\$aFenfluramine
=450  \\$wnnna$aFenfluramine, (+-)-Isomer
=450  \\$wnnna$aFenfluramine Hydrochloride
=450  \\$wnnna$aFenfluramine Hydrochloride, (+-)-Isomer
=450  \\$wnnna$aFenfluramine Hydrochloride, R-Isomer
=450  \\$wnnna$aFenfluramine Hydrochloride, R Isomer
=450  \\$wnnna$aFenfluramine, R-Isomer
=450  \\$wnnna$aFenfluramine, R Isomer
=450  \\$wnnna$aHydrochloride, Fenfluramine
=450  \\$wnnna$aIsomeride
=450  \\$wnnna$aPondimin
=450  \\$wnnna$aRobins Brand of Fenfluramine Hydrochloride
=550  \\$wg$aPhenethylamines
=550  \\$wh$aNorfenfluramine
=680  \\$iA centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.
=688  \\$a72(66)
=750  \0$aFenfluramine$5IEN-M$0(DLC)sh 96010149

=LDR  00852cz  a2200241n  4500
=001  9880363524402441
=005  20141212201407.0
=008  790301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005275
=035  \\$aCAZ8420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x450
=150  \\$aFendiline
=450  \\$wnnna$aCelltech Brand of Fendiline Hydrochloride
=450  \\$wnnna$aFendilin
=450  \\$wnnna$aFendiline Hydrochloride
=450  \\$wnnna$aHydrochloride, Fendiline
=450  \\$wnnna$aSensit
=450  \\$wnnna$aSenzit
=550  \\$wg$aPhenethylamines
=680  \\$iCoronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
=688  \\$a91(80); was see under PHENETHYLAMINES 1980-90
=750  \0$aFendiline$5IEN$0(DLC)sh 85047787

=LDR  00633cz  a2200205n  4500
=001  9880363524502441
=005  20141212201407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005272
=035  \\$aCAZ8417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x650.$x247.$x510
=150  \\$aFemur Neck
=450  \\$aFemoral Neck
=450  \\$wnnna$aNeck, Femoral
=450  \\$wnnna$aNeck, Femur
=550  \\$wg$aFemur
=667  \\$afractures = FEMORAL NECK FRACTURES
=680  \\$iThe constricted portion of the thigh bone between the femur head and the trochanters.
=750  \0$aFemur neck$5IEN$0(DLC)sh 85047775

=LDR  00827cz  a2200241n  4500
=001  9880363524602441
=005  20141212201406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005269
=035  \\$aCAZ8414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x650.$x247
=150  \\$aFemur
=450  \\$wnnna$aFemurs
=450  \\$aTrochanter
=450  \\$wnnna$aTrochanters
=550  \\$wg$aLeg Bones
=550  \\$wh$aFemur Head
=550  \\$wh$aFemur Neck
=550  \\$aThigh
=667  \\$afractures: FEMORAL FRACTURES & FEMORAL NECK FRACTURES are available but see note under HIP FRACTURES; do not index under FEMUR when THIGH is meant: see note there
=680  \\$iThe longest and largest bone of the skeleton, it is situated between the hip and the knee.
=750  \0$aFemur$5IEN$0(DLC)sh 85047769

=LDR  00634cz  a2200193n  4500
=001  9880363524702441
=005  20141212201406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005268
=035  \\$aCAZ8413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x314
=150  \\$aFemoral Vein
=450  \\$wnnna$aFemoral Veins
=450  \\$wnnna$aVein, Femoral
=450  \\$wnnna$aVeins, Femoral
=550  \\$wg$aVeins
=680  \\$iThe vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein.
=750  \0$aFemoral vein$5IEN$0(DLC)sh 85047768

=LDR  00994cz  a2200205n  4500
=001  9880363524802441
=005  20141212201406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005267
=035  \\$aCAZ8412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x450.$x250
=150  \\$aFemoral Nerve
=450  \\$wnnna$aFemoral Nerves
=450  \\$wnnna$aNerve, Femoral
=450  \\$wnnna$aNerves, Femoral
=550  \\$wg$aLumbosacral Plexus
=667  \\$adis = FEMORAL NEUROPATHY; neopl = FEMORAL NEUROPATHY (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM); posterior femoral cutaneous nerve: index under PERIPHERAL NERVES
=680  \\$iA nerve originating in the lumbar spinal cord (usually L2 to L4) and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints.
=750  \0$aFemoral nerve$5IEN$0(DLC)sh 85047766

=LDR  00758cz  a2200205n  4500
=001  9880363524902441
=005  20141212201405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005265
=035  \\$aCAZ8410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x61.$x425.$x500
=072  \\$aC26.$x558.$x276.$x425.$x500
=150  \\$aFemoral Neck Fractures
=450  \\$wnnna$aFemoral Neck Fracture
=450  \\$wnnna$aFemur Neck Fracture
=450  \\$wnnna$aFemur Neck Fractures
=550  \\$wg$aHip Fractures
=680  \\$iFractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES.
=750  \0$aFemur neck$xFractures$5IEN-M$0(IEN)368339

=LDR  00713cz  a2200241n  4500
=001  9880363525002441
=005  20141212201405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005264
=035  \\$aCAZ8409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x61
=072  \\$aC26.$x558.$x276
=150  \\$aFemoral Fractures
=450  \\$wnnna$aFemoral Fracture
=450  \\$wnnna$aFracture, Femoral
=450  \\$wnnna$aFractures, Femoral
=550  \\$wg$aFractures, Bone
=550  \\$wg$aLeg Injuries
=550  \\$wh$aHip Fractures
=667  \\$aof femoral shaft only; see X refs & note at HIP FRACTURES
=680  \\$iFractures of the femur.
=750  \0$aFemur$xFractures$5IEN$0(DLC)sh2009124221

=LDR  00583cz  a2200193n  4500
=001  9880363525102441
=005  20141212201404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005263
=035  \\$aCAZ8408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x351
=150  \\$aFemoral Artery
=450  \\$wnnna$aArteries, Femoral
=450  \\$wnnna$aArtery, Femoral
=450  \\$wnnna$aFemoral Arteries
=550  \\$wg$aArteries
=680  \\$iThe main artery of the thigh, a continuation of the external iliac artery.
=750  \0$aFemoral artery$5IEN$0(DLC)sh 85047764

=LDR  00906cz  a2200241n  4500
=001  9880363525202441
=005  20141212201403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005257
=035  \\$aCAZ8402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x483.$x838.$x276
=150  \\$aFellowships and Scholarships
=450  \\$wnnna$aFellowship
=450  \\$wnnna$aFellowships
=450  \\$wnnna$aScholarship
=450  \\$aScholarships
=450  \\$wnnna$aScholarships and Fellowships
=550  \\$wg$aTraining Support
=667  \\$aSPEC qualif; specify agency or govt & geog if possible; DF: FELLOWSHIPS
=680  \\$iStipends or grants-in-aid granted by foundations or institutions to individuals for study.
=688  \\$a79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS & SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78
=750  \0$aScholarships$5IEN$0(DLC)sh 85118243

=LDR  01562cz  a2200349n  4500
=001  9880363525302441
=005  20141212201403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005256
=035  \\$aCAZ8401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x375.$x500
=072  \\$aB4.$x909.$x574.$x807.$x375.$x500
=072  \\$aB4.$x909.$x777.$x731.$x375.$x500
=150  \\$aLeukemia Virus, Feline
=450  \\$aCat Leukemia Virus
=450  \\$wnnna$aCat Leukemia Viruses
=450  \\$aFeline leukemia virus
=450  \\$wnnna$aFeline Leukemia Viruses
=450  \\$aFeline Lymphoma Virus
=450  \\$wnnna$aFeline Lymphoma Viruses
=450  \\$aFeLV
=450  \\$wnnna$aLeukemia Virus, Cat
=450  \\$wnnna$aLeukemia Viruses, Cat
=450  \\$wnnna$aLeukemia Viruses, Feline
=450  \\$wnnna$aLymphoma Virus, Feline
=450  \\$wnnna$aLymphoma Viruses, Feline
=550  \\$wg$aGammaretrovirus
=667  \\$ainfection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) or if so specified by author index instead under LEUKEMIA, FELINE (IM but see note there) or FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME (IM but see note there); DF: FELV
=680  \\$iA species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas (see also SARCOMA VIRUSES, FELINE).
=688  \\$a94; was FELINE LEUKEMIA VIRUS 1973-93
=750  \0$aFeline leukemia virus$5IEN$0(DLC)sh 85047700

=LDR  02115cz  a2200445n  4500
=001  9880363525402441
=005  20141212201401.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005253
=035  \\$aCAZ8398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x265.$x590
=072  \\$aB4.$x820.$x650.$x375.$x800
=072  \\$aB4.$x909.$x574.$x807.$x375.$x800
=072  \\$aB4.$x909.$x777.$x731.$x375.$x800
=150  \\$aSarcoma Viruses, Feline
=450  \\$aFeline Sarcoma Virus, Gardner-Arnstein
=450  \\$wnnna$aFeline Sarcoma Virus, Gardner Arnstein
=450  \\$aFeline Sarcoma Virus, Hardy-Zuckerman
=450  \\$wnnna$aFeline Sarcoma Virus, Hardy Zuckerman
=450  \\$aFeline Sarcoma Virus, Snyder-Theilen
=450  \\$wnnna$aFeline Sarcoma Virus, Snyder Theilen
=450  \\$aFeline Sarcoma Viruses
=450  \\$aGardner-Arnstein feline sarcoma virus
=450  \\$wnnna$aGardner Arnstein feline sarcoma virus
=450  \\$aHardy-Zuckerman feline sarcoma virus
=450  \\$wnnna$aHardy Zuckerman feline sarcoma virus
=450  \\$wnnoa$aSarcoma Virus, Feline$5IEN-HS
=450  \\$aSarcoma Virus, Feline, Gardner-Arnstein
=450  \\$aSarcoma Virus, Feline, Hardy-Zuckerman
=450  \\$aSarcoma Virus, Feline, Snyder-Theilen
=450  \\$aSnyder-Theilen feline sarcoma virus
=450  \\$wnnna$aSnyder Theilen feline sarcoma virus
=550  \\$wg$aDefective Viruses
=550  \\$wg$aGammaretrovirus
=550  \\$aLeukemia Virus, Feline
=667  \\$ainfection: coordinate IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM); add SARCOMA, EXPERIMENTAL (IM), SARCOMA (IM), or FIBROSARCOMA (IM) if pertinent; DF: FESV
=680  \\$iSpecies of GAMMARETROVIRUS isolated from fibrosarcoma in cats. The viruses are actually recombinant feline leukemia viruses (FeLV) where part of the genome has been replaced by cellular oncogenes. It is unique to individuals and not transmitted naturally to other cats. FeSVs are replication defective and require FeLV to reproduce.
=688  \\$a2002 (1975)
=750  \0$aFeline sarcoma virus$5IEN$0(DLC)sh 85047701

=LDR  01283cz  a2200349n  4500
=001  9880363525502441
=005  20141212201401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005252
=035  \\$aCAZ8397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x442.$x551
=150  \\$aFees, Pharmaceutical
=450  \\$wnnna$aFee, Pharmaceutic
=450  \\$wnnna$aFee, Pharmaceutical
=450  \\$wnnna$aFee, Pharmacy
=450  \\$wnnna$aFees, Pharmaceutic
=450  \\$wnnna$aFees, Pharmacy
=450  \\$wnnna$aPharmaceutic Fee
=450  \\$wnnna$aPharmaceutic Fees
=450  \\$wnnna$aPharmaceutical Fee
=450  \\$wnnna$aPharmaceutical Fees
=450  \\$wnnna$aPharmacy Fee
=450  \\$wnnna$aPharmacy Fees
=550  \\$wg$aFees and Charges
=550  \\$wh$aPrescription Fees
=550  \\$aEconomics, Pharmaceutical
=550  \\$aPharmacy Administration
=667  \\$acosts to the patient or third-party payer: do not confuse with DRUG COSTS which are costs to a health facility or organiz; DF: FEES PHARM
=680  \\$iAmounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.
=688  \\$a68
=750  \0$aDrugs$xPrices$5IEN-M$0(DLC)sh 91005431

=LDR  00685cz  a2200241n  4500
=001  9880363525602441
=005  20141212201400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005251
=035  \\$aCAZ8396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x300.$x426
=072  \\$aN3.$x219.$x442.$x426
=150  \\$aFees, Medical
=450  \\$wnnna$aFee, Medical
=450  \\$wnnna$aMedical Fee
=450  \\$wnnna$aMedical Fees
=550  \\$wg$aEconomics, Medical
=550  \\$wg$aFees and Charges
=667  \\$aDF: FEES MED
=680  \\$iAmounts charged to the patient as payer for medical services.
=688  \\$a68
=750  \0$aMedical fees$5IEN$0(DLC)sh 85082936

=LDR  00679cz  a2200241n  4500
=001  9880363525702441
=005  20141212201400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005250
=035  \\$aCAZ8395HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x224.$x426
=072  \\$aN3.$x219.$x442.$x301
=150  \\$aFees, Dental
=450  \\$wnnna$aDental Fee
=450  \\$wnnna$aDental Fees
=450  \\$wnnna$aFee, Dental
=550  \\$wg$aEconomics, Dental
=550  \\$wg$aFees and Charges
=667  \\$aDF: FEES DENT
=680  \\$iAmounts charged to the patient as payer for dental services.
=688  \\$a68
=750  \0$aDental fees$5IEN$0(DLC)sh 85036890

=LDR  00967cz  a2200349n  4500
=001  9880363525802441
=005  20141212201400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005249
=035  \\$aCAZ8394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x442
=150  \\$aFees and Charges
=450  \\$wnnna$aCharge
=450  \\$aCharges
=450  \\$wnnna$aCharges and Fees
=450  \\$wnnna$aFee
=450  \\$wnnna$aFees
=550  \\$wg$aEconomics
=550  \\$wh$aCapitation Fee
=550  \\$wh$aFee-for-Service Plans
=550  \\$wh$aFees, Dental
=550  \\$wh$aFees, Medical
=550  \\$wh$aFees, Pharmaceutical
=550  \\$wh$aHospital Charges
=550  \\$wh$aPrescription Fees
=550  \\$wh$aRate Setting and Review
=550  \\$aFee Schedules
=667  \\$aDF: FEES
=680  \\$iAmounts charged to the patient as payer for health care services.
=688  \\$a68
=750  \0$aMedical fees$5IEN$0(DLC)sh 85082936

=LDR  00673cz  a2200217n  4500
=001  9880363525902441
=005  20141212201358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005245
=035  \\$aCAZ8390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x313
=150  \\$aFee Schedules
=450  \\$wnnna$aFee Schedule
=450  \\$wnnna$aSchedule, Fee
=450  \\$wnnna$aSchedules, Fee
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aRelative Value Scales
=680  \\$iA listing of established professional service charges, for specified dental and medical procedures.
=688  \\$a68
=750  \0$aMedical fees$5IEN$0(DLC)sh 85082936

=LDR  00622cz  a2200205n  4500
=001  9880363526002441
=005  20141212201358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005244
=035  \\$aCAZ8389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x531.$x424
=150  \\$aFecal Impaction
=450  \\$aFecalith
=450  \\$wnnna$aFeces, Impacted
=450  \\$wnnna$aImpaction, Fecal
=550  \\$wg$aIntestinal Obstruction
=680  \\$iFormation of a firm impassable mass of stool in the RECTUM or distal COLON.
=688  \\$a2004 (1964)
=750  \0$aFeces$xImpaction$5IEN-M$0(DLC)sh 85047544

=LDR  00835cz  a2200205n  4500
=001  9880363526102441
=005  20141212201358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005243
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x459
=150  \\$aFeces
=550  \\$wg$aFluids and Secretions
=550  \\$wh$aMeconium
=550  \\$wh$aMelena
=550  \\$aGastrointestinal Contents
=550  \\$aManure
=667  \\$a/parasitol: often coord with PARASITE EGG COUNT; consider also DEFECATION; CONSTIPATION; DIARRHEA; FECAL IMPACTION & FECAL INCONTINENCE; fecalith: index FECAL IMPACTION; fecal blood: index under OCCULT BLOOD & not also here
=680  \\$iExcrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
=750  \0$aFeces$5IEN$0(DLC)sh 85047542

=LDR  00772cz  a2200229n  4500
=001  9880363526202441
=005  20141212201358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005242
=035  \\$aCAZ8387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x860.$x300
=150  \\$aFecal Incontinence
=450  \\$wnnna$aFecal Incontinences
=450  \\$wnnna$aIncontinence, Fecal
=450  \\$wnnna$aIncontinences, Fecal
=550  \\$wg$aRectal Diseases
=550  \\$aDefecation
=667  \\$aof organic origin: differentiate from ENCOPRESIS, of psychol origin
=680  \\$iFailure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.
=688  \\$a70(66)
=750  \0$aFecal incontinence$5IEN$0(DLC)sh 85047545

=LDR  00957cz  a2200265n  4500
=001  9880363526402441
=005  20141212201357.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005240
=035  \\$aCAZ8385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x550
=072  \\$aE5.$x337.$x675
=072  \\$aN5.$x715.$x360.$x775.$x350
=072  \\$aN6.$x850.$x520.$x450.$x550
=150  \\$aFeasibility Studies
=450  \\$wnnna$aFeasibility Study
=450  \\$wnnna$aStudies, Feasibility
=450  \\$wnnna$aStudy, Feasibility
=550  \\$wg$aEpidemiologic Study Characteristics as Topic
=550  \\$wg$aEvaluation Studies as Topic
=667  \\$aIM general only; coordinate NIM with specific subject (IM)
=680  \\$iStudies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.
=688  \\$a80
=750  \0$aFeasibility studies$5IEN$0(DLC)sh 85047526

=LDR  00609cz  a2200205n  4500
=001  9880363526502441
=005  20141212201357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005239
=035  \\$aCAZ8384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x361
=150  \\$aFear
=450  \\$wnnna$aFears
=550  \\$wg$aEmotions
=550  \\$wh$aDental Anxiety
=550  \\$wh$aPanic
=667  \\$ahuman & animal
=680  \\$iThe affective response to an actual current external danger which subsides with the elimination of the threatening condition.
=750  \0$aFear$5IEN$0(DLC)sh 85047514

=LDR  00979cz  a2200265n  4500
=001  9880363526602441
=005  20141212201357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005236
=035  \\$aCAZ8381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x150.$x480.$x370
=072  \\$aC15.$x378.$x71.$x141.$x370
=072  \\$aC16.$x320.$x70.$x480.$x370
=072  \\$aC25.$x723.$x415.$x341
=072  \\$aC25.$x723.$x756.$x375
=150  \\$aFavism
=450  \\$wnnna$aFavisms
=550  \\$wg$aAnemia, Hemolytic
=550  \\$wg$aFoodborne Diseases
=550  \\$wg$aGlucosephosphate Dehydrogenase Deficiency
=550  \\$wg$aPlant Poisoning
=667  \\$aa hemolytic anemia caused by fava bean or its pollen
=680  \\$iHemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes.
=750  \0$aFavism$5IEN$0(DLC)sh 85047498

=LDR  01282cz  a2200337n  4500
=001  9880363526702441
=005  20141212192210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005234
=035  \\$aCAZ8379HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x241
=150  \\$aFatty Liver
=450  \\$wnnna$aLiver, Fatty
=450  \\$wnnna$aLiver Steatoses
=450  \\$wnnna$aLiver Steatosis
=450  \\$wnnna$aSteatohepatitides
=450  \\$wnnna$aSteatohepatitis
=450  \\$wnnna$aSteatoses, Liver
=450  \\$wnnna$aSteatoses, Visceral
=450  \\$wnnna$aSteatosis, Liver
=450  \\$wnnna$aSteatosis of Liver
=450  \\$wnnna$aSteatosis, Visceral
=450  \\$wnnna$aVisceral Steatoses
=450  \\$wnnna$aVisceral Steatosis
=550  \\$wg$aLiver Diseases
=550  \\$wh$aFatty Liver, Alcoholic
=550  \\$wh$aNon-alcoholic Fatty Liver Disease
=550  \\$wh$aReye Syndrome
=680  \\$iLipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
=750  \0$aFatty liver$5IEN$0(DLC)sh 85047473

=LDR  01179cz  a2200325n  4500
=001  9880363526802441
=005  20201123172828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005233
=035  \\$aCAZ8378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x415
=072  \\$aD10.$x289
=150  \\$aFatty Alcohols
=450  \\$wnnna$aAlcohols, Fatty
=550  \\$wg$aAlcohols
=550  \\$wg$aLipids
=550  \\$wh$aAcetogenins
=550  \\$wh$aButanols
=550  \\$wh$aDodecanol
=550  \\$wh$aDolichols
=550  \\$wh$aFarnesol
=550  \\$wh$aHeptanol
=550  \\$wh$aHexanols
=550  \\$wh$aOctanols
=550  \\$wh$aPentanols
=550  \\$wh$aSodium Tetradecyl Sulfate
=680  \\$iUsually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=688  \\$a72
=750  \0$aFatty alcohols$5IEN$0(DLC)sh 85047472

=LDR  01273cz  a2200385n  4500
=001  9880363526902441
=005  20141212201355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005231
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355
=150  \\$aFatty Acids, Unsaturated
=450  \\$wnnna$aAcids, Polyunsaturated Fatty
=450  \\$wnnna$aAcids, Unsaturated Fatty
=450  \\$aFatty Acids, Polyunsaturated
=450  \\$wnnna$aPolyunsaturated Fatty Acids
=450  \\$wnnna$aUnsaturated Fatty Acids
=550  \\$wg$aFatty Acids
=550  \\$wh$aArachidonic Acids
=550  \\$wh$aEicosanoids
=550  \\$wh$aFatty Acids, Essential
=550  \\$wh$aFatty Acids, Monounsaturated
=550  \\$wh$aFatty Acids, Omega-3
=550  \\$wh$aFatty Acids, Omega-6
=550  \\$wh$aGefarnate
=550  \\$wh$aIonomycin
=550  \\$wh$aIsoprostanes
=550  \\$wh$aLinolenic Acids
=550  \\$wh$aOxylipins
=550  \\$wh$aSorbic Acid
=550  \\$wh$aTrans Fatty Acids
=667  \\$aGEN or unspecified; prefer specific groups or specific acid
=680  \\$iFATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.
=688  \\$a73
=750  \0$aUnsaturated fatty acids$5IEN$0(DLC)sh 85141196

=LDR  00814cz  a2200229n  4500
=001  9880363527002441
=005  20141212201354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005228
=035  \\$aCAZ8373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x310
=150  \\$aFatty Acids, Essential
=450  \\$wnnna$aAcids, Essential Fatty
=450  \\$wnnna$aEssential Fatty Acids
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wh$aArachidonic Acids
=550  \\$wh$aLinoleic Acids
=550  \\$wh$aLinolenic Acids
=667  \\$aGEN or unspecified; prefer specific groups or specific acid
=680  \\$iLong chain organic acid molecules that must be obtained from the diet. Examples are LINOLEIC ACIDS and LINOLENIC ACIDS.
=750  \0$aEssential fatty acids$5IEN$0(DLC)sh 85143990

=LDR  01671cz  a2200481n  4500
=001  9880363527102441
=005  20141212201354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251
=150  \\$aFatty Acids
=450  \\$wnnna$aAcids, Aliphatic
=450  \\$wnnna$aAcids, Esterified Fatty
=450  \\$wnnna$aAcids, Fatty
=450  \\$wnnna$aAcids, Saturated Fatty
=450  \\$wnnna$aAliphatic Acids
=450  \\$wnnna$aEsterified Fatty Acids
=450  \\$aFatty Acids, Esterified
=450  \\$aFatty Acids, Saturated
=450  \\$wnnna$aSaturated Fatty Acids
=550  \\$wg$aLipids
=550  \\$wh$aCaprylates
=550  \\$wh$aDecanoic Acids
=550  \\$wh$aEicosanoic Acids
=550  \\$wh$aEndocannabinoids
=550  \\$wh$aFatty Acids, Nonesterified
=550  \\$wh$aFatty Acids, Unsaturated
=550  \\$wh$aFatty Acids, Volatile
=550  \\$wh$aHeptanoic Acids
=550  \\$wh$aLauric Acids
=550  \\$wh$aMupirocin
=550  \\$wh$aMycolic Acids
=550  \\$wh$aMycophenolic Acid
=550  \\$wh$aMyristic Acids
=550  \\$wh$aPalmitic Acids
=550  \\$wh$aProstanoic Acids
=550  \\$wh$aSodium Morrhuate
=550  \\$wh$aStearic Acids
=550  \\$wh$aThioctic Acid
=680  \\$iOrganic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a/metabolism was FATTY ACID METABOLISM 1965
=750  \0$aFatty acids$5IEN$0(DLC)sh 85000535

=LDR  01212cz  a2200217n  4500
=001  9880363527202441
=005  20141212201353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212
=150  \\$aFats
=550  \\$wg$aLipids
=550  \\$wh$aDietary Fats
=550  \\$wh$aFats, Unsaturated
=550  \\$aLipids
=667  \\$atable fats only or fats "outside the body"; differentiate from LIPIDS ("inside the body" but not body fat which = ADIPOSE TISSUE); do not confuse with DIETARY FATS
=680  \\$iThe glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet (DIETARY FATS) as a source of energy. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65
=750  \0$aOils and fats$5IEN-M$0(DLC)sh 85094407
=750  \0$aFat$5IEN-HS$0(DLC)sh 85047430

=LDR  00753cz  a2200229n  4500
=001  9880363527302441
=005  20180208142413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005222
=035  \\$aCAZ8367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x369.$x500
=072  \\$aF1.$x145.$x126.$x937
=150  \\$aMental Fatigue
=450  \\$aFatigue, Mental
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aFatigue
=550  \\$wh$aAlert Fatigue, Health Personnel
=550  \\$wh$aCompassion Fatigue
=680  \\$iA condition of low alertness or cognitive impairment, usually associated with prolonged mental activities or stress.
=688  \\$a95; was FATIGUE, MENTAL 1963-94
=750  \0$aMental fatigue$5IEN$0(DLC)sh 85047466

=LDR  00771cz  a2200217n  4500
=001  9880363527402441
=005  20141212201353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005221
=035  \\$aCAZ8366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x369
=150  \\$aFatigue
=450  \\$aLassitude
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aMental Fatigue
=550  \\$aAsthenia
=550  \\$aPhysical Exertion
=667  \\$ado not use for fatigue of isolated muscle fibers in physiol exper ( = MUSCLE FATIGUE)
=680  \\$iThe state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
=750  \0$aFatigue$5IEN$0(DLC)sh 85047465

=LDR  00632cz  a2200217n  4500
=001  9880363527502441
=005  20141212192210.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005220
=035  \\$aCAZ8365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x500.$x320.$x100
=072  \\$aI1.$x880.$x853.$x150.$x500.$x340.$x210
=072  \\$aM1.$x620.$x390
=150  \\$aFathers
=450  \\$wnnna$aFather
=550  \\$wg$aParents
=667  \\$ahuman & animal; /psychol: consider also FATHER-CHILD RELATIONS
=680  \\$iMale parents, human or animal.
=688  \\$a78
=750  \0$aFathers$5IEN$0(DLC)sh 85047451

=LDR  00967cz  a2200289n  4500
=001  9880363527602441
=005  20141212201352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005219
=035  \\$aCAZ8364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x290.$x110
=150  \\$aFather-Child Relations
=450  \\$wnnna$aFather-Child Relation
=450  \\$wnnna$aFather Child Relations
=450  \\$wnnna$aFather-Child Relationship
=450  \\$wnnna$aFather Child Relationship
=450  \\$wnnna$aFather-Child Relationships
=450  \\$wnnna$aRelation, Father-Child
=450  \\$wnnna$aRelations, Father-Child
=450  \\$wnnna$aRelationship, Father-Child
=450  \\$wnnna$aRelationships, Father-Child
=550  \\$wg$aParent-Child Relations
=667  \\$ahuman only; DF: FATHER CHILD RELAT
=680  \\$iInteraction between the father and the child.
=688  \\$a68
=750  \0$aFather and child$5IEN$0(DLC)sh 85047444

=LDR  00698cz  a2200217n  4500
=001  9880363527702441
=005  20141212201352.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005218
=035  \\$aCAZ8363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x717.$x365
=150  \\$aFat Necrosis
=450  \\$wnnna$aFat Necroses
=450  \\$wnnna$aNecrosis, Fat
=450  \\$wnnna$aSteatonecroses
=450  \\$aSteatonecrosis
=550  \\$wg$aNecrosis
=680  \\$iA condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.
=688  \\$a91(77); was see under NECROSIS 1977-90
=750  \0$aFat necrosis$5IEN$0(DLC)sh 85047434

=LDR  01022cz  a2200301n  4500
=001  9880363527802441
=005  20141212192209.0
=008  771209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005217
=035  \\$aCAZ8362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x165.$x260.$x270
=072  \\$aD26.$x776.$x708.$x733.$x500
=072  \\$aD27.$x505.$x954.$x578.$x733.$x500
=072  \\$aD27.$x720.$x752.$x733.$x500
=150  \\$aFat Emulsions, Intravenous
=450  \\$wnnna$aEmulsions, Intravenous Fat
=450  \\$wnnna$aEmulsions, Intravenous Lipid
=450  \\$wnnna$aIntravenous Fat Emulsions
=450  \\$wnnna$aIntravenous Lipid Emulsions
=450  \\$aLipid Emulsions, Intravenous
=550  \\$wg$aEmulsions
=550  \\$wg$aParenteral Nutrition Solutions
=550  \\$aParenteral Nutrition
=667  \\$acoordinate with disease /ther
=680  \\$iEmulsions of fats or lipids used primarily in parenteral feeding.
=688  \\$a79
=750  \0$aFat emulsions, Intravenous$5IEN$0(DLC)sh 85047432

=LDR  00624cz  a2200205n  4500
=001  9880363527902441
=005  20141212201352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005215
=035  \\$aCAZ8360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x400
=072  \\$aG7.$x610.$x240.$x587
=150  \\$aFasting
=550  \\$wg$aDiet
=550  \\$wg$aFeeding Behavior
=550  \\$aFood Deprivation
=667  \\$ahuman & animal; differs from STARVATION in matter of degree: TN 80; FOOD DEPRIVATION is also available
=680  \\$iAbstaining from all food.
=750  \0$aFasting$5IEN$0(DLC)sh 85047403

=LDR  00696cz  a2200217n  4500
=001  9880363528002441
=005  20141212201351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005214
=035  \\$aCAZ8359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x645.$x368
=150  \\$aFast Neutrons
=450  \\$wnnna$aFast Neutron
=450  \\$wnnna$aNeutron, Fast
=450  \\$wnnna$aNeutrons, Fast
=550  \\$wg$aNeutrons
=667  \\$aelementary particles; IM
=680  \\$iNeutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts.
=688  \\$a91(71); was see under NEUTRONS 1971-90
=750  \0$aFast neutrons$5IEN$0(DLC)sh 85047395

=LDR  01117cz  a2200241n  4500
=001  9880363528102441
=005  20141212201351.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005212
=035  \\$aCAZ8357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x408
=150  \\$aFasciolidae
=450  \\$wnnna$aFascioloide
=450  \\$aFascioloides
=450  \\$wnnna$aFasciolopses
=450  \\$aFasciolopsis
=550  \\$wg$aTrematoda
=550  \\$wh$aFasciola
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM) but note specific FASCIOL- disease terms; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man.
=688  \\$a82; FASCIOLOPSIS was heading 1963-81
=750  \0$aFasciolidae$5IEN$0(DLC)sh 88021743

=LDR  00824cz  a2200217n  4500
=001  9880363528202441
=005  20141212201351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005211
=035  \\$aCAZ8356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x354
=072  \\$aC3.$x518.$x424
=072  \\$aC6.$x552.$x664.$x424
=150  \\$aFascioliasis
=450  \\$wnnna$aFascioliases
=550  \\$wg$aLiver Diseases, Parasitic
=550  \\$wg$aTrematode Infections
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; do not confuse with FASCIOLOIDIASIS (caused by Fascioloides) or FASCIOLOPSIASIS (caused by Fasciolopsis)
=680  \\$iLiver disease caused by infections with parasitic flukes of the genus FASCIOLA, such as FASCIOLA HEPATICA.
=750  \0$aFascioliasis$5IEN$0(DLC)sh 98005704

=LDR  01188cz  a2200253n  4500
=001  9880363528302441
=005  20141212201350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005210
=035  \\$aCAZ8355M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x408.$x380.$x420
=150  \\$aFasciola hepatica
=450  \\$wnnna$aFasciola hepaticas
=450  \\$wnnna$aFluke, Liver
=450  \\$wnnna$aFlukes, Liver
=450  \\$wnnna$ahepatica, Fasciola
=450  \\$wnnna$ahepaticas, Fasciola
=450  \\$aLiver Fluke
=450  \\$wnnna$aLiver Flukes
=550  \\$wg$aFasciola
=667  \\$ainfection = FASCIOLIASIS & do not bother to coord with FASCIOLA HEPATICA unless particularly discussed (index IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle.
=750  \0$aFasciola hepatica$5IEN$0(DLC)sh 98005705

=LDR  00872cz  a2200193n  4500
=001  9880363528402441
=005  20141212201350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005209
=035  \\$aCAZ8354M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x408.$x380
=150  \\$aFasciola
=450  \\$wnnna$aFasciolas
=550  \\$wg$aFasciolidae
=550  \\$wh$aFasciola hepatica
=667  \\$ainfection = FASCIOLIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.
=750  \0$aFasciola$5IEN$0(DLC)sh 98005700

=LDR  01463cz  a2200241n  4500
=001  9880363528502441
=005  20141212201350.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005208
=035  \\$aCAZ8353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x321
=150  \\$aFasciitis
=450  \\$wnnna$aFasciitides
=450  \\$wnnna$aFascitides
=450  \\$wnnna$aFascitis
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aFasciitis, Necrotizing
=550  \\$wh$aFasciitis, Plantar
=667  \\$asee MeSH definition for major types; eosinophilic fasciitis: coord IM with EOSINOPHILIA (IM); FASCIITIS, NECROTIZING is available
=680  \\$iInflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.
=688  \\$a81
=750  \0$aFasciae (Anatomy)$xInflammation$5IEN-M$0(DLC)sh 85047353

=LDR  00466cz  a2200181n  4500
=001  9880363528602441
=005  20141212201349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005205
=035  \\$aCAZ8350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x340
=150  \\$aFascia
=450  \\$wnnna$aFascias
=550  \\$wg$aMusculoskeletal System
=550  \\$wh$aFascia Lata
=550  \\$wh$aTenon Capsule
=750  \0$aFasciae (Anatomy)$5IEN$0(DLC)sh 85047352

=LDR  01201cz  a2200301n  4500
=001  9880363528702441
=005  20141212201348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005203
=035  \\$aCAZ8348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x125.$x365
=072  \\$aC8.$x674.$x55.$x365
=072  \\$aC20.$x543.$x480.$x680.$x75.$x365
=072  \\$aC24.$x80.$x365
=150  \\$aFarmer's Lung
=450  \\$wnnna$aFarmer Lung
=450  \\$wnnna$aFarmers Lung
=450  \\$wnnna$aFarmer's Lungs
=450  \\$wnnna$aMushroom Worker Lung
=450  \\$aMushroom Worker's Lung
=450  \\$wnnna$aMushroom Workers Lung
=450  \\$wnnna$aMushroom Worker's Lungs
=550  \\$wg$aAgricultural Workers' Diseases
=550  \\$wg$aAlveolitis, Extrinsic Allergic
=680  \\$iA form of alveolitis or pneumonitis due to an acquired hypersensitivity to inhaled antigens associated with farm environment. Antigens in the farm dust are commonly from bacteria actinomycetes (SACCHAROPOLYSPORA and THERMOACTINOMYCES), fungi, and animal proteins in the soil, straw, crops, pelts, serum, and excreta.
=688  \\$a65(63)
=750  \0$aFarmer's lung$5IEN$0(DLC)sh 85047289

=LDR  00829cz  a2200289n  4500
=001  9880363528802441
=005  20141212201347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005201
=035  \\$aCAZ8346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x351
=072  \\$aF2.$x463.$x188.$x634.$x507
=150  \\$aFantasy
=450  \\$wnnna$aDay Dream
=450  \\$aDay Dreams
=450  \\$wnnna$aDaydream
=450  \\$wnnna$aDaydreams
=450  \\$wnnna$aDream, Day
=450  \\$wnnna$aDreams, Day
=450  \\$wnnna$aFantasies
=550  \\$wg$aDefense Mechanisms
=550  \\$wg$aImagination
=667  \\$ano qualif
=680  \\$iAn imagined sequence of events or mental images, e.g., daydreams.
=688  \\$a68; DAY DREAMS was see under FANTASY 1968-78
=750  \0$aFantasy$5IEN$0(DLC)sh 85047157

=LDR  01646cz  a2200325n  4500
=001  9880363528902441
=005  20141212201347.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005199
=035  \\$aCAZ8344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x85.$x80.$x280
=072  \\$aC15.$x378.$x190.$x196.$x80.$x280
=072  \\$aC16.$x320.$x77.$x280
=072  \\$aC18.$x452.$x284.$x280
=150  \\$aFanconi Anemia
=450  \\$aAnemia, Fanconi
=450  \\$wnnna$aAnemia, Fanconi's
=450  \\$wnnna$aAnemias, Fanconi
=450  \\$wnnna$aFanconi Anemias
=450  \\$wnnna$aFanconi Hypoplastic Anemia
=450  \\$wnnna$aFanconi Pancytopenia
=450  \\$wnnna$aFanconi Panmyelopathy
=450  \\$wnnna$aFanconi's Anemia
=550  \\$wg$aAnemia, Hypoplastic, Congenital
=550  \\$wg$aDNA Repair-Deficiency Disorders
=667  \\$ado not confuse with FANCONI SYNDROME, a dysfunction of proximal renal tubules
=680  \\$iCongenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)
=688  \\$a2002(1975); was see under ANEMIA, APLASTIC 1975-1990
=750  \0$aFanconi's anemia$0(DLC) sh 88007051$5IEN-M

=LDR  00661cz  a2200229n  4500
=001  9880363529002441
=005  20141212201345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005197
=035  \\$aCAZ8342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x211.$x506
=072  \\$aM1.$x228
=150  \\$aFamous Persons
=450  \\$aCelebrities$5IEN
=450  \\$wnnna$aFamous Person
=450  \\$wnnna$aPerson, Famous
=450  \\$wnnna$aPersons, Famous
=550  \\$wg$aBiography as Topic
=550  \\$wg$aPersons
=667  \\$aIM; no qualif; Manual 32.16.11, 32.16.12; when not to use: 32.16.7
=750  \0$aCelebrities$5IEN$0(DLC)sh 85021618

=LDR  00786cz  a2200229n  4500
=001  9880363529102441
=005  20141212201345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005196
=035  \\$aCAZ8341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x581.$x273
=150  \\$aFamily Therapy
=450  \\$aFamily Psychotherapy$5IEN
=450  \\$wnnna$aFamily Therapies
=450  \\$wnnna$aTherapies, Family
=450  \\$wnnna$aTherapy, Family
=550  \\$wg$aPsychotherapy, Group
=667  \\$aa group psychother technique; DF: FAMILY THER
=680  \\$iA form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session.
=688  \\$a68(65)
=750  \0$aFamily psychotherapy$5IEN$0(DLC)sh 85047061

=LDR  00808cz  a2200217n  4500
=001  9880363529202441
=005  20141212201344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005194
=035  \\$aCAZ8339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x340.$x500
=150  \\$aFamily Practice
=450  \\$aFamily Medicine$5IEN
=450  \\$wnnna$aFamily Practices
=450  \\$wnnna$aPractice, Family
=450  \\$wnnna$aPractices, Family
=550  \\$wg$aGeneral Practice
=680  \\$iA medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.
=688  \\$a78; was see under GENERAL PRACTICE 1975-77, was see GENERAL PRACTICE 1969-74; GENERAL PRACTICE was heading 1963-77
=750  \0$aFamily medicine$5IEN$0(DLC)sh 85047057

=LDR  01023cz  a2200241n  4500
=001  9880364074602441
=005  20141212212939.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019043
=035  \\$aCSK5846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x839.$x750
=072  \\$aC14.$x907.$x936
=150  \\$aVascular Neoplasms
=450  \\$wnnna$aNeoplasm, Vascular
=450  \\$wnnna$aNeoplasms, Vascular
=450  \\$wnnna$aVascular Neoplasm
=550  \\$wg$aSoft Tissue Neoplasms
=550  \\$wg$aVascular Diseases
=667  \\$ado not confuse with NEOPLASMS, VASCULAR TISSUE, neoplasms composed of vascular tissue; coordinate IM with specific vessel (IM) + histologic type of neoplasm (IM); DF: VASCULAR NEOPL
=680  \\$iNeoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.
=688  \\$a96
=750  \0$aBlood-vessels$xTumors$5IEN-M$0(DLC)sh 85015030

=LDR  01166cz  a2200265n  4500
=001  9880364074702441
=005  20141212212940.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019046
=035  \\$aCSK5845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x448.$x200
=072  \\$aC15.$x378.$x190.$x250
=072  \\$aC15.$x378.$x400.$x200
=150  \\$aBone Marrow Neoplasms
=450  \\$wnnna$aBone Marrow Neoplasm
=450  \\$wnnna$aNeoplasm, Bone Marrow
=450  \\$wnnna$aNeoplasms, Bone Marrow
=550  \\$wg$aBone Marrow Diseases
=550  \\$wg$aHematologic Neoplasms
=667  \\$aneopl located in bone marrow: do not confuse with neopl composed of bone marrow cells (like myeloma); /blood supply /chem /secret /second /ultrastruct permitted; coord IM with histol type of neopl (IM): DF: BONE MARROW NEOPL
=680  \\$iNeoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
=688  \\$a96
=750  \0$aBone marrow$xCancer$5IEN-M$0(DLC)sh2010008296
=750  \0$aBone marrow$xTumors$5IEN-HS$0(DLC)sh 85081544

=LDR  01374cz  a2200265n  4500
=001  9880364074802441
=005  20141212192843.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019024
=035  \\$aCSK5840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x552.$x53
=150  \\$aBarber Surgeons
=450  \\$wnnna$aBarber Surgeon
=450  \\$wnnna$aSurgeon, Barber
=450  \\$wnnna$aSurgeons, Barber
=550  \\$wg$aHistory of Medicine
=550  \\$aBarbering
=550  \\$aGeneral Surgery
=550  \\$aSurgeons
=680  \\$iIn the late Middle Ages barbers who also let blood, sold unguents, pulled teeth, applied cups, and gave enemas. They generally had the right to practice surgery. They began to acquire importance about 1100, when the monks, who required the barber's services for the tonsure, also had recourse to them for blood-letting, a practice required by ecclesiastic law. By the 18th century barbers continued to practice minor surgery and dentistry and many famous surgeons acquired their skill in the shops of barbers. (From Castiglioni, A History of Medicine, 2d ed, pp402, 568, 658)
=688  \\$a96
=750  \0$81$wb$aBarbers$5IEN-M$0(DLC)sh 85011797
=750  \0$81$wb$aSurgeons$5IEN-HS$0(DLC)sh 85130761
=788  \2$iSearch also under the following headings used together in the same record:$aBarbers$iand$aSurgeons$5IEN-M

=LDR  01459cz  a2200337n  4500
=001  9880364074902441
=005  20141212212956.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019075
=035  \\$aCSK5839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x190
=072  \\$aE5.$x301.$x300.$x190
=150  \\$aElectrophoresis, Capillary
=450  \\$wnnna$aCapillary Electrophoreses
=450  \\$wnnna$aCapillary Electrophoresis
=450  \\$wnnna$aCapillary Zone Electrophoreses
=450  \\$wnnna$aCapillary Zone Electrophoresis
=450  \\$wnnna$aElectrophoreses, Capillary
=450  \\$wnnna$aElectrophoreses, Capillary Zone
=450  \\$wnnna$aElectrophoresis, Capillary Zone
=450  \\$wnnna$aZone Electrophoreses, Capillary
=450  \\$wnnna$aZone Electrophoresis, Capillary
=550  \\$wg$aElectrophoresis
=550  \\$wh$aCapillary Electrochromatography
=550  \\$wh$aElectrophoresis, Microchip
=550  \\$aChromatography, Micellar Electrokinetic Capillary
=667  \\$acapillary refers to the size of the chambers used for the electrophoresis; NIM
=680  \\$iA highly-sensitive (in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis) and efficient technique that allows separation of PROTEINS; NUCLEIC ACIDS; and CARBOHYDRATES. (Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a96
=750  \0$aCapillary electrophoresis$0(DLC) sh 90002644$5IEN-M

=LDR  00858cz  a2200265n  4500
=001  9880364075002441
=005  20141212212956.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019076
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x825
=150  \\$aTransgenes
=450  \\$wnnna$aRecombinant Transgene
=450  \\$wnnna$aRecombinant Transgenes
=450  \\$wnnna$aTransgene
=450  \\$wnnna$aTransgene, Recombinant
=450  \\$wnnna$aTransgenes, Recombinant
=550  \\$wg$aGenes
=550  \\$wh$aGenes, Transgenic, Suicide
=550  \\$aAnimals, Genetically Modified
=550  \\$aOrganisms, Genetically Modified
=550  \\$aPlants, Genetically Modified
=680  \\$iGenes that are introduced into an organism using GENE TRANSFER TECHNIQUES.
=688  \\$a96
=750  \0$aTransgenes$5IEN-M$0(DLC)sh 99010678

=LDR  01118cz  a2200289n  4500
=001  9880364075102441
=005  20141212213003.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019087
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x200.$x700
=072  \\$aD12.$x776.$x503.$x843
=072  \\$aD12.$x776.$x543.$x550.$x200.$x700
=072  \\$aD23.$x50.$x301.$x264.$x35.$x912
=072  \\$aD23.$x50.$x301.$x350.$x700
=072  \\$aD23.$x101.$x100.$x110.$x918
=150  \\$aSelectins
=550  \\$wg$aAntigens, CD
=550  \\$wg$aCell Adhesion Molecules
=550  \\$wg$aLectins
=550  \\$wh$aE-Selectin
=550  \\$wh$aL-Selectin
=550  \\$wh$aP-Selectin
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iTransmembrane proteins consisting of a lectin-like domain, an epidermal growth factor-like domain, and a variable number of domains that are homologous to complement regulatory proteins. They are important cell adhesion molecules which help LEUKOCYTES attach to VASCULAR ENDOTHELIUM.
=688  \\$a96
=750  \0$aSelectins$5IEN-M$0(DLC)sh2003001138

=LDR  01432cz  a2200289n  4500
=001  9880364075202441
=005  20141212212930.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019033
=035  \\$aCSK5828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x374.$x142
=072  \\$aN5.$x300.$x262
=150  \\$aDelivery of Health Care, Integrated
=450  \\$wnnna$aDelivery System, Integrated
=450  \\$wnnna$aDelivery Systems, Integrated
=450  \\$wnnna$aIntegrated Delivery System
=450  \\$aIntegrated Delivery Systems
=450  \\$aIntegrated Health Care Systems
=450  \\$wnnna$aSystem, Integrated Delivery
=450  \\$wnnna$aSystems, Integrated Delivery
=550  \\$wg$aDelivery of Health Care
=550  \\$wh$aProvider-Sponsored Organizations
=667  \\$aspecify geog if pertinent
=680  \\$iA health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. (Coddington et al., Integrated Health Care: Reorganizing the Physician, Hospital and Health Plan Relationship, 1994, p7)
=688  \\$a96
=750  \0$aIntegrated delivery of health care$5IEN-M$0(DLC)sh 96000871

=LDR  01228cz  a2200313n  4500
=001  9880364075302441
=005  20141212212944.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019052
=035  \\$aCSK5827HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x844.$x253
=072  \\$aF3.$x600.$x300.$x350
=150  \\$aDepression, Postpartum
=450  \\$wnnna$aDepression, Post-Natal
=450  \\$wnnna$aDepression, Post-Partum
=450  \\$wnnna$aDepression, Postnatal
=450  \\$wnnna$aPost-Natal Depression
=450  \\$wnnna$aPost Natal Depression
=450  \\$wnnna$aPost-Partum Depression
=450  \\$wnnna$aPost Partum Depression
=450  \\$aPostnatal Depression
=450  \\$aPostpartum Depression
=550  \\$wg$aDepressive Disorder
=550  \\$wg$aPuerperal Disorders
=667  \\$acoordinate IM with specific psychiatric disease (IM) if relevant; check the tag FEMALE
=680  \\$iDepression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)
=688  \\$a96
=750  \0$aPostpartum depression$5IEN-M$0(DLC)sh 85105565

=LDR  00988cz  a2200229n  4500
=001  9880364075402441
=005  20141212212943.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019050
=035  \\$aCSK5826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x599.$x750.$x500
=072  \\$aE2.$x779.$x867.$x880.$x500
=150  \\$aAcupressure
=450  \\$aChih Ya
=450  \\$aShiatsu
=450  \\$aShiatzu
=450  \\$aZhi Ya
=550  \\$wg$aTherapy, Soft Tissue
=680  \\$iA type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. Although the anatomical locations are the same as the ACUPUNCTURE POINTS used in ACUPUNCTURE THERAPY (hence acu-), no needle or other acupuncture technique is employed in acupressure. (From Random House Unabridged Dictionary, 2d ed). Shiatsu is a modern outgrowth that focuses more on prevention than healing.
=688  \\$a96
=750  \0$aAcupressure$5IEN-M$0(DLC)sh 85000760

=LDR  01147cz  a2200313n  4500
=001  9880364075502441
=005  20141212212614.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018432
=035  \\$aCSK5825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x320.$x300
=150  \\$aDrug Resistance, Multiple
=450  \\$wnnna$aMulti-Drug Resistance
=450  \\$aMultidrug Resistance
=450  \\$wnnna$aMultiple Drug Resistance
=450  \\$wnnna$aResistance, Multiple Drug
=550  \\$wg$aDrug Resistance
=550  \\$wh$aDrug Resistance, Multiple, Bacterial
=550  \\$wh$aDrug Resistance, Multiple, Fungal
=550  \\$wh$aDrug Resistance, Multiple, Viral
=550  \\$aGenes, MDR
=550  \\$aMultidrug Resistance-Associated Proteins
=550  \\$aP-Glycoprotein
=550  \\$aP-Glycoproteins
=667  \\$aDRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, VIRAL; and DRUG RESISTANCE, MULTIPLE, FUNGAL are also available
=680  \\$iSimultaneous resistance to several structurally and functionally distinct drugs.
=688  \\$a95
=750  \0$aMultidrug resistance$0(DLC) sh 90005206$5IEN-M

=LDR  00941cz  a2200253n  4500
=001  9880364075602441
=005  20141212212804.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018793
=035  \\$aCSK5824M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x513
=072  \\$aD12.$x776.$x467.$x374.$x465.$x513
=072  \\$aD23.$x529.$x374.$x465.$x513
=150  \\$aInterleukin-13
=450  \\$wnnna$aIL 13
=450  \\$aIL-13
=450  \\$wnnna$aIL13
=450  \\$wnnna$aInterleukin 13
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 13 or IL13
=680  \\$iA cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses.
=688  \\$a95; was INTERLEUKIN 13 (NM) 1993-94
=750  \0$aInterleukin-13$0(DLC) sh2003010926$5IEN-M

=LDR  01504cz  a2200373n  4500
=001  9880364075702441
=005  20141212212728.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018664
=035  \\$aCSK5823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x512
=072  \\$aD12.$x776.$x467.$x374.$x465.$x512
=072  \\$aD23.$x529.$x374.$x465.$x512
=150  \\$aInterleukin-12
=450  \\$wnnna$aCytotoxic Lymphocyte Maturation Factor
=450  \\$aEdodekin Alfa
=450  \\$wnnna$aIL 12
=450  \\$aIL-12
=450  \\$wnnna$aIL-12 p70
=450  \\$wnnna$aIL12
=450  \\$wnnna$aInterleukin 12
=450  \\$wnnna$aInterleukin-12 p70
=450  \\$wnnna$aInterleukin 12 p70
=450  \\$aNatural Killer Cell Stimulatory Factor
=450  \\$wnnna$ap70, Interleukin-12
=550  \\$wg$aInterleukins
=550  \\$wh$aInterleukin-12 Subunit p35
=550  \\$wh$aInterleukin-12 Subunit p40
=667  \\$aDF: IL 12 or IL12
=680  \\$iA heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS.
=688  \\$a1995(1995)
=688  \\$a95; was INTERLEUKIN 12 (NM) 1991-94
=750  \0$aInterleukin-12$0(DLC) sh 96009262$5IEN-M

=LDR  00845cz  a2200253n  4500
=001  9880364075802441
=005  20141212212751.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x283.$x170
=072  \\$aD13.$x444.$x308.$x435.$x275
=150  \\$aDNA, Chloroplast
=450  \\$aChloroplast DNA
=450  \\$wnnna$aChloroplast DNAs
=450  \\$wnnna$aDNAs, Chloroplast
=550  \\$wg$aDNA, Circular
=550  \\$wg$aDNA, Plant
=550  \\$aExtrachromosomal Inheritance
=550  \\$aGenes, Chloroplast
=667  \\$aIM; coord with PLANTS; ALGAE; or specific plant or alga IM; /drug eff /ultrastruct permitted
=680  \\$iDeoxyribonucleic acid that makes up the genetic material of CHLOROPLASTS.
=688  \\$a95
=750  \0$aChloroplast DNA$0sh2003004668$5IEN-M

=LDR  01282cz  a2200301n  4500
=001  9880364076002441
=005  20141212212923.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019015
=035  \\$aCSK5810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x330
=072  \\$aG16.$x500.$x320
=150  \\$aGeologic Sediments
=450  \\$wnnna$aGeologic Sediment
=450  \\$wnnna$aMarine Sediment
=450  \\$wnnna$aMarine Sediments
=450  \\$wnnna$aSediment, Geologic
=450  \\$wnnna$aSediment, Marine
=450  \\$aSediments, Geologic
=450  \\$aSediments, Marine
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aGeological Phenomena
=550  \\$aSeawater
=667  \\$aDF: GEOL SEDIMENTS
=680  \\$iA mass of organic or inorganic solid fragmented material, or the solid fragment itself, that comes from the weathering of rock and is carried by, suspended in, or dropped by air, water, or ice. It refers also to a mass that is accumulated by any other natural agent and that forms in layers on the earth's surface, such as sand, gravel, silt, mud, fill, or loess. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1689)
=688  \\$a96
=750  \0$aSediments (Geology)$5IEN-M$0(DLC)sh 85119509

=LDR  01038cz  a2200241n  4500
=001  9880364076102441
=005  20141212212849.0
=008  950217\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018928
=035  \\$aCSK5808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x573
=150  \\$aImmunity, Mucosal
=450  \\$aImmune Response, Mucosal
=450  \\$wnnna$aImmune Responses, Mucosal
=450  \\$wnnna$aMucosal Immune Response
=450  \\$wnnna$aMucosal Immune Responses
=450  \\$aMucosal Immunity
=550  \\$wg$aImmunity
=667  \\$aIM general only, NIM with specific disease /immunol (IM)
=680  \\$iNonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
=688  \\$a96
=750  \0$aMucous membrane$xImmunology$5IEN-M

=LDR  01948cz  a2200493n  4500
=001  9880364076202441
=005  20141212192840.0
=008  950217\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018891
=035  \\$aCSK5807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x405.$x200
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x345.$x200
=150  \\$aDentate Gyrus
=450  \\$wnnna$aArea Dentata
=450  \\$wnnna$aArea Dentatas
=450  \\$wnnna$aCA4 Field, Hippocampal
=450  \\$wnnna$aCA4 Field of Hippocampal Formation
=450  \\$wnnna$aCA4, Hippocampal Sector
=450  \\$wnnna$aCA4 of Lorente de No
=450  \\$wnnna$aCA4 Region, Hippocampal
=450  \\$wnnna$aCornu Ammonis 4 Area
=450  \\$wnnna$aDentata, Area
=450  \\$wnnna$aDentata, Fascia
=450  \\$wnnna$aDentatas, Area
=450  \\$aDentate Fascia
=450  \\$aFascia Dentata
=450  \\$wnnna$aFascia, Dentate
=450  \\$wnnna$aField, Hippocampal CA4
=450  \\$wnnna$aGyrus, Dentate
=450  \\$aGyrus Dentatus
=450  \\$wnnna$aHilus Gyri Dentati
=450  \\$wnnna$aHilus of Dentate Gyrus
=450  \\$wnnna$aHilus of the Fascia Dentata
=450  \\$wnnna$aHippocampal CA4 Field
=450  \\$wnnna$aHippocampal CA4 Region
=450  \\$wnnna$aHippocampal Sector CA4
=450  \\$wnnna$aRegion, Hippocampal CA4
=450  \\$wnnna$aSector CA4, Hippocampal
=550  \\$wg$aHippocampus
=550  \\$wh$aMossy Fibers, Hippocampal
=680  \\$iGRAY MATTER situated above the GYRUS HIPPOCAMPI. It is composed of three layers. The molecular layer is continuous with the HIPPOCAMPUS in the hippocampal fissure. The granular layer consists of closely arranged spherical or oval neurons, called GRANULE CELLS, whose AXONS pass through the polymorphic layer ending on the DENDRITES of PYRAMIDAL CELLS in the hippocampus.
=688  \\$a1996
=750  \0$aDentate gyrus$0(DLC) sh 92002557$5IEN-M

=LDR  00896cz  a2200229n  4500
=001  9880364076302441
=005  20141212212906.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018978
=035  \\$aCSK5806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x550.$x750
=150  \\$aMolting
=450  \\$wnnna$aEcdyses
=450  \\$aEcdysis
=450  \\$wnnna$aMoltings
=450  \\$wnnna$aMoulting
=450  \\$wnnna$aMoultings
=550  \\$wg$aMetamorphosis, Biological
=680  \\$iPeriodic casting off FEATHERS; HAIR; or cuticle. Molting is a process of sloughing or desquamation, especially the shedding of an outer covering and the development of a new one. This phenomenon permits growth in ARTHROPODS, skin renewal in AMPHIBIANS and REPTILES, and the shedding of winter coats in BIRDS and MAMMALS.
=688  \\$a96
=750  \0$aMolting$5IEN-M$0(DLC)sh 85086630

=LDR  00884cz  a2200217n  4500
=001  9880364076402441
=005  20141212212916.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019004
=035  \\$aCSK5800M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x250
=072  \\$aD12.$x776.$x641.$x650.$x250
=150  \\$aGalanin
=450  \\$wnnna$aGalanin (1-29)
=450  \\$wnnna$aGalanin (1-30)
=550  \\$wg$aNeuropeptides
=680  \\$iA neuropeptide of 29-30 amino acids depending on the species. Galanin is widely distributed throughout the BRAIN; SPINAL CORD; and INTESTINES. There are various subtypes of GALANIN RECEPTORS implicating roles of galanin in regulating FOOD INTAKE; pain perception; memory; and other neuroendocrine functions.
=688  \\$a1996 (1984)
=688  \\$a96; was GALANIN (NM) 1984-95
=750  \0$aGalanin$5IEN-M$0(DLC)sh 98007595

=LDR  01134cz  a2200229n  4500
=001  9880364076502441
=005  20141212212652.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018559
=035  \\$aCSK5799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x295
=150  \\$aExobiology
=450  \\$aAstrobiology
=450  \\$aExtraterrestrial Life
=450  \\$wnnna$aLife, Extraterrestrial
=550  \\$wg$aBiology
=550  \\$aExtraterrestrial Environment
=667  \\$athe discipline (education, history, etc) only; may also be used for articles about the possibility of extraterrestrial life
=680  \\$iThe interdisciplinary science that studies evolutionary biology, including the origin and evolution of the major elements required for life, their processing in the interstellar medium and in protostellar systems. This field also includes the study of chemical evolution and the subsequent interactions between evolving biota and planetary evolution as well as the field of biology that deals with the study of extraterrestrial life.
=688  \\$a95
=750  \0$aExobiology$5IEN-M$0(DLC)sh 90004216

=LDR  01034cz  a2200289n  4500
=001  9880364076602441
=005  20141212212628.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018474
=035  \\$aCSK5798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x977
=072  \\$aN6.$x230.$x150.$x440.$x950
=150  \\$aWeightlessness Simulation
=450  \\$aMicrogravity Simulation
=450  \\$aModels, Weightlessness
=450  \\$wnnna$aSimulation, Microgravity
=450  \\$wnnna$aSimulation, Weightlessness
=450  \\$wnnna$aWeightlessness Model
=450  \\$wnnna$aWeightlessness Models
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aSpace Simulation
=550  \\$wh$aHindlimb Suspension
=550  \\$aSpace Simulation
=680  \\$iCondition under normal Earth gravity where the force of gravity itself is not actually altered but its influence or effect may be modified and studied. (From ASGSB Bull 1992;5(2):27)
=688  \\$a95
=750  \0$aWeightlessness simulators$5IEN-M$0(DLC)sh 85145962

=LDR  00849cz  a2200253n  4500
=001  9880364076702441
=005  20141212212906.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018977
=035  \\$aCSK5797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x605
=072  \\$aJ2.$x500.$x631
=150  \\$aMicronutrients
=450  \\$wnnna$aMicronutrient
=550  \\$wg$aFood
=550  \\$wg$aGrowth Substances
=550  \\$wh$aTrace Elements
=550  \\$wh$aVitamins
=550  \\$aTrace Elements
=667  \\$acoord IM with specific micronutrient (IM)
=680  \\$iEssential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.
=688  \\$a96; was see TRACE ELEMENTS 1994-95
=750  \0$aTrace elements in nutrition$5IEN-M$0(DLC)sh 85136391

=LDR  01473cz  a2200289n  4500
=001  9880364076802441
=005  20141212212906.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018979
=035  \\$aCSK5796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x594.$x600
=072  \\$aC10.$x668.$x491.$x562.$x500
=150  \\$aMyositis, Inclusion Body
=450  \\$wnnna$aInclusion Body Myopathy, Sporadic
=450  \\$wnnna$aInclusion Body Myositides
=450  \\$aInclusion Body Myositis
=450  \\$wnnna$aInclusion Body Myositis, Sporadic
=450  \\$aMyopathy, Inclusion Body, Sporadic
=450  \\$wnnna$aMyositides, Inclusion Body
=450  \\$wnnna$aMyositis, Inclusion Body, Sporadic
=450  \\$wnnna$aSporadic Inclusion Body Myositis
=550  \\$wg$aMyositis
=667  \\$ado not coord with INCLUSION BODIES but coord with INCLUSION BODIES, VIRAL if relevant (IM or NIM)
=680  \\$iProgressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
=688  \\$a96
=750  \0$aInclusion body myositis$5IEN-M$0(DLC)sh 96009714

=LDR  00965cz  a2200265n  4500
=001  9880364076902441
=005  20141212212918.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019008
=035  \\$aCSK5795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x320.$x395
=150  \\$aDrug Resistance, Neoplasm
=450  \\$aAntibiotic Resistance, Neoplasm
=450  \\$wnnna$aAntineoplastic Agent Resistance
=450  \\$aAntineoplastic Drug Resistance
=450  \\$aDrug Resistance, Antineoplastic
=450  \\$wnnna$aNeoplasm Drug Resistance
=450  \\$wnnna$aResistance, Antineoplastic Agent
=450  \\$wnnna$aResistance, Antineoplastic Drug
=550  \\$wg$aDrug Resistance
=667  \\$aDF: DRUG RESISTANCE NEOPL
=680  \\$iResistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
=688  \\$a96
=750  \0$aDrug resistance in cancer cells$5IEN-M$0(DLC)sh 90005205

=LDR  01785cz  a2200517n  4500
=001  9880364077002441
=005  20141212212834.0
=008  950524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018884
=035  \\$aCSK5794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400.$x425
=150  \\$aIxodes
=450  \\$wnnna$aBean Tick, Castor
=450  \\$wnnna$aBean Ticks, Castor
=450  \\$aBlack-legged Tick
=450  \\$wnnna$aBlack legged Tick
=450  \\$wnnna$aBlack-legged Ticks
=450  \\$aCastor Bean Tick
=450  \\$wnnna$aCastor Bean Ticks
=450  \\$wnnna$adammini, Ixodes
=450  \\$wnnna$adamminus, Ixodes
=450  \\$aDeer Tick
=450  \\$wnnna$aDeer Ticks
=450  \\$wnnna$aIxode
=450  \\$aIxodes dammini
=450  \\$wnnna$aIxodes damminus
=450  \\$aIxodes persulcatus
=450  \\$aIxodes ricinus
=450  \\$wnnna$aIxodes scapulari
=450  \\$aIxodes scapularis
=450  \\$wnnna$apersulcatus, Ixodes
=450  \\$wnnna$aricinus, Ixodes
=450  \\$wnnna$ascapulari, Ixodes
=450  \\$wnnna$ascapularis, Ixodes
=450  \\$wnnna$aTick, Black-legged
=450  \\$wnnna$aTick, Castor Bean
=450  \\$wnnna$aTick, Deer
=450  \\$wnnna$aTicks, Black-legged
=450  \\$wnnna$aTicks, Castor Bean
=450  \\$wnnna$aTicks, Deer
=550  \\$wg$aIxodidae
=667  \\$ainfestation: coordinate IM with TICK INFESTATIONS (IM)
=680  \\$iThe largest genus of TICKS in the family IXODIDAE, containing over 200 species. Many infest humans and other mammals and several are vectors of diseases such as LYME DISEASE, tick-borne encephalitis (ENCEPHALITIS, TICK-BORNE), and KYASANUR FOREST DISEASE.
=688  \\$a96
=750  \0$aIxodes$5IEN-M$0(DLC)sh 85069142

=LDR  02203cz  a2200469n  4500
=001  9880364077102441
=005  20141212212608.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018408
=035  \\$aCSK5791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x242.$x800
=150  \\$aPatch-Clamp Techniques
=450  \\$wnnna$aPatch-Clamp Technic
=450  \\$wnnna$aPatch-Clamp Technics
=450  \\$wnnna$aPatch Clamp Technics
=450  \\$wnnna$aPatch-Clamp Technique
=450  \\$wnnna$aPatch Clamp Techniques
=450  \\$wnnna$aRecording, Whole-Cell
=450  \\$wnnna$aRecordings, Whole-Cell
=450  \\$wnnna$aTechnic, Patch-Clamp
=450  \\$wnnna$aTechnic, Voltage-Clamp
=450  \\$wnnna$aTechnics, Patch-Clamp
=450  \\$wnnna$aTechnics, Voltage-Clamp
=450  \\$wnnna$aTechnique, Patch-Clamp
=450  \\$wnnna$aTechnique, Voltage-Clamp
=450  \\$wnnna$aTechniques, Patch-Clamp
=450  \\$wnnna$aTechniques, Voltage-Clamp
=450  \\$wnnna$aVoltage-Clamp Technic
=450  \\$wnnna$aVoltage-Clamp Technics
=450  \\$wnnna$aVoltage Clamp Technics
=450  \\$wnnna$aVoltage-Clamp Technique
=450  \\$aVoltage-Clamp Techniques
=450  \\$wnnna$aVoltage Clamp Techniques
=450  \\$aWhole-Cell Recording
=450  \\$wnnna$aWhole Cell Recording
=450  \\$wnnna$aWhole-Cell Recordings
=550  \\$wg$aCytological Techniques
=667  \\$aa cytol technique for removing a tiny patch of plasma membrane; NIM
=680  \\$iAn electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
=688  \\$a95
=750  \0$aPatch-clamp techniques (Electrophysiology)$5IEN-M$0(DLC)sh 95001113

=LDR  01239cz  a2200289n  4500
=001  9880364077202441
=005  20170619091110.0
=008  950106\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018919
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x630
=150  \\$aNeovascularization, Physiologic
=450  \\$aAngiogenesis, Physiologic
=450  \\$wnnna$aAngiogenesis, Physiological
=450  \\$wnnna$aNeovascularization, Physiological
=450  \\$wnnna$aPhysiologic Angiogenesis
=450  \\$wnnna$aPhysiologic Neovascularization
=450  \\$wnnna$aPhysiological Angiogenesis
=450  \\$wnnna$aPhysiological Neovascularization
=550  \\$wg$aCardiovascular Physiological Phenomena
=550  \\$aCollateral Circulation
=550  \\$aNeovascularization, Pathologic
=550  \\$aVascular Remodeling
=667  \\$acoordinate with organ / blood supply; NEOVASCULARIZATION, PATHOLOGIC is also available; do not confuse with COLLATERAL CIRCULATION: circulation through secondary channels after obstruction of a principal vessel
=680  \\$iThe development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process.
=688  \\$a96
=750  \0$aNeovascularization$5IEN$0(DLC)sh 87002299

=LDR  00868cz  a2200253n  4500
=001  9880364077302441
=005  20141212212844.0
=008  950106\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018912
=035  \\$aCSK5785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x754.$x167
=150  \\$aArabs
=450  \\$wnnna$aArab
=450  \\$wnnna$aBedouin
=450  \\$aBedouins
=450  \\$wnnna$aPalestinian
=450  \\$aPalestinians
=550  \\$wg$aEthnic Groups
=550  \\$aIslam
=667  \\$aspecify geog if relevant
=680  \\$iMembers of a Semitic people inhabiting the Arabian peninsula or other countries of the Middle East and North Africa. The term may be used with reference to ancient, medieval, or modern ethnic or cultural groups. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a96
=750  \0$aArabs$5IEN-M$0(DLC)sh 85006349

=LDR  01040cz  a2200325n  4500
=001  9880364077402441
=005  20141212192842.0
=008  950106\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018929
=035  \\$aCSK5782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x223
=072  \\$aE5.$x200.$x500.$x223
=072  \\$aE5.$x242.$x223
=072  \\$aE5.$x481.$x500.$x249
=150  \\$aCell Culture Techniques
=450  \\$wnnna$aCell Culture
=450  \\$wnnna$aCell Culture Technique
=450  \\$wnnna$aCell Cultures
=450  \\$wnnna$aCulture Technique, Cell
=450  \\$wnnna$aCulture Techniques, Cell
=550  \\$wg$aCulture Techniques
=550  \\$wg$aCytological Techniques
=550  \\$wh$aBatch Cell Culture Techniques
=550  \\$wh$aPrimary Cell Culture
=550  \\$aCells, Cultured
=667  \\$anote category: do not confuse with CELLS, CULTURED
=680  \\$iMethods for maintaining or growing CELLS in vitro.
=688  \\$a2005 (1996)
=750  \0$aCell culture$0(DLC) sh 85021642$5IEN-M

=LDR  01401cz  a2200361n  4500
=001  9880364077502441
=005  20141212212848.0
=008  950217\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018925
=035  \\$aCSK5777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x200
=072  \\$aD12.$x776.$x467.$x374.$x200
=072  \\$aD23.$x125.$x300
=072  \\$aD23.$x469.$x200
=072  \\$aD23.$x529.$x374.$x200
=150  \\$aChemokines
=450  \\$aChemotactic Cytokines
=450  \\$aCytokines, Chemotactic
=450  \\$aIntercrines
=550  \\$wg$aChemotactic Factors
=550  \\$wg$aCytokines
=550  \\$wg$aInflammation Mediators
=550  \\$wh$abeta-Thromboglobulin
=550  \\$wh$aChemokines, C
=550  \\$wh$aChemokines, CC
=550  \\$wh$aChemokines, CX3C
=550  \\$wh$aChemokines, CXC
=550  \\$wh$aMacrophage Inflammatory Proteins
=667  \\$aa class of cytokines that attract & activate leukocytes; chemokines stands for CHEMOtactic cytoKINES; GEN or unspecified; prefer specifics
=680  \\$iClass of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.
=688  \\$a96
=750  \0$aChemokines$0sh 94002232$5IEN-M

=LDR  00989cz   2200229n  4500
=001  9880364077602441
=005  20230831174734.0
=008  950222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018966
=035  \\$aCSK5775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x476
=150  \\$aLibrary Materials
=450  \\$wnnna$aLibrary Material
=450  \\$wnnna$aMaterial, Library
=450  \\$wnnna$aMaterials, Library
=550  \\$wg$aCommunications Media
=667  \\$aprint & non-print materials in libraries: not restricted to books
=680  \\$iPrint and non-print materials collected, processed, and stored by libraries. They comprise books, periodicals, pamphlets, reports, microforms, maps, manuscripts, motion pictures, and all other forms of audiovisual records. (Harrod, The Librarians' Glossary, 4th ed, p497)
=688  \\$a96
=750  \0$aLibrary materials$5IEN-M$0(DLC)sh 85076704
=750  \0$iNarrower mapping$aRealia (Library materials)$0(DLC)sh2022007139$4NM$5IEN-M

=LDR  01338cz  a2200385n  4500
=001  9880364077702441
=005  20141212212833.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018882
=035  \\$aCSK5773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x522
=150  \\$aHeat Stress Disorders
=450  \\$wnnna$aCramp, Heat
=450  \\$wnnna$aCramps, Heat
=450  \\$wnnna$aDisorder, Heat Stress
=450  \\$wnnna$aDisorders, Heat Stress
=450  \\$wnnna$aHeat Cramp
=450  \\$aHeat Cramps
=450  \\$wnnna$aHeat Stress Disorder
=450  \\$wnnna$aHeat Stress Syndrome
=450  \\$aHeat Stress Syndromes
=450  \\$wnnna$aStress Disorder, Heat
=450  \\$wnnna$aStress Disorders, Heat
=450  \\$wnnna$aStress Syndrome, Heat
=450  \\$wnnna$aStress Syndromes, Heat
=450  \\$wnnna$aSyndrome, Heat Stress
=450  \\$wnnna$aSyndromes, Heat Stress
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aHeat Exhaustion
=550  \\$wh$aHeat Stroke
=667  \\$ageneral or unspecified; prefer specifics; restrict to humans and vertebrates; not for microorganisms or plants
=680  \\$iA group of conditions that develop due to overexposure or overexertion in excessive environmental heat.
=688  \\$a96
=750  \0$aHeat$xPhysiological effect$5IEN-M$0(DLC)sh 85059765

=LDR  01008cz  a2200241n  4500
=001  9880364077802441
=005  20141212212852.0
=008  950217\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018939
=035  \\$aCSK5771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x313
=072  \\$aK1.$x752.$x712.$x708
=072  \\$aN2.$x421.$x533.$x282
=150  \\$aHolistic Nursing
=450  \\$aNursing, Holistic
=550  \\$wg$aNursing Care
=550  \\$wg$aPhilosophy, Nursing
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC; SPEC qualif; DF: HOLISTIC NURS
=680  \\$iA philosophy of nursing practice that takes into account total patient care, considering the physical, emotional, social, economic, and spiritual needs of patients, their response to their illnesses, and the effect of illness on patients' abilities to meet self-care needs. (From Mosby's Medical, Nursing, & Allied Health Dictionary, 4th ed, p745)
=688  \\$a96
=750  \0$aHolistic nursing$5IEN-M$0(DLC)sh 88002286

=LDR  01070cz  a2200217n  4500
=001  9880364077902441
=005  20141212212857.0
=008  950221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018953
=035  \\$aCSK5770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x599.$x186
=072  \\$aE2.$x779.$x867.$x344
=150  \\$aKinesiology, Applied
=450  \\$wnnna$aApplied Kinesiology
=550  \\$wg$aMusculoskeletal Manipulations
=550  \\$aMovement
=667  \\$aa type of alternative med; do not confuse with KINESIS; KINETICS or KINESTHESIS; DF: KINESIOL APPLIED
=680  \\$iThe study of muscles and the movement of the human body. In holistic medicine it is the balance of movement and the interaction of a person's energy systems. Applied kinesiology is the name given by its inventor, Dr. George Goodheart, to the system of applying muscle testing diagnostically and therapeutically to different aspects of health care. (Thorsons Introductory Guide to Kinesiology, 1992, p13)
=688  \\$a96
=750  \0$aApplied kinesiology$5IEN-M$0(DLC)sh 89003530

=LDR  01013cz  a2200289n  4500
=001  9880364078002441
=005  20141212212606.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018402
=035  \\$aCSK5769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x561.$x650.$x525
=150  \\$aManduca
=450  \\$wnnna$aHornworm, Tobacco
=450  \\$wnnna$aHornworms, Tobacco
=450  \\$aManduca sexta
=450  \\$wnnna$aManduca sextas
=450  \\$wnnna$aManducas
=450  \\$wnnna$asexta, Manduca
=450  \\$wnnna$asextas, Manduca
=450  \\$aTobacco Hornworm
=450  \\$wnnna$aTobacco Hornworms
=550  \\$wg$aMoths
=667  \\$aa genus of moth; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle.
=688  \\$a95
=750  \0$aManduca$5IEN-M$0(DLC)sh 85080468

=LDR  00838cz  a2200193n  4500
=001  9880364078102441
=005  20141212212613.0
=008  940603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018428
=035  \\$aCSK5767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x310
=150  \\$aDrosophilidae
=550  \\$wg$aDiptera
=550  \\$wh$aDrosophila
=667  \\$aa family of Diptera; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity.
=688  \\$a95
=750  \0$aDrosophilidae$0(DLC) sh 85039654$5IEN

=LDR  01262cz  a2200313n  4500
=001  9880364078202441
=005  20141212192835.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018765
=035  \\$aCSK5764M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x437.$x220
=072  \\$aD27.$x505.$x519.$x625.$x150.$x800
=072  \\$aD27.$x505.$x519.$x625.$x600.$x220
=072  \\$aD27.$x505.$x696.$x577.$x150.$x800
=072  \\$aD27.$x505.$x696.$x577.$x600.$x220
=150  \\$aDopamine Uptake Inhibitors
=450  \\$aDopamine Reuptake Inhibitors
=450  \\$wnnna$aInhibitors, Dopamine Reuptake
=450  \\$wnnna$aInhibitors, Dopamine Uptake
=450  \\$wnnna$aReuptake Inhibitors, Dopamine
=450  \\$wnnna$aUptake Inhibitors, Dopamine
=550  \\$wg$aDopamine Agents
=550  \\$wg$aNeurotransmitter Uptake Inhibitors
=550  \\$aAdrenergic Uptake Inhibitors
=667  \\$aGEN or unspecified; prefer specifics; DF: DOPAMINE UPTAKE INHIB
=680  \\$iDrugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.
=688  \\$a95
=750  \0$aDopamine uptake inhibitors$0(DLC)sh2007004830$5IEN-M

=LDR  01440cz  a2200349n  4500
=001  9880364078302441
=005  20141212212656.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018571
=035  \\$aCSK5762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x700.$x650
=072  \\$aE5.$x318.$x650
=072  \\$aN5.$x715.$x360.$x300.$x375.$x625.$x650
=072  \\$aN6.$x850.$x520.$x308.$x250.$x700.$x650
=072  \\$aN6.$x850.$x520.$x699
=072  \\$aN6.$x850.$x780.$x675.$x650
=150  \\$aSentinel Surveillance
=450  \\$wnnna$aEvent, Sentinel Health
=450  \\$wnnna$aEvents, Sentinel Health
=450  \\$wnnna$aHealth Event, Sentinel
=450  \\$wnnna$aHealth Events, Sentinel
=450  \\$aSentinel Health Event
=450  \\$wnnna$aSentinel Health Events
=450  \\$wnnna$aSentinel Surveillances
=450  \\$wnnna$aSurveillance, Sentinel
=450  \\$wnnna$aSurveillances, Sentinel
=550  \\$wg$aEpidemiologic Methods
=550  \\$wg$aPopulation Surveillance
=680  \\$iMonitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in larger population. (From Last, Dictionary of Epidemiology, 2d ed)
=688  \\$a95
=750  \0$aSentinel health events$5IEN-M$0(DLC)sh 88000579

=LDR  01157cz  a2200265n  4500
=001  9880364078402441
=005  20141212212814.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018817
=035  \\$aCSK5760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x152.$x670
=150  \\$aN-Methyl-3,4-methylenedioxyamphetamine
=450  \\$wnnna$aEcstasy (Drug)
=450  \\$wnnna$aHydrochloride, N-Methyl-3,4-methylenedioxyamphetamine
=450  \\$aMDMA
=450  \\$aMethylenedioxymethamphetamine
=450  \\$wnnna$aN Methyl 3,4 methylenedioxyamphetamine
=450  \\$wnnna$aN-Methyl-3,4-methylenedioxyamphetamine Hydrochloride
=450  \\$wnnna$aN Methyl 3,4 methylenedioxyamphetamine Hydrochloride
=550  \\$wg$aAmphetamines
=667  \\$astreet drug Ecstasy goes here; DF: note short X ref
=680  \\$iAn N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
=688  \\$a95; was N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE (NM) 1984-94
=750  \0$aMDMA (Drug)$5IEN-M

=LDR  01195cz  a2200277n  4500
=001  9880364078502441
=005  20141212212809.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018803
=035  \\$aCSK5759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x500.$x600
=072  \\$aE5.$x599.$x835.$x890
=072  \\$aN5.$x715.$x360.$x750.$x530.$x500
=072  \\$aN6.$x850.$x520.$x830.$x500.$x600
=150  \\$aModels, Economic
=450  \\$wnnna$aEconomic Model
=450  \\$aEconomic Models
=450  \\$wnnna$aModel, Economic
=550  \\$wg$aModels, Statistical
=550  \\$wh$aModels, Econometric
=550  \\$aEconomics
=667  \\$ano qualif; TN 128: application of MODELS, THEORETICAL; MODELS, ECONOMETRIC is also available; DF: MODELS ECON
=680  \\$iStatistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.
=688  \\$a95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994
=750  \0$aEconomics$xMathematical models$5IEN-M$0(DLC)sh 85040857

=LDR  01631cz  a2200289n  4500
=001  9880364078602441
=005  20141212212620.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018455
=035  \\$aCSK5753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x800
=072  \\$aC15.$x378.$x147.$x890
=072  \\$aC15.$x378.$x925.$x800
=150  \\$aProtein S Deficiency
=450  \\$wnnna$aDeficiencies, Protein S
=450  \\$wnnna$aDeficiency, Protein S
=450  \\$wnnna$aHereditary Thrombophilia Due To Protein S Deficiency
=450  \\$wnnna$aProtein S Deficiencies
=450  \\$aProtein S$xdeficiency
=550  \\$wg$aBlood Coagulation Disorders
=550  \\$wg$aBlood Protein Disorders
=550  \\$wg$aThrombophilia
=667  \\$aa blood protein disord causing thromboses; DF: PROTEIN S DEFIC
=680  \\$iAn autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C (also a vitamin K-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. (From Harrison's Principles of Internal Medicine, 12th ed, p1511; Wintrobe's Clinical Hematology, 9th ed, p1523)
=688  \\$a95
=750  \0$aProtein S deficiency$5IEN-M$0(DLC)sh 87007326

=LDR  01068cz  a2200289n  4500
=001  9880364078702441
=005  20200608123942.0
=008  940125\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018384
=035  \\$aCSK5749HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x673.$x345
=072  \\$aG7.$x775.$x750.$x500
=150  \\$aOxidative Stress
=450  \\$wnnna$aOxidative Stresses
=450  \\$aStress, Oxidative
=450  \\$wnnna$aStresses, Oxidative
=550  \\$wg$aMetabolism
=550  \\$wg$aStress, Physiological
=550  \\$wh$aEndoplasmic Reticulum Stress
=550  \\$wh$aNitrosative Stress
=550  \\$wh$aProtein Carbonylation
=550  \\$aAntioxidants
=550  \\$aReactive Oxygen Species
=680  \\$iA disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
=688  \\$a95
=750  \0$aOxidative stress$5IEN-M$0(DLC)sh2003008365

=LDR  01296cz  a2200229n  4500
=001  9880364078802441
=005  20141212212729.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018668
=035  \\$aCSK5748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x373.$x322
=150  \\$aMuntjacs
=450  \\$aMuntiacus
=450  \\$wnnna$aMuntjac
=450  \\$wnnna$aMuntjak
=450  \\$wnnna$aMuntjaks
=550  \\$wg$aDeer
=667  \\$aspecies of deer;IM; qualif permitted
=680  \\$iA genus, Muntiacus, of the deer family (Cervidae) comprising six species living in China, Tibet, Nepal, India, the Malay Peninsula, and neighboring island countries. They are usually found in forests and areas of dense vegetation, usually not far from water. They emit a deep barklike sound which gives them the name "barking deer." If they sense a predator they will "bark" for an hour or more. They are hunted for their meat and skins; they thrive in captivity and are found in many zoos. The Indian muntjac is believed to have the lowest chromosome number in mammals and cell lines derived from them figure widely in chromosome and DNA studies. (From Walker's Mammals of the World, 5th ed., p1366)
=688  \\$a95
=750  \0$aMuntiacus$5IEN-M$0(DLC)sh 85088512

=LDR  01712cz  a2200385n  4500
=001  9880364078902441
=005  20141212212815.0
=008  940527\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018819
=035  \\$aCSK5746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x350.$x126
=072  \\$aD8.$x811.$x277.$x656.$x959.$x250
=072  \\$aD23.$x50.$x301.$x264.$x35.$x283
=072  \\$aD23.$x50.$x301.$x264.$x894.$x160
=072  \\$aD23.$x101.$x100.$x110.$x282
=072  \\$aD23.$x101.$x100.$x894.$x160
=150  \\$aDipeptidyl Peptidase 4
=450  \\$wnnna$aAdenosine Deaminase Complexing Protein 2
=450  \\$wnnna$aAntigen, CD26
=450  \\$aAntigens, CD26
=450  \\$wnnna$aCD26 Antigen
=450  \\$aCD26 Antigens
=450  \\$aDipeptidyl-Peptidase IV
=450  \\$wnnna$aDipeptidyl Peptidase IV
=550  \\$wg$aAntigens, CD
=550  \\$wg$aAntigens, Differentiation, T-Lymphocyte
=550  \\$wg$aDipeptidyl-Peptidases and Tripeptidyl-Peptidases
=550  \\$wg$aSerine Proteases
=680  \\$iA serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl peptidase 4 substrates including INCRETINS; NEUROPEPTIDES; and CHEMOKINES. The protein is also found bound to ADENOSINE DEAMINASE on the T-CELL surface and is believed to play a role in T-cell activation.
=688  \\$a2011(1998)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Antigens, CD26
=688  \\$a1995
=688  \\$a95; was CD26 ANTIGEN (NM) 1990-94, DIPEPTIDYL PEPTIDASE IV (NM) 1980-94, & ADENOSINE DEAMINASE-BINDING PROTEINS (NM) 1978-94
=750  \0$aCD26 antigen$0(DLC) sh 95004652$5IEN-M

=LDR  00827cz  a2200229n  4500
=001  9880364079002441
=005  20141212212722.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018651
=035  \\$aCSK5739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x200
=072  \\$aJ2.$x500.$x850.$x237
=150  \\$aChicory
=450  \\$aCichorium intybus
=550  \\$wg$aAsteraceae
=550  \\$wg$aVegetables
=550  \\$aCoffee
=667  \\$aas plant & flavoring agent for coffee
=680  \\$iA thick-rooted perennial (Cichorium intybus) native to Europe but widely grown for its young leaves used as salad greens and for its roots, dried and ground-roasted, used to flavor or adulterate coffee. (From Webster, 3d ed)
=688  \\$a95
=750  \0$aChicory$5IEN-M$0(DLC)sh 85023316

=LDR  01472cz  a2200409n  4500
=001  9880364079102441
=005  20141212212658.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018576
=035  \\$aCSK5737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x350
=072  \\$aN2.$x360.$x67.$x350
=150  \\$aHome Health Aides
=450  \\$wnnna$aAide, Home Care
=450  \\$wnnna$aAide, Home Health
=450  \\$wnnna$aAide, Homemaker-Home Health
=450  \\$wnnna$aAides, Home Care
=450  \\$wnnna$aAides, Home Health
=450  \\$wnnna$aAides, Homemaker-Home Health
=450  \\$wnnna$aCare Aide, Home
=450  \\$wnnna$aCare Aides, Home
=450  \\$wnnna$aHealth Aide, Home
=450  \\$wnnna$aHealth Aide, Homemaker-Home
=450  \\$wnnna$aHealth Aides, Home
=450  \\$wnnna$aHealth Aides, Homemaker-Home
=450  \\$wnnna$aHome Care Aide
=450  \\$aHome Care Aides
=450  \\$wnnna$aHome Health Aide
=450  \\$wnnna$aHomemaker-Home Health Aide
=450  \\$aHomemaker-Home Health Aides
=450  \\$wnnna$aHomemaker Home Health Aides
=550  \\$wg$aAllied Health Personnel
=667  \\$acoord IM with specific home health care (IM)
=680  \\$iPersons who assist ill, elderly, or disabled persons in the home, carrying out personal care and housekeeping tasks. (From Slee & Slee, Health Care Terms. 2d ed, p202)
=688  \\$a95
=750  \0$aHome health aides$5IEN-M$0(DLC)sh 85061693

=LDR  00898cz  a2200265n  4500
=001  9880364079202441
=005  20141212212703.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018589
=035  \\$aCSK5736M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x543
=072  \\$aC23.$x888.$x592.$x636.$x263
=150  \\$aGastroparesis
=450  \\$wnnna$aGastric Stases
=450  \\$aGastric Stasis
=450  \\$wnnna$aGastropareses
=450  \\$wnnna$aStases, Gastric
=450  \\$wnnna$aStasis, Gastric
=550  \\$wg$aParalysis
=550  \\$wg$aStomach Diseases
=550  \\$aDiabetes Mellitus
=680  \\$iChronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
=688  \\$a95
=750  \0$aGastroparesis$0(DLC)sh2012001012$5IEN-M

=LDR  01357cz  a2200385n  4500
=001  9880364079302441
=005  20141212212753.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018752
=035  \\$aCSK5735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x260
=072  \\$aG7.$x610.$x240.$x260
=150  \\$aDiet, Fat-Restricted
=450  \\$aDiet, Fat-Free
=450  \\$wnnna$aDiet, Fat Free
=450  \\$wnnna$aDiet, Fat Restricted
=450  \\$aDiet, Low-Fat
=450  \\$wnnna$aDiet, Low Fat
=450  \\$wnnna$aDiets, Fat-Free
=450  \\$wnnna$aDiets, Fat-Restricted
=450  \\$wnnna$aDiets, Low-Fat
=450  \\$wnnna$aFat-Free Diet
=450  \\$wnnna$aFat-Free Diets
=450  \\$aFat-Restricted Diet
=450  \\$wnnna$aFat Restricted Diet
=450  \\$wnnna$aFat-Restricted Diets
=450  \\$wnnna$aLow-Fat Diet
=450  \\$wnnna$aLow-Fat Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=667  \\$aIM; coord with dis /diet ther (IM)
=680  \\$iA diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIAS. (From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed)
=688  \\$a95
=750  \0$aLow-fat diet$5IEN-M$0(DLC)sh 85078632

=LDR  03436cz  a2200721n  4500
=001  9880364079402441
=005  20141212212840.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018901
=035  \\$aCSK5734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x680
=072  \\$aC16.$x320.$x565.$x189.$x680
=072  \\$aC16.$x320.$x565.$x663
=072  \\$aC18.$x452.$x132.$x100.$x680
=072  \\$aC18.$x452.$x648.$x189.$x680
=072  \\$aC18.$x452.$x648.$x663
=150  \\$aPeroxisomal Disorders
=450  \\$wnnna$aAcidemia, Hyperpipecolic
=450  \\$wnnna$aAcidemias, Hyperpipecolic
=450  \\$wnnna$aAdrenoleukodystrophies, Neonatal
=450  \\$wnnna$aAdrenoleukodystrophy, Autosomal Neonatal Form
=450  \\$wnnna$aAdrenoleukodystrophy, Autosomal, Neonatal Form
=450  \\$aAdrenoleukodystrophy, Neonatal
=450  \\$wnnna$aDysfunction, General Peroxisomal
=450  \\$wnnna$aDysfunction, Multiple Peroxisomal
=450  \\$wnnna$aDysfunction, Single Peroxisomal
=450  \\$wnnna$aDysfunctions, General Peroxisomal
=450  \\$wnnna$aDysfunctions, Multiple Peroxisomal
=450  \\$wnnna$aDysfunctions, Single Peroxisomal
=450  \\$wnnna$aGeneral Peroxisomal Dysfunction
=450  \\$wnnna$aGeneral Peroxisomal Dysfunctions
=450  \\$wnnna$aHyperpipecolatemia
=450  \\$aHyperpipecolic Acidemia
=450  \\$wnnna$aHyperpipecolic Acidemias
=450  \\$wnnna$aMultiple Peroxisomal Dysfunction
=450  \\$wnnna$aMultiple Peroxisomal Dysfunctions
=450  \\$wnnna$aNeonatal Adrenoleukodystrophies
=450  \\$wnnna$aNeonatal Adrenoleukodystrophy
=450  \\$wnnna$aPeroxisomal Disorder
=450  \\$wnnna$aPeroxisomal Dysfunction, General
=450  \\$wnnna$aPeroxisomal Dysfunction, Multiple
=450  \\$wnnna$aPeroxisomal Dysfunction, Single
=450  \\$wnnna$aPeroxisomal Dysfunctions, General
=450  \\$wnnna$aPeroxisomal Dysfunctions, Multiple
=450  \\$wnnna$aPeroxisomal Dysfunctions, Single
=450  \\$wnnna$aSingle Peroxisomal Dysfunction
=450  \\$wnnna$aSingle Peroxisomal Dysfunctions
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aAcatalasia
=550  \\$wh$aAdrenoleukodystrophy
=550  \\$wh$aChondrodysplasia Punctata, Rhizomelic
=550  \\$wh$aMevalonate Kinase Deficiency
=550  \\$wh$aRefsum Disease
=550  \\$wh$aRefsum Disease, Infantile
=550  \\$wh$aZellweger Syndrome
=550  \\$aPeroxisomes
=667  \\$ageneral or unspecified; prefer specifics; do not confuse entry term ADRENOLEUKODYSTROPHY, NEONATAL with ADRENOLEUKODYSTROPHY
=680  \\$iA heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; INFANTILE REFSUM DISEASE; rhizomelic chondrodysplasia (CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY (X-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders.
=688  \\$a1996
=688  \\$a96
=750  \0$aPeroxisomal disorders$5IEN-M$0(DLC)sh 90001241

=LDR  01303cz  a2200361n  4500
=001  9880364079502441
=005  20141212212842.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018907
=035  \\$aCSK5730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x352.$x500
=072  \\$aN3.$x706.$x437.$x352.$x500
=072  \\$aN3.$x706.$x615.$x862
=150  \\$aPrivacy
=450  \\$wnnna$aAct, Privacy
=450  \\$wnnna$aLaw 93-579, Public
=450  \\$wnnna$aPL 93-579
=450  \\$wnnna$aPL 93 579
=450  \\$wnnna$aPL93-579
=450  \\$wnnna$aPL93 579
=450  \\$aPrivacy Act
=450  \\$aPublic Law 93-579
=450  \\$wnnna$aPublic Law 93 579
=550  \\$wg$aCivil Rights
=550  \\$wg$aLegislation as Topic
=550  \\$wh$aAccess to Information
=550  \\$wh$aGenetic Privacy
=550  \\$aConfidentiality
=667  \\$aa civil right to freedom from intrusion in one's private affairs; note X ref, a Federal statute; privacy of patient data or records: index under CONFIDENTIALITY
=680  \\$iThe state of being free from intrusion or disturbance in one's private life or affairs. (Random House Unabridged Dictionary, 2d ed, 1993)
=688  \\$a96; PRIVACY ACT was see CIVIL RIGHTS 1980-95
=750  \0$aPrivacy$5IEN-M$0(DLC)sh 85107027

=LDR  01050cz  a2200253n  4500
=001  9880364079602441
=005  20141212212834.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018883
=035  \\$aCSK5728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x522.$x500
=150  \\$aHeat Stroke
=450  \\$wnnna$aHeat Strokes
=450  \\$wnnna$aHeatstroke
=450  \\$wnnna$aHeatstrokes
=450  \\$wnnna$aStroke, Heat
=450  \\$wnnna$aStrokes, Heat
=550  \\$wg$aHeat Stress Disorders
=550  \\$wh$aSunstroke
=667  \\$aSUNSTROKE is also available
=680  \\$iA condition caused by the failure of body to dissipate heat in an excessively hot environment or during PHYSICAL EXERTION in a hot environment. Contrast to HEAT EXHAUSTION, the body temperature in heat stroke patient is dangerously high with red, hot skin accompanied by DELUSIONS; CONVULSIONS; or COMA. It can be a life-threatening emergency and is most common in infants and the elderly.
=688  \\$a96
=750  \0$aHeat stroke$5IEN-M$0(DLC)sh 85059837

=LDR  01826cz  a2200361n  4500
=001  9880364079702441
=005  20141212212835.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018886
=035  \\$aCSK5723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x100.$x111
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x100.$x111
=150  \\$aAphasia, Conduction
=450  \\$aAphasia, Associative
=450  \\$wnnna$aAphasias, Associative
=450  \\$wnnna$aAphasias, Conduction
=450  \\$wnnna$aAssociative Aphasia
=450  \\$wnnna$aAssociative Aphasias
=450  \\$wnnna$aAssociative Dysphasia
=450  \\$wnnna$aAssociative Dysphasias
=450  \\$wnnna$aConduction Aphasia
=450  \\$wnnna$aConduction Aphasias
=450  \\$wnnna$aConduction Dysphasia
=450  \\$wnnna$aConduction Dysphasias
=450  \\$aDysphasia, Associative
=450  \\$aDysphasia, Conduction
=450  \\$wnnna$aDysphasias, Associative
=450  \\$wnnna$aDysphasias, Conduction
=550  \\$wg$aAphasia
=680  \\$iA type of fluent aphasia characterized by an impaired ability to repeat one and two word phrases, despite retained comprehension. This condition is associated with dominant hemisphere lesions involving the arcuate fasciculus (a white matter projection between Broca's and Wernicke's areas) and adjacent structures. Like patients with Wernicke aphasia (APHASIA, WERNICKE), patients with conduction aphasia are fluent but commit paraphasic errors during attempts at written and oral forms of communication. (From Adams et al., Principles of Neurology, 6th ed, p482; Brain & Bannister, Clinical Neurology, 7th ed, p142; Kandel et al., Principles of Neural Science, 3d ed, p848)
=688  \\$a1996
=750  \0$aConduction aphasia$5IEN-M$0(DLC)sh 92002375

=LDR  00776cz  a2200229n  4500
=001  9880364079802441
=005  20200526130034.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018890
=035  \\$aCSK5722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x162
=150  \\$aChemoprevention
=450  \\$aChemoprophylaxis
=550  \\$wg$aDrug Therapy
=550  \\$wh$aAntibiotic Prophylaxis
=550  \\$wh$aMass Drug Administration
=550  \\$aSecondary Prevention
=667  \\$aIM general or unspecified only; prefer specific chemotherapeutic agent /ther use + disease /prev; DF: CHEMOPREV
=680  \\$iThe use of chemical compounds to prevent the development of a specific disease.
=688  \\$a96
=750  \0$aChemoprevention$5IEN-M$0(DLC)sh 92002504

=LDR  01627cz  a2200421n  4500
=001  9880364079902441
=005  20141212212838.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018893
=035  \\$aCSK5721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x927.$x100
=150  \\$aBronchoalveolar Lavage
=450  \\$aBronchial Lavage
=450  \\$wnnna$aBronchial Lavages
=450  \\$wnnna$aBronchioalveolar Lavage
=450  \\$wnnna$aBronchioalveolar Lavages
=450  \\$wnnna$aBronchoalveolar Lavages
=450  \\$wnnna$aBronchopulmonary Lavage
=450  \\$wnnna$aBronchopulmonary Lavages
=450  \\$wnnna$aLavage, Bronchial
=450  \\$wnnna$aLavage, Bronchioalveolar
=450  \\$wnnna$aLavage, Bronchoalveolar
=450  \\$wnnna$aLavage, Bronchopulmonary
=450  \\$wnnna$aLavage, Lung
=450  \\$wnnna$aLavages, Bronchial
=450  \\$wnnna$aLavages, Bronchioalveolar
=450  \\$wnnna$aLavages, Bronchoalveolar
=450  \\$wnnna$aLavages, Bronchopulmonary
=450  \\$wnnna$aLavages, Lung
=450  \\$aLung Lavage
=450  \\$wnnna$aLung Lavages
=550  \\$wg$aTherapeutic Irrigation
=550  \\$wh$aBronchoalveolar Lavage Fluid
=667  \\$aan irrigation technique: do not confuse with BRONCHOALVEOLAR LAVAGE FLUID, the washings obtained by lavage; DF: note short X ref
=680  \\$iWashing out of the lungs with saline or mucolytic agents for diagnostic or therapeutic purposes. It is very useful in the diagnosis of diffuse pulmonary infiltrates in immunosuppressed patients.
=688  \\$a96
=750  \0$aBronchoalveolar lavage$5IEN-M$0(DLC)sh 87006859

=LDR  00632cz  a2200217n  4500
=001  9880364080002441
=005  20141212212748.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018736
=035  \\$aCSK5720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x135
=072  \\$aG5.$x355.$x180.$x104
=150  \\$aDNA Adducts
=450  \\$wnnna$aAdducts, DNA
=550  \\$wg$aDNA
=550  \\$wg$aDNA Damage
=550  \\$aMutagens
=680  \\$iThe products of chemical reactions that result in the addition of extraneous chemical groups to DNA.
=688  \\$a95
=750  \0$aDNA adducts$0(DLC) sh2003011401$5IEN-M

=LDR  01771cz  a2200457n  4500
=001  9880364080102441
=005  20200622120033.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018570
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x800.$x715
=072  \\$aN4.$x452.$x871.$x715
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700.$x690
=072  \\$aN6.$x850.$x505.$x715
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800.$x715
=150  \\$aRisk Assessment
=450  \\$wnnna$aAssessment, Benefit-Risk
=450  \\$aAssessment, Risk
=450  \\$wnnna$aAssessment, Risk-Benefit
=450  \\$wnnna$aAssessments, Benefit-Risk
=450  \\$wnnna$aAssessments, Risk
=450  \\$wnnna$aAssessments, Risk-Benefit
=450  \\$aBenefit-Risk Assessment
=450  \\$wnnna$aBenefit Risk Assessment
=450  \\$wnnna$aBenefit-Risk Assessments
=450  \\$wnnna$aBenefits and Risks
=450  \\$wnnna$aRisk Assessments
=450  \\$aRisk-Benefit Assessment
=450  \\$wnnna$aRisk Benefit Assessment
=450  \\$wnnna$aRisk-Benefit Assessments
=450  \\$wnnna$aRisks and Benefits
=550  \\$wg$aEpidemiologic Measurements
=550  \\$wg$aRisk
=550  \\$wg$aRisk Management
=550  \\$wh$aHealthcare Failure Mode and Effect Analysis
=550  \\$wh$aRisk Adjustment
=550  \\$wh$aRisk Evaluation and Mitigation
=667  \\$acoord NIM with specific disease or other concept (IM); DF: RISK ASSESS
=680  \\$iThe qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
=688  \\$a95
=750  \0$aRisk assessment$5IEN-M$0(DLC)sh 87002638

=LDR  00895cz  a2200241n  4500
=001  9880364080202441
=005  20141212212645.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018529
=035  \\$aCSK5713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x500
=150  \\$aNutritional Support
=450  \\$wnnna$aArtificial Feeding
=450  \\$wnnna$aFeeding, Artificial
=450  \\$wnnna$aSupport, Nutritional
=550  \\$wg$aNutrition Therapy
=550  \\$wh$aEnteral Nutrition
=550  \\$wh$aParenteral Nutrition
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iThe administration of nutrients for assimilation and utilization by a patient by means other than normal eating. It does not include FLUID THERAPY which normalizes body fluids to restore WATER-ELECTROLYTE BALANCE.
=688  \\$a95
=750  \0$aArtificial feeding$0(DLC) sh 85008165$5IEN-M

=LDR  04856cz  a2201117n  4500
=001  9880364080302441
=005  20141212212624.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018458
=035  \\$aCSK5712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x140.$x627
=072  \\$aC10.$x597.$x606.$x358.$x800.$x400
=072  \\$aC23.$x888.$x592.$x604.$x359.$x800.$x400
=150  \\$aPersistent Vegetative State
=450  \\$aMinimally Conscious State
=450  \\$wnnna$aMinimally Conscious States
=450  \\$aPermanent Vegetative State
=450  \\$wnnna$aPermanent Vegetative States
=450  \\$wnnna$aPersistent Unawareness State
=450  \\$wnnna$aPersistent Unawareness States
=450  \\$wnnna$aPersistent Vegetative States
=450  \\$wnnna$aPost-Comatose Unawareness State
=450  \\$wnnna$aPost Comatose Unawareness State
=450  \\$wnnna$aPost-Comatose Unawareness States
=450  \\$wnnna$aPost-Traumatic Unawareness, Prolonged
=450  \\$wnnna$aPost-Traumatic Unawareness State
=450  \\$wnnna$aPost Traumatic Unawareness State
=450  \\$wnnna$aPost-Traumatic Unawareness States
=450  \\$wnnna$aPost-Traumatic Unawarenesses, Prolonged
=450  \\$aPost-Traumatic Vegetative State
=450  \\$wnnna$aPost Traumatic Vegetative State
=450  \\$wnnna$aPost-Traumatic Vegetative States
=450  \\$wnnna$aPostcomatose Unawareness State
=450  \\$wnnna$aPostcomatose Unawareness States
=450  \\$wnnna$aPosttraumatic Unawareness State
=450  \\$wnnna$aPosttraumatic Unawareness States
=450  \\$wnnna$aProlonged Post-Traumatic Unawareness
=450  \\$wnnna$aProlonged Post Traumatic Unawareness
=450  \\$wnnna$aProlonged Post-Traumatic Unawarenesses
=450  \\$wnnna$aPVS (Persistent Vegetative State)
=450  \\$wnnna$aPVSs (Persistent Vegetative State)
=450  \\$wnnna$aState, Minimally Conscious
=450  \\$wnnna$aState, Permanent Vegetative
=450  \\$wnnna$aState, Persistent Unawareness
=450  \\$wnnna$aState, Persistent Vegetative
=450  \\$wnnna$aState, Post-Comatose Unawareness
=450  \\$wnnna$aState, Post-Traumatic Unawareness
=450  \\$wnnna$aState, Post-Traumatic Vegetative
=450  \\$wnnna$aState, Postcomatose Unawareness
=450  \\$wnnna$aState, Posttraumatic Unawareness
=450  \\$wnnna$aState, Transient Vegetative
=450  \\$wnnna$aState, Vegetative
=450  \\$wnnna$aStates, Minimally Conscious
=450  \\$wnnna$aStates, Permanent Vegetative
=450  \\$wnnna$aStates, Persistent Unawareness
=450  \\$wnnna$aStates, Persistent Vegetative
=450  \\$wnnna$aStates, Post-Comatose Unawareness
=450  \\$wnnna$aStates, Post-Traumatic Unawareness
=450  \\$wnnna$aStates, Post-Traumatic Vegetative
=450  \\$wnnna$aStates, Postcomatose Unawareness
=450  \\$wnnna$aStates, Posttraumatic Unawareness
=450  \\$wnnna$aStates, Transient Vegetative
=450  \\$wnnna$aStates, Vegetative
=450  \\$wnnna$aTransient Vegetative State
=450  \\$wnnna$aTransient Vegetative States
=450  \\$wnnna$aUnawareness, Prolonged Post-Traumatic
=450  \\$wnnna$aUnawareness State, Persistent
=450  \\$wnnna$aUnawareness State, Post-Comatose
=450  \\$wnnna$aUnawareness State, Post-Traumatic
=450  \\$wnnna$aUnawareness State, Postcomatose
=450  \\$wnnna$aUnawareness State, Posttraumatic
=450  \\$wnnna$aUnawareness States, Persistent
=450  \\$wnnna$aUnawareness States, Post-Comatose
=450  \\$wnnna$aUnawareness States, Post-Traumatic
=450  \\$wnnna$aUnawareness States, Postcomatose
=450  \\$wnnna$aUnawareness States, Posttraumatic
=450  \\$wnnna$aUnawarenesses, Prolonged Post-Traumatic
=450  \\$wnnna$aVegetative State
=450  \\$wnnna$aVegetative State, Permanent
=450  \\$aVegetative State, Persistent
=450  \\$wnnna$aVegetative State, Post-Traumatic
=450  \\$wnnna$aVegetative State, Transient
=450  \\$wnnna$aVegetative States
=450  \\$wnnna$aVegetative States, Permanent
=450  \\$wnnna$aVegetative States, Persistent
=450  \\$wnnna$aVegetative States, Post-Traumatic
=450  \\$wnnna$aVegetative States, Transient
=550  \\$wg$aBrain Damage, Chronic
=550  \\$wg$aUnconsciousness
=550  \\$aAkinetic Mutism
=550  \\$aComa
=667  \\$asee also AKINETIC MUTISM
=680  \\$iVegetative state refers to the neurocognitive status of individuals with severe brain damage, in whom physiologic functions (sleep-wake cycles, autonomic control, and breathing) persist, but awareness (including all cognitive function and emotion) is abolished.
=688  \\$a1995; VEGETATIVE STATE was see COMA 1980-1994
=750  \0$aPersistent vegetative state$5IEN-M$0(DLC)sh 97003183

=LDR  00944cz  a2200229n  4500
=001  9880364080402441
=005  20141212212845.0
=008  950106\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018914
=035  \\$aCSK5711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x270
=150  \\$aCells, Immobilized
=450  \\$wnnna$aCell, Immobilized
=450  \\$wnnna$aImmobilized Cell
=450  \\$aImmobilized Cells
=550  \\$wg$aCells
=550  \\$aCulture Techniques
=667  \\$aNIM; specify cell if relevant, probably NIM; A 11 qualif
=680  \\$iMicrobial, plant, or animal cells which are immobilized by attachment to solid structures, usually a column matrix. A common use of immobilized cells is in biotechnology for the bioconversion of a substrate to a particular product. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=688  \\$a96
=750  \0$aImmobilized cells$5IEN-M$0(DLC)sh 85064524

=LDR  01112cz  a2200217n  4500
=001  9880364080502441
=005  20141212212847.0
=008  950106\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018918
=035  \\$aCSK5710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x825.$x249.$x704
=072  \\$aE4.$x943.$x875
=150  \\$aPhacoemulsification
=450  \\$wnnna$aPhacoemulsifications
=550  \\$wg$aCataract Extraction
=550  \\$wg$aUltrasonic Surgical Procedures
=667  \\$aa type of cataract extraction; do not use /util except by MeSH definition
=680  \\$iA procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. (Cline, et al., Dictionary of Visual Science, 4th ed & In Focus 1993;1(1):1)
=688  \\$a96
=750  \0$aPhacoemulsification$5IEN-M$0(DLC)sh 87000890

=LDR  01518cz  a2200373n  4500
=001  9880364080602441
=005  20141212212730.0
=008  940523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018672
=035  \\$aCSK5709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x185
=150  \\$aCommunity Health Planning
=450  \\$wnnna$aCommunity Health Plannings
=450  \\$wnnna$aCommunity Health System
=450  \\$wnnna$aCommunity Health Systems
=450  \\$wnnna$aHealth Planning, Community
=450  \\$wnnna$aHealth Plannings, Community
=450  \\$wnnna$aHealth System, Community
=450  \\$wnnna$aHealth Systems, Community
=450  \\$wnnna$aPlanning, Community Health
=450  \\$wnnna$aPlanning, Population-Based
=450  \\$wnnna$aPlannings, Community Health
=450  \\$wnnna$aPlannings, Population-Based
=450  \\$aPopulation-Based Planning
=450  \\$wnnna$aPopulation Based Planning
=450  \\$wnnna$aPopulation-Based Plannings
=450  \\$wnnna$aSystem, Community Health
=450  \\$wnnna$aSystems, Community Health
=550  \\$wg$aRegional Health Planning
=667  \\$aspecify geog
=680  \\$iPlanning that has the goals of improving health, improving accessibility to health services, and promoting efficiency in the provision of services and resources on a comprehensive basis for a whole community. (From Facts on File Dictionary of Health Care Management, 1988, p299)
=688  \\$a95
=750  \0$aCommunity health services$xPlanning$5IEN-M

=LDR  01031cz  a2200241n  4500
=001  9880364080702441
=005  20141212212848.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018923
=035  \\$aCSK5706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC24.$x653
=150  \\$aPersian Gulf Syndrome
=450  \\$aGulf War Syndrome
=450  \\$wnnna$aSyndrome, Gulf War
=450  \\$wnnna$aSyndrome, Persian Gulf
=550  \\$wg$aOccupational Diseases
=550  \\$aEnvironmental Exposure
=550  \\$aMultiple Chemical Sensitivity
=667  \\$acoord IM with specific dis or manifest (IM)
=680  \\$iUnexplained symptoms reported by veterans of the Persian Gulf War with Iraq in 1991. The symptoms reported include fatigue, skin rash, muscle and joint pain, headaches, loss of memory, shortness of breath, gastrointestinal and respiratory symptoms, and extreme sensitivity to commonly occurring chemicals. (Nature 1994 May 5;369(6475):8)
=688  \\$a96
=750  \0$aPersian Gulf syndrome$5IEN-M$0(DLC)sh 98000483

=LDR  01711cz  a2200385n  4500
=001  9880364080802441
=005  20190419135132.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018721
=035  \\$aCSK5704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x120.$x140.$x500
=072  \\$aD27.$x505.$x696.$x577.$x120.$x140.$x500
=150  \\$aMuscarinic Agonists
=450  \\$wnnna$aAgonist, Muscarinic
=450  \\$wnnna$aAgonist, Muscarinic Cholinergic
=450  \\$wnnna$aAgonists, Cholinergic Muscarinic
=450  \\$wnnna$aAgonists, Muscarinic
=450  \\$wnnna$aAgonists, Muscarinic Cholinergic
=450  \\$wnnna$aCholinergic Agonist, Muscarinic
=450  \\$aCholinergic Agonists, Muscarinic
=450  \\$wnnna$aCholinergic Muscarinic Agonists
=450  \\$wnnna$aMuscarinic Agonist
=450  \\$wnnna$aMuscarinic Agonists, Cholinergic
=450  \\$wnnna$aMuscarinic Cholinergic Agonist
=450  \\$wnnna$aMuscarinic Cholinergic Agonists
=450  \\$aReceptors, Muscarinic$xagonists
=550  \\$wg$aCholinergic Agonists
=550  \\$aMiotics
=550  \\$aParasympathomimetics
=680  \\$iDrugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
=688  \\$a95
=750  \0$81$wb$iBroader mapping$aMuscarine$0(DLC)sh 85088669$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAgonists$0(DLC)sh 99002380$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMuscarine--Agonists$5IEN-M

=LDR  01219cz  a2200265n  4500
=001  9880364080902441
=005  20141212212712.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018616
=035  \\$aCSK5702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x850.$x850
=150  \\$aUltrasonography, Doppler, Duplex
=450  \\$wnnna$aDoppler Duplex Ultrasonography
=450  \\$aDoppler Ultrasonography, Duplex
=450  \\$wnnna$aDuplex Doppler Ultrasonography
=450  \\$wnnna$aDuplex Ultrasonography, Doppler
=450  \\$wnnna$aUltrasonography, Doppler Duplex
=450  \\$aUltrasonography, Duplex Doppler
=550  \\$wg$aUltrasonography, Doppler
=550  \\$wh$aUltrasonography, Doppler, Color
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER DUPLEX
=680  \\$iUltrasonography applying the Doppler effect combined with real-time imaging. The real-time image is created by rapid movement of the ultrasound beam. A powerful advantage of this technique is the ability to estimate the velocity of flow from the Doppler shift frequency.
=688  \\$a95
=750  \0$aDuplex ultrasonography$5IEN-M$0(DLC)sh 87006392

=LDR  01272cz  a2200265n  4500
=001  9880364081002441
=005  20141212212712.0
=008  940228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018615
=035  \\$aCSK5701M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x850.$x850.$x850
=150  \\$aUltrasonography, Doppler, Color
=450  \\$wnnna$aColor Doppler Ultrasonography
=450  \\$wnnna$aColor Ultrasonography, Doppler
=450  \\$wnnna$aDoppler Color Ultrasonography
=450  \\$aDoppler Ultrasonography, Color
=450  \\$aUltrasonography, Color Doppler
=450  \\$wnnna$aUltrasonography, Doppler Color
=550  \\$wg$aUltrasonography, Doppler, Duplex
=550  \\$wh$aEchocardiography, Doppler, Color
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER COLOR
=680  \\$iUltrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow (such as in a stenosis) or of mapping the extent of flow in a certain region.
=688  \\$a95
=750  \0$aColor Doppler ultrasonography$0(DLC) sh2004007343$5IEN-M

=LDR  01361cz  a2200325n  4500
=001  9880364081202441
=005  20170609110125.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018892
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x765
=072  \\$aG2.$x842.$x750.$x710
=072  \\$aG3.$x295.$x770
=150  \\$aProton-Motive Force
=450  \\$wnnna$aChemiosmotic Mechanism
=450  \\$aChemiosmotic Mechanisms
=450  \\$adelta pH
=450  \\$wnnna$adeltapH
=450  \\$wnnna$agradient, pH
=450  \\$wnnna$apH, delta
=450  \\$apH gradient
=450  \\$wnnna$aProton Motive Force
=450  \\$wnnna$aProton-Motive Forces
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aEnergy Metabolism
=550  \\$wh$aMembrane Potential, Mitochondrial
=550  \\$aBiological Transport
=680  \\$iEnergy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a PURPLE MEMBRANE, and the hydrolysis of ATP by a proton ATPase. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p171)
=688  \\$a96
=750  \0$aChemiosmosis$5IEN-M$0(DLC)sh 86005423

=LDR  00980cz  a2200277n  4500
=001  9880364081302441
=005  20141212212844.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018911
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x708.$x800.$x500.$x850
=072  \\$aG5.$x360.$x80.$x708.$x800.$x500.$x850
=072  \\$aG5.$x360.$x340.$x24.$x850.$x500.$x850
=150  \\$aTrinucleotide Repeats
=450  \\$wnnna$aRepeat, Trinucleotide
=450  \\$wnnna$aRepeat, Triplet
=450  \\$wnnna$aRepeats, Trinucleotide
=450  \\$wnnna$aRepeats, Triplet
=450  \\$wnnna$aTrinucleotide Repeat
=450  \\$wnnna$aTriplet Repeat
=450  \\$aTriplet Repeats
=550  \\$wg$aMicrosatellite Repeats
=550  \\$wh$aTrinucleotide Repeat Expansion
=680  \\$iMicrosatellite repeats consisting of three nucleotides dispersed in the euchromatic arms of chromosomes.
=688  \\$a96
=750  \0$aTrinucleotide repeats$0(DLC) sh2003008331$5IEN-M

=LDR  01242cz  a2200205n  4500
=001  9880364081402441
=005  20141212212830.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018877
=035  \\$aCSK5689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x312.$x750
=072  \\$aC21.$x223.$x750
=150  \\$aSick Building Syndrome
=450  \\$wnnna$aSyndrome, Sick Building
=550  \\$wg$aEnvironmental Illness
=667  \\$acoord IM with specific manifest if pertinent (IM)
=680  \\$iA group of symptoms that are two- to three-fold more common in those who work in large, energy-efficient buildings, associated with an increased frequency of headaches, lethargy, and dry skin. Clinical manifestations include hypersensitivity pneumonitis (ALVEOLITIS, EXTRINSIC ALLERGIC); allergic rhinitis (RHINITIS, ALLERGIC, PERENNIAL); ASTHMA; infections, skin eruptions, and mucous membrane irritation syndromes. Current usage tends to be less restrictive with regard to the type of building and delineation of complaints. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91
=750  \0$aSick building syndrome$5IEN-M$0(DLC)sh 91005846

=LDR  01041cz  a2200217n  4500
=001  9880364081502441
=005  20141212212827.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018865
=035  \\$aCSK5688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x124
=072  \\$aH2.$x163.$x90
=150  \\$aDental Research
=450  \\$aResearch, Dental
=550  \\$wg$aBiomedical Research
=550  \\$wg$aDentistry
=667  \\$adent research as a field; avoid since most dental articles indexed contribute to "dental research"; IM general only on dent research as a field; NIM for status or progress of research in a special dent field or subject (IM); /methods: consider also RESEARCH DESIGN; DF: DENT RESEARCH
=680  \\$iThe study of laws, theories, and hypotheses through a systematic examination of pertinent facts and their interpretation in the field of dentistry. (From Jablonski, Illustrated Dictionary of Dentistry, 1982, p674)
=688  \\$a96
=750  \0$aDentistry$xResearch$5IEN-M$0(DLC)sh 85036960

=LDR  02598cz  a2200649n  4500
=001  9880364081602441
=005  20141212212839.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018895
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x708.$x800.$x500
=072  \\$aG5.$x360.$x80.$x708.$x800.$x500
=072  \\$aG5.$x360.$x340.$x24.$x850.$x500
=150  \\$aMicrosatellite Repeats
=450  \\$wnnna$aMarker, Microsatellite
=450  \\$wnnna$aMarkers, Microsatellite
=450  \\$wnnna$aMicrosatellite
=450  \\$wnnna$aMicrosatellite Marker
=450  \\$aMicrosatellite Markers
=450  \\$wnnna$aMicrosatellite Repeat
=450  \\$wnnna$aMicrosatellites
=450  \\$wnnna$aPentanucleotide Repeat
=450  \\$aPentanucleotide Repeats
=450  \\$wnnna$aRepeat, Microsatellite
=450  \\$wnnna$aRepeat, Pentanucleotide
=450  \\$wnnna$aRepeat, Short Tandem
=450  \\$wnnna$aRepeat, Simple Sequence
=450  \\$wnnna$aRepeat, Tetranucleotide
=450  \\$wnnna$aRepeats, Microsatellite
=450  \\$wnnna$aRepeats, Pentanucleotide
=450  \\$wnnna$aRepeats, Short Tandem
=450  \\$wnnna$aRepeats, Simple Sequence
=450  \\$wnnna$aRepeats, Tetranucleotide
=450  \\$wnnna$aRepetitive Sequence, Simple
=450  \\$wnnna$aRepetitive Sequences, Simple
=450  \\$wnnna$aSequence Repeat, Simple
=450  \\$wnnna$aSequence Repeats, Simple
=450  \\$wnnna$aSequence, Simple Repetitive
=450  \\$wnnna$aSequences, Simple Repetitive
=450  \\$wnnna$aShort Tandem Repeat
=450  \\$wnnna$aShort Tandem Repeats
=450  \\$aSimple Repetitive Sequence
=450  \\$wnnna$aSimple Repetitive Sequences
=450  \\$wnnna$aSimple Sequence Repeat
=450  \\$wnnna$aSimple Sequence Repeats
=450  \\$wnnna$aTandem Repeat, Short
=450  \\$wnnna$aTandem Repeats, Short
=450  \\$wnnna$aTetranucleotide Repeat
=450  \\$aTetranucleotide Repeats
=550  \\$wg$aTandem Repeat Sequences
=550  \\$wh$aDinucleotide Repeats
=550  \\$wh$aTrinucleotide Repeats
=550  \\$aMicrosatellite Instability
=680  \\$iA variety of simple repeat sequences that are distributed throughout the GENOME. They are characterized by a short repeat unit of 2-8 basepairs that is repeated up to 100 times. They are also known as short tandem repeats (STRs).
=688  \\$a1996; for SIMPLE REPETITIVE SEQUENCE use MINISATELLITE REPEATS 1999-2011, use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-1998
=688  \\$a96
=750  \0$aMicrosatellites (Genetics)$0(DLC) sh 98007300$5IEN-M

=LDR  01316cz  a2200313n  4500
=001  9880364081702441
=005  20141212212825.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018856
=035  \\$aCSK5686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829.$x495.$x500
=072  \\$aC13.$x351.$x968.$x829.$x495.$x500
=150  \\$aCystitis, Interstitial
=450  \\$wnnna$aChronic Interstitial Cystitides
=450  \\$wnnna$aChronic Interstitial Cystitis
=450  \\$wnnna$aCystitides, Chronic Interstitial
=450  \\$wnnna$aCystitides, Interstitial
=450  \\$aCystitis, Chronic Interstitial
=450  \\$wnnna$aInterstitial Cystitides
=450  \\$wnnna$aInterstitial Cystitides, Chronic
=450  \\$aInterstitial Cystitis
=450  \\$wnnna$aInterstitial Cystitis, Chronic
=450  \\$wnnna$aPainful Bladder Syndrome
=550  \\$wg$aCystitis
=667  \\$ausually chronic so do not coordinate with CHRONIC DISEASE
=680  \\$iA condition with recurring discomfort or pain in the URINARY BLADDER and the surrounding pelvic region without an identifiable disease. Severity of pain in interstitial cystitis varies greatly and often is accompanied by increased urination frequency and urgency.
=688  \\$a96
=750  \0$aInterstitial cystitis$5IEN-M$0(DLC)sh 90000763

=LDR  01059cz  a2200241n  4500
=001  9880364081802441
=005  20141212212826.0
=008  941227\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018859
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x272.$x497.$x500
=072  \\$aA17.$x360.$x710
=072  \\$aA17.$x815.$x250.$x500
=150  \\$aHair Follicle
=450  \\$wnnna$aFollicle, Hair
=450  \\$wnnna$aFollicles, Hair
=450  \\$wnnna$aHair Follicles
=550  \\$wg$aEpidermis
=550  \\$wg$aHair
=667  \\$adis = HAIR FOLLICLE (IM) + HAIR DISEASES (NIM); inflammation = FOLLICULITIS
=680  \\$iA tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (Stedman, 26th ed) Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.
=688  \\$a96
=750  \0$aHair follicles$5IEN$0(DLC)sh 85058320

=LDR  01676cz  a2200337n  4500
=001  9880364081902441
=005  20141212212722.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018650
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x75
=150  \\$aArnica
=450  \\$aArnica montana
=450  \\$wnnna$aArnica montanas
=450  \\$wnnna$aArnicas
=450  \\$wnnna$aBane, Leopard's
=450  \\$wnnna$aBane, Leopards
=450  \\$wnnna$aBanes, Leopard's
=450  \\$wnnna$aBanes, Leopards
=450  \\$wnnna$aLeopard Bane
=450  \\$wnnna$aLeopard's Bane
=450  \\$aLeopards Bane
=450  \\$wnnna$aLeopard's Banes
=450  \\$wnnna$aLeopards Banes
=450  \\$wnnna$amontana, Arnica
=450  \\$wnnna$amontanas, Arnica
=550  \\$wg$aAsteraceae
=667  \\$afor Traumeel or homeopathic or 30x dilution coord with HOMEOPATHY (IM); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The dried flower heads of Arnica montana are used externally as a counterirritant and tincture for sprains and bruises, either as crude extract or in homeopathic dilution (HOMEOPATHY). Arnica contains volatile oils (OILS, VOLATILE), arnicin, arnisterol, FLAVONOIDS; TANNINS; and resin. The common name of Wolf's Bane is similar to the common name for ACONITUM.
=688  \\$a95; was ARNICA (NM) 1985-94
=750  \0$aArnica$5IEN-M$0(DLC)sh 85007378

=LDR  01167cz  a2200277n  4500
=001  9880364082002441
=005  20141212212639.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018508
=035  \\$aCSK5678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x900.$x900
=072  \\$aN6.$x850.$x860.$x510.$x900.$x900
=150  \\$aWater Purification
=450  \\$wnnna$aPurification, Water
=450  \\$wnnna$aPurifications, Water
=450  \\$wnnna$aTreatment, Water
=450  \\$wnnna$aTreatments, Water
=450  \\$wnnna$aWater Purifications
=450  \\$wnnna$aWater Treatment
=450  \\$wnnna$aWater Treatments
=550  \\$wg$aWaste Management
=550  \\$aWater Supply
=680  \\$iAny of several processes in which undesirable impurities in water are removed or neutralized; for example, chlorination, filtration, primary treatment, ion exchange, and distillation. It includes treatment of WASTE WATER to provide potable and hygienic water in a controlled or closed environment as well as provision of public drinking water supplies.
=688  \\$a95
=750  \0$aWater$xPurification$5IEN-M$0(DLC)sh 85145478

=LDR  01133cz  a2200325n  4500
=001  9880364082102441
=005  20141212212732.0
=008  940628\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018677
=035  \\$aCSK5676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x850
=072  \\$aC26.$x900
=150  \\$aTooth Injuries
=450  \\$wnnna$aInjuries, Teeth
=450  \\$wnnna$aInjuries, Tooth
=450  \\$wnnna$aInjury, Teeth
=450  \\$wnnna$aInjury, Tooth
=450  \\$wnnna$aTeeth Injuries
=450  \\$wnnna$aTeeth Injury
=450  \\$aTooth$xinjuries
=450  \\$wnnna$aTooth Injury
=550  \\$wg$aTooth Diseases
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aTooth Avulsion
=550  \\$wh$aTooth Fractures
=667  \\$aGEN or unspecified; prefer /inj with specific tooth, as CUSPID /inj; also available are TOOTH FRACTURES & TOOTH AVULSION; DF: TOOTH INJ
=680  \\$iTraumatic or other damage to teeth including fractures (TOOTH FRACTURES) or displacements (TOOTH LUXATION).
=688  \\$a95; was TOOTH/injuries 1966-94
=750  \0$aTeeth$xWounds and injuries$5IEN-M$0(DLC)sh 85133234

=LDR  01528cz  a2200409n  4500
=001  9880364082202441
=005  20200605123110.0
=008  940701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018802
=035  \\$aCSK5673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x675
=072  \\$aN4.$x590.$x233.$x727.$x407
=072  \\$aN4.$x590.$x720
=150  \\$aPatient-Centered Care
=450  \\$wnnna$aCare, Patient-Centered
=450  \\$wnnna$aCare, Patient-Focused
=450  \\$wnnna$aHome, Medical
=450  \\$wnnna$aHomes, Medical
=450  \\$wnnna$aMedical Home
=450  \\$wnnna$aMedical Homes
=450  \\$aNursing, Patient-Centered
=450  \\$wnnna$aNursing, Patient Centered
=450  \\$wnnna$aPatient Centered Care
=450  \\$aPatient-Centered Nursing
=450  \\$wnnna$aPatient Centered Nursing
=450  \\$aPatient-Focused Care
=450  \\$wnnna$aPatient Focused Care
=550  \\$wg$aComprehensive Health Care
=550  \\$wg$aPatient Care Management
=550  \\$wg$aPrimary Health Care
=550  \\$wh$aNarrative Medicine
=550  \\$wh$aPatient Navigation
=667  \\$ainstitutional & administrative management: do not confuse with PATIENT CARE PLANNING involving individual patient
=680  \\$iDesign of patient care wherein institutional resources and personnel are organized around patients rather than around specialized departments. (From Hospitals 1993 Feb 5;67(3):14)
=688  \\$a95
=750  \0$aPatient-centered health care$0(DLC)sh2012000674$5IEN-M

=LDR  01698cz  a2200373n  4500
=001  9880364082302441
=005  20141212212701.0
=008  940701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018581
=035  \\$aCSK5672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x900
=072  \\$aL1.$x143.$x320.$x800
=150  \\$aTechnology Transfer
=450  \\$wnnna$aCommercialization, Research
=450  \\$wnnna$aCommercialization, Technology
=450  \\$wnnna$aCommercializations, Research
=450  \\$wnnna$aCommercializations, Technology
=450  \\$wnnna$aLicensing, Technology
=450  \\$wnnna$aLicensings, Technology
=450  \\$wnnna$aResearch Commercialization
=450  \\$wnnna$aResearch Commercializations
=450  \\$wnnna$aTechnology Commercialization
=450  \\$wnnna$aTechnology Commercializations
=450  \\$wnnna$aTechnology Licensing
=450  \\$wnnna$aTechnology Licensings
=450  \\$wnnna$aTechnology Transfers
=450  \\$wnnna$aTransfer, Technology
=450  \\$wnnna$aTransfers, Technology
=550  \\$wg$aDiffusion of Innovation
=550  \\$wg$aTechnology
=680  \\$iSpread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.
=688  \\$a95
=750  \0$aTechnology transfer$5IEN-M$0(DLC)sh 85133192

=LDR  02135cz  a2200481n  4500
=001  9880364082402441
=005  20141212212803.0
=008  940630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018788
=035  \\$aCSK5671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x848
=150  \\$aRadioactive Hazard Release
=450  \\$wnnna$aAccident, Nuclear
=450  \\$wnnna$aAccident, Nuclear Reactor
=450  \\$wnnna$aAccident, Radiation
=450  \\$aAccidents, Nuclear
=450  \\$aAccidents, Nuclear Reactor
=450  \\$aAccidents, Radiation
=450  \\$wnnna$aHazard Release, Radioactive
=450  \\$wnnna$aHazard Releases, Radioactive
=450  \\$wnnna$aNuclear Accident
=450  \\$aNuclear Accidents
=450  \\$wnnna$aNuclear Reactor Accident
=450  \\$aNuclear Reactor Accidents
=450  \\$wnnna$aRadiation Accident
=450  \\$aRadiation Accidents
=450  \\$wnnna$aRadioactive Hazard Releases
=450  \\$wnnna$aReactor Accident, Nuclear
=450  \\$wnnna$aReactor Accidents, Nuclear
=450  \\$wnnna$aRelease, Radioactive Hazard
=450  \\$wnnna$aReleases, Radioactive Hazard
=550  \\$wg$aAccidents
=550  \\$wh$aChernobyl Nuclear Accident
=550  \\$wh$aFukushima Nuclear Accident
=550  \\$aNuclear Reactors
=550  \\$aRadiation Injuries
=667  \\$afor release resulting in disaster, coordinate with DISASTERS; for deliberate release of radioactive material, coordinate RADIOACTIVE HAZARD RELEASE with TERRORISM; specify geographic location; note entry term ACCIDENTS, RADIATION: do not index here for radiation injuries during radiotherapy or radiodiagnosis: index under specific radiotherapy or radiodiagnosis heading + RADIATION INJURIES
=680  \\$iUncontrolled release of radioactive material from its containment. This either threatens to, or does, cause exposure to a radioactive hazard. Such an incident may occur accidentally or deliberately.
=688  \\$a2009(1995)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Accidents, Radiation
=688  \\$a95
=750  \0$aNuclear accidents$0(DLC) sh 98004645$5IEN-M

=LDR  00720cz  a2200229n  4500
=001  9880364082502441
=005  20141212212608.0
=008  940628\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018409
=035  \\$aCSK5669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x558.$x300
=150  \\$aFoot Injuries
=450  \\$aFoot$xinjuries
=450  \\$wnnna$aFoot Injury
=450  \\$wnnna$aInjuries, Foot
=450  \\$wnnna$aInjury, Foot
=550  \\$wg$aLeg Injuries
=667  \\$aGEN or unspecified; consider also /inj with specific sites of foot
=680  \\$iGeneral or unspecified injuries involving the foot.
=688  \\$a95; was FOOT/injuries 1966-94
=750  \0$aFoot$xWounds and injuries$5IEN-M$0(DLC)sh 85050397

=LDR  01384cz  a2200325n  4500
=001  9880364082602441
=005  20141212212823.0
=008  940616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018847
=035  \\$aCSK5667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x575
=072  \\$aD12.$x644.$x468
=072  \\$aD12.$x776.$x641.$x650.$x575
=150  \\$aOpioid Peptides
=450  \\$wnnna$aEndogenous Opiates
=450  \\$wnnna$aOpiate Peptides
=450  \\$aOpiates, Endogenous
=450  \\$wnnna$aOpioid Peptide
=450  \\$wnnna$aPeptide, Opioid
=450  \\$wnnna$aPeptides, Opiate
=450  \\$wnnna$aPeptides, Opioid
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptides
=550  \\$wh$aDynorphins
=550  \\$wh$aEndorphins
=550  \\$wh$aEnkephalins
=680  \\$iThe endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way.
=688  \\$a95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94
=750  \0$aOpioid peptides$5IEN-M$0(DLC)sh 94009171

=LDR  00887cz  a2200253n  4500
=001  9880364082702441
=005  20141212212628.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018472
=035  \\$aCSK5664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x60.$x535.$x369.$x400
=150  \\$aHypogravity
=450  \\$wnnna$aGravity, Low
=450  \\$wnnna$aGravity, Reduced
=450  \\$aLow Gravity
=450  \\$aReduced Gravity
=550  \\$wg$aGravity, Altered
=550  \\$wh$aWeightlessness
=550  \\$aWeightlessness
=667  \\$anatural or artificial; do not confuse with HYPERGRAVITY; /adv eff permitted
=680  \\$iCondition wherein the force of gravity is less than or is decreased below that on the surface of the earth. This is expressed as being between 0 and 1 g.
=688  \\$a95
=750  \0$aReduced gravity environments$5IEN-M$0(DLC)sh 86005173

=LDR  00686cz  a2200193n  4500
=001  9880364082802441
=005  20141212212625.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018462
=035  \\$aCSK5663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x738
=150  \\$aPhotobiology
=550  \\$wg$aBiology
=550  \\$aLight
=667  \\$athe discipline (education, history, etc) only; use PHOTOTROPHIC PROCESSES or specifics treed under it for processes and properties using sunlight by phototrophic organisms
=680  \\$iThe branch of biology dealing with the effect of light on organisms.
=688  \\$a95
=750  \0$aPhotobiology$5IEN-M$0(DLC)sh 85101138

=LDR  00898cz  a2200241n  4500
=001  9880364082902441
=005  20141212212643.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018523
=035  \\$aCSK5660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x249.$x845
=072  \\$aG15.$x744.$x900
=150  \\$aTropism
=450  \\$wnnna$aTropisms
=550  \\$wg$aGrowth
=550  \\$wg$aPlant Physiological Processes
=550  \\$wh$aGravitropism
=550  \\$wh$aPhototropism
=667  \\$adistinguish -tropic from -trophic (nutritional)
=680  \\$iThe directional growth of an organism in response to an external stimulus such as light, touch, or gravity. Growth towards the stimulus is a positive tropism; growth away from the stimulus is a negative tropism. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aTropisms$5IEN-M$0(DLC)sh 85138077

=LDR  01120cz  a2200253n  4500
=001  9880364083002441
=005  20141212212651.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018551
=035  \\$aCSK5659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x322
=072  \\$aJ2.$x500.$x850.$x533
=150  \\$aLycopersicon esculentum
=450  \\$wnnna$alycopersicum, Solanum
=450  \\$wnnna$aSolanum lycopersicum
=450  \\$wnnna$aTomato
=450  \\$aTomatoes
=550  \\$wg$aSolanaceae
=550  \\$wg$aVegetables
=667  \\$aX ref SOLANUM LYCOPERSICUM: SOLANUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit.
=688  \\$a2003(1995)
=750  \0$aTomatoes$5IEN-M$0(DLC)sh 85135924

=LDR  01253cz  a2200385n  4500
=001  9880364083102441
=005  20141212212646.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018531
=035  \\$aCSK5657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285.$x850.$x900
=150  \\$aSpacecraft
=450  \\$wnnna$aArtificial Satellite
=450  \\$wnnna$aArtificial Satellites
=450  \\$wnnna$aBiosatellite
=450  \\$aBiosatellites
=450  \\$wnnna$aCraft, Space
=450  \\$wnnna$aCrafts, Space
=450  \\$wnnna$aMan-Made Satellite
=450  \\$wnnna$aMan-Made Satellites
=450  \\$wnnna$aSatellite, Artificial
=450  \\$wnnna$aSatellite, Man-Made
=450  \\$aSatellites, Artificial
=450  \\$aSatellites, Man-Made
=450  \\$wnnna$aSatellites, Man Made
=450  \\$aSpace Craft
=450  \\$wnnna$aSpace Crafts
=450  \\$wnnna$aSpacecrafts
=550  \\$wg$aSpace Flight
=550  \\$aSpace Flight
=667  \\$amanned or unmanned
=680  \\$iDevices, manned and unmanned, which are designed to be placed into an orbit about the Earth or into a trajectory to another celestial body. (NASA Thesaurus, 1988)
=688  \\$a95
=750  \0$aSpace vehicles$5IEN-M$0(DLC)sh 85125971

=LDR  00914cz  a2200217n  4500
=001  9880364083202441
=005  20141212212644.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018526
=035  \\$aCSK5652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x744.$x750
=150  \\$aPlant Transpiration
=450  \\$wnnna$aPlant Transpirations
=450  \\$wnnna$aTranspiration, Plant
=450  \\$wnnna$aTranspirations, Plant
=550  \\$wg$aPlant Physiological Processes
=667  \\$aloss of water vapor in plants
=680  \\$iThe loss of water vapor by plants to the atmosphere. It occurs mainly from the leaves through pores (stomata) whose primary function is gas exchange. The water is replaced by a continuous column of water moving upwards from the roots within the xylem vessels. (Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aPlants$xTranspiration$5IEN-M$0(DLC)sh 85102880

=LDR  00865cz  a2200253n  4500
=001  9880364083302441
=005  20141212212649.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018547
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x937
=150  \\$aPlant Stems
=450  \\$wnnna$aPlant Stem
=450  \\$wnnna$aStem, Plant
=450  \\$wnnna$aStems, Plant
=550  \\$wg$aPlant Components, Aerial
=550  \\$wh$aHypocotyl
=550  \\$wh$aMeristem
=550  \\$wh$aPlant Vascular Bundle
=550  \\$wh$aRhizome
=667  \\$acoord with specific plant; PLANT BARK is also available
=680  \\$iParts of plants that usually grow vertically upwards towards the light and support the leaves, buds, and reproductive structures. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aStems (Botany)$5IEN-M$0(DLC)sh 85127927

=LDR  00780cz  a2200253n  4500
=001  9880364083402441
=005  20141212212642.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018520
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x875
=150  \\$aPlant Shoots
=450  \\$wnnna$aPlant Shoot
=450  \\$wnnna$aShoot, Plant
=450  \\$wnnna$aShoots, Plant
=550  \\$wg$aPlant Components, Aerial
=550  \\$wh$aCotyledon
=550  \\$wh$aHypocotyl
=550  \\$wh$aMeristem
=550  \\$aSeedling
=667  \\$afor new root growth use MERISTEM; coordinate with specific plant
=680  \\$iNew immature growth of a plant including stem, leaves, tips of branches, and SEEDLINGS.
=688  \\$a95
=750  \0$aShoots (Botany)$5IEN-M$0(DLC)sh 85121769

=LDR  01124cz  a2200337n  4500
=001  9880364083502441
=005  20141212212641.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018517
=035  \\$aCSK5649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x400
=150  \\$aPlant Roots
=450  \\$wnnna$aBulb, Plant
=450  \\$wnnna$aBulbs, Plant
=450  \\$wnnna$aPlant Bulb
=450  \\$wnnna$aPlant Bulbs
=450  \\$wnnna$aPlant Root
=450  \\$wnnna$aRoot, Plant
=450  \\$wnnna$aRoots, Plant
=550  \\$wg$aPlant Structures
=550  \\$wh$aMeristem
=550  \\$wh$aMycorrhizae
=550  \\$wh$aPlant Tubers
=550  \\$wh$aPlant Vascular Bundle
=550  \\$wh$aRhizome
=550  \\$wh$aRoot Nodules, Plant
=667  \\$acoordinate with specific plant if pertinent
=680  \\$iThe usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aRoots (Botany)$0(DLC) sh 85115375$5IEN-M

=LDR  01103cz  a2200277n  4500
=001  9880364083602441
=005  20141212212640.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018515
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x812
=150  \\$aPlant Leaves
=450  \\$wnnna$aLeaf, Plant
=450  \\$wnnna$aLeave, Plant
=450  \\$wnnna$aLeaves, Plant
=450  \\$wnnna$aPlant Leaf
=450  \\$wnnna$aPlant Leave
=550  \\$wg$aPlant Components, Aerial
=550  \\$wh$aMesophyll Cells
=550  \\$wh$aPlant Stomata
=550  \\$wh$aPlant Vascular Bundle
=550  \\$wh$aPulvinus
=667  \\$apart of a plant shoot; IM GEN or unspecified; coord probably IM in genetics & space physiol, NIM in pharmacognosy, with specific plant (IM or NIM)
=680  \\$iExpanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed)
=688  \\$a95
=750  \0$aLeaves$5IEN-M$0(DLC)sh 85075608

=LDR  00891cz  a2200241n  4500
=001  9880364083702441
=005  20141212212643.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018524
=035  \\$aCSK5646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x249.$x845.$x700
=072  \\$aG15.$x744.$x900.$x700
=150  \\$aPhototropism
=450  \\$aHeliotropism
=450  \\$wnnna$aHeliotropisms
=450  \\$wnnna$aPhototropisms
=550  \\$wg$aTropism
=550  \\$aLight
=667  \\$adistinguish from PHOTOTROPHIC PROCESSES
=680  \\$iThe directional growth of organisms in response to light. In plants, aerial shoots usually grow towards light. The phototropic response is thought to be controlled by auxin (= AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aPhototropism$0(DLC) sh 85101419$5IEN-M

=LDR  00822cz  a2200217n  4500
=001  9880364083802441
=005  20141212212646.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018532
=035  \\$aCSK5645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x625
=072  \\$aJ2.$x500.$x850.$x500.$x500
=150  \\$aPeas
=450  \\$wnnna$aPea
=450  \\$aPisum sativum
=550  \\$wg$aFabaceae
=667  \\$aas plant & food
=680  \\$iA variable annual leguminous vine (Pisum sativum) that is cultivated for its rounded smooth or wrinkled edible protein-rich seeds, the seed of the pea, and the immature pods with their included seeds. (From Webster's New Collegiate Dictionary, 1973)
=688  \\$a95; was see LEGUMES 1978-94
=750  \0$aPeas$5IEN-M$0(DLC)sh 85099045

=LDR  01011cz  a2200265n  4500
=001  9880364083902441
=005  20160422095000.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018554
=035  \\$aCSK5644HS
=040  \\$aDNLM$beng$cDNLM
=150  \\$aAvena
=450  \\$wnno$aAvena sativa
=450  \\$wnnna$aAvenas
=450  \\$wnnna$aCultivated Oat
=450  \\$wnnna$aCultivated Oats
=450  \\$wnnna$aOat
=450  \\$aOats
=450  \\$wnnna$aOat, Cultivated
=450  \\$wnnna$aOats, Cultivated
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iOats, genus of the family POACEAE
=688  \\$a2016; use AVENA SATIVA 2003-2015, OATS 1995-2002; CEREALS 1985-1994, GRAIN 1963-1984
=750  \0$aOats$5IEN-M$0(DLC)sh 85093606

=LDR  00967cz  a2200301n  4500
=001  9880364084002441
=005  20141212212642.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018519
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x875.$x875
=072  \\$aA18.$x24.$x937.$x500
=072  \\$aA18.$x400.$x500
=150  \\$aMeristem
=450  \\$wnnna$aMeristems
=450  \\$aRoot Tip
=450  \\$wnnna$aRoot Tips
=450  \\$wnnna$aTip, Root
=450  \\$wnnna$aTips, Root
=550  \\$wg$aPlant Roots
=550  \\$wg$aPlant Shoots
=550  \\$wg$aPlant Stems
=550  \\$wh$aCambium
=550  \\$wh$aPlant Root Cap
=667  \\$acoord with specific plant
=680  \\$iA group of plant cells that are capable of dividing infinitely and whose main function is the production of new growth at the growing tip of a root or stem. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aMeristems$5IEN-M$0(DLC)sh 85083841

=LDR  00898cz  a2200241n  4500
=001  9880364084102441
=005  20170608141926.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018499
=035  \\$aCSK5636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x154.$x240.$x400
=072  \\$aG2.$x111.$x255
=072  \\$aG2.$x216.$x400
=150  \\$aLinear Energy Transfer
=450  \\$aEnergy Transfer, Linear
=450  \\$aLET
=450  \\$wnnna$aTransfer, Linear Energy
=550  \\$wg$aEnergy Transfer
=667  \\$aDF: note short X ref
=680  \\$iRate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/micrometer T).
=688  \\$a95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94
=750  \0$aLinear energy transfer$5IEN-M$0(DLC)sh 85077174

=LDR  00701cz  a2200217n  4500
=001  9880364084202441
=005  20141212212649.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018545
=035  \\$aCSK5635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x500
=072  \\$aJ2.$x500.$x850.$x525
=150  \\$aLettuce
=450  \\$aLactuca sativa
=550  \\$wg$aAsteraceae
=550  \\$wg$aVegetables
=667  \\$aas plant & food
=680  \\$iAny of the various plants of the genus Lactuca, especially L. sativa, cultivated for its edible leaves. (From American Heritage Dictionary, 2d ed)
=688  \\$a95
=750  \0$aLettuce$5IEN-M$0(DLC)sh 85076251

=LDR  01064cz  a2200289n  4500
=001  9880364084302441
=005  20141212212628.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018476
=035  \\$aCSK5633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x400
=072  \\$aC23.$x888.$x592.$x350.$x400
=150  \\$aHypokinesia
=450  \\$wnnna$aAntiorthostatic Hypokinesia
=450  \\$wnnna$aAntiorthostatic Hypokinesias
=450  \\$aBradykinesia
=450  \\$wnnna$aBradykinesias
=450  \\$aHypodynamia
=450  \\$wnnna$aHypokinesia, Antiorthostatic
=450  \\$wnnna$aHypokinesias, Antiorthostatic
=550  \\$wg$aDyskinesias
=550  \\$aImmobilization
=667  \\$ain Russian lit "hypokinesia" = IMMOBILIZATION
=680  \\$iSlow or diminished movement of body musculature. It may be associated with BASAL GANGLIA DISEASES; MENTAL DISORDERS; prolonged inactivity due to illness; and other conditions.
=688  \\$a1995; for KINESIA use IMMOBILIZATION 1992-1994
=750  \0$aHypokinesia$5IEN-M$0(DLC)sh 85063792

=LDR  00716cz  a2200193n  4500
=001  9880364084402441
=005  20141212212644.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018527
=035  \\$aCSK5629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x581
=150  \\$aHydroponics
=450  \\$wnnna$aHydroponic
=550  \\$wg$aAgriculture
=667  \\$aa plant-growing method; SPEC: SPEC qualif
=680  \\$iA technique for growing plants in culture solutions rather than in soil. The roots are immersed in an aerated solution containing the correct proportions of essential mineral salts. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aHydroponics$5IEN$0(DLC)sh 85063484

=LDR  00779cz  a2200253n  4500
=001  9880364084502441
=005  20141212212627.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018470
=035  \\$aCSK5627M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x60.$x535.$x369
=150  \\$aGravity, Altered
=450  \\$wnnna$aArtificial Gravity
=450  \\$aGravity, Artificial
=550  \\$wg$aGravitation
=550  \\$wh$aHypergravity
=550  \\$wh$aHypogravity
=550  \\$aCentrifugation
=550  \\$aRotation
=667  \\$anatural or artificial; /adv eff permitted
=680  \\$iA change in, or manipulation of, gravitational force. This may be a natural or artificial effect.
=688  \\$a95
=750  \0$aArtificial gravity$5IEN-M$0(DLC)sh2002011286

=LDR  01033cz  a2200241n  4500
=001  9880364084602441
=005  20141212212643.0
=008  940607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018522
=035  \\$aCSK5625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x249.$x845.$x400
=072  \\$aG15.$x744.$x900.$x400
=150  \\$aGravitropism
=450  \\$aGeotropism
=450  \\$wnnna$aGeotropisms
=450  \\$wnnna$aGravitropisms
=550  \\$wg$aTropism
=550  \\$aGravitation
=667  \\$adirectional growth of a plant in response to gravity
=680  \\$iThe directional growth of organisms in response to gravity. In plants, the main root is positively gravitropic (growing downwards) and a main stem is negatively gravitropic (growing upwards), irrespective of the positions in which they are placed. Plant gravitropism is thought to be controlled by auxin (AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990)
=688  \\$a95
=750  \0$aGeotropism$0(DLC) sh 85054275$5IEN-M

=LDR  00965cz  a2200217n  4500
=001  9880364054602441
=005  20141212210326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014131
=035  \\$aCBA7465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x605.$x555
=072  \\$aJ2.$x500.$x631.$x555
=150  \\$aTrace Elements
=450  \\$wnnna$aBiometals
=450  \\$wnnna$aElements, Trace
=550  \\$wg$aMicronutrients
=550  \\$aMicronutrients
=667  \\$ado not coordinate with METALS for "trace metals" nor with MINERALS for "trace minerals"; do not confuse with "tracers" used for detection or with trace amounts of substances in tissue, food, etc.
=680  \\$iA group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aTrace elements$5IEN$0(DLC)sh 85136387

=LDR  01118cz  a2200241n  4500
=001  9880364054702441
=005  20141212210324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014126
=035  \\$aCBA7460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x300.$x781
=072  \\$aC3.$x752.$x250.$x800.$x640
=072  \\$aC11.$x294.$x725.$x781
=150  \\$aToxoplasmosis, Ocular
=450  \\$wnnna$aOcular Toxoplasmoses
=450  \\$aOcular Toxoplasmosis
=450  \\$wnnna$aToxoplasmoses, Ocular
=550  \\$wg$aEye Infections, Parasitic
=550  \\$wg$aToxoplasmosis
=667  \\$a/congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL
=680  \\$iInfection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.
=750  \0$aOcular toxoplasmosis$5IEN$0(DLC)sh 85136340

=LDR  02253cz  a2200457n  4500
=001  9880364054802441
=005  20141212210324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014125
=035  \\$aCBA7459M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x250.$x800.$x445
=072  \\$aC10.$x228.$x228.$x205.$x300.$x900
=072  \\$aC16.$x614.$x909
=150  \\$aToxoplasmosis, Congenital
=450  \\$wnnna$aCongenital Infection, Toxoplasma gondii
=450  \\$aCongenital Toxoplasma gondii Infection
=450  \\$wnnna$aCongenital Toxoplasma Infection
=450  \\$wnnna$aCongenital Toxoplasma Infections
=450  \\$wnnna$aCongenital Toxoplasmoses
=450  \\$wnnna$aCongenital Toxoplasmosis
=450  \\$wnnna$aFetal Toxoplasmoses
=450  \\$wnnna$aFetal Toxoplasmosis
=450  \\$wnnna$aInfection, Congenital Toxoplasma
=450  \\$wnnna$aInfections, Congenital Toxoplasma
=450  \\$wnnna$aPrenatal Toxoplasmoses
=450  \\$wnnna$aPrenatal Toxoplasmosis
=450  \\$wnnna$aToxoplasma Infection, Congenital
=450  \\$wnnna$aToxoplasma Infections, Congenital
=450  \\$wnnna$aToxoplasmoses, Congenital
=450  \\$wnnna$aToxoplasmoses, Fetal
=450  \\$wnnna$aToxoplasmoses, Prenatal
=450  \\$aToxoplasmosis$xcongenital
=450  \\$aToxoplasmosis, Fetal
=450  \\$aToxoplasmosis, Prenatal
=550  \\$wg$aCentral Nervous System Protozoal Infections
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aToxoplasmosis
=667  \\$a/vet = TOXOPLASMOSIS, ANIMAL /congen
=680  \\$iPrenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)
=750  \0$aCongenital toxoplasmosis$5IEN-M$0(DLC)sh 99011591

=LDR  00968cz  a2200277n  4500
=001  9880364054902441
=005  20141212210323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014124
=035  \\$aCBA7458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x688.$x817
=072  \\$aC3.$x752.$x250.$x800.$x110
=072  \\$aC3.$x752.$x625.$x817
=072  \\$aC22.$x674.$x710.$x817
=150  \\$aToxoplasmosis, Animal
=450  \\$wnnna$aAnimal Toxoplasmoses
=450  \\$wnnna$aAnimal Toxoplasmosis
=450  \\$wnnna$aToxoplasmoses, Animal
=450  \\$aToxoplasmosis In Animals$5IEN
=450  \\$aToxoplasmosis$xveterinary
=550  \\$wg$aProtozoan Infections, Animal
=550  \\$wg$aToxoplasmosis
=667  \\$aexper or vet; /congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL
=680  \\$iAcquired infection of non-human animals by organisms of the genus TOXOPLASMA.
=750  \0$aToxoplasmosis in animals$5IEN$0(DLC)sh 85136341

=LDR  00921cz  a2200277n  4500
=001  9880364055002441
=005  20141212210323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014123
=035  \\$aCBA7457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x250.$x800
=150  \\$aToxoplasmosis
=450  \\$wnnna$aInfection, Toxoplasma gondii
=450  \\$wnnna$aInfections, Toxoplasma gondii
=450  \\$aToxoplasma gondii Infection
=450  \\$wnnna$aToxoplasma gondii Infections
=450  \\$wnnna$aToxoplasmoses
=550  \\$wg$aCoccidiosis
=550  \\$wh$aToxoplasmosis, Animal
=550  \\$wh$aToxoplasmosis, Cerebral
=550  \\$wh$aToxoplasmosis, Congenital
=550  \\$wh$aToxoplasmosis, Ocular
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iThe acquired form of infection by Toxoplasma gondii in animals and man.
=750  \0$aToxoplasmosis$5IEN$0(DLC)sh 85136339

=LDR  00923cz  a2200229n  4500
=001  9880364055102441
=005  20141212210323.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014122
=035  \\$aCBA7456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x750.$x800
=150  \\$aToxoplasma
=450  \\$wnnna$agondii, Toxoplasma
=450  \\$wnnna$agondius, Toxoplasma
=450  \\$aToxoplasma gondii
=450  \\$wnnna$aToxoplasma gondius
=450  \\$wnnna$aToxoplasmas
=550  \\$wg$aSarcocystidae
=667  \\$ainfection = TOXOPLASMOSIS & its specifics; agents used to treat toxoplasmosis = COCCIDIOSTATS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.
=750  \0$aToxoplasma$5IEN$0(DLC)sh 88021464

=LDR  00876cz  a2200193n  4500
=001  9880364055202441
=005  20141212210322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014119
=035  \\$aCBA7453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x100.$x100.$x780
=150  \\$aToxocara
=450  \\$wnnna$aToxocaras
=550  \\$wg$aAscaridoidea
=550  \\$wh$aToxocara canis
=667  \\$aa genus of nematodes common in cat & dog intestine but TOXOCARA CANIS is available; do not confuse with TOXASCARIS, also a nematode genus; infection = TOXOCARIASIS (not to be confused with TOXASCARIASIS); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.
=750  \0$aToxocara$5IEN$0(DLC)sh 88021668

=LDR  01155cz  a2200325n  4500
=001  9880364055302441
=005  20141212210322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014118
=035  \\$aCBA7452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946
=150  \\$aToxins, Biological
=450  \\$wnnna$aBiological Toxins
=550  \\$wg$aBiological Factors
=550  \\$wh$aBacterial Toxins
=550  \\$wh$aEnterotoxins
=550  \\$wh$aExotoxins
=550  \\$wh$aHypoglycins
=550  \\$wh$aMarine Toxins
=550  \\$wh$aMycotoxins
=550  \\$wh$aVenoms
=550  \\$wh$aVirulence Factors
=550  \\$aToxoids
=667  \\$ageneral or unspecified; prefer specifics; /antag permitted but consider also ANTITOXINS
=680  \\$iSpecific, characterizable, poisonous chemicals, often PROTEINS, with specific biological properties, including immunogenicity, produced by microbes, higher plants (PLANTS, TOXIC), or ANIMALS.
=688  \\$a2006(1966)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Toxins
=688  \\$a66; TOXINS AND ANTITOXINS was heading 1963-65
=750  \0$aToxins$0(DLC) sh 85136335$5IEN

=LDR  01040cz  a2200253n  4500
=001  9880364055402441
=005  20141212210321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014116
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x795
=072  \\$aH2.$x628.$x795
=150  \\$aToxicology
=450  \\$aToxinology
=550  \\$wg$aPharmacology
=550  \\$wh$aEcotoxicology
=550  \\$wh$aForensic Toxicology
=550  \\$wh$aToxicogenetics
=550  \\$aPharmacogenetics
=667  \\$athe discipline (education, history, etc) only; use DRUG TOXICITY or specifics or specific drug with /adv eff /pois or/tox for studies of the adverse effects of drugs
=680  \\$iThe science concerned with the detection, chemical composition, and biological action of toxic substances or poisons and the treatment and prevention of toxic manifestations.
=750  \0$aToxicology, Experimental$5IEN-M$0(DLC)sh 85136332
=750  \0$aToxicologists$5IEN-HS$0(DLC)sh 85136330
=750  \0$aToxicology$5IEN-HS$0(DLC)sh 85136331

=LDR  00958cz  a2200217n  4500
=001  9880364055502441
=005  20141212210320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014112
=035  \\$aCBA7447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x913
=072  \\$aD2.$x455.$x849.$x575.$x781.$x795
=150  \\$aToxaphene
=450  \\$wnnna$aPolychlorocamphene
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wg$aNorbornanes
=667  \\$aTN 111 for eff on insects
=680  \\$iA very complex, but reproducible mixture of at least 177 C10 polychloro derivatives, having an approximate overall empirical formula of C10-H10-Cl8. It is used as an insecticide and may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
=688  \\$a91(72); was see under INSECTICIDES, ORGANOCHLORINE 1972-90
=750  \0$aToxaphene$5IEN$0(DLC)sh 86005964

=LDR  00633cz  a2200181n  4500
=001  9880364055602441
=005  20141212210320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014111
=035  \\$aCBA7446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x926
=150  \\$aTourniquets
=450  \\$wnnna$aTourniquet
=550  \\$wg$aEquipment and Supplies
=680  \\$iDevices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. (From Dorland, 28th ed)
=688  \\$a66(63)
=750  \0$aTourniquets$5IEN$0(DLC)sh 85136277

=LDR  02200cz  a2200457n  4500
=001  9880364055702441
=005  20141212201724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005879
=035  \\$aCBA7445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x898
=072  \\$aC10.$x228.$x662.$x825.$x800
=072  \\$aC10.$x574.$x500.$x850
=072  \\$aC16.$x320.$x400.$x820
=072  \\$aF3.$x550.$x825.$x850
=150  \\$aTourette Syndrome
=450  \\$wnnna$aChronic Motor and Vocal Tic Disorder
=450  \\$wnnna$aCombined Multiple Motor and Vocal Tic Disorder
=450  \\$wnnna$aCombined Vocal and Multiple Motor Tic Disorder
=450  \\$wnnna$aGilles de la Tourette Syndrome
=450  \\$aGilles de la Tourette's Disease
=450  \\$wnnna$aGilles De La Tourette's Syndrome
=450  \\$wnnna$aMultiple Motor and Vocal Tic Disorder, Combined
=450  \\$wnnna$aSyndrome, Tourette's
=450  \\$aTic Disorder, Combined Vocal and Multiple Motor
=450  \\$wnnna$aTourette Disease
=450  \\$wnnna$aTourette Disorder
=450  \\$wnnna$aTourette's Disease
=450  \\$wnnna$aTourettes Disease
=450  \\$wnnna$aTourette's Disorder
=450  \\$wnnna$aTourettes Disorder
=450  \\$wnnna$aTourette's Syndrome
=450  \\$wnnna$aTourettes Syndrome
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aTic Disorders
=550  \\$aTics
=680  \\$iA neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a general medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
=688  \\$a1989(1966)
=750  \0$aTourette syndrome$5IEN$0(DLC)sh 85054937

=LDR  01030cz  a2200289n  4500
=001  9880364055802441
=005  20141212210320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014110
=035  \\$aCBA7444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x850
=072  \\$aG11.$x561.$x600.$x810.$x850
=150  \\$aTouch
=450  \\$wnnna$aSense of Touch
=450  \\$wnnna$aSense, Tactile
=450  \\$wnnna$aSenses, Tactile
=450  \\$aTactile Sense
=450  \\$wnnna$aTactile Senses
=450  \\$wnnna$aTaction
=450  \\$wnnna$aTactions
=450  \\$wnnna$aTouch Sense
=450  \\$wnnna$aTouch Senses
=550  \\$wg$aSensation
=667  \\$adifferentiate from TOUCH PERCEPTION: TOUCH takes place in the skin and mucous membranes, TOUCH PERCEPTION takes place in the brain
=680  \\$iSensation of making physical contact with objects, animate or inanimate. Tactile stimuli are detected by MECHANORECEPTORS in the skin and mucous membranes.
=750  \0$aTouch$5IEN$0(DLC)sh 85136234

=LDR  00796cz   2200217n  4500
=001  9880364055902441
=005  20220922154947.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014104
=035  \\$aCBA7438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x825
=072  \\$aI1.$x880.$x735.$x900.$x825
=150  \\$aTorture
=550  \\$wg$aViolence
=550  \\$aHuman Rights Abuses
=667  \\$aof humans or animals; physical or mental torture
=680  \\$iThe intentional infliction of physical or mental suffering upon an individual or individuals, including the torture of animals.
=688  \\$a84(75); was see under AGGRESSION 1975-83
=750  \0$aTorture$5IEN$0(DLC)sh 85136190
=750  \0$iNarrower mapping$aPeine forte et dure$0(DLC)sh2021006835$4NM$5IEN-M

=LDR  01174cz  a2200289n  4500
=001  9880364056002441
=005  20141212210317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014103
=035  \\$aCBA7437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662.$x300.$x750
=072  \\$aC10.$x597.$x350.$x300.$x800
=072  \\$aC23.$x888.$x592.$x350.$x300.$x800
=150  \\$aTorticollis
=450  \\$aCervical Dystonia
=450  \\$wnnna$aIntermittent Torticollis
=450  \\$wnnna$aPsychogenic Torticollis
=450  \\$aSpasmodic Torticollis
=450  \\$wnnna$aTorticollis, Intermittent
=450  \\$wnnna$aTorticollis, Psychogenic
=450  \\$wnnna$aTorticollis, Spasmodic
=450  \\$aWryneck
=550  \\$wg$aDystonia
=550  \\$wg$aDystonic Disorders
=680  \\$iA symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.
=750  \0$aTorticollis$5IEN$0(DLC)sh 85136171

=LDR  00870cz  a2200241n  4500
=001  9880364056102441
=005  20141212210317.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014101
=035  \\$aCBA7435M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x935
=072  \\$aB1.$x50.$x150.$x900.$x493.$x378.$x722
=150  \\$aTorpedo
=450  \\$aElectric Rays
=450  \\$wnnna$aRays, Electric
=450  \\$wnnna$aTorpedinidae
=550  \\$wg$aElasmobranchii
=550  \\$wg$aElectric Fish
=667  \\$ado not confuse X ref ELECTRIC RAYS with RAYS (FISH) see SKATES (FISH)
=680  \\$iA genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.
=688  \\$a1982
=750  \0$aTorpedo (Fish genus)$0(DLC)sh2007001497$5IEN-M

=LDR  00784cz  a2200217n  4500
=001  9880364056202441
=005  20141212210316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014100
=035  \\$aCBA7434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x376.$x711
=072  \\$aJ1.$x637.$x51.$x376.$x711
=150  \\$aToothpastes
=450  \\$aToothpaste
=550  \\$wg$aDentifrices
=680  \\$iDentifrices that are formulated into a paste form. They typically contain abrasives, HUMECTANTS; DETERGENTS; FLAVORING AGENTS; and CARIOSTATIC AGENTS.
=688  \\$a2011(1975); use DENTIFRICES 1975-1990
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Toothpaste
=688  \\$a91(75); was see under DENTIFRICES 1975-90
=750  \0$aToothpaste$0(DLC) sh 96010366$5IEN

=LDR  00776cz  a2200229n  4500
=001  9880364056302441
=005  20141212210316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014099
=035  \\$aCBA7433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x761.$x726.$x794
=150  \\$aToothbrushing
=450  \\$aToothbrushes$5IEN
=450  \\$wnnna$aToothbrushings
=550  \\$wg$aOral Hygiene
=550  \\$aDental Devices, Home Care
=550  \\$aOral Hygiene
=667  \\$arestrict to brushing with a toothbrush: see note at DENTAL DEVICES, HOME CARE
=680  \\$iThe act of cleaning teeth with a brush to remove plaque and prevent tooth decay. (From Webster, 3d ed)
=688  \\$a70; was TOOTHBRUSHES 1963-69
=750  \0$aToothbrushes$5IEN$0(DLC)sh 85136059

=LDR  00591cz  a2200217n  4500
=001  9880364056402441
=005  20141212210316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014098
=035  \\$aCBA7432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x929
=072  \\$aC23.$x888.$x646.$x429.$x800
=150  \\$aToothache
=450  \\$aOdontalgia
=450  \\$wnnna$aOdontalgias
=450  \\$wnnna$aToothaches
=550  \\$wg$aFacial Pain
=550  \\$wg$aTooth Diseases
=680  \\$iPain in the adjacent areas of the teeth.
=750  \0$aToothache$5IEN$0(DLC)sh 85136058

=LDR  01419cz  a2200457n  4500
=001  9880364056502441
=005  20141212210315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014094
=035  \\$aCBA7428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x700
=150  \\$aTooth, Deciduous
=450  \\$wnnna$aBaby Teeth
=450  \\$wnnna$aBaby Tooth
=450  \\$wnnna$aDeciduous Dentition
=450  \\$wnnna$aDeciduous Dentitions
=450  \\$wnnna$aDeciduous Teeth
=450  \\$wnnna$aDeciduous Tooth
=450  \\$wnnna$aDentition, Deciduous
=450  \\$wnnna$aDentition, Primary
=450  \\$wnnna$aDentitions, Deciduous
=450  \\$wnnna$aDentitions, Primary
=450  \\$wnnna$aMilk Teeth
=450  \\$wnnna$aMilk Tooth
=450  \\$wnnna$aPrimary Dentition
=450  \\$wnnna$aPrimary Dentitions
=450  \\$wnnna$aPrimary Teeth
=450  \\$aPrimary Tooth
=450  \\$wnnna$aTeeth, Baby
=450  \\$wnnna$aTeeth, Deciduous
=450  \\$wnnna$aTeeth, Milk
=450  \\$wnnna$aTeeth, Primary
=450  \\$wnnna$aTooth, Baby
=450  \\$wnnna$aTooth, Milk
=450  \\$aTooth, Primary
=550  \\$wg$aTooth
=550  \\$wh$aNatal Teeth
=680  \\$iThe teeth of the first dentition, which are shed and replaced by the permanent teeth.
=688  \\$a65; was TEETH, DECIDUOUS 1963-64
=750  \0$aDeciduous teeth$0(DLC)sh 85133235$5IEN-M

=LDR  01267cz  a2200229n  4500
=001  9880364056602441
=005  20141212210314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014092
=035  \\$aCBA7426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x900.$x750
=150  \\$aTooth Root
=450  \\$wnnna$aRoot, Tooth
=450  \\$wnnna$aRoots, Tooth
=450  \\$wnnna$aTooth Roots
=550  \\$wg$aTooth Components
=550  \\$wh$aTooth Apex
=667  \\$adis: coord IM with TOOTH DISEASES (IM); root fract or radicular fract: index under TOOTH ROOT /inj (IM) + TOOTH FRACTURES (IM); dilaceration of root: index under TOOTH ROOT /abnorm; TOOTH APEX is available
=680  \\$iThe part of a tooth from the neck to the apex, embedded in the alveolar process and covered with cementum. A root may be single or divided into several branches, usually identified by their relative position, e.g., lingual root or buccal root. Single-rooted teeth include mandibular first and second premolars and the maxillary second premolar teeth. The maxillary first premolar has two roots in most cases. Maxillary molars have three roots. (Jablonski, Dictionary of Dentistry, 1992, p690)
=688  \\$a65
=750  \0$aTeeth$xRoots$5IEN$0(DLC)sh 85133228

=LDR  02083cz  a2200565n  4500
=001  9880364056702441
=005  20180122105644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014087
=035  \\$aCBA7421HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x578.$x836
=150  \\$aTooth Movement Techniques
=450  \\$wnno$aTooth Movement
=450  \\$wnnna$aDepression, Tooth
=450  \\$wnnna$aDepressions, Tooth
=450  \\$wnnna$aIntrusion, Tooth
=450  \\$wnnna$aIntrusions, Tooth
=450  \\$wnnna$aOrthodontic Tooth Movement
=450  \\$wnnna$aOrthodontic Tooth Movements
=450  \\$wnnna$aMinor Tooth Movement
=450  \\$wnnna$aMinor Tooth Movements
=450  \\$wnnna$aMovement, Orthodontic Tooth
=450  \\$wnnna$aMovement, Tooth
=450  \\$wnnna$aMovement Techniques, Tooth
=450  \\$wnnna$aMovement Techniques, Tooth
=450  \\$wnnna$aMovements, Orthodontic Tooth
=450  \\$wnnna$aMovements, Tooth
=450  \\$wnnna$aTechnique, Tooth Movement
=450  \\$wnnna$aTechniques, Tooth Movement
=450  \\$aTooth Depression
=450  \\$wnnna$aTooth Depressions
=450  \\$aTooth Intrusion
=450  \\$wnnna$aTooth Intrusions
=450  \\$aTooth Movement, Minor
=450  \\$wnnna$aTooth Movement, Orthodontic
=450  \\$wnnna$aTooth Movement Technique
=450  \\$wnnna$aTooth Movements, Orthodontic
=450  \\$wnnna$aTooth Movements, Minor
=450  \\$aTooth Uprighting
=450  \\$wnnna$aTooth Uprightings
=450  \\$wnnna$aUprighting, Tooth
=450  \\$wnnna$aUprightings, Tooth
=550  \\$wg$aOrthodontics, Corrective
=667  \\$anote category; do not confuse with TOOTH MIGRATION or TOOTH MOBILITY
=680  \\$iOrthodontic techniques used to correct the malposition of a single tooth or teeth.
=688  \\$a97; was TOOTH MOVEMENT, MINOR 1973-96
=750  \0$81$wb$aTeeth$0(DLC)sh 85133203$5IEN-M
=780  \0$81$wb$xMovements$0(DLC)sh2002006195$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading$aTeeth--Movements

=LDR  01229cz  a2200241n  4500
=001  9880364056802441
=005  20141212210312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014086
=035  \\$aCBA7420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x898
=072  \\$aG10.$x549.$x840
=150  \\$aTooth Mobility
=450  \\$wnnna$aMobilities, Tooth
=450  \\$wnnna$aMobility, Tooth
=450  \\$wnnna$aTooth Mobilities
=550  \\$wg$aDental Physiological Phenomena
=550  \\$wg$aPeriodontal Diseases
=667  \\$aphysiol mobility of deciduous teeth or pathol mobility of permanent teeth in periodontal dis or trauma; use Cat C qualif; do not confuse with TOOTH MOVEMENT (an orthodontic procedure)
=680  \\$iHorizontal and, to a lesser degree, axial movement of a tooth in response to normal forces, as in occlusion. It refers also to the movability of a tooth resulting from loss of all or a portion of its attachment and supportive apparatus, as seen in periodontitis, occlusal trauma, and periodontosis. (From Jablonski, Dictionary of Dentistry, 1992, p507 & Boucher's Clinical Dental Terminology, 4th ed, p313)
=688  \\$a65
=750  \0$aTeeth$xMobility$5IEN$0(DLC)sh 85133223

=LDR  00704cz  a2200241n  4500
=001  9880364056902441
=005  20141212210311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014082
=035  \\$aCBA7416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x850.$x750
=072  \\$aC26.$x900.$x750
=150  \\$aTooth Fractures
=450  \\$wnnna$aFracture, Tooth
=450  \\$wnnna$aFractures, Tooth
=450  \\$wnnna$aTooth Fracture
=550  \\$wg$aTooth Injuries
=550  \\$wh$aCracked Tooth Syndrome
=667  \\$acoord IM with specific tooth /inj (IM)
=680  \\$iBreak or rupture of a tooth or tooth root.
=688  \\$a66(65)
=750  \0$aTeeth$xFractures$5IEN$0(IEN)379323

=LDR  00847cz  a2200253n  4500
=001  9880364057002441
=005  20141212210311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014081
=035  \\$aCBA7415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x700
=072  \\$aE6.$x645.$x700
=150  \\$aTooth Extraction
=450  \\$wnnna$aExtraction, Tooth
=450  \\$wnnna$aExtractions, Tooth
=450  \\$wnnna$aTooth Extractions
=550  \\$wg$aOral Surgical Procedures
=550  \\$wh$aSerial Extraction
=550  \\$aDry Socket
=667  \\$aSERIAL EXTRACTION is available as orthodontic proced for sequential removal of teeth over a period of years
=680  \\$iThe surgical removal of a tooth. (Dorland, 28th ed)
=688  \\$a65; was TEETH EXTRACTION 1963-64
=750  \0$aTeeth$xExtraction$5IEN$0(DLC)sh 85133217

=LDR  00854cz  a2200241n  4500
=001  9880364057102441
=005  20141212210310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014078
=035  \\$aCBA7412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x549.$x235.$x726
=150  \\$aTooth Eruption
=450  \\$wnnna$aEruption, Tooth
=450  \\$wnnna$aEruptions, Tooth
=450  \\$aTeething
=450  \\$wnnna$aTooth Eruptions
=550  \\$wg$aDental Physiological Processes
=550  \\$aTooth Eruption, Ectopic
=680  \\$iThe emergence of a tooth from within its follicle in the ALVEOLAR PROCESS of the MAXILLA or MANDIBLE into the ORAL CAVITY. (Boucher's Clinical Dental Terminology, 4th ed)
=688  \\$a65
=750  \0$aTeeth$xEruption$0(DLC)sh 92004395$5IEN-M
=750  \0$aDeciduous teeth$xEruption$0(DLC)sh 85133236$5IEN-M

=LDR  00896cz  a2200217n  4500
=001  9880364057202441
=005  20141212210310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014077
=035  \\$aCBA7411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x818.$x500
=150  \\$aTooth Erosion
=450  \\$wnnna$aErosion, Tooth
=450  \\$wnnna$aErosions, Tooth
=450  \\$wnnna$aTooth Erosions
=550  \\$wg$aTooth Wear
=667  \\$aloss of substance caused by chem action without bact action: differentiate from TOOTH ABRASION (loss of substance caused by friction) & TOOTH ATTRITION (wearing away through tooth-to-tooth contact)
=680  \\$iProgressive loss of the hard substance of a tooth by chemical processes that do not involve bacterial action. (Jablonski, Dictionary of Dentistry, 1992, p296)
=688  \\$a65
=750  \0$aTeeth$xErosion$5IEN$0(DLC)sh 85133216

=LDR  01333cz  a2200469n  4500
=001  9880364057302441
=005  20141212210309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014076
=035  \\$aCBA7410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793
=150  \\$aTooth Diseases
=450  \\$wnnna$aDisease, Tooth
=450  \\$wnnna$aDiseases, Tooth
=450  \\$wnnna$aTooth Disease
=550  \\$wg$aStomatognathic Diseases
=550  \\$wh$aBruxism
=550  \\$wh$aDental Deposits
=550  \\$wh$aDental Leakage
=550  \\$wh$aDental Pulp Diseases
=550  \\$wh$aDentin Sensitivity
=550  \\$wh$aFluorosis, Dental
=550  \\$wh$aFocal Infection, Dental
=550  \\$wh$aHypercementosis
=550  \\$wh$aMalocclusion
=550  \\$wh$aMouth, Edentulous
=550  \\$wh$aTooth Abnormalities
=550  \\$wh$aTooth Ankylosis
=550  \\$wh$aTooth Demineralization
=550  \\$wh$aTooth Discoloration
=550  \\$wh$aTooth Eruption, Ectopic
=550  \\$wh$aTooth, Impacted
=550  \\$wh$aTooth Injuries
=550  \\$wh$aTooth Loss
=550  \\$wh$aTooth Resorption
=550  \\$wh$aTooth, Unerupted
=550  \\$wh$aTooth Wear
=550  \\$wh$aToothache
=667  \\$aGEN: prefer specifics
=688  \\$a65
=750  \0$aTeeth$xDiseases$5IEN$0(DLC)sh 85133211

=LDR  00990cz  a2200217n  4500
=001  9880364057402441
=005  20141212210309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014075
=035  \\$aCBA7409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x735
=150  \\$aTooth Discoloration
=450  \\$wnnna$aDiscoloration, Tooth
=450  \\$wnnna$aDiscolorations, Tooth
=450  \\$wnnna$aTooth Discolorations
=550  \\$wg$aTooth Diseases
=667  \\$aexternal staining or staining within pulp; from any cause; coord IM with cause if pertinent (IM or NIM); do not confuse with FLUOROSIS, DENTAL (occurring during tooth calcification)
=680  \\$iAny change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs (both topical and systemic), pulpal necrosis, or hemorrhage may be responsible. (Jablonski, Dictionary of Dentistry, 1992, p253)
=688  \\$a65
=750  \0$aTeeth$xDiscoloration$5IEN$0(DLC)sh 85133210

=LDR  01147cz  a2200289n  4500
=001  9880364057502441
=005  20141212210309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014074
=035  \\$aCBA7408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x186.$x710
=072  \\$aG10.$x549.$x235.$x688
=150  \\$aTooth Calcification
=450  \\$wnnna$aCalcification, Teeth
=450  \\$aCalcification, Tooth
=450  \\$wnnna$aCalcifications, Teeth
=450  \\$wnnna$aCalcifications, Tooth
=450  \\$wnnna$aTeeth Calcification
=450  \\$wnnna$aTeeth Calcifications
=450  \\$wnnna$aTooth Calcifications
=550  \\$wg$aCalcification, Physiologic
=550  \\$wg$aDental Physiological Processes
=667  \\$athe physiol process; hypocalcification is probably indexed under AMELOGENESIS IMPERFECTA or DENTAL ENAMEL HYPOPLASIA
=680  \\$iThe process whereby calcium salts are deposited in the dental enamel. The process is normal in the development of bones and teeth. (Boucher's Clinical Dental Terminology, 4th ed, p43)
=688  \\$a65
=750  \0$aTeeth$xCalcification$5IEN$0(DLC)sh2010006841

=LDR  00903cz  a2200277n  4500
=001  9880364057602441
=005  20141212210308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014073
=035  \\$aCBA7407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x420.$x750
=150  \\$aTooth Bleaching
=450  \\$wnnna$aBleaching, Teeth
=450  \\$wnnna$aBleaching, Tooth
=450  \\$wnnna$aTeeth Bleaching
=450  \\$wnnna$aTeeth Whitening
=450  \\$wnnna$aTooth Whitening
=450  \\$wnnna$aWhitening, Teeth
=450  \\$wnnna$aWhitening, Tooth
=550  \\$wg$aEsthetics, Dental
=550  \\$aTooth Bleaching Agents
=550  \\$aTooth Discoloration
=680  \\$iThe use of a chemical oxidizing agent to whiten TEETH. In some procedures the oxidation process is activated by the use of heat or light.
=688  \\$a72(71)
=750  \0$aTeeth$xBleaching$5IEN$0(DLC)sh 85133207

=LDR  01121cz  a2200229n  4500
=001  9880364057702441
=005  20141212210308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014072
=035  \\$aCBA7406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x818.$x124
=150  \\$aTooth Abrasion
=450  \\$wnnna$aAbrasion, Dental
=450  \\$wnnna$aAbrasion, Tooth
=450  \\$aDental Abrasion
=550  \\$wg$aTooth Wear
=667  \\$ado not confuse with TOOTH ATTRITION or TOOTH EROSION
=680  \\$iThe pathologic wearing away of the tooth substance by brushing, bruxism, clenching, and other mechanical causes. It is differentiated from TOOTH ATTRITION in that this type of wearing away is the result of tooth-to-tooth contact, as in mastication, occurring only on the occlusal, incisal, and proximal surfaces. It differs also from TOOTH EROSION, the progressive loss of the hard substance of a tooth by chemical processes not involving bacterial action. (From Jablonski, Dictionary of Dentistry, 1992, p2)
=688  \\$a1965
=688  \\$a65
=750  \0$aTeeth$xAbrasion$5IEN$0(DLC)sh 85133205

=LDR  01569cz  a2200433n  4500
=001  9880364057802441
=005  20141212210308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014071
=035  \\$aCBA7405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x650.$x800
=072  \\$aC7.$x793.$x700
=072  \\$aC16.$x131.$x850.$x800
=150  \\$aTooth Abnormalities
=450  \\$wnnna$aAbnormalities, Teeth
=450  \\$wnnna$aAbnormalities, Tooth
=450  \\$wnnna$aAbnormality, Teeth
=450  \\$wnnna$aAbnormality, Tooth
=450  \\$aOdontome
=450  \\$wnnna$aOdontomes
=450  \\$wnnna$aTeeth Abnormalities
=450  \\$wnnna$aTeeth Abnormality
=450  \\$aTooth$xabnormalities
=450  \\$wnnna$aTooth Abnormality
=550  \\$wg$aStomatognathic System Abnormalities
=550  \\$wg$aTooth Diseases
=550  \\$wh$aAnodontia
=550  \\$wh$aDens in Dente
=550  \\$wh$aDental Enamel Hypoplasia
=550  \\$wh$aDentin Dysplasia
=550  \\$wh$aDentinogenesis Imperfecta
=550  \\$wh$aFused Teeth
=550  \\$wh$aOdontodysplasia
=550  \\$wh$aTooth, Supernumerary
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; duplication of teeth = TOOTH, SUPERNUMERARY; abnorm in congen syphilis = HUTCHINSON'S TEETH see SYPHILIS, CONGENITAL; X ref ODONTOME (a form of developmental dental anomaly): do not confuse with ODONTOMA
=680  \\$iCongenital absence of or defects in structures of the teeth.
=688  \\$a65
=750  \0$aTeeth$xAbnormalities$5IEN$0(DLC)sh 85133204

=LDR  01291cz  a2200325n  4500
=001  9880364057902441
=005  20190328102906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014070
=035  \\$aCBA7404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860
=150  \\$aTooth
=360  \\$iconsider also terms at$aDENT-$aODONTO-
=450  \\$wnnna$aTeeth
=550  \\$wg$aDentition
=550  \\$wh$aBicuspid
=550  \\$wh$aCuspid
=550  \\$wh$aIncisor
=550  \\$wh$aMolar
=550  \\$wh$aTooth, Deciduous
=550  \\$wh$aTooth, Unerupted
=550  \\$aDentition
=550  \\$aMastication
=550  \\$aOdontogenesis
=550  \\$aPaleodontology
=667  \\$a/embryol: consider also TOOTH GERM & ODONTOGENESIS; /ph permitted but consider DENTAL PHYSIOLOGICAL PHENOMENA for function of dentition as a whole; tooth size & dimension = TOOTH /anat (IM) + ODONTOMETRY (NIM); permanent tooth = TOOTH, deciduous tooth = TOOTH, DECIDUOUS; tooth pain = TOOTHACHE; tooth sensitivity = DENTIN SENSITIVITY
=680  \\$iOne of a set of bone-like structures in the mouth used for biting and chewing.
=688  \\$a65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965
=750  \0$iBroader mapping$aTeeth$0(DLC)sh 85133203$4BM$5IEN-M

=LDR  00900cz  a2200217n  4500
=001  9880364058002441
=005  20141212210307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014069
=035  \\$aCBA7403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x550.$x781.$x750
=072  \\$aC8.$x730.$x561.$x750
=072  \\$aC9.$x775.$x649.$x750
=150  \\$aTonsillitis
=450  \\$wnnna$aTonsillitides
=550  \\$wg$aPharyngitis
=550  \\$wh$aPeritonsillar Abscess
=667  \\$acoordinate IM with infection (IM) if specified; lingual tonsillitis: coordinate IM with TONGUE (NIM)
=680  \\$iInflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.
=750  \0$aTonsillitis$5IEN$0(DLC)sh 85136023

=LDR  00697cz  a2200193n  4500
=001  9880364058102441
=005  20141212210306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014068
=035  \\$aCBA7402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x848
=150  \\$aTonsillectomy
=450  \\$wnnna$aTonsillectomies
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=550  \\$aPalatine Tonsil
=667  \\$ado not use /util except by MeSH definition; post-tonsillectomy hemorrh = HEMORRHAGE + POSTOPERATIVE COMPLICATIONS, not HEMORRHAGE, ORAL
=680  \\$iSurgical removal of a tonsil or tonsils. (Dorland, 28th ed)
=750  \0$aTonsillectomy$5IEN$0(DLC)sh 85136021

=LDR  01318cz  a2200409n  4500
=001  9880364058202441
=005  20141212210306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014067
=035  \\$aCBA7401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x710.$x684.$x800
=072  \\$aC7.$x550.$x745.$x671.$x800
=072  \\$aC9.$x647.$x710.$x685.$x800
=072  \\$aC9.$x775.$x549.$x685.$x800
=150  \\$aTonsillar Neoplasms
=450  \\$wnnna$aCancer of the Tonsil
=450  \\$aCancer of Tonsil
=450  \\$wnnna$aCancer, Tonsil
=450  \\$wnnna$aCancer, Tonsillar
=450  \\$wnnna$aCancers, Tonsil
=450  \\$wnnna$aCancers, Tonsillar
=450  \\$wnnna$aNeoplasm, Tonsil
=450  \\$wnnna$aNeoplasm, Tonsillar
=450  \\$wnnna$aNeoplasms, Tonsil
=450  \\$wnnna$aNeoplasms, Tonsillar
=450  \\$wnnna$aTonsil Cancer
=450  \\$wnnna$aTonsil Cancers
=450  \\$wnnna$aTonsil Neoplasm
=450  \\$wnnna$aTonsil Neoplasms
=450  \\$aTonsillar Cancer
=450  \\$wnnna$aTonsillar Cancers
=450  \\$wnnna$aTonsillar Neoplasm
=550  \\$wg$aOropharyngeal Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the PALATINE TONSIL.
=750  \0$aTonsils$xCancer$5IEN-M$0(DLC)sh 85136026

=LDR  01226cz  a2200289n  4500
=001  9880364058302441
=005  20141212210306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014066
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x623.$x603.$x925
=072  \\$aA10.$x549.$x580
=072  \\$aA14.$x724.$x603.$x925
=072  \\$aA15.$x382.$x520.$x604.$x580
=150  \\$aPalatine Tonsil
=450  \\$wnnna$aPalatine Tonsils
=450  \\$aTonsil
=450  \\$aTonsil, Palatine
=450  \\$wnnna$aTonsils
=450  \\$wnnna$aTonsils, Palatine
=550  \\$wg$aLymphoid Tissue
=550  \\$wg$aOropharynx
=667  \\$a/surg is probably TONSILLECTOMY; inflammation = TONSILLITIS; lingual tonsils = PALATINE TONSIL (IM) + TONGUE (NIM); PHARYNGEAL TONSIL see ADENOIDS is also available; enlarged tonsils = PALATINE TONSIL / pathol (IM) + HYPERPLASIA (NIM)
=680  \\$iA round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX. There is one on each side of the oropharynx in the fauces between the anterior and posterior pillars of the SOFT PALATE.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Tonsil
=750  \0$aTonsils$0(DLC) sh 85136024$5IEN

=LDR  00795cz  a2200217n  4500
=001  9880364058402441
=005  20141212210305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014065
=035  \\$aCBA7399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x750
=150  \\$aTonometry, Ocular
=450  \\$wnnna$aOcular Tonometry
=450  \\$wnnoa$aTonometry$5IEN-HS
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$aIntraocular Pressure
=667  \\$aTONOMETRY see MANOMETRY is available for non-ocular tension or pressure
=680  \\$iMeasurement of ocular tension (INTRAOCULAR PRESSURE) with a tonometer. (Cline, et al., Dictionary of Visual Science, 4th ed)
=688  \\$a2004; use TONOMETRY 1966-2003
=750  \0$aTonometry$5IEN$0(DLC)sh 85136018

=LDR  00940cz  a2200313n  4500
=001  9880364058502441
=005  20141212210305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014062
=035  \\$aCBA7396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591.$x925
=072  \\$aC7.$x465.$x565.$x925
=072  \\$aC7.$x465.$x910.$x874
=150  \\$aTongue Neoplasms
=450  \\$wnnna$aCancer of the Tongue
=450  \\$aCancer of Tongue
=450  \\$wnnna$aCancer, Tongue
=450  \\$wnnna$aCancers, Tongue
=450  \\$wnnna$aNeoplasm, Tongue
=450  \\$wnnna$aNeoplasms, Tongue
=450  \\$aTongue Cancer
=450  \\$wnnna$aTongue Cancers
=450  \\$wnnna$aTongue Neoplasm
=550  \\$wg$aMouth Neoplasms
=550  \\$wg$aTongue Diseases
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the TONGUE.
=750  \0$aTongue$xCancer$5IEN-M$0(DLC)sh 85135994

=LDR  00850cz  a2200313n  4500
=001  9880364058602441
=005  20141212210304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014060
=035  \\$aCBA7394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x910
=150  \\$aTongue Diseases
=450  \\$wnnna$aDisease, Tongue
=450  \\$wnnna$aDiseases, Tongue
=450  \\$wnnna$aMicroglossia
=450  \\$wnnna$aMicroglossias
=450  \\$wnnna$aTongue Disease
=550  \\$wg$aMouth Diseases
=550  \\$wh$aGlossalgia
=550  \\$wh$aGlossitis
=550  \\$wh$aGlossoptosis
=550  \\$wh$aMacroglossia
=550  \\$wh$aTongue, Fissured
=550  \\$wh$aTongue, Hairy
=550  \\$wh$aTongue Neoplasms
=667  \\$ainflamm dis = GLOSSITIS
=688  \\$a65
=750  \0$aTongue$xDiseases$5IEN$0(DLC)sh 85135995

=LDR  00839cz  a2200229n  4500
=001  9880364058702441
=005  20141212210304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014059
=035  \\$aCBA7393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x885
=072  \\$aA14.$x549.$x885
=150  \\$aTongue
=360  \\$iconsider also terms at$aGLOSS-$aLINGUAL
=450  \\$wnnna$aTongues
=550  \\$wg$aMouth
=550  \\$wh$aLingual Frenum
=550  \\$wh$aTaste Buds
=667  \\$a/surg: consider GLOSSECTOMY; /transpl permitted for tongue grafts as in palate surg; inflammation = GLOSSITIS; tongue thrust: index under TONGUE HABITS; painful or sore tongue = GLOSSALGIA; scrotal tongue = TONGUE, FISSURED
=688  \\$a/abnormalities was TONGUE ABNORMALITIES 1965
=750  \0$aTongue$5IEN$0(DLC)sh 85135992

=LDR  03492cz  a2200793n  4500
=001  9880364058802441
=005  20141212210301.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014055
=035  \\$aCBA7389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x350.$x800
=072  \\$aE1.$x370.$x350.$x600.$x350.$x800
=072  \\$aE1.$x370.$x350.$x710.$x800
=072  \\$aE1.$x370.$x350.$x825.$x800
=072  \\$aE1.$x370.$x384.$x730.$x800
=150  \\$aTomography, Emission-Computed
=450  \\$aCAT Scan, Radionuclide
=450  \\$wnnna$aCAT Scans, Radionuclide
=450  \\$wnnna$aComputed Radionuclide Tomography
=450  \\$wnnna$aComputed Tomographic Scintigraphy
=450  \\$wnnna$aComputed Tomography, Radionuclide-Emission
=450  \\$wnnna$aComputer-Assisted Tomographies, Radionuclide
=450  \\$wnnna$aComputer-Assisted Tomography, Radionuclide
=450  \\$aComputerized Emission Tomography
=450  \\$wnnna$aComputerized Tomography, Radionuclide
=450  \\$aCT Scan, Radionuclide
=450  \\$wnnna$aCT Scans, Radionuclide
=450  \\$wnnna$aEmission-Computed Tomography
=450  \\$wnnna$aEmission Computed Tomography
=450  \\$wnnna$aEmission Tomography, Computerized
=450  \\$wnnna$aRadionuclide CAT Scan
=450  \\$wnnna$aRadionuclide CAT Scans
=450  \\$wnnna$aRadionuclide-Computed Tomography
=450  \\$wnnna$aRadionuclide Computed Tomography
=450  \\$wnnna$aRadionuclide Computer-Assisted Tomographies
=450  \\$wnnna$aRadionuclide Computer-Assisted Tomography
=450  \\$wnnna$aRadionuclide Computer Assisted Tomography
=450  \\$wnnna$aRadionuclide Computerized Tomography
=450  \\$wnnna$aRadionuclide CT Scan
=450  \\$wnnna$aRadionuclide CT Scans
=450  \\$wnnna$aRadionuclide-Emission Computed Tomography
=450  \\$wnnna$aRadionuclide Emission Computed Tomography
=450  \\$aRadionuclide Tomography, Computed
=450  \\$wnnna$aScan, Radionuclide CAT
=450  \\$wnnna$aScan, Radionuclide CT
=450  \\$wnnna$aScans, Radionuclide CAT
=450  \\$wnnna$aScans, Radionuclide CT
=450  \\$aScintigraphy, Computed Tomographic
=450  \\$wnnna$aTomographic Scintigraphy, Computed
=450  \\$wnnna$aTomographies, Radionuclide Computer-Assisted
=450  \\$wnnna$aTomography, Computed Radionuclide
=450  \\$wnnna$aTomography, Computerized Emission
=450  \\$wnnna$aTomography, Emission Computed
=450  \\$aTomography, Radionuclide-Computed
=450  \\$wnnna$aTomography, Radionuclide Computed
=450  \\$wnnna$aTomography, Radionuclide Computer-Assisted
=450  \\$wnnna$aTomography, Radionuclide Computerized
=450  \\$wnnna$aTomography, Radionuclide-Emission Computed
=550  \\$wg$aImage Enhancement
=550  \\$wg$aImage Interpretation, Computer-Assisted
=550  \\$wg$aRadionuclide Imaging
=550  \\$wg$aTomography
=550  \\$wh$aPositron-Emission Tomography
=550  \\$wh$aTomography, Emission-Computed, Single-Photon
=667  \\$auses radionuclides & computer: do not confuse with TOMOGRAPHY, X-RAY COMPUTED using x-rays & computer; "computed tomography" unspecified is probably TOMOGRAPHY, X-RAY COMPUTED;
=680  \\$iTomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image.
=688  \\$a90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89
=750  \0$aTomography, Emission$5IEN$0(DLC)sh 85135956

=LDR  01123cz  a2200253n  4500
=001  9880364058902441
=005  20141212210300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014054
=035  \\$aCBA7388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x825
=150  \\$aTomography
=450  \\$wnnna$aTomographies
=550  \\$wg$aDiagnostic Imaging
=550  \\$wh$aElectron Microscope Tomography
=550  \\$wh$aMagnetic Resonance Imaging
=550  \\$wh$aTomography, Emission-Computed
=550  \\$wh$aTomography, Optical
=550  \\$wh$aTomography, X-Ray
=550  \\$aAnatomy, Cross-Sectional
=667  \\$ado not use /util except by MeSH definition; used for non-x-ray & non-radionuclide tomographies; echotomography seen in foreign lit is probably ULTRASONOGRAPHY & if so use "ultrasonics" or "ultrasonic diagnosis" or "ultrasonography" in translations & not "echotomography"; DF: TOMOGR
=680  \\$iImaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.
=750  \0$aTomography$5IEN$0(DLC)sh 85135955

=LDR  01058cz  a2200301n  4500
=001  9880364059002441
=005  20141212210259.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014051
=035  \\$aCBA7385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x832.$x500
=072  \\$aD2.$x500.$x800
=150  \\$aToluene 2,4-Diisocyanate
=450  \\$wnnna$a2,4-Diisocyanate, Toluene
=450  \\$wnnna$a2,4-Toluenediisocyanate
=450  \\$wnnna$a2,4 Toluenediisocyanate
=450  \\$wnnna$aDiisocyanate, Toluene
=450  \\$wnnna$aDiisocyanate, Tolylene
=450  \\$aDiisocyanatotoluene
=450  \\$wnnna$aToluene 2,4 Diisocyanate
=450  \\$wnnna$aToluene Diisocyanate
=450  \\$aTolylene Diisocyanate
=550  \\$wg$aIsocyanates
=550  \\$wg$aToluene
=680  \\$iSkin irritant and allergen used in the manufacture of polyurethane foams and other elastomers.
=688  \\$a94; was TOLUENE DIISOCYANATE 1975-93 (see under CYANATES 1975-90)
=750  \0$aToluene diisocyanate$5IEN-M$0(DLC)sh 90001733

=LDR  00906cz  a2200301n  4500
=001  9880364059102441
=005  20141212210259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014050
=035  \\$aCBA7384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x832
=150  \\$aToluene
=550  \\$wg$aBenzene Derivatives
=550  \\$wh$aBromcresol Green
=550  \\$wh$aBromcresol Purple
=550  \\$wh$aBromphenol Blue
=550  \\$wh$aBromthymol Blue
=550  \\$wh$aToluene 2,4-Diisocyanate
=550  \\$wh$aToluidines
=550  \\$wh$aTosyl Compounds
=550  \\$wh$aTosylarginine Methyl Ester
=550  \\$wh$aTosyllysine Chloromethyl Ketone
=550  \\$wh$aTosylphenylalanyl Chloromethyl Ketone
=550  \\$wh$aTrifluralin
=550  \\$wh$aTrinitrotoluene
=680  \\$iA widely used industrial solvent.
=750  \0$aToluene$5IEN$0(DLC)sh 85135907

=LDR  01139cz  a2200301n  4500
=001  9880364059202441
=005  20141212210258.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014048
=035  \\$aCBA7382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x369.$x869
=072  \\$aD3.$x494.$x741.$x869
=150  \\$aTolonium Chloride
=450  \\$wnnna$aBlue O, Toluidine
=450  \\$wnnna$aBlue, Toluidine
=450  \\$wnnna$aChloride, Tolonium
=450  \\$wnnna$aCI-52040
=450  \\$wnnna$aCI 52040
=450  \\$wnnna$aCI52040
=450  \\$wnnna$aO, Toluidine Blue
=450  \\$wnnna$aToluidine Blue
=450  \\$aToluidine Blue O
=550  \\$wg$aPhenothiazines
=667  \\$aD25-26 qualif
=680  \\$iA phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery.
=688  \\$a74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 (Prov)
=750  \0$aToluidine blue$5IEN$0(DLC)sh 85135909

=LDR  01105cz  a2200325n  4500
=001  9880364059302441
=005  20141212210257.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014046
=035  \\$aCBA7380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x910
=150  \\$aTolmetin
=450  \\$wnnna$aAnhydrous Tolmetin Sodium
=450  \\$wnnna$aAnhydrous, Tolmetin Sodium
=450  \\$wnnna$aDihydrate Tolmetin Sodium
=450  \\$wnnna$aMcN-2559
=450  \\$wnnna$aMcN 2559
=450  \\$wnnna$aMcN2559
=450  \\$wnnna$aSodium Anhydrous, Tolmetin
=450  \\$wnnna$aSodium, Tolmetin
=450  \\$wnnna$aTolectin
=450  \\$wnnna$aTolmetin Sodium
=450  \\$wnnna$aTolmetin Sodium Anhydrous
=450  \\$wnnna$aTolmetin Sodium, Anhydrous
=450  \\$wnnna$aTolmetin Sodium, Dihydrate
=550  \\$wg$aPyrroles
=680  \\$iA non-steroidal anti-inflammatory agent (ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL) similar in mode of action to INDOMETHACIN.
=688  \\$a90(76); was see under PYRROLES 1976-89
=750  \0$aTolmetin$5IEN$0(DLC)sh 85135901

=LDR  01593cz  a2200445n  4500
=001  9880364059402441
=005  20141212210257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014044
=035  \\$aCBA7378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x795.$x896
=072  \\$aD2.$x948.$x828.$x896
=150  \\$aTolbutamide
=450  \\$wnnna$aApo-Tolbutamide
=450  \\$wnnna$aApotex Brand of Tolbutamide
=450  \\$wnnna$aArtosin
=450  \\$wnnna$aAventis Brand of Tolbutamide
=450  \\$wnnna$aBerlin-Chemie Brand of Tolbutamide
=450  \\$wnnna$aBerlin Chemie Brand of Tolbutamide
=450  \\$aButamide Brand of Tolbutamide
=450  \\$wnnna$aDiabetol
=450  \\$wnnna$aDiaval
=450  \\$wnnna$aDolipol
=450  \\$wnnna$aHoechst Brand of Tolbutamide
=450  \\$wnnna$aOrabet
=450  \\$wnnna$aOrinase
=450  \\$wnnna$aPfizer Brand of Tolbutamide
=450  \\$wnnna$aR.A.N. Brand of Tolbutamide
=450  \\$wnnna$aRastinon
=450  \\$wnnna$aTolbutamid R.A.N.
=450  \\$wnnna$aTolbutamide Aventis Brand
=450  \\$wnnna$aTolbutamide Butamide Brand
=450  \\$wnnna$aTolbutamide Hoechst Brand
=450  \\$wnnna$aTolbutamide Pfizer Brand
=450  \\$wnnna$aValdecasas Brand of Tolbutamide
=450  \\$wnnna$aYamanouchi Brand of Tolbutamide
=550  \\$wg$aSulfonylurea Compounds
=680  \\$iA sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
=750  \0$aTolbutamide$5IEN$0(DLC)sh 85135874

=LDR  00930cz  a2200265n  4500
=001  9880364059502441
=005  20141212210256.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014040
=035  \\$aCBA7374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x770.$x836.$x500
=150  \\$aToken Economy
=450  \\$wnnna$aEconomies, Token
=450  \\$wnnna$aEconomy, Token
=450  \\$wnnna$aReinforcement, Token
=450  \\$wnnna$aReinforcements, Token
=450  \\$wnnna$aToken Economies
=450  \\$aToken Reinforcement
=450  \\$wnnna$aToken Reinforcements
=550  \\$wg$aReward
=667  \\$ano qualif
=680  \\$iA practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances.
=688  \\$a79(75); was see under REWARD 1975-78
=750  \0$aToken economy (Psychology)$5IEN$0(DLC)sh 85135838

=LDR  00625cz  a2200217n  4500
=001  9880364059602441
=005  20141212210255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014039
=035  \\$aCBA7373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x318.$x709
=150  \\$aToilet Training
=450  \\$wnnna$aToilet Trainings
=450  \\$wnnna$aTraining, Toilet
=450  \\$wnnna$aTrainings, Toilet
=550  \\$wg$aChild Rearing
=667  \\$ano qualif
=680  \\$iConditioning to defecate and urinate in culturally acceptable places.
=688  \\$a68
=750  \0$aToilet training$5IEN$0(DLC)sh 85135824

=LDR  00876cz  a2200277n  4500
=001  9880364059702441
=005  20141212210255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014038
=035  \\$aCBA7372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x410.$x560
=072  \\$aN6.$x850.$x860.$x510.$x490
=150  \\$aToilet Facilities
=450  \\$wnnna$aFacilities, Toilet
=450  \\$wnnna$aFacility, Toilet
=450  \\$wnnna$aLatrine
=450  \\$aLatrines
=450  \\$wnnna$aToilet Facility
=450  \\$aToilets$5IEN
=550  \\$wg$aPublic Facilities
=550  \\$wg$aSanitary Engineering
=667  \\$aincludes bed pans, urinals, commodes, etc.
=680  \\$iFacilities provided for human excretion, often with accompanying handwashing facilities.
=688  \\$a77; was LATRINES 1963-76
=750  \0$aToilets$5IEN$0(DLC)sh 85135825

=LDR  01113cz  a2200337n  4500
=001  9880364059802441
=005  20141212210255.0
=008  800513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014036
=035  \\$aCBA7370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x930
=150  \\$aTogaviridae Infections
=450  \\$wnnna$aDisease, Togaviridae
=450  \\$wnnna$aDiseases, Togaviridae
=450  \\$wnnna$aInfection, Togaviridae
=450  \\$wnnna$aInfection, Togavirus
=450  \\$wnnna$aInfections, Togaviridae
=450  \\$wnnna$aInfections, Togavirus
=450  \\$wnnna$aTogaviridae Disease
=450  \\$wnnna$aTogaviridae Diseases
=450  \\$wnnna$aTogaviridae Infection
=450  \\$wnnna$aTogavirus Infection
=450  \\$aTogavirus Infections
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aAlphavirus Infections
=550  \\$wh$aRubivirus Infections
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the TOGAVIRIDAE.
=688  \\$a94; was TOGAVIRUS INFECTIONS 1981-93
=750  \0$aTogavirus infections$5IEN$0(DLC)sh 91004571

=LDR  00972cz  a2200253n  4500
=001  9880364059902441
=005  20141212210254.0
=008  800522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014035
=035  \\$aCBA7369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x850
=072  \\$aB4.$x909.$x777.$x923
=150  \\$aTogaviridae
=450  \\$wnnna$aTogavirus
=450  \\$wnnna$aTogaviruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aAlphavirus
=550  \\$wh$aRubivirus
=550  \\$aArboviruses
=667  \\$a"a family of RNA viruses, mainly arboviruses"; infection = TOGAVIRIDAE INFECTIONS
=680  \\$iA family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS (group A arboviruses), and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid.
=688  \\$a81; was TOGAVIRUSES see ARBOVIRUSES 1978-80
=750  \0$aTogaviruses$5IEN$0(DLC)sh 85135798

=LDR  00577cz  a2200169n  4500
=001  9880364060002441
=005  20141212210254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014034
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x250.$x300.$x792
=150  \\$aToes
=450  \\$wnnna$aToe
=550  \\$wg$aForefoot, Human
=550  \\$wh$aHallux
=667  \\$aTN 117: use for human & other vertebrates; TN 238: differentiation from TOE JOINT & indexing instructions; NIM when merely locational as in FOOT DERMATOSES (IM)
=750  \0$aToes$5IEN$0(DLC)sh 85135784

=LDR  01046cz  a2200277n  4500
=001  9880364060102441
=005  20210217133728.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014031
=035  \\$aCBA7363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x476.$x600.$x800
=150  \\$aTobramycin
=450  \\$wnnna$aBrulamycin
=450  \\$wnnna$aNebcin
=450  \\$wnnna$aNebicin
=450  \\$aNebramycin Factor 6
=450  \\$wnnna$aObracin
=450  \\$wnnna$aSulfate, Tobramycin
=450  \\$wnnna$aTobracin
=450  \\$wnnna$aTobramycin Sulfate
=550  \\$wg$aNebramycin
=550  \\$wh$aTobramycin, Dexamethasone Drug Combination
=680  \\$iAn aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
=688  \\$a84(75); was see under ANTIBIOTICS 1975-83
=750  \0$aTobramycin$5IEN$0(DLC)sh 85135762

=LDR  01093cz  a2200313n  4500
=001  9880364060202441
=005  20141212210253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014030
=035  \\$aCBA7362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x836.$x500
=150  \\$aTobacco, Smokeless
=450  \\$aChewing Tobacco
=450  \\$wnnna$aChewing Tobaccos
=450  \\$wnnna$aMint Snuff
=450  \\$aOral Tobacco
=450  \\$aSmokeless Tobacco
=450  \\$aSnuff
=450  \\$wnnna$aSnuff, Mint
=450  \\$wnnna$aSnuffs, Mint
=450  \\$wnnna$aTobacco, Chewing
=450  \\$wnnna$aTobacco, Oral
=450  \\$wnnna$aTobaccos, Chewing
=450  \\$wnnna$aTobaccos, Smokeless
=550  \\$wg$aTobacco Products
=680  \\$iPowdered or cut pieces of leaves of NICOTIANA TABACUM which are inhaled through the nose, chewed, or stored in cheek pouches. It includes any product of tobacco that is not smoked.
=688  \\$a91(86); was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85
=750  \0$aSmokeless tobacco$5IEN$0(DLC)sh 86004170

=LDR  01448cz  a2200385n  4500
=001  9880364060302441
=005  20141212210252.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014029
=035  \\$aCBA7361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x912
=072  \\$aF3.$x900.$x912
=150  \\$aTobacco Use Disorder
=450  \\$wnnna$aDependence, Nicotine
=450  \\$wnnna$aDependence, Tobacco
=450  \\$wnnna$aDisorder, Nicotine Use
=450  \\$wnnna$aDisorder, Tobacco Use
=450  \\$wnnna$aDisorder, Tobacco-Use
=450  \\$aNicotine Dependence
=450  \\$aNicotine Use Disorder
=450  \\$wnnna$aNicotine Use Disorders
=450  \\$aTobacco Dependence
=450  \\$wnnna$aTobacco Dependences
=450  \\$aTobacco Habit$5IEN
=450  \\$wnnna$aTobacco-Use Disorder
=450  \\$wnnna$aTobacco Use Disorders
=450  \\$wnnna$aUse Disorder, Nicotine
=550  \\$wg$aSubstance-Related Disorders
=550  \\$aSmoking
=550  \\$aTobacco
=667  \\$aincludes cigarettes, cigars, chewing tobacco & snuff; a psychiatric diag: do not confuse with SMOKING /adv eff; note X ref NICOTINE DEPENDENCE: do not coord with NICOTINE unless nicotine is substantially discussed as a chemical
=680  \\$iTobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.
=688  \\$a81
=750  \0$aNicotine addiction$0(DLC) sh2005002478$5IEN-M

=LDR  02073cz  a2200601n  4500
=001  9880364060402441
=005  20141212210252.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014028
=035  \\$aCBA7360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x937.$x680
=072  \\$aN6.$x850.$x460.$x100.$x555
=150  \\$aTobacco Smoke Pollution
=450  \\$aAir Pollution, Tobacco Smoke
=450  \\$aEnvironmental Pollution, Tobacco Smoke
=450  \\$wnnna$aEnvironmental Smoke Pollution, Tobacco
=450  \\$wnnna$aEnvironmental Tobacco Smoke Pollution
=450  \\$wnnna$aHand Smoke, Second
=450  \\$wnnna$aHand Smokes, Second
=450  \\$wnnna$aInvoluntary Smoking
=450  \\$wnnna$aInvoluntary Smokings
=450  \\$aPassive Smoking
=450  \\$wnnna$aPassive Smokings
=450  \\$wnnna$aPollution, Tobacco Smoke
=450  \\$wnnna$aPollutions, Tobacco Smoke
=450  \\$wnnna$aSecond Hand Smoke
=450  \\$wnnna$aSecond Hand Smokes
=450  \\$wnnna$aSecondhand Smoke
=450  \\$wnnna$aSecondhand Smokes
=450  \\$wnnna$aSecondhand Smoking
=450  \\$wnnna$aSecondhand Smokings
=450  \\$wnnna$aSmoke Pollution, Tobacco
=450  \\$wnnna$aSmoke Pollutions, Tobacco
=450  \\$wnnna$aSmoke, Second Hand
=450  \\$wnnna$aSmoke, Secondhand
=450  \\$wnnna$aSmokes, Second Hand
=450  \\$wnnna$aSmokes, Secondhand
=450  \\$wnnna$aSmoking, Involuntary
=450  \\$aSmoking, Passive
=450  \\$wnnna$aSmoking, Secondhand
=450  \\$wnnna$aSmokings, Involuntary
=450  \\$wnnna$aSmokings, Passive
=450  \\$wnnna$aSmokings, Secondhand
=450  \\$wnnna$aTobacco Smoke Pollutions
=550  \\$wg$aAir Pollution
=550  \\$wg$aSmoke
=550  \\$aAir Pollution, Indoor
=550  \\$aSmoking
=667  \\$anote entry term PASSIVE SMOKING; disease caused by passive smoking = disease /etiol, not /chem ind
=680  \\$iContamination of the air by tobacco smoke.
=688  \\$a82
=750  \0$aTobacco smoke pollution$5IEN-M$0(DLC)sh 89006816

=LDR  00839cz  a2200229n  4500
=001  9880364060502441
=005  20141212192608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014027
=035  \\$aCBA7359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x464.$x725.$x800
=150  \\$aTobacco Mosaic Virus
=450  \\$wnnna$aMosaic Virus, Tobacco
=450  \\$wnnna$aMosaic Viruses, Tobacco
=450  \\$wnnna$aTobacco Mosaic Viruses
=450  \\$wnnna$aVirus, Tobacco Mosaic
=450  \\$wnnna$aViruses, Tobacco Mosaic
=550  \\$wg$aTobamovirus
=667  \\$aa species of plant virus; coord IM with TOBACCO /virol (IM or NIM)
=680  \\$iThe type species of TOBAMOVIRUS which causes mosaic disease of tobacco. Transmission occurs by mechanical inoculation.
=750  \0$aTobacco mosaic virus$5IEN$0(DLC)sh 85135738

=LDR  01159cz  a2200253n  4500
=001  9880364060602441
=005  20141212210251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014026
=035  \\$aCBA7358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x900
=150  \\$aTobacco
=450  \\$aNicotiana
=450  \\$wnnna$aNicotiana tabacum
=450  \\$wnnna$aNicotiana tabacums
=450  \\$wnnna$aNicotianas
=450  \\$wnnna$atabacum, Nicotiana
=450  \\$wnnna$atabacums, Nicotiana
=450  \\$wnnna$aTobaccos
=550  \\$wg$aSolanaceae
=667  \\$aas plant & for smoking ( = SMOKING), sniffing ( = SNUFF see TOBACCO, SMOKELESS) & chewing ( = CHEWING TOBACCO see TOBACCO, SMOKELESS); for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.
=750  \0$aTobacco$5IEN$0(DLC)sh 85135709

=LDR  00941cz  a2200229n  4500
=001  9880364060702441
=005  20141212210251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014025
=035  \\$aCBA7357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x557.$x800
=072  \\$aD1.$x268.$x956.$x878
=072  \\$aD1.$x552.$x547.$x800
=150  \\$aTitanium
=450  \\$aTitanium Compounds$5IEN
=550  \\$wg$aMetals, Light
=550  \\$wg$aTransition Elements
=667  \\$aTi-48; Ti-46, 47, 49, 50 = TITANIUM (IM) + ISOTOPES (NIM); Ti-43-45, 51 = TITANIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA dark-gray, metallic element of widespread distribution but occurring in small amounts; atomic number, 22; atomic weight, 47.90; symbol, Ti; specific gravity, 4.5; used for fixation of fractures. (Dorland, 28th ed)
=750  \0$aTitanium compounds$5IEN-M$0(DLC)sh 85135624
=750  \0$aTitanium$5IEN-HS$0(DLC)sh 85135605

=LDR  01200cz  a2200337n  4500
=001  9880364060802441
=005  20181002104255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014024
=035  \\$aCBA7356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10
=150  \\$aTissues
=450  \\$wnnna$aTissue
=550  \\$wh$aBody Fluid Compartments
=550  \\$wh$aConnective Tissue
=550  \\$wh$aEpithelium
=550  \\$wh$aExocrine Glands
=550  \\$wh$aLymphoid Tissue
=550  \\$wh$aMargins of Excision
=550  \\$wh$aMembranes
=550  \\$wh$aMuscles
=550  \\$wh$aNerve Tissue
=550  \\$wh$aOrganoids
=550  \\$wh$aParenchymal Tissue
=550  \\$wh$aPeritoneal Stomata
=550  \\$wh$aSurgically-Created Structures
=667  \\$aused for searching: indexers apply specifics; may be used by catalogers
=680  \\$iCollections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.
=688  \\$a98; use explode 1967-97
=750  \0$aTissues$5IEN-M$0(DLC)sh 85135594

=LDR  01571cz  a2200385n  4500
=001  9880364060902441
=005  20141212210250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014021
=035  \\$aCBA7353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x760
=072  \\$aE1.$x370.$x225.$x750.$x600.$x760
=072  \\$aE2.$x792.$x833
=072  \\$aE5.$x200.$x500.$x620.$x760
=072  \\$aE5.$x200.$x750.$x600.$x760
=072  \\$aE5.$x760.$x833
=150  \\$aTissue Preservation
=450  \\$wnnna$aPreservation, Tissue
=450  \\$wnnna$aPreservations, Tissue
=450  \\$wnnna$aTissue Preservations
=550  \\$wg$aHistocytological Preparation Techniques
=550  \\$wg$aPreservation, Biological
=550  \\$wh$aBlood Preservation
=550  \\$wh$aCold Ischemia
=550  \\$wh$aCryopreservation
=550  \\$wh$aOrgan Preservation
=550  \\$wh$aSemen Preservation
=550  \\$wh$aTissue Fixation
=550  \\$aTissue and Organ Harvesting
=550  \\$aTissue Transplantation
=667  \\$aGEN: prefer specifics; cryopreservation of tissue: coord specific tissue heading (no qualif) + CRYOPRESERVATION; ORGAN PRESERVATION is also available
=680  \\$iThe process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
=688  \\$a67
=750  \0$aPreservation of organs, tissues, etc.$5IEN$0(DLC)sh 85106452

=LDR  01030cz  a2200253n  4500
=001  9880364061002441
=005  20141212210250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014020
=035  \\$aCBA7352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x777
=150  \\$aTissue Extracts
=450  \\$wnnna$aExtracts, Tissue
=550  \\$wg$aComplex Mixtures
=550  \\$wh$aActihaemyl
=550  \\$wh$aCell Extracts
=550  \\$wh$aLiver Extracts
=550  \\$wh$aPancreatic Extracts
=550  \\$wh$aPlacental Extracts
=550  \\$wh$aThymus Extracts
=667  \\$anot for chemical substances "extracted" from tissues (= specific chemical + organ or tissue /chem)
=680  \\$iPreparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.
=750  \0$aTissue extracts$5IEN$0(DLC)sh 85135589

=LDR  01785cz  a2200529n  4500
=001  9880364061102441
=005  20141212192607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014019
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x898
=150  \\$aTissue Donors
=450  \\$wnnna$aDonor
=450  \\$wnnna$aDonor, Organ
=450  \\$wnnna$aDonor, Ovum
=450  \\$wnnna$aDonor, Semen
=450  \\$wnnna$aDonor, Tissue
=450  \\$wnnna$aDonor, Transplant
=450  \\$wnnna$aDonors
=450  \\$wnnna$aDonors, Organ
=450  \\$wnnna$aDonors, Ovum
=450  \\$wnnna$aDonors, Semen
=450  \\$wnnna$aDonors, Tissue
=450  \\$wnnna$aDonors, Transplant
=450  \\$wnnna$aOrgan Donor
=450  \\$aOrgan Donors
=450  \\$wnnna$aOvum Donor
=450  \\$wnnna$aOvum Donors
=450  \\$wnnna$aSemen Donor
=450  \\$wnnna$aSemen Donors
=450  \\$wnnna$aTissue Donor
=450  \\$wnnna$aTransplant Donor
=450  \\$wnnna$aTransplant Donors
=550  \\$wg$aPersons
=550  \\$wh$aBlood Donors
=550  \\$wh$aLiving Donors
=550  \\$wh$aUnrelated Donors
=550  \\$aDirected Tissue Donation
=550  \\$aTissue and Organ Procurement
=550  \\$aTissue Transplantation
=550  \\$aTransplant Donor Site
=550  \\$aTransplantation
=667  \\$asemen or sperm donors: coord IM with SEMEN (IM) or SPERMATOZOA (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) (IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) (IM)
=680  \\$iIndividuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.
=688  \\$a1967(1964)
=688  \\$a67(64)
=750  \0$aOrgan donors$5IEN-M$0(DLC)sh 85095463

=LDR  00891cz  a2200265n  4500
=001  9880364061202441
=005  20141212210249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014015
=035  \\$aCBA7347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65.$x900
=150  \\$aTissue Banks
=450  \\$wnnna$aBank, Tissue
=450  \\$wnnna$aBanking, Tissue
=450  \\$wnnna$aBanks, Tissue
=450  \\$wnnna$aTissue Bank
=450  \\$wnnna$aTissue Banking
=550  \\$wg$aBiological Specimen Banks
=550  \\$wh$aBone Banks
=550  \\$wh$aEye Banks
=550  \\$aTissue and Organ Procurement
=667  \\$aGEN or unspecified for tissues or organs: prefer specifics; coord IM with specific organ or tissue (IM)
=680  \\$iCenters for acquiring, characterizing, and storing organs or tissue for future use.
=750  \0$aTissue banks$5IEN$0(DLC)sh 85135587

=LDR  00975cz  a2200289n  4500
=001  9880364061302441
=005  20141212210248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014014
=035  \\$aCBA7346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x919
=072  \\$aD27.$x720.$x102.$x919
=072  \\$aE7.$x858.$x690.$x860
=072  \\$aJ1.$x637.$x51.$x919
=150  \\$aTissue Adhesives
=450  \\$wnnna$aAdhesive, Tissue
=450  \\$wnnna$aAdhesives, Tissue
=450  \\$wnnna$aTissue Adhesive
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aSurgical Fixation Devices
=550  \\$wh$aCyanoacrylates
=550  \\$aAdhesives
=667  \\$aIM; coord with specific substance used as adhesive if pertinent (IM); D25-26 qualif
=680  \\$iSubstances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses.
=688  \\$a65(63)
=750  \0$aAdhesives in surgery$5IEN$0(DLC)sh 85000867

=LDR  02374cz  a2200517n  4500
=001  9880364061402441
=005  20141212210248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014012
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x670
=072  \\$aC10.$x597.$x751.$x418.$x670
=072  \\$aC23.$x888.$x592.$x763.$x393.$x670
=150  \\$aTinnitus
=450  \\$wnnna$aClicking Tinnitus
=450  \\$wnnna$aInduced Tinnitus, Noise
=450  \\$wnnna$aLeudet Tinnitus
=450  \\$wnnna$aLeudet's Tinnitus
=450  \\$wnnna$aNoise Induced Tinnitus
=450  \\$wnnna$aObjective Tinnitus
=450  \\$aPulsatile Tinnitus
=450  \\$wnnna$aRinging-Buzzing-Tinnitus
=450  \\$wnnna$aRinging Buzzing Tinnitus
=450  \\$wnnna$aSpontaneous Oto-Acoustic Emission Tinnitus
=450  \\$wnnna$aSpontaneous Oto Acoustic Emission Tinnitus
=450  \\$wnnna$aSubjective Tinnitus
=450  \\$wnnna$aTensor Palatini Induced Tinnitus
=450  \\$wnnna$aTensor Tympani Induced Tinnitus
=450  \\$wnnna$aTinnitus, Clicking
=450  \\$wnnna$aTinnitus, Leudet
=450  \\$wnnna$aTinnitus, Leudet's
=450  \\$wnnna$aTinnitus, Leudets
=450  \\$wnnna$aTinnitus, Noise Induced
=450  \\$wnnna$aTinnitus, Objective
=450  \\$wnnna$aTinnitus of Vascular Origin
=450  \\$wnnna$aTinnitus, Pulsatile
=450  \\$wnnna$aTinnitus, Spontaneous Oto-Acoustic Emission
=450  \\$wnnna$aTinnitus, Spontaneous Oto Acoustic Emission
=450  \\$wnnna$aTinnitus, Subjective
=450  \\$wnnna$aTinnitus, Tensor Palatini Induced
=450  \\$wnnna$aTinnitus, Tensor Tympani Induced
=450  \\$wnnna$aTinnitus, Vascular Origin
=450  \\$wnnna$aVascular Origin Tinnitus
=550  \\$wg$aHearing Disorders
=680  \\$iA nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.
=750  \0$aTinnitus$5IEN$0(DLC)sh 85135532

=LDR  01245cz  a2200361n  4500
=001  9880364061502441
=005  20141212210246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014009
=035  \\$aCBA7341M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x720.$x550
=072  \\$aC1.$x703.$x295.$x872.$x458
=072  \\$aC17.$x800.$x529.$x550
=072  \\$aC17.$x800.$x838.$x208.$x883.$x458
=150  \\$aOnychomycosis
=450  \\$wnnna$aFungus, Nail
=450  \\$aNail Fungus
=450  \\$wnnna$aOnychomycoses
=450  \\$wnnna$aTinea Ungui
=450  \\$wnnna$aTinea Unguis
=450  \\$aTinea Unguium
=450  \\$wnnna$aTinea Unguiums
=450  \\$wnnna$aUngui, Tinea
=450  \\$wnnna$aUnguis, Tinea
=450  \\$wnnna$aUnguium, Tinea
=450  \\$wnnna$aUnguiums, Tinea
=550  \\$wg$aNail Diseases
=550  \\$wg$aTinea
=667  \\$acoordinate IM with FOOT DERMATOSES (IM) or HAND DERMATOSES (IM); do not coordinate with NAILS
=680  \\$iA fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.
=688  \\$a93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92
=750  \0$aOnychomycosis$5IEN-M$0(DLC)sh 98008068

=LDR  00924cz  a2200277n  4500
=001  9880364061602441
=005  20141212210246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014008
=035  \\$aCBA7340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x720.$x760
=072  \\$aC1.$x703.$x295.$x872.$x707
=072  \\$aC17.$x800.$x321.$x125.$x500
=072  \\$aC17.$x800.$x838.$x208.$x883.$x658
=072  \\$aC23.$x888.$x885.$x625.$x500
=150  \\$aTinea Pedis
=450  \\$wnnna$aAthlete Foot
=450  \\$aAthlete's Foot
=450  \\$wnnna$aAthletes Foot
=550  \\$wg$aFoot Dermatoses
=550  \\$wg$aPruritus
=550  \\$wg$aTinea
=667  \\$ado not coord with FOOT or FOOT DERMATOSES
=680  \\$iDermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.
=750  \0$aAthlete's foot$5IEN$0(DLC)sh 85009142

=LDR  01124cz  a2200217n  4500
=001  9880364061702441
=005  20141212210246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014007
=035  \\$aCBA7339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x720.$x730.$x740
=072  \\$aC1.$x703.$x295.$x872.$x541.$x500
=072  \\$aC17.$x800.$x738.$x708.$x708
=072  \\$aC17.$x800.$x838.$x208.$x883.$x558.$x708
=150  \\$aTinea Favosa
=450  \\$aFavus
=550  \\$wg$aTinea Capitis
=667  \\$aringworm of the scalp; caused by Trichophyton schoenleini
=680  \\$iA disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p319)
=750  \0$aFavus$5IEN$0(DLC)sh 85047503

=LDR  01556cz  a2200409n  4500
=001  9880364061802441
=005  20141212210245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014006
=035  \\$aCBA7338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x720.$x730
=072  \\$aC1.$x703.$x295.$x872.$x541
=072  \\$aC17.$x800.$x738.$x708
=072  \\$aC17.$x800.$x838.$x208.$x883.$x558
=150  \\$aTinea Capitis
=450  \\$wnnna$aBarbae, Trichophytia Profunda
=450  \\$wnnna$aCapitides, Trichophytia Profunda
=450  \\$wnnna$aCapitis Profunda, Tinea
=450  \\$wnnna$aCapitis Profundas, Tinea
=450  \\$wnnna$aCapitis, Trichophytia Profunda
=450  \\$aKerion Celsi
=450  \\$wnnna$aProfunda Barbae, Trichophytia
=450  \\$wnnna$aProfunda Capitides, Trichophytia
=450  \\$wnnna$aProfunda Capitis, Trichophytia
=450  \\$wnnna$aProfunda, Tinea Capitis
=450  \\$wnnna$aProfundas, Tinea Capitis
=450  \\$wnnna$aTinea Capitis Profunda
=450  \\$wnnna$aTinea Capitis Profundas
=450  \\$wnnna$aTrichophytia Profunda Barbae
=450  \\$wnnna$aTrichophytia Profunda Capitides
=450  \\$wnnna$aTrichophytia Profunda Capitis
=550  \\$wg$aScalp Dermatoses
=550  \\$wg$aTinea
=550  \\$wh$aTinea Favosa
=680  \\$iRingworm of the scalp and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.
=750  \0$aTinea capitis$5IEN$0(DLC)sh 85135515

=LDR  01093cz  a2200325n  4500
=001  9880364061902441
=005  20141212210245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014005
=035  \\$aCBA7337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x720
=072  \\$aC1.$x703.$x295.$x872
=072  \\$aC17.$x800.$x838.$x208.$x883
=150  \\$aTinea
=450  \\$aDermatophytoses
=450  \\$wnnna$aDermatophytosis
=450  \\$wnnna$aEpidermophytoses
=450  \\$aEpidermophytosis
=450  \\$aRingworm
=450  \\$wnnna$aTineas
=450  \\$wnnna$aTrichophytoses
=450  \\$aTrichophytosis
=550  \\$wg$aDermatomycoses
=550  \\$wh$aOnychomycosis
=550  \\$wh$aTinea Capitis
=550  \\$wh$aTinea Pedis
=667  \\$athe disease ringworm: do not confuse with TAENIA, tapeworm; GEN or unspecified: prefer specifics
=680  \\$iFungal infection of keratinized tissues such as hair, skin and nails. The main causative fungi include MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON.
=750  \0$aRingworm$5IEN$0(DLC)sh 85114145

=LDR  00775cz  a2200205n  4500
=001  9880364062002441
=005  20141212210244.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014004
=035  \\$aCBA7336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x910
=150  \\$aTin Radioisotopes
=450  \\$wnnna$aRadioisotopes, Tin
=550  \\$wg$aRadioisotopes
=550  \\$aTin
=667  \\$aSn-108-111, 113, 120-121, 123, 125-128; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of tin that decay or disintegrate emitting radiation. Sn atoms with atomic weights 108-111, 113, 120-121, 123 and 125-128 are tin radioisotopes.
=688  \\$a88
=750  \0$aTin$xIsotopes$5IEN-M$0(DLC)sh 85135485

=LDR  00711cz  a2200193n  4500
=001  9880364062102441
=005  20141212210243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014001
=035  \\$aCBA7333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x875
=072  \\$aD1.$x552.$x544.$x875
=150  \\$aTin
=450  \\$aStannum
=550  \\$wg$aMetals, Heavy
=667  \\$aSn-118; Sn-112, 114-117, 119, 122, 124 = TIN (IM) + ISOTOPES (NIM); Sn-108-111, 113, 120, 121, 123, 125-128 = TIN RADIOISOTOPES (IM)
=680  \\$iA trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.
=750  \0$aTin$5IEN-M$0(DLC)sh 85135484

=LDR  01602cz  a2200433n  4500
=001  9880364062202441
=005  20141212210243.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013999
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x915
=072  \\$aD2.$x33.$x755.$x624.$x915
=072  \\$aD2.$x92.$x63.$x624.$x915
=072  \\$aD2.$x886.$x675.$x867.$x768
=072  \\$aD3.$x383.$x129.$x708.$x867.$x768
=072  \\$aD3.$x383.$x533.$x640.$x775
=150  \\$aTimolol
=450  \\$wnnna$aBlocadren
=450  \\$wnnna$aHemihydrate, Timolol
=450  \\$wnnna$aL-714,465
=450  \\$wnnna$aL 714,465
=450  \\$wnnna$aL714,465
=450  \\$wnnna$aMK-950
=450  \\$wnnna$aMK 950
=450  \\$wnnna$aMK950
=450  \\$wnnna$aOptimol
=450  \\$wnnna$a(S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol
=450  \\$wnnna$aTimacar
=450  \\$wnnna$aTimolol Hemihydrate
=450  \\$wnnna$aTimolol Maleate
=450  \\$wnnna$aTimolol Maleate, (1:1) Salt
=450  \\$wnnna$aTimoptic
=450  \\$wnnna$aTimoptol
=550  \\$wg$aMorpholines
=550  \\$wg$aPropanolamines
=550  \\$wg$aThiadiazoles
=680  \\$iA beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.
=688  \\$a84(77); was see under PROPANOLAMINES 1977-83
=750  \0$aTimolol maleate$5IEN$0(DLC)sh 85135461

=LDR  00581cz  a2200193n  4500
=001  9880364062302441
=005  20141212210242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013998
=035  \\$aCBA7330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x857
=150  \\$aTime Perception
=450  \\$wnnna$aPerception, Time
=450  \\$wnnna$aPerceptions, Time
=450  \\$wnnna$aTime Perceptions
=550  \\$wg$aPerception
=680  \\$iThe ability to estimate periods of time lapsed or duration of time.
=750  \0$aTime perception$5IEN$0(DLC)sh 85135422

=LDR  01266cz  a2200349n  4500
=001  9880364062402441
=005  20141212210242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013995
=035  \\$aCBA7327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910
=150  \\$aTime
=450  \\$wnnna$aEffect, Long-Term
=450  \\$wnnna$aEffect, Longterm
=450  \\$wnnna$aEffects, Long-Term
=450  \\$wnnna$aEffects, Long Term
=450  \\$wnnna$aEffects, Longterm
=450  \\$wnnna$aLong-Term Effect
=450  \\$wnnna$aLong-Term Effects
=450  \\$wnnna$aLong Term Effects
=450  \\$wnnna$aLongterm Effect
=450  \\$wnnna$aLongterm Effects
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aChronology as Topic
=550  \\$wh$aHalf-Life
=550  \\$wh$aPeriodicity
=550  \\$wh$aPhotoperiod
=550  \\$wh$aTime Factors
=667  \\$aIM as the abstraction; do not confuse with TIME FACTORS, the NIM coordinate with a given subject; "diurnal" & "nocturnal": consider preferably CIRCADIAN RHYTHM
=680  \\$iThe dimension of the physical universe which, at a given place, orders the sequence of events. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aTime$5IEN$0(DLC)sh 85135395

=LDR  01120cz  a2200337n  4500
=001  9880364062502441
=005  20141212192607.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013988
=035  \\$aCBA7320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x778.$x823.$x500
=072  \\$aD3.$x383.$x725.$x849.$x500
=072  \\$aD3.$x383.$x903.$x830.$x500
=072  \\$aD3.$x438.$x928.$x500
=150  \\$aTiclopidine
=450  \\$wnnna$a53-32C
=450  \\$wnnna$a53 32C
=450  \\$wnnna$a5332C
=450  \\$wnnna$aAlmirall Brand of Ticlopidine Hydrochloride
=450  \\$wnnna$aHydrochloride, Ticlopidine
=450  \\$wnnna$aRoche Brand of Ticlopidine Hydrochloride
=450  \\$wnnna$aTiclid
=450  \\$wnnna$aTiclodix
=450  \\$wnnna$aTiclodone
=450  \\$wnnna$aTiclopidine Hydrochloride
=450  \\$wnnna$aVitoria Brand of Ticlopidine Hydrochloride
=550  \\$wg$aThienopyridines
=680  \\$iAn effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
=688  \\$a87
=750  \0$aTiclopidine$0(DLC) sh 85135258$5IEN

=LDR  01344cz  a2200229n  4500
=001  9880364062602441
=005  20141212210239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013987
=035  \\$aCBA7319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832
=150  \\$aTicks
=450  \\$aIxodida
=450  \\$wnnna$aIxodidas
=450  \\$wnnna$aTick
=550  \\$wg$aAcari
=550  \\$wh$aArgasidae
=550  \\$wh$aIxodidae
=667  \\$aTICK BITES, TICK TOXICOSES and TICK PARALYSIS are available; tick vectors = ARACHNID VECTORS (IM) + TICKS (IM); infection = TICK INFESTATIONS; for chemicals for killing or controlling ticks use ACARICIDES
=680  \\$iBlood-sucking acarid parasites of the order Ixodida comprising two families: the softbacked ticks (ARGASIDAE) and hardbacked ticks (IXODIDAE). Ticks are larger than their relatives, the MITES. They penetrate the skin of their host by means of highly specialized, hooked mouth parts and feed on its blood. Ticks attack all groups of terrestrial vertebrates. In humans they are responsible for many TICK-BORNE DISEASES, including the transmission of ROCKY MOUNTAIN SPOTTED FEVER; TULAREMIA; BABESIOSIS; AFRICAN SWINE FEVER; and RELAPSING FEVER. (From Barnes, Invertebrate Zoology, 5th ed, pp543-44)
=750  \0$aTicks$5IEN$0(DLC)sh 85135253

=LDR  00734cz  a2200217n  4500
=001  9880364062702441
=005  20141212210239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013985
=035  \\$aCBA7317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x127.$x789.$x500.$x707
=150  \\$aTick Paralysis
=450  \\$wnnna$aParalyses, Tick
=450  \\$wnnna$aParalysis, Tick
=450  \\$wnnna$aTick Paralyses
=550  \\$wg$aTick Toxicoses
=667  \\$aparalysis caused by tick bite; see note under TICKS
=680  \\$iParalysis caused by a neurotropic toxin secreted by the salivary glands of ticks.
=688  \\$a91(75); was see under TICK TOXICOSES 1975-90
=750  \0$aTick paralysis$5IEN$0(DLC)sh 85135249

=LDR  00947cz  a2200229n  4500
=001  9880364062802441
=005  20141212210238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013983
=035  \\$aCBA7315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650.$x850
=150  \\$aTick Control
=450  \\$wnnna$aControl, Mite
=450  \\$wnnna$aControl, Tick
=450  \\$wnnna$aControls, Mite
=450  \\$aMite Control
=550  \\$wg$aPest Control
=667  \\$achemicals killing or controlling ticks are indexed under acaricides; mite control can go here as MITES (IM) + TICK CONTROL (IM)
=680  \\$iChemical, biological, or medical measures designed to prevent the spread of ticks or the concomitant infestations which result in tick-borne diseases. It includes the veterinary as well as the public health aspects of tick and mite control.
=688  \\$a73
=750  \0$aTicks$xControl$5IEN$0(DLC)sh 85135254

=LDR  01358cz  a2200385n  4500
=001  9880364062902441
=005  20141212210238.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013982
=035  \\$aCBA7314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x875
=072  \\$aD2.$x886.$x108.$x750.$x875
=072  \\$aD3.$x438.$x260.$x825.$x875
=072  \\$aD3.$x605.$x84.$x737.$x875
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x875
=150  \\$aTicarcillin
=450  \\$wnnna$aBRL-2288
=450  \\$wnnna$aBRL 2288
=450  \\$wnnna$aBRL2288
=450  \\$wnnna$aCSL Brand of Ticarcillin Disodium
=450  \\$wnnna$aDisodium, Ticarcillin
=450  \\$wnnna$aGlaxoSmithKline Brand of Ticarcillin Disodium
=450  \\$wnnna$aGlaxoSmithKline Brand of Ticarcillin Disodium Salt
=450  \\$wnnna$aSmithKline Beecham Brand of Ticarcillin Disodium
=450  \\$wnnna$aSmithKline Beecham Brand of Ticarcillin Disodium Salt
=450  \\$wnnna$aTarcil
=450  \\$wnnna$aTicar
=450  \\$wnnna$aTicarcillin Disodium
=450  \\$wnnna$aTicarpen
=450  \\$wnnna$aTicillin
=550  \\$wg$aPenicillins
=680  \\$iAn antibiotic derived from penicillin similar to CARBENICILLIN in action.
=688  \\$a91(75); was see under PENICILLINS 1975-90
=750  \0$aTicarcillin$5IEN$0(DLC)sh 92000709

=LDR  02253cz  a2200529n  4500
=001  9880364063002441
=005  20170717165932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013981
=035  \\$aCBA7313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662.$x825
=072  \\$aF3.$x625.$x992
=150  \\$aTic Disorders
=450  \\$wnnna$aChildhood Tic Disorder
=450  \\$wnnna$aChildhood Tic Disorders
=450  \\$wnnna$aChronic Motor or Vocal Tic Disorder
=450  \\$wnnna$aMotor or Vocal Tic Disorder, Chronic
=450  \\$wnnna$aMotor Tic Disorder
=450  \\$wnnna$aMotor Tic Disorders
=450  \\$aPost-Traumatic Tic Disorder
=450  \\$wnnna$aPost Traumatic Tic Disorder
=450  \\$wnnna$aPost-Traumatic Tic Disorders
=450  \\$wnnna$aTic Disorder
=450  \\$wnnna$aTic Disorder, Childhood
=450  \\$aTic Disorder, Chronic Motor or Vocal
=450  \\$wnnna$aTic Disorder, Motor
=450  \\$aTic Disorder, Post-Traumatic
=450  \\$wnnna$aTic Disorder, Post Traumatic
=450  \\$aTic Disorder, Transient
=450  \\$wnnna$aTic Disorder, Vocal
=450  \\$wnnna$aTic Disorders, Childhood
=450  \\$wnnna$aTic Disorders, Motor
=450  \\$wnnna$aTic Disorders, Post-Traumatic
=450  \\$wnnna$aTic Disorders, Transient
=450  \\$aTic Disorders, Vocal
=450  \\$wnnna$aTransient Tic Disorder
=450  \\$wnnna$aTransient Tic Disorders
=450  \\$wnnna$aVocal Tic Disorder
=450  \\$aVocal Tic Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=550  \\$wg$aMovement Disorders
=550  \\$wh$aTourette Syndrome
=667  \\$aTICS is available; TIC DOULOUREUX see TRIGEMINAL NEURALGIA is also available
=680  \\$iDisorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany general medical conditions. (From DSM-IV, 1994)
=688  \\$a1998(1966)
=750  \0$aTic disorders$5IEN$0(DLC)sh 85135241

=LDR  01451cz  a2200373n  4500
=001  9880364063102441
=005  20141212210237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013979
=035  \\$aCBA7311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x450.$x760.$x820
=150  \\$aTibial Nerve
=450  \\$aMedial Plantar Nerve
=450  \\$wnnna$aMedial Plantar Nerves
=450  \\$wnnna$aNerve, Medial Plantar
=450  \\$wnnna$aNerve, Posterior Tibial
=450  \\$wnnna$aNerve, Tibial
=450  \\$wnnna$aNerves, Medial Plantar
=450  \\$wnnna$aNerves, Posterior Tibial
=450  \\$wnnna$aNerves, Tibial
=450  \\$wnnna$aPlantar Nerve, Medial
=450  \\$wnnna$aPlantar Nerves, Medial
=450  \\$aPosterior Tibial Nerve
=450  \\$wnnna$aPosterior Tibial Nerves
=450  \\$wnnna$aTibial Nerve, Posterior
=450  \\$wnnna$aTibial Nerves
=450  \\$wnnna$aTibial Nerves, Posterior
=550  \\$wg$aSciatic Nerve
=550  \\$wh$aSural Nerve
=667  \\$adis = TIBIAL NEUROPATHY; neopl = TIBIAL NEUROPATHY (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe medial terminal branch of the sciatic nerve. The tibial nerve fibers originate in lumbar and sacral spinal segments (L4 to S2). They supply motor and sensory innervation to parts of the calf and foot.
=688  \\$a72(71)
=750  \0$aTibial nerve$5IEN$0(DLC)sh 85135236

=LDR  00844cz  a2200181n  4500
=001  9880364063202441
=005  20141212210236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013977
=035  \\$aCBA7309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x650.$x883
=150  \\$aTibia
=450  \\$wnnna$aTibias
=550  \\$wg$aLeg Bones
=667  \\$a/blood supply: consider also TIBIAL ARTERIES; /inj: consider also TIBIAL FRACTURES; avoid TIBIA /metab, TIBIA /chem, etc. when BONE AND BONES /metab, etc. is meant; tibia vara: index under TIBIA (IM) + BONE DISEASES, DEVELOPMENTAL (IM)
=680  \\$iThe second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.
=750  \0$aTibia$5IEN$0(DLC)sh 85135234

=LDR  04732cz  a2201177n  4500
=001  9880364063302441
=005  20141212192606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013974
=035  \\$aCBA7306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x931.$x812
=072  \\$aD12.$x125.$x72.$x50.$x767
=150  \\$aThyroxine
=450  \\$wnnna$a3,5,3',5'-Tetraiodothyronine
=450  \\$wnnna$aAbbot Brand of Levothyroxine Sodium
=450  \\$wnnna$aAllphar Brand of Levothyroxine Sodium
=450  \\$wnnna$aAventis Brand of Levothyroxine Sodium
=450  \\$wnnna$aBerlin-Chemie Brand of Levothyroxine Sodium
=450  \\$wnnna$aBerlin Chemie Brand of Levothyroxine Sodium
=450  \\$wnnna$aBerlthyrox
=450  \\$wnnna$abetapharm Brand of Levothyroxine Sodium
=450  \\$wnnna$aByk Brand of Levothyroxine Sodium
=450  \\$wnnna$aDeladande, Levothyroxin
=450  \\$wnnna$aDelalande Brand of Levothyroxine Sodium
=450  \\$wnnna$aDelalande, Levothyroxin
=450  \\$wnnna$aDexnon
=450  \\$wnnna$aEferox
=450  \\$wnnna$aEltroxin
=450  \\$wnnna$aEltroxine
=450  \\$wnnna$aEuthyrox
=450  \\$wnnna$aEutirox
=450  \\$wnnna$aForest Brand of Levothyroxine Sodium
=450  \\$wnnna$aGenpharm Brand of Levothyroxine Sodium
=450  \\$wnnna$aGlaxoSmithKline Brand of Levothyroxine Sodium
=450  \\$wnnna$aGlaxoWellcome Brand of Levothyroxine Sodium
=450  \\$wnnna$aGoldshield Brand of Levothyroxine Sodium
=450  \\$wnnna$aHenning Berlin Brand of Levothyroxine Sodium
=450  \\$wnnna$aHexal Brand 1 of Levothyroxine Sodium
=450  \\$wnnna$aHexal Brand 2 of Levothyroxine Sodium
=450  \\$wnnna$aKern Brand of Levothyroxine Sodium
=450  \\$wnnna$aL-3,5,3',5'-Tetraiodothyronine
=450  \\$wnnna$aL-Thyrox
=450  \\$wnnna$aL Thyrox
=450  \\$wnnna$aL-Thyroxin beta
=450  \\$wnnna$aL Thyroxin beta
=450  \\$wnnna$aL-Thyroxin Henning
=450  \\$wnnna$aL Thyroxin Henning
=450  \\$aL-Thyroxine
=450  \\$wnnna$aL Thyroxine
=450  \\$wnnna$aL-Thyroxine Roche
=450  \\$wnnna$aL Thyroxine Roche
=450  \\$wnnna$aLévothyrox
=450  \\$wnnna$aLeo, Tiroxina
=450  \\$wnnna$aLevo-T
=450  \\$wnnna$aLevo T
=450  \\$wnnna$aLevoT
=450  \\$wnnna$aLevothroid
=450  \\$wnnna$aLevothyroid
=450  \\$wnnna$aLevothyroxin Deladande
=450  \\$wnnna$aLevothyroxin Delalande
=450  \\$aLevothyroxine
=450  \\$wnnna$aLevothyroxine Sodium
=450  \\$wnnna$aLevoxine
=450  \\$wnnna$aLevoxyl
=450  \\$wnnna$aLThyroxin beta
=450  \\$wnnna$aLThyroxin Henning
=450  \\$wnnna$aMerck Brand of Levothyroxine Sodium
=450  \\$wnnna$aMerck Lipha Santé Brand of Levothyroxine Sodium
=450  \\$wnnna$aMonarch Brand of Levothyroxine Sodium
=450  \\$wnnna$aMova Brand of Levothyroxine Sodium
=450  \\$wnnna$aNourypharma Brand of Levothyroxine Sodium
=450  \\$wnnna$aNovothyral
=450  \\$wnnna$aNovothyrox
=450  \\$wnnna$aO-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine
=450  \\$wnnna$aO-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine
=450  \\$wnnna$aOroxine
=450  \\$wnnna$aRoche Brand of Levothyroxine Sodium
=450  \\$wnnna$aRudefsa Brand of Levothyroxine Sodium
=450  \\$wnnna$aSanofi Synthelabo Brand of Levothyroxine Sodium
=450  \\$wnnna$aSigma Brand of Levothyroxine Sodium
=450  \\$wnnna$aSodium Levothyroxine
=450  \\$wnnna$aSynthroid
=450  \\$wnnna$aSynthrox
=450  \\$aT4 Thyroid Hormone
=450  \\$wnnna$aThevier
=450  \\$wnnna$aThyrax
=450  \\$wnnna$aThyroid Hormone, T4
=450  \\$wnnna$aThyroxin
=450  \\$wnnna$aTiroidine
=450  \\$wnnna$aTiroxina Leo
=450  \\$wnnna$aUnithroid
=450  \\$wnnna$aVortex Brand of Levothyroxine Sodium
=450  \\$wnnna$aWatson Brand of Levothyroxine Sodium
=550  \\$wg$aAmino Acids, Aromatic
=550  \\$wg$aThyroid Hormones
=550  \\$wh$aThyronines
=667  \\$a/blood: consider also HYPERTHYROXINEMIA
=680  \\$iThe major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
=688  \\$a1965; use THYROXIN 1963-1964; for LEVOTHYROXINE use LEVOTHYROXINE 1991-2001, use THYROXINE 1966-1990
=750  \0$aThyroxine$5IEN$0(DLC)sh 85135182

=LDR  03055cz  a2200733n  4500
=001  9880364063402441
=005  20141212210235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013973
=035  \\$aCBA7305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x740.$x880
=072  \\$aD12.$x644.$x400.$x400.$x740.$x880
=072  \\$aD12.$x644.$x456.$x837
=072  \\$aD12.$x644.$x548.$x365.$x740.$x880
=072  \\$aD12.$x776.$x641.$x650.$x405.$x740.$x880
=072  \\$aD12.$x776.$x641.$x650.$x810
=150  \\$aThyrotropin-Releasing Hormone
=450  \\$wnnna$aAbbott-38579
=450  \\$wnnna$aAbbott 38579
=450  \\$wnnna$aAbbott Brand of Protirelin
=450  \\$wnnna$aAbbott38579
=450  \\$wnnna$aAntepan
=450  \\$wnnna$aAventis Brand of Protirelin
=450  \\$wnnna$aFerring Brand of Protirelin
=450  \\$wnnna$aHenning Berlin Brand of Protirelin
=450  \\$wnnna$aHydrate, Proterelin Tartrate
=450  \\$wnnna$aMerck Brand of Protirelin
=450  \\$wnnna$aNovartis Brand of Protirelin
=450  \\$wnnna$aPrem, TRH
=450  \\$wnnna$aProterelin Tartrate
=450  \\$wnnna$aProterelin Tartrate Hydrate
=450  \\$aProtirelin
=450  \\$wnnna$aProtirelin Abbott Brand
=450  \\$wnnna$aProtirelin Aventis Brand
=450  \\$wnnna$aProtirelin Ferring Brand
=450  \\$wnnna$aProtirelin Merck Brand
=450  \\$wnnna$aProtirelin Novartis Brand
=450  \\$wnnna$aProtirelin Tartrate (1:1)
=450  \\$wnnna$aRelefact TRH
=450  \\$wnnna$aStimu-TSH
=450  \\$wnnna$aStimu TSH
=450  \\$wnnna$aStimuTSH
=450  \\$wnnna$aTartrate Hydrate, Proterelin
=450  \\$wnnna$aThypinone
=450  \\$aThyroliberin
=450  \\$wnnna$aThyroliberin TRH Merck
=450  \\$wnnna$aThyrotropin-Releasing Factor
=450  \\$wnnna$aThyrotropin Releasing Factor
=450  \\$wnnna$aThyrotropin Releasing Hormone
=450  \\$wnnna$aThyrotropin-Releasing Hormone Tartrate
=450  \\$wnnna$aThyrotropin Releasing Hormone Tartrate
=450  \\$wnnna$aTRH Ferring
=450  \\$wnnna$aTRH Prem
=450  \\$wnnna$aTRH, Relefact
=550  \\$wg$aNeuropeptides
=550  \\$wg$aOligopeptides
=550  \\$wg$aPituitary Hormone-Releasing Hormones
=680  \\$iA tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.
=688  \\$a2006(1968)
=688  \\$a2006(1992); was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Protirelin
=688  \\$a92; was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73
=750  \0$aThyrotropin releasing factor$0(DLC) sh 85135181$5IEN-M

=LDR  01477cz  a2200277n  4500
=001  9880364063502441
=005  20141212210234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x525.$x883
=072  \\$aD12.$x644.$x548.$x691.$x525.$x883
=150  \\$aThyrotropin
=450  \\$wnnna$aHormone, Thyroid-Stimulating
=450  \\$wnnna$aThyreotropin
=450  \\$aThyroid-Stimulating Hormone
=450  \\$wnnna$aThyroid Stimulating Hormone
=450  \\$wnnna$aThyrotrophin
=450  \\$wnnna$aTSH (Thyroid Stimulating Hormone)
=550  \\$wg$aPituitary Hormones, Anterior
=550  \\$wh$aGlycoprotein Hormones, alpha Subunit
=550  \\$wh$aThyrotropin Alfa
=550  \\$wh$aThyrotropin, beta Subunit
=667  \\$afor alpha subunit, coord with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; THYROTROPIN, BETA SUBUNIT is also available
=680  \\$iA glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity.
=750  \0$aThyrotropin$5IEN$0(DLC)sh 85135180

=LDR  00870cz  a2200241n  4500
=001  9880364063602441
=005  20141212210234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013970
=035  \\$aCBA7302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x931.$x740
=072  \\$aD12.$x125.$x72.$x50.$x767.$x741
=150  \\$aThyronines
=450  \\$wnnna$aThyronine
=550  \\$wg$aThyroid Hormones
=550  \\$wg$aThyroxine
=550  \\$wh$aDiiodothyronines
=550  \\$wh$aTriiodothyronine
=550  \\$wh$aTriiodothyronine, Reverse
=680  \\$iA group of metabolites derived from THYROXINE and TRIIODOTHYRONINE via the peripheral enzymatic removal of iodines from the thyroxine nucleus. Thyronine is the thyroxine nucleus devoid of its four iodine atoms.
=688  \\$a79; was THYRONINE 1963-78
=750  \0$aThyronines$5IEN$0(DLC)sh 85135179

=LDR  01474cz  a2200349n  4500
=001  9880364063702441
=005  20141212210232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013967
=035  \\$aCBA7299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x871.$x102
=072  \\$aC20.$x111.$x809
=150  \\$aThyroiditis, Autoimmune
=450  \\$wnnna$aAutoimmune Thyroiditides
=450  \\$aAutoimmune Thyroiditis
=450  \\$wnnna$aLymphocytic Thyroiditides
=450  \\$wnnna$aLymphocytic Thyroiditis
=450  \\$wnnna$aLymphomatous Thyroiditides
=450  \\$wnnna$aLymphomatous Thyroiditis
=450  \\$wnnna$aThyroiditides, Autoimmune
=450  \\$wnnna$aThyroiditides, Lymphocytic
=450  \\$wnnna$aThyroiditides, Lymphomatous
=450  \\$aThyroiditis, Lymphocytic
=450  \\$aThyroiditis, Lymphomatous
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aThyroiditis
=550  \\$wh$aHashimoto Disease
=550  \\$wh$aPostpartum Thyroiditis
=680  \\$iInflammatory disease of the THYROID GLAND due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-CELLS and thyroid AUTOANTIBODIES. The clinical signs can range from HYPOTHYROIDISM to THYROTOXICOSIS depending on the type of autoimmune thyroiditis.
=688  \\$a87; was THYROIDITIS, LYMPHOMATOUS 1963-86
=750  \0$aAutoimmune thyroiditis$5IEN$0(DLC)sh 91001893

=LDR  00913cz  a2200217n  4500
=001  9880364063802441
=005  20141212210232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013966
=035  \\$aCBA7298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x871
=150  \\$aThyroiditis
=450  \\$wnnna$aThyroiditides
=550  \\$wg$aThyroid Diseases
=550  \\$wh$aThyroiditis, Autoimmune
=550  \\$wh$aThyroiditis, Subacute
=550  \\$wh$aThyroiditis, Suppurative
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iInflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes.
=750  \0$aThyroiditis$0(DLC) sh 85135177$5IEN

=LDR  01134cz  a2200277n  4500
=001  9880364063902441
=005  20141212210206.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013879
=035  \\$aCBA7210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x915
=150  \\$aThioredoxins
=450  \\$wnnna$aThioredoxin
=450  \\$wnnna$aThioredoxin 1
=450  \\$wnnna$aThioredoxin-1
=450  \\$wnnna$aThioredoxin 2
=450  \\$wnnna$aThioredoxin-2
=550  \\$wg$aProteins
=550  \\$wh$aChloroplast Thioredoxins
=550  \\$wh$aThioredoxin h
=680  \\$iHydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE.
=688  \\$a2008(1975)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Thioredoxin
=688  \\$a91(75); was see under BACTERIAL PROTEINS 1975-90
=750  \0$aThioredoxin$0(DLC) sh 86001432$5IEN

=LDR  00874cz  a2200325n  4500
=001  9880364064002441
=005  20171012133556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013876
=035  \\$aCBA7207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x778
=072  \\$aD3.$x383.$x903
=150  \\$aThiophenes
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aCanagliflozin
=550  \\$wh$aCarticaine
=550  \\$wh$aDuloxetine Hydrochloride
=550  \\$wh$aKetotifen
=550  \\$wh$aMorantel
=550  \\$wh$aPizotyline
=550  \\$wh$aPyrantel
=550  \\$wh$aRivaroxaban
=550  \\$wh$aThenoyltrifluoroacetone
=550  \\$wh$aThienopyridines
=550  \\$wh$aThioctic Acid
=550  \\$wh$aTicrynafen
=550  \\$wh$aTiletamine
=750  \0$aThiophenes$5IEN$0(DLC)sh 85134885

=LDR  00589cz  a2200205n  4500
=001  9880364064102441
=005  20141212210202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013864
=035  \\$aCBA7195M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x900
=072  \\$aD2.$x886.$x489.$x828
=150  \\$aThioglycolates
=450  \\$wnnna$aThioglycollates
=550  \\$wg$aAcetates
=550  \\$wg$aSulfhydryl Compounds
=680  \\$iOrganic esters of thioglycolic acid (HS-CH2COOH).
=688  \\$a70(64)
=750  \0$aThioglycolic acid$0(DLC)sh2010014516$5IEN-M

=LDR  00587cz  a2200205n  4500
=001  9880364064202441
=005  20141212210201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013861
=035  \\$aCBA7192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x262.$x775
=072  \\$aD2.$x886.$x728
=150  \\$aThiocyanates
=450  \\$aRhodanates
=550  \\$wg$aCyanates
=550  \\$wg$aSulfur Compounds
=550  \\$aIsothiocyanates
=680  \\$iOrganic derivatives of thiocyanic acid which contain the general formula R-SCN.
=750  \0$aThiocyanates$5IEN$0(DLC)sh 85134880

=LDR  00742cz  a2200205n  4500
=001  9880364064302441
=005  20141212210200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013856
=035  \\$aCBA7187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x103.$x800
=072  \\$aB3.$x660.$x250.$x15.$x800
=150  \\$aAcidithiobacillus thiooxidans
=450  \\$aThiobacillus thiooxidans
=550  \\$wg$aAcidithiobacillus
=667  \\$aTHIOBACILLUS is also available
=680  \\$iA strictly autotrophic species of bacteria that oxidizes sulfur and thiosulfate to sulfuric acid. It was formerly called Thiobacillus thiooxidans.
=688  \\$a2004 (1972)
=750  \0$aThiobacillus thiooxidans$5IEN$0(DLC)sh 88023350

=LDR  00792cz  a2200205n  4500
=001  9880364064402441
=005  20141212210200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013855
=035  \\$aCBA7186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x450.$x800
=072  \\$aB3.$x660.$x75.$x400.$x800
=150  \\$aThiobacillus
=450  \\$aThiobacillus denitrificans
=450  \\$aThiobacillus thioparus
=550  \\$wg$aGram-Negative Chemolithotrophic Bacteria
=550  \\$wg$aHydrogenophilaceae
=680  \\$iA genus of gram-negative, rod-shaped bacteria that derives energy from the oxidation of one or more reduced sulfur compounds. Many former species have been reclassified to other classes of PROTEOBACTERIA.
=750  \0$aThiobacillus$5IEN$0(DLC)sh 88023348

=LDR  00817cz  a2200217n  4500
=001  9880364064502441
=005  20160429145711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013851
=035  \\$aCBA7182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144.$x828
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x828
=072  \\$aG7.$x100.$x100.$x160.$x120.$x828
=150  \\$aThinness
=450  \\$aLeanness
=450  \\$wnnna$aUnderweight
=550  \\$wg$aBody Weight
=550  \\$aEmaciation
=680  \\$iA state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards. Depending on age, sex, and genetic background, a BODY MASS INDEX of less than 18.5 is considered as underweight.
=750  \0$aLeanness$5IEN$0(DLC)sh 85075512

=LDR  00988cz  a2200181n  4500
=001  9880364337702441
=005  20141212214626.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029767
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x241
=150  \\$aCornaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCornus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Cornales, subclass Rosidae, class Magnoliopsida that is a loose grouping of woody ornamentals: 11 of its 14 genera have been placed in single families by some authorities. Some botanists combine members of NYSSACEAE into this family.
=688  \\$a2002
=750  \0$aCornaceae$5IEN-M$0(DLC)sh 88022701

=LDR  01046cz  a2200265n  4500
=001  9880364337802441
=005  20141212214423.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x325.$x750
=150  \\$aTamus
=450  \\$wnnna$aBlack Bryonies
=450  \\$aBlack Bryony
=450  \\$wnnna$aBryonies, Black
=450  \\$aBryony, Black
=450  \\$wnnna$acommuni, Tamus
=450  \\$wnnna$acommunis, Tamus
=450  \\$wnnna$aTamus communi
=450  \\$wnnna$aTamus communis
=550  \\$wg$aDioscoreaceae
=667  \\$ado not confuse with bryony = BRYONIA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the DIOSCOREACEAE plant family.
=688  \\$a2002
=750  \0$aTamus$5IEN-M$0(DLC)sh 88023144

=LDR  00951cz  a2200217n  4500
=001  9880364337902441
=005  20141212214423.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027743
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x325
=150  \\$aDioscoreaceae
=450  \\$wnnna$aTacca
=450  \\$wnnna$aTaccas
=550  \\$wg$aAngiosperms
=550  \\$wh$aDioscorea
=550  \\$wh$aTamus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe yam plant family, of the order Liliales, has thick roots or tubers and net-veined, heart-shaped leaves that sometimes are lobed.
=688  \\$a2002
=750  \0$aDioscoreaceae$5IEN-M$0(DLC)sh 85038134

=LDR  01426cz  a2200361n  4500
=001  9880364338002441
=005  20141212193009.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x325.$x500
=150  \\$aDioscorea
=450  \\$wnnna$aChinese Yam
=450  \\$wnnna$aChinese Yams
=450  \\$wnnna$aDioscorea batatas
=450  \\$wnnna$aDioscorea opposita
=450  \\$wnnna$aDioscorea polystachya
=450  \\$wnnna$aDioscoreas
=450  \\$wnnna$aShan Yao
=450  \\$wnnna$aShan Yaos
=450  \\$aYam
=450  \\$wnnna$aYam, Chinese
=450  \\$wnnna$aYams
=450  \\$wnnna$aYams, Chinese
=450  \\$wnnna$aYao, Shan
=450  \\$wnnna$aYaos, Shan
=550  \\$wg$aDioscoreaceae
=550  \\$aIpomoea
=550  \\$aIpomoea batatas
=667  \\$ado not confuse entry term YAM with PSEUDO-YAM see IPOMOEA BATATAS; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus best known for edible underground tubers. Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.
=688  \\$a2002; use Liliaceae 1998-2001
=750  \0$aYams$5IEN-M$0(DLC)sh 85148976

=LDR  00896cz  a2200217n  4500
=001  9880364338102441
=005  20141212214422.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238.$x500
=150  \\$aIpomoea
=450  \\$wnnna$aIpomoeas
=550  \\$wg$aConvolvulaceae
=550  \\$wh$aIpomoea batatas
=550  \\$wh$aIpomoea nil
=550  \\$aDioscorea
=667  \\$afor morning glory check whether it is IPOMOEA or CONVOLVULUS; specify Plant Components; for /Chem crd with D tree compound and/or Preparation; for therap. coordinate with Food or Toxicity or Diseases and PHYTOTHERAPY
=680  \\$iA plant genus in the family CONVOLVULACEAE best known for morning glories (a common name also used with CONVOLVULUS) and sweet potato.
=688  \\$a2002
=750  \0$aIpomoea$0(DLC) sh 85067869$5IEN-M

=LDR  01385cz  a2200325n  4500
=001  9880364338202441
=005  20141212214421.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238.$x500.$x500
=150  \\$aIpomoea batatas
=450  \\$wnnna$abatata, Ipomoea
=450  \\$wnnna$abatatas, Ipomoea
=450  \\$wnnna$aIpomoea batata
=450  \\$wnnna$aPotato, Sweet
=450  \\$wnnna$aPotatos, Sweet
=450  \\$wnnna$aPseudo-Yam
=450  \\$wnnna$aPseudo Yam
=450  \\$wnnna$aPseudo Yams
=450  \\$wnnna$aPseudo-Yams
=450  \\$aSweet Potato
=450  \\$wnnna$aSweet Potatos
=450  \\$aYam, Pseudo
=450  \\$wnnna$aYams, Pseudo
=550  \\$wg$aIpomoea
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus IPOMOEA, family CONVOLVULACEAE. Some cultivars are sweet and edible whereas bitter varieties are a source of SAPONINS. This sweet potato is sometimes referred to as a yam (DIOSCOREA).
=688  \\$a2002; use Solanaceae 1998-2001
=750  \0$aSweet potatoes$0(DLC) sh 85131186$5IEN-M

=LDR  01277cz  a2200301n  4500
=001  9880364338302441
=005  20141212214421.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238
=150  \\$aConvolvulaceae
=450  \\$aEvolvulus
=450  \\$aMerremia
=450  \\$wnnna$aMerremias
=450  \\$aRivea
=450  \\$wnnna$aRiveas
=450  \\$aTurbina
=450  \\$wnnna$aTurbinas
=550  \\$wg$aAngiosperms
=550  \\$wh$aBonamia Plant
=550  \\$wh$aCalystegia
=550  \\$wh$aConvolvulus
=550  \\$wh$aIpomoea
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.
=688  \\$a2002
=750  \0$aConvolvulaceae$5IEN-M$0(DLC)sh 85031753

=LDR  01293cz  a2200265n  4500
=001  9880364338402441
=005  20141212214420.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027721
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x37.$x130
=150  \\$aAmaranthus
=450  \\$aAmaranth Plant
=450  \\$wnnna$aAmaranth Plants
=450  \\$wnnna$aPigweed, Redroot
=450  \\$wnnna$aPigweeds, Redroot
=450  \\$wnnna$aPlant, Amaranth
=450  \\$wnnna$aPlants, Amaranth
=450  \\$wnnna$aRedroot Pigweed
=450  \\$wnnna$aRedroot Pigweeds
=550  \\$wg$aAmaranthaceae
=667  \\$aX ref REDROOT PIGWEED: REDROOT see SANGUINARIA is also available; AMARANTH DYE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 (AMARANTH DYE). Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.
=688  \\$a2002
=750  \0$aAmaranths$5IEN-M$0(DLC)sh 85004105

=LDR  01312cz  a2200373n  4500
=001  9880364338502441
=005  20141212214347.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x171
=072  \\$aM1.$x526.$x276
=072  \\$aN5.$x350.$x262
=150  \\$aEthicists
=450  \\$wnnna$aBioethicist
=450  \\$aBioethicists
=450  \\$wnnna$aBioethics Consultant
=450  \\$wnnna$aBioethics Consultants
=450  \\$wnnna$aClinical Ethicist
=450  \\$wnnna$aClinical Ethicists
=450  \\$wnnna$aConsultants, Bioethics
=450  \\$wnnna$aConsultants, Ethics
=450  \\$wnnna$aEthicist
=450  \\$wnnna$aEthicist, Clinical
=450  \\$wnnna$aEthicists, Clinical
=450  \\$wnnna$aEthics Consultant
=450  \\$wnnna$aEthics Consultants
=550  \\$wg$aEthics
=550  \\$wg$aOccupational Groups
=550  \\$aBioethics
=550  \\$aEthics, Clinical
=680  \\$iPersons trained in philosophical or theological ethics who work in clinical, research, public policy, or other settings where they bring their expertise to bear on the analysis of ethical dilemmas in policies or cases. (Bioethics Thesaurus)
=688  \\$a2002; use ETHICS 1993-2001
=750  \0$aEthicists$5IEN-M$0(DLC)sh 85045095

=LDR  01308cz   2200301n  4500
=001  9880364338602441
=005  20230831160448.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x100
=150  \\$aAmaranthaceae
=450  \\$wnnna$aAerva
=450  \\$wnnna$aAervas
=450  \\$wnnna$aPfaffia
=450  \\$wnnna$aPfaffias
=550  \\$wg$aCaryophyllales
=550  \\$wh$aAchyranthes
=550  \\$wh$aAmaranthus
=550  \\$wh$aAtriplex
=550  \\$wh$aCelosia
=550  \\$wh$aChenopodium
=550  \\$wh$aSalsola
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.
=688  \\$a2002
=750  \0$aAmaranthaceae$0(DLC) sh 85004104$5IEN-M
=750  \0$iNarrower mapping$aCorispermum$0(DLC)sh2022006876$4NM$5IEN-M

=LDR  00599cz  a2200169n  4500
=001  9880364338702441
=005  20141212214419.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x755.$x624
=150  \\$aEclecticism, Historical
=450  \\$wnnna$aHistorical Eclecticism
=550  \\$wg$aPhytotherapy
=680  \\$iA system of medicine, most popular in the 19th century, that advocates the use of indigenous plants in the treatment of specific signs and symptoms.
=688  \\$a2002
=750  \0$aMedicine, Eclectic$5IEN-M$0(DLC)sh 85083136

=LDR  01678cz  a2200337n  4500
=001  9880364338802441
=005  20141212214347.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x347
=150  \\$aMandragora
=450  \\$aAtropa mandragora
=450  \\$wnnna$aAtropa mandragoras
=450  \\$wnnna$aEuropean Mandrake
=450  \\$wnnna$aEuropean Mandrakes
=450  \\$wnnna$amandragora, Atropa
=450  \\$wnnna$aMandragora vernali
=450  \\$wnnna$aMandragora vernalis
=450  \\$wnnna$aMandragoras
=450  \\$wnnna$amandragoras, Atropa
=450  \\$aMandrake, European
=450  \\$wnnna$aMandrakes, European
=450  \\$wnnna$avernali, Mandragora
=450  \\$wnnna$avernalis, Mandragora
=550  \\$wg$aSolanaceae
=550  \\$aPodophyllum
=667  \\$ado not confuse X ref MANDRAKE, EUROPEAN with MANDRAKE, AMERICAN see PODOPHYLLUM; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iPlants of the Mandragora genus in the SOLANACEAE family, including Mandragora officinarum L. and Mandragora vernalis Bertol (sometimes called Atropa mandragora). They contain TROPANES that are anticholinergic (CHOLINERGIC ANTAGONISTS). Mandrake may also refer to PODOPHYLLUM.
=688  \\$a2002, 1963-1996; use PLANTS, TOXIC 1997-2001; for MANDRAKE, EUROPEAN use PLANTS, TOXIC 1986-2001
=750  \0$aMandrakes$5IEN-M$0(DLC)sh 85080467

=LDR  00712cz  a2200217n  4500
=001  9880364338902441
=005  20141212214418.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x311
=150  \\$aLaughter Therapy
=450  \\$aLaughter$xtherapeutic use
=450  \\$wnnna$aTherapy, Laughter
=450  \\$aWit and Humor as Topic$xtherapeutic use
=550  \\$wg$aMind-Body Therapies
=550  \\$aLaughter
=550  \\$aWit and Humor as Topic
=680  \\$iTherapeutic use of humor and laughter to improve emotional well being in order to facilitate improvement in health.
=688  \\$a2002
=750  \0$aLaughter$xTherapeutic use$5IEN-M

=LDR  00848cz  a2200181n  4500
=001  9880364339002441
=005  20170524142228.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x980
=150  \\$aYucca
=450  \\$wnnna$aYuccas
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus (and common name) in the ASPARAGACEAE family. It is known for SAPONINS in the root that are used in SOAPS.
=688  \\$a2002; use Liliaceae 1998-2001
=750  \0$aYucca$5IEN-M$0(DLC)sh 85149426

=LDR  01204cz  a2200289n  4500
=001  9880364339102441
=005  20141212214346.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x10.$x625
=150  \\$aPhysical Therapy Specialty
=450  \\$wnno$aPhysical Therapy$5IEN-M
=450  \\$wnnna$aPhysiotherapy Specialty
=450  \\$wnnna$aSpecialty, Physical Therapy
=450  \\$wnnna$aSpecialty, Physiotherapy
=450  \\$wnnna$aTherapy Specialty, Physical
=550  \\$wg$aAllied Health Occupations
=550  \\$aPhysical Therapist Assistants
=550  \\$aPhysical Therapists
=550  \\$aPhysical Therapy Modalities
=667  \\$ause for the specialty only; use MUSCULOSKELETAL MANIPULATIONS or PHYSICAL THERAPY MODALITIES or their specifics for therapy
=680  \\$iThe auxiliary health profession which makes use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiological origin.
=688  \\$a2012 (1963)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Physical Therapy (Specialty)
=688  \\$a2002
=750  \0$aPhysical therapy$0(DLC) sh 85101568$5IEN-M

=LDR  00989cz  a2200241n  4500
=001  9880364339202441
=005  20141212214418.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x549.$x500
=150  \\$aCrocus
=450  \\$wnnna$aCrocus, Saffron
=450  \\$wnnna$aCrocus sativus
=450  \\$wnnna$aSaffron
=450  \\$aSaffron Crocus
=450  \\$wnnna$aSaffrons
=450  \\$wnnna$asativus, Crocus
=550  \\$wg$aIridaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus, in the IRIDACEAE family, known as a source of Saffron.
=688  \\$a2002; for SAFFRON use Liliaceae 1998-2001
=750  \0$aCrocuses$5IEN-M$0(DLC)sh 85034216

=LDR  01984cz  a2200505n  4500
=001  9880364339302441
=005  20200508140619.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779
=072  \\$aE2.$x831.$x535
=150  \\$aPhysical Therapy Modalities
=450  \\$wnnna$aModalities, Physical Therapy
=450  \\$wnnna$aModality, Physical Therapy
=450  \\$wnno$aPhysical Therapy$5IEN-M
=450  \\$wnnna$aPhysical Therapy Modality
=450  \\$wnnna$aPhysical Therapy Technique
=450  \\$wnnna$aPhysical Therapy Techniques
=450  \\$wnnoa$aPhysical Therapy Techniques$xmethods$5IEN-M
=450  \\$wnnna$aPhysiotherapies (Techniques)
=450  \\$aPhysiotherapy (Techniques)
=450  \\$wnnna$aTechniques, Physical Therapy
=550  \\$wg$aTherapeutics
=550  \\$wh$aAnimal Assisted Therapy
=550  \\$wh$aBalneology
=550  \\$wh$aDrainage, Postural
=550  \\$wh$aElectric Stimulation Therapy
=550  \\$wh$aExercise Movement Techniques
=550  \\$wh$aExercise Therapy
=550  \\$wh$aExtracorporeal Shockwave Therapy
=550  \\$wh$aHydrotherapy
=550  \\$wh$aHyperthermia, Induced
=550  \\$wh$aMusculoskeletal Manipulations
=550  \\$wh$aMyofunctional Therapy
=550  \\$aPhysical Therapist Assistants
=550  \\$aPhysical Therapists
=550  \\$aPhysical Therapy Specialty
=550  \\$aPostoperative Care
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with the specialty PHYSICAL THERAPY SPECIALTY
=680  \\$iTherapeutic modalities frequently used in PHYSICAL THERAPY SPECIALTY by PHYSICAL THERAPISTS or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual.
=688  \\$a2006 (2002)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Physical Therapy Techniques
=688  \\$a2002
=750  \0$aPhysical Therapy$0(DLC) sh 101568$5IEN-M

=LDR  00776cz  a2200229n  4500
=001  9880364339402441
=005  20180222104011.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x400
=150  \\$aIridaceae
=450  \\$aHomeria
=450  \\$wnnna$aHomerias
=450  \\$aMoraea
=450  \\$wnnna$aMoraeas
=550  \\$wg$aAsparagales
=550  \\$wh$aCrocus
=550  \\$wh$aIris Plant
=680  \\$iA plant family of the Asparagales order. Comprised of perennial herbs with BULBS, corms, or RHIZOMES and grass-like leaves with bisexual flowers that have 2 whorls of petaloid tepals which are usually showy.
=688  \\$a2002
=750  \0$aIridaceae$5IEN-M$0(DLC)sh 85068064

=LDR  00856cz  a2200193n  4500
=001  9880364339502441
=005  20141212214417.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x721
=150  \\$aPolyomavirus Infections
=450  \\$wnnna$aPolyomavirus Infection
=550  \\$wg$aDNA Virus Infections
=550  \\$wh$aCarcinoma, Merkel Cell
=550  \\$wh$aLeukoencephalopathy, Progressive Multifocal
=680  \\$iInfections with POLYOMAVIRUS, which are often cultured from the urine of kidney transplant patients. Excretion of BK VIRUS is associated with ureteral strictures and CYSTITIS, and that of JC VIRUS with progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL).
=688  \\$a2002
=750  \0$aPolyomavirus infections$0(DLC) sh2005006125$5IEN-M

=LDR  00850cz  a2200193n  4500
=001  9880364339602441
=005  20141212214417.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x175.$x750
=150  \\$aHumulus
=450  \\$wnnna$aHop
=450  \\$aHops
=550  \\$wg$aCannabaceae
=667  \\$aBEER is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the CANNABACEAE family. Best known for the buds of Humulus lupulus L. used in BEER.
=688  \\$a2002
=750  \0$aHumulus$5IEN-M$0(DLC)sh 85062984

=LDR  00919cz  a2200193n  4500
=001  9880364339702441
=005  20141212214416.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x175
=150  \\$aCannabaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCannabis
=550  \\$wh$aHumulus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.
=688  \\$a2002; use Cannabis 1999-2001
=750  \0$aCannabaceae$5IEN-M$0(DLC)sh 97005475

=LDR  01362cz  a2200409n  4500
=001  9880364339802441
=005  20141212214344.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026712
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x400.$x900
=150  \\$aValue of Life
=450  \\$wnnna$aEconomic Life Valuation
=450  \\$wnnna$aEconomic Life Valuations
=450  \\$wnnna$aEconomic Value, Life
=450  \\$aEconomic Value of Life
=450  \\$wnnna$aEconomic Values, Life
=450  \\$wnnna$aLife Economic Value
=450  \\$wnnna$aLife Economic Values
=450  \\$wnnna$aLife, Respect for
=450  \\$wnnna$aLife, Right to
=450  \\$wnnna$aLife Sanctities
=450  \\$wnnna$aLife Sanctity
=450  \\$aLife Valuation, Economic
=450  \\$wnnna$aLife Valuations, Economic
=450  \\$wnnna$aRespect for Life
=450  \\$wnnna$aRight to Life
=450  \\$wnnna$aSanctity of Life
=450  \\$wnnna$aValuation, Economic Life
=450  \\$wnnna$aValuations, Economic Life
=550  \\$wg$aLife
=550  \\$aQuality of Life
=550  \\$aSocial Values
=667  \\$aX ref ECONOMIC VALUE OF LIFE: coord with /econ + specific economics tern
=680  \\$iThe intrinsic moral worth ascribed to a living being. (Bioethics Thesaurus)
=688  \\$a2002
=750  \0$aRight to life$5IEN-M$0(DLC)sh 85114091

=LDR  00821cz  a2200205n  4500
=001  9880364339902441
=005  20141212214416.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027544
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x922
=150  \\$aSalvia
=450  \\$wnnna$aSalvias
=550  \\$wg$aLamiaceae
=550  \\$wh$aSalvia miltiorrhiza
=550  \\$wh$aSalvia officinalis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus in the mint family (LAMIACEAE).
=688  \\$a2002
=750  \0$aSalvia$5IEN-M$0(DLC)sh 85116966

=LDR  00815cz  a2200193n  4500
=001  9880364340002441
=005  20141212214343.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026706
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x547
=150  \\$aPaternalism
=550  \\$wg$aPsychology, Social
=550  \\$aBeneficence
=550  \\$aPersonal Autonomy
=667  \\$ado not confuse with FATHERS or PATERNITY
=680  \\$iInterference with the FREEDOM or PERSONAL AUTONOMY of another person, with justifications referring to the promotion of the person's good or the prevention of harm to the person. (from Cambridge Dictionary of Philosophy, 1995); more generally, not allowing a person to make decisions on his or her own behalf.
=688  \\$a2002
=750  \0$aPaternalism$5IEN-M$0(DLC)sh 85098670

=LDR  00832cz  a2200217n  4500
=001  9880364340102441
=005  20141212214342.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x756.$x500
=072  \\$aK1.$x752.$x566.$x479.$x830.$x500
=150  \\$aBeneficence
=450  \\$wnnna$aBenevolence
=450  \\$wnnna$aNonmaleficence
=550  \\$wg$aPrinciple-Based Ethics
=550  \\$aAltruism
=550  \\$aPaternalism
=680  \\$iThe state or quality of being kind, charitable, or beneficial. (from American Heritage Dictionary of the English Language, 4th ed). The ethical principle of BENEFICENCE requires producing net benefit over harm. (Bioethics Thesaurus)
=688  \\$a2002; use ALTRUISM 1978-2001
=750  \0$aBenevolence$5IEN-M$0(DLC)sh 85013139

=LDR  01056cz  a2200253n  4500
=001  9880364340202441
=005  20141212214416.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027543
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x922.$x770
=150  \\$aSalvia officinalis
=450  \\$wnnna$aofficinali, Salvia
=450  \\$wnnna$aofficinalis, Salvia
=450  \\$wnnna$aPlant, Sage
=450  \\$wnnna$aPlants, Sage
=450  \\$wnnna$aSage Plant
=450  \\$wnnna$aSage Plants
=450  \\$wnnna$aSalvia officinali
=550  \\$wg$aSalvia
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the Salvia genus known as a spice and medicinal plant.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aSage$5IEN-M$0(DLC)sh 85116476

=LDR  01076cz  a2200301n  4500
=001  9880364340302441
=005  20141212214342.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026684
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x600
=072  \\$aI1.$x880.$x604.$x473.$x380.$x500
=072  \\$aK1.$x559.$x411.$x756.$x650
=072  \\$aK1.$x752.$x566.$x479.$x830.$x650
=072  \\$aN3.$x706.$x437.$x380.$x500
=150  \\$aPersonal Autonomy
=450  \\$aAutonomy, Personal
=450  \\$wnnna$aFree Will
=450  \\$wnnna$aSelf Determination
=550  \\$wg$aFreedom
=550  \\$wg$aPrinciple-Based Ethics
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$aPaternalism
=550  \\$aProfessional Autonomy
=550  \\$aSelf Concept
=680  \\$iSelf-directing freedom and especially moral independence. An ethical principle holds that the autonomy of persons ought to be respected. (Bioethics Thesaurus)
=688  \\$a2002; for SELF DETERMINATION use FREEDOM 1990-2001
=750  \0$aAutonomy (Psychology)$5IEN-M$0(DLC)sh 85010458

=LDR  01132cz  a2200265n  4500
=001  9880364340402441
=005  20141212214415.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x757
=150  \\$aRosmarinus
=450  \\$wnnna$aofficinali, Rosmarinus
=450  \\$wnnna$aofficinalis, Rosmarinus
=450  \\$wnnna$aPlant, Rosemary
=450  \\$wnnna$aPlants, Rosemary
=450  \\$wnnna$aRosemary Plant
=450  \\$wnnna$aRosemary Plants
=450  \\$wnnna$aRosmarinus officinali
=450  \\$wnnna$aRosmarinus officinalis
=550  \\$wg$aLamiaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the LAMIACEAE family. It is known as a spice and medicinal plant.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aRosmarinus$5IEN-M$0(DLC)sh 85115460

=LDR  01005cz  a2200241n  4500
=001  9880364340502441
=005  20141212214415.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x483
=150  \\$aMentha
=450  \\$wnnna$aMenthas
=450  \\$aMint
=450  \\$wnnna$aMints
=550  \\$wg$aLamiaceae
=550  \\$wh$aMentha piperita
=550  \\$wh$aMentha pulegium
=550  \\$wh$aMentha spicata
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iMentha is a genus of the mint family (LAMIACEAE). It is known for species having characteristic flavor and aroma.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aMints (Plants)$5IEN-M$0(DLC)sh 85083723

=LDR  00834cz  a2200205n  4500
=001  9880364340602441
=005  20141212214415.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x428
=150  \\$aLavandula
=450  \\$wnnna$aLavandulas
=450  \\$aLavender
=450  \\$wnnna$aLavenders
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the LAMIACEAE family.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aLavenders$5IEN-M$0(DLC)sh 85075112

=LDR  01553cz  a2200349n  4500
=001  9880364340702441
=005  20141212214341.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x901
=150  \\$aVitamin B 6 Deficiency
=450  \\$wnnna$aB6 Deficiencies, Vitamin
=450  \\$wnnna$aB6 Deficiency, Vitamin
=450  \\$wnnna$aB6 Vitamin Deficiencies
=450  \\$wnnna$aB6 Vitamin Deficiency
=450  \\$wnnna$aDeficiencies, B6 Vitamin
=450  \\$wnnna$aDeficiencies, Vitamin B6
=450  \\$wnnna$aDeficiency, B6 Vitamin
=450  \\$wnnna$aDeficiency, Pyridoxine
=450  \\$wnnna$aDeficiency, Vitamin B 6
=450  \\$wnnna$aDeficiency, Vitamin B6
=450  \\$aPyridoxine Deficiency
=450  \\$aVitamin B 6$xdeficiency
=450  \\$wnnna$aVitamin B6 Deficiencies
=450  \\$wnnna$aVitamin B6 Deficiency
=450  \\$wnnna$aVitamin Deficiencies, B6
=450  \\$wnnna$aVitamin Deficiency, B6
=550  \\$wg$aVitamin B Deficiency
=680  \\$iA nutritional condition produced by a deficiency of VITAMIN B 6 in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Deficiency can be caused by certain medications, such as isoniazid.
=688  \\$a2000
=750  \0$aVitamin B6 deficiency$5IEN$0(DLC)sh 85143968

=LDR  00897cz  a2200229n  4500
=001  9880364340802441
=005  20141212214339.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x67.$x500.$x275
=072  \\$aD12.$x125.$x119.$x170.$x275
=150  \\$aIsoaspartic Acid
=450  \\$wnnna$abeta-Aspartate
=450  \\$wnnna$abeta Aspartate
=450  \\$wnnna$abeta-Aspartic Acid
=450  \\$wnnna$abeta Aspartic Acid
=450  \\$wnnna$aIsoaspartate
=550  \\$wg$aAspartic Acid
=680  \\$iAn ASPARTIC ACID residue in polypeptide chains that is linked at the beta-carboxyl group instead of at the normal, alpha-carboxyl group, polypeptide linkage. It is a result of the spontaneous decomposition of aspartic acid or ASPARAGINE residues.
=688  \\$a2002; use ASPARTIC ACID 1993-2001
=750  \0$aIsoaspartic a cid$5IEN-M

=LDR  01509cz  a2200349n  4500
=001  9880364340902441
=005  20141212214414.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027522
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x465
=150  \\$aMarrubium
=450  \\$wnnna$aCommon Horehound
=450  \\$wnnna$aCommon Horehounds
=450  \\$aHorehound
=450  \\$aHorehound, Common
=450  \\$aHorehound, Woolly
=450  \\$wnnna$aHorehounds
=450  \\$wnnna$aHorehounds, Common
=450  \\$wnnna$aHorehounds, Woolly
=450  \\$wnnna$aMarrubium vulgare
=450  \\$wnnna$aMarrubium vulgares
=450  \\$wnnna$aMarrubiums
=450  \\$wnnna$avulgare, Marrubium
=450  \\$wnnna$avulgares, Marrubium
=450  \\$wnnna$aWoolly Horehound
=450  \\$wnnna$aWoolly Horehounds
=550  \\$wg$aLamiaceae
=667  \\$aX ref HOREHOUND: HOREHOUND, BLACK see BALLOTA and HOREHOUND, WATER see LYCOPUS are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the LAMIACEAE family that contains marrubiin (a labdane diterpene). It is known as a traditional medicinal for sore throat.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aMarrubium$5IEN-M$0(DLC)sh 85081547

=LDR  01056cz  a2200253n  4500
=001  9880364341002441
=005  20141212214414.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x538
=150  \\$aNepeta
=450  \\$wnnna$acataria, Nepeta
=450  \\$wnnna$acatarias, Nepeta
=450  \\$aCatnip
=450  \\$wnnna$aCatnips
=450  \\$wnnna$aNepeta cataria
=450  \\$wnnna$aNepeta catarias
=450  \\$wnnna$aNepetas
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of the LAMIACEAE family. It is known for its mild calming effect and for the way cats are attracted to the aroma.
=688  \\$a2002; use LAMIACEAE 1998-2001
=750  \0$aNepeta$5IEN-M$0(DLC)sh 85090848

=LDR  01976cz  a2200481n  4500
=001  9880364341102441
=005  20141212214337.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026503
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x526.$x100
=072  \\$aD12.$x776.$x543.$x750.$x710.$x450.$x500.$x100
=072  \\$aD23.$x50.$x301.$x264.$x35.$x502
=072  \\$aD23.$x101.$x100.$x110.$x498
=150  \\$aLow Density Lipoprotein Receptor-Related Protein-1
=450  \\$aalpha-2-Macroglobulin Receptor
=450  \\$wnnna$aalpha 2 Macroglobulin Receptor
=450  \\$wnnna$aalpha-2 Macroglobulin Receptor
=450  \\$wnnna$aalpha2-Macroglobulin Signaling Receptor
=450  \\$wnnna$aalpha2 Macroglobulin Signaling Receptor
=450  \\$wnnna$aAntigen, CD91
=450  \\$wnnna$aAntigens, CD91
=450  \\$wnnna$aApo E Receptor
=450  \\$wnnna$aApoE Receptor
=450  \\$aApolipoprotein E Receptor
=450  \\$wnnna$aCD91 Antigen
=450  \\$wnnna$aCD91 Antigens
=450  \\$wnnna$aLDL-Receptor Related Protein
=450  \\$wnnna$aLDL Receptor Related Protein
=450  \\$aLDL-Receptor Related Protein 1
=450  \\$wnnna$aLDL Receptor Related Protein 1
=450  \\$wnnna$aLow Density Lipoprotein Receptor Related Protein 1
=450  \\$aReceptor, alpha-2 Macroglobulin
=450  \\$wnnna$aReceptor, Apo E
=450  \\$wnnna$aReceptor, ApoE
=450  \\$aReceptor, Apolipoprotein E
=550  \\$wg$aAntigens, CD
=550  \\$wg$aLDL-Receptor Related Proteins
=680  \\$iA LDL-receptor related protein involved in clearance of chylomicron remnants and of activated ALPHA-MACROGLOBULINS from plasma.
=688  \\$a2012(2002)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a LDL-Receptor Related Protein 1
=688  \\$a2002; for ALPHA-2-MACROGLOBULIN RECEPTOR & APOLIPOPROTEIN E RECEPTOR use LDL-RECEPTOR RELATED PROTEIN 1 (NM) 1981-2001
=750  \0$aApolipoprotein E$xReceptors$0(IEN)6266175$5IEN-M

=LDR  01642cz   2200373n  4500
=001  9880364341202441
=005  20230831161025.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027481
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x087
=150  \\$aAraliaceae
=450  \\$aCussonia
=450  \\$wnnna$aCussonias
=450  \\$wnnna$aPolyscia
=450  \\$wnnna$aPolyscias
=450  \\$aSchefflera
=450  \\$wnnna$aScheffleras
=450  \\$wnnna$aTree, Umbrella
=450  \\$wnnna$aTrees, Umbrella
=450  \\$aUmbrella Tree
=450  \\$wnnna$aUmbrella Trees
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAralia
=550  \\$wh$aEleutherococcus
=550  \\$wh$aHedera
=550  \\$wh$aKalopanax
=550  \\$wh$aOplopanax
=550  \\$wh$aPanax
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).
=688  \\$a2002
=750  \0$aAraliaceae$5IEN-M$0(DLC)sh 85006403
=750  \0$iNarrower mapping$aSchefflera$0(DLC)sh2022007220$4NM$5IEN-M

=LDR  00938cz  a2200241n  4500
=001  9880364341302441
=005  20141212214335.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x222.$x265.$x165
=072  \\$aD4.$x808.$x247.$x808.$x756.$x143
=072  \\$aD6.$x472.$x445.$x573.$x271
=150  \\$aEcdysteroids
=450  \\$wnnna$aEcdysteroid
=550  \\$wg$aCholestenones
=550  \\$wg$aInsect Hormones
=550  \\$wg$aPhytosterols
=550  \\$wh$aEcdysone
=550  \\$wh$aEcdysterone
=680  \\$iSteroids that bring about MOLTING or ecdysis in insects. Ecdysteroids include the endogenous insect hormones (ECDYSONE and ECDYSTERONE) and the insect-molting hormones found in plants, the phytoecdysteroids. Phytoecdysteroids are natural insecticides.
=688  \\$a2002; use ECDYSTEROIDS (NM) 1976-2001
=750  \0$aEcdysteroids$5IEN-M$0(DLC)sh 90004349

=LDR  01087cz  a2200373n  4500
=001  9880364341402441
=005  20141212214334.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x901
=150  \\$aSpiritual Therapies
=450  \\$aSpiritual Healing
=450  \\$wnnna$aTherapies, Spiritual
=550  \\$wg$aComplementary Therapies
=550  \\$wh$aFaith Healing
=550  \\$wh$aHomeopathy
=550  \\$wh$aMagic
=550  \\$wh$aMedicine, African Traditional
=550  \\$wh$aMeditation
=550  \\$wh$aMental Healing
=550  \\$wh$aOccultism
=550  \\$wh$aRadiesthesia
=550  \\$wh$aShamanism
=550  \\$wh$aTherapeutic Touch
=550  \\$wh$aWitchcraft
=550  \\$wh$aYoga
=550  \\$aMind-Body Therapies
=550  \\$aParapsychology
=550  \\$aSpirituality
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iMystical, religious, or spiritual practices performed for health benefit.
=688  \\$a2002
=750  \0$aSpiritual healing$5IEN-M$0(DLC)sh 85126755

=LDR  00860cz  a2200181n  4500
=001  9880364341502441
=005  20201019145414.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x765
=150  \\$aMyristicaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aMyristica
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA family of flowering plants in the order Magnoliales. Many of the species are tropical and have fragrant wood and leaves.
=688  \\$a2002
=750  \0$aMyristicaceae$5IEN-M$0(DLC)sh 85089300

=LDR  01155cz  a2200301n  4500
=001  9880364341602441
=005  20141212214412.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027468
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x255
=150  \\$aCrepis
=450  \\$wnnna$aBeard, Hawk's
=450  \\$wnnna$aBeards, Hawk's
=450  \\$wnnna$acapillari, Crepis
=450  \\$wnnna$acapillaris, Crepis
=450  \\$wnnna$aCrepi
=450  \\$wnnna$aCrepis capillari
=450  \\$wnnna$aCrepis capillaris
=450  \\$wnnna$aHawk Beard
=450  \\$aHawk's Beard
=450  \\$wnnna$aHawks Beard
=450  \\$wnnna$aHawk's Beards
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the ASTERACEAE family.
=688  \\$a2002; use ASTERACEAE 1998-2001, use HERBS 1995-1997
=750  \0$aCrepis$5IEN-M$0(DLC)sh 88022714

=LDR  00817cz  a2200205n  4500
=001  9880364341702441
=005  20141212214411.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027466
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x199
=150  \\$aAtriplex
=450  \\$wnnna$aAtriplices
=450  \\$aSaltbush
=450  \\$wnnna$aSaltbushs
=550  \\$wg$aChenopodiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the CHENOPODIACEAE family.
=688  \\$a2002
=750  \0$aAtriplex$5IEN-M$0(DLC)sh 85009357

=LDR  01060cz  a2200229n  4500
=001  9880364342002441
=005  20141212214411.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027465
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x599.$x875
=150  \\$aChenopodium quinoa
=450  \\$wnnna$aChenopodium quinoas
=450  \\$aQuinoa
=450  \\$wnnna$aquinoa, Chenopodium
=450  \\$wnnna$aQuinoas
=450  \\$wnnna$aquinoas, Chenopodium
=550  \\$wg$aChenopodium
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA species of the Chenopodium genus which is the source of edible seed called quinoa. It contains makisterone A and other STEROIDS, some having ECDYSTEROID activity on insects.
=688  \\$a2002
=750  \0$aQuinoa$5IEN-M$0(DLC)sh 85109886

=LDR  00919cz  a2200193n  4500
=001  9880364342102441
=005  20141212214330.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812
=150  \\$aPiperaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aPeperomia
=550  \\$wh$aPiper
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.
=688  \\$a2002
=750  \0$aPiperaceae$5IEN-M$0(DLC)sh 85102396

=LDR  01184cz  a2200301n  4500
=001  9880364342202441
=005  20141212214410.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027463
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x599.$x500
=150  \\$aChenopodium album
=450  \\$wnnna$aalbum, Chenopodium
=450  \\$wnnna$aalbums, Chenopodium
=450  \\$wnnna$aChenopodium albums
=450  \\$wnnna$aLamb Quarters
=450  \\$wnnna$aLamb's Quarter
=450  \\$aLamb's Quarters
=450  \\$wnnna$aLambs Quarters
=450  \\$wnnna$aLambsquarter
=450  \\$wnnna$aLambsquarters
=450  \\$wnnna$aQuarter, Lamb's
=450  \\$wnnna$aQuarters, Lamb's
=550  \\$wg$aChenopodium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species in the CHENOPODIUM genus known for edible greens.
=688  \\$a2002
=750  \0$aChenopodium album$5IEN-M$0(DLC)sh 85023059

=LDR  01185cz  a2200337n  4500
=001  9880364342302441
=005  20141212214330.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x890
=072  \\$aE2.$x779.$x474.$x913
=072  \\$aI3.$x450.$x642.$x845.$x560.$x500
=150  \\$aTai Ji
=450  \\$wnnna$aChi, Tai
=450  \\$wnnna$aJi Quan, Tai
=450  \\$wnnna$aQuan, Tai Ji
=450  \\$aT'ai Chi
=450  \\$aTai Chi
=450  \\$wnnna$aTai Chi Chuan
=450  \\$aTai-ji
=450  \\$aTai Ji Quan
=450  \\$aTaiji
=450  \\$aTaijiquan
=550  \\$wg$aExercise Movement Techniques
=550  \\$wg$aMartial Arts
=550  \\$wg$aMind-Body Therapies
=667  \\$ado not confuse with 'Taiji study' carried out in that region of Japan; do not confuse with Japanese interpretation of "Taiji" which means 'embryo' or 'fetus'
=680  \\$iOne of the MARTIAL ARTS and also a form of meditative exercise using methodically slow circular stretching movements and positions of body balance.
=688  \\$a2002; use MARTIAL ARTS 1996-2001
=750  \0$aTai chi$5IEN-M$0(DLC)sh 85131930

=LDR  00990cz  a2200241n  4500
=001  9880364342402441
=005  20141212214410.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027462
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x599
=150  \\$aChenopodium
=450  \\$wnnna$aChenopodiums
=450  \\$aGoosefoot
=450  \\$wnnna$aGoosefoots
=550  \\$wg$aChenopodiaceae
=550  \\$wh$aChenopodium album
=550  \\$wh$aChenopodium ambrosioides
=550  \\$wh$aChenopodium quinoa
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the CHENOPODIACEAE family.
=688  \\$a2002; for GOOSEFOOT use CHENOPODIACEAE 1998-2001
=750  \0$aGoosefoots$5IEN-M$0(DLC)sh 85023058

=LDR  01019cz  a2200253n  4500
=001  9880364342502441
=005  20141212214410.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x399
=150  \\$aBeta vulgaris
=450  \\$wnnna$aBeet
=450  \\$aBeets
=450  \\$wnnna$aBeta vulgari
=450  \\$aChard
=450  \\$wnnna$aChards
=450  \\$wnnna$avulgari, Beta
=450  \\$wnnna$avulgaris, Beta
=550  \\$wg$aChenopodiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA species of the Beta genus. Cultivars are used as a source of beets (root) or chard (leaves).
=688  \\$a2002; use CHENOPODIACEAE 1998-2001
=750  \0$aBeets$5IEN-M$0(DLC)sh 85012871

=LDR  01610cz  a2200445n  4500
=001  9880364342602441
=005  20141212214327.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x599
=072  \\$aE2.$x779.$x867
=150  \\$aMusculoskeletal Manipulations
=450  \\$wnnna$aManipulation Therapies
=450  \\$aManipulation Therapy
=450  \\$aManipulations, Musculoskeletal
=450  \\$wnnna$aManipulative Therapies
=450  \\$wnnna$aManipulative Therapy
=450  \\$wnnna$aManual Therapies
=450  \\$wnnna$aManual Therapy
=450  \\$wnnna$aTherapies, Manipulation
=450  \\$wnnna$aTherapies, Manipulative
=450  \\$wnnna$aTherapies, Manual
=450  \\$wnnna$aTherapy, Manipulation
=450  \\$wnnna$aTherapy, Manipulative
=450  \\$wnnna$aTherapy, Manual
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wh$aKinesiology, Applied
=550  \\$wh$aManipulation, Chiropractic
=550  \\$wh$aManipulation, Orthopedic
=550  \\$wh$aManipulation, Osteopathic
=550  \\$wh$aManipulation, Spinal
=550  \\$wh$aMotion Therapy, Continuous Passive
=550  \\$wh$aTherapy, Soft Tissue
=550  \\$aPhysical Therapy Modalities
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iVarious manipulations of body tissues, muscles and bones by hands or equipment to improve health and circulation, relieve fatigue, promote healing.
=688  \\$a2002
=750  \0$aManipulation (Therapeutics)$5IEN$0(DLC)sh 85080557

=LDR  01300cz  a2200301n  4500
=001  9880364342702441
=005  20141212214409.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x524
=150  \\$aLindera
=450  \\$wnnna$aAllspice, Wild
=450  \\$wnnna$aAllspices, Wild
=450  \\$wnnna$abenzoin, Lindera
=450  \\$wnnna$abenzoins, Lindera
=450  \\$wnnna$aLindera benzoin
=450  \\$wnnna$aLindera benzoins
=450  \\$wnnna$aLinderas
=450  \\$aSpicebush
=450  \\$wnnna$aSpicebushs
=450  \\$wnnna$aWild Allspice
=450  \\$wnnna$aWild Allspices
=550  \\$wg$aLauraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. Lindera benzoin is a source of a balsamic resin called benzoin which is up to 1/3 BENZOIC ACID. This should not be confused with the chemical BENZOIN or the plant STYRAX BENZOIDES.
=688  \\$a2002
=750  \0$aLindera (Plants)$0(DLC)sh2008005310$5IEN-M

=LDR  00860cz  a2200289n  4500
=001  9880364342802441
=005  20180119092148.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026121
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436
=072  \\$aD3.$x438.$x473.$x402
=150  \\$aIndole Alkaloids
=450  \\$wnnna$aAlkaloids, Indole
=550  \\$wg$aAlkaloids
=550  \\$wg$aIndoles
=550  \\$wh$aHarmaline
=550  \\$wh$aHarmine
=550  \\$wh$aLyngbya Toxins
=550  \\$wh$aPhysostigmine
=550  \\$wh$aPsilocybin
=550  \\$wh$aSecologanin Tryptamine Alkaloids
=550  \\$wh$aStaurosporine
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iGroup of alkaloids containing a benzylpyrrole group (derived from TRYPTOPHAN)
=688  \\$a2002
=750  \0$aIndole alkaloids$5IEN-M$0(DLC)sh 85065726

=LDR  00757cz  a2200193n  4500
=001  9880364342902441
=005  20141212214325.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x339.$x431.$x500
=150  \\$aSinglet Oxygen
=450  \\$wnnna$aDioxygen, Singlet
=450  \\$wnnna$aOxygen, Singlet
=450  \\$wnnna$aSinglet Dioxygen
=550  \\$wg$aReactive Oxygen Species
=680  \\$iAn excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.
=688  \\$a2002; use OXYGEN (NM) 1974-2001
=750  \0$aActive oxygen$5IEN-M$0(DLC)sh 85000738

=LDR  01135cz  a2200253n  4500
=001  9880364343002441
=005  20141212214408.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027442
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x399
=150  \\$aLaurus
=450  \\$aBay Laurel
=450  \\$wnnna$aBay Laurels
=450  \\$aBay Leaf
=450  \\$wnnna$aLaurel, Bay
=450  \\$wnnna$aLaurels, Bay
=450  \\$wnnna$aLaurus nobilis
=450  \\$wnnna$aLeaf, Bay
=550  \\$wg$aLauraceae
=667  \\$ado not confuse X ref BAY LAUREL with BAY LAUREL, CALIFORNIA see UMBELLULARIA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.
=688  \\$a2002; use LAURACEAE 1998-2001
=750  \0$aLaurel$5IEN-M$0(DLC)sh 85075081

=LDR  01043cz  a2200301n  4500
=001  9880364343102441
=005  20141212214322.0
=008  010806\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x601.$x690
=150  \\$aProtein Interaction Mapping
=450  \\$wnnna$aInteraction Mapping, Protein
=450  \\$wnnna$aInteraction Mappings, Protein
=450  \\$wnnna$aMapping, Protein Interaction
=450  \\$wnnna$aMappings, Protein Interaction
=450  \\$wnnna$aProtein Interaction Mappings
=550  \\$wg$aMolecular Probe Techniques
=550  \\$wh$aBlotting, Far-Western
=550  \\$wh$aEpitope Mapping
=550  \\$wh$aTwo-Hybrid System Techniques
=550  \\$aMolecular Docking Simulation
=550  \\$aProtein Array Analysis
=550  \\$aProtein Interaction Domains and Motifs
=550  \\$aProtein Interaction Maps
=680  \\$iMethods for determining interaction between PROTEINS.
=688  \\$a2002
=750  \0$aProtein-protein interactions$5IEN-M$0(DLC)sh2003008324

=LDR  01156cz  a2200277n  4500
=001  9880364343202441
=005  20141212214408.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x737
=150  \\$aSassafras
=450  \\$wnnna$aalbidum, Sassafras
=450  \\$wnnna$aalbidums, Sassafras
=450  \\$wnnna$aofficinale, Sassafras
=450  \\$wnnna$aofficinales, Sassafras
=450  \\$wnnna$aSassafra
=450  \\$wnnna$aSassafras albidum
=450  \\$wnnna$aSassafras albidums
=450  \\$wnnna$aSassafras officinale
=450  \\$wnnna$aSassafras officinales
=550  \\$wg$aLauraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. The tree bark has been used medicinally.
=688  \\$a2002; use LAURACEAE 1996-2001
=750  \0$aSassafras$5IEN-M$0(DLC)sh 88023088

=LDR  01151cz  a2200253n  4500
=001  9880364343302441
=005  20141212214322.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025924
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x750
=150  \\$aChromatography, Supercritical Fluid
=450  \\$wnnna$aExtraction, Supercritical Fluid
=450  \\$wnnna$aFluid Chromatography, Supercritical
=450  \\$wnnna$aFluid Extraction, Supercritical
=450  \\$wnnna$aSFC (Supercritical Fluid Chromatography)
=450  \\$wnnna$aSFE (Supercritical Fluid Extraction)
=450  \\$aSupercritical Fluid Chromatography
=450  \\$aSupercritical Fluid Extraction
=550  \\$wg$aChromatography
=667  \\$aDF: SFC Chromatogr
=680  \\$iA CHROMATOGRAPHY method using supercritical fluid, usually carbon dioxide under very high pressure (around 73 atmospheres or 1070 psi at room temperature) as the mobile phase. Other solvents are sometimes added as modifiers. This is used both for analytical (SFC) and extraction (SFE) purposes.
=688  \\$a2002
=750  \0$aSupercritical fluid chromatography$5IEN-M$0(DLC)sh 88000878

=LDR  00631cz  a2200193n  4500
=001  9880364343402441
=005  20141212214318.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x249.$x270
=150  \\$aElectric Capacitance
=450  \\$wnnna$aCapacitance, Electric
=450  \\$aCapacitance, Electrical
=450  \\$wnnna$aElectrical Capacitance
=550  \\$wg$aElectricity
=680  \\$iThe ability of a substrate to retain an electrical charge.
=688  \\$a2002; use ELECTRIC CONDUCTIVITY 1968-2001
=750  \0$aElectric capacity$5IEN-M$0(DLC)sh 85041605

=LDR  00969cz  a2200217n  4500
=001  9880364343502441
=005  20141212214407.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027424
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x149
=150  \\$aCinnamomum
=450  \\$wnnna$aCinnamomums
=550  \\$wg$aLauraceae
=550  \\$wh$aCinnamomum aromaticum
=550  \\$wh$aCinnamomum camphora
=550  \\$wh$aCinnamomum zeylanicum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. The bark of the trees is used in FOLK MEDICINE and FLAVORING AGENTS.
=688  \\$a2002
=750  \0$aCinnamomum$5IEN-M$0(DLC)sh 85026032

=LDR  01242cz  a2200277n  4500
=001  9880364343602441
=005  20141212214318.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x947.$x500
=150  \\$aUbiquitin
=450  \\$wnnna$aAPF-1
=450  \\$wnnna$aATP-Dependent Proteolysis Factor 1
=450  \\$wnnna$aATP Dependent Proteolysis Factor 1
=450  \\$wnnna$aHigh Mobility Protein 20
=450  \\$wnnna$aHMG-20
=450  \\$wnnna$aHuman Ubiquitin
=450  \\$wnnna$aUbiquitin, Human
=550  \\$wg$aUbiquitins
=550  \\$wh$aPolyubiquitin
=550  \\$wh$aUbiquitin C
=667  \\$aUBIQUITINS
=680  \\$iA highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These "ubiquitinated" proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell.
=688  \\$a2002; use UBIQUITINS (1985-2001)
=750  \0$aUbiquitin$0(DLC) sh 88001325$5IEN

=LDR  00854cz  a2200253n  4500
=001  9880364343702441
=005  20141212214311.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025543
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x370.$x400.$x240
=072  \\$aB4.$x280.$x400.$x400.$x240
=150  \\$aBacteriophage IKe
=450  \\$aEnterobacteria phage IKe
=450  \\$aIKe Phage
=450  \\$wnnna$aIKe Phages
=450  \\$aPhage IKe
=450  \\$wnnna$aPhage, IKe
=450  \\$wnnna$aPhages, IKe
=550  \\$wg$aInovirus
=667  \\$acoord with specific bacterium /virol
=680  \\$iA species of filamentous phage in the genus INOVIRUS, family INOVIRIDAE. They are specific for enterobacteria that contain an IncN plasmid.
=688  \\$a2002; use INOVIRUS 1994-2001
=750  \0$aBacteriophage IKe$5IEN-HS$0(DLC)sh 89004022

=LDR  01214cz  a2200301n  4500
=001  9880364343802441
=005  20141212214407.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x149.$x249
=150  \\$aCinnamomum camphora
=450  \\$aCamphor Laurel
=450  \\$wnnna$aCamphor Laurels
=450  \\$aCamphor Tree
=450  \\$wnnna$aCamphor Trees
=450  \\$wnnna$acamphora, Cinnamomum
=450  \\$wnnna$acamphoras, Cinnamomum
=450  \\$wnnna$aCinnamomum camphoras
=450  \\$wnnna$aLaurel, Camphor
=450  \\$wnnna$aLaurels, Camphor
=450  \\$wnnna$aTree, Camphor
=450  \\$wnnna$aTrees, Camphor
=550  \\$wg$aCinnamomum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA tree, Cinnamomum camphora (L.) J. Presl, known as the source of CAMPHOR.
=688  \\$a2002; use LAURACEAE 1998-2001
=750  \0$aCamphor tree$5IEN-M$0(DLC)sh 85019225

=LDR  01046cz  a2200205n  4500
=001  9880364343902441
=005  20141212214406.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x825
=150  \\$aUmbellularia
=450  \\$aBay Laurel, California
=450  \\$aCalifornia Bay Laurel
=450  \\$wnnna$aUmbellularias
=550  \\$wg$aLauraceae
=667  \\$ado not confuse X ref BAY LAUREL, CALIFORNIA with BAY LAUREL see LAURUS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. The tree, Umbellularia californica (Hook. & Arn.) Nutt., is known for aromatic leaves used in SPICES having a similar flavor to LAURUS.
=688  \\$a2002
=750  \0$aUmbellularia$5IEN-M$0(DLC)sh 88023175

=LDR  02013cz  a2200529n  4500
=001  9880364344002441
=005  20210218092609.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x624.$x776
=150  \\$aTumor Suppressor Proteins
=450  \\$aGrowth Suppressor Proteins
=450  \\$aMetastasis Suppressor Proteins
=450  \\$wnnna$aProteins, Growth Suppressor
=450  \\$wnnna$aProteins, Metastasis Suppressor
=450  \\$wnnna$aProteins, Tumor Suppressor
=550  \\$wg$aNeoplasm Proteins
=550  \\$wh$aAdenomatous Polyposis Coli Protein
=550  \\$wh$aAntigens, CD82
=550  \\$wh$aBRCA1 Protein
=550  \\$wh$aBRCA2 Protein
=550  \\$wh$aCyclin-Dependent Kinase Inhibitor Proteins
=550  \\$wh$aCystatin M
=550  \\$wh$aFanconi Anemia Complementation Group N Protein
=550  \\$wh$aInhibitor of Growth Protein 1
=550  \\$wh$aKisspeptins
=550  \\$wh$aNeurofibromin 1
=550  \\$wh$aNeurofibromin 2
=550  \\$wh$aPromyelocytic Leukemia Protein
=550  \\$wh$aPTEN Phosphohydrolase
=550  \\$wh$aRetinoblastoma-Like Protein p107
=550  \\$wh$aRetinoblastoma-Like Protein p130
=550  \\$wh$aRetinoblastoma Protein
=550  \\$wh$aSmad4 Protein
=550  \\$wh$aTumor Suppressor Protein p14ARF
=550  \\$wh$aTumor Protein p73
=550  \\$wh$aTumor Suppressor Protein p53
=550  \\$wh$aVon Hippel-Lindau Tumor Suppressor Protein
=550  \\$wh$aWT1 Proteins
=550  \\$wh$aWW Domain-Containing Oxidoreductase
=550  \\$wh$aTuberous Sclerosis Complex 1 Protein
=550  \\$wh$aTuberous Sclerosis Complex 2 Protein
=550  \\$aGenes, Tumor Suppressor
=680  \\$iProteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
=688  \\$a2002
=750  \0$aTumor suppressor proteins$5IEN-M$0(DLC)sh2002008814

=LDR  01072cz  a2200253n  4500
=001  9880364344102441
=005  20141212214406.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x590.$x650
=150  \\$aPersea
=450  \\$wnnna$aamericana, Persea
=450  \\$wnnna$aamericanas, Persea
=450  \\$aAvocado
=450  \\$wnnna$aAvocados
=450  \\$wnnna$aPersea americana
=450  \\$wnnna$aPersea americanas
=450  \\$wnnna$aPerseas
=550  \\$wg$aLauraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the LAURACEAE family. The tree, Persea americana Mill., is known for the Avocado fruit, the food of commerce.
=688  \\$a2002; use LAURACEAE 1998-2001
=750  \0$aPersea$5IEN-M$0(DLC)sh 85100049

=LDR  01281cz  a2200277n  4500
=001  9880364344202441
=005  20160912154508.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027383
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x210.$x655
=072  \\$aB4.$x613.$x204.$x655
=150  \\$aPapillomaviridae
=450  \\$wnno$aPapillomavirus$5IEN-M
=550  \\$wg$aDNA Tumor Viruses
=550  \\$wh$aAlphapapillomavirus
=550  \\$wh$aBetapapillomavirus
=550  \\$wh$aDeltapapillomavirus
=550  \\$wh$aGammapapillomavirus
=550  \\$wh$aKappapapillomavirus
=550  \\$wh$aLambdapapillomavirus
=550  \\$wh$aMupapillomavirus
=550  \\$wh$aXipapillomavirus
=680  \\$iA family of small, non-enveloped DNA viruses infecting birds and most mammals, especially humans. They are grouped into multiple genera, but the viruses are highly host-species specific and tissue-restricted. They are commonly divided into hundreds of papillomavirus "types", each with specific gene function and gene control regions, despite sequence homology. Human papillomaviruses are found in the genera ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; and MUPAPILLOMAVIRUS.
=688  \\$a2002
=750  \0$aPapillomaviruses$0(DLC) sh 85097679$5IEN-M

=LDR  01243cz  a2200313n  4500
=001  9880364344302441
=005  20141212214306.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x750.$x228
=072  \\$aE1.$x370.$x350.$x850.$x220.$x228
=072  \\$aE1.$x370.$x370.$x380.$x220.$x228
=150  \\$aEchocardiography, Stress
=450  \\$wnnna$aDobutamine Stress Echocardiographies
=450  \\$aDobutamine Stress Echocardiography
=450  \\$wnnna$aEchocardiographies, Dobutamine Stress
=450  \\$wnnna$aEchocardiographies, Stress
=450  \\$wnnna$aEchocardiography, Dobutamine Stress
=450  \\$aEchocardiography, Stress, Dobutamine
=450  \\$wnnna$aStress Echocardiographies
=450  \\$wnnna$aStress Echocardiographies, Dobutamine
=450  \\$aStress Echocardiography
=450  \\$wnnna$aStress Echocardiography, Dobutamine
=550  \\$wg$aEchocardiography
=550  \\$aExercise Test
=680  \\$iA method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing (EXERCISE TEST) or pharmacologic stress.
=688  \\$a2002
=750  \0$aStress echocardiography$5IEN$0(DLC)sh 91004821

=LDR  00943cz  a2200253n  4500
=001  9880364344402441
=005  20141212214356.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x340.$x685
=072  \\$aA8.$x637.$x685
=072  \\$aA11.$x650.$x775
=150  \\$aSatellite Cells, Perineuronal
=450  \\$wnnna$aCell, Perineuronal Satellite
=450  \\$wnnna$aCells, Perineuronal Satellite
=450  \\$wnnna$aPerineuronal Satellite Cell
=450  \\$aPerineuronal Satellite Cells
=450  \\$wnnna$aSatellite Cell, Perineuronal
=550  \\$wg$aGanglia
=550  \\$wg$aNeuroglia
=680  \\$iThe non-neuronal cells that surround the neuronal cell bodies of the GANGLIA. They are distinguished from the perineuronal satellite oligodendrocytes (OLIGODENDROGLIA) found in the central nervous system.
=688  \\$a2002
=750  \0$aSatellite cells$5IEN-M$0(DLC)sh 85117627

=LDR  00979cz  a2200253n  4500
=001  9880364344502441
=005  20141212214304.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x802
=072  \\$aD12.$x644.$x641.$x802
=150  \\$aStreptogramins
=450  \\$wnnna$aStreptogramin
=550  \\$wg$aPeptides, Cyclic
=550  \\$wh$aMikamycin
=550  \\$wh$aPristinamycin
=550  \\$wh$aStreptogramin Group A
=550  \\$wh$aStreptogramin Group B
=550  \\$wh$aVernamycin B
=550  \\$wh$aVirginiamycin
=680  \\$iA class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth.
=688  \\$a2002, 1981-1993; use VIRGINIAMYCIN 1994-2001
=750  \0$aStreptogramins$5IEN-M$0(DLC)sh 98003484

=LDR  01094cz  a2200229n  4500
=001  9880364344602441
=005  20190726132536.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027003
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x937.$x937
=150  \\$aUrticaceae
=450  \\$wnno$aCecropiaceae
=450  \\$aMyrianthus
=550  \\$wg$aRosales
=550  \\$wh$aBoehmeria
=550  \\$wh$aParietaria
=550  \\$wh$aUrtica dioica
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe nettles plant family of the order ROSALES, superorder ROSANAE, and class MAGNOLIOPSIDA. Many have stinging hairs on stems and leaves with flowers that are small and greenish in leaf axils. The fruit is dry and one-seeded.
=688  \\$a2002
=750  \0$aUrticaceae$5IEN-M$0(DLC)sh 85141472

=LDR  00741cz  a2200193n  4500
=001  9880364344702441
=005  20141212214303.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x562
=150  \\$aPrincipal Component Analysis
=450  \\$wnnna$aAnalyses, Principal Component
=450  \\$wnnna$aAnalysis, Principal Component
=450  \\$wnnna$aPrincipal Component Analyses
=550  \\$wg$aStatistics as Topic
=680  \\$iMathematical procedure that transforms a number of possibly correlated variables into a smaller number of uncorrelated variables called principal components.
=688  \\$a2002
=750  \0$aPrincipal components analysis$5IEN-M$0(DLC)sh 85106729

=LDR  01204cz  a2200265n  4500
=001  9880364344802441
=005  20141212214354.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x950.$x888
=150  \\$aUrtica dioica
=450  \\$wnnna$adioica, Urtica
=450  \\$wnnna$adioicas, Urtica
=450  \\$aNettle, Stinging
=450  \\$wnnna$aNettles, Stinging
=450  \\$aStinging Nettle
=450  \\$wnnna$aStinging Nettles
=450  \\$wnnoa$aUrtica diocia$5IEN-HS
=450  \\$wnnna$aUrtica dioicas
=550  \\$wg$aUrticaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus Urtica, family URTICACEAE. Roots have been used to treat PROSTATIC HYPERPLASIA. Leaves are edible after the stinging quality is eliminated by brief heating.
=688  \\$a2002; use HAMAMELIDAE 1999-2001
=750  \0$aStinging nettle$5IEN-M$0(DLC)sh 85128155

=LDR  01654cz  a2200421n  4500
=001  9880364344902441
=005  20141212214303.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x950.$x875
=072  \\$aE4.$x749
=072  \\$aL1.$x700.$x508.$x100.$x710.$x800
=150  \\$aSurgery, Computer-Assisted
=450  \\$wnnna$aComputer-Aided Surgeries
=450  \\$wnnna$aComputer-Aided Surgery
=450  \\$wnnna$aComputer Aided Surgery
=450  \\$wnnna$aComputer-Assisted Surgeries
=450  \\$aComputer-Assisted Surgery
=450  \\$wnnna$aComputer Assisted Surgery
=450  \\$wnnna$aImage-Guided Surgeries
=450  \\$aImage-Guided Surgery
=450  \\$wnnna$aImage Guided Surgery
=450  \\$wnnna$aSurgeries, Computer-Aided
=450  \\$wnnna$aSurgeries, Computer-Assisted
=450  \\$wnnna$aSurgeries, Image-Guided
=450  \\$wnnna$aSurgery, Computer-Aided
=450  \\$wnnna$aSurgery, Computer Assisted
=450  \\$aSurgery, Image-Guided
=450  \\$wnnna$aSurgery, Image Guided
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wg$aTherapy, Computer-Assisted
=550  \\$wh$aRobotic Surgical Procedures
=550  \\$aImage-Guided Biopsy
=550  \\$aNeuronavigation
=680  \\$iSurgical procedures conducted with the aid of computers. This is most frequently used in orthopedic and laparoscopic surgery for implant placement and instrument guidance. Image-guided surgery interactively combines prior CT scans or MRI images with real-time video.
=688  \\$a2002
=750  \0$aComputer-assisted surgery$0(DLC)sh2006007439$5IEN-M

=LDR  00607cz  a2200193n  4500
=001  9880364345002441
=005  20141212214303.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA19.$x687.$x400
=150  \\$aHyphae
=450  \\$wnnna$aHypha
=450  \\$wnnna$aHyphas
=550  \\$wg$aMycelium
=667  \\$acoord with specific fungus
=680  \\$iMicroscopic threadlike filaments in FUNGI that are filled with a layer of protoplasm. Collectively, the hyphae make up the MYCELIUM.
=688  \\$a2002
=750  \0$aFungi$xHyphae$5IEN-M$0(DLC)sh 85052447

=LDR  00905cz  a2200193n  4500
=001  9880364345102441
=005  20141212214353.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x403
=150  \\$aDNA Topoisomerases
=450  \\$wnnna$aTopoisomerases, DNA
=550  \\$wg$aIsomerases
=550  \\$wh$aDNA Topoisomerases, Type I
=550  \\$wh$aDNA Topoisomerases, Type II
=680  \\$iEnzymes that regulate the topology of DNA by actions such as breaking, relaxing, passing, and rejoining strands of DNA in cells. These enzymes are important components of the DNA replication system. They are classified by their substrate specificities. DNA TOPOISOMERASE I enzymes act on a single strand of DNA. DNA TOPOISOMERASE II enzymes act on double strands of DNA.
=688  \\$a2002
=750  \0$aDNA topoisomerases$0(DLC) sh 99000716$5IEN-M

=LDR  00524cz  a2200193n  4500
=001  9880364345202441
=005  20141212214302.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA19.$x687
=150  \\$aMycelium
=450  \\$wnnna$aMyceliums
=550  \\$wg$aFungal Structures
=550  \\$wh$aHyphae
=667  \\$acoord with specific fungus
=680  \\$iThe body of a fungus which is made up of HYPHAE.
=688  \\$a2002
=750  \0$aMycelium$5IEN-M$0(DLC)sh 85089174

=LDR  01291cz  a2200301n  4500
=001  9880364345302441
=005  20141212214353.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x750
=072  \\$aD27.$x505.$x954.$x411.$x720
=150  \\$aSodium Channel Blockers
=450  \\$aChannel Blockers, Sodium
=450  \\$wnnna$aChannel Inhibitors, Sodium
=450  \\$aDegenerin Sodium Channels$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, Sodium Channel
=450  \\$wnnna$aSodium Channel Inhibitors
=450  \\$aSodium Channels$xantagonists & inhibitors
=550  \\$wg$aCardiovascular Agents
=550  \\$wg$aMembrane Transport Modulators
=550  \\$wh$aAcid Sensing Ion Channel Blockers
=550  \\$wh$aEpithelial Sodium Channel Blockers
=550  \\$wh$aVoltage-Gated Sodium Channel Blockers
=667  \\$acoordinate with DIURETICS if pertinent; DF: NA CHANNEL BLOCK
=680  \\$iA class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.
=688  \\$a2002
=750  \0$aSodium channels$xAntagonists$5IEN-M

=LDR  01387cz  a2200313n  4500
=001  9880364345402441
=005  20141212214301.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x853.$x625.$x800
=072  \\$aC5.$x550.$x114.$x865.$x800
=150  \\$aSpondylarthropathies
=450  \\$wnnna$aBechterew Syndrome
=450  \\$wnnna$aMarie-Strumpell Spondylitis
=450  \\$wnnna$aMarie Strumpell Spondylitis
=450  \\$wnnna$aSpondylarthropathy
=450  \\$wnnna$aSpondylitis, Marie-Strumpell
=450  \\$wnnna$aSpondyloarthropathies
=450  \\$wnnna$aSpondyloarthropathy
=450  \\$wnnna$aSyndrome, Bechterew
=550  \\$wg$aSpondylarthritis
=550  \\$wh$aArthritis, Psoriatic
=550  \\$wh$aArthritis, Reactive
=550  \\$wh$aSpondylitis, Ankylosing
=667  \\$acoordinate with specific vertebra
=680  \\$iHeterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.
=688  \\$a2002
=750  \0$aSpondyloarthropathies$5IEN-M$0(DLC)sh 85126847

=LDR  00956cz  a2200241n  4500
=001  9880364345502441
=005  20141212214350.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x500
=072  \\$aD27.$x505.$x954.$x411.$x645
=150  \\$aPotassium Channel Blockers
=450  \\$wnnna$aBlockers, Potassium Channel
=450  \\$aChannel Blockers, Potassium
=450  \\$aPotassium Channels$xantagonists & inhibitors
=550  \\$wg$aCardiovascular Agents
=550  \\$wg$aMembrane Transport Modulators
=550  \\$aKATP Channels
=667  \\$aDF: K CHANNEL BLOCK
=680  \\$iA class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.
=688  \\$a2002
=750  \0$aPotassium channels$xAntagonists$5IEN-M

=LDR  00321cz  a2200109n  4500
=001  9880364345602441
=005  20120717143659.0
=008  010725\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D026882Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aManipulation, Chiropractic$xveterinary
=750  \0$aVeterinary chiropractic$5IEN-M$0(DLC)sh 97003834

=LDR  00645cz  a2200181n  4500
=001  9880364345702441
=005  20141212214349.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026881
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x4
=150  \\$aAcupuncture
=550  \\$wg$aHealth Occupations
=550  \\$aAcupuncture Therapy
=667  \\$aSPEC only; do not confuse with ACUPUNCTURE THERAPY
=680  \\$iThe occupational discipline of the traditional Chinese methods of ACUPUNCTURE THERAPY for treating disease by inserting needles along specific pathways or meridians.
=688  \\$a2002
=750  \0$aAcupuncture$5IEN$0(DLC)sh 85000761

=LDR  00614cz  a2200181n  4500
=001  9880364345802441
=005  20141212214349.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026864
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x100.$x100
=150  \\$aArgas
=450  \\$wnnna$aArga
=550  \\$wg$aArgasidae
=667  \\$ainfestation: coord IM with TICK INFESTATIONS (IM)
=680  \\$iA genus of softbacked TICKS in the family ARGASIDAE. Most infect birds or bats but a few parasitize terrestrial mammals.
=688  \\$a2002
=750  \0$aArgas$5IEN-M$0(DLC)sh 85007012

=LDR  01626cz  a2200421n  4500
=001  9880364345902441
=005  20141212214259.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x880
=072  \\$aE5.$x200.$x880
=072  \\$aE5.$x393.$x520
=150  \\$aMolecular Diagnostic Techniques
=450  \\$wnnna$aDiagnostic Technic, Molecular
=450  \\$wnnna$aDiagnostic Technics, Molecular
=450  \\$wnnna$aDiagnostic Technique, Molecular
=450  \\$wnnna$aDiagnostic Techniques, Molecular
=450  \\$wnnna$aDiagnostic Testing, Molecular
=450  \\$wnnna$aMolecular Diagnostic Technic
=450  \\$wnnna$aMolecular Diagnostic Technics
=450  \\$wnnna$aMolecular Diagnostic Technique
=450  \\$wnnna$aMolecular Diagnostic Testing
=450  \\$wnnna$aTechnic, Molecular Diagnostic
=450  \\$wnnna$aTechnics, Molecular Diagnostic
=450  \\$wnnna$aTechnique, Molecular Diagnostic
=450  \\$wnnna$aTechniques, Molecular Diagnostic
=450  \\$wnnna$aTesting, Molecular Diagnostic
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aComparative Genomic Hybridization
=550  \\$wh$aHuman Papillomavirus DNA Tests
=550  \\$aCytogenetic Analysis
=550  \\$aGenetic Testing
=667  \\$acoordinate with specific technique
=680  \\$iMOLECULAR BIOLOGY techniques used in the diagnosis of disease.
=688  \\$a2002; for MOLECULAR DIAGNOSTIC TESTING use CYTOGENETIC ANALYSIS 2000-2001
=750  \0$aMolecular diagnosis$5IEN-M$0(DLC)sh 93001015

=LDR  00939cz  a2200301n  4500
=001  9880364346002441
=005  20141212214348.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400
=150  \\$aIxodidae
=450  \\$wnnna$aHard Tick
=450  \\$wnnna$aHard Ticks
=450  \\$wnnna$aHardbacked Tick
=450  \\$wnnna$aHardbacked Ticks
=450  \\$wnnna$aTick, Hard
=450  \\$wnnna$aTick, Hardbacked
=450  \\$wnnna$aTicks, Hard
=450  \\$aTicks, Hardbacked
=550  \\$wg$aTicks
=550  \\$wh$aDermacentor
=550  \\$wh$aIxodes
=550  \\$wh$aRhipicephalus
=667  \\$ainfestation: coord IM with TICK INFESTATIONS (IM)
=680  \\$iA family of hardbacked TICKS, in the subclass ACARI. Genera include DERMACENTOR and IXODES among others.
=688  \\$a2002
=750  \0$aIxodidae$5IEN-M$0(DLC)sh 85069146

=LDR  01320cz  a2200217n  4500
=001  9880364346102441
=005  20141212214257.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x676.$x925
=150  \\$aVitamin B 6
=450  \\$wnnna$aVitamin B6
=550  \\$wg$aPicolines
=550  \\$wh$aPyridoxal
=550  \\$wh$aPyridoxamine
=550  \\$wh$aPyridoxine
=667  \\$a/ther use: coordinate with disease /drug ther, not /diet ther
=680  \\$iVITAMIN B 6 refers to several PICOLINES (especially PYRIDOXINE; PYRIDOXAL; & PYRIDOXAMINE) that are efficiently converted by the body to PYRIDOXAL PHOSPHATE which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, and aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into PYRIDOXAMINE phosphate. Although pyridoxine and Vitamin B 6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading (EE Snell; Ann NY Acad Sci, vol 585 pg 1, 1990). Most of vitamin B6 is eventually degraded to PYRIDOXIC ACID and excreted in the urine.
=688  \\$a2002; use PYRIDOXINE 1963-2001
=750  \0$aVitamin B6$5IEN-M$0(DLC)sh 85143967

=LDR  00816cz  a2200205n  4500
=001  9880364346202441
=005  20141212214257.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711.$x193.$x150.$x125
=072  \\$aB3.$x851.$x595.$x193.$x150.$x125
=150  \\$aBorrelia burgdorferi
=450  \\$aBorrelia burgdorferi sensu stricto
=450  \\$aLyme Disease Spirochete
=550  \\$wg$aBorrelia burgdorferi Group
=667  \\$ainfection: coord IM with LYME DISEASE or specifics (IM); BORRELIA BURGDORFERI GROUP is also available
=680  \\$iA specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.
=688  \\$a2002
=750  \0$aBorrelia burgdorferi$5IEN$0(DLC)sh 99011745

=LDR  00908cz  a2200289n  4500
=001  9880364346302441
=005  20141212214348.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026862
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x100
=150  \\$aArgasidae
=450  \\$wnnna$aSoft Tick
=450  \\$wnnna$aSoft Ticks
=450  \\$wnnna$aSoftbacked Tick
=450  \\$wnnna$aSoftbacked Ticks
=450  \\$wnnna$aTick, Soft
=450  \\$wnnna$aTick, Softbacked
=450  \\$wnnna$aTicks, Soft
=450  \\$aTicks, Softbacked
=550  \\$wg$aTicks
=550  \\$wh$aArgas
=550  \\$wh$aOrnithodoros
=667  \\$ainfestation: coord IM with TICK INFESTATIONS (IM)
=680  \\$iA family of softbacked TICKS, in the subclass ACARI. Genera include ARGAS and ORNITHODOROS among others.
=688  \\$a2002
=750  \0$aArgasidae$5IEN-M$0(DLC)sh 85007014

=LDR  00521cz  a2200169n  4500
=001  9880364346402441
=005  20141212214255.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025061
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x150
=150  \\$aDinosaurs
=450  \\$wnnna$aDinosaur
=550  \\$wg$aReptiles
=680  \\$iGeneral name for two extinct orders of reptiles from the Mesozoic era: Saurischia and Ornithischia.
=688  \\$a2002
=750  \0$aDinosaurs$0(DLC) sh 85038094$5IEN-M

=LDR  00781cz  a2200205n  4500
=001  9880364346502441
=005  20141212214255.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x69.$x500
=150  \\$aAnimal Migration
=450  \\$wnnna$aAnimal Migrations
=450  \\$aMigration, Animal
=450  \\$wnnna$aMigrations, Animal
=550  \\$wg$aAnimal Distribution
=550  \\$aHoming Behavior
=680  \\$iPeriodic movements of animals in response to seasonal changes or reproductive instinct. Hormonal changes are the trigger in at least some animals. Most migrations are made for reasons of climatic change, feeding, or breeding.
=688  \\$a2002
=750  \0$aAnimal migration$5IEN-M$0(DLC)sh 85005211

=LDR  00919cz  a2200253n  4500
=001  9880364346602441
=005  20141212214348.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D026861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x100.$x700
=150  \\$aOrnithodoros
=450  \\$wnnna$aFever Tick, Relapsing
=450  \\$wnnna$aFever Ticks, Relapsing
=450  \\$wnnna$aOrnithodoro
=450  \\$wnnna$aRelapsing Fever Tick
=450  \\$aRelapsing Fever Ticks
=450  \\$wnnna$aTick, Relapsing Fever
=450  \\$aTicks, Relapsing Fever
=550  \\$wg$aArgasidae
=667  \\$ainfestation: coord IM with TICK INFESTATIONS (IM)
=680  \\$iA genus of softbacked TICKS, in the family ARGASIDAE, serving as the vector of BORRELIA, causing RELAPSING FEVER, and of the AFRICAN SWINE FEVER VIRUS.
=688  \\$a2002
=750  \0$aOrnithodoros$5IEN-M$0(DLC)sh 85095713

=LDR  00571cz  a2200181n  4500
=001  9880364346702441
=005  20141212214255.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D025021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x124
=150  \\$aCementogenesis
=450  \\$aDental Cementum$xgrowth & development
=550  \\$wg$aOrganogenesis
=550  \\$aDental Cementum
=680  \\$iThe formation of DENTAL CEMENTUM, a bone-like material that covers the root of the tooth.
=688  \\$a2002
=750  \0$aCementum$xGrowth$5IEN-M

=LDR  01176cz  a2200229n  4500
=001  9880364346802441
=005  20141212214254.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x460.$x400.$x186
=150  \\$aGlycogen Phosphorylase
=450  \\$wnnna$aPhosphorylase ab
=450  \\$wnnna$aPhosphorylase, Glycogen
=550  \\$wg$aPhosphorylases
=550  \\$wh$aGlycogen Phosphorylase, Brain Form
=550  \\$wh$aGlycogen Phosphorylase, Liver Form
=550  \\$wh$aGlycogen Phosphorylase, Muscle Form
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iAn enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form ( PHOSPHORYLASE A) and an inactive un-phosphorylated form (PHOSPHORYLASE B). Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.
=688  \\$a2002
=750  \0$aGlycogen Phosphorylase$5IEN-M$0(DLC)sh 90006166

=LDR  00631cz  a2200217n  4500
=001  9880364346902441
=005  20141212214251.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x835.$x322
=150  \\$aFluoroquinolones
=550  \\$wg$aQuinolones
=550  \\$wh$aCiprofloxacin
=550  \\$wh$aEnoxacin
=550  \\$wh$aNorfloxacin
=550  \\$wh$aOfloxacin
=550  \\$wh$aPefloxacin
=680  \\$iA group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
=688  \\$a2002
=750  \0$aFluoroquinolones$5IEN-M$0(DLC)sh2012000857

=LDR  01954cz  a2200445n  4500
=001  9880364347102441
=005  20141212214244.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x600.$x150
=072  \\$aD12.$x776.$x543.$x550.$x425.$x750.$x150
=072  \\$aD12.$x776.$x543.$x585.$x400.$x750.$x150
=150  \\$aPotassium Channels, Calcium-Activated
=450  \\$wnnna$aCa2+-Activated K+ Channels
=450  \\$wnnna$aCa2+ Activated K+ Channels
=450  \\$wnnna$aCalcium-Activated K+ Channels
=450  \\$wnnna$aCalcium-Activated Potassium Channel
=450  \\$wnnna$aCalcium Activated Potassium Channel
=450  \\$aCalcium-Activated Potassium Channels
=450  \\$wnnna$aCalcium Activated Potassium Channels
=450  \\$wnnna$aCalcium-Dependent Potassium Channels
=450  \\$wnnna$aCalcium Dependent Potassium Channels
=450  \\$wnnna$aChannels, Calcium-Dependent Potassium
=450  \\$wnnna$aK+ Channels, Ca2+-Activated
=450  \\$wnnna$aK+ Channels, Ca2+ Activated
=450  \\$wnnna$aK+ Channels, Calcium-Activated
=450  \\$wnnna$aK+ Channels, Calcium Activated
=450  \\$wnnna$aPotassium Channel, Calcium-Activated
=450  \\$wnnna$aPotassium Channel, Calcium Activated
=450  \\$wnnna$aPotassium Channels, Calcium Activated
=450  \\$wnnna$aPotassium Channels, Calcium-Dependent
=450  \\$wnnna$aPotassium Channels, Calcium Dependent
=550  \\$wg$aPotassium Channels
=550  \\$wh$aIntermediate-Conductance Calcium-Activated Potassium Channels
=550  \\$wh$aLarge-Conductance Calcium-Activated Potassium Channels
=550  \\$wh$aSmall-Conductance Calcium-Activated Potassium Channels
=680  \\$iPotassium channels whose activation is dependent on intracellular calcium concentrations.
=688  \\$a2002
=750  \0$aCalcium-dependent potassium channels$0(DLC) sh 93006761$5IEN-M

=LDR  00608cz  a2200193n  4500
=001  9880364347202441
=005  20141212214241.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x39
=150  \\$aBatrachoidiformes
=450  \\$aOpsanus
=450  \\$aPorichthys
=450  \\$aToadfishes
=550  \\$wg$aFishes
=680  \\$iAn order of bottom fishes with short, small, spinous dorsal fins. It is comprised of one family (Batrachoididae) and about 70 species.
=688  \\$a2002
=750  \0$aToadfishes$5IEN-M$0(DLC)sh 85135695

=LDR  00984cz  a2200217n  4500
=001  9880364347302441
=005  20141212214241.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024522
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x249.$x105
=072  \\$aG5.$x360.$x340.$x24.$x340.$x415.$x400.$x105
=150  \\$aGenes, BRCA2
=450  \\$aBRCA2 Gene
=450  \\$wnnna$aBRCA2 Genes
=450  \\$wnnna$aGene, BRCA2
=550  \\$wg$aGenes, Tumor Suppressor
=667  \\$aBRCA stands for "BReast CAncer"
=680  \\$iA tumor suppressor gene (GENES, TUMOR SUPPRESSOR) located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. (from Genes Dev 2000;14(11):1400-6)
=688  \\$a2002
=750  \0$aBRCA genes$0(DLC)sh2006006447$5IEN-M

=LDR  01010cz  a2200253n  4500
=001  9880364347402441
=005  20141212214240.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024510
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625.$x590
=072  \\$aG11.$x427.$x590.$x560.$x590
=150  \\$aMuscle Development
=450  \\$wnnna$aDevelopment, Muscle
=450  \\$wnnna$aDevelopment, Muscular
=450  \\$aMuscles$xgrowth & development
=450  \\$wnnna$aMuscular Development
=450  \\$aMyofibrillogenesis
=450  \\$aMyogenesis
=550  \\$wg$aMusculoskeletal Development
=667  \\$acoord with specific muscle term if pertinent
=680  \\$iDevelopmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.
=688  \\$a2002
=750  \0$aMyogenesis$5IEN-M$0(DLC)sh 85089256

=LDR  00739cz  a2200193n  4500
=001  9880364347502441
=005  20141212214240.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024508
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x909.$x875
=072  \\$aD3.$x830.$x219.$x909.$x875
=150  \\$aTocotrienols
=450  \\$wnnna$aTocotrienol
=550  \\$wg$aVitamin E
=667  \\$adeficiency: coordinate TOCOTRIENOLS with VITAMIN E DEFICIENCY
=680  \\$iNatural analogs of TOCOPHEROLS exhibiting antioxidant activity. These tocol derivatives and isomers contain a benzopyran ring and an unsaturated isoprenoid side chain.
=688  \\$a2002; use VITAMIN E 1966-2001
=750  \0$aTocotrienol$0(DLC)sh2008003390$5IEN-M

=LDR  01130cz  a2200265n  4500
=001  9880364347602441
=005  20141212214233.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x721.$x374.$x844
=072  \\$aD2.$x455.$x849.$x291.$x523.$x500.$x844
=072  \\$aD2.$x806.$x550.$x750
=072  \\$aD4.$x615.$x638.$x721.$x374.$x844
=150  \\$aVitamin K 2
=450  \\$aMenaquinone
=450  \\$wnnna$aMenaquinones
=450  \\$wnnna$aVitamin K Quinone
=450  \\$wnnna$aVitamin K2
=550  \\$wg$aNaphthoquinones
=550  \\$wg$aVitamin K
=667  \\$adeficiency: coordinate VITAMIN K 2 (IM) with VITAMIN K DEFICIENCY (IM)
=680  \\$iA group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.
=688  \\$a2002; use VITAMIN K 1965-2001
=750  \0$aVitamin K2$0(DLC)sh2006004121$5IEN-M

=LDR  00893cz  a2200277n  4500
=001  9880364347702441
=005  20141212214228.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x868
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x887
=072  \\$aD2.$x455.$x849.$x131.$x868
=072  \\$aD23.$x767.$x261.$x887
=150  \\$aXanthophylls
=450  \\$wnnna$aCarotenoids, Xanthophyll
=450  \\$wnnna$aXanthophyll Carotenoids
=550  \\$wg$aCarotenoids
=550  \\$wh$aCanthaxanthin
=550  \\$wh$aCryptoxanthins
=550  \\$wh$aLutein
=550  \\$wh$aMacular Pigment
=550  \\$wh$aZeaxanthins
=680  \\$iOxygenated forms of carotenoids. They are usually derived from alpha and beta carotene.
=688  \\$a2002
=750  \0$aXanthophylls$5IEN-M$0(DLC)sh 85148772

=LDR  05628cz  a2201213n  4500
=001  9880364347802441
=005  20141212214129.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x245
=072  \\$aE1.$x370.$x405.$x267
=150  \\$aElectrophysiologic Techniques, Cardiac
=450  \\$wnnna$aAtrial Electrogram
=450  \\$wnnna$aAtrial Electrograms
=450  \\$wnnna$aBundle Electrogram, His
=450  \\$wnnna$aBundle Electrograms, His
=450  \\$wnnna$aBundle of His Electrogram
=450  \\$wnnna$aCardiac Electrophysiologic Studies
=450  \\$wnnna$aCardiac Electrophysiologic Study
=450  \\$wnnna$aCardiac Electrophysiologic Technic
=450  \\$wnnna$aCardiac Electrophysiologic Technics
=450  \\$wnnna$aCardiac Electrophysiologic Technique
=450  \\$aCardiac Electrophysiologic Techniques
=450  \\$wnnna$aCardiac Electrophysiological Technique
=450  \\$wnnna$aCardiac Electrophysiological Techniques
=450  \\$wnnna$aCardiac Programmed Electrostimulation
=450  \\$wnnna$aCardiac Programmed Electrostimulations
=450  \\$wnnna$aElectrogram, Atrial
=450  \\$wnnna$aElectrogram Bundle, His
=450  \\$wnnna$aElectrogram Bundles, His
=450  \\$wnnna$aElectrogram, His Bundle
=450  \\$wnnna$aElectrogram, Intra-Atrial
=450  \\$wnnna$aElectrogram, Intracardiac
=450  \\$wnnna$aElectrograms, Atrial
=450  \\$wnnna$aElectrograms, His Bundle
=450  \\$wnnna$aElectrograms, Intra-Atrial
=450  \\$wnnna$aElectrograms, Intracardiac
=450  \\$wnnna$aElectrophysiologic Studies, Cardiac
=450  \\$wnnna$aElectrophysiologic Studies, Transesophageal
=450  \\$aElectrophysiologic Study, Cardiac
=450  \\$wnnna$aElectrophysiologic Study, Transesophageal
=450  \\$wnnna$aElectrophysiologic Technic, Cardiac
=450  \\$wnnna$aElectrophysiologic Technics, Cardiac
=450  \\$wnnna$aElectrophysiologic Technique, Cardiac
=450  \\$wnnna$aElectrophysiologic Technique, Intracardiac
=450  \\$wnnna$aElectrophysiologic Techniques, Intracardiac
=450  \\$wnnna$aElectrophysiological Studies, Transesophageal
=450  \\$wnnna$aElectrophysiological Study, Transesophageal
=450  \\$wnnna$aElectrophysiological Technic, Intracardiac
=450  \\$wnnna$aElectrophysiological Technics, Intracardiac
=450  \\$wnnna$aElectrophysiological Technique, Cardiac
=450  \\$wnnna$aElectrophysiological Technique, Intracardiac
=450  \\$wnnna$aElectrophysiological Techniques, Cardiac
=450  \\$wnnna$aElectrophysiological Techniques, Intracardiac
=450  \\$wnnna$aElectrostimulation, Cardiac Programmed
=450  \\$wnnna$aElectrostimulations, Cardiac Programmed
=450  \\$wnnna$aHis Bundle Electrogram
=450  \\$wnnna$aHis Bundle Electrograms
=450  \\$wnnna$aHis Electrogram Bundle
=450  \\$wnnna$aHis Electrogram Bundles
=450  \\$wnnna$aIntra-Atrial Electrogram
=450  \\$wnnna$aIntra Atrial Electrogram
=450  \\$wnnna$aIntra-Atrial Electrograms
=450  \\$wnnna$aIntracardiac Electrogram
=450  \\$wnnna$aIntracardiac Electrograms
=450  \\$wnnna$aIntracardiac Electrophysiologic Technique
=450  \\$wnnna$aIntracardiac Electrophysiologic Techniques
=450  \\$wnnna$aIntracardiac Electrophysiological Technic
=450  \\$wnnna$aIntracardiac Electrophysiological Technics
=450  \\$wnnna$aIntracardiac Electrophysiological Technique
=450  \\$wnnna$aIntracardiac Electrophysiological Techniques
=450  \\$wnnna$aProgrammed Electrostimulation, Cardiac
=450  \\$wnnna$aProgrammed Electrostimulations, Cardiac
=450  \\$wnnna$aStudies, Cardiac Electrophysiologic
=450  \\$wnnna$aStudies, Transesophageal Electrophysiologic
=450  \\$wnnna$aStudies, Transesophageal Electrophysiological
=450  \\$wnnna$aStudy, Cardiac Electrophysiologic
=450  \\$wnnna$aStudy, Transesophageal Electrophysiologic
=450  \\$wnnna$aStudy, Transesophageal Electrophysiological
=450  \\$wnnna$aTechnic, Cardiac Electrophysiologic
=450  \\$wnnna$aTechnic, Intracardiac Electrophysiological
=450  \\$wnnna$aTechnics, Cardiac Electrophysiologic
=450  \\$wnnna$aTechnics, Intracardiac Electrophysiological
=450  \\$wnnna$aTechnique, Cardiac Electrophysiologic
=450  \\$wnnna$aTechnique, Cardiac Electrophysiological
=450  \\$wnnna$aTechnique, Intracardiac Electrophysiologic
=450  \\$wnnna$aTechnique, Intracardiac Electrophysiological
=450  \\$wnnna$aTechniques, Cardiac Electrophysiologic
=450  \\$wnnna$aTechniques, Cardiac Electrophysiological
=450  \\$wnnna$aTechniques, Intracardiac Electrophysiologic
=450  \\$wnnna$aTechniques, Intracardiac Electrophysiological
=450  \\$wnnna$aTransesophageal Electrophysiologic Studies
=450  \\$wnnna$aTransesophageal Electrophysiologic Study
=450  \\$wnnna$aTransesophageal Electrophysiological Studies
=450  \\$wnnna$aTransesophageal Electrophysiological Study
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aHeart Function Tests
=550  \\$wh$aEpicardial Mapping
=550  \\$aCardiac Electrophysiology
=680  \\$iMethods to induce and measure electrical activities at specific sites in the heart to diagnose and treat problems with the heart's electrical system.
=688  \\$a2001
=750  \0$aHeart cells$xElectric properties$0(DLC) sh 91002331$5IEN-M
=750  \0$aInvasive electrophysiologic testing$0(DLC) sh 90002399$5IEN-M

=LDR  00849cz  a2200169n  4500
=001  9880364347902441
=005  20141212214125.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x165.$x360
=150  \\$aHemidesmosomes
=450  \\$wnnna$aHemidesmosome
=550  \\$wg$aCell-Matrix Junctions
=680  \\$iAn anchoring junction of the cell to a non-cellular substrate, similar in morphology to halves of DESMOSOMES. They are composed of specialized areas of the plasma membrane where INTERMEDIATE FILAMENTS bind on the cytoplasmic face to the transmembrane linkers, INTEGRINS, via intracellular attachment proteins, while the extracellular domain of the integrins binds to EXTRACELLULAR MATRIX PROTEINS.
=688  \\$a2001
=750  \0$aHemidesmosomes$0(DLC) sh 94007405$5IEN-M

=LDR  00984cz  a2200265n  4500
=001  9880363661202441
=005  20180321102309.0
=008  880519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015277
=035  \\$aCAZ9970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x181.$x500
=150  \\$aHotlines
=450  \\$wnnna$aHotline
=450  \\$wnnna$aHotline, Telephone
=450  \\$wnnna$aHotlines, Telephone
=450  \\$wnnna$aTelephone Hotline
=450  \\$aTelephone Hotlines
=550  \\$wg$aCall Centers
=550  \\$aCrisis Intervention
=550  \\$aEmergencies
=550  \\$aEmergency Services, Psychiatric
=680  \\$iA direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides.
=688  \\$a89
=750  \0$aHotlines (Counseling)$5IEN$0(DLC)sh 85062508

=LDR  00549cz  a2200193n  4500
=001  9880363661302441
=005  20141212202229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006791
=035  \\$aCAZ9969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x596
=150  \\$aHostility
=450  \\$wnnna$aHostilities
=550  \\$wg$aEmotions
=667  \\$ano qualif
=680  \\$iTendency to feel anger toward and to seek to inflict harm upon a person or group.
=688  \\$a68
=750  \0$aHostility (Psychology)$5IEN$0(DLC)sh 85062429

=LDR  02200cz  a2200517n  4500
=001  9880363661402441
=005  20141212202229.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006790
=035  \\$aCAZ9968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x100.$x380.$x400
=150  \\$aHost-Parasite Interactions
=450  \\$wnnna$aHost-Parasite Interaction
=450  \\$wnnna$aHost Parasite Interactions
=450  \\$wnnna$aHost-Parasite Relation
=450  \\$aHost-Parasite Relations
=450  \\$wnnna$aHost Parasite Relations
=450  \\$wnnna$aHost-Parasite Relationship
=450  \\$wnnna$aHost Parasite Relationship
=450  \\$wnnna$aHost-Parasite Relationships
=450  \\$wnnna$aInteraction, Host-Parasite
=450  \\$wnnna$aInteraction, Parasite-Host
=450  \\$wnnna$aInteractions, Host-Parasite
=450  \\$wnnna$aInteractions, Parasite-Host
=450  \\$wnnna$aParasite-Host Interaction
=450  \\$wnnna$aParasite-Host Interactions
=450  \\$wnnna$aParasite Host Interactions
=450  \\$wnnna$aParasite-Host Relation
=450  \\$aParasite-Host Relations
=450  \\$wnnna$aParasite Host Relations
=450  \\$wnnna$aRelation, Host-Parasite
=450  \\$wnnna$aRelation, Parasite-Host
=450  \\$wnnna$aRelations, Host-Parasite
=450  \\$wnnna$aRelations, Parasite-Host
=450  \\$wnnna$aRelationship, Host-Parasite
=450  \\$wnnna$aRelationships, Host-Parasite
=550  \\$wg$aHost-Pathogen Interactions
=550  \\$wh$aHost Specificity
=550  \\$aParasites
=667  \\$acoordinate with host /parasitol + parasite /physiol or other more specific qualifier; HOST-PATHOGEN INTERACTIONS is also available; DF: HOST PARASITE RELAT
=680  \\$iThe relationship between an invertebrate and another organism (the host), one of which lives at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.
=688  \\$a2008 (1980)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Host-Parasite Relations
=688  \\$a80
=750  \0$aHost-parasite relationships$0(DLC) sh 85062418$5IEN

=LDR  01439cz  a2200349n  4500
=001  9880363661502441
=005  20141212202228.0
=008  780504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006788
=035  \\$aCAZ9966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x481.$x800
=150  \\$aHospitals, Voluntary
=450  \\$wnnna$aHospital, Voluntary
=450  \\$aHospitals, Private, Not-for-Profit
=450  \\$wnnna$aHospitals Private, Not-for-Profit
=450  \\$wnnna$aHospitals Privates, Not-for-Profit
=450  \\$wnnna$aHospitals Privates, Not for Profit
=450  \\$wnnna$aNot-for-Profit Hospitals Private
=450  \\$wnnna$aNot for Profit Hospitals Private
=450  \\$wnnna$aNot-for-Profit Hospitals Privates
=450  \\$wnnna$aNot for Profit Hospitals Privates
=450  \\$wnnna$aPrivate, Not-for-Profit Hospitals
=450  \\$wnnna$aPrivate, Not for Profit Hospitals
=450  \\$wnnna$aPrivates, Not-for-Profit Hospitals
=450  \\$wnnna$aVoluntary Hospital
=450  \\$wnnna$aVoluntary Hospitals
=550  \\$wg$aHospitals, Private
=667  \\$acoord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iPrivate, not-for-profit hospitals that are autonomous, self-established, and self-supported.
=688  \\$a91(79); was see under HOSPITALS 1979-90
=750  \0$aVoluntary hospitals$5IEN$0(DLC)sh 85062411

=LDR  00757cz  a2200205n  4500
=001  9880363661602441
=005  20141212202228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006787
=035  \\$aCAZ9965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x510.$x180.$x400
=150  \\$aHospitals, Veterans
=450  \\$wnnna$aHospital, Veterans
=450  \\$wnnna$aVeterans Hospital
=450  \\$aVeterans Hospitals
=550  \\$wg$aHospitals, Federal
=667  \\$acoord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, PSYCHIATRIC; etc.) or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals providing medical care to veterans of wars.
=750  \0$aVeterans' hospitals$5IEN$0(DLC)sh 85062405

=LDR  00943cz  a2200205n  4500
=001  9880363661702441
=005  20141212202227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006785
=035  \\$aCAZ9963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x20.$x300.$x310
=072  \\$aN2.$x278.$x421.$x639.$x725
=150  \\$aHospitals, University
=450  \\$wnnna$aUniversity Hospitals
=550  \\$wg$aHospitals, Teaching
=667  \\$acoord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog; DF: HOSP UNIV
=680  \\$iHospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.
=688  \\$a91(78); was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77
=750  \0$aUniversity hospitals$5IEN$0(DLC)sh 85062404

=LDR  00972cz  a2200253n  4500
=001  9880363661802441
=005  20141212202227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006784
=035  \\$aCAZ9962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x20.$x300
=072  \\$aN2.$x278.$x421.$x639
=150  \\$aHospitals, Teaching
=450  \\$wnnna$aHospital, Teaching
=450  \\$wnnna$aTeaching Hospital
=450  \\$wnnna$aTeaching Hospitals
=550  \\$wg$aAcademic Medical Centers
=550  \\$wg$aHospitals
=550  \\$wh$aHospitals, University
=667  \\$acoord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog; consider also INTERNSHIP AND RESIDENCY
=680  \\$iHospitals engaged in educational and research programs, as well as providing medical care to the patients.
=688  \\$a68
=750  \0$aTeaching hospitals$5IEN$0(DLC)sh 85062403

=LDR  00867cz  a2200217n  4500
=001  9880363661902441
=005  20141212202226.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006783
=035  \\$aCAZ9961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x510.$x300
=150  \\$aHospitals, State
=450  \\$wnnna$aHospital, State
=450  \\$wnnna$aState Hospital
=450  \\$wnnna$aState Hospitals
=550  \\$wg$aHospitals, Public
=667  \\$acoord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify state if US, province if Canada, or other country
=680  \\$iHospitals controlled by agencies and departments of the state government.
=688  \\$a91(78); was see under HOSPITALS, PUBLIC 1978-90
=750  \0$aState hospitals$5IEN$0(DLC)sh 85062400

=LDR  01486cz  a2200361n  4500
=001  9880363662002441
=005  20141212202226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006782
=035  \\$aCAZ9960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556
=150  \\$aHospitals, Special
=450  \\$wnnna$aHospital, Special
=450  \\$wnnna$aSpecial Hospital
=450  \\$wnnna$aSpecial Hospitals
=550  \\$wg$aHospitals
=550  \\$wh$aCancer Care Facilities
=550  \\$wh$aCardiac Care Facilities
=550  \\$wh$aHospices
=550  \\$wh$aHospitals, Chronic Disease
=550  \\$wh$aHospitals, Convalescent
=550  \\$wh$aHospitals, Isolation
=550  \\$wh$aHospitals, Maternity
=550  \\$wh$aHospitals, Osteopathic
=550  \\$wh$aHospitals, Pediatric
=550  \\$wh$aHospitals, Psychiatric
=550  \\$wh$aSurgicenters
=550  \\$aTertiary Care Centers
=667  \\$acoordinate IM with medical specialty & hospital ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geographic location if pertinent; sanatoria & sanitaria (often used interchangeably) can go here but consider also HEALTH RESORTS; note SANITARIA, TUBERCULOSIS see HOSPITALS, CHRONIC DISEASE is available
=680  \\$iHospitals which provide care for a single category of illness with facilities and staff directed toward a specific service.
=688  \\$a68
=750  \0$aSpecialty hospitals$0(DLC) sh2003010987$5IEN-M

=LDR  00692cz  a2200217n  4500
=001  9880363662102441
=005  20141212202225.0
=008  850523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006780
=035  \\$aCAZ9958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x518
=150  \\$aHospitals, Rural
=450  \\$wnnna$aHospital, Rural
=450  \\$wnnna$aRural Hospital
=450  \\$aRural Hospitals
=550  \\$wg$aHospitals
=667  \\$acoord IM with special hosp or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals located in a rural area.
=688  \\$a91(86); was see under HOSPITALS 1986-90
=750  \0$aRural hospitals$5IEN$0(DLC)sh 85062399

=LDR  01003cz  a2200277n  4500
=001  9880363662202441
=005  20141212202225.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006779
=035  \\$aCAZ9957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x510
=150  \\$aHospitals, Public
=450  \\$wnnna$aHospital, Public
=450  \\$wnnna$aPublic Hospital
=450  \\$wnnna$aPublic Hospitals
=550  \\$wg$aHospitals
=550  \\$wh$aHospitals, County
=550  \\$wh$aHospitals, District
=550  \\$wh$aHospitals, Federal
=550  \\$wh$aHospitals, Municipal
=550  \\$wh$aHospitals, State
=667  \\$agovernment-owned; coord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals controlled by various types of government, i.e., city, county, district, state or federal.
=688  \\$a78
=750  \0$aPublic hospitals$5IEN$0(DLC)sh 85062397

=LDR  01131cz  a2200313n  4500
=001  9880363662302441
=005  20141212202225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006778
=035  \\$aCAZ9956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x508
=150  \\$aHospitals, Psychiatric
=450  \\$wnnna$aHospital, Mental
=450  \\$wnnna$aHospital, Psychiatric
=450  \\$wnnna$aHospitals, Mental
=450  \\$wnnna$aInstitution, Mental
=450  \\$wnnna$aInstitutions, Mental
=450  \\$wnnna$aMental Hospital
=450  \\$aMental Hospitals
=450  \\$wnnna$aMental Institution
=450  \\$wnnna$aMental Institutions
=450  \\$wnnna$aPsychiatric Hospital
=450  \\$aPsychiatric Hospital Care$5IEN
=450  \\$wnnna$aPsychiatric Hospitals
=550  \\$wg$aHospitals, Special
=667  \\$acoord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog
=680  \\$iSpecial hospitals which provide care to the mentally ill patient.
=750  \0$aPsychiatric hospitals$5IEN-M$0(DLC)sh 85108356

=LDR  01242cz  a2200289n  4500
=001  9880363662402441
=005  20141212202224.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006777
=035  \\$aCAZ9955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x215.$x110
=072  \\$aN2.$x278.$x421.$x481.$x500
=150  \\$aHospitals, Proprietary
=450  \\$wnnna$aHospital, Proprietary
=450  \\$aHospitals, Private, for-Profit
=450  \\$aHospitals, Private, Investor-Owned
=450  \\$wnnna$aPrivate, for-Profit Hospitals
=450  \\$wnnna$aPrivate, Investor-Owned Hospitals
=450  \\$wnnna$aProprietary Hospital
=450  \\$wnnna$aProprietary Hospitals
=550  \\$wg$aHealth Facilities, Proprietary
=550  \\$wg$aHospitals, Private
=667  \\$aprivately organized & controlled hosp operated for profit; coord NIM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE) or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals owned and operated by a corporation or an individual that operate on a for-profit basis, also referred to as investor-owned hospitals.
=688  \\$a91(75); was see under HOSPITALS 1975-90
=750  \0$aHospitals, Proprietary$5IEN$0(DLC)sh 85062396

=LDR  00842cz  a2200217n  4500
=001  9880363662502441
=005  20141212202224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006776
=035  \\$aCAZ9954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x437
=150  \\$aHospitals, Pediatric
=450  \\$wnnna$aHospital, Pediatric
=450  \\$wnnna$aPediatric Hospital
=450  \\$wnnna$aPediatric Hospitals
=550  \\$wg$aHospitals, Special
=667  \\$acoord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; check also tag CHILD or specific; specify geog
=680  \\$iSpecial hospitals which provide care for ill children.
=688  \\$a91(75); was see under HOSPITALS, SPECIAL 1975-90
=750  \0$aChildren$xHospitals$5IEN$0(DLC)sh 85023451

=LDR  00881cz  a2200217n  4500
=001  9880363662602441
=005  20141212202224.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006774
=035  \\$aCAZ9952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x386
=150  \\$aHospitals, Osteopathic
=450  \\$wnnna$aHospital, Osteopathic
=450  \\$wnnna$aOsteopathic Hospital
=450  \\$wnnna$aOsteopathic Hospitals
=550  \\$wg$aHospitals, Special
=667  \\$acoord IM with hosp ownership term (e.g., HOSPITALS, PROPRIETARY) (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals providing care utilizing the generally accepted medical and surgical methods but with emphasis on the osteopathic system of therapy.
=688  \\$a91(82); was see under HOSPITALS, SPECIAL 1982-90
=750  \0$aOsteopathic hospitals$5IEN$0(DLC)sh 85095972

=LDR  01431cz  a2200385n  4500
=001  9880363662702441
=005  20141212202223.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006772
=035  \\$aCAZ9950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x445.$x500
=072  \\$aN2.$x278.$x421.$x510.$x180.$x250
=150  \\$aHospitals, Military
=450  \\$wnnna$aAir Force Hospital
=450  \\$wnnna$aAir Force Hospitals
=450  \\$wnnna$aArmy Hospital
=450  \\$wnnna$aArmy Hospitals
=450  \\$wnnna$aHospital, Air Force
=450  \\$wnnna$aHospital, Army
=450  \\$wnnna$aHospital, Military
=450  \\$wnnna$aHospital, Navy
=450  \\$aHospitals, Air Force
=450  \\$aHospitals, Army
=450  \\$aHospitals, Navy
=450  \\$wnnna$aMilitary Hospital
=450  \\$wnnna$aMilitary Hospitals
=450  \\$wnnna$aNavy Hospital
=450  \\$wnnna$aNavy Hospitals
=550  \\$wg$aHospitals, Federal
=550  \\$wg$aMilitary Facilities
=667  \\$aadd country of ownership and specify geographic location, if different; for U.S hospitals located within the U.S., index UNITED STATES for ownership plus the state for location if pertinent
=680  \\$iHospitals which provide care for the military personnel and usually for their dependents.
=688  \\$a91(78); was see under HOSPITALS, PUBLIC 1978-90
=750  \0$aMilitary hospitals$5IEN$0(DLC)sh 85062387

=LDR  00886cz  a2200217n  4500
=001  9880363662802441
=005  20141212202222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006771
=035  \\$aCAZ9949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x366
=150  \\$aHospitals, Maternity
=450  \\$wnnna$aHospital, Maternity
=450  \\$wnnna$aMaternity Hospital
=450  \\$wnnna$aMaternity Hospitals
=550  \\$wg$aHospitals, Special
=667  \\$acoord IM with hosp ownership term (e.g., HOSPITALS, COUNTY; HOSPITALS, PROPRIETARY; etc.) (IM or NIM) if pertinent; specify geog; check also tags FEMALE & PREGNANCY
=680  \\$iSpecial hospitals which provide care to women during pregnancy and parturition.
=688  \\$a91(75); was see under HOSPITALS, SPECIAL 1975-90
=750  \0$aHospitals, Gynecologic and obstetric$5IEN$0(DLC)sh 85062384

=LDR  00831cz  a2200241n  4500
=001  9880363662902441
=005  20141212202222.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006768
=035  \\$aCAZ9946HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x510.$x180
=150  \\$aHospitals, Federal
=450  \\$wnnna$aFederal Hospital
=450  \\$wnnna$aFederal Hospitals
=450  \\$wnnna$aHospital, Federal
=550  \\$wg$aHospitals, Public
=550  \\$wh$aHospitals, Military
=550  \\$wh$aHospitals, Veterans
=667  \\$aUS only; add UNITED STATES + state for location if pertinent
=680  \\$iHospitals controlled by agencies and departments of the U.S. federal government.
=688  \\$a91(78); was see under HOSPITALS, PUBLIC 1978-90
=750  \0$aPublic hospitals$5IEN$0(DLC)sh 85062397

=LDR  00800cz  a2200217n  4500
=001  9880363663002441
=005  20141212202221.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006766
=035  \\$aCAZ9944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x510.$x100
=150  \\$aHospitals, County
=450  \\$wnnna$aCounty Hospital
=450  \\$wnnna$aCounty Hospitals
=450  \\$wnnna$aHospital, County
=550  \\$wg$aHospitals, Public
=667  \\$acoord IM with special hosp (e.g., HOSPITALS, CHRONIC DISEASE; HOSPITALS, MATERNITY; etc.) or med specialty (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals controlled by the county government.
=688  \\$a91(78); was see under HOSPITALS, PUBLIC 1978-90
=750  \0$aCounty hospitals$5IEN$0(DLC)sh 85062383

=LDR  00836cz  a2200205n  4500
=001  9880363663102441
=005  20141212202221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006765
=035  \\$aCAZ9943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x294
=150  \\$aHospitals, Convalescent
=450  \\$wnnna$aConvalescent Hospital
=450  \\$wnnna$aConvalescent Hospitals
=450  \\$wnnna$aHospital, Convalescent
=550  \\$wg$aHospitals, Special
=667  \\$acoord IM with special hosp or med specialty (IM or NIM) or with hosp ownership term (e.g., HOSPITALS, COUNTY) (IM or NIM) if pertinent; specify geog
=680  \\$iHospitals which provide care to the patient for the period following an acute illness until health is restored.
=750  \0$aHospitals, Convalescent$5IEN$0(DLC)sh 85062382

=LDR  00974cz  a2200325n  4500
=001  9880363663202441
=005  20141212192237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006762
=035  \\$aCAZ9940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x280
=072  \\$aN6.$x230.$x150.$x360.$x250.$x200
=150  \\$aHospitals, Animal
=450  \\$wnnna$aAnimal Hospital
=450  \\$aAnimal Hospitals
=450  \\$wnnna$aClinics, Veterinary
=450  \\$wnnna$aHospital, Animal
=450  \\$wnnna$aHospital, Veterinary
=450  \\$aHospitals, Special$xveterinary
=450  \\$aHospitals, Veterinary
=450  \\$aVeterinary Clinics
=450  \\$wnnna$aVeterinary Hospital
=450  \\$aVeterinary Hospitals
=550  \\$wg$aHospitals
=550  \\$wg$aHousing, Animal
=550  \\$aPractice Management, Veterinary
=667  \\$aspecify geographic location
=688  \\$a74
=750  \0$aVeterinary hospitals$5IEN$0(DLC)sh 85143037

=LDR  01499cz  a2200385n  4500
=001  9880363663302441
=005  20141212202220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006761
=035  \\$aCAZ9939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421
=150  \\$aHospitals
=450  \\$wnnna$aHospital
=550  \\$wg$aHealth Facilities
=550  \\$wh$aHospitals, Animal
=550  \\$wh$aHospitals, Community
=550  \\$wh$aHospitals, General
=550  \\$wh$aHospitals, Group Practice
=550  \\$wh$aHospitals, High-Volume
=550  \\$wh$aHospitals, Low-Volume
=550  \\$wh$aHospitals, Private
=550  \\$wh$aHospitals, Public
=550  \\$wh$aHospitals, Rural
=550  \\$wh$aHospitals, Satellite
=550  \\$wh$aHospitals, Special
=550  \\$wh$aHospitals, Teaching
=550  \\$wh$aHospitals, Urban
=550  \\$wh$aMobile Health Units
=550  \\$wh$aSecondary Care Centers
=550  \\$wh$aTertiary Care Centers
=667  \\$a/legis = LEGISLATION, HOSPITAL or HOSPITALS (IM) + JURISPRUDENCE (IM); note specific hosp depts & specific types of hosp available; hosp admission, discharge & readmiss are available as PATIENT ADMISSION; PATIENT DISCHARGE & PATIENT READMISSION (see notes under each); specify geog: Manual 36.19
=680  \\$iInstitutions with an organized medical staff which provide medical care to patients.
=750  \0$aHospital care$5IEN-M$0(DLC)sh 85062238
=750  \0$aHospitals$5IEN-HS$0(DLC)sh 85062285

=LDR  02120cz  a2200505n  4500
=001  9880363663402441
=005  20141212202219.0
=008  850523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006759
=035  \\$aCAZ9937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x550.$x380
=072  \\$aN4.$x452.$x442.$x550.$x380
=150  \\$aHospital-Physician Joint Ventures
=450  \\$wnnna$aHospital-Physician Joint Venture
=450  \\$wnnna$aHospital Physician Joint Venture
=450  \\$wnnna$aHospital Physician Joint Ventures
=450  \\$wnnna$aHospital-Physician Organization
=450  \\$wnnna$aHospital-Physician Organizations
=450  \\$wnnna$aHospital Physician Organizations
=450  \\$wnnna$aJoint Venture
=450  \\$wnnna$aJoint Venture, Hospital-Physician
=450  \\$wnnna$aJoint Venture, Hospital Physician
=450  \\$wnnna$aJoint Ventures
=450  \\$aJoint Ventures, Hospital-Physician
=450  \\$wnnna$aJoint Ventures, Hospital Physician
=450  \\$wnnna$aOrganization, Hospital-Physician
=450  \\$wnnna$aOrganization, Physician-Hospital
=450  \\$wnnna$aOrganizations, Hospital-Physician
=450  \\$wnnna$aOrganizations, Hospital Physician
=450  \\$wnnna$aOrganizations, Physician-Hospital
=450  \\$wnnna$aOrganizations, Physician Hospital
=450  \\$wnnna$aPhysician-Hospital Organization
=450  \\$aPhysician-Hospital Organizations
=450  \\$wnnna$aPhysician Hospital Organizations
=450  \\$wnnna$aVenture, Hospital-Physician Joint
=450  \\$wnnna$aVenture, Joint
=450  \\$wnnna$aVentures, Hospital-Physician Joint
=450  \\$wnnna$aVentures, Joint
=550  \\$wg$aHospital Restructuring
=550  \\$wh$aPhysician Self-Referral
=667  \\$aDF: JOINT VENTURES
=680  \\$iA formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization.
=688  \\$a91(86); was see under HOSPITAL ADMINISTRATION 1986-90
=750  \0$aHospital-physician joint ventures$5IEN$0(DLC)sh 86001531

=LDR  00895cz  a2200277n  4500
=001  9880363663502441
=005  20141212202218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006758
=035  \\$aCAZ9935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x740.$x400
=072  \\$aM1.$x955.$x473
=072  \\$aN2.$x360.$x740.$x400
=150  \\$aHospital Volunteers
=450  \\$wnnna$aHospital Volunteer
=450  \\$wnnna$aVolunteer, Hospital
=450  \\$wnnna$aVolunteers, Hospital
=550  \\$wg$aPersonnel, Hospital
=550  \\$wg$aVolunteers
=550  \\$wh$aHospital Auxiliaries
=550  \\$wh$aPatient Escort Service
=667  \\$ado not confuse with HOSPITAL AUXILIARIES, volunteer organizations
=680  \\$iIndividuals who donate their services to the hospital.
=688  \\$a66(65)
=750  \0$aVolunteer workers in hospitals$5IEN$0(DLC)sh 85144355

=LDR  01055cz  a2200301n  4500
=001  9880363663602441
=005  20141212202218.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006756
=035  \\$aCAZ9933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x580
=072  \\$aN4.$x452.$x442.$x585
=150  \\$aHospital Shops
=450  \\$wnnna$aGift Shop, Hospital
=450  \\$wnnna$aGift Shops, Hospital
=450  \\$wnnna$aHospital Gift Shop
=450  \\$aHospital Gift Shops
=450  \\$wnnna$aHospital Shop
=450  \\$wnnna$aShop, Hospital
=450  \\$wnnna$aShop, Hospital Gift
=450  \\$wnnna$aShops, Hospital
=450  \\$wnnna$aShops, Hospital Gift
=550  \\$wg$aHospital Administration
=667  \\$afor purchases by visitors, patients or staff
=680  \\$iStores located in hospitals selling merchandise or services for the convenience of patients, staff, and visitors.
=688  \\$a91(Aug 77); was see under HOSPITAL ADMINISTRATION 1977-90
=750  \0$aHospital gift shops$5IEN$0(DLC)sh 85062243

=LDR  01270cz  a2200349n  4500
=001  9880363663702441
=005  20141212202217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006755
=035  \\$aCAZ9932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x565
=072  \\$aN4.$x452.$x442.$x565
=072  \\$aN4.$x452.$x540.$x308
=150  \\$aHospital Shared Services
=450  \\$wnnna$aHospital Service, Shared
=450  \\$wnnna$aHospital Services, Shared
=450  \\$wnnna$aHospital Shared Service
=450  \\$wnnna$aService, Hospital Shared
=450  \\$wnnna$aService, Shared Hospital
=450  \\$wnnna$aServices, Hospital Shared
=450  \\$wnnna$aServices, Shared Hospital
=450  \\$wnnna$aShared Hospital Service
=450  \\$wnnna$aShared Hospital Services
=450  \\$wnnna$aShared Service, Hospital
=450  \\$wnnna$aShared Services, Hospital
=550  \\$wg$aHospital Administration
=550  \\$wg$aMulti-Institutional Systems
=667  \\$asharing between or among hosp
=680  \\$iCooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.
=688  \\$a72(68)
=750  \0$aHospitals$xShared services$5IEN$0(DLC)sh 85062365

=LDR  00987cz  a2200265n  4500
=001  9880363663802441
=005  20141212202217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006753
=035  \\$aCAZ9930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x425
=072  \\$aL1.$x280.$x900.$x425
=072  \\$aN4.$x452.$x859.$x380
=072  \\$aN5.$x715.$x360.$x300.$x715.$x380
=072  \\$aN6.$x850.$x520.$x308.$x940.$x425
=150  \\$aHospital Records
=450  \\$wnnna$aHospital Record
=450  \\$wnnna$aRecord, Hospital
=450  \\$wnnna$aRecords, Hospital
=550  \\$wg$aRecords as Topic
=667  \\$aFORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: HOSP RECORDS
=680  \\$iCompilations of data on hospital activities and programs; excludes patient medical records.
=688  \\$a89(75); was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78
=750  \0$aHospital records$5IEN$0(DLC)sh 85062259

=LDR  01191cz  a2200265n  4500
=001  9880363663902441
=005  20141212202216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006752
=035  \\$aCAZ9929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x250.$x200
=150  \\$aHospital Planning
=450  \\$wnnna$aHospital Planning, Regional
=450  \\$wnnna$aHospital Plannings, Regional
=450  \\$wnnna$aPlanning, Hospital
=450  \\$wnnna$aPlanning, Regional Hospital
=450  \\$wnnna$aPlannings, Hospital
=450  \\$aRegional Hospital Planning
=450  \\$aRegional Hospital Plannings
=550  \\$wg$aHealth Facility Planning
=667  \\$adifferentiate from HOSPITAL DESIGN AND CONSTRUCTION (architecture & decor): HOSPITAL PLANNING is for develop of plans at a community, state, regional or natl level
=680  \\$iAreawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans.
=688  \\$a68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67
=750  \0$aHospitals$xPlanning$5IEN$0(DLC)sh 85062350

=LDR  01958cz  a2200469n  4500
=001  9880363664002441
=005  20141212202216.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006751
=035  \\$aCAZ9928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300.$x408
=072  \\$aL1.$x700.$x508.$x300.$x680.$x360
=072  \\$aN4.$x452.$x442.$x452
=072  \\$aN4.$x452.$x515.$x360
=150  \\$aHospital Information Systems
=450  \\$wnnna$aHospital Information System
=450  \\$wnnna$aInformation System, Hospital
=450  \\$wnnna$aInformation System, Multi-Hospital
=450  \\$wnnna$aInformation System, Multihospital
=450  \\$wnnna$aInformation Systems, Hospital
=450  \\$wnnna$aInformation Systems, Multi-Hospital
=450  \\$wnnna$aInformation Systems, Multihospital
=450  \\$wnnna$aMulti-Hospital Information System
=450  \\$aMulti-Hospital Information Systems
=450  \\$wnnna$aMulti Hospital Information Systems
=450  \\$wnnna$aMultihospital Information System
=450  \\$wnnna$aMultihospital Information Systems
=550  \\$wg$aHospital Administration
=550  \\$wg$aInformation Systems
=550  \\$wg$aManagement Information Systems
=550  \\$wh$aAmbulatory Care Information Systems
=550  \\$wh$aClinical Laboratory Information Systems
=550  \\$wh$aClinical Pharmacy Information Systems
=550  \\$wh$aMedical Order Entry Systems
=550  \\$wh$aOperating Room Information Systems
=550  \\$wh$aPoint-of-Care Systems
=550  \\$wh$aRadiology Information Systems
=667  \\$aDF: HOSP INFORMATION SYSTEMS
=680  \\$iIntegrated, computer-assisted systems designed to store, manipulate, and retrieve information concerned with the administrative and clinical aspects of providing medical services within the hospital.
=688  \\$a87
=750  \0$aInformation storage and retrieval systems$xHospitals$5IEN$0(DLC)sh 85066210

=LDR  01301cz  a2200325n  4500
=001  9880363664102441
=005  20141212202215.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006749
=035  \\$aCAZ9926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x250
=072  \\$aN2.$x278.$x200.$x403
=150  \\$aHospital Design and Construction
=450  \\$wnnna$aConstruction, Hospital
=450  \\$wnnna$aDesign, Hospital
=450  \\$wnnna$aDesigns, Hospital
=450  \\$wnnna$aHospital Construction
=450  \\$wnnna$aHospital Construction and Design
=450  \\$wnnna$aHospital Design
=450  \\$wnnna$aHospital Designs
=450  \\$aHospital Renovation
=450  \\$aHospital Renovations
=450  \\$wnnna$aRenovation, Hospital
=450  \\$wnnna$aRenovations, Hospital
=550  \\$wg$aFacility Design and Construction
=667  \\$adifferentiate from HOSPITAL PLANNING (develop of plans at a community, state, regional or natl level): HOSPITAL DESIGN AND CONSTRUCTION refers to architecture & decor; DF: HOSP DESIGN
=680  \\$iThe architecture, functional design, and construction of hospitals.
=688  \\$a68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67
=750  \0$aHospital buildings$xDesign and construction$5IEN$0(DLC)sh 85062313

=LDR  01208cz  a2200325n  4500
=001  9880363664202441
=005  20141212202214.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006747
=035  \\$aCAZ9924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x322
=072  \\$aN4.$x452.$x442.$x322
=150  \\$aHospital Communication Systems
=450  \\$wnnna$aCommunication Hospital System
=450  \\$wnnna$aCommunication Hospital Systems
=450  \\$wnnna$aCommunication System, Hospital
=450  \\$wnnna$aCommunication Systems, Hospital
=450  \\$wnnna$aHospital Communication System
=450  \\$wnnna$aHospital System, Communication
=450  \\$wnnna$aHospital Systems, Communication
=450  \\$wnnna$aSystem, Communication Hospital
=450  \\$wnnna$aSystem, Hospital Communication
=450  \\$wnnna$aSystems, Communication Hospital
=450  \\$wnnna$aSystems, Hospital Communication
=550  \\$wg$aHospital Administration
=667  \\$acommunication with staff or patients
=680  \\$iThe transmission of messages to staff and patients within a hospital.
=688  \\$a73(64)
=750  \0$aHospitals$xCommunication systems$5IEN$0(DLC)sh 85062305

=LDR  01668cz  a2200433n  4500
=001  9880363664302441
=005  20141212202213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006742
=035  \\$aCAZ9919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x306.$x472
=150  \\$aHospital Bed Capacity
=450  \\$wnnna$aBed Capacities, Hospital
=450  \\$aBed Capacity, Hospital
=450  \\$wnnna$aBed Size
=450  \\$aBed Size, Hospital
=450  \\$wnnna$aBed Sizes
=450  \\$wnnna$aBed Sizes, Hospital
=450  \\$wnnna$aCapacities, Hospital Bed
=450  \\$wnnna$aCapacity, Hospital Bed
=450  \\$wnnna$aHospital Bed Capacities
=450  \\$wnnna$aHospital Bed Size
=450  \\$wnnna$aHospital Bed Sizes
=450  \\$aHospital Size$5IEN
=450  \\$wnnna$aSize, Bed
=450  \\$wnnna$aSize, Hospital Bed
=450  \\$wnnna$aSizes, Bed
=450  \\$wnnna$aSizes, Hospital Bed
=550  \\$wg$aHealth Facility Size
=550  \\$wh$aHospital Bed Capacity, 100 to 299
=550  \\$wh$aHospital Bed Capacity, 300 to 499
=550  \\$wh$aHospital Bed Capacity, 500 and over
=550  \\$wh$aHospital Bed Capacity, under 100
=550  \\$aBed Occupancy
=667  \\$aGEN or unspecified; prefer specific capacity; specify geog; do not confuse with BED OCCUPANCY which is for actual no. of beds occupied; DF: HOSP BED CAPAC
=680  \\$iThe number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use.
=688  \\$a78(75); was see under HEALTH FACILITY SIZE 1968-77
=750  \0$aHospital size$5IEN$0(DLC)sh 85062264

=LDR  01004cz  a2200277n  4500
=001  9880363664402441
=005  20141212202212.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006740
=035  \\$aCAZ9917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70.$x490.$x490
=072  \\$aM1.$x526.$x485.$x430.$x490
=072  \\$aM1.$x526.$x485.$x740.$x380
=072  \\$aN2.$x360.$x430.$x490
=072  \\$aN2.$x360.$x740.$x380
=150  \\$aHospital Administrators
=450  \\$wnnna$aAdministrator, Hospital
=450  \\$wnnna$aAdministrators, Hospital
=450  \\$wnnna$aHospital Administrator
=550  \\$wg$aHealth Facility Administrators
=550  \\$wg$aPersonnel, Hospital
=550  \\$wh$aChief Executive Officers, Hospital
=680  \\$iManagerial personnel responsible for implementing policy and directing the activities of hospitals.
=688  \\$a90(78); was see under HEALTH FACILITY ADMINISTRATORS 1978-89
=750  \0$aHospital administrators$5IEN$0(DLC)sh 85062233

=LDR  01726cz  a2200493n  4500
=001  9880363664502441
=005  20141212202212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006739
=035  \\$aCAZ9916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x309
=072  \\$aN2.$x278.$x216.$x500
=072  \\$aN2.$x278.$x354
=072  \\$aN4.$x452.$x442
=150  \\$aHospital Administration
=450  \\$wnnna$aAdministration, Hospital
=450  \\$aHospital Organization and Administration
=450  \\$aHospitals$xorganization & administration
=450  \\$aOrganization and Administration, Hospital
=550  \\$wg$aHealth Facilities
=550  \\$wg$aHealth Facility Administration
=550  \\$wg$aHealth Occupations
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aAncillary Services, Hospital
=550  \\$wh$aCentralized Hospital Services
=550  \\$wh$aFinancial Management, Hospital
=550  \\$wh$aHospital Communication Systems
=550  \\$wh$aHospital Departments
=550  \\$wh$aHospital Distribution Systems
=550  \\$wh$aHospital Information Systems
=550  \\$wh$aHospital-Patient Relations
=550  \\$wh$aHospital-Physician Relations
=550  \\$wh$aHospital Restructuring
=550  \\$wh$aHospital Shared Services
=550  \\$wh$aHospital Shops
=550  \\$wh$aLibraries, Hospital
=550  \\$wh$aMaterials Management, Hospital
=550  \\$wh$aMedication Systems, Hospital
=550  \\$wh$aProduct Line Management
=550  \\$aHospitals
=667  \\$aSPEC: SPEC qualif; DF: HOSP ADMIN
=680  \\$iManagement of the internal organization of the hospital.
=750  \0$aHospitals$xAdministration$5IEN$0(DLC)sh 85062289

=LDR  00843cz  a2200217n  4500
=001  9880363664602441
=005  20141212202211.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006738
=035  \\$aCAZ9915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x185
=072  \\$aN2.$x421.$x143.$x550
=150  \\$aHospices
=450  \\$wnnna$aHospice
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aHospitals, Special
=667  \\$a"palliative & supportive care to the dying patient & his family"; specify geog
=680  \\$iFacilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness and to the patient's family.
=688  \\$a80(Aug 77); was see under HOSPITALS, SPECIAL Aug 77-79
=750  \0$aHospice care$5IEN-M$0(DLC)sh 85062231

=LDR  00873cz  a2200277n  4500
=001  9880363664702441
=005  20141212202211.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006737
=035  \\$aCAZ9914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x450
=150  \\$aHorseshoe Crabs
=450  \\$wnnna$aCrab, Horseshoe
=450  \\$aCrabs, Horseshoe
=450  \\$wnnna$aHorseshoe Crab
=450  \\$aLimulus
=450  \\$aLimulus polyphemus
=450  \\$wnnna$apolyphemus, Limulus
=450  \\$aTachypleus
=450  \\$aXiphosura
=450  \\$wnnna$aXiphosuras
=550  \\$wg$aArthropods
=680  \\$iAn arthropod subclass (Xiphosura) comprising the North American (Limulus) and Asiatic (Tachypleus) genera of horseshoe crabs.
=688  \\$a78; was LIMULUS see under ARTHROPODS 1977
=750  \0$aXiphosura$5IEN$0(DLC)sh 85148838

=LDR  00951cz  a2200253n  4500
=001  9880363664802441
=005  20141212202210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006736
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x709.$x235.$x472
=150  \\$aHorses
=360  \\$iconsider also terms at$aEQUINE
=450  \\$wnnna$aDomestic Horse
=450  \\$wnnna$aDomestic Horses
=450  \\$wnnna$aEquus caballus
=450  \\$wnnna$aEquus przewalskii
=450  \\$wnnna$aHorse
=450  \\$wnnna$aHorse, Domestic
=450  \\$wnnna$aHorses, Domestic
=550  \\$wg$aEquidae
=667  \\$asee X refs at EQUIDAE
=680  \\$iLarge, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.
=750  \0$aHorses$5IEN$0(DLC)sh 85062160

=LDR  01125cz  a2200301n  4500
=001  9880363664902441
=005  20141212202210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006734
=035  \\$aCAZ9911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x488
=150  \\$aHorse Diseases
=450  \\$wnnna$aDisease, Equine
=450  \\$wnnna$aDisease, Horse
=450  \\$wnnna$aDiseases, Equine
=450  \\$wnnna$aDiseases, Horse
=450  \\$wnnna$aEquine Disease
=450  \\$wnnna$aEquine Diseases
=450  \\$wnnna$aHorse Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aAfrican Horse Sickness
=550  \\$wh$aEquine Infectious Anemia
=550  \\$wh$aGlanders
=550  \\$wh$aStrongyle Infections, Equine
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific horse dis (IM); for abnormalities or injuries index under HORSES /abnorm or HORSES /inj; don't forget also HORSES (NIM) & check tag ANIMALS; DF: HORSE DIS
=680  \\$iDiseases of domestic and wild horses of the species Equus caballus.
=750  \0$aHorses$xDiseases$5IEN$0(DLC)sh 85062163

=LDR  00601cz  a2200193n  4500
=001  9880363665002441
=005  20141212202209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006733
=035  \\$aCAZ9910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x507
=150  \\$aHorns
=450  \\$wnnna$aHorn
=550  \\$wg$aAnimal Structures
=550  \\$wh$aAntlers
=667  \\$aanimal anat only: not for cutaneous horn ( = SKIN DISEASES or SKIN /abnorm); horn cancer: coord IM with NEOPLASMS /vet (IM) + histol type of neopl /vet (IM)
=688  \\$a68
=750  \0$aHorns$5IEN$0(DLC)sh 85062055

=LDR  00777cz  a2200229n  4500
=001  9880363665102441
=005  20160425095614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006729
=035  \\$aCAZ9906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x397
=072  \\$aD23.$x101.$x840.$x375
=150  \\$aHormones, Ectopic
=450  \\$wnnna$aEctopic Hormones
=550  \\$wg$aHormones
=550  \\$wg$aBiomarkers, Tumor
=550  \\$aParaneoplastic Endocrine Syndromes
=667  \\$acoord IM with specific hormone (IM) + ectopic site (IM) or neopl term (IM) if applicable
=680  \\$iHormones released from neoplasms or from other cells that are not the usual sources of hormones.
=688  \\$a68
=750  \0$aHormones, Ectopic$5IEN$0(DLC)sh 85061982

=LDR  01803cz  a2200457n  4500
=001  9880363665202441
=005  20141212192236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006728
=035  \\$aCAZ9905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472
=072  \\$aD27.$x505.$x696.$x399.$x472
=150  \\$aHormones
=450  \\$wnnna$aAgonists, Hormone Receptor
=450  \\$wnnna$aHormone
=450  \\$wnnna$aHormone Receptor Agonists
=450  \\$wnnoa$aHormones, Synthetic$5IEN-M
=450  \\$wnnna$aReceptor Agonists, Hormone
=550  \\$wg$aHormones, Hormone Substitutes, and Hormone Antagonists
=550  \\$wh$aAdrenal Cortex Hormones
=550  \\$wh$aAnabolic Agents
=550  \\$wh$aAndrogens
=550  \\$wh$aCannabinoid Receptor Modulators
=550  \\$wh$aEstrogens
=550  \\$wh$aGastrointestinal Hormones
=550  \\$wh$aGlucocorticoids
=550  \\$wh$aGonadal Hormones
=550  \\$wh$aHormones, Ectopic
=550  \\$wh$aIncretins
=550  \\$wh$aInvertebrate Hormones
=550  \\$wh$aMelatonin
=550  \\$wh$aMineralocorticoids
=550  \\$wh$aPeptide Hormones
=550  \\$wh$aProgestins
=550  \\$wh$aThymus Hormones
=550  \\$wh$aThyroid Hormones
=550  \\$aEndocrine Glands
=667  \\$ageneral; prefer specifics; for hormone receptors, see note at RECEPTORS, CELL SURFACE
=680  \\$iChemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
=750  \0$aHormones$5IEN$0(DLC)sh 85061980

=LDR  01234cz  a2200337n  4500
=001  9880363665302441
=005  20141212192235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006727
=035  \\$aCAZ9904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347
=072  \\$aD27.$x505.$x696.$x399.$x450
=150  \\$aHormone Antagonists
=450  \\$wnnna$aAntagonists, Hormone
=450  \\$aHormones$xantagonists & inhibitors
=550  \\$wg$aHormones, Hormone Substitutes, and Hormone Antagonists
=550  \\$wh$aAndrogen Antagonists
=550  \\$wh$aAntithyroid Agents
=550  \\$wh$aCalcimimetic Agents
=550  \\$wh$aEstrogen Antagonists
=550  \\$wh$aEstrogen Receptor Modulators
=550  \\$wh$aInsulin Antagonists
=550  \\$wh$aLeukotriene Antagonists
=550  \\$wh$aMineralocorticoid Receptor Antagonists
=550  \\$wh$aProstaglandin Antagonists
=550  \\$wh$aSteroid Synthesis Inhibitors
=667  \\$aDF: HORMONE ANTAG
=680  \\$iChemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
=688  \\$a75
=750  \0$aHormone antagonists$5IEN$0(DLC)sh 85061977

=LDR  00797cz  a2200241n  4500
=001  9880363665402441
=005  20141212202208.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006726
=035  \\$aCAZ9903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x354.$x400
=072  \\$aC1.$x539.$x375.$x354.$x400
=072  \\$aC11.$x294.$x354.$x400
=072  \\$aC11.$x338.$x648
=150  \\$aHordeolum
=450  \\$aStye
=450  \\$wnnna$aStyes
=550  \\$wg$aEye Infections, Bacterial
=550  \\$wg$aEyelid Diseases
=667  \\$abact eye infect
=680  \\$iPurulent infection of one of the sebaceous glands of Zeis along the eyelid margin (external) or of the meibomian gland on the conjunctival side of the eyelid (internal).
=750  \0$aHordeolum$5IEN$0(DLC)sh 85061962

=LDR  01122cz  a2200277n  4500
=001  9880363665502441
=005  20141212202207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006725
=035  \\$aCAZ9902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x775.$x455
=150  \\$aHookworm Infections
=450  \\$wnnna$aBunostomiases
=450  \\$aBunostomiasis
=450  \\$aHookworm Disease$5IEN
=450  \\$wnnna$aHookworm Infection
=450  \\$wnnna$aInfection, Hookworm
=450  \\$wnnna$aInfections, Hookworm
=550  \\$wg$aStrongylida Infections
=550  \\$wh$aAncylostomiasis
=550  \\$wh$aNecatoriasis
=667  \\$aGEN: prefer specifics; New World hookworm infection = NECATORIASIS, Old World hookworm infection = ANCYLOSTOMIASIS
=680  \\$iInfection of humans or animals with hookworms other than those caused by the genus Ancylostoma or Necator, for which the specific terms ANCYLOSTOMIASIS and NECATORIASIS are available.
=688  \\$a73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92
=750  \0$aHookworm disease$5IEN$0(DLC)sh 85061908

=LDR  00790cz  a2200265n  4500
=001  9880363665602441
=005  20141212202207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006724
=035  \\$aCAZ9901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x491
=150  \\$aHoof and Claw
=450  \\$aClaw
=450  \\$wnnna$aClaw and Hoof
=450  \\$wnnna$aClaws
=450  \\$wnnna$aClaws and Hooves
=450  \\$wnnna$aHoof
=450  \\$wnnna$aHooves
=450  \\$wnnna$aHooves and Claws
=550  \\$wg$aAnimal Structures
=667  \\$afor cat & dog claws (nails): not for chicken claws (whole foot); diseases: coord IM with FOOT DISEASES /vet (IM); DF: HOOF
=688  \\$a68
=750  \0$aHoofs$5IEN-M$0(DLC)sh 85061898
=750  \0$aClaws$5IEN-HS$0(DLC)sh 94006333

=LDR  00794cz  a2200205n  4500
=001  9880363665702441
=005  20141212202206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006722
=035  \\$aCAZ9899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x581
=150  \\$aHoney
=450  \\$wnnna$aHoneys
=550  \\$wg$aFood
=550  \\$aApitherapy
=550  \\$aBees
=550  \\$aPlant Nectar
=680  \\$iA sweet viscous liquid food, produced in the honey sacs of various bees from nectar collected from flowers. The nectar is ripened into honey by inversion of its sucrose sugar into fructose and glucose. It is somewhat acidic and has mild antiseptic properties, being sometimes used in the treatment of burns and lacerations.
=750  \0$aHoney$0(DLC) sh 85061842$5IEN

=LDR  00871cz  a2200241n  4500
=001  9880363665802441
=005  20141212202206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006719
=035  \\$aCAZ9896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x601.$x521
=150  \\$aHomovanillic Acid
=450  \\$wnnna$a3-Methoxy-4-Hydroxyphenylacetic Acid
=450  \\$wnnna$a3 Methoxy 4 Hydroxyphenylacetic Acid
=450  \\$wnnna$a4-Hydroxy-3-Methoxyphenylacetic Acid
=450  \\$wnnna$a4 Hydroxy 3 Methoxyphenylacetic Acid
=450  \\$wnnna$aAcid, 3-Methoxy-4-Hydroxyphenylacetic
=450  \\$wnnna$aAcid, 4-Hydroxy-3-Methoxyphenylacetic
=450  \\$wnnna$aAcid, Homovanillic
=550  \\$wg$aPhenylacetates
=688  \\$a86(73); was see under PHENYLACETATES 1975-85, was Prov 1973-74
=750  \0$aHomovanillic acid$5IEN-M$0(DLC)sh 96008519

=LDR  00964cz  a2200301n  4500
=001  9880363665902441
=005  20161115140335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006716
=035  \\$aCAZ9893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x975.$x500
=072  \\$aG8.$x686.$x867.$x500
=150  \\$aHomosexuality
=450  \\$wnnna$aEgo-Dystonic Homosexuality
=450  \\$aGays
=450  \\$wnnna$aHomosexual
=450  \\$aHomosexuality, Ego-Dystonic
=450  \\$wnnna$aHomosexuality, Ego Dystonic
=450  \\$wnnna$aHomosexuals
=450  \\$aQueers
=550  \\$wg$aSexuality
=550  \\$wh$aHomosexuality, Female
=550  \\$wh$aHomosexuality, Male
=667  \\$ageneral; prefer HOMOSEXUALITY, MALE or HOMOSEXUALITY, FEMALE
=680  \\$iThe sexual attraction or relationship between members of the same SEX.
=750  \0$aHomosexuality$5IEN-M$0(DLC)sh 85061780
=750  \0$aGays$5IEN-HS$0(DLC)sh 85061795

=LDR  00833cz  a2200253n  4500
=001  9880363666002441
=005  20141212202204.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006710
=035  \\$aCAZ9887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x498
=072  \\$aD12.$x125.$x166.$x498
=150  \\$aHomocysteine
=450  \\$a2-amino-4-mercaptobutyric acid
=450  \\$wnnna$a2 amino 4 mercaptobutyric acid
=450  \\$wnnna$aHomocysteine, L-Isomer
=450  \\$wnnna$aHomocysteine, L Isomer
=450  \\$wnnna$aL-Isomer Homocysteine
=550  \\$wg$aAmino Acids, Sulfur
=550  \\$wh$aS-Adenosylhomocysteine
=667  \\$ado not confuse with HOMOCYSTINE
=680  \\$iA thiol-containing amino acid formed by a demethylation of METHIONINE.
=750  \0$aHomocysteine$0(DLC) sh 96011736$5IEN-M

=LDR  01425cz  a2200385n  4500
=001  9880363666102441
=005  20141212210908.0
=008  880419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015186
=035  \\$aCAZ9885M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400
=150  \\$aHominidae
=450  \\$wnnna$aApe
=450  \\$aApes
=450  \\$wnnna$aHominid
=450  \\$aHominids
=450  \\$wnnna$aHominin
=450  \\$wnnna$aHominini
=450  \\$aHominins
=450  \\$wnnna$aHomininus
=450  \\$aHomo
=450  \\$wnnna$aPongidae
=550  \\$wg$aCatarrhini
=550  \\$wh$aGorilla gorilla
=550  \\$wh$aHumans
=550  \\$wh$aNeanderthals
=550  \\$wh$aPan paniscus
=550  \\$wh$aPan troglodytes
=550  \\$wh$aPongo
=550  \\$aAnthropology
=667  \\$adiseases: coordinate IM with PRIMATE DISEASES (IM); note entry term APES: diseases in an unspecified ape, index APE DISEASES (IM) + HOMINIDAE (NIM); extinct humans (Homo sp. other than Homo sapiens) go here; NEANDERTHALS is also available
=680  \\$iFamily of the suborder HAPLORHINI (Anthropoidea) comprising bipedal primate MAMMALS. It includes modern man (HOMO SAPIENS) and the great apes: gorillas (GORILLA GORILLA), chimpanzees (PAN PANISCUS and PAN TROGLODYTES), and orangutans (PONGO PYGMAEUS).
=688  \\$a89
=750  \0$aHominids$5IEN-M$0(DLC)sh 96001186

=LDR  00918cz  a2200337n  4500
=001  9880363666202441
=005  20141212202203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006708
=035  \\$aCAZ9884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x470
=072  \\$aI1.$x880.$x735.$x344
=150  \\$aHomicide
=450  \\$wnnna$aDeath, Wrongful
=450  \\$wnnna$aDeaths, Wrongful
=450  \\$wnnna$aHomicides
=450  \\$wnnna$aKilling
=450  \\$wnnna$aKillings
=450  \\$aMurder
=450  \\$wnnna$aMurders
=450  \\$wnnna$aWrongful Death
=450  \\$wnnna$aWrongful Deaths
=550  \\$wg$aCrime
=550  \\$wg$aSocial Problems
=550  \\$wh$aEuthanasia
=550  \\$wh$aInfanticide
=550  \\$aDeath
=680  \\$iThe killing of one person by another.
=750  \0$aHomicide$5IEN-M$0(DLC)sh 85061743
=750  \0$aMurder$5IEN-HS$0(DLC)sh 85088613

=LDR  00907cz  a2200253n  4500
=001  9880363666302441
=005  20141212202203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006707
=035  \\$aCAZ9883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x462
=150  \\$aHomes for the Aged
=450  \\$wnnna$aHome, Old Age
=450  \\$wnnna$aHomes, Old Age
=450  \\$wnnna$aOld Age Home
=450  \\$aOld Age Homes
=550  \\$wg$aResidential Facilities
=550  \\$aAged
=550  \\$aHousing for the Elderly
=667  \\$anursing homes for the aged: coord IM with NURSING HOMES (IM); check also tag AGED
=680  \\$iGeriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.
=688  \\$a68; was OLD AGE HOMES 1963-67
=750  \0$aOld age homes$5IEN$0(DLC)sh 85094511

=LDR  00690cz  a2200217n  4500
=001  9880363666402441
=005  20141212202202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006706
=035  \\$aCAZ9882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x345
=150  \\$aHomeostasis
=450  \\$aAutoregulation
=550  \\$wg$aPhysiological Processes
=550  \\$wh$aAcid-Base Equilibrium
=550  \\$wh$aBody Temperature Regulation
=550  \\$wh$aFeedback, Physiological
=550  \\$wh$aOsmoregulation
=680  \\$iThe processes whereby the internal environment of an organism tends to remain balanced and stable.
=750  \0$aHomeostasis$0(DLC) sh 85061731$5IEN

=LDR  00885cz  a2200229n  4500
=001  9880363666502441
=005  20141212202202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006705
=035  \\$aCAZ9881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x388
=072  \\$aE2.$x190.$x901.$x249
=150  \\$aHomeopathy
=450  \\$aHomeopathic Physicians$5IEN
=450  \\$wnnna$aHomoeopathy
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aSpiritual Therapies
=550  \\$aMateria Medica
=680  \\$iA system of therapeutics founded by Samuel Hahnemann (1755-1843), based on the Law of Similars where "like cures like". Diseases are treated by highly diluted substances that cause, in healthy persons, symptoms like those of the disease to be treated.
=750  \0$aHomeopathy$0sh 85061725$5IEN-M
=750  \0$aHomeopathic physicians$0sh 85061723$5IEN-M

=LDR  01695nz  a2200493n  4500
=001  9882549679502441
=005  20250214143620.0
=008  850320\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006703
=035  \\$a(DNLM)D006703
=035  \\$a(NLM)98198770590000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x325
=150  \\$aIll-Housed Persons
=450  \\$wnnna$aHomelessness
=450  \\$aHomeless Persons
=450  \\$aHomeless Shelters
=450  \\$aShelterless Persons
=450  \\$aShelters for Homeless Persons
=450  \\$aStreet People
=450  \\$aUnhoused Persons
=450  \\$wnnna$aHomeless Person
=450  \\$wnnna$aHomeless Shelter
=450  \\$wnnna$aIll-Housed Person
=450  \\$wnnna$aIll Housed Persons
=450  \\$wnnna$aPeople, Street
=450  \\$wnnna$aPerson, Homeless
=450  \\$wnnna$aPerson, Ill-Housed
=450  \\$wnnna$aPerson, Shelterless
=450  \\$wnnna$aPersons, Homeless
=450  \\$wnnna$aPersons, Ill-Housed
=450  \\$wnnna$aPersons, Shelterless
=450  \\$wnnna$aPersons, Unhoused
=450  \\$wnnna$aPerson, Unhoused
=450  \\$wnnna$aShelter, Homeless
=450  \\$wnnna$aShelterless Person
=450  \\$wnnna$aShelters, Homeless
=450  \\$wnnna$aUnhoused Person
=550  \\$aTransients and Migrants
=667  \\$anot for nomads; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iPersons without adequate housing or without permanent residence. The concept excludes nomadic peoples.
=680  \\$iHousing created or provided for ILL-HOUSED PERSONS.
=688  \\$a2023 (1996)
=750  \0$aHomeless persons$5IEN-HS$0(DLC)sh 85061718

=LDR  00972cz  a2200265n  4500
=001  9880363666702441
=005  20141212202201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006702
=035  \\$aCAZ9878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x646
=150  \\$aHoming Behavior
=450  \\$wnnna$aBehavior, Homing
=450  \\$wnnna$aBehaviors, Homing
=450  \\$aHome Range
=450  \\$wnnna$aHome Ranges
=450  \\$wnnna$aHoming Behaviors
=450  \\$wnnna$aRange, Home
=450  \\$wnnna$aRanges, Home
=550  \\$wg$aBehavior, Animal
=550  \\$aAnimal Migration
=680  \\$iInstinctual patterns of activity related to a specific area including ability of certain animals to return to a given place when displaced from it, often over great distances using navigational clues such as those used in migration (ANIMAL MIGRATION).
=688  \\$a98;(68)
=750  \0$aHome range (Animal geography)$5IEN$0(DLC)sh 85061704

=LDR  01425cz  a2200325n  4500
=001  9880363666802441
=005  20141212202201.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006701
=035  \\$aCAZ9877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x611.$x470
=072  \\$aN2.$x421.$x143.$x524.$x470
=072  \\$aN2.$x421.$x533.$x320
=150  \\$aHome Nursing
=450  \\$wnnna$aCare, Non-Professional Home
=450  \\$wnnna$aCare, Nonprofessional Home
=450  \\$aHome Care, Non-Professional
=450  \\$wnnna$aHome Care, Non Professional
=450  \\$wnnna$aHome Care, Nonprofessional
=450  \\$wnnna$aNon-Professional Home Care
=450  \\$wnnna$aNonprofessional Home Care
=450  \\$aNursing, Home
=550  \\$wg$aHome Care Services
=550  \\$wg$aNursing Care
=550  \\$wh$aRespite Care
=667  \\$aby non-professionals only (family, friends, etc.): do not confuse with HOME CARE SERVICES (by professional: visiting nurse, public health nurse, etc.)
=680  \\$iNursing care given to an individual in the home. The care may be provided by a family member or a friend. Home nursing as care by a non-professional is differentiated from HOME CARE SERVICES provided by professionals: visiting nurse, home health agencies, hospital, or other organized community group.
=688  \\$a66; was NURSING, HOME 1963-65
=750  \0$aHome nursing$5IEN$0(DLC)sh 85061700

=LDR  00756cz  a2200241n  4500
=001  9880363666902441
=005  20141212202201.0
=008  820505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006700
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x490.$x124
=150  \\$aHome Childbirth
=450  \\$aChildbirth at Home
=450  \\$wnnna$aChildbirth, Home
=450  \\$wnnna$aChildbirths at Home
=450  \\$wnnna$aChildbirths, Home
=450  \\$wnnna$aHome Childbirths
=550  \\$wg$aParturition
=550  \\$aMidwifery
=667  \\$acheck the tags FEMALE and PREGNANCY
=680  \\$iChildbirth taking place in the home.
=688  \\$a91(83); was see under DELIVERY 1983-90
=750  \0$aChildbirth at home$5IEN$0(DLC)sh 85023410

=LDR  01600cz  a2200397n  4500
=001  9880363667002441
=005  20141212202200.0
=008  771207\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006699
=035  \\$aCAZ9875HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x524
=072  \\$aN2.$x421.$x539.$x89
=150  \\$aHome Care Services
=450  \\$wnnna$aCare, Domiciliary
=450  \\$wnnna$aCare, Home
=450  \\$wnnna$aCare Services, Home
=450  \\$aDomiciliary Care
=450  \\$aHealth Agencies, Home$5IEN-M
=450  \\$wnnna$aHome Care
=450  \\$wnnna$aHome Care Service
=450  \\$wnnna$aService, Home Care
=450  \\$wnnna$aServices, Home Care
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aNursing Services
=550  \\$wh$aHemodialysis, Home
=550  \\$wh$aHome Care Services, Hospital-Based
=550  \\$wh$aHome Health Nursing
=550  \\$wh$aHome Infusion Therapy
=550  \\$wh$aHome Nursing
=550  \\$wh$aHomemaker Services
=550  \\$wh$aParenteral Nutrition, Home
=667  \\$aIM; coord with specific home care (IM); DF: HOME CARE SERV
=680  \\$iCommunity health and NURSING SERVICES providing coordinated multiple services to the patient at the patient's homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.
=688  \\$a67; was HOME CARE SERVICE 1966
=750  \0$aHome care services$5IEN-M$0(DLC)sh 85061666

=LDR  00697cz  a2200217n  4500
=001  9880363667102441
=005  20141212202159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006696
=035  \\$aCAZ9872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x400.$x500
=072  \\$aE1.$x370.$x350.$x600.$x300
=150  \\$aHolography
=550  \\$wg$aImaging, Three-Dimensional
=550  \\$wg$aPhotography
=550  \\$aLasers
=667  \\$aDF: HOLOGR
=680  \\$iThe recording of images in three-dimensional form on a photographic film by exposing it to a laser beam reflected from the object under study.
=688  \\$a74(69)
=750  \0$aHolography$5IEN$0(DLC)sh 85061533

=LDR  00716cz  a2200193n  4500
=001  9880363667202441
=005  20141212202159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006695
=035  \\$aCAZ9871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x492
=072  \\$aD1.$x268.$x558.$x362.$x492
=072  \\$aD1.$x552.$x550.$x399.$x492
=150  \\$aHolmium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Ho-165; Ho-151-170, except Ho-165 = HOLMIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iHolmium. An element of the rare earth family of metals. It has the atomic symbol Ho, atomic number 67, and atomic weight 164.93.
=750  \0$aHolmium$5IEN$0(DLC)sh 85061510

=LDR  01124cz  a2200337n  4500
=001  9880363667302441
=005  20141212202159.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006694
=035  \\$aCAZ9870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x321
=072  \\$aK1.$x752.$x667.$x710
=072  \\$aN1.$x400.$x350
=150  \\$aHolistic Health
=450  \\$wnnna$aHealth, Holistic
=450  \\$wnnna$aHealth, Wholistic
=450  \\$aHolistic Medicine
=450  \\$aHolistic Therapies
=450  \\$aMedicine, Holistic
=450  \\$wnnna$aMedicine, Wholistic
=450  \\$aWholistic Health
=450  \\$wnnna$aWholistic Medicine
=450  \\$wnnna$aWholistic Therapies
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aHealth
=550  \\$wg$aPhilosophy, Medical
=667  \\$acoord with specific complementary therapy if pertinent
=680  \\$iHealth as viewed from the perspective that humans and other organisms function as complete, integrated units rather than as aggregates of separate parts.
=688  \\$a80
=750  \0$aHolistic medicine$5IEN-M$0(DLC)sh 85061482

=LDR  00648cz  a2200217n  4500
=001  9880363667402441
=005  20141212202159.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006693
=035  \\$aCAZ9869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x345
=150  \\$aHolidays
=450  \\$wnnna$aFestival
=450  \\$aFestivals
=450  \\$wnnna$aHoliday
=550  \\$wg$aLeisure Activities
=680  \\$iDays commemorating events. Holidays also include vacation periods.
=688  \\$aFESTIVALS was see under HOLIDAYS 1963-82
=750  \0$aFestivals$5IEN-M$0(DLC)sh 85047932
=750  \0$aHolidays$5IEN-HS$0(DLC)sh 85061453

=LDR  00921cz  a2200253n  4500
=001  9880363667502441
=005  20141212202158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006691
=035  \\$aCAZ9867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350.$x675.$x200
=072  \\$aC22.$x905.$x170
=150  \\$aClassical Swine Fever
=450  \\$wnnna$aCholera, Hog
=450  \\$aHog Cholera
=450  \\$aSwine Fever
=450  \\$aSwine Fever, Classical
=550  \\$wg$aPestivirus Infections
=550  \\$wg$aSwine Diseases
=667  \\$ado not confuse X ref SWINE FEVER with AFRICAN SWINE FEVER; don't forget also SWINE (NIM)
=680  \\$iAn acute, highly contagious disease affecting swine of all ages and caused by the CLASSICAL SWINE FEVER VIRUS. It has a sudden onset with high morbidity and mortality.
=688  \\$a2002 (1963)
=750  \0$aClassical swine fever$5IEN$0(DLC)sh 85061375

=LDR  02355cz  a2200589n  4500
=001  9880363667602441
=005  20141212202157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006689
=035  \\$aCAZ9865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386.$x355
=072  \\$aC15.$x604.$x515.$x569.$x355
=072  \\$aC20.$x683.$x515.$x761.$x355
=150  \\$aHodgkin Disease
=450  \\$wnnna$aAdult Hodgkin Lymphoma
=450  \\$wnnna$aDisease, Hodgkin
=450  \\$wnnna$aDisease, Hodgkin's
=450  \\$wnnna$aDisease, Hodgkins
=450  \\$aGranuloma, Hodgkin
=450  \\$wnnna$aGranuloma, Hodgkin's
=450  \\$wnnna$aGranuloma, Hodgkins
=450  \\$aGranuloma, Malignant
=450  \\$wnnna$aHodgkin Granuloma
=450  \\$aHodgkin Lymphoma
=450  \\$wnnna$aHodgkin Lymphoma, Adult
=450  \\$wnnna$aHodgkin's Disease
=450  \\$wnnna$aHodgkins Disease
=450  \\$wnnna$aHodgkin's Granuloma
=450  \\$wnnna$aHodgkins Granuloma
=450  \\$wnnna$aHodgkin's Lymphoma
=450  \\$wnnna$aHodgkins Lymphoma
=450  \\$wnnna$aLymphocyte Depletion Hodgkin's Lymphoma
=450  \\$wnnna$aLymphocyte-Rich Classical Hodgkin's Lymphoma
=450  \\$wnnna$aLymphocyte Rich Classical Hodgkin's Lymphoma
=450  \\$aLymphogranuloma, Malignant
=450  \\$wnnna$aLymphogranulomas, Malignant
=450  \\$wnnna$aLymphoma, Hodgkin
=450  \\$wnnna$aLymphoma, Hodgkin's
=450  \\$wnnna$aMalignant Granuloma
=450  \\$wnnna$aMalignant Granulomas
=450  \\$wnnna$aMalignant Lymphogranuloma
=450  \\$wnnna$aMalignant Lymphogranulomas
=450  \\$wnnna$aMixed Cellularity Hodgkin's Lymphoma
=450  \\$wnnna$aNodular Lymphocyte-Predominant Hodgkin's Lymphoma
=450  \\$wnnna$aNodular Lymphocyte Predominant Hodgkin's Lymphoma
=450  \\$wnnna$aNodular Sclerosing Hodgkin's Lymphoma
=550  \\$wg$aLymphoma
=550  \\$aReed-Sternberg Cells
=680  \\$iA malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
=688  \\$a98(66)
=750  \0$aHodgkin's disease$0(DLC) sh 85061347$5IEN

=LDR  01001cz  a2200289n  4500
=001  9880363667702441
=005  20141212202157.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006688
=035  \\$aCAZ9864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x475
=150  \\$aHockey
=450  \\$aField Hockey
=450  \\$wnnna$aField Hockeys
=450  \\$wnnna$aHockey, Field
=450  \\$wnnna$aHockey, Ice
=450  \\$wnnna$aHockeys
=450  \\$wnnna$aHockeys, Field
=450  \\$wnnna$aHockeys, Ice
=450  \\$aIce Hockey
=450  \\$wnnna$aIce Hockeys
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA game in which two parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals. This applies to either ice hockey or field hockey.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aHockey$5IEN$0(DLC)sh 85061326

=LDR  01480cz  a2200373n  4500
=001  9880363667802441
=005  20141212202045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006454
=035  \\$aCAZ9626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x400
=072  \\$aD12.$x776.$x422.$x316.$x762
=150  \\$aHemoglobins
=450  \\$wnnna$aEryhem
=450  \\$wnnna$aFerrous Hemoglobin
=450  \\$wnnna$aHemoglobin
=450  \\$wnnna$aHemoglobin, Ferrous
=550  \\$wg$aBlood Proteins
=550  \\$wg$aGlobins
=550  \\$wh$aCarboxyhemoglobin
=550  \\$wh$aErythrocruorins
=550  \\$wh$aFetal Hemoglobin
=550  \\$wh$aHemoglobin A
=550  \\$wh$aHemoglobin Subunits
=550  \\$wh$aHemoglobins, Abnormal
=550  \\$wh$aMethemoglobin
=550  \\$wh$aOxyhemoglobins
=550  \\$wh$aSulfhemoglobin
=550  \\$wh$aTruncated Hemoglobins
=667  \\$ageneral or unspecified; prefer specifics; MEAN CELL HEMOGLOBIN CONCENTRATION see = ERYTHROCYTE INDICES is available; Bohr effect is indexed OXYHEMOGLOBINS / metab (IM) + PH (NIM)
=680  \\$iThe oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.
=688  \\$a75; was HEMOGLOBIN 1963-74
=750  \0$aHemoglobin$0(DLC)  sh 85060198$5IEN

=LDR  01044cz  a2200265n  4500
=001  9880363667902441
=005  20141212202045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006453
=035  \\$aCAZ9625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x420
=072  \\$aC16.$x320.$x365
=150  \\$aHemoglobinopathies
=450  \\$wnnna$aHemoglobinopathy
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aAnemia, Sickle Cell
=550  \\$wh$aHemoglobin C Disease
=550  \\$wh$aThalassemia
=550  \\$aHemoglobins, Abnormal
=667  \\$ado not confuse with HEMOGLOBINS, ABNORMAL (D12): use term in the text; coord IM with specific abnormal hemoglobin (IM) but HEMOGLOBIN C DISEASE; THALASSEMIA (hemoglobin H disease) & ANEMIA, SICKLE CELL (hemoglobin S disease) are available
=680  \\$iA group of inherited disorders characterized by structural alterations within the hemoglobin molecule.
=688  \\$a68
=750  \0$aHemoglobinopathy$5IEN$0(DLC)sh 85060203

=LDR  00673cz  a2200193n  4500
=001  9880363668002441
=005  20141212202044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006452
=035  \\$aCAZ9624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x410
=072  \\$aE5.$x200.$x625.$x410
=150  \\$aHemoglobinometry
=450  \\$wnnna$aHemoglobinometries
=550  \\$wg$aHematologic Tests
=667  \\$aNIM; do not equate with HEMOGLOBINS /anal; note ERYTHROCYTE HEMOGLOBIN, MEAN CELL see ERYTHROCYTE INDICES is available
=680  \\$iMeasurement of hemoglobin concentration in blood.
=750  \0$aHemoglobinometry$5IEN$0(DLC)sh 85060202

=LDR  01758cz  a2200469n  4500
=001  9880363668202441
=005  20141212202041.0
=008  870508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006440
=035  \\$aCAZ9612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x350
=072  \\$aE2.$x912.$x400
=072  \\$aE4.$x292.$x471
=072  \\$aE4.$x292.$x975.$x300
=072  \\$aE5.$x196.$x454.$x807.$x300
=150  \\$aHemofiltration
=450  \\$aArteriovenous Hemofiltration
=450  \\$wnnna$aArteriovenous Hemofiltration, Continuous
=450  \\$wnnna$aArteriovenous Hemofiltrations
=450  \\$wnnna$aArteriovenous Hemofiltrations, Continuous
=450  \\$aCAVH
=450  \\$wnnna$aContinuous Arteriovenous Hemofiltration
=450  \\$wnnna$aContinuous Arteriovenous Hemofiltrations
=450  \\$wnnna$aHemofiltration, Arteriovenous
=450  \\$aHemofiltration, Continuous Arteriovenous
=450  \\$wnnna$aHemofiltration, Venovenous
=450  \\$wnnna$aHemofiltrations
=450  \\$wnnna$aHemofiltrations, Arteriovenous
=450  \\$wnnna$aHemofiltrations, Continuous Arteriovenous
=450  \\$wnnna$aHemofiltrations, Venovenous
=450  \\$aVenovenous Hemofiltration
=450  \\$wnnna$aVenovenous Hemofiltrations
=550  \\$wg$aExtracorporeal Circulation
=550  \\$wg$aRenal Replacement Therapy
=550  \\$wg$aSorption Detoxification
=550  \\$wg$aUltrafiltration
=550  \\$wh$aHemodiafiltration
=550  \\$aUltrafiltration
=680  \\$iExtracorporeal ultrafiltration technique without hemodialysis for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.
=688  \\$a88
=750  \0$aBlood$xFiltration$5IEN-HS$0(DLC)sh 85014942

=LDR  01555cz  a2200469n  4500
=001  9880363668302441
=005  20170609115402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006439
=035  \\$aCAZ9611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380
=150  \\$aHemodynamics
=450  \\$wnnna$aHemodynamic
=450  \\$wnnoa$aHemodynamic Phenomena$5IEN-M
=450  \\$wnnoa$aHemodynamic Processes$5IEN-M
=550  \\$wg$aCardiovascular Physiological Phenomena
=550  \\$wh$aAtrial Pressure
=550  \\$wh$aBaroreflex
=550  \\$wh$aBlood Pressure
=550  \\$wh$aBlood Volume
=550  \\$wh$aCardiac Output
=550  \\$wh$aCardiac Volume
=550  \\$wh$aHeart Rate
=550  \\$wh$aHeart Sounds
=550  \\$wh$aHemorheology
=550  \\$wh$aKallikrein-Kinin System
=550  \\$wh$aPulse
=550  \\$wh$aRenin-Angiotensin System
=550  \\$wh$aValsalva Maneuver
=550  \\$wh$aVascular Capacitance
=550  \\$wh$aVascular Resistance
=550  \\$wh$aVasoconstriction
=550  \\$wh$aVasodilation
=550  \\$wh$aVentricular Pressure
=550  \\$aBlood Circulation
=680  \\$iThe movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
=688  \\$a2008, 1966-2003 (1964)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Hemodynamic Processes
=688  \\$a2004(1964)
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20071115: 150:##:_{dollar}a Hemodynamics
=750  \0$aHemodynamics$0(DLC) sh 85060196$5IEN

=LDR  00768cz  a2200193n  4500
=001  9880363668402441
=005  20141212202039.0
=008  780126\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006438
=035  \\$aCAZ9610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x514
=150  \\$aHemodilution
=450  \\$wnnna$aHemodilutions
=550  \\$wg$aTherapeutics
=667  \\$ado not use /util except by MeSH definition
=680  \\$iReduction of blood viscosity usually by the addition of cell free solutions. Used clinically (1) in states of impaired microcirculation, (2) for replacement of intraoperative blood loss without homologous blood transfusion, and (3) in cardiopulmonary bypass and hypothermia.
=688  \\$a79
=750  \0$aHemodilution$5IEN$0(DLC)sh 92001810

=LDR  01016cz  a2200325n  4500
=001  9880363668502441
=005  20141212202039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006437
=035  \\$aCAZ9609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x300.$x300
=072  \\$aE2.$x912.$x800.$x300
=072  \\$aN2.$x421.$x143.$x524.$x337
=150  \\$aHemodialysis, Home
=450  \\$wnnna$aDialyses, Home Renal
=450  \\$wnnna$aDialysis, Home Renal
=450  \\$wnnna$aHemodialyses, Home
=450  \\$wnnna$aHome Hemodialyses
=450  \\$aHome Hemodialysis
=450  \\$wnnna$aHome Renal Dialyses
=450  \\$wnnna$aHome Renal Dialysis
=450  \\$wnnna$aRenal Dialyses, Home
=450  \\$aRenal Dialysis, Home
=550  \\$wg$aHome Care Services
=550  \\$wg$aRenal Dialysis
=667  \\$a/instrum permitted if not KIDNEYS, ARTIFICIAL
=680  \\$iLong-term maintenance hemodialysis in the home.
=688  \\$a73
=750  \0$aHome hemodialysis$5IEN$0(DLC)sh 85060191

=LDR  01240cz  a2200361n  4500
=001  9880363668602441
=005  20141212202039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006435
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x300
=072  \\$aE2.$x912.$x800
=150  \\$aRenal Dialysis
=450  \\$wnnna$aDialyses, Extracorporeal
=450  \\$wnnna$aDialyses, Renal
=450  \\$aDialysis, Extracorporeal
=450  \\$aDialysis, Renal
=450  \\$wnnna$aExtracorporeal Dialyses
=450  \\$aExtracorporeal Dialysis
=450  \\$wnnna$aHemodialyses
=450  \\$aHemodialysis
=450  \\$wnnna$aRenal Dialyses
=550  \\$wg$aRenal Replacement Therapy
=550  \\$wg$aSorption Detoxification
=550  \\$wh$aHemodiafiltration
=550  \\$wh$aHemodialysis, Home
=550  \\$wh$aPeritoneal Dialysis
=550  \\$aKidney Failure, Chronic
=550  \\$aKidneys, Artificial
=667  \\$a/instrum permitted but consider also KIDNEYS, ARTIFICIAL
=680  \\$iTherapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
=688  \\$a2001(1967)
=750  \0$aHemodialysis$5IEN$0(DLC)sh 85060189

=LDR  02875cz  a2200709n  4500
=001  9880363668802441
=005  20141212202038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006432
=035  \\$aCAZ9603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x618.$x337
=072  \\$aC18.$x452.$x565.$x500.$x480
=072  \\$aC18.$x452.$x648.$x618.$x337
=150  \\$aHemochromatosis
=450  \\$wnnna$aBronze Diabetes
=450  \\$wnnna$aBronzed Cirrhoses
=450  \\$wnnna$aBronzed Cirrhosis
=450  \\$wnnna$aCirrhoses, Bronzed
=450  \\$wnnna$aCirrhoses, Pigmentary
=450  \\$wnnna$aCirrhosis, Bronzed
=450  \\$wnnna$aCirrhosis, Pigmentary
=450  \\$aDiabetes, Bronze
=450  \\$wnnna$aDisease, Von Recklenhausen-Applebaum
=450  \\$wnnna$aDiseases, Von Recklenhausen-Applebaum
=450  \\$wnnna$aDisorder, Iron Storage
=450  \\$wnnna$aDisorders, Iron Storage
=450  \\$wnnna$aFamilial Hemochromatoses
=450  \\$wnnna$aFamilial Hemochromatosis
=450  \\$wnnna$aGenetic Hemochromatoses
=450  \\$wnnna$aGenetic Hemochromatosis
=450  \\$wnnna$aHaemochromatoses
=450  \\$wnnna$aHaemochromatosis
=450  \\$wnnna$aHemochromatose
=450  \\$wnnna$aHemochromatoses
=450  \\$wnnna$aHemochromatoses, Familial
=450  \\$wnnna$aHemochromatoses, Genetic
=450  \\$wnnna$aHemochromatosis, Familial
=450  \\$wnnna$aHemochromatosis, Genetic
=450  \\$wnnna$aIron Storage Disorder
=450  \\$wnnna$aIron Storage Disorders
=450  \\$wnnna$aPigmentary Cirrhoses
=450  \\$wnnna$aPigmentary Cirrhosis
=450  \\$wnnna$aPrimary Hemochromatosis
=450  \\$wnnna$aRecklenhausen-Applebaum Disease, Von
=450  \\$wnnna$aRecklenhausen-Applebaum Diseases, Von
=450  \\$wnnna$aStorage Disorder, Iron
=450  \\$wnnna$aStorage Disorders, Iron
=450  \\$wnnna$aSyndrome, Troisier-Hanot-Chauffard
=450  \\$wnnna$aSyndromes, Troisier-Hanot-Chauffard
=450  \\$wnnna$aTroisier-Hanot-Chauffard Syndrome
=450  \\$wnnna$aTroisier Hanot Chauffard Syndrome
=450  \\$wnnna$aTroisier-Hanot-Chauffard Syndromes
=450  \\$wnnna$aVon Recklenhausen-Applebaum Disease
=450  \\$wnnna$aVon Recklenhausen Applebaum Disease
=450  \\$wnnna$aVon Recklenhausen-Applebaum Diseases
=550  \\$wg$aIron Overload
=550  \\$wg$aMetal Metabolism, Inborn Errors
=550  \\$aHepcidins
=667  \\$aaccumulation of hemosiderin in tissue
=680  \\$iA disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
=750  \0$aHemochromatosis$5IEN$0(DLC)sh 85060186

=LDR  01684cz  a2200565n  4500
=001  9880363668902441
=005  20141212202036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006430
=035  \\$aCAZ9601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412
=150  \\$aHemiptera
=450  \\$aAleurodoidea
=450  \\$wnnna$aAleurodoideas
=450  \\$wnnna$aCicada
=450  \\$aCicadas
=450  \\$aCicadelloidea
=450  \\$wnnna$aCicadelloideas
=450  \\$aCicadoidea
=450  \\$wnnna$aCicadoideas
=450  \\$aCoccoidea
=450  \\$wnnna$aCoccoideas
=450  \\$aFulgoroidea
=450  \\$wnnna$aFulgoroideas
=450  \\$wnnna$aHemipteras
=450  \\$wnnna$aHomoptera
=450  \\$wnnna$aHomopteras
=450  \\$wnnna$aInsect, Scale
=450  \\$wnnna$aInsects, Scale
=450  \\$wnnna$aLeafhopper
=450  \\$aLeafhoppers
=450  \\$wnnna$aPsyllid
=450  \\$aPsyllids
=450  \\$aPsylloidea
=450  \\$wnnna$aPsylloideas
=450  \\$wnnna$aScale Insect
=450  \\$aScale Insects
=450  \\$wnnna$aTreehopper
=450  \\$aTreehoppers
=450  \\$aWhiteflies
=450  \\$wnnna$aWhitefly
=550  \\$wg$aInsects
=550  \\$wh$aAphids
=550  \\$wh$aHeteroptera
=550  \\$wh$aPlanococcus Insect
=667  \\$afor killing Hemiptera with insecticides, see note at INSECTICIDES
=680  \\$iA large order of insects characterized by having the mouth parts adapted to piercing or sucking. It is comprised of four suborders: HETEROPTERA, Auchenorrhyncha, Sternorrhyncha, and Coleorrhyncha.
=688  \\$a75
=750  \0$aHemiptera$5IEN$0(DLC)sh 85060175

=LDR  02148cz  a2200529n  4500
=001  9880363669002441
=005  20141212202036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006429
=035  \\$aCAZ9600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x622.$x295
=072  \\$aC23.$x888.$x592.$x636.$x312
=150  \\$aHemiplegia
=450  \\$wnnna$aCrossed Hemiplegia
=450  \\$wnnna$aCrossed Hemiplegias
=450  \\$wnnna$aFlaccid Hemiplegia
=450  \\$wnnna$aFlaccid Hemiplegias
=450  \\$wnnna$aHemiplegia, Crossed
=450  \\$wnnna$aHemiplegia, Flaccid
=450  \\$wnnna$aHemiplegia, Infantile
=450  \\$wnnna$aHemiplegia, Post-Ictal
=450  \\$wnnna$aHemiplegia, Post Ictal
=450  \\$wnnna$aHemiplegia, Spastic
=450  \\$wnnna$aHemiplegia, Transient
=450  \\$wnnna$aHemiplegias
=450  \\$wnnna$aHemiplegias, Crossed
=450  \\$wnnna$aHemiplegias, Flaccid
=450  \\$wnnna$aHemiplegias, Infantile
=450  \\$wnnna$aHemiplegias, Post-Ictal
=450  \\$wnnna$aHemiplegias, Spastic
=450  \\$wnnna$aHemiplegias, Transient
=450  \\$aHemiplegics$5IEN
=450  \\$wnnna$aInfantile Hemiplegia
=450  \\$wnnna$aInfantile Hemiplegias
=450  \\$aMonoplegia
=450  \\$wnnna$aMonoplegias
=450  \\$wnnna$aPost-Ictal Hemiplegia
=450  \\$wnnna$aPost-Ictal Hemiplegias
=450  \\$wnnna$aSpastic Hemiplegia
=450  \\$wnnna$aSpastic Hemiplegias
=450  \\$wnnna$aTransient Hemiplegia
=450  \\$wnnna$aTransient Hemiplegias
=550  \\$wg$aParalysis
=680  \\$iSevere or complete loss of motor function on one side of the body. This condition is usually caused by BRAIN DISEASES that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, BRAIN STEM lesions; cervical SPINAL CORD DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; and other conditions may manifest as hemiplegia. The term hemiparesis (see PARESIS) refers to mild to moderate weakness involving one side of the body.
=750  \0$aHemiplegics$5IEN-M$0(DLC)sh 85060174
=750  \0$aHemiplegia$5IEN-HS$0(DLC)sh 85060173

=LDR  00604cz  a2200193n  4500
=001  9880363669102441
=005  20141212202035.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006428
=035  \\$aCAZ9599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x80.$x380
=150  \\$aHemipelvectomy
=450  \\$wnnna$aHemipelvectomies
=550  \\$wg$aAmputation
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAmputation of a lower limb through the sacroiliac joint.
=688  \\$a91(75); was see under AMPUTATION 1975-90
=750  \0$aHemipelvectomy$5IEN$0(DLC)sh 85060170

=LDR  02829cz  a2200661n  4500
=001  9880363669202441
=005  20141212202034.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006423
=035  \\$aCAZ9594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x512
=072  \\$aC11.$x966.$x75.$x500
=072  \\$aC23.$x888.$x592.$x763.$x941.$x512
=150  \\$aHemianopsia
=450  \\$wnnna$aAltidudinal Hemianopia
=450  \\$wnnna$aAltidudinal Hemianopias
=450  \\$wnnna$aAltitudinal Hemianopsia
=450  \\$wnnna$aAltitudinal Hemianopsias
=450  \\$wnnna$aBinasal Hemianopia
=450  \\$wnnna$aBinasal Hemianopias
=450  \\$wnnna$aBinasal Hemianopsia
=450  \\$wnnna$aBinasal Hemianopsias
=450  \\$wnnna$aBitemporal Hemianopia
=450  \\$wnnna$aBitemporal Hemianopias
=450  \\$wnnna$aBitemporal Hemianopsia
=450  \\$wnnna$aBitemporal Hemianopsias
=450  \\$wnnna$aHemianopia
=450  \\$wnnna$aHemianopia, Altidudinal
=450  \\$wnnna$aHemianopia, Binasal
=450  \\$wnnna$aHemianopia, Bitemporal
=450  \\$wnnna$aHemianopia, Homonymous
=450  \\$wnnna$aHemianopias
=450  \\$wnnna$aHemianopias, Altidudinal
=450  \\$wnnna$aHemianopias, Binasal
=450  \\$wnnna$aHemianopias, Bitemporal
=450  \\$wnnna$aHemianopias, Homonymous
=450  \\$wnnna$aHemianopsia, Altitudinal
=450  \\$aHemianopsia, Binasal
=450  \\$aHemianopsia, Bitemporal
=450  \\$aHemianopsia, Homonymous
=450  \\$wnnna$aHemianopsias
=450  \\$wnnna$aHemianopsias, Altitudinal
=450  \\$wnnna$aHemianopsias, Binasal
=450  \\$wnnna$aHemianopsias, Bitemporal
=450  \\$wnnna$aHemianopsias, Homonymous
=450  \\$wnnna$aHomonymous Hemianopia
=450  \\$wnnna$aHomonymous Hemianopias
=450  \\$wnnna$aHomonymous Hemianopsia
=450  \\$wnnna$aHomonymous Hemianopsias
=450  \\$wnnna$aQuadrantanopia
=450  \\$wnnna$aQuadrantanopias
=450  \\$aQuadrantanopsia
=450  \\$wnnna$aQuadrantanopsias
=550  \\$wg$aBlindness
=550  \\$wg$aVision Disorders
=680  \\$iPartial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes.
=750  \0$aHemianopsia$5IEN$0(DLC)sh 85060152

=LDR  00740cz  a2200181n  4500
=001  9880363669302441
=005  20141212202033.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x427.$x374.$x187
=072  \\$aD12.$x776.$x556.$x579.$x374.$x187
=150  \\$aHemerythrin
=550  \\$wg$aNonheme Iron Proteins
=667  \\$a/biosyn /physiol permitted
=680  \\$iA non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein.
=688  \\$a91(75); was see under METALLOPROTEINS 1975-90
=750  \0$aHemoerythrin$5IEN$0(DLC)sh 85060197

=LDR  00825cz  a2200265n  4500
=001  9880363669402441
=005  20190716131923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006420
=035  \\$aCAZ9591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x422
=150  \\$aHemeproteins
=450  \\$wnnna$aHeme Protein
=450  \\$wnnna$aHeme Proteins
=450  \\$aHemoproteins$5IEN
=450  \\$wnnna$aProtein, Heme
=450  \\$wnnna$aProteins, Heme
=550  \\$wg$aProteins
=550  \\$wh$aCytochromes
=550  \\$wh$aGlobins
=550  \\$wh$aMethemalbumin
=680  \\$iProteins that contain an iron-porphyrin, or heme, prosthetic group resembling that of hemoglobin. (From Lehninger, Principles of Biochemistry, 1982, p480)
=688  \\$a73
=750  \0$aHemoproteins$5IEN$0(DLC)sh 85060223

=LDR  00941cz  a2200217n  4500
=001  9880363669502441
=005  20141212202033.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006419
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x708.$x410
=150  \\$aHeme Oxygenase (Decyclizing)
=450  \\$aHaem Oxygenase
=450  \\$wnnna$aHeme Oxygenase
=450  \\$wnnna$aOxygenase, Haem
=450  \\$wnnna$aOxygenase, Heme
=550  \\$wg$aMixed Function Oxygenases
=550  \\$wh$aHeme Oxygenase-1
=680  \\$iA mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3.
=688  \\$a98; was HEME OXYGENASE 1980-97 (see under HYDROXYLASES 1980-90)
=750  \0$aHeme oxygenase$0(DLC) sh 91006132$5IEN

=LDR  00820cz  a2200253n  4500
=001  9880363669602441
=005  20141212202032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006418
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500.$x640.$x587
=072  \\$aD3.$x549.$x909.$x500.$x640.$x587
=072  \\$aD4.$x345.$x783.$x500.$x640.$x587
=072  \\$aD23.$x767.$x727.$x640.$x587
=150  \\$aHeme
=450  \\$aFerroprotoporphyrin
=450  \\$wnnna$aHaem
=450  \\$wnnna$aHeme b
=450  \\$aProtoheme
=450  \\$wnnna$aProtoheme IX
=550  \\$wg$aMetalloporphyrins
=550  \\$wh$aHemin
=680  \\$iThe color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.
=750  \0$aHeme$5IEN$0(DLC)sh 85060147

=LDR  00593cz  a2200217n  4500
=001  9880363669702441
=005  20141212202032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006417
=035  \\$aCAZ9588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x442
=072  \\$aC13.$x351.$x968.$x934.$x442
=072  \\$aC23.$x550.$x414.$x849
=150  \\$aHematuria
=450  \\$wnnna$aHematurias
=550  \\$wg$aHemorrhage
=550  \\$wg$aUrination Disorders
=550  \\$aUrine
=680  \\$iPresence of blood in the urine.
=750  \0$aHematuria$0(DLC) sh 85060143$5IEN

=LDR  00983cz  a2200253n  4500
=001  9880363669802441
=005  20141212202032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006415
=035  \\$aCAZ9586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500.$x462
=072  \\$aD3.$x549.$x909.$x500.$x462
=072  \\$aD4.$x345.$x783.$x500.$x462
=072  \\$aD23.$x767.$x727.$x462
=150  \\$aHematoporphyrins
=450  \\$wnnna$aHaematoporphyrin IX
=450  \\$wnnna$aHematoporphyrin
=450  \\$wnnna$aHemedonin
=550  \\$wg$aPorphyrins
=550  \\$wh$aHematoporphyrin Derivative
=680  \\$iIron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. Some of these PHOTOSENSITIZING AGENTS are used in the PHOTOTHERAPY of malignant NEOPLASMS.
=688  \\$a80; was HEMATOPORPHYRIN 1965-79 (Prov 1965-73)
=750  \0$aHematoporphyrin$5IEN$0(DLC)sh 85060142

=LDR  00616cz  a2200205n  4500
=001  9880363669902441
=005  20141212202031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006413
=035  \\$aCAZ9584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x378
=150  \\$aHematopoietic System
=450  \\$wnnna$aHematopoietic Systems
=450  \\$wnnna$aSystem, Hematopoietic
=450  \\$wnnna$aSystems, Hematopoietic
=550  \\$wg$aHemic and Immune Systems
=550  \\$wh$aBone Marrow Cells
=667  \\$a/physiol: consider also HEMATOPOIESIS
=750  \0$aHematopoietic system$5IEN$0(DLC)sh 85060140

=LDR  01779cz  a2200481n  4500
=001  9880363670002441
=005  20181008113109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006412
=035  \\$aCAZ9583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x148.$x378
=072  \\$aA11.$x872.$x378
=072  \\$aA15.$x378.$x316.$x378
=150  \\$aHematopoietic Stem Cells
=450  \\$wnnna$aCell, Hematopoietic Progenitor
=450  \\$wnnna$aCell, Hematopoietic Stem
=450  \\$wnnna$aCells, Hematopoietic Progenitor
=450  \\$wnnna$aCells, Hematopoietic Stem
=450  \\$wnnna$aColony-Forming Unit, Hematopoietic
=450  \\$aColony-Forming Units, Hematopoietic
=450  \\$wnnna$aColony Forming Units, Hematopoietic
=450  \\$wnnna$aHematopoietic Colony-Forming Unit
=450  \\$wnnna$aHematopoietic Colony-Forming Units
=450  \\$wnnna$aHematopoietic Progenitor Cell
=450  \\$wnnna$aHematopoietic Progenitor Cells
=450  \\$wnnna$aHematopoietic Stem Cell
=450  \\$wnnna$aProgenitor Cell, Hematopoietic
=450  \\$aProgenitor Cells, Hematopoietic
=450  \\$wnnna$aStem Cell, Hematopoietic
=450  \\$aStem Cells, Hematopoietic
=450  \\$wnnna$aUnit, Hematopoietic Colony-Forming
=450  \\$wnnna$aUnits, Hematopoietic Colony-Forming
=550  \\$wg$aBone Marrow Cells
=550  \\$wg$aStem Cells
=550  \\$wh$aHemangioblasts
=550  \\$wh$aLymphoid Progenitor Cells
=550  \\$wh$aMyeloid Progenitor Cells
=550  \\$wh$aPeripheral Blood Stem Cells
=667  \\$aA 11 qualif; /transpl = HEMATOPOIETIC STEM CELL TRANSPLANTATION
=680  \\$iProgenitor cells from which all blood cells derive.
=688  \\$a72(71)
=750  \0$aHematopoietic stem cells$0(DLC) sh 85060138$5IEN

=LDR  00980cz  a2200277n  4500
=001  9880363670102441
=005  20170609114843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x152.$x825
=072  \\$aG9.$x188.$x343
=150  \\$aHematopoiesis
=450  \\$wnnna$aHaematopoiesis
=450  \\$aHematopoiesis, Medullary
=450  \\$wnnna$aMedullary Hematopoiesis
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aCell Differentiation
=550  \\$wh$aErythropoiesis
=550  \\$wh$aHematopoiesis, Extramedullary
=550  \\$wh$aLeukopoiesis
=550  \\$wh$aThrombopoiesis
=550  \\$aBlood
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iThe development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).
=750  \0$aHematopoiesis$5IEN$0(DLC)sh 85060136

=LDR  02029cz  a2200457n  4500
=001  9880363670202441
=005  20141212202029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006408
=035  \\$aCAZ9579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x535.$x450.$x400
=072  \\$aC10.$x900.$x300.$x837.$x600
=072  \\$aC14.$x907.$x253.$x573.$x400.$x450
=072  \\$aC23.$x550.$x414.$x838.$x700
=072  \\$aC23.$x550.$x414.$x913.$x700
=072  \\$aC26.$x260.$x616.$x600
=072  \\$aC26.$x915.$x300.$x490.$x450
=150  \\$aHematoma, Subdural
=450  \\$wnnna$aHematoma, Traumatic Subdural
=450  \\$wnnna$aHematomas, Subdural
=450  \\$wnnna$aHematomas, Traumatic Subdural
=450  \\$aHemorrhage, Subdural
=450  \\$wnnna$aHemorrhages, Subdural
=450  \\$aSubdural Hematoma
=450  \\$wnnna$aSubdural Hematoma, Traumatic
=450  \\$wnnna$aSubdural Hematomas
=450  \\$wnnna$aSubdural Hematomas, Traumatic
=450  \\$wnnna$aSubdural Hemorrhage
=450  \\$wnnna$aSubdural Hemorrhages
=450  \\$wnnna$aTraumatic Subdural Hematoma
=450  \\$wnnna$aTraumatic Subdural Hematomas
=550  \\$wg$aHematoma
=550  \\$wg$aIntracranial Hemorrhage, Traumatic
=550  \\$wg$aIntracranial Hemorrhages
=550  \\$wh$aHematoma, Subdural, Acute
=550  \\$wh$aHematoma, Subdural, Chronic
=550  \\$wh$aHematoma, Subdural, Intracranial
=550  \\$wh$aHematoma, Subdural, Spinal
=680  \\$iAccumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
=750  \0$aSubdural hematoma$5IEN$0(DLC)sh 85129418

=LDR  02835cz  a2200649n  4500
=001  9880363670302441
=005  20141212202029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006407
=035  \\$aCAZ9578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x535.$x450.$x300
=072  \\$aC10.$x900.$x300.$x837.$x300
=072  \\$aC14.$x907.$x253.$x573.$x400.$x400
=072  \\$aC23.$x550.$x414.$x838.$x349
=072  \\$aC23.$x550.$x414.$x913.$x400
=072  \\$aC26.$x260.$x616.$x300
=072  \\$aC26.$x915.$x300.$x490.$x400
=150  \\$aHematoma, Epidural, Cranial
=450  \\$aCranial Epidural Hematoma
=450  \\$wnnna$aCranial Epidural Hematomas
=450  \\$wnnna$aCranial Epidural Hemorrhage
=450  \\$wnnna$aCranial Epidural Hemorrhages
=450  \\$wnnna$aCranial Extradural Hematoma
=450  \\$wnnna$aCranial Extradural Hematomas
=450  \\$wnnna$aCranial Extradural Hemorrhage
=450  \\$wnnna$aCranial Extradural Hemorrhages
=450  \\$wnnna$aEpidural Hematoma, Cranial
=450  \\$wnnna$aEpidural Hematoma, Intracranial
=450  \\$wnnna$aEpidural Hematomas, Cranial
=450  \\$wnnna$aEpidural Hematomas, Intracranial
=450  \\$wnnna$aEpidural Hemorrhage, Cranial
=450  \\$wnnna$aEpidural Hemorrhages, Cranial
=450  \\$wnnna$aExtradural Hematoma, Cranial
=450  \\$wnnna$aExtradural Hematomas, Cranial
=450  \\$wnnna$aExtradural Hemorrhage, Cranial
=450  \\$wnnna$aExtradural Hemorrhages, Cranial
=450  \\$wnnna$aHematoma, Cranial Epidural
=450  \\$wnnna$aHematoma, Cranial Extradural
=450  \\$wnnoa$aHematoma, Epidural$5IEN-HS
=450  \\$wnnna$aHematoma, Epidural, Intracranial
=450  \\$wnnna$aHematoma, Intracranial Epidural
=450  \\$wnnna$aHematomas, Cranial Epidural
=450  \\$wnnna$aHematomas, Cranial Extradural
=450  \\$wnnna$aHematomas, Intracranial Epidural
=450  \\$aHemorrhage, Cranial Epidural
=450  \\$wnnna$aHemorrhage, Cranial Extradural
=450  \\$wnnna$aHemorrhages, Cranial Epidural
=450  \\$wnnna$aHemorrhages, Cranial Extradural
=450  \\$wnnna$aIntracranial Epidural Hematoma
=450  \\$wnnna$aIntracranial Epidural Hematomas
=550  \\$wg$aHematoma
=550  \\$wg$aIntracranial Hemorrhage, Traumatic
=550  \\$wg$aIntracranial Hemorrhages
=680  \\$iAccumulation of blood in the EPIDURAL SPACE between the SKULL and the DURA MATER, often as a result of bleeding from the MENINGEAL ARTERIES associated with a temporal or parietal bone fracture. Epidural hematoma tends to expand rapidly, compressing the dura and underlying brain. Clinical features may include HEADACHE; VOMITING; HEMIPARESIS; and impaired mental function.
=688  \\$a2005 (1966)
=750  \0$aEpidural hematoma$0(DLC) sh 88003079$5IEN

=LDR  00743cz  a2200217n  4500
=001  9880363670402441
=005  20141212202028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006406
=035  \\$aCAZ9577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x414.$x838
=150  \\$aHematoma
=450  \\$wnnna$aHematomas
=550  \\$wg$aHemorrhage
=550  \\$wh$aHematoma, Epidural, Cranial
=550  \\$wh$aHematoma, Epidural, Spinal
=550  \\$wh$aHematoma, Subdural
=667  \\$anot a neoplasm: coordinate with organ/disease or organ/hemorrhage term (IM)
=680  \\$iA collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.
=750  \0$aHematoma$5IEN$0(DLC)sh 85060135

=LDR  00749cz  a2200205n  4500
=001  9880363670502441
=005  20141212202028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006405
=035  \\$aCAZ9576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x445
=150  \\$aHematology
=450  \\$aHematologists$5IEN
=550  \\$wg$aInternal Medicine
=550  \\$wh$aTransfusion Medicine
=667  \\$aSPEC: SPEC qualif; immunohematology is indexed under BLOOD GROUPS; DF: HEMATOL
=680  \\$iA subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.
=750  \0$aHematologists$5IEN-M$0(DLC)sh 85060129
=750  \0$aHematology$5IEN-HS$0(DLC)sh 85060130

=LDR  01676cz  a2200493n  4500
=001  9880363670602441
=005  20141212202027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006403
=035  \\$aCAZ9574HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625
=072  \\$aE5.$x200.$x625
=150  \\$aHematologic Tests
=450  \\$wnnna$aBlood Test
=450  \\$aBlood Tests
=450  \\$wnnna$aHematologic Test
=450  \\$wnnna$aHematological Test
=450  \\$wnnna$aHematological Tests
=450  \\$wnnna$aTest, Blood
=450  \\$wnnna$aTest, Hematologic
=450  \\$wnnna$aTest, Hematological
=450  \\$wnnna$aTests, Blood
=450  \\$wnnna$aTests, Hematologic
=450  \\$wnnna$aTests, Hematological
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wh$aBlood Cell Count
=550  \\$wh$aBlood Coagulation Tests
=550  \\$wh$aBlood Grouping and Crossmatching
=550  \\$wh$aBlood Sedimentation
=550  \\$wh$aBone Marrow Examination
=550  \\$wh$aErythrocyte Aggregation
=550  \\$wh$aErythrocyte Indices
=550  \\$wh$aFibrin Clot Lysis Time
=550  \\$wh$aFIGLU Test
=550  \\$wh$aHematocrit
=550  \\$wh$aHemoglobinometry
=550  \\$wh$aOsmotic Fragility
=550  \\$wh$aPlatelet Function Tests
=550  \\$wh$aSchilling Test
=667  \\$aGEN: prefer specifics; does not include BLOOD CHEMICAL ANALYSIS or SEROLOGIC TESTS; NIM; do not use /util except by MeSH definition; DF: HEMATOL TESTS
=680  \\$iTests used in the analysis of the hemic system.
=688  \\$a78; was NON MESH before 1978
=750  \0$aBlood$xExamination$5IEN$0(DLC)sh 85014941

=LDR  01778cz  a2200541n  4500
=001  9880363670702441
=005  20141212202027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006402
=035  \\$aCAZ9573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378
=150  \\$aHematologic Diseases
=450  \\$wnnna$aBlood Disease
=450  \\$aBlood Diseases
=450  \\$wnnna$aDisease, Blood
=450  \\$wnnna$aDisease, Hematologic
=450  \\$wnnna$aDisease, Hematological
=450  \\$wnnna$aDiseases, Blood
=450  \\$wnnna$aDiseases, Hematologic
=450  \\$wnnna$aDiseases, Hematological
=450  \\$wnnna$aHematologic Disease
=450  \\$wnnna$aHematological Disease
=450  \\$wnnna$aHematological Diseases
=550  \\$wg$aHemic and Lymphatic Diseases
=550  \\$wh$aAnemia
=550  \\$wh$aBlood Coagulation Disorders
=550  \\$wh$aBlood Platelet Disorders
=550  \\$wh$aBlood Protein Disorders
=550  \\$wh$aBone Marrow Diseases
=550  \\$wh$aErythroblastosis, Fetal
=550  \\$wh$aHematologic Neoplasms
=550  \\$wh$aHemoglobinopathies
=550  \\$wh$aHemorrhagic Disorders
=550  \\$wh$aLeukocyte Disorders
=550  \\$wh$aMethemoglobinemia
=550  \\$wh$aPancytopenia
=550  \\$wh$aPolycythemia
=550  \\$wh$aPregnancy Complications, Hematologic
=550  \\$wh$aPreleukemia
=550  \\$wh$aSulfhemoglobinemia
=550  \\$wh$aThrombophilia
=550  \\$wh$aTransfusion Reaction
=550  \\$aHematology
=667  \\$ageneral or unspecified: prefer specifics; DF: HEMATOL DIS
=680  \\$iDisorders of the blood and blood forming tissues.
=688  \\$a65; was BLOOD DISEASES see under HEMATOLOGY 1963-64
=750  \0$aBlood$xDiseases$5IEN$0(DLC)sh 85014939

=LDR  01056cz  a2200301n  4500
=001  9880363670802441
=005  20141212202026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006401
=035  \\$aCAZ9572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502
=150  \\$aHematologic Agents
=450  \\$wnnna$aAgents, Hematologic
=450  \\$wnnna$aAgents, Hematological
=450  \\$wnnna$aHematological Agents
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnticoagulants
=550  \\$wh$aAntisickling Agents
=550  \\$wh$aBlood Substitutes
=550  \\$wh$aCoagulants
=550  \\$wh$aFibrinolytic Agents
=550  \\$wh$aHematinics
=550  \\$wh$aPlatelet Aggregation Inhibitors
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals; consider also BLOOD COAGULATION /drug eff
=680  \\$iDrugs that act on blood and blood-forming organs and those that affect the hemostatic system.
=688  \\$a98; use explode 1967-97
=750  \0$aHematologic agents$5IEN-M$0(DLC)sh 88004457

=LDR  01499cz  a2200385n  4500
=001  9880363670902441
=005  20141212202026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006400
=035  \\$aCAZ9571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x400
=072  \\$aE5.$x200.$x625.$x400
=072  \\$aG9.$x188.$x370.$x374
=150  \\$aHematocrit
=450  \\$aErythrocyte Volume, Packed
=450  \\$wnnna$aErythrocyte Volumes, Packed
=450  \\$wnnna$aHematocrits
=450  \\$wnnna$aPacked Erythrocyte Volume
=450  \\$wnnna$aPacked Erythrocyte Volumes
=450  \\$aPacked Red-Cell Volume
=450  \\$wnnna$aPacked Red Cell Volume
=450  \\$wnnna$aPacked Red-Cell Volumes
=450  \\$wnnna$aRed-Cell Volume, Packed
=450  \\$wnnna$aRed-Cell Volumes, Packed
=450  \\$wnnna$aVolume, Packed Erythrocyte
=450  \\$wnnna$aVolume, Packed Red-Cell
=450  \\$wnnna$aVolumes, Packed Erythrocyte
=450  \\$wnnna$aVolumes, Packed Red-Cell
=550  \\$wg$aHematologic Tests
=550  \\$wg$aHemorheology
=550  \\$aErythrocyte Volume
=667  \\$ausually NIM
=680  \\$iThe volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.
=750  \0$aHematocrit$5IEN$0(DLC)sh 85060126

=LDR  01031cz  a2200289n  4500
=001  9880363671002441
=005  20141212202025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006398
=035  \\$aCAZ9569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x287
=072  \\$aC23.$x550.$x414.$x817
=150  \\$aHematocele
=450  \\$wnnna$aHematocele, Scrotal
=450  \\$wnnna$aHematocele, Testicular
=450  \\$wnnna$aHematoceles
=450  \\$wnnna$aHematoceles, Scrotal
=450  \\$wnnna$aHematoceles, Testicular
=450  \\$wnnna$aScrotal Hematocele
=450  \\$wnnna$aScrotal Hematoceles
=450  \\$wnnna$aTesticular Hematocele
=450  \\$wnnna$aTesticular Hematoceles
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aHemorrhage
=680  \\$iHemorrhage into a canal or cavity of the body, such as the space covered by the serous membrane (tunica vaginalis) around the TESTIS leading to testicular hematocele or scrotal hematocele.
=750  \0$aHematocele$5IEN$0(DLC)sh 85060124

=LDR  00676cz  a2200193n  4500
=001  9880363671102441
=005  20141212202025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006397
=035  \\$aCAZ9568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x543
=150  \\$aHematinics
=450  \\$wnnna$aErythropoiesis Stimulating Agents
=450  \\$aHematopoietic Agents
=550  \\$wg$aHematologic Agents
=680  \\$iAgents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.
=688  \\$a75
=750  \0$aHematopoietic agents$5IEN$0(DLC)sh 85060137

=LDR  00712cz  a2200205n  4500
=001  9880363671202441
=005  20141212202025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006396
=035  \\$aCAZ9567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x227.$x400
=072  \\$aC23.$x550.$x414.$x788.$x400
=072  \\$aC23.$x888.$x821.$x937.$x19
=150  \\$aHematemesis
=450  \\$wnnna$aHematemeses
=550  \\$wg$aGastrointestinal Hemorrhage
=550  \\$wg$aVomiting
=680  \\$iVomiting of blood that is either fresh bright red, or older "coffee-ground" in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.
=750  \0$aHematemesis$5IEN$0(DLC)sh 85060121

=LDR  00639cz  a2200217n  4500
=001  9880363671302441
=005  20141212202024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006395
=035  \\$aCAZ9566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x459
=072  \\$aC23.$x550.$x414.$x794
=150  \\$aHemarthrosis
=450  \\$wnnna$aHemarthroses
=550  \\$wg$aHemorrhage
=550  \\$wg$aJoint Diseases
=550  \\$aHemophilia A
=680  \\$iBleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.
=688  \\$a67(64)
=750  \0$aHemarthrosis$5IEN$0(DLC)sh 85060120

=LDR  01152cz  a2200277n  4500
=001  9880364317402441
=005  20141212214840.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031248
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x200.$x699
=150  \\$aSalsola
=450  \\$wnnna$aRussian Thistle
=450  \\$wnnna$aRussian Thistles
=450  \\$wnnna$aSalsolas
=450  \\$aSaltwort
=450  \\$wnnna$aSaltworts
=450  \\$aThistle, Russian
=450  \\$wnnna$aThistles, Russian
=450  \\$aTumbleweed
=450  \\$wnnna$aTumbleweeds
=550  \\$wg$aChenopodiaceae
=667  \\$aother 'thistle' plants are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CHENOPODIACEAE. The extract may be called lochein. Tumbleweed may occasionally refer to AMARANTHUS.
=688  \\$a2003
=750  \0$aSalsola$5IEN-M$0(DLC)sh 88023080

=LDR  00806cz  a2200169n  4500
=001  9880364317502441
=005  20200422115142.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031247
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x500.$x750.$x199
=150  \\$aCelastrus
=550  \\$wg$aCelastraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CELASTRACEAE that contains insecticidal sesquiterpenoids and celastrus oil.
=688  \\$a2003
=750  \0$aCelastrus$5IEN-M$0(DLC)sh 88022659

=LDR  00777cz  a2200181n  4500
=001  9880364317602441
=005  20141212214918.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x406
=150  \\$aHosta
=450  \\$wnnna$aHostas
=550  \\$wg$aLiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE. Members contain steroidal saponins.
=688  \\$a2003
=750  \0$aHosta$5IEN-M$0(DLC)sh 85062422

=LDR  00809cz  a2200181n  4500
=001  9880364317702441
=005  20141212214839.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031244
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x416
=150  \\$aLychnis
=450  \\$wnnna$aLychni
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE. The common name "Campion" is also used with SILENE.
=688  \\$a2003
=750  \0$aLychnis$5IEN-M$0(DLC)sh 93000033

=LDR  01090cz  a2200205n  4500
=001  9880364317802441
=005  20141212214839.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031243
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x77
=150  \\$aArenaria Plant
=450  \\$wnnna$aArenaria Plants
=450  \\$wnnna$aPlant, Arenaria
=450  \\$wnnna$aPlants, Arenaria
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE. The common name of sandwort is used with other plants. Do not confuse with Arenaria bird or with other genera which use arenaria as the species name such as Mya arenaria (softshell clam) or Meloidogyne arenaria, or Ammophila arenaria (marram grass).
=688  \\$a2003
=750  \0$aArenaria (Plant)$5IEN-M

=LDR  00831cz  a2200205n  4500
=001  9880364317902441
=005  20141212214917.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x387
=150  \\$aHemerocallis
=450  \\$wnnna$aDaylilies
=450  \\$aDaylily
=450  \\$wnnna$aHemerocalli
=550  \\$wg$aLiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE. Members contain steroidal saponins.
=688  \\$a2003
=750  \2$aDaylilies$5IEN-M

=LDR  00889cz  a2200205n  4500
=001  9880364318002441
=005  20141212214838.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x55
=150  \\$aAgrostemma
=450  \\$wnnna$aAgrostemmas
=450  \\$aCorncockle
=450  \\$wnnna$aCorncockles
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE that contains ALLANTOIN and a ribosome-inactivating protein.
=688  \\$a2003
=750  \0$aAgrostemma$0(DLC)sh2006000195$5IEN-M

=LDR  00809cz  a2200181n  4500
=001  9880364318102441
=005  20141212214838.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x192
=150  \\$aCaricaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCarica
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aCaricaceae$5IEN-M$0(DLC)sh 88022647

=LDR  00921cz  a2200205n  4500
=001  9880364318202441
=005  20141212214917.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x313
=150  \\$aFritillaria
=450  \\$wnnna$aFritillarias
=450  \\$wnnna$aFritillaries
=450  \\$aFritillary
=550  \\$wg$aLiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE. Members of this genus produce imperialine, a steroidal alkaloid which acts at muscarinic receptors.
=688  \\$a2003
=750  \0$aFritillaria$5IEN-M$0(DLC)sh 88000929

=LDR  00873cz  a2200193n  4500
=001  9880364318302441
=005  20141212214838.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031240
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x180.$x625
=150  \\$aSymphoricarpos
=450  \\$wnnna$aSymphoricarpo
=450  \\$wnnna$aSymphoricarpus
=550  \\$wg$aCaprifoliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CAPRIFOLIACEAE. The common name of "snowberry" is also used for GAULTHERIA.
=688  \\$a2003
=750  \0$aSymphoricarpos$5IEN-M$0(DLC)sh 85123795

=LDR  00863cz  a2200205n  4500
=001  9880364318402441
=005  20141212214837.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031239
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x180.$x388
=150  \\$aLonicera
=450  \\$aHoneysuckle
=450  \\$wnnna$aHoneysuckles
=450  \\$wnnna$aLoniceras
=550  \\$wg$aCaprifoliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CAPRIFOLIACEAE. Members contain iridoid glucosides.
=688  \\$a2003
=750  \0$aHoneysuckles$5IEN-M$0(DLC)sh 85061867

=LDR  00849cz  a2200181n  4500
=001  9880364318502441
=005  20170524130140.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031409
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x250
=150  \\$aDracaena
=450  \\$wnnna$aDracaenas
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE. The common name of "dragon's blood" is also used for CROTON and Daemonorops (ARECACEAE).
=688  \\$a2003
=750  \0$aDracaena$5IEN-M$0(DLC)sh 85039256

=LDR  00768cz  a2200169n  4500
=001  9880364318602441
=005  20141212214837.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031237
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x169
=150  \\$aCalycanthaceae
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aCalycanthaceae$5IEN-M$0(DLC)sh 88022629

=LDR  00517cz  a2200169n  4500
=001  9880364318702441
=005  20180212095101.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x50.$x178
=150  \\$aCrinum
=450  \\$wnnna$aCrinums
=550  \\$wg$aAmaryllidaceae
=680  \\$iA plant genus of the family Amaryllidaceae that contains ALKALOIDS.
=688  \\$a2003
=750  \0$aCrinum$5IEN-M$0(DLC)sh 88022717

=LDR  00804cz  a2200193n  4500
=001  9880364318802441
=005  20141212214836.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031235
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x165.$x500
=150  \\$aBuxus
=450  \\$aBoxwood
=450  \\$wnnna$aBoxwoods
=550  \\$wg$aBuxaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BUXACEAE. Members contain steroidal alkaloids.
=688  \\$a2003
=750  \0$aBoxwood$5IEN-M$0(DLC)sh 85016174

=LDR  00811cz  a2200181n  4500
=001  9880364318902441
=005  20170524130354.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031406
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x195
=150  \\$aCordyline
=450  \\$wnnna$aCordylines
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE that contains spirostanol & furostanol SAPONINS.
=688  \\$a2003
=750  \0$aCordyline$5IEN-M$0(DLC)sh 95010052

=LDR  01019cz  a2200217n  4500
=001  9880364319002441
=005  20141212214836.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031234
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x165
=150  \\$aBuxaceae
=450  \\$aSarcococca
=450  \\$wnnna$aSarcococcas
=550  \\$wg$aAngiosperms
=550  \\$wh$aBuxus
=550  \\$wh$aPachysandra
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Euphorbiales, subclass Rosidae, class Magnoliopsida. Leaves are alternate, simple, and leathery. Fruits are one- or two-seeded capsules or drupes (stony-pitted fleshy fruits).
=688  \\$a2003
=750  \0$aBuxaceae$5IEN-M$0(DLC)sh 85018408

=LDR  01080cz  a2200277n  4500
=001  9880364319102441
=005  20141212214835.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031233
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x162.$x138
=150  \\$aBursera
=450  \\$wnnna$aBursera simaruba
=450  \\$wnnna$aBursera simarubas
=450  \\$wnnna$aBurseras
=450  \\$aGumbo Limbo
=450  \\$wnnna$aGumbo Limbos
=450  \\$wnnna$aLimbo, Gumbo
=450  \\$wnnna$aLimbos, Gumbo
=450  \\$wnnna$asimaruba, Bursera
=450  \\$wnnna$asimarubas, Bursera
=550  \\$wg$aBurseraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BURSERACEAE. Members contain a PODOPHYLLOTOXIN.
=688  \\$a2003
=750  \0$aBursera$5IEN-M$0(DLC)sh 92006393

=LDR  00808cz  a2200181n  4500
=001  9880364319202441
=005  20141212214835.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031232
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x159.$x622
=150  \\$aTillandsia
=450  \\$wnnna$aTillandsias
=550  \\$wg$aBromeliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BROMELIACEAE. Members contain 3-methoxy-5-hydroxyflavonols.
=688  \\$a2003
=750  \0$aTillandsia$5IEN-M$0(DLC)sh 87000834

=LDR  01088cz  a2200265n  4500
=001  9880364319302441
=005  20170524130644.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031405
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x188
=150  \\$aConvallaria
=450  \\$wnnna$aConvallaria majali
=450  \\$wnnna$aConvallaria majalis
=450  \\$wnnna$aConvallarias
=450  \\$aLily-of-the-Valley
=450  \\$wnnna$aLily of the Valley
=450  \\$wnnna$aLily-of-the-Valleys
=450  \\$wnnna$amajali, Convallaria
=450  \\$wnnna$amajalis, Convallaria
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE that contains CARDIAC GLYCOSIDES.
=688  \\$a2003
=750  \0$aConvallaria$5IEN-M$0(DLC)sh 85031676

=LDR  00829cz  a2200181n  4500
=001  9880364319402441
=005  20141212214835.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031231
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x159.$x244
=150  \\$aBromelia
=450  \\$wnnna$aBromelias
=550  \\$wg$aBromeliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BROMELIACEAE. Members contain karatasin and balansain (ENDOPEPTIDASES) and BROMELAINS.
=688  \\$a2003
=750  \0$aBromelia$5IEN-M$0(DLC)sh 88022609

=LDR  00891cz  a2200205n  4500
=001  9880364319502441
=005  20170524130557.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031404
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x125
=150  \\$aCamassia
=450  \\$wnnna$aCama
=450  \\$aCamas
=450  \\$wnnna$aCamassias
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE that contains steroidal SAPONINS and should not be confused with Death Camas (ZIGADENUS).
=688  \\$a2003
=750  \0$aCamases$0sh2013000137$5IEN

=LDR  00866cz  a2200205n  4500
=001  9880364319602441
=005  20141212214834.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031230
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x159.$x99
=150  \\$aAnanas
=450  \\$wnnna$aAnana
=450  \\$aPineapple
=450  \\$wnnna$aPineapples
=550  \\$wg$aBromeliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BROMELIACEAE known for the edible fruit that is the source of BROMELAINS.
=688  \\$a2003
=750  \0$aAnanas$5IEN-M$0(DLC)sh 88022547

=LDR  00866cz  a2200205n  4500
=001  9880364319702441
=005  20141212214834.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031229
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x159
=150  \\$aBromeliaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aAnanas
=550  \\$wh$aBromelia
=550  \\$wh$aTillandsia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Bromeliales, subclass Zingiberidae, class Liliopsida (monocotyledons).
=688  \\$a2003
=750  \0$aBromeliaceae$5IEN-M$0(DLC)sh 85017046

=LDR  01371cz  a2200325n  4500
=001  9880364319802441
=005  20170524141322.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031384
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99..$x60.$x650
=150  \\$aPolygonatum
=450  \\$wnnna$aFalse Smilacina
=450  \\$wnnna$aFalse Smilacinas
=450  \\$wnnna$aPolygonatums
=450  \\$wnnna$aSeal, Solomon
=450  \\$wnnna$aSeal, Solomon's
=450  \\$wnnna$aSeals, Solomon's
=450  \\$wnnna$aSmilacina, False
=450  \\$wnnna$aSmilacinas, False
=450  \\$aSolomon Seal
=450  \\$wnnna$aSolomon's Seal
=450  \\$wnnna$aSolomon's-seal
=450  \\$wnnna$aSolomons Seal
=450  \\$wnnna$aSolomon's Seals
=550  \\$wg$aAsparagaceae
=667  \\$anote X refs: SOLOMON SEAL, FALSE see SMILACINA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE. Members contain benzoquinones, steroidal saponin, and ribosome-inactivating proteins.
=688  \\$a2003
=750  \0$aSolomon's seal$5IEN-M$0(DLC)sh 85124715

=LDR  01108cz  a2200229n  4500
=001  9880364319902441
=005  20141212214833.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x905
=150  \\$aThlaspi
=450  \\$wnnna$aarvense, Thlaspi
=450  \\$wnnna$aarvenses, Thlaspi
=450  \\$wnnna$aThlaspi arvense
=450  \\$wnnna$aThlaspi arvenses
=450  \\$wnnna$aThlaspus
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE that is grown in rock gardens. T. arvense is grown for its large, round ornamental seed pods. The common name of pennycress usually refers to this genus but may also refer to the genus Microthlaspi.
=688  \\$a2003
=750  \0$aThlaspi$0(DLC) sh 88023155$5IEN-M

=LDR  01161cz  a2200289n  4500
=001  9880364320002441
=005  20141212214914.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031383
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x600.$x133
=150  \\$aBertholletia
=450  \\$wnnna$aBertholletia excelsa
=450  \\$wnnna$aBertholletia excelsas
=450  \\$wnnna$aBertholletias
=450  \\$aBrazil Nut Tree
=450  \\$aBrazil Nuts
=450  \\$wnnna$aexcelsa, Bertholletia
=450  \\$wnnna$aexcelsas, Bertholletia
=450  \\$wnnna$aNut Tree, Brazil
=450  \\$wnnna$aNuts, Brazil
=450  \\$wnnna$aTree, Brazil Nut
=550  \\$wg$aLecythidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Lecythidaceae which is the source of edible Brazil nuts.
=688  \\$a2003
=750  \0$aBertholletia$5IEN-M$0(DLC)sh 88022596

=LDR  01065cz  a2200229n  4500
=001  9880364320102441
=005  20141212214832.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031225
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x744
=150  \\$aRorippa
=450  \\$aCress, Yellow
=450  \\$wnnna$aCresses, Yellow
=450  \\$wnnna$aRorippas
=450  \\$wnnna$aYellow Cress
=450  \\$wnnna$aYellow Cresses
=550  \\$wg$aBrassicaceae
=667  \\$aRORIPPA NASTURTIUM-AQUATICUM see NASTURTIUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE that includes several marshy plants. The common name of watercress is also used for NASTURTIUM & TROPAEOLUM.
=688  \\$a2003
=750  \0$aRorippa$0(DLC) sh 88023075$5IEN-M

=LDR  00843cz  a2200193n  4500
=001  9880364320202441
=005  20190702124657.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341.$x968
=150  \\$aLecythidaceae
=550  \\$wg$aEricales
=550  \\$wh$aBarringtonia
=550  \\$wh$aBertholletia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Lecythidales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aLecythidaceae$5IEN-M$0(DLC)sh 87002334

=LDR  00808cz  a2200193n  4500
=001  9880364320302441
=005  20141212214832.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031224
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x711
=150  \\$aRaphanus
=450  \\$aRadish
=450  \\$wnnna$aRadishs
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE known for its peppery red root.
=688  \\$a2003
=750  \0$aRadishes$5IEN-M$0(DLC)sh 85110802

=LDR  00895cz  a2200205n  4500
=001  9880364320402441
=005  20141212214912.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x948
=150  \\$aTeucrium
=450  \\$aGermander
=450  \\$wnnna$aGermanders
=450  \\$wnnna$aTeucriums
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE. Members contain teuscordonin. There have been reports of hepatoxicity by this genus.
=688  \\$a2003
=750  \0$aGermander$5IEN-M$0(DLC)sh 85054433

=LDR  01040cz  a2200277n  4500
=001  9880364320502441
=005  20141212214912.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031366
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x947
=150  \\$aStachys
=450  \\$wnnna$aBetonica
=450  \\$wnnna$aBetonicas
=450  \\$wnnna$aHedge Nettle
=450  \\$wnnna$aHedge Nettles
=450  \\$aHedgenettle
=450  \\$wnnna$aHedgenettles
=450  \\$aNettle, Hedge
=450  \\$wnnna$aNettles, Hedge
=450  \\$wnnna$aStachy
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that has a characteristic odor.
=688  \\$a2003
=750  \0$aStachys$5IEN-M$0(DLC)sh 85127202

=LDR  01546cz  a2200289n  4500
=001  9880364320602441
=005  20141212214832.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x644
=150  \\$aNasturtium
=450  \\$wnnna$anasturtium-aquaticum, Rorippa
=450  \\$wnnna$anasturtium-aquaticums, Rorippa
=450  \\$wnnna$aNasturtium officinale
=450  \\$wnnna$aNasturtium officinales
=450  \\$wnnna$aNasturtiums
=450  \\$wnnna$aofficinale, Nasturtium
=450  \\$wnnna$aofficinales, Nasturtium
=450  \\$wnnna$aRorippa nasturtium-aquaticum
=450  \\$wnnna$aRorippa nasturtium aquaticum
=450  \\$wnnna$aRorippa nasturtium-aquaticums
=550  \\$wg$aBrassicaceae
=667  \\$aNASTURTIUM, GARDEN see TROPAEOLUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE. Nasturtium is also used as a common name for TROPAEOLUM. The common name of watercress is also used for RORIPPA & TROPAEOLUM. This is the most popular of the edible cresses, is a hardy creeping perennial plant, native to Europe but extensively naturalized elsewhere in moist places.
=688  \\$a2003
=750  \0$aNasturtium (Genus)$0(DLC) sh 85089910$5IEN-M

=LDR  00755cz  a2200229n  4500
=001  9880364320702441
=005  20141212214831.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x289.$x625
=072  \\$aC26.$x558.$x554.$x750
=150  \\$aPatellar Dislocation
=450  \\$wnnna$aDislocation, Patellar
=450  \\$wnnna$aDislocations, Patellar
=450  \\$wnnna$aPatellar Dislocations
=550  \\$wg$aDislocations
=550  \\$wg$aKnee Injuries
=667  \\$ado not confuse with KNEE DISLOCATION, which is slippage of the femur off the tibia
=680  \\$iDisplacement of the PATELLA from the femoral groove.
=688  \\$a2003
=750  \0$aPatella$xDislocation$5IEN-M$0(DLC)sh 85098638

=LDR  00733cz  a2200229n  4500
=001  9880364320802441
=005  20141212214831.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x289.$x500
=072  \\$aC26.$x558.$x554.$x500
=150  \\$aKnee Dislocation
=450  \\$wnnna$aDislocation, Knee
=450  \\$wnnna$aDislocations, Knee
=450  \\$wnnna$aKnee Dislocations
=550  \\$wg$aDislocations
=550  \\$wg$aKnee Injuries
=667  \\$ado not confuse with PATELLAR DISLOCATION, which is displacement of the patella (knee cap) from the femoral groove
=680  \\$iSlippage of the FEMUR off the TIBIA.
=688  \\$a2003
=750  \0$aKnee$xDislocation$5IEN-M

=LDR  00890cz  a2200205n  4500
=001  9880364320902441
=005  20141212214830.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031219
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x438
=150  \\$aIsatis
=450  \\$wnnna$aIsati
=450  \\$aWoad
=450  \\$wnnna$aWoads
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE that is an ingredient of the preparation PC-SPES that is used to treat PROSTATIC HYPERPLASIA.
=688  \\$a2003
=750  \0$aIsatis$5IEN-M$0(DLC)sh 85068334

=LDR  01121cz  a2200265n  4500
=001  9880364321002441
=005  20141212214830.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031218
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x277
=150  \\$aCrambe Plant
=450  \\$wnnna$aabyssinica, Crambe
=450  \\$wnnna$aabyssinicas, Crambe
=450  \\$wnnoa$aCrambe$5IEN-HS
=450  \\$wnnna$aCrambe abyssinica
=450  \\$wnnna$aCrambe abyssinicas
=450  \\$wnnna$aCrambe Plants
=450  \\$wnnna$aPlant, Crambe
=450  \\$wnnna$aPlants, Crambe
=550  \\$wg$aBrassicaceae
=667  \\$ado not confuse with CRAMBE SPONGE, an invertebrate; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE. Members contain crambin.
=688  \\$a2005 (2003)
=750  \0$aCrambe$0(DLC) sh 88022710$5IEN-M

=LDR  01338cz  a2200325n  4500
=001  9880364321102441
=005  20141212214829.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031217
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x255
=150  \\$aCardamine
=450  \\$wnnna$aBitter Cress
=450  \\$wnnna$aBitter Cresses
=450  \\$wnnna$aCardamine pratenses
=450  \\$wnnna$aCardamine pratensis
=450  \\$wnnna$aCardamines
=450  \\$aCress, Bitter
=450  \\$aCress, Meadow
=450  \\$wnnna$aCresses, Bitter
=450  \\$wnnna$aCresses, Meadow
=450  \\$wnnna$aMeadow Cress
=450  \\$wnnna$aMeadow Cresses
=450  \\$wnnna$apratenses, Cardamine
=450  \\$wnnna$apratensis, Cardamine
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE that is low-growing in damp meadows of the Northern Hemisphere and has pinnately divided leaves and small white to rose flowers.
=688  \\$a2003
=750  \0$aCardamine$0(DLC) sh 88022643$5IEN-M

=LDR  01531cz  a2200421n  4500
=001  9880364321202441
=005  20141212214829.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031216
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x187
=150  \\$aBarbarea
=450  \\$wnnna$aBarbarea verna
=450  \\$wnnna$aBarbarea vernas
=450  \\$wnnna$aBarbarea vulgari
=450  \\$wnnna$aBarbarea vulgaris
=450  \\$wnnna$aBarbareas
=450  \\$wnnna$aCress, Upland
=450  \\$aCress, Winter
=450  \\$wnnna$aCresses, Upland
=450  \\$wnnna$aCresses, Winter
=450  \\$aRocket, Yellow
=450  \\$wnnna$aRockets, Yellow
=450  \\$wnnna$aUpland Cress
=450  \\$wnnna$aUpland Cresses
=450  \\$wnnna$averna, Barbarea
=450  \\$wnnna$avernas, Barbarea
=450  \\$wnnna$avulgari, Barbarea
=450  \\$wnnna$avulgaris, Barbarea
=450  \\$wnnna$aWinter Cress
=450  \\$wnnna$aWinter Cresses
=450  \\$wnnna$aYellow Rocket
=450  \\$wnnna$aYellow Rockets
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE. Members contain glucobrassicin.
=688  \\$a2003
=750  \0$aYellowrockets$5IEN$0(DLC)sh 00008442

=LDR  01115cz  a2200229n  4500
=001  9880364321302441
=005  20141212193023.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031215
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x175
=150  \\$aArmoracia
=450  \\$wnnna$aArmoracia lapathifolia
=450  \\$wnnna$aArmoracia rusticana
=450  \\$wnnna$aArmoracias
=450  \\$aHorseradish
=450  \\$wnnna$aHorseradishs
=550  \\$wg$aBrassicaceae
=667  \\$anote entry term HORSERADISH: HORSERADISH, JAPANESE see WASABIA is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family BRASSICACEAE known for the root used in hot SPICES. It is also the source of HORSERADISH PEROXIDASE which is widely used in laboratories.
=688  \\$a2003
=750  \0$aHorse-radish$5IEN-M$0(DLC)sh 85062124

=LDR  00985cz  a2200229n  4500
=001  9880364321402441
=005  20141212214828.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031214
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x150
=150  \\$aArabis
=450  \\$wnnna$aArabi
=450  \\$aCress, Rock
=450  \\$wnnna$aCresses, Rock
=450  \\$wnnna$aRock Cress
=450  \\$wnnna$aRock Cresses
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE. Member species are ornamentals grown for their numerous small white, yellow, pink, or purplish flowers.
=688  \\$a2003
=750  \0$aArabis$0(DLC) sh 88022563$5IEN-M

=LDR  00852cz  a2200205n  4500
=001  9880364321502441
=005  20141212214828.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031213
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x327
=150  \\$aCordia
=450  \\$wnnna$aCordias
=450  \\$aManjack
=450  \\$wnnna$aManjacks
=550  \\$wg$aBoraginaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BORAGINACEAE. Members contain TRITERPENES and naphthoxirene.
=688  \\$a2003
=750  \0$aCordia$5IEN-M$0(DLC)sh 88003093

=LDR  01039cz  a2200241n  4500
=001  9880364321602441
=005  20141212214828.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x146
=150  \\$aBixaceae
=450  \\$wnnna$aBixa
=450  \\$wnnna$aBixas
=450  \\$wnnna$aCochlospermum
=450  \\$wnnna$aCochlospermums
=450  \\$aKondagogu
=450  \\$wnnna$aKondagogus
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. Bixa contains bixin. Cochlospermum contains arjunolic acid and gum kondagogu (POLYSACCHARIDES).
=688  \\$a2003
=750  \0$aBixaceae$5IEN-M$0(DLC)sh 86006934

=LDR  00856cz  a2200217n  4500
=001  9880364321702441
=005  20141212214827.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031211
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x137.$x875
=150  \\$aCorylus
=450  \\$aFilbert
=450  \\$wnnna$aFilberts
=450  \\$aHazelnut
=450  \\$wnnna$aHazelnuts
=550  \\$wg$aBetulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BETULACEAE known for the edible nuts.
=688  \\$a2003
=750  \0$aCorylus$5IEN-M$0(DLC)sh 88002589

=LDR  01207cz  a2200301n  4500
=001  9880364321802441
=005  20141212214827.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031210
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x994
=150  \\$aXanthium
=450  \\$aCocklebur
=450  \\$aCocklebur, Spiny
=450  \\$wnnna$aCockleburs
=450  \\$wnnna$aCockleburs, Spiny
=450  \\$wnnna$aspinosum, Xanthium
=450  \\$wnnna$aspinosums, Xanthium
=450  \\$wnnna$aSpiny Cocklebur
=450  \\$wnnna$aSpiny Cockleburs
=450  \\$wnnna$aXanthium spinosum
=450  \\$wnnna$aXanthium spinosums
=450  \\$wnnna$aXanthiums
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The name "prickly burweed" is sometimes used but causes confusion with AMSINCKIA.
=688  \\$a2003
=750  \0$aXanthium$5IEN-M$0(DLC)sh 89003780

=LDR  01050cz  a2200253n  4500
=001  9880364321902441
=005  20141212214826.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031207
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x958
=150  \\$aTussilago
=450  \\$aColtsfoot
=450  \\$wnnna$aColtsfoots
=450  \\$wnnna$afarfara, Tussilago
=450  \\$wnnna$afarfaras, Tussilago
=450  \\$wnnna$aTussilago farfara
=450  \\$wnnna$aTussilago farfaras
=450  \\$wnnna$aTussilagos
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Flower buds contain farfaratin (SESQUITERPENES) and bisabolene epoxide.
=688  \\$a2003
=750  \0$aTussilago$5IEN-M$0(DLC)sh 85138984

=LDR  00966cz  a2200193n  4500
=001  9880364322002441
=005  20141212214825.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031206
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x358
=150  \\$aHaplopappus
=450  \\$aTansyaster
=450  \\$wnnna$aTansyasters
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Many of the member species have been reclassified to other genera such as Machaeranthera, Isocoma, Ericameria, etc. Ingestion of the plant has been associated with MILK SICKNESS.
=688  \\$a2003
=750  \0$aHaplopappus$5IEN-M$0(DLC)sh 85058797

=LDR  00913cz  a2200205n  4500
=001  9880364322102441
=005  20141212214825.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031205
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x895
=150  \\$aTaraxacum
=450  \\$aDandelion
=450  \\$wnnna$aDandelions
=450  \\$wnnna$aTaraxacums
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain chicoric and chlorogenic acids and germacrane- and eudesmane-type SESQUITERPENES.
=688  \\$a2003
=750  \0$aDandelions$5IEN-M$0(DLC)sh 85035696

=LDR  00990cz  a2200265n  4500
=001  9880364322202441
=005  20141212214825.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031204
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x200
=072  \\$aG7.$x610.$x240.$x340.$x150
=150  \\$aCaloric Restriction
=450  \\$wnnna$aDiet, Low-Calorie
=450  \\$wnnna$aDiets, Low-Calorie
=450  \\$wnnna$aLow-Calorie Diet
=450  \\$wnnna$aLow Calorie Diet
=450  \\$wnnna$aLow-Calorie Diets
=450  \\$wnnna$aRestriction, Caloric
=550  \\$wg$aDiet Therapy
=550  \\$wg$aEnergy Intake
=667  \\$acoordinate IM with specific disease / diet ther (IM) if pertinent
=680  \\$iReduction in caloric intake without reduction in adequate nutrition. In experimental animals, caloric restriction has been shown to extend lifespan and enhance other physiological variables.
=688  \\$a2003
=750  \0$aLow-calorie diet$5IEN-M$0(DLC)sh 85078625

=LDR  01387cz  a2200265n  4500
=001  9880364322302441
=005  20141212214824.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031203
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x874
=150  \\$aTanacetum
=450  \\$wnnna$aTanacetum vulgare
=450  \\$wnnna$aTanacetum vulgares
=450  \\$wnnna$aTanacetums
=450  \\$wnnna$aTansies
=450  \\$wnnna$aTansy
=450  \\$wnnna$avulgare, Tanacetum
=450  \\$wnnna$avulgares, Tanacetum
=550  \\$wg$aAsteraceae
=550  \\$wh$aTanacetum parthenium
=667  \\$aTANACETUM CINERARIIFOLIUM and TANACETUM COCCINEUM see CHRYSANTHEMUM CINERARIIFOLIUM are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Some species of the CHRYSANTHEMUM and the old Pyrethrum genera have been reclassified to this genus. The common name of tansy usually refers to this but also forms part of the common name of other plants such as Tansy Ragwort (SENECIO) and Tansyaster (HAPLOPAPPUS).
=688  \\$a2003
=750  \0$aTanacetum$5IEN-M$0(DLC)sh 85132235

=LDR  01054cz  a2200193n  4500
=001  9880364322402441
=005  20141212214824.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x206
=150  \\$aChrysanthemum
=450  \\$wnnna$aChrysanthemums
=550  \\$wg$aAsteraceae
=550  \\$wh$aChrysanthemum cinerariifolium
=667  \\$aCHRYSANTHEMUM PARTHENIUM see TANACETUM PARTHENIUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The common names of daisy or marguerite are easily confused with other plants. Some species in this genus have been reclassified to TANACETUM.
=688  \\$a2003; use PYRETHRUM 1977-2002
=750  \0$aChrysanthemums$5IEN-M$0(DLC)sh 85025424

=LDR  01569cz  a2200421n  4500
=001  9880364322502441
=005  20141212214823.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x916
=150  \\$aTragopogon
=450  \\$wnnna$aBeard, Goat's
=450  \\$wnnna$aBeards, Goat's
=450  \\$wnnna$aCommon Salsifies
=450  \\$wnnna$aCommon Salsify
=450  \\$wnnna$aGoat Beard
=450  \\$aGoat's Beard
=450  \\$wnnna$aGoats Beard
=450  \\$wnnna$aGoat's Beards
=450  \\$wnnna$aporrifolius, Tragopogon
=450  \\$wnnna$apratenses, Tragopogon
=450  \\$wnnna$apratensis, Tragopogon
=450  \\$wnnna$aSalsifies, Common
=450  \\$wnnna$aSalsifies, Yellow
=450  \\$aSalsify, Common
=450  \\$aSalsify, Yellow
=450  \\$wnnna$aTragopogon porrifolius
=450  \\$wnnna$aTragopogon pratenses
=450  \\$wnnna$aTragopogon pratensis
=450  \\$wnnna$aTragopogons
=450  \\$wnnna$aYellow Salsifies
=450  \\$wnnna$aYellow Salsify
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The root and shoots have been used for food.
=688  \\$a2003
=750  \0$aTragopogon$5IEN-M$0(DLC)sh 85136794

=LDR  00914cz  a2200205n  4500
=001  9880364322602441
=005  20141212214823.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031187
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x181.$x500
=150  \\$aCarthamus tinctorius
=450  \\$aSafflower
=450  \\$wnnna$aSafflowers
=450  \\$wnnna$atinctorius, Carthamus
=550  \\$wg$aCarthamus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Oil from the seed (SAFFLOWER OIL) is an important food oil of commerce.
=688  \\$a2003
=750  \0$aSafflower$0(DLC) sh 85116463$5IEN-M

=LDR  01065cz  a2200253n  4500
=001  9880364322702441
=005  20141212214822.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x775
=150  \\$aScorzonera
=450  \\$wnnna$aBlack Salsifies
=450  \\$wnnna$aBlack Salsify
=450  \\$wnnna$aSalsifies, Black
=450  \\$aSalsify, Black
=450  \\$wnnna$aScorsonera
=450  \\$wnnna$aScorsoneras
=450  \\$wnnna$aScorzoneras
=550  \\$wg$aAsteraceae
=667  \\$aCommon Salsify = TRAGOPOGON is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. INULIN and SESQUITERPENES have been found in it.
=688  \\$a2003
=750  \0$aScorzonera$5IEN-M$0(DLC)sh 85118796

=LDR  01378cz  a2200337n  4500
=001  9880364322802441
=005  20141212214822.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031184
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x833
=150  \\$aSonchus
=450  \\$wnnna$aarvenses, Sonchus
=450  \\$wnnna$aarvensis, Sonchus
=450  \\$wnnna$aField Milk Thistle
=450  \\$wnnna$aField Milk Thistles
=450  \\$wnnna$aMilk Thistle, Field
=450  \\$wnnna$aMilk Thistles, Field
=450  \\$wnnna$aSonchus arvenses
=450  \\$wnnna$aSonchus arvensis
=450  \\$wnnna$aSow Thistle
=450  \\$wnnna$aSow Thistles
=450  \\$aThistle, Field Milk
=450  \\$aThistle, Sow
=450  \\$wnnna$aThistles, Field Milk
=450  \\$wnnna$aThistles, Sow
=550  \\$wg$aAsteraceae
=667  \\$aother 'thistle' plants are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Sesquiterpene lactone glucosides (SESQUITERPENES) have been found in it.
=688  \\$a2003
=750  \0$aSow thistles$5IEN-M$0(DLC)sh 95009366

=LDR  00998cz  a2200229n  4500
=001  9880364322902441
=005  20141212214821.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031183
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x562
=150  \\$aOnopordum
=450  \\$wnnna$aCotton Thistle
=450  \\$wnnna$aCotton Thistles
=450  \\$wnnna$aOnopordums
=450  \\$aThistle, Cotton
=450  \\$wnnna$aThistles, Cotton
=550  \\$wg$aAsteraceae
=667  \\$aother 'thistle' plants are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain eudesmane and elemane SESQUITERPENES.
=688  \\$a2003
=750  \0$aOnopordum$5IEN-M$0(DLC)sh 98004423

=LDR  01511cz  a2200373n  4500
=001  9880364323102441
=005  20141212214819.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031179
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x188
=150  \\$aCentaurea
=450  \\$wnnna$aCentaureas
=450  \\$aCornflower
=450  \\$wnnna$aCornflowers
=450  \\$aKnapweed
=450  \\$wnnna$aKnapweeds
=450  \\$wnnna$aRed Star Thistle
=450  \\$wnnna$aRed Star Thistles
=450  \\$wnnna$aStar Thistle, Red
=450  \\$wnnna$aStar Thistle, Yellow
=450  \\$wnnna$aStar Thistles, Red
=450  \\$wnnna$aStar Thistles, Yellow
=450  \\$aThistle, Red Star
=450  \\$aThistle, Yellow Star
=450  \\$wnnna$aThistles, Red Star
=450  \\$wnnna$aThistles, Yellow Star
=450  \\$wnnna$aYellow Star Thistle
=450  \\$wnnna$aYellow Star Thistles
=550  \\$wg$aAsteraceae
=667  \\$aother 'thistle' plants are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain 5-methyl-8-hydroxycoumarin. The common name of centaury is more often used for CENTAURIUM
=688  \\$a2003
=750  \0$aCentaurea$0(DLC) sh 86001671$5IEN-M

=LDR  00951cz  a2200229n  4500
=001  9880364323202441
=005  20141212214819.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031178
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x181
=150  \\$aCarthamus
=450  \\$wnnna$aDistaff Thistle
=450  \\$wnnna$aDistaff Thistles
=450  \\$aThistle, Distaff
=450  \\$wnnna$aThistles, Distaff
=550  \\$wg$aAsteraceae
=550  \\$wh$aCarthamus tinctorius
=667  \\$aother 'thistle' plants are available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE.
=688  \\$a2003
=750  \0$aCarthamus$0(DLC) sh 85020505$5IEN-M

=LDR  01111cz  a2200265n  4500
=001  9880364323302441
=005  20141212214818.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031177
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x168
=150  \\$aCarduus
=450  \\$wnnna$aMusk Thistle
=450  \\$wnnna$aMusk Thistles
=450  \\$wnnna$aPlumeless Thistle
=450  \\$wnnna$aPlumeless Thistles
=450  \\$aThistle, Musk
=450  \\$aThistle, Plumeless
=450  \\$wnnna$aThistles, Musk
=450  \\$wnnna$aThistles, Plumeless
=550  \\$wg$aAsteraceae
=667  \\$aCARDUUS MARIANUS see MILK THISTLE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain arctiin and onopordopicrin.
=688  \\$a2003
=750  \0$aCarduus$5IEN-M$0(DLC)sh 85020250

=LDR  01013cz  a2200253n  4500
=001  9880364323402441
=005  20141212214818.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031176
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x137
=150  \\$aBidens
=450  \\$wnnna$aBeggartick
=450  \\$aBeggarticks
=450  \\$wnnna$aBiden
=450  \\$wnnna$aBidens pilosa
=450  \\$wnnna$aBidens pilosas
=450  \\$wnnna$apilosa, Bidens
=450  \\$wnnna$apilosas, Bidens
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain bidensyneosides (polyacetylene glucosides).
=688  \\$a2003
=750  \0$aBidens$5IEN-M$0(DLC)sh 85013919

=LDR  01183cz  a2200277n  4500
=001  9880364323502441
=005  20141212214817.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031175
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x133
=150  \\$aBaccharis
=450  \\$wnnna$aBacchari
=450  \\$aBroom, Desert
=450  \\$wnnna$aBrooms, Desert
=450  \\$wnnna$aDesert Broom
=450  \\$wnnna$aDesert Brooms
=450  \\$wnnna$aWater Willow
=450  \\$wnnna$aWater Willows
=450  \\$aWillow, Water
=450  \\$wnnna$aWillows, Water
=550  \\$wg$aAsteraceae
=667  \\$aX ref BROOM, DESERT: several other Broom terms are also available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Other plants called broom include CYTISUS; SPARTIUM; and BROMUS.
=688  \\$a2003
=750  \0$aBaccharis$0(DLC)sh2006004926$5IEN-M

=LDR  01094cz  a2200253n  4500
=001  9880364323602441
=005  20141212214817.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031174
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x126
=150  \\$aAtractylodes
=450  \\$wnnna$aAtractylode
=450  \\$wnnna$aAtractylodes lancea
=450  \\$wnnna$aAtractylodes lanceas
=450  \\$aJutsu
=450  \\$wnnna$aJutsus
=450  \\$wnnna$alancea, Atractylodes
=450  \\$wnnna$alanceas, Atractylodes
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.
=688  \\$a2003
=750  \0$aAtractylodes$5IEN-M$0(DLC)sh2001008013

=LDR  00964cz  a2200205n  4500
=001  9880364323702441
=005  20141212214817.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031173
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x111
=150  \\$aAster Plant
=450  \\$wnnna$aAster Plants
=450  \\$wnnna$aPlant, Aster
=450  \\$wnnna$aPlants, Aster
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. This plant should not be confused with microtubule asters (MICROTUBULES) nor with aster yellows phytoplasma (mycoplasma-like organisms).
=688  \\$a2003
=750  \0$aAsters$5IEN-M$0(DLC)sh 85008854

=LDR  01007cz  a2200205n  4500
=001  9880364323802441
=005  20141212214816.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031171
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x100.$x99
=150  \\$aArtemisia absinthium
=450  \\$wnnna$aabsinthium, Artemisia
=450  \\$wnnna$aabsinthiums, Artemisia
=450  \\$wnnna$aArtemisia absinthiums
=550  \\$wg$aArtemisia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus ARTEMISIA, family ASTERACEAE that has been used in ABSINTHE. The oil contains neurotoxic 1-thujone and d-isothujone.
=688  \\$a2003; use ARTEMISIA 1998-2002
=750  \0$aAbsinth wormwood$0(DLC)sh2009000322$5IEN

=LDR  01422cz  a2200409n  4500
=001  9880364323902441
=005  20141212193022.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x72
=150  \\$aArctium
=450  \\$wnnna$aArctium lappa
=450  \\$wnnna$aArctium minus
=450  \\$wnnna$aArctiums
=450  \\$wnnna$aBurdock
=450  \\$aBurdock, Greater
=450  \\$aBurdock, Lesser
=450  \\$aBurdock Plant
=450  \\$wnnna$aBurdock Plants
=450  \\$wnnna$aBurdocks
=450  \\$wnnna$aBurdocks, Greater
=450  \\$wnnna$aBurdocks, Lesser
=450  \\$aGobo
=450  \\$wnnna$aGobos
=450  \\$aGobou
=450  \\$wnnna$aGreater Burdock
=450  \\$wnnna$aGreater Burdocks
=450  \\$wnnna$aLesser Burdock
=450  \\$wnnna$aLesser Burdocks
=450  \\$wnnna$aPlant, Burdock
=450  \\$wnnna$aPlants, Burdock
=550  \\$wg$aAsteraceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family ASTERACEAE. Arctiin (LIGNANS) is in the seed.
=688  \\$a2003
=750  \0$aBurdocks$5IEN-M$0(DLC)sh 85018045

=LDR  02524cz  a2200517n  4500
=001  9880364324002441
=005  20141212214815.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031168
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x195.$x488
=150  \\$aMatricaria
=450  \\$aCamomile, German
=450  \\$aChamomile, German
=450  \\$wnnna$achamomilla, Matricaria
=450  \\$aChamomilla recutita
=450  \\$wnnna$aChamomilla recutitas
=450  \\$wnnna$achamomillas, Matricaria
=450  \\$wnnna$aCrown Mayweed
=450  \\$wnnna$aCrown Mayweeds
=450  \\$wnnna$aGerman Camomile
=450  \\$wnnna$aGerman Chamomile
=450  \\$aMatricaria chamomilla
=450  \\$wnnna$aMatricaria chamomillas
=450  \\$wnnna$aMatricaria matricarioide
=450  \\$wnnna$aMatricaria matricarioides
=450  \\$aMatricaria recutita
=450  \\$wnnna$aMatricaria recutitas
=450  \\$wnnna$aMatricarias
=450  \\$wnnna$amatricarioide, Matricaria
=450  \\$wnnna$amatricarioides, Matricaria
=450  \\$aMayweed, Crown
=450  \\$wnnna$aMayweeds, Crown
=450  \\$aPineapple Weed
=450  \\$wnnna$aPineapple Weeds
=450  \\$wnnna$arecutita, Chamomilla
=450  \\$wnnna$arecutita, Matricaria
=450  \\$wnnna$arecutitas, Chamomilla
=450  \\$wnnna$arecutitas, Matricaria
=450  \\$wnnna$aWeed, Pineapple
=450  \\$wnnna$aWeeds, Pineapple
=550  \\$wg$aChamomile
=667  \\$aX refs: distinguish from related plants with similar common names; check text and MeSH; for Matricaria parthenium use TANACETUM; MATRICARIA PERFORATA see TRIPLEUROSPERMUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. M. chamomilla appears similar to Anthemis but this flower disk is conical and hollow and lacks chaffy bract scales and the odor is weaker. The common name of 'manzanilla' is confused with other meanings of the word. 'Matricaria chamomilla sensu' is classified by some as Tripleurospermum perforata. Other plants with similar common names include CHAMAEMELUM; TRIPLEUROSPERMUM and ANTHEMIS.
=688  \\$a2003; for MATRICARIA CHAMOMILLA use CHAMOMILE 1999-2002
=750  \0$aMatricaria$5IEN-M$0(DLC)sh 85082208

=LDR  01574cz  a2200349n  4500
=001  9880364324102441
=005  20141212214813.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031167
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x195.$x288
=150  \\$aChamaemelum
=450  \\$wnnna$aAnthemis nobili
=450  \\$aAnthemis nobilis
=450  \\$aCamomile, Roman
=450  \\$wnnna$aChamaemelum nobile
=450  \\$wnnna$aChamaemelum nobiles
=450  \\$wnnna$aChamaemelums
=450  \\$wnnna$aChamomile, English
=450  \\$aChamomile, Roman
=450  \\$wnnna$aEnglish Chamomile
=450  \\$wnnna$anobile, Chamaemelum
=450  \\$wnnna$anobiles, Chamaemelum
=450  \\$wnnna$anobili, Anthemis
=450  \\$wnnna$anobilis, Anthemis
=450  \\$wnnna$aRoman Camomile
=450  \\$wnnna$aRoman Chamomile
=550  \\$wg$aChamomile
=667  \\$aX refs: distinguish from related plants with similar common names; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that is used in folk medicine as CHAMOMILE. Other plants with similar common names include MATRICARIA; TRIPLEUROSPERMUM and ANTHEMIS.
=688  \\$a2003; for CHAMAEMELUM NOBILE use CHAMOMILE 1999-2002
=750  \0$aChamaemelum$5IEN-M$0(DLC)sh 99005119

=LDR  01905cz  a2200421n  4500
=001  9880364324202441
=005  20141212214813.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031166
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x195.$x99
=150  \\$aAnthemis
=450  \\$wnnna$aAnthemi
=450  \\$wnnna$aAnthemis cotula
=450  \\$wnnna$aAnthemis cotulas
=450  \\$aCamomile, Stinking
=450  \\$wnnna$aCamomiles, Stinking
=450  \\$aChamomile, Stinking
=450  \\$wnnna$aChamomiles, Stinking
=450  \\$wnnna$acotula, Anthemis
=450  \\$wnnna$acotulas, Anthemis
=450  \\$wnnna$aDog Fennel
=450  \\$wnnna$aDog Fennels
=450  \\$aFennel, Dog
=450  \\$wnnna$aFennels, Dog
=450  \\$aMayweed, Stinking
=450  \\$wnnna$aMayweeds, Stinking
=450  \\$wnnna$aStinking Camomile
=450  \\$wnnna$aStinking Camomiles
=450  \\$wnnna$aStinking Chamomile
=450  \\$wnnna$aStinking Chamomiles
=450  \\$wnnna$aStinking Mayweed
=450  \\$wnnna$aStinking Mayweeds
=550  \\$wg$aChamomile
=667  \\$aX refs: distinguish from related plants with similar common names; check text and MeSH; ANTHEMIS NOBILIS see CHAMAEMELUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that is similar to MATRICARIA but this has tiny chaffy bract scales between each pair of florets. Members contain sesquiterpene lactones. Other plants with similar common names include FERULA; FOENICULUM; MATRICARIA; CHAMAEMELUM and TRIPLEUROSPERMUM.
=688  \\$a2003
=750  \0$aAnthemis$0(DLC)sh2009010914$5IEN-M

=LDR  00927cz  a2200229n  4500
=001  9880364324302441
=005  20141212214812.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031165
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x70
=150  \\$aAmmi
=450  \\$wnnna$aAmmi visnaga
=450  \\$wnnna$aAmmi visnagas
=450  \\$wnnna$aAmmus
=450  \\$wnnna$avisnaga, Ammi
=450  \\$wnnna$avisnagas, Ammi
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that is the primary plant source of KHELLIN.
=688  \\$a2003
=750  \0$aAmmi$5IEN-M$0(DLC)sh 85004528

=LDR  00843cz  a2200205n  4500
=001  9880364324402441
=005  20141212214811.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031164
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x65
=150  \\$aAmbrosia
=450  \\$wnnna$aAmbrosias
=450  \\$aRagweed
=450  \\$wnnna$aRagweeds
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The POLLEN is one cause of HAYFEVER.
=688  \\$a2003
=750  \0$aRagweeds$5IEN-M$0(DLC)sh 85110854

=LDR  00890cz  a2200181n  4500
=001  9880364324502441
=005  20141212214811.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x56
=150  \\$aAgeratum
=450  \\$wnnna$aAgeratums
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that contains PYRROLIZIDINE ALKALOIDS. Yellow vein disease of Ageratum is caused by a viral DNA complex of a begomovirus (GEMINIVIRIDAE).
=688  \\$a2003
=750  \0$aAgeratums$0(DLC)sh2005020073$5IEN-M

=LDR  01039cz  a2200253n  4500
=001  9880364324602441
=005  20141212214810.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x37
=150  \\$aAchillea
=450  \\$wnnna$aAchillea millefolium
=450  \\$wnnna$aAchillea millefoliums
=450  \\$wnnna$aAchilleas
=450  \\$wnnna$amillefolium, Achillea
=450  \\$wnnna$amillefoliums, Achillea
=450  \\$aYarrow
=450  \\$wnnna$aYarrows
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE that has long been used in folk medicine for treating wounds.
=688  \\$a2003
=750  \0$aYarrow$5IEN-M$0(DLC)sh 85000501

=LDR  01053cz  a2200193n  4500
=001  9880364324702441
=005  20190702134309.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031112
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x118
=150  \\$aBegoniaceae
=450  \\$aBegonia
=450  \\$wnnna$aBegonias
=550  \\$wg$aMagnoliopsida
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales (by some in Begoniales), subclass Dilleniidae, class Magnoliopsida. Members are found throughout tropical and warm temperate habitats. Most are perennial herbs with monoecious flowers (both sexes on the same plant). Fruits are usually capsules containing many tiny seeds.
=688  \\$a2003
=750  \0$aBegoniaceae$5IEN-M$0(DLC)sh 85012888

=LDR  00912cz  a2200205n  4500
=001  9880364324802441
=005  20190702101331.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031111
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x106
=150  \\$aBalanophoraceae
=450  \\$aThonningia
=450  \\$wnnna$aThonningias
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aCynomorium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are root parasites lacking CHLOROPHYLL.
=688  \\$a2003
=750  \0$aBalanophoraceae$5IEN-M$0(DLC)sh 95000478

=LDR  00874cz  a2200181n  4500
=001  9880364324902441
=005  20160928161528.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x691
=150  \\$aPeriploca
=450  \\$wnnna$aPeriplocas
=550  \\$wg$aApocynaceae
=667  \\$aPERIPLOCA INDICA see HEMIDESMUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASCLEPIADACEAE. It is a source of periplocosides (pregnane steroid glycosides).
=688  \\$a2003
=750  \0$aPeriploca$5IEN-M$0(DLC)sh 88006914

=LDR  01099cz  a2200229n  4500
=001  9880364325002441
=005  20160928161114.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x153
=150  \\$aAsclepias
=450  \\$wnnna$aAsclepia
=450  \\$wnnna$aCommon Milkweed
=450  \\$wnnna$aCommon Milkweeds
=450  \\$aMilkweed, Common
=450  \\$wnnna$aMilkweeds, Common
=550  \\$wg$aApocynaceae
=667  \\$afor ASCLEPIAS ASTHMATICA see TYLOPHORA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASCLEPIADACEAE. This is the true milkweed; APOCYNUM & EUPHORBIA hirta are rarely called milkweed. Asclepias asthmatica has been changed to TYLOPHORA.
=688  \\$a2003
=750  \0$aMilkweeds$5IEN-M$0(DLC)sh 85085374

=LDR  01163cz  a2200277n  4500
=001  9880364325102441
=005  20160928161305.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031107
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x260
=150  \\$aCalotropis
=450  \\$wnnna$aCalotropi
=450  \\$wnnna$aCalotropis gigantea
=450  \\$wnnna$aCalotropis giganteas
=450  \\$wnnna$aCalotropis procera
=450  \\$wnnna$aCalotropis proceras
=450  \\$wnnna$agigantea, Calotropis
=450  \\$wnnna$agiganteas, Calotropis
=450  \\$wnnna$aprocera, Calotropis
=450  \\$wnnna$aproceras, Calotropis
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASCLEPIADACEAE. The downy akund floss fiber from the seeds is used like kapok.
=688  \\$a2003
=750  \0$aCalotropis$5IEN-M$0(DLC)sh 88022627

=LDR  01286cz  a2200301n  4500
=001  9880364325202441
=005  20160928161432.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x411
=150  \\$aMarsdenia
=450  \\$aCondurango
=450  \\$wnnna$acondurango, Marsdenia
=450  \\$wnnna$aCondurangos
=450  \\$wnnna$acondurangos, Marsdenia
=450  \\$wnnna$aMarsdenia condurango
=450  \\$wnnna$aMarsdenia condurangos
=450  \\$wnnna$aMarsdenia tenacissima
=450  \\$wnnna$aMarsdenia tenacissimas
=450  \\$wnnna$aMarsdenias
=450  \\$wnnna$atenacissima, Marsdenia
=450  \\$wnnna$atenacissimas, Marsdenia
=550  \\$wg$aApocynaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASCLEPIADACEAE. Members contain pregnane glycosides (marsdekoiside & marstomentosides, maryal) and hainaneosides (SAPONINS).
=688  \\$a2003
=750  \0$aCundurango$5IEN-M$0(DLC)sh 85034802

=LDR  00940cz  a2200217n  4500
=001  9880364325302441
=005  20141212214805.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x188
=150  \\$aCalamus
=450  \\$aPalm, Rattan
=450  \\$wnnna$aPalms, Rattan
=450  \\$wnnna$aRattan Palm
=450  \\$wnnna$aRattan Palms
=550  \\$wg$aArecaceae
=667  \\$aCALAMUS ROOT see ACORUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARECACEAE that should not be confused with ACORUS CALAMUS.
=688  \\$a2003
=750  \0$aCalamus$5IEN-M$0(DLC)sh 85018742

=LDR  00817cz  a2200181n  4500
=001  9880364325502441
=005  20141212214803.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x488
=150  \\$aPhilodendron
=450  \\$wnnna$aPhilodendrons
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. As a houseplant it sometimes poisons children and animals.
=688  \\$a2003
=750  \0$aPhilodendrons$5IEN-M$0(DLC)sh 88022986

=LDR  01066cz  a2200229n  4500
=001  9880364325602441
=005  20141212214803.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031060
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x199
=150  \\$aColocasia
=450  \\$wnnna$aColocasias
=450  \\$aDasheen
=450  \\$wnnna$aDasheens
=450  \\$aTaro
=450  \\$wnnna$aTaros
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. Members contain acrid calcium oxalate and LECTINS. Polynesians prepare the root into poi. Common names of Taro and Coco Yam (Cocoyam) may be confused with other ARACEAE; XANTHOSOMA; or with common yam (DIOSCOREA).
=688  \\$a2003
=750  \0$aColocasia$5IEN-M$0(DLC)sh 85028468

=LDR  00927cz  a2200205n  4500
=001  9880364325702441
=005  20141212214802.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031059
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x177
=150  \\$aCalla Plant
=450  \\$wnnna$aCalla Plants
=450  \\$wnnna$aPlant, Calla
=450  \\$wnnna$aPlants, Calla
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. Calla Lily (Callalily) also refers to the ZANTEDESCHIA. There is no relationship with CALLA ANTIGEN.
=688  \\$a2003
=750  \0$aCalla lilies$5IEN-M$0(DLC)sh 85018932

=LDR  00822cz  a2200181n  4500
=001  9880364325802441
=005  20141212214802.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031058
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x109
=150  \\$aArum
=450  \\$wnnna$aArums
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. The name derived from ar (fire in Arabic) due to the irritating sap. Flower is a spathe.
=688  \\$a2003
=750  \0$aArum$5IEN-M$0(DLC)sh 95001315

=LDR  01439cz  a2200385n  4500
=001  9880364325902441
=005  20141212214801.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031057
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x88
=150  \\$aArisaema
=450  \\$wnnna$aArisaema dracontium
=450  \\$wnnna$aArisaema dracontiums
=450  \\$wnnna$aArisaema triphyllum
=450  \\$wnnna$aArisaema triphyllums
=450  \\$wnnna$aArisaemas
=450  \\$wnnna$adracontium, Arisaema
=450  \\$wnnna$adracontiums, Arisaema
=450  \\$aDragon, Green
=450  \\$aDragonroot
=450  \\$wnnna$aDragonroots
=450  \\$wnnna$aDragons, Green
=450  \\$wnnna$aGreen Dragon
=450  \\$wnnna$aGreen Dragons
=450  \\$aJack-in-the-Pulpit
=450  \\$wnnna$aJack in the Pulpit
=450  \\$wnnna$aJack-in-the-Pulpits
=450  \\$wnnna$atriphyllum, Arisaema
=450  \\$wnnna$atriphyllums, Arisaema
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. It has a stemless, tuberous root.
=688  \\$a2003
=750  \0$aArisaema$5IEN-M$0(DLC)sh 90004560

=LDR  01017cz  a2200241n  4500
=001  9880364326002441
=005  20141212214801.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031056
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x85.$x77
=150  \\$aAmorphophallus
=450  \\$wnnna$aAmorphophallus konjac
=450  \\$wnnna$aAmorphophallus konjacs
=450  \\$aKonjac
=450  \\$wnnna$akonjac, Amorphophallus
=450  \\$wnnna$aKonjacs
=450  \\$wnnna$akonjacs, Amorphophallus
=550  \\$wg$aAraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARACEAE. Members contain konjac glucomannan (MANNANS) and SEROTONIN.
=688  \\$a2003
=750  \0$aAmorphophallus$5IEN-M$0(DLC)sh 85004576

=LDR  01219cz  a2200301n  4500
=001  9880364326102441
=005  20141212214800.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031053
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x972
=150  \\$aVinca
=450  \\$wnnna$amajor, Vinca
=450  \\$wnnna$amajors, Vinca
=450  \\$wnnna$aminor, Vinca
=450  \\$wnnna$aminors, Vinca
=450  \\$aPeriwinkle
=450  \\$wnnna$aPeriwinkles
=450  \\$wnnna$aVinca major
=450  \\$wnnna$aVinca majors
=450  \\$wnnna$aVinca minor
=450  \\$wnnna$aVinca minors
=450  \\$wnnna$aVincas
=550  \\$wg$aApocynaceae
=667  \\$afor VINCA ROSEA; (= PERIWINKLE, MADAGASCAR;) see CATHARANTHUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE. Vinca rosea has been changed to CATHARANTHUS roseus.
=688  \\$a2003
=750  \0$aVinca$5IEN-M$0(DLC)sh 85143388

=LDR  01245cz  a2200301n  4500
=001  9880364326202441
=005  20141212214800.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031052
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x944
=150  \\$aThevetia
=450  \\$aOleander Tree, Yellow
=450  \\$wnnna$aOleander Trees, Yellow
=450  \\$wnnna$aperuviana, Thevetia
=450  \\$wnnna$aperuvianas, Thevetia
=450  \\$wnnna$aThevetia peruviana
=450  \\$wnnna$aThevetia peruvianas
=450  \\$wnnna$aThevetias
=450  \\$wnnna$aTree, Yellow Oleander
=450  \\$wnnna$aTrees, Yellow Oleander
=450  \\$wnnna$aYellow Oleander Tree
=450  \\$wnnna$aYellow Oleander Trees
=550  \\$wg$aApocynaceae
=667  \\$aOleander see NERIUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APOCYNACEAE. Members contain thevetin.
=688  \\$a2003
=750  \0$aThevetia$5IEN-M$0(DLC)sh 85134839

=LDR  01039cz  a2200241n  4500
=001  9880364326302441
=005  20141212193021.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031051
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x43
=150  \\$aAlstonia
=450  \\$wnnna$aAlstonia scholaris
=450  \\$wnnna$aAlstonias
=450  \\$wnnna$aMilky Pine
=450  \\$wnnna$aMilky Pines
=450  \\$wnnna$aPine, Milky
=450  \\$wnnna$aPines, Milky
=550  \\$wg$aApocynaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family APOCYNACEAE. Members contain echitovenidine, echitamine, venenatine (an indole alkaloid), and anti-inflammatory triterpenoids
=688  \\$a2003
=750  \0$aAlstonia$5IEN-M$0(DLC)sh 88022542

=LDR  00935cz  a2200229n  4500
=001  9880364326402441
=005  20141212214759.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031049
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x75.$x294
=150  \\$aEryngium
=450  \\$wnnna$aEryngiums
=450  \\$wnnna$aHollies, Sea
=450  \\$aHolly, Sea
=450  \\$wnnna$aSea Hollies
=450  \\$wnnna$aSea Holly
=550  \\$wg$aApiaceae
=667  \\$aHolly see ILEX is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family APIACEAE. Members contain SAPONINS.
=688  \\$a2003
=750  \0$aEryngium$5IEN-M$0(DLC)sh 85044735

=LDR  00806cz  a2200181n  4500
=001  9880364326502441
=005  20141212214758.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x65.$x968
=150  \\$aRollinia
=450  \\$wnnna$aRollinias
=550  \\$wg$aAnnonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANNONACEAE. Members contain aporphines, acetogenins and rollinone.
=688  \\$a2003
=750  \0$aRollinia$5IEN-M$0(DLC)sh 93000809

=LDR  00909cz  a2200205n  4500
=001  9880364326602441
=005  20141212214757.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x65.$x750
=150  \\$aAsimina
=450  \\$wnnna$aAsiminas
=450  \\$aPawpaw
=450  \\$wnnna$aPawpaws
=550  \\$wg$aAnnonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain asitrocin, asitrilobins, and other tetrahydrofuran acetogenins.
=688  \\$a2003
=750  \0$aAsimina$5IEN-M$0(DLC)sh 85008664

=LDR  01127cz  a2200277n  4500
=001  9880364326702441
=005  20141212214757.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x65.$x500
=150  \\$aAnnona
=450  \\$wnnna$aAnnona cherimolia
=450  \\$wnnna$aAnnona cherimolias
=450  \\$wnnna$aAnnonas
=450  \\$wnnna$acherimolia, Annona
=450  \\$wnnna$acherimolias, Annona
=450  \\$aCherimoya
=450  \\$wnnna$aCherimoyas
=450  \\$wnnna$aSoursop
=450  \\$wnnna$aSoursops
=550  \\$wg$aAnnonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain acetogenins and benzoquinazoline and other alkaloids.
=688  \\$a2003
=750  \0$aAnnona$5IEN-M$0(DLC)sh 87006178

=LDR  01003cz  a2200253n  4500
=001  9880364326802441
=005  20141212214756.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x44.$x416
=150  \\$aMangifera
=450  \\$wnnna$aindica, Mangifera
=450  \\$wnnna$aindicas, Mangifera
=450  \\$wnnna$aMangifera indica
=450  \\$wnnna$aMangifera indicas
=450  \\$wnnna$aMangiferas
=450  \\$aMango
=450  \\$wnnna$aMangos
=550  \\$wg$aAnacardiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANACARDIACEAE best known for the edible fruit.
=688  \\$a2003
=750  \0$aMangifera$5IEN-M$0(DLC)sh 99000539

=LDR  01257cz  a2200253n  4500
=001  9880364326902441
=005  20141212214756.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x44.$x277
=150  \\$aAnacardium
=450  \\$wnnna$aAnacardium occidentale
=450  \\$wnnna$aAnacardium occidentales
=450  \\$wnnna$aAnacardiums
=450  \\$aCashew
=450  \\$wnnna$aCashews
=450  \\$wnnna$aoccidentale, Anacardium
=450  \\$wnnna$aoccidentales, Anacardium
=550  \\$wg$aAnacardiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid (frequently abbreviated as CNSL) is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.
=688  \\$a2003
=750  \0$aAnacardium$5IEN-M$0(DLC)sh 85004742

=LDR  01000cz  a2200241n  4500
=001  9880364327002441
=005  20190624104740.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031003
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x500
=150  \\$aAdoxaceae
=450  \\$aAdoxa
=450  \\$wnnna$aAdoxas
=450  \\$aMuskroot
=450  \\$wnnna$aMuskroots
=550  \\$wg$aDipsacales
=550  \\$wh$aSambucus
=550  \\$wh$aViburnum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.
=688  \\$a2003
=750  \0$aAdoxaceae$5IEN-M$0(DLC)sh 85000991

=LDR  01408cz  a2200397n  4500
=001  9880364327102441
=005  20190619094552.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x9.$x500
=150  \\$aAcer
=450  \\$wnnna$aAcer negundo
=450  \\$wnnna$aAcer negundos
=450  \\$wnnna$aAcer saccharum
=450  \\$wnnna$aAcer saccharums
=450  \\$wnnna$aAcers
=450  \\$wnnna$aBox Elder
=450  \\$wnnna$aBox Elders
=450  \\$aElder, Box
=450  \\$wnnna$aElders, Box
=450  \\$wnnna$aMaple
=450  \\$wnnna$aMaple, Sugar
=450  \\$wnnna$aMaples
=450  \\$wnnna$aMaples, Sugar
=450  \\$wnnna$anegundo, Acer
=450  \\$wnnna$anegundos, Acer
=450  \\$wnnna$asaccharum, Acer
=450  \\$wnnna$asaccharums, Acer
=450  \\$wnnna$aSugar Maple
=450  \\$wnnna$aSugar Maples
=550  \\$wg$aSapindaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ACERACEAE, best known for trees with palmately lobed leaves.
=688  \\$a2003
=750  \0$aMaple$5IEN-M$0(DLC)sh 85080843

=LDR  00985cz  a2200169n  4500
=001  9880364327202441
=005  20190619094423.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x9
=150  \\$aAceraceae
=550  \\$wg$aAlismatales
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are opposite and usually toothed or lobed. The fruit, a samara (a winged nutlet), splits into two (rarely three) winged, one-seeded parts. This family is widely distributed in the Northern Hemisphere.
=688  \\$a2003
=750  \0$aAceraceae$5IEN-M$0(DLC)sh 85000443

=LDR  00297cz  a2200109n  4500
=001  9880364327302441
=005  20090403133032.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D011570Q000941
=040  \\$aDNLM$cDNLM
=150  \\$aPsychiatry$xethics
=750  \0$aPsychiatric ethics$0(DLC) sh 85108350$5IEN-M

=LDR  00319cz  a2200109n  4500
=001  9880364327402441
=005  20070928104849.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D008511Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aMedicine$xinstrumentation
=750  \0$aMedical instruments and apparatus$0(DLC) sh 85082949$5IEN-M

=LDR  01108cz  a2200301n  4500
=001  9880364155202441
=005  20141212210729.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014862
=035  \\$aCBA8209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65.$x970
=072  \\$aD23.$x946.$x833.$x65.$x970
=150  \\$aWasp Venoms
=450  \\$wnnna$aVenom, Vespid
=450  \\$wnnna$aVenom, Wasp
=450  \\$wnnna$aVenoms, Vespa
=450  \\$wnnna$aVenoms, Vespid
=450  \\$wnnna$aVenoms, Wasp
=450  \\$wnnna$aVespa Venoms
=450  \\$wnnna$aVespid Venom
=450  \\$aVespid Venoms
=450  \\$wnnna$aWasp Venom
=550  \\$wg$aArthropod Venoms
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted
=680  \\$iVenoms produced by the wasp (Vespid) family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms.
=688  \\$a91(78); was see under BEE VENOMS 1978-90
=750  \0$aWasps$xVenom$0(IEN)3998737$5IEN-M

=LDR  00974cz  a2200313n  4500
=001  9880364155302441
=005  20141212210728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014860
=035  \\$aCBA8207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x650.$x810
=072  \\$aC2.$x825.$x810
=072  \\$aC2.$x928.$x914
=072  \\$aC4.$x925.$x744
=072  \\$aC17.$x800.$x838.$x790.$x810
=150  \\$aWarts
=450  \\$aVerruca
=450  \\$wnnna$aVerrucas
=450  \\$wnnna$aWart
=550  \\$wg$aPapillomavirus Infections
=550  \\$wg$aSkin Diseases, Viral
=550  \\$wg$aTumor Virus Infections
=550  \\$wh$aCondylomata Acuminata
=550  \\$wh$aEpidermodysplasia Verruciformis
=550  \\$aPapilloma
=667  \\$aa non-neoplastic tumor virus infect; coord IM with precoord organ/dis term (IM)
=680  \\$iBenign epidermal proliferations or tumors; some are viral in origin.
=750  \0$aWarts$5IEN$0(DLC)sh 85145322

=LDR  01896cz  a2200445n  4500
=001  9880364155402441
=005  20141212210728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014859
=035  \\$aCBA8206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x446.$x520.$x914
=072  \\$aD3.$x830.$x219.$x446.$x520.$x914
=150  \\$aWarfarin
=450  \\$wnnna$a4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
=450  \\$wnnna$aAldo Brand of Warfarin Sodium
=450  \\$wnnna$aAldocumar
=450  \\$wnnna$aAntigen Brand of Warfarin Sodium
=450  \\$wnnna$aApo-Warfarin
=450  \\$wnnna$aApotex Brand of Warfarin Sodium
=450  \\$wnnna$aBailly Brand of Warfarin Sodium
=450  \\$wnnna$aBoots Brand of Warfarin Sodium
=450  \\$wnnna$aBristol-Myers Squibb Brand of Warfarin Sodium
=450  \\$wnnna$aCoumadin
=450  \\$wnnna$aCoumadine
=450  \\$wnnna$aEstedi Brand of Warfarin Sodium
=450  \\$wnnna$aGen-Warfarin
=450  \\$wnnna$aGenpharm Brand of Warfarin Sodium
=450  \\$wnnna$aGoldshield Brand of Warfarin Sodium
=450  \\$wnnna$aMarevan
=450  \\$wnnna$aPotassium, Warfarin
=450  \\$wnnna$aSodium, Warfarin
=450  \\$wnnna$aTedicumar
=450  \\$wnnna$aWarfant
=450  \\$wnnna$aWarfarin Potassium
=450  \\$wnnna$aWarfarin Sodium
=550  \\$wg$a4-Hydroxycoumarins
=667  \\$aan anticoagulant & rodenticide
=680  \\$iAn anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
=750  \0$aWarfarin$5IEN$0(DLC)sh 87004217

=LDR  00783cz  a2200253n  4500
=001  9880364155502441
=005  20160826102658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014858
=035  \\$aCBA8205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x903
=072  \\$aI1.$x880.$x735.$x950.$x500.$x903
=150  \\$aWar Crimes
=450  \\$wnnna$aCrime, War
=450  \\$wnnna$aCrimes, War
=450  \\$wnnna$aWar Crime
=550  \\$wg$aCrime
=550  \\$wg$aWarfare
=550  \\$wh$aEthnic Cleansing
=550  \\$wh$aGenocide
=550  \\$aHuman Rights Abuses
=680  \\$iCriminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.
=750  \0$aWar crimes$5IEN$0(DLC)sh 85145168

=LDR  00770cz  a2200265n  4500
=001  9880364155602441
=005  20160826104429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014857
=035  \\$aCBA8204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x500
=150  \\$aWarfare
=450  \\$wnno$aWar
=450  \\$wnnna$aWars
=550  \\$wg$aWarfare and Armed Conflicts
=550  \\$wh$aBiological Warfare
=550  \\$wh$aChemical Warfare
=550  \\$wh$aNuclear Warfare
=550  \\$wh$aPsychological Warfare
=550  \\$wh$aWar Crimes
=550  \\$wh$aWar Exposure
=550  \\$aViolence
=680  \\$iHostile conflict between organized groups of people.$5IEN-M
=750  \0$aMilitary art and science$0(DLC)sh 85085132$5IEN-M

=LDR  00740cz  a2200205n  4500
=001  9880364155702441
=005  20190726102807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014856
=035  \\$aCBA8203M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x750.$x250.$x821
=150  \\$aWalruses
=450  \\$aOdobenidae
=450  \\$wnnna$aOdobenus rosmarus
=450  \\$wnnna$aWalrus
=550  \\$wg$aCaniformia
=680  \\$iThe family Odobenidae, suborder PINNIPEDIA, order CARNIVORA. It is represented by a single species of large, nearly hairless mammal found on Arctic shorelines, whose upper canines are modified into tusks.
=688  \\$a2005 (1975)
=750  \0$aWalrus$0(DLC) sh 85122976$5IEN-M

=LDR  00603cz  a2200193n  4500
=001  9880364155802441
=005  20141212210726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014851
=035  \\$aCBA8198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x104.$x821
=072  \\$aG11.$x561.$x600.$x42.$x738
=150  \\$aWakefulness
=450  \\$wnnna$aWakefulnesses
=550  \\$wg$aArousal
=680  \\$iA state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.
=688  \\$a69(67)
=750  \0$aWakefulness$5IEN$0(DLC)sh 85144851

=LDR  02437cz  a2200493n  4500
=001  9880364155902441
=005  20141212210725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014849
=035  \\$aCBA8196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x77.$x938
=150  \\$aWaardenburg Syndrome
=450  \\$wnnna$aKlein Syndrome
=450  \\$aKlein-Waardenburg Syndrome
=450  \\$wnnna$aKlein Waardenburg Syndrome
=450  \\$wnnna$aKlein's Syndrome
=450  \\$wnnna$aKleins Syndrome
=450  \\$wnnna$aSyndrome, Klein
=450  \\$wnnna$aSyndrome, Klein-Waardenburg
=450  \\$wnnna$aSyndrome, Klein's
=450  \\$wnnna$aSyndrome, Waardenburg
=450  \\$wnnna$aSyndrome, Waardenburg-Klein
=450  \\$wnnna$aSyndrome, Waardenburg's
=450  \\$wnnna$aWaardenburg-Klein Syndrome
=450  \\$wnnna$aWaardenburg Klein Syndrome
=450  \\$wnnna$aWaardenburg Syndrome Type 1
=450  \\$wnnna$aWaardenburg Syndrome, Type 1
=450  \\$wnnna$aWaardenburg Syndrome Type 3
=450  \\$wnnna$aWaardenburg Syndrome, Type 3
=450  \\$wnnna$aWaardenburg Syndrome, Type III
=450  \\$wnnna$aWaardenburg Syndrome with Dystopia Canthorum
=450  \\$wnnna$aWaardenburg Syndrome with Upper Limb Anomalies
=450  \\$aWaardenburg's Syndrome
=450  \\$wnnna$aWaardenburgs Syndrome
=450  \\$wnnna$aWaardenburg's Syndrome Type 1
=450  \\$wnnna$aWhite Forelock (Poliosis) Syndrome with Multiple Congenital Malformations
=550  \\$wg$aAbnormalities, Multiple
=550  \\$aPiebaldism
=680  \\$iRare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest (neurocristopathy). Waardenburg's syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities.
=688  \\$a2013 (1966); use ABNORMALITIES, MULTIPLE 1975-1990; Waardenburg's Syndrome 1991-2012
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Waardenburg's Syndrome
=688  \\$a91(66); was see under ABNORMALITIES, MULTIPLE 1975-90
=750  \0$aKlein-Waardenburg syndrome$0(DLC)sh 85072629$5IEN-M

=LDR  00660cz  a2200205n  4500
=001  9880364156002441
=005  20141212210724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014848
=035  \\$aCBA8195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x894.$x906.$x820
=072  \\$aC13.$x351.$x500.$x944.$x902.$x737
=150  \\$aVulvovaginitis
=450  \\$wnnna$aVulvovaginitides
=550  \\$wg$aVaginitis
=550  \\$wg$aVulvitis
=550  \\$wh$aCandidiasis, Vulvovaginal
=680  \\$iInflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.
=750  \0$aVulvovaginitis$5IEN$0(DLC)sh 85144476

=LDR  01367cz  a2200421n  4500
=001  9880364156102441
=005  20141212210724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014846
=035  \\$aCBA8193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418.$x968
=072  \\$aC13.$x351.$x500.$x944.$x819
=072  \\$aC13.$x351.$x937.$x418.$x968
=150  \\$aVulvar Neoplasms
=450  \\$wnnna$aCancer of the Vulva
=450  \\$aCancer of Vulva
=450  \\$wnnna$aCancer, Vulva
=450  \\$wnnna$aCancer, Vulvar
=450  \\$wnnna$aCancers, Vulva
=450  \\$wnnna$aCancers, Vulvar
=450  \\$wnnna$aNeoplasm, Vulva
=450  \\$wnnna$aNeoplasm, Vulvar
=450  \\$wnnna$aNeoplasms, Vulva
=450  \\$wnnna$aNeoplasms, Vulvar
=450  \\$wnnna$aVulva Cancer
=450  \\$wnnna$aVulva Cancers
=450  \\$wnnna$aVulva Neoplasm
=450  \\$wnnna$aVulva Neoplasms
=450  \\$aVulvar Cancer
=450  \\$wnnna$aVulvar Cancers
=450  \\$wnnna$aVulvar Neoplasm
=550  \\$wg$aGenital Neoplasms, Female
=550  \\$wg$aVulvar Diseases
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the VULVA.
=750  \0$aVulva$xCancer$0(DLC)sh2010010521$5IEN-M
=750  \0$aVulva$xTumors$0(IEN)381474$5IEN-M

=LDR  00826cz  a2200277n  4500
=001  9880364156202441
=005  20141212210724.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014845
=035  \\$aCBA8192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x944
=150  \\$aVulvar Diseases
=450  \\$wnnna$aDisease, Vulvar
=450  \\$wnnna$aDiseases, Vulvar
=450  \\$wnnna$aVulvar Disease
=550  \\$wg$aGenital Diseases, Female
=550  \\$wh$aPruritus Vulvae
=550  \\$wh$aVulvar Lichen Sclerosus
=550  \\$wh$aVulvar Neoplasms
=550  \\$wh$aVulvitis
=550  \\$wh$aVulvodynia
=667  \\$ainflammatory disease = VULVITIS
=680  \\$iPathological processes of the VULVA.
=688  \\$a76; was NON MESH before 1976
=750  \0$aVulva$xDiseases$5IEN$0(DLC)sh 85144474

=LDR  00623cz  a2200205n  4500
=001  9880364156302441
=005  20141212210723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014844
=035  \\$aCBA8191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x887
=150  \\$aVulva
=450  \\$wnnna$aVulvas
=550  \\$wg$aGenitalia, Female
=550  \\$wh$aBartholin's Glands
=550  \\$wh$aClitoris
=667  \\$ainflammation = VULVITIS
=680  \\$iThe external genitalia of the female. It includes the CLITORIS, the labia, the vestibule, and its glands.
=750  \0$aVulva$5IEN$0(DLC)sh 85144473

=LDR  00733cz  a2200181n  4500
=001  9880364156402441
=005  20160609132432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014843
=035  \\$aCBA8190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x657.$x900
=150  \\$aVoyeurism
=450  \\$wnnna$aVoyeurisms
=550  \\$wg$aParaphilic Disorders
=680  \\$iA paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement.
=688  \\$a91(75); was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80
=750  \0$aVoyeurism$5IEN$0(DLC)sh 85118773

=LDR  02217cz  a2200517n  4500
=001  9880364156502441
=005  20141212210723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014842
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x100.$x900
=072  \\$aC15.$x378.$x100.$x141.$x900
=072  \\$aC15.$x378.$x140.$x900
=072  \\$aC15.$x378.$x463.$x920
=072  \\$aC16.$x320.$x99.$x920
=150  \\$avon Willebrand Diseases
=450  \\$aAngiohemophilia
=450  \\$wnnna$aAngiohemophilias
=450  \\$wnnna$aDisorder, Von Willebrand
=450  \\$aHemophilia, Vascular
=450  \\$wnnna$aPseudohemophilia, Vascular
=450  \\$wnnna$aPseudohemophilias, Vascular
=450  \\$wnnna$aVascular Hemophilia
=450  \\$wnnna$aVascular Hemophilias
=450  \\$wnnna$aVascular Pseudohemophilia
=450  \\$wnnna$aVascular Pseudohemophilias
=450  \\$avon Willebrand Disease
=450  \\$wnnna$avon Willebrand Disease, Recessive Form
=450  \\$wnnna$aVon Willebrand Disorder
=450  \\$wnnna$avon Willebrand's Disease
=450  \\$wnnna$avon Willebrand's Diseases
=450  \\$wnnna$aVon Willebrand's Factor Deficiency
=550  \\$wg$aBlood Coagulation Disorders, Inherited
=550  \\$wg$aBlood Platelet Disorders
=550  \\$wg$aCoagulation Protein Disorders
=550  \\$wg$aHemorrhagic Disorders
=550  \\$wh$avon Willebrand Disease, Type 1
=550  \\$wh$avon Willebrand Disease, Type 2
=550  \\$wh$avon Willebrand Disease, Type 3
=550  \\$avon Willebrand Factor
=667  \\$anote specific types of Von Willebrand Disease are available
=680  \\$iGroup of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
=688  \\$a2010(1963)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a von Willebrand Disease
=688  \\$a99(63)
=750  \0$aVon Willebrand disease$0(DLC) sh 85144394$5IEN-M

=LDR  01758cz  a2200337n  4500
=001  9880364156602441
=005  20141212210722.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014841
=035  \\$aCBA8188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125.$x920
=072  \\$aD23.$x119.$x985
=150  \\$avon Willebrand Factor
=450  \\$aFactor VIII-Related Antigen
=450  \\$wnnna$aFactor VIII Related Antigen
=450  \\$wnnna$aFactor VIIIR-Ag
=450  \\$wnnna$aFactor VIIIR Ag
=450  \\$wnnna$aFactor VIIIR-RCo
=450  \\$wnnna$aFactor VIIIR RCo
=450  \\$wnnna$aPlasma Factor VIII Complex
=450  \\$wnnna$aRistocetin Cofactor
=450  \\$wnnna$aRistocetin-Willebrand Factor
=450  \\$wnnna$aRistocetin Willebrand Factor
=450  \\$wnnna$avon Willebrand Protein
=550  \\$wg$aBlood Coagulation Factors
=550  \\$aWeibel-Palade Bodies
=667  \\$a/ defic = VON WILLEBRAND DISEASE or specific type of Von Willebrand Disease
=680  \\$iA high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.
=688  \\$a86(76); was see under BLOOD COAGULATION FACTORS 1976-85; FACTOR VIII RELATED ANTIGEN, previously in the Supplementary Chemical File, was mapped to both FACTOR VIII & ANTIGENS 1977-89
=750  \0$aVon Willebrand factor$5IEN$0(DLC)sh 88003864

=LDR  00755cz  a2200229n  4500
=001  9880364156702441
=005  20141212210721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014839
=035  \\$aCBA8186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x937
=150  \\$aVomiting
=450  \\$aEmesis
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$wh$aHematemesis
=550  \\$wh$aMorning Sickness
=550  \\$wh$aPostoperative Nausea and Vomiting
=550  \\$wh$aVomiting, Anticipatory
=667  \\$a/chem ind: EMETICS is also available; /drug ther: ANTIEMETICS is also available
=680  \\$iThe forcible expulsion of the contents of the STOMACH through the MOUTH.
=750  \0$aVomiting$5IEN$0(DLC)sh 85144382

=LDR  01043cz  a2200349n  4500
=001  9880364156802441
=005  20141212210721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014838
=035  \\$aCBA8185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x955
=150  \\$aVolunteers
=450  \\$wnnna$aPersonnel, Untrained
=450  \\$wnnna$aUntrained Personnel
=450  \\$wnnna$aVoluntary Worker
=450  \\$aVoluntary Workers
=450  \\$wnnna$aVolunteer
=450  \\$wnnna$aVolunteer Worker
=450  \\$wnnna$aVolunteer Workers
=450  \\$wnnna$aVolunteerism
=450  \\$wnnna$aWorker, Voluntary
=450  \\$wnnna$aWorker, Volunteer
=450  \\$wnnna$aWorkers, Voluntary
=450  \\$wnnna$aWorkers, Volunteer
=550  \\$wg$aPersons
=550  \\$wh$aHealthy Volunteers
=550  \\$wh$aHospital Volunteers
=680  \\$iPersons who donate their services.
=688  \\$a68
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Voluntary Workers
=750  \0$aVolunteers$5IEN$0(DLC)sh 85144372

=LDR  01089cz  a2200289n  4500
=001  9880364156902441
=005  20161123105528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014837
=035  \\$aCBA8184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x630.$x780
=150  \\$aVoluntary Health Agencies
=450  \\$wnnna$aAgencies, Voluntary Health
=450  \\$wnnna$aAgency, Voluntary Health
=450  \\$wnnna$aHealth Agencies, Voluntary
=450  \\$wnnna$aHealth Agency, Voluntary
=450  \\$wnnna$aVoluntary Health Agency
=550  \\$wg$aOrganizations, Nonprofit
=550  \\$wh$aAmerican Cancer Society
=550  \\$wh$aAmerican Heart Association
=550  \\$wh$aMental Health Associations
=550  \\$wh$aRed Cross
=550  \\$wh$aTuberculosis Societies
=667  \\$aIM; coord with specific pertinent med specialty (IM); TN 174: definition & use
=680  \\$iNon-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc.
=750  \0$aVoluntary health agencies$5IEN$0(DLC)sh 85144342

=LDR  00446cz  a2200169n  4500
=001  9880364157002441
=005  20141212210720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014836
=035  \\$aCBA8183HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x902
=150  \\$aVolition
=450  \\$aWill
=550  \\$wg$aMental Processes
=680  \\$iVoluntary activity without external compulsion.
=750  \0$aWill$5IEN$0(DLC)sh 85146775

=LDR  00585cz  a2200205n  4500
=001  9880364157102441
=005  20141212210720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014834
=035  \\$aCBA8181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x727.$x862
=150  \\$aVoice Training
=450  \\$wnnna$aTraining, Voice
=450  \\$wnnna$aTrainings, Voice
=450  \\$wnnna$aVoice Trainings
=550  \\$wg$aRehabilitation of Speech and Language Disorders
=550  \\$aSpeech Therapy
=667  \\$ano qualif
=750  \0$aVoice culture$5IEN$0(DLC)sh 85144229

=LDR  01493cz  a2200409n  4500
=001  9880364157202441
=005  20141212210720.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014832
=035  \\$aCBA8179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x940
=072  \\$aC9.$x400.$x940
=072  \\$aC10.$x597.$x975
=072  \\$aC23.$x888.$x592.$x979
=150  \\$aVoice Disorders
=450  \\$wnnna$aDisturbance, Voice
=450  \\$wnnna$aDisturbances, Voice
=450  \\$wnnna$aFatigue, Voice
=450  \\$wnnna$aFatigues, Voice
=450  \\$wnnna$aNeurologic Voice Disorder
=450  \\$wnnna$aNeurologic Voice Disorders
=450  \\$wnnna$aVoice Disorder
=450  \\$wnnna$aVoice Disorder, Neurologic
=450  \\$wnnna$aVoice Disorders, Neurologic
=450  \\$wnnna$aVoice Disturbance
=450  \\$wnnna$aVoice Disturbances
=450  \\$wnnna$aVoice Fatigue
=450  \\$wnnna$aVoice Fatigues
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aAphonia
=550  \\$wh$aDysphonia
=550  \\$wh$aHoarseness
=680  \\$iPathological processes that affect voice production, usually involving VOCAL CORDS and the LARYNGEAL MUCOSA. Voice disorders can be caused by organic (anatomical), or functional (emotional or psychological) factors leading to DYSPHONIA; APHONIA; and defects in VOICE QUALITY, loudness, and pitch.
=688  \\$a1979
=750  \0$aVoice disorders$0(DLC) sh 85144231$5IEN

=LDR  00718cz  a2200205n  4500
=001  9880364157302441
=005  20141212210719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014831
=035  \\$aCBA8178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772.$x925
=150  \\$aVoice
=450  \\$wnnna$aVoices
=550  \\$wg$aRespiratory Physiological Phenomena
=550  \\$wh$aVoice Quality
=550  \\$aPhonation
=667  \\$ahuman only: for animal use VOCALIZATION, ANIMAL
=680  \\$iThe sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.
=750  \0$aVoice$5IEN$0(DLC)sh 85144224

=LDR  00830cz  a2200241n  4500
=001  9880364157402441
=005  20141212210719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014830
=035  \\$aCBA8177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x937
=072  \\$aF2.$x784.$x692.$x887
=150  \\$aVocational Guidance
=450  \\$aCareer Counseling
=450  \\$wnnna$aCounseling, Career
=450  \\$wnnna$aGuidance, Vocational
=550  \\$wg$aPsychology, Educational
=550  \\$wg$aPsychology, Industrial
=550  \\$aCounseling
=667  \\$aconsider also APTITUDE or APTITUDE TESTS
=680  \\$iSystematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc.
=750  \0$aVocational guidance$5IEN$0(DLC)sh 85144186

=LDR  00703cz  a2200217n  4500
=001  9880364157502441
=005  20141212210719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014829
=035  \\$aCBA8176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x862
=150  \\$aVocational Education
=450  \\$wnnna$aEducation, Vocational
=450  \\$wnnna$aEducations, Vocational
=450  \\$aOccupational Training$5IEN
=450  \\$wnnna$aVocational Educations
=550  \\$wg$aEducation, Nonprofessional
=680  \\$iEducation for specific trades or occupations.
=750  \0$aVocational education$5IEN-M$0(DLC)sh 85144178
=750  \0$aOccupational training$5IEN-HS$0(DLC)sh 85093855

=LDR  01403cz  a2200409n  4500
=001  9880364157602441
=005  20141212210718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014828
=035  \\$aCBA8175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x55.$x800
=150  \\$aVocalization, Animal
=450  \\$wnnna$aAnimal Singing
=450  \\$wnnna$aAnimal Singings
=450  \\$wnnna$aAnimal Sound Communication
=450  \\$wnnna$aAnimal Sound Communications
=450  \\$wnnna$aAnimal Vocal Communication
=450  \\$wnnna$aAnimal Vocal Communications
=450  \\$wnnna$aAnimal Vocalization
=450  \\$wnnna$aAnimal Vocalizations
=450  \\$wnnna$aCommunication, Animal Sound
=450  \\$wnnna$aCommunication, Animal Vocal
=450  \\$wnnna$aCommunications, Animal Sound
=450  \\$wnnna$aCommunications, Animal Vocal
=450  \\$wnnna$aSinging, Animal
=450  \\$wnnna$aSingings, Animal
=450  \\$wnnna$aSound Communication, Animal
=450  \\$wnnna$aSound Communications, Animal
=450  \\$wnnna$aVocal Communication, Animal
=450  \\$wnnna$aVocal Communications, Animal
=450  \\$wnnna$aVocalizations, Animal
=550  \\$wg$aAnimal Communication
=550  \\$aAnimal Communication
=680  \\$iSounds used in animal communication.
=688  \\$a68
=750  \0$aSound production by animals$5IEN$0(DLC)sh 85125385

=LDR  01137cz  a2200301n  4500
=001  9880364157702441
=005  20141212210718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014827
=035  \\$aCBA8174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x329.$x364.$x737
=150  \\$aVocal Cords
=450  \\$wnnna$aCord, Vocal
=450  \\$wnnna$aCords, Vocal
=450  \\$wnnna$aFold, Vocal
=450  \\$wnnna$aFolds, Vocal
=450  \\$wnnna$aLigament, Vocal
=450  \\$wnnna$aLigaments, Vocal
=450  \\$wnnna$aVocal Cord
=450  \\$aVocal Fold
=450  \\$wnnna$aVocal Folds
=450  \\$wnnna$aVocal Ligament
=450  \\$wnnna$aVocal Ligaments
=550  \\$wg$aGlottis
=667  \\$ainflammation = LARYNGITIS
=680  \\$iA pair of cone-shaped elastic mucous membrane projecting from the laryngeal wall and forming a narrow slit between them. Each contains a thickened free edge (vocal ligament) extending from the THYROID CARTILAGE to the ARYTENOID CARTILAGE, and a VOCAL MUSCLE that shortens or relaxes the vocal cord to control sound production.
=750  \0$aVocal cords$5IEN$0(DLC)sh 85144060

=LDR  01307cz  a2200313n  4500
=001  9880364157802441
=005  20141212210629.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014681
=035  \\$aCBA8021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x525.$x955
=072  \\$aC7.$x550.$x966
=072  \\$aC7.$x650.$x525.$x955
=072  \\$aC9.$x775.$x955
=072  \\$aC16.$x131.$x850.$x525.$x955
=150  \\$aVelopharyngeal Insufficiency
=450  \\$wnnna$aInadequate Velopharyngeal Closure
=450  \\$wnnna$aIncompetence, Palatopharyngeal
=450  \\$wnnna$aIncompetence, Velopharyngeal
=450  \\$wnnna$aInsufficiency, Velopharyngeal
=450  \\$aPalatopharyngeal Incompetence
=450  \\$wnnna$aVelopharyngeal Closures, Inadequate
=450  \\$wnnna$aVelopharyngeal Incompetence
=550  \\$wg$aMouth Abnormalities
=550  \\$wg$aPharyngeal Diseases
=680  \\$iFailure of the SOFT PALATE to reach the posterior pharyngeal wall to close the opening between the oral and nasal cavities. Incomplete velopharyngeal closure is primarily related to surgeries (ADENOIDECTOMY; CLEFT PALATE) or an incompetent PALATOPHARYNGEAL SPHINCTER. It is characterized by hypernasal speech.
=688  \\$a78
=750  \0$aVelopharyngeal insufficiency$5IEN$0(DLC)sh 85142587

=LDR  01512cz  a2200433n  4500
=001  9880364157902441
=005  20141212210628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014680
=035  \\$aCBA8020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908
=150  \\$aVeins
=360  \\$iconsider also terms at$aPHLEB-
=450  \\$wnnna$aVein
=550  \\$wg$aBlood Vessels
=550  \\$wh$aAxillary Vein
=550  \\$wh$aAzygos Vein
=550  \\$wh$aBrachiocephalic Veins
=550  \\$wh$aCerebral Veins
=550  \\$wh$aCoronary Vessels
=550  \\$wh$aCranial Sinuses
=550  \\$wh$aFemoral Vein
=550  \\$wh$aHepatic Veins
=550  \\$wh$aIliac Vein
=550  \\$wh$aJugular Veins
=550  \\$wh$aPopliteal Vein
=550  \\$wh$aPortal System
=550  \\$wh$aPulmonary Veins
=550  \\$wh$aRenal Veins
=550  \\$wh$aRetinal Vein
=550  \\$wh$aSaphenous Vein
=550  \\$wh$aSubclavian Vein
=550  \\$wh$aVenae Cavae
=550  \\$wh$aVenous Valves
=550  \\$wh$aVenules
=667  \\$aIM general only; NIM as coordinate to indicate a specific vein, as 'pancreatic' vein = PANCREAS / blood supply (IM) + VEINS (NIM); venous blood: coordinate BLOOD + VEINS or specific vein but do not index here for routine venous blood samples; venous pressure = VENOUS PRESSURE or CENTRAL VENOUS PRESSURE; inflammation = PHLEBITIS
=680  \\$iThe vessels carrying blood away from the capillary beds.
=750  \0$aVeins$5IEN$0(DLC)sh 85142544

=LDR  00612cz  a2200169n  4500
=001  9880364158002441
=005  20141212210628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014678
=035  \\$aCBA8018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x96.$x938
=150  \\$aVeillonella
=550  \\$wg$aVeillonellaceae
=667  \\$ain mouth, intestines & resp tract of man & other animals
=680  \\$iA genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals.
=750  \0$aVeillonella$5IEN$0(DLC)sh 88023355

=LDR  00955cz  a2200265n  4500
=001  9880364158102441
=005  20141212210628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014677
=035  \\$aCBA8017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x650.$x700
=072  \\$aD27.$x720.$x744.$x770
=072  \\$aE2.$x319.$x300.$x754
=150  \\$aPharmaceutical Vehicles
=450  \\$wnnna$aPharmaceutical Vehicle
=450  \\$wnnna$aVehicle, Pharmaceutical
=450  \\$wnnna$aVehicles, Pharmaceutical
=550  \\$wg$aDrug Delivery Systems
=550  \\$wg$aPharmaceutic Aids
=550  \\$wh$aExcipients
=680  \\$iA carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)
=688  \\$a2011 (1963)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Vehicles
=750  \0$aDrug carriers (Pharmacy)$0(DLC) sh 85039758$5IEN

=LDR  00941cz  a2200277n  4500
=001  9880364158202441
=005  20161110092826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014676
=035  \\$aCBA8016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x300
=072  \\$aG7.$x203$x650.$x240.$x300
=150  \\$aDiet, Vegetarian
=450  \\$wnnna$aDiets, Vegetarian
=450  \\$aVegetarian Diet
=450  \\$wnnna$aVegetarian Diets
=450  \\$aVegetarianism
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$wh$aDiet, Macrobiotic
=550  \\$wh$aDiet, Vegan
=667  \\$aIM; coord with specific edible (IM) if pertinent
=680  \\$iDietary practice of completely avoiding meat products in their DIET, consuming vegetables, grains, and nuts. Some who are called lacto-ovo also include milk and egg products.
=688  \\$a2003(1963)
=750  \0$aVegetarianism$5IEN-HS$0(DLC)sh 85142520

=LDR  00851cz  a2200253n  4500
=001  9880364158302441
=005  20201028132630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014675
=035  \\$aCBA8015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x160.$x956
=072  \\$aB1.$x650.$x510.$x956
=072  \\$aG7.$x203.$x300.$x850
=072  \\$aJ2.$x500.$x850
=150  \\$aVegetables
=450  \\$wnnna$aVegetable
=550  \\$wg$aCrops, Agricultural
=550  \\$wg$aFood
=550  \\$wg$aPlants, Edible
=550  \\$wh$aVegetable Products
=550  \\$wh$aPlant Proteins, Dietary
=667  \\$aas plant & food; for health effects or therapeutic use of vegetables, index VEGETABLES (IM) + specific plant (IM) if pertinent + disease / diet ther; PHYTOTHERAPY is also available
=750  \0$aVegetables$5IEN$0(DLC)sh 85142489

=LDR  01807cz  a2200457n  4500
=001  9880364158402441
=005  20141212210626.0
=008  860602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014673
=035  \\$aCBA8013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54.$x40.$x920
=150  \\$aVecuronium Bromide
=450  \\$wnnna$aBromide, Vecuronium
=450  \\$wnnna$aCitrate, Vecuronium
=450  \\$wnnna$aHydrobromide, Vecuronium
=450  \\$wnnna$aHydrochloride, Vecuronium
=450  \\$wnnna$aMaleate, Vecuronium
=450  \\$wnnna$aNC-45
=450  \\$wnnna$aNC 45
=450  \\$wnnna$aNC45
=450  \\$wnnna$aNorcuron
=450  \\$wnnna$aORG-NC 45
=450  \\$wnnna$aORG-NC-45
=450  \\$wnnna$aORG NC 45
=450  \\$wnnna$aORG-NC45
=450  \\$wnnna$aORG NC45
=450  \\$wnnna$aORGNC 45
=450  \\$wnnna$aORGNC45
=450  \\$wnnna$aPhosphate, Vecuronium
=450  \\$wnnna$aVecuronium
=450  \\$wnnna$aVecuronium Bromide, Quaternary Ion
=450  \\$wnnna$aVecuronium Citrate
=450  \\$wnnna$aVecuronium Hydrobromide
=450  \\$wnnna$aVecuronium Hydrochloride
=450  \\$wnnna$aVecuronium Maleate
=450  \\$wnnna$aVecuronium Phosphate
=550  \\$wg$aAndrostanols
=680  \\$iMonoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents.
=688  \\$a95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94
=750  \0$aVecuronium bromide$5IEN$0(DLC)sh 85142461

=LDR  01333cz  a2200313n  4500
=001  9880364158502441
=005  20141212210626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014672
=035  \\$aCBA8012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x240.$x850
=072  \\$aE1.$x370.$x405.$x240.$x850
=150  \\$aVectorcardiography
=450  \\$wnnna$aElectrocardiographies, Vector
=450  \\$wnnna$aElectrocardiography, Vector
=450  \\$wnnna$aPolarcardiographies
=450  \\$aPolarcardiography
=450  \\$wnnna$aVectercardiographies
=450  \\$wnnna$aVectercardiography
=450  \\$wnnna$aVector Electrocardiographies
=450  \\$wnnna$aVector Electrocardiography
=450  \\$wnnna$aVectorcardiographies
=550  \\$wg$aElectrocardiography
=550  \\$wh$aBody Surface Potential Mapping
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VECTORCARDIOGR or VECTOR ECG
=680  \\$iRecording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time.
=688  \\$aPOLARCARDIOGRAPHY was heading 1975-96 (see under VECTORCARDIOGRAPHY 1975-90); was see under VECTORCARDIOGRAPHY 1965-74 (Prov 1965-73)
=750  \0$aVectorcardiography$5IEN$0(DLC)sh 85142459

=LDR  01530cz  a2200349n  4500
=001  9880364158602441
=005  20141212210625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014670
=035  \\$aCBA8010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x159.$x183.$x79.$x300.$x950
=072  \\$aA3.$x556.$x124.$x684.$x124.$x236
=072  \\$aA3.$x556.$x875.$x249.$x160
=150  \\$aAmpulla of Vater
=450  \\$wnnna$aAmpulla, Hepatopancreatic
=450  \\$wnnna$aAmpulla, Vater's
=450  \\$wnnna$aAmpullas, Hepatopancreatic
=450  \\$aDuodenal Papilla, Major
=450  \\$wnnna$aHepatopancreatic Ampulla
=450  \\$wnnna$aHepatopancreatic Ampullas
=450  \\$wnnna$aMajor Duodenal Papilla
=450  \\$wnnna$aVater Ampulla
=450  \\$aVater's Ampulla
=450  \\$wnnna$aVaters Ampulla
=550  \\$wg$aCommon Bile Duct
=550  \\$wg$aDuodenum
=550  \\$wh$aSphincter of Oddi
=667  \\$adiseases: coord IM with COMMON BILE DUCT DISEASES (IM); inflammation: coord IM with CHOLANGITIS (IM); neopl: coord IM with COMMON BILE DUCT NEOPLASMS (IM); note X ref DUODENAL PAPILLA, MAJOR: do not confuse with DUODENAL PAPILLA, MINOR see PANCREATIC DUCTS; "duodenal papilla" unspecified is probably DUODENAL PAPILLA, MAJOR
=680  \\$iA dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.
=688  \\$a2004 (1963)
=750  \0$aAmpulla of Vater$5IEN$0(DLC)sh 85004658

=LDR  01087cz  a2200325n  4500
=001  9880364158702441
=005  20141212210625.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014669
=035  \\$aCBA8009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x956
=072  \\$aE4.$x950.$x599.$x500.$x800
=072  \\$aE4.$x950.$x774.$x860.$x956
=150  \\$aVasovasostomy
=450  \\$wnnna$aReversal, Vasectomy
=450  \\$wnnna$aReversals, Vasectomy
=450  \\$aVasectomy Reversal
=450  \\$wnnna$aVasectomy Reversals
=450  \\$wnnna$aVasostomies
=450  \\$aVasostomy
=450  \\$wnnna$aVasovasostomies
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aSterilization Reversal
=550  \\$wg$aUrologic Surgical Procedures, Male
=550  \\$aVas Deferens
=667  \\$ato reverse sterilization; do not use /util except by MeSH definition
=680  \\$iSurgical anastomosis or fistulization of the spermatic ducts to restore fertility in a previously vasectomized male.
=688  \\$a88
=750  \0$aVasovasostomy$5IEN$0(DLC)sh 85142405

=LDR  01920cz  a2200409n  4500
=001  9880364158802441
=005  20141212210624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014667
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x692.$x781
=072  \\$aD12.$x644.$x400.$x900
=072  \\$aD12.$x644.$x456.$x925
=072  \\$aD12.$x644.$x548.$x691.$x692.$x781
=072  \\$aD12.$x776.$x641.$x650.$x937
=150  \\$aVasopressins
=450  \\$wnnna$aAmerican Pharmaceutical Brand of Vasopressin
=450  \\$wnnna$aAmerican Regent Brand of Vasopressin
=450  \\$aAntidiuretic Hormones
=450  \\$abeta-Hypophamine
=450  \\$wnnna$abeta Hypophamine
=450  \\$wnnna$aMonarch Brand of Vasopressin
=450  \\$wnnna$aParke-Davis Brand of Vasopressin (USP)
=450  \\$wnnna$aPitressin
=450  \\$wnnna$aVasopressin
=450  \\$wnnna$aVasopressin Monarch Brand
=450  \\$wnnna$aVasopressin (USP)
=550  \\$wg$aNeuropeptides
=550  \\$wg$aOligopeptides
=550  \\$wg$aPituitary Hormones, Posterior
=550  \\$wh$aArginine Vasopressin
=550  \\$wh$aLypressin
=550  \\$wh$aOrnipressin
=667  \\$ageneral or unspecified; prefer specifics; /secret: consider also INAPPROPRIATE ADH SYNDROME
=680  \\$iAntidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
=688  \\$a79; was VASOPRESSIN 1963-78
=750  \0$aVasopressin$5IEN$0(DLC)sh 85142404

=LDR  00893cz  a2200241n  4500
=001  9880364158902441
=005  20141212210623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014666
=035  \\$aCBA8006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x800.$x900
=150  \\$aVasomotor System
=450  \\$aNervous System, Vasomotor$5IEN
=450  \\$wnnna$aSystem, Vasomotor
=450  \\$wnnna$aSystems, Vasomotor
=450  \\$wnnna$aVasomotor Systems
=550  \\$wg$aSympathetic Nervous System
=550  \\$wh$aPressoreceptors
=550  \\$aBlood Vessels
=667  \\$a/drug eff: consider also VASOCONSTRICTOR AGENTS & VASODILATOR AGENTS
=680  \\$iThe neural systems which act on VASCULAR SMOOTH MUSCLE to control blood vessel diameter. The major neural control is through the sympathetic nervous system.
=750  \0$aVasomotor system$5IEN$0(DLC)sh 85090945

=LDR  00987cz  a2200313n  4500
=001  9880364159002441
=005  20141212210623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014665
=035  \\$aCBA8005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411.$x918
=150  \\$aVasodilator Agents
=450  \\$wnnna$aAgents, Vasodilator
=450  \\$wnnna$aAntagonists, Vasoactive
=450  \\$wnnna$aDrugs, Vasodilator
=450  \\$aVasoactive Antagonists
=450  \\$wnnna$aVasodilator Drugs
=450  \\$wnnna$aVasodilators
=450  \\$wnnna$aVasorelaxants
=550  \\$wg$aCardiovascular Agents
=550  \\$wh$aEndothelium-Dependent Relaxing Factors
=550  \\$aAntihypertensive Agents
=550  \\$aCalcium Channel Blockers
=550  \\$aPotassium Channel Blockers
=550  \\$aVasodilation
=550  \\$aVasomotor System
=680  \\$iDrugs used to cause dilation of the blood vessels.
=750  \0$aVasodilators$5IEN$0(DLC)sh 85142401

=LDR  01080cz  a2200265n  4500
=001  9880364159102441
=005  20141212210623.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014664
=035  \\$aCBA8004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x400.$x925
=150  \\$aVasodilation
=450  \\$wnnna$aEndothelium-Dependent Relaxation, Vascular
=450  \\$wnnna$aRelaxation, Vascular Endothelium-Dependent
=450  \\$wnnna$aVascular Endothelium-Dependent Relaxation
=450  \\$wnnna$aVascular Endothelium Dependent Relaxation
=450  \\$aVasodilatation
=450  \\$aVasorelaxation
=550  \\$wg$aHemodynamics
=550  \\$aVasomotor System
=667  \\$acoord IM with specific vessel or specific organ /blood supply; the physiol process; pathol dilat = specific blood vessel (IM) + DILATATION, PATHOLOGIC (NIM) or ANEURYSM and its specifics
=680  \\$iThe physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE.
=688  \\$a78
=750  \0$aBlood-vessels$xDilatation$5IEN$0(DLC)sh 88000636

=LDR  01063cz  a2200337n  4500
=001  9880364159202441
=005  20141212210622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014662
=035  \\$aCBA8002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411.$x793
=150  \\$aVasoconstrictor Agents
=450  \\$wnnna$aAgents, Vasoconstrictor
=450  \\$wnnna$aAgents, Vasopressor
=450  \\$wnnna$aAgonists, Vasoactive
=450  \\$wnnna$aDrugs, Vasoconstrictor
=450  \\$aVasoactive Agonists
=450  \\$wnnna$aVasoconstrictor Drugs
=450  \\$wnnna$aVasoconstrictors
=450  \\$aVasopressor Agents
=550  \\$wg$aCardiovascular Agents
=550  \\$wh$aCalcium Channel Agonists
=550  \\$wh$aNasal Decongestants
=550  \\$aHemostatics
=550  \\$aVasoconstriction
=550  \\$aVasomotor System
=667  \\$aconsider also VASOMOTOR SYSTEM /drug eff
=680  \\$iDrugs used to cause constriction of the blood vessels.
=688  \\$a67(65)
=750  \0$aVasoconstrictors$5IEN$0(DLC)sh 90000776

=LDR  01420cz  a2200325n  4500
=001  9880364159302441
=005  20141212210621.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014660
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x950
=072  \\$aD6.$x472.$x699.$x952
=072  \\$aD12.$x644.$x400.$x875
=072  \\$aD12.$x644.$x548.$x952
=072  \\$aD12.$x776.$x641.$x650.$x875
=150  \\$aVasoactive Intestinal Peptide
=450  \\$wnnna$aIntestinal Peptide, Vasoactive
=450  \\$wnnna$aIntestinal Polypeptide, Vasoactive
=450  \\$wnnna$aPeptide, Vasoactive Intestinal
=450  \\$wnnna$aPeptide, Vasointestinal
=450  \\$wnnna$aPolypeptide, Vasoactive Intestinal
=450  \\$wnnna$aVasoactive Intestinal Polypeptide
=450  \\$wnnna$aVasointestinal Peptide
=450  \\$wnnna$aVIP (Vasoactive Intestinal Peptide)
=550  \\$wg$aGastrointestinal Hormones
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=680  \\$iA highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE).
=688  \\$a84(77); was see under GASTROINTESTINAL HORMONES 1977-83
=750  \0$aVasoactive intestinal peptide$5IEN$0(DLC)sh 85142400

=LDR  01993cz  a2200565n  4500
=001  9880364159402441
=005  20141212210621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014659
=035  \\$aCBA7999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x599.$x900
=072  \\$aE4.$x950.$x774.$x860.$x856
=150  \\$aVasectomy
=450  \\$wnnna$aIntravasal Thread
=450  \\$wnnna$aIntravasal Threads
=450  \\$wnnna$aLigation, Vas
=450  \\$wnnna$aLigations, Vas
=450  \\$wnnna$aNonchemical Vas Occlusion
=450  \\$wnnna$aNonchemical Vas Occlusions
=450  \\$wnnna$aOcclusion, Nonchemical Vas
=450  \\$wnnna$aOcclusion, Vas
=450  \\$wnnna$aOcclusions, Nonchemical Vas
=450  \\$wnnna$aOcclusions, Vas
=450  \\$wnnna$aRefused Vasectomy Seeker
=450  \\$wnnna$aRefused Vasectomy Seekers
=450  \\$wnnna$aSeeker, Refused Vasectomy
=450  \\$wnnna$aSeeker, Vasectomy
=450  \\$wnnna$aSeekers, Refused Vasectomy
=450  \\$wnnna$aSeekers, Vasectomy
=450  \\$wnnna$aThread, Intravasal
=450  \\$wnnna$aThreads, Intravasal
=450  \\$wnnna$aVas Ligation
=450  \\$wnnna$aVas Ligations
=450  \\$wnnna$aVas Occlusion
=450  \\$wnnna$aVas Occlusion, Nonchemical
=450  \\$wnnna$aVas Occlusions
=450  \\$wnnna$aVas Occlusions, Nonchemical
=450  \\$wnnna$aVasectomies
=450  \\$wnnna$aVasectomy Seeker
=450  \\$wnnna$aVasectomy Seeker, Refused
=450  \\$wnnna$aVasectomy Seekers
=450  \\$wnnna$aVasectomy Seekers, Refused
=550  \\$wg$aSterilization, Reproductive
=550  \\$wg$aUrologic Surgical Procedures, Male
=550  \\$aVas Deferens
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal of the ductus deferens, or a portion of it. It is done in association with prostatectomy, or to induce infertility. (Dorland, 28th ed)
=688  \\$a73
=750  \0$aVasectomy$5IEN-HS$0(DLC)sh 85142370

=LDR  01411cz  a2200397n  4500
=001  9880364159502441
=005  20141212210620.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014657
=035  \\$aCBA7997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x940
=150  \\$aVasculitis
=450  \\$wnnna$aAngiitides
=450  \\$aAngiitis
=450  \\$wnnna$aVasculitides
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAortitis
=550  \\$wh$aArteritis
=550  \\$wh$aBehcet Syndrome
=550  \\$wh$aCogan Syndrome
=550  \\$wh$aMalignant Atrophic Papulosis
=550  \\$wh$aMucocutaneous Lymph Node Syndrome
=550  \\$wh$aPhlebitis
=550  \\$wh$aPurpura, Schoenlein-Henoch
=550  \\$wh$aRetinal Vasculitis
=550  \\$wh$aShwartzman Phenomenon
=550  \\$wh$aSystemic Vasculitis
=550  \\$wh$aThromboangiitis Obliterans
=550  \\$wh$aVasculitis, Central Nervous System
=550  \\$wh$aVasculitis, Leukocytoclastic, Cutaneous
=667  \\$ageneral or unspecified; consider SYSTEMIC VASCULITIS; ARTERITIS; or PHLEBITIS & their indentions; VASCULITIS, HEMORRHAGIC see PURPURA, SCHOENLEIN-HENOCH is also available
=680  \\$iInflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
=688  \\$a1978
=688  \\$a78
=750  \0$aVasculitis$5IEN$0(DLC)sh 85142363

=LDR  01326cz  a2200385n  4500
=001  9880364159602441
=005  20141212210620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014656
=035  \\$aCBA7996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814
=150  \\$aVascular Surgical Procedures
=450  \\$aBlood Vessels$xsurgery
=450  \\$wnnna$aProcedure, Vascular Surgical
=450  \\$wnnna$aProcedures, Vascular Surgical
=450  \\$wnnna$aSurgical Procedure, Vascular
=450  \\$wnnna$aSurgical Procedures, Vascular
=450  \\$wnnoa$aVascular Surgery$5IEN
=450  \\$wnnna$aVascular Surgical Procedure
=550  \\$wg$aCardiovascular Surgical Procedures
=550  \\$wh$aAxillofemoral Bypass Grafting
=550  \\$wh$aEmbolectomy
=550  \\$wh$aEndarterectomy
=550  \\$wh$aEndovascular Procedures
=550  \\$wh$aLimb Salvage
=550  \\$wh$aPeritoneovenous Shunt
=550  \\$wh$aThrombectomy
=550  \\$wh$aVascular Grafting
=550  \\$wh$aVenous Cutdown
=550  \\$aBlood Vessels
=667  \\$aGEN only: prefer specific blood vessel /surg; SPEC: SPEC qualif
=680  \\$iOperative procedures for the treatment of vascular disorders.
=688  \\$a98; was VASCULAR SURGERY 1963-97
=750  \0$aBlood-vessels$xSurgery$5IEN$0(DLC)sh 85015027

=LDR  01437cz  a2200385n  4500
=001  9880364159702441
=005  20141212210619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014655
=035  \\$aCBA7995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380.$x921
=150  \\$aVascular Resistance
=450  \\$aPeripheral Resistance
=450  \\$wnnna$aPeripheral Resistance, Total
=450  \\$wnnna$aPulmonary Vascular Resistance
=450  \\$wnnna$aResistance, Peripheral
=450  \\$wnnna$aResistance, Pulmonary Vascular
=450  \\$wnnna$aResistance, Systemic Vascular
=450  \\$wnnna$aResistance, Total Peripheral
=450  \\$wnnna$aResistance, Vascular
=450  \\$wnnna$aSystemic Vascular Resistance
=450  \\$aTotal Peripheral Resistance
=450  \\$wnnna$aVascular Resistance, Pulmonary
=450  \\$wnnna$aVascular Resistance, Systemic
=550  \\$wg$aHemodynamics
=550  \\$wh$aCapillary Resistance
=550  \\$aBlood Vessels
=550  \\$aHypertension
=550  \\$aVascular Capacitance
=550  \\$aVasoconstriction
=667  \\$ado not confuse with VASCULAR CAPACITANCE, blood volume within a vessel
=680  \\$iThe force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.
=688  \\$a67(64)
=750  \0$aVascular resistance$5IEN$0(DLC)sh 88003386

=LDR  02693cz  a2200745n  4500
=001  9880364159802441
=005  20190102105742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014652
=035  \\$aCBA7992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907
=150  \\$aVascular Diseases
=450  \\$wnnna$aDisease, Vascular
=450  \\$wnnna$aDiseases, Vascular
=450  \\$wnnna$aVascular Disease
=550  \\$wg$aCardiovascular Diseases
=550  \\$wh$aAneurysm
=550  \\$wh$aAngiodysplasia
=550  \\$wh$aAngioedema
=550  \\$wh$aAngiomatosis
=550  \\$wh$aAortic Diseases
=550  \\$wh$aArterial Occlusive Diseases
=550  \\$wh$aArteriovenous Malformations
=550  \\$wh$aArteritis
=550  \\$wh$aCapillary Leak Syndrome
=550  \\$wh$aCerebrovascular Disorders
=550  \\$wh$aColitis, Ischemic
=550  \\$wh$aCompartment Syndromes
=550  \\$wh$aDiabetic Angiopathies
=550  \\$wh$aEmbolism and Thrombosis
=550  \\$wh$aHand-Arm Vibration Syndrome
=550  \\$wh$aHemorrhoids
=550  \\$wh$aHemostatic Disorders
=550  \\$wh$aHepatic Veno-Occlusive Disease
=550  \\$wh$aHyperemia
=550  \\$wh$aHypertension
=550  \\$wh$aHypotension
=550  \\$wh$aMesenteric Ischemia
=550  \\$wh$aMyocardial Ischemia
=550  \\$wh$aOptic Neuropathy, Ischemic
=550  \\$wh$aPeripheral Vascular Diseases
=550  \\$wh$aPrehypertension
=550  \\$wh$aPulmonary Veno-Occlusive Disease
=550  \\$wh$aReperfusion Injury
=550  \\$wh$aRetinal Vein Occlusion
=550  \\$wh$aScimitar Syndrome
=550  \\$wh$aSpinal Cord Vascular Diseases
=550  \\$wh$aSplenic Infarction
=550  \\$wh$aStenosis, Pulmonary Vein
=550  \\$wh$aSuperior Vena Cava Syndrome
=550  \\$wh$aTelangiectasis
=550  \\$wh$aThoracic Outlet Syndrome
=550  \\$wh$aVaricocele
=550  \\$wh$aVaricose Veins
=550  \\$wh$aVascular Fistula
=550  \\$wh$aVascular Neoplasms
=550  \\$wh$aVascular System Injuries
=550  \\$wh$aVasculitis
=550  \\$wh$aVasoplegia
=550  \\$wh$aVenous Insufficiency
=550  \\$aCardiology
=667  \\$ageneral, prefer specifics; inflammatory vascular disease = VASCULITIS; vascular compression syndromes: coordinate PERIPHERAL VASCULAR DISEASES (IM) with CONSTRICTION, PATHOLOGIC (NIM) + specific blood vessel if pertinent (IM)
=680  \\$iPathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
=750  \0$aBlood-vessels$xDiseases$0(DLC) sh 85015023$5IEN

=LDR  00694cz  a2200205n  4500
=001  9880364159902441
=005  20141212210617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014649
=035  \\$aCBA7989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x930
=150  \\$aVas Deferens
=450  \\$wnnna$aDeferens, Ductus
=450  \\$wnnna$aDeferens, Vas
=450  \\$aDuctus Deferens
=550  \\$wg$aGenitalia, Male
=667  \\$a/surg: consider also VASECTOMY
=680  \\$iThe excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct.
=750  \0$aVas deferens$5IEN$0(DLC)sh 85142353

=LDR  00853cz  a2200241n  4500
=001  9880364160002441
=005  20141212210617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014648
=035  \\$aCBA7988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x927
=150  \\$aVaricose Veins
=450  \\$aVarices
=450  \\$wnnna$aVaricose Vein
=450  \\$wnnna$aVarix
=450  \\$wnnna$aVein, Varicose
=450  \\$wnnna$aVeins, Varicose
=550  \\$wg$aVascular Diseases
=550  \\$wh$aVaricose Ulcer
=667  \\$aassume to be of legs so do not coord with LEG; other sites: coord VARICOSE VEINS (IM) + organ /blood supply (IM), not organ/dis, as orbit varix = VARICOSE VEINS (IM) + ORBIT /blood supply (IM) (not ORBITAL DISEASES)
=680  \\$iEnlarged and tortuous VEINS.
=750  \0$aVaricose veins$5IEN$0(DLC)sh 85142328

=LDR  00758cz  a2200193n  4500
=001  9880364160102441
=005  20141212210616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014646
=035  \\$aCBA7986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x936
=072  \\$aC14.$x907.$x903
=150  \\$aVaricocele
=450  \\$wnnna$aVaricoceles
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aVascular Diseases
=680  \\$iA condition characterized by the dilated tortuous veins of the SPERMATIC CORD with a marked left-sided predominance. Adverse effect on male fertility occurs when varicocele leads to an increased scrotal (and testicular) temperature and reduced testicular volume.
=750  \0$aVaricocele$5IEN$0(DLC)sh 85142325

=LDR  01342cz  a2200361n  4500
=001  9880364160202441
=005  20141212210615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014645
=035  \\$aCBA7985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x100.$x900.$x460
=072  \\$aB4.$x909.$x204.$x382.$x100.$x900.$x460
=150  \\$aHerpesvirus 3, Human
=450  \\$aChickenpox Virus
=450  \\$wnnna$aChickenpox Viruses
=450  \\$aHerpes zoster Virus
=450  \\$wnnna$aHerpes zoster Viruses
=450  \\$wnnna$aHerpesvirus 3 (alpha), Human
=450  \\$aHerpesvirus varicellae
=450  \\$wnnna$aHHV-3
=450  \\$aHuman herpesvirus 3
=450  \\$aOcular Herpes zoster Virus
=450  \\$aVaricella-Zoster Virus
=450  \\$wnnna$aVaricella Zoster Virus
=450  \\$wnnna$aVaricella-Zoster Viruses
=450  \\$aVZ Virus
=450  \\$wnnna$aVZ Viruses
=550  \\$wg$aVaricellovirus
=667  \\$ado not confuse with other numbered herpesviruses; infection = CHICKENPOX or HERPES ZOSTER; consider also ENCEPHALITIS, VARICELLA ZOSTER; DF: HHV 3
=680  \\$iThe type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans.
=688  \\$a94; was VARICELLA-ZOSTER VIRUS 1963-93
=750  \0$aVaricella-zoster virus$5IEN$0(DLC)sh 85142324

=LDR  01089cz  a2200337n  4500
=001  9880364160302441
=005  20200618150624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014644
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365
=150  \\$aGenetic Variation
=450  \\$wnnna$aDiversities, Genetic
=450  \\$wnnna$aDiversity, Genetic
=450  \\$wnnna$aGenetic Diversities
=450  \\$aGenetic Diversity
=450  \\$wnnna$aGenetic Variations
=450  \\$aVariation, Genetic
=450  \\$wnnna$aVariations, Genetic
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aAntibody Diversity
=550  \\$wh$aAntigenic Variation
=550  \\$wh$aGenetic Heterogeneity
=550  \\$wh$aMutation
=550  \\$wh$aPolymorphism, Genetic
=550  \\$wh$aQuasispecies
=680  \\$iGenotypic differences observed among individuals in a population
=688  \\$a2009 (1968)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Variation (Genetics)
=688  \\$a68
=750  \0$iNarrower mapping$aHuman genetics$xVariation$0(DLC) sh 85062878$4NM$5IEN-M

=LDR  02469cz  a2200613n  4500
=001  9880364160402441
=005  20141212210614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014640
=035  \\$aCBA7980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x420.$x925
=072  \\$aD12.$x644.$x233.$x925
=150  \\$aVancomycin
=450  \\$wnnna$aAB-Vancomycin
=450  \\$wnnna$aAbbott Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aAzupharma Brand of Vancomycin Hydrochloride
=450  \\$wnnna$acell pharm Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aChiesi Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aCombino Brand of Vancomycin Hydrochloride
=450  \\$wnnna$acurasan Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aDakota Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aDiatracin
=450  \\$wnnna$aDista Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aEli Lilly Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aHexal Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aHydrochloride, Vancomycin
=450  \\$wnnna$aLilly Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aMIP Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aNorman Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aratiopharm Brand of Vancomycin Hydrochloride
=450  \\$wnnna$aSulfate, Vancomycin
=450  \\$wnnna$aVanco Azupharma
=450  \\$wnnna$aVANCO-cell
=450  \\$wnnna$aVanco-saar
=450  \\$wnnna$aVancocin
=450  \\$wnnna$aVancocin HCl
=450  \\$wnnna$aVancocine
=450  \\$wnnna$aVancomicina Abbott
=450  \\$wnnna$aVancomicina Chiesi
=450  \\$wnnna$aVancomicina Combino Phar
=450  \\$wnnna$aVancomicina Norman
=450  \\$wnnna$aVancomycin Hexal
=450  \\$wnnna$aVancomycin Hydrochloride
=450  \\$wnnna$aVancomycin Lilly
=450  \\$wnnna$aVancomycin Phosphate (1:2)
=450  \\$wnnna$aVancomycin Phosphate (1:2), Decahydrate
=450  \\$wnnna$aVancomycin-ratiopharm
=450  \\$wnnna$aVancomycin Sulfate
=450  \\$wnnna$aVancomycine Dakota
=550  \\$wg$aGlycopeptides
=667  \\$ado not confuse with trade name Vancomin, a vitamin B12 deriv
=680  \\$iAntibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
=750  \0$aVancomycin$5IEN$0(DLC)sh 85142027

=LDR  00843cz  a2200205n  4500
=001  9880364160502441
=005  20141212210613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014639
=035  \\$aCBA7979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x920
=072  \\$aD1.$x268.$x956.$x886
=072  \\$aD1.$x552.$x544.$x920
=150  \\$aVanadium
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aV-51; V-50 = VANADIUM (IM) + ISOTOPES (NIM); V-46-49, 52-54 = VANADIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element with the atomic symbol V, atomic number 23, and atomic weight 50.94. It is used in the manufacture of vanadium steel. Prolonged exposure can lead to chronic intoxication caused by absorption usually via the lungs.
=750  \0$aVanadium$5IEN$0(DLC)sh 85142005

=LDR  01081cz  a2200313n  4500
=001  9880364160602441
=005  20141212210612.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014638
=035  \\$aCBA7978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x952
=072  \\$aD1.$x960.$x960
=150  \\$aVanadates
=450  \\$aDecavanadate
=450  \\$aMetavanadate
=450  \\$wnnna$aMonovanadate
=450  \\$aOrthovanadate
=450  \\$aOxyvanadium
=450  \\$wnnna$aSodium Vanadate
=450  \\$wnnna$aVanadate
=450  \\$wnnna$aVanadate, Sodium
=450  \\$aVanadyl
=550  \\$wg$aAnions
=550  \\$wg$aVanadium Compounds
=667  \\$aenzyme inhib
=680  \\$iOxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.
=688  \\$a88
=750  \0$aVanadates$5IEN$0(DLC)sh 85142004

=LDR  01972cz  a2200529n  4500
=001  9880364160702441
=005  20141212210612.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014635
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x944.$x509.$x900
=072  \\$aD10.$x251.$x400.$x895.$x593.$x900
=150  \\$aValproic Acid
=450  \\$wnnna$a2-Propylpentanoic Acid
=450  \\$wnnna$a2 Propylpentanoic Acid
=450  \\$wnnna$aAcetate, Dipropyl
=450  \\$wnnna$aAcid, Propylisopropylacetic
=450  \\$wnnna$aAcid, Valproic
=450  \\$wnnna$aCalcium Valproate
=450  \\$wnnna$aCalcium, Valproate
=450  \\$wnnna$aConvulsofin
=450  \\$wnnna$aDepakene
=450  \\$wnnna$aDepakine
=450  \\$wnnna$aDepakote
=450  \\$aDipropyl Acetate
=450  \\$aDivalproex
=450  \\$wnnna$aDivalproex Sodium
=450  \\$wnnna$aErgenyl
=450  \\$wnnna$aMagnesium Valproate
=450  \\$wnnna$aPropylisopropylacetic Acid
=450  \\$wnnna$aSemisodium Valproate
=450  \\$wnnna$aSodium, Divalproex
=450  \\$aSodium Valproate
=450  \\$wnnna$aSodium, Valproate
=450  \\$wnnna$aValproate
=450  \\$wnnna$aValproate Calcium
=450  \\$wnnna$aValproate, Calcium
=450  \\$wnnna$aValproate, Magnesium
=450  \\$wnnna$aValproate, Semisodium
=450  \\$wnnna$aValproate Sodium
=450  \\$wnnna$aValproate, Sodium
=450  \\$wnnna$aValproic Acid, Sodium Salt (2:1)
=450  \\$wnnna$aVupral
=550  \\$wg$aPentanoic Acids
=680  \\$iA fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of voltage dependent sodium channels.
=688  \\$a91; was VALPROATE 1979-90; was DIPROPYL ACETATE see under VALERATES 1975-78
=750  \0$aValproic acid$5IEN$0(DLC)sh 85141922

=LDR  00833cz  a2200241n  4500
=001  9880364160802441
=005  20171215153507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014633
=035  \\$aCBA7973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x70.$x950
=072  \\$aD12.$x125.$x142.$x930
=150  \\$aValine
=450  \\$wnnna$aL-Valine
=450  \\$wnnna$aL Valine
=550  \\$wg$aAmino Acids, Branched-Chain
=550  \\$wg$aAmino Acids, Essential
=550  \\$wh$a2-Amino-5-phosphonovalerate
=550  \\$wh$aValsartan
=667  \\$a/biosyn /defic /physiol permitted
=680  \\$iA branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.
=750  \0$aValine$0(DLC) sh 89004962$5IEN

=LDR  01500cz  a2200301n  4500
=001  9880364160902441
=005  20141212210610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014632
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x955.$x888
=150  \\$aValerian
=450  \\$wnnna$aGarden Heliotrope
=450  \\$wnnna$aGarden Heliotropes
=450  \\$aHeliotrope, Garden
=450  \\$wnnna$aHeliotropes, Garden
=450  \\$wnnna$aofficinali, Valeriana
=450  \\$wnnna$aofficinalis, Valeriana
=450  \\$aValeriana
=450  \\$wnnna$aValeriana officinali
=450  \\$aValeriana officinalis
=450  \\$wnnna$aValerianas
=450  \\$wnnna$aValerians
=550  \\$wg$aValerianaceae
=667  \\$ado not confuse X ref HELIOTROPE, GARDEN with HELIOTROPIUM; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida. It is best known for the sedative use and valepotriate content of the roots. It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope (HELIOTROPIUM).
=688  \\$a91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
=750  \0$aValeriana$0(DLC) sh 85141835$5IEN-M

=LDR  00601cz  a2200217n  4500
=001  9880364161002441
=005  20141212210610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014631
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x944
=072  \\$aD10.$x251.$x400.$x895
=150  \\$aValerates
=450  \\$aPentanoates
=550  \\$wg$aAcids, Acyclic
=550  \\$wg$aFatty Acids, Volatile
=550  \\$wh$aPentanoic Acids
=550  \\$wh$aProadifen
=667  \\$a2-propylvalerate, 2-propylvaleric acid = VALPROATE
=688  \\$a66
=750  \0$aValerates$5IEN$0(DLC)sh 85141834

=LDR  01904cz  a2200493n  4500
=001  9880364161102441
=005  20141212192618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014630
=035  \\$aCBA7970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x925
=072  \\$aA8.$x800.$x50.$x600.$x825
=072  \\$aA8.$x800.$x800.$x60.$x920
=072  \\$aA8.$x800.$x800.$x120.$x900
=150  \\$aVagus Nerve
=450  \\$wnnna$aCranial Nerve, Tenth
=450  \\$aCranial Nerve X
=450  \\$wnnna$aCranial Nerves, Tenth
=450  \\$wnnna$aNerve, Pneumogastric
=450  \\$wnnna$aNerve, Tenth Cranial
=450  \\$wnnna$aNerve, Vagus
=450  \\$wnnna$aNerve X
=450  \\$wnnna$aNerve X, Cranial
=450  \\$wnnna$aNerve Xs
=450  \\$wnnna$aNerves, Pneumogastric
=450  \\$wnnna$aNerves, Tenth Cranial
=450  \\$wnnna$aNerves, Vagus
=450  \\$wnnna$aNervus Vagus
=450  \\$aPneumogastric Nerve
=450  \\$wnnna$aPneumogastric Nerves
=450  \\$aTenth Cranial Nerve
=450  \\$wnnna$aTenth Cranial Nerves
=450  \\$wnnna$aVagus Nerves
=450  \\$wnnna$aVagus, Nervus
=450  \\$wnnna$aX, Cranial Nerve
=550  \\$wg$aAutonomic Pathways
=550  \\$wg$aCranial Nerves
=550  \\$wg$aParasympathetic Nervous System
=550  \\$wh$aLaryngeal Nerves
=550  \\$wh$aNodose Ganglion
=667  \\$aneoplasm = VAGUS NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).
=750  \0$aVagus nerve$0(DLC) sh 85141766$5IEN

=LDR  00862cz  a2200241n  4500
=001  9880364161202441
=005  20141212210609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014628
=035  \\$aCBA7967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x210.$x80.$x600.$x850
=072  \\$aE4.$x525.$x210.$x850
=150  \\$aVagotomy
=450  \\$wnnna$aVagotomies
=550  \\$wg$aDenervation
=550  \\$wg$aParasympathectomy
=550  \\$wh$aVagotomy, Proximal Gastric
=550  \\$wh$aVagotomy, Truncal
=550  \\$aVagus Nerve
=667  \\$aalso called "hyperselective," "superselective," "supraselective," "ultraselective" vagotomy
=680  \\$iThe interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.
=750  \0$aVagotomy$5IEN$0(DLC)sh 85141763

=LDR  00756cz  a2200229n  4500
=001  9880364161302441
=005  20141212210609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014627
=035  \\$aCBA7966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x894.$x906
=150  \\$aVaginitis
=450  \\$wnnna$aVaginitides
=550  \\$wg$aVaginal Diseases
=550  \\$wh$aAtrophic Vaginitis
=550  \\$wh$aTrichomonas Vaginitis
=550  \\$wh$aVaginosis, Bacterial
=550  \\$wh$aVulvovaginitis
=667  \\$ageneral or unspecified; prefer specifics; TRICHOMONAS VAGINITIS is also available
=680  \\$iInflammation of the vagina characterized by pain and a purulent discharge.
=750  \0$aVaginitis$5IEN$0(DLC)sh 85141762

=LDR  01222cz  a2200337n  4500
=001  9880364161402441
=005  20141212210609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014626
=035  \\$aCBA7965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100.$x800
=072  \\$aE1.$x370.$x225.$x998.$x54.$x800
=072  \\$aE1.$x370.$x378.$x900
=072  \\$aE4.$x74.$x800
=072  \\$aE5.$x200.$x500.$x384.$x100.$x800
=072  \\$aE5.$x200.$x998.$x54.$x800
=072  \\$aE5.$x242.$x384.$x100.$x800
=150  \\$aVaginal Smears
=450  \\$wnnna$aCervical Smear
=450  \\$aCervical Smears
=450  \\$wnnna$aSmear, Cervical
=450  \\$wnnna$aSmear, Vaginal
=450  \\$wnnna$aSmears, Cervical
=450  \\$wnnna$aSmears, Vaginal
=450  \\$wnnna$aVaginal Smear
=550  \\$wg$aBiopsy
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=667  \\$anote entry term CERVICAL SMEARS: do not coordinate with CERVIX UTERI; Pap smear: coordinate VAGINAL SMEARS with PAPANICOLAOU TEST
=680  \\$iCollection of pooled secretions of the posterior vaginal fornix for cytologic examination.
=750  \0$aVaginal smears$5IEN$0(DLC)sh 85141760

=LDR  01340cz  a2200421n  4500
=001  9880364161502441
=005  20141212210608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014625
=035  \\$aCBA7964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418.$x955
=072  \\$aC13.$x351.$x500.$x894.$x834
=072  \\$aC13.$x351.$x937.$x418.$x937
=150  \\$aVaginal Neoplasms
=450  \\$wnnna$aCancer of the Vagina
=450  \\$aCancer of Vagina
=450  \\$wnnna$aCancer, Vagina
=450  \\$wnnna$aCancer, Vaginal
=450  \\$wnnna$aCancers, Vagina
=450  \\$wnnna$aCancers, Vaginal
=450  \\$wnnna$aNeoplasm, Vagina
=450  \\$wnnna$aNeoplasm, Vaginal
=450  \\$wnnna$aNeoplasms, Vagina
=450  \\$wnnna$aNeoplasms, Vaginal
=450  \\$wnnna$aVagina Cancer
=450  \\$wnnna$aVagina Cancers
=450  \\$wnnna$aVagina Neoplasm
=450  \\$wnnna$aVagina Neoplasms
=450  \\$aVaginal Cancer
=450  \\$wnnna$aVaginal Cancers
=450  \\$wnnna$aVaginal Neoplasm
=550  \\$wg$aGenital Neoplasms, Female
=550  \\$wg$aVaginal Diseases
=667  \\$acoordinate IM with histologic type of neoplasm (IM)
=680  \\$iTumors or cancer of the VAGINA.
=750  \0$aVagina$xCancer$0(DLC)sh 85141756$5IEN-M
=750  \0$aVagina$xTumors$0(IEN)381456$5IEN-M

=LDR  00866cz  a2200301n  4500
=001  9880364161602441
=005  20141212210607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014623
=035  \\$aCBA7962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x894
=150  \\$aVaginal Diseases
=450  \\$wnnna$aDisease, Vaginal
=450  \\$wnnna$aDiseases, Vaginal
=450  \\$wnnna$aVaginal Disease
=550  \\$wg$aGenital Diseases, Female
=550  \\$wh$aHematocolpos
=550  \\$wh$aHydrocolpos
=550  \\$wh$aVaginal Discharge
=550  \\$wh$aVaginal Fistula
=550  \\$wh$aVaginal Neoplasms
=550  \\$wh$aVaginismus
=550  \\$wh$aVaginitis
=667  \\$ainflammatory disease = VAGINITIS
=680  \\$iPathological processes of the VAGINA.
=688  \\$a66
=750  \0$aVagina$xDiseases$5IEN$0(DLC)sh 85141757

=LDR  01983cz  a2200529n  4500
=001  9880364161702441
=005  20141212192617.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014622
=035  \\$aCBA7961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x955
=072  \\$aD26.$x908
=072  \\$aE7.$x357.$x750
=150  \\$aVaginal Creams, Foams, and Jellies
=450  \\$wnnna$aCream, Vaginal
=450  \\$wnnna$aCreams, Vaginal
=450  \\$wnnna$aFoam, Vaginal
=450  \\$wnnna$aFoams, Vaginal
=450  \\$wnnna$aGel, Vaginal
=450  \\$wnnna$aGels, Vaginal
=450  \\$wnnna$aJellies, Vaginal
=450  \\$wnnna$aJelly, Vaginal
=450  \\$wnnna$aTablet, Vaginal
=450  \\$wnnna$aTablets, Vaginal
=450  \\$wnnna$aVaginal Cream
=450  \\$wnnna$aVaginal Creams
=450  \\$aVaginal Creams, Foams and Jellies
=450  \\$wnnna$aVaginal Foam
=450  \\$wnnna$aVaginal Foams
=450  \\$wnnna$aVaginal Gel
=450  \\$wnnna$aVaginal Gels
=450  \\$wnnna$aVaginal Jellies
=450  \\$wnnna$aVaginal Jelly
=450  \\$wnnna$aVaginal Tablet
=450  \\$wnnna$aVaginal Tablets
=550  \\$wg$aDosage Forms
=550  \\$wg$aFeminine Hygiene Products
=550  \\$wg$aPharmaceutical Preparations
=550  \\$aAdministration, Intravaginal
=550  \\$aContraceptive Agents, Female
=667  \\$aIM general only; coordinate NIM with specific drug (IM)
=680  \\$iMedicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.
=688  \\$a2007 (1975)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Vaginal Creams, Foams and Jellies
=688  \\$a1975
=750  \0$aVagina, Medication by$0(DLC) sh 85141759$5IEN-M

=LDR  00858cz  a2200205n  4500
=001  9880364161802441
=005  20141212210607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014621
=035  \\$aCBA7960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x779
=150  \\$aVagina
=360  \\$iconsider also terms at$aCOLPO-
=450  \\$wnnna$aVaginas
=550  \\$wg$aGenitalia, Female
=550  \\$wh$aHymen
=667  \\$a"vaginal bleeding" is probably UTERINE HEMORRHAGE but check text; inflammation = VAGINITIS or specifics; surg: consider COLPOTOMY; "vaginal opening" (assessing SEXUAL MATURATION by repeated daily inspection of laboratory animals): index SEXUAL MATURATION + VAGINA
=680  \\$iThe genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
=750  \0$aVagina$5IEN$0(DLC)sh 85141754

=LDR  01731cz  a2200373n  4500
=001  9880364161902441
=005  20141212210607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014620
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x875.$x970
=150  \\$aVacuum Extraction, Obstetrical
=450  \\$wnnna$aDeliveries, Vacuum Extraction
=450  \\$aDelivery, Vacuum Extraction
=450  \\$wnnna$aExtraction Deliveries, Vacuum
=450  \\$wnnna$aExtraction Delivery, Vacuum
=450  \\$wnnna$aExtraction, Obstetric Vacuum
=450  \\$wnnna$aExtraction, Obstetrical Vacuum
=450  \\$wnnna$aExtractions, Obstetric Vacuum
=450  \\$wnnna$aExtractions, Obstetrical Vacuum
=450  \\$wnnna$aObstetric Vacuum Extraction
=450  \\$wnnna$aObstetric Vacuum Extractions
=450  \\$wnnna$aObstetrical Vacuum Extraction
=450  \\$wnnna$aObstetrical Vacuum Extractions
=450  \\$wnnna$aVacuum Extraction Deliveries
=450  \\$wnnna$aVacuum Extraction Delivery
=450  \\$wnnna$aVacuum Extraction, Obstetric
=450  \\$wnnna$aVacuum Extractions, Obstetric
=450  \\$wnnna$aVacuum Extractions, Obstetrical
=550  \\$wg$aExtraction, Obstetrical
=667  \\$aremoval of fetus from uterus at delivery; do not use /util except by MeSH definition
=680  \\$iRemoval of the fetus from the uterus or vagina at or near the end of pregnancy with a metal traction cup that is attached to the fetus' head. Negative pressure is applied and traction is made on a chain passed through the suction tube. (From Stedman, 26th ed & Dorland, 28th ed)
=688  \\$a91(75); was see under EXTRACTION, OBSTETRICAL 1975-90
=750  \0$aObstetrical extraction$5IEN$0(DLC)sh 85093759

=LDR  01033cz  a2200313n  4500
=001  9880364162002441
=005  20141212210606.0
=008  750204\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014619
=035  \\$aCBA7958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x157.$x310.$x970
=072  \\$aE4.$x950.$x300.$x299.$x970
=150  \\$aVacuum Curettage
=450  \\$wnnna$aAspirator, Uterine
=450  \\$wnnna$aAspirators, Uterine
=450  \\$wnnna$aCurettage, Suction
=450  \\$wnnna$aCurettage, Vacuum
=450  \\$wnnna$aCurettages, Suction
=450  \\$wnnna$aCurettages, Vacuum
=450  \\$aSuction Curettage
=450  \\$wnnna$aSuction Curettages
=450  \\$wnnna$aUterine Aspirator
=450  \\$wnnna$aUterine Aspirators
=450  \\$wnnna$aVacuum Curettages
=550  \\$wg$aDilatation and Curettage
=680  \\$iAspiration of the contents of the uterus with a vacuum curette.
=688  \\$a91(75); was see under DILATATION AND CURETTAGE 1975-90
=750  \0$aCurettage, Vacuum$5IEN$0(DLC)sh 85034851

=LDR  00795cz  a2200229n  4500
=001  9880364162102441
=005  20141212210606.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014618
=035  \\$aCBA7957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x715.$x902
=072  \\$aG16.$x500.$x750.$x274.$x902
=072  \\$aN6.$x230.$x300.$x100.$x185.$x902
=150  \\$aVacuum
=450  \\$wnnna$aVacuums
=550  \\$wg$aAtmospheric Pressure
=550  \\$wg$aPressure
=667  \\$aalmost never IM; no qualif
=680  \\$iA space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space.
=688  \\$a91(78); was see under ATMOSPHERIC PRESSURE 1978-90
=750  \0$aVacuum$5IEN$0(DLC)sh 85141726

=LDR  00598cz  a2200181n  4500
=001  9880364162202441
=005  20141212210605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014615
=035  \\$aCBA7954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x929
=150  \\$aVaccinia
=450  \\$wnnna$aVaccinias
=550  \\$wg$aPoxviridae Infections
=667  \\$acaused by a poxvirus after smallpox vaccination
=680  \\$iThe cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine.
=750  \0$aVaccinia$5IEN$0(DLC)sh 85141721

=LDR  01706cz  a2200457n  4500
=001  9880364162302441
=005  20141212210604.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014614
=035  \\$aCBA7953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x828.$x868
=072  \\$aD20.$x215.$x894.$x865
=072  \\$aD23.$x50.$x865
=150  \\$aVaccines, Synthetic
=450  \\$aAntigens, Synthetic
=450  \\$aChemical Vaccines
=450  \\$aImmunogens, Synthetic
=450  \\$aMolecular Vaccines
=450  \\$wnnna$aRecombinant Vaccines
=450  \\$aSemisynthetic Vaccines
=450  \\$wnnna$aSynthetic Antigens
=450  \\$wnnna$aSynthetic Immunogens
=450  \\$aSynthetic Vaccines
=450  \\$wnnna$aVaccines, Chemical
=450  \\$wnnna$aVaccines, Molecular
=450  \\$aVaccines, Recombinant
=450  \\$wnnna$aVaccines, Semisynthetic
=550  \\$wg$aAntigens
=550  \\$wg$aRecombinant Proteins
=550  \\$wg$aVaccines
=550  \\$wh$aVaccines, Conjugate
=550  \\$wh$aVaccines, DNA
=550  \\$wh$aVaccines, Edible
=550  \\$wh$aVaccines, Virosome
=550  \\$wh$aVaccines, Virus-Like Particle
=667  \\$aIM general only; coord NIM with specific vaccine (IM)
=680  \\$iSmall synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
=688  \\$a91(87); was see under VACCINES 1989-90; was see under ANTIGENS 1987-88
=750  \0$aSynthetic vaccines$5IEN-M$0(DLC)sh 88007866
=750  \0$aSynthetic antigens$5IEN-HS$0(DLC)sh 88007864

=LDR  01271cz  a2200349n  4500
=001  9880364162402441
=005  20141212210603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014612
=035  \\$aCBA7950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894
=150  \\$aVaccines
=550  \\$wg$aBiological Products
=550  \\$wh$aAlzheimer Vaccines
=550  \\$wh$aBacterial Vaccines
=550  \\$wh$aCancer Vaccines
=550  \\$wh$aFungal Vaccines
=550  \\$wh$aProtozoan Vaccines
=550  \\$wh$aToxoids
=550  \\$wh$aVaccines, Attenuated
=550  \\$wh$aVaccines, Combined
=550  \\$wh$aVaccines, Contraceptive
=550  \\$wh$aVaccines, Inactivated
=550  \\$wh$aVaccines, Live, Unattenuated
=550  \\$wh$aVaccines, Marker
=550  \\$wh$aVaccines, Subunit
=550  \\$wh$aVaccines, Synthetic
=550  \\$wh$aViral Vaccines
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iSuspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa, or rickettsiae), antigenic proteins derived from them, or synthetic constructs, administered for the prevention, amelioration, or treatment of infectious and other diseases.
=750  \0$aVaccines$5IEN$0(DLC)sh 85141718

=LDR  01193cz  a2200313n  4500
=001  9880364162502441
=005  20200717175329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014611
=035  \\$aCBA7949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465.$x425.$x400.$x530.$x890
=072  \\$aE5.$x478.$x550.$x600.$x890
=072  \\$aN2.$x421.$x726.$x758.$x310.$x890
=072  \\$aN6.$x850.$x780.$x200.$x425.$x900
=072  \\$aN6.$x850.$x780.$x680.$x310.$x890
=150  \\$aVaccination
=450  \\$wnnna$aActive Immunization
=450  \\$wnnna$aActive Immunizations
=450  \\$aImmunization, Active
=450  \\$wnnna$aImmunizations, Active
=450  \\$wnnna$aVaccinations
=550  \\$wg$aImmunization
=550  \\$wg$aImmunotherapy, Active
=550  \\$wh$aMass Vaccination
=550  \\$wh$aVaccination Coverage
=667  \\$aManual 26.22.2.2+; coordinate IM with disease /prev (IM); REVACCINATION see IMMUNIZATION, SECONDARY is also available
=680  \\$iAdministration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
=750  \0$aVaccination$5IEN$0(DLC)sh 85141709

=LDR  00450cz  a2200169n  4500
=001  9880364162602441
=005  20141212210602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014609
=035  \\$aCBA7947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x617.$x780.$x729
=150  \\$aUvula
=450  \\$wnnna$aUvulas
=550  \\$wg$aPalate, Soft
=688  \\$a65(63); was see under PALATE 1963-64
=750  \0$aUvula$5IEN$0(DLC)sh 85141651

=LDR  00805cz  a2200229n  4500
=001  9880364162702441
=005  20141212210601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014605
=035  \\$aCBA7943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x879
=150  \\$aUveitis
=450  \\$wnnna$aUveitides
=550  \\$wg$aUveal Diseases
=550  \\$wh$aPanuveitis
=550  \\$wh$aUveitis, Intermediate
=550  \\$wh$aUveitis, Suppurative
=550  \\$wh$aUveomeningoencephalitic Syndrome
=667  \\$ainflamm of uvea; GEN: prefer specifics
=680  \\$iInflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
=750  \0$aUveitis$5IEN$0(DLC)sh 85141648

=LDR  00700cz  a2200193n  4500
=001  9880364162802441
=005  20141212210532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014518
=035  \\$aCBA7856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x725.$x876
=072  \\$aC13.$x351.$x968.$x725.$x876
=150  \\$aUreterocele
=450  \\$wnnna$aUreteroceles
=550  \\$wg$aUreteral Diseases
=680  \\$iA cystic dilatation of the end of a URETER as it enters into the URINARY BLADDER. It is characterized by the ballooning of the ureteral orifice into the lumen of the bladder and may obstruct urine flow.
=688  \\$a68(63)
=750  \0$aUreterocele$5IEN$0(DLC)sh 85141371

=LDR  01097cz  a2200217n  4500
=001  9880364162902441
=005  20141212210532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014517
=035  \\$aCBA7855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x725.$x776
=072  \\$aC13.$x351.$x968.$x725.$x776
=150  \\$aUreteral Obstruction
=450  \\$wnnna$aObstruction, Ureteral
=450  \\$wnnna$aObstructions, Ureteral
=450  \\$wnnna$aUreteral Obstructions
=550  \\$wg$aUreteral Diseases
=667  \\$ado not confuse with URETHRAL OBSTRUCTION, especially in Romance languages: see note on "ureteral" & "urethral" under URETERAL DISEASES
=680  \\$iBlockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
=750  \0$aUreters$xObstructions$5IEN$0(DLC)sh 85141376

=LDR  01608cz  a2200421n  4500
=001  9880364163002441
=005  20141212210531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014516
=035  \\$aCBA7854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x947.$x940
=072  \\$aC12.$x758.$x820.$x875
=072  \\$aC12.$x777.$x725.$x676
=072  \\$aC13.$x351.$x937.$x820.$x875
=072  \\$aC13.$x351.$x968.$x725.$x676
=150  \\$aUreteral Neoplasms
=450  \\$wnnna$aCancer of the Ureter
=450  \\$aCancer of Ureter
=450  \\$wnnna$aCancer, Ureteral
=450  \\$wnnna$aCancers, Ureteral
=450  \\$wnnna$aNeoplasm, Ureteral
=450  \\$wnnna$aNeoplasms of Ureter
=450  \\$wnnna$aNeoplasms, Ureteral
=450  \\$wnnna$aUreter Cancer
=450  \\$wnnna$aUreter, Cancer Of
=450  \\$wnnna$aUreter Cancers
=450  \\$wnnna$aUreter Neoplasm
=450  \\$wnnna$aUreter Neoplasms
=450  \\$aUreteral Cancer
=450  \\$wnnna$aUreteral Cancers
=450  \\$wnnna$aUreteral Neoplasm
=550  \\$wg$aUreteral Diseases
=550  \\$wg$aUrologic Neoplasms
=667  \\$ado not confuse with URETHRAL NEOPLASMS, especially in Romance language: see note on "ureteral" & "urethral" under URETERAL DISEASES; coordinate IM with histological type of neoplasm (IM)
=680  \\$iCancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.
=750  \0$aUreters$xCancer$5IEN-M$0(DLC)sh2010010459
=750  \0$aUreters$xTumors$5IEN-HS$0(DLC)sh 85141380

=LDR  01008cz  a2200277n  4500
=001  9880364163102441
=005  20141212192617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014515
=035  \\$aCBA7853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x725
=072  \\$aC13.$x351.$x968.$x725
=150  \\$aUreteral Diseases
=450  \\$wnnna$aDisease, Ureteral
=450  \\$wnnna$aDiseases, Ureteral
=450  \\$wnnna$aUreteral Disease
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aUreteral Neoplasms
=550  \\$wh$aUreteral Obstruction
=550  \\$wh$aUreterocele
=550  \\$wh$aUreterolithiasis
=667  \\$ado not confuse with URETHRAL DISEASES, especially in Romance languages: urétéral (French), ureteral (Spanish), ureterale (Italian) = "ureteral", while urétral (French), uretral (Spanish), uretrale (Italian) = "urethral"
=680  \\$iPathological processes involving the URETERS.
=688  \\$a66
=750  \0$aUreters$xDiseases$5IEN$0(DLC)sh 85141374

=LDR  00901cz  a2200193n  4500
=001  9880364163202441
=005  20141212192616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014513
=035  \\$aCBA7851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x776
=150  \\$aUreter
=450  \\$wnnna$aUreters
=550  \\$wg$aUrinary Tract
=550  \\$aRetrocaval Ureter
=667  \\$ado not confuse with URETHRA, espec in Romance lang: uretère (French), uréter (Span), uretere (Ital) = URETER, while urètre (French), uretra (Span), uretra (Ital) = URETHRA; /surg: consider URETEROSTOMY & URINARY DIVERSION (TN 189: probably do not index under URETER); ureteral catheterization: coord NIM with URINARY CATHETERIZATION (IM)
=680  \\$iOne of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.
=750  \0$aUreters$5IEN$0(DLC)sh 85141373

=LDR  00911cz  a2200217n  4500
=001  9880364163302441
=005  20141212210530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014511
=035  \\$aCBA7849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x936
=072  \\$aC13.$x351.$x968.$x419.$x936
=150  \\$aUremia
=450  \\$wnnna$aUremias
=550  \\$wg$aKidney Diseases
=550  \\$wh$aAzotemia
=550  \\$wh$aHemolytic-Uremic Syndrome
=550  \\$aKidney Failure, Chronic
=680  \\$iA clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
=750  \0$aUremia$5IEN$0(DLC)sh 85141368

=LDR  00607cz  a2200193n  4500
=001  9880364163402441
=005  20141212210530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014510
=035  \\$aCBA7848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x902
=150  \\$aUrease
=450  \\$wnnna$aAmidohydrolase, Urea
=450  \\$wnnna$aPhytourease
=450  \\$wnnna$aUrea Amidohydrolase
=550  \\$wg$aAmidohydrolases
=680  \\$iAn enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.
=750  \0$aUrease$5IEN$0(DLC)sh 85141365

=LDR  00999cz  a2200313n  4500
=001  9880364163502441
=005  20141212210530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014508
=035  \\$aCBA7846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x948
=150  \\$aUrea
=450  \\$wnnna$aBasodexan
=450  \\$wnnna$aCarbamide
=450  \\$wnnna$aCarmol
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAllantoin
=550  \\$wh$aBiureas
=550  \\$wh$aBiuret
=550  \\$wh$aBromisovalum
=550  \\$wh$aHydroxyurea
=550  \\$wh$aMethylurea Compounds
=550  \\$wh$aNitrosourea Compounds
=550  \\$wh$aPhenylurea Compounds
=550  \\$wh$aSulfonylurea Compounds
=550  \\$wh$aThiourea
=680  \\$iA compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.
=750  \0$aUrea$5IEN$0(DLC)sh 85141359

=LDR  00863cz  a2200265n  4500
=001  9880364163602441
=005  20141212192616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014507
=035  \\$aCBA7845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x400.$x726
=150  \\$aUrbanization
=450  \\$wnnna$aCentral Cities
=450  \\$wnnna$aCentral City
=450  \\$wnnna$aCities, Central
=450  \\$wnnna$aCity, Central
=450  \\$wnnna$aUrbanizations
=550  \\$wg$aSocial Change
=550  \\$aCities
=550  \\$aUrban Population
=667  \\$aspecify geog if pertinent
=680  \\$iThe process whereby a society changes from a rural to an urban way of life. It refers also to the gradual increase in the proportion of people living in urban areas.
=688  \\$a68
=750  \0$aUrbanization$5IEN$0(DLC)sh 85141338

=LDR  00925cz  a2200265n  4500
=001  9880364163702441
=005  20141212210529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014506
=035  \\$aCBA7844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x709.$x876
=150  \\$aUrban Renewal
=450  \\$wnnna$aDevelopment, Urban
=450  \\$wnnna$aDevelopments, Urban
=450  \\$wnnna$aRenewal, Urban
=450  \\$wnnna$aRenewals, Urban
=450  \\$aUrban Development
=450  \\$wnnna$aUrban Developments
=450  \\$wnnna$aUrban Renewals
=550  \\$wg$aSocial Planning
=667  \\$aPublic Law 89-754; specify locale
=680  \\$iThe planned upgrading of a deteriorating urban area, involving rebuilding, renovation, or restoration. It frequently refers to programs of major demolition and rebuilding of blighted areas.
=688  \\$a68
=750  \0$aUrban renewal$5IEN$0(DLC)sh 85141324

=LDR  00563cz  a2200205n  4500
=001  9880364163802441
=005  20141212210529.0
=008  780510\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014504
=035  \\$aCBA7842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x800
=150  \\$aUrban Health
=450  \\$wnnna$aHealth, Urban
=550  \\$wg$aHealth
=550  \\$aCities
=667  \\$aspecify geog
=680  \\$iThe status of health in urban populations.
=688  \\$a90(79); was see under HEALTH 1979-89
=750  \0$aUrban health$5IEN$0(DLC)sh 85141316

=LDR  00854cz  a2200229n  4500
=001  9880364163902441
=005  20141212210528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014501
=035  \\$aCBA7839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x950
=072  \\$aD1.$x268.$x271.$x100.$x950
=072  \\$aD1.$x268.$x556.$x900
=072  \\$aD1.$x552.$x20.$x940
=072  \\$aD1.$x552.$x544.$x900
=150  \\$aUranium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iUranium. A radioactive element of the actinide series of metals. It has an atomic symbol U, atomic number 92, and atomic weight 238.03. U-235 is used as the fissionable fuel in nuclear weapons and as fuel in nuclear power reactors.
=750  \0$aUranium$5IEN-M$0(DLC)sh 85141276

=LDR  00784cz  a2200253n  4500
=001  9880364164002441
=005  20141212210527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014498
=035  \\$aCBA7836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x875
=150  \\$aUracil
=550  \\$wg$aPyrimidinones
=550  \\$wh$aBromouracil
=550  \\$wh$aFluorouracil
=550  \\$wh$aHydroxyphenylazouracil
=550  \\$wh$aOrotic Acid
=550  \\$wh$aPentoxyl
=550  \\$wh$aThiouracil
=550  \\$wh$aThymine
=550  \\$wh$aUracil Mustard
=667  \\$a/biosyn /physiol permitted; uracil deoxyriboside, uracil deoxyribonucleoside = DEOXYURIDINE; uracil riboside, uracil ribonucleoside = URIDINE
=750  \0$aUracil$0(DLC) sh 85141257$5IEN

=LDR  00759cz  a2200169n  4500
=001  9880364164102441
=005  20141212210527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014497
=035  \\$aCBA7835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x890
=150  \\$aUrachus
=550  \\$wg$aEmbryonic Structures
=667  \\$apatent urachus: index under URACHUS /abnorm: do not confuse with URACHAL CYST
=680  \\$iAn embryonic structure originating from the ALLANTOIS. It is a canal connecting the fetal URINARY BLADDER and the UMBILICUS. It is normally converted into a fibrous cord postnatally. When the canal fails to be filled and remains open (patent urachus), urine leaks through the umbilicus.
=750  \0$aUrachus$5IEN$0(DLC)sh 85141256

=LDR  00970cz  a2200205n  4500
=001  9880364164202441
=005  20141212210526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014495
=035  \\$aCBA7833HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x850
=150  \\$aUniversities
=450  \\$aColleges$5IEN
=450  \\$aUniversities and Colleges$5IEN
=450  \\$wnnna$aUniversity
=550  \\$wg$aSchools
=667  \\$aIM; Manual 30.8, 36.18; specify locale if pertinent; colleges as educ institutions go here: do not confuse with bodies such as "College of Physicians" which are indexed under SOCIETIES, MEDICAL; Uniformed Services University of the Health Sciences (USUHS), under US Dept of Defense, goes under SCHOOLS, MEDICAL + UNITED STATES; DF: UNIV
=680  \\$iEducational institutions providing facilities for teaching and research and authorized to grant academic degrees.
=750  \0$aUniversities and colleges$5IEN$0(DLC)sh 85141086

=LDR  00559cz  a2200193n  4500
=001  9880364164302441
=005  20141212210520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014478
=035  \\$aCBA7816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x245.$x850
=150  \\$aUnemployment
=450  \\$aUnemployed$5IEN
=550  \\$wg$aEmployment
=550  \\$aEmployment
=680  \\$iThe state of not being engaged in a gainful occupation.
=750  \0$aUnemployment$5IEN-M$0(DLC)sh 85139643
=750  \0$aUnemployed$5IEN-HS$0(DLC)sh 85139639

=LDR  00697cz  a2200217n  4500
=001  9880364164402441
=005  20141212210519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014477
=035  \\$aCBA7815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x880
=150  \\$aUnderachievement
=450  \\$wnnna$aUnderachievements
=450  \\$aUnderachievers$5IEN
=550  \\$wg$aPsychology, Educational
=667  \\$ano qualif
=680  \\$iPerformance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing.
=688  \\$a68
=750  \0$aUnderachievement$5IEN-M$0(DLC)sh 88003307
=750  \0$aUnderachievers$5IEN-HS$0(DLC)sh 85139573

=LDR  01163cz  a2200313n  4500
=001  9880364164502441
=005  20141212210519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014474
=035  \\$aCBA7812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x358.$x800
=072  \\$aC23.$x888.$x592.$x604.$x359.$x800
=150  \\$aUnconsciousness
=450  \\$aConsciousness, Loss of
=450  \\$wnnna$aLoss of Consciousness
=450  \\$wnnna$aState, Unconscious
=450  \\$aUnconscious State
=450  \\$wnnna$aUnconscious States
=550  \\$wg$aConsciousness Disorders
=550  \\$wh$aComa
=550  \\$wh$aPersistent Vegetative State
=550  \\$wh$aStupor
=550  \\$wh$aSyncope
=550  \\$aConsciousness
=550  \\$aSyncope
=667  \\$ado not confuse with UNCONSCIOUS (PSYCHOLOGY), unconscious behavior or "the unconscious" in psychol
=680  \\$iLoss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5)
=750  \0$aLoss of consciousness$5IEN$0(DLC)sh 85078433

=LDR  00568cz  a2200181n  4500
=001  9880364164702441
=005  20141212210518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014472
=035  \\$aCBA7810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x849
=150  \\$aUmbilicus
=360  \\$iconsider also terms at$aOMPHALO- (navel)
=450  \\$aNavel$5IEN
=550  \\$wg$aAbdomen
=680  \\$iThe pit in the center of the ABDOMINAL WALL marking the point where the UMBILICAL CORD entered in the FETUS.
=750  \0$aNavel$5IEN$0(DLC)sh 85139524

=LDR  00855cz  a2200229n  4500
=001  9880364164802441
=005  20141212210518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014470
=035  \\$aCBA7808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x378.$x693
=150  \\$aUmbilical Cord
=450  \\$wnnna$aCord, Umbilical
=450  \\$wnnna$aCords, Umbilical
=450  \\$wnnna$aUmbilical Cords
=550  \\$wg$aFetus
=550  \\$wh$aUmbilical Arteries
=550  \\$wh$aUmbilical Veins
=667  \\$aCORD BLOOD see FETAL BLOOD is available
=680  \\$iThe flexible rope-like structure that connects a developing FETUS to the PLACENTA in mammals. The cord contains blood vessels which carry oxygen and nutrients from the mother to the fetus and waste products away from the fetus.
=750  \0$aUmbilical cord$5IEN$0(DLC)sh 85139520

=LDR  01251cz  a2200277n  4500
=001  9880364164902441
=005  20141212210517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014467
=035  \\$aCBA7805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x774.$x945
=150  \\$aUltraviolet Therapy
=450  \\$wnnna$aActinotherapies
=450  \\$aActinotherapy
=450  \\$wnnna$aTherapies, Ultraviolet
=450  \\$wnnna$aTherapy, Ultraviolet
=450  \\$aUltraviolet Rays$xtherapeutic use
=450  \\$wnnna$aUltraviolet Therapies
=550  \\$wg$aPhototherapy
=550  \\$wh$aPUVA Therapy
=550  \\$aLight
=667  \\$anon-ionizing but short-wave UV is ionizing; do not use /util except by MeSH definition; coord with dis /radiother, not dis /ther; do not index here for ultraviolet ther in PUVA THERAPY unless particularly discussed
=680  \\$iThe use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.
=688  \\$a65
=750  \0$aUltraviolet radiation$xTherapeutic use$0(IEN)379787$5IEN

=LDR  02117cz  a2200529n  4500
=001  9880364165002441
=005  20141212210516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014466
=035  \\$aCBA7804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650.$x891
=072  \\$aG1.$x590.$x540.$x891
=072  \\$aG1.$x750.$x250.$x650.$x891
=072  \\$aG1.$x750.$x750.$x659
=072  \\$aG1.$x750.$x770.$x578.$x891
=072  \\$aG16.$x500.$x275.$x63.$x725.$x525.$x600
=072  \\$aG16.$x500.$x750.$x775.$x525.$x600
=072  \\$aN6.$x230.$x300.$x100.$x725.$x525.$x600
=150  \\$aUltraviolet Rays
=450  \\$wnnna$aActinic Ray
=450  \\$aActinic Rays
=450  \\$wnnna$aBlack Light, Ultraviolet
=450  \\$wnnna$aBlack Lights, Ultraviolet
=450  \\$wnnna$aLight, Ultraviolet
=450  \\$wnnna$aLight, UV
=450  \\$wnnna$aRay, Actinic
=450  \\$wnnna$aRay, Ultra-Violet
=450  \\$wnnna$aRay, Ultraviolet
=450  \\$wnnna$aRays, Actinic
=450  \\$wnnna$aRays, Ultra-Violet
=450  \\$wnnna$aRays, Ultraviolet
=450  \\$wnnna$aUltra-Violet Ray
=450  \\$wnnna$aUltra-Violet Rays
=450  \\$wnnna$aUltra Violet Rays
=450  \\$wnnna$aUltraviolet Black Light
=450  \\$wnnna$aUltraviolet Black Lights
=450  \\$wnnna$aUltraviolet Light
=450  \\$aUltraviolet Radiation$5IEN
=450  \\$wnnna$aUltraviolet Ray
=450  \\$wnnna$aUV Light
=550  \\$wg$aLight
=550  \\$wg$aRadiation, Ionizing
=550  \\$wg$aSunlight
=667  \\$anon-ionizing but short-wave UV is ionizing
=680  \\$iThat portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.
=750  \0$aUltraviolet radiation$5IEN$0(DLC)sh 85139506

=LDR  01175cz  a2200193n  4500
=001  9880364165102441
=005  20141212210516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014465
=035  \\$aCBA7803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x31.$x849
=150  \\$aUltrasonics
=450  \\$wnnna$aUltrasonic
=450  \\$aUltrasonic Waves$5IEN
=550  \\$wg$aAcoustics
=667  \\$athe discipline (education, history, etc) only; use ULTRASONOGRAPHY or ULTRASONIC THERAPY or specifics treed under them for diagnostic or therapeutic use of ultrasonic waves; the qualifier / ultrasonography is available for use with specific anatomical terms and diseases
=680  \\$iA subfield of acoustics dealing in the radio frequency range higher than acoustic SOUND waves (approximately above 20 kilohertz). Ultrasonic radiation is used therapeutically (DIATHERMY and ULTRASONIC THERAPY) to generate HEAT and to selectively destroy tissues. It is also used in diagnostics, for example, ULTRASONOGRAPHY; ECHOENCEPHALOGRAPHY; and ECHOCARDIOGRAPHY, to visually display echoes received from irradiated tissues.
=750  \0$aUltrasonics$5IEN-HS$0(DLC)sh 85139494

=LDR  01106cz  a2200277n  4500
=001  9880364165202441
=005  20200508141106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014464
=035  \\$aCBA7802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x565.$x280.$x945
=072  \\$aE2.$x779.$x496.$x280.$x945
=150  \\$aUltrasonic Therapy
=450  \\$wnnna$aTherapies, Ultrasonic
=450  \\$wnnna$aTherapy, Ultrasonic
=450  \\$wnnna$aUltrasonic Therapies
=450  \\$aUltrasonic Waves$xtherapeutic use
=450  \\$aUltrasonics$xtherapeutic use
=550  \\$wg$aDiathermy
=550  \\$wh$aExtracorporeal Shockwave Therapy
=550  \\$wh$aHigh-Intensity Focused Ultrasound Ablation
=550  \\$aUltrasonic Surgical Procedures
=667  \\$ado not use /util except by MeSH definition; coord with dis /ther, not dis /radiother
=680  \\$iThe use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue.
=750  \0$aUltrasonic waves$xTherapeutic use$0(DLC) sh 85139492$5IEN

=LDR  01508cz  a2200337n  4500
=001  9880363702002441
=005  20141212203803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009364
=035  \\$aCBA2628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x655
=072  \\$aC23.$x550.$x727.$x655
=150  \\$aNeoplasm Recurrence, Local
=450  \\$wnnna$aLocal Neoplasm Recurrence
=450  \\$wnnna$aLocal Neoplasm Recurrences
=450  \\$wnnna$aLocoregional Neoplasm Recurrence
=450  \\$wnnna$aLocoregional Neoplasm Recurrences
=450  \\$wnnna$aNeoplasm Recurrence, Locoregional
=450  \\$wnnna$aNeoplasm Recurrences, Local
=450  \\$wnnna$aNeoplasm Recurrences, Locoregional
=450  \\$wnnna$aRecurrence, Local Neoplasm
=450  \\$wnnna$aRecurrence, Locoregional Neoplasm
=450  \\$wnnna$aRecurrences, Local Neoplasm
=450  \\$wnnna$aRecurrences, Locoregional Neoplasm
=550  \\$wg$aNeoplastic Processes
=550  \\$aRecurrence
=667  \\$aIM; differentiate from NEOPLASMS, MULTIPLE PRIMARY (Manual 24.4.1.5 - 24.4.1.6) and NEOPLASMS, SECOND PRIMARY (Manual 24.4.1.7); do not confuse with NEOPLASM, RESIDUAL; DF: NEOPL RECURRENCE LOCAL
=680  \\$iThe local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
=688  \\$a66(64)
=750  \0$aCancer$xRelapse$5IEN$0(DLC)sh 85019535

=LDR  01504cz  a2200265n  4500
=001  9880363702102441
=005  20160425101339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009363
=035  \\$aCBA2627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x624
=150  \\$aNeoplasm Proteins
=450  \\$wnnna$aProteins, Neoplasm
=450  \\$aTumor Proteins$5IEN
=550  \\$wg$aProteins
=550  \\$wh$aMelanoma-Specific Antigens
=550  \\$wh$aMyeloma Proteins
=550  \\$wh$aOncogene Proteins
=550  \\$wh$aTumor Suppressor Proteins
=550  \\$aGenes, Neoplasm
=550  \\$aBiomarkers, Tumor$5IEN-M
=667  \\$aIM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); Manual 24.4.4.4
=680  \\$iProteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (TUMOR MARKERS, BIOLOGICAL) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
=750  \0$aTumor proteins$5IEN$0(DLC)sh 85138552

=LDR  01447cz  a2200313n  4500
=001  9880363702202441
=005  20141212203802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009362
=035  \\$aCBA2626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x650
=072  \\$aC23.$x550.$x727.$x650
=150  \\$aNeoplasm Metastasis
=450  \\$wnnna$aMetastases
=450  \\$wnnna$aMetastases, Neoplasm
=450  \\$aMetastasis
=450  \\$wnnna$aMetastasis, Neoplasm
=450  \\$wnnna$aNeoplasm Metastases
=450  \\$aNeoplasms$xsecondary
=550  \\$wg$aNeoplastic Processes
=550  \\$wh$aLymphatic Metastasis
=550  \\$wh$aNeoplasm Micrometastasis
=550  \\$wh$aNeoplasm Seeding
=550  \\$wh$aNeoplasms, Unknown Primary
=550  \\$wh$aNeoplastic Cells, Circulating
=667  \\$aGEN only for metastatic process or neoplasm metast in general; when IM for GEN only, qualif permitted; unlikely as NIM coord: prefer /second with organ/neopl & histol type for metastatic neopl; policy on metastasis & /second: Manual 19.8.65, 24.3.1, 24.4.1.3+; do not confuse with NEOPLASM INVASIVENESS (Manual 24.4.1.1+), LEUKEMIC INFILTRATION (Manual 24.4.1.2), NEOPLASMS, SECOND PRIMARY (Manual 24.4.1.7) or NEOPLASM, RESIDUAL; DF: NEOPL METASTASIS
=680  \\$iThe transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
=750  \0$aMetastasis$5IEN$0(DLC)sh 85084296

=LDR  00859cz  a2200253n  4500
=001  9880363702302441
=005  20141212203801.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009361
=035  \\$aCBA2625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x645
=072  \\$aC23.$x550.$x727.$x645
=150  \\$aNeoplasm Invasiveness
=450  \\$aCancer Invasiveness$5IEN
=450  \\$wnnna$aInvasion, Neoplasm
=450  \\$aInvasiveness, Neoplasm
=450  \\$wnnna$aNeoplasm Invasion
=550  \\$wg$aNeoplastic Processes
=550  \\$wh$aLeukemic Infiltration
=667  \\$aIM general only or for invasive process; coordinate NIM with specific neoplasm terms / pathol (IM)
=680  \\$iAbility of neoplasms to infiltrate and actively destroy surrounding tissue.
=688  \\$a77
=750  \0$aCancer invasiveness$5IEN$0(DLC)sh 85019554

=LDR  01904cz  a2200541n  4500
=001  9880363702402441
=005  20141212203801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009360
=035  \\$aCBA2624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x642
=072  \\$aC4.$x697.$x650.$x900
=072  \\$aC23.$x550.$x727.$x650.$x900
=150  \\$aNeoplastic Cells, Circulating
=450  \\$wnnna$aCell, Circulating Neoplastic
=450  \\$wnnna$aCell, Circulating Tumor
=450  \\$wnnna$aCell, Embolic Tumor
=450  \\$wnnna$aCell, Neoplasm Circulating
=450  \\$wnnna$aCells, Circulating Neoplastic
=450  \\$wnnna$aCells, Circulating Tumor
=450  \\$wnnna$aCells, Embolic Tumor
=450  \\$wnnna$aCells, Neoplasm Circulating
=450  \\$wnnna$aCirculating Cells, Neoplasm
=450  \\$wnnna$aCirculating Neoplastic Cell
=450  \\$aCirculating Neoplastic Cells
=450  \\$wnnna$aCirculating Tumor Cell
=450  \\$wnnna$aCirculating Tumor Cells
=450  \\$wnnna$aEmbolic Tumor Cell
=450  \\$aEmbolic Tumor Cells
=450  \\$aEmbolism, Tumor
=450  \\$wnnna$aEmbolisms, Tumor
=450  \\$wnnna$aNeoplasm Circulating Cell
=450  \\$aNeoplasm Circulating Cells
=450  \\$wnnna$aNeoplastic Cell, Circulating
=450  \\$wnnna$aTumor Cell, Circulating
=450  \\$wnnna$aTumor Cell, Embolic
=450  \\$wnnna$aTumor Cells, Circulating
=450  \\$aTumor Cells, Embolic
=450  \\$wnnna$aTumor Embolism
=450  \\$wnnna$aTumor Embolisms
=550  \\$wg$aCells
=550  \\$wg$aNeoplasm Metastasis
=680  \\$iExfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.
=688  \\$a2009 (1965)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Neoplasm Circulating Cells
=688  \\$a66(65)
=750  \0$aCancer cells$xMotility$0(DLC) sh 85019552$5IEN

=LDR  00695cz  a2200181n  4500
=001  9880363702502441
=005  20141212203800.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009359
=035  \\$aCBA2623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x670.$x400
=150  \\$aNeonatology
=550  \\$wg$aPediatrics
=667  \\$aSPEC: SPEC qualif; differentiate from INFANT, NEWBORN, the physiol, psychol or social entity; differentiate from PERINATOLOGY: NEONATOLOGY is newborn inf only, PERINATOLOGY covers fetus & infant; DF: NEONATOL
=680  \\$iA subspecialty of Pediatrics concerned with the newborn infant.
=688  \\$a77
=750  \0$aNeonatology$5IEN$0(DLC)sh 85090800

=LDR  00750cz  a2200181n  4500
=001  9880363702602441
=005  20141212203759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009356
=035  \\$aCBA2620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613.$x600
=072  \\$aD1.$x362.$x641.$x592
=150  \\$aNeon
=550  \\$wg$aNoble Gases
=667  \\$aa rare gas; Ne-20; Ne-21, 22 = NEON (IM) + ISOTOPES (NIM); Ne-17-19, 23, 24 = NEON (IM) + RADIOISOTOPES (IM)
=680  \\$iNeon. A noble gas with the atomic symbol Ne, atomic number 10, and atomic weight 20.18. It is found in the earth's crust and atmosphere as an inert, odorless gas and is used in vacuum tubes and incandescent lamps.
=750  \0$aNeon$5IEN$0(DLC)sh 85090790

=LDR  00879cz  a2200265n  4500
=001  9880363702702441
=005  20141212203759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009355
=035  \\$aCBA2619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x623
=150  \\$aNeomycin
=450  \\$wnnna$aFradiomycin Sulfate
=450  \\$wnnna$aNeomycin Palmitate
=450  \\$wnnna$aNeomycin Sulfate
=450  \\$wnnna$aPalmitate, Neomycin
=450  \\$wnnna$aSulfate, Fradiomycin
=450  \\$wnnna$aSulfate, Neomycin
=550  \\$wg$aAminoglycosides
=550  \\$wh$aFramycetin
=550  \\$wh$aParomomycin
=550  \\$wh$aRibostamycin
=680  \\$iAntibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C. It acts by inhibiting translation during protein synthesis.
=750  \0$aNeomycin$5IEN$0(DLC)sh 85090789

=LDR  00833cz  a2200193n  4500
=001  9880363702802441
=005  20141212203758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009354
=035  \\$aCBA2618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x625
=072  \\$aD1.$x268.$x558.$x362.$x625
=072  \\$aD1.$x552.$x550.$x399.$x625
=150  \\$aNeodymium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth element; Nd-142; Nd-143, 145, 146, 148, 150 = NEODYMIUM (IM) + ISOTOPES (NIM); Nd-138-141, 144, 147, 149, 151 = NEODYMIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iNeodymium. An element of the rare earth family of metals. It has the atomic symbol Nd, atomic number 60, and atomic weight 144.24, and is used in industrial applications.
=750  \0$aNeodymium$5IEN$0(DLC)sh 85090754

=LDR  00669cz  a2200193n  4500
=001  9880363702902441
=005  20141212203758.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009353
=035  \\$aCBA2617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x244.$x500
=072  \\$aD2.$x455.$x326.$x397.$x662.$x500.$x500.$x500
=150  \\$aZinostatin
=450  \\$aNeocarzinostatin
=550  \\$wg$aEnediynes
=680  \\$iAn enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic.
=688  \\$a93; was NEOCARZINOSTATIN 1975-92 (see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90)
=750  \0$aZinostatin$5IEN-M$0(DLC)sh 96010102

=LDR  00990cz  a2200241n  4500
=001  9880363703002441
=005  20190801103720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009348
=035  \\$aCBA2612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294
=150  \\$aNematoda
=450  \\$wnnna$aNematodas
=450  \\$wnno$aSecernentea
=450  \\$aSipunculida
=450  \\$wnnna$aSipunculidas
=550  \\$wg$aHelminths
=550  \\$wh$aAdenophorea
=667  \\$aGEN or unspecified; prefer specifics; infection = NEMATODE INFECTIONS; /drug eff: consider also ANTINEMATODAL AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.
=688  \\$aSIPUNCULIDA was heading 1980-84
=750  \0$aNematodes$5IEN$0(DLC)sh 85090702

=LDR  00761cz  a2200253n  4500
=001  9880363703102441
=005  20141212203757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009346
=035  \\$aCBA2610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x550
=072  \\$aB3.$x660.$x75.$x525
=150  \\$aNeisseriaceae
=550  \\$wg$aBetaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aChromobacterium
=550  \\$wh$aEikenella
=550  \\$wh$aKingella
=550  \\$wh$aNeisseria
=550  \\$wh$aVitreoscilla
=680  \\$iA family of gram-negative, parasitic bacteria including several important pathogens of man.
=688  \\$a75
=750  \0$aNeisseriaceae$5IEN$0(DLC)sh 85090677

=LDR  01477cz  a2200241n  4500
=001  9880363703202441
=005  20141212203757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009345
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x550.$x550.$x641
=072  \\$aB3.$x660.$x75.$x525.$x520.$x500
=150  \\$aNeisseria meningitidis
=450  \\$aMeningococcus
=550  \\$wg$aNeisseria
=550  \\$wh$aNeisseria meningitidis, Serogroup A
=550  \\$wh$aNeisseria meningitidis, Serogroup B
=550  \\$wh$aNeisseria meningitidis, Serogroup C
=550  \\$wh$aNeisseria meningitidis, Serogroup W-135
=550  \\$wh$aNeisseria meningitidis, Serogroup Y
=667  \\$aspecific serogroups are also available; infection: probably MENINGITIS, MENINGOCOCCAL or, if not meningitis, MENINGOCOCCAL INFECTIONS
=680  \\$iA species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.
=750  \0$aNeisseria meningitidis$5IEN$0(DLC)sh 85090675

=LDR  00671cz  a2200193n  4500
=001  9880363703302441
=005  20141212203756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009344
=035  \\$aCBA2608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x550.$x550.$x474
=072  \\$aB3.$x660.$x75.$x525.$x520.$x400
=150  \\$aNeisseria gonorrhoeae
=450  \\$aGonococcus
=550  \\$wg$aNeisseria
=667  \\$ainfection = GONORRHEA
=680  \\$iA species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.
=750  \0$aNeisseria gonorrhoeae$5IEN$0(DLC)sh 85090674

=LDR  00909cz  a2200253n  4500
=001  9880363703402441
=005  20141212203756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009343
=035  \\$aCBA2607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x550.$x550
=072  \\$aB3.$x660.$x75.$x525.$x520
=150  \\$aNeisseria
=550  \\$wg$aNeisseriaceae
=550  \\$wh$aNeisseria cinerea
=550  \\$wh$aNeisseria elongata
=550  \\$wh$aNeisseria gonorrhoeae
=550  \\$wh$aNeisseria lactamica
=550  \\$wh$aNeisseria meningitidis
=550  \\$wh$aNeisseria mucosa
=550  \\$wh$aNeisseria sicca
=680  \\$iA genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.
=750  \0$aNeisseria$5IEN$0(DLC)sh 85090672

=LDR  00659cz  a2200181n  4500
=001  9880363703502441
=005  20141212203756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009341
=035  \\$aCBA2605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x698
=150  \\$aNegativism
=550  \\$wg$aPersonality
=667  \\$ano qualif
=680  \\$iState of mind or behavior characterized by extreme skepticism and persistent opposition or resistance to outside suggestions or advice. (APA, Thesaurus of Psychological Index Terms, 1994)
=688  \\$a91(75); was see under DEFENSE MECHANISMS 1975-90
=750  \0$aNegativism$5IEN$0(DLC)sh 85090631

=LDR  00799cz  a2200241n  4500
=001  9880363703602441
=005  20141212203755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009339
=035  \\$aCBA2603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x612
=150  \\$aNeedles
=450  \\$wnnna$aHypodermic Needle
=450  \\$wnnna$aHypodermic Needles
=450  \\$wnnna$aNeedle
=450  \\$wnnna$aNeedle, Hypodermic
=450  \\$wnnna$aNeedles, Hypodermic
=550  \\$wg$aEquipment and Supplies
=667  \\$aDisinfection of needles with household bleach as by intravenous drug users index NEEDLES + DISINFECTION + SODIUM HYPOCHLORITE
=680  \\$iSharp instruments used for puncturing or suturing.
=688  \\$a73(71)
=750  \0$aHypodermic needles$5IEN$0(DLC)sh 85063772

=LDR  00698cz  a2200193n  4500
=001  9880363703702441
=005  20141212203755.0
=008  800403\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009338
=035  \\$aCBA2602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x630.$x510.$x508
=150  \\$aNecturus maculosus
=450  \\$wnnna$amaculosus, Necturus
=550  \\$wg$aNecturus
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA neotenic aquatic species of mudpuppy (Necturus) occurring from Manitoba to Louisiana and Texas.
=688  \\$a91(81); was see under NECTURUS 1981-90
=750  \0$aNecturus maculosus$5IEN$0(DLC)sh 85090588

=LDR  00700cz  a2200217n  4500
=001  9880363703802441
=005  20141212203755.0
=008  800403\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009337
=035  \\$aCBA2601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x630.$x510
=150  \\$aNecturus
=450  \\$wnnna$aMudpuppies
=450  \\$aMudpuppy
=550  \\$wg$aProteidae
=550  \\$wh$aNecturus maculosus
=667  \\$aNIM as exper animal: no qualif; when IM, qualif permitted
=680  \\$iA genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages.
=688  \\$a81
=750  \0$aNecturus$5IEN$0(DLC)sh 85090587

=LDR  00796cz  a2200169n  4500
=001  9880363703902441
=005  20141212203716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009229
=035  \\$aCBA2491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x647
=150  \\$aMythology
=550  \\$wg$aLiterature
=667  \\$aclassical or modern; includes legends & folk tales; med mythology: do not coord with MEDICINE; DF: MYTHOL
=680  \\$iA body of stories, the origins of which may be unknown or forgotten, that serve to explain practices, beliefs, institutions or natural phenomena. Mythology includes legends and folk tales. It may refer to classical mythology or to a body of modern thought and modern life. (From Webster's 1st ed)
=750  \0$aMythology$5IEN$0(DLC)sh 85089371

=LDR  00595cz  a2200181n  4500
=001  9880363704002441
=005  20141212203716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009228
=035  \\$aCBA2490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x799.$x430
=150  \\$aMysticism
=450  \\$wnnna$aMysticisms
=550  \\$wg$aReligious Philosophies
=667  \\$aIM; specify geog if pertinent
=680  \\$iA philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding.
=750  \0$aMysticism$5IEN$0(DLC)sh 85089345

=LDR  00719cz  a2200217n  4500
=001  9880363704102441
=005  20141212203716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009225
=035  \\$aCBA2487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x450.$x505
=150  \\$aMyringoplasty
=450  \\$wnnna$aMyringoplasties
=550  \\$wg$aOtologic Surgical Procedures
=550  \\$aTympanic Membrane
=550  \\$aTympanoplasty
=667  \\$afor repair of tympanic membrane perf; do not use /util except by MeSH definition
=680  \\$iSurgical restoration of a perforated tympanic membrane by grafting. (Dorland, 28th ed.)
=688  \\$a66(64)
=750  \0$aMyringoplasty$5IEN$0(DLC)sh 85089297

=LDR  02359cz  a2200529n  4500
=001  9880363704202441
=005  20141212203715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009224
=035  \\$aCBA2486HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x662.$x500
=072  \\$aC10.$x574.$x500.$x545
=072  \\$aC10.$x668.$x491.$x606.$x500
=072  \\$aC16.$x320.$x400.$x540
=150  \\$aMyotonia Congenita
=450  \\$wnnna$aBatten Turner Congenital Myopathy
=450  \\$wnnna$aBatten-Turner Congenital Myopathy
=450  \\$wnnna$aBecker Disease
=450  \\$aBecker Generalized Myotonia
=450  \\$wnnna$aCongenital Myotonia
=450  \\$wnnna$aDisease, Becker
=450  \\$wnnna$aDisease, Thomsen
=450  \\$wnnna$aDisease, Thomsen's
=450  \\$wnnna$aDisease, Thomsens
=450  \\$wnnna$aGeneralized Myotonia
=450  \\$wnnna$aGeneralized Myotonia, Becker
=450  \\$wnnna$aGeneralized Myotonia of Becker
=450  \\$wnnna$aGeneralized Myotonia of Thomsen
=450  \\$wnnna$aGeneralized Myotonias
=450  \\$wnnna$aMyopathy, Congenital
=450  \\$wnnna$aMyotonia, Becker Generalized
=450  \\$wnnna$aMyotonia Congenita, Autosomal Dominant
=450  \\$wnnna$aMyotonia Congenita, Autosomal Recessive
=450  \\$aMyotonia$xcongenital
=450  \\$wnnna$aMyotonia, Generalized
=450  \\$aMyotonia, Generalized, Becker
=450  \\$wnnna$aMyotonia Levior
=450  \\$wnnna$aMyotonias, Generalized
=450  \\$aThomsen Disease
=450  \\$wnnna$aThomsen Generalized Myotonia
=450  \\$wnnna$aThomsen's Disease
=450  \\$wnnna$aThomsens Disease
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aMyotonic Disorders
=680  \\$iInherited myotonic disorders with early childhood onset MYOTONIA. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. It is classified as Thomsen (autosomal dominant) or Becker (autosomal recessive) generalized myotonia mainly based on the inheritance pattern. Becker type is also clinically more severe. An autosomal dominant variant with milder symptoms and later onset is known as myotonia levior. Mutations in the voltage-dependent skeletal muscle chloride channel are associated with the disorders.
=750  \0$aMyotonia congenita$5IEN$0(DLC)sh 85089287

=LDR  03346cz  a2200829n  4500
=001  9880363704302441
=005  20141212192341.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009223
=035  \\$aCBA2485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x534.$x500.$x500
=072  \\$aC5.$x651.$x662.$x750
=072  \\$aC10.$x574.$x500.$x547
=072  \\$aC10.$x668.$x491.$x175.$x500.$x500
=072  \\$aC10.$x668.$x491.$x606.$x750
=072  \\$aC16.$x320.$x400.$x542
=072  \\$aC16.$x320.$x577.$x500
=150  \\$aMyotonic Dystrophy
=450  \\$wnnna$aAtrophica, Myotonia
=450  \\$wnnna$aAtrophicas, Myotonia
=450  \\$wnnna$aCongenital Myotonic Dystrophies
=450  \\$wnnna$aCongenital Myotonic Dystrophy
=450  \\$wnnna$aDisease, Steinert
=450  \\$wnnna$aDisease, Steinert's
=450  \\$aDystrophia Myotonica
=450  \\$wnnna$aDystrophia Myotonica 1
=450  \\$wnnna$aDystrophia Myotonica 2
=450  \\$wnnna$aDystrophia Myotonica 2s
=450  \\$wnnna$aDystrophia Myotonicas
=450  \\$wnnna$aDystrophica, Myotonia
=450  \\$wnnna$aDystrophicas, Myotonia
=450  \\$wnnna$aDystrophies, Congenital Myotonic
=450  \\$wnnna$aDystrophies, Myotonic
=450  \\$wnnna$aDystrophy, Congenital Myotonic
=450  \\$wnnna$aDystrophy, Myotonic
=450  \\$wnnna$aDystrophy, Steinert Myotonic
=450  \\$wnnna$aMyopathies, Proximal Myotonic
=450  \\$wnnna$aMyopathy, Proximal Myotonic
=450  \\$wnnna$aMyotonia Atrophica
=450  \\$wnnna$aMyotonia Atrophicas
=450  \\$wnnna$aMyotonia Dystrophica
=450  \\$wnnna$aMyotonia Dystrophicas
=450  \\$wnnna$aMyotonic Dystrophies
=450  \\$wnnna$aMyotonic Dystrophies, Congenital
=450  \\$wnnna$aMyotonic Dystrophy 1
=450  \\$wnnna$aMyotonic Dystrophy 2
=450  \\$aMyotonic Dystrophy, Congenital
=450  \\$wnnna$aMyotonic Dystrophy, Steinert
=450  \\$wnnna$aMyotonic Myopathies, Proximal
=450  \\$aMyotonic Myopathy, Proximal
=450  \\$wnnna$aMyotonica, Dystrophia
=450  \\$wnnna$aMyotonicas, Dystrophia
=450  \\$wnnna$aPROMM (Proximal Myotonic Myopathy)
=450  \\$wnnna$aPROMMs (Proximal Myotonic Myopathy)
=450  \\$wnnna$aProximal Myotonic Myopathies
=450  \\$wnnna$aProximal Myotonic Myopathy
=450  \\$wnnna$aRicker Syndrome
=450  \\$aSteinert Disease
=450  \\$wnnna$aSteinert Myotonic Dystrophy
=450  \\$wnnna$aSteinert's Disease
=450  \\$wnnna$aSteinerts Disease
=450  \\$wnnna$aSyndrome, Ricker
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aMuscular Dystrophies
=550  \\$wg$aMyotonic Disorders
=550  \\$aMyotonin-Protein Kinase
=550  \\$aTrinucleotide Repeat Expansion
=667  \\$ado not confuse with MUSCULAR DYSTROPHIES
=680  \\$iNeuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
=688  \\$a2000(1966)
=750  \0$aMyotonia atrophica$5IEN$0(DLC)sh 85089286

=LDR  01043cz  a2200277n  4500
=001  9880363704402441
=005  20141212203715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009222
=035  \\$aCBA2484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x700
=072  \\$aC23.$x888.$x592.$x608.$x700
=150  \\$aMyotonia
=450  \\$wnnna$aMyotonia, Percussion
=450  \\$wnnna$aMyotonias
=450  \\$wnnna$aMyotonias, Percussion
=450  \\$wnnna$aMyotonic Phenomenon
=450  \\$wnnna$aMyotonic Phenomenons
=450  \\$wnnna$aPercussion Myotonia
=450  \\$wnnna$aPercussion Myotonias
=450  \\$wnnna$aPhenomenon, Myotonic
=450  \\$wnnna$aPhenomenons, Myotonic
=550  \\$wg$aNeuromuscular Manifestations
=680  \\$iProlonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.
=750  \0$aMyotonia$5IEN$0(DLC)sh 85089285

=LDR  02175cz  a2200613n  4500
=001  9880363704502441
=005  20141212203714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009220
=035  \\$aCBA2482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x594
=072  \\$aC10.$x668.$x491.$x562
=150  \\$aMyositis
=450  \\$wnnna$aFocal Myositides
=450  \\$wnnna$aFocal Myositis
=450  \\$wnnna$aIdiopathic Inflammatory Myopathies
=450  \\$wnnna$aIdiopathic Inflammatory Myopathy
=450  \\$wnnna$aIdiopathic Inflammatory Myositis
=450  \\$wnnna$aInfectious Myositides
=450  \\$wnnna$aInfectious Myositis
=450  \\$wnnna$aInflammatory Muscle Disease
=450  \\$wnnna$aInflammatory Muscle Diseases
=450  \\$wnnna$aInflammatory Myopathies
=450  \\$wnnna$aInflammatory Myopathies, Idiopathic
=450  \\$aInflammatory Myopathy
=450  \\$wnnna$aInflammatory Myopathy, Idiopathic
=450  \\$wnnna$aMuscle Disease, Inflammatory
=450  \\$wnnna$aMuscle Diseases, Inflammatory
=450  \\$wnnna$aMyopathies, Idiopathic Inflammatory
=450  \\$wnnna$aMyopathies, Inflammatory
=450  \\$wnnna$aMyopathy, Idiopathic Inflammatory
=450  \\$wnnna$aMyopathy, Inflammatory
=450  \\$wnnna$aMyositides
=450  \\$wnnna$aMyositides, Focal
=450  \\$wnnna$aMyositides, Infectious
=450  \\$wnnna$aMyositides, Proliferative
=450  \\$aMyositis, Focal
=450  \\$aMyositis, Infectious
=450  \\$wnnna$aMyositis, Proliferative
=450  \\$wnnna$aProliferative Myositides
=450  \\$wnnna$aProliferative Myositis
=550  \\$wg$aMuscular Diseases
=550  \\$wh$aDermatomyositis
=550  \\$wh$aMyositis, Inclusion Body
=550  \\$wh$aMyositis Ossificans
=550  \\$wh$aOrbital Myositis
=550  \\$wh$aPolymyositis
=550  \\$wh$aPyomyositis
=667  \\$anote many specific myositis terms are available
=680  \\$iInflammation of a muscle or muscle tissue.
=688  \\$aMYOSITIS, EOSINOPHILIC was heading 1970-1980
=688  \\$aMYOSITIS, EOSINOPHILIC was heading 1970-80
=750  \0$aMyositis$0(DLC) sh 85089276$5IEN

=LDR  02621cz  a2200517n  4500
=001  9880363704602441
=005  20141212203713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009218
=035  \\$aCBA2480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x730.$x475
=072  \\$aD8.$x811.$x277.$x40.$x25.$x193.$x750
=072  \\$aD12.$x776.$x210.$x500.$x600
=072  \\$aD12.$x776.$x220.$x525.$x475
=150  \\$aMyosins
=450  \\$wnnna$aActin-Activated ATPase
=450  \\$wnnna$aActin Activated ATPase
=450  \\$wnnna$aActomyosin Adenosinetriphosphatase
=450  \\$wnnna$aActomyosin ATPase
=450  \\$wnnna$aAdenosine Triphosphatase, Myosin
=450  \\$wnnna$aAdenosinetriphosphatase, Actomyosin
=450  \\$wnnna$aAdenosinetriphosphatase, Myosin
=450  \\$wnnna$aATPase, Actin-Activated
=450  \\$wnnna$aATPase, Actin Activated
=450  \\$wnnna$aATPase, Actomyosin
=450  \\$wnnna$aATPase, Myosin
=450  \\$wnnna$aMyosin
=450  \\$wnnna$aMyosin Adenosine Triphosphatase
=450  \\$wnnna$aMyosin Adenosinetriphosphatase
=450  \\$aMyosin ATPase
=550  \\$wg$aMicrofilament Proteins
=550  \\$wg$aMolecular Motor Proteins
=550  \\$wg$aMuscle Proteins
=550  \\$wh$aMyosin Heavy Chains
=550  \\$wh$aMyosin Light Chains
=550  \\$wh$aMyosin Subfragments
=550  \\$wh$aMyosin Type I
=550  \\$wh$aMyosin Type II
=550  \\$wh$aMyosin Type III
=550  \\$wh$aMyosin Type IV
=550  \\$wh$aMyosin Type V
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain.
=688  \\$a2002(1971); use ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1984-1988; for ACTOMYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1985-1988
=750  \0$aMyosin$5IEN$0(DLC)sh 85089275

=LDR  00895cz  a2200217n  4500
=001  9880363704702441
=005  20141212203712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009216
=035  \\$aCBA2478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744.$x636
=150  \\$aMyopia
=450  \\$wnnna$aMyopias
=450  \\$aNearsightedness
=450  \\$wnnna$aNearsightednesses
=550  \\$wg$aRefractive Errors
=550  \\$wh$aMyopia, Degenerative
=667  \\$aMYOPIA, DEGENERATIVE is also available
=680  \\$iA refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.
=750  \0$aMyopia$5IEN$0(DLC)sh 85089271

=LDR  00892cz  a2200265n  4500
=001  9880363704802441
=005  20141212203711.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009215
=035  \\$aCBA2477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x570.$x500
=072  \\$aA5.$x360.$x319.$x679.$x690
=072  \\$aA10.$x690.$x467.$x500
=150  \\$aMyometrium
=450  \\$wnnna$aMuscle, Uterine
=450  \\$wnnna$aMuscles, Uterine
=450  \\$aUterine Muscle
=450  \\$wnnna$aUterine Muscles
=550  \\$wg$aMuscle, Smooth
=550  \\$wg$aUterus
=667  \\$a/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe smooth muscle coat of the uterus, which forms the main mass of the organ.
=688  \\$a84(75); was see under UTERUS 1975-83
=750  \0$aMyometrium$5IEN$0(DLC)sh 85089265

=LDR  00706cz  a2200193n  4500
=001  9880363704902441
=005  20141212203711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009212
=035  \\$aCBA2474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x807.$x628
=150  \\$aMyoglobinuria
=450  \\$aMyoglobin$xurine
=450  \\$wnnna$aMyoglobinurias
=550  \\$wg$aRhabdomyolysis
=667  \\$amyoglobinuria in rhabdomyolysis: index under RHABDOMYOLYSIS (IM) + MYOGLOBINURIA (NIM) only if myoglobinuria is particularly discussed
=688  \\$a91(84)65(63); was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83; was Prov 1963-64
=750  \0$aMyoglobinuria$5IEN$0(DLC)sh 85089259

=LDR  00712cz  a2200205n  4500
=001  9880363705002441
=005  20141212203710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009211
=035  \\$aCBA2473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x210.$x500.$x588
=072  \\$aD12.$x776.$x422.$x316.$x940
=150  \\$aMyoglobin
=550  \\$wg$aGlobins
=550  \\$wg$aMuscle Proteins
=550  \\$wh$aMetmyoglobin
=667  \\$aa hemeprotein & muscle protein; /biosyn /physiol permitted
=680  \\$iA conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.
=750  \0$aMyoglobin$5IEN$0(DLC)sh 85089258

=LDR  01405cz  a2200277n  4500
=001  9880363705102441
=005  20141212203710.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009209
=035  \\$aCBA2471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x550
=150  \\$aMyofascial Pain Syndromes
=450  \\$wnnna$aMyofascial Pain Syndrome
=450  \\$wnnna$aMyofascial Trigger Point Pain
=450  \\$wnnna$aPain Syndrome, Myofascial
=450  \\$wnnna$aPain Syndromes, Myofascial
=450  \\$wnnna$aSyndrome, Myofascial Pain
=450  \\$wnnna$aSyndromes, Myofascial Pain
=450  \\$wnnna$aTrigger Point Pain, Myofascial
=550  \\$wg$aMuscular Diseases
=550  \\$wh$aTemporomandibular Joint Dysfunction Syndrome
=667  \\$ado not confuse with MYOFASCIAL PAIN DYSFUNCTION SYNDROME, TEMPOROMANDIBULAR JOINT see TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME; for myofasciaI trigger point injections coordinate, MYOFASCIAL PAIN SYNDROMES/ drug ther with TRIGGER POINTS + INJECTIONS or specifics
=680  \\$iMuscular pain in numerous body regions that can be reproduced by pressure on TRIGGER POINTS, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.
=688  \\$a82
=750  \0$aMyofascial pain syndromes$0(DLC) sh 93006828$5IEN-M

=LDR  01341cz  a2200385n  4500
=001  9880363705202441
=005  20141212203708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009206
=035  \\$aCBA2468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x580
=072  \\$aA7.$x541.$x704
=072  \\$aA10.$x690.$x552.$x750
=150  \\$aMyocardium
=360  \\$iconsider also terms at$aCARDIAC$aHEART
=450  \\$wnnna$aCardiac Muscle
=450  \\$wnnna$aCardiac Muscles
=450  \\$wnnna$aHeart Muscle
=450  \\$wnnna$aHeart Muscles
=450  \\$aMuscle, Cardiac
=450  \\$aMuscle, Heart
=450  \\$wnnna$aMuscles, Cardiac
=450  \\$wnnna$aMuscles, Heart
=450  \\$wnnna$aMyocardia
=550  \\$wg$aHeart
=550  \\$wg$aMuscle, Striated
=550  \\$wg$aMuscles
=550  \\$wh$aMyoblasts, Cardiac
=550  \\$wh$aMyocytes, Cardiac
=550  \\$wh$aPapillary Muscles
=550  \\$aHeart
=667  \\$athe heart as tissue, differentiated from the heart as a pump ( = HEART); Manual 21.48; ischemia = MYOCARDIAL ISCHEMIA; inflammation = MYOCARDITIS
=680  \\$iThe muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.
=750  \0$aMyocardium$5IEN$0(DLC)sh 85059694

=LDR  00939cz  a2200181n  4500
=001  9880363705302441
=005  20141212203708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009205
=035  \\$aCBA2467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x238.$x625
=150  \\$aMyocarditis
=450  \\$aCarditis
=450  \\$wnnna$aMyocarditides
=550  \\$wg$aCardiomyopathies
=680  \\$iInflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
=750  \0$aMyocarditis$5IEN$0(DLC)sh 85089246

=LDR  01206cz  a2200313n  4500
=001  9880363705402441
=005  20141212203708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009204
=035  \\$aCBA2466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x719
=072  \\$aE4.$x928.$x220.$x520
=150  \\$aMyocardial Revascularization
=450  \\$aInternal Mammary Artery Implantation
=450  \\$wnnna$aMyocardial Revascularizations
=450  \\$wnnna$aRevascularization, Myocardial
=450  \\$wnnna$aRevascularizations, Myocardial
=550  \\$wg$aCardiac Surgical Procedures
=550  \\$wh$aAngioplasty, Balloon, Coronary
=550  \\$wh$aAtherectomy, Coronary
=550  \\$wh$aCoronary Artery Bypass
=550  \\$wh$aTransmyocardial Laser Revascularization
=550  \\$aCoronary Disease
=550  \\$aMyocardial Ischemia
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe restoration of blood supply to the myocardium. (From Dorland, 28th ed)
=688  \\$a73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 (see under MYOCARDIAL REVASCULARIZATION 1975-90)
=750  \0$aMyocardial revascularization$5IEN$0(DLC)sh 85089245

=LDR  01536cz  a2200301n  4500
=001  9880363705502441
=005  20141212211037.0
=008  880607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015425
=035  \\$aCBA2464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x700.$x600
=072  \\$aE5.$x680.$x730.$x600
=150  \\$aMyocardial Reperfusion
=450  \\$aCoronary Reperfusion
=450  \\$wnnna$aCoronary Reperfusions
=450  \\$wnnna$aMyocardial Reperfusions
=450  \\$wnnna$aReperfusion, Coronary
=450  \\$aReperfusion, Myocardial
=450  \\$wnnna$aReperfusions, Coronary
=450  \\$wnnna$aReperfusions, Myocardial
=550  \\$wg$aReperfusion
=550  \\$aMyocardial Ischemia
=550  \\$aMyocardial Reperfusion Injury
=667  \\$anote category: a technique; /adv eff permitted but consider also MYOCARDIAL REPERFUSION INJURY
=680  \\$iGenerally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.
=688  \\$a89
=750  \0$aMyocardial reperfusion$5IEN$0(DLC)sh 92002146

=LDR  01573cz  a2200433n  4500
=001  9880363705602441
=005  20190102094437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009203
=035  \\$aCBA2463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x500
=072  \\$aC14.$x907.$x585.$x500
=150  \\$aMyocardial Infarction
=450  \\$wnnna$aCardiovascular Stroke
=450  \\$wnnna$aCardiovascular Strokes
=450  \\$wnnna$aInfarct, Myocardial
=450  \\$wnnna$aInfarction, Myocardial
=450  \\$wnnna$aInfarctions, Myocardial
=450  \\$wnnna$aInfarcts, Myocardial
=450  \\$wnnna$aMyocardial Infarct
=450  \\$wnnna$aMyocardial Infarctions
=450  \\$wnnna$aMyocardial Infarcts
=450  \\$wnnna$aStroke, Cardiovascular
=450  \\$wnnna$aStrokes, Cardiovascular
=550  \\$wg$aMyocardial Ischemia
=550  \\$wh$aAnterior Wall Myocardial Infarction
=550  \\$wh$aInferior Wall Myocardial Infarction
=550  \\$wh$aMyocardial Stunning
=550  \\$wh$aNon-ST Elevated Myocardial Infarction
=550  \\$wh$aNo-Reflow Phenomenon
=550  \\$wh$aShock, Cardiogenic
=550  \\$wh$aST Elevation Myocardial Infarction
=550  \\$aInfarction
=550  \\$aMyocardial Ischemia
=667  \\$ado not coordinate with ACUTE DISEASE for "acute infarct"
=680  \\$iNECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
=688  \\$a79; was MYOCARDIAL INFARCT 1963-78
=750  \0$aMyocardial infarction$5IEN$0(DLC)sh 85059683

=LDR  02799cz  a2200661n  4500
=001  9880363705702441
=005  20141212203707.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x238
=150  \\$aCardiomyopathies
=450  \\$wnnna$aCardiomyopathies, Primary
=450  \\$wnnna$aCardiomyopathies, Secondary
=450  \\$wnnna$aCardiomyopathy
=450  \\$wnnna$aCardiomyopathy, Primary
=450  \\$wnnna$aCardiomyopathy, Secondary
=450  \\$wnnna$aDisease, Myocardial
=450  \\$wnnna$aDisease, Primary Myocardial
=450  \\$wnnna$aDisease, Secondary Myocardial
=450  \\$wnnna$aDiseases, Myocardial
=450  \\$wnnna$aDiseases, Primary Myocardial
=450  \\$wnnna$aDiseases, Secondary Myocardial
=450  \\$wnnna$aMyocardial Disease
=450  \\$wnnna$aMyocardial Disease, Primary
=450  \\$wnnna$aMyocardial Disease, Secondary
=450  \\$aMyocardial Diseases
=450  \\$aMyocardial Diseases, Primary
=450  \\$aMyocardial Diseases, Secondary
=450  \\$aMyocardiopathies
=450  \\$wnnna$aMyocardiopathy
=450  \\$wnnna$aPrimary Cardiomyopathies
=450  \\$wnnna$aPrimary Cardiomyopathy
=450  \\$wnnna$aPrimary Myocardial Disease
=450  \\$wnnna$aPrimary Myocardial Diseases
=450  \\$wnnna$aSecondary Cardiomyopathies
=450  \\$wnnna$aSecondary Cardiomyopathy
=450  \\$wnnna$aSecondary Myocardial Disease
=450  \\$wnnna$aSecondary Myocardial Diseases
=550  \\$wg$aHeart Diseases
=550  \\$wh$aArrhythmogenic Right Ventricular Dysplasia
=550  \\$wh$aCardiomyopathy, Alcoholic
=550  \\$wh$aCardiomyopathy, Dilated
=550  \\$wh$aCardiomyopathy, Hypertrophic
=550  \\$wh$aCardiomyopathy, Restrictive
=550  \\$wh$aChagas Cardiomyopathy
=550  \\$wh$aDiabetic Cardiomyopathies
=550  \\$wh$aEndocardial Fibroelastosis
=550  \\$wh$aEndomyocardial Fibrosis
=550  \\$wh$aGlycogen Storage Disease Type IIb
=550  \\$wh$aKearns-Sayre Syndrome
=550  \\$wh$aMyocardial Reperfusion Injury
=550  \\$wh$aMyocarditis
=550  \\$wh$aSarcoglycanopathies
=667  \\$aGEN; prefer specifics; for infections of the myocardium, coord here (IM) with infection term (IM), not with HEART DISEASES
=680  \\$iA group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
=688  \\$a2005 (1979)
=750  \0$aMyocardium$xDiseases$0(DLC) sh 85059695$5IEN-M

=LDR  01501cz  a2200361n  4500
=001  9880363705802441
=005  20170619090602.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009200
=035  \\$aCBA2460HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x580
=072  \\$aG11.$x427.$x494.$x570
=150  \\$aMyocardial Contraction
=450  \\$wnnna$aCardiac Inotropism
=450  \\$wnnna$aCardiac Inotropisms
=450  \\$wnnna$aContractilities, Heart
=450  \\$wnnna$aContractility, Heart
=450  \\$wnnna$aContraction, Myocardial
=450  \\$wnnna$aContractions, Myocardial
=450  \\$wnnna$aHeart Contractilities
=450  \\$aHeart Contractility
=450  \\$aInotropism, Cardiac
=450  \\$wnnna$aInotropisms, Cardiac
=450  \\$wnnna$aMyocardial Contractions
=550  \\$wg$aCardiovascular Physiological Phenomena
=550  \\$wg$aMuscle Contraction
=550  \\$wh$aDiastole
=550  \\$wh$aSystole
=667  \\$ainotropic action of drugs = MYOCARDIAL CONTRACTION /drug eff (IM) + drug with /pharmacol (IM) + STIMULATION, CHEMICAL (NIM) for positive inotropic action & DEPRESSION, CHEMICAL (NIM) for negative but note that INOTROPIC AGENTS, POSITIVE CARDIAC see CARDIOTONIC AGENTS is available; for chronotropic action see note on HEART RATE; relaxation of cardiac muscle: DIASTOLE, do not add MUSCLE RELAXATION
=680  \\$iContractile activity of the MYOCARDIUM.
=688  \\$a75
=750  \0$aHeart$xContraction$5IEN$0(DLC)sh 85059647

=LDR  00781cz  a2200253n  4500
=001  9880363705902441
=005  20141212203706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009198
=035  \\$aCBA2458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x858.$x211.$x503
=150  \\$aMyiasis
=450  \\$wnnna$aInfestation, Maggot
=450  \\$wnnna$aInfestations, Maggot
=450  \\$wnnna$aMaggot Infestation
=450  \\$aMaggot Infestations
=450  \\$wnnna$aMyiases
=550  \\$wg$aEctoparasitic Infestations
=550  \\$wh$aHypodermyiasis
=550  \\$wh$aScrew Worm Infection
=667  \\$ainfestation by fly maggots
=680  \\$iThe invasion of living tissues of man and other mammals by dipterous larvae.
=750  \0$aMyiasis$5IEN$0(DLC)sh 85089232

=LDR  01226cz  a2200277n  4500
=001  9880363706002441
=005  20141212203705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009197
=035  \\$aCBA2457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x500
=072  \\$aA8.$x800.$x50.$x150.$x500
=072  \\$aA8.$x800.$x800.$x60.$x500
=150  \\$aMyenteric Plexus
=450  \\$wnnna$aAuerbach Plexus
=450  \\$aAuerbach's Plexus
=450  \\$wnnna$aAuerbachs Plexus
=450  \\$wnnna$aPlexus, Auerbach's
=450  \\$wnnna$aPlexus, Myenteric
=550  \\$wg$aAutonomic Pathways
=550  \\$wg$aEnteric Nervous System
=667  \\$aa neural network in the enteric nerv syst
=680  \\$iOne of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38)
=688  \\$a65
=750  \0$aMyenteric plexus$5IEN$0(DLC)sh 85089227

=LDR  01323cz  a2200313n  4500
=001  9880363706102441
=005  20141212203705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009196
=035  \\$aCBA2456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x190.$x636
=150  \\$aMyeloproliferative Disorders
=450  \\$wnnna$aDisorder, Myeloproliferative
=450  \\$wnnna$aDisorders, Myeloproliferative
=450  \\$wnnna$aMyeloproliferative Disorder
=550  \\$wg$aBone Marrow Diseases
=550  \\$wh$aAnemia, Myelophthisic
=550  \\$wh$aLeukemia, Erythroblastic, Acute
=550  \\$wh$aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
=550  \\$wh$aLeukemia, Neutrophilic, Chronic
=550  \\$wh$aLeukemoid Reaction
=550  \\$wh$aPolycythemia Vera
=550  \\$wh$aPrimary Myelofibrosis
=550  \\$wh$aThrombocytosis
=667  \\$amyelo- here = bone marrow, not spinal cord; general; prefer specifics
=680  \\$iConditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
=688  \\$a70(66)
=750  \0$aMyeloproliferative disorders$0(DLC) sh 85089225$5IEN

=LDR  01008cz  a2200217n  4500
=001  9880363706202441
=005  20141212203705.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009195
=035  \\$aCBA2455HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x732.$x700
=150  \\$aPeroxidase
=450  \\$wnnna$aHemi-Myeloperoxidase
=450  \\$wnnna$aHemi Myeloperoxidase
=450  \\$aMyeloperoxidase
=550  \\$wg$aPeroxidases
=667  \\$aa hemeprotein synthesized by leukocytes: do not confuse with PEROXIDASES, a subclass of oxidoreductases
=680  \\$iA hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.
=688  \\$a94; was MYELOPEROXIDASE 1975-93 (see under PEROXIDASES 1975-85); GUAIACOL PEROXIDASE & HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93
=750  \0$aPeroxidase$5IEN$0(DLC)sh 85100032

=LDR  00793cz  a2200253n  4500
=001  9880363706302441
=005  20141212203704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009194
=035  \\$aCBA2454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x900.$x500
=072  \\$aD12.$x776.$x124.$x790.$x651.$x900.$x500
=072  \\$aD12.$x776.$x377.$x715.$x548.$x900.$x500
=072  \\$aD12.$x776.$x624.$x553
=150  \\$aMyeloma Proteins
=450  \\$wnnna$aM Components
=450  \\$wnnna$aProteins, Myeloma
=550  \\$wg$aNeoplasm Proteins
=550  \\$wg$aParaproteins
=550  \\$aMultiple Myeloma
=680  \\$iAbnormal immunoglobulins characteristic of MULTIPLE MYELOMA.
=688  \\$a72
=750  \0$aMyeloma proteins$5IEN$0(DLC)sh 85089223

=LDR  01089cz  a2200289n  4500
=001  9880363706402441
=005  20141212203704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009192
=035  \\$aCBA2452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x505
=072  \\$aE1.$x370.$x350.$x700.$x560.$x505
=072  \\$aE1.$x370.$x376.$x537.$x750.$x505
=072  \\$aE5.$x629.$x937.$x505
=150  \\$aMyelography
=450  \\$wnnna$aCisternographies, Myelographic
=450  \\$aCisternography, Myelographic
=450  \\$wnnna$aMyelographic Cisternographies
=450  \\$wnnna$aMyelographic Cisternography
=450  \\$wnnna$aMyelographies
=550  \\$wg$aNeuroradiography
=550  \\$aSpinal Cord
=667  \\$amyelo- here = spinal cord, not bone marrow; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: MYELOGR
=680  \\$iX-ray visualization of the spinal cord following injection of contrast medium into the spinal arachnoid space.
=688  \\$a66(64)
=750  \0$aMyelography$5IEN$0(DLC)sh 85089221

=LDR  01431cz  a2200349n  4500
=001  9880363706502441
=005  20141212203704.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009190
=035  \\$aCBA2450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x190.$x625
=150  \\$aMyelodysplastic Syndromes
=450  \\$wnnna$aDysmyelopoietic Syndrome
=450  \\$aDysmyelopoietic Syndromes
=450  \\$wnnna$aHematopoetic Myelodysplasia
=450  \\$wnnna$aHematopoetic Myelodysplasias
=450  \\$wnnna$aMyelodysplasia, Hematopoetic
=450  \\$wnnna$aMyelodysplasias, Hematopoetic
=450  \\$wnnna$aMyelodysplastic Syndrome
=450  \\$wnnna$aSyndrome, Dysmyelopoietic
=450  \\$wnnna$aSyndrome, Myelodysplastic
=450  \\$wnnna$aSyndromes, Dysmyelopoietic
=450  \\$wnnna$aSyndromes, Myelodysplastic
=550  \\$wg$aBone Marrow Diseases
=550  \\$wh$aAnemia, Refractory
=550  \\$wh$aAnemia, Sideroblastic
=550  \\$wh$aHemoglobinuria, Paroxysmal
=667  \\$amyelo- here = bone marrow, not spinal cord
=680  \\$iClonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
=688  \\$a86
=750  \0$aMyelodysplastic syndromes$5IEN$0(DLC)sh 88001636

=LDR  01901cz  a2200433n  4500
=001  9880363706602441
=005  20141212203702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009187
=035  \\$aCBA2447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182.$x600
=072  \\$aC10.$x228.$x228.$x210.$x575
=072  \\$aC10.$x228.$x228.$x618
=072  \\$aC10.$x228.$x854.$x525
=150  \\$aMyelitis
=450  \\$wnnna$aInfectious Myelitis
=450  \\$wnnna$aInflammation, Spinal Cord
=450  \\$wnnna$aInflammations, Spinal Cord
=450  \\$wnnna$aInflammatory Myelopathies
=450  \\$wnnna$aInflammatory Myelopathy
=450  \\$wnnna$aMyelitides
=450  \\$wnnna$aMyelitis, Infectious
=450  \\$wnnna$aMyelitis, Subacute Necrotising
=450  \\$wnnna$aMyelopathies, Inflammatory
=450  \\$aMyelopathy, Inflammatory
=450  \\$wnnna$aNecrotising Myelitis, Subacute
=450  \\$aSpinal Cord Inflammation
=450  \\$wnnna$aSpinal Cord Inflammations
=450  \\$wnnna$aSubacute Necrotising Myelitis
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aCentral Nervous System Viral Diseases
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wh$aMyelitis, Transverse
=550  \\$wh$aParaparesis, Tropical Spastic
=550  \\$wh$aPoliomyelitis
=667  \\$ado not confuse with inflamm of the bone marrow ( = OSTEOMYELITIS); SMON (subacute-myelo-optico-neuropathy) is indexed here + OPTIC NEURITIS + SYNDROME; coord IM with specific cause (IM) if pertinent
=680  \\$iInflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction.
=750  \0$aMyelitis$5IEN$0(DLC)sh 85126673

=LDR  01661cz  a2200385n  4500
=001  9880363706702441
=005  20141212192339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637.$x600.$x500
=072  \\$aA8.$x637.$x800.$x500
=072  \\$aA8.$x675.$x542.$x512.$x560
=072  \\$aA8.$x800.$x800.$x690.$x500
=072  \\$aA10.$x755.$x503
=072  \\$aA11.$x284.$x149.$x165.$x600
=072  \\$aA11.$x650.$x600.$x500
=072  \\$aA11.$x650.$x800.$x500
=072  \\$aA11.$x671.$x501.$x512.$x560
=072  \\$aA11.$x671.$x514.$x553
=150  \\$aMyelin Sheath
=450  \\$aMyelin
=450  \\$wnnna$aMyelin Sheaths
=450  \\$wnnna$aSheath, Myelin
=450  \\$wnnna$aSheaths, Myelin
=550  \\$wg$aCell Membrane Structures
=550  \\$wg$aNerve Fibers, Myelinated
=550  \\$wg$aNerve Tissue
=550  \\$wg$aOligodendroglia
=550  \\$wg$aSchwann Cells
=550  \\$wh$aNeurilemma
=550  \\$wh$aRanvier's Nodes
=667  \\$anote entry term MYELIN; do not confuse with MYELIN PROTEINS; myelination: index under MYELIN SHEATH / physiol
=680  \\$iThe lipid-rich sheath surrounding AXONS in both the CENTRAL NERVOUS SYSTEMS and PERIPHERAL NERVOUS SYSTEM. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.
=750  \0$aMyelin sheath$5IEN$0(DLC)sh 85089215

=LDR  01348cz  a2200337n  4500
=001  9880363706802441
=005  20180913101057.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009185
=035  \\$aCBA2445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x620
=072  \\$aD12.$x776.$x631.$x580
=150  \\$aMyelin Proteins
=450  \\$wnnna$aProteins, Myelin
=550  \\$wg$aMembrane Proteins
=550  \\$wg$aNerve Tissue Proteins
=550  \\$wh$a2',3'-Cyclic Nucleotide 3'-Phosphodiesterase
=550  \\$wh$aMyelin and Lymphocyte-Associated Proteolipid Proteins
=550  \\$wh$aMyelin-Associated Glycoprotein
=550  \\$wh$aMyelin Basic Protein
=550  \\$wh$aMyelin-Oligodendrocyte Glycoprotein
=550  \\$wh$aMyelin P0 Protein
=550  \\$wh$aMyelin P2 Protein
=550  \\$wh$aMyelin Proteolipid Protein
=550  \\$wh$aNogo Proteins
=550  \\$wh$aOligodendrocyte-Myelin Glycoprotein
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with MYELIN see MYELIN SHEATH; do not coordinate with MYELIN SHEATH unless this is particularly discussed
=680  \\$iMYELIN-specific proteins that play a structural or regulatory role in the genesis and maintenance of the lamellar MYELIN SHEATH structure.
=688  \\$a77
=750  \0$aMyelin proteins$5IEN$0(DLC)sh 89006591

=LDR  00886cz  a2200265n  4500
=001  9880363706902441
=005  20141212203701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009184
=035  \\$aCBA2444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x500
=150  \\$aMydriatics
=450  \\$aCycloplegics
=450  \\$wnnna$aEffect, Mydriatic
=450  \\$wnnna$aEffects, Mydriatic
=450  \\$wnnna$aMydriatic Effect
=450  \\$wnnna$aMydriatic Effects
=550  \\$wg$aAutonomic Agents
=550  \\$aMydriasis
=550  \\$aPupil
=667  \\$anote entry term MYDRIATIC EFFECT: use only for the mydriatic effect of a chemical substance
=680  \\$iAgents that dilate the pupil. They may be either sympathomimetics or parasympatholytics.
=688  \\$aCYCLOPLEGICS was heading 1963-78
=750  \0$aMydriatics$5IEN$0(DLC)sh 85089214

=LDR  01179cz  a2200433n  4500
=001  9880363707002441
=005  20141212203701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009183
=035  \\$aCBA2443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946.$x587
=150  \\$aMycotoxins
=450  \\$aFungal Toxins
=450  \\$wnnna$aToxins, Fungal
=550  \\$wg$aToxins, Biological
=550  \\$wh$aAflatoxins
=550  \\$wh$aAmanitins
=550  \\$wh$aCitrinin
=550  \\$wh$aCytochalasins
=550  \\$wh$aFumonisins
=550  \\$wh$aGliotoxin
=550  \\$wh$aIbotenic Acid
=550  \\$wh$aKiller Factors, Yeast
=550  \\$wh$aMuscimol
=550  \\$wh$aOchratoxins
=550  \\$wh$aPatulin
=550  \\$wh$aPenicillic Acid
=550  \\$wh$aPhalloidine
=550  \\$wh$aSporidesmins
=550  \\$wh$aSterigmatocystin
=550  \\$wh$aTenuazonic Acid
=550  \\$wh$aTrichothecenes
=550  \\$wh$aZearalenone
=550  \\$aMushroom Poisoning
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iToxic compounds produced by FUNGI.
=688  \\$a67
=750  \0$aMycotoxins$5IEN$0(DLC)sh 85089202

=LDR  00765cz  a2200205n  4500
=001  9880363707102441
=005  20141212203700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009182
=035  \\$aCBA2442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x386.$x480.$x750.$x800.$x550
=072  \\$aC15.$x604.$x515.$x569.$x480.$x750.$x800.$x550
=072  \\$aC20.$x683.$x515.$x761.$x480.$x750.$x800.$x550
=150  \\$aMycosis Fungoides
=550  \\$wg$aLymphoma, T-Cell, Cutaneous
=550  \\$wh$aPagetoid Reticulosis
=667  \\$acoordinate IM with SKIN NEOPLASMS (IM)
=680  \\$iA chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
=750  \0$aMycosis fungoides$5IEN$0(DLC)sh 85089199

=LDR  01399cz  a2200457n  4500
=001  9880363707202441
=005  20180725095047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009181
=035  \\$aCBA2441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703
=150  \\$aMycoses
=450  \\$wnnna$aDisease, Fungus
=450  \\$wnnna$aDiseases, Fungus
=450  \\$wnnna$aFungus Disease
=450  \\$aFungus Diseases
=550  \\$wg$aBacterial Infections and Mycoses
=550  \\$wh$aBlastomycosis
=550  \\$wh$aCandidiasis
=550  \\$wh$aCentral Nervous System Fungal Infections
=550  \\$wh$aCoccidioidomycosis
=550  \\$wh$aCryptococcosis
=550  \\$wh$aDermatomycoses
=550  \\$wh$aEye Infections, Fungal
=550  \\$wh$aFungemia
=550  \\$wh$aGeotrichosis
=550  \\$wh$aHistoplasmosis
=550  \\$wh$aHyalohyphomycosis
=550  \\$wh$aInvasive Fungal Infections
=550  \\$wh$aLung Diseases, Fungal
=550  \\$wh$aMicrosporidiosis
=550  \\$wh$aOtomycosis
=550  \\$wh$aParacoccidioidomycosis
=550  \\$wh$aPhaeohyphomycosis
=550  \\$wh$aPiedra
=550  \\$wh$aPneumocystis Infections
=550  \\$wh$aTrichosporonosis
=550  \\$wh$aZygomycosis
=667  \\$aGEN: prefer specifics; of skin = DERMATOMYCOSES; /drug ther: consider also ANTIFUNGAL AGENTS
=750  \0$aMycoses$5IEN$0(DLC)sh 85089198

=LDR  00613cz  a2200193n  4500
=001  9880363707302441
=005  20141212203659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009179
=035  \\$aCBA2439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x860.$x580
=150  \\$aMycoplasmatales
=550  \\$wg$aTenericutes
=550  \\$wh$aMycoplasmataceae
=667  \\$ainfection = MYCOPLASMATALES INFECTIONS
=680  \\$iAn order of highly pleomorphic, gram-negative bacteria including both pathogenic and saprophytic species.
=688  \\$a75
=750  \0$aMycoplasmatales$0(DLC) sh 85089196$5IEN

=LDR  00672cz  a2200205n  4500
=001  9880363707402441
=005  20141212203659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009178
=035  \\$aCBA2438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x860.$x580.$x553
=150  \\$aMycoplasmataceae
=550  \\$wg$aMycoplasmatales
=550  \\$wh$aMycoplasma
=550  \\$wh$aUreaplasma
=667  \\$ainfection: coord IM with MYCOPLASMATALES INFECTIONS (IM)
=680  \\$iA family of gram-negative, non-motile bacteria from human and animal sources. One saprophytic species is known.
=688  \\$a75
=750  \0$aMycoplasmataceae$5IEN$0(DLC)sh 88023294

=LDR  00812cz  a2200193n  4500
=001  9880363707502441
=005  20141212203659.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009177
=035  \\$aCBA2437M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x860.$x580.$x553.$x553.$x650
=150  \\$aMycoplasma pneumoniae
=450  \\$aEaton Agent
=550  \\$wg$aMycoplasma
=667  \\$ado not confuse with MYCOPLASMA PNEUMONIA, the dis; infection = PNEUMONIA, MYCOPLASMA
=680  \\$iShort filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man.
=688  \\$a80; EATON AGENT was see MYCOPLASMA 1967-91
=750  \0$aMycoplasma pneumoniae$5IEN-M$0(DLC)sh 99004182

=LDR  00933cz  a2200265n  4500
=001  9880363707602441
=005  20141212203658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009175
=035  \\$aCBA2435HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x610.$x610
=150  \\$aMycoplasma Infections
=450  \\$wnnna$aEperythrozoonoses
=450  \\$aEperythrozoonosis
=450  \\$wnnna$aInfection, Mycoplasma
=450  \\$wnnna$aInfections, Mycoplasma
=450  \\$aMycoplasma Diseases$5IEN
=450  \\$wnnna$aMycoplasma Infection
=550  \\$wg$aMycoplasmatales Infections
=550  \\$wh$aPleuropneumonia, Contagious
=550  \\$wh$aPneumonia, Mycoplasma
=680  \\$iInfections with species of the genus MYCOPLASMA.
=688  \\$a1968; for EPERYTHROZOONOSIS use ANAPLASMATACEAE INFECTIONS 1977-1990, use BARTONELLA INFECTIONS 1975-1976
=750  \0$aMycoplasma diseases$5IEN$0(DLC)sh 85089190

=LDR  01977cz  a2200541n  4500
=001  9880363707702441
=005  20141212203658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009174
=035  \\$aCBA2434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x860.$x580.$x553.$x553
=150  \\$aMycoplasma
=450  \\$aEperythrozoon
=450  \\$aHaemobartonella
=450  \\$aMycoplasma putrefaciens
=450  \\$wnnna$aPleuropneumonia Like Organisms
=450  \\$aPleuropneumonia-Like Organisms
=450  \\$aPPLO
=550  \\$wg$aMycoplasmataceae
=550  \\$wh$aMycoplasma agalactiae
=550  \\$wh$aMycoplasma arthritidis
=550  \\$wh$aMycoplasma bovigenitalium
=550  \\$wh$aMycoplasma bovis
=550  \\$wh$aMycoplasma capricolum
=550  \\$wh$aMycoplasma conjunctivae
=550  \\$wh$aMycoplasma dispar
=550  \\$wh$aMycoplasma fermentans
=550  \\$wh$aMycoplasma gallisepticum
=550  \\$wh$aMycoplasma genitalium
=550  \\$wh$aMycoplasma hominis
=550  \\$wh$aMycoplasma hyopneumoniae
=550  \\$wh$aMycoplasma hyorhinis
=550  \\$wh$aMycoplasma hyosynoviae
=550  \\$wh$aMycoplasma iowae
=550  \\$wh$aMycoplasma meleagridis
=550  \\$wh$aMycoplasma mycoides
=550  \\$wh$aMycoplasma orale
=550  \\$wh$aMycoplasma ovipneumoniae
=550  \\$wh$aMycoplasma penetrans
=550  \\$wh$aMycoplasma pneumoniae
=550  \\$wh$aMycoplasma pulmonis
=550  \\$wh$aMycoplasma salivarium
=550  \\$wh$aMycoplasma synoviae
=667  \\$ainfection = MYCOPLASMA INFECTIONS
=680  \\$iA genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.
=688  \\$a1963; for HAEMOBARTONELLA use ANAPLASMATACEAE 1980-2003
=750  \0$aMycoplasma$5IEN$0(DLC)sh 88023292

=LDR  01091cz  a2200205n  4500
=001  9880363707802441
=005  20141212203657.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009173
=035  \\$aCBA2433M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x193.$x678
=072  \\$aD10.$x251.$x618
=150  \\$aMycophenolic Acid
=450  \\$wnnna$aAcid, Mycophenolic
=550  \\$wg$aCaproates
=550  \\$wg$aFatty Acids
=680  \\$iAn antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1301)
=688  \\$a73(72)
=750  \0$aMycophenolic acid$0(DLC)sh2010012388$5IEN-M

=LDR  00804cz  a2200241n  4500
=001  9880363707902441
=005  20141212203657.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009172
=035  \\$aCBA2432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x553
=150  \\$aMycology
=450  \\$aMedical Mycology$5IEN
=450  \\$aMycologists$5IEN
=550  \\$wg$aMicrobiology
=550  \\$aInfectious Disease Medicine
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
=688  \\$a72
=750  \0$aMycology$5IEN-M$0(DLC)sh 85089188
=750  \0$aMycologists$5IEN-HS$0(DLC)sh 85089187
=750  \0$aMedical mycology$5IEN-HS$0(DLC)sh 85082976

=LDR  02039cz  a2200481n  4500
=001  9880363708002441
=005  20200530171530.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x720
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x720
=150  \\$aNontuberculous Mycobacteria
=450  \\$aAtypical Mycobacteria
=450  \\$wnnna$aAtypical Mycobacterium
=450  \\$aMycobacteria, Atypical
=450  \\$wnnna$aMycobacterium, Atypical
=450  \\$aMycobacterium duvalii
=450  \\$aMycobacterium flavescens
=450  \\$aMycobacterium gilvum
=450  \\$aMycobacterium gordonae
=450  \\$aMycobacterium obuense
=450  \\$aMycobacterium szulgai
=450  \\$aMycobacterium terrae
=450  \\$wnnna$aNontuberculous Mycobacterium
=450  \\$aTuberculoid Bacillus
=550  \\$wg$aMycobacterium
=550  \\$wh$aMycobacterium ascessus
=550  \\$wh$aMycobacterium avium Complex
=550  \\$wh$aMycobacterium chelonae
=550  \\$wh$aMycobacterium fortuitum
=550  \\$wh$aMycobacterium kansasii
=550  \\$wh$aMycobacterium marinum
=550  \\$wh$aMycobacterium scrofulaceum
=550  \\$wh$aMycobacterium smegmatis
=550  \\$wh$aMycobacterium ulcerans
=550  \\$wh$aMycobacterium xenopi
=667  \\$anote entry terms and specific indentions; infection = MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS
=680  \\$iSo-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi.
=688  \\$a2012 (1999)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Mycobacteria, Atypical
=688  \\$a99
=750  \0$aAtypical mycobacteria$0(DLC) sh 85089181$5IEN-M

=LDR  00862cz  a2200181n  4500
=001  9880363708102441
=005  20141212203656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009169
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x702
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x702
=150  \\$aMycobacterium tuberculosis
=450  \\$wnnna$aMycobacterium tuberculosis H37Rv
=550  \\$wg$aMycobacterium
=667  \\$ainfection = TUBERCULOSIS or specifics; DF: M TUBERC
=680  \\$iA species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
=750  \0$aMycobacterium tuberculosis$5IEN$0(DLC)sh 85089186

=LDR  00651cz  a2200181n  4500
=001  9880363708202441
=005  20141212203656.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009168
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x640
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x640
=150  \\$aMycobacterium phlei
=550  \\$wg$aMycobacterium
=667  \\$ain soil, dust & plants; DF: MYCOBACT PHLEI
=680  \\$iA saprophytic bacterium widely distributed in soil and dust and on plants.
=688  \\$a91(75); was see under MYCOBACTERIUM 1975-90
=750  \0$aMycobacterium phlei$5IEN$0(DLC)sh 85089185

=LDR  00736cz  a2200169n  4500
=001  9880363708302441
=005  20141212203655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009166
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x502
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x502
=150  \\$aMycobacterium leprae
=550  \\$wg$aMycobacterium
=667  \\$ainfection = LEPROSY; /drug eff: consider also LEPROSTATIC AGENTS; DF: MYCOBACT LEPRAE
=680  \\$iA species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
=750  \0$aMycobacterium leprae$5IEN$0(DLC)sh 88023290

=LDR  00935cz  a2200277n  4500
=001  9880363708402441
=005  20141212203654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009164
=035  \\$aCBA2423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552
=150  \\$aMycobacterium Infections
=450  \\$wnnna$aInfection, Mycobacterium
=450  \\$wnnna$aInfections, Mycobacterium
=450  \\$aMycobacterial Diseases$5IEN
=450  \\$wnnna$aMycobacterium Infection
=550  \\$wg$aActinomycetales Infections
=550  \\$wh$aLeprosy
=550  \\$wh$aMycobacterium Infections, Nontuberculous
=550  \\$wh$aParatuberculosis
=550  \\$wh$aTuberculosis
=667  \\$agram-pos bact infect; GEN; consider also TUBERCULOSIS; DF: MYCOBACT INFECT
=680  \\$iInfections with bacteria of the genus MYCOBACTERIUM.
=688  \\$a64
=750  \0$aMycobacterial diseases$5IEN$0(DLC)sh 85089182

=LDR  00872cz  a2200205n  4500
=001  9880363708502441
=005  20141212203654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x402
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x402
=150  \\$aMycobacterium bovis
=450  \\$aBCG
=450  \\$aCalmette-Guerin Bacillus
=550  \\$wg$aMycobacterium
=667  \\$a= M. tuberc. bovis; infection = TUBERCULOSIS, BOVINE if in cattle, TUBERCULOSIS /vet (IM) + MYCOBACTERIUM BOVIS (IM) if in other animals; DF: MYCOBACT BOVIS or short X ref
=680  \\$iThe bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.
=688  \\$aBCG was see under MYCOBACTERIUM BOVIS 1975-79
=750  \0$aMycobacterium bovis$5IEN-M$0(DLC)sh 94009050

=LDR  01056cz  a2200205n  4500
=001  9880363708602441
=005  20141212203654.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500.$x300
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552.$x300
=150  \\$aMycobacterium avium
=550  \\$wg$aMycobacterium
=550  \\$wh$aMycobacterium avium subsp. paratuberculosis
=550  \\$aMycobacterium avium Complex
=667  \\$ainfection in birds = TUBERCULOSIS, AVIAN; infection in other animals = TUBERCULOSIS /vet (IM) + MYCOBACTERIUM AVIUM (IM); DF: MYCOBACT AVIUM
=680  \\$iA bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.
=688  \\$a87(75); was see under MYCOBACTERIUM 1975-86
=750  \0$aMycobacterium avium$5IEN$0(DLC)sh 88023289

=LDR  01040cz  a2200265n  4500
=001  9880363708702441
=005  20141212203653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525.$x500
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552.$x552
=150  \\$aMycobacterium
=550  \\$wg$aMycobacteriaceae
=550  \\$wh$aMycobacterium avium
=550  \\$wh$aMycobacterium bovis
=550  \\$wh$aMycobacterium haemophilum
=550  \\$wh$aMycobacterium leprae
=550  \\$wh$aMycobacterium lepraemurium
=550  \\$wh$aMycobacterium phlei
=550  \\$wh$aMycobacterium tuberculosis
=550  \\$wh$aNontuberculous Mycobacteria
=667  \\$ageneral; prefer specifics; infection = MYCOBACTERIUM INFECTIONS; DF: MYCOBACT
=680  \\$iA genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.
=750  \0$aMycobacterium$5IEN$0(DLC)sh 85089183

=LDR  00675cz  a2200193n  4500
=001  9880363708802441
=005  20141212203653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009159
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x525
=072  \\$aB3.$x510.$x460.$x400.$x410.$x552
=150  \\$aMycobacteriaceae
=550  \\$wg$aActinomycetales
=550  \\$wg$aGram-Positive Asporogenous Rods, Regular
=550  \\$wh$aMycobacterium
=680  \\$iA family of gram-positive bacteria found in soil and dairy products and as parasites on animals and man. Several are important pathogens.
=688  \\$a75
=750  \0$aMycobacteria$5IEN$0(DLC)sh 85089179

=LDR  00841cz  a2200193n  4500
=001  9880363708902441
=005  20201216131219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009016
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x537.$x525
=072  \\$aB3.$x660.$x250.$x530.$x525
=150  \\$aMoraxella
=550  \\$wg$aMoraxellaceae
=550  \\$wh$aMoraxella catarrhalis
=550  \\$wh$aMoraxella bovis
=667  \\$ainfection: coord IM with MORAXELLACEAE INFECTIONS (IM); note specifics but MORAXELLA KINGAE see KINGELLA KINGAE is available
=680  \\$iA genus of gram-negative, aerobic bacteria occurring as rods (subgenus Moraxella) or cocci (subgenus Branhamella). Its organisms are parasitic on the mucous membranes of humans and other warm-blooded animals.
=750  \0$aMoraxella$5IEN$0(DLC)sh 88023288

=LDR  00839cz  a2200289n  4500
=001  9880363709002441
=005  20180821162935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009014
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x500
=072  \\$aK1.$x752.$x566
=150  \\$aMorals
=450  \\$wnnna$aMorality
=550  \\$wg$aHumanities
=550  \\$wg$aPhilosophy
=550  \\$wg$aPsychology, Social
=550  \\$wh$aConscience
=550  \\$wh$aEthics
=550  \\$wh$aMoral Development
=550  \\$wh$aMoral Status
=550  \\$wh$aSocial Responsibility
=550  \\$wh$aVirtues
=550  \\$aRetrospective Moral Judgment
=680  \\$iStandards of conduct that distinguish right from wrong.
=750  \0$aMoral conditions$5IEN-M$0(DLC)sh 85087198
=750  \0$aConduct of life$5IEN-HS$0(DLC)sh 85030802

=LDR  00575cz  a2200193n  4500
=001  9880363709102441
=005  20141212192334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009013
=035  \\$aCBA2270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x477
=150  \\$aMorale
=450  \\$wnnna$aMorales
=550  \\$wg$aPsychology, Social
=550  \\$aCourage
=667  \\$ano qualif
=680  \\$iThe prevailing temper or spirit of an individual or group in relation to the tasks or functions which are expected.
=750  \0$aMorale$5IEN$0(DLC)sh 85087205

=LDR  01025cz  a2200289n  4500
=001  9880363709302441
=005  20141212203555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009008
=035  \\$aCBA2265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x85
=150  \\$aAbnormalities, Severe Teratoid
=450  \\$wnnna$aAbnormality, Severe Teratoid
=450  \\$wnno$aMonsters$5IEN-M
=450  \\$wnnna$aSevere Teratoid Abnormalities
=450  \\$wnnna$aSevere Teratoid Abnormality
=450  \\$wnnna$aTeratoid Abnormalities, Severe
=450  \\$wnnna$aTeratoid Abnormality, Severe
=550  \\$wg$aCongenital Abnormalities
=550  \\$wh$aAnencephaly
=550  \\$wh$aTwins, Conjoined
=667  \\$afetus in fetu: index under FETUS /abnorm; "monsters" in historical literature goes here
=680  \\$iMarked developmental anomalies of a fetus or infant.
=688  \\$a2010 (1963)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Monsters
=750  \0$aMonsters$0(DLC) sh 85086994$5IEN

=LDR  00612cz  a2200217n  4500
=001  9880363709402441
=005  20141212203555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009007
=035  \\$aCBA2264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x627
=150  \\$aMonotremata
=450  \\$wnnna$aMonotrematas
=450  \\$aMonotremes$5IEN
=550  \\$wg$aMammals
=550  \\$wh$aEchidna
=550  \\$wh$aPlatypus
=667  \\$aGEN or unspecified; prefer ECHIDNA & PLATYPUS; IM; qualif permitted
=688  \\$a75(73)63-67
=750  \0$aMonotremes$5IEN$0(DLC)sh 85086980

=LDR  00881cz  a2200277n  4500
=001  9880363709502441
=005  20141212203554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009005
=035  \\$aCBA2262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546
=150  \\$aMonosaccharides
=550  \\$wg$aCarbohydrates
=550  \\$wh$aCarbasugars
=550  \\$wh$aHeptoses
=550  \\$wh$aHexoses
=550  \\$wh$aImino Sugars
=550  \\$wh$aKetoses
=550  \\$wh$aPentoses
=550  \\$wh$aTetroses
=550  \\$wh$aThiosugars
=550  \\$wh$aTrioses
=667  \\$aGEN; prefer specifics
=680  \\$iSimple sugars, carbohydrates which cannot be decomposed by hydrolysis. They are colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. (From Dorland, 28th ed)
=750  \0$aMonosaccharides$5IEN$0(DLC)sh 85086973

=LDR  01268cz  a2200349n  4500
=001  9880363709602441
=005  20141212203553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009000
=035  \\$aCBA2257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x652
=072  \\$aA11.$x148.$x580
=072  \\$aA11.$x627.$x624
=072  \\$aA11.$x733.$x547
=072  \\$aA15.$x145.$x229.$x637.$x555.$x652
=072  \\$aA15.$x378.$x316.$x580
=072  \\$aA15.$x382.$x490.$x555.$x652
=072  \\$aA15.$x382.$x680.$x547
=072  \\$aA15.$x382.$x812.$x547
=150  \\$aMonocytes
=450  \\$wnnna$aMonocyte
=550  \\$wg$aBone Marrow Cells
=550  \\$wg$aLeukocytes, Mononuclear
=550  \\$wg$aMononuclear Phagocyte System
=550  \\$wg$aMyeloid Cells
=550  \\$wg$aPhagocytes
=550  \\$wh$aMonocyte-Macrophage Precursor Cells
=550  \\$wh$aMonocytes, Activated Killer
=667  \\$ado not confuse with LEUKOCYTES, MONONUCLEAR
=680  \\$iLarge, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.
=750  \0$aMonocytes$5IEN$0(DLC)sh 85086902

=LDR  01673cz  a2200397n  4500
=001  9880363709702441
=005  20141212203553.0
=008  850225\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008998
=035  \\$aCBA2255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x147.$x542.$x640
=072  \\$aC20.$x683.$x460.$x640
=072  \\$aC20.$x683.$x780.$x640
=150  \\$aMonoclonal Gammopathy of Undetermined Significance
=450  \\$wnnna$aBenign Monoclonal Gammapathies
=450  \\$wnnna$aBenign Monoclonal Gammapathy
=450  \\$aBenign Monoclonal Gammopathies
=450  \\$wnnna$aBenign Monoclonal Gammopathy
=450  \\$wnnna$aGammapathies, Benign Monoclonal
=450  \\$wnnna$aGammapathy, Benign Monoclonal
=450  \\$wnnna$aGammopathies, Benign Monoclonal
=450  \\$wnnna$aGammopathy, Benign Monoclonal
=450  \\$wnnna$aMonoclonal Gammapathies, Benign
=450  \\$wnnna$aMonoclonal Gammapathy, Benign
=450  \\$aMonoclonal Gammapathy of Undetermined Significance
=450  \\$aMonoclonal Gammopathies, Benign
=450  \\$wnnna$aMonoclonal Gammopathy, Benign
=550  \\$wg$aHypergammaglobulinemia
=550  \\$wg$aParaproteinemias
=550  \\$wh$aSchnitzler Syndrome
=680  \\$iConditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.
=688  \\$a1991(1986); use HYPERGAMMAGLOBULINEMIA 1986-1990
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Monoclonal Gammopathies, Benign
=688  \\$a91(86); was see under HYPERGAMMAGLOBULINEMIA 1986-90
=750  \0$aMonoclonal gammopathies$0(DLC) sh 85052999$5IEN-M

=LDR  01290cz  a2200313n  4500
=001  9880363709802441
=005  20141212203552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008996
=035  \\$aCBA2253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x616
=150  \\$aMonoamine Oxidase Inhibitors
=450  \\$wnnna$aInhibitor, Monoamine Oxidase
=450  \\$wnnna$aInhibitors, MAO
=450  \\$wnnna$aInhibitors, Monoamine Oxidase
=450  \\$aMAO Inhibitors
=450  \\$aMonoamine Oxidase$xantagonists & inhibitors
=450  \\$wnnna$aMonoamine Oxidase Inhibitor
=450  \\$wnnna$aReversible Inhibitor of Monoamine Oxidase
=450  \\$aReversible Inhibitors of Monoamine Oxidase
=450  \\$wnnna$aRIMA (Reversible Inhibitor of Monoamine Oxidase A)
=550  \\$wg$aEnzyme Inhibitors
=550  \\$aAntidepressive Agents
=550  \\$aSerotonin Syndrome
=550  \\$aSympathomimetics
=667  \\$aDF: MAO INHIB
=680  \\$iA chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
=750  \0$aMonoamine oxidase$xInhibitors$5IEN$0(DLC)sh 85086887

=LDR  01679cz  a2200337n  4500
=001  9880363709902441
=005  20141212203551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008995
=035  \\$aCBA2252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x664.$x750
=150  \\$aMonoamine Oxidase
=450  \\$aAmine Oxidase (Flavin-Containing)
=450  \\$aMAO
=450  \\$wnnna$aMAO-A
=450  \\$wnnna$aMAO A
=450  \\$wnnna$aMAO-B
=450  \\$wnnna$aMAO B
=450  \\$wnnna$aMonoamine Oxidase A
=450  \\$wnnna$aMonoamine Oxidase B
=450  \\$wnnna$aOxidase, Monoamine
=450  \\$wnnna$aOxidase, Tyramine
=450  \\$wnnna$aType A Monoamine Oxidase
=450  \\$wnnna$aType B Monoamine Oxidase
=450  \\$wnnna$aTyramine Oxidase
=550  \\$wg$aOxidoreductases Acting on CH-NH2 Group Donors
=550  \\$wh$aBenzylamine Oxidase
=680  \\$iAn enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4.
=688  \\$a63; for TYRAMINE OXIDASE use MONOAMINE OXIDASE (NM) 1980-98
=750  \0$aMonoamine oxidase$5IEN$0(DLC)sh 85086886

=LDR  00916cz  a2200253n  4500
=001  9880363710002441
=005  20141212203550.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008993
=035  \\$aCBA2250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x650.$x160.$x650.$x500
=072  \\$aB4.$x909.$x204.$x783.$x160.$x650.$x500
=150  \\$aMonkeypox virus
=450  \\$wnnna$aMonkey Pox Virus
=450  \\$wnnna$aMonkey Pox Viruses
=450  \\$wnnna$aMonkeypox viruses
=450  \\$wnnna$aMonkeypoxvirus
=450  \\$wnnna$aMonkeypoxviruses
=550  \\$wg$aOrthopoxvirus
=667  \\$ainfection = MONKEYPOX
=680  \\$iA species of ORTHOPOXVIRUS causing an epidemic disease among captive primates.
=688  \\$a97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 (see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80)
=750  \0$aMonkeypox virus$5IEN$0(DLC)sh 88003282

=LDR  01188cz  a2200229n  4500
=001  9880363710102441
=005  20141212203550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008992
=035  \\$aCBA2249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x735.$x500
=150  \\$aMonkey Diseases
=450  \\$wnnna$aDisease, Monkey
=450  \\$wnnna$aDiseases, Monkey
=450  \\$wnnna$aMonkey Disease
=550  \\$wg$aPrimate Diseases
=550  \\$wh$aMarburg Virus Disease
=550  \\$wh$aSimian Acquired Immunodeficiency Syndrome
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific monkey dis (IM); coord IM with specific monkey (IM); for abnormalities or injuries, index under specific monkey heading /abnorm or /inj; does not include diseases of chimpanzees: CHIMPANZEE is an ape, not monkey ( = APE DISEASES: see note there); don't forget also MONKEYS (NIM) if no specific monkey is indexed; also check tag ANIMALS; DF: MONKEY DIS
=680  \\$iDiseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas (= APE DISEASES).
=750  \0$aMonkeys$xDiseases$5IEN-M$0(IEN)369306

=LDR  01743cz  a2200409n  4500
=001  9880363710202441
=005  20200515115453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008991
=035  \\$aCBA2248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520
=150  \\$aMonitoring, Physiologic
=450  \\$wnnna$aMonitoring, Patient
=450  \\$wnnna$aMonitoring, Physiological
=450  \\$aPatient Monitoring
=450  \\$wnnna$aPhysiologic Monitoring
=450  \\$wnnna$aPhysiological Monitoring
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aActigraphy
=550  \\$wh$aBlood Glucose Self-Monitoring
=550  \\$wh$aDrug Monitoring
=550  \\$wh$aEsophageal pH Monitoring
=550  \\$wh$aFetal Monitoring
=550  \\$wh$aHemodynamic Monitoring
=550  \\$wh$aMonitoring, Ambulatory
=550  \\$wh$aMonitoring, Immunologic
=550  \\$wh$aMonitoring, Intraoperative
=550  \\$wh$aNeuromuscular Monitoring
=550  \\$wh$aNeurophysiological Monitoring
=550  \\$wh$aPolysomnography
=550  \\$wh$aTelemetry
=550  \\$wh$aUterine Monitoring
=667  \\$aIM GEN only; avoid indexing routinely word "monitoring": must be "continuous" (see MeSH definition); note see related: there emphasis is on the computer-assisted processing
=680  \\$iThe continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.
=688  \\$a78; MONITORING SYSTEMS was heading 1966-77
=750  \0$aPatient monitoring$5IEN$0(DLC)sh 85098704

=LDR  01102cz  a2200349n  4500
=001  9880363710302441
=005  20141212203549.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008988
=035  \\$aCBA2244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x400
=150  \\$aHerpestidae
=450  \\$aCrossarchus
=450  \\$aCusimanses
=450  \\$wnnna$aDwarf Mongoose
=450  \\$aDwarf Mongooses
=450  \\$aHelogale
=450  \\$aHerpestes
=450  \\$aLiberian Mongoose
=450  \\$aLiberiictis
=450  \\$wnnna$aMongoose
=450  \\$wnnna$aMongoose, Dwarf
=450  \\$wnnna$aMongoose, Liberian
=450  \\$aMongooses
=450  \\$wnnna$aMongooses, Dwarf
=450  \\$aMungos
=550  \\$wg$aCarnivora
=667  \\$anote entry terms: MONGOOSE, RING-TAILED; MONGOOSE, BROWN-TAILED; and MALAGASY MONGOOSE see EUPLERIDAE are also available
=680  \\$iThe family of agile, keen-sighted mongooses of Asia and Africa that feed on RODENTS and SNAKES.
=688  \\$a2005 (1975)
=750  \0$aHerpestidae$0(DLC) sh 92000381$5IEN-M

=LDR  00989cz  a2200229n  4500
=001  9880363710402441
=005  20141212203547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008982
=035  \\$aCBA2238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x555
=072  \\$aD1.$x268.$x956.$x500
=072  \\$aD1.$x552.$x544.$x555
=150  \\$aMolybdenum
=450  \\$aMolybdenum Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aMo-98; Mo-92, 94-97, 100 = MOLYBDENUM (IM) + ISOTOPES (NIM); Mo-88-91, 93, 99, 101-105 = MOLYBDENUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. (From Dorland, 27th ed)
=750  \0$aMolybdenum compounds$5IEN-M$0(DLC)sh 85086643
=750  \0$aMolybdenum$5IEN-HS$0(DLC)sh 85086637

=LDR  00725cz  a2200205n  4500
=001  9880363710502441
=005  20141212203544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008975
=035  \\$aCBA2231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700.$x596
=072  \\$aD27.$x720.$x723.$x596
=072  \\$aD27.$x888.$x723.$x596
=150  \\$aMolluscacides
=450  \\$aMolluscicides$5IEN
=550  \\$wg$aPesticides
=667  \\$aspecify the mollusk if pertinent; eff of molluscacides on mollusks is indexed under each without a qualif: cf TN 111 for eff of insecticides on insects
=680  \\$iAgents destructive to snails and other mollusks.
=750  \0$aMolluscicides$5IEN$0(DLC)sh 85086610

=LDR  01186cz  a2200301n  4500
=001  9880363710602441
=005  20141212203544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008974
=035  \\$aCBA2230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644
=150  \\$aMollusca
=450  \\$aMalacologists$5IEN
=450  \\$wnnna$aMollusc
=450  \\$wnnna$aMolluscas
=450  \\$wnnna$aMolluscs
=450  \\$wnnna$aMollusk
=450  \\$wnnna$aMollusks
=550  \\$wg$aInvertebrates
=550  \\$wh$aBivalvia
=550  \\$wh$aCephalopoda
=550  \\$wh$aGastropoda
=550  \\$wh$aPolyplacophora
=667  \\$aas animal & food; IM; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA phylum of the kingdom Metazoa. Mollusca have soft, unsegmented bodies with an anterior head, a dorsal visceral mass, and a ventral foot. Most are encased in a protective calcareous shell. It includes the classes GASTROPODA; BIVALVIA; CEPHALOPODA; Aplacophora; Scaphopoda; Polyplacophora; and Monoplacophora.
=750  \0$aMalacologists$5IEN-M$0(DLC)sh 85080018
=750  \0$aMollusks$5IEN-HS$0(DLC)sh 85086611

=LDR  00612cz  a2200217n  4500
=001  9880363710702441
=005  20170629113320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008970
=035  \\$aCBA2226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x494
=150  \\$aMolecular Weight
=450  \\$wnnna$aMolecular Weights
=450  \\$wnnna$aWeight, Molecular
=450  \\$wnnna$aWeights, Molecular
=550  \\$wg$aChemical Phenomena
=667  \\$aNIM
=680  \\$iThe sum of the weight of all the atoms in a molecule.
=688  \\$a67(64)
=750  \0$aMolecular weights$5IEN$0(DLC)sh 85086596

=LDR  01405cz  a2200373n  4500
=001  9880363710802441
=005  20141212211024.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015394
=035  \\$aCBA2225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570
=072  \\$aG2.$x575
=072  \\$aG2.$x842.$x575
=150  \\$aMolecular Structure
=450  \\$wnnna$aMolecular Structures
=450  \\$aStructure, Molecular
=450  \\$wnnna$aStructures, Molecular
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPhysicochemical Phenomena
=550  \\$wh$aAmino Acid Sequence
=550  \\$wh$aBase Sequence
=550  \\$wh$aBinding Sites
=550  \\$wh$aCarbohydrate Sequence
=550  \\$wh$aConserved Sequence
=550  \\$wh$aIsomerism
=550  \\$wh$aMolecular Conformation
=550  \\$wh$aMolecular Dynamics Simulation
=550  \\$aModels, Molecular
=667  \\$aalmost never IM; do not confuse with MOLECULAR CONFORMATION; AMINO ACID SEQUENCE; BASE SEQUENCE; and CARBOHYDRATE SEQUENCE are also available; protein architecture = PROTEIN CONFORMATION or its specifics; DF: MOL STRUCT
=680  \\$iThe location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds.
=688  \\$a89
=750  \0$aMolecular structure$5IEN$0(DLC)sh 85086594

=LDR  01127cz  a2200277n  4500
=001  9880363710902441
=005  20141212211006.0
=008  880601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015335
=035  \\$aCBA2223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x259.$x750
=072  \\$aD27.$x720.$x470.$x530
=150  \\$aMolecular Probes
=450  \\$wnnna$aMolecular Probe
=450  \\$wnnna$aProbe, Molecular
=450  \\$wnnna$aProbes, Molecular
=550  \\$wg$aDiagnostic Uses of Chemicals
=550  \\$wg$aLaboratory Chemicals
=550  \\$wh$aNucleic Acid Probes
=550  \\$aBiological Markers
=550  \\$aMolecular Diagnostic Techniques
=667  \\$aMOLECULAR PROBE TECHNIQUES is also available; DF: MOL PROBES
=680  \\$iA group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in MOLECULAR GENETICS to detect the presence of a complementary sequence by NUCLEIC ACID HYBRIDIZATION.
=688  \\$a89
=750  \0$aMolecular probes$5IEN$0(DLC)sh 88007475

=LDR  01601cz  a2200445n  4500
=001  9880363711002441
=005  20141212203542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008968
=035  \\$aCBA2221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x790
=072  \\$aG2.$x575.$x500
=072  \\$aG2.$x842.$x575.$x500
=150  \\$aMolecular Conformation
=450  \\$wnnna$a3D Molecular Structure
=450  \\$wnnna$a3D Molecular Structures
=450  \\$wnnna$aConfiguration, Molecular
=450  \\$wnnna$aConfigurations, Molecular
=450  \\$wnnna$aConformation, Molecular
=450  \\$wnnna$aConformations, Molecular
=450  \\$aMolecular Configuration
=450  \\$wnnna$aMolecular Configurations
=450  \\$wnnna$aMolecular Conformations
=450  \\$wnnna$aMolecular Structure, 3D
=450  \\$wnnna$aMolecular Structure, Three Dimensional
=450  \\$wnnna$aMolecular Structures, 3D
=450  \\$wnnna$aStructure, 3D Molecular
=450  \\$wnnna$aStructures, 3D Molecular
=450  \\$wnnna$aThree Dimensional Molecular Structure
=550  \\$wg$aMolecular Structure
=550  \\$wh$aBay-Region, Polycyclic Aromatic Hydrocarbon
=550  \\$wh$aCarbohydrate Conformation
=550  \\$wh$aNucleic Acid Conformation
=550  \\$wh$aProtein Conformation
=550  \\$aModels, Molecular
=667  \\$ageneral; prefer specifics; do not confuse with MOLECULAR STRUCTURE; DF: MOL CONFORMATION
=680  \\$iThe characteristic three-dimensional shape of a molecule.
=688  \\$a73
=750  \0$aMolecules$5IEN$0(DLC)sh 85086597

=LDR  01179cz  a2200337n  4500
=001  9880363711102441
=005  20141212203542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008967
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x636
=072  \\$aH1.$x158.$x273.$x343.$x595
=072  \\$aH1.$x181.$x122.$x650
=150  \\$aMolecular Biology
=450  \\$wnnna$aBiochemical Genetic
=450  \\$wnnna$aBiochemical Genetics
=450  \\$wnnna$aBiology, Molecular
=450  \\$wnnna$aGenetic, Biochemical
=450  \\$wnnna$aGenetic, Molecular
=450  \\$wnnna$aGenetics, Biochemical
=450  \\$wnnna$aGenetics, Molecular
=450  \\$wnnna$aMolecular Genetic
=450  \\$wnnna$aMolecular Genetics
=550  \\$wg$aBiochemistry
=550  \\$wg$aGenetics
=550  \\$wh$aMolecular Medicine
=667  \\$ause for the discipline only (education, history, etc)
=680  \\$iA discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules.
=688  \\$a70(68)
=750  \0$aMolecular biologists$5IEN-M$0(DLC)sh 85086576
=750  \0$aMolecular biology$5IEN-HS$0(DLC)sh 85086577

=LDR  00608cz  a2200169n  4500
=001  9880363711202441
=005  20141212203541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008965
=035  \\$aCBA2218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x662
=150  \\$aMolasses
=450  \\$wnnna$aMolasse
=550  \\$wg$aFood
=680  \\$iThe syrup remaining after sugar is crystallized out of SUGARCANE or sugar beet juice. It is also used in ANIMAL FEED, and in a fermented form, is used to make industrial ETHYL ALCOHOL and ALCOHOLIC BEVERAGES.
=750  \0$aMolasses$5IEN$0(DLC)sh 85086544

=LDR  00797cz  a2200265n  4500
=001  9880363711302441
=005  20141212203541.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008964
=035  \\$aCBA2217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x525.$x500
=150  \\$aMolar, Third
=450  \\$wnnna$aMolars, Third
=450  \\$wnnna$aTeeth, Wisdom
=450  \\$wnnna$aThird Molar
=450  \\$wnnna$aThird Molars
=450  \\$aTooth, Wisdom
=450  \\$wnnna$aWisdom Teeth
=450  \\$wnnna$aWisdom Tooth
=550  \\$wg$aMolar
=667  \\$athe last tooth, behind the 2d molar; human only; IM
=680  \\$iThe aftermost permanent tooth on each side in the maxilla and mandible.
=688  \\$a82
=750  \0$aThird molars$5IEN$0(DLC)sh 86004183

=LDR  00873cz  a2200205n  4500
=001  9880363711402441
=005  20141212203540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008963
=035  \\$aCBA2216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x525
=150  \\$aMolar
=450  \\$wnnna$aMolars
=550  \\$wg$aTooth
=550  \\$wh$aMolar, Third
=667  \\$athe most posterior teeth; for grinding; NIM when merely locational
=680  \\$iThe most posterior teeth on either side of the jaw, totaling eight in the deciduous dentition (2 on each side, upper and lower), and usually 12 in the permanent dentition (three on each side, upper and lower). They are grinding teeth, having large crowns and broad chewing surfaces. (Jablonski, Dictionary of Dentistry, 1992, p821)
=688  \\$a65
=750  \0$aMolars$5IEN$0(DLC)sh 85086541

=LDR  01782cz  a2200517n  4500
=001  9880363711502441
=005  20141212203540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008962
=035  \\$aCBA2215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599
=150  \\$aModels, Theoretical
=450  \\$wnnna$aExperimental Model
=450  \\$wnnna$aExperimental Models
=450  \\$wnnna$aMathematical Model
=450  \\$wnnna$aModel, Experimental
=450  \\$wnnna$aModel (Theoretical)
=450  \\$wnnna$aModel, Theoretical
=450  \\$wnnna$aModels, Experimental
=450  \\$wnnna$aModels, Theoretic
=450  \\$wnnna$aModels (Theoretical)
=450  \\$wnnna$aStudies, Theoretical
=450  \\$wnnna$aStudy, Theoretical
=450  \\$wnnna$aTheoretical Model
=450  \\$wnnna$aTheoretical Models
=450  \\$wnnna$aTheoretical Studies
=450  \\$wnnna$aTheoretical Study
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aFractals
=550  \\$wh$aFuzzy Logic
=550  \\$wh$aModels, Biological
=550  \\$wh$aModels, Chemical
=550  \\$wh$aModels, Educational
=550  \\$wh$aModels, Molecular
=550  \\$wh$aModels, Nursing
=550  \\$wh$aModels, Organizational
=550  \\$wh$aModels, Psychological
=550  \\$wh$aModels, Statistical
=550  \\$wh$aNonlinear Dynamics
=550  \\$aComputer Simulation
=550  \\$aSystems Theory
=667  \\$ageneral; prefer specifics
=680  \\$iTheoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a68; MODELS was heading 1966-67
=750  \0$aMathematical models$5IEN$0(DLC)sh 85082124

=LDR  01094cz  a2200277n  4500
=001  9880363711602441
=005  20141212203539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008960
=035  \\$aCBA2212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x695
=150  \\$aModels, Psychological
=450  \\$wnnna$aModel, Psychologic
=450  \\$wnnna$aModel, Psychological
=450  \\$wnnna$aModels, Psychologic
=450  \\$wnnna$aPsychologic Model
=450  \\$wnnna$aPsychologic Models
=450  \\$wnnna$aPsychological Model
=450  \\$wnnna$aPsychological Models
=550  \\$wg$aModels, Theoretical
=550  \\$wh$aNeurolinguistic Programming
=667  \\$ano qualif; TN 128: definition & relation to MODELS, THEORETICAL; DF: MODELS PSYCHOL
=680  \\$iTheoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a73; was MODELS, PSYCHOLOGIC 1968-72
=750  \0$aPsychology$xMathematical models$5IEN$0(DLC)sh 85108463

=LDR  01107cz  a2200277n  4500
=001  9880363711702441
=005  20141212203539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008959
=035  \\$aCBA2211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395.$x642
=150  \\$aModels, Neurological
=450  \\$wnnna$aModel, Neurologic
=450  \\$wnnna$aModel, Neurological
=450  \\$wnnna$aModels, Neurologic
=450  \\$wnnna$aNeurologic Model
=450  \\$aNeurologic Models
=450  \\$wnnna$aNeurological Model
=450  \\$wnnna$aNeurological Models
=550  \\$wg$aModels, Biological
=550  \\$wh$aNeurolinguistic Programming
=667  \\$ano qualif; TN 128: definition & relation to MODELS, THEORETICAL; DF: MODELS NEUROL
=680  \\$iTheoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a77; was MODELS, NEUROLOGIC 1968-76
=750  \0$aNervous system$xMathematical models$5IEN-M$0(IEN)369304

=LDR  01041cz  a2200265n  4500
=001  9880363711802441
=005  20141212203539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008958
=035  \\$aCBA2210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x595
=150  \\$aModels, Molecular
=450  \\$wnnna$aModel, Molecular
=450  \\$wnnna$aMolecular Model
=450  \\$aMolecular Models
=550  \\$wg$aModels, Theoretical
=550  \\$wh$aMolecular Docking Simulation
=550  \\$wh$aMolecular Dynamics Simulation
=550  \\$aMolecular Conformation
=550  \\$aMolecular Structure
=667  \\$ano qualif; TN 37: relation to MODELS, CHEMICAL; DF: MODELS MOL
=680  \\$iModels used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
=688  \\$a84(75); was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83
=750  \0$aMolecules$xModels$5IEN$0(DLC)sh 85086598

=LDR  00807cz  a2200205n  4500
=001  9880363711902441
=005  20141212203538.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008957
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395.$x397
=150  \\$aModels, Genetic
=450  \\$wnnna$aGenetic Model
=450  \\$wnnna$aGenetic Models
=450  \\$wnnna$aModel, Genetic
=550  \\$wg$aModels, Biological
=667  \\$ano qualif; apply TN 128 for relation to MODELS, THEORETICAL; DF: MODELS GENET
=680  \\$iTheoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment.
=688  \\$a80
=750  \0$aGenetics$xMathematical models$5IEN$0(DLC)sh 85053879

=LDR  00826cz  a2200229n  4500
=001  9880363378902441
=005  20141212201907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006195
=035  \\$aCAZ9363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x337
=072  \\$aD1.$x268.$x956.$x249
=072  \\$aD1.$x552.$x544.$x337
=150  \\$aHafnium
=450  \\$aHafnium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aHf-180; Hf-176-179 = HAFNIUM (IM) + ISOTOPES (NIM); Hf-168-175, 181-183 = HAFNIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iHafnium. A metal element of atomic number 72 and atomic weight 178.49, symbol Hf. (From Dorland, 28th ed)
=750  \0$aHafnium compounds$5IEN-M$0(DLC)sh 85058242
=750  \0$aHafnium$5IEN-HS$0(DLC)sh 85058238

=LDR  00811cz  a2200205n  4500
=001  9880363379002441
=005  20141212201906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006193
=035  \\$aCAZ9361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x450.$x330
=072  \\$aB3.$x660.$x250.$x550.$x290.$x330
=150  \\$aHaemophilus influenzae
=450  \\$aHemophilus influenzae
=550  \\$wg$aHaemophilus
=550  \\$wh$aHaemophilus influenzae type b
=667  \\$ainfection: coord IM with HAEMOPHILUS INFECTIONS (IM); vaccine = HAEMOPHILUS VACCINES
=680  \\$iA species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
=750  \0$aHaemophilus influenzae$5IEN$0(DLC)sh 85060220

=LDR  01060cz  a2200301n  4500
=001  9880363379102441
=005  20141212201906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006192
=035  \\$aCAZ9360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x700.$x433
=150  \\$aHaemophilus Infections
=450  \\$wnnna$aHaemophilus Infection
=450  \\$aHemophilus Diseases$5IEN
=450  \\$wnnna$aHemophilus Infection
=450  \\$aHemophilus Infections
=450  \\$wnnna$aInfection, Haemophilus
=450  \\$wnnna$aInfection, Hemophilus
=450  \\$wnnna$aInfections, Haemophilus
=450  \\$wnnna$aInfections, Hemophilus
=550  \\$wg$aPasteurellaceae Infections
=550  \\$wh$aChancroid
=550  \\$wh$aMeningitis, Haemophilus
=667  \\$agram-neg bact infect; check text for species & index by instructions on species; MENINGITIS, HAEMOPHILUS is also available
=680  \\$iInfections with bacteria of the genus HAEMOPHILUS.
=688  \\$a68
=750  \0$aHaemophilus infections$5IEN-M$0(DLC)sh 85060219

=LDR  00665cz  a2200193n  4500
=001  9880363379202441
=005  20141212201906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006191
=035  \\$aCAZ9359M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x450.$x125
=072  \\$aB3.$x660.$x250.$x550.$x290.$x125
=150  \\$aHaemophilus ducreyi
=450  \\$aHemophilus ducreyi
=550  \\$wg$aHaemophilus
=667  \\$ainfection = CHANCROID
=680  \\$iA species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.
=750  \0$aHaemophilus ducreyi$0(DLC)sh2006002253$5IEN-M

=LDR  01121cz  a2200277n  4500
=001  9880363379302441
=005  20141212201906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006190
=035  \\$aCAZ9358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x450
=072  \\$aB3.$x660.$x250.$x550.$x290
=150  \\$aHaemophilus
=450  \\$aHemophilus
=550  \\$wg$aPasteurellaceae
=550  \\$wh$aHaemophilus ducreyi
=550  \\$wh$aHaemophilus influenzae
=550  \\$wh$aHaemophilus paragallinarum
=550  \\$wh$aHaemophilus parainfluenzae
=550  \\$wh$aHaemophilus paraphrophilus
=550  \\$wh$aHaemophilus parasuis
=550  \\$wh$aHaemophilus somnus
=667  \\$ause this spelling in translations; infection = HAEMOPHILUS INFECTIONS but check text for species & index by instructions on species
=680  \\$iA genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.
=750  \0$aHaemophilus$5IEN$0(DLC)sh 85060218

=LDR  00837cz  a2200193n  4500
=001  9880363379402441
=005  20141212201905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006189
=035  \\$aCAZ9357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x746.$x410
=150  \\$aHaemonchus
=450  \\$wnnna$aHemonchus
=550  \\$wg$aTrichostrongyloidea
=667  \\$ainfection = HAEMONCHIASIS; coordinate with specific helminth terms (ANTIGENS, HELMINTH, etc) if pertinent
=680  \\$iA genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses (POACEAE) they eat. Infestation of man is accidental.
=688  \\$a91(75); was see under TRICHOSTRONGYLOIDEA 1975-90
=750  \0$aHaemonchus$5IEN$0(DLC)sh 87020008

=LDR  01127cz  a2200313n  4500
=001  9880363379502441
=005  20141212192227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006185
=035  \\$aCAZ9353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x393
=072  \\$aF2.$x830.$x422
=072  \\$aG11.$x561.$x600.$x227
=150  \\$aHabituation, Psychophysiologic
=450  \\$wnnna$aHabituation, Psychophysiological
=450  \\$wnnna$aHabituation (Psychophysiology)
=450  \\$wnnna$aHabituations (Psychophysiology)
=450  \\$wnnna$aPsychophysiologic Habituation
=450  \\$wnnna$aPsychophysiological Habituation
=550  \\$wg$aLearning
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aPsychophysiology
=667  \\$aDF: HABITUATION
=680  \\$iThe disappearance of responsiveness to a repeated stimulation. It does not include drug habituation.
=688  \\$a2007 (1968)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Habituation (Psychophysiology)
=688  \\$a70(68)
=750  \0$aHabituation (Neuropsychology)$0(DLC) sh 85058163$5IEN

=LDR  00860cz  a2200265n  4500
=001  9880363379602441
=005  20141212201905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006184
=035  \\$aCAZ9352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x466
=150  \\$aHabits
=450  \\$wnnna$aHabit
=450  \\$wnnna$aHabit Disturbance
=450  \\$aHabit Disturbances
=550  \\$wg$aBehavior
=550  \\$wh$aFingersucking
=550  \\$wh$aFood Habits
=550  \\$wh$aNail Biting
=550  \\$wh$aTongue Habits
=667  \\$ano qualif; do not use for "drug habit" ( = SUBSTANCE ABUSE or SUBSTANCE DEPENDENCE) nor for "smoking habit" ( = SMOKING or TOBACCO USE DISORDER)
=680  \\$iAcquired or learned responses which are regularly manifested.
=688  \\$a69; was HABIT 1963-68
=750  \0$aHabit$5IEN$0(DLC)sh 85058157

=LDR  01023cz  a2200265n  4500
=001  9880363379702441
=005  20141212201904.0
=008  780317\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006182
=035  \\$aCAZ9350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x500.$x600.$x400
=072  \\$aD23.$x50.$x705.$x552.$x600.$x400
=150  \\$aH-Y Antigen
=450  \\$wnnna$aAntigen, H-Y
=450  \\$wnnna$aAntigen, HY
=450  \\$wnnna$aGA-1 Germ Cell Antigen
=450  \\$wnnna$aGA 1 Germ Cell Antigen
=450  \\$wnnna$aH Y Antigen
=450  \\$aHY Antigen
=550  \\$wg$aMinor Histocompatibility Antigens
=667  \\$amammals only
=680  \\$iA sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals. It causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis.
=688  \\$a79
=750  \0$aH-Y antigen$5IEN$0(DLC)sh 85058136

=LDR  00818cz  a2200265n  4500
=001  9880363379802441
=005  20160801091930.0
=008  780428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006178
=035  \\$aCAZ9346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x754.$x283
=150  \\$aRoma
=450  \\$wnno$aGypsies
=450  \\$wnnna$aGipsies
=450  \\$wnnna$aGipsy
=450  \\$wnnna$aGypsy
=450  \\$wnnna$aRomani
=450  \\$wnnna$aRomanies
=450  \\$wnnna$aRomany
=550  \\$wg$aEthnic Groups
=667  \\$ause this spelling in translations; specify geog
=680  \\$iEthnic group originating in India and entering Europe in the 14th or 15th century.
=688  \\$a2016(1979); use Gypsies 1991-2015; was see under ETHNIC GROUPS 1979-90
=750  \0$aRomanies$5IEN$0(DLC)sh 85058109

=LDR  00749cz  a2200193n  4500
=001  9880363379902441
=005  20251118145153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006176
=035  \\$aCAZ9344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x310
=150  \\$aGynecology
=450  \\$aGynecologists$5IEN
=550  \\$wg$aSpecialties, Surgical
=550  \\$aGynecologic Surgical Procedures
=667  \\$aSPEC: SPEC qualif; corresponding organ term is GENITALIA, FEMALE; DF: GYNECOL
=680  \\$iA medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology.
=750  \0$aGynecology$5IEN-HS$0(DLC)sh 85058092

=LDR  01137cz  a2200265n  4500
=001  9880363380002441
=005  20141212201901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006173
=035  \\$aCAZ9341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x543.$x454
=072  \\$aI3.$x450.$x642.$x845.$x417
=150  \\$aGymnastics
=450  \\$wnnna$aCalisthenic
=450  \\$aCalisthenics
=450  \\$wnnna$aGymnastic
=450  \\$aGymnasts$5IEN
=550  \\$wg$aPhysical Education and Training
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; a systematic set of exercises; differentiate from PHYSICAL EDUCATION AND TRAINING: instruction in hygiene as well as systematic exerc usually in formal setting; "corrective gymnastics" is probably EXERCISE THERAPY
=680  \\$iSystematic physical exercise. This includes calisthenics, a system of light gymnastics for promoting strength and grace of carriage.
=688  \\$aCALISTHENICS was see under GYMNASTICS 1963-82
=750  \0$aGymnasts$5IEN-M$0(DLC)sh 85058067
=750  \0$aGymnastics$5IEN-HS$0(DLC)sh 85058059

=LDR  01073cz  a2200289n  4500
=001  9880363380102441
=005  20141212201900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006171
=035  \\$aCAZ9339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x721.$x61
=072  \\$aD25.$x339.$x859.$x495
=072  \\$aD25.$x720.$x327.$x840.$x119
=072  \\$aJ1.$x637.$x51.$x339.$x859.$x495
=150  \\$aGutta-Percha
=450  \\$wnnna$aGutta Percha
=450  \\$wnnna$aGuttapercha
=450  \\$wnnna$aThermofil
=450  \\$wnnna$aUltrafil
=550  \\$wg$aPlant Exudates
=550  \\$wg$aRoot Canal Filling Materials
=550  \\$wg$aRubber
=667  \\$aD25-26 qualif
=680  \\$iCoagulated exudate isolated from several species of the tropical tree Palaquium (Sapotaceae). It is the trans-isomer of natural rubber and is used as a filling and impression material in dentistry and orthopedics and as an insulator in electronics. It has also been used as a rubber substitute.
=688  \\$a65
=750  \0$aGutta-percha$5IEN$0(DLC)sh 85058001

=LDR  00911cz  a2200253n  4500
=001  9880363380202441
=005  20141212201900.0
=008  790430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x739.$x500
=072  \\$aD9.$x698.$x700.$x500
=072  \\$aD20.$x215.$x721.$x249.$x500
=150  \\$aGum Arabic
=450  \\$aAcacia Gum
=450  \\$wnnna$aAcacia, Gum
=450  \\$wnnna$aArabic, Gum
=450  \\$aGum Acacia
=450  \\$wnnna$aGum, Acacia
=550  \\$wg$aPlant Gums
=667  \\$aD25-26 qualif
=680  \\$iPowdered exudate from various Acacia species, especially A. senegal (Leguminosae). It forms mucilage or syrup in water. Gum arabic is used as a suspending agent, excipient, and emulsifier in foods and pharmaceuticals.
=688  \\$a91(80); was see under POLYSACCHARIDES 1980-90
=750  \0$aGum arabic$5IEN$0(DLC)sh 85057900

=LDR  00760cz  a2200229n  4500
=001  9880363380302441
=005  20141212201859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006168
=035  \\$aCAZ9336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x550
=150  \\$aGuinea Pigs
=450  \\$aCavia
=450  \\$wnnna$aCavia porcellus
=450  \\$wnnna$aGuinea Pig
=450  \\$wnnna$aPig, Guinea
=450  \\$wnnna$aPigs, Guinea
=550  \\$wg$aRodentia
=667  \\$acheck tag: no qualif
=680  \\$iA common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
=750  \0$aGuinea pigs$5IEN$0(DLC)sh 85057793

=LDR  00635cz  a2200193n  4500
=001  9880363380402441
=005  20141212201859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006167
=035  \\$aCAZ9335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x483
=150  \\$aGuilt
=450  \\$wnnna$aGuilts
=550  \\$wg$aEmotions
=550  \\$wh$aShame
=667  \\$ano qualif
=680  \\$iSubjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one's personal conscience.
=750  \0$aGuilt$5IEN$0(DLC)sh 85057753

=LDR  01188cz  a2200325n  4500
=001  9880363380502441
=005  20141212201858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006162
=035  \\$aCAZ9330M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x650.$x600
=072  \\$aD12.$x644.$x360.$x350
=072  \\$aD12.$x776.$x476.$x350
=150  \\$aGuanylate Cyclase
=450  \\$wnnna$aCyclase, Deoxyguanylate
=450  \\$wnnna$aCyclase, Guanyl
=450  \\$wnnna$aCyclase, Guanylate
=450  \\$wnnna$aCyclase, Guanylyl
=450  \\$wnnna$aCyclase, Inosinate
=450  \\$wnnna$aDeoxyguanylate Cyclase
=450  \\$aGuanyl Cyclase
=450  \\$wnnna$aGuanylyl Cyclase
=450  \\$wnnna$aInosinate Cyclase
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aPhosphorus-Oxygen Lyases
=550  \\$wh$aReceptors, Guanylate Cyclase-Coupled
=680  \\$iAn enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2.
=688  \\$a94; was GUANYL CYCLASE 1973-94
=750  \0$aGuanylate cyclase$0(DLC)sh2002000839$5IEN-M

=LDR  00876cz  a2200253n  4500
=001  9880363380602441
=005  20141212201857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006160
=035  \\$aCAZ9328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x454.$x504
=072  \\$aD13.$x695.$x667.$x454.$x504
=072  \\$aD13.$x695.$x827.$x426.$x504
=150  \\$aGuanosine Triphosphate
=450  \\$aGTP
=450  \\$wnnna$aTriphosphate, Guanosine
=550  \\$wg$aGuanine Nucleotides
=550  \\$wh$aGuanosine 5'-O-(3-Thiotriphosphate)
=550  \\$wh$aGuanylyl Imidodiphosphate
=667  \\$a/biosyn /physiol permitted
=680  \\$iGuanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety.
=688  \\$a72
=750  \0$aGuanosine triphosphate$5IEN$0(DLC)sh 93000028

=LDR  02086cz  a2200385n  4500
=001  9880363380702441
=005  20141212201854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006152
=035  \\$aCAZ9320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x646.$x454.$x160
=072  \\$aD13.$x695.$x462.$x275
=072  \\$aD13.$x695.$x667.$x454.$x160
=072  \\$aD13.$x695.$x827.$x426.$x160
=150  \\$aCyclic GMP
=450  \\$wnnna$a3',5'-Monophosphate, Guanosine Cyclic
=450  \\$wnnna$aCyclic 3',5'-Monophosphate, Guanosine
=450  \\$wnnna$aCyclic-3',5'-Monophosphate, Guanosine
=450  \\$aCyclic Guanylic Acid$5IEN
=450  \\$wnnna$aCyclic Monophosphate, Guanosine
=450  \\$wnnna$aGMP, Cyclic
=450  \\$wnnna$aGuanosine Cyclic 3,5 Monophosphate
=450  \\$wnnna$aGuanosine Cyclic-3',5'-Monophosphate
=450  \\$aGuanosine Cyclic 3',5'-Monophosphate
=450  \\$wnnna$aGuanosine Cyclic 3',5' Monophosphate
=450  \\$wnnna$aGuanosine Cyclic Monophosphate
=450  \\$wnnna$aMonophosphate, Guanosine Cyclic
=550  \\$wg$aGuanine Nucleotides
=550  \\$wg$aNucleotides, Cyclic
=550  \\$wh$aDibutyryl Cyclic GMP
=667  \\$a/biosyn /physiol permitted; DF: CYCL GMP
=680  \\$iGuanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed)
=688  \\$a94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3',5'-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3',5' MONOPHOSPHATE 1971-77 (Prov 1971); CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2',3'-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93
=750  \0$aCyclic guanylic acid$5IEN$0(DLC)sh 85035067

=LDR  01296cz  a2200421n  4500
=001  9880363380802441
=005  20141212201853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006146
=035  \\$aCAZ9314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370
=150  \\$aGuanidines
=450  \\$aGuanidino Compounds$5IEN
=450  \\$aGuanoxan$5IEN-M
=550  \\$wg$aAmidines
=550  \\$wh$a3-Iodobenzylguanidine
=550  \\$wh$aAgmatine
=550  \\$wh$aBethanidine
=550  \\$wh$aBiguanides
=550  \\$wh$aCimetidine
=550  \\$wh$aCreatine
=550  \\$wh$aGabexate
=550  \\$wh$aGuanabenz
=550  \\$wh$aGuanethidine
=550  \\$wh$aGuanfacine
=550  \\$wh$aGuanidine
=550  \\$wh$aImpromidine
=550  \\$wh$aMethylguanidine
=550  \\$wh$aMitoguazone
=550  \\$wh$aNitrosoguanidines
=550  \\$wh$aPinacidil
=550  \\$wh$aRobenidine
=550  \\$wh$aSulfaguanidine
=550  \\$wh$aZanamivir
=667  \\$ado not confuse with GUANINE
=680  \\$iA family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
=750  \0$aGuanidines$5IEN-M$0(DLC)sh 85057590

=LDR  01275cz  a2200313n  4500
=001  9880363380902441
=005  20141212201852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006145
=035  \\$aCAZ9313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x460
=150  \\$aGuanethidine
=450  \\$wnnna$a((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine
=450  \\$wnnna$aGuanethidine Monosulfate
=450  \\$wnnna$aGuanethidine Sulfate
=450  \\$wnnna$aGuanethidine Sulfate (1:1)
=450  \\$wnnna$aGuanethidine Sulfate (1:2)
=450  \\$wnnna$aGuanethidine Sulfate (2:1)
=450  \\$wnnna$aGuanethidine Sulfate (2:1), 14C-Labeled
=450  \\$wnnna$aIsmelin
=450  \\$wnnna$aIsobarin
=450  \\$wnnna$aMonosulfate, Guanethidine
=450  \\$wnnna$aOctadine
=450  \\$wnnna$aOktadin
=450  \\$wnnna$aSulfate, Guanethidine
=550  \\$wg$aGuanidines
=680  \\$iAn antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
=750  \0$aGuanethidine$5IEN$0(DLC)sh 88007115

=LDR  01326cz  a2200421n  4500
=001  9880363381002441
=005  20141212201851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006140
=035  \\$aCAZ9308M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601.$x536.$x400
=072  \\$aD2.$x355.$x726.$x453.$x400
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166.$x453.$x400
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x453.$x400
=150  \\$aGuaifenesin
=450  \\$wnnna$aBreonesin
=450  \\$wnnna$aEther, Guaiacol Glyceryl
=450  \\$wnnna$aGlycerol Guaiacolate
=450  \\$wnnna$aGlyceryl Ether, Guaiacol
=450  \\$aGuaiacol Glyceryl Ether
=450  \\$wnnna$aGuaiacolate, Glycerol
=450  \\$aGuaiphenesin
=450  \\$wnnna$aGuaiphenezine
=450  \\$wnnna$aGuiatuss
=450  \\$wnnna$aHumibid
=450  \\$wnnna$aHytuss
=450  \\$wnnna$aMy-301
=450  \\$wnnna$aMy 301
=450  \\$wnnna$aMy301
=450  \\$wnnna$aScott-Tussin
=450  \\$wnnna$aScott Tussin
=450  \\$wnnna$aScottTussin
=550  \\$wg$aGuaiacol
=550  \\$wh$aMethocarbamol
=680  \\$iAn expectorant that also has some muscle relaxing action. It is used in many cough preparations.
=688  \\$a2004(1966)
=750  \0$aGuaifenesin$0(DLC)sh2005001163$5IEN-M

=LDR  01036cz  a2200313n  4500
=001  9880363381102441
=005  20141212201850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006139
=035  \\$aCAZ9307M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x601.$x536
=072  \\$aD2.$x355.$x726.$x453
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166.$x453
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x453
=150  \\$aGuaiacol
=450  \\$wnnna$a2-Hydroxy-Anisole
=450  \\$wnnna$a2-Hydroxyanisole
=450  \\$wnnna$a2-Methoxy-Phenol
=450  \\$wnnna$a2-Methoxyphenol
=450  \\$wnnna$aCatechol, Methyl
=450  \\$wnnna$aGuaicol
=450  \\$wnnna$aMethyl Catechol
=550  \\$wg$aCatechols
=550  \\$wg$aMethyl Ethers
=550  \\$wg$aPhenyl Ethers
=550  \\$wh$aGuaifenesin
=680  \\$iAn agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
=750  \0$aGuaiacol$5IEN-M$0(DLC)sh 99013827

=LDR  00488cz  a2200157n  4500
=001  9880363381202441
=005  20141212201850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006138
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x721.$x500.$x490
=150  \\$aGuaiac
=550  \\$wg$aResins, Plant
=667  \\$aD25-26 qualif
=680  \\$iResin from wood of certain species of GUAIACUM. It is used as clinical reagent for occult blood.
=750  \0$aGuaiac$5IEN$0(DLC)sh 85057581

=LDR  00852cz  a2200205n  4500
=001  9880363381302441
=005  20141212201849.0
=008  850315\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006135
=035  \\$aCAZ9303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x678.$x410
=150  \\$aGryllidae
=450  \\$wnnna$aCricket
=450  \\$aCrickets
=550  \\$wg$aOrthoptera
=667  \\$a/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iThe family Gryllidae consists of the common house cricket, Acheta domesticus, which is used in neurological and physiological studies. Other genera include Gryllotalpa (mole cricket); Gryllus (field cricket); and Oecanthus (tree cricket).
=688  \\$a91(86); was see under ORTHOPTERA 1986-90
=750  \0$aCrickets$5IEN$0(DLC)sh 85033988

=LDR  00844cz  a2200253n  4500
=001  9880363381402441
=005  20141212201849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006133
=035  \\$aCAZ9301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377
=150  \\$aGrowth Substances
=450  \\$wnnna$aEndogenous Mitogens
=450  \\$aMitogens, Endogenous
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAngiogenesis Modulating Agents
=550  \\$wh$aGrowth Inhibitors
=550  \\$wh$aMicronutrients
=550  \\$wh$aPlant Growth Regulators
=550  \\$aAgricultural Inoculants
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iSignal molecules that are involved in the control of cell growth and differentiation.
=750  \0$aGrowth factors$0(DLC) sh 85057532$5IEN

=LDR  00922cz  a2200301n  4500
=001  9880363381502441
=005  20141212201849.0
=008  830209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006132
=035  \\$aCAZ9300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x251.$x352
=150  \\$aGrowth Plate
=450  \\$aCartilage, Epiphyseal
=450  \\$wnnna$aCartilages, Epiphyseal
=450  \\$aEpiphyseal Cartilage
=450  \\$wnnna$aEpiphyseal Cartilages
=450  \\$aEpiphyseal Plate
=450  \\$wnnna$aEpiphyseal Plates
=450  \\$wnnna$aGrowth Plates
=450  \\$wnnna$aPlate, Epiphyseal
=450  \\$wnnna$aPlate, Growth
=450  \\$wnnna$aPlates, Epiphyseal
=450  \\$wnnna$aPlates, Growth
=550  \\$wg$aEpiphyses
=680  \\$iThe area between the EPIPHYSIS and the DIAPHYSIS within which bone growth occurs.
=688  \\$a84
=750  \0$aGrowth plate$5IEN$0(DLC)sh 88001051

=LDR  00892cz  a2200217n  4500
=001  9880363381602441
=005  20141212201848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006130
=035  \\$aCAZ9298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x393
=150  \\$aGrowth Disorders
=450  \\$wnnna$aDisorder, Growth
=450  \\$wnnna$aGrowth Disorder
=550  \\$wg$aPathologic Processes
=550  \\$wh$aFetal Growth Retardation
=667  \\$ado not confuse with NUTRITION DISORDERS (disord of assimilating & utilizing nutrients)
=680  \\$iDeviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
=688  \\$a72(69)
=750  \0$aGrowth disorders$5IEN$0(DLC)sh 85057530

=LDR  00879cz  a2200241n  4500
=001  9880363381702441
=005  20141212201848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006128
=035  \\$aCAZ9296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x249
=150  \\$aGrowth
=550  \\$wg$aGrowth and Development
=550  \\$wh$aBody Size
=550  \\$wh$aCell Growth Processes
=550  \\$wh$aOrgan Size
=550  \\$wh$aTropism
=550  \\$aChild Development
=667  \\$aGeneral only; prefer /growth with specific organ or organism: Manual 19.7+, 19.8.35
=680  \\$iGradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.
=750  \0$aGrowth$5IEN-M$0(DLC)sh 85057525
=750  \0$aHuman growth$5IEN-HS$0(DLC)sh 85062879

=LDR  00736cz  a2200217n  4500
=001  9880363381802441
=005  20141212201848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006127
=035  \\$aCAZ9295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x274
=150  \\$aGroup Structure
=450  \\$wnnna$aGroup Structures
=450  \\$wnnna$aStructure, Group
=450  \\$wnnna$aStructures, Group
=550  \\$wg$aGroup Processes
=667  \\$ano qualif
=680  \\$iThe informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group.
=688  \\$a69(68)
=750  \0$aSocial groups$5IEN$0(DLC)sh 85123946

=LDR  01202cz  a2200397n  4500
=001  9880363381902441
=005  20170104104041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316
=150  \\$aGroup Processes
=450  \\$wnnna$aGroup Meeting
=450  \\$wnnna$aGroup Meetings
=450  \\$wnnna$aGroup Process
=450  \\$wnnna$aGroup Thinking
=450  \\$wnnna$aGroup Thinkings
=450  \\$wnnna$aMeeting, Group
=450  \\$wnnna$aMeetings, Group
=450  \\$wnnna$aProcess, Group
=450  \\$wnnna$aProcesses, Group
=450  \\$wnnna$aThinking, Group
=450  \\$wnnna$aThinkings, Group
=550  \\$wg$aPsychology, Social
=550  \\$wh$aConsensus
=550  \\$wh$aDiplomacy
=550  \\$wh$aGroup Structure
=550  \\$wh$aPeer Group
=550  \\$wh$aPeer Review
=550  \\$wh$aRole
=550  \\$wh$aSensitivity Training Groups
=550  \\$wh$aSocial Distance
=550  \\$aSociology
=667  \\$adifferentiate from MASS BEHAVIOR
=680  \\$iThe procedures through which a group approaches, attacks, and solves a common problem.
=750  \0$aSmall groups$5IEN$0(DLC)sh 85123590

=LDR  01169cz  a2200253n  4500
=001  9880363382002441
=005  20141212201847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006124
=035  \\$aCAZ9292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x244.$x369
=150  \\$aGroup Practice, Dental
=450  \\$wnnna$aDental Group Practice
=450  \\$wnnna$aDental Group Practices
=450  \\$aGroup Dental Practice$5IEN
=450  \\$wnnna$aGroup Practices, Dental
=450  \\$wnnna$aPractice, Dental Group
=450  \\$wnnna$aPractices, Dental Group
=550  \\$wg$aGroup Practice
=667  \\$acoord IM with specific dent specialty (IM); do not confuse with PARTNERSHIP PRACTICE, DENTAL but do not interpret: use word of text; DF: GROUP PRACTICE DENT
=680  \\$iAny group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.
=688  \\$a67
=750  \0$aGroup dental practice$5IEN$0(DLC)sh 85057474

=LDR  01156cz  a2200253n  4500
=001  9880363382102441
=005  20141212201846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006123
=035  \\$aCAZ9291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x244
=150  \\$aGroup Practice
=450  \\$wnnna$aGroup Practices
=450  \\$wnnna$aPractice, Group
=450  \\$wnnna$aPractices, Group
=550  \\$wg$aProfessional Practice
=550  \\$wh$aGroup Practice, Dental
=550  \\$wh$aGroup Practice, Prepaid
=550  \\$wh$aHealth Maintenance Organizations
=550  \\$wh$aIndependent Practice Associations
=667  \\$acoord IM with med or other specialty (IM); do not confuse with PARTNERSHIP PRACTICE but do not interpret: use word of text
=680  \\$iAny group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.
=750  \0$aGroup medical practice$5IEN$0(DLC)sh 85057487

=LDR  00611cz  a2200193n  4500
=001  9880363382202441
=005  20141212201846.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006119
=035  \\$aCAZ9287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x365
=150  \\$aGroin
=450  \\$wnnna$aGroins
=550  \\$wg$aAbdomen
=667  \\$aexternal only: do not confuse with INGUINAL CANAL, internal only; NIM when merely locational
=680  \\$iThe external junctural region between the lower part of the abdomen and the thigh.
=688  \\$a81
=750  \0$aGroin$5IEN$0(DLC)sh 85057405

=LDR  00682cz  a2200229n  4500
=001  9880363382302441
=005  20141212201846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006117
=035  \\$aCAZ9285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x142.$x110
=150  \\$aGrief
=450  \\$wnnna$aGriefs
=450  \\$aMourning
=450  \\$wnnna$aMournings
=550  \\$wg$aBereavement
=550  \\$aBereavement
=667  \\$ahuman & animal; no qualif
=680  \\$iNormal, appropriate sorrowful response to an immediate cause. It is self-limiting and gradually subsides within a reasonable time.
=688  \\$a68
=750  \0$aGrief$5IEN$0(DLC)sh 85057330

=LDR  00915cz  a2200253n  4500
=001  9880363382402441
=005  20170607093934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006112
=035  \\$aCAZ9280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x350
=150  \\$aGravitation
=450  \\$wnnna$aForce, G
=450  \\$aG Force
=450  \\$wnnna$aG Forces
=450  \\$aGravistimulation
=450  \\$wnnna$aGravities
=450  \\$aGravity
=550  \\$wg$aAstronomical Phenomena
=550  \\$wh$aGravity, Altered
=667  \\$ano qualif
=680  \\$iAcceleration produced by the mutual attraction of two masses, and of magnitude inversely proportional to the square of the distance between the two centers of mass. It is also the force imparted by the earth, moon, or a planet to an object near its surface. (From NASA Thesaurus, 1988)
=750  \0$aGravitation$5IEN$0(DLC)sh 85056558

=LDR  01860cz  a2200457n  4500
=001  9880363382502441
=005  20141212201844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006111
=035  \\$aCAZ9279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x675.$x349.$x500
=072  \\$aC19.$x874.$x283.$x605
=072  \\$aC19.$x874.$x397.$x370
=072  \\$aC20.$x111.$x555
=150  \\$aGraves Disease
=450  \\$wnnna$aBasedow Disease
=450  \\$aBasedow's Disease
=450  \\$wnnna$aBasedows Disease
=450  \\$wnnna$aDisease, Basedow
=450  \\$wnnna$aDisease, Basedow's
=450  \\$wnnna$aDisease, Graves
=450  \\$wnnna$aDisease, Graves'
=450  \\$aExophthalmic Goiter
=450  \\$wnnna$aExophthalmic Goiters
=450  \\$aGoiter, Exophthalmic
=450  \\$wnnna$aGoiters, Exophthalmic
=450  \\$aGraves' Disease
=450  \\$wnnna$aHyperthyroidism, Autoimmune
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aExophthalmos
=550  \\$wg$aGoiter
=550  \\$wg$aHyperthyroidism
=550  \\$wh$aGraves Ophthalmopathy
=550  \\$aImmunoglobulins, Thyroid-Stimulating
=667  \\$aGRAVES OPHTHALMOPATHY is also available
=680  \\$iA common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
=688  \\$a2006 (1987); use GOITER, EXOPHTHALMIC 1963-1986
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Graves' Disease
=688  \\$a87; was GOITER, EXOPHTHALMIC 1963-86
=750  \0$aGraves' disease$0(DLC) sh 85056549$5IEN

=LDR  02270cz  a2200733n  4500
=001  9880363382702441
=005  20160801105355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822
=150  \\$aPoaceae
=450  \\$aAlopecurus
=450  \\$aArundo
=450  \\$wnnna$aArundos
=450  \\$aGramineae
=450  \\$wnnna$aGrass
=450  \\$wnnna$aGrasse
=450  \\$aGrasses
=450  \\$aImperata
=450  \\$wnnna$aImperatas
=550  \\$wg$aAngiosperms
=550  \\$wh$aAgropyron
=550  \\$wh$aAgrostis
=550  \\$wh$aAndropogon
=550  \\$wh$aAvena
=550  \\$wh$aBambusa
=550  \\$wh$aBrachiaria
=550  \\$wh$aBrachypodium
=550  \\$wh$aBromus
=550  \\$wh$aCenchrus
=550  \\$wh$aCoix
=550  \\$wh$aCymbopogon
=550  \\$wh$aCynodon
=550  \\$wh$aDactylis
=550  \\$wh$aDigitaria
=550  \\$wh$aEchinochloa
=550  \\$wh$aEleusine
=550  \\$wh$aElymus
=550  \\$wh$aEragrostis
=550  \\$wh$aFestuca
=550  \\$wh$aHolcus
=550  \\$wh$aHordeum
=550  \\$wh$aLolium
=550  \\$wh$aMelinis repens
=550  \\$wh$aOryza
=550  \\$wh$aPanicum
=550  \\$wh$aPaspalum
=550  \\$wh$aPennisetum
=550  \\$wh$aPhalaris
=550  \\$wh$aPhleum
=550  \\$wh$aPoa
=550  \\$wh$aSaccharum
=550  \\$wh$aSasa
=550  \\$wh$aSecale
=550  \\$wh$aSetaria Plant
=550  \\$wh$aSorghum
=550  \\$wh$aTriticum
=550  \\$wh$aVetiveria
=550  \\$wh$aZea mays
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons). Food grains (CEREALS) come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.
=688  \\$a2002(1963)
=750  \0$aGrasses$5IEN$0(DLC)sh 85056515

=LDR  01478cz  a2200469n  4500
=001  9880363382802441
=005  20141212201733.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005907
=035  \\$aCAZ9070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x795.$x475
=072  \\$aD2.$x948.$x828.$x475
=150  \\$aGliclazide
=450  \\$wnnna$aAlphapharm Brand of Gliclazide
=450  \\$wnnna$aDiabrezide
=450  \\$wnnna$aDiaglyk
=450  \\$wnnna$aDiaikron
=450  \\$wnnna$aDiamicron
=450  \\$wnnna$aGen-Gliclazide
=450  \\$wnnna$aGen Gliclazide
=450  \\$wnnna$aGenerics Brand of Gliclazide
=450  \\$wnnna$aGenpharm Brand of Gliclazide
=450  \\$wnnna$aGliclazide Servier Brand
=450  \\$wnnna$aGliklazid
=450  \\$wnnna$aGlyade
=450  \\$wnnna$aGlyclazide
=450  \\$wnnna$aHelsinn Brand of Gliclazide
=450  \\$wnnna$aNovo-Gliclazide
=450  \\$wnnna$aNovo Gliclazide
=450  \\$wnnna$aNovopharm Brand of Gliclazide
=450  \\$wnnna$aS-1702
=450  \\$wnnna$aS 1702
=450  \\$wnnna$aS-852
=450  \\$wnnna$aS 852
=450  \\$wnnna$aS1702
=450  \\$wnnna$aS852
=450  \\$wnnna$aServier Brand of Gliclazide
=550  \\$wg$aSulfonylurea Compounds
=680  \\$iAn oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
=688  \\$a91(75); was see under SULFONYLUREA COMPOUNDS 1975-90
=750  \0$aGliclazide$5IEN$0(DLC)sh 85055268

=LDR  01094cz  a2200361n  4500
=001  9880363382902441
=005  20141212201732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005905
=035  \\$aCAZ9068HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x795.$x575
=072  \\$aD2.$x948.$x828.$x575
=150  \\$aGlyburide
=450  \\$wnnna$aDaonil
=450  \\$wnnna$aDiabeta
=450  \\$wnnna$aEuglucon 5
=450  \\$wnnna$aEuglucon N
=450  \\$aGlibenclamide
=450  \\$wnnna$aGlybenclamide
=450  \\$wnnna$aHB-419
=450  \\$wnnna$aHB 419
=450  \\$wnnna$aHB-420
=450  \\$wnnna$aHB 420
=450  \\$wnnna$aHB419
=450  \\$wnnna$aHB420
=450  \\$wnnna$aManinil
=450  \\$wnnna$aMicronase
=450  \\$wnnna$aNeogluconin
=550  \\$wg$aSulfonylurea Compounds
=680  \\$iAn antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
=688  \\$a92; was GLIBENCLAMIDE 1971-91 (Prov 1971-72); GLYBURIDE was see GLIBENCLAMIDE 1973-91
=750  \0$aGlibenclamide$5IEN-M$0(DLC)sh 85055266

=LDR  01793cz  a2200517n  4500
=001  9880363383002441
=005  20141212201731.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005902
=035  \\$aCAZ9065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x525.$x381.$x407
=150  \\$aGlaucoma, Open-Angle
=450  \\$wnnna$aCompensated Glaucoma
=450  \\$wnnna$aCompensated Glaucomas
=450  \\$wnnna$aCompensative Glaucoma
=450  \\$wnnna$aCompensative Glaucomas
=450  \\$wnnna$aGlaucoma, Compensated
=450  \\$wnnna$aGlaucoma, Compensative
=450  \\$wnnna$aGlaucoma, Open Angle
=450  \\$aGlaucoma, Pigmentary
=450  \\$aGlaucoma, Simple
=450  \\$aGlaucoma Simplex
=450  \\$wnnna$aGlaucomas, Compensated
=450  \\$wnnna$aGlaucomas, Compensative
=450  \\$wnnna$aGlaucomas, Open Angle
=450  \\$wnnna$aGlaucomas, Open-Angle
=450  \\$wnnna$aGlaucomas, Pigmentary
=450  \\$wnnna$aGlaucomas, Simple
=450  \\$aOpen-Angle Glaucoma
=450  \\$wnnna$aOpen Angle Glaucoma
=450  \\$wnnna$aOpen Angle Glaucomas
=450  \\$wnnna$aOpen-Angle Glaucomas
=450  \\$wnnna$aPigmentary Glaucoma
=450  \\$wnnna$aPigmentary Glaucomas
=450  \\$wnnna$aSimple Glaucoma
=450  \\$wnnna$aSimple Glaucomas
=450  \\$wnnna$aSimplex, Glaucoma
=450  \\$wnnna$aSimplices, Glaucoma
=550  \\$wg$aGlaucoma
=550  \\$wh$aHydrophthalmos
=550  \\$aExfoliation Syndrome
=667  \\$ado not confuse with GLAUCOMA, CLOSED-ANGLE see GLAUCOMA, ANGLE-CLOSURE
=680  \\$iGlaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.
=688  \\$a82
=750  \0$aOpen-angle glaucoma$5IEN$0(DLC)sh 85055230

=LDR  01361cz  a2200241n  4500
=001  9880363383102441
=005  20141212201731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005901
=035  \\$aCAZ9063HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x525.$x381
=150  \\$aGlaucoma
=450  \\$wnnna$aGlaucomas
=550  \\$wg$aOcular Hypertension
=550  \\$wh$aGlaucoma, Angle-Closure
=550  \\$wh$aGlaucoma, Neovascular
=550  \\$wh$aGlaucoma, Open-Angle
=550  \\$aIntraocular Pressure
=550  \\$aIridocorneal Endothelial Syndrome
=667  \\$adifferentiate from OCULAR HYPERTENSION; / surg: consider FILTERING SURGERY or SCLEROSTOMY or TRABECULECTOMY
=680  \\$iAn ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
=750  \0$aGlaucoma$5IEN$0(DLC)sh 85055227

=LDR  00670cz  a2200181n  4500
=001  9880363383202441
=005  20141212201730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005898
=035  \\$aCAZ9060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x241.$x400
=072  \\$aJ1.$x637.$x437
=150  \\$aGlass
=550  \\$wg$aConstruction Materials
=550  \\$wg$aManufactured Materials
=680  \\$iHard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc.
=750  \0$aGlass$5IEN$0(DLC)sh 85055102

=LDR  00640cz  a2200169n  4500
=001  9880363383302441
=005  20141212201729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005896
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x170.$x400
=072  \\$aC22.$x488.$x409
=150  \\$aGlanders
=550  \\$wg$aBurkholderia Infections
=550  \\$wg$aHorse Diseases
=680  \\$iA contagious disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin.
=750  \0$aGlanders$5IEN$0(DLC)sh 85055089

=LDR  01032cz  a2200253n  4500
=001  9880363383402441
=005  20180103100500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005895
=035  \\$aCAZ9057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x853.$x363
=150  \\$aGizzard, Avian
=450  \\$wnno$aGizzard
=450  \\$wnnna$aAvian Gizzard
=450  \\$wnnna$aAvian Gizzards
=450  \\$wnnna$aGizzards
=450  \\$wnnna$aGizzards, Avian
=550  \\$wg$aStomach, Avian
=550  \\$aGizzard, Non-avian
=667  \\$adiseases: coordinate IM with STOMACH DISEASES /vet (IM); neoplasms: coordinate IM with STOMACH NEOPLASMS /vet (IM) + histological type of neoplasm/vet (IM)
=680  \\$iThe posterior portion of the avian stomach located between the PROVENTRICULUS and INTESTINE. It consists of a thick muscular wall and small stones (gastroliths) that function to mechanically grind SEEDS and other foods.
=688  \\$a2017; use Gizzard (NM) 1968-2016
=750  \0$aGizzard$5IEN$0(DLC)sh 85055040

=LDR  01617cz  a2200409n  4500
=001  9880363383502441
=005  20141212201729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005894
=035  \\$aCAZ9056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x87.$x500
=150  \\$aPanax
=450  \\$aGinseng
=450  \\$wnnna$aginseng, Panax
=450  \\$wnnna$aGinsengs
=450  \\$wnnna$aginsengs, Panax
=450  \\$wnnna$aJen Shen
=450  \\$wnnna$aJen Shens
=450  \\$wnnna$aNinjin
=450  \\$wnnna$aNinjins
=450  \\$aPanax ginseng
=450  \\$wnnna$aPanax ginsengs
=450  \\$wnnna$aPanaxs
=450  \\$wnnna$aRenshen
=450  \\$wnnna$aRenshens
=450  \\$wnnna$aSchinseng
=450  \\$wnnna$aSchinsengs
=450  \\$wnnna$aShen, Jen
=450  \\$wnnna$aShens, Jen
=450  \\$wnnna$aShinseng
=450  \\$wnnna$aShinsengs
=550  \\$wg$aAraliaceae
=550  \\$wh$aPanax notoginseng
=667  \\$ado not confuse X ref GINSENG with SIBERIAN GINSENG see Eleutherococcus; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAn araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. Sometimes confused with Siberian ginseng (ELEUTHEROCOCCUS).
=750  \0$aPanax$0(DLC) sh 85097357$5IEN-M

=LDR  02923cz  a2200721n  4500
=001  9880363383602441
=005  20141212201728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005892
=035  \\$aCAZ9054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x388.$x350.$x400
=072  \\$aC1.$x539.$x424
=072  \\$aC7.$x465.$x714.$x258.$x480.$x446
=150  \\$aGingivitis, Necrotizing Ulcerative
=450  \\$wnnna$aAcute Membranous Gingivitides
=450  \\$wnnna$aAcute Membranous Gingivitis
=450  \\$wnnna$aAcute Necrotizing Ulcerative Gingivitis
=450  \\$wnnna$aAngina, Vincent
=450  \\$wnnna$aAnginas, Vincent
=450  \\$wnnna$aFusospirillary Gingivitides
=450  \\$wnnna$aFusospirillary Gingivitis
=450  \\$wnnna$aFusospirilloses
=450  \\$wnnna$aFusospirillosis
=450  \\$wnnna$aGingivitides, Acute Membranous
=450  \\$wnnna$aGingivitides, Fusospirillary
=450  \\$wnnna$aGingivitides, Phagedenic
=450  \\$wnnna$aGingivitis, Acute Membranous
=450  \\$wnnna$aGingivitis, Fusospirillary
=450  \\$wnnna$aGingivitis, Phagedenic
=450  \\$wnnna$aGingivitis, Vincent's
=450  \\$wnnna$aInfection, Vincent
=450  \\$wnnna$aInfection, Vincent's
=450  \\$wnnna$aMembranous Gingivitides, Acute
=450  \\$wnnna$aMembranous Gingivitis, Acute
=450  \\$wnnna$aMouth, Trench
=450  \\$wnnna$aNecrotizing Ulcerative Gingivitis
=450  \\$wnnna$aPhagedenic Gingivitides
=450  \\$wnnna$aPhagedenic Gingivitis
=450  \\$wnnna$aStomatitides, Ulcerative
=450  \\$aStomatitis, Ulcerative
=450  \\$wnnna$aStomatitis, Vincent's
=450  \\$aTrench Mouth
=450  \\$wnnna$aUlcerative Gingivitis, Necrotizing
=450  \\$wnnna$aUlcerative Stomatitides
=450  \\$wnnna$aUlcerative Stomatitis
=450  \\$aVincent Angina
=450  \\$wnnna$aVincent Gingivitis
=450  \\$aVincent Infection
=450  \\$wnnna$aVincent Stomatitis
=450  \\$wnnna$aVincent's Gingivitis
=450  \\$wnnna$aVincents Gingivitis
=450  \\$wnnna$aVincent's Infection
=450  \\$wnnna$aVincents Infection
=450  \\$wnnna$aVincent's Stomatitis
=450  \\$wnnna$aVincents Stomatitis
=550  \\$wg$aFusobacterium Infections
=550  \\$wg$aGingivitis
=550  \\$wg$aInfection
=550  \\$aOral Ulcer
=680  \\$iAn acute or chronic GINGIVITIS characterized by redness and swelling, NECROSIS extending from the interdental papillae along the gingival margins, PAIN; HEMORRHAGE, necrotic odor, and often a pseudomembrane. The condition may extend to the ORAL MUCOSA; TONGUE; PALATE; or PHARYNX. The etiology is somewhat unclear, but may involve a complex of FUSOBACTERIUM NUCLEATUM along with spirochetes BORRELIA or TREPONEMA.
=688  \\$a73; was VINCENT'S INFECTIONS 1963-72
=750  \0$aGingivitis, Necrotizing ulcerative$5IEN$0(DLC)sh 85054981

=LDR  00594cz  a2200193n  4500
=001  9880363383702441
=005  20141212201727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005891
=035  \\$aCAZ9053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x258.$x480
=150  \\$aGingivitis
=450  \\$wnnna$aGingivitides
=550  \\$wg$aGingival Diseases
=550  \\$wh$aGingival Pocket
=550  \\$wh$aGingivitis, Necrotizing Ulcerative
=680  \\$iInflammation of gum tissue (GINGIVA) without loss of connective tissue.
=750  \0$aGingivitis$5IEN$0(DLC)sh 85054980

=LDR  00949cz  a2200241n  4500
=001  9880363383802441
=005  20141212201727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005890
=035  \\$aCAZ9052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x350
=072  \\$aE6.$x645.$x350
=072  \\$aE6.$x721.$x321
=150  \\$aGingivectomy
=450  \\$wnnna$aGingivectomies
=550  \\$wg$aOral Surgical Procedures
=550  \\$wg$aPeriodontics
=550  \\$aGingiva
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical excision of the gingiva at the level of its attachment, thus creating new marginal gingiva. This procedure is used to eliminate gingival or periodontal pockets or to provide an approach for extensive surgical interventions, and to gain access necessary to remove calculus within the pocket. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aGingivectomy$5IEN$0(DLC)sh 85054979

=LDR  00851cz  a2200217n  4500
=001  9880363383902441
=005  20141212201726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005885
=035  \\$aCAZ9047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x258.$x428.$x250
=150  \\$aGingival Hyperplasia
=450  \\$wnnna$aGingival Hyperplasias
=450  \\$wnnna$aHyperplasia, Gingival
=450  \\$wnnna$aHyperplasias, Gingival
=550  \\$wg$aGingival Overgrowth
=667  \\$adifferentiate from GINGIVAL HYPERTROPHY
=680  \\$iNon-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
=688  \\$a65
=750  \0$aGingival hyperplasia$5IEN$0(DLC)sh 85054978

=LDR  01403cz  a2200289n  4500
=001  9880363384002441
=005  20141212201725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005883
=035  \\$aCAZ9045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x383.$x500
=150  \\$aGingival Crevicular Fluid
=450  \\$wnnna$aCrevicular Fluid, Gingival
=450  \\$wnnna$aCrevicular Fluids, Gingival
=450  \\$wnnna$aExudate, Gingival
=450  \\$wnnna$aExudates, Gingival
=450  \\$wnnna$aFluid, Gingival Crevicular
=450  \\$wnnna$aFluids, Gingival Crevicular
=450  \\$wnnna$aGingival Crevicular Fluids
=450  \\$aGingival Exudate
=450  \\$wnnna$aGingival Exudates
=550  \\$wg$aExudates and Transudates
=667  \\$anote X ref; crevicular refers to the gingival crevice
=680  \\$iA fluid occurring in minute amounts in the gingival crevice, believed by some authorities to be an inflammatory exudate and by others to cleanse material from the crevice, containing sticky plasma proteins which improve adhesions of the epithelial attachment, have antimicrobial properties, and exert antibody activity. (From Jablonski, Illustrated Dictionary of Dentistry, 1982)
=688  \\$a91(72); was GINGIVAL EXUDATE see under GINGIVITIS 1972-90 (Prov 1972-74); was in Cat A & C 1972-83, was in Cat C 1984-95
=750  \0$aGingival fluid$5IEN-M$0(DLC)sh 85054977

=LDR  01078cz  a2200337n  4500
=001  9880363384102441
=005  20141212201725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005882
=035  \\$aCAZ9044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x258
=150  \\$aGingival Diseases
=450  \\$wnnna$aDisease, Gingival
=450  \\$wnnna$aDiseases, Gingival
=450  \\$wnnna$aEpulides
=450  \\$aEpulis
=450  \\$wnnna$aGingival Disease
=450  \\$wnnna$aGingivoses
=450  \\$aGingivosis
=550  \\$wg$aPeriodontal Diseases
=550  \\$wh$aGingival Hemorrhage
=550  \\$wh$aGingival Neoplasms
=550  \\$wh$aGingival Overgrowth
=550  \\$wh$aGingival Recession
=550  \\$wh$aGingivitis
=550  \\$wh$aGranuloma, Giant Cell
=550  \\$wh$aPericoronitis
=667  \\$ainflamm dis = GINGIVITIS or PERICORONITIS; note X ref EPULIS: EPULIS /congen = EPULIS, CONGENITAL see GINGIVAL NEOPLASMS & is indexed GINGIVAL NEOPLASMS /congen
=688  \\$a65
=750  \0$aGums$xDiseases$5IEN$0(DLC)sh 85057912

=LDR  00811cz  a2200217n  4500
=001  9880363384202441
=005  20141212201724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005881
=035  \\$aCAZ9043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x646.$x480
=150  \\$aGingiva
=450  \\$wnnna$aGum
=450  \\$aGums
=450  \\$aInterdental Papilla
=450  \\$wnnna$aPapilla, Interdental
=550  \\$wg$aPeriodontium
=667  \\$a/surg: prefer GINGIVOPLASTY or GINGIVECTOMY; inflammation = GINGIVITIS; peripheral giant cell granuloma = GINGIVAL DISEASES (IM) + GRANULOMA, GIANT CELL (IM), central giant cell granuloma = JAW DISEASES (IM) + GRANULOMA, GIANT CELL (IM)
=680  \\$iOral tissue surrounding and attached to TEETH.
=750  \0$aGums$5IEN$0(DLC)sh 85057910

=LDR  00401cz  a2200169n  4500
=001  9880363384302441
=005  20141212201724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005880
=035  \\$aCAZ9042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x421
=150  \\$aGills
=450  \\$wnnna$aGill
=550  \\$wg$aAnimal Structures
=688  \\$a68
=750  \0$aGills$5IEN$0(DLC)sh 85054948

=LDR  00682cz  a2200157n  4500
=001  9880363384402441
=005  20141212201722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005875
=035  \\$aCAZ9038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291.$x239.$x500
=150  \\$aGibberellins
=550  \\$wg$aDiterpenes, Kaurane
=680  \\$iA class of plant growth hormone isolated from cultures of Gibberella fujikuroi, a fungus causing Bakanae disease in rice. There are many different members of the family as well as mixtures of multiple members; all are diterpenoid acids based on the gibberellane skeleton.
=750  \0$aGibberellins$5IEN$0(DLC)sh 85054850

=LDR  00762cz  a2200205n  4500
=001  9880363384502441
=005  20141212201722.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005874
=035  \\$aCAZ9037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x501.$x400
=150  \\$aGibberella
=450  \\$wnnna$aGibberellas
=550  \\$wg$aHypocreales
=550  \\$aFusarium
=667  \\$aan ascomycete yielding gibberellin & gibberellic acid
=680  \\$iA genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals. It is also the source of plant growth regulators such as gibberellin and gibberellic acid.
=688  \\$a91(75)
=750  \0$aGibberella$5IEN$0(DLC)sh 88021954

=LDR  00780cz  a2200229n  4500
=001  9880363384602441
=005  20141212201722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005873
=035  \\$aCAZ9036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x432.$x481
=072  \\$aC3.$x752.$x400
=072  \\$aC6.$x405.$x469.$x452.$x481
=150  \\$aGiardiasis
=450  \\$wnnna$aGiardiases
=450  \\$wnnna$aLambliases
=450  \\$aLambliasis
=550  \\$wg$aIntestinal Diseases, Parasitic
=550  \\$wg$aProtozoan Infections
=680  \\$iAn infection of the SMALL INTESTINE caused by the flagellated protozoan GIARDIA LAMBLIA. It is spread via contaminated food and water and by direct person-to-person contact.
=750  \0$aGiardiasis$5IEN$0(DLC)sh 85054848

=LDR  00875cz  a2200217n  4500
=001  9880363384702441
=005  20141212201721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005872
=035  \\$aCAZ9035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x237.$x385
=150  \\$aGiardia
=450  \\$wnnna$aGiardias
=450  \\$aLamblia
=450  \\$wnnna$aLamblias
=550  \\$wg$aDiplomonadida
=550  \\$wh$aGiardia lamblia
=667  \\$ainfection = GIARDIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of flagellate intestinal EUKARYOTES parasitic in various vertebrates, including humans. Characteristics include the presence of four pairs of flagella arising from a complicated system of axonemes and cysts that are ellipsoidal to ovoidal in shape.
=750  \0$aGiardia$5IEN$0(DLC)sh 85054847

=LDR  01090cz  a2200253n  4500
=001  9880363384802441
=005  20180712135428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005870
=035  \\$aCAZ9033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x380
=150  \\$aGiant Cell Tumors
=450  \\$wnnna$aCell Tumor, Giant
=450  \\$wnnna$aCell Tumors, Giant
=450  \\$wnnna$aGiant Cell Tumor
=450  \\$wnnna$aTumor, Giant Cell
=450  \\$wnnna$aTumors, Giant Cell
=550  \\$wg$aNeoplasms, Connective Tissue
=550  \\$wh$aGiant Cell Tumor of Bone
=550  \\$wh$aGiant Cell Tumor of Tendon Sheath
=667  \\$abenign or malignant; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM) but GIANT CELL TUMOR OF BONE is available
=680  \\$iTumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.
=750  \0$aGiant cell tumors$5IEN$0(DLC)sh 85054833

=LDR  00603cz  a2200193n  4500
=001  9880363384902441
=005  20141212201720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005868
=035  \\$aCAZ9031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530.$x538.$x445
=150  \\$aGestures
=450  \\$wnnna$aGesture
=550  \\$wg$aKinesics
=667  \\$ano qualif
=680  \\$iMovement of a part of the body for the purpose of communication.
=688  \\$a91(75); was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67
=750  \0$aGesture$5IEN$0(DLC)sh 85054727

=LDR  01278cz  a2200349n  4500
=001  9880363385002441
=005  20141212201719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x235.$x968
=072  \\$aG8.$x686.$x320
=150  \\$aGestational Age
=450  \\$wnnna$aAge, Fetal
=450  \\$wnnna$aAge, Gestational
=450  \\$wnnna$aAges, Fetal
=450  \\$wnnna$aAges, Gestational
=450  \\$wnnna$aChronologic Fetal Maturity
=450  \\$wnnna$aFetal Age
=450  \\$wnnna$aFetal Ages
=450  \\$aFetal Maturity, Chronologic
=450  \\$wnnna$aGestational Ages
=450  \\$wnnna$aMaturity, Chronologic Fetal
=550  \\$wg$aFetal Development
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$aEmbryo, Mammalian
=550  \\$aFetus
=550  \\$aTerm Birth
=667  \\$amammalian only; for fetus not mother
=680  \\$iThe age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated as the time from the last day of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization.
=688  \\$a70(68)
=750  \0$aGestational age$5IEN$0(DLC)sh 85054725

=LDR  00789cz  a2200205n  4500
=001  9880363385102441
=005  20141212201719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005864
=035  \\$aCAZ9026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x360
=150  \\$aGestalt Therapy
=450  \\$wnnna$aTherapy, Gestalt
=550  \\$wg$aPsychotherapy
=667  \\$aa psychother technique; DF: GESTALT THER
=680  \\$iA form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence.
=688  \\$a91(73); was see under PSYCHOTHERAPY 1973-90
=750  \0$aGestalt therapy$5IEN$0(DLC)sh 85054724
=750  \0$aGestalt therapists$5IEN-HS$0(DLC)sh 91005358

=LDR  00849cz  a2200229n  4500
=001  9880363385202441
=005  20141212201717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005857
=035  \\$aCAZ9019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x513.$x750
=072  \\$aD1.$x268.$x556.$x305
=072  \\$aD1.$x552.$x544.$x305
=150  \\$aGermanium
=450  \\$aGermanium Compounds$5IEN
=550  \\$wg$aMetalloids
=550  \\$wg$aMetals, Heavy
=667  \\$aGe-74; Ge-70, 72, 73, 76 = GERMANIUM (IM) + ISOTOPES (NIM); Ge-65-69, 71, 75, 77, 78 = GERMANIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA rare metal element with a blue-gray appearance and atomic symbol Ge, atomic number 32, and atomic weight 72.63.
=750  \0$aGermanium$5IEN-HS$0(DLC)sh 85054449
=750  \0$aGermanium compounds$5IEN-HS$0(DLC)sh 85054455

=LDR  00920cz  a2200313n  4500
=001  9880363385302441
=005  20141212201716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005856
=035  \\$aCAZ9018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x320
=150  \\$aGerm-Free Life
=450  \\$wnnna$aAnimal, Axenic
=450  \\$wnnna$aAnimals, Axenic
=450  \\$wnnna$aAxenic Animal
=450  \\$aAxenic Animals
=450  \\$wnnna$aGerm Free Life
=450  \\$wnnna$aGermfree Life
=450  \\$wnnna$aGnotobiotic
=450  \\$aGnotobiotics
=450  \\$wnnna$aLife, Germ-Free
=450  \\$wnnna$aLife, Germfree
=550  \\$wg$aMicrobiological Phenomena
=550  \\$wh$aSpecific Pathogen-Free Organisms
=550  \\$aAxenic Culture
=667  \\$aIM
=680  \\$iAnimals not contaminated by or associated with any foreign organisms.
=750  \0$aGermfree life$5IEN$0(DLC)sh 85054679

=LDR  01112cz  a2200373n  4500
=001  9880363385402441
=005  20170117103322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005854
=035  \\$aCAZ9016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490
=072  \\$aA11.$x497
=150  \\$aGerm Cells
=450  \\$wnnna$aCell, Germ
=450  \\$wnnna$aCell, Germ-Line
=450  \\$wnnna$aCells, Germ
=450  \\$wnnna$aCells, Germ-Line
=450  \\$aGametes
=450  \\$wnnna$aGerm Cell
=450  \\$wnnna$aGerm Line
=450  \\$wnnna$aGerm-Line Cell
=450  \\$aGerm-Line Cells
=450  \\$wnnna$aGerm Line Cells
=450  \\$wnnna$aGerm Lines
=550  \\$wg$aCells
=550  \\$wg$aGenitalia
=550  \\$wh$aEmbryonic Germ Cells
=550  \\$wh$aGerm Cells, Plant
=550  \\$wh$aOvum
=550  \\$wh$aSpermatozoa
=667  \\$ageneral; prefer OVUM or SPERMATOZOA; GERM CELLS, PLANT is also available
=680  \\$iThe reproductive cells in multicellular organisms at various stages during GAMETOGENESIS.
=750  \0$aGerm cells$5IEN$0(DLC)sh 85054322

=LDR  00698cz  a2200193n  4500
=001  9880363385502441
=005  20180712133622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005853
=035  \\$aCAZ9015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x355
=150  \\$aGeriatrics
=450  \\$aGerontology
=550  \\$wg$aMedicine
=667  \\$aspecialty; when permitted for "geriatric diseases": Manual 28.9.1
=680  \\$iThe branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility.
=750  \0$aGerontology$5IEN-HS$0(DLC)sh 85054694
=750  \0$aGeriatrics$5IEN-HS$0(DLC)sh 85054315

=LDR  00732cz  a2200217n  4500
=001  9880363385602441
=005  20141212201715.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005852
=035  \\$aCAZ9014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x380
=072  \\$aH2.$x403.$x690.$x260
=150  \\$aGeriatric Psychiatry
=450  \\$aPsychiatry, Geriatric
=450  \\$aPsychogeriatrics
=550  \\$wg$aPsychiatry
=667  \\$aSPEC: SPEC qualif, not for mental disorders in the aged ( = MENTAL DISORDERS (IM) + AGED (NIM) ): Manual 27.9
=680  \\$iA subspecialty of psychiatry concerned with the mental health of the aged.
=688  \\$a75
=750  \0$aGeriatric psychiatry$5IEN$0(DLC)sh 85054311

=LDR  00820cz  a2200241n  4500
=001  9880363385702441
=005  20141212201715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005851
=035  \\$aCAZ9013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x236
=072  \\$aN2.$x421.$x533.$x245
=150  \\$aGeriatric Nursing
=450  \\$wnnna$aGeriatric Nursings
=450  \\$wnnna$aNursing, Geriatric
=450  \\$wnnna$aNursings, Geriatric
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=667  \\$aSPEC: SPEC qualif; check also tag AGED
=680  \\$iNursing care of the aged patient given in the home, the hospital, or special institutions such as nursing homes, psychiatric institutions, etc.
=688  \\$a67
=750  \0$aGeriatric nursing$5IEN$0(DLC)sh 85054304

=LDR  00590cz  a2200193n  4500
=001  9880363385802441
=005  20141212201715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005850
=035  \\$aCAZ9012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x394
=150  \\$aGeriatric Dentistry
=450  \\$aDentistry, Geriatric
=550  \\$wg$aDentistry
=667  \\$aSPEC: SPEC qualif; DF: GERIATRIC DENT
=680  \\$iThe branch of dentistry concerned with the dental problems of older people.
=688  \\$a66
=750  \0$aOlder people$xDental care$5IEN-M$0(DLC)sh 85002094

=LDR  00966cz  a2200301n  4500
=001  9880363385902441
=005  20141212201714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005849
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x300
=150  \\$aGerbillinae
=450  \\$wnnna$aGerbil
=450  \\$aGerbils
=450  \\$aJird
=450  \\$wnnna$aJirds
=450  \\$wnnna$aMerione
=450  \\$aMeriones
=450  \\$aPsammomys
=450  \\$wnnna$aRat, Sand
=450  \\$aRats, Sand
=450  \\$wnnna$aSand Rat
=450  \\$wnnna$aSand Rats
=550  \\$wg$aMuridae
=667  \\$arodents; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys.
=688  \\$a82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90
=750  \0$aGerbils$5IEN$0(DLC)sh 85054289

=LDR  00651cz  a2200193n  4500
=001  9880363386002441
=005  20141212201714.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005848
=035  \\$aCAZ9010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x380
=150  \\$aGeotrichum
=450  \\$wnnna$aGeotrichums
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection = GEOTRICHOSIS
=680  \\$iA mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces.
=688  \\$a91(75)
=750  \0$aGeotrichum$5IEN$0(DLC)sh 88022058

=LDR  01000cz  a2200193n  4500
=001  9880363386102441
=005  20141212201713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005844
=035  \\$aCAZ9006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x562
=150  \\$aGeology
=450  \\$aGeologists$5IEN
=550  \\$wg$aEarth Sciences
=667  \\$athe discipline (education, history, etc) only; use GEOLOGICAL PHENOMENA or specifics treed under it for structures and properties of the inanimate matter of Earth and other celestial bodies and processes affecting them; DF: GEOL
=680  \\$iThe science of the earth and other celestial bodies and their history as recorded in the rocks. It includes the study of geologic processes of an area such as rock formations, weathering and erosion, and sedimentation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aGeology$5IEN-M$0(DLC)sh 85054037
=750  \0$aGeologists$5IEN-HS$0(DLC)sh 85054036

=LDR  01251cz  a2200289n  4500
=001  9880363386202441
=005  20141212201713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005843
=035  \\$aCAZ9005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x277.$x500
=150  \\$aGeography
=450  \\$wnnna$aFactor, Geographic
=450  \\$wnnna$aFactors, Geographic
=450  \\$wnnna$aGeographic Factor
=450  \\$wnnna$aGeographic Factors
=450  \\$wnnna$aGeography, Human
=450  \\$wnnna$aHuman Geography
=550  \\$wg$aEarth Sciences
=550  \\$wh$aGeography, Medical
=550  \\$wh$aOceanography
=550  \\$wh$aPhylogeography
=667  \\$aIM as the discipline (education, history, etc); NIM with no qualifiers as a coordinate; do not use for epidemiologic aspects of disease, index disease /epidemiol + geographic location term
=680  \\$iThe science dealing with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including humanity and human industries with reference to the mutual relations of these elements. (From Webster, 3d ed)
=750  \0$aGeography$5IEN-M$0(DLC)sh 85053986
=750  \0$aGeographers$5IEN-M$0(DLC)sh 85053977

=LDR  01319cz  a2200385n  4500
=001  9880363386302441
=005  20141212192223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005840
=035  \\$aCAZ9002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146.$x400
=150  \\$aGentian Violet
=450  \\$wnnna$aC.I. 42555
=450  \\$wnnna$aChloride, Hexamethylpararosaniline
=450  \\$wnnna$aChloride, Methylrosaniline
=450  \\$aCrystal Violet
=450  \\$wnnna$aDr. K. Hollborn Brand of Gentian Violet
=450  \\$wnnna$aEstedi Brand of Gentian Violet
=450  \\$wnnna$aFNA Brand of Gentian Violet
=450  \\$wnnna$aFNA, Gentiaanviolet
=450  \\$wnnna$aGentiaanviolet FNA
=450  \\$wnnna$aHexamethylpararosaniline Chloride
=450  \\$wnnna$aKristallviolett-Lösung
=450  \\$wnnna$aKristallviolett Lösung
=450  \\$aMethyl Violet
=450  \\$aMethylrosaniline Chloride
=450  \\$wnnna$aVigencial
=450  \\$wnnna$aViolet, Crystal
=450  \\$wnnna$aViolet, Gentian
=450  \\$wnnna$aViolet, Methyl
=550  \\$wg$aAniline Compounds
=667  \\$aD25-26 qualif
=680  \\$iA dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.
=750  \0$aGentian violet$5IEN$0(DLC)sh 90005568

=LDR  01137cz  a2200337n  4500
=001  9880363386402441
=005  20141212201712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005839
=035  \\$aCAZ9001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x374
=150  \\$aGentamicins
=450  \\$wnnna$aG-Myticin
=450  \\$wnnna$aG Myticin
=450  \\$wnnna$aGaramycin
=450  \\$wnnna$aGentacycol
=450  \\$wnnna$aGentamicin
=450  \\$wnnna$aGentamicin Sulfate
=450  \\$aGentamicin Sulfate (USP)
=450  \\$aGentamycin
=450  \\$wnnna$aGentamycins
=450  \\$wnnna$aGentavet
=450  \\$wnnna$aGenticin
=450  \\$wnnna$aGMyticin
=450  \\$wnnna$aSulfate, Gentamicin
=550  \\$wg$aAminoglycosides
=550  \\$wh$aSisomicin
=680  \\$iA complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
=688  \\$a78; was GENTAMICIN 1963-77 (Prov 1963-65)
=750  \0$aGentamicin$5IEN$0(DLC)sh 85053943

=LDR  01233cz  a2200349n  4500
=001  9880363386502441
=005  20141212201711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005837
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444
=150  \\$aGenitalia, Male
=450  \\$aAccessory Sex Organs, Male
=450  \\$aGenital Organs, Male
=450  \\$wnnna$aMale Genital Organs
=450  \\$wnnna$aMale Genitalia
=450  \\$wnnna$aOrgans, Male Genital
=450  \\$aSex Organs, Accessory, Male
=550  \\$wg$aGenitalia
=550  \\$wh$aBulbourethral Glands
=550  \\$wh$aEjaculatory Ducts
=550  \\$wh$aEpididymis
=550  \\$wh$aPenis
=550  \\$wh$aProstate
=550  \\$wh$aScrotum
=550  \\$wh$aSeminal Vesicles
=550  \\$wh$aSpermatic Cord
=550  \\$wh$aTestis
=550  \\$wh$aVas Deferens
=667  \\$aGEN: prefer specifics; dis = GENITAL DISEASES, MALE
=680  \\$iThe male reproductive organs. They are divided into the external organs (PENIS; SCROTUM;and URETHRA) and the internal organs (TESTIS; EPIDIDYMIS; VAS DEFERENS; SEMINAL VESICLES; EJACULATORY DUCTS; PROSTATE; and BULBOURETHRAL GLANDS).
=750  \0$aGenerative organs, Male$5IEN$0(DLC)sh 85053842

=LDR  01052cz  a2200277n  4500
=001  9880363386602441
=005  20141212201711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005836
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319
=150  \\$aGenitalia, Female
=450  \\$aAccessory Sex Organs, Female
=450  \\$wnnna$aFemale Genital Organs
=450  \\$wnnna$aFemale Genitalia
=450  \\$wnnna$aGenital Organs, Female
=450  \\$wnnna$aOrgans, Female Genital
=450  \\$aSex Organs, Accessory, Female
=550  \\$wg$aGenitalia
=550  \\$wh$aAdnexa Uteri
=550  \\$wh$aUterus
=550  \\$wh$aVagina
=550  \\$wh$aVulva
=667  \\$aGEN: prefer specifics; /surg: consider also GYNECOLOGIC SURGICAL PROCEDURES; dis = GENITAL DISEASES, FEMALE
=680  \\$iThe female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES.
=750  \0$aGenerative organs, Female$5IEN$0(DLC)sh 85053831

=LDR  01034cz  a2200325n  4500
=001  9880363386702441
=005  20141212201710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005835
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360
=150  \\$aGenitalia
=450  \\$wnnna$aAccessory Sex Organ
=450  \\$aAccessory Sex Organs
=450  \\$wnnna$aGenital Organ
=450  \\$aGenital Organs
=450  \\$wnnna$aOrgan, Accessory Sex
=450  \\$wnnna$aOrgan, Genital
=450  \\$wnnna$aOrgans, Accessory Sex
=450  \\$wnnna$aOrgans, Genital
=450  \\$wnnna$aSex Organ, Accessory
=450  \\$aSex Organs, Accessory
=550  \\$wg$aUrogenital System
=550  \\$wh$aGenitalia, Female
=550  \\$wh$aGenitalia, Male
=550  \\$wh$aGerm Cells
=550  \\$wh$aGonads
=667  \\$aGEN; GENITALIA, FEMALE and GENITALIA, MALE and their specifics are also available
=680  \\$iThe external and internal organs related to reproduction.
=750  \0$aGenerative organs$0(DLC) sh 85053822$5IEN

=LDR  01111cz  a2200313n  4500
=001  9880363386802441
=005  20141212201710.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005834
=035  \\$aCAZ8996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x440
=072  \\$aC12.$x294.$x260
=072  \\$aC12.$x758.$x409
=150  \\$aGenital Neoplasms, Male
=450  \\$wnnna$aGenital Neoplasm, Male
=450  \\$wnnna$aMale Genital Neoplasm
=450  \\$aMale Genital Neoplasms
=450  \\$wnnna$aNeoplasm, Male Genital
=450  \\$wnnna$aNeoplasms, Male Genital
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aUrogenital Neoplasms
=550  \\$wh$aPenile Neoplasms
=550  \\$wh$aProstatic Neoplasms
=550  \\$wh$aTesticular Neoplasms
=667  \\$ahuman & animal; general or unspecified only: prefer specifics; coordinate IM with histological type of neoplasm (IM); /vet: consider also VENEREAL TUMORS, VETERINARY
=680  \\$iTumor or cancer of the MALE GENITALIA.
=688  \\$a78
=750  \0$aGenerative organs, Male$xCancer$5IEN-M$0(DLC)sh 99013821

=LDR  01375cz  a2200361n  4500
=001  9880363386902441
=005  20141212201710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005833
=035  \\$aCAZ8995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418
=072  \\$aC13.$x351.$x937.$x418
=150  \\$aGenital Neoplasms, Female
=450  \\$wnnna$aFemale Genital Neoplasm
=450  \\$wnnna$aFemale Genital Neoplasms
=450  \\$wnnna$aGenital Neoplasm, Female
=450  \\$wnnna$aGynecologic Neoplasm
=450  \\$aGynecologic Neoplasms
=450  \\$wnnna$aNeoplasm, Female Genital
=450  \\$wnnna$aNeoplasm, Gynecologic
=450  \\$wnnna$aNeoplasms, Female Genital
=450  \\$wnnna$aNeoplasms, Gynecologic
=550  \\$wg$aUrogenital Neoplasms
=550  \\$wh$aFallopian Tube Neoplasms
=550  \\$wh$aOvarian Neoplasms
=550  \\$wh$aUterine Neoplasms
=550  \\$wh$aVaginal Neoplasms
=550  \\$wh$aVulvar Neoplasms
=667  \\$ahuman & animal; general or unspecified only: prefer specifics; coordinate IM with histological type of neoplasm (IM); /vet: consider also VENEREAL TUMORS, VETERINARY
=680  \\$iTumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
=688  \\$a79; was GYNECOLOGIC NEOPLASMS 1963-78
=750  \0$aGenerative organs, Female$xTumors$5IEN-M$0(DLC)sh 85053841

=LDR  01489cz  a2200457n  4500
=001  9880363387002441
=005  20141212201709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005832
=035  \\$aCAZ8994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294
=150  \\$aGenital Diseases, Male
=450  \\$wnnna$aDisease, Male Genital
=450  \\$wnnna$aDiseases, Male Genital
=450  \\$wnnna$aGenital Disease, Male
=450  \\$wnnna$aMale Genital Disease
=450  \\$aMale Genital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wh$aEpididymitis
=550  \\$wh$aFournier Gangrene
=550  \\$wh$aGenital Neoplasms, Male
=550  \\$wh$aHematocele
=550  \\$wh$aHemospermia
=550  \\$wh$aHerpes Genitalis
=550  \\$wh$aInfertility
=550  \\$wh$aPenile Diseases
=550  \\$wh$aProstatic Diseases
=550  \\$wh$aReproductive Tract Infections
=550  \\$wh$aSexual Dysfunction, Physiological
=550  \\$wh$aSexually Transmitted Diseases
=550  \\$wh$aSpermatic Cord Torsion
=550  \\$wh$aSpermatocele
=550  \\$wh$aTesticular Diseases
=550  \\$wh$aTesticular Hydrocele
=550  \\$wh$aTuberculosis, Male Genital
=550  \\$wh$aVaricocele
=667  \\$ahuman & animal; general: prefer specifics
=680  \\$iPathological processes involving the male reproductive tract (GENITALIA, MALE).
=688  \\$a66
=750  \0$aGenerative organs, Male$xDiseases$5IEN-M$0(DLC)sh 85053843

=LDR  01518cz  a2200433n  4500
=001  9880363387102441
=005  20141212201709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005831
=035  \\$aCAZ8993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500
=150  \\$aGenital Diseases, Female
=450  \\$wnnna$aDiseases, Female Genital
=450  \\$wnnna$aDiseases, Gynecologic
=450  \\$wnnna$aFemale Genital Disease
=450  \\$wnnna$aFemale Genital Diseases
=450  \\$wnnna$aGenital Disease, Female
=450  \\$wnnna$aGynecologic Disease
=450  \\$aGynecologic Diseases
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wh$aAdnexal Diseases
=550  \\$wh$aEndometriosis
=550  \\$wh$aGynatresia
=550  \\$wh$aHerpes Genitalis
=550  \\$wh$aInfertility
=550  \\$wh$aReproductive Tract Infections
=550  \\$wh$aSexual Dysfunction, Physiological
=550  \\$wh$aSexually Transmitted Diseases
=550  \\$wh$aTuberculosis, Female Genital
=550  \\$wh$aUterine Diseases
=550  \\$wh$aVaginal Diseases
=550  \\$wh$aVulvar Diseases
=550  \\$aGynecology
=667  \\$ahuman & animal; general: prefer specifics
=680  \\$iPathological processes involving the female reproductive tract (GENITALIA, FEMALE).
=688  \\$a79; was GYNECOLOGIC DISEASES 1965-78
=750  \0$aGenerative organs, Female$xDiseases$5IEN-M$0(DLC)sh 85053835
=750  \0$aGenerative organs, Female$xInfections$5IEN-M$0(DLC)sh2008117859

=LDR  02305cz  a2200553n  4500
=001  9880363387202441
=005  20141212192222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005829
=035  \\$aCAZ8991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x317.$x826.$x701.$x444
=150  \\$aGeniculate Bodies
=450  \\$wnnna$aBodies, Geniculate
=450  \\$wnnna$aComplex, Medial Geniculate
=450  \\$wnnna$aComplices, Medial Geniculate
=450  \\$wnnna$aCorpus Geniculatum Mediale
=450  \\$wnnna$aCorpus Geniculatum Mediales
=450  \\$wnnna$aGeniculate Bodies, Lateral
=450  \\$wnnna$aGeniculate Bodies, Medial
=450  \\$wnnna$aGeniculate Body
=450  \\$wnnna$aGeniculate Body, Lateral
=450  \\$wnnna$aGeniculate Body, Medial
=450  \\$wnnna$aGeniculate Complex, Medial
=450  \\$wnnna$aGeniculate Complices, Medial
=450  \\$wnnna$aGeniculate Nucleus
=450  \\$wnnna$aGeniculate Nucleus, Lateral
=450  \\$wnnna$aGeniculate Nucleus, Medial
=450  \\$wnnna$aGeniculatum Mediale, Corpus
=450  \\$wnnna$aGeniculatum Mediales, Corpus
=450  \\$wnnna$aLateral Geniculate Bodies
=450  \\$aLateral Geniculate Body
=450  \\$wnnna$aLateral Geniculate Nucleus
=450  \\$wnnna$aMedial Geniculate Bodies
=450  \\$aMedial Geniculate Body
=450  \\$wnnna$aMedial Geniculate Complex
=450  \\$wnnna$aMedial Geniculate Complices
=450  \\$wnnna$aMedial Geniculate Nucleus
=450  \\$wnnna$aMediale, Corpus Geniculatum
=450  \\$wnnna$aMediales, Corpus Geniculatum
=450  \\$aMetathalamus
=450  \\$wnnna$aNucleus, Geniculate
=450  \\$wnnna$aNucleus Geniculatus Lateralis Dorsalis
=450  \\$wnnna$aNucleus Geniculatus Lateralis Pars Dorsalis
=450  \\$wnnna$aNucleus, Lateral Geniculate
=450  \\$wnnna$aNucleus, Medial Geniculate
=550  \\$wg$aThalamic Nuclei
=680  \\$iPart of the DIENCEPHALON inferior to the caudal end of the dorsal THALAMUS. Includes the lateral geniculate body which relays visual impulses from the OPTIC TRACT to the calcarine cortex, and the medial geniculate body which relays auditory impulses from the lateral lemniscus to the AUDITORY CORTEX.
=750  \0$aGeniculate bodies$5IEN$0(DLC)sh 85053893

=LDR  00903cz  a2200205n  4500
=001  9880363387302441
=005  20141212201708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x335
=150  \\$aGenetics, Population
=450  \\$wnnna$aPopulation Genetics
=550  \\$wg$aGenetics
=550  \\$wh$aPhylogeography
=550  \\$aPopulation Dynamics
=667  \\$aGEN or SPEC; prefer specifics treed under GENETIC PHENOMENA: Manual 28.22, 28.22.5; human & animal specify geog
=680  \\$iThe discipline studying genetic composition of populations and effects of factors such as GENETIC SELECTION, population size, MUTATION, migration, and GENETIC DRIFT on the frequencies of various GENOTYPES and PHENOTYPES using a variety of GENETIC TECHNIQUES.
=688  \\$a66
=750  \0$aPopulation genetics$5IEN-HS$0(DLC)sh 85104920

=LDR  01078cz  a2200265n  4500
=001  9880363387402441
=005  20141212201707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005827
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x330
=072  \\$aH1.$x158.$x273.$x540.$x367
=150  \\$aGenetics, Microbial
=450  \\$wnnna$aGenetic, Microbial
=450  \\$wnnna$aMicrobial Genetic
=450  \\$wnnna$aMicrobial Genetics
=550  \\$wg$aGenetics
=550  \\$wg$aMicrobiology
=550  \\$aBacterial Physiological Phenomena
=550  \\$aGenome, Microbial
=550  \\$aVirus Physiological Phenomena
=667  \\$aGEN & unspecified only: prefer /genet with specific microbes: Manual 19.8.34; Manual 22.25; Manual 28.36.8.1; TN 196: avoid as an added coord with better specifics; SPEC qualif permitted when viewed as specialty; DF: GENET MICROBIAL
=680  \\$iA subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms.
=688  \\$a68
=750  \0$aMicrobial genetics$5IEN-M$0(DLC)sh 85084760

=LDR  01106cz  a2200277n  4500
=001  9880363387502441
=005  20200515140917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005826
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x385.$x500
=072  \\$aH2.$x403.$x350
=150  \\$aGenetics, Medical
=450  \\$aMedical Genetics
=550  \\$wg$aHuman Genetics
=550  \\$wg$aMedicine
=550  \\$wh$aGenetic Counseling
=550  \\$aAnthropology, Physical
=550  \\$aChromosome Disorders
=550  \\$aGenetic Diseases, Inborn
=550  \\$aMolecular Medicine
=550  \\$aSex Chromosome Disorders
=667  \\$aSPEC; restrict to the field of human genetics dealing with genet or hered disord; see note on GENETICS; DF: GENET MED
=680  \\$iA subdiscipline of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of an individual or of any two parents or potential parents.
=688  \\$a80; was GENETICS, HUMAN 1963-79
=750  \0$aMedical genetics$0(DLC)sh 85082937$5IEN-M

=LDR  00892cz  a2200253n  4500
=001  9880363387602441
=005  20141212201707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005824
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x276
=072  \\$aH1.$x158.$x273.$x343.$x290
=150  \\$aGenetics, Behavioral
=450  \\$wnnna$aBehavioral Genetics
=450  \\$aPsychogenetics
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aGenetics
=550  \\$wh$aGenetic Determinism
=550  \\$aBehavior
=550  \\$aSociobiology
=667  \\$aSPEC or GEN; prefer specifics
=680  \\$iThe experimental study of the relationship between the genotype of an organism and its behavior. The scope includes the effects of genes on simple sensory processes to complex organization of the nervous system.
=688  \\$a68
=750  \0$aBehavior genetics$5IEN$0(DLC)sh 85012896

=LDR  01348cz  a2200349n  4500
=001  9880363387702441
=005  20200515142253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005823
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343
=150  \\$aGenetics
=550  \\$wg$aBiology
=550  \\$wh$aCytogenetics
=550  \\$wh$aGenetic Research
=550  \\$wh$aGenetics, Behavioral
=550  \\$wh$aGenetics, Medical
=550  \\$wh$aGenetics, Microbial
=550  \\$wh$aGenetics, Population
=550  \\$wh$aGenomics
=550  \\$wh$aHuman Genetics
=550  \\$wh$aImmunogenetics
=550  \\$wh$aMolecular Biology
=550  \\$wh$aPharmacogenetics
=550  \\$wh$aRadiation Genetics
=550  \\$aGenetic Phenomena
=550  \\$aGenetic Processes
=550  \\$aGenetic Structures
=667  \\$athe discipline (education, history, etc) only; use GENETIC PHENOMENA or specifics treed under it for genetic processes and properties of organisms, or the qualifier / genet with specific anatomical terms, organisms, diseases, etc.
=680  \\$iThe branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance. (Stedman, 26th ed)
=750  \0$aGenetics$5IEN-M$0(DLC)sh 85053877
=750  \0$aGeneticists$5IEN-HS$0(DLC)sh 85053876

=LDR  01533cz  a2200349n  4500
=001  9880363387802441
=005  20200514105820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005740
=035  \\$aCAZ8892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362
=150  \\$aGases
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aAmmonia
=550  \\$wh$aCarbon Dioxide
=550  \\$wh$aCarbon Monoxide
=550  \\$wh$aChlorine
=550  \\$wh$aGasotransmitters
=550  \\$wh$aGreenhouse Gases
=550  \\$wh$aHydrogen
=550  \\$wh$aHydrogen Sulfide
=550  \\$wh$aNitrogen
=550  \\$wh$aNitrogen Oxides
=550  \\$wh$aNoble Gases
=550  \\$wh$aOxygen
=550  \\$wh$aPlasma Gases
=550  \\$wh$aSulfur Dioxide
=550  \\$wh$aSulfur Hexafluoride
=667  \\$adoes not include natural gas ( = NATURAL GAS see FOSSIL FUELS); does not include blood gases ( = OXYGEN /blood or CARBON DIOXIDE /blood); gas embolism = EMBOLISM, AIR; intestinal gases = GASES + INTESTINES /physiol unless clinically referred to as FLATULENCE (Cat C)
=680  \\$iThe vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aGases$5IEN$0(DLC)sh 85053380

=LDR  00726cz  a2200241n  4500
=001  9880363387902441
=005  20141212201634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005739
=035  \\$aCAZ8891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x455
=150  \\$aGas Poisoning
=450  \\$wnnna$aGas Poisonings
=450  \\$aGases$xpoisoning
=450  \\$wnnna$aPoisoning, Gas
=450  \\$wnnna$aPoisonings, Gas
=550  \\$wg$aPoisoning
=550  \\$wh$aCarbon Monoxide Poisoning
=550  \\$wh$aInert Gas Narcosis
=550  \\$aChemical Warfare
=667  \\$aGEN or unspecified gas; prefer /pois with specific gas term
=750  \0$aGases, Asphyxiating and poisonous$5IEN$0(DLC)sh 85053395

=LDR  00991cz  a2200205n  4500
=001  9880363388002441
=005  20141212201634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005738
=035  \\$aCAZ8890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x222.$x440
=150  \\$aGas Gangrene
=450  \\$wnnna$aGangrene, Gas
=450  \\$wnnna$aGangrenes, Gas
=450  \\$wnnna$aGas Gangrenes
=550  \\$wg$aClostridium Infections
=667  \\$ausually caused by Clostridium perfringens but all C. perfringens infections need not be gas gangrene
=680  \\$iA severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.
=750  \0$aGas gangrene$5IEN$0(DLC)sh 85053301

=LDR  00745cz  a2200205n  4500
=001  9880363388102441
=005  20141212201634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005737
=035  \\$aCAZ8889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x100.$x300
=072  \\$aJ2.$x500.$x850.$x100.$x300
=150  \\$aGarlic
=450  \\$aAllium sativum
=450  \\$wnnna$asativum, Allium
=550  \\$wg$aAllium
=667  \\$aas plant & food
=680  \\$iAllium sativum. One of the Liliaceae used as a spice and traditional remedy. It contains allicin, the pungent active ingredient, which may reduce blood cholesterol and inhibit platelet aggregation.
=750  \0$aGarlic$5IEN$0(DLC)sh 85053172

=LDR  00574cz  a2200181n  4500
=001  9880363388202441
=005  20141212201633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005734
=035  \\$aCAZ8886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x717.$x427
=150  \\$aGangrene
=450  \\$wnnna$aGangrenes
=550  \\$wg$aNecrosis
=667  \\$aIM for general or for gangrene process; coord NIM with tissue/pathol (IM)
=680  \\$iDeath and putrefaction of tissue usually due to a loss of blood supply.
=750  \0$aGangrene$5IEN$0(DLC)sh 85053025

=LDR  01981cz  a2200445n  4500
=001  9880363388302441
=005  20141212201632.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005733
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x300
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x300
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x350
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x300
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x300
=072  \\$aC18.$x452.$x584.$x687.$x803.$x350
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x300
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x350
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x300
=150  \\$aGangliosidoses
=450  \\$wnnna$aGanglioside Storage Disease
=450  \\$wnnna$aGanglioside Storage Diseases
=450  \\$wnnna$aGanglioside Storage Disorder
=450  \\$wnnna$aGanglioside Storage Disorders
=450  \\$wnnna$aGangliosidosis
=450  \\$wnnna$aStorage Disease, Ganglioside
=450  \\$wnnna$aStorage Diseases, Ganglioside
=450  \\$wnnna$aStorage Disorder, Ganglioside
=450  \\$wnnna$aStorage Disorders, Ganglioside
=550  \\$wg$aSphingolipidoses
=550  \\$wh$aGangliosidoses, GM2
=550  \\$wh$aGangliosidosis, GM1
=550  \\$wh$aSandhoff Disease
=550  \\$aGalactosidases
=550  \\$aHexosaminidases
=550  \\$aMucolipidoses
=667  \\$acoordinate IM with specific ganglioside (IM) but GANGLIOSIDOSIS, GM1 and GANGLIOSIDOSES, GM2 are available
=680  \\$iA group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
=688  \\$a1992(1976)
=750  \0$aGangliosidoses$0(DLC) sh 85053024$5IEN-M

=LDR  01133cz  a2200229n  4500
=001  9880363388402441
=005  20141212201632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005732
=035  \\$aCAZ8884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x410.$x420.$x25.$x475
=072  \\$aD10.$x390.$x470.$x25.$x475
=072  \\$aD10.$x570.$x877.$x360.$x25.$x475
=150  \\$aGangliosides
=450  \\$aSialoglycosphingolipids
=550  \\$wg$aAcidic Glycosphingolipids
=550  \\$wh$aG(M1) Ganglioside
=550  \\$wh$aG(M2) Ganglioside
=550  \\$wh$aG(M3) Ganglioside
=680  \\$iA subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997)
=750  \0$aGangliosides$5IEN$0(DLC)sh 85053023

=LDR  00999cz  a2200205n  4500
=001  9880363388502441
=005  20141212201632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005731
=035  \\$aCAZ8883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x400
=150  \\$aGanglionic Stimulants
=450  \\$aGanglionic Stimulating Agents$5IEN
=450  \\$wnnna$aStimulants, Ganglionic
=550  \\$wg$aAutonomic Agents
=667  \\$aGEN or unspecified; prefer specifics; consider also GANGLIA /drug eff
=680  \\$iAgents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.
=688  \\$a72(71)
=750  \0$aGanglionic stimulating agents$5IEN$0(DLC)sh 85053022

=LDR  01490cz  a2200289n  4500
=001  9880363388602441
=005  20141212201631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005730
=035  \\$aCAZ8882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x340
=150  \\$aGanglionic Blockers
=450  \\$wnnna$aAgents, Ganglionic Blocking
=450  \\$wnnna$aAgents, Ganglioplegic
=450  \\$wnnna$aBlockaders, Ganglionic
=450  \\$wnnna$aBlockers, Ganglionic
=450  \\$wnnna$aBlocking Agents, Ganglionic
=450  \\$wnnna$aGanglionic Blockaders
=450  \\$aGanglionic Blocking Agents
=450  \\$aGanglioplegic Agents
=550  \\$wg$aAutonomic Agents
=550  \\$aAntihypertensive Agents
=667  \\$aGEN or unspecified; prefer specifics; consider also GANGLIA /drug eff; DF: GANGLIONIC BLOCK
=680  \\$iAgents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.
=688  \\$a95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69
=750  \0$aGanglionic blocking agents$5IEN$0(DLC)sh 85053021

=LDR  01174cz  a2200289n  4500
=001  9880363388702441
=005  20141212201630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005727
=035  \\$aCAZ8878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x340.$x390.$x340
=072  \\$aA8.$x800.$x350.$x340
=072  \\$aA8.$x800.$x800.$x720.$x725.$x350
=150  \\$aGanglia, Spinal
=450  \\$aDorsal Root Ganglia
=450  \\$wnnna$aDorsal Root Ganglion
=450  \\$wnnna$aGanglia, Dorsal Root
=450  \\$wnnna$aGanglion, Dorsal Root
=450  \\$wnnna$aGanglion, Spinal
=450  \\$aSpinal Ganglia
=450  \\$wnnna$aSpinal Ganglion
=550  \\$wg$aGanglia, Sensory
=550  \\$wg$aSpinal Nerve Roots
=667  \\$asensory ganglia on spinal nerve roots
=680  \\$iSensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain.
=750  \0$aSpinal ganglia$5IEN-M$0(DLC)sh 85126683

=LDR  01045cz  a2200241n  4500
=001  9880363388802441
=005  20141212201630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005725
=035  \\$aCAZ8876HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x340.$x315
=072  \\$aA8.$x800.$x50.$x300
=150  \\$aGanglia, Autonomic
=450  \\$aAutonomic Ganglia
=450  \\$wnnna$aAutonomic Ganglion
=450  \\$wnnna$aGanglion, Autonomic
=550  \\$wg$aAutonomic Nervous System
=550  \\$wg$aGanglia
=550  \\$wh$aGanglia, Parasympathetic
=550  \\$wh$aGanglia, Sympathetic
=680  \\$iClusters of neurons and their processes in the autonomic nervous system. In the autonomic ganglia, the preganglionic fibers from the central nervous system synapse onto the neurons whose axons are the postganglionic fibers innervating target organs. The ganglia also contain intrinsic neurons and supporting cells and preganglionic fibers passing through to other ganglia.
=750  \0$aAutonomic ganglia$5IEN$0(DLC)sh 85053019

=LDR  01619cz  a2200325n  4500
=001  9880363499202441
=005  20141212201839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006099
=035  \\$aCAZ9267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x515.$x292
=072  \\$aC23.$x550.$x382
=150  \\$aGranuloma
=450  \\$wnnna$aGranulomas
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAngiolymphoid Hyperplasia with Eosinophilia
=550  \\$wh$aChurg-Strauss Syndrome
=550  \\$wh$aEosinophilic Granuloma
=550  \\$wh$aGranuloma Annulare
=550  \\$wh$aGranuloma, Foreign-Body
=550  \\$wh$aGranuloma, Giant Cell
=550  \\$wh$aGranuloma, Plasma Cell
=550  \\$wh$aGranuloma, Pyogenic
=550  \\$wh$aGranuloma, Respiratory Tract
=550  \\$wh$aNecrobiotic Xanthogranuloma
=667  \\$aGEN: prefer specifics; coord IM with organ/dis (IM); malignant of nose = GRANULOMA, LETHAL MIDLINE; central giant cell granuloma & giant cell granuloma = GRANULOMA, GIANT CELL; granulomatous dis or granulomatous dis of childhood = GRANULOMATOUS DISEASE, CHRONIC; cholesterol granuloma = GRANULOMA, FOREIGN BODY (IM) + CHOLESTEROL (IM); talc granuloma = GRANULOMA, FOREIGN BODY /etiol (not/chem ind) + TALC /adv eff; xanthogranuloma = XANTHOMATOSIS (IM) + GRANULOMA (IM) but XANTHOGRANULOMA, JUVENILE is available
=680  \\$iA relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.
=750  \0$aGranuloma$5IEN$0(DLC)sh 85056443

=LDR  01127cz  a2200313n  4500
=001  9880363499302441
=005  20141212201839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006098
=035  \\$aCAZ9266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x415
=072  \\$aA11.$x148.$x350
=072  \\$aA11.$x627.$x340
=072  \\$aA15.$x145.$x229.$x637.$x415
=072  \\$aA15.$x378.$x316.$x340
=072  \\$aA15.$x382.$x490.$x315
=150  \\$aGranulocytes
=450  \\$wnnna$aGranulocyte
=550  \\$wg$aBone Marrow Cells
=550  \\$wg$aLeukocytes
=550  \\$wg$aMyeloid Cells
=550  \\$wh$aBasophils
=550  \\$wh$aEosinophils
=550  \\$wh$aGranulocyte Precursor Cells
=550  \\$wh$aNeutrophils
=680  \\$iLeukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS.
=688  \\$a79(75); was see under LEUKOCYTES 1968-78
=750  \0$aGranulocytes$5IEN$0(DLC)sh 85056441

=LDR  00767cz  a2200205n  4500
=001  9880363499402441
=005  20141212201838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006097
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x450
=150  \\$aGranulation Tissue
=450  \\$wnnna$aGranulation Tissues
=450  \\$wnnna$aTissue, Granulation
=450  \\$wnnna$aTissues, Granulation
=550  \\$wg$aConnective Tissue
=550  \\$wh$aCicatrix
=550  \\$aWound Healing
=680  \\$iA vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, macrophages, and plasma cells.
=750  \0$aGranulation tissue$5IEN$0(DLC)sh 85056439

=LDR  01399cz  a2200397n  4500
=001  9880363499502441
=005  20141212201838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006096
=035  \\$aCAZ9264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x850.$x300
=072  \\$aD12.$x644.$x641.$x850.$x300
=072  \\$aD12.$x644.$x905.$x300
=072  \\$aD12.$x776.$x543.$x695.$x221
=150  \\$aGramicidin
=450  \\$wnnna$aGramicidin A
=450  \\$wnnna$aGramicidin A(1)
=450  \\$wnnna$aGramicidin B
=450  \\$wnnna$aGramicidin C
=450  \\$wnnna$aGramicidin D
=450  \\$wnnna$aGramicidin Dubos
=450  \\$wnnna$aGramicidin J
=450  \\$wnnna$aGramicidin K
=450  \\$wnnna$aGramicidin, Linear
=450  \\$wnnna$aGramicidin NF
=450  \\$wnnna$aGramicidin P
=450  \\$wnnna$aGramicidin S
=450  \\$wnnna$aGramicidins
=450  \\$wnnna$aGramoderm
=450  \\$wnnna$aLinear Gramicidin
=550  \\$wg$aPore Forming Cytotoxic Proteins
=550  \\$wg$aTyrothricin
=680  \\$iA group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN.
=688  \\$a96; was GRAMICIDINS 1963-95 (see under TYROTHRICIN 1963-73)
=750  \0$aGramicidins$5IEN$0(DLC)sh 85056257

=LDR  00947cz  a2200265n  4500
=001  9880363499602441
=005  20141212201837.0
=008  830603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006094
=035  \\$aCAZ9262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510
=150  \\$aGram-Positive Bacteria
=450  \\$wnnna$aGram Positive Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aActinobacteria
=550  \\$wh$aBacillales
=550  \\$wh$aGram-Positive Cocci
=550  \\$wh$aGram-Positive Endospore-Forming Bacteria
=550  \\$wh$aGram-Positive Rods
=550  \\$wh$aLactobacillales
=667  \\$aGEN: avoid; prefer specifics; do not use as a routine coord for a gram-positive bact; infection = GRAM-POSITIVE BACTERIAL INFECTIONS; DF: GRAM POS BACT
=680  \\$iBacteria which retain the crystal violet stain when treated by Gram's method.
=688  \\$a84,73-75
=750  \0$aGram-positive bacteria$5IEN$0(DLC)sh 92006518

=LDR  01719cz  a2200517n  4500
=001  9880363499702441
=005  20141212201836.0
=008  830603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006090
=035  \\$aCAZ9258HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440
=150  \\$aGram-Negative Bacteria
=450  \\$wnnna$aGram Negative Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aAnaplasmataceae
=550  \\$wh$aArcobacter
=550  \\$wh$aBartonellaceae
=550  \\$wh$aBrachyspira
=550  \\$wh$aBuchnera
=550  \\$wh$aCampylobacter
=550  \\$wh$aChlamydiales
=550  \\$wh$aChloroflexus
=550  \\$wh$aGram-Negative Aerobic Bacteria
=550  \\$wh$aGram-Negative Anaerobic Bacteria
=550  \\$wh$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wh$aGram-Negative Oxygenic Photosynthetic Bacteria
=550  \\$wh$aHelicobacter
=550  \\$wh$aLawsonia Bacteria
=550  \\$wh$aMethylosinus
=550  \\$wh$aOceanospirillaceae
=550  \\$wh$aOrnithobacterium
=550  \\$wh$aPiscirickettsiaceae
=550  \\$wh$aPlanctomycetales
=550  \\$wh$aRhodobacter
=550  \\$wh$aRhodomicrobium
=550  \\$wh$aRhodovulum
=550  \\$wh$aRickettsiaceae
=550  \\$wh$aRoseobacter
=550  \\$wh$aSpirillaceae
=550  \\$wh$aTenericutes
=550  \\$wh$aVerrucomicrobia
=667  \\$aGEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative bact; infection = GRAM-NEGATIVE BACTERIAL INFECTIONS; DF: GRAM NEG BACT
=680  \\$iBacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
=688  \\$a84,73-75
=750  \0$aGram negative bacteria$5IEN$0(DLC)sh 85056256

=LDR  01055cz  a2200241n  4500
=001  9880363499802441
=005  20200429110033.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006089
=035  \\$aCAZ9257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425
=150  \\$aGram-Negative Anaerobic Bacteria
=450  \\$wnnna$aGram Negative Anaerobic Bacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aDesulfovibrionaceae
=550  \\$wh$aGram-Negative Anaerobic Cocci
=550  \\$wh$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=667  \\$aGEN: avoid; prefer specifics; do not use as a routine coord for a gram-negative anaerobic bact; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM); DF: GRAM NEG ANAEROBIC BACT
=680  \\$iA large group of anaerobic bacteria which show up as pink (negative) when treated by the Gram-staining method.
=688  \\$a76
=750  \0$81$wb$aGram-negative bacteria$5IEN$0(DLC)sh 85056256
=750  \0$81$wb$aAnaerobic bacteria$5IEN-HS$0(DLC)sh 85010822

=LDR  00881cz  a2200205n  4500
=001  9880363499902441
=005  20141212201834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006087
=035  \\$aCAZ9255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x901.$x402
=150  \\$aGraft vs Host Reaction
=450  \\$aGraft versus Host Reaction$5IEN
=550  \\$wg$aTransplantation Immunology
=550  \\$wh$aGraft vs Tumor Effect
=667  \\$ado not confuse with HOST VS GRAFT REACTION nor with GRAFT VS HOST DISEASE
=680  \\$iAn immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.
=688  \\$a70
=750  \0$aGraft versus host reaction$5IEN$0(DLC)sh 85056192

=LDR  01409cz  a2200361n  4500
=001  9880363500002441
=005  20141212201834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006086
=035  \\$aCAZ9254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x452
=150  \\$aGraft vs Host Disease
=450  \\$wnnna$aDisease, Graft-Versus-Host
=450  \\$wnnna$aDisease, Graft-vs-Host
=450  \\$wnnna$aDisease, Homologous Wasting
=450  \\$wnnna$aDisease, Runt
=450  \\$wnnna$aDiseases, Graft-Versus-Host
=450  \\$wnnna$aDiseases, Graft-vs-Host
=450  \\$aGraft-Versus-Host Disease
=450  \\$wnnna$aGraft Versus Host Disease
=450  \\$wnnna$aGraft-Versus-Host Diseases
=450  \\$wnnna$aGraft-vs-Host Disease
=450  \\$wnnna$aGraft-vs-Host Diseases
=450  \\$aHomologous Wasting Disease
=450  \\$aRunt Disease
=550  \\$wg$aImmune System Diseases
=550  \\$aGraft vs Host Reaction
=550  \\$aImmune Tolerance
=667  \\$ado not confuse with GRAFT VS HOST REACTION (Cat G); DF: note short X ref
=680  \\$iThe clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
=688  \\$a84; was HOMOLOGOUS WASTING DISEASE 1964-83 (Prov 1964-66)
=750  \0$aGraft versus host disease$0(DLC) sh 90001317$5IEN

=LDR  01191cz  a2200325n  4500
=001  9880363500102441
=005  20141212201833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006084
=035  \\$aCAZ9252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x901.$x545.$x328
=150  \\$aGraft Rejection
=450  \\$wnnna$aGraft Rejections
=450  \\$wnnna$aRejection, Graft
=450  \\$wnnna$aRejection, Transplant
=450  \\$wnnna$aRejection, Transplantation
=450  \\$wnnna$aRejections, Graft
=450  \\$wnnna$aRejections, Transplant
=450  \\$wnnna$aRejections, Transplantation
=450  \\$aTransplant Rejection
=450  \\$wnnna$aTransplant Rejections
=450  \\$wnnna$aTransplantation Rejection
=450  \\$wnnna$aTransplantation Rejections
=550  \\$wg$aHost vs Graft Reaction
=550  \\$aDelayed Graft Function
=667  \\$amay be used with transplanted neoplasms
=680  \\$iAn immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.
=688  \\$a73(71)
=750  \0$aGraft rejection$5IEN$0(DLC)sh 85056191

=LDR  01605cz  a2200373n  4500
=001  9880363500202441
=005  20141212201832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006080
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x114.$x630.$x535
=072  \\$aA6.$x407.$x312.$x497.$x535
=150  \\$aOvarian Follicle
=450  \\$wnnna$aAtretic Follicle
=450  \\$wnnna$aAtretic Follicles
=450  \\$wnnna$aFollicle, Atretic
=450  \\$wnnna$aFollicle, Graafian
=450  \\$wnnna$aFollicle, Ovarian
=450  \\$wnnna$aFollicles, Atretic
=450  \\$wnnna$aFollicles, Graafian
=450  \\$wnnna$aFollicles, Ovarian
=450  \\$aGraafian Follicle
=450  \\$wnnna$aGraafian Follicles
=450  \\$wnnna$aOvarian Follicles
=550  \\$wg$aOvary
=550  \\$wh$aFollicular Fluid
=550  \\$wh$aGranulosa Cells
=550  \\$wh$aTheca Cells
=550  \\$aOvum
=550  \\$aTheca Cells
=667  \\$a/cytol: consider also THECA CELLS; GRANULOSA CELLS; for follicular development use /physiol, not /growth
=680  \\$iAn OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.
=688  \\$a99
=750  \0$aGraafian follicle$5IEN$0(DLC)sh 85056147

=LDR  00722cz  a2200193n  4500
=001  9880363500302441
=005  20141212201832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006079
=035  \\$aCAZ9247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x492
=150  \\$aGovernment Publications as Topic
=550  \\$wg$aPublications
=667  \\$ado not confuse with Publication Type GOVERNMENT PUBLICATIONS
=680  \\$iDiscussion of documents issued by local, regional, or national governments or by their agencies or subdivisions.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Government Publications
=750  \0$aGovernment publications$0(DLC) sh 85056095$5IEN

=LDR  00816cz  a2200241n  4500
=001  9880363500402441
=005  20141212201831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006077
=035  \\$aCAZ9245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x409.$x418
=072  \\$aN3.$x540.$x400
=150  \\$aGovernment Agencies
=450  \\$wnnna$aAgencies, Government
=450  \\$wnnna$aAgency, Government
=450  \\$wnnna$aGovernment Agency
=550  \\$wg$aGovernment
=550  \\$wg$aOrganizations
=667  \\$aspecify country or state; CATALOG: coordinate with specific NAF entry if applicable
=680  \\$iAdministrative units of government responsible for policy making and management of governmental activities.
=688  \\$a68
=750  \0$aAdministrative agencies$5IEN$0(DLC)sh 85000901

=LDR  00789cz  a2200241n  4500
=001  9880363500502441
=005  20141212201831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006076
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x409
=072  \\$aN3.$x540.$x348
=150  \\$aGovernment
=450  \\$wnnna$aGovernments
=550  \\$wg$aOrganizations
=550  \\$wg$aSocial Sciences
=550  \\$wh$aFederal Government
=550  \\$wh$aGovernment Agencies
=550  \\$wh$aLocal Government
=550  \\$wh$aState Government
=667  \\$aspecify country or state
=680  \\$iThe complex of political institutions, laws, and customs through which the function of governing is carried out in a specific political unit.
=750  \0$aPolitical science$5IEN$0(DLC)sh 85104440

=LDR  00751cz  a2200229n  4500
=001  9880363500602441
=005  20141212201831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006075
=035  \\$aCAZ9243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x394
=150  \\$aGoverning Board
=450  \\$aBoard, Governing
=450  \\$wnnna$aBoards, Governing
=450  \\$wnnna$aGoverning Boards
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aTrustees
=667  \\$acoord NIM with society, hosp or other organiz (IM)
=680  \\$iThe group in which legal authority is vested for the control of health-related institutions and organizations.
=688  \\$a68
=750  \0$aHospital trustees$5IEN-M$0(DLC)sh 85062376

=LDR  00926cz  a2200253n  4500
=001  9880363500702441
=005  20141212201830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006074
=035  \\$aCAZ9241M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x329.$x337
=150  \\$aGout Suppressants
=450  \\$wnnna$aAgents, Antigout
=450  \\$aAntigout Agents
=450  \\$wnnna$aAntihyperuricemics
=450  \\$wnnna$aSuppressants, Gout
=550  \\$wg$aAntirheumatic Agents
=550  \\$wh$aUricosuric Agents
=550  \\$aGout
=667  \\$aGEN or unspecified; prefer specifics; consider also GOUT /drug ther
=680  \\$iAgents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.
=688  \\$a75
=750  \0$aGout suppressants$0(DLC)sh2007003071$5IEN-M

=LDR  01134cz  a2200301n  4500
=001  9880363500802441
=005  20180403132247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006073
=035  \\$aCAZ9240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x423
=072  \\$aC5.$x550.$x354.$x500
=072  \\$aC5.$x799.$x414
=072  \\$aC16.$x320.$x565.$x798.$x368
=072  \\$aC18.$x452.$x648.$x798.$x368
=150  \\$aGout
=450  \\$wnnna$aGouts
=550  \\$wg$aArthritis
=550  \\$wg$aPurine-Pyrimidine Metabolism, Inborn Errors
=550  \\$wg$aRheumatic Diseases
=550  \\$wh$aArthritis, Gouty
=550  \\$aChondrocalcinosis
=550  \\$aGout Suppressants
=550  \\$aHypoxanthine Phosphoribosyltransferase
=667  \\$aa rheum dis; /drug ther: consider also GOUT SUPPRESSANTS & its indentions; ARTHRITIS, GOUTY is also available
=680  \\$iHereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.
=750  \0$aGout$5IEN$0(DLC)sh 85056029

=LDR  00904cz  a2200241n  4500
=001  9880363500902441
=005  20141212201830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006072
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x765.$x444
=150  \\$aGossypol
=450  \\$wnnna$aDipotassium Salt, Gossypol
=450  \\$wnnna$aGossypol, (+)-Isomer
=450  \\$wnnna$aGossypol, (+-)-Isomer
=450  \\$wnnna$aGossypol Dipotassium Salt
=450  \\$wnnna$aGossypol, (-)-Isomer
=450  \\$wnnna$aGossypol Sodium Salt
=450  \\$wnnna$aSodium Salt, Gossypol
=550  \\$wg$aSesquiterpenes
=550  \\$aCottonseed Oil
=680  \\$iA dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
=750  \0$aGossypol$5IEN$0(DLC)sh 85055985

=LDR  00955cz  a2200241n  4500
=001  9880363501002441
=005  20141212201829.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006071
=035  \\$aCAZ9238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x375
=150  \\$aGorilla gorilla
=450  \\$wnnna$aGorilla
=450  \\$wnnna$agorilla, Gorilla
=450  \\$wnnna$aGorilla gorillas
=450  \\$wnnna$aGorillas
=450  \\$wnnna$agorillas, Gorilla
=550  \\$wg$aHominidae
=667  \\$adiseases: coord IM with APE DISEASES (IM) + specific dis /vet (IM); DF: GORILLA
=680  \\$iThis single species of Gorilla, which is a member of the HOMINIDAE family, is the largest and most powerful of the PRIMATES. It is distributed in isolated scattered populations throughout forests of equatorial Africa.
=688  \\$a81; was GORILLAS 1975-80
=750  \0$aGorilla$5IEN$0(DLC)sh 85055955

=LDR  00920cz  a2200253n  4500
=001  9880363501102441
=005  20141212201829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006069
=035  \\$aCAZ9236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x625.$x391
=072  \\$aC1.$x252.$x810.$x401
=072  \\$aC1.$x539.$x778.$x281.$x401
=072  \\$aC12.$x294.$x668.$x281.$x401
=072  \\$aC13.$x351.$x500.$x711.$x281.$x401
=150  \\$aGonorrhea
=450  \\$wnnna$aGonorrheas
=550  \\$wg$aNeisseriaceae Infections
=550  \\$wg$aSexually Transmitted Diseases, Bacterial
=550  \\$wh$aOphthalmia Neonatorum
=667  \\$acaused by Neisseria gonorrhoeae
=680  \\$iAcute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
=750  \0$aGonorrhea$5IEN$0(DLC)sh 85055863

=LDR  00585cz  a2200169n  4500
=001  9880363501202441
=005  20141212201829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006068
=035  \\$aCAZ9235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x300
=150  \\$aGonioscopy
=450  \\$wnnna$aGonioscopies
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=680  \\$iExamination of the angle of the anterior chamber of the eye with a specialized optical instrument (gonioscope) or a contact prism lens.
=750  \0$aGonioscopy$5IEN$0(DLC)sh 85055856

=LDR  00762cz  a2200229n  4500
=001  9880363501302441
=005  20141212201828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006066
=035  \\$aCAZ9233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x576
=072  \\$aA6.$x407.$x312
=150  \\$aGonads
=450  \\$wnnna$aGonad
=550  \\$wg$aEndocrine Glands
=550  \\$wg$aGenitalia
=550  \\$wh$aOvary
=550  \\$wh$aTestis
=667  \\$ageneral: prefer OVARY or TESTIS; disorders = GONADAL DISORDERS or specifics; /abnormalities: agenesis & dysgenesis: index under GONADAL DYSGENESIS; excision: see note under CASTRATION
=680  \\$iThe gamete-producing glands, OVARY or TESTIS.
=750  \0$aGonads$5IEN$0(DLC)sh 85055840

=LDR  02013cz  a2200409n  4500
=001  9880363501402441
=005  20141212201827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006063
=035  \\$aCAZ9230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x322.$x326
=072  \\$aD6.$x472.$x699.$x649.$x367
=072  \\$aD12.$x644.$x548.$x726.$x367
=072  \\$aD12.$x776.$x780.$x400
=150  \\$aChorionic Gonadotropin
=450  \\$wnnna$aBiogonadil
=450  \\$wnnna$aChoriogonadotropin
=450  \\$wnnna$aChoriogonin
=450  \\$aChorionic Gonadotropin, Human
=450  \\$wnnna$aChorulon
=450  \\$wnnna$aGonabion
=450  \\$wnnna$aGonadotropin, Chorionic
=450  \\$wnnna$aGonadotropin, Human Chorionic
=450  \\$wnnoa$aGonadotropins, Chorionic$5IEN-HS
=450  \\$aHCG (Human Chorionic Gonadotropin)
=450  \\$wnnna$aHuman Chorionic Gonadotropin
=450  \\$wnnna$aPregnyl
=550  \\$wg$aGonadotropins
=550  \\$wg$aPlacental Hormones
=550  \\$wg$aPregnancy Proteins
=550  \\$wh$aChorionic Gonadotropin, beta Subunit, Human
=550  \\$wh$aGlycoprotein Hormones, alpha Subunit
=667  \\$afor alpha subunit, coordinate with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN is also available
=680  \\$iA gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN).
=688  \\$a2003; use GONADOTROPINS, CHORIONIC (1964-2002)
=750  \0$aChorionic gonadotropins$5IEN$0(DLC)sh 85024750

=LDR  00943cz  a2200205n  4500
=001  9880363501502441
=005  20141212201827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x322
=150  \\$aGonadotropins
=450  \\$wnnna$aGonadotropin
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aChorionic Gonadotropin
=550  \\$wh$aGonadotropins, Equine
=550  \\$wh$aGonadotropins, Pituitary
=667  \\$aGEN; prefer specifics
=680  \\$iHormones that stimulate gonadal functions such as GAMETOGENESIS and sex steroid hormone production in the OVARY and the TESTIS. Major gonadotropins are glycoproteins produced primarily by the adenohypophysis (GONADOTROPINS, PITUITARY) and the placenta (CHORIONIC GONADOTROPIN). In some species, pituitary PROLACTIN and PLACENTAL LACTOGEN exert some luteotropic activities.
=750  \0$aGonadotropin$5IEN$0(DLC)sh 85055839

=LDR  00970cz  a2200301n  4500
=001  9880363501602441
=005  20141212201825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006058
=035  \\$aCAZ9225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x391
=150  \\$aGonadal Disorders
=450  \\$wnnna$aDisorder, Gonadal
=450  \\$wnnna$aDisorders, Gonadal
=450  \\$wnnna$aGonadal Disorder
=550  \\$wg$aEndocrine System Diseases
=550  \\$wh$aDisorders of Sex Development
=550  \\$wh$aFemale Athlete Triad Syndrome
=550  \\$wh$aHypogonadism
=550  \\$wh$aOvarian Diseases
=550  \\$wh$aPuberty, Delayed
=550  \\$wh$aPuberty, Precocious
=550  \\$wh$aTesticular Diseases
=667  \\$ageneral or unspecified; prefer specifics; DF: GONADAL DIS
=680  \\$iPathological processes of the OVARIES or the TESTES.
=688  \\$a98; use explode 1975-97
=750  \0$aGonads$xDiseases$5IEN-M$0(DLC)sh 97002795

=LDR  01041cz  a2200205n  4500
=001  9880363501702441
=005  20141212201825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006056
=035  \\$aCAZ9223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x336
=150  \\$aGolgi Apparatus
=450  \\$wnnna$aApparatus, Golgi
=450  \\$wnnna$aComplex, Golgi
=450  \\$wnnna$aGolgi Complex
=550  \\$wg$aOrganelles
=550  \\$wh$atrans-Golgi Network
=680  \\$iA stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990)
=750  \0$aGolgi apparatus$5IEN$0(DLC)sh 85055819

=LDR  00673cz  a2200193n  4500
=001  9880363501802441
=005  20141212201825.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006055
=035  \\$aCAZ9222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x400
=150  \\$aGolf
=450  \\$wnnna$aGolfs
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aGolf$5IEN$0(DLC)sh 85055804

=LDR  00555cz  a2200181n  4500
=001  9880363501902441
=005  20141212201824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006054
=035  \\$aCAZ9221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x200.$x244.$x248.$x480
=150  \\$aGoldfish
=450  \\$aCarassius auratus
=550  \\$wg$aCarps
=680  \\$iCommon name for Carassius auratus, a type of carp (CARPS).
=688  \\$a91(75); was see under CYPRINIDAE 1975-90
=750  \0$aGoldfish$5IEN$0(DLC)sh 85055774

=LDR  00637cz  a2200205n  4500
=001  9880363502002441
=005  20141212201821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006049
=035  \\$aCAZ9216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x381
=150  \\$aGold Isotopes
=450  \\$wnnna$aIsotopes, Gold
=550  \\$wg$aIsotopes
=550  \\$wh$aGold Radioisotopes
=550  \\$aGold
=667  \\$aAu-197; NIM
=680  \\$iStable gold atoms that have the same atomic number as the element gold, but differ in atomic weight. Au-197 is a stable isotope.
=750  \0$aGold$xIsotopes$5IEN$0(DLC)sh 85055695

=LDR  00859cz  a2200277n  4500
=001  9880363502102441
=005  20141212201821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006047
=035  \\$aCAZ9214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x379.$x375
=072  \\$aD1.$x552.$x33.$x533
=072  \\$aD25.$x58.$x451
=072  \\$aD25.$x339.$x208.$x534
=072  \\$aJ1.$x637.$x51.$x58.$x451
=072  \\$aJ1.$x637.$x51.$x339.$x208.$x534
=150  \\$aGold Alloys
=450  \\$wnnna$aAlloys, Gold
=550  \\$wg$aAlloys
=550  \\$wg$aDental Alloys
=550  \\$wg$aGold Compounds
=667  \\$aused in dental prosth & restor; IM; D25-26 qualif
=680  \\$iAlloys that contain a high percentage of gold. They are used in restorative or prosthetic dentistry.
=688  \\$a65
=750  \0$aGold alloys$5IEN$0(DLC)sh 85055704

=LDR  00795cz  a2200205n  4500
=001  9880363502202441
=005  20141212201821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006046
=035  \\$aCAZ9213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x322
=072  \\$aD1.$x268.$x956.$x186
=072  \\$aD1.$x552.$x544.$x322
=150  \\$aGold
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aAu-197
=680  \\$iA yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
=750  \0$aGold$5IEN-M$0(DLC)sh 85055692

=LDR  00956cz  a2200241n  4500
=001  9880363502302441
=005  20141212201820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006045
=035  \\$aCAZ9212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x283.$x601
=150  \\$aGoiter, Substernal
=450  \\$aGoiter, Intrathoracic
=450  \\$wnnna$aGoiters, Intrathoracic
=450  \\$wnnna$aGoiters, Substernal
=450  \\$wnnna$aIntrathoracic Goiter
=450  \\$wnnna$aIntrathoracic Goiters
=450  \\$wnnna$aSubsternal Goiter
=450  \\$wnnna$aSubsternal Goiters
=550  \\$wg$aGoiter
=680  \\$iAn enlarged THYROID GLAND with at least 50% of the gland situated behind the STERNUM. It is an unusual presentation of an intrathoracic goiter. Substernal goiters frequently cause compression on the TRACHEA leading to deviation, narrowing, and respiratory symptoms.
=750  \0$aSubsternal goiter$5IEN$0(DLC)sh 85129542

=LDR  00811cz  a2200205n  4500
=001  9880363502402441
=005  20141212201820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006043
=035  \\$aCAZ9210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x283.$x300
=150  \\$aGoiter, Endemic
=450  \\$wnnna$aEndemic Goiter
=450  \\$wnnna$aEndemic Goiters
=450  \\$wnnna$aGoiters, Endemic
=550  \\$wg$aGoiter
=680  \\$iA form of IODINE deficiency disorders characterized by an enlargement of the THYROID GLAND in a significantly large fraction of a POPULATION GROUP. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the DIET contains insufficient amount of iodine.
=688  \\$a72(69)
=750  \0$aEndemic goiter$5IEN$0(DLC)sh 85043047

=LDR  00974cz  a2200241n  4500
=001  9880363502502441
=005  20141212201820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006042
=035  \\$aCAZ9209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x283
=150  \\$aGoiter
=450  \\$wnnna$aGoiters
=550  \\$wg$aThyroid Diseases
=550  \\$wh$aGoiter, Endemic
=550  \\$wh$aGoiter, Nodular
=550  \\$wh$aGoiter, Substernal
=550  \\$wh$aGraves Disease
=550  \\$wh$aLingual Goiter
=667  \\$anote specific goiter terms
=680  \\$iEnlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC).
=750  \0$aGoiter$5IEN$0(DLC)sh 85055684

=LDR  00685cz  a2200217n  4500
=001  9880363502602441
=005  20141212201819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006041
=035  \\$aCAZ9208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x513
=150  \\$aGoats
=450  \\$aCapra
=450  \\$wnnna$aCapras
=450  \\$wnnna$aGoat
=550  \\$wg$aRuminants
=550  \\$wh$aRupicapra
=667  \\$amountain goat = GOATS, MOUNTAIN see RUMINANTS
=680  \\$iAny of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP.
=750  \0$aGoats$5IEN$0(DLC)sh 85055494

=LDR  00630cz  a2200205n  4500
=001  9880363502702441
=005  20141212201819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006040
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x500
=150  \\$aGoals
=450  \\$wnnna$aGoal
=550  \\$wg$aMotivation
=550  \\$aIntention
=667  \\$ano qualif
=680  \\$iThe end-result or objective, which may be specified or required in advance.
=688  \\$a79; was GOAL see under MOTIVATION 1969-78
=750  \0$aGoal (Psychology)$5IEN-M$0(DLC)sh 85055484
=750  \0$aGoal (Philosophy)$5IEN-HS$0(DLC)sh 85055483

=LDR  00857cz  a2200193n  4500
=001  9880363502802441
=005  20141212201819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006039
=035  \\$aCAZ9206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x750.$x700.$x722.$x375
=150  \\$aGnathostoma
=450  \\$wnnna$aGnathostomas
=550  \\$wg$aThelazioidea
=667  \\$ainfection = GNATHOSTOMIASIS; coordinate with specific precoordinated helminth terms (e.g., ANTIGENS, HELMINTH) if pertinent
=680  \\$iA genus of parasitic nematodes that occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by ingestion of uncooked fish.
=688  \\$a91(75); was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85
=750  \0$aGnathostoma$5IEN$0(DLC)sh 87000736

=LDR  00548cz  a2200205n  4500
=001  9880363502902441
=005  20141212201818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006037
=035  \\$aCAZ9204M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x644
=150  \\$aGlyoxal
=450  \\$wnnna$aEthanedial
=450  \\$wnnna$aEthanedione
=550  \\$wg$aAldehydes
=550  \\$wh$aPhenylglyoxal
=550  \\$wh$aPyruvaldehyde
=688  \\$a91(73); was see under ALDEHYDES 1973-90
=750  \0$aGlyoxal$0(DLC) sh2005003558$5IEN-M

=LDR  00945cz  a2200241n  4500
=001  9880363503002441
=005  20141212201818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006035
=035  \\$aCAZ9202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x300
=150  \\$aGlycyrrhiza
=450  \\$wnnna$aGlycyrrhizas
=450  \\$aLicorice
=450  \\$wnnna$aLicorices
=450  \\$wnnna$aLiquorice
=450  \\$wnnna$aLiquorices
=550  \\$wg$aFabaceae
=550  \\$wh$aGlycyrrhiza uralensis
=667  \\$anote category; yields the flavoring LICORICE (X ref)
=680  \\$iA genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivatives, CARBENOXOLONE for example. Licorice toxicity is manifested as hypokalemia, low blood potassium. Licorice is used as flavoring and aromatic in pharmaceuticals and as candy.
=750  \0$aGlycyrrhiza$5IEN$0(DLC)sh 91000210

=LDR  01058cz  a2200301n  4500
=001  9880363503102441
=005  20141212201817.0
=008  860624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006031
=035  \\$aCAZ9198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x812
=072  \\$aG2.$x149.$x115.$x160.$x812
=072  \\$aG2.$x149.$x465.$x350
=072  \\$aG2.$x607.$x750.$x350
=072  \\$aG3.$x495.$x256.$x812
=150  \\$aGlycosylation
=450  \\$wnnna$aGlycosylation, Protein
=450  \\$wnnna$aGlycosylations
=450  \\$wnnna$aGlycosylations, Protein
=450  \\$aProtein Glycosylation
=450  \\$wnnna$aProtein Glycosylations
=550  \\$wg$aCarbohydrate Metabolism
=550  \\$wg$aOrganic Chemistry Processes
=667  \\$aalmost never IM
=680  \\$iThe chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. Glycosyl transferases are used in this biochemical reaction.
=688  \\$a87
=750  \0$aGlycosylation$5IEN$0(DLC)sh 91003264

=LDR  00841cz  a2200241n  4500
=001  9880363503202441
=005  20141212201817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006029
=035  \\$aCAZ9196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x363
=072  \\$aC13.$x351.$x968.$x934.$x363
=072  \\$aC18.$x452.$x394.$x937
=150  \\$aGlycosuria
=450  \\$aGlucose$xurine
=550  \\$wg$aGlucose Metabolism Disorders
=550  \\$wg$aUrination Disorders
=550  \\$wh$aGlycosuria, Renal
=550  \\$aGlucose
=550  \\$aUrine
=680  \\$iThe appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
=750  \0$aGlycosuria$5IEN$0(DLC)sh 85055409

=LDR  01216cz  a2200265n  4500
=001  9880363503302441
=005  20141212201816.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006028
=035  \\$aCAZ9195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x410.$x420
=072  \\$aD10.$x390.$x470
=072  \\$aD10.$x570.$x877.$x360
=150  \\$aGlycosphingolipids
=450  \\$aAsialogangliosides
=450  \\$aSphingoglycolipids
=550  \\$wg$aGlycolipids
=550  \\$wg$aSphingolipids
=550  \\$wh$aAcidic Glycosphingolipids
=550  \\$wh$aNeutral Glycosphingolipids
=550  \\$wh$aPsychosine
=680  \\$iLipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage)
=688  \\$a75
=750  \0$aGlycosphingolipids$5IEN$0(DLC)sh 85055408

=LDR  01633cz  a2200409n  4500
=001  9880363503402441
=005  20141212201816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006027
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408
=150  \\$aGlycosides
=550  \\$wg$aCarbohydrates
=550  \\$wh$aAminoglycosides
=550  \\$wh$aAnthocyanins
=550  \\$wh$aAtractyloside
=550  \\$wh$aCardiac Glycosides
=550  \\$wh$aChromomycins
=550  \\$wh$aGalactosides
=550  \\$wh$aGlucosides
=550  \\$wh$aHemoglobin A, Glycosylated
=550  \\$wh$aIridoid Glycosides
=550  \\$wh$aLincosamides
=550  \\$wh$aMannosides
=550  \\$wh$aMethylglycosides
=550  \\$wh$aNovobiocin
=550  \\$wh$aNucleosides
=550  \\$wh$aNucleotides
=550  \\$wh$aOlivomycins
=550  \\$wh$aPhlorhizin
=550  \\$wh$aSaponins
=550  \\$wh$aTeichoic Acids
=550  \\$wh$aThioglycosides
=550  \\$wh$aTomatine
=667  \\$acoordinate with compound (aglycone) that is glycosylated; GEN; do not confuse with GLUCOSIDES; glucides is a European term for CARBOHYDRATES
=680  \\$iAny compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed)
=750  \0$aGlycosides$5IEN$0(DLC)sh 85055407

=LDR  01256cz  a2200445n  4500
=001  9880363503502441
=005  20141212201815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006026
=035  \\$aCAZ9193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450
=150  \\$aGlycoside Hydrolases
=450  \\$wnnna$aEndoglycosidases
=450  \\$wnnna$aExoglycosidases
=450  \\$wnnna$aGlycohydrolases
=450  \\$aGlycosidases
=450  \\$wnnna$aHydrolases, Glycoside
=550  \\$wg$aHydrolases
=550  \\$wh$aalpha-L-Fucosidase
=550  \\$wh$aAmylases
=550  \\$wh$abeta-Fructofuranosidase
=550  \\$wh$aChitinase
=550  \\$wh$aDextranase
=550  \\$wh$aDisaccharidases
=550  \\$wh$aGalactosidases
=550  \\$wh$aGlucosidases
=550  \\$wh$aGlucuronidase
=550  \\$wh$aHexosaminidases
=550  \\$wh$aHyaluronoglucosaminidase
=550  \\$wh$aIduronidase
=550  \\$wh$aIsoamylase
=550  \\$wh$aMannosidases
=550  \\$wh$aMuramidase
=550  \\$wh$aN-Glycosyl Hydrolases
=550  \\$wh$aNeuraminidase
=550  \\$wh$aOligo-1,6-Glucosidase
=550  \\$wh$aPolygalacturonase
=550  \\$wh$aXylosidases
=750  \0$aGlycosidases$5IEN$0(DLC)sh 85055406

=LDR  01017cz  a2200253n  4500
=001  9880363503602441
=005  20141212201815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006025
=035  \\$aCAZ9192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x373
=150  \\$aGlycosaminoglycans
=450  \\$aMucopolysaccharides
=550  \\$wg$aPolysaccharides
=550  \\$wh$aChondroitin
=550  \\$wh$aHeparin
=550  \\$wh$aHeparitin Sulfate
=550  \\$wh$aHyaluronic Acid
=550  \\$wh$aKeratan Sulfate
=667  \\$apolysaccharides; note X ref
=680  \\$iHeteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine.
=688  \\$a77(75); was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92
=750  \0$aGlycosaminoglycans$5IEN$0(DLC)sh 85055405

=LDR  02091cz  a2200685n  4500
=001  9880363503702441
=005  20190530172720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006023
=035  \\$aCAZ9190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x430
=072  \\$aD12.$x776.$x395
=150  \\$aGlycoproteins
=450  \\$wnnna$aGlycoprotein
=450  \\$wnnna$aNeoglycoproteins
=550  \\$wg$aGlycoconjugates
=550  \\$wg$aProteins
=550  \\$wh$a4-1BB Ligand
=550  \\$wh$aActivins
=550  \\$wh$aADAM Proteins
=550  \\$wh$aalpha 1-Antichymotrypsin
=550  \\$wh$aalpha 1-Antitrypsin
=550  \\$wh$aalpha-2-Antiplasmin
=550  \\$wh$aalpha-2-HS-Glycoprotein
=550  \\$wh$aAnti-Mullerian Hormone
=550  \\$wh$aAsialoglycoproteins
=550  \\$wh$aAvidin
=550  \\$wh$aB-Cell Activating Factor
=550  \\$wh$abeta 2-Glycoprotein I
=550  \\$wh$aCD27 Ligand
=550  \\$wh$aCholesterol Ester Transfer Proteins
=550  \\$wh$aClusterin
=550  \\$wh$aColony-Stimulating Factors
=550  \\$wh$aComplement C1 Inhibitor Protein
=550  \\$wh$aFibrillins
=550  \\$wh$aGlycated Hemoglobin A
=550  \\$wh$aGlycodelin
=550  \\$wh$aHemopexin
=550  \\$wh$aHSP47 Heat-Shock Proteins
=550  \\$wh$aInhibins
=550  \\$wh$aLactoferrin
=550  \\$wh$aMembrane Glycoproteins
=550  \\$wh$aMucoproteins
=550  \\$wh$aMyelin P0 Protein
=550  \\$wh$aOsteonectin
=550  \\$wh$aProtein C
=550  \\$wh$aProtein S
=550  \\$wh$aProteoglycans
=550  \\$wh$aSerum Amyloid P-Component
=550  \\$wh$aSialoglycoproteins
=550  \\$wh$aThrombopoietin
=550  \\$wh$aThyroglobulin
=550  \\$wh$aThyroxine-Binding Proteins
=550  \\$wh$aTranscortin
=550  \\$wh$aTumor Necrosis Factor-alpha
=550  \\$wh$aVitronectin
=667  \\$aGEN; prefer specifics
=680  \\$iConjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.
=750  \0$aGlycoproteins$5IEN$0(DLC)sh 85055403

=LDR  00929cz  a2200277n  4500
=001  9880363503802441
=005  20141212201813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006020
=035  \\$aCAZ9186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x420
=072  \\$aD12.$x644.$x233
=150  \\$aGlycopeptides
=550  \\$wg$aGlycoconjugates
=550  \\$wg$aPeptides
=550  \\$wh$aAcetylmuramyl-Alanyl-Isoglutamine
=550  \\$wh$aBleomycin
=550  \\$wh$aPeptidoglycan
=550  \\$wh$aRistocetin
=550  \\$wh$aSialoglycoproteins
=550  \\$wh$aTeicoplanin
=550  \\$wh$aVancomycin
=680  \\$iProteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight.
=688  \\$a73(71)
=750  \0$aGlycopeptides$5IEN-M$0(DLC)sh 94001082

=LDR  01400cz  a2200337n  4500
=001  9880363503902441
=005  20141212201812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006019
=035  \\$aCAZ9185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x750
=072  \\$aG2.$x149.$x115.$x160.$x750
=072  \\$aG3.$x495.$x256.$x750
=072  \\$aG3.$x495.$x335.$x436
=072  \\$aG3.$x495.$x553.$x360
=150  \\$aGlycolysis
=450  \\$wnnna$aEmbden-Meyerhof-Parnas Pathway
=450  \\$wnnna$aEmbden Meyerhof Parnas Pathway
=450  \\$wnnna$aEmbden-Meyerhof Pathway
=450  \\$wnnna$aEmbden Meyerhof Pathway
=450  \\$wnnna$aEmbden-Meyerhof Pathways
=450  \\$wnnna$aPathway, Embden-Meyerhof
=450  \\$wnnna$aPathway, Embden-Meyerhof-Parnas
=450  \\$wnnna$aPathways, Embden-Meyerhof
=550  \\$wg$aCarbohydrate Metabolism
=550  \\$wg$aEnergy Metabolism
=550  \\$wg$aMetabolic Networks and Pathways
=680  \\$iA metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.
=688  \\$a66(64)
=750  \0$aGlycolysis$5IEN$0(DLC)sh 85055402

=LDR  00695cz  a2200205n  4500
=001  9880363504002441
=005  20141212201812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006018
=035  \\$aCAZ9184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455
=150  \\$aGlycols
=550  \\$wg$aAlcohols
=550  \\$wh$aButylene Glycols
=550  \\$wh$aEthylene Glycols
=550  \\$wh$aPropylene Glycols
=550  \\$wh$aSphingosine
=680  \\$iA generic grouping for dihydric alcohols with the hydroxy groups (-OH) located on different carbon atoms. They are viscous liquids with high boiling points for their molecular weights.
=750  \0$aGlycols$5IEN$0(DLC)sh 85055401

=LDR  00949cz  a2200253n  4500
=001  9880363504102441
=005  20141212201812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006017
=035  \\$aCAZ9183HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x410
=072  \\$aD10.$x390
=150  \\$aGlycolipids
=550  \\$wg$aGlycoconjugates
=550  \\$wg$aLipids
=550  \\$wh$aCord Factors
=550  \\$wh$aGalactolipids
=550  \\$wh$aGlycosphingolipids
=550  \\$wh$aGlycosylphosphatidylinositols
=550  \\$wh$aPolyisoprenyl Phosphate Sugars
=680  \\$iAny compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)
=688  \\$a66(63); was see under LIPIDS 1963-65
=750  \0$aGlycolipids$5IEN$0(DLC)sh 85055400

=LDR  01707cz  a2200385n  4500
=001  9880363504202441
=005  20141212201806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006008
=035  \\$aCAZ9171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x202.$x449
=072  \\$aC18.$x452.$x648.$x202.$x449
=150  \\$aGlycogen Storage Disease
=450  \\$wnnna$aDisease, Glycogen Storage
=450  \\$wnnna$aDiseases, Glycogen Storage
=450  \\$wnnna$aGlycogen Storage Diseases
=450  \\$wnnna$aGlycogenoses
=450  \\$aGlycogenosis
=450  \\$wnnna$aStorage Disease, Glycogen
=450  \\$wnnna$aStorage Diseases, Glycogen
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wh$aGlycogen Storage Disease Type I
=550  \\$wh$aGlycogen Storage Disease Type II
=550  \\$wh$aGlycogen Storage Disease Type IIb
=550  \\$wh$aGlycogen Storage Disease Type III
=550  \\$wh$aGlycogen Storage Disease Type IV
=550  \\$wh$aGlycogen Storage Disease Type V
=550  \\$wh$aGlycogen Storage Disease Type VI
=550  \\$wh$aGlycogen Storage Disease Type VII
=550  \\$wh$aGlycogen Storage Disease Type VIII
=667  \\$aan inborn error of carbohydrate metab; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
=688  \\$a89; was GLYCOGENOSIS 1963-88
=750  \0$aGlycogenosis$0(DLC) sh 85055399$5IEN

=LDR  00988cz  a2200265n  4500
=001  9880363504302441
=005  20141212201805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006005
=035  \\$aCAZ9170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x460.$x400
=150  \\$aPhosphorylases
=450  \\$wnnna$aalpha-Glucan Phosphorylases
=450  \\$aGlucan Phosphorylase
=450  \\$wnnoa$aPhosphorylase$5IEN-HS
=550  \\$wg$aGlucosyltransferases
=550  \\$wh$aGlycogen Phosphorylase
=550  \\$wh$aPhosphorylase a
=550  \\$wh$aPhosphorylase b
=550  \\$wh$aStarch Phosphorylase
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals (GLYCOGEN PHOSPHORYLASE) and in plants (STARCH PHOSPHORYLASE).
=688  \\$a98(71)
=750  \0$aPhosphorylase$5IEN$0(DLC)sh 85101131

=LDR  00532cz  a2200181n  4500
=001  9880363504402441
=005  20141212201804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006003
=035  \\$aCAZ9168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x388
=072  \\$aD9.$x698.$x365.$x388
=150  \\$aGlycogen
=550  \\$wg$aGlucans
=550  \\$wh$aLiver Glycogen
=667  \\$a/metab consider also GLYCOGENOLYSIS or GLYCOGEN STORAGE DISEASE and specifics
=750  \0$aGlycogen$5IEN$0(DLC)sh 85055397

=LDR  00883cz  a2200229n  4500
=001  9880363504502441
=005  20141212201803.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006001
=035  \\$aCAZ9166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400
=150  \\$aGlycoconjugates
=550  \\$wg$aCarbohydrates
=550  \\$wh$aGlycolipids
=550  \\$wh$aGlycopeptides
=550  \\$wh$aGlycoproteins
=550  \\$wh$aLipopolysaccharides
=667  \\$aGEN: prefer specific glycoconjugate
=680  \\$iCarbohydrates covalently linked to a nonsugar moiety (lipids or proteins). The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. (From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed)
=688  \\$a88
=750  \0$aGlycoconjugates$5IEN$0(DLC)sh 92001641

=LDR  02004cz  a2200529n  4500
=001  9880363504602441
=005  20141212201802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005998
=035  \\$aCAZ9163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x481
=150  \\$aGlycine
=450  \\$wnnna$aAcid, Aminoacetic
=450  \\$aAminoacetic Acid
=450  \\$wnnna$aCalcium Salt Glycine
=450  \\$wnnna$aCobalt Salt Glycine
=450  \\$wnnna$aCopper Salt Glycine
=450  \\$wnnna$aGlycine, Calcium Salt
=450  \\$wnnna$aGlycine, Calcium Salt (2:1)
=450  \\$wnnna$aGlycine Carbonate (1:1), Monosodium Salt
=450  \\$wnnna$aGlycine Carbonate (2:1), Monolithium Salt
=450  \\$wnnna$aGlycine Carbonate (2:1), Monopotassium Salt
=450  \\$wnnna$aGlycine Carbonate (2:1), Monosodium Salt
=450  \\$wnnna$aGlycine, Cobalt Salt
=450  \\$wnnna$aGlycine, Copper Salt
=450  \\$wnnna$aGlycine Hydrochloride
=450  \\$wnnna$aGlycine Hydrochloride (2:1)
=450  \\$wnnna$aGlycine, Monoammonium Salt
=450  \\$wnnna$aGlycine, Monopotasssium Salt
=450  \\$wnnna$aGlycine, Monosodium Salt
=450  \\$wnnna$aGlycine Phosphate
=450  \\$wnnna$aGlycine Phosphate (1:1)
=450  \\$wnnna$aGlycine, Sodium Hydrogen Carbonate
=450  \\$wnnna$aGlycine Sulfate (3:1)
=450  \\$wnnna$aHydrochloride, Glycine
=450  \\$wnnna$aMonoammonium Salt Glycine
=450  \\$wnnna$aMonopotasssium Salt Glycine
=450  \\$wnnna$aMonosodium Salt Glycine
=450  \\$wnnna$aPhosphate, Glycine
=450  \\$wnnna$aSalt Glycine, Monoammonium
=450  \\$wnnna$aSalt Glycine, Monosodium
=550  \\$wg$aAmino Acids
=550  \\$wh$aAllylglycine
=550  \\$wh$aN-substituted Glycines
=680  \\$iA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.
=750  \0$aGlycine$5IEN$0(DLC)sh 85055394

=LDR  01761cz  a2200565n  4500
=001  9880363504702441
=005  20141212201801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005996
=035  \\$aCAZ9161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x421.$x560
=072  \\$aD2.$x640.$x636
=150  \\$aNitroglycerin
=450  \\$wnnna$aAnginine
=450  \\$wnnna$aDynamite
=450  \\$wnnna$aGilustenon
=450  \\$aGlyceryl Trinitrate
=450  \\$wnnna$aNitrangin
=450  \\$wnnna$aNitro-Bid
=450  \\$wnnna$aNitro Bid
=450  \\$wnnna$aNitro-Dur
=450  \\$wnnna$aNitro Dur
=450  \\$wnnna$aNitroBid
=450  \\$wnnna$aNitrocard
=450  \\$wnnna$aNitroderm
=450  \\$wnnna$aNitroderm TTS
=450  \\$wnnna$aNitroDur
=450  \\$wnnna$aNitroglyn
=450  \\$wnnna$aNitrol
=450  \\$wnnna$aNitrolan
=450  \\$wnnna$aNitrong
=450  \\$wnnna$aNitrospan
=450  \\$wnnna$aNitrostat
=450  \\$wnnna$aPerlinganit
=450  \\$wnnna$aSusadrin
=450  \\$wnnna$aSustac
=450  \\$wnnna$aSustak
=450  \\$wnnna$aSustonit
=450  \\$wnnna$aTransderm Nitro
=450  \\$wnnna$aTridil
=450  \\$wnnna$aTrinitrate, Glyceryl
=450  \\$wnnna$aTrinitrin
=450  \\$wnnna$aTrinitrolong
=550  \\$wg$aGlycerol
=550  \\$wg$aNitro Compounds
=680  \\$iA volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
=688  \\$a92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91
=750  \0$aNitroglycerin$5IEN-M$0(DLC)sh 85092085
=750  \0$aDynamite$5IEN-HS$0(DLC)sh 85040322

=LDR  01023cz  a2200277n  4500
=001  9880363504802441
=005  20141212201801.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005995
=035  \\$aCAZ9160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x421.$x400
=072  \\$aD2.$x355.$x460
=150  \\$aGlyceryl Ethers
=450  \\$aAlkyl Glyceryl Ethers
=450  \\$wnnna$aEthers, Alkyl Glyceryl
=450  \\$wnnna$aEthers, Glycerol
=450  \\$wnnna$aEthers, Glyceryl
=450  \\$aGlycerol Ethers
=450  \\$wnnna$aGlyceryl Ethers, Alkyl
=550  \\$wg$aEthers
=550  \\$wg$aGlycerol
=550  \\$wh$aPhospholipid Ethers
=680  \\$iCompounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue.
=688  \\$a88
=750  \0$aGlyceryl ethers$5IEN-M$0(DLC)sh 97007072

=LDR  00774cz  a2200241n  4500
=001  9880363504902441
=005  20141212201759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005990
=035  \\$aCAZ9155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x421
=072  \\$aD9.$x853.$x421
=150  \\$aGlycerol
=450  \\$wnnna$a1,2,3-Trihydroxypropane
=450  \\$aGlycerin
=450  \\$wnnna$aGlycerine
=550  \\$wg$aSugar Alcohols
=550  \\$wh$aGlyceryl Ethers
=550  \\$wh$aNitroglycerin
=680  \\$iA trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
=688  \\$a98
=750  \0$aGlycerin$5IEN$0(DLC)sh 85055393

=LDR  00580cz  a2200217n  4500
=001  9880363505002441
=005  20141212201759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005989
=035  \\$aCAZ9154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x351
=150  \\$aGlycerides
=450  \\$wnnna$aAcylglycerol
=450  \\$wnnna$aAcylglycerols
=550  \\$wg$aLipids
=550  \\$wh$aDiglycerides
=550  \\$wh$aMonoglycerides
=550  \\$wh$aTriglycerides
=680  \\$iGLYCEROL esterified with FATTY ACIDS.
=750  \0$aGlycerides$5IEN-M$0(DLC)sh 85055392

=LDR  00907cz  a2200301n  4500
=001  9880363505102441
=005  20141212201757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005983
=035  \\$aCAZ9148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x725.$x500.$x500
=150  \\$aGlutens
=450  \\$wnnna$aGlutelin
=450  \\$wnnna$aGlutelins
=450  \\$aGluten
=450  \\$wnnna$aGluten Proteins
=450  \\$wnnna$aHordein
=450  \\$wnnna$aHordeins
=450  \\$wnnna$aProteins, Gluten
=450  \\$wnnna$aSecalin
=450  \\$wnnna$aSecalins
=550  \\$wg$aProlamins
=550  \\$wh$aGliadin
=680  \\$iProlamins in the endosperm of SEEDS from the Triticeae tribe which includes species of WHEAT; BARLEY; and RYE.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Gluten
=750  \0$aGluten$0(DLC) sh 85055386$5IEN

=LDR  03402cz  a2200781n  4500
=001  9880363505202441
=005  20141212201757.0
=008  760419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005982
=035  \\$aCAZ9147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x225.$x500
=150  \\$aGlutathione Transferase
=450  \\$wnnna$aGlutathione Lyase, S-Hydroxyalkyl
=450  \\$wnnna$aGlutathione Organic Nitrate Ester Reductase
=450  \\$aGlutathione S-Alkyltransferase
=450  \\$wnnna$aGlutathione S Alkyltransferase
=450  \\$aGlutathione S-Aryltransferase
=450  \\$wnnna$aGlutathione S Aryltransferase
=450  \\$aGlutathione S-Epoxidetransferase
=450  \\$wnnna$aGlutathione S Epoxidetransferase
=450  \\$wnnna$aGlutathione S-Transferase
=450  \\$wnnna$aGlutathione S Transferase
=450  \\$wnnna$aGlutathione S-Transferase 3
=450  \\$wnnna$aGlutathione S Transferase 3
=450  \\$wnnna$aGlutathione S-Transferase A
=450  \\$wnnna$aGlutathione S Transferase A
=450  \\$wnnna$aGlutathione S-Transferase B
=450  \\$wnnna$aGlutathione S Transferase B
=450  \\$wnnna$aGlutathione S-Transferase C
=450  \\$wnnna$aGlutathione S Transferase C
=450  \\$wnnna$aGlutathione S-Transferase III
=450  \\$wnnna$aGlutathione S Transferase III
=450  \\$wnnna$aGlutathione S-Transferase P
=450  \\$wnnna$aGlutathione S Transferase P
=450  \\$wnnna$aGlutathione Transferase E
=450  \\$wnnna$aGlutathione Transferase mu
=450  \\$wnnna$aGlutathione Transferases
=450  \\$wnnna$aHeme Transfer Protein
=450  \\$wnnna$aLigandin
=450  \\$aLigandins
=450  \\$wnnna$aLyase, S-Hydroxyalkyl Glutathione
=450  \\$wnnna$aP, Glutathione S-Transferase
=450  \\$wnnna$aProtein, Heme Transfer
=450  \\$wnnna$aS-Alkyltransferase, Glutathione
=450  \\$wnnna$aS-Aryltransferase, Glutathione
=450  \\$wnnna$aS-Epoxidetransferase, Glutathione
=450  \\$aS-Hydroxyalkyl Glutathione Lyase
=450  \\$wnnna$aS Hydroxyalkyl Glutathione Lyase
=450  \\$wnnna$aS-Transferase 3, Glutathione
=450  \\$wnnna$aS-Transferase A, Glutathione
=450  \\$wnnna$aS-Transferase B, Glutathione
=450  \\$wnnna$aS-Transferase C, Glutathione
=450  \\$wnnna$aS-Transferase, Glutathione
=450  \\$wnnna$aS-Transferase III, Glutathione
=450  \\$wnnna$aS-Transferase P, Glutathione
=450  \\$wnnna$aTransfer Protein, Heme
=450  \\$wnnna$aTransferase E, Glutathione
=450  \\$wnnna$aTransferase, Glutathione
=450  \\$wnnna$aTransferase mu, Glutathione
=450  \\$wnnna$aTransferases, Glutathione
=450  \\$wnnna$aYb-Glutathione-S-Transferase
=550  \\$wg$aAlkyl and Aryl Transferases
=550  \\$wh$aGlutathione S-Transferase pi
=680  \\$iA transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite.
=688  \\$a1977; use CARRIER PROTEINS & TRANSFERASES 1975-1976
=688  \\$a77; LIGANDINS was LIGANDIN see under CARRIER PROTEINS 1975-76; GLUTATHIONE S-ARYLTRANSFERASE was see under TRANSFERASES 1975-76
=750  \0$aGlutathione transferase$5IEN$0(DLC)sh 87002506

=LDR  01005cz  a2200265n  4500
=001  9880363505302441
=005  20141212201755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005978
=035  \\$aCAZ9143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x448
=150  \\$aGlutathione
=450  \\$wnnna$agamma-L-Glu-L-Cys-Gly
=450  \\$wnnna$agamma L Glu L Cys Gly
=450  \\$wnnna$agamma-L-Glutamyl-L-Cysteinylglycine
=450  \\$wnnna$agamma L Glutamyl L Cysteinylglycine
=450  \\$wnnna$aGlutathione, Reduced
=450  \\$wnnna$aReduced Glutathione
=550  \\$wg$aOligopeptides
=550  \\$wh$aGlutathione Disulfide
=550  \\$wh$aPhytochelatins
=550  \\$wh$aS-Nitrosoglutathione
=680  \\$iA tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.
=750  \0$aGlutathione$5IEN$0(DLC)sh 85055385

=LDR  01329cz  a2200385n  4500
=001  9880363505402441
=005  20141212201755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005976
=035  \\$aCAZ9141M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x532
=150  \\$aGlutaral
=450  \\$wnnna$aBioglan Brand of Glutaral
=450  \\$wnnna$aBode Brand of Glutaral
=450  \\$wnnna$aCahill May Roberts Brand of Glutaral
=450  \\$wnnna$aCidex
=450  \\$wnnna$aDermal Brand of Glutaral
=450  \\$wnnna$aDermatech Brand of Glutaral
=450  \\$wnnna$aDiswart
=450  \\$wnnna$aEcolab Brand of Glutaral
=450  \\$wnnna$aGludesin
=450  \\$aGlutaraldehyde
=450  \\$wnnna$aGlutardialdehyde
=450  \\$wnnna$aGlutarol
=450  \\$wnnna$aJohnson & Johnson Brand of Glutaral
=450  \\$wnnna$aKorsolex
=450  \\$wnnna$aNovaruca
=450  \\$wnnna$aSekumatic
=450  \\$wnnna$aSonacide
=450  \\$wnnna$aSporicidin
=550  \\$wg$aAldehydes
=680  \\$iOne of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.
=688  \\$a92; was GLUTARALDEHYDE 1973-91 (see under ALDEHYDES 1973-90)
=750  \0$aGlutaral$0(DLC)sh2010014517$5IEN-M

=LDR  00934cz  a2200277n  4500
=001  9880363505502441
=005  20141212201754.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005975
=035  \\$aCAZ9140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464.$x263.$x200.$x250
=150  \\$aGlutamate-tRNA Ligase
=450  \\$wnnna$aGlu-tRNA Ligase
=450  \\$wnnna$aGlu tRNA Ligase
=450  \\$wnnna$aGlutamate tRNA Ligase
=450  \\$aGlutamyl T RNA Synthetase
=450  \\$wnnna$aGlutamyl-tRNA Synthetase
=450  \\$wnnna$aGlutamyl tRNA Synthetase
=450  \\$wnnna$aLigase, Glu-tRNA
=450  \\$wnnna$aLigase, Glutamate-tRNA
=450  \\$wnnna$aSynthetase, Glutamyl-tRNA
=550  \\$wg$aAmino Acyl-tRNA Synthetases
=680  \\$iAn enzyme that activates glutamic acid with its specific transfer RNA. EC 6.1.1.17.
=688  \\$a98(75)
=750  \0$aGlutamyl-tRNA synthetase$5IEN$0(DLC)sh 85055384

=LDR  00916cz  a2200229n  4500
=001  9880363505602441
=005  20141212201754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005974
=035  \\$aCAZ9139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x464.$x259.$x200.$x600
=150  \\$aGlutamate-Ammonia Ligase
=450  \\$wnnna$aGlutamate Ammonia Ligase
=450  \\$wnnna$aGlutamate Ammonia Ligase (ADP)
=450  \\$aGlutamine Synthetase
=450  \\$wnnna$aLigase, Glutamate-Ammonia
=450  \\$wnnna$aSynthetase, Glutamine
=550  \\$wg$aAmide Synthases
=680  \\$iAn enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2.
=688  \\$a95; was GLUTAMINE SYNTHETASE 1972-94
=750  \0$aGlutamine synthetase$5IEN$0(DLC)sh 85055383

=LDR  01018cz  a2200277n  4500
=001  9880363505702441
=005  20141212201754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005973
=035  \\$aCAZ9138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x68.$x330
=072  \\$aD12.$x125.$x95.$x461
=072  \\$aD12.$x125.$x154.$x424
=150  \\$aGlutamine
=450  \\$wnnna$aD-Glutamine
=450  \\$wnnna$aD Glutamine
=450  \\$wnnna$aL-Glutamine
=450  \\$wnnna$aL Glutamine
=550  \\$wg$aAmino Acids, Basic
=550  \\$wg$aAmino Acids, Diamino
=550  \\$wg$aAmino Acids, Neutral
=550  \\$wh$aProglumide
=667  \\$a/biosyn /physiol permitted
=680  \\$iA non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.
=750  \0$aGlutamine$5IEN$0(DLC)sh 85055382

=LDR  00670cz  a2200181n  4500
=001  9880363505802441
=005  20141212201752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005969
=035  \\$aCAZ9134M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x664.$x500.$x398
=150  \\$aGlutamate Dehydrogenase
=450  \\$wnnna$aDehydrogenase, Glutamate
=550  \\$wg$aAmino Acid Oxidoreductases
=680  \\$iAn enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2.
=688  \\$a65
=750  \0$aGlutamate dehydrogenase$0(DLC) sh2004008819$5IEN-M

=LDR  01244cz  a2200253n  4500
=001  9880363505902441
=005  20141212201752.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005968
=035  \\$aCAZ9133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x224.$x125.$x250
=150  \\$aGlutamate Decarboxylase
=450  \\$wnnna$aAcid Decarboxylase, Glutamic
=450  \\$wnnna$aCarboxy-Lyase, Glutamate
=450  \\$wnnna$aDecarboxylase, Glutamate
=450  \\$wnnna$aDecarboxylase, Glutamic Acid
=450  \\$aGlutamate Carboxy-Lyase
=450  \\$wnnna$aGlutamate Carboxy Lyase
=450  \\$wnnna$aGlutamic Acid Decarboxylase
=550  \\$wg$aCarboxy-Lyases
=680  \\$iA pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.
=688  \\$a84(75); was see under CARBOXY-LYASES 1975-83
=750  \0$aGlutamate decarboxylase$5IEN$0(DLC)sh 85055378

=LDR  00703cz  a2200229n  4500
=001  9880363506002441
=005  20141212201751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005966
=035  \\$aCAZ9131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x426
=150  \\$aGlucuronidase
=450  \\$wnnna$abeta-Glucuronidase
=450  \\$wnnna$abeta Glucuronidase
=450  \\$wnnna$aEndo-beta-D-Glucuronidase
=450  \\$wnnna$aEndo beta D Glucuronidase
=450  \\$wnnna$aEndoglucuronidase
=450  \\$wnnna$aExo-beta-D-Glucuronidase
=450  \\$wnnna$aExo beta D Glucuronidase
=550  \\$wg$aGlycoside Hydrolases
=750  \0$aGlucuronidase$5IEN$0(DLC)sh 85055370

=LDR  00791cz  a2200193n  4500
=001  9880363506102441
=005  20141212201750.0
=008  780518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005961
=035  \\$aCAZ9126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x740.$x703.$x350
=072  \\$aD9.$x408.$x348.$x820.$x350
=072  \\$aD9.$x408.$x903.$x703.$x350
=150  \\$aGlucosinolates
=550  \\$wg$aThioglucosides
=680  \\$iSubstituted thioglucosides. They are found in rapeseed (Brassica campestris) products and related cruciferae. They are metabolized to a variety of toxic products which are most likely the cause of hepatocytic necrosis in animals and humans.
=688  \\$a91(79); was see under THIOGLYCOSIDES 1979-90
=750  \0$aGlucosinolates$5IEN$0(DLC)sh 87001978

=LDR  00780cz  a2200289n  4500
=001  9880363506202441
=005  20161216095800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005960
=035  \\$aCAZ9125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x348
=150  \\$aGlucosides
=550  \\$wg$aGlycosides
=550  \\$wh$aAmygdalin
=550  \\$wh$aArbutin
=550  \\$wh$aCanagliflozin
=550  \\$wh$aChloralose
=550  \\$wh$aEsculin
=550  \\$wh$aEtoposide
=550  \\$wh$aIridoid Glucosides
=550  \\$wh$aMethylglucosides
=550  \\$wh$aTeniposide
=550  \\$wh$aThioglucosides
=667  \\$ado not confuse with GLYCOSIDES
=688  \\$a91(75); was see under GLYCOSIDES 1975-90
=750  \0$aGlucosides$5IEN$0(DLC)sh 85055367

=LDR  00823cz  a2200253n  4500
=001  9880363506302441
=005  20141212201749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005959
=035  \\$aCAZ9124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x420
=150  \\$aGlucosidases
=450  \\$wnnna$aGlucosidase
=550  \\$wg$aGlycoside Hydrolases
=550  \\$wh$aalpha-Glucosidases
=550  \\$wh$aCellulases
=550  \\$wh$aGlucan 1,4-alpha-Glucosidase
=550  \\$wh$aGlucosylceramidase
=550  \\$wh$aGlycogen Debranching Enzyme System
=550  \\$wh$aLactase-Phlorizin Hydrolase
=680  \\$iEnzymes that hydrolyze O-glucosyl-compounds. (Enzyme Nomenclature, 1992) EC 3.2.1.-.
=688  \\$a75; was GLUCOSIDASE 1963-74
=750  \0$aGlucosidases$5IEN$0(DLC)sh 86007720

=LDR  02280cz  a2200517n  4500
=001  9880363506402441
=005  20141212201748.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005955
=035  \\$aCAZ9120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x150.$x480
=072  \\$aC16.$x320.$x70.$x480
=072  \\$aC16.$x320.$x565.$x202.$x402
=072  \\$aC18.$x452.$x648.$x202.$x402
=150  \\$aGlucosephosphate Dehydrogenase Deficiency
=450  \\$wnnna$aDeficiencies, G6PD
=450  \\$wnnna$aDeficiencies, Glucose-6-Phosphate Dehydrogenase
=450  \\$wnnna$aDeficiencies, Glucosephosphate Dehydrogenase
=450  \\$wnnna$aDeficiencies, GPD
=450  \\$wnnna$aDeficiency, G6PD
=450  \\$wnnna$aDeficiency, Glucose-6-Phosphate Dehydrogenase
=450  \\$wnnna$aDeficiency, Glucosephosphate Dehydrogenase
=450  \\$wnnna$aDeficiency, GPD
=450  \\$wnnna$aDeficiency of Glucose-6-Phosphate Dehydrogenase
=450  \\$wnnna$aDeficiency of Glucose 6 Phosphate Dehydrogenase
=450  \\$wnnna$aDehydrogenase Deficiencies, Glucose-6-Phosphate
=450  \\$wnnna$aDehydrogenase Deficiencies, Glucosephosphate
=450  \\$wnnna$aDehydrogenase Deficiency, Glucose-6-Phosphate
=450  \\$wnnna$aDehydrogenase Deficiency, Glucosephosphate
=450  \\$wnnna$aG6PD Deficiencies
=450  \\$wnnna$aG6PD Deficiency
=450  \\$wnnna$aGlucose-6-Phosphate Dehydrogenase Deficiencies
=450  \\$wnnna$aGlucose 6 Phosphate Dehydrogenase Deficiency
=450  \\$wnnna$aGlucose-6-Phosphate Dehydrogenase Deficiency
=450  \\$wnnna$aGlucosephosphate Dehydrogenase Deficiencies
=450  \\$aGlucosephosphate Dehydrogenase$xdeficiency
=450  \\$wnnna$aGPD Deficiencies
=450  \\$wnnna$aGPD Deficiency
=450  \\$wnnna$aHemolytic Anemia Due to G6PD Deficiency
=550  \\$wg$aAnemia, Hemolytic, Congenital
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wh$aFavism
=680  \\$iA disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
=688  \\$a64
=750  \0$aGlucose-6-phosphate dehydrogenase deficiency$5IEN$0(DLC)sh 85055364

=LDR  00681cz  a2200205n  4500
=001  9880363506502441
=005  20141212201747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005954
=035  \\$aCAZ9119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x150.$x300
=150  \\$aGlucosephosphate Dehydrogenase
=450  \\$wnnna$aDehydrogenase, Glucose-6-Phosphate
=450  \\$wnnna$aDehydrogenase, Glucosephosphate
=450  \\$aGlucose-6-Phosphate Dehydrogenase
=450  \\$wnnna$aGlucose 6 Phosphate Dehydrogenase
=550  \\$wg$aCarbohydrate Dehydrogenases
=667  \\$aDF: GPD
=750  \0$aGlucose-6-phosphate dehydrogenase$5IEN$0(DLC)sh 86005738

=LDR  00824cz  a2200217n  4500
=001  9880363506602441
=005  20141212201746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005952
=035  \\$aCAZ9118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x225
=150  \\$aGlucose-6-Phosphatase
=450  \\$wnnna$aGlucose 6-Phosphatase
=450  \\$wnnna$aGlucose 6 Phosphatase
=450  \\$wnnna$aGlucose-6-Phosphate Phosphohydrolase
=450  \\$aGlucosephosphatase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=680  \\$iAn enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9.
=688  \\$a94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964
=750  \0$aGlucose-6-phosphatase$5IEN$0(DLC)sh 89001446

=LDR  01245cz  a2200313n  4500
=001  9880363506702441
=005  20141212201746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005951
=035  \\$aCAZ9117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x355
=072  \\$aE1.$x370.$x374.$x355
=072  \\$aE5.$x200.$x124.$x100.$x355
=150  \\$aGlucose Tolerance Test
=450  \\$wnnna$aGlucose Tolerance, Oral
=450  \\$wnnna$aGlucose Tolerance Tests
=450  \\$wnnna$aIntravenous Glucose Tolerance
=450  \\$wnnna$aIntravenous Glucose Tolerance Test
=450  \\$wnnna$aOGTT
=450  \\$wnnna$aOral Glucose Tolerance
=450  \\$wnnna$aOral Glucose Tolerance Test
=550  \\$wg$aBlood Chemical Analysis
=550  \\$wg$aDiagnostic Techniques, Endocrine
=550  \\$aBlood Glucose
=550  \\$aGlucose Intolerance
=667  \\$aNIM
=680  \\$iA test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
=750  \0$aGlucose tolerance tests$5IEN$0(DLC)sh 85055363

=LDR  01385cz  a2200361n  4500
=001  9880363506802441
=005  20141212201745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005947
=035  \\$aCAZ9112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x359.$x448
=150  \\$aGlucose
=450  \\$wnnna$aAnhydrous Dextrose
=450  \\$wnnna$aD-Glucose
=450  \\$wnnna$aD Glucose
=450  \\$aDextrose
=450  \\$wnnna$aDextrose, Anhydrous
=450  \\$wnnna$aGlucose, (alpha-D)-Isomer
=450  \\$wnnna$aGlucose, (beta-D)-Isomer
=450  \\$wnnna$aGlucose, (DL)-Isomer
=450  \\$wnnna$aGlucose, (L)-Isomer
=450  \\$wnnna$aGlucose Monohydrate
=450  \\$wnnna$aL-Glucose
=450  \\$wnnna$aL Glucose
=450  \\$wnnna$aMonohydrate, Glucose
=550  \\$wg$aHexoses
=550  \\$wh$aBlood Glucose
=667  \\$a/blood = BLOOD GLUCOSE but consider also HYPERGLYCEMIA & HYPOGLYCEMIA; /defic: consider also HYPOGLYCEMIA
=680  \\$iA primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
=688  \\$a/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66
=750  \0$aDextrose$5IEN-M$0(DLC)sh 85037427
=750  \0$aGlucose$5IEN-HS$0(DLC)sh 85055360

=LDR  00894cz  a2200289n  4500
=001  9880363506902441
=005  20141212201744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005944
=035  \\$aCAZ9109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x67.$x342.$x531
=150  \\$aGlucosamine
=450  \\$wnnna$a2-Amino-2-Deoxyglucose
=450  \\$wnnna$a2 Amino 2 Deoxyglucose
=450  \\$wnnna$aDona
=450  \\$wnnna$aDona S
=450  \\$wnnna$aFides Ecopharma Brand of Glucosamine Sulfate
=450  \\$wnnna$aGlucosamine Sulfate
=450  \\$wnnna$aHespercorbin
=450  \\$wnnna$aOpfermann Brand of Glucosamine Sulfate
=450  \\$wnnna$aRottapharm Brand of Glucosamine Sulfate
=450  \\$wnnna$aSulfate, Glucosamine
=450  \\$wnnna$aXicil
=550  \\$wg$aHexosamines
=550  \\$wh$aAcetylglucosamine
=750  \0$aGlucosamine$5IEN-M$0(DLC)sh 96012184

=LDR  00637cz  a2200193n  4500
=001  9880363507002441
=005  20141212201743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005943
=035  \\$aCAZ9108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x500
=072  \\$aG2.$x149.$x115.$x160.$x500
=072  \\$aG3.$x495.$x256.$x500
=150  \\$aGluconeogenesis
=550  \\$wg$aCarbohydrate Metabolism
=680  \\$iBiosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
=688  \\$a67(65)
=750  \0$aGluconeogenesis$5IEN$0(DLC)sh 86001999

=LDR  00721cz  a2200169n  4500
=001  9880363507102441
=005  20141212201743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005941
=035  \\$aCAZ9106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x250
=150  \\$aGlucokinase
=550  \\$wg$aPhosphotransferases (Alcohol Group Acceptor)
=680  \\$iA group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2.
=688  \\$a65; was see under HEXOKINASE 1963-64
=750  \0$aGlucokinase$5IEN-M$0(DLC)sh 95003449

=LDR  01279cz  a2200253n  4500
=001  9880363507202441
=005  20141212201743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005938
=035  \\$aCAZ9103HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x40.$x543
=072  \\$aD27.$x505.$x696.$x399.$x472.$x488
=150  \\$aGlucocorticoids
=450  \\$wnnna$aEffect, Glucocorticoid
=450  \\$wnnna$aEffects, Glucorticoid
=450  \\$wnnna$aGlucocorticoid Effect
=450  \\$wnnna$aGlucorticoid Effects
=550  \\$wg$aAdrenal Cortex Hormones
=550  \\$wg$aHormones
=667  \\$anote entry term GLUCOCORTICOID EFFECT: use only for the glucocorticoid effect of a chemical substance
=680  \\$iA group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
=688  \\$a67
=750  \0$aGlucocorticoids$5IEN$0(DLC)sh 85055358

=LDR  00985cz  a2200349n  4500
=001  9880363507302441
=005  20141212201742.0
=008  771215\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005936
=035  \\$aCAZ9101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562
=072  \\$aD9.$x698.$x365
=150  \\$aGlucans
=450  \\$wnnna$aGlucan (BO)
=450  \\$wnnna$aGlucose Polymer
=450  \\$wnnna$aPolycose
=450  \\$aPolyglucoses
=450  \\$wnnna$aPolymer, Glucose
=550  \\$wg$aBiopolymers
=550  \\$wg$aPolysaccharides
=550  \\$wh$abeta-Glucans
=550  \\$wh$aCellulose
=550  \\$wh$aDextrans
=550  \\$wh$aGlycogen
=550  \\$wh$aIsomaltose
=550  \\$wh$aMaltose
=550  \\$wh$aStarch
=550  \\$wh$aTrehalose
=680  \\$iPolysaccharides composed of repeating glucose units. They can consist of branched or unbranched chains in any linkages.
=688  \\$a79
=750  \0$aGlucans$0(DLC) sh 85055355$5IEN

=LDR  01790cz  a2200433n  4500
=001  9880363507402441
=005  20141212201741.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005935
=035  \\$aCAZ9100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25.$x290.$x750
=072  \\$aC4.$x588.$x274.$x761.$x500.$x249
=072  \\$aC4.$x588.$x322.$x475.$x500.$x249
=072  \\$aC6.$x301.$x761.$x500.$x249
=072  \\$aC6.$x689.$x667.$x500.$x249
=072  \\$aC19.$x344.$x421.$x500.$x249
=150  \\$aGlucagonoma
=450  \\$aAdenoma, alpha-Cell
=450  \\$wnnna$aAdenoma, alpha Cell
=450  \\$wnnna$aAdenomas, alpha-Cell
=450  \\$wnnna$aalpha-Cell Adenoma
=450  \\$wnnna$aalpha-Cell Adenomas
=450  \\$aalpha-Cell Tumor
=450  \\$wnnna$aalpha Cell Tumor
=450  \\$wnnna$aalpha-Cell Tumors
=450  \\$wnnna$aGlucagonoma Syndrome
=450  \\$wnnna$aGlucagonoma Syndromes
=450  \\$wnnna$aGlucagonomas
=450  \\$wnnna$aSyndrome, Glucagonoma
=450  \\$wnnna$aSyndromes, Glucagonoma
=450  \\$wnnna$aTumor, alpha-Cell
=450  \\$wnnna$aTumors, alpha-Cell
=550  \\$wg$aCarcinoma, Islet Cell
=550  \\$aNecrolytic Migratory Erythema
=667  \\$acoordinate IM with PANCREATIC NEOPLASMS (IM); for glucagonoma syndrome, coordinate also with NECROLYTIC MIGRATORY ERYTHEMA
=680  \\$iAn almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
=688  \\$a91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981
=750  \0$aGlucagonoma$5IEN$0(DLC)sh 85055354

=LDR  01255cz  a2200265n  4500
=001  9880363507502441
=005  20141212201741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005934
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x587.$x469.$x500
=072  \\$aD12.$x644.$x548.$x586.$x469.$x500
=150  \\$aGlucagon
=450  \\$wnnna$aGlucagon (1-29)
=450  \\$wnnna$aGlukagon
=450  \\$wnnna$aHG-Factor
=450  \\$wnnna$aHG Factor
=450  \\$wnnna$aHyperglycemic-Glycogenolytic Factor
=450  \\$wnnna$aHyperglycemic Glycogenolytic Factor
=450  \\$wnnna$aProglucagon (33-61)
=550  \\$wg$aProglucagon
=550  \\$aReceptors, Glucagon
=667  \\$ado not confuse with GLUCAGON-LIKE PEPTIDES secreted by the intestine
=680  \\$iA 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
=750  \0$aGlucagon$5IEN$0(DLC)sh 85055353

=LDR  00918cz  a2200253n  4500
=001  9880363507602441
=005  20141212201740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005932
=035  \\$aCAZ9097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x600.$x400.$x400
=072  \\$aE7.$x858.$x594.$x500
=072  \\$aJ1.$x637.$x215.$x600.$x400.$x400
=072  \\$aJ1.$x637.$x708.$x600.$x400.$x400
=150  \\$aGloves, Surgical
=450  \\$wnnna$aGlove, Surgical
=450  \\$wnnna$aSurgical Glove
=450  \\$aSurgical Gloves
=550  \\$wg$aGloves, Protective
=550  \\$wg$aSurgical Attire
=667  \\$ado not use /util except by MeSH definition: DF: GLOVES SURG
=680  \\$iGloves, usually rubber, worn by surgeons, examining physicians, dentists, and other health personnel for the mutual protection of personnel and patient.
=750  \0$aSurgical gloves$5IEN-M$0(DLC)sh 85055349

=LDR  00781cz  a2200217n  4500
=001  9880363507702441
=005  20141212201740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005931
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x329.$x364
=150  \\$aGlottis
=450  \\$wnnna$aGlottidi, Rima
=450  \\$wnnna$aGlottidis, Rima
=450  \\$wnnna$aRima Glottidi
=450  \\$wnnna$aRima Glottidis
=550  \\$wg$aLarynx
=550  \\$wh$aVocal Cords
=667  \\$aglottitis: coordinate NIM with LARYNGITIS (IM); stenosis = LARYNGOSTENOSIS
=680  \\$iThe vocal apparatus of the larynx, situated in the middle section of the larynx. Glottis consists of the VOCAL FOLDS and an opening (rima glottidis) between the folds.
=750  \0$aGlottis$5IEN$0(DLC)sh 85055343

=LDR  01708cz  a2200361n  4500
=001  9880363507802441
=005  20141212201740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005930
=035  \\$aCAZ9095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x337
=072  \\$aA8.$x800.$x50.$x600.$x387
=072  \\$aA8.$x800.$x800.$x60.$x337
=072  \\$aA8.$x800.$x800.$x120.$x290
=150  \\$aGlossopharyngeal Nerve
=450  \\$aCranial Nerve IX
=450  \\$wnnna$aCranial Nerve IXs
=450  \\$wnnna$aCranial Nerve, Ninth
=450  \\$wnnna$aCranial Nerves, Ninth
=450  \\$wnnna$aGlossopharyngeal Nerves
=450  \\$wnnna$aNerve, Glossopharyngeal
=450  \\$wnnna$aNerve, Ninth Cranial
=450  \\$wnnna$aNerves, Glossopharyngeal
=450  \\$wnnna$aNerves, Ninth Cranial
=450  \\$aNinth Cranial Nerve
=450  \\$wnnna$aNinth Cranial Nerves
=550  \\$wg$aAutonomic Pathways
=550  \\$wg$aCranial Nerves
=550  \\$wg$aParasympathetic Nervous System
=667  \\$aneoplasm = GLOSSOPHARYNGEAL NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and CHEMORECEPTOR CELLS of the carotid sinus.
=750  \0$aGlossopharyngeal nerve$0(DLC) sh 85055337$5IEN

=LDR  01462cz  a2200265n  4500
=001  9880363507902441
=005  20141212201739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005925
=035  \\$aCAZ9090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x700.$x705.$x340
=072  \\$aC4.$x557.$x580.$x625.$x650.$x700.$x705.$x340
=150  \\$aGlomus Jugulare Tumor
=450  \\$wnnna$aGlomus Jugulare Tumors
=450  \\$wnnna$aGlomus Tumors, Familial, 1
=450  \\$wnnna$aJugulare Tumor, Glomus
=450  \\$wnnna$aJugulare Tumors, Glomus
=450  \\$wnnna$aTumor, Glomus Jugulare
=450  \\$wnnna$aTumors, Glomus Jugulare
=550  \\$wg$aParaganglioma, Extra-Adrenal
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; organ/neopl & histol coords not necessary
=680  \\$iA paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. (From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1603-4)
=688  \\$a91(75); was see under PARAGANGLIOMA, NONCHROMAFFIN 1975-90
=750  \0$aGlomus jugulare$xTumors$5IEN$0(DLC)sh 85055321

=LDR  00881cz  a2200217n  4500
=001  9880363508002441
=005  20141212192224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005924
=035  \\$aCAZ9089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x500.$x600.$x350
=072  \\$aA8.$x800.$x950.$x500.$x600.$x350
=072  \\$aA11.$x671.$x650.$x915.$x500.$x600.$x350
=150  \\$aGlomus Jugulare
=450  \\$wnnna$aJugulare, Glomus
=550  \\$wg$aParaganglia, Nonchromaffin
=667  \\$aa nonchromaffin paraganglion
=680  \\$iA nonchromaffin paraganglion located in the wall of the jugular bulb. The most common tumors of the middle ear arise from this tissue. (Lockard, Desk Reference for Neuroscience, 1992, p114)
=688  \\$a91(75); was see under PARAGANGLIA, NONCHROMAFFIN 1975-90
=750  \0$aGlomus jugulare$5IEN$0(DLC)sh 85055320

=LDR  01518cz  a2200373n  4500
=001  9880363508102441
=005  20141212201738.0
=008  840412\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005922
=035  \\$aCAZ9085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570.$x363.$x608
=072  \\$aC13.$x351.$x968.$x419.$x570.$x363.$x608
=072  \\$aC20.$x111.$x525
=150  \\$aGlomerulonephritis, IGA
=450  \\$aBerger Disease
=450  \\$wnnna$aBerger's Disease
=450  \\$wnnna$aBergers Disease
=450  \\$wnnna$aGlomerulonephritides, IGA
=450  \\$wnnna$aIGA Glomerulonephritis
=450  \\$wnnna$aIGA Nephropathy
=450  \\$wnnna$aIga Nephropathy 1
=450  \\$wnnna$aIGA Type Nephritis
=450  \\$aImmunoglobulin A Nephropathy
=450  \\$wnnna$aNephritis, IGA Type
=450  \\$wnnna$aNephropathy 1, Iga
=450  \\$aNephropathy, IGA
=450  \\$wnnna$aNephropathy, Immunoglobulin A
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aGlomerulonephritis
=667  \\$ado not confuse X ref BERGER'S DISEASE with BUERGER'S DISEASE see THROMBOANGIITIS OBLITERANS
=680  \\$iA chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.
=688  \\$a85
=750  \0$aIgA glomerulonephritis$5IEN$0(DLC)sh 86006812

=LDR  01303cz  a2200289n  4500
=001  9880363508202441
=005  20141212201737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005921
=035  \\$aCAZ9084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570.$x363
=072  \\$aC13.$x351.$x968.$x419.$x570.$x363
=150  \\$aGlomerulonephritis
=450  \\$aBright Disease
=450  \\$wnnna$aGlomerulonephritides
=550  \\$wg$aNephritis
=550  \\$wh$aAnti-Glomerular Basement Membrane Disease
=550  \\$wh$aGlomerulonephritis, IGA
=550  \\$wh$aGlomerulonephritis, Membranoproliferative
=550  \\$wh$aGlomerulonephritis, Membranous
=550  \\$wh$aGlomerulosclerosis, Focal Segmental
=550  \\$wh$aLupus Nephritis
=550  \\$aHeymann Nephritis Antigenic Complex
=680  \\$iInflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
=688  \\$aBRIGHT DISEASE was BRIGHT'S DISEASE see NEPHRITIS 1963-78
=750  \0$aGlomerulonephritis$5IEN$0(DLC)sh 85055317

=LDR  01005cz  a2200265n  4500
=001  9880363508302441
=005  20141212201736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005919
=035  \\$aCAZ9082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x390.$x400.$x300
=072  \\$aG8.$x852.$x357
=150  \\$aGlomerular Filtration Rate
=450  \\$wnnna$aFiltration Rate, Glomerular
=450  \\$wnnna$aFiltration Rates, Glomerular
=450  \\$wnnna$aGlomerular Filtration Rates
=450  \\$wnnna$aRate, Glomerular Filtration
=450  \\$wnnna$aRates, Glomerular Filtration
=550  \\$wg$aKidney Function Tests
=550  \\$wg$aUrinary Tract Physiological Phenomena
=550  \\$aKidney Glomerulus
=680  \\$iThe volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.
=688  \\$a66(65)
=750  \0$aGlomerular filtration rate$5IEN$0(DLC)sh 85055316

=LDR  00811cz  a2200217n  4500
=001  9880363508402441
=005  20141212192223.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005917
=035  \\$aCAZ9080HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x487.$x397
=150  \\$aGlobus Pallidus
=450  \\$aPaleostriatum
=450  \\$wnnna$aPallidum
=450  \\$wnnna$aPallidums
=550  \\$wg$aCorpus Striatum
=550  \\$aEntopeduncular Nucleus
=667  \\$amedial globus pallidus in non-primates = ENTOPEDUNCULAR NUCLEUS
=680  \\$iThe representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus.
=750  \0$aGlobus pallidus$5IEN$0(DLC)sh 85055308

=LDR  00705cz  a2200205n  4500
=001  9880363508502441
=005  20141212201736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005916
=035  \\$aCAZ9079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x377
=150  \\$aGlobulins
=550  \\$wg$aProteins
=550  \\$wh$aFetal Globulins
=550  \\$wh$aLactoglobulins
=550  \\$wh$aSerum Globulins
=550  \\$wh$aThyroglobulin
=667  \\$aGEN; permeability globulins: index under SERUM GLOBULINS; EUGLOBULINS & PSEUDOGLOBULINS are see refs to SERUM GLOBULINS; do not confuse with GLOBULINS, IMMUNE see IMMUNOGLOBULINS, INTRAVENOUS
=750  \0$aGlobulins$5IEN$0(DLC)sh 85055307

=LDR  00682cz  a2200217n  4500
=001  9880363508602441
=005  20141212201735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005914
=035  \\$aCAZ9077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x422.$x316
=150  \\$aGlobins
=450  \\$aGlobin
=550  \\$wg$aHemeproteins
=550  \\$wh$aHemoglobins
=550  \\$wh$aLeghemoglobin
=550  \\$wh$aMyoglobin
=680  \\$iA superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure.
=688  \\$a2001, 1965-1971(1972)
=750  \0$aGlobin$0(DLC) sh 85055303$5IEN

=LDR  01913cz  a2200433n  4500
=001  9880363508702441
=005  20141212201734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005910
=035  \\$aCAZ9073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x380
=072  \\$aC4.$x557.$x470.$x670.$x380
=072  \\$aC4.$x557.$x580.$x625.$x600.$x380
=150  \\$aGlioma
=450  \\$wnnna$aGlial Cell Tumor
=450  \\$aGlial Cell Tumors
=450  \\$wnnna$aGlioma, Malignant
=450  \\$wnnna$aGlioma, Mixed
=450  \\$wnnna$aGliomas
=450  \\$wnnna$aGliomas, Malignant
=450  \\$wnnna$aGliomas, Mixed
=450  \\$wnnna$aMalignant Glioma
=450  \\$wnnna$aMalignant Gliomas
=450  \\$wnnna$aMixed Glioma
=450  \\$wnnna$aMixed Gliomas
=450  \\$wnnna$aTumor, Glial Cell
=450  \\$wnnna$aTumors, Glial Cell
=550  \\$wg$aNeoplasms, Neuroepithelial
=550  \\$wh$aAstrocytoma
=550  \\$wh$aEpendymoma
=550  \\$wh$aGanglioglioma
=550  \\$wh$aGliosarcoma
=550  \\$wh$aMedulloblastoma
=550  \\$wh$aOligodendroglioma
=550  \\$wh$aOptic Nerve Glioma
=667  \\$acoord IM with precoord CNS/neopl term + site (IM); GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA
=680  \\$iBenign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
=750  \0$aGliomas$5IEN$0(DLC)sh 85055282

=LDR  01651cz  a2200325n  4500
=001  9880363508802441
=005  20141212201733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005909
=035  \\$aCAZ9072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x380.$x80.$x335
=072  \\$aC4.$x557.$x470.$x670.$x380.$x80.$x335
=072  \\$aC4.$x557.$x580.$x625.$x600.$x380.$x80.$x335
=150  \\$aGlioblastoma
=450  \\$aAstrocytoma, Grade IV
=450  \\$wnnna$aAstrocytomas, Grade IV
=450  \\$aGiant Cell Glioblastoma
=450  \\$wnnna$aGiant Cell Glioblastomas
=450  \\$wnnna$aGlioblastoma, Giant Cell
=450  \\$aGlioblastoma Multiforme
=450  \\$wnnna$aGlioblastomas
=450  \\$wnnna$aGlioblastomas, Giant Cell
=450  \\$wnnna$aGrade IV Astrocytoma
=450  \\$wnnna$aGrade IV Astrocytomas
=550  \\$wg$aAstrocytoma
=667  \\$acoord IM with probably precoord CNS/neopl term + site (IM); for GLIOBLASTOMA WITH SARCOMATOUS COMPONENT see GLIOSARCOMA; for GLIOBLASTOMA, RETINAL see RETINOBLASTOMA
=680  \\$iA malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
=688  \\$a94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993
=750  \0$aGlioblastoma multiforme$5IEN$0(DLC)sh 91003964

=LDR  01459cz  a2200385n  4500
=001  9880363508902441
=005  20141212201706.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005822
=035  \\$aCAZ8984HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x337
=150  \\$aGenetic Vectors
=450  \\$wnnna$aCloning Vector
=450  \\$aCloning Vectors
=450  \\$wnnna$aGenetic Vector
=450  \\$wnnna$aShuttle Vector
=450  \\$aShuttle Vectors
=450  \\$wnnna$aVector, Cloning
=450  \\$wnnna$aVector, Genetic
=450  \\$wnnna$aVector, Shuttle
=450  \\$wnnna$aVectors, Cloning
=450  \\$aVectors, Genetic
=450  \\$wnnna$aVectors, Shuttle
=550  \\$wg$aGenetic Structures
=550  \\$wh$aChromosomes, Artificial
=550  \\$wh$aCosmids
=550  \\$aBacteriophages
=550  \\$aDNA, Recombinant
=550  \\$aPlasmids
=550  \\$aViruses
=667  \\$acoord with specific bacterium, virus, phage or plasmid
=680  \\$iDNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.
=688  \\$a80
=750  \0$aGenetic vectors$5IEN$0(DLC)sh 85053875

=LDR  02399cz  a2200709n  4500
=001  9880363509002441
=005  20190716133128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393
=150  \\$aGenetic Techniques
=450  \\$wnnna$aGenetic Technic
=450  \\$wnnna$aGenetic Technics
=450  \\$wnnna$aGenetic Technique
=450  \\$aGenetics$xmethods
=450  \\$wnnna$aTechnic, Genetic
=450  \\$wnnna$aTechnics, Genetic
=450  \\$wnnna$aTechnique, Genetic
=450  \\$wnnna$aTechniques, Genetic
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aCellular Reprogramming Techniques
=550  \\$wh$aChromatin Immunoprecipitation
=550  \\$wh$aChromosome Mapping
=550  \\$wh$aCloning, Molecular
=550  \\$wh$aCloning, Organism
=550  \\$wh$aContig Mapping
=550  \\$wh$aCrosses, Genetic
=550  \\$wh$aCytogenetic Analysis
=550  \\$wh$aDNA Fingerprinting
=550  \\$wh$aDNA Footprinting
=550  \\$wh$aGene Expression Profiling
=550  \\$wh$aGene Targeting
=550  \\$wh$aGene Transfer Techniques
=550  \\$wh$aGenetic Association Studies
=550  \\$wh$aGenetic Carrier Screening
=550  \\$wh$aGenetic Engineering
=550  \\$wh$aGenetic Testing
=550  \\$wh$aGenotyping Techniques
=550  \\$wh$aHuman Papillomavirus DNA Tests
=550  \\$wh$aIn Situ Nick-End Labeling
=550  \\$wh$aMolecular Diagnostic Techniques
=550  \\$wh$aMolecular Epidemiology
=550  \\$wh$aMolecular Probe Techniques
=550  \\$wh$aMolecular Typing
=550  \\$wh$aMutagenicity Tests
=550  \\$wh$aNuclease Protection Assays
=550  \\$wh$aNucleic Acid Amplification Techniques
=550  \\$wh$aNucleic Acid Denaturation
=550  \\$wh$aNucleic Acid Hybridization
=550  \\$wh$aOptogenetics
=550  \\$wh$aPedigree
=550  \\$wh$aRestriction Mapping
=550  \\$wh$aReverse Genetics
=550  \\$wh$aSequence Alignment
=550  \\$wh$aSequence Analysis
=550  \\$aGenetic Counseling
=550  \\$aGenetic Processes
=667  \\$ado not use /util except by MeSH definition
=680  \\$iChromosomal, biochemical, intracellular, and other methods used in the study of genetics.
=688  \\$a91; was GENETIC TECHNICS 1973-90
=750  \0$aGenetics$xTechnique$5IEN$0(DLC)sh 85053881

=LDR  02294cz  a2200589n  4500
=001  9880363509102441
=005  20181011111053.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005820
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x562
=072  \\$aE5.$x200.$x562
=072  \\$aE5.$x393.$x435
=072  \\$aN2.$x421.$x726.$x233.$x221
=072  \\$aN2.$x421.$x308.$x430
=150  \\$aGenetic Testing
=450  \\$wnnna$aGenetic Predictive Testing
=450  \\$aGenetic Predisposition Testing
=450  \\$aGenetic Predisposition to Disease$xdiagnosis
=450  \\$wnnna$aGenetic Screening
=450  \\$wnnna$aGenetic Screenings
=450  \\$wnnna$aGenetic Testing, Predictive
=450  \\$wnnna$aPredictive Genetic Testing
=450  \\$wnnna$aPredictive Testing, Genetic
=450  \\$wnnna$aPredisposition Testing, Genetic
=450  \\$wnnna$aScreening, Genetic
=450  \\$wnnna$aScreenings, Genetic
=450  \\$wnnna$aTesting, Genetic
=450  \\$wnnna$aTesting, Genetic Predictive
=450  \\$wnnna$aTesting, Genetic Predisposition
=450  \\$wnnna$aTesting, Predictive Genetic
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aDiagnostic Services
=550  \\$wg$aGenetic Services
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aGenetic Carrier Screening
=550  \\$wh$aPharmacogenomic Testing
=550  \\$aCytogenetic Analysis
=550  \\$aDatabases, Genetic
=550  \\$aDatabases, Nucleic Acid
=550  \\$aGenetic Predisposition to Disease
=550  \\$aGenetic Privacy
=550  \\$aMolecular Diagnostic Techniques
=550  \\$aPreimplantation Diagnosis
=550  \\$aPrenatal Diagnosis
=667  \\$ahuman and animal; for phenotype or genotype
=680  \\$iDetection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing.
=688  \\$a2010 (1978)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Genetic Screening
=688  \\$a78
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20100901: 150:##:_{dollar}a Genetic Screening
=750  \0$aGenetic screening$0(DLC) sh 99000370$5IEN-M

=LDR  02183cz  a2200565n  4500
=001  9880363842802441
=005  20141212192438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011248
=035  \\$aCBA4539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703
=150  \\$aPregnancy Complications
=450  \\$wnnna$aComplication, Pregnancy
=450  \\$wnnna$aComplications, Pregnancy
=450  \\$wnnna$aPregnancy Complication
=450  \\$aPregnancy$xcomplications
=550  \\$wg$aFemale Urogenital Diseases and Pregnancy Complications
=550  \\$wh$aAbortion, Spontaneous
=550  \\$wh$aChorea Gravidarum
=550  \\$wh$aDiabetes, Gestational
=550  \\$wh$aFetal Death
=550  \\$wh$aFetal Diseases
=550  \\$wh$aHypertension, Pregnancy-Induced
=550  \\$wh$aMaternal Death
=550  \\$wh$aMorning Sickness
=550  \\$wh$aNuchal Cord
=550  \\$wh$aObstetric Labor Complications
=550  \\$wh$aOligohydramnios
=550  \\$wh$aPelvic Floor Disorders
=550  \\$wh$aPemphigoid Gestationis
=550  \\$wh$aPerinatal Death
=550  \\$wh$aPhenylketonuria, Maternal
=550  \\$wh$aPlacenta Diseases
=550  \\$wh$aPolyhydramnios
=550  \\$wh$aPregnancy Complications, Cardiovascular
=550  \\$wh$aPregnancy Complications, Hematologic
=550  \\$wh$aPregnancy Complications, Infectious
=550  \\$wh$aPregnancy Complications, Neoplastic
=550  \\$wh$aPregnancy, Ectopic
=550  \\$wh$aPregnancy in Diabetics
=550  \\$wh$aPregnancy, Prolonged
=550  \\$wh$aPrenatal Injuries
=550  \\$wh$aPuerperal Disorders
=550  \\$aObstetrics
=550  \\$aPerinatology
=550  \\$aPregnancy, High-Risk
=667  \\$acoordinate IM with specific disease (IM); / surg: consider also OBSTETRIC SURGICAL PROCEDURES
=680  \\$iConditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
=750  \0$aPregnancy$xComplications$5IEN$0(DLC)sh 85106287

=LDR  01661cz  a2200433n  4500
=001  9880363842902441
=005  20190322142335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011247
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x784.$x769
=150  \\$aPregnancy
=450  \\$aGestation
=450  \\$wnnna$aPregnancies
=550  \\$wg$aReproduction
=550  \\$wh$aGravidity
=550  \\$wh$aLabor, Obstetric
=550  \\$wh$aMaternal-Fetal Exchange
=550  \\$wh$aParity
=550  \\$wh$aParturition
=550  \\$wh$aPlacentation
=550  \\$wh$aPregnancy, Animal
=550  \\$wh$aPregnancy, High-Risk
=550  \\$wh$aPregnancy in Adolescence
=550  \\$wh$aPregnancy Maintenance
=550  \\$wh$aPregnancy, Multiple
=550  \\$wh$aPregnancy Outcome
=550  \\$wh$aPregnancy, Unplanned
=550  \\$wh$aPregnancy, Unwanted
=550  \\$wh$aPrenatal Nutritional Physiological Phenomena
=550  \\$wh$aPseudopregnancy
=550  \\$aLitter Size
=550  \\$aMaternal-Fetal Relations
=550  \\$aPregnant Women
=550  \\$aPrenatal Care
=667  \\$aIM for articles on normal pregnancy, NIM as check tag; in children or adolescents, see note under PREGNANCY IN ADOLESCENCE; surrogate pregnancy = SURROGATE MOTHERS; for "pregnancy" in non-placental organisms (fish, reptiles, monotremes for example): use OVIPARITY; OVOVIVIPARITY; or VIVIPARITY, NONMAMMALIAN
=680  \\$iThe status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
=688  \\$a1963
=750  \0$aPregnancy$0(DLC) sh 85106276$5IEN-M

=LDR  01219cz  a2200241n  4500
=001  9880363843002441
=005  20141212204804.0
=008  840413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011243
=035  \\$aCBA4534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x800.$x750
=072  \\$aN4.$x590.$x374.$x410.$x750
=150  \\$aPreferred Provider Organizations
=450  \\$wnnna$aOrganization, Preferred Provider
=450  \\$wnnna$aOrganizations, Preferred Provider
=450  \\$wnnna$aPreferred Provider Organization
=550  \\$wg$aManaged Care Programs
=550  \\$aCompetitive Medical Plans
=667  \\$aspecify geog if possible; DF: PPO
=680  \\$iArrangements negotiated between a third-party payer (often a self-insured company or union trust fund) and a group of health-care providers (hospitals and physicians) who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.
=688  \\$a91(85); was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984
=750  \0$aPreferred provider organizations (Medical care)$5IEN$0(DLC)sh 85106274

=LDR  02795cz  a2200793n  4500
=001  9880363843102441
=005  20141212204804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011241
=035  \\$aCBA4532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x719.$x702
=150  \\$aPrednisone
=450  \\$wnnna$aacis Brand of Prednisone
=450  \\$wnnna$aApo-Prednisone
=450  \\$wnnna$aApotex Brand of Prednisone
=450  \\$wnnna$aAventis Brand of Prednisone
=450  \\$wnnna$aCortan
=450  \\$wnnna$aCortancyl
=450  \\$wnnna$aCutason
=450  \\$wnnna$aDacortin
=450  \\$wnnna$aDecortin
=450  \\$wnnna$aDecortisyl
=450  \\$aDehydrocortisone
=450  \\$adelta-Cortisone
=450  \\$wnnna$aDeltasone
=450  \\$wnnna$aDiba Brand of Prednisone
=450  \\$wnnna$aEncorton
=450  \\$wnnna$aEncortone
=450  \\$wnnna$aEnkortolon
=450  \\$wnnna$aFawns & McAllan Brand of Prednisone
=450  \\$wnnna$aFerring Brand of Prednisone
=450  \\$wnnna$aGALENpharma Brand of Prednisone
=450  \\$wnnna$aHalsey Drug Brand of Prednisone
=450  \\$wnnna$aHexal Brand of Prednisone
=450  \\$wnnna$aHoechst Brand of Prednisone
=450  \\$wnnna$aICN Brand of Prednisone
=450  \\$wnnna$aKortancyl
=450  \\$wnnna$aLichtenstein Brand of Prednisone
=450  \\$wnnna$aLiquid Pred
=450  \\$wnnna$aMerck Brand of Prednisone
=450  \\$wnnna$aMerz Brand of Prednisone
=450  \\$wnnna$aMeticorten
=450  \\$wnnna$amibe Brand of Prednisone
=450  \\$wnnna$aOrasone
=450  \\$wnnna$aPanafcort
=450  \\$wnnna$aPanasol
=450  \\$wnnna$aPharmacia Brand of Prednisone
=450  \\$wnnna$aPredni Tablinen
=450  \\$wnnna$aPrednidib
=450  \\$wnnna$aPredniment
=450  \\$wnnna$aPrednison acsis
=450  \\$wnnna$aPrednison Galen
=450  \\$wnnna$aPrednison Hexal
=450  \\$wnnna$aPronisone
=450  \\$wnnna$aRectodelt
=450  \\$wnnna$aSchering-Plough Brand of Prednisone
=450  \\$wnnna$aSeatrace Brand of Prednisone
=450  \\$wnnna$aSolvay Brand of Prednisone
=450  \\$wnnna$aSone
=450  \\$wnnna$aSterapred
=450  \\$wnnna$aTrommsdorff Brand of Prednisone
=450  \\$wnnna$aUltracorten
=450  \\$wnnna$aWinpred
=550  \\$wg$aPregnadienediols
=667  \\$anote entry term DECORTIN: DECORTIN (DESOXYCORTICOSTERONE) see DESOXYCORTICOSTERONE is also available
=680  \\$iA synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
=688  \\$a/adv eff-pois-tox was PREDNISONE TOXICOLOGY 1963-65; /ther use was PREDNISONE, THERAPEUTIC 1965
=750  \0$aPrednisone$5IEN$0(DLC)sh 85106259

=LDR  01021cz  a2200253n  4500
=001  9880363843202441
=005  20141212204802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011236
=035  \\$aCBA4527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x750.$x774
=072  \\$aC19.$x246.$x774
=150  \\$aPrediabetic State
=450  \\$aPrediabetes
=450  \\$wnnna$aPrediabetic States
=450  \\$wnnna$aState, Prediabetic
=450  \\$wnnna$aStates, Prediabetic
=550  \\$wg$aDiabetes Mellitus
=550  \\$aDiabetes Mellitus
=667  \\$ado not use /compl for development into diabetes mellitus; coordinate IM with specific type of diabetes mellitus (IM) if pertinent
=680  \\$iThe time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
=688  \\$a68(65)
=750  \0$aPrediabetic state$5IEN$0(DLC)sh 85106249

=LDR  01010cz  a2200277n  4500
=001  9880363843302441
=005  20141212204802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011233
=035  \\$aCBA4524M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x645
=072  \\$aE5.$x196.$x150.$x639.$x500
=072  \\$aE5.$x200.$x812.$x735.$x645
=072  \\$aE5.$x478.$x594.$x760.$x645
=072  \\$aE5.$x478.$x605.$x492
=150  \\$aPrecipitin Tests
=450  \\$wnnna$aPrecipitin Test
=450  \\$wnnna$aTest, Precipitin
=450  \\$wnnna$aTests, Precipitin
=550  \\$wg$aImmunoprecipitation
=550  \\$wg$aSerologic Tests
=550  \\$wh$aFlocculation Tests
=550  \\$wh$aImmunodiffusion
=680  \\$iSerologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate.
=750  \0$aPrecipitin reaction$0(DLC) sh 85106230$5IEN-M

=LDR  01046cz  a2200289n  4500
=001  9880363843402441
=005  20170628111144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011232
=035  \\$aCBA4523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x150
=072  \\$aG2.$x159
=150  \\$aChemical Precipitation
=450  \\$wnnna$aPrecipitation, Chemical
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aFlocculation
=550  \\$wh$aFractional Precipitation
=550  \\$wh$aImmunoprecipitation
=550  \\$aPhase Transition
=667  \\$ado not use for precipitation as a weather phenomenon
=680  \\$iThe formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution.
=688  \\$a2010 (1964)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Precipitation
=688  \\$a66(64)
=750  \0$aPrecipitation (Chemistry)$0(DLC) sh 85106216$5IEN

=LDR  01363cz  a2200397n  4500
=001  9880363843502441
=005  20200706114428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011230
=035  \\$aCBA4521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x834
=150  \\$aPrecancerous Conditions
=450  \\$wnnna$aCondition, Precancerous
=450  \\$wnnna$aCondition, Preneoplastic
=450  \\$wnnna$aConditions, Precancerous
=450  \\$wnnna$aConditions, Preneoplastic
=450  \\$wnnna$aPrecancerous Condition
=450  \\$wnnna$aPreneoplastic Condition
=450  \\$aPreneoplastic Conditions
=550  \\$wg$aNeoplasms
=550  \\$wh$aAberrant Crypt Foci
=550  \\$wh$aErythroplasia
=550  \\$wh$aKeratosis, Actinic
=550  \\$wh$aLeukoplakia
=550  \\$wh$aLymphomatoid Granulomatosis
=550  \\$wh$aPreleukemia
=550  \\$wh$aSmoldering Multiple Myeloma
=550  \\$wh$aUterine Cervical Dysplasia
=550  \\$wh$aXeroderma Pigmentosum
=550  \\$aHyperplasia
=550  \\$aNeoplasms
=667  \\$aIM; do not use /compl for develop into cancer: use /pathol; coord IM with organ/neopl term (IM); Manual 24.4.1.13
=680  \\$iPathological processes that tend eventually to become malignant. (From Dorland, 27th ed)
=688  \\$a68
=750  \0$aPrecancerous conditions$5IEN$0(DLC)sh 85106190

=LDR  00707cz  a2200229n  4500
=001  9880363843602441
=005  20141212204800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011229
=035  \\$aCBA4520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x806
=072  \\$aE4.$x604.$x750.$x619
=150  \\$aPreanesthetic Medication
=450  \\$wnnna$aMedication, Preanesthetic
=450  \\$wnnna$aMedications, Preanesthetic
=450  \\$wnnna$aPreanesthetic Medications
=550  \\$wg$aAnesthesia and Analgesia
=550  \\$wg$aPreoperative Care
=550  \\$aPremedication
=667  \\$ado not use /util except by MeSH definition
=750  \0$aPreanesthetic medication$5IEN$0(DLC)sh 85106188

=LDR  02172cz  a2200505n  4500
=001  9880363843702441
=005  20141212204759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011225
=035  \\$aCBA4516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x395.$x249
=150  \\$aPre-Eclampsia
=450  \\$wnnna$aEdema-Proteinuria-Hypertension Gestosis
=450  \\$wnnna$aEdema Proteinuria Hypertension Gestosis
=450  \\$wnnna$aEPH Complex
=450  \\$wnnna$aEPH Gestosis
=450  \\$wnnna$aEPH Toxemia
=450  \\$wnnna$aEPH Toxemias
=450  \\$wnnna$aGestosis, Edema-Proteinuria-Hypertension
=450  \\$wnnna$aGestosis, EPH
=450  \\$wnnna$aGestosis, Hypertension-Edema-Proteinuria
=450  \\$wnnna$aGestosis, Proteinuria-Edema-Hypertension
=450  \\$wnnna$aHypertension-Edema-Proteinuria Gestosis
=450  \\$wnnna$aHypertension Edema Proteinuria Gestosis
=450  \\$wnnna$aPre Eclampsia
=450  \\$wnnna$aPreeclampsia
=450  \\$wnnna$aPreeclampsia/Eclampsia 1
=450  \\$wnnna$aPregnancy Toxemia
=450  \\$wnnna$aPregnancy Toxemias
=450  \\$wnnna$aProteinuria-Edema-Hypertension Gestosis
=450  \\$wnnna$aProteinuria Edema Hypertension Gestosis
=450  \\$wnnna$aToxemia, EPH
=450  \\$wnnna$aToxemia Of Pregnancy
=450  \\$wnnna$aToxemia, Pregnancy
=450  \\$wnnna$aToxemias, EPH
=450  \\$aToxemias, Pregnancy
=550  \\$wg$aHypertension, Pregnancy-Induced
=550  \\$aToxemia
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iA complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
=688  \\$a1979(1963)
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Gestosis, EPH
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Pregnancy Toxemias
=750  \0$aPreeclampsia$0(DLC) sh 91004039$5IEN-M

=LDR  01022cz  a2200289n  4500
=001  9880363843802441
=005  20141212204758.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011224
=035  \\$aCBA4515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x786.$x750
=150  \\$aPrazosin
=450  \\$wnnna$aDouglas Brand of Prazosin Hydrochloride
=450  \\$aFurazosin
=450  \\$wnnna$aHCL, Prazosin
=450  \\$wnnna$aHydrochloride, Prazosin
=450  \\$wnnna$aMinipress
=450  \\$wnnna$aPfizer Brand of Prazosin Hydrochloride
=450  \\$wnnna$aPratsiol
=450  \\$wnnna$aPrazosin HCL
=450  \\$wnnna$aPrazosin Hydrochloride
=550  \\$wg$aQuinazolines
=550  \\$wh$aDoxazosin
=680  \\$iA selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
=688  \\$a86(77); was see under QUINAZOLINES 1977-85
=750  \0$aPrazosin$5IEN$0(DLC)sh 85106152

=LDR  00730cz  a2200193n  4500
=001  9880363843902441
=005  20141212204757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011221
=035  \\$aCBA4512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x750
=072  \\$aD1.$x268.$x558.$x362.$x750
=072  \\$aD1.$x552.$x550.$x399.$x750
=150  \\$aPraseodymium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Pr-141; Pr-134-140, 142-148 = PRASEODYMIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iPraseodymium. An element of the rare earth family of metals. It has the atomic symbol Pr, atomic number 59, and atomic weight 140.91.
=750  \0$aPraseodymium$5IEN$0(DLC)sh 85106095

=LDR  02129cz  a2200505n  4500
=001  9880363844002441
=005  20141212204756.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011218
=035  \\$aCBA4509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x690
=072  \\$aC16.$x131.$x77.$x730
=072  \\$aC16.$x131.$x260.$x700
=072  \\$aC16.$x320.$x180.$x700
=072  \\$aC18.$x654.$x726.$x500.$x740
=150  \\$aPrader-Willi Syndrome
=450  \\$wnnna$aLabhart-Willi-Prader-Fanconi Syndrome
=450  \\$wnnna$aLabhart Willi Prader Fanconi Syndrome
=450  \\$aLabhart-Willi Syndrome
=450  \\$wnnna$aLabhart Willi Syndrome
=450  \\$wnnna$aPrader Labhart Willi Syndrome
=450  \\$wnnna$aPrader-Labhart-Willi Syndrome
=450  \\$wnnna$aPrader Willi Syndrome
=450  \\$aRoyer Syndrome
=450  \\$wnnna$aRoyer's Syndrome
=450  \\$wnnna$aRoyers Syndrome
=450  \\$wnnna$aSyndrome, Labhart-Willi
=450  \\$wnnna$aSyndrome, Labhart-Willi-Prader-Fanconi
=450  \\$wnnna$aSyndrome, Prader-Labhart-Willi
=450  \\$wnnna$aSyndrome, Prader-Willi
=450  \\$wnnna$aSyndrome, Royer
=450  \\$wnnna$aSyndrome, Royer's
=450  \\$wnnna$aSyndrome, Willi-Prader
=450  \\$wnnna$aWilli-Prader Syndrome
=450  \\$wnnna$aWilli Prader Syndrome
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aIntellectual Disability
=550  \\$wg$aObesity
=550  \\$aIntellectual Disability
=680  \\$iAn autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)
=688  \\$a1977
=688  \\$a77
=750  \0$aPrader-Willi syndrome$5IEN$0(DLC)sh 85106050

=LDR  00899cz  a2200289n  4500
=001  9880363844102441
=005  20141212204755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011217
=035  \\$aCBA4508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x705
=072  \\$aD2.$x33.$x755.$x624.$x698.$x705
=072  \\$aD2.$x65.$x199.$x92.$x800
=072  \\$aD2.$x92.$x63.$x624.$x698.$x705
=150  \\$aPractolol
=450  \\$wnnna$aDalzic
=450  \\$wnnna$aEralzdin Practolol
=450  \\$wnnna$aICI-50172
=450  \\$wnnna$aICI 50172
=450  \\$wnnna$aICI50172
=450  \\$wnnna$aPractolol, Eralzdin
=550  \\$wg$aAcetanilides
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
=688  \\$a74
=750  \0$aPractolol$5IEN$0(DLC)sh 85106049

=LDR  01129cz  a2200301n  4500
=001  9880363844202441
=005  20161221104900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011216
=035  \\$aCBA4507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x708.$x450
=150  \\$aPractice Management, Medical
=450  \\$wnnna$aManagement, Medical Practice
=450  \\$wnnna$aManagements, Medical Practice
=450  \\$wnnna$aMedical Practice Management
=450  \\$aMedical Practice Management Services
=450  \\$wnnna$aMedical Practice Managements
=450  \\$wnnna$aPractice Management Services, Medical
=450  \\$wnnna$aPractice Managements, Medical
=550  \\$wg$aPractice Management
=550  \\$wh$aConcierge Medicine
=550  \\$aProfessional Practice
=667  \\$aDF: PRACTICE MANAGEMENT MED
=680  \\$iThe organization and operation of the business aspects of a physician's practice.
=688  \\$a2015(1968); for MEDICAL PRACTICE MANAGEMENT SERVICES use PRACTICE MANAGEMENT 1968-2014
=688  \\$a68
=750  \0$aMedical offices$xManagement$5IEN$0(DLC)sh2008107646

=LDR  00925cz  a2200253n  4500
=001  9880363844302441
=005  20141212192436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011215
=035  \\$aCBA4506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x708.$x300
=150  \\$aPractice Management, Dental
=450  \\$wnnna$aDental Practice Management
=450  \\$aDental Practice Management Services
=450  \\$wnnna$aManagement, Dental Practice
=450  \\$wnnna$aPractice Management Services, Dental
=550  \\$wg$aPractice Management
=550  \\$aProfessional Practice
=667  \\$aDF: PRACTICE MANAGEMENT DENT
=680  \\$iThe organization and operation of the business aspects of a dental practice.
=688  \\$a2015(1968); for DENTAL PRACTICE MANAGEMENT SERVICES use PRACTICE MANAGEMENT 1968-2014
=688  \\$a68
=750  \0$aDental offices$xManagement$5IEN$0(DLC)sh2009123192

=LDR  01520cz  a2200469n  4500
=001  9880363844402441
=005  20141212204755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011213
=035  \\$aCBA4504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743
=150  \\$aPoxviridae Infections
=450  \\$wnnna$aInfection, Poxviridae
=450  \\$wnnna$aInfection, Poxvirus
=450  \\$wnnna$aInfections, Poxviridae
=450  \\$wnnna$aInfections, Poxvirus
=450  \\$wnnna$aMilker Nodes
=450  \\$wnnna$aMilker's Node
=450  \\$aMilker's Nodes
=450  \\$wnnna$aMilkers Nodes
=450  \\$wnnna$aNode, Milker's
=450  \\$wnnna$aNodes, Milker's
=450  \\$wnnna$aPoxviridae Infection
=450  \\$aPoxvirus Diseases$5IEN-M
=450  \\$wnnna$aPoxvirus Infection
=450  \\$aPoxvirus Infections
=550  \\$wg$aDNA Virus Infections
=550  \\$wh$aCowpox
=550  \\$wh$aEcthyma, Contagious
=550  \\$wh$aEctromelia, Infectious
=550  \\$wh$aFowlpox
=550  \\$wh$aLumpy Skin Disease
=550  \\$wh$aMolluscum Contagiosum
=550  \\$wh$aMonkeypox
=550  \\$wh$aMyxomatosis, Infectious
=550  \\$wh$aSmallpox
=550  \\$wh$aVaccinia
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the POXVIRIDAE.
=688  \\$a94; was POXVIRUS INFECTIONS 1963-93; MILKER'S NODES was heading 1975-96 (see under POXVIRUS INFECTIONS 1975-90)
=750  \0$aPoxvirus diseases$5IEN-M$0(DLC)sh 85106027

=LDR  00876cz  a2200229n  4500
=001  9880363844502441
=005  20141212204754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011212
=035  \\$aCBA4503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x650
=072  \\$aB4.$x909.$x204.$x783
=150  \\$aPoxviridae
=450  \\$wnnna$aPoxviruses
=550  \\$wg$aDNA Viruses
=550  \\$wh$aChordopoxvirinae
=550  \\$wh$aEntomopoxvirinae
=667  \\$aa family of DNA viruses; infection = POXVIRIDAE INFECTIONS
=680  \\$iA family of double-stranded DNA viruses infecting mammals (including humans), birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects.
=688  \\$a81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74
=750  \0$aPoxviruses$5IEN$0(DLC)sh 85106028

=LDR  01313cz  a2200373n  4500
=001  9880363844602441
=005  20141212204754.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011211
=035  \\$aCBA4502HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x124
=150  \\$aElectric Power Supplies
=450  \\$wnnna$aElectric Power Source
=450  \\$wnnna$aElectric Power Sources
=450  \\$wnnna$aElectric Power Supply
=450  \\$wnnna$aPower Source
=450  \\$wnnna$aPower Source, Electric
=450  \\$aPower Sources
=450  \\$wnnna$aPower Sources, Electric
=450  \\$aPower Supplies
=450  \\$wnnna$aPower Supplies, Electric
=450  \\$wnnna$aPower Supply
=450  \\$wnnna$aPower Supply, Electric
=450  \\$wnnna$aSupply, Electric Power
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wh$aBioelectric Energy Sources
=550  \\$aEnergy-Generating Resources
=667  \\$ado not confuse with POWER PLANTS which are on an industrial level
=680  \\$iDevices that control the supply of electric current for running electrical equipment.
=688  \\$a2006 (1977)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Power Sources
=688  \\$a77
=750  \0$aElectric power supplies to apparatus$0(DLC) sh 85041917$5IEN-M

=LDR  01808cz  a2200493n  4500
=001  9880363844702441
=005  20180816122835.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011210
=035  \\$aCBA4501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x780
=072  \\$aJ3.$x540.$x680
=150  \\$aPower Plants
=450  \\$wnnna$aElectric Power Plant
=450  \\$aElectric Power Plants
=450  \\$wnnna$aHydroelectric Power Plant
=450  \\$aHydroelectric Power Plants
=450  \\$wnnna$aPlant, Electric Power
=450  \\$wnnna$aPlant, Hydroelectric Power
=450  \\$wnnna$aPlant, Power
=450  \\$wnnna$aPlant, Thermoelectric Power
=450  \\$wnnna$aPlants, Electric Power
=450  \\$wnnna$aPlants, Hydroelectric Power
=450  \\$wnnna$aPlants, Power
=450  \\$wnnna$aPlants, Thermoelectric Power
=450  \\$wnnna$aPower Plant
=450  \\$wnnna$aPower Plant, Electric
=450  \\$wnnna$aPower Plant, Hydroelectric
=450  \\$wnnna$aPower Plant, Thermoelectric
=450  \\$wnnna$aPower Plants, Electric
=450  \\$wnnna$aPower Plants, Hydroelectric
=450  \\$wnnna$aPower Plants, Thermoelectric
=450  \\$wnnna$aThermoelectric Power Plant
=450  \\$aThermoelectric Power Plants
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wg$aManufacturing and Industrial Facilities
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aNuclear Power Plants
=550  \\$aEnergy-Generating Resources
=667  \\$aon an industrial & technology level: differentiate from POWER SOURCES; coordinate IM with source of power (IM) if pertinent
=680  \\$iUnits that convert some other form of energy into electrical energy.
=688  \\$a77
=750  \0$aPower-plants$0(DLC) sh 85105986$5IEN

=LDR  00802cz  a2200169n  4500
=001  9880363844902441
=005  20141212192436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011208
=035  \\$aCBA4499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x779
=150  \\$aPowders
=550  \\$wg$aDosage Forms
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in powder form, not the powder
=680  \\$iSubstances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)
=750  \0$aPowders (Pharmacy)$5IEN-M$0(DLC)sh 85105964

=LDR  01888cz  a2200541n  4500
=001  9880363845002441
=005  20141212204753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011206
=035  \\$aCBA4497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x475.$x557.$x500
=072  \\$aD2.$x455.$x326.$x271.$x884.$x533.$x710
=072  \\$aD3.$x383.$x773.$x812.$x615.$x630
=072  \\$aD5.$x750.$x716.$x721.$x838.$x745
=072  \\$aD25.$x720.$x716.$x721.$x838.$x745
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x721.$x838.$x745
=150  \\$aPovidone-Iodine
=450  \\$wnnna$aAlphadine
=450  \\$wnnna$aAlphadines
=450  \\$wnnna$aBetadine
=450  \\$wnnna$aBetadines
=450  \\$wnnna$aBetaisodona
=450  \\$wnnna$aBetaisodonas
=450  \\$wnnna$aDisadine
=450  \\$wnnna$aDisadines
=450  \\$wnnna$aHuntington Laboratories Brand of Povidone-Iodine
=450  \\$wnnna$aHuntington Laboratories Brand of Povidone Iodine
=450  \\$wnnna$aIsodine
=450  \\$wnnna$aIsodines
=450  \\$wnnna$aPharmadine
=450  \\$wnnna$aPharmadines
=450  \\$aPolyvinylpyrrolidone Iodine
=450  \\$wnnna$aPolyvinylpyrrolidone Iodines
=450  \\$wnnna$aPovidone Iodine
=450  \\$wnnna$aPovidone-Iodines
=450  \\$wnnna$aProvidine
=450  \\$wnnna$aProvidines
=450  \\$wnnna$aPVP-I
=450  \\$aPVP-Iodine
=450  \\$wnnna$aPVP Iodine
=450  \\$wnnna$aPVP-Iodines
=550  \\$wg$aIodophors
=550  \\$wg$aPolyvinyls
=550  \\$wg$aPovidone
=680  \\$iAn iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.
=688  \\$a91(66); was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80
=750  \0$aPovidone-iodine$5IEN$0(DLC)sh 85105954

=LDR  02537cz  a2200769n  4500
=001  9880363845102441
=005  20141212192435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011205
=035  \\$aCBA4496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x884.$x533.$x699
=072  \\$aD3.$x383.$x773.$x812.$x615
=072  \\$aD5.$x750.$x716.$x721.$x838
=072  \\$aD25.$x720.$x716.$x721.$x838
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x721.$x838
=150  \\$aPovidone
=450  \\$wnnna$aAlcon Brand of Povidone
=450  \\$wnnna$aAllergan Brand of Povidone
=450  \\$wnnna$aArufil
=450  \\$wnnna$aBolinan
=450  \\$wnnna$aBolinan 40
=450  \\$wnnna$aChauvin Brand of Povidone
=450  \\$wnnna$aCiba Vision Brand of Povidone
=450  \\$wnnna$aCrospovidone
=450  \\$wnnna$aDulcilarmes
=450  \\$wnnna$aDuratears Free
=450  \\$wnnna$aEnterodes
=450  \\$wnnna$aEnterodez
=450  \\$wnnna$aHamilton Brand of Povidone
=450  \\$wnnna$aHypotears
=450  \\$wnnna$aKollidon
=450  \\$wnnna$aLacophtal
=450  \\$wnnna$aLacri-Stulln
=450  \\$wnnna$aLagrifilm
=450  \\$wnnna$aLiquifilm Lagrimas
=450  \\$wnnna$aMann Brand of Povidone
=450  \\$wnnna$aNovartis Brand of Povidone
=450  \\$wnnna$aNovartis Ophthalmics Brand of Povidone
=450  \\$wnnna$aNutrivisc
=450  \\$wnnna$aOculotect
=450  \\$wnnna$aPeriston
=450  \\$wnnna$aPlasdone
=450  \\$aPolvidone
=450  \\$wnnna$aPolyplasdone XL
=450  \\$aPolyvidon
=450  \\$aPolyvinylpyrrolidone
=450  \\$wnnna$aProtagens
=450  \\$wnnna$aProtagent
=450  \\$wnnna$aPVP 40
=450  \\$wnnna$aRoche Brand of Povidone
=450  \\$wnnna$aStulln Brand of Povidone
=450  \\$wnnna$aThéa Brand of Povidone
=450  \\$wnnna$aTramedico Brand of Povidone
=450  \\$wnnna$aUnifluid
=450  \\$wnnna$aUrsapharm Brand of Povidone
=450  \\$wnnna$aVidirakt S mit PVP
=450  \\$wnnna$aVidisic PVP Ophtiole
=450  \\$wnnna$aWet-Comod
=450  \\$wnnna$aWinzer Brand of Povidone
=550  \\$wg$aPolyvinyls
=550  \\$wg$aPyrrolidinones
=550  \\$wh$aPovidone-Iodine
=667  \\$aD25-26 qualif
=680  \\$iA polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.
=688  \\$a81; was POLYVINYLPYRROLIDONE 1963-80
=750  \0$aPovidone$5IEN$0(DLC)sh 85105953

=LDR  00873cz  a2200277n  4500
=001  9880363845202441
=005  20141212192435.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011204
=035  \\$aCBA4495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x535.$x550
=072  \\$aN1.$x824.$x600.$x550
=150  \\$aPoverty Areas
=450  \\$wnnna$aArea, Poverty
=450  \\$wnnna$aAreas, Poverty
=450  \\$wnnna$aGhetto
=450  \\$aGhettos
=450  \\$wnnna$aPoverty Area
=450  \\$wnnna$aSlum
=450  \\$aSlums
=550  \\$wg$aPoverty
=667  \\$ano qualif; specify geog
=680  \\$iCity, urban, rural, or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay.
=688  \\$a91(80); was see under POVERTY 1980-90
=750  \0$aSlums$5IEN$0(DLC)sh 85123553

=LDR  01202cz  a2200361n  4500
=001  9880363845302441
=005  20141212192434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011203
=035  \\$aCBA4494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x634
=072  \\$aI1.$x880.$x853.$x996.$x535
=072  \\$aN1.$x824.$x600
=150  \\$aPoverty
=450  \\$aIndigency
=450  \\$wnnna$aIndigent
=450  \\$wnnna$aIndigents
=450  \\$wnnna$aLow Income Population
=450  \\$aLow-Income Population
=450  \\$wnnna$aLow Income Populations
=450  \\$wnnna$aLow-Income Populations
=450  \\$wnnna$aPopulation, Low Income
=450  \\$wnnna$aPopulation, Low-Income
=450  \\$wnnna$aPopulations, Low Income
=450  \\$wnnna$aPopulations, Low-Income
=550  \\$wg$aSocial Problems
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aPoverty Areas
=667  \\$aspecify geog if pertinent
=680  \\$iA situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.
=688  \\$a68
=750  \0$aPoverty$5IEN-M$0(DLC)sh 85105939

=LDR  01256cz  a2200241n  4500
=001  9880363845402441
=005  20141212204752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011201
=035  \\$aCBA4492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x131.$x728
=150  \\$aPoultry Diseases
=450  \\$wnnna$aDisease, Poultry
=450  \\$wnnna$aDiseases, Poultry
=450  \\$wnnna$aPoultry Disease
=550  \\$wg$aBird Diseases
=550  \\$wh$aEnteritis, Transmissible, of Turkeys
=550  \\$wh$aInfluenza in Birds
=550  \\$wh$aPoult Enteritis Mortality Syndrome
=667  \\$acoord IM with specific poultry (IM); for abnormalities or injuries, index under POULTRY /abnorm or POULTRY /inj; don't forget also POULTRY (NIM) if no specific fowl is indexed; also check tag ANIMALS; differentiate from BIRD DISEASES on basis of definition of BIRDS & POULTRY under POULTRY
=680  \\$iDiseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild.
=750  \0$aPoultry$xDiseases$5IEN$0(DLC)sh 85105896

=LDR  01191cz  a2200337n  4500
=001  9880363845502441
=005  20141212192434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011200
=035  \\$aCBA4491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x625
=072  \\$aB1.$x50.$x150.$x900.$x248.$x617
=072  \\$aJ2.$x500.$x600.$x750
=150  \\$aPoultry
=450  \\$wnnna$aDomestic Fowl
=450  \\$wnnna$aDomestic Fowls
=450  \\$wnnna$aFowl, Domestic
=450  \\$aFowls, Domestic
=450  \\$wnnna$aPoultries
=550  \\$wg$aAnimals, Domestic
=550  \\$wg$aBirds
=550  \\$wg$aMeat
=550  \\$wh$aChickens
=550  \\$wh$aDucks
=550  \\$wh$aGeese
=550  \\$wh$aPoultry Products
=550  \\$wh$aTurkeys
=667  \\$ageneral or unspecified; prefer specifics; differentiate from BIRDS: "birds" in zoos, parks, forest, streets, pet shops = BIRDS, "birds" in barnyard, hatchery, butcher shop = POULTRY; canned poultry meat: see note at POULTRY PRODUCTS
=680  \\$iDomesticated birds raised for food. It typically includes CHICKENS; TURKEYS, DUCKS; GEESE; and others.
=750  \0$aPoultry$5IEN$0(DLC)sh 85105892

=LDR  00750cz  a2200205n  4500
=001  9880363845602441
=005  20141212204752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011199
=035  \\$aCBA4490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x922.$x750
=072  \\$aE5.$x301.$x710
=150  \\$aPotentiometry
=550  \\$wg$aElectrochemical Techniques
=550  \\$wg$aTitrimetry
=667  \\$aa type of titrimetry; NIM
=680  \\$iSolution titration in which the end point is read from the electrode-potential variations with the concentrations of potential determining ions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a67(64)
=750  \0$aPotentiometry$5IEN$0(DLC)sh 86007819

=LDR  01136cz  a2200241n  4500
=001  9880363845702441
=005  20141212204751.0
=008  850503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011198
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x725.$x777
=072  \\$aJ2.$x500.$x850.$x790
=150  \\$aSolanum tuberosum
=450  \\$wnnna$aPotato
=450  \\$aPotatoes
=550  \\$wg$aSolanum
=550  \\$wg$aVegetables
=667  \\$aSolanum tuberosum only: does not include sweet potatoes ( = SWEET POTATO see IPOMOEA BATATAS); coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus SOLANUM, family SOLANACEAE. The starchy roots are used as food. SOLANINE is found in green parts.
=688  \\$a2006(1986)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Potatoes
=688  \\$a86
=750  \0$aPotatoes$0(DLC) sh 85101652$5IEN

=LDR  00732cz  a2200193n  4500
=001  9880363845802441
=005  20141212204751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011196
=035  \\$aCBA4487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x530.$x700
=072  \\$aD1.$x745.$x750
=150  \\$aPotassium Permanganate
=450  \\$wnnna$aPermanganate, Potassium
=550  \\$wg$aManganese Compounds
=550  \\$wg$aPotassium Compounds
=680  \\$iPermanganic acid (HMnO4), potassium salt. A highly oxidative, water-soluble compound with purple crystals, and a sweet taste. (From McGraw-Hill Dictionary of Scientific and Technical Information, 4th ed)
=750  \0$aPotassium permanganate$5IEN$0(DLC)sh 85105616

=LDR  00678cz  a2200205n  4500
=001  9880363845902441
=005  20141212204750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011194
=035  \\$aCBA4485HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x705
=150  \\$aPotassium Isotopes
=450  \\$wnnna$aIsotopes, Potassium
=550  \\$wg$aIsotopes
=550  \\$wh$aPotassium Radioisotopes
=550  \\$aPotassium
=667  \\$aK-41; NIM
=680  \\$iStable potassium atoms that have the same atomic number as the element potassium, but differ in atomic weight. K-41 is a stable potassium isotope.
=750  \0$aPotassium$xIsotopes$5IEN$0(DLC)sh 85105594

=LDR  02179cz  a2200613n  4500
=001  9880363846002441
=005  20141212192433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011193
=035  \\$aCBA4484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x475.$x410.$x700
=072  \\$aD1.$x745.$x680
=150  \\$aPotassium Iodide
=450  \\$wnnna$aAnbex Brand of Potassium Iodide
=450  \\$wnnna$aAntistrumin
=450  \\$wnnna$abetapharm Brand of Potassium Iodide
=450  \\$wnnna$aFleming Brand of Potassium Iodide
=450  \\$wnnna$aHenning Berlin Brand of Potassium Iodide
=450  \\$wnnna$aHexal Brand of Potassium Iodide
=450  \\$wnnna$aIodide, Potassium
=450  \\$wnnna$aIoduro Potasico Rovi
=450  \\$wnnna$aIosat
=450  \\$wnnna$aJod beta
=450  \\$wnnna$aJodetten Henning
=450  \\$wnnna$aJodgamma
=450  \\$wnnna$aJodid
=450  \\$wnnna$aJodid dura
=450  \\$wnnna$aJodid Hexal
=450  \\$wnnna$aJodid-ratiopharm
=450  \\$wnnna$aJodid ratiopharm
=450  \\$wnnna$aJodid Verla
=450  \\$wnnna$aMerck Brand of Potassium Iodide
=450  \\$wnnna$aMerck dura Brand of Potassium Iodide
=450  \\$wnnna$aMono-Jod
=450  \\$wnnna$aMono Jod
=450  \\$wnnna$aPhilopharm Brand of Potassium Iodide
=450  \\$wnnna$aPima
=450  \\$wnnna$aratiopharm Brand of Potassium Iodide
=450  \\$wnnna$aRovi Brand of Potassium Iodide
=450  \\$wnnna$aSSKI
=450  \\$wnnna$aThyro-Block
=450  \\$wnnna$aThyro Block
=450  \\$wnnna$aThyroprotect
=450  \\$wnnna$aUpsher-Smith Brand of Potassium Iodide
=450  \\$wnnna$aVerla Brand of Potassium Iodide
=450  \\$wnnna$aWörwag Brand of Potassium Iodide
=450  \\$wnnna$aWallace Brand of Potassium Iodide
=550  \\$wg$aIodides
=550  \\$wg$aPotassium Compounds
=667  \\$auseful source of iodine in thyrotoxic crisis
=680  \\$iAn inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
=688  \\$a65
=750  \0$aPotassium iodide$5IEN$0(DLC)sh 85105614

=LDR  01059cz  a2200253n  4500
=001  9880363846102441
=005  20141212204750.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011192
=035  \\$aCBA4483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x220.$x150.$x650
=072  \\$aD1.$x745.$x650
=150  \\$aPotassium Dichromate
=450  \\$wnnna$aBichromate, Potassium
=450  \\$wnnna$aDichromate, Potassium
=450  \\$wnnna$aK2Cr2O7
=450  \\$aPotassium Bichromate
=550  \\$wg$aChromates
=550  \\$wg$aPotassium Compounds
=667  \\$aan astringent, caustic, antiseptic & dye
=680  \\$iChromic acid (H2Cr2O7), dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison.
=688  \\$a91(75); was see under CHROMATES 1975-90
=750  \0$aPotassium dichromate$5IEN$0(DLC)sh 85105608

=LDR  01302cz  a2200217n  4500
=001  9880363846202441
=005  20141212204750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011191
=035  \\$aCBA4482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x617
=150  \\$aPotassium Deficiency
=450  \\$wnnna$aDeficiencies, Potassium
=450  \\$wnnna$aDeficiency, Potassium
=450  \\$wnnna$aPotassium Deficiencies
=450  \\$aPotassium$xdeficiency
=550  \\$wg$aDeficiency Diseases
=667  \\$aDF: POTASSIUM DEFIC
=680  \\$iA condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)
=750  \0$aPotassium deficiency diseases$5IEN$0(DLC)sh 85105606

=LDR  00880cz  a2200229n  4500
=001  9880363846302441
=005  20141212204749.0
=008  780313\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011190
=035  \\$aCBA4481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x400.$x100.$x750
=072  \\$aD1.$x745.$x635
=150  \\$aPotassium Cyanide
=450  \\$wnnna$aCyanide, Potassium
=450  \\$wnnna$aPotassium Cyanide (K(14)CN)
=450  \\$wnnna$aPotassium Cyanide (K(C(15)N))
=550  \\$wg$aCyanides
=550  \\$wg$aPotassium Compounds
=680  \\$iA highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes.
=688  \\$a91(79); was see under CYANIDES 1979-90
=750  \0$aPotassium cyanide$5IEN$0(DLC)sh 85105605

=LDR  00758cz  a2200217n  4500
=001  9880363846402441
=005  20141212204749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011189
=035  \\$aCBA4480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150.$x750
=072  \\$aD1.$x745.$x625
=150  \\$aPotassium Chloride
=450  \\$wnnna$aChloride, Potassium
=450  \\$wnnna$aSlow-K
=550  \\$wg$aChlorides
=550  \\$wg$aPotassium Compounds
=680  \\$iA white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
=688  \\$a66(64)
=750  \0$aPotassium chloride$5IEN$0(DLC)sh 85105603

=LDR  01361cz  a2200361n  4500
=001  9880363846502441
=005  20141212210922.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015221
=035  \\$aCBA4479HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x600
=072  \\$aD12.$x776.$x543.$x550.$x425.$x750
=072  \\$aD12.$x776.$x543.$x585.$x400.$x750
=150  \\$aPotassium Channels
=450  \\$wnnna$aChannel, Potassium
=450  \\$wnnna$aChannel, Potassium Ion
=450  \\$wnnna$aChannels, Potassium
=450  \\$wnnna$aChannels, Potassium Ion
=450  \\$wnnna$aIon Channel, Potassium
=450  \\$aIon Channels, Potassium
=450  \\$wnnna$aPotassium Channel
=450  \\$wnnna$aPotassium Ion Channel
=450  \\$wnnna$aPotassium Ion Channels
=550  \\$wg$aIon Channels
=550  \\$wh$aPotassium Channels, Calcium-Activated
=550  \\$wh$aPotassium Channels, Inwardly Rectifying
=550  \\$wh$aPotassium Channels, Tandem Pore Domain
=550  \\$wh$aPotassium Channels, Voltage-Gated
=667  \\$aDF: K CHANNELS
=680  \\$iCell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.
=688  \\$a89
=750  \0$aPotassium channels$5IEN$0(DLC)sh 89005133

=LDR  00972cz  a2200217n  4500
=001  9880363846602441
=005  20141212192433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011188
=035  \\$aCBA4478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549.$x550
=072  \\$aD1.$x268.$x557.$x575
=072  \\$aD1.$x552.$x528.$x652
=072  \\$aD1.$x552.$x547.$x650
=150  \\$aPotassium
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Light
=667  \\$a/blood: note also HYPERKALEMIA and HYPOKALEMIA; POTASSIUM, DIETARY is also available
=680  \\$iAn element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
=750  \0$aPotassium$5IEN-M$0(DLC)sh 85105593

=LDR  00863cz  a2200277n  4500
=001  9880363846702441
=005  20141212204749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011187
=035  \\$aCBA4477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x695
=150  \\$aPosture
=450  \\$wnnna$aPostures
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wh$aHead-Down Tilt
=550  \\$wh$aKnee-Chest Position
=550  \\$wh$aProne Position
=550  \\$wh$aSupine Position
=550  \\$aHypotension, Orthostatic
=550  \\$aKinesics
=550  \\$aPatient Positioning
=667  \\$aPRONE POSITION; SUPINE POSITION; & HEAD-DOWN TILT are also available
=680  \\$iThe position or attitude of the body.
=750  \0$aPosture disorders$5IEN-M$0(DLC)sh 85105573
=750  \0$aPosture$5IEN-HS$0(DLC)sh 85105571

=LDR  01172cz  a2200277n  4500
=001  9880363846802441
=005  20141212204748.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011185
=035  \\$aCBA4475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x793
=072  \\$aC23.$x550.$x767.$x863
=150  \\$aPostpericardiotomy Syndrome
=450  \\$aPostcommissurotomy Syndrome
=450  \\$wnnna$aPostcommissurotomy Syndromes
=450  \\$wnnna$aPostpericardiotomy Syndromes
=450  \\$wnnna$aSyndrome, Postcommissurotomy
=450  \\$wnnna$aSyndrome, Postpericardiotomy
=450  \\$wnnna$aSyndromes, Postcommissurotomy
=450  \\$wnnna$aSyndromes, Postpericardiotomy
=550  \\$wg$aHeart Diseases
=550  \\$wg$aPostoperative Complications
=680  \\$iA nonspecific hypersensitivity reaction caused by TRAUMA to the PERICARDIUM, often following PERICARDIOTOMY. It is characterized by PERICARDIAL EFFUSION; high titers of anti-heart antibodies; low-grade FEVER; LETHARGY; loss of APPETITE; or ABDOMINAL PAIN.
=688  \\$a91(65); was see under HEART DISEASES 1965-90
=750  \0$aPostpericardiotomy syndrome$5IEN$0(DLC)sh 85105567

=LDR  00827cz  a2200241n  4500
=001  9880363846902441
=005  20141212204748.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011184
=035  \\$aCBA4474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x614.$x750
=072  \\$aN2.$x421.$x585.$x753.$x750
=150  \\$aPostoperative Period
=450  \\$wnnna$aPeriod, Postoperative
=450  \\$wnnna$aPeriods, Postoperative
=450  \\$wnnna$aPostoperative Periods
=550  \\$wg$aPerioperative Period
=550  \\$wh$aAnesthesia Recovery Period
=667  \\$aalmost never IM; no qualif; DF: POSTOP PERIOD
=680  \\$iThe period following a surgical operation.
=688  \\$a86(79); was see under SURGERY, OPERATIVE 1979-85, was in Cat E & H 1979-81
=750  \0$aPostoperative period$5IEN$0(DLC)sh 87006455

=LDR  02177cz  a2200541n  4500
=001  9880363847002441
=005  20180618134232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011183
=035  \\$aCBA4473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x767
=150  \\$aPostoperative Complications
=450  \\$wnnna$aComplication, Postoperative
=450  \\$wnnna$aComplications, Postoperative
=450  \\$wnnna$aPostoperative Complication
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAfferent Loop Syndrome
=550  \\$wh$aAnastomotic Leak
=550  \\$wh$aBreast Cancer Lymphedema
=550  \\$wh$aCorneal Endothelial Cell Loss
=550  \\$wh$aCoronary-Subclavian Steal Syndrome
=550  \\$wh$aDelayed Emergence from Anesthesia
=550  \\$wh$aEmergence Delirium
=550  \\$wh$aFailed Back Surgery Syndrome
=550  \\$wh$aGraft Occlusion, Vascular
=550  \\$wh$aIncisional Hernia
=550  \\$wh$aMalignant Hyperthermia
=550  \\$wh$aPain, Postoperative
=550  \\$wh$aPostcholecystectomy Syndrome
=550  \\$wh$aPostgastrectomy Syndromes
=550  \\$wh$aPostoperative Hemorrhage
=550  \\$wh$aPostoperative Nausea and Vomiting
=550  \\$wh$aPostpericardiotomy Syndrome
=550  \\$wh$aProsthesis Failure
=550  \\$wh$aProsthesis-Related Infections
=550  \\$wh$aReperfusion Injury
=550  \\$wh$aShock, Surgical
=550  \\$wh$aShort Bowel Syndrome
=550  \\$wh$aSlit Ventricle Syndrome
=550  \\$wh$aSurgical Wound Dehiscence
=550  \\$wh$aSurgical Wound Infection
=550  \\$wh$aVasoplegia
=550  \\$aSurgical Procedures, Operative
=667  \\$acoordinate IM with specific postoperative complication (IM); not restricted to immediate postoperative period; differentiate from specific surgical procedure terms with / adv eff: Manual 23.18+
=680  \\$iPathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
=688  \\$a64
=750  \0$aSurgery$xComplications$5IEN$0(DLC)sh 85130768

=LDR  01000cz  a2200265n  4500
=001  9880363847102441
=005  20141212204747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011182
=035  \\$aCBA4472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x731.$x700
=072  \\$aE4.$x604.$x500
=072  \\$aN2.$x421.$x585.$x722.$x700
=150  \\$aPostoperative Care
=450  \\$aCare, Postoperative
=450  \\$wnnna$aPostoperative Procedure
=450  \\$wnnna$aPostoperative Procedures
=450  \\$wnnna$aProcedure, Postoperative
=450  \\$wnnna$aProcedures, Postoperative
=550  \\$wg$aPerioperative Care
=550  \\$aPhysical Therapy Modalities
=667  \\$aDF: POSTOP CARE
=680  \\$iThe period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed)
=750  \0$aPostoperative care$5IEN$0(DLC)sh 85105563

=LDR  00963cz  a2200301n  4500
=001  9880363847202441
=005  20141212204746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011181
=035  \\$aCBA4471HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x703.$x500
=072  \\$aN2.$x421.$x143.$x620.$x550.$x500
=072  \\$aN2.$x421.$x585.$x703.$x500
=150  \\$aPostnatal Care
=450  \\$wnnna$aCare, Postnatal
=450  \\$wnnna$aCare, Postpartum
=450  \\$wnnna$aCares, Postpartum
=450  \\$wnnna$aPostpartum Care
=450  \\$wnnna$aPostpartum Cares
=450  \\$wnnna$aPostpartum Program
=450  \\$wnnna$aPostpartum Programs
=450  \\$wnnna$aProgram, Postpartum
=450  \\$wnnna$aPrograms, Postpartum
=550  \\$wg$aPerinatal Care
=680  \\$iThe care provided to women and their NEWBORNS for the first few months following CHILDBIRTH.
=688  \\$a71
=750  \0$aPostnatal care$5IEN$0(DLC)sh 85105558

=LDR  00971cz  a2200301n  4500
=001  9880363847302441
=005  20141212204746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011180
=035  \\$aCBA4470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x224.$x617
=150  \\$aPostmortem Changes
=450  \\$aAdipocere
=450  \\$aAlgor Mortis
=450  \\$wnnna$aChange, Postmortem
=450  \\$wnnna$aChanges, Postmortem
=450  \\$aCruor
=450  \\$aLivor Mortis
=450  \\$wnnna$aPostmortem Change
=550  \\$wg$aCadaver
=550  \\$wh$aAutolysis
=550  \\$wh$aRigor Mortis
=550  \\$aExhumation
=667  \\$ado not use for routine postmortem pathol ( = /pathol)
=680  \\$iPhysiological changes that occur in bodies after death.
=688  \\$a70; ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS & MUMMIFICATION were see under POSTMORTEM CHANGES 1970-78
=750  \0$aPostmortem changes$5IEN$0(DLC)sh 85105418

=LDR  00952cz  a2200241n  4500
=001  9880363847402441
=005  20141212204746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011178
=035  \\$aCBA4468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x748.$x630
=072  \\$aC23.$x550.$x767.$x812
=150  \\$aPostgastrectomy Syndromes
=450  \\$wnnna$aPostgastrectomy Syndrome
=450  \\$wnnna$aSyndrome, Postgastrectomy
=450  \\$wnnna$aSyndromes, Postgastrectomy
=550  \\$wg$aPostoperative Complications
=550  \\$wg$aStomach Diseases
=550  \\$wh$aDumping Syndrome
=550  \\$aGastrectomy
=680  \\$iSequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.
=750  \0$aPostgastrectomy syndromes$5IEN$0(DLC)sh 85105549

=LDR  01023cz  a2200313n  4500
=001  9880363847502441
=005  20141212204745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011177
=035  \\$aCBA4467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x451.$x617
=150  \\$aPostal Service
=450  \\$wnnna$aDistribution, Mail
=450  \\$wnnna$aDistributions, Mail
=450  \\$wnnna$aMail
=450  \\$wnnna$aMail Distribution
=450  \\$wnnna$aMail Distributions
=450  \\$wnnna$aMail-Order
=450  \\$wnnna$aMail Order
=450  \\$wnnna$aMail-Orders
=450  \\$wnnna$aMails
=450  \\$wnnna$aPostal Services
=450  \\$wnnna$aService, Postal
=450  \\$wnnna$aServices, Postal
=550  \\$wg$aGovernment Programs
=667  \\$aspecify geog; DF: POSTAL SERV
=680  \\$iThe functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.
=750  \0$aPostal service$5IEN$0(DLC)sh 85105472

=LDR  01487cz  a2200421n  4500
=001  9880363847602441
=005  20141212204745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011176
=035  \\$aCBA4466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323.$x428.$x100.$x500
=072  \\$aE6.$x323.$x528.$x250.$x500
=072  \\$aE6.$x780.$x345.$x250.$x500
=072  \\$aE6.$x780.$x345.$x737.$x100.$x500
=150  \\$aPost and Core Technique
=450  \\$wnnna$aDental Dowel
=450  \\$aDental Dowels
=450  \\$wnnna$aDowel, Dental
=450  \\$wnnna$aDowels, Dental
=450  \\$wnnna$aPost and Core Technic
=450  \\$wnnna$aPost-Core Technic
=450  \\$wnnna$aPost-Core Technics
=450  \\$wnnna$aPost Technic
=450  \\$wnnna$aPost Technics
=450  \\$wnnna$aPost Technique
=450  \\$wnnna$aPost Techniques
=450  \\$wnnna$aTechnic, Post
=450  \\$wnnna$aTechnic, Post-Core
=450  \\$wnnna$aTechnics, Post
=450  \\$wnnna$aTechnics, Post-Core
=450  \\$wnnna$aTechnique, Post
=450  \\$wnnna$aTechniques, Post
=550  \\$wg$aCrowns
=667  \\$ado not use /util except by MeSH definition; DF: POST TECHNIQUE
=680  \\$iUse of a metal casting, usually with a post in the pulp or root canal, designed to support and retain an artificial crown.
=688  \\$a91(75); was POST AND CORE TECHNIC see under CROWNS 1975-90
=750  \0$aCrowns (Dentistry)$xPost and core technique$5IEN$0(DLC)sh 85034349

=LDR  01974cz  a2200421n  4500
=001  9880363847702441
=005  20141212204745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011175
=035  \\$aCBA4465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x41.$x625.$x790
=072  \\$aE2.$x880.$x820.$x790
=150  \\$aPositive-Pressure Respiration
=450  \\$wnnna$aEnd-Expiratory Pressure, Positive
=450  \\$wnnna$aEnd-Expiratory Pressures, Positive
=450  \\$aPositive End-Expiratory Pressure
=450  \\$wnnna$aPositive End Expiratory Pressure
=450  \\$wnnna$aPositive End-Expiratory Pressures
=450  \\$wnnna$aPositive Pressure Respiration
=450  \\$wnnna$aPositive-Pressure Respirations
=450  \\$wnnna$aPositive-Pressure Ventilation
=450  \\$wnnna$aPositive Pressure Ventilation
=450  \\$wnnna$aPositive-Pressure Ventilations
=450  \\$wnnna$aPressure, Positive End-Expiratory
=450  \\$wnnna$aPressures, Positive End-Expiratory
=450  \\$wnnna$aRespiration, Positive-Pressure
=450  \\$wnnna$aRespirations, Positive-Pressure
=450  \\$wnnna$aVentilation, Positive-Pressure
=450  \\$wnnna$aVentilations, Positive-Pressure
=550  \\$wg$aRespiration, Artificial
=550  \\$wh$aContinuous Positive Airway Pressure
=550  \\$wh$aIntermittent Positive-Pressure Breathing
=550  \\$wh$aIntermittent Positive-Pressure Ventilation
=667  \\$anote category: a type of artificial respiration; do not confuse with POSITIVE-PRESSURE RESPIRATION, INTRINSIC, a type of respiratory insufficiency
=680  \\$iA method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange.
=688  \\$a91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78
=750  \0$aPressure breathing$5IEN$0(DLC)sh 85106534

=LDR  00762cz  a2200193n  4500
=001  9880363847802441
=005  20141212204744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011173
=035  \\$aCBA4463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x742
=150  \\$aPortraits as Topic
=550  \\$wg$aArt
=667  \\$ause only for portraits as a subject; for individual or group portraits in an article, use the Publication Type PORTRAITS
=680  \\$iGraphic representations, especially of the face, of real persons, usually posed, living or dead. (From Thesaurus for Graphic Materials II, p540, 1995)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Portraits
=750  \0$aPortraits$0(DLC) sh 85105182$5IEN

=LDR  01119cz  a2200313n  4500
=001  9880363847902441
=005  20141212204743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011172
=035  \\$aCBA4462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x60.$x610
=072  \\$aE1.$x370.$x350.$x700.$x715.$x610
=072  \\$aE1.$x370.$x370.$x50.$x610
=072  \\$aE1.$x370.$x372.$x610
=150  \\$aPortography
=450  \\$aPortal Vein,$xradiography$5IEN
=450  \\$wnnna$aPortographies
=450  \\$wnnna$aSplenoportographies
=450  \\$aSplenoportography
=550  \\$wg$aAngiography
=550  \\$wg$aDiagnostic Techniques, Digestive System
=550  \\$wg$aRadiography, Abdominal
=550  \\$aPortal System
=550  \\$aPortal Vein
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PORTOGR
=680  \\$iExamination of the portal circulation by the use of X-ray films after injection of radiopaque material.
=688  \\$a86; was SPLENOPORTOGRAPHY 1963-85
=750  \0$aPortal vein$xRadiography$5IEN$0(DLC)sh 85105070

=LDR  00657cz  a2200205n  4500
=001  9880363848002441
=005  20141212204742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011169
=035  \\$aCBA4459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x670.$x567
=150  \\$aPortal Vein
=450  \\$wnnna$aPortal Veins
=450  \\$wnnna$aVein, Portal
=450  \\$wnnna$aVeins, Portal
=550  \\$wg$aPortal System
=667  \\$a/radiogr permitted but PORTOGRAPHY is more likely
=680  \\$iA short thick vein formed by union of the superior mesenteric vein and the splenic vein.
=750  \0$aPortal vein$5IEN$0(DLC)sh 85105068

=LDR  01402cz  a2200373n  4500
=001  9880363848102441
=005  20141212204742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011167
=035  \\$aCBA4457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x760.$x755
=072  \\$aE4.$x100.$x814.$x868.$x937.$x790
=150  \\$aPortacaval Shunt, Surgical
=450  \\$wnnna$aAnastomoses, Portacaval
=450  \\$wnnna$aAnastomosis, Portacaval
=450  \\$aEck Fistula
=450  \\$wnnna$aFistula, Eck
=450  \\$wnnna$aPortacaval Anastomoses
=450  \\$wnnna$aPortacaval Anastomosis
=450  \\$wnnna$aPortacaval Shunt
=450  \\$wnnna$aPortacaval Shunts
=450  \\$wnnna$aPortacaval Shunts, Surgical
=450  \\$wnnna$aShunt, Portacaval
=450  \\$wnnna$aShunt, Surgical Portacaval
=450  \\$wnnna$aShunts, Portacaval
=450  \\$wnnna$aShunts, Surgical Portacaval
=450  \\$wnnna$aSurgical Portacaval Shunt
=450  \\$wnnna$aSurgical Portacaval Shunts
=550  \\$wg$aPortasystemic Shunt, Surgical
=667  \\$ado not use /util except by MeSH definition; DF: PORTACAVAL SHUNT
=680  \\$iSurgical portasystemic shunt between the portal vein and inferior vena cava.
=688  \\$a81; was PORTACAVAL ANASTOMOSIS 1963-80; ECK FISTULA was see under PORTACAVAL ANASTOMOSIS 1974-80
=750  \0$aPortacaval anastomosis$5IEN$0(DLC)sh 85105060

=LDR  01476cz  a2200349n  4500
=001  9880363848302441
=005  20141212204741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011164
=035  \\$aCBA4454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x708
=072  \\$aC17.$x800.$x849.$x617
=072  \\$aC18.$x452.$x648.$x708
=072  \\$aC18.$x452.$x811
=072  \\$aC18.$x452.$x880.$x617
=150  \\$aPorphyrias
=450  \\$wnnna$aDisorder, Porphyrin
=450  \\$wnnna$aDisorders, Porphyrin
=450  \\$wnnna$aPorphyria
=450  \\$wnnna$aPorphyrin Disorder
=450  \\$wnnna$aPorphyrin Disorders
=550  \\$wg$aMetabolic Diseases
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wg$aSkin Diseases, Metabolic
=550  \\$wh$aPorphyria, Erythropoietic
=550  \\$wh$aPorphyrias, Hepatic
=550  \\$aHydroxymethylbilane Synthase
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iA diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.
=688  \\$a2005 (1963)
=750  \0$aPorphyria$0(DLC) sh 85105021$5IEN

=LDR  01380cz  a2200373n  4500
=001  9880363848402441
=005  20141212204739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011161
=035  \\$aCBA4451HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x802
=150  \\$aPorifera
=450  \\$aDemospongiae
=450  \\$wnnna$aPoriferas
=450  \\$wnnna$aSponge
=450  \\$wnnna$aSponge (Zoology)
=450  \\$wnnna$aSponges
=450  \\$aSponges (Zoology)
=550  \\$wg$aInvertebrates
=550  \\$wh$aAgelas
=550  \\$wh$aAxinella
=550  \\$wh$aCallyspongia
=550  \\$wh$aCrambe Sponge
=550  \\$wh$aDysidea
=550  \\$wh$aGeodia
=550  \\$wh$aHaliclona
=550  \\$wh$aPetrosia
=550  \\$wh$aPlakortis
=550  \\$wh$aSuberites
=550  \\$wh$aTheonella
=550  \\$wh$aXestospongia
=680  \\$iThe phylum of sponges which are sessile, suspension-feeding, multicellular animals that utilize flagellated cells called choanocytes to circulate water. Most are hermaphroditic. They are probably an early evolutionary side branch that gave rise to no other group of animals. Except for about 150 freshwater species, sponges are marine animals. They are a source of ALKALOIDS; STEROLS; and other complex molecules useful in medicine and biological research.
=750  \0$aSponges$5IEN$0(DLC)sh 85126853

=LDR  01744cz  a2200493n  4500
=001  9880363848502441
=005  20170405111426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011158
=035  \\$aCBA4448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x600.$x660
=072  \\$aN1.$x224.$x625.$x660
=072  \\$aN6.$x850.$x505.$x400.$x700.$x660
=150  \\$aPopulation Growth
=450  \\$wnnna$aBaby Boom
=450  \\$wnnna$aBaby Booms
=450  \\$wnnna$aBaby Bust
=450  \\$wnnna$aBaby Busts
=450  \\$wnnna$aExplosion, Population
=450  \\$wnnna$aExplosions, Population
=450  \\$wnnna$aGrowth, Population
=450  \\$wnnna$aHigh Fertility Population
=450  \\$wnnna$aHigh Fertility Populations
=450  \\$wnnna$aIncrease, Natural
=450  \\$wnnna$aIncreases, Natural
=450  \\$wnnna$aNatural Increase
=450  \\$wnnna$aNatural Increases
=450  \\$wnnna$aPast Trend
=450  \\$wnnna$aPast Trends
=450  \\$aPopulation Explosion
=450  \\$wnnna$aPopulation Explosions
=450  \\$wnnna$aPopulation Growth and Natural Resources
=450  \\$wnnna$aPopulation, High Fertility
=450  \\$wnnna$aPopulation Size and Growth
=450  \\$wnnna$aPopulations, High Fertility
=450  \\$wnnna$aTrend, Past
=450  \\$wnnna$aTrends, Past
=450  \\$wnnna$aZero Population Growth
=550  \\$wg$aPopulation Dynamics
=667  \\$aIM human, NIM animal; no qualif; specify geog
=680  \\$iIncrease, over a specific period of time, in the number of individuals living in a country or region.
=688  \\$a68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78
=750  \0$iBroader mapping$aPopulation$0(DLC)sh 85104910$4BM$5IEN-M

=LDR  02972cz  a2200829n  4500
=001  9880363848602441
=005  20141212204738.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011157
=035  \\$aCBA4447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x600
=072  \\$aN1.$x224.$x625
=072  \\$aN6.$x850.$x505.$x400.$x700
=150  \\$aPopulation Dynamics
=450  \\$wnnna$aAging, Demographic
=450  \\$wnnna$aDecrease, Population
=450  \\$wnnna$aDecreases, Population
=450  \\$wnnna$aDemographic Aging
=450  \\$wnnna$aDemographic Transition
=450  \\$wnnna$aDemographic Transitions
=450  \\$wnnna$aDynamics, Population
=450  \\$aMalthusianism
=450  \\$wnnna$aMigration, Rural-Urban
=450  \\$wnnna$aMigrations, Rural-Urban
=450  \\$wnnna$aMobilities, Residential
=450  \\$wnnna$aMobility, Residential
=450  \\$aNeomalthusianism
=450  \\$wnnna$aOptimum Population
=450  \\$wnnna$aOptimum Populations
=450  \\$wnnna$aPopulation Decrease
=450  \\$wnnna$aPopulation Decreases
=450  \\$wnnna$aPopulation, Optimum
=450  \\$wnnna$aPopulation Pressure
=450  \\$wnnna$aPopulation Pressures
=450  \\$wnnna$aPopulation Replacement
=450  \\$wnnna$aPopulation Replacements
=450  \\$wnnna$aPopulation, Stable
=450  \\$wnnna$aPopulation, Stationary
=450  \\$wnnna$aPopulation Theories
=450  \\$wnnna$aPopulation Theory
=450  \\$wnnna$aPopulations, Optimum
=450  \\$wnnna$aPopulations, Stable
=450  \\$wnnna$aPopulations, Stationary
=450  \\$wnnna$aPressure, Population
=450  \\$wnnna$aPressures, Population
=450  \\$wnnna$aReplacement, Population
=450  \\$wnnna$aReplacements, Population
=450  \\$wnnna$aResidential Mobilities
=450  \\$wnnna$aResidential Mobility
=450  \\$wnnna$aRural-Urban Migration
=450  \\$wnnna$aRural Urban Migration
=450  \\$wnnna$aRural-Urban Migrations
=450  \\$wnnna$aStable Population
=450  \\$wnnna$aStable Populations
=450  \\$wnnna$aStationary Population
=450  \\$wnnna$aStationary Populations
=450  \\$wnnna$aTheories, Population
=450  \\$wnnna$aTheory, Population
=450  \\$wnnna$aTransition, Demographic
=450  \\$wnnna$aTransitions, Demographic
=550  \\$wg$aDemography
=550  \\$wh$aHealth Transition
=550  \\$wh$aHuman Migration
=550  \\$wh$aPopulation Control
=550  \\$wh$aPopulation Growth
=550  \\$aGenetics, Population
=667  \\$aIM human, NIM animal; specify geographic location
=680  \\$iThe pattern of any process, or the interrelationship of phenomena, which affects growth or change within a population.
=688  \\$a76; was NON MESH before 1976
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Residential Mobility
=750  \0$aDemographic transition$5IEN$0(DLC)sh 85036658

=LDR  00839cz  a2200277n  4500
=001  9880363848702441
=005  20141212204737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011156
=035  \\$aCBA4446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x224.$x600
=072  \\$aN6.$x850.$x505.$x400.$x600
=150  \\$aPopulation Density
=450  \\$wnnna$aDensities, Population
=450  \\$wnnna$aDensity, Population
=450  \\$aOverpopulation
=450  \\$wnnna$aPopulation Densities
=450  \\$aPopulation Size
=450  \\$wnnna$aPopulation Sizes
=450  \\$aUnderpopulation
=550  \\$wg$aDemography
=667  \\$aIM human, NIM animal; no qualif; specify geog
=680  \\$iNumber of individuals in a population relative to space.
=688  \\$a68
=750  \0$aPopulation density$5IEN$0(DLC)sh 85104918

=LDR  01160cz  a2200313n  4500
=001  9880363848802441
=005  20170410130500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011153
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x600
=150  \\$aPopulation
=450  \\$wnnna$aPopulation, School Age
=450  \\$wnnna$aPopulation, School-Age
=450  \\$wnnna$aPopulations
=450  \\$wnnna$aPopulations, School Age
=450  \\$wnnna$aPopulations, School-Age
=450  \\$wnnna$aSchool Age Population
=450  \\$wnnna$aSchool-Age Population
=450  \\$wnnna$aSchool Age Populations
=450  \\$wnnna$aSchool-Age Populations
=550  \\$wg$aPopulation Characteristics
=550  \\$wh$aRural Population
=550  \\$wh$aSuburban Population
=550  \\$wh$aUrban Population
=667  \\$aIM human, NIM animal; /genet allowed; differentiate from DEMOGRAPHY (the statist study of population characteristics)
=680  \\$iThe total number of individuals inhabiting a particular region or area.
=750  \0$iNarrower mapping$aPopulation research$0(DLC)sh 85104928$4NM$5IEN-M
=750  \0$aPopulation$5IEN-HS$0(DLC)sh 85104910

=LDR  01181cz  a2200313n  4500
=001  9880363848902441
=005  20141212192432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011149
=035  \\$aCBA4439HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600
=150  \\$aPons
=450  \\$wnnna$aPons Varolii
=450  \\$wnnna$aPons Varolius
=450  \\$wnnna$aPonte
=450  \\$wnnna$aPontes
=450  \\$wnnna$aVarolii, Pons
=450  \\$wnnna$aVarolius, Pons
=550  \\$wg$aMetencephalon
=550  \\$wh$aBarrington's Nucleus
=550  \\$wh$aCochlear Nucleus
=550  \\$wh$aKolliker-Fuse Nucleus
=550  \\$wh$aMiddle Cerebellar Peduncle
=550  \\$wh$aPontine Tegmentum
=550  \\$wh$aVestibular Nuclei
=680  \\$iThe front part of the hindbrain (RHOMBENCEPHALON) that lies between the MEDULLA and the midbrain (MESENCEPHALON) ventral to the cerebellum. It is composed of two parts, the dorsal and the ventral. The pons serves as a relay station for neural pathways between the CEREBELLUM to the CEREBRUM.
=750  \0$aPons Varolii$5IEN$0(DLC)sh 85104800

=LDR  00782cz  a2200217n  4500
=001  9880363849002441
=005  20141212204734.0
=008  800509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011148
=035  \\$aCBA4438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x400.$x635.$x650
=150  \\$aPongo pygmaeus
=450  \\$wnnna$aBornean Orangutan
=450  \\$aOrangutan, Bornean
=450  \\$wnnna$aPongo pygmaeus pygmaeus
=550  \\$wg$aPongo
=667  \\$adiseases: coordinate IM with APE DISEASES (IM) + specific disease /vet (IM);
=680  \\$iA species of orangutan, family HOMINIDAE, found in the forests on the island of Borneo.
=688  \\$a91(81); was see under PONGIDAE 1981-90
=750  \0$aOrangutan$0(DLC) sh 85095285$5IEN

=LDR  01607cz  a2200385n  4500
=001  9880363849102441
=005  20141212204734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011146
=035  \\$aCBA4436HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x620.$x300
=072  \\$aC17.$x800.$x815.$x620.$x300
=072  \\$aC17.$x800.$x865.$x385
=150  \\$aEczema, Dyshidrotic
=450  \\$wnnna$aDyshidrotic Eczema
=450  \\$wnnna$aDyshidrotic Eczemas
=450  \\$wnnna$aDyshydrotic Eczema
=450  \\$wnnna$aDyshydrotic Eczemas
=450  \\$wnnna$aEczema, Dyshydrotic
=450  \\$aEczema, Vesicular Palmoplantar
=450  \\$wnnna$aEczemas, Dyshidrotic
=450  \\$wnnna$aEczemas, Dyshydrotic
=450  \\$wnnna$aEczemas, Vesicular Palmoplantar
=450  \\$wnnna$aPalmoplantar Eczema, Vesicular
=450  \\$wnnna$aPalmoplantar Eczemas, Vesicular
=450  \\$aPompholyx
=450  \\$aVesicular Palmoplantar Eczema
=450  \\$wnnna$aVesicular Palmoplantar Eczemas
=550  \\$wg$aEczema
=550  \\$wg$aSkin Diseases, Vesiculobullous
=667  \\$aeczema with hyperhidrosis
=680  \\$iA recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed)
=688  \\$a93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92
=750  \0$aPompholyx (Disease)$5IEN$0(DLC)sh 85104773

=LDR  01367cz  a2200397n  4500
=001  9880363849202441
=005  20141212204733.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011143
=035  \\$aCBA4433HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x884.$x533.$x565
=072  \\$aD5.$x750.$x716.$x721.$x812
=072  \\$aD25.$x720.$x327.$x811
=072  \\$aD25.$x720.$x716.$x721.$x812
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x721.$x812
=150  \\$aPolyvinyl Chloride
=450  \\$wnnna$aChloride, Polyvinyl
=450  \\$wnnna$aChloroethylene Homopolymer
=450  \\$aChloroethylene Polymer
=450  \\$wnnna$aGeon
=450  \\$wnnna$aHomopolymer, Chloroethylene
=450  \\$aPolychloroethylene
=450  \\$wnnna$aPolymer, Chloroethylene
=450  \\$wnnna$aPolymer, Vinyl Chloride
=450  \\$wnnna$aPVC
=450  \\$wnnna$aUltron
=450  \\$wnnna$aViaflex
=450  \\$aVinyl Chloride Polymer
=450  \\$wnnna$aVinylite
=550  \\$wg$aElastomers
=550  \\$wg$aPolyvinyls
=667  \\$aD25-26 qualif
=680  \\$iA polyvinyl resin used extensively in the manufacture of plastics, including medical devices, tubing, and other packaging. It is also used as a rubber substitute.
=688  \\$a91(75); was see under POLYVINYLS 1975-90
=750  \0$aPolyvinyl chloride$5IEN$0(DLC)sh 85104742

=LDR  01079cz  a2200289n  4500
=001  9880363849302441
=005  20141212204732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011142
=035  \\$aCBA4432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x750
=072  \\$aD2.$x455.$x326.$x271.$x884.$x533.$x532
=072  \\$aD5.$x750.$x716.$x721.$x616
=072  \\$aD25.$x720.$x716.$x721.$x616
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x721.$x616
=150  \\$aPolyvinyl Alcohol
=450  \\$wnnna$aAlcohol, Polyvinyl
=450  \\$wnnna$aLiquifilm Tears
=450  \\$wnnna$aPolyviol
=450  \\$wnnna$aTears, Liquifilm
=550  \\$wg$aAlcohols
=550  \\$wg$aPolyvinyls
=667  \\$aD25-26 qualif
=680  \\$iA polymer prepared from polyvinyl acetates by replacement of the acetate groups with hydroxyl groups. It is used as a pharmaceutic aid and ophthalmic lubricant as well as in the manufacture of surface coatings artificial sponges, cosmetics, and other products.
=688  \\$a74(71)
=750  \0$aPolyvinyl alcohol$5IEN$0(DLC)sh 91003332

=LDR  01317cz  a2200397n  4500
=001  9880363849402441
=005  20141212204732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011140
=035  \\$aCBA4430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x944.$x750
=072  \\$aD5.$x750.$x716.$x650
=072  \\$aD25.$x720.$x327.$x782
=072  \\$aD25.$x720.$x716.$x650
=072  \\$aJ1.$x637.$x51.$x720.$x327.$x782
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x650
=072  \\$aJ1.$x637.$x412.$x700
=150  \\$aPolyurethanes
=450  \\$wnnna$aOstamer
=450  \\$wnnna$aOstamers
=450  \\$wnnna$aPellethane
=450  \\$wnnna$aPellethanes
=450  \\$wnnna$aPolyisocyanate
=450  \\$aPolyisocyanates
=450  \\$wnnna$aPolyurethane
=450  \\$wnnna$aSpandex
=450  \\$wnnna$aSpandices
=550  \\$wg$aElastomers
=550  \\$wg$aPlastics
=550  \\$wg$aUrethane
=667  \\$aURETHANE is available
=680  \\$iA group of thermoplastic or thermosetting polymers containing polyisocyanate. They are used as ELASTOMERS, as coatings, as fibers and as foams.
=688  \\$a1968; for SPANDEX use POLYURETHANES (NM) 1975-1999
=750  \0$aPolyurethanes in medicine$5IEN-M$0(DLC)sh 85104741
=750  \0$aPolyurethanes$5IEN-HS$0(DLC)sh 85104740

=LDR  01333cz  a2200385n  4500
=001  9880363849502441
=005  20141212204731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011138
=035  \\$aCBA4428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x395.$x616
=072  \\$aD25.$x720.$x395.$x616
=072  \\$aJ1.$x637.$x51.$x720.$x395.$x616
=150  \\$aPolytetrafluoroethylene
=450  \\$wnnna$aExpanded PTFE
=450  \\$aFEP
=450  \\$aFluon
=450  \\$wnnna$aFluoroplast
=450  \\$wnnna$aGORE-TEX
=450  \\$wnnna$aGORE TEX
=450  \\$wnnna$aGoretex
=450  \\$aPolitef
=450  \\$aPolytef
=450  \\$wnnna$aPTFE
=450  \\$wnnna$aPTFE, Expanded
=450  \\$wnnna$aTarflen
=450  \\$aTeflon
=450  \\$aTFE
=550  \\$wg$aFluorocarbon Polymers
=550  \\$wh$aProplast
=667  \\$aa fluorocarbon polymer; D25-26 qualif
=680  \\$iHomopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron.
=688  \\$a73; was see under FLUOROCARBON POLYMERS 1966-72
=750  \0$aPolytef$5IEN$0(DLC)sh 86000451

=LDR  00983cz  a2200265n  4500
=001  9880363849602441
=005  20141212204731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011137
=035  \\$aCBA4427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x750.$x800.$x830
=072  \\$aD5.$x750.$x716.$x579
=072  \\$aD25.$x720.$x716.$x579
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x579
=150  \\$aPolystyrenes
=450  \\$wnnna$aPolystyrene
=450  \\$wnnna$aPolystyrol
=450  \\$wnnna$aPolystyrols
=550  \\$wg$aPlastics
=550  \\$wg$aStyrene
=550  \\$wh$aCholestyramine Resin
=667  \\$aSTYRENES and STYRENE are available
=680  \\$iPolymerized forms of styrene used as a biocompatible material, especially in dentistry. They are thermoplastic and are used as insulators, for injection molding and casting, as sheets, plates, rods, rigid forms and beads.
=750  \0$aPolystyrene$5IEN-M$0(DLC)sh2002004630

=LDR  00970cz  a2200289n  4500
=001  9880363849702441
=005  20141212204730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011135
=035  \\$aCBA4425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x718
=072  \\$aD23.$x50.$x161.$x616
=150  \\$aPolysaccharides, Bacterial
=450  \\$aBacterial Polysaccharides
=450  \\$aMicrobial Polysaccharides$5IEN
=550  \\$wg$aAntigens, Bacterial
=550  \\$wg$aPolysaccharides
=550  \\$wh$aBambermycins
=550  \\$wh$aLipopolysaccharides
=550  \\$wh$aPeptidoglycan
=550  \\$wh$aPrebiotics
=550  \\$wh$aProdigiozan
=550  \\$wh$aTeichoic Acids
=667  \\$ageneral or unspecified; prefer specifics; coordinate with specific bacterium + specific polysaccahride if pertinent
=680  \\$iPolysaccharides found in bacteria and in capsules thereof.
=750  \0$aMicrobial polysaccharides$5IEN$0(DLC)sh 85084770

=LDR  01089cz  a2200409n  4500
=001  9880363849802441
=005  20141212204730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011134
=035  \\$aCBA4424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698
=150  \\$aPolysaccharides
=450  \\$aGlycans
=550  \\$wg$aCarbohydrates
=550  \\$wh$aAlginates
=550  \\$wh$aCarrageenan
=550  \\$wh$aChitin
=550  \\$wh$aFicoll
=550  \\$wh$aFructans
=550  \\$wh$aFungal Polysaccharides
=550  \\$wh$aGalactans
=550  \\$wh$aGlucans
=550  \\$wh$aGlycosaminoglycans
=550  \\$wh$aMannans
=550  \\$wh$aOligosaccharides
=550  \\$wh$aPectins
=550  \\$wh$aPentosan Sulfuric Polyester
=550  \\$wh$aPlant Gums
=550  \\$wh$aPlant Mucilage
=550  \\$wh$aPolysaccharides, Bacterial
=550  \\$wh$aProteoglycans
=550  \\$wh$aSepharose
=550  \\$wh$aXylans
=550  \\$aBiopolymers
=667  \\$a13 or more units; GEN; prefer specifics
=750  \0$aPolysaccharides$5IEN$0(DLC)sh 85104728

=LDR  01271cz  a2200325n  4500
=001  9880363849902441
=005  20141212204728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011128
=035  \\$aCBA4418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x800.$x750.$x700
=150  \\$aPolyradiculopathy
=450  \\$wnnna$aAbdominal Polyradiculopathies
=450  \\$wnnna$aAbdominal Polyradiculopathy
=450  \\$aCauda Equina Syndrome
=450  \\$wnnna$aCauda Equina Syndromes
=450  \\$wnnna$aPolyradiculitides
=450  \\$aPolyradiculitis
=450  \\$wnnna$aPolyradiculopathies
=450  \\$wnnna$aPolyradiculopathies, Abdominal
=450  \\$aPolyradiculopathy, Abdominal
=450  \\$wnnna$aSyndrome, Cauda Equina
=450  \\$wnnna$aSyndromes, Cauda Equina
=550  \\$wg$aPolyradiculoneuropathy
=550  \\$aSpinal Nerve Roots
=667  \\$ado not confuse with POLYRADICULONEUROPATHY (dis of both spinal nerve roots & peripheral nerves) nor with RADICULOPATHY (dis of a single spinal nerve root)
=680  \\$iDisease or injury involving multiple SPINAL NERVE ROOTS. Polyradiculitis refers to inflammation of multiple spinal nerve roots.
=688  \\$a2000(1966)
=750  \0$aPolyradiculitis$5IEN$0(DLC)sh 85104724

=LDR  01031cz  a2200217n  4500
=001  9880363850002441
=005  20141212204727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011127
=035  \\$aCBA4417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x825
=150  \\$aPolyps
=450  \\$wnnna$aPolyp
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aIntestinal Polyps
=550  \\$wh$aNasal Polyps
=667  \\$aif neoplastic, coord IM with precoord organ/neopl term (IM), otherwise coord with precoord organ/dis term (IM); COLONIC POLYPS; INTESTINAL POLYPS & NASAL POLYPS are also available
=680  \\$iDiscrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.
=688  \\$a65; was POLYPI 1963-64
=750  \0$aPolyps (Pathology)$5IEN$0(DLC)sh 85104720

=LDR  01342cz  a2200373n  4500
=001  9880363850102441
=005  20141212204727.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011126
=035  \\$aCBA4416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x590
=072  \\$aD5.$x750.$x716.$x550
=072  \\$aD25.$x720.$x716.$x550
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x550
=150  \\$aPolypropylenes
=450  \\$wnnna$aHostalen
=450  \\$wnnna$aMarlex
=450  \\$wnnna$aMarlex Polypropylene
=450  \\$wnnna$aPolymers, Propene
=450  \\$wnnna$aPolymers, Propylene
=450  \\$wnnna$aPolypro
=450  \\$wnnna$aPolypropylene
=450  \\$wnnna$aPolypropylene, Marlex
=450  \\$wnnna$aProlene
=450  \\$aPropene Polymers
=450  \\$aPropylene Polymers
=550  \\$wg$aPlastics
=550  \\$wg$aPolyenes
=667  \\$aD25-26 qualif
=680  \\$iPropylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms. They are used as a copolymer in plastics, especially polyethylene. The fibers are used for fabrics, filters and surgical sutures.
=688  \\$a1991(1975); for MARLEX use PLASTIPORE (NM) 1978-1999
=750  \0$aPolypropylene fibers$5IEN-M$0(DLC)sh 85104719
=750  \0$aPolypropylene$5IEN-HS$0(DLC)sh 85104718

=LDR  00658cz  a2200217n  4500
=001  9880363850202441
=005  20190204132753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011124
=035  \\$aCBA4414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x760
=150  \\$aPolyporaceae
=550  \\$wg$aPolyporales
=550  \\$wh$aPhanerochaete
=550  \\$wh$aPolyporus
=550  \\$wh$aPycnoporus
=550  \\$wh$aWolfiporia
=680  \\$iA family of bracket fungi, order POLYPORALES, living in decaying plant matter and timber.
=688  \\$a91(75); use BASIDIOMYCOTA 1963-74
=750  \0$aPolyporaceae$5IEN$0(DLC)sh 85104715

=LDR  01029cz  a2200325n  4500
=001  9880363850302441
=005  20141212204724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011123
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x702
=072  \\$aG5.$x365.$x590.$x175.$x677
=072  \\$aG5.$x700.$x740
=150  \\$aPolyploidy
=450  \\$wnnna$aCell, Polyploid
=450  \\$wnnna$aCells, Polyploid
=450  \\$wnnna$aPolyploid
=450  \\$wnnna$aPolyploid Cell
=450  \\$wnnna$aPolyploid Cells
=450  \\$wnnna$aPolyploidies
=450  \\$wnnna$aPolyploids
=550  \\$wg$aChromosome Aberrations
=550  \\$wg$aPloidies
=550  \\$wh$aTetraploidy
=550  \\$wh$aTriploidy
=550  \\$aPolytene Chromosomes
=667  \\$ano qualif
=680  \\$iThe chromosomal constitution of a cell containing multiples of the normal number of CHROMOSOMES; includes triploidy (symbol: 3N), tetraploidy (symbol: 4N), etc.
=688  \\$a68
=750  \0$aPolyploidy$5IEN$0(DLC)sh 85104712

=LDR  00753cz  a2200217n  4500
=001  9880363850402441
=005  20141212204723.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011122
=035  \\$aCBA4412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374.$x775
=072  \\$aD1.$x248.$x497.$x158.$x730.$x650
=072  \\$aD1.$x695.$x625.$x675.$x650.$x775
=150  \\$aPolyphosphates
=550  \\$wg$aPhosphates
=550  \\$wh$aDiphosphates
=550  \\$wh$aTin Polyphosphates
=680  \\$iLinear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms.
=688  \\$a78
=750  \0$aPolyphosphates$5IEN$0(DLC)sh 91005155

=LDR  01761cz  a2200469n  4500
=001  9880363850502441
=005  20141212204723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011120
=035  \\$aCBA4410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x640.$x615
=072  \\$aB4.$x909.$x204.$x210.$x620.$x615
=072  \\$aB4.$x909.$x574.$x204.$x670.$x615
=072  \\$aB4.$x909.$x675.$x615
=150  \\$aPolyomavirus
=450  \\$aBovine polyomavirus
=450  \\$wnnna$aBovine polyomaviruses
=450  \\$wnnna$aHamster polyomavirus
=450  \\$wnnna$aHamster polyomaviruses
=450  \\$aMurine polyomavirus
=450  \\$wnnna$aMurine polyomaviruses
=450  \\$wnnna$aPolyoma Virus
=450  \\$wnnna$aPolyoma Viruses
=450  \\$wnnna$apolyomavirus, Bovine
=450  \\$wnnna$apolyomavirus, Hamster
=450  \\$wnnna$apolyomavirus, Murine
=450  \\$wnnna$aPolyomaviruses
=450  \\$wnnna$apolyomaviruses, Bovine
=450  \\$wnnna$apolyomaviruses, Hamster
=450  \\$wnnna$apolyomaviruses, Murine
=450  \\$wnnna$aVirus, Polyoma
=450  \\$wnnna$aViruses, Polyoma
=550  \\$wg$aPolyomaviridae
=550  \\$wh$aBK Virus
=550  \\$wh$aJC Virus
=550  \\$wh$aMerkel cell polyomavirus
=550  \\$wh$aSimian virus 40
=667  \\$ainfection: coordinate IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM)
=680  \\$iA genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin.
=688  \\$a94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77
=750  \0$aPolyomaviruses$0(DLC) sh 85$5IEN

=LDR  02424cz  a2200517n  4500
=001  9880363850602441
=005  20141212204721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011115
=035  \\$aCBA4405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x800
=150  \\$aPolyneuropathies
=450  \\$wnnna$aAcquired Polyneuropathies
=450  \\$wnnna$aAcquired Polyneuropathy
=450  \\$wnnna$aCritical Illness Polyneuropathies
=450  \\$wnnna$aCritical Illness Polyneuropathy
=450  \\$wnnna$aFamilial Polyneuropathies
=450  \\$wnnna$aFamilial Polyneuropathy
=450  \\$wnnna$aInherited Polyneuropathies
=450  \\$wnnna$aInherited Polyneuropathy
=450  \\$wnnna$aMotor Polyneuropathies
=450  \\$wnnna$aMotor Polyneuropathy
=450  \\$aNeuritis, Multiple$5IEN
=450  \\$wnnna$aPolyneuropathies, Acquired
=450  \\$wnnna$aPolyneuropathies, Critical Illness
=450  \\$wnnna$aPolyneuropathies, Familial
=450  \\$wnnna$aPolyneuropathies, Inherited
=450  \\$wnnna$aPolyneuropathies, Motor
=450  \\$wnnna$aPolyneuropathy
=450  \\$aPolyneuropathy, Acquired
=450  \\$wnnna$aPolyneuropathy, Critical Illness
=450  \\$wnnna$aPolyneuropathy, Familial
=450  \\$wnnna$aPolyneuropathy, Inherited
=450  \\$wnnna$aPolyneuropathy, Motor
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aAlcoholic Neuropathy
=550  \\$wh$aHereditary Sensory and Autonomic Neuropathies
=550  \\$wh$aHereditary Sensory and Motor Neuropathy
=550  \\$wh$aParaneoplastic Polyneuropathy
=550  \\$wh$aPOEMS Syndrome
=550  \\$wh$aPolyradiculoneuropathy
=550  \\$wh$aTangier Disease
=680  \\$iDiseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.
=688  \\$a2000(1966)
=750  \0$aPolyneuritis$5IEN$0(DLC)sh 85091110

=LDR  01052cz  a2200289n  4500
=001  9880363850702441
=005  20141212204720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011113
=035  \\$aCBA4403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x780
=072  \\$aD10.$x477.$x750
=072  \\$aD12.$x644.$x50.$x600
=072  \\$aD12.$x644.$x641.$x780
=072  \\$aD12.$x776.$x543.$x695.$x54.$x600
=150  \\$aPolymyxins
=450  \\$aPolymyxin
=450  \\$wnnna$aPolymyxin M
=550  \\$wg$aAntimicrobial Cationic Peptides
=550  \\$wg$aLipopeptides
=550  \\$wg$aPeptides, Cyclic
=550  \\$wh$aColistin
=550  \\$wh$aPolymyxin B
=680  \\$iBasic lipopeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter.
=688  \\$a1994,1963-1977
=750  \0$aPolymyxin$5IEN$0(DLC)sh 85104686

=LDR  01591cz  a2200337n  4500
=001  9880363850802441
=005  20141212204719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011111
=035  \\$aCBA4401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x742
=072  \\$aC5.$x799.$x720
=072  \\$aC17.$x300.$x775.$x720
=150  \\$aPolymyalgia Rheumatica
=450  \\$aForestier-Certonciny Syndrome
=450  \\$wnnna$aForestier Certonciny Syndrome
=450  \\$wnnna$aPeri-Extra-Articular Rheumatism
=450  \\$wnnna$aPseudopolyarthritides, Rhizomelic
=450  \\$aPseudopolyarthritis, Rhizomelic
=450  \\$aRheumatism, Peri-Extra-Articular
=450  \\$wnnna$aRheumatism, Peri Extra Articular
=450  \\$wnnna$aRhizomelic Pseudopolyarthritides
=450  \\$wnnna$aRhizomelic Pseudopolyarthritis
=450  \\$wnnna$aSyndrome, Forestier-Certonciny
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aRheumatic Diseases
=550  \\$aGiant Cell Arteritis
=680  \\$iA syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.
=688  \\$a65
=750  \0$aPolymyalgia rheumatica$5IEN$0(DLC)sh 85104684

=LDR  01182cz  a2200277n  4500
=001  9880363850902441
=005  20181011113940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011110
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365.$x795
=150  \\$aPolymorphism, Genetic
=450  \\$aGenetic Polymorphism
=450  \\$wnnna$aGenetic Polymorphisms
=450  \\$aPolymorphism (Genetics)
=450  \\$wnnna$aPolymorphisms, Genetic
=550  \\$wg$aGenetic Variation
=550  \\$wh$aGenomic Structural Variation
=550  \\$wh$aPharmacogenomic Variants
=550  \\$wh$aPolymorphism, Restriction Fragment Length
=550  \\$wh$aPolymorphism, Single Nucleotide
=550  \\$wh$aPolymorphism, Single-Stranded Conformational
=667  \\$aDF: POLYMORPHISM
=680  \\$iThe regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.
=688  \\$a2005(1968)
=750  \0$aGenetic polymorphisms$0(DLC) sh 85053865$5IEN

=LDR  01511cz  a2200457n  4500
=001  9880363851002441
=005  20200528134658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750
=072  \\$aD25.$x720
=072  \\$aJ1.$x637.$x51.$x720
=150  \\$aPolymers
=450  \\$wnnna$aPolymer
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aMacromolecular Substances
=550  \\$wh$aBiopolymers
=550  \\$wh$aColestipol
=550  \\$wh$aCyanoacrylates
=550  \\$wh$aDendrimers
=550  \\$wh$aElastomers
=550  \\$wh$aFluorocarbon Polymers
=550  \\$wh$aHexadimethrine Bromide
=550  \\$wh$aLatex
=550  \\$wh$aMetal-Organic Frameworks
=550  \\$wh$aOrganically Modified Ceramics
=550  \\$wh$aPlastics
=550  \\$wh$aPolyanetholesulfonate
=550  \\$wh$aPolyanhydrides
=550  \\$wh$aPolyelectrolytes
=550  \\$wh$aPolyesters
=550  \\$wh$aPolyethylene Glycols
=550  \\$wh$aPolygeline
=550  \\$wh$aPolyphloretin Phosphate
=550  \\$wh$aPyran Copolymer
=550  \\$wh$aSiloxanes
=680  \\$iCompounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS).
=688  \\$awas in Cat D & J 1975-82, was in Cat D only 1963-74
=750  \0$aPolymers in medicine$0(DLC) sh 85104678$5IEN-M
=750  \0$aPolymers$0(DLC) sh 85104660$5IEN-M

=LDR  00878cz  a2200229n  4500
=001  9880363851102441
=005  20141212204714.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011096
=035  \\$aCBA4386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x800
=150  \\$aPolygalacturonase
=450  \\$wnnna$aDepolymerase, Pectin
=450  \\$wnnna$aEndopolygalacturonase
=450  \\$aPectin Depolymerase
=450  \\$aPectinase
=550  \\$wg$aGlycoside Hydrolases
=667  \\$ain microorganisms & higher plants
=680  \\$iA cell wall-degrading enzyme found in microorganisms and higher plants. It catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15.
=688  \\$a91(77); was see under GLYCOSIDE HYDROLASES 1977-90
=750  \0$aPolygalacturonase$5IEN$0(DLC)sh 85099117

=LDR  01015cz  a2200265n  4500
=001  9880363851202441
=005  20141212204713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011093
=035  \\$aCBA4383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x728.$x764
=072  \\$aD25.$x720.$x728.$x764
=072  \\$aJ1.$x637.$x51.$x720.$x728.$x764
=150  \\$aPolyethylene Terephthalates
=450  \\$wnnna$aDacron
=450  \\$wnnna$aPolyethylene Terephthalate
=450  \\$wnnna$aTerephthalate, Polyethylene
=450  \\$wnnna$aTerephthalates, Polyethylene
=550  \\$wg$aPolyesters
=667  \\$aD25-26 qualif
=680  \\$iPolyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics.
=688  \\$a93; was POLYETHYLENE TEREPHTHALATE 1973-92
=750  \0$aDacron$5IEN$0(DLC)sh 85035362
=750  \0$aPolyethylene terephthalate$5IEN-M$0(DLC)sh 00009609

=LDR  03252cz  a2200913n  4500
=001  9880363851302441
=005  20190716133733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011092
=035  \\$aCBA4382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x455.$x250.$x700
=072  \\$aD5.$x750.$x741
=072  \\$aD25.$x720.$x741
=072  \\$aJ1.$x637.$x51.$x720.$x741
=150  \\$aPolyethylene Glycols
=450  \\$wnnna$a1000, PEG
=450  \\$wnnna$a3350, PEG
=450  \\$wnnna$a4000, Polyethylene Glycol
=450  \\$wnnna$a6000, Polyethylene Glycol
=450  \\$wnnna$aCarbowax-400
=450  \\$wnnna$aCarbowax 400
=450  \\$wnnna$aCarbowax 600
=450  \\$wnnna$aCarbowax400
=450  \\$wnnna$aGlycol 2000, Polyethylene
=450  \\$wnnna$aGlycol 400, Polyethylene
=450  \\$wnnna$aGlycol 4000, Polyethylene
=450  \\$wnnna$aGlycol 6000, Polyethylene
=450  \\$wnnna$aGlycol, Polyethylene
=450  \\$wnnna$aGlycols, Polyethylene
=450  \\$wnnna$aLauromacrogol
=450  \\$wnnna$aLauromacrogols
=450  \\$wnnna$aMacrogol
=450  \\$wnnna$aMacrogol 300
=450  \\$aMacrogols
=450  \\$wnnna$aMiralax
=450  \\$wnnna$aMiralaxs
=450  \\$wnnna$aOxide, Polyethylene
=450  \\$wnnna$aOxides, Polyethylene
=450  \\$wnnna$aPEG 1000
=450  \\$wnnna$aPEG 3350
=450  \\$wnnna$aPEG-400
=450  \\$wnnna$aPeg 400
=450  \\$wnnna$aPEG 6000
=450  \\$wnnna$aPEG 8000
=450  \\$wnnna$aPEO-400
=450  \\$wnnna$aPEO 400
=450  \\$wnnna$aPolyethylene Glycol
=450  \\$wnnna$aPolyethylene Glycol 1000
=450  \\$wnnna$aPolyethylene Glycol 2000
=450  \\$wnnna$aPolyethylene Glycol 300
=450  \\$wnnna$aPolyethylene Glycol 3350
=450  \\$wnnna$aPolyethylene Glycol 400
=450  \\$wnnna$aPolyethylene Glycol 4000
=450  \\$wnnna$aPolyethylene Glycol 6000
=450  \\$wnnna$aPolyethylene Glycol 8000
=450  \\$wnnna$aPolyethylene Oxide
=450  \\$wnnna$aPolyethylene Oxides
=450  \\$wnnna$aPolyethyleneoxide
=450  \\$wnnna$aPolyethyleneoxides
=450  \\$wnnna$aPolyox FRA
=450  \\$wnnna$aPolyoxyethylene
=450  \\$aPolyoxyethylenes
=450  \\$aTritons
=450  \\$wnnna$aVigilon
=550  \\$wg$aEthylene Glycols
=550  \\$wg$aPolymers
=550  \\$wh$aCertolizumab Pegol
=550  \\$wh$aCetomacrogol
=550  \\$wh$aHydrogel, Polyethylene Glycol Dimethacrylate
=550  \\$wh$aNonoxynol
=550  \\$wh$aOctoxynol
=550  \\$wh$aPoloxalene
=550  \\$wh$aPoloxamer
=550  \\$wh$aPolyhydroxyethyl Methacrylate
=550  \\$wh$aPolysorbates
=680  \\$iPolymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
=688  \\$a74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74
=750  \0$aPolyethylene glycol$5IEN$0(DLC)sh 92002568

=LDR  00932cz  a2200277n  4500
=001  9880363851402441
=005  20141212204712.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011091
=035  \\$aCBA4381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x728
=072  \\$aD25.$x720.$x728
=072  \\$aJ1.$x637.$x51.$x720.$x728
=150  \\$aPolyesters
=450  \\$wnnna$aPolyester
=550  \\$wg$aPolymers
=550  \\$wh$aPolydioxanone
=550  \\$wh$aPolyethylene Terephthalates
=550  \\$wh$aPolyglactin 910
=550  \\$wh$aPolyglycolic Acid
=550  \\$wh$aPolyhydroxyalkanoates
=667  \\$aD25-26 qualif
=680  \\$iPolymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours.
=688  \\$a77
=750  \0$aPolyesters$5IEN$0(DLC)sh 85104622

=LDR  00854cz  a2200313n  4500
=001  9880363851502441
=005  20141212204711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011090
=035  \\$aCBA4380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665
=150  \\$aPolyenes
=450  \\$wnnna$aCumulenes
=550  \\$wg$aAlkenes
=550  \\$wh$aAlkadienes
=550  \\$wh$aAurodox
=550  \\$wh$aCarotenoids
=550  \\$wh$aDiphenylhexatriene
=550  \\$wh$aFilipin
=550  \\$wh$aMepartricin
=550  \\$wh$aNeoprene
=550  \\$wh$aPolyethylenes
=550  \\$wh$aPolypropylenes
=550  \\$wh$aPolyvinyls
=550  \\$wh$aSqualene
=680  \\$iHydrocarbons with more than one double bond. They are a reduced form of POLYYNES.
=688  \\$a74
=750  \0$aPolyenes$5IEN$0(DLC)sh 86005602

=LDR  01429cz  a2200337n  4500
=001  9880363851602441
=005  20180416092107.0
=008  770523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011088
=035  \\$aCBA4378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x74.$x500
=072  \\$aD8.$x811.$x464.$x754.$x600
=150  \\$aDNA Ligases
=450  \\$aDNA Joinases
=450  \\$wnnna$aDNA Ligase, T4
=450  \\$wnnna$aJoinases, DNA
=450  \\$wnnna$aLigase, T4 DNA
=450  \\$wnnna$aLigases, DNA
=450  \\$wnnna$aLigases, Polydeoxyribonucleotide
=450  \\$aPolydeoxyribonucleotide Ligases
=450  \\$aPolydeoxyribonucleotide Synthetases
=450  \\$wnnna$aSynthetases, Polydeoxyribonucleotide
=450  \\$wnnna$aT4 DNA Ligase
=550  \\$wg$aDNA Repair Enzymes
=550  \\$wg$aPolynucleotide Ligases
=550  \\$wh$aDNA Ligase, ATP
=667  \\$ado not confuse X ref POLYDEOXYRIBONUCLEOTIDE SYNTHETASES with X ref POLYRIBONUCLEOTIDE SYNTHETASE
=680  \\$iPoly(deoxyribonucleotide):poly(deoxyribonucleotide)ligases. Enzymes that catalyze the joining of preformed deoxyribonucleotides in phosphodiester linkage during genetic processes during repair of a single-stranded break in duplex DNA. The class includes both EC 6.5.1.1 (ATP) and EC 6.5.1.2 (NAD).
=688  \\$a98(77); for DNA LIGASES use POLYNUCLEOTIDE SYNTHETASES 1973-76
=750  \0$aDNA ligases$5IEN$0(DLC)sh 89005027

=LDR  01303cz  a2200301n  4500
=001  9880363851702441
=005  20141212204710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011087
=035  \\$aCBA4377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x190.$x636.$x753
=150  \\$aPolycythemia Vera
=450  \\$wnnna$aDisease, Osler-Vaquez
=450  \\$aErythremia
=450  \\$wnnna$aErythremias
=450  \\$aOsler-Vaquez Disease
=450  \\$wnnna$aOsler Vaquez Disease
=450  \\$wnnna$aPolycythemia Ruba Vera
=450  \\$aPolycythemia Rubra Vera
=450  \\$wnnna$aPolycythemia Rubra Veras
=450  \\$wnnna$aPrimary Polycythemia
=450  \\$wnnna$aVera, Polycythemia Rubra
=450  \\$wnnna$aVeras, Polycythemia Rubra
=550  \\$wg$aMyeloproliferative Disorders
=667  \\$aa myeloproliferative disord
=680  \\$iA myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
=750  \0$aPolycythemia vera$5IEN$0(DLC)sh 85104611

=LDR  00618cz  a2200205n  4500
=001  9880363851802441
=005  20141212204710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011086
=035  \\$aCBA4376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x738
=150  \\$aPolycythemia
=450  \\$wnnna$aErythrocytoses
=450  \\$aErythrocytosis
=450  \\$wnnna$aPolycythemias
=550  \\$wg$aHematologic Diseases
=667  \\$aincrease in total red cell mass
=680  \\$iAn increase in the total red cell mass of the blood. (Dorland, 27th ed)
=750  \0$aPolycythemia$5IEN$0(DLC)sh 85104610

=LDR  01577cz  a2200361n  4500
=001  9880363851902441
=005  20141212204710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011085
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x612.$x765
=072  \\$aC13.$x351.$x500.$x56.$x630.$x580.$x765
=072  \\$aC19.$x391.$x630.$x580.$x765
=150  \\$aPolycystic Ovary Syndrome
=450  \\$wnnna$aOvarian Degeneration, Sclerocystic
=450  \\$wnnna$aOvarian Syndrome, Polycystic
=450  \\$wnnna$aOvary, Sclerocystic
=450  \\$wnnna$aOvary Syndrome, Polycystic
=450  \\$wnnna$aPolycystic Ovarian Syndrome
=450  \\$wnnna$aPolycystic Ovary Syndrome 1
=450  \\$wnnna$aSclerocystic Ovarian Degeneration
=450  \\$wnnna$aSclerocystic Ovaries
=450  \\$wnnna$aSclerocystic Ovary
=450  \\$wnnna$aSclerocystic Ovary Syndrome
=450  \\$aStein-Leventhal Syndrome
=450  \\$wnnna$aStein Leventhal Syndrome
=450  \\$wnnna$aSyndrome, Polycystic Ovary
=450  \\$wnnna$aSyndrome, Stein-Leventhal
=550  \\$wg$aOvarian Cysts
=667  \\$anon-neoplastic
=680  \\$iA complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
=688  \\$a85; was STEIN-LEVENTHAL SYNDROME 1963-84
=750  \0$aPolycystic ovary syndrome$5IEN$0(DLC)sh 85127892

=LDR  01472cz  a2200445n  4500
=001  9880363852002441
=005  20180117161629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011084
=035  \\$aCBA4374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847
=072  \\$aD4.$x615
=150  \\$aPolycyclic Aromatic Hydrocarbons
=450  \\$wnno$aPolycyclic Hydrocarbons, Aromatic
=450  \\$wnnna$aAromatic Hydrocarbons, Polycyclic
=450  \\$wnnna$aAromatic Hydrocarbons, Polynuclear
=450  \\$wnnna$aAromatic Polycyclic Hydrocarbons
=450  \\$wnnna$aHydrocarbons, Aromatic Polycyclic
=450  \\$wnnna$aHydrocarbons, Polycyclic Aromatic
=450  \\$wnnna$aHydrocarbons, Polynuclear Aromatic
=450  \\$aPolynuclear Aromatic Hydrocarbons
=550  \\$wg$aHydrocarbons, Aromatic
=550  \\$wg$aPolycyclic Compounds
=550  \\$wh$aAnthracenes
=550  \\$wh$aAzulenes
=550  \\$wh$aBenz(a)Anthracenes
=550  \\$wh$aBenzocycloheptenes
=550  \\$wh$aFluorenes
=550  \\$wh$aIndenes
=550  \\$wh$aNaphthacenes
=550  \\$wh$aNaphthalenes
=550  \\$wh$aPhenalenes
=550  \\$wh$aPhenanthrenes
=550  \\$wh$aPyrenes
=550  \\$aFused-Ring Compounds
=550  \\$aBridged-Ring Compounds
=680  \\$iAromatic hydrocarbons that contain extended fused-ring structures.
=688  \\$a2017 (1996)
=750  \0$aPolycyclic aromatic hydrocarbons$0(DLC)sh 85104606$5IEN-M

=LDR  00912cz  a2200265n  4500
=001  9880363852102441
=005  20180710122644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011083
=035  \\$aCBA4373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4
=150  \\$aPolycyclic Compounds
=450  \\$wnnna$aCompounds, Polycyclic
=450  \\$aHydrocarbons, Polycyclic
=450  \\$aPolycyclic Hydrocarbons
=550  \\$wh$aBridged-Ring Compounds
=550  \\$wh$aFused-Ring Compounds
=550  \\$wh$aMacrocyclic Compounds
=550  \\$wh$aPolycyclic Aromatic Hydrocarbons
=550  \\$wh$aSpiro Compounds
=550  \\$aHeterocyclic Compounds
=680  \\$iCompounds which contain two or more rings in their structure.
=688  \\$a2005(1974); POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995
=750  \0$aPolycyclic compounds$0(DLC) sh 85104607$5IEN

=LDR  01170cz  a2200277n  4500
=001  9880363852202441
=005  20180409113141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011078
=035  \\$aCBA4368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x185.$x698
=072  \\$aD2.$x455.$x526.$x439.$x773
=150  \\$aPolychlorinated Biphenyls
=450  \\$wnnna$aBiphenyls, Polychlorinated
=450  \\$wnnna$aCompounds, Polychlorobiphenyl
=450  \\$aPCBs
=450  \\$aPolychlorobiphenyl Compounds
=550  \\$wg$aBiphenyl Compounds
=550  \\$wg$aDioxins and Dioxin-like Compounds
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wh$aAroclors
=667  \\$a"yusho poisoning": see note on RICE
=680  \\$iIndustrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants.
=688  \\$a92; was POLYCHLOROBIPHENYL COMPOUNDS 1971-91 (Prov 1971-72)
=750  \0$aPolychlorinated biphenyls$5IEN-M$0(DLC)sh 85104599

=LDR  00703cz  a2200217n  4500
=001  9880363852302441
=005  20141212204707.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011077
=035  \\$aCBA4367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x91.$x700
=150  \\$aPolychaeta
=450  \\$aMyxicola
=450  \\$wnnna$aMyxicolas
=450  \\$wnnna$aPolychaetas
=550  \\$wg$aAnnelida
=667  \\$amarine worms; /microbiol /parasitol /virol permitted
=680  \\$iA class of marine annelids including sandworms, tube worms, clamworms, and fire worms. It includes also the genus Myxicola infundibulum.
=688  \\$a75
=750  \0$aPolychaeta$5IEN$0(DLC)sh 85104596

=LDR  00906cz  a2200241n  4500
=001  9880363852402441
=005  20141212204707.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011075
=035  \\$aCBA4365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x185.$x680
=072  \\$aD2.$x455.$x526.$x368.$x700
=150  \\$aPolybrominated Biphenyls
=450  \\$wnnna$aBiphenyls, Polybrominated
=450  \\$wnnna$aCompounds, Polybromobiphenyl
=450  \\$aPolybromobiphenyl Compounds
=550  \\$wg$aBiphenyl Compounds
=550  \\$wg$aHydrocarbons, Brominated
=667  \\$aDF: PBBS
=680  \\$iBiphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants.
=688  \\$a94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 (see under BIPHENYL COMPOUNDS 1977-83)
=750  \0$aPolybrominated biphenyls$5IEN$0(DLC)sh 85104593

=LDR  00699cz  a2200265n  4500
=001  9880363852502441
=005  20171012164856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011073
=035  \\$aCBA4363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782
=150  \\$aPolyamines
=550  \\$wg$aAmines
=550  \\$wh$aColestipol
=550  \\$wh$aDiamines
=550  \\$wh$aHexadimethrine Bromide
=550  \\$wh$aMethenamine
=550  \\$wh$aPentetic Acid
=550  \\$wh$aSevelamer
=550  \\$wh$aSpermidine
=550  \\$wh$aSpermine
=688  \\$a72(71)
=750  \0$aPolyamines in the body$5IEN-M$0(DLC)sh 85104590
=750  \0$aPolyamines$5IEN-HS$0(DLC)sh 85104589

=LDR  00801cz  a2200217n  4500
=001  9880363852602441
=005  20141212204702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011059
=035  \\$aCBA4349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185.$x600
=072  \\$aD1.$x268.$x271.$x680
=072  \\$aD1.$x268.$x513.$x875
=150  \\$aPolonium
=550  \\$wg$aChalcogens
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aMetalloids
=667  \\$anaturally radioactive; IM
=680  \\$iPolonium. A radioactive element that is a member of the chalcogen family. It has the atomic symbol Po, atomic number 84, and the atomic weight of the isotope with the longest half-life (209Po) is 208.98. It decays by alpha-emission.
=750  \0$aPolonium$5IEN$0(DLC)sh 85104579

=LDR  01452cz  a2200409n  4500
=001  9880363852702441
=005  20141212204701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011058
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x249.$x500.$x249.$x500
=150  \\$aPollen
=450  \\$wnnna$aGamete, Plant Male
=450  \\$wnnna$aGametes, Plant Male
=450  \\$wnnna$aGametophyte, Male
=450  \\$wnnna$aGametophytes, Male
=450  \\$wnnna$aGrain, Pollen
=450  \\$wnnna$aGrains, Pollen
=450  \\$wnnna$aMale Gamete, Plant
=450  \\$wnnna$aMale Gametes, Plant
=450  \\$wnnna$aMale Gametophyte
=450  \\$wnnna$aMale Gametophytes
=450  \\$wnnna$aMicrospore, Plant
=450  \\$wnnna$aMicrospores, Plant
=450  \\$wnnna$aPlant Male Gamete
=450  \\$wnnna$aPlant Male Gametes
=450  \\$wnnna$aPlant Microspore
=450  \\$wnnna$aPlant Microspores
=450  \\$wnnna$aPollen Grain
=450  \\$wnnna$aPollen Grains
=550  \\$wg$aGerm Cells, Plant
=550  \\$wh$aPollen Tube
=550  \\$aPlants
=550  \\$aPoaceae
=667  \\$acoordinate with specific plant; pollen as an allergen: coordinate IM with ALLERGENS (IM); hypersensitivity: consider RESPIRATORY HYPERSENSITIVITY and its specifics particularly RHINITIS, ALLERGIC, SEASONAL
=680  \\$iThe fertilizing element of plants that contains the male GAMETOPHYTES.
=750  \0$aPollen$5IEN$0(DLC)sh 85104512

=LDR  01151nz  a2200325n  4500
=001  9880480467602441
=005  20161114165559.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069457
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x320.$x500
=072  \\$aN1.$x224.$x667
=150  \\$aPopulation Forecast
=450  \\$wnnna$aPopulation Growth Estimation
=450  \\$wnnna$aPopulation Projection
=450  \\$wnnna$aEstimation, Population Growth
=450  \\$wnnna$aEstimations, Population Growth
=450  \\$wnnna$aForecasts, Population
=450  \\$wnnna$aGrowth Estimation, Population
=450  \\$wnnna$aGrowth Estimations, Population
=450  \\$wnnna$aPopulation Forecasts
=450  \\$wnnna$aPopulation Growth Estimations
=450  \\$wnnna$aPopulation Projections
=450  \\$wnnna$aProjection, Population
=550  \\$wg$aDemography
=550  \\$wg$aForecasting
=550  \\$aPopulation Growth
=680  \\$iEstimates of projected population.
=688  \\$a2016; use FORECASTING 1981-2015; for POPULATION GROWTH ESTIMATE use POPULATION GROWTH 1980-2015
=750  \0$aPopulation forecasting$0(DLC)sh 85104919$5IEN-M

=LDR  00819nz  a2200229n  4500
=001  9880480649902441
=005  20161117141651.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068377
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x700
=150  \\$aPlantaginaceae
=450  \\$wnnna$aSpeedwell Family
=450  \\$aGlobularia
=450  \\$aStemodia
=450  \\$wnnna$aFamilies, Speedwell
=450  \\$wnnna$aFamily, Speedwell
=450  \\$wnnna$aSpeedwell Families
=550  \\$wg$aLamiales
=680  \\$iA plant family of order Lamiales. The Plantago genus is best known. Lesser known members include Hippuris, Littorella and Callitriche.
=688  \\$a2016; for GLOBULARIA and STEMODIA use SCROPHULARIACEAE 2003-2015
=750  \0$aPlantaginaceae$0(DLC)sh 88023004$5IEN-M

=LDR  01227nz  a2200361n  4500
=001  9880480654502441
=005  20161117105357.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068378
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583
=150  \\$aLamiales
=450  \\$aProboscidea Plant
=450  \\$wnnna$aPlant, Proboscidea
=450  \\$wnnna$aPlants, Proboscidea
=450  \\$wnnna$aProboscidea Plants
=550  \\$wg$aAngiosperms
=550  \\$wh$aAcanthaceae
=550  \\$wh$aBignoniaceae
=550  \\$wh$aCalceolariaceae
=550  \\$wh$aCraterostigma
=550  \\$wh$aLamiaceae
=550  \\$wh$aMimulus
=550  \\$wh$aOleaceae
=550  \\$wh$aOrobanchaceae
=550  \\$wh$aPedaliaceae
=550  \\$wh$aPlantaginaceae
=550  \\$wh$aRehmannia
=550  \\$wh$aScrophulariaceae
=550  \\$wh$aVerbenaceae
=680  \\$iAn order of the Lamiidae clade. Lamiales is one of the largest orders of flowering plants and includes pot-herbs in the mint family (MINT; SAGE; OREGANO; BASIL); SESAME, foxgloves; SNAPDRAGONS; and the olive family.
=688  \\$a2016; for PROBOSCIDEA PLANT use PEDALIACEAE 2003-2015
=750  \0$aLamiales$0(DLC)sh 85074202$5IEN-M

=LDR  02632cz  a2200553n  4500
=001  9880480654802441
=005  20161117100413.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D056656
=040  \\$aDNLM$cDNLM
=060  \0$aQT 26
=072  \\$aE7.$x305.$x343.$x500
=150  \\$aLab-On-A-Chip Devices
=450  \\$wnnna$aMicrochip Analytical Devices
=450  \\$wnnna$aMicrofluidic Devices
=450  \\$wnnna$aMicrofluidic Lab-On-A-Chip
=450  \\$wnnna$aMicrofluidic Microchips
=450  \\$wnnna$aNanochip Analytical Devices
=450  \\$wnnna$aAnalytical Device, Microchip
=450  \\$wnnna$aAnalytical Device, Nanochip
=450  \\$wnnna$aAnalytical Devices, Microchip
=450  \\$wnnna$aAnalytical Devices, Nanochip
=450  \\$wnnna$aDevice, Lab-On-A-Chip
=450  \\$wnnna$aDevice, Microchip Analytical
=450  \\$wnnna$aDevice, Microfluidic
=450  \\$wnnna$aDevice, Nanochip Analytical
=450  \\$wnnna$aDevices, Lab-On-A-Chip
=450  \\$wnnna$aDevices, Microchip Analytical
=450  \\$wnnna$aDevices, Microfluidic
=450  \\$wnnna$aDevices, Nanochip Analytical
=450  \\$wnnna$aLab On A Chip Devices
=450  \\$wnnna$aLab-On-A-Chip Device
=450  \\$wnnna$aLab-On-A-Chip, Microfluidic
=450  \\$wnnna$aLab-On-A-Chips, Microfluidic
=450  \\$wnnna$aMicrochip Analytical Device
=450  \\$wnnna$aMicrochip, Microfluidic
=450  \\$wnnna$aMicrochips, Microfluidic
=450  \\$wnnna$aMicrofluidic Device
=450  \\$wnnna$aMicrofluidic Lab On A Chip
=450  \\$wnnna$aMicrofluidic Lab-On-A-Chips
=450  \\$wnnna$aMicrofluidic Microchip
=450  \\$wnnna$aNanochip Analytical Device
=450  \\$aMicrochip Analytical Procedures$xinstrumentation
=550  \\$wg$aMicro-Electrical-Mechanical Systems
=550  \\$aMicrochip Analytical Procedures
=667  \\$anote entry term MICROCHIP ANALYTICAL DEVICES: MICROCHIP ANALYTICAL PROCEDURES is also available
=680  \\$iMicrodevices that combine microfluidics technology with electrical and/or mechanical functions for analyzing very small fluid volumes. They consist of microchannels etched into substrates made of silicon, glass, or polymer using processes similar to photolithography. The test fluids in the channels can then interact with different elements such as electrodes, photodetectors, chemical sensors, pumps, and valves.
=688  \\$a2010; use MICROCHIP ANALYTICAL PROCEDURES 2005-2009; for MICROCHIP ANALYTICAL DEVICES & NANOCHIP ANALYTICAL DEVICES use MICROCHIP ANALYTICAL PROCEDURES 2005-2009
=750  \0$aMicrofluidic devices$0(DLC)sh2005007502$5IEN-M

=LDR  00311nz  a2200109n  4500
=001  9880480655002441
=005  20161117094008.0
=008  030709\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D044085Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aMicrofluidics$xinstrumentation
=750  \0$aMicrofluidic devices$0(DLC)sh2005007502$5IEN-M

=LDR  01089nz  a2200325n  4500
=001  9880480664702441
=005  20161116103003.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068104
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x400.$x388
=150  \\$aInfant Health
=450  \\$wnnna$aBaby Health
=450  \\$wnnna$aHealth of Newborn Infants
=450  \\$wnnna$aHealth of the Newborn Infant
=450  \\$wnnna$aNeonatal Health
=450  \\$wnnna$aNewborn Health
=450  \\$wnnna$aNewborn Infant Health
=450  \\$wnnna$aHealth, Baby
=450  \\$wnnna$aHealth, Infant
=450  \\$wnnna$aHealth, Neonatal
=450  \\$wnnna$aHealth, Newborn
=450  \\$wnnna$aHealth, Newborn Infant
=450  \\$wnnna$aInfant Health, Newborn
=550  \\$wg$aHealth
=550  \\$aInfant Welfare
=680  \\$iThe concept covering the physical and mental conditions of INFANTS.
=688  \\$a2016; use INFANT WELFARE 1994-2015
=750  \0$aInfants$xHealth and hygiene$0(DLC) sh 86007528$5IEN-M
=750  \0$aNewborn infants$xHealth and hygiene$0(DLC) sh 86007265$5IEN-M

=LDR  00960nz  a2200265n  4500
=001  9880480665102441
=005  20161116093930.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067896
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x261.$x262.$x500
=072  \\$aJ1.$x576.$x519
=150  \\$aIndustrial Development
=450  \\$wnnna$aTechnology Development
=450  \\$aIndustrialization
=450  \\$wnnna$aDevelopment, Industrial
=450  \\$wnnna$aDevelopment, Technology
=450  \\$wnnna$aDevelopments, Industrial
=450  \\$wnnna$aIndustrial Developments
=450  \\$wnnna$aTechnology Developments
=550  \\$wg$aEconomic Development
=550  \\$wg$aIndustry
=680  \\$iActivity concerned with the planning and building of industries through manufacturing, provision of specialized services, and COMMERCE.
=688  \\$a2016; for INDUSTRIALIZATION use INDUSTRY 2000-2015
=750  \0$aIndustrialization$0(DLC)sh 85065956$5IEN-M

=LDR  00854nz  a2200217n  4500
=001  9880480670002441
=005  20161115131232.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068956
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x385.$x500
=150  \\$aPrisoner Dilemma
=450  \\$wnnna$aPrisoners Dilemma
=450  \\$aPrisoner's Dilemma
=450  \\$wnnna$aDilemma, Prisoner
=450  \\$wnnna$aDilemma, Prisoner's
=450  \\$wnnna$aDilemma, Prisoners
=550  \\$wg$aGames, Experimental
=680  \\$iA scenario in decision analysis in which two individuals motivated entirely by self-preservation at the expense of the other, end up in a worse state than if they had cooperated with each other in the decision-making process.
=688  \\$a2016; use GAME THEORY 1985-2015
=750  \0$aPrisoner's dilemma game$0(DLC) sh 85106969$5IEN-M

=LDR  01893nz  a2200505n  4500
=001  9880481341202441
=005  20161123115912.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069453
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x750.$x770.$x776.$x891
=150  \\$aUltrasonic Waves
=450  \\$wnnna$aLIPUS
=450  \\$wnnna$aLow Intensity Pulsed Ultrasound
=450  \\$wnnna$aLow Intensity Pulsed Ultrasound Radiation
=450  \\$wnnna$aLow-Intensity Pulsed Ultrasound (LIPUS)
=450  \\$wnnna$aPulsed Ultrasound
=450  \\$wnnna$aUltrasonic Vibration
=450  \\$wnnna$aUltrasound Radiation
=450  \\$wnnna$aUltrasound Waves
=450  \\$wnnna$aLow Intensity Pulsed Ultrasound (LIPUS)
=450  \\$wnnna$aLow-Intensity Pulsed Ultrasounds (LIPUS)
=450  \\$wnnna$aPulsed Ultrasound, Low-Intensity (LIPUS)
=450  \\$wnnna$aPulsed Ultrasounds
=450  \\$wnnna$aPulsed Ultrasounds, Low-Intensity (LIPUS)
=450  \\$wnnna$aRadiation, Ultrasound
=450  \\$wnnna$aUltrasonic Vibrations
=450  \\$wnnna$aUltrasonic Wave
=450  \\$wnnna$aUltrasound Wave
=450  \\$wnnna$aUltrasound, Low-Intensity Pulsed (LIPUS)
=450  \\$wnnna$aUltrasound, Pulsed
=450  \\$wnnna$aUltrasounds, Low-Intensity Pulsed (LIPUS)
=450  \\$wnnna$aUltrasounds, Pulsed
=450  \\$wnnna$aVibration, Ultrasonic
=450  \\$wnnna$aVibrations, Ultrasonic
=450  \\$wnnna$aWave, Ultrasonic
=450  \\$wnnna$aWave, Ultrasound
=450  \\$wnnna$aWaves, Ultrasonic
=450  \\$wnnna$aWaves, Ultrasound
=550  \\$wg$aSound
=550  \\$wh$aHigh-Energy Shock Waves
=550  \\$aUltrasonics
=680  \\$iOscillating sound wave with a frequency higher than the upper limit of the human hearing range.
=688  \\$a2016; for ULTRASOUND RADIATION use SOUND 2012-2015
=750  \0$aUltrasonic waves$0(DLC) sh85139488$5IEN-M

=LDR  00818nz  a2200193n  4500
=001  9880481342302441
=005  20161123105153.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068217
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x919
=150  \\$aSocial Workers
=450  \\$wnnna$aSocial Worker
=450  \\$wnnna$aWorker, Social
=450  \\$wnnna$aWorkers, Social
=550  \\$wg$aOccupational Groups
=680  \\$iProfessionals who work with persons affected by social disadvantages such as POVERTY; mental and physical illness or disability, and social injustice.  Their focus is on both the individual and his or her environment, including violations of their civil liberties and human rights.
=688  \\$a2016 (1976); use SOCIAL WORK 1976-2015
=750  \0$aSocial workers$5IEN-M$0(DLC)sh 85124114

=LDR  00663nz  a2200193n  4500
=001  9880481344802441
=005  20161123095542.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068543
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x190
=150  \\$aCalceolariaceae
=450  \\$wnnna$aJovellana
=450  \\$wnnna$aPorodittia
=450  \\$aCalceolaria
=550  \\$wg$aLamiales
=680  \\$iA family in the order Lamiales with several species that are used in TRADITIONAL MEDICINE.
=688  \\$a2016; for CALCEOLARIA use SCROPHULARIACEAE 2004-2015
=750  \0$iNarrower mapping$aCalceolaria$4NM$0(DLC)sh2001005769$5IEN-M

=LDR  00734nz  a2200229n  4500
=001  9880481356602441
=005  20161121142229.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068239
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x750
=150  \\$aPrunus persica
=450  \\$wnnna$aPeach Tree
=450  \\$wnnna$aPeaches
=450  \\$aPeach
=450  \\$wnnna$aPeach Trees
=450  \\$wnnna$aTree, Peach
=450  \\$wnnna$aTrees, Peach
=550  \\$wg$aPrunus
=680  \\$iA plant species in the family ROSACEAE. It is a tree that produces peach fruit.
=688  \\$a2016; use PRUNUS 2002-2015; for PEACH use PRUNUS 2002-2015
=750  \0$aPeach$0(DLC) sh 85098962$5IEN-M

=LDR  01339nz  a2200409n  4500
=001  9880481357602441
=005  20161121140045.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068242
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x450
=150  \\$aPrunus domestica
=450  \\$wnnna$aCherry Plum Tree
=450  \\$wnnna$aJapanese Plum
=450  \\$wnnna$aPlum Tree
=450  \\$wnnna$aPlums
=450  \\$wnnna$aPrunus cerasifera
=450  \\$wnnna$aPrunus salicina
=450  \\$aPlum
=450  \\$wnnna$aCherry Plum Trees
=450  \\$wnnna$aJapanese Plums
=450  \\$wnnna$aPlum Tree, Cherry
=450  \\$wnnna$aPlum Trees
=450  \\$wnnna$aPlum Trees, Cherry
=450  \\$wnnna$aPlum, Japanese
=450  \\$wnnna$aPlums, Japanese
=450  \\$wnnna$aPrunus salicinas
=450  \\$wnnna$aTree, Cherry Plum
=450  \\$wnnna$aTree, Plum
=450  \\$wnnna$aTrees, Cherry Plum
=450  \\$wnnna$aTrees, Plum
=450  \\$wnnna$asalicina, Prunus
=450  \\$wnnna$asalicinas, Prunus
=550  \\$wg$aPrunus
=680  \\$iA plant species in the family ROSACEAE. It is a tree that produces fruits called plums.
=688  \\$a2016; for PRUNUS CERASIFERA use PRUNUS 2002-2015; for PLUM use PRUNUS 2002-2015
=750  \0$aPlum$0(DLC)sh 85103540$5IEN

=LDR  01003nz  a2200313n  4500
=001  9880481357902441
=005  20161121134824.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068181
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x500
=150  \\$aPrunus dulcis
=450  \\$wnnna$aAlmond Tree
=450  \\$wnnna$aAlmonds
=450  \\$wnnna$aAmygdalus communis
=450  \\$wnnna$aPrunis communis
=450  \\$wnnna$aPrunus amygdalus
=450  \\$wnnna$aSweet Almond
=450  \\$wnnna$aAlmond
=450  \\$wnnna$aAlmond Trees
=450  \\$wnnna$aAlmond, Sweet
=450  \\$wnnna$aAlmonds, Sweet
=450  \\$wnnna$aSweet Almonds
=450  \\$wnnna$aTree, Almond
=450  \\$wnnna$aTrees, Almond
=550  \\$wg$aPrunus
=680  \\$iA plant species in the family ROSACEAE, genus Prunus which produces edible seeds called almonds.
=688  \\$a2016; for ALMONDS use PRUNUS 2002-2015
=750  \0$aAlmond$0(DLC)sh 85003773$5IEN-M

=LDR  01436nz  a2200445n  4500
=001  9880481364002441
=005  20161121105013.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068220
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x400
=150  \\$aPrunus avium
=150  \\$wg$aPrunus
=450  \\$wnnna$aBlack Cherry
=450  \\$wnnna$aPie Cherry
=450  \\$wnnna$aPrunus cerasus
=450  \\$wnnna$aPrunus serotina
=450  \\$wnnna$aSour Cherry
=450  \\$wnnna$aSweet Cherries
=450  \\$wnnna$aSweet Cherry Tree
=450  \\$wnnna$aBlack Cherries
=450  \\$wnnna$aCherries, Black
=450  \\$wnnna$aCherries, Pie
=450  \\$wnnna$aCherries, Sour
=450  \\$wnnna$aCherries, Sweet
=450  \\$wnnna$aCherry Tree, Sweet
=450  \\$wnnna$aCherry Trees, Sweet
=450  \\$wnnna$aCherry, Black
=450  \\$wnnna$aCherry, Pie
=450  \\$wnnna$aCherry, Sour
=450  \\$wnnna$aCherry, Sweet
=450  \\$wnnna$aPie Cherries
=450  \\$wnnna$aSour Cherries
=450  \\$wnnna$aSweet Cherry
=450  \\$wnnna$aSweet Cherry Trees
=450  \\$wnnna$aTree, Sweet Cherry
=450  \\$wnnna$aTrees, Sweet Cherry
=680  \\$iA plant species in the family ROSACEAE. It is the source of the sweet cherry fruit.
=688  \\$a2016; for PRUNUS SEROTINA use PRUNUS 2002-2015
=750  \0$aSweet cherry$0(DLC)sh 85131169$5IEN-M

=LDR  00767nz  a2200229n  4500
=001  9880481364402441
=005  20161121103703.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068219
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625.$x375
=150  \\$aPrunus armeniaca
=450  \\$wnnna$aApricot Tree
=450  \\$wnnna$aApricots
=450  \\$aApricot
=450  \\$wnnna$aApricot Trees
=450  \\$wnnna$aTree, Apricot
=450  \\$wnnna$aTrees, Apricot
=550  \\$wg$aPrunus
=680  \\$iA plant species in the family ROSACEAE. It is the source of apricot fruit.
=688  \\$a2016; use PRUNUS 2002-2015; for APRICOT use PRUNUS 2002-2015 and ROSALES 1998-2001
=750  \0$aApricot$0(DLC)sh 85006194$5IEN-M

=LDR  00992nz  a2200241n  4500
=001  9880481366002441
=005  20161121094428.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067716
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x874.$x500
=150  \\$aPoint-of-Care Testing
=450  \\$wnnna$aPoint of Care Testing
=450  \\$aBedside Testing
=450  \\$wnnna$aBedside Testings
=450  \\$wnnna$aPoint-of-Care Testings
=450  \\$wnnna$aTesting, Bedside
=450  \\$wnnna$aTesting, Point-of-Care
=450  \\$wnnna$aTestings, Point-of-Care
=550  \\$wg$aPoint-of-Care Systems
=680  \\$iAllows patient diagnoses in the physician's office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)
=688  \\$a2016; for BEDSIDE TESTING use POINT-OF-CARE SYSTEMS 1995-2015
=750  \0$aPoint-of-care testing$0(DLC)sh2002008700$5IEN-M

=LDR  01603nz  a2200409n  4500
=001  9880481373402441
=005  20200610123252.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010829
=040  \\$aDNLM$cDNLM
=072  \\$aG7
=150  \\$aPhysiological Phenomena
=450  \\$wnnna$aPhysiological Concepts
=450  \\$wnnna$aPhysiological Phenomenon
=450  \\$wnnna$aConcept, Physiological
=450  \\$wnnna$aConcepts, Physiological
=450  \\$wnnna$aPhenomena, Physiological
=450  \\$wnnna$aPhenomenas, Physiological
=450  \\$wnnna$aPhenomenon, Physiological
=450  \\$wnnna$aPhysiological Concept
=450  \\$wnno$aPhysiological Processes
=550  \\$wh$aAnatomic Variation
=550  \\$wh$aBody Temperature
=550  \\$wh$aBody Constitution
=550  \\$wh$aChronbiology Phenomena
=550  \\$wh$aDose-Response Relationship, Radiation
=550  \\$wh$aElectrophysiological Phenomena
=550  \\$wh$aFetal Viability
=550  \\$wh$aLongevity
=550  \\$wh$aNutritional Physiological Phenomena
=550  \\$wh$aOrgan Specificity
=550  \\$wh$aOrganism Hydration Status
=550  \\$wh$aPharmacological Phenomena
=667  \\$ageneral or unspecified; prefer specifics; differentiate from PHYSIOLOGY, the specialty or discipline
=680  \\$iThe functions and properties of living organisms, including both the physical and chemical factors and processes, supporting life in single- or multi-cell organisms from their origin through the progression of life.
=688  \\$a2009 (1975)
=750  \2$aPhysiology$0(DLC)sh 85101679$5IEN-M

=LDR  01911nz  a2200493n  4500
=001  9880481373602441
=005  20161118104224.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069437
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x690.$x773
=150  \\$aPharmacological Phenomena
=450  \\$wnnna$aPharmacologic Phenomena
=450  \\$wnnna$aPharmacologic Phenomenon
=450  \\$wnnna$aPharmacologic Process
=450  \\$wnnna$aPharmacological Concepts
=450  \\$wnnna$aPharmacological Phenomenon
=450  \\$aPharmacologic Processes
=450  \\$aPharmacological Processes
=450  \\$wnnna$aConcept, Pharmacological
=450  \\$wnnna$aConcepts, Pharmacological
=450  \\$wnnna$aPharmacological Concept
=450  \\$wnnna$aPhenomena, Pharmacologic
=450  \\$wnnna$aPhenomena, Pharmacological
=450  \\$wnnna$aPhenomenon, Pharmacologic
=450  \\$wnnna$aPhenomenon, Pharmacological
=450  \\$wnnna$aProcess, Pharmacologic
=450  \\$wnnna$aProcesses, Pharmacologic
=450  \\$wnnna$aProcesses, Pharmacological
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aCytoprotection
=550  \\$wh$aDepression, Chemical
=550  \\$wh$aDose-Response Relationship, Drug
=550  \\$wh$aDown-Regulation
=550  \\$wh$aDrug Interactions
=550  \\$wh$aDrug Resistance
=550  \\$wh$aDrug Tolerance
=550  \\$wh$aStimulation, Chemical
=550  \\$wh$aStructure-Activity Relationship
=550  \\$wh$aUp-Regulation
=667  \\$ageneral or unspecified; prefer specifics
=688  \\$a2016 (2009); for PHARMACOLOGICAL PROCESSES use PHARMACOLOGICAL PROCESSES 2009-2015; for PHARMACOLOGICAL PHENOMENA use PHARMACOLOGICAL PHENOMENA 2009-2015.
=680  \\$iInteractions that occur between a living organism and chemicals that affect normal or abnormal biochemical function.
=750  \0$aPharmacology$0(DLC)sh 85100599$5IEN-M

=LDR  00920nz  a2200217n  4500
=001  9880482110002441
=005  20161202132603.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067575
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x452.$x859.$x564.$x137
=150  \\$aAdministrative Claims, Healthcare
=450  \\$wnnna$aAdministrative Claim, Healthcare
=450  \\$wnnna$aClaim, Healthcare Administrative
=450  \\$wnnna$aClaims, Healthcare Administrative
=450  \\$wnnna$aHealthcare Administrative Claim
=450  \\$wnnna$aHealthcare Administrative Claims
=550  \\$wg$aMedical Records
=680  \\$iInformation relating to itemized coding of procedures and costs associated with healthcare delivery, used as a means for tracking healthcare utilization, patterns of care, and treatment outcomes.
=688  \\$a2016
=750  \0$iNarrower mapping$aHealth insurance claims$4NM$0(DLC)sh 85066933$5IEN-M

=LDR  00815nz  a2200229n  4500
=001  9880482146902441
=005  20161130101436.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067956
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x108
=150  \\$aAdenylyl Cyclase Inhibitors
=450  \\$wnnna$aAdenylate Cyclase Inhibitors
=450  \\$wnnna$aCyclase Inhibitors, Adenylate
=450  \\$wnnna$aCyclase Inhibitors, Adenylyl
=450  \\$wnnna$aInhibitors, Adenylate Cyclase
=450  \\$wnnna$aInhibitors, Adenylyl Cyclase
=450  \\$aAdenylyl Cyclases$xantagonists & inhibitors
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds that bind to and inhibit the action of ADENYLYL CYCLASES.
=688  \\$a2016
=750  \0$aAdenylate cyclase$xInhibitors$0(DLC)sh 85000856$5IEN-M

=LDR  00867nz  a2200253n  4500
=001  9880482869202441
=005  20161205105750.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068881
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x50.$x126
=150  \\$aAnimals, Exotic
=450  \\$wnnna$aExotic Animals
=450  \\$wnnna$aExotic Pets
=450  \\$wnnna$aAnimal, Exotic
=450  \\$wnnna$aExotic Animal
=450  \\$wnnna$aExotic Pet
=450  \\$wnnna$aPet, Exotic
=450  \\$wnnna$aPets, Exotic
=550  \\$wg$aAnimal Population Groups
=667  \\$ause only when specified by author; coordinate with ANIMALS, WILD or ANIMALS, ZOO as needed
=680  \\$iAnimals native to a foreign country or of foreign origin or character, that are not native to the United States.
=688  \\$a2016
=750  \0$aExotic animals$0(DLC)sh 90000787$5IEN-M

=LDR  00839nz  a2200253n  4500
=001  9880482871802441
=005  20161205102832.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067292
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x317.$x269.$x625
=150  \\$aAlcohol Drinking in College
=450  \\$wnnna$aAlcohol Drinking, College Students
=450  \\$wnnna$aCollege Drinking
=450  \\$wnnna$aCollege Student Drinking
=450  \\$wnnna$aUniversity Student Drinking
=450  \\$wnnna$aDrinking, College
=450  \\$wnnna$aStudent Drinking, College
=450  \\$wnnna$aStudent Drinking, University
=550  \\$wg$aAlcohol Drinking
=550  \\$aUnderage Drinking
=680  \\$iAlcohol consumption among college students.
=688  \\$a2016
=750  \0$aCollege students$xAlcohol use$0(DLC)sh2008007970$5IEN-M

=LDR  01204nz  a2200349n  4500
=001  9880483141602441
=005  20161208105948.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067290
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x711.$x271
=150  \\$aBehavior Rating Scale
=450  \\$wnnna$aBehavior Test
=450  \\$wnnna$aBehavioral Rating Scale
=450  \\$wnnna$aBehavioral Test
=450  \\$wnnna$aBehavior Rating Scales
=450  \\$wnnna$aBehavior Tests
=450  \\$wnnna$aBehavioral Rating Scales
=450  \\$wnnna$aBehavioral Tests
=450  \\$wnnna$aRating Scale, Behavior
=450  \\$wnnna$aRating Scale, Behavioral
=450  \\$wnnna$aRating Scales, Behavior
=450  \\$wnnna$aRating Scales, Behavioral
=450  \\$wnnna$aScale, Behavioral Rating
=450  \\$wnnna$aTest, Behavior
=450  \\$wnnna$aTest, Behavioral
=450  \\$wnnna$aTests, Behavior
=450  \\$wnnna$aTests, Behavioral
=550  \\$wg$aPsychological Tests
=680  \\$iInstrument designed to assess human or animal behavior, using a standardized format.
=688  \\$a2016
=750  \0$iNarrower mapping$aBehavioral and Emotional Rating Scale$4NM$0(DLC)sh2003005185$5IEN-M

=LDR  01308nz  a2200361n  4500
=001  9880483144002441
=005  20161208102213.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067012
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x463.$x30.$x100
=150  \\$aBanking, Personal
=450  \\$wnnna$aBank Accounts
=450  \\$wnnna$aBanking, Commercial
=450  \\$wnnna$aBanking, Financial
=450  \\$wnnna$aChecking Accounts
=450  \\$wnnna$aSavings Accounts
=450  \\$wnnna$aAccount, Bank
=450  \\$wnnna$aAccount, Checking
=450  \\$wnnna$aAccount, Savings
=450  \\$wnnna$aAccounts, Bank
=450  \\$wnnna$aAccounts, Checking
=450  \\$wnnna$aAccounts, Savings
=450  \\$wnnna$aBank Account
=450  \\$wnnna$aChecking Account
=450  \\$wnnna$aCommercial Banking
=450  \\$wnnna$aFinancial Banking
=450  \\$wnnna$aPersonal Banking
=450  \\$wnnna$aSavings Account
=550  \\$wg$aAccounting
=680  \\$iA financial account set up between a financial institution (such as a commercial bank) and a customer (individual, group, or business), whereby the latter may deposit and withdraw money, and where applicable, be paid interest.
=688  \\$a2016
=750  \0$aBanks and banking$xCustomer services$0(DLC)sh 85011618$5IEN-M

=LDR  02072nz  a2200493n  4500
=001  9880483171602441
=005  20161206110331.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069237
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x329.$x465
=072  \\$aE2.$x800.$x550.$x310
=072  \\$aE4.$x665.$x600.$x465
=072  \\$aE5.$x200.$x998.$x329.$x465
=150  \\$aArthrocentesis
=450  \\$wnnna$aArthrocentesis, TMJ
=450  \\$wnnna$aArthrocentesis,Temporomandibular Joint
=450  \\$wnnna$aAspiration,Temporomandibular Joint
=450  \\$wnnna$aTemporomandibular Joint Arthrocentesis
=450  \\$wnnna$aTemporomandibular Joint Aspiration
=450  \\$wnnna$aArthrocenteses
=450  \\$wnnna$aArthrocenteses, TMJ
=450  \\$wnnna$aArthrocenteses, Temporomandibular Joint
=450  \\$wnnna$aArthrocentesis, Temporomandibular Joint
=450  \\$wnnna$aArthrocentesis,Temporomandibular Joints
=450  \\$wnnna$aAspiration, Temporomandibular Joint
=450  \\$wnnna$aAspiration,Temporomandibular Joints
=450  \\$wnnna$aAspirations, Temporomandibular Joint
=450  \\$wnnna$aJoint Arthrocenteses, Temporomandibular
=450  \\$wnnna$aJoint Arthrocentesis, Temporomandibular
=450  \\$wnnna$aJoint Aspiration, Temporomandibular
=450  \\$wnnna$aJoint Aspirations, Temporomandibular
=450  \\$wnnna$aJoint, Arthrocentesis,Temporomandibular
=450  \\$wnnna$aJoint, Aspiration,Temporomandibular
=450  \\$wnnna$aJoints, Arthrocentesis,Temporomandibular
=450  \\$wnnna$aJoints, Aspiration,Temporomandibular
=450  \\$wnnna$aTMJ Arthrocenteses
=450  \\$wnnna$aTMJ Arthrocentesis
=450  \\$wnnna$aTemporomandibular Joint Arthrocenteses
=450  \\$wnnna$aTemporomandibular Joint Aspirations
=550  \\$wg$aParacentesis
=680  \\$iPuncture and aspiration of fluid (e.g., SYNOVIAL FLUID) from a joint cavity. It is used sometimes to irrigate or administer drugs into a joint cavity.
=688  \\$a2016
=750  \0$aArthrocentesis$0(DLC)sh 85008125$5IEN-M

=LDR  01238nz  a2200361n  4500
=001  9880483953902441
=005  20161213115520.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067558
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x100.$x57.$x750
=150  \\$aBiological Mimicry
=450  \\$wnnna$aAposematism
=450  \\$wnnna$aBatesian Mimicry
=450  \\$wnnna$aBiological Camouflage
=450  \\$wnnna$aCrypses
=450  \\$wnnna$aMullerian Mimicry
=450  \\$wnnna$aAposematisms
=450  \\$wnnna$aBatesian Mimicries
=450  \\$wnnna$aBiological Camouflages
=450  \\$wnnna$aCamouflage, Biological
=450  \\$wnnna$aCamouflages, Biological
=450  \\$wnnna$aMimicries, Batesian
=450  \\$wnnna$aMimicries, Mullerian
=450  \\$wnnna$aMimicry, Batesian
=450  \\$wnnna$aMimicry, Biological
=450  \\$wnnna$aMimicry, Mullerian
=450  \\$wnnna$aMullerian Mimicries
=550  \\$wg$aAdaptation, Biological
=550  \\$aBiomimetics
=680  \\$iResemblance in appearance, structure, function, sound, scent or behavior between related or unrelated species, occurring in the same geographic location.
=688  \\$a2016
=750  \0$aMimicry (Biology)$0(DLC)sh 85085457$5IEN-M

=LDR  00635nz  a2200169n  4500
=001  9880483955002441
=005  20161213111708.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068258
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x60.$x375
=150  \\$aBevacizumab
=450  \\$wnnna$aAvastin
=550  \\$wg$aAntibodies, Monoclonal, Humanized
=680  \\$iAn anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF receptors and prevents the proliferation of blood vessels.
=688  \\$a2016 (2002)
=750  \0$aBevacizumab$0(DLC)sh2007003617$5IEN-M

=LDR  00432nz  a2200181n  4500
=001  9880483956502441
=005  20161213104230.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068476
=040  \\$aDNLM$cDNLM
=072  \\$aZ1.$x252.$x474.$x164.$x225
=072  \\$aZ1.$x433.$x114
=151  \\$aBeijing (China)
=451  \\$aPeking
=551  \\$wg$aChina
=550  \\$wg$aCities
=680  \\$iCapital of CHINA.
=688  \\$a2016

=LDR  01550nz  a2200445n  4500
=001  9880484433402441
=005  20161219141824.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068376
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x369.$x500.$x500
=072  \\$aF1.$x145.$x126.$x937.$x500
=072  \\$aF1.$x145.$x126.$x990.$x469
=072  \\$aF2.$x830.$x900.$x333
=150  \\$aCompassion Fatigue
=450  \\$wnnna$aSecondary Trauma
=450  \\$wnnna$aSecondary Traumatic Stress
=450  \\$wnnna$aSecondary Traumatization
=450  \\$wnnna$aVicarious Trauma
=450  \\$wnnna$aVicarious Traumatization
=450  \\$wnnna$aFatigue, Compassion
=450  \\$wnnna$aSecondary Traumas
=450  \\$wnnna$aSecondary Traumatizations
=450  \\$wnnna$aStress, Secondary Traumatic
=450  \\$wnnna$aStresses, Secondary Traumatic
=450  \\$wnnna$aTrauma, Secondary
=450  \\$wnnna$aTrauma, Vicarious
=450  \\$wnnna$aTraumas, Secondary
=450  \\$wnnna$aTraumas, Vicarious
=450  \\$wnnna$aTraumatic Stress, Secondary
=450  \\$wnnna$aTraumatization, Secondary
=450  \\$wnnna$aTraumatization, Vicarious
=450  \\$wnnna$aTraumatizations, Secondary
=450  \\$wnnna$aVicarious Traumas
=550  \\$wg$aBurnout, Professional
=550  \\$wg$aMental Fatigue
=550  \\$wg$aStress, Psychological
=680  \\$iStress response that occurs in individuals working in care giving professions.
=688  \\$a2016
=750  \0$aSecondary traumatic stress$0(DLC)sh2006007438$5IEN-M

=LDR  00700nz  a2200205n  4500
=001  9880484437602441
=005  20161219102304.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066494
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x96.$x628.$x255.$x500
=072  \\$aH1.$x158.$x610.$x30
=150  \\$aCognitive Neuroscience
=450  \\$wnnna$aNeuroscience, Cognitive
=550  \\$wg$aCognitive Science
=550  \\$wg$aNeurosciences
=667  \\$ause for the discipline only (education, history, etc)
=680  \\$iField of study concerning MENTAL PROCESSES, LEARNING, and the brain regions associated with them.
=688  \\$a2016
=750  \0$aCognitive neuroscience$0(DLC) sh 91005166$5IEN-M

=LDR  00607cz  a2200193n  4500
=001  9880484438702441
=005  20161219093500.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066428
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x200
=150  \\$aCoal Industry
=450  \\$wnnna$aCoal Industries
=450  \\$wnnna$aIndustries, Coal
=450  \\$wnnna$aIndustry, Coal
=550  \\$wg$aExtraction and Processing Industry
=680  \\$iEnterprise associated with the mining, processing, marketing and distribution of COAL.
=688  \\$a2016
=750  \0$aCoal trade$0(DLC)sh 85027411

=LDR  00827nz  a2200265n  4500
=001  9880484439202441
=005  20161219092452.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067917
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x97
=150  \\$aCloud Computing
=450  \\$wnnna$aCloud Processing
=450  \\$wnnna$aCloud Service
=450  \\$wnnna$aCloud Storage
=450  \\$wnnna$aCloud Storages
=450  \\$wnnna$aComputing, Cloud
=450  \\$wnnna$aProcessing, Cloud
=450  \\$wnnna$aService, Cloud
=450  \\$wnnna$aStorage, Cloud
=450  \\$wnnna$aStorages, Cloud
=550  \\$wg$aComputing Methodologies
=680  \\$iStoring and processing data on multiple servers that can be accessed through the Internet.
=688  \\$a2016
=750  \0$aCloud computing$0(DLC)sh2008004883$5IEN-M

=LDR  00851nz  a2200229n  4500
=001  9880484441002441
=005  20161217181903.0
=008  150702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066491
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x55
=150  \\$aClinical Decision-Making
=450  \\$wnnna$aMedical Decision-Making
=450  \\$wnnna$aClinical Decision Making
=450  \\$wnnna$aDecision-Making, Clinical
=450  \\$wnnna$aDecision-Making, Medical
=450  \\$wnnna$aMedical Decision Making
=550  \\$wg$aDiagnosis
=667  \\$ause DECISION MAKING for decision making by the patient
=680  \\$iProcess of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention.
=688  \\$a2016
=750  \0$aClinical medicine$xDecision making$0(DLC)sh 98001051$5IEN-M

=LDR  01040nz  a2200277n  4500
=001  9880484445702441
=005  20161216113706.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068818
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x60.$x750
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x60.$x750
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x200.$x750
=150  \\$aCetuximab
=450  \\$wnnna$aC225
=450  \\$wnnna$aErbitux
=450  \\$wnnna$aIMC C225
=450  \\$wnnna$aIMC-C225
=450  \\$wnnna$aMAb C225
=450  \\$wnnna$aC225, IMC
=450  \\$wnnna$aC225, MAb
=450  \\$wnnna$aIMCC225
=550  \\$wg$aAntibodies, Monoclonal, Humanized
=680  \\$iA chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.
=688  \\$a2016 (2000)
=750  \0$aCetuximab$0(DLC)sh2003003564$5IEN-M

=LDR  00966nz  a2200241n  4500
=001  9880484446902441
=005  20161216111406.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068597
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x238
=072  \\$aK1.$x752.$x566.$x479.$x173.$x200
=072  \\$aN5.$x350.$x670.$x250
=150  \\$aCensorship, Research
=450  \\$wnnna$aResearch Censorship
=550  \\$wg$aEthics, Research
=550  \\$wg$aSocial Control, Formal
=550  \\$aDual Use Research
=680  \\$iThe act or practice of scrutinizing the practice of scientific research for the purpose of preventing or suppressing the unethical applications as well knowledge derived from it.
=688  \\$a2016
=750  \0$81$wb$aCensorship$0(DLC)sh 85021828$5IEN-M
=750  \0$81$wb$aResearch$0(DLC)sh 85113021$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record:$aCensorship$iand$aResearch$5IEN-M

=LDR  01868nz  a2200433n  4500
=001  9880484457702441
=005  20161215130312.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069479
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x150.$x500
=072  \\$aD3.$x132.$x577.$x249.$x706.$x275
=072  \\$aD3.$x549.$x686.$x150.$x500
=072  \\$aD3.$x549.$x686.$x750.$x275
=072  \\$aD3.$x605.$x497.$x150.$x500
=072  \\$aD3.$x605.$x497.$x750.$x275
=072  \\$aD4.$x615.$x723.$x795.$x150.$x500
=072  \\$aD4.$x615.$x723.$x795.$x706.$x275
=072  \\$aD26.$x310.$x352
=150  \\$aBuprenorphine, Naloxone Drug Combination
=450  \\$wnnna$aBuprenorphine Naloxone
=450  \\$wnnna$aBuprenorphine Naloxone Drug Combination
=450  \\$wnnna$aBuprenorphine-Naloxone
=450  \\$wnnna$aBuprenorphine-Naloxone Combination
=450  \\$wnnna$aBuprenorphine-Naloxone Drug Combination
=450  \\$wnnna$aSuboxone
=450  \\$wnnna$aBuprenorphine Naloxone Combination
=450  \\$wnnna$aCombination, Buprenorphine-Naloxone
=450  \\$wnnna$aCombination, Buprenorphine-Naloxone Drug
=450  \\$wnnna$aDrug Combination, Buprenorphine-Naloxone
=450  \\$wnnna$aNaloxone, Buprenorphine
=550  \\$wg$aBuprenorphine
=550  \\$wg$aDrug Combinations
=550  \\$wg$aNaloxone
=680  \\$iA pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESIC with naloxone, a NARCOTIC ANTAGONIST to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIATE SUBSTITUTION THERAPY.
=688  \\$a2016 (2006)
=750  \0$81$wb$aBuprenorphine$5IEN$0(DLC)sh 85018028
=750  \0$81$wb$aNaloxone$5IEN$0(DLC)sh 85089574
=788  \0$iSearch also under the following headings used together in the same record:$aBuprenorphine$iand$aNaloxone$5IEN-M

=LDR  01069nz  a2200289n  4500
=001  9880484459502441
=005  20170616100142.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067029
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x450
=072  \\$aG7.$x100.$x175
=150  \\$aPhysical Appearance, Body
=450  \\$wnnna$aOutward Appearance
=450  \\$wnnna$aPhysical Appearance
=450  \\$wnnna$aPhysical Appearance, Body
=450  \\$wnnna$aAppearance Body, Physical
=450  \\$wnnna$aAppearance, Body Physical
=450  \\$wnnna$aAppearance, Outward
=450  \\$wnnna$aAppearance, Physical
=450  \\$wnno$aBody, Physical Appearance
=450  \\$wnnna$aPhysical Appearance Body
=550  \\$wg$aBody Constitution
=550  \\$wh$aSkin Pigmentation
=680  \\$iThe superficial physical looks, characteristics, or qualities of an individual as distinguished from the underlying unseen nature or attributes.
=688  \\$a2016
=750  \0$iNarrower mapping$aPhysical-appearance-based bias$0(DLC)sh 96011401$4NM$5IEN-M

=LDR  00636nz  a2200205n  4500
=001  9880484460002441
=005  20161215101207.0
=008  880608\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015430
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x144.$x243.$x926
=072  \\$aG7.$x700.$x320.$x249.$x314.$x120.$x200.$x926
=150  \\$aWeight Gain
=450  \\$wnnna$aGain, Weight
=450  \\$wnnna$aGains, Weight
=450  \\$wnnna$aWeight Gains
=550  \\$wg$aBody Weight Changes
=680  \\$iIncrease in BODY WEIGHT over existing weight.
=688  \\$a89; was see BODY WEIGHT 1966-88
=750  \0$aWeight gain$0(DLC) sh 96006716$5IEN-M

=LDR  00802nz  a2200253n  4500
=001  9880484462202441
=005  20161215095851.0
=008  150702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067401
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x33.$x375.$x135
=150  \\$aBlood Alcohol Content
=450  \\$wnnna$aBlood Alcohol Concentration
=450  \\$wnnna$aBlood Alcohol Level
=450  \\$wnnna$aAlcohol Concentration, Blood
=450  \\$wnnna$aAlcohol Content, Blood
=450  \\$wnnna$aAlcohol Level, Blood
=450  \\$wnnna$aConcentration, Blood Alcohol
=450  \\$wnnna$aContent, Blood Alcohol
=450  \\$wnnna$aLevel, Blood Alcohol
=550  \\$wg$aEthanol
=680  \\$iMass of alcohol per unit of BLOOD volume.
=688  \\$a2016
=750  \0$aBlood alcohol$0(DLC)sh 85014959$5IEN-M

=LDR  00937nz  a2200229n  4500
=001  9880484983202441
=005  20170105104002.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067088
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x219.$x687.$x274.$x500
=150  \\$aDirect-to-Consumer Advertising
=450  \\$wnnna$aDirect-to-Consumer Marketing
=450  \\$wnnna$aAdvertising, Direct-to-Consumer
=450  \\$wnnna$aDirect to Consumer Advertising
=450  \\$wnnna$aDirect to Consumer Marketing
=450  \\$wnnna$aMarketing, Direct-to-Consumer
=550  \\$wg$aAdvertising as Topic
=680  \\$iAdvertising that directly targets consumers of certain products such as pharmaceuticals.
=688  \\$a2016
=750  \0$iNarrower mapping$aDirect-to-consumer prescription drug advertising$4NM$0DLC) sh2005001620$5IEN-M
=750  \0$iNarrower mapping$aDirect-to-consumer medical device advertising$4NM$0(DLC)sh2009006855$5IEN-M

=LDR  00697nz  a2200229n  4500
=001  9880484991702441
=005  20170104104600.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067551
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x316.$x171
=072  \\$aF2.$x463.$x785.$x373.$x520.$x500
=072  \\$aI1.$x738.$x305
=150  \\$aDiplomacy
=450  \\$wnnna$aDiplomat
=450  \\$wnnna$aDiplomats
=550  \\$wg$aGroup Processes
=550  \\$wg$aNegotiating
=550  \\$wg$aPolitics
=680  \\$iThe art and practice of conducting negotiations between people, nations or other parties such as organizations.
=688  \\$a2016
=750  \2$aDiplomacy$0(DLC)sh 85038179$5IEN-M

=LDR  00768nz  a2200169n  4500
=001  9880484992402441
=005  20170104103338.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066310
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x230.$x500
=150  \\$aDigital Divide
=450  \\$wnnna$aDivide, Digital
=550  \\$wg$aCommunication Barriers
=680  \\$iGap between individuals, households, businesses and geographic areas at different socioeconomic levels with regard to both their opportunities to access electronic  information and communication technologies (ICTs). Their use of the Internet for a wide variety of activities, reflects various differences among and within countries.
=688  \\$a2016
=750  \0$aDigital divide$0(DLC)sh 00006536$5IEN-M

=LDR  00810nz  a2200265n  4500
=001  9880485009502441
=005  20170103103130.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067448
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x240
=072  \\$aI1.$x880.$x735.$x191.$x51
=150  \\$aDefamation
=450  \\$wnnna$aCalumny
=450  \\$wnnna$aLibel
=450  \\$wnnna$aSlander
=450  \\$wnnna$aVilification
=450  \\$wnnna$aCalumnies
=450  \\$wnnna$aDefamations
=450  \\$wnnna$aLibels
=450  \\$wnnna$aVilifications
=550  \\$wg$aCrime
=680  \\$iPublic false statements that are illegal and damaging to the reputation of a person, group, business, organization, or institution.
=688  \\$a2016
=750  \0$aLibel and slander$0(DLC)sh 85076432$5IEN-M

=LDR  01227nz  a2200313n  4500
=001  9880485023202441
=005  20161222105156.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067568
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x52
=150  \\$aCulturally Appropriate Technology
=450  \\$wnnna$aIntermediate Technology
=450  \\$wnnna$aSoft Technology
=450  \\$wnnna$aAppropriate Technologies, Culturally
=450  \\$wnnna$aAppropriate Technology, Culturally
=450  \\$wnnna$aCulturally Appropriate Technologies
=450  \\$wnnna$aIntermediate Technologies
=450  \\$wnnna$aSoft Technologies
=450  \\$wnnna$aTechnologies, Culturally Appropriate
=450  \\$wnnna$aTechnologies, Intermediate
=450  \\$wnnna$aTechnologies, Soft
=450  \\$wnnna$aTechnology, Culturally Appropriate
=450  \\$wnnna$aTechnology, Intermediate
=450  \\$wnnna$aTechnology, Soft
=550  \\$wg$aTechnology
=680  \\$iA SCIENCE or TECHNOLOGY that promotes self-sufficiency and is suitable to the cultural, environmental, economic and social conditions of the geographic area in which it is applied.
=688  \\$a2016
=750  \0$aAppropriate technology$0(DLC)sh 85006184$5IEN-M

=LDR  00579nz  a2200169n  4500
=001  9880485024002441
=005  20161222103917.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069601
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x237
=150  \\$aCrop Protection
=450  \\$wnnna$aProtection, Crop
=550  \\$wg$aAgriculture
=680  \\$iThe science and practice of preventing, minimizing, or eliminating damage to AGRICULTURAL CROPS by pest organisms, weeds, and disease-causing agents.
=688  \\$a2016
=750  \0$aPlants, Protection of$0(DLC)sh 85103025$5IEN-M

=LDR  00657nz  a2200169n  4500
=001  9880485024602441
=005  20161222103053.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069600
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x227.$x500
=150  \\$aPlant Breeding
=450  \\$wnnna$aBreeding, Plant
=550  \\$wg$aCrop Production
=680  \\$iThe purposeful manipulation of plant species with the goal of creating desired genotypes and phenotypes, using techniques such as controlled pollination and or genetic engineering, followed by artificial selection of progeny.
=688  \\$a2016
=750  \0$aPlant breeding$0(DLC) sh 85102702$5IEN-M

=LDR  00660nz  a2200181n  4500
=001  9880485024902441
=005  20161222102739.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069599
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x227
=150  \\$aCrop Production
=450  \\$wnnna$aProduction, Crop
=550  \\$wg$aAgriculture
=550  \\$wh$aPlant Breeding
=680  \\$iThe science and practice of cultivating PLANTS that have economic value to man. It includes plant breeding, seed production, weeding, use of fertilizers, harvesting, storage, transportation, and marketing.
=688  \\$a2016
=750  \0$aCrop science$0(DLC)sh 95004499$5IEN-M

=LDR  01324nz  a2200421n  4500
=001  9880485025802441
=005  20170106114259.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066479
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x250
=150  \\$aCriminal Behavior
=450  \\$wnnna$aCriminal Conduct
=450  \\$wnnna$aCriminal Intent
=450  \\$wnnna$aIllegal Behavior
=450  \\$wnnna$aIllicit Behavior
=450  \\$wnnna$aUnlawful Behavior
=450  \\$wnnna$aBehavior, Criminal
=450  \\$wnnna$aBehavior, Illegal
=450  \\$wnnna$aBehavior, Illicit
=450  \\$wnnna$aBehavior, Unlawful
=450  \\$wnnna$aBehaviors, Criminal
=450  \\$wnnna$aBehaviors, Illegal
=450  \\$wnnna$aBehaviors, Illicit
=450  \\$wnnna$aBehaviors, Unlawful
=450  \\$wnnna$aConduct, Criminal
=450  \\$wnnna$aCriminal Behaviors
=450  \\$wnnna$aCriminal Intents
=450  \\$wnnna$aIllegal Behaviors
=450  \\$wnnna$aIllicit Behaviors
=450  \\$wnnna$aIntent, Criminal
=450  \\$wnnna$aIntents, Criminal
=450  \\$wnnna$aUnlawful Behaviors
=550  \\$wg$aBehavior
=550  \\$wh$aDriving Under the Influence
=680  \\$iConduct leading to commission of unlawful acts.
=688  \\$a2016
=750  \0$aCriminal behavior$0(DLC)sh 85034037$5IEN-M

=LDR  00930nz  a2200241n  4500
=001  9880485026202441
=005  20161222093045.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067498
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x254
=150  \\$aCrew Resource Management, Healthcare
=450  \\$wnnna$aCrisis Resource Management, Healthcare
=450  \\$wnnna$aHealthcare CRM
=450  \\$wnnna$aHealthcare Crew Resource Management
=450  \\$wnnna$aHealthcare Crisis Resource Management
=450  \\$wnnna$aCRM, Healthcare
=450  \\$wnnna$aCRMs, Healthcare
=450  \\$wnnna$aHealthcare CRMs
=550  \\$wg$aPatient Care Management
=680  \\$iA range of healthcare related training designed to reduce MEDICAL ERRORS and improve PATIENT SAFETY by emphasizing TEAMWORK and human factors (see HUMAN ENGINEERING).
=688  \\$a2016
=750  \0$aHealth care teams$xTraining of$0(DLC)sh85059534$5IEN-M

=LDR  02063cz  a2200529n  4500
=001  9880364426202441
=005  20141212222640.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063731
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x685
=150  \\$aMobile Applications
=450  \\$wnnna$aApp, Mobile
=450  \\$wnnna$aApp, Portable Electronic
=450  \\$wnnna$aApp, Portable Software
=450  \\$wnnna$aApplication, Mobile
=450  \\$wnnna$aApplication, Portable Electronic
=450  \\$wnnna$aApplication, Portable Software
=450  \\$wnnna$aApplications, Mobile
=450  \\$wnnna$aApplications, Portable Electronic
=450  \\$wnnna$aApplications, Portable Software
=450  \\$wnnna$aApps, Mobile
=450  \\$wnnna$aApps, Portable Electronic
=450  \\$wnnna$aApps, Portable Software
=450  \\$wnnna$aElectronic App, Portable
=450  \\$wnnna$aElectronic Application, Portable
=450  \\$wnnna$aElectronic Applications, Portable
=450  \\$wnnna$aElectronic Apps, Portable
=450  \\$wnnna$aMobile App
=450  \\$wnnna$aMobile Application
=450  \\$aMobile Apps
=450  \\$wnnna$aPortable Electronic App
=450  \\$wnnna$aPortable Electronic Application
=450  \\$wnnna$aPortable Electronic Applications
=450  \\$wnnna$aPortable Electronic Apps
=450  \\$wnnna$aPortable Software App
=450  \\$wnnna$aPortable Software Application
=450  \\$wnnna$aPortable Software Applications
=450  \\$wnnna$aPortable Software Apps
=450  \\$wnnna$aSoftware App, Portable
=450  \\$wnnna$aSoftware Application, Portable
=450  \\$wnnna$aSoftware Applications, Portable
=450  \\$wnnna$aSoftware Apps, Portable
=550  \\$wg$aSoftware
=680  \\$iComputer programs or software installed on mobile electronic devices which support a wide range of functions and uses which include television, telephone, video, music, word processing, and Internet service.
=688  \\$a2014
=750  \0$aMobile computing$0(DLC)sh 95004596$5IEN-M

=LDR  01733cz  a2200349n  4500
=001  9880364426302441
=005  20141212222637.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x277.$x220
=072  \\$aC16.$x300.$x70
=072  \\$aC25.$x775.$x100.$x87.$x323
=150  \\$aFetal Alcohol Spectrum Disorders
=450  \\$wnnna$aAlcohol-Related Birth Defects
=450  \\$wnnna$aAlcohol Related Birth Defects
=450  \\$wnnna$aAlcohol Related Neurodevelopmental Disorder
=450  \\$aAlcoholism$xcongenital
=450  \\$wnnna$aBirth Defects, Alcohol-Related
=450  \\$wnnna$aFAE (Fetal Alcohol Effects)
=450  \\$wnnna$aFAEs (Fetal Alcohol Effects)
=450  \\$wnnna$aFASD
=450  \\$wnnna$aFASDs
=450  \\$wnnna$aFetal Alcohol Syndrome
=450  \\$wnnna$aGrowth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction
=450  \\$wnnna$aPartial Fetal Alcohol Syndrome
=450  \\$wnnna$aSyndrome, Fetal Alcohol
=550  \\$wg$aAlcohol-Induced Disorders
=550  \\$wg$aFetal Diseases
=680  \\$iAn umbrella term used to describe a pattern of disabilities and abnormalities that result from fetal exposure to ETHANOL during pregnancy. It encompasses a phenotypic range that can vary greatly between individuals, but reliably includes one or more of the following: characteristic facial dysmorphism, FETAL GROWTH RETARDATION, central nervous system abnormalities, cognitive and/or behavioral dysfunction, BIRTH DEFECTS. The level of maternal alcohol consumption does not necessarily correlate directly with disease severity.
=688  \\$a2014
=750  \0$aFetal alcohol syndrome$0(DLC)sh 85047941$5IEN-M

=LDR  01048cz  a2200253n  4500
=001  9880364426402441
=005  20141212222637.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063646
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x98
=072  \\$aC23.$x550.$x727.$x98
=150  \\$aCarcinogenesis
=450  \\$wnnna$aCarcinogeneses
=450  \\$wnnna$aOncogeneses
=450  \\$wnnna$aOncogenesis
=450  \\$wnnna$aTumorigeneses
=450  \\$aTumorigenesis
=550  \\$wg$aNeoplastic Processes
=550  \\$wh$aCell Transformation, Neoplastic
=550  \\$wh$aCocarcinogenesis
=680  \\$iThe origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
=688  \\$a2014; for TUMORIGENESIS and ONCOGENESIS see CELL TRANSFORMATION, NEOPLASTIC 2012-2013
=750  \0$aCarcinogenesis$0(DLC)sh 85020155$5IEN-M

=LDR  00958cz  a2200265n  4500
=001  9880364426502441
=005  20141212222635.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063566
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x195
=072  \\$aD25.$x720.$x716.$x195
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x195
=150  \\$aBiodegradable Plastics
=450  \\$wnnna$aBiodegradable Plastic
=450  \\$wnnna$aCompostable Plastic
=450  \\$wnnna$aCompostable Plastics
=450  \\$wnnna$aPlastic, Biodegradable
=450  \\$wnnna$aPlastic, Compostable
=450  \\$wnnna$aPlastics, Biodegradable
=450  \\$wnnna$aPlastics, Compostable
=550  \\$wg$aPlastics
=680  \\$iOrganic polymeric materials which can be broken down by naturally occurring processes. This includes plastics created from bio-based or petrochemical-based materials.
=688  \\$a2014
=750  \0$aBiodegradable plastics$0(DLC)sh2001002928

=LDR  01276cz  a2200361n  4500
=001  9880364426602441
=005  20141212222622.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063246
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x765
=072  \\$aG15.$x277
=150  \\$aOrganogenesis, Plant
=450  \\$wnnna$aDevelopment, Plant Organ
=450  \\$wnnna$aDevelopments, Plant Organ
=450  \\$wnnna$aFormation, Plant Organ
=450  \\$wnnna$aFormations, Plant Organ
=450  \\$wnnna$aOrgan Development, Plant
=450  \\$wnnna$aOrgan Developments, Plant
=450  \\$wnnna$aOrgan Formation, Plant
=450  \\$wnnna$aOrgan Formations, Plant
=450  \\$wnnna$aOrganogeneses, Plant
=450  \\$wnnna$aPlant Organ Development
=450  \\$wnnna$aPlant Organ Developments
=450  \\$wnnna$aPlant Organ Formation
=450  \\$wnnna$aPlant Organ Formations
=450  \\$wnnna$aPlant Organogeneses
=450  \\$wnnna$aPlant Organogenesis
=550  \\$wg$aOrganogenesis
=550  \\$wg$aPlant Physiological Phenomena
=680  \\$iTransformative processes which occur in cells and tissues to produce differentiated plant organs.
=688  \\$a2013
=750  \0$aPlant morphogenesis$0(DLC)sh 85102778$5IEN-M

=LDR  00651cz  a2200241n  4500
=001  9880364426702441
=005  20141212194900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001004
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x860.$x101
=150  \\$aAnus Diseases
=450  \\$wnnna$aAnus Disease
=450  \\$wnnna$aDisease, Anus
=450  \\$wnnna$aDiseases, Anus
=550  \\$wg$aRectal Diseases
=550  \\$wh$aAnus Neoplasms
=550  \\$wh$aFissure in Ano
=550  \\$wh$aPruritus Ani
=667  \\$ainflamm dis = PROCTITIS
=688  \\$a66
=688  \\$a1999
=750  \0$aAnus$xDiseases$5IEN-M$0(DLC)sh 85005828

=LDR  01052cz  a2200301n  4500
=001  9880364426802441
=005  20141212222658.0
=008  121214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064098
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x640.$x74.$x500.$x500
=072  \\$aD3.$x383.$x725.$x24.$x500.$x500
=072  \\$aD3.$x438.$x103.$x34.$x500.$x500
=150  \\$aEsomeprazole
=450  \\$wnnna$aAstraZeneca Brand of Esomeprazole Magnesium
=450  \\$wnnna$aEsomeprazole Magnesium
=450  \\$wnnna$aEsomeprazole Potassium
=450  \\$wnnna$aEsomeprazole Sodium
=450  \\$wnnna$aEsomeprazole Strontium
=450  \\$wnnna$aEsomeprazole Strontium Anhydrous
=450  \\$wnnna$aNexium
=450  \\$wnnna$aStrontium, Esomeprazole
=550  \\$wg$aOmeprazole
=680  \\$iThe S-isomer of omeprazole.
=688  \\$a2014(2013); use OMEPRAZOLE 2003-2012
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Esomeprazole Sodium
=688  \\$a2013; use OMEPRAZOLE 2003-2012
=750  \0$aEsomeprazole$0(DLC)sh2004001933$5IEN-M

=LDR  00688cz  a2200169n  4500
=001  9880364426902441
=005  20141212222635.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x211.$x753
=150  \\$aPersonal Narratives as Topic
=550  \\$wg$aBiography as Topic
=667  \\$ause only for personal narratives as a subject; for accounts of individual experiences use the Publication Type PERSONAL NARRATIVES.
=680  \\$iWorks about accounts of individual experience in relation to a particular field or of participation in related activities.
=688  \\$a2013
=750  \0$aPersonal narratives$0(DLC)sh 85100101$5IEN-M

=LDR  01064cz  a2200325n  4500
=001  9880364427002441
=005  20141212222635.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063509
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x374
=072  \\$aF1.$x145.$x813.$x629.$x562
=072  \\$aF1.$x829.$x595.$x374
=150  \\$aHomophobia
=450  \\$wnnna$aAnti-Gay Bia
=450  \\$wnnna$aAnti-Gay Bias
=450  \\$wnnna$aAnti Gay Bias
=450  \\$wnnna$aAnti-Homosexual Bia
=450  \\$wnnna$aAnti-Homosexual Bias
=450  \\$wnnna$aAnti Homosexual Bias
=450  \\$wnnna$aBia, Anti-Gay
=450  \\$wnnna$aBia, Anti-Homosexual
=450  \\$wnnna$aBias, Anti-Gay
=450  \\$wnnna$aBias, Anti-Homosexual
=450  \\$wnnna$aHomophobias
=550  \\$wg$aPrejudice
=550  \\$wg$aSocial Discrimination
=680  \\$iDifferential treatment or unequal access to opportunities or services based on perceived homosexual preference or orientation.
=688  \\$a2013
=750  \0$aHomophobia$0(DLC)sh 88006552$5IEN-M

=LDR  00740cz  a2200241n  4500
=001  9880364427102441
=005  20141212222634.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063508
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x629
=150  \\$aSocial Discrimination
=450  \\$wnnna$aDiscrimination, Social
=550  \\$wg$aSocial Behavior
=550  \\$wh$aAgeism
=550  \\$wh$aHomophobia
=550  \\$wh$aRacism
=550  \\$wh$aSexism
=550  \\$wh$aXenophobia
=667  \\$ado not confuse with DISCRIMINATION (PSYCHOLOGY)
=680  \\$iGroup behavior toward others by virtue of their group membership.
=688  \\$a2013; use PREJUDICE 1982-2012
=750  \0$aDiscrimination$0(DLC)sh 85038376$5IEN-M

=LDR  00851cz  a2200265n  4500
=001  9880364427202441
=005  20141212222634.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063507
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x750
=072  \\$aF1.$x145.$x813.$x629.$x750
=072  \\$aF1.$x829.$x595.$x750
=150  \\$aSexism
=450  \\$wnnna$aBias, Gender
=450  \\$wnnna$aBias, Sex
=450  \\$wnnna$aDiscrimination, Sex
=450  \\$aGender Bias
=450  \\$aSex Bias
=450  \\$wnnna$aSex Discrimination
=550  \\$wg$aPrejudice
=550  \\$wg$aSocial Discrimination
=680  \\$iPrejudice or discrimination based on gender or behavior or attitudes that foster stereotyped social roles based on gender.
=688  \\$a2013; use PREJUDICE 1994-2012
=750  \0$aSexism$0(DLC)sh 85120678$5IEN-M

=LDR  00818cz  a2200241n  4500
=001  9880364427302441
=005  20141212222634.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063506
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x249
=072  \\$aF1.$x145.$x813.$x629.$x500
=072  \\$aF1.$x829.$x595.$x249
=150  \\$aAgeism
=450  \\$wnnna$aAge Discrimination
=450  \\$wnnna$aAge Discriminations
=450  \\$wnnna$aDiscrimination, Age
=450  \\$wnnna$aDiscriminations, Age
=550  \\$wg$aPrejudice
=550  \\$wg$aSocial Discrimination
=680  \\$iBiased behaviors or attitudes, differential treatment, unequal access to social participation or opportunities based on age.
=688  \\$a2013; use PREJUDICE 1995-2012
=750  \0$aAgeism$0(DLC)sh 90001720$5IEN-M

=LDR  01086cz  a2200265n  4500
=001  9880364427502441
=005  20200501111637.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063487
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x306.$x500
=150  \\$aPrescription Drug Misuse
=450  \\$wnnna$aDrug Misuse, Prescription
=450  \\$wnnna$aMisuse, Prescription Drug
=450  \\$wnnna$aNMUPD
=450  \\$wnnna$aNon-Medical Use of Prescription Drugs
=450  \\$wnnna$aNon Medical Use of Prescription Drugs
=450  \\$wnnna$aPrescription Drug Misuses
=550  \\$wg$aDrug Misuse
=550  \\$wh$aDrug Overdose
=550  \\$wh$aPrescription Drug Overuse
=550  \\$aPrescription Drug Diversion
=680  \\$iImproper use of drugs or medications outside the intended purpose, scope, or guidelines for use. This is in contrast to MEDICATION ADHERENCE, and distinguished from DRUG ABUSE, which is a deliberate or willful action frequently associated with psychological disorders.
=688  \\$a2013
=750  \0$aMedication abuse$0(DLC)sh 85083059$5IEN-M

=LDR  00873cz  a2200277n  4500
=001  9880364427602441
=005  20141212222632.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730
=072  \\$aN6.$x850.$x601
=150  \\$aFood Quality
=450  \\$wnnna$aFood Qualities
=450  \\$wnnna$aQualities, Food
=450  \\$wnnna$aQuality, Food
=550  \\$wg$aFood Technology
=550  \\$wg$aPublic Health
=550  \\$wh$aFood Safety
=550  \\$wh$aNutritive Value
=550  \\$aFood Analysis
=550  \\$aFood Handling
=550  \\$aFood Labeling
=680  \\$iRatings of the characteristics of food including flavor, appearance, nutritional content, and the amount of microbial and chemical contamination.
=688  \\$a2013
=750  \0$aFood$xQuality$0(DLC)sh 88006843$5IEN

=LDR  00843cz  a2200241n  4500
=001  9880364427702441
=005  20141212222632.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063426
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x600.$x525
=072  \\$aN1.$x224.$x625.$x525
=072  \\$aN6.$x850.$x505.$x400.$x700.$x525
=150  \\$aHuman Migration
=450  \\$wnnna$aHuman Migrations
=450  \\$wnnna$aMigration, Human
=450  \\$wnnna$aMigrations, Human
=550  \\$wg$aPopulation Dynamics
=550  \\$wh$aEmigration and Immigration
=667  \\$amigration of ancient populations goes here; ANIMAL MIGRATION is available for animals
=680  \\$iPeriodic movement of human settlement from one geographical location to another.
=688  \\$a2013
=750  \0$aHuman beings$xMigrations$0(DLC)sh 85080300$5IEN-M

=LDR  00640cz  a2200205n  4500
=001  9880364427802441
=005  20141212222632.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063425
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x100.$x437
=072  \\$aF1.$x145.$x317.$x269.$x500
=072  \\$aF3.$x900.$x100.$x550
=150  \\$aBinge Drinking
=450  \\$wnnna$aDrinking, Binge
=550  \\$wg$aAlcohol Drinking
=550  \\$wg$aAlcohol-Related Disorders
=680  \\$iDrinking an excessive amount of ALCOHOLIC BEVERAGES in a short period of time.
=688  \\$a2013
=750  \0$aBinge drinking$0(DLC)sh2003009109$5IEN-M

=LDR  01172cz  a2200301n  4500
=001  9880364427902441
=005  20141212222630.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063372
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x738
=072  \\$aN2.$x360.$x67.$x732
=150  \\$aPhysical Therapist Assistants
=450  \\$wnnna$aAssistant, Physical Therapist
=450  \\$wnnna$aAssistant, Physical Therapy
=450  \\$wnnna$aAssistants, Physical Therapist
=450  \\$wnnna$aAssistants, Physical Therapy
=450  \\$wnnna$aPhysical Therapist Assistant
=450  \\$wnnna$aPhysical Therapy Assistant
=450  \\$wnnna$aPhysical Therapy Assistants
=450  \\$wnnna$aTherapist Assistant, Physical
=450  \\$wnnna$aTherapist Assistants, Physical
=450  \\$wnnna$aTherapy Assistant, Physical
=450  \\$wnnna$aTherapy Assistants, Physical
=550  \\$wg$aAllied Health Personnel
=680  \\$iPersons who, under the supervision of licensed PHYSICAL THERAPISTS, provide patient treatment using various PHYSICAL THERAPY THECHNIQUES.
=688  \\$a2013
=750  \0$aPhysical therapy assistants$0(DLC)sh 85101573$5IEN-M

=LDR  01085cz  a2200241n  4500
=001  9880364428002441
=005  20141212222629.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137.$x506.$x662
=150  \\$aVirtual Reality Exposure Therapy
=450  \\$wnnna$aReality Therapies, Virtual
=450  \\$wnnna$aReality Therapy, Virtual
=450  \\$wnnna$aTherapies, Virtual Reality
=450  \\$wnnna$aTherapy, Virtual Reality
=450  \\$wnnna$aVirtual Reality Immersion Therapy
=450  \\$wnnna$aVirtual Reality Therapies
=450  \\$wnnna$aVirtual Reality Therapy
=550  \\$wg$aDesensitization, Psychologic
=680  \\$iTreatment technique in a virtual environment which allows the participant to experience a sense of presence in an immersive, computer-generated, three-dimensional, interactive environment that minimizes avoidance behavior and facilitates emotional involvement. (from Curr Psychiatry Rep (2010) 12:298)
=688  \\$a2013
=750  \0$aVirtual reality therapy$0(DLC)sh 97002964$5IEN-M

=LDR  00835cz  a2200193n  4500
=001  9880364428102441
=005  20141212222629.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063366
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x625.$x540
=150  \\$aEstuaries
=450  \\$wnnna$aEstuary
=450  \\$wnnna$aFjord
=450  \\$wnnna$aFjords
=550  \\$wg$aOceans and Seas
=680  \\$iA partially enclosed body of water, and its surrounding coastal habitats, where saltwater from the ocean mixes with fresh water from rivers or streams. The resulting mixture of seawater and fresh water is called brackish water and its salinity can range from 0.5 to 35 ppt. (accessed http://oceanservice.noaa.gov/education/kits/estuaries/estuaries01_whatis.html)
=688  \\$a2013
=750  \0$aEstuaries$0(DLC)sh 85045018$5IEN-M

=LDR  00925cz  a2200301n  4500
=001  9880364428302441
=005  20141212222628.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063346
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772.$x770.$x680.$x500
=150  \\$aSinging
=450  \\$wnnna$aChant
=450  \\$wnnna$aChants
=450  \\$wnnna$aRhythmic Vocalization
=450  \\$wnnna$aRhythmic Vocalizations
=450  \\$wnnna$aSinger
=450  \\$wnnna$aSingers
=450  \\$wnnna$aVocalization, Rhythmic
=450  \\$wnnna$aVocalizations, Rhythmic
=450  \\$wnnna$aWhistling
=450  \\$wnnna$aWhistlings
=550  \\$wg$aPhonation
=550  \\$aMusic
=667  \\$aSINGING, ANIMAL see VOCALIZATION, ANIMAL is also available
=680  \\$iModulation of human voice to produce sounds augmented by musical tonality and rhythm.
=688  \\$a2013
=750  \0$aSinging$0(DLC)sh 85122827$5IEN-M

=LDR  01316cz  a2200361n  4500
=001  9880364428402441
=005  20141212222625.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063287
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x803.$x600
=150  \\$aBrown Recluse Spider
=450  \\$wnnna$aBrown Recluse Spiders
=450  \\$wnnna$aBrown Violin Spider
=450  \\$wnnna$aBrown Violin Spiders
=450  \\$wnnna$aLoxosceles reclusa
=450  \\$wnnna$aRecluse Spider, Brown
=450  \\$wnnna$aRecluse Spiders, Brown
=450  \\$wnnna$aSpider, Brown Recluse
=450  \\$wnnna$aSpider, Brown Violin
=450  \\$wnnna$aSpider, Violin
=450  \\$wnnna$aSpiders, Brown Recluse
=450  \\$wnnna$aSpiders, Brown Violin
=450  \\$wnnna$aSpiders, Violin
=450  \\$wnnna$aViolin Spider
=450  \\$wnnna$aViolin Spider, Brown
=450  \\$wnnna$aViolin Spiders
=450  \\$wnnna$aViolin Spiders, Brown
=550  \\$wg$aSpiders
=667  \\$abite: coordinate IM with ARACHNIDISM (IM)
=680  \\$iA spider of the genus Loxosceles, found in the midwestern and other parts of the United States, which carries a hemolytic venom that produces local necrosis or ulceration.
=688  \\$a2013
=750  \0$aBrown recluse spider$0(DLC)sh 85078682$5IEN-M

=LDR  00677cz  a2200193n  4500
=001  9880364428502441
=005  20201216130747.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063269
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x599
=150  \\$aMitochondrial Turnover
=450  \\$wnnna$aTurnover, Mitochondrial
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aMitophagy
=550  \\$wh$aMitochondrial Dynamics
=680  \\$iThe cellular processes involved in adjustments to the MITOCHONDRIAL VOLUME, content, and activity, that depend on the energy demands of the cell.
=688  \\$a2013
=750  \0$aMitochondria$xFormation$0(DLC)sh2003010528$5IEN-M

=LDR  01263cz  a2200325n  4500
=001  9880364428602441
=005  20141212222622.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063245
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x625
=072  \\$aG15.$x744.$x723
=150  \\$aPlant Development
=450  \\$wnnna$aDevelopment, Plant
=450  \\$wnnna$aDevelopments, Plant
=450  \\$wnnna$aMorphogeneses, Plant
=450  \\$wnnna$aMorphogenesis, Plant
=450  \\$wnnna$aPlant Developments
=450  \\$wnnna$aPlant Morphogeneses
=450  \\$wnnna$aPlant Morphogenesis
=450  \\$aPlants$xgrowth & development
=550  \\$wg$aGrowth and Development
=550  \\$wg$aPlant Physiological Processes
=550  \\$wh$aEtiolation
=550  \\$wh$aGermination
=550  \\$wh$aPlant Dormancy
=667  \\$ageneral or unspecified; prefer /growth with specific plant
=680  \\$iProcesses orchestrated or driven by a plethora of genes, plant hormones, and inherent biological timing mechanisms facilitated by secondary molecules, which result in the systematic transformation of plants and plant parts, from one stage of maturity to another.
=688  \\$a2013
=750  \0$aPlants$xDevelopment$0(DLC)sh 85102848$5IEN-M

=LDR  01164cz  a2200337n  4500
=001  9880364428702441
=005  20141212222616.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063193
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x250
=150  \\$aHeavy Ion Radiotherapy
=450  \\$wnnna$aCarbon Ion Radiation Therapy
=450  \\$wnnna$aCarbon Ion Radiotherapy
=450  \\$wnnna$aCarbon Ion Therapies
=450  \\$wnnna$aCarbon Ion Therapy
=450  \\$wnnna$aHeavy Ion Radiation Therapy
=450  \\$wnnna$aHeavy Ion Radiotherapies
=450  \\$wnnna$aHeavy Ion Therapies
=450  \\$wnnna$aHeavy Ion Therapy
=450  \\$wnnna$aRadiotherapies, Heavy Ion
=450  \\$wnnna$aRadiotherapy, Carbon Ion
=450  \\$wnnna$aRadiotherapy, Heavy Ion
=450  \\$wnnna$aTherapies, Carbon Ion
=450  \\$wnnna$aTherapies, Heavy Ion
=450  \\$wnnna$aTherapy, Carbon Ion
=450  \\$wnnna$aTherapy, Heavy Ion
=550  \\$wg$aRadiotherapy
=680  \\$iThe use of a heavy ion particle beam for radiotherapy, such as the HEAVY IONS of CARBON.
=688  \\$a2013
=750  \0$aHeavy ions$xtherapeutic use$0(IEN)10040555$5IEN-M

=LDR  00641cz  a2200205n  4500
=001  9880364428902441
=005  20141212222504.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x655.$x249
=150  \\$aSmoke-Free Policy
=450  \\$wnnna$aPolicies, Smoke-Free
=450  \\$wnnna$aPolicy, Smoke-Free
=450  \\$wnnna$aSmoke-Free Policies
=450  \\$wnnna$aSmoke Free Policy
=550  \\$wg$aPolicy
=680  \\$iProhibition against tobacco smoking in specific areas to control TOBACCO SMOKE POLLUTION.
=688  \\$a2013
=750  \0$aNonsmoking areas$0(DLC)sh 87003516$5IEN-M

=LDR  00756cz  a2200265n  4500
=001  9880364429002441
=005  20141212222502.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061808
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x454.$x201
=072  \\$aE7.$x39
=150  \\$aAir Filters
=450  \\$aAir Filter
=450  \\$wnnna$aAir Purifier
=450  \\$wnnna$aAir Purifiers
=450  \\$wnnna$aFilter, Air
=450  \\$wnnna$aFilters, Air
=450  \\$wnnna$aPurifier, Air
=450  \\$wnnna$aPurifiers, Air
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aFiltration
=680  \\$iBarriers used to separate and remove PARTICULATE MATTER from air.
=688  \\$a2013
=750  \0$aAir filters$0(DLC)sh 85002634$5IEN-M

=LDR  00482cz  a2200169n  4500
=001  9880364429102441
=005  20141212222500.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061725
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x3
=150  \\$aAccelerometry
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aActigraphy
=680  \\$iQualitative and quantitative measurement of MOVEMENT patterns.
=688  \\$a2013
=750  \0$aAccelerometers$0(DLC)sh 85000350$5IEN-M

=LDR  01009cz  a2200277n  4500
=001  9880364429202441
=005  20141212222459.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x644.$x743
=072  \\$aF3.$x800.$x800.$x700
=150  \\$aPremature Ejaculation
=450  \\$wnnna$aEjaculatio Praecox
=450  \\$wnnna$aEjaculatio Praecoxs
=450  \\$wnnna$aEjaculation, Premature
=450  \\$wnnna$aEjaculations, Premature
=450  \\$wnnna$aPraecox, Ejaculatio
=450  \\$wnnna$aPraecoxs, Ejaculatio
=450  \\$wnnna$aPremature Ejaculations
=550  \\$wg$aSexual Dysfunction, Physiological
=550  \\$wg$aSexual Dysfunctions, Psychological
=550  \\$aEjaculation
=680  \\$iThe emission of SEMEN and seminal fluid during the act of preparation for sexual intercourse, i.e. before there is penetration, or shortly after penetration.
=688  \\$a2013
=750  \0$aPremature ejaculation$0(DLC)sh 88007626$5IEN-M

=LDR  01250cz  a2200337n  4500
=001  9880364429302441
=005  20141212222455.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061565
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x39.$x406
=072  \\$aG2.$x607.$x750.$x155.$x374
=072  \\$aJ1.$x897.$x836.$x249.$x374
=150  \\$aCycloaddition Reaction
=450  \\$aCycloaddition
=450  \\$wnnna$aCycloaddition Reaction Technique
=450  \\$wnnna$aCycloaddition Reaction Techniques
=450  \\$wnnna$aCycloaddition Reactions
=450  \\$wnnna$aDiels-Alder Reaction
=450  \\$wnnna$aDiels Alder Reaction
=450  \\$wnnna$aReaction, Cycloaddition
=450  \\$wnnna$aReaction, Diels-Alder
=450  \\$wnnna$aReaction Technique, Cycloaddition
=450  \\$wnnna$aReaction Techniques, Cycloaddition
=450  \\$wnnna$aReactions, Cycloaddition
=450  \\$wnnna$aTechnique, Cycloaddition Reaction
=450  \\$wnnna$aTechniques, Cycloaddition Reaction
=550  \\$wg$aChemistry Techniques, Synthetic
=680  \\$iSynthetic organic reactions that use reactions between unsaturated molecules to form cyclical products.
=688  \\$a2013
=750  \0$aDiels-Alder reaction$0(DLC)sh 85037799$5IEN-M

=LDR  00673cz  a2200205n  4500
=001  9880364429502441
=005  20141212222451.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x373.$x400
=150  \\$aFirefighters
=450  \\$wnnna$aFire and Rescue Personnel
=450  \\$wnnna$aFire Fighter
=450  \\$wnnna$aFire Fighters
=450  \\$wnnna$aFirefighter
=550  \\$wg$aEmergency Responders
=680  \\$iProfessional or volunteer members of a fire department who are trained to suppress fire and respond to related emergency.
=688  \\$a2012
=750  \0$aFire fighters$0(DLC) sh 85048493$5IEN-M

=LDR  01185cz  a2200313n  4500
=001  9880364429602441
=005  20141212222451.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061387
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x210.$x210.$x124
=072  \\$aC1.$x252.$x400.$x210.$x250.$x299
=072  \\$aC1.$x252.$x620.$x249
=072  \\$aC8.$x381.$x677.$x540.$x249
=072  \\$aC8.$x730.$x610.$x540.$x249
=150  \\$aChlamydial Pneumonia
=450  \\$wnnna$aChlamydial Pneumonias
=450  \\$wnnna$aChlamydophila Pneumonia
=450  \\$wnnna$aChlamydophila Pneumonias
=450  \\$wnnna$aPneumonia, Chlamydial
=450  \\$wnnna$aPneumonia, Chlamydophila
=450  \\$wnnna$aPneumonias, Chlamydial
=450  \\$wnnna$aPneumonias, Chlamydophila
=550  \\$wg$aChlamydia Infections
=550  \\$wg$aChlamydophila Infections
=550  \\$wg$aPneumonia, Bacterial
=680  \\$iPneumonia caused by infections with the genus CHLAMYDIA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.
=688  \\$a2012; use PSITTACOSIS 2006-2011; use ORNITHOSIS 1963-2005
=750  \0$aChlamydophila pneumoniae infections$0(DLC) sh 99000105$5IEN-M

=LDR  00661cz  a2200157n  4500
=001  9880364429702441
=005  20141212222450.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x754.$x133
=150  \\$aAmish
=550  \\$wg$aEthnic Groups
=680  \\$iAn ethnic group with shared religious beliefs. Originating in Switzerland in the late 1600s, and first migrating to the mid-Atlantic, they now live throughout Eastern and Mid-Western United States and elsewhere. Communities are usually close-knit and marriage is within the community.
=688  \\$a2012
=750  \0$aAmish$0(DLC) sh 85004511$5IEN-M

=LDR  00562cz  a2200205n  4500
=001  9880364429802441
=005  20141212222449.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061353
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x387
=150  \\$aFood Storage
=450  \\$wnnna$aStorage, Food
=550  \\$wg$aFood Handling
=550  \\$aFood Packaging
=550  \\$aFood Preservation
=550  \\$aFood Supply
=680  \\$iKeeping food for later consumption.
=688  \\$a2012
=750  \0$aFood$xStorage$0(DLC) sh 85050226$5IEN-M

=LDR  00959cz  a2200265n  4500
=001  9880364429902441
=005  20150601152118.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061352
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x850
=072  \\$aJ1.$x576.$x423.$x850.$x700.$x700
=150  \\$aPasteurization
=450  \\$wnnna$aPasteurizations
=450  \\$wnnna$aUltrapasteurization
=450  \\$wnnna$aUltrapasteurizations
=550  \\$wg$aFood Handling
=550  \\$wg$aFood Preservation
=550  \\$wh$aFood Irradiation
=550  \\$aSterilization
=680  \\$iTreatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.
=688  \\$a2012
=750  \0$aPasteurization$0(DLC)sh2014002794$5IEN-M
=750  \0$aMilk$xPasteurization$0(DLC) sh 85085327$5IEN-M
=750  \0$aFood$xPasteurization$0(DLC)sh2005003525$5IEN-M

=LDR  00524cz  a2200193n  4500
=001  9880364430002441
=005  20141212222449.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061351
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x875
=150  \\$aTelescopes
=450  \\$wnnna$aBinocular
=450  \\$wnnna$aBinoculars
=450  \\$wnnna$aTelescope
=550  \\$wg$aOptical Devices
=680  \\$iInstruments used to observe distant objects.
=688  \\$a2012
=750  \0$aTelescopes$0(DLC) sh 85133444$5IEN-M

=LDR  00565cz  a2200193n  4500
=001  9880364430102441
=005  20141212222448.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061347
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x383
=072  \\$aF1.$x829.$x401.$x166
=150  \\$aForgiveness
=450  \\$wnnna$aForgivenesses
=550  \\$wg$aEmotions
=550  \\$wg$aInterpersonal Relations
=680  \\$iExcusing or pardoning for an offense or release of anger or resentment.
=688  \\$a2012
=750  \0$aForgiveness$0(DLC) sh 85050781$5IEN-M

=LDR  00611cz  a2200193n  4500
=001  9880364430302441
=005  20141212222445.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061305
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x710.$x299
=072  \\$aE1.$x370.$x384.$x730.$x176
=150  \\$aLymphoscintigraphy
=450  \\$aLymphatic System$xradionuclide imaging
=450  \\$wnnna$aLymphoscintigraphies
=550  \\$wg$aRadionuclide Imaging
=680  \\$iRadionuclide imaging of the LYMPHATIC SYSTEM.
=688  \\$a2012
=750  \0$aLymphatics$xRadionuclide imaging$0(IEN)9757522$5IEN-M

=LDR  03596cz  a2200865n  4500
=001  9880364430402441
=005  20141212222444.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061287
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x531
=072  \\$aC10.$x292.$x450.$x500
=072  \\$aC10.$x900.$x300.$x218.$x331
=072  \\$aC26.$x260.$x237.$x365
=072  \\$aC26.$x915.$x300.$x400.$x343
=150  \\$aGlossopharyngeal Nerve Injuries
=450  \\$wnnna$aAvulsion, Glossopharyngeal Nerve
=450  \\$wnnna$aAvulsions, Glossopharyngeal Nerve
=450  \\$wnnna$aContusion, Glossopharyngeal Nerve
=450  \\$wnnna$aContusions, Glossopharyngeal Nerve
=450  \\$wnnna$aCranial Nerve IX Injury
=450  \\$wnnna$aGlossopharyngeal Nerve Avulsion
=450  \\$wnnna$aGlossopharyngeal Nerve Avulsions
=450  \\$wnnna$aGlossopharyngeal Nerve Contusion
=450  \\$wnnna$aGlossopharyngeal Nerve Contusions
=450  \\$aGlossopharyngeal Nerve$xinjuries
=450  \\$wnnna$aGlossopharyngeal Nerve Injury
=450  \\$wnnna$aGlossopharyngeal Nerve Transection
=450  \\$wnnna$aGlossopharyngeal Nerve Transections
=450  \\$wnnna$aGlossopharyngeal Nerve Trauma
=450  \\$wnnna$aGlossopharyngeal Nerve Traumas
=450  \\$wnnna$aGlossopharyngeal Neuropathies, Traumatic
=450  \\$wnnna$aGlossopharyngeal Neuropathy, Traumatic
=450  \\$wnnna$aInjuries, Glossopharyngeal Nerve
=450  \\$wnnna$aInjury, Cranial Nerve IX
=450  \\$wnnna$aInjury, Glossopharyngeal Nerve
=450  \\$wnnna$aInjury, Ninth Cranial Nerve
=450  \\$wnnna$aNerve Avulsion, Glossopharyngeal
=450  \\$wnnna$aNerve Avulsions, Glossopharyngeal
=450  \\$wnnna$aNerve Contusion, Glossopharyngeal
=450  \\$wnnna$aNerve Contusions, Glossopharyngeal
=450  \\$wnnna$aNerve Injuries, Glossopharyngeal
=450  \\$wnnna$aNerve Injury, Glossopharyngeal
=450  \\$wnnna$aNerve Transection, Glossopharyngeal
=450  \\$wnnna$aNerve Transections, Glossopharyngeal
=450  \\$wnnna$aNerve Trauma, Glossopharyngeal
=450  \\$wnnna$aNerve Traumas, Glossopharyngeal
=450  \\$wnnna$aNeuropathies, Traumatic Glossopharyngeal
=450  \\$wnnna$aNeuropathy, Traumatic Glossopharyngeal
=450  \\$wnnna$aNinth Cranial Nerve Injuries
=450  \\$wnnna$aNinth Cranial Nerve Injury
=450  \\$wnnna$aNinth-Nerve Palsies, Traumatic
=450  \\$wnnna$aNinth-Nerve Palsy, Traumatic
=450  \\$wnnna$aNinth Nerve Palsy, Traumatic
=450  \\$wnnna$aNinth-Nerve Trauma
=450  \\$wnnna$aNinth Nerve Trauma
=450  \\$wnnna$aNinth-Nerve Traumas
=450  \\$wnnna$aPalsies, Traumatic Ninth-Nerve
=450  \\$wnnna$aPalsy, Traumatic Ninth-Nerve
=450  \\$wnnna$aTransection, Glossopharyngeal Nerve
=450  \\$wnnna$aTransections, Glossopharyngeal Nerve
=450  \\$wnnna$aTrauma, Glossopharyngeal Nerve
=450  \\$wnnna$aTrauma, Ninth-Nerve
=450  \\$wnnna$aTraumas, Glossopharyngeal Nerve
=450  \\$wnnna$aTraumas, Ninth-Nerve
=450  \\$wnnna$aTraumatic Glossopharyngeal Neuropathies
=450  \\$wnnna$aTraumatic Glossopharyngeal Neuropathy
=450  \\$wnnna$aTraumatic Ninth-Nerve Palsies
=450  \\$wnnna$aTraumatic Ninth-Nerve Palsy
=450  \\$wnnna$aTraumatic Ninth Nerve Palsy
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aGlossopharyngeal Nerve Diseases
=680  \\$iTraumatic injuries to the GLOSSOPHARYNGEAL NERVE.
=688  \\$a2012
=750  \0$aGlossopharyngeal nerve$xWounds and injuries$0(IEN)9729774$5IEN-M

=LDR  03688cz  a2200877n  4500
=001  9880364430502441
=005  20141212222443.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x807.$x800.$x918
=072  \\$aC10.$x292.$x262.$x968
=072  \\$aC10.$x292.$x910.$x925
=072  \\$aC10.$x900.$x300.$x218.$x943
=072  \\$aC26.$x260.$x237.$x956
=072  \\$aC26.$x915.$x300.$x400.$x956
=150  \\$aVestibulocochlear Nerve Injuries
=450  \\$wnnna$aAvulsion, Vestibulocochlear Nerve
=450  \\$wnnna$aAvulsions, Vestibulocochlear Nerve
=450  \\$wnnna$aContusion, Vestibulocochlear Nerve
=450  \\$wnnna$aContusions, Vestibulocochlear Nerve
=450  \\$wnnna$aCranial Nerve VIII Injury
=450  \\$wnnna$aEighth Cranial Nerve Injuries
=450  \\$wnnna$aEighth Cranial Nerve Injury
=450  \\$wnnna$aEighth-Nerve Palsies, Traumatic
=450  \\$wnnna$aEighth-Nerve Palsy, Traumatic
=450  \\$wnnna$aEighth Nerve Palsy, Traumatic
=450  \\$wnnna$aEighth-Nerve Trauma
=450  \\$wnnna$aEighth Nerve Trauma
=450  \\$wnnna$aEighth-Nerve Traumas
=450  \\$wnnna$aInjuries, Vestibulocochlear Nerve
=450  \\$wnnna$aInjury, Cranial Nerve VIII
=450  \\$wnnna$aInjury, Eighth Cranial Nerve
=450  \\$wnnna$aInjury, Vestibulocochlear Nerve
=450  \\$wnnna$aNerve Avulsion, Vestibulocochlear
=450  \\$wnnna$aNerve Avulsions, Vestibulocochlear
=450  \\$wnnna$aNerve Contusion, Vestibulocochlear
=450  \\$wnnna$aNerve Contusions, Vestibulocochlear
=450  \\$wnnna$aNerve Injuries, Vestibulocochlear
=450  \\$wnnna$aNerve Injury, Vestibulocochlear
=450  \\$wnnna$aNerve Transection, Vestibulocochlear
=450  \\$wnnna$aNerve Transections, Vestibulocochlear
=450  \\$wnnna$aNerve Trauma, Vestibulocochlear
=450  \\$wnnna$aNerve Traumas, Vestibulocochlear
=450  \\$wnnna$aNeuropathies, Traumatic Vestibulocochlear
=450  \\$wnnna$aNeuropathy, Traumatic Vestibulocochlear
=450  \\$wnnna$aPalsies, Traumatic Eighth-Nerve
=450  \\$wnnna$aPalsy, Traumatic Eighth-Nerve
=450  \\$wnnna$aTransection, Vestibulocochlear Nerve
=450  \\$wnnna$aTransections, Vestibulocochlear Nerve
=450  \\$wnnna$aTrauma, Eighth-Nerve
=450  \\$wnnna$aTrauma, Vestibulocochlear Nerve
=450  \\$wnnna$aTraumas, Eighth-Nerve
=450  \\$wnnna$aTraumas, Vestibulocochlear Nerve
=450  \\$wnnna$aTraumatic Eighth-Nerve Palsies
=450  \\$wnnna$aTraumatic Eighth-Nerve Palsy
=450  \\$wnnna$aTraumatic Eighth Nerve Palsy
=450  \\$wnnna$aTraumatic Vestibulocochlear Neuropathies
=450  \\$wnnna$aTraumatic Vestibulocochlear Neuropathy
=450  \\$wnnna$aVestibulocochlear Nerve Avulsion
=450  \\$wnnna$aVestibulocochlear Nerve Avulsions
=450  \\$wnnna$aVestibulocochlear Nerve Contusion
=450  \\$wnnna$aVestibulocochlear Nerve Contusions
=450  \\$aVestibulocochlear Nerve$xinjuries
=450  \\$wnnna$aVestibulocochlear Nerve Injury
=450  \\$wnnna$aVestibulocochlear Nerve Transection
=450  \\$wnnna$aVestibulocochlear Nerve Transections
=450  \\$wnnna$aVestibulocochlear Nerve Trauma
=450  \\$wnnna$aVestibulocochlear Nerve Traumas
=450  \\$wnnna$aVestibulocochlear Neuropathies, Traumatic
=450  \\$wnnna$aVestibulocochlear Neuropathy, Traumatic
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aVestibulocochlear Nerve Diseases
=680  \\$iTraumatic injuries to the VESTIBULOCOCHLEAR NERVE.
=688  \\$a2012
=750  \0$aAcoustic nerve$xWounds and injuries$0(IEN)9814870$5IEN

=LDR  03777cz  a2200937n  4500
=001  9880364430602441
=005  20141212222436.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061227
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x175.$x500
=072  \\$aC10.$x292.$x262.$x350
=072  \\$aC10.$x900.$x300.$x218.$x225
=072  \\$aC26.$x260.$x237.$x243
=072  \\$aC26.$x915.$x300.$x400.$x200
=150  \\$aAccessory Nerve Injuries
=450  \\$wnnna$aAccessory Nerve Avulsion
=450  \\$wnnna$aAccessory Nerve Avulsions
=450  \\$wnnna$aAccessory Nerve Contusion
=450  \\$wnnna$aAccessory Nerve Contusions
=450  \\$aAccessory Nerve$xinjuries
=450  \\$wnnna$aAccessory Nerve Injury
=450  \\$wnnna$aAccessory Nerve Transection
=450  \\$wnnna$aAccessory Nerve Transections
=450  \\$wnnna$aAccessory Nerve Trauma
=450  \\$wnnna$aAccessory Nerve Traumas
=450  \\$wnnna$aAccessory Neuropathies, Traumatic
=450  \\$wnnna$aAccessory Neuropathy, Traumatic
=450  \\$wnnna$aAvulsion, Accessory Nerve
=450  \\$wnnna$aAvulsions, Accessory Nerve
=450  \\$wnnna$aContusion, Accessory Nerve
=450  \\$wnnna$aContusions, Accessory Nerve
=450  \\$wnnna$aCranial Nerve XI Injury
=450  \\$wnnna$aEleventh Cranial Nerve Injuries
=450  \\$wnnna$aEleventh Cranial Nerve Injury
=450  \\$wnnna$aEleventh-Nerve Palsies, Traumatic
=450  \\$wnnna$aEleventh-Nerve Palsy, Traumatic
=450  \\$wnnna$aEleventh Nerve Palsy, Traumatic
=450  \\$wnnna$aEleventh-Nerve Trauma
=450  \\$wnnna$aEleventh Nerve Trauma
=450  \\$wnnna$aEleventh-Nerve Traumas
=450  \\$wnnna$aInjuries, Accessory Nerve
=450  \\$wnnna$aInjury, Accessory Nerve
=450  \\$wnnna$aInjury, Cranial Nerve XI
=450  \\$wnnna$aInjury, Eleventh Cranial Nerve
=450  \\$wnnna$aNerve Avulsion, Accessory
=450  \\$wnnna$aNerve Avulsions, Accessory
=450  \\$wnnna$aNerve Contusion, Accessory
=450  \\$wnnna$aNerve Contusions, Accessory
=450  \\$wnnna$aNerve Injuries, Accessory
=450  \\$wnnna$aNerve Injury, Accessory
=450  \\$wnnna$aNerve Transection, Accessory
=450  \\$wnnna$aNerve Transections, Accessory
=450  \\$wnnna$aNerve Trauma, Accessory
=450  \\$wnnna$aNerve Traumas, Accessory
=450  \\$wnnna$aNeuropathies, Traumatic Accessory
=450  \\$wnnna$aNeuropathy, Traumatic Accessory
=450  \\$wnnna$aPalsies, Traumatic Eleventh-Nerve
=450  \\$wnnna$aPalsy, Traumatic Eleventh-Nerve
=450  \\$wnnna$aSpinal Accessory Nerve Avulsion
=450  \\$wnnna$aSpinal Accessory Nerve Contusion
=450  \\$wnnna$aSpinal Accessory Nerve Injury
=450  \\$wnnna$aSpinal Accessory Nerve Transection
=450  \\$wnnna$aSpinal Accessory Nerve Trauma
=450  \\$wnnna$aSpinal Accessory Neuropathy, Traumatic
=450  \\$wnnna$aTransection, Accessory Nerve
=450  \\$wnnna$aTransections, Accessory Nerve
=450  \\$wnnna$aTrauma, Accessory Nerve
=450  \\$wnnna$aTrauma, Eleventh-Nerve
=450  \\$wnnna$aTraumas, Accessory Nerve
=450  \\$wnnna$aTraumas, Eleventh-Nerve
=450  \\$wnnna$aTraumatic Accessory Neuropathies
=450  \\$wnnna$aTraumatic Accessory Neuropathy
=450  \\$wnnna$aTraumatic Eleventh-Nerve Palsies
=450  \\$wnnna$aTraumatic Eleventh-Nerve Palsy
=450  \\$wnnna$aTraumatic Eleventh Nerve Palsy
=550  \\$wg$aAccessory Nerve Diseases
=550  \\$wg$aCranial Nerve Injuries
=680  \\$iTraumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.
=688  \\$a2012
=750  \0$aAccessory nerve$xWounds and injuries$0(IEN)9716053$5IEN-M

=LDR  02548cz  a2200673n  4500
=001  9880364430702441
=005  20141212222434.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061224
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x424
=072  \\$aC9.$x400.$x424
=072  \\$aC10.$x292.$x262.$x937.$x750
=072  \\$aC10.$x900.$x300.$x218.$x887.$x750
=072  \\$aC26.$x260.$x237.$x912.$x750
=072  \\$aC26.$x915.$x300.$x400.$x912.$x750
=150  \\$aLaryngeal Nerve Injuries
=450  \\$wnnna$aAvulsion, Laryngeal Nerve
=450  \\$wnnna$aAvulsions, Laryngeal Nerve
=450  \\$wnnna$aContusion, Laryngeal Nerve
=450  \\$wnnna$aContusions, Laryngeal Nerve
=450  \\$wnnna$aInjuries, Laryngeal Nerve
=450  \\$wnnna$aInjury, Laryngeal Nerve
=450  \\$wnnna$aLaryngeal Nerve Avulsion
=450  \\$wnnna$aLaryngeal Nerve Avulsions
=450  \\$wnnna$aLaryngeal Nerve Contusion
=450  \\$wnnna$aLaryngeal Nerve Contusions
=450  \\$wnnna$aLaryngeal Nerve Injury
=450  \\$wnnna$aLaryngeal Nerve Transection
=450  \\$wnnna$aLaryngeal Nerve Transections
=450  \\$wnnna$aLaryngeal Nerve Trauma
=450  \\$wnnna$aLaryngeal Nerve Traumas
=450  \\$aLaryngeal Nerves$xinjuries
=450  \\$wnnna$aLaryngeal Neuropathies, Traumatic
=450  \\$wnnna$aLaryngeal Neuropathy, Traumatic
=450  \\$wnnna$aNerve Avulsion, Laryngeal
=450  \\$wnnna$aNerve Avulsions, Laryngeal
=450  \\$wnnna$aNerve Contusion, Laryngeal
=450  \\$wnnna$aNerve Contusions, Laryngeal
=450  \\$wnnna$aNerve Injuries, Laryngeal
=450  \\$wnnna$aNerve Injury, Laryngeal
=450  \\$wnnna$aNerve Transection, Laryngeal
=450  \\$wnnna$aNerve Transections, Laryngeal
=450  \\$wnnna$aNerve Trauma, Laryngeal
=450  \\$wnnna$aNerve Traumas, Laryngeal
=450  \\$wnnna$aNeuropathies, Traumatic Laryngeal
=450  \\$wnnna$aNeuropathy, Traumatic Laryngeal
=450  \\$wnnna$aTransection, Laryngeal Nerve
=450  \\$wnnna$aTransections, Laryngeal Nerve
=450  \\$wnnna$aTrauma, Laryngeal Nerve
=450  \\$wnnna$aTraumas, Laryngeal Nerve
=450  \\$wnnna$aTraumatic Laryngeal Neuropathies
=450  \\$wnnna$aTraumatic Laryngeal Neuropathy
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aVagus Nerve Injuries
=550  \\$wh$aRecurrent Laryngeal Nerve Injuries
=680  \\$iTraumatic injuries to the LARYNGEAL NERVE.
=688  \\$a2012
=750  \0$aLaryngeal nerve$xWounds and injuries$0(IEN)9757518$5IEN-M

=LDR  03363cz  a2200877n  4500
=001  9880364430802441
=005  20141212222433.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061223
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x937
=072  \\$aC10.$x292.$x887.$x399
=072  \\$aC10.$x900.$x300.$x218.$x887
=072  \\$aC26.$x260.$x237.$x912
=072  \\$aC26.$x915.$x300.$x400.$x912
=150  \\$aVagus Nerve Injuries
=450  \\$wnnna$aAvulsion, Vagus Nerve
=450  \\$wnnna$aAvulsions, Vagus Nerve
=450  \\$wnnna$aContusion, Vagus Nerve
=450  \\$wnnna$aContusions, Vagus Nerve
=450  \\$wnnna$aCranial Nerve X Injury
=450  \\$wnnna$aInjuries, Vagus Nerve
=450  \\$wnnna$aInjury, Cranial Nerve X
=450  \\$wnnna$aInjury, Tenth Cranial Nerve
=450  \\$wnnna$aInjury, Vagus Nerve
=450  \\$wnnna$aNerve Avulsion, Vagus
=450  \\$wnnna$aNerve Avulsions, Vagus
=450  \\$wnnna$aNerve Contusion, Vagus
=450  \\$wnnna$aNerve Contusions, Vagus
=450  \\$wnnna$aNerve Injuries, Vagus
=450  \\$wnnna$aNerve Injury, Vagus
=450  \\$wnnna$aNerve Transection, Vagus
=450  \\$wnnna$aNerve Transections, Vagus
=450  \\$wnnna$aNerve Trauma, Vagus
=450  \\$wnnna$aNerve Traumas, Vagus
=450  \\$wnnna$aNeuropathies, Traumatic Vagus
=450  \\$wnnna$aNeuropathy, Traumatic Vagus
=450  \\$wnnna$aPalsies, Traumatic Tenth-Nerve
=450  \\$wnnna$aPalsy, Traumatic Tenth-Nerve
=450  \\$wnnna$aTenth Cranial Nerve Injuries
=450  \\$wnnna$aTenth Cranial Nerve Injury
=450  \\$wnnna$aTenth-Nerve Palsies, Traumatic
=450  \\$wnnna$aTenth-Nerve Palsy, Traumatic
=450  \\$wnnna$aTenth Nerve Palsy, Traumatic
=450  \\$wnnna$aTenth-Nerve Trauma
=450  \\$wnnna$aTenth Nerve Trauma
=450  \\$wnnna$aTenth-Nerve Traumas
=450  \\$wnnna$aTransection, Vagus Nerve
=450  \\$wnnna$aTransections, Vagus Nerve
=450  \\$wnnna$aTrauma, Tenth-Nerve
=450  \\$wnnna$aTrauma, Vagus Nerve
=450  \\$wnnna$aTraumas, Tenth-Nerve
=450  \\$wnnna$aTraumas, Vagus Nerve
=450  \\$wnnna$aTraumatic Tenth-Nerve Palsies
=450  \\$wnnna$aTraumatic Tenth-Nerve Palsy
=450  \\$wnnna$aTraumatic Tenth Nerve Palsy
=450  \\$wnnna$aTraumatic Vagus Neuropathies
=450  \\$wnnna$aTraumatic Vagus Neuropathy
=450  \\$wnnna$aVagus Nerve Avulsion
=450  \\$wnnna$aVagus Nerve Avulsions
=450  \\$wnnna$aVagus Nerve Contusion
=450  \\$wnnna$aVagus Nerve Contusions
=450  \\$aVagus Nerve$xinjuries
=450  \\$wnnna$aVagus Nerve Injury
=450  \\$wnnna$aVagus Nerve Transection
=450  \\$wnnna$aVagus Nerve Transections
=450  \\$wnnna$aVagus Nerve Trauma
=450  \\$wnnna$aVagus Nerve Traumas
=450  \\$wnnna$aVagus Neuropathies, Traumatic
=450  \\$wnnna$aVagus Neuropathy, Traumatic
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aVagus Nerve Diseases
=550  \\$wh$aLaryngeal Nerve Injuries
=680  \\$iTraumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.
=688  \\$a2012
=750  \0$aVagus nerve$xWounds and injuries$0(IEN)9814868$5IEN-M

=LDR  03664cz  a2200889n  4500
=001  9880364430902441
=005  20141212222431.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x875
=072  \\$aC10.$x292.$x775.$x349
=072  \\$aC10.$x900.$x300.$x218.$x775
=072  \\$aC26.$x260.$x237.$x825
=072  \\$aC26.$x915.$x300.$x400.$x825
=150  \\$aTrigeminal Nerve Injuries
=450  \\$wnnna$aAvulsion, Trigeminal Nerve
=450  \\$wnnna$aAvulsions, Trigeminal Nerve
=450  \\$wnnna$aContusion, Trigeminal Nerve
=450  \\$wnnna$aContusions, Trigeminal Nerve
=450  \\$wnnna$aCranial Nerve V Injury
=450  \\$wnnna$aFifth Cranial Nerve Injuries
=450  \\$wnnna$aFifth Cranial Nerve Injury
=450  \\$wnnna$aFifth-Nerve Palsies, Traumatic
=450  \\$wnnna$aFifth-Nerve Palsy, Traumatic
=450  \\$wnnna$aFifth Nerve Palsy, Traumatic
=450  \\$wnnna$aFifth-Nerve Trauma
=450  \\$wnnna$aFifth Nerve Trauma
=450  \\$wnnna$aFifth-Nerve Traumas
=450  \\$wnnna$aInjuries, Trigeminal Nerve
=450  \\$wnnna$aInjury, Cranial Nerve V
=450  \\$wnnna$aInjury, Fifth Cranial Nerve
=450  \\$wnnna$aInjury, Trigeminal Nerve
=450  \\$aMandibular Nerve$xinjuries
=450  \\$wnnna$aNerve Avulsion, Trigeminal
=450  \\$wnnna$aNerve Avulsions, Trigeminal
=450  \\$wnnna$aNerve Contusion, Trigeminal
=450  \\$wnnna$aNerve Contusions, Trigeminal
=450  \\$wnnna$aNerve Injuries, Trigeminal
=450  \\$wnnna$aNerve Injury, Trigeminal
=450  \\$wnnna$aNerve Transection, Trigeminal
=450  \\$wnnna$aNerve Transections, Trigeminal
=450  \\$wnnna$aNerve Trauma, Trigeminal
=450  \\$wnnna$aNerve Traumas, Trigeminal
=450  \\$wnnna$aNeuropathies, Traumatic Trigeminal
=450  \\$wnnna$aNeuropathy, Traumatic Trigeminal
=450  \\$wnnna$aPalsies, Traumatic Fifth-Nerve
=450  \\$wnnna$aPalsy, Traumatic Fifth-Nerve
=450  \\$wnnna$aTransection, Trigeminal Nerve
=450  \\$wnnna$aTransections, Trigeminal Nerve
=450  \\$wnnna$aTrauma, Fifth-Nerve
=450  \\$wnnna$aTrauma, Trigeminal Nerve
=450  \\$wnnna$aTraumas, Fifth-Nerve
=450  \\$wnnna$aTraumas, Trigeminal Nerve
=450  \\$wnnna$aTraumatic Fifth-Nerve Palsies
=450  \\$wnnna$aTraumatic Fifth-Nerve Palsy
=450  \\$wnnna$aTraumatic Fifth Nerve Palsy
=450  \\$wnnna$aTraumatic Trigeminal Neuropathies
=450  \\$wnnna$aTraumatic Trigeminal Neuropathy
=450  \\$wnnna$aTrigeminal Nerve Avulsion
=450  \\$wnnna$aTrigeminal Nerve Avulsions
=450  \\$wnnna$aTrigeminal Nerve Contusion
=450  \\$wnnna$aTrigeminal Nerve Contusions
=450  \\$aTrigeminal Nerve$xinjuries
=450  \\$wnnna$aTrigeminal Nerve Injury
=450  \\$wnnna$aTrigeminal Nerve Transection
=450  \\$wnnna$aTrigeminal Nerve Transections
=450  \\$wnnna$aTrigeminal Nerve Trauma
=450  \\$wnnna$aTrigeminal Nerve Traumas
=450  \\$wnnna$aTrigeminal Neuropathies, Traumatic
=450  \\$wnnna$aTrigeminal Neuropathy, Traumatic
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aTrigeminal Nerve Diseases
=550  \\$wh$aLingual Nerve Injuries
=680  \\$iTraumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing. It is sometimes associated with various dental treatments.
=688  \\$a2012
=750  \0$aTrigeminal nerve$xWounds and injuries$0(IEN)9814821$5IEN-M

=LDR  03384cz  a2200865n  4500
=001  9880364431002441
=005  20141212222428.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061219
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x687
=072  \\$aC10.$x292.$x650.$x600
=072  \\$aC10.$x900.$x300.$x218.$x487
=072  \\$aC26.$x260.$x237.$x568
=072  \\$aC26.$x915.$x300.$x400.$x562
=150  \\$aOlfactory Nerve Injuries
=450  \\$wnnna$aAvulsion, Olfactory Nerve
=450  \\$wnnna$aAvulsions, Olfactory Nerve
=450  \\$wnnna$aContusion, Olfactory Nerve
=450  \\$wnnna$aContusions, Olfactory Nerve
=450  \\$wnnna$aCranial Nerve I Injury
=450  \\$wnnna$aFirst Cranial Nerve Injuries
=450  \\$wnnna$aFirst Cranial Nerve Injury
=450  \\$wnnna$aFirst-Nerve Palsies, Traumatic
=450  \\$wnnna$aFirst-Nerve Palsy, Traumatic
=450  \\$wnnna$aFirst Nerve Palsy, Traumatic
=450  \\$wnnna$aFirst-Nerve Trauma
=450  \\$wnnna$aFirst Nerve Trauma
=450  \\$wnnna$aFirst-Nerve Traumas
=450  \\$wnnna$aInjuries, Olfactory Nerve
=450  \\$wnnna$aInjury, Cranial Nerve I
=450  \\$wnnna$aInjury, First Cranial Nerve
=450  \\$wnnna$aInjury, Olfactory Nerve
=450  \\$wnnna$aNerve Avulsion, Olfactory
=450  \\$wnnna$aNerve Avulsions, Olfactory
=450  \\$wnnna$aNerve Contusion, Olfactory
=450  \\$wnnna$aNerve Contusions, Olfactory
=450  \\$wnnna$aNerve Injuries, Olfactory
=450  \\$wnnna$aNerve Injury, Olfactory
=450  \\$wnnna$aNerve Transection, Olfactory
=450  \\$wnnna$aNerve Transections, Olfactory
=450  \\$wnnna$aNerve Trauma, Olfactory
=450  \\$wnnna$aNerve Traumas, Olfactory
=450  \\$wnnna$aNeuropathies, Traumatic Olfactory
=450  \\$wnnna$aNeuropathy, Traumatic Olfactory
=450  \\$wnnna$aOlfactory Nerve Avulsion
=450  \\$wnnna$aOlfactory Nerve Avulsions
=450  \\$wnnna$aOlfactory Nerve Contusion
=450  \\$wnnna$aOlfactory Nerve Contusions
=450  \\$aOlfactory Nerve$xinjuries
=450  \\$aOlfactory Nerve Injury
=450  \\$wnnna$aOlfactory Nerve Transection
=450  \\$wnnna$aOlfactory Nerve Transections
=450  \\$wnnna$aOlfactory Nerve Trauma
=450  \\$wnnna$aOlfactory Nerve Traumas
=450  \\$wnnna$aOlfactory Neuropathies, Traumatic
=450  \\$wnnna$aOlfactory Neuropathy, Traumatic
=450  \\$wnnna$aPalsies, Traumatic First-Nerve
=450  \\$wnnna$aPalsy, Traumatic First-Nerve
=450  \\$wnnna$aTransection, Olfactory Nerve
=450  \\$wnnna$aTransections, Olfactory Nerve
=450  \\$wnnna$aTrauma, First-Nerve
=450  \\$wnnna$aTrauma, Olfactory Nerve
=450  \\$wnnna$aTraumas, First-Nerve
=450  \\$wnnna$aTraumas, Olfactory Nerve
=450  \\$wnnna$aTraumatic First-Nerve Palsies
=450  \\$wnnna$aTraumatic First-Nerve Palsy
=450  \\$wnnna$aTraumatic First Nerve Palsy
=450  \\$wnnna$aTraumatic Olfactory Neuropathies
=450  \\$wnnna$aTraumatic Olfactory Neuropathy
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aOlfactory Nerve Diseases
=680  \\$iTraumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.
=688  \\$a2012
=750  \0$aOlfactory nerve$xWounds and injuries$09795316$5IEN

=LDR  00687cz  a2200193n  4500
=001  9880364431102441
=005  20141212222426.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061215
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x512
=150  \\$aEnergy Drinks
=450  \\$wnnna$aDrink, Energy
=450  \\$wnnna$aDrinks, Energy
=450  \\$wnnna$aEnergy Drink
=550  \\$wg$aBeverages
=680  \\$iBeverages consumed as stimulants and tonics. They usually contain a combination of CAFFEINE with other substances such as herbal supplements; VITAMINS; AMINO ACIDS; and sugar or sugar derivatives.
=688  \\$a2012
=750  \0$aEnergy drinks$0(DLC)sh2006002693$5IEN-M

=LDR  00644cz  a2200193n  4500
=001  9880364431202441
=005  20141212222426.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061214
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x60.$x75.$x399
=150  \\$aPatient Safety
=450  \\$wnnna$aPatient Safeties
=450  \\$wnnna$aSafeties, Patient
=450  \\$wnnna$aSafety, Patient
=550  \\$wg$aSafety
=680  \\$iEfforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.
=688  \\$a2012
=750  \0$aPatients$xSafety measures$0(DLC)sh2010105261$5IEN-M

=LDR  01010cz  a2200301n  4500
=001  9880364431302441
=005  20141212222426.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061213
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x550
=072  \\$aL1.$x280.$x975.$x550.$x550
=072  \\$aN1.$x224.$x935.$x698.$x700
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x550
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x550
=150  \\$aMortality, Premature
=450  \\$aDeath, Premature
=450  \\$wnnna$aDeaths, Premature
=450  \\$wnnna$aMortalities, Premature
=450  \\$aPremature Death
=450  \\$wnnna$aPremature Deaths
=450  \\$wnnna$aPremature Mortalities
=450  \\$aPremature Mortality
=550  \\$wg$aMortality
=550  \\$aLife Expectancy
=680  \\$iDeaths that occur before LIFE EXPECTANCY is reached within a given population.
=688  \\$a2012; use Mortality 1995-2011
=750  \0$aPremature death$0(DLC)sh2007002257$5IEN-M

=LDR  00990cz  a2200289n  4500
=001  9880364431402441
=005  20141212222425.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x254
=150  \\$aMemory, Episodic
=450  \\$wnnna$aAutobiographical Memories
=450  \\$wnnna$aAutobiographical Memory
=450  \\$wnnna$aEpisodic Memories
=450  \\$aEpisodic Memory
=450  \\$wnnna$aMemories, Autobiographical
=450  \\$wnnna$aMemories, Episodic
=450  \\$wnnna$aMemories, Prospective
=450  \\$wnnna$aMemory, Autobiographical
=450  \\$wnnna$aMemory, Prospective
=450  \\$wnnna$aProspective Memories
=450  \\$wnnna$aProspective Memory
=550  \\$wg$aMemory
=680  \\$iType of declarative memory, consisting of personal memory in contrast to general knowledge.
=688  \\$a2012; use MENTAL RECALL 2010-2011
=750  \0$aEpisodic memory$0(DLC)sh2013001651$5IEN-M

=LDR  01119cz  a2200265n  4500
=001  9880364431502441
=005  20141212222424.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061205
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174.$x130.$x780
=150  \\$aVascular Calcification
=450  \\$wnnna$aCalcification, Vascular
=450  \\$wnnna$aCalcifications, Vascular
=450  \\$wnnna$aCalcinoses, Vascular
=450  \\$wnnna$aCalcinosis, Vascular
=450  \\$wnnna$aVascular Calcifications
=450  \\$wnnna$aVascular Calcinoses
=450  \\$wnnna$aVascular Calcinosis
=550  \\$wg$aCalcinosis
=550  \\$wh$aMonckeberg Medial Calcific Sclerosis
=550  \\$aVascular Stiffness
=680  \\$iDeposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
=688  \\$a2012
=750  \0$aBlood-vessels$xCalcification$0(IEN)9814869$5IEN-M

=LDR  01604cz  a2200457n  4500
=001  9880364431602441
=005  20141212222423.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x199.$x500
=150  \\$aBreast Milk Expression
=450  \\$wnnna$aBreast Milk Collection
=450  \\$wnnna$aBreast Milk Collections
=450  \\$wnnna$aBreast Milk Expressions
=450  \\$wnnna$aBreast Pumping
=450  \\$wnnna$aBreast Pumpings
=450  \\$wnnna$aBreastmilk Collection
=450  \\$wnnna$aBreastmilk Collections
=450  \\$wnnna$aBreastmilk Expression
=450  \\$wnnna$aBreastmilk Expressions
=450  \\$wnnna$aCollection, Breast Milk
=450  \\$wnnna$aCollection, Breastmilk
=450  \\$wnnna$aCollections, Breast Milk
=450  \\$wnnna$aCollections, Breastmilk
=450  \\$wnnna$aExpression, Breast Milk
=450  \\$wnnna$aExpression, Breastmilk
=450  \\$wnnna$aExpressions, Breast Milk
=450  \\$wnnna$aExpressions, Breastmilk
=450  \\$wnnna$aMilk Collection, Breast
=450  \\$wnnna$aMilk Collections, Breast
=450  \\$wnnna$aMilk Expression, Breast
=450  \\$wnnna$aMilk Expressions, Breast
=450  \\$wnnna$aPumping, Breast
=450  \\$wnnna$aPumpings, Breast
=550  \\$wg$aBreast Feeding
=550  \\$aMilk Ejection
=667  \\$acoordinate with BOTTLE FEEDING if pertinent
=680  \\$iThe act of evacuating BREAST MILK by hand or with a pump.
=688  \\$a2012
=750  \0$aBreast milk$xCollection and preservation$0(DLC)sh2001002011$5IEN-M

=LDR  00583cz  a2200181n  4500
=001  9880364431702441
=005  20141212222422.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x800
=150  \\$aThysanoptera
=450  \\$wnnna$aThrips
=550  \\$wg$aInsects
=667  \\$afor killing THYSANOPTERA with insecticides, see note at INSECTICIDES
=680  \\$iAn order of very small, fringed-wing INSECTS including many agricultural pests.
=688  \\$a2012
=750  \0$aThrips$0(DLC) sh 85135052$5IEN-M

=LDR  00908cz  a2200229n  4500
=001  9880364431802441
=005  20141212222421.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x960
=150  \\$aTherapy with Helminths
=450  \\$wnnna$aHelminthic Therapies
=450  \\$aHelminthic Therapy
=450  \\$wnnna$aTherapies, Helminthic
=450  \\$wnnna$aTherapy, Helminthic
=450  \\$wnnna$aTherapy with Helminth
=550  \\$wg$aTherapeutics
=550  \\$aHygiene Hypothesis
=680  \\$iThe treatment of immune system diseases by deliberate infestation with helminths. This therapy is partly based on the HYGIENE HYPOTHESIS which states that the absence of parasites increases immune dysregulation because of the lack of stimulation of REGULATORY T-CELLS.
=688  \\$a2012
=750  \0$aHelminths$xTherapeutic use$0(IEN)9814817$5IEN-M

=LDR  00948cz  a2200253n  4500
=001  9880364431902441
=005  20161116104713.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061108
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x110.$x500.$x750
=150  \\$aSocial Media
=450  \\$aTwitter Messaging
=450  \\$wnnna$a2.0s, Web
=450  \\$wnnna$aMedia, Social
=450  \\$wnnna$aMediums, Social
=450  \\$wnnna$aSocial Medium
=450  \\$wnnna$aSocial Mediums
=450  \\$aWeb 2.0
=450  \\$wnnna$aWeb 2.0s
=550  \\$wg$aInternet
=680  \\$iPlatforms that provide the ability and tools to create and publish information accessed via the INTERNET. Generally these platforms have three characteristics with content user generated, high degree of interaction between creator and viewer, and easily integrated with other sites.
=688  \\$a2012
=750  \0$aSocial media$0(DLC)sh2006007023$5IEN-M

=LDR  01325cz  a2200313n  4500
=001  9880364432002441
=005  20141212222419.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061089
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x768
=150  \\$aRadiotherapy, Image-Guided
=450  \\$wnnna$aImage-Guided Radiation Therapies
=450  \\$wnnna$aImage-Guided Radiation Therapy
=450  \\$wnnna$aImage Guided Radiation Therapy
=450  \\$wnnna$aImage-Guided Radiotherapies
=450  \\$wnnna$aImage-Guided Radiotherapy
=450  \\$wnnna$aRadiation Therapies, Image-Guided
=450  \\$wnnna$aRadiation Therapy, Image-Guided
=450  \\$wnnna$aRadiotherapies, Image-Guided
=450  \\$wnnna$aRadiotherapy, Image Guided
=450  \\$wnnna$aRadiotherapy Target Organ Alignment
=450  \\$wnnna$aTarget Organ Alignment, Radiotherapy
=450  \\$wnnna$aTherapies, Image-Guided Radiation
=450  \\$wnnna$aTherapy, Image-Guided Radiation
=550  \\$wg$aRadiotherapy
=680  \\$iThe use of pre-treatment imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.
=688  \\$a2012
=750  \0$aImage-guided radiation therapy$0(DLC)sh2008001229$5IEN-M

=LDR  01529cz  a2200373n  4500
=001  9880364432102441
=005  20141212222418.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061088
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x565
=072  \\$aE5.$x696
=150  \\$aPhotoacoustic Techniques
=450  \\$wnnna$aOptoacoustic Technique
=450  \\$wnnna$aOptoacoustic Techniques
=450  \\$wnnna$aOptoacoustic Technologies
=450  \\$wnnna$aOptoacoustic Technology
=450  \\$wnnna$aPhotoacoustic Technique
=450  \\$wnnna$aPhotoacoustic Technologies
=450  \\$wnnna$aPhotoacoustic Technology
=450  \\$wnnna$aTechnique, Optoacoustic
=450  \\$wnnna$aTechnique, Photoacoustic
=450  \\$wnnna$aTechniques, Optoacoustic
=450  \\$wnnna$aTechniques, Photoacoustic
=450  \\$wnnna$aTechnologies, Optoacoustic
=450  \\$wnnna$aTechnologies, Photoacoustic
=450  \\$wnnna$aTechnology, Optoacoustic
=450  \\$wnnna$aTechnology, Photoacoustic
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aInvestigative Techniques
=667  \\$acoordinate with specific investigative or diagnostic technique (DIAGNOSTIC IMAGING; MICROSCOPY; TOMOGRAPHY; etc.) if pertinent
=680  \\$iInvestigative and diagnostic methods and procedures based on the photoacoustic effect, which is the generation of SOUND WAVES from the absorption of ELECTROMAGNETIC RADIATION.
=688  \\$a2012
=750  \0$aOptoacoustic spectroscopy$0(DLC) sh 85095199$5IEN-M

=LDR  01994cz  a2200445n  4500
=001  9880364432202441
=005  20141212222417.0
=008  110627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061085
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x34
=072  \\$aC16.$x131.$x666.$x34
=072  \\$aC23.$x300.$x8
=150  \\$aAgenesis of Corpus Callosum
=450  \\$aAbsence of Corpus Callosum
=450  \\$wnnna$aAgeneses, Corpus Callosum
=450  \\$wnnna$aAgenesis, Corpus Callosum
=450  \\$aCorpus Callosum$xabnormalities
=450  \\$wnnna$aCorpus Callosum Absence
=450  \\$wnnna$aCorpus Callosum Absences
=450  \\$wnnna$aCorpus Callosum Ageneses
=450  \\$aCorpus Callosum Agenesis
=450  \\$wnnna$aCorpus Callosum, Agenesis Of
=450  \\$wnnna$aCorpus Callosum Dysgeneses
=450  \\$wnnna$aCorpus Callosum Dysgenesis
=450  \\$wnnna$aCorpus Callosum Hypogeneses
=450  \\$wnnna$aCorpus Callosum Hypogenesis
=450  \\$wnnna$aCorpus Callosum Malformation
=450  \\$wnnna$aDysgeneses, Corpus Callosum
=450  \\$wnnna$aDysgenesis, Corpus Callosum
=450  \\$wnnna$aHypogeneses, Corpus Callosum
=450  \\$wnnna$aHypogenesis, Corpus Callosum
=550  \\$wg$aNervous System Malformations
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aAcrocallosal Syndrome
=550  \\$wh$aAicardi Syndrome
=550  \\$wh$aHoloprosencephaly
=680  \\$iBirth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.
=688  \\$a2012; for Absence of Corpus Callosum use Acrocallosal Syndrome 2009-2011; for Agenesis of Corpus Callosum use Aicardi Syndrome 2011
=750  \0$aCorpus callosum$xAbnormalities$0(DLC)sh2007005767$5IEN-M

=LDR  00745cz  a2200205n  4500
=001  9880364432302441
=005  20141212222415.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x576
=072  \\$aD4.$x345.$x674
=150  \\$aPolyketides
=450  \\$wnnna$aKetides
=550  \\$wg$aLactones
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wh$aMacrolides
=680  \\$iNatural compounds containing alternating carbonyl and methylene groups (beta-polyketones), bioenergenetically derived from repeated condensation of acetyl coenzyme A via malonyl coenzyme A, in a process similar to fatty acid synthesis.
=688  \\$a2012
=750  \0$aPolyketides$0(DLC) sh 85104652$5IEN-M

=LDR  00853cz  a2200241n  4500
=001  9880364432402441
=005  20141212222415.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061046
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x191
=072  \\$aJ1.$x40.$x226
=150  \\$aBiological Control Agents
=450  \\$wnnna$aAgent, Biological Control
=450  \\$wnnna$aAgents, Biological Control
=450  \\$wnnna$aBiological Control Agent
=450  \\$wnnna$aControl Agent, Biological
=450  \\$wnnna$aControl Agents, Biological
=550  \\$wg$aAgriculture
=550  \\$wg$aBiological Products
=680  \\$iOrganisms used strategically for their positive or adverse effect on the physiology and/or reproductive health of other species.
=688  \\$a2012
=750  \0$aBiological pest control agents$0(DLC) sh 89006480$5IEN-M

=LDR  00558cz  a2200193n  4500
=001  9880364432502441
=005  20141212222413.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061006
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x625.$x80
=150  \\$aBays
=450  \\$wnnna$aBay
=450  \\$wnnna$aInlet
=450  \\$aInlets
=550  \\$wg$aOceans and Seas
=680  \\$iAn area of water mostly surrounded by land, usually smaller than a gulf, and affording access to the sea.
=688  \\$a2012
=750  \0$aBays$0(DLC) sh 85012515$5IEN-M

=LDR  00821cz  a2200217n  4500
=001  9880364432602441
=005  20141212222413.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D061005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x718
=072  \\$aG16.$x500.$x275.$x280.$x625
=072  \\$aN6.$x230.$x232.$x625
=150  \\$aPonds
=450  \\$wnnna$aPond
=550  \\$wg$aFresh Water
=550  \\$wg$aGeological Phenomena
=667  \\$ado not use for salt ponds
=680  \\$iInland bodies of standing FRESHWATER usually smaller than LAKES. They can be man-made or natural but there is no universal agreement as to their exact size. Some consider a pond to be a small body of water that is shallow enough for sunlight to reach the bottom.
=688  \\$a2012
=750  \0$aPonds$0(DLC) sh 85104792$5IEN-M

=LDR  00679cz  a2200241n  4500
=001  9880364432702441
=005  20141212222412.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060986
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x355.$x875
=150  \\$aWater Wells
=450  \\$wnnna$aArtesian Well
=450  \\$wnnna$aArtesian Wells
=450  \\$wnnna$aWater Well
=450  \\$wnnna$aWell, Artesian
=450  \\$wnnna$aWell, Water
=450  \\$wnnna$aWells, Artesian
=450  \\$wnnna$aWells, Water
=550  \\$wg$aGroundwater
=680  \\$iConstructions built to access underground water.
=688  \\$a2012
=750  \0$aWells$0(DLC) sh 85146057$5IEN-M

=LDR  00627cz  a2200217n  4500
=001  9880364432802441
=005  20141212222412.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060985
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x355.$x750
=150  \\$aNatural Springs
=450  \\$wnnna$aNatural Spring
=450  \\$wnnna$aSpring, Natural
=450  \\$wnnna$aSprings, Natural
=550  \\$wg$aGroundwater
=550  \\$wh$aHot Springs
=550  \\$aMineral Waters
=680  \\$iWater that emerges to the surface of the earth from underground.
=688  \\$a2012
=750  \0$aSprings$0(DLC) sh 85127014$5IEN-M

=LDR  01091cz  a2200289n  4500
=001  9880364432902441
=005  20141212222412.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x199
=072  \\$aG12.$x450.$x50.$x184
=150  \\$aClonal Selection, Antigen-Mediated
=450  \\$wnnna$aAntigen-Mediated Clonal Selection
=450  \\$wnnna$aAntigen Mediated Clonal Selection
=450  \\$wnnna$aClonal Selection, Antigen Mediated
=450  \\$wnnna$aClonal Selection Theory
=450  \\$wnnna$aSelection, Antigen-Mediated Clonal
=450  \\$wnnna$aSelection Theory, Clonal
=450  \\$wnnna$aTheory, Clonal Selection
=550  \\$wg$aAdaptive Immunity
=550  \\$wg$aImmune System Processes
=550  \\$aAntibody Formation
=550  \\$aClonal Evolution
=680  \\$iLYMPHOCYTE ACTIVATION by a specific ANTIGEN thus triggering clonal expansion of LYMPHOCYTES already capable of mounting an immune response to the antigen.
=688  \\$a2012
=750  \0$aClonal selection theory$0(DLC) sh 85027119$5IEN-M

=LDR  00755cz  a2200205n  4500
=001  9880364433002441
=005  20141212222410.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x286
=072  \\$aN3.$x219.$x215
=150  \\$aEconomics, Behavioral
=450  \\$wnnna$aBehavioral Economics
=550  \\$wg$aEconomics
=550  \\$wg$aPsychology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe combined discipline of psychology and economics that investigates what happens in markets in which some of the agents display human limitations and complications.
=688  \\$a2012
=750  \0$aEconomics$xPsychological aspects$0(DLC) sh 85040859$5IEN-M

=LDR  00841cz  a2200217n  4500
=001  9880364433102441
=005  20141212222408.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060891
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x360.$x700
=150  \\$aRoot Cause Analysis
=450  \\$wnnna$aAnalyses, Root Cause
=450  \\$wnnna$aAnalysis, Root Cause
=450  \\$wnnna$aCause Analyses, Root
=450  \\$wnnna$aCause Analysis, Root
=450  \\$wnnna$aRoot Cause Analyses
=550  \\$wg$aHealth Care Evaluation Mechanisms
=680  \\$iMulti-step systematic review process used for improving safety by investigation of incidents to find what happened, why it happened, and to determine what can be done to prevent it from happening again.
=688  \\$a2012
=750  \0$aRoot cause analysis$0(DLC)sh2012004678$5IEN-M

=LDR  01146cz  a2200217n  4500
=001  9880364433202441
=005  20141212222405.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x300.$x380.$x500
=150  \\$aAccountable Care Organizations
=450  \\$aAccountable Care Organization
=450  \\$wnnna$aCare Organization, Accountable
=450  \\$wnnna$aCare Organizations, Accountable
=450  \\$wnnna$aOrganization, Accountable Care
=450  \\$wnnna$aOrganizations, Accountable Care
=550  \\$wg$aHealth Care Reform
=680  \\$iOrganizations of health care providers that agree to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it. Assigned means those beneficiaries for whom the professionals in the organization provide the bulk of primary care services. (www.cms.gov/OfficeofLegislation/Downloads/Accountable CareOrganization.pdf accessed 03/16/2011)
=688  \\$a2012
=750  \0$aAccountable care organizations (Medical care)$5IEN-M$0(DLC)sh2012001720

=LDR  00593cz  a2200169n  4500
=001  9880364433302441
=005  20141212222405.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x739
=150  \\$aRepetition Priming
=450  \\$wnnna$aPriming, Repetition
=550  \\$wg$aMemory
=680  \\$iA type of procedural memory manifested as a change in the ability to identify an item as a result of a previous encounter with the item or stimuli.
=688  \\$a2012
=750  \0$aPriming (Psychology)$0(DLC) sh 87006196$5IEN-M

=LDR  00505cz  a2200169n  4500
=001  9880364433402441
=005  20180111111022.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x145.$x655
=150  \\$aHoarding
=550  \\$wg$aBehavior
=667  \\$adifferentiate from HOARDING DISORDER
=680  \\$iA persistent difficulty discarding or parting with possessions.
=688  \\$a2017(2012)
=750  \0$aCompulsive hoarding$0(DLC)sh2008001071$5IEN-M

=LDR  00754cz  a2200205n  4500
=001  9880364433502441
=005  20141212222403.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060832
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x830.$x249
=072  \\$aG15.$x744.$x74
=150  \\$aApomixis
=450  \\$wnnna$aApomixis, Male
=450  \\$wnnna$aMale Apomixis
=550  \\$wg$aPlant Physiological Processes
=550  \\$wg$aReproduction, Asexual
=680  \\$iAsexual reproduction resulting in the formation of viable seeds from FLOWERS without fertlization (i.e. use of POLLEN). Progeny plants produced from apomictic seeds are perfect clones of the parent.
=688  \\$a2012
=750  \0$aApomixis$0(DLC) sh 85006043$5IEN-M

=LDR  01743cz  a2200481n  4500
=001  9880364433602441
=005  20180109174637.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060825
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x615.$x250.$x700
=150  \\$aCognitive Dysfunction
=450  \\$wnno$aMild Cognitive Impairment
=450  \\$wnnna$aCognitive Decline
=450  \\$wnnna$aCognitive Declines
=450  \\$wnnna$aCognitive Dysfunctions
=450  \\$wnnna$aCognitive Impairment
=450  \\$wnnna$aCognitive Impairment, Mild
=450  \\$wnnna$aCognitive Impairments
=450  \\$wnnna$aCognitive Impairments, Mild
=450  \\$wnnna$aDecline, Cognitive
=450  \\$wnnna$aDeclines, Cognitive
=450  \\$wnnna$aDeterioration, Mental
=450  \\$wnnna$aDeteriorations, Mental
=450  \\$wnnna$aDisorder, Mild Neurocognitive
=450  \\$wnnna$aDisorders, Mild Neurocognitive
=450  \\$wnnna$aDysfunction, Cognitive
=450  \\$wnnna$aDysfunctions, Cognitive
=450  \\$wnnna$aImpairment, Cognitive
=450  \\$wnnna$aImpairment, Mild Cognitive
=450  \\$wnnna$aImpairments, Cognitive
=450  \\$wnnna$aMental Deterioration
=450  \\$wnnna$aMental Deteriorations
=450  \\$wnnna$aImpairments, Mild Cognitive
=450  \\$wnnna$aMild Cognitive Impairments
=450  \\$wnnna$aMild Neurocognitive Disorder
=450  \\$wnnna$aMild Neurocognitive Disorders
=450  \\$wnnna$aNeurocognitive Disorder, Mild
=450  \\$wnnna$aNeurocognitive Disorders, Mild
=550  \\$wg$aCognition Disorders
=680  \\$iDiminished or impaired mental and/or intellectual function.
=688  \\$a2017(2012)
=750  \0$aMild cognitive impairment$0(DLC)sh2010014555$5IEN-M

=LDR  00619cz  a2200193n  4500
=001  9880364433702441
=005  20141212222401.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x132.$x650
=150  \\$aPerformance Anxiety
=450  \\$wnnna$aAnxieties, Performance
=450  \\$wnnna$aAnxiety, Performance
=450  \\$wnnna$aPerformance Anxieties
=550  \\$wg$aAnxiety
=680  \\$iAnxiety related to the execution of a task. (Campbell's Psychiatric Dictionary, 9th ed.)
=688  \\$a2012
=750  \0$aPerformance anxiety$0(DLC) sh 96010228$5IEN-M

=LDR  00776cz  a2200277n  4500
=001  9880364433802441
=005  20141212222359.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D060766
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x900.$x300
=072  \\$aD1.$x650.$x550.$x925.$x199
=072  \\$aJ2.$x200.$x418
=150  \\$aDrinking Water
=450  \\$wnnna$aBottled Water
=450  \\$wnnna$aPotable Water
=450  \\$wnnna$aWater, Bottled
=450  \\$wnnna$aWater, Drinking
=450  \\$wnnna$aWater, Potable
=550  \\$wg$aBeverages
=550  \\$wg$aWater
=550  \\$wh$aCarbonated Water
=550  \\$aFresh Water
=680  \\$iWater that is intended to be ingested.
=688  \\$a2012
=750  \0$aDrinking water$0(DLC) sh 85039599$5IEN-M

=LDR  00625cz  a2200193n  4500
=001  9880364433902441
=005  20141212222257.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059746
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x476
=150  \\$aHeimlich Maneuver
=450  \\$wnnna$aAbdominal Thrust
=450  \\$wnnna$aAbdominal Thrusts
=450  \\$wnnna$aManeuver, Heimlich
=550  \\$wg$aEmergency Treatment
=680  \\$iAn emergency treatment commonly used to clear food and other foreign objects causing AIRWAY OBSTRUCTION.
=688  \\$a2012
=750  \0$aHeimlich maneuver$0(DLC) sh 85059954$5IEN-M

=LDR  01255cz  a2200313n  4500
=001  9880364434002441
=005  20141212222256.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059708
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x943
=150  \\$aUltrasonic Surgical Procedures
=450  \\$wnnna$aProcedure, Ultrasonic Surgical
=450  \\$wnnna$aProcedures, Ultrasonic Surgical
=450  \\$wnnna$aSurgeries, Ultrasonic
=450  \\$wnnna$aSurgery, Ultrasonic
=450  \\$wnnna$aSurgical Procedure, Ultrasonic
=450  \\$wnnna$aSurgical Procedures, Ultrasonic
=450  \\$wnnna$aUltrasonic Surgeries
=450  \\$wnnna$aUltrasonic Surgery
=450  \\$wnnna$aUltrasonic Surgical Procedure
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aLithotripsy
=550  \\$wh$aPhacoemulsification
=550  \\$wh$aPiezosurgery
=550  \\$aUltrasonic Therapy
=680  \\$iThe use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-60 kHz, to cut through or remove tissue. The tissue fragmentation by ultrasonic surgical instruments is caused by mechanical effects not heat as with HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION.
=688  \\$a2012
=750  \0$aUltrasonics in surgery$0(DLC) sh 85139503$5IEN-M

=LDR  00838cz  a2200253n  4500
=001  9880364434102441
=005  20141212222255.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x680.$x325
=150  \\$aHerniorrhaphy
=450  \\$wnnna$aHernia Repair
=450  \\$wnnna$aHernia Repairs
=450  \\$aHernia$xsurgery
=450  \\$wnnna$aHernioplasties
=450  \\$wnnna$aHernioplasty
=450  \\$wnnna$aHerniorrhaphies
=450  \\$wnnna$aRepair, Hernia
=450  \\$wnnna$aRepairs, Hernia
=550  \\$wg$aReconstructive Surgical Procedures
=680  \\$iSurgical procedures undertaken to repair abnormal openings through which tissue or parts of organs can protrude or are already protruding.
=688  \\$a2012
=750  \0$aHernia$xSurgery$0(DLC) sh 85060425$5IEN-M

=LDR  01057cz  a2200289n  4500
=001  9880364434202441
=005  20141212222254.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x695.$x337
=150  \\$aGene-Environment Interaction
=450  \\$wnnna$aEnvironment-Gene Interaction
=450  \\$wnnna$aEnvironment Gene Interaction
=450  \\$wnnna$aEnvironment-Gene Interactions
=450  \\$wnnna$aGene Environment Interaction
=450  \\$wnnna$aGene-Environment Interactions
=450  \\$wnnna$aInteraction, Environment-Gene
=450  \\$wnnna$aInteraction, Gene-Environment
=450  \\$wnnna$aInteractions, Environment-Gene
=450  \\$wnnna$aInteractions, Gene-Environment
=550  \\$wg$aPhenotype
=550  \\$aEcotype
=550  \\$aGenetic Predisposition to Disease
=680  \\$iThe combined effects of genotypes and environmental factors together on phenotypic characteristics.
=688  \\$a2012
=750  \0$aGenotype-environment interaction$0(DLC) sh 96001717$5IEN-M

=LDR  02546cz  a2200577n  4500
=001  9880364434302441
=005  20141212222253.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x830.$x500
=072  \\$aA11.$x872.$x590.$x500
=150  \\$aMesenchymal Stromal Cells
=450  \\$wnnna$aBone Marrow Stromal Cell
=450  \\$wnnna$aBone Marrow Stromal Cells
=450  \\$wnnna$aBone Marrow Stromal Cells, Multipotent
=450  \\$wnnna$aCell, Mesenchymal Progenitor
=450  \\$wnnna$aCell, Mesenchymal Stem
=450  \\$wnnna$aCell, Mesenchymal Stromal
=450  \\$wnnna$aCell, Wharton's Jelly
=450  \\$wnnna$aCells, Mesenchymal Progenitor
=450  \\$wnnna$aCells, Mesenchymal Stem
=450  \\$wnnna$aCells, Mesenchymal Stromal
=450  \\$wnnna$aCells, Wharton Jelly
=450  \\$wnnna$aCells, Wharton's Jelly
=450  \\$wnnna$aJelly Cell, Wharton's
=450  \\$wnnna$aMesenchymal Progenitor Cell
=450  \\$wnnna$aMesenchymal Progenitor Cells
=450  \\$wnnna$aMesenchymal Stem Cell
=450  \\$wnnna$aMesenchymal Stem Cells
=450  \\$wnnna$aMesenchymal Stromal Cell
=450  \\$wnnna$aMesenchymal Stromal Cells, Multipotent
=450  \\$wnnna$aMultipotent Bone Marrow Stromal Cells
=450  \\$wnnna$aMultipotent Mesenchymal Stromal Cells
=450  \\$wnnna$aProgenitor Cell, Mesenchymal
=450  \\$wnnna$aProgenitor Cells, Mesenchymal
=450  \\$wnnna$aStem Cell, Mesenchymal
=450  \\$wnnna$aStem Cells, Mesenchymal
=450  \\$wnnna$aStromal Cell, Mesenchymal
=450  \\$wnnna$aStromal Cells, Mesenchymal
=450  \\$wnnna$aWharton Jelly Cells
=450  \\$wnnna$aWharton's Jelly Cell
=450  \\$wnnna$aWharton's Jelly Cells
=450  \\$wnnna$aWhartons Jelly Cells
=550  \\$wg$aMultipotent Stem Cells
=550  \\$wg$aStromal Cells
=667  \\$anote entry term WHARTON JELLY CELLS: consider also WHARTON JELLY /cytol
=680  \\$iBone-marrow-derived, non-hematopoietic cells that support HEMATOPOETIC STEM CELLS. They have also been isolated from other organs and tissues such as UMBILICAL CORD BLOOD, umbilical vein subendothelium, and WHARTON JELLY. These cells are considered to be a source of multipotent stem cells because they include subpopulations of mesenchymal stem cells.
=688  \\$a2012
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Mesenchymal Stem Cells
=750  \2$aMesenchymal stem cells$0(DLC)sh2010012753$5IEN-M

=LDR  00702cz  a2200169n  4500
=001  9880364434402441
=005  20141212222250.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059609
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x420.$x500
=150  \\$aMallory Bodies
=450  \\$wnnna$aBodies, Mallory
=550  \\$wg$aInclusion Bodies
=680  \\$iCytoplasmic hyaline inclusions in HEPATOCYTES. They are associated with ALCOHOLIC STEATOHEPATITIS and non-alcoholic STEATOHEPATITIS, but are also present in benign and malignant hepatocellular neoplasms, and metabolic, toxic, and chronic cholestatic LIVER DISEASES.
=688  \\$a2012
=750  \0$aMallory bodies$0(DLC) sh 85080168$5IEN-M

=LDR  00526cz  a2200157n  4500
=001  9880364434502441
=005  20141212222248.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059586
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x299
=150  \\$aDuddingtonia
=550  \\$wg$aMitosporic Fungi
=680  \\$iA genus of ascomycetous mitosporic fungi in the family Orbiliaceae. It is used for the biological control of nematodes in livestock.
=688  \\$a2012
=750  \0$aDuddingtonia$0(DLC) sh 98008092$5IEN-M

=LDR  00623cz  a2200217n  4500
=001  9880364434602441
=005  20141212222246.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059552
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x169
=072  \\$aG16.$x500.$x275.$x67
=072  \\$aN6.$x230.$x66
=150  \\$aCaves
=450  \\$wnnna$aCavern
=450  \\$wnnna$aCaverns
=550  \\$wg$aEnvironment
=550  \\$wg$aGeological Phenomena
=680  \\$iGeological formations consisting of underground enclosures with access from the surface.
=688  \\$a2012
=750  \0$aCaves$0(DLC) sh 85021504$5IEN-M

=LDR  00777cz  a2200229n  4500
=001  9880364434702441
=005  20141212222241.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059466
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x489.$x907
=150  \\$aWhite Coat Hypertension
=450  \\$wnnna$aClinic Hypertension, Isolated
=450  \\$wnnna$aHypertension, Isolated Clinic
=450  \\$wnnna$aHypertension, White Coat
=450  \\$wnnna$aIsolated Clinic Hypertension
=450  \\$wnnna$aSyndrome, White Coat
=450  \\$aWhite Coat Syndrome
=550  \\$wg$aHypertension
=680  \\$iPhenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings.
=688  \\$a2012
=750  \0$aFear of doctors$0(DLC)sh2002008624$5IEN-M

=LDR  01056cz  a2200289n  4500
=001  9880364434802441
=005  20141212222239.0
=008  110627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x57
=072  \\$aC23.$x888.$x592.$x604.$x39
=072  \\$aF1.$x700.$x39
=150  \\$aAnhedonia
=450  \\$wnnna$aAnhedonia, Physical
=450  \\$wnnna$aAnhedonia, Social
=450  \\$wnnna$aAnhedonias
=450  \\$wnnna$aAnhedonias, Physical
=450  \\$wnnna$aAnhedonias, Social
=450  \\$wnnna$aPhysical Anhedonia
=450  \\$wnnna$aPhysical Anhedonias
=450  \\$wnnna$aSocial Anhedonia
=450  \\$wnnna$aSocial Anhedonias
=550  \\$wg$aNeurobehavioral Manifestations
=680  \\$iInability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).
=688  \\$a2012
=750  \0$aAnhedonia$0(DLC) sh 87000813$5IEN-M

=LDR  00847cz  a2200253n  4500
=001  9880364434902441
=005  20141212222237.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059408
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x745
=072  \\$aN4.$x590.$x607.$x500
=150  \\$aPain Management
=450  \\$wnnna$aManagement, Pain
=450  \\$wnnna$aManagements, Pain
=450  \\$wnnna$aPain Managements
=450  \\$aPain$xtherapy
=550  \\$wg$aDisease Management
=550  \\$wg$aTherapeutics
=550  \\$aChronic Disease
=667  \\$aconsider also PALLIATIVE CARE
=680  \\$iA form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.
=688  \\$a2012
=750  \0$aPain$xTreatment$0(DLC) sh 97003721$5IEN-M

=LDR  00870cz  a2200289n  4500
=001  9880364435002441
=005  20141212222236.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059392
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x660
=150  \\$aPetroleum Pollution
=450  \\$aOil Pollution
=450  \\$wnnna$aOil Pollutions
=450  \\$wnnna$aOil Spill
=450  \\$aOil Spills
=450  \\$wnnna$aPetroleum Pollutions
=450  \\$wnnna$aPollution, Oil
=450  \\$wnnna$aPollution, Petroleum
=450  \\$wnnna$aPollutions, Oil
=450  \\$wnnna$aPollutions, Petroleum
=450  \\$wnnna$aSpill, Oil
=450  \\$wnnna$aSpills, Oil
=550  \\$wg$aEnvironmental Pollution
=680  \\$iRelease of oil into the environment usually due to human activity.
=688  \\$a2012
=750  \0$aOil spills$0(DLC) sh 85094365$5IEN-M

=LDR  00633cz  a2200169n  4500
=001  9880364435102441
=005  20141212222235.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059386
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x731
=150  \\$aReverse Genetics
=450  \\$wnnna$aGenetics, Reverse
=550  \\$wg$aGenetic Techniques
=680  \\$iThe use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene.
=688  \\$a2012
=750  \0$aReverse genetics$0(DLC)sh2012000362$5IEN-M

=LDR  02142cz  a2200541n  4500
=001  9880364435202441
=005  20141212222235.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059385
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x483.$x812
=072  \\$aE2.$x831.$x387.$x812
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x374
=072  \\$aI3.$x350.$x374
=150  \\$aPlyometric Exercise
=450  \\$wnnna$aCycle Exercise, Stretch-Shortening
=450  \\$wnnna$aCycle Exercises, Stretch-Shortening
=450  \\$wnnna$aDrill, Plyometric
=450  \\$wnnna$aDrill, Stretch-Shortening
=450  \\$wnnna$aDrills, Plyometric
=450  \\$wnnna$aDrills, Stretch-Shortening
=450  \\$wnnna$aExercise, Plyometric
=450  \\$wnnna$aExercise, Stretch-Shortening
=450  \\$wnnna$aExercise, Stretch-Shortening Cycle
=450  \\$wnnna$aExercises, Plyometric
=450  \\$wnnna$aExercises, Stretch-Shortening
=450  \\$wnnna$aExercises, Stretch-Shortening Cycle
=450  \\$wnnna$aPlyometric Drill
=450  \\$wnnna$aPlyometric Drills
=450  \\$wnnna$aPlyometric Exercises
=450  \\$wnnna$aPlyometric Training
=450  \\$wnnna$aPlyometric Trainings
=450  \\$wnnna$aStretch-Shortening Cycle Exercise
=450  \\$wnnna$aStretch Shortening Cycle Exercise
=450  \\$wnnna$aStretch-Shortening Cycle Exercises
=450  \\$wnnna$aStretch-Shortening Drill
=450  \\$wnnna$aStretch Shortening Drill
=450  \\$wnnna$aStretch-Shortening Drills
=450  \\$wnnna$aStretch-Shortening Exercise
=450  \\$wnnna$aStretch Shortening Exercise
=450  \\$wnnna$aStretch-Shortening Exercises
=450  \\$wnnna$aTraining, Plyometric
=450  \\$wnnna$aTrainings, Plyometric
=550  \\$wg$aExercise
=550  \\$wg$aExercise Therapy
=680  \\$iExercises in which muscles are repeatedly and rapidly stretched, followed by shortening, concentric MUSCLE CONTRACTION (e.g. jumping and rebounding). They are designed to exert maximal force in minimal time by increasing STRETCH REFLEX.
=688  \\$a2012
=750  \0$aPlyometrics$0(DLC) sh 97003876$5IEN-M

=LDR  01143cz  a2200301n  4500
=001  9880364435302441
=005  20141212222231.0
=008  110701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059350
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x258
=072  \\$aC23.$x888.$x592.$x612.$x274
=150  \\$aChronic Pain
=450  \\$wnnna$aChronic Pain, Widespread
=450  \\$wnnna$aChronic Pains
=450  \\$wnnna$aChronic Pains, Widespread
=450  \\$wnnna$aPain, Chronic
=450  \\$wnnna$aPain, Widespread Chronic
=450  \\$wnnna$aPains, Chronic
=450  \\$wnnna$aPains, Widespread Chronic
=450  \\$wnnna$aWidespread Chronic Pain
=450  \\$wnnna$aWidespread Chronic Pains
=550  \\$wg$aPain
=550  \\$aAcute Pain
=667  \\$adifferentiate from PAIN, INTRACTABLE
=680  \\$iAching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
=688  \\$a2012
=750  \0$aChronic pain$0(DLC) sh 93009482$5IEN-M

=LDR  01000cz  a2200277n  4500
=001  9880364435402441
=005  20141212222230.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059348
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x712
=072  \\$aC10.$x900.$x575
=072  \\$aC26.$x915.$x650
=150  \\$aPeripheral Nerve Injuries
=450  \\$wnnna$aInjuries, Peripheral Nerve
=450  \\$wnnna$aInjury, Peripheral Nerve
=450  \\$wnnna$aNerve Injuries, Peripheral
=450  \\$wnnna$aNerve Injury, Peripheral
=450  \\$aPeripheral Nerve Injury
=450  \\$aPeripheral Nerves$xinjuries
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wg$aTrauma, Nervous System
=667  \\$acoordinate IM with specific peripheral nerve/ inj (IM) but note CRANIAL NERVE INJURIES and specifics are available
=680  \\$iInjuries to the PERIPHERAL NERVES.
=688  \\$a2012
=750  \0$aNerves, Peripheral$xWounds and injuries$0(DLC) sh 85090908$5IEN-M

=LDR  00805cz  a2200289n  4500
=001  9880364435502441
=005  20141212222229.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059346
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x507
=150  \\$aMagnets
=450  \\$wnnna$aElectromagnet
=450  \\$wnnna$aElectromagnets
=450  \\$wnnna$aFerrimagnet
=450  \\$wnnna$aFerrimagnets
=450  \\$wnnna$aFerromagnet
=450  \\$wnnna$aFerromagnets
=450  \\$wnnna$aMagnet
=550  \\$wg$aManufactured Materials
=550  \\$wh$aMagnetite Nanoparticles
=550  \\$aMagnetic Field Therapy
=550  \\$aMagnetic Phenomena
=550  \\$aMagnetics
=680  \\$iObjects that produce a magnetic field.
=688  \\$a2012
=750  \0$aMagnets$0(DLC) sh 85079796$5IEN-M

=LDR  00895cz  a2200289n  4500
=001  9880364435602441
=005  20141212193202.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059331
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x100
=072  \\$aA11.$x671.$x50
=150  \\$aAdrenergic Neurons
=450  \\$wnnna$aAdrenergic Neuron
=450  \\$wnnna$aNeuron, Adrenergic
=450  \\$wnnna$aNeuron, Noradrenergic
=450  \\$wnnna$aNeurons, Adrenergic
=450  \\$wnnna$aNeurons, Noradrenergic
=450  \\$wnnna$aNoradrenergic Neuron
=450  \\$aNoradrenergic Neurons
=550  \\$wg$aNeurons
=550  \\$wh$aAdrenergic Fibers
=550  \\$aAdrenergic Fibers
=667  \\$aADRENERGIC FIBERS is also available
=680  \\$iNeurons whose primary neurotransmitter is EPINEPHRINE.
=688  \\$a2012
=750  \0$aNoradrenergic neurons$0(DLC) sh 89004584$5IEN-M

=LDR  00607cz  a2200205n  4500
=001  9880364435702441
=005  20141212193201.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059290
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x278
=072  \\$aA11.$x671.$x270
=150  \\$aDopaminergic Neurons
=450  \\$wnnna$aDopaminergic Neuron
=450  \\$wnnna$aNeuron, Dopaminergic
=450  \\$wnnna$aNeurons, Dopaminergic
=550  \\$wg$aNeurons
=680  \\$iNeurons whose primary neurotransmitter is DOPAMINE.
=688  \\$a2012
=750  \0$aDopaminergic neurons$0(DLC) sh 00000066$5IEN-M

=LDR  01193cz  a2200349n  4500
=001  9880364435802441
=005  20141212222226.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059270
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x160.$x495.$x750
=072  \\$aC5.$x116.$x165.$x495.$x500
=072  \\$aC9.$x218.$x705.$x663.$x841
=150  \\$aPetrositis
=450  \\$wnnna$aApicitides, Petrous
=450  \\$wnnna$aApicitis, Petrous
=450  \\$wnnna$aGradenigo-Lannois Syndrome
=450  \\$wnnna$aGradenigo Lannois Syndrome
=450  \\$wnnna$aGradenigo Syndrome
=450  \\$wnnna$aGradenigo's Syndrome
=450  \\$wnnna$aGradenigos Syndrome
=450  \\$wnnna$aPetrositides
=450  \\$wnnna$aPetrous Apicitides
=450  \\$wnnna$aPetrous Apicitis
=450  \\$wnnna$aSyndrome, Gradenigo
=450  \\$wnnna$aSyndrome, Gradenigo-Lannois
=450  \\$wnnna$aSyndrome, Gradenigo's
=550  \\$wg$aOsteomyelitis
=550  \\$wg$aOtitis Media
=680  \\$iInflammation of PETROUS BONE.
=688  \\$a2012; for GRADENIGO'S SYNDROME see under OTITIS MEDIA 1963-81, use OTITIS MEDIA 1982-92
=750  \0$aTemporal bone$xDiseases$0(DLC) sh 85133780$5IEN-M

=LDR  00647cz  a2200217n  4500
=001  9880364435902441
=005  20141212222223.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059249
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x658
=072  \\$aC9.$x218.$x736
=150  \\$aOtomycosis
=450  \\$wnnna$aOtomycoses
=550  \\$wg$aEar Diseases
=550  \\$wg$aMycoses
=550  \\$aOtitis Externa
=667  \\$acoordinate IM with specific fungal disease (IM) if pertinent
=680  \\$iFungus infection of the external ear, usually by ASPERGILLUS species
=688  \\$a2012
=750  \0$aOtomycoses$0(DLC) sh 85040391$5IEN-M

=LDR  01197cz  a2200337n  4500
=001  9880364436002441
=005  20141212222221.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059232
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x502
=150  \\$aLaboratory Personnel
=450  \\$wnnna$aAssistant, Laboratory
=450  \\$wnnna$aAssistants, Laboratory
=450  \\$wnnna$aLaboratory Assistant
=450  \\$wnnna$aLaboratory Assistants
=450  \\$wnnna$aLaboratory Scientist
=450  \\$wnnna$aLaboratory Scientists
=450  \\$wnnna$aLaboratory Technician
=450  \\$aLaboratory Technicians
=450  \\$wnnna$aPersonnel, Laboratory
=450  \\$wnnna$aScientist, Laboratory
=450  \\$wnnna$aScientists, Laboratory
=450  \\$wnnna$aTechnician, Laboratory
=450  \\$wnnna$aTechnicians, Laboratory
=550  \\$wg$aOccupational Groups
=550  \\$wh$aMedical Laboratory Personnel
=667  \\$acoordinate IM with type of lab or occup (IM)
=680  \\$iProfessionals, technicians, and assistants staffing LABORATORIES.
=688  \\$a2012; use MEDICAL LABORATORY PERSONNEL 1992-2011
=750  \0$aLaboratory technicians$0(DLC) sh 85073754$5IEN-M

=LDR  01128cz  a2200337n  4500
=001  9880364436102441
=005  20141212222219.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059226
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x735
=072  \\$aC23.$x888.$x592.$x612.$x720
=072  \\$aC23.$x888.$x646.$x511
=150  \\$aNociceptive Pain
=450  \\$wnnna$aNociceptive Pains
=450  \\$wnnna$aPain, Nociceptive
=450  \\$wnnna$aPain, Somatic
=450  \\$wnnna$aPain, Tissue
=450  \\$wnnna$aPains, Nociceptive
=450  \\$wnnna$aPains, Somatic
=450  \\$wnnna$aPains, Tissue
=450  \\$wnnna$aSomatic Pain
=450  \\$wnnna$aSomatic Pains
=450  \\$wnnna$aTissue Pain
=450  \\$wnnna$aTissue Pains
=550  \\$wg$aPain
=550  \\$wh$aVisceral Pain
=667  \\$aNOCICEPTION is also available
=680  \\$iDull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.
=688  \\$a2012
=750  \0$aNociceptive pain$0(DLC)sh2013002782$5IEN-M

=LDR  00652cz  a2200169n  4500
=001  9880364436202441
=005  20141212222218.0
=008  110624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D059207
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x132.$x644.$x186
=150  \\$aGeothermal Energy
=450  \\$wnnna$aEnergy, Geothermal
=550  \\$wg$aRenewable Energy
=680  \\$iThermal energy contained in the earth. It can be used directly to supply heat or converted to mechanical or electrical energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2012
=750  \0$aGeothermal resources$0(DLC) sh 85054271$5IEN-M

=LDR  01160cz  a2200337n  4500
=001  9880363509202441
=005  20141212201704.0
=008  790524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005819
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x101.$x387
=072  \\$aG5.$x695.$x450
=150  \\$aGenetic Markers
=450  \\$wnnna$aChromosome Marker
=450  \\$aChromosome Markers
=450  \\$wnnna$aDNA Marker
=450  \\$aDNA Markers
=450  \\$wnnna$aGenetic Marker
=450  \\$wnnna$aMarker, Chromosome
=450  \\$wnnna$aMarker, DNA
=450  \\$wnnna$aMarker, Genetic
=450  \\$wnnna$aMarkers, Chromosome
=450  \\$aMarkers, DNA
=450  \\$aMarkers, Genetic
=550  \\$wg$aBiological Markers
=550  \\$wg$aPhenotype
=550  \\$aRandom Amplified Polymorphic DNA Technique
=667  \\$ausually NIM; IM GEN only; coord with specific genetic feature (IM) if pertinent
=680  \\$iA phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.
=688  \\$a89; was GENETIC MARKER 1980-88
=750  \0$aGenetic markers$5IEN-M$0(DLC)sh 98007299

=LDR  01572cz  a2200433n  4500
=001  9880363509302441
=005  20180711100839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005818
=035  \\$aCAZ8980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x420
=150  \\$aGenetic Engineering
=450  \\$wnnna$aEngineering, Genetic
=450  \\$aGenetic Intervention
=450  \\$wnnna$aGenetic Interventions
=450  \\$wnnna$aIntervention, Genetic
=450  \\$wnnna$aInterventions, Genetic
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aDirected Molecular Evolution
=550  \\$wh$aDNA Shuffling
=550  \\$wh$aGene Editing
=550  \\$wh$aGenetic Enhancement
=550  \\$wh$aGenetic Therapy
=550  \\$wh$aMetabolic Engineering
=550  \\$wh$aProtein Engineering
=550  \\$wh$aSex Preselection
=550  \\$aAnimals, Genetically Modified
=550  \\$aArtificial Gene Fusion
=550  \\$aBiotechnology
=550  \\$aCloning, Molecular
=550  \\$aDNA, Recombinant
=550  \\$aIndustrial Microbiology
=550  \\$aOrganisms, Genetically Modified
=550  \\$aPlants, Genetically Modified
=667  \\$aDF: GENET ENGINEERING
=680  \\$iDirected modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.
=688  \\$a89; was GENETIC INTERVENTION 1973-88; was in Cat E & G 1973-79
=750  \0$aGenetic engineering$5IEN$0(DLC)sh 85053855

=LDR  01131cz  a2200253n  4500
=001  9880363509402441
=005  20141212201703.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x315.$x384
=072  \\$aN2.$x421.$x308.$x400
=150  \\$aGenetic Counseling
=450  \\$wnnna$aCounseling, Genetic
=450  \\$wnnna$aGenetic Counseling, Prenatal
=450  \\$wnnna$aPrenatal Genetic Counseling
=550  \\$wg$aGenetic Services
=550  \\$wg$aGenetics, Medical
=550  \\$aDirective Counseling
=550  \\$aEugenics
=550  \\$aPrenatal Diagnosis
=680  \\$iAn educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.
=688  \\$a73
=750  \0$aGenetic counseling$5IEN$0(DLC)sh 85053853

=LDR  00928cz  a2200277n  4500
=001  9880363509502441
=005  20141212201702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005815
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x335
=150  \\$aGenetic Code
=450  \\$wnnna$aCode, Genetic
=450  \\$wnnna$aCodes, Genetic
=450  \\$wnnna$aGenetic Codes
=550  \\$wg$aGenetic Structures
=550  \\$wh$aAnticodon
=550  \\$wh$aCodon
=550  \\$wh$aReading Frames
=550  \\$aCodon
=550  \\$aDNA
=550  \\$aHistone Code
=550  \\$aProtein Biosynthesis
=680  \\$iThe meaning ascribed to the BASE SEQUENCE with respect to how it is translated into AMINO ACID SEQUENCE. The start, stop, and order of amino acids of a protein is specified by consecutive triplets of nucleotides called codons (CODON).
=688  \\$a66(64)
=750  \0$aGenetic code$5IEN$0(DLC)sh 85053852

=LDR  01161cz  a2200397n  4500
=001  9880363509602441
=005  20141212201702.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005814
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x364.$x875
=072  \\$aG5.$x360.$x340.$x358.$x24.$x875
=072  \\$aG5.$x360.$x340.$x358.$x840.$x500
=150  \\$aGenes, Viral
=450  \\$wnnna$aGene, Viral
=450  \\$wnnna$aViral Gene
=450  \\$aViral Genes
=550  \\$wg$aGenes, Microbial
=550  \\$wg$aGenome, Viral
=550  \\$wh$aGenes, env
=550  \\$wh$aGenes, gag
=550  \\$wh$aGenes, Immediate-Early
=550  \\$wh$aGenes, Intracisternal A-Particle
=550  \\$wh$aGenes, nef
=550  \\$wh$aGenes, pol
=550  \\$wh$aGenes, pX
=550  \\$wh$aGenes, rev
=550  \\$wh$aGenes, tat
=550  \\$wh$aGenes, vif
=550  \\$wh$aGenes, vpr
=550  \\$wh$aGenes, vpu
=550  \\$aGenome, Viral
=667  \\$acoordinate IM with specific virus /genet (IM)
=680  \\$iThe functional hereditary units of VIRUSES.
=688  \\$a78
=750  \0$aViral genetics$5IEN$0(DLC)sh 85143730

=LDR  01611cz  a2200349n  4500
=001  9880363509702441
=005  20141212201658.0
=008  870511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005803
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x335
=072  \\$aG12.$x500.$x299
=150  \\$aGenes, Immunoglobulin
=450  \\$wnnna$aGene, Ig
=450  \\$wnnna$aGene, Immunoglobulin
=450  \\$aGenes, Ig
=450  \\$wnnna$aIg Gene
=450  \\$wnnna$aIg Genes
=450  \\$wnnna$aImmunoglobulin Gene
=450  \\$aImmunoglobulin Genes
=550  \\$wg$aGenes
=550  \\$wg$aImmunogenetic Phenomena
=550  \\$wh$aGenes, Immunoglobulin Heavy Chain
=550  \\$wh$aGenes, Immunoglobulin Light Chain
=550  \\$wh$aVDJ Exons
=550  \\$aGene Rearrangement
=550  \\$aImmunoglobulin Allotypes
=550  \\$aImmunoglobulin Gm Allotypes
=550  \\$aImmunoglobulin Joining Region
=680  \\$iGenes encoding the different subunits of the IMMUNOGLOBULINS, for example the IMMUNOGLOBULIN LIGHT CHAIN GENES and the IMMUNOGLOBULIN HEAVY CHAIN GENES. The heavy and light immunoglobulin genes are present as gene segments in the germline cells. The completed genes are created when the segments are shuffled and assembled (B-LYMPHOCYTE GENE REARRANGEMENT) during B-LYMPHOCYTE maturation. The gene segments of the human light and heavy chain germline genes are symbolized V (variable), J (joining) and C (constant). The heavy chain germline genes have an additional segment D (diversity).
=688  \\$a88
=750  \0$aImmunoglobulin genes$0(DLC) sh 90000447$5IEN

=LDR  01363cz  a2200361n  4500
=001  9880363509802441
=005  20141212201658.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x610.$x600
=072  \\$aG5.$x360.$x340.$x24.$x380.$x500.$x600
=072  \\$aG12.$x500.$x500.$x600
=150  \\$aGenes, MHC Class II
=450  \\$wnnna$aClass II Gene
=450  \\$aClass II Genes
=450  \\$wnnna$aGene, Class II
=450  \\$wnnna$aGene, Immune Response
=450  \\$wnnna$aGene, Ir
=450  \\$aGenes, Class II
=450  \\$aGenes, HLA Class II
=450  \\$aGenes, Immune Response
=450  \\$wnnna$aGenes, Ir
=450  \\$wnnna$aImmune Response Gene
=450  \\$aImmune Response Genes
=450  \\$wnnna$aIr Gene
=450  \\$aIr Genes
=450  \\$aMHC Class II Genes
=550  \\$wg$aMajor Histocompatibility Complex
=667  \\$amhc stands for "Major Histocompatibility Complex"; DF: note short X ref
=680  \\$iGenetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and in the I region in mice.
=688  \\$a92; was GENES, IMMUNE RESPONSE 1978-91
=750  \0$aIr genes$5IEN-M$0(DLC)sh 85067881

=LDR  01867cz  a2200481n  4500
=001  9880363509902441
=005  20141212201657.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x230.$x500
=150  \\$aGenes, Homeobox
=450  \\$wnnna$aGene, Homeo Box
=450  \\$wnnna$aGene, Homeobox
=450  \\$wnnna$aGene, Homeotic
=450  \\$wnnna$aGene, Hox
=450  \\$wnnna$aGenes, Homeo Box
=450  \\$aGenes, Homeotic
=450  \\$wnnna$aGenes, Hox
=450  \\$wnnna$aHomeo Box
=450  \\$wnnna$aHomeo Box Gene
=450  \\$wnnna$aHomeo Box Genes
=450  \\$wnnna$aHomeo Box Sequence
=450  \\$wnnna$aHomeo Box Sequences
=450  \\$wnnna$aHomeo Boxes
=450  \\$wnnna$aHomeobox
=450  \\$wnnna$aHomeobox Gene
=450  \\$wnnna$aHomeobox Genes
=450  \\$aHomeobox Sequence
=450  \\$wnnna$aHomeobox Sequences
=450  \\$wnnna$aHomeoboxes
=450  \\$wnnna$aHomeotic Gene
=450  \\$aHomeotic Genes
=450  \\$wnnna$aHox Gene
=450  \\$wnnna$aHox Genes
=450  \\$wnnna$aSequence, Homeo Box
=450  \\$wnnna$aSequence, Homeobox
=450  \\$wnnna$aSequences, Homeo Box
=450  \\$wnnna$aSequences, Homeobox
=550  \\$wg$aGenes, Developmental
=680  \\$iGenes that encode highly conserved TRANSCRIPTION FACTORS that control positional identity of cells (BODY PATTERNING) and MORPHOGENESIS throughout development. Their sequences contain a 180 nucleotide sequence designated the homeobox, so called because mutations of these genes often results in homeotic transformations, in which one body structure replaces another. The proteins encoded by homeobox genes are called HOMEODOMAIN PROTEINS.
=688  \\$a95; was GENES, HOMEO BOX 1987-94
=750  \0$aHomeobox genes$0(DLC) sh 93009682$5IEN-M

=LDR  00823cz  a2200253n  4500
=001  9880363510002441
=005  20141212201656.0
=008  810223\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005798
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x364.$x249
=072  \\$aG5.$x360.$x340.$x358.$x24.$x249
=072  \\$aG5.$x360.$x340.$x358.$x207.$x249
=150  \\$aGenes, Bacterial
=450  \\$wnnna$aBacterial Gene
=450  \\$wnnna$aBacterial Genes
=450  \\$wnnna$aGene, Bacterial
=550  \\$wg$aGenes, Microbial
=550  \\$wg$aGenome, Bacterial
=550  \\$aGenome, Bacterial
=667  \\$acoordinate IM with specific bacterium /genet (IM); DF: GENES BACT
=680  \\$iThe functional hereditary units of BACTERIA.
=688  \\$a82
=750  \0$aBacterial genetics$5IEN$0(DLC)sh 85010849

=LDR  02612cz  a2200709n  4500
=001  9880363510102441
=005  20141212201655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005796
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340
=150  \\$aGenes
=450  \\$wnnna$aCistron
=450  \\$wnnna$aCistrons
=450  \\$wnnna$aGene
=450  \\$wnnoa$aGenes, Structural$5IEN-M
=450  \\$wnnna$aGenetic Material
=450  \\$wnnna$aGenetic Materials
=450  \\$wnnna$aMaterial, Genetic
=450  \\$wnnna$aMaterials, Genetic
=550  \\$wg$aGenome Components
=550  \\$wh$aAlleles
=550  \\$wh$aGene Components
=550  \\$wh$aGenes, cdc
=550  \\$wh$aGenes, Chloroplast
=550  \\$wh$aGenes, Developmental
=550  \\$wh$aGenes, Dominant
=550  \\$wh$aGenes, Duplicate
=550  \\$wh$aGenes, Essential
=550  \\$wh$aGenes, Helminth
=550  \\$wh$aGenes, Immediate-Early
=550  \\$wh$aGenes, Immunoglobulin
=550  \\$wh$aGenes, Insect
=550  \\$wh$aGenes, Lethal
=550  \\$wh$aGenes, MDR
=550  \\$wh$aGenes, Microbial
=550  \\$wh$aGenes, Mitochondrial
=550  \\$wh$aGenes, Modifier
=550  \\$wh$aGenes, Neoplasm
=550  \\$wh$aGenes, Overlapping
=550  \\$wh$aGenes, Plant
=550  \\$wh$aGenes, Protozoan
=550  \\$wh$aGenes, RAG-1
=550  \\$wh$aGenes, Recessive
=550  \\$wh$aGenes, Regulator
=550  \\$wh$aGenes, Reporter
=550  \\$wh$aGenes, sry
=550  \\$wh$aGenes, Suppressor
=550  \\$wh$aGenes, Synthetic
=550  \\$wh$aGenes, T-Cell Receptor
=550  \\$wh$aGenes, X-Linked
=550  \\$wh$aGenes, Y-Linked
=550  \\$wh$aMajor Histocompatibility Complex
=550  \\$wh$aMultigene Family
=550  \\$wh$aPseudogenes
=550  \\$wh$aTransgenes
=550  \\$aGenome
=667  \\$ageneral or unspecified; prefer specifics; restorer genes: index GENES, SUPPRESSOR and probably PLANT INFERTILITY; repressor genes = GENES, REGULATOR but also consider REPRESSOR PROTEINS; lac gene = LAC OPERON but consider also LAC FACTORS or LAC REPRESSORS (see note on REPRESSOR PROTEINS); split genes = EXONS or INTRONS
=680  \\$iA category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.
=688  \\$a1965; (1963); for CISTRON use GENES, STRUCTURAL 1980-2005
=688  \\$a65; was see under CHROMOSOMES 1963-64; SPLIT GENES was see RNA SPLICING 1982-92
=750  \0$aGenes$5IEN$0(DLC)sh 91000344

=LDR  00729cz  a2200205n  4500
=001  9880363510202441
=005  20201124172215.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005795
=035  \\$aCAZ8957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x357.$x526
=150  \\$aGeneralization, Stimulus
=450  \\$wnnna$aGeneralizations, Stimulus
=450  \\$wnnna$aStimulus Generalization
=450  \\$wnnna$aStimulus Generalizations
=550  \\$wg$aGeneralization, Psychological
=680  \\$iThe tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus.
=688  \\$a69(65)
=750  \0$aStimulus generalization$5IEN$0(DLC)sh 85128151

=LDR  00925cz  a2200241n  4500
=001  9880363510302441
=005  20141212201654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005792
=035  \\$aCAZ8954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x342
=150  \\$aGeneral Practice, Dental
=450  \\$wnnna$aDental General Practice
=450  \\$wnnna$aDental General Practices
=450  \\$wnnna$aGeneral Practices, Dental
=450  \\$wnnna$aPractice, Dental General
=450  \\$wnnna$aPractices, Dental General
=550  \\$wg$aDentistry
=667  \\$aSPEC: SPEC qualif; "extraction in general practice in dentistry" is GENERAL PRACTICE, DENTAL (NIM) if indexed there at all; DF: GENERAL PRACTICE DENT
=680  \\$iNonspecialized dental practice which is concerned with providing primary and continuing dental care.
=688  \\$a67
=750  \0$aDentistry$xPractice$5IEN-M$0(DLC)sh 85036958

=LDR  02021cz  a2200625n  4500
=001  9880363510402441
=005  20181002115203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005791
=035  \\$aCAZ8953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760
=072  \\$aN2.$x421.$x585
=150  \\$aPatient Care
=450  \\$wnnna$acare, Informal
=450  \\$wnnna$aCare, Patient
=450  \\$wnnna$acares, Informal
=450  \\$wnnna$aInformal care
=450  \\$wnnna$aInformal cares
=550  \\$wg$aHealth Services
=550  \\$wg$aTherapeutics
=550  \\$wh$aAftercare
=550  \\$wh$aAmbulatory Care
=550  \\$wh$aBloodless Medical and Surgical Procedures
=550  \\$wh$aContinuity of Patient Care
=550  \\$wh$aCritical Care
=550  \\$wh$aCustodial Care
=550  \\$wh$aDay Care, Medical
=550  \\$wh$aEpisode of Care
=550  \\$wh$aFoster Home Care
=550  \\$wh$aHospitalization
=550  \\$wh$aInstitutionalization
=550  \\$wh$aLife Support Care
=550  \\$wh$aLong-Term Care
=550  \\$wh$aMoving and Lifting Patients
=550  \\$wh$aNight Care
=550  \\$wh$aNursing Care
=550  \\$wh$aPalliative Care
=550  \\$wh$aPatient Comfort
=550  \\$wh$aPatient Positioning
=550  \\$wh$aPerinatal Care
=550  \\$wh$aPerioperative Care
=550  \\$wh$aPerioperative Period
=550  \\$wh$aPreconception Care
=550  \\$wh$aPrenatal Care
=550  \\$wh$aPreoperative Care
=550  \\$wh$aSubacute Care
=550  \\$wh$aTerminal Care
=550  \\$wh$aTime-to-Treatment
=550  \\$wh$aTransitional Care
=550  \\$wh$aWithholding Treatment
=667  \\$ageneral or unspecified; prefer specifics; not a synonym for NURSING CARE: nursing care is only one type of patient care
=680  \\$iThe services rendered by members of the health profession and non-professionals under their supervision.
=688  \\$a98; use explode 1975-97
=750  \0$aPatients$xCare$5IEN-M$0(IEN)4729886

=LDR  00850cz  a2200277n  4500
=001  9880363510502441
=005  20141212201653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005789
=035  \\$aCAZ8951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x359
=150  \\$aGenealogy and Heraldry
=450  \\$wnnna$aGenealogies
=450  \\$wnnna$aGenealogy
=450  \\$wnnna$aGeneologies
=450  \\$wnnna$aGeneology
=450  \\$wnnna$aGeneology and Heraldry
=450  \\$aHeraldry
=450  \\$wnnna$aHeraldry and Genealogy
=450  \\$wnnna$aHeraldry and Geneology
=550  \\$wg$aHistory
=550  \\$aEmblems and Insignia
=667  \\$aIM; no qualif; do not confuse with GENEALOGICAL TREE see PEDIGREE; DF: GENEALOGY
=750  \0$aGenealogy$5IEN-M$0(DLC)sh 85053742
=750  \0$aHeraldry$5IEN-HS$0(DLC)sh 85060322

=LDR  01925cz  a2200529n  4500
=001  9880363510602441
=005  20171012140216.0
=008  880531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015316
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x301
=072  \\$aE5.$x393.$x420.$x301
=150  \\$aGenetic Therapy
=450  \\$wnnna$aDNA Therapy
=450  \\$wnnna$aGametic Genetic Therapies
=450  \\$wnnna$aGametic Genetic Therapy
=450  \\$aGene Therapy
=450  \\$wnnna$aGene Therapy, Somatic
=450  \\$wnnna$aGenetic Therapies
=450  \\$wnnna$aGenetic Therapies, Gametic
=450  \\$wnnna$aGenetic Therapies, Somatic
=450  \\$wnnna$aGenetic Therapy, Gametic
=450  \\$wnnna$aGenetic Therapy, Somatic
=450  \\$aSomatic Gene Therapy
=450  \\$wnnna$aSomatic Genetic Therapies
=450  \\$wnnna$aSomatic Genetic Therapy
=450  \\$wnnna$aTherapies, Gametic Genetic
=450  \\$wnnna$aTherapies, Genetic
=450  \\$wnnna$aTherapies, Somatic Genetic
=450  \\$wnnna$aTherapy, DNA
=450  \\$wnnna$aTherapy, Gametic Genetic
=450  \\$wnnna$aTherapy, Gene
=450  \\$wnnna$aTherapy, Genetic
=450  \\$wnnna$aTherapy, Somatic Gene
=450  \\$wnnna$aTherapy, Somatic Genetic
=550  \\$wg$aBiological Therapy
=550  \\$wg$aGenetic Engineering
=550  \\$wh$aRNAi Therapeutics
=550  \\$wh$aTargeted Gene Repair
=550  \\$aGene Transfer Techniques
=550  \\$aGenes, Transgenic, Suicide
=550  \\$aGenetic Services
=680  \\$iTechniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions.
=688  \\$a2012; use Gene Therapy 1988-2011
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Gene Therapy
=688  \\$a89
=750  \0$aGene therapy$5IEN$0(DLC)sh 85053738

=LDR  01008cz  a2200301n  4500
=001  9880363510702441
=005  20141212211000.0
=008  880531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x330
=150  \\$aGene Rearrangement
=450  \\$aDNA Rearrangement
=450  \\$wnnna$aDNA Rearrangements
=450  \\$wnnna$aGene Rearrangements
=450  \\$wnnna$aRearrangement, DNA
=450  \\$wnnna$aRearrangement, Gene
=450  \\$wnnna$aRearrangements, DNA
=450  \\$wnnna$aRearrangements, Gene
=550  \\$wg$aGenetic Processes
=550  \\$wh$aGene Rearrangement, B-Lymphocyte
=550  \\$wh$aGene Rearrangement, T-Lymphocyte
=550  \\$wh$aV(D)J Recombination
=550  \\$aVDJ Recombinases
=667  \\$aDF: GENE REARR
=680  \\$iThe ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.
=688  \\$a89
=750  \0$aGene rearrangement$0(DLC)sh2007009103$5IEN-M

=LDR  00967cz  a2200289n  4500
=001  9880363510802441
=005  20141212201652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005787
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x330
=150  \\$aGene Frequency
=450  \\$wnnna$aAllele Frequencies
=450  \\$aAllele Frequency
=450  \\$wnnna$aEquilibrium, Genetic
=450  \\$wnnna$aFrequencies, Allele
=450  \\$wnnna$aFrequencies, Gene
=450  \\$wnnna$aFrequency, Allele
=450  \\$wnnna$aFrequency, Gene
=450  \\$wnnna$aGene Frequencies
=450  \\$aGenetic Equilibrium
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aGene Flow
=550  \\$wh$aGenetic Drift
=680  \\$iThe proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.
=688  \\$a1968; for GENETIC EQUILIBRIUM use GENETICS, POPULATION 1998-2002
=750  \0$aGene frequency$0(DLC) sh 85053735$5IEN

=LDR  01092cz  a2200265n  4500
=001  9880363510902441
=005  20141212201651.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x615.$x475
=150  \\$aGene Conversion
=450  \\$wnnna$aConversion, Gene
=450  \\$wnnna$aConversions, Gene
=450  \\$wnnna$aGene Conversions
=450  \\$aPolar Recombination
=450  \\$wnnna$aPolar Recombinations
=450  \\$aPolaron
=450  \\$wnnna$aPolarons
=450  \\$wnnna$aRecombination, Polar
=450  \\$wnnna$aRecombinations, Polar
=550  \\$wg$aHomologous Recombination
=680  \\$iThe asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa.
=688  \\$a80
=750  \0$aGene conversion$0(DLC)sh2007002858$5IEN-M

=LDR  01399cz  a2200229n  4500
=001  9880363511002441
=005  20141212201651.0
=008  790417\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005784
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x250
=072  \\$aG5.$x355.$x600.$x315
=072  \\$aG5.$x365.$x590.$x310
=150  \\$aGene Amplification
=450  \\$wnnna$aAmplification, Gene
=550  \\$wg$aGene Expression Regulation
=550  \\$wg$aMutagenesis
=550  \\$wg$aMutation
=667  \\$afor physiol process only; for technique use NUCLEIC ACID AMPLIFICATION TECHNIQUES or specifics
=680  \\$iA selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.
=688  \\$a80
=750  \0$aGene amplification$5IEN$0(DLC)sh 85053732

=LDR  02052cz   2200541n  4500
=001  9880363511102441
=005  20220720111930.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005783
=035  \\$aCAZ8939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x446.$x250
=072  \\$aF1.$x752.$x747.$x385.$x200
=072  \\$aF1.$x752.$x747.$x722.$x200
=072  \\$aF2.$x739.$x794.$x793.$x200
=150  \\$aGender Identity
=450  \\$wnnna$aGender
=450  \\$wnnna$aGender Identities
=450  \\$aGender Role
=450  \\$wnnna$aGender Roles
=450  \\$wnnna$aIdentity, Gender
=450  \\$wnnna$aMan's Role
=450  \\$wnnna$aMen's Role
=450  \\$wnnna$aRole, Man's
=450  \\$wnnna$aRole, Men's
=450  \\$wnnna$aRole, Sex
=450  \\$wnnna$aRole, Woman's
=450  \\$wnnna$aRole, Women's
=450  \\$wnnna$aRoles, Gender
=450  \\$wnnna$aRoles, Men's
=450  \\$wnnna$aRoles, Sex
=450  \\$wnnna$aRoles, Woman's
=450  \\$wnnna$aRoles, Women's
=450  \\$aSex Role
=450  \\$wnnna$aSex Roles
=450  \\$wnnna$aWoman's Role
=450  \\$wnnna$aWoman's Roles
=450  \\$wnnna$aWomen's Role
=450  \\$wnnna$aWomen's Roles
=550  \\$wg$aIdentification, Psychological
=550  \\$wg$aPsychosexual Development
=550  \\$wh$aFemininity
=550  \\$wh$aMasculinity
=550  \\$aTransgendered Persons
=667  \\$apsychological; do not confuse with SEX CHARACTERISTICS (physiological); do not confuse with SEXUAL ORIENTATION see SEX BEHAVIOR: gender identity is knowing that one is male or female; sexual orientation is preferring heterosexual or homosexual behavior; no qualif
=680  \\$iA person's concept of self as being male and masculine or female and feminine, or ambivalent, based in part on physical characteristics, parental responses, and psychological and social pressures. It is the internal experience of gender role.
=688  \\$a1991(1975); for GENDER use SEX 1991-2003
=750  \0$aGender identity$5IEN$0(DLC)sh 91003756

=LDR  00783cz  a2200205n  4500
=001  9880363511202441
=005  20141212192221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005782
=035  \\$aCAZ8937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x280.$x320
=072  \\$aD26.$x255.$x165.$x320
=150  \\$aGels
=550  \\$wg$aColloids
=550  \\$wh$aHydrogels
=550  \\$wh$aSilica Gel
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif)
=680  \\$iColloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
=750  \0$aGels (Pharmacy)$5IEN$0(DLC)sh 85053700

=LDR  00662cz  a2200169n  4500
=001  9880363511302441
=005  20141212201649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005780
=035  \\$aCAZ8935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x860.$x476
=150  \\$aGelatin
=450  \\$wnnna$aGelafusal
=550  \\$wg$aScleroproteins
=680  \\$iA product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.
=750  \0$aGelatin$5IEN$0(DLC)sh 85053686

=LDR  01246cz  a2200325n  4500
=001  9880363511402441
=005  20141212201649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005779
=035  \\$aCAZ8934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x645.$x350
=072  \\$aE5.$x200.$x812.$x735.$x645.$x350
=072  \\$aE5.$x478.$x594.$x760.$x645.$x350
=072  \\$aE5.$x478.$x605.$x492.$x350
=150  \\$aImmunodiffusion
=450  \\$wnnna$aDiffusion Test, Gel
=450  \\$wnnna$aDiffusion Tests, Gel
=450  \\$wnnna$aGel Diffusion Test
=450  \\$aGel Diffusion Tests
=450  \\$wnnna$aImmunodiffusions
=450  \\$aOuchterlony Technique$5IEN-M
=450  \\$wnnna$aTest, Gel Diffusion
=450  \\$wnnna$aTests, Gel Diffusion
=550  \\$wg$aPrecipitin Tests
=550  \\$wh$aImmunoelectrophoresis
=667  \\$aNIM
=680  \\$iTechnique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction.
=688  \\$a92(63); was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65
=750  \0$aImmunodiffusion$5IEN-M$0(DLC)sh 85064556

=LDR  00666cz  a2200205n  4500
=001  9880363511502441
=005  20141212201648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005777
=035  \\$aCAZ8932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x50.$x350
=072  \\$aB1.$x50.$x150.$x900.$x248.$x617.$x492
=150  \\$aGeese
=450  \\$wnnna$aGeeses
=550  \\$wg$aAnseriformes
=550  \\$wg$aPoultry
=667  \\$adomestic or wild; IM; qualif permitted; diseases: coord IM with POULTRY DISEASES (IM); diseases of wild geese: coord IM with BIRD DISEASES (IM)
=688  \\$a68
=750  \0$aGeese$5IEN$0(DLC)sh 85053661

=LDR  06700cz  a2201525n  4500
=001  9880363511602441
=005  20200821140924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005776
=035  \\$aCAZ8931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x400
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x400
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x441
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x400
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x400
=072  \\$aC18.$x452.$x584.$x687.$x803.$x441
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x400
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x441
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x400
=150  \\$aGaucher Disease
=450  \\$wnnna$aAcid beta-Glucosidase Deficiency
=450  \\$wnnna$aAcid beta-Glucosidase Deficiency Disease
=450  \\$wnnna$aAcute Neuronopathic Gaucher Disease
=450  \\$wnnna$aCerebroside Lipidoses, Glucosyl
=450  \\$wnnna$aCerebroside Lipidosis, Glucosyl
=450  \\$aCerebroside Lipidosis Syndrome
=450  \\$wnnna$aCerebroside Lipidosis Syndromes
=450  \\$wnnna$aChronic Gaucher Disease
=450  \\$wnnna$aDeficiencies, GBA
=450  \\$wnnna$aDeficiencies, Glucocerebrosidase
=450  \\$wnnna$aDeficiency Disease, Glucocerebrosidase
=450  \\$wnnna$aDeficiency Diseases, Glucocerebrosidase
=450  \\$wnnna$aDeficiency, GBA
=450  \\$wnnna$aDeficiency, Glucocerebrosidase
=450  \\$wnnna$aDisease, Chronic Gaucher
=450  \\$wnnna$aDisease, Gaucher
=450  \\$wnnna$aDisease, Gaucher's
=450  \\$wnnna$aDisease, Gauchers
=450  \\$wnnna$aDisease, Glucocerebrosidase Deficiency
=450  \\$wnnna$aDisease, Infantile Gaucher
=450  \\$wnnna$aDisease, Juvenile Gaucher
=450  \\$wnnna$aDisease, Neuronopathic Gaucher
=450  \\$wnnna$aDisease, Non-Neuronopathic Gaucher
=450  \\$wnnna$aDiseases, Gauchers
=450  \\$wnnna$aDiseases, Glucocerebrosidase Deficiency
=450  \\$wnnna$aGaucher Disease, Acute Neuronopathic
=450  \\$wnnna$aGaucher Disease, Acute Neuronopathic Type
=450  \\$wnnna$aGaucher Disease, Chronic
=450  \\$wnnna$aGaucher Disease, Chronic Neuronopathic Type
=450  \\$wnnna$aGaucher Disease, Infantile
=450  \\$wnnna$aGaucher Disease, Infantile Cerebral
=450  \\$wnnna$aGaucher Disease, Juvenile
=450  \\$wnnna$aGaucher Disease, Juvenile and Adult, Cerebral
=450  \\$wnnna$aGaucher Disease, Neuronopathic
=450  \\$wnnna$aGaucher Disease, Non-Neuronopathic
=450  \\$wnnna$aGaucher Disease, Non-Neuronopathic Form
=450  \\$wnnna$aGaucher Disease, Non Neuronopathic Form
=450  \\$wnnna$aGaucher Disease, Noncerebral Juvenile
=450  \\$wnnna$aGaucher Disease, Subacute Neuronopathic Form
=450  \\$wnnna$aGaucher Disease, Subacute Neuronopathic Type
=450  \\$wnnna$aGaucher Disease, Type 1
=450  \\$aGaucher Disease Type 1
=450  \\$wnnna$aGaucher Disease, Type 2
=450  \\$aGaucher Disease Type 2
=450  \\$wnnna$aGaucher Disease Type 3
=450  \\$wnnna$aGaucher Disease, Type 3
=450  \\$wnnna$aGaucher Disease, Type I
=450  \\$wnnna$aGaucher Disease, Type II
=450  \\$wnnna$aGaucher Disease, Type III
=450  \\$wnnna$aGaucher Splenomegaly
=450  \\$wnnna$aGaucher Syndrome
=450  \\$wnnna$aGaucher's Disease
=450  \\$wnnna$aGauchers Disease
=450  \\$wnnna$aGauchers Diseases
=450  \\$wnnna$aGBA Deficiencies
=450  \\$wnnna$aGBA Deficiency
=450  \\$wnnna$aGlucocerebrosidase Deficiencies
=450  \\$wnnna$aGlucocerebrosidase Deficiency
=450  \\$aGlucocerebrosidase Deficiency Disease
=450  \\$wnnna$aGlucocerebrosidase Deficiency Diseases
=450  \\$wnnna$aGlucocerebrosidoses
=450  \\$wnnna$aGlucocerebrosidosis
=450  \\$wnnna$aGlucosyl Cerebroside Lipidoses
=450  \\$wnnna$aGlucosyl Cerebroside Lipidosis
=450  \\$wnnna$aGlucosylceramidase Deficiency
=450  \\$wnnna$aGlucosylceramide Beta-Glucosidase Deficiency
=450  \\$aGlucosylceramide Beta-Glucosidase Deficiency Disease
=450  \\$wnnna$aGlucosylceramide Lipidoses
=450  \\$wnnna$aGlucosylceramide Lipidosis
=450  \\$wnnna$aHistiocytoses, Kerasin
=450  \\$wnnna$aHistiocytoses, Lipoid (Kerasin Type)
=450  \\$wnnna$aHistiocytosis, Kerasin
=450  \\$wnnna$aHistiocytosis, Lipoid (Kerasin Type)
=450  \\$wnnna$aInfantile Gaucher Disease
=450  \\$wnnna$aJuvenile Gaucher Disease
=450  \\$wnnna$aKerasin Histiocytoses
=450  \\$wnnna$aKerasin Histiocytosis
=450  \\$wnnna$aKerasin Lipoidoses
=450  \\$wnnna$aKerasin Lipoidosis
=450  \\$wnnna$aKerasin thesaurismoses
=450  \\$wnnna$aKerasin thesaurismosis
=450  \\$wnnna$aLipidoses, Glucosyl Cerebroside
=450  \\$wnnna$aLipidoses, Glucosylceramide
=450  \\$wnnna$aLipidosis, Glucosyl Cerebroside
=450  \\$wnnna$aLipidosis, Glucosylceramide
=450  \\$wnnna$aLipidosis Syndrome, Cerebroside
=450  \\$wnnna$aLipidosis Syndromes, Cerebroside
=450  \\$wnnna$aLipoid Histiocytoses (Kerasin Type)
=450  \\$wnnna$aLipoid Histiocytosis (Kerasin Type)
=450  \\$wnnna$aLipoidoses, Kerasin
=450  \\$wnnna$aLipoidosis, Kerasin
=450  \\$aNeuronopathic Gaucher Disease
=450  \\$wnnna$aNon-Neuronopathic Gaucher Disease
=450  \\$wnnna$aNon Neuronopathic Gaucher Disease
=450  \\$wnnna$aSplenomegaly, Gaucher
=450  \\$wnnna$aSubacute Neuronopathic Gaucher Disease
=450  \\$wnnna$aSyndrome, Cerebroside Lipidosis
=450  \\$wnnna$aSyndrome, Gaucher
=450  \\$wnnna$aSyndromes, Cerebroside Lipidosis
=450  \\$wnnna$athesaurismoses, Kerasin
=450  \\$wnnna$athesaurismosis, Kerasin
=450  \\$wnnna$aType 1 Gaucher Disease
=450  \\$wnnna$aType 2 Gaucher Disease
=450  \\$wnnna$aType 3 Gaucher Disease
=550  \\$wg$aSphingolipidoses
=550  \\$aGlucosylceramidase
=680  \\$iAn autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.
=688  \\$a2000(1966)
=750  \0$aGaucher disease$0(DLC)sh 85053526$5IEN-M

=LDR  00789cz  a2200253n  4500
=001  9880363511702441
=005  20141212201645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005774
=035  \\$aCAZ8929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x496
=072  \\$aE4.$x579.$x408
=150  \\$aGastrostomy
=450  \\$wnnna$aGastrostomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wg$aOstomy
=550  \\$aEnteral Nutrition
=550  \\$aGastric Fistula
=550  \\$aStomach
=667  \\$ado not use /util except by MeSH definition
=680  \\$iCreation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.
=688  \\$a67(65)
=750  \0$aGastrostomy$5IEN$0(DLC)sh 85053496

=LDR  01291cz  a2200361n  4500
=001  9880363511802441
=005  20141212192221.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005773
=035  \\$aCAZ8928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x325
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x320
=072  \\$aE4.$x210.$x240.$x250.$x320
=072  \\$aE4.$x502.$x250.$x250.$x250.$x320
=150  \\$aGastroscopy
=450  \\$wnnna$aGastroscopic Surgeries
=450  \\$wnnna$aGastroscopic Surgery
=450  \\$wnnna$aGastroscopic Surgical Procedure
=450  \\$aGastroscopic Surgical Procedures
=450  \\$wnnna$aGastroscopies
=450  \\$wnnna$aProcedure, Gastroscopic Surgical
=450  \\$wnnna$aProcedures, Gastroscopic Surgical
=450  \\$wnnna$aSurgeries, Gastroscopic
=450  \\$wnnna$aSurgery, Gastroscopic
=450  \\$wnnna$aSurgical Procedure, Gastroscopic
=450  \\$aSurgical Procedures, Gastroscopic
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$aGastroscopes
=550  \\$aStomach
=667  \\$a/ instrum permitted but consider also GASTROSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the interior of the stomach.
=750  \0$aGastroscopy$5IEN$0(DLC)sh 85053494

=LDR  01479cz  a2200397n  4500
=001  9880363511902441
=005  20141212201645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005770
=035  \\$aCAZ8924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476
=072  \\$aC6.$x301.$x371
=072  \\$aC6.$x405.$x249
=150  \\$aGastrointestinal Neoplasms
=450  \\$wnnna$aCancer, Gastrointestinal
=450  \\$wnnna$aCancer of Gastrointestinal Tract
=450  \\$wnnna$aCancer of the Gastrointestinal Tract
=450  \\$wnnna$aCancers, Gastrointestinal
=450  \\$aGastrointestinal Cancer
=450  \\$wnnna$aGastrointestinal Cancers
=450  \\$wnnna$aGastrointestinal Neoplasm
=450  \\$wnnna$aGastrointestinal Tract Cancer
=450  \\$wnnna$aGastrointestinal Tract Cancers
=450  \\$wnnna$aNeoplasm, Gastrointestinal
=450  \\$wnnna$aNeoplasms, Gastrointestinal
=550  \\$wg$aDigestive System Neoplasms
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wh$aEsophageal Neoplasms
=550  \\$wh$aGastrointestinal Stromal Tumors
=550  \\$wh$aIntestinal Neoplasms
=550  \\$wh$aStomach Neoplasms
=550  \\$wh$aZollinger-Ellison Syndrome
=667  \\$aGEN: prefer specific precoord; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
=750  \0$aGastrointestinal system$xCancer$5IEN-M$0(DLC)sh2010009172

=LDR  01148cz  a2200313n  4500
=001  9880363512002441
=005  20141212201644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005769
=035  \\$aCAZ8923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261.$x326.$x310
=150  \\$aGastrointestinal Motility
=450  \\$wnnna$aGastrointestinal Motilities
=450  \\$wnnna$aIntestinal Motilities
=450  \\$aIntestinal Motility
=450  \\$wnnna$aMotilities, Gastrointestinal
=450  \\$wnnna$aMotilities, Intestinal
=450  \\$wnnna$aMotility, Gastrointestinal
=450  \\$wnnna$aMotility, Intestinal
=550  \\$wg$aDigestive System Processes
=550  \\$wh$aGastric Emptying
=550  \\$wh$aGastrointestinal Transit
=550  \\$wh$aMyoelectric Complex, Migrating
=550  \\$wh$aPeristalsis
=667  \\$ado not coordinate with STOMACH or INTESTINES, but coordinate with specific intestine / physiol if pertinent (IM); GASTRIC EMPTYING is available
=680  \\$iThe motor activity of the GASTROINTESTINAL TRACT.
=688  \\$a66
=750  \0$aGastrointestinal system$xMotility$5IEN$0(DLC)sh 85053489

=LDR  01198cz  a2200349n  4500
=001  9880363512102441
=005  20141212201644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005768
=035  \\$aCAZ8922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317
=150  \\$aGastrointestinal Hormones
=450  \\$aEnteric Hormones
=450  \\$wnnna$aHormones, Enteric
=450  \\$wnnna$aHormones, Gastrointestinal
=450  \\$wnnna$aHormones, Intestinal
=450  \\$aIntestinal Hormones
=550  \\$wg$aHormones
=550  \\$wh$aCholecystokinin
=550  \\$wh$aEpidermal Growth Factor
=550  \\$wh$aGastric Inhibitory Polypeptide
=550  \\$wh$aGastrin-Releasing Peptide
=550  \\$wh$aGastrins
=550  \\$wh$aMotilin
=550  \\$wh$aPeptide YY
=550  \\$wh$aProglucagon
=550  \\$wh$aSecretin
=550  \\$wh$aVasoactive Intestinal Peptide
=550  \\$aIntestinal Secretions
=680  \\$iHORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.
=750  \0$aGastrointestinal hormones$5IEN$0(DLC)sh 85053486

=LDR  01579cz  a2200433n  4500
=001  9880363512202441
=005  20141212201643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005767
=035  \\$aCAZ8921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405
=150  \\$aGastrointestinal Diseases
=450  \\$aCholera Infantum
=450  \\$wnnna$aDisease, Gastrointestinal
=450  \\$wnnna$aDiseases, Gastrointestinal
=450  \\$wnnna$aDisorder, Functional Gastrointestinal
=450  \\$wnnna$aDisorders, Functional Gastrointestinal
=450  \\$wnnna$aFunctional Gastrointestinal Disorder
=450  \\$wnnna$aFunctional Gastrointestinal Disorders
=450  \\$wnnna$aGastrointestinal Disease
=450  \\$wnnna$aGastrointestinal Disorder, Functional
=450  \\$wnnna$aGastrointestinal Disorders, Functional
=450  \\$wnnna$aInfantum, Cholera
=550  \\$wg$aDigestive System Diseases
=550  \\$wh$aEsophageal Diseases
=550  \\$wh$aGastroenteritis
=550  \\$wh$aGastrointestinal Hemorrhage
=550  \\$wh$aGastrointestinal Neoplasms
=550  \\$wh$aIntestinal Diseases
=550  \\$wh$aPeptic Ulcer
=550  \\$wh$aStomach Diseases
=550  \\$wh$aTuberculosis, Gastrointestinal
=550  \\$wh$aVisceral Prolapse
=550  \\$aGastroenterology
=667  \\$ageneral: prefer specifics; inflammatory disease = GASTROENTERITIS
=680  \\$iDiseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
=688  \\$a65
=750  \0$aGastrointestinal system$xDiseases$5IEN$0(DLC)sh 85053488

=LDR  01590cz  a2200493n  4500
=001  9880363512302441
=005  20200514111329.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005765
=035  \\$aCAZ8919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x483
=150  \\$aGastrointestinal Agents
=450  \\$wnnna$aAgents, Gastric
=450  \\$wnnna$aAgents, Gastrointestinal
=450  \\$aDigestants
=450  \\$wnnna$aDrugs, Gastric
=450  \\$wnnna$aDrugs, Gastrointestinal
=450  \\$wnnna$aGastric Agents
=450  \\$wnnna$aGastric Drugs
=450  \\$wnnna$aGastrointestinal Drugs
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAntacids
=550  \\$wh$aAnti-Ulcer Agents
=550  \\$wh$aAntidiarrheals
=550  \\$wh$aAntiemetics
=550  \\$wh$aCathartics
=550  \\$wh$aCholagogues and Choleretics
=550  \\$wh$aDemulcents
=550  \\$wh$aEmetics
=550  \\$wh$aGuanylyl Cyclase C Agonists
=550  \\$wh$aLaxatives
=550  \\$wh$aLipotropic Agents
=550  \\$aCholecystokinin
=550  \\$aEpidermal Growth Factor
=550  \\$aGastrins
=550  \\$aGastrointestinal Hormones
=550  \\$aGlucagon-Like Peptides
=550  \\$aPentagastrin
=550  \\$aSincalide
=550  \\$aTetragastrin
=680  \\$iDrugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
=688  \\$a67; DIGESTANTS was heading 1967-86
=750  \0$aGastrointestinal agents$0(DLC) sh 85053482$5IEN-M

=LDR  01666cz  a2200397n  4500
=001  9880363512402441
=005  20141212201642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005764
=035  \\$aCAZ8918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x119.$x500.$x484
=150  \\$aGastroesophageal Reflux
=450  \\$wnnna$aAcid Reflux, Gastric
=450  \\$aEsophageal Reflux
=450  \\$wnnna$aGastric Acid Reflux
=450  \\$wnnna$aGastric Acid Reflux Disease
=450  \\$wnnna$aGastro-Esophageal Reflux
=450  \\$wnnna$aGastro Esophageal Reflux
=450  \\$wnnna$aGastro-oesophageal Reflux
=450  \\$wnnna$aGastro oesophageal Reflux
=450  \\$wnnna$aGastroesophageal Reflux Disease
=450  \\$wnnna$aGERD
=450  \\$wnnna$aReflux, Gastric Acid
=450  \\$wnnna$aReflux, Gastro-Esophageal
=450  \\$wnnna$aReflux, Gastro-oesophageal
=450  \\$wnnna$aReflux, Gastroesophageal
=550  \\$wg$aEsophageal Motility Disorders
=550  \\$wh$aLaryngopharyngeal Reflux
=550  \\$aEsophageal Sphincter, Lower
=550  \\$aHeartburn
=667  \\$anote ESOPHAGITIS, REFLUX see ESOPHAGITIS, PEPTIC is available
=680  \\$iRetrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
=688  \\$a84; was ESOPHAGEAL REFLUX 1964-83 (Prov 1964-65)
=688  \\$a84; was ESOPHAGEAL REFLUX 1964-83 (Prov 1964-65); REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78
=750  \0$aGastroesophageal reflux$0(DLC) sh 85053480$5IEN

=LDR  00673cz  a2200181n  4500
=001  9880363512502441
=005  20180711100414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005762
=035  \\$aCAZ8916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x405
=150  \\$aGastroenterology
=450  \\$aHepatology
=550  \\$wg$aInternal Medicine
=667  \\$aSPEC: SPEC qualif; DF: GASTROENTEROL
=680  \\$iA subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas).
=750  \0$aGastroenterology$5IEN-HS$0(DLC)sh 85053479

=LDR  02010cz  a2200445n  4500
=001  9880363512602441
=005  20141212201641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005761
=035  \\$aCAZ8915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x600.$x550.$x200.$x400
=072  \\$aC22.$x905.$x469
=150  \\$aGastroenteritis, Transmissible, of Swine
=450  \\$wnnna$aGastroenteritides, Porcine Transmissible
=450  \\$wnnna$aGastroenteritides, Swine Transmissible
=450  \\$wnnna$aGastroenteritides, Transmissible Porcine
=450  \\$wnnna$aGastroenteritis, Porcine Transmissible
=450  \\$wnnna$aGastroenteritis, Swine Transmissible
=450  \\$aGastroenteritis, Transmissible, Porcine
=450  \\$wnnna$aGastroenteritis, Transmissible Porcine
=450  \\$wnnna$aPorcine Gastroenteritides, Transmissible
=450  \\$aPorcine Gastroenteritis, Transmissible
=450  \\$wnnna$aPorcine Transmissible Gastroenteritides
=450  \\$wnnna$aPorcine Transmissible Gastroenteritis
=450  \\$wnnna$aSwine Transmissible Gastroenteritides
=450  \\$aSwine Transmissible Gastroenteritis
=450  \\$wnnna$aTransmissible Gastroenteritides, Porcine
=450  \\$wnnna$aTransmissible Gastroenteritides, Swine
=450  \\$aTransmissible Gastroenteritis of Swine
=450  \\$wnnna$aTransmissible Gastroenteritis, Porcine
=450  \\$wnnna$aTransmissible Gastroenteritis, Swine
=450  \\$wnnna$aTransmissible Porcine Gastroenteritides
=450  \\$wnnna$aTransmissible Porcine Gastroenteritis
=550  \\$wg$aCoronavirus Infections
=550  \\$wg$aSwine Diseases
=667  \\$aa specific disease caused by a coronavirus; don't forget also SWINE (NIM) and check tag ANIMALS; DF: GASTROENTERITIS TRANSM SWINE
=680  \\$iA condition of chronic gastroenteritis in adult pigs and fatal gastroenteritis in piglets caused by a CORONAVIRUS.
=688  \\$a70
=750  \0$aTransmissible gastroenteritis of swine$5IEN$0(DLC)sh 85136984

=LDR  01090cz  a2200337n  4500
=001  9880363512702441
=005  20200430152645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005759
=035  \\$aCAZ8913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205
=150  \\$aGastroenteritis
=450  \\$wnnna$aGastroenteritides
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wh$aAppendicitis
=550  \\$wh$aCholera Morbus
=550  \\$wh$aColitis
=550  \\$wh$aDiverticular Diseases
=550  \\$wh$aDiverticulitis
=550  \\$wh$aDysentery
=550  \\$wh$aEnteritis
=550  \\$wh$aEnterocolitis
=550  \\$wh$aEsophagitis
=550  \\$wh$aGastritis
=550  \\$wh$aInflammatory Bowel Diseases
=550  \\$wh$aMucositis
=550  \\$wh$aProctitis
=550  \\$wh$aTyphlitis
=680  \\$iINFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER.
=750  \0$aGastroenteritis$5IEN$0(DLC)sh 85053475

=LDR  00668cz  a2200217n  4500
=001  9880363512802441
=005  20141212201639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005756
=035  \\$aCAZ8910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x697
=072  \\$aC6.$x405.$x748.$x398
=150  \\$aGastritis
=450  \\$wnnna$aGastritides
=550  \\$wg$aGastroenteritis
=550  \\$wg$aStomach Diseases
=550  \\$wh$aGastritis, Atrophic
=550  \\$wh$aGastritis, Hypertrophic
=680  \\$iInflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
=750  \0$aGastritis$0(DLC) sh 85128265$5IEN

=LDR  00975cz  a2200277n  4500
=001  9880363512902441
=005  20141212201639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x317.$x413
=072  \\$aD6.$x472.$x699.$x280
=072  \\$aD12.$x644.$x400.$x320
=072  \\$aD12.$x644.$x548.$x280
=072  \\$aD12.$x776.$x641.$x650.$x320
=150  \\$aGastrins
=450  \\$wnnna$aGastrin
=550  \\$wg$aGastrointestinal Hormones
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aPentagastrin
=550  \\$wh$aTetragastrin
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.
=688  \\$a78; was GASTRIN 1963-77
=750  \0$aGastrin$5IEN$0(DLC)sh 85053467

=LDR  02035cz  a2200445n  4500
=001  9880363513002441
=005  20141212201638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005753
=035  \\$aCAZ8906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x875.$x440
=072  \\$aA10.$x615.$x550.$x291
=150  \\$aGastric Mucosa
=450  \\$wnnna$aCardiac Gland
=450  \\$aCardiac Glands
=450  \\$wnnna$aGastric Gland
=450  \\$aGastric Glands
=450  \\$wnnna$aGastric Mucosas
=450  \\$wnnna$aGland, Cardiac
=450  \\$wnnna$aGland, Gastric
=450  \\$wnnna$aGland, Pyloric
=450  \\$wnnna$aGlands, Cardiac
=450  \\$wnnna$aGlands, Gastric
=450  \\$wnnna$aGlands, Pyloric
=450  \\$wnnna$aMucosa, Gastric
=450  \\$wnnna$aMucosas, Gastric
=450  \\$wnnna$aPyloric Gland
=450  \\$aPyloric Glands
=550  \\$wg$aMucous Membrane
=550  \\$wg$aStomach
=550  \\$wh$aChief Cells, Gastric
=550  \\$wh$aEnterochromaffin Cells
=550  \\$wh$aGastrin-Secreting Cells
=550  \\$wh$aParietal Cells, Gastric
=550  \\$wh$aSomatostatin-Secreting Cells
=667  \\$a/secret permitted but consider GASTRIC JUICE /secret if pertinent; mucosal neoplasms: coordinate IM with STOMACH NEOPLASMS (IM) + histological type of neoplasm (IM); mucosal prolapse: = GASTRIC MUCOSA (IM) + STOMACH DISEASES (NIM) + PROLAPSE (NIM)
=680  \\$iLining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.
=688  \\$a64; GASTRIC MUCOSA PROLAPSE was heading 1963-96
=750  \0$aGastric mucosa$5IEN$0(DLC)sh 85053463

=LDR  00737cz  a2200253n  4500
=001  9880363513102441
=005  20141212201637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005751
=035  \\$aCAZ8904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x927.$x441
=150  \\$aGastric Lavage
=450  \\$wnnna$aGastric Irrigation
=450  \\$wnnna$aGastric Irrigations
=450  \\$wnnna$aGastric Lavages
=450  \\$aIrrigation, Gastric
=450  \\$wnnna$aIrrigations, Gastric
=450  \\$aLavage, Gastric
=450  \\$wnnna$aLavages, Gastric
=550  \\$wg$aTherapeutic Irrigation
=667  \\$ado not use /util except by MeSH definition
=688  \\$a66(63)
=750  \0$aGastric lavage$0(DLC) sh 85053462$5IEN

=LDR  01077cz  a2200241n  4500
=001  9880363513202441
=005  20141212201637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005750
=035  \\$aCAZ8903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x307
=150  \\$aGastric Juice
=450  \\$wnnna$aGastric Juices
=450  \\$wnnna$aJuice, Gastric
=450  \\$wnnna$aJuices, Gastric
=550  \\$wg$aBodily Secretions
=550  \\$wh$aGastric Acid
=550  \\$aAchlorhydria
=550  \\$aPepsinogens
=667  \\$a/secret permitted but consider GASTRIC MUCOSA /secret if pertinent, and not STOMACH /secret; GASTRIC ACID is also available; absence of gastric HCl = ACHLORHYDRIA; hyperacidity: index under GASTRIC ACID /secret
=680  \\$iThe liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)
=750  \0$aGastric juice$5IEN$0(DLC)sh 85053461

=LDR  00677cz  a2200193n  4500
=001  9880363513302441
=005  20141212201636.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005748
=035  \\$aCAZ8901M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x875.$x875.$x419
=150  \\$aGastric Fundus
=450  \\$wnnna$aFundus, Gastric
=550  \\$wg$aStomach
=667  \\$aNIM when merely locational; neopl of gastric fundus: coord NIM with STOMACH NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe superior portion of the body of the stomach above the level of the cardiac notch.
=688  \\$a81
=750  \0$aGastric fundus$5IEN-M$0(DLC)sh2001006315

=LDR  00659cz  a2200217n  4500
=001  9880363513402441
=005  20141212201636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005747
=035  \\$aCAZ8900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x267.$x375
=072  \\$aC23.$x300.$x575.$x185.$x375
=150  \\$aGastric Fistula
=450  \\$wnnna$aFistula, Gastric
=450  \\$wnnna$aFistula, Stomach
=450  \\$wnnna$aStomach Fistula
=550  \\$wg$aDigestive System Fistula
=667  \\$afistula policy: Manual 23.19+
=680  \\$iAbnormal passage communicating with the STOMACH.
=750  \0$aFistula, Gastric$5IEN$0(DLC)sh 85048897

=LDR  01547cz  a2200373n  4500
=001  9880363513502441
=005  20141212211022.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015390
=035  \\$aCAZ8898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x65.$x62.$x249
=072  \\$aE4.$x35.$x398.$x385
=072  \\$aE4.$x62.$x249
=072  \\$aE4.$x210.$x457.$x430
=150  \\$aGastric Bypass
=450  \\$wnnna$aBypass, Gastric
=450  \\$wnnna$aBypass, Gastroileal
=450  \\$wnnna$aBypass, Roux-en-Y Gastric
=450  \\$wnnna$aGastric Bypass, Greenville
=450  \\$wnnna$aGastric Bypass, Roux-en-Y
=450  \\$aGastroileal Bypass
=450  \\$wnnna$aGastrojejunostomies
=450  \\$wnnna$aGastrojejunostomy
=450  \\$wnnna$aGreenville Gastric Bypass
=450  \\$wnnna$aRoux-en-Y Gastric Bypass
=450  \\$wnnna$aRoux en Y Gastric Bypass
=550  \\$wg$aBariatric Surgery
=550  \\$wg$aGastroenterostomy
=550  \\$aObesity, Morbid
=667  \\$ado not routinely add ANASTOMOSIS, ROUX-EN-Y
=680  \\$iSurgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.
=688  \\$a89
=750  \0$aGastric bypass$5IEN-M$0(DLC)sh2003008450

=LDR  00772cz  a2200217n  4500
=001  9880363513602441
=005  20200618140326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005743
=035  \\$aCAZ8895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x419
=150  \\$aGastrectomy
=450  \\$wnnna$aGastrectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wh$aPyloromyotomy
=550  \\$aPeptic Ulcer
=550  \\$aStomach
=667  \\$aincludes partial, total & subtotal; do not use /util except by MeSH definition
=680  \\$iExcision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)
=750  \0$aGastrectomy$5IEN$0(DLC)sh 85053459

=LDR  00826cz  a2200241n  4500
=001  9880363513702441
=005  20141212201635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005742
=035  \\$aCAZ8894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x630.$x540
=072  \\$aN6.$x230.$x132.$x258.$x630.$x540
=150  \\$aGasoline
=450  \\$wnnna$aDiesel Fuel
=450  \\$wnnna$aDiesel Fuels
=450  \\$wnnna$aFuel, Diesel
=450  \\$wnnna$aFuels, Diesel
=450  \\$wnnna$aGasolines
=550  \\$wg$aPetroleum
=680  \\$iVolative flammable fuel (liquid hydrocarbons) derived from crude petroleum by processes such as distillation reforming, polymerization, etc.
=688  \\$a91(75); was see under PETROLEUM 1975-90; was in Cat J only 1975-81
=750  \0$aGasoline$5IEN$0(DLC)sh 85053418

=LDR  01091cz  a2200361n  4500
=001  9880363513802441
=005  20141212201635.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005741
=035  \\$aCAZ8893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613
=072  \\$aD1.$x362.$x641
=150  \\$aNoble Gases
=450  \\$wnnna$aElements, Group 18
=450  \\$aGases, Inert
=450  \\$wnnna$aGases, Noble
=450  \\$aGases, Rare
=450  \\$wnnna$aGroup 18 Elements
=450  \\$wnnna$aInert Gases
=450  \\$aRare Gases
=550  \\$wg$aElements
=550  \\$wg$aGases
=550  \\$wh$aArgon
=550  \\$wh$aHelium
=550  \\$wh$aKrypton
=550  \\$wh$aNeon
=550  \\$wh$aRadon
=550  \\$wh$aXenon
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iElements that constitute group 18 (formerly the zero group) of the periodic table. They are gases that generally do not react chemically.
=688  \\$a94; was GASES, RARE 1976-93; was RARE GASES (NON MESH) 1971-76
=750  \0$aGases, Rare$5IEN$0(DLC)sh 85053403

=LDR  01652cz  a2200481n  4500
=001  9880363513902441
=005  20210217152527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005632
=035  \\$aCAZ8779HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x546.$x359.$x250
=072  \\$aD9.$x546.$x465.$x354
=150  \\$aFructose
=450  \\$wnnna$aApir Levulosa
=450  \\$wnnna$aBaxter Brand of Fructose
=450  \\$wnnna$aBieffe Brand of Fructose
=450  \\$wnnna$aBraun Brand of Fructose
=450  \\$wnnna$aErn Brand of Fructose
=450  \\$wnnna$aFleboplast Levulosa
=450  \\$wnnna$aFresenius Kabi Brand of Fructose
=450  \\$wnnna$aGrifols Brand of Fructose
=450  \\$wnnna$aInstituto Farmacologico Brand of Fructose
=450  \\$wnnna$aLevulosa
=450  \\$wnnna$aLevulosa, Apir
=450  \\$wnnna$aLevulosa Baxter
=450  \\$wnnna$aLevulosa Braun
=450  \\$wnnna$aLevulosa, Fleboplast
=450  \\$wnnna$aLevulosa Grifols
=450  \\$wnnna$aLevulosa Ibys
=450  \\$wnnna$aLevulosa Ife
=450  \\$wnnna$aLevulosa Mein
=450  \\$wnnna$aLevulosado Bieffe Medit
=450  \\$wnnna$aLevulosado Braun
=450  \\$wnnna$aLevulosado Vitulia
=450  \\$aLevulose
=450  \\$wnnna$aPlast Apyr Levulosa Mein
=550  \\$wg$aHexoses
=550  \\$wg$aKetoses
=550  \\$wh$aTopiramate
=680  \\$iA monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.
=750  \0$aLevulose$5IEN-M$0(DLC)sh 85076337
=750  \0$aFructose$5IEN-HS$0(DLC)sh 85052102

=LDR  00569cz  a2200205n  4500
=001  9880363514002441
=005  20141212201557.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005630
=035  \\$aCAZ8777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x350
=150  \\$aFructans
=450  \\$aLevans
=550  \\$wg$aPolysaccharides
=550  \\$wh$aInulin
=667  \\$apolysaccharides
=680  \\$iPolysaccharides composed of D-fructose units.
=688  \\$a91(75); was see under POLYSACCHARIDES 1975-90
=750  \0$aFructans$5IEN$0(DLC)sh 85052101

=LDR  00556cz  a2200193n  4500
=001  9880363514102441
=005  20141212201557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005628
=035  \\$aCAZ8775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x521.$x500
=150  \\$aFrozen Foods
=450  \\$aFood, Frozen
=450  \\$wnnna$aFoods, Frozen
=450  \\$wnnna$aFrozen Food
=550  \\$wg$aFood, Preserved
=688  \\$a91(64); was see under FOOD PRESERVATION 1964-90 (Prov 1964-67)
=750  \0$aFrozen foods$5IEN$0(DLC)sh 85050244

=LDR  00607cz  a2200217n  4500
=001  9880363514202441
=005  20161219135937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005627
=035  \\$aCAZ8774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x212.$x500
=072  \\$aC26.$x417
=150  \\$aFrostbite
=450  \\$wnnna$aFrostbites
=550  \\$wg$aCold Injury
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aChilblains
=550  \\$aCold Temperature
=680  \\$iDamage to tissues as the result of low environmental temperatures.
=750  \0$aFrostbite$5IEN$0(DLC)sh 85052091

=LDR  00771cz  a2200181n  4500
=001  9880363514302441
=005  20141212201556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005626
=035  \\$aCAZ8773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x621.$x387
=150  \\$aFrontal Sinus
=450  \\$wnnna$aSinus, Frontal
=550  \\$wg$aParanasal Sinuses
=667  \\$ainflammation or sinusitis = FRONTAL SINUSITIS; fractures: coordinate FRONTAL SINUS /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with PARANASAL SINUS NEOPLASMS (IM)
=680  \\$iOne of the paired, but seldom symmetrical, air spaces located between the inner and outer compact layers of the FRONTAL BONE in the forehead.
=750  \0$aFrontal sinus$5IEN$0(DLC)sh 85052071

=LDR  02084cz  a2200577n  4500
=001  9880363514402441
=005  20141212192219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005625
=035  \\$aCAZ8772HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x270
=150  \\$aFrontal Lobe
=450  \\$wnnna$aAnterior Central Gyrus
=450  \\$wnnna$aCentral Gyrus, Anterior
=450  \\$wnnna$aCortex, Frontal
=450  \\$wnnna$aCortices, Frontal
=450  \\$wnnna$aEye Field, Frontal
=450  \\$wnnna$aEye Field, Supplementary
=450  \\$wnnna$aEye Fields, Frontal
=450  \\$wnnna$aEye Fields, Supplementary
=450  \\$wnnna$aField, Frontal Eye
=450  \\$wnnna$aField, Supplementary Eye
=450  \\$wnnna$aFields, Frontal Eye
=450  \\$wnnna$aFields, Supplementary Eye
=450  \\$wnnna$aFrontal Cortex
=450  \\$wnnna$aFrontal Cortices
=450  \\$wnnna$aFrontal Eye Field
=450  \\$wnnna$aFrontal Eye Fields
=450  \\$wnnna$aFrontal Lobes
=450  \\$wnnna$aFrontali, Lobus
=450  \\$wnnna$aFrontalis, Lobus
=450  \\$wnnna$aGyrus, Anterior Central
=450  \\$wnnna$aGyrus, Precentral
=450  \\$wnnna$aGyrus Precentrali
=450  \\$wnnna$aGyrus Precentralis
=450  \\$wnnna$aLobe, Frontal
=450  \\$wnnna$aLobes, Frontal
=450  \\$wnnna$aLobus Frontali
=450  \\$wnnna$aLobus Frontalis
=450  \\$wnnna$aPrecentral Gyrus
=450  \\$wnnna$aPrecentrali, Gyrus
=450  \\$wnnna$aPrecentralis, Gyrus
=450  \\$wnnna$aSupplementary Eye Field
=450  \\$wnnna$aSupplementary Eye Fields
=550  \\$wg$aCerebral Cortex
=550  \\$wh$aMotor Cortex
=550  \\$wh$aPrefrontal Cortex
=667  \\$adiseases: coordinate IM with BRAIN DISEASES (IM); neoplasms: coordinate IM with BRAIN NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus.
=750  \0$aFrontal lobes$5IEN$0(DLC)sh 85052069

=LDR  01168cz  a2200253n  4500
=001  9880363514502441
=005  20141212201556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x375.$x525.$x225
=072  \\$aB4.$x909.$x574.$x807.$x375.$x525.$x225
=072  \\$aB4.$x909.$x777.$x731.$x375.$x525.$x225
=150  \\$aFriend murine leukemia virus
=450  \\$aFriend Virus
=450  \\$aRowson-Parr Virus
=450  \\$wnnna$aRowson Parr Virus
=450  \\$wnnna$aVirus, Friend
=450  \\$wnnna$aVirus, Rowson-Parr
=550  \\$wg$aLeukemia Virus, Murine
=667  \\$ainfection: coord IM with RETROVIRIDAE INFECTIONS (IM) + TUMOR VIRUS INFECTIONS (IM) + LEUKEMIA, EXPERIMENTAL (IM) or LEUKEMIA (IM); Friend erythroleukemia cells: coord IM with LEUKEMIA, ERYTHROBLASTIC, ACUTE + TUMOR CELLS, CULTURED
=680  \\$iA strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice.
=688  \\$a2002 (1966)
=750  \0$aFriend virus$5IEN$0(DLC)sh 85051985

=LDR  03597cz  a2200697n  4500
=001  9880363514602441
=005  20141212201555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005621
=035  \\$aCAZ8768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x252.$x700.$x150
=072  \\$aC10.$x228.$x854.$x787.$x200
=072  \\$aC10.$x574.$x500.$x825.$x200
=072  \\$aC16.$x320.$x400.$x780.$x200
=072  \\$aC18.$x452.$x660.$x300
=150  \\$aFriedreich Ataxia
=450  \\$wnnna$aAtaxia, Friedreich
=450  \\$wnnna$aAtaxia, Friedreich Familial
=450  \\$wnnna$aAtaxia, Friedreich Hereditary
=450  \\$wnnna$aAtaxia, Friedreich Spinocerebellar
=450  \\$wnnna$aAtaxia, Friedreich's
=450  \\$wnnna$aAtaxia, Friedreich's Familial
=450  \\$wnnna$aAtaxia, Friedreich's Hereditary
=450  \\$wnnna$aAtaxias, Friedreich
=450  \\$wnnna$aAtaxias, Friedreich's Hereditary
=450  \\$wnnna$aDisease, Friedreich
=450  \\$wnnna$aDisease, Friedreich's
=450  \\$wnnna$aFamilial Ataxia, Friedreich
=450  \\$wnnna$aFamilial Ataxia, Friedreich's
=450  \\$wnnna$aFriedreich Ataxias
=450  \\$aFriedreich Disease
=450  \\$wnnna$aFriedreich Familial Ataxia
=450  \\$wnnna$aFriedreich Hereditary Ataxia
=450  \\$wnnna$aFriedreich Hereditary Spinal Ataxia
=450  \\$wnnna$aFriedreich Spinocerebellar Ataxia
=450  \\$wnnna$aFriedreich's Ataxia
=450  \\$wnnna$aFriedreich's Disease
=450  \\$wnnna$aFriedreich's Familial Ataxia
=450  \\$wnnna$aFriedreichs Familial Ataxia
=450  \\$wnnna$aFriedreich's Hereditary Ataxia
=450  \\$wnnna$aFriedreichs Hereditary Ataxia
=450  \\$wnnna$aFriedreich's Hereditary Ataxias
=450  \\$wnnna$aFriedreich's Hereditary Spinal Ataxia
=450  \\$wnnna$aHereditary Ataxia, Friedreich
=450  \\$wnnna$aHereditary Ataxia, Friedreich's
=450  \\$wnnna$aHereditary Ataxias, Friedreich's
=450  \\$wnnna$aHereditary Spinal Ataxia, Friedreich
=450  \\$wnnna$aHereditary Spinal Ataxia, Friedreich's
=450  \\$wnnna$aHereditary Spinal Scleroses
=450  \\$aHereditary Spinal Sclerosis
=450  \\$wnnna$aScleroses, Hereditary Spinal
=450  \\$aSclerosis, Hereditary Spinal
=450  \\$wnnna$aSpinal Scleroses, Hereditary
=450  \\$wnnna$aSpinal Sclerosis, Hereditary
=450  \\$wnnna$aSpinocerebellar Ataxia, Friedreich
=550  \\$wg$aMitochondrial Diseases
=550  \\$wg$aSpinocerebellar Degenerations
=680  \\$iAn autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure (secondary to a cardiomyopathy), and lower extremity weakness. Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. (From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335(16):1169-75) The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. (From Durr et al, N Engl J Med 1996 Oct 17;335(16):1169-75)
=688  \\$a2000(1966); for FRIEDREICH'S DISEASE use MYOCLONUS 1997-1999
=750  \0$aFriedreich's ataxia$5IEN$0(DLC)sh 85051980

=LDR  00861cz  a2200301n  4500
=001  9880363514702441
=005  20141212201554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005618
=035  \\$aCAZ8765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x280
=072  \\$aN6.$x230.$x232
=150  \\$aFresh Water
=450  \\$wnnna$aFresh Waters
=450  \\$wnnna$aFreshwater
=450  \\$wnnna$aFreshwaters
=450  \\$wnnna$aWater, Fresh
=450  \\$wnnna$aWaters, Fresh
=550  \\$wg$aEnvironment
=550  \\$wh$aLakes
=550  \\$wh$aPonds
=550  \\$wh$aRivers
=550  \\$aDrinking Water
=550  \\$aWater
=680  \\$iWater containing no significant amounts of salts, such as water from RIVERS and LAKES.
=688  \\$a91(72); was see under WATER 1972-90
=750  \0$aFresh water$5IEN$0(DLC)sh 85051939

=LDR  01163cz  a2200265n  4500
=001  9880363514802441
=005  20141212201553.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005614
=035  \\$aCAZ8761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x620.$x260
=072  \\$aE1.$x370.$x225.$x750.$x600.$x620.$x260
=072  \\$aE5.$x200.$x500.$x620.$x620.$x260
=072  \\$aE5.$x200.$x750.$x600.$x620.$x260
=150  \\$aFreeze Fracturing
=450  \\$wnnna$aFracturing, Freeze
=450  \\$wnnna$aFracturings, Freeze
=450  \\$wnnna$aFreeze Fracturings
=550  \\$wg$aReplica Techniques
=550  \\$wh$aFreeze Etching
=667  \\$ado not confuse with FREEZE ETCHING (wherein no cryoprotectant is used)
=680  \\$iPreparation for electron microscopy of minute replicas of exposed surfaces of the cell which have been ruptured in the frozen state. The specimen is frozen, then cleaved under high vacuum at the same temperature. The exposed surface is shadowed with carbon and platinum and coated with carbon to obtain a carbon replica.
=688  \\$a75
=750  \0$aFreeze fracturing$5IEN$0(DLC)sh 85051738

=LDR  01253cz  a2200229n  4500
=001  9880363514902441
=005  20141212201552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005613
=035  \\$aCAZ8760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x620.$x260.$x400
=072  \\$aE1.$x370.$x225.$x750.$x600.$x620.$x260.$x400
=072  \\$aE5.$x200.$x500.$x620.$x620.$x260.$x400
=072  \\$aE5.$x200.$x750.$x600.$x620.$x260.$x400
=150  \\$aFreeze Etching
=450  \\$wnnna$aEtching, Freeze
=550  \\$wg$aFreeze Fracturing
=667  \\$ado not confuse with FREEZE FRACTURING (wherein a cryoprotectant is used)
=680  \\$iA replica technique in which cells are frozen to a very low temperature and cracked with a knife blade to expose the interior surfaces of the cells or cell membranes. The cracked cell surfaces are then freeze-dried to expose their constituents. The surfaces are now ready for shadowing to be viewed using an electron microscope. This method differs from freeze-fracturing in that no cryoprotectant is used and, thus, allows for the sublimation of water during the freeze-drying process to etch the surfaces.
=688  \\$a73(69)
=750  \0$aFreeze-etching$5IEN$0(DLC)sh 85051737

=LDR  01134cz  a2200313n  4500
=001  9880363515002441
=005  20141212201552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005612
=035  \\$aCAZ8759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x760.$x160.$x260
=072  \\$aE1.$x370.$x225.$x750.$x600.$x760.$x160.$x260
=072  \\$aE2.$x792.$x156.$x260
=072  \\$aE5.$x200.$x500.$x620.$x760.$x160.$x260
=072  \\$aE5.$x200.$x750.$x600.$x760.$x160.$x260
=072  \\$aE5.$x760.$x156.$x260
=150  \\$aFreeze Drying
=450  \\$wnnna$aDrying, Freeze
=450  \\$wnnna$aDryings, Freeze
=450  \\$wnnna$aFreeze Dryings
=450  \\$aLyophilization
=450  \\$wnnna$aLyophilizations
=550  \\$wg$aCryopreservation
=550  \\$wh$aFreeze Substitution
=550  \\$aDesiccation
=667  \\$aNIM
=680  \\$iMethod of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products.
=750  \0$aFreeze-drying$5IEN$0(DLC)sh 85051736

=LDR  00694cz  a2200229n  4500
=001  9880363515102441
=005  20141212201551.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005610
=035  \\$aCAZ8757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x380
=072  \\$aN3.$x706.$x437.$x380
=150  \\$aFreedom
=450  \\$wnnna$aFreedoms
=450  \\$wnnna$aLibertarianism
=450  \\$aLiberty
=550  \\$wg$aHuman Rights
=550  \\$wh$aPersonal Autonomy
=680  \\$iThe rights of individuals to act and make decisions without external constraints.
=688  \\$a91(78); was see under HUMAN RIGHTS 1978-90
=750  \0$aLiberty$5IEN$0(DLC)sh 85076480

=LDR  01180cz  a2200289n  4500
=001  9880363515202441
=005  20141212201551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005609
=035  \\$aCAZ8756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x339
=072  \\$aD2.$x389
=150  \\$aFree Radicals
=450  \\$wnnna$aRadicals, Free
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aNitric Oxide
=550  \\$wh$aPeroxides
=550  \\$wh$aReactive Oxygen Species
=550  \\$wh$aSpin Labels
=550  \\$aFree Radical Scavengers
=550  \\$aReactive Oxygen Species
=667  \\$aIM GEN only; usually NIM with coord IM
=680  \\$iHighly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated.
=688  \\$a76(67)
=750  \0$aFree radicals (Chemistry)$5IEN$0(DLC)sh 85051674

=LDR  00651cz  a2200217n  4500
=001  9880363515302441
=005  20141212201551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005608
=035  \\$aCAZ8755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x709.$x437
=150  \\$aFree Association
=450  \\$aAssociation, Free
=450  \\$wnnna$aAssociations, Free
=450  \\$wnnna$aFree Associations
=550  \\$wg$aPsychoanalytic Therapy
=667  \\$ano qualif; DF: FREE ASSOC
=680  \\$iSpontaneous verbalization of whatever comes to mind.
=688  \\$a69
=750  \0$aFree association (Psychology)$5IEN$0(DLC)sh 85051651

=LDR  01002cz  a2200313n  4500
=001  9880363515402441
=005  20141212201550.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005607
=035  \\$aCAZ8754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x300
=150  \\$aFraud
=450  \\$aFraud, Health Care
=450  \\$wnnna$aFrauds
=450  \\$wnnna$aFrauds, Health Care
=450  \\$aHealth Care Fraud
=450  \\$wnnna$aHealth Care Frauds
=450  \\$wnnna$aHealthcare Fraud
=450  \\$wnnna$aKickback
=450  \\$aKickbacks
=550  \\$wg$aCrime
=550  \\$wh$aIdentity Theft
=550  \\$aDeception
=550  \\$aProfessional Misconduct
=667  \\$anote FRAUD, SCIENTIFIC see SCIENTIFIC MISCONDUCT
=680  \\$iExploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.
=688  \\$a91(Aug 77); was see under CRIME 1977-90; KICKBACKS was see CRIME 1992-93
=750  \0$aFraud$5IEN$0(DLC)sh 85051619

=LDR  00944cz  a2200169n  4500
=001  9880363515502441
=005  20141212201550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005606
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x840.$x666
=150  \\$aRhamnus
=550  \\$wg$aRhamnaceae
=667  \\$aRHAMMUS FRANGULA and RHAMMUS PURSHIANA see FRANGULA are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RHAMNACEAE. Several species have been reclassified to the FRANGULA genus. It is often called buckthorn but should not be confused with other plants called that.
=688  \\$a1991(1963)
=750  \0$aFrangula$5IEN$0(DLC)sh 85051562

=LDR  00845cz  a2200241n  4500
=001  9880363515602441
=005  20141212201550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005605
=035  \\$aCAZ8752HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x380
=072  \\$aD1.$x268.$x549.$x250
=072  \\$aD1.$x268.$x556.$x277
=072  \\$aD1.$x552.$x528.$x328
=072  \\$aD1.$x552.$x544.$x277
=150  \\$aFrancium
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iFrancium. A radioactive alkali metal with the atomic symbol Fr, atomic number 87, and atomic weight 223. The mass numbers of other known isotopes are 204-213, 217-222, and 224. Its valence is +1.
=750  \0$aFrancium$5IEN$0(DLC)sh 85051541

=LDR  00669cz  a2200205n  4500
=001  9880363515702441
=005  20141212201549.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005604
=035  \\$aCAZ8751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x340.$x590
=072  \\$aB3.$x660.$x250.$x200.$x750
=150  \\$aFrancisella tularensis
=450  \\$aPasteurella tularensis
=550  \\$wg$aFrancisella
=667  \\$ainfection = TULAREMIA
=680  \\$iThe etiologic agent of TULAREMIA in man and other warm-blooded animals.
=688  \\$a76; was PASTEURELLA TULARENSIS 1963-75
=750  \0$aFrancisella tularensis$5IEN$0(DLC)sh 88023260

=LDR  00832cz  a2200229n  4500
=001  9880363515802441
=005  20141212201549.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005603
=035  \\$aCAZ8750HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x340
=072  \\$aB3.$x660.$x250.$x200
=150  \\$aFrancisella
=450  \\$aFrancisellaceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aFrancisella tularensis
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iThe lone genus of bacteria in the family Francisellaceae, frequently found in natural waters. It can be parasitic in humans, other MAMMALS; BIRDS; and ARTHROPODS.
=688  \\$a76
=750  \0$aFrancisella$5IEN$0(DLC)sh 88023259

=LDR  02577cz  a2200589n  4500
=001  9880363515902441
=005  20141212201548.0
=008  820422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005600
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x455.$x500
=072  \\$aC16.$x131.$x260.$x830.$x300
=072  \\$aC16.$x320.$x180.$x830.$x300
=072  \\$aC16.$x320.$x322.$x500.$x500
=072  \\$aC16.$x320.$x400.$x525.$x500
=150  \\$aFragile X Syndrome
=450  \\$wnnna$aFra(X) Syndrome
=450  \\$wnnna$aFragile X-F Mental Retardation Syndrome
=450  \\$aFragile X Mental Retardation Protein$xdeficiency
=450  \\$wnnna$aFragile X Mental Retardation Syndrome
=450  \\$wnnna$aFragile X Syndromes
=450  \\$aFRAXA Syndrome
=450  \\$wnnna$aFRAXA Syndromes
=450  \\$aFRAXE Syndrome
=450  \\$wnnna$aFRAXE Syndromes
=450  \\$wnnna$aMar (X) Syndrome
=450  \\$wnnna$aMarker X Syndrome
=450  \\$wnnna$aMarker X Syndromes
=450  \\$aMartin-Bell Syndrome
=450  \\$wnnna$aMartin Bell Syndrome
=450  \\$wnnna$aMental Retardation, X-Linked, Associated With Fragile Site Fraxe
=450  \\$wnnna$aMental Retardation, X-Linked, Associated With Marxq28
=450  \\$wnnna$aSyndrome, Fragile X
=450  \\$wnnna$aSyndrome, FRAXA
=450  \\$wnnna$aSyndrome, FRAXE
=450  \\$wnnna$aSyndrome, Marker X
=450  \\$wnnna$aSyndrome, Martin-Bell
=450  \\$wnnna$aSyndromes, Fragile X
=450  \\$wnnna$aSyndromes, FRAXA
=450  \\$wnnna$aSyndromes, FRAXE
=450  \\$wnnna$aSyndromes, Marker X
=450  \\$wnnna$aX-Linked Mental Retardation and Macroorchidism
=450  \\$wnnna$aX Linked Mental Retardation and Macroorchidism
=550  \\$wg$aMental Retardation, X-Linked
=550  \\$wg$aSex Chromosome Disorders
=550  \\$aChromosome Fragile Sites
=550  \\$aChromosome Fragility
=550  \\$aIntellectual Disability
=550  \\$aTrinucleotide Repeat Expansion
=680  \\$iA condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
=688  \\$a91(83); was see under SEX CHROMOSOME ABNORMALITIES 1983-90
=750  \0$aFragile X syndrome$0(DLC) sh 85051162$5IEN-M

=LDR  00860cz  a2200217n  4500
=001  9880363516002441
=005  20141212201547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005599
=035  \\$aCAZ8746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x468
=150  \\$aFractures, Ununited
=450  \\$wnnna$aFracture, Ununited
=450  \\$wnnna$aUnunited Fracture
=450  \\$wnnna$aUnunited Fractures
=550  \\$wg$aFractures, Bone
=550  \\$wh$aPseudarthrosis
=667  \\$afract where union does not occur; do not confuse with FRACTURES, MALUNITED; IM; coord with specific organ/inj or precoord organ/fract term (IM)
=680  \\$iA fracture in which union fails to occur, the ends of the bone becoming rounded and eburnated, and a false joint occurs. (Stedman, 25th ed)
=750  \0$aFractures, Ununited$0(DLC) sh 85051159$5IEN

=LDR  01120cz  a2200301n  4500
=001  9880363516102441
=005  20141212201547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005598
=035  \\$aCAZ8745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x374
=150  \\$aFractures, Spontaneous
=450  \\$wnnna$aFracture, Pathologic
=450  \\$wnnna$aFracture, Pathological
=450  \\$wnnna$aFracture, Spontaneous
=450  \\$wnnna$aFractures, Pathologic
=450  \\$aFractures, Pathological
=450  \\$wnnna$aPathologic Fracture
=450  \\$wnnna$aPathologic Fractures
=450  \\$wnnna$aPathological Fracture
=450  \\$wnnna$aPathological Fractures
=450  \\$wnnna$aSpontaneous Fracture
=450  \\$wnnna$aSpontaneous Fractures
=550  \\$wg$aFractures, Bone
=667  \\$afract not caused by trauma; IM; coord with specific organ /inj or organ/fract term (IM)
=680  \\$iFractures occurring as a result of disease of a bone or from some undiscoverable cause, and not due to trauma. (Dorland, 27th ed)
=750  \0$aFractures, Spontaneous$5IEN$0(DLC)sh 85051158

=LDR  00887cz  a2200265n  4500
=001  9880363516202441
=005  20141212201547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005597
=035  \\$aCAZ8744HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x311
=150  \\$aFractures, Open
=450  \\$wnnna$aCompound Fracture
=450  \\$wnnna$aCompound Fractures
=450  \\$wnnna$aFracture, Compound
=450  \\$wnnna$aFracture, Open
=450  \\$aFractures, Compound
=450  \\$wnnna$aOpen Fracture
=450  \\$wnnna$aOpen Fractures
=550  \\$wg$aFractures, Bone
=667  \\$afract causing an open wound; IM; coord with specific organ/inj or precoord organ/fract term (IM)
=680  \\$iFractures in which there is an external wound communicating with the break of the bone.
=688  \\$a78(73)
=750  \0$aFractures, Open$5IEN$0(DLC)sh 85051157

=LDR  01044cz  a2200289n  4500
=001  9880363516302441
=005  20141212201546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005594
=035  \\$aCAZ8741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x300.$x300.$x300
=150  \\$aFracture Fixation, Intramedullary
=450  \\$wnnna$aFixation, Intramedullary Fracture
=450  \\$wnnna$aFixations, Intramedullary Fracture
=450  \\$wnnna$aFracture Fixations, Intramedullary
=450  \\$wnnna$aIntramedullary Fracture Fixation
=450  \\$wnnna$aIntramedullary Fracture Fixations
=450  \\$aIntramedullary Nailing
=450  \\$wnnna$aIntramedullary Nailings
=450  \\$aNailing, Intramedullary
=450  \\$wnnna$aNailings, Intramedullary
=450  \\$aOsteosynthesis, Fracture, Intramedullary
=550  \\$wg$aFracture Fixation, Internal
=667  \\$ado not use /util except by MeSH definition; TN 87: definition
=688  \\$a70
=750  \0$aIntramedullary fracture fixation$5IEN$0(DLC)sh 85067619

=LDR  01206cz  a2200301n  4500
=001  9880363516402441
=005  20141212201546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005593
=035  \\$aCAZ8740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x300.$x300
=150  \\$aFracture Fixation, Internal
=450  \\$wnnna$aFixation, Internal Fracture
=450  \\$wnnna$aFixations, Internal Fracture
=450  \\$wnnna$aFracture Fixations, Internal
=450  \\$wnnna$aFracture Osteosyntheses
=450  \\$wnnna$aFracture Osteosynthesis
=450  \\$wnnna$aInternal Fracture Fixation
=450  \\$wnnna$aInternal Fracture Fixations
=450  \\$wnnna$aOsteosyntheses, Fracture
=450  \\$aOsteosynthesis, Fracture
=550  \\$wg$aFracture Fixation
=550  \\$wh$aFracture Fixation, Intramedullary
=667  \\$ado not use /util except by MeSH definition; TN 87; osteosynthesis in fracture surg goes here or under FRACTURE FIXATION, INTRAMEDULLARY
=680  \\$iThe use of internal devices (metal plates, nails, rods, etc.) to hold the position of a fracture in proper alignment.
=688  \\$a72(70)
=750  \0$aInternal fixation in fractures$5IEN$0(DLC)sh 85067343

=LDR  01364cz  a2200361n  4500
=001  9880363516502441
=005  20180329114818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005592
=035  \\$aCAZ8739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x300
=150  \\$aFracture Fixation
=450  \\$wnnna$aFixation, Fracture
=450  \\$wnnna$aFixation, Skeletal
=450  \\$wnnna$aFixations, Fracture
=450  \\$wnnna$aFixations, Skeletal
=450  \\$wnnna$aFracture Fixations
=450  \\$wnnna$aFracture Reduction
=450  \\$wnnna$aFracture Reductions
=450  \\$wnnna$aReduction, Fracture
=450  \\$wnnna$aReductions, Fracture
=450  \\$aSkeletal Fixation
=450  \\$wnnna$aSkeletal Fixations
=550  \\$wg$aOrthopedic Procedures
=550  \\$wh$aClosed Fracture Reduction
=550  \\$wh$aFracture Fixation, Internal
=550  \\$wh$aIlizarov Technique
=550  \\$wh$aOpen Fracture Reduction
=550  \\$aImmobilization
=667  \\$aTN 87: various types of fracture surg & related MeSH terms; osteosynthesis in fract surg goes under FRACTURE FIXATION, INTERNAL or FRACTURE FIXATION, INTRAMEDULLARY
=680  \\$iThe use of metallic devices inserted into or through bone to hold a fracture in a set position and alignment while it heals.
=750  \0$aFracture fixation$5IEN$0(DLC)sh 85051152

=LDR  01113cz  a2200265n  4500
=001  9880363516602441
=005  20141212201545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005591
=035  \\$aCAZ8738M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x155
=150  \\$aChemical Fractionation
=450  \\$wnnna$aChemical Fractionations
=450  \\$aFractionation, Chemical
=450  \\$wnnna$aFractionations, Chemical
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aDistillation
=550  \\$wh$aFractionation, Field Flow
=550  \\$wh$aLiquid-Liquid Extraction
=550  \\$wh$aSolid Phase Extraction
=667  \\$aDOSE FRACTIONATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available
=680  \\$iSeparation of a mixture in successive stages, each stage removing from the mixture some proportion of one of the substances, for example by differential solubility in water-solvent mixtures. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a2003(1964)
=750  \0$aSeparation (Technology)$5IEN-M$0(DLC)sh 85120087

=LDR  00782cz  a2200241n  4500
=001  9880363516702441
=005  20141212201545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005589
=035  \\$aCAZ8736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x250
=150  \\$aFoxes
=450  \\$aAlopex
=450  \\$aArctic Fox
=450  \\$wnnna$aFox, Arctic
=450  \\$aPseudalopex
=450  \\$aUrocyon
=450  \\$aVulpes
=550  \\$wg$aCanidae
=680  \\$iAny of several carnivores in the family CANIDAE, that possess erect ears and long bushy tails and are smaller than WOLVES. They are classified in several genera and found on all continents except Antarctica.
=688  \\$a68
=750  \0$aFoxes$0(DLC) sh 85051130$5IEN

=LDR  01211cz  a2200337n  4500
=001  9880363516802441
=005  20141212201544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005586
=035  \\$aCAZ8733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x366
=072  \\$aC22.$x131.$x321
=150  \\$aFowlpox
=450  \\$wnnna$aBird Pox
=450  \\$aBirdpox
=450  \\$wnnna$aDiphtheria, Fowl
=450  \\$wnnna$aDiphtherias, Fowl
=450  \\$aEpithelioma Contagiosum
=450  \\$aFowl Diphtheria
=450  \\$wnnna$aFowl Diphtherias
=450  \\$wnnna$aFowl Pox
=450  \\$wnnna$aPox, Bird
=450  \\$wnnna$aPox, Fowl
=450  \\$aVariola Avium
=550  \\$wg$aBird Diseases
=550  \\$wg$aPoxviridae Infections
=667  \\$acaused by a poxvirus; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMALS
=680  \\$iA poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts.
=688  \\$a94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93
=750  \0$aFowl pox$5IEN$0(DLC)sh 85023296

=LDR  01315cz  a2200361n  4500
=001  9880363516902441
=005  20141212201543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005585
=035  \\$aCAZ8732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x620.$x375
=072  \\$aC22.$x131.$x450
=072  \\$aC22.$x131.$x728.$x450
=150  \\$aInfluenza in Birds
=450  \\$aAvian Flu
=450  \\$aAvian Influenza
=450  \\$wnnna$aAvian Influenzas
=450  \\$wnnna$aFlu, Avian
=450  \\$aFowl Plague
=450  \\$aInfluenza, Avian
=450  \\$wnnna$aInfluenza in Bird
=450  \\$wnnna$aInfluenzas, Avian
=450  \\$wnnna$aPlague, Fowl
=550  \\$wg$aBird Diseases
=550  \\$wg$aOrthomyxoviridae Infections
=550  \\$wg$aPoultry Diseases
=667  \\$acoordinate IM with specific virus subtype (IM) if pertinent; don't forget also BIRDS or POULTRY (NIM) & check tag ANIMALS
=680  \\$iInfection of domestic and wild fowl and other BIRDS with INFLUENZA A VIRUS. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic POULTRY.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Influenza, Avian
=688  \\$a2005 (1963)
=750  \0$aAvian influenza$0(DLC) sh 85010531$5IEN-M

=LDR  01577cz  a2200337n  4500
=001  9880363517002441
=005  20141212201543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005583
=035  \\$aCAZ8730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x377
=072  \\$aG17.$x226
=072  \\$aL1.$x224.$x800.$x625
=150  \\$aFourier Analysis
=450  \\$wnnna$aAnalyses, Cyclic
=450  \\$wnnna$aAnalysis, Cyclic
=450  \\$wnnna$aAnalysis, Fourier
=450  \\$wnnna$aCyclic Analyses
=450  \\$wnnna$aCyclic Analysis
=450  \\$aFourier Series
=450  \\$aFourier Transform
=450  \\$wnnna$aSeries, Fourier
=450  \\$wnnna$aTransform, Fourier
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aSignal Processing, Computer-Assisted
=550  \\$aWavelet Analysis
=680  \\$iAnalysis based on the mathematical function first formulated by Jean-Baptiste-Joseph Fourier in 1807. The function, known as the Fourier transform, describes the sinusoidal pattern of any fluctuating pattern in the physical world in terms of its amplitude and its phase. It has broad applications in biomedicine, e.g., analysis of the x-ray crystallography data pivotal in identifying the double helical nature of DNA and in analysis of other molecules, including viruses, and the modified back-projection algorithm universally used in computerized tomography imaging, etc. (From Segen, The Dictionary of Modern Medicine, 1992)
=688  \\$a73
=750  \0$aFourier analysis$5IEN$0(DLC)sh 85051088

=LDR  00616cz  a2200193n  4500
=001  9880363517102441
=005  20141212201542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005582
=035  \\$aCAZ8729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x483.$x311
=072  \\$aN3.$x540.$x630.$x180
=150  \\$aFoundations
=450  \\$wnnna$aFoundation
=550  \\$wg$aFinancial Support
=550  \\$wg$aOrganizations, Nonprofit
=680  \\$iOrganizations established by endowments with provision for future maintenance.
=750  \0$aCharitable uses, trusts, and foundations$5IEN$0(DLC)sh 85022656

=LDR  00950cz  a2200313n  4500
=001  9880363517202441
=005  20141212201542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005581
=035  \\$aCAZ8728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x352
=072  \\$aI1.$x880.$x787.$x416
=072  \\$aN2.$x421.$x143.$x452
=072  \\$aN2.$x421.$x585.$x352
=150  \\$aFoster Home Care
=450  \\$aAdult Foster Care
=450  \\$wnnna$aCare, Adult Foster
=450  \\$wnnna$aCare, Foster Home
=450  \\$wnnna$aCare, Kinship
=450  \\$wnnna$aFoster Care, Adult
=450  \\$wnnna$aFostering
=450  \\$aKinship Care
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aPatient Care
=550  \\$wg$aSocial Welfare
=550  \\$aChild Welfare
=680  \\$iFamilies who care for neglected children or patients unable to care for themselves.
=750  \0$aFoster home care$5IEN$0(DLC)sh 85051033

=LDR  00600cz  a2200181n  4500
=001  9880363517302441
=005  20141212201542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005580
=035  \\$aCAZ8727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x584.$x311
=150  \\$aFossils
=450  \\$wnnna$aFossil
=550  \\$wg$aPaleontology
=680  \\$iRemains, impressions, or traces of animals or plants of past geological times which have been preserved in the earth's crust.
=688  \\$a91(75); was see under PALEONTOLOGY 1975-90
=750  \0$aFossils$5IEN$0(DLC)sh 89005492

=LDR  00864cz  a2200265n  4500
=001  9880363517402441
=005  20141212201541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005579
=035  \\$aCAZ8726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345
=072  \\$aN6.$x230.$x132.$x258
=150  \\$aFossil Fuels
=450  \\$wnnna$aFossil Fuel
=450  \\$wnnna$aFuel, Fossil
=450  \\$wnnna$aFuels, Fossil
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aEnergy-Generating Resources
=550  \\$wh$aCoal
=550  \\$wh$aNatural Gas
=550  \\$wh$aPetroleum
=680  \\$iAny combustible hydrocarbon deposit formed from the remains of prehistoric organisms. Examples are petroleum, coal, and natural gas.
=688  \\$a82; was FUELS (Cat J heading only) 1966-81 (Prov 1966-67)
=750  \0$aFossil fuels$5IEN$0(DLC)sh 85051023

=LDR  00791cz  a2200253n  4500
=001  9880363517502441
=005  20141212201541.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005578
=035  \\$aCAZ8725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x429.$x625
=150  \\$aFosfomycin
=450  \\$wnnna$aFosfomycin Trometamol Salt
=450  \\$wnnna$aFosfomycin Tromethamine
=450  \\$wnnna$aMonuril
=450  \\$wnnna$aPhosphomycin
=450  \\$aPhosphonomycin
=450  \\$wnnna$aTromethamine, Fosfomycin
=550  \\$wg$aOrganophosphonates
=680  \\$iAn antibiotic produced by Streptomyces fradiae.
=688  \\$a1986(1975); use ANTIBIOTICS 1975-1985
=688  \\$a86(75); was see under ANTIBIOTICS 1975-85
=750  \0$aFosfomycin$5IEN$0(DLC)sh 87002510

=LDR  01137cz  a2200265n  4500
=001  9880363517602441
=005  20141212201541.0
=008  850308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005576
=035  \\$aCAZ8723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291.$x300
=150  \\$aColforsin
=450  \\$aColeonol
=450  \\$aForskolin
=450  \\$wnnna$aN,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl
=450  \\$wnnna$aNKH 477
=450  \\$wnnna$aNKH-477
=450  \\$wnnna$aNKH477
=550  \\$wg$aDiterpenes
=680  \\$iPotent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland.
=688  \\$a2014(1986)
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Forskolin
=688  \\$a86
=750  \0$aForskolin$5IEN$0(DLC)sh 90001774

=LDR  00709cz  a2200217n  4500
=001  9880363517702441
=005  20141212201539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005571
=035  \\$aCAZ8718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x535.$x435
=150  \\$aFormularies, Homeopathic
=450  \\$wnnna$aFormulary, Homeopathic
=450  \\$wnnna$aHomeopathic Formularies
=450  \\$wnnna$aHomeopathic Formulary
=550  \\$wg$aFormularies as Topic
=550  \\$aHomeopathy
=667  \\$aIM
=750  \0$aHomeopathy$xFormulae, receipts, prescriptions$5IEN-M$0(IEN)368400
=750  \0$aHomeopathy$xMateria medica and therapeutics$5IEN-M$0(DLC)sh 85061729

=LDR  01341cz  a2200241n  4500
=001  9880363517902441
=005  20190530161949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005569
=035  \\$aCAZ8716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x535
=150  \\$aFormularies as Topic
=550  \\$wg$aReference Books
=550  \\$wh$aFormularies, Dental as Topic
=550  \\$wh$aFormularies, Homeopathic as Topic
=550  \\$wh$aFormularies, Hospital as Topic
=550  \\$aDrugs, Essential
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with PHARMACOPOEIAS AS TOPIC; NATIONAL FORMULARY see PHARMACOPOEIAS AS TOPIC is also available; do not confuse with the Publication Type FORMULARIES
=680  \\$iWorks about lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations. Formularies differ from PHARMACOPOEIAS in that they are less complete, lacking full descriptions of the drugs, their formulations, analytic composition, chemical properties, etc. In hospitals, formularies list all drugs commonly stocked in the hospital pharmacy.
=688  \\$a2009(1966)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Formularies
=750  \0$aMedicine$vFormulae, receipts, prescriptions$0(DLC) sh 85083077$5IEN

=LDR  00816cz  a2200229n  4500
=001  9880363518002441
=005  20141212201538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005561
=035  \\$aCAZ8708M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x420
=150  \\$aFormates
=450  \\$wnnna$aAcids, Formic
=450  \\$wnnna$aFormic Acids
=550  \\$wg$aAcids, Acyclic
=550  \\$wh$aFormamides
=550  \\$wh$aFormic Acid Esters
=680  \\$iDerivatives of formic acids. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are formed with a single carbon carboxy group.
=688  \\$a1966
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Formic Acids
=750  \0$aFormic acid$0(DLC)sh 85050819$5IEN-M

=LDR  00622cz  a2200217n  4500
=001  9880363518102441
=005  20141212201537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005559
=035  \\$aCAZ8706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x463
=072  \\$aD2.$x241.$x81.$x420.$x500
=150  \\$aFormamides
=550  \\$wg$aAmides
=550  \\$wg$aFormates
=550  \\$wh$aDimethylformamide
=667  \\$aD25-26 qualif
=680  \\$iA group of amides with the general formula of R-CONH2.
=688  \\$a75; was FORMAMIDE 1964-74 (Prov 1964-72)
=750  \0$aFormamide$5IEN$0(DLC)sh 91005518

=LDR  00937cz  a2200217n  4500
=001  9880363518202441
=005  20141212201537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005557
=035  \\$aCAZ8704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x407
=150  \\$aFormaldehyde
=450  \\$wnnna$aFormalin
=450  \\$wnnna$aFormol
=450  \\$wnnna$aMethanal
=450  \\$wnnna$aOxomethane
=550  \\$wg$aAldehydes
=550  \\$wh$aFormocresols
=680  \\$iA highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)
=750  \0$aFormaldehyde$5IEN$0(DLC)sh 85050805

=LDR  01047cz  a2200325n  4500
=001  9880363518302441
=005  20141212201536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005556
=035  \\$aCAZ8703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x373
=072  \\$aF2.$x463.$x593.$x932.$x869.$x435
=150  \\$aForm Perception
=450  \\$aContour Perception
=450  \\$wnnna$aContour Perceptions
=450  \\$wnnna$aForm Perceptions
=450  \\$wnnna$aPerception, Contour
=450  \\$wnnna$aPerception, Form
=450  \\$wnnna$aPerceptions, Contour
=450  \\$wnnna$aPerceptions, Form
=550  \\$wg$aPerception
=550  \\$wg$aSpace Perception
=550  \\$wh$aContrast Sensitivity
=550  \\$wh$aPattern Recognition, Visual
=550  \\$wh$aStereognosis
=550  \\$aContrast Sensitivity
=680  \\$iThe sensory discrimination of a pattern shape or outline.
=688  \\$aCONTOUR PERCEPTION was see under FORM PERCEPTION 1970-78
=750  \0$aForm perception$5IEN$0(DLC)sh 85050798

=LDR  01298cz  a2200325n  4500
=001  9880363518402441
=005  20141212201536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005555
=035  \\$aCAZ8702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x335
=072  \\$aH2.$x403.$x690.$x208
=072  \\$aI1.$x198.$x780.$x937.$x469
=072  \\$aI1.$x880.$x604.$x583.$x310
=072  \\$aN3.$x706.$x535.$x351
=150  \\$aForensic Psychiatry
=450  \\$aJurisprudence, Psychiatric
=450  \\$wnnna$aPsychiatric Jurisprudence
=450  \\$wnnna$aPsychiatry, Forensic
=550  \\$wg$aForensic Medicine
=550  \\$wg$aJurisprudence
=550  \\$wg$aPsychiatry
=550  \\$wh$aCommitment of Mentally Ill
=550  \\$wh$aConfidentiality
=550  \\$wh$aInsanity Defense
=667  \\$aSPEC qualif
=680  \\$iPsychiatry in its legal aspects. This includes criminology, penology, commitment of mentally ill, the psychiatrist's role in compensation cases, the problems of releasing information to the court, and of expert testimony.
=688  \\$a69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74, was heading 1963-64
=750  \0$aForensic psychiatry$5IEN$0(DLC)sh 85050558

=LDR  01578cz  a2200409n  4500
=001  9880363518502441
=005  20180315170256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005554
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x330
=072  \\$aI1.$x198.$x780.$x937
=150  \\$aForensic Medicine
=450  \\$aLegal Medicine
=450  \\$wnnna$aMedicine, Forensic
=450  \\$wnnna$aMedicine, Legal
=550  \\$wg$aForensic Sciences
=550  \\$wg$aMedicine
=550  \\$wh$aAutopsy
=550  \\$wh$aBlood Stains
=550  \\$wh$aBody Remains
=550  \\$wh$aDermatoglyphics
=550  \\$wh$aDNA Fingerprinting
=550  \\$wh$aExhumation
=550  \\$wh$aForensic Genetics
=550  \\$wh$aForensic Pathology
=550  \\$wh$aForensic Psychiatry
=550  \\$wh$aLie Detection
=550  \\$wh$aPaternity
=550  \\$aBiometric Identification
=550  \\$aDNA Contamination
=550  \\$aJurisprudence
=550  \\$aLaw Enforcement
=667  \\$afor crime or identification: differentiate from JURISPRUDENCE, usually civil suits; for human identification of skeletal remains HUMAN IDENTIFICATION see FORENSIC ANTHROPOLOGY is available; for human identification by teeth see FORENSIC DENTISTRY; note other specific forensic terms are also available DF: FORENSIC MED
=680  \\$iThe application of medical knowledge to questions of law.
=688  \\$a65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64
=750  \0$aMedical jurisprudence$5IEN$0(DLC)sh 85082955

=LDR  00932cz  a2200241n  4500
=001  9880363518602441
=005  20141212201535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005553
=035  \\$aCAZ8700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x285
=072  \\$aI1.$x198.$x780.$x875
=150  \\$aForensic Dentistry
=450  \\$aDental Jurisprudence$5IEN
=450  \\$wnnna$aDentistry, Forensic
=550  \\$wg$aDentistry
=550  \\$wg$aForensic Sciences
=550  \\$aJurisprudence
=667  \\$aSPEC qualif; see note on FORENSIC MEDICINE; for human identif by teeth: coord FORENSIC DENTISTRY (IM) + specific dent heading (IM); DF: FORENSIC DENT
=680  \\$iThe application of dental knowledge to questions of law.
=688  \\$a65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY & FORENSIC MEDICINE 1965-74; was heading 1963-64
=750  \0$aDental jurisprudence$5IEN$0(DLC)sh 85036901

=LDR  00872cz  a2200229n  4500
=001  9880363518702441
=005  20141212201534.0
=008  780329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005551
=035  \\$aCAZ8698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x407
=150  \\$aForeign Professional Personnel
=450  \\$wnnna$aPersonnel, Foreign Professional
=450  \\$wnnna$aProfessional Personnel, Foreign
=550  \\$wg$aOccupational Groups
=550  \\$wh$aForeign Medical Graduates
=550  \\$wh$aNurses, International
=667  \\$aspecify geog
=680  \\$iPersons who have acquired academic or specialized training in countries other than that in which they are working. The concept excludes physicians for which FOREIGN MEDICAL GRADUATES is the likely heading.
=688  \\$a71
=750  \0$aMedical personnel, Foreign$5IEN$0(DLC)sh 85082999

=LDR  01052cz  a2200301n  4500
=001  9880363518802441
=005  20141212201534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005550
=035  \\$aCAZ8697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x407.$x435
=072  \\$aM1.$x526.$x485.$x810.$x390
=072  \\$aN2.$x360.$x810.$x390
=150  \\$aForeign Medical Graduates
=450  \\$wnnna$aForeign Medical Graduate
=450  \\$wnnna$aGraduate, Foreign Medical
=450  \\$wnnna$aGraduates, Foreign Medical
=450  \\$wnnna$aMedical Graduate, Foreign
=450  \\$wnnna$aMedical Graduates, Foreign
=450  \\$aPhysicians, Foreign$5IEN
=550  \\$wg$aForeign Professional Personnel
=550  \\$wg$aPhysicians
=550  \\$aInternational Educational Exchange
=667  \\$aspecify geog; DF: FOREIGN MED GRAD
=680  \\$iPhysicians who hold degrees from medical schools in countries other than the ones in which they practice.
=688  \\$a70(68)
=750  \0$aPhysicians, Foreign$5IEN$0(DLC)sh 85101629

=LDR  01228cz  a2200253n  4500
=001  9880363518902441
=005  20141212201442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005382
=035  \\$aCAZ8528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x559
=150  \\$aFinancing, Personal
=450  \\$wnnna$aExpenditure, Personal
=450  \\$wnnna$aExpenditures, Personal
=450  \\$wnnna$aPersonal Expenditure
=450  \\$aPersonal Expenditures
=450  \\$wnnna$aPersonal Financing
=550  \\$wg$aEconomics
=550  \\$wh$aMedical Savings Accounts
=667  \\$arestricted to a person's payment of health care expenditures: read MeSH definition; not for the personal finances of physicans & other health care professionals: index under PHYSICIANS; DENTISTS; NURSES; PHARMACISTS; etc., for personal non-professional expenses or under PRACTICE MANAGEMENT, MEDICAL; PRACTICE MANAGEMENT, DENTAL & similar headings for finances assoc with professional practice
=680  \\$iPayment by individuals or their family for health care services which are not covered by a third-party payer, either insurance or medical assistance.
=688  \\$a68
=750  \0$aFinance, Personal$5IEN$0(DLC)sh 85048263

=LDR  01507cz  a2200421n  4500
=001  9880363519102441
=005  20210809173134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005380
=035  \\$aCAZ8526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346
=150  \\$aFinancing, Government
=450  \\$wnnna$aAct, Hill-Burton
=450  \\$wnnna$aAid, Federal
=450  \\$wnnna$aAids, Federal
=450  \\$aFederal Aid
=450  \\$wnnna$aFederal Aids
=450  \\$aFinancing, Public
=450  \\$wnnna$aGovernment Financing
=450  \\$wnnna$aGovernment Subsidies
=450  \\$wnnna$aGovernment Subsidy
=450  \\$aGrants and Subsidies, Government
=450  \\$aHill-Burton Act
=450  \\$wnnna$aHill Burton Act
=450  \\$wnnna$aPublic Financing
=450  \\$aSubsidies, Government
=450  \\$wnnna$aSubsidy, Government
=550  \\$wg$aFinancing, Organized
=550  \\$wh$aPublic Assistance
=550  \\$wh$aVeterans Disability Claims
=550  \\$wh$aWorkers' Compensation
=667  \\$aspecify geog for the govt; CATALOG: coordinate with specific NAF entry if applicable
=680  \\$iFederal, state, or local government organized methods of financial assistance.
=688  \\$a68; FEDERAL AID see FINANCIAL SUPPORT 1994-2000
=750  \0$aSubsidies$5IEN-M$0(DLC)sh 85129533
=750  \0$aFinance, Public$0(DLC)sh 85048270$5IEN-M
=788  \0$iSearch also under the Medical Subject Headings:$aSubsidies$ior$aFinance, Public$5IEN-M

=LDR  00993cz  a2200277n  4500
=001  9880363519202441
=005  20141212201440.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005377
=035  \\$aCAZ8523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x180
=072  \\$aN3.$x219.$x463.$x280
=072  \\$aN4.$x452.$x442.$x180
=150  \\$aFinancial Management, Hospital
=450  \\$wnnna$aFinancial Managements, Hospital
=450  \\$aHospital Financial Management
=450  \\$aHospital Financial Managements
=450  \\$wnnna$aManagement, Hospital Financial
=450  \\$wnnna$aManagements, Hospital Financial
=550  \\$wg$aFinancial Management
=550  \\$wg$aHospital Administration
=550  \\$aEconomics, Hospital
=680  \\$iThe obtaining and management of funds for hospital needs and responsibility for fiscal affairs.
=688  \\$a91(82); was see under FINANCIAL MANAGEMENT 1982-90
=750  \0$aHospitals$xFinance$5IEN$0(DLC)sh 85062326

=LDR  00637cz  a2200205n  4500
=001  9880949173702441
=005  20200622114239.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073879
=035  \\$a(NLM)9810900772800041
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x627.$x700.$x819
=072  \\$aD20.$x215.$x784.$x750.$x784
=150  \\$aRice Bran Oil
=450  \\$wnnna$aBran Oil, Rice
=450  \\$wnnna$aOil, Rice Bran
=550  \\$wg$aPlant Oils
=680  \\$iOIL extracted from the hard outer brown layer of rice bran after the husk has been removed.
=688  \\$a2018(1987)
=750  \0$aRice oil$0(DLC) sh 85113900$5IEN-M

=LDR  00817cz  a2200205n  4500
=001  9880949264902441
=005  20200625175648.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073819
=035  \\$a(NLM)9810900814400041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x818
=072  \\$aI2.$x903.$x771
=150  \\$aSelf-Directed Learning as Topic
=450  \\$wnnna$aSelf Directed Learning as Topic
=550  \\$wg$aLearning
=550  \\$wg$aTeaching
=680  \\$iProcess in which individuals take the initiative, in diagnosing their learning needs, formulating learning goals, identifying resources for learning, choosing and implementing learning strategies and evaluating learning outcomes (Knowles, 1975)
=688  \\$a2018
=750  \0$aSelf-Directed Learning as Topic$0(DLC)sh2005001262$5IEN-M

=LDR  01145cz  a2200193n  4500
=001  9880949265102441
=005  20200625172627.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073798
=035  \\$a(NLM)9810900819200041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x717.$x500
=072  \\$aE5.$x595.$x717.$x500
=150  \\$aSecond Harmonic Generation Microscopy
=450  \\$wnnna$aThird Harmonic Generation Microscopy
=550  \\$wg$aNonlinear Optical Microscopy
=680  \\$iA microscopic imaging technique that takes advantage of the process of harmonic generation that occurs when photons interact to generate new photons of a different wavelength. In second harmonic generation, two photons of the same wavelength and frequency, such as from a LASER, interact inside a medium and are converted to a photon of twice the frequency and half of the wavelength of the two incident photons. The light signals captured are used to produce images that are dependent on the unique optical properties of the material.
=688  \\$a2018
=750  \\$iRelated mapping$aSecond harmonic generation$0(DLC) sh 94005544$4RM$5IEN-M

=LDR  01839cz  a2200493n  4500
=001  9880949265302441
=005  20200625170944.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073886
=035  \\$a(NLM)9810900760600041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x370.$x725.$x250.$x500
=072  \\$aN5.$x715.$x360.$x300.$x202.$x500
=150  \\$aScientific Experimental Error
=450  \\$wnnna$aExperimental Error
=450  \\$wnnna$aExperimental Mistakes
=450  \\$wnnna$aResearch Errors
=450  \\$wnnna$aScientific Errors
=450  \\$wnnna$aScientific Mistakes
=450  \\$wnnna$aError, Experimental
=450  \\$wnnna$aError, Research
=450  \\$wnnna$aError, Scientific
=450  \\$wnnna$aError, Scientific Experimental
=450  \\$wnnna$aErrors, Experimental
=450  \\$wnnna$aErrors, Research
=450  \\$wnnna$aErrors, Scientific
=450  \\$wnnna$aErrors, Scientific Experimental
=450  \\$wnnna$aExperimental Error, Scientific
=450  \\$wnnna$aExperimental Errors
=450  \\$wnnna$aExperimental Errors, Scientific
=450  \\$wnnna$aExperimental Mistake
=450  \\$wnnna$aMistake, Experimental
=450  \\$wnnna$aMistake, Scientific
=450  \\$wnnna$aMistakes, Experimental
=450  \\$wnnna$aMistakes, Scientific
=450  \\$wnnna$aResearch Error
=450  \\$wnnna$aScientific Error
=450  \\$wnnna$aScientific Experimental Errors
=450  \\$wnnna$aScientific Mistake
=550  \\$wg$aData Accuracy
=667  \\$afor intentional falsification of scientific data, use SCIENTIFIC MISCONDUCT
=680  \\$iDeviation or aberration in the practical implementation of standard empirical procedures, distinct from MEDICAL ERRORS and SCIENTIFIC MISCONDUCT.
=688  \\$a2018
=750  \0$aErrors, Scientific$0(DLC) sh 85044729$5IEN-M

=LDR  00727cz  a2200217n  4500
=001  9880949266102441
=005  20200625140205.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075862
=035  \\$a(NLM)9810901346900041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x93.$x796
=150  \\$aScience in the Arts
=450  \\$wnnna$aScience in Art
=450  \\$wnnna$aArt, Science in
=450  \\$wnnna$aScience in Arts
=550  \\$wg$aArt
=667  \\$acoordinate IM with scientific aspect (IM) + specific art heading (IM)
=680  \\$iDepiction of scientific issues or themes via the arts including visual, oral, or written forms of expression.
=688  \\$a2018
=750  \0$aScience in art$0(DLC) sh 97001340$5IEN-M

=LDR  00673cz  a2200205n  4500
=001  9880949266402441
=005  20200625132410.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075863
=035  \\$a(NLM)9810901346600041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x517.$x864
=150  \\$aScience in Literature
=450  \\$wnnna$aLiteratures, Science in
=450  \\$wnnna$ain Literature, Science
=450  \\$wnnna$ain Literatures, Science
=550  \\$wg$aLiterature
=680  \\$iLiterary works whose subject matter is science or about the profession of science and related areas.
=688  \\$a2018
=750  \0$aScience in literature$0(DLC) sh 85118667$5IEN-M

=LDR  01211cz  a2200253n  4500
=001  9880949266602441
=005  20200625124932.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073820
=035  \\$a(NLM)9810900813800041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x865
=072  \\$aL1.$x143.$x910.$x500
=150  \\$aScholarly Communication
=450  \\$wnnna$aScholarly Publishing
=450  \\$wnnna$aCommunication, Scholarly
=450  \\$wnnna$aCommunications, Scholarly
=450  \\$wnnna$aPublishing, Scholarly
=450  \\$wnnna$aScholarly Communications
=550  \\$wg$aCommunication
=550  \\$wg$aSocial Networking
=680  \\$iSystem through which research and other scholarly writings are created, evaluated for quality, disseminated to the scholarly community, and preserved for future use. It includes both formal means of communication, such as publication in peer-reviewed journals, and informal channels, such as electronic listservs. (from Association of College & Research Libraries, "Principles and Strategies for the Reform of Scholarly Communication 1," 2003)
=688  \\$a2018
=750  \0$aCommunication in learning and scholarship$0(DLC) sh 97005983$5IEN-M

=LDR  00628cz  a2200193n  4500
=001  9880952373802441
=005  20200706180109.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074706
=035  \\$a(NLM)9810901205500041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x645.$x563
=072  \\$aG2.$x734.$x700
=150  \\$aSublimation, Chemical
=450  \\$wnnna$aChemical Sublimation
=550  \\$wg$aPhase Transition
=680  \\$iThe process of solids transforming into a gaseous state or vice versa, without passing through a liquid state.
=688  \\$a2018
=750  \0$aSublimation (Chemistry)$0(DLC) sh 85129475$5IEN-M

=LDR  00664cz  a2200217n  4500
=001  9880954572802441
=005  20200710122015.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074242
=035  \\$a(NLM)9810900986600041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x215.$x784.$x750.$x910
=150  \\$aSunflower Oil
=450  \\$wnnna$aSunflower Seed Oil
=450  \\$wnnna$aOil, Sunflower
=450  \\$wnnna$aOil, Sunflower Seed
=450  \\$wnnna$aSeed Oil, Sunflower
=550  \\$wg$aPlant Oils
=680  \\$iOil derived from the seeds of SUNFLOWER plant, Helianthus.
=688  \\$a2018(1980)
=750  \0$aSunflower seed oil$0(DLC) sh 85130540$5IEN-M

=LDR  01125cz  a2200229n  4500
=001  9880954573002441
=005  20200710120622.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073893
=035  \\$a(NLM)9810900754500041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 81
=072  \\$aD9.$x947
=150  \\$aSugars
=450  \\$wnnna$aSugar
=550  \\$wg$aCarbohydrates
=550  \\$wh$aDietary Sugar
=550  \\$wh$aDisaccharides
=550  \\$wh$aMonosaccharides
=680  \\$iShort chain carbohydrate molecules that have hydroxyl groups attached to each carbon atom unit with the exception of one carbon that has a doubly-bond aldehyde or ketone oxygen. Cyclical sugar molecules are formed when the aldehyde or ketone groups respectively form a hemiacetal or hemiketal bond with one of the hydroxyl carbons. The three dimensional structure of the sugar molecule occurs in a vast array of biological and synthetic classes of specialized compounds including AMINO SUGARS; CARBASUGARS; DEOXY SUGARS; SUGAR ACIDS; SUGAR ALCOHOLS; and SUGAR PHOSPHATES.
=688  \\$a2018
=750  \0$aSugars$0(DLC) sh 85129732$5IEN-M

=LDR  01042cz  a2200289n  4500
=001  9880954573202441
=005  20200710105545.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075067
=035  \\$a(NLM)9810901326800041
=040  \\$aDNLM$cDNLM
=072  \\$aC25.$x775.$x814
=072  \\$aF3.$x900.$x809
=150  \\$aSubstance Abuse, Oral
=450  \\$wnnna$aDrug Bombing
=450  \\$wnnna$aDrug Parachuting
=450  \\$wnnna$aOral Substance Abuse
=450  \\$wnnna$aAbuse, Oral Substance
=450  \\$wnnna$aBombing, Drug
=450  \\$wnnna$aParachuting, Drug
=450  \\$wnnna$aSubstance Abuses, Oral
=550  \\$wg$aSubstance-Related Disorders
=680  \\$iAbuse, overuse, or misuse of a substance by ingestion.
=688  \\$a2018
=750  \0$81$wb$iBroader mapping$aSubstance abuse$0sh 85129539$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aOral habits$0(DLC)sh 85095236$4BM$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record:$aSubstance abuse$iand$aOral habits

=LDR  01600cz  a2200421n  4500
=001  9880955073202441
=005  20200710142532.0
=008  970620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019637
=035  \\$a(NLM)98196678630000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x718
=072  \\$aE4.$x555
=150  \\$aOrthopedic Procedures
=450  \\$wnnna$aOrthopedic Rehabilitation Surgery
=450  \\$wnnna$aOrthopedic Surgical Procedures
=450  \\$aOrthopedic Surgery
=450  \\$aSurgery, Orthopedic
=450  \\$wnnna$aOrthopedic Procedure
=450  \\$wnnna$aOrthopedic Rehabilitation Surgeries
=450  \\$wnnna$aOrthopedic Surgeries
=450  \\$wnnna$aOrthopedic Surgical Procedure
=450  \\$wnnna$aProcedure, Orthopedic
=450  \\$wnnna$aProcedure, Orthopedic Surgical
=450  \\$wnnna$aProcedures, Orthopedic
=450  \\$wnnna$aProcedures, Orthopedic Surgical
=450  \\$wnnna$aRehabilitation Surgeries, Orthopedic
=450  \\$wnnna$aRehabilitation Surgery, Orthopedic
=450  \\$wnnna$aSurgeries, Orthopedic
=450  \\$wnnna$aSurgeries, Orthopedic Rehabilitation
=450  \\$wnnna$aSurgery, Orthopedic Rehabilitation
=450  \\$wnnna$aSurgical Procedure, Orthopedic
=450  \\$wnnna$aSurgical Procedures, Orthopedic
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aOrthopedics
=680  \\$iProcedures used to treat and correct deformities, diseases, and injuries to the MUSCULOSKELETAL SYSTEM, its articulations, and associated structures.
=688  \\$a98
=750  \0$aOrthopedic surgery$0(DLC) sh 85095812$5IEN-M

=LDR  00696cz  a2200241n  4500
=001  9880955073302441
=005  20200710141025.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074402
=035  \\$a(NLM)9810901124000041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 300
=072  \\$aE4.$x555.$x640
=150  \\$aSynovectomy
=450  \\$wnnna$aSynovium Resection
=450  \\$wnnna$aResection, Synovium
=450  \\$wnnna$aSynovectomies
=450  \\$wnnna$aSynovium Resections
=450  \\$aSynovial Membrane$xsurgery
=550  \\$wg$aOrthopedic Procedures
=680  \\$iSurgical removal of the SYNOVIAL MEMBRANE.
=688  \\$a2018
=750  \0$aSynovectomy$0(DLC) sh 85131646$5IEN-M

=LDR  01694nz  a2200481n  4500
=001  9880957970602441
=005  20200721143121.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080310
=035  \\$a(NLM)9812405877500041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x305.$x906.$x750
=072  \\$aL1.$x224.$x230.$x260.$x550.$x750
=150  \\$aSmart Glasses
=450  \\$aGoogle Glass
=450  \\$aHead Mounted Display
=450  \\$aHead Up Display
=450  \\$aHead Worn Display
=450  \\$aSmartglasses
=450  \\$wnnna$aDisplay, Head Mounted
=450  \\$wnnna$aDisplay, Head Up
=450  \\$wnnna$aDisplay, Head Worn
=450  \\$wnnna$aDisplays, Head Mounted
=450  \\$wnnna$aDisplays, Head Up
=450  \\$wnnna$aDisplays, Head Worn
=450  \\$wnnna$aGlass, Google
=450  \\$wnnna$aGlasses, Google
=450  \\$wnnna$aGlasses, Smart
=450  \\$wnnna$aGoogle Glasses
=450  \\$wnnna$aHead Mounted Displays
=450  \\$wnnna$aHead Up Displays
=450  \\$wnnna$aHead Worn Displays
=450  \\$wnnna$aMounted Display, Head
=450  \\$wnnna$aMounted Displays, Head
=450  \\$wnnna$aUp Display, Head
=450  \\$wnnna$aUp Displays, Head
=450  \\$wnnna$aWorn Display, Head
=450  \\$wnnna$aWorn Displays, Head
=550  \\$wg$aMicrocomputers
=550  \\$wg$aWearable Electronic Devices
=680  \\$iComputerized eyewear with multiple technological applications for advanced computing and interoperability. Smart glasses are optimized to facilitate information and data access, capture, display, transfer, and manipulation.
=688  \\$a2020
=750  \\$aGoogle Glass (Computer)$0(DLC)sh2015001202$5IEN-M

=LDR  01468cz  a2200385n  4500
=001  9880957971202441
=005  20200721141322.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076251
=035  \\$a(NLM)9810901625900041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x305.$x906
=150  \\$aWearable Electronic Devices
=450  \\$wnnna$aElectronic Skin
=450  \\$wnnna$aWearable Devices
=450  \\$wnnna$aWearable Technology
=450  \\$wnnna$aDevice, Wearable
=450  \\$wnnna$aDevice, Wearable Electronic
=450  \\$wnnna$aDevices, Wearable
=450  \\$wnnna$aDevices, Wearable Electronic
=450  \\$wnnna$aElectronic Device, Wearable
=450  \\$wnnna$aElectronic Devices, Wearable
=450  \\$wnnna$aSkin, Electronic
=450  \\$wnnna$aTechnologies, Wearable
=450  \\$wnnna$aTechnology, Wearable
=450  \\$wnnna$aWearable Device
=450  \\$wnnna$aWearable Electronic Device
=450  \\$wnnna$aWearable Technologies
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wh$aFitness Trackers
=550  \\$wh$aHearing Aids
=550  \\$wh$aSmart Glasses
=680  \\$iElectronic implements worn on  the body as an implant or as an accessory. Examples include wearable diagnostic devices, wearable ACTIVITY TRACKERS, wearable INFUSION PUMPS, wearable computing devices, SENSORY AIDS, and electronic pest repellents.
=688  \\$a2018
=750  \0$aWearable technology$0(DLC)sh2015001347$5IEN-M

=LDR  00508cz  a2200181n  4500
=001  9880957971702441
=005  20200720152436.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074883
=035  \\$a(NLM)9810901165500041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x950.$x300.$x970
=150  \\$aVulvectomy
=450  \\$wnnna$aVulvectomies
=550  \\$wh$aGynecologic Surgical Procedures
=680  \\$iSurgical resection of the VULVA.
=688  \\$a2018
=750  \0$aVulvectomy$0(DLC) sh 85144475$5IEN-M

=LDR  01278cz  a2200373n  4500
=001  9880958165702441
=005  20200722135400.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074824
=035  \\$a(NLM)9810901173100041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x946.$x562
=072  \\$aN4.$x452.$x677.$x896
=150  \\$aWork Engagement
=450  \\$wnnna$aEmployee Engagement
=450  \\$wnnna$aEmployee Participation
=450  \\$wnnna$aStaff Engagement
=450  \\$wnnna$aStaff Participation
=450  \\$wnnna$aWorker Participation
=450  \\$wnnna$aWorkplace Engagement
=450  \\$wnnna$aEngagement, Employee
=450  \\$wnnna$aEngagement, Staff
=450  \\$wnnna$aEngagement, Work
=450  \\$wnnna$aEngagement, Workplace
=450  \\$wnnna$aParticipation, Employee
=450  \\$wnnna$aParticipation, Staff
=450  \\$wnnna$aParticipation, Worker
=450  \\$wnnna$aParticipations, Worker
=550  \\$wg$aPersonnel Management
=550  \\$wg$aWork
=550  \\$aReturn to Work
=680  \\$iExtent to which members of a workplace perceive their emotional commitment to and involvement in the organization and its goals.
=688  \\$a2018
=750  \0$iRelated mapping$aEmployee empowerment$0(DLC) sh 93006687$4RM$5IEN-M

=LDR  00750nz  a2200217n  4500
=001  9880958166602441
=005  20200722150944.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077587
=035  \\$a(NLM)9811675371200041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x230.$x100.$x230
=150  \\$aNatural Disasters
=450  \\$wnnna$aNatural Disaster
=450  \\$wnnna$aDisaster, Natural
=450  \\$wnnna$aDisasters, Natural
=550  \\$wg$aDisasters
=550  \\$wh$aAvalanches
=680  \\$iDisasters linked to natural hazards including widespread fires, floods, storms, earthquakes and drought.These events may result in significant damage and loss of lives.
=688  \\$a2019
=750  \0$aNatural disasters$0(DLC)sh 85090214$5IEN-M

=LDR  00842cz  a2200193n  4500
=001  9880958167002441
=005  20200722123851.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073218
=035  \\$a(NLM)9810900727000041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x711.$x513.$x919
=150  \\$aWisconsin Card Sorting Test
=450  \\$wnnna$aM-WCST
=450  \\$wnnna$aModified Wisconsin Card Sorting Test
=550  \\$wg$aNeuropsychological Tests
=680  \\$iA neuropsychological test designed to assess EXECUTIVE FUNCTION typically assigned to the FRONTAL LOBE (e.g., abstract thinking, and strategic planning). The subjects are asked to sort numbered response cards according to different principles and to alter their approach during testing.
=688  \\$a2018
=750  \0$aWisconsin Card Sorting Test$0(DLC) sh 94001375$5IEN-M

=LDR  01220cz  a2200397n  4500
=001  9880958168102441
=005  20200722122935.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075923
=035  \\$a(NLM)9810901346800041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x988
=072  \\$aN6.$x230.$x100.$x230.$x925
=072  \\$aN6.$x230.$x216.$x875
=150  \\$aWildfires
=450  \\$wnnna$aBrush Fires
=450  \\$wnnna$aForest Fires
=450  \\$wnnna$aWild Fires
=450  \\$wnnna$aWildland Fires
=450  \\$wnnna$aBrush Fire
=450  \\$wnnna$aFire, Brush
=450  \\$wnnna$aFire, Forest
=450  \\$wnnna$aFire, Wild
=450  \\$wnnna$aFires, Brush
=450  \\$wnnna$aFires, Forest
=450  \\$wnnna$aFires, Wild
=450  \\$wnnna$aForest Fire
=450  \\$wnnna$aWild Fire
=450  \\$wnnna$aWildfire
=550  \\$wg$aFires
=550  \\$wg$aGeological Phenomena
=550  \\$wg$aNatural Disasters
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iFires that occur outdoors in the natural environment caused by natural forces or human activity.
=688  \\$a2018
=750  \0$aWildfires$0(DLC) sh 85146723$5IEN-M

=LDR  00893cz  a2200229n  4500
=001  9880958272802441
=005  20200716172231.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073056
=035  \\$a(NLM)9810900550500041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x268.$x271.$x935
=072  \\$aD1.$x496.$x749.$x305.$x935
=150  \\$aTransactinide Series Elements
=450  \\$wnnna$aSuper Heavy Elements
=450  \\$wnnna$aSuperheavy Elements
=450  \\$wnnna$aTransactinide Elements
=450  \\$wnnna$aTransactinides
=550  \\$wg$aElements, Radioactive
=680  \\$iA series of radioactive elements with atomic numbers greater than 103. Current members include Rutherfordium, atomic number 104, to and including Ununoctium, atomic number 118. All members are synthetic with short half-lives.
=688  \\$a2018
=750  \0$aSuperheavy Elements$0(DLC)sh 85130605$5IEN-M

=LDR  01248cz  a2200325n  4500
=001  9880958370402441
=005  20200720142741.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076142
=035  \\$a(NLM)9810901488300041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x160.$x875
=072  \\$aL1.$x296.$x555
=150  \\$aVirtual Reality
=450  \\$wnnna$aVirtual Reality, Educational
=450  \\$wnnna$aVirtual Reality, Instructional
=450  \\$wnnna$aEducational Virtual Realities
=450  \\$wnnna$aEducational Virtual Reality
=450  \\$wnnna$aInstructional Virtual Realities
=450  \\$wnnna$aInstructional Virtual Reality
=450  \\$wnnna$aRealities, Instructional Virtual
=450  \\$wnnna$aReality, Educational Virtual
=450  \\$wnnna$aReality, Instructional Virtual
=450  \\$wnnna$aReality, Virtual
=450  \\$wnnna$aVirtual Realities, Educational
=450  \\$wnnna$aVirtual Realities, Instructional
=550  \\$wg$aComputer Simulation
=680  \\$iUsing computer technology to create and maintain an environment and project a user's physical presence in that environment allowing the user to interact with it.
=688  \\$a2018
=750  \0$aVirtual Reality$0(DLC)sh 92000880$5IEN-M

=LDR  00975cz  a2200349n  4500
=001  9880958468302441
=005  20200721124957.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073678
=035  \\$a(NLM)9810900833000041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x945
=150  \\$aWater Sports
=450  \\$wnnna$aBoating
=450  \\$wnnna$aCanoeing
=450  \\$wnnna$aKayaking
=450  \\$wnnna$aRowing
=450  \\$wnnna$aSurfboarding
=450  \\$wnnna$aSurfing, Wave
=450  \\$wnnna$aWater Polo
=450  \\$wnnna$aWater Skiing
=450  \\$wnnna$aWave Surfing
=450  \\$wnnna$aPolo, Water
=450  \\$wnnna$aSkiing, Water
=450  \\$wnnna$aSport, Water
=450  \\$wnnna$aSports, Water
=450  \\$wnnna$aWater Sport
=550  \\$wg$aSports
=550  \\$wh$aSwimming
=680  \\$iActivities or games performed in a body of water.
=688  \\$a2018
=750  \0$aAquatic sports$0(DLC) sh 85006247$5IEN-M

=LDR  00912nz  a2200241n  4500
=001  9880958473402441
=005  20200717185022.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077410
=035  \\$a(NLM)9811675676300041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x56.$x31
=072  \\$aD1.$x210.$x450.$x150.$x25
=150  \\$aAluminum Chloride
=450  \\$wnnna$aAlCl3
=450  \\$wnnna$aAluminum Chloride Hexahydrate
=450  \\$wnnna$aAluminum Chloride, Anhydrous
=450  \\$wnnna$aAluminum Trichloride
=450  \\$wnnna$aDrysol
=450  \\$wnnna$aAnhydrous Aluminum Chloride
=680  \\$iA compound with the chemical formula AlCl3; the anhydrous salt is used as a catalyst in organic chemical synthesis, and hydrated salts are used topically as antiperspirants, and for the management of HYPERHYDROSIS.
=688  \\$a2019 (1975)
=750  \0$aAluminum Chloride$0(DLC) sh 86001873$5IEN-M

=LDR  00561nz  a2200169n  4500
=001  9880958473602441
=005  20180904000000.0
=008  180712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077314
=035  \\$a(NLM)9811675545300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x223.$x125
=072  \\$aI3.$x125.$x150
=150  \\$aAggressive Driving
=450  \\$wnnna$aDriving, Aggressive
=680  \\$iCombination of moving traffic offenses so as to endanger other persons or property. (https://nhtsa.gov/Driving-Safety/Aggressive-Driving)
=688  \\$a2019

=LDR  00612nz  a2200157n  4500
=001  9880958473702441
=005  20200717180512.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078065
=035  \\$a(NLM)9811675144700041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x822.$x17
=150  \\$aAegilops
=680  \\$iA genus of grasses known generally as goatgrasses, presumed to be wild ancestors of domestic WHEAT. They belong to the grass family, POACEAE, and are distributed widely in Eurasia and North America.
=688  \\$a2019
=750  \0$aAegilops$0(DLC)sh 88022526$5IEN-M

=LDR  03940cz  a2200973n  4500
=001  9880962472002441
=005  20200817123207.0
=008  991105\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020925
=035  \\$a(NLM)98193839660000041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x150.$x716
=072  \\$aC10.$x228.$x140.$x624.$x500
=072  \\$aC14.$x907.$x253.$x92.$x716
=150  \\$aHypoxia-Ischemia, Brain
=450  \\$wnnna$aEncephalopathy, Anoxic-Ischemic
=450  \\$wnnna$aEncephalopathy, Hypoxic-Ischemic
=450  \\$aAnoxia-Ischemia, Brain
=450  \\$aAnoxia-Ischemia, Cerebral
=450  \\$aAnoxic-Ischemic Encephalopathy
=450  \\$aBrain Anoxia-Ischemia
=450  \\$aBrain Hypoxia-Ischemia
=450  \\$aBrain Ischemia-Anoxia
=450  \\$aBrain Ischemia-Hypoxia
=450  \\$aCerebral Anoxia-Ischemia
=450  \\$aCerebral Hypoxia-Ischemia
=450  \\$aCerebral Ischemia-Anoxia
=450  \\$aCerebral Ischemia-Hypoxia
=450  \\$aHypoxia-Ischemia, Cerebral
=450  \\$aHypoxic-Ischemic Encephalopathy
=450  \\$aIschemia-Anoxia, Brain
=450  \\$aIschemia-Anoxia, Cerebral
=450  \\$aIschemia-Hypoxia, Brain
=450  \\$aIschemia-Hypoxia, Cerebral
=450  \\$aIschemic-Hypoxic Encephalopathy
=450  \\$wnnna$aAnoxia Ischemia, Brain
=450  \\$wnnna$aAnoxia Ischemia, Cerebral
=450  \\$wnnna$aAnoxia-Ischemias, Brain
=450  \\$wnnna$aAnoxia-Ischemias, Cerebral
=450  \\$wnnna$aAnoxic Ischemic Encephalopathy
=450  \\$wnnna$aAnoxic-Ischemic Encephalopathies
=450  \\$wnnna$aBrain Anoxia Ischemia
=450  \\$wnnna$aBrain Anoxia-Ischemias
=450  \\$wnnna$aBrain Hypoxia Ischemia
=450  \\$wnnna$aBrain Hypoxia-Ischemias
=450  \\$wnnna$aBrain Ischemia Anoxia
=450  \\$wnnna$aBrain Ischemia Hypoxia
=450  \\$wnnna$aBrain Ischemia-Anoxias
=450  \\$wnnna$aBrain Ischemia-Hypoxias
=450  \\$wnnna$aCerebral Anoxia Ischemia
=450  \\$wnnna$aCerebral Anoxia-Ischemias
=450  \\$wnnna$aCerebral Hypoxia Ischemia
=450  \\$wnnna$aCerebral Hypoxia-Ischemias
=450  \\$wnnna$aCerebral Ischemia Anoxia
=450  \\$wnnna$aCerebral Ischemia Hypoxia
=450  \\$wnnna$aCerebral Ischemia-Anoxias
=450  \\$wnnna$aCerebral Ischemia-Hypoxias
=450  \\$wnnna$aEncephalopathies, Anoxic-Ischemic
=450  \\$wnnna$aEncephalopathies, Hypoxic-Ischemic
=450  \\$wnnna$aEncephalopathies, Ischemic-Hypoxic
=450  \\$wnnna$aEncephalopathy, Anoxic Ischemic
=450  \\$wnnna$aEncephalopathy, Hypoxic Ischemic
=450  \\$wnnna$aEncephalopathy, Ischemic-Hypoxic
=450  \\$wnnna$aHypoxia Ischemia, Brain
=450  \\$wnnna$aHypoxia Ischemia, Cerebral
=450  \\$wnnna$aHypoxia-Ischemias, Brain
=450  \\$wnnna$aHypoxia-Ischemias, Cerebral
=450  \\$wnnna$aHypoxic Ischemic Encephalopathy
=450  \\$wnnna$aHypoxic-Ischemic Encephalopathies
=450  \\$wnnna$aIschemia Anoxia, Brain
=450  \\$wnnna$aIschemia Anoxia, Cerebral
=450  \\$wnnna$aIschemia Hypoxia, Brain
=450  \\$wnnna$aIschemia Hypoxia, Cerebral
=450  \\$wnnna$aIschemia-Anoxias, Brain
=450  \\$wnnna$aIschemia-Anoxias, Cerebral
=450  \\$wnnna$aIschemia-Hypoxias, Brain
=450  \\$wnnna$aIschemia-Hypoxias, Cerebral
=450  \\$wnnna$aIschemic Hypoxic Encephalopathy
=450  \\$wnnna$aIschemic-Hypoxic Encephalopathies
=550  \\$wg$aBrain Ischemia
=550  \\$aHypoxia
=680  \\$iA disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.
=688  \\$a2000
=750  \0$aHypoxic-ischemic encephalopathy$0(DLC)sh2018000075$5IEN-M

=LDR  00621cz  a2200181n  4500
=001  9880962860402441
=005  20210323111608.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D049883
=035  \\$a(NLM)98198642660000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x537.$x600
=150  \\$aPerna
=450  \\$wnnna$aPernas
=550  \\$wg$aMytilidae
=680  \\$iA genus of freshwater mussel in the family MYTILIDAE, class BIVALVIA. It is found in tropical and warm temperate coastal waters. Most species have green in their shells.
=688  \\$a2006
=750  \0$aPerna$0(DLC) sh 93001269$5IEN-M

=LDR  01008nz  a2200253n  4500
=001  9880962861802441
=005  20200820145505.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077320
=035  \\$a(NLM)9811675541600041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x92
=072  \\$aG7.$x345.$x155
=072  \\$aG7.$x345.$x500.$x325.$x377.$x625.$x50
=072  \\$aG11.$x427.$x578.$x50
=150  \\$aBiomineralization
=450  \\$wnnna$aBiocrystallization
=450  \\$wnnna$aBioprecipitation
=450  \\$wnnna$aBiocrystallizations
=450  \\$wnnna$aBiomineralizations
=450  \\$wnnna$aBioprecipitations
=680  \\$iProcess by which living organisms produce MINERALS that accumulate into hardened tissues (e.g., bones, teeth and shells), and cellular nanostructures that sequester away into macromolecules. Biosynthesized minerals include CALCIUM CARBONATE; FLUOROAPATITE; HYDROXYAPATITE; and MAGNETITE.
=688  \\$a2019
=750  \2$aBiomineralization$0(DLC)sh 85014247$5IEN-M

=LDR  00656cz  a2200181n  4500
=001  9880962862102441
=005  20200820131149.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077558
=035  \\$a(NLM)9811675397500041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x313.$x500.$x750.$x300.$x92
=150  \\$aBig Data
=550  \\$aData Science
=550  \\$aData Management
=680  \\$iExtremely large amounts of data which require rapid and often complex computational analyses to reveal patterns, trends, and associations, relating to various facets of human and non-human entities.
=688  \\$a2019
=750  \0$aBig data$0(DLC)sh2012003227$5IEN-M

=LDR  01294nz  a2200373n  4500
=001  9880962862302441
=005  20200820105553.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077237
=035  \\$a(NLM)9811683545100041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x75.$x38
=072  \\$aD1.$x650.$x550.$x125
=150  \\$aArsenic Trioxide
=450  \\$wnnna$aArsenic Oxide (As2O3)
=450  \\$wnnna$aArsenic Oxide (As4O6)
=450  \\$wnnna$aArsenic(III) Oxide
=450  \\$wnnna$aArsenolite
=450  \\$wnnna$aArsenous Anhydride
=450  \\$wnnna$aAs2O3
=450  \\$wnnna$aAs4O6
=450  \\$wnnna$aDiarsenic Trioxide
=450  \\$wnnna$aNaonobin
=450  \\$wnnna$aTetra-Arsenic Hexaoxide
=450  \\$wnnna$aTetra-Arsenic Oxide
=450  \\$wnnna$aTetraarsenic Hexaoxide
=450  \\$wnnna$aTetraarsenic Oxide
=450  \\$wnnna$aTrisenox
=450  \\$wnnna$aTrixenox
=450  \\$wnnna$aTetra Arsenic Hexaoxide
=450  \\$wnnna$aTetra Arsenic Oxide
=680  \\$iAn inorganic compound with the chemical formula As2O3 that is used for the treatment of ACUTE PROMYELOCYTIC LEUKEMIA in patients who have relapsed from, or are resistant to, conventional drug therapy.
=688  \\$a2019 (1975)
=750  \0$aArsenic trioxide$0(DLC) sh2005007343$5IEN-M

=LDR  00947cz  a2200289n  4500
=001  9880962862402441
=005  20200819175542.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077102
=035  \\$a(NLM)9811683461100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x75.$x94
=150  \\$aApium
=450  \\$wnnna$aApium graveolens var. dulce
=450  \\$wnnna$aApium graveolens var. rapaceum
=450  \\$wnnna$aCeleriac
=450  \\$wnnna$aWild Celery
=450  \\$aApium graveolens
=450  \\$aCelery
=450  \\$wnnna$aCeleriacs
=450  \\$wnnna$aCeleries
=450  \\$wnnna$aCeleries, Wild
=450  \\$wnnna$aCelery, Wild
=450  \\$wnnna$aWild Celeries
=680  \\$iA genus comprising several species of flowering plants with global distribution in the family APIACEAE.
=688  \\$a2019(2002); for CELERY see APIACEAE 1998-2001
=750  \0$aCelery$0(DLC)sh 85021621$5IEN-M

=LDR  00914cz  a2200217n  4500
=001  9880962864202441
=005  20200817174248.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D060588
=035  \\$a(NLM)98194116930000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x512
=150  \\$aLIM Domain Proteins
=550  \\$wg$aProteins
=550  \\$wh$aLIM Kinases
=550  \\$wh$aLIM-Homeodomain Proteins
=550  \\$aPaxillin
=550  \\$wh$aZyxin
=680  \\$iA large class of structurally-related proteins that contain one or more LIM zinc finger domains. Many of the proteins in this class are involved in intracellular signaling processes and mediate their effects via LIM domain protein-protein interactions. The name LIM is derived from the first three proteins in which the motif was found: LIN-11, Isl1 and Mec-3.
=688  \\$a2012
=750  \0$aLIM domain proteins$0(DLC)sh2017005254$5IEN-M

=LDR  01837cz  a2200469n  4500
=001  9880962864502441
=005  20200817151106.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D053722
=035  \\$a(NLM)98199896780000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x820
=150  \\$aReceptors, Interleukin-17
=450  \\$wnnna$aCDw217 Antigen
=450  \\$wnnna$aInterleukin-17 Receptor
=450  \\$wnnna$aInterleukin-17 Receptor A
=450  \\$wnnna$aInterleukin-17 Receptor B
=450  \\$wnnna$aInterleukin-17 Receptor C
=450  \\$wnnna$aInterleukin-17 Receptor D
=450  \\$wnnna$aInterleukin-17 Receptor E
=450  \\$aAntigens, CDw217
=450  \\$aCdw217 Antigens
=450  \\$aIL-17 Receptors
=450  \\$aInterleukin-17 Receptors
=450  \\$wnnna$aAntigen, CDw217
=450  \\$wnnna$aIL 17 Receptors
=450  \\$wnnna$aInterleukin 17 Receptor
=450  \\$wnnna$aInterleukin 17 Receptor A
=450  \\$wnnna$aInterleukin 17 Receptor B
=450  \\$wnnna$aInterleukin 17 Receptor C
=450  \\$wnnna$aInterleukin 17 Receptor D
=450  \\$wnnna$aInterleukin 17 Receptor E
=450  \\$wnnna$aInterleukin 17 Receptors
=450  \\$wnnna$aReceptor, Interleukin-17
=450  \\$wnnna$aReceptors, IL-17
=450  \\$wnnna$aReceptors, Interleukin 17
=550  \\$wg$aReceptors, Interleukin
=680  \\$iCell surface receptors for INTERLEUKIN-17. Several subtypes of receptors have been found, each with its own in specificity for interleukin-17 subtype.
=688  \\$a2007
=750  \0$81$wb$iBroader mapping$aInterleukin-17$0(DLC)sh2018000072$4BM$5IEN-M
=780  \\$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \\$iSearch under the Library of Congress Subject Heading$aInterleukin-17--Receptors$5IEN-M

=LDR  01745cz  a2200529n  4500
=001  9880962864702441
=005  20200817142559.0
=008  980610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020381
=035  \\$a(NLM)98196198540000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x517
=072  \\$aD12.$x776.$x467.$x374.$x465.$x517
=072  \\$aD23.$x529.$x374.$x465.$x517
=150  \\$aInterleukin-17
=450  \\$wnnna$aCTLA-8
=450  \\$wnnna$aCTLA8
=450  \\$wnnna$aCytokine CX2
=450  \\$wnnna$aCytokine ML-1
=450  \\$wnnna$aCytotoxic T lymphocyte-Associated Antigen 8
=450  \\$wnnna$aIL-17A
=450  \\$wnnna$aIL-17B
=450  \\$wnnna$aIL-17C
=450  \\$wnnna$aIL-17E
=450  \\$wnnna$aIL-17F
=450  \\$wnnna$aInterleukin 17
=450  \\$wnnna$aInterleukin-17A
=450  \\$wnnna$aInterleukin-17B
=450  \\$wnnna$aInterleukin-17C
=450  \\$wnnna$aInterleukin-17E
=450  \\$wnnna$aInterleukin-17F
=450  \\$wnnna$aInterleukin-25
=450  \\$aIL-17
=450  \\$wnnna$aCX2, Cytokine
=450  \\$wnnna$aCytokine ML 1
=450  \\$wnnna$aCytotoxic T lymphocyte Associated Antigen 8
=450  \\$wnnna$aIL 17E
=450  \\$wnnna$aInterleukin 17A
=450  \\$wnnna$aInterleukin 17B
=450  \\$wnnna$aInterleukin 17C
=450  \\$wnnna$aInterleukin 17E
=450  \\$wnnna$aInterleukin 17F
=450  \\$wnnna$aInterleukin 25
=550  \\$wg$aInterleukins
=680  \\$iA proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene.
=688  \\$a1999(1996)
=750  \0$aInterleukin-17$0(DLC)sh2018000072$5IEN-M

=LDR  05488cz  a2201285n  4500
=001  9880962959602441
=005  20200818131726.0
=008  991103\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020798
=035  \\$a(NLM)98199973040000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x393.$x220.$x870
=072  \\$aE5.$x601.$x690.$x650
=072  \\$aE5.$x601.$x870
=150  \\$aTwo-Hybrid System Techniques
=450  \\$wnnna$aOne-Hybrid System Technics
=450  \\$wnnna$aReverse Three-Hybrid System Techniques
=450  \\$wnnna$aThree-Hybrid System Technics
=450  \\$wnnna$aTri-Hybrid System Techniques
=450  \\$wnnna$aTwo-Hybrid Assay
=450  \\$wnnna$aTwo-Hybrid Method
=450  \\$wnnna$aTwo-Hybrid System Technics
=450  \\$wnnna$aYeast One-Hybrid System Techniques
=450  \\$wnnna$aYeast Three-Hybrid Assay
=450  \\$wnnna$aYeast Three-Hybrid System
=450  \\$wnnna$aYeast Three-Hybrid System Techniques
=450  \\$wnnna$aYeast Two-Hybrid System
=450  \\$wnnna$an-Hybrid System Techniques
=450  \\$aOne-Hybrid System Techniques
=450  \\$aReverse One-Hybrid System Techniques
=450  \\$aReverse Two-Hybrid System Techniques
=450  \\$aThree-Hybrid System Techniques
=450  \\$aYeast Two-Hybrid Assay
=450  \\$aYeast Two-Hybrid System Techniques
=450  \\$wnnna$aAssay, Two-Hybrid
=450  \\$wnnna$aAssay, Yeast Three-Hybrid
=450  \\$wnnna$aAssay, Yeast Two-Hybrid
=450  \\$wnnna$aAssays, Two-Hybrid
=450  \\$wnnna$aAssays, Yeast Three-Hybrid
=450  \\$wnnna$aAssays, Yeast Two-Hybrid
=450  \\$wnnna$aMethod, Two-Hybrid
=450  \\$wnnna$aMethods, Two-Hybrid
=450  \\$wnnna$aOne Hybrid System Technics
=450  \\$wnnna$aOne Hybrid System Techniques
=450  \\$wnnna$aOne-Hybrid System Technic
=450  \\$wnnna$aOne-Hybrid System Technique
=450  \\$wnnna$aReverse One Hybrid System Techniques
=450  \\$wnnna$aReverse Three Hybrid System Techniques
=450  \\$wnnna$aReverse Two Hybrid System Techniques
=450  \\$wnnna$aSystem Technique, n-Hybrid
=450  \\$wnnna$aSystem Techniques, n-Hybrid
=450  \\$wnnna$aSystem, Yeast Three-Hybrid
=450  \\$wnnna$aSystem, Yeast Two-Hybrid
=450  \\$wnnna$aSystems, Yeast Three-Hybrid
=450  \\$wnnna$aSystems, Yeast Two-Hybrid
=450  \\$wnnna$aTechnic, One-Hybrid System
=450  \\$wnnna$aTechnic, Three-Hybrid System
=450  \\$wnnna$aTechnic, Two-Hybrid System
=450  \\$wnnna$aTechnics, One-Hybrid System
=450  \\$wnnna$aTechnics, Three-Hybrid System
=450  \\$wnnna$aTechnics, Two-Hybrid System
=450  \\$wnnna$aTechnique, One-Hybrid System
=450  \\$wnnna$aTechnique, Three-Hybrid System
=450  \\$wnnna$aTechnique, Tri-Hybrid System
=450  \\$wnnna$aTechnique, Two-Hybrid System
=450  \\$wnnna$aTechnique, n-Hybrid System
=450  \\$wnnna$aTechniques, One-Hybrid System
=450  \\$wnnna$aTechniques, Three-Hybrid System
=450  \\$wnnna$aTechniques, Tri-Hybrid System
=450  \\$wnnna$aTechniques, Two-Hybrid System
=450  \\$wnnna$aTechniques, n-Hybrid System
=450  \\$wnnna$aThree Hybrid System Technics
=450  \\$wnnna$aThree Hybrid System Techniques
=450  \\$wnnna$aThree-Hybrid Assay, Yeast
=450  \\$wnnna$aThree-Hybrid Assays, Yeast
=450  \\$wnnna$aThree-Hybrid System Technic
=450  \\$wnnna$aThree-Hybrid System Technique
=450  \\$wnnna$aThree-Hybrid System, Yeast
=450  \\$wnnna$aThree-Hybrid Systems, Yeast
=450  \\$wnnna$aTri Hybrid System Techniques
=450  \\$wnnna$aTri-Hybrid System Technique
=450  \\$wnnna$aTwo Hybrid Assay
=450  \\$wnnna$aTwo Hybrid Method
=450  \\$wnnna$aTwo Hybrid System Technics
=450  \\$wnnna$aTwo Hybrid System Techniques
=450  \\$wnnna$aTwo-Hybrid Assay, Yeast
=450  \\$wnnna$aTwo-Hybrid Assays
=450  \\$wnnna$aTwo-Hybrid Assays, Yeast
=450  \\$wnnna$aTwo-Hybrid Methods
=450  \\$wnnna$aTwo-Hybrid System Technic
=450  \\$wnnna$aTwo-Hybrid System Technique
=450  \\$wnnna$aTwo-Hybrid System, Yeast
=450  \\$wnnna$aTwo-Hybrid Systems, Yeast
=450  \\$wnnna$aYeast One Hybrid System Techniques
=450  \\$wnnna$aYeast Three Hybrid Assay
=450  \\$wnnna$aYeast Three Hybrid System
=450  \\$wnnna$aYeast Three Hybrid System Techniques
=450  \\$wnnna$aYeast Three-Hybrid Assays
=450  \\$wnnna$aYeast Three-Hybrid Systems
=450  \\$wnnna$aYeast Two Hybrid Assay
=450  \\$wnnna$aYeast Two Hybrid System
=450  \\$wnnna$aYeast Two Hybrid System Techniques
=450  \\$wnnna$aYeast Two-Hybrid Assays
=450  \\$wnnna$aYeast Two-Hybrid Systems
=450  \\$wnnna$an Hybrid System Techniques
=450  \\$wnnna$an-Hybrid System Technique
=550  \\$aBlotting, Far-Western
=680  \\$iScreening techniques first developed in yeast to identify genes encoding interacting proteins. Variations are used to evaluate interplay between proteins and other molecules. Two-hybrid techniques refer to analysis for protein-protein interactions, one-hybrid for DNA-protein interactions, three-hybrid interactions for RNA-protein interactions or ligand-based interactions. Reverse n-hybrid techniques refer to analysis for mutations or other small molecules that dissociate known interactions.
=688  \\$a2000
=750  \0$aYeast two-hybrid assay$0(DLC)sh2017005287$5IEN-M

=LDR  01075cz  a2200301n  4500
=001  9880962959802441
=005  20200818130605.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066127
=035  \\$a(NLM)983985649500041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 300
=072  \\$aA8.$x186.$x211.$x204
=072  \\$aA8.$x186.$x854.$x880
=150  \\$aWhite Matter
=450  \\$aCerebellar White Matter
=450  \\$wnnna$aCerebellar White Matters
=450  \\$wnnna$aMatter, Cerebellar White
=450  \\$wnnna$aMatter, White
=450  \\$wnnna$aMatters, Cerebellar White
=450  \\$wnnna$aMatters, White
=450  \\$wnnna$aWhite Matter, Cerebellar
=450  \\$wnnna$aWhite Matters
=450  \\$wnnna$aWhite Matters, Cerebellar
=550  \\$aNerve Fibers, Myelinated
=680  \\$iThe region of CENTRAL NERVOUS SYSTEM that appears lighter in color than the other type, GRAY MATTER. It mainly consists of MYELINATED NERVE FIBERS and contains few neuronal cell bodies or DENDRITES.
=688  \\$a2015
=750  \0$aWhite matter$0(DLC)sh2017005145$5IEN-M

=LDR  01538cz  a2200373n  4500
=001  9880962960002441
=005  20200818125444.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D058504
=035  \\$a(NLM)98198637540000041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x550.$x500.$x400.$x915
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569.$x200.$x400.$x915
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569.$x500.$x400.$x915
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x550.$x500.$x400.$x770
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569.$x200.$x400.$x770
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569.$x500.$x400.$x770
=072  \\$aA15.$x382.$x490.$x555.$x567.$x550.$x500.$x400.$x915
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569.$x200.$x400.$x915
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569.$x500.$x400.$x915
=150  \\$aTh17 Cells
=450  \\$wnnna$aT Helper 17 Cells
=450  \\$wnnna$aTH-17 Cells
=450  \\$wnnna$aType 17 Helper T Cells
=450  \\$wnnna$aCell, TH-17
=450  \\$wnnna$aCell, Th17
=450  \\$wnnna$aCells, TH-17
=450  \\$wnnna$aCells, Th17
=450  \\$wnnna$aTH 17 Cells
=450  \\$wnnna$aTH-17 Cell
=450  \\$wnnna$aTh17 Cell
=680  \\$iA subset of helper-effector T-lymphocytes which synthesize and secrete INTERLEUKINS IL-17; IL-17F; and IL-22. These cytokines are involved in host defenses and tissue inflammation in autoimmune diseases.
=688  \\$a2011
=750  \0$aTh17 Cells$0(DLC)sh2018000073$5IEN-M

=LDR  00896cz  a2200205n  4500
=001  9880962960402441
=005  20200818121516.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D051419
=035  \\$a(NLM)98198127130000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x24.$x316
=072  \\$aD12.$x776.$x157.$x57.$x92
=072  \\$aD12.$x776.$x476.$x24.$x397
=072  \\$aD12.$x776.$x512.$x374
=072  \\$aD12.$x776.$x744.$x665
=150  \\$aPaxillin
=680  \\$iPaxillin is a signal transducing adaptor protein that localizes to FOCAL ADHESIONS via its four LIM domains. It undergoes PHOSPHORYLATION in response to integrin-mediated CELL ADHESION, and interacts with a variety of proteins including VINCULIN; FOCAL ADHESION KINASE; PROTO-ONCOGENE PROTEIN PP60(C-SRC); and PROTO-ONCOGENE PROTEIN C-CRK.
=688  \\$a2006(1991)
=750  \0$aPaxillin$0(DLC)sh2017005250$5IEN-M

=LDR  02199cz  a2200505n  4500
=001  9880962960702441
=005  20200818120416.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001281
=035  \\$a(NLM)98194202160000041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 330.5.A5
=072  \\$aC14.$x280.$x67.$x198
=072  \\$aC23.$x550.$x73.$x198
=150  \\$aAtrial Fibrillation
=450  \\$wnnna$aFamilial Atrial Fibrillation
=450  \\$wnnna$aParoxysmal Atrial Fibrillation
=450  \\$wnnna$aPersistent Atrial Fibrillation
=450  \\$aAuricular Fibrillation
=450  \\$wnnna$aAtrial Fibrillation, Familial
=450  \\$wnnna$aAtrial Fibrillation, Paroxysmal
=450  \\$wnnna$aAtrial Fibrillation, Persistent
=450  \\$wnnna$aAtrial Fibrillations
=450  \\$wnnna$aAtrial Fibrillations, Familial
=450  \\$wnnna$aAtrial Fibrillations, Paroxysmal
=450  \\$wnnna$aAtrial Fibrillations, Persistent
=450  \\$wnnna$aAuricular Fibrillations
=450  \\$wnnna$aFamilial Atrial Fibrillations
=450  \\$wnnna$aFibrillation, Atrial
=450  \\$wnnna$aFibrillation, Auricular
=450  \\$wnnna$aFibrillation, Familial Atrial
=450  \\$wnnna$aFibrillation, Paroxysmal Atrial
=450  \\$wnnna$aFibrillation, Persistent Atrial
=450  \\$wnnna$aFibrillations, Atrial
=450  \\$wnnna$aFibrillations, Auricular
=450  \\$wnnna$aFibrillations, Familial Atrial
=450  \\$wnnna$aFibrillations, Paroxysmal Atrial
=450  \\$wnnna$aFibrillations, Persistent Atrial
=450  \\$wnnna$aParoxysmal Atrial Fibrillations
=450  \\$wnnna$aPersistent Atrial Fibrillations
=667  \\$ado not confuse with ATRIAL FLUTTER
=680  \\$iAbnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
=688  \\$a84; was AURICULAR FIBRILLATION 1963-83
=750  \0$aAtrial Fibrillation$0(DLC)sh 85009546$5IEN-M
=750  \0$aParoxysmal atrial fibrillation$0(DLC)sh2017005246$5IEN-M

=LDR  01079cz  a2200253n  4500
=001  9880962967702441
=005  20200812125948.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003474
=035  \\$a(NLM)98195406730000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x485.$x222.$x222
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166.$x200
=072  \\$aD2.$x455.$x426.$x559.$x694.$x222
=150  \\$aCurcumin
=450  \\$aDiferuloylmethane
=450  \\$aTurmeric Yellow
=450  \\$wnnna$aYellow, Turmeric
=550  \\$wg$aDiarylheptanoids
=550  \\$wg$aCatechols
=667  \\$aX ref TURMERIC YELLOW: TUMERIC see CURCUMA is also available
=680  \\$iA yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
=688  \\$a91(75); was see under CATECHOLS 1975-90
=750  \0$aCurcumin$0(DLC)sh2018000043$5IEN-M

=LDR  02363cz  a2200673n  4500
=001  9880962968102441
=005  20200812122730.0
=008  130708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D064112
=035  \\$a(NLM)983984816500041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x708.$x800.$x325.$x500
=072  \\$aG5.$x360.$x80.$x708.$x800.$x325.$x500
=072  \\$aG5.$x360.$x340.$x24.$x850.$x69
=150  \\$aClustered Regularly Interspaced Short Palindromic Repeats
=450  \\$wnnna$aCRISPR Arrays
=450  \\$wnnna$aCRISPR Clusters
=450  \\$wnnna$aCRISPR Elements
=450  \\$wnnna$aCRISPR Loci
=450  \\$wnnna$aCRISPR Locus
=450  \\$wnnna$aCRISPR Sequences
=450  \\$wnnna$aCRISPR Spacer Sequences
=450  \\$wnnna$aCRISPR Spacers
=450  \\$wnnna$aCRISPR-Cas Loci
=450  \\$wnnna$aCRISPRs
=450  \\$wnnna$aClustered Regularly Interspaced Short Palindromic Repeat
=450  \\$wnnna$aArray, CRISPR
=450  \\$wnnna$aArrays, CRISPR
=450  \\$wnnna$aCRISPR
=450  \\$wnnna$aCRISPR Array
=450  \\$wnnna$aCRISPR Cas Loci
=450  \\$wnnna$aCRISPR Cluster
=450  \\$wnnna$aCRISPR Element
=450  \\$wnnna$aCRISPR Sequence
=450  \\$wnnna$aCRISPR Spacer
=450  \\$wnnna$aCRISPR Spacer Sequence
=450  \\$wnnna$aCRISPR-Cas Locus
=450  \\$wnnna$aCluster, CRISPR
=450  \\$wnnna$aClusters, CRISPR
=450  \\$wnnna$aElement, CRISPR
=450  \\$wnnna$aElements, CRISPR
=450  \\$wnnna$aLoci, CRISPR
=450  \\$wnnna$aLoci, CRISPR-Cas
=450  \\$wnnna$aLocus, CRISPR
=450  \\$wnnna$aLocus, CRISPR-Cas
=450  \\$wnnna$aSequence, CRISPR
=450  \\$wnnna$aSequence, CRISPR Spacer
=450  \\$wnnna$aSequences, CRISPR
=450  \\$wnnna$aSequences, CRISPR Spacer
=450  \\$wnnna$aSpacer Sequence, CRISPR
=450  \\$wnnna$aSpacer Sequences, CRISPR
=450  \\$wnnna$aSpacer, CRISPR
=450  \\$wnnna$aSpacers, CRISPR
=550  \\$wg$aInverted Repeat Sequences
=550  \\$wg$aTandem Repeat Sequences
=550  \\$aCRISPR-Associated Proteins
=680  \\$iRepetitive nucleic acid sequences that are principal components of the archaeal and bacterial CRISPR-CAS SYSTEMS, which function as adaptive antiviral defense systems.
=688  \\$a2014
=750  \0$aCRISPR (Genetics)$0(DLC)sh2018000091$5IEN-M

=LDR  01383cz  a2200301n  4500
=001  9880965273602441
=005  20200827122330.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002333
=035  \\$a(NLM)98194978440000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x50.$x350
=150  \\$aCarnitine Acyltransferases
=450  \\$wnnna$aAcylcarnitine Translocase
=450  \\$wnnna$aCarnitine Translocase
=450  \\$wnnna$aCarnitine-Acetylcarnitine Translocase
=450  \\$wnnna$aCarnitine-Acylcarnitine Translocase
=450  \\$wnnna$aAcyltransferases, Carnitine
=450  \\$wnnna$aCarnitine Acetylcarnitine Translocase
=450  \\$wnnna$aCarnitine Acylcarnitine Translocase
=450  \\$wnnna$aTranslocase, Acylcarnitine
=450  \\$wnnna$aTranslocase, Carnitine
=450  \\$wnnna$aTranslocase, Carnitine-Acetylcarnitine
=450  \\$wnnna$aTranslocase, Carnitine-Acylcarnitine
=667  \\$ado not confuse with CARNITINE ACETYLTRANSFERASE see CARNITINE O-ACETYLTRANSFERASE
=680  \\$iAcyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1.
=688  \\$a91(75); was see under ACYLTRANSFERASES 1975-90
=750  \0$aCarnitine acyltransferases$0(DLC)sh2016002165$5IEN-M

=LDR  00706nz  a2200217n  4500
=001  9880965468202441
=005  20200831170621.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079225
=035  \\$a(NLM)9812405650500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x315
=150  \\$aPsychological Distress
=450  \\$wnnna$aEmotional Distress
=450  \\$aEmotional Stress
=450  \\$wnnna$aDistress, Emotional
=450  \\$wnnna$aDistress, Psychological
=450  \\$wnnna$aStress, Emotional
=680  \\$iNegative emotional state characterized by physical and/or emotional discomfort, pain, or anguish.
=688  \\$a2020
=750  \0$aDistress (Psychology)$0(DLC) sh 95009310$5IEN-M

=LDR  00759cz  a2200205n  4500
=001  9880965473902441
=005  20200826114833.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D060735
=035  \\$a(NLM)98194065630000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 771
=072  \\$aE5.$x337.$x800.$x600
=072  \\$aN6.$x850.$x505.$x636
=150  \\$aPharmacovigilance
=450  \\$wnnna$aPharmacovigilances
=550  \\$aDrug Monitoring
=680  \\$iThe detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.
=688  \\$a2012
=750  \0$aPharmacovigilance$0(DLC)sh2018001145$5IEN-M

=LDR  00773nz  a2200217n  4500
=001  9880965568302441
=005  20200827145002.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080386
=035  \\$a(NLM)9812406022000041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x217
=072  \\$aD20.$x280.$x320.$x531
=072  \\$aD25.$x720.$x501
=072  \\$aD26.$x255.$x165.$x320.$x531
=072  \\$aJ1.$x637.$x51.$x720.$x562
=150  \\$aMicrogels
=450  \\$wnnna$aMicrogel
=680  \\$iThree-dimensional biocompatible polymers in micrometer size range. They are typically spherical particles in a size range of 1-350 micrometers when used for drug delivery and 3D cell culture applications.
=688  \\$a2020
=750  \0$aMicrogels$0(DLC)sh2018001002$5IEN-M

=LDR  00767cz  a2200229n  4500
=001  9880968974102441
=005  20200907143115.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066289
=035  \\$a(NLM)983985929100041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x313.$x500.$x875.$x500
=072  \\$aL1.$x453.$x245.$x332
=150  \\$aData Curation
=450  \\$wnnna$aData Annotation
=450  \\$wnnna$aData Archiving
=450  \\$wnnna$aAnnotation, Data
=450  \\$wnnna$aArchiving, Data
=450  \\$wnnna$aCuration, Data
=680  \\$iManagement activities required to maintain research data to ensure that they are fit for contemporary use and available for discovery and reuse.
=688  \\$a2015
=750  \0$aData curation$0(DLC)sh20150018555IEN-M

=LDR  00753cz  a2200253n  4500
=001  9880969173802441
=005  20200908144208.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D053139
=035  \\$a(NLM)98197634460000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x64.$x525
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x500
=150  \\$aOseltamivir
=450  \\$wnnna$aGS 4104
=450  \\$wnnna$aGS-4071
=450  \\$wnnna$aGS-4104
=450  \\$wnnna$aGS4071
=450  \\$wnnna$aGS4104
=450  \\$wnnna$aTamiflu
=450  \\$aGS 4071
=680  \\$iAn acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.
=688  \\$a2007(1997)
=750  \0$aOseltamivir$0(DLC)sh2018002641$5IEN-M

=LDR  00363cz  a2200121n  4500
=001  9880969174002441
=005  20200908143311.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D009439Q000037
=035  \\$a(NLM)98196100080000041
=040  \\$aDNLM$cDNLM
=150  \\$aNeuraminidase$xantagonists & inhibitors
=750  \0$aNeuraminidase inhibitors$0(DLC)sh2018003220$5IEN-M

=LDR  00655nz  a2200193n  4500
=001  9880969274102441
=005  20200908125425.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080183
=035  \\$a(NLM)9812405899600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x777.$x250
=150  \\$aIntersex Persons
=450  \\$wnnna$aIntersex Person
=450  \\$wnnna$aPerson, Intersex
=450  \\$wnnna$aPersons, Intersex
=680  \\$iThose individuals with INTERSEX CONDITIONS, with or without a desire to undergo SEX REASSIGNMENT PROCEDURES.
=688  \\$a2020; was Transgender Persons 2013-2019
=750  \0$aIntersex people$0(DLC)sh2007003860$5IEN-M

=LDR  00671cz  a2200157n  4500
=001  9880970071602441
=005  20200910182431.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076609
=035  \\$a(NLM)9811684065400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x908.$x500.$x97
=150  \\$aBrugmansia
=680  \\$iA genus of solanaceae that refers to small to mid-size trees with large, strong-smelling, trumpet-shaped flowers hanging downward. Most parts of the plant contain ATROPINE, SCOPOLAMINE HYDROBROMIDE and HYOSCYAMINE.
=688  \\$a2019(2002); use SOLANACEAE 2002-2018
=750  \0$aBrugmansia$0(DLC) sh 92003274$5IEN-M

=LDR  00536nz  a2200157n  4500
=001  9880973353102441
=005  20180904000000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077105
=035  \\$a(NLM)9811683459000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x511
=150  \\$aChlorophyceae
=450  \\$aChlamydomonadales
=680  \\$iA class of green algae in the subdivision CHLOROPHYTINA distinguished by its ultrastructural morphology. Some species have distinct arrangement of flagella.
=688  \\$a2019

=LDR  00665cz  a2200181n  4500
=001  9880973353302441
=005  20200929215932.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078463
=035  \\$a(NLM)9811675291800041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 327
=072  \\$aI1.$x880.$x735.$x105
=072  \\$aN1.$x824.$x245.$x263
=150  \\$aChild Labor
=680  \\$iEmployment of MINORS in work that deprives children of their childhood, potential, dignity, and is harmful to their physical and mental development. (International Labor Organization, UN)
=688  \\$a2019; see Employment 1979-2018
=750  \0$aChild labor$0(DLC) sh 85023444$5IEN-M

=LDR  00492nz  a2200169n  4500
=001  9880973353902441
=005  20200929131613.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077228
=035  \\$a(NLM)9811683547300041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x580.$x500
=150  \\$aCaspian Sea
=450  \\$wnnna$aCaspian Lake
=680  \\$iThe largest inland body of water, located between ASIA and EUROPE.
=688  \\$a2019
=750  \0$aCaspian Sea$0(DLC)sh 85020611$5IEN-M

=LDR  01095nz  a2200349n  4500
=001  9880973355002441
=005  20210107141309.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077482
=035  \\$a(NLM)9811675225600041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x268.$x150.$x38
=072  \\$aD5.$x750.$x139
=072  \\$aD25.$x720.$x150
=072  \\$aJ1.$x637.$x51.$x720.$x150
=150  \\$aCarbon Fiber
=450  \\$wnnna$aCarbon Felt
=450  \\$wnnna$aCarbon Fibre
=450  \\$wnnna$aComposipost
=450  \\$wnnna$aGrafil
=450  \\$wnnna$aCarbon Felts
=450  \\$wnnna$aCarbon Fibers
=450  \\$wnnna$aCarbon Fibres
=450  \\$wnnna$aFelt, Carbon
=450  \\$wnnna$aFelts, Carbon
=450  \\$wnnna$aFiber, Carbon
=450  \\$wnnna$aFibers, Carbon
=450  \\$wnnna$aFibre, Carbon
=450  \\$wnnna$aFibres, Carbon
=680  \\$iFiber with a diameter of approximately 5 to 10 micrometers that is composed mostly of carbon atoms. It has a variety of applications.
=688  \\$a2019 (1978)
=750  \0$aCarbon fibers$0(DLC) sh 85020118$5IEN-M

=LDR  00809cz  a2200205n  4500
=001  9880973356102441
=005  20200928153203.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077264
=035  \\$a(NLM)9811683921300041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x696.$x260
=150  \\$aCalcium-Regulating Hormones and Agents
=450  \\$wnnna$aCalcium-Regulating Hormones
=450  \\$wnnna$aCalcium Regulating Hormones
=450  \\$wnnna$aCalcium Regulating Hormones and Agents
=450  \\$wnnna$aHormones, Calcium-Regulating
=680  \\$iHormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis.
=688  \\$a2019
=750  \0$aCalcium regulating hormones$0(DLC) sh 90001218$5IEN-M

=LDR  01381nz  a2200397n  4500
=001  9880973357002441
=005  20200928163133.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077062
=035  \\$a(NLM)9811683464800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x126.$x990.$x367
=072  \\$aF2.$x830.$x900.$x333
=150  \\$aBurnout, Psychological
=450  \\$wnnna$aBurn-out
=450  \\$wnnna$aBurn-out Syndrome
=450  \\$wnnna$aBurnout
=450  \\$wnnna$aBurnout Syndrome
=450  \\$wnnna$aBurnout, Caregiver
=450  \\$wnnna$aBurnout, School
=450  \\$wnnna$aBurnout, Student
=450  \\$wnnna$aCaregiver Burnout
=450  \\$wnnna$aCaregiver Exhaustion
=450  \\$wnnna$aPsychological Burn-out
=450  \\$wnnna$aSchool Burnout
=450  \\$wnnna$aStudent Burnout
=450  \\$wnnna$aBurn out
=450  \\$wnnna$aBurn out Syndrome
=450  \\$wnnna$aBurn-out, Psychological
=450  \\$wnnna$aExhaustion, Caregiver
=450  \\$wnnna$aPsychological Burn out
=450  \\$wnnna$aPsychological Burnout
=550  \\$aKaroshi Death
=680  \\$iAn excessive reaction to stress caused by one's environment that may be characterized by feelings of emotional and physical exhaustion, coupled with a sense of frustration and failure.
=688  \\$a2019
=750  \0$aBurn out (Psychology)$0(DLC) sh 85018150$5IEN-M

=LDR  00659cz  a2200181n  4500
=001  9880973366802441
=005  20200921144309.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D027885
=035  \\$a(NLM)98196566520000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x401.$x87.$x750
=150  \\$aAstragalus propinquus
=450  \\$wnnna$aAstragalus mongholicus
=450  \\$wnne$aAstragalus membranaceus
=680  \\$iA plant species of the Astragalus genus which is source of Huang qi preparation used in TRADITIONAL CHINESE MEDICINE.
=688  \\$a2019(2002)
=750  \2$aAstragalus membranaceus$0(DLC)sh 88022582$5IEN-M

=LDR  00892cz  a2200277n  4500
=001  9880973431802441
=005  20200929171317.0
=008  970620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019660
=035  \\$a(NLM)98194404490000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x821.$x500
=150  \\$aMalvaceae
=450  \\$wnnna$aAlcea
=450  \\$wnnna$aHollyhock
=450  \\$wnnna$aMallow Family
=450  \\$aHelicteres
=450  \\$aMansonia
=450  \\$aSterculiaceae
=450  \\$aWaltheria
=450  \\$wnnna$aHelictere
=450  \\$wnnna$aHollyhocks
=450  \\$wnnna$aMallow Families
=680  \\$iThe mallow family of the order MALVALES, subclass Dilleniidae, class Magnoliopsida. The common names of hollyhock and mallow are used for several genera of Malvaceae.
=688  \\$a98
=750  \0$aMalvaceae$5IEN-M$0(DLC)sh 85080231

=LDR  00809cz  a2200181n  4500
=001  9880974245702441
=005  20201015114053.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D031308
=035  \\$a(NLM)98195334950000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x797.$x875
=150  \\$aSalicaceae
=450  \\$aFlacourtiaceae
=680  \\$iA plant family of the order MALPIGHIALES, superorder ROSANAE, class MAGNOLIOPSIDA. The leaves are alternate and simple, and staminate (male) flowers consist of one to several stamens; pistillate (female) flowers consist of a single-chambered ovary with several ovules that produce silky seeds.
=688  \\$a2019(2001)
=750  \0$aSalicaceae$0(DLC)sh 85116749$5IEN-M
=750  \0$aFlacourtiaceae$0(DLC)sh 85048949$5IEN-M

=LDR  01171cz  a2200301n  4500
=001  9880974245902441
=005  20201030150601.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D031955
=035  \\$a(NLM)98195819110000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x937.$x437.$x316
=150  \\$aRhamnus
=450  \\$wnno$aCascara
=450  \\$wnnna$aCascara Sagrada
=450  \\$wnnna$aFrangula alnus
=450  \\$wnnna$aFrangula purshiana
=450  \\$wnnna$aRhamnus frangula
=450  \\$wnnna$aRhamnus purshiana
=450  \\$wnnna$aSacred Bark
=450  \\$aCascara Buckthorn
=450  \\$aFrangula
=450  \\$wnnna$aBuckthorn, Cascara
=450  \\$wnnna$aBuckthorns, Cascara
=450  \\$wnnna$aFrangulas
=680  \\$iA plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with HIPPOPHAE or KARWINSKIA. Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada. Members contain frangulanin, frangulin, and anthraquinones such as EMODIN.
=688  \\$a2019(1991)
=750  \0$aBuckthorns$0(DLC)sh 85017443$5IEN-M

=LDR  03212cz  a2200721n  4500
=001  9880974246102441
=005  20200929144327.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066246
=035  \\$a(NLM)983985763400041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 55.7
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x9
=072  \\$aD12.$x776.$x543.$x750.$x630.$x9
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x74
=150  \\$aErbB Receptors
=450  \\$wnnna$aEGF Receptors
=450  \\$wnnna$aEpidermal Growth Factor Receptor Family Proteins
=450  \\$wnnna$aEpidermal Growth Factor Receptor Kinase
=450  \\$wnnna$aHER Family Receptors
=450  \\$wnnna$aProto-oncogene c-ErbB-1 Protein
=450  \\$wnnna$aReceptor Tyrosine-protein Kinase erbB-1
=450  \\$wnnna$aReceptor, ErbB-1
=450  \\$wnnna$aReceptors, Epidermal Growth Factor
=450  \\$aEGF Receptor
=450  \\$aEpidermal Growth Factor Receptor
=450  \\$aEpidermal Growth Factor Receptor Protein-Tyrosine Kinase
=450  \\$aReceptor, EGF
=450  \\$aReceptor, Epidermal Growth Factor
=450  \\$aReceptor, TGF-alpha
=450  \\$aReceptor, Transforming-Growth Factor alpha
=450  \\$aReceptor, Urogastrone
=450  \\$aReceptors, Epidermal Growth Factor-Urogastrone
=450  \\$aTGF-alpha Receptor
=450  \\$aTransforming Growth Factor alpha Receptor
=450  \\$aUrogastrone Receptor
=450  \\$ac-erbB-1 Protein
=450  \\$aerbB-1 Proto-Oncogene Protein
=450  \\$wnnna$aEpidermal Growth Factor Receptor Protein Tyrosine Kinase
=450  \\$wnnna$aErbB-1 Receptor
=450  \\$wnnna$aFamily Receptors, HER
=450  \\$wnnna$aProto oncogene c ErbB 1 Protein
=450  \\$wnnna$aProto-Oncogene Protein, erbB-1
=450  \\$wnnna$aReceptor Tyrosine protein Kinase erbB 1
=450  \\$wnnna$aReceptor, ErbB 1
=450  \\$wnnna$aReceptor, TGF alpha
=450  \\$wnnna$aReceptor, Transforming Growth Factor alpha
=450  \\$wnnna$aReceptors, EGF
=450  \\$wnnna$aReceptors, Epidermal Growth Factor Urogastrone
=450  \\$wnnna$aReceptors, ErbB
=450  \\$wnnna$aReceptors, HER Family
=450  \\$wnnna$ac erbB 1 Protein
=450  \\$wnnna$ac-ErbB-1 Protein, Proto-oncogene
=450  \\$wnnna$aerbB 1 Proto Oncogene Protein
=550  \\$aCetuximab
=550  \\$aEpidermal Growth Factor
=550  \\$aGenes, erbB-2
=550  \\$aGenes, erbB-1
=680  \\$iA family of structurally-related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS.
=688  \\$a2019 (2015); for RECEPTOR, EPIDERMAL GROWTH FACTOR use RECEPTOR, EPIDERMAL GROWTH FACTOR 1999-2018; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, EPIDERMAL GROWTH FACTOR 1994-1999
=750  \0$81$wb$iBroader mapping$aEpidermal growth factor$0(DLC)sh 89005597$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aEpidermal growth factor--Receptors$5IEN-M

=LDR  00685cz  a2200229n  4500
=001  9880974246302441
=005  20200929140111.0
=008  130708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D064028
=035  \\$a(NLM)983984710800041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912
=150  \\$aTracheophyta
=450  \\$aConiferophyta
=450  \\$aConifers
=450  \\$aPinophyta
=450  \\$aPteridophyta
=450  \\$aTracheobionta
=450  \\$wnnna$aConifer
=680  \\$iA subset of plants bearing a vascular system. Examples are ferns and seed-bearing species.
=688  \\$a2018 (2001); use FERNS 2001-2013
=750  \0$aConifers$0(DLC)sh 85031129$5IEN-M

=LDR  00636cz  a2200193n  4500
=001  9881049572302441
=005  20201006143033.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002379
=035  \\$a(NLM)98199380150000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x290.$x183
=150  \\$aCatalogs, Commercial as Topic
=450  \\$wnnna$aCommercial Catalogs as Topic
=550  \\$aEquipment and Supplies
=667  \\$ado not confuse with the Publication Type CATALOG, COMMERCIAL
=680  \\$iWorks about lists of merchandise for sale.
=688  \\$a2019(1966)
=750  \0$aCommercial catalogs$0(DLC)sh 85020909$5IEN-M

=LDR  01377cz  a2200397n  4500
=001  9881188271002441
=005  20201006123119.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001330
=035  \\$a(NLM)98196500190000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x85
=150  \\$aElectronic Data Processing
=450  \\$wnnna$aInformation Processing
=450  \\$aAutomatic Data Processing
=450  \\$aBar Codes
=450  \\$aComputer Data Processing
=450  \\$aData Processing, Automatic
=450  \\$aInformation Processing, Automatic
=450  \\$aOptical Readers
=450  \\$wnnna$aAutomatic Information Processing
=450  \\$wnnna$aBar Code
=450  \\$wnnna$aCodes, Bar
=450  \\$wnnna$aData Processing, Computer
=450  \\$wnnna$aData Processing, Electronic
=450  \\$wnnna$aOptical Reader
=450  \\$wnnna$aProcessing, Automatic Data
=450  \\$wnnna$aProcessing, Automatic Information
=450  \\$wnnna$aProcessing, Computer Data
=450  \\$wnnna$aProcessing, Electronic Data
=450  \\$wnnna$aProcessing, Information
=550  \\$aComputers
=667  \\$ageneral or unspecified only; prefer specific informatics & computer terms
=680  \\$iApplications that store and process large quantities of data.
=688  \\$a2019(1996)
=750  \0$aElectronic data processing$0(DLC)sh 85042288$5IEN-M

=LDR  00591cz  a2200193n  4500
=001  9881195566702441
=005  20201007124452.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002380
=035  \\$a(NLM)98199380140000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 772
=072  \\$aL1.$x178.$x682.$x290.$x283
=150  \\$aCatalogs, Drug as Topic
=450  \\$wnnna$aDrug Catalogs as Topic
=667  \\$ado not confuse with the Publication Type CATALOG, DRUG
=680  \\$iWorks about lists of drugs for sale.
=688  \\$a2019(1966)
=750  \0$aDrugs$vCatalogs$5IEN$0(DLC)sh2009123914

=LDR  00666cz  a2200181n  4500
=001  9881195567002441
=005  20201007110608.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002383
=035  \\$a(NLM)98199380110000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x290.$x483
=150  \\$aCatalogs, Union as Topic
=450  \\$wnnna$aUnion Catalog as Topic
=667  \\$ado not confuse with the Publication Type CATALOG, UNION
=680  \\$iWorks about lists of books and other information sources held among a cooperating group of LIBRARIES.
=688  \\$a2019(1966); was CATALOGS, UNION 1966-2018
=750  \0$aUnion catalogs$0(DLC)sh 85020922$5IEN-M

=LDR  01972cz  a2200433n  4500
=001  9881195668702441
=005  20201008103709.0
=008  890515\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015928
=035  \\$a(NLM)98194781980000041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x754.$x137.$x350
=150  \\$aCognitive Behavioral Therapy
=450  \\$wnnna$aCognition Therapy
=450  \\$wnnna$aCognitive Behavior Therapy
=450  \\$wnnna$aCognitive Psychotherapy
=450  \\$wnnna$aTherapy, Cognition
=450  \\$wnnna$aTherapy, Cognitive
=450  \\$wnnna$aTherapy, Cognitive Behavior
=450  \\$aBehavior Therapy, Cognitive
=450  \\$aCognitive Therapy
=450  \\$aPsychotherapy, Cognitive
=450  \\$wnnna$aBehavior Therapies, Cognitive
=450  \\$wnnna$aBehavioral Therapies, Cognitive
=450  \\$wnnna$aBehavioral Therapy, Cognitive
=450  \\$wnnna$aCognition Therapies
=450  \\$wnnna$aCognitive Behavior Therapies
=450  \\$wnnna$aCognitive Behavioral Therapies
=450  \\$wnnna$aCognitive Psychotherapies
=450  \\$wnnna$aCognitive Therapies
=450  \\$wnnna$aPsychotherapies, Cognitive
=450  \\$wnnna$aTherapies, Cognition
=450  \\$wnnna$aTherapies, Cognitive
=450  \\$wnnna$aTherapies, Cognitive Behavior
=450  \\$wnnna$aTherapies, Cognitive Behavioral
=450  \\$wnnna$aTherapy, Cognitive Behavioral
=680  \\$iA directive form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.
=688  \\$a2019(1990); was Cognitive Therapy 1990-2018
=750  \0$aCognitive therapy$0(DLC)sh 85027756$5IEN-M

=LDR  00561cz  a2200157n  4500
=001  9881195869202441
=005  20201008173913.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004015
=035  \\$a(NLM)98198615260000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x285.$x206
=150  \\$aDictionaries, Chemical as Topic
=667  \\$ado not confuse with the Publication Type DICTIONARY, CHEMICAL
=680  \\$iWorks about sources listing chemicals and their characteristics.
=750  \0$aChemistry$vDictionaries$0(DLC)sh2008100329$5IEN-M

=LDR  00686cz  a2200229n  4500
=001  9881220720802441
=005  20240216170130.0
=008  130708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D063948
=035  \\$a(NLM)983984552700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x210
=150  \\$aEnslaved Persons
=450  \\$aSlaves
=450  \\$wnnna$aEnslaved Person
=450  \\$wnnna$aPerson, Enslaved
=450  \\$wnnna$aPersons, Enslaved
=450  \\$wnnna$aSlave
=550  \\$aEnslavement
=680  \\$iPersons involuntarily controlled by another and exploited for forced or compulsory work or service.
=688  \\$a2019(1986)
=750  \0$aEnslaved persons$0(DLC)sh 85123347$5IEN-M

=LDR  00864cz  a2200217n  4500
=001  9881220750902441
=005  20201015125522.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005571
=035  \\$a(NLM)98193993730000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x535.$x435
=150  \\$aFormularies, Homeopathic as Topic
=450  \\$wnnna$aHomeopathic Formularies as Topic
=550  \\$aHomeopathy
=550  \\$aPharmacopoeias, Homeopathic as Topic
=667  \\$ado not confuse with the Publication Type FORMULARY, HOMEOPATHIC
=680  \\$iWorks about formularies concerned with HOMEOPATHIC REMEDIES.
=688  \\$a2019(1966); was FORMULARIES, HOMEOPATHIC 1966-2018
=750  \0$aHomeopathy$xFormulae, receipts, prescriptions$5IEN-M$0(IEN)368400
=750  \0$aHomeopathy$xMateria medica and therapeutics$5IEN-M$0(DLC)sh 85061729

=LDR  00810cz  a2200241n  4500
=001  9881220842402441
=005  20201023151208.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D057185
=035  \\$a(NLM)98194731080000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x749
=072  \\$aF1.$x829.$x458.$x705
=150  \\$aSedentary Behavior
=450  \\$wnnna$aPhysical Inactivity
=450  \\$aSedentary Lifestyle
=450  \\$wnnna$aBehavior, Sedentary
=450  \\$wnnna$aInactivity, Physical
=450  \\$wnnna$aLifestyle, Sedentary
=450  \\$wnnna$aSedentary Behaviors
=680  \\$iBehaviors during waking hours that have low energy expenditure and are often performed in a sitting or reclining POSTURE.
=688  \\$a2019(2010)
=750  \0$aSedentary behavior$0(DLC)sh2010009481$5IEN-M

=LDR  01476cz  a2200397n  4500
=001  9881220842702441
=005  20201023150451.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012601
=035  \\$a(NLM)98196029490000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 134
=072  \\$aD2.$x145.$x74.$x722.$x822.$x775
=072  \\$aD3.$x132.$x760.$x180.$x848
=072  \\$aD3.$x132.$x889.$x601.$x775
=072  \\$aD3.$x605.$x84.$x500.$x722.$x822.$x775
=072  \\$aD3.$x605.$x869.$x822.$x775
=150  \\$aScopolamine
=450  \\$wnnna$aBoro-Scopol
=450  \\$wnnna$aIsopto Hyoscine
=450  \\$wnnna$aKwells
=450  \\$wnnna$aScoburen
=450  \\$wnnna$aScopace
=450  \\$wnnna$aScopoderm TTS
=450  \\$wnnna$aScopolamine Cooper
=450  \\$wnnna$aTransderm Scop
=450  \\$wnnna$aTransderm-V
=450  \\$wnnna$aTravacalm HO
=450  \\$wnnna$aVorigeno
=450  \\$aHyoscine
=450  \\$aScopolamine Hydrobromide
=450  \\$wnnna$aBoro Scopol
=450  \\$wnnna$aTransderm V
=680  \\$iAn alkaloid from SOLANACEAE, especially DATURA and SCOPOLIA. Scopolamine and its quaternary derivatives act as antimuscarinics like ATROPINE, but may have more central nervous system effects. Its many uses include an anesthetic premedication, the treatment of URINARY INCONTINENCE and MOTION SICKNESS, an antispasmodic, and a mydriatic and cycloplegic.
=688  \\$a2019 (1966)
=750  \0$aScopolamine$0(DLC) sh 85118772$5IEN-M

=LDR  01345cz  a2200313n  4500
=001  9881220850502441
=005  20180904000000.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011996
=035  \\$a(NLM)98197622760000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x308.$x940
=072  \\$aL1.$x399.$x250.$x900
=072  \\$aN4.$x452.$x859
=072  \\$aN5.$x715.$x360.$x300.$x715
=072  \\$aN6.$x850.$x520.$x308.$x940
=150  \\$aRecords
=450  \\$wnnna$aPersonal Identification Systems
=450  \\$wnnna$aTravel Documents
=450  \\$aRecords as Topic
=450  \\$wnnna$aDocuments, Travel
=450  \\$wnnna$aIdentification Systems, Personal
=450  \\$wnnna$aPersonal Identification System
=450  \\$wnnna$aRecord
=450  \\$wnnna$aRecords as Topics
=550  \\$aDocumentation
=667  \\$ageneral or unspecified only; prefer specifics; veterinary records: coordinate with VETERINARY MEDICINE; case reports as a form of writing = probably MEDICAL RECORDS or specific records term; FORMS AND RECORDS CONTROL is also available; do not confuse with Publication Type FORM
=680  \\$iWorks on authentic evidence, of something having legal importance. The concept includes certificates of birth, death, etc., as well as hospital, medical, and other institutional records.
=688  \\$a2008(1968)

=LDR  00815nz  a2200241n  4500
=001  9881220850602441
=005  20201021122648.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078789
=035  \\$a(NLM)9811675274700041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x515
=072  \\$aD5.$x750.$x223
=072  \\$aD25.$x720.$x719
=072  \\$aJ1.$x637.$x51.$x720.$x719
=150  \\$aPolyacetylene Polymer
=450  \\$wnnna$aPolyacetylene
=450  \\$wnnna$aPolyacetylene Polymers
=450  \\$wnnna$aPolymer, Polyacetylene
=450  \\$wnnna$aPolymers, Polyacetylene
=680  \\$iA polyene polymer that consists of alternating single and double bonds.
=688  \\$a2019; use POLYACETYLENES 2007-2018
=750  \0$iRelated mapping$aPolyacetylenes$0(DLC)sh 85104584$4RM$5IEN-M

=LDR  00513cz  a2200157n  4500
=001  9881220850802441
=005  20201021121507.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(NLM)98197957440000041
=035  \\$a(DNLM)D053279
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x397.$x680
=150  \\$aPolyynes
=680  \\$iHydrocarbons that contain more than one triple bond; or an oxidized form of POLYENES.
=688  \\$a2019 (2007); was POLYACETYLENES 2007-2018
=750  \0$aPolyynes$0(DLC) sh2005004401$5IEN-M

=LDR  00756cz  a2200193n  4500
=001  9881220851002441
=005  20201021114933.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010603
=035  \\$a(NLM)98196773390000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x749.$x599
=150  \\$aPharmacopoeias, Homeopathic as Topic
=450  \\$wnnna$aHomeopathic Pharmacopoeias as Topic
=550  \\$aHomeopathy
=667  \\$ado not confuse with the Publication Type PHARMACOPOEIA, HOMEOPATHIC
=680  \\$iWorks about authoritative resources describing the composition, properties, manufacture, and quality control of HOMEOPATHIC REMEDIES.
=688  \\$a2019(1966)
=750  \0$aPharmacopoeias, Homeopathic$0(DLC)sh 85100602$5IEN-M

=LDR  00918cz  a2200313n  4500
=001  9881220854002441
=005  20201019150635.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009728
=035  \\$a(NLM)98198269580000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x652
=072  \\$aN2.$x360.$x67.$x652
=150  \\$aNursing Assistants
=450  \\$aNurses' Aides
=450  \\$aNursing Auxiliaries
=450  \\$wnnna$aAides, Nurses'
=450  \\$wnnna$aAssistant, Nursing
=450  \\$wnnna$aAssistants, Nursing
=450  \\$wnnna$aAuxiliaries, Nursing
=450  \\$wnnna$aAuxiliary, Nursing
=450  \\$wnnna$aNurse Aides
=450  \\$wnnna$aNurse's Aides
=450  \\$wnnna$aNurses Aides
=450  \\$wnnna$aNurses' Aide
=450  \\$wnnna$aNursing Assistant
=450  \\$wnnna$aNursing Auxiliary
=688  \\$a2019(1966)
=750  \0$aNurses' aides$0(DLC)sh 85093360$5IEN-M

=LDR  00732cz  a2200193n  4500
=001  9881220855102441
=005  20201019145057.0
=008  010803\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D026323
=035  \\$a(NLM)98195642300000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x765.$x500
=150  \\$aMyristica
=450  \\$aMyristica fragrans
=450  \\$aNutmeg
=667  \\$afor food coordinate with SPICES
=680  \\$iA plant genus in the MYRISTICACEAE family. The seed is used as a spice and used for antimicrobial and psychoactive effects. Myristicin, SAFROLE, and methyleugenol are key components.
=688  \\$a2019(2002); use SPICES 1993-2001
=750  \0$aMyristica$0(DLC) sh 85089299$5IEN-M

=LDR  01558cz  a2200385n  4500
=001  9881220855702441
=005  20201019135854.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009105
=035  \\$a(NLM)98197270300000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 173.6
=072  \\$aF3.$x300.$x500
=150  \\$aDissociative Identity Disorder
=450  \\$wnnna$aMultiple Identity Disorder
=450  \\$wnnna$aMultiple Personalities
=450  \\$aDual Personality
=450  \\$aMultiple Personality Disorder
=450  \\$wnnna$aDisorder, Dissociative Identity
=450  \\$wnnna$aDisorder, Multiple Identity
=450  \\$wnnna$aDisorder, Multiple Personality
=450  \\$wnnna$aIdentity Disorder, Dissociative
=450  \\$wnnna$aIdentity Disorder, Multiple
=450  \\$wnnna$aMultiple Identity Disorders
=450  \\$wnnna$aMultiple Personality
=450  \\$wnnna$aMultiple Personality Disorders
=450  \\$wnnna$aPersonalities, Dual
=450  \\$wnnna$aPersonalities, Multiple
=450  \\$wnnna$aPersonality Disorder, Multiple
=450  \\$wnnna$aPersonality Disorders, Multiple
=450  \\$wnnna$aPersonality, Dual
=450  \\$wnnna$aPersonality, Multiple
=680  \\$iA dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.
=688  \\$a2019(1968)
=750  \0$aMultiple personality$0(DLC)sh 85088368$5IEN-M

=LDR  02305cz  a2200637n  4500
=001  9881221932402441
=005  20210211144544.0
=008  110705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D061485
=035  \\$a(NLM)98194549320000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x980
=150  \\$aTobacco Use Cessation Devices
=450  \\$wnnna$aNicotine Delivery Devices
=450  \\$wnnna$aNicotine Inhalant
=450  \\$wnnna$aNicotine Lozenge
=450  \\$wnnna$aNicotine Lozenges
=450  \\$wnnna$aNicotine Nasal Spray
=450  \\$wnnna$aNicotine Patch
=450  \\$wnnna$aNicotine Polacrilex
=450  \\$wnnna$aNicotine Replacement Products
=450  \\$wnnna$aNicotine Transdermal Patch
=450  \\$wnnna$aSmoking Cessation Products
=450  \\$aTobacco Use Cessation Products
=450  \\$wnnna$aDelivery Device, Nicotine
=450  \\$wnnna$aDelivery Devices, Nicotine
=450  \\$wnnna$aDevice, Nicotine Delivery
=450  \\$wnnna$aDevices, Nicotine Delivery
=450  \\$wnnna$aInhalant, Nicotine
=450  \\$wnnna$aInhalants, Nicotine
=450  \\$wnnna$aLozenge, Nicotine
=450  \\$wnnna$aLozenges, Nicotine
=450  \\$wnnna$aNasal Spray, Nicotine
=450  \\$wnnna$aNasal Sprays, Nicotine
=450  \\$wnnna$aNicotine Delivery Device
=450  \\$wnnna$aNicotine Inhalants
=450  \\$wnnna$aNicotine Nasal Sprays
=450  \\$wnnna$aNicotine Replacement Product
=450  \\$wnnna$aPatch, Nicotine
=450  \\$wnnna$aPatch, Nicotine Transdermal
=450  \\$wnnna$aPolacrilex, Nicotine
=450  \\$wnnna$aProduct, Nicotine Replacement
=450  \\$wnnna$aProduct, Smoking Cessation
=450  \\$wnnna$aProducts, Nicotine Replacement
=450  \\$wnnna$aProducts, Smoking Cessation
=450  \\$wnnna$aReplacement Product, Nicotine
=450  \\$wnnna$aReplacement Products, Nicotine
=450  \\$wnnna$aSmoking Cessation Product
=450  \\$wnnna$aSpray, Nicotine Nasal
=450  \\$wnnna$aSprays, Nicotine Nasal
=450  \\$wnnna$aTransdermal Patch, Nicotine
=550  \\$aSmoking Cessation Agents
=550  \\$aTobacco Use Cessation
=680  \\$iDevices or delivery systems used to aid in ending a TOBACCO habit.
=688  \\$a2019(1968)
=750  \0$aSmoking cessation products$0(DLC)sh2002004214$5IEN-M

=LDR  01509cz  a2200361n  4500
=001  9881221951302441
=005  20201020134442.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009629
=035  \\$a(NLM)98195555780000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.N8
=072  \\$aF4.$x754.$x592
=150  \\$aPerson-Centered Psychotherapy
=450  \\$wnnna$aTherapy, Client-Centered
=450  \\$wnnna$aTherapy, Nondirective
=450  \\$wnnna$aTherapy, Rogerian
=450  \\$aClient-Centered Therapy
=450  \\$aNondirective Therapy
=450  \\$aRogerian Therapy
=450  \\$wnnna$aClient Centered Therapy
=450  \\$wnnna$aClient-Centered Therapies
=450  \\$wnnna$aNondirective Therapies
=450  \\$wnnna$aPerson Centered Psychotherapy
=450  \\$wnnna$aPerson-Centered Psychotherapies
=450  \\$wnnna$aPsychotherapies, Person-Centered
=450  \\$wnnna$aPsychotherapy, Person-Centered
=450  \\$wnnna$aTherapies, Client-Centered
=450  \\$wnnna$aTherapies, Nondirective
=450  \\$wnnna$aTherapy, Client Centered
=680  \\$iA nondirective psychotherapy approach originated by Carl Rogers. The goals of therapy are to promote the client's congruence, self awareness, and self acceptance. This approach views the client as naturally directed toward self actualization, and only needing facilitative conditions in order to promote this tendency.
=688  \\$a2019(1969)
=750  \0$aClient-centered psychotherapy$0(DLC)sh 85027022$5IEN-M

=LDR  01059cz  a2200313n  4500
=001  9881221956802441
=005  20201016150814.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008493
=035  \\$a(NLM)98195865600000041
=040  \\$aDNLM$cDNLM
=060  \0$aW 323
=072  \\$aI1.$x615.$x500.$x750
=150  \\$aMedical Missions
=450  \\$wnnna$aOfficial Medical Missions
=450  \\$aMedical Missions, Official
=450  \\$aMissions, Official Medical
=450  \\$wnnna$aMedical Mission
=450  \\$wnnna$aMedical Mission, Official
=450  \\$wnnna$aMission, Medical
=450  \\$wnnna$aMission, Official Medical
=450  \\$wnnna$aMissions, Medical
=450  \\$wnnna$aOfficial Medical Mission
=550  \\$aReligious Missions
=550  \\$aMissionaries
=667  \\$aRELIGIOUS MISSIONS and MISSIONARIES are also available
=680  \\$iTravel by a group for the purpose of undertaking a health-care related project of short-term duration.
=688  \\$a2019(1966)
=750  \0$aMissions, Medical$0(DLC)sh 85086083$5IEN-M

=LDR  00951cz  a2200241n  4500
=001  9881221956902441
=005  20201016145857.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070116
=035  \\$a(NLM)987390563400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x401.$x565
=150  \\$aLotus
=450  \\$wnnna$aLoteae
=450  \\$wnnna$aLotus arabicus
=450  \\$wnnna$aLotus corniculatus
=450  \\$wnnna$aLotus japonicus
=450  \\$aTrefoil
=450  \\$wnnna$aTrefoils
=667  \\$aAMERICAN LOTUS, INDIAN LOTUS and SACRED LOTUS see NELUMBO are also available; lotus seeds and lotus nuts are from the genus NELUMBO, especially NELUMBO NUCIFERA
=680  \\$iA genus of the PEA FAMILY. The genus Lotus, formerly known as Tetragonolobus, is unrelated to other plants with the common name of lotus (NELUMBO and NYMPHAEA).
=688  \\$a2017(2002)
=750  \0$aLotus$0(DLC)sh 85078460$5IEN-M

=LDR  01881cz  a2200541n  4500
=001  9881221957002441
=005  20201016143819.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001556
=035  \\$a(NLM)98194956090000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x600
=150  \\$aHexachlorocyclohexane
=450  \\$wnnna$aBHC Insecticide
=450  \\$wnnna$aDelitex
=450  \\$wnnna$aEpsilon-hexachlorocyclohexane
=450  \\$wnnna$aEta-hexachlorocyclohexane
=450  \\$wnnna$aGamma-666
=450  \\$wnnna$aGammexane
=450  \\$wnnna$aHexachlorane
=450  \\$wnnna$aJacutin
=450  \\$wnnna$aKwell
=450  \\$wnnna$aPMS-Lindane
=450  \\$wnnna$aScabecid
=450  \\$wnnna$aScabene
=450  \\$wnnna$aScabisan
=450  \\$wnnna$aTetocid
=450  \\$wnnna$aZeta-hexachlorocyclohexane
=450  \\$wnnna$agamma-HCH
=450  \\$wnnna$agamma-Hexachlorocyclohexane
=450  \\$aBenzene Hexachloride
=450  \\$aLindane
=450  \\$agamma-Benzene Hexachloride
=450  \\$wnnna$aEpsilon hexachlorocyclohexane
=450  \\$wnnna$aEta hexachlorocyclohexane
=450  \\$wnnna$aGamma 666
=450  \\$wnnna$aHexachloride, Benzene
=450  \\$wnnna$aHexachloride, gamma-Benzene
=450  \\$wnnna$aInsecticide, BHC
=450  \\$wnnna$aPMS Lindane
=450  \\$wnnna$aZeta hexachlorocyclohexane
=450  \\$wnnna$agamma Benzene Hexachloride
=450  \\$wnnna$agamma HCH
=450  \\$wnnna$agamma Hexachlorocyclohexane
=667  \\$ado not confuse entry term BENZENE HEXACHLORIDE with HEXACHLOROBENZENE
=680  \\$iAny of several polyhalogenated organic compounds consisting of a six-carbon ring with one chlorine and one hydrogen attached to each carbon.
=688  \\$a2019(1996); use BENZENE HEXACHLORIDE 1963-95; LINDANE 1995-2018
=750  \0$aLindane$0(DLC)sh 94007703$5IEN-M

=LDR  00984cz  a2200289n  4500
=001  9881222212602441
=005  20201030152140.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004642
=035  \\$a(NLM)98198763570000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x117.$x159.$x353
=072  \\$aD2.$x806.$x100.$x353
=072  \\$aD4.$x615.$x117.$x159.$x353
=150  \\$aEmodin
=450  \\$wnnna$aArchin
=450  \\$wnnna$aFrangulic Acid
=450  \\$aCasanthranol
=450  \\$aFrangula Emodin
=450  \\$aPeristim
=450  \\$aRheum Emodin
=450  \\$wnnna$aEmodin, Frangula
=450  \\$wnnna$aEmodin, Rheum
=667  \\$aemodin from aloe goes here not under SCR term aloe emodin
=680  \\$iPurgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
=688  \\$a1991(1975)
=750  \0$aFrangula$0sh 85051562$5IEN-M

=LDR  01120cz  a2200205n  4500
=001  9881222221102441
=005  20201023173629.0
=008  130708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D063947
=035  \\$a(NLM)983984553800041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x384.$x350
=150  \\$aEnslavement
=450  \\$wnnna$aSlaveholding
=450  \\$aSlavery
=450  \\$wnnna$aEnslavements
=550  \\$aEnslaved Persons
=680  \\$iThe status or condition of a person over whom any or all of the powers attaching to the right of ownership are exercised. The slave trade is all acts involved in the capture, acquisition or disposal of persons with intent to reduce them to enslavement; all acts involved in the acquisition of enslaved persons with a view to selling or exchanging them; all acts of disposal by sale or exchange of persons acquired with a view to being sold or exchanged, and, in general, every act of trade or transport of slaves. (from http://www.ohchr.org/Documents/Publications/slaveryen.pdf accessed 10/18/2012)
=688  \\$a2019(2014)
=750  \0$aSlavery$0(DLC)sh 85123314$5IEN-M

=LDR  01093cz  a2200253n  4500
=001  9881222247502441
=005  20201015174912.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006280
=035  \\$a(NLM)98194338070000041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x350
=072  \\$aN4.$x452.$x525.$x500
=072  \\$aN5.$x300.$x420.$x400
=150  \\$aHealth Workforce
=450  \\$wnnna$aManpower, Health
=450  \\$wnnna$aManpower, Health Occupations
=450  \\$aHealth Manpower
=450  \\$aHealth Occupations Manpower
=450  \\$wnnna$aWorkforce, Health
=667  \\$ado not confuse with HEALTH PERSONNEL, the persons in the field of health care & delivery; coordinate with specific health discipline, occupation or program if pertinent
=680  \\$iThe availability of HEALTH PERSONNEL. It includes the demand and recruitment of both professional and allied health personnel, their present and future supply and distribution, and their assignment and utilization.
=688  \\$a2019(1968)
=750  \0$aMedical personnel$xSupply and demand$0(DLC) sh 85082994$5IEN-M

=LDR  00617cz  a2200169n  4500
=001  9881222259102441
=005  20201012173832.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004207
=035  \\$a(NLM)98195523850000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x390
=150  \\$aDispensatories as Topic
=450  \\$wnnna$aDispensatories as Topics
=667  \\$ado not confuse with the Publication Type DISPENSATORY
=680  \\$iWorks about systematic description of the drugs and preparations used generally or in a specific setting.
=750  \0$aDispensatories$0(DLC)sh 85038455$5IEN-M

=LDR  01129cz  a2200289n  4500
=001  9881477373502441
=005  20201102122232.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D014167
=035  \\$a(NLM)98194053960000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 62
=072  \\$aF4.$x754.$x720.$x864
=150  \\$aTransference, Psychology
=450  \\$aPsychological Transference
=450  \\$aTransference (Psychology)
=450  \\$wnnna$aPsychological Transferences
=450  \\$wnnna$aPsychology Transference
=450  \\$wnnna$aPsychology Transferences
=450  \\$wnnna$aTransference, Psychological
=450  \\$wnnna$aTransferences (Psychology)
=450  \\$wnnna$aTransferences, Psychological
=450  \\$wnnna$aTransferences, Psychology
=667  \\$ahuman only
=680  \\$iThe unconscious transfer to others (including psychotherapists) of feelings and attitudes which were originally associated with important figures (parents, siblings, etc.) in one's early life.
=688  \\$a2020 (1965); was TRANSFERENCE (PSYCHOLOGY) 1965-2019
=750  \0$aTransference (Psychology)$5IEN$0(DLC)sh 85136914

=LDR  00599cz  a2200181n  4500
=001  9881477373702441
=005  20201102121106.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D029779
=035  \\$a(NLM)98198326100000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x625.$x750
=150  \\$aCupressaceae
=450  \\$aCalocedrus
=450  \\$aTaxodiaceae
=680  \\$iA plant family of the order Pinales, class Pinopsida, division Tracheophyta. They are mainly resinous, aromatic evergreen trees.
=688  \\$a2002
=750  \0$aCupressaceae$0(DLC) sh 85034833$5IEN-M

=LDR  00768cz  a2200217n  4500
=001  9881478457402441
=005  20201106172325.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001325
=035  \\$a(NLM)98196502110000041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x517.$x211.$x215
=150  \\$aAutobiographies as Topic
=450  \\$aAutobiography as Topic
=450  \\$wnnna$aAutobiographies as Topics
=450  \\$wnnna$aas Topic, Autobiographies
=550  \\$aBiographies as Topic
=667  \\$ause only for autobiography as a subject; for autobiographies of persons use the Publication Type AUTOBIOGRAPHY
=680  \\$iWorks about self-described narratives of a person's life.
=688  \\$a2011 (1963)
=750  \0$aAutobiography$0(DLC) sh 85010050$5IEN-M

=LDR  00977cz  a2200241n  4500
=001  9881478672502441
=005  20201103174930.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D014473
=035  \\$a(NLM)98194158120000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x747.$x930
=072  \\$aF2.$x739.$x794.$x942
=150  \\$aUnconscious, Psychology
=450  \\$aPsychological Unconscious
=450  \\$aSubconscious
=450  \\$aUnconscious (Psychology)
=450  \\$wnnna$aPsychology Unconscious
=450  \\$wnnna$aUnconscious, Psychological
=667  \\$a"the unconscious" or unconscious behavior: do not confuse with UNCONSCIOUSNESS, the physiologic loss of consciousness
=680  \\$iThose forces and content of the mind which are not ordinarily available to conscious awareness or to immediate recall.
=688  \\$a2020 (1969); was UNCONCSCIOUS (PSYCHOLOGY) 1969-2019; was SUBCONSCIOUS 1963-1968
=750  \0$aSubconsciousness$0(DLC)sh 85129414$5IEN-M

=LDR  00840cz  a2200229n  4500
=001  9881478757102441
=005  20201106145922.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001240
=035  \\$a(NLM)98199243830000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x658.$x100
=072  \\$aF2.$x784.$x629.$x155
=150  \\$aAspirations, Psychological
=450  \\$wnnna$aAspiration, Psychological
=450  \\$wnnna$aAspiration, Psychology
=450  \\$wnnna$aAspirations, Psychology
=450  \\$wnnna$aPsychological Aspiration
=450  \\$wnnna$aPsychological Aspirations
=680  \\$iStrong desires to accomplish something. This usually pertains to greater values or high ideals.
=688  \\$a2020 (1975); was ASPIRATIONS (PSYCHOLOGY) 1975-2019
=750  \0$iRelated mapping$aLevel of aspiration$0(DLC)sh 85076316$4RM$5IEN-M

=LDR  01069cz  a2200253n  4500
=001  9881478766902441
=005  20201105124053.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066240
=035  \\$a(NLM)983985804500041
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x200.$x885.$x800.$x500
=150  \\$aAnterior Commissure, Brain
=450  \\$aAnterior Cerebellar Commissure
=450  \\$aAnterior Commissure of Brain
=450  \\$wnnna$aAnterior Cerebellar Commissures
=450  \\$wnnna$aBrain Anterior Commissure
=450  \\$wnnna$aCerebellar Commissure, Anterior
=450  \\$wnnna$aCerebellar Commissures, Anterior
=450  \\$wnnna$aCommissure, Anterior Cerebellar
=450  \\$wnnna$aCommissure, Brain Anterior
=680  \\$iBundle of MYELINATED NERVE FIBERS that connects the two CEREBRAL HEMISPHERES in the LAMINA TERMINALIS. It is located ventral to the SEPTAL NUCLEI, and caudal to the median PREOPTIC NUCLEUS.
=688  \\$a2020; was Anterior Cerebellar Commissure 2015-2019
=750  \0$aAnterior commissure$0(DLC)sh 85005519$5IEN-M

=LDR  01095cz  a2200277n  4500
=001  9881478772502441
=005  20201104123054.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000043
=035  \\$a(NLM)98193958520000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x453.$x245.$x100
=150  \\$aAbstracting and Indexing
=450  \\$wnnna$aAbstracting
=450  \\$wnnna$aIndexing
=450  \\$wnnna$aIndexing and Abstracting
=450  \\$wnnna$aIndexing and Abstracting as Topic
=450  \\$aAbstracting and Indexing as Topic
=450  \\$aAbstracting as Topic
=450  \\$aIndexes as Topic
=450  \\$aIndexing as Topic
=667  \\$amedical abstracting & indexing: do not coordinate with MEDICINE; do not confuse with Publication Types ABSTRACTS or MEETING ABSTRACT
=680  \\$iWorks about activities performed to identify concepts and aspects of published information and research reports.
=688  \\$a2008(1963); for INDEXES as topic use REFERENCE BOOKS 1996-1998
=750  \0$aIndexing$0(DLC) sh 85064867$5IEN-M
=750  \0$aAbstracting$0(DLC) sh 85000256$5IEN-M

=LDR  01051nz  a2200193n  4500
=001  9882104696702441
=005  20230109155255.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004490
=035  \\$a(DNLM)D004490
=035  \\$a(NLM)98198426940000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x999
=150  \\$aXenarthra
=450  \\$aCingulata
=450  \\$aEdentata
=680  \\$iA superorder of New World mammals characterized by the absence of incisors and canines from among their teeth, and comprising the ARMADILLOS and the SLOTHS. The superorder is distinguished from all others by what are known as xenarthrous vertebrae (xenos, strange; arthron, joint): there are secondary, and sometimes even more, articulations between the vertebrae of the lumbar series. The superorder in part was formerly called Edentata. (From Random House Unabridged Dictionary, 2d ed; Walker's Mammals of the World, 5th ed, vol. I, p515)
=688  \\$a2022(1963)
=750  \0$aXenarthra$0(DLC)sh 85040951$5IEN-M

=LDR  00694cz  a2200181n  4500
=001  9881478871102441
=005  20201105102716.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000487
=035  \\$a(NLM)98196865020000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x849.$x575.$x188.$x750.$x272
=150  \\$aAllethrins
=450  \\$aAllethrin
=450  \\$aCyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl ester
=680  \\$iSynthetic analogs of the naturally occurring insecticides cinerin, jasmolin, and pyrethrin. (From Merck Index, 11th ed)
=688  \\$a2020(1972)
=750  \0$aAllethrin$0(DLC)sh 85003670$5IEN-M

=LDR  00984cz  a2200229n  4500
=001  9881478871402441
=005  20201104174646.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000329
=035  \\$a(NLM)98197297280000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x219.$x687.$x274
=072  \\$aL1.$x143.$x50
=150  \\$aAdvertising
=450  \\$wnnna$aAdvertisement as Topic
=450  \\$wnnna$aTelemarketing
=450  \\$aAdvertising as Topic
=450  \\$wnnna$aAdvertisings
=667  \\$amedical advertising: do not coordinate with MEDICINE; coordinate with subject of advertising & medium if relevant; do not confuse with Publication Type ADVERTISEMENT
=680  \\$iWorks about the act or practice of calling public attention to a product, service, need, etc., especially by paid announcements in newspapers, magazines, on radio, or on television. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a2008(1963)
=750  \0$aAdvertising$0(DLC) sh 85001086$5IEN

=LDR  00915cz  a2200241n  4500
=001  9881486564102441
=005  20201113170631.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003213
=035  \\$a(NLM)98193832870000041
=040  \\$aDNLM$cDNLM
=060  \0$aBF 319
=072  \\$aF2.$x463.$x425.$x179
=150  \\$aConditioning, Psychological
=450  \\$wnnna$aConditioning, Psychology
=450  \\$wnnna$aPsychological Conditioning
=450  \\$wnnna$aSocial Learning Theory
=450  \\$wnnna$aSocial Learning Theories
=450  \\$wnnna$aTheory, Social Learning
=667  \\$ahuman & animal
=680  \\$iSimple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response.
=688  \\$a2020 (1965); was CONDITIONING (PSYCHOLOGY) 1965-2019; was CONDITIONED LEARNING 1963-1964
=750  \0$aConditioned response$0(DLC)sh 85030776$5IEN-M

=LDR  01505cz  a2200373n  4500
=001  9880364348002441
=005  20141212214125.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x165.$x285
=150  \\$aFocal Adhesions
=450  \\$wnnna$aAdherens Junction, Cell-Matrix
=450  \\$wnnna$aAdherens Junctions, Cell-Matrix
=450  \\$wnnna$aAdhesion, Focal
=450  \\$wnnna$aAdhesion Plaque
=450  \\$aAdhesion Plaques
=450  \\$wnnna$aAdhesions, Focal
=450  \\$wnnna$aCell-Matrix Adherens Junction
=450  \\$aCell-Matrix Adherens Junctions
=450  \\$wnnna$aCell Matrix Adherens Junctions
=450  \\$wnnna$aContact, Focal
=450  \\$wnnna$aContacts, Focal
=450  \\$wnnna$aFocal Adhesion
=450  \\$wnnna$aFocal Contact
=450  \\$aFocal Contacts
=450  \\$wnnna$aJunction, Cell-Matrix Adherens
=450  \\$wnnna$aJunctions, Cell-Matrix Adherens
=450  \\$wnnna$aPlaque, Adhesion
=450  \\$wnnna$aPlaques, Adhesion
=550  \\$wg$aCell-Matrix Junctions
=680  \\$iAn anchoring junction of the cell to a non-cellular substrate. It is composed of a specialized area of the plasma membrane where bundles of the ACTIN CYTOSKELETON terminate and attach to the transmembrane linkers, INTEGRINS, which in turn attach through their extracellular domains to EXTRACELLULAR MATRIX PROTEINS.
=688  \\$a2001
=750  \0$aFocal adhesions$0(DLC)sh2011005663$5IEN-M

=LDR  00938cz  a2200277n  4500
=001  9880364348102441
=005  20141212214124.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x165
=150  \\$aCell-Matrix Junctions
=450  \\$wnnna$aAdhesions, Cell-Matrix
=450  \\$aCell-Matrix Adhesions
=450  \\$wnnna$aCell Matrix Adhesions
=450  \\$wnnna$aCell-Matrix Junction
=450  \\$wnnna$aCell Matrix Junctions
=450  \\$wnnna$aJunction, Cell-Matrix
=450  \\$wnnna$aJunctions, Cell-Matrix
=550  \\$wg$aCell Membrane Structures
=550  \\$wh$aCostameres
=550  \\$wh$aFocal Adhesions
=550  \\$wh$aHemidesmosomes
=680  \\$iSpecialized areas at the CELL MEMBRANE where a cell attaches to the EXTRACELLULAR MATRIX or other substratum.
=688  \\$a2001
=750  \0$aCell-matrix adhesions$0(DLC)sh2011005720$5IEN-M

=LDR  01007cz  a2200229n  4500
=001  9880364348202441
=005  20141212214121.0
=008  000627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x275.$x99
=072  \\$aB3.$x660.$x250.$x150.$x170.$x49
=150  \\$aEnterobacter aerogenes
=450  \\$aAerobacter aerogenes
=450  \\$aKlebsiella aerogenes
=450  \\$wnnna$aKlebsiella mobilus
=550  \\$wg$aEnterobacter
=550  \\$aKlebsiella pneumoniae
=667  \\$ainfection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iGram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections
=688  \\$a2001; for AEROBACTER AEROGENES use KLEBSIELLA PNEUMONIAE 1992-2000 & ENTEROBACTER 1963-1991
=750  \0$aEnterobacter aerogenes$5IEN-M$0(DLC)sh 88023250

=LDR  00671cz  a2200217n  4500
=001  9880364348302441
=005  20141212214118.0
=008  000627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x845
=150  \\$aSafe Sex
=450  \\$aProtected Sex
=450  \\$aResponsible Sex
=450  \\$wnnna$aSex, Protected
=450  \\$wnnna$aSex, Responsible
=450  \\$wnnna$aSex, Safe
=550  \\$wg$aSexual Behavior
=680  \\$iSexual behavior that prevents or reduces the spread of SEXUALLY TRANSMITTED DISEASES or PREGNANCY.
=688  \\$a2001
=750  \0$aSafe sex in AIDS prevention$5IEN-M$0(DLC)sh 86005274

=LDR  02553cz  a2200613n  4500
=001  9880364348402441
=005  20141212214118.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x221.$x500
=150  \\$aCommunicable Diseases, Emerging
=450  \\$wnnna$aCommunicable Disease, Emerging
=450  \\$wnnna$aCommunicable Disease, Re-Emerging
=450  \\$wnnna$aCommunicable Disease, Reemerging
=450  \\$wnnna$aCommunicable Diseases, Re-Emerging
=450  \\$wnnna$aCommunicable Diseases, Re Emerging
=450  \\$wnnna$aCommunicable Diseases, Reemerging
=450  \\$wnnna$aDisease, Emerging Communicable
=450  \\$wnnna$aDisease, Emerging Infectious
=450  \\$wnnna$aDisease, Re-Emerging Communicable
=450  \\$wnnna$aDisease, Re-Emerging Infectious
=450  \\$wnnna$aDisease, Reemerging Communicable
=450  \\$wnnna$aDisease, Reemerging Infectious
=450  \\$wnnna$aDiseases, Emerging Communicable
=450  \\$wnnna$aDiseases, Emerging Infectious
=450  \\$wnnna$aDiseases, Re-Emerging Communicable
=450  \\$wnnna$aDiseases, Re-Emerging Infectious
=450  \\$wnnna$aDiseases, Reemerging Communicable
=450  \\$wnnna$aDiseases, Reemerging Infectious
=450  \\$wnnna$aEmerging Communicable Disease
=450  \\$wnnna$aEmerging Communicable Diseases
=450  \\$wnnna$aEmerging Infectious Disease
=450  \\$wnnna$aEmerging Infectious Diseases
=450  \\$wnnna$aInfectious Disease, Emerging
=450  \\$wnnna$aInfectious Disease, Re-Emerging
=450  \\$wnnna$aInfectious Disease, Reemerging
=450  \\$aInfectious Diseases, Emerging
=450  \\$wnnna$aInfectious Diseases, Re-Emerging
=450  \\$wnnna$aInfectious Diseases, Re Emerging
=450  \\$wnnna$aInfectious Diseases, Reemerging
=450  \\$wnnna$aRe-Emerging Communicable Disease
=450  \\$wnnna$aRe-Emerging Communicable Diseases
=450  \\$wnnna$aRe-Emerging Infectious Disease
=450  \\$wnnna$aRe-Emerging Infectious Diseases
=450  \\$wnnna$aReemerging Communicable Disease
=450  \\$wnnna$aReemerging Communicable Diseases
=450  \\$wnnna$aReemerging Infectious Disease
=450  \\$wnnna$aReemerging Infectious Diseases
=550  \\$wg$aCommunicable Diseases
=550  \\$aZoonoses
=680  \\$iInfectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
=688  \\$a2001
=750  \0$aEmerging infectious diseases$0(DLC) sh2003008316$5IEN-M

=LDR  01031cz  a2200229n  4500
=001  9880364348502441
=005  20141212214116.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021745
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x750
=150  \\$aSarcocystidae
=450  \\$wnnna$aBesnoitia
=450  \\$wnnna$aBesnoitias
=550  \\$wg$aEimeriida
=550  \\$wh$aNeospora
=550  \\$wh$aSarcocystis
=550  \\$wh$aToxoplasma
=667  \\$ainfection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA family of parasitic organisms in the order EIMERIIDAE. They form tissue-cysts in their intermediate hosts, ultimately leading to pathogenesis in the final hosts that includes various mammals (including humans) and birds. The most important genera include NEOSPORA; SARCOCYSTIS; and TOXOPLASMA.
=688  \\$a2001; for BESNOITIA use EIMERIIDA 1992-2000
=750  \0$aSarcocystidae$5IEN-M$0(DLC)sh 88021428

=LDR  00741cz  a2200205n  4500
=001  9880364348602441
=005  20141212214115.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021743
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x250
=150  \\$aEimeriidae
=550  \\$wg$aEimeriida
=550  \\$wh$aCyclospora
=550  \\$wh$aEimeria
=550  \\$wh$aIsospora
=667  \\$ainfection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA large family of parasites in the order EIMERIIDA. They cause COCCIDIOSIS in a number of vertebrates including humans.
=688  \\$a2001
=750  \0$aEimeriidae$5IEN-M$0(DLC)sh 88021323

=LDR  00557cz  a2200169n  4500
=001  9880364348702441
=005  20141212214113.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x706
=150  \\$aRecognition (Psychology)
=450  \\$aFamiliarity
=550  \\$wg$aMemory
=680  \\$iThe knowledge or perception that someone or something present has been previously encountered.
=688  \\$a2001; use MEMORY 1998-2000
=750  \0$aRecognition (Psychology)$5IEN-M$0(DLC)sh 85111840

=LDR  02894cz  a2200661n  4500
=001  9880364348802441
=005  20141212214113.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x400
=072  \\$aL1.$x224.$x308.$x410
=150  \\$aImaging, Three-Dimensional
=450  \\$wnnna$a3-D Image
=450  \\$wnnna$a3 D Image
=450  \\$wnnna$a3-D Images
=450  \\$wnnna$a3-D Imaging
=450  \\$wnnna$a3 D Imaging
=450  \\$wnnna$a3-D Imagings
=450  \\$wnnna$a3D Imaging, Computer-Generated
=450  \\$wnnna$a3D Imagings, Computer-Generated
=450  \\$aComputer-Assisted Three-Dimensional Imaging
=450  \\$wnnna$aComputer Assisted Three Dimensional Imaging
=450  \\$wnnna$aComputer-Assisted Three-Dimensional Imagings
=450  \\$wnnna$aComputer-Generated 3D Imaging
=450  \\$wnnna$aComputer Generated 3D Imaging
=450  \\$wnnna$aComputer-Generated 3D Imagings
=450  \\$wnnna$aImage, 3-D
=450  \\$wnnna$aImage, Three-Dimensional
=450  \\$wnnna$aImages, 3-D
=450  \\$wnnna$aImages, Three-Dimensional
=450  \\$wnnna$aImaging, 3-D
=450  \\$wnnna$aImaging, Computer-Assisted Three-Dimensional
=450  \\$wnnna$aImaging, Computer-Generated 3D
=450  \\$wnnna$aImaging, Three Dimensional
=450  \\$aImaging, Three-Dimensional, Computer Assisted
=450  \\$wnnna$aImagings, 3-D
=450  \\$wnnna$aImagings, Computer-Assisted Three-Dimensional
=450  \\$wnnna$aImagings, Computer-Generated 3D
=450  \\$wnnna$aImagings, Three-Dimensional
=450  \\$wnnna$aThree-Dimensional Image
=450  \\$wnnna$aThree Dimensional Image
=450  \\$wnnna$aThree-Dimensional Images
=450  \\$wnnna$aThree-Dimensional Imaging
=450  \\$wnnna$aThree-Dimensional Imaging, Computer-Assisted
=450  \\$wnnna$aThree-Dimensional Imaging, Computer Generated
=450  \\$wnnna$aThree Dimensional Imaging, Computer Generated
=450  \\$wnnna$aThree-Dimensional Imagings
=450  \\$wnnna$aThree-Dimensional Imagings, Computer-Assisted
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aImage Processing, Computer-Assisted
=550  \\$wh$aEchocardiography, Three-Dimensional
=550  \\$wh$aFour-Dimensional Computed Tomography
=550  \\$wh$aHolography
=550  \\$aAnatomy, Cross-Sectional
=550  \\$aVisible Human Projects
=680  \\$iThe process of generating three-dimensional images by electronic, photographic, or other methods. For example, three-dimensional images can be generated by assembling multiple tomographic images with the aid of a computer, while photographic 3-D images (HOLOGRAPHY) can be made by exposing film to the interference pattern created when two laser light sources shine on an object.
=750  \0$aThree-dimensional imaging$5IEN-M$0(DLC)sh2001000478

=LDR  01034cz  a2200337n  4500
=001  9880364348902441
=005  20141212214111.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x750
=150  \\$aSea Bream
=450  \\$wnnna$aGilthead Bream
=450  \\$wnnna$aGilthead Breams
=450  \\$wnnna$aGilthead Sea Bream
=450  \\$wnnna$aGilthead Sea Breams
=450  \\$wnnna$aGilthead Seabream
=450  \\$wnnna$aGilthead Seabreams
=450  \\$wnnna$aSea Bream, Gilthead
=450  \\$wnnna$aSea Breams
=450  \\$wnnna$aSea Breams, Gilthead
=450  \\$wnnna$aSeabream
=450  \\$wnnna$aSeabream, Gilthead
=450  \\$wnnna$aSeabreams
=450  \\$wnnna$aSeabreams, Gilthead
=450  \\$aSparus aurata
=450  \\$wnnna$aSparus auratus
=550  \\$wg$aPerciformes
=680  \\$iA species of PERCIFORMES commonly used in saline aquaculture.
=688  \\$a2001
=750  \0$aSparus aurata$5IEN-M$0(DLC)sh 85126338

=LDR  00798cz  a2200253n  4500
=001  9880364349002441
=005  20141212214106.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x319.$x150.$x750
=150  \\$aScaphoid Bone
=450  \\$wnnna$aBone, Scaphoid
=450  \\$wnnna$aBones, Scaphoid
=450  \\$wnnna$aHand Navicular Bone
=450  \\$wnnna$aHand Navicular Bones
=450  \\$aNavicular Bone of Hand
=450  \\$wnnna$aOs Naviculare Manus
=450  \\$wnnna$aOs Scaphoideum
=450  \\$wnnna$aScaphoid Bones
=550  \\$wg$aCarpal Bones
=680  \\$iThe bone which is located most lateral in the proximal row of CARPAL BONES.
=688  \\$a2001
=750  \0$aScaphoid bone$5IEN-M$0(DLC)sh 90002815

=LDR  01301cz  a2200349n  4500
=001  9880364349102441
=005  20141212214104.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x53
=150  \\$aAntifreeze Proteins
=450  \\$wnnna$aAFGP
=450  \\$wnnna$aAntifreeze Glycopeptides
=450  \\$aAntifreeze Glycoproteins
=450  \\$wnnna$aAntifreeze Peptides
=450  \\$wnnna$aGlycopeptides, Antifreeze
=450  \\$wnnna$aGlycoproteins, Antifreeze
=450  \\$wnnna$aHysteresis Proteins, Thermal
=450  \\$wnnna$aPeptides, Antifreeze
=450  \\$wnnna$aProteins, Antifreeze
=450  \\$wnnna$aProteins, Thermal Hysteresis
=450  \\$wnnna$aThermal Hysteresis Proteins
=550  \\$wg$aProteins
=550  \\$wh$aAntifreeze Proteins, Type I
=550  \\$wh$aAntifreeze Proteins, Type II
=550  \\$wh$aAntifreeze Proteins, Type III
=550  \\$wh$aAntifreeze Proteins, Type IV
=667  \\$aGEN or unspecified; prefer specific types
=680  \\$iProteins that bind to ice and modify the growth of ice crystals. They perform a cryoprotective role in a variety of organisms.
=688  \\$a2001; use ANTIFREEZE PROTEINS (NM) 1980-2000
=750  \0$aAntifreeze Proteins$5IEN-M$0(DLC)sh2002000819

=LDR  01437cz  a2200349n  4500
=001  9880364349202441
=005  20141212214104.0
=008  000627\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x830.$x500
=072  \\$aG7.$x690.$x830.$x500
=150  \\$aQuantitative Structure-Activity Relationship
=450  \\$wnnna$a3D-QSAR
=450  \\$wnnna$a3D QSAR
=450  \\$wnnna$a3D-QSARs
=450  \\$wnnna$aModeling, QSPR
=450  \\$wnnna$aQSAR
=450  \\$wnnna$aQSPR Modeling
=450  \\$wnnna$aQuantitative Structure Activity Relationship
=450  \\$wnnna$aQuantitative Structure-Activity Relationships
=450  \\$wnnna$aQuantitative Structure Property Relationship
=450  \\$wnnna$aRelationship, Quantitative Structure-Activity
=450  \\$wnnna$aRelationships, Quantitative Structure-Activity
=450  \\$aStructure Activity Relationship, Quantitative
=450  \\$wnnna$aStructure-Activity Relationship, Quantitative
=450  \\$wnnna$aStructure-Activity Relationships, Quantitative
=550  \\$wg$aStructure-Activity Relationship
=667  \\$aDF:QSAR
=680  \\$iA quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds.
=688  \\$a2001
=750  \0$aQSAR (Biochemistry)$5IEN-M$0(DLC)sh 91000992

=LDR  01260cz  a2200205n  4500
=001  9880364349302441
=005  20141212214102.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D021241
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x566.$x600
=150  \\$aSpectrometry, Mass, Electrospray Ionization
=450  \\$aElectrospray Ionization Mass Spectrometry
=450  \\$aESI Mass Spectrometry
=450  \\$wnnna$aMass Spectrometry, ESI
=450  \\$wnnna$aSpectrometry, ESI Mass
=550  \\$wg$aMass Spectrometry
=680  \\$iA mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry.
=688  \\$a2001
=750  \0$aElectrospray ionization mass spectrometry$5IEN-M$0(DLC)sh2001000681

=LDR  01041cz  a2200181n  4500
=001  9880364349402441
=005  20141212213603.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x659.$x633.$x800
=072  \\$aF3.$x870.$x664.$x633.$x800
=150  \\$aSleep Paralysis
=450  \\$aParalysis, Sleep
=550  \\$wg$aREM Sleep Parasomnias
=680  \\$iA common condition characterized by transient partial or total paralysis of skeletal muscles and areflexia that occurs upon awakening from sleep or less often while falling asleep. Stimuli such as touch or sound may terminate the episode, which usually has a duration of seconds to minutes. This condition may occur in normal subjects or be associated with NARCOLEPSY; CATAPLEXY; and hypnagogic HALLUCINATIONS. The pathophysiology of this condition is closely related to the normal hypotonia that occur during REM sleep. (From Adv Neurol 1995;67:245-271)
=688  \\$a2000
=750  \0$aSleep paralysis$5IEN-M$0(DLC)sh 85123409

=LDR  02165cz  a2200385n  4500
=001  9880364349502441
=005  20141212213752.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020435
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x450
=150  \\$aGlossopharyngeal Nerve Diseases
=450  \\$aCranial Nerve IX Diseases
=450  \\$wnnna$aCranial Nerve IX Disorders
=450  \\$wnnna$aGlossopharyngeal Motor Neuropathies
=450  \\$wnnna$aGlossopharyngeal Motor Neuropathy
=450  \\$wnnna$aGlossopharyngeal Nerve Disease
=450  \\$wnnna$aGlossopharyngeal Nerve Sensory Neuropathy
=450  \\$wnnna$aGlossopharyngeal Nerve Taste Disorder
=450  \\$aGlossopharyngeal Neuralgia
=450  \\$wnnna$aGlossopharyngeal Neuralgias
=450  \\$wnnna$aMotor Neuropathies, Glossopharyngeal
=450  \\$wnnna$aMotor Neuropathy, Glossopharyngeal
=450  \\$wnnna$aNeuralgia, Glossopharyngeal
=450  \\$wnnna$aNeuralgias, Glossopharyngeal
=450  \\$aNinth Cranial Nerve Diseases
=450  \\$wnnna$aSensory Neuropathy, Glossopharyngeal Nerve
=450  \\$wnnna$aTaste Disorder, Glossopharyngeal Nerve
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aGlossopharyngeal Nerve Injuries
=550  \\$aCranial Nerve Injuries
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the ninth cranial (glossopharyngeal) nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve's extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. (Adams et al., Principles of Neurology, 6th ed, p1390)
=688  \\$a2000
=750  \0$aGlossopharyngeal nerve$xDiseases$0(IEN)5665461$5IEN-M

=LDR  01614cz  a2200409n  4500
=001  9880364349602441
=005  20141212213620.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020214
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x350
=072  \\$aC10.$x900.$x250
=072  \\$aC14.$x907.$x253.$x535
=072  \\$aC26.$x915.$x200
=150  \\$aCerebrovascular Trauma
=450  \\$wnnna$aBrain Injury, Vascular
=450  \\$wnnna$aBrain Vascular Injury
=450  \\$wnnna$aBrain Vascular Trauma
=450  \\$wnnna$aInjury, Brain Vascular
=450  \\$wnnna$aInjury, Vascular, Brain
=450  \\$wnnna$aInjury, Vascular Brain
=450  \\$wnnna$aTrauma, Brain Vascular
=450  \\$wnnna$aTrauma, Cerebrovascular
=450  \\$wnnna$aVascular Brain Injuries
=450  \\$wnnna$aVascular Brain Injury
=450  \\$aVascular Injury, Brain
=450  \\$wnnna$aVascular Trauma, Brain
=450  \\$wnnna$aVascular Traumas, Brain
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wg$aTrauma, Nervous System
=550  \\$wh$aCarotid Artery Injuries
=550  \\$wh$aSubarachnoid Hemorrhage, Traumatic
=550  \\$wh$aVertebral Artery Dissection
=667  \\$ageneral or unspecified only: prefer specific vessel/inj
=680  \\$iPenetrating and nonpenetrating traumatic injuries to an extracranial or intracranial blood vessel that supplies the brain. This includes the CAROTID ARTERIES; VERTEBRAL ARTERIES; MENINGEAL ARTERIES; CEREBRAL ARTERIES; veins, and venous sinuses.
=688  \\$a2000
=750  \0$aBrain$xBlood-vessels$xWounds and injuries$5IEN-M

=LDR  00320cz  a2200109n  4500
=001  9880364349702441
=005  20090219090650.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D010946Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aPlants, Medicinal$xtherapeutic use
=750  \0$aMateria medica, Vegetable$0(DLC) sh 85082059$5IEN-M

=LDR  02963cz  a2200649n  4500
=001  9880364349802441
=005  20141212213642.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020261
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x720.$x475.$x150
=072  \\$aC25.$x723.$x97
=150  \\$aArsenic Poisoning
=450  \\$wnnna$aArsenic Encephalopathies
=450  \\$wnnna$aArsenic Encephalopathy
=450  \\$wnnna$aArsenic-Induced Polyneuropathies
=450  \\$wnnna$aArsenic Induced Polyneuropathy
=450  \\$wnnna$aArsenic-Induced Polyneuropathy
=450  \\$aArsenic$xpoisoning
=450  \\$wnnna$aArsenic Poisoning, Inorganic
=450  \\$wnnna$aArsenic Poisoning, Nervous System
=450  \\$wnnna$aArsenic Poisoning, Organic
=450  \\$wnnna$aArsenic Poisonings
=450  \\$wnnna$aArsenic Poisonings, Inorganic
=450  \\$wnnna$aArsenic Poisonings, Organic
=450  \\$wnnna$aArsenical Neurotoxicity Syndrome
=450  \\$wnnna$aArsenical Neurotoxicity Syndromes
=450  \\$aArsenicals$xpoisoning
=450  \\$aArsenicals$xtoxicity
=450  \\$wnnna$aEncephalopathies, Arsenic
=450  \\$wnnna$aEncephalopathy, Arsenic
=450  \\$wnnna$aInorganic Arsenic Poisoning
=450  \\$wnnna$aInorganic Arsenic Poisonings
=450  \\$wnnna$aNervous System, Organic Arsenic Poisoning
=450  \\$wnnna$aNervous System Poisoning, Arsenic
=450  \\$wnnna$aNeurotoxicity Syndrome, Arsenical
=450  \\$wnnna$aNeurotoxicity Syndromes, Arsenical
=450  \\$wnnna$aOrganic Arsenic Poisoning
=450  \\$wnnna$aOrganic Arsenic Poisoning, Nervous System
=450  \\$wnnna$aOrganic Arsenic Poisonings
=450  \\$wnnna$aPoisoning, Arsenic
=450  \\$wnnna$aPoisoning, Arsenic, Nervous System
=450  \\$wnnna$aPoisoning, Inorganic Arsenic
=450  \\$wnnna$aPoisoning, Organic Arsenic
=450  \\$wnnna$aPoisonings, Arsenic
=450  \\$wnnna$aPoisonings, Inorganic Arsenic
=450  \\$wnnna$aPoisonings, Organic Arsenic
=450  \\$wnnna$aPolyneuropathy, Arsenic-Induced
=450  \\$wnnna$aPolyneuropathy, Arsenic Induced
=450  \\$wnnna$aSyndrome, Arsenical Neurotoxicity
=450  \\$wnnna$aSyndromes, Arsenical Neurotoxicity
=550  \\$wg$aHeavy Metal Poisoning, Nervous System
=550  \\$wg$aPoisoning
=667  \\$acoord IM with specific arsenic cpd (IM) if given
=680  \\$iDisorders associated with acute or chronic exposure to compounds containing ARSENIC (ARSENICALS) which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse (Mees) lines in the fingernails. (Adams et al., Principles of Neurology, 6th ed, p1212)
=688  \\$a2000
=750  \0$aArsenic$xToxicology$5IEN-M$0(DLC)sh 85007456

=LDR  01568cz  a2200349n  4500
=001  9880364349902441
=005  20141212213544.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x720.$x475.$x500
=072  \\$aC25.$x723.$x618
=150  \\$aManganese Poisoning
=450  \\$aManganese Compounds$xpoisoning
=450  \\$aManganese Compounds$xtoxicity
=450  \\$wnnna$aManganese Neurotoxicity Syndrome
=450  \\$wnnna$aManganese Neurotoxicity Syndromes
=450  \\$aManganese$xpoisoning
=450  \\$aNervous System Diseases, Manganese-Induced
=450  \\$wnnna$aNervous System Diseases, Manganese Induced
=450  \\$aNervous System Poisoning, Manganese
=450  \\$aNeurotoxicity Syndrome, Manganese
=450  \\$wnnna$aNeurotoxicity Syndromes, Manganese
=450  \\$wnnna$aPoisoning, Manganese
=450  \\$wnnna$aSyndrome, Manganese Neurotoxicity
=450  \\$wnnna$aSyndromes, Manganese Neurotoxicity
=550  \\$wg$aHeavy Metal Poisoning, Nervous System
=550  \\$wg$aPoisoning
=667  \\$acoord IM with specific manganese cpd (IM) if given
=680  \\$iManganese poisoning is associated with chronic inhalation of manganese particles by individuals who work with manganese ore. Clinical features include CONFUSION; HALLUCINATIONS; and an extrapyramidal syndrome (PARKINSON DISEASE, SECONDARY) that includes rigidity; DYSTONIA; retropulsion; and TREMOR. (Adams, Principles of Neurology, 6th ed, p1213)
=688  \\$a2000
=750  \0$aManganese$xToxicology$5IEN-M

=LDR  01414cz  a2200373n  4500
=001  9880364350002441
=005  20141212213610.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020196
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x900
=072  \\$aC26.$x915
=150  \\$aTrauma, Nervous System
=450  \\$aCraniocervical Injuries
=450  \\$wnnna$aCraniocervical Injury
=450  \\$wnnna$aInjuries, Craniocervical
=450  \\$wnnna$aInjuries, Nervous System
=450  \\$wnnna$aInjury, Craniocervical
=450  \\$wnnna$aInjury, Nervous System
=450  \\$aNervous System Injuries
=450  \\$aNervous System$xinjuries
=450  \\$wnnna$aNervous System Injury
=450  \\$wnnna$aNervous System Trauma
=450  \\$wnnna$aNervous System Traumas
=550  \\$wg$aNervous System Diseases
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aCerebrovascular Trauma
=550  \\$wh$aCraniocerebral Trauma
=550  \\$wh$aPeripheral Nerve Injuries
=550  \\$wh$aSpinal Cord Injuries
=667  \\$aGEN: prefer specific precoord organ/injuries term or organ/inj; DF: NERVOUS SYSTEM INJ
=680  \\$iTraumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.
=688  \\$a2000
=750  \0$aNervous system$xWounds and injuries$5IEN-M$0(DLC)sh 85090937

=LDR  01312cz  a2200325n  4500
=001  9880364350102441
=005  20141212214017.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020888
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x500.$x350.$x900
=072  \\$aD12.$x125.$x190.$x350.$x900
=150  \\$aVigabatrin
=450  \\$wnnna$aAcid, gamma-Vinyl-gamma-Aminobutyric
=450  \\$wnnna$aAventis Brand of Vigabatrin
=450  \\$wnnna$agamma-Vinyl-GABA
=450  \\$wnnna$agamma Vinyl GABA
=450  \\$agamma-Vinyl-gamma-Aminobutyric Acid
=450  \\$wnnna$agamma Vinyl gamma Aminobutyric Acid
=450  \\$wnnna$aHoechst Brand of Vigabatrin
=450  \\$wnnna$aSabril
=450  \\$wnnna$aSabrilex
=450  \\$wnnna$aVigabatrin Aventis Brand
=450  \\$wnnna$aVigabatrin Hoechst Brand
=450  \\$wnnna$aVigabatrin Yamanouchi Brand
=450  \\$wnnna$aYamanouchi Brand of Vigabatrin
=550  \\$wg$agamma-Aminobutyric Acid
=680  \\$iAn analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID. (From Martindale The Extra Pharmacopoeia, 31st ed)
=688  \\$a2000; use VIGABATRIN 1977-1999
=750  \0$aVigabatrin$5IEN-M$0(DLC)sh 95005039

=LDR  00307cz  a2200109n  4500
=001  9880364350202441
=005  20060427162034.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D009422Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aNervous System Diseases$xgenetics
=750  \0$aNeurogenetics$0(DLC) sh 85091122$5IEN-M

=LDR  01780cz  a2200337n  4500
=001  9880364350302441
=005  20141212214050.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020961
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x862.$x400
=072  \\$aC10.$x228.$x140.$x380.$x422
=072  \\$aC10.$x228.$x662.$x600.$x200
=072  \\$aC10.$x574.$x531
=072  \\$aF3.$x87.$x400.$x512
=150  \\$aLewy Body Disease
=450  \\$wnnna$aCortical Lewy Body Disease
=450  \\$aDementia, Lewy Body
=450  \\$aDiffuse Lewy Body Disease
=450  \\$wnnna$aLewy Body Dementia
=450  \\$wnnna$aLewy Body Disease, Cortical
=450  \\$wnnna$aLewy Body Disease, Diffuse
=450  \\$wnnna$aLewy Body Type Senile Dementia
=550  \\$wg$aDementia
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wg$aParkinsonian Disorders
=550  \\$aLewy Bodies
=667  \\$aLEWY BODY PARKINSON DISEASE see PARKINSON DISEASE is also available
=680  \\$iA neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
=688  \\$a2000; use PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE & LEWY BODY DISEASE, DIFFUSE use PARKINSON DISEASE 1992-1999
=750  \0$aLewy body dementia$5IEN-M$0(DLC)sh 96004033

=LDR  01200cz  a2200361n  4500
=001  9880364350402441
=005  20141212192958.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020954
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x750
=072  \\$aI1.$x880.$x853.$x150.$x750
=150  \\$aSingle-Parent Family
=450  \\$wnnna$aFamilies, One Parent
=450  \\$wnnna$aFamilies, One-Parent
=450  \\$wnnna$aFamilies, Single Parent
=450  \\$wnnna$aFamilies, Single-Parent
=450  \\$wnnna$aFamily, One Parent
=450  \\$wnnna$aFamily, One-Parent
=450  \\$aFamily, Single-Parent
=450  \\$wnnna$aFamily, Single Parent
=450  \\$wnnna$aOne Parent Families
=450  \\$wnnna$aOne-Parent Families
=450  \\$wnnna$aOne Parent Family
=450  \\$aOne-Parent Family
=450  \\$wnnna$aSingle Parent Families
=450  \\$wnnna$aSingle-Parent Families
=450  \\$wnnna$aSingle Parent Family
=550  \\$wg$aFamily
=550  \\$aSingle Parent
=680  \\$iA household that includes children and is headed by one adult.
=688  \\$a2000; use SINGLE PARENT (1989-1999)
=750  \0$aSingle-parent families$5IEN-M$0(DLC)sh 85122844

=LDR  00301cz  a2200109n  4500
=001  9880364350502441
=005  20120717143649.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D001766Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aBlindness$xveterinary
=750  \0$aBlindness in animals$5IEN-M$0(DLC)sh 98004879

=LDR  01068cz  a2200301n  4500
=001  9880364350602441
=005  20141212213828.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020558
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x330
=150  \\$aGTP Phosphohydrolases
=450  \\$wnnna$aGTP Phosphohydrolase
=450  \\$aGTPase
=450  \\$aGTPases
=450  \\$aGuanosine Triphosphate Phosphohydrolases
=450  \\$aGuanosinetriphosphatases
=450  \\$wnnna$aPhosphohydrolase, GTP
=450  \\$wnnna$aPhosphohydrolases, GTP
=450  \\$wnnna$aPhosphohydrolases, Guanosine Triphosphate
=450  \\$wnnna$aTriphosphate Phosphohydrolases, Guanosine
=550  \\$wg$aAcid Anhydride Hydrolases
=550  \\$wh$aDynamins
=550  \\$wh$aGTP-Binding Proteins
=667  \\$aGTP PHOSPHOHYDROLASE ACTIVATORS is available
=680  \\$iEnzymes that hydrolyze GTP to GDP. EC 3.6.1.-.
=688  \\$a2000; for GTP PHOSPHOHYDROLASE use GTP PHOSPHOHYDROLASES 1975-1999
=750  \0$aGuanosine triphosphatase$5IEN$0(DLC)sh 93000026

=LDR  02702cz  a2200649n  4500
=001  9880364350702441
=005  20190419142241.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020794
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400
=072  \\$aD12.$x776.$x543.$x750.$x60
=150  \\$aReceptor Protein-Tyrosine Kinases
=450  \\$wnnna$aKinase, Receptor Protein-Tyrosine
=450  \\$wnnna$aKinases, Receptor Protein-Tyrosine
=450  \\$wnnna$aProtein-Tyrosine Kinase Receptor
=450  \\$wnnna$aProtein-Tyrosine Kinase, Receptor
=450  \\$wnnna$aProtein-Tyrosine Kinase Receptors
=450  \\$wnnna$aProtein-Tyrosine Kinases, Receptor
=450  \\$wnnna$aPTK Receptors
=450  \\$wnnna$aReceptor Protein-Tyrosine Kinase
=450  \\$wnnna$aReceptor Protein Tyrosine Kinase
=450  \\$wnnna$aReceptor, Protein-Tyrosine Kinase
=450  \\$wnnna$aReceptor Protein Tyrosine Kinases
=450  \\$aReceptors, Protein-Tyrosine Kinase
=450  \\$wnnna$aReceptors, Protein Tyrosine Kinase
=450  \\$wnnna$aReceptors, PTK
=450  \\$aTyrosine Kinase Linked Receptors
=450  \\$aTyrosine Kinase Receptors
=550  \\$wg$aProtein-Tyrosine Kinases
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aErbB Receptors
=550  \\$wh$afms-Like Tyrosine Kinase 3
=550  \\$wh$aProto-Oncogene Proteins c-kit
=550  \\$wh$aProto-Oncogene Proteins c-met
=550  \\$wh$aProto-Oncogene Proteins c-ret
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 1
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 2
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 3
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 4
=550  \\$wh$aReceptor, IGF Type 1
=550  \\$wh$aReceptor, Insulin
=550  \\$wh$aReceptor, Macrophage Colony-Stimulating Factor
=550  \\$wh$aReceptor, trkA
=550  \\$wh$aReceptor, trkB
=550  \\$wh$aReceptor, trkC
=550  \\$wh$aReceptor Tyrosine Kinase-like Orphan Receptors
=550  \\$wh$aReceptors, Eph Family
=550  \\$wh$aReceptors, Platelet-Derived Growth Factor
=550  \\$wh$aReceptors, TIE
=550  \\$wh$aReceptors, Vascular Endothelial Growth Factor
=667  \\$aDF: PTK RECEPT
=680  \\$iA class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.
=688  \\$a2000
=750  \0$81$wb$iBroader mapping$aProtein-tyrosine kinase$0(DLC)sh 91006259$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aProtein-tyrosine kinase--Receptors$5IEN-M

=LDR  01012cz  a2200253n  4500
=001  9880364350802441
=005  20141212213825.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x760
=072  \\$aA10.$x615.$x550.$x760
=150  \\$aRespiratory Mucosa
=450  \\$wnnna$aEpithelium, Respiratory
=450  \\$wnnna$aMucosa, Respiratory
=450  \\$aRespiratory Epithelium
=550  \\$wg$aMucous Membrane
=550  \\$wg$aRespiratory System
=550  \\$wh$aGoblet Cells
=550  \\$wh$aLaryngeal Mucosa
=550  \\$wh$aNasal Mucosa
=680  \\$iThe mucous membrane lining the RESPIRATORY TRACT, including the NASAL CAVITY; the LARYNX; the TRACHEA; and the BRONCHI tree. The respiratory mucosa consists of various types of epithelial cells ranging from ciliated columnar to simple squamous, mucous GOBLET CELLS, and glands containing both mucous and serous cells.
=688  \\$a2000
=750  \0$aRespiratory mucosa$5IEN-M$0(DLC)sh 88004529

=LDR  01572cz  a2200301n  4500
=001  9880364350902441
=005  20141212214033.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020928
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x567
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x646.$x750
=072  \\$aD12.$x644.$x360.$x450
=072  \\$aD12.$x776.$x476.$x450
=150  \\$aMitogen-Activated Protein Kinases
=450  \\$wnnna$aKinases, Mitogen-Activated Protein
=450  \\$wnnna$aMitogen Activated Protein Kinases
=450  \\$wnnna$aProtein Kinases, Mitogen-Activated
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aProline-Directed Protein Kinases
=550  \\$wg$aProtein-Serine-Threonine Kinases
=550  \\$wh$aExtracellular Signal-Regulated MAP Kinases
=550  \\$wh$aJNK Mitogen-Activated Protein Kinases
=550  \\$wh$ap38 Mitogen-Activated Protein Kinases
=550  \\$aMAP Kinase Signaling System
=680  \\$iA superfamily of PROTEIN-SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES, which in turn are activated by mitogen-activated protein kinase kinase kinases (MAP KINASE KINASE KINASES).
=688  \\$a2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES use CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999
=750  \0$aMitogen-activated protein kinases$0(DLC)sh2005006737$5IEN-M

=LDR  02867cz  a2200637n  4500
=001  9880364351002441
=005  20141212213937.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x190
=072  \\$aC14.$x240.$x850.$x875
=072  \\$aC16.$x131.$x240.$x850.$x875
=072  \\$aC16.$x131.$x666.$x190
=150  \\$aCentral Nervous System Vascular Malformations
=450  \\$wnnna$aArteriovenous Fistula, Dural
=450  \\$wnnna$aArteriovenous Fistulas, Dural
=450  \\$wnnna$aBrain Capillary Telangiectasia
=450  \\$wnnna$aBrain Capillary Telangiectasias
=450  \\$wnnna$aBrain Vascular Malformation
=450  \\$wnnna$aBrain Vascular Malformations
=450  \\$wnnna$aCapillary Telangiectasia, Brain
=450  \\$wnnna$aCapillary Telangiectasia, Pontine
=450  \\$wnnna$aCapillary Telangiectasias, Brain
=450  \\$wnnna$aCapillary Telangiectasias, Pontine
=450  \\$wnnna$aCentral Nervous System Congenital Vascular Malformations
=450  \\$wnnna$aCentral Nervous System Vascular Anomalies
=450  \\$wnnna$aCerebral Embryonic Artery, Persistent
=450  \\$wnnna$aCongenital Vascular Malformations, Central Nevous System
=450  \\$wnnna$aDural Arteriovenous Fistula
=450  \\$wnnna$aDural Arteriovenous Fistulas
=450  \\$wnnna$aEmbryonic Artery, Persistent, Cerebral
=450  \\$wnnna$aMalformation, Brain Vascular
=450  \\$wnnna$aMalformations, Brain Vascular
=450  \\$wnnna$aPersistent Cerebral Embryonic Artery
=450  \\$wnnna$aPontine Capillary Telangiectasia
=450  \\$wnnna$aPontine Capillary Telangiectasias
=450  \\$wnnna$aTelangiectasia, Brain Capillary
=450  \\$wnnna$aTelangiectasia, Pontine Capillary
=450  \\$wnnna$aTelangiectasias, Brain Capillary
=450  \\$wnnna$aTelangiectasias, Pontine Capillary
=450  \\$wnnna$aVascular Anomalies, Central Nervous System
=450  \\$wnnna$aVascular Malformation, Brain
=450  \\$aVascular Malformations, Brain
=450  \\$aVascular Malformations, Central Nervous System
=450  \\$wnnna$aVascular Malformations, Congenital, Nervous System
=550  \\$wg$aNervous System Malformations
=550  \\$wg$aVascular Malformations
=550  \\$wh$aCentral Nervous System Venous Angioma
=550  \\$wh$aHemangioma, Cavernous, Central Nervous System
=550  \\$wh$aIntracranial Arteriovenous Malformations
=550  \\$wh$aSinus Pericranii
=667  \\$ado not confuse x-refs CAPILLARY TELANGIECTASIA, BRAIN and PONTINE CAPILLARY TELANGIECTASIAS with TELANGIECTASIS
=680  \\$iCongenital, inherited, or acquired abnormalities involving ARTERIES; VEINS; or venous sinuses in the BRAIN; SPINAL CORD; and MENINGES.
=688  \\$a2000
=750  \0$aCentral nervous system$xBlood-vessels$xAbnormalities$5IEN-M

=LDR  02210cz  a2200421n  4500
=001  9880364351102441
=005  20141212213732.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020391
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x534.$x500.$x400
=072  \\$aC10.$x668.$x491.$x175.$x500.$x400
=072  \\$aC16.$x320.$x577.$x400
=150  \\$aMuscular Dystrophy, Facioscapulohumeral
=450  \\$wnnna$aAtrophies, Facioscapulohumeral
=450  \\$wnnna$aAtrophy, Facioscapulohumeral
=450  \\$wnnna$aDystrophies, Facioscapulohumeral Muscular
=450  \\$wnnna$aDystrophies, Landouzy-Dejerine
=450  \\$wnnna$aDystrophy, Facioscapulohumeral Muscular
=450  \\$wnnna$aDystrophy, Landouzy-Dejerine
=450  \\$wnnna$aFacio-Scapulo-Humeral Dystrophy
=450  \\$wnnna$aFacioscapulohumeral Atrophies
=450  \\$wnnna$aFacioscapulohumeral Atrophy
=450  \\$wnnna$aFacioscapulohumeral Muscular Dystrophies
=450  \\$aFacioscapulohumeral Muscular Dystrophy
=450  \\$wnnna$aFacioscapulohumeral Type Progressive Muscular Dystrophy
=450  \\$wnnna$aFacioscapuloperoneal Muscular Dystrophy
=450  \\$wnnna$aFSH Muscular Dystrophy
=450  \\$wnnna$aLandouzy-Dejerine Dystrophies
=450  \\$aLandouzy-Dejerine Dystrophy
=450  \\$wnnna$aLandouzy Dejerine Dystrophy
=450  \\$wnnna$aMuscular Dystrophies, Facioscapulohumeral
=450  \\$wnnna$aMuscular Dystrophy, Landouzy Dejerine
=450  \\$wnnna$aProgressive Muscular Dystrophy, Facioscapulohumeral Type
=550  \\$wg$aMuscular Dystrophies
=680  \\$iAn autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)
=688  \\$a2000
=750  \0$aFacioscapulohumeral muscular dystrophy$0(DLC) sh2004000546$5IEN-M

=LDR  01878cz  a2200493n  4500
=001  9880364351202441
=005  20141212192933.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020530
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x317.$x800
=150  \\$aSubthalamus
=450  \\$wnnna$aAnsa Lenticularis Nucleus
=450  \\$wnnna$aCampi Foreli, Nucleus
=450  \\$wnnna$aCampi Forelus, Nucleus
=450  \\$wnnna$aFasciculus, Lenticular
=450  \\$wnnna$aFasciculus, Thalamic
=450  \\$wnnna$aFasciculus Thalamicus
=450  \\$wnnna$aField H Nucleus
=450  \\$wnnna$aField H1, Forel's
=450  \\$wnnna$aField H1 of Forel
=450  \\$wnnna$aField H2, Forel's
=450  \\$wnnna$aForel Field H1
=450  \\$wnnna$aForel Field H2
=450  \\$wnnna$aForeli, Nucleus Campi
=450  \\$wnnna$aForel's Field H1
=450  \\$wnnna$aForels Field H1
=450  \\$wnnna$aForel's Field H2
=450  \\$wnnna$aForels Field H2
=450  \\$wnnna$aForelus, Nucleus Campi
=450  \\$wnnna$aLenticular Fasciculus
=450  \\$wnnna$aNucleus Campi Foreli
=450  \\$wnnna$aNucleus Campi Forelus
=450  \\$aNucleus of Ansa Lenticularis
=450  \\$aNucleus of Field H
=450  \\$wnnna$aThalamic Fasciculus
=450  \\$wnnna$aThalamicus, Fasciculus
=550  \\$wg$aDiencephalon
=550  \\$wh$aEntopeduncular Nucleus
=550  \\$wh$aSubthalamic Nucleus
=550  \\$wh$aZona Incerta
=680  \\$iA transition zone in the anterior part of the diencephalon interposed between the thalamus, hypothalamus, and tegmentum of the mesencephalon. Components of the subthalamus include the SUBTHALAMIC NUCLEUS, zona incerta, nucleus of field H, and the nucleus of ansa lenticularis. The latter contains the ENTOPEDUNCULAR NUCLEUS.
=688  \\$a2000
=750  \0$aSubthalamus$5IEN-M$0(DLC)sh 85129559

=LDR  01335cz  a2200289n  4500
=001  9880364351302441
=005  20141212213913.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020731
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x594.$x480.$x750
=072  \\$aE4.$x14.$x520.$x480.$x750
=072  \\$aE4.$x540.$x825.$x437.$x374
=150  \\$aKeratomileusis, Laser In Situ
=450  \\$wnnna$aIntrastromal Keratomileuses, Laser
=450  \\$wnnna$aIntrastromal Keratomileusis, Laser
=450  \\$wnnna$aLaser-Assisted Stromal In Situ Keratomileusis
=450  \\$wnnna$aLaser Assisted Stromal In Situ Keratomileusis
=450  \\$aLaser In Situ Keratomileusis
=450  \\$wnnna$aLaser Intrastromal Keratomileuses
=450  \\$wnnna$aLaser Intrastromal Keratomileusis
=450  \\$aLASIK
=550  \\$wg$aCorneal Surgery, Laser
=667  \\$acoordinate with specific LASER when discussed
=680  \\$iA surgical procedure to correct MYOPIA by CORNEAL STROMA subtraction. It involves the use of a microkeratome to make a lamellar dissection of the CORNEA creating a flap with intact CORNEAL EPITHELIUM. After the flap is lifted, the underlying midstroma is reshaped with an EXCIMER LASER and the flap is returned to its original position.
=688  \\$a2000
=750  \0$aLASIK (Eye surgery)$5IEN-M$0(DLC)sh 99011761

=LDR  03136cz  a2200553n  4500
=001  9880364351402441
=005  20141212213730.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x534.$x500.$x300
=072  \\$aC10.$x668.$x491.$x175.$x500.$x300
=072  \\$aC16.$x320.$x322.$x562
=072  \\$aC16.$x320.$x577.$x300
=150  \\$aMuscular Dystrophy, Duchenne
=450  \\$aBecker Muscular Dystrophy
=450  \\$wnnna$aBecker's Muscular Dystrophy
=450  \\$wnnna$aCardiomyopathy, Dilated, 3B
=450  \\$wnnna$aCardiomyopathy, Dilated, X-Linked
=450  \\$wnnna$aChildhood Muscular Dystrophy, Pseudohypertrophic
=450  \\$wnnna$aChildhood Pseudohypertrophic Muscular Dystrophy
=450  \\$wnnna$aDuchenne and Becker Muscular Dystrophy
=450  \\$wnnna$aDuchenne-Becker Muscular Dystrophy
=450  \\$wnnna$aDuchenne Becker Muscular Dystrophy
=450  \\$aDuchenne Muscular Dystrophy
=450  \\$wnnna$aDuchenne-Type Progressive Muscular Dystrophy
=450  \\$wnnna$aDuchenne Type Progressive Muscular Dystrophy
=450  \\$aMuscular Dystrophy, Becker
=450  \\$wnnna$aMuscular Dystrophy, Becker Type
=450  \\$wnnna$aMuscular Dystrophy, Becker's
=450  \\$wnnna$aMuscular Dystrophy, Childhood, Pseudohypertrophic
=450  \\$wnnna$aMuscular Dystrophy, Duchenne and Becker Types
=450  \\$wnnna$aMuscular Dystrophy, Duchenne-Becker
=450  \\$wnnna$aMuscular Dystrophy, Duchenne Type
=450  \\$aMuscular Dystrophy, Pseudohypertrophic
=450  \\$wnnna$aMuscular Dystrophy, Pseudohypertrophic, Childhood
=450  \\$wnnna$aMuscular Dystrophy Pseudohypertrophic Progressive, Becker Type
=450  \\$wnnna$aMuscular Dystrophy, Pseudohypertrophic Progressive, Becker Type
=450  \\$wnnna$aMuscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type
=450  \\$wnnna$aProgressive Muscular Dystrophy, Duchenne Type
=450  \\$wnnna$aPseudohypertrophic Childhood Muscular Dystrophy
=450  \\$wnnna$aPseudohypertrophic Muscular Dystrophy
=450  \\$wnnna$aPseudohypertrophic Muscular Dystrophy, Childhood
=550  \\$wg$aGenetic Diseases, X-Linked
=550  \\$wg$aMuscular Dystrophies
=550  \\$aDystrophin
=680  \\$iAn X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
=688  \\$a2000; use MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER & BECKER MUSCULAR DYSTROPHY use MUSCULAR DYSTROPHIES 1991-1999
=750  \0$aBecker muscular dystrophy$5IEN-M$0(DLC)sh 89005203

=LDR  01083cz  a2200289n  4500
=001  9880364351502441
=005  20141212213951.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020811
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x115
=150  \\$aBiomedical Technology
=450  \\$wnnna$aBiomedical Technologies
=450  \\$aHealth Care Technology
=450  \\$aHealth Technology
=450  \\$wnnna$aTechnology, Biomedical
=450  \\$wnnna$aTechnology, Health
=450  \\$wnnna$aTechnology, Health Care
=550  \\$wg$aTechnology
=550  \\$wh$aBiomedical Enhancement
=550  \\$wh$aNanomedicine
=550  \\$aBiomedical Engineering
=550  \\$aMedical Informatics
=667  \\$avery general - application of technology to medical problems
=680  \\$iThe application of technology to the solution of medical problems.
=688  \\$a2000; BIOMEDICAL TECHNOLOGY was see TECHNOLOGY, MEDICAL (1991-1999); HEALTH CARE TECHNOLOGY & HEALTH TECHNOLOGY see TECHNOLOGY, MEDICAL (1998-1999)
=750  \0$aMedical technology$0(DLC) sh 85083046$5IEN-M

=LDR  01398cz  a2200265n  4500
=001  9880364351602441
=005  20141212213752.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020436
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x175
=150  \\$aAccessory Nerve Diseases
=450  \\$wnnna$aAccessory Nerve Disease
=450  \\$wnnna$aCranial Nerve Eleven Diseases
=450  \\$wnnna$aCranial Nerve Eleven Disorders
=450  \\$aCranial Nerve XI Diseases
=450  \\$aEleventh Cranial Nerve Disease
=450  \\$aSpinal Accessory Nerve Diseases
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aAccessory Nerve Injuries
=550  \\$aCranial Nerve Injuries
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the eleventh cranial (spinal accessory) nerve. This nerve originates from motor neurons in the lower medulla (accessory portion of nerve) and upper spinal cord (spinal portion of nerve). The two components of the nerve join and exit the skull via the jugular foramen, innervating the sternocleidomastoid and trapezius muscles, which become weak or paralyzed if the nerve is injured. The nerve is commonly involved in MOTOR NEURON DISEASE, and may be injured by trauma to the posterior triangle of the neck.
=688  \\$a2000
=750  \0$aAccessory nerve$xDiseases$0(IEN)5665366$5IEN-M

=LDR  01715cz  a2200409n  4500
=001  9880364351702441
=005  20141212213743.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x887
=150  \\$aVagus Nerve Diseases
=450  \\$aCranial Nerve X Diseases
=450  \\$wnnna$aDisorder, Pneumogastric Nerve
=450  \\$wnnna$aDisorders, Pneumogastric Nerve
=450  \\$wnnna$aMotor Disorder, Vagus Nerve
=450  \\$wnnna$aNeuropathies, Vagus
=450  \\$wnnna$aNeuropathy, Vagus
=450  \\$wnnna$aPneumogastric Nerve Disorder
=450  \\$aPneumogastric Nerve Disorders
=450  \\$aSensory Disorder, Vagus Nerve
=450  \\$aTenth Cranial Nerve Diseases
=450  \\$wnnna$aVagus Nerve Disease
=450  \\$wnnna$aVagus Nerve Disorder
=450  \\$wnnna$aVagus Nerve Disorders
=450  \\$wnnna$aVagus Nerve Motor Disorder
=450  \\$wnnna$aVagus Nerve Sensory Disorder
=450  \\$wnnna$aVagus Neuropathies
=450  \\$wnnna$aVagus Neuropathy
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aVagus Nerve Injuries
=550  \\$wh$aVocal Cord Paralysis
=550  \\$aCranial Nerve Injuries
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the tenth cranial nerve, including brain stem lesions involving its nuclei (solitary, ambiguus, and dorsal motor), nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen.
=688  \\$a2000
=750  \0$aVagus nerve$xDiseases$0(IEN)5681225$5IEN-M

=LDR  00299cz  a2200109n  4500
=001  9880364351802441
=005  20120717143648.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004827Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEpilepsy$xveterinary
=750  \0$aEpilepsy in animals$5IEN-M$0(DLC)sh 98005210

=LDR  02257cz  a2200541n  4500
=001  9880364351902441
=005  20141212213702.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x900
=072  \\$aC14.$x907.$x253.$x951
=150  \\$aVasospasm, Intracranial
=450  \\$wnnna$aAngiospasm, Cerebral
=450  \\$aAngiospasm, Intracranial
=450  \\$wnnna$aAngiospasms, Cerebral
=450  \\$wnnna$aAngiospasms, Intracranial
=450  \\$wnnna$aArtery Spasm, Cerebral
=450  \\$wnnna$aArtery Spasms, Cerebral
=450  \\$wnnna$aCerebral Angiospasm
=450  \\$wnnna$aCerebral Angiospasms
=450  \\$wnnna$aCerebral Artery Spasm
=450  \\$wnnna$aCerebral Artery Spasms
=450  \\$aCerebral Vasospasm
=450  \\$wnnna$aCerebral Vasospasms
=450  \\$wnnna$aCerebrovascular Spasm
=450  \\$wnnna$aCerebrovascular Spasms
=450  \\$wnnna$aIntracranial Angiospasm
=450  \\$wnnna$aIntracranial Angiospasms
=450  \\$wnnna$aIntracranial Vascular Spasm
=450  \\$wnnna$aIntracranial Vascular Spasms
=450  \\$aIntracranial Vasospasm
=450  \\$wnnna$aIntracranial Vasospasms
=450  \\$wnnna$aSpasm, Cerebral Artery
=450  \\$wnnna$aSpasm, Cerebrovascular
=450  \\$wnnna$aSpasm, Intracranial Vascular
=450  \\$wnnna$aSpasms, Cerebral Artery
=450  \\$wnnna$aSpasms, Cerebrovascular
=450  \\$wnnna$aSpasms, Intracranial Vascular
=450  \\$wnnna$aVascular Spasm, Intracranial
=450  \\$wnnna$aVascular Spasms, Intracranial
=450  \\$wnnna$aVasospasm, Cerebral
=450  \\$wnnna$aVasospasms, Cerebral
=450  \\$wnnna$aVasospasms, Intracranial
=550  \\$wg$aCerebrovascular Disorders
=680  \\$iConstriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).
=688  \\$a2000; for CEREBRAL VASOSPASM use CEREBRAL ISCHEMIA, TRANSIENT 1966-1999
=750  \0$aCerebrovascular spasm$5IEN-M$0(DLC)sh 85022127

=LDR  00329cz  a2200109n  4500
=001  9880364352002441
=005  20110721092421.0
=008  940531\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D018798Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aAnemia, Iron-Deficiency$xveterinary
=750  \0$aIron deficiency anemia in animals$0(DLC)sh2008008911$5IEN-M

=LDR  01143cz  a2200301n  4500
=001  9880364352102441
=005  20160801090527.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020849
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x700.$x900.$x775
=150  \\$aRaloxifene Hydrochloride
=450  \\$wnno$aRaloxifene
=450  \\$wnnna$aELi Lilly Brand of Raloxifene
=450  \\$wnnna$aEvista
=450  \\$wnnna$aKeoxifene
=450  \\$wnnna$aKeoxifene Hydrochloride
=450  \\$wnnna$aLY 139481
=450  \\$wnnna$aLY-139481
=450  \\$wnnna$aLY 156758
=450  \\$wnnna$aLY-156758
=450  \\$wnnna$aLY139481
=450  \\$wnnna$aLY156758
=450  \\$wnnna$aRaloxifene HCl
=550  \\$wg$aTamoxifen
=680  \\$iA second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
=688  \\$a2000; use RALOXIFENE (NM) 1983-1999
=750  \0$aRaloxifene$5IEN-M$0(DLC)sh 00009274

=LDR  00542cz  a2200193n  4500
=001  9880364352202441
=005  20141212213903.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020704
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x525
=072  \\$aE7.$x858.$x240.$x525
=150  \\$aLaryngoscopes
=450  \\$wnnna$aLaryngoscope
=550  \\$wg$aEndoscopes
=550  \\$aLaryngoscopy
=680  \\$iEndoscopes for examining the interior of the larynx.
=688  \\$a2000
=750  \0$aLaryngoscopes$5IEN-M$0(DLC)sh 87003032

=LDR  01145cz  a2200229n  4500
=001  9880364352302441
=005  20141212214002.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020838
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x141
=150  \\$aCalendula
=450  \\$wnnna$aCalendula officinali
=450  \\$aCalendula officinalis
=450  \\$wnnna$aCalendulas
=450  \\$wnnna$aofficinali, Calendula
=450  \\$wnnna$aofficinalis, Calendula
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain CAROTENOIDS, essential oils (OILS, VOLATILE), flavonoids, mucilage, SAPONINS, and STEROLS. The plants are used both topically and internally. The common name of Marigold is also used for TAGETES.
=688  \\$a2000
=750  \0$aCalendula (Genus)$5IEN-M$0(DLC)sh 98000287

=LDR  01540cz  a2200397n  4500
=001  9880364352402441
=005  20161024093153.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x164.$x100
=150  \\$aAsperger Syndrome
=450  \\$wnnna$aAsperger Disease
=450  \\$wnnna$aAsperger Disorder
=450  \\$wnnna$aAsperger's Disease
=450  \\$wnnna$aAsperger's Disorder
=450  \\$wnnna$aAspergers Disorder
=450  \\$wnnna$aAsperger's Syndrome
=450  \\$wnnna$aAspergers Syndrome
=450  \\$wnnna$aAsperger Diseases
=450  \\$wnnna$aAsperger Disorders
=450  \\$wnnna$aAsperger's Diseases
=450  \\$wnnna$aAspergers Diseases
=450  \\$wnnna$aDisease, Asperger
=450  \\$wnnna$aDisease, Asperger's
=450  \\$wnnna$aDiseases, Asperger
=450  \\$wnnna$aDiseases, Asperger's
=450  \\$wnnna$aDisorder, Asperger
=450  \\$wnnna$aDisorder, Asperger's
=450  \\$wnnna$aDisorders, Asperger
=450  \\$wnnna$aSyndrome, Asperger
=450  \\$wnnna$aSyndrome, Asperger's
=550  \\$wg$aChild Development Disorders, Pervasive
=680  \\$iA disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted repetitive patterns of behavior. interest, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)
=688  \\$a2000
=750  \0$aAsperger's syndrome$0(DLC) sh 91001353$5IEN-M

=LDR  00535cz  a2200193n  4500
=001  9880364352502441
=005  20141212213857.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020679
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x60
=072  \\$aE7.$x858.$x240.$x60
=150  \\$aArthroscopes
=450  \\$wnnna$aArthroscope
=550  \\$wg$aEndoscopes
=550  \\$aArthroscopy
=680  \\$iEndoscopes for visualizing the interior of a joint.
=688  \\$a2000
=750  \0$aArthroscopes$5IEN-M$0(DLC)sh 87003036

=LDR  00724cz  a2200229n  4500
=001  9880364352602441
=005  20141212214011.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020868
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x203.$x374
=150  \\$aGene Silencing
=450  \\$aGene Inactivation
=450  \\$wnnna$aInactivation, Gene
=450  \\$wnnna$aSilencing, Gene
=550  \\$wg$aEpigenesis, Genetic
=550  \\$wh$aCRISPR-Cas Systems
=550  \\$wh$aRNA Interference
=550  \\$aDNA Methylation
=680  \\$iInterruption or suppression of the expression of a gene at transcriptional or translational levels.
=688  \\$a2000
=750  \0$aGene silencing$5IEN-M$0(DLC)sh 00006759

=LDR  02309cz  a2200601n  4500
=001  9880364352702441
=005  20141212213618.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020209
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262
=072  \\$aC10.$x900.$x300.$x218
=072  \\$aC26.$x260.$x237
=072  \\$aC26.$x915.$x300.$x400
=150  \\$aCranial Nerve Injuries
=450  \\$wnnna$aCranial Nerve Injury
=450  \\$aCranial Nerves$xinjuries
=450  \\$wnnna$aCranial Neuropathies, Traumatic
=450  \\$wnnna$aCranial Neuropathy, Traumatic
=450  \\$wnnna$aInjuries, Cranial Nerve
=450  \\$wnnna$aInjury, Cranial Nerve
=450  \\$wnnna$aNerve Injuries, Cranial
=450  \\$wnnna$aNerve Injury, Cranial
=450  \\$wnnna$aNeuropathies, Traumatic Cranial
=450  \\$wnnna$aNeuropathy, Traumatic Cranial
=450  \\$wnnna$aTraumatic Cranial Neuropathies
=450  \\$wnnna$aTraumatic Cranial Neuropathy
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aCraniocerebral Trauma
=550  \\$wh$aAbducens Nerve Injury
=550  \\$wh$aAccessory Nerve Injuries
=550  \\$wh$aFacial Nerve Injuries
=550  \\$wh$aGlossopharyngeal Nerve Injuries
=550  \\$wh$aHypoglossal Nerve Injuries
=550  \\$wh$aOculomotor Nerve Injuries
=550  \\$wh$aOlfactory Nerve Injuries
=550  \\$wh$aOptic Nerve Injuries
=550  \\$wh$aTrigeminal Nerve Injuries
=550  \\$wh$aTrochlear Nerve Injuries
=550  \\$wh$aVagus Nerve Injuries
=550  \\$wh$aVestibulocochlear Nerve Injuries
=550  \\$aAccessory Nerve Diseases
=550  \\$aGlossopharyngeal Nerve Diseases
=550  \\$aHypoglossal Nerve Diseases
=550  \\$aOculomotor Nerve Diseases
=550  \\$aOlfactory Nerve Diseases
=550  \\$aTrigeminal Nerve Diseases
=550  \\$aVagus Nerve Diseases
=550  \\$aVestibulocochlear Nerve Diseases
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iDysfunction of one or more cranial nerves causally related to a traumatic injury. Penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA; NECK INJURIES; and trauma to the facial region are conditions associated with cranial nerve injuries.
=688  \\$a2000
=750  \0$aNerves, Cranial$xWounds and injuries$5IEN-M

=LDR  00342cz  a2200109n  4500
=001  9880364352802441
=005  20091116104359.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D012749Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aSexually Transmitted Diseases$xveterinary
=750  \0$aSexually transmitted diseases in animals$0(DLC)sh2008004330$5IEN-M

=LDR  00358cz  a2200121n  4500
=001  9880364352902441
=005  20120717143643.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$a(DNLM)D012725Q000523
=040  \\$aDNLM$cDNLM
=150  \\$aSexual Behavior$xpsychology
=450  \\$wnnoa$aSex Behavior$xpsychology$5IEN-HS
=750  \0$aSex (Psychology)$5IEN-M$0(DLC)sh 85120562

=LDR  00314cz  a2200109n  4500
=001  9880364353002441
=005  20080512093953.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D012216Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aRheumatic Diseases$xveterinary
=750  \0$aVeterinary rheumatology$0(DLC) sh 99002548$5IEN-M

=LDR  00814cz  a2200193n  4500
=001  9880364353102441
=005  20141212213837.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020578
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x750
=072  \\$aB3.$x660.$x50.$x800.$x750
=150  \\$aSphingomonas
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wg$aSphingomonadaceae
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, aerobic, rod-shaped bacteria characterized by an outer membrane that contains glycosphingolipids but lacks lipopolysaccharide. They have the ability to degrade a broad range of substituted aromatic compounds.
=688  \\$a2000
=750  \0$aSphingomonas$0(DLC)sh2010009386$5IEN-M

=LDR  00699cz  a2200181n  4500
=001  9880364353202441
=005  20141212213842.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x487.$x500.$x150
=072  \\$aB3.$x660.$x50.$x500.$x500.$x150
=150  \\$aMethylobacterium extorquens
=550  \\$wg$aMethylobacterium
=667  \\$aDF: METHYLOBACT EXTORQUENS
=680  \\$iA species of METHYLOBACTERIUM which can utilize acetate, ethanol, or methylamine as a sole carbon source. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aMethylobacterium extorquens$0(DLC)sh2002000346$5IEN-M

=LDR  00318cz  a2200109n  4500
=001  9880364353302441
=005  20120717143643.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D011634Q000331
=040  \\$aDNLM$cDNLM
=150  \\$aPublic Health$xlegislation & jurisprudence
=750  \0$aPublic health laws$5IEN$0(DLC)sh 85108658

=LDR  02282cz  a2200517n  4500
=001  9880364353402441
=005  20141212213620.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x200.$x345
=072  \\$aC10.$x228.$x140.$x300.$x350.$x500
=072  \\$aC10.$x900.$x250.$x300
=072  \\$aC14.$x907.$x253.$x123.$x345
=072  \\$aC14.$x907.$x253.$x535.$x500
=072  \\$aC26.$x915.$x200.$x200
=150  \\$aCarotid Artery Injuries
=450  \\$wnnna$aArtery Injuries, Carotid
=450  \\$wnnna$aArtery Injury, Carotid
=450  \\$wnnna$aArtery Trauma, Carotid
=450  \\$aCarotid Arteries$xinjuries
=450  \\$wnnna$aCarotid Arteriopathies, Traumatic
=450  \\$wnnna$aCarotid Arteriopathy, Traumatic
=450  \\$aCarotid Artery, Common$xinjuries
=450  \\$aCarotid Artery, External$xinjuries
=450  \\$wnnna$aCarotid Artery Injury
=450  \\$aCarotid Artery, Internal$xinjuries
=450  \\$wnnna$aCarotid Artery Trauma
=450  \\$wnnna$aCarotid False Aneurysm
=450  \\$wnnna$aCarotid False Aneurysms
=450  \\$aCarotid Pseudoaneurysm
=450  \\$wnnna$aFalse Aneurysm, Carotid
=450  \\$wnnna$aInjuries, Carotid Artery
=450  \\$wnnna$aInjury, Carotid Artery
=450  \\$wnnna$aPseudoaneurysm, Carotid
=450  \\$aTrauma, Carotid Artery
=450  \\$wnnna$aTraumatic Carotid Arteriopathy
=550  \\$wg$aCarotid Artery Diseases
=550  \\$wg$aCerebrovascular Trauma
=550  \\$wh$aCarotid Artery, Internal, Dissection
=550  \\$wh$aCarotid-Cavernous Sinus Fistula
=667  \\$acoordinate IM with specific carotid artery (IM) if pertinent
=680  \\$iDamages to the CAROTID ARTERIES caused either by blunt force or penetrating trauma, such as CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damaged carotid arteries can lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and INTERNAL CAROTID ARTERY DISSECTION. (From Am J Forensic Med Pathol 1997, 18:251; J Trauma 1994, 37:473)
=688  \\$a2000; for CAROTID PSEUDOANEURYSM use CAROTID-CAVERNOUS SINUS FISTULA 2000-2007
=688  \\$a2000
=750  \0$aCarotid artery$xWounds and injuries$5IEN-M

=LDR  00320cz  a2200109n  4500
=001  9880364353502441
=005  20120717143643.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004493Q000706
=040  \\$aDNLM$cDNLM
=150  \\$aEducation$xstatistics & numerical data
=750  \0$aEducational statistics$5IEN-M$0(DLC)sh 85041147

=LDR  01533cz  a2200385n  4500
=001  9880364353602441
=005  20141212213852.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020650
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x916.$x39.$x312
=072  \\$aG2.$x607.$x750.$x155.$x249
=072  \\$aJ1.$x897.$x836.$x249.$x249
=150  \\$aCombinatorial Chemistry Techniques
=450  \\$wnnna$aChemistry Technic, Combinatorial
=450  \\$wnnna$aChemistry Technics, Combinatorial
=450  \\$wnnna$aChemistry Technique, Combinatorial
=450  \\$aChemistry Techniques, Combinatorial
=450  \\$wnnna$aCombinatorial Chemistry Technic
=450  \\$wnnna$aCombinatorial Chemistry Technics
=450  \\$wnnna$aCombinatorial Chemistry Technique
=450  \\$wnnna$aTechnic, Combinatorial Chemistry
=450  \\$wnnna$aTechnics, Combinatorial Chemistry
=450  \\$wnnna$aTechnique, Combinatorial Chemistry
=450  \\$aTechniques, Combinatorial Chemistry
=550  \\$wg$aChemistry Techniques, Synthetic
=550  \\$wh$aSELEX Aptamer Technique
=550  \\$aClick Chemistry
=550  \\$aGene Library
=550  \\$aHigh-Throughput Screening Assays
=550  \\$aOligonucleotide Array Sequence Analysis
=550  \\$aPeptide Library
=680  \\$iA technology, in which sets of reactions for solution or solid-phase synthesis, is used to create molecular libraries for analysis of compounds on a large scale.
=688  \\$a2000
=750  \0$aCombinatorial chemistry$5IEN-M$0(DLC)sh 96005121

=LDR  01015cz  a2200205n  4500
=001  9880364353702441
=005  20141212213840.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020594
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x260
=072  \\$aB3.$x660.$x250.$x150.$x160
=150  \\$aEdwardsiella
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aEdwardsiella ictaluri
=550  \\$wh$aEdwardsiella tarda
=667  \\$ainfection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA genus of small, straight gram-negative rods which are facultatively anaerobic, chemoorganotrophic, and usually motile by peritrichous flagella. Members of this genus are usually found in the intestines of cold-blooded animals and in fresh water. They are pathogenic for eels, CATFISHES, and other animals and are rare opportunistic pathogens for humans. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aEdwardsiella$5IEN-M$0(DLC)sh 92002340

=LDR  00618cz  a2200169n  4500
=001  9880364353802441
=005  20141212213836.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020577
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x647.$x825
=072  \\$aB3.$x660.$x50.$x765.$x825
=150  \\$aWolbachia
=550  \\$wg$aRickettsiaceae
=680  \\$iA genus of bacteria comprised of a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. (From Bergey's Manual of Systematic Bacteriology, vol 1, 1984)
=688  \\$a2000
=750  \0$aWolbachia$0(DLC)sh2007001355$5IEN-M

=LDR  01292cz  a2200277n  4500
=001  9880364353902441
=005  20141212214021.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x874.$x500
=150  \\$aTanacetum parthenium
=450  \\$aChrysanthemum parthenium
=450  \\$wnnna$aChrysanthemum partheniums
=450  \\$aFeverfew
=450  \\$wnnna$aFeverfews
=450  \\$wnnna$aparthenium, Chrysanthemum
=450  \\$wnnna$aparthenium, Tanacetum
=450  \\$wnnna$apartheniums, Chrysanthemum
=450  \\$wnnna$apartheniums, Tanacetum
=450  \\$wnnna$aTanacetum partheniums
=550  \\$wg$aTanacetum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAn aromatic perennial plant species that has been used to treat migraines, arthritis, and as a febrifuge. It contains TANNINS, volatile oils (OILS, ESSENTIAL), and sesquiterpene lactones, especially parthenolide.
=688  \\$a2003(2000)
=750  \0$aFeverfew$5IEN-M$0(DLC)sh 86003208

=LDR  01633cz  a2200409n  4500
=001  9880364354002441
=005  20141212213745.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020425
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x650
=150  \\$aRadial Neuropathy
=450  \\$wnnna$aCrutch Palsies
=450  \\$aCrutch Palsy
=450  \\$wnnna$aLesion, Radial Nerve
=450  \\$wnnna$aLesion, Superficial Radial Nerve
=450  \\$wnnna$aLesions, Radial Nerve
=450  \\$wnnna$aNerve Disease, Radial
=450  \\$wnnna$aNerve Diseases, Radial
=450  \\$wnnna$aNerve Lesion, Radial
=450  \\$wnnna$aNerve Lesions, Radial
=450  \\$wnnna$aNeuropathies, Radial
=450  \\$wnnna$aNeuropathy, Radial
=450  \\$wnnna$aPalsies, Crutch
=450  \\$wnnna$aPalsy, Crutch
=450  \\$wnnna$aRadial Nerve Disease
=450  \\$wnnna$aRadial Nerve Diseases
=450  \\$wnnna$aRadial Nerve Lesion
=450  \\$wnnna$aRadial Nerve Lesions
=450  \\$wnnna$aRadial Neuropathies
=450  \\$wnnna$aSaturday Night Palsies
=450  \\$aSaturday Night Palsy
=450  \\$wnnna$aSuperficial Radial Nerve Lesion
=550  \\$wg$aMononeuropathies
=680  \\$iDisease involving the RADIAL NERVE. Clinical features include weakness of elbow extension, elbow flexion, supination of the forearm, wrist and finger extension, and thumb abduction. Sensation may be impaired over regions of the dorsal forearm. Common sites of compression or traumatic injury include the AXILLA and radial groove of the HUMERUS.
=688  \\$a2000
=750  \0$aRadial nerve$xDiseases$5IEN-M

=LDR  02266cz  a2200469n  4500
=001  9880364354102441
=005  20141212213950.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020808
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x105.$x300
=072  \\$aC3.$x752.$x100
=072  \\$aC10.$x228.$x228.$x205.$x300
=150  \\$aCentral Nervous System Protozoal Infections
=450  \\$wnnna$aAmebic Meningoencephalitides
=450  \\$wnnna$aAmebic Meningoencephalitis
=450  \\$wnnna$aCerebral Protozoal Infection
=450  \\$aCerebral Protozoal Infections
=450  \\$wnnna$aInfection, Central Nervous System, Protozoal
=450  \\$wnnna$aInfection, Cerebral Protozoal
=450  \\$wnnna$aInfections, Cerebral Protozoal
=450  \\$wnnna$aInfections, Protozoal, Central Nervous System
=450  \\$wnnna$aMeningoencephalitides, Amebic
=450  \\$wnnna$aMeningoencephalitides, Protozoal
=450  \\$wnnna$aMeningoencephalitis, Amebic
=450  \\$aMeningoencephalitis, Protozoal
=450  \\$wnnna$aProtozoal Infection, Cerebral
=450  \\$aProtozoal Infections, Central Nervous System
=450  \\$wnnna$aProtozoal Infections, Cerebral
=450  \\$wnnna$aProtozoal Meningoencephalitides
=450  \\$wnnna$aProtozoal Meningoencephalitis
=550  \\$wg$aCentral Nervous System Parasitic Infections
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aMalaria, Cerebral
=550  \\$wh$aToxoplasmosis, Cerebral
=550  \\$wh$aToxoplasmosis, Congenital
=667  \\$acoordinate IM with specific protozoan infection (IM) and specific site/disease term (IM) if pertinent
=680  \\$iInfections of the brain, spinal cord, or meninges by single celled organisms of the former subkingdom known as protozoa. The central nervous system may be the primary or secondary site of protozoal infection. These diseases may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.
=688  \\$a2000
=750  \0$81$wb$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632
=750  \0$81$wb$aProtozoan diseases$5IEN-M$0(DLC)sh 88003025
=788  \0$iSearch also under the following headings used together in the same record:$aCentral nervous system--Infections$iand$aProtozoan diseases$5IEN-M

=LDR  00650cz  a2200193n  4500
=001  9880364354202441
=005  20141212192947.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020713
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x99.$x225.$x984
=072  \\$aG6.$x225.$x347.$x984
=072  \\$aG7.$x690.$x320.$x269.$x347.$x984
=150  \\$aVancomycin Resistance
=550  \\$wg$aDrug Resistance, Bacterial
=550  \\$aVancomycin-Resistant Enterococci
=680  \\$iNonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.
=688  \\$a2000
=750  \0$aVancomycin resistance$5IEN-M$0(DLC)sh 98004195

=LDR  01452cz  a2200337n  4500
=001  9880364354302441
=005  20141212213949.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020806
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200
=072  \\$aC1.$x395.$x500
=072  \\$aC10.$x228.$x228.$x180
=150  \\$aCentral Nervous System Bacterial Infections
=450  \\$aBacterial Infections, Central Nervous System
=450  \\$wnnna$aInfections, Bacterial, Central Nervous System
=550  \\$wg$aBacterial Infections
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wh$aBrain Abscess
=550  \\$wh$aEmpyema, Subdural
=550  \\$wh$aEpidural Abscess
=550  \\$wh$aLyme Neuroborreliosis
=550  \\$wh$aMeningitis, Bacterial
=550  \\$wh$aNeurosyphilis
=550  \\$wh$aTuberculosis, Central Nervous System
=667  \\$acoord IM with precoord bacterial infection (IM) and specific site/dis term (IM) if pertinent; DF: CNS BACT INFECT
=680  \\$iBacterial infections of the brain, spinal cord, and meninges, including infections involving the perimeningeal spaces.
=688  \\$a2000
=750  \0$81$wb$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632
=750  \0$81$wb$aBacterial diseases$5IEN-M$0(DLC)sh 85010843
=788  \0$iSearch also under the following headings used together in the same record:$aCentral nervous system--Infections$iand$aBacterial diseases$5IEN-M

=LDR  00990cz  a2200229n  4500
=001  9880364354402441
=005  20141212213926.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020757
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x162.$x125
=072  \\$aC11.$x966.$x75.$x125
=072  \\$aC23.$x888.$x592.$x763.$x941.$x162.$x125
=150  \\$aAmaurosis Fugax
=450  \\$aBlindness, Monocular, Transient
=450  \\$wnnna$aBlindness, Transient Monocular
=450  \\$aMonocular Blindness, Transient
=450  \\$wnnna$aTransient Monocular Blindness
=550  \\$wg$aBlindness
=680  \\$iTransient complete or partial monocular blindness due to retinal ischemia. This may be caused by emboli from the CAROTID ARTERY (usually in association with CAROTID STENOSIS) and other locations that enter the central RETINAL ARTERY. (From Adams et al., Principles of Neurology, 6th ed, p245)
=688  \\$a2000
=750  \0$aAmaurosis fugax$5IEN-M$0(DLC)sh 87005303

=LDR  01939cz  a2200505n  4500
=001  9880364354502441
=005  20141212214030.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020922
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x659.$x700
=072  \\$aF3.$x870.$x664.$x700
=150  \\$aSleep-Wake Transition Disorders
=450  \\$wnnna$aCramp, Nocturnal Leg
=450  \\$wnnna$aCramps, Nocturnal Leg
=450  \\$wnnna$aJactatio Capitis Nocturna
=450  \\$wnnna$aLeg Cramp, Nocturnal
=450  \\$wnnna$aLeg Cramps, Nocturnal
=450  \\$wnnna$aMovement Disorders, Rhythmic Nocturnal
=450  \\$wnnna$aNocturna, Jactatio Capitis
=450  \\$wnnna$aNocturnal Leg Cramp
=450  \\$aNocturnal Leg Cramps
=450  \\$wnnna$aNocturnal Sleep Head Banging
=450  \\$wnnna$aRhythmic Movement Disorders, Nocturnal
=450  \\$aSleep Starts
=450  \\$aSleep Talking
=450  \\$wnnna$aSleep-Wake Transition Disorder
=450  \\$wnnna$aSleep Wake Transition Disorders
=450  \\$wnnna$aSleep-Wake Transitional Disorder
=450  \\$wnnna$aSleep-Wake Transitional Disorders
=450  \\$wnnna$aSleep Wake Transitional Disorders
=450  \\$aSomnolescent Starts
=450  \\$wnnna$aStarts, Sleep
=450  \\$wnnna$aStarts, Somnolescent
=450  \\$wnnna$aTalking, Sleep
=450  \\$wnnna$aTransition Disorder, Sleep-Wake
=450  \\$wnnna$aTransition Disorders, Sleep-Wake
=450  \\$wnnna$aTransition Disorders, Sleep Wake
=450  \\$wnnna$aTransitional Disorder, Sleep-Wake
=450  \\$wnnna$aTransitional Disorders, Sleep-Wake
=450  \\$wnnna$aTransitional Disorders, Sleep Wake
=550  \\$wg$aParasomnias
=680  \\$iParasomnias characterized by behavioral abnormalities that occur during the transition between wakefulness and sleep (or between sleep and wakefulness).
=688  \\$a2000
=750  \0$aSleeptalking$5IEN-M$0(DLC)sh 85123415

=LDR  00960cz  a2200217n  4500
=001  9880364354602441
=005  20141212213819.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x985
=072  \\$aE1.$x370.$x985
=072  \\$aE5.$x200.$x875.$x985
=150  \\$aXenodiagnosis
=450  \\$wnnna$aXenodiagnoses
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aMicrobiological Techniques
=667  \\$apermitted with parasitic diseases as well as microbial infections
=680  \\$iA method for diagnosing a disease in one organism by inoculating the putative causative organism in a second animal of a different species. It has been used for the detection of parasites (Trypanosoma cruzi and Trichinella spiralis) when peripheral blood smears are negative. (Segen, Current Med Talk, 1995)
=688  \\$a2000
=750  \0$aXenodiagnosis$5IEN-M$0(DLC)sh 89005766

=LDR  00990cz  a2200277n  4500
=001  9880364354702441
=005  20141212213916.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020738
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x42.$x500
=072  \\$aD12.$x644.$x276.$x24.$x500
=072  \\$aD12.$x644.$x548.$x11.$x500
=072  \\$aD12.$x776.$x467.$x24.$x500
=072  \\$aD23.$x529.$x24.$x500
=150  \\$aLeptin
=450  \\$wnnna$aGene Product, Ob
=450  \\$wnnna$aGene Product, Obese
=450  \\$wnnna$aOb Gene Product
=450  \\$aOb Protein
=450  \\$wnnna$aObese Gene Product
=450  \\$aObese Protein
=550  \\$wg$aAdipokines
=680  \\$iA 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.
=688  \\$a2000; use LEPTIN (NM) 1995-1999
=750  \0$aLeptin$0(DLC) sh 99005469$5IEN-M

=LDR  01951cz  a2200457n  4500
=001  9880364354802441
=005  20141212213756.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020447
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x659
=072  \\$aF3.$x870.$x664
=150  \\$aParasomnias
=450  \\$wnnna$aBenign Neonatal Sleep Myoclonus
=450  \\$wnnna$aDrunkenness, Sleep
=450  \\$wnnna$aDrunkennesses, Sleep
=450  \\$wnnna$aMyoclonus, Benign Neonatal Sleep
=450  \\$aNeonatal Sleep Myoclonus, Benign
=450  \\$wnnna$aParasomnia
=450  \\$wnnna$aParoxysm, Sleep Sensory
=450  \\$wnnna$aParoxysms, Sleep Sensory
=450  \\$wnnna$aSensory Paroxysm, Sleep
=450  \\$wnnna$aSensory Paroxysms, Sleep
=450  \\$aSleep Drunkenness
=450  \\$wnnna$aSleep Drunkennesses
=450  \\$wnnna$aSleep-Related Abnormal Swallowing Syndrome
=450  \\$wnnna$aSleep Related Abnormal Swallowing Syndrome
=450  \\$wnnna$aSleep Sensory Paroxysm
=450  \\$wnnna$aSleep Sensory Paroxysms
=550  \\$wg$aSleep Disorders
=550  \\$wh$aNocturnal Myoclonus Syndrome
=550  \\$wh$aNocturnal Paroxysmal Dystonia
=550  \\$wh$aREM Sleep Parasomnias
=550  \\$wh$aRestless Legs Syndrome
=550  \\$wh$aSleep Arousal Disorders
=550  \\$wh$aSleep Bruxism
=550  \\$wh$aSleep-Wake Transition Disorders
=667  \\$ado not confuse x-ref BENIGN NEONATAL SLEEP MYOCLONUS with MYOCLONUS, NOCTURNAL and MYOCLONUS, SLEEP see MYOCLONUS
=680  \\$iMovements or behaviors associated with sleep, sleep stages, or partial arousals from sleep that may impair sleep maintenance. Parasomnias are generally divided into four groups: arousal disorders, sleep-wake transition disorders, parasomnias of REM sleep, and nonspecific parasomnias. (From Thorpy, Sleep Disorders Medicine, 1994, p191)
=688  \\$a2000
=750  \0$aSleep movements$5IEN-M$0(DLC)sh 85123408

=LDR  01201cz  a2200337n  4500
=001  9880364354902441
=005  20141212192945.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x750
=072  \\$aA8.$x186.$x211.$x730.$x885.$x750
=150  \\$aSeptum of Brain
=450  \\$wnnna$aArea, Septal
=450  \\$wnnna$aBodies, Paraterminal
=450  \\$wnnna$aBody, Paraterminal
=450  \\$wnnna$aBrain Septum
=450  \\$wnnna$aBrain Septums
=450  \\$wnnna$aParaterminal Bodies
=450  \\$wnnna$aParaterminal Body
=450  \\$wnnna$aRegion, Septal
=450  \\$aSeptal Area
=450  \\$aSeptal Region
=550  \\$wg$aLimbic System
=550  \\$wg$aTelencephalon
=550  \\$wh$aSeptal Nuclei
=550  \\$wh$aSeptum Pellucidum
=667  \\$aSEPTUM PELLUCIDUM is also available
=680  \\$iGRAY MATTER structures of the telencephalon and LIMBIC SYSTEM in the brain, but containing widely varying definitions among authors. Included here is the cortical septal area, subcortical SEPTAL NUCLEI, and the SEPTUM PELLUCIDUM.
=688  \\$a2000
=750  \0$aSeptum (Brain)$5IEN-M$0(DLC)sh 85120125

=LDR  00315cz  a2200109n  4500
=001  9880364355002441
=005  20120717143642.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D010535Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aLaparoscopy$xveterinary
=750  \0$aVeterinary laparoscopic surgery$5IEN-M$0(DLC)sh2001001662

=LDR  00674cz  a2200181n  4500
=001  9880364355102441
=005  20141212213844.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020609
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x260.$x750
=072  \\$aB3.$x660.$x250.$x150.$x160.$x750
=150  \\$aEdwardsiella tarda
=550  \\$wg$aEdwardsiella
=667  \\$ainfection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA species of EDWARDSIELLA distinguished by its hydrogen sulfide production. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aEdwardsiella tarda$5IEN-M$0(DLC)sh 92002341

=LDR  00952cz  a2200205n  4500
=001  9880364355202441
=005  20141212213840.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020593
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x890
=072  \\$aB3.$x660.$x250.$x150.$x910
=150  \\$aXenorhabdus
=450  \\$aXenorhabdus nematophila
=450  \\$wnnna$aXenorhabdus nematophilus
=550  \\$wg$aEnterobacteriaceae
=667  \\$aXENORHABDUS LUMINESCENS see PHOTORHABDUS is also available
=680  \\$iA genus of gram-negative, facultatively anaerobic rod-shaped cells which are motile by peritrichous flagella. Late in the growth cycle, spheroplasts or coccoid bodies occur, resulting from disintegration of the cell wall. The natural habitat is the intestinal lumen of certain nematodes. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aXenorhabdus$5IEN-M$0(DLC)sh 93007241

=LDR  02502cz  a2200625n  4500
=001  9880364355302441
=005  20141212213822.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020533
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x77.$x99
=072  \\$aD27.$x505.$x696.$x377.$x450.$x100
=072  \\$aD27.$x505.$x954.$x248.$x25
=150  \\$aAngiogenesis Inhibitors
=450  \\$wnnna$aAgents, Angiostatic
=450  \\$wnnna$aAgents, Anti-Angiogenetic
=450  \\$wnnna$aAgents, Antiangiogenic
=450  \\$wnnna$aAngiogenesis Factor Inhibitors
=450  \\$wnnna$aAngiogenetic Antagonists
=450  \\$wnnna$aAngiogenetic Inhibitors
=450  \\$aAngiogenic Antagonists
=450  \\$wnnna$aAngiogenic Inhibitors
=450  \\$aAngiostatic Agents
=450  \\$wnnna$aAntagonists, Angiogenetic
=450  \\$wnnna$aAntagonists, Angiogenic
=450  \\$wnnna$aAnti-Angiogenesis Effect
=450  \\$wnnna$aAnti Angiogenesis Effect
=450  \\$wnnna$aAnti-Angiogenesis Effects
=450  \\$wnnna$aAnti Angiogenesis Effects
=450  \\$wnnna$aAnti-Angiogenetic Agents
=450  \\$wnnna$aAnti Angiogenetic Agents
=450  \\$aAnti-Angiogenic Drugs
=450  \\$wnnna$aAnti Angiogenic Drugs
=450  \\$wnnna$aAntiangiogenesis Effect
=450  \\$wnnna$aAntiangiogenesis Effects
=450  \\$wnnna$aAntiangiogenic Agents
=450  \\$wnnna$aDrugs, Anti-Angiogenic
=450  \\$wnnna$aEffect, Anti-Angiogenesis
=450  \\$wnnna$aEffect, Antiangiogenesis
=450  \\$wnnna$aEffects, Anti-Angiogenesis
=450  \\$wnnna$aEffects, Antiangiogenesis
=450  \\$wnnna$aFactor Inhibitors, Angiogenesis
=450  \\$wnnna$aInhibitors, Angiogenesis
=450  \\$wnnna$aInhibitors, Angiogenesis Factor
=450  \\$wnnna$aInhibitors, Angiogenetic
=450  \\$wnnna$aInhibitors, Angiogenic
=450  \\$wnnna$aInhibitors, Neovascularization
=450  \\$aNeovascularization Inhibitors
=550  \\$wg$aAngiogenesis Modulating Agents
=550  \\$wg$aAntineoplastic Agents
=550  \\$wg$aGrowth Inhibitors
=667  \\$anote entry term ANTI-ANGIOGENESIS EFFECT: use only for the anti-angiogenesis effect of a chemical substance
=680  \\$iAgents and endogenous substances that antagonize or inhibit the development of new blood vessels.
=688  \\$a2004(2000); for ANGIOGENESIS FACTOR INHIBITORS use ANGIOGENESIS INHIBITORS (NM) 1981-2003
=750  \0$aNeovascularization inhibitors$5IEN-M$0(DLC)sh 93004625

=LDR  01516cz  a2200433n  4500
=001  9880364355402441
=005  20141212214013.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020879
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613
=072  \\$aC23.$x888.$x592.$x608
=150  \\$aNeuromuscular Manifestations
=450  \\$wnnna$aDisease Manifestation, Muscle
=450  \\$wnnna$aDisease Manifestations, Muscle
=450  \\$wnnna$aManifestation, Muscle Disease
=450  \\$wnnna$aManifestation, Neuromuscular
=450  \\$wnnna$aManifestations, Muscle Disease
=450  \\$wnnna$aManifestations, Neuromuscular
=450  \\$wnnna$aMuscle Disease Manifestation
=450  \\$aMuscle Disease Manifestations
=450  \\$wnnna$aNeuromuscular Manifestation
=450  \\$wnnna$aNeuromuscular Signs and Symptoms
=450  \\$wnnna$aSigns and Symptoms, Neuromuscular
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aFasciculation
=550  \\$wh$aMuscle Cramp
=550  \\$wh$aMuscle Hypertonia
=550  \\$wh$aMuscle Hypotonia
=550  \\$wh$aMuscle Weakness
=550  \\$wh$aMuscular Atrophy
=550  \\$wh$aMyokymia
=550  \\$wh$aMyotonia
=550  \\$wh$aSpasm
=550  \\$wh$aTetany
=667  \\$anot used for indexing
=680  \\$iSigns and symptoms associated with diseases of the muscle, neuromuscular junction, or peripheral nerves.
=688  \\$a2000
=750  \0$aNeuromuscular manifestations of general diseases$5IEN-M$0(DLC)sh 85091149

=LDR  00732cz  a2200181n  4500
=001  9880364355502441
=005  20141212213845.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020613
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x500.$x500
=072  \\$aB3.$x660.$x250.$x150.$x500.$x500
=150  \\$aMorganella morganii
=550  \\$wg$aMorganella
=667  \\$ainfection: coord IM with ENTEROBACTERIACEAE INFECTIONS (IM)
=680  \\$iA species of MORGANELLA formerly classified as a Proteus species. It is found in the feces of humans, dogs, other mammals, and reptiles. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aProteus morganii$5IEN-M$0(DLC)sh 88023306

=LDR  00633cz  a2200181n  4500
=001  9880364355602441
=005  20141212213845.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020614
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x690.$x590
=072  \\$aB3.$x660.$x250.$x21.$x755.$x750
=150  \\$aShewanella putrefaciens
=550  \\$wg$aShewanella
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA species of SHEWANELLA noted for its ability to reduce iron and manganese anaerobically.
=688  \\$a2000
=750  \0$aShewanella putrefaciens$5IEN-M$0(DLC)sh 98005963

=LDR  00552cz  a2200193n  4500
=001  9880364355702441
=005  20141212213857.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020680
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x90
=072  \\$aE7.$x858.$x240.$x90
=150  \\$aBronchoscopes
=450  \\$wnnna$aBronchoscope
=550  \\$wg$aEndoscopes
=550  \\$aBronchoscopy
=680  \\$iEndoscopes for the visualization of the interior of the bronchi.
=688  \\$a2000
=750  \0$aBronchoscopes$5IEN-M$0(DLC)sh 87003024

=LDR  01040cz  a2200217n  4500
=001  9880364355802441
=005  20141212213820.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020527
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x666
=072  \\$aE5.$x595.$x666
=150  \\$aMicroscopy, Scanning Probe
=450  \\$aScanning Probe Microscopy
=550  \\$wg$aMicroscopy
=550  \\$wh$aMicroscopy, Atomic Force
=550  \\$wh$aMicroscopy, Electrochemical, Scanning
=550  \\$wh$aMicroscopy, Scanning Tunneling
=680  \\$iScanning microscopy in which a very sharp probe is employed in close proximity to a surface, exploiting a particular surface-related property. When this property is local topography, the method is atomic force microscopy (MICROSCOPY, ATOMIC FORCE), and when it is local conductivity, the method is scanning tunneling microscopy (MICROSCOPY, SCANNING TUNNELING).
=688  \\$a2000; use MICROSCOPY, ATOMIC FORCE 1999
=750  \0$aScanning probe microscopy$5IEN-M$0(DLC)sh 92001586

=LDR  02772cz  a2200625n  4500
=001  9880364355902441
=005  20141212213912.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x774.$x860.$x625.$x750
=150  \\$aTransurethral Resection of Prostate
=450  \\$aContact Laser Ablation of Prostate
=450  \\$wnnna$aMicrowave Thermotherapy, Transurethral
=450  \\$wnnna$aProstate Resection, Transurethral
=450  \\$wnnna$aProstate Resections, Transurethral
=450  \\$wnnna$aProstate Transurethral Electroresection
=450  \\$wnnna$aProstate Transurethral Electroresections
=450  \\$wnnna$aProstate Transurethral Electrovaporization
=450  \\$wnnna$aProstate Transurethral Electrovaporizations
=450  \\$wnnna$aProstate Transurethral Resection
=450  \\$wnnna$aProstate Transurethral Resections
=450  \\$wnnna$aProstate Transurethral Vaporesection
=450  \\$wnnna$aProstate Transurethral Vaporesections
=450  \\$wnnna$aProstatectomies, Transurethral
=450  \\$aProstatectomy, Transurethral
=450  \\$wnnna$aResection, Transurethral Prostate
=450  \\$wnnna$aResections, Transurethral Prostate
=450  \\$wnnna$aThermotherapies, Transurethral
=450  \\$wnnna$aThermotherapy, Transurethral
=450  \\$wnnna$aThermotherapy, Transurethral Microwave
=450  \\$aTransurethral Electroresection of Prostate
=450  \\$aTransurethral Electrovaporization of Prostate
=450  \\$aTransurethral Microwave Thermotherapy
=450  \\$aTransurethral Needle Ablation of Prostate
=450  \\$wnnna$aTransurethral Prostate Resection
=450  \\$wnnna$aTransurethral Prostate Resections
=450  \\$wnnna$aTransurethral Prostatectomies
=450  \\$wnnna$aTransurethral Prostatectomy
=450  \\$aTransurethral Radiofrequency Thermal Ablation
=450  \\$wnnna$aTransurethral Thermotherapies
=450  \\$aTransurethral Thermotherapy
=450  \\$aTransurethral Ultrasound-Guided Laser-Induced Prostatectomy
=450  \\$wnnna$aTransurethral Ultrasound Guided Laser Induced Prostatectomy
=450  \\$aTransurethral Vaporesection of Prostate
=450  \\$aTransurethral Visual Laser Ablation of Prostate
=450  \\$aTURP
=450  \\$wnnna$aTURPs
=450  \\$aTUVP
=450  \\$aVLAP
=550  \\$wg$aProstatectomy
=667  \\$acoordinate with specific ablation technique if pertinent
=680  \\$iRemoval of all or part of the PROSTATE, often using a cystoscope and/or resectoscope passed through the URETHRA.
=688  \\$a2000; use PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL use PROSTATECTOMY 1992-1999
=750  \0$aProstatectomy, Transurethral$5IEN-M$0(DLC)sh 85107612

=LDR  02065cz  a2200421n  4500
=001  9880364356002441
=005  20141212213550.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x937.$x750
=072  \\$aC16.$x320.$x322.$x828
=072  \\$aC16.$x320.$x565.$x100.$x940.$x750
=072  \\$aC16.$x320.$x565.$x189.$x937.$x750
=072  \\$aC18.$x452.$x132.$x100.$x937.$x500
=072  \\$aC18.$x452.$x648.$x100.$x940.$x500
=072  \\$aC18.$x452.$x648.$x189.$x937.$x500
=150  \\$aOrnithine Carbamoyltransferase Deficiency Disease
=450  \\$wnnna$aDeficiencies, Ornithine Transcarbamylase
=450  \\$wnnna$aDeficiencies, OTC
=450  \\$wnnna$aDeficiency Disease, Ornithine Carbamoyltransferase
=450  \\$wnnna$aDeficiency Disease, Ornithine Transcarbamylase
=450  \\$wnnna$aDeficiency, Ornithine Transcarbamylase
=450  \\$wnnna$aDeficiency, OTC
=450  \\$wnnna$aOrnithine Carbamoyltransferase Deficiency
=450  \\$aOrnithine Carbamoyltransferase$xdeficiency
=450  \\$wnnna$aOrnithine Transcarbamylase Deficiencies
=450  \\$aOrnithine Transcarbamylase Deficiency
=450  \\$aOrnithine Transcarbamylase Deficiency Disease
=450  \\$wnnna$aOrnithine Transcarbamylase Deficiency, Hyperammonemia Due To
=450  \\$wnnna$aOTC Deficiencies
=450  \\$aOTC Deficiency
=550  \\$wg$aGenetic Diseases, X-Linked
=550  \\$wg$aUrea Cycle Disorders, Inborn
=550  \\$aOrnithine Carbamoyltransferase
=680  \\$iAn inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
=688  \\$a2000
=750  \0$aOrnithine carbamoyltransferase deficiency$0(DLC) sh2003008349$5IEN-M

=LDR  01244cz  a2200337n  4500
=001  9880364356102441
=005  20141212214020.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812.$x666.$x249
=150  \\$aKava
=450  \\$wnnna$aKava Kava
=450  \\$wnnna$aKava, Kava
=450  \\$wnnna$aKava Kavas
=450  \\$wnnna$aKavas
=450  \\$wnnna$aKavas, Kava
=450  \\$wnnna$aKawa
=450  \\$wnnna$aKawa Kawa
=450  \\$wnnna$aKawa, Kawa
=450  \\$wnnna$aKawa Kawas
=450  \\$wnnna$aKawas
=450  \\$wnnna$aKawas, Kawa
=450  \\$wnnna$amethysticum, Piper
=450  \\$wnnna$amethysticums, Piper
=450  \\$aPiper methysticum
=450  \\$wnnna$aPiper methysticums
=550  \\$wg$aPiper
=680  \\$iDried rhizome and roots of Piper methysticum, a shrub native to Oceania and known for its anti-anxiety and sedative properties. Heavy usage results in some adverse effects. It contains ALKALOIDS; LACTONES; kawain, methysticin, mucilage, STARCH, and yangonin. Kava is also the name of the pungent beverage prepared from the plant's roots.
=688  \\$a2000
=750  \0$aKava plant$5IEN-M$0(DLC)sh 87007857

=LDR  01951cz  a2200445n  4500
=001  9880364356202441
=005  20141212214020.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249.$x500
=150  \\$aHypericum
=450  \\$aHypericum perforatum
=450  \\$wnnna$aHypericum perforatums
=450  \\$wnnna$aHypericums
=450  \\$wnnna$aJohn's Wort, Saint
=450  \\$wnnna$aJohns Wort, Saint
=450  \\$wnnna$aJohn's Wort, St.
=450  \\$wnnna$aJohns Wort, St.
=450  \\$wnnna$aJohnswort, Saint
=450  \\$wnnna$aJohnswort, St.
=450  \\$wnnna$aperforatum, Hypericum
=450  \\$wnnna$aperforatums, Hypericum
=450  \\$wnnna$aSaint John Wort
=450  \\$wnnna$aSaint John's Wort
=450  \\$aSaint Johns Wort
=450  \\$wnnna$aSaint Johnswort
=450  \\$wnnna$aSt. John Wort
=450  \\$wnnna$aSt. John's Wort
=450  \\$aSt. Johns Wort
=450  \\$wnnna$aSt. Johnswort
=450  \\$wnnna$aWort, Saint John's
=450  \\$wnnna$aWort, Saint Johns
=450  \\$wnnna$aWort, St. John's
=450  \\$wnnna$aWort, St. Johns
=550  \\$wg$aClusiaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iGenus of perennial plants in the family CLUSIACEAE (sometimes classified as Hypericaceae). Herbal and homeopathic preparations are used for depression, neuralgias, and a variety of other conditions. Hypericum contains flavonoids; GLYCOSIDES; mucilage, TANNINS; volatile oils (OILS, ESSENTIAL), hypericin and hyperforin.
=688  \\$a2000; for Hypericum & St. Johns Wort use THEALES 1999
=750  \0$aHypericum$5IEN-M$0(DLC)sh 85063700

=LDR  02250cz  a2200517n  4500
=001  9880364356302441
=005  20141212213959.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x622.$x714
=072  \\$aC23.$x888.$x592.$x636.$x711
=150  \\$aPseudobulbar Palsy
=450  \\$wnnna$aBulbar Palsies, Spastic
=450  \\$wnnna$aBulbar Palsy, Spastic
=450  \\$aDysarthria, Pseudobulbar
=450  \\$wnnna$aDysarthrias, Pseudobulbar
=450  \\$wnnna$aMutism, Pseudobulbar
=450  \\$wnnna$aMutisms, Pseudobulbar
=450  \\$wnnna$aPalsies, Pseudobulbar
=450  \\$wnnna$aPalsies, Spastic Bulbar
=450  \\$wnnna$aPalsy, Pseudobulbar
=450  \\$wnnna$aPalsy, Spastic Bulbar
=450  \\$wnnna$aParalyses, Pseudobulbar
=450  \\$aParalysis, Pseudobulbar
=450  \\$wnnna$aPareses, Pseudobulbar
=450  \\$wnnna$aParesis, Pseudobulbar
=450  \\$wnnna$aPseudobulbar Dysarthria
=450  \\$wnnna$aPseudobulbar Dysarthrias
=450  \\$wnnna$aPseudobulbar Mutism
=450  \\$wnnna$aPseudobulbar Mutisms
=450  \\$wnnna$aPseudobulbar Palsies
=450  \\$wnnna$aPseudobulbar Paralyses
=450  \\$wnnna$aPseudobulbar Paralysis
=450  \\$wnnna$aPseudobulbar Pareses
=450  \\$wnnna$aPseudobulbar Paresis
=450  \\$wnnna$aPseudobulbar Syndrome
=450  \\$wnnna$aPseudobulbar Syndromes
=450  \\$wnnna$aSpastic Bulbar Palsies
=450  \\$aSpastic Bulbar Palsy
=450  \\$wnnna$aSyndrome, Pseudobulbar
=450  \\$wnnna$aSyndromes, Pseudobulbar
=550  \\$wg$aParalysis
=680  \\$iA syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM (i.e., corticobulbar tracts); including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, p489)
=688  \\$a2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR use PARALYSIS 1985-1999
=750  \0$aPseudobulbar paralysis$5IEN-M$0(DLC)sh 85097837

=LDR  03015cz  a2200733n  4500
=001  9880364356402441
=005  20141212213815.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020516
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x100
=150  \\$aBrachial Plexus Neuropathies
=450  \\$aBrachial Plexopathy
=450  \\$wnnna$aBrachial Plexus Disease
=450  \\$wnnna$aBrachial Plexus Diseases
=450  \\$wnnna$aBrachial Plexus Disorder
=450  \\$wnnna$aBrachial Plexus Disorders
=450  \\$wnnna$aBrachial Plexus Neuropathy
=450  \\$wnnna$aDejerine-Klumpke Palsy
=450  \\$wnnna$aDejerine Klumpke Palsy
=450  \\$wnnna$aErb-Duchenne Paralyses
=450  \\$wnnna$aErb-Duchenne Paralysis
=450  \\$wnnna$aErb Duchenne Paralysis
=450  \\$wnnna$aErb Palsy
=450  \\$wnnna$aErb Paralyses
=450  \\$aErb Paralysis
=450  \\$wnnna$aErb's Palsies
=450  \\$wnnna$aErb's Palsy
=450  \\$wnnna$aErbs Palsy
=450  \\$wnnna$aKlumpke Palsy
=450  \\$aKlumpke Paralysis
=450  \\$wnnna$aKlumpke's Palsy
=450  \\$wnnna$aKlumpkes Palsy
=450  \\$wnnna$aLower Brachial Plexus Neuropathy
=450  \\$wnnna$aLower Brachial Plexus Palsy
=450  \\$wnnna$aMiddle Brachial Plexus Neuropathy
=450  \\$wnnna$aNeuropathies, Brachial Plexus
=450  \\$wnnna$aNeuropathy, Brachial Plexus
=450  \\$wnnna$aPalsies, Erb's
=450  \\$wnnna$aPalsy, Dejerine-Klumpke
=450  \\$wnnna$aPalsy, Erb's
=450  \\$wnnna$aPalsy, Klumpke's
=450  \\$wnnna$aParalyses, Erb
=450  \\$wnnna$aParalyses, Erb-Duchenne
=450  \\$wnnna$aParalysis, Erb
=450  \\$wnnna$aParalysis, Erb-Duchenne
=450  \\$wnnna$aParalysis, Klumpke
=450  \\$wnnna$aParalysis of the Lower Brachial Plexus
=450  \\$wnnna$aPlexopathies, Brachial
=450  \\$wnnna$aPlexopathy, Brachial
=450  \\$wnnna$aPlexus Disease, Brachial
=450  \\$wnnna$aPlexus Diseases, Brachial
=450  \\$wnnna$aPlexus Disorder, Brachial
=450  \\$wnnna$aPlexus Disorders, Brachial
=450  \\$wnnna$aPlexus Neuropathies, Brachial
=450  \\$wnnna$aPlexus Neuropathy, Brachial
=450  \\$wnnna$aUpper Brachial Plexus Neuropathy
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aBrachial Plexus Neuritis
=550  \\$aBrachial Plexus
=550  \\$aBrachial Plexus Neuritis
=680  \\$iDiseases of the cervical (and first thoracic) roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation (HYPESTHESIA) in the upper extremity. These disorders may be associated with trauma (including BIRTH INJURIES); THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, pp1351-2)
=688  \\$a2000
=750  \0$aBrachial plexus$xDiseases$5IEN-M$0(DLC)sh 85016237

=LDR  00307cz  a2200109n  4500
=001  9880364356502441
=005  20080520092529.0
=008  680401\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D006570Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aHeterochromatin$xgenetics
=750  \0$aHeterochromatic genes$0(DLC)sh2007020116$5IEN-M

=LDR  01728cz  a2200373n  4500
=001  9880364356602441
=005  20200403143203.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020915
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x525.$x400
=072  \\$aC10.$x720.$x112.$x100.$x500
=072  \\$aC23.$x888.$x592.$x604.$x529.$x400
=072  \\$aC25.$x723.$x705.$x150.$x100.$x500
=072  \\$aC25.$x775.$x100.$x87.$x193.$x100.$x500
=072  \\$aF1.$x700.$x625.$x400
=072  \\$aF3.$x87.$x200.$x125.$x500
=072  \\$aF3.$x900.$x100.$x50.$x500
=150  \\$aKorsakoff Syndrome
=450  \\$wnnna$aKorsakoff Psychoses
=450  \\$aKorsakoff Psychosis
=450  \\$wnnna$aPsychoses, Korsakoff
=450  \\$wnnna$aPsychosis, Korsakoff
=450  \\$wnnna$aSyndrome, Korsakoff
=450  \\$wnnna$aSyndrome, Wernicke-Korsakoff
=450  \\$wnnna$aSyndromes, Wernicke-Korsakoff
=450  \\$aWernicke-Korsakoff Syndrome
=450  \\$wnnna$aWernicke Korsakoff Syndrome
=450  \\$wnnna$aWernicke-Korsakoff Syndromes
=550  \\$wg$aMemory Disorders
=550  \\$wh$aAlcoholic Korsakoff Syndrome
=680  \\$iAn acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. (Adams et al., Principles of Neurology, 6th ed, p1139)
=688  \\$a2000; use ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS use ALCOHOL AMNESTIC DISORDER 1980-1999
=750  \0$aKorsakoff's syndrome$5IEN-M$0(DLC)sh 85073155

=LDR  01271cz  a2200289n  4500
=001  9880364356702441
=005  20141212214044.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020944
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x525
=150  \\$aMilk Thistle
=450  \\$aCarduus marianus
=450  \\$wnnna$amarianum, Silybum
=450  \\$wnnna$amarianums, Silybum
=450  \\$wnnna$amarianus, Carduus
=450  \\$wnnna$aMilk Thistles
=450  \\$aSilybum marianum
=450  \\$wnnna$aSilybum marianums
=450  \\$wnnna$aThistle, Milk
=450  \\$wnnna$aThistles, Milk
=550  \\$wg$aAsteraceae
=550  \\$aSilymarin
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe plant Silybum marianum in the family ASTERACEAE containing the bioflavonoid complex SILYMARIN. For centuries this has been used traditionally to treat liver disease. Silybum marianum (L.) Gaertn. = Carduus marianus L.
=688  \\$a2000
=750  \0$aMilk thistle$5IEN-M$0(DLC)sh 97008688

=LDR  01556cz  a2200409n  4500
=001  9880364356802441
=005  20141212213700.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020300
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x535
=072  \\$aC14.$x907.$x253.$x573
=072  \\$aC23.$x550.$x414.$x913
=150  \\$aIntracranial Hemorrhages
=450  \\$aBrain Hemorrhage
=450  \\$wnnna$aBrain Hemorrhages
=450  \\$wnnna$aHemorrhage, Brain
=450  \\$aHemorrhage, Intracranial
=450  \\$wnnna$aHemorrhage, Posterior Fossa
=450  \\$wnnna$aHemorrhages, Brain
=450  \\$wnnna$aHemorrhages, Intracranial
=450  \\$wnnna$aHemorrhages, Posterior Fossa
=450  \\$wnnna$aIntracranial Hemorrhage
=450  \\$wnnna$aPosterior Fossa Hemorrhage
=450  \\$wnnna$aPosterior Fossa Hemorrhages
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wg$aHemorrhage
=550  \\$wh$aCerebral Hemorrhage
=550  \\$wh$aHematoma, Epidural, Cranial
=550  \\$wh$aHematoma, Subdural
=550  \\$wh$aIntracranial Hemorrhage, Hypertensive
=550  \\$wh$aIntracranial Hemorrhage, Traumatic
=550  \\$wh$aPituitary Apoplexy
=550  \\$wh$aSubarachnoid Hemorrhage
=680  \\$iBleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces.
=688  \\$a2000
=750  \0$aBrain$xHemorrhage$5IEN-M$0(DLC)sh 85016339

=LDR  00936cz  a2200193n  4500
=001  9880364356902441
=005  20141212213837.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020580
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x487.$x500
=072  \\$aB3.$x660.$x50.$x500.$x500
=150  \\$aMethylobacterium
=550  \\$wg$aMethylobacteriaceae
=550  \\$wh$aMethylobacterium extorquens
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM); DF: METHYLOBACT
=680  \\$iA genus of gram-negative, aerobic, facultatively methylotrophic rods occurring singly or occasionally in rosettes. Members of this genus are usually motile and are isolated from soil, dust, fresh water, lake sediments, leaf surfaces, rice, air, and hospital environments. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aMethylobacterium$0(DLC)sh2002000345$5IEN-M

=LDR  00297cz  a2200109n  4500
=001  9880364357002441
=005  20090723093908.0
=008  980101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D014024Q000378
=040  \\$aDNLM$cDNLM
=150  \\$aTissues$xmetabolism
=750  \0$aTissue metabolism$0(DLC) sh 85135590$5IEN-M

=LDR  01717cz  a2200469n  4500
=001  9880364357102441
=005  20141212213922.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x562
=072  \\$aC16.$x131.$x77.$x350.$x712
=072  \\$aC16.$x131.$x831.$x350.$x712
=072  \\$aC16.$x320.$x850.$x250.$x712
=072  \\$aC17.$x800.$x804.$x350.$x712
=072  \\$aC17.$x800.$x827.$x250.$x712
=150  \\$aNeurocutaneous Syndromes
=450  \\$wnnna$aNeurocutaneous Disorder
=450  \\$wnnna$aNeurocutaneous Disorders
=450  \\$wnnna$aNeurocutaneous Syndrome
=450  \\$wnnna$aNeuroectodermal Dysplasia Syndrome
=450  \\$aNeuroectodermal Dysplasia Syndromes
=450  \\$wnnna$aPhacomatoses
=450  \\$aPhacomatosis
=450  \\$aPhakomatoses
=450  \\$wnnna$aPhakomatosis
=450  \\$wnnna$aSyndrome, Neurocutaneous
=450  \\$wnnna$aSyndrome, Neuroectodermal Dysplasia
=450  \\$wnnna$aSyndromes, Neurocutaneous
=450  \\$wnnna$aSyndromes, Neuroectodermal Dysplasia
=550  \\$wg$aEctodermal Dysplasia
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aAtaxia Telangiectasia
=550  \\$wh$aNeurofibromatoses
=550  \\$wh$aNevus, Sebaceous of Jadassohn
=550  \\$wh$aSturge-Weber Syndrome
=550  \\$wh$aTuberous Sclerosis
=550  \\$wh$avon Hippel-Lindau Disease
=667  \\$afor neurocutaneous melanosis, coord with MELANOSIS
=680  \\$iA group of disorders characterized by ectodermal-based malformations and neoplastic growths in the skin, nervous system, and other organs.
=688  \\$a2000
=750  \0$aNeurocutaneous disorders$0(DLC) sh 85091117$5IEN-M

=LDR  03549cz  a2200925n  4500
=001  9880364357202441
=005  20141212213956.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x662.$x300
=150  \\$aDystonic Disorders
=450  \\$wnnna$aAdult-Onset Dystonia
=450  \\$wnnna$aAdult-Onset Dystonias
=450  \\$wnnna$aAdult Onset Dystonias
=450  \\$wnnna$aAdult-Onset Idiopathic Focal Dystonias
=450  \\$wnnna$aAdult Onset Idiopathic Focal Dystonias
=450  \\$wnnna$aAdult-Onset Idiopathic Torsion Dystonias
=450  \\$wnnna$aAdult Onset Idiopathic Torsion Dystonias
=450  \\$wnnna$aAutosomal Dominant Familial Dystonia
=450  \\$wnnna$aAutosomal Recessive Familial Dystonia
=450  \\$wnnna$aChildhood Onset Dystonia
=450  \\$wnnna$aChildhood Onset Dystonias
=450  \\$wnnna$aDystonia, Adult-Onset
=450  \\$wnnna$aDystonia, Childhood Onset
=450  \\$wnnna$aDystonia Disorder
=450  \\$wnnna$aDystonia Disorders
=450  \\$wnnna$aDystonia, Familial
=450  \\$wnnna$aDystonia, Focal
=450  \\$wnnna$aDystonia, Hereditary
=450  \\$wnnna$aDystonia, Idiopathic Familial
=450  \\$wnnna$aDystonia, Primary
=450  \\$wnnna$aDystonia, Psychogenic
=450  \\$wnnna$aDystonia, Secondary
=450  \\$wnnna$aDystonia, Sporadic
=450  \\$wnnna$aDystonias, Adult-Onset
=450  \\$wnnna$aDystonias, Childhood Onset
=450  \\$wnnna$aDystonias, Familial
=450  \\$wnnna$aDystonias, Focal
=450  \\$wnnna$aDystonias, Hereditary
=450  \\$wnnna$aDystonias, Idiopathic Familial
=450  \\$wnnna$aDystonias, Primary
=450  \\$wnnna$aDystonias, Psychogenic
=450  \\$wnnna$aDystonias, Secondary
=450  \\$wnnna$aDystonias, Sporadic
=450  \\$wnnna$aDystonic Disorder
=450  \\$aFamilial Dystonia
=450  \\$wnnna$aFamilial Dystonia, Autosomal Dominant
=450  \\$wnnna$aFamilial Dystonia, Autosomal Recessive
=450  \\$wnnna$aFamilial Dystonia, Idiopathic
=450  \\$wnnna$aFamilial Dystonias
=450  \\$wnnna$aFamilial Dystonias, Idiopathic
=450  \\$aFocal Dystonia
=450  \\$wnnna$aFocal Dystonias
=450  \\$wnnna$aHereditary Dystonia
=450  \\$wnnna$aHereditary Dystonias
=450  \\$wnnna$aIdiopathic Familial Dystonia
=450  \\$wnnna$aIdiopathic Familial Dystonias
=450  \\$wnnna$aPrimary Dystonia
=450  \\$wnnna$aPrimary Dystonias
=450  \\$aPseudodystonia
=450  \\$wnnna$aPseudodystonias
=450  \\$wnnna$aPsychogenic Dystonia
=450  \\$wnnna$aPsychogenic Dystonias
=450  \\$wnnna$aSecondary Dystonia
=450  \\$wnnna$aSecondary Dystonias
=450  \\$wnnna$aSporadic Dystonia
=450  \\$wnnna$aSporadic Dystonias
=450  \\$wnnna$aWriter Cramp
=450  \\$aWriter's Cramp
=450  \\$wnnna$aWriters Cramp
=550  \\$wg$aMovement Disorders
=550  \\$wh$aDystonia Musculorum Deformans
=550  \\$wh$aMeige Syndrome
=550  \\$wh$aTorticollis
=550  \\$aDystonia
=667  \\$aDYSTONIA is also available
=680  \\$iAcquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
=688  \\$a2000
=750  \0$aWriters' cramp$5IEN-M$0(DLC)sh 85148636

=LDR  00724cz  a2200241n  4500
=001  9880364357302441
=005  20141212213904.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020706
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x520
=072  \\$aE7.$x858.$x240.$x520
=150  \\$aLaparoscopes
=450  \\$wnnna$aCelioscope
=450  \\$aCelioscopes
=450  \\$wnnna$aLaparoscope
=450  \\$wnnna$aPeritoneoscope
=450  \\$aPeritoneoscopes
=550  \\$wg$aEndoscopes
=550  \\$aLaparoscopy
=680  \\$iENDOSCOPES for examining the abdominal and pelvic organs in the peritoneal cavity.
=688  \\$a2000; use ENDOSCOPES 1998-1999
=750  \0$aLaparoscopes$5IEN-M$0(DLC)sh 87003074

=LDR  00795cz  a2200217n  4500
=001  9880364357402441
=005  20141212214041.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020939
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x975.$x900.$x444
=150  \\$aGinger
=450  \\$wnnna$aGingers
=450  \\$wnnna$aofficinale, Zingiber
=450  \\$wnnna$aofficinales, Zingiber
=450  \\$aZingiber officinale
=450  \\$wnnna$aZingiber officinales
=550  \\$wg$aZingiberaceae
=680  \\$iDeciduous plant rich in volatile oil (OILS, VOLATILE). It is used as a flavoring agent and has many other uses both internally and topically.
=688  \\$a2000; use ZINGIBERALES 1998-1999, use SPICES 1993-1997
=750  \0$aGinger$5IEN-M$0(DLC)sh 85054971

=LDR  00605cz  a2200193n  4500
=001  9880364357502441
=005  20141212213857.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x220.$x170
=072  \\$aE7.$x858.$x240.$x170
=150  \\$aColposcopes
=450  \\$wnnna$aColposcope
=550  \\$wg$aEndoscopes
=550  \\$aColposcopy
=680  \\$iInstruments inserted into the vagina for examination of the tissues of the vagina and cervix by means of a magnifying lens.
=688  \\$a2000
=750  \0$aColposcopes$5IEN-M$0(DLC)sh 87003043

=LDR  01151cz  a2200241n  4500
=001  9880364357602441
=005  20141212213819.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020524
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x700.$x140.$x800
=150  \\$aThylakoids
=450  \\$aGrana
=450  \\$wnnna$aMembrane, Thylakoid
=450  \\$wnnna$aMembranes, Thylakoid
=450  \\$wnnna$aThylakoid
=450  \\$aThylakoid Membrane
=450  \\$wnnna$aThylakoid Membranes
=550  \\$wg$aChloroplasts
=550  \\$aPhotosynthetic Reaction Center Complex Proteins
=680  \\$iMembranous cisternae of the CHLOROPLAST containing photosynthetic pigments, reaction centers, and the electron-transport chain. Each thylakoid consists of a flattened sac of membrane enclosing a narrow intra-thylakoid space (Lackie and Dow, Dictionary of Cell Biology, 2nd ed). Individual thylakoids are interconnected and tend to stack to form aggregates called grana. They are found in cyanobacteria and all plants.
=688  \\$a2000; for GRANA use CHLOROPLASTS 1979-1999
=750  \0$aThylakoids$5IEN-M$0(DLC)sh 89001418

=LDR  01910cz  a2200517n  4500
=001  9880364357702441
=005  20141212213641.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020258
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x720
=072  \\$aC25.$x723.$x705
=150  \\$aNeurotoxicity Syndromes
=450  \\$wnnna$aEncephalitides, Toxic
=450  \\$wnnna$aEncephalitis, Toxic
=450  \\$wnnna$aEncephalopathies, Toxic
=450  \\$wnnna$aEncephalopathy, Toxic
=450  \\$wnnna$aNervous System Poisoning
=450  \\$wnnna$aNervous System Poisonings
=450  \\$wnnna$aNeurotoxic Disorder
=450  \\$wnnna$aNeurotoxic Disorders
=450  \\$wnnna$aNeurotoxicity Syndrome
=450  \\$wnnna$aNeurotoxin Disease
=450  \\$wnnna$aNeurotoxin Diseases
=450  \\$wnnna$aNeurotoxin Disorder
=450  \\$wnnna$aNeurotoxin Disorders
=450  \\$aPoisoning, Nervous System
=450  \\$wnnna$aPoisonings, Nervous System
=450  \\$wnnna$aSyndrome, Neurotoxicity
=450  \\$wnnna$aSyndromes, Neurotoxicity
=450  \\$wnnna$aToxic Encephalitides
=450  \\$wnnna$aToxic Encephalitis
=450  \\$wnnna$aToxic Encephalopathies
=450  \\$wnnna$aToxic Encephalopathy
=550  \\$wg$aNervous System Diseases
=550  \\$wg$aPoisoning
=550  \\$wh$aAkathisia, Drug-Induced
=550  \\$wh$aAlcohol-Induced Disorders, Nervous System
=550  \\$wh$aBotulism
=550  \\$wh$aDyskinesia, Drug-Induced
=550  \\$wh$aHeavy Metal Poisoning, Nervous System
=550  \\$wh$aMPTP Poisoning
=550  \\$wh$aNeuroleptic Malignant Syndrome
=680  \\$iNeurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.
=688  \\$a2000
=750  \0$aNervous system$xToxicology$5IEN-M

=LDR  02836cz  a2200721n  4500
=001  9880364357802441
=005  20141212213624.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x750
=072  \\$aC10.$x292.$x700.$x475
=072  \\$aC10.$x900.$x300.$x218.$x550
=072  \\$aC11.$x640.$x530
=072  \\$aC26.$x260.$x237.$x650
=072  \\$aC26.$x915.$x300.$x400.$x650
=150  \\$aOptic Nerve Injuries
=450  \\$wnnna$aAvulsion, Optic Nerve
=450  \\$wnnna$aAvulsions, Optic Nerve
=450  \\$wnnna$aContusion, Optic Nerve
=450  \\$wnnna$aContusions, Optic Nerve
=450  \\$wnnna$aCranial Nerve II Injuries
=450  \\$wnnna$aInjuries, Optic Nerve
=450  \\$wnnna$aInjury, Optic Nerve
=450  \\$wnnna$aNerve Avulsion, Optic
=450  \\$wnnna$aNerve Avulsions, Optic
=450  \\$wnnna$aNerve Contusion, Optic
=450  \\$wnnna$aNerve Contusions, Optic
=450  \\$wnnna$aNerve Injuries, Optic
=450  \\$wnnna$aNerve Injury, Optic
=450  \\$wnnna$aNerve Transection, Optic
=450  \\$wnnna$aNerve Transections, Optic
=450  \\$wnnna$aNerve Trauma, Optic
=450  \\$wnnna$aNerve Traumas, Optic
=450  \\$wnnna$aNeuropathies, Traumatic Optic
=450  \\$wnnna$aNeuropathy, Traumatic Optic
=450  \\$wnnna$aOptic Nerve Avulsion
=450  \\$wnnna$aOptic Nerve Avulsions
=450  \\$wnnna$aOptic Nerve Contusion
=450  \\$wnnna$aOptic Nerve Contusions
=450  \\$aOptic Nerve$xinjuries
=450  \\$wnnna$aOptic Nerve Injury
=450  \\$wnnna$aOptic Nerve Transection
=450  \\$wnnna$aOptic Nerve Transections
=450  \\$aOptic Nerve Trauma
=450  \\$wnnna$aOptic Nerve Traumas
=450  \\$wnnna$aOptic Neuropathies, Traumatic
=450  \\$aOptic Neuropathy, Traumatic
=450  \\$wnnna$aSecond Cranial Nerve Injuries
=450  \\$aSecond Cranial Nerve Trauma
=450  \\$wnnna$aTransection, Optic Nerve
=450  \\$wnnna$aTransections, Optic Nerve
=450  \\$wnnna$aTrauma, Optic Nerve
=450  \\$wnnna$aTrauma, Second Cranial Nerve
=450  \\$wnnna$aTraumas, Optic Nerve
=450  \\$wnnna$aTraumatic Optic Neuropathies
=450  \\$wnnna$aTraumatic Optic Neuropathy
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aOptic Nerve Diseases
=550  \\$aCraniocerebral Trauma
=680  \\$iInjuries to the optic nerve induced by a trauma to the face or head. These may occur with closed or penetrating injuries. Relatively minor compression of the superior aspect of orbit may also result in trauma to the optic nerve. Clinical manifestations may include visual loss, PAPILLEDEMA, and an afferent pupillary defect.
=688  \\$a2000
=750  \0$aOptic nerve$xWounds and injuries$5IEN-M$0(DLC)sh 85095134

=LDR  02000cz  a2200397n  4500
=001  9880364357902441
=005  20141212213753.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020437
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x525
=150  \\$aHypoglossal Nerve Diseases
=450  \\$aCranial Nerve XII Diseases
=450  \\$wnnna$aCranial Nerve XII Disorders
=450  \\$wnnna$aHypoglossal Nerve Disease
=450  \\$wnnna$aHypoglossal Nerve Palsies
=450  \\$wnnna$aHypoglossal Nerve Palsy
=450  \\$wnnna$aHypoglossal Neuralgia
=450  \\$wnnna$aHypoglossal Neuralgias
=450  \\$wnnna$aHypoglossal Neuropathies
=450  \\$wnnna$aHypoglossal Neuropathy
=450  \\$wnnna$aNeuralgia, Hypoglossal
=450  \\$wnnna$aNeuralgias, Hypoglossal
=450  \\$wnnna$aNeuropathies, Hypoglossal
=450  \\$wnnna$aNeuropathy, Hypoglossal
=450  \\$wnnna$aPalsies, Hypoglossal Nerve
=450  \\$wnnna$aPalsy, Hypoglossal Nerve
=450  \\$aTwelfth Cranial Nerve Diseases
=450  \\$wnnna$aTwelfth Cranial Nerve Disorder
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wh$aHypoglossal Nerve Injuries
=550  \\$aCranial Nerve Injuries
=667  \\$aneopl: coord IM with CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iDiseases of the twelfth cranial (hypoglossal) nerve or nuclei. The nuclei and fascicles of the nerve are located in the medulla, and the nerve exits the skull via the hypoglossal foramen and innervates the muscles of the tongue. Lower brain stem diseases, including ischemia and MOTOR NEURON DISEASES may affect the nuclei or nerve fascicles. The nerve may also be injured by diseases of the posterior fossa or skull base. Clinical manifestations include unilateral weakness of tongue musculature and lingual dysarthria, with deviation of the tongue towards the side of weakness upon attempted protrusion.
=688  \\$a2000
=750  \0$aHypoglossal nerve$xDiseases$0(IEN)5665463$5IEN-M

=LDR  00522cz  a2200169n  4500
=001  9880364456502441
=005  20141212221417.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055068
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x945
=150  \\$aTerahertz Spectroscopy
=450  \\$wnnna$aSpectroscopy, Terahertz
=550  \\$wg$aSpectrum Analysis
=680  \\$iSpectrum analysis of absorbed or emitted TERAHERTZ RADIATION.
=688  \\$a2009
=750  \0$aTerahertz spectroscopy$0(DLC)sh2007004152$5IEN-M

=LDR  01973cz  a2200589n  4500
=001  9880364456602441
=005  20141212221416.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055051
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x723
=150  \\$aSalt-Tolerant Plants
=450  \\$wnnna$aHalophilic Plant
=450  \\$wnnna$aHalophilic Plants
=450  \\$wnnna$aHalophyte
=450  \\$aHalophytes
=450  \\$wnnna$aHalophytic Plant
=450  \\$wnnna$aHalophytic Plants
=450  \\$wnnna$aPlant, Halophilic
=450  \\$wnnna$aPlant, Halophytic
=450  \\$wnnna$aPlant, Saline-Resistant
=450  \\$wnnna$aPlant, Saline-Tolerant
=450  \\$wnnna$aPlant, Salt-Adapted
=450  \\$wnnna$aPlant, Salt-Resistant
=450  \\$wnnna$aPlant, Salt-Tolerant
=450  \\$wnnna$aPlants, Halophilic
=450  \\$wnnna$aPlants, Halophytic
=450  \\$wnnna$aPlants, Saline-Resistant
=450  \\$wnnna$aPlants, Saline-Tolerant
=450  \\$wnnna$aPlants, Salt-Adapted
=450  \\$wnnna$aPlants, Salt-Resistant
=450  \\$aPlants, Salt-Tolerant
=450  \\$wnnna$aPlants, Salt Tolerant
=450  \\$wnnna$aSaline-Resistant Plant
=450  \\$wnnna$aSaline-Resistant Plants
=450  \\$wnnna$aSaline Resistant Plants
=450  \\$wnnna$aSaline-Tolerant Plant
=450  \\$wnnna$aSaline-Tolerant Plants
=450  \\$wnnna$aSaline Tolerant Plants
=450  \\$wnnna$aSalt-Adapted Plant
=450  \\$wnnna$aSalt-Adapted Plants
=450  \\$wnnna$aSalt Adapted Plants
=450  \\$wnnna$aSalt-Resistant Plant
=450  \\$wnnna$aSalt-Resistant Plants
=450  \\$wnnna$aSalt Resistant Plants
=450  \\$wnnna$aSalt-Tolerant Plant
=450  \\$wnnna$aSalt Tolerant Plants
=550  \\$wg$aPlants
=550  \\$aPlants, Genetically Modified
=680  \\$iPlants that can grow well in soils that have a high SALINITY.
=688  \\$a2009
=750  \0$aSalt-tolerant crops$0(DLC) sh 85116885$5IEN-M

=LDR  00904cz  a2200241n  4500
=001  9880364456702441
=005  20141212221415.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055050
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x265
=072  \\$aG7.$x610.$x240.$x265
=150  \\$aDiet, Gluten-Free
=450  \\$wnnna$aDiet, Gluten Free
=450  \\$wnnna$aDiets, Gluten-Free
=450  \\$aGluten-Free Diet
=450  \\$wnnna$aGluten Free Diet
=450  \\$wnnna$aGluten-Free Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=680  \\$iA diet which is devoid of GLUTENS from WHEAT; BARLEY; RYE; and other wheat-related varieties. The diet is designed to reduce exposure to those proteins in gluten that trigger INFLAMMATION of the small intestinal mucosa in patients with CELIAC DISEASE.
=688  \\$a2009
=750  \0$aGluten-free diet$0(DLC) sh 85055387$5IEN-M

=LDR  00645cz  a2200169n  4500
=001  9880364456802441
=005  20141212221415.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055048
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x400
=150  \\$aIntegrative Medicine
=450  \\$wnnna$aMedicine, Integrative
=550  \\$wg$aMedicine
=680  \\$iThe discipline concerned with using the combination of conventional ALLOPATHIC MEDICINE and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness.
=688  \\$a2009
=750  \0$aIntegrative medicine$0(DLC)sh2003001256$5IEN

=LDR  01320cz  a2200289n  4500
=001  9880364456902441
=005  20141212221413.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055034
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x821
=150  \\$aOsteochondrosis
=450  \\$aKoehler Disease
=450  \\$wnnna$aKoehler's Disease
=450  \\$wnnna$aKoehlers Disease
=450  \\$wnnna$aNavicular Osteochondroses
=450  \\$wnnna$aNavicular Osteochondrosis
=450  \\$aOsgood-Schlatter Disease
=450  \\$wnnna$aOsgood Schlatter Disease
=450  \\$wnnna$aOsteochondroses
=450  \\$wnnna$aOsteochondroses, Navicular
=450  \\$wnnna$aOsteochondrosis, Navicular
=550  \\$wg$aBone Diseases
=550  \\$wh$aSpinal Osteochondrosis
=680  \\$iAny of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).
=688  \\$a2009; use OSTEOCHONDRITIS 1963-2008
=750  \0$aOsteochondrosis$0(DLC) sh 85095963$5IEN-M

=LDR  00925cz  a2200265n  4500
=001  9880364457002441
=005  20141212221412.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055030
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x169
=150  \\$aDrug Users
=450  \\$wnnna$aAbuser, Drug
=450  \\$wnnna$aAbusers, Drug
=450  \\$wnnna$aDrug Abuser
=450  \\$aDrug Abusers
=450  \\$aDrug Addicts
=450  \\$wnnna$aDrug User
=450  \\$wnnna$aUser, Drug
=450  \\$wnnna$aUsers, Drug
=550  \\$wg$aPersons
=667  \\$afor drug users as persons only; for the disorder, use SUBSTANCE-RELATED DISORDERS
=680  \\$iPeople who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.
=688  \\$a2009
=750  \0$aDrug addicts$0(DLC) sh 85089803$5IEN-M

=LDR  01677cz  a2200373n  4500
=001  9880364457102441
=005  20141212221411.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D055028
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x285.$x240
=072  \\$aE5.$x393.$x520.$x500
=072  \\$aE5.$x393.$x661.$x187
=150  \\$aComparative Genomic Hybridization
=450  \\$wnnna$aArray-Based Comparative Genomic Hybridization
=450  \\$wnnna$aArray Based Comparative Genomic Hybridization
=450  \\$wnnna$aArray Comparative Genomic Hybridization
=450  \\$wnnna$aComparative Genome Hybridization
=450  \\$wnnna$aComparative Genome Hybridizations
=450  \\$wnnna$aComparative Genomic Hybridizations
=450  \\$wnnna$aGenome Hybridization, Comparative
=450  \\$wnnna$aGenome Hybridizations, Comparative
=450  \\$wnnna$aGenomic Hybridization, Comparative
=450  \\$wnnna$aGenomic Hybridizations, Comparative
=450  \\$wnnna$aHybridization, Comparative Genome
=450  \\$wnnna$aHybridization, Comparative Genomic
=450  \\$wnnna$aHybridizations, Comparative Genome
=450  \\$wnnna$aHybridizations, Comparative Genomic
=550  \\$wg$aCytogenetic Analysis
=550  \\$wg$aMolecular Diagnostic Techniques
=550  \\$wg$aNucleic Acid Hybridization
=680  \\$iA method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations.
=688  \\$a2009
=750  \0$aComparative genomic hybridization$0(DLC)sh2004005391$5IEN-M

=LDR  01107cz  a2200277n  4500
=001  9880364457202441
=005  20141212221401.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054969
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177.$x575
=150  \\$aPrimary Dysautonomias
=450  \\$aDysautonomia
=450  \\$wnnna$aDysautonomia, Primary
=450  \\$wnnna$aDysautonomias
=450  \\$wnnna$aDysautonomias, Primary
=450  \\$wnnna$aPrimary Dysautonomia
=550  \\$wg$aAutonomic Nervous System Diseases
=550  \\$wh$aDysautonomia, Familial
=550  \\$wh$aMultiple System Atrophy
=550  \\$wh$aOrthostatic Intolerance
=550  \\$wh$aPure Autonomic Failure
=667  \\$ado not confuse X ref DYSAUTONOMIA with DYSAUTONOMIA, FAMILIAL
=680  \\$iDisorders of the AUTONOMIC NERVOUS SYSTEM occurring as a primary condition. Manifestations can involve any or all body systems but commonly affect the BLOOD PRESSURE and HEART RATE.
=688  \\$a2009; for DYSAUTONOMIA use AUTONOMIC NERVOUS SYSTEM DISEASES 1989-2008
=750  \0$aDysautonomia$0(DLC) sh 85040331$5IEN-M

=LDR  01407cz  a2200337n  4500
=001  9880364457302441
=005  20141212221354.0
=008  080708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054880
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x595.$x100
=072  \\$aC18.$x452.$x648.$x595.$x100
=150  \\$aAspartylglucosaminuria
=450  \\$wnnna$aAGA Deficiencies
=450  \\$wnnna$aAGA Deficiency
=450  \\$wnnna$aAspartylglucosamidase Deficiencies
=450  \\$wnnna$aAspartylglucosamidase Deficiency
=450  \\$wnnna$aAspartylglucosaminurias
=450  \\$aAspartylglucosylaminase$xdeficiency
=450  \\$wnnna$aAspartylglycosaminuria
=450  \\$wnnna$aAspartylglycosaminurias
=450  \\$wnnna$aDeficiencies, AGA
=450  \\$wnnna$aDeficiencies, Aspartylglucosamidase
=450  \\$wnnna$aDeficiency, AGA
=450  \\$wnnna$aDeficiency, Aspartylglucosamidase
=450  \\$wnnna$aGlycoasparaginase
=450  \\$wnnna$aGlycoasparaginases
=550  \\$wg$aLysosomal Storage Diseases
=680  \\$iA recessively inherited, progressive lysosomal storage disease caused by a deficiency of GLYCOSYLASPARAGINASE activity. The lack of this enzyme activity results in the accumulation of N-acetylglucosaminylasparagine (the linkage unit of asparagine-linked glycoproteins) in LYSOSOMES.
=688  \\$a2009
=750  \0$aAspartylglycosaminuria$0(DLC) sh 85008693$5IEN-M

=LDR  00664cz  a2200193n  4500
=001  9880364457402441
=005  20141212221400.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054910
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x246
=150  \\$aCompound Eye, Arthropod
=450  \\$wnnna$aArthropod Compound Eye
=450  \\$wnnna$aArthropod Compound Eyes
=450  \\$wnnna$aCompound Eyes, Arthropod
=550  \\$wg$aAnimal Structures
=680  \\$iLight sensory organ in ARTHROPODS consisting of a large number of ommatidia, each functioning as an independent photoreceptor unit.
=688  \\$a2008
=750  \0$aCompound eye$0(DLC) sh 85029411$5IEN-M

=LDR  00643cz  a2200241n  4500
=001  9880364457502441
=005  20170608143459.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054879
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x323
=072  \\$aG3.$x360
=150  \\$aHalogenation
=450  \\$aBromination
=450  \\$aChlorination
=450  \\$aFluorination
=450  \\$wnnna$aIodation
=450  \\$aIodination
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=680  \\$iCovalent attachment of HALOGENS to other compounds.
=688  \\$a2008
=750  \0$aHalogenation$0(DLC) sh 85058507$5IEN-M

=LDR  01112cz  a2200253n  4500
=001  9880364457602441
=005  20141212221351.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054873
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x335
=072  \\$aD27.$x505.$x696.$x422.$x500
=150  \\$aDipeptidyl-Peptidase IV Inhibitors
=450  \\$aDipeptidyl Peptidase 4$xantagonists & inhibitors
=450  \\$wnnna$aDipeptidyl-Peptidase 4 Inhibitors
=450  \\$wnnna$aDipeptidyl Peptidase 4 Inhibitors
=450  \\$wnnna$aDipeptidyl Peptidase IV Inhibitors
=450  \\$aGliptins
=450  \\$wnnna$aInhibitors, Dipeptidyl-Peptidase IV
=550  \\$wg$aHypoglycemic Agents
=550  \\$wg$aProtease Inhibitors
=680  \\$iCompounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.
=688  \\$a2008
=750  \0$aCD26 antigen$xInhibitors$0(IEN)8269707

=LDR  01926cz  a2200481n  4500
=001  9880364457702441
=005  20141212221350.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054856
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x790.$x486.$x550
=072  \\$aG5.$x360.$x580.$x550
=150  \\$aG-Quadruplexes
=450  \\$wnnna$aDNA G-Quadruplexes
=450  \\$wnnna$aDNA G Quadruplexes
=450  \\$wnnna$aDNA, Quadruplex
=450  \\$wnnna$aDNA, Tetraplex
=450  \\$wnnna$aG Quadruplexes
=450  \\$wnnna$aG-Quadruplexes, DNA
=450  \\$wnnna$aG Quadruplexes, DNA
=450  \\$wnnna$aG-Quadruplexes, RNA
=450  \\$wnnna$aG Quadruplexes, RNA
=450  \\$wnnna$aG-Quadruplexes RNA
=450  \\$wnnna$aG-Quadruplexes RNAs
=450  \\$wnnna$aGuanine-Quadruplexes
=450  \\$wnnna$aGuanine Quadruplexes
=450  \\$wnnna$aGuanine-Quartet
=450  \\$wnnna$aGuanine-Quartets
=450  \\$wnnna$aGuanine Quartets
=450  \\$wnnna$aGuanine-Tetrad
=450  \\$wnnna$aGuanine-Tetrads
=450  \\$wnnna$aGuanine Tetrads
=450  \\$wnnna$aQuadruplex DNA
=450  \\$wnnna$aRNA, G-Quadruplexes
=450  \\$wnnna$aRNA G-Quadruplexes
=450  \\$wnnna$aRNA, G Quadruplexes
=450  \\$wnnna$aRNAs, G-Quadruplexes
=450  \\$wnnna$aTetraplex DNA
=550  \\$wg$aNucleic Acid Conformation
=550  \\$aDNA, Cruciform
=680  \\$iHigher-order DNA and RNA structures formed from guanine-rich sequences. They are formed around a core of at least 2 stacked tetrads of hydrogen-bonded GUANINE bases. They can be formed from one two or four separate strands of DNA (or RNA) and can display a wide variety of topologies, which are a consequence of various combinations of strand direction, length, and sequence. (From Nucleic Acids Res. 2006;34(19):5402-15)
=688  \\$a2008 (1994)
=750  \0$aQuadruplex nucleic acids$0(DLC)sh2007001218$5IEN-M

=LDR  00966cz  a2200289n  4500
=001  9880364457802441
=005  20141212221349.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054855
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x750.$x500
=150  \\$aDrug-Eluting Stents
=450  \\$wnnna$aDrug-Coated Stent
=450  \\$aDrug-Coated Stents
=450  \\$wnnna$aDrug Coated Stents
=450  \\$wnnna$aDrug-Eluting Stent
=450  \\$wnnna$aDrug Eluting Stents
=450  \\$wnnna$aStent, Drug-Coated
=450  \\$wnnna$aStent, Drug-Eluting
=450  \\$aStents, Drug-Coated
=450  \\$wnnna$aStents, Drug Coated
=450  \\$aStents, Drug-Eluting
=450  \\$wnnna$aStents, Drug Eluting
=550  \\$wg$aStents
=680  \\$iStents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
=688  \\$a2008
=750  \0$aDrug-eluting stents$0(DLC)sh2011003253$5IEN-M

=LDR  00737cz  a2200229n  4500
=001  9880364457902441
=005  20170705111304.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054833
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100.$x513
=150  \\$aIsoindoles
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aCaptan
=550  \\$wh$aChlorisondamine
=550  \\$wh$aIndoprofen
=550  \\$wh$aLurasidone Hydrochloride
=550  \\$wh$aMazindol
=550  \\$wh$aPhthalimides
=680  \\$iBenzopyrroles with the nitrogen at the number two carbon, in contrast to INDOLES which have the nitrogen adjacent to the six-membered ring.
=688  \\$a2008
=750  \0$aIsoindole$0(DLC) sh 85068636$5IEN-M

=LDR  00584cz  a2200193n  4500
=001  9880364458002441
=005  20141212221341.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x743
=072  \\$aG15.$x744.$x800
=150  \\$aPollination
=550  \\$wg$aPlant Physiological Processes
=550  \\$wg$aReproduction
=550  \\$aPlant Nectar
=680  \\$iThe transfer of POLLEN grains (male gametes) to the plant ovule (female gamete).
=688  \\$a2008
=750  \0$aPollination$0(DLC) sh 85104524$5IEN-M

=LDR  00500cz  a2200181n  4500
=001  9880364458102441
=005  20141212221340.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054814
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x133
=072  \\$aN2.$x360.$x133
=150  \\$aAnatomists
=450  \\$wnnna$aAnatomist
=550  \\$wg$aHealth Personnel
=680  \\$iThose persons skilled in anatomy or dissection.
=688  \\$a2008
=750  \0$aAnatomists$0(DLC) sh 85004834$5IEN-M

=LDR  00553cz  a2200157n  4500
=001  9880364458202441
=005  20141212221339.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054812
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x138
=150  \\$aCyclitols
=550  \\$wg$aCycloparaffins
=680  \\$iCycloalkanes containing three or more hydroxyl groups on the ring atoms. Some polyhydroxypiperidines (PIPERIDINES) are called iminocyclitols or aza-sugars.
=688  \\$a2008
=750  \0$aCyclitols$0(DLC) sh 85035077$5IEN-M

=LDR  00742cz  a2200181n  4500
=001  9880364458302441
=005  20141212221337.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x655
=150  \\$aMolecular Imprinting
=450  \\$wnnna$aImprinting, Molecular
=550  \\$wg$aChemistry Techniques, Analytical
=667  \\$anote category, a technique
=680  \\$iA methodology for chemically synthesizing polymer molds of specific molecules or recognition sites of specific molecules. Applications for molecularly imprinted polymers (MIPs) include separations, assays and biosensors, and catalysis.
=688  \\$a2008
=750  \0$aMolecular imprinting$0(DLC) sh 98002021$5IEN-M

=LDR  00600cz  a2200181n  4500
=001  9880364458402441
=005  20141212221335.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054798
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x932
=150  \\$aVolleyball
=450  \\$wnnna$aVolleyballs
=550  \\$wg$aSports
=667  \\$a/inj: coordinate IM with specific injury (IM); Manual 30.15.1
=680  \\$iA team sport in which two teams hit an inflated ball back and forth over a high net using their hands.
=688  \\$a2008
=750  \0$aVolleyball$0(DLC) sh 85144299$5IEN-M

=LDR  01121cz  a2200289n  4500
=001  9880364458502441
=005  20141212221334.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054796
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x305
=150  \\$aDrug Dosage Calculations
=450  \\$wnnna$aArithmetic, Pharmaceutical
=450  \\$wnnna$aCalculation, Drug Dosage
=450  \\$wnnna$aCalculation, Pharmaceutical
=450  \\$wnnna$aCalculations, Drug Dosage
=450  \\$wnnna$aCalculations, Pharmaceutical
=450  \\$wnnna$aDosage Calculation, Drug
=450  \\$wnnna$aDosage Calculations, Drug
=450  \\$wnnna$aDrug Dosage Calculation
=450  \\$wnnna$aPharmaceutical Arithmetic
=450  \\$wnnna$aPharmaceutical Calculation
=450  \\$wnnna$aPharmaceutical Calculations
=550  \\$wg$aDrug Therapy
=680  \\$iMath calculations done for preparing appropriate doses of medicines, taking into account conversions of WEIGHTS AND MEASURES. Mistakes are one of the sources of MEDICATION ERRORS.
=688  \\$a2008
=750  \0$aPharmaceutical arithmetic$0(DLC) sh 85100583$5IEN-M

=LDR  00850cz  a2200241n  4500
=001  9880364458602441
=005  20141212221334.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054794
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x85.$x320
=072  \\$aH1.$x158.$x273.$x180.$x350.$x150
=072  \\$aH1.$x158.$x273.$x343.$x350.$x86
=072  \\$aH1.$x181.$x122.$x508
=150  \\$aGlycomics
=450  \\$wnnna$aGlycobiology
=450  \\$wnnna$aGlycomic
=550  \\$wg$aBiochemistry
=550  \\$wg$aCarbohydrate Biochemistry
=550  \\$wg$aGenomics
=680  \\$iThe systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins.
=688  \\$a2008
=750  \2$aGlycomics$0(DLC)sh2003010544$5IEN-M

=LDR  00851cz  a2200241n  4500
=001  9880364458702441
=005  20141212221333.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054792
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x690.$x552
=150  \\$aMuscle, Striated
=450  \\$wnnna$aMuscles, Striated
=450  \\$aStriated Muscle
=450  \\$wnnna$aStriated Muscles
=550  \\$wg$aMuscles
=550  \\$wh$aMuscle, Skeletal
=550  \\$wh$aMyocardium
=550  \\$wh$aMyofibrils
=680  \\$iOne of two types of muscle in the body, characterized by the array of bands observed under microscope. Striated muscles can be divided into two subtypes: the CARDIAC MUSCLE and the SKELETAL MUSCLE.
=688  \\$a2008; use MUSCLE, SKELETAL 1995-2007
=688  \\$a2008 (1994)
=750  \0$aStriated muscle$0(DLC) sh 85128719$5IEN-M

=LDR  00863cz  a2200181n  4500
=001  9880364458802441
=005  20141212221330.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054773
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x872.$x260
=072  \\$aB3.$x510.$x550.$x737.$x872.$x260
=150  \\$aStreptococcus gordonii
=550  \\$wg$aStreptococcus
=667  \\$ainfection: coordinate IM with STREPTOCOCCAL INFECTIONS (IM) and ENDOCARDITIS, BACTERIAL (IM) or DENTAL PLAQUE (IM) if pertinent
=680  \\$iA species of gram-positive, facultatively anaerobic bacteria in the family STREPTOCOCCACEAE. It is a normal inhabitant of the human oral cavity, and causes DENTAL PLAQUE and ENDOCARDITIS. It is being investigated as a vehicle for vaccine delivery.
=688  \\$a2008
=750  \0$aStreptococcus gordonii$0(DLC)sh2009005158$5IEN-M

=LDR  01086cz  a2200241n  4500
=001  9880364458902441
=005  20190419133509.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x827.$x137
=150  \\$aImidazoline Receptors
=450  \\$aImidazoline-Guanidinium Receptors
=450  \\$wnnna$aImidazoline Guanidinium Receptors
=450  \\$wnnna$aReceptors, Imidazoline
=450  \\$aReceptors, Imidazoline-Guanidinium
=450  \\$wnnna$aReceptors, Imidazoline Guanidinium
=550  \\$wg$aReceptors, Drug
=680  \\$iReceptors of CLONIDINE and other IMIDAZOLINES. Activity of the ligands was earlier attributed to ADRENERGIC ALPHA-2 RECEPTORS. Endogenous ligands include AGMATINE, imidazoleacetic acid ribotide, and harman.
=688  \\$a2008(1988)
=750  \0$81$wb$iBroader mapping$aImidazolines$0(DLC)sh 85064492$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aImidazolines--Receptors$5IEN-M

=LDR  00883cz  a2200253n  4500
=001  9880364459002441
=005  20141212221324.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x500
=072  \\$aH1.$x158.$x703.$x795.$x211
=072  \\$aH1.$x277.$x249.$x500
=072  \\$aH2.$x628.$x795.$x211
=150  \\$aEcotoxicology
=450  \\$wnnna$aEnvironmental Toxicologies
=450  \\$wnnna$aEnvironmental Toxicology
=450  \\$wnnna$aToxicologies, Environmental
=450  \\$wnnna$aToxicology, Environmental
=550  \\$wg$aEcology
=550  \\$wg$aToxicology
=680  \\$iThe study of ENVIRONMENTAL POLLUTION and the toxic effects of ENVIRONMENTAL POLLUTANTS on the ECOSYSTEM. The term was coined by Truhaut in 1969.
=688  \\$a2008
=750  \0$aEnvironmental toxicology$0sh 96003462$5IEN-M

=LDR  00653cz  a2200169n  4500
=001  9880364459102441
=005  20141212221315.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054712
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x640.$x500
=072  \\$aG2.$x842.$x640.$x500
=150  \\$aSalinity
=550  \\$wg$aOsmolar Concentration
=680  \\$iDegree of saltiness, which is largely the OSMOLAR CONCENTRATION of SODIUM CHLORIDE plus any other SALTS present. It is an ecological factor of considerable importance, influencing the types of organisms that live in an ENVIRONMENT.
=688  \\$a2008
=750  \0$aSalinity$0(DLC) sh 85116792$5IEN-M

=LDR  01060cz  a2200205n  4500
=001  9880364459202441
=005  20141212221314.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x800.$x806
=072  \\$aD20.$x215.$x784.$x500.$x492
=150  \\$aLecithins
=450  \\$wnnna$aLecithin
=550  \\$wg$aPhosphatidylcholines
=550  \\$wg$aPlant Extracts
=550  \\$wh$aGlycerylphosphorylcholine
=680  \\$iA complex mixture of PHOSPHOLIPIDS; GLYCOLIPIDS; and TRIGLYCERIDES; with substantial amounts of PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; and PHOSPHATIDYLINOSITOLS, which are sometimes loosely termed as 1,2-diacyl-3-phosphocholines. Lecithin is a component of the CELL MEMBRANE and commercially extracted from SOYBEANS and EGG YOLK. The emulsifying and surfactant properties are useful in FOOD ADDITIVES and for forming organogels (GELS).
=688  \\$a2008, 1963-1976; use PHOSPHATIDYLCHOLINES 1977-2007
=750  \0$aLecithin$0(DLC) sh 85075666$5IEN

=LDR  00955cz  a2200253n  4500
=001  9880364459302441
=005  20141212221303.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x350.$x349
=072  \\$aH1.$x158.$x273.$x343.$x350.$x349
=150  \\$aNutrigenomics
=450  \\$wnnna$aGenetics, Nutritional
=450  \\$wnnna$aGenomics, Nutritional
=450  \\$wnnna$aNutrigenetics
=450  \\$wnnna$aNutrigenomic
=450  \\$wnnna$aNutritional Genetics
=450  \\$wnnna$aNutritional Genomics
=550  \\$wg$aGenomics
=550  \\$aMetabolomics
=680  \\$iThe study of the relationship between NUTRITIONAL PHYSIOLOGY and genetic makeup. It includes the effect of different food components on GENE EXPRESSION and how variations in GENES effect responses to food components.
=688  \\$a2008
=750  \0$aNutrition$xGenetic aspects$0(DLC) sh sh 85093454$5IEN-M

=LDR  01964cz  a2200469n  4500
=001  9880364459402441
=005  20141212221300.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054638
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x587.$x200
=072  \\$aD8.$x811.$x277.$x352.$x650.$x625.$x225.$x200
=072  \\$aD8.$x811.$x277.$x352.$x650.$x775.$x250.$x200
=072  \\$aD8.$x811.$x641.$x755.$x200
=072  \\$aD12.$x644.$x360.$x268.$x200
=072  \\$aD12.$x644.$x360.$x445.$x100
=072  \\$aD12.$x776.$x476.$x268.$x200
=072  \\$aD12.$x776.$x476.$x445.$x200
=150  \\$aDual Specificity Phosphatase 1
=450  \\$wnnna$a3CH134 Phosphatase
=450  \\$wnnna$aCL100 Phosphatase
=450  \\$wnnna$aExternally Regulated Phosphatase (ERP)
=450  \\$wnnna$aMap Kinase Phosphatase 1
=450  \\$wnnna$aMAP Phosphatase-1
=450  \\$wnnna$aMAP Phosphatase 1
=450  \\$wnnna$aMAPK Phosphatase
=450  \\$wnnna$aMitogen-Activated Protein Phosphatase-1
=450  \\$wnnna$aMitogen Activated Protein Phosphatase 1
=450  \\$wnnna$aMKP-1 Phosphatase
=450  \\$wnnna$aMKP 1 Phosphatase
=450  \\$wnnna$aPhosphatase-1, MAP
=450  \\$wnnna$aPhosphatase-1, Mitogen-Activated Protein
=450  \\$wnnna$aPhosphatase, 3CH134
=450  \\$wnnna$aPhosphatase, CL100
=450  \\$wnnna$aPhosphatase, MAPK
=450  \\$wnnna$aPhosphatase, MKP-1
=450  \\$wnnna$aProtein Phosphatase-1, Mitogen-Activated
=550  \\$wg$aDual-Specificity Phosphatases
=550  \\$wg$aMitogen-Activated Protein Kinase Phosphatases
=680  \\$iA dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES and JNK MITOGEN-ACTIVATED PROTEIN KINASES.
=688  \\$a2008(1992)
=750  \0$aDual specificity phosphatase 1$0(DLC)sh2010013015$5IEN-M

=LDR  00680cz  a2200181n  4500
=001  9880364459502441
=005  20141212221252.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x230
=150  \\$aDisaster Medicine
=450  \\$wnnna$aMedicine, Disaster
=550  \\$wg$aMedicine
=667  \\$aspecialty; differentiate from DISASTERS
=680  \\$iBranch of medicine involved with management and organization of public health response to disasters and major events including the special health and medical needs of a community in a disaster.
=688  \\$a2008
=750  \0$aDisaster medicine$0(DLC) sh 85038295$5IEN-M

=LDR  00862cz  a2200241n  4500
=001  9880364459602441
=005  20160826165728.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x782
=072  \\$aK1.$x400.$x504.$x984.$x249
=150  \\$aIraq War, 2003-2011
=450  \\$wnnna$a2003-2011 Iraq Wars
=450  \\$wnnna$aIraq War, 2003 2011
=450  \\$wnnna$aIraq Wars, 2003-2011
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 21st Century
=680  \\$iAn armed intervention involving multi-national forces in the country of IRAQ.
=688  \\$a2008
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Iraq War, 2003 - 2011
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Iraq War, 2003 -
=750  \0$aIraq War, 2003-2011$0(DLC)sh2003003059$5IEN-M

=LDR  01140cz  a2200349n  4500
=001  9880364459702441
=005  20141212221238.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x54
=072  \\$aF1.$x829.$x401.$x142
=150  \\$aFamily Conflict
=450  \\$wnnna$aConflict, Family
=450  \\$wnnna$aConflict, Interparental
=450  \\$wnnna$aConflict, Marital
=450  \\$wnnna$aConflicts, Family
=450  \\$wnnna$aConflicts, Interparental
=450  \\$wnnna$aConflicts, Marital
=450  \\$wnnna$aCurrently Married
=450  \\$wnnna$aEver Married
=450  \\$wnnna$aFamily Conflicts
=450  \\$aInterparental Conflict
=450  \\$wnnna$aInterparental Conflicts
=450  \\$aMarital Conflict
=450  \\$wnnna$aMarital Conflicts
=450  \\$wnnna$aMarried, Currently
=550  \\$wg$aFamily Relations
=550  \\$wg$aInterpersonal Relations
=680  \\$iStruggle or disagreement between parents, parent and child or other members of a family.
=688  \\$a2008
=750  \0$aMarital conflict$0(DLC) sh 96002376$5IEN-M

=LDR  00633cz  a2200217n  4500
=001  9880364459802441
=005  20141212221238.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054540
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x108
=150  \\$aChild, Orphaned
=450  \\$wnnna$aChildren, Orphaned
=450  \\$wnnna$aOrphan
=450  \\$wnnna$aOrphaned Child
=450  \\$wnnna$aOrphaned Children
=450  \\$aOrphans
=550  \\$wg$aPersons
=680  \\$iChild who has lost both parents through death or desertion.
=688  \\$a2008; use Foster Home Care 1995-2007
=750  \0$aOrphans$0(DLC) sh 85095750$5IEN-M

=LDR  00934cz  a2200265n  4500
=001  9880364459902441
=005  20141212221237.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054538
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x675
=072  \\$aN2.$x360.$x810.$x675
=150  \\$aOccupational Health Physicians
=450  \\$wnnna$aCompany Physician
=450  \\$wnnna$aCompany Physicians
=450  \\$wnnna$aHealth Physician, Occupational
=450  \\$wnnna$aOccupational Health Physician
=450  \\$wnnna$aPhysician, Company
=450  \\$wnnna$aPhysician, Occupational Health
=450  \\$wnnna$aPhysicians, Company
=450  \\$aPhysicians, Occupational Health
=550  \\$wg$aPhysicians
=680  \\$iPhysicians employed in a company or corporate setting that is generally not in the health care industry.
=688  \\$a2008
=750  \0$aOccupational physicians$0(DLC) sh 86000696$5IEN-M

=LDR  01131cz  a2200301n  4500
=001  9880364460002441
=005  20141212221236.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054527
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x800.$x537
=072  \\$aI1.$x880.$x735.$x900.$x800.$x575
=072  \\$aN6.$x230.$x100.$x160
=150  \\$aMass Casualty Incidents
=450  \\$wnnna$aCasualties, Mass
=450  \\$wnnna$aCasualty Incident, Mass
=450  \\$wnnna$aCasualty Incidents, Mass
=450  \\$wnnna$aCasualty, Mass
=450  \\$wnnna$aIncident, Mass Casualty
=450  \\$wnnna$aIncidents, Mass Casualty
=450  \\$wnnna$aMass Casualties
=450  \\$wnnna$aMass Casualty
=450  \\$wnnna$aMass Casualty Incident
=550  \\$wg$aDisasters
=550  \\$wg$aTerrorism
=680  \\$iEvents that overwhelm the resources of local HOSPITALS and health care providers. They are likely to impose a sustained demand for HEALTH SERVICES rather than the short, intense peak customary with smaller scale disasters.
=688  \\$a2008
=750  \0$aMass casualties$0(DLC) sh 85081858$5IEN-M

=LDR  00522cz  a2200181n  4500
=001  9880364460102441
=005  20141212221236.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054526
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x425
=150  \\$aMen's Health
=450  \\$wnnna$aHealth, Men's
=450  \\$wnnna$aMens Health
=550  \\$wg$aHealth
=680  \\$iThe concept covering the physical and mental conditions of men.
=688  \\$a2008
=750  \0$aMen$xHealth and hygiene$0(DLC) sh 85083512$5IEN-M

=LDR  00652cz  a2200193n  4500
=001  9880364460202441
=005  20141212221236.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x400.$x512
=150  \\$aMinority Health
=450  \\$wnnna$aHealth, Minority
=450  \\$wnnna$aMinority Health and Health Disparities Research and Education Act of 2000
=550  \\$wg$aHealth
=550  \\$aMinority Groups
=680  \\$iThe concept covering the physical and mental conditions of members of minority groups.
=688  \\$a2008
=750  \0$aMinorities$xHealth and hygiene$0(DLC) sh 85085804$5IEN-M

=LDR  00725cz  a2200217n  4500
=001  9880364460302441
=005  20141212193128.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x135.$x500
=072  \\$aM1.$x643.$x836.$x199
=150  \\$aAdult Survivors of Child Abuse
=450  \\$wnnna$aAdult Survivors, Child Abuse
=450  \\$aChild Abuse, Adult Survivors
=550  \\$wg$aCrime Victims
=550  \\$wg$aSurvivors
=550  \\$aBattered Child Syndrome
=680  \\$iPersons who were child victims of violence and abuse including physical, sexual, or emotional maltreatment.
=688  \\$a2008
=750  \0$aAdult child abuse victims$0(DLC) sh 85001025$5IEN-M

=LDR  01087cz  a2200229n  4500
=001  9880364460402441
=005  20141212193128.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x100.$x364
=150  \\$aCultural Competency
=450  \\$wnnna$aCompetence, Cultural
=450  \\$wnnna$aCompetency, Cultural
=450  \\$wnnna$aCultural Competence
=450  \\$wnnna$aCultural Competencies
=550  \\$wg$aCulture
=550  \\$aCulturally Competent Care
=667  \\$aconsider also TRANSCULTURAL NURSING
=680  \\$iCultural and linguistic competence is a set of congruent behaviors, attitudes, and policies that come together in a system, agency, or among professionals that enables effective work in cross-cultural situations. Competence implies the capacity to function effectively as an individual and an organization within the context of the cultural beliefs, behaviors, and needs presented by consumers and their communities.
=688  \\$a2008
=750  \0$aCultural competence$0(DLC)sh2009005565$5IEN-M

=LDR  01177cz  a2200229n  4500
=001  9880364460502441
=005  20190502120954.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054507
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x783
=150  \\$aReceptors, Phospholipase A2
=450  \\$aPhospholipase A2 Receptor
=450  \\$wnnna$aPhospholipase A2 Receptors
=450  \\$wnnna$aPLA(2) Receptor
=450  \\$wnnna$aReceptor, Phospholipase A2
=550  \\$wg$aReceptors, Cell Surface
=680  \\$iCell surface receptors that bind to and internalize SECRETED PHOSPHOLIPASES A2. Although primarily acting as scavenger receptors, these proteins may also play a role in intracellular signaling. Soluble forms of phospholipase A2 receptors occur through the action of proteases and may a play a role in the inhibition of extracellular phospholipase activity.
=688  \\$a2008
=750  \0$81$wb$iBroader mapping$aPhospholipase A2$0(DLC)sh 90001215$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aPhospholipase A2--Receptors$5IEN-M

=LDR  01234cz  a2200277n  4500
=001  9880364460602441
=005  20141212221226.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054477
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x667.$x84
=150  \\$aGlutaredoxins
=450  \\$aGlutaredoxin
=450  \\$wnnna$aGlutaredoxin 1
=450  \\$wnnna$aGlutaredoxin 2
=450  \\$wnnna$aGlutaredoxin 3
=450  \\$wnnna$aGlutaredoxin 5
=450  \\$wnnna$aThioltransferase
=450  \\$wnnna$aThioltransferase-1
=450  \\$wnnna$aThioltransferase 1
=450  \\$wnnna$aTTase-1
=450  \\$wnnna$aTTase 1
=550  \\$wg$aOxidoreductases Acting on Sulfur Group Donors
=680  \\$iA family of thioltransferases that contain two active site CYSTEINE residues, which either form a disulfide (oxidized form) or a dithiol (reduced form). They function as an electron carrier in the GLUTHIONE-dependent synthesis of deoxyribonucleotides by RIBONUCLEOTIDE REDUCTASES and may play a role in the deglutathionylation of protein thiols. The oxidized forms of glutaredoxins are directly reduced by the GLUTATHIONE.
=688  \\$a2008(1980); use PROTEINS 1979
=750  \0$aGlutaredoxin$0(DLC) sh 86001434$5IEN-M

=LDR  00882cz  a2200241n  4500
=001  9880364460702441
=005  20141212221225.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054467
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x680.$x750.$x937
=150  \\$aPhospholipases A2
=450  \\$aLecithinase A2
=450  \\$wnnna$aPhospholipase A2
=550  \\$wg$aPhospholipases A
=550  \\$wh$a1-Alkyl-2-acetylglycerophosphocholine Esterase
=550  \\$wh$aPhospholipases A2, Calcium-Independent
=550  \\$wh$aPhospholipases A2, Cytosolic
=550  \\$wh$aPhospholipases A2, Secretory
=667  \\$ageneral; prefer specifics
=680  \\$iPhospholipases that hydrolyze the acyl group attached to the 2-position of PHOSPHOGLYCERIDES.
=688  \\$a2008; use PHOSPHOLIPASES A 1980-2007
=750  \0$aPhospholipase A2$0(DLC) sh 90001215$5IEN

=LDR  02683cz  a2200601n  4500
=001  9880364460802441
=005  20150601133600.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054460
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x814
=072  \\$aD12.$x644.$x360.$x590
=072  \\$aD12.$x776.$x476.$x595
=150  \\$arho-Associated Kinases
=450  \\$wnnna$aCoiled-Coil Kinase, rho-Associated
=450  \\$wnnna$ap160 rhoA-Binding Kinase ROKalpha
=450  \\$wnnna$ap160 rhoA Binding Kinase ROKalpha
=450  \\$wnnna$ap160ROCK
=450  \\$wnnna$aProtein Kinases, ROCK
=450  \\$wnnna$arho-Associated Coiled-Coil Containing Protein Kinase 1
=450  \\$wnnna$arho Associated Coiled Coil Containing Protein Kinase 1
=450  \\$wnnna$arho-Associated Coiled-Coil Containing Protein Kinase 2
=450  \\$wnnna$arho Associated Coiled Coil Containing Protein Kinase 2
=450  \\$wnnna$arho-Associated Coiled-Coil Kinase
=450  \\$wnnna$arho Associated Coiled Coil Kinase
=450  \\$arho-Associated Kinase
=450  \\$wnnna$arho Associated Kinase
=450  \\$wnnna$arho-Associated Kinase 1
=450  \\$wnnna$arho Associated Kinase 1
=450  \\$wnnna$arho-Associated Kinase 2
=450  \\$wnnna$arho Associated Kinase 2
=450  \\$wnnna$arho-Associated Kinase alpha
=450  \\$wnnna$arho Associated Kinase alpha
=450  \\$wnnna$arho-Associated Kinase beta
=450  \\$wnnna$arho Associated Kinase beta
=450  \\$wnnna$arho Associated Kinases
=450  \\$wnnna$arho-Associated Protein Kinase alpha
=450  \\$wnnna$arho Associated Protein Kinase alpha
=450  \\$wnnna$arho-Associated Protein Kinase beta
=450  \\$wnnna$arho Associated Protein Kinase beta
=450  \\$wnnna$arho-Kinase
=450  \\$wnnna$arho Kinase
=450  \\$wnnna$aROCK-I Protein Kinase
=450  \\$wnnna$aROCK I Protein Kinase
=450  \\$wnnna$aROCK-II Protein Kinase
=450  \\$wnnna$aROCK II Protein Kinase
=450  \\$wnnna$aROCK Protein Kinases
=450  \\$wnnna$aROK Kinase
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wg$aProtein-Serine-Threonine Kinases
=680  \\$iA group of intracellular-signaling serine threonine kinases that bind to RHO GTP-BINDING PROTEINS. They were originally found to mediate the effects of rhoA GTP-BINDING PROTEIN on the formation of STRESS FIBERS and FOCAL ADHESIONS. Rho-associated kinases have specificity for a variety of substrates including MYOSIN-LIGHT-CHAIN PHOSPHATASE and LIM KINASES.
=688  \\$a2008
=750  \0$aRho-associated protein kinases$0(DLC)sh2014002075$5IEN-M

=LDR  02480cz  a2200541n  4500
=001  9880364460902441
=005  20141212221221.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054459
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850.$x270
=150  \\$aElasticity Imaging Techniques
=450  \\$wnnna$aAcoustic Radiation Force Impulse Imaging
=450  \\$wnnna$aARFI Imaging
=450  \\$wnnna$aARFI Imagings
=450  \\$wnnna$aElasticity Imaging Technique
=450  \\$wnnna$aElasticity Imaging, Tissue
=450  \\$wnnna$aElasticity Imagings, Tissue
=450  \\$wnnna$aElastogram
=450  \\$wnnna$aElastograms
=450  \\$wnnna$aElastographies
=450  \\$wnnna$aElastographies, Magnetic Resonance
=450  \\$wnnna$aElastography
=450  \\$wnnna$aElastography, Magnetic Resonance
=450  \\$wnnna$aImaging, ARFI
=450  \\$wnnna$aImaging Technique, Elasticity
=450  \\$wnnna$aImaging Techniques, Elasticity
=450  \\$wnnna$aImaging, Tissue Elasticity
=450  \\$wnnna$aImagings, ARFI
=450  \\$wnnna$aImagings, Tissue Elasticity
=450  \\$wnnna$aMagnetic Resonance Elastographies
=450  \\$wnnna$aMagnetic Resonance Elastography
=450  \\$wnnna$aResonance Elastographies, Magnetic
=450  \\$wnnna$aResonance Elastography, Magnetic
=450  \\$wnnna$aSonoelastographies
=450  \\$wnnna$aSonoelastography
=450  \\$wnnna$aTechnique, Elasticity Imaging
=450  \\$wnnna$aTechniques, Elasticity Imaging
=450  \\$wnnna$aTissue Elasticity Imaging
=450  \\$wnnna$aTissue Elasticity Imagings
=450  \\$wnnna$aVibro-Acoustographies
=450  \\$wnnna$aVibro-Acoustography
=450  \\$wnnna$aVibro Acoustography
=550  \\$wg$aUltrasonography
=667  \\$acoordinate with specific technique for elasticity imaging techniques other than ultrasonography
=680  \\$iNon-invasive imaging methods based on the mechanical response of an object to a vibrational or impulsive force. It is used for determining the viscoelastic properties of tissue, and thereby differentiating soft from hard inclusions in tissue such as microcalcifications, and some cancer lesions. Most techniques use ultrasound to create the images - eliciting the response with an ultrasonic radiation force and/or recording displacements of the tissue by Doppler ultrasonography.
=688  \\$a2008
=750  \0$aAcoustic radiation force impulse imaging$0(DLC)sh2004001956$5IEN-M

=LDR  00949cz  a2200265n  4500
=001  9880364461002441
=005  20141212221220.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054457
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x206.$x627
=072  \\$aE7.$x695.$x825
=150  \\$aTissue Scaffolds
=450  \\$wnnna$aScaffold, Tissue
=450  \\$wnnna$aScaffolding, Tissue
=450  \\$wnnna$aScaffoldings, Tissue
=450  \\$wnnna$aScaffolds, Tissue
=450  \\$wnnna$aTissue Scaffold
=450  \\$wnnna$aTissue Scaffolding
=450  \\$wnnna$aTissue Scaffoldings
=550  \\$wg$aCulture Media
=550  \\$wg$aProstheses and Implants
=680  \\$iCell growth support structures composed of BIOCOMPATIBLE MATERIALS. They are specially designed solid support matrices for cell attachment in TISSUE ENGINEERING and GUIDED TISSUE REGENERATION uses.
=688  \\$a2008
=750  \0$aTissue scaffolds$0(DLC)sh2010008165$5IEN-M

=LDR  01391cz  a2200361n  4500
=001  9880364461102441
=005  20141212221217.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x450.$x825.$x249
=150  \\$aFacial Transplantation
=450  \\$wnnna$aFace Transplant
=450  \\$wnnna$aFace Transplantation
=450  \\$aFace$xtransplantation
=450  \\$wnnna$aFace Transplantations
=450  \\$wnnna$aFace Transplants
=450  \\$wnnna$aFacial Transplant
=450  \\$wnnna$aFacial Transplantations
=450  \\$wnnna$aFacial Transplants
=450  \\$wnnna$aTransplant, Face
=450  \\$wnnna$aTransplant, Facial
=450  \\$wnnna$aTransplantation, Face
=450  \\$wnnna$aTransplantation, Facial
=450  \\$wnnna$aTransplantations, Face
=450  \\$wnnna$aTransplantations, Facial
=450  \\$wnnna$aTransplants, Face
=450  \\$wnnna$aTransplants, Facial
=550  \\$wg$aVascularized Composite Allotransplantation
=667  \\$afor facial skin flaps coordinate FACE or specifics with SKIN TRANSPLANTATION
=680  \\$iThe transference between individuals of the entire face or major facial structures. In addition to the skin and cartilaginous tissue (CARTILAGE), it may include muscle and bone as well.
=688  \\$a2008
=750  \0$aFace$xTransplantation$0(IEN)8269717$5IEN-M

=LDR  01647cz  a2200373n  4500
=001  9880364461202441
=005  20190503112326.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054440
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x322
=150  \\$aReceptors, Ghrelin
=450  \\$wnnna$aGhrelin Receptor
=450  \\$wnnna$aGhrelin Receptors
=450  \\$wnnna$aGHS-R Type 1A
=450  \\$wnnna$aGHS R Type 1A
=450  \\$wnnna$aGHS-R1A
=450  \\$wnnna$aGHS-R1B
=450  \\$wnnna$aGHS Receptor Type 1
=450  \\$wnnna$aGHSR Protein
=450  \\$aGrowth Hormone Secretagogue Receptor
=450  \\$wnnna$aGrowth Hormone Secretagogue Receptor Type 1
=450  \\$wnnna$aGrowth Hormone Secretagogue Receptor Type 1A
=450  \\$wnnna$aGrowth Hormone Secretagogue Receptor Type 1B
=450  \\$aGrowth Hormone Secretagogue Receptors
=450  \\$wnnna$aGrowth Hormone Secretogogue Receptor 1B
=450  \\$wnnna$aReceptor, Ghrelin
=450  \\$wnnna$aReceptor, Growth Hormone Secretagogue 1A
=550  \\$wg$aReceptors, G-Protein-Coupled
=680  \\$iTransmembrane proteins that recognize and bind GHRELIN, a potent stimulator of GROWTH HORMONE secretion and food intake in mammals. Ghrelin receptors are found in the pituitary and HYPOTHALAMUS. They belong to the family of G-PROTEIN-COUPLED RECEPTORS.
=688  \\$a2008 (1999)
=750  \0$81$wb$iBroader mapping$aGhrelin$0(DLC)sh2004000537$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGhrelin--Receptors$5IEN-M

=LDR  01629cz  a2200373n  4500
=001  9880364461302441
=005  20141212221214.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054439
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x301
=072  \\$aD12.$x644.$x548.$x322
=150  \\$aGhrelin
=450  \\$wnnna$aAppetite-Regulating Hormone
=450  \\$wnnna$aAppetite Regulating Hormone
=450  \\$wnnna$aGastric MLTRP
=450  \\$wnnna$aGhrelin-Obestatin Preprohormone
=450  \\$wnnna$aGhrelin Obestatin Preprohormone
=450  \\$wnnna$aGhrelin Precursor
=450  \\$wnnna$aGHRL Protein
=450  \\$wnnna$aMotilin-Related Peptide
=450  \\$wnnna$aMotilin Related Peptide
=450  \\$wnnna$aMotilin-Related Peptide Precursor
=450  \\$wnnna$aMotilin Related Peptide Precursor
=450  \\$wnnna$aObestatin
=450  \\$wnnna$aPeptide Precursor, Motilin-Related
=450  \\$wnnna$aPpghrelin
=450  \\$wnnna$aPpMTLRP
=450  \\$wnnna$aPrecursor, Ghrelin
=450  \\$wnnna$aPrecursor, Motilin-Related Peptide
=550  \\$wg$aPeptide Hormones
=680  \\$iA 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin.
=688  \\$a2008 (2000)
=750  \0$aGhrelin$0(DLC)sh2004000537$5IEN

=LDR  01475cz  a2200373n  4500
=001  9880364461402441
=005  20190429154002.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054411
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x650.$x500
=150  \\$aReceptors, Leptin
=450  \\$aAntigens, CD295
=450  \\$aCD295 Antigens
=450  \\$wnnna$aLEPR Protein
=450  \\$wnnna$aLeptin-Binding Protein
=450  \\$wnnna$aLeptin Binding Protein
=450  \\$wnnna$aLeptin Receptor
=450  \\$wnnna$aLeptin Receptor, Large Isoform
=450  \\$wnnna$aLeptin Receptor, Small Isoform
=450  \\$aLeptin Receptors
=450  \\$aOB Receptor
=450  \\$wnnna$aOBRa Receptor
=450  \\$wnnna$aOBRb Receptor
=450  \\$wnnna$aReceptor, Leptin
=450  \\$wnnna$aReceptor, OB
=450  \\$wnnna$aReceptor, OBRa
=450  \\$wnnna$aReceptor, OBRb
=550  \\$wg$aReceptors, Adipokine
=680  \\$iCell surface receptors for obesity factor (LEPTIN), a hormone secreted by the WHITE ADIPOCYTES. Upon leptin-receptor interaction, the signal is mediated through the JAK2/STAT3 pathway to regulate food intake, energy balance and fat storage.
=688  \\$a2008 (1996)
=750  \0$81$wb$iBroader mapping$aLeptin$0(DLC)sh 9900546915$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLeptins--Receptors$5IEN-M

=LDR  00640cz  a2200181n  4500
=001  9880364461502441
=005  20141212221155.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x483.$x620
=150  \\$aLaxatives
=450  \\$wnnna$aBulk Laxatives
=450  \\$wnnna$aLaxatives, Bulk
=550  \\$wg$aGastrointestinal Agents
=680  \\$iAgents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION.
=688  \\$a2008; use CATHARTICS 1963-2007
=750  \0$aLaxatives$0(DLC) sh 85109180$5IEN

=LDR  00813cz  a2200181n  4500
=001  9880364461602441
=005  20141212221145.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054336
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x65.$x992
=150  \\$aXylopia
=450  \\$wnnna$aXylopias
=550  \\$wg$aAnnonaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ANNONACEAE. Members contain DITERPENES.
=688  \\$a2008; use ANNONACEAE 2003-2007
=750  \0$aXylopia$0(DLC) sh 85148867$5IEN-M

=LDR  00759cz  a2200193n  4500
=001  9880364461702441
=005  20141212221143.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x848
=150  \\$aProton Pump Inhibitors
=450  \\$aH(+)-K(+)-Exchanging ATPase$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, Proton Pump
=450  \\$aProton Pumps$xantagonists & inhibitors
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
=688  \\$a2008
=750  \0$aProton pump inhibitors$0(DLC) sh 98006912$5IEN-M

=LDR  00760cz  a2200229n  4500
=001  9880364461802441
=005  20141212193127.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054327
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x556
=150  \\$aLubricants
=450  \\$wnnna$aAgents, Lubricating
=450  \\$wnnna$aAgents, Lubrication
=450  \\$wnnna$aLubricating Agents
=450  \\$wnnna$aLubrication Agents
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aLubricant Eye Drops
=550  \\$wh$aViscosupplements
=680  \\$iCompounds that provide LUBRICATION between surfaces in order to reduce FRICTION.
=688  \\$a2008; use LUBRICATION 1963-2007
=750  \0$aLubrication and lubricants$0(DLC) sh 85078720$5IEN-M

=LDR  00915cz  a2200217n  4500
=001  9880364461902441
=005  20141212221139.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054313
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x812.$x240.$x154
=072  \\$aG7.$x700.$x680.$x240.$x154
=150  \\$aDrug Agonism
=450  \\$wnnna$aAgonism, Drug
=550  \\$wg$aDrug Interactions
=550  \\$wh$aDrug Partial Agonism
=550  \\$aDrug Inverse Agonism
=667  \\$ageneral only; prefer specific drug with / agon; DRUG PARTIAL AGONISM and DRUG INVERSE AGONISM are also available
=680  \\$iPhenomena and pharmaceutics of compounds that selectively bind to a specific receptor and trigger a response. They mimic the action of endogenous biochemical molecules. Their effect can be countered by antagonists (DRUG ANTAGONISM).
=688  \\$a2008
=750  \0$aDrugs$xAgonits$0(IEN)8269713$5IEN-M

=LDR  00567cz  a2200169n  4500
=001  9880364462002441
=005  20141212221135.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054300
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x612
=072  \\$aB3.$x440.$x475.$x100.$x612
=150  \\$aOscillatoria
=550  \\$wg$aCyanobacteria
=680  \\$iA genus of filamentous CYANOBACTERIA in the order Oscillatoriales. It is commonly found in freshwater environments, especially hot springs.
=688  \\$a2008
=750  \0$aOscillatoria$0(DLC) sh 88001035$5IEN-M

=LDR  00710cz  a2200157n  4500
=001  9880364462102441
=005  20141212221134.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x180.$x812
=150  \\$aGastrulation
=550  \\$wg$aEmbryonic Development
=680  \\$iA process of complicated morphogenetic cell movements that reorganizes a bilayer embryo into one with three GERM LAYERS and specific orientation (dorsal/ventral; anterior/posterior). Gastrulation describes the germ layer development of a non-mammalian BLASTULA or that of a mammalian BLASTOCYST.
=688  \\$a2008
=750  \2$aGastrulation$0(DLC) sh 85053502$5IEN

=LDR  00971cz  a2200241n  4500
=001  9880364462202441
=005  20141212221133.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054259
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x630
=150  \\$aNeural Tube
=450  \\$wnnna$aCanal, Neural
=450  \\$wnnna$aCanals, Neural
=450  \\$wnnna$aNeural Canal
=450  \\$wnnna$aNeural Canals
=450  \\$wnnna$aNeural Tubes
=450  \\$wnnna$aTube, Neural
=450  \\$wnnna$aTubes, Neural
=550  \\$wg$aEmbryonic Structures
=680  \\$iA tube of ectodermal tissue in an embryo that will give rise to the CENTRAL NERVOUS SYSTEM, including the SPINAL CORD and the BRAIN. Lumen within the neural tube is called neural canal which gives rise to the central canal of the spinal cord and the ventricles of the brain. For malformation of the neural tube, see NEURAL TUBE DEFECTS.
=688  \\$a2008
=750  \0$aNeural tube$0(DLC) sh 85091098$5IEN-M

=LDR  01109cz  a2200253n  4500
=001  9880364462302441
=005  20141212221132.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054243
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x580.$x830.$x825
=072  \\$aC7.$x465.$x864.$x968
=072  \\$aC22.$x952
=150  \\$aVesicular Stomatitis
=450  \\$wnnna$aStomatitides, Vesicular
=450  \\$aStomatitis, Vesicular
=450  \\$wnnna$aVesicular Stomatitides
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aRhabdoviridae Infections
=550  \\$wg$aStomatitis
=667  \\$acoordinate IM with specifici virus species (IM) if pertinent
=680  \\$iA viral disease caused by at least two distinct species (serotypes) in the VESICULOVIRUS genus: VESICULAR STOMATITIS INDIANA VIRUS and VESICULAR STOMATITIS NEW JERSEY VIRUS. It is characterized by vesicular eruptions on the ORAL MUCOSA in cattle, horses, pigs, and other animals. In humans, vesicular stomatitis causes an acute influenza-like illness.
=688  \\$a2008
=750  \0$aVesicular stomatitis$0(DLC) sh 85142932$5IEN-M

=LDR  01130cz  a2200301n  4500
=001  9880364462402441
=005  20171215150700.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x189
=150  \\$aEmigrants and Immigrants
=450  \\$wnnna$aAlien
=450  \\$wnnna$aAliens
=450  \\$wnnna$aEmigrant
=450  \\$aEmigrants
=450  \\$wnnna$aForeigner
=450  \\$wnnna$aForeigners
=450  \\$wnnna$aImmigrant
=450  \\$aImmigrants
=450  \\$wnnna$aImmigrants and Emigrants
=550  \\$wg$aPersons
=550  \\$wh$aUndocumented Immigrants
=550  \\$aEmigration and Immigration
=667  \\$aEMIGRATION AND IMMIGRATION is also available
=680  \\$iPeople who leave their place of residence in one country and settle in a different country.
=688  \\$a2008; for EMIGRANTS use EMIGRATION AND IMMIGRATION 1995-2007; for IMMIGRATION use EMIGRATION AND IMMIGRATION 1996-2005; for ALIENS use EMIGRATION AND IMMIGRATION 1989-2007; for FOREIGNERS use EMIGRATION AND IMMIGRATION 1992-2007
=750  \0$aImmigrants$0(DLC) sh 85064517$5IEN-M

=LDR  01139cz  a2200277n  4500
=001  9880364462502441
=005  20141212221131.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054238
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x700
=072  \\$aL1.$x280.$x975.$x550.$x700
=072  \\$aN1.$x224.$x935.$x698.$x739
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x700
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x700
=150  \\$aPerinatal Mortality
=450  \\$wnnna$aMortalities, Perinatal
=450  \\$wnnna$aMortality, Perinatal
=450  \\$wnnna$aPerinatal Mortalities
=550  \\$wg$aMortality
=550  \\$aInfant Death
=550  \\$aPerinatal Death
=667  \\$aa statistical concept and not a substitute for /mortal with FETAL DISEASES; INFANT, NEWBORN, DISEASES or specific diseases; do not confuse with PERINATAL DEATH; add geographic term if pertinent
=680  \\$aDeaths occurring from the 28th week of GESTATION to the 28th day after birth in a given population.
=688  \\$a2008; use INFANT MORTALITY 1990-2007
=750  \0$aPerinatal death$0(DLC) sh 85099874$5IEN-M

=LDR  02834cz  a2200637n  4500
=001  9880364462602441
=005  20141212221129.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054198
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x428.$x600
=072  \\$aC15.$x604.$x515.$x560.$x600
=072  \\$aC20.$x683.$x515.$x528.$x600
=150  \\$aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
=450  \\$wnnna$aAcute Lymphoblastic Leukemia
=450  \\$wnnna$aAcute Lymphocytic Leukemia
=450  \\$wnnna$aAcute Lymphoid Leukemia
=450  \\$wnnna$aALL, Childhood
=450  \\$wnnna$aChildhood ALL
=450  \\$wnnna$aL1 Lymphocytic Leukemia
=450  \\$wnnna$aL2 Lymphocytic Leukemia
=450  \\$wnnna$aLeukemia, Acute Lymphoblastic
=450  \\$wnnna$aLeukemia, Acute Lymphocytic
=450  \\$wnnna$aLeukemia, Acute Lymphoid
=450  \\$wnnna$aLeukemia, L1 Lymphocytic
=450  \\$wnnna$aLeukemia, L2 Lymphocytic
=450  \\$aLeukemia, Lymphoblastic
=450  \\$wnnna$aLeukemia, Lymphoblastic, Acute
=450  \\$wnnna$aLeukemia, Lymphoblastic, Acute, L1
=450  \\$wnnna$aLeukemia, Lymphoblastic, Acute, L2
=450  \\$wnnna$aLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
=450  \\$wnnna$aLeukemia, Lymphocytic, Acute
=450  \\$wnnna$aLeukemia, Lymphocytic, Acute, L1
=450  \\$wnnna$aLeukemia, Lymphocytic, Acute, L2
=450  \\$aLeukemia, Lymphoid, Acute
=450  \\$wnnoa$aLeukemia, Null-Cell$5IEN-M
=450  \\$aLymphoblastic Leukemia
=450  \\$wnnna$aLymphoblastic Leukemia, Acute
=450  \\$wnnna$aLymphoblastic Leukemia, Acute, Adult
=450  \\$wnnna$aLymphoblastic Leukemia, Acute, Childhood
=450  \\$wnnna$aLymphoblastic Leukemia, Acute, L1
=450  \\$wnnna$aLymphoblastic Leukemia, Acute, L2
=450  \\$aLymphoblastic Lymphoma
=450  \\$aLymphocytic Leukemia, Acute
=450  \\$wnnna$aLymphocytic Leukemia, L1
=450  \\$wnnna$aLymphocytic Leukemia, L2
=450  \\$wnnna$aLymphoid Leukemia, Acute
=450  \\$aLymphoma, Lymphoblastic
=450  \\$wnnna$aPrecursor Cell Lymphoblastic Leukemia Lymphoma
=550  \\$wg$aLeukemia, Lymphoid
=550  \\$wh$aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
=550  \\$wh$aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
=680  \\$iA neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
=688  \\$a2008; for LYMPHOBLASTIC LEUKEMIA use LEUKEMIA, LYMPHOID 1989-2007
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Leukemia, Lymphocytic, Acute
=750  \0$aLymphoblastic leukemia$0(DLC) sh 85079143$5IEN-M

=LDR  00822cz  a2200253n  4500
=001  9880364462702441
=005  20141212221127.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054159
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x676.$x860
=072  \\$aG1.$x595.$x540.$x860
=150  \\$aTorsion, Mechanical
=450  \\$wnnna$aForce, Torsional
=450  \\$wnnna$aMechanical Torsion
=450  \\$wnnna$aTorsional Force
=450  \\$wnnna$aTorsional Forces
=550  \\$wg$aMechanical Processes
=550  \\$wh$aTorque
=550  \\$aRotation
=667  \\$aTORSION ABNORMALITY is also available
=680  \\$iA twisting deformation of a solid body about an axis. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a2008
=750  \0$aTorsion$0(DLC) sh 85136148$5IEN

=LDR  00948cz  a2200205n  4500
=001  9880364462802441
=005  20141212221127.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054158
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x706
=150  \\$aOrthokeratologic Procedures
=450  \\$wnnna$aOrthokeratologic Procedure
=450  \\$wnnna$aProcedure, Orthokeratologic
=450  \\$wnnna$aProcedures, Orthokeratologic
=550  \\$wg$aTherapeutics
=550  \\$aRefractive Surgical Procedures
=680  \\$iAn alternative to REFRACTIVE SURGICAL PROCEDURES. A therapeutic procedure for correcting REFRACTIVE ERRORS. It involves wearing CONTACT LENSES designed to force corrective changes to the curvature of the CORNEA that remain after the lenses are removed. The effect is temporary but is maintained by wearing the therapeutic lenses daily, usually during sleep.
=688  \\$a2008
=750  \0$aOrthokeratology$0(DLC) sh 94006281$5IEN

=LDR  01920cz  a2200457n  4500
=001  9880364462902441
=005  20141212221126.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054140
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x825
=150  \\$aRefractive Surgical Procedures
=450  \\$wnnna$aKeratorefractive Surgical Procedure
=450  \\$aKeratorefractive Surgical Procedures
=450  \\$wnnna$aProcedure, Keratorefractive Surgical
=450  \\$wnnna$aProcedure, Refractive Surgical
=450  \\$wnnna$aProcedures, Keratorefractive Surgical
=450  \\$wnnna$aProcedures, Refractive Surgical
=450  \\$aRefractive Errors$xsurgery
=450  \\$wnnna$aRefractive Surgeries
=450  \\$wnnna$aRefractive Surgery
=450  \\$wnnna$aRefractive Surgical Procedure
=450  \\$wnnna$aSurgeries, Refractive
=450  \\$wnnna$aSurgery, Refractive
=450  \\$wnnna$aSurgical Procedure, Keratorefractive
=450  \\$wnnna$aSurgical Procedure, Refractive
=450  \\$wnnna$aSurgical Procedures, Keratorefractive
=450  \\$wnnna$aSurgical Procedures, Refractive
=550  \\$wg$aOphthalmologic Surgical Procedures
=550  \\$wh$aCataract Extraction
=550  \\$wh$aCorneal Surgery, Laser
=550  \\$wh$aCorneal Transplantation
=550  \\$wh$aKeratotomy, Radial
=550  \\$wh$aLens Implantation, Intraocular
=550  \\$wh$aPosterior Capsulotomy
=550  \\$wh$aScleroplasty
=550  \\$aOrthokeratologic Procedures
=667  \\$ageneral; prefer specific procedures
=680  \\$iSurgical procedures employed to correct REFRACTIVE ERRORS such as MYOPIA; HYPEROPIA; or ASTIGMATISM. These may involve altering the curvature of the CORNEA; removal or replacement of the CRYSTALLINE LENS; or modification of the SCLERA to change the axial length of the eye.
=688  \\$a2008
=750  \0$aEye$xRefractive errors$xSurgery$0(IEN)8283217$5IEN-M

=LDR  01561cz  a2200337n  4500
=001  9880364463002441
=005  20141212193124.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x507.$x450.$x499
=072  \\$aC16.$x131.$x666.$x507.$x450.$x499
=150  \\$aLissencephaly
=450  \\$aAgyria
=450  \\$wnnna$aAgyrias
=450  \\$wnnna$aBroad Gyri of Cerebrum
=450  \\$wnnna$aLarge Gyri of Cerebrum
=450  \\$wnnna$aLissencephalia
=450  \\$wnnna$aLissencephalias
=450  \\$wnnna$aLissencephalies
=450  \\$wnnna$aMacrogyria
=450  \\$wnnna$aMacrogyrias
=450  \\$aPachygyria
=450  \\$wnnna$aPachygyrias
=550  \\$wg$aMalformations of Cortical Development, Group II
=550  \\$wh$aClassical Lissencephalies and Subcortical Band Heterotopias
=550  \\$wh$aCobblestone Lissencephaly
=667  \\$anote specifics; MICROLISSENCEPHALY is also available
=680  \\$iA "smooth brain" malformation of the CEREBRAL CORTEX resulting from abnormal location of developing neurons during corticogenesis. It is characterized by an absence of normal convoluted indentations on the surface of the brain (agyria), or fewer and shallower indentations (pachygryia). There is a reduced number of cortical layers, typically 4 instead of 6, resulting in a thickened cortex, and reduced cerebral white matter that is a reversal of the normal ratio of cerebral white matter to cortex.
=688  \\$a2008
=750  \0$aLissencephaly$0(DLC) sh 00010142$5IEN-M

=LDR  02963cz  a2200805n  4500
=001  9880364463102441
=005  20141212221116.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054062
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x341.$x186.$x500
=072  \\$aC10.$x597.$x751.$x418.$x341.$x186.$x500
=072  \\$aC10.$x597.$x751.$x941.$x162.$x625
=072  \\$aC11.$x966.$x75.$x375
=072  \\$aC16.$x131.$x77.$x299
=072  \\$aC23.$x888.$x592.$x763.$x393.$x341.$x186.$x500
=072  \\$aC23.$x888.$x592.$x763.$x941.$x162.$x625
=150  \\$aDeaf-Blind Disorders
=450  \\$wnnna$aBlind-Deaf Disorder
=450  \\$aBlind-Deaf Disorders
=450  \\$wnnna$aBlind Deaf Disorders
=450  \\$wnnna$aBlindness-Deafness
=450  \\$wnnna$aBlindness Deafness
=450  \\$wnnna$aDeaf-Blind Disorder
=450  \\$wnnna$aDeaf-Blind Disorder, Prelingual
=450  \\$wnnna$aDeaf Blind Disorders
=450  \\$wnnna$aDeaf-Blind Disorders, Prelingual
=450  \\$wnnna$aDeaf-Blind Syndrome
=450  \\$wnnna$aDeaf-Blind Syndromes
=450  \\$wnnna$aDeaf Blind Syndromes
=450  \\$wnnna$aDeaf-Blindness Disorder
=450  \\$wnnna$aDeaf-Blindness Disorders
=450  \\$wnnna$aDeaf Blindness Disorders
=450  \\$wnnna$aDeaf-Mutism-Blind Disorder
=450  \\$wnnna$aDeaf-Mutism-Blind Disorders
=450  \\$wnnna$aDeaf Mutism Blind Disorders
=450  \\$wnnna$aDeafness-Blindness
=450  \\$wnnna$aDeafness Blindness
=450  \\$wnnna$aDeafness-Blindness, Prelingual
=450  \\$wnnna$aDeafness-Blindnesses, Prelingual
=450  \\$wnnna$aDisorder, Blind-Deaf
=450  \\$wnnna$aDisorder, Deaf-Blind
=450  \\$wnnna$aDisorder, Deaf-Blindness
=450  \\$wnnna$aDisorder, Deaf-Mutism-Blind
=450  \\$wnnna$aDisorder, Prelingual Deaf-Blind
=450  \\$wnnna$aDisorders, Blind-Deaf
=450  \\$wnnna$aDisorders, Deaf-Blind
=450  \\$wnnna$aDisorders, Deaf-Blindness
=450  \\$wnnna$aDisorders, Deaf-Mutism-Blind
=450  \\$wnnna$aDisorders, Prelingual Deaf-Blind
=450  \\$wnnna$aHearing and Vision Loss
=450  \\$wnnna$aPrelingual Deaf-Blind Disorder
=450  \\$wnnna$aPrelingual Deaf-Blind Disorders
=450  \\$wnnna$aPrelingual Deaf Blind Disorders
=450  \\$wnnna$aPrelingual Deafness-Blindness
=450  \\$wnnna$aPrelingual Deafness Blindness
=450  \\$wnnna$aPrelingual Deafness-Blindnesses
=450  \\$wnnna$aSyndrome, Deaf-Blind
=450  \\$wnnna$aSyndromes, Deaf-Blind
=450  \\$wnnna$aVision and Hearing Loss
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aBlindness
=550  \\$wg$aDeafness
=550  \\$wh$aUsher Syndromes
=550  \\$wh$aWolfram Syndrome
=550  \\$aPersons With Hearing Impairments
=550  \\$aVisually Impaired Persons
=680  \\$iThe absence of both hearing and vision.
=688  \\$a2008
=750  \0$aDeafblind people$0(DLC) sh 85014878$5IEN-M

=LDR  00742cz  a2200217n  4500
=001  9880364463202441
=005  20141212221113.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054046
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x750.$x650
=072  \\$aA18.$x24.$x812.$x650
=150  \\$aPlant Stomata
=450  \\$wnnna$aPlant Stomatas
=450  \\$aStomata, Plant
=450  \\$wnnna$aStomatas, Plant
=550  \\$wg$aPlant Epidermis
=550  \\$wg$aPlant Leaves
=680  \\$iClosable openings in the epidermis of plants on the underside of leaves. They allow the exchange of gases between the internal tissues of the plant and the outside atmosphere.
=688  \\$a2008
=750  \0$aStomata$0(DLC) sh sh 85128277$5IEN-M

=LDR  01072cz  a2200313n  4500
=001  9880364463302441
=005  20141212221113.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x226
=072  \\$aJ1.$x637.$x870.$x125
=072  \\$aJ1.$x637.$x870.$x900.$x100
=150  \\$aBiological Warfare Agents
=450  \\$wnnna$aAgent, Biological Warfare
=450  \\$wnnna$aAgents, Biological Warfare
=450  \\$wnnna$aBiological Warfare Agent
=450  \\$wnnna$aBiological Weapon
=450  \\$wnnna$aBiological Weapons
=450  \\$wnnna$aWarfare Agent, Biological
=450  \\$wnnna$aWarfare Agents, Biological
=450  \\$wnnna$aWeapon, Biological
=450  \\$wnnna$aWeapons, Biological
=550  \\$wg$aBiological Products
=550  \\$wg$aWeapons
=550  \\$wg$aWeapons of Mass Destruction
=680  \\$iLiving organisms or their toxic products that are used to cause disease or death of humans during war.
=688  \\$a2008
=750  \0$aBiological weapons$0(DLC) sh 88007496$5IEN-M

=LDR  00870cz  a2200229n  4500
=001  9880364463402441
=005  20141212221112.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054044
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x870.$x900
=150  \\$aWeapons of Mass Destruction
=450  \\$wnnna$aMass Destruction Weapon
=450  \\$wnnna$aMass Destruction Weapons
=450  \\$wnnna$aWeapon of Mass Destruction
=550  \\$wg$aWeapons
=550  \\$wh$aBiological Warfare Agents
=550  \\$wh$aChemical Warfare Agents
=550  \\$wh$aNuclear Weapons
=680  \\$iWeapons that are capable of a high order of destruction and/or of being used to destroy large numbers of people. It includes NUCLEAR WEAPONS, and biological, chemical, and radiation weapons.
=688  \\$a2008
=750  \0$aWeapons of mass destruction$0(DLC) sh 96004190$5IEN-M

=LDR  01299cz  a2200397n  4500
=001  9880364463502441
=005  20141212221112.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054043
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x870.$x575
=072  \\$aJ1.$x637.$x870.$x900.$x575
=150  \\$aNuclear Weapons
=450  \\$wnnna$aAtomic Bomb
=450  \\$aAtomic Bombs
=450  \\$wnnna$aBomb, Atomic
=450  \\$wnnna$aBomb, Hydrogen
=450  \\$aBombs, Atomic
=450  \\$aBombs, Hydrogen
=450  \\$wnnna$aHydrogen Bomb
=450  \\$aHydrogen Bombs
=450  \\$wnnna$aNuclear Weapon
=450  \\$aNuclear Weapons Testing
=450  \\$wnnna$aNuclear Weapons Testings
=450  \\$wnnna$aTesting, Nuclear Weapons
=450  \\$wnnna$aTestings, Nuclear Weapons
=450  \\$wnnna$aWeapon, Nuclear
=450  \\$wnnna$aWeapons, Nuclear
=450  \\$wnnna$aWeapons Testing, Nuclear
=450  \\$wnnna$aWeapons Testings, Nuclear
=550  \\$wg$aWeapons
=550  \\$wg$aWeapons of Mass Destruction
=550  \\$aBombs
=680  \\$iA weapon that derives its destructive force from nuclear fission and/or fusion.
=688  \\$a2008; for NUCLEAR WEAPONS TESTING use NUCLEAR WARFARE 1998-2007
=750  \0$aNuclear weapons$0(DLC) sh sh 85093127$5IEN-M

=LDR  00567cz  a2200193n  4500
=001  9880364463602441
=005  20141212221112.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054042
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x870.$x175
=150  \\$aBombs
=450  \\$wnnna$aBomb
=550  \\$wg$aWeapons
=550  \\$aExplosive Agents
=550  \\$aNuclear Weapons
=680  \\$iA weapon designed to explode when deployed. It frequently refers to a hollow case filled with EXPLOSIVE AGENTS.
=688  \\$a2008
=750  \0$aBombs$0(DLC) sh 85015477

=LDR  00743cz  a2200253n  4500
=001  9880364463702441
=005  20141212221112.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x870
=150  \\$aWeapons
=450  \\$wnnna$aWeapon
=550  \\$wg$aManufactured Materials
=550  \\$wh$aBiological Warfare Agents
=550  \\$wh$aBombs
=550  \\$wh$aChemical Warfare Agents
=550  \\$wh$aFirearms
=550  \\$wh$aNuclear Weapons
=550  \\$wh$aTear Gases
=550  \\$wh$aWeapons of Mass Destruction
=680  \\$iDevices or tools used in combat or fighting in order to kill or incapacitate.
=688  \\$a2008
=750  \0$aWeapons$0(DLC) sh 85007341$5IEN-M

=LDR  01655cz  a2200373n  4500
=001  9880364463802441
=005  20141212221111.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054025
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490.$x230
=072  \\$aE7.$x710.$x520.$x230
=150  \\$aLasers, Dye
=450  \\$wnnna$aDye Laser
=450  \\$wnnna$aDye Laser, Pulsed
=450  \\$wnnna$aDye Laser, Tunable
=450  \\$aDye Lasers
=450  \\$wnnna$aDye Lasers, Pulsed
=450  \\$wnnna$aDye Lasers, Tunable
=450  \\$wnnna$aLaser, Dye
=450  \\$wnnna$aLaser, Pulsed Dye
=450  \\$wnnna$aLaser, Tunable Dye
=450  \\$wnnna$aLasers, Pulsed Dye
=450  \\$wnnna$aLasers, Tunable Dye
=450  \\$wnnna$aPulsed Dye Laser
=450  \\$aPulsed Dye Lasers
=450  \\$wnnna$aTunable Dye Laser
=450  \\$wnnna$aTunable Dye Lasers
=550  \\$wg$aLasers
=550  \\$aIntense Pulsed Light Therapy
=667  \\$a/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LASER THERAPY, LOW-LEVEL (IM)
=680  \\$iTunable liquid lasers with organic compounds (i.e., dye) which have a strong absorption band, used as the active medium. During emission, the dye has to be optically excited by another light source (e.g., another laser or flash lamp). The range of the emission wavelength may be anywhere from the ultraviolet to the near infrared (i.e., from 180 to 1100nm). These lasers are operated in continuous wave and pulsed modes. (UMDNS, 2005)
=688  \\$a2008
=750  \0$aDye lasers$0(DLC) sh 85040278$5IEN-M

=LDR  01146cz  a2200301n  4500
=001  9880364463902441
=005  20141212220329.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050616
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865.$x100
=150  \\$aBalaenoptera
=450  \\$wnnna$aBalaenoptera borealis
=450  \\$wnnna$aBalaenoptera brydei
=450  \\$wnnna$aBalaenoptera musculus
=450  \\$aBlue Whale
=450  \\$wnnna$aBlue Whales
=450  \\$wnnna$aBryde Whale
=450  \\$aBryde's Whale
=450  \\$wnnna$aBrydes Whale
=450  \\$aSei Whale
=450  \\$wnnna$aSei Whales
=550  \\$wg$aWhales
=550  \\$wh$aFin Whale
=550  \\$wh$aMinke Whale
=680  \\$iA genus of WHALES in the family Balaenopteridae, consisting of five species: Blue Whale, Bryde's Whale, FIN WHALE, Sei Whale, and MINKE WHALE. They are distinguished by a relatively slender body, a compressed tail stock, and a pointed snout.
=688  \\$a2006; use WHALES 1998-2005; for Blue Whale, Bryde's Whale, and Sei Whale use WHALES 1998-2005
=750  \0$aBalaenoptera$0(DLC) sh 85011107$5IEN-M

=LDR  00851cz  a2200205n  4500
=001  9880364464002441
=005  20141212220327.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050612
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x300
=072  \\$aD12.$x776.$x543.$x585.$x300
=150  \\$aFatty Acid Transport Proteins
=450  \\$aFatty Acid-Transport Protein
=450  \\$wnnna$aFatty Acid Transport Protein
=550  \\$wg$aMembrane Transport Proteins
=550  \\$wh$aAntigens, CD36
=680  \\$iA broad category of membrane transport proteins that specifically transport FREE FATTY ACIDS across cellular membranes. They play an important role in LIPID METABOLISM in CELLS that utilize free fatty acids as an energy source.
=688  \\$a2006(1997)
=750  \0$aFatty acid-binding proteins$0(DLC) sh 90003862$5IEN-M

=LDR  00733cz  a2200205n  4500
=001  9880364464102441
=005  20141212220324.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050607
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x675
=150  \\$aOrganogold Compounds
=450  \\$wnnna$aCompounds, Organogold
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aAurothioglucose
=550  \\$wh$aGold Sodium Thiomalate
=550  \\$aGold
=680  \\$iOrganic compounds that contain GOLD as an integral part of the molecule. Some are used as ANTIRHEUMATIC AGENTS. The term chrysotherapy derives from an ancient Greek term for gold.
=688  \\$a2006
=750  \0$aOrganogold compounds$0(DLC) sh 85095549$5IEN-M

=LDR  00791cz  a2200205n  4500
=001  9880364464202441
=005  20150529164047.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050558
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x416.$x319
=150  \\$aCysteine Dioxygenase
=450  \\$wnnna$aCysteine Dioxygenase Type I
=450  \\$wnnna$aCysteine Oxidase
=450  \\$wnnna$aDioxygenase, Cysteine
=450  \\$wnnna$aOxidase, Cysteine
=550  \\$wg$aDioxygenases
=680  \\$iAn enzyme that catalyzes the conversion of L-CYSTEINE to 3-sulfinoalanine (3-sulfino-L-alanine) in the CYSTEINE metabolism and TAURINE and hypotaurine metabolic pathways.
=688  \\$a2006(1980); use CYSTEINE 1973-1979
=750  \2$aCysteine dioxygenase$0(DLC)sh2014002132$5IEN-M

=LDR  03126cz  a2200625n  4500
=001  9880364464302441
=005  20200511102855.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050556
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x170
=150  \\$aFatty Acid-Binding Proteins
=450  \\$wnnna$aAdipocyte Lipid Binding Protein
=450  \\$wnnna$aAdipocyte-Specific Fatty Acid-Binding Protein
=450  \\$wnnna$aAdipocyte Specific Fatty Acid Binding Protein
=450  \\$wnnna$aBrain-Type Fatty Acid-Binding Protein
=450  \\$wnnna$aBrain Type Fatty Acid Binding Protein
=450  \\$wnnna$aCytosolic Lipid-Binding Proteins
=450  \\$wnnna$aCytosolic Lipid Binding Proteins
=450  \\$wnnna$aFatty Acid-Binding Protein, Cardiac Myocyte
=450  \\$wnnna$aFatty Acid Binding Protein, Cardiac Myocyte
=450  \\$wnnna$aFatty Acid-Binding Protein, Myocardial
=450  \\$wnnna$aFatty Acid Binding Protein, Myocardial
=450  \\$wnnna$aFatty Acid Binding Proteins
=450  \\$wnnna$aFatty Acid-Binding Proteins, Adipocyte-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Adipocyte Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Brain-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Brain Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Cytosolic-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Cytosolic Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Intestinal-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Intestinal Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Liver-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Liver Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Myocardial-Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Myocardial Specific
=450  \\$wnnna$aFatty Acid-Binding Proteins, Plasma-Membrane Specific
=450  \\$wnnna$aFatty Acid Binding Proteins, Plasma Membrane Specific
=450  \\$wnnna$aIntestinal Fatty Acid-Binding Protein
=450  \\$wnnna$aIntestinal Fatty Acid Binding Protein
=450  \\$wnnna$aLipid-Binding Proteins, Cytosolic
=450  \\$wnnna$aLiver Fatty Acid-Binding Protein
=450  \\$wnnna$aLiver Fatty Acid Binding Protein
=450  \\$wnnna$aMyocardial Fatty Acid-Binding Protein
=450  \\$wnnna$aMyocardial Fatty Acid Binding Protein
=450  \\$wnnna$aPlasma Membrane Fatty Acid-Binding Protein
=450  \\$wnnna$aPlasma Membrane Fatty Acid Binding Protein
=550  \\$wg$aCarrier Proteins
=550  \\$wh$aFatty Acid-Binding Protein 3
=550  \\$wh$aFatty Acid-Binding Protein 7
=550  \\$wh$aMyelin P2 Protein
=667  \\$asee SCR for organism-specific terms
=680  \\$iIntracellular proteins that reversibly bind hydrophobic ligands including: saturated and unsaturated FATTY ACIDS; EICOSANOIDS; and RETINOIDS. They are considered a highly conserved and ubiquitously expressed family of proteins that may play a role in the metabolism of LIPIDS.
=688  \\$a2006
=750  \0$aFatty acid-binding proteins$0(DLC) sh 90003862$5IEN-M

=LDR  01240cz  a2200361n  4500
=001  9880364464402441
=005  20141212220308.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050528
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x245
=072  \\$aG7.$x610.$x240.$x245
=150  \\$aDiet, Carbohydrate-Restricted
=450  \\$wnnna$aAtkins Diet
=450  \\$wnnna$aBeach Diet, South
=450  \\$wnnna$aCarbohydrate Diet, Low
=450  \\$wnnna$aCarbohydrate Diets, Low
=450  \\$wnnna$aCarbohydrate-Restricted Diet
=450  \\$wnnna$aCarbohydrate-Restricted Diets
=450  \\$wnnna$aDiet, Atkins
=450  \\$wnnna$aDiet, Carbohydrate Restricted
=450  \\$wnnna$aDiet, Low Carbohydrate
=450  \\$wnnna$aDiet, South Beach
=450  \\$wnnna$aDiets, Carbohydrate-Restricted
=450  \\$wnnna$aDiets, Low Carbohydrate
=450  \\$wnnna$aLow Carbohydrate Diet
=450  \\$wnnna$aLow Carbohydrate Diets
=450  \\$wnnna$aSouth Beach Diet
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=680  \\$iA diet that contains limited amounts of CARBOHYDRATES. This is in distinction to a regular DIET.
=688  \\$a2006
=750  \0$aLow-carbohydrate diet$0(DLC) sh 85078627$5IEN-M

=LDR  00665cz  a2200205n  4500
=001  9880364464502441
=005  20141212193104.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050497
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x223.$x650
=072  \\$aC23.$x550.$x260.$x585.$x630
=072  \\$aG8.$x686.$x785.$x760.$x769.$x530.$x500
=150  \\$aStillbirth
=450  \\$wnnna$aStillbirths
=550  \\$wg$aFetal Death
=550  \\$wg$aPregnancy Outcome
=680  \\$iThe event that a FETUS is born dead or stillborn.
=688  \\$a2006; use PREGNANCY OUTCOME 2004-2005, use FETAL DEATH 1963-2003
=750  \0$aStillbirth$0(DLC) sh 85128116$5IEN-M

=LDR  00728cz  a2200217n  4500
=001  9880364464602441
=005  20141212220253.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050437
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x230
=150  \\$aGenes, Developmental
=450  \\$wnnna$aDevelopmental Gene
=450  \\$aDevelopmental Genes
=450  \\$wnnna$aGene, Developmental
=550  \\$wg$aGenes
=550  \\$wh$aGenes, Homeobox
=550  \\$aGene Expression Regulation, Developmental
=680  \\$iGenes that determine the fate of a cell or CELLS in a region of the embryo during EMBRYONIC DEVELOPMENT.
=688  \\$a2006
=750  \0$aDevelopmental genetics$0(DLC) sh 85037356$5IEN-M

=LDR  01343cz  a2200373n  4500
=001  9880364464702441
=005  20141212220252.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050417
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x734.$x414.$x131
=072  \\$aA6.$x390.$x131
=072  \\$aA6.$x407.$x414.$x87
=072  \\$aA11.$x382.$x625.$x92
=072  \\$aA11.$x436.$x294.$x92
=150  \\$aInsulin-Secreting Cells
=450  \\$wnnna$aB Cell, Pancreatic
=450  \\$wnnna$aB Cells, Pancreatic
=450  \\$wnnna$abeta Cell, Pancreatic
=450  \\$abeta Cells, Pancreatic
=450  \\$wnnna$aCell, Insulin-Secreting
=450  \\$wnnna$aCells, Insulin-Secreting
=450  \\$wnnna$aInsulin-Secreting Cell
=450  \\$wnnna$aInsulin Secreting Cells
=450  \\$wnnna$aPancreatic B Cell
=450  \\$wnnna$aPancreatic B Cells
=450  \\$wnnna$aPancreatic beta Cell
=450  \\$aPancreatic beta Cells
=550  \\$wg$aEnteroendocrine Cells
=550  \\$wg$aIslets of Langerhans
=667  \\$a/transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION
=680  \\$iA type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN.
=688  \\$a2006; use ISLETS OF LANGERHANS 1980-2005
=750  \0$aPancreatic beta cells$0(DLC) sh 89006279$5IEN-M

=LDR  02965cz  a2200685n  4500
=001  9880364464802441
=005  20141212220250.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050378
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x550.$x500.$x700
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569.$x200.$x700
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569.$x500.$x700
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x550.$x500.$x700
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569.$x200.$x700
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569.$x500.$x700
=072  \\$aA15.$x382.$x490.$x555.$x567.$x550.$x500.$x700
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569.$x200.$x700
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569.$x500.$x700
=150  \\$aT-Lymphocytes, Regulatory
=450  \\$wnnna$aCell, Th3
=450  \\$wnnna$aCell, Tr1
=450  \\$wnnna$aCell, Treg
=450  \\$wnnna$aCells, Th3
=450  \\$wnnna$aCells, Tr1
=450  \\$wnnna$aCells, Treg
=450  \\$wnnna$aNaturally-Occurring Suppressor T-Cell
=450  \\$wnnna$aNaturally-Occurring Suppressor T-Cells
=450  \\$wnnna$aNaturally-Occurring Suppressor T-Lymphocyte
=450  \\$wnnna$aNaturally-Occurring Suppressor T-Lymphocytes
=450  \\$wnnna$aRegulatory T-Cells
=450  \\$wnnna$aRegulatory T Cells
=450  \\$wnnna$aRegulatory T-Lymphocyte
=450  \\$aRegulatory T-Lymphocytes
=450  \\$wnnna$aRegulatory T Lymphocytes
=450  \\$wnnna$aSuppressor T-Cell, Naturally-Occurring
=450  \\$wnnna$aSuppressor T-Cells, Naturally-Occurring
=450  \\$wnnna$aSuppressor T Cells, Naturally Occurring
=450  \\$wnnna$aSuppressor T-Lymphocyte, Naturally-Occurring
=450  \\$aSuppressor T-Lymphocytes, Naturally-Occurring
=450  \\$wnnna$aSuppressor T Lymphocytes, Naturally Occurring
=450  \\$wnnna$aT-Cell, Naturally-Occurring Suppressor
=450  \\$wnnna$aT-Cells, Naturally-Occurring Suppressor
=450  \\$aT-Cells, Regulatory
=450  \\$wnnna$aT Cells, Regulatory
=450  \\$wnnna$aT-Lymphocyte, Regulatory
=450  \\$wnnna$aT Lymphocytes, Regulatory
=450  \\$wnnoa$aT-Lymphocytes, Suppressor-Effector$5IEN-M
=450  \\$wnnoa$aT-Lymphocytes, Suppressor-Inducer$5IEN-M
=450  \\$wnnna$aTh3 Cell
=450  \\$aTh3 Cells
=450  \\$wnnna$aTr1 Cell
=450  \\$wnnna$aTr1 Cells
=450  \\$wnnna$aTreg Cell
=450  \\$wnnna$aTreg Cells
=550  \\$wg$aCD4-Positive T-Lymphocytes
=550  \\$wg$aT-Lymphocyte Subsets
=680  \\$iCD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells.
=688  \\$a2006, 1985-1994; use T-LYMPHOCYTES 1995-2005
=750  \0$aSuppressor cells$0(DLC) sh 85130698$5IEN-M

=LDR  00708cz  a2200229n  4500
=001  9880364464902441
=005  20141212220248.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050356
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x520
=150  \\$aLipid Metabolism
=450  \\$aLipids$xmetabolism
=450  \\$wnnna$aMetabolism, Lipid
=550  \\$wg$aMetabolism
=550  \\$wh$aLipogenesis
=550  \\$wh$aLipolysis
=550  \\$wh$aLipoylation
=667  \\$ageneral; prefer/metab with specific lipids
=680  \\$iPhysiological processes in biosynthesis (anabolism) and degradation (catabolism) of LIPIDS.
=688  \\$a2006
=750  \0$aLipids$xMetabolism$0(DLC) sh 85077297$5IEN-M

=LDR  00931cz  a2200277n  4500
=001  9880364465002441
=005  20141212220246.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050296
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x580
=150  \\$aMicrobial Viability
=450  \\$wnnna$aBacteria Viability
=450  \\$aBacterial Viability
=450  \\$wnnna$aInactivation, Microbial
=450  \\$wnnna$aMicrobial Inactivation
=450  \\$wnnna$aViability, Bacteria
=450  \\$wnnna$aViability, Bacterial
=450  \\$wnnna$aViability, Microbial
=450  \\$wnnna$aViability, Virus
=450  \\$aVirus Viability
=550  \\$wg$aMicrobiological Phenomena
=550  \\$aColony Count, Microbial
=680  \\$iAbility of a microbe to survive under given conditions. This can also be related to a colony's ability to replicate.
=688  \\$a2006
=750  \0$aMicrobial inactivation$0(DLC)sh2012003775$5IEN-M

=LDR  01023cz  a2200277n  4500
=001  9880364465102441
=005  20141212220245.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050280
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x90
=150  \\$aArm Bones
=450  \\$wnnna$aArm Bone
=450  \\$wnnna$aBone, Arm
=450  \\$wnnna$aBones, Arm
=450  \\$aBones of Arm
=550  \\$wg$aBones of Upper Extremity
=550  \\$wh$aHumerus
=550  \\$wh$aRadius
=550  \\$wh$aUlna
=667  \\$ageneral or unspecified; prefer specifics; primates only; Manual 21.58
=680  \\$iThe bones of the free part of the upper extremity including the HUMERUS; RADIUS; and ULNA.
=688  \\$a2006; use BONES OF UPPER EXTREMITY 1998-2005
=750  \0$81$wb$aArm$0(DLC) sh 85007224$5IEN-M$0(DLC)sh 85007224
=750  \0$81$wb$aBones$0(DLC) sh 85015539$5IEN-M$0(DLC)sh 85015539
=788  \0$iSearch also under the following headings used together in the same record:$aArm$iand$aBones$5IEN-M

=LDR  00777cz  a2200241n  4500
=001  9880364465202441
=005  20141212220244.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050278
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x319.$x350
=150  \\$aFinger Phalanges
=450  \\$wnnna$aBones, Finger
=450  \\$aBones of Fingers
=450  \\$aFinger Bones
=450  \\$wnnna$aFingers Bones
=450  \\$wnnna$aPhalanges, Finger
=450  \\$aPhalanges of Fingers
=550  \\$wg$aHand Bones
=667  \\$aprimates only; Manual 21.58
=680  \\$iBones that make up the SKELETON of the FINGERS, consisting of two for the THUMB, and three for each of the other fingers.
=688  \\$a2006
=750  \0$aPhalanges$0(DLC) sh2005020094$5IEN-M

=LDR  00771cz  a2200241n  4500
=001  9880364465302441
=005  20141212220244.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050277
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x300.$x800
=150  \\$aToe Phalanges
=450  \\$aBones of Toes
=450  \\$wnnna$aBones, Toe
=450  \\$aPhalanges of Toes
=450  \\$wnnna$aPhalanges, Toe
=450  \\$aToe Bones
=450  \\$wnnna$aToes Bones
=550  \\$wg$aFoot Bones
=667  \\$apermitted with all vertebrates; Manual 21.58
=680  \\$iBones that make up the SKELETON of the TOES, consisting of two for the great toe, and three for each of the other toes.
=688  \\$a2006
=750  \0$aPhalanges$0(DLC) sh2005020094$5IEN-M

=LDR  01033cz  a2200277n  4500
=001  9880364465402441
=005  20141212220244.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050276
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x319
=150  \\$aHand Bones
=450  \\$wnnna$aBones, Hand
=450  \\$aBones of Hand
=450  \\$wnnna$aBones of Hands
=450  \\$wnnna$aHands Bones
=550  \\$wg$aBones of Upper Extremity
=550  \\$wh$aCarpal Bones
=550  \\$wh$aFinger Phalanges
=550  \\$wh$aMetacarpal Bones
=667  \\$aprimates only; Manual 21.58
=680  \\$iThe CARPAL BONES; METACARPAL BONES; and FINGER PHALANGES. In each hand there are eight carpal bones, five metacarpal bones, and 14 phalanges.
=688  \\$a2006
=750  \0$81$wb$aHand$0(DLC) sh 85058615$5IEN-M$0(DLC)sh 85058615
=750  \0$81$wb$aBones$0(DLC) sh 85015539$5IEN-M$0(DLC)sh 85015539
=788  \0$iSearch also under the following headings used together in the same record:$aHand$iand$aBones$5IEN-M

=LDR  00951cz  a2200301n  4500
=001  9880364465502441
=005  20170608132423.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050260
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x158
=072  \\$aG3.$x191
=150  \\$aCarbohydrate Metabolism
=450  \\$aCarbohydrates$xmetabolism
=450  \\$aMetabolism, Carbohydrate
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wh$aFermentation
=550  \\$wh$aGluconeogenesis
=550  \\$wh$aGlycogenolysis
=550  \\$wh$aGlycolysis
=550  \\$wh$aGlycosylation
=550  \\$wh$aPentose Phosphate Pathway
=550  \\$wh$aPhotosynthesis
=667  \\$ageneral; prefer specific carbohydrate/metab
=680  \\$iCellular processes in biosynthesis (anabolism) and degradation (catabolism) of CARBOHYDRATES.
=688  \\$a2006
=750  \0$aCarbohydrates$xMetabolism$0(DLC) sh 85020081$5IEN-M

=LDR  00826cz  a2200253n  4500
=001  9880364465602441
=005  20141212220241.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050256
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x593.$x249
=072  \\$aD27.$x505.$x954.$x248.$x147
=150  \\$aAntimitotic Agents
=450  \\$wnnna$aAgents, Antimitotic
=450  \\$wnnna$aAntimitotic Drugs
=450  \\$wnnna$aAntimitotics
=450  \\$wnnna$aDrugs, Antimitotic
=550  \\$wg$aAntineoplastic Agents
=550  \\$wg$aMitosis Modulators
=550  \\$wh$aTubulin Modulators
=550  \\$aMitosis
=680  \\$iAgents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS.
=688  \\$a2006; use ANTINEOPLASTIC AGENTS 1988-2005
=750  \0$aAntimitotic agents$0(DLC) sh 85005701$5IEN-M

=LDR  00773cz  a2200217n  4500
=001  9880364465702441
=005  20141212220240.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050197
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137.$x126.$x307
=150  \\$aAtherosclerosis
=450  \\$aAtherogenesis
=450  \\$wnnna$aAtheroscleroses
=550  \\$wg$aArteriosclerosis
=550  \\$wh$aPeripheral Arterial Disease
=550  \\$aChylomicron Remnants
=550  \\$aPlaque, Atherosclerotic
=680  \\$iA thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
=688  \\$a2006; use ARTERIOSCLEROSIS 1963-2005
=750  \0$aAtherosclerosis$0(DLC) sh 85009129$5IEN-M

=LDR  00508cz  a2200169n  4500
=001  9880364465802441
=005  20141212220239.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050178
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x351.$x676
=150  \\$aMonoglycerides
=450  \\$aMonoacylglycerols
=550  \\$wg$aGlycerides
=680  \\$iGLYCEROL esterified with a single acyl (FATTY ACIDS) chain.
=688  \\$a2006; use GLYCERIDES (1963-2005)
=750  \0$aMonoglycerides$0(DLC) sh 85086911$5IEN-M

=LDR  00833cz  a2200193n  4500
=001  9880364465902441
=005  20141212220239.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050177
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144.$x699
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x699
=072  \\$aG7.$x100.$x100.$x160.$x120.$x699
=150  \\$aOverweight
=550  \\$wg$aBody Weight
=550  \\$wh$aObesity
=680  \\$iA status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".
=688  \\$a2006
=750  \0$aOverweight persons$0(DLC) sh 89004326$5IEN-M

=LDR  00679cz  a2200169n  4500
=001  9880364466002441
=005  20141212220235.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050150
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x270
=150  \\$aChalones
=550  \\$wg$aOligopeptides
=667  \\$ado not confuse with CHALCONES
=680  \\$iPeptides that inhibit mitosis (ANTIMITOTICS). During the 1960's the term referred to crude extracts that inhibited cell proliferation; the activity was later attributed to PYROGLUTAMATE type oligopeptides.
=688  \\$a2006, 1969-1992; use GROWTH INHIBITORS 1993-2005
=750  \0$aChalones$0(DLC) sh 85022396$5IEN-M

=LDR  00719cz  a2200217n  4500
=001  9880364466102441
=005  20141212220234.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050111
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x491.$x567
=072  \\$aD9.$x546.$x412
=150  \\$aImino Sugars
=450  \\$wnnna$aSugars, Imino
=550  \\$wg$aImines
=550  \\$wg$aMonosaccharides
=550  \\$wh$aImino Furanoses
=550  \\$wh$aImino Pyranoses
=680  \\$iSugars in which the OXYGEN is replaced by a NITROGEN atom. This substitution prevents normal METABOLISM resulting in inhibition of GLYCOSIDASES and GLYCOSYLTRANSFERASES.
=688  \\$a2006
=750  \0$aImino sugars$0(DLC)sh2007003871$5IEN-M

=LDR  01435cz  a2200421n  4500
=001  9880364466202441
=005  20141212220234.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050110
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x65.$x62
=072  \\$aE4.$x62
=150  \\$aBariatric Surgery
=450  \\$wnnna$aBariatric Surgeries
=450  \\$wnnna$aBariatric Surgical Procedure
=450  \\$wnnna$aBariatric Surgical Procedures
=450  \\$wnnna$aMetabolic Surgeries
=450  \\$wnnna$aMetabolic Surgery
=450  \\$wnnna$aProcedure, Bariatric Surgical
=450  \\$wnnna$aProcedures, Bariatric Surgical
=450  \\$wnnna$aStapling, Stomach
=450  \\$wnnna$aStomach Stapling
=450  \\$wnnna$aSurgeries, Bariatric
=450  \\$wnnna$aSurgeries, Metabolic
=450  \\$wnnna$aSurgery, Bariatric
=450  \\$wnnna$aSurgery, Metabolic
=450  \\$wnnna$aSurgical Procedure, Bariatric
=450  \\$wnnna$aSurgical Procedures, Bariatric
=550  \\$wg$aBariatrics
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aGastric Bypass
=550  \\$wh$aGastroplasty
=550  \\$wh$aJejunoileal Bypass
=550  \\$wh$aLipectomy
=550  \\$aBariatric Medicine
=680  \\$iSurgical procedures aimed at affecting metabolism and producing major WEIGHT REDUCTION in patients with MORBID OBESITY.
=688  \\$a2006
=750  \0$aBariatric surgery$0(DLC) sh 85093648$5IEN-M

=LDR  01264cz  a2200337n  4500
=001  9880364466302441
=005  20141212220233.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x327
=072  \\$aE2.$x319.$x300.$x380.$x200
=072  \\$aJ1.$x637.$x512.$x600.$x200
=150  \\$aDendrimers
=450  \\$wnnna$aCompound, Dendritic
=450  \\$wnnna$aDendrimer
=450  \\$wnnna$aDendritic Compound
=450  \\$wnnna$aDendritic Compounds
=450  \\$wnnna$aDendritic Polymer
=450  \\$wnnna$aDendritic Polymers
=450  \\$wnnna$aDendrons
=450  \\$wnnna$aPolymer, Dendritic
=450  \\$wnnna$aPolymers, Dendritic
=550  \\$wg$aDrug Carriers
=550  \\$wg$aNanoparticles
=550  \\$wg$aPolymers
=667  \\$acoordinate with compounds comprising the dendrimers
=680  \\$iTree-like, highly branched, polymeric compounds. They grow three-dimensionally by the addition of shells of branched molecules to a central core. The overall globular shape and presence of cavities gives potential as drug carriers and CONTRAST AGENTS.
=688  \\$a2006
=750  \0$aDendrimers$0(DLC) sh 97003940$5IEN-M
=750  \0$aDendrimers in medicine$0(DLC)sh2007001788$5IEN-M

=LDR  01621cz  a2200313n  4500
=001  9880364466402441
=005  20200717130721.0
=008  050630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D050051
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x901
=072  \\$aD12.$x776.$x543.$x585.$x400.$x901
=150  \\$aTransient Receptor Potential Channels
=450  \\$wnnna$aCation Channels, TRP
=450  \\$wnnna$aChannels, TRP Cation
=450  \\$wnnna$aMembrane Proteins, TRP
=450  \\$wnnna$aProteins, TRP Membrane
=450  \\$wnnna$aTRP Cation Channels
=450  \\$wnnna$aTRP Membrane Proteins
=550  \\$wg$aIon Channels
=550  \\$wh$aTRPA1 Cation Channel
=550  \\$wh$aTRPC Cation Channels
=550  \\$wh$aTRPM Cation Channels
=550  \\$wh$aTRPP Cation Channels
=550  \\$wh$aTRPV Cation Channels
=667  \\$anote entry terms: TRP refers to transient receptor potential not TRYPTOPHAN
=680  \\$iA broad group of eukaryotic six-transmembrane cation channels that are classified by sequence homology because their functional involvement with SENSATION is varied. They have only weak voltage sensitivity and ion selectivity. They are named after a DROSOPHILA mutant that displayed transient receptor potentials in response to light. A 25-amino-acid motif containing a TRP box (EWKFAR) just C-terminal to S6 is found in TRPC, TRPV and TRPM subgroups. ANKYRIN repeats are found in TRPC, TRPV & TRPN subgroups. Some are functionally associated with TYROSINE KINASE or TYPE C PHOSPHOLIPASES.
=688  \\$a2006
=750  \0$aTRP channels$0(DLC)sh2004000502$5IEN-M

=LDR  00839cz  a2200229n  4500
=001  9880758430402441
=005  20190225122201.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003045
=035  \\$a(NLM)98199103500000041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 180.5.P4
=072  \\$aB1.$x300.$x381.$x230
=150  \\$aCoccidioides
=450  \\$aCoccidioides immitis
=450  \\$wnnna$aCoccidioide
=450  \\$wnnna$aCoccidioides immitides
=450  \\$wnnna$aimmitides, Coccidioides
=550  \\$wg$aMitosporic Fungi
=667  \\$ado not confuse with the sporozoon COCCIDIA; "coccidioidal" refers to COCCIDIOIDES: do not confuse with "coccidial" (refers to COCCIDIA); infection = COCCIDIOIDOMYCOSIS
=680  \\$iA mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.
=750  \0$aCoccidioides$0(DLC)sh2016000923$5IEN-M

=LDR  00635cz  a2200181n  4500
=001  9880758434702441
=005  20190222131458.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D062528
=035  \\$a(NLM)98197376160000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x250
=150  \\$aMedicalization
=450  \\$wnnna$aMedicalizations
=550  \\$wg$aSociological Factors
=680  \\$iA process by which nonmedical problems become defined and treated as medical problems, usually in terms of illnesses, or disorders. (Annu Rev Sociol 1992 18:209)
=688  \\$a2013
=750  \0$aMedicalization$0(DLC)sh2016000450$5IEN-M

=LDR  00996cz  a2200241n  4500
=001  9880758438402441
=005  20190221151117.0
=008  070709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D054458
=035  \\$a(NLM)98199007430000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x393.$x290.$x382
=072  \\$aE5.$x393.$x620.$x500.$x324
=150  \\$aAmplified Fragment Length Polymorphism Analysis
=450  \\$aAFLP Analysis
=450  \\$wnnna$aAFLP Analyses
=450  \\$wnnna$aAnalyses, AFLP
=450  \\$wnnna$aAnalysis, AFLP
=550  \\$wg$aPolymerase Chain Reaction
=550  \\$aPolymorphism, Restriction Fragment Length
=680  \\$iThe detection of RESTRICTION FRAGMENT LENGTH POLYMORPHISMS by selective PCR amplification of restriction fragments derived from genomic DNA followed by electrophoretic analysis of the amplified restriction fragments.
=688  \\$a2008
=750  \0$iRelated mapping$aTerminal restriction fragment length polymorphism analysis$0(DLC)sh2015000263$4RM$5IEN-M

=LDR  00691cz  a2200217n  4500
=001  9880758463102441
=005  20190218101835.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D027444
=035  \\$a(NLM)98197184520000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x595.$x400.$x587
=150  \\$aOcotea
=450  \\$wnnna$aOcotea bullata
=450  \\$wnnna$aOcotea bullatas
=450  \\$wnnna$aOcoteas
=450  \\$wnnna$abullata, Ocotea
=550  \\$wg$aLauraceae
=680  \\$iA plant genus in the LAURACEAE family. The common name of stinkwood is also used for Zieria (RUTACEAE).
=688  \\$a2002
=750  \0$aOcotea$0(DLC)sh2015002971$5IEN-M

=LDR  00765cz  a2200253n  4500
=001  9880758463302441
=005  20190218100402.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D063165
=035  \\$a(NLM)98193889980000041
=040  \\$aDNLM$cDNLM
=060  \0$aWV 21
=072  \\$aH2.$x403.$x600.$x500
=072  \\$aH2.$x403.$x810.$x526.$x500
=150  \\$aNeurotology
=450  \\$wnnna$aNeuro-Otology
=450  \\$wnnna$aOtoneurology
=450  \\$wnnna$aNeuro Otology
=550  \\$wg$aNeurology
=550  \\$wg$aOtolaryngology
=667  \\$ause for the specialty only
=680  \\$iA subspecialty of otolaryngology dealing with the parts of the nervous system related to the ear.
=688  \\$a2013
=750  \0$aNeurotology$0(DLC)sh2015003035$5IEN-M

=LDR  00861cz  a2200241n  4500
=001  9880758473102441
=005  20190215112005.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D061350
=035  \\$a(NLM)98195046190000041
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x910
=150  \\$aSympatry
=450  \\$wnnna$aSympatric Species
=450  \\$wnnna$aSpecies, Sympatric
=450  \\$wnnna$aSpecy, Sympatric
=450  \\$wnnna$aSympatric Specy
=450  \\$wnnna$aSympatries
=550  \\$wg$aGenetic Phenomena
=667  \\$afor sympatric speciation, coordinate with GENETIC SPECIATION
=680  \\$iIn evolutionary theory, overlapping geographic distribution of diverging species. In sympatric GENETIC SPECIATION, genetic diversion occurs without geographic separation.
=688  \\$a2012
=750  \0$aCoexistence of species$0(DLC)sh2010010172$5IEN-M

=LDR  01320cz  a2200325n  4500
=001  9880759447102441
=005  20190228133105.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D053823
=035  \\$a(NLM)98199820080000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x276.$x671
=072  \\$aD12.$x776.$x467.$x671
=072  \\$aD23.$x529.$x671
=150  \\$aHedgehog Proteins
=450  \\$wnnna$aBanded Hedgehog Protein
=450  \\$wnnna$aDesert Hedgehog Protein
=450  \\$wnnna$aIndian Hedgehog Protein
=450  \\$wnnna$aSonic Hedgehog Protein
=450  \\$wnnna$aVertebrate Hedgehog Protein
=450  \\$aHedgehog Protein, Vertebrate
=450  \\$wnnna$aHedgehog Protein, Banded
=450  \\$wnnna$aHedgehog Protein, Desert
=450  \\$wnnna$aHedgehog Protein, Indian
=450  \\$wnnna$aHedgehog Protein, Sonic
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$aZinc Finger Protein Gli2
=680  \\$iA family of intercellular signaling proteins that play an important role in regulating the development of many TISSUES and organs. Their name derives from the observation of a hedgehog-like appearance in DROSOPHILA embryos with genetic mutations that block their action.
=688  \\$a2007(1994)
=750  \0$aHedgehog proteins$0(DLC)sh2016001518$5IEN-M

=LDR  01964cz  a2200457n  4500
=001  9880759450402441
=005  20190228114036.0
=008  960610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019253
=035  \\$a(NLM)98199238570000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x75.$x718
=072  \\$aD12.$x776.$x476.$x75.$x718
=072  \\$aD12.$x776.$x624.$x664.$x700.$x169
=150  \\$aProto-Oncogene Proteins c-bcl-2
=450  \\$wnnna$aB-Cell Leukemia 2 Family Proteins
=450  \\$wnnna$aBCL2 Family Proteins
=450  \\$wnnna$aBCL2 Proteins
=450  \\$abcl-2 Proto-Oncogene Proteins
=450  \\$ac-bcl-2 Proteins
=450  \\$wnnna$aB Cell Leukemia 2 Family Proteins
=450  \\$wnnna$aFamily Proteins, BCL2
=450  \\$wnnna$aProteins, BCL2
=450  \\$wnnna$aProteins, BCL2 Family
=450  \\$wnnna$aProto Oncogene Proteins c bcl 2
=450  \\$wnnna$aProto-Oncogene Proteins, bcl-2
=450  \\$wnnna$abcl 2 Proto Oncogene Proteins
=450  \\$wnnna$ac bcl 2 Proteins
=450  \\$wnnna$ac-bcl-2, Proto-Oncogene Proteins
=550  \\$wg$aApoptosis Regulatory Proteins
=550  \\$wg$aProto-Oncogene Proteins
=550  \\$wh$abcl-Associated Death Protein
=550  \\$wh$abcl-2-Associated X Protein
=550  \\$wh$abcl-2 Homologous Antagonist-Killer Protein
=550  \\$wh$abcl-X Protein
=550  \\$wh$aBH3 Interacting Domain Death Agonist Protein
=550  \\$wh$aMyeloid Cell Leukemia Sequence 1 Protein
=550  \\$aGenes, bcl-2
=680  \\$iMembrane proteins encoded by the BCL-2 GENES and serving as potent inhibitors of cell death by APOPTOSIS. The proteins are found on mitochondrial, microsomal, and NUCLEAR MEMBRANE sites within many cell types. Overexpression of bcl-2 proteins, due to a translocation of the gene, is associated with follicular lymphoma.
=688  \\$a97; was PROTO-ONCOGENE PROTEIN BCL-2 (NM) 1989-96
=750  \0$aBcl-2 protein family$0(DLC)sh2016001643$5IEN-M

=LDR  00705cz  a2200193n  4500
=001  9880759454802441
=005  20190304142442.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D014994
=035  \\$a(NLM)98197650860000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 81
=072  \\$aD9.$x947.$x875.$x627.$x867
=150  \\$aXylose
=450  \\$wnnna$aD-Xylose
=450  \\$wnnna$aD Xylose
=550  \\$wg$aPentoses
=680  \\$aA pentose sugar found in many woody materials; combustible, white crystals with a sweet taste; soluble in water and alcohol; melts about 148 C; used as a nonnutritive sweetener and in dyeing and tanning. Also known as wood sugar
=750  \0$aXylose$0(DLC)sh2016001496$5IEN-M

=LDR  01765cz  a2200421n  4500
=001  9880759456502441
=005  20190227113128.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D035683
=035  \\$a(NLM)98197863460000041
=040  \\$aDNLM$cDNLM
=072  \\$aD13.$x150.$x650.$x319
=072  \\$aD13.$x444.$x735.$x150.$x319
=072  \\$aD13.$x444.$x735.$x790.$x552.$x500
=150  \\$aMicroRNAs
=450  \\$wnnna$aMicro RNA
=450  \\$wnnna$aMicroRNA
=450  \\$wnnna$aPrimary MicroRNA
=450  \\$wnnna$aPrimary miRNA
=450  \\$wnnna$amiRNAs
=450  \\$wnnna$apre-miRNA
=450  \\$wnnna$apri-miRNA
=450  \\$aRNA, Small Temporal
=450  \\$aSmall Temporal RNA
=450  \\$amiRNA
=450  \\$astRNA
=450  \\$wnnna$aMicroRNA, Primary
=450  \\$wnnna$aRNA, Micro
=450  \\$wnnna$aTemporal RNA, Small
=450  \\$wnnna$amiRNA, Primary
=450  \\$wnnna$apre miRNA
=450  \\$wnnna$apri miRNA
=550  \\$wg$aRNA, Antisense
=550  \\$wh$aCirculating MicroRNA
=550  \\$aRNA, Small Interfering
=680  \\$iSmall double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing.
=688  \\$a2003; use MICRORNAS (NM) 2001-2002
=750  \2$aMicroRNA$0(DLC)sh2016001376$5IEN-M

=LDR  00870cz  a2200217n  4500
=001  9880759456902441
=005  20190227105553.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004610
=035  \\$a(NLM)98200010350000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x663.$x283.$x500
=072  \\$aD3.$x633.$x100.$x150.$x500
=150  \\$aEllagic Acid
=450  \\$aBenzoaric Acid
=450  \\$wnnna$aAcid, Benzoaric
=450  \\$wnnna$aAcid, Ellagic
=550  \\$wg$aBenzopyrans
=680  \\$iA fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye.
=688  \\$a91(75); was see under BENZOPYRANS 1975-90
=750  \0$aEllagic acid$0(DLC)sh2016001484$5IEN-M

=LDR  00574cz  a2200169n  4500
=001  9880759457302441
=005  20190227100933.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D058530
=035  \\$a(NLM)98196128970000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x908.$x500.$x188.$x550
=150  \\$aDatura metel
=550  \\$wg$aDatura
=680  \\$iA plant species and perennial herb of the genus DATURA, family SOLANACEAE, containing poisonous tropane ALKALOIDS.
=688  \\$a2011
=750  \0$aDatura inoxia$0(DLC)sh 85035893$5IEN-M

=LDR  01234cz  a2200313n  4500
=001  9880759469302441
=005  20190225162817.0
=008  160126\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071243
=035  \\$a(NLM)985402204200041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 524
=072  \\$aC2.$x81.$x990
=072  \\$aC2.$x782.$x350.$x250.$x990
=150  \\$aZika Virus Infection
=450  \\$wnnna$aFever, Zika
=450  \\$wnnna$aZikV Infection
=450  \\$wnnna$aZika Fever
=450  \\$wnnna$aZika Virus Disease
=450  \\$wnnna$aDisease, Zika Virus
=450  \\$wnnna$aInfection, ZikV
=450  \\$wnnna$aInfection, Zika Virus
=450  \\$wnnna$aVirus Disease, Zika
=450  \\$wnnna$aVirus Infection, Zika
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aFlavivirus Infections
=680  \\$iA viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is a cause of congenital brain abnormalities, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME.
=688  \\$a2016
=750  \0$aZika virus infection$0(DLC)sh2016001078$5IEN-M

=LDR  00727cz  a2200217n  4500
=001  9880759469602441
=005  20190225161722.0
=008  160126\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071244
=035  \\$a(NLM)985402200300041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 168.5.F5
=072  \\$aB4.$x820.$x250.$x350.$x995
=150  \\$aZika Virus
=450  \\$wnnna$aVirus, Zika
=450  \\$wnnna$aZikV
=550  \\$wg$aFlavivirus
=667  \\$ainfection = ZIKA VIRUS INFECTION
=680  \\$iAn arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas.
=688  \\$a2016
=750  \0$aZika virus$0(DLC)sh2016001016$5IEN-M

=LDR  00727cz  a2200229n  4500
=001  9880759470402441
=005  20190225151337.0
=008  980610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020036
=035  \\$a(NLM)98197642590000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x650
=150  \\$aOnygenales
=450  \\$aAjellomyces
=450  \\$wnnna$aAjellomyce
=450  \\$wnnna$aOnygenale
=550  \\$wg$aAscomycota
=550  \\$aBlastomyces
=550  \\$aChrysosporium
=680  \\$iAn order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic (anamorphic) forms are prominent.
=688  \\$a99
=750  \0$aOnygenales$0(DLC)sh2016001305$5IEN-M

=LDR  01622cz  a2200517n  4500
=001  9880759472602441
=005  20190225142031.0
=008  810514\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003411
=035  \\$a(NLM)98199359420000041
=040  \\$aDNLM$cDNLM
=060  \0$aQL 737.R666
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992.$x635.$x75
=150  \\$aArvicolinae
=450  \\$wnnna$aArvicolines
=450  \\$wnnna$aMicrotines
=450  \\$wnnna$aMouse, Red-Backed
=450  \\$wnnna$aMyodes
=450  \\$wnnna$aOndatra zibethicus
=450  \\$aClethrionomys
=450  \\$aCricetidae
=450  \\$aDicrostonyx
=450  \\$aLemmings
=450  \\$aLemmus
=450  \\$aMice, Red-Backed
=450  \\$aMicrotinae
=450  \\$aMicrotus
=450  \\$aMuskrats
=450  \\$aOndatra
=450  \\$aVoles
=450  \\$wnnna$aArvicoline
=450  \\$wnnna$aLemming
=450  \\$wnnna$aMice, Red Backed
=450  \\$wnnna$aMicrotine
=450  \\$wnnna$aMouse, Red Backed
=450  \\$wnnna$aMuskrat
=450  \\$wnnna$aRed-Backed Mice
=450  \\$wnnna$aRed-Backed Mouse
=450  \\$wnnna$aVole
=550  \\$wg$aMuridae
=550  \\$wh$aCricetinae
=550  \\$wh$aSigmodontinae
=667  \\$afor entry term MICE, RED-BACKED & other species commonly called "mouse" but taxonomically ARVICOLINAE, do not check tag MICE
=680  \\$iA subfamily of MURIDAE found nearly world-wide and consisting of about 20 genera. Voles, lemmings, and muskrats are members.
=688  \\$a2006 (1991); for VOLES & MICROTUS use RODENTS 1975-1981
=750  \0$aMicrotus$0(DLC)sh 85084942$5IEN-M

=LDR  01077cz  a2200241n  4500
=001  9880761066202441
=005  20180904000000.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065207
=035  \\$a(NLM)983985428100041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x820.$x504.$x540.$x150.$x113.$x750
=150  \\$aMiddle East Respiratory Syndrome Coronavirus
=450  \\$wnnna$aMERS Virus
=450  \\$wnnna$aMERS-CoV
=450  \\$wnnna$aMiddle East respiratory syndrome-related coronavirus
=450  \\$wnnna$aMERS Viruses
=450  \\$wnnna$aMiddle East respiratory syndrome related coronavirus
=450  \\$wnnna$aVirus, MERS
=450  \\$wnnna$aViruses, MERS
=667  \\$ainfection: coordinate IM with MIDDLE EAST RESPIRATORY SYNDROME see CORONAVIRUS INFECTIONS (IM)
=680  \\$iA coronavirus first reported in the summer of 2012 in a pneumonia patient in SAUDI ARABIA. It is related to SARS VIRUS. MERS-CoV has an estimated incubation period of 12 days and symptoms include renal failure and severe acute pneumonia with often fatal outcome.
=688  \\$a2015

=LDR  00757cz  a2200229n  4500
=001  9880761067802441
=005  20190304143951.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010403
=035  \\$a(NLM)98199458870000041
=040  \\$aDNLM$cDNLM
=072  \\$aG6.$x99.$x225.$x500.$x600
=072  \\$aG6.$x225.$x347.$x500.$x600
=072  \\$aG7.$x690.$x773.$x984.$x269.$x347.$x500.$x600
=150  \\$aPenicillin Resistance
=450  \\$wnnna$aPenicillin Resistances
=450  \\$wnnna$aResistance, Penicillin
=450  \\$wnnna$aResistances, Penicillin
=550  \\$wg$abeta-Lactam Resistance
=680  \\$iNonsusceptibility of an organism to the action of penicillins.
=688  \\$a64
=750  \0$aPenicillin resistance$0(DLC)sh2016001935$5IEN-M

=LDR  01261cz  a2200289n  4500
=001  9880761068002441
=005  20190304141540.0
=008  891020\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015693
=035  \\$a(NLM)98194823470000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x964.$x775.$x362
=072  \\$aD12.$x776.$x964.$x925.$x500
=150  \\$aGene Products, nef
=450  \\$wnnna$a3'-orf Protein
=450  \\$wnnna$aGene Product, nef
=450  \\$anef Gene Products
=450  \\$anef Protein
=450  \\$wnnna$a3' orf Protein
=450  \\$wnnna$anef Gene Product
=550  \\$wg$aRetroviridae Proteins
=550  \\$wg$aViral Regulatory and Accessory Proteins
=550  \\$wh$anef Gene Products, Human Immunodeficiency Virus
=550  \\$aHIV Long Terminal Repeat
=680  \\$iProducts of the retroviral NEF GENE. They play a role as accessory proteins that influence the rate of viral infectivity and the destruction of the host immune system. nef gene products were originally found as factors that trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor.
=688  \\$a91(90); was see under VIRAL REGULATORY PROTEINS 1990
=750  \0$aNef protein$0(DLC)sh2015001326$5IEN-M

=LDR  00603cz  a2200205n  4500
=001  9880761069902441
=005  20190304115205.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003596
=035  \\$a(NLM)98194324290000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x421
=150  \\$aCytosine
=550  \\$wg$aPyrimidinones
=550  \\$wh$aCidofovir
=550  \\$wh$aFlucytosine
=550  \\$wh$a5-Methylcytosine
=667  \\$a/biosyn /physiol permitted
=680  \\$iA pyrimidine base that is a fundamental unit of nucleic acids.
=750  \0$aCytosine$0(DLC)sh2016002047$5IEN-M

=LDR  00762cz  a2200205n  4500
=001  9880761073802441
=005  20190304105325.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073624
=035  \\$a(NLM)9810900644400041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x970.$x500
=072  \\$aK1.$x752.$x798.$x750
=150  \\$aSymbolic Interactionism
=450  \\$wnnna$aSymbolic Interactionisms
=550  \\$wg$aSocial Theory
=550  \\$wg$aSymbolism
=680  \\$iTheoretical approach to social processes with a fundamental concern with power phenomena. There is a focus on the analysis of culture, the influence of Foucault, and the development of feminist perspectives.
=688  \\$a2018
=750  \\$aSymbolic interactionism$0(DLC)sh 85131404$5IEN-M

=LDR  02261cz  a2200565n  4500
=001  9880761073902441
=005  20190304100833.0
=008  900529\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016254
=035  \\$a(NLM)98198016450000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 55.95
=072  \\$aE5.$x393.$x420.$x601.$x550
=072  \\$aG5.$x365.$x590.$x575
=072  \\$aG5.$x558.$x550
=150  \\$aMutagenesis, Insertional
=450  \\$aGene Insertion
=450  \\$aInsertion Mutation
=450  \\$aInsertional Activation
=450  \\$aInsertional Mutagenesis
=450  \\$aLinker-Insertion Mutagenesis
=450  \\$aMutagenesis, Cassette
=450  \\$aSequence Insertion
=450  \\$aViral Insertional Mutagenesis
=450  \\$wnnna$aActivation, Insertional
=450  \\$wnnna$aActivations, Insertional
=450  \\$wnnna$aCassette Mutagenesis
=450  \\$wnnna$aGene Insertions
=450  \\$wnnna$aInsertion Mutations
=450  \\$wnnna$aInsertion, Gene
=450  \\$wnnna$aInsertion, Sequence
=450  \\$wnnna$aInsertional Activations
=450  \\$wnnna$aInsertional Mutagenesis, Viral
=450  \\$wnnna$aInsertions, Gene
=450  \\$wnnna$aInsertions, Sequence
=450  \\$wnnna$aLinker Insertion Mutagenesis
=450  \\$wnnna$aMutagenesis, Linker-Insertion
=450  \\$wnnna$aMutagenesis, Viral Insertional
=450  \\$wnnna$aMutation, Insertion
=450  \\$wnnna$aMutations, Insertion
=450  \\$wnnna$aSequence Insertions
=550  \\$aDNA Transposable Elements
=550  \\$aProviruses
=550  \\$aRetroelements
=550  \\$aInterspersed Repetitive Sequences
=550  \\$wg$aMutation
=550  \\$aAlu Elements
=680  \\$iMutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene or extragenic sequence. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA insertions into or adjacent to a cellular proto-oncogene can interrupt GENETIC TRANSLATION of the coding sequences or interfere with recognition of regulatory elements and cause unregulated expression of the proto-oncogene resulting in tumor formation.
=688  \\$a91
=750  \0$aInsertional mutagenesis$0(DLC)sh2016001982$5IEN-M

=LDR  01581cz  a2200457n  4500
=001  9880763260402441
=005  20190308141918.0
=008  790529\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010362
=035  \\$a(NLM)98196906900000041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x220.$x640
=150  \\$aPatients' Rooms
=450  \\$aPrivate Rooms
=450  \\$aRooms, Patient
=450  \\$aSemi-Private Rooms
=450  \\$aWards, General
=450  \\$wnnna$aGeneral Ward
=450  \\$wnnna$aGeneral Wards
=450  \\$wnnna$aPatient Room
=450  \\$wnnna$aPatient Rooms
=450  \\$wnnna$aPatient's Rooms
=450  \\$wnnna$aPatients Rooms
=450  \\$wnnna$aPatients' Room
=450  \\$wnnna$aPrivate Room
=450  \\$wnnna$aRoom, Patient
=450  \\$wnnna$aRoom, Patients'
=450  \\$wnnna$aRoom, Private
=450  \\$wnnna$aRoom, Semi-Private
=450  \\$wnnna$aRooms, Patients'
=450  \\$wnnna$aRooms, Private
=450  \\$wnnna$aRooms, Semi-Private
=450  \\$wnnna$aSemi Private Rooms
=450  \\$wnnna$aSemi-Private Room
=450  \\$wnnna$aWard, General
=550  \\$wg$aHealth Facility Environment
=550  \\$wg$aHealth Services Accessibility
=667  \\$anote X ref WARDS, GENERAL but special care wards = HOSPITAL UNITS or specific
=680  \\$iRooms occupied by one or more individuals during a stay in a health facility. The concept includes aspects of environment, design, care, or economics.
=688  \\$a91(80); was see under HEALTH FACILITIES 1980-90
=750  \0$aPatient rooms$0(DLC)sh2016002756$5IEN-M

=LDR  01252cz  a2200301n  4500
=001  9880763260802441
=005  20190308140707.0
=008  790529\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006272
=035  \\$a(NLM)98198139400000041
=040  \\$aDNLM$cDNLM
=060  \0$aWX 140
=072  \\$aN2.$x278.$x220
=072  \\$aN5.$x300.$x430.$x400
=150  \\$aHealth Facility Environment
=450  \\$wnnna$aEnvironment, Health Facility
=450  \\$wnnna$aFamily Planning, Environment
=450  \\$wnnna$aEnvironments, Health Facility
=450  \\$wnnna$aFacility Environment, Health
=450  \\$wnnna$aHealth Facility Environments
=550  \\$wg$aHealth Facilities
=550  \\$wg$aHealth Services Accessibility
=550  \\$wh$aPatients' Rooms
=680  \\$iPhysical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff.
=688  \\$a91(80); was see under HEALTH FACILITIES 1980-90
=750  \0$iBroader mapping$aHealth facilities$0(DLC)sh 85059543$4BM$5IEN-M
=780  \0$iBroader mapping$aEnvironmental aspects$0(DLC)sh 99005383$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading:$aHealth Facilities--Environmental aspects$5IEN-M

=LDR  00659cz  a2200229n  4500
=001  9880764268102441
=005  20190315161434.0
=008  780517\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001087
=035  \\$a(NLM)98193873680000041
=040  \\$aDNLM$cDNLM
=072  \\$aD13.$x570.$x65
=150  \\$aArabinonucleosides
=450  \\$aArabinofuranosylnucleosides
=550  \\$wg$aNucleosides
=550  \\$wh$aArabinofuranosyluracil
=550  \\$wh$aClofarabine
=550  \\$wh$aCytarabine
=550  \\$wh$aVidarabine
=680  \\$iNucleosides containing arabinose as their sugar moiety.
=688  \\$a79
=750  \0$aArabinonucleosides$0(DLC)sh2017000416$5IEN-M

=LDR  01020cz  a2200361n  4500
=001  9880764272102441
=005  20190311114902.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013400
=035  \\$a(NLM)98197601910000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 84
=072  \\$aD2.$x241.$x81.$x844
=072  \\$aD2.$x241.$x511.$x902
=072  \\$aD9.$x811
=150  \\$aSugar Acids
=450  \\$wnnna$aAcids, Sugar
=550  \\$wg$aAcids, Acyclic
=550  \\$wg$aCarbohydrates
=550  \\$wg$aHydroxy Acids
=550  \\$wh$aAscorbic Acid
=550  \\$wh$a2,3-Diketogulonic Acid
=550  \\$wh$aGlucaric Acid
=550  \\$wh$aGluconates
=550  \\$wh$aGlyceric Acids
=550  \\$wh$aMuramic Acids
=550  \\$wh$aNeuramic Acids
=550  \\$wh$aTartrates
=550  \\$wh$aTartronates
=550  \\$wh$aUronic Acids
=680  \\$iMONOSACCHARIDES and other sugars that contain one or more carboxylic acid moieties.
=688  \\$a73
=750  \0$aSugar acids$0(DLC)sh2017000295$5IEN-M

=LDR  01075cz  a2200241n  4500
=001  9880764273902441
=005  20190311101542.0
=008  771205\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000229
=035  \\$a(NLM)98198646330000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x280.$x580.$x650.$x170
=150  \\$aDependovirus
=450  \\$wnnna$aAdeno-Associated Virus
=450  \\$wnnna$aVirus, Adeno-Associated
=450  \\$wnnna$aViruses, Adeno-Associated
=450  \\$aAdeno-Associated Viruses
=450  \\$wnnna$aDependoviruses
=550  \\$wg$aParvovirinae
=667  \\$ainfection: coord IM with PARVOVIRIDAE INFECTIONS (IM)
=680  \\$iA genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.
=688  \\$a94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93
=750  \0$aDependoviruses$0(DLC)sh2017000361$5IEN-M

=LDR  01052cz  a2200349n  4500
=001  9880764274102441
=005  20190311110424.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000144
=035  \\$a(NLM)98194634400000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x81.
=150  \\$aAcids, Acyclic
=450  \\$aAcyclic Acids
=550  \\$wg$aCarboxylic Acids
=550  \\$wh$aAcetates
=550  \\$wh$aAcrylates
=550  \\$wh$aButyrates
=550  \\$wh$aCaproates
=550  \\$wh$aCaprylates
=550  \\$wh$aCarbamates
=550  \\$wh$aDicarboxylic Acids
=550  \\$wh$aFormates
=550  \\$wh$aImino Acids
=550  \\$wh$aPropionates
=550  \\$wh$aSugar Acids
=550  \\$wh$aTricarboxylic Acids
=550  \\$wh$aValerates
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iCarboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.
=688  \\$a98; use explode 1967-97
=750  \0$aAcyclic acids$0(DLC)sh2017000296$5IEN-M

=LDR  01956cz  a2200529n  4500
=001  9880767036102441
=005  20190320160317.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D058765
=035  \\$a(NLM)98195923260000041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 103.3
=072  \\$aE2.$x190.$x525.$x123.$x500
=072  \\$aF2.$x830.$x131.$x500
=072  \\$aF4.$x754.$x137.$x301.$x750
=072  \\$aF4.$x754.$x308.$x500.$x750
=150  \\$aNeurofeedback
=450  \\$wnnna$aEEG Feedback
=450  \\$wnnna$aElectroencephalography Biofeedback
=450  \\$wnnna$aElectromyography Feedback
=450  \\$aAlpha Biofeedback
=450  \\$aAlpha Feedback
=450  \\$aBrainwave Biofeedback
=450  \\$aBrainwave Feedback
=450  \\$wnnna$aAlpha Biofeedbacks
=450  \\$wnnna$aAlpha Feedbacks
=450  \\$wnnna$aBiofeedback, Alpha
=450  \\$wnnna$aBiofeedback, Brainwave
=450  \\$wnnna$aBiofeedback, Electroencephalography
=450  \\$wnnna$aBiofeedbacks, Alpha
=450  \\$wnnna$aBiofeedbacks, Brainwave
=450  \\$wnnna$aBiofeedbacks, Electroencephalography
=450  \\$wnnna$aBrainwave Biofeedbacks
=450  \\$wnnna$aBrainwave Feedbacks
=450  \\$wnnna$aEEG Feedbacks
=450  \\$wnnna$aElectroencephalography Biofeedbacks
=450  \\$wnnna$aFeedback, Alpha
=450  \\$wnnna$aFeedback, Brainwave
=450  \\$wnnna$aFeedback, EEG
=450  \\$wnnna$aFeedbacks, Alpha
=450  \\$wnnna$aFeedbacks, Brainwave
=450  \\$wnnna$aFeedbacks, EEG
=450  \\$wnnna$aNeurofeedbacks
=550  \\$wg$aBiofeedback, Psychology
=680  \\$iA technique to self-regulate brain activities provided as a feedback in order to better control or enhance one's own performance, control or function. This is done by trying to bring brain activities into a range associated with a desired brain function or status.
=688  \\$a2011
=750  \0$aNeurofeedback$0(DLC)sh2017003467$5IEN-M

=LDR  00700cz  a2200241n  4500
=001  9880767045602441
=005  20190319100331.0
=008  020702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D031842
=035  \\$a(NLM)98194448180000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x836.$x750.$x33
=150  \\$aActaea
=450  \\$aBaneberry
=450  \\$aBugbane
=450  \\$wnnna$aActaeas
=450  \\$wnnna$aBaneberries
=450  \\$wnnna$aBugbanes
=550  \\$wg$aRanunculaceae
=667  \\$aACTAEA RACEMOSA see CIMICIFUGA is also available
=680  \\$iA plant genus of the family RANUNCULACEAE.
=688  \\$a2003
=750  \0$aActaea$0(DLC)sh2017003185$5IEN-M

=LDR  01072cz  a2200241n  4500
=001  9880767046802441
=005  20190318144631.0
=008  940531\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018809
=035  \\$a(NLM)98199949390000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x660.$x740
=072  \\$aD23.$x50.$x290.$x750
=072  \\$aD23.$x101.$x140.$x600
=150  \\$aProliferating Cell Nuclear Antigen
=450  \\$aAntigen, Proliferating Cell Nuclear
=450  \\$aPCNA
=550  \\$wg$aAntigens, Nuclear
=550  \\$wg$aBiomarkers, Tumor
=550  \\$wg$aNuclear Proteins
=680  \\$iNuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types.
=688  \\$a95; was PROLIFERATING CELL NUCLEAR ANTIGEN (NM) 1983-94
=750  \0$aProliferating cell nuclear antigen$0(DLC)sh2017003086$5IEN-M

=LDR  01566cz  a2200361n  4500
=001  9880767047402441
=005  20190318142531.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008473
=035  \\$a(NLM)98198235690000041
=040  \\$aDNLM$cDNLM
=072  \\$aA6.$x688.$x178.$x750
=072  \\$aA6.$x688.$x357.$x500
=072  \\$aA8.$x186.$x211.$x180.$x497.$x352.$x435.$x249
=072  \\$aA8.$x186.$x211.$x200.$x317.$x357.$x352.$x435.$x249
=072  \\$aA8.$x713.$x49.$x750
=072  \\$aA8.$x713.$x357.$x500
=150  \\$aMedian Eminence
=450  \\$wnnna$aEminentia Mediana
=450  \\$wnnna$aMedial Eminence
=450  \\$wnnna$aEminence, Medial
=450  \\$wnnna$aEminence, Median
=450  \\$wnnna$aEminences, Medial
=450  \\$wnnna$aEminentia Medianas
=450  \\$wnnna$aMedial Eminences
=450  \\$wnnna$aMediana, Eminentia
=450  \\$wnnna$aMedianas, Eminentia
=550  \\$wg$aCircumventricular Organs
=550  \\$wg$aHypothalamo-Hypophyseal System
=667  \\$adiseases: coordinate IM with BRAIN DISEASES (IM)
=680  \\$iRaised area at the infundibular region of the HYPOTHALAMUS at the floor of the BRAIN, ventral to the THIRD VENTRICLE and adjacent to the ARCUATE NUCLEUS OF HYPOTHALAMUS. It contains the terminals of hypothalamic neurons and the capillary network of hypophyseal portal system, thus serving as a neuroendocrine link between the brain and the PITUITARY GLAND.
=688  \\$a83(75); was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82
=750  \0$aMedian eminence$0(DLC)sh2017003090$5IEN-M

=LDR  01212cz  a2200349n  4500
=001  9880767051102441
=005  20190318104101.0
=008  750718\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006853
=035  \\$a(NLM)98194688230000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x562.$x149.$x287
=072  \\$aD3.$x605.$x497.$x607.$x204.$x540
=072  \\$aD3.$x633.$x400.$x686.$x607.$x204.$x540
=072  \\$aD4.$x615.$x723.$x795.$x576.$x149.$x287
=150  \\$aHydrocodone
=450  \\$wnnna$aCodinovo
=450  \\$wnnna$aDicodid
=450  \\$wnnna$aHycodan
=450  \\$wnnna$aHycon
=450  \\$wnnna$aHydrocodon
=450  \\$wnnna$aHydrocodone Bitartrate
=450  \\$wnnna$aHydrocodone Tartrate (1:1), Hydrate (2:5)
=450  \\$wnnna$aRobidone
=450  \\$aDihydrocodeinone
=450  \\$aHydrocodeinonebitartrate
=450  \\$aHydrocon
=550  \\$wg$aCodeine
=667  \\$ado not confuse HYDROCODONE x refs with OXYCODONE x refs
=680  \\$iNarcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant.
=688  \\$a91(76); was see under CODEINE 1976-90
=750  \0$aHydrocodone$0(DLC)sh2017002967$5IEN-M

=LDR  01206cz  a2200301n  4500
=001  9880767051302441
=005  20190318101548.0
=008  760505\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006478
=035  \\$a(NLM)98195298540000041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 534
=072  \\$aC2.$x782.$x82.$x440
=072  \\$aC2.$x782.$x417.$x400
=150  \\$aHemorrhagic Fever, American
=450  \\$aHemorrhagic Fever, Argentinian
=450  \\$aHemorrhagic Fever, Bolivian
=450  \\$wnnna$aAmerican Hemorrhagic Fever
=450  \\$wnnna$aArgentinian Hemorrhagic Fever
=450  \\$wnnna$aBolivian Hemorrhagic Fever
=450  \\$wnnna$aFever, American Hemorrhagic
=450  \\$wnnna$aFever, Argentinian Hemorrhagic
=450  \\$wnnna$aFever, Bolivian Hemorrhagic
=550  \\$wg$aArenaviridae Infections
=667  \\$acaused by ARENAVIRUSES, NEW WORLD
=680  \\$iDiseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD).
=688  \\$a77; HEMORRHAGIC FEVER, ARGENTINIAN & HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76
=750  \0$aHemorrhagic fever, American$0(DLC)sh2017003034$5IEN-M

=LDR  01804cz  a2200457n  4500
=001  9880767054702441
=005  20190315161735.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D014740
=035  \\$a(NLM)98196345510000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 268.5
=072  \\$aD3.$x633.$x100.$x759.$x590.$x138.$x900
=072  \\$aD13.$x570.$x65.$x950
=072  \\$aD13.$x570.$x583.$x138.$x900
=150  \\$aVidarabine
=450  \\$wnnna$a9-beta-Arabinofuranosyladenine
=450  \\$wnnna$a9-beta-D-Arabinofuranosyladenine
=450  \\$wnnna$aAra A
=450  \\$wnnna$aVira-A
=450  \\$wnnna$aalpha-Ara A
=450  \\$wnnna$aalpha-D-Arabinofuranosyladenine
=450  \\$wnnna$abeta-Ara A
=450  \\$aAdenine Arabinoside
=450  \\$aAra-A
=450  \\$aArabinofuranosyladenine
=450  \\$aArabinosyladenine
=450  \\$wnnna$a9 beta Arabinofuranosyladenine
=450  \\$wnnna$a9 beta D Arabinofuranosyladenine
=450  \\$wnnna$aArabinoside, Adenine
=450  \\$wnnna$aVira A
=450  \\$wnnna$aViraA
=450  \\$wnnna$aalpha Ara A
=450  \\$wnnna$aalpha D Arabinofuranosyladenine
=450  \\$wnnna$abeta Ara A
=550  \\$wg$aAdenosine
=550  \\$wg$aArabinonucleosides
=667  \\$aan antiviral & antimetabolite
=680  \\$iA nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.
=688  \\$a79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76
=750  \0$aVidarabine$0(DLC)sh2017000370$5IEN-M

=LDR  00919cz  a2200313n  4500
=001  9880767055202441
=005  20190315155000.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012263
=035  \\$a(NLM)98195020310000041
=040  \\$aDNLM$cDNLM
=072  \\$aD13.$x570.$x800
=150  \\$aRibonucleosides
=550  \\$wg$aNucleosides
=550  \\$wh$aAdenosine
=550  \\$wh$aCytidine
=550  \\$wh$aDichlororibofuranosylbenzimidazole
=550  \\$wh$aFormycins
=550  \\$wh$aGuanosine
=550  \\$wh$aInosine
=550  \\$wh$aRibavirin
=550  \\$wh$aShowdomycin
=550  \\$wh$aToyocamycin
=550  \\$wh$aTubercidin
=550  \\$wh$aUridine
=667  \\$adeoxy or desoxy = DEOXYRIBONUCLEOSIDES
=680  \\$iNucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
=688  \\$a73(71)
=750  \0$aRibonucleosides$0(DLC)sh2017000430$5IEN-M

=LDR  00757cz  a2200265n  4500
=001  9880767057002441
=005  20190315143307.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011684
=035  \\$a(NLM)98193830060000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 57
=072  \\$aD3.$x633.$x100.$x759.$x590
=072  \\$aD13.$x570.$x583
=150  \\$aPurine Nucleosides
=450  \\$wnnna$aNucleosides, Purine
=550  \\$wg$aNucleosides
=550  \\$wg$aPurines
=550  \\$wh$aAdenosine
=550  \\$wh$aGuanosine
=550  \\$wh$aInosine
=550  \\$wh$aTubercidin
=680  \\$iPurines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES.
=688  \\$a74
=750  \0$aPurine nucleosides$0(DLC)sh2017000423$5IEN-M

=LDR  01889cz  a2200517n  4500
=001  9880767060702441
=005  20190314155757.0
=008  750725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005937
=035  \\$a(NLM)98197763250000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x300
=072  \\$aD2.$x241.$x511.$x902.$x300
=072  \\$aD9.$x811.$x295
=150  \\$aGlucaric Acid
=450  \\$wnnna$aCalcium Glucarate
=450  \\$wnnna$aCalcium Glucarate, Anhydrous
=450  \\$wnnna$aCalcium Saccharate
=450  \\$wnnna$aCalcium Saccharate Anhydrous
=450  \\$wnnna$aCalcium Saccharate Tetrahydrate
=450  \\$wnnna$aCalcium Saccharate, Anhydrous
=450  \\$wnnna$aD-Glucaric Acid
=450  \\$wnnna$aD-Saccharic Acid
=450  \\$wnnna$aSaccharic Acid
=450  \\$aGlucosaccharic Acid
=450  \\$aL-Gularic Acid
=450  \\$aLevo-Gularic Acid
=450  \\$aTetrahydroxyadipic Acid
=450  \\$wnnna$aAcid, Saccharic
=450  \\$wnnna$aAnhydrous Calcium Glucarate
=450  \\$wnnna$aAnhydrous Calcium Saccharate
=450  \\$wnnna$aD Glucaric Acid
=450  \\$wnnna$aD Saccharic Acid
=450  \\$wnnna$aGlucarate, Anhydrous Calcium
=450  \\$wnnna$aGlucarate, Calcium
=450  \\$wnnna$aL Gularic Acid
=450  \\$wnnna$aLevo Gularic Acid
=450  \\$wnnna$aSaccharate Tetrahydrate, Calcium
=450  \\$wnnna$aSaccharate, Anhydrous Calcium
=450  \\$wnnna$aSaccharate, Calcium
=450  \\$wnnna$aTetrahydrate, Calcium Saccharate
=550  \\$wg$aSugar Acids
=550  \\$wh$aFerric Oxide, Saccharated
=680  \\$iA sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.
=688  \\$a91(76); was see under SUGAR ACIDS 1976-90
=750  \0$aGlucaric acid$0(DLC)sh2017000294$5IEN-M

=LDR  01222nz  a2200313n  4500
=001  9880767061002441
=005  20190314153835.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077317
=035  \\$a(NLM)9811675543800041
=040  \\$aDNLM$cDNLM
=072  \\$aA20.$x593.$x500
=072  \\$aG6.$x120.$x500
=150  \\$aExtracellular Polymeric Substance Matrix
=450  \\$wnnna$aBiofilm Matrix
=450  \\$wnnna$aEPS Matrix
=450  \\$wnnna$aExopolymers
=450  \\$wnnna$aExtracellular Polymeric Substances
=450  \\$wnnna$aBiofilm Matrices
=450  \\$wnnna$aEPS Matrices
=450  \\$wnnna$aExopolymer
=450  \\$wnnna$aExtracellular Polymeric Substance
=450  \\$wnnna$aMatrix, Biofilm
=450  \\$wnnna$aMatrix, EPS
=450  \\$wnnna$aPolymeric Substance, Extracellular
=550  \\$wg$aBiofilms
=680  \\$iExtracellular matrix formed by secreted polymeric organic compounds by microorganisms. This secreted compound is mostly polysaccharides but may include proteins, lipids, and nucleic acids. The matrix facilitates attachment of microbes to form various BIOFILM communities.
=688  \\$a2019
=750  \0$aExtracellular polymeric substances$0(DLC)sh2017000052$5IEN-M

=LDR  00699cz  a2200217n  4500
=001  9880767061602441
=005  20190314144010.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002213
=035  \\$a(NLM)98194671910000041
=040  \\$aDNLM$cDNLM
=072  \\$aA21.$x249.$x500.$x250
=072  \\$aB4.$x950.$x500.$x250
=150  \\$aCapsid
=450  \\$wnnna$aCapsids
=550  \\$wg$aNucleocapsid
=550  \\$aCapsid Proteins
=667  \\$aCAPSID PROTEINS is also available
=680  \\$iThe outer protein protective shell of a virus, which protects the viral nucleic acid.
=688  \\$a84(75); was see under VIRAL PROTEINS 1975-83
=750  \0$aCapsids (Virology)$0(DLC)sh2017000364$5IEN-M

=LDR  00806cz  a2200241n  4500
=001  9880767061802441
=005  20190314142923.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D036022
=035  \\$a(NLM)98199480470000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x964.$x970.$x600.$x550
=150  \\$aCapsid Proteins
=450  \\$wnnna$aCapsid Protein
=450  \\$wnnna$aViral Outer Coat Protein
=450  \\$aCoat Proteins
=450  \\$aViral Coat Proteins
=450  \\$wnnna$aCoat Proteins, Viral
=550  \\$wg$aNucleocapsid Proteins
=667  \\$aCAPSID is also available; see SCR for many organism-specific VP numbered proteins
=680  \\$iProteins that form the CAPSID of VIRUSES.
=688  \\$a2003; use CAPSID 1988-2002
=750  \0$aCapsid proteins$0(DLC)sh2017000359$5IEN-M

=LDR  01137cz  a2200241n  4500
=001  9880767070902441
=005  20190313115728.0
=008  960610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019276
=035  \\$a(NLM)98197045870000041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x355
=150  \\$aGlycocalyx
=450  \\$wnnna$aGlycocalix
=450  \\$aCell Coat
=450  \\$wnnna$aCell Coats
=450  \\$wnnna$aCoat, Cell
=450  \\$wnnna$aCoats, Cell
=550  \\$wg$aCell Membrane Structures
=667  \\$aa carbohydrate-rich zone on cell surface
=680  \\$iThe carbohydrate-rich zone on the cell surface. This zone can be visualized by a variety of stains as well as by its affinity for lectins. Although most of the carbohydrate is attached to intrinsic plasma membrane molecules, the glycocalyx usually also contains both glycoproteins and proteoglycans that have been secreted into the extracellular space and then adsorbed onto the cell surface. (Alberts et al., Molecular Biology of the Cell, 3d ed, p502)
=688  \\$a97; was GLYCOCALYX (NM) 1976-96
=750  \0$aGlycocalyces$0(DLC)sh2017000049$5IEN-M

=LDR  00556cz  a2200181n  4500
=001  9880768151702441
=005  20190325120821.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074221
=035  \\$a(NLM)9810900988900041
=040  \\$aDNLM$cDNLM
=072  \\$aG10.$x261.$x190.$x400
=150  \\$aRumination, Digestive
=450  \\$wnnna$aDigestive Rumination
=550  \\$wg$aDigestion
=680  \\$iRegurgitation and re-chewing of previously swallowed food in RUMINANTS.
=688  \\$a2018
=750  \0$aRumination (Digestion)$0(DLC)sh 85115832$5IEN-M

=LDR  00540cz  a2200181n  4500
=001  9880768152202441
=005  20200622122119.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074222
=035  \\$a(NLM)9810900987500041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x188.$x878
=150  \\$aRumination, Cognitive
=450  \\$wnnna$aCognitive Rumination
=550  \\$wg$aCognition
=680  \\$iObsessive thinking about an idea, situation, or choice.
=688  \\$a2018
=750  \0$aRumination (Psychology)$0DLC)sh2017003647$5IEN-M

=LDR  01126cz  a2200289n  4500
=001  9880768152502441
=005  20190325113254.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065129
=035  \\$a(NLM)983985282300041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x421.$x726.$x758.$x655
=072  \\$aN6.$x850.$x780.$x680.$x655
=150  \\$aPre-Exposure Prophylaxis
=450  \\$wnnna$aPre-Exposure Prophylaxis (PrEP)
=450  \\$wnnna$aPre Exposure Prophylaxis
=450  \\$wnnna$aPre Exposure Prophylaxis (PrEP)
=450  \\$wnnna$aPre-Exposure Prophylaxi
=450  \\$wnnna$aPre-Exposure Prophylaxi (PrEP)
=450  \\$wnnna$aProphylaxi, Pre-Exposure
=450  \\$wnnna$aProphylaxi, Pre-Exposure (PrEP)
=450  \\$wnnna$aProphylaxis, Pre-Exposure
=450  \\$wnnna$aProphylaxis, Pre-Exposure (PrEP)
=550  \\$wg$aPrimary Prevention
=680  \\$iA method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.
=688  \\$a2015
=750  \0$aPre-exposure prophylaxis$0(DLC)sh2017003696$5IEN-M

=LDR  01011cz  a2200289n  4500
=001  9880768167102441
=005  20190322142554.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D049168
=035  \\$a(NLM)98196214320000041
=040  \\$aDNLM$cDNLM
=072  \\$aG8.$x686.$x784.$x769.$x570
=150  \\$aPregnancy, Unplanned
=450  \\$wnnna$aUnintended Pregnancy
=450  \\$wnnna$aUnplanned Pregnancy
=450  \\$wnnna$aPregnancies, Unintended
=450  \\$wnnna$aPregnancies, Unplanned
=450  \\$wnnna$aPregnancy, Unintended
=450  \\$wnnna$aUnintended Pregnancies
=450  \\$wnnna$aUnplanned Pregnancies
=550  \\$wg$aPregnancy
=550  \\$aContraceptive Effectiveness
=550  \\$aPregnancy, Unwanted
=667  \\$aPREGNANCY, UNWANTED is also available
=680  \\$iUnintended or accidental pregnancy, including pregnancy resulting from failed contraceptive measures.
=688  \\$a2005; use PREGNANCY 1980-2004
=750  \0$aUnplanned pregnancy$0(DLC)sh2017003566$5IEN-M

=LDR  00682cz  a2200205n  4500
=001  9880768168902441
=005  20190322111557.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069077
=035  \\$a(NLM)985399823100041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x305.$x500
=150  \\$aMemory Consolidation
=450  \\$wnnna$aConsolidation, Memory
=450  \\$wnnna$aConsolidations, Memory
=450  \\$wnnna$aMemory Consolidations
=550  \\$wg$aMemory, Long-Term
=680  \\$iNeurological process involving the conversion of learned information into long-term memory.
=688  \\$a2016
=750  \0$aMemory consolidation$0(DLC)sh2017003464$5IEN-M

=LDR  00820cz  a2200205n  4500
=001  9880768171402441
=005  20190321152337.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075022
=035  \\$a(NLM)9810901143000041
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x824.$x196.$x125
=150  \\$aAcademic Failure
=450  \\$wnnna$aAcademic Failures
=450  \\$wnnna$aFailure, Academic
=450  \\$wnnna$aFailures, Academic
=550  \\$wg$aEducational Status
=680  \\$iStudent's unsuccessful attempt at academic achievement or a marked inadequacy in the areas of scholarship or study. This is not underachievement which is performance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing.
=688  \\$a2018
=750  \0$aSchool failure$0(DLC)sh 91001431$5IEN-M

=LDR  00682cz  a2200193n  4500
=001  9880772958602441
=005  20190411112644.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D058433
=035  \\$a(NLM)98199230720000041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x115.$x600
=072  \\$aJ1.$x897.$x120.$x115.$x600
=150  \\$aPhotobioreactors
=450  \\$wnnna$aPhotobioreactor
=550  \\$wg$aBioreactors
=680  \\$iDevices for generating biological products that use light as the energy source. They are used for controlled BIOMASS production such as growing cyanobacteria, mosses, or algae.
=688  \\$a2011
=750  \0$aPhotobioreactors$0(DLC)sh2017004204$5IEN-M

=LDR  02964cz  a2200673n  4500
=001  9880775467802441
=005  20190419105624.0
=008  950526\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018955
=035  \\$a(NLM)98198217020000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x300.$x500
=072  \\$aD12.$x776.$x395.$x550.$x625.$x136
=072  \\$aD12.$x776.$x543.$x550.$x625.$x136
=072  \\$aD12.$x776.$x543.$x585.$x300.$x500
=072  \\$aD12.$x776.$x543.$x750.$x11
=072  \\$aD12.$x776.$x543.$x750.$x705.$x675.$x136
=072  \\$aD12.$x776.$x543.$x750.$x705.$x940.$x625.$x249
=072  \\$aD12.$x776.$x543.$x750.$x710.$x450.$x750.$x625.$x249
=150  \\$aCD36 Antigens
=450  \\$wnnna$aAdipocyte Membrane Protein p88
=450  \\$wnnna$aCD36 Antigen
=450  \\$wnnna$aCD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor)
=450  \\$wnnna$aCD36 Fatty Acid Transporter
=450  \\$wnnna$aCD36 Protein
=450  \\$wnnna$aFAT (Fatty Acid Translocase) - CD36 Antigen
=450  \\$wnnna$aGPIIIb Platelet Glycoprotein
=450  \\$wnnna$aGPIV Platelet Glycoprotein
=450  \\$wnnna$aPlatelet Glycoprotein IIIb
=450  \\$wnnna$aPlatelet Membrane Glycoprotein IV
=450  \\$wnnna$aSR-BI Protein
=450  \\$wnnna$aSR-BI Receptor
=450  \\$wnnna$aThrombospondin Receptor
=450  \\$aAntigens, CD36
=450  \\$aOKM5 Antigen
=450  \\$aPlatelet Glycoprotein IV
=450  \\$aPlatelet Membrane Glycoprotein IIIb
=450  \\$aReceptors, Thrombospondin
=450  \\$aScavenger Receptors, Class B, Type I
=450  \\$aThrombospondin Receptors
=450  \\$wnnna$aAntigen, CD36
=450  \\$wnnna$aAntigen, OKM5
=450  \\$wnnna$aGlycoprotein IIIb, Platelet
=450  \\$wnnna$aGlycoprotein IV, Platelet
=450  \\$wnnna$aPlatelet Glycoprotein, GPIIIb
=450  \\$wnnna$aPlatelet Glycoprotein, GPIV
=450  \\$wnnna$aReceptor, SR-BI
=450  \\$wnnna$aReceptor, Thrombospondin
=450  \\$wnnna$aSR BI Protein
=450  \\$wnnna$aSR BI Receptor
=550  \\$wg$aFatty Acid Transport Proteins
=550  \\$wg$aPlatelet Membrane Glycoproteins
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aScavenger Receptors, Class B
=680  \\$iLeukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
=688  \\$a2018 (1996)
=750  \0$81$wb$iBroader mapping$xThrombospondins$0(DLC)sh 92006106$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC) sh2002007652$4BM$5IEN-M
=788  \0$iSee also under the Library of Congress Subject Heading:$aThrombospondins--Receptors$5IEN-M

=LDR  01701cz  a2200409n  4500
=001  9880775901802441
=005  20190503110846.0
=008  860325\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011967
=035  \\$a(NLM)98196116490000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x350
=150  \\$aReceptors, Gonadotropin
=450  \\$wnnna$aGonadotopin Receptor
=450  \\$wnnna$aPituitary Gonadotropin Receptor
=450  \\$wnnna$aReceptors, Gonadotropins
=450  \\$wnnna$aReceptors, Pituitary Gonadotropin
=450  \\$aGonadotropin Receptors
=450  \\$aMenotropin Receptors
=450  \\$aPituitary Gonadotropin Receptors
=450  \\$aReceptors, Menotropin
=450  \\$wnnna$aGonadotropin Receptor, Pituitary
=450  \\$wnnna$aGonadotropin Receptors, Pituitary
=450  \\$wnnna$aGonadotropins Receptors
=450  \\$wnnna$aReceptor, Gonadotopin
=450  \\$wnnna$aReceptor, Pituitary Gonadotropin
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aGonadotropins
=550  \\$aChorionic Gonadotropin
=550  \\$aGonadotropins, Pituitary
=550  \\$aMenotropins
=667  \\$aGEN; prefer specifics
=680  \\$iThose protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCG, LH, and FOLLICLE STIMULATING HORMONE are the major specific gonadotropins.
=688  \\$a87
=750  \0$81$wb$aGonadotropin$0sh 85055839$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aGonadotropin--Receptors$5IEN-M

=LDR  01482cz  a2200313n  4500
=001  9880775905002441
=005  20190502162720.0
=008  860331\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011979
=035  \\$a(NLM)98195708250000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660
=150  \\$aReceptors, Pituitary Hormone
=450  \\$wnnna$aReceptors, Pituitary Hormones
=450  \\$aPituitary Hormone Receptors
=450  \\$wnnna$aPituitary Hormones Receptors
=550  \\$wg$aReceptors, Peptide
=550  \\$wh$aReceptors, Corticotropin
=550  \\$wh$aReceptors, Gonadotropin
=550  \\$wh$aReceptors, Oxytocin
=550  \\$wh$aReceptors, Somatostatin
=550  \\$wh$aReceptors, Thyrotropin
=550  \\$wh$aReceptors, Vasopressin
=550  \\$aPituitary Hormones
=667  \\$aGEN: prefer specifics; coord IM with specific pituit hormone (IM); DF: RECEPT PITUITARY HORMONE
=680  \\$iCell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.
=750  \0$81$wb$iBroader mapping$aPituitary hormones$0(DLC)sh 85102529$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aPituitary hormones--Receptors$5IEN-M

=LDR  01147cz  a2200313n  4500
=001  9880775946502441
=005  20190423131753.0
=008  890515\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015777
=035  \\$a(NLM)98195743050000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 90
=072  \\$aD10.$x251.$x355.$x255
=072  \\$aD23.$x469.$x50.$x175
=150  \\$aEicosanoids
=450  \\$aIcosanoids
=550  \\$wg$aAutacoids
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wh$aArachidonic Acids
=550  \\$wh$aEicosapentaenoic Acid
=550  \\$wh$a5,8,11,14-Eicosatetraynoic Acid
=550  \\$wh$a8,11,14-Eicosatrienoic Acid
=550  \\$wh$aLeukotrienes
=550  \\$wh$aLipoxins
=550  \\$wh$aProstaglandins
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA class of compounds named after and generally derived from C20 fatty acids (EICOSANOIC ACIDS) that includes PROSTAGLANDINS; LEUKOTRIENES; THROMBOXANES, and HYDROXYEICOSATETRAENOIC ACIDS. They have hormone-like effects mediated by specialized receptors (RECEPTORS, EICOSANOID).
=688  \\$a90
=750  \0$aEicosanoids$0(DLC)sh 97001640$5IEN-M

=LDR  02074cz  a2200433n  4500
=001  9880781270902441
=005  20190506144944.0
=008  860331\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011989
=035  \\$a(NLM)98197624290000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x850
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x850
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x825
=150  \\$aReceptors, Thyrotropin
=450  \\$wnnna$aLATS Receptors
=450  \\$wnnna$aReceptor, LATS Immunoglobulins
=450  \\$wnnna$aReceptors, LATS
=450  \\$wnnna$aReceptors, Long-Acting Thyroid Stimulator
=450  \\$wnnna$aReceptors, TSH
=450  \\$wnnna$aTSH Receptor
=450  \\$wnnna$aThyroid Stimulating Hormone Receptor
=450  \\$wnnna$aThyrotropin Receptor
=450  \\$aReceptors, Thyroid Stimulating Hormone
=450  \\$aTSH Receptors
=450  \\$aThyroid Stimulating Hormone Receptors
=450  \\$aThyrotropin Receptors
=450  \\$wnnna$aReceptor, TSH
=450  \\$wnnna$aReceptor, Thyrotropin
=450  \\$wnnna$aReceptors, Long Acting Thyroid Stimulator
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aThyrotropin
=550  \\$aImmunoglobulins, Thyroid-Stimulating
=680  \\$iCell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE).
=688  \\$a1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR use RECEPTORS, THYROID HORMONE 1993-2002
=750  \0$81$wb$iBroader mapping$aThyrotropin$0(DLC)sh 851351804BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThyrotropin--Receptors$5IEN-M

=LDR  01476cz  a2200409n  4500
=001  9880782894102441
=005  20190523161626.0
=008  940531\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018800
=035  \\$a(NLM)98196322090000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x50
=072  \\$aD12.$x776.$x543.$x550.$x189
=072  \\$aD23.$x50.$x301.$x264.$x894.$x123
=072  \\$aD23.$x101.$x100.$x894.$x123
=150  \\$aThy-1 Antigens
=450  \\$wnnna$aCD90 Antigen
=450  \\$wnnna$aThy-1 Antigen
=450  \\$wnnna$aThy-1.1 Antigen
=450  \\$wnnna$aThy-1.2 Antigen
=450  \\$aAntigens, CD90
=450  \\$aAntigens, Thy-1
=450  \\$aCD90 Antigens
=450  \\$wnnna$aAntigen, CD90
=450  \\$wnnna$aAntigen, Thy-1
=450  \\$wnnna$aAntigen, Thy-1.1
=450  \\$wnnna$aAntigen, Thy-1.2
=450  \\$wnnna$aAntigens, Thy 1
=450  \\$wnnna$aThy 1 Antigen
=450  \\$wnnna$aThy 1 Antigens
=450  \\$wnnna$aThy 1.1 Antigen
=450  \\$wnnna$aThy 1.2 Antigen
=550  \\$wg$aAntigens, Differentiation, T-Lymphocyte
=550  \\$wg$aMembrane Glycoproteins
=680  \\$iA group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.
=688  \\$a2018 (1995)
=750  \0$aThy-1 antigen$0(DLC)sh 88005697$5IEN-M

=LDR  01780cz  a2200397n  4500
=001  9880782906902441
=005  20190520152336.0
=008  980720\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020168
=035  \\$a(NLM)98196256230000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x100.$x75.$x63
=072  \\$aD12.$x776.$x157.$x530.$x450.$x74.$x500.$x500.$x250.$x125
=072  \\$aD12.$x776.$x395.$x550.$x20.$x400.$x153
=072  \\$aD12.$x776.$x543.$x550.$x192.$x400.$x153
=072  \\$aD12.$x776.$x543.$x585.$x100.$x200.$x125
=072  \\$aD12.$x776.$x543.$x585.$x450.$x74.$x500.$x500.$x250.$x125
=150  \\$aATP Binding Cassette Transporter, Subfamily B, Member 1
=450  \\$wnnna$aABCB1 Protein
=450  \\$wnnna$aATP Binding Cassette Transporter, Sub-Family B, Member 1
=450  \\$wnnna$aATP-Binding Cassette, Sub-Family B, Member 1
=450  \\$wnnna$aCD243 Antigen
=450  \\$wnnna$aPGY-1 Protein
=450  \\$aMDR1 Protein
=450  \\$aMultidrug Resistance Protein 1
=450  \\$wnno$aP-Glycoprotein
=450  \\$wnnna$aAntigen, CD243
=450  \\$wnnna$aP Glycoprotein
=450  \\$wnnna$aPGY 1 Protein
=550  \\$wg$aATP Binding Cassette Transporter, Subfamily B
=550  \\$aGenes, MDR
=550  \\$aRhodamine 123
=667  \\$anote entry term: ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B is also available
=680  \\$iA 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance (see DRUG RESISTANCE, MULTIPLE).
=688  \\$a2019 (1995)
=750  \0$aP-glycoprotein$0(DLC)sh 90005207$5IEN-M

=LDR  00896cz  a2200313n  4500
=001  9880782910702441
=005  20190628095244.0
=008  020702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D035961
=035  \\$a(NLM)98194886860000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x50
=150  \\$aAlismatales
=450  \\$wnno$aAlismatidae
=450  \\$aNajas
=450  \\$aPosidonia
=450  \\$aRuppia
=450  \\$wnnna$aAlismatale
=450  \\$wnnna$aPosidonias
=450  \\$wnnna$aRuppias
=550  \\$wg$aLilianae
=550  \\$wh$aAlismataceae
=550  \\$wh$aAraceae
=550  \\$wh$aHydrocharitaceae
=550  \\$wh$aPotamogetonaceae
=550  \\$wh$aZosteraceae
=680  \\$iA plant of the class MAGNOLIOPSIDA. It is a primitive group of mostly aquatic plants.
=688  \\$a2018(2003)
=750  \0$aHelobiae$0(DLC)sh 85060079$5IEN-M

=LDR  02136cz  a2200565n  4500
=001  9880785049902441
=005  20190531121004.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006804
=035  \\$a(NLM)98194659850000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x784.$x412
=072  \\$aJ1.$x293.$x556
=150  \\$aErgonomics
=450  \\$wnnna$aCognitive Ergonomics
=450  \\$wnnna$aErgonomic Assessment
=450  \\$wnnna$aHuman Factors Engineering
=450  \\$wnnna$aHuman Factors and Ergonomics
=450  \\$wnnna$aOrganizational Ergonomics
=450  \\$wnnna$aPhysical Ergonomics
=450  \\$wnnna$aPsychology, Engineering
=450  \\$wnnna$aVisual Ergonomics
=450  \\$aEngineering Psychology
=450  \\$aHuman Engineering
=450  \\$wnnna$aCognitive Ergonomic
=450  \\$wnnna$aErgonomic
=450  \\$wnnna$aErgonomic Assessments
=450  \\$wnnna$aErgonomic, Cognitive
=450  \\$wnnna$aErgonomic, Organizational
=450  \\$wnnna$aErgonomic, Physical
=450  \\$wnnna$aErgonomic, Visual
=450  \\$wnnna$aErgonomics, Cognitive
=450  \\$wnnna$aErgonomics, Organizational
=450  \\$wnnna$aErgonomics, Physical
=450  \\$wnnna$aErgonomics, Visual
=450  \\$wnnna$aHuman Factors Engineerings
=450  \\$wnnna$aOrganizational Ergonomic
=450  \\$wnnna$aPhysical Ergonomic
=450  \\$wnnna$aVisual Ergonomic
=550  \\$wg$aEngineering
=550  \\$wg$aPsychology, Applied
=550  \\$wh$aData Display
=550  \\$wh$aMan-Machine Systems
=550  \\$wh$aTask Performance and Analysis
=550  \\$wh$aTime Management
=550  \\$aPsychology, Industrial
=667  \\$aindex "medical ergonomics" here but do not coordinate with MEDICINE
=680  \\$iThe science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them.
=688  \\$a2018; use HUMAN ENGINEERING 1966-2017; use HUMAN ENGINEERING to search ENGINEERING PSYCHOLOGY 1969-78
=750  \0$aHuman engineering$0(DLC)sh 85062867$5IEN-M

=LDR  03265nz  a2200745n  4500
=001  9882549679702441
=005  20250214142357.0
=008  810512\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006442
=035  \\$a(DNLM)D006442
=035  \\$a(NLM)98197759470000041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x205.$x625.$x500.$x250
=072  \\$aD9.$x400.$x430.$x825.$x500.$x250
=072  \\$aD12.$x776.$x124.$x400.$x354
=072  \\$aD12.$x776.$x395.$x351.$x500.$x250
=072  \\$aD12.$x776.$x422.$x316.$x762.$x350
=072  \\$aD23.$x946.$x381.$x625.$x500.$x250
=150  \\$aGlycated Hemoglobin
=450  \\$wnnna$aGlycated Hemoglobin A
=450  \\$wnnna$aGlycated Hemoglobin A1c
=450  \\$wnnna$aGlycated Hemoglobins
=450  \\$wnnna$aGlycosylated Hemoglobin A1c
=450  \\$wnnna$aHb A1
=450  \\$wnnna$aHb A1a-1
=450  \\$wnnna$aHb A1a-2
=450  \\$wnnna$aHb A1a+b
=450  \\$wnnna$aHb A1b
=450  \\$wnnna$aHemoglobin, Glycated A1a-2
=450  \\$wnnna$aHemoglobin, Glycated A1b
=450  \\$wnnna$aHemoglobin, Glycosylated
=450  \\$wnnna$aHemoglobin, Glycosylated A1a-1
=450  \\$wnnna$aHemoglobin, Glycosylated A1b
=450  \\$aFructated Hemoglobins
=450  \\$aGlycohemoglobin
=450  \\$aGlycohemoglobin A
=450  \\$aGlycohemoglobins
=450  \\$aGlycosylated Hemoglobin A
=450  \\$aHbA1
=450  \\$aHb A1c
=450  \\$aHemoglobin A(1)
=450  \\$aHemoglobin A, Glycosylated
=450  \\$wnnna$aA1a-1 Hemoglobin, Glycosylated
=450  \\$wnnna$aA1a-2 Hemoglobin, Glycated
=450  \\$wnnna$aA1b Hemoglobin, Glycated
=450  \\$wnnna$aA1b Hemoglobin, Glycosylated
=450  \\$wnnna$aGlycated A1a-2 Hemoglobin
=450  \\$wnnna$aGlycated A1b Hemoglobin
=450  \\$wnnna$aGlycosylated A1a-1 Hemoglobin
=450  \\$wnnna$aGlycosylated A1b Hemoglobin
=450  \\$wnnna$aGlycosylated Hemoglobin
=450  \\$wnnna$aHemoglobin A1c, Glycated
=450  \\$wnnna$aHemoglobin A1c, Glycosylated
=450  \\$wnnna$aHemoglobin A, Glycated
=450  \\$wnnna$aHemoglobin, Glycated
=450  \\$wnnna$aHemoglobin, Glycated A1a 2
=450  \\$wnnna$aHemoglobin, Glycosylated A1a 1
=450  \\$wnnna$aHemoglobins, Fructated
=450  \\$wnnna$aHemoglobins, Glycated
=550  \\$aBlood Glucose
=667  \\$aurine: coordinate with HEMOGLOBINURIA
=680  \\$iProducts of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.
=680  \\$iProducts of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN A, occurring as a minor fraction of the hemoglobin components of human erythrocytes. Hemoglobin A1c is hemoglobin A with glucose covalently bound to the terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.
=688  \\$a2018 (1982)
=750  \0$aGlycosylated hemoglobin$0(DLC)sh 85055410$5IEN-M

=LDR  00708cz  a2200193n  4500
=001  9880785056102441
=005  20190530162218.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005570
=035  \\$a(NLM)98193993800000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 50
=072  \\$aL1.$x178.$x682.$x192.$x836.$x535.$x310
=150  \\$aFormularies, Dental as Topic
=550  \\$wg$aFormularies as Topic
=667  \\$ado not confuse with the Publication Type FORMULARIES, DENTAL
=680  \\$iWorks on or about reference lists of descriptions and uses of drugs related to oral medicine and dentistry.
=688  \\$a2018(1966)
=750  \0$aDentistry$vFormulae, receipts, prescriptions$0(DLC) sh 85036956$5IEN

=LDR  00914cz  a2200229n  4500
=001  9880785061902441
=005  20190529124947.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004212
=035  \\$a(NLM)98195523090000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x389
=150  \\$aAcademic Dissertations as Topic
=450  \\$wnnna$aDissertation, Academic as Topic
=450  \\$wnno$aDissertations, Academic as Topic
=450  \\$aTheses as Topic
=450  \\$wnnna$aTheses as Topics
=550  \\$wg$aPublications
=667  \\$ado not confuse with Publication Type ACADEMIC DISSERTATION
=680  \\$iWorks about substantial papers written by candidates for an academic degree under the individual direction of a professor or papers written by undergraduates desirous of achieving honors or distinction.
=688  \\$a2018(1963)
=750  \0$aDissertations, Academic$0(DLC) sh 85038494$5IEN

=LDR  00689cz  a2200181n  4500
=001  9880785062002441
=005  20190529122520.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004017
=035  \\$a(NLM)98198615240000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x285.$x348
=150  \\$aDictionaries, Dental as Topic
=550  \\$wg$aDictionaries as Topic
=667  \\$ado not confuse with the Publication Type DICTIONARY, DENTAL
=680  \\$iWorks about or subject matter related to reference works listing and describing concepts related to oral medicine and dentistry.
=688  \\$a2018(1966)
=750  \0$aDentistry$vDictionaries$0(DLC)sh2009123194$5IEN-M

=LDR  00737cz  a2200205n  4500
=001  9880785064502441
=005  20190529103601.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004016
=035  \\$a(NLM)98198615250000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x285.$x277
=150  \\$aDictionaries, Classical as Topic
=450  \\$wnnna$aClassical Dictionaries
=450  \\$wnno$aDictionaries, Classical
=550  \\$wg$aDictionaries as Topic
=667  \\$ado not confuse with the Publication Type DICTIONARY, CLASSICAL
=680  \\$iWorks about or subject matter related to reference works on the Greco-Roman world.
=688  \\$a2018(1966)
=750  \0$aClassical dictionaries$0(DLC)sh 85026697$5IEN-M

=LDR  00964cz  a2200289n  4500
=001  9880785065802441
=005  20190528150824.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D032462
=035  \\$a(NLM)98196828690000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x156
=150  \\$aCycadopsida
=450  \\$wnnna$aCycadales
=450  \\$wnno$aCycadophyta
=450  \\$wnno$aGymnosperms
=450  \\$wnnna$aCycadale
=450  \\$wnnna$aCycadophytas
=450  \\$wnnna$aGymnosperm
=550  \\$wg$aEmbryophyta
=550  \\$wh$aConiferophyta
=550  \\$wh$aCycas
=550  \\$wh$aGnetophyta
=550  \\$wh$aZamiaceae
=680  \\$iA class of vascular seed plants also known as gymnosperms in the subdivision spermatophytina. They have large cones and pinnate leaves. Examples are pines, spruces, cedars and sequoias.
=688  \\$a2018(2003); use GYMNOSPERMS 1998-2002
=750  \0$aGymnosperms$0(DLC)sh 85058078$5IEN-M

=LDR  02001cz  a2200553n  4500
=001  9880785066002441
=005  20190528140438.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D040421
=035  \\$a(NLM)98194018530000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x847.$x698.$x300
=150  \\$aCell Phone
=450  \\$wnnna$aMobile Telephone
=450  \\$wnnna$aPortable Cellular Phone
=450  \\$wnnna$aTransportable Cellular Phone
=450  \\$aCar Phone
=450  \\$aCell Phones
=450  \\$aCellular Phone
=450  \\$aMobile Phone
=450  \\$aTelephone, Cellular
=450  \\$wnnna$aCar Phones
=450  \\$wnnna$aCellular Phone, Portable
=450  \\$wnnna$aCellular Phone, Transportable
=450  \\$wnnna$aCellular Phones
=450  \\$wnnna$aCellular Phones, Portable
=450  \\$wnnna$aCellular Phones, Transportable
=450  \\$wnnna$aCellular Telephone
=450  \\$wnnna$aCellular Telephones
=450  \\$wnnna$aMobile Phones
=450  \\$wnnna$aMobile Telephones
=450  \\$wnnna$aPhone, Car
=450  \\$wnnna$aPhone, Cell
=450  \\$wnnna$aPhone, Cellular
=450  \\$wnnna$aPhone, Mobile
=450  \\$wnnna$aPhones, Car
=450  \\$wnnna$aPhones, Cell
=450  \\$wnnna$aPhones, Cellular
=450  \\$wnnna$aPhones, Mobile
=450  \\$wnnna$aPortable Cellular Phones
=450  \\$wnnna$aTelephone, Mobile
=450  \\$wnnna$aTelephones, Cellular
=450  \\$wnnna$aTelephones, Mobile
=450  \\$wnnna$aTransportable Cellular Phones
=550  \\$wg$aTelephone
=550  \\$wh$aText Messaging
=550  \\$aComputers, Handheld
=680  \\$iAnalog or digital communications device in which the user has a wireless connection from a telephone to a nearby transmitter. It is termed cellular because the service area is divided into multiple "cells." As the user moves from one cell area to another, the call is transferred to the local transmitter.
=750  \0$aCell phones (DLC)sh 98003865$5IEN-M

=LDR  01552cz  a2200421n  4500
=001  9880785067902441
=005  20190528111727.0
=008  910530\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016922
=035  \\$a(NLM)98195454170000041
=040  \\$aDNLM$cDNLM
=072  \\$aG4.$x43
=150  \\$aCellular Senescence
=450  \\$wnnna$aCell Ageing
=450  \\$wnnna$aCellular Ageing
=450  \\$wnnna$aCellular Aging
=450  \\$wnnna$aSenescence-Associated Secretory Phenotype
=450  \\$aAging, Cell
=450  \\$wnno$aCell Aging
=450  \\$aCell Senescence
=450  \\$aReplicative Senescence
=450  \\$aSenescence, Cellular
=450  \\$aSenescence, Replicative
=450  \\$wnnna$aAgeing, Cell
=450  \\$wnnna$aAgeing, Cellular
=450  \\$wnnna$aAging, Cellular
=450  \\$wnnna$aPhenotype, Senescence-Associated Secretory
=450  \\$wnnna$aSecretory Phenotype, Senescence-Associated
=450  \\$wnnna$aSenescence Associated Secretory Phenotype
=450  \\$wnnna$aSenescence, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aErythrocyte Aging
=550  \\$wh$aTelomere Shortening
=550  \\$aAging
=667  \\$anot for micro-organisms
=680  \\$iProcess by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS.
=688  \\$a2018 (1992); use CELL SURVIVAL 1977-1991
=750  \0$aCells$xAging$0(DLC)sh 85021680$5IEN-M

=LDR  00881cz  a2200265n  4500
=001  9880785072002441
=005  20190524131638.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001517
=035  \\$a(NLM)98195169140000041
=040  \\$aDNLM$cDNLM
=060  \0$aQX 555
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x375
=150  \\$aColeoptera
=450  \\$wnno$aBeetles
=450  \\$wnnna$aBeetle
=550  \\$wg$aHolometabola
=550  \\$wh$aFireflies
=550  \\$wh$aTenebrio
=550  \\$wh$aTribolium
=550  \\$wh$aWeevils
=667  \\$afor killing beetles with insecticides, see note at INSECTICIDES
=680  \\$iOrder of winged insects also known as beetles comprising over 350,000 species in 150 families. They possess hard bodies with mouthparts adapted for chewing.
=688  \\$a2018(1963)
=750  \0$aBeetles$0(DLC)sh 85012867$5IEN-M

=LDR  00661cz  a2200181n  4500
=001  9880785072302441
=005  20190524130054.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001108
=035  \\$a(NLM)98198923170000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x86
=150  \\$aArchitecture
=550  \\$wh$aFacility Design and Construction
=680  \\$iWorks on the art and science of designing buildings and structures, design of the total built environment, including town planning, urban design, and landscape architecture.
=688  \\$a2008(1963)
=750  \0$aArchitecture$0(DLC)sh 85006611$5IEN-M
=750  \0$aArchitects$0(DLC)sh 85006565$5IEN-M

=LDR  01256cz  a2200301n  4500
=001  9880786467002441
=005  20190603164410.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007313
=035  \\$a(NLM)98194956670000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617
=150  \\$aInsecta
=450  \\$aInsects
=450  \\$wnnna$aInsect
=550  \\$wg$aArthropods
=550  \\$wh$aCockroaches
=550  \\$wh$aHemiptera
=550  \\$wh$aIsoptera
=550  \\$wh$aLepisma
=550  \\$wh$aOrthoptera
=550  \\$wh$aPhthiraptera
=550  \\$wh$aPterygota
=550  \\$wh$aThysanoptera
=667  \\$ageneral or unspecified; prefer specifics; for killing insects with insecticides, see note at INSECTICIDES
=680  \\$iMembers of the phylum ARTHROPODA composed or organisms characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth with several hundred thousand different kinds. Three orders, HEMIPTERA; DIPTERA; and SIPHONAPTERA; are of medical interest in that they cause disease in humans and animals. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p1).
=688  \\$a2018(1966)
=750  \0$aInsects$0(DLC)sh 85066670$5IEN-M

=LDR  01841cz  a2200445n  4500
=001  9880788759702441
=005  20190607150012.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D024821
=035  \\$a(NLM)98196953210000041
=040  \\$aDNLM$cDNLM
=060  \0$aWK 820
=072  \\$aC18.$x452.$x394.$x968.$x500.$x570
=072  \\$aC18.$x452.$x625
=150  \\$aMetabolic Syndrome
=450  \\$wnnna$aDysmetabolic Syndrome X
=450  \\$wnnna$aMetabolic Cardiovascular Syndrome
=450  \\$wnnna$aMetabolic X Syndrome
=450  \\$wnnna$aSyndrome X, Insulin Resistance
=450  \\$wnnna$aSyndrome X, Metabolic
=450  \\$aInsulin Resistance Syndrome X
=450  \\$wnno$aMetabolic Syndrome X
=450  \\$aReaven Syndrome X
=450  \\$wnnna$aCardiovascular Syndrome, Metabolic
=450  \\$wnnna$aCardiovascular Syndromes, Metabolic
=450  \\$wnnna$aMetabolic Syndromes
=450  \\$wnnna$aSyndrome X, Dysmetabolic
=450  \\$wnnna$aSyndrome X, Reaven
=450  \\$wnnna$aSyndrome, Metabolic
=450  \\$wnnna$aSyndrome, Metabolic Cardiovascular
=450  \\$wnnna$aSyndrome, Metabolic X
=450  \\$wnnna$aSyndromes, Metabolic
=450  \\$wnnna$aX Syndrome, Metabolic
=550  \\$wg$aMetabolic Diseases
=550  \\$wg$aInsulin Resistance
=550  \\$aDiabetes Mellitus, Type 2
=550  \\$aMicrovascular Angina
=680  \\$iA cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
=688  \\$a2018 (2002); for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001
=750  \0$aMetabolic syndrome$0(DLC) sh2005005763$5IEN-M

=LDR  00746cz  a2200217n  4500
=001  9880788759902441
=005  20190607142455.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008374
=035  \\$a(NLM)98197104150000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x608.$x526
=150  \\$aManuscripts, Medical as Topic
=550  \\$wg$aManuscripts as Topic
=550  \\$aMedical Writing
=667  \\$asee note on MANUSCRIPTS AS TOPIC
=680  \\$iWorks about unpublished medical works.
=688  \\$a2018(1966)
=750  \0$81$wb$aMedicine$0(DLC)sh 85083064$5IEN-M
=780  \0$81$wb$xManuscripts$0(DLC)sh2002012491$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aMedicine--Manuscripts$5IEN-M

=LDR  00716cz  a2200205n  4500
=001  9880789772302441
=005  20190610130533.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008512
=035  \\$a(NLM)98195279550000041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x93.$x530
=150  \\$aMedicine in the Arts
=450  \\$wnno$aMedicine in Art
=450  \\$wnnna$aMedicine in Arts
=550  \\$wg$aArt
=667  \\$acoordinate IM with medical aspect (IM) + specific art heading (IM)
=680  \\$iDepiction of medical issues or themes via the arts including visual, oral, or written forms of expression.
=688  \\$a2018; use Medicine in Art (1966-2017)
=750  \0$aMedicine in art$0(DLC)sh 96011913$5IEN-M

=LDR  00704cz  a2200181n  4500
=001  9880789773002441
=005  20190610111559.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013359
=035  \\$a(NLM)98194507420000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x898
=150  \\$aSublimation, Psychological
=450  \\$wnnna$aPsychological Sublimation
=550  \\$wg$aDefense Mechanisms
=680  \\$iA defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities.
=688  \\$a2018 (1968)
=750  \0$aSublimation (Psychology)$0(DLC)sh 85129474$5IEN-M

=LDR  01439cz  a2200361n  4500
=001  9880791507802441
=005  20210323112328.0
=008  940527\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018826
=035  \\$a(NLM)98194345440000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x100.$x160
=072  \\$aD8.$x811.$x277.$x656.$x350.$x555.$x100
=072  \\$aD8.$x811.$x277.$x656.$x675.$x555.$x100
=072  \\$aD23.$x50.$x301.$x264.$x894.$x113
=072  \\$aD23.$x101.$x100.$x894.$x113
=150  \\$aCD13 Antigens
=450  \\$wnnna$aAlanine Aminopeptidase
=450  \\$wnnna$aAlanyl Aminopeptidase
=450  \\$wnnna$aAmino-oligopeptidase
=450  \\$wnnna$aAminooligopeptidase
=450  \\$wnnna$aCD13 Antigen
=450  \\$aAminopeptidase M
=450  \\$aAminopeptidase N
=450  \\$aAntigens, CD13
=450  \\$aMembrane Alanyl Aminopeptidase
=450  \\$wnnna$aAntigen, CD13
=550  \\$wg$aAminopeptidases
=550  \\$wg$aAntigens, Differentiation, T-Lymphocyte
=550  \\$wg$aMetalloexopeptidases
=680  \\$iZinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide.
=688  \\$a2018 (1975)
=750  \0$aAlanine aminopeptidase$0(DLC)sh 85003137$5IEN-M

=LDR  01286cz  a2200325n  4500
=001  9880791518702441
=005  20190702133717.0
=008  980611\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020448
=035  \\$a(NLM)98193905820000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341
=150  \\$aEricales
=450  \\$wnnna$aCaryocaraceae
=450  \\$wnno$aTheales
=450  \\$wnnna$aEricale
=450  \\$wnnna$aTheale
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aActinidiaceae
=550  \\$wh$aBalsaminaceae
=550  \\$wh$aEbenaceae
=550  \\$wh$aEricaceae
=550  \\$wh$aLecythidaceae
=550  \\$wh$aPrimulaceae
=550  \\$wh$aSarraceniaceae
=550  \\$wh$aStyracaceae
=550  \\$wh$aTheaceae
=680  \\$iA large and diverse order of dicotyledonous flowering plants in the subclass DILLENIIDAE. Most members have weakly fused petals and radially symmetric flowers which form fruit capsules and thin seed coats. Members also contain IRIDOIDS, compounds which protect against herbivores. Common examples of the ericales are economically important species such as TEA, PERSIMMON, BLUEBERRY, BRAZIL NUTS,  azalea, CRANBERRIES, and RHODODENDRON.
=688  \\$a2018(1998)
=750  \0$aEricales$0(DLC)sh 85044613$5IEN-M

=LDR  04829cz  a2201765n  4500
=001  9880791574202441
=005  20190617141821.0
=008  970620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019684
=035  \\$a(NLM)98197725600000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250
=150  \\$aMagnoliopsida
=450  \\$wnnna$aAngiosperma
=450  \\$wnnna$aAngiospermae
=450  \\$wnnna$aArecidae
=450  \\$wnnna$aAsteridae
=450  \\$wnnna$aCaryophyllidae
=450  \\$wnnna$aCommelinidae
=450  \\$wnnna$aDicotyledoneae
=450  \\$wnnna$aDilleniidae
=450  \\$wnnna$aFlowering Plants
=450  \\$wnnna$aHamamelidae
=450  \\$wnnna$aHamamelididae
=450  \\$wnnna$aIcacinales
=450  \\$wnnna$aLiliatae
=450  \\$wnnna$aLiliidae
=450  \\$wnnna$aLiliopsida
=450  \\$wnnna$aMagnoliatae
=450  \\$wnnna$aMetteniusales
=450  \\$wnnna$aOncothecales
=450  \\$wnnna$aRosidae
=450  \\$wnnna$aVahliales
=450  \\$wnnna$aZingiberidae
=450  \\$wnno$aAngiosperms
=450  \\$wnnna$aAngiosperm
=450  \\$wnnna$aFlowering Plant
=450  \\$wnnna$aIcacinale
=450  \\$wnnna$aMetteniusale
=450  \\$wnnna$aOncothecale
=450  \\$wnnna$aPlant, Flowering
=450  \\$wnnna$aPlants, Flowering
=450  \\$wnnna$aVahliale
=550  \\$wg$aTracheophyta
=550  \\$wh$aAcoraceae
=550  \\$wh$aAlangiaceae
=550  \\$wh$aAnacardiaceae
=550  \\$wh$aAnnonaceae
=550  \\$wh$aApiaceae
=550  \\$wh$aAquifoliaceae
=550  \\$wh$aAraliaceae
=550  \\$wh$aArecaceae
=550  \\$wh$aAristolochiaceae
=550  \\$wh$aAsteraceae
=550  \\$wh$aAustrobaileyales
=550  \\$wh$aBalanophoraceae
=550  \\$wh$aBegoniaceae
=550  \\$wh$aBerberidaceae
=550  \\$wh$aBixaceae
=550  \\$wh$aBombacaceae
=550  \\$wh$aBoraginaceae
=550  \\$wh$aBrassicaceae
=550  \\$wh$aBromeliaceae
=550  \\$wh$aBurseraceae
=550  \\$wh$aBuxaceae
=550  \\$wh$aCampanulaceae
=550  \\$wh$aCapparaceae
=550  \\$wh$aCaricaceae
=550  \\$wh$aCaryophyllanae
=550  \\$wh$aChenopodiaceae
=550  \\$wh$aCistaceae
=550  \\$wh$aCombretaceae
=550  \\$wh$aCommelinaceae
=550  \\$wh$aConvolvulaceae
=550  \\$wh$aCornaceae
=550  \\$wh$aCucurbitaceae
=550  \\$wh$aCyperaceae
=550  \\$wh$aDilleniaceae
=550  \\$wh$aDioscoreaceae
=550  \\$wh$aDipsacales
=550  \\$wh$aElaeocarpaceae
=550  \\$wh$aEricales
=550  \\$wh$aEriocaulaceae
=550  \\$wh$aErythroxylaceae
=550  \\$wh$aEucommiaceae
=550  \\$wh$aEuphorbiaceae
=550  \\$wh$aFabaceae
=550  \\$wh$aGentianales
=550  \\$wh$aGeraniaceae
=550  \\$wh$aHamamelidaceae
=550  \\$wh$aHippocastanaceae
=550  \\$wh$aHippocrateaceae
=550  \\$wh$aHydrophyllaceae
=550  \\$wh$aKrameriaceae
=550  \\$wh$aLamiales
=550  \\$wh$aLinaceae
=550  \\$wh$aLilianae
=550  \\$wh$aLaurales
=550  \\$wh$aLythraceae
=550  \\$wh$aMagnoliaceae
=550  \\$wh$aMalpighiaceae
=550  \\$wh$aMelastomataceae
=550  \\$wh$aMeliaceae
=550  \\$wh$aMenispermaceae
=550  \\$wh$aMistletoe
=550  \\$wh$aMoringa
=550  \\$wh$aMyoporaceae
=550  \\$wh$aMyristicaceae
=550  \\$wh$aMyrtaceae
=550  \\$wh$aNelumbonaceae
=550  \\$wh$aNymphaeaceae
=550  \\$wh$aNyssaceae
=550  \\$wh$aOchnaceae
=550  \\$wh$aOlacaceae
=550  \\$wh$aOnagraceae
=550  \\$wh$aOxalidaceae
=550  \\$wh$aPaeonia
=550  \\$wh$aPandanaceae
=550  \\$wh$aPassifloraceae
=550  \\$wh$aPiperaceae
=550  \\$wh$aPoaceae
=550  \\$wh$aPolygonaceae
=550  \\$wh$aPontederiaceae
=550  \\$wh$aPrimula
=550  \\$wh$aProteaceae
=550  \\$wh$aPunicaceae
=550  \\$wh$aPyrolaceae
=550  \\$wh$aRanunculales
=550  \\$wh$aRhizophoraceae
=550  \\$wh$aRosanae
=550  \\$wh$aRutaceae
=550  \\$wh$aSalvadoraceae
=550  \\$wh$aSantalaceae
=550  \\$wh$aSapindaceae
=550  \\$wh$aSaururaceae
=550  \\$wh$aSaxifragales
=550  \\$wh$aSimaroubaceae
=550  \\$wh$aSolanales
=550  \\$wh$aStemonaceae
=550  \\$wh$aThymelaeaceae
=550  \\$wh$aTiliaceae
=550  \\$wh$aTropaeolaceae
=550  \\$wh$aTyphaceae
=550  \\$wh$aViolaceae
=550  \\$wh$aVitaceae
=550  \\$wh$aWinteraceae
=550  \\$wh$aZygophyllaceae
=680  \\$iA class of vascular plants which produce flowers and seeds. They include monocotyledons, dicotyledons, and about 80% of all known plant species.
=688  \\$a2018(1998)
=750  \0$aAngiosperms$5IEN-M$0(DLC)sh 85005034

=LDR  01049cz  a2200253n  4500
=001  9880799871902441
=005  20180904000000.0
=008  950526\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018958
=035  \\$a(NLM)98198721200000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x448.$x130
=072  \\$aD12.$x776.$x543.$x484.$x500.$x130
=072  \\$aD12.$x776.$x543.$x550.$x418.$x130
=150  \\$aCD55 Antigens
=450  \\$wnnna$aCD55 Antigen
=450  \\$wnnna$aComplement Decay-Accelerating Factor
=450  \\$aAntigens, CD55
=450  \\$aDecay-Accelerating Factor
=450  \\$wnnna$aComplement Decay Accelerating Factor
=450  \\$wnnna$aDecay Accelerating Factor
=450  \\$wnnna$aDecay-Accelerating Factor, Complement
=680  \\$iGPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex.
=688  \\$a2018 (1985)

=LDR  00909cz  a2200265n  4500
=001  9880801760702441
=005  20190711130128.0
=008  960610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019180
=035  \\$a(NLM)98195157410000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x715.$x700
=072  \\$aB4.$x820.$x700
=150  \\$aSecoviridae
=450  \\$wnnna$aComovirinae
=450  \\$aComoviridae
=550  \\$wg$aPlant Viruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aComovirus
=550  \\$wh$aFabavirus
=550  \\$wh$aNepovirus
=667  \\$aa family of plant viruses
=680  \\$iA family of non-enveloped RNA plant viruses, transmitted by biological vectors and experimentally by mechanical inoculation. Subfamily Comovirinae includes all members of old taxonomic family Comoviridae: COMOVIRUS; FABAVIRUS; and NEPOVIRUS.
=688  \\$a2018
=750  \0$aComoviridae$0(DLC)2007009419$5IEN-M

=LDR  01003cz  a2200325n  4500
=001  9880803051102441
=005  20190719115446.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010872
=035  \\$a(NLM)98198464340000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x750.$x250
=150  \\$aCaniformia
=450  \\$wnnna$aPinnipeds
=450  \\$wnno$aPinnipedia
=550  \\$wg$aCarnivora
=550  \\$wh$aAiluridae
=550  \\$wh$aCanidae
=550  \\$wh$aFur Seals
=550  \\$wh$aMephitidae
=550  \\$wh$aMustelidae
=550  \\$wh$aProcyonidae
=550  \\$wh$aSea Lions
=550  \\$wh$aSeals, Earless
=550  \\$wh$aUrsidae
=550  \\$wh$aWalruses
=667  \\$ageneral or unspecified only; prefer specifics
=680  \\$iSuborder of dog-like carnivores which include dogs, coyotes, skunks, mustelids, walruses, seals, bears, and procyonids.
=688  \\$a2018(1966)
=750  \0$iRelated mapping$aPinnipedia$0(DLC)sh 85102257$4RM$5IEN

=LDR  00912cz  a2200217n  4500
=001  9880803064602441
=005  20190716135244.0
=008  080708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D055423
=035  \\$a(NLM)98196667110000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x642.$x249.$x245.$x500
=072  \\$aG7.$x203.$x650.$x240.$x245.$x500
=150  \\$aDiet, Ketogenic
=450  \\$aKetogenic Diet
=450  \\$wnnna$aDiets, Ketogenic
=450  \\$wnnna$aKetogenic Diets
=550  \\$wg$aDiet, Carbohydrate-Restricted
=680  \\$iA course of food intake that is high in FATS and low in CARBOHYDRATES. This diet provides sufficient PROTEINS for growth but insufficient amount of carbohydrates for the energy needs of the body. A ketogenic diet generates 80-90% of caloric requirements from fats and the remainder from proteins.
=688  \\$a2018 (2009)
=750  \0$aKetogenic diet$0(DLC) sh 85072093$5IEN-M

=LDR  01131cz  a2200313n  4500
=001  9880803064902441
=005  20190716131616.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D006433
=035  \\$a(NLM)98198356220000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 55.8
=072  \\$aD12.$x776.$x93.$x375
=072  \\$aD12.$x776.$x556.$x462
=072  \\$aD23.$x767.$x482
=150  \\$aHemocyanins
=450  \\$wnnna$aalpha-Haemocyanin
=450  \\$wnnna$aalpha-Hemocyanin
=450  \\$wnnna$aalpha-Hemocyanins
=450  \\$aHemocyanin
=450  \\$wnnna$aalpha Haemocyanin
=450  \\$wnnna$aalpha Hemocyanin
=450  \\$wnnna$aalpha Hemocyanins
=550  \\$wg$aArthropod Proteins
=550  \\$wg$aMetalloproteins
=550  \\$wg$aPigments, Biological
=680  \\$iMetalloproteins that function as oxygen transport proteins in the HEMOLYMPH of MOLLUSKS and ARTHROPODS. They are characterized by two copper atoms, coordinated with HISTIDINE residues, that reversibly bind a single oxygen molecule; they do not contain HEME groups.
=688  \\$a2018 (1964)
=750  \0$aHemocyanin$0(DLC)sh 85060187$5IEN-M

=LDR  00919cz  a2200301n  4500
=001  9880803067402441
=005  20190716112430.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066300
=035  \\$a(NLM)983985920800041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 137
=072  \\$aJ1.$x637.$x767.$x500
=150  \\$aElectronic Nicotine Delivery Systems
=450  \\$wnnna$aE-Cigarettes
=450  \\$wnnna$aE-Cigs
=450  \\$wnno$aElectronic Cigarettes
=450  \\$wnnna$aCigarette, Electronic
=450  \\$wnnna$aCigarettes, Electronic
=450  \\$wnnna$aE Cigarettes
=450  \\$wnnna$aE Cigs
=450  \\$wnnna$aE-Cig
=450  \\$wnnna$aE-Cigarette
=450  \\$wnnna$aElectronic Cigarette
=550  \\$wg$aSmoking Devices
=680  \\$iSMOKING vapors produced from ELECTRONIC NICOTINE DELIVERY SYSTEMS.
=688  \\$a2018 (2015)
=750  \0$aElectronic cigarettes$0(DLC)sh2014000074$5IEN-M

=LDR  02160cz  a2200601n  4500
=001  9880803633002441
=005  20190801122017.0
=008  770422\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004546
=035  \\$a(NLM)98196289770000041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x888.$x850.$x325
=072  \\$aD23.$x946.$x833.$x850.$x325
=150  \\$aElapid Venoms
=450  \\$wnnna$aCobra Venom
=450  \\$wnnna$aElapid Venom
=450  \\$wnnna$aHydrophid Venom
=450  \\$wnnna$aHydrophid Venoms
=450  \\$wnnna$aKing Cobra Venom
=450  \\$wnnna$aNaja Venom
=450  \\$wnnna$aOphiophagus hannah Venom
=450  \\$wnnna$aSea Snake Venom
=450  \\$wnnna$aSea Snake Venoms
=450  \\$aCobra Venoms
=450  \\$aNaja Venoms
=450  \\$wnnna$aVenom, Cobra
=450  \\$wnnna$aVenom, Elapid
=450  \\$wnnna$aVenom, Hydrophid
=450  \\$wnnna$aVenom, King Cobra
=450  \\$wnnna$aVenom, Naja
=450  \\$wnnna$aVenom, Ophiophagus hannah
=450  \\$wnnna$aVenom, Sea Snake
=450  \\$wnnna$aVenoms, Cobra
=450  \\$wnnna$aVenoms, Elapid
=450  \\$wnnna$aVenoms, Hydrophid
=450  \\$wnnna$aVenoms, Naja
=450  \\$wnnna$aVenoms, Sea Snake
=550  \\$wg$aSnake Venoms
=550  \\$wh$aBungarotoxins
=550  \\$wh$aCobra Cardiotoxin Proteins
=550  \\$wh$aCobra Neurotoxin Proteins
=550  \\$aNaja
=550  \\$aDendroaspis
=550  \\$aHydrophiidae
=550  \\$aCoral Snakes
=550  \\$aOphiophagus hannah
=550  \\$aElapidae
=667  \\$a/antag permitted but consider also ANTIVENINS
=680  \\$iVenoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized.
=688  \\$a78
=750  \0$81$wb$iBroader mapping$aElapidae$0(DLC)sh 85041501$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$xVenom$0(DLC) sh2002006433$4BM$5IEN-M
=788  \0$iSearch also under the LCSH heading$aElapidae--Venom$5IEN-M

=LDR  01105cz  a2200325n  4500
=001  9880803653902441
=005  20190726110549.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D049930
=035  \\$a(NLM)98193996760000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x822.$x180
=150  \\$aChrysopogon
=450  \\$wnnna$aChrysopogon zizanioides
=450  \\$wnnna$aVetiver Grass
=450  \\$wnnna$aVetiveria zizanioides
=450  \\$wnno$aVetiveria
=450  \\$wnnna$aChrysopogon zizanioide
=450  \\$wnnna$aChrysopogons
=450  \\$wnnna$aGrass, Vetiver
=450  \\$wnnna$aGrasses, Vetiver
=450  \\$wnnna$aVetiver Grasses
=450  \\$wnnna$aVetiveria zizanioide
=450  \\$wnnna$azizanioide, Chrysopogon
=450  \\$wnnna$azizanioides, Chrysopogon
=450  \\$wnnna$azizanioides, Vetiveria
=550  \\$wg$aPoaceae
=680  \\$iA plant genus of the family POACEAE. The RHIZOME contains SESQUITERPENES and is the source of vetiver oil used in PERFUME.
=688  \\$a2018(2005)
=750  \0$aVetiveria$0(DLC) sh 88023184$5IEN-M

=LDR  01232cz  a2200289n  4500
=001  9880909169802441
=005  20200403113848.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075182
=035  \\$a(NLM)9810901301900041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x224.$x500
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x800.$x500
=072  \\$aD2.$x241.$x511.$x316.$x682.$x149.$x500
=072  \\$aD2.$x241.$x511.$x316.$x682.$x800.$x500
=072  \\$aD2.$x309.$x500.$x450.$x500
=072  \\$aD3.$x633.$x300.$x786.$x500
=150  \\$aAgent Orange
=450  \\$wnnna$a(2,4-dichlorophenoxy)acetic acid, butyl ester, mixt. with butyl (2,4,5-trichlorophenoxy)acetate
=450  \\$wnnna$a2,4-D - 2,4,5-T mixture
=450  \\$wnnna$aOrange, Agent
=550  \\$wg$a2,4-Dichlorophenoxyacetic Acid
=550  \\$wg$a2,4,5-Trichlorophenoxyacetic Acid
=550  \\$wg$aPolychlorinated Dibenzodioxins
=680  \\$iA herbicide that contains equal parts of 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), as well as traces of the contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
=688  \\$a2018 (1980)
=750  \0$aAgent Orange$0(DLC)sh 85002177$5IEN-M

=LDR  00634cz  a2200193n  4500
=001  9880909169902441
=005  20200402175135.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074762
=035  \\$a(NLM)9810901182100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x250.$x18
=150  \\$aAeromonadales
=550  \\$wg$aGammaproteobacteria
=550  \\$wh$aAeromonadaceae
=550  \\$wh$aSuccinivibrionaceae
=680  \\$iAn order of Gram-negative bacteria in the class GAMMAPROTEOBACTERIA, phylum PROTEOBACTERIA, which include important pathogens.
=688  \\$a2018
=750  \0$aAeromonadales$0(DLC) sh2005020186$5IEN-M

=LDR  01842cz  a2200541n  4500
=001  9880909170202441
=005  20200402152245.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074744
=035  \\$a(NLM)9810901193700041
=035  \\$a(NLM)9810901193700041
=035  \\$a(NLM)9810901193700041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x660.$x871.$x790.$x600.$x200
=072  \\$aG2.$x111.$x691.$x600.$x200
=072  \\$aG3.$x734.$x871.$x790.$x600.$x200
=072  \\$aG5.$x308.$x670.$x600.$x200
=150  \\$aADP-Ribosylation
=450  \\$wnnna$a(ADP-Ribosyl)ation
=450  \\$wnnna$a(ADPRibosyl)ation
=450  \\$wnnna$aADP Ribosylation
=450  \\$wnnna$aADPRibosylation
=450  \\$wnnna$aMARylation
=450  \\$wnnna$aMono ADPRibosylation
=450  \\$wnnna$aMono(ADP-Ribosyl)ation
=450  \\$wnnna$aMono(ADPRibosyl)ation
=450  \\$wnnna$aMono-ADP-Ribosylation
=450  \\$wnnna$aMono-ADPRibosylation
=450  \\$wnnna$aMonoADPRibosylation
=450  \\$wnnna$aADP Ribosylations
=450  \\$wnnna$aADP-Ribosylations
=450  \\$wnnna$aADPRibosylation, Mono
=450  \\$wnnna$aADPRibosylations
=450  \\$wnnna$aADPRibosylations, Mono
=450  \\$wnnna$aMARylations
=450  \\$wnnna$aMono ADP Ribosylation
=450  \\$wnnna$aMono ADPRibosylations
=450  \\$wnnna$aMono-ADP-Ribosylations
=450  \\$wnnna$aMono-ADPRibosylations
=450  \\$wnnna$aMonoADPRibosylations
=450  \\$wnnna$aRibosylation, ADP
=450  \\$wnnna$aRibosylations, ADP
=550  \\$wg$aProtein Processing, Post-Translational
=550  \\$wh$aPoly ADP Ribosylation
=550  \\$aADP Ribose Transferases
=680  \\$iPost-translational modification of proteins with ADENOSINE DIPHOSPHATE RIBOSE.
=688  \\$a2018
=750  \0$aADP-ribosylation$0(DLC)sh 89006797$5IEN-M

=LDR  01511cz  a2200373n  4500
=001  9880909291602441
=005  20200403144316.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(NLM)9810901506800041
=035  \\$a(DNLM)D000076042
=040  \\$aDNLM$cDNLM
=060  \0$aWM 173.7
=072  \\$aC10.$x597.$x606.$x525.$x400.$x500
=072  \\$aC10.$x720.$x112.$x100.$x250
=072  \\$aC23.$x888.$x592.$x604.$x529.$x400.$x500
=072  \\$aC25.$x723.$x705.$x150.$x100.$x250
=072  \\$aC25.$x775.$x100.$x87.$x193.$x100.$x250
=072  \\$aF1.$x700.$x625.$x400.$x500
=072  \\$aF3.$x615.$x200.$x131
=072  \\$aF3.$x900.$x100.$x50.$x250
=150  \\$aAlcoholic Korsakoff Syndrome
=450  \\$wnnna$aAlcohol-Induced Korsakoff Syndrome
=450  \\$wnnna$aAlcoholic Wernicke-Korsakoff Syndrome
=450  \\$wnnna$aAlcohol Induced Korsakoff Syndrome
=450  \\$wnnna$aAlcoholic Wernicke Korsakoff Syndrome
=450  \\$wnnna$aKorsakoff Syndrome, Alcohol-Induced
=450  \\$wnnna$aKorsakoff Syndrome, Alcoholic
=450  \\$wnnna$aWernicke-Korsakoff Syndrome, Alcoholic
=550  \\$wg$aAlcohol Amnestic Disorder
=550  \\$wg$aAmnesia
=550  \\$wg$aKorsakoff Syndrome
=680  \\$iA neurological disorder characterized by inattentiveness and the inability to form short term memories. It is caused by THIAMINE DEFICIENCY due to chronic ALCOHOLISM.
=688  \\$a2018(2000); use KORSAKOFF SYNDROME 2000-2017
=750  \0$aWernicke-Korsakoff syndrome$0(DLC) sh 96004581$5IEN-M

=LDR  00929cz  a2200253n  4500
=001  9880909474102441
=005  20200402145520.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076363
=035  \\$a(NLM)9810901615600041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x399.$x136.$x500
=150  \\$aAcademic Success
=450  \\$wnnna$aAcademic Achievement
=450  \\$wnnna$aAcademic Achievements
=450  \\$wnnna$aAcademic Successes
=450  \\$wnnna$aAchievement, Academic
=450  \\$wnnna$aAchievements, Academic
=450  \\$wnnna$aSuccess, Academic
=450  \\$wnnna$aSuccesses, Academic
=550  \\$wg$aAcademic Performance
=680  \\$iLevel of engagement in educationally purposeful activities, satisfaction, acquisition of desired knowledge, skills, and competencies, persistence and attainment of educational outcomes.
=688  \\$a2018
=750  \0$aAcademic achievement$0(DLC)sh 85000296$5IEN-M

=LDR  01308cz  a2200373n  4500
=001  9880910755202441
=005  20200410142814.0
=008  170712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000075342
=035  \\$a(NLM)9810901274700041
=040  \\$aDNLM$cDNLM
=072  \\$aA13.$x79
=072  \\$aA17.$x100
=150  \\$aAnimal Scales
=450  \\$wnnna$aCuticular Scales
=450  \\$wnnna$aDermal Scales
=450  \\$wnnna$aEpidermal Scales
=450  \\$wnnna$aAnimal Scale
=450  \\$wnnna$aCuticular Scale
=450  \\$wnnna$aDermal Scale
=450  \\$wnnna$aEpidermal Scale
=450  \\$wnnna$aScale, Animal
=450  \\$wnnna$aScale, Cuticular
=450  \\$wnnna$aScale, Dermal
=450  \\$wnnna$aScale, Epidermal
=450  \\$wnnna$aScales, Animal
=450  \\$wnnna$aScales, Cuticular
=450  \\$wnnna$aScales, Dermal
=450  \\$wnnna$aScales, Epidermal
=550  \\$wg$aIntegumentary System
=680  \\$iTough, horny, brittle, smooth, striated or plate-like extensions of the stratum corneum or outer layer of the skin. It serves as a protective layer in fishes, reptiles, birds, and mammals.
=688  \\$a2018
=750  \0$iNarrower mapping$aScales (Fishes)$0(DLC) sh 85117912$4NM$5IEN-M
=750  \0$iNarrower mapping$aScales (Reptiles)$0(DLC) sh 85117913$4NM$5IEN-M

=LDR  00572cz  a2200205n  4500
=001  9880910755602441
=005  20200409150005.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076203
=035  \\$a(NLM)9810901473900041
=040  \\$aDNLM$cDNLM
=072  \\$aA13.$x78
=072  \\$aA17.$x360.$x148
=150  \\$aAnimal Fur
=450  \\$wnnna$aFur, Animal
=550  \\$wg$aAnimal Structures
=550  \\$wg$aHair
=680  \\$iUsually densely-packed hairs on the skin of MAMMALS.
=688  \\$a2018; use Hair (1963-2017)
=750  \0$aFur$0(DLC) sh 85052483$5IEN-M

=LDR  01201cz  a2200337n  4500
=001  9880910972602441
=005  20200407173718.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074022
=035  \\$a(NLM)9810900884100041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 460
=072  \\$aE3.$x155.$x403
=150  \\$aAnesthesia, Cardiac Procedures
=450  \\$wnnna$aAnesthesia, Cardiac
=450  \\$wnnna$aCardiac Anaesthesia
=450  \\$wnnna$aCardiac Anesthesia
=450  \\$wnnna$aCardiothoracic Anaesthesia
=450  \\$wnnna$aCardiothoracic Anesthesia
=450  \\$wnnna$aCardiovascular Anesthesia
=450  \\$wnnna$aAnaesthesia, Cardiothoracic
=450  \\$wnnna$aAnesthesia, Cardiothoracic
=450  \\$wnnna$aAnesthesia, Cardiovascular
=450  \\$wnnna$aAnesthesias, Cardiac Procedures
=450  \\$wnnna$aCardiac Anaesthesias
=450  \\$wnnna$aCardiac Procedures Anesthesia
=450  \\$wnnna$aCardiac Procedures Anesthesias
=550  \\$wg$aAnesthesia
=680  \\$iA range of methods used to induce UNCONSCIOUSNESS; ANALGESIA; and MUSCLE RELAXATION during cardiac procedures.
=688  \\$a2018
=750  \0$aAnesthesia in cardiology$0(DLC) sh 85004959$5IEN-M

=LDR  00778cz  a2200205n  4500
=001  9880910973402441
=005  20200407174823.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074885
=035  \\$a(NLM)9810901161000041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x520.$x252.$x968.$x500
=150  \\$aAmniotomy
=450  \\$wnnna$aArtificial Rupture of Membranes
=550  \\$wg$aLabor, Induced
=680  \\$iA method of inducing labor by deliberate rupture of the AMNION to cause the release of amniotic fluid.
=688  \\$a2018
=750  \0$81$wb$iBroader mapping$aAmnion$0(DLC) sh 85004562$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xRupture$0(DLC) sh 00007669$4BM$5IEN-M
=788  \0$iBroader mapping,$iSearch under the LCSH heading:$aAmnion--Rupture$4BM$5IEN-M

=LDR  03812cz  a2200877n  4500
=001  9880914573302441
=005  20200416175819.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073537
=035  \\$a(NLM)9810900688000041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x117
=150  \\$aBiological Variation, Population
=450  \\$wnnna$aBetween-Individual Biological Variation
=450  \\$wnnna$aBetween-Person Biological Variation
=450  \\$wnnna$aBetween-Person Variation
=450  \\$wnnna$aBetween-Subject Biological Variation
=450  \\$wnnna$aBetween-Subject Variation
=450  \\$wnnna$aBiologic Variability, Population
=450  \\$wnnna$aInter-Individual Biological Variation
=450  \\$wnnna$aPhenotypic Variability
=450  \\$wnnna$aPhenotypic Variation
=450  \\$wnnna$aBetween Individual Biological Variation
=450  \\$wnnna$aBetween Person Biological Variation
=450  \\$wnnna$aBetween Person Variation
=450  \\$wnnna$aBetween Subject Biological Variation
=450  \\$wnnna$aBetween Subject Variation
=450  \\$wnnna$aBetween-Individual Biological Variations
=450  \\$wnnna$aBetween-Person Biological Variations
=450  \\$wnnna$aBetween-Person Variations
=450  \\$wnnna$aBetween-Subject Biological Variations
=450  \\$wnnna$aBetween-Subject Variations
=450  \\$wnnna$aBiologic Variabilities, Population
=450  \\$wnnna$aBiological Variation, Between-Individual
=450  \\$wnnna$aBiological Variation, Between-Person
=450  \\$wnnna$aBiological Variation, Between-Subject
=450  \\$wnnna$aBiological Variation, Inter-Individual
=450  \\$wnnna$aBiological Variations, Between-Individual
=450  \\$wnnna$aBiological Variations, Between-Person
=450  \\$wnnna$aBiological Variations, Between-Subject
=450  \\$wnnna$aBiological Variations, Inter-Individual
=450  \\$wnnna$aBiological Variations, Population
=450  \\$wnnna$aInter Individual Biological Variation
=450  \\$wnnna$aInter-Individual Biological Variations
=450  \\$wnnna$aPhenotypic Variabilities
=450  \\$wnnna$aPhenotypic Variations
=450  \\$wnnna$aPopulation Biologic Variabilities
=450  \\$wnnna$aPopulation Biologic Variability
=450  \\$wnnna$aPopulation Biological Variation
=450  \\$wnnna$aPopulation Biological Variations
=450  \\$wnnna$aVariabilities, Phenotypic
=450  \\$wnnna$aVariabilities, Population Biologic
=450  \\$wnnna$aVariability, Phenotypic
=450  \\$wnnna$aVariability, Population Biologic
=450  \\$wnnna$aVariation, Between-Individual Biological
=450  \\$wnnna$aVariation, Between-Person
=450  \\$wnnna$aVariation, Between-Person Biological
=450  \\$wnnna$aVariation, Between-Subject
=450  \\$wnnna$aVariation, Between-Subject Biological
=450  \\$wnnna$aVariation, Inter-Individual Biological
=450  \\$wnnna$aVariation, Phenotypic
=450  \\$wnnna$aVariation, Population Biological
=450  \\$wnnna$aVariations, Between-Individual Biological
=450  \\$wnnna$aVariations, Between-Person
=450  \\$wnnna$aVariations, Between-Person Biological
=450  \\$wnnna$aVariations, Between-Subject
=450  \\$wnnna$aVariations, Between-Subject Biological
=450  \\$wnnna$aVariations, Inter-Individual Biological
=450  \\$wnnna$aVariations, Phenotypic
=450  \\$wnnna$aVariations, Population Biological
=550  \\$wg$aBiological Phenomena
=550  \\$wh$aAnatomic Variation
=550  \\$aReference Values
=680  \\$iDifferences in measurable biological values, characteristics, or traits, among individuals of a population or between population groups.
=688  \\$a2018
=750  \0$aVariation (Biology)$0(DLC)sh 85142095$5IEN-M

=LDR  01236cz  a2200373n  4500
=001  9880914660802441
=005  20200430134259.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074766
=035  \\$a(NLM)9810901179600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328
=150  \\$aDipsacales
=450  \\$wnnna$aAdoxales
=450  \\$wnnna$aCaprifoliales
=450  \\$wnnna$aLonicerales
=450  \\$wnnna$aSambucales
=450  \\$wnnna$aValerianales
=450  \\$wnnna$aViburnales
=450  \\$wnnna$aAdoxale
=450  \\$wnnna$aCaprifoliale
=450  \\$wnnna$aDipsacale
=450  \\$wnnna$aLonicerale
=450  \\$wnnna$aSambucale
=450  \\$wnnna$aValerianale
=450  \\$wnnna$aViburnale
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAdoxaceae
=550  \\$wh$aCaprifoliaceae
=550  \\$wh$aDipsacaceae
=550  \\$wh$aValerianaceae
=680  \\$iAn order of dicotyledonous flowering plants which includes six families. It is best known for its ornamental plants such as LONICERA (honeysuckle), VIBURNUM (arrowwood and guelder rose), and SCABIOSA (scabious, or pincushion flower).
=688  \\$a2018
=750  \0$aDipsacales$0(DLC)sh 85038234$5IEN-M

=LDR  00841cz  a2200277n  4500
=001  9880914661502441
=005  20200429125252.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073600
=035  \\$a(NLM)9810900660600041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 426
=072  \\$aE2.$x642.$x249.$x268
=072  \\$aG7.$x203.$x650.$x240.$x269
=150  \\$aDiet, High-Protein
=450  \\$wnnna$aHigh-Protein Diet
=450  \\$wnnna$aDiet, High Protein
=450  \\$wnnna$aDiets, High-Protein
=450  \\$wnnna$aHigh Protein Diet
=450  \\$wnnna$aHigh-Protein Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$wh$aDiet, High-Protein Low-Carbohydrate
=680  \\$iA diet that includes foods with a high protein content.
=688  \\$a2018
=750  \0$aHigh-protein diet$0(DLC) sh 85060687$5IEN-M

=LDR  00752cz  a2200193n  4500
=001  9880914661802441
=005  20200429112327.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000074767
=035  \\$a(NLM)9810901175500041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x345.$x500.$x550.$x500.$x250
=150  \\$aDiapause
=550  \\$wg$aLife Cycle Stages
=550  \\$wh$aDiapause, Insect
=550  \\$aTorpor
=680  \\$iA period of arrested growth or development in animals that is triggered by external conditions, such as length of day, extreme temperatures, or reduced food availability. It can occur at the embryonic, larval, pupal, or adult stage, depending on the species.
=688  \\$a2018
=750  \0$aDiapause$0(DLC) sh 85037578$5IEN-M

=LDR  01348cz  a2200421n  4500
=001  9880914662002441
=005  20200429104134.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073178
=035  \\$a(NLM)9810900540900041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672.$x125.$x875.$x419
=150  \\$aDendroaspis
=450  \\$wnnna$aBlack Mamba
=450  \\$wnnna$aDendroaspis angusticeps
=450  \\$wnnna$aDendroaspis jamesoni
=450  \\$wnnna$aDendroaspis polylepis
=450  \\$wnnna$aDendroaspis viridis
=450  \\$wnnna$aEastern Green Mamba
=450  \\$wnnna$aGreen Mamba
=450  \\$wnnna$aJameson's Mamba
=450  \\$aMamba
=450  \\$wnnna$aBlack Mambas
=450  \\$wnnna$aEastern Green Mambas
=450  \\$wnnna$aGreen Mamba, Eastern
=450  \\$wnnna$aGreen Mambas
=450  \\$wnnna$aGreen Mambas, Eastern
=450  \\$wnnna$aJameson Mamba
=450  \\$wnnna$aMamba, Black
=450  \\$wnnna$aMamba, Eastern Green
=450  \\$wnnna$aMamba, Green
=450  \\$wnnna$aMamba, Jameson's
=450  \\$wnnna$aMambas, Eastern Green
=550  \\$wg$aElapidae
=550  \\$aElapid Venoms
=680  \\$iA genus of highly venomous elapid snake indigenous to sub-Saharan Africa.
=688  \\$a2018; use ELAPIDAE 1994-2017
=750  \0$aMambas$0(DLC) sh 86004578$5IEN-M

=LDR  01331cz  a2200409n  4500
=001  9880914662202441
=005  20200429101232.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073458
=035  \\$a(NLM)9810900694700041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x313.$x500.$x750.$x280.$x300
=072  \\$aL1.$x470.$x563.$x500
=072  \\$aL1.$x470.$x688
=150  \\$aData Warehousing
=450  \\$wnnna$aData Mart
=450  \\$wnnna$aData Warehouse
=450  \\$wnnna$aDatawarehouse
=450  \\$wnnna$aDatawarehousing
=450  \\$wnnna$aEnterprise Data Warehouse
=450  \\$wnnna$aData Marts
=450  \\$wnnna$aData Warehouse, Enterprise
=450  \\$wnnna$aData Warehouses
=450  \\$wnnna$aData Warehouses, Enterprise
=450  \\$wnnna$aDatawarehouses
=450  \\$wnnna$aEnterprise Data Warehouses
=450  \\$wnnna$aMart, Data
=450  \\$wnnna$aMarts, Data
=450  \\$wnnna$aWarehouse, Data
=450  \\$wnnna$aWarehouse, Enterprise Data
=450  \\$wnnna$aWarehouses, Data
=450  \\$wnnna$aWarehouses, Enterprise Data
=450  \\$wnnna$aWarehousing, Data
=550  \\$wg$aInformation Storage and Retrieval
=680  \\$iA system for storing electronic data derived from various sources.
=688  \\$a2018
=750  \0$aData warehousing$0(DLC) sh 97003695$5IEN-M

=LDR  00738cz  a2200229n  4500
=001  9880363772402441
=005  20141212202453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007220
=035  \\$aCBA0411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944.$x420
=072  \\$aN6.$x850.$x460.$x710.$x420
=150  \\$aIndustrial Waste
=450  \\$wnnna$aIndustrial Wastes
=450  \\$wnnna$aWaste, Industrial
=450  \\$wnnna$aWastes, Industrial
=550  \\$wg$aWaste Products
=667  \\$aspecify geog if pertinent; DF: INDUST WASTE
=680  \\$iWorthless, damaged, defective, superfluous or effluent material from industrial operations.
=688  \\$a66
=750  \0$aFactory and trade waste$5IEN$0(DLC)sh 85046847

=LDR  00868cz  a2200217n  4500
=001  9880363772502441
=005  20141212202452.0
=008  860327\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007218
=035  \\$aCBA0409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x460
=072  \\$aJ1.$x897.$x120.$x460
=150  \\$aIndustrial Microbiology
=450  \\$wnnna$aMicrobiology, Industrial
=550  \\$wg$aBiotechnology
=550  \\$wg$aMicrobiology
=667  \\$aSPEC: SPEC qualif; coord IM with specific bact, virus or fungus (IM) if pertinent; DF: INDUST MICROBIOL
=680  \\$iThe study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms.
=688  \\$a87
=750  \0$aIndustrial microbiology$5IEN$0(DLC)sh 85065899

=LDR  00426cz  a2200157n  4500
=001  9880363772602441
=005  20141212202451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007215
=035  \\$aCBA0406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x446
=150  \\$aIndophenol
=550  \\$wg$aPhenols
=550  \\$wh$a2,6-Dichloroindophenol
=750  \0$aIndophenol$5IEN$0(DLC)sh 85065790

=LDR  01014cz  a2200301n  4500
=001  9880363772702441
=005  20141212202450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007213
=035  \\$aCBA0404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x420
=150  \\$aIndomethacin
=450  \\$wnnna$aAmuno
=450  \\$wnnna$aHydrochloride, Indomethacin
=450  \\$wnnna$aIndocid
=450  \\$wnnna$aIndocin
=450  \\$wnnna$aIndomet 140
=450  \\$wnnna$aIndometacin
=450  \\$wnnna$aIndomethacin Hydrochloride
=450  \\$wnnna$aMetindol
=450  \\$wnnna$aOsmosin
=550  \\$wg$aIndoles
=550  \\$wh$aKetorolac
=550  \\$wh$aKetorolac Tromethamine
=680  \\$iA non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
=688  \\$a66(64)
=750  \0$aIndomethacin$5IEN$0(DLC)sh 85065731

=LDR  01463cz  a2200493n  4500
=001  9880363772802441
=005  20171219113729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007211
=035  \\$aCBA0402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473
=150  \\$aIndoles
=550  \\$wg$aHeterocyclic Compounds, 2-Ring
=550  \\$wh$aAdrenochrome
=550  \\$wh$aAlcian Blue
=550  \\$wh$aCarbazoles
=550  \\$wh$aCarbolines
=550  \\$wh$aCytochalasins
=550  \\$wh$aDelavirdine
=550  \\$wh$aGliotoxin
=550  \\$wh$aHydroxytryptophol
=550  \\$wh$aIbogaine
=550  \\$wh$aIndapamide
=550  \\$wh$aIndican
=550  \\$wh$aIndigo Carmine
=550  \\$wh$aIndocyanine Green
=550  \\$wh$aIndole Alkaloids
=550  \\$wh$aIndoleacetic Acids
=550  \\$wh$aIndolequinones
=550  \\$wh$aIndomethacin
=550  \\$wh$aIndoramin
=550  \\$wh$aIprindole
=550  \\$wh$aIsatin
=550  \\$wh$aMethisazone
=550  \\$wh$aMolindone
=550  \\$wh$aOxyphenisatin Acetate
=550  \\$wh$aPerindopril
=550  \\$wh$aSkatole
=550  \\$wh$aSporidesmins
=550  \\$wh$aTryptamines
=550  \\$wh$aVilazodone Hydrochloride
=680  \\$iBenzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
=750  \0$aIndole$5IEN$0(DLC)sh 85065725

=LDR  00947cz  a2200289n  4500
=001  9880363772902441
=005  20141212202449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007210
=035  \\$aCBA0401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x288
=072  \\$aD3.$x438.$x473.$x404
=150  \\$aIndoleacetic Acids
=450  \\$wnnna$aAcids, Indoleacetic
=450  \\$wnnna$aAcids, Indolylacetic
=450  \\$wnnna$aAuxin
=450  \\$wnnna$aAuxins
=450  \\$wnnna$aIndolylacetic Acids
=550  \\$wg$aAcids, Heterocyclic
=550  \\$wg$aIndoles
=550  \\$wh$aEtodolac
=550  \\$wh$aHydroxyindoleacetic Acid
=680  \\$iAcetic acid derivatives of the heterocyclic compound indole. (Merck Index, 11th ed)
=688  \\$a75; was INDOLEACETIC ACID 1963-74
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20061114: 150:##:_{dollar}a Auxins
=750  \0$aIndoleacetic acid$5IEN$0(DLC)sh 85065729

=LDR  00851cz  a2200277n  4500
=001  9880363773002441
=005  20141212202449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007208
=035  \\$aCBA0399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x400
=150  \\$aIndocyanine Green
=450  \\$wnnna$aCardio-Green
=450  \\$wnnna$aCardio Green
=450  \\$wnnna$aCardiogreen
=450  \\$wnnna$aGreen, Indocyanine
=450  \\$wnnna$aUjoveridin
=450  \\$wnnna$aVofaverdin
=450  \\$wnnna$aVophaverdin
=450  \\$wnnna$aWofaverdin
=550  \\$wg$aIndoles
=667  \\$aD25-26 qualif
=680  \\$iA tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.
=688  \\$a68(63)
=750  \0$aIndocyanine green$5IEN$0(DLC)sh 85065724

=LDR  00646cz  a2200193n  4500
=001  9880363773102441
=005  20141212202448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007207
=035  \\$aCBA0398HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x466
=150  \\$aIndividuation
=450  \\$wnnna$aIndividuations
=550  \\$wg$aPersonality Development
=667  \\$ano qualif
=680  \\$iA process of differentiation having for its goal the development of the individual personality.
=688  \\$a91(75); was see under PERSONALITY DEVELOPMENT 1975-90
=750  \0$aIndividuation (Psychology)$5IEN$0(DLC)sh 90005208

=LDR  00814cz  a2200241n  4500
=001  9880363773202441
=005  20141212202448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007206
=035  \\$aCBA0397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x488
=150  \\$aIndividuality
=450  \\$wnnna$aDifference, Individual
=450  \\$wnnna$aDifferences, Individual
=450  \\$wnnna$aIndividual Difference
=450  \\$aIndividual Differences
=550  \\$wg$aPersonality
=667  \\$ado not confuse with PERSONHOOD
=680  \\$iThose psychological characteristics which differentiate individuals from one another.
=688  \\$a75; was see under PERSONALITY 1963-74
=750  \0$aIndividuality$5IEN-M$0(DLC)sh 85065689
=750  \0$aIndividual differences$5IEN-HS$0(DLC)sh 88004306

=LDR  00785cz  a2200205n  4500
=001  9880363773302441
=005  20141212202448.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007205
=035  \\$aCBA0396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x460
=150  \\$aIndium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Indium
=550  \\$wg$aRadioisotopes
=550  \\$aIndium
=667  \\$aIn-106-112, 113m, 114, 116-124; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes.
=688  \\$a88
=750  \0$aIndium$xIsotopes$5IEN-M$0(DLC)sh 85065673

=LDR  00815cz  a2200205n  4500
=001  9880363773402441
=005  20141212202448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007204
=035  \\$aCBA0395HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x381
=072  \\$aD1.$x552.$x544.$x381
=150  \\$aIndium
=450  \\$aIndium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=667  \\$aIn-115; In-113 = INDIUM (IM) + ISOTOPES (NIM) but In-113m = INDIUM RADIOISOTOPES (IM); In-106-112, 114, 116-124 = INDIUM RADIOISOTOPES (IM)
=680  \\$iA metallic element, atomic number 49, atomic weight 114.82, symbol In. It is named from its blue line in the spectrum. (From Dorland, 28th ed)
=750  \0$aIndium compounds$5IEN-M$0(DLC)sh 85065678
=750  \0$aIndium$5IEN-HS$0(DLC)sh 85065672

=LDR  01883cz  a2200361n  4500
=001  9880363773502441
=005  20141212192247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007202
=035  \\$aCBA0393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x410
=150  \\$aIndicators and Reagents
=450  \\$wnnna$aIndicators
=450  \\$aReagents
=450  \\$wnnna$aReagents and Indicators
=550  \\$wg$aLaboratory Chemicals
=550  \\$wh$aAffinity Labels
=550  \\$wh$aChromogenic Compounds
=550  \\$wh$aCross-Linking Reagents
=550  \\$wh$aIntercalating Agents
=550  \\$wh$aLuminescent Agents
=550  \\$wh$aNeuronal Tract-Tracers
=550  \\$wh$aRadiopharmaceuticals
=550  \\$wh$aReagent Kits, Diagnostic
=550  \\$wh$aReducing Agents
=550  \\$wh$aSulfhydryl Reagents
=550  \\$wh$aThiobarbituric Acid Reactive Substances
=550  \\$aSulfanilic Acids
=667  \\$aNIM; coord with specific substance (IM or NIM); D25-26 qualif except /diag use; REAGENT KITS, DIAGNOSTIC & REAGENT STRIPS are also available; DF: INDICATORS
=680  \\$iSubstances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499)
=750  \0$aChemical tests and reagents$5IEN-M$0(DLC)sh 85022957
=750  \0$aIndicators and test-papers$5IEN-HS$0(DLC)sh 85065658

=LDR  01888cz  a2200445n  4500
=001  9880363773602441
=005  20141212202447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007201
=035  \\$aCBA0392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x484
=150  \\$aIndicator Dilution Techniques
=450  \\$wnnna$aDilution Technic
=450  \\$wnnna$aDilution Technic, Indicator
=450  \\$wnnna$aDilution Technics
=450  \\$wnnna$aDilution Technics, Indicator
=450  \\$wnnna$aDilution Technique
=450  \\$wnnna$aDilution Technique, Indicator
=450  \\$aDilution Techniques
=450  \\$wnnna$aDilution Techniques, Indicator
=450  \\$wnnna$aIndicator Dilution Technic
=450  \\$wnnna$aIndicator Dilution Technics
=450  \\$wnnna$aIndicator Dilution Technique
=450  \\$wnnna$aTechnic, Dilution
=450  \\$wnnna$aTechnic, Indicator Dilution
=450  \\$wnnna$aTechnics, Dilution
=450  \\$wnnna$aTechnics, Indicator Dilution
=450  \\$wnnna$aTechnique, Dilution
=450  \\$wnnna$aTechnique, Indicator Dilution
=450  \\$wnnna$aTechniques, Dilution
=450  \\$wnnna$aTechniques, Indicator Dilution
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aDye Dilution Technique
=550  \\$wh$aRadioisotope Dilution Technique
=550  \\$wh$aThermodilution
=667  \\$aNIM; do not use /util except by MeSH definition; DYE DILUTION TECHNIQUE and RADIOISOTOPE DILUTION TECHNIQUE are also available
=680  \\$iMethods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. (From Dorland, 28th ed)
=688  \\$a91; was INDICATOR DILUTION TECHNICS 1967-90
=750  \0$aIndicator dilution$5IEN$0(DLC)sh 85065656

=LDR  01051cz  a2200253n  4500
=001  9880363773702441
=005  20141212202446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007200
=035  \\$aCBA0391HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x393
=150  \\$aIndican
=450  \\$wnnna$a1H-Indol-3-ol Hydrogen Sulfate Ester
=450  \\$wnnna$aIndican Monopotassium Salt
=450  \\$wnnna$aIndican Monosodium Salt
=450  \\$wnnna$aIndoxyl Sulfate
=450  \\$wnnna$aMonopotassium Salt, Indican
=450  \\$wnnna$aMonosodium Salt, Indican
=450  \\$wnnna$aSulfate, Indoxyl
=550  \\$wg$aIndoles
=667  \\$ado not confuse with indican, a glycoside from plants yielding indigo (index under GLYCOSIDES)
=680  \\$iA substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan.
=750  \0$aIndican$5IEN$0(DLC)sh 85065655

=LDR  01347cz  a2200373n  4500
=001  9880363773902441
=005  20141212202446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007198
=035  \\$aCBA0389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x508.$x150.$x600
=150  \\$aIndians, North American
=450  \\$wnnna$aAmerican Indian
=450  \\$wnnna$aAmerican Indian, North
=450  \\$wnnna$aAmerican Indians
=450  \\$wnnna$aAmerican Indians, North
=450  \\$wnnna$aAmerican, Native
=450  \\$wnnna$aAmericans, Native
=450  \\$wnnna$aAmerind, North American
=450  \\$aAmerinds, North American
=450  \\$wnnna$aIndian, American
=450  \\$wnnna$aIndian, North American
=450  \\$wnnna$aIndians, American
=450  \\$wnnna$aNative American
=450  \\$aNative Americans
=450  \\$wnnna$aNorth American Amerind
=450  \\$wnnna$aNorth American Amerinds
=450  \\$wnnna$aNorth American Indian
=450  \\$wnnna$aNorth American Indians
=550  \\$wg$aAmerican Native Continental Ancestry Group
=667  \\$aspecify geog if possible; in titles capitalize both Native and American
=680  \\$iIndividual members of North American ethnic groups with ancient historic ancestral origins in Asia.
=750  \0$aIndians of North America$5IEN$0(DLC)sh 85065184

=LDR  01233cz  a2200313n  4500
=001  9880363774002441
=005  20141212202445.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007197
=035  \\$aCBA0388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x508.$x150.$x575
=150  \\$aIndians, Central American
=450  \\$wnnna$aAmerican Amerind, Central
=450  \\$wnnna$aAmerican Amerinds, Central
=450  \\$wnnna$aAmerican Indian, Central
=450  \\$wnnna$aAmerican Indians, Central
=450  \\$wnnna$aAmerind, Central American
=450  \\$aAmerinds, Central American
=450  \\$wnnna$aCentral American Amerind
=450  \\$wnnna$aCentral American Amerinds
=450  \\$wnnna$aCentral American Indian
=450  \\$wnnna$aCentral American Indians
=450  \\$wnnna$aIndian, Central American
=550  \\$wg$aAmerican Native Continental Ancestry Group
=667  \\$aspecify geog if possible; not for Indians of Mexico ( = INDIANS, NORTH AMERICAN + MEXICO)
=680  \\$iIndividual members of Central American ethnic groups with ancient historic ancestral origins in Asia. Mexican Indians are not included.
=688  \\$a78
=750  \0$aIndians of Central America$5IEN$0(DLC)sh 85065085

=LDR  00762cz  a2200229n  4500
=001  9880363774102441
=005  20141212202443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007192
=035  \\$aCBA0383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x486
=072  \\$aD4.$x615.$x486
=150  \\$aIndenes
=550  \\$wg$aPolycyclic Hydrocarbons, Aromatic
=550  \\$wh$aDimethindene
=550  \\$wh$aIndans
=550  \\$wh$aSulindac
=667  \\$aaromatic hydrocarbons
=680  \\$iA family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
=688  \\$a68
=750  \0$aIndenes$5IEN$0(DLC)sh 85064827

=LDR  00697cz  a2200229n  4500
=001  9880363774202441
=005  20141212202443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007189
=035  \\$aCBA0380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x486.$x487
=072  \\$aD4.$x615.$x486.$x487
=150  \\$aIndans
=450  \\$wnnna$aIndanones
=550  \\$wg$aIndenes
=550  \\$wh$aAprindine
=550  \\$wh$aNinhydrin
=550  \\$wh$aPhenindione
=680  \\$iAryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.
=688  \\$a91(75)63-67; was see under INDENES 1975-90; was heading 1963-67
=750  \0$aIndan$5IEN$0(DLC)sh 85064818

=LDR  00587cz  a2200193n  4500
=001  9880363774302441
=005  20141212202442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007187
=035  \\$aCBA0378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x515
=150  \\$aIncunabula as Topic
=550  \\$wg$aBooks
=667  \\$ado not confuse with the Publication Type INCUNABULA
=680  \\$iBooks printed before 1501.
=688  \\$a2010(1966)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Incunabula
=750  \0$aIncunabula$0(DLC) sh 85064810$5IEN

=LDR  02450cz  a2200637n  4500
=001  9880363774402441
=005  20190107111943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013482
=035  \\$aCBA6811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x881
=150  \\$aSuperoxide Dismutase
=450  \\$wnnna$aAg-Zn Superoxide Dismutase
=450  \\$wnnna$aAg Zn Superoxide Dismutase
=450  \\$wnnna$aCobalt Superoxide Dismutase
=450  \\$wnnna$aCu-Superoxide Dismutase
=450  \\$wnnna$aCu Superoxide Dismutase
=450  \\$aCu-Zn Superoxide Dismutase
=450  \\$wnnna$aCu Zn Superoxide Dismutase
=450  \\$wnnna$aCuprozinc Superoxide Dismutase
=450  \\$wnnna$aDismutase, Ag-Zn Superoxide
=450  \\$wnnna$aDismutase, Cobalt Superoxide
=450  \\$wnnna$aDismutase, Cu-Superoxide
=450  \\$wnnna$aDismutase, Cu-Zn Superoxide
=450  \\$wnnna$aDismutase, Cuprozinc Superoxide
=450  \\$wnnna$aDismutase, Fe-Superoxide
=450  \\$wnnna$aDismutase, Fe-Zn Superoxide
=450  \\$wnnna$aDismutase, Iron Superoxide
=450  \\$wnnna$aDismutase, Manganese Superoxide
=450  \\$wnnna$aDismutase, Mn-Superoxide
=450  \\$wnnna$aDismutase, Superoxide
=450  \\$wnnna$aErythrocuprein
=450  \\$wnnna$aFe-Superoxide Dismutase
=450  \\$wnnna$aFe Superoxide Dismutase
=450  \\$wnnna$aFe-Zn Superoxide Dismutase
=450  \\$wnnna$aFe Zn Superoxide Dismutase
=450  \\$aHemocuprein
=450  \\$wnnna$aIron Superoxide Dismutase
=450  \\$wnnna$aManganese Superoxide Dismutase
=450  \\$wnnna$aMn-SOD
=450  \\$wnnna$aMn SOD
=450  \\$wnnna$aMn-Superoxide Dismutase
=450  \\$wnnna$aMn Superoxide Dismutase
=450  \\$wnnna$aSuperoxide Dismutase, Ag-Zn
=450  \\$wnnna$aSuperoxide Dismutase, Cobalt
=450  \\$wnnna$aSuperoxide Dismutase, Fe-Zn
=450  \\$wnnna$aSuperoxide Dismutase, Iron
=450  \\$wnnna$aSuperoxide Dismutase, Manganese
=550  \\$wg$aOxidoreductases
=550  \\$wh$aSuperoxide Dismutase-1
=550  \\$aMenkes Kinky Hair Syndrome
=550  \\$aSuperoxides
=680  \\$iAn oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC 1.15.1.1.
=688  \\$a74(73)
=750  \0$aSuperoxide dismutase$5IEN$0(DLC)sh 85130641

=LDR  01100cz  a2200253n  4500
=001  9880363774502441
=005  20141212205958.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013481
=035  \\$aCBA6810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x685.$x750.$x850
=072  \\$aD1.$x339.$x431.$x374.$x850
=072  \\$aD1.$x339.$x431.$x750
=072  \\$aD1.$x650.$x550.$x750.$x800
=150  \\$aSuperoxides
=450  \\$wnnna$aSuperoxide
=450  \\$wnnna$aSuperoxide Anion
=450  \\$aSuperoxide Radical
=550  \\$wg$aPeroxides
=550  \\$wg$aReactive Oxygen Species
=680  \\$iHighly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to METHEMOGLOBIN. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxides.
=688  \\$a1994; was SUPEROXIDE 1975-1993 (see under OXYGEN 1975-1983)
=750  \0$aSuperoxides$5IEN$0(DLC)sh 85130640

=LDR  01597cz  a2200421n  4500
=001  9880363774602441
=005  20141212192547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013477
=035  \\$aCBA6806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x800.$x816
=072  \\$aA8.$x186.$x211.$x653.$x727.$x500
=150  \\$aSuperior Colliculi
=450  \\$wnnna$aAnterior Colliculus
=450  \\$wnnna$aColliculi, Superior
=450  \\$wnnna$aColliculus, Anterior
=450  \\$aColliculus, Superior
=450  \\$wnnna$aHuman Optic Lobe
=450  \\$wnnna$aHuman Optic Lobes
=450  \\$wnnna$aMammalian Optic Lobe
=450  \\$wnnna$aMammalian Optic Lobes
=450  \\$aOptic Lobe, Human
=450  \\$aOptic Lobe, Mammalian
=450  \\$wnnna$aOptic Lobes, Human
=450  \\$wnnna$aOptic Lobes, Mammalian
=450  \\$aOptic Tectum
=450  \\$wnnna$aOptic Tectums
=450  \\$wnnna$aSuperior Colliculus
=450  \\$wnnna$aTectum, Optic
=450  \\$wnnna$aTectums, Optic
=550  \\$wg$aTectum Mesencephali
=667  \\$anote entry term OPTIC LOBE, MAMMALIAN: OPTIC LOBE, NONMAMMALIAN is also available
=680  \\$iThe anterior pair of the quadrigeminal bodies which coordinate the general behavioral orienting responses to visual stimuli, such as whole-body turning, and reaching.
=688  \\$a2008 (1971); for OPTIC LOBE, HUMAN use CORPORA QUADRIGEMINA 2004-2007
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Superior Colliculus
=688  \\$a71
=750  \0$aSuperior colliculus$0(DLC)sh2003001483$5IEN-M

=LDR  00734cz  a2200217n  4500
=001  9880363774702441
=005  20141212205957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013475
=035  \\$aCBA6803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x859
=072  \\$aF2.$x739.$x794.$x881
=150  \\$aSuperego
=450  \\$wnnna$aSuperegos
=550  \\$wg$aPersonality Development
=550  \\$wg$aPsychoanalytic Theory
=667  \\$ano qualif
=680  \\$iThe component of the personality associated with ethics, standards, and self-criticism - the "conscience". It is derived mainly from identification with parents and parent substitutes.
=688  \\$a68
=750  \0$aSuperego$5IEN$0(DLC)sh 85130573

=LDR  00945cz  a2200289n  4500
=001  9880363774802441
=005  20141212205957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013473
=035  \\$aCBA6801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x706.$x776.$x800
=072  \\$aD27.$x505.$x954.$x444.$x695
=072  \\$aD27.$x720.$x269.$x800
=072  \\$aD27.$x720.$x799.$x763.$x764
=150  \\$aSunscreening Agents
=450  \\$wnnna$aAgents, Sunscreening
=450  \\$wnnna$aSunscreens
=550  \\$wg$aCosmetics
=550  \\$wg$aDermatologic Agents
=550  \\$wg$aRadiation-Protective Agents
=550  \\$aSun Protection Factor
=550  \\$aSunburn
=667  \\$aD25-26 qualif
=680  \\$iChemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation.
=688  \\$a72(66)
=750  \0$aSunscreens (Cosmetics)$5IEN$0(DLC)sh 90000649

=LDR  00920cz  a2200289n  4500
=001  9880363774902441
=005  20141212205956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013472
=035  \\$aCBA6800HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x650.$x836
=072  \\$aG1.$x750.$x250.$x650.$x836
=072  \\$aG1.$x750.$x770.$x578.$x836
=072  \\$aG16.$x500.$x275.$x63.$x725.$x525
=072  \\$aG16.$x500.$x750.$x775.$x525
=072  \\$aN6.$x230.$x300.$x100.$x725.$x525
=150  \\$aSunlight
=450  \\$wnnna$aSunshine
=550  \\$wg$aLight
=550  \\$wg$aWeather
=550  \\$wh$aInfrared Rays
=550  \\$wh$aUltraviolet Rays
=550  \\$aLight
=667  \\$a/adv eff permitted but consider also SUNBURN & SUNSTROKE; using sunlight therapeutically = HELIOTHERAPY
=680  \\$iIrradiation directly from the sun.
=750  \0$aSunshine$5IEN$0(DLC)sh 85130560

=LDR  00767cz  a2200229n  4500
=001  9880363775002441
=005  20141212205956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013471
=035  \\$aCBA6799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x600.$x725
=072  \\$aC26.$x200.$x855
=150  \\$aSunburn
=450  \\$wnnna$aSunburns
=550  \\$wg$aBurns
=550  \\$wg$aPhotosensitivity Disorders
=550  \\$aSunbathing
=550  \\$aSuntan
=667  \\$a/prev: consider also SUNSCREENING AGENTS
=680  \\$iAn injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.
=750  \2$aSunburn$5IEN

=LDR  01891cz  a2200517n  4500
=001  9880363775102441
=005  20141212205956.0
=008  780208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013467
=035  \\$aCBA6795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x486.$x875
=072  \\$aD4.$x615.$x486.$x875
=150  \\$aSulindac
=450  \\$wnnna$aAclin
=450  \\$wnnna$aAlphapharm Brand of Sulindac
=450  \\$wnnna$aApo-Sulin
=450  \\$wnnna$aApo Sulin
=450  \\$wnnna$aApotex Brand of Sulindac
=450  \\$wnnna$aArthrobid
=450  \\$wnnna$aArthrocine
=450  \\$wnnna$aCahill May Roberts Brand of Sulindac
=450  \\$wnnna$aChemia Brand of Sulindac
=450  \\$wnnna$aChibret
=450  \\$wnnna$aClinoril
=450  \\$wnnna$aCopal
=450  \\$wnnna$aKenalin
=450  \\$wnnna$aKendrick Brand of Sulindac
=450  \\$wnnna$aKlinoril
=450  \\$wnnna$aMerck Brand of Sulindac
=450  \\$wnnna$aMerck Sharp & Dohme Brand of Sulindac
=450  \\$wnnna$aMK-231
=450  \\$wnnna$aMK 231
=450  \\$wnnna$aMK231
=450  \\$wnnna$aNovo-Sundac
=450  \\$wnnna$aNovo Sundac
=450  \\$wnnna$aNovopharm Brand of Sulindac
=450  \\$wnnna$aNu-Pharm Brand of Sulindac
=450  \\$wnnna$aNu Pharm Brand of Sulindac
=450  \\$wnnna$aNu-Sulindac
=450  \\$wnnna$aNu Sulindac
=450  \\$wnnna$aSulindal
=550  \\$wg$aIndenes
=680  \\$iA sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.
=688  \\$a90(79); was see under INDENES 1979-89
=750  \0$aSulindac$5IEN$0(DLC)sh 85130323

=LDR  00919cz  a2200265n  4500
=001  9880363775202441
=005  20141212205955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013464
=035  \\$aCBA6792HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x877.$x800
=072  \\$aD1.$x875.$x800.$x800
=072  \\$aD2.$x886.$x645.$x655
=150  \\$aSulfuric Acids
=450  \\$wnnna$aAcids, Sulfuric
=550  \\$wg$aSulfur Acids
=550  \\$wh$aPentosan Sulfuric Polyester
=550  \\$wh$aSulfates
=550  \\$wh$aSulfuric Acid Esters
=550  \\$wh$aTetrathionic Acid
=667  \\$ado not confuse with SULFUR ACIDS
=680  \\$iInorganic and organic derivatives of sulfuric acid (H2SO4). The salts and esters of sulfuric acid are known as SULFATES and SULFURIC ACID ESTERS respectively.
=688  \\$a68; was SULFURIC ACID 1963-67
=750  \0$aSulfuric acid$5IEN-M$0(DLC)sh 85130391

=LDR  00663cz  a2200241n  4500
=001  9880363775302441
=005  20141212205954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013461
=035  \\$aCBA6789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x650.$x550.$x850
=072  \\$aD1.$x875.$x825
=150  \\$aSulfur Oxides
=450  \\$wnnna$aOxides, Sulfur
=450  \\$aSulphur Oxides$5IEN
=550  \\$wg$aOxides
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aSulfur Dioxide
=667  \\$ainorganic; SULFUR DIOXIDE is available
=680  \\$iInorganic oxides of sulfur.
=688  \\$a75
=750  \0$aSulfur oxides$5IEN$0(DLC)sh 85130388

=LDR  00672cz  a2200205n  4500
=001  9880363775402441
=005  20141212205954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013460
=035  \\$aCBA6788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x868
=150  \\$aSulfur Isotopes
=450  \\$wnnna$aIsotopes, Sulfur
=550  \\$wg$aIsotopes
=550  \\$wh$aSulfur Radioisotopes
=550  \\$aSulfur
=667  \\$aS-33,34,36; NIM
=680  \\$iStable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes.
=750  \0$aSulfur$xIsotopes$5IEN$0(DLC)sh 85130366

=LDR  00986cz  a2200253n  4500
=001  9880363775502441
=005  20141212205953.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013459
=035  \\$aCBA6787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x303.$x350.$x300.$x900
=072  \\$aD1.$x362.$x820
=072  \\$aD1.$x875.$x812
=150  \\$aSulfur Hexafluoride
=450  \\$wnnna$aHexafluoride, Sulfur
=450  \\$aSulphur Hexafluoride$5IEN
=550  \\$wg$aFluorides
=550  \\$wg$aGases
=550  \\$wg$aSulfur Compounds
=667  \\$aan inert gas used in resp physiol studies
=680  \\$iSulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants.
=688  \\$a91(80); was see under FLUORIDES 1980-90
=750  \0$aSulfur hexafluoride$5IEN$0(DLC)sh 85130381

=LDR  00818cz  a2200253n  4500
=001  9880363775602441
=005  20141212205953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013458
=035  \\$aCBA6786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x810
=072  \\$aD1.$x650.$x550.$x850.$x925
=072  \\$aD1.$x875.$x825.$x925
=150  \\$aSulfur Dioxide
=450  \\$wnnna$aAnhydride, Sulfurous
=450  \\$wnnna$aDioxide, Sulfur
=450  \\$wnnna$aSulfurous Anhydride
=450  \\$aSulphur Dioxide$5IEN
=550  \\$wg$aGases
=550  \\$wg$aSulfur Oxides
=680  \\$iA highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.
=688  \\$a66(64)
=750  \0$aSulfur dioxide$5IEN$0(DLC)sh 85130378

=LDR  01879cz  a2200625n  4500
=001  9880363775702441
=005  20141212205953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013457
=035  \\$aCBA6785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x875
=072  \\$aD2.$x886
=150  \\$aSulfur Compounds
=450  \\$wnnna$aCompounds, Sulfur
=450  \\$aOrganosulphur Compounds$5IEN
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAmino Acids, Sulfur
=550  \\$wh$aBenzothiepins
=550  \\$wh$abeta-Lactams
=550  \\$wh$aCyclic S-Oxides
=550  \\$wh$aHydrogen Sulfide
=550  \\$wh$aIsothiocyanates
=550  \\$wh$aOrganothiophosphorus Compounds
=550  \\$wh$aPhenothiazines
=550  \\$wh$aSulfhydryl Compounds
=550  \\$wh$aSulfides
=550  \\$wh$aSulfites
=550  \\$wh$aSulfones
=550  \\$wh$aSulfonium Compounds
=550  \\$wh$aSulfoxides
=550  \\$wh$aSulfur Acids
=550  \\$wh$aSulfur Hexafluoride
=550  \\$wh$aSulfur Oxides
=550  \\$wh$aTechnetium Tc 99m Sulfur Colloid
=550  \\$wh$aThiazides
=550  \\$wh$aThiazines
=550  \\$wh$aThiazoles
=550  \\$wh$aThiepins
=550  \\$wh$aThioamides
=550  \\$wh$aThiocarbamates
=550  \\$wh$aThiocyanates
=550  \\$wh$aThioglycosides
=550  \\$wh$aThiones
=550  \\$wh$aThionucleosides
=550  \\$wh$aThionucleotides
=550  \\$wh$aThiophenes
=550  \\$wh$aThiosemicarbazones
=550  \\$wh$aThiourea
=550  \\$wh$aThioxanthenes
=667  \\$aGEN or unspecified; prefer specific groups or specific drugs; DF: SULFUR CPDS
=680  \\$iInorganic or organic compounds that contain sulfur as an integral part of the molecule.
=688  \\$a98; use explode 1968-97
=750  \0$aSulfur compounds$5IEN-M$0(DLC)sh 85130373

=LDR  00955cz  a2200301n  4500
=001  9880363775802441
=005  20141212205952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013456
=035  \\$aCBA6784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x877
=072  \\$aD1.$x875.$x800
=072  \\$aD2.$x886.$x645
=150  \\$aSulfur Acids
=450  \\$wnnna$aAcids, Sulfur
=450  \\$wnnna$aAcids, Sulfurous
=450  \\$aSulfurous Acids
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aSulfenic Acids
=550  \\$wh$aSulfinic Acids
=550  \\$wh$aSulfonic Acids
=550  \\$wh$aSulfuric Acids
=667  \\$ado not confuse with SULFURIC ACIDS
=680  \\$iInorganic or organic acids that contain sulfur as an integral part of the molecule.
=688  \\$a94; was NON MESH 1971-93; SULFUROUS ACIDS was heading 1968-93
=750  \0$aSulfur acids$0(DLC)sh2007003784$5IEN-M

=LDR  00619cz  a2200181n  4500
=001  9880363775902441
=005  20141212205952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013455
=035  \\$aCBA6783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185.$x900
=150  \\$aSulfur
=450  \\$aSulphur$5IEN
=550  \\$wg$aChalcogens
=667  \\$aS-32
=680  \\$iAn element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight [32.059; 32.076]. It is found in the amino acids cysteine and methionine.
=750  \0$aSulfur$5IEN-M$0(DLC)sh 85130365

=LDR  00707cz  a2200205n  4500
=001  9880363776002441
=005  20141212205952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013454
=035  \\$aCBA6782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x640
=150  \\$aSulfoxides
=450  \\$aSulphoxides$5IEN
=550  \\$wg$aSulfur Compounds
=550  \\$wh$a2-Pyridinylmethylsulfinylbenzimidazoles
=550  \\$wh$aDimethyl Sulfoxide
=680  \\$iOrganic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed)
=688  \\$a66
=750  \0$aSulfoxides$0(DLC) sh 85130363$5IEN

=LDR  00740cz  a2200193n  4500
=001  9880363776102441
=005  20141212210929.0
=008  880514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015238
=035  \\$aCBA6781M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x817.$x400
=150  \\$aSulfotransferases
=550  \\$wg$aSulfur Group Transferases
=550  \\$wh$aArylsulfotransferase
=667  \\$ado not confuse with SULFURTRANSFERASES
=680  \\$iEnzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.
=688  \\$a89
=750  \0$aSulfotransferases$0(DLC)sh2004014824$5IEN-M

=LDR  00846cz  a2200313n  4500
=001  9880363776202441
=005  20141212205951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013453
=035  \\$aCBA6780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x795
=072  \\$aD2.$x948.$x828
=150  \\$aSulfonylurea Compounds
=450  \\$wnnna$aCompounds, Sulfonylurea
=450  \\$wnno$aGlibornuride$5IEN-M
=550  \\$wg$aSulfones
=550  \\$wg$aUrea
=550  \\$wh$aAcetohexamide
=550  \\$wh$aCarbutamide
=550  \\$wh$aChlorpropamide
=550  \\$wh$aGliclazide
=550  \\$wh$aGlipizide
=550  \\$wh$aGlyburide
=550  \\$wh$aTolazamide
=550  \\$wh$aTolbutamide
=667  \\$ahypoglycemics; DF: SULFONYLUREA CPDS
=688  \\$a72
=750  \0$aSulfonylureas$0(DLC)sh2007001704$5IEN-M

=LDR  00617cz  a2200229n  4500
=001  9880363776302441
=005  20141212205951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013450
=035  \\$aCBA6777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590
=150  \\$aSulfones
=450  \\$aSulphones$5IEN
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aDansyl Compounds
=550  \\$wh$aDapsone
=550  \\$wh$aPhenylmethylsulfonyl Fluoride
=550  \\$wh$aSulfonamides
=550  \\$wh$aSulfonylurea Compounds
=550  \\$wh$aTosyl Compounds
=750  \0$aSulfones$5IEN$0(DLC)sh 85130357

=LDR  01534cz  a2200541n  4500
=001  9880363776402441
=005  20210217152958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013449
=035  \\$aCBA6776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884
=072  \\$aD2.$x886.$x590.$x700
=150  \\$aSulfonamides
=450  \\$aGlymidine$5IEN-M
=450  \\$wnnna$aMixtures, Sulfonamide
=450  \\$wnnna$aSulfonamide Mixtures
=450  \\$aSulphonamides$5IEN
=550  \\$wg$aAmides
=550  \\$wg$aSulfones
=550  \\$wh$a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
=550  \\$wh$aBenzolamide
=550  \\$wh$aBenzothiadiazines
=550  \\$wh$aBumetanide
=550  \\$wh$aCelecoxib
=550  \\$wh$aChloramines
=550  \\$wh$aChlorthalidone
=550  \\$wh$aClopamide
=550  \\$wh$aDarunavir
=550  \\$wh$aDichlorphenamide
=550  \\$wh$aEthoxzolamide
=550  \\$wh$aIndapamide
=550  \\$wh$aMafenide
=550  \\$wh$aMefruside
=550  \\$wh$aMetolazone
=550  \\$wh$aProbenecid
=550  \\$wh$aRosuvastatin Calcium
=550  \\$wh$aSidenafil Citrate
=550  \\$wh$aSimeprevir
=550  \\$wh$aSulfanilamides
=550  \\$wh$aSulfasalazine
=550  \\$wh$aSumatriptan
=550  \\$wh$aXipamide
=550  \\$wh$aTamsulosin
=550  \\$wh$aTorsemide
=680  \\$iA group of compounds that contain the structure SO2NH2.
=688  \\$aSULFONAMIDE MIXTURES was heading 1963-79
=750  \0$aSulfonamides$5IEN$0(DLC)sh 85130353

=LDR  01132cz  a2200325n  4500
=001  9880363776502441
=005  20141212205948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013442
=035  \\$aCBA6769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x850.$x777.$x800
=150  \\$aSulfinpyrazone
=450  \\$wnnna$aAnturan
=450  \\$wnnna$aAnturane
=450  \\$wnnna$aApo-Sulfinpyrazone
=450  \\$wnnna$aApo Sulfinpyrazone
=450  \\$wnnna$aApotex Brand of Sulfinpyrazone
=450  \\$wnnna$aNovartis Brand of Sulfinpyrazone
=450  \\$wnnna$aNu-Pharm Brand of Sulfinpyrazone
=450  \\$wnnna$aNu Pharm Brand of Sulfinpyrazone
=450  \\$wnnna$aNu-Sulfinpyrazone
=450  \\$wnnna$aNu Sulfinpyrazone
=450  \\$aSulfoxyphenylpyrazolidin
=450  \\$wnnna$aSulphinpyrazone
=550  \\$wg$aPhenylbutazone
=667  \\$aa uricosuric
=680  \\$iA uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
=688  \\$a65(64)
=750  \0$aSulfinpyrazone$5IEN$0(DLC)sh 85130321

=LDR  00871cz  a2200289n  4500
=001  9880363776602441
=005  20141212205948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013440
=035  \\$aCBA6767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x874
=072  \\$aD1.$x875.$x350.$x850
=072  \\$aD2.$x886.$x520
=150  \\$aSulfides
=450  \\$wnnna$aEthers, Sulfur
=450  \\$wnnna$aSulfur Ethers
=450  \\$aSulphides$5IEN
=450  \\$aThioethers
=550  \\$wg$aAnions
=550  \\$wg$aHydrogen Sulfide
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aCarbon Disulfide
=550  \\$wh$aDisulfides
=550  \\$wh$aMoxalactam
=680  \\$iChemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties.
=750  \0$aSulfides$5IEN$0(DLC)sh 85130342

=LDR  01224cz  a2200409n  4500
=001  9880363776702441
=005  20141212205947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013438
=035  \\$aCBA6765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x489
=150  \\$aSulfhydryl Compounds
=450  \\$wnnna$aCompounds, Mercapto
=450  \\$wnnna$aCompounds, Sulfhydryl
=450  \\$wnnna$aMercaptans
=450  \\$aMercapto Compounds
=450  \\$aThiols
=550  \\$wg$aSulfur Compounds
=550  \\$wh$a3-Mercaptopropionic Acid
=550  \\$wh$a6-Mercaptopurine
=550  \\$wh$aCysteine
=550  \\$wh$aDimercaprol
=550  \\$wh$aErgothioneine
=550  \\$wh$aMercaptoethanol
=550  \\$wh$aMercaptoethylamines
=550  \\$wh$aMesna
=550  \\$wh$aMethimazole
=550  \\$wh$aPantetheine
=550  \\$wh$aS-Nitrosothiols
=550  \\$wh$aSuccimer
=550  \\$wh$aThiocholine
=550  \\$wh$aThioglycolates
=550  \\$wh$aThiomalates
=667  \\$ado not confuse with SULFHYDRYL REAGENTS; /physiol permitted with only endogenous SH cpds; DF: SULFHYDRYL CPDS
=680  \\$iCompounds containing the -SH radical.
=750  \0$aThiols$5IEN$0(DLC)sh 85134883

=LDR  00709cz  a2200193n  4500
=001  9880363776802441
=005  20141212205946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013434
=035  \\$aCBA6761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x645.$x575
=150  \\$aSulfenic Acids
=450  \\$wnnna$aAcids, Sulfenic
=450  \\$aSulphenic Acids$5IEN
=550  \\$wg$aSulfur Acids
=680  \\$iOxy acids of sulfur with the general formula RSOH, where R is an alkyl or aryl group such as CH3. They are often encountered as esters and halides. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a68
=750  \0$aSulfenic acids$5IEN$0(DLC)sh 89005602

=LDR  00669cz  a2200229n  4500
=001  9880363776902441
=005  20141212205946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013432
=035  \\$aCBA6759M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x935
=072  \\$aD2.$x92.$x146.$x807.$x935
=072  \\$aD2.$x886.$x590.$x700.$x725.$x935
=072  \\$aD2.$x886.$x675.$x725
=072  \\$aD3.$x383.$x129.$x708.$x725
=150  \\$aSulfathiazoles
=550  \\$wg$aSulfanilamides
=550  \\$wg$aThiazoles
=550  \\$wh$aSulfamethizole
=667  \\$asulfanilamide anti-infectives
=750  \0$aSulfathiazoles$0(DLC)sh2007003949$5IEN-M

=LDR  00876cz  a2200313n  4500
=001  9880363777002441
=005  20141212205945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013431
=035  \\$aCBA6758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x845
=072  \\$aD1.$x875.$x800.$x800.$x850
=150  \\$aSulfates
=450  \\$wnnna$aInorganic Sulfates
=450  \\$aSulfates, Inorganic
=450  \\$aSulphates$5IEN
=550  \\$wg$aAnions
=550  \\$wg$aSulfuric Acids
=550  \\$wh$aAlum Compounds
=550  \\$wh$aAmmonium Sulfate
=550  \\$wh$aBarium Sulfate
=550  \\$wh$aCalcium Sulfate
=550  \\$wh$aCopper Sulfate
=550  \\$wh$aMagnesium Sulfate
=550  \\$wh$aThiosulfates
=550  \\$wh$aZinc Sulfate
=680  \\$iInorganic salts of sulfuric acid.
=750  \0$aSulfates$5IEN$0(DLC)sh 85130337

=LDR  00538cz  a2200193n  4500
=001  9880363777102441
=005  20141212205945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013429
=035  \\$aCBA6756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x827
=150  \\$aSulfatases
=450  \\$aSulphatases$5IEN
=550  \\$wg$aEsterases
=550  \\$wh$aArylsulfatases
=550  \\$wh$aChondroitinases and Chondroitin Lyases
=550  \\$wh$aIduronate Sulfatase
=750  \0$aSulfatases$5IEN$0(DLC)sh 85130332

=LDR  00850cz  a2200217n  4500
=001  9880363777202441
=005  20141212205945.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013428
=035  \\$aCBA6755M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x925
=072  \\$aD2.$x92.$x146.$x807.$x925
=072  \\$aD2.$x886.$x590.$x700.$x725.$x925
=150  \\$aSulfaquinoxaline
=450  \\$aSulfabenzpyrazine
=450  \\$aSulfachinoxalin
=550  \\$wg$aSulfanilamides
=680  \\$iAn antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl, and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis.
=688  \\$a91(75); was see under SULFANILAMIDES 1975-90
=750  \0$aSulfaquinoxaline$0(DLC)sh2007003950$5IEN-M

=LDR  00699cz  a2200217n  4500
=001  9880363777302441
=005  20141212205944.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013427
=035  \\$aCBA6754M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x900
=072  \\$aD2.$x92.$x146.$x807.$x900
=072  \\$aD2.$x886.$x590.$x700.$x725.$x900
=150  \\$aSulfapyridine
=450  \\$wnnna$aSulphapyridin
=450  \\$wnnna$aSulphapyridine
=550  \\$wg$aSulfanilamides
=680  \\$iAntibacterial, potentially toxic, used to treat certain skin diseases.
=688  \\$a91(75); was see under SULFANILAMIDES 1975-90
=750  \0$aSulfapyridine$0(DLC)sh2007003934$5IEN-M

=LDR  01423cz  a2200469n  4500
=001  9880363777402441
=005  20141212205944.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013424
=035  \\$aCBA6751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725
=072  \\$aD2.$x92.$x146.$x807
=072  \\$aD2.$x886.$x590.$x700.$x725
=150  \\$aSulfanilamides
=550  \\$wg$aAniline Compounds
=550  \\$wg$aSulfonamides
=550  \\$wh$aFurosemide
=550  \\$wh$aSulfacetamide
=550  \\$wh$aSulfachlorpyridazine
=550  \\$wh$aSulfadiazine
=550  \\$wh$aSulfadimethoxine
=550  \\$wh$aSulfadoxine
=550  \\$wh$aSulfaguanidine
=550  \\$wh$aSulfalene
=550  \\$wh$aSulfamerazine
=550  \\$wh$aSulfameter
=550  \\$wh$aSulfamethazine
=550  \\$wh$aSulfamethoxazole
=550  \\$wh$aSulfamethoxypyridazine
=550  \\$wh$aSulfamonomethoxine
=550  \\$wh$aSulfamoxole
=550  \\$wh$aSulfaphenazole
=550  \\$wh$aSulfapyridine
=550  \\$wh$aSulfaquinoxaline
=550  \\$wh$aSulfathiazoles
=550  \\$wh$aSulfisomidine
=550  \\$wh$aSulfisoxazole
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iCompounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline.
=688  \\$a75; was SULFANILAMIDE 1963-74
=750  \0$aSulfanilamides$0(DLC)sh2007003930$5IEN-M

=LDR  00562cz  a2200193n  4500
=001  9880363777502441
=005  20141212205943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013423
=035  \\$aCBA6750M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x882
=072  \\$aD2.$x92.$x146.$x807.$x882
=072  \\$aD2.$x886.$x590.$x700.$x725.$x882
=150  \\$aSulfamoxole
=450  \\$wnnna$aSulphamoxole
=550  \\$wg$aSulfanilamides
=680  \\$iA sulfanilamide antibacterial agent.
=750  \0$aSulfamoxole$0(DLC)sh2007003951$5IEN-M

=LDR  01016cz  a2200265n  4500
=001  9880363777602441
=005  20141212205942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013420
=035  \\$aCBA6747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x867
=072  \\$aD2.$x92.$x146.$x807.$x867
=072  \\$aD2.$x886.$x590.$x700.$x725.$x867
=150  \\$aSulfamethoxazole
=450  \\$wnnna$aGantanol
=450  \\$aSulfamethylisoxazole
=450  \\$wnnna$aSulfisomezole
=450  \\$wnnna$aSulphamethoxazole
=550  \\$wg$aSulfanilamides
=550  \\$wh$aTrimethoprim-Sulfamethoxazole Combination
=667  \\$aa sulfanilamide anti-infective
=680  \\$iA bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
=688  \\$a68(63)
=750  \0$aSulfamethoxazole$5IEN$0(DLC)sh 85130331

=LDR  00732cz  a2200229n  4500
=001  9880363777702441
=005  20141212205942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013418
=035  \\$aCBA6745M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x862
=072  \\$aD2.$x92.$x146.$x807.$x862
=072  \\$aD2.$x886.$x590.$x700.$x725.$x862
=150  \\$aSulfamethazine
=450  \\$wnnna$aSulfadimezine
=450  \\$aSulfadimidine
=450  \\$wnnna$aSulphamezathine
=550  \\$wg$aSulfanilamides
=680  \\$iA sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
=688  \\$a1963
=750  \0$aSulfamethazine$0(DLC)sh2007003952$5IEN-M

=LDR  00992cz  a2200301n  4500
=001  9880363777802441
=005  20141212205941.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013415
=035  \\$aCBA6742M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x850
=072  \\$aD2.$x92.$x146.$x807.$x850
=072  \\$aD2.$x886.$x590.$x700.$x725.$x850
=150  \\$aSulfalene
=450  \\$wnnna$aKelfizine
=450  \\$wnnna$aLongum
=450  \\$wnnna$aPharmacia Brand of Sulfalene
=450  \\$aSulfamethopyrazine
=450  \\$aSulfamethoxypyrazine
=450  \\$wnnna$aSulfametopyrazine
=450  \\$aSulfapyrazinmethoxine
=450  \\$wnnna$aSulphalene
=450  \\$wnnna$aSulphametopyrazine
=550  \\$wg$aSulfanilamides
=680  \\$iLong-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.
=688  \\$a91(75); was see under SULFANILAMIDES 1975-90
=750  \0$aSulfalene$0(DLC)sh2007003932$5IEN-M

=LDR  00955cz  a2200289n  4500
=001  9880363777902441
=005  20141212205941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013414
=035  \\$aCBA6741M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x810
=072  \\$aD2.$x78.$x370.$x853
=072  \\$aD2.$x92.$x146.$x807.$x810
=072  \\$aD2.$x886.$x590.$x700.$x725.$x810
=150  \\$aSulfaguanidine
=450  \\$wnnna$aGastro-Entericanis Biocanina
=450  \\$wnnna$aGastro Entericanis Biocanina
=450  \\$wnnna$aGastroEntericanis Biocanina
=450  \\$wnnna$aSulphaguanidine
=450  \\$wnnna$aVeto-centre
=450  \\$wnnna$aVeto centre
=550  \\$wg$aGuanidines
=550  \\$wg$aSulfanilamides
=680  \\$iA sulfanilamide antimicrobial agent that is used to treat enteric infections.
=688  \\$a91(63); was see under GUANIDINES 1963-90
=750  \0$aSulfaguanidine$0(DLC)sh2007003953$5IEN-M

=LDR  00962cz  a2200265n  4500
=001  9880363778002441
=005  20141212205940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013411
=035  \\$aCBA6738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x755
=072  \\$aD2.$x92.$x146.$x807.$x755
=072  \\$aD2.$x886.$x590.$x700.$x725.$x755
=150  \\$aSulfadiazine
=450  \\$wnnna$aSulfadiazine, Zinc
=450  \\$wnnna$aSulfazin
=450  \\$wnnna$aSulfazine
=450  \\$wnnna$aSulphadiazine
=450  \\$wnnna$aZinc Sulfadiazine
=550  \\$wg$aSulfanilamides
=550  \\$wh$aSilver Sulfadiazine
=667  \\$anote: METHYLSULFADIAZINE see SULFAMERAZINE
=680  \\$iOne of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
=750  \0$aSulfadiazine$5IEN$0(DLC)sh 85130330

=LDR  00771cz  a2200265n  4500
=001  9880363778102441
=005  20141212205939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013405
=035  \\$aCBA6732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x980.$x875
=072  \\$aI1.$x880.$x735.$x856
=150  \\$aSuicide
=450  \\$wnnna$aSuicides
=550  \\$wg$aSelf-Injurious Behavior
=550  \\$wg$aSocial Problems
=550  \\$wh$aSuicidal Ideation
=550  \\$wh$aSuicide, Assisted
=550  \\$wh$aSuicide, Attempted
=550  \\$aDeath
=667  \\$aPARASUICIDE is also available
=680  \\$iThe act of killing oneself.
=750  \0$aSuicide$5IEN-M$0(DLC)sh 85129742
=750  \0$aSuicidal behavior$5IEN-HS$0(DLC)sh 88005706

=LDR  00679cz  a2200217n  4500
=001  9880363778202441
=005  20141212205939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013404
=035  \\$aCBA6731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x217.$x771
=072  \\$aF4.$x754.$x424.$x771
=150  \\$aSuggestion
=450  \\$wnnna$aSuggestions
=550  \\$wg$aHypnosis
=550  \\$wh$aAutosuggestion
=550  \\$aPersuasive Communication
=667  \\$ano qualif; consider also PERSUASION see PERSUASIVE COMMUNICATION
=680  \\$iThe uncritical acceptance of an idea or plan of action.
=750  \0$aMental suggestion$5IEN$0(DLC)sh 85083665

=LDR  00749cz  a2200265n  4500
=001  9880363778302441
=005  20141212205938.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013403
=035  \\$aCBA6730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x894
=150  \\$aSugar Phosphates
=450  \\$wnnna$aPhosphates, Sugar
=550  \\$wg$aCarbohydrates
=550  \\$wh$aDihydroxyacetone Phosphate
=550  \\$wh$aGlycerophosphates
=550  \\$wh$aHexosephosphates
=550  \\$wh$aInositol Phosphates
=550  \\$wh$aMannitol Phosphates
=550  \\$wh$aPentosephosphates
=550  \\$wh$aPolyisoprenyl Phosphate Sugars
=550  \\$wh$aTeichoic Acids
=688  \\$a74
=750  \0$aSugar phosphates$5IEN$0(DLC)sh 85129712

=LDR  01225cz  a2200325n  4500
=001  9880363778402441
=005  20141212192544.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013398
=035  \\$aCBA6725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x322.$x625
=072  \\$aC23.$x550.$x260.$x657.$x500
=150  \\$aSudden Infant Death
=450  \\$aCot Death
=450  \\$wnnna$aCot Deaths
=450  \\$aCrib Death
=450  \\$wnnna$aDeath, Cot
=450  \\$wnnna$aDeath, Crib
=450  \\$wnnna$aDeath, Sudden Infant
=450  \\$wnnna$aInfant Death, Sudden
=450  \\$wnnna$aSID
=450  \\$aSIDS
=450  \\$wnnna$aSudden Infant Death Syndrome
=550  \\$wg$aDeath, Sudden
=550  \\$wg$aInfant Death
=550  \\$aDeath, Sudden
=680  \\$iThe abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (Pediatr Pathol 1991 Sep-Oct;11(5):677-84)
=688  \\$a75; SID was see SUDDEN INFANT DEATH 1993
=750  \0$aSudden infant death syndrome$5IEN$0(DLC)sh 85129616

=LDR  00873cz  a2200205n  4500
=001  9880363778502441
=005  20141212205937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013395
=035  \\$aCBA6722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x305.$x770
=150  \\$aSucrose
=450  \\$wnnna$aSaccharose
=550  \\$wg$aDisaccharides
=550  \\$wh$aDietary Sucrose
=550  \\$wh$aSucralfate
=667  \\$ado not confuse with SUCRASE; table sugar is DIETARY SUCROSE; sucrose density gradient is CENTRIFUGATION, DENSITY GRADIENT & ignore sucrose
=680  \\$iA nonreducing disaccharide composed of GLUCOSE and FRUCTOSE linked via their anomeric carbons. It is obtained commercially from SUGARCANE, sugar beet (BETA VULGARIS), and other plants and used extensively as a food and a sweetener.
=750  \0$aSucrose$5IEN$0(DLC)sh 85129598

=LDR  00931cz  a2200253n  4500
=001  9880363778602441
=005  20141212205934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013388
=035  \\$aCBA6715M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x478.$x770
=072  \\$aD3.$x383.$x773.$x812.$x852
=150  \\$aSuccinimides
=450  \\$wnnna$aButanimides
=450  \\$wnnna$aPyrrolidinediones
=550  \\$wg$aImides
=550  \\$wg$aPyrrolidinones
=550  \\$wh$aBromosuccinimide
=550  \\$wh$aEthosuximide
=550  \\$aSuccinates
=680  \\$iA subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants.
=688  \\$a74(72); PHENSUXIMIDE was heading l963-84 (Prov l963-72)
=750  \0$aSuccinimides$5IEN-M$0(DLC)sh 99005595

=LDR  01543cz  a2200373n  4500
=001  9880363778702441
=005  20141212205933.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013385
=035  \\$aCBA6712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x562.$x750.$x249.$x500
=072  \\$aD8.$x811.$x600.$x250.$x500.$x750.$x500
=072  \\$aD8.$x811.$x600.$x250.$x875.$x249.$x500
=072  \\$aD8.$x811.$x682.$x660.$x385.$x500
=072  \\$aD8.$x811.$x682.$x660.$x750
=072  \\$aD8.$x811.$x682.$x830.$x249.$x500
=072  \\$aD12.$x776.$x157.$x427.$x374.$x375.$x909.$x500
=072  \\$aD12.$x776.$x331.$x199.$x750.$x500
=072  \\$aD12.$x776.$x543.$x277.$x500.$x750.$x500
=072  \\$aD12.$x776.$x543.$x277.$x875.$x249.$x500
=072  \\$aD12.$x776.$x556.$x579.$x374.$x375.$x141.$x500
=150  \\$aSuccinate Dehydrogenase
=450  \\$wnnna$aDehydrogenase, Succinate
=450  \\$wnnna$aDehydrogenase, Succinic
=450  \\$wnnna$aFumarate Reductase
=450  \\$wnnna$aOxidase, Succinic
=450  \\$wnnna$aReductase, Fumarate
=450  \\$wnnna$aSuccinic Dehydrogenase
=450  \\$aSuccinic Oxidase
=550  \\$wg$aElectron Transport Complex II
=550  \\$wg$aOxidoreductases Acting on CH-CH Group Donors
=680  \\$iA flavoprotein containing oxidoreductase that catalyzes the dehydrogenation of SUCCINATE to fumarate. In most eukaryotic organisms this enzyme is a component of mitochondrial electron transport complex II.
=750  \0$aSuccinate dehydrogenase$5IEN$0(DLC)sh 85129592

=LDR  01500cz  a2200469n  4500
=001  9880363778802441
=005  20141212205932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013381
=035  \\$aCBA6708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x787
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x787
=150  \\$aSubtilisins
=450  \\$wnnna$aAlcalase
=450  \\$wnnna$aAlcalase, Novo
=450  \\$wnnna$aAprA-Subtilisin
=450  \\$wnnna$aAprA Subtilisin
=450  \\$wnnna$aBacillus amyloliquefaciens Serine Protease
=450  \\$wnnna$aBacillus subtilis Alkaline Proteinase
=450  \\$wnnna$aCarlsberg Subtilisin
=450  \\$wnnna$aMaxatase
=450  \\$wnnna$aNagarse
=450  \\$wnnna$aNovo Alcalase
=450  \\$wnnna$aProfezim
=450  \\$wnnna$aProtease VII
=450  \\$wnnna$aSubtilisin 72
=450  \\$wnnna$aSubtilisin A
=450  \\$wnnna$aSubtilisin BPN'
=450  \\$wnnna$aSubtilisin Carlsberg
=450  \\$wnnna$aSubtilisin, Carlsberg
=450  \\$wnnna$aSubtilisin DY
=450  \\$wnnna$aSubtilisin E
=450  \\$wnnna$aSubtilisin GX
=450  \\$wnnna$aSubtilisin Novo
=450  \\$wnnna$aSubtilopeptidase A
=550  \\$wg$aSerine Endopeptidases
=550  \\$wh$aSubtilisin
=667  \\$aSUBTILISIN is available
=680  \\$iA family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-
=688  \\$a74(73)
=750  \0$aSubtilisins$5IEN$0(DLC)sh 85129561

=LDR  01439cz  a2200397n  4500
=001  9880363778902441
=005  20201223122347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013194
=035  \\$aCBA6516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x670
=072  \\$aE1.$x370.$x225.$x750.$x600.$x670
=072  \\$aE5.$x200.$x500.$x620.$x670
=072  \\$aE5.$x200.$x750.$x600.$x670
=150  \\$aStaining and Labeling
=450  \\$aHistological Labeling
=450  \\$wnnna$aHistological Labelings
=450  \\$wnnna$aLabeling and Staining
=450  \\$wnnna$aLabeling, Histological
=450  \\$wnnna$aLabelings, Histological
=450  \\$aStaining
=450  \\$wnnna$aStainings
=550  \\$wg$aHistocytological Preparation Techniques
=550  \\$wh$aChromosome Banding
=550  \\$wh$aIn Situ Hybridization
=550  \\$wh$aNegative Staining
=550  \\$wh$aNeuroanatomical Tract-Tracing Techniques
=550  \\$wh$aPeriodic Acid-Schiff Reaction
=550  \\$wh$aPrussian Blue Reaction
=550  \\$wh$aShadowing Technique, Histology
=550  \\$wh$aSilver Staining
=550  \\$aColoring Agents
=680  \\$iThe marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts.
=688  \\$a2001(1963)
=750  \0$aStains and staining (Microscopy)$5IEN$0(DLC)sh 85127263

=LDR  00777cz  a2200229n  4500
=001  9880363779002441
=005  20141212205830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013193
=035  \\$aCBA6515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x490.$x800.$x900
=072  \\$aD1.$x552.$x33.$x847.$x681
=072  \\$aD25.$x58.$x807.$x681
=072  \\$aJ1.$x637.$x51.$x58.$x807.$x681
=150  \\$aStainless Steel
=450  \\$wnnna$aSteel, Stainless
=550  \\$wg$aSteel
=667  \\$aD25-26 qualif
=680  \\$iStainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. (Grant & Hack's Chemical Dictionary, 5th ed)
=688  \\$a68(65)
=750  \0$aStainless Steel$0(DLC)sh 85127793$5IEN

=LDR  00577cz  a2200181n  4500
=001  9880363779102441
=005  20141212205830.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013191
=035  \\$aCBA6513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x840
=150  \\$aStachybotrys
=450  \\$wnnna$aStachybotry
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses.
=688  \\$a91(75)
=750  \0$aStachybotrys$5IEN$0(DLC)sh 85127200

=LDR  00718cz  a2200217n  4500
=001  9880363779202441
=005  20141212205828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013183
=035  \\$aCBA6505HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x808
=150  \\$aSputum
=450  \\$wnnna$aInduced Sputum
=450  \\$wnnna$aInduced Sputums
=450  \\$wnnna$aSputum, Induced
=450  \\$wnnna$aSputums
=450  \\$wnnna$aSputums, Induced
=550  \\$wg$aBodily Secretions
=680  \\$iMaterial coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus.
=750  \0$aSputum$5IEN$0(DLC)sh 85127062

=LDR  00933cz  a2200217n  4500
=001  9880363779302441
=005  20141212205828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013182
=035  \\$aCBA6504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637.$x850
=072  \\$aC18.$x452.$x603.$x850
=150  \\$aSprue, Tropical
=450  \\$wnnna$aIdiopathic Tropical Malabsorption Syndrome
=450  \\$wnnna$aTropical Sprue
=550  \\$wg$aMalabsorption Syndromes
=550  \\$aCeliac Disease
=667  \\$anote "tropical": do not confuse with non-tropical sprue which is CELIAC DISEASE
=680  \\$iA chronic malabsorption syndrome, occurring mainly in residents of or visitors to the tropics or subtropics. The failed INTESTINAL ABSORPTION of nutrients from the SMALL INTESTINE results in MALNUTRITION and ANEMIA that is due to FOLIC ACID deficiency.
=750  \0$aTropical sprue$5IEN$0(DLC)sh 85138063

=LDR  01569cz  a2200361n  4500
=001  9880363779402441
=005  20141212205827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013181
=035  \\$aCBA6503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x270.$x300
=150  \\$aCortical Spreading Depression
=450  \\$aCortical Depression, Spreading
=450  \\$wnnna$aCortical Depressions, Spreading
=450  \\$wnnna$aCortical Spreading Depressions
=450  \\$wnnna$aDepression, Cortical Spreading
=450  \\$wnnna$aDepression, Spreading Cortical
=450  \\$wnnna$aDepressions, Cortical Spreading
=450  \\$wnnna$aDepressions, Spreading Cortical
=450  \\$wnnna$aLeao Spreading Depression
=450  \\$aSpreading Cortical Depression
=450  \\$wnnna$aSpreading Cortical Depressions
=450  \\$wnnna$aSpreading Depression, Cortical
=450  \\$wnnna$aSpreading Depression of Leao
=450  \\$wnnna$aSpreading Depressions, Cortical
=550  \\$wg$aEvoked Potentials
=550  \\$aCerebral Cortex
=680  \\$iThe decrease in neuronal activity (related to a decrease in metabolic demand) extending from the site of cortical stimulation. It is believed to be responsible for the decrease in cerebral blood flow that accompanies the aura of MIGRAINE WITH AURA. (Campbell's Psychiatric Dictionary, 8th ed.)
=688  \\$a2010(1964)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Spreading Cortical Depression
=688  \\$a67(64)
=750  \0$aSpreading cortical depression$0(DLC) sh 85126996$5IEN

=LDR  01171cz  a2200241n  4500
=001  9880363779502441
=005  20141212205827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013180
=035  \\$aCBA6502HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x844
=150  \\$aSprains and Strains
=450  \\$wnnna$aSprain
=450  \\$wnnna$aSprains
=450  \\$wnnna$aStrain
=450  \\$wnnna$aStrains
=450  \\$wnnna$aStrains and Sprains
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aCumulative Trauma Disorders
=667  \\$aIM; coord sprain with specific joint /inj (IM) or ligament /inj (IM) & strain with specific muscle /inj (IM); CUMULATIVE TRAUMA DISORDERS is available; "strain fracture": index under FRACTURES, BONE (IM) + CUMULATIVE TRAUMA DISORDERS (IM); DF: SPRAINS
=680  \\$iA collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature.
=750  \0$aSprains$5IEN$0(DLC)sh 85126981

=LDR  01016cz  a2200325n  4500
=001  9880363779602441
=005  20170406093506.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013179
=035  \\$aCBA6501HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x350.$x750
=072  \\$aI1.$x198.$x240.$x856.$x575.$x500
=072  \\$aI1.$x880.$x735.$x900.$x350.$x750
=072  \\$aI1.$x880.$x735.$x900.$x688.$x500
=150  \\$aSpouse Abuse
=450  \\$wnnna$aAbuse, Partner
=450  \\$wnnna$aAbuse, Spousal
=450  \\$wnnna$aAbuse, Spouse
=450  \\$wnnna$aAbuse, Wife
=450  \\$aPartner Abuse
=450  \\$wnnna$aSpousal Abuse
=450  \\$aWife Abuse
=550  \\$wg$aDomestic Violence
=550  \\$wg$aIntimate Partner Violence
=550  \\$aBattered Women
=667  \\$awife or husband abused or abuser
=680  \\$iDeliberate severe and repeated injury to one domestic partner by the other.
=688  \\$a77
=750  \0$aSpousal abuse$0(DLC)sh2005002714$5IEN-M

=LDR  00958cz  a2200253n  4500
=001  9880363779702441
=005  20141212205826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013178
=035  \\$aCBA6500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x830
=150  \\$aSports Medicine
=450  \\$wnnna$aMedicine, Sport
=450  \\$wnnna$aMedicine, Sports
=450  \\$wnnna$aSport Medicine
=550  \\$wg$aMedicine
=550  \\$wh$aSports Nutritional Sciences
=550  \\$wh$aVeterinary Sports Medicine
=550  \\$aPhysical Conditioning, Human
=667  \\$ause for the discipline (education, history, etc) only; SPORTS is available for the activity; policy Manual 30.15
=680  \\$iThe field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in exercise and sports activities.
=688  \\$a80; was SPORT MEDICINE 1963-79
=750  \0$aSports medicine$5IEN$0(DLC)sh 85126948

=LDR  01664cz  a2200565n  4500
=001  9880363779802441
=005  20200721124235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013177
=035  \\$aCBA6499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845
=150  \\$aSports
=450  \\$wnnna$aAthletic
=450  \\$aAthletics
=450  \\$wnnna$aSport
=550  \\$wg$aRecreation
=550  \\$wh$aAthletic Performance
=550  \\$wh$aBaseball
=550  \\$wh$aBasketball
=550  \\$wh$aBicycling
=550  \\$wh$aBoxing
=550  \\$wh$aFootball
=550  \\$wh$aGolf
=550  \\$wh$aGymnastics
=550  \\$wh$aHockey
=550  \\$wh$aMartial Arts
=550  \\$wh$aMountaineering
=550  \\$wh$aRacquet Sports
=550  \\$wh$aReturn to Sports
=550  \\$wh$aRunning
=550  \\$wh$aSkating
=550  \\$wh$aSnow Sports
=550  \\$wh$aSoccer
=550  \\$wh$aSports for Persons with Disabilities
=550  \\$wh$aTrack and Field
=550  \\$wh$aVolleyball
=550  \\$wh$aWalking
=550  \\$wh$aWater Sports
=550  \\$wh$aWeight Lifting
=550  \\$wh$aWrestling
=550  \\$wh$aYouth Sports
=550  \\$aExercise
=550  \\$aExercise Movement Techniques
=550  \\$aExercise Therapy
=550  \\$aPhysical Exertion
=667  \\$aSPORTS is the activity, SPORTS MEDICINE is the specialty
=680  \\$iActivities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward.
=688  \\$aATHLETICS was see under SPORTS 1963-75
=750  \0$aSports$5IEN$0(DLC)sh 85126887

=LDR  00800cz  a2200217n  4500
=001  9880363779902441
=005  20141212205825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013175
=035  \\$aCBA6497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x820
=150  \\$aSporothrix
=450  \\$wnnna$aSporothrices
=450  \\$aSporotrichum
=450  \\$wnnna$aSporotrichums
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection = SPOROTRICHOSIS
=680  \\$iA mitosporic Ophiostomataceae fungal genus, whose species Sporothrix schenckii is a well-known animal pathogen. The conidia of this soil fungus may be inhaled causing a primary lung infection, or may infect independently via skin punctures.
=688  \\$a99(63)
=750  \0$aSporotrichum$5IEN$0(DLC)sh 88022093

=LDR  00761cz  a2200205n  4500
=001  9880363780002441
=005  20141212205824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013174
=035  \\$aCBA6496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x675
=072  \\$aC1.$x703.$x295.$x675
=072  \\$aC17.$x800.$x838.$x208.$x675
=150  \\$aSporotrichosis
=450  \\$wnnna$aSporotrichoses
=550  \\$wg$aDermatomycoses
=667  \\$afungus dis of skin
=680  \\$iThe commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound.
=750  \0$aSporotrichosis$5IEN$0(DLC)sh 85126874

=LDR  00819cz  a2200277n  4500
=001  9880363780102441
=005  20141212205824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013172
=035  \\$aCBA6494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x870.$x710
=072  \\$aA19.$x374.$x500
=072  \\$aB5.$x775.$x710
=150  \\$aSpores, Fungal
=450  \\$aConidia
=450  \\$wnnna$aConidium
=450  \\$wnnna$aFungal Spore
=450  \\$aFungal Spores
=450  \\$wnnna$aSpore, Fungal
=550  \\$wg$aFruiting Bodies, Fungal
=550  \\$wg$aSpores
=667  \\$acoordinate with specific fungus; sporulation: coordinate specific fungus /physiol; Manual 22.31
=680  \\$iReproductive bodies produced by fungi.
=688  \\$a74(71)
=750  \0$aFungi$xSpores$5IEN$0(DLC)sh 85052456

=LDR  00809cz  a2200229n  4500
=001  9880363780202441
=005  20141212205824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013171
=035  \\$aCBA6493HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x870.$x700
=072  \\$aB5.$x775.$x700
=150  \\$aSpores, Bacterial
=450  \\$wnnna$aBacterial Spore
=450  \\$aBacterial Spores
=450  \\$wnnna$aSpore, Bacterial
=550  \\$wg$aSpores
=667  \\$aNIM; sporulation: coord specific bacterium /physiol (IM) + SPORES, BACTERIAL (NIM); Manual 22.31
=680  \\$iHeat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium.
=688  \\$a74(71)
=750  \0$aBacterial spores$5IEN$0(DLC)sh 85126868

=LDR  00813cz  a2200241n  4500
=001  9880363780302441
=005  20141212205823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x870
=072  \\$aB5.$x775
=150  \\$aSpores
=450  \\$wnnna$aSpore
=550  \\$wg$aCells
=550  \\$wg$aOrganism Forms
=550  \\$wh$aSpores, Bacterial
=550  \\$wh$aSpores, Fungal
=550  \\$wh$aSpores, Protozoan
=667  \\$aGEN: SPORES, BACTERIAL; SPORES, FUNGAL; and SPORES, PROTOZOAN are available; sporulation: coord organism /physiol (IM) + SPORES (NIM); Manual 22.31
=680  \\$iThe reproductive elements of lower organisms, such as BACTERIA; FUNGI; and cryptogamic plants.
=688  \\$a68(64)
=750  \0$aSpores$0(DLC)sh2007009669$5IEN

=LDR  00661cz  a2200205n  4500
=001  9880363780402441
=005  20141212205823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013168
=035  \\$aCBA6490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x938.$x500.$x500
=150  \\$aSpondylolisthesis
=450  \\$wnnna$aSpondylistheses
=450  \\$wnnna$aSpondylisthesis
=450  \\$wnnna$aSpondylolistheses
=550  \\$wg$aSpondylolysis
=667  \\$acoordinate with specific vertebra
=680  \\$iForward displacement of a superior vertebral body over the vertebral body below.
=750  \0$aSpondylolisthesis$5IEN$0(DLC)sh 85126848

=LDR  01817cz  a2200445n  4500
=001  9880363780502441
=005  20141212205823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013167
=035  \\$aCBA6489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x853.$x625.$x800.$x850
=072  \\$aC5.$x550.$x69.$x680
=072  \\$aC5.$x550.$x114.$x865.$x800.$x850
=150  \\$aSpondylitis, Ankylosing
=450  \\$wnnna$aAnkylosing Spondylarthritides
=450  \\$wnnna$aAnkylosing Spondylarthritis
=450  \\$aAnkylosing Spondylitis
=450  \\$wnnna$aAnkylosing Spondyloarthritides
=450  \\$wnnna$aAnkylosing Spondyloarthritis
=450  \\$aBechterew Disease
=450  \\$wnnna$aBechterew's Disease
=450  \\$wnnna$aBechterews Disease
=450  \\$aMarie-Struempell Disease
=450  \\$wnnna$aMarie Struempell Disease
=450  \\$aRheumatoid Spondylitis
=450  \\$wnnna$aSpondylarthritides, Ankylosing
=450  \\$aSpondylarthritis Ankylopoietica
=450  \\$wnnna$aSpondylarthritis, Ankylosing
=450  \\$wnnna$aSpondylitis Ankylopoietica
=450  \\$wnnna$aSpondylitis, Rheumatoid
=450  \\$wnnna$aSpondyloarthritides, Ankylosing
=450  \\$wnnna$aSpondyloarthritis Ankylopoietica
=450  \\$wnnna$aSpondyloarthritis, Ankylosing
=550  \\$wg$aAnkylosis
=550  \\$wg$aSpondylarthropathies
=550  \\$aSpondylarthritis
=667  \\$acoordinate with specific vertebra
=680  \\$iA chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
=750  \0$aAnkylosing spondylitis$5IEN$0(DLC)sh 85005328

=LDR  00811cz  a2200241n  4500
=001  9880363780602441
=005  20141212205822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013166
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x160.$x762
=072  \\$aC5.$x116.$x165.$x762
=072  \\$aC5.$x116.$x900.$x853
=150  \\$aSpondylitis
=450  \\$wnnna$aSpondylitides
=550  \\$wg$aBone Diseases, Infectious
=550  \\$wg$aSpinal Diseases
=550  \\$wh$aDiscitis
=550  \\$wh$aSpondylarthritis
=550  \\$wh$aTuberculosis, Spinal
=667  \\$acoordinate with specific vertebra; do not confuse with SPONDYLOSIS or SPONDYLOLYSIS
=680  \\$iInflammation of the SPINE. This includes both arthritic and non-arthritic conditions.
=750  \0$aSpondylitis$5IEN$0(DLC)sh 85126846

=LDR  00640cz  a2200181n  4500
=001  9880363780702441
=005  20141212192539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013165
=035  \\$aCBA6487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x660.$x430.$x750
=072  \\$aE7.$x858.$x690.$x725.$x430.$x750
=150  \\$aSplints
=450  \\$wnnna$aSplint
=550  \\$wg$aExternal Fixators
=680  \\$iRigid or flexible appliances used to maintain in position a displaced or movable part or to keep in place and protect an injured part. (Dorland, 28th ed)
=750  \0$aSplints (Surgery)$5IEN$0(DLC)sh 85126834

=LDR  01133cz  a2200301n  4500
=001  9880363780802441
=005  20141212205822.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013164
=035  \\$aCBA6486HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x760.$x835
=072  \\$aE4.$x100.$x814.$x868.$x937.$x870
=150  \\$aSplenorenal Shunt, Surgical
=450  \\$wnnna$aShunt, Splenorenal
=450  \\$wnnna$aShunt, Surgical Splenorenal
=450  \\$wnnna$aShunts, Splenorenal
=450  \\$wnnna$aShunts, Surgical Splenorenal
=450  \\$wnnna$aSplenorenal Shunt
=450  \\$wnnna$aSplenorenal Shunts
=450  \\$wnnna$aSplenorenal Shunts, Surgical
=450  \\$wnnna$aSurgical Splenorenal Shunt
=450  \\$wnnna$aSurgical Splenorenal Shunts
=550  \\$wg$aPortasystemic Shunt, Surgical
=667  \\$ado not use /util except by MeSH definition; DF: SPLENORENAL SHUNT
=680  \\$iAnastomosis of splenic vein to renal vein to relieve portal hypertension.
=688  \\$a88(81); was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87
=750  \0$aSplenorenal shunt, Surgical$5IEN$0(DLC)sh 85126827

=LDR  00634cz  a2200193n  4500
=001  9880363780902441
=005  20141212205821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013162
=035  \\$aCBA6484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x670.$x730
=150  \\$aSplenic Vein
=450  \\$wnnna$aSplenic Veins
=450  \\$wnnna$aVein, Splenic
=450  \\$wnnna$aVeins, Splenic
=550  \\$wg$aPortal System
=680  \\$iVein formed by the union (at the hilus of the spleen) of several small veins from the stomach, pancreas, spleen and mesentery.
=750  \0$aSplenic vein$5IEN$0(DLC)sh 85126824

=LDR  01264cz  a2200409n  4500
=001  9880363781002441
=005  20141212205821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013160
=035  \\$aCBA6482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x842
=072  \\$aC15.$x604.$x744.$x680
=150  \\$aSplenic Neoplasms
=450  \\$aCancer of Spleen
=450  \\$wnnna$aCancer of the Spleen
=450  \\$wnnna$aCancer, Spleen
=450  \\$wnnna$aCancer, Splenic
=450  \\$wnnna$aCancers, Spleen
=450  \\$wnnna$aCancers, Splenic
=450  \\$wnnna$aNeoplasm, Spleen
=450  \\$wnnna$aNeoplasm, Splenic
=450  \\$wnnna$aNeoplasms, Spleen
=450  \\$wnnna$aNeoplasms, Splenic
=450  \\$aSpleen Cancer
=450  \\$wnnna$aSpleen Cancers
=450  \\$wnnna$aSpleen Neoplasm
=450  \\$wnnna$aSpleen Neoplasms
=450  \\$wnnna$aSplenic Cancer
=450  \\$wnnna$aSplenic Cancers
=450  \\$wnnna$aSplenic Neoplasm
=550  \\$wg$aNeoplasms by Site
=550  \\$wg$aSplenic Diseases
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the SPLEEN.
=750  \0$aSpleen$xTumors$5IEN-M$0(DLC)sh 85126821
=750  \0$aSpleen$xCancer$5IEN-HS$0(DLC)sh 85126815

=LDR  00780cz  a2200277n  4500
=001  9880363781102441
=005  20141212205820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013158
=035  \\$aCBA6480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x744
=150  \\$aSplenic Diseases
=450  \\$wnnna$aDisease, Splenic
=450  \\$wnnna$aDiseases, Splenic
=450  \\$wnnna$aSplenic Disease
=550  \\$wg$aLymphatic Diseases
=550  \\$wh$aHeterotaxy Syndrome
=550  \\$wh$aHypersplenism
=550  \\$wh$aSplenic Infarction
=550  \\$wh$aSplenic Neoplasms
=550  \\$wh$aSplenic Rupture
=550  \\$wh$aTuberculosis, Splenic
=550  \\$wh$aWandering Spleen
=688  \\$a66
=750  \0$aSpleen$xDiseases$0(DLC) sh 85126816$5IEN

=LDR  00550cz  a2200181n  4500
=001  9880363781202441
=005  20141212205819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013156
=035  \\$aCBA6478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x726
=150  \\$aSplenectomy
=450  \\$wnnna$aSplenectomies
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aSpleen
=667  \\$ado not use /util except by MeSH definition; coord IM with non-splenic dis /surg (IM), not /ther
=750  \0$aSplenectomy$5IEN$0(DLC)sh 85126822

=LDR  00595cz  a2200181n  4500
=001  9880363781302441
=005  20141212205819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013154
=035  \\$aCBA6476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x549.$x700
=072  \\$aA15.$x382.$x520.$x604.$x700
=150  \\$aSpleen
=450  \\$wnnna$aSpleens
=550  \\$wg$aLymphoid Tissue
=667  \\$a/inj: consider also SPLENIC RUPTURE but traumatic spleen perforation is indexed under SPLEEN /inj; accessory spleen: index under SPLEEN /abnorm
=750  \0$aSpleen$5IEN$0(DLC)sh 85126812

=LDR  01175cz  a2200253n  4500
=001  9880363781402441
=005  20141212205819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013153
=035  \\$aCBA6475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x800
=072  \\$aA8.$x800.$x50.$x800.$x800
=072  \\$aA8.$x800.$x800.$x60.$x800
=150  \\$aSplanchnic Nerves
=450  \\$wnnna$aNerve, Splanchnic
=450  \\$wnnna$aNerves, Splanchnic
=450  \\$wnnna$aSplanchnic Nerve
=550  \\$wg$aAutonomic Pathways
=550  \\$wg$aSympathetic Nervous System
=667  \\$amajor nerves of sympath innerv of abdomen
=680  \\$iThe major nerves supplying sympathetic innervation to the abdomen. The greater, lesser, and lowest (or smallest) splanchnic nerves are formed by preganglionic fibers from the spinal cord which pass through the paravertebral ganglia and then to the celiac ganglia and plexuses. The lumbar splanchnic nerves carry fibers which pass through the lumbar paravertebral ganglia to the mesenteric and hypogastric ganglia.
=750  \0$aNerves, Splanchnic$5IEN
=750  \0$aSplanchnic nerves$0(DLC)sh 85090915$5IEN-M

=LDR  00915cz  a2200277n  4500
=001  9880363781502441
=005  20141212205818.0
=008  800515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013152
=035  \\$aCBA6474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x881
=150  \\$aSplanchnic Circulation
=450  \\$wnnna$aCirculation, Mesenteric
=450  \\$wnnna$aCirculation, Splanchnic
=450  \\$wnnna$aCirculations, Mesenteric
=450  \\$wnnna$aCirculations, Splanchnic
=450  \\$aMesenteric Circulation
=450  \\$wnnna$aMesenteric Circulations
=450  \\$wnnna$aSplanchnic Circulations
=550  \\$wg$aBlood Circulation
=550  \\$wh$aLiver Circulation
=667  \\$aDF: SPLANCHNIC CIRC
=680  \\$iThe circulation of blood through the BLOOD VESSELS supplying the abdominal VISCERA.
=688  \\$a81
=750  \0$aAbdomen$xBlood-vessels$5IEN$0(DLC)sh 85000093

=LDR  03148cz  a2200817n  4500
=001  9880363781602441
=005  20141212192539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013148
=035  \\$aCBA6470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x679
=072  \\$aD4.$x808.$x745.$x745.$x855
=150  \\$aSpironolactone
=450  \\$wnnna$aAldactone
=450  \\$wnnna$aAldactone A
=450  \\$wnnna$aAlphapharm Brand of Spironolactone
=450  \\$wnnna$aAlpharma Brand of Spironolactone
=450  \\$wnnna$aAlter Brand of Spironolactone
=450  \\$wnnna$aAquareduct
=450  \\$wnnna$aAshbourne Brand of Spironolactone
=450  \\$wnnna$aAzupharma Brand of Spironolactone
=450  \\$wnnna$abetapharm Brand of Spironolactone
=450  \\$wnnna$aCardel Brand of Spironolactone
=450  \\$wnnna$act-Arzneimittel Brand of Spironolactone
=450  \\$wnnna$act Arzneimittel Brand of Spironolactone
=450  \\$wnnna$aDexo Brand of Spironolactone
=450  \\$wnnna$aduraspiron
=450  \\$wnnna$aEspironolactona Alter
=450  \\$wnnna$aEspironolactona Mundogen
=450  \\$wnnna$aFlumach
=450  \\$wnnna$aFrumikal
=450  \\$wnnna$aGenerosan Brand of Spironolactone
=450  \\$wnnna$aHormosan Brand of Spironolactone
=450  \\$wnnna$aJenapharm Brand of Spironolactone
=450  \\$wnnna$aJenaspiron
=450  \\$wnnna$aMayoly-Spindler Brand of Spironolactone
=450  \\$wnnna$aMerck dura Brand of Spironolactone
=450  \\$wnnna$aMundogen Brand of Spironolactone
=450  \\$wnnna$aNovo-Spiroton
=450  \\$wnnna$aNovo Spiroton
=450  \\$wnnna$aNovopharm Brand of Spironolactone
=450  \\$wnnna$aNovoSpiroton
=450  \\$wnnna$aPfizer Brand of Spironolactone
=450  \\$wnnna$aPharmafrid Brand of Spironolactone
=450  \\$wnnna$aPracton
=450  \\$wnnna$aRoche Brand of Spironolactone
=450  \\$wnnna$aSC-9420
=450  \\$wnnna$aSC 9420
=450  \\$wnnna$aSC9420
=450  \\$wnnna$aSearle Brand of Spironolactone
=450  \\$wnnna$aSpiractin
=450  \\$wnnna$aSpiro L.U.T.
=450  \\$wnnna$aspiro von ct
=450  \\$wnnna$aSpirobeta
=450  \\$wnnna$aSpirogamma
=450  \\$aSpirolactone
=450  \\$wnnna$aSpirolang
=450  \\$wnnna$aSpirono-Isis
=450  \\$wnnna$aSpirono Isis
=450  \\$wnnna$aSpironone
=450  \\$wnnna$aSpirospare
=450  \\$wnnna$aVeroshpiron
=450  \\$wnnna$aVerospiron
=450  \\$wnnna$aVerospirone
=450  \\$wnnna$avon ct, spiro
=450  \\$wnnna$aWörwag Brand of Spironolactone
=550  \\$wg$aLactones
=550  \\$wg$aPregnenes
=680  \\$iA potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
=750  \0$aSpironolactone$5IEN$0(DLC)sh 85126790

=LDR  00641cz  a2200193n  4500
=001  9880363781702441
=005  20141212205817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013147
=035  \\$aCBA6469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x750
=150  \\$aSpirometry
=450  \\$wnnna$aSpirometries
=550  \\$wg$aRespiratory Function Tests
=550  \\$wh$aBronchospirometry
=667  \\$aNIM; do not use /util except by MeSH definition; BRONCHOSPIROMETRY is also available
=680  \\$iMeasurement of volume of air inhaled or exhaled by the lung.
=750  \0$aSpirometry$5IEN$0(DLC)sh 85126789

=LDR  01082cz  a2200313n  4500
=001  9880363781802441
=005  20141212205817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013145
=035  \\$aCBA6467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x847
=150  \\$aSpirochaetales Infections
=450  \\$wnnna$aInfection, Spirochaetales
=450  \\$wnnna$aInfection, Spirochete
=450  \\$wnnna$aInfections, Spirochaetales
=450  \\$wnnna$aInfections, Spirochete
=450  \\$wnnna$aSpirochaetales Infection
=450  \\$aSpirochaetosis$5IEN
=450  \\$wnnna$aSpirochete Infection
=450  \\$aSpirochete Infections
=550  \\$wg$aBacterial Infections
=550  \\$wh$aBorrelia Infections
=550  \\$wh$aLeptospirosis
=550  \\$wh$aTreponemal Infections
=667  \\$ainfect by "spirochetes"; GEN or unspecified only: prefer specific spirochete infection
=680  \\$iInfections with bacteria of the order SPIROCHAETALES.
=688  \\$a79; was SPIROCHETE INFECTIONS 1972-78
=750  \0$aSpirochaetosis$5IEN$0(DLC)sh 85126787

=LDR  00782cz  a2200229n  4500
=001  9880363781902441
=005  20141212205816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013144
=035  \\$aCBA6466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x851
=150  \\$aSpirochaetales
=450  \\$wnnna$aSpirochete
=450  \\$aSpirochetes
=550  \\$wg$aBacteria
=550  \\$wh$aLeptospiraceae
=550  \\$wh$aSpirochaetaceae
=667  \\$apathogenic & non-pathogenic; infection = SPIROCHAETALES INFECTIONS
=680  \\$iAn order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.
=688  \\$a76(66); was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74
=750  \0$aSpirochetes$5IEN$0(DLC)sh 87003152

=LDR  00772cz  a2200241n  4500
=001  9880363782002441
=005  20141212205816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013143
=035  \\$aCBA6465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711
=072  \\$aB3.$x851.$x595
=150  \\$aSpirochaetaceae
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$wg$aSpirochaetales
=550  \\$wh$aBorrelia
=550  \\$wh$aSpirochaeta
=550  \\$wh$aTreponema
=667  \\$aa family in the order SPIROCHAETALES; in stagnant water & in bivalve mollusks
=680  \\$iA family of spiral bacteria of the order SPIROCHAETALES.
=688  \\$a75
=750  \0$aSpirochaetaceae$5IEN$0(DLC)sh 87003151

=LDR  00771cz  a2200181n  4500
=001  9880363782102441
=005  20141212205816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013142
=035  \\$aCBA6464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711.$x679
=072  \\$aB3.$x851.$x595.$x679
=150  \\$aSpirochaeta
=550  \\$wg$aSpirochaetaceae
=667  \\$aa genus of the family SPIROCHAETACEAE of the order SPIROCHAETALES; do not confuse with SPIROCHETES see SPIROCHAETALES; found in mud & slime
=680  \\$iA genus of flexible, spiral rods found in hydrogen sulfide-containing mud, sewage, and polluted water. None of the species properly referred to in this genus are pathogenic.
=750  \0$aSpirochaeta$5IEN$0(DLC)sh 88023340

=LDR  00631cz  a2200169n  4500
=001  9880363782202441
=005  20141212205816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013140
=035  \\$aCBA6462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x799.$x679
=150  \\$aSpiritualism
=550  \\$wg$aReligious Philosophies
=667  \\$aIM; specify geog if pertinent; do not confuse with SPIRITUAL HEALING see MENTAL HEALING
=680  \\$iReligious philosophy expressing the fundamental belief that departed spirits may be contacted by the living through a medium.
=750  \0$aSpiritualism$5IEN$0(DLC)sh 85126775

=LDR  00802cz  a2200181n  4500
=001  9880363782302441
=005  20141212205815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013139
=035  \\$aCBA6461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x840.$x750
=072  \\$aB3.$x660.$x75.$x710.$x750
=150  \\$aSpirillum
=550  \\$wg$aSpirillaceae
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) or RAT-BITE FEVER (IM)
=680  \\$iA genus of gram-negative, curved and spiral-shaped bacteria found in stagnant, freshwater environments. These organisms are motile by bipolar tufts of flagella having a long wavelength and about one helical turn. Some species of Spirillum cause a form of RAT-BITE FEVER.
=750  \0$aSpirillum$5IEN$0(DLC)sh 88023338

=LDR  00881cz  a2200229n  4500
=001  9880363276602441
=005  20141212200610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003871
=035  \\$aCAZ6998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x373.$x200.$x380
=150  \\$aDermatan Sulfate
=450  \\$abeta-Heparin
=450  \\$wnnna$abeta Heparin
=450  \\$aChondroitin Sulfate B
=450  \\$wnnna$aSulfate B, Chondroitin
=450  \\$wnnna$aSulfate, Dermatan
=550  \\$wg$aChondroitin
=680  \\$iA naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed)
=688  \\$a91(75)
=750  \0$aDermatan sulfate$5IEN-M$0(DLC)sh 85037081

=LDR  00805cz  a2200193n  4500
=001  9880363276702441
=005  20141212200610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003870
=035  \\$aCAZ6997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400.$x200
=150  \\$aDermacentor
=450  \\$wnnna$aDermacentors
=550  \\$wg$aIxodidae
=667  \\$ainfestation: coord IM with TICK INFESTATIONS (IM)
=680  \\$iA widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest humans and other mammals. Several are vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.
=688  \\$a91(73); was see under TICKS 1973-90
=750  \0$aDermacentor$5IEN$0(DLC)sh 85037077

=LDR  00693cz  a2200193n  4500
=001  9880363276802441
=005  20141212200610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003869
=035  \\$aCAZ6996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x210
=072  \\$aE4.$x680.$x275.$x250
=150  \\$aDermabrasion
=450  \\$wnnna$aDermabrasions
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aDermatologic Surgical Procedures
=680  \\$iThe mechanical planing of the SKIN with sand paper, emery paper, or wire brushes, to promote reepithelialization and smoothing of skin disfigured by ACNE scars or dermal NEVI.
=750  \0$aDermabrasion$5IEN$0(DLC)sh 85037076

=LDR  01024cz  a2200325n  4500
=001  9880363276902441
=005  20141212200609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003867
=035  \\$aCAZ6994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x200
=072  \\$aF2.$x463.$x593.$x932.$x869.$x255
=150  \\$aDepth Perception
=450  \\$wnnna$aDepth Perceptions
=450  \\$wnnna$aPerception, Depth
=450  \\$wnnna$aPerceptions, Depth
=450  \\$wnnna$aStereopses
=450  \\$aStereopsis
=450  \\$aStereoscopic Vision
=450  \\$wnnna$aStereoscopic Visions
=450  \\$wnnna$aVision, Stereoscopic
=450  \\$wnnna$aVisions, Stereoscopic
=550  \\$wg$aPerception
=550  \\$wg$aSpace Perception
=550  \\$wh$aDistance Perception
=550  \\$wh$aVision Disparity
=667  \\$adisord of depth perception: coord IM with PERCEPTUAL DISORDERS (IM)
=680  \\$iPerception of three-dimensionality.
=750  \0$aDepth perception$5IEN$0(DLC)sh 85037070

=LDR  02136cz  a2200553n  4500
=001  9880363277002441
=005  20141212200609.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003866
=035  \\$aCAZ6993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x600.$x300
=150  \\$aDepressive Disorder
=450  \\$aDepression, Endogenous
=450  \\$aDepression, Neurotic
=450  \\$aDepression, Unipolar
=450  \\$wnnna$aDepressions, Endogenous
=450  \\$wnnna$aDepressions, Neurotic
=450  \\$wnnna$aDepressions, Unipolar
=450  \\$wnnna$aDepressive Disorders
=450  \\$wnnna$aDepressive Neuroses
=450  \\$wnnna$aDepressive Neurosis
=450  \\$aDepressive Syndrome
=450  \\$wnnna$aDepressive Syndromes
=450  \\$wnnna$aDisorder, Depressive
=450  \\$wnnna$aDisorders, Depressive
=450  \\$wnnna$aEndogenous Depression
=450  \\$wnnna$aEndogenous Depressions
=450  \\$aMelancholia
=450  \\$wnnna$aMelancholias
=450  \\$wnnna$aNeuroses, Depressive
=450  \\$aNeurosis, Depressive
=450  \\$wnnna$aNeurotic Depression
=450  \\$wnnna$aNeurotic Depressions
=450  \\$wnnna$aSyndrome, Depressive
=450  \\$wnnna$aSyndromes, Depressive
=450  \\$aUnipolar Depression
=450  \\$wnnna$aUnipolar Depressions
=550  \\$wg$aMood Disorders
=550  \\$wh$aDepression, Postpartum
=550  \\$wh$aDepressive Disorder, Major
=550  \\$wh$aDepressive Disorder, Treatment-Resistant
=550  \\$wh$aDysthymic Disorder
=550  \\$wh$aPremenstrual Dysphoric Disorder
=550  \\$wh$aSeasonal Affective Disorder
=667  \\$ado not confuse with DEPRESSION: see note there; depression lasting over 2 years = DYSTHYMIC DISORDER
=680  \\$iAn affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
=688  \\$a81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78
=750  \0$aDepression, Mental$5IEN$0(DLC)sh 85037053

=LDR  01170cz  a2200277n  4500
=001  9880363277102441
=005  20141212200608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003863
=035  \\$aCAZ6990HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x350
=150  \\$aDepression
=450  \\$wnnna$aDepression, Emotional
=450  \\$wnnna$aDepressions
=450  \\$wnnna$aDepressions, Emotional
=450  \\$wnnna$aDepressive Symptom
=450  \\$aDepressive Symptoms
=450  \\$wnnna$aEmotional Depression
=450  \\$wnnna$aEmotional Depressions
=450  \\$wnnna$aSymptom, Depressive
=450  \\$wnnna$aSymptoms, Depressive
=550  \\$wg$aBehavioral Symptoms
=667  \\$ahuman & animal; /drug ther: consider also ANTIDEPRESSIVE AGENTS; do not confuse this or X ref (depression of "moderate intensity") with DEPRESSIVE DISORDER ("prominent & relatively persistent" depression): psychiatrists differentiate on basis of degree
=680  \\$iDepressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.
=750  \0$aDepression, Mental$5IEN$0(DLC)sh 85037053

=LDR  00593cz  a2200193n  4500
=001  9880363277202441
=005  20141212200607.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003862
=035  \\$aCAZ6989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x30.$x120
=150  \\$aDepreciation
=450  \\$wnnna$aDepreciations
=550  \\$wg$aAccounting
=667  \\$aNIM
=680  \\$iDecline in value of capital assets of a permanent or fixed nature over time with use.
=688  \\$a91(78); was see under ACCOUNTING 1978-90
=750  \0$aDepreciation$5IEN$0(DLC)sh 85037049

=LDR  01028cz  a2200253n  4500
=001  9880363277302441
=005  20141212200607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003861
=035  \\$aCAZ6988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x300
=150  \\$aDepersonalization
=450  \\$aDepersonalization Disorder
=450  \\$wnnna$aDepersonalization Disorders
=450  \\$wnnna$aDepersonalizations
=450  \\$aDerealization
=450  \\$wnnna$aDerealizations
=450  \\$wnnna$aDisorder, Depersonalization
=450  \\$wnnna$aDisorders, Depersonalization
=550  \\$wg$aBehavioral Symptoms
=680  \\$iState in which an individual perceives or experiences a sensation of unreality concerning the self or the environment; it is seen in disorders such as schizophrenia, affection disorders, organic mental disorders, and personality disorders. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a98(63)
=750  \0$aDepersonalization$5IEN$0(DLC)sh 85037028

=LDR  00458cz  a2200181n  4500
=001  9880363277502441
=005  20141212200606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003855
=035  \\$aCAZ6982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x254.$x330
=150  \\$aDeoxyribose
=450  \\$wnnna$a2-Deoxyribose
=450  \\$wnnna$a2 Deoxyribose
=550  \\$wg$aDeoxy Sugars
=688  \\$a74
=750  \0$aDeoxyribose$5IEN$0(DLC)sh 85037011

=LDR  00871cz  a2200253n  4500
=001  9880363277602441
=005  20141212200605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003854
=035  \\$aCAZ6981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x695.$x201
=150  \\$aDeoxyribonucleotides
=550  \\$wg$aNucleotides
=550  \\$wh$aDeoxyadenine Nucleotides
=550  \\$wh$aDeoxycytosine Nucleotides
=550  \\$wh$aDeoxyguanine Nucleotides
=550  \\$wh$aDeoxyuracil Nucleotides
=550  \\$wh$aNucleoside Diphosphate Sugars
=550  \\$wh$aThymine Nucleotides
=667  \\$aGEN or unspecified; prefer specific
=680  \\$iA purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group.
=688  \\$a73; was RIBONUCLEOTIDES, DEOXY 1971-72 (Prov)
=750  \0$aDeoxyribonucleotides$5IEN$0(DLC)sh 86007801

=LDR  01052cz  a2200313n  4500
=001  9880363277702441
=005  20141212200605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003851
=035  \\$aCAZ6978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x335
=150  \\$aDeoxyribonucleases
=450  \\$wnnna$aAcid DNase
=450  \\$wnnna$aAlkaline DNase
=450  \\$aDesoxyribonucleases
=450  \\$wnnna$aDNA Nucleases
=450  \\$aDNAase
=450  \\$aDNase
=450  \\$wnnna$aDNase, Acid
=450  \\$wnnna$aDNase, Alkaline
=450  \\$aNucleases, DNA
=550  \\$wg$aEsterases
=550  \\$wh$aEndodeoxyribonucleases
=550  \\$wh$aExodeoxyribonucleases
=667  \\$adifferentiate STREPTODORNASE referred to here and STREPTODORNASE AND STREPTOKINASE (see note there)
=680  \\$iEnzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.
=688  \\$a83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65
=750  \0$aDeoxyribonucleases$5IEN$0(DLC)sh 85037006

=LDR  00536cz  a2200217n  4500
=001  9880363277802441
=005  20141212200600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003837
=035  \\$aCAZ6961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x254
=150  \\$aDeoxy Sugars
=450  \\$wnnna$aSugars, Deoxy
=550  \\$wg$aCarbohydrates
=550  \\$wh$aDeoxyglucose
=550  \\$wh$aDeoxyribose
=550  \\$wh$aFucose
=550  \\$wh$aRhamnose
=688  \\$a74
=750  \0$aDeoxy sugars$5IEN$0(DLC)sh 85037004

=LDR  00657cz  a2200169n  4500
=001  9880363277902441
=005  20141212200600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003836
=035  \\$aCAZ6960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x385
=150  \\$aDeodorants
=450  \\$wnnna$aDeodorant
=550  \\$wg$aCosmetics
=680  \\$iAgents that remove, correct, repress, or mask undesirable ODORS. In personal hygiene, deodorants often contain astringent preparations that reduce SWEATING, referred to as ANTIPERSPIRANTS. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aDeodorants$5IEN$0(DLC)sh 88002617

=LDR  02052cz  a2200445n  4500
=001  9880363278002441
=005  20141212200559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003834
=035  \\$aCAZ6958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x433.$x555
=072  \\$aE7.$x695.$x190.$x200.$x220.$x245
=150  \\$aDenture Precision Attachment
=450  \\$wnnna$aAttachment, Dental Slotted
=450  \\$wnnna$aAttachment Denture, Precision
=450  \\$wnnna$aAttachment, Denture Precision
=450  \\$wnnna$aAttachment Dentures, Precision
=450  \\$wnnna$aAttachment, Intracoronal
=450  \\$wnnna$aAttachments, Dental Slotted
=450  \\$wnnna$aAttachments, Denture Precision
=450  \\$wnnna$aAttachments, Intracoronal
=450  \\$wnnna$aDental Slotted Attachment
=450  \\$wnnna$aDental Slotted Attachments
=450  \\$wnnna$aDenture, Precision Attachment
=450  \\$wnnna$aDenture Precision Attachments
=450  \\$wnnna$aDentures, Precision Attachment
=450  \\$aIntracoronal Attachment
=450  \\$wnnna$aIntracoronal Attachments
=450  \\$aPrecision Attachment, Denture
=450  \\$wnnna$aPrecision Attachment Denture
=450  \\$wnnna$aPrecision Attachment Dentures
=450  \\$wnnna$aPrecision Attachments, Denture
=450  \\$aSlotted Attachment, Dental
=450  \\$wnnna$aSlotted Attachments, Dental
=550  \\$wg$aDenture, Partial
=667  \\$arestrict to partial dentures
=680  \\$iA precision device used for attaching a fixed or removable partial denture to the crown of an abutment tooth or a restoration. One type is the intracoronal attachment and the other type is the extracoronal attachment. It consists of a female portion within the coronal portion of the crown of an abutment and a fitted male portion attached to the denture proper. (Jablonski, Dictionary of Dentistry, 1992, p85; from Boucher's Clinical Dental Terminology, 4th ed, p264)
=688  \\$a70
=750  \0$aDenture attachments$5IEN$0(DLC)sh 85036983

=LDR  00923cz  a2200253n  4500
=001  9880363278102441
=005  20141212200558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003832
=035  \\$aCAZ6956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x433.$x413
=072  \\$aE7.$x695.$x190.$x200.$x220.$x230
=150  \\$aDenture, Partial, Removable
=450  \\$wnnna$aDenture, Removable Partial
=450  \\$wnnna$aDentures, Removable Partial
=450  \\$wnnna$aPartial Denture, Removable
=450  \\$wnnna$aPartial Dentures, Removable
=450  \\$wnnna$aRemovable Partial Denture
=450  \\$wnnna$aRemovable Partial Dentures
=550  \\$wg$aDenture, Partial
=680  \\$iA partial denture designed and constructed to be removed readily from the mouth.
=688  \\$a65; CROWN AND BRIDGEWORK was heading 1963-64
=750  \0$aPartial dentures, Removable$5IEN$0(DLC)sh 85098347

=LDR  00875cz  a2200193n  4500
=001  9880363278202441
=005  20141212200558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003831
=035  \\$aCAZ6955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x433.$x342
=072  \\$aE7.$x695.$x190.$x200.$x220.$x225
=150  \\$aDenture, Partial, Immediate
=550  \\$wg$aDenture, Partial
=680  \\$iA partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture.
=688  \\$a65; CROWN AND BRIDGEWORK was heading 1963-64
=750  \0$81$wb$aDentures, Immediate$5IEN$0(DLC)sh 85036987
=750  \0$81$wb$aPartial dentures$5IEN-HS$0(DLC)sh 85098345

=LDR  01137cz  a2200337n  4500
=001  9880363278302441
=005  20141212200558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003830
=035  \\$aCAZ6954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x433.$x271
=072  \\$aE7.$x695.$x190.$x200.$x220.$x220
=150  \\$aDenture, Partial, Fixed
=450  \\$wnnna$aBridge, Fixed
=450  \\$wnnna$aBridges, Fixed
=450  \\$wnnna$aDenture, Fixed Partial
=450  \\$wnnna$aDentures, Fixed Partial
=450  \\$aFixed Bridge
=450  \\$wnnna$aFixed Bridges
=450  \\$aFixed Partial Denture
=450  \\$wnnna$aFixed Partial Dentures
=450  \\$wnnna$aPartial Denture, Fixed
=450  \\$wnnna$aPartial Dentures, Fixed
=450  \\$aPontic
=450  \\$wnnna$aPontics
=550  \\$wg$aDenture, Partial
=550  \\$wh$aDenture, Partial, Fixed, Resin-Bonded
=680  \\$iA partial denture attached to prepared natural teeth, roots, or implants by cementation.
=688  \\$a65; CROWN AND BRIDGEWORK was heading 1963-64
=750  \0$aBridges (Dentistry)$5IEN$0(DLC)sh 85016893

=LDR  01253cz  a2200337n  4500
=001  9880363278402441
=005  20141212200557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003829
=035  \\$aCAZ6953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x433
=072  \\$aE7.$x695.$x190.$x200.$x220
=150  \\$aDenture, Partial
=450  \\$wnnna$aBridgework, Dental
=450  \\$wnnna$aBridgeworks, Dental
=450  \\$aDental Bridgework
=450  \\$wnnna$aDental Bridgeworks
=450  \\$wnnna$aDentures, Partial
=450  \\$wnnna$aPartial Denture
=450  \\$wnnna$aPartial Dentures
=550  \\$wg$aDentures
=550  \\$wh$aDenture, Partial, Fixed
=550  \\$wh$aDenture, Partial, Immediate
=550  \\$wh$aDenture, Partial, Removable
=550  \\$wh$aDenture, Partial, Temporary
=550  \\$wh$aDenture Precision Attachment
=667  \\$alabeling for ownership or identification = DENTURE IDENTIFICATION MARKING
=680  \\$iA denture replacing one or more (but not all) natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth.
=688  \\$a65; CROWN AND BRIDGEWORK was heading 1963-64
=750  \0$aPartial dentures$5IEN$0(DLC)sh 85098345

=LDR  00840cz  a2200253n  4500
=001  9880363278502441
=005  20141212200557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003828
=035  \\$aCAZ6952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x395
=072  \\$aE7.$x695.$x190.$x200.$x215
=150  \\$aDenture, Overlay
=450  \\$wnnna$aDentures, Overlay
=450  \\$aOverdenture
=450  \\$wnnna$aOverdentures
=450  \\$wnnna$aOverlay Denture
=450  \\$wnnna$aOverlay Dentures
=550  \\$wg$aDentures
=667  \\$acoordinate IM with specific denture term (IM or NIM)
=680  \\$iRemovable prosthesis constructed over natural teeth or implanted studs.
=688  \\$a74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92
=750  \0$aOverlay dentures$5IEN$0(DLC)sh 85096199

=LDR  00897cz  a2200205n  4500
=001  9880363278602441
=005  20141212200556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003825
=035  \\$aCAZ6949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x290.$x254
=072  \\$aE7.$x695.$x190.$x200.$x205.$x205
=150  \\$aDenture, Complete, Immediate
=550  \\$wg$aDenture, Complete
=550  \\$aAlveoloplasty
=680  \\$iA complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture.
=688  \\$a65
=750  \0$81$wb$aDentures, Immediate$5IEN$0(DLC)sh 85036987
=750  \0$81$wb$aComplete dentures$5IEN-HS$0(DLC)sh 85029359

=LDR  01108cz  a2200289n  4500
=001  9880363278702441
=005  20141212200554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003817
=035  \\$aCAZ6944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x379
=072  \\$aA14.$x549.$x167
=150  \\$aDentition
=450  \\$wnnna$aDentitions
=550  \\$wg$aMouth
=550  \\$wh$aDentition, Mixed
=550  \\$wh$aDentition, Permanent
=550  \\$wh$aDiastema
=550  \\$wh$aPeriodontium
=550  \\$wh$aTooth
=550  \\$wh$aTooth Components
=550  \\$aMalocclusion
=550  \\$aTooth
=667  \\$ageneral or unspecified; prefer DENTITION, PRIMARY; DENTITION, PERMANENT; or DENTITION, MIXED; differentiate from TOOTH
=680  \\$iThe teeth collectively in the dental arch. Dentition ordinarily refers to the natural teeth in position in their alveoli. Dentition referring to the deciduous teeth is DENTITION, PRIMARY; to the permanent teeth, DENTITION, PERMANENT. (From Jablonski, Dictionary of Dentistry, 1992)
=750  \0$aDentition$5IEN$0(DLC)sh 85036980

=LDR  00782cz  a2200277n  4500
=001  9880363278802441
=005  20141212200554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003816
=035  \\$aCAZ6943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x330.$x310
=072  \\$aM1.$x975.$x310
=072  \\$aN2.$x360.$x330.$x310
=150  \\$aDentists, Women
=450  \\$wnnna$aDentist, Woman
=450  \\$wnnna$aDentists, Woman
=450  \\$wnnna$aWoman Dentist
=450  \\$wnnna$aWoman Dentists
=450  \\$wnnna$aWomen Dentists
=550  \\$wg$aDentists
=550  \\$wg$aWomen
=667  \\$a/educ = EDUCATION, DENTAL or specific; Manual 34.11.3
=680  \\$iFemale dentists.
=688  \\$a65
=750  \0$aWomen dentists$5IEN$0(DLC)sh 85147515

=LDR  00831cz  a2200205n  4500
=001  9880363278902441
=005  20141212200350.0
=008  771205\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003421
=035  \\$aCAZ6567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868.$x110
=150  \\$aCrithidia
=450  \\$wnnna$aCrithidias
=550  \\$wg$aTrypanosomatina
=550  \\$wh$aCrithidia fasciculata
=667  \\$ainfection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of parasitic protozoans found in the digestive tract of invertebrates, especially insects. Organisms of this genus have an amastigote and choanomastigote stage in their life cycle.
=688  \\$a79
=750  \0$aCrithidia$5IEN$0(DLC)sh 88021305

=LDR  01080cz  a2200241n  4500
=001  9880363279002441
=005  20141212200349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003419
=035  \\$aCAZ6565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x252
=150  \\$aCrisis Intervention
=450  \\$wnnna$aCrisis Interventions
=450  \\$aCritical Incident Stress Debriefing
=450  \\$wnnna$aIntervention, Crisis
=450  \\$wnnna$aInterventions, Crisis
=550  \\$wg$aPsychotherapy
=550  \\$aEmergencies
=667  \\$aa psychother technique
=680  \\$iBrief therapeutic approach which is ameliorative rather than curative of acute psychiatric emergencies. Used in contexts such as emergency rooms of psychiatric or general hospitals, or in the home or place of crisis occurrence, this treatment approach focuses on interpersonal and intrapsychic factors and environmental modification. (APA Thesaurus of Psychological Index Terms, 7th ed)
=688  \\$a70
=750  \0$aCrisis intervention (Mental health services)$5IEN$0(DLC)sh 85034121

=LDR  00759cz  a2200229n  4500
=001  9880363279102441
=005  20141212200349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003418
=035  \\$aCAZ6564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198
=150  \\$aCriminology
=450  \\$aCriminologists$5IEN
=550  \\$wg$aSocial Sciences
=550  \\$wh$aCrime
=550  \\$wh$aCriminal Law
=550  \\$wh$aForensic Sciences
=667  \\$aSPEC: SPEC qualif; DF: CRIMINOL
=680  \\$iThe study of crime and criminals with special reference to the personality factors and social conditions leading toward, or away from crime.
=750  \0$aCriminologists$0(DLC) sh 85034103$5IEN-M
=750  \0$aCrimonology$0(DLC) sh 89002994$5IEN-M

=LDR  00751cz  a2200193n  4500
=001  9880363279202441
=005  20141212200349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003417
=035  \\$aCAZ6563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x240
=150  \\$aCriminal Psychology
=450  \\$aPsychology, Criminal
=550  \\$wg$aPsychology, Applied
=550  \\$wh$aLie Detection
=667  \\$aas SPEC, SPEC qualif; as psychol of the criminal mind, no qualif; consider also PRISONERS /psychol; DF: CRIMINAL PSYCHOL
=680  \\$iThe branch of psychology which investigates the psychology of crime with particular reference to the personality factors of the criminal.
=750  \0$aCriminal psychology$5IEN$0(DLC)sh 85034097

=LDR  00967cz  a2200265n  4500
=001  9880363279302441
=005  20141212200349.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003416
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x290
=072  \\$aI1.$x880.$x604.$x583.$x100
=150  \\$aCriminal Law
=450  \\$aCriminal Justice
=450  \\$wnnna$aCriminal Laws
=450  \\$wnnna$aJustice, Criminal
=450  \\$wnnna$aLaw, Criminal
=450  \\$wnnna$aLaws, Criminal
=550  \\$wg$aCriminology
=550  \\$wg$aJurisprudence
=550  \\$aLaw Enforcement
=667  \\$aSPEC: SPEC qualif; specify state or country
=680  \\$iA branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons, and fixes the penalties and modes of treatment applicable to convicted offenders.
=688  \\$a91(78); was see under JURISPRUDENCE 1978-90
=750  \0$aCriminal law$5IEN$0(DLC)sh 85034058

=LDR  01393cz   2200409n  4500
=001  9880363279402441
=005  20220926163356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003415
=035  \\$aCAZ6561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240
=072  \\$aI1.$x880.$x735.$x191
=150  \\$aCrime
=450  \\$wnnna$aCrimes
=450  \\$aKidnapping
=450  \\$wnnna$aKidnappings
=550  \\$wg$aCriminology
=550  \\$wg$aSocial Problems
=550  \\$wh$aAbortion, Criminal
=550  \\$wh$aCorpse Dismemberment
=550  \\$wh$aDefamation
=550  \\$wh$aDrug Trafficking
=550  \\$wh$aFraud
=550  \\$wh$aHomicide
=550  \\$wh$aOrgan Trafficking
=550  \\$wh$aPrescription Drug Diversion
=550  \\$wh$aRecidivism
=550  \\$wh$aSex Offenses
=550  \\$wh$aTheft
=550  \\$wh$aViolence
=550  \\$wh$aWar Crimes
=667  \\$aspecify geog if pertinent
=680  \\$iA violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. The concept includes unacceptable actions whether prosecuted or going unpunished.
=688  \\$a68
=750  \0$aCrime$0(DLC) sh 85033993$5IEN-M
=750  \0$iNarrower mapping$aCopycat crimes$0(DLC)sh2021008711$4NM$5IEN-M

=LDR  01563cz  a2200373n  4500
=001  9880363279602441
=005  20141212200345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003409
=035  \\$aCAZ6555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x343.$x347
=072  \\$aC5.$x116.$x132.$x256
=072  \\$aC16.$x320.$x240.$x625
=072  \\$aC19.$x297.$x155
=072  \\$aC19.$x874.$x482.$x281
=150  \\$aCongenital Hypothyroidism
=450  \\$aCretinism
=450  \\$wnnna$aCretinism, Endemic
=450  \\$wnnna$aEndemic Cretinism
=450  \\$wnnna$aFetal Iodine Deficiency Disorder
=450  \\$wnnna$aHypothyroidism, Congenital
=450  \\$aHypothyroidism$xcongenital
=450  \\$aMyxedema, Congenital
=450  \\$aMyxedema$xcongenital
=550  \\$wg$aBone Diseases, Endocrine
=550  \\$wg$aDwarfism
=550  \\$wg$aHypothyroidism
=550  \\$aHypothyroidism
=550  \\$aIntellectual Disability
=680  \\$iA condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA.
=688  \\$a2006 (1966)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Cretinism
=750  \0$aCongenital hypothyroidism$0(DLC) sh 89000883$5IEN-M

=LDR  00756cz  a2200277n  4500
=001  9880363279702441
=005  20171102172039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003408
=035  \\$aCAZ6554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x239
=150  \\$aCresols
=550  \\$wg$aPhenols
=550  \\$wh$aBisacodyl
=550  \\$wh$aBrocresine
=550  \\$wh$aBromcresol Green
=550  \\$wh$aBromcresol Purple
=550  \\$wh$aButylated Hydroxytoluene
=550  \\$wh$aCreosote
=550  \\$wh$aCyclofenil
=550  \\$wh$aDinitrocresols
=550  \\$wh$aFormocresols
=550  \\$wh$aTolterodine Tartrate
=550  \\$wh$aTritolyl Phosphates
=750  \0$aCresol$5IEN$0(DLC)sh 85033934

=LDR  00925cz  a2200193n  4500
=001  9880363279802441
=005  20141212200345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003407
=035  \\$aCAZ6553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x239.$x327
=150  \\$aCreosote
=450  \\$wnnna$aBeechwood Creosote
=450  \\$wnnna$aCreosote, Beechwood
=550  \\$wg$aCresols
=680  \\$iA greasy substance with a smoky odor and burned taste created by high temperature treatment of BEECH and other WOOD; COAL TAR; or resin of the CREOSOTE BUSH. It contains CRESOLS and POLYCYCLIC AROMATIC HYDROCARBONS which are CARCINOGENS. It has been widely used as wood preservative and in PESTICIDES and had former use medicinally in DISINFECTANTS; LAXATIVES; and DERMATOLOGIC AGENTS.
=688  \\$a91(75); was see under CRESOLS 1975-90
=750  \0$aCreosote$5IEN$0(DLC)sh 85033929

=LDR  00842cz  a2200277n  4500
=001  9880363279902441
=005  20141212200344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003405
=035  \\$aCAZ6551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x264
=072  \\$aF2.$x463.$x785.$x302
=150  \\$aCreativity
=450  \\$wnnna$aAbilities, Creative
=450  \\$wnnna$aAbility, Creative
=450  \\$wnnna$aCreative Abilities
=450  \\$wnnna$aCreative Ability
=450  \\$aCreativeness
=550  \\$wg$aPersonality
=550  \\$wg$aThinking
=667  \\$ahuman & animal (especially primates)
=680  \\$iThe ability to generate new ideas or images.
=688  \\$a2013 (1966)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Creativeness
=750  \0$aCreative ability$0(DLC) sh 85033833$5IEN-M

=LDR  00710cz  a2200229n  4500
=001  9880363280002441
=005  20141212200344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003404
=035  \\$aCAZ6550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x207
=150  \\$aCreatinine
=450  \\$wnnna$aCreatinine Sulfate Salt
=450  \\$wnnna$aKrebiozen
=450  \\$wnnna$aSalt, Creatinine Sulfate
=450  \\$wnnna$aSulfate Salt, Creatinine
=550  \\$wg$aImidazoles
=667  \\$ado not confuse with CREATINE
=688  \\$a68; CREATINE AND CREATININE was heading 1963-67
=750  \0$aCreatinine$5IEN-M$0(DLC)sh 85033821
=750  \0$aKrebiozen$5IEN-HS$0(DLC)sh 85073259

=LDR  01676cz  a2200349n  4500
=001  9880363280102441
=005  20141212200344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003402
=035  \\$aCAZ6548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x640.$x150
=150  \\$aCreatine Kinase
=450  \\$wnnna$aADP Phosphocreatine Phosphotransferase
=450  \\$wnnna$aATP Creatine Phosphotransferase
=450  \\$wnno$aCreatine Kinase Isoenzymes$5IEN-HS
=450  \\$aCreatine Phosphokinase
=450  \\$wnnna$aCreatine Phosphotransferase, ATP
=450  \\$wnnna$aKinase, Creatine
=450  \\$wnnna$aMacro-Creatine Kinase
=450  \\$wnnna$aMacro Creatine Kinase
=450  \\$wnnna$aPhosphocreatine Phosphotransferase, ADP
=450  \\$wnnna$aPhosphokinase, Creatine
=450  \\$wnnna$aPhosphotransferase, ADP Phosphocreatine
=450  \\$wnnna$aPhosphotransferase, ATP Creatine
=550  \\$wg$aPhosphotransferases (Nitrogenous Group Acceptor)
=550  \\$wh$aCreatine Kinase, BB Form
=550  \\$wh$aCreatine Kinase, MB Form
=550  \\$wh$aCreatine Kinase, Mitochondrial Form
=550  \\$wh$aCreatine Kinase, MM Form
=680  \\$iA transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.
=750  \0$aCreatine kinase$0(DLC) sh 85033820$5IEN

=LDR  00804cz  a2200217n  4500
=001  9880363280202441
=005  20141212200343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003401
=035  \\$aCAZ6547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x78.$x370.$x280
=072  \\$aD12.$x125.$x373
=150  \\$aCreatine
=550  \\$wg$aAmino Acids
=550  \\$wg$aGuanidines
=550  \\$wh$aPhosphocreatine
=667  \\$ado not confuse with CREATININE; CREATINE PHOSPHATE see PHOSPHOCREATINE
=680  \\$iAn amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
=688  \\$a68; CREATINE AND CREATININE was heading 1963-67
=750  \0$aCreatine$5IEN$0(DLC)sh 85033819

=LDR  00876cz  a2200253n  4500
=001  9880363280302441
=005  20201118173831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003400
=035  \\$aCAZ6546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x70
=150  \\$aAstacoidea
=450  \\$wnnna$aAstacoideas
=450  \\$aAstacus
=450  \\$aCrayfish
=450  \\$wnnna$aCrayfishs
=450  \\$aProcambarus
=550  \\$wg$aDecapoda
=550  \\$aShellfish
=667  \\$aas animal & food; IM; as food, coord IM with SHELLFISH (IM)
=680  \\$iA superfamily of various freshwater CRUSTACEA, in the infraorder Astacidea, comprising the crayfish. Common genera include Astacus and Procambarus. Crayfish resemble lobsters, but are usually much smaller.
=688  \\$a2003 (1972)
=750  \0$aCrayfish$5IEN$0(DLC)sh 85033794

=LDR  00686cz  a2200229n  4500
=001  9880363280402441
=005  20141212200343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003399
=035  \\$aCAZ6545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x190
=150  \\$aCraniotomy
=450  \\$wnnna$aCraniotomies
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wh$aDecompressive Craniectomy
=550  \\$wh$aTrephining
=550  \\$aSkull
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAny operation on the cranium or incision into the cranium. (Dorland, 28th ed)
=688  \\$a65(64)
=750  \0$aCraniotomy$0(DLC) sh 85033759$5IEN

=LDR  01582cz  a2200313n  4500
=001  9880363280502441
=005  20141212200418.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003528
=035  \\$aCAZ6669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25.$x220
=150  \\$aCarcinoma, Adenoid Cystic
=450  \\$wnnna$aAdenocystic Carcinoma
=450  \\$wnnna$aAdenocystic Carcinomas
=450  \\$wnnna$aAdenoid Cystic Carcinoma
=450  \\$wnnna$aAdenoid Cystic Carcinomas
=450  \\$wnnna$aCarcinoma, Adenocystic
=450  \\$wnnna$aCarcinomas, Adenocystic
=450  \\$wnnna$aCarcinomas, Adenoid Cystic
=450  \\$aCylindroma
=450  \\$wnnna$aCylindromas
=450  \\$wnnna$aCystic Carcinoma, Adenoid
=450  \\$wnnna$aCystic Carcinomas, Adenoid
=550  \\$wg$aAdenocarcinoma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iCarcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)
=688  \\$a94; was CYLINDROMA 1963-93
=750  \0$aAdenoid cystic carcinoma$0(DLC) sh 91002009$5IEN

=LDR  00569cz  a2200205n  4500
=001  9880363280602441
=005  20141212200417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003521
=035  \\$aCAZ6662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x533
=150  \\$aCyclopropanes
=450  \\$aCyclopropane$5IEN
=550  \\$wg$aCycloparaffins
=550  \\$wh$aCilastatin
=550  \\$wh$aHypoglycins
=667  \\$aincludes cyclopropenes
=688  \\$a75; was CYCLOPROPANE 1963-74
=750  \0$aCyclopropane$5IEN$0(DLC)sh 85035101

=LDR  01465cz  a2200385n  4500
=001  9880363280702441
=005  20141212200415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003516
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368
=072  \\$aD4.$x345.$x133
=150  \\$aCycloparaffins
=450  \\$wnnna$aAlkenes, Cyclic
=450  \\$wnnna$aCyclic Acetylenes
=450  \\$wnnna$aCyclic Alkenes
=450  \\$aCyclic Olefins
=450  \\$aCycloalkanes
=450  \\$aCycloalkenes
=450  \\$aCycloalkynes
=450  \\$wnnna$aOlefins, Cyclic
=550  \\$wg$aHydrocarbons, Alicyclic
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wh$aAdamantane
=550  \\$wh$aCyclitols
=550  \\$wh$aCyclobutanes
=550  \\$wh$aCyclodecanes
=550  \\$wh$aCycloheptanes
=550  \\$wh$aCyclohexanes
=550  \\$wh$aCyclooctanes
=550  \\$wh$aCyclopentanes
=550  \\$wh$aCyclopropanes
=550  \\$aHydrocarbons, Cyclic
=680  \\$iAlicyclic hydrocarbons in which three or more of the carbon atoms in each molecule are united in a ring structure and each of the ring carbon atoms is joined to two hydrogen atoms or alkyl groups. The simplest members are cyclopropane (C3H6), cyclobutane (C4H8), cyclohexane (C6H12), and derivatives of these such as methylcyclohexane (C6H11CH3). (From Sax, et al., Hawley's Condensed Chemical Dictionary, 11th ed)
=750  \0$aCycloalkanes$5IEN$0(DLC)sh 85035091

=LDR  00704cz  a2200217n  4500
=001  9880363280802441
=005  20141212200415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003514
=035  \\$aCAZ6655M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x384
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x418
=150  \\$aCyclohexylamines
=450  \\$wnnna$aCyclohexylamine
=550  \\$wg$aAmines
=550  \\$wg$aCyclohexanes
=550  \\$wh$aBromhexine
=680  \\$iA family of alicyclic hydrocarbons containing an amine group with the general formula R-C6H10NH2.
=688  \\$a75; was CYCLOHEXYLAMINE 1971-74 (Prov 1971-72)
=750  \0$aCyclohexylamine$0(DLC)sh2010014519$5IEN-M

=LDR  03667cz  a2200925n  4500
=001  9880363280902441
=005  20141212200342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003398
=035  \\$aCAZ6544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x370.$x894.$x232
=072  \\$aC5.$x660.$x207.$x240
=072  \\$aC5.$x660.$x207.$x707.$x249
=072  \\$aC5.$x660.$x906.$x364
=072  \\$aC16.$x131.$x621.$x207.$x240
=072  \\$aC16.$x131.$x621.$x207.$x707.$x249
=072  \\$aC16.$x131.$x621.$x906.$x364
=150  \\$aCraniosynostoses
=450  \\$aAcrocephaly
=450  \\$wnnna$aAnterior Plagiocephalies, Synostotic
=450  \\$wnnna$aAnterior Plagiocephaly, Synostotic
=450  \\$wnnna$aBrachycephalies
=450  \\$wnnna$aBrachycephaly
=450  \\$wnnna$aCoronal Synostoses, Unilateral
=450  \\$wnnna$aCoronal Synostosis, Unilateral
=450  \\$wnnna$aCraniostenoses
=450  \\$wnnna$aCraniostenosis
=450  \\$wnnna$aCraniosynostoses, Lambdoidal
=450  \\$wnnna$aCraniosynostosis
=450  \\$wnnna$aCraniosynostosis, Lambdoidal
=450  \\$wnnna$aCraniosynostosis Plagiocephalies
=450  \\$wnnna$aCraniosynostosis Plagiocephaly
=450  \\$wnnna$aCraniosynostosis, Type 1
=450  \\$wnnna$aLambdoid Synostoses
=450  \\$wnnna$aLambdoid Synostosis
=450  \\$wnnna$aLambdoidal Craniosynostoses
=450  \\$wnnna$aLambdoidal Craniosynostosis
=450  \\$wnnna$aMetopic Synostoses
=450  \\$wnnna$aMetopic Synostosis
=450  \\$aOxycephaly
=450  \\$wnnna$aPlagiocephalies, Craniosynostosis
=450  \\$wnnna$aPlagiocephalies, Synostotic
=450  \\$wnnna$aPlagiocephalies, Synostotic Anterior
=450  \\$wnnna$aPlagiocephalies, Synostotic Posterior
=450  \\$wnnna$aPlagiocephaly, Craniosynostosis
=450  \\$wnnna$aPlagiocephaly, Synostotic
=450  \\$wnnna$aPlagiocephaly, Synostotic Anterior
=450  \\$wnnna$aPlagiocephaly, Synostotic Posterior
=450  \\$wnnna$aPosterior Plagiocephalies, Synostotic
=450  \\$wnnna$aPosterior Plagiocephaly, Synostotic
=450  \\$wnnna$aSagittal Synostoses
=450  \\$wnnna$aSagittal Synostosis
=450  \\$wnnna$aScaphocephalies
=450  \\$wnnna$aScaphocephaly
=450  \\$wnnna$aSynostoses, Lambdoid
=450  \\$wnnna$aSynostoses, Metopic
=450  \\$wnnna$aSynostoses, Sagittal
=450  \\$wnnna$aSynostoses, Unilateral Coronal
=450  \\$wnnna$aSynostosis, Lambdoid
=450  \\$wnnna$aSynostosis, Metopic
=450  \\$wnnna$aSynostosis, Sagittal
=450  \\$wnnna$aSynostosis, Unilateral Coronal
=450  \\$wnnna$aSynostotic Anterior Plagiocephalies
=450  \\$wnnna$aSynostotic Anterior Plagiocephaly
=450  \\$wnnna$aSynostotic Plagiocephalies
=450  \\$wnnna$aSynostotic Plagiocephaly
=450  \\$wnnna$aSynostotic Posterior Plagiocephalies
=450  \\$wnnna$aSynostotic Posterior Plagiocephaly
=450  \\$wnnna$aTrigonocephalies
=450  \\$wnnna$aTrigonocephaly
=450  \\$wnnna$aUnilateral Coronal Synostoses
=450  \\$wnnna$aUnilateral Coronal Synostosis
=550  \\$wg$aCraniofacial Abnormalities
=550  \\$wg$aPlagiocephaly
=550  \\$wg$aSynostosis
=550  \\$wh$aAcrocephalosyndactylia
=680  \\$iPremature closure of one or more CRANIAL SUTURES. It often results in plagiocephaly. Craniosynostoses that involve multiple sutures are sometimes associated with congenital syndromes such as ACROCEPHALOSYNDACTYLIA; and CRANIOFACIAL DYSOSTOSIS.
=688  \\$aOXYCEPHALY was see under CRANIOSYNOSTOSES 1963-78
=750  \0$aCraniosynostoses$5IEN$0(DLC)sh 85033757

=LDR  00682cz  a2200217n  4500
=001  9880363281002441
=005  20141212200414.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003512
=035  \\$aCAZ6653M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x340
=072  \\$aD2.$x522.$x400
=150  \\$aCyclohexanones
=550  \\$wg$aCyclohexanes
=550  \\$wg$aKetones
=550  \\$wh$aTiletamine
=667  \\$ado not confuse with CYCLOHEXANOLS
=680  \\$iCyclohexane ring substituted by one or more ketones in any position.
=688  \\$a91(75); was see under CYCLOHEXANES 1975-90
=750  \0$aCyclohexanones$0(DLC)sh2006005740$5IEN-M

=LDR  00929cz  a2200313n  4500
=001  9880363281102441
=005  20141212200414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003510
=035  \\$aCAZ6651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367
=150  \\$aCyclohexanes
=550  \\$wg$aCycloparaffins
=550  \\$wh$aCuprizone
=550  \\$wh$aCyclamates
=550  \\$wh$aCyclohexanecarboxylic Acids
=550  \\$wh$aCyclohexanols
=550  \\$wh$aCyclohexanones
=550  \\$wh$aCyclohexenes
=550  \\$wh$aCyclohexylamines
=550  \\$wh$aDicyclomine
=550  \\$wh$aKetamine
=550  \\$wh$aPicrotoxin
=550  \\$wh$aTiletamine
=550  \\$wh$atrans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride
=680  \\$iSix-carbon alicyclic hydrocarbons.
=688  \\$a75; was CYCLOHEXANE 1963-74
=750  \0$aCyclohexane$0(DLC) sh 85035082$5IEN

=LDR  01149cz  a2200289n  4500
=001  9880363281202441
=005  20141212200413.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003505
=035  \\$aCAZ6646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x103
=072  \\$aD9.$x698.$x365.$x855.$x400.$x375
=150  \\$aCyclodextrins
=450  \\$aCycloamylose
=450  \\$wnnna$aCyclodextrin Derivatives
=450  \\$wnnna$aCyclomaltooligosaccharides
=450  \\$wnnna$aDerivatives, Cyclodextrin
=550  \\$wg$aDextrins
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wh$aalpha-Cyclodextrins
=550  \\$wh$abeta-Cyclodextrins
=550  \\$wh$agamma-Cyclodextrins
=667  \\$anote specifics
=680  \\$iA homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances.
=688  \\$a91(80); was see under DEXTRINS 1980-90
=750  \0$aCyclodextrins$5IEN$0(DLC)sh 85035079

=LDR  00453cz  a2200169n  4500
=001  9880363281302441
=005  20141212200412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003503
=035  \\$aCAZ6644M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x201
=150  \\$aCyclobutanes
=550  \\$wg$aCycloparaffins
=667  \\$aincludes cyclobutenes
=688  \\$a74(72)
=750  \0$aCyclobutane$0(DLC) sh2004007295$5IEN-M

=LDR  01806cz  a2200469n  4500
=001  9880363281402441
=005  20141212200340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003394
=035  \\$aCAZ6542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x370.$x231
=072  \\$aC5.$x660.$x207.$x231
=072  \\$aC16.$x131.$x621.$x207.$x231
=150  \\$aCraniofacial Dysostosis
=450  \\$wnnna$aCraniofacial Dysarthrosis
=450  \\$wnnna$aCraniofacial Dysostoses
=450  \\$wnnna$aCraniofacial Dysostosis, Crouzon
=450  \\$wnnna$aCraniofacial Dysostosis Syndrome
=450  \\$wnnna$aCraniofacial Dysostosis Type 1
=450  \\$wnnna$aCraniofacial Dysostosis, Type 1; CFD1
=450  \\$wnnna$aCraniofacial Dysostosis, Type I
=450  \\$wnnna$aCrouzon Craniofacial Dysostosis
=450  \\$wnnna$aCrouzon Disease
=450  \\$wnnna$aCrouzon Syndrome
=450  \\$aCrouzon's Disease
=450  \\$wnnna$aCrouzons Disease
=450  \\$wnnna$aDisease, Crouzon
=450  \\$wnnna$aDisease, Crouzon's
=450  \\$wnnna$aDysostoses, Craniofacial
=450  \\$aDysostosis, Craniofacial
=450  \\$wnnna$aDysostosis, Crouzon Craniofacial
=450  \\$wnnna$aSyndrome, Crouzon
=550  \\$wg$aCraniofacial Abnormalities
=550  \\$wg$aDysostoses
=550  \\$wh$aHallermann's Syndrome
=550  \\$wh$aHypertelorism
=550  \\$wh$aMandibulofacial Dysostosis
=550  \\$aReceptor, Fibroblast Growth Factor, Type 2
=667  \\$a"craniofacial dysmorphism" does not go here: index under FACIAL BONES / abnorm + SKULL / abnorm but not also ABNORMALITIES, MULTIPLE
=680  \\$iAutosomal dominant CRANIOSYNOSTOSIS with shallow ORBITS; EXOPHTHALMOS; and maxillary hypoplasia.
=750  \0$aCraniofacial dysostosis$5IEN$0(DLC)sh 85033750

=LDR  00876cz  a2200253n  4500
=001  9880363281502441
=005  20170608133353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003500
=035  \\$aCAZ6641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x180
=072  \\$aG2.$x607.$x133
=072  \\$aG3.$x208
=150  \\$aCyclization
=450  \\$wnnna$aCyclizations
=450  \\$aRing Formation (Chemistry)$5IEN
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic cyclization: coord NIM with specific enzyme (IM) + substrate (NIM)
=680  \\$iChanging an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=688  \\$a74(71)
=750  \0$aRing formation (Chemistry)$5IEN$0(DLC)sh 85114120

=LDR  00737cz  a2200217n  4500
=001  9880363281602441
=005  20141212200339.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003393
=035  \\$aCAZ6541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x200
=150  \\$aCranial Sutures
=450  \\$wnnna$aCranial Suture
=450  \\$wnnna$aSuture, Cranial
=450  \\$wnnna$aSutures, Cranial
=550  \\$wg$aSkull
=667  \\$anote category: a fibrous joint in bones of head; do not confuse with SUTURES (E7) or SUTURE TECHNIQUES (E4)
=680  \\$iA type of fibrous joint between bones of the head.
=688  \\$a91(81); was see under SKULL 1981-90
=750  \0$aCranial sutures$5IEN$0(DLC)sh 85033749

=LDR  01065cz  a2200301n  4500
=001  9880363281702441
=005  20141212200410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003494
=035  \\$aCAZ6635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x204
=150  \\$aCyclamates
=450  \\$wnnna$aCalcium Cyclamate
=450  \\$wnnna$aCyclamate
=450  \\$wnnna$aCyclamate, Calcium
=450  \\$wnnna$aCyclamate Calcium (2:1) Salt
=450  \\$wnnna$aCyclamate, Calcium (2:1) Salt, Dihydrate
=450  \\$wnnna$aCyclamate, Potassium
=450  \\$wnnna$aCyclamate, Sodium
=450  \\$wnnna$aCyclamate, Sodium Salt
=450  \\$aCyclamic Acid
=450  \\$wnnna$aPotassium Cyclamate
=450  \\$wnnna$aSodium Cyclamate
=550  \\$wg$aCyclohexanes
=680  \\$iSalts and esters of cyclamic acid.
=688  \\$a71(70); was CYCLAMATE see under SWEETENING AGENTS 1963-70; was in Cat D & J 1973-82, was in Cat D only 1963-72; CYCLAMIC ACID was (NM) 1982-95
=750  \0$aCyclamates$5IEN$0(DLC)sh 85035057

=LDR  01077cz  a2200337n  4500
=001  9880363281802441
=005  20141212200339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003391
=035  \\$aCAZ6539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120
=150  \\$aCranial Nerves
=450  \\$wnnna$aCranial Nerve
=450  \\$wnnna$aNerve, Cranial
=450  \\$wnnna$aNerves, Cranial
=550  \\$wg$aPeripheral Nerves
=550  \\$wh$aAbducens Nerve
=550  \\$wh$aAccessory Nerve
=550  \\$wh$aFacial Nerve
=550  \\$wh$aGlossopharyngeal Nerve
=550  \\$wh$aHypoglossal Nerve
=550  \\$wh$aOculomotor Nerve
=550  \\$wh$aOlfactory Nerve
=550  \\$wh$aOptic Nerve
=550  \\$wh$aTrigeminal Nerve
=550  \\$wh$aTrochlear Nerve
=550  \\$wh$aVagus Nerve
=550  \\$wh$aVestibulocochlear Nerve
=680  \\$iTwelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.
=750  \0$aNerves, Cranial$5IEN$0(DLC)sh 85090902

=LDR  00854cz  a2200277n  4500
=001  9880363281902441
=005  20141212200410.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003493
=035  \\$aCAZ6634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x249
=072  \\$aD2.$x886.$x108.$x750.$x249
=072  \\$aD3.$x438.$x260.$x825.$x249
=072  \\$aD3.$x605.$x84.$x737.$x249
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x249
=150  \\$aCyclacillin
=450  \\$wnnna$aAminocyclohexylpenicillin
=450  \\$aCiclacillin
=450  \\$wnnna$aWy-4508
=450  \\$wnnna$aWy 4508
=450  \\$wnnna$aWy4508
=550  \\$wg$aPenicillins
=680  \\$iA cyclohexylamido analog of PENICILLANIC ACID.
=688  \\$a91(75); was see under PENICILLINS 1975-90
=750  \0$aCyclacillin$5IEN$0(DLC)sh 85035054

=LDR  00783cz   2200193n  4500
=001  9880363282002441
=005  20220302164805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003490
=035  \\$aCAZ6632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x248
=150  \\$aCyanosis
=450  \\$wnnna$aCyanoses
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aBrief, Resolved, Unexplained Event
=667  \\$ado not use for cyanotic heart disease unless particularly discussed (=probably HEART DEFECTS, CONGENITAL)
=680  \\$iA bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
=750  \0$aCyanosis$5IEN$0(DLC)sh 85035033

=LDR  01005cz  a2200313n  4500
=001  9880363282102441
=005  20141212200408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003487
=035  \\$aCAZ6629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x69.$x366
=072  \\$aD2.$x626.$x290
=072  \\$aD5.$x750.$x259
=072  \\$aD25.$x720.$x259
=072  \\$aD25.$x919.$x367
=072  \\$aJ1.$x637.$x51.$x720.$x259
=072  \\$aJ1.$x637.$x51.$x919.$x367
=150  \\$aCyanoacrylates
=450  \\$wnnna$aCyanoacrylate
=550  \\$wg$aAcrylates
=550  \\$wg$aNitriles
=550  \\$wg$aPolymers
=550  \\$wg$aTissue Adhesives
=550  \\$wh$aBucrylate
=550  \\$wh$aEnbucrilate
=680  \\$iA group of compounds having the general formula CH2=C(CN)-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties.
=688  \\$a72
=750  \0$aCyanoacrylates$5IEN$0(DLC)sh 86004636

=LDR  01959cz  a2200517n  4500
=001  9880363282202441
=005  20141212200338.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003390
=035  \\$aCAZ6538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x300
=072  \\$aC4.$x588.$x614.$x596.$x240
=072  \\$aC10.$x292.$x225
=072  \\$aC10.$x551.$x360
=150  \\$aCranial Nerve Neoplasms
=450  \\$wnnna$aBenign Cranial Nerve Neoplasms
=450  \\$wnnna$aBenign Cranial Nerve Tumors
=450  \\$wnnna$aBenign Cranial Neuroma
=450  \\$wnnna$aBenign Cranial Neuromas
=450  \\$wnnna$aCranial Nerve Neoplasm
=450  \\$wnnna$aCranial Nerve Neoplasms, Benign
=450  \\$wnnna$aCranial Nerve Neoplasms, Malignant
=450  \\$wnnna$aCranial Nerve Tumors, Benign
=450  \\$wnnna$aCranial Nerve Tumors, Malignant
=450  \\$aCranial Neuroma, Benign
=450  \\$wnnna$aCranial Neuromas, Benign
=450  \\$wnnna$aMalignant Cranial Nerve Neoplasms
=450  \\$wnnna$aMalignant Cranial Nerve Tumors
=450  \\$wnnna$aNeoplasm, Cranial Nerve
=450  \\$wnnna$aNeoplasms, Cranial Nerve
=450  \\$wnnna$aNeoplasms, Cranial Nerve, Benign
=450  \\$wnnna$aNeoplasms, Cranial Nerve, Malignant
=450  \\$wnnna$aNeuroma, Benign Cranial
=450  \\$wnnna$aNeuromas, Benign Cranial
=450  \\$wnnna$aTumors, Cranial Nerve, Benign
=450  \\$wnnna$aTumors, Cranial Nerve, Malignant
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aNervous System Neoplasms
=550  \\$wg$aPeripheral Nervous System Neoplasms
=550  \\$wh$aNeuroma, Acoustic
=550  \\$wh$aOptic Nerve Neoplasms
=667  \\$acoord IM with specific cranial nerve dis (IM) + histol type of neopl (IM)
=680  \\$iBenign and malignant neoplasms that arise from one or more of the twelve cranial nerves.
=688  \\$a78
=750  \0$aNerves, Cranial$xTumors$5IEN-M$0(IEN)367182

=LDR  00980cz  a2200277n  4500
=001  9880363282302441
=005  20141212200408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003486
=035  \\$aCAZ6628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x291
=072  \\$aD1.$x625.$x400.$x100
=150  \\$aCyanides
=450  \\$aIsocyanides
=550  \\$wg$aAnions
=550  \\$wg$aHydrogen Cyanide
=550  \\$wh$aCyanamide
=550  \\$wh$aFerricyanides
=550  \\$wh$aFerrocyanides
=550  \\$wh$aPotassium Cyanide
=550  \\$wh$aSodium Cyanide
=550  \\$aNitriles
=667  \\$ainorganic salts having -CN radical: differentiate from NITRILES which are organic with -CN
=680  \\$iInorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical.
=750  \0$aCyanides$5IEN$0(DLC)sh 85035028

=LDR  00469cz  a2200169n  4500
=001  9880363282402441
=005  20141212200408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003485
=035  \\$aCAZ6627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x262
=150  \\$aCyanates
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aThiocyanates
=680  \\$iOrganic salts of cyanic acid containing the -OCN radical.
=750  \0$aCyanates$0(DLC)sh2007003844$5IEN-M

=LDR  01433cz  a2200385n  4500
=001  9880363282502441
=005  20141212200407.0
=008  780518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003484
=035  \\$aCAZ6626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x400.$x100.$x150
=072  \\$aD2.$x491.$x203.$x362
=150  \\$aCyanamide
=450  \\$wnnna$aAbstem
=450  \\$aCalcium Carbimide
=450  \\$aCalcium Cyanamide
=450  \\$wnnna$aCalcium Cyanamide, Citrated
=450  \\$wnnna$aCalcium Salt Cyanamide
=450  \\$wnnna$aCarbimide
=450  \\$wnnna$aCarbimide, Calcium
=450  \\$aCitrated Calcium Cyanamide
=450  \\$wnnna$aColme
=450  \\$wnnna$aCyanamide, Calcium
=450  \\$wnnna$aCyanamide, Calcium (1:1) Salt
=450  \\$wnnna$aCyanamide, Calcium (2:1) Salt
=450  \\$wnnna$aCyanamide, Calcium Salt
=450  \\$wnnna$aCyanamide, Citrated Calcium
=450  \\$wnnna$aIpsen Brand of Calcium Carbimide
=450  \\$wnnna$aTemposil
=550  \\$wg$aCarbodiimides
=550  \\$wg$aCyanides
=680  \\$iA cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism.
=688  \\$a91(79); was see under CYANIDES 1979-90
=750  \0$aCalcium cyanamide$0(DLC)sh2006005142$5IEN-M

=LDR  02397cz  a2200637n  4500
=001  9880363282602441
=005  20141212200338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003389
=035  \\$aCAZ6537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292
=150  \\$aCranial Nerve Diseases
=450  \\$wnnna$aCranial Nerve Disease
=450  \\$wnnna$aCranial Nerve Disorder
=450  \\$wnnna$aCranial Nerve Disorders
=450  \\$wnnna$aCranial Nerve Palsies
=450  \\$wnnna$aCranial Nerve Palsy
=450  \\$aCranial Neuropathies
=450  \\$aCranial Neuropathies, Multiple
=450  \\$wnnna$aCranial Neuropathy
=450  \\$wnnna$aCranial Neuropathy, Multiple
=450  \\$wnnna$aMultiple Cranial Neuropathies
=450  \\$wnnna$aMultiple Cranial Neuropathy
=450  \\$wnnna$aNervus Cranialis Disorder
=450  \\$wnnna$aNervus Cranialis Disorders
=450  \\$aNeuropathies, Cranial
=450  \\$wnnna$aNeuropathies, Multiple Cranial
=450  \\$wnnna$aNeuropathy, Cranial
=450  \\$wnnna$aNeuropathy, Multiple Cranial
=450  \\$wnnna$aPalsies, Cranial Nerve
=450  \\$wnnna$aPalsy, Cranial Nerve
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aAbducens Nerve Diseases
=550  \\$wh$aAccessory Nerve Diseases
=550  \\$wh$aCranial Nerve Injuries
=550  \\$wh$aCranial Nerve Neoplasms
=550  \\$wh$aFacial Nerve Diseases
=550  \\$wh$aFacial Neuralgia
=550  \\$wh$aGlossopharyngeal Nerve Diseases
=550  \\$wh$aHypoglossal Nerve Diseases
=550  \\$wh$aOcular Motility Disorders
=550  \\$wh$aOculomotor Nerve Diseases
=550  \\$wh$aOlfactory Nerve Diseases
=550  \\$wh$aOphthalmoplegic Migraine
=550  \\$wh$aOptic Nerve Diseases
=550  \\$wh$aTrigeminal Nerve Diseases
=550  \\$wh$aTrochlear Nerve Diseases
=550  \\$wh$aVagus Nerve Diseases
=550  \\$wh$aVestibulocochlear Nerve Diseases
=550  \\$aMeningitis, Cryptococcal
=550  \\$aNeuroaspergillosis
=667  \\$aGEN: prefer specifics
=680  \\$iDisorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.
=688  \\$a1981; was NON MESH before 1981
=750  \0$aNerves, Cranial$xDiseases$5IEN-M$0(IEN)367180

=LDR  00839cz  a2200241n  4500
=001  9880363282702441
=005  20141212200406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003481
=035  \\$aCAZ6623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x200
=150  \\$aCuspid
=450  \\$wnnna$aCanine Teeth
=450  \\$aCanine Tooth
=450  \\$wnnna$aCuspids
=450  \\$wnnna$aTeeth, Canine
=450  \\$wnnna$aTooth, Canine
=550  \\$wg$aTooth
=667  \\$abetween the 2d incisor & premolars; NIM when merely locational
=680  \\$iThe third tooth to the left and to the right of the midline of either jaw, situated between the second INCISOR and the premolar teeth (BICUSPID). (Jablonski, Dictionary of Dentistry, 1992, p817)
=688  \\$a65
=750  \0$aCuspids$5IEN$0(DLC)sh 85034945

=LDR  01314cz  a2200253n  4500
=001  9880363282802441
=005  20141212200337.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x830.$x200
=072  \\$aA2.$x835.$x232.$x781.$x750.$x400
=150  \\$aCranial Fossa, Posterior
=450  \\$aClivus
=450  \\$wnnna$aCranial Fossas, Posterior
=450  \\$wnnna$aFossa, Posterior Cranial
=450  \\$wnnna$aFossas, Posterior Cranial
=450  \\$wnnna$aPosterior Cranial Fossa
=450  \\$wnnna$aPosterior Cranial Fossas
=550  \\$wg$aSkull Base
=667  \\$aNIM when merely locational; X ref CLIVUS: restrict to posterior cranial fossa; other clivus sites are indexed under specific cranial bone, as clivus ossis occipitalis goes under OCCIPITAL BONE; neopl: coord IM with SKULL BASE NEOPLASMS (IM)
=680  \\$iThe infratentorial compartment that contains the CEREBELLUM and BRAIN STEM. It is formed by the posterior third of the superior surface of the body of the sphenoid (SPHENOID BONE), by the occipital, the petrous, and mastoid portions of the TEMPORAL BONE, and the posterior inferior angle of the PARIETAL BONE.
=688  \\$a91(64); was see under SKULL 1964-90
=750  \0$aCranial fossa, Posterior$5IEN$0(DLC)sh 85033748

=LDR  01201cz  a2200241n  4500
=001  9880363282902441
=005  20141212200406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003480
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53.$x800.$x367
=150  \\$aCushing Syndrome
=450  \\$wnnna$aCushing's Syndrome
=450  \\$wnnna$aHypercortisolism
=450  \\$wnnna$aSyndrome, Cushing
=450  \\$wnnna$aSyndrome, Cushing's
=550  \\$wg$aAdrenocortical Hyperfunction
=550  \\$aAdenoma, Basophil
=550  \\$aPituitary ACTH Hypersecretion
=667  \\$ado not confuse with CUSHING DISEASE see PITUITARY ACTH HYPERSECRETION
=680  \\$iA condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
=688  \\$a99(66)
=750  \0$aCushing's Syndrome$5IEN-M$0(DLC)sh 85034937

=LDR  00871cz  a2200289n  4500
=001  9880363283002441
=005  20201209133652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003479
=035  \\$aCAZ6621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x158
=150  \\$aCurriculum
=450  \\$wnnna$aCourse, Short-Term
=450  \\$wnnna$aCourses, Short-Term
=450  \\$wnnna$aCurricula
=450  \\$wnnna$aShort-Term Course
=450  \\$wnnna$aShort-Term Courses
=450  \\$wnnna$aShort Term Courses
=550  \\$wg$aEducation
=550  \\$wh$aCompetency-Based Education
=550  \\$wh$aInterdisciplinary Studies
=550  \\$wh$aMainstreaming, Education
=550  \\$wh$aProblem-Based Learning
=680  \\$iA course of study offered by an educational institution.
=688  \\$a66
=750  \0$aCurriculum planning$5IEN$0(DLC)sh 85034895

=LDR  00876cz  a2200229n  4500
=001  9880363283102441
=005  20141212200405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003476
=035  \\$aCAZ6618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x175
=072  \\$aD1.$x268.$x271.$x100.$x175
=072  \\$aD1.$x268.$x556.$x200
=072  \\$aD1.$x552.$x20.$x272
=072  \\$aD1.$x552.$x544.$x200
=150  \\$aCurium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iA radioactive actinide with atomic symbol Cm, atomic number 96, and atomic weight 247. Thirteen curium isotopes have been produced with mass numbers ranging from 238-250. Its valence can be +3 or +4. It is intensely radioactive and decays by alpha-emission.
=750  \0$aCurium$5IEN$0(DLC)sh 85034863

=LDR  00957cz  a2200205n  4500
=001  9880363283202441
=005  20141212200405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003475
=035  \\$aCAZ6617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x157
=150  \\$aCurettage
=450  \\$wnnna$aCurettages
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aDilatation and Curettage
=667  \\$aof any cavity but note DILATATION AND CURETTAGE for cervix & endometrium; do not use /util except by MeSH definition; gingival curettage = SUBGINGIVAL CURETTAGE
=680  \\$iA scraping, usually of the interior of a cavity or tract, for removal of new growth or other abnormal tissue, or to obtain material for tissue diagnosis. It is performed with a curet (curette), a spoon-shaped instrument designed for that purpose. (From Stedman, 25th ed & Dorland, 27th ed)
=688  \\$a65(64)
=750  \0$aCurettes$5IEN$0(DLC)sh 85034852

=LDR  01941cz  a2200625n  4500
=001  9880363283302441
=005  20201118173857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003386
=035  \\$aCAZ6534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x190.$x110
=150  \\$aBrachyura
=450  \\$aBlue Crab
=450  \\$wnnna$aBlue Crabs
=450  \\$wnnna$aBrachyuras
=450  \\$aCallinectes sapidus
=450  \\$wnnna$aCarcinus maena
=450  \\$aCarcinus maenas
=450  \\$wnnna$aCommon Shore Crab
=450  \\$wnnna$aCommon Shore Crabs
=450  \\$aCrab, Blue
=450  \\$aCrab, Common Shore
=450  \\$wnnna$aCrab, European Shore
=450  \\$aCrab, Green
=450  \\$wnnna$aCrab, Short-Tailed
=450  \\$wnnna$aCrab, True
=450  \\$wnno$aCrabs$5IEN-HS
=450  \\$wnnna$aCrabs, Blue
=450  \\$wnnna$aCrabs, Common Shore
=450  \\$wnnna$aCrabs, Green
=450  \\$aCrabs, Short-Tailed
=450  \\$wnnna$aCrabs, Short Tailed
=450  \\$aCrabs, True
=450  \\$wnnna$aEuropean Shore Crab
=450  \\$aGreen Crab
=450  \\$wnnna$aGreen Crabs
=450  \\$wnnna$amaena, Carcinus
=450  \\$wnnna$amaenas, Carcinus
=450  \\$wnnna$asapidus, Callinectes
=450  \\$wnnna$aShore Crab, Common
=450  \\$wnnna$aShore Crab, European
=450  \\$wnnna$aShore Crabs, Common
=450  \\$wnnna$aShort-Tailed Crab
=450  \\$wnnna$aShort-Tailed Crabs
=450  \\$wnnna$aTrue Crab
=450  \\$wnnna$aTrue Crabs
=450  \\$aUca
=450  \\$wnnna$aUcas
=550  \\$wg$aDecapoda
=550  \\$aShellfish
=667  \\$aas animal & food; IM; as food, coord IM with SHELLFISH (IM)
=680  \\$iAn infraorder of chiefly marine, largely carnivorous CRUSTACEA, in the order DECAPODA, including the genera Cancer, Uca, and Callinectes.
=688  \\$a2003 (1972)
=750  \0$aCrabs$5IEN$0(DLC)sh 85033701

=LDR  01988cz  a2200337n  4500
=001  9880363283402441
=005  20141212200405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003473
=035  \\$aCAZ6615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x700.$x710.$x575
=150  \\$aNeuromuscular Nondepolarizing Agents
=450  \\$wnnna$aAgents, Curare-Like
=450  \\$wnnna$aAgents, Neuromuscular Nondepolarizing
=450  \\$wnnna$aBlockers, Nondepolarizing
=450  \\$aCurare-Like Agents
=450  \\$wnnna$aCurare Like Agents
=450  \\$aCurariform Drugs
=450  \\$wnnna$aDrugs, Curariform
=450  \\$aMuscle Relaxants, Non-Depolarizing
=450  \\$wnnna$aMuscle Relaxants, Non Depolarizing
=450  \\$aNeuromuscular Blocking Agents, Competitive
=450  \\$wnnna$aNon-Depolarizing Muscle Relaxants
=450  \\$wnnna$aNondepolarizing Agents, Neuromuscular
=450  \\$wnnna$aNondepolarizing Blockers
=550  \\$wg$aNeuromuscular Blocking Agents
=667  \\$aGEN or unspecified; prefer specifics; note X ref CURARE-LIKE AGENTS: consider also CURARE; DF: note short X ref
=680  \\$iDrugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.
=688  \\$a93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS & PACHYCURARES were see CURARE-LIKE AGENTS 1975-92; CURARIFORM DRUGS was see under MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS & MUSCLE RELAXANTS, CENTRAL & NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69
=750  \0$aCurare-like agents$5IEN$0(DLC)sh 85034842

=LDR  01183cz  a2200277n  4500
=001  9880363283502441
=005  20141212200336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003384
=035  \\$aCAZ6532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x359.$x213
=150  \\$aCoxsackievirus Infections
=450  \\$wnnna$aCoxsackie Virus Infection
=450  \\$wnnna$aCoxsackie Virus Infections
=450  \\$wnnna$aCoxsackievirus Infection
=450  \\$wnnna$aInfections, Coxsackie Virus
=450  \\$wnnna$aInfections, Coxsackievirus
=550  \\$wg$aEnterovirus Infections
=550  \\$wh$aConjunctivitis, Acute Hemorrhagic
=550  \\$wh$aHand, Foot and Mouth Disease
=550  \\$wh$aHerpangina
=550  \\$wh$aPleurodynia, Epidemic
=680  \\$iA heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS.
=688  \\$a79; was COXSACKIE VIRUS INFECTIONS 1963-78
=750  \0$aCoxsackievirus infections$5IEN$0(DLC)sh 88000752

=LDR  00804cz  a2200181n  4500
=001  9880363283602441
=005  20141212200404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003472
=035  \\$aCAZ6614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x200
=150  \\$aCurare
=550  \\$wg$aPlant Extracts
=667  \\$a/analogs: consider also CURARE-LIKE AGENTS see NEUROMUSCULAR NONDEPOLARIZING AGENTS
=680  \\$iPlant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.
=688  \\$aCURARIFORM ANTAGONISTS was heading 1963-69
=750  \0$aCurare$5IEN$0(DLC)sh 85034841

=LDR  00735cz  a2200181n  4500
=001  9880363283702441
=005  20141212200335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003381
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x297.$x150
=072  \\$aB3.$x660.$x250.$x132.$x150
=150  \\$aCoxiella
=550  \\$wg$aCoxiellaceae
=550  \\$wh$aCoxiella burnetii
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, rod-shaped bacteria that is widely distributed in TICKS and various mammals throughout the world. Infection with this genus is particularly prevalent in CATTLE; SHEEP; and GOATS.
=750  \0$aCoxiella$5IEN$0(DLC)sh 88023247

=LDR  01093cz  a2200241n  4500
=001  9880363283802441
=005  20141212200403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003470
=035  \\$aCAZ6612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x470.$x305
=072  \\$aE7.$x206
=150  \\$aCulture Media
=450  \\$wnnna$aMedia, Culture
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aLaboratory Chemicals
=550  \\$wh$aCulture Media, Conditioned
=550  \\$wh$aCulture Media, Serum-Free
=550  \\$wh$aTissue Scaffolds
=550  \\$aBacteriological Techniques
=680  \\$iAny liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
=750  \0$aCulture media (Biology)$5IEN$0(DLC)sh 85034761

=LDR  00540cz  a2200193n  4500
=001  9880363283902441
=005  20141212200335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003380
=035  \\$aCAZ6528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x279
=150  \\$aCourtship
=450  \\$wnnna$aCourtships
=550  \\$wg$aSexual Behavior
=550  \\$aLove
=667  \\$ahuman & animal
=680  \\$iActivities designed to attract the attention or favors of another.
=750  \0$aCourtship$5IEN$0(DLC)sh 85033596

=LDR  01725cz  a2200529n  4500
=001  9880363284102441
=005  20200616144736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003469
=035  \\$aCAZ6611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450
=072  \\$aI1.$x880.$x853.$x100
=150  \\$aCulture
=450  \\$wnnna$aBackground, Cultural
=450  \\$wnnna$aBackgrounds, Cultural
=450  \\$wnnna$aBelief
=450  \\$wnnna$aBeliefs
=450  \\$wnnna$aCultural Background
=450  \\$wnnna$aCultural Backgrounds
=450  \\$wnnna$aCultures
=450  \\$wnnna$aCustom
=450  \\$aCustoms
=550  \\$wg$aAnthropology, Cultural
=550  \\$wg$aSociological Factors
=550  \\$wh$aAcculturation
=550  \\$wh$aCeremonial Behavior
=550  \\$wh$aCircumcision, Female
=550  \\$wh$aCivilization
=550  \\$wh$aCross-Cultural Comparison
=550  \\$wh$aCultural Characteristics
=550  \\$wh$aCultural Competency
=550  \\$wh$aCultural Deprivation
=550  \\$wh$aCultural Diversity
=550  \\$wh$aCultural Evolution
=550  \\$wh$aEthnology
=550  \\$wh$aFolklore
=550  \\$wh$aFuneral Rites
=550  \\$wh$aHuman Body
=550  \\$wh$aMedicine, Traditional
=550  \\$wh$aPopular Culture
=550  \\$wh$aPsychosocial Deprivation
=550  \\$wh$aSuperstitions
=550  \\$wh$aTaboo
=667  \\$anot for microbial or tissue cultures; no qualif; subhead with coord is probably /ethnol
=680  \\$iA collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language.
=750  \0$aCulture$5IEN$0(DLC)sh 85034755

=LDR  00938cz  a2200241n  4500
=001  9880363284202441
=005  20141212200334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003377
=035  \\$aCAZ6525M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x181.$x400.$x555
=072  \\$aE5.$x196.$x278
=150  \\$aCountercurrent Distribution
=450  \\$aChromatography, Countercurrent
=450  \\$aCountercurrent Chromatography
=450  \\$wnnna$aDistribution, Countercurrent
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aChromatography, Liquid
=667  \\$aNIM
=680  \\$iA method of separation of two or more substances by repeated distribution between two immiscible liquid phases that move past each other in opposite directions. It is a form of liquid-liquid chromatography. (Stedman, 25th ed)
=688  \\$a67(64)
=750  \0$aCountercurrent chromatography$0(DLC) sh 88000872$5IEN-M

=LDR  00724cz  a2200217n  4500
=001  9880363284302441
=005  20141212200333.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003375
=035  \\$aCAZ6524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x400.$x187
=072  \\$aD3.$x438.$x150.$x446.$x350
=072  \\$aD3.$x830.$x219.$x266.$x450.$x400.$x187
=072  \\$aD3.$x830.$x219.$x446.$x350
=150  \\$aCoumestrol
=550  \\$wg$aCoumarins
=550  \\$wg$aIsoflavones
=680  \\$iA daidzein derivative occurring naturally in forage crops which has some estrogenic activity.
=688  \\$a91(75); was see under COUMARINS 1975-90
=750  \0$aCoumestrol$5IEN$0(DLC)sh 85033406

=LDR  00751cz  a2200217n  4500
=001  9880363284402441
=005  20141212200403.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003468
=035  \\$aCAZ6610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x370
=150  \\$aCultural Evolution
=450  \\$wnnna$aCultural Evolutions
=450  \\$wnnna$aEvolution, Cultural
=450  \\$wnnna$aEvolutions, Cultural
=450  \\$aSocial Evolution$5IEN
=550  \\$wg$aCulture
=680  \\$iThe continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities.
=688  \\$a91(78); was see under CULTURE 1978-90
=750  \0$aSocial evolution$5IEN-HS$0(DLC)sh 85123940

=LDR  01115cz  a2200277n  4500
=001  9880363284502441
=005  20141212192123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003467
=035  \\$aCAZ6609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x100.$x400
=150  \\$aCultural Deprivation
=450  \\$wnnna$aCultural Deprivations
=450  \\$aCultural Disadvantagement
=450  \\$wnnna$aCultural Disadvantagements
=450  \\$wnnna$aDeprivation, Cultural
=450  \\$wnnna$aDeprivations, Cultural
=450  \\$wnnna$aDisadvantagement, Cultural
=450  \\$wnnna$aDisadvantagements, Cultural
=550  \\$wg$aCulture
=550  \\$aPoverty
=667  \\$ano qualif
=680  \\$iThe absence of certain expected and acceptable cultural phenomena in the environment which results in the failure of the individual to communicate and respond in the most appropriate manner within the context of society. Language acquisition and language use are commonly used in assessing this concept.
=688  \\$a68
=750  \0$aPeople with social disabilities$5IEN$0(DLC)sh 85124155

=LDR  00777cz  a2200181n  4500
=001  9880363284602441
=005  20141212200403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003465
=035  \\$aCAZ6607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x275.$x225
=150  \\$aCulex
=450  \\$wnnna$aCulices
=550  \\$wg$aCulicidae
=667  \\$amosquito: do not confuse with CULICOIDES, gnat; do not use /drug eff for insecticides: TN 111; /microbiol /parasitol /virol permitted
=680  \\$iA genus of mosquitoes (CULICIDAE) commonly found in tropical regions. Species of this genus are vectors for ST. LOUIS ENCEPHALITIS as well as many other diseases of man and domestic and wild animals.
=750  \0$aCulex$5IEN$0(DLC)sh 85034703

=LDR  01343cz  a2200433n  4500
=001  9880363284702441
=005  20141212192122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003374
=035  \\$aCAZ6523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x446
=072  \\$aD3.$x830.$x219.$x446
=150  \\$aCoumarins
=450  \\$wnnna$a1,2-Benzo-Pyrones
=450  \\$wnnna$a1,2 Benzo Pyrones
=450  \\$wnnna$a1,2-Benzopyrone Derviatives
=450  \\$wnnna$a1,2 Benzopyrone Derviatives
=450  \\$a1,2-Benzopyrones
=450  \\$wnnna$a1,2 Benzopyrones
=450  \\$wnnna$aBenzopyran-2-ones
=450  \\$wnnna$aBenzopyran 2 ones
=450  \\$wnnna$aCoumarin Derivatives
=450  \\$wnnna$aCoumarines
=450  \\$wnnna$aDerivatives, Coumarin
=450  \\$wnnna$aDerviatives, 1,2-Benzopyrone
=550  \\$wg$aBenzopyrans
=550  \\$wh$a4-Hydroxycoumarins
=550  \\$wh$aAminocoumarins
=550  \\$wh$aChromonar
=550  \\$wh$aCoumestrol
=550  \\$wh$aEsculin
=550  \\$wh$aFurocoumarins
=550  \\$wh$aIsocoumarins
=550  \\$wh$aPyranocoumarins
=550  \\$wh$aUmbelliferones
=550  \\$aPyrones
=680  \\$iSynthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid.
=750  \0$aCoumarins$5IEN$0(DLC)sh 85033405

=LDR  00899cz  a2200241n  4500
=001  9880363284802441
=005  20141212200402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003461
=035  \\$aCAZ6603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x309
=072  \\$aH1.$x181.$x529.$x240
=150  \\$aCrystallography
=450  \\$wnnna$aCrystallographies
=550  \\$wg$aChemistry, Physical
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aNeutron Diffraction
=550  \\$wh$aPowder Diffraction
=550  \\$wh$aX-Ray Diffraction
=667  \\$aNIM; coord with crystalline substance (IM or NIM); DF: CRYSTALLOGR
=680  \\$iThe branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aCrystallography$5IEN$0(DLC)sh 85034498

=LDR  00819cz  a2200241n  4500
=001  9880363284902441
=005  20141212200332.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003370
=035  \\$aCAZ6520M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350.$x650.$x350
=150  \\$aCoturnix
=450  \\$wnnna$aCoturnix japonica
=450  \\$aJapanese Quail
=450  \\$wnnna$aJapanese Quails
=450  \\$wnnna$aQuail, Japanese
=450  \\$wnnna$aQuails, Japanese
=550  \\$wg$aQuail
=667  \\$adiseases: coord IM with BIRD DISEASES (IM)
=680  \\$iA genus of BIRDS in the family Phasianidae, order GALLIFORMES, containing the common European and other Old World QUAIL.
=688  \\$a91(75); was see under QUAIL 1975-90
=750  \0$aCoturnix$5IEN-M$0(DLC)n  80111287

=LDR  01149cz  a2200325n  4500
=001  9880363285002441
=005  20141212200332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003369
=035  \\$aCAZ6519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x380
=072  \\$aD10.$x212.$x507.$x350
=072  \\$aD10.$x627.$x700.$x263
=072  \\$aD20.$x215.$x784.$x750.$x263
=072  \\$aJ2.$x500.$x375.$x400.$x300
=150  \\$aCottonseed Oil
=450  \\$aCottonseed
=450  \\$wnnna$aCottonseed Oils
=450  \\$wnnna$aCottonseeds
=450  \\$wnnna$aOil, Cottonseed
=450  \\$wnnna$aOils, Cottonseed
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=550  \\$aGossypol
=680  \\$iOil obtained from the seeds of Gossypium herbaceum L., the cotton plant. It is used in dietary products such as oleomargarine and many cooking oils. Cottonseed oil is commonly used in soaps and cosmetics.
=688  \\$a87; was COTTONSEED 1963-86
=750  \0$aCottonseed$5IEN-M$0(DLC)sh 85033362
=750  \0$aCottonseed oil$5IEN-HS$0(DLC)sh 85033369

=LDR  01529cz  a2200409n  4500
=001  9880363285102441
=005  20170628111554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003460
=035  \\$aCAZ6602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x300
=072  \\$aG2.$x171
=150  \\$aCrystallization
=450  \\$wnnna$aCrystal Growth
=450  \\$wnnna$aCrystal, Polymorphic
=450  \\$wnnna$aCrystalline Polymorph
=450  \\$aCrystalline Polymorphs
=450  \\$wnnna$aCrystallization Polymorphism
=450  \\$wnnna$aCrystallization Polymorphisms
=450  \\$wnnna$aCrystals, Polymorphic
=450  \\$wnnna$aGrowth, Crystal
=450  \\$wnnna$aPolymorph, Crystalline
=450  \\$wnnna$aPolymorphic Crystal
=450  \\$wnnna$aPolymorphic Crystals
=450  \\$aPolymorphism, Crystallization
=450  \\$wnnna$aPolymorphisms, Crystallization
=450  \\$wnnna$aPolymorphs, Crystalline
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$aPhase Transition
=550  \\$aTransition Temperature
=667  \\$ado not confuse with genetic, protein and other polymorphs; NIM; no qualif; coordinate NIM with substance being crystallized (IM or NIM)
=680  \\$iThe formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a66(64)
=750  \0$aCrystals$5IEN-M$0(DLC)sh 85034503
=750  \0$aCrystallization$5IEN-HS$0(DLC)sh 85034495

=LDR  01228cz  a2200265n  4500
=001  9880363285202441
=005  20141212200332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003368
=035  \\$aCAZ6518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x700.$x244
=150  \\$aGossypium
=450  \\$wnnoa$aCotton$5IEN-HS
=450  \\$aCotton Plant
=450  \\$wnnna$aCotton Plants
=450  \\$wnnna$aGossypiums
=450  \\$wnnna$aPlant, Cotton
=450  \\$wnnna$aPlants, Cotton
=550  \\$wg$aMalvaceae
=550  \\$aCotton Fiber
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29; X ref COTTON PLANT; COTTON FIBER is also available for textile fiber
=680  \\$iA plant genus of the family MALVACEAE. It is the source of COTTON FIBER; COTTONSEED OIL, which is used for cooking, and GOSSYPOL. The economically important cotton crop is a major user of agricultural PESTICIDES.
=688  \\$a2003(1963)
=750  \0$aCotton$5IEN$0(DLC)sh 85033302

=LDR  00791cz  a2200205n  4500
=001  9880363285302441
=005  20141212200401.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003458
=035  \\$aCAZ6600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x150.$x160
=150  \\$aCryptosporidium
=450  \\$wnnna$aCryptosporidiums
=550  \\$wg$aCryptosporidiidae
=550  \\$wh$aCryptosporidium parvum
=667  \\$ainfection = CRYPTOSPORIDIOSIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of coccidian parasites of the family CRYPTOSPORIDIIDAE, found in the intestinal epithelium of many vertebrates including humans.
=688  \\$a1991(1985)
=750  \0$aCryptosporidium$5IEN$0(DLC)sh 91004854

=LDR  00665cz  a2200181n  4500
=001  9880363285402441
=005  20141212200331.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003367
=035  \\$aCAZ6517M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x773.$x812.$x180
=150  \\$aCotinine
=450  \\$wnnna$aScotine
=550  \\$wg$aPyrrolidinones
=680  \\$iThe N-glucuronide conjugate of cotinine is a major urinary metabolite of NICOTINE. It thus serves as a biomarker of exposure to tobacco SMOKING. It has CNS stimulating properties.
=688  \\$a91(75); was see under PYRROLIDINONES 1975-90
=750  \0$aCotinine$0(DLC)sh2006007411$5IEN-M

=LDR  00883cz  a2200265n  4500
=001  9880363285502441
=005  20141212200401.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003457
=035  \\$aCAZ6599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x432.$x269
=072  \\$aC3.$x701.$x688.$x235
=072  \\$aC3.$x752.$x250.$x269
=072  \\$aC3.$x752.$x625.$x235
=072  \\$aC6.$x405.$x469.$x452.$x269
=072  \\$aC22.$x674.$x710.$x235
=150  \\$aCryptosporidiosis
=450  \\$wnnna$aCryptosporidioses
=550  \\$wg$aCoccidiosis
=550  \\$wg$aIntestinal Diseases, Parasitic
=550  \\$wg$aProtozoan Infections, Animal
=680  \\$iIntestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA.
=688  \\$a1985
=750  \0$aCryptosporidiosis$5IEN$0(DLC)sh 90000929

=LDR  01562cz  a2200385n  4500
=001  9880363285602441
=005  20141212200400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003456
=035  \\$aCAZ6598HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x829.$x258
=072  \\$aC12.$x706.$x258
=072  \\$aC16.$x131.$x939.$x258
=072  \\$aC19.$x391.$x829.$x258
=150  \\$aCryptorchidism
=450  \\$wnnna$aAbdominal Cryptorchidism
=450  \\$wnnna$aBilateral Cryptorchidism
=450  \\$wnnna$aCryptorchidism, Abdominal
=450  \\$wnnna$aCryptorchidism, Bilateral
=450  \\$wnnna$aCryptorchidism, Inguinal
=450  \\$wnnna$aCryptorchidism, Unilateral
=450  \\$wnnna$aCryptorchidism, Unilateral Or Bilateral
=450  \\$wnnna$aCryptorchism
=450  \\$wnnna$aInguinal Cryptorchidism
=450  \\$wnnna$aTestes, Undescended
=450  \\$aTestis, Undescended
=450  \\$wnnna$aUndescended Testes
=450  \\$wnnna$aUndescended Testis
=450  \\$wnnna$aUnilateral Cryptorchidism
=550  \\$wg$aTesticular Diseases
=550  \\$wg$aUrogenital Abnormalities
=680  \\$iA developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis.
=688  \\$a95; was CRYPTORCHISM 1963-94
=750  \0$aCryptorchism$5IEN$0(DLC)sh 85034467

=LDR  01758cz  a2200541n  4500
=001  9880363285702441
=005  20141212192121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003365
=035  \\$aCAZ6515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151
=150  \\$aCosts and Cost Analysis
=450  \\$wnnna$aAnalyses, Cost
=450  \\$wnnna$aAnalyses, Cost-Minimization
=450  \\$wnnna$aAnalysis, Cost
=450  \\$wnnna$aAnalysis, Cost-Minimization
=450  \\$wnnna$aComparison, Cost
=450  \\$wnnna$aComparisons, Cost
=450  \\$wnnna$aCost
=450  \\$wnnna$aCost Analyses
=450  \\$wnnna$aCost Analysis
=450  \\$wnnna$aCost Comparison
=450  \\$wnnna$aCost Comparisons
=450  \\$wnnna$aCost, Cost Analysis
=450  \\$wnnna$aCost Measure
=450  \\$wnnna$aCost Measures
=450  \\$wnnna$aCost-Minimization Analyses
=450  \\$wnnna$aCost-Minimization Analysis
=450  \\$wnnna$aCost Minimization Analysis
=450  \\$wnnna$aCosts
=450  \\$wnnna$aCosts and Cost Analyses
=450  \\$wnnna$aCosts, Cost Analysis
=450  \\$wnnna$aMeasure, Cost
=450  \\$wnnna$aMeasures, Cost
=450  \\$wnnna$aPricing
=550  \\$wg$aEconomics
=550  \\$wh$aCost Allocation
=550  \\$wh$aCost-Benefit Analysis
=550  \\$wh$aCost Control
=550  \\$wh$aCost of Illness
=550  \\$wh$aCost Sharing
=550  \\$wh$aHealth Care Costs
=550  \\$wh$aHealth Expenditures
=680  \\$iAbsolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.
=688  \\$a66
=750  \0$aCost$5IEN-M$0(DLC)sh 85033192
=750  \0$aPricing$5IEN-HS$0(DLC)sh 85106617

=LDR  00833cz  a2200241n  4500
=001  9880363285802441
=005  20141212200400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003455
=035  \\$aCAZ6597M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x258.$x366
=072  \\$aB1.$x300.$x930.$x316.$x366
=150  \\$aCryptococcus neoformans
=450  \\$wnnna$aCryptococcus neoforman
=450  \\$wnnna$aCryptococcus neoformans var. grubii
=450  \\$wnnna$aneoforman, Cryptococcus
=450  \\$wnnna$aneoformans, Cryptococcus
=550  \\$wg$aCryptococcus
=667  \\$ainfection: coordinate IM with CRYPTOCOCCOSIS (IM)
=680  \\$iA species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans.
=688  \\$a91(72)
=750  \0$aCryptococcus neoformans$0(DLC) sh 88022039$5IEN-M

=LDR  00800cz  a2200241n  4500
=001  9880363285902441
=005  20141212200359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003454
=035  \\$aCAZ6596HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x258
=072  \\$aB1.$x300.$x930.$x316
=150  \\$aCryptococcus
=450  \\$aTorula
=450  \\$wnnna$aTorulas
=550  \\$wg$aMitosporic Fungi
=550  \\$wg$aYeasts
=550  \\$wh$aCryptococcus gattii
=550  \\$wh$aCryptococcus neoformans
=667  \\$ainfection = CRYPTOCOCCOSIS
=680  \\$iA mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.
=750  \0$aCryptococcus$5IEN-HS$0(DLC)sh 85034444

=LDR  01128cz  a2200277n  4500
=001  9880363286002441
=005  20141212200330.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003363
=035  \\$aCAZ6513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x160
=150  \\$aCost Control
=450  \\$wnnna$aContainment, Cost
=450  \\$wnnna$aContainments, Cost
=450  \\$wnnna$aControl, Cost
=450  \\$wnnna$aControls, Cost
=450  \\$aCost Containment
=450  \\$wnnna$aCost Containments
=450  \\$wnnna$aCost Controls
=550  \\$wg$aCosts and Cost Analysis
=550  \\$wh$aCost Savings
=667  \\$aNIM
=680  \\$iThe containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)
=688  \\$a80(79); was see under COSTS AND COST ANALYSIS 1979
=750  \0$aCost control$5IEN$0(DLC)sh 85033196

=LDR  00609cz  a2200217n  4500
=001  9880363286102441
=005  20141212200359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003453
=035  \\$aCAZ6595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x248
=150  \\$aCryptococcosis
=450  \\$wnnna$aCryptococcoses
=450  \\$wnnna$aToruloses
=450  \\$aTorulosis
=550  \\$wg$aMycoses
=550  \\$wh$aMeningitis, Cryptococcal
=667  \\$afungus dis
=680  \\$iInfection with a fungus of the species CRYPTOCOCCUS NEOFORMANS.
=750  \0$aTorulosis$5IEN$0(DLC)sh 85136196

=LDR  00860cz  a2200241n  4500
=001  9880363286202441
=005  20141212200359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003452
=035  \\$aCAZ6594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x14.$x180
=150  \\$aCryosurgery
=450  \\$aCryoablation
=450  \\$wnnna$aCryoablations
=450  \\$wnnna$aCryosurgeries
=550  \\$wg$aAblation Techniques
=550  \\$aCold Temperature
=550  \\$aFreezing
=667  \\$acoordinate with organ or disease /surg; differentiate from HYPOTHERMIA, INDUCED for cooling of organs during surgery
=680  \\$iThe use of freezing as a special surgical technique to destroy or excise tissue.
=688  \\$a84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1964-83 (Prov 1964-66)
=750  \0$aCryosurgery$5IEN$0(DLC)sh 85034425

=LDR  00728cz  a2200193n  4500
=001  9880363286302441
=005  20141212200358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003450
=035  \\$aCAZ6592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x900.$x225
=072  \\$aD12.$x776.$x124.$x790.$x651.$x900.$x225
=072  \\$aD12.$x776.$x377.$x715.$x548.$x900.$x225
=150  \\$aCryoglobulins
=450  \\$wnnna$aCryoproteins
=550  \\$wg$aParaproteins
=680  \\$iAbnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.
=750  \0$aCryoglobulins$5IEN$0(DLC)sh 86003067

=LDR  00906cz  a2200229n  4500
=001  9880363286402441
=005  20141212200358.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003449
=035  \\$aCAZ6591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x454.$x140
=072  \\$aC15.$x378.$x147.$x780.$x243
=072  \\$aC15.$x378.$x463.$x515.$x140
=072  \\$aC20.$x683.$x780.$x250
=150  \\$aCryoglobulinemia
=450  \\$wnnna$aCryoglobulinemias
=550  \\$wg$aHemostatic Disorders
=550  \\$wg$aParaproteinemias
=680  \\$iA condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
=688  \\$a85(82); was see under PARAPROTEINEMIAS 1982-84
=750  \0$aCryoglobulinemia$5IEN$0(DLC)sh 86003088

=LDR  00646cz  a2200205n  4500
=001  9880363286502441
=005  20141212200358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003448
=035  \\$aCAZ6590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530.$x258
=072  \\$aF1.$x525.$x200.$x310.$x300
=150  \\$aCrying
=450  \\$wnnna$aCryings
=550  \\$wg$aLanguage Development
=550  \\$wg$aNonverbal Communication
=680  \\$iTo utter an inarticulate, characteristic sound in order to communicate or express a feeling, or desire for attention.
=688  \\$a70
=750  \0$aCrying$5IEN$0(DLC)sh 85034408

=LDR  02151cz  a2200541n  4500
=001  9880363286602441
=005  20141212192121.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003362
=035  \\$aCAZ6512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x125
=150  \\$aCost-Benefit Analysis
=450  \\$wnnna$aAnalyses, Cost Benefit
=450  \\$wnnna$aAnalyses, Cost-Benefit
=450  \\$wnnna$aAnalyses, Cost-Utility
=450  \\$wnnna$aAnalyses, Marginal
=450  \\$wnnna$aAnalysis, Cost Benefit
=450  \\$wnnna$aAnalysis, Cost-Benefit
=450  \\$wnnna$aAnalysis, Cost-Effectiveness
=450  \\$wnnna$aAnalysis, Cost-Utility
=450  \\$wnnna$aAnalysis, Marginal
=450  \\$wnnna$aBenefits and Costs
=450  \\$wnnna$aCost Benefit
=450  \\$wnnna$aCost Benefit Analyses
=450  \\$wnnna$aCost-Benefit Analyses
=450  \\$wnnna$aCost Benefit Analysis
=450  \\$aCost-Benefit Data
=450  \\$wnnna$aCost Benefit Data
=450  \\$aCost Effectiveness
=450  \\$wnnna$aCost-Effectiveness Analysis
=450  \\$wnnna$aCost Effectiveness Analysis
=450  \\$wnnna$aCost-Utility Analyses
=450  \\$wnnna$aCost-Utility Analysis
=450  \\$wnnna$aCost Utility Analysis
=450  \\$wnnna$aCosts and Benefits
=450  \\$wnnna$aData, Cost-Benefit
=450  \\$wnnna$aEconomic Evaluation
=450  \\$wnnna$aEconomic Evaluations
=450  \\$wnnna$aEffectiveness, Cost
=450  \\$wnnna$aEvaluation, Economic
=450  \\$wnnna$aEvaluations, Economic
=450  \\$wnnna$aMarginal Analyses
=450  \\$wnnna$aMarginal Analysis
=550  \\$wg$aCosts and Cost Analysis
=680  \\$iA method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
=688  \\$a76
=750  \0$aCost effectiveness$5IEN-M$0(DLC)sh 85033197

=LDR  00438cz  a2200145n  4500
=001  9880363286702441
=005  20141212200358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x281
=150  \\$aCrutches
=550  \\$wg$aOrthopedic Equipment
=680  \\$iWooden or metal staffs designed to aid a person in walking. (UMDNS,1999)
=750  \0$aCrutches$5IEN$0(DLC)sh 85034406

=LDR  01126cz  a2200229n  4500
=001  9880363286802441
=005  20180403124556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003444
=035  \\$aCAZ6587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$a26$x257.$x500
=072  \\$aC26.$x797.$x240
=150  \\$aCrush Syndrome
=450  \\$wnnna$aCrush Syndromes
=450  \\$wnnna$aSyndrome, Crush
=450  \\$wnnna$aSyndromes, Crush
=550  \\$wg$aCrush Injuries
=550  \\$wg$aShock, Traumatic
=680  \\$iSevere systemic manifestation of trauma and ischemia involving soft tissues, principally skeletal muscle, due to prolonged severe crushing. It leads to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia.
=688  \\$a91(75); was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE RENAL FAILURE 1963-66
=750  \0$aCrush syndrome$5IEN-M$0(DLC)sh 97000617

=LDR  03057cz  a2200733n  4500
=001  9880364024302441
=005  20141212192643.0
=008  890706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015596
=035  \\$aCBD0639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x585
=072  \\$aN5.$x715.$x360.$x300.$x560
=072  \\$aN6.$x850.$x505.$x557
=072  \\$aN6.$x850.$x520.$x308.$x585
=150  \\$aNutrition Assessment
=450  \\$wnnna$aAssessment, Mini Nutrition
=450  \\$wnnna$aAssessment, Mini Nutritional
=450  \\$wnnna$aAssessment, Nutrition
=450  \\$wnnna$aAssessment, Nutritional
=450  \\$wnnna$aAssessments, Mini Nutrition
=450  \\$wnnna$aAssessments, Mini Nutritional
=450  \\$wnnna$aAssessments, Nutrition
=450  \\$wnnna$aAssessments, Nutritional
=450  \\$wnnna$aIndex, Nutrition
=450  \\$wnnna$aIndex, Nutritional
=450  \\$wnnna$aIndex, Prognostic Nutritional
=450  \\$wnnna$aIndex, Prognostic Nutritional (PNI)
=450  \\$wnnna$aIndexes, Nutrition
=450  \\$wnnna$aIndices, Nutrition
=450  \\$wnnna$aIndices, Nutritional
=450  \\$wnnna$aIndices, Prognostic Nutritional
=450  \\$wnnna$aIndices, Prognostic Nutritional (PNI)
=450  \\$wnnna$aMini Nutrition Assessment
=450  \\$wnnna$aMini Nutrition Assessments
=450  \\$wnnna$aMini Nutritional Assessment
=450  \\$wnnna$aMini Nutritional Assessments
=450  \\$wnnna$aNutrition Assessment, Mini
=450  \\$wnnna$aNutrition Assessments
=450  \\$wnnna$aNutrition Assessments, Mini
=450  \\$wnnna$aNutrition Index
=450  \\$wnnna$aNutrition Indexes
=450  \\$wnnna$aNutrition Indices
=450  \\$wnnna$aNutritional Assessment
=450  \\$wnnna$aNutritional Assessment, Mini
=450  \\$wnnna$aNutritional Assessments
=450  \\$wnnna$aNutritional Assessments, Mini
=450  \\$wnnna$aNutritional Index
=450  \\$wnnna$aNutritional Index, Prognostic
=450  \\$wnnna$aNutritional Index, Prognostic (PNI)
=450  \\$wnnna$aNutritional Indices
=450  \\$wnnna$aNutritional Indices, Prognostic
=450  \\$wnnna$aNutritional Indices, Prognostic (PNI)
=450  \\$wnnna$aPrognostic Nutritional Index
=450  \\$aPrognostic Nutritional Index (PNI)
=450  \\$wnnna$aPrognostic Nutritional Indices
=450  \\$wnnna$aPrognostic Nutritional Indices (PNI)
=550  \\$wg$aData Collection
=550  \\$wg$aEpidemiologic Measurements
=667  \\$ado not confuse with NUTRITION SURVEYS: survey refers to a population in a given geographic area, assessment refers to an individual; coordinate with GERIATRIC ASSESSMENT if relevant
=680  \\$iEvaluation and measurement of nutritional variables in order to assess the level of nutrition or the NUTRITIONAL STATUS of the individual. NUTRITION SURVEYS may be used in making the assessment.
=688  \\$a1990; for NUTRITION INDEXES use NUTRITION PHYSIOLOGY 1992-2006
=688  \\$a90
=750  \0$aNutrition$xEvaluation$5IEN$0(DLC)sh 85093452

=LDR  00885cz  a2200253n  4500
=001  9880364024402441
=005  20141212211123.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015595
=035  \\$aCBD0638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG13.$x750.$x829.$x826
=150  \\$aSkin Aging
=450  \\$wnnna$aAging, Skin
=450  \\$aPhotoaging of Skin
=450  \\$aSkin Wrinkling
=450  \\$wnnna$aSkin Wrinklings
=450  \\$aSolar Aging of Skin
=450  \\$wnnna$aWrinkling, Skin
=550  \\$wg$aSkin Physiological Processes
=550  \\$aAging
=680  \\$iThe process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.
=688  \\$a90
=750  \0$aSkin$xAging$5IEN$0(DLC)sh 85123165

=LDR  00977cz  a2200205n  4500
=001  9880364024502441
=005  20141212211122.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015591
=035  \\$aCBD0634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726.$x300
=072  \\$aE5.$x196.$x867.$x826.$x300
=150  \\$aMicrospectrophotometry
=450  \\$wnnna$aMicrospectrophotometries
=550  \\$wg$aSpectrophotometry
=667  \\$aa type of spectrum anal; NIM
=680  \\$iAnalytical technique for studying substances present at enzyme concentrations in single cells, in situ, by measuring light absorption. Light from a tungsten strip lamp or xenon arc dispersed by a grating monochromator illuminates the optical system of a microscope. The absorbance of light is measured (in nanometers) by comparing the difference between the image of the sample and a reference image.
=688  \\$a90
=750  \0$aMicrospectrophotometry$5IEN$0(DLC)sh 85084922

=LDR  00994cz  a2200301n  4500
=001  9880364024602441
=005  20141212211120.0
=008  890620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015577
=035  \\$aCBD0631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x225
=072  \\$aI1.$x240.$x425.$x350
=072  \\$aL1.$x280.$x360
=072  \\$aN1.$x224.$x425.$x350
=072  \\$aN5.$x715.$x360.$x300.$x360
=072  \\$aN6.$x850.$x505.$x400.$x425.$x350
=072  \\$aN6.$x850.$x520.$x308.$x225
=150  \\$aGeriatric Assessment
=450  \\$wnnna$aAssessment, Geriatric
=450  \\$wnnna$aAssessments, Geriatric
=450  \\$wnnna$aGeriatric Assessments
=550  \\$wg$aData Collection
=550  \\$wg$aHealth Status
=667  \\$aDF: GERIATRIC ASSESS
=680  \\$iEvaluation of the level of physical, physiological, or mental functioning in the older population group.
=688  \\$a90
=750  \0$aOlder people$xFunctional assessment$0(DLC)sh 88002556$5IEN-M

=LDR  00753cz  a2200241n  4500
=001  9880364024702441
=005  20141212211119.0
=008  890502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015551
=035  \\$aCBD0623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x192
=150  \\$aAutoimmunity
=450  \\$aAutoimmune Response
=450  \\$wnnna$aAutoimmune Responses
=450  \\$wnnna$aAutoimmunities
=550  \\$wg$aImmunity
=550  \\$wh$aPlant Immunity
=550  \\$aAutoantibodies
=550  \\$aAutoimmune Diseases
=680  \\$iProcess whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES.
=688  \\$a90
=750  \0$aAutoimmunity$5IEN$0(DLC)sh 87006465

=LDR  01908cz  a2200541n  4500
=001  9880364024802441
=005  20141212211118.0
=008  890619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015541
=035  \\$aCBD0617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x500.$x600
=150  \\$aOff-Road Motor Vehicles
=450  \\$wnnna$aAll-Terrain Vehicle
=450  \\$aAll-Terrain Vehicles
=450  \\$wnnna$aAll Terrain Vehicles
=450  \\$wnnna$aDirt-Bike
=450  \\$aDirt-Bikes
=450  \\$wnnna$aDirt Bikes
=450  \\$wnnna$aMinibike
=450  \\$aMinibikes
=450  \\$wnnna$aMotor Vehicle, Off-Road
=450  \\$aMotor Vehicles, Off-Road
=450  \\$wnnna$aMotor Vehicles, Off Road
=450  \\$wnnna$aMotorbike
=450  \\$aMotorbikes
=450  \\$wnnna$aOff-Road Motor Vehicle
=450  \\$wnnna$aOff Road Motor Vehicles
=450  \\$wnnna$aSnowmobile
=450  \\$aSnowmobiles
=450  \\$wnnna$aThree-Wheeled Vehicle
=450  \\$aThree-Wheeled Vehicles
=450  \\$wnnna$aThree Wheeled Vehicles
=450  \\$wnnna$aThree-Wheeler Vehicle
=450  \\$wnnna$aThree-Wheeler Vehicles
=450  \\$wnnna$aThree Wheeler Vehicles
=450  \\$wnnna$aVehicle, All-Terrain
=450  \\$wnnna$aVehicle, Three-Wheeled
=450  \\$wnnna$aVehicle, Three-Wheeler
=450  \\$wnnna$aVehicles, All-Terrain
=450  \\$wnnna$aVehicles, Three-Wheeled
=450  \\$wnnna$aVehicles, Three-Wheeler
=550  \\$wg$aMotor Vehicles
=550  \\$aMotorcycles
=667  \\$ado not confuse with MOTORCYCLES which are public-road vehicles
=680  \\$iMotorized, recreational vehicles used on non-public roads. They include all-terrain vehicles, dirt-bikes, minibikes, motorbikes, trailbikes, and snowmobiles. Excludes MOTORCYCLES, which are considered public road vehicles.
=688  \\$a90
=750  \0$aAll terrain vehicles$5IEN$0(DLC)sh 85003619

=LDR  01039cz  a2200265n  4500
=001  9880364024902441
=005  20141212211117.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015539
=035  \\$aCBD0616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x124.$x560.$x600
=150  \\$aPlatelet Activation
=450  \\$wnnna$aActivation, Platelet
=450  \\$wnnna$aActivations, Platelet
=450  \\$wnnna$aPlatelet Activations
=550  \\$wg$aHemostasis
=550  \\$wh$aClot Retraction
=550  \\$wh$aPlatelet Adhesiveness
=550  \\$wh$aPlatelet Aggregation
=550  \\$aBleeding Time
=550  \\$aBlood Platelets
=680  \\$iA series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
=688  \\$a90
=750  \0$aBlood platelets$xActivation$5IEN$0(DLC)sh 86008099

=LDR  00814cz  a2200241n  4500
=001  9880364025002441
=005  20170608152547.0
=008  890619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015538
=035  \\$aCBD0615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x595
=072  \\$aG2.$x607.$x598
=072  \\$aG3.$x558
=150  \\$aNitrosation
=450  \\$wnnna$aNitrosations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic nitrosation: coord NIM with NITRATES (IM) + substrate (NIM)
=680  \\$iConversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines.
=688  \\$a90
=750  \0$aNitrosation$5IEN$0(DLC)sh 85092090

=LDR  01269cz  a2200337n  4500
=001  9880364025102441
=005  20141212211116.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015535
=035  \\$aCBD0612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x853.$x625.$x800.$x424
=072  \\$aC5.$x550.$x114.$x145
=072  \\$aC5.$x550.$x114.$x865.$x800.$x424
=072  \\$aC17.$x800.$x859.$x675.$x175
=150  \\$aArthritis, Psoriatic
=450  \\$wnnna$aArthritic Psoriasis
=450  \\$wnnna$aArthropathies, Psoriatic
=450  \\$wnnna$aArthropathy, Psoriatic
=450  \\$aPsoriasis, Arthritic
=450  \\$aPsoriasis Arthropathica
=450  \\$wnnna$aPsoriatic Arthritis
=450  \\$wnnna$aPsoriatic Arthropathies
=450  \\$wnnna$aPsoriatic Arthropathy
=550  \\$wg$aArthritis
=550  \\$wg$aPsoriasis
=550  \\$wg$aSpondylarthropathies
=550  \\$aArthritis
=680  \\$iA type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
=688  \\$a90
=750  \0$aPsoriatic arthritis$5IEN$0(DLC)sh 85108335

=LDR  01146cz  a2200289n  4500
=001  9880364025202441
=005  20141212211114.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015530
=035  \\$aCBD0607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x700
=150  \\$aNuclear Matrix
=450  \\$wnnna$aMatrices, Nuclear
=450  \\$wnnna$aMatrix, Nuclear
=450  \\$wnnna$aNuclear Matrices
=450  \\$aNuclear Scaffold
=450  \\$wnnna$aNuclear Scaffolds
=450  \\$wnnna$aNucleoskeleton
=450  \\$wnnna$aNucleoskeletons
=450  \\$wnnna$aScaffold, Nuclear
=450  \\$wnnna$aScaffolds, Nuclear
=550  \\$wg$aIntranuclear Space
=550  \\$wh$aNuclear Lamina
=680  \\$iThe residual framework structure of the CELL NUCLEUS that maintains many of the overall architectural features of the cell nucleus including the nuclear lamina with NUCLEAR PORE complex structures, residual CELL NUCLEOLI and an extensive fibrogranular structure in the nuclear interior. (Advan. Enzyme Regul. 2002; 42:39-52)
=688  \\$a90
=750  \0$aNuclear matrix$5IEN-M$0(DLC)sh 93006896

=LDR  02615cz  a2200577n  4500
=001  9880364025302441
=005  20141212211112.0
=008  890721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015526
=035  \\$aCBD0604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x400.$x70
=072  \\$aC2.$x800.$x801.$x400.$x70
=072  \\$aC10.$x228.$x140.$x380.$x70
=072  \\$aC20.$x673.$x480.$x70
=072  \\$aF3.$x87.$x400.$x50
=150  \\$aAIDS Dementia Complex
=450  \\$wnnna$aAcquired-Immune Deficiency Syndrome Dementia Complex
=450  \\$wnnna$aAIDS Encephalopathies
=450  \\$aAIDS Encephalopathy
=450  \\$wnnna$aAIDS-Related Dementia Complex
=450  \\$wnnna$aAIDS Related Dementia Complex
=450  \\$wnnna$aComplex, AIDS Dementia
=450  \\$wnnna$aComplex, AIDS-Related Dementia
=450  \\$wnnna$aDementia Complex, Acquired Immune Deficiency Syndrome
=450  \\$wnnna$aDementia Complex, AIDS
=450  \\$aDementia Complex, AIDS-Related
=450  \\$wnnna$aDementia Complex, AIDS Related
=450  \\$wnnna$aDementia, HIV
=450  \\$wnnna$aDementias, HIV
=450  \\$wnnna$aEncephalopathies, AIDS
=450  \\$wnnna$aEncephalopathies, HIV
=450  \\$wnnna$aEncephalopathy, AIDS
=450  \\$wnnna$aEncephalopathy, HIV
=450  \\$aHIV-1-Associated Cognitive Motor Complex
=450  \\$wnnna$aHIV 1 Associated Cognitive Motor Complex
=450  \\$wnnna$aHIV-1 Cognitive and Motor Complex
=450  \\$wnnna$aHIV 1 Cognitive and Motor Complex
=450  \\$aHIV-Associated Cognitive Motor Complex
=450  \\$wnnna$aHIV Associated Cognitive Motor Complex
=450  \\$aHIV Dementia
=450  \\$wnnna$aHIV Dementias
=450  \\$wnnna$aHIV Encephalopathies
=450  \\$aHIV Encephalopathy
=550  \\$wg$aDementia
=550  \\$wg$aHIV Infections
=550  \\$aAcquired Immunodeficiency Syndrome
=667  \\$acoord IM with HIV-1 or HIV-2 (IM or NIM) if pertinent
=680  \\$iA neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)
=688  \\$a1990
=750  \0$aAIDS dementia complex$5IEN-M$0(DLC)sh 93006438

=LDR  01556cz  a2200385n  4500
=001  9880364025402441
=005  20141212211111.0
=008  890608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x410
=072  \\$aD10.$x251.$x355.$x337
=072  \\$aD10.$x627.$x430.$x450
=150  \\$aFatty Acids, Omega-3
=450  \\$wnnna$aAcids, Omega-3 Fatty
=450  \\$wnnna$aFatty Acids, n-3
=450  \\$wnnna$aFatty Acids, Omega 3
=450  \\$an-3 Fatty Acids
=450  \\$wnnna$an 3 Fatty Acids
=450  \\$wnnna$an-3 Polyunsaturated Fatty Acid
=450  \\$wnnna$an 3 Polyunsaturated Fatty Acid
=450  \\$wnnna$an-3 PUFA
=450  \\$aOmega-3 Fatty Acids
=450  \\$wnnna$aOmega 3 Fatty Acids
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wg$aFish Oils
=550  \\$wh$aalpha-Linolenic Acid
=550  \\$wh$aDocosahexaenoic Acids
=550  \\$wh$aEicosapentaenoic Acid
=667  \\$aspecify source if pertinent
=680  \\$iA group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness.
=688  \\$a1990; for n-3 POLYUNSATURATED FATTY ACID use PIKASOL (NM) 2000-2005
=688  \\$a90
=750  \0$aOmega-3 fatty acids$5IEN$0(DLC)sh 87001199

=LDR  00832cz  a2200229n  4500
=001  9880364025502441
=005  20141212211111.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015523
=035  \\$aCBD0601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x692.$x752.$x578
=072  \\$aC8.$x730.$x749.$x578
=072  \\$aC9.$x603.$x692.$x752.$x578
=150  \\$aMaxillary Sinusitis
=450  \\$wnnna$aMaxillary Sinusitides
=450  \\$wnnna$aSinusitides, Maxillary
=450  \\$aSinusitis, Maxillary
=550  \\$wg$aSinusitis
=680  \\$iInflammation of the NASAL MUCOSA in the MAXILLARY SINUS. In many cases, it is caused by an infection of the bacteria HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE; or STAPHYLOCOCCUS AUREUS.
=688  \\$a90
=750  \0$aMaxillary sinus$xDiseases$5IEN$0(DLC)sh 85082358

=LDR  00941cz  a2200265n  4500
=001  9880364025602441
=005  20141212211108.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015511
=035  \\$aCBD0593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x405
=150  \\$aGoat Diseases
=450  \\$wnnna$aCaprine Disease
=450  \\$wnnna$aCaprine Diseases
=450  \\$wnnna$aDisease, Caprine
=450  \\$wnnna$aDisease, Goat
=450  \\$wnnna$aDiseases, Caprine
=450  \\$wnnna$aDiseases, Goat
=450  \\$wnnna$aGoat Disease
=550  \\$wg$aAnimal Diseases
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM); for abnormalities or injuries, index under GOATS /abnorm or GOATS /inj; don't forget also GOATS (NIM) & check tag ANIMALS; DF: GOAT DIS
=680  \\$iDiseases of the domestic or wild goat of the genus Capra.
=688  \\$a90
=750  \0$aGoats$xDiseases$5IEN$0(DLC)sh 85055495

=LDR  00660cz  a2200217n  4500
=001  9880364025702441
=005  20160729112252.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015510
=035  \\$aCBD0592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x200
=150  \\$aClinical Medicine
=450  \\$wnnna$aMedicine, Clinical
=550  \\$wg$aMedicine
=550  \\$wh$aEvidence-Based Medicine
=550  \\$wh$aPrecision Medicine
=667  \\$aDF: CLIN MED
=680  \\$iThe study and practice of medicine by direct examination of the patient.
=688  \\$a90; was see MEDICINE 1986-89
=750  \0$aClinical medicine$5IEN$0(DLC)sh 85083129

=LDR  00778cz  a2200241n  4500
=001  9880364025802441
=005  20141212211108.0
=008  890901\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015509
=035  \\$aCBD0591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x200
=150  \\$aDevelopmental Biology
=450  \\$wnnna$aBiology, Developmental
=550  \\$wg$aBiology
=550  \\$wh$aEmbryology
=550  \\$wh$aPlant Pathology
=550  \\$aEmbryonic and Fetal Development
=550  \\$aGrowth and Development
=667  \\$aSPEC: SPEC qualif; DF: DEVELOPMENTAL BIOL
=680  \\$iThe field of biology which deals with the process of the growth and differentiation of an organism.
=688  \\$a90
=750  \0$aDevelopmental biology$5IEN$0(DLC)sh 85037352

=LDR  03746cz  a2200829n  4500
=001  9880364025902441
=005  20141212211106.0
=008  891004\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015502
=035  \\$aCBD0586M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x24
=072  \\$aE5.$x196.$x712.$x224.$x187
=150  \\$aAbsorptiometry, Photon
=450  \\$wnnna$aAbsorptiometries, DPX
=450  \\$wnnna$aAbsorptiometry, DPX
=450  \\$wnnna$aAbsorptiometry, Dual-Energy Radiographic
=450  \\$wnnna$aAbsorptiometry, Dual Energy Radiographic
=450  \\$wnnna$aAbsorptiometry, Dual-Energy X-Ray
=450  \\$wnnna$aAbsorptiometry, Dual Energy X Ray
=450  \\$wnnna$aAbsorptiometry, Dual-Photon
=450  \\$wnnna$aAbsorptiometry, Dual X-Ray
=450  \\$wnnna$aAbsorptiometry, Dual X Ray
=450  \\$wnnna$aAbsorptiometry, Single-Photon
=450  \\$aAbsorptiometry, X-Ray
=450  \\$wnnna$aAbsorptiometry, X Ray
=450  \\$wnnna$aDensitometry, X-Ray
=450  \\$wnnna$aDensitometry, X Ray
=450  \\$wnnna$aDensitometry, Xray
=450  \\$wnnna$aDEXA Scan
=450  \\$wnnna$aDEXA Scans
=450  \\$wnnna$aDPX Absorptiometry
=450  \\$wnnna$aDual-Energy Radiographic Absorptiometry
=450  \\$wnnna$aDual Energy Radiographic Absorptiometry
=450  \\$wnnna$aDual-Energy X-Ray Absorptiometry
=450  \\$wnnna$aDual Energy X Ray Absorptiometry
=450  \\$wnnna$aDual-Energy X-Ray Absorptiometry Scan
=450  \\$wnnna$aDual Energy X Ray Absorptiometry Scan
=450  \\$aDual-Photon Absorptiometry
=450  \\$wnnna$aDual Photon Absorptiometry
=450  \\$wnnna$aDual X-Ray Absorptiometry
=450  \\$wnnna$aDual X Ray Absorptiometry
=450  \\$wnnna$aDXA Scan
=450  \\$wnnna$aDXA Scans
=450  \\$aPhotodensitometry, X-Ray
=450  \\$wnnna$aPhotodensitometry, X Ray
=450  \\$aPhoton Absorptiometry
=450  \\$wnnna$aRadiographic Absorptiometry, Dual-Energy
=450  \\$wnnna$aRadiographic Absorptiometry, Dual Energy
=450  \\$wnnna$aScan, DEXA
=450  \\$wnnna$aScan, DXA
=450  \\$wnnna$aScans, DEXA
=450  \\$wnnna$aScans, DXA
=450  \\$aSingle-Photon Absorptiometry
=450  \\$wnnna$aSingle Photon Absorptiometry
=450  \\$aX-Ray Absorptiometry
=450  \\$wnnna$aX Ray Absorptiometry
=450  \\$wnnna$aX-Ray Absorptiometry, Dual
=450  \\$wnnna$aX-Ray Absorptiometry, Dual-Energy
=450  \\$wnnna$aX Ray Absorptiometry, Dual Energy
=450  \\$wnnna$aX-Ray Densitometry
=450  \\$wnnna$aX-Ray Photodensitometry
=450  \\$wnnna$aX Ray Photodensitometry
=450  \\$wnnna$aXray Densitometry
=550  \\$wg$aDensitometry
=550  \\$wg$aRadiography
=550  \\$aBone Density
=680  \\$iA noninvasive method for assessing BODY COMPOSITION. It is based on the differential absorption of X-RAYS (or GAMMA RAYS) by different tissues such as bone, fat and other soft tissues. The source of (X-ray or gamma-ray) photon beam is generated either from radioisotopes such as GADOLINIUM 153, IODINE 125, or Americanium 241 which emit GAMMA RAYS in the appropriate range; or from an X-ray tube which produces X-RAYS in the desired range. It is primarily used for quantitating BONE MINERAL CONTENT, especially for the diagnosis of OSTEOPOROSIS, and also in measuring BONE MINERALIZATION.
=688  \\$a90; was see RADIONUCLIDE IMAGING 1985-1989; for DUAL-ENERGY RADIOGRAPHIC ABSORPTIOMETRY use DENSITOMETRY, X-RAY
=688  \\$a90; was see RADIONUCLIDE IMAGING 1985-89
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Densitometry, X-Ray
=750  \0$aDual-energy X-ray absorptiometry$0(DLC)sh2010012892$5IEN-M

=LDR  00599cz  a2200193n  4500
=001  9880364026002441
=005  20141212200809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004231
=035  \\$aCBA8588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852.$x796.$x241
=150  \\$aDiuresis
=450  \\$wnnna$aDiureses
=550  \\$wg$aUrinary Tract Physiological Processes
=550  \\$wh$aNatriuresis
=550  \\$aKidney
=680  \\$iAn increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aDiuresis$5IEN$0(DLC)sh 85038565

=LDR  01012cz  a2200277n  4500
=001  9880364026102441
=005  20141212200800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004198
=035  \\$aCBA8587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x687
=072  \\$aG7.$x100.$x250
=150  \\$aDisease Susceptibility
=450  \\$wnnna$aDiatheses
=450  \\$aDiathesis
=450  \\$wnnna$aDisease Susceptibilities
=450  \\$wnnna$aSusceptibilities, Disease
=450  \\$wnnna$aSusceptibility, Disease
=550  \\$wg$aBody Constitution
=550  \\$wg$aDisease Attributes
=550  \\$wh$aGenetic Predisposition to Disease
=667  \\$aIM GEN only
=680  \\$iA constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
=688  \\$a81; was DIATHESIS 1963-80
=750  \0$aDisease susceptibility$5IEN$0(DLC)sh 85037625

=LDR  00497cz  a2200157n  4500
=001  9880364026202441
=005  20141212200715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004046
=035  \\$aCBA8585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x533.$x290
=150  \\$aDietetics
=550  \\$wg$aNutritional Sciences
=680  \\$iThe application of nutritional principles to regulation of the diet and feeding persons or groups of persons.
=750  \0$aDietetics$5IEN$0(DLC)sh 86005508

=LDR  00734cz  a2200241n  4500
=001  9880364026302441
=005  20141212200711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004036
=035  \\$aCBA8584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x263
=072  \\$aG7.$x610.$x240.$x242
=150  \\$aDiet, Atherogenic
=450  \\$wnnna$aAtherogenic Diet
=450  \\$wnnna$aAtherogenic Diets
=450  \\$wnnna$aDiets, Atherogenic
=550  \\$wg$aDiet
=550  \\$wg$aInvestigative Techniques
=550  \\$aArteriosclerosis
=680  \\$iA diet that contributes to the development and acceleration of ATHEROGENESIS.
=688  \\$a67
=750  \0$aArteriosclerosis$xNutritional aspects$5IEN-M$0(DLC)sh 85008112

=LDR  01595cz  a2200469n  4500
=001  9880364026402441
=005  20201124174913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004032
=035  \\$aCBA8583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x650.$x240
=150  \\$aDiet
=450  \\$wnnna$aDiets
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aDiet, Atherogenic
=550  \\$wh$aDiet, Carbohydrate Loading
=550  \\$wh$aDiet, Cariogenic
=550  \\$wh$aDiet, Diabetic
=550  \\$wh$aDiet Fads
=550  \\$wh$aDiet, Fat-Restricted
=550  \\$wh$aDiet, Gluten-Free
=550  \\$wh$aDiet, Healthy
=550  \\$wh$aDiet, High-Fat
=550  \\$wh$aDiet, High-Protein
=550  \\$wh$aDiet, Mediterranean
=550  \\$wh$aDiet, Paleolithic
=550  \\$wh$aDiet, Protein-Restricted
=550  \\$wh$aDiet, Reducing
=550  \\$wh$aDiet, Sodium-Restricted
=550  \\$wh$aDiet, Vegetarian
=550  \\$wh$aDiet, Western
=550  \\$wh$aDietary Approaches to Stop Hypertension
=550  \\$wh$aEnergy Intake
=550  \\$wh$aFasting
=550  \\$wh$aPortion Size
=550  \\$wh$aServing Size
=550  \\$aFood
=550  \\$aNutritional Physiological Phenomena
=667  \\$ageneral or unspecified; prefer specific diets; DIET THERAPY and specifics are also available; /trends: do not confuse with DIET FADS; in veterinary journals consider also ANIMAL FEED; SILAGE; etc.
=680  \\$iRegular course of eating and drinking adopted by a person or animal.
=750  \0$aDiet$0(DLC) sh 85037853$5IEN

=LDR  01478cz  a2200337n  4500
=001  9880364026502441
=005  20180814120243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003920
=035  \\$aCBA8582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x750
=072  \\$aC19.$x246
=150  \\$aDiabetes Mellitus
=450  \\$wnno$aObesity in Diabetes$5IEN-M
=550  \\$wg$aEndocrine System Diseases
=550  \\$wg$aGlucose Metabolism Disorders
=550  \\$wh$aDiabetes Complications
=550  \\$wh$aDiabetes, Gestational
=550  \\$wh$aDiabetes Mellitus, Experimental
=550  \\$wh$aDiabetes Mellitus, Type 1
=550  \\$wh$aDiabetes Mellitus, Type 2
=550  \\$wh$aDiabetic Ketoacidosis
=550  \\$wh$aDonohue Syndrome
=550  \\$wh$aLatent Autoimmune Diabetes in Adults
=550  \\$wh$aPrediabetic State
=550  \\$aDiabetes Insipidus
=550  \\$aGlucose Intolerance
=667  \\$aGEN or unspecified; prefer specifics; pregnancy of diabetic patients = PREGNANCY IN DIABETICS but do not confuse with DIABETES, GESTATIONAL: see note there; PREDIABETIC STATE is also available & includes subclinical diabetes; /diet ther: consider coord with DIABETIC DIET but see note there; alloxan- & streptozocin-induced diabetes: see note on DIABETES MELLITUS, EXPERIMENTAL
=680  \\$iA heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
=750  \0$aDiabetes$5IEN$0(DLC)sh 85037456

=LDR  00591cz  a2200181n  4500
=001  9880364026602441
=005  20180406091336.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003880
=035  \\$aCBA8581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x225
=150  \\$aDermatology
=550  \\$wg$aMedicine
=667  \\$aSPEC: SPEC qualif; DF: DERMATOL
=680  \\$iA medical specialty concerned with the skin, its structure, functions, diseases, and treatment.
=750  \0$aDermatology$5IEN$0(DLC)sh 85037090
=750  \0$aDermatology, Experimental$5IEN-HS$0(DLC)sh 85037094

=LDR  01311cz  a2200385n  4500
=001  9880364026702441
=005  20141212200614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003879
=035  \\$aCBA8580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x444
=150  \\$aDermatologic Agents
=450  \\$wnnna$aAgent, Dermatologic
=450  \\$wnnna$aAgent, Dermatological
=450  \\$wnnna$aAgents, Dermatologic
=450  \\$wnnna$aAgents, Dermatological
=450  \\$wnnna$aDermatologic Agent
=450  \\$wnnna$aDermatological Agent
=450  \\$wnnna$aDermatological Agents
=450  \\$aIchthammol$5IEN
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAntipruritics
=550  \\$wh$aAstringents
=550  \\$wh$aEmollients
=550  \\$wh$aKeratolytic Agents
=550  \\$wh$aPhotosensitizing Agents
=550  \\$wh$aSunscreening Agents
=550  \\$aSkin
=550  \\$aSkin Diseases
=667  \\$aGEN or unspecified; prefer specifics; consider also SKIN /drug eff & SKIN DISEASES /drug ther; DF: DERMATOL AGENTS
=680  \\$iDrugs used to treat or prevent skin disorders or for the routine care of skin.
=688  \\$a67
=750  \0$aDermatologic agents industry$5IEN-M$0(DLC)sh 85037087
=750  \0$aDermatologic agents$5IEN-HS$0(DLC)sh 85037086

=LDR  00943cz  a2200277n  4500
=001  9880364026802441
=005  20141212200556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003824
=035  \\$aCBA8579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760.$x290
=072  \\$aE7.$x695.$x190.$x200.$x205
=150  \\$aDenture, Complete
=450  \\$wnnna$aComplete Denture
=450  \\$wnnna$aComplete Dentures
=450  \\$wnnna$aDentures, Complete
=550  \\$wg$aDentures
=550  \\$wh$aDenture, Complete, Immediate
=550  \\$wh$aDenture, Complete, Lower
=550  \\$wh$aDenture, Complete, Upper
=550  \\$aMouth, Edentulous
=667  \\$alabeling for ownership or identification = DENTURE IDENTIFICATION MARKING
=680  \\$iA denture replacing all natural teeth and associated structures in both the maxilla and mandible.
=688  \\$a65
=750  \0$aComplete dentures$5IEN$0(DLC)sh 85029359

=LDR  00939cz  a2200229n  4500
=001  9880364026902441
=005  20141212200549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003804
=035  \\$aCBA8576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x900.$x280
=150  \\$aDentin
=450  \\$aDentine
=450  \\$wnnna$aDentines
=450  \\$wnnna$aDentins
=550  \\$wg$aTooth Components
=550  \\$wh$aDentin, Secondary
=550  \\$aOdontoblasts
=667  \\$a/embryol: consider also DENTINOGENESIS; reparative dentin = DENTIN, SECONDARY; dentin bridge = DENTIN, SECONDARY
=680  \\$iThe hard portion of the tooth surrounding the pulp, covered by enamel on the crown and cementum on the root, which is harder and denser than bone but softer than enamel, and is thus readily abraded when left unprotected. (From Jablonski, Dictionary of Dentistry, 1992)
=750  \0$aDentin$5IEN$0(DLC)sh 85036947

=LDR  01809cz  a2200433n  4500
=001  9880364027002441
=005  20141212200546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003794
=035  \\$aCBA8575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323.$x528
=072  \\$aE6.$x780.$x345.$x740
=072  \\$aE7.$x695.$x190.$x192
=150  \\$aDental Restoration, Temporary
=450  \\$wnnna$aDental Filling, Temporary
=450  \\$aDental Fillings, Temporary
=450  \\$wnnna$aDental Prostheses, Temporary
=450  \\$aDental Prosthesis, Temporary
=450  \\$wnnna$aDental Restorations, Temporary
=450  \\$wnnna$aFilling, Temporary Dental
=450  \\$wnnna$aFillings, Temporary Dental
=450  \\$wnnna$aProsthesis, Temporary Dental
=450  \\$wnnna$aRestoration, Temporary Dental
=450  \\$wnnna$aRestorations, Temporary Dental
=450  \\$wnnna$aTemporary Dental Filling
=450  \\$wnnna$aTemporary Dental Fillings
=450  \\$wnnna$aTemporary Dental Prostheses
=450  \\$wnnna$aTemporary Dental Prosthesis
=450  \\$wnnna$aTemporary Dental Restoration
=450  \\$wnnna$aTemporary Dental Restorations
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aDentistry, Operative
=550  \\$wh$aCrowns
=550  \\$aDental Prosthesis
=667  \\$adent restoration unspecified probably goes under DENTAL RESTORATION, PERMANENT; DF: DENT RESTORATION TEMPORARY
=680  \\$iA prosthesis or restoration placed for a limited period, from several days to several months, which is designed to seal the tooth and maintain its position until a permanent restoration (DENTAL RESTORATION, PERMANENT) will replace it. (From Jablonski, Dictionary of Dentistry, 1992)
=688  \\$a65
=750  \0$aFillings (Dentistry)$5IEN$0(DLC)sh 85048221

=LDR  01127cz  a2200337n  4500
=001  9880364027102441
=005  20141212200544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003788
=035  \\$aCBA8574HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x237
=150  \\$aDental Pulp Diseases
=450  \\$wnnna$aDental Pulp Disease
=450  \\$wnnna$aDisease, Dental Pulp
=450  \\$wnnna$aDiseases, Dental Pulp
=450  \\$wnnna$aPulp Disease, Dental
=450  \\$wnnna$aPulp Diseases, Dental
=550  \\$wg$aTooth Diseases
=550  \\$wh$aDental Pulp Calcification
=550  \\$wh$aDental Pulp Exposure
=550  \\$wh$aDental Pulp Necrosis
=550  \\$wh$aDentin, Secondary
=550  \\$wh$aPulpitis
=550  \\$wh$aTooth, Nonvital
=550  \\$aEndodontics
=550  \\$aPeriapical Diseases
=667  \\$ainflamm dis = PULPITIS; DF: DENT PULP DIS
=680  \\$iEndodontic diseases of the DENTAL PULP inside the tooth, which is distinguished from PERIAPICAL DISEASES of the tissue surrounding the root.
=688  \\$a65
=750  \0$aDental pulp$xDiseases$5IEN$0(DLC)sh 85036925

=LDR  01050cz  a2200289n  4500
=001  9880364027202441
=005  20141212200543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003785
=035  \\$aCBA8573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x397.$x370
=150  \\$aDental Pulp Capping
=450  \\$wnnna$aCapping, Dental Pulp
=450  \\$wnnna$aCapping, Pulp
=450  \\$wnnna$aCappings, Dental Pulp
=450  \\$wnnna$aCappings, Pulp
=450  \\$wnnna$aDental Pulp Cappings
=450  \\$aPulp Capping
=450  \\$wnnna$aPulp Capping, Dental
=450  \\$wnnna$aPulp Cappings
=450  \\$wnnna$aPulp Cappings, Dental
=550  \\$wg$aEndodontics
=667  \\$aDF: DENT PULP CAPPING
=680  \\$iApplication of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function.
=688  \\$a65
=750  \0$aDental pulp$xCapping$5IEN$0(DLC)sh 85036924

=LDR  00854cz  a2200205n  4500
=001  9880364027302441
=005  20141212200542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003782
=035  \\$aCBA8572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x900.$x260
=150  \\$aDental Pulp
=450  \\$wnnna$aDental Pulps
=450  \\$wnnna$aPulp, Dental
=450  \\$wnnna$aPulps, Dental
=550  \\$wg$aTooth Components
=667  \\$a/surg = PULPECTOMY or PULPOTOMY; inflammation = PULPITIS; DF: DENT PULP
=680  \\$iA richly vascularized and innervated connective tissue of mesodermal origin, contained in the central cavity of a tooth and delimited by the dentin, and having formative, nutritive, sensory, and protective functions. (Jablonski, Dictionary of Dentistry, 1992)
=750  \0$aDental pulp$5IEN$0(DLC)sh 85036923

=LDR  01391cz  a2200265n  4500
=001  9880364027402441
=005  20141212200540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003777
=035  \\$aCBA8571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x189
=072  \\$aE6.$x761.$x227
=150  \\$aDental Prophylaxis
=450  \\$wnnna$aProphylaxis, Dental
=550  \\$wg$aPeriodontics
=550  \\$wg$aPreventive Dentistry
=550  \\$wh$aDental Scaling
=550  \\$wh$aPeriodontal Debridement
=550  \\$aDental Calculus
=667  \\$aremoval of calculus & stains by dentist or hygienist: prev of calculus & stains by patient = DENTAL HYGIENE see ORAL HYGIENE or TOOTHBRUSHING or DENTAL DEVICES, HOME CARE; DF: DENT PROPHYLAXIS
=680  \\$iTreatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office using the procedures of DENTAL SCALING and DENTAL POLISHING. The treatment may include plaque detection, removal of supra- and subgingival plaque and calculus, application of caries-preventing agents, checking of restorations and prostheses and correcting overhanging margins and proximal contours of restorations, and checking for signs of food impaction.
=688  \\$a65
=750  \0$aDental hygiene$5IEN-M$0(DLC)sh 85036893
=750  \0$aDental prophylaxis$5IEN-HS$0(DLC)sh 85036918

=LDR  01507cz  a2200385n  4500
=001  9880364027502441
=005  20141212200537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003766
=035  \\$aCBA8570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x276
=072  \\$aG10.$x549.$x235.$x202
=150  \\$aDental Occlusion
=450  \\$aCanine Guidance
=450  \\$wnnna$aDental Occlusions
=450  \\$wnnna$aGuidance, Canine
=450  \\$wnnna$aGuidance, Occlusal
=450  \\$aOcclusal Guidance
=450  \\$wnnna$aOcclusal Guidances
=450  \\$aOcclusal Plane
=450  \\$wnnna$aOcclusal Planes
=450  \\$wnnna$aOcclusion, Dental
=450  \\$wnnna$aOcclusions, Dental
=450  \\$wnnna$aPlane, Occlusal
=450  \\$wnnna$aPlanes, Occlusal
=550  \\$wg$aDental Physiological Processes
=550  \\$wg$aDentistry
=550  \\$wh$aBite Force
=550  \\$wh$aDental Occlusion, Balanced
=550  \\$wh$aDental Occlusion, Centric
=667  \\$ano qualif; MALOCCLUSION & its specifics are also available; DF: DENT OCCLUSION
=680  \\$iThe relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472)
=688  \\$a65
=750  \0$aOcclusion (Dentistry)$5IEN$0(DLC)sh 85093815

=LDR  01353cz  a2200409n  4500
=001  9880364027602441
=005  20141212200537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003764
=035  \\$aCBA8569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339
=072  \\$aD27.$x720.$x102.$x339
=072  \\$aJ1.$x637.$x51.$x339
=150  \\$aDental Materials
=450  \\$wnnna$aDental Material
=450  \\$wnnna$aMaterial, Dental
=450  \\$wnnna$aMaterials, Dental
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wh$aDental Alloys
=550  \\$wh$aDental Casting Investment
=550  \\$wh$aDental Cements
=550  \\$wh$aDental Implants
=550  \\$wh$aDental Impression Materials
=550  \\$wh$aDental Porcelain
=550  \\$wh$aPhotoinitiators, Dental
=550  \\$wh$aPit and Fissure Sealants
=550  \\$wh$aPulp Capping and Pulpectomy Agents
=550  \\$wh$aResins, Synthetic
=550  \\$wh$aRoot Canal Filling Materials
=550  \\$aAcrylic Resins
=550  \\$aChromium Alloys
=550  \\$aDental Restoration, Permanent
=550  \\$aDental Restoration, Temporary
=667  \\$aD25-26 qualif; DF: DENT MATERIALS
=680  \\$iMaterials used in the production of dental bases, restorations, impressions, prostheses, etc.
=750  \0$aDental materials$5IEN$0(DLC)sh 85036905

=LDR  01460cz  a2200397n  4500
=001  9880364027702441
=005  20141212200524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003731
=035  \\$aCBA8567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x720.$x210
=150  \\$aDental Caries
=450  \\$aCaries, Dental
=450  \\$wnnna$aCarious Dentin
=450  \\$wnnna$aCarious Dentins
=450  \\$wnnna$aDecay, Dental
=450  \\$aDental Decay
=450  \\$wnnna$aDental White Spot
=450  \\$aDental White Spots
=450  \\$wnnna$aDentin, Carious
=450  \\$wnnna$aDentins, Carious
=450  \\$wnnna$aSpot, White
=450  \\$wnnna$aSpots, White
=450  \\$wnnna$aWhite Spot
=450  \\$wnnna$aWhite Spot, Dental
=450  \\$aWhite Spots
=450  \\$wnnna$aWhite Spots, Dental
=550  \\$wg$aTooth Demineralization
=550  \\$wh$aDental Fissures
=550  \\$wh$aRoot Caries
=550  \\$aTooth Demineralization
=667  \\$aDIET, CARIOGENIC, CARIOGENIC AGENTS, CARIOSTATIC AGENTS & DMF INDEX are also available
=680  \\$iLocalized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp.
=688  \\$aDENTAL CARIES CONTROL was heading 1965-66
=750  \0$aDental caries$5IEN$0(DLC)sh 85036872

=LDR  01136cz  a2200265n  4500
=001  9880364027802441
=005  20141212200524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003729
=035  \\$aCBA8566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x170
=072  \\$aN2.$x421.$x240.$x190
=150  \\$aDental Care
=450  \\$wnnna$aCare, Dental
=550  \\$wg$aDental Health Services
=550  \\$wg$aDentistry
=550  \\$wh$aDental Care for Aged
=550  \\$wh$aDental Care for Children
=550  \\$wh$aDental Care for Chronically Ill
=550  \\$wh$aDental Care for Disabled
=667  \\$a= professional care by a professional; ORAL HYGIENE = personal care by the subject himself; do not confuse with DENTISTRY: DENTISTRY is the dentist & the profession, DENTAL CARE is the patient & the care given him; GEN only: do not confuse with TOOTH DISEASES; DF: DENT CARE
=680  \\$iThe total of dental diagnostic, preventive, and restorative services provided to meet the needs of a patient (from Illustrated Dictionary of Dentistry, 1982).
=688  \\$a73
=750  \0$aDental care$5IEN$0(DLC)sh 85036869

=LDR  00942cz  a2200217n  4500
=001  9880364027902441
=005  20141212200509.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950.$x179
=072  \\$aC23.$x550.$x274
=150  \\$aDehydration
=450  \\$wnnna$aStress, Water
=450  \\$aWater Stress
=550  \\$wg$aPathologic Processes
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$aBody Fluids
=667  \\$adifferentiate from DESICCATION, a technique for removing moisture from matter; /ther: coord with ORAL REHYDRATION THERAPY see FLUID THERAPY if pertinent; do not use X ref WATER STRESS for water stress test: consider IMMERSION; permitted (NIM) with microorganisms, lower animals and plants
=680  \\$iThe condition that results from excessive loss of water from a living organism.
=750  \0$aDehydration (Physiology)$5IEN$0(DLC)sh 85036490

=LDR  00671cz  a2200205n  4500
=001  9880364028002441
=005  20141212192128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003672
=035  \\$aCBA8564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261.$x326.$x210
=150  \\$aDefecation
=450  \\$aDefecation Disorders$5IEN
=450  \\$wnnna$aDefecations
=550  \\$wg$aDigestive System Processes
=667  \\$ado not confuse with INTESTINAL ELIMINATION
=680  \\$iThe normal process of elimination of fecal material from the RECTUM.
=750  \0$aDefecation disorders$5IEN-M$0(DLC)sh 87001954
=750  \0$aDefecation$5IEN-HS$0(DLC)sh 85036416

=LDR  00706cz  a2200205n  4500
=001  9880364028102441
=005  20141212200458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003645
=035  \\$aCBA8563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x322
=150  \\$aDeath, Sudden
=450  \\$wnnna$aSudden Death
=550  \\$wg$aDeath
=550  \\$wh$aDeath, Sudden, Cardiac
=550  \\$wh$aSudden Infant Death
=667  \\$aDEATH, SUDDEN, CARDIAC is also available
=680  \\$iThe abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
=750  \0$aSudden death$5IEN$0(DLC)sh 85129615

=LDR  01463cz  a2200385n  4500
=001  9880364028202441
=005  20180315155547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003643
=035  \\$aCBA8562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260
=150  \\$aDeath
=360  \\$iconsider also terms at$aTHANATO-
=450  \\$wnnna$aCardiac Death
=450  \\$wnnna$aDeath, Cardiac
=450  \\$wnnna$aDetermination of Death
=450  \\$aNear-Death Experience
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAsphyxia
=550  \\$wh$aBody Remains
=550  \\$wh$aBrain Death
=550  \\$wh$aCadaver
=550  \\$wh$aDeath, Sudden
=550  \\$wh$aDrowning
=550  \\$wh$aEmbryo Loss
=550  \\$wh$aFetal Death
=550  \\$wh$aInfant Death
=550  \\$wh$aParental Death
=550  \\$wh$aPerinatal Death
=550  \\$aFatal Outcome
=550  \\$aThanatology
=667  \\$aIM; /mortal is available with Cat C, F, E; do not confuse with MORTALITY, a statist concept: DEATH is the biol or physiol, psychol concept; for theory, doctrine & philosophy of death THANATOLOGY is available; for death as a result of a dis or ther or diag procedure, FATAL OUTCOME is available: see note there
=680  \\$iIrreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.
=750  \0$aDeath$5IEN$0(DLC)sh 85036085

=LDR  01351cz  a2200385n  4500
=001  9880364028302441
=005  20141212200455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003638
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x341.$x186
=072  \\$aC10.$x597.$x751.$x418.$x341.$x186
=072  \\$aC23.$x888.$x592.$x763.$x393.$x341.$x186
=150  \\$aDeafness
=450  \\$wnnna$aAcquired Deafness
=450  \\$wnnna$aBilateral Deafness
=450  \\$wnnna$aComplete Hearing Loss
=450  \\$wnnna$aDeaf Mutism
=450  \\$wnnna$aDeaf-Mutism
=450  \\$wnnna$aDeafness, Acquired
=450  \\$wnnna$aDeafness, Bilateral
=450  \\$wnnna$aDeafness, Prelingual
=450  \\$wnnna$aExtreme Hearing Loss
=450  \\$wnnna$aHearing Loss, Complete
=450  \\$wnnna$aHearing Loss, Extreme
=450  \\$aPrelingual Deafness
=550  \\$wg$aHearing Loss
=550  \\$wh$aDeaf-Blind Disorders
=550  \\$aLipreading
=550  \\$aPersons With Hearing Impairments
=667  \\$adifferentiate from HEARING LOSS, BILATERAL; see various specific terms under HEARING LOSS
=680  \\$iA general term for the complete loss of the ability to hear from both ears.
=688  \\$aDEAF-MUTISM was heading 1963-79
=750  \0$aDeafness$5IEN-M$0(DLC)sh 85036068
=750  \0$aDeaf$5IEN-HS$0(DLC)sh 85036047

=LDR  00633cz  a2200205n  4500
=001  9880364028402441
=005  20141212200409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003491
=035  \\$aCBA8560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x283
=150  \\$aCybernetics
=450  \\$wnnna$aCybernetic
=550  \\$wg$aCommunication
=550  \\$wh$aFeedback
=550  \\$aBionics
=667  \\$aSPEC: SPEC qualif
=680  \\$iThat branch of learning which brings together theories and studies on communication and control in living organisms and machines.
=750  \0$aCybernetics$5IEN$0(DLC)sh 85035046

=LDR  01134cz  a2200337n  4500
=001  9880364028502441
=005  20201118174254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365
=150  \\$aCrustacea
=450  \\$wnnna$aCrustaceas
=450  \\$wnnna$aOstracod
=450  \\$aOstracoda
=450  \\$wnnna$aOstracodas
=450  \\$wnnna$aOstracods
=550  \\$wg$aArthropods
=550  \\$wh$aAmphipoda
=550  \\$wh$aAnostraca
=550  \\$wh$aArguloida
=550  \\$wh$aCladocera
=550  \\$wh$aCopepoda
=550  \\$wh$aDecapoda
=550  \\$wh$aEuphausiacea
=550  \\$wh$aIsopoda
=550  \\$wh$aPentastomida
=550  \\$wh$aThoracica
=667  \\$aas animal & food; IM; GEN or unspecified; prefer specifics; as food, coord IM with SHELLFISH (IM)
=680  \\$iA large subphylum of mostly marine ARTHROPODS containing over 42,000 species. They include familiar arthropods such as lobsters (NEPHROPIDAE), crabs (BRACHYURA), shrimp (PENAEIDAE), and barnacles (THORACICA).
=750  \0$aCrustacea$5IEN-M$0(DLC)sh 85034396

=LDR  01313cz  a2200325n  4500
=001  9880364028602441
=005  20141212200357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003442
=035  \\$aCBA8558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323.$x428.$x100
=072  \\$aE6.$x323.$x528.$x250
=072  \\$aE6.$x780.$x345.$x250
=072  \\$aE6.$x780.$x345.$x737.$x100
=072  \\$aE7.$x695.$x190.$x190.$x150
=150  \\$aCrowns
=450  \\$wnnna$aCrown
=450  \\$wnnna$aCrown, Dental
=450  \\$wnnna$aCrowns, Dental
=450  \\$wnnna$aDental Crown
=450  \\$aDental Crowns
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aDental Restoration, Permanent
=550  \\$wg$aDental Restoration, Temporary
=550  \\$wh$aPost and Core Technique
=667  \\$anote category: anatomical crown of tooth = TOOTH CROWN; do not confuse X ref DENTAL CROWNS with TOOTH CROWN
=680  \\$iA prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial (covering three or more surfaces of a tooth) or complete (covering all surfaces). It is made of gold or other metal, porcelain, or resin.
=688  \\$a65; CROWN AND BRIDGEWORK was heading 1963-64
=750  \0$aCrowns (Dentistry)$5IEN$0(DLC)sh 85034347

=LDR  00653cz  a2200217n  4500
=001  9880364028702441
=005  20141212200356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003441
=035  \\$aCBA8557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x875.$x281
=150  \\$aCrowding
=550  \\$wg$aSpatial Behavior
=550  \\$aPopulation Density
=550  \\$aStress, Psychological
=667  \\$ahuman & animal
=680  \\$iAn excessive number of individuals, human or animal, in relation to available space.
=688  \\$a68
=750  \0$aCrowding stress$5IEN-M$0(DLC)sh 85034331
=750  \0$aCrowds$5IEN-HS$0(DLC)sh 85034333

=LDR  01424cz  a2200373n  4500
=001  9880364028802441
=005  20141212200352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003428
=035  \\$aCBA8556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x248
=150  \\$aCross Infection
=450  \\$wnnna$aCross Infections
=450  \\$wnnna$aHospital Infection
=450  \\$aHospital Infections
=450  \\$wnnna$aInfection, Cross
=450  \\$wnnna$aInfection, Hospital
=450  \\$wnnna$aInfection, Nosocomial
=450  \\$wnnna$aInfections, Cross
=450  \\$wnnna$aInfections, Hospital
=450  \\$wnnna$aInfections, Nosocomial
=450  \\$wnnna$aNosocomial Infection
=450  \\$aNosocomial Infections
=550  \\$wg$aInfection
=550  \\$wh$aPneumonia, Ventilator-Associated
=550  \\$aCatheter-Related Infections
=550  \\$aCommunity-Acquired Infections
=550  \\$aStaphylococcal Infections
=667  \\$anote INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL and INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT are also available
=680  \\$iAny infection which a patient contracts in a health-care institution.
=688  \\$aHOSPITAL INFECTIONS was see under CROSS INFECTION 1971-78, was see CROSS INFECTIONS 1963-70
=750  \0$aNosocomial infections$5IEN-M$0(DLC)sh 85092770
=750  \0$aCross infection$5IEN-HS$0(DLC)sh 85034276

=LDR  02150cz  a2200421n  4500
=001  9880364028902441
=005  20141212210836.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015087
=035  \\$aCBA8444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x640.$x160
=150  \\$a2',3'-Cyclic-Nucleotide Phosphodiesterases
=450  \\$wnnna$a2',3'-Cyclic Nucleotide Phosphodiesterase
=450  \\$wnnna$a2,3-Cyclic Nucleotide Phosphodiesterase
=450  \\$wnnna$a2',3' Cyclic Nucleotide Phosphodiesterase
=450  \\$wnnna$a2,3 Cyclic Nucleotide Phosphodiesterase
=450  \\$wnnna$a2',3'-Cyclic Nucleotide Phosphodiesterases
=450  \\$wnnna$a2,3-Cyclic Nucleotide Phosphodiesterases
=450  \\$wnnna$a2',3' Cyclic Nucleotide Phosphodiesterases
=450  \\$wnnna$a2,3 Cyclic Nucleotide Phosphodiesterases
=450  \\$wnnna$aCNPase
=450  \\$aCyclic Nucleotide Phosphodiesterases$5IEN
=450  \\$wnnna$aNucleotide Phosphodiesterase, 2',3'-Cyclic
=450  \\$wnnna$aNucleotide Phosphodiesterase, 2,3-Cyclic
=450  \\$wnnna$aNucleotide Phosphodiesterases, 2',3'-Cyclic
=450  \\$wnnna$aNucleotide Phosphodiesterases, 2,3-Cyclic
=450  \\$wnnna$aPhosphodiesterase, 2',3'-Cyclic Nucleotide
=450  \\$wnnna$aPhosphodiesterase, 2,3-Cyclic Nucleotide
=450  \\$wnnna$aPhosphodiesterases, 2',3'-Cyclic Nucleotide
=450  \\$wnnna$aPhosphodiesterases, 2',3'-Cyclic-Nucleotide
=450  \\$wnnna$aPhosphodiesterases, 2,3-Cyclic Nucleotide
=550  \\$wg$aPhosphoric Diester Hydrolases
=550  \\$wh$a2',3'-Cyclic Nucleotide 3'-Phosphodiesterase
=667  \\$aDF: 2 3 CYCL NPD
=680  \\$iNucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.
=688  \\$a94; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2',3'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84
=750  \0$aCyclic nucleotide phosphodiesterases$0sh 90000406$5IEN

=LDR  00825cz  a2200217n  4500
=001  9880364029002441
=005  20200403105517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015085
=035  \\$aCBA8442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x800
=072  \\$aD2.$x241.$x511.$x316.$x682.$x800
=150  \\$a2,4,5-Trichlorophenoxyacetic Acid
=450  \\$a2,4,5-T
=450  \\$aTrichlorophenoxyacetic Acid$5IEN
=550  \\$wg$aPhenoxyacetates
=550  \\$wh$aAgent Orange
=680  \\$iAn herbicide with strong irritant properties. Use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. (From Merck Index, 11th ed)
=688  \\$a74(71)
=750  \0$aTrichlorophenoxyacetic acid$5IEN$0(DLC)sh 85137455

=LDR  01005cz  a2200277n  4500
=001  9880364029102441
=005  20141212210834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015084
=035  \\$aCBA8441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x224
=072  \\$aD2.$x241.$x511.$x316.$x682.$x149
=150  \\$a2,4-Dichlorophenoxyacetic Acid
=450  \\$a2,4-D
=450  \\$wnnna$a2,4 Dichlorophenoxyacetic Acid
=450  \\$wnnna$a2,4-Dichlorophenoxyacetic Acid, Ammonium Salt
=450  \\$wnnna$a2,4-Dichlorophenoxyacetic Acid, Lithium Salt
=450  \\$wnnna$a2,4-Dichlorophenoxyacetic Acid, Potassium Salt
=450  \\$wnnna$a2,4-Dichlorophenoxyacetic Acid, Sodium Salt
=450  \\$wnnna$aMonosan
=550  \\$wg$aPhenoxyacetates
=667  \\$aDF: note short X ref
=680  \\$iAn herbicide with irritant effects on the eye and the gastrointestinal system.
=688  \\$a73(71)
=750  \0$aDichlorophenoxyacetic acid$5IEN$0(DLC)sh 85037669

=LDR  01057cz  a2200337n  4500
=001  9880364029202441
=005  20141212210834.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x220
=150  \\$a2,2'-Dipyridyl
=450  \\$wnnna$a2,2'-Bipyridine
=450  \\$a2,2-Bipyridine
=450  \\$wnnna$a2,2 Bipyridine
=450  \\$wnnna$a2,2' Bipyridine
=450  \\$wnnna$a2,2-Bipyridyl
=450  \\$wnnna$a2,2 Bipyridyl
=450  \\$wnnna$a2,2 Dipyridyl
=450  \\$wnnna$a2,2' Dipyridyl
=450  \\$wnnna$a2,2-Dipyridyl
=450  \\$aalpha,alpha-Dipyridyl
=450  \\$wnnna$aalpha,alpha Dipyridyl
=450  \\$aBipyridyl
=450  \\$wnnna$aDipyridyl, 2,2
=450  \\$wnnna$aDipyridyl, 2,2'
=550  \\$wg$aPyridines
=667  \\$aDF: DIPYRIDYL
=680  \\$iA reagent used for the determination of iron.
=688  \\$a91(77); was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76
=750  \0$aBipyridine$5IEN$0(DLC)sh 85014275

=LDR  01665cz  a2200433n  4500
=001  9880364029302441
=005  20141212210831.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015073
=035  \\$aCBA8430HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x64.$x150
=072  \\$aD2.$x241.$x81.$x18.$x110.$x80
=072  \\$aD2.$x455.$x426.$x559.$x847.$x389.$x50
=072  \\$aD4.$x615.$x389.$x50
=150  \\$a2-Acetylaminofluorene
=450  \\$wnnna$a2-AAF
=450  \\$a2-Acetamidofluorene
=450  \\$wnnna$a2 Acetamidofluorene
=450  \\$wnnna$a2 Acetylaminofluorene
=450  \\$wnnna$a2-Fluorenylacetamide
=450  \\$wnnna$a2 Fluorenylacetamide
=450  \\$wnnna$aAAF, Aminofluorene
=450  \\$wnnna$aAcetylaminofluorene
=450  \\$wnnna$aAminofluorene AAF
=450  \\$aFluoren-2-ylacetamide
=450  \\$wnnna$aFluoren 2 ylacetamide
=450  \\$wnnna$aN-2-Fluorenylacetamide
=450  \\$wnnna$aN 2 Fluorenylacetamide
=450  \\$wnnna$aN-Acetyl-2-Aminofluorene
=450  \\$wnnna$aN Acetyl 2 Aminofluorene
=550  \\$wg$aAcetamides
=550  \\$wg$aFluorenes
=550  \\$wh$aAcetoxyacetylaminofluorene
=550  \\$wh$aHydroxyacetylaminofluorene
=667  \\$aD25-26 qualif
=680  \\$iA hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
=688  \\$a83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79
=750  \0$aAcetylaminofluorene$5IEN$0(DLC)sh 85000466

=LDR  00435cz  a2200169n  4500
=001  9880364029402441
=005  20141212210825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015054
=035  \\$aCBA8411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x365.$x89.$x750
=150  \\$aZymosan
=450  \\$wnnna$aA, Zymosan
=450  \\$wnnna$aZymosan A
=550  \\$wg$abeta-Glucans
=750  \0$aZymosan$5IEN$0(DLC)sh 85150091

=LDR  00799cz  a2200277n  4500
=001  9880364029502441
=005  20141212210825.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015053
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490.$x690.$x970
=072  \\$aA11.$x497.$x497.$x950
=072  \\$aA16.$x950
=150  \\$aZygote
=450  \\$wnnna$aEgg, Fertilized
=450  \\$wnnna$aEggs, Fertilized
=450  \\$wnnna$aFertilized Egg
=450  \\$wnnna$aFertilized Eggs
=450  \\$aFertilized Ovum
=450  \\$aOvum, Fertilized
=450  \\$wnnna$aZygotes
=550  \\$wg$aEmbryonic Structures
=550  \\$wg$aOvum
=680  \\$iThe fertilized OVUM resulting from the fusion of a male and a female gamete.
=688  \\$a75
=750  \0$aZygotes$5IEN$0(DLC)sh 85150089

=LDR  00667cz  a2200229n  4500
=001  9880364029602441
=005  20141212210825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015051
=035  \\$aCBA8408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x260.$x275.$x500.$x950
=072  \\$aC26.$x404.$x750.$x959
=150  \\$aZygomatic Fractures
=450  \\$wnnna$aFracture, Zygomatic
=450  \\$wnnna$aFractures, Zygomatic
=450  \\$wnnna$aZygomatic Fracture
=550  \\$wg$aMaxillofacial Injuries
=550  \\$wg$aSkull Fractures
=680  \\$iFractures of the zygoma.
=688  \\$a72(71)
=750  \0$aZygoma$xFractures$5IEN$0(DLC)sh 85150084

=LDR  00917cz  a2200337n  4500
=001  9880364029702441
=005  20141212210825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015050
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x995
=150  \\$aZygoma
=450  \\$wnnna$aArch, Zygomatic
=450  \\$wnnna$aArches, Zygomatic
=450  \\$wnnna$aBone, Cheek
=450  \\$wnnna$aBone, Jugal
=450  \\$wnnna$aBone, Malar
=450  \\$wnnna$aBones, Cheek
=450  \\$wnnna$aBones, Jugal
=450  \\$wnnna$aBones, Malar
=450  \\$aCheek Bone
=450  \\$wnnna$aCheek Bones
=450  \\$aJugal Bone
=450  \\$wnnna$aJugal Bones
=450  \\$aMalar Bone
=450  \\$wnnna$aMalar Bones
=450  \\$wnnna$aZygomas
=450  \\$aZygomatic Arch
=450  \\$wnnna$aZygomatic Arches
=550  \\$wg$aFacial Bones
=750  \0$aZygoma$5IEN$0(DLC)sh 85150083

=LDR  00573cz  a2200181n  4500
=001  9880364029802441
=005  20141212210824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015048
=035  \\$aCBA8405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80.$x500.$x980
=150  \\$aZooplankton
=550  \\$wg$aPlankton
=667  \\$alive in almost all natural waters
=680  \\$iMinute free-floating animal organisms which live in practically all natural waters.
=688  \\$a91(71); was see under PLANKTON 1971-90
=750  \0$aZooplankton$5IEN$0(DLC)sh 85150002

=LDR  01540cz  a2200445n  4500
=001  9880364029902441
=005  20141212210824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015047
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x908
=072  \\$aC2.$x968
=072  \\$aC3.$x908
=072  \\$aC22.$x969
=150  \\$aZoonoses
=450  \\$wnnna$aDisease, Zoonotic
=450  \\$wnnna$aDisease, Zoonotic Infectious
=450  \\$wnnna$aDiseases, Zoonotic
=450  \\$wnnna$aDiseases, Zoonotic Infectious
=450  \\$wnnna$aInfection, Zoonotic
=450  \\$wnnna$aInfections, Zoonotic
=450  \\$wnnna$aInfectious Disease, Zoonotic
=450  \\$wnnna$aInfectious Diseases, Zoonotic
=450  \\$wnnna$aZoonotic Disease
=450  \\$wnnna$aZoonotic Diseases
=450  \\$wnnna$aZoonotic Infection
=450  \\$wnnna$aZoonotic Infections
=450  \\$wnnna$aZoonotic Infectious Disease
=450  \\$wnnna$aZoonotic Infectious Diseases
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aBacterial Infections and Mycoses
=550  \\$wg$aParasitic Diseases
=550  \\$wg$aVirus Diseases
=550  \\$wh$aPythiosis
=550  \\$aCommunicable Diseases, Emerging
=550  \\$aDisease Reservoirs
=550  \\$aPublic Health
=667  \\$anot a routine coordinate for every zoonotic disease; index only when discussed
=680  \\$iDiseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.
=750  \0$aZoonoses$5IEN$0(DLC)sh 85150001

=LDR  00656cz  a2200205n  4500
=001  9880364030002441
=005  20141212210824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015046
=035  \\$aCBA8403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x943
=150  \\$aZoology
=450  \\$aZoologists$5IEN
=550  \\$wg$aBiology
=550  \\$wh$aEntomology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of animals - their morphology, growth, distribution, classification, and behavior.
=750  \0$aZoology$5IEN-M$0(DLC)sh 85149983
=750  \0$aZoologists$5IEN-HS$0(DLC)sh 85149982

=LDR  00682cz  a2200205n  4500
=001  9880364030102441
=005  20141212210823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015045
=035  \\$aCBA8402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x983
=072  \\$aB3.$x660.$x75.$x655.$x975
=150  \\$aZoogloea
=450  \\$wnnna$aZooglea
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wg$aRhodocyclaceae
=680  \\$iA genus of RHODOCYCLACEAE occurring as rod-shaped cells embedded in a gelatinous matrix. It includes Z. filipendula.
=688  \\$a79,63-65; was ZOOGLEA 1972-78
=750  \0$aZoogloea$5IEN$0(DLC)sh 88023366

=LDR  00737cz  a2200193n  4500
=001  9880364030202441
=005  20141212211020.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015385
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x71.$x140.$x970
=150  \\$aZona Reticularis
=450  \\$aAdrenal Reticularis
=450  \\$wnnna$aReticularis, Adrenal
=450  \\$wnnna$aReticularis, Zona
=550  \\$wg$aAdrenal Cortex
=680  \\$iThe inner zone of the adrenal cortex. This zone produces the enzymes that convert PREGNENOLONE, a 21-carbon steroid, to 19-carbon steroids (DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE) via 17-ALPHA-HYDROXYPREGNENOLONE.
=688  \\$a89
=750  \0$aZona reticularis$5IEN$0(DLC)sh 85149951

=LDR  00675cz  a2200205n  4500
=001  9880364030302441
=005  20141212210823.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015044
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490.$x690.$x950
=072  \\$aA11.$x284.$x295.$x310.$x990
=072  \\$aA11.$x497.$x497.$x900
=072  \\$aA16.$x690.$x900
=150  \\$aZona Pellucida
=550  \\$wg$aExtracellular Matrix
=550  \\$wg$aOvum
=680  \\$iA tough transparent membrane surrounding the OVUM. It is penetrated by the sperm during FERTILIZATION.
=688  \\$a91(75); was see under OVUM 1975-90
=750  \0$aZona pellucida$5IEN$0(DLC)sh 88007451

=LDR  01200cz  a2200313n  4500
=001  9880364030402441
=005  20141212210823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015043
=035  \\$aCBA8397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x730.$x713.$x988
=072  \\$aC6.$x301.$x371.$x883
=072  \\$aC6.$x405.$x249.$x883
=072  \\$aC6.$x405.$x469.$x965
=072  \\$aC6.$x405.$x608.$x924
=072  \\$aC6.$x405.$x748.$x947
=150  \\$aZollinger-Ellison Syndrome
=450  \\$wnnna$aSyndrome, Zollinger-Ellison
=450  \\$wnnna$aZollinger Ellison Syndrome
=550  \\$wg$aGastrointestinal Neoplasms
=550  \\$wg$aIntestinal Diseases
=550  \\$wg$aParaneoplastic Endocrine Syndromes
=550  \\$wg$aPeptic Ulcer
=550  \\$wg$aStomach Diseases
=550  \\$aGastrinoma
=550  \\$aPeptic Ulcer
=680  \\$iA syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.
=750  \0$aZollinger-Ellison syndrome$5IEN$0(DLC)sh 85149946

=LDR  00860cz  a2200229n  4500
=001  9880364030502441
=005  20141212210822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015040
=035  \\$aCBA8394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x950
=072  \\$aD1.$x268.$x956.$x937
=072  \\$aD1.$x552.$x544.$x950
=150  \\$aZirconium
=450  \\$aZirconium Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aZr-90; Zr-91, 92, 94, 96 = ZIRCONIUM (IM) + ISOTOPES (NIM); Zr-81-89, 93, 95, 97, 98 = ZIRCONIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iZirconium. A rather rare metallic element, atomic number 40, atomic weight 91.22, symbol Zr. (From Dorland, 28th ed)
=750  \0$aZirconium compounds$5IEN-M$0(DLC)sh 85149908
=750  \0$aZirconium$5IEN-HS$0(DLC)sh 85149899

=LDR  00863cz  a2200265n  4500
=001  9880364030602441
=005  20141212210821.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015034
=035  \\$aCBA8388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x650.$x550.$x975
=072  \\$aD1.$x975.$x975
=150  \\$aZinc Oxide
=450  \\$wnnna$aLassar Paste
=450  \\$wnnna$aLassar's Paste
=450  \\$wnnna$aLassars Paste
=450  \\$wnnna$aOxide, Zinc
=450  \\$wnnna$aPaste, Lassar's
=550  \\$wg$aOxides
=550  \\$wg$aZinc Compounds
=667  \\$aa dermatol agent
=680  \\$iA mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.
=688  \\$a91(75); was see under ZINC 1975-90
=750  \0$aZinc oxide$5IEN$0(DLC)sh 90003294

=LDR  00665cz  a2200205n  4500
=001  9880364030702441
=005  20141212210820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015033
=035  \\$aCBA8387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x966
=150  \\$aZinc Isotopes
=450  \\$wnnna$aIsotopes, Zinc
=550  \\$wg$aIsotopes
=550  \\$wh$aZinc Radioisotopes
=550  \\$aZinc
=667  \\$aZn-66, 67, 68, 70; NIM
=680  \\$iStable zinc atoms that have the same atomic number as the element zinc, but differ in atomic weight. Zn-66-68, and 70 are stable zinc isotopes.
=750  \0$aZinc$xIsotopes$5IEN-M$0(DLC)sh 85149846

=LDR  00857cz  a2200193n  4500
=001  9880364030802441
=005  20141212210820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015032
=035  \\$aCBA8386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x940
=072  \\$aD1.$x268.$x956.$x906
=072  \\$aD1.$x552.$x544.$x940
=150  \\$aZinc
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=680  \\$iA metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
=750  \0$aZinc$5IEN-M$0(DLC)sh 85149842

=LDR  01764cz  a2200385n  4500
=001  9880364030902441
=005  20141212210920.0
=008  880509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015215
=035  \\$aCBA8383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x705.$x950
=072  \\$aD13.$x570.$x230.$x500.$x950
=072  \\$aD13.$x570.$x230.$x855.$x950
=072  \\$aD13.$x570.$x685.$x705.$x950
=150  \\$aZidovudine
=450  \\$wnnna$a3'-Azido-2',3'-Dideoxythymidine
=450  \\$wnnna$a3' Azido 2',3' Dideoxythymidine
=450  \\$wnnna$a3'-Azido-3'-deoxythymidine
=450  \\$wnnna$a3' Azido 3' deoxythymidine
=450  \\$wnnna$aAntiviral AZT
=450  \\$aAzidothymidine
=450  \\$wnnna$aAZT Antiviral
=450  \\$wnnna$aAZT, Antiviral
=450  \\$aAZT (Antiviral)
=450  \\$wnnna$aBW A509U
=450  \\$wnnna$aBWA-509U
=450  \\$wnnna$aBWA 509U
=450  \\$wnnna$aBWA509U
=450  \\$wnnna$aRetrovir
=550  \\$wg$aDideoxynucleosides
=550  \\$wg$aThymidine
=680  \\$iA dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.
=688  \\$a89
=750  \0$aAZT (Drug)$5IEN$0(DLC)sh 89007049

=LDR  00827cz  a2200289n  4500
=001  9880364031002441
=005  20141212210819.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015029
=035  \\$aCBA8382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x852.$x900.$x975
=072  \\$aD2.$x540.$x950.$x975
=150  \\$aZeranol
=450  \\$aDihydroxyundecyl Resorcylic Acid Lactone
=450  \\$wnnna$aP-1496
=450  \\$wnnna$aP 1496
=450  \\$wnnna$aP1496
=450  \\$wnnna$aRalgro
=450  \\$wnnna$aRalone
=450  \\$wnnna$aXeranol
=450  \\$aZearalanol
=450  \\$wnnna$aZearanol
=550  \\$wg$aZearalenone
=680  \\$iA non-steroidal estrogen analog.
=688  \\$a91(75); was see under RESORCINOLS 1975-90
=750  \0$aZeranol$5IEN$0(DLC)sh 85149756

=LDR  00912cz  a2200241n  4500
=001  9880364031102441
=005  20141212210819.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015027
=035  \\$aCBA8379HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x200.$x244.$x828
=150  \\$aZebrafish
=450  \\$aBrachydanio rerio
=450  \\$aDanio rerio
=450  \\$wnnna$aZebra Danio
=450  \\$wnnna$aZebra Fish
=450  \\$wnnna$aZebrafishes
=550  \\$wg$aCyprinidae
=550  \\$aZebrafish Proteins
=680  \\$iAn exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.
=688  \\$a91(87); was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93
=750  \0$aZebra danio$5IEN$0(DLC)sh 85149694

=LDR  00692cz  a2200205n  4500
=001  9880364031202441
=005  20141212210817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015020
=035  \\$aCBA8372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x943
=150  \\$aYttrium Isotopes
=450  \\$wnnna$aIsotopes, Yttrium
=550  \\$wg$aIsotopes
=550  \\$wh$aYttrium Radioisotopes
=550  \\$aYttrium
=667  \\$aY-89; NIM
=680  \\$iStable yttrium atoms that have the same atomic number as the element yttrium, but differ in atomic weight. Y-89 is the only naturally occurring stable isotope of yttrium.
=750  \0$aYttrium$xIsotopes$5IEN$0(DLC)sh 85149411

=LDR  00816cz  a2200205n  4500
=001  9880364031302441
=005  20141212210817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015019
=035  \\$aCBA8371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x558.$x975
=072  \\$aD1.$x268.$x956.$x890
=072  \\$aD1.$x552.$x550.$x975
=150  \\$aYttrium
=550  \\$wg$aMetals, Rare Earth
=550  \\$wg$aTransition Elements
=667  \\$aa rare earth metal; Y-89
=680  \\$iAn element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers.
=750  \0$aYttrium$5IEN$0(DLC)sh 85149410

=LDR  00843cz  a2200193n  4500
=001  9880364031402441
=005  20141212210816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015018
=035  \\$aCBA8370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x992
=072  \\$aD1.$x268.$x558.$x362.$x992
=072  \\$aD1.$x552.$x550.$x399.$x992
=150  \\$aYtterbium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Yb-174; Yb-168, 170-173, 176 = YTTERBIUM (IM) + ISOTOPES (NIM); Yb-164-167, 169, 175, 177 = YTTERBIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iYtterbium. An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.
=750  \0$aYtterbium$5IEN$0(DLC)sh 85149406

=LDR  01254cz  a2200277n  4500
=001  9880364031502441
=005  20141212210816.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015017
=035  \\$aCBA8369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615.$x284.$x981
=072  \\$aA16.$x254.$x750.$x981
=072  \\$aA16.$x331.$x800
=150  \\$aYolk Sac
=450  \\$wnnna$aEmbryo Vitelline Sac
=450  \\$wnnna$aEmbryo Vitelline Sacs
=450  \\$wnnna$aSac, Yolk
=450  \\$wnnna$aSacs, Yolk
=450  \\$wnnna$aVitelline Sac of Embryo
=450  \\$wnnna$aYolk Sacs
=550  \\$wg$aEmbryo, Nonmammalian
=550  \\$wg$aExtraembryonic Membranes
=680  \\$iThe first of four extra-embryonic membranes to form during EMBRYOGENESIS. In REPTILES and BIRDS, it arises from endoderm and mesoderm to incorporate the EGG YOLK into the DIGESTIVE TRACT for nourishing the embryo. In placental MAMMALS, its nutritional function is vestigial; however, it is the source of INTESTINAL MUCOSA; BLOOD CELLS; and GERM CELLS. It is sometimes called the vitelline sac, which should not be confused with the VITELLINE MEMBRANE of the egg.
=688  \\$a78; was see VITELLINE MEMBRANE 1973-77
=750  \0$aYolk sac$5IEN$0(DLC)sh 85149208

=LDR  01752cz  a2200457n  4500
=001  9880364031602441
=005  20141212192634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015016
=035  \\$aCBA8368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x933
=072  \\$aD3.$x438.$x473.$x402.$x681.$x933
=150  \\$aYohimbine
=450  \\$wnnna$aAphrodine Hydrochloride
=450  \\$wnnna$aAphrodyne
=450  \\$wnnna$aAventis Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aCorynanthine
=450  \\$wnnna$aCorynanthine Tartrate
=450  \\$wnnna$aGlenwood Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aHydrochloride, Aphrodine
=450  \\$wnnna$aHydrochloride, Yohimbine
=450  \\$wnnna$aKramer Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aPalisades Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aPluriviron
=450  \\$wnnna$aRauhimbine
=450  \\$aRauwolscine
=450  \\$wnnna$aSolvay Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aStar Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aStegroPharm Brand of Yohimbine Hydrochloride
=450  \\$wnnna$aTartrate, Corynanthine
=450  \\$wnnna$aYocon
=450  \\$wnnna$aYohimbin Spiegel
=450  \\$wnnna$aYohimbine Houdé
=450  \\$wnnna$aYohimbine Hydrochloride
=450  \\$wnnna$aYohimex
=550  \\$wg$aSecologanin Tryptamine Alkaloids
=550  \\$wh$aReserpine
=680  \\$iA plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION.
=688  \\$aYOHIMBINE DERIVATIVES was see under YOHIMBINE 1975-77, was see under YOHIMBANS 1969-74
=750  \0$aYohimbine$5IEN$0(DLC)sh 85149195

=LDR  00625cz  a2200181n  4500
=001  9880364031702441
=005  20141212210816.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015014
=035  \\$aCBA8366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x350.$x525.$x221.$x888
=150  \\$aYogurt
=450  \\$aYoghurt
=550  \\$wg$aCultured Milk Products
=680  \\$iA slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus.
=688  \\$a91(78); was see under DAIRY PRODUCTS 1978-90
=750  \0$aYogurt$5IEN$0(DLC)sh 85149192

=LDR  00664cz  a2200193n  4500
=001  9880364031902441
=005  20141212210814.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015011
=035  \\$aCBA8363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x900.$x615
=072  \\$aB3.$x660.$x250.$x150.$x950.$x590
=150  \\$aYersinia pseudotuberculosis
=550  \\$wg$aYersinia
=667  \\$anote category; infect = YERSINIA PSEUDOTUBERCULOSIS INFECTIONS
=680  \\$iA human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and bacteremia.
=688  \\$a87
=750  \0$aYersinia pseudotuberculosis$5IEN$0(DLC)sh 88023365

=LDR  00656cz  a2200205n  4500
=001  9880364032002441
=005  20141212210814.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015010
=035  \\$aCBA8362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x900.$x600
=072  \\$aB3.$x660.$x250.$x150.$x950.$x580
=150  \\$aYersinia pestis
=450  \\$aPasteurella pestis
=550  \\$wg$aYersinia
=667  \\$ainfection = PLAGUE
=680  \\$iThe etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents.
=688  \\$a76; was PASTEURELLA PESTIS 1963-75
=750  \0$aYersinia pestis$5IEN$0(DLC)sh 88023364

=LDR  00852cz  a2200241n  4500
=001  9880364032102441
=005  20141212210814.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015009
=035  \\$aCBA8361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x980
=150  \\$aYersinia Infections
=450  \\$wnnna$aInfection, Yersinia
=450  \\$wnnna$aInfections, Yersinia
=450  \\$wnnna$aYersinia Infection
=550  \\$wg$aEnterobacteriaceae Infections
=550  \\$wh$aPlague
=550  \\$wh$aYersinia pseudotuberculosis Infections
=667  \\$agram-neg bact infect; Yersinia pestis infect = PLAGUE; Yersinia pseudotuberculosis infect = YERSINIA PSEUDOTUBERCULOSIS INFECTIONS
=680  \\$iInfections with bacteria of the genus YERSINIA.
=688  \\$a77
=750  \0$aYersinia infections$5IEN$0(DLC)sh 85149132

=LDR  00688cz  a2200193n  4500
=001  9880364032202441
=005  20141212210813.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015008
=035  \\$aCBA8360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x900.$x300
=072  \\$aB3.$x660.$x250.$x150.$x950.$x160
=150  \\$aYersinia enterocolitica
=550  \\$wg$aYersinia
=667  \\$ainfection: coord IM with YERSINIA INFECTIONS (IM)
=680  \\$iA species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children.
=688  \\$a83
=750  \0$aYersinia enterocolitica$5IEN$0(DLC)sh 85149131

=LDR  00867cz  a2200241n  4500
=001  9880364032302441
=005  20141212210813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015007
=035  \\$aCBA8359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x900
=072  \\$aB3.$x660.$x250.$x150.$x950
=150  \\$aYersinia
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aYersinia enterocolitica
=550  \\$wh$aYersinia pestis
=550  \\$wh$aYersinia pseudotuberculosis
=550  \\$wh$aYersinia ruckeri
=667  \\$ainfect = YERSINIA INFECTIONS but YERSINIA PESTIS infect = PLAGUE
=680  \\$iA genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.
=688  \\$a75; was see under PASTEURELLA 1972-74
=750  \0$aYersinia$5IEN$0(DLC)sh 88023363

=LDR  00893cz  a2200241n  4500
=001  9880364032402441
=005  20141212210812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015004
=035  \\$aCBA8356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x980
=072  \\$aC2.$x782.$x350.$x250.$x980
=072  \\$aC2.$x782.$x417.$x881
=150  \\$aYellow Fever
=450  \\$wnnna$aFever, Yellow
=450  \\$wnnna$aFevers, Yellow
=450  \\$wnnna$aYellow Fevers
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aFlavivirus Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=680  \\$iAn acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.
=750  \0$aYellow fever$5IEN$0(DLC)sh 85149092

=LDR  01534cz   2200481n  4500
=001  9880364032502441
=005  20220302164531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015003
=035  \\$aCBA8355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x930
=150  \\$aYeasts
=450  \\$wnnna$aYeast
=450  \\$aYeast Fungi$5IEN
=550  \\$wg$aFungi
=550  \\$wh$aBrettanomyces
=550  \\$wh$aCandida
=550  \\$wh$aCryptococcus
=550  \\$wh$aDebaryomyces
=550  \\$wh$aDekkera
=550  \\$wh$aDipodascus
=550  \\$wh$aEndomyces
=550  \\$wh$aEremothecium
=550  \\$wh$aHanseniaspora
=550  \\$wh$aKloeckera
=550  \\$wh$aKluyveromyces
=550  \\$wh$aLipomyces
=550  \\$wh$aMalassezia
=550  \\$wh$aMetschnikowia
=550  \\$wh$aPichia
=550  \\$wh$aRhodotorula
=550  \\$wh$aSaccharomyces
=550  \\$wh$aSaccharomycopsis
=550  \\$wh$aSchizosaccharomyces
=550  \\$wh$aTorulaspora
=550  \\$wh$aTrichosporon
=550  \\$wh$aWilliopsis
=550  \\$wh$aYarrowia
=550  \\$aFungal Proteins
=667  \\$anot for "yeast" ( = YEAST, DRIED; see note there); most "yeast infections" = CANDIDIASIS or specific but if general or unspecified yeast infect, index under MYCOSES
=680  \\$iA general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED.
=750  \0$aYeast fungi$0(DLC) sh 85149066$5IEN

=LDR  00904cz  a2200277n  4500
=001  9880364032602441
=005  20141212210811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015001
=035  \\$aCBA8353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x892
=072  \\$aC1.$x252.$x825.$x910
=072  \\$aC1.$x252.$x847.$x840.$x892
=072  \\$aC1.$x539.$x800.$x720.$x910
=072  \\$aC17.$x800.$x838.$x765.$x910
=150  \\$aYaws
=450  \\$aFrambesia
=450  \\$wnnna$aFrambesia Tropica
=450  \\$wnnna$aFrambesia Tropicas
=450  \\$wnnna$aFrambesias
=550  \\$wg$aSkin Diseases, Bacterial
=550  \\$wg$aTreponemal Infections
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iA systemic non-venereal infection of the tropics caused by TREPONEMA PALLIDUM subspecies pertenue.
=750  \0$aYaws$5IEN$0(DLC)sh 85149048

=LDR  00550cz  a2200181n  4500
=001  9880364032702441
=005  20141212210811.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015000
=035  \\$aCBA8352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772.$x770.$x980
=150  \\$aYawning
=450  \\$wnnna$aYawnings
=550  \\$wg$aRespiratory Physiological Processes
=680  \\$iAn involuntary deep INHALATION with the MOUTH open, often accompanied by the act of stretching.
=688  \\$a87
=750  \0$aYawning$5IEN$0(DLC)sh 85149047

=LDR  01055cz  a2200229n  4500
=001  9880364032802441
=005  20141212210810.0
=008  770429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014998
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x865.$x983
=072  \\$aG5.$x360.$x162.$x865.$x983
=150  \\$aY Chromosome
=450  \\$wnnna$aChromosome, Y
=450  \\$wnnna$aChromosomes, Y
=450  \\$wnnna$aY Chromosomes
=550  \\$wg$aSex Chromosomes
=550  \\$wh$aChromosomes, Human, Y
=667  \\$aabnormalities; coordinate IM with SEX CHROMOSOME ABERRATIONS (IM) or specific disease (IM) + SEX CHROMOSOME ABERRATIONS (NIM); Y CHROMOSOME, HUMAN is also available
=680  \\$iThe male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X chromosome has been retained.
=688  \\$a84(78); was see under SEX CHROMOSOMES 1968-83
=750  \0$aY chromosome$5IEN$0(DLC)sh 85148874

=LDR  00585cz  a2200181n  4500
=001  9880364032902441
=005  20141212210809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014993
=035  \\$aCBA8345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x936
=072  \\$aD9.$x853.$x936
=150  \\$aXylitol
=550  \\$wg$aSugar Alcohols
=680  \\$iA five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.
=688  \\$a72(63)
=750  \0$aXylitol$5IEN$0(DLC)sh 85148854

=LDR  00808cz  a2200193n  4500
=001  9880364033002441
=005  20141212210809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014992
=035  \\$aCBA8344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x948
=150  \\$aXylenes
=450  \\$wnnna$aDimethylbenzenes
=450  \\$wnnna$aXylene
=550  \\$wg$aBenzene Derivatives
=680  \\$iA family of isomeric, colorless aromatic hydrocarbon liquids, that contain the general formula C6H4(CH3)2. They are produced by the destructive distillation of coal or by the catalytic reforming of petroleum naphthenic fractions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
=688  \\$a75; was XYLENE 1963-74
=750  \0$aXylene$5IEN$0(DLC)sh 85148853

=LDR  00895cz  a2200289n  4500
=001  9880364033102441
=005  20141212210809.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014991
=035  \\$aCBA8343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x665.$x985
=072  \\$aD3.$x383.$x855.$x985
=150  \\$aXylazine
=450  \\$wnnna$aBAY-Va 1470
=450  \\$wnnna$aBAY Va 1470
=450  \\$wnnna$aBAYVa 1470
=450  \\$wnnna$aRompun
=450  \\$wnnna$aXylaxine
=450  \\$wnnna$aXylazin
=450  \\$wnnna$aXylazine Hydrochloride
=450  \\$wnnna$aXylazine Monohydrochloride
=450  \\$wnnna$aXylazine Phosphate (1:1)
=550  \\$wg$aThiazines
=680  \\$iAn adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
=688  \\$a91(75)
=750  \0$aXylazine$5IEN-M$0(DLC)sh 97003665

=LDR  00568cz  a2200181n  4500
=001  9880364033202441
=005  20141212210808.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014990
=035  \\$aCBA8342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x925
=150  \\$aXylans
=550  \\$wg$aPolysaccharides
=550  \\$aXylan Endo-1,3-beta-Xylosidase
=680  \\$iPolysaccharides consisting of xylose units.
=688  \\$a91(75); was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74
=750  \0$aXylans$5IEN$0(DLC)sh 92003659

=LDR  00731cz  a2200205n  4500
=001  9880364033302441
=005  20141212210808.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014986
=035  \\$aCBA8338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x975
=150  \\$aXeroradiography
=450  \\$wnnna$aXeroradiographies
=550  \\$wg$aRadiography
=550  \\$wh$aXeromammography
=667  \\$ado not use /util except by MeSH definition; DF: XERORADIOGR
=680  \\$iA photoelectric method of recording an X-ray image on a coated metal plate, using low-energy photon beams, long exposure time and dry chemical developers.
=688  \\$a73(67)
=750  \0$aXeroradiography$5IEN$0(DLC)sh 85148813

=LDR  00892cz  a2200217n  4500
=001  9880364033402441
=005  20141212210807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014985
=035  \\$aCBA8337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187.$x810
=072  \\$aC11.$x496.$x260.$x892
=150  \\$aXerophthalmia
=450  \\$wnnna$aXerophthalmias
=550  \\$wg$aConjunctival Diseases
=550  \\$wg$aDry Eye Syndromes
=550  \\$aVitamin A Deficiency
=667  \\$adryness of the eyes; do not restrict to the xerosis of vit A defic: use for any cause; do not confuse with DRY EYE SYNDROMES
=680  \\$iDryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.
=750  \0$aXerophthalmia$5IEN$0(DLC)sh 85148810

=LDR  01629cz  a2200385n  4500
=001  9880364033502441
=005  20141212210807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014983
=035  \\$aCBA8335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x834.$x867
=072  \\$aC16.$x131.$x831.$x936
=072  \\$aC16.$x320.$x850.$x970
=072  \\$aC17.$x800.$x600.$x925
=072  \\$aC17.$x800.$x621.$x936
=072  \\$aC17.$x800.$x804.$x936
=072  \\$aC17.$x800.$x827.$x970
=072  \\$aC18.$x452.$x284.$x975
=150  \\$aXeroderma Pigmentosum
=450  \\$aKaposi Disease
=450  \\$wnnna$aKaposi's Disease
=450  \\$wnnna$aKaposis Disease
=450  \\$aXeroderma Pigmentosum Group A Protein$xdeficiency
=550  \\$wg$aDNA Repair-Deficiency Disorders
=550  \\$wg$aPhotosensitivity Disorders
=550  \\$wg$aPigmentation Disorders
=550  \\$wg$aPrecancerous Conditions
=550  \\$wg$aSkin Abnormalities
=550  \\$wg$aSkin Diseases, Genetic
=550  \\$aXeroderma Pigmentosum Group D Protein
=667  \\$aif non-neoplastic, coordinate IM with precoordinated organ/disease term (IM); if neoplastic, coordinate IM with organ/neoplasm term (IM); do not confuse KAPOSI DISEASE with SARCOMA, KAPOSI
=680  \\$iA rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.
=688  \\$a63; KAPOSI DISEASE was KAPOSI'S DISEASE 1963-97
=750  \0$aXeroderma pigmentosum$5IEN$0(DLC)sh 85148808

=LDR  00863cz  a2200229n  4500
=001  9880364033602441
=005  20141212210806.0
=008  800513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014982
=035  \\$aCBA8334HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x610.$x500.$x562
=150  \\$aXenopus laevis
=450  \\$wnnna$alaevis, Xenopus
=450  \\$aPlatanna
=450  \\$wnnna$aPlatannas
=550  \\$wg$aXenopus
=550  \\$aXenopus Proteins
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iThe commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals.
=688  \\$a81
=750  \0$aXenopus laevis$5IEN$0(DLC)sh 85148805

=LDR  00660cz  a2200193n  4500
=001  9880364033702441
=005  20141212210806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014981
=035  \\$aCBA8333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x610.$x500
=150  \\$aXenopus
=550  \\$wg$aPipidae
=550  \\$wh$aXenopus laevis
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iAn aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.
=688  \\$a72
=750  \0$aXenopus$5IEN$0(DLC)sh 85148804

=LDR  00717cz  a2200217n  4500
=001  9880364033802441
=005  20141212210806.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014979
=035  \\$aCBA8331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x920
=150  \\$aXenon Isotopes
=450  \\$wnnna$aIsotopes, Xenon
=550  \\$wg$aIsotopes
=550  \\$wh$aXenon Radioisotopes
=550  \\$aXenon
=667  \\$aXe-124,126,128-131,134,136; NIM
=680  \\$iStable xenon atoms that have the same atomic number as the element xenon, but differ in atomic weight. Xe-124, 126, 128-131, 134, and 136 are stable xenon isotopes.
=688  \\$a75
=750  \0$aXenon$xIsotopes$5IEN$0(DLC)sh 85148791

=LDR  00670cz  a2200181n  4500
=001  9880364033902441
=005  20141212210717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014825
=035  \\$aCBA8172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x901
=150  \\$aVocabulary
=450  \\$wnnna$aVocabularies
=550  \\$wg$aLinguistics
=667  \\$aa person's stock of words; do not use for nomenclature ( = NOMENCLATURE) or for THESAURUS see VOCABULARY, CONTROLLED; no qualif
=680  \\$iThe sum or the stock of words used by a language, a group, or an individual. (From Webster, 3d ed)
=750  \0$aVocabulary$5IEN$0(DLC)sh 85144057

=LDR  00566cz  a2200157n  4500
=001  9880364034002441
=005  20141212210717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014824
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x17.$x900
=150  \\$aVivisection
=450  \\$wnnna$aVivisections
=550  \\$wg$aAnimal Experimentation
=680  \\$iThe cutting of or surgical operation on a living animal, usually for physiological or pathological investigation. (from Merriam-Webster's Collegiate Dict, 10th ed)
=750  \0$aVivisection$0(DLC) sh 85144042$5IEN

=LDR  01072cz  a2200253n  4500
=001  9880364034102441
=005  20141212210716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014822
=035  \\$aCBA8169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x714.$x500
=150  \\$aVitreous Body
=450  \\$wnnna$aBodies, Vitreous
=450  \\$wnnna$aBody, Vitreous
=450  \\$wnnna$aHumor, Vitreous
=450  \\$wnnna$aHumors, Vitreous
=450  \\$wnnna$aVitreous Bodies
=450  \\$wnnna$aVitreous Humor
=450  \\$wnnna$aVitreous Humors
=550  \\$wg$aPosterior Eye Segment
=667  \\$a/surg: consider also VITRECTOMY; VITREOUS DETACHMENT is available; opacities, muscae volitantes & other diseases are indexed VITREOUS BODY (IM) and EYE DISEASES (IM)
=680  \\$iThe transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
=750  \0$aVitreous body$5IEN$0(DLC)sh 85144027

=LDR  00723cz  a2200205n  4500
=001  9880364034202441
=005  20141212210716.0
=008  830209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014821
=035  \\$aCBA8168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x960
=150  \\$aVitrectomy
=450  \\$wnnna$aVitrectomies
=550  \\$wg$aOphthalmologic Surgical Procedures
=550  \\$aVitreous Body
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRemoval of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.
=688  \\$a84
=750  \0$aVitrectomy$5IEN$0(DLC)sh 85144026

=LDR  00880cz  a2200253n  4500
=001  9880364145202441
=005  20141212192101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002657
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x525.$x200
=072  \\$aG7.$x700.$x320.$x374.$x750
=150  \\$aChild Development
=450  \\$wnnna$aDevelopment, Child
=450  \\$wnnna$aDevelopment, Infant
=450  \\$aInfant Development
=550  \\$wg$aHuman Development
=550  \\$wh$aLanguage Development
=550  \\$aGrowth
=550  \\$aPsychology, Child
=667  \\$aincludes infant and child but not adolescents; add the appropriate age check tag
=680  \\$iThe continuous sequential physiological and psychological maturing of an individual from birth up to but not including ADOLESCENCE.
=688  \\$a68
=750  \0$aChild development$5IEN$0(DLC)sh 85023357

=LDR  01017cz  a2200313n  4500
=001  9880364145302441
=005  20201216180538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002656
=035  \\$aCBA8528HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x293.$x392
=150  \\$aChild Day Care Centers
=450  \\$wnnna$aCenter, Child Daycare
=450  \\$wnnna$aCenters, Child Daycare
=450  \\$wnnna$aChild Daycare Center
=450  \\$wnnna$aChild Daycare Centers
=450  \\$aDay Care Centers$5IEN
=450  \\$aDay Care Centers for Children
=450  \\$wnnna$aDaycare Center, Child
=450  \\$wnnna$aDaycare Centers, Child
=450  \\$wnnna$aDaycare Centers for Children
=550  \\$wg$aChild Welfare
=550  \\$aNurseries, Infant
=550  \\$aSchools, Nursery
=667  \\$acheck also tag CHILD or specific
=680  \\$iFacilities which provide care for pre-school and school-age children.
=688  \\$a73
=750  \0$aDay care centers$5IEN$0(DLC)sh 85035951

=LDR  00851cz  a2200253n  4500
=001  9880364145402441
=005  20141212195726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x97
=072  \\$aI1.$x76.$x201.$x450.$x170
=150  \\$aCeremonial Behavior
=450  \\$wnnna$aBehavior, Ceremonial
=450  \\$wnnna$aBehaviors, Ceremonial
=450  \\$wnnna$aCeremonial Behaviors
=450  \\$aRituals
=550  \\$wg$aCulture
=550  \\$wg$aSocial Behavior
=550  \\$aAppetitive Behavior
=667  \\$ahuman & animal; no qualif
=680  \\$iA series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance.
=688  \\$a98(68)
=750  \0$aRites and ceremonies$5IEN$0(DLC)sh 85114211

=LDR  02023cz  a2200589n  4500
=001  9880364145502441
=005  20141212192053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002540
=035  \\$aCBA8525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500
=150  \\$aCerebral Cortex
=450  \\$wnnna$aAllocortex
=450  \\$wnnna$aAllocortices
=450  \\$wnnna$aArchipallium
=450  \\$wnnna$aArchipalliums
=450  \\$wnnna$aCerebral Cortices
=450  \\$wnnna$aCerebri, Cortex
=450  \\$wnnna$aCerebrus, Cortex
=450  \\$wnnna$aCortex, Cerebral
=450  \\$wnnna$aCortex Cerebri
=450  \\$wnnna$aCortex Cerebrus
=450  \\$wnnna$aCortex, Insular
=450  \\$wnnna$aCortical Plate
=450  \\$wnnna$aCortical Plates
=450  \\$wnnna$aCortices, Cerebral
=450  \\$wnnna$aCortices, Insular
=450  \\$aInsula of Reil
=450  \\$wnnna$aInsular Cortex
=450  \\$wnnna$aInsular Cortices
=450  \\$wnnna$aPaleocortex
=450  \\$wnnna$aPaleocortices
=450  \\$wnnna$aPeriallocortex
=450  \\$wnnna$aPeriallocortices
=450  \\$wnnna$aPlate, Cortical
=450  \\$wnnna$aPlates, Cortical
=450  \\$wnnna$aReil Insula
=550  \\$wg$aCerebrum
=550  \\$wh$aFrontal Lobe
=550  \\$wh$aHippocampus
=550  \\$wh$aLimbic Lobe
=550  \\$wh$aNeocortex
=550  \\$wh$aOccipital Lobe
=550  \\$wh$aOlfactory Cortex
=550  \\$wh$aParietal Lobe
=550  \\$wh$aSensorimotor Cortex
=550  \\$wh$aTemporal Lobe
=667  \\$a/surg: probably CEREBRAL DECORTICATION
=680  \\$iThe thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
=688  \\$aINSULA OF REIL was see under CEREBRAL CORTEX 1968-78
=750  \0$aCerebral cortex$5IEN$0(DLC)sh 85022087

=LDR  00663cz  a2200241n  4500
=001  9880364145602441
=005  20141212195704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002508
=035  \\$aCBA8524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x24.$x250
=072  \\$aE5.$x41.$x250
=072  \\$aN6.$x850.$x505.$x200.$x100.$x300
=150  \\$aCephalometry
=450  \\$aCraniometry
=550  \\$wg$aAnthropometry
=550  \\$aCraniology
=550  \\$aMaxillofacial Development
=550  \\$aSkull
=680  \\$iThe measurement of the dimensions of the HEAD.
=688  \\$a1965
=750  \0$aCephalometry$5IEN$0(DLC)sh 85021971

=LDR  01015cz  a2200193n  4500
=001  9880364145702441
=005  20141212195701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002498
=035  \\$aCBA8523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x181
=150  \\$aCentrifugation
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aUltracentrifugation
=550  \\$aRotation
=667  \\$aas a lab technique & to simulate gravitational eff in space; NIM
=680  \\$iProcess of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aCentrifugation$5IEN$0(DLC)sh 85021937

=LDR  01468cz  a2200409n  4500
=001  9880364145802441
=005  20141212195656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002482
=035  \\$aCBA8521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x180
=072  \\$aD9.$x698.$x365.$x180
=072  \\$aD25.$x720.$x99.$x500
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x500
=150  \\$aCellulose
=450  \\$wnnna$aAcid, Polyanhydroglucuronic
=450  \\$wnnna$aalpha-Cellulose
=450  \\$wnnna$aalpha Cellulose
=450  \\$wnnna$aAlphacel
=450  \\$wnnna$aAvicel
=450  \\$wnnna$aHeweten
=450  \\$wnnna$aPolyanhydroglucuronic Acid
=450  \\$wnnna$aRayophane
=450  \\$wnnna$aSulfite Cellulose
=550  \\$wg$aBiopolymers
=550  \\$wg$aGlucans
=550  \\$wh$aCellobiose
=550  \\$wh$aCellophane
=550  \\$wh$aCellulose, Oxidized
=550  \\$wh$aCollodion
=550  \\$wh$aDEAE-Cellulose
=550  \\$wh$aHypromellose Derivatives
=550  \\$wh$aLignin
=550  \\$wh$aMethylcellulose
=680  \\$iA polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
=750  \0$aCellulose$5IEN$0(DLC)sh 85021705

=LDR  01240cz  a2200277n  4500
=001  9880364145902441
=005  20141212195649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002467
=035  \\$aCBA8520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x117
=150  \\$aCell Nucleus
=450  \\$wnnna$aCell Nuclei
=450  \\$wnnna$aNuclei, Cell
=450  \\$wnnna$aNucleus, Cell
=550  \\$wg$aIntracellular Space
=550  \\$wg$aOrganelles
=550  \\$wh$aCell Nucleus Structures
=550  \\$wh$aMacronucleus
=550  \\$wh$aMicronuclei, Chromosome-Defective
=550  \\$wh$aMicronucleus, Germline
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iWithin a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=750  \0$aCell nuclei$0(DLC) sh 85021658$5IEN

=LDR  00989cz  a2200253n  4500
=001  9880364146002441
=005  20141212195648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002463
=035  \\$aCBA8519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x166.$x335
=072  \\$aG4.$x175
=150  \\$aCell Membrane Permeability
=450  \\$aPermeability, Cell Membrane
=550  \\$wg$aBiological Transport
=550  \\$wg$aCell Physiological Phenomena
=550  \\$aBiological Transport
=550  \\$aIonophores
=667  \\$acoord with substance /pharmacokin (IM) or /metab (IM); for cell membrane only; intracellular membrane permeability: index INTRACELLULAR MEMBRANES + specific organelle + PERMEABILITY
=680  \\$iA quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
=688  \\$a65
=750  \0$81$wb$aCell membranes$5IEN$0(DLC)sh 85021654
=750  \0$81$wb$aBiological transport$5IEN-HS$0(DLC)sh 85014197

=LDR  00840cz  a2200253n  4500
=001  9880364146102441
=005  20170620110502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002459
=035  \\$aCBA8518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x242.$x307
=072  \\$aG4.$x155
=150  \\$aCell Fusion
=450  \\$wnnna$aCell Fusions
=450  \\$aCell Hybridization$5IEN
=450  \\$wnnna$aFusion, Cell
=450  \\$wnnna$aFusions, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wg$aCytological Techniques
=667  \\$aNIM; not for micro-organisms; somatic cells only: not for sperm-ovum fusion ( = fertilization)
=680  \\$iFusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization.
=688  \\$a73(71)
=750  \0$aSomatic hybrids$5IEN$0(DLC)sh 85124778

=LDR  00816cz  a2200229n  4500
=001  9880364146202441
=005  20141212195646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002458
=035  \\$aCBA8517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x242.$x251
=150  \\$aCell Fractionation
=450  \\$wnnna$aCell Fractionations
=450  \\$wnnna$aFractionation, Cell
=450  \\$wnnna$aFractionations, Cell
=550  \\$wg$aCytological Techniques
=550  \\$aSubcellular Fractions
=667  \\$ado not confuse with CELL SEPARATION; NIM, no qualif; when IM, /instrum /methods permitted; permitted with micro-organisms
=680  \\$iTechniques to partition various components of the cell into SUBCELLULAR FRACTIONS.
=688  \\$a73(71)
=750  \0$aCell fractionation$5IEN$0(DLC)sh 85021647

=LDR  01038cz  a2200325n  4500
=001  9880364146402441
=005  20141212195616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002357
=035  \\$aCBA8515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x182
=072  \\$aC17.$x300.$x182
=150  \\$aCartilage Diseases
=450  \\$wnnna$aCartilage Disease
=450  \\$aChondromalacia
=450  \\$wnnna$aChondromalacias
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aMusculoskeletal Diseases
=550  \\$wh$aChondromalacia Patellae
=550  \\$wh$aLaryngomalacia
=550  \\$wh$aOsteochondritis
=550  \\$wh$aPectus Carinatum
=550  \\$wh$aPolychondritis, Relapsing
=550  \\$wh$aTietze's Syndrome
=550  \\$wh$aTracheobronchomalacia
=667  \\$ageneral; inflammatory disease (chondritis) is likely to be OSTEOCHONDRITIS
=680  \\$iPathological processes involving the chondral tissue (CARTILAGE).
=688  \\$a68
=750  \0$aCartilage$xDiseases$5IEN$0(DLC)sh 85020510

=LDR  00993cz  a2200253n  4500
=001  9880364146502441
=005  20141212195616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002356
=035  \\$aCBA8514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x165
=072  \\$aA10.$x165.$x382
=150  \\$aCartilage
=360  \\$iconsider also terms at$aCHONDRO-
=450  \\$wnnna$aCartilages
=550  \\$wg$aConnective Tissue
=550  \\$wg$aMusculoskeletal System
=550  \\$wh$aElastic Cartilage
=550  \\$wh$aFibrocartilage
=550  \\$wh$aHyaline Cartilage
=667  \\$ageneral: prefer specifics; inflammation (chondritis) is likely to be OSTEOCHONDRITIS
=680  \\$iA non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
=750  \0$aCartilage$0(DLC) sh 85020509$5IEN

=LDR  01621cz  a2200301n  4500
=001  9880364146602441
=005  20141212195613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002349
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x500.$x200
=072  \\$aC10.$x668.$x829.$x550.$x200
=072  \\$aC26.$x844.$x150.$x206
=150  \\$aCarpal Tunnel Syndrome
=450  \\$wnnna$aAmyotrophy, Thenar, Of Carpal Origin
=450  \\$wnnna$aCarpal Tunnel Syndromes
=450  \\$aCompression Neuropathy, Carpal Tunnel
=450  \\$aEntrapment Neuropathy, Carpal Tunnel
=450  \\$wnnna$aMedian Neuropathy, Carpal Tunnel
=450  \\$wnnna$aSyndrome, Carpal Tunnel
=450  \\$wnnna$aSyndromes, Carpal Tunnel
=550  \\$wg$aCumulative Trauma Disorders
=550  \\$wg$aMedian Neuropathy
=550  \\$wg$aNerve Compression Syndromes
=550  \\$aMedian Nerve
=680  \\$iEntrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma (CUMULATIVE TRAUMA DISORDERS); wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis (see ARTHRITIS, RHEUMATOID); ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. (Joynt, Clinical Neurology, 1995, Ch51, p45)
=688  \\$a1965(1963)
=750  \0$aCarpal tunnel syndrome$5IEN$0(DLC)sh 85020424

=LDR  00669cz  a2200169n  4500
=001  9880364146702441
=005  20141212195612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002346
=035  \\$aCBA8512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x186.$x456
=150  \\$aCarotid Sinus
=450  \\$wnnna$aSinus, Carotid
=550  \\$wg$aCarotid Arteries
=680  \\$iThe dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure.
=750  \0$aCarotid sinus$5IEN$0(DLC)sh 85020418

=LDR  01315cz  a2200385n  4500
=001  9880364146802441
=005  20141212195605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002327
=035  \\$aCBA8511HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x223
=072  \\$aD27.$x505.$x696.$x706.$x222
=072  \\$aD27.$x720.$x102.$x223
=072  \\$aD27.$x720.$x799.$x113
=072  \\$aJ1.$x637.$x51.$x223
=150  \\$aCariostatic Agents
=450  \\$wnnna$aAgent, Cariostatic
=450  \\$wnnna$aAgents, Cariostatic
=450  \\$wnnna$aCariostatic Agent
=450  \\$wnnna$aCariostatic Effect
=450  \\$wnnna$aCariostatic Effects
=450  \\$wnnna$aEffect, Cariostatic
=450  \\$wnnna$aEffects, Cariostatic
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aProtective Agents
=550  \\$wh$aAcidulated Phosphate Fluoride
=550  \\$wh$aFluorides, Topical
=550  \\$wh$aSodium Fluoride
=550  \\$wh$aTin Fluorides
=550  \\$aDental Caries
=667  \\$anote entry term CARIOSTATIC EFFECT: use only for the cariostatic effect of a chemical
=680  \\$iSubstances that inhibit or arrest DENTAL CARIES formation. (Boucher's Clinical Dental Terminology, 4th ed)
=688  \\$a65
=750  \0$aDental caries$xPrevention$5IEN$0(DLC)sh 85036873

=LDR  01214cz  a2200265n  4500
=001  9880364146902441
=005  20160826094507.0
=008  880531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015302
=035  \\$aCBA8506M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x589.$x650.$x800
=072  \\$aB4.$x820.$x650.$x805.$x700
=150  \\$aSimian Immunodeficiency Virus
=450  \\$wnnna$aImmunodeficiency Virus, Simian
=450  \\$wnnna$aImmunodeficiency Viruses, Simian
=450  \\$wnnna$aSimian Immunodeficiency Viruses
=450  \\$aSIV (Simian immunodeficiency virus)
=550  \\$wg$aLentiviruses, Primate
=550  \\$wg$aRetroviruses, Simian
=667  \\$ado not confuse SIV with swine influenza virus see INFLUENZA A VIRUS; infection = SAIDS often a model for AIDS
=680  \\$iSpecies of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV.
=688  \\$a2006 (1989)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a SIV
=750  \0$aSimian immunodeficiency virus$0(DLC)sh2010008423$5IEN-M

=LDR  01909cz  a2200349n  4500
=001  9880364147002441
=005  20141212202904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007986
=035  \\$aCBA8502HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x322.$x576.$x463
=072  \\$aD6.$x472.$x699.$x631.$x525.$x343.$x463
=072  \\$aD12.$x644.$x548.$x691.$x525.$x343.$x463
=150  \\$aLuteinizing Hormone
=450  \\$wnnna$aHormone, Interstitial Cell-Stimulating
=450  \\$wnnna$aHormone, Luteinizing
=450  \\$aICSH (Interstitial Cell Stimulating Hormone)
=450  \\$aInterstitial Cell-Stimulating Hormone
=450  \\$wnnna$aInterstitial Cell Stimulating Hormone
=450  \\$wnnoa$aLH$5IEN-HS
=450  \\$aLH (Luteinizing Hormone)
=450  \\$wnnna$aLuteoziman
=450  \\$wnnna$aLuteozyman
=450  \\$aLutropin
=550  \\$wg$aGonadotropins, Pituitary
=550  \\$wh$aGlycoprotein Hormones, alpha Subunit
=550  \\$wh$aLuteinizing Hormone, beta Subunit
=667  \\$ado not confuse X ref LUTROPIN with PLACENTAL LUTEOTROPIN; for alpha subunit, coordinate with GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; LUTEINIZING HORMONE, BETA SUBUNIT is also available
=680  \\$iA major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity.
=688  \\$a2003 (1968); use ICSH 1963-1967
=750  \0$aLuteinizing hormone$5IEN$0(DLC)sh 85078985

=LDR  01787cz  a2200457n  4500
=001  9880364147102441
=005  20141212211059.0
=008  880610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x254.$x150.$x440
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x254.$x150.$x440
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x254.$x150.$x440
=150  \\$aHIV Antibodies
=450  \\$aAIDS Antibodies
=450  \\$wnnna$aAntibodies, AIDS
=450  \\$wnnna$aAntibodies, HIV
=450  \\$wnnna$aAntibodies, HIV Associated
=450  \\$wnnna$aAntibodies, HIV-Associated
=450  \\$wnnna$aAntibodies, HTLV III
=450  \\$wnnna$aAntibodies, HTLV-III
=450  \\$wnnna$aAntibodies, HTLV-III-LAV
=450  \\$wnnna$aAntibodies, LAV
=450  \\$wnnna$aAntibodies, Lymphadenopathy Associated
=450  \\$wnnna$aAntibodies, Lymphadenopathy-Associated
=450  \\$wnnna$aHIV Associated Antibodies
=450  \\$aHIV-Associated Antibodies
=450  \\$wnnna$aHTLV III Antibodies
=450  \\$aHTLV-III Antibodies
=450  \\$wnnna$aHTLV III LAV Antibodies
=450  \\$aHTLV-III-LAV Antibodies
=450  \\$aLAV Antibodies
=450  \\$wnnna$aLymphadenopathy Associated Antibodies
=450  \\$aLymphadenopathy-Associated Antibodies
=450  \\$wnnna$aT Lymphotropic Virus Type III Antibodies, Human
=450  \\$aT-Lymphotropic Virus Type III Antibodies, Human
=550  \\$wg$aDeltaretrovirus Antibodies
=667  \\$acoordinate IM with HIV-1/ immunol (IM) or HIV-2/ immunol (IM) if pertinent; do not coordinate with ANTIBODY FORMATION for /biosyn
=680  \\$iAntibodies reactive with HIV ANTIGENS.
=688  \\$a89
=750  \0$aHIV antibodies$5IEN$0(DLC)sh 87003995

=LDR  02256cz  a2200445n  4500
=001  9880364147202441
=005  20141212194413.0
=008  830318\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000163
=035  \\$aCBA8499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x400.$x40
=072  \\$aC2.$x800.$x801.$x400.$x40
=072  \\$aC2.$x839.$x40
=072  \\$aC20.$x673.$x480.$x40
=150  \\$aAcquired Immunodeficiency Syndrome
=450  \\$wnnna$aAcquired Immune Deficiency Syndrome
=450  \\$wnnna$aAcquired Immuno-Deficiency Syndrome
=450  \\$wnnna$aAcquired Immuno Deficiency Syndrome
=450  \\$wnnna$aAcquired Immuno-Deficiency Syndromes
=450  \\$wnnna$aAcquired Immunodeficiency Syndromes
=450  \\$aAIDS
=450  \\$wnnna$aImmuno-Deficiency Syndrome, Acquired
=450  \\$wnnna$aImmuno-Deficiency Syndromes, Acquired
=450  \\$aImmunodeficiency Syndrome, Acquired
=450  \\$wnnna$aImmunodeficiency Syndromes, Acquired
=450  \\$aImmunologic Deficiency Syndrome, Acquired
=450  \\$wnnna$aSyndrome, Acquired Immuno-Deficiency
=450  \\$wnnna$aSyndrome, Acquired Immunodeficiency
=450  \\$wnnna$aSyndromes, Acquired Immuno-Deficiency
=450  \\$wnnna$aSyndromes, Acquired Immunodeficiency
=550  \\$wg$aHIV Infections
=550  \\$wg$aSlow Virus Diseases
=550  \\$aAIDS Arteritis, Central Nervous System
=550  \\$aCD4-Positive T-Lymphocytes
=550  \\$aHIV-1
=667  \\$acaused by HIV; coord IM with HIV-1 or HIV-2 (IM) if pertinent; /epidemiol: consider also HIV SEROPREVALENCE; AIDS-RELATED OPPORTUNISTIC INFECTIONS is available if particularly discussed: see note there; for lymphoma with AIDS, use LYMPHOMA, AIDS-RELATED
=680  \\$iAn acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
=688  \\$a83
=750  \0$aAIDS (Disease)$5IEN$0(DLC)sh 85002541

=LDR  05212cz  a2201093n  4500
=001  9880364147302441
=005  20141212195741.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002607
=035  \\$aCBA8494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x300.$x200
=072  \\$aC10.$x574.$x500.$x495.$x200
=072  \\$aC10.$x668.$x829.$x800.$x300.$x200
=072  \\$aC16.$x131.$x666.$x300.$x200
=072  \\$aC16.$x320.$x400.$x375.$x200
=150  \\$aCharcot-Marie-Tooth Disease
=450  \\$wnnna$aAreflexic Dystasia, Hereditary
=450  \\$wnnna$aAreflexic Dystasias, Hereditary
=450  \\$wnnna$aAtrophies, Peroneal Muscular
=450  \\$aAtrophy, Muscular, Peroneal
=450  \\$wnnna$aAtrophy, Peroneal Muscular
=450  \\$wnnna$aCharcot-Marie Disease
=450  \\$wnnna$aCharcot Marie Disease
=450  \\$wnnna$aCharcot Marie Tooth Disease
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1A
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Demyelinating, Type 1B
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type 1A
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type 1A
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type 1B
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type 1B
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type I
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type I
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type IA
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type IA
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type IB
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type IB
=450  \\$wnnna$aCharcot-Marie-Tooth Disease, Type II
=450  \\$wnnna$aCharcot Marie Tooth Disease, Type II
=450  \\$wnnna$aCharcot-Marie-Tooth Hereditary Neuropathy
=450  \\$wnnna$aCharcot Marie Tooth Hereditary Neuropathy
=450  \\$wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1A
=450  \\$wnnna$aCharcot Marie Tooth Neuropathy, Type 1A
=450  \\$wnnna$aCharcot-Marie-Tooth Neuropathy, Type 1B
=450  \\$wnnna$aCharcot Marie Tooth Neuropathy, Type 1B
=450  \\$wnnna$aCharcot-Marie-Tooth Syndrome
=450  \\$wnnna$aCharcot Marie Tooth Syndrome
=450  \\$wnnna$aDystasia, Hereditary Areflexic
=450  \\$wnnna$aDystasias, Hereditary Areflexic
=450  \\$wnnna$aHereditary Areflexic Dystasia
=450  \\$wnnna$aHereditary Areflexic Dystasias
=450  \\$wnnna$aHereditary Motor and Sensory Neuropathy 1A
=450  \\$wnnna$aHereditary Motor and Sensory Neuropathy 1B
=450  \\$wnnna$aHereditary Motor and Sensory Neuropathy IA
=450  \\$wnnna$aHereditary Motor And Sensory Neuropathy IB
=450  \\$aHereditary Motor, and Sensory Neuropathy Type I
=450  \\$aHereditary Motor and Sensory-Neuropathy Type II
=450  \\$wnnna$aHereditary Motor and Sensory Neuropathy Type II
=450  \\$wnnna$aHereditary Neuropathy, Charcot-Marie-Tooth
=450  \\$wnnna$aHereditary Type I Motor and Sensory Neuropathy
=450  \\$wnnna$aHMN Distal Type I
=450  \\$wnnna$aHMSN 1A
=450  \\$wnnna$aHMSN 1B
=450  \\$wnnna$aHMSN I
=450  \\$wnnna$aHMSN IA
=450  \\$wnnna$aHMSN IB
=450  \\$wnnna$aHMSN II
=450  \\$aHMSN Type I
=450  \\$aHMSN Type II
=450  \\$wnnna$aHMSN1A
=450  \\$wnnna$aHMSN1B
=450  \\$wnnna$aMuscular Atrophies, Peroneal
=450  \\$aMuscular Atrophy, Peroneal
=450  \\$wnnna$aNeuropathy, Type I Hereditary Motor and Sensory
=450  \\$wnnna$aNeuropathy, Type II Hereditary Motor and Sensory
=450  \\$wnnna$aPeroneal Muscular Atrophies
=450  \\$aPeroneal Muscular Atrophy
=450  \\$wnnna$aRoussy-Levy Disease
=450  \\$wnnna$aRoussy Levy Disease
=450  \\$wnnna$aRoussy Levy Hereditary Areflexic Dystasia
=450  \\$wnnna$aRoussy-Levy Hereditary Areflexic Dystasia
=450  \\$aRoussy-Levy Syndrome
=450  \\$wnnna$aRoussy Levy Syndrome
=450  \\$wnnna$aSyndrome, Charcot-Marie-Tooth
=450  \\$wnnna$aSyndrome, Roussy-Levy
=550  \\$wg$aHereditary Sensory and Motor Neuropathy
=550  \\$aEarly Growth Response Protein 2
=550  \\$aMyelin P0 Protein
=680  \\$iA hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)
=688  \\$a2000(1966)
=750  \0$aCharcot-Marie-Tooth disease$5IEN$0(DLC)sh 85022641

=LDR  02747cz  a2200577n  4500
=001  9880364147402441
=005  20141212194839.0
=008  800513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000949
=035  \\$aCBA8490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x509
=072  \\$aD12.$x776.$x543.$x550.$x423
=072  \\$aD23.$x50.$x301.$x500.$x400
=072  \\$aD23.$x50.$x705.$x552.$x410
=150  \\$aHistocompatibility Antigens Class II
=450  \\$wnnna$aAntigen, Class II
=450  \\$wnnna$aAntigen, I-A
=450  \\$wnnna$aAntigen, IA
=450  \\$wnnna$aAntigens, Class II
=450  \\$wnnna$aAntigens, Ia
=450  \\$wnnna$aAntigens, Ia-Like
=450  \\$wnnna$aAntigens, Immune-Associated
=450  \\$aAntigens, Immune Response
=450  \\$wnnna$aAntigens, Immune-Response-Associated
=450  \\$wnnna$aClass II Antigen
=450  \\$aClass II Antigens
=450  \\$wnnna$aClass II Histocompatibility Antigens
=450  \\$wnnna$aClass II Major Histocompatibility Antigens
=450  \\$wnnna$aI-A Antigen
=450  \\$wnnna$aI-A-Antigen
=450  \\$wnnna$aI A Antigen
=450  \\$wnnna$aIA Antigen
=450  \\$aIa Antigens
=450  \\$aIa-Like Antigens
=450  \\$wnnna$aIa Like Antigens
=450  \\$aImmune-Associated Antigens
=450  \\$wnnna$aImmune Associated Antigens
=450  \\$aImmune Response Antigens
=450  \\$aImmune-Response-Associated Antigens
=450  \\$wnnna$aImmune Response Associated Antigens
=550  \\$wg$aHistocompatibility Antigens
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wh$aH-2 Antigens
=550  \\$wh$aHLA-D Antigens
=550  \\$aAntigen-Presenting Cells
=550  \\$aInterleukin-4
=667  \\$ahuman & animal; GEN: prefer specifics; see also HLA ANTIGENS & specifics for human; X ref IA ANTIGENS refers to any class II histocompatibility antigen
=680  \\$iLarge, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen.
=688  \\$a89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was NM 1987-93
=750  \0$aIa antigens$5IEN$0(DLC)sh 85063875

=LDR  01924cz  a2200493n  4500
=001  9880364147502441
=005  20141212210851.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015125
=035  \\$aCBA8483HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x350.$x625
=150  \\$aOxyquinoline
=450  \\$wnnna$a8-Hydroxyquinoline
=450  \\$wnnna$a8 Hydroxyquinoline
=450  \\$wnnna$a8-Hydroxyquinoline Sulfate
=450  \\$wnnna$a8 Hydroxyquinoline Sulfate
=450  \\$wnnna$a8-Oxyquinoline
=450  \\$wnnna$a8 Oxyquinoline
=450  \\$a8-Quinolinol
=450  \\$wnnna$a8 Quinolinol
=450  \\$wnnna$aBioquin
=450  \\$wnnna$aChinosol
=450  \\$wnnna$aChinosol Brand of Oxyquinoline Potassium Sulfate (2:1)
=450  \\$wnnna$aKhinozol
=450  \\$wnnna$aLeioderm
=450  \\$aOxine
=450  \\$aOxyquinol
=450  \\$wnnna$aOxyquinoline Potassium Sulfate (2:1)
=450  \\$wnnna$aOxyquinoline Sulfate
=450  \\$wnnna$aQuinosol
=450  \\$wnnna$aRiemser Brand of Oxyquinoline Sulfate
=450  \\$wnnna$aSulfate, 8-Hydroxyquinoline
=450  \\$wnnna$aSulfate, Oxyquinoline
=450  \\$wnnna$aSuperol
=450  \\$wnnna$aTendem Brand of Oxyquinoline Sulfate
=550  \\$wg$aHydroxyquinolines
=550  \\$wh$aChloroquinolinols
=550  \\$wh$aClioquinol
=550  \\$wh$aIodoquinol
=667  \\$aDF: note short X ref
=680  \\$iAn antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
=688  \\$a92; was 8-HYDROXYQUINOLINE 1975-91 (see under HYDROXYQUINOLINES 1975-90); OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91
=750  \0$aHydroxyquinoline$5IEN-M$0(DLC)sh 90004291

=LDR  01313cz  a2200289n  4500
=001  9880364147602441
=005  20141212210848.0
=008  850605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015118
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x410.$x385
=072  \\$aD10.$x251.$x355.$x255.$x200
=072  \\$aD10.$x251.$x355.$x337.$x290
=072  \\$aD10.$x627.$x430.$x450.$x390
=150  \\$aEicosapentaenoic Acid
=450  \\$a5,8,11,14,17-Eicosapentaenoic Acid
=450  \\$wnnna$a5,8,11,14,17-Icosapentaenoic Acid
=450  \\$wnnna$aAcid, Eicosapentanoic
=450  \\$wnnna$aEicosapentanoic Acid
=450  \\$wnnna$aomega-3-Eicosapentaenoic Acid
=450  \\$wnnna$aomega 3 Eicosapentaenoic Acid
=450  \\$wnnna$aTimnodonic Acid
=550  \\$wg$aEicosanoids
=550  \\$wg$aFatty Acids, Omega-3
=680  \\$iImportant polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families.
=688  \\$a2003(1986);
=750  \0$aEicosapentaenoic Acid$5IEN-M$0(DLC)sh2001003379

=LDR  00924cz  a2200253n  4500
=001  9880364147702441
=005  20141212210845.0
=008  741114\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015112
=035  \\$aCBA8469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x640.$x820.$x600
=072  \\$aD3.$x438.$x810.$x470.$x450
=072  \\$aD3.$x661.$x243.$x500
=150  \\$a4-Nitroquinoline-1-oxide
=450  \\$wnnna$a4 Nitroquinoline 1 oxide
=450  \\$a4-Nitroquinoline-N-oxide
=450  \\$wnnna$a4 Nitroquinoline N oxide
=550  \\$wg$aCyclic N-Oxides
=550  \\$wg$aNitroquinolines
=667  \\$aD25-26 qualif
=680  \\$iA potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage.
=688  \\$a91(75); was see under NITROQUINOLINES 1975-90
=750  \0$aNitroquinoline oxide$5IEN$0(DLC)sh 85092089

=LDR  00649cz  a2200181n  4500
=001  9880364147802441
=005  20141212210805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014978
=035  \\$aCBA8330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613.$x900
=072  \\$aD1.$x362.$x641.$x918
=150  \\$aXenon
=550  \\$wg$aNoble Gases
=667  \\$aa rare gas; Xe-132; sometimes used as an inhalation anesthetic
=680  \\$iA noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth's atmosphere and has been used as an anesthetic.
=750  \0$aXenon$5IEN$0(DLC)sh 85148790

=LDR  00659cz  a2200181n  4500
=001  9880364147902441
=005  20141212210940.0
=008  880518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015262
=035  \\$aCBA8329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x969
=150  \\$aXenobiotics
=550  \\$wg$aPharmaceutical Preparations
=667  \\$aGEN only; do not interpret: use the term if used by the author
=680  \\$iChemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.
=688  \\$a89
=750  \0$aXenobiotics$5IEN$0(DLC)sh 85148783

=LDR  00744cz  a2200217n  4500
=001  9880364148002441
=005  20141212210805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014974
=035  \\$aCBA8325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x967.$x930
=072  \\$aB3.$x660.$x250.$x915.$x930
=150  \\$aXanthomonas
=450  \\$aXanthomonas albilineans
=550  \\$wg$aXanthomonadaceae
=550  \\$wh$aXanthomonas axonopodis
=550  \\$wh$aXanthomonas campestris
=550  \\$wh$aXanthomonas vesicatoria
=680  \\$iA genus in the family XANTHOMONADACEAE whose cells produce a yellow pigment (Gr. xanthos - yellow). It is pathogenic to plants.
=750  \0$aXanthomonas$0(DLC) sh 85148767$5IEN

=LDR  01084cz  a2200229n  4500
=001  9880364148102441
=005  20141212210805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014973
=035  \\$aCBA8324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584.$x750
=150  \\$aXanthomatosis
=450  \\$aXanthoma
=450  \\$wnnna$aXanthomas
=450  \\$wnnna$aXanthomatoses
=550  \\$wg$aLipid Metabolism Disorders
=550  \\$wh$aNecrobiotic Xanthogranuloma
=550  \\$wh$aXanthomatosis, Cerebrotendinous
=667  \\$anon-neoplastic; coordinate IM with organ/disease term (IM); xanthogranuloma goes here (IM) + GRANULOMA (IM) but note XANTHOGRANULOMA, JUVENILE is available
=680  \\$iA condition marked by the development of widespread xanthomas, yellow tumor-like structures filled with lipid deposits. Xanthomas can be found in a variety of tissues including the SKIN; TENDONS; joints of KNEES and ELBOWS. Xanthomatosis is associated with disturbance of LIPID METABOLISM and formation of FOAM CELLS.
=750  \0$aXanthoma$5IEN$0(DLC)sh 85148766

=LDR  01283cz  a2200313n  4500
=001  9880364148202441
=005  20141212210803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014969
=035  \\$aCBA8320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x928
=150  \\$aXanthine Oxidase
=450  \\$wnnna$aDehydrogenase, Hypoxanthine
=450  \\$wnnna$aHypoxanthine Dehydrogenase
=450  \\$aHypoxanthine Oxidase
=450  \\$wnnna$aHypoxanthine-Xanthine Oxidase
=450  \\$wnnna$aHypoxanthine Xanthine Oxidase
=450  \\$wnnna$aOxidase, Hypoxanthine
=450  \\$wnnna$aOxidase, Hypoxanthine-Xanthine
=450  \\$wnnna$aOxidase, Purine-Xanthine
=450  \\$wnnna$aOxidase, Xanthine
=450  \\$wnnna$aPurine-Xanthine Oxidase
=450  \\$wnnna$aPurine Xanthine Oxidase
=550  \\$wg$aAlcohol Oxidoreductases
=667  \\$a/defic: consider also XANTHINES /urine (IM) + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS (IM)
=680  \\$iAn iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria.
=688  \\$a65
=750  \0$aXanthine oxidase$5IEN$0(DLC)sh 85148765

=LDR  00720cz  a2200241n  4500
=001  9880364148302441
=005  20141212210802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014966
=035  \\$aCBA8317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x953
=150  \\$aXanthenes
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wh$aFluoresceins
=550  \\$wh$aPropantheline
=550  \\$wh$aPyronine
=550  \\$wh$aRhodamines
=550  \\$wh$aThioxanthenes
=550  \\$wh$aXanthones
=667  \\$ado not confuse with XANTHINES
=680  \\$iCompounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.
=750  \0$aXanthene$5IEN$0(DLC)sh 85148760

=LDR  01907cz  a2200385n  4500
=001  9880364148402441
=005  20141212210802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014965
=035  \\$aCBA8316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x505.$x970
=072  \\$aG1.$x750.$x250.$x970
=072  \\$aG1.$x750.$x750.$x918
=150  \\$aX-Rays
=450  \\$aGrenz Rays
=450  \\$wnnna$aRadiation, X
=450  \\$wnnna$aRadiations, X
=450  \\$wnnna$aRays, Grenz
=450  \\$wnnna$aRays, Roentgen
=450  \\$aRoentgen Rays
=450  \\$wnnna$aX-Radiation
=450  \\$wnnna$aX Radiation
=450  \\$wnnna$aX Radiations
=450  \\$wnnna$aX-Radiations
=450  \\$wnnna$aX-Ray
=450  \\$wnnna$aX Rays
=450  \\$wnnna$aXray
=450  \\$wnnna$aXrays
=550  \\$wg$aElectromagnetic Radiation
=550  \\$wg$aRadiation, Ionizing
=667  \\$aalmost never IM; /diag use = RADIOGRAPHY (general) or /radiogr with diseases; /ther use = X-RAY THERAPY (general)or /radiother with diseases; do not index X-rays when using / rad eff: assume all /rad eff is X-RAYS unless otherwise specified (as /rad eff + GAMMA RAYS); Manual 19.8.60, 19.8.61, 19.8.63, 28.10; X-ray or x-ray in translations: follow text
=680  \\$iPenetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard X-rays are the higher energy, shorter wavelength X-rays. Soft x-rays or Grenz rays are less energetic and longer in wavelength. The short wavelength end of the X-ray spectrum overlaps the GAMMA RAYS wavelength range. The distinction between gamma rays and X-rays is based on their radiation source.
=688  \\$a91(75); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75
=750  \0$aX-rays$5IEN$0(DLC)sh 85148749

=LDR  02692cz  a2200577n  4500
=001  9880364148502441
=005  20141212210801.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014963
=035  \\$aCBA8314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x970
=150  \\$aX-Ray Intensifying Screens
=450  \\$wnnna$aFilm-Screen System, X-Ray
=450  \\$aFilm-Screen Systems, X-Ray
=450  \\$wnnna$aFilm Screen Systems, X Ray
=450  \\$wnnna$aIntensifying Screen, Radiographic
=450  \\$wnnna$aIntensifying Screen, X-Ray
=450  \\$wnnna$aIntensifying Screen, Xray
=450  \\$wnnna$aIntensifying Screens, Radiographic
=450  \\$wnnna$aIntensifying Screens, X-Ray
=450  \\$wnnna$aIntensifying Screens, Xray
=450  \\$wnnna$aRadiographic Intensifying Screen
=450  \\$aRadiographic Intensifying Screens
=450  \\$wnnna$aScreen-Film System, X-Ray
=450  \\$aScreen-Film Systems, X-Ray
=450  \\$wnnna$aScreen Film Systems, X Ray
=450  \\$wnnna$aScreen, Radiographic Intensifying
=450  \\$wnnna$aScreen, X-Ray Intensifying
=450  \\$wnnna$aScreen, Xray Intensifying
=450  \\$wnnna$aScreens, Radiographic Intensifying
=450  \\$wnnna$aScreens, X-Ray Intensifying
=450  \\$wnnna$aScreens, Xray Intensifying
=450  \\$wnnna$aSystem, X-Ray Film-Screen
=450  \\$wnnna$aSystem, X-Ray Screen-Film
=450  \\$wnnna$aSystems, X-Ray Film-Screen
=450  \\$wnnna$aSystems, X-Ray Screen-Film
=450  \\$wnnna$aX-Ray Film-Screen System
=450  \\$aX-Ray Film-Screen Systems
=450  \\$wnnna$aX Ray Film Screen Systems
=450  \\$wnnna$aX-Ray Intensifying Screen
=450  \\$wnnna$aX Ray Intensifying Screens
=450  \\$wnnna$aX-Ray Screen-Film System
=450  \\$wnnna$aX-Ray Screen-Film Systems
=450  \\$wnnna$aXray Intensifying Screen
=450  \\$wnnna$aXray Intensifying Screens
=550  \\$wg$aEquipment and Supplies
=550  \\$aRadiographic Image Enhancement
=680  \\$iScreens which absorb the energy in the x-ray beam that has penetrated the patient and convert this energy into a light pattern which has as nearly as possible the same information as the original x-ray beam. The more light a screen produces for a given input of x-radiation, the less x-ray exposure and thus shorter exposure time are needed to expose the film. In most film-screen systems, the film is sandwiched between two screens in a cassette so that the emulsion on each side is exposed to the light from its contiguous screen.
=688  \\$a89(82); was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88
=750  \0$aScreen film radiography$5IEN$0(DLC)sh 91005963

=LDR  01497cz  a2200349n  4500
=001  9880364148602441
=005  20170629133000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014961
=035  \\$aCBA8312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x309.$x742
=072  \\$aE5.$x196.$x822.$x950
=072  \\$aG1.$x867.$x950
=072  \\$aG2.$x965
=150  \\$aX-Ray Diffraction
=450  \\$wnnna$aDiffraction, X-Ray
=450  \\$wnnna$aDiffraction, Xray
=450  \\$wnnna$aDiffractions, X-Ray
=450  \\$wnnna$aDiffractions, Xray
=450  \\$wnnna$aX Ray Diffraction
=450  \\$wnnna$aX-Ray Diffractions
=450  \\$wnnna$aXray Diffraction
=450  \\$wnnna$aXray Diffractions
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aCrystallography
=550  \\$wg$aScattering, Radiation
=550  \\$wh$aCrystallography, X-Ray
=667  \\$aapplication to study of crystal structure = CRYSTALLOGRAPHY, X-RAY; for SAXS (small angle X-ray scattering) coordinate with SCATTERING, SMALL ANGLE
=680  \\$iThe scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a65(63)
=750  \0$aX-rays$xDiffraction$5IEN$0(DLC)sh 85148750

=LDR  01039cz  a2200229n  4500
=001  9880364148702441
=005  20141212210759.0
=008  770429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014960
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x865.$x982
=072  \\$aG5.$x360.$x162.$x865.$x982
=150  \\$aX Chromosome
=450  \\$wnnna$aChromosome, X
=450  \\$wnnna$aChromosomes, X
=450  \\$wnnna$aX Chromosomes
=550  \\$wg$aSex Chromosomes
=550  \\$wh$aChromosomes, Human, X
=667  \\$aabnormalities: coordinate IM with SEX CHROMOSOME ABERRATIONS (IM) or specific diseases (IM) + SEX CHROMOSOME ABERRATIONS (NIM); X-lined disease = GENETIC DISEASES, X-LINKED or specifics; X CHROMOSOME, HUMAN is also available
=680  \\$iThe female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species.
=688  \\$a84(78); was see under SEX CHROMOSOMES 1968-83
=750  \0$aX chromosome$5IEN$0(DLC)sh 85148724

=LDR  01160cz  a2200229n  4500
=001  9880364148802441
=005  20150416164820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014956
=035  \\$aCBA8307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906
=150  \\$aWriting
=550  \\$wg$aLanguage Arts
=550  \\$wh$aAuthorship
=550  \\$wh$aCorrespondence as Topic
=550  \\$wh$aHandwriting
=550  \\$wh$aMedical Writing
=550  \\$wh$aResearch Report
=667  \\$athe act or profession of writing or its product; do not confuse with PUBLISHING or LITERATURE or AUTHORSHIP or JOURNALISM; style of writing goes here; includes typewriting; editing for publication is indexed as PUBLISHING; writing for periodicals is indexed as PERIODICALS AS TOPIC; letters & correspondence of biographees & famous persons are indexed as CORRESPONDENCE AS TOPIC (IM); HANDWRITING and MEDICAL WRITING are also available
=680  \\$iThe act or practice of literary composition, the occupation of writer, or producing or engaging in literary work as a profession.
=750  \0$aWritten communication$5IEN-M$0(DLC)sh 85148659

=LDR  00921cz  a2200229n  4500
=001  9880364148902441
=005  20141212210758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014955
=035  \\$aCBA8306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x405.$x930
=150  \\$aWrist Joint
=450  \\$wnnna$aJoint, Wrist
=450  \\$wnnna$aJoints, Wrist
=450  \\$wnnna$aWrist Joints
=550  \\$wg$aHand Joints
=550  \\$wh$aTriangular Fibrocartilage
=667  \\$aprimates only; use CARPUS, ANIMAL for non-primate vertebrates; differentiate from wrist; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM)
=680  \\$iThe joint that is formed by the distal end of the RADIUS, the articular disc of the distal radioulnar joint, and the proximal row of CARPAL BONES; (SCAPHOID BONE; LUNATE BONE; triquetral bone).
=688  \\$a65
=750  \0$aWrist$5IEN$0(DLC)sh 85148626

=LDR  00700cz  a2200241n  4500
=001  9880364149002441
=005  20141212210758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014954
=035  \\$aCBA8305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x88.$x906
=150  \\$aWrist Injuries
=450  \\$wnnna$aInjuries, Wrist
=450  \\$wnnna$aInjury, Wrist
=450  \\$aWrist$xinjuries
=450  \\$wnnna$aWrist Injury
=450  \\$aWrist Joint$xinjuries
=550  \\$wg$aArm Injuries
=550  \\$aHand Injuries
=667  \\$aconsider also CARPAL BONES /inj
=680  \\$iInjuries to the wrist or the wrist joint.
=750  \0$aWrist$xWounds and injuries$5IEN$0(DLC)sh 85148630

=LDR  00657cz  a2200169n  4500
=001  9880364149102441
=005  20141212210758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014953
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x667.$x715
=150  \\$aWrist
=450  \\$wnnna$aWrists
=550  \\$wg$aHand
=667  \\$aprimates only; for non-primate vertebrates: Manual 21.58; wrist ganglion is indexed under WRIST (IM) + SYNOVIAL CYST (IM); differentiate from WRIST JOINT; wrist bone = CARPAL BONES or specifics
=680  \\$iThe region of the upper limb between the metacarpus and the FOREARM.
=750  \0$aWrist$5IEN$0(DLC)sh 85148626

=LDR  00710cz  a2200205n  4500
=001  9880364149202441
=005  20141212210757.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014952
=035  \\$aCBA8303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x975
=150  \\$aWrestling
=450  \\$wnnna$aWrestlings
=550  \\$wg$aSports
=550  \\$aMartial Arts
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted
=680  \\$iA sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other's shoulders to the ground.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aWrestling$5IEN$0(DLC)sh 85148615

=LDR  00669cz  a2200229n  4500
=001  9880364149302441
=005  20141212210757.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014951
=035  \\$aCBA8302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x986.$x950
=150  \\$aWounds, Stab
=450  \\$wnnna$aStab Wound
=450  \\$wnnna$aStab Wounds
=450  \\$wnnna$aWound, Stab
=550  \\$wg$aWounds, Penetrating
=550  \\$wh$aNeedlestick Injuries
=667  \\$aIM; coord with organ /inj or precoord inj term (IM)
=680  \\$iPenetrating wounds caused by a pointed object.
=688  \\$a76
=750  \0$aStab wounds$5IEN-M$0(DLC)sh 94005297

=LDR  00926cz  a2200289n  4500
=001  9880364149402441
=005  20141212210757.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014950
=035  \\$aCBA8301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x986
=150  \\$aWounds, Penetrating
=450  \\$wnnna$aPenetrating Wound
=450  \\$wnnna$aPenetrating Wounds
=450  \\$wnnna$aWound, Penetrating
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aCorpse Dismemberment
=550  \\$wh$aDecapitation
=550  \\$wh$aEye Injuries, Penetrating
=550  \\$wh$aHead Injuries, Penetrating
=550  \\$wh$aWounds, Gunshot
=550  \\$wh$aWounds, Stab
=667  \\$anote WOUNDS, GUNSHOT & WOUNDS, STAB; IM; coord with organ /inj or precoord inj term (IM)
=680  \\$iWounds caused by objects penetrating the skin.
=688  \\$a76
=750  \0$aPenetrating wounds$0(DLC) sh 94005296$5IEN-M

=LDR  01161cz  a2200361n  4500
=001  9880364149502441
=005  20141212210757.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014949
=035  \\$aCBA8300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x974
=150  \\$aWounds, Nonpenetrating
=450  \\$aBlunt Injuries
=450  \\$wnnna$aBlunt Injury
=450  \\$aBlunt Trauma$5IEN
=450  \\$wnnna$aInjuries, Blunt
=450  \\$aInjuries, Nonpenetrating
=450  \\$wnnna$aInjury, Blunt
=450  \\$wnnna$aInjury, Nonpenetrating
=450  \\$wnnna$aNonpenetrating Injuries
=450  \\$wnnna$aNonpenetrating Injury
=450  \\$wnnna$aNonpenetrating Wound
=450  \\$wnnna$aNonpenetrating Wounds
=450  \\$wnnna$aWound, Nonpenetrating
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBrain Concussion
=550  \\$wh$aContusions
=550  \\$wh$aHead Injuries, Closed
=667  \\$aIM; coord with organ /inj or precoord inj term (IM)
=680  \\$iInjuries caused by impact with a blunt object where there is no penetration of the skin.
=688  \\$a76
=750  \0$aBlunt trauma$5IEN$0(DLC)sh 85148588

=LDR  00770cz  a2200229n  4500
=001  9880364149602441
=005  20141212210756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014948
=035  \\$aCBA8299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x986.$x900
=150  \\$aWounds, Gunshot
=450  \\$wnnna$aGunshot Wound
=450  \\$wnnna$aGunshot Wounds
=450  \\$wnnna$aWound, Gunshot
=550  \\$wg$aWounds, Penetrating
=550  \\$aFirearms
=550  \\$aForensic Ballistics
=667  \\$acoord IM with organ /inj (IM) or precoord inj term (IM); FORENSIC BALLISTICS is also available
=680  \\$iDisruption of structural continuity of the body as a result of the discharge of firearms.
=750  \0$aGunshot wounds$5IEN$0(DLC)sh 85057943

=LDR  03082cz  a2200973n  4500
=001  9880364149702441
=005  20190114111622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014947
=035  \\$aCBA8298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26
=150  \\$aWounds and Injuries
=450  \\$aInjuries
=450  \\$wnnna$aInjuries and Wounds
=450  \\$wnnna$aInjuries, Wounds
=450  \\$wnnna$aInjury
=450  \\$wnnna$aInjury and Wounds
=450  \\$aTrauma
=450  \\$wnnna$aTraumas
=450  \\$wnnna$aWound
=450  \\$wnnna$aWounds
=450  \\$wnnna$aWounds and Injury
=450  \\$wnnna$aWounds, Injury
=550  \\$wh$aAbdominal Injuries
=550  \\$wh$aAmputation, Traumatic
=550  \\$wh$aArm Injuries
=550  \\$wh$aAsphyxia
=550  \\$wh$aAthletic Injuries
=550  \\$wh$aBack Injuries
=550  \\$wh$aBarotrauma
=550  \\$wh$aBattered Child Syndrome
=550  \\$wh$aBirth Injuries
=550  \\$wh$aBites and Stings
=550  \\$wh$aBurns
=550  \\$wh$aCold Injury
=550  \\$wh$aContrecoup Injury
=550  \\$wh$aContusions
=550  \\$wh$aCraniocerebral Trauma
=550  \\$wh$aCrush Injuries
=550  \\$wh$aDislocations
=550  \\$wh$aDrowning
=550  \\$wh$aElectric Injuries
=550  \\$wh$aEsophageal Perforation
=550  \\$wh$aExtravasation of Diagnostic and Therapeutic Materials
=550  \\$wh$aForeign Bodies
=550  \\$wh$aFractures, Bone
=550  \\$wh$aFractures, Cartilage
=550  \\$wh$aFrostbite
=550  \\$wh$aHand Injuries
=550  \\$wh$aHeat Stress Disorders
=550  \\$wh$aHip Injuries
=550  \\$wh$aLacerations
=550  \\$wh$aLeg Injuries
=550  \\$wh$aMicrotrauma, Physical
=550  \\$wh$aMultiple Trauma
=550  \\$wh$aNasal Septal Perforation
=550  \\$wh$aNeck Injuries
=550  \\$wh$aOccupational Injuries
=550  \\$wh$aRadiation Injuries
=550  \\$wh$aRetropneumoperitoneum
=550  \\$wh$aRupture
=550  \\$wh$aSelf Mutilation
=550  \\$wh$aShock, Traumatic
=550  \\$wh$aShoulder Injuries
=550  \\$wh$aSoft Tissue Injuries
=550  \\$wh$aSpinal Cord Injuries
=550  \\$wh$aSpinal Injuries
=550  \\$wh$aSprains and Strains
=550  \\$wh$aSurgical Wound
=550  \\$wh$aTendon Injuries
=550  \\$wh$aThoracic Injuries
=550  \\$wh$aTooth Injuries
=550  \\$wh$aTrauma, Nervous System
=550  \\$wh$aTympanic Membrane Perforation
=550  \\$wh$aVascular System Injuries
=550  \\$wh$aWound Infection
=550  \\$wh$aWounds, Nonpenetrating
=550  \\$wh$aWounds, Penetrating
=550  \\$aFirst Aid
=550  \\$aTraumatology
=667  \\$ageneral or unspecified; prefer / inj with organs (Manual 19.7+, 19.8.38) or specific organ / inj precoordinates; policy: Manual 23.23
=680  \\$iDamage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.
=750  \0$aWounds and injuries$5IEN$0(DLC)sh 85148589

=LDR  00825cz  a2200241n  4500
=001  9880364149802441
=005  20141212210755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014946
=035  \\$aCBA8297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x947
=072  \\$aC26.$x951
=150  \\$aWound Infection
=450  \\$wnnna$aInfection, Wound
=450  \\$wnnna$aInfections, Wound
=450  \\$wnnna$aWound Infections
=550  \\$wg$aInfection
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aSurgical Wound Infection
=667  \\$aIM; do not coord with BACTERIAL INFECTIONS unless particularly discussed but coord IM with specific bact infect (IM)
=680  \\$iInvasion of the site of trauma by pathogenic microorganisms.
=750  \0$aWounds and injuries$xInfections$5IEN$0(DLC)sh 85148591

=LDR  00850cz   2200265n  4500
=001  9880364149902441
=005  20230901102457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014945
=035  \\$aCBA8296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x100.$x856.$x891
=150  \\$aWound Healing
=450  \\$wnnna$aHealing, Wound
=450  \\$wnnna$aHealings, Wound
=450  \\$wnnna$aWound Healings
=550  \\$wg$aRegeneration
=550  \\$wh$aCicatrix
=550  \\$wh$aFracture Healing
=550  \\$wh$aRe-Epithelialization
=550  \\$aRegeneration
=667  \\$aalso available is FRACTURE HEALING; not for invertebrates or plants
=680  \\$iRestoration of integrity to traumatized tissue.
=750  \0$aWound healing$5IEN$0(DLC)sh 85148581
=750  \0$iNarrower mapping$aScabs (Wounds)$0(DLC)sh2022006730$4NM$5IEN-M

=LDR  01325cz  a2200337n  4500
=001  9880364150002441
=005  20141212192630.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014943
=035  \\$aCBA8294HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x371
=072  \\$aN1.$x400.$x337
=150  \\$aGlobal Health
=450  \\$wnnna$aHealth, Global
=450  \\$wnnna$aHealth Problem, International
=450  \\$wnnna$aHealth Problems, International
=450  \\$wnnna$aHealth, World
=450  \\$wnnna$aInternational Health Problem
=450  \\$aInternational Health Problems
=450  \\$wnnna$aProblem, International Health
=450  \\$wnnna$aProblems, International Health
=450  \\$aWorld Health
=550  \\$wg$aHealth
=550  \\$wg$aMedicine
=550  \\$aWorld Health Organization
=680  \\$iA multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care.
=688  \\$a2015 (978)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a World Health
=688  \\$a78
=750  \0$aWorld health$5IEN$0(DLC)sh 85148199

=LDR  01687cz  a2200457n  4500
=001  9880364150102441
=005  20141212210754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x866
=072  \\$aN3.$x219.$x521.$x576.$x300.$x900
=150  \\$aWorkers' Compensation
=450  \\$wnnna$aCompensation, Worker's
=450  \\$wnnna$aCompensation, Workers'
=450  \\$wnnna$aCompensation, Workman's
=450  \\$wnnna$aCompensation, Workmen's
=450  \\$wnnna$aCompensations, Worker's
=450  \\$wnnna$aCompensations, Workers'
=450  \\$wnnna$aCompensations, Workman's
=450  \\$wnnna$aCompensations, Workmen's
=450  \\$wnnna$aWorker Compensation
=450  \\$wnnna$aWorker's Compensation
=450  \\$wnnna$aWorkers Compensation
=450  \\$wnnna$aWorker's Compensations
=450  \\$wnnna$aWorkers' Compensations
=450  \\$wnnna$aWorkman Compensation
=450  \\$wnnna$aWorkman's Compensation
=450  \\$wnnna$aWorkmans Compensation
=450  \\$wnnna$aWorkman's Compensations
=450  \\$wnnna$aWorkmen Compensation
=450  \\$aWorkmen's Compensation
=450  \\$wnnna$aWorkmens Compensation
=450  \\$wnnna$aWorkmen's Compensations
=550  \\$wg$aFinancing, Government
=550  \\$wg$aInsurance, Disability
=550  \\$aCompensation and Redress
=667  \\$aspecify country or state
=680  \\$iInsurance coverage providing compensation and medical benefits to individuals because of work-connected injuries or disease.
=688  \\$a93; was WORKMEN'S COMPENSATION 1963-92
=750  \0$aWorkers' compensation$5IEN$0(DLC)sh 85148162

=LDR  00847cz  a2200229n  4500
=001  9880364150202441
=005  20141212210754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014941
=035  \\$aCBA8292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x412.$x846.$x853
=072  \\$aF2.$x784.$x692.$x746.$x853
=150  \\$aWork Simplification
=450  \\$wnnna$aSimplification, Work
=450  \\$wnnna$aSimplifications, Work
=450  \\$wnnna$aWork Simplifications
=550  \\$wg$aTask Performance and Analysis
=667  \\$ano qualif
=680  \\$iThe construction or arrangement of a task so that it may be done with the greatest possible efficiency.
=688  \\$a75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY & TASK PERFORMANCE AND ANALYSIS 1974
=750  \0$aMethods engineering$5IEN$0(DLC)sh 85084415

=LDR  01064cz  a2200241n  4500
=001  9880364150302441
=005  20141212210753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014938
=035  \\$aCBA8289HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x400.$x925
=150  \\$aWork Capacity Evaluation
=450  \\$wnnna$aCapacity Evaluation, Work
=450  \\$wnnna$aCapacity Evaluations, Work
=450  \\$wnnna$aEvaluation, Work Capacity
=450  \\$wnnna$aEvaluations, Work Capacity
=450  \\$wnnna$aWork Capacity Evaluations
=550  \\$wg$aDisability Evaluation
=667  \\$ano qualif; DF: WORK CAPAC EVALUATION
=680  \\$iAssessment of physiological capacities in relation to job requirements. It is usually done by measuring certain physiological (e.g., circulatory and respiratory) variables during a gradually increasing workload until specific limitations occur with respect to those variables.
=688  \\$a86(75); was see under DISABILITY EVALUATION 1966-85
=750  \0$aWork capacity evaluation$5IEN$0(DLC)sh 90003216

=LDR  00793cz  a2200241n  4500
=001  9880364150402441
=005  20171219144321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014937
=035  \\$aCBA8288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x946
=150  \\$aWork
=550  \\$wg$aHuman Activities
=550  \\$wh$aPersonnel Staffing and Scheduling
=550  \\$wh$aReturn to Work
=550  \\$wh$aWork Engagement
=550  \\$wh$aWork Performance
=550  \\$aPhysical Exertion
=667  \\$apurposeful activity: differentiate from PHYSICAL EXERTION; EMPLOYMENT; and ENERGY EXPENDITURE; BURNOUT, PROFESSIONAL is available
=680  \\$iProductive or purposeful activities.
=688  \\$a66; was see under EXERTION 1963-65
=750  \0$aWork$5IEN$0(DLC)sh 85148133

=LDR  00672cz  a2200229n  4500
=001  9880364150502441
=005  20141212211043.0
=008  880608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015443
=035  \\$aCBA8287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x950
=072  \\$aN4.$x452.$x515.$x708.$x950
=150  \\$aWord Processing
=450  \\$wnnna$aProcessing, Word
=450  \\$wnnna$aProcessings, Word
=450  \\$wnnna$aWord Processings
=550  \\$wg$aOffice Automation
=550  \\$wg$aSoftware
=680  \\$iText editing and storage functions using computer software.
=688  \\$a1989
=750  \0$aWord processing$5IEN$0(DLC)sh 85148107

=LDR  00838cz  a2200253n  4500
=001  9880364150602441
=005  20141212210752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014936
=035  \\$aCBA8286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x905
=150  \\$aWord Association Tests
=450  \\$wnnna$aAssociation Test, Word
=450  \\$wnnna$aAssociation Tests, Word
=450  \\$wnnna$aTest, Word Association
=450  \\$wnnna$aTests, Word Association
=450  \\$wnnna$aWord Association Test
=550  \\$wg$aPersonality Tests
=550  \\$aAssociation
=667  \\$aDF: WORD ASSOC TESTS
=680  \\$iLists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual.
=688  \\$a69
=750  \0$aAssociation tests$5IEN$0(DLC)sh 85008808

=LDR  00750cz  a2200253n  4500
=001  9880364150702441
=005  20141212192630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014935
=035  \\$aCBA8285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x970
=072  \\$aA17.$x360.$x855
=072  \\$aJ1.$x576.$x655.$x937.$x800.$x800
=072  \\$aJ1.$x637.$x883
=150  \\$aWool
=450  \\$wnnna$aWools
=550  \\$wg$aAnimal Structures
=550  \\$wg$aHair
=550  \\$wg$aManufactured Materials
=550  \\$wg$aTextiles
=667  \\$aas animal hair & as textile; not for ASBESTOS wool nor for STEEL wool
=680  \\$iThe hair of SHEEP or other animals that is used for weaving.
=750  \0$aWool$5IEN$0(DLC)sh 85148044

=LDR  00703cz  a2200205n  4500
=001  9880364150802441
=005  20141212192630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014934
=035  \\$aCBA8284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x700.$x888
=072  \\$aJ1.$x637.$x241.$x900
=150  \\$aWood
=450  \\$wnnna$aWoods
=550  \\$wg$aConstruction Materials
=550  \\$wg$aXylem
=550  \\$aForests
=680  \\$iA product of hard secondary xylem composed of CELLULOSE, hemicellulose, and LIGNANS, that is under the bark of trees and shrubs. It is used in construction and as a source of CHARCOAL and many other products.
=750  \0$aWood$5IEN$0(DLC)sh 85147783

=LDR  01115cz  a2200361n  4500
=001  9880364150902441
=005  20141212210752.0
=008  760505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014933
=035  \\$aCBA8283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x850
=072  \\$aN3.$x706.$x437.$x850
=150  \\$aWomen's Rights
=450  \\$wnnna$aLiberation, Women's
=450  \\$wnnna$aRight, Woman's
=450  \\$wnnna$aRight, Women's
=450  \\$wnnna$aRights, Woman's
=450  \\$wnnna$aRights, Women's
=450  \\$wnnna$aStatus, Women's
=450  \\$wnnna$aWoman Rights
=450  \\$wnnna$aWoman's Right
=450  \\$wnnna$aWoman's Rights
=450  \\$wnnna$aWomen Status
=450  \\$aWomen's Liberation
=450  \\$wnnna$aWomen's Right
=450  \\$wnnna$aWomen's Status
=550  \\$wg$aHuman Rights
=550  \\$aHuman Rights
=667  \\$aspecify geog
=680  \\$iThe rights of women to equal status pertaining to social, economic, and educational opportunities afforded by society.
=688  \\$a77
=750  \0$aWomen's rights$5IEN$0(DLC)sh 85147765

=LDR  01704cz  a2200433n  4500
=001  9880364151002441
=005  20141212210752.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014932
=035  \\$aCBA8282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x920
=150  \\$aWomen's Health Services
=450  \\$wnnna$aHealth Service, Woman's
=450  \\$wnnna$aHealth Service, Women's
=450  \\$wnnna$aHealth Services, Woman
=450  \\$wnnna$aHealth Services, Woman's
=450  \\$wnnna$aHealth Services, Womans
=450  \\$wnnna$aHealth Services, Women
=450  \\$aHealth Services, Women's
=450  \\$wnnna$aService, Woman's Health
=450  \\$wnnna$aService, Women's Health
=450  \\$wnnna$aServices, Woman Health
=450  \\$wnnna$aServices, Woman's Health
=450  \\$wnnna$aServices, Womans Health
=450  \\$wnnna$aServices, Women Health
=450  \\$wnnna$aServices, Women's Health
=450  \\$wnnna$aServices, Womens Health
=450  \\$wnnna$aWoman Health Services
=450  \\$wnnna$aWoman's Health Service
=450  \\$wnnna$aWoman's Health Services
=450  \\$wnnna$aWomen Health Services
=450  \\$wnnna$aWomen's Health Service
=550  \\$wg$aHealth Services
=550  \\$wh$aPreconception Care
=667  \\$adoes not include maternal care services: index under MATERNAL HEALTH SERVICES; check also tags HUMANS and FEMALE; DF: WOMENS HEALTH SERV
=680  \\$iOrganized services to provide health care to women. It excludes maternal care services for which MATERNAL HEALTH SERVICES is available.
=688  \\$a89(88); was see under HEALTH SERVICES 1988
=750  \0$aWomen's health services$5IEN$0(DLC)sh 85147744

=LDR  01103cz  a2200301n  4500
=001  9880364151102441
=005  20141212210751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014930
=035  \\$aCBA8280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x975
=150  \\$aWomen
=450  \\$wnnna$aGroup, Women's
=450  \\$wnnna$aGroups, Women's
=450  \\$wnnna$aWoman
=450  \\$wnnna$aWomen Groups
=450  \\$wnnna$aWomen's Group
=450  \\$wnnna$aWomen's Groups
=550  \\$wg$aPersons
=550  \\$wh$aBattered Women
=550  \\$wh$aDentists, Women
=550  \\$wh$aPhysicians, Women
=550  \\$wh$aPregnant Women
=550  \\$wh$aWomen, Working
=667  \\$afor women or girls only as a cultural, social, sociological, political, economic force; distinguish from the check tag FEMALE; when indexing WOMEN, check the tags HUMANS & FEMALE; Manual 18.9.6, 34.12 CATALOG: Coordinate with age group if appropriate
=680  \\$iHuman females as cultural, psychological, sociological, political, and economic entities.
=750  \0$aWomen$0(DLC) sh 85147274$5IEN

=LDR  01597cz  a2200313n  4500
=001  9880364151202441
=005  20141212210750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014927
=035  \\$aCBA8276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x780.$x977
=072  \\$aC16.$x131.$x240.$x400.$x980
=150  \\$aWolff-Parkinson-White Syndrome
=450  \\$wnnna$aAnomalous Ventricular Excitation Syndrome
=450  \\$wnnna$aAuriculoventricular Accessory Pathway Syndrome
=450  \\$wnnna$aFalse Bundle-Branch Block Syndrome
=450  \\$wnnna$aSyndrome, Wolf-Parkinson-White
=450  \\$wnnna$aSyndrome, Wolff-Parkinson-White
=450  \\$wnnna$aSyndrome, WPW
=450  \\$wnnna$aVentricular Pre-Excitation with Arrhythmia
=450  \\$wnnna$aWolf-Parkinson-White Syndrome
=450  \\$wnnna$aWolf Parkinson White Syndrome
=450  \\$wnnna$aWolff Parkinson White Syndrome
=450  \\$aWPW Syndrome
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wg$aPre-Excitation Syndromes
=680  \\$iA form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
=750  \0$aWolff-Parkinson-White syndrome$5IEN$0(DLC)sh 85147229

=LDR  00684cz  a2200217n  4500
=001  9880364151402441
=005  20160818115157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014921
=035  \\$aCBA8270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x395.$x823
=150  \\$aWings, Animal
=450  \\$wnno$aWing$5IEN-M
=450  \\$wnnna$aAnimal Wing
=450  \\$wnnna$aAnimal Wings
=450  \\$wnnna$aWing, Animal
=550  \\$wg$aForelimb
=680  \\$iMovable feathered or membranous paired appendages by means of which certain animals such as birds, bats, or insects are able to fly.
=688  \\$a2016 (1989)
=750  \0$aWings (Anatomy)$5IEN$0(DLC)sh 85147012

=LDR  00744cz  a2200241n  4500
=001  9880364151502441
=005  20200511143910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014920
=035  \\$aCBA8269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7$x.203.$x100.$x100.$x900
=072  \\$aG7.$x203.$x200.$x887
=072  \\$aJ2.$x200.$x100.$x900
=072  \\$aJ2.$x350.$x887
=150  \\$aWine
=450  \\$wnnna$aWines
=550  \\$wg$aFermented Foods and Beverages
=550  \\$wg$aAlcoholic Beverages
=550  \\$aVitis
=680  \\$iFermented juice of fresh grapes or of other fruit or plant products used as a beverage.
=750  \0$aWine$0(DLC) sh 85146968$5IEN
=750  \0$aWine and wine making$0(DLC) sh 85146975$5IEN-M

=LDR  00960cz  a2200277n  4500
=001  9880364151602441
=005  20141212210747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014919
=035  \\$aCBA8268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x249.$x200
=072  \\$aG16.$x500.$x275.$x63.$x725.$x154.$x200
=072  \\$aG16.$x500.$x750.$x775.$x780
=072  \\$aN6.$x230.$x132.$x644.$x875
=072  \\$aN6.$x230.$x300.$x100.$x150.$x185.$x200
=072  \\$aN6.$x230.$x300.$x100.$x725.$x780
=150  \\$aWind
=450  \\$wnnna$aWinds
=550  \\$wg$aAir Movements
=550  \\$wg$aRenewable Energy
=550  \\$wg$aWeather
=667  \\$aCYCLONIC STORMS and entry terms TYPHOONS and HURRICANES are also available
=680  \\$iThe motion of air relative to the earth's surface.
=688  \\$a91(75); was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73
=750  \0$aWinds$5IEN$0(DLC)sh 85146948

=LDR  00827cz  a2200193n  4500
=001  9880364151702441
=005  20141212210747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014918
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x927
=150  \\$aWills
=450  \\$wnnna$aInheritance
=450  \\$wnnna$aInheritances
=550  \\$wg$aJurisprudence
=550  \\$wh$aLiving Wills
=667  \\$ado not confuse X ref INHERITANCE with HEREDITY
=680  \\$iLegal documents that are declarations of individuals' wishes regarding the disposal of their property or estate after death; esp: written instruments, legally executed, by which dispositions are made of estates. LIVING WILLS are written declarations regarding prolongation of life by extraordinary means.
=750  \0$aWills$5IEN$0(DLC)sh 85146810

=LDR  00913cz  a2200265n  4500
=001  9880364151802441
=005  20141212210747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014917
=035  \\$aCBA8266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x143.$x740
=072  \\$aC1.$x539.$x739.$x969
=072  \\$aC8.$x730.$x969
=150  \\$aWhooping Cough
=450  \\$wnnna$aBordetella pertussis Infection, Respiratory
=450  \\$wnnna$aCough, Whooping
=450  \\$wnnna$aPertusses
=450  \\$aPertussis
=550  \\$wg$aBordetella Infections
=550  \\$wg$aRespiratory Tract Infections
=550  \\$aPertussis Vaccine
=667  \\$acaused by Bordetella pertussis
=680  \\$iA respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.
=750  \0$aWhooping-cough$5IEN$0(DLC)sh 85146578

=LDR  00873cz  a2200253n  4500
=001  9880364151902441
=005  20141212210746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014915
=035  \\$aCBA8264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799.$x950
=150  \\$aWhole-Body Counting
=450  \\$wnnna$aCounter, Whole-Body
=450  \\$wnnna$aCounters, Whole-Body
=450  \\$wnnna$aCounting, Whole-Body
=450  \\$wnnna$aWhole-Body Counter
=450  \\$wnnna$aWhole-Body Counters
=450  \\$wnnna$aWhole Body Counters
=450  \\$wnnna$aWhole Body Counting
=550  \\$wg$aRadiometry
=680  \\$iMeasurement of radioactivity in the entire human body.
=688  \\$a92; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78; was WHOLE BODY COUNTER 1971-72 (Prov)
=750  \0$aWhole body counters$5IEN-M$0(DLC)sh 85146573

=LDR  00750cz  a2200205n  4500
=001  9880364152002441
=005  20141212210745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014911
=035  \\$aCBA8260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x700.$x500
=150  \\$aWhiplash Injuries
=450  \\$wnnna$aInjuries, Whiplash
=450  \\$wnnna$aInjury, Whiplash
=450  \\$wnnna$aWhiplash Injury
=550  \\$wg$aNeck Injuries
=680  \\$iHyperextension injury to the neck, often the result of being struck from behind by a fast-moving vehicle, in an automobile accident. (From Segen, The Dictionary of Modern Medicine, 1992)
=688  \\$a73; was WHIPLASH INJURY 1963-72
=750  \0$aWhiplash injuries$5IEN$0(DLC)sh 85146432

=LDR  00677cz  a2200229n  4500
=001  9880364152102441
=005  20141212210745.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014910
=035  \\$aCBA8259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x796.$x980
=150  \\$aWheelchairs
=450  \\$wnnna$aChair, Wheel
=450  \\$wnnna$aChairs, Wheel
=450  \\$wnnna$aWheel Chair
=450  \\$wnnna$aWheel Chairs
=450  \\$wnnna$aWheelchair
=550  \\$wg$aSelf-Help Devices
=680  \\$iChairs mounted on wheels and designed to be propelled by the occupant.
=688  \\$a76; was WHEEL CHAIRS 1963-75
=750  \0$aWheelchairs$5IEN$0(DLC)sh 85146406

=LDR  01419cz  a2200289n  4500
=001  9880364152202441
=005  20160422112401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014908
=035  \\$aCBA8257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x918
=072  \\$aJ2.$x500.$x200.$x875
=150  \\$aTriticum
=450  \\$wnnna$aDurum Wheat
=450  \\$wnnna$aDurum Wheats
=450  \\$wnnna$aTriticum aestivum
=450  \\$wnnna$aTriticum durum
=450  \\$wnnna$aTriticum spelta
=450  \\$wnnna$aTriticum turgidum
=450  \\$wnnna$aTriticum vulgare
=450  \\$aWheat
=450  \\$wnnna$aWheat, Durum
=550  \\$wg$aPoaceae
=667  \\$awheat germ: index under TRITICUM, not TRITICUM /embryol; do not confuse X ref WHEAT with FAGOPYRUM nor TRITICUM with the rye-wheat hybrid TRITICALE; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that is the source of wheat grain. A hybrid with rye (SECALE CEREALE) is called TRITICALE. The seed is ground into FLOUR and used to make BREAD, and is the source of WHEAT GERM AGGLUTININS.
=750  \0$aWheat$5IEN$0(DLC)sh 85146366

=LDR  02910cz  a2200805n  4500
=001  9880364152302441
=005  20141212210744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014907
=035  \\$aCBA8256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x189.$x865
=150  \\$aWhales
=450  \\$wnnna$aBeaked Whale
=450  \\$aBeaked Whales
=450  \\$aBerardius
=450  \\$wnnna$aBottle-Nosed Whale, Giant
=450  \\$wnnna$aBottle-Nosed Whales, Giant
=450  \\$aCaperea
=450  \\$aDwarf Sperm Whale
=450  \\$wnnna$aDwarf Sperm Whales
=450  \\$wnnna$aEschrichtius robustus
=450  \\$wnnna$aEubalaena australis
=450  \\$wnnna$aGiant Bottle-Nosed Whale
=450  \\$aGiant Bottle-Nosed Whales
=450  \\$wnnna$aGiant Bottle Nosed Whales
=450  \\$aGoose-Beaked Whale
=450  \\$wnnna$aGoose Beaked Whale
=450  \\$wnnna$aGoose-Beaked Whales
=450  \\$aGray Whale
=450  \\$wnnna$aGray Whales
=450  \\$wnnna$aGrey Whale
=450  \\$wnnna$aGrey Whales
=450  \\$aMesoplodon
=450  \\$wnnna$aMonodon monoceros
=450  \\$wnnna$aNarwhal
=450  \\$aNarwhals
=450  \\$wnnna$aNorth Atlantic Right Whale
=450  \\$aPygmy Right Whale
=450  \\$wnnna$aPygmy Right Whales
=450  \\$aPygmy Sperm Whale
=450  \\$wnnna$aPygmy Sperm Whales
=450  \\$aRight Whale, North Atlantic
=450  \\$wnnna$aRight Whale, Pygmy
=450  \\$aRight Whale, Southern
=450  \\$wnnna$aRight Whales, Pygmy
=450  \\$wnnna$aRight Whales, Southern
=450  \\$wnnna$aSouthern Right Whale
=450  \\$wnnna$aSouthern Right Whales
=450  \\$wnnna$aSperm Whale, Dwarf
=450  \\$wnnna$aSperm Whale, Pygmy
=450  \\$wnnna$aSperm Whales, Dwarf
=450  \\$wnnna$aSperm Whales, Pygmy
=450  \\$wnnna$aWhale
=450  \\$wnnna$aWhale, Grey
=450  \\$wnnna$aWhale, Southern Right
=450  \\$wnnna$aWhales, Grey
=450  \\$wnnna$aWhales, Southern Right
=450  \\$aZiphiidae
=450  \\$aZiphius
=550  \\$wg$aCetacea
=550  \\$wh$aBalaenoptera
=550  \\$wh$aBeluga Whale
=550  \\$wh$aBowhead Whale
=550  \\$wh$aHumpback Whale
=550  \\$wh$aSperm Whale
=667  \\$asome dolphins are misnamed "whales": note FALSE KILLER WHALE; PYGMY KILLER WHALE; and MELON-HEADED WHALE; are entry terms to DOLPHINS; PILOT WHALES; and KILLER WHALE; both types of dolphin, are also available
=680  \\$iLarge marine mammals of the order CETACEA. In the past, they were commercially valued for whale oil, for their flesh as human food and in ANIMAL FEED and FERTILIZERS, and for baleen. Today, there is a moratorium on most commercial whaling, as all species are either listed as endangered or threatened.
=688  \\$a91(75); was see under CETACEA 1975-90
=750  \0$aWhales$5IEN$0(DLC)sh 85146352

=LDR  00691cz  a2200193n  4500
=001  9880364152402441
=005  20141212210743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014906
=035  \\$aCBA8255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x877.$x974
=150  \\$aWetting Agents
=450  \\$wnnna$aAgents, Wetting
=550  \\$wg$aSurface-Active Agents
=667  \\$afor electrowetting agents coordinate with ELECTROWETTING
=680  \\$iA surfactant that renders a surface wettable by water or enhances the spreading of water over the surface.
=688  \\$a91(75); was see under SURFACE-ACTIVE AGENTS 1975-90
=750  \0$aWetting agents$5IEN$0(DLC)sh 85146334

=LDR  01258cz  a2200229n  4500
=001  9880364152502441
=005  20141212210742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014902
=035  \\$aCBA8251M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250.$x350.$x300.$x950
=072  \\$aB4.$x909.$x777.$x270.$x475.$x950
=072  \\$aB4.$x909.$x777.$x310.$x350.$x300.$x950
=150  \\$aWest Nile virus
=450  \\$aEgypt 101 virus
=450  \\$aKunjin virus
=550  \\$wg$aEncephalitis Viruses, Japanese
=667  \\$ainfection = WEST NILE FEVER
=680  \\$iA species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.
=688  \\$a1973 (1965); for KUNJIN VIRUS use ENCEPHALITIS VIRUSES, JAPANESE 1994-2001
=750  \0$aWest Nile virus$0(DLC)2002008949$5IEN-M

=LDR  01529cz  a2200325n  4500
=001  9880364152602441
=005  20141212210741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014901
=035  \\$aCBA8250M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x343.$x950
=072  \\$aC2.$x182.$x500.$x300.$x300.$x850
=072  \\$aC2.$x290.$x310.$x950
=072  \\$aC2.$x782.$x310.$x950
=072  \\$aC2.$x782.$x350.$x250.$x900
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x300.$x887
=072  \\$aC10.$x228.$x228.$x245.$x340.$x310.$x950
=150  \\$aWest Nile Fever
=450  \\$wnnna$aEncephalitis, West Nile Fever
=450  \\$wnnna$aWest Nile Fever Encephalitis
=450  \\$wnnna$aWest Nile Fever Meningitis
=450  \\$wnnna$aWest Nile Fever Meningoencephalitis
=450  \\$wnnna$aWest Nile Fever Myelitis
=550  \\$wg$aEncephalitis, Arbovirus
=550  \\$wg$aFlavivirus Infections
=550  \\$aWest Nile virus
=680  \\$iA mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71)
=688  \\$a1991(1966)
=750  \0$aWest Nile fever$0(DLC) sh 00009585$5IEN-M

=LDR  02389cz  a2200493n  4500
=001  9880364152702441
=005  20141212210740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014899
=035  \\$aCBA8248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x960
=072  \\$aC18.$x452.$x132.$x960
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x827.$x822
=072  \\$aC25.$x775.$x100.$x625
=072  \\$aF3.$x900.$x100.$x875
=150  \\$aWernicke Encephalopathy
=450  \\$aBeriberi, Cerebral
=450  \\$wnnna$aCerebral Beriberi
=450  \\$wnnna$aEncephalopathies, Wernicke
=450  \\$wnnna$aEncephalopathy, Gayet-Wernicke
=450  \\$wnnna$aEncephalopathy, Gayet Wernicke
=450  \\$aEncephalopathy, Wernicke
=450  \\$wnnna$aEncephalopathy, Wernicke's
=450  \\$wnnna$aEncephalopathy, Wernickes
=450  \\$wnnna$aGayet-Wernicke Encephalopathy
=450  \\$wnnna$aGayet Wernicke Encephalopathy
=450  \\$wnnna$aWernicke Disease
=450  \\$wnnna$aWernicke Encephalopathies
=450  \\$wnnna$aWernicke Polioencephalitis, Superior Hemorrhagic
=450  \\$wnnna$aWernicke Superior Hemorrhagic Polioencephalitis
=450  \\$wnnna$aWernicke Syndrome
=450  \\$wnnna$aWernicke's Disease
=450  \\$wnnna$aWernicke's Encephalopathy
=450  \\$wnnna$aWernicke's Polioencephalitis, Superior Hemorrhagic
=450  \\$wnnna$aWernicke's Superior Hemorrhagic Polioencephalitis
=450  \\$wnnna$aWernicke's Syndrome
=550  \\$wg$aAlcohol-Related Disorders
=550  \\$wg$aBrain Diseases, Metabolic
=550  \\$wg$aThiamine Deficiency
=667  \\$aDF: WERNICKE ENCEPH
=680  \\$iAn acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. (Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp452-3)
=688  \\$a2000(1964)
=750  \0$aWernicke's encephalopathy$5IEN$0(DLC)sh 85146125

=LDR  01225cz  a2200313n  4500
=001  9880364152802441
=005  20141212210740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014898
=035  \\$aCBA8247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x925
=072  \\$aC18.$x452.$x284.$x960
=150  \\$aWerner Syndrome
=450  \\$wnnna$aAdult Premature Aging Syndrome
=450  \\$wnnna$aAdult Progeria
=450  \\$aProgeria, Adult
=450  \\$wnnna$aSyndrome, Werner
=450  \\$wnnna$aSyndrome, Werner's
=450  \\$wnnna$aSyndrome, Werners
=450  \\$wnnna$aWerner's Syndrome
=450  \\$wnnna$aWerners Syndrome
=550  \\$wg$aDNA Repair-Deficiency Disorders
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$aProgeria
=550  \\$aRecQ Helicases
=680  \\$iAn autosomal recessive disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.
=688  \\$a98; was WERNER'S SYNDROME 1964-97 (Prov 1964-67)
=750  \0$aWerner's syndrome$5IEN$0(DLC)sh 85146124

=LDR  00406cz  a2200157n  4500
=001  9880364152902441
=005  20141212192629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014896
=035  \\$aCBA8245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x400.$x900
=150  \\$aWelding
=450  \\$wnnna$aWeldings
=550  \\$wg$aMetallurgy
=750  \0$aWelding$5IEN$0(DLC)sh 85146012

=LDR  01233cz  a2200289n  4500
=001  9880364153002441
=005  20141212210738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014895
=035  \\$aCBA8244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x511.$x739
=072  \\$aC1.$x252.$x847.$x511.$x739
=150  \\$aWeil Disease
=450  \\$wnnna$aDisease, Weil
=450  \\$wnnna$aDisease, Weil's
=450  \\$wnnna$aIcterohemorrhagic Leptospirosis
=450  \\$aJaundice, Spirochetal
=450  \\$aLeptospirosis, Icterohemorrhagic
=450  \\$wnnna$aSpirochetal Jaundice
=450  \\$wnnna$aWeil's Disease
=450  \\$wnnna$aWeils Disease
=550  \\$wg$aLeptospirosis
=667  \\$aif not caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE, coord IM with specific Leptospira interrogans serovar (IM) or LEPTOSPIRA INTERROGANS (IM)
=680  \\$iA severe form of LEPTOSPIROSIS, usually caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE and occasionally other serovars. It is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying JAUNDICE.
=688  \\$a2003 (1963)
=750  \0$aWeil's disease$5IEN$0(DLC)sh 85145979

=LDR  00958cz  a2200301n  4500
=001  9880364153102441
=005  20141212210737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014894
=035  \\$aCBA8243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x978
=150  \\$aWeights and Measures
=450  \\$wnnna$aMeasure
=450  \\$wnnna$aMeasures
=450  \\$wnnna$aMeasures and Weights
=450  \\$wnnna$aScales
=450  \\$wnnna$aWeights
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aCalibration
=550  \\$wh$aInternational System of Units
=550  \\$wh$aMetric System
=550  \\$wh$aQuartz Crystal Microbalance Techniques
=550  \\$wh$aReference Standards
=550  \\$wh$aReference Values
=667  \\$atypes and systems of measurement: not for "weight" ; METRIC SYSTEM is available
=680  \\$iMeasuring and weighing systems and processes.
=750  \0$aWeights and measures$5IEN$0(DLC)sh 85145963

=LDR  00995cz  a2200229n  4500
=001  9880364153202441
=005  20141212210737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014893
=035  \\$aCBA8242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x60.$x535.$x369.$x400.$x900
=150  \\$aWeightlessness
=450  \\$wnnna$aGravity, Zero
=450  \\$aMicrogravity
=450  \\$aZero Gravity
=550  \\$wg$aHypogravity
=550  \\$aHypogravity
=550  \\$aSpace Flight
=667  \\$anatural only: WEIGHTLESSNESS SIMULATION and WEIGHTLESSNESS COUNTERMEASURES are also available
=680  \\$iCondition in which no acceleration, whether due to gravity or any other force, can be detected by an observer within a system. It also means the absence of weight or the absence of the force of gravity acting on a body. Microgravity, gravitational force between 0 and 10 -6 g, is included here. (From NASA Thesaurus, 1988)
=750  \0$aWeightlessness$5IEN$0(DLC)sh 85145961

=LDR  00868cz  a2200289n  4500
=001  9880364153302441
=005  20141212211038.0
=008  880608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015431
=035  \\$aCBA8240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x144.$x243.$x963
=072  \\$aG7.$x700.$x320.$x249.$x314.$x120.$x200.$x963
=150  \\$aWeight Loss
=450  \\$wnnna$aLoss, Weight
=450  \\$wnnna$aLosses, Weight
=450  \\$aReducing$5IEN
=450  \\$wnnna$aReduction, Weight
=450  \\$wnnna$aReductions, Weight
=450  \\$wnnna$aWeight Losses
=450  \\$aWeight Reduction
=450  \\$wnnna$aWeight Reductions
=550  \\$wg$aBody Weight Changes
=550  \\$wh$aEmaciation
=680  \\$iDecrease in existing BODY WEIGHT.
=688  \\$a89; was see BODY WEIGHT 1966-88
=750  \0$aWeight loss$5IEN$0(DLC)sh 85112135

=LDR  00809cz  a2200217n  4500
=001  9880364153402441
=005  20141212210737.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014891
=035  \\$aCBA8239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x950
=150  \\$aWeight Lifting
=450  \\$wnnna$aLifting, Weight
=450  \\$wnnna$aLiftings, Weight
=450  \\$wnnna$aWeight Liftings
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15+; includes body building if restricted to weight lifting, otherwise index under EXERCISE
=680  \\$iA sport in which weights are lifted competitively or as an exercise.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aWeight lifting$5IEN$0(DLC)sh 85145957

=LDR  01657cz  a2200349n  4500
=001  9880364153502441
=005  20141212192622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014890
=035  \\$aCBA8237HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x950
=072  \\$aC14.$x907.$x940.$x897.$x249.$x750
=072  \\$aC20.$x111.$x193.$x875
=150  \\$aGranulomatosis with Polyangiitis
=450  \\$wnnna$aGranulomatosis, Wegener
=450  \\$aGranulomatosis, Wegener's
=450  \\$wnnna$aGranulomatosis with Polyangiitides
=450  \\$wnnna$aPolyangiitides, Granulomatosis with
=450  \\$wnnna$aPolyangiitis, Granulomatosis with
=450  \\$aWegener Granulomatosis
=450  \\$wnnna$aWegener's Granulomatosis
=450  \\$wnnna$awith Polyangiitides, Granulomatosis
=450  \\$wnnna$awith Polyangiitis, Granulomatosis
=550  \\$wg$aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
=550  \\$wg$aLung Diseases, Interstitial
=550  \\$aMyeloblastin
=680  \\$iA multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.
=688  \\$a2015(1963)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Wegener Granulomatosis
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Wegener's Granulomatosis
=750  \0$aWegener's granulomatosis$0(DLC) sh2004000511$5IEN-M

=LDR  00702cz  a2200205n  4500
=001  9880364153602441
=005  20200527103519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014888
=035  \\$aCBA8235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x141.$x493.$x822
=150  \\$aWechsler Scales
=450  \\$wnnna$aScales, Wechsler
=450  \\$aWechsler Adult Intelligence Scale$5IEN
=550  \\$wg$aIntelligence Tests
=550  \\$wh$aWechsler Memory Scale
=680  \\$iTests designed to measure intellectual functioning in children and adults.
=688  \\$a79(75); was see under INTELLIGENCE TESTS 1963-78
=750  \0$aWechsler adult intelligence scale$5IEN$0(DLC)sh 85145890

=LDR  01134cz  a2200409n  4500
=001  9880364153702441
=005  20201124145124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014887
=035  \\$aCBA8234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x63.$x725
=072  \\$aG16.$x500.$x750.$x775
=072  \\$aN6.$x230.$x300.$x100.$x725
=150  \\$aWeather
=450  \\$aFog
=450  \\$wnnna$aFogs
=550  \\$wg$aAtmosphere
=550  \\$wg$aMeteorological Concepts
=550  \\$wh$aAir Movements
=550  \\$wh$aCold Temperature
=550  \\$wh$aDroughts
=550  \\$wh$aExtreme Cold Weather
=550  \\$wh$aExtreme Heat
=550  \\$wh$aHot Temperature
=550  \\$wh$aHumidity
=550  \\$wh$aIce
=550  \\$wh$aLightning
=550  \\$wh$aRain
=550  \\$wh$aSnow
=550  \\$wh$aSunlight
=550  \\$wh$aTemperature
=550  \\$wh$aTornadoes
=550  \\$wh$aWind
=667  \\$ado not confuse entry term FOG with SMOG, a mixture of smoke & fog
=680  \\$iThe state of the ATMOSPHERE over minutes to months.
=750  \0$aWeather$5IEN$0(DLC)sh 85145843

=LDR  00819cz  a2200229n  4500
=001  9880364153802441
=005  20141212210736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014886
=035  \\$aCBA8233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x220.$x500.$x750
=072  \\$aG7.$x610.$x593.$x762
=072  \\$aG7.$x700.$x620.$x762
=150  \\$aWeaning
=450  \\$wnnna$aWeanings
=550  \\$wg$aInfant Nutritional Physiological Phenomena
=550  \\$wg$aNutrition Processes
=667  \\$ahuman & animal; no qualif; NIM when merely an aspect of growth (as "in newborn, suckling & weaned")
=680  \\$iPermanent deprivation of breast milk and commencement of nourishment with other food. (From Stedman, 25th ed)
=688  \\$a66(63)
=750  \0$aInfants$xWeaning$5IEN$0(DLC)sh 85066043

=LDR  00777cz  a2200181n  4500
=001  9880364153902441
=005  20141212210736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014885
=035  \\$aCBA8232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x945
=150  \\$aWaxes
=550  \\$wg$aLipids
=550  \\$wh$aLanolin
=667  \\$aD25-26 qualif
=680  \\$iA plastic substance deposited by insects or obtained from plants. Waxes are esters of various fatty acids with higher, usually monohydric alcohols. The wax of pharmacy is principally yellow wax (beeswax), the material of which honeycomb is made. It consists chiefly of cerotic acid and myricin and is used in making ointments, cerates, etc. (Dorland, 27th ed)
=750  \0$aWaxes$5IEN$0(DLC)sh 85145802

=LDR  01203cz  a2200385n  4500
=001  9880364154002441
=005  20141212210735.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014883
=035  \\$aCBA8230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950
=150  \\$aWater-Electrolyte Imbalance
=450  \\$wnnna$aImbalance, Water-Electrolyte
=450  \\$wnnna$aImbalances, Water-Electrolyte
=450  \\$wnnna$aWater Electrolyte Imbalance
=450  \\$wnnna$aWater-Electrolyte Imbalances
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aDehydration
=550  \\$wh$aHypercalcemia
=550  \\$wh$aHyperkalemia
=550  \\$wh$aHypernatremia
=550  \\$wh$aHypocalcemia
=550  \\$wh$aHypokalemia
=550  \\$wh$aHyponatremia
=550  \\$wh$aInappropriate ADH Syndrome
=550  \\$wh$aWater Intoxication
=550  \\$aElectrolytes
=550  \\$aOsmotic Pressure
=550  \\$aWater-Electrolyte Balance
=550  \\$aWater Intoxication
=667  \\$anote category
=680  \\$iDisturbances in the body's WATER-ELECTROLYTE BALANCE.
=688  \\$a76; was NON MESH before 1976
=750  \0$aWater-electrolyte imbalances$5IEN$0(DLC)sh 85145556

=LDR  01210cz  a2200313n  4500
=001  9880364154102441
=005  20141212210734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014882
=035  \\$aCBA8229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x635.$x500
=072  \\$aG3.$x615.$x500
=072  \\$aG7.$x700.$x345.$x810.$x500
=150  \\$aWater-Electrolyte Balance
=450  \\$wnnna$aBalance, Electrolyte
=450  \\$wnnna$aBalance, Fluid
=450  \\$wnnna$aBalance, Water-Electrolyte
=450  \\$wnnna$aElectrolyte Balance
=450  \\$aFluid Balance
=450  \\$wnnna$aWater Electrolyte Balance
=550  \\$wg$aOsmoregulation
=550  \\$wh$aKallikrein-Kinin System
=550  \\$wh$aWater Loss, Insensible
=550  \\$aElectrolytes
=550  \\$aOsmotic Pressure
=550  \\$aWater-Electrolyte Imbalance
=680  \\$iThe balance of fluid in the BODY FLUID COMPARTMENTS; total BODY WATER; BLOOD VOLUME; EXTRACELLULAR SPACE; INTRACELLULAR SPACE, maintained by processes in the body that regulate the intake and excretion of WATER and ELECTROLYTES, particularly SODIUM and POTASSIUM.
=750  \0$aWater-electrolyte balance (Physiology)$5IEN$0(DLC)sh 85145555

=LDR  00879cz  a2200229n  4500
=001  9880364154202441
=005  20141212210734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014881
=035  \\$aCBA8228HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248.$x875.$x500
=150  \\$aWater Supply
=450  \\$wnnna$aSupplies, Water
=450  \\$wnnna$aSupply, Water
=450  \\$wnnna$aWater Supplies
=450  \\$aWater$xsupply & distribution
=550  \\$wg$aHydrology
=550  \\$aGroundwater
=667  \\$ado not use WATER SUPPLY with regard to FLUORIDATION: assume to be of the water supply
=680  \\$iMeans or process of supplying water (as for a community) usually including reservoirs, tunnels, and pipelines and often the watershed from which the water is ultimately drawn. (Webster, 3d ed)
=750  \0$aWater-supply$5IEN$0(DLC)sh 85145648

=LDR  00514cz  a2200181n  4500
=001  9880364154302441
=005  20141212210733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014880
=035  \\$aCBA8227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x510.$x910
=150  \\$aWater Softening
=450  \\$wnnna$aSoftening, Water
=450  \\$wnnna$aSoftenings, Water
=450  \\$wnnna$aWater Softenings
=550  \\$wg$aSanitary Engineering
=750  \0$aWater$xSoftening$5IEN$0(DLC)sh 85145509

=LDR  00859cz  a2200253n  4500
=001  9880364154402441
=005  20141212210733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014878
=035  \\$aCBA8225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x790.$x460
=072  \\$aN6.$x850.$x810.$x530
=150  \\$aWater Pollution, Radioactive
=450  \\$wnnna$aPollution, Radioactive Water
=450  \\$wnnna$aPollutions, Radioactive Water
=450  \\$wnnna$aRadioactive Water Pollution
=450  \\$wnnna$aRadioactive Water Pollutions
=450  \\$wnnna$aWater Pollutions, Radioactive
=550  \\$wg$aRadiologic Health
=550  \\$wg$aWater Pollution
=667  \\$aIM; coord with specific source of pollution (IM); specify geog if pertinent
=688  \\$a66
=750  \0$aRadioactive pollution of water$5IEN$0(DLC)sh 85110606

=LDR  00778cz  a2200217n  4500
=001  9880364154602441
=005  20141212210732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014873
=035  \\$aCBA8220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x284.$x903
=150  \\$aWater Pollutants
=450  \\$wnnna$aPollutants, Water
=550  \\$wg$aEnvironmental Pollutants
=550  \\$wh$aWater Pollutants, Chemical
=550  \\$wh$aWater Pollutants, Radioactive
=667  \\$aspecify pollutant if pertinent (IM or NIM)
=680  \\$iSubstances or organisms which pollute the water or bodies of water. Use for water pollutants in general or those for which there is no specific heading.
=688  \\$a75
=750  \0$aWater$xPollution$5IEN$0(DLC)sh 85145467

=LDR  00741cz  a2200205n  4500
=001  9880364154702441
=005  20141212210731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014871
=035  \\$aCBA8218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x274.$x777
=072  \\$aN6.$x850.$x425.$x450
=150  \\$aWater Microbiology
=450  \\$wnnna$aMicrobiology, Water
=450  \\$aWater$xmicrobiology
=550  \\$wg$aEnvironmental Microbiology
=667  \\$aIM; coord with specific bact, virus or fungus (IM); DF: WATER MICROBIOL
=680  \\$iThe presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms.
=750  \0$aWater$xMicrobiology$5IEN$0(DLC)sh 85145462

=LDR  00647cz  a2200217n  4500
=001  9880364154802441
=005  20141212210731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014869
=035  \\$aCBA8216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x950.$x932
=072  \\$aC25.$x723.$x932
=150  \\$aWater Intoxication
=450  \\$aWater$xpoisoning
=450  \\$aWater$xtoxicity
=550  \\$wg$aPoisoning
=550  \\$wg$aWater-Electrolyte Imbalance
=680  \\$iA condition resulting from the excessive retention of water with sodium depletion.
=688  \\$a65
=750  \0$aWater intoxication$5IEN$0(DLC)sh 85145574

=LDR  01585cz  a2200301n  4500
=001  9880364154902441
=005  20141212210730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014867
=035  \\$aCBA8214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x900
=072  \\$aD1.$x650.$x550.$x925
=150  \\$aWater
=450  \\$wnnna$aHydrogen Oxide
=450  \\$wnnna$aOxide, Hydrogen
=550  \\$wg$aHydroxides
=550  \\$wg$aOxides
=550  \\$wh$aDeuterium Oxide
=550  \\$wh$aDrinking Water
=550  \\$wh$aIce
=550  \\$wh$aMineral Waters
=550  \\$wh$aSteam
=550  \\$aIce
=550  \\$aSteam
=667  \\$anote specifics; in body or tissue = BODY WATER; / admin: consider also FLUID THERAPY or INFUSIONS, PARENTERAL or REHYDRATION SOLUTIONS; / adv eff: consider also WATER INTOXICATION; / metab must refer to metabolism of exogenous water; / stand: consider also WATER SUPPLY; / ther use: consider HYDROTHERAPY & related terms; / virol = WATER MICROBIOLOGY + specific virus; atmospheric water = HUMIDITY; hardness or softness of water: probably WATER / chem & not also HARDNESS but consider also WATER SOFTENING; water consumption = WATER or WATER SUPPLY if on a wide scale: on a personal level = WATER CONSUMPTION see DRINKING
=680  \\$iA clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aWater$5IEN$0(DLC)sh 85145447

=LDR  01145cz  a2200313n  4500
=001  9880364155002441
=005  20141212210730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014866
=035  \\$aCBA8213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944
=072  \\$aN6.$x850.$x460.$x710
=150  \\$aWaste Products
=450  \\$wnnna$aProduct, Waste
=450  \\$wnnna$aProducts, Waste
=450  \\$wnnna$aWaste Product
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aEnvironmental Pollution
=550  \\$wh$aElectronic Waste
=550  \\$wh$aHazardous Waste
=550  \\$wh$aIndustrial Waste
=550  \\$wh$aMedical Waste
=550  \\$wh$aSolid Waste
=550  \\$wh$aWaste Water
=667  \\$aMEDICAL WASTE & DENTAL WASTE are also available
=680  \\$iDebris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. (From Webster's New Collegiate Dictionary, 1981)
=688  \\$a76; was NON MESH before 1976
=750  \0$aWaste products$5IEN$0(DLC)sh 85145424

=LDR  02106cz  a2200565n  4500
=001  9880363489202441
=005  20141212202115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006551
=035  \\$aCAZ9723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707.$x500.$x467
=150  \\$aHernia, Hiatal
=450  \\$wnnna$aEsophageal Hernia
=450  \\$wnnna$aEsophageal Hernia, Sliding
=450  \\$wnnna$aEsophageal Hernias
=450  \\$wnnna$aEsophageal Hernias, Sliding
=450  \\$aHernia, Esophageal
=450  \\$wnnna$aHernia, Hiatus
=450  \\$aHernia, Paraesophageal
=450  \\$wnnna$aHernia, Paraesophageal Hiatal
=450  \\$wnnna$aHernia, Sliding Esophageal
=450  \\$wnnna$aHernia, Sliding Hiatal
=450  \\$wnnna$aHernias, Esophageal
=450  \\$wnnna$aHernias, Hiatal
=450  \\$wnnna$aHernias, Hiatus
=450  \\$wnnna$aHernias, Paraesophageal
=450  \\$wnnna$aHernias, Paraesophageal Hiatal
=450  \\$wnnna$aHernias, Sliding Esophageal
=450  \\$wnnna$aHernias, Sliding Hiatal
=450  \\$aHiatal Hernia
=450  \\$wnnna$aHiatal Hernia, Paraesophageal
=450  \\$wnnna$aHiatal Hernia, Sliding
=450  \\$wnnna$aHiatal Hernias
=450  \\$wnnna$aHiatal Hernias, Paraesophageal
=450  \\$wnnna$aHiatal Hernias, Sliding
=450  \\$wnnna$aHiatus Hernia
=450  \\$wnnna$aHiatus Hernias
=450  \\$wnnna$aParaesophageal Hernia
=450  \\$wnnna$aParaesophageal Hernias
=450  \\$wnnna$aParaesophageal Hiatal Hernia
=450  \\$wnnna$aParaesophageal Hiatal Hernias
=450  \\$wnnna$aSliding Esophageal Hernia
=450  \\$wnnna$aSliding Esophageal Hernias
=450  \\$wnnna$aSliding Hiatal Hernia
=450  \\$wnnna$aSliding Hiatal Hernias
=550  \\$wg$aHernia, Diaphragmatic
=680  \\$iSTOMACH herniation located at or near the diaphragmatic opening for the ESOPHAGUS, the esophageal hiatus.
=688  \\$a91(80); was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79
=750  \0$aHiatal hernia$5IEN$0(DLC)sh 85060595

=LDR  00842cz  a2200205n  4500
=001  9880363489302441
=005  20141212202115.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006550
=035  \\$aCAZ9722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707.$x374.$x750
=150  \\$aHernia, Femoral
=450  \\$aFemoral Hernia
=450  \\$wnnna$aFemoral Hernias
=450  \\$wnnna$aHernias, Femoral
=550  \\$wg$aHernia, Abdominal
=680  \\$iA groin hernia occurring inferior to the inguinal ligament and medial to the FEMORAL VEIN and FEMORAL ARTERY. The femoral hernia sac has a small neck but may enlarge considerably when it enters the subcutaneous tissue of the thigh. It is caused by defects in the ABDOMINAL WALL.
=688  \\$a80; was FEMORAL HERNIA 1963-79
=750  \0$aFemoral hernia$5IEN$0(DLC)sh 85047765

=LDR  00917cz  a2200253n  4500
=001  9880363489402441
=005  20141212202114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006548
=035  \\$aCAZ9720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707.$x500
=150  \\$aHernia, Diaphragmatic
=450  \\$aDiaphragmatic Hernia
=450  \\$wnnna$aDiaphragmatic Hernias
=450  \\$wnnna$aHernias, Diaphragmatic
=550  \\$wg$aHernia
=550  \\$wh$aHernia, Diaphragmatic, Traumatic
=550  \\$wh$aHernia, Hiatal
=550  \\$wh$aHernias, Diaphragmatic, Congenital
=667  \\$aHERNIA, DIAPHRAGMATIC, TRAUMATIC is also available
=680  \\$iProtrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.
=688  \\$a80; was DIAPHRAGMATIC HERNIA 1963-79
=750  \0$aDiaphragmatic hernia$5IEN$0(DLC)sh 85037586

=LDR  01158cz  a2200289n  4500
=001  9880363489502441
=005  20170404154009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006547
=035  \\$aCAZ9719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x707
=150  \\$aHernia
=450  \\$aEnterocele
=450  \\$wnnna$aHernias
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aEncephalocele
=550  \\$wh$aHernia, Abdominal
=550  \\$wh$aHernia, Diaphragmatic
=550  \\$wh$aHernia, Obturator
=550  \\$wh$aIncisional Hernia
=550  \\$wh$aIntervertebral Disc Displacement
=550  \\$wh$aMeningocele
=550  \\$aProlapse
=667  \\$ageneral or unspecified; prefer specifics; coordinate with specific organ/disease; /surg: consider HERNIORRHAPHY
=680  \\$iProtrusion of tissue, structure, or part of an organ through the bone, muscular tissue, or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.
=750  \0$aHernia$5IEN$0(DLC)sh 85060424

=LDR  00918cz  a2200265n  4500
=001  9880363489602441
=005  20141212202113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006540
=035  \\$aCAZ9712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700.$x366
=072  \\$aD27.$x720.$x723.$x366
=072  \\$aD27.$x888.$x723.$x366
=150  \\$aHerbicides
=450  \\$wnnoa$aHerbicides, Carbamate$5IEN-M
=450  \\$wnnoa$aHerbicides, Triazine$5IEN-M
=450  \\$wnnoa$aHerbicides, Urea$5IEN-M
=550  \\$wg$aPesticides
=550  \\$wh$aDefoliants, Chemical
=550  \\$aPlants
=550  \\$aWeed Control
=667  \\$aHERBICIDE RESISTANCE is available
=680  \\$iPesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE.
=750  \0$aHerbicides$5IEN$0(DLC)sh 85060342

=LDR  00711cz  a2200205n  4500
=001  9880363489702441
=005  20141212202113.0
=008  770520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006536
=035  \\$aCAZ9708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x485
=150  \\$aHeptanes
=450  \\$aIsoheptanes
=550  \\$wg$aAlkanes
=550  \\$wh$aDiarylheptanoids
=667  \\$adoes not include heptenes ( = ALKENES), heptadienes ( = ALKADIENES), or heptatrienes ( = POLYENES); CYCLOHEPTANES is also available
=680  \\$iSeven-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.
=688  \\$a78
=750  \0$aHeptane$5IEN$0(DLC)sh 85060312

=LDR  00971cz  a2200193n  4500
=001  9880363489802441
=005  20141212202112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006533
=035  \\$aCAZ9705HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x516
=150  \\$aHeptachlor
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wh$aHeptachlor Epoxide
=667  \\$aTN 111 for eff on insects
=680  \\$iA man-made compound previously used to control termites and other insects. Even though production of heptachlor was phased out of use in the United States during the late 1980's it remains in soil and hazardous waste sites. It is clearly toxic to animals and humans but, the International Agency for Research on Cancer (IARC) has determined that heptachlor is not classifiable as to its carcinogenicity to humans. (From ATSDR Public Heath Statement, April 1989)
=688  \\$a73(71)
=750  \0$aHeptachlor$5IEN$0(DLC)sh 87000851

=LDR  00945cz  a2200217n  4500
=001  9880363489902441
=005  20141212202111.0
=008  860404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006530
=035  \\$aCAZ9702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x465
=072  \\$aC12.$x777.$x419.$x291
=072  \\$aC13.$x351.$x968.$x419.$x291
=150  \\$aHepatorenal Syndrome
=450  \\$wnnna$aSyndrome, Hepatorenal
=550  \\$wg$aKidney Diseases
=550  \\$wg$aLiver Diseases
=680  \\$iFunctional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.
=688  \\$a91(87); was see under KIDNEY DISEASES 1987-90
=750  \0$aHepatorenal syndrome$5IEN$0(DLC)sh 85060303

=LDR  01925cz  a2200445n  4500
=001  9880363490002441
=005  20141212202111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006528
=035  \\$aCAZ9700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x25.$x255
=072  \\$aC4.$x588.$x274.$x623.$x160
=072  \\$aC6.$x301.$x623.$x160
=072  \\$aC6.$x552.$x697.$x160
=150  \\$aCarcinoma, Hepatocellular
=450  \\$wnnna$aAdult Liver Cancer
=450  \\$wnnna$aAdult Liver Cancers
=450  \\$wnnna$aCancer, Adult Liver
=450  \\$wnnna$aCancers, Adult Liver
=450  \\$wnnna$aCarcinoma, Liver Cell
=450  \\$wnnna$aCarcinomas, Hepatocellular
=450  \\$wnnna$aCarcinomas, Liver Cell
=450  \\$wnnna$aCell Carcinoma, Liver
=450  \\$wnnna$aCell Carcinomas, Liver
=450  \\$aHepatocellular Carcinoma
=450  \\$wnnna$aHepatocellular Carcinomas
=450  \\$aHepatoma
=450  \\$wnnna$aHepatomas
=450  \\$wnnna$aLiver Cancer, Adult
=450  \\$wnnna$aLiver Cancers, Adult
=450  \\$wnnna$aLiver Cell Carcinoma
=450  \\$wnnna$aLiver Cell Carcinoma, Adult
=450  \\$wnnna$aLiver Cell Carcinomas
=550  \\$wg$aAdenocarcinoma
=550  \\$wg$aLiver Neoplasms
=667  \\$ahuman & vet only: note X ref HEPATOMA: also available is HEPATOMA, EXPERIMENTAL see LIVER NEOPLASMS, EXPERIMENTAL for exper anim; coord IM with LIVER NEOPLASMS (IM)
=680  \\$iA primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
=688  \\$a94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93
=750  \0$aHepatoma$5IEN$0(DLC)sh 85060302

=LDR  03518cz  a2200805n  4500
=001  9880363490102441
=005  20141212202110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006527
=035  \\$aCAZ9699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x413
=072  \\$aC10.$x228.$x140.$x79.$x493
=072  \\$aC10.$x228.$x140.$x163.$x100.$x360
=072  \\$aC10.$x228.$x662.$x400
=072  \\$aC10.$x574.$x500.$x487
=072  \\$aC16.$x320.$x400.$x361
=072  \\$aC16.$x320.$x565.$x189.$x360
=072  \\$aC16.$x320.$x565.$x618.$x403
=072  \\$aC18.$x452.$x132.$x100.$x360
=072  \\$aC18.$x452.$x648.$x189.$x360
=072  \\$aC18.$x452.$x648.$x618.$x403
=150  \\$aHepatolenticular Degeneration
=450  \\$wnnna$aCerebral Pseudoscleroses
=450  \\$aCerebral Pseudosclerosis
=450  \\$wnnna$aCopper Storage Disease
=450  \\$wnnna$aDegeneration, Hepatocerebral
=450  \\$wnnna$aDegeneration, Hepatolenticular
=450  \\$wnnna$aDegeneration, Neurohepatic
=450  \\$wnnna$aDegeneration, Progressive Lenticular
=450  \\$wnnna$aDegenerations, Hepatocerebral
=450  \\$wnnna$aDegenerations, Neurohepatic
=450  \\$wnnna$aDiseases, Hepato-Neurologic Wilson
=450  \\$wnnna$aDiseases, Kinnier-Wilson
=450  \\$wnnna$aHepatic Form of Wilson Disease
=450  \\$wnnna$aHepato-Neurologic Wilson Disease
=450  \\$wnnna$aHepato Neurologic Wilson Disease
=450  \\$wnnna$aHepato-Neurologic Wilson Diseases
=450  \\$wnnna$aHepatocerebral Degeneration
=450  \\$wnnna$aHepatocerebral Degenerations
=450  \\$wnnna$aHepatolenticular Degeneration Syndrome
=450  \\$wnnna$aKinnier-Wilson Disease
=450  \\$wnnna$aKinnier Wilson Disease
=450  \\$wnnna$aKinnier-Wilson Diseases
=450  \\$wnnna$aLenticular Degeneration, Progressive
=450  \\$aNeurohepatic Degeneration
=450  \\$wnnna$aNeurohepatic Degenerations
=450  \\$wnnna$aProgressive Lenticular Degeneration
=450  \\$wnnna$aPseudoscleroses, Cerebral
=450  \\$aPseudosclerosis
=450  \\$wnnna$aPseudosclerosis, Cerebral
=450  \\$wnnna$aWestphal-Strumpell Syndrome
=450  \\$wnnna$aWestphal Strumpell Syndrome
=450  \\$wnnna$aWestphal-Strumpell Syndromes
=450  \\$aWilson Disease
=450  \\$wnnna$aWilson Disease, Hepatic Form
=450  \\$wnnna$aWilson Disease, Hepato-Neurologic
=450  \\$wnnna$aWilson Diseases, Hepato-Neurologic
=450  \\$wnnna$aWilson's Disease
=450  \\$wnnna$aWilsons Disease
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aLiver Diseases
=550  \\$wg$aMetal Metabolism, Inborn Errors
=550  \\$wg$aMovement Disorders
=667  \\$alenticular refers to the lenticular nucleus in the brain
=680  \\$iA rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
=688  \\$a1964(1963)
=750  \0$aHepatolenticular degeneration$5IEN$0(DLC)sh 85060301

=LDR  01375cz  a2200277n  4500
=001  9880363490202441
=005  20141212202109.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006526
=035  \\$aCAZ9698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x440.$x440
=072  \\$aC2.$x782.$x350.$x350
=072  \\$aC6.$x552.$x380.$x705.$x440
=150  \\$aHepatitis C
=450  \\$aHepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
=450  \\$aParenterally-Transmitted Non-A, Non-B Hepatitis
=450  \\$wnnna$aParenterally Transmitted Non A, Non B Hepatitis
=450  \\$wnnna$aPT-NANBH
=550  \\$wg$aFlaviviridae Infections
=550  \\$wg$aHepatitis, Viral, Human
=550  \\$wh$aHepatitis C, Chronic
=667  \\$achronic = HEPATITIS C, CHRONIC
=680  \\$iINFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
=688  \\$a92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 (see under HEPATITIS, VIRAL, HUMAN 1980-90); HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91
=750  \0$aHepatitis C$5IEN-M$0(DLC)sh 85060290

=LDR  01493cz  a2200349n  4500
=001  9880363490302441
=005  20141212202108.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006521
=035  \\$aCAZ9693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x380.$x350
=150  \\$aHepatitis, Chronic
=450  \\$wnnna$aChronic Active Hepatitis
=450  \\$aChronic Hepatitis
=450  \\$wnnna$aChronic Hepatitis, Cryptogenic
=450  \\$wnnna$aChronic Persistent Hepatitides
=450  \\$wnnna$aChronic Persistent Hepatitis
=450  \\$aCryptogenic Chronic Hepatitis
=450  \\$wnnna$aHepatitis, Chronic Active
=450  \\$aHepatitis, Chronic, Cryptogenic
=450  \\$wnnna$aHepatitis, Chronic Persistent
=450  \\$wnnna$aHepatitis, Cryptogenic Chronic
=550  \\$wg$aHepatitis
=550  \\$wh$aHepatitis, Autoimmune
=550  \\$wh$aHepatitis B, Chronic
=550  \\$wh$aHepatitis C, Chronic
=550  \\$wh$aHepatitis D, Chronic
=667  \\$aGEN or unspecified; prefer specifics; chronic alcoholic hepatitis = HEPATITIS, ALCOHOLIC
=680  \\$iINFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
=688  \\$a98; was HEPATITIS, CHRONIC ACTIVE 1983-97
=750  \0$aChronic active hepatitis$5IEN$0(DLC)sh 88007100

=LDR  01517cz  a2200409n  4500
=001  9880363490402441
=005  20141212202106.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006518
=035  \\$aCAZ9690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x450
=150  \\$aHepatitis Viruses
=450  \\$wnnna$aHepatitis Virus
=450  \\$aHepatitis Virus, Marmoset
=450  \\$wnnna$aHepatitis Viruses, Marmoset
=450  \\$wnnna$aMarmoset Hepatitis Virus
=450  \\$wnnna$aMarmoset Hepatitis Viruses
=450  \\$wnnna$aVirus, Hepatitis
=450  \\$wnnna$aVirus, Marmoset Hepatitis
=450  \\$wnnna$aViruses, Hepatitis
=450  \\$wnnna$aViruses, Marmoset Hepatitis
=550  \\$wg$aViruses
=550  \\$wh$aAdenoviruses, Canine
=550  \\$wh$aGB virus B
=550  \\$wh$aGB virus C
=550  \\$wh$aHepacivirus
=550  \\$wh$aHepadnaviridae
=550  \\$wh$aHepatitis Delta Virus
=550  \\$wh$aHepatitis E virus
=550  \\$wh$aHepatitis Virus, Duck
=550  \\$wh$aHepatovirus
=550  \\$wh$aMurine hepatitis virus
=667  \\$aGEN or unspecified; prefer specifics; infection = HEPATITIS, VIRAL, HUMAN or HEPATITIS, VIRAL, ANIMAL or their specifics: see notes there
=680  \\$iAny of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.
=688  \\$aHEPATITIS VIRUS, MARMOSET was see under HEPATITIS VIRUSES 1975-85
=750  \0$aHepatitis viruses$5IEN$0(DLC)sh 85060300

=LDR  01275cz  a2200289n  4500
=001  9880363490502441
=005  20141212202105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006515
=035  \\$aCAZ9687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x375.$x650.$x425
=072  \\$aB4.$x450.$x390.$x650.$x425
=072  \\$aB4.$x909.$x204.$x340.$x650.$x425
=150  \\$aHepatitis B virus
=450  \\$wnnna$aB virus, Hepatitis
=450  \\$aDane Particle
=450  \\$wnnna$aHepatitis B viruses
=450  \\$aHepatitis Virus, Homologous Serum
=450  \\$wnnna$aParticle, Dane
=450  \\$wnnna$avirus, Hepatitis B
=450  \\$wnnna$aviruses, Hepatitis B
=550  \\$wg$aOrthohepadnavirus
=667  \\$ainfection = HEPATITIS B or HEPATITIS B, CHRONIC
=680  \\$iThe type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
=688  \\$a77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80
=750  \0$aHepatitis B virus$0(DLC) sh 85060298$5IEN

=LDR  00962cz  a2200241n  4500
=001  9880363490602441
=005  20141212202104.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006511
=035  \\$aCAZ9683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x327.$x495.$x500
=150  \\$aHepatitis B Antigens
=450  \\$wnnna$aAntigens, Hepatitis B
=450  \\$wnnna$aB Antigens, Hepatitis
=450  \\$aHBAg
=550  \\$wg$aHepatitis Antigens
=550  \\$wh$aHepatitis B Core Antigens
=550  \\$wh$aHepatitis B e Antigens
=550  \\$wh$aHepatitis B Surface Antigens
=680  \\$iAntigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS.
=688  \\$a77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76
=750  \0$aHepatitis associated antigen$5IEN$0(DLC)sh 85060294

=LDR  00954cz  a2200229n  4500
=001  9880363490702441
=005  20141212202103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006509
=035  \\$aCAZ9681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x430.$x400
=072  \\$aC2.$x440.$x435
=072  \\$aC6.$x552.$x380.$x705.$x437
=150  \\$aHepatitis B
=550  \\$wg$aHepadnaviridae Infections
=550  \\$wg$aHepatitis, Viral, Human
=550  \\$wh$aHepatitis B, Chronic
=667  \\$achronic = HEPATITIS B, CHRONIC
=680  \\$iINFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
=688  \\$a77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76
=750  \0$aHepatitis B$5IEN$0(DLC)sh 85060295

=LDR  00922cz  a2200253n  4500
=001  9880363490802441
=005  20141212202102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006506
=035  \\$aCAZ9678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x440.$x420
=072  \\$aC2.$x782.$x687.$x359.$x500
=072  \\$aC6.$x552.$x380.$x705.$x422
=150  \\$aHepatitis A
=450  \\$wnnna$aHepatitides, Infectious
=450  \\$aHepatitis, Infectious
=450  \\$wnnna$aInfectious Hepatitides
=450  \\$wnnna$aInfectious Hepatitis
=550  \\$wg$aEnterovirus Infections
=550  \\$wg$aHepatitis, Viral, Human
=680  \\$iINFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.
=688  \\$a77; was HEPATITIS, INFECTIOUS 1963-76
=750  \0$aHepatitis A$5IEN$0(DLC)sh 85060293

=LDR  00849cz  a2200229n  4500
=001  9880363490902441
=005  20141212202102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006505
=035  \\$aCAZ9677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x380
=150  \\$aHepatitis
=450  \\$wnnna$aHepatitides
=550  \\$wg$aLiver Diseases
=550  \\$wh$aHepatitis, Alcoholic
=550  \\$wh$aHepatitis, Animal
=550  \\$wh$aHepatitis, Chronic
=550  \\$wh$aHepatitis, Viral, Human
=667  \\$aGEN or unspecified; prefer specifics; probably non-viral; viral hepatitis = HEPATITIS, VIRAL, HUMAN & HEPATITIS, VIRAL, ANIMAL or their specifics; /chem ind = DRUG-INDUCED LIVER INJURY but note HEPATITIS, ALCOHOLIC is also available
=680  \\$iINFLAMMATION of the LIVER.
=750  \0$aHepatitis$5IEN$0(DLC)sh 85060288

=LDR  02421cz  a2200517n  4500
=001  9880363491002441
=005  20141212202101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006501
=035  \\$aCAZ9673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x308.$x500.$x356
=072  \\$aC10.$x228.$x140.$x163.$x360
=072  \\$aC18.$x452.$x132.$x360
=150  \\$aHepatic Encephalopathy
=450  \\$wnnna$aComa, Hepatic
=450  \\$wnnna$aComas, Hepatic
=450  \\$wnnna$aEncephalopathies, Hepatic
=450  \\$wnnna$aEncephalopathies, Hepatocerebral
=450  \\$wnnna$aEncephalopathies, Portal-Systemic
=450  \\$wnnna$aEncephalopathies, Portosystemic
=450  \\$aEncephalopathy, Hepatic
=450  \\$wnnna$aEncephalopathy, Hepatocerebral
=450  \\$wnnna$aEncephalopathy, Portal-Systemic
=450  \\$wnnna$aEncephalopathy, Portal Systemic
=450  \\$wnnna$aEncephalopathy, Portosystemic
=450  \\$wnnna$aFulminant Hepatic Failure with Cerebral Edema
=450  \\$wnnna$aHepatic Coma
=450  \\$wnnna$aHepatic Comas
=450  \\$wnnna$aHepatic Encephalopathies
=450  \\$wnnna$aHepatic Stupor
=450  \\$wnnna$aHepatic Stupors
=450  \\$wnnna$aHepatocerebral Encephalopathies
=450  \\$wnnna$aHepatocerebral Encephalopathy
=450  \\$wnnna$aPortal-Systemic Encephalopathies
=450  \\$wnnna$aPortal-Systemic Encephalopathy
=450  \\$wnnna$aPortal Systemic Encephalopathy
=450  \\$wnnna$aPortosystemic Encephalopathies
=450  \\$aPortosystemic Encephalopathy
=450  \\$wnnna$aStupor, Hepatic
=450  \\$wnnna$aStupors, Hepatic
=550  \\$wg$aBrain Diseases, Metabolic
=550  \\$wg$aLiver Failure
=680  \\$iA syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)
=688  \\$a1984; use HEPATIC COMA 1975-83
=750  \0$aHepatic encephalopathy$5IEN-HS$0(DLC)sh 87007318

=LDR  00632cz  a2200193n  4500
=001  9880363491102441
=005  20141212202059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006499
=035  \\$aCAZ9671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x407
=150  \\$aHepatic Artery
=450  \\$wnnna$aArteries, Hepatic
=450  \\$wnnna$aArtery, Hepatic
=450  \\$wnnna$aHepatic Arteries
=550  \\$wg$aArteries
=680  \\$iA branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.
=750  \0$aHepatic artery$5IEN$0(DLC)sh 85060285

=LDR  00581cz  a2200193n  4500
=001  9880363491202441
=005  20141212202059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006498
=035  \\$aCAZ9670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x556
=150  \\$aHepatectomy
=450  \\$wnnna$aHepatectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aLiver
=667  \\$ado not use /util except by MeSH definition
=680  \\$iExcision of all or part of the liver. (Dorland, 28th ed)
=750  \0$aHepatectomy$5IEN$0(DLC)sh 85060284

=LDR  01257cz  a2200301n  4500
=001  9880363491302441
=005  20141212202058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006493
=035  \\$aCAZ9665HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x373.$x400
=150  \\$aHeparin
=450  \\$aalpha-Heparin
=450  \\$wnnna$aalpha Heparin
=450  \\$wnnna$aHeparin Sodium
=450  \\$wnnna$aHeparin, Sodium
=450  \\$wnnna$aHeparin, Unfractionated
=450  \\$aHeparinic Acid
=450  \\$wnnna$aLiquaemin
=450  \\$wnnna$aSodium Heparin
=450  \\$wnnna$aUnfractionated Heparin
=550  \\$wg$aGlycosaminoglycans
=550  \\$wh$aHeparin, Low-Molecular-Weight
=550  \\$wh$aHeparinoids
=680  \\$iA highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
=688  \\$a/therapeutic use was HEPARIN, THERAPEUTIC 1965
=750  \0$aHeparin$5IEN$0(DLC)sh 85060283

=LDR  00980cz  a2200217n  4500
=001  9880363491402441
=005  20141212192231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006490
=035  \\$aCAZ9662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x270.$x463
=150  \\$aHemostatics
=450  \\$wnnna$aAntihemorrhagics
=550  \\$wg$aCoagulants
=550  \\$wh$aAntifibrinolytic Agents
=550  \\$aBlood Coagulation
=550  \\$aFibrinogen
=550  \\$aVascular Closure Devices
=680  \\$iAgents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
=750  \0$aHemostatics$0(DLC) sh 85060242$5IEN

=LDR  00935cz  a2200277n  4500
=001  9880363491502441
=005  20141212202057.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006488
=035  \\$aCAZ9660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x520.$x490
=072  \\$aE4.$x350
=150  \\$aHemostasis, Surgical
=450  \\$wnnna$aHemostases, Surgical
=450  \\$wnnna$aSurgical Hemostases
=450  \\$wnnna$aSurgical Hemostasis
=550  \\$wg$aHemostatic Techniques
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aArgon Plasma Coagulation
=550  \\$wh$aLight Coagulation
=550  \\$aBlood Loss, Surgical
=667  \\$a= perop or postop control of bleeding; do not use /util except by MeSH
=680  \\$iControl of bleeding during or after surgery.
=688  \\$a76; was indexed under HEMOSTASIS 1963-75 (Cat E heading)
=750  \0$aHemostasis, Surgical$5IEN$0(DLC)sh 85060241

=LDR  00998cz  a2200217n  4500
=001  9880363491602441
=005  20170609123549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006487
=035  \\$aCAZ9659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x390
=150  \\$aHemostasis
=450  \\$wnnna$aHemostases
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wh$aBlood Coagulation
=550  \\$wh$aPlatelet Activation
=667  \\$anote Cat G, a physiol process; differentiate from HEMOSTATIC TECHNIQUES and specifics, Cat E; coord HEMOSTASIS in diseases with disease /blood, not /physiopathol
=680  \\$iThe process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.
=688  \\$awas in Cat E only 1963-75
=750  \0$aHemostasis$5IEN$0(DLC)sh 85060240

=LDR  00839cz  a2200205n  4500
=001  9880363491702441
=005  20141212202056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006486
=035  \\$aCAZ9658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x565.$x500.$x500
=150  \\$aHemosiderosis
=450  \\$wnnna$aHemosideroses
=550  \\$wg$aIron Overload
=550  \\$aIron
=550  \\$aSiderosis
=667  \\$aa form of tissue iron accumulation in total body iron overload
=680  \\$iConditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.
=750  \0$aHemosiderosis$5IEN$0(DLC)sh 85060238

=LDR  00454cz  a2200181n  4500
=001  9880363491802441
=005  20141212202056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006485
=035  \\$aCAZ9657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x556.$x526
=150  \\$aHemosiderin
=550  \\$wg$aMetalloproteins
=550  \\$aIron
=667  \\$aa metalloprotein
=688  \\$a66(63)
=750  \0$aHemosiderin$5IEN$0(DLC)sh 85060237

=LDR  00849cz  a2200205n  4500
=001  9880363491902441
=005  20141212202056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006484
=035  \\$aCAZ9656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x860.$x401
=072  \\$aC14.$x907.$x449
=150  \\$aHemorrhoids
=450  \\$wnnna$aHemorrhoid
=550  \\$wg$aRectal Diseases
=550  \\$wg$aVascular Diseases
=667  \\$a/surg : consider also HEMORRHOIDECTOMY
=680  \\$iSwollen veins in the lower part of the RECTUM or ANUS. Hemorrhoids can be inside the anus (internal), under the skin around the anus (external), or protruding from inside to outside of the anus. People with hemorrhoids may or may not exhibit symptoms which include bleeding, itching, and pain.
=750  \0$aHemorrhoids$5IEN$0(DLC)sh 85060235

=LDR  01544cz  a2200361n  4500
=001  9880363492002441
=005  20141212202056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x100.$x375
=072  \\$aC1.$x252.$x400.$x700.$x662.$x297
=072  \\$aC1.$x539.$x757.$x100.$x375
=072  \\$aC23.$x550.$x470.$x790.$x500.$x100.$x375
=150  \\$aHemorrhagic Septicemia
=450  \\$wnnna$aBacteremia, Haemorrhagic
=450  \\$aBacteremia, Hemorrhagic
=450  \\$wnnna$aHaemorrhagic Bacteremia
=450  \\$wnnna$aHaemorrhagic Septicaemia
=450  \\$wnnna$aHaemorrhagic Septicemia
=450  \\$aHemorrhagic Bacteremia
=450  \\$wnnna$aHemorrhagic Septicaemia
=450  \\$wnnna$aSepticaemia, Haemorrhagic
=450  \\$wnnna$aSepticaemia, Hemorrhagic
=450  \\$wnnna$aSepticemia, Haemorrhagic
=450  \\$aSepticemia, Hemorrhagic
=550  \\$wg$aBacteremia
=550  \\$wg$aPasteurella Infections
=550  \\$aHemorrhagic Septicemia, Viral
=667  \\$acoord (IM) with PASTEURELLA MULTOCIDA (IM) or specific organism /infection term (IM) if pertinent
=680  \\$iAny of several bacterial diseases, usually caused by PASTEURELLA MULTOCIDA, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. The diseases primarily affect animals and rarely humans.
=688  \\$a2003, 1975-1991
=750  \0$aHemorrhagic septicemia$0(DLC)sh2007000824$5IEN-M

=LDR  01787cz  a2200373n  4500
=001  9880363492102441
=005  20141212202055.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006482
=035  \\$aCAZ9654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x417
=150  \\$aHemorrhagic Fevers, Viral
=450  \\$wnnna$aFever, Viral Hemorrhagic
=450  \\$wnnna$aFevers, Viral Hemorrhagic
=450  \\$wnnna$aHemorrhagic Fever, Viral
=450  \\$wnnna$aViral Hemorrhagic Fever
=450  \\$wnnna$aViral Hemorrhagic Fevers
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aDengue
=550  \\$wh$aHemorrhagic Fever, American
=550  \\$wh$aHemorrhagic Fever, Crimean
=550  \\$wh$aHemorrhagic Fever, Ebola
=550  \\$wh$aHemorrhagic Fever, Omsk
=550  \\$wh$aHemorrhagic Fever with Renal Syndrome
=550  \\$wh$aKyasanur Forest Disease
=550  \\$wh$aLassa Fever
=550  \\$wh$aMarburg Virus Disease
=550  \\$wh$aRift Valley Fever
=550  \\$wh$aYellow Fever
=667  \\$aGEN or unspecified; prefer specifics; if renal involvement, dis is probably HEMORRHAGIC FEVER WITH RENAL SYNDROME
=680  \\$iA group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.
=688  \\$a78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings & x-refs as of 1977
=750  \0$aHemorrhagic fever$5IEN$0(DLC)sh 85060231

=LDR  00890cz  a2200253n  4500
=001  9880363492202441
=005  20141212202055.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006481
=035  \\$aCAZ9653HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x885.$x440
=072  \\$aC2.$x782.$x350.$x250.$x560
=072  \\$aC2.$x782.$x417.$x435
=150  \\$aHemorrhagic Fever, Omsk
=450  \\$wnnna$aFever, Omsk Hemorrhagic
=450  \\$wnnna$aOmsk Hemorrhagic Fever
=550  \\$wg$aFlavivirus Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=550  \\$wg$aTick-Borne Diseases
=667  \\$acaused by a flavivirus
=680  \\$iInfection with the Omsk hemorrhagic fever virus, a Flavivirus.
=688  \\$a78(77); was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76
=750  \0$aHemorrhagic fever, Omsk$5IEN$0(DLC)sh 85060232

=LDR  01752cz  a2200349n  4500
=001  9880363492302441
=005  20141212202054.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006480
=035  \\$aCAZ9652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x147.$x420.$x400
=072  \\$aC2.$x782.$x417.$x450
=150  \\$aHemorrhagic Fever with Renal Syndrome
=450  \\$wnnna$aEpidemic Hemorrhagic Fever
=450  \\$wnnna$aEpidemic Hemorrhagic Fevers
=450  \\$aHemorrhagic Fever, Epidemic
=450  \\$aHemorrhagic Fever, Korean
=450  \\$wnnna$aHemorrhagic Fevers, Epidemic
=450  \\$wnnna$aHemorrhagic Nephroso-Nephritides
=450  \\$aHemorrhagic Nephroso-Nephritis
=450  \\$wnnna$aHemorrhagic Nephroso Nephritis
=450  \\$aHFRS
=450  \\$wnnna$aKorean Hemorrhagic Fever
=450  \\$aNephropathia Epidemica
=450  \\$wnnna$aNephroso-Nephritides, Hemorrhagic
=450  \\$wnnna$aNephroso-Nephritis, Hemorrhagic
=550  \\$wg$aHantavirus Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=680  \\$iAn acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.
=688  \\$a1995 (1977); for NEUROPATHIA EPIDEMICA use HANTAVIRUS INFECTIONS 1994-2001
=750  \0$aHemorrhagic fever with renal syndrome$5IEN$0(DLC)sh 91003558

=LDR  01078cz  a2200289n  4500
=001  9880363492402441
=005  20141212202052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006475
=035  \\$aCAZ9647HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x920.$x360
=072  \\$aC15.$x378.$x463.$x841.$x464
=072  \\$aC16.$x614.$x940
=072  \\$aC18.$x654.$x422.$x360
=072  \\$aC18.$x654.$x521.$x500.$x133.$x912.$x360
=150  \\$aVitamin K Deficiency Bleeding
=450  \\$aHemorrhagic Disease of Newborn
=450  \\$wnnna$aNewborn Hemorrhagic Disease
=450  \\$wnnna$aNewborn Hemorrhagic Diseases
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aInfant Nutrition Disorders
=550  \\$wg$aVitamin K Deficiency
=667  \\$ado not confuse with HEMOLYTIC DISEASE OF NEWBORN see ERYTHROBLASTOSIS, FETAL
=680  \\$iHemorrhage caused by vitamin K deficiency.
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Hemorrhagic Disease of Newborn
=750  \0$aHemorrhagic disease of newborn$0(DLC) sh 85060227$5IEN-M

=LDR  01934cz  a2200505n  4500
=001  9880363492502441
=005  20141212202052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006474
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x463
=150  \\$aHemorrhagic Disorders
=450  \\$wnnna$aDiatheses, Hemorrhagic
=450  \\$wnnna$aDiathesis, Hemorrhagic
=450  \\$wnnna$aDisorder, Hemorrhagic
=450  \\$wnnna$aDisorders, Hemorrhagic
=450  \\$wnnna$aHemorrhagic Diatheses
=450  \\$aHemorrhagic Diathesis
=450  \\$wnnna$aHemorrhagic Disorder
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aAfibrinogenemia
=550  \\$wh$aBernard-Soulier Syndrome
=550  \\$wh$aDisseminated Intravascular Coagulation
=550  \\$wh$aFactor V Deficiency
=550  \\$wh$aFactor VII Deficiency
=550  \\$wh$aFactor X Deficiency
=550  \\$wh$aFactor XI Deficiency
=550  \\$wh$aFactor XII Deficiency
=550  \\$wh$aFactor XIII Deficiency
=550  \\$wh$aHemophilia A
=550  \\$wh$aHemophilia B
=550  \\$wh$aHemostatic Disorders
=550  \\$wh$aHypoprothrombinemias
=550  \\$wh$aPlatelet Storage Pool Deficiency
=550  \\$wh$aPurpura, Thrombocytopenic, Idiopathic
=550  \\$wh$aThrombasthenia
=550  \\$wh$aThrombocythemia, Essential
=550  \\$wh$aVitamin K Deficiency
=550  \\$wh$avon Willebrand Diseases
=550  \\$wh$aWaterhouse-Friderichsen Syndrome
=550  \\$wh$aWiskott-Aldrich Syndrome
=667  \\$a"predisposition to abnormal hemostasis"; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iSpontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).
=688  \\$a99(63)
=750  \0$aHemorrhagic diseases$5IEN-M$0(DLC)sh 85060228

=LDR  01277cz  a2200301n  4500
=001  9880363492602441
=005  20141212202050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006471
=035  \\$aCAZ9643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x227
=072  \\$aC23.$x550.$x414.$x788
=150  \\$aGastrointestinal Hemorrhage
=450  \\$aGastrointestinal Bleeding$5IEN-M
=450  \\$wnnna$aGastrointestinal Hemorrhages
=450  \\$aHematochezia
=450  \\$wnnna$aHematochezias
=450  \\$aHemorrhage, Gastrointestinal
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wg$aHemorrhage
=550  \\$wh$aHematemesis
=550  \\$wh$aMelena
=550  \\$wh$aPeptic Ulcer Hemorrhage
=667  \\$acoord IM with specific intestinal dis (IM), as colonic hemorrhage = GASTROINTESTINAL HEMORRHAGE (IM) + COLONIC DISEASES (IM); rectal bleeding: see note under RECTUM; X ref HEMATOCHEZIA is red blood in the feces when bleeding is from the lower bowel: do not coord with FECES unless feces are particularly discussed
=680  \\$iBleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
=688  \\$a90; was HEMORRHAGE, GASTROINTESTINAL 1966-89
=750  \0$aGastrointestinal hemorrhage$5IEN$0(DLC)sh 85053485

=LDR  01427cz  a2200445n  4500
=001  9880363492702441
=005  20141212202050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006470
=035  \\$aCAZ9642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x414
=150  \\$aHemorrhage
=450  \\$aBleeding
=450  \\$wnnna$aHemorrhages
=550  \\$wg$aPathologic Processes
=550  \\$wh$aBlood Loss, Surgical
=550  \\$wh$aEcchymosis
=550  \\$wh$aEpistaxis
=550  \\$wh$aExsanguination
=550  \\$wh$aEye Hemorrhage
=550  \\$wh$aGastrointestinal Hemorrhage
=550  \\$wh$aHemarthrosis
=550  \\$wh$aHematocele
=550  \\$wh$aHematoma
=550  \\$wh$aHematuria
=550  \\$wh$aHemobilia
=550  \\$wh$aHemoperitoneum
=550  \\$wh$aHemoptysis
=550  \\$wh$aHemothorax
=550  \\$wh$aIntracranial Hemorrhages
=550  \\$wh$aOral Hemorrhage
=550  \\$wh$aPostoperative Hemorrhage
=550  \\$wh$aPurpura
=550  \\$wh$aRetrobulbar Hemorrhage
=550  \\$wh$aShock, Hemorrhagic
=550  \\$wh$aUterine Hemorrhage
=667  \\$aGEN or unspecified; prefer specifics; coord IM with organ/dis precoord (IM), not organ /blood supply; consider also terms for presence of blood within cavities, as HEMOTHORAX; HEMATOCOLPOS; etc.
=680  \\$iBleeding or escape of blood from a vessel.
=750  \0$aHemorrhage$5IEN$0(DLC)sh 85060224

=LDR  00551cz  a2200193n  4500
=001  9880363492802441
=005  20141212202049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006468
=035  \\$aCAZ9640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x338
=072  \\$aC23.$x550.$x414.$x904.$x500
=150  \\$aHemopneumothorax
=550  \\$wg$aHemothorax
=550  \\$wg$aPleural Diseases
=550  \\$aPneumothorax
=680  \\$iCollection of air and blood in the pleural cavity.
=750  \0$aHemopneumothorax$5IEN$0(DLC)sh 85060222

=LDR  01844cz  a2200505n  4500
=001  9880363492902441
=005  20141212202049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006467
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x100.$x500
=072  \\$aC15.$x378.$x100.$x141.$x500
=072  \\$aC15.$x378.$x463.$x500
=072  \\$aC16.$x320.$x99.$x500
=150  \\$aHemophilia A
=450  \\$wnnna$aAs, Autosomal Hemophilia
=450  \\$wnnna$aAutosomal Hemophilia A
=450  \\$wnnna$aAutosomal Hemophilia As
=450  \\$wnnna$aClassic Hemophilia
=450  \\$wnnna$aClassic Hemophilias
=450  \\$wnnna$aCongenital Hemophilia A
=450  \\$wnnna$aCongenital Hemophilia As
=450  \\$wnnna$aDeficiency, Factor VIII
=450  \\$wnnna$aFactor 8 Deficiency, Congenital
=450  \\$aFactor VIII Deficiency
=450  \\$aFactor VIII$xdeficiency
=450  \\$wnnna$aFactor VIII Deficiency, Congenital
=450  \\$aFactor VIIIa$xdeficiency
=450  \\$wnnna$aHaemophilia
=450  \\$aHemophilia
=450  \\$wnnna$aHemophilia A, Autosomal
=450  \\$wnnna$aHemophilia A, Congenital
=450  \\$wnnna$aHemophilia As
=450  \\$wnnna$aHemophilia As, Autosomal
=450  \\$wnnna$aHemophilia As, Congenital
=450  \\$wnnna$aHemophilia, Classic
=450  \\$wnnna$aHemophilias, Classic
=550  \\$wg$aBlood Coagulation Disorders, Inherited
=550  \\$wg$aCoagulation Protein Disorders
=550  \\$wg$aHemorrhagic Disorders
=550  \\$aHemophilia B
=680  \\$iThe classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.
=688  \\$a99(66)
=750  \0$aHemophiliacs$5IEN-M$0(DLC)sh 85060217
=750  \0$aHemophilia$5IEN-HS$0(DLC)sh 85060214

=LDR  01088cz  a2200241n  4500
=001  9880363493002441
=005  20141212202048.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006464
=035  \\$aCAZ9636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x912.$x430
=072  \\$aE4.$x292.$x510
=150  \\$aHemoperfusion
=450  \\$wnnna$aHemoperfusions
=450  \\$aHemosorption
=450  \\$wnnna$aHemosorptions
=550  \\$wg$aExtracorporeal Circulation
=550  \\$wg$aSorption Detoxification
=667  \\$ado not confuse with RENAL DIALYSIS or PERFUSION; HEMOFILTRATION is available
=680  \\$iRemoval of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose).
=688  \\$a78
=750  \0$aHemoperfusion$5IEN$0(DLC)sh 90001759

=LDR  01141cz  a2200301n  4500
=001  9880363493102441
=005  20141212192231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006463
=035  \\$aCAZ9635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x936.$x463
=072  \\$aC13.$x351.$x968.$x419.$x936.$x463
=072  \\$aC15.$x378.$x71.$x141.$x610
=072  \\$aC15.$x378.$x140.$x855.$x925.$x500
=150  \\$aHemolytic-Uremic Syndrome
=450  \\$wnnna$aGasser Syndrome
=450  \\$aGasser's Syndrome
=450  \\$wnnna$aGassers Syndrome
=450  \\$wnnna$aHemolytic Uremic Syndrome
=450  \\$wnnna$aSyndrome, Hemolytic-Uremic
=550  \\$wg$aAnemia, Hemolytic
=550  \\$wg$aThrombotic Microangiopathies
=550  \\$wg$aUremia
=550  \\$wh$aAtypical Hemolytic Uremic Syndrome
=680  \\$iA syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.
=688  \\$a74(72)
=750  \0$aHemolytic-uremic syndrome$5IEN$0(DLC)sh 85060213

=LDR  01978cz  a2200469n  4500
=001  9880363493202441
=005  20141212202048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006462
=035  \\$aCAZ9634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x375
=072  \\$aE5.$x200.$x812.$x375
=072  \\$aE5.$x478.$x594.$x375
=150  \\$aHemolytic Plaque Technique
=450  \\$wnnna$aHemolytic Plaque Technic
=450  \\$wnnna$aHemolytic Plaque Technics
=450  \\$wnnna$aHemolytic Plaque Techniques
=450  \\$wnnna$aJerne Plaque Technic
=450  \\$wnnna$aJerne Plaque Technique
=450  \\$wnnna$aJerne's Plaque Technic
=450  \\$wnnna$aJernes Plaque Technic
=450  \\$aJerne's Plaque Technique
=450  \\$wnnna$aJernes Plaque Technique
=450  \\$wnnna$aPlaque Technic, Hemolytic
=450  \\$wnnna$aPlaque Technic, Jerne's
=450  \\$wnnna$aPlaque Technics, Hemolytic
=450  \\$wnnna$aPlaque Technique, Hemolytic
=450  \\$wnnna$aPlaque Technique, Jerne's
=450  \\$wnnna$aPlaque Techniques, Hemolytic
=450  \\$wnnna$aTechnic, Hemolytic Plaque
=450  \\$wnnna$aTechnic, Jerne's Plaque
=450  \\$wnnna$aTechnics, Hemolytic Plaque
=450  \\$wnnna$aTechnique, Hemolytic Plaque
=450  \\$wnnna$aTechnique, Jerne's Plaque
=450  \\$wnnna$aTechniques, Hemolytic Plaque
=550  \\$wg$aImmunologic Tests
=550  \\$aAntibody-Producing Cells
=667  \\$ahemolysis in gel goes here
=680  \\$iA method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed)
=688  \\$a91(69); was HEMOLYTIC PLAQUE TECHNIC 1969-90 (Prov 1969-72)
=750  \0$aHemolytic plaque technique$5IEN$0(DLC)sh 85060212

=LDR  00693cz  a2200193n  4500
=001  9880363493302441
=005  20141212202047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006461
=035  \\$aCAZ9633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x403
=072  \\$aG12.$x425.$x143.$x545
=150  \\$aHemolysis
=550  \\$wg$aAntigen-Antibody Reactions
=550  \\$wg$aPathologic Processes
=667  \\$ahemolysis in gel = HEMOLYTIC PLAQUE TECHNIQUE
=680  \\$iThe destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
=750  \0$aHemolysis and Hemolysins$0(DLC) sh 85060209$5IEN

=LDR  00837cz  a2200217n  4500
=001  9880363493402441
=005  20141212202047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006460
=035  \\$aCAZ9632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x695.$x444
=150  \\$aHemolysin Proteins
=450  \\$wnnna$aHemalysins
=450  \\$aHemolysins
=450  \\$wnnna$aProteins, Hemolysin
=550  \\$wg$aPore Forming Cytotoxic Proteins
=680  \\$iProteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS.
=688  \\$a2007(1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Hemolysins
=750  \0$aHemolysis and Hemolysins$0(DLC) sh 85060209$5IEN

=LDR  00533cz  a2200181n  4500
=001  9880363493502441
=005  20141212202046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006458
=035  \\$aCAZ9630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x453
=150  \\$aHemolymph
=450  \\$wnnna$aHemolymphs
=550  \\$wg$aAnimal Structures
=680  \\$iThe blood/lymphlike nutrient fluid of some invertebrates.
=750  \0$aHemolymph$0(DLC) sh 85060207$5IEN-M
=750  \0$aHemolymph glands$0(DLC) sh 85060208$5IEN-HS

=LDR  01762cz  a2200361n  4500
=001  9880363493602441
=005  20141212202046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006457
=035  \\$aCAZ9629M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x560
=072  \\$aC15.$x378.$x190.$x625.$x460
=150  \\$aHemoglobinuria, Paroxysmal
=450  \\$wnnna$aCold Paroxysmal Hemoglobinuria
=450  \\$wnnna$aHemoglobinuria, Cold Paroxysmal
=450  \\$wnnna$aHemoglobinuria, Nocturnal Paroxysmal
=450  \\$wnnna$aHemoglobinuria, Paroxysmal Cold
=450  \\$wnnna$aHemoglobinuria, Paroxysmal Nocturnal
=450  \\$wnnna$aMarchiafava-Micheli Syndrome
=450  \\$wnnna$aMarchiafava Micheli Syndrome
=450  \\$wnnna$aNocturnal Paroxysmal Hemoglobinuria
=450  \\$aParoxysmal Cold Hemoglobinuria
=450  \\$wnnna$aParoxysmal Hemoglobinuria
=450  \\$wnnna$aParoxysmal Hemoglobinuria, Cold
=450  \\$wnnna$aParoxysmal Hemoglobinuria, Nocturnal
=450  \\$aParoxysmal Nocturnal Hemoglobinuria
=450  \\$wnnna$aSyndrome, Marchiafava-Micheli
=550  \\$wg$aAnemia, Hemolytic
=550  \\$wg$aMyelodysplastic Syndromes
=680  \\$iA condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.
=688  \\$a78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77
=750  \0$aParoxysmal hemoglobinuria$5IEN-M$0(DLC)sh 99004283

=LDR  00854cz  a2200217n  4500
=001  9880363493702441
=005  20141212202046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006456
=035  \\$aCAZ9628M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x734.$x634
=072  \\$aC13.$x351.$x968.$x934.$x734.$x634
=072  \\$aC23.$x888.$x942.$x750.$x634
=150  \\$aHemoglobinuria
=450  \\$aHemoglobins$xurine
=550  \\$wg$aProteinuria
=550  \\$aUrine
=667  \\$aHEMOGLOBINURIA, PAROXYSMAL is also available: see note there
=680  \\$iThe presence of free HEMOGLOBIN in the URINE, indicating hemolysis of ERYTHROCYTES within the vascular system. After saturating the hemoglobin-binding proteins (HAPTOGLOBINS), free hemoglobin begins to appear in the urine.
=750  \0$aHemoglobinuria$5IEN-M$0(DLC)sh 99004390

=LDR  01103cz  a2200277n  4500
=001  9880363493802441
=005  20141212202045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006455
=035  \\$aCAZ9627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x400.$x463
=072  \\$aD12.$x776.$x422.$x316.$x762.$x426
=150  \\$aHemoglobins, Abnormal
=450  \\$wnnna$aAbnormal Hemoglobins
=550  \\$wg$aHemoglobins
=550  \\$wh$aHemoglobin C
=550  \\$wh$aHemoglobin E
=550  \\$wh$aHemoglobin H
=550  \\$wh$aHemoglobin J
=550  \\$wh$aHemoglobin M
=550  \\$wh$aHemoglobin, Sickle
=550  \\$aHemoglobinopathies
=667  \\$a/urine: coord IM with HEMOGLOBINURIA (IM); do not confuse with HEMOGLOBINOPATHIES: use term in the text
=680  \\$iHemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains.
=750  \0$aHemoglobinopathy$5IEN$0(DLC)sh 85060203

=LDR  00773cz  a2200205n  4500
=001  9880363493902441
=005  20141212202013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006366
=035  \\$aCAZ9537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x290.$x330.$x315.$x335
=072  \\$aA11.$x284.$x420.$x204.$x335
=072  \\$aA15.$x145.$x229.$x334.$x330.$x340.$x335
=150  \\$aHeinz Bodies
=450  \\$wnnna$aBodies, Heinz
=550  \\$wg$aErythrocyte Inclusions
=680  \\$iAbnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.
=688  \\$a68(63)
=750  \0$aHeinz bodies$5IEN$0(DLC)sh 85059964

=LDR  00692cz  a2200181n  4500
=001  9880363494002441
=005  20141212202013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006364
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x473.$x376
=150  \\$aHedgehogs
=450  \\$aErinaceidae
=450  \\$wnnna$aHedgehog
=550  \\$wg$aInsectivora
=680  \\$iThe family Erinaceidae, in the order INSECTIVORA. Most are true hedgehogs possessing a coat of spines and a very short tail. Those members of the family found in Southeast Asia (moonrats or gymnures) have normal body hair and a long tail.
=688  \\$a72
=750  \0$aHedgehogs$5IEN$0(DLC)sh 85059909

=LDR  00745cz  a2200169n  4500
=001  9880363494102441
=005  20141212202012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006361
=035  \\$aCAZ9532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x300
=150  \\$aHeating
=550  \\$wg$aEnvironment, Controlled
=667  \\$athe environment: differentiate from HEAT, the principle of physics; /adv eff permitted but do not confuse with HEAT /adv eff
=680  \\$iThe application of heat to raise the temperature of the environment, ambient or local, or the systems for accomplishing this effect. It is distinguished from HEAT, the physical property and principle of physics.
=750  \0$aHeating$5IEN$0(DLC)sh 85059822

=LDR  01226cz  a2200337n  4500
=001  9880363494202441
=005  20141212202011.0
=008  830616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006360
=035  \\$aCAZ9531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x580.$x216
=150  \\$aHeat-Shock Proteins
=450  \\$wnnna$aHeat-Shock Protein
=450  \\$wnnna$aHeat Shock Protein
=450  \\$wnnna$aHeat Shock Proteins
=450  \\$aStress Proteins
=550  \\$wg$aMolecular Chaperones
=550  \\$wh$aChaperonins
=550  \\$wh$aHeat-Shock Proteins, Small
=550  \\$wh$aHSP40 Heat-Shock Proteins
=550  \\$wh$aHSP47 Heat-Shock Proteins
=550  \\$wh$aHSP70 Heat-Shock Proteins
=550  \\$wh$aHSP90 Heat-Shock Proteins
=550  \\$aCold Shock Proteins and Peptides
=550  \\$aFever
=550  \\$aHeat-Shock Response
=550  \\$aMolecular Chaperones
=680  \\$iProteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions.
=688  \\$a84
=750  \0$aHeat shock proteins$0(DLC) sh 85059812$5IEN

=LDR  01241cz  a2200337n  4500
=001  9880363494302441
=005  20141212202011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006358
=035  \\$aCAZ9529HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x595.$x543
=072  \\$aG16.$x500.$x275.$x63.$x725.$x710.$x380
=072  \\$aG16.$x500.$x750.$x775.$x710.$x380
=072  \\$aN6.$x230.$x300.$x100.$x725.$x232
=072  \\$aN6.$x230.$x300.$x100.$x725.$x710.$x380
=150  \\$aHot Temperature
=360  \\$iconsider also terms at$aTHERM-
=450  \\$aHeat
=450  \\$wnnna$aHot Temperatures
=450  \\$wnnna$aTemperature, Hot
=450  \\$wnnna$aTemperatures, Hot
=550  \\$wg$aTemperature
=550  \\$wg$aWeather
=550  \\$wh$aExtreme Heat
=550  \\$aHyperthermia, Induced
=667  \\$adifferentiate from HEATING (the environment); /ther use: consider also HYPERTHERMIA, INDUCED; HOT TEMPERATURE /adv eff: consider also HEAT STRESS DISORDERS & its specifics
=680  \\$iPresence of warmth or heat or a temperature notably higher than an accustomed norm.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Heat
=750  \0$aHeat$0(DLC) sh 85059758$5IEN

=LDR  00680cz  a2200217n  4500
=001  9880363494402441
=005  20141212202010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006357
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x54.$x160.$x400
=072  \\$aC1.$x252.$x400.$x825.$x300
=072  \\$aC22.$x434
=150  \\$aHeartwater Disease
=450  \\$wnnna$aDisease, Heartwater
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aEhrlichiosis
=550  \\$wg$aTick-Borne Diseases
=680  \\$iA tick-borne septicemic disease of domestic and wild ruminants caused by EHRLICHIA RUMINANTIUM.
=688  \\$a70
=750  \0$aHeartwater$5IEN$0(DLC)sh 85059757

=LDR  00629cz  a2200205n  4500
=001  9880363494502441
=005  20141212202010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006356
=035  \\$aCAZ9527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x525
=150  \\$aHeartburn
=450  \\$wnnna$aPyroses
=450  \\$aPyrosis
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$aGastroesophageal Reflux
=680  \\$iSubsternal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.
=688  \\$a64
=750  \0$aHeartburn$5IEN$0(DLC)sh 85059754

=LDR  01367cz  a2200277n  4500
=001  9880363494602441
=005  20141212202010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006355
=035  \\$aCAZ9526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x82.$x458
=150  \\$aHeart-Lung Machine
=450  \\$aCardiopulmonary Bypass$xinstrumentation$5IEN-M
=450  \\$wnnna$aHeart Lung Machine
=450  \\$wnnna$aHeart-Lung Machines
=450  \\$wnnoa$aHeart, Mechanical$5IEN
=450  \\$wnnna$aMachine, Heart-Lung
=450  \\$wnnna$aMachines, Heart-Lung
=550  \\$wg$aArtificial Organs
=550  \\$aCardiopulmonary Bypass
=550  \\$aOxygenators
=667  \\$aexternal: do not confuse with HEART, ARTIFICIAL (pump replacing whole or part of heart)
=680  \\$iApparatus that provides mechanical circulatory support during open-heart surgery, by passing the heart to facilitate surgery on the organ. The basic function of the machine is to oxygenate the body's venous supply of blood and then pump it back into the arterial system. The machine also provides intracardiac suction, filtration, and temperature control. Some of the more important components of these machines include pumps, oxygenators, temperature regulators, and filters. (UMDNS, 1999)
=688  \\$a98(63)
=750  \0$aHeart, Mechanical$5IEN$0(DLC)sh 85059739

=LDR  01038cz  a2200253n  4500
=001  9880363494702441
=005  20141212202010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006354
=035  \\$aCAZ9525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x300
=072  \\$aE7.$x858.$x82.$x374
=150  \\$aHeart, Artificial
=450  \\$aArtificial Heart
=450  \\$wnnna$aArtificial Hearts
=450  \\$wnnna$aHearts, Artificial
=550  \\$wg$aArtificial Organs
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aHeart-Assist Devices
=667  \\$apump replacing whole or part of heart: do not confuse with HEART-LUNG MACHINE (external to heart); /psychol permitted
=680  \\$iA pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)
=688  \\$a67
=750  \0$aHeart, Artificial$5IEN$0(DLC)sh 85059736

=LDR  01504cz  a2200361n  4500
=001  9880363494802441
=005  20141212202008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006352
=035  \\$aCAZ9523HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x560
=150  \\$aHeart Ventricles
=450  \\$wnnna$aCardiac Ventricle
=450  \\$wnnna$aCardiac Ventricles
=450  \\$wnnna$aHeart Ventricle
=450  \\$wnnna$aLeft Ventricle
=450  \\$wnnna$aLeft Ventricles
=450  \\$wnnna$aRight Ventricle
=450  \\$wnnna$aRight Ventricles
=450  \\$wnnna$aVentricle, Cardiac
=450  \\$wnnna$aVentricle, Heart
=450  \\$wnnna$aVentricle, Left
=450  \\$wnnna$aVentricle, Right
=450  \\$wnnna$aVentricles, Cardiac
=450  \\$wnnna$aVentricles, Heart
=450  \\$wnnna$aVentricles, Left
=450  \\$wnnna$aVentricles, Right
=550  \\$wg$aHeart
=667  \\$a/ radionuclide permitted but consider also RADIONUCLIDE VENTRICULOGRAPHY; ventricular hypertrophy = HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; false ventricular tendons: index under PURKINJE FIBERS but see note there; PAPILLARY MUSCLES & CHORDAE TENDINEAE are also available
=680  \\$iThe lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.
=688  \\$a2004(1966)
=750  \0$aHeart$xVentricles$5IEN$0(DLC)sh 85059731

=LDR  01048cz  a2200325n  4500
=001  9880363494902441
=005  20141212202008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006351
=035  \\$aCAZ9522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510
=150  \\$aHeart Valves
=450  \\$wnnna$aCardiac Valve
=450  \\$wnnna$aCardiac Valves
=450  \\$wnnna$aHeart Valve
=450  \\$wnnna$aValve, Cardiac
=450  \\$wnnna$aValve, Heart
=450  \\$wnnna$aValves, Cardiac
=450  \\$wnnna$aValves, Heart
=550  \\$wg$aHeart
=550  \\$wh$aAortic Valve
=550  \\$wh$aChordae Tendineae
=550  \\$wh$aMitral Valve
=550  \\$wh$aPapillary Muscles
=550  \\$wh$aPulmonary Valve
=550  \\$wh$aTricuspid Valve
=667  \\$aGEN or unspecified: prefer specifics
=680  \\$iFlaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.
=750  \0$aHeart valves$5IEN$0(DLC)sh 85059727

=LDR  01297cz  a2200325n  4500
=001  9880363495002441
=005  20141212202008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006350
=035  \\$aCAZ9521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x310
=150  \\$aHeart Valve Prosthesis
=450  \\$wnnna$aCardiac Valve Prostheses
=450  \\$wnnna$aCardiac Valve Prosthesis
=450  \\$wnnna$aHeart Valve Prostheses
=450  \\$wnnna$aProstheses, Cardiac Valve
=450  \\$wnnna$aProstheses, Heart Valve
=450  \\$wnnna$aProsthesis, Cardiac Valve
=450  \\$aProsthesis, Heart Valve
=450  \\$wnnna$aValve Prostheses, Cardiac
=450  \\$wnnna$aValve Prostheses, Heart
=450  \\$wnnna$aValve Prosthesis, Cardiac
=450  \\$wnnna$aValve Prosthesis, Heart
=550  \\$wg$aProstheses and Implants
=550  \\$aHeart Valve Prosthesis Implantation
=667  \\$acoord IM with specific valve (IM); for bioprostheses coord IM with BIOPROSTHESIS (IM) & do not specify source of biol material unless especially discussed
=680  \\$iA device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.
=688  \\$a65
=750  \0$aHeart valve prosthesis$5IEN$0(DLC)sh 85059753

=LDR  01623cz  a2200445n  4500
=001  9880363495102441
=005  20141212202007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006349
=035  \\$aCAZ9520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484
=150  \\$aHeart Valve Diseases
=450  \\$wnnna$aDisease, Heart Valve
=450  \\$wnnna$aDisease, Valvular Heart
=450  \\$wnnna$aDiseases, Heart Valve
=450  \\$wnnna$aDiseases, Valvular Heart
=450  \\$wnnna$aHeart Disease, Valvular
=450  \\$wnnna$aHeart Diseases, Valvular
=450  \\$wnnna$aHeart Valve Disease
=450  \\$wnnna$aValve Disease, Heart
=450  \\$wnnna$aValve Diseases, Heart
=450  \\$wnnna$aValvular Heart Disease
=450  \\$aValvular Heart Diseases
=550  \\$wg$aHeart Diseases
=550  \\$wh$aAortic Valve Insufficiency
=550  \\$wh$aAortic Valve Stenosis
=550  \\$wh$aHeart Valve Prolapse
=550  \\$wh$aMitral Valve Insufficiency
=550  \\$wh$aMitral Valve Stenosis
=550  \\$wh$aPulmonary Atresia
=550  \\$wh$aPulmonary Valve Insufficiency
=550  \\$wh$aPulmonary Valve Stenosis
=550  \\$wh$aTricuspid Atresia
=550  \\$wh$aTricuspid Valve Insufficiency
=550  \\$wh$aTricuspid Valve Stenosis
=667  \\$acoordinate IM with specific valve (IM)
=680  \\$iPathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
=688  \\$a67; AORTIC VALVE DISEASES was heading 1963-66
=750  \0$aHeart valves$xDiseases$5IEN$0(DLC)sh 85059728

=LDR  01975cz  a2200529n  4500
=001  9880363495202441
=005  20141212202007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006348
=035  \\$aCAZ9519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376
=072  \\$aE4.$x928.$x220
=150  \\$aCardiac Surgical Procedures
=450  \\$wnnna$aCardiac Surgical Procedure
=450  \\$aHeart$xsurgery
=450  \\$wnnoa$aHeart Surgery$5IEN
=450  \\$wnnna$aHeart Surgical Procedure
=450  \\$wnnna$aHeart Surgical Procedures
=450  \\$aMyocardium$xsurgery
=450  \\$wnnna$aProcedure, Cardiac Surgical
=450  \\$wnnna$aProcedure, Heart Surgical
=450  \\$wnnna$aProcedures, Cardiac Surgical
=450  \\$wnnna$aProcedures, Heart Surgical
=450  \\$wnnna$aSurgical Procedure, Cardiac
=450  \\$wnnna$aSurgical Procedure, Heart
=450  \\$wnnna$aSurgical Procedures, Cardiac
=450  \\$wnnna$aSurgical Procedures, Heart
=550  \\$wg$aCardiovascular Surgical Procedures
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$wh$aCardiac Valve Annuloplasty
=550  \\$wh$aCardiomyoplasty
=550  \\$wh$aHeart Arrest, Induced
=550  \\$wh$aHeart Bypass, Right
=550  \\$wh$aHeart Massage
=550  \\$wh$aHeart Transplantation
=550  \\$wh$aHeart Valve Prosthesis Implantation
=550  \\$wh$aMyocardial Revascularization
=550  \\$wh$aNorwood Procedures
=550  \\$wh$aPericardial Window Techniques
=550  \\$wh$aPericardiectomy
=550  \\$wh$aPericardiocentesis
=550  \\$aThoracic Surgery
=667  \\$aGEN only: do not use for surg of specific part of heart ( = specific heart term /surg) or specific heart dis ( = disease /surg); HEART TRANSPLANTATION & HEART-LUNG TRANSPLANTATION are also available
=680  \\$iSurgery performed on the heart.
=688  \\$a98; was HEART SURGERY 1963-97
=750  \0$aHeart$xSurgery$5IEN$0(DLC)sh 85059711

=LDR  01350cz  a2200277n  4500
=001  9880363495302441
=005  20141212202006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006347
=035  \\$aCAZ9518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380.$x510
=150  \\$aHeart Sounds
=450  \\$wnnna$aCardiac Sound
=450  \\$wnnna$aCardiac Sounds
=450  \\$wnnna$aHeart Sound
=450  \\$wnnna$aSound, Cardiac
=450  \\$wnnna$aSound, Heart
=450  \\$wnnna$aSounds, Cardiac
=450  \\$wnnna$aSounds, Heart
=550  \\$wg$aHemodynamics
=550  \\$aHeart Murmurs
=667  \\$anote category: do not confuse with HEART MURMURS, a disease concept
=680  \\$iThe sounds heard over the cardiac region produced by the functioning of the heart. There are four distinct sounds: the first occurs at the beginning of SYSTOLE and is heard as a "lubb" sound; the second is produced by the closing of the AORTIC VALVE and PULMONARY VALVE and is heard as a "dupp" sound; the third is produced by vibrations of the ventricular walls when suddenly distended by the rush of blood from the HEART ATRIA; and the fourth is produced by atrial contraction and ventricular filling.
=688  \\$a91(75); was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90
=750  \0$aHeart$xSounds$5IEN$0(DLC)sh 85059710

=LDR  01027cz  a2200289n  4500
=001  9880363495402441
=005  20141212202005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006346
=035  \\$aCAZ9517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x459
=150  \\$aHeart Septum
=450  \\$wnnna$aCardiac Septum
=450  \\$wnnna$aHeart Septa
=450  \\$wnnna$aSepta, Heart
=450  \\$wnnna$aSeptum, Cardiac
=450  \\$wnnna$aSeptum, Heart
=550  \\$wg$aHeart
=550  \\$wh$aAtrial Septum
=550  \\$wh$aEndocardial Cushions
=550  \\$wh$aForamen Ovale
=550  \\$wh$aVentricular Septum
=667  \\$aheart septal disease: coordinate IM with CARDIOMYOPATHIES (IM)
=680  \\$iThis structure includes the thin muscular atrial septum between the two HEART ATRIA, and the thick muscular ventricular septum between the two HEART VENTRICLES.
=688  \\$aHEART SEPTUM, ATRIAL & HEART SEPTUM, VENTRICULAR were headings 1963
=750  \0$aHeart septum$0(DLC) sh 85059750$5IEN

=LDR  01525cz  a2200337n  4500
=001  9880363495502441
=005  20141212202005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006345
=035  \\$aCAZ9516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x560.$x540
=072  \\$aC14.$x280.$x400.$x560.$x540
=072  \\$aC16.$x131.$x240.$x400.$x560.$x540
=150  \\$aHeart Septal Defects, Ventricular
=450  \\$wnnna$aDefect, Intraventricular Septal
=450  \\$wnnna$aDefect, Ventricular Septal
=450  \\$wnnna$aDefects, Intraventricular Septal
=450  \\$wnnna$aIntraventricular Septal Defect
=450  \\$wnnna$aIntraventricular Septal Defects
=450  \\$wnnna$aSeptal Defect, Intraventricular
=450  \\$wnnna$aSeptal Defect, Ventricular
=450  \\$wnnna$aSeptal Defects, Intraventricular
=450  \\$wnnna$aSeptal Defects, Ventricular
=450  \\$wnnna$aVentricular Septal Defect
=450  \\$aVentricular Septal Defects
=450  \\$aVentricular Septum$xabnormalities
=550  \\$wg$aHeart Septal Defects
=680  \\$iDevelopmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
=688  \\$a64
=750  \0$aVentricular septal defects$5IEN$0(DLC)sh 85142754

=LDR  01344cz  a2200337n  4500
=001  9880363495602441
=005  20141212202004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006343
=035  \\$aCAZ9514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x560
=072  \\$aC14.$x280.$x400.$x560
=072  \\$aC16.$x131.$x240.$x400.$x560
=150  \\$aHeart Septal Defects
=450  \\$wnnna$aCardiac Septal Defects
=450  \\$wnnna$aDefect, Heart Septal
=450  \\$wnnna$aDefects, Heart Septal
=450  \\$wnnna$aHeart Septal Defect
=450  \\$aHeart Septum$xabnormalities
=450  \\$wnnna$aSeptal Defect, Heart
=450  \\$wnnna$aSeptal Defects, Heart
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wh$aAortopulmonary Septal Defect
=550  \\$wh$aEndocardial Cushion Defects
=550  \\$wh$aHeart Septal Defects, Atrial
=550  \\$wh$aHeart Septal Defects, Ventricular
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iAbnormalities in any part of the HEART SEPTUM resulting in abnormal communication between the left and the right chambers of the heart. The abnormal blood flow inside the heart may be caused by defects in the ATRIAL SEPTUM, the VENTRICULAR SEPTUM, or both.
=688  \\$a64
=750  \0$aHeart septum$xAbnormalities$5IEN$0(DLC)sh 85059751

=LDR  01169cz  a2200265n  4500
=001  9880363495702441
=005  20141212202003.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006341
=035  \\$aCAZ9512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x470
=150  \\$aHeart Rupture
=450  \\$wnnna$aCardiac Free Wall Rupture
=450  \\$aCardiac Rupture
=450  \\$wnnna$aCardiac Ruptures
=450  \\$wnnna$aFree Wall Rupture, Heart
=450  \\$wnnna$aHeart Ruptures
=450  \\$wnnna$aVentricular Free Wall Rupture
=550  \\$wg$aHeart Diseases
=550  \\$wh$aHeart Rupture, Post-Infarction
=667  \\$ado not confuse with HEART RUPTURE, TRAUMATIC see HEART INJURIES; coordinate IM with specific part (IM) if pertinent but VENTRICULAR SEPTAL RUPTURE is available
=680  \\$iDisease-related laceration or tearing of tissues of the heart, including the free-wall MYOCARDIUM; HEART SEPTUM; PAPILLARY MUSCLES; CHORDAE TENDINEAE; and any of the HEART VALVES. Pathological rupture usually results from myocardial infarction (HEART RUPTURE, POST-INFARCTION).
=688  \\$a78
=750  \0$aHeart$xRupture$5IEN$0(DLC)sh 85059706

=LDR  01519cz  a2200421n  4500
=001  9880363495802441
=005  20180717113724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006339
=035  \\$aCAZ9510HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x875.$x500
=072  \\$aG9.$x330.$x380.$x500
=150  \\$aHeart Rate
=450  \\$wnnna$aCardiac Chronotropism
=450  \\$wnnna$aCardiac Chronotropy
=450  \\$aChronotropism, Cardiac
=450  \\$wnnna$aChronotropy, Cardiac
=450  \\$wnnna$aControl, Heart Rate
=450  \\$aHeart Beat$5IEN
=450  \\$aHeart Rate Control
=450  \\$wnnna$aHeart Rates
=450  \\$aPulse Rate
=450  \\$wnnna$aPulse Rates
=450  \\$wnnna$aRate Control, Heart
=450  \\$wnnna$aRate, Heart
=450  \\$wnnna$aRate, Pulse
=450  \\$wnnna$aRates, Heart
=450  \\$wnnna$aRates, Pulse
=550  \\$wg$aHemodynamics
=550  \\$wg$aVital Signs
=550  \\$wh$aHeart Rate, Fetal
=550  \\$wh$aRespiratory Sinus Arrhythmia
=550  \\$aPulse
=667  \\$apolicy: Manual 23.27+; chronotropic action of drugs = HEART RATE /drug eff (IM) + drug with /pharmacol (IM) + STIMULATION, CHEMICAL (NIM) for positive chronotropic action & DEPRESSION, CHEMICAL (NIM) for negative; for inotropic action see note on MYOCARDIAL CONTRACTION
=680  \\$iThe number of times the HEART VENTRICLES contract per unit of time, usually per minute.
=688  \\$a66(64)
=750  \0$aHeart beat$0(DLC)sh 85059741$5IEN-M

=LDR  02317cz  a2200613n  4500
=001  9880363495902441
=005  20141212202002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006338
=035  \\$aCAZ9509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x309
=072  \\$aC14.$x280.$x459
=150  \\$aHeart Neoplasms
=450  \\$wnnna$aCancer, Cardiac
=450  \\$wnnna$aCancer, Heart
=450  \\$wnnna$aCancers, Cardiac
=450  \\$wnnna$aCancers, Heart
=450  \\$wnnna$aCarcinoma, Cardiac
=450  \\$wnnna$aCarcinomas, Cardiac
=450  \\$wnnna$aCardiac Cancer
=450  \\$wnnna$aCardiac Cancers
=450  \\$wnnna$aCardiac Carcinoma
=450  \\$wnnna$aCardiac Carcinomas
=450  \\$wnnna$aCardiac Neoplasm
=450  \\$wnnna$aCardiac Neoplasms
=450  \\$wnnna$aCardiac Tumor
=450  \\$wnnna$aCardiac Tumors
=450  \\$wnnna$aHeart Cancer
=450  \\$wnnna$aHeart Cancers
=450  \\$wnnna$aHeart Neoplasm
=450  \\$wnnna$aHeart Tumor
=450  \\$wnnna$aHeart Tumors
=450  \\$wnnna$aIntracavitary Tumors of the Heart
=450  \\$wnnna$aMyocardial Tumor (Rhabdomyomas and Fibromas)
=450  \\$wnnna$aMyocardial Tumors (Rhabdomyomas and Fibromas)
=450  \\$wnnna$aNeoplasm, Cardiac
=450  \\$wnnna$aNeoplasm, Heart
=450  \\$wnnna$aNeoplasms, Cardiac
=450  \\$wnnna$aNeoplasms, Heart
=450  \\$wnnna$aPrimary Cardiac Tumors, Childhood
=450  \\$wnnna$aTumor, Cardiac
=450  \\$wnnna$aTumor, Heart
=450  \\$wnnna$aTumor, Myocardial (Rhabdomyomas and Fibromas)
=450  \\$wnnna$aTumors, Cardiac
=450  \\$wnnna$aTumors, Heart
=450  \\$wnnna$aTumors, Myocardial (Rhabdomyomas and Fibromas)
=550  \\$wg$aHeart Diseases
=550  \\$wg$aThoracic Neoplasms
=550  \\$wh$aCarney Complex
=667  \\$acoordinate IM with specific site in heart (NIM) + histological type of neoplasm (IM)
=680  \\$iTumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
=750  \0$aHeart$xTumors$5IEN-M$0(DLC)sh 85059726
=750  \0$aHeart$xCancer$5IEN-HS$0(DLC)sh2010009359

=LDR  01494cz  a2200385n  4500
=001  9880363496002441
=005  20141212202001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006337
=035  \\$aCAZ9508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x447
=150  \\$aHeart Murmurs
=450  \\$wnnna$aCardiac Murmur
=450  \\$wnnna$aCardiac Murmurs
=450  \\$wnnna$aDiastolic Murmur
=450  \\$wnnna$aDiastolic Murmurs
=450  \\$wnnna$aHeart Murmur
=450  \\$wnnna$aInnocent Murmur
=450  \\$wnnna$aInnocent Murmurs
=450  \\$wnnna$aMurmur, Cardiac
=450  \\$wnnna$aMurmur, Diastolic
=450  \\$wnnna$aMurmur, Heart
=450  \\$wnnna$aMurmur, Innocent
=450  \\$wnnna$aMurmurs, Cardiac
=450  \\$wnnna$aMurmurs, Diastolic
=450  \\$wnnna$aMurmurs, Heart
=450  \\$wnnna$aMurmurs, Innocent
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aSystolic Murmurs
=550  \\$aHeart Sounds
=667  \\$ado not confuse with HEART SOUNDS, a physiological concept
=680  \\$iHeart sounds caused by vibrations resulting from the flow of blood through the heart. Heart murmurs can be examined by HEART AUSCULTATION, and analyzed by their intensity (6 grades), duration, timing (systolic, diastolic, or continuous), location, transmission, and quality (musical, vibratory, blowing, etc).
=688  \\$a91(75); was see under HEART AUSCULTATION in Cat E 1972-90
=750  \0$aHeart murmurs$0(DLC) sh 85059748$5IEN

=LDR  01100cz  a2200289n  4500
=001  9880363496102441
=005  20141212202001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006336
=035  \\$aCAZ9507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x365.$x647.$x375
=072  \\$aE4.$x100.$x376.$x458
=072  \\$aE4.$x928.$x220.$x380
=150  \\$aHeart Massage
=450  \\$wnnna$aCardiac Massage
=450  \\$wnnna$aCardiac Massages
=450  \\$wnnna$aHeart Massages
=450  \\$wnnna$aMassage, Cardiac
=450  \\$wnnna$aMassage, Heart
=450  \\$wnnna$aMassages, Cardiac
=450  \\$wnnna$aMassages, Heart
=550  \\$wg$aCardiac Surgical Procedures
=550  \\$wg$aResuscitation
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRhythmic compression of the heart by pressure applied manually over the sternum (closed heart massage) or directly to the heart through an opening in the chest wall (open heart massage). It is done to reinstate and maintain circulation. (Dorland, 28th ed)
=750  \0$aCardiac massage$5IEN$0(DLC)sh 85020183

=LDR  01302cz  a2200385n  4500
=001  9880363496202441
=005  20180822122229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006335
=035  \\$aCAZ9506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x891.$x375
=150  \\$aHeart Injuries
=450  \\$aCardiac Rupture, Traumatic
=450  \\$wnnna$aCardiac Ruptures, Traumatic
=450  \\$aHeart$xinjuries
=450  \\$wnnna$aHeart Injury
=450  \\$aHeart Rupture, Traumatic
=450  \\$wnnna$aHeart Ruptures, Traumatic
=450  \\$wnnna$aInjuries, Heart
=450  \\$wnnna$aInjury, Heart
=450  \\$aMyocardium$xinjuries
=450  \\$wnnna$aRupture, Traumatic Cardiac
=450  \\$wnnna$aRupture, Traumatic Heart
=450  \\$wnnna$aRuptures, Traumatic Cardiac
=450  \\$wnnna$aRuptures, Traumatic Heart
=450  \\$wnnna$aTraumatic Cardiac Rupture
=450  \\$wnnna$aTraumatic Cardiac Ruptures
=450  \\$wnnna$aTraumatic Heart Rupture
=450  \\$wnnna$aTraumatic Heart Ruptures
=550  \\$wg$aThoracic Injuries
=550  \\$wh$aMyocardial Contusions
=667  \\$acoord IM with specific part of heart /inj (NIM)
=680  \\$iGeneral or unspecified injuries to the heart.
=750  \0$aHeart$xWounds and injuries$5IEN$0(DLC)sh 85059733

=LDR  01770cz  a2200541n  4500
=001  9880363496302441
=005  20180717113234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006334
=035  \\$aCAZ9505HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380
=150  \\$aHeart Function Tests
=450  \\$wnnna$aCardiac Function Test
=450  \\$wnnna$aCardiac Function Tests
=450  \\$wnnna$aFunction Test, Cardiac
=450  \\$wnnna$aFunction Test, Heart
=450  \\$wnnna$aFunction Tests, Cardiac
=450  \\$wnnna$aFunction Tests, Heart
=450  \\$wnnna$aHeart Function Test
=450  \\$wnnna$aTest, Cardiac Function
=450  \\$wnnna$aTest, Heart Function
=450  \\$wnnna$aTests, Cardiac Function
=450  \\$wnnna$aTests, Heart Function
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wh$aAngiocardiography
=550  \\$wh$aBallistocardiography
=550  \\$wh$aCardiac Catheterization
=550  \\$wh$aCardiac Output
=550  \\$wh$aCardiography, Impedance
=550  \\$wh$aCardiotocography
=550  \\$wh$aCoronary Angiography
=550  \\$wh$aEchocardiography
=550  \\$wh$aElectrocardiography
=550  \\$wh$aElectrophysiologic Techniques, Cardiac
=550  \\$wh$aExercise Test
=550  \\$wh$aHeart Auscultation
=550  \\$wh$aHeart Rate Determination
=550  \\$wh$aKinetocardiography
=550  \\$wh$aMagnetocardiography
=550  \\$wh$aMyocardial Perfusion Imaging
=550  \\$wh$aOximetry
=550  \\$wh$aPulse
=550  \\$wh$aRadionuclide Ventriculography
=550  \\$wh$aValsalva Maneuver
=550  \\$aVentricular Function
=667  \\$a/drug eff /rad eff permitted
=750  \0$aHeart function tests$5IEN$0(DLC)sh 85059746

=LDR  01875cz  a2200421n  4500
=001  9880363496402441
=005  20141212201959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006333
=035  \\$aCAZ9504HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x434
=150  \\$aHeart Failure
=450  \\$aCardiac Failure
=450  \\$wnnna$aCongestive Heart Failure
=450  \\$wnnna$aDecompensation, Heart
=450  \\$aHeart Decompensation
=450  \\$wnnna$aHeart Failure, Congestive
=450  \\$wnnna$aHeart Failure, Left-Sided
=450  \\$wnnna$aHeart Failure, Left Sided
=450  \\$wnnna$aHeart Failure, Right-Sided
=450  \\$wnnna$aHeart Failure, Right Sided
=450  \\$wnnna$aLeft-Sided Heart Failure
=450  \\$wnnna$aLeft Sided Heart Failure
=450  \\$wnnna$aMyocardial Failure
=450  \\$wnnna$aRight-Sided Heart Failure
=450  \\$wnnna$aRight Sided Heart Failure
=550  \\$wg$aHeart Diseases
=550  \\$wh$aCardio-Renal Syndrome
=550  \\$wh$aDyspnea, Paroxysmal
=550  \\$wh$aEdema, Cardiac
=550  \\$wh$aHeart Failure, Diastolic
=550  \\$wh$aHeart Failure, Systolic
=667  \\$a"scompenso di cuore" is "heart decompensation" in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE
=680  \\$iA heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
=688  \\$a2008 (1966)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Heart Failure, Congestive
=750  \0$aHeart failure$0(DLC) sh 85059745$5IEN

=LDR  01481cz  a2200325n  4500
=001  9880363496502441
=005  20141212201959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006332
=035  \\$aCAZ9503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x195
=072  \\$aC23.$x300.$x775.$x250
=150  \\$aCardiomegaly
=450  \\$aCardiac Hypertrophy
=450  \\$aEnlarged Heart
=450  \\$wnnna$aEnlargement, Heart
=450  \\$wnnna$aHeart, Enlarged
=450  \\$wnnna$aHeart Enlargement
=450  \\$aHeart Hypertrophy
=550  \\$wg$aHeart Diseases
=550  \\$wg$aHypertrophy
=550  \\$wh$aCardiomyopathy, Dilated
=550  \\$wh$aHypertrophy, Left Ventricular
=550  \\$wh$aHypertrophy, Right Ventricular
=667  \\$ageneral or unspecified; prefer HYPERTROPHY, LEFT VENTRICULAR or HYPERTROPHY, RIGHT VENTRICULAR; note entry term CARDIAC HYPERTROPHY: do not confuse with CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMEGALY, EXERCISE-INDUCED is also available
=680  \\$iEnlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
=688  \\$a2000(1963)
=750  \0$aHeart$xDilatation$5IEN-M$0(DLC)sh 85059650
=750  \0$aHeart$xHypertrophy$5IEN-HS$0(DLC)sh 85059682

=LDR  01768cz  a2200553n  4500
=001  9880363496602441
=005  20200420120321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006331
=035  \\$aCAZ9502HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280
=150  \\$aHeart Diseases
=450  \\$wnnna$aCardiac Disease
=450  \\$wnnna$aCardiac Diseases
=450  \\$wnnna$aDisease, Cardiac
=450  \\$wnnna$aDisease, Heart
=450  \\$wnnna$aDiseases, Cardiac
=450  \\$wnnna$aDiseases, Heart
=450  \\$wnnna$aHeart Disease
=550  \\$wg$aCardiovascular Diseases
=550  \\$wh$aArrhythmias, Cardiac
=550  \\$wh$aCarcinoid Heart Disease
=550  \\$wh$aCardiac Conduction System Disease
=550  \\$wh$aCardiac Output, High
=550  \\$wh$aCardiac Output, Low
=550  \\$wh$aCardiac Tamponade
=550  \\$wh$aCardiomegaly
=550  \\$wh$aCardiomyopathies
=550  \\$wh$aEndocarditis
=550  \\$wh$aHeart Aneurysm
=550  \\$wh$aHeart Arrest
=550  \\$wh$aHeart Defects, Congenital
=550  \\$wh$aHeart Failure
=550  \\$wh$aHeart Neoplasms
=550  \\$wh$aHeart Rupture
=550  \\$wh$aHeart Valve Diseases
=550  \\$wh$aMyocardial Ischemia
=550  \\$wh$aPericardial Effusion
=550  \\$wh$aPericarditis
=550  \\$wh$aPneumopericardium
=550  \\$wh$aPostpericardiotomy Syndrome
=550  \\$wh$aPulmonary Heart Disease
=550  \\$wh$aRheumatic Heart Disease
=550  \\$wh$aVentricular Dysfunction
=550  \\$wh$aVentricular Outflow Obstruction
=550  \\$aCardiology
=680  \\$iPathological conditions involving the HEART including its structural and functional abnormalities.
=750  \0$aHeart$xDiseases$5IEN$0(DLC)sh 85059651

=LDR  02665cz  a2200721n  4500
=001  9880363496702441
=005  20200717125544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006330
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400
=072  \\$aC14.$x280.$x400
=072  \\$aC16.$x131.$x240.$x400
=150  \\$aHeart Defects, Congenital
=450  \\$wnnna$aAbnormalities, Heart
=450  \\$wnnna$aAbnormality, Heart
=450  \\$wnnna$aCongenital Heart Defect
=450  \\$wnnna$aCongenital Heart Defects
=450  \\$wnnna$aDefect, Congenital Heart
=450  \\$wnnna$aDefects, Congenital Heart
=450  \\$aHeart Abnormalities
=450  \\$aHeart$xabnormalities
=450  \\$wnnna$aHeart Abnormality
=450  \\$wnnna$aHeart Defect, Congenital
=450  \\$wnnna$aHeart, Malformation Of
=450  \\$aMyocardium$xabnormalities
=550  \\$wg$aCardiovascular Abnormalities
=550  \\$wg$aHeart Diseases
=550  \\$wh$a22q11 Deletion Syndrome
=550  \\$wh$aAlagille Syndrome
=550  \\$wh$aAortic Coarctation
=550  \\$wh$aArrhythmogenic Right Ventricular Dysplasia
=550  \\$wh$aBarth Syndrome
=550  \\$wh$aCor Triatriatum
=550  \\$wh$aCoronary Vessel Anomalies
=550  \\$wh$aCrisscross Heart
=550  \\$wh$aDextrocardia
=550  \\$wh$aDuctus Arteriosus, Patent
=550  \\$wh$aEbstein Anomaly
=550  \\$wh$aEctopia Cordis
=550  \\$wh$aEisenmenger Complex
=550  \\$wh$aHeart Septal Defects
=550  \\$wh$aHeterotaxy Syndrome
=550  \\$wh$aHypoplastic Left Heart Syndrome
=550  \\$wh$aIsolated Noncompaction of the Ventricular Myocardium
=550  \\$wh$aLEOPARD Syndrome
=550  \\$wh$aLevocardia
=550  \\$wh$aLong QT Syndrome
=550  \\$wh$aMarfan Syndrome
=550  \\$wh$aNoonan Syndrome
=550  \\$wh$aTetralogy of Fallot
=550  \\$wh$aTransposition of Great Vessels
=550  \\$wh$aTricuspid Atresia
=550  \\$wh$aTrilogy of Fallot
=550  \\$wh$aTrisomy 13 Syndrome
=550  \\$wh$aTrisomy 18 Syndrome
=550  \\$wh$aTurner Syndrome
=550  \\$wh$aWolff-Parkinson-White Syndrome
=550  \\$aCardiovascular Abnormalities
=667  \\$ageneral only; do not use as coordinate for specific term /abnorm; cyanotic defects probably go here but do not also index under CYANOSIS unless especially discussed
=680  \\$iDevelopmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
=750  \0$aHeart$xAbnormalities$5IEN-M$0(DLC)sh 85059634
=750  \0$aCongenital heart disease$5IEN-HS$0(DLC)sh 89000801

=LDR  01018cz  a2200277n  4500
=001  9880363496802441
=005  20141212201957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006329
=035  \\$aCAZ9500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x409
=150  \\$aHeart Conduction System
=450  \\$wnnna$aConduction System, Heart
=450  \\$wnnna$aConduction Systems, Heart
=450  \\$wnnna$aHeart Conduction Systems
=450  \\$wnnna$aSystem, Heart Conduction
=450  \\$wnnna$aSystems, Heart Conduction
=550  \\$wg$aHeart
=550  \\$wh$aAtrioventricular Node
=550  \\$wh$aBundle of His
=550  \\$wh$aPurkinje Fibers
=550  \\$wh$aSinoatrial Node
=667  \\$adisorders = ARRHYTHMIAS, CARDIAC or specifics
=680  \\$iAn impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.
=750  \0$aHeart conduction system$5IEN$0(DLC)sh 85059743

=LDR  01128cz  a2200325n  4500
=001  9880363496902441
=005  20141212201956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006328
=035  \\$aCAZ9499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x140
=072  \\$aE2.$x148.$x442
=150  \\$aCardiac Catheterization
=450  \\$wnnna$aCardiac Catheterizations
=450  \\$aCatheterization, Cardiac
=450  \\$aCatheterization, Heart
=450  \\$wnnna$aCatheterizations, Cardiac
=450  \\$wnnna$aCatheterizations, Heart
=450  \\$aHeart Catheterization
=450  \\$wnnna$aHeart Catheterizations
=550  \\$wg$aCatheterization
=550  \\$wg$aHeart Function Tests
=550  \\$wh$aCatheter Ablation
=550  \\$wh$aCatheterization, Swan-Ganz
=550  \\$aCardiac Catheters
=680  \\$iProcedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.
=688  \\$a2013 (1966)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Heart Catheterization
=750  \0$aCardiac catheterization$5IEN$0(DLC)sh 85020181

=LDR  01870cz  a2200457n  4500
=001  9880363497002441
=005  20200517175051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006327
=035  \\$aCAZ9498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x558
=072  \\$aC14.$x123.$x500
=072  \\$aC23.$x550.$x73.$x425
=150  \\$aHeart Block
=450  \\$wnnna$aA-V Dissociation
=450  \\$wnnna$aA V Dissociation
=450  \\$wnnna$aA-V Dissociations
=450  \\$wnnna$aAtrioventricular Dissociation
=450  \\$wnnna$aAtrioventricular Dissociations
=450  \\$aAuriculo-Ventricular Dissociation
=450  \\$wnnna$aAuriculo Ventricular Dissociation
=450  \\$wnnna$aAuriculo-Ventricular Dissociations
=450  \\$wnnna$aBlock, Heart
=450  \\$wnnna$aBlocks, Heart
=450  \\$wnnna$aDissociation, A-V
=450  \\$wnnna$aDissociation, Atrioventricular
=450  \\$wnnna$aDissociation, Auriculo-Ventricular
=450  \\$wnnna$aDissociations, A-V
=450  \\$wnnna$aDissociations, Atrioventricular
=450  \\$wnnna$aDissociations, Auriculo-Ventricular
=450  \\$wnnna$aHeart Blocks
=550  \\$wg$aArrhythmias, Cardiac
=550  \\$wh$aAdams-Stokes Syndrome
=550  \\$wh$aAtrioventricular Block
=550  \\$wh$aBundle-Branch Block
=550  \\$wh$aInteratrial Block
=550  \\$wh$aSick Sinus Syndrome
=550  \\$wh$aSinoatrial Block
=680  \\$iImpaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.
=750  \0$aHeart block$0(DLC) sh 85059742$5IEN

=LDR  01091cz  a2200325n  4500
=001  9880363497102441
=005  20141212201955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006326
=035  \\$aCAZ9497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x400
=072  \\$aE1.$x370.$x600.$x60.$x400
=150  \\$aHeart Auscultation
=450  \\$wnnna$aAuscultation, Cardiac
=450  \\$wnnna$aAuscultation, Heart
=450  \\$wnnna$aAuscultations, Cardiac
=450  \\$wnnna$aAuscultations, Heart
=450  \\$wnnna$aCardiac Auscultation
=450  \\$wnnna$aCardiac Auscultations
=450  \\$wnnna$aHeart Auscultations
=550  \\$wg$aAuscultation
=550  \\$wg$aHeart Function Tests
=550  \\$wh$aPhonocardiography
=550  \\$aAuscultation
=550  \\$aHeart Murmurs
=550  \\$aHeart Sounds
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; /instrum: STETHOSCOPES is also available
=680  \\$iAct of listening for sounds within the heart.
=750  \0$aHeart$xSounds$5IEN$0(DLC)sh 85059710

=LDR  00790cz  a2200277n  4500
=001  9880363497202441
=005  20141212201954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006325
=035  \\$aCAZ9496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x358
=150  \\$aHeart Atria
=450  \\$wnnna$aAtria, Heart
=450  \\$wnnna$aAtrium, Heart
=450  \\$wnnna$aAtrium, Left
=450  \\$wnnna$aAtrium, Right
=450  \\$aHeart Atrium
=450  \\$wnnna$aLeft Atrium
=450  \\$wnnna$aRight Atrium
=550  \\$wg$aHeart
=550  \\$wh$aAtrial Appendage
=667  \\$aNIM: Manual 21.51
=680  \\$iThe chambers of the heart, to which the BLOOD returns from the circulation.
=688  \\$a2004(1966)
=750  \0$aHeart atrium$5IEN$0(DLC)sh 85059740

=LDR  01085cz  a2200265n  4500
=001  9880363497302441
=005  20141212201954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006324
=035  \\$aCAZ9495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x374
=072  \\$aE4.$x928.$x220.$x360
=150  \\$aHeart Arrest, Induced
=450  \\$aCardiac Arrest, Induced
=450  \\$aCardioplegia
=450  \\$wnnna$aCardioplegias
=450  \\$wnnna$aInduced Cardiac Arrest
=450  \\$wnnna$aInduced Heart Arrest
=550  \\$wg$aCardiac Surgical Procedures
=550  \\$wh$aCirculatory Arrest, Deep Hypothermia Induced
=550  \\$aHeart Arrest
=667  \\$anote category: a technique, not a disease; do not coordinate with HYPOTHERMIA, INDUCED unless this is particularly discussed
=680  \\$iA procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate).
=750  \0$aCardiac arrest, Induced$5IEN$0(DLC)sh 85020179

=LDR  01150cz  a2200313n  4500
=001  9880363497402441
=005  20141212201953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006323
=035  \\$aCAZ9494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x383
=150  \\$aHeart Arrest
=450  \\$wnnna$aArrest, Cardiac
=450  \\$wnnna$aArrest, Cardiopulmonary
=450  \\$wnnna$aArrest, Heart
=450  \\$aAsystole
=450  \\$wnnna$aAsystoles
=450  \\$aCardiac Arrest
=450  \\$aCardiopulmonary Arrest
=550  \\$wg$aHeart Diseases
=550  \\$wh$aDeath, Sudden, Cardiac
=550  \\$wh$aOut-of-Hospital Cardiac Arrest
=550  \\$aAdvanced Cardiac Life Support
=550  \\$aCardiopulmonary Resuscitation
=667  \\$ado not confuse with CARDIAC ARREST, SUDDEN see DEATH, SUDDEN, CARDIAC
=680  \\$iCessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.
=688  \\$aASYSTOLE was see under ARRHYTHMIA 1969-90
=750  \0$aCardiac arrest$5IEN$0(DLC)sh 85020177

=LDR  02007cz  a2200313n  4500
=001  9880363497502441
=005  20141212201953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006321
=035  \\$aCAZ9492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541
=150  \\$aHeart
=360  \\$iconsider also terms at$aCARDI-$aMYOCARDI-
=450  \\$wnnna$aHearts
=550  \\$wg$aCardiovascular System
=550  \\$wh$aEndocardium
=550  \\$wh$aFetal Heart
=550  \\$wh$aHeart Atria
=550  \\$wh$aHeart Conduction System
=550  \\$wh$aHeart Septum
=550  \\$wh$aHeart Valves
=550  \\$wh$aHeart Ventricles
=550  \\$wh$aMyocardium
=550  \\$wh$aPapillary Muscles
=550  \\$wh$aPericardium
=667  \\$aheart as pump, not tissue (MYOCARDIUM); qualif permitted: /anat /drug eff /embryol (FETAL HEART also exists) /growth /innerv (HEART CONDUCTION SYSTEM also exists) /microbiol /parasitol /physiol (see also ATRIAL FUNCTION & VENTRICULAR FUNCTION & their specifics; see also MYOCARDIAL CONTRACTION & its specifics) /physiopathol /rad eff /radiogr (do not confuse with ANGIOCARDIOGRAPHY) /radionuclide /virol; /blood supply = CORONARY VESSELS but consider also CORONARY CIRCULATION; /drug eff: consider also MYOCARDIAL DEPRESSANTS see ANTI-ARRHYTHMIA AGENTS & CARDIOTONIC AGENTS; /transpl = HEART TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; /ultrasonogr = ECHOCARDIOGRAPHY or ECHOCARDIOGRAPHY, DOPPLER; inotropism: INOTROPISM, CARDIAC see MYOCARDIAL CONTRACTION & INOTROPIC AGENTS, POSITIVE CARDIAC are available but see MYOCARDIAL CONTRACTION note; chronotropism: see HEART RATE note; DIASTOLE & SYSTOLE are also available; heart-lung prep: index HEART /physiol (probably NIM); Manual 21.48+; carditis = MYOCARDITIS; mural thrombosis: index HEART DISEASE (IM) + THROMBOSIS (IM)
=680  \\$iThe hollow, muscular organ that maintains the circulation of the blood.
=750  \0$aHeart$5IEN$0(DLC)sh 85059633

=LDR  00971cz  a2200241n  4500
=001  9880363497602441
=005  20141212201952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006317
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x341.$x887.$x460
=072  \\$aC10.$x597.$x751.$x418.$x341.$x887.$x460
=072  \\$aC23.$x888.$x592.$x763.$x393.$x341.$x887.$x460
=150  \\$aHearing Loss, Noise-Induced
=450  \\$aAcoustic Trauma
=450  \\$wnnna$aHearing Loss, Noise Induced
=450  \\$wnnna$aNoise-Induced Hearing Loss
=550  \\$wg$aHearing Loss, Sensorineural
=550  \\$aNoise
=680  \\$iHearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.
=688  \\$a79; was ACOUSTIC TRAUMA 1963-78
=750  \0$aAcoustic trauma$5IEN-M$0(DLC)sh 85000594
=750  \0$aDeafness, Noise induced$5IEN-HS$0(DLC)sh 85036071

=LDR  01062cz  a2200301n  4500
=001  9880363497702441
=005  20141212201950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006311
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458
=072  \\$aC10.$x597.$x751.$x418
=072  \\$aC23.$x888.$x592.$x763.$x393
=150  \\$aHearing Disorders
=450  \\$wnnna$aDistorted Hearing
=450  \\$wnnna$aDysacusis
=450  \\$wnnna$aHearing Disorder
=450  \\$wnnna$aHearing, Distorted
=450  \\$wnnna$aParacousis
=450  \\$wnnna$aParacusis
=550  \\$wg$aEar Diseases
=550  \\$wg$aSensation Disorders
=550  \\$wh$aHearing Loss
=550  \\$wh$aHyperacusis
=550  \\$wh$aTinnitus
=667  \\$aGEN or unspecified; consider also DEAFNESS and HEARING LOSS and its indentations
=680  \\$iConditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.
=750  \0$aHearing disorders$5IEN$0(DLC)sh 85059621

=LDR  01139cz  a2200313n  4500
=001  9880363497802441
=005  20200721140806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006310
=035  \\$aCAZ9481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE07.$x305.$x906.$x500
=072  \\$aE7.$x814.$x458
=150  \\$aHearing Aids
=450  \\$wnnna$aAid, Hearing
=450  \\$wnnna$aAids, Hearing
=450  \\$wnnna$aEar Mold
=450  \\$aEar Molds
=450  \\$wnnna$aHearing Aid
=450  \\$wnnna$aMold, Ear
=450  \\$wnnna$aMolds, Ear
=550  \\$wg$aSensory Aids
=550  \\$wg$aWearable Electronic Devices
=550  \\$wh$aAuditory Brain Stem Implants
=550  \\$wh$aCochlear Implants
=550  \\$aDeafness
=667  \\$a"hearing aid" is correct translation for "prothèse auditive", not "auditory prosthesis" unless you mean COCHLEAR IMPLANT
=680  \\$iWearable sound-amplifying devices that are intended to compensate for impaired hearing. These generic devices include air-conduction hearing aids and bone-conduction hearing aids. (UMDNS, 1999)
=750  \0$aHearing aids$5IEN$0(DLC)sh 85059616

=LDR  00952cz  a2200229n  4500
=001  9880363497902441
=005  20141212201949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006309
=035  \\$aCAZ9480HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x263
=072  \\$aG11.$x561.$x600.$x810.$x263
=150  \\$aHearing
=360  \\$iconsider also terms at$aACOUSTIC$aAUDIO-
=450  \\$wnnna$aAudition
=550  \\$wg$aSensation
=550  \\$wh$aBone Conduction
=550  \\$wh$aOtoacoustic Emissions, Spontaneous
=667  \\$adifferentiate from AUDITORY PERCEPTION: auditory perception takes place in the brain, hearing takes place in the ear; PSYCHOACOUSTICS is also available; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is available
=680  \\$iThe ability or act of sensing and transducing ACOUSTIC STIMULATION to the CENTRAL NERVOUS SYSTEM. It is also called audition.
=750  \0$aHearing$5IEN$0(DLC)sh 85059612

=LDR  00956cz  a2200253n  4500
=001  9880363498002441
=005  20141212201949.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006307
=035  \\$aCAZ9478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x452.$x508.$x440
=150  \\$aHealth Systems Agencies
=450  \\$wnnna$aAgencies, Health Systems
=450  \\$wnnna$aAgency, Health Systems
=450  \\$aComprehensive Health Planning Agencies
=450  \\$wnnna$aHealth Systems Agency
=450  \\$wnnna$aSystems Agencies, Health
=450  \\$wnnna$aSystems Agency, Health
=550  \\$wg$aState Health Planning and Development Agencies
=667  \\$aPublic Law 93-641; specify geog & add UNITED STATES also
=680  \\$iHealth planning and resources development agencies which function in each health service area of the United States (PL 93-641).
=688  \\$a78
=750  \0$aHealth systems agencies$5IEN$0(DLC)sh 86007198

=LDR  01391cz  a2200361n  4500
=001  9880363498102441
=005  20160902140212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006306
=035  \\$aCAZ9477HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250
=072  \\$aN5.$x715.$x360.$x300.$x375
=072  \\$aN6.$x850.$x520.$x308.$x250
=150  \\$aHealth Surveys
=450  \\$wnnna$aAbortion Survey
=450  \\$wnnna$aAbortion Surveys
=450  \\$wnnna$aHealth Survey
=450  \\$wnnna$aSurvey, Abortion
=450  \\$wnnna$aSurvey, Health
=450  \\$wnnna$aSurveys, Abortion
=450  \\$wnnna$aSurveys, Health
=550  \\$wg$aSurveys and Questionnaires
=550  \\$wh$aBehavioral Risk Factor Surveillance System
=550  \\$wh$aDental Health Surveys
=550  \\$wh$aHealth Status Indicators
=550  \\$wh$aMass Screening
=550  \\$wh$aNutrition Surveys
=550  \\$wh$aPopulation Surveillance
=667  \\$ado not confuse with HEALTH CARE SURVEYS: health surveys are on health statistics, health care surveys are on health services provided; specify geographic term if pertinent
=680  \\$iA systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.
=688  \\$aSANITARY SURVEYS was heading 1963-66
=750  \0$aHealth surveys$5IEN$0(DLC)sh 85059605

=LDR  01675cz  a2200457n  4500
=001  9880363498202441
=005  20180712141947.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006305
=035  \\$aCAZ9476HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x980.$x438.$x475
=072  \\$aL1.$x280.$x960.$x500.$x475
=072  \\$aN5.$x715.$x360.$x300.$x800.$x438.$x375
=072  \\$aN6.$x850.$x520.$x308.$x980.$x438.$x475
=150  \\$aHealth Status Indicators
=450  \\$wnnna$aAppraisal, Health Risk
=450  \\$wnnna$aAppraisals, Health Risk
=450  \\$aHealth Risk Appraisal
=450  \\$wnnna$aHealth Risk Appraisals
=450  \\$aHealth Status Index
=450  \\$wnnna$aHealth Status Indexes
=450  \\$wnnna$aHealth Status Indicator
=450  \\$wnnna$aHealth Status Indices
=450  \\$wnnna$aIndex, Health Status
=450  \\$wnnna$aIndexes, Health Status
=450  \\$wnnna$aIndicator, Health Status
=450  \\$wnnna$aIndicators, Health Status
=450  \\$wnnna$aIndices, Health Status
=450  \\$wnnna$aRisk Appraisal, Health
=450  \\$wnnna$aRisk Appraisals, Health
=550  \\$wg$aHealth Surveys
=550  \\$wh$aAPACHE
=550  \\$wh$aGlobal Burden of Disease
=550  \\$wh$aOrgan Dysfunction Scores
=550  \\$wh$aPatient Acuity
=550  \\$wh$aSickness Impact Profile
=667  \\$ano qualif
=680  \\$iThe measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources.
=688  \\$a90(75); was see under HEALTH SURVEYS 1975-89
=750  \0$aHealth status indicators$5IEN$0(DLC)sh 85059604

=LDR  01901cz  a2200457n  4500
=001  9880363498302441
=005  20141212201947.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006302
=035  \\$aCAZ9473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x360
=072  \\$aN3.$x349.$x380
=072  \\$aN5.$x425
=150  \\$aHealth Services Research
=450  \\$wnnna$aAction Research
=450  \\$wnnna$aEvaluation, Health Services
=450  \\$wnnna$aEvaluations, Health Services
=450  \\$aHealth Care Research
=450  \\$wnnna$aHealth Services Evaluation
=450  \\$wnnna$aHealth Services Evaluations
=450  \\$wnnna$aHealthcare Research
=450  \\$aMedical Care Research
=450  \\$wnnna$aResearch, Action
=450  \\$wnnna$aResearch, Health Care
=450  \\$aResearch, Health Services
=450  \\$wnnna$aResearch, Healthcare
=450  \\$wnnna$aResearch, Medical Care
=550  \\$wg$aBiomedical Research
=550  \\$wg$aHealth Care Quality, Access, and Evaluation
=550  \\$wg$aHealth Planning
=550  \\$wh$aCommunity-Based Participatory Research
=550  \\$wh$aComparative Effectiveness Research
=550  \\$wh$aHealth Care Surveys
=550  \\$wh$aHealth Services Needs and Demand
=550  \\$wh$aNeeds Assessment
=550  \\$wh$aOrganizational Case Studies
=667  \\$aIM; DF: HEALTH SERV RESEARCH
=680  \\$iThe integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed)
=688  \\$a80
=750  \0$aMedical care$xResearch$5IEN$0(DLC)sh 85082882

=LDR  01421cz  a2200361n  4500
=001  9880363498402441
=005  20141212201946.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006301
=035  \\$aCAZ9472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x380.$x420
=072  \\$aN5.$x300.$x450
=150  \\$aHealth Services Needs and Demand
=450  \\$wnnna$aHealth Services Need
=450  \\$wnnna$aHealth Services Needs
=450  \\$wnnna$aNeed, Health Services
=450  \\$wnnna$aNeeds
=450  \\$wnnna$aNeeds and Demand, Health Services
=450  \\$wnnna$aNeeds, Health Services
=450  \\$wnnna$aPopulation, Target
=450  \\$wnnna$aPopulations, Target
=450  \\$wnnna$aTarget Population
=450  \\$wnnna$aTarget Populations
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aHealth Services Research
=550  \\$wh$aMedically Underserved Area
=550  \\$wh$aSurge Capacity
=550  \\$aHealth Care Sector
=667  \\$aspecify geog; DF: HEALTH SERV NEEDS
=680  \\$iHealth services required by a population or community as well as the health services that the population or community is able and willing to pay for.
=688  \\$a91(Aug 77); was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING 1977-78
=750  \0$aMedical care$xNeeds assessment$0(DLC) sh 86005567$5IEN-M

=LDR  01204cz  a2200325n  4500
=001  9880363498502441
=005  20141212201945.0
=008  781222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006299
=035  \\$aCAZ9470HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x320
=150  \\$aHealth Services for the Aged
=450  \\$aAged, Health Services for the$5IEN-M
=450  \\$aElderly, Health Services for the$5IEN-M
=450  \\$wnnna$aGeriatric Health Service
=450  \\$aGeriatric Health Services
=450  \\$wnnna$aHealth Service, Geriatric
=450  \\$wnnna$aHealth Services for Aged
=450  \\$wnnna$aHealth Services for the Elderly
=450  \\$wnnna$aHealth Services, Geriatric
=450  \\$wnnna$aService, Geriatric Health
=450  \\$wnnna$aServices, Geriatric Health
=550  \\$wg$aHealth Services
=550  \\$aAged
=550  \\$aFrail Elderly
=667  \\$acoord IM with specific serv (IM or NIM) if pertinent; check also tag AGED; DF: HEALTH SERV AGED
=680  \\$iServices for the diagnosis and treatment of diseases in the aged and the maintenance of health in the elderly.
=688  \\$a80
=750  \0$aOlder people$xMedical care$5IEN$0(DLC)sh 85002111

=LDR  01010cz  a2200265n  4500
=001  9880363498602441
=005  20180720111753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006298
=035  \\$aCAZ9469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x269
=072  \\$aN4
=150  \\$aHealth Services Administration
=450  \\$wnnna$aAdministration, Health Services
=450  \\$aHealth Services$xorganization & administration
=550  \\$wg$aHealth Occupations
=550  \\$wh$aIntersectoral Collaboration
=550  \\$wh$aOrganization and Administration
=550  \\$wh$aPatient Care Management
=550  \\$wh$aQuality of Health Care
=667  \\$aGEN or unspecified; prefer specific health serv with /organ (for /organization & administration); DF: HEALTH SERV ADMIN
=680  \\$iThe organization and administration of health services dedicated to the delivery of health care.
=688  \\$a1998; use explode 1970-97
=750  \0$aHealth services administration$0sh 85059600$5IEN

=LDR  01606cz  a2200397n  4500
=001  9880363498702441
=005  20170329105224.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006297
=035  \\$aCAZ9468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x374.$x350
=072  \\$aN5.$x300.$x430
=150  \\$aHealth Services Accessibility
=450  \\$aAccess to Health Care
=450  \\$wnnna$aAccessibility, Health Services
=450  \\$aAccessibility of Health Services
=450  \\$wnnna$aAccessibility, Program
=450  \\$wnnna$aAvailability, Contraceptive
=450  \\$aAvailability of Health Services
=450  \\$wnnna$aContraceptive Availability
=450  \\$wnnna$aHealth Services Availability
=450  \\$wnnna$aHealth Services Geographic Accessibility
=450  \\$wnnna$aProgram Accessibility
=550  \\$wg$aDelivery of Health Care
=550  \\$wh$aHealth Care Rationing
=550  \\$wh$aHealth Equity
=550  \\$wh$aHealth Facility Closure
=550  \\$wh$aHealth Facility Environment
=550  \\$wh$aHealth Facility Size
=550  \\$wh$aMarketing of Health Services
=550  \\$aMedically Underserved Area
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others.
=688  \\$a78
=750  \0$aHealth services accessibility$0sh 92006496$5IEN

=LDR  01973cz  a2200577n  4500
=001  9880363498802441
=005  20160511175524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006296
=035  \\$aCAZ9467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421
=150  \\$aHealth Services
=450  \\$wnnna$aHealth Service
=450  \\$wnnna$aService, Health
=450  \\$wnnna$aServices, Health
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=550  \\$wh$aAdolescent Health Services
=550  \\$wh$aChild Care
=550  \\$wh$aCommunity Health Services
=550  \\$wh$aDental Health Services
=550  \\$wh$aDietary Services
=550  \\$wh$aEmergency Medical Services
=550  \\$wh$aGenetic Services
=550  \\$wh$aHealth Services for Persons with Disabilities
=550  \\$wh$aHealth Services for the Aged
=550  \\$wh$aHealth Services for Transgender Persons
=550  \\$wh$aHealth Services, Indigenous
=550  \\$wh$aHealth Services Misuse
=550  \\$wh$aMedical Errors
=550  \\$wh$aMental Health Services
=550  \\$wh$aNursing Care
=550  \\$wh$aNursing Services
=550  \\$wh$aPatient Care
=550  \\$wh$aPersonal Health Services
=550  \\$wh$aPharmaceutical Services
=550  \\$wh$aPreventive Health Services
=550  \\$wh$aRehabilitation
=550  \\$wh$aReproductive Health Services
=550  \\$wh$aRural Health Services
=550  \\$wh$aSocial Work
=550  \\$wh$aStudent Health Services
=550  \\$wh$aSuburban Health Services
=550  \\$wh$aTissue and Organ Procurement
=550  \\$wh$aTransition to Adult Care
=550  \\$wh$aUrban Health Services
=550  \\$wh$aWomen's Health Services
=667  \\$aIM GEN or unspecified; prefer specifics; DF: HEALTH SERV
=680  \\$iServices for the diagnosis and treatment of disease and the maintenance of health.
=688  \\$a74
=750  \0$aMedical care$5IEN$0(DLC)sh 85082871

=LDR  00686cz  a2200205n  4500
=001  9880363498902441
=005  20141212201842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006108
=035  \\$aCAZ9276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x300
=072  \\$aD1.$x578.$x300
=150  \\$aGraphite
=450  \\$wnnna$aGraphene
=550  \\$wg$aCarbon
=550  \\$wg$aMinerals
=680  \\$iAn allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation.
=688  \\$a91(75); was see under CARBON 1975-90
=750  \0$aGraphite$5IEN$0(DLC)sh 85056487

=LDR  01671cz  a2200325n  4500
=001  9880363499002441
=005  20141212201841.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x553.$x774.$x535
=072  \\$aC16.$x320.$x322.$x233
=072  \\$aC20.$x673.$x774.$x535
=150  \\$aGranulomatous Disease, Chronic
=450  \\$wnnna$aAutosomal Recessive Chronic Granulomatous Disease
=450  \\$wnnna$aChronic Granulomatous Disease
=450  \\$wnnna$aChronic Granulomatous Diseases
=450  \\$wnnna$aDisease, Chronic Granulomatous
=450  \\$wnnna$aDiseases, Chronic Granulomatous
=450  \\$wnnna$aGranulomatous Diseases, Chronic
=450  \\$wnnna$aX-Linked Chronic Granulomatous Disease
=450  \\$wnnna$aX Linked Chronic Granulomatous Disease
=550  \\$wg$aGenetic Diseases, X-Linked
=550  \\$wg$aPhagocyte Bactericidal Dysfunction
=550  \\$aNADPH Oxidase
=550  \\$aRespiratory Burst
=667  \\$aalso called granulomatous disease of childhood
=680  \\$iA defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.
=688  \\$a78(75); was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77
=750  \0$aChronic granulomatous disease$5IEN$0(DLC)sh 85025396

=LDR  01240cz  a2200301n  4500
=001  9880363499102441
=005  20141212201840.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006100
=035  \\$aCAZ9268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x416
=072  \\$aC1.$x252.$x810.$x451
=072  \\$aC1.$x252.$x825.$x360
=072  \\$aC1.$x539.$x778.$x281.$x451
=072  \\$aC1.$x539.$x800.$x720.$x360
=072  \\$aC12.$x294.$x668.$x281.$x451
=072  \\$aC13.$x351.$x500.$x711.$x281.$x451
=072  \\$aC17.$x800.$x838.$x765.$x360
=150  \\$aGranuloma Inguinale
=450  \\$aDonovanosis
=450  \\$aGranuloma Venereum
=550  \\$wg$aEnterobacteriaceae Infections
=550  \\$wg$aSexually Transmitted Diseases, Bacterial
=550  \\$wg$aSkin Diseases, Bacterial
=667  \\$anon-neoplastic; gram-neg bact infect; sexually transmitted
=680  \\$iAnogenital ulcers caused by Calymmatobacterium granulomatis as distinguished from lymphogranuloma inguinale (see LYMPHOGRANULOMA VENEREUM) caused by CHLAMYDIA TRACHOMATIS. Diagnosis is made by demonstration of typical intracellular Donovan bodies in crushed-tissue smears.
=750  \0$aGranuloma venereum$5IEN$0(DLC)sh 85056445

=LDR  01014cz  a2200265n  4500
=001  9880364215602441
=005  20141212193023.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x569.$x500
=150  \\$aJuglans
=450  \\$wnnna$aBlack Walnut
=450  \\$wnnna$aBlack Walnuts
=450  \\$wnnna$aJuglan
=450  \\$wnnna$aJuglans nigra
=450  \\$aWalnut
=450  \\$wnnna$aWalnut, Black
=450  \\$wnnna$aWalnuts
=450  \\$wnnna$aWalnuts, Black
=550  \\$wg$aJuglandaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family JUGLANDACEAE that provides the familiar walnut.
=688  \\$a2003
=750  \0$aWalnut$5IEN-M$0(DLC)sh 85144968

=LDR  00916cz  a2200205n  4500
=001  9880364215702441
=005  20141212214903.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031323
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x549.$x750
=150  \\$aIris Plant
=450  \\$wnnna$aIris Plants
=450  \\$wnnna$aPlant, Iris
=450  \\$wnnna$aPlants, Iris
=550  \\$wg$aIridaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family IRIDACEAE that contains IRIP, a type-1 ribosome-inactivating protein, and iridals (TRITERPENES).
=688  \\$a2003
=750  \0$aIrises (Plants)$5IEN-M$0(DLC)sh 85068079

=LDR  01136cz  a2200277n  4500
=001  9880364215802441
=005  20141212214903.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x531.$x500
=150  \\$aEriodictyon
=450  \\$wnnna$acalifornicum, Eriodictyon
=450  \\$wnnna$acalifornicums, Eriodictyon
=450  \\$wnnna$aEriodictyon californicum
=450  \\$wnnna$aEriodictyon californicums
=450  \\$wnnna$aEriodictyons
=450  \\$wnnna$aSanta, Yerba
=450  \\$wnnna$aSantas, Yerba
=450  \\$aYerba Santa
=450  \\$wnnna$aYerba Santas
=550  \\$wg$aHydrophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family HYDROPHYLLACEAE that has a characteristic strong smell.
=688  \\$a2003
=750  \0$aEriodictyon$5IEN-M$0(DLC)sh 88022776

=LDR  01082cz  a2200289n  4500
=001  9880364215902441
=005  20141212214902.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x399
=150  \\$aHydrocharitaceae
=450  \\$aElodea
=450  \\$wnnna$aElodeas
=450  \\$aHydrilla
=450  \\$wnnna$aHydrillas
=450  \\$aLimnobium
=450  \\$wnnna$aLimnobiums
=450  \\$aOttelia
=450  \\$wnnna$aOttelias
=450  \\$aThalassia
=450  \\$wnnna$aThalassias
=550  \\$wg$aAlismatidae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Hydrocharitales, subclass ALISMATIDAE, class Liliopsida (monocotyledons).
=688  \\$a2003
=750  \0$aHydrocharitaceae$0(DLC) sh 85063380$5IEN-M

=LDR  00920cz  a2200193n  4500
=001  9880364216002441
=005  20141212214902.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031320
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x517
=150  \\$aHippocrateaceae
=450  \\$aHippocratea
=450  \\$wnnna$aHippocrateas
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida. The Hippocratea genus contains friedelanes, triterpenoid quinone, and hippocrateine I.
=688  \\$a2003
=750  \0$aHippocrateaceae$5IEN-M$0(DLC)sh2001005623

=LDR  01269cz  a2200289n  4500
=001  9880364216102441
=005  20141212214902.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031319
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x503.$x500
=150  \\$aAesculus
=450  \\$wnnna$aAesculus hippocastanum
=450  \\$wnnna$aAesculus hippocastanums
=450  \\$aBuckeye
=450  \\$wnnna$aBuckeyes
=450  \\$aChestnut, Horse
=450  \\$wnnna$aChestnuts, Horse
=450  \\$wnnna$ahippocastanum, Aesculus
=450  \\$wnnna$ahippocastanums, Aesculus
=450  \\$aHorse Chestnut
=450  \\$wnnna$aHorse Chestnuts
=550  \\$wg$aHippocastanaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family HIPPOCASTANACEAE (or SAPINDACEAE by some) that contains antimicrobial protein 1 and escin. A. hippocastanum is used in folk medicine for treating chronic venous insufficiency.
=688  \\$a2003
=750  \0$aAesculus$5IEN-M$0(DLC)sh 87001246

=LDR  00821cz  a2200181n  4500
=001  9880364216202441
=005  20141212214901.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031318
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x503
=150  \\$aHippocastanaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aAesculus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aHippocastanaceae$5IEN-M$0(DLC)sh 85060983

=LDR  00924cz  a2200205n  4500
=001  9880364216302441
=005  20141212214901.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031317
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x475.$x750
=150  \\$aLiquidambar
=450  \\$wnnna$aLiquidambars
=450  \\$aSweetgum
=450  \\$wnnna$aSweetgums
=550  \\$wg$aHamamelidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family HAMAMELIDACEAE. The sap is a source of storax, which should not be confused with the similar named STYRAX genus.
=688  \\$a2003
=750  \0$aLiquidambar$5IEN-M$0(DLC)sh2002008937

=LDR  00829cz  a2200181n  4500
=001  9880364216402441
=005  20141212214900.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031316
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x462.$x750
=150  \\$aPelargonium
=450  \\$wnnna$aPelargoniums
=550  \\$wg$aGeraniaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family GERANIACEAE. The common name of geranium is also used for the GERANIUM genus.
=688  \\$a2003
=750  \0$aPelargoniums$5IEN-M$0(DLC)sh 86001561

=LDR  00811cz  a2200181n  4500
=001  9880364216502441
=005  20141212214900.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031315
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x462.$x500
=150  \\$aGeranium
=450  \\$wnnna$aGeraniums
=550  \\$wg$aGeraniaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family GERANIACEAE. Geranium is also used as a common name for PELARGONIUM.
=688  \\$a2003
=750  \0$aGeraniums$5IEN-M$0(DLC)sh 85054281

=LDR  00842cz  a2200193n  4500
=001  9880364216602441
=005  20141212214900.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031314
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x462
=150  \\$aGeraniaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aGeranium
=550  \\$wh$aPelargonium
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aGeraniaceae$5IEN-M$0(DLC)sh 86001562

=LDR  00884cz  a2200205n  4500
=001  9880364216702441
=005  20141212214859.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031313
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x450.$x492
=150  \\$aGentianella
=450  \\$wnnna$aGentianellas
=450  \\$aHercumpuri
=450  \\$wnnna$aHercumpurus
=550  \\$wg$aGentianaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family GENTIANACEAE that contains nitiol (a C25 sesterterpenoid) & nitidasin.
=688  \\$a2003
=750  \0$aGentianella$0(DLC) sh 93006997$5IEN-M

=LDR  00886cz  a2200205n  4500
=001  9880364216802441
=005  20141212214859.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031311
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x443.$x500
=150  \\$aCorydalis
=450  \\$wnnna$aCorydali
=450  \\$aFumewort
=450  \\$wnnna$aFumeworts
=550  \\$wg$aFumariaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FUMARIACEAE (classified by some in PAPAVERACEAE) that contains isoquinoline alkaloids.
=688  \\$a2003
=750  \0$aCorydalis$5IEN-M$0(DLC)sh 85033117

=LDR  00942cz  a2200229n  4500
=001  9880364216902441
=005  20141212214858.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031309
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x437.$x500
=150  \\$aRyania
=450  \\$wnnna$aRyania speciosa
=450  \\$wnnna$aRyania speciosas
=450  \\$wnnna$aRyanias
=450  \\$wnnna$aspeciosa, Ryania
=450  \\$wnnna$aspeciosas, Ryania
=550  \\$wg$aFlacourtiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FLACOURTIACEAE that is the source of RYANODINE.
=688  \\$a2003
=750  \0$aRyania$5IEN-M$0(DLC)sh 88023076

=LDR  01535cz  a2200373n  4500
=001  9880364217102441
=005  20141212214857.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031307
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x968.$x500
=150  \\$aVicia faba
=450  \\$aBean, Faba
=450  \\$wnnna$aBean, Fava
=450  \\$aBean, Horse
=450  \\$wnnna$aBeans, Faba
=450  \\$wnnna$aBeans, Fava
=450  \\$wnnna$aBeans, Horse
=450  \\$aFaba Bean
=450  \\$wnnna$aFaba Beans
=450  \\$wnnna$afaba, Vicia
=450  \\$wnnna$afabas, Vicia
=450  \\$aFava Bean
=450  \\$wnnna$aFava Beans
=450  \\$wnnna$aHorse Bean
=450  \\$wnnna$aHorse Beans
=450  \\$aHorsebean
=450  \\$wnnna$aHorsebeans
=450  \\$wnnna$aVicia fabas
=550  \\$wg$aVicia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus VICIA, family FABACEAE. The edible beans are well known but they cause FAVISM in some individuals with GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY. This plant contains vicine, convicine, Vicia lectins, unknown seed protein, AAP2 transport protein, and Vicia faba DNA-binding protein 1.
=688  \\$a2003
=750  \0$aFava bean$5IEN-M$0(DLC)sh 85046735

=LDR  00988cz  a2200229n  4500
=001  9880364217202441
=005  20141212214857.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x968
=150  \\$aVicia
=450  \\$aVetch
=450  \\$wnnna$aVetchs
=450  \\$wnnna$aVicias
=550  \\$wg$aFabaceae
=550  \\$wh$aVicia faba
=550  \\$wh$aVicia sativa
=667  \\$ado not confuse X ref VETCH with milkvetch see ASTRAGALUS PLANT; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is widely used as ground cover and forage and known for the edible beans, VICIA FABA.
=688  \\$a2003
=750  \2$aVetch$5IEN-M

=LDR  00811cz  a2200181n  4500
=001  9880364217302441
=005  20141212214856.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x890
=150  \\$aTephrosia
=450  \\$wnnna$aTephrosias
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains tephrorin, tephrosone, and C-prenylflavonoids.
=688  \\$a2003
=750  \0$aTephrosia$5IEN-M$0(DLC)sh 88023146

=LDR  01301cz  a2200277n  4500
=001  9880364217402441
=005  20141212214855.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x812
=150  \\$aSpartium
=450  \\$aBroom, Spanish
=450  \\$wnnna$aBrooms, Spanish
=450  \\$wnnna$ajunceum, Spartium
=450  \\$wnnna$ajunceums, Spartium
=450  \\$wnnna$aSpanish Broom
=450  \\$wnnna$aSpanish Brooms
=450  \\$wnnna$aSpartium junceum
=450  \\$wnnna$aSpartium junceums
=450  \\$wnnna$aSpartiums
=550  \\$wg$aFabaceae
=667  \\$aX ref BROOM, SPANISH: several other Broom terms are also available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is a source of SPARTEINE. Do not confuse with Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Brome (BROMUS).
=688  \\$a2003
=750  \0$aSpanish broom$5IEN-M$0(DLC)sh 85126236

=LDR  01103cz  a2200277n  4500
=001  9880364217502441
=005  20141212214854.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x716
=150  \\$aRobinia
=450  \\$wnnna$aBlack Locust
=450  \\$wnnna$aBlack Locusts
=450  \\$aLocust, Black
=450  \\$wnnna$aLocusts, Black
=450  \\$wnnna$apseudoacacia, Robinia
=450  \\$wnnna$apseudoacacias, Robinia
=450  \\$wnnna$aRobinia pseudoacacia
=450  \\$wnnna$aRobinia pseudoacacias
=450  \\$wnnna$aRobinias
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains linarin (acaciin) and LECTINS.
=688  \\$a2003
=750  \0$aRobinia$5IEN-M$0(DLC)sh 85114614

=LDR  00964cz  a2200253n  4500
=001  9880364217602441
=005  20141212214853.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031299
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x598
=150  \\$aMucuna
=450  \\$aBean, Velvet
=450  \\$wnnna$aBeans, Velvet
=450  \\$aCowitch
=450  \\$wnnna$aCowitchs
=450  \\$wnnna$aMucunas
=450  \\$wnnna$aVelvet Bean
=450  \\$wnnna$aVelvet Beans
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is the source of mucuna gum.
=688  \\$a2003
=750  \0$aMucuna$5IEN-M$0(DLC)sh 87020020

=LDR  00779cz  a2200181n  4500
=001  9880364217702441
=005  20141212214852.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031298
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x596
=150  \\$aMimosa
=450  \\$wnnna$aMimosas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.
=688  \\$a2003
=750  \0$aMimosa$5IEN-M$0(DLC)sh 85085459

=LDR  01082cz  a2200277n  4500
=001  9880364217902441
=005  20141212214850.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031293
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x181
=150  \\$aCyamopsis
=450  \\$wnnna$aCyamopses
=450  \\$wnnna$aCyamopsis tetragonoloba
=450  \\$wnnna$aCyamopsis tetragonolobas
=450  \\$wnnna$aCyamposes
=450  \\$wnnna$aCyamposis
=450  \\$aGuar
=450  \\$wnnna$aGuars
=450  \\$wnnna$atetragonoloba, Cyamopsis
=450  \\$wnnna$atetragonolobas, Cyamopsis
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is the source of guar gum.
=688  \\$a2003
=750  \0$aCyamopsis$5IEN-M$0(DLC)sh 88022726

=LDR  00914cz  a2200229n  4500
=001  9880364218002441
=005  20141212214848.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031289
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x51
=150  \\$aAlbizzia
=450  \\$wnnna$aAlbizia
=450  \\$wnnna$aAlbizias
=450  \\$wnnna$aAlbizzias
=450  \\$aSilktree
=450  \\$wnnna$aSilktrees
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains julibroside (triterpenoid saponins).
=688  \\$a2003
=750  \0$aAlbizia$5IEN-M$0(DLC)sh 88022535

=LDR  01163cz  a2200301n  4500
=001  9880364218102441
=005  20141212214848.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031288
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x125
=150  \\$aChamaecrista
=450  \\$wnnna$aChamaecristas
=450  \\$wnnna$aPartridge Pea
=450  \\$wnnna$aPartridge Peas
=450  \\$aPartridgepea
=450  \\$wnnna$aPartridgepeas
=450  \\$aPea, Partridge
=450  \\$aPea, Sensitive
=450  \\$wnnna$aPeas, Partridge
=450  \\$wnnna$aPeas, Sensitive
=450  \\$wnnna$aSensitive Pea
=450  \\$wnnna$aSensitive Peas
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.
=688  \\$a2003
=750  \0$aChamaecrista$5IEN-M$0(DLC)sh 85022405

=LDR  00921cz  a2200217n  4500
=001  9880364218202441
=005  20141212214847.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031287
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x737
=150  \\$aSapium
=450  \\$wnnna$aChinese Tallow Tree
=450  \\$wnnna$aSapiums
=450  \\$aTallow Tree, Chinese
=450  \\$wnnna$aTree, Chinese Tallow
=550  \\$wg$aEuphorbiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE that contains bukittinggine and PHORBOL ESTERS.
=688  \\$a2003
=750  \0$aSapium$5IEN-M$0(DLC)sh 85117450

=LDR  01014cz  a2200253n  4500
=001  9880364218302441
=005  20141212214847.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031286
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x488
=150  \\$aJatropha
=450  \\$wnnna$aJatrophas
=450  \\$wnnna$aNettle Spurge
=450  \\$wnnna$aNettle Spurges
=450  \\$aNettlespurge
=450  \\$wnnna$aNettlespurges
=450  \\$aSpurge, Nettle
=450  \\$wnnna$aSpurges, Nettle
=550  \\$wg$aEuphorbiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE. Members contain jatrophone and other diterpenes.
=688  \\$a2003
=750  \0$aJatropha$5IEN-M$0(DLC)sh 85069780

=LDR  00954cz  a2200229n  4500
=001  9880364218402441
=005  20141212214847.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x461
=150  \\$aHippomane
=450  \\$wnnna$aHippomanes
=450  \\$wnnna$aManchincel
=450  \\$wnnna$aManchincels
=450  \\$aManchineel
=450  \\$wnnna$aManchineels
=550  \\$wg$aEuphorbiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE. The trees contain hippomanin A and the latex is a skin irritant.
=688  \\$a2003
=750  \0$aHippomane$5IEN-M$0(DLC)sh 85060991

=LDR  00877cz  a2200205n  4500
=001  9880364218502441
=005  20141212214846.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031284
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x350.$x77
=150  \\$aAleurites
=450  \\$wnnna$aAleurite
=450  \\$aTung
=450  \\$wnnna$aTungs
=550  \\$wg$aEuphorbiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family EUPHORBIACEAE that is the source of tung oil and a phorbol diester (PHORBOL ESTERS).
=688  \\$a2003
=750  \0$aAleurites$5IEN-M$0(DLC)sh 85003353

=LDR  01598cz  a2200253n  4500
=001  9880364218602441
=005  20141212214846.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031283
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x348
=150  \\$aEucommiaceae
=450  \\$aDu-zhong
=450  \\$wnnna$aDu zhong
=450  \\$wnnna$aDu-zhongs
=450  \\$wnnna$aEucommia ulmoide
=450  \\$wnnna$aEucommia ulmoides
=450  \\$wnnna$aulmoide, Eucommia
=450  \\$wnnna$aulmoides, Eucommia
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Eucommiales, subclass Hamamelidae, class Magnoliopsida (some botanists have classified this in the order Hamamelidales or Urticales). Eucomia is an elmlike tree of central and eastern China. Leaves are alternate; deciduous flowers are solitary and unisexual and lack petals and sepals. The male flowers have 6 to 10 stamens and female flowers have one ovary of two carpels, one of which aborts during development so the fruit (a dry, winged structure) contains only one seed. The latex is a source of RUBBER. Tochu tea is an aqueous extract of Eucommia ulmoides leaves and a popular beverage in Japan. (Mutat Res 1997 Jan 15;388(1):7-20).
=688  \\$a2003
=750  \0$aEucommiaceae$5IEN-M$0(DLC)sh 85045521

=LDR  00862cz  a2200181n  4500
=001  9880364218702441
=005  20141212214846.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x343.$x267
=150  \\$aGaultheria
=450  \\$wnnna$aGaultherias
=550  \\$wg$aEricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ERICACEAE. The common name of "wintergreen" is also used for PYROLA and "snowberry" is also used for SYMPHORICARPOS.
=688  \\$a2003
=750  \0$aGaultheria$5IEN-M$0(DLC)sh 99013520

=LDR  01139cz  a2200241n  4500
=001  9880364218802441
=005  20141212214845.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x336.$x500
=150  \\$aHippophae
=450  \\$aBuckthorn, Sea
=450  \\$wnnna$aBuckthorns, Sea
=450  \\$aFructus Hippophae
=450  \\$wnnna$aHippophae, Fructus
=450  \\$aSea Buckthorn
=450  \\$wnnna$aSea Buckthorns
=550  \\$wg$aElaeagnaceae
=667  \\$aunrelated to "artificial sea buckthorn oil"; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ELAEAGNACEAE. Linoleic (18:2n-6) and alpha-linolenic acids (18:3n-3) comprised about 70% of seed oil fatty acids. This is unrelated to 'artificial sea buckthorn oil'.
=688  \\$a2003
=750  \0$aSea buckthorn$5IEN-M$0(DLC)sh 85119211

=LDR  01009cz  a2200217n  4500
=001  9880364218902441
=005  20200422110821.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029606
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x937
=150  \\$aPlumbaginaceae
=450  \\$aLimonium
=450  \\$wnnna$aLimoniums
=450  \\$aPlumbago
=450  \\$wnnna$aPlumbagos
=550  \\$wg$aCaryophyllales
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Plumbaginales, subclass Caryophyllidae, class Magnoliopsida of shrubs and herbs. Some members contain anthocyanins and naphthaquinones.
=688  \\$a2002
=750  \0$aPlumbaginaceae$5IEN-M$0(DLC)sh 88023007

=LDR  01055cz  a2200229n  4500
=001  9880364219002441
=005  20200422110259.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029605
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x875.$x500.$x750
=150  \\$aPhytolacca dodecandra
=450  \\$wnnna$adodecandra, Phytolacca
=450  \\$wnnna$adodecandras, Phytolacca
=450  \\$aEndod
=450  \\$wnnna$aEndods
=450  \\$wnnna$aPhytolacca dodecandras
=550  \\$wg$aPhytolacca
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains SAPONINS used to poison SNAILS.
=688  \\$a2002
=750  \0$aPhytolacca dodecandra$5IEN-M$0(DLC)sh 86001775

=LDR  00910cz  a2200205n  4500
=001  9880364219102441
=005  20200422105944.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029603
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x875.$x500
=150  \\$aPhytolacca
=450  \\$wnnna$aPhytolaccas
=550  \\$wg$aPhytolaccaceae
=550  \\$wh$aPhytolacca americana
=550  \\$wh$aPhytolacca dodecandra
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PHYTOLACCACEAE, order Caryophyllales.
=688  \\$a2002
=750  \0$aPhytolacca$0(DLC)sh 86001774$5IEN-M

=LDR  01104cz  a2200229n  4500
=001  9880364219202441
=005  20200422105401.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029602
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x875
=150  \\$aPhytolaccaceae
=450  \\$wnnna$aPetiveria
=450  \\$wnnna$aPetiverias
=450  \\$wnnna$aRivina
=450  \\$wnnna$aRivinas
=550  \\$wg$aCaryophyllales
=550  \\$wh$aPhytolacca
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe pokeweed plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The leaves are alternate, simple and smooth-edged and the flowers are in spikes or panicles and are usually bisexual.
=688  \\$a2002
=750  \0$aPhytolaccaceae$5IEN-M$0(DLC)sh 85101692

=LDR  00564cz  a2200181n  4500
=001  9880364219302441
=005  20161117135145.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x690
=150  \\$aPedaliaceae
=550  \\$wg$aLamiales
=550  \\$wh$aHarpagophytum
=550  \\$wh$aSesamum
=680  \\$iThe sesame family of the order Lamiales that are mainly herbs and shrubs growing in warm regions.
=688  \\$a2002
=750  \0$aPedaliaceae$5IEN-M$0(DLC)sh 85099125

=LDR  01474cz  a2200373n  4500
=001  9880364219402441
=005  20141212214555.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029598
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x803.$x500
=150  \\$aPassiflora
=450  \\$wnnna$aalata, Passiflora
=450  \\$wnnna$aalatas, Passiflora
=450  \\$wnnna$aeduli, Passiflora
=450  \\$wnnna$aedulis, Passiflora
=450  \\$wnnna$aFlower, Passion
=450  \\$wnnna$aFlowers, Passion
=450  \\$aGranadilla
=450  \\$wnnna$aGranadillas
=450  \\$wnnna$aPassiflora alata
=450  \\$wnnna$aPassiflora alatas
=450  \\$wnnna$aPassiflora eduli
=450  \\$wnnna$aPassiflora edulis
=450  \\$wnnna$aPassifloras
=450  \\$aPassion Flower
=450  \\$wnnna$aPassion Flowers
=450  \\$aPassionfruit
=450  \\$wnnna$aPassionfruits
=550  \\$wg$aPassifloraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Passifloraceae, order Violales, subclass Dilleniidae, class Magnoliopsida. They are vines with ornamental flowers and edible fruit.
=688  \\$a2002
=750  \0$aPassiflora$5IEN-M$0(DLC)sh 85098513

=LDR  01329cz  a2200277n  4500
=001  9880364219502441
=005  20141212193016.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029596
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x791
=150  \\$aPaeonia
=450  \\$wnnna$aPaeoniae Radices
=450  \\$aPaeoniae Radix
=450  \\$wnnna$aPaeonias
=450  \\$wnnna$aPeonies
=450  \\$aPeony
=450  \\$wnnna$aRadices, Paeoniae
=450  \\$wnnna$aRadix, Paeoniae
=450  \\$aShakuyaku
=450  \\$wnnna$aShakuyakus
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Paeoniaceae, order Dilleniales, subclass Dilleniidae, class Magnoliopsida. These perennial herbs are up to 2 m (6') tall. Leaves are alternate and are divided into three lobes, each lobe being further divided into three smaller lobes. The large flowers are symmetrical, bisexual, have 5 sepals, 5 petals (sometimes 10), and many stamens.
=688  \\$a2002
=750  \0$aPeonies$5IEN-M$0(DLC)sh 85099653

=LDR  01057cz  a2200229n  4500
=001  9880364219602441
=005  20180222103429.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029595
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x787
=150  \\$aOrchidaceae
=450  \\$wnnna$aPhalaenopses
=450  \\$aPhalaenopsis
=550  \\$wg$aAsparagales
=550  \\$wh$aDendrobium
=550  \\$wh$aGastrodia
=550  \\$wh$aVanilla
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Orchidales, subclass Liliidae, class Liliopsida (monocotyledons). All orchids have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.
=688  \\$a2002
=750  \0$aOrchids$5IEN-M$0(DLC)sh 85095334

=LDR  01186cz  a2200313n  4500
=001  9880364219702441
=005  20141212193018.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029766
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x228.$x583
=150  \\$aTerminalia
=450  \\$wnnna$aArjun Tree
=450  \\$wnnna$aArjun Trees
=450  \\$wnnna$aArjuna Tree
=450  \\$wnnna$aArjuna Trees
=450  \\$wnnna$aMyrobalan
=450  \\$aMyrobalans
=450  \\$wnnna$aTerminalia arjuna
=450  \\$wnnna$aTerminalias
=450  \\$wnnna$aTree, Arjun
=450  \\$wnnna$aTree, Arjuna
=450  \\$wnnna$aTrees, Arjun
=450  \\$wnnna$aTrees, Arjuna
=550  \\$wg$aCombretaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family COMBRETACEAE. Members contain arjunin, an ellagitannin (TANNINS).
=688  \\$a2002
=750  \0$aTerminalia$5IEN-M$0(DLC)sh 85134017

=LDR  00975cz  a2200229n  4500
=001  9880364219802441
=005  20141212214554.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029594
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x786
=150  \\$aOnagraceae
=450  \\$aLudwigia
=450  \\$wnnna$aLudwigias
=550  \\$wg$aAngiosperms
=550  \\$wh$aClarkia
=550  \\$wh$aEpilobium
=550  \\$wh$aOenothera
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe evening primrose plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Flower parts are mostly in fours and the ovary is inferior.
=688  \\$a2002
=750  \0$aOnagraceae$5IEN$0(DLC)sh 85094716

=LDR  00898cz  a2200193n  4500
=001  9880364219902441
=005  20141212214625.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029764
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x228
=150  \\$aCombretaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCombretum
=550  \\$wh$aTerminalia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mostly trees and shrubs growing in warm areas.
=688  \\$a2002
=750  \0$aCombretaceae$5IEN-M$0(DLC)sh 85028827

=LDR  00976cz  a2200229n  4500
=001  9880364220102441
=005  20141212214625.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249.$x333.$x600
=150  \\$aGarcinia mangostana
=450  \\$wnnna$aGarcinia mangostanas
=450  \\$wnnna$amangostana, Garcinia
=450  \\$wnnna$amangostanas, Garcinia
=450  \\$aMangosteen
=450  \\$wnnna$aMangosteens
=550  \\$wg$aGarcinia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CLUSIACEAE. It is the source of the mangosteen fruit.
=688  \\$a2002
=750  \0$aMangosteen$5IEN-M$0(DLC)sh 85080526

=LDR  00988cz  a2200241n  4500
=001  9880364220302441
=005  20141212214624.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029760
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249.$x333
=150  \\$aGarcinia
=450  \\$wnnna$aGamboge
=450  \\$wnnna$aGamboges
=450  \\$wnnna$aGarcinias
=550  \\$wg$aClusiaceae
=550  \\$wh$aGarcinia cambogia
=550  \\$wh$aGarcinia kola
=550  \\$wh$aGarcinia mangostana
=667  \\$aprefer specific plant; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CLUSIACEAE. Members contain XANTHONES.
=688  \\$a2002
=750  \0$aGarcinia$5IEN-M$0(DLC)sh 85053063

=LDR  01222cz  a2200253n  4500
=001  9880364220402441
=005  20200508144751.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029590
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x750.$x700
=150  \\$aMyricaceae
=450  \\$aComptonia
=450  \\$wnnna$aComptonias
=450  \\$aFern, Sweet
=450  \\$wnnna$aFerns, Sweet
=450  \\$wnnna$aSweet Fern
=450  \\$wnnna$aSweet Ferns
=550  \\$wg$aFagales
=550  \\$wh$aMyrica
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Myricales, subclass Hamamelidae, class Magnoliopsida. They are trees and shrubs having aromatic leaves that often have yellow glandular dots on the surface. Single-seeded fruits are often covered with waxy granules, bumps, or layers. The flowers are small, greenish, and inconspicuous.
=688  \\$a2002
=750  \0$aMyricaceae$5IEN-M$0(DLC)sh 85089296

=LDR  00846cz  a2200181n  4500
=001  9880364220502441
=005  20141212214551.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029589
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x866
=150  \\$aSeminal Plasma Proteins
=550  \\$wg$aProteins
=550  \\$wh$aProstatic Secretory Proteins
=550  \\$wh$aSeminal Vesicle Secretory Proteins
=680  \\$iProteins found in SEMEN. Major seminal plasma proteins are secretory proteins from the male sex accessory glands, such as the SEMINAL VESICLES and the PROSTATE. They include the seminal vesicle-specific antigen, an ejaculate clotting protein; and the PROSTATE-SPECIFIC ANTIGEN, a protease and an esterase.
=688  \\$a2002; use SEMINAL PLASMA PROTEINS (NM) 1979-2001
=750  \0$aSeminal proteins$5IEN-M$0(DLC)sh 88007605

=LDR  00903cz  a2200205n  4500
=001  9880364220602441
=005  20141212193018.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029759
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249.$x166
=150  \\$aCalophyllum
=450  \\$wnnna$aCalophyllums
=450  \\$aPunna
=450  \\$wnnna$aPunnas
=550  \\$wg$aClusiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CLUSIACEAE. Members contain costatolide, calanolides and 4-phenylfuranocoumarins (FUROCOUMARINS).
=688  \\$a2002
=750  \0$aCalophyllum$5IEN-M$0(DLC)sh 88022625

=LDR  01035cz  a2200229n  4500
=001  9880364220702441
=005  20141212214551.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029588
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x752.$x500
=150  \\$aMoringa oleifera
=450  \\$aDrumsticktree
=450  \\$wnnna$aDrumsticktrees
=450  \\$wnnna$aMoringa oleiferas
=450  \\$wnnna$aoleifera, Moringa
=450  \\$wnnna$aoleiferas, Moringa
=550  \\$wg$aMoringa
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family Moringaceae, order Capparales, subclass Dilleniidae. It is a source of niaziminin and hypotensive thiocarbamate glycosides.
=688  \\$a2002
=750  \0$aMoringa oleifera$5IEN-M$0(DLC)sh 98005164

=LDR  01023cz  a2200241n  4500
=001  9880364220802441
=005  20200422115344.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029756
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x912.$x250.$x859.$x500.$x750.$x366
=150  \\$aEuonymus
=450  \\$aBurningbush (Euonymus)
=450  \\$wnnna$aBurningbushs (Euonymus)
=450  \\$wnnna$aEuonymus sieboldianus
=450  \\$wnnna$asieboldianus, Euonymus
=450  \\$aSpindletree
=450  \\$wnnna$aSpindletrees
=550  \\$wg$aCelastraceae
=667  \\$adistinguish from BURNINGBUSH (BASSIA); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CELASTRACEAE.
=688  \\$a2002
=750  \0$aEuonymus$5IEN-M$0(DLC)sh 85126690

=LDR  00865cz  a2200193n  4500
=001  9880364220902441
=005  20141212214551.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029587
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x752
=150  \\$aMoringa
=450  \\$wnnna$aMoringas
=550  \\$wg$aAngiosperms
=550  \\$wh$aMoringa oleifera
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Moringaceae, order Capparales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aMoringa$5IEN-M$0(DLC)sh 98005162

=LDR  00741cz  a2200169n  4500
=001  9880364221002441
=005  20200422115725.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x500.$x750.$x577
=150  \\$aMaytenus
=550  \\$wg$aCelastraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CELASTRACEAE.
=688  \\$a2002
=750  \0$aMaytenus$5IEN-M$0(DLC)sh 88022919

=LDR  01375cz  a2200373n  4500
=001  9880364221102441
=005  20141212214550.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029586
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750
=150  \\$aMoraceae
=450  \\$aBrosimum
=450  \\$wnnna$aBrosimums
=450  \\$aCastilla Plant
=450  \\$wnnna$aCastilla Plants
=450  \\$aCudrania
=450  \\$wnnna$aCudranias
=450  \\$aDorstenia
=450  \\$wnnna$aDorstenias
=450  \\$wnnna$aPlant, Castilla
=450  \\$wnnna$aPlants, Castilla
=450  \\$wnnna$aStreblus
=550  \\$wg$aAngiosperms
=550  \\$wh$aAntiaris
=550  \\$wh$aArtocarpus
=550  \\$wh$aBroussonetia
=550  \\$wh$aFicus
=550  \\$wh$aMaclura
=550  \\$wh$aMorus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe mulberry plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. They have milky latex and small, petalless male or female flowers.
=688  \\$a2002
=750  \0$aMoraceae$5IEN-M$0(DLC)sh 85087194

=LDR  00904cz  a2200229n  4500
=001  9880364221202441
=005  20141212214550.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x745
=150  \\$aMonimiaceae
=450  \\$aDoryphora
=450  \\$wnnna$aDoryphoras
=450  \\$aHortonia
=450  \\$wnnna$aHortonias
=550  \\$wg$aAngiosperms
=550  \\$wh$aPeumus
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aMonimiaceae$5IEN-M$0(DLC)sh 88022925

=LDR  01410cz  a2200349n  4500
=001  9880364221302441
=005  20200422114945.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029754
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x500.$x750.$x155
=150  \\$aCatha
=450  \\$wnnna$aCatha eduli
=450  \\$wnnna$aCatha edulis
=450  \\$wnnna$aCathas
=450  \\$wnnna$aeduli, Catha
=450  \\$wnnna$aedulis, Catha
=450  \\$aKhat
=450  \\$wnnna$aKhats
=450  \\$wnnna$aMairungi
=450  \\$wnnna$aMairungus
=450  \\$wnnna$aMiraa
=450  \\$wnnna$aMiraas
=450  \\$wnnna$aPlant, Qat
=450  \\$wnnna$aPlants, Qat
=450  \\$wnnna$aQat Plant
=450  \\$wnnna$aQat Plants
=550  \\$wg$aCelastraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CELASTRACEAE. The leafy stems of khat are chewed by some individuals for stimulating effect. Members contain ((+)-norpseudoephedrine), cathionine, cathedulin, cathinine & cathidine.
=688  \\$a2002; for MIRAA use MIRAA (NM) 1981-2002
=750  \0$aCatha$5IEN-M$0(DLC)sh 93002878

=LDR  01182cz  a2200277n  4500
=001  9880364221402441
=005  20141212214549.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029583
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x725
=150  \\$aMenispermaceae
=450  \\$aTriclisia
=450  \\$wnnna$aTriclisias
=550  \\$wg$aAngiosperms
=550  \\$wh$aCissampelos
=550  \\$wh$aCocculus
=550  \\$wh$aCyclea
=550  \\$wh$aMenispermum
=550  \\$wh$aSinomenium
=550  \\$wh$aStephania
=550  \\$wh$aTinospora
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.
=688  \\$a2002
=750  \0$aMenispermaceae$5IEN-M$0(DLC)sh 85083578

=LDR  01102cz  a2200289n  4500
=001  9880364221502441
=005  20200422114057.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029753
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x500.$x750
=150  \\$aCelastraceae
=450  \\$aGlyptopetalum
=450  \\$wnnna$aGlyptopetalums
=450  \\$wnnna$aKokoona
=450  \\$wnnna$aKokoonas
=550  \\$wg$aCelastrales
=550  \\$wh$aCatha
=550  \\$wh$aCelastrus
=550  \\$wh$aEuonymus
=550  \\$wh$aMaytenus
=550  \\$wh$aSalacia
=550  \\$wh$aTripterygium
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aCelastraceae$0(DLC) sh 85021612$5IEN-M

=LDR  01345cz  a2200409n  4500
=001  9880364221602441
=005  20141212214549.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x715
=150  \\$aMeliaceae
=450  \\$wnnna$aCarapa
=450  \\$wnnna$aCarapas
=450  \\$aDysoxylum
=450  \\$wnnna$aDysoxylums
=450  \\$aGuarea
=450  \\$wnnna$aGuareas
=450  \\$aKhaya
=450  \\$wnnna$aKhayas
=450  \\$aSandoricum
=450  \\$wnnna$aSandoricums
=450  \\$wnnna$aSwietenia
=450  \\$wnnna$aSwietenias
=450  \\$aTrichilia
=450  \\$wnnna$aTrichilias
=450  \\$wnnna$aTurraea
=450  \\$wnnna$aTurraeas
=550  \\$wg$aAngiosperms
=550  \\$wh$aAglaia
=550  \\$wh$aAzadirachta
=550  \\$wh$aCedrela
=550  \\$wh$aMelia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe mahogany plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aMeliaceae$0(DLC) sh 85083411$5IEN-M

=LDR  00824cz  a2200205n  4500
=001  9880364221702441
=005  20141212214621.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x827
=150  \\$aStellaria
=450  \\$aChickweed
=450  \\$wnnna$aChickweeds
=450  \\$wnnna$aStellarias
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE.
=688  \\$a2002
=750  \0$aStellaria$5IEN-M$0(DLC)sh 85127917

=LDR  01014cz  a2200229n  4500
=001  9880364221802441
=005  20190304142325.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029751
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x655
=150  \\$aSilene
=450  \\$wnnna$aCatchflies, Pink
=450  \\$aCatchfly, Pink
=450  \\$wnnna$aPink Catchflies
=450  \\$wnnna$aPink Catchfly
=450  \\$wnnna$aSilenes
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE. The common name of campion is also used with LYCHNIS. The common name of 'pink' can be confused with other plants.
=688  \\$a2002
=750  \0$aSilene$0(DLC)sh 88023108$5IEN-M

=LDR  01244cz  a2200289n  4500
=001  9880364221902441
=005  20141212214548.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x690
=150  \\$aMalpighiaceae
=450  \\$wnnna$aAcerola Cherries
=450  \\$wnnna$aAcerola Cherry
=450  \\$wnnna$aCherries, Acerola
=450  \\$aCherry, Acerola
=450  \\$wnnna$aglabra, Malpighia
=450  \\$wnnna$aglabras, Malpighia
=450  \\$wnnna$aMalpighia glabra
=450  \\$wnnna$aMalpighia glabras
=550  \\$wg$aAngiosperms
=550  \\$wh$aBanisteriopsis
=550  \\$wh$aGalphimia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.
=688  \\$a2002
=750  \0$aMalpighiaceae$5IEN-M$0(DLC)sh 85080188

=LDR  01092cz  a2200229n  4500
=001  9880364222002441
=005  20141212214620.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x611
=150  \\$aSaponaria
=450  \\$wnnna$aofficinali, Saponaria
=450  \\$wnnna$aofficinalis, Saponaria
=450  \\$wnnna$aSaponaria officinali
=450  \\$wnnna$aSaponaria officinalis
=450  \\$wnnna$aSaponarias
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family CARYOPHYLLACEAE. It is a source of SAPONINS. The common name "Soapwort" is also used with VACCARIA. The common name of "Bouncing Bet" is occasionally used with VIOLA.
=688  \\$a2002
=750  \0$aSaponaria$5IEN-M$0(DLC)sh 90004371

=LDR  00863cz  a2200193n  4500
=001  9880364222102441
=005  20141212214619.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029749
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x195.$x222
=150  \\$aDianthus
=450  \\$aCarnation
=450  \\$wnnna$aCarnations
=550  \\$wg$aCaryophyllaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CARYOPHYLLACEAE. Members contain dianthins, which are ribosome inactivating proteins.
=688  \\$a2002
=750  \0$aPinks (Plants)$5IEN-M$0(DLC)sh 85102255

=LDR  01090cz  a2200217n  4500
=001  9880364222202441
=005  20141212214547.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x680
=150  \\$aMagnoliaceae
=450  \\$wnnna$aMichelia
=450  \\$wnnna$aMichelias
=550  \\$wg$aAngiosperms
=550  \\$wh$aLiriodendron
=550  \\$wh$aMagnolia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.
=688  \\$a2002
=750  \0$aMagnoliaceae$5IEN-M$0(DLC)sh 85079806

=LDR  00850cz  a2200169n  4500
=001  9880364222302441
=005  20201102112529.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x665
=150  \\$aLythraceae
=450  \\$aPunicaceae
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe loosestrife plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. Members are mainly herbs and many of them contain ALKALOIDS.
=688  \\$a2002
=750  \0$aLythraceae$5IEN-M$0(DLC)sh 85079200

=LDR  01762cz  a2200469n  4500
=001  9880364222402441
=005  20200422102103.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029748
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x250
=150  \\$aCaryophyllaceae
=450  \\$wnnna$aBrachystemma
=450  \\$wnnna$aBrachystemmas
=450  \\$wnnna$aCerastium
=450  \\$wnnna$aCerastiums
=450  \\$wnnna$aChickweed, Mouse-ear
=450  \\$wnnna$aChickweed, Mouse ear
=450  \\$wnnna$aChickweeds, Mouse-ear
=450  \\$wnnna$aDrymaria
=450  \\$wnnna$aDrymarias
=450  \\$wnnna$aHerniaria
=450  \\$wnnna$aHerniarias
=450  \\$wnnna$aMouse-ear Chickweed
=450  \\$wnnna$aMouse-ear Chickweeds
=450  \\$wnnna$aRupturewort
=450  \\$wnnna$aRuptureworts
=450  \\$wnnna$aSpergularia
=450  \\$wnnna$aSpergularias
=550  \\$wg$aCaryophyllales
=550  \\$wh$aAgrostemma
=550  \\$wh$aArenaria Plant
=550  \\$wh$aDianthus
=550  \\$wh$aLychnis
=550  \\$wh$aSaponaria
=550  \\$wh$aSilene
=550  \\$wh$aStellaria
=550  \\$wh$aVaccaria
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.
=688  \\$a2002
=750  \0$aCaryophyllaceae$5IEN-M$0(DLC)sh 85020552

=LDR  00789cz  a2200205n  4500
=001  9880364222502441
=005  20141212214547.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029544
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x70.$x250
=072  \\$aB4.$x909.$x777.$x618.$x70.$x250
=150  \\$aFoot-and-Mouth Disease Virus
=450  \\$wnnna$aFoot and Mouth Disease Virus
=450  \\$wnnna$aFoot-and-Mouth Disease Viruses
=550  \\$wg$aAphthovirus
=667  \\$ainfection = FOOT AND MOUTH DISEASE
=680  \\$iThe type species of APHTHOVIRUS, causing FOOT-AND-MOUTH DISEASE in cloven-hoofed animals. Several different serotypes exist.
=688  \\$a2002, 1963-1993; use APHTHOVIRUS 1994-2001
=750  \0$aFoot-and-mouth disease virus$0(DLC) sh 85050401$5IEN

=LDR  01095cz  a2200265n  4500
=001  9880364222602441
=005  20141212214618.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029747
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x168.$x500
=150  \\$aOpuntia
=450  \\$wnnna$aCactus, Cholla
=450  \\$wnnna$aCactus, Prickly-pear
=450  \\$aCholla Cactus
=450  \\$wnnna$aficus, Opuntia
=450  \\$wnnna$aOpuntia ficus
=450  \\$wnnna$aOpuntias
=450  \\$aPrickly-pear Cactus
=450  \\$wnnna$aPrickly pear Cactus
=550  \\$wg$aCactaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CACTACEAE. Species with cylindrical joints are called Cholla; flat jointed ones are Prickly-pear.
=688  \\$a2002
=750  \0$aOpuntia$5IEN-M$0(DLC)sh 88000232

=LDR  00800cz  a2200181n  4500
=001  9880364222702441
=005  20141212214617.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029746
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x171.$x600
=150  \\$aLobelia
=450  \\$wnnna$aLobelias
=550  \\$wg$aCampanulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CAMPANULACEAE used medicinally and is a source of LOBELINE.
=688  \\$a2002
=750  \0$aLobelia$5IEN-M$0(DLC)sh 88022894

=LDR  01223cz  a2200265n  4500
=001  9880364222802441
=005  20141212214546.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x525
=150  \\$aLycopodiaceae
=450  \\$wnnna$aClub Moss
=450  \\$wnnna$aClub Mosses
=450  \\$aClubmoss
=450  \\$wnnna$aClubmosses
=450  \\$aMoss, Club
=450  \\$wnnna$aMosses, Club
=550  \\$wg$aEmbryophyta
=550  \\$wh$aHuperzia
=550  \\$wh$aLycopodium
=667  \\$ado not confuse with the true MOSSES; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe club-moss plant family of the order Lycopodiales, class Lycopodiopsida, division Lycopodiophyta, subkingdom Tracheobionta. The common name of clubmoss applies to several genera of this family. Despite the name this is not one of the true mosses (BRYOPSIDA ).
=688  \\$a2002
=750  \0$aLycopodiaceae$5IEN-M$0(DLC)sh 85079093

=LDR  01089cz  a2200217n  4500
=001  9880364222902441
=005  20180712120522.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x456.$x875
=150  \\$aLoganiaceae
=450  \\$wnnna$aSpigelia
=450  \\$wnnna$aSpigelias
=550  \\$wg$aGentianales
=550  \\$wh$aGelsemium
=550  \\$wh$aStrychnos
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida. They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.
=688  \\$a2002
=750  \0$aLoganiaceae$5IEN-M$0(DLC)sh 85078088

=LDR  01486cz  a2200361n  4500
=001  9880364223002441
=005  20141212193017.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x162.$x166
=150  \\$aCommiphora
=450  \\$aBisabol Myrrh
=450  \\$wnnna$aBisabol Myrrhs
=450  \\$wnnna$aCommiphora erythraea
=450  \\$wnnna$aCommiphora kataf
=450  \\$wnnna$aCommiphora molmol
=450  \\$wnnna$aCommiphora mukul
=450  \\$wnnna$aCommiphora myrrha
=450  \\$wnnna$aCommiphora wightii
=450  \\$wnnna$aCommon Myrrh Tree
=450  \\$wnnna$aCommon Myrrh Trees
=450  \\$aMyrrh, Bisabol
=450  \\$wnnna$aMyrrh Tree, Common
=450  \\$wnnna$aMyrrh Trees, Common
=450  \\$wnnna$aMyrrhs, Bisabol
=450  \\$wnnna$aTree, Common Myrrh
=450  \\$wnnna$aTrees, Common Myrrh
=550  \\$wg$aBurseraceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family BURSERACEAE which is a source of gugulipid and guggulu extract. Balm of Gilead is a common name more often referring to POPULUS and sometimes to ABIES.
=688  \\$a2002
=750  \0$aCommiphora$5IEN-M$0(DLC)sh 94001674

=LDR  00993cz  a2200229n  4500
=001  9880364223202441
=005  20141212214616.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x200.$x277
=150  \\$aBrassica rapa
=450  \\$wnnna$aBrassica rapas
=450  \\$wnnna$arapa, Brassica
=450  \\$wnnna$arapas, Brassica
=450  \\$aRapeseed
=450  \\$wnnna$aRapeseeds
=550  \\$wg$aBrassica
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species cultivated for the seed used as animal feed and as a source of canola cooking oil.
=688  \\$a2002; for RAPESEED use BRASSICA 1977-2001
=750  \0$aRapeseed$5IEN-M$0(DLC)sh 85111416

=LDR  00963cz  a2200229n  4500
=001  9880364223302441
=005  20141212214615.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029688
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x200.$x249
=150  \\$aBrassica napus
=450  \\$wnnna$anapus, Brassica
=450  \\$aRutabaga
=450  \\$wnnna$aRutabagas
=450  \\$aTurnip
=450  \\$wnnna$aTurnips
=550  \\$wg$aBrassica
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family BRASSICACEAE best known for the edible roots.
=688  \\$a2002; for TURNIP & RUTABAGA use BRASSICA 1998-2001
=750  \0$aRape (Plant)$5IEN-M$0(DLC)sh 85111405

=LDR  01424cz  a2200325n  4500
=001  9880364223402441
=005  20141212214544.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x539
=150  \\$aIllicium
=450  \\$wnnna$aanisatum, Illicium
=450  \\$wnnna$aanisatums, Illicium
=450  \\$aAnise, Star
=450  \\$wnnna$aAnises, Star
=450  \\$wnnna$aIllicium anisatum
=450  \\$wnnna$aIllicium anisatums
=450  \\$wnnna$aIllicium verum
=450  \\$wnnna$aIllicium verums
=450  \\$wnnna$aIlliciums
=450  \\$aStar Anise
=450  \\$wnnna$aStar Anises
=450  \\$wnnna$averum, Illicium
=450  \\$wnnna$averums, Illicium
=550  \\$wg$aAngiosperms
=667  \\$adistinguish X ref STAR ANISE from Anise (PIMPINELLA); coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Illiciaceae, order Illiciales, subclass Magnoliidae, class Magnoliopsida. They have evergreen, aromatic leaves and bisexual flowers. The female portion of the flower consists of 7 to 15 carpels.
=688  \\$a2002
=750  \0$aIllicium$5IEN-M$0(DLC)sh 88022848

=LDR  00953cz  a2200181n  4500
=001  9880364223502441
=005  20141212214544.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029522
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x531
=150  \\$aHydrophyllaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aEriodictyon
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe waterleaf plant family of the order Solanales, subclass Asteridae, class Magnoliopsida. They have alternate leaves, regular flowers with five-lobed corollas (united petals), and a one- or two-celled ovary.
=688  \\$a2002
=750  \0$aHydrophyllaceae$5IEN-M$0(DLC)sh 87002351

=LDR  01331cz  a2200349n  4500
=001  9880364223602441
=005  20141212214614.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029687
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x244
=150  \\$aCapsella
=450  \\$wnnna$abursa-pastori, Capsella
=450  \\$wnnna$abursa-pastoris, Capsella
=450  \\$wnnna$aCapsella bursa-pastori
=450  \\$wnnna$aCapsella bursa-pastoris
=450  \\$wnnna$aCapsella bursa pastoris
=450  \\$wnnna$aCapsellas
=450  \\$wnnna$aPurse, Shepherd's
=450  \\$wnnna$aPurse, Shepherds
=450  \\$wnnna$aPurses, Shepherd's
=450  \\$wnnna$aPurses, Shepherds
=450  \\$wnnna$aShepherd Purse
=450  \\$wnnna$aShepherds Purse
=450  \\$aShepherd's Purse
=450  \\$wnnna$aShepherd's Purses
=450  \\$wnnna$aShepherds Purses
=550  \\$wg$aBrassicaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CRUCIFERAE.
=688  \\$a2002
=750  \0$aCapsella$5IEN-M$0(DLC)sh 88022642

=LDR  01058cz  a2200265n  4500
=001  9880364223702441
=005  20141212214613.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x600
=150  \\$aLepidium
=450  \\$wnnna$aLepidium meyenii
=450  \\$wnnna$aLepidium meyenius
=450  \\$wnnna$aLepidiums
=450  \\$aMaca
=450  \\$wnnna$aMacas
=450  \\$wnnna$ameyenii, Lepidium
=450  \\$wnnna$ameyenius, Lepidium
=550  \\$wg$aBrassicaceae
=550  \\$wh$aLepidium sativum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BRASSICACEAE growing in Peru mountains. It is the source of maca root.
=688  \\$a2002
=750  \0$aLepidium$0(DLC) sh 88022876$5IEN-M

=LDR  00832cz  a2200205n  4500
=001  9880364223802441
=005  20150120103638.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x750
=150  \\$aPulmonaria
=450  \\$aLungwort
=450  \\$wnnna$aLungworts
=450  \\$wnnna$aPulmonarias
=550  \\$wg$aBoraginaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BORAGINACEAE.
=688  \\$a2002
=750  \0$aPulmonaria (Angiosperms)$5IEN-M$0(DLC)sh 85108993

=LDR  01001cz  a2200253n  4500
=001  9880364223902441
=005  20141212214613.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029684
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x501
=150  \\$aLithospermum
=450  \\$aGromwell
=450  \\$wnnna$aGromwells
=450  \\$wnnna$aLithospermi
=450  \\$wnnna$aLithospermums
=450  \\$wnnna$aLithospermus
=450  \\$aPuccoon
=450  \\$wnnna$aPuccoons
=550  \\$wg$aBoraginaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.
=688  \\$a2002
=750  \0$aLithospermum$5IEN-M$0(DLC)sh 88022891

=LDR  01313cz  a2200277n  4500
=001  9880364224002441
=005  20141212214542.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x475.$x500
=150  \\$aHamamelis
=450  \\$wnnna$aHamameli
=450  \\$wnnna$aHamamelis virginiana
=450  \\$wnnna$aHamamelis virginianas
=450  \\$wnnna$aHazel, Witch
=450  \\$wnnna$aHazels, Witch
=450  \\$wnnna$avirginiana, Hamamelis
=450  \\$wnnna$avirginianas, Hamamelis
=450  \\$aWitch Hazel
=450  \\$wnnna$aWitch Hazels
=550  \\$wg$aHamamelidaceae
=667  \\$ado not confuse with HAMELIA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Hamamelidaceae, order Hamamelidales. It is known for the astringent (ASTRINGENTS) extract of leaves and bark used in over the counter preparations. This should not be confused with the similar named Hamelia genus (RUBIACEAE).
=688  \\$a2002
=750  \0$aWitch hazels$5IEN-M$0(DLC)sh 85058533

=LDR  00811cz  a2200205n  4500
=001  9880364224102441
=005  20141212193016.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029683
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x188
=150  \\$aBorago
=450  \\$aBorage
=450  \\$wnnna$aBorages
=450  \\$wnnna$aBorago officinalis
=550  \\$wg$aBoraginaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family BORAGINACEAE.
=688  \\$a2002
=750  \0$aBorago$5IEN-M$0(DLC)sh 88022603

=LDR  00868cz  a2200181n  4500
=001  9880364224202441
=005  20141212214612.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029682
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x122
=150  \\$aAmsinckia
=450  \\$wnnna$aAmsinckias
=550  \\$wg$aBoraginaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BORAGINACEAE. Members contain PYRROLIZIDINE ALKALOIDS. The common name of burweed is also used for Triumfetta (TILIACEAE).
=688  \\$a2002
=750  \0$aAmsinckia$0(DLC)sh2003006795$5IEN-M

=LDR  01075cz  a2200277n  4500
=001  9880364224302441
=005  20141212214611.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x143.$x500
=150  \\$aTabebuia
=450  \\$wnnna$ad'arco, Pau
=450  \\$wnnna$ad'arcos, Pau
=450  \\$wnnna$alapacho, Tabebuia
=450  \\$wnnna$alapachos, Tabebuia
=450  \\$aPau d'arco
=450  \\$wnnna$aPau d'arcos
=450  \\$wnnna$aTabebuia lapacho
=450  \\$wnnna$aTabebuia lapachos
=450  \\$wnnna$aTabebuias
=550  \\$wg$aBignoniaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BIGNONIACEAE that is a source of lapachol.
=688  \\$a2002
=750  \0$aTabebuia$5IEN-M$0(DLC)sh 94000970

=LDR  01051cz  a2200253n  4500
=001  9880364224402441
=005  20141212214540.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x192.$x500
=150  \\$aCarica
=450  \\$wnnna$aCarica papaya
=450  \\$wnnna$aCarica papayas
=450  \\$wnnna$aCaricas
=450  \\$aPapaya
=450  \\$wnnna$apapaya, Carica
=450  \\$wnnna$aPapayas
=450  \\$wnnna$apapayas, Carica
=550  \\$wg$aCaricaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Caricaceae, order Violales, subclass Dilleniidae, class Magnoliopsida. It is the source of edible fruit and PAPAIN.
=688  \\$a2002
=750  \0$aCarica$5IEN-M$0(DLC)sh 88022646

=LDR  00942cz  a2200205n  4500
=001  9880364224502441
=005  20141212214611.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029662
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x137.$x750
=150  \\$aBetula
=450  \\$wnnna$aBetulas
=450  \\$aBirch
=450  \\$wnnna$aBirchs
=550  \\$wg$aBetulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BETULACEAE. The tree has smooth, resinous, varicolored or white bark, marked by horizontal pores (lenticels), which usually peels horizontally in thin sheets.
=688  \\$a2002
=750  \0$aBirch$5IEN-M$0(DLC)sh 85014281

=LDR  00927cz  a2200193n  4500
=001  9880364224602441
=005  20141212214611.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x137.$x500
=150  \\$aAlnus
=450  \\$aAlder
=450  \\$wnnna$aAlders
=550  \\$wg$aBetulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BETULACEAE that is distinguished from birch (BETULA) by its usually stalked winter buds and by cones that remain on the branches after the small, winged nutlets are released.
=688  \\$a2002
=750  \0$aAlder$5IEN-M$0(DLC)sh 85003327

=LDR  00809cz  a2200193n  4500
=001  9880364224702441
=005  20141212214610.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x962
=150  \\$aViolaceae
=450  \\$aHybanthus
=550  \\$wg$aAngiosperms
=550  \\$wh$aViola
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aViolaceae$5IEN-M$0(DLC)sh 88023185

=LDR  00661cz  a2200193n  4500
=001  9880364224802441
=005  20161117142331.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029648
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x990
=150  \\$aVerbenaceae
=550  \\$wg$aLamiales
=550  \\$wh$aLantana
=550  \\$wh$aLippia
=550  \\$wh$aVerbena
=680  \\$iA plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.
=688  \\$a2002
=750  \0$aVerbenaceae$5IEN-M$0(DLC)sh 85142803

=LDR  01017cz  a2200253n  4500
=001  9880364224902441
=005  20141212214540.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x171
=150  \\$aCampanulaceae
=450  \\$wnnna$aAdenophora
=450  \\$wnnna$aAdenophoras
=450  \\$aCampanula
=450  \\$wnnna$aCampanulas
=550  \\$wg$aAngiosperms
=550  \\$wh$aCodonopsis
=550  \\$wh$aLobelia
=550  \\$wh$aPlatycodon
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida
=688  \\$a2002
=750  \0$aCampanulaceae$5IEN-M$0(DLC)sh 85019212

=LDR  00860cz  a2200205n  4500
=001  9880364225002441
=005  20141212214609.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x947
=150  \\$aTurnera
=450  \\$aDamiana
=450  \\$wnnna$aDamianas
=450  \\$wnnna$aTurneras
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Turneraceae, order Violales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2002
=750  \2$aTurnera$0(DLC)sh2004007269$5IEN-M

=LDR  00927cz  a2200193n  4500
=001  9880364225102441
=005  20200115145640.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x912.$x250.$x198.$x500.$x200
=150  \\$aCactaceae
=450  \\$aCactus
=550  \\$wg$aCaryophyllales
=550  \\$wh$aOpuntia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe cactus plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Cacti are succulent perennial plants well adapted to dry regions.
=688  \\$a2002
=750  \0$aCactus$5IEN-M$0(DLC)sh 85018606

=LDR  00868cz  a2200217n  4500
=001  9880364225202441
=005  20141212214609.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029646
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x938
=150  \\$aTiliaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aCorchorus
=550  \\$wh$aGrewia
=550  \\$wh$aTilia
=550  \\$wh$aTriumfetta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aTiliaceae$5IEN-M$0(DLC)sh 85135361

=LDR  01032cz  a2200241n  4500
=001  9880364225302441
=005  20141212214608.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029645
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x932
=150  \\$aThymelaeaceae
=450  \\$aAquilaria
=450  \\$wnnna$aAquilarias
=450  \\$aDirca
=450  \\$wnnna$aDircas
=550  \\$wg$aAngiosperms
=550  \\$wh$aDaphne
=550  \\$wh$aWikstroemia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.
=688  \\$a2002
=750  \0$aThymelaeaceae$0(DLC) sh 85135137$5IEN-M

=LDR  02057cz  a2200349n  4500
=001  9880364225402441
=005  20190419105344.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029404
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x62
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x820.$x500
=150  \\$aActivin Receptors
=450  \\$wnnna$aActivin Receptor
=450  \\$wnnna$aActivin Receptor-like Kinase
=450  \\$wnnna$aActivin Receptor like Kinase
=450  \\$aActivin Receptor-Like Kinases
=450  \\$wnnna$aActivin Receptor like Kinases
=450  \\$wnnna$aKinase, Activin Receptor-like
=450  \\$wnnna$aKinases, Activin Receptor-like
=450  \\$wnnna$aReceptor, Activin
=450  \\$wnnna$aReceptor-like Kinase, Activin
=450  \\$wnnna$aReceptor-like Kinases, Activin
=550  \\$wg$aProtein-Serine-Threonine Kinases
=550  \\$wg$aReceptors, Transforming Growth Factor beta
=550  \\$wh$aActivin Receptors, Type I
=550  \\$wh$aActivin Receptors, Type II
=680  \\$iReceptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases (ALK's). Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily (RECEPTORS, TRANSFORMING GROWTH FACTOR BETA), ALK's consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors (ACTIVIN RECEPTORS, TYPE II ) which then recruit and phosphorylate the type I receptors (ACTIVIN RECEPTORS, TYPE I ) with subsequent activation of the type I kinase activity.
=688  \\$a2002; use ACTIVIN RECEPTORS (NM) 1991-2001
=750  \0$81$wb$iBroader mapping$aActivin$0(DLC)sh 97005108$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSee also under the Library of Congress Subject Heading$aActivin--Receptors$5IEN-M

=LDR  00797cz  a2200181n  4500
=001  9880364225502441
=005  20190702133139.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029644
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341.$x996
=150  \\$aStyracaceae
=550  \\$wg$aEricales
=550  \\$wh$aStyrax
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aStyracaceae$5IEN-M$0(DLC)sh 88023138

=LDR  00953cz  a2200205n  4500
=001  9880364225602441
=005  20141212214537.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029403
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x162
=150  \\$aBurseraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aBoswellia
=550  \\$wh$aBursera
=550  \\$wh$aCommiphora
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. They are resinous trees and shrubs with alternate leaves composed of many leaflets.
=688  \\$a2002
=750  \0$aBurseraceae$5IEN-M$0(DLC)sh 88022612

=LDR  01127cz  a2200229n  4500
=001  9880364225802441
=005  20161117110534.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D029402
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x080
=150  \\$aBignoniaceae
=450  \\$wnnna$aStereospermum
=450  \\$wnnna$aStereospermums
=450  \\$wnnna$aTecoma
=450  \\$wnnna$aTecomas
=550  \\$wg$aLamiales
=550  \\$wh$aTabebuia
=667  \\$aGEN or unspecified; prefer specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. The family is characterized by oppositely paired, usually compound leaves and bell- or funnel-shaped, bisexual flowers having a five-lobed calyx and corolla.
=688  \\$a2002
=750  \0$aBignoniaceae$5IEN-M$0(DLC)sh 88022599

=LDR  00698cz  a2200217n  4500
=001  9880363204902441
=005  20200511120056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001515
=035  \\$aCAZ4672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x100.$x100.$x200
=072  \\$aG7.$x203.$x200.$x250
=072  \\$aJ2.$x200.$x100.$x200
=072  \\$aJ2.$x350.$x250
=150  \\$aBeer
=450  \\$wnnna$aBeers
=550  \\$wg$aAlcoholic Beverages
=550  \\$wg$aFermented Foods and Beverages
=680  \\$iAn alcoholic beverage usually made from malted cereal grain (as barley), flavored with hops, and brewed by slow fermentation.
=750  \0$aBeer$0(DLC)sh 85012832$5IEN-M

=LDR  01058cz  a2200289n  4500
=001  9880363205002441
=005  20141212195144.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001514
=035  \\$aCAZ4671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65.$x115
=072  \\$aD23.$x946.$x833.$x65.$x115
=150  \\$aBee Venoms
=450  \\$aApis Venoms
=450  \\$wnnna$aApitoxin
=450  \\$wnnna$aBee Venom
=450  \\$wnnna$aVenom, Bee
=450  \\$wnnna$aVenoms, Apis
=450  \\$wnnna$aVenoms, Bee
=550  \\$wg$aArthropod Venoms
=550  \\$wh$aApamin
=550  \\$wh$aMelitten
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted
=680  \\$iVenoms obtained from Apis mellifera (honey bee) and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system.
=688  \\$a78
=750  \0$aBees$xVenom$xIEN-M$5IEN-HS

=LDR  00605cz  a2200205n  4500
=001  9880363205102441
=005  20141212195144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001513
=035  \\$aCAZ4670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x220
=150  \\$aBeds
=450  \\$wnnna$aBed
=450  \\$aHospital Beds$5IEN
=450  \\$aMattresses
=550  \\$wg$aEquipment and Supplies, Hospital
=550  \\$wh$aStretchers
=680  \\$iEquipment on which one may lie and sleep, especially as used to care for the hospital patient.
=750  \0$aBeds$5IEN-HS$0(DLC)sh 85012788

=LDR  01088cz  a2200301n  4500
=001  9880363205202441
=005  20141212195144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001512
=035  \\$aCAZ4669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x137
=072  \\$aJ1.$x494.$x221
=150  \\$aBedding and Linens
=450  \\$wnnna$aBedding
=450  \\$wnnna$aBeddings
=450  \\$wnnna$aLinen
=450  \\$aLinens
=450  \\$wnnna$aLinens and Bedding
=550  \\$wg$aEquipment and Supplies, Hospital
=550  \\$wg$aHousehold Articles
=550  \\$wh$aMosquito Nets
=550  \\$wh$aSurgical Drapes
=550  \\$aLaundry Service, Hospital
=667  \\$aincludes all bedclothes & towels, washcloths, gowns, pajamas; DF: BEDDING
=680  \\$iArticles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians' examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like.
=688  \\$a68(63)
=750  \0$aBedding$5IEN-HS$0(DLC)sh 85012768

=LDR  01208cz  a2200253n  4500
=001  9880363205302441
=005  20141212195143.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001511
=035  \\$aCAZ4668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x150.$x100
=150  \\$aBedbugs
=450  \\$wnnna$aBed Bug
=450  \\$wnnna$aBed Bugs
=450  \\$wnnna$aBedbug
=450  \\$wnnna$aBug, Bed
=450  \\$wnnna$aBugs, Bed
=450  \\$aCimex
=450  \\$wnnna$aCimices
=550  \\$wg$aCimicidae
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iBugs of the family CIMICIDAE, genus Cimex. They are flattened, oval, reddish insects which inhabit houses, wallpaper, furniture, and beds. C. lectularius, of temperate regions, is the common bedbug that attacks humans and is frequently a serious pest in houses, hotels, barracks, and other living quarters. Experiments have shown that bedbugs can transmit a variety of diseases, but they are not normal vectors under natural conditions. (From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed, p272)
=750  \0$aBedbugs$5IEN-M$0(DLC)sh 85012767

=LDR  00704cz  a2200253n  4500
=001  9880363205402441
=005  20141212195143.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001510
=035  \\$aCAZ4667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x75
=150  \\$aBed Rest
=450  \\$wnnna$aBed Rests
=450  \\$wnnna$aBedrest
=450  \\$wnnna$aBedrests
=450  \\$wnnna$aRest, Bed
=450  \\$wnnna$aRests, Bed
=550  \\$wg$aTherapeutics
=550  \\$aRest
=667  \\$ado not confuse with IMMOBILIZATION: TN 166
=680  \\$iConfinement of an individual to bed for therapeutic or experimental reasons.
=688  \\$a77
=750  \0$aBed rest$5IEN$0(DLC)sh 85012763

=LDR  00906cz  a2200265n  4500
=001  9880363205502441
=005  20141212195142.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001508
=035  \\$aCAZ4665HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x250.$x80
=150  \\$aBed Conversion
=450  \\$wnnna$aBed Conversions
=450  \\$wnnna$aBed, Swing
=450  \\$aBeds, Swing
=450  \\$wnnna$aConversion, Bed
=450  \\$wnnna$aConversions, Bed
=450  \\$wnnna$aSwing Bed
=450  \\$aSwing Beds
=550  \\$wg$aHealth Facility Planning
=667  \\$afrom one type of care service to another
=680  \\$iThe reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds.
=688  \\$a91(82); was see under HEALTH FACILITY PLANNING 1982-90
=750  \0$aHospital swing beds$5IEN-M$0(DLC)sh 87003885

=LDR  03681cz  a2200973n  4500
=001  9880363205602441
=005  20141212195142.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001507
=035  \\$aCAZ4664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x769.$x125
=072  \\$aD4.$x808.$x883.$x154
=150  \\$aBeclomethasone
=450  \\$wnnna$a3M Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aA & H Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aAerobec
=450  \\$wnnna$aAeroBec Forte
=450  \\$wnnna$aAldecin
=450  \\$wnnna$aAldo Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aAllen & Hanburys Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aApo-Beclomethasone
=450  \\$wnnna$aApotex Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aAsche Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aAscocortonyl
=450  \\$wnnna$aAsmabec Clickhaler
=450  \\$wnnna$aAzupharma Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aBeclamet
=450  \\$wnnna$aBeclazone
=450  \\$wnnna$aBeclazone Easy Breathe
=450  \\$wnnna$aBeclo Asma
=450  \\$wnnna$aBeclo AZU
=450  \\$wnnna$aBeclocort
=450  \\$wnnna$aBecloforte
=450  \\$wnnna$aBeclomet
=450  \\$wnnna$aBeclometasone
=450  \\$aBeclomethasone Dipropionate
=450  \\$wnnna$aBeclorhinol
=450  \\$wnnna$aBecloturmant
=450  \\$wnnna$aBeclovent
=450  \\$wnnna$aBecodisk
=450  \\$wnnna$aBecodisks
=450  \\$wnnna$aBeconase
=450  \\$wnnna$aBeconase AQ
=450  \\$wnnna$aBecotide
=450  \\$wnnna$aBemedrex Easyhaler
=450  \\$wnnna$aBronchocort
=450  \\$wnnna$aCelltech Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aDipropionate, Beclomethasone
=450  \\$wnnna$aEcobec
=450  \\$wnnna$aFilair
=450  \\$wnnna$aFilair Forte
=450  \\$wnnna$aFujisawa Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aGlaxo Wellcome Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aGlaxoSmithKline Brand 1 of Beclomethasone Dipropionate
=450  \\$wnnna$aGlaxoSmithKline Brand 2 of Beclomethasone Dipropionate
=450  \\$wnnna$aGlaxoSmithKline Brand 3 of Beclomethasone Dipropionate
=450  \\$wnnna$aIvax Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aJunik
=450  \\$wnnna$aMedeva Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aNasobec Aqueous
=450  \\$wnnna$aNorton Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aOrion Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aProlair
=450  \\$wnnna$aPropaderm
=450  \\$wnnna$aQvar
=450  \\$wnnna$aRespocort
=450  \\$wnnna$aSanasthmax
=450  \\$wnnna$aSanasthmyl
=450  \\$wnnna$aSchering Brand 1 of Beclomethasone Dipropionate
=450  \\$wnnna$aSchering Brand 2 of Beclomethasone Dipropionate
=450  \\$wnnna$aSchering-Plough Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aShire Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aUnited Drug Brand of Beclomethasone Dipropionate
=450  \\$wnnna$aVancenase
=450  \\$wnnna$aVanceril
=450  \\$wnnna$aVentolair
=450  \\$wnnna$aViarin
=550  \\$wg$aPregnadienetriols
=550  \\$wg$aSteroids, Chlorinated
=680  \\$iAn anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.
=688  \\$a1977(1973)
=688  \\$a77(73); was see under METHYLPREDNISOLONE 1975-76
=750  \0$aBeclomethasone dipropionate$5IEN$0(DLC)sh 85012757

=LDR  00518cz  a2200193n  4500
=001  9880363205702441
=005  20141212195140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001505
=035  \\$aCAZ4662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x112
=150  \\$aBeauty Culture
=450  \\$wnnna$aBeauty Cultures
=450  \\$wnnna$aCulture, Beauty
=450  \\$wnnna$aCultures, Beauty
=550  \\$wg$aIndustry
=667  \\$aSPEC: SPEC qualif
=750  \0$aBeauty culture$5IEN$0(DLC)sh 85012726

=LDR  00622cz  a2200193n  4500
=001  9880363205802441
=005  20141212195140.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001504
=035  \\$aCAZ4661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x477.$x304
=072  \\$aK1.$x752.$x210.$x304
=150  \\$aBeauty
=550  \\$wg$aEsthetics
=667  \\$ano qualif
=680  \\$iCharacteristics or attributes of persons or things which elicit pleasurable feelings.
=688  \\$a91(75)63; was see under ESTHETICS 1967-90; was heading 1963-66
=750  \0$aBeauty, Personal$5IEN-M$0(DLC)sh 85012720

=LDR  01672cz  a2200529n  4500
=001  9880363205902441
=005  20190726103221.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001503
=035  \\$aCAZ4660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x750.$x250.$x761
=150  \\$aUrsidae
=450  \\$aAiluropoda
=450  \\$wnnna$aBear
=450  \\$wnnna$aBear, Black
=450  \\$wnnna$aBear, Grizzly
=450  \\$wnnna$aBear, Polar
=450  \\$wnnna$aBear, Spectacled
=450  \\$aBears
=450  \\$wnnna$aBears, Black
=450  \\$wnnna$aBears, Grizzly
=450  \\$wnnna$aBears, Polar
=450  \\$wnnna$aBears, Spectacled
=450  \\$wnnna$aBlack Bear
=450  \\$aBlack Bears
=450  \\$wnnna$aGiant Panda
=450  \\$aGiant Pandas
=450  \\$wnnna$aGreater Panda
=450  \\$wnnna$aGreater Pandas
=450  \\$wnnna$aGrizzly Bear
=450  \\$aGrizzly Bears
=450  \\$wnnna$aPanda, Giant
=450  \\$wnnna$aPanda, Greater
=450  \\$aPandas, Giant
=450  \\$aPandas, Greater
=450  \\$wnnna$aPolar Bear
=450  \\$aPolar Bears
=450  \\$aSpectacled Bear
=450  \\$wnnna$aSpectacled Bears
=450  \\$aTremarctos
=450  \\$aUrsus
=550  \\$wg$aCaniformia
=667  \\$anote X refs PANDAS, GIANT and PANDAS, GREATER: PANDAS, LESSER see PROCYONIDAE is also available
=680  \\$iThe family of carnivorous or omnivorous bears, having massive bodies, coarse heavy fur, relatively short limbs, and almost rudimentary tails.
=688  \\$a2005 (1975); for PANDAS, GREATER use CARNIVORA 1997
=750  \0$aBears$0(DLC) sh 85012691$5IEN

=LDR  00623cz  a2200205n  4500
=001  9880363206002441
=005  20180309103917.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001501
=035  \\$aCAZ4658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x180
=072  \\$aB3.$x660.$x125.$x50
=150  \\$aBdellovibrio
=150  \\$aBdellovibrio bacteriovorus
=550  \\$wg$aDeltaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=680  \\$iA genus of bacteria capable of developing within other bacteria.
=688  \\$a77
=750  \0$aBdellovibrio$5IEN$0(DLC)sh 85012594

=LDR  01218cz  a2200265n  4500
=001  9880363206102441
=005  20141212195139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001500
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x825.$x100
=150  \\$aBCG Vaccine
=450  \\$aBacillus Calmette Guerin Vaccine
=450  \\$aCalmette Guerin Bacillus Vaccine
=450  \\$wnnna$aCalmette Vaccine
=450  \\$wnnna$aCalmette's Vaccine
=450  \\$wnnna$aCalmettes Vaccine
=450  \\$wnnna$aVaccine, BCG
=450  \\$wnnna$aVaccine, Calmette's
=550  \\$wg$aTuberculosis Vaccines
=667  \\$aBCG vaccination in prev of tuberc = BCG VACCINE (IM) + TUBERCULOSIS /prev (IM); BCG ther of various diseases = BCG VACCINE /ther use (IM) + dis /drug ther (IM)
=680  \\$iAn active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
=688  \\$a1979 (1974)
=750  \0$aBCG vaccines$5IEN-M$0(DLC)sh 88000480
=750  \0$aBCG vaccination$5IEN-HS$0(DLC)sh 85012590

=LDR  01046cz  a2200289n  4500
=001  9880363206202441
=005  20141212192018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001497
=035  \\$aCAZ4654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x130
=072  \\$aF3.$x80.$x931.$x124
=150  \\$aBattered Child Syndrome
=450  \\$wnnna$aBattered Child Syndromes
=450  \\$wnnna$aChild Syndrome, Battered
=450  \\$wnnna$aChild Syndromes, Battered
=450  \\$wnnna$aNonaccidental Trauma in Children
=450  \\$wnnna$aSyndrome, Battered Child
=450  \\$wnnna$aSyndromes, Battered Child
=550  \\$wg$aStress Disorders, Traumatic
=550  \\$wg$aWounds and Injuries
=550  \\$aAdult Survivors of Child Abuse
=550  \\$aViolence
=680  \\$iA clinical condition resulting from repeated physical and psychological injuries inflicted on a child by the parents or caregivers.
=688  \\$a91(75); was see under CHILD ABUSE 1975-90
=750  \0$aBattered child syndrome$5IEN$0(DLC)sh 85012404

=LDR  01062cz  a2200193n  4500
=001  9880363206302441
=005  20141212195137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001494
=035  \\$aCAZ4651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x56.$x110
=072  \\$aE2.$x779.$x249.$x110
=150  \\$aBaths
=450  \\$wnnna$aBath
=550  \\$wg$aBalneology
=667  \\$afor personal hygiene or med treatment; at home or in hosp, often not plain water (see note on HYDROTHERAPY), usually with additives; do not confuse with BALNEOLOGY (see note there); general only or unspecified; prefer specifics; note MUD BATHS see MUD THERAPY & SAND BATHS see AMMOTHERAPY; bathing in seawater is probably CLIMATOTHERAPY
=680  \\$iThe immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc.
=750  \0$aBaths$5IEN-HS$0(DLC)sh 85012337

=LDR  00539cz  a2200169n  4500
=001  9880363206402441
=005  20170830172518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001493
=035  \\$aCAZ4650HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x860.$x410.$x110
=150  \\$aBathing Beaches
=450  \\$wnnna$aBeaches, Bathing
=550  \\$wg$aSports and Recreational Facilities
=680  \\$iBeaches, both natural and man-made, used for bathing and other activities.
=750  \0$aBathing beaches$5IEN$0(DLC)sh 85012326

=LDR  01013cz  a2200337n  4500
=001  9880363206502441
=005  20141212195137.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001492
=035  \\$aCAZ4649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x105
=150  \\$aBass
=450  \\$wnnna$aBass, Sea
=450  \\$wnnna$aBasses, Sea
=450  \\$wnnna$aBasses, Temperate
=450  \\$aDicentrarchus
=450  \\$aMicropterus
=450  \\$aMorone
=450  \\$wnnna$aMorone americana
=450  \\$aMoronidae
=450  \\$wnnna$aPerch, White
=450  \\$wnnna$aSea Bass
=450  \\$wnnna$aSea Basses
=450  \\$aSerranidae
=450  \\$wnnna$aTemperate Basses
=450  \\$wnnna$aWhite Perch
=550  \\$wg$aPerciformes
=680  \\$iCommon name for FISHES belonging to the order Perciformes and occurring in three different families.
=688  \\$a91(87); was see under PERCIFORMES 1987-90
=750  \0$aBasses (Fish)$5IEN-HS$0(DLC)sh 85012149

=LDR  00843cz  a2200217n  4500
=001  9880363206602441
=005  20141212195136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001491
=035  \\$aCAZ4648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x415.$x120
=072  \\$aA11.$x627.$x340.$x120
=072  \\$aA15.$x145.$x229.$x637.$x415.$x120
=072  \\$aA15.$x382.$x490.$x315.$x120
=150  \\$aBasophils
=450  \\$wnnna$aBasophil
=550  \\$wg$aGranulocytes
=667  \\$arestrict to leukocytes: not for "basophilic" when referring only to staining ( = STAINING)
=680  \\$iGranular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.
=750  \0$aBasophils$5IEN$0(DLC)sh 85012133

=LDR  00655cz  a2200193n  4500
=001  9880363206702441
=005  20141212195136.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001490
=035  \\$aCAZ4647HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x117
=150  \\$aBasketball
=450  \\$wnnna$aBasketballs
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA competitive team sport played on a rectangular court having a raised basket at each end.
=688  \\$a90(87); was see under SPORTS 1987-89
=750  \0$aBasketball$5IEN$0(DLC)sh 85012111

=LDR  01072cz  a2200229n  4500
=001  9880363206802441
=005  20141212195136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001489
=035  \\$aCAZ4646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x246.$x125
=072  \\$aA10.$x615.$x179.$x124
=150  \\$aBasilar Membrane
=450  \\$wnnna$aBasilar Membranes
=450  \\$wnnna$aMembrane, Basilar
=450  \\$wnnna$aMembranes, Basilar
=550  \\$wg$aBasement Membrane
=550  \\$wg$aCochlea
=680  \\$iA basement membrane in the cochlea that supports the hair cells of the ORGAN OF CORTI, consisting keratin-like fibrils. It stretches from the SPIRAL LAMINA to the basilar crest. The movement of fluid in the cochlea, induced by sound, causes displacement of the basilar membrane and subsequent stimulation of the attached hair cells which transform the mechanical signal into neural activity.
=688  \\$a91(75); was see under COCHLEA 1990; was see under LABYRINTH 1960-89
=750  \0$aBasilar membrane$5IEN$0(DLC)sh 85012090

=LDR  00939cz  a2200253n  4500
=001  9880363206902441
=005  20170914130948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001487
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179
=150  \\$aBasidiomycota
=450  \\$wnnna$aBasidiomycete
=450  \\$aBasidiomycetes
=450  \\$wnnna$aBasidiomycotas
=550  \\$wg$aFungi
=550  \\$wh$aAgaricales
=550  \\$wh$aPhakopsora pachyrhizi
=550  \\$wh$aPolyporales
=550  \\$wh$aUstilaginales
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA phylum of fungi that produce their sexual spores (basidiospores) on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird's-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi.
=688  \\$a99
=750  \0$aBasidiomycetes$5IEN-M$0(DLC)sh 85012088

=LDR  01719cz  a2200385n  4500
=001  9880363207002441
=005  20141212195135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001485
=035  \\$aCAZ4642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x272.$x220
=072  \\$aA10.$x615.$x179
=150  \\$aBasement Membrane
=450  \\$aBasal Lamina
=450  \\$wnnna$aBasal Laminas
=450  \\$aBasement Lamina
=450  \\$wnnna$aBasement Laminas
=450  \\$wnnna$aBasement Membranes
=450  \\$wnnna$aLamina, Basal
=450  \\$wnnna$aLamina, Basement
=450  \\$wnnna$aLaminas, Basal
=450  \\$wnnna$aLaminas, Basement
=450  \\$wnnna$aMembrane, Basement
=450  \\$wnnna$aMembranes, Basement
=550  \\$wg$aEpithelium
=550  \\$wg$aMembranes
=550  \\$wh$aBasilar Membrane
=550  \\$wh$aBruch Membrane
=550  \\$wh$aDescemet Membrane
=550  \\$wh$aGlomerular Basement Membrane
=667  \\$ado not confuse X ref BASAL LAMINA with "lamina basalis", the basal plate of the embryonic neural tube
=680  \\$iA darkly stained mat-like EXTRACELLULAR MATRIX (ECM) that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane (BM) can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.
=688  \\$a67(65)
=750  \0$aMembrane, Basement$5IEN$0(DLC)sh 85083467

=LDR  00672cz  a2200217n  4500
=001  9880363207102441
=005  20141212195134.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001484
=035  \\$aCAZ4641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x110
=150  \\$aBaseball
=450  \\$wnnna$aBaseballs
=450  \\$aSoftball
=450  \\$wnnna$aSoftballs
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA competitive nine-member team sport including softball.
=688  \\$a90(77); was see under SPORTS 1977-89
=750  \0$aBaseball$5IEN$0(DLC)sh 85012026

=LDR  01894cz  a2200493n  4500
=001  9880363207202441
=005  20141212195134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80
=072  \\$aG5.$x360.$x80
=072  \\$aL1.$x453.$x245.$x667.$x80
=150  \\$aBase Sequence
=450  \\$wnnna$aBase Sequences
=450  \\$aDNA Sequence
=450  \\$wnnna$aDNA Sequences
=450  \\$aNucleotide Sequence
=450  \\$wnnna$aNucleotide Sequences
=450  \\$aRNA Sequence
=450  \\$wnnna$aRNA Sequences
=450  \\$wnnna$aSequence, Base
=450  \\$wnnna$aSequence, DNA
=450  \\$wnnna$aSequence, Nucleotide
=450  \\$wnnna$aSequence, RNA
=450  \\$wnnna$aSequences, Base
=450  \\$wnnna$aSequences, DNA
=450  \\$wnnna$aSequences, Nucleotide
=450  \\$wnnna$aSequences, RNA
=550  \\$wg$aGenetic Structures
=550  \\$wg$aMolecular Sequence Data
=550  \\$wg$aMolecular Structure
=550  \\$wh$aAT Rich Sequence
=550  \\$wh$aGC Rich Sequence
=550  \\$wh$aMatrix Attachment Regions
=550  \\$wh$aNucleotide Motifs
=550  \\$wh$aRegulatory Sequences, Nucleic Acid
=550  \\$wh$aRepetitive Sequences, Nucleic Acid
=550  \\$aGenes
=550  \\$aNucleotides
=667  \\$aIM general only; coord with specific nucleic acid; do not confuse with BASE COMPOSITION: comp = what components & how many, sequ = order in which arranged; for base sequencing, use SEQUENCE ANALYSIS, DNA or SEQUENCE ANALYSIS, RNA; when to index with MOLECULAR SEQUENCE DATA: see note there; DF: BASE SEQ
=680  \\$iThe sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
=688  \\$a78(71); was see under BIOCHEMISTRY 1975-77
=750  \0$aNucleotide sequence$5IEN$0(DLC)sh 85093159

=LDR  01255cz  a2200289n  4500
=001  9880363207302441
=005  20141212195133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001481
=035  \\$aCAZ4638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x374.$x750.$x100
=072  \\$aG3.$x495.$x335.$x154
=150  \\$aBasal Metabolism
=450  \\$wnnna$aBasal Metabolic Rate
=450  \\$wnnna$aBasal Metabolic Rates
=450  \\$wnnna$aMetabolic Rate, Basal
=450  \\$wnnna$aMetabolic Rates, Basal
=450  \\$aMetabolism, Basal
=450  \\$wnnna$aRate, Basal Metabolic
=450  \\$wnnna$aRates, Basal Metabolic
=550  \\$wg$aEnergy Metabolism
=550  \\$wg$aThyroid Function Tests
=550  \\$aSecondary Metabolism
=667  \\$aresting state only; energy expenditure, energy cost = ENERGY METABOLISM
=680  \\$iHeat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilized.
=750  \0$aBasal metabolism$5IEN$0(DLC)sh 85012016

=LDR  01935cz  a2200493n  4500
=001  9880363207402441
=005  20141212195130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001474
=035  \\$aCAZ4631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x126.$x100
=150  \\$aBartonella Infections
=450  \\$wnnna$aBartonella Infection
=450  \\$wnnna$aBartonelloses
=450  \\$aBartonellosis
=450  \\$wnnna$aCarrion Disease
=450  \\$aCarrion's Disease
=450  \\$wnnna$aCarrions Disease
=450  \\$wnnna$aCat Scratch Fever
=450  \\$wnnna$aCat Scratch Fevers
=450  \\$wnnna$aDisease, Carrion
=450  \\$wnnna$aDisease, Carrion's
=450  \\$wnnna$aFever, Cat Scratch
=450  \\$wnnna$aFever, Oroya
=450  \\$wnnna$aFevers, Cat Scratch
=450  \\$wnnna$aInfection, Bartonella
=450  \\$wnnna$aInfection, Rochalimaea
=450  \\$wnnna$aInfections, Bartonella
=450  \\$wnnna$aInfections, Rochalimaea
=450  \\$aOroya Fever
=450  \\$wnnna$aRochalimaea Infection
=450  \\$aRochalimaea Infections
=450  \\$wnnna$aScratch Fever, Cat
=450  \\$wnnna$aScratch Fevers, Cat
=450  \\$aVerruga Peruana
=550  \\$wg$aBartonellaceae Infections
=550  \\$wh$aAngiomatosis, Bacillary
=550  \\$wh$aCat-Scratch Disease
=550  \\$wh$aTrench Fever
=667  \\$agram-neg bact infect
=680  \\$iInfections by the genus BARTONELLA. Bartonella bacilliformis can cause acute febrile anemia, designated Oroya fever, and a benign skin eruption, called verruga peruana. BARTONELLA QUINTANA causes TRENCH FEVER, while BARTONELLA HENSELAE is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY) and is also one of the causes of CAT-SCRATCH DISEASE in immunocompetent patients.
=688  \\$aROCHALIMAEA INFECTIONS was heading 1995
=750  \0$aBartonella infections$5IEN-M$0(DLC)sh 98002720

=LDR  01138cz  a2200241n  4500
=001  9880363207502441
=005  20141212195130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001473
=035  \\$aCAZ4630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x90.$x100
=072  \\$aB3.$x660.$x50.$x30.$x40
=150  \\$aBartonella
=450  \\$aRochalimaea
=550  \\$wg$aBartonellaceae
=550  \\$wh$aBartonella bacilliformis
=550  \\$wh$aBartonella henselae
=550  \\$wh$aBartonella quintana
=667  \\$ainfection = BARTONELLA INFECTIONS
=680  \\$iA genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. The genus Rochalimaea, once considered a separate genus, has recently been combined with the genus Bartonella as a result of high levels of relatedness in 16S rRNA sequence data and DNA hybridization data.
=688  \\$aROCHALIMAEA was heading 1995
=750  \0$aBartonella$5IEN$0(DLC)sh 88023216

=LDR  01810cz  a2200409n  4500
=001  9880363207602441
=005  20141212195132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001480
=035  \\$aCAZ4637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79
=150  \\$aBasal Ganglia Diseases
=450  \\$wnnna$aBasal Ganglia Disease
=450  \\$wnnna$aBasal Ganglia Disorder
=450  \\$wnnna$aBasal Ganglia Disorders
=450  \\$wnnna$aExtrapyramidal Disorder
=450  \\$aExtrapyramidal Disorders
=450  \\$wnnna$aLenticulostriate Disorder
=450  \\$wnnna$aLenticulostriate Disorders
=550  \\$wg$aBrain Diseases
=550  \\$wh$aBasal Ganglia Cerebrovascular Disease
=550  \\$wh$aChorea Gravidarum
=550  \\$wh$aDystonia Musculorum Deformans
=550  \\$wh$aHepatolenticular Degeneration
=550  \\$wh$aHuntington Disease
=550  \\$wh$aMeige Syndrome
=550  \\$wh$aMultiple System Atrophy
=550  \\$wh$aNeuroleptic Malignant Syndrome
=550  \\$wh$aPantothenate Kinase-Associated Neurodegeneration
=550  \\$wh$aParkinsonian Disorders
=550  \\$wh$aSupranuclear Palsy, Progressive
=550  \\$wh$aTourette Syndrome
=667  \\$aGEN: prefer specifics; coord IM with specific site (IM)
=680  \\$iDiseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
=688  \\$a79; was EXTRAPYRAMIDAL DISORDERS 1972-78 (Prov 1972-73)
=750  \0$aBasal ganglia$xDiseases$5IEN-HS$0(DLC)sh 95003155

=LDR  00688cz  a2200217n  4500
=001  9880363207702441
=005  20141212195129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001472
=035  \\$aCAZ4629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x887.$x220
=072  \\$aA10.$x336.$x95
=150  \\$aBartholin's Glands
=450  \\$wnnna$aBartholin Glands
=450  \\$wnnna$aBartholins Glands
=450  \\$wnnna$aGlands, Bartholin's
=550  \\$wg$aExocrine Glands
=550  \\$wg$aVulva
=680  \\$iMucus-secreting glands situated on the posterior and lateral aspect of the vestibule of the vagina.
=750  \0$aBartholin's gland$5IEN$0(DLC)sh 85011986

=LDR  00997cz  a2200277n  4500
=001  9880363207802441
=005  20141212192018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001479
=035  \\$aCAZ4636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249
=150  \\$aBasal Ganglia
=450  \\$aBasal Nuclei
=450  \\$aClaustrum
=450  \\$aGanglia, Basal
=450  \\$wnnna$aGanglion, Basal
=450  \\$wnnna$aNuclei, Basal
=550  \\$wg$aCerebrum
=550  \\$wh$aAmygdala
=550  \\$wh$aCorpus Striatum
=550  \\$wh$aSubstantia Innominata
=550  \\$wh$aClaustrum
=667  \\$adis = BASAL GANGLIA DISEASES; do not confuse X ref VENTRAL STRIATUM with CORPUS STRIATUM
=680  \\$iLarge subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.
=688  \\$a82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78
=750  \0$aBasal ganglia$5IEN$0(DLC)sh 85012014

=LDR  01524cz  a2200349n  4500
=001  9880363207902441
=005  20141212195129.0
=008  800404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001471
=035  \\$aCAZ4628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x198.$x102
=072  \\$aC6.$x405.$x117.$x102
=150  \\$aBarrett Esophagus
=450  \\$wnnna$aBarrett Epithelium
=450  \\$wnnna$aBarrett Metaplasia
=450  \\$aBarrett Syndrome
=450  \\$wnnna$aBarrett's Esophagus
=450  \\$wnnna$aBarretts Esophagus
=450  \\$wnnna$aBarrett's Syndrome
=450  \\$wnnna$aBarretts Syndrome
=450  \\$wnnna$aEpithelium, Barrett
=450  \\$aEsophagus, Barrett
=450  \\$wnnna$aEsophagus, Barrett's
=450  \\$wnnna$aSyndrome, Barrett
=450  \\$wnnna$aSyndrome, Barrett's
=550  \\$wg$aDigestive System Abnormalities
=550  \\$wg$aEsophageal Diseases
=667  \\$anote category; do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.
=688  \\$a89(81); was see under ESOPHAGEAL DISEASES 1981-88
=750  \0$aBarrett's esophagus$0(DLC)sh2006020260$5IEN-M

=LDR  00867cz  a2200241n  4500
=001  9880363208002441
=005  20141212195128.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001469
=035  \\$aCAZ4626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x120
=150  \\$aBarotrauma
=450  \\$wnnna$aBarotraumas
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBlast Injuries
=550  \\$wh$aDecompression Sickness
=550  \\$aAtmospheric Pressure
=550  \\$aHigh Pressure Neurological Syndrome
=667  \\$ainj caused by pressure changes: not restricted to ear; IM; coord with organ injured by pressure with /inj; also available is BLAST INJURIES
=680  \\$iInjury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach.
=688  \\$a79
=750  \0$aBarotrauma, Aural$5IEN$0(DLC)sh 85011918

=LDR  02026cz  a2200457n  4500
=001  9880363208102441
=005  20141212195132.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001478
=035  \\$aCAZ4635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530.$x690.$x150
=072  \\$aC4.$x557.$x470.$x200.$x165.$x150
=072  \\$aC4.$x557.$x470.$x565.$x165.$x150
=072  \\$aC4.$x700.$x175
=072  \\$aC5.$x116.$x99.$x105
=072  \\$aC5.$x500.$x470.$x690.$x150
=072  \\$aC7.$x320.$x450.$x670.$x130
=072  \\$aC16.$x131.$x77.$x130
=072  \\$aC16.$x320.$x700.$x175
=150  \\$aBasal Cell Nevus Syndrome
=450  \\$wnnna$aFifth Phacomatoses
=450  \\$wnnna$aFifth Phacomatosis
=450  \\$wnnna$aGorlin-Goltz Syndrome
=450  \\$wnnna$aGorlin Goltz Syndrome
=450  \\$aGorlin Syndrome
=450  \\$wnnna$aMultiple Basal Cell Nevi, Odontogenic Keratocysts, and Skeletal Anomalies
=450  \\$wnnna$aNBCCS
=450  \\$aNevoid Basal Cell Carcinoma Syndrome
=450  \\$aNevus Syndrome, Basal Cell
=450  \\$wnnna$aSyndrome, Gorlin
=450  \\$wnnna$aSyndrome, Gorlin-Goltz
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aCarcinoma, Basal Cell
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wg$aOdontogenic Cysts
=667  \\$acoordinate IM with precoordinated organ/neoplasm (IM or NIM) only if pertinent; do not confuse entry term GORLIN-GOLTZ SYNDROME with GOLTZ- GORLIN SYNDROME see FOCAL DERMAL HYPOPLASIA
=680  \\$iHereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant.
=688  \\$a91(80); was see under CARCINOMA, BASAL CELL 1980-90
=750  \0$aBasal cell nevus syndrome$5IEN$0(DLC)sh 85012013

=LDR  00917cz  a2200265n  4500
=001  9880363208202441
=005  20141212195128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001468
=035  \\$aCAZ4625HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x880
=150  \\$aThoracica
=450  \\$aBalanus
=450  \\$wnnna$aBarnacle
=450  \\$aBarnacles
=450  \\$aPedunculata
=450  \\$wnnna$aPedunculatas
=450  \\$aSessilia
=450  \\$wnnna$aSessilias
=450  \\$wnnna$aThoracicas
=550  \\$wg$aCrustacea
=680  \\$iA superorder of marine CRUSTACEA, free swimming in the larval state, but permanently fixed as adults. There are some 800 described species, grouped in several genera, and comprising of two major orders of barnacles: stalked (Pedunculata) and sessile (Sessilia).
=688  \\$a2003 (1972)
=750  \0$aBarnacles$5IEN$0(DLC)sh 85011893

=LDR  00683cz  a2200205n  4500
=001  9880363208302441
=005  20141212195130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001475
=035  \\$aCAZ4632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x90
=072  \\$aB3.$x660.$x50.$x30
=150  \\$aBartonellaceae
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aBartonella
=680  \\$iA family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases.
=688  \\$a75
=750  \0$aBartonellaceae$5IEN$0(DLC)sh 88023217

=LDR  00757cz  a2200217n  4500
=001  9880363208402441
=005  20160516154819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001467
=035  \\$aCAZ4624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x481
=150  \\$aHordeum
=450  \\$aBarley
=450  \\$wnnna$aHordeum vulgare
=550  \\$wg$aPoaceae
=667  \\$amalted barley = HORDEUM + SEEDLINGS
=680  \\$iA plant genus of the family POACEAE. The EDIBLE GRAIN, barley, is widely used as food.
=688  \\$a2003(1963); for MALTED BARLEY use MALT see CEREALS 1985-2011
=688  \\$a2003; use BARLEY 1991-2002. CEREALS 1985-1990, GAIN 1963-1984
=750  \0$aHordeum$5IEN-M$0(DLC)sh 85061964

=LDR  01109cz  a2200313n  4500
=001  9880363208502441
=005  20141212195128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001466
=035  \\$aCAZ4623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x103.$x75
=072  \\$aD1.$x875.$x800.$x800.$x850.$x75
=150  \\$aBarium Sulfate
=450  \\$wnnna$aBarite
=450  \\$wnnna$aBaritop
=450  \\$wnnna$aBarium Sulfate (2:1)
=450  \\$aBarium Sulphate$5IEN
=450  \\$wnnna$aE-Z-CAT
=450  \\$wnnna$aE Z CAT
=450  \\$wnnna$aEZCAT
=450  \\$wnnna$aMicropaque Oral
=450  \\$wnnna$aSulfate, Barium
=550  \\$wg$aBarium Compounds
=550  \\$wg$aSulfates
=667  \\$aD25-26 qualif; for enema use BARIUM SULFATE /diag use, not BARIUM
=680  \\$iA compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
=750  \0$aBarium sulfate$5IEN-M$0(DLC)sh 85011860
=750  \0$aBarite$5IEN-HS$0(DLC)sh 85011844

=LDR  00764cz  a2200205n  4500
=001  9880363208602441
=005  20141212195127.0
=008  870331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001465
=035  \\$aCAZ4622HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x75
=150  \\$aBarium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Barium
=550  \\$wg$aRadioisotopes
=550  \\$aBarium
=667  \\$aBa-126-129, 131, 133, 139-143; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of barium that decay or disintegrate emitting radiation. Ba atoms with atomic weights 126-129, 131, 133, and 139-143 are radioactive barium isotopes.
=688  \\$a88
=750  \0$aBarium$xIsotopes$5IEN-M

=LDR  00905cz  a2200217n  4500
=001  9880363208702441
=005  20141212195127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001464
=035  \\$aCAZ4621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x552.$x50
=072  \\$aD1.$x268.$x556.$x62
=072  \\$aD1.$x552.$x539.$x124
=072  \\$aD1.$x552.$x544.$x62
=150  \\$aBarium
=550  \\$wg$aMetals, Alkaline Earth
=550  \\$wg$aMetals, Heavy
=667  \\$aan alkaline earth metal; Ba-138; Ba-130, 132, 134-137 = BARIUM (IM) + ISOTOPES (NIM); Ba-126-129, 131, 133, 139-143 = BARIUM RADIOISOTOPES (IM); barium enema = BARIUM SULFATE /diag use + ENEMA
=680  \\$iAn element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.
=750  \0$aBarium$5IEN-M$0(DLC)sh 85011853

=LDR  01018cz  a2200301n  4500
=001  9880363208802441
=005  20141212195127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001463
=035  \\$aCAZ4620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x253
=150  \\$aBarbiturates
=550  \\$wg$aPyrimidinones
=550  \\$wh$aAmobarbital
=550  \\$wh$aBarbital
=550  \\$wh$aHexobarbital
=550  \\$wh$aMephobarbital
=550  \\$wh$aMethohexital
=550  \\$wh$aMurexide
=550  \\$wh$aPentobarbital
=550  \\$wh$aPhenobarbital
=550  \\$wh$aSecobarbital
=550  \\$wh$aThiobarbiturates
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.
=688  \\$a/adv eff-pois-tox was BARBITURATE TOXICOLOGY 1963-65
=750  \0$aBarbiturates$5IEN$0(DLC)sh 85011804

=LDR  00687cz  a2200193n  4500
=001  9880363208902441
=005  20141212195126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001461
=035  \\$aCAZ4618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x82
=150  \\$aBarbering
=450  \\$wnnna$aBarberings
=550  \\$wg$aIndustry
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe occupation concerned with the cutting and dressing of the hair of customers and, of men, the shaving and trimming of the beard and mustache. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aBarbering$5IEN-M$0(DLC)sh 85011794
=750  \0$aBarbers$5IEN-HS$0(DLC)sh 85011797

=LDR  00879cz  a2200277n  4500
=001  9880363209002441
=005  20141212195125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001458
=035  \\$aCAZ4615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x101
=150  \\$aBandages
=450  \\$wnnna$aBandage
=450  \\$wnnna$aDressing
=450  \\$aDressings
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aAthletic Tape
=550  \\$wh$aBandages, Hydrocolloid
=550  \\$wh$aBiological Dressings
=550  \\$wh$aCompression Bandages
=550  \\$wh$aOcclusive Dressings
=667  \\$aspray-on bandages = OCCLUSIVE DRESSINGS
=680  \\$iMaterial used for wrapping or binding any part of the body.
=688  \\$aELASTIC STOCKINGS & STOCKINGS, COMPRESSION were see CLOTHING 1982-89
=750  \0$aBandages and bandaging$5IEN-M$0(DLC)sh 85011479

=LDR  00571cz  a2200169n  4500
=001  9880363209102441
=005  20141212195123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x840.$x219
=072  \\$aD20.$x215.$x721.$x500.$x219
=150  \\$aBalsams
=550  \\$wg$aResins, Plant
=667  \\$aD25-26 qualif
=680  \\$iResinous substances which most commonly originate from trees. In addition to resins, they contain oils, cinnamic acid and BENZOIC ACID.
=750  \0$aBalsams$5IEN$0(DLC)sh 85011351

=LDR  01016cz  a2200253n  4500
=001  9880363209202441
=005  20141212195123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001452
=035  \\$aCAZ4608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x56
=072  \\$aE2.$x779.$x249
=150  \\$aBalneology
=450  \\$aBalneotherapy
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aTherapeutics
=550  \\$wh$aAmmotherapy
=550  \\$wh$aBaths
=550  \\$wh$aMud Therapy
=550  \\$wh$aSteam Bath
=667  \\$abalneotherapy goes here or under specifics; differentiate from HYDROTHERAPY where emphasis is on plain water (not natural mineral water; see note there); coordinate with MINERAL WATERS as appropriate
=680  \\$iTherapy by various hot or warm baths in natural mineral waters, spas, or "cures". It includes not only bathing in, but also drinking the waters, but it does not include whirlpool baths (HYDROTHERAPY).
=750  \0$aBalneology$5IEN$0(DLC)sh 85011345

=LDR  01075cz  a2200193n  4500
=001  9880363209302441
=005  20141212195123.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001450
=035  \\$aCAZ4606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x100
=150  \\$aBallistocardiography
=450  \\$wnnna$aBallistocardiographies
=550  \\$wg$aHeart Function Tests
=550  \\$aHeart
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: BALLISTOCARDIOGR
=680  \\$iTechnique of graphic representation of the movements of the body imparted by the ballistic forces (recoil and impact) associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device (transducer) into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine.
=750  \0$aBallistocardiography$5IEN$0(DLC)sh 85011316

=LDR  01254cz  a2200265n  4500
=001  9880363209402441
=005  20141212195123.0
=008  810223\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001449
=035  \\$aCAZ4605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570.$x643.$x150
=072  \\$aC13.$x351.$x968.$x419.$x570.$x643.$x150
=150  \\$aBalkan Nephropathy
=450  \\$wnnna$aBalkan Endemic Nephropathy
=450  \\$wnnna$aDanubian Endemic Familial Nephropathy
=450  \\$aEndemic Nephropathy, Balkan
=450  \\$aNephropathy, Balkan
=450  \\$wnnna$aNephropathy, Balkan Endemic
=550  \\$wg$aNephritis, Interstitial
=667  \\$ado not specify geography unless particularly discussed
=680  \\$iA form of chronic interstitial nephritis that is endemic to limited areas of BULGARIA, the former YUGOSLAVIA, and ROMANIA. It is characterized by a progressive shrinking of the KIDNEYS that is often associated with uroepithelial tumors.
=688  \\$a1991(1982); use NEPHRITIS, INTERSTITIAL 1982-90; for Danubian Endemic Familial Nephropathy use Hemorrhagic Fever with Renal Syndrome 2012
=688  \\$a91(82); was see under NEPHRITIS, INTERSTITIAL 1982-90
=750  \0$aBalkan nephropathy$5IEN$0(DLC)sh 87007105

=LDR  00813cz  a2200181n  4500
=001  9880363209502441
=005  20141212195122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001448
=035  \\$aCAZ4604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x375.$x650.$x650.$x153
=150  \\$aBalantidium
=450  \\$wnnna$aBalantidiums
=550  \\$wg$aTrichostomatina
=667  \\$ainfection = BALANTIDIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body.
=750  \0$aBalantidium$5IEN$0(DLC)sh 88021288

=LDR  00868cz  a2200193n  4500
=001  9880363209602441
=005  20141212195120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001439
=035  \\$aCAZ4595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x94.$x152
=072  \\$aB3.$x440.$x425.$x410.$x194.$x152
=150  \\$aBacteroides
=550  \\$wg$aBacteroidaceae
=550  \\$wh$aBacteroides fragilis
=667  \\$ainfection = BACTEROIDES INFECTIONS; BACTEROIDES CORRODENS see EIKENELLA CORRODENS and BACTEROIDES NODOSUS see DICHELOBACTER NODOSUS are also available
=680  \\$iA genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.
=750  \0$aBacteroides$5IEN$0(DLC)sh 85010882

=LDR  00785cz  a2200229n  4500
=001  9880363209702441
=005  20141212195120.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001438
=035  \\$aCAZ4594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x94
=072  \\$aB3.$x440.$x425.$x410.$x194
=150  \\$aBacteroidaceae
=550  \\$wg$aBacteroidetes
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$wh$aBacteroides
=550  \\$wh$aPorphyromonas
=550  \\$wh$aPrevotella
=680  \\$iA family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.
=688  \\$a75
=750  \0$aBacteroidaceae$5IEN$0(DLC)sh 85010881

=LDR  01048cz  a2200265n  4500
=001  9880363209802441
=005  20141212195119.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001436
=035  \\$aCAZ4592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x90.$x200
=072  \\$aD12.$x776.$x157.$x530.$x450.$x250.$x875.$x249
=072  \\$aD12.$x776.$x543.$x585.$x450.$x250.$x875.$x249
=072  \\$aD12.$x776.$x752.$x812.$x249
=150  \\$aBacteriorhodopsins
=450  \\$wnnna$aBacteriorhodopsin
=550  \\$wg$aArchaeal Proteins
=550  \\$wg$aProton Pumps
=550  \\$wg$aRhodopsins, Microbial
=550  \\$aPurple Membrane
=667  \\$ado not confuse with BACTERIAL RHODOPSINS see RHODOPSINS, MICROBIAL
=680  \\$iRhodopsins found in the PURPLE MEMBRANE of halophilic archaea such as HALOBACTERIUM HALOBIUM. Bacteriorhodopsins function as an energy transducers, converting light energy into electrochemical energy via PROTON PUMPS.
=688  \\$a2002(1976)
=750  \0$aBacteriorhodopsin$5IEN$0(DLC)sh 85010880

=LDR  01368cz  a2200421n  4500
=001  9880363209902441
=005  20141212195119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001435
=035  \\$aCAZ4591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123
=150  \\$aBacteriophages
=450  \\$wnnna$aBacteriophage
=450  \\$wnnna$aPhage
=450  \\$aPhages
=550  \\$wg$aViruses
=550  \\$wh$aBacillus Phages
=550  \\$wh$aCaudovirales
=550  \\$wh$aColiphages
=550  \\$wh$aCorticoviridae
=550  \\$wh$aCystoviridae
=550  \\$wh$aInoviridae
=550  \\$wh$aLeviviridae
=550  \\$wh$aMicroviridae
=550  \\$wh$aMycobacteriophages
=550  \\$wh$aProphages
=550  \\$wh$aPseudomonas Phages
=550  \\$wh$aRNA Phages
=550  \\$wh$aSalmonella Phages
=550  \\$wh$aStaphylococcus Phages
=550  \\$wh$aStreptococcus Phages
=550  \\$wh$aTectiviridae
=550  \\$aGenetic Vectors
=667  \\$a= "bacterial virus"; GEN or unspecified: prefer specific available phages; for other phages, coord IM with specific bacterium /virol (NIM; IM only when identity of bacterium is particularly significant); policy: Manual 22.24.3
=680  \\$iViruses whose hosts are bacterial cells.
=688  \\$a75; was BACTERIOPHAGE 1963-74
=750  \0$aBacteriophages$5IEN$0(DLC)sh 85010874

=LDR  00779cz  a2200217n  4500
=001  9880363210002441
=005  20141212195119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001434
=035  \\$aCAZ4590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x150.$x125.$x150
=072  \\$aE5.$x200.$x875.$x150.$x125.$x150
=150  \\$aBacteriophage Typing
=450  \\$aPhage Typing
=450  \\$aTyping, Bacteriophage
=450  \\$wnnna$aTyping, Phage
=550  \\$wg$aBacterial Typing Techniques
=667  \\$apolicy: Manual 22.24.4
=680  \\$iA technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.
=750  \0$aBacteriophage typing$5IEN$0(DLC)sh 85010879

=LDR  00598cz  a2200181n  4500
=001  9880363210102441
=005  20170607113319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001433
=035  \\$aCAZ4589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x99.$x115
=150  \\$aBacteriolysis
=450  \\$wnnna$aBacteriolyses
=550  \\$wg$aBacterial Physiological Phenomena
=667  \\$acoord with specific bacterium
=680  \\$iRupture of bacterial cells due to mechanical force, chemical action, or the lytic growth of BACTERIOPHAGES.
=750  \0$aBacteriolysis$0(DLC) sh 85010873$5IEN

=LDR  00794cz  a2200193n  4500
=001  9880363210202441
=005  20141212195118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001432
=035  \\$aCAZ4588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x177
=150  \\$aBacteriology
=550  \\$wg$aMicrobiology
=550  \\$aInfectious Disease Medicine
=667  \\$athe discipline (education, history, etc) only; use BACTERIAL PHYSIOLOGICAL PHENOMENA or specifics treed under it for biological processes and properties of bacteria
=680  \\$iThe study of the structure, growth, function, genetics, and reproduction of bacteria, and BACTERIAL INFECTIONS.
=750  \0$aBacteriologists$5IEN-M$0(DLC)sh 85010863
=750  \0$aBacteriology$5IEN-HS$0(DLC)sh 85010864

=LDR  01414cz  a2200409n  4500
=001  9880363210302441
=005  20141212195118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001431
=035  \\$aCAZ4587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x150
=072  \\$aE5.$x200.$x875.$x150
=150  \\$aBacteriological Techniques
=450  \\$wnnna$aBacteriologic Technic
=450  \\$wnnna$aBacteriologic Technics
=450  \\$wnnna$aBacteriologic Technique
=450  \\$wnnna$aBacteriologic Techniques
=450  \\$wnnna$aBacteriological Technic
=450  \\$wnnna$aBacteriological Technics
=450  \\$wnnna$aBacteriological Technique
=450  \\$aBacteriology$xmethods
=450  \\$wnnna$aTechnic, Bacteriologic
=450  \\$wnnna$aTechnic, Bacteriological
=450  \\$wnnna$aTechnics, Bacteriologic
=450  \\$wnnna$aTechnics, Bacteriological
=450  \\$wnnna$aTechnique, Bacteriologic
=450  \\$wnnna$aTechnique, Bacteriological
=450  \\$wnnna$aTechniques, Bacteriologic
=450  \\$wnnna$aTechniques, Bacteriological
=550  \\$wg$aMicrobiological Techniques
=550  \\$wh$aBacterial Load
=550  \\$wh$aBacterial Typing Techniques
=550  \\$wh$aLimulus Test
=667  \\$aNIM; DF: BACTERIOL TECHNIQUES
=688  \\$a91; was BACTERIOLOGICAL TECHNICS 1963-90
=750  \0$aBacteriology$xTechnique$5IEN$0(DLC)sh 85010869

=LDR  00905cz  a2200265n  4500
=001  9880363210402441
=005  20181008102929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001430
=035  \\$aCAZ4586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97.$x151
=072  \\$aD12.$x776.$x543.$x695.$x110
=150  \\$aBacteriocins
=450  \\$wnnna$aLantibiotics
=550  \\$wg$aBacterial Proteins
=550  \\$wg$aPore Forming Cytotoxic Proteins
=550  \\$wh$aCloacin
=550  \\$wh$aMegacins
=550  \\$wh$aNisin
=550  \\$wh$aPediocins
=550  \\$wh$aPyocins
=680  \\$iSubstances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria.
=688  \\$a68(65)
=750  \0$aBacteriocins$5IEN$0(DLC)sh 85010861

=LDR  01640cz  a2200469n  4500
=001  9880363210502441
=005  20141212195117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001428
=035  \\$aCAZ4584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135
=150  \\$aBacterial Vaccines
=450  \\$wnnna$aBacterial Vaccine
=450  \\$wnnna$aBacterin
=450  \\$wnnna$aVaccine, Bacterial
=450  \\$wnnna$aVaccines, Bacterial
=550  \\$wg$aVaccines
=550  \\$wh$aAnthrax Vaccines
=550  \\$wh$aAutovaccines
=550  \\$wh$aBrucella Vaccine
=550  \\$wh$aCholera Vaccines
=550  \\$wh$aDiphtheria-Tetanus-acellular Pertussis Vaccines
=550  \\$wh$aDiphtheria-Tetanus-Pertussis Vaccine
=550  \\$wh$aDiphtheria-Tetanus Vaccine
=550  \\$wh$aEscherichia coli Vaccines
=550  \\$wh$aHaemophilus Vaccines
=550  \\$wh$aLyme Disease Vaccines
=550  \\$wh$aMeningococcal Vaccines
=550  \\$wh$aPertussis Vaccine
=550  \\$wh$aPlague Vaccine
=550  \\$wh$aPseudomonas Vaccines
=550  \\$wh$aRickettsial Vaccines
=550  \\$wh$aSalmonella Vaccines
=550  \\$wh$aShigella Vaccines
=550  \\$wh$aStaphylococcal Vaccines
=550  \\$wh$aStreptococcal Vaccines
=550  \\$wh$aTuberculosis Vaccines
=667  \\$afor specifics not indented here coord IM with specific bacterium /immunol (IM); DF: BACT VACCINES
=680  \\$iSuspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
=688  \\$a65
=750  \0$aBacterial vaccines$5IEN$0(DLC)sh 85010858

=LDR  01221cz  a2200313n  4500
=001  9880363210602441
=005  20141212195116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001427
=035  \\$aCAZ4582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x946.$x123
=150  \\$aBacterial Toxins
=450  \\$wnnna$aToxins, Bacterial
=550  \\$wg$aToxins, Biological
=550  \\$wh$aBotulinum Toxins
=550  \\$wh$aCholera Toxin
=550  \\$wh$aCord Factors
=550  \\$wh$aDiphtheria Toxin
=550  \\$wh$aEndotoxins
=550  \\$wh$aExfoliatins
=550  \\$wh$aShiga Toxins
=550  \\$wh$aStreptolysins
=550  \\$wh$aTetanus Toxin
=550  \\$wh$aVirulence Factors, Bordetella
=667  \\$aGEN or unspecified: prefer specifics; coord IM with specific bacterium (IM); /antag permitted but consider also ANTITOXINS; DF: BACT TOXINS
=680  \\$iToxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
=688  \\$a77; was NON MESH before 1977
=750  \0$aBacterial toxins$5IEN$0(DLC)sh 85010856

=LDR  02484cz  a2200685n  4500
=001  9880363210702441
=005  20190128124534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001426
=035  \\$aCAZ4581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x97
=150  \\$aBacterial Proteins
=450  \\$wnnna$aBacterial Gene Product
=450  \\$aBacterial Gene Products
=450  \\$wnnna$aBacterial Gene Protein
=450  \\$aBacterial Gene Proteins
=450  \\$wnnna$aBacterial Protein
=450  \\$wnnna$aGene Product, Bacterial
=450  \\$aGene Products, Bacterial
=450  \\$wnnna$aGene Protein, Bacterial
=450  \\$wnnna$aGene Proteins, Bacterial
=450  \\$wnnna$aProtein, Bacterial
=450  \\$wnnna$aProteins, Bacterial
=550  \\$wg$aProteins
=550  \\$wh$aAraC Transcription Factor
=550  \\$wh$aAzurin
=550  \\$wh$aBacterial Outer Membrane Proteins
=550  \\$wh$aBacterial Proton-Translocating ATPases
=550  \\$wh$aBacterial Transferrin Receptor Complex
=550  \\$wh$aBacteriocins
=550  \\$wh$aBotulinum Toxins
=550  \\$wh$aCell Wall Skeleton
=550  \\$wh$aCoagulase
=550  \\$wh$aColicins
=550  \\$wh$aDNA Gyrase
=550  \\$wh$aDNA Topoisomerase IV
=550  \\$wh$aEscherichia coli Proteins
=550  \\$wh$aExfoliatins
=550  \\$wh$aFactor For Inversion Stimulation Protein
=550  \\$wh$aFerredoxins
=550  \\$wh$aFlagellin
=550  \\$wh$aFlavodoxin
=550  \\$wh$aIntegration Host Factors
=550  \\$wh$aLac Repressors
=550  \\$wh$aLuciferases, Bacterial
=550  \\$wh$aMethyl-Accepting Chemotaxis Proteins
=550  \\$wh$aMutS DNA Mismatch-Binding Protein
=550  \\$wh$aNADP Transhydrogenase, B-Specific
=550  \\$wh$aPenicillin-Binding Proteins
=550  \\$wh$aPeriplasmic Proteins
=550  \\$wh$aRNA Polymerase Sigma 54
=550  \\$wh$aStaphylococcal Protein A
=550  \\$wh$aStreptavidin
=550  \\$wh$aTetanus Toxin
=550  \\$wh$aTranscription Activator-Like Effectors
=667  \\$a/drug eff /ultrastruct permitted; /physiol permitted for function within the bacterium; coord IM with specific protein (IM) + specific bacterium (IM); BACTERIAL OUTER MEMBRANE PROTEINS is also available; DF: BACT PROTEINS
=680  \\$iProteins found in any species of bacterium.
=688  \\$aGENE PROTEINS, BACTERIAL was (NM) 1981-93
=750  \0$aBacterial proteins$5IEN$0(DLC)sh 86001023

=LDR  01386cz  a2200373n  4500
=001  9880363210802441
=005  20141212195114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001424
=035  \\$aCAZ4579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252
=150  \\$aBacterial Infections
=450  \\$aBacterial Diseases$5IEN
=450  \\$wnnna$aBacterial Infection
=450  \\$wnnna$aInfection, Bacterial
=450  \\$wnnna$aInfections, Bacterial
=550  \\$wg$aBacterial Infections and Mycoses
=550  \\$wh$aBacteremia
=550  \\$wh$aCentral Nervous System Bacterial Infections
=550  \\$wh$aEndocarditis, Bacterial
=550  \\$wh$aEye Infections, Bacterial
=550  \\$wh$aFournier Gangrene
=550  \\$wh$aGram-Negative Bacterial Infections
=550  \\$wh$aGram-Positive Bacterial Infections
=550  \\$wh$aPneumonia, Bacterial
=550  \\$wh$aSexually Transmitted Diseases, Bacterial
=550  \\$wh$aSkin Diseases, Bacterial
=550  \\$wh$aSpirochaetales Infections
=550  \\$wh$aVaginosis, Bacterial
=667  \\$aGEN: prefer specifics; many texts saying "sepsis" mean BACTERIAL INFECTIONS: check text; TN 209: differentiation from presence of bacteria in organs; DF: BACT INFECT
=680  \\$iInfections by bacteria, general or unspecified.
=688  \\$a72
=750  \0$aBacterial diseases$5IEN$0(DLC)sh 85010843

=LDR  00944cz  a2200241n  4500
=001  9880363210902441
=005  20170607112750.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001422
=035  \\$aCAZ4577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x99.$x50
=150  \\$aBacterial Adhesion
=450  \\$aAdhesion, Bacterial
=450  \\$wnnna$aAdhesions, Bacterial
=450  \\$wnnna$aBacterial Adhesions
=550  \\$wg$aBacterial Physiological Phenomena
=550  \\$aAdhesins, Bacterial
=550  \\$aBiofilms
=667  \\$ado not confuse with X ref BACTERIAL ADHESINS see ADHESINS, BACTERIAL, bact antigens; DF: BACT ADHESION
=680  \\$iPhysicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
=688  \\$a87
=750  \0$aBacteria$xadhesion$5IEN$0(DLC)sh 88006584

=LDR  00678cz  a2200181n  4500
=001  9880363211002441
=005  20141212195113.0
=008  830603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001421
=035  \\$aCAZ4576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x130
=150  \\$aBacteria, Anaerobic
=450  \\$aAnaerobic Bacteria
=550  \\$wg$aBacteria
=667  \\$aGEN: avoid; prefer specifics; do not use as a routine coord for an anaerobic bact; facultatively anaerobic bact: index only here & not also under BACTERIA, AEROBIC; infection: coord IM with BACTERIAL INFECTIONS (IM); DF: BACT ANAEROBIC
=688  \\$a84
=750  \0$aAnaerobic bacteria$5IEN$0(DLC)sh 85010822

=LDR  00586cz  a2200181n  4500
=001  9880363211102441
=005  20141212195113.0
=008  830603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001420
=035  \\$aCAZ4575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x120
=150  \\$aBacteria, Aerobic
=450  \\$aAerobic Bacteria
=550  \\$wg$aBacteria
=667  \\$aGEN: avoid; prefer specifics; do not use as a routine coord for an aerobic bact; infection: coord IM with BACTERIAL INFECTIONS (IM); DF: BACT AEROBIC
=688  \\$a84
=750  \0$aAerobic bacteria$5IEN$0(DLC)sh 85010821

=LDR  02755cz  a2200505n  4500
=001  9880363211202441
=005  20180228145604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001419
=035  \\$aCAZ4574HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3
=150  \\$aBacteria
=450  \\$aEubacteria
=450  \\$wnno$aGliding Bacteria$5IEN-M
=450  \\$wnno$aPhototrophic Bacteria$5IEN-M
=450  \\$wnno$aSpiral and Curved Bacteria$5IEN-M
=550  \\$wh$aAcidobacteria
=550  \\$wh$aAgricultural Inoculants
=550  \\$wh$aAtypical Bacterial Forms
=550  \\$wh$aBacteria, Aerobic
=550  \\$wh$aBacteria, Anaerobic
=550  \\$wh$aBacteria, Thermoduric
=550  \\$wh$aBacteroidetes
=550  \\$wh$aBlood-Borne Pathogens
=550  \\$wh$aChlorobi
=550  \\$wh$aChloroflexi
=550  \\$wh$aCyanobacteria
=550  \\$wh$aEndospore-Forming Bacteria
=550  \\$wh$aFibrobacteres
=550  \\$wh$aFirmicutes
=550  \\$wh$aFusobacteria
=550  \\$wh$aGram-Negative Bacteria
=550  \\$wh$aGram-Positive Bacteria
=550  \\$wh$aNitrogen-Fixing Bacteria
=550  \\$wh$aPlanctomycetales
=550  \\$wh$aProteobacteria
=550  \\$wh$aSpirochaetales
=550  \\$wh$aSulfur-Reducing Bacteria
=550  \\$wh$aVerrucomicrobia
=550  \\$aMicrobiology
=667  \\$ageneral; prefer specifics; relation to bacterial disease: Manual 22.12-22.16; presence of bacteria in organs vs infection: Manual 22.11; note many precoordinated bacterial - terms (BACTERIAL PROTEINS; ANTIBODIES, BACTERIAL; etc); "coliform bacteria" = COLIFORM BACILLI see ENTEROBACTERIACEAE; presence of bacteria in blood = BACTEREMIA: see note there; DF: BACT
=680  \\$iOne of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
=688  \\$a1963
=750  \0$aBacteria$5IEN$0(DLC)sh 85010813

=LDR  00931cz  a2200253n  4500
=001  9880363211302441
=005  20141212195112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001417
=035  \\$aCAZ4572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x750.$x115
=150  \\$aBackground Radiation
=450  \\$wnnna$aBackground Radiations
=450  \\$aNatural Radiation
=450  \\$wnnna$aNatural Radiations
=450  \\$wnnna$aRadiation, Background
=450  \\$wnnna$aRadiation, Natural
=450  \\$wnnna$aRadiations, Background
=450  \\$wnnna$aRadiations, Natural
=550  \\$wg$aRadiation, Ionizing
=680  \\$iRadiation from sources other than the source of interest. It is due to cosmic rays and natural radioactivity in the environment.
=688  \\$a91(71); was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975
=750  \0$aRadiation, Background$5IEN$0(DLC)sh 85110349

=LDR  01589cz  a2200433n  4500
=001  9880363211402441
=005  20141212195112.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001416
=035  \\$aCAZ4571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x232
=072  \\$aC23.$x888.$x592.$x612.$x107
=072  \\$aC23.$x888.$x646.$x172
=150  \\$aBack Pain
=450  \\$wnnna$aAche, Back
=450  \\$wnnna$aAches, Back
=450  \\$wnnna$aBack Ache
=450  \\$wnnna$aBack Aches
=450  \\$wnnna$aBack Pain with Radiation
=450  \\$wnnna$aBack Pain without Radiation
=450  \\$wnnna$aBack Pains
=450  \\$aBackache
=450  \\$wnnna$aBackaches
=450  \\$wnnna$aPain, Back
=450  \\$wnnna$aPain Syndrome, Vertebrogenic
=450  \\$wnnna$aPain Syndromes, Vertebrogenic
=450  \\$wnnna$aPains, Back
=450  \\$wnnna$aSyndrome, Vertebrogenic Pain
=450  \\$wnnna$aSyndromes, Vertebrogenic Pain
=450  \\$wnnna$aVertebrogenic Pain Syndrome
=450  \\$wnnna$aVertebrogenic Pain Syndromes
=550  \\$wg$aPain
=550  \\$wh$aFailed Back Surgery Syndrome
=550  \\$wh$aLow Back Pain
=667  \\$aGEN or unspecified; "lombo-sciatique" in French texts is indexed under LOW BACK PAIN (IM) + SCIATICA (IM); for lower back pain or pain in the lumbar region, LOW BACK PAIN is available
=680  \\$iAcute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.
=688  \\$a93; was BACKACHE 1963-92
=750  \0$aBackache$5IEN$0(DLC)sh 85010795

=LDR  00579cz  a2200193n  4500
=001  9880363211502441
=005  20141212195111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001415
=035  \\$aCAZ4570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x176
=150  \\$aBack
=450  \\$wnnna$aBacks
=550  \\$wg$aTorso
=550  \\$wh$aLumbosacral Region
=550  \\$wh$aSacrococcygeal Region
=667  \\$aa region; in humans, the posterior trunk from the neck to the pelvis; prefer a more specific term if possible
=750  \0$aBack$5IEN$0(DLC)sh 85010785

=LDR  02329cz  a2200613n  4500
=001  9880363211602441
=005  20141212195111.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001414
=035  \\$aCAZ4569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x75
=072  \\$aD12.$x644.$x641.$x75
=150  \\$aBacitracin
=450  \\$wnnna$aA.L. Labs Brand of Bacitracin Zinc Salt
=450  \\$wnnna$aAk-Tracin
=450  \\$wnnna$aAk Tracin
=450  \\$wnnna$aAkorn Brand of Bacitracin
=450  \\$wnnna$aAltracin
=450  \\$wnnna$aBaci-IM
=450  \\$wnnna$aBaci IM
=450  \\$wnnna$aBaci-Rx
=450  \\$wnnna$aBaci Rx
=450  \\$wnnna$aBaciguent
=450  \\$wnnna$aBacitin
=450  \\$wnnna$aBacitracin Akorn Brand
=450  \\$wnnna$aBacitracin Dioptic Brand
=450  \\$wnnna$aBacitracin Lee Brand
=450  \\$wnnna$aBacitracin McNeil Brand
=450  \\$wnnna$aBacitracin Pharmascience Brand
=450  \\$wnnna$aBacitracin Zinc
=450  \\$wnnna$aBacitracin, Zinc
=450  \\$wnnna$aBacitracin Zinc Complex
=450  \\$wnnna$aBacitracine Martinet
=450  \\$wnnna$aCiba Vision Brand of Bacitracin
=450  \\$wnnna$aDioptic Brand of Bacitracin
=450  \\$wnnna$aLee Brand of Bacitracin
=450  \\$wnnna$aMartinet, Bacitracine
=450  \\$wnnna$aMcNeil Brand of Bacitracin
=450  \\$wnnna$aOcu-Tracin
=450  \\$wnnna$aOcu Tracin
=450  \\$wnnna$aOcumed Brand of Bacitracin
=450  \\$wnnna$aOcuTracin
=450  \\$wnnna$aPharma Tek Brand of Bacitracin
=450  \\$wnnna$aPharmascience Brand of Bacitracin
=450  \\$wnnna$aReed & Carnrick Brand of Bacitracin
=450  \\$wnnna$aTopitracin
=450  \\$wnnna$aZeba-Rx
=450  \\$wnnna$aZeba Rx
=450  \\$wnnna$aZinc Bacitracin
=450  \\$wnnna$aZinc, Bacitracin
=550  \\$wg$aPeptides, Cyclic
=680  \\$iA complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140)
=750  \0$aBacitracin$5IEN$0(DLC)sh 85010784

=LDR  00870cz  a2200253n  4500
=001  9880363211702441
=005  20141212195110.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001413
=035  \\$aCAZ4568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218.$x800
=072  \\$aB3.$x510.$x100.$x100.$x218.$x800
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218.$x800
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218.$x800
=150  \\$aBacillus thuringiensis
=450  \\$wnnna$aBacilan
=450  \\$wnnna$aDipel
=450  \\$wnnna$aThuricide
=550  \\$wg$aBacillus
=667  \\$apathogenic for insects
=680  \\$iA species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.
=688  \\$a75
=750  \0$aBacillus thuringiensis$5IEN$0(DLC)sh 85010783

=LDR  00784cz  a2200229n  4500
=001  9880363211802441
=005  20141212195110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001412
=035  \\$aCAZ4567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218.$x725
=072  \\$aB3.$x510.$x100.$x100.$x218.$x725
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218.$x725
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218.$x725
=150  \\$aBacillus subtilis
=450  \\$wnnna$aBacillus subtilis (natto)
=450  \\$wnnna$aBacillus subtilis var. natto
=450  \\$aNatto Bacteria
=550  \\$wg$aBacillus
=680  \\$iA species of gram-positive bacteria that is a common soil and water saprophyte.
=750  \0$aBacillus subtilis$5IEN$0(DLC)sh 85010782

=LDR  00800cz  a2200217n  4500
=001  9880363211902441
=005  20141212195110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001410
=035  \\$aCAZ4565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218.$x500
=072  \\$aB3.$x510.$x100.$x100.$x218.$x500
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218.$x500
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218.$x500
=150  \\$aBacillus megaterium
=450  \\$wnnna$aBacillus megatherium
=550  \\$wg$aBacillus
=667  \\$asame as B. megatherium; in soil, water, dust, decomposing material
=680  \\$iA species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.
=750  \0$aBacillus megaterium$5IEN$0(DLC)sh 89005555

=LDR  00800cz  a2200205n  4500
=001  9880363212002441
=005  20141212195109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001409
=035  \\$aCAZ4564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218.$x252
=072  \\$aB3.$x510.$x100.$x100.$x218.$x252
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218.$x252
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218.$x252
=150  \\$aBacillus cereus
=550  \\$wg$aBacillus
=667  \\$ain soil, dust, plants
=680  \\$iA species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.
=750  \0$aBacillus cereus$5IEN-M$0(DLC)sh 93005860

=LDR  00677cz  a2200205n  4500
=001  9880363212102441
=005  20141212195109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001408
=035  \\$aCAZ4563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218.$x151
=072  \\$aB3.$x510.$x100.$x100.$x218.$x151
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218.$x151
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218.$x151
=150  \\$aBacillus anthracis
=550  \\$wg$aBacillus
=667  \\$ainfection = ANTHRAX
=680  \\$iA species of bacteria that causes ANTHRAX in humans and animals.
=750  \0$aBacillus anthracis$5IEN$0(DLC)sh 85010780

=LDR  01274cz  a2200349n  4500
=001  9880363212202441
=005  20180228142043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001407
=035  \\$aCAZ4562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158.$x218
=072  \\$aB3.$x510.$x100.$x100.$x218
=072  \\$aB3.$x510.$x415.$x400.$x158.$x218
=072  \\$aB3.$x510.$x460.$x410.$x158.$x218
=150  \\$aBacillus
=450  \\$aBacillus mesentericus$5IEN-M
=550  \\$wg$aBacillaceae
=550  \\$wh$aBacillus amyloliquefaciens
=550  \\$wh$aBacillus anthracis
=550  \\$wh$aBacillus cereus
=550  \\$wh$aBacillus clausii
=550  \\$wh$aBacillus coagulans
=550  \\$wh$aBacillus firmus
=550  \\$wh$aBacillus licheniformis
=550  \\$wh$aBacillus megaterium
=550  \\$wh$aBacillus pumilus
=550  \\$wh$aBacillus subtilis
=550  \\$wh$aBacillus thuringiensis
=667  \\$aspecific genus: do not confuse with "bacillus" as "bacterium"; Bacillus mesentericus goes here
=680  \\$iA genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.
=750  \0$aBacillus (Bacteria)$0(DLC) sh 85010778$5IEN

=LDR  01005cz  a2200313n  4500
=001  9880363212302441
=005  20141212195108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001406
=035  \\$aCAZ4561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x158
=072  \\$aB3.$x510.$x100.$x100
=072  \\$aB3.$x510.$x415.$x400.$x158
=072  \\$aB3.$x510.$x460.$x410.$x158
=150  \\$aBacillaceae
=550  \\$wg$aBacillales
=550  \\$wg$aGram-Positive Endospore-Forming Rods
=550  \\$wh$aAnoxybacillus
=550  \\$wh$aBacillus
=550  \\$wh$aGeobacillus
=550  \\$wh$aHalobacillus
=550  \\$wh$aPlanococcaceae
=550  \\$wh$aThermoactinomyces
=550  \\$wh$aVirgibacillus
=667  \\$apathogenic & non-pathogenic
=680  \\$iA family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens.
=688  \\$a75
=750  \0$aBacillaceae$0(DLC) sh 85010777$5IEN

=LDR  01472cz  a2200397n  4500
=001  9880363212402441
=005  20141212195108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001404
=035  \\$aCAZ4559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x188
=072  \\$aC3.$x701.$x688.$x122
=072  \\$aC3.$x752.$x625.$x122
=072  \\$aC3.$x752.$x875.$x175
=072  \\$aC22.$x674.$x710.$x122
=150  \\$aBabesiosis
=450  \\$wnnna$aBabesia Parasite Infection
=450  \\$wnnna$aBabesia Parasite Infections
=450  \\$wnnna$aBabesiases
=450  \\$aBabesiasis
=450  \\$wnnna$aBabesioses
=450  \\$wnnna$aBabesioses, Human
=450  \\$wnnna$aBabesiosis, Human
=450  \\$wnnna$aHuman Babesioses
=450  \\$wnnna$aHuman Babesiosis
=450  \\$wnnna$aInfection, Babesia Parasite
=450  \\$wnnna$aInfections, Babesia Parasite
=450  \\$wnnna$aPiroplasmoses
=450  \\$aPiroplasmosis
=550  \\$wg$aParasitic Diseases, Animal
=550  \\$wg$aProtozoan Infections, Animal
=550  \\$wg$aTick-Borne Diseases
=680  \\$iA group of tick-borne diseases of mammals including ZOONOSES in humans. They are caused by protozoa of the genus BABESIA, which parasitize erythrocytes, producing hemolysis. In the U.S., the organism's natural host is mice and transmission is by the deer tick IXODES SCAPULARIS.
=688  \\$a82; was BABESIASIS 1968-81
=750  \0$aBabesiosis$5IEN-M$0(DLC)sh 85010731

=LDR  00856cz  a2200241n  4500
=001  9880363212502441
=005  20141212195108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001403
=035  \\$aCAZ4558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x600.$x580.$x70
=150  \\$aBabesia
=450  \\$wnnna$aBabesias
=450  \\$aPiroplasma
=450  \\$wnnna$aPiroplasmas
=550  \\$wg$aPiroplasmida
=550  \\$wh$aBabesia bovis
=550  \\$wh$aBabesia microti
=667  \\$ainfection = BABESIOSIS; coordinate with specific terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.
=688  \\$a74
=750  \0$aBabesia$5IEN$0(DLC)sh 85010730

=LDR  01572cz  a2200397n  4500
=001  9880363212602441
=005  20141212195107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001402
=035  \\$aCAZ4557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x63.$x438
=072  \\$aA11.$x118.$x637.$x555.$x567.$x562
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x562
=072  \\$aA15.$x382.$x32.$x438
=072  \\$aA15.$x382.$x490.$x555.$x567.$x562
=150  \\$aB-Lymphocytes
=450  \\$wnnna$aB-Cell
=450  \\$aB-Cells
=450  \\$wnnna$aB Cells
=450  \\$wnnna$aB-Lymphocyte
=450  \\$wnnna$aB Lymphocytes
=450  \\$wnnna$aBursa-Dependent Lymphocyte
=450  \\$aBursa-Dependent Lymphocytes
=450  \\$wnnna$aBursa Dependent Lymphocytes
=450  \\$wnnna$aLymphocyte, Bursa-Dependent
=450  \\$wnnna$aLymphocytes, Bursa-Dependent
=550  \\$wg$aAntibody-Producing Cells
=550  \\$wg$aLymphocytes
=550  \\$wh$aB-Lymphocyte Subsets
=550  \\$wh$aPlasma Cells
=550  \\$wh$aPrecursor Cells, B-Lymphoid
=667  \\$ainvolved in antibody formation; do not confuse X ref B-CELLS with pancreatic B cells or beta cells (index under ISLANDS OF LANGERHANS); A 11 qualif; subpopulations = B-LYMPHOCYTE SUBSETS
=680  \\$iLymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.
=688  \\$a90; was B LYMPHOCYTES 1973-89
=750  \0$aB cells$5IEN$0(DLC)sh 85010707

=LDR  00668cz  a2200193n  4500
=001  9880363212702441
=005  20141212195107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001401
=035  \\$aCAZ4556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x106
=150  \\$aAzygos Vein
=450  \\$wnnna$aAzygos Veins
=450  \\$wnnna$aVein, Azygos
=450  \\$wnnna$aVeins, Azygos
=550  \\$wg$aVeins
=680  \\$iA vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.
=750  \0$aAzygos vein$5IEN$0(DLC)sh 85010694

=LDR  00880cz  a2200193n  4500
=001  9880363212802441
=005  20141212194946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001151
=035  \\$aCAZ4305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x67
=072  \\$aD1.$x268.$x513.$x249
=150  \\$aArsenic
=550  \\$wg$aElements
=550  \\$wg$aMetalloids
=667  \\$aAs-75; As-69-81, except As-75 = ARSENIC (IM) + RADIOISOTOPES (IM)
=680  \\$iA shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed)
=750  \0$aArsenic$5IEN$0(DLC)sh 85007449

=LDR  00633cz  a2200217n  4500
=001  9880363212902441
=005  20141212194946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001149
=035  \\$aCAZ4303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x75.$x25
=072  \\$aD1.$x248.$x497.$x158.$x50
=072  \\$aD2.$x691.$x88.$x42
=150  \\$aArsenates
=550  \\$wg$aAnions
=550  \\$wg$aArsenicals
=667  \\$ado not confuse with ARSENITES
=680  \\$iInorganic or organic salts and esters of arsenic acid.
=688  \\$a91(75); was see under ARSENIC 1975-90
=750  \0$aArsenates$5IEN$0(DLC)sh 85007448

=LDR  01664cz  a2200481n  4500
=001  9880363213002441
=005  20141212194944.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001145
=035  \\$aCAZ4299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67
=072  \\$aC23.$x550.$x73
=150  \\$aArrhythmias, Cardiac
=450  \\$wnnna$aArrhythmia
=450  \\$wnnna$aArrhythmia, Cardiac
=450  \\$wnnna$aArrythmia
=450  \\$wnnna$aCardiac Arrhythmia
=450  \\$wnnna$aCardiac Arrhythmias
=450  \\$wnnna$aCardiac Dysrhythmia
=450  \\$wnnna$aDysrhythmia, Cardiac
=550  \\$wg$aHeart Diseases
=550  \\$wg$aPathologic Processes
=550  \\$wh$aArrhythmia, Sinus
=550  \\$wh$aAtrial Fibrillation
=550  \\$wh$aAtrial Flutter
=550  \\$wh$aBradycardia
=550  \\$wh$aBrugada Syndrome
=550  \\$wh$aCardiac Complexes, Premature
=550  \\$wh$aCommotio Cordis
=550  \\$wh$aHeart Block
=550  \\$wh$aLong QT Syndrome
=550  \\$wh$aParasystole
=550  \\$wh$aPre-Excitation Syndromes
=550  \\$wh$aTachycardia
=550  \\$wh$aVentricular Fibrillation
=550  \\$wh$aVentricular Flutter
=550  \\$aHeart Conduction System
=667  \\$ageneral: prefer specifics
=680  \\$iAny disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Arrhythmia
=750  \0$aArrhythmia$0(DLC) sh 85007430$5IEN

=LDR  00837cz  a2200265n  4500
=001  9880363213102441
=005  20180402102721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001143
=035  \\$aCAZ4297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x104
=072  \\$aG11.$x561.$x600.$x42
=150  \\$aArousal
=450  \\$wnnna$aArousals
=450  \\$wnnna$aCortical Vigilance
=450  \\$aVigilance, Cortical
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aPsychophysiology
=550  \\$wh$aAttention
=550  \\$wh$aWakefulness
=667  \\$ahuman & animal
=680  \\$iCortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.
=688  \\$a66(64)
=750  \0$aArousal (Physiology)$5IEN$0(DLC)sh 85007409

=LDR  01532cz  a2200373n  4500
=001  9880363213202441
=005  20141212192006.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001142
=035  \\$aCAZ4296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x224.$x125.$x100
=150  \\$aAromatic-L-Amino-Acid Decarboxylases
=450  \\$wnnna$a5-HTPase
=450  \\$wnnna$a5 HTPase
=450  \\$wnnna$a5-Hydroxytryptophan Decarboxylase
=450  \\$wnnna$a5 Hydroxytryptophan Decarboxylase
=450  \\$aAmino Acid Decarboxylases, Aromatic
=450  \\$aAromatic Amino Acid Decarboxylases
=450  \\$wnnna$aAromatic-L-Amino-Acid Decarboxylase
=450  \\$wnnna$aAromatic L Amino Acid Decarboxylase
=450  \\$wnnna$aAromatic L Amino Acid Decarboxylases
=450  \\$wnnna$aDecarboxylase, 5-Hydroxytryptophan
=450  \\$wnnna$aDecarboxylase, Aromatic-L-Amino-Acid
=450  \\$wnnna$aDecarboxylase, Hydroxytryptophan
=450  \\$wnnna$aDecarboxylase, Tryptophan
=450  \\$wnnna$aDecarboxylases, Aromatic-L-Amino-Acid
=450  \\$wnnna$aHydroxytryptophan Decarboxylase
=450  \\$wnnna$aTryptophan Decarboxylase
=550  \\$wg$aCarboxy-Lyases
=550  \\$wh$aDopa Decarboxylase
=680  \\$iAn enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine (DOPA DECARBOXYLASE); TRYPTOPHAN; and HYDROXYTRYPTOPHAN.
=688  \\$a98(80)
=750  \0$aAromatic amino acid decarboxylases$5IEN$0(DLC)sh 85007395

=LDR  01561cz  a2200349n  4500
=001  9880363213302441
=005  20141212194944.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001141
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x453.$x915.$x99
=072  \\$aD8.$x811.$x682.$x690.$x708.$x170.$x915.$x99
=072  \\$aD8.$x811.$x682.$x690.$x708.$x783.$x99
=072  \\$aD12.$x776.$x422.$x220.$x453.$x915.$x99
=150  \\$aAromatase
=450  \\$wnnna$aAndrostenedione Aromatase
=450  \\$wnnna$aAromatase, Androstenedione
=450  \\$wnnna$aCYP 19
=450  \\$aCYP19
=450  \\$wnnna$aCYP19 Protein
=450  \\$aCytochrome P-450(AROM)
=450  \\$aCytochrome P-450 CYP19
=450  \\$wnnna$aCytochrome P 450 CYP19
=450  \\$wnnna$aCytochrome P450 19
=450  \\$wnnna$aEstrogen Synthase
=450  \\$wnnna$aEstrogen Synthetase
=450  \\$wnnna$aP450AROM
=450  \\$wnnna$aProtein, CYP19
=550  \\$wg$aSteroid Hydroxylases
=680  \\$iAn enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.
=688  \\$a86(75); was see under OXIDOREDUCTASES 1975-85
=750  \0$aAromatase$0(DLC) sh 97006427$5IEN-M

=LDR  03447cz  a2200637n  4500
=001  9880363213402441
=005  20141212192005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001139
=035  \\$aCAZ4293HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x291
=072  \\$aC16.$x131.$x666.$x680.$x291
=150  \\$aArnold-Chiari Malformation
=450  \\$wnnna$aArnold-Chiari Deformity
=450  \\$wnnna$aArnold Chiari Deformity
=450  \\$wnnna$aArnold Chiari Malformation
=450  \\$wnnna$aArnold-Chiari Malformation, Type 1
=450  \\$wnnna$aArnold Chiari Malformation, Type 1
=450  \\$wnnna$aArnold-Chiari Malformation, Type 2
=450  \\$wnnna$aArnold Chiari Malformation, Type 2
=450  \\$wnnna$aArnold-Chiari Malformation, Type 3
=450  \\$wnnna$aArnold Chiari Malformation, Type 3
=450  \\$wnnna$aArnold-Chiari Malformation, Type 4
=450  \\$wnnna$aArnold Chiari Malformation, Type 4
=450  \\$wnnna$aArnold-Chiari Malformation, Type I
=450  \\$wnnna$aArnold Chiari Malformation, Type I
=450  \\$wnnna$aArnold-Chiari Malformation, Type II
=450  \\$wnnna$aArnold Chiari Malformation, Type II
=450  \\$wnnna$aArnold-Chiari Malformation, Type III
=450  \\$wnnna$aArnold Chiari Malformation, Type III
=450  \\$wnnna$aArnold-Chiari Malformation, Type IV
=450  \\$wnnna$aArnold Chiari Malformation, Type IV
=450  \\$wnnna$aArnold-Chiari Syndrome
=450  \\$wnnna$aArnold Chiari Syndrome
=450  \\$wnnna$aChiari Malformation Type 2
=450  \\$wnnna$aChiari Malformation Type I
=450  \\$wnnna$aChiari Malformation Type II
=450  \\$wnnna$aDeformity, Arnold-Chiari
=450  \\$wnnna$aMalformation, Arnold-Chiari
=450  \\$wnnna$aMalformation, Arnold Chiari
=450  \\$wnnna$aSyndrome, Arnold-Chiari
=450  \\$wnnna$aType I Arnold-Chiari Malformation
=450  \\$wnnna$aType I Arnold Chiari Malformation
=450  \\$wnnna$aType II Arnold-Chiari Malformation
=450  \\$wnnna$aType II Arnold Chiari Malformation
=450  \\$wnnna$aType III Arnold-Chiari Malformation
=450  \\$wnnna$aType III Arnold Chiari Malformation
=450  \\$wnnna$aType IV Arnold-Chiari Malformation
=450  \\$wnnna$aType IV Arnold Chiari Malformation
=550  \\$wg$aNeural Tube Defects
=550  \\$aPlatybasia
=667  \\$ado not confuse with CHIARI'S SYNDROME see BUDD-CHIARI SYNDROME
=680  \\$iA group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. (From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46)
=688  \\$a2000(1963)
=750  \0$aArnold-Chiari deformity$5IEN$0(DLC)sh 89001592

=LDR  00707cz  a2200193n  4500
=001  9880363213502441
=005  20201104120357.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001135
=035  \\$aCAZ4289HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x900.$x200
=150  \\$aArmadillos
=450  \\$wnnna$aArmadillo
=550  \\$wg$aCingulata
=667  \\$aIM; qualif permitted
=680  \\$iBurrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.
=688  \\$a91(75); was see under EDENTATA 1975-90
=750  \0$aArmadillos$5IEN$0(DLC)sh 85007236

=LDR  01004cz  a2200289n  4500
=001  9880363213602441
=005  20141212194942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001134
=035  \\$aCAZ4288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x88
=150  \\$aArm Injuries
=450  \\$aArm$xinjuries
=450  \\$wnnna$aArm Injury
=450  \\$wnnna$aInjuries, Arm
=450  \\$wnnna$aInjury, Arm
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aForearm Injuries
=550  \\$wh$aHumeral Fractures
=550  \\$wh$aShoulder Dislocation
=550  \\$wh$aShoulder Fractures
=550  \\$wh$aTennis Elbow
=550  \\$wh$aWrist Injuries
=667  \\$aGEN or unspecified; consider also /inj with specific bones of arm; also available are FOREARM INJURIES; HAND INJURIES; FINGER INJURIES; WRIST INJURIES & many specific organ/fract precoords
=680  \\$iGeneral or unspecified injuries involving the arm.
=750  \0$aArm$xWounds and injuries$5IEN$0(DLC)sh 85046618

=LDR  00633cz  a2200169n  4500
=001  9880363213702441
=005  20141212194941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001132
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x75
=150  \\$aArm
=450  \\$wnnna$aArms
=550  \\$wg$aUpper Extremity
=667  \\$aprimates only; for whole arm or upper arm; FOREARM is also available; Manual 21.58: extremities of humans & animals; NIM when merely locational as in skin dis (IM)
=680  \\$iThe superior part of the upper extremity between the SHOULDER and the ELBOW.
=750  \0$aArm$5IEN$0(DLC)sh 85007224

=LDR  00726cz  a2200217n  4500
=001  9880363213802441
=005  20141212194940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001129
=035  \\$aCAZ4283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x621.$x166
=072  \\$aC25.$x723.$x68
=150  \\$aArgyria
=450  \\$wnnna$aArgyrias
=450  \\$aSilver$xpoisoning
=550  \\$wg$aPigmentation Disorders
=550  \\$wg$aPoisoning
=667  \\$acaused by prolonged use of silver salts
=680  \\$iA permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed)
=750  \0$aArgyria$5IEN$0(DLC)sh 85007122

=LDR  00739cz  a2200181n  4500
=001  9880363213902441
=005  20141212194940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001128
=035  \\$aCAZ4282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613.$x50
=072  \\$aD1.$x362.$x641.$x113
=150  \\$aArgon
=550  \\$wg$aNoble Gases
=667  \\$aa rare gas; Ar-40; Ar-36, 38 = ARGON (IM) + ISOTOPES (NIM); Ar-35, 37, 39, 41, 42 = ARGON (IM) + RADIOISOTOPES (IM)
=680  \\$iArgon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.
=750  \0$aArgon$5IEN$0(DLC)sh 85007108

=LDR  01449cz  a2200433n  4500
=001  9880363214002441
=005  20141212194938.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001120
=035  \\$aCAZ4274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x68.$x50
=072  \\$aD12.$x125.$x95.$x104
=072  \\$aD12.$x125.$x142.$x87
=150  \\$aArginine
=450  \\$wnnna$aArginine Hydrochloride
=450  \\$wnnna$aArginine, L-Isomer
=450  \\$wnnna$aArginine, L Isomer
=450  \\$wnnna$aDL-Arginine Acetate, Monohydrate
=450  \\$wnnna$aDL Arginine Acetate, Monohydrate
=450  \\$wnnna$aHydrochloride, Arginine
=450  \\$wnnna$aL-Arginine
=450  \\$wnnna$aL Arginine
=450  \\$wnnna$aL-Isomer Arginine
=450  \\$wnnna$aMonohydrate DL-Arginine Acetate
=550  \\$wg$aAmino Acids, Basic
=550  \\$wg$aAmino Acids, Diamino
=550  \\$wg$aAmino Acids, Essential
=550  \\$wh$aArgininosuccinic Acid
=550  \\$wh$aBenzoylarginine-2-Naphthylamide
=550  \\$wh$aBenzoylarginine Nitroanilide
=550  \\$wh$aHomoarginine
=550  \\$wh$aNG-Nitroarginine Methyl Ester
=550  \\$wh$aNitroarginine
=550  \\$wh$aomega-N-Methylarginine
=550  \\$wh$aTosylarginine Methyl Ester
=667  \\$a/biosyn /defic /physiol permitted
=680  \\$iAn essential amino acid that is physiologically active in the L-form.
=750  \0$aArginine$5IEN$0(DLC)sh 90001568

=LDR  01037cz  a2200313n  4500
=001  9880363214102441
=005  20141212194937.0
=008  800513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001117
=035  \\$aCAZ4271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x82
=150  \\$aArenaviridae Infections
=450  \\$wnnna$aArenaviridae Infection
=450  \\$aArenavirus Diseases$5IEN
=450  \\$wnnna$aArenavirus Infection
=450  \\$aArenavirus Infections
=450  \\$wnnna$aInfection, Arenaviridae
=450  \\$wnnna$aInfection, Arenavirus
=450  \\$wnnna$aInfections, Arenaviridae
=450  \\$wnnna$aInfections, Arenavirus
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aHemorrhagic Fever, American
=550  \\$wh$aLassa Fever
=550  \\$wh$aLymphocytic Choriomeningitis
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the ARENAVIRIDAE.
=688  \\$a94; was ARENAVIRUS INFECTIONS 1981-93
=750  \0$aArenavirus diseases$5IEN-M$0(DLC)sh 86003817

=LDR  01018cz  a2200229n  4500
=001  9880363214202441
=005  20141212194936.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001116
=035  \\$aCAZ4270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x57
=072  \\$aB4.$x909.$x777.$x80
=150  \\$aArenaviridae
=450  \\$aArenaviruses$5IEN-M
=550  \\$wg$aRNA Viruses
=550  \\$wh$aArenavirus
=550  \\$aArboviruses
=667  \\$ainfection = ARENAVIRIDAE INFECTIONS
=680  \\$iA family of RNA viruses naturally infecting rodents and consisting of one genus (ARENAVIRUS) with two groups: Old World Arenaviruses (ARENAVIRUSES, OLD WORLD) and New World Arenaviruses (ARENAVIRUSES, NEW WORLD). Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.
=688  \\$a81; was ARENAVIRUSES 1978-80
=750  \0$aArenaviruses$5IEN$0(DLC)sh 85007002

=LDR  01453cz  a2200277n  4500
=001  9880363214302441
=005  20141212194936.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001114
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x88
=150  \\$aAreca
=450  \\$wnnna$aAreca catechu
=450  \\$wnnna$aAreca catechus
=450  \\$wnnna$aArecas
=450  \\$aBetel Nut
=450  \\$wnnna$aBetel Nuts
=450  \\$wnnna$acatechu, Areca
=450  \\$wnnna$acatechus, Areca
=450  \\$wnnna$aNut, Betel
=450  \\$wnnna$aNuts, Betel
=550  \\$wg$aArecaceae
=667  \\$aBetel may go here or under PIPER BETLE; 'catechu' may go here or under ACACIA CATECHU see ACACIA; check text; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.
=688  \\$a91(86)63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85
=750  \0$aAreca$5IEN$0(DLC)sh 85006994

=LDR  00874cz  a2200193n  4500
=001  9880363214402441
=005  20141212194935.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001113
=035  \\$aCAZ4267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x783.$x660.$x125
=150  \\$aArea Health Education Centers
=450  \\$wnnna$aArea Health Education Center
=550  \\$wg$aSchools, Health Occupations
=667  \\$aspecify geog if pertinent; DF: AHEC
=680  \\$iEducation centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.
=688  \\$a91(75); was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90
=750  \0$aArea Health Education Centers Program$5IEN$0(DLC)n 2011182508

=LDR  00848cz  a2200229n  4500
=001  9880363214502441
=005  20141212194934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001109
=035  \\$aCAZ4263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x152
=072  \\$aL1.$x346.$x208
=150  \\$aArchives
=450  \\$wnnna$aArchive
=450  \\$aArchivists$5IEN
=550  \\$wg$aHistory
=550  \\$wg$aInformation Centers
=550  \\$wh$aMuseums
=667  \\$arestricted use; note category; archives of clinical or other biological specimens = BIOLOGICAL SPECIMEN BANKS or specifics; for "medical archives" do not coordinate with MEDICINE; note PICTURE ARCHIVING, RADIOLOGIC see RADIOLOGY INFORMATION SYSTEMS is available
=750  \0$aArchivists$5IEN-M$0(DLC)sh 85006928
=750  \0$aArchives$5IEN-HS$0(DLC)sh 85006913

=LDR  01078cz  a2200313n  4500
=001  9880363214702441
=005  20141212194934.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001107
=035  \\$aCAZ4261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x70
=150  \\$aArchitectural Accessibility
=450  \\$wnnna$aAccess, Facility
=450  \\$wnnna$aAccesses, Facility
=450  \\$wnnna$aAccessibility, Architectural
=450  \\$wnnna$aArchitectural Barrier
=450  \\$wnnna$aArchitectural Barriers
=450  \\$wnnna$aBarrier, Architectural
=450  \\$aBarriers, Architectural
=450  \\$aFacility Access
=450  \\$wnnna$aFacility Accesses
=450  \\$wnnna$aRamp
=450  \\$aRamps
=550  \\$wg$aFacility Design and Construction
=667  \\$afor approaching inside or outside areas; DF: note short X ref
=680  \\$iDesigns for approaching areas inside or outside facilities.
=688  \\$a91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
=750  \0$aBarrier-free design$5IEN$0(DLC)sh 85006899

=LDR  00680cz  a2200205n  4500
=001  9880363214802441
=005  20141212194934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001106
=035  \\$aCAZ4260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x208
=150  \\$aArchaeology
=450  \\$aArchaeologists$5IEN
=450  \\$wnnna$aArcheology
=550  \\$wg$aAnthropology, Cultural
=667  \\$aIM; SPEC; SPEC qualif; pre-Columbian: nothing later; DF: ARCHAEOL
=680  \\$iThe scientific study of past societies through artifacts, fossils, etc.
=750  \0$aArchaeologists$5IEN-M$0(DLC)sh 85006505
=750  \0$aArchaeology$5IEN-HS$0(DLC)sh 85006507

=LDR  00898cz  a2200193n  4500
=001  9880363630802441
=005  20141212202809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007836
=035  \\$aCBA1040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x57.$x70.$x100.$x500
=072  \\$aB4.$x909.$x777.$x80.$x70.$x100.$x500
=150  \\$aLassa virus
=550  \\$wg$aArenaviruses, Old World
=667  \\$ainfection = LASSA FEVER
=680  \\$iA species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), and the etiologic agent of LASSA FEVER. LASSA VIRUS is a common infective agent in humans in West Africa. Its natural host is the multimammate mouse Mastomys natalensis.
=688  \\$a91(72); was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77
=750  \0$aLassa fever virus$5IEN-M$0(DLC)sh 85074821

=LDR  00724cz  a2200241n  4500
=001  9880363630902441
=005  20141212202809.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007835
=035  \\$aCBA1039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x82.$x545
=072  \\$aC2.$x782.$x417.$x505
=150  \\$aLassa Fever
=450  \\$wnnna$aFever, Lassa
=450  \\$wnnna$aFevers, Lassa
=450  \\$wnnna$aLassa Fevers
=550  \\$wg$aArenaviridae Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=667  \\$aa hemorrhagic fever caused by an arenavirus
=680  \\$iAn acute febrile human disease caused by the LASSA VIRUS.
=688  \\$a77
=750  \0$aLassa fever$5IEN$0(DLC)sh 85074820

=LDR  02030cz  a2200481n  4500
=001  9880363631002441
=005  20141212202808.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007834
=035  \\$aCBA1038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490
=072  \\$aE7.$x710.$x520
=150  \\$aLasers
=450  \\$wnnna$aContinuous Wave Laser
=450  \\$wnnna$aContinuous Wave Lasers
=450  \\$wnnna$aLaser
=450  \\$wnnna$aLaser, Continuous Wave
=450  \\$wnnna$aLaser, Pulsed
=450  \\$wnnna$aLaser, Q-Switched
=450  \\$wnnna$aLasers, Continuous Wave
=450  \\$wnnna$aLasers, Pulsed
=450  \\$wnnna$aLasers, Q-Switched
=450  \\$wnnna$aMaser
=450  \\$aMasers
=450  \\$wnnna$aPulsed Laser
=450  \\$wnnna$aPulsed Lasers
=450  \\$wnnna$aQ-Switched Laser
=450  \\$wnnna$aQ-Switched Lasers
=450  \\$wnnna$aQ Switched Lasers
=550  \\$wg$aOptical Devices
=550  \\$wg$aRadiation Equipment and Supplies
=550  \\$wh$aLasers, Dye
=550  \\$wh$aLasers, Excimer
=550  \\$wh$aLasers, Gas
=550  \\$wh$aLasers, Semiconductor
=550  \\$wh$aLasers, Solid-State
=550  \\$aLaser Therapy
=550  \\$aOptical Tweezers
=667  \\$ageneral or unspecified; prefer specifics; laser injuries = LASERS /adv eff + organ / inj but do not coordinate with RADIATION INJURIES or any BURNS term; effect of laser as radiation: coordinate IM with anatomical term, organism or chemical substance / rad eff (IM); LASER THERAPY and LASER THERAPY, LOW-LEVEL are also available
=680  \\$iAn optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum.
=688  \\$a65(63)
=750  \0$aLasers$5IEN$0(DLC)sh 85074788

=LDR  01374cz  a2200349n  4500
=001  9880363631102441
=005  20141212202807.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007831
=035  \\$aCBA1035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x450
=072  \\$aE7.$x858.$x82.$x595
=150  \\$aLarynx, Artificial
=450  \\$wnnna$aArtificial Larynges
=450  \\$aArtificial Larynx
=450  \\$wnnna$aLaryngeal Prostheses
=450  \\$aLaryngeal Prosthesis
=450  \\$wnnna$aLarynges, Artificial
=450  \\$wnnna$aProstheses, Laryngeal
=450  \\$wnnna$aProstheses, Voice
=450  \\$wnnna$aProsthesis, Laryngeal
=450  \\$wnnna$aProsthesis, Voice
=450  \\$wnnna$aVoice Prostheses
=450  \\$aVoice Prosthesis
=550  \\$wg$aArtificial Organs
=550  \\$wg$aProstheses and Implants
=550  \\$aLaryngectomy
=550  \\$aSpeech, Alaryngeal
=680  \\$iA device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges. Electronic devices include the Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe.
=688  \\$a80
=750  \0$aArtificial larynx$5IEN$0(DLC)sh 85008187

=LDR  02039cz  a2200505n  4500
=001  9880363631202441
=005  20141212192257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007830
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x329
=150  \\$aLarynx
=360  \\$iconsider also terms at$aVOCAL$aVOICE
=450  \\$wnnna$aAnterior Commissure, Laryngeal
=450  \\$wnnna$aAnterior Commissure, Larynx
=450  \\$wnnna$aAnterior Commissures, Laryngeal
=450  \\$wnnna$aAnterior Commissures, Larynx
=450  \\$wnnna$aCommissure, Laryngeal Anterior
=450  \\$wnnna$aCommissure, Laryngeal Posterior
=450  \\$wnnna$aCommissure, Larynx Anterior
=450  \\$wnnna$aCommissure, Larynx Posterior
=450  \\$wnnna$aCommissures, Laryngeal Anterior
=450  \\$wnnna$aCommissures, Laryngeal Posterior
=450  \\$wnnna$aCommissures, Larynx Anterior
=450  \\$wnnna$aCommissures, Larynx Posterior
=450  \\$wnnna$aLaryngeal Anterior Commissure
=450  \\$wnnna$aLaryngeal Anterior Commissures
=450  \\$wnnna$aLaryngeal Posterior Commissure
=450  \\$wnnna$aLaryngeal Posterior Commissures
=450  \\$wnnna$aLarynx Anterior Commissure
=450  \\$wnnna$aLarynx Anterior Commissures
=450  \\$wnnna$aLarynx Posterior Commissure
=450  \\$wnnna$aLarynx Posterior Commissures
=450  \\$wnnna$aPosterior Commissure, Laryngeal
=450  \\$wnnna$aPosterior Commissure, Larynx
=450  \\$wnnna$aPosterior Commissures, Laryngeal
=450  \\$wnnna$aPosterior Commissures, Larynx
=550  \\$wg$aRespiratory System
=550  \\$wh$aGlottis
=550  \\$wh$aLaryngeal Cartilages
=550  \\$wh$aLaryngeal Mucosa
=550  \\$wh$aLaryngeal Muscles
=667  \\$aLARYNGEAL CARTILAGES is available; /surg: probably LARYNGECTOMY; inflammation = LARYNGITIS
=680  \\$iA tubular organ of VOICE production. It is located in the anterior neck, superior to the TRACHEA and inferior to the tongue and HYOID BONE.
=750  \0$aLarynx$5IEN$0(DLC)sh 85074745

=LDR  01862cz  a2200481n  4500
=001  9880363631302441
=005  20141212202807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007829
=035  \\$aCBA1033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x591
=072  \\$aC9.$x400.$x591
=072  \\$aC16.$x131.$x740.$x658
=150  \\$aLaryngostenosis
=450  \\$wnnna$aAcquired Laryngeal Stenoses
=450  \\$wnnna$aAcquired Laryngeal Stenosis
=450  \\$wnnna$aAcquired Subglottic Stenoses
=450  \\$wnnna$aAcquired Subglottic Stenosis
=450  \\$wnnna$aCongenital Subglottic Stenoses
=450  \\$wnnna$aCongenital Subglottic Stenosis
=450  \\$wnnna$aLaryngeal Stenoses
=450  \\$wnnna$aLaryngeal Stenoses, Acquired
=450  \\$aLaryngeal Stenosis
=450  \\$wnnna$aLaryngeal Stenosis, Acquired
=450  \\$wnnna$aLaryngostenoses
=450  \\$wnnna$aStenoses, Acquired Laryngeal
=450  \\$wnnna$aStenoses, Acquired Subglottic
=450  \\$wnnna$aStenoses, Congenital Subglottic
=450  \\$wnnna$aStenoses, Laryngeal
=450  \\$wnnna$aStenosis, Acquired Laryngeal
=450  \\$wnnna$aStenosis, Acquired Subglottic
=450  \\$wnnna$aStenosis, Congenital Subglottic
=450  \\$wnnna$aStenosis, Laryngeal
=450  \\$wnnna$aSubglottic Stenoses, Acquired
=450  \\$wnnna$aSubglottic Stenoses, Congenital
=450  \\$wnnna$aSubglottic Stenosis, Acquired
=450  \\$wnnna$aSubglottic Stenosis, Congenital
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aRespiratory System Abnormalities
=667  \\$aspasmodic closure = LARYNGOSPASM see LARYNGISMUS
=680  \\$iDevelopmental or acquired stricture or narrowing of the LARYNX. Symptoms of respiratory difficulty depend on the degree of laryngeal narrowing.
=750  \0$aLarynx$xStenosis$5IEN$0(DLC)sh 85074754

=LDR  01394cz  a2200385n  4500
=001  9880363631402441
=005  20141212192256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007828
=035  \\$aCBA1032HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x460
=072  \\$aE1.$x370.$x388.$x250.$x525
=072  \\$aE4.$x502.$x250.$x525
=072  \\$aE4.$x580.$x373
=150  \\$aLaryngoscopy
=450  \\$wnnna$aLaryngoscopic Surgeries
=450  \\$wnnna$aLaryngoscopic Surgery
=450  \\$wnnna$aLaryngoscopic Surgical Procedure
=450  \\$aLaryngoscopic Surgical Procedures
=450  \\$wnnna$aLaryngoscopies
=450  \\$wnnna$aProcedure, Laryngoscopic Surgical
=450  \\$wnnna$aProcedures, Laryngoscopic Surgical
=450  \\$wnnna$aSurgeries, Laryngoscopic
=450  \\$wnnna$aSurgery, Laryngoscopic
=450  \\$wnnna$aSurgical Procedure, Laryngoscopic
=450  \\$aSurgical Procedures, Laryngoscopic
=550  \\$wg$aDiagnostic Techniques, Respiratory System
=550  \\$wg$aEndoscopy
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=550  \\$aLaryngoscopes
=550  \\$aLarynx
=667  \\$a/ instrum permitted but consider also LARYNGOSCOPES
=680  \\$iExamination, therapy or surgery of the interior of the larynx performed with a specially designed endoscope.
=750  \0$aLaryngoscopy$5IEN$0(DLC)sh 85074743

=LDR  00770cz  a2200217n  4500
=001  9880363631502441
=005  20141212202806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007827
=035  \\$aCBA1031M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360.$x535
=072  \\$aC8.$x730.$x368
=072  \\$aC9.$x400.$x535
=150  \\$aLaryngitis
=450  \\$wnnna$aLaryngitides
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aCroup
=680  \\$iInflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS.
=750  \0$aLaryngitis$5IEN-M$0(DLC)sh 98007005

=LDR  00668cz  a2200217n  4500
=001  9880363631602441
=005  20141212202806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007825
=035  \\$aCBA1029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x369
=150  \\$aLaryngectomy
=450  \\$aLaryngectomees$5IEN
=450  \\$wnnna$aLaryngectomies
=550  \\$wg$aOtorhinolaryngologic Surgical Procedures
=550  \\$aLarynx
=667  \\$ado not use /util except by MeSH definition
=680  \\$iTotal or partial excision of the larynx.
=750  \0$aLaryngectomees$5IEN-M$0(DLC)sh 85074738
=750  \0$aLaryngectomy$5IEN-HS$0(DLC)sh 85074740

=LDR  01803cz  a2200361n  4500
=001  9880363631702441
=005  20141212202806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007823
=035  \\$aCBA1027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x925.$x450
=072  \\$aA8.$x800.$x50.$x600.$x825.$x450
=072  \\$aA8.$x800.$x800.$x60.$x920.$x450
=072  \\$aA8.$x800.$x800.$x120.$x900.$x450
=150  \\$aLaryngeal Nerves
=450  \\$wnnna$aLaryngeal Nerve
=450  \\$aLaryngeal Nerve, Superior
=450  \\$wnnna$aLaryngeal Nerves, Superior
=450  \\$aLarynx$xinnervation
=450  \\$wnnna$aNerve, Laryngeal
=450  \\$wnnna$aNerve, Superior Laryngeal
=450  \\$wnnna$aNerves, Laryngeal
=450  \\$wnnna$aNerves, Superior Laryngeal
=450  \\$wnnna$aSuperior Laryngeal Nerve
=450  \\$wnnna$aSuperior Laryngeal Nerves
=550  \\$wg$aVagus Nerve
=550  \\$wh$aRecurrent Laryngeal Nerve
=667  \\$adisease: coordinate IM with CRANIAL NERVE DISEASES (IM); neoplasm: coordinate IM with CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iBranches of the VAGUS NERVE. The superior laryngeal nerves originate near the nodose ganglion and separate into external branches, which supply motor fibers to the cricothyroid muscles, and internal branches, which carry sensory fibers. The RECURRENT LARYNGEAL NERVE originates more caudally and carries efferents to all muscles of the larynx except the cricothyroid. The laryngeal nerves and their various branches also carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.
=688  \\$a65
=750  \0$aLaryngeal nerve$0(DLC) sh 85074737$5IEN-M
=750  \0$aLarynx$xInnervation$0(DLC) sh 85074750$5IEN-HS

=LDR  01597cz  a2200457n  4500
=001  9880363631802441
=005  20141212202805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007822
=035  \\$aCBA1026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x481
=072  \\$aC8.$x360.$x369
=072  \\$aC8.$x785.$x481
=072  \\$aC9.$x400.$x369
=072  \\$aC9.$x647.$x481
=150  \\$aLaryngeal Neoplasms
=450  \\$wnnna$aCancer, Laryngeal
=450  \\$wnnna$aCancer, Larynx
=450  \\$aCancer of Larynx
=450  \\$wnnna$aCancer of the Larynx
=450  \\$wnnna$aCancers, Laryngeal
=450  \\$wnnna$aCancers, Larynx
=450  \\$aLaryngeal Cancer
=450  \\$wnnna$aLaryngeal Cancers
=450  \\$wnnna$aLaryngeal Neoplasm
=450  \\$wnnna$aLarynx Cancer
=450  \\$wnnna$aLarynx Cancers
=450  \\$wnnna$aLarynx Neoplasm
=450  \\$aLarynx Neoplasms
=450  \\$wnnna$aNeoplasm, Laryngeal
=450  \\$wnnna$aNeoplasm, Larynx
=450  \\$wnnna$aNeoplasms, Laryngeal
=450  \\$wnnna$aNeoplasms, Larynx
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aOtorhinolaryngologic Neoplasms
=550  \\$wg$aRespiratory Tract Neoplasms
=667  \\$acoord IM with histol type of neopl (IM); laryngeal polyps = LARYNGEAL NEOPLASMS (IM) + POLYPS (IM)
=680  \\$iCancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
=750  \0$aLarynx$xTumors$5IEN-M$0(DLC)sh 85074756
=750  \0$aLarynx$xCancer$5IEN-HS$0(DLC)sh 85074746

=LDR  02252cz  a2200625n  4500
=001  9880363631902441
=005  20141212202805.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007821
=035  \\$aCBA1025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x500
=072  \\$aA4.$x329.$x604
=150  \\$aLaryngeal Muscles
=450  \\$wnnna$aAryepiglottic Muscle
=450  \\$wnnna$aAryepiglottic Muscles
=450  \\$wnnna$aArytenoid Muscle
=450  \\$wnnna$aArytenoid Muscles
=450  \\$wnnna$aCricoarytenoid Muscle
=450  \\$wnnna$aCricoarytenoid Muscles
=450  \\$wnnna$aCricothyroid Muscle
=450  \\$aCricothyroid Muscles
=450  \\$wnnna$aLaryngeal Muscle
=450  \\$wnnna$aMuscle, Aryepiglottic
=450  \\$wnnna$aMuscle, Arytenoid
=450  \\$wnnna$aMuscle, Cricoarytenoid
=450  \\$wnnna$aMuscle, Cricothyroid
=450  \\$wnnna$aMuscle, Laryngeal
=450  \\$wnnna$aMuscle, Thyroarytenoid
=450  \\$wnnna$aMuscle, Thyroepiglottic
=450  \\$wnnna$aMuscle, Vocal
=450  \\$wnnna$aMuscle, Vocalis
=450  \\$wnnna$aMuscles, Aryepiglottic
=450  \\$wnnna$aMuscles, Arytenoid
=450  \\$wnnna$aMuscles, Cricoarytenoid
=450  \\$wnnna$aMuscles, Cricothyroid
=450  \\$wnnna$aMuscles, Laryngeal
=450  \\$wnnna$aMuscles, Thyroarytenoid
=450  \\$wnnna$aMuscles, Thyroepiglottic
=450  \\$wnnna$aMuscles, Vocal
=450  \\$wnnna$aMuscles, Vocalis
=450  \\$wnnna$aThyroarytenoid Muscle
=450  \\$wnnna$aThyroarytenoid Muscles
=450  \\$wnnna$aThyroepiglottic Muscle
=450  \\$wnnna$aThyroepiglottic Muscles
=450  \\$wnnna$aVocal Muscle
=450  \\$wnnna$aVocal Muscles
=450  \\$wnnna$aVocalis Muscle
=450  \\$wnnna$aVocalis Muscles
=550  \\$wg$aLarynx
=550  \\$wg$aMuscle, Skeletal
=667  \\$a/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe striated muscle groups which move the LARYNX as a whole or its parts, such as altering tension of the VOCAL CORDS, or size of the slit (RIMA GLOTTIDIS).
=688  \\$a91(79); was see under MUSCLES 1979-90
=750  \0$aLarynx$xMuscles$5IEN$0(DLC)sh 85074752

=LDR  01779cz  a2200517n  4500
=001  9880363632002441
=005  20141212202803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007818
=035  \\$aCBA1022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x360
=072  \\$aC9.$x400
=150  \\$aLaryngeal Diseases
=450  \\$wnnna$aDisease, Laryngeal
=450  \\$wnnna$aDisease, Larynx
=450  \\$wnnna$aDiseases, Laryngeal
=450  \\$wnnna$aDiseases, Larynx
=450  \\$wnnna$aLaryngeal Disease
=450  \\$wnnna$aLaryngeal Perichondritides
=450  \\$aLaryngeal Perichondritis
=450  \\$wnnna$aLarynx Disease
=450  \\$wnnna$aLarynx Diseases
=450  \\$wnnna$aPerichondritides, Laryngeal
=450  \\$wnnna$aPerichondritis, Laryngeal
=550  \\$wg$aOtorhinolaryngologic Diseases
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aGranuloma, Laryngeal
=550  \\$wh$aLaryngeal Edema
=550  \\$wh$aLaryngeal Neoplasms
=550  \\$wh$aLaryngeal Nerve Injuries
=550  \\$wh$aLaryngitis
=550  \\$wh$aLaryngocele
=550  \\$wh$aLaryngomalacia
=550  \\$wh$aLaryngopharyngeal Reflux
=550  \\$wh$aLaryngostenosis
=550  \\$wh$aSupraglottitis
=550  \\$wh$aTuberculosis, Laryngeal
=550  \\$wh$aVocal Cord Dysfunction
=550  \\$wh$aVocal Cord Paralysis
=550  \\$wh$aVoice Disorders
=550  \\$aOtorhinolaryngologic Diseases
=667  \\$ainflammatory disease = LARYNGITIS
=680  \\$iPathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.
=688  \\$a66; LARYNGEAL PERICHONDRITIS was heading 1963-96
=750  \0$aLarynx$xDiseases$5IEN$0(DLC)sh 85074747

=LDR  01265cz  a2200277n  4500
=001  9880363632102441
=005  20141212202802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007816
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x523.$x780
=072  \\$aC3.$x335.$x508.$x700.$x100.$x868.$x420
=150  \\$aLarva Migrans, Visceral
=450  \\$wnnna$aLarva Migran, Visceral
=450  \\$wnnna$aMigran, Visceral Larva
=450  \\$wnnna$aMigrans, Visceral Larva
=450  \\$wnnna$aVisceral Larva Migran
=450  \\$wnnna$aVisceral Larva Migrans
=450  \\$aVisceral Larva Migrans Syndrome
=550  \\$wg$aLarva Migrans
=550  \\$wg$aToxocariasis
=667  \\$anote category: a disease; in human only, caused by Toxocara: coord IM with TOXOCARA CANIS (IM) if caused by T. canis but not with TOXOCARA if by T. cati; in animal probably = TOXOCARIASIS
=680  \\$iA condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati.
=688  \\$a1968
=688  \\$a68
=750  \0$aLarva migrans, Visceral$5IEN$0(DLC)sh 85074733

=LDR  00929cz  a2200277n  4500
=001  9880363632202441
=005  20141212202802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007814
=035  \\$aCBA1018HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x500.$x500
=072  \\$aG7.$x700.$x320.$x500.$x550.$x500.$x500
=150  \\$aLarva
=450  \\$wnnna$aLarvae
=450  \\$wnnna$aMaggot
=450  \\$aMaggots
=450  \\$wnnna$aTadpole
=450  \\$aTadpoles
=550  \\$wg$aLife Cycle Stages
=550  \\$wh$aCercaria
=550  \\$aImaginal Discs
=667  \\$aNIM; only for metamorphosing animals (so correct for tadpoles); do not use /embryol with reference to larvae; maggot is the larval form of a fly
=680  \\$iWormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals.
=688  \\$a74(70)
=750  \0$aLarvae$5IEN$0(DLC)sh 85074735

=LDR  01009cz  a2200217n  4500
=001  9880363632302441
=005  20141212202801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007811
=035  \\$aCBA1015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x500
=072  \\$aD1.$x268.$x558.$x362.$x500
=072  \\$aD1.$x552.$x550.$x399.$x500
=150  \\$aLanthanum
=450  \\$aLanthanum Compounds$5IEN
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; La-139; La-138 = LANTHANUM (IM) + ISOTOPES (NIM); La-126-137, 140-144 = LANTHANUM (IM) + RADIOISOTOPES (IM)
=680  \\$iLanthanum. The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass.
=750  \0$aLanthanum$5IEN-M$0(DLC)sh 85074635
=750  \0$aLanthanum compounds$5IEN-HS$0(DLC)sh 88003375

=LDR  00470cz  a2200157n  4500
=001  9880363632402441
=005  20141212202800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007809
=035  \\$aCBA1013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x945.$x507
=150  \\$aLanolin
=550  \\$wg$aWaxes
=680  \\$iA yellow fat obtained from sheep's wool. It is used as an emollient, cosmetic, and pharmaceutic aid.
=750  \0$aLanolin$5IEN$0(DLC)sh 85074623

=LDR  01629cz  a2200337n  4500
=001  9880363632502441
=005  20141212202800.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007807
=035  \\$aCBA1011HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x400
=150  \\$aLanguage Tests
=450  \\$wnnna$aComprehension Test, Language
=450  \\$wnnna$aComprehension Tests, Language
=450  \\$wnnna$aLanguage Comprehension Test
=450  \\$aLanguage Comprehension Tests
=450  \\$wnnna$aLanguage Test
=450  \\$wnnna$aTest, Language
=450  \\$wnnna$aTest, Language Comprehension
=450  \\$wnnna$aTest, Vocabulary
=450  \\$wnnna$aTests, Language
=450  \\$wnnna$aTests, Language Comprehension
=450  \\$wnnna$aTests, Vocabulary
=450  \\$wnnna$aVocabulary Test
=450  \\$aVocabulary Tests
=550  \\$wg$aPsychological Tests
=680  \\$iTests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children's Language Comprehension.
=688  \\$a79
=750  \0$aLanguage and languages$xAbility testing$5IEN-M$0(DLC)sh 85074519
=750  \0$aVocabulary tests$5IEN-HS$0(DLC)sh 85144059

=LDR  01380cz  a2200349n  4500
=001  9880363632602441
=005  20141212202759.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007806
=035  \\$aCBA1010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500
=150  \\$aLanguage Disorders
=450  \\$wnnna$aAcquired Language Disorder
=450  \\$wnnna$aAcquired Language Disorders
=450  \\$wnnna$aLanguage Disorder
=450  \\$wnnna$aLanguage Disorder, Acquired
=450  \\$wnnna$aLanguage Disorders, Acquired
=550  \\$wg$aCommunication Disorders
=550  \\$wh$aAgraphia
=550  \\$wh$aAnomia
=550  \\$wh$aDyslexia
=550  \\$wh$aLanguage Development Disorders
=550  \\$wh$aSpeech Disorders
=550  \\$aSpeech Disorders
=550  \\$aVerbal Behavior
=550  \\$aVerbal Learning
=667  \\$a/ther: consider also LANGUAGE THERAPY; do not confuse with SPEECH DISORDERS: read differentiation of LANGUAGE & SPEECH under LANGUAGE; do not confuse with LANGUAGE DEVELOPMENT DISORDERS: see note there
=680  \\$iConditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.
=688  \\$a1967
=750  \0$aLanguage disorders$5IEN$0(DLC)sh 85074558

=LDR  01996cz  a2200421n  4500
=001  9880363632702441
=005  20141212202759.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007805
=035  \\$aCBA1009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x550
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x550
=150  \\$aLanguage Development Disorders
=450  \\$wnnna$aAuditory Processing Disorder, Central
=450  \\$wnnna$aCentral Auditory Processing Disorder
=450  \\$wnnna$aDelay, Speech
=450  \\$wnnna$aDelays, Speech
=450  \\$wnnna$aDevelopment Disorder, Language
=450  \\$wnnna$aDevelopmental Disorder, Speech or Language
=450  \\$wnnna$aDevelopmental Language Disorder
=450  \\$wnnna$aDevelopmental Language Disorders
=450  \\$aLanguage Delay
=450  \\$wnnna$aLanguage Delays
=450  \\$wnnna$aLanguage Development Disorder
=450  \\$wnnna$aLanguage Disorder, Developmental
=450  \\$wnnna$aLanguage Disorders, Developmental
=450  \\$wnnna$aSemantic-Pragmatic Disorder
=450  \\$wnnna$aSemantic Pragmatic Disorder
=450  \\$wnnna$aSemantic-Pragmatic Disorders
=450  \\$aSpeech Delay
=450  \\$wnnna$aSpeech Delays
=450  \\$wnnna$aSpeech or Language, Developmental Disorder
=550  \\$wg$aLanguage Disorders
=667  \\$ado not confuse with LANGUAGE DISORDERS, disord of use or comprehension of language: LANGUAGE DEVELOPMENT DISORDERS is "failure to understand or speak the language at the expected age"; DF: LANGUAGE DEVELOPMENT DIS
=680  \\$iConditions characterized by language abilities (comprehension and expression of speech and writing) that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.
=688  \\$a1986(1980)
=750  \0$aLanguage disorders$5IEN$0(DLC)sh 85074558

=LDR  00995cz  a2200265n  4500
=001  9880363632802441
=005  20141212202758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007804
=035  \\$aCBA1008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x525.$x200.$x310
=150  \\$aLanguage Development
=450  \\$wnnna$aDevelopment, Language
=450  \\$wnnna$aDevelopments, Language
=450  \\$aLangauge Acquisition$5IEN
=450  \\$wnnna$aLanguage Developments
=550  \\$wg$aChild Development
=550  \\$wh$aChild Language
=550  \\$wh$aCrying
=550  \\$aPsycholinguistics
=667  \\$ano qualif
=680  \\$iThe gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition, and use of short sentences.
=688  \\$a68
=750  \0$aLanguage acquisition$5IEN$0(DLC)sh 85074511

=LDR  00960cz  a2200289n  4500
=001  9880363632902441
=005  20141212202758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007803
=035  \\$aCBA1007HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423
=150  \\$aLanguage Arts
=450  \\$wnnna$aArt, Language
=450  \\$wnnna$aArts, Language
=450  \\$wnnna$aLanguage Art
=550  \\$wg$aLanguage
=550  \\$wh$aLipreading
=550  \\$wh$aMultilingualism
=550  \\$wh$aReading
=550  \\$wh$aSpeech
=550  \\$wh$aTranslating
=550  \\$wh$aWriting
=667  \\$aemphasis here is on skill & applic of language: differentiate from LANGUAGE itself: see note there; GEN or unspecified; prefer specifics
=680  \\$iSkills in the use of language which lead to proficiency in written or spoken communication.
=688  \\$a98; use explode 1975-97
=750  \0$aLanguage arts$5IEN-M$0(DLC)sh 85074546

=LDR  00731cz  a2200217n  4500
=001  9880363633002441
=005  20141212202758.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007802
=035  \\$aCBA1006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x399
=072  \\$aL1.$x143.$x506
=150  \\$aLanguage
=450  \\$wnnna$aLanguages
=550  \\$wg$aCommunication
=550  \\$wh$aLanguage Arts
=550  \\$wh$aLinguistics
=667  \\$awhat is spoken or written; do not confuse with LINGUISTICS (see note there) or SPEECH (language as it comes out of the mouth)
=680  \\$iA verbal or nonverbal means of communicating ideas or feelings.
=750  \0$aLanguage and languages$5IEN$0(DLC)sh 85074518

=LDR  02008cz  a2200445n  4500
=001  9880363633102441
=005  20141212202757.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007801
=035  \\$aCBA1005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x66.$x270.$x500
=072  \\$aA11.$x436.$x270.$x545
=072  \\$aA15.$x382.$x66.$x270.$x500
=072  \\$aA15.$x382.$x812.$x260.$x500
=150  \\$aLangerhans Cells
=450  \\$wnnna$aCell, Dermal Dendritic
=450  \\$wnnna$aCell, Epidermal Dendritic
=450  \\$wnnna$aCell, Skin Dendritic
=450  \\$wnnna$aCells, Dermal Dendritic
=450  \\$wnnna$aCells, Epidermal Dendritic
=450  \\$wnnna$aCells, Langerhans
=450  \\$wnnna$aCells, Skin Dendritic
=450  \\$wnnna$aDendritic Cell, Dermal
=450  \\$wnnna$aDendritic Cell, Epidermal
=450  \\$wnnna$aDendritic Cell, Skin
=450  \\$wnnna$aDendritic Cells, Dermal
=450  \\$wnnna$aDendritic Cells, Epidermal
=450  \\$wnnna$aDendritic Cells, Skin
=450  \\$wnnna$aDermal Dendritic Cell
=450  \\$wnnna$aDermal Dendritic Cells
=450  \\$wnnna$aEpidermal Dendritic Cell
=450  \\$wnnna$aEpidermal Dendritic Cells
=450  \\$wnnna$aSkin Dendritic Cell
=450  \\$wnnna$aSkin Dendritic Cells
=550  \\$wg$aDendritic Cells
=667  \\$acutaneous cells: do not confuse with ISLETS OF LANGERHANS (pancreas) nor with GIANT CELLS, LANGHANS (macrophages)
=680  \\$iRecirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS.
=688  \\$a73(69)
=750  \0$aLangerhans cells$0(DLC) sh 90001839$5IEN

=LDR  00872cz  a2200265n  4500
=001  9880363633202441
=005  20141212202756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007798
=035  \\$aCBA1002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x559
=150  \\$aLampreys
=450  \\$wnnna$aEel, Lamprey
=450  \\$aEels, Lamprey
=450  \\$wnnna$aLamprey
=450  \\$wnnna$aLamprey Eel
=450  \\$wnnna$aLamprey Eels
=450  \\$aPetromyzontidae
=450  \\$wnnna$aPetromyzontiformes
=550  \\$wg$aFishes
=550  \\$wh$aPetromyzon
=680  \\$iCommon name for the only family (Petromyzontidae) of eellike fish in the order Petromyzontiformes. They are jawless but have a sucking mouth with horny teeth.
=688  \\$a91(75); was see under CYCLOSTOMES 1975-90
=750  \0$aLampreys$5IEN$0(DLC)sh 85074247

=LDR  00908cz  a2200229n  4500
=001  9880363633302441
=005  20141212202756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007796
=035  \\$aCBA1000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x450
=150  \\$aLaminectomy
=450  \\$wnnna$aLaminectomies
=450  \\$wnnna$aLaminotomies
=450  \\$wnnna$aLaminotomy
=550  \\$wg$aNeurosurgical Procedures
=550  \\$aSpinal Fusion
=550  \\$aSpine
=680  \\$iA surgical procedure that entails removing all (laminectomy) or part (laminotomy) of selected vertebral lamina to relieve pressure on the SPINAL CORD and/or SPINAL NERVE ROOTS. Vertebral lamina is the thin flattened posterior wall of vertebral arch that forms the vertebral foramen through which pass the spinal cord and nerve roots.
=688  \\$a67(64)
=750  \0$aLaminectomy$5IEN$0(DLC)sh 85074221

=LDR  01144cz  a2200313n  4500
=001  9880363633402441
=005  20141212202756.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007795
=035  \\$aCBA0999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x450
=150  \\$aLaminaria
=450  \\$wnnna$ajaponica, Laminaria
=450  \\$wnnna$ajaponicas, Laminaria
=450  \\$wnnna$aKombu
=450  \\$wnnna$aKombus
=450  \\$wnnna$aLaminaria japonica
=450  \\$wnnna$aLaminaria japonicas
=450  \\$wnnna$aLaminaria Tent
=450  \\$aLaminaria Tents
=450  \\$wnnna$aLaminarias
=450  \\$wnnna$aTent, Laminaria
=450  \\$wnnna$aTents, Laminaria
=550  \\$wg$aPhaeophyta
=667  \\$afor dried Laminaria for cervical dilat & "laminaria tent" (note X ref & read MeSH definition), use no qualif
=680  \\$iA genus of BROWN ALGAE in the family Laminariaceae. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, serving as osmotic dilators.
=688  \\$a91(80); was see under SEAWEED 1980-90
=750  \0$aLaminaria$5IEN$0(DLC)sh 86003713

=LDR  01199cz  a2200277n  4500
=001  9880363633502441
=005  20200508124918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007793
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$968
=150  \\$aLagomorpha
=450  \\$wnnna$aLagomorph
=450  \\$wnnna$aLagomorphs
=450  \\$wnnna$aLeporidae
=450  \\$aOchotona
=450  \\$wnnna$aOchotonidae
=450  \\$wnnna$aPika
=450  \\$aPikas
=550  \\$wg$aEutheria
=550  \\$wh$aHares
=550  \\$wh$aRabbits
=667  \\$aHARES and RABBITS are available; note X refs
=680  \\$iAn order of small mammals comprising two families, Ochotonidae (pikas) and Leporidae (RABBITS and HARES). Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. (From Nowak, Walker's Mammals of the World, 5th ed, p539-41)
=688  \\$a91(75); was see under MAMMALS 1975-90; was see under RABBITS 1963-74
=750  \0$aLagomorpha$5IEN$0(DLC)sh 85073948

=LDR  00807cz  a2200217n  4500
=001  9880363633602441
=005  20141212202755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007792
=035  \\$aCBA0996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x305.$x423
=150  \\$aLactulose
=450  \\$wnnna$aAmivalex
=450  \\$wnnna$aDuphalac
=450  \\$wnnna$aNormase
=550  \\$wg$aDisaccharides
=667  \\$ado not confuse with LACTOSE
=680  \\$iA synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887)
=688  \\$a91(73); was see under DISACCHARIDES 1973-90
=750  \0$aLactulose$5IEN$0(DLC)sh 88003122

=LDR  01392cz  a2200337n  4500
=001  9880363633702441
=005  20141212202753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007787
=035  \\$aCBA0991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637.$x506
=072  \\$aC16.$x320.$x565.$x202.$x589
=072  \\$aC18.$x452.$x603.$x506
=072  \\$aC18.$x452.$x648.$x202.$x589
=150  \\$aLactose Intolerance
=450  \\$wnnna$aAlactasia
=450  \\$wnnna$aDairy Product Intolerance
=450  \\$wnnna$aHypolactasia
=450  \\$wnnna$aIntolerance, Lactose
=450  \\$aLactose Malabsorption
=450  \\$wnnna$aMalabsorption, Lactose
=450  \\$wnnna$aMilk Sugar Intolerance
=550  \\$wg$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wg$aMalabsorption Syndromes
=550  \\$aLactase
=550  \\$aLactase-Phlorizin Hydrolase
=550  \\$aMilk Hypersensitivity
=680  \\$iThe condition resulting from the absence or deficiency of LACTASE in the MUCOSA cells of the GASTROINTESTINAL TRACT, and the inability to break down LACTOSE in milk for ABSORPTION. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (DYSPEPSIA) to severe DIARRHEA. Lactose intolerance may be an inborn error or acquired.
=688  \\$a67(64)
=750  \0$aLactose intolerance$5IEN$0(DLC)sh 85073873

=LDR  00612cz  a2200181n  4500
=001  9880363633802441
=005  20141212202752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007785
=035  \\$aCBA0989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x305.$x340
=150  \\$aLactose
=450  \\$wnnna$aAnhydrous Lactose
=450  \\$wnnna$aLactose, Anhydrous
=550  \\$wg$aDisaccharides
=680  \\$iA disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
=750  \0$aLactose$5IEN$0(DLC)sh 85073871

=LDR  01038cz  a2200301n  4500
=001  9880363633902441
=005  20141212202752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007783
=035  \\$aCBA0987HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540
=150  \\$aLactones
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$a4-Butyrolactone
=550  \\$wh$aAcetogenins
=550  \\$wh$aAcyl-Butyrolactones
=550  \\$wh$aDehydroascorbic Acid
=550  \\$wh$aMacrolides
=550  \\$wh$aPicrotoxin
=550  \\$wh$aPolyketides
=550  \\$wh$aPropiolactone
=550  \\$wh$aSpironolactone
=550  \\$wh$aVenturicidins
=550  \\$wh$aZearalenone
=667  \\$apyran-2-ones: index PYRONES + LACTONES but BENZOPYRAN-2-ONES is available; for cyclic lactones over 12 atoms consider MACROLIDES
=680  \\$iCyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES.
=750  \0$aLactones$0(DLC) sh 85073870$5IEN

=LDR  01686cz  a2200493n  4500
=001  9880363634002441
=005  20171219135646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007782
=035  \\$aCBA0986M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x256.$x626.$x816.$x500
=072  \\$aD12.$x776.$x377.$x457
=150  \\$aLactoglobulins
=450  \\$wnnna$aA, beta-Lactoglobulin
=450  \\$wnnna$aB, beta-Lactoglobulin
=450  \\$wnnna$abeta-Lactoglobulin
=450  \\$wnnna$abeta Lactoglobulin
=450  \\$wnnna$abeta-Lactoglobulin A
=450  \\$wnnna$abeta Lactoglobulin A
=450  \\$wnnna$abeta-Lactoglobulin B
=450  \\$wnnna$abeta Lactoglobulin B
=450  \\$wnnna$abeta-Lactoglobulin C
=450  \\$wnnna$abeta Lactoglobulin C
=450  \\$wnnna$abeta-Lactoglobulin E
=450  \\$wnnna$abeta Lactoglobulin E
=450  \\$wnnna$abeta-Lactoglobulin F
=450  \\$wnnna$abeta Lactoglobulin F
=450  \\$wnnna$abeta-Lactoglobulin G
=450  \\$wnnna$abeta Lactoglobulin G
=450  \\$wnnna$abeta-Lactoglobulin I
=450  \\$wnnna$abeta Lactoglobulin I
=450  \\$wnnna$aC, beta-Lactoglobulin
=450  \\$wnnna$aE, beta-Lactoglobulin
=450  \\$wnnna$aF, beta-Lactoglobulin
=450  \\$wnnna$aG, beta-Lactoglobulin
=450  \\$wnnna$aI, beta-Lactoglobulin
=550  \\$wg$aGlobulins
=550  \\$wg$aWhey Proteins
=550  \\$wh$aLactoferrin
=667  \\$amilk proteins; /biosyn /physiol permitted
=680  \\$iGlobulins occurring in milk. (From Dorland, 28th ed)
=688  \\$a67; was LACTOGLOBULIN see under GLOBULINS 1963-66 (Prov)
=750  \0$aLactoglobulins$0(DLC)sh2009005156$5IEN-M

=LDR  01248cz  a2200277n  4500
=001  9880363634102441
=005  20141212202751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x471
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x471
=072  \\$aD12.$x776.$x157.$x427.$x750.$x249
=072  \\$aD12.$x776.$x256.$x626.$x632.$x507
=072  \\$aD12.$x776.$x377.$x457.$x507
=072  \\$aD12.$x776.$x395.$x507
=072  \\$aD12.$x776.$x556.$x579.$x750.$x249
=150  \\$aLactoferrin
=450  \\$wnnna$aLactotransferrin
=550  \\$wg$aGlycoproteins
=550  \\$wg$aLactoglobulins
=550  \\$wg$aSerine Endopeptidases
=550  \\$wg$aTransferrins
=680  \\$iAn iron-binding protein that was originally characterized as a milk protein. It is widely distributed in secretory fluids and is found in the neutrophilic granules of LEUKOCYTES. The N-terminal part of lactoferrin possesses a serine protease which functions to inactivate the type III secretion system used by bacteria to export virulence proteins for host cell invasion.
=688  \\$a91(73); was see under LACTOGLOBULINS 1973-90
=750  \0$aLactoferrin$5IEN$0(DLC)sh 85073869

=LDR  00854nz  a2200205n  4500
=001  9882549679302441
=005  20250214144054.0
=008  990101\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007780
=035  \\$a(DNLM)D007780
=035  \\$a(NLM)98200027880000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x353.$x750.$x450.$x606.$x500
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x737.$x500
=072  \\$aB3.$x510.$x550.$x450.$x606.$x500
=150  \\$aLacticaseibacillus casei
=450  \\$aLactobacillus casei
=680  \\$iA rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. L. casei is CATALASE positive.
=688  \\$a2023(1974)
=750  \0$aLactobacillus casei$5IEN$0(DLC)sh 88023272

=LDR  00738cz  a2200181n  4500
=001  9880363634302441
=005  20141212202751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007779
=035  \\$aCBA0983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x475.$x100
=072  \\$aB3.$x510.$x550.$x450.$x475.$x100
=150  \\$aLactobacillus acidophilus
=450  \\$wnnna$aLactobacillus amylovorus
=550  \\$wg$aLactobacillus
=680  \\$iA species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.
=750  \0$aLactobacillus acidophilus$0(DLC) sh 88023270$5IEN

=LDR  01484cz  a2200385n  4500
=001  9880363634402441
=005  20180730135609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007778
=035  \\$aCBA0982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x353.$x750.$x450.$x475
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475.$x475
=072  \\$aB3.$x510.$x550.$x450.$x475
=150  \\$aLactobacillus
=550  \\$wg$aLactobacillaceae
=550  \\$wh$aLactobacillus acidophilus
=550  \\$wh$aLactobacillus brevis
=550  \\$wh$aLactobacillus casei
=550  \\$wh$aLactobacillus crispatus
=550  \\$wh$aLactobacillus delbrueckii
=550  \\$wh$aLactobacillus fermentum
=550  \\$wh$aLactobacillus gasseri
=550  \\$wh$aLactobacillus helveticus
=550  \\$wh$aLactobacillus johnsonii
=550  \\$wh$aLactobacillus leichmannii
=550  \\$wh$aLactobacillus paracasei
=550  \\$wh$aLactobacillus pentosus
=550  \\$wh$aLactobacillus plantarum
=550  \\$wh$aLactobacillus reuteri
=550  \\$wh$aLactobacillus rhamnosus
=550  \\$wh$aLactobacillus sakei
=550  \\$wh$aLactobacillus salivarius
=680  \\$iA genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.
=750  \0$aLactobacillus$0(DLC) sh 88023269$5IEN

=LDR  00868cz  a2200229n  4500
=001  9880363634502441
=005  20141212202750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007777
=035  \\$aCBA0981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x410.$x475
=072  \\$aB3.$x510.$x550.$x450
=150  \\$aLactobacillaceae
=550  \\$wg$aGram-Positive Asporogenous Rods, Regular
=550  \\$wg$aLactobacillales
=550  \\$wh$aLactobacillus
=550  \\$wh$aPediococcus
=667  \\$ain food, dairy prod, plants, digestive system
=680  \\$iA family of gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices. A few species are highly pathogenic.
=688  \\$a75
=750  \0$aLactobacillaceae$5IEN$0(DLC)sh 88023268

=LDR  00792cz  a2200253n  4500
=001  9880363634602441
=005  20141212202750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007775
=035  \\$aCBA0979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x844.$x506
=072  \\$aC17.$x800.$x90.$x937
=150  \\$aLactation Disorders
=450  \\$wnnna$aDisorder, Lactation
=450  \\$wnnna$aDisorders, Lactation
=450  \\$aHypogalactia
=450  \\$wnnna$aHypogalactias
=450  \\$wnnna$aLactation Disorder
=550  \\$wg$aBreast Diseases
=550  \\$wg$aPuerperal Disorders
=550  \\$wh$aGalactorrhea
=680  \\$iDisturbances of MILK secretion in either SEX, not necessarily related to PREGNANCY.
=750  \0$aLactation disorders$5IEN$0(DLC)sh 85073865

=LDR  01473cz  a2200313n  4500
=001  9880363634702441
=005  20141212202749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007774
=035  \\$aCBA0978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x702.$x500
=072  \\$aG8.$x686.$x785.$x420
=150  \\$aLactation
=450  \\$aLactation, Prolonged
=450  \\$wnnna$aLactations, Prolonged
=450  \\$wnnna$aProlonged Lactation
=450  \\$wnnna$aProlonged Lactations
=550  \\$wg$aPostpartum Period
=550  \\$wg$aReproductive Physiological Processes
=550  \\$wh$aMilk Ejection
=550  \\$aBreast
=550  \\$aGalactogogues
=550  \\$aMilk
=550  \\$aMilk, Human
=667  \\$acheck the tag FEMALE usually but occasionally MALE; "postpartum amenorrhea" is indexed under PUERPERIUM + AMENORRHEA and not LACTATION unless lactation is particularly discussed; ANIMALS, SUCKLING is available but the suckling of an animal goes here: human suckling goes under BREAST FEEDING
=680  \\$iThe processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN.
=688  \\$aLACTATION, PROLONGED was heading 1975-96 (see under LACTATION 1975-90)
=750  \0$aLactation$5IEN$0(DLC)sh 85073863

=LDR  00640cz  a2200205n  4500
=001  9880363634802441
=005  20141212202749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007773
=035  \\$aCBA0977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x511.$x459
=150  \\$aLactates
=450  \\$aSodium Lactate$xanalogs & derivatives
=550  \\$wg$aHydroxy Acids
=550  \\$wh$aLactic Acid
=550  \\$wh$aSodium Lactate
=667  \\$ado not confuse with LACTATE see LACTIC ACID
=680  \\$iSalts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
=750  \0$aLactates$5IEN-M$0(DLC)sh 94005186

=LDR  01202cz  a2200277n  4500
=001  9880363634902441
=005  20141212202749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007772
=035  \\$aCBA0976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x504.$x80.$x100.$x500
=072  \\$aB4.$x909.$x777.$x500.$x80.$x500.$x500
=150  \\$aLactate dehydrogenase-elevating virus
=450  \\$wnnna$aLactate dehydrogenase elevating virus
=450  \\$wnnna$aLactate dehydrogenase-elevating viruses
=450  \\$wnnna$aLactate Dehydrogenase Virus
=450  \\$wnnna$aLactate Dehydrogenase Viruses
=450  \\$wnnna$aLactic Dehydrogenase Virus
=450  \\$wnnna$aLactic Dehydrogenase Viruses
=450  \\$aRiley Virus
=550  \\$wg$aArterivirus
=667  \\$ainfection: coord IM with ARTERIVIRUS INFECTIONS (IM)
=680  \\$iA species ARTERIVIRUS, occurring in a number of transplantable mouse tumors. Infected mice have permanently elevated serum levels of lactate dehydrogenase.
=688  \\$a2002(1969); for LACTIC DEHYDROGENASE VIRUSES use LACTATE DEHYDROGENASE VIRUS 1977-1993, use RILEY VIRUS 1975-1976
=750  \0$aLactate dehydrogenase virus$5IEN$0(DLC)sh 85073868

=LDR  00752cz  a2200253n  4500
=001  9880363635002441
=005  20141212202748.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007769
=035  \\$aCBA0973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589
=072  \\$aD3.$x383.$x411
=150  \\$aLactams
=450  \\$wnnna$aLactims
=550  \\$wg$aAmides
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$abeta-Lactams
=550  \\$wh$aCaprolactam
=550  \\$wh$aLactams, Macrocyclic
=550  \\$wh$aMonobactams
=680  \\$iCyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.
=688  \\$a74(72)
=750  \0$aLactams$5IEN$0(DLC)sh 85073858

=LDR  00999cz  a2200325n  4500
=001  9880363635102441
=005  20171219135250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007768
=035  \\$aCBA0972M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x34.$x398
=072  \\$aD12.$x776.$x256.$x626.$x816.$x250
=150  \\$aLactalbumin
=450  \\$wnnna$aA, alpha-Lactalbumin
=450  \\$wnnna$aalpha-Lactalbumin
=450  \\$wnnna$aalpha Lactalbumin
=450  \\$wnnna$aalpha-Lactalbumin A
=450  \\$wnnna$aalpha Lactalbumin A
=450  \\$wnnna$aalpha-Lactalbumin B
=450  \\$wnnna$aalpha Lactalbumin B
=450  \\$wnnna$aalpha-Lactalbumin C
=450  \\$wnnna$aalpha Lactalbumin C
=450  \\$wnnna$aB, alpha-Lactalbumin
=450  \\$wnnna$aC, alpha-Lactalbumin
=550  \\$wg$aAlbumins
=550  \\$wg$aWhey Proteins
=667  \\$aa milk protein
=688  \\$a73; was see under ALBUMINS 1963-72
=750  \2$aLactalbumin$0(DLC) sh2004000506$5IEN-M

=LDR  00929cz  a2200289n  4500
=001  9880363635202441
=005  20141212202747.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007766
=035  \\$aCBA0970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x496
=150  \\$aLacrimal Apparatus Diseases
=450  \\$wnnna$aApparatus Disease, Lacrimal
=450  \\$wnnna$aApparatus Diseases, Lacrimal
=450  \\$wnnna$aDisease, Lacrimal Apparatus
=450  \\$wnnna$aDiseases, Lacrimal Apparatus
=450  \\$aEpiphora
=450  \\$wnnna$aLacrimal Apparatus Disease
=550  \\$wg$aEye Diseases
=550  \\$wh$aDacryocystitis
=550  \\$wh$aDry Eye Syndromes
=550  \\$wh$aLacrimal Duct Obstruction
=667  \\$ainflamm dis = DACRYOCYSTITIS
=680  \\$iDiseases of the lacrimal apparatus.
=688  \\$a76; was NON MESH before 1976
=750  \0$aLacrimal apparatus$xDiseases$5IEN$0(DLC)sh 85073849

=LDR  00995cz  a2200265n  4500
=001  9880363635302441
=005  20141212202747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007765
=035  \\$aCBA0969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x463
=072  \\$aA10.$x336.$x422
=150  \\$aLacrimal Apparatus
=450  \\$wnnna$aApparatus, Lacrimal
=450  \\$wnnna$aGland, Lacrimal
=450  \\$wnnna$aGlands, Lacrimal
=450  \\$aLacrimal Gland
=450  \\$wnnna$aLacrimal Glands
=550  \\$wg$aExocrine Glands
=550  \\$wg$aEye
=550  \\$wh$aNasolacrimal Duct
=667  \\$ainflammation = DACRYOCYSTITIS; lacrimation: index TEARS /secret unless LACRIMAL APPARATUS /secret or LACRIMAL APPARATUS /physiol is particularly discussed
=680  \\$iThe tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.
=750  \0$aLacrimal Apparatus$5IEN$0(DLC)sh 85073848

=LDR  00456cz  a2200169n  4500
=001  9880363635402441
=005  20141212202746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007764
=035  \\$aCBA0968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x597.$x422
=150  \\$aLacquer
=450  \\$wnnna$aLacquers
=550  \\$wg$aPaint
=688  \\$a91(75); was see under PAINT 1975-90
=750  \0$aLacquer and Lacquering$5IEN$0(DLC)sh 85073830

=LDR  00828cz  a2200229n  4500
=001  9880363635502441
=005  20141212202746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007761
=035  \\$aCBA0965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x270.$x517
=150  \\$aLabyrinthine Fluids
=450  \\$wnnna$aFluid, Labyrinthine
=450  \\$wnnna$aFluids, Labyrinthine
=450  \\$wnnna$aLabyrinthine Fluid
=550  \\$wg$aExtracellular Fluid
=550  \\$wh$aEndolymph
=550  \\$wh$aPerilymph
=667  \\$aGEN or unspecified; prefer ENDOLYMPH & PERILYMPH
=680  \\$iFluids found within the osseous labyrinth (PERILYMPH) and the membranous labyrinth (ENDOLYMPH) of the inner ear. (From Gray's Anatomy, 30th American ed, p1328, 1332)
=750  \0$aLabyrinthine fluids$5IEN$0(DLC)sh 85073792

=LDR  00952cz  a2200277n  4500
=001  9880363635602441
=005  20141212202745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007759
=035  \\$aCBA0963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x568
=150  \\$aLabyrinth Diseases
=450  \\$wnnna$aEar Disease, Inner
=450  \\$wnnna$aEar Diseases, Inner
=450  \\$aInner Ear Disease
=450  \\$wnnna$aInner Ear Diseases
=450  \\$wnnna$aLabyrinth Disease
=550  \\$wg$aEar Diseases
=550  \\$wh$aCochlear Diseases
=550  \\$wh$aEndolymphatic Hydrops
=550  \\$wh$aLabyrinthitis
=550  \\$wh$aVestibular Diseases
=667  \\$ainflammatory disease = LABYRINTHITIS
=680  \\$iPathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).
=750  \0$aLabyrinth (Ear)$xDiseases$5IEN$0(DLC)sh 85073790

=LDR  02102cz  a2200445n  4500
=001  9880363635702441
=005  20141212202745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007758
=035  \\$aCBA0962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631
=150  \\$aEar, Inner
=450  \\$wnnna$aBony Labyrinth
=450  \\$wnnna$aBony Labyrinths
=450  \\$wnnna$aEar, Internal
=450  \\$wnnna$aEars, Inner
=450  \\$wnnna$aEars, Internal
=450  \\$wnnna$aInner Ear
=450  \\$wnnna$aInner Ears
=450  \\$wnnna$aInternal Ear
=450  \\$wnnna$aInternal Ears
=450  \\$aLabyrinth
=450  \\$wnnna$aLabyrinth, Bony
=450  \\$wnnna$aLabyrinth, Membranous
=450  \\$wnnna$aLabyrinths
=450  \\$wnnna$aLabyrinths, Bony
=450  \\$wnnna$aLabyrinths, Membranous
=450  \\$wnnna$aMembranous Labyrinth
=450  \\$wnnna$aMembranous Labyrinths
=550  \\$wg$aEar
=550  \\$wh$aCochlea
=550  \\$wh$aSemicircular Canals
=550  \\$wh$aVestibule, Labyrinth
=550  \\$aTemporal Bone
=667  \\$a/inj: pressure-induced injuries = EAR, INNER / inj (IM) + BAROTRAUMA (IM), noise-induced injuries = HEARING LOSS, NOISE-INDUCED; inflammation = LABYRINTHITIS; neoplasms = LABYRINTH DISEASES (IM) + EAR NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe essential part of the hearing organ consists of two labyrinthine compartments: the bony labyrinthine and the membranous labyrinth. The bony labyrinth is a complex of three interconnecting cavities or spaces (COCHLEA; VESTIBULAR LABYRINTH; and SEMICIRCULAR CANALS) in the TEMPORAL BONE. Within the bony labyrinth lies the membranous labyrinth which is a complex of sacs and tubules (COCHLEAR DUCT; SACCULE AND UTRICLE; and SEMICIRCULAR DUCTS) forming a continuous space enclosed by EPITHELIUM and connective tissue. These spaces are filled with LABYRINTHINE FLUIDS of various compositions.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Labyrinth
=750  \0$aLabyrinth (Ear)$0(DLC) sh 85073788$5IEN

=LDR  00796cz  a2200241n  4500
=001  9880363635802441
=005  20141212202744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007757
=035  \\$aCBA0961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x503
=072  \\$aC24.$x506
=150  \\$aLaboratory Infection
=450  \\$wnnna$aInfection, Laboratory
=450  \\$wnnna$aInfections, Laboratory
=450  \\$wnnna$aLaboratory Infections
=550  \\$wg$aInfection
=550  \\$wg$aOccupational Diseases
=667  \\$a"accidentally acquired infect in laboratory"; IM; coord with specific infection (IM) + lab animal (IM)
=680  \\$iAccidentally acquired infection in laboratory workers.
=688  \\$a68(64)
=750  \0$aLaboratory infections$5IEN$0(DLC)sh 85073750

=LDR  00784cz  a2200253n  4500
=001  9880363635902441
=005  20141212202744.0
=008  870502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007755
=035  \\$aCBA0959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x420
=072  \\$aN2.$x278.$x487.$x410
=072  \\$aN4.$x452.$x442.$x422.$x420
=150  \\$aLaboratories, Hospital
=450  \\$aHospital Laboratories
=450  \\$wnnna$aHospital Laboratory
=450  \\$wnnna$aLaboratory, Hospital
=550  \\$wg$aHospital Departments
=550  \\$wg$aLaboratories
=667  \\$aDF: LABORATORIES HOSP
=680  \\$iHospital facilities equipped to carry out investigative procedures.
=688  \\$a88
=750  \0$aHospital laboratories$5IEN$0(DLC)sh 85062245

=LDR  00712cz  a2200217n  4500
=001  9880363636002441
=005  20141212202743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007754
=035  \\$aCBA0958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x192.$x631
=150  \\$aLaboratories, Dental
=450  \\$wnnna$aDental Laboratories
=450  \\$wnnna$aDental Laboratory
=450  \\$wnnna$aLaboratory, Dental
=550  \\$wg$aDental Facilities
=667  \\$aDF: LABORATORIES DENT
=680  \\$iFacilities for the performance of services related to dental treatment but not done directly in the patient's mouth.
=688  \\$a74(72)
=750  \0$aDental laboratories$5IEN$0(DLC)sh 85036902

=LDR  00735cz  a2200217n  4500
=001  9880363636102441
=005  20141212202743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007753
=035  \\$aCBA0957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x487
=150  \\$aLaboratories
=450  \\$wnnna$aLaboratory
=550  \\$wg$aHealth Facilities
=550  \\$wh$aLaboratories, Hospital
=550  \\$aClinical Laboratory Services
=667  \\$acoord IM with type of lab (IM), as hematol lab = LABORATORIES (IM) + HEMATOLOGY (IM)
=680  \\$iFacilities equipped to carry out investigative procedures.
=750  \0$aMedical laboratories$5IEN-M$0(DLC)sh 85082957
=750  \0$aLaboratories$5IEN-HS$0(DLC)sh 85073739

=LDR  01234cz  a2200301n  4500
=001  9880363636202441
=005  20141212202743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x420.$x491
=150  \\$aObstetric Labor, Premature
=450  \\$wnnna$aLabor, Premature
=450  \\$wnnna$aLabor, Premature Obstetric
=450  \\$wnnna$aLabor, Preterm
=450  \\$wnnna$aPremature Labor
=450  \\$wnnna$aPremature Obstetric Labor
=450  \\$aPreterm Labor
=550  \\$wg$aObstetric Labor Complications
=550  \\$wh$aPremature Birth
=550  \\$aPremature Birth
=550  \\$aUterine Contraction
=667  \\$acheck the tags FEMALE & PREGNANCY; PREMATURE BIRTH is also available
=680  \\$iOnset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE).
=688  \\$a2006 (1964)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Labor, Premature
=688  \\$a67(64)
=750  \0$aPremature labor$0(DLC) sh 85073635$5IEN

=LDR  00722cz  a2200181n  4500
=001  9880363636302441
=005  20200407143008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007751
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x968
=150  \\$aLabor, Induced
=450  \\$wnnna$aInduced Labor
=550  \\$wg$aDelivery, Obstetric
=550  \\$wh$aAmniotomy
=667  \\$acheck tags FEMALE & PREGNANCY; amniotomy in inducing labor: coord IM with AMNION /surg (IM)
=680  \\$iArtificially induced UTERINE CONTRACTION. Generally, LABOR, OBSTETRIC is induced with the intent to cause delivery of the fetus and termination of pregnancy.
=750  \0$aLabor, Induced (Obstetrics)$5IEN-M$0(DLC)sh 85073634

=LDR  00947cz  a2200277n  4500
=001  9880363636402441
=005  20141212202742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007750
=035  \\$aCBA0954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x571
=150  \\$aLabor Unions
=450  \\$wnnna$aLabor Union
=450  \\$wnnna$aTrade Union
=450  \\$aTrade Unions
=450  \\$wnnna$aUnion, Labor
=450  \\$wnnna$aUnion, Trade
=450  \\$wnnna$aUnions, Labor
=450  \\$wnnna$aUnions, Trade
=550  \\$wg$aOrganizations
=550  \\$wh$aCollective Bargaining
=550  \\$wh$aStrikes, Employee
=680  \\$iOrganizations comprising wage and salary workers in health-related fields for the purpose of improving their status and conditions. The concept includes labor union activities toward providing health services to members.
=688  \\$a67(64)
=750  \0$aLabor unions$5IEN$0(DLC)sh 85136516

=LDR  01073cz  a2200265n  4500
=001  9880363636502441
=005  20141212202741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007746
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x520
=072  \\$aG8.$x686.$x785.$x760.$x769.$x326.$x520
=150  \\$aLabor Presentation
=450  \\$wnnna$aFetal Malpresentation
=450  \\$wnnna$aFetal Malpresentations
=450  \\$aFetal Presentation
=450  \\$wnnna$aMalpresentation, Fetal
=450  \\$aPresentation, Fetal
=450  \\$wnnna$aPresentation, Labor
=550  \\$wg$aLabor, Obstetric
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wh$aBreech Presentation
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iThe position or orientation of the FETUS at near term or during OBSTETRIC LABOR, determined by its relation to the SPINE of the mother and the birth canal. The normal position is a vertical, cephalic presentation with the fetal vertex flexed on the NECK.
=750  \0$aFetal presentation$5IEN$0(DLC)sh 85047954

=LDR  01679cz  a2200445n  4500
=001  9880363636602441
=005  20141212202740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x420
=150  \\$aObstetric Labor Complications
=450  \\$wnnna$aComplication, Labor
=450  \\$wnnna$aComplication, Obstetric Labor
=450  \\$aComplications, Labor
=450  \\$wnnna$aComplications, Obstetric Labor
=450  \\$wnnna$aLabor Complication
=450  \\$wnnna$aLabor Complication, Obstetric
=450  \\$aLabor Complications
=450  \\$wnnna$aLabor Complications, Obstetric
=450  \\$wnnna$aObstetric Labor Complication
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aAbruptio Placentae
=550  \\$wh$aBreech Presentation
=550  \\$wh$aCephalopelvic Disproportion
=550  \\$wh$aDystocia
=550  \\$wh$aFetal Membranes, Premature Rupture
=550  \\$wh$aObstetric Labor, Premature
=550  \\$wh$aPlacenta Accreta
=550  \\$wh$aPlacenta Previa
=550  \\$wh$aPostpartum Hemorrhage
=550  \\$wh$aUterine Inversion
=550  \\$wh$aUterine Rupture
=550  \\$wh$aVasa Previa
=667  \\$acheck the tags FEMALE & PREGNANCY
=680  \\$iMedical problems associated with OBSTETRIC LABOR, such as BREECH PRESENTATION; PREMATURE OBSTETRIC LABOR; HEMORRHAGE; or others. These complications can affect the well-being of the mother, the FETUS, or both.
=688  \\$a2006 (1964)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Labor Complications
=688  \\$a64
=750  \0$aLabor (Obstetrics)$xComplications$0(DLC) sh 85073633$5IEN

=LDR  00999cz  a2200253n  4500
=001  9880363636702441
=005  20141212202740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007743
=035  \\$aCBA0947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x326
=150  \\$aLabor, Obstetric
=450  \\$aObstetric Labor
=550  \\$wg$aPregnancy
=550  \\$wh$aCervical Ripening
=550  \\$wh$aLabor Onset
=550  \\$wh$aLabor Presentation
=550  \\$wh$aTrial of Labor
=550  \\$wh$aUterine Contraction
=667  \\$acheck tags FEMALE & PREGNANCY; LABOR, INDUCED is also available
=680  \\$iThe repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED).
=688  \\$a2003
=750  \0$aLabor (Obstetrics)$5IEN-HS$0(DLC)sh 85073636

=LDR  02124cz  a2200577n  4500
=001  9880363636802441
=005  20141212202739.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007741
=035  \\$aCBA0945HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x460
=072  \\$aD2.$x65.$x793.$x324
=072  \\$aD2.$x92.$x63.$x291.$x460
=150  \\$aLabetalol
=450  \\$wnnna$aAH-5158
=450  \\$wnnna$aAH 5158
=450  \\$wnnna$aAH5158
=450  \\$wnnna$aAlbetol
=450  \\$wnnna$aAlphapharm Brand of Labetalol Hydrochloride
=450  \\$wnnna$aApo-Labetalol
=450  \\$wnnna$aApo Labetalol
=450  \\$wnnna$aApoLabetalol
=450  \\$wnnna$aApotex Brand of Labetalol Hydrochloride
=450  \\$wnnna$aCelltech Brand of Labetalol Hydrochloride
=450  \\$wnnna$aDilevalol
=450  \\$wnnna$aFaro Brand of Labetalol Hydrochloride
=450  \\$wnnna$aGlaxo Wellcome Brand of Labetalol Hydrochloride
=450  \\$wnnna$aGlaxoSmithKline Brand of Labetalol Hydrochloride
=450  \\$wnnna$aHydrochloride, Labetalol
=450  \\$wnnna$aKern Brand of Labetalol Hydrochloride
=450  \\$wnnna$aLabetalol Hydrochloride
=450  \\$wnnna$aLabetalol, (R,R)-Isomer
=450  \\$wnnna$aLabetolol
=450  \\$wnnna$aLeiras Brand of Labetalol Hydrochloride
=450  \\$wnnna$aNormodyne
=450  \\$wnnna$aPresolol
=450  \\$wnnna$aR,R-Labetalol
=450  \\$wnnna$aR,R Labetalol
=450  \\$wnnna$aSCH-19927
=450  \\$wnnna$aSCH 19927
=450  \\$wnnna$aSCH19927
=450  \\$wnnna$aSchering Brand of Labetalol Hydrochloride
=450  \\$wnnna$aShire Brand of Labetalol Hydrochloride
=450  \\$wnnna$aSigma Brand of Labetalol Hydrochloride
=450  \\$wnnna$aTrandate
=550  \\$wg$aEthanolamines
=550  \\$wg$aSalicylamides
=680  \\$iA salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
=688  \\$a86(78); was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77
=750  \0$aLabetalol$5IEN$0(DLC)sh 85073626

=LDR  00819cz  a2200205n  4500
=001  9880363636902441
=005  20141212202739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007740
=035  \\$aCBA0944HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x110.$x422
=072  \\$aB5.$x110.$x422
=150  \\$aL Forms
=450  \\$aL-Form Bacteria$5IEN
=550  \\$wg$aAtypical Bacterial Forms
=667  \\$acoord IM with specific bacterium (IM)
=680  \\$iBacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.
=688  \\$a66(65)
=750  \0$aL-form bacteria$5IEN$0(DLC)sh 85073591

=LDR  00693cz  a2200181n  4500
=001  9880363637002441
=005  20141212202738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007738
=035  \\$aCBA0942HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x800.$x500
=150  \\$aKyphosis
=450  \\$wnnna$aKyphoses
=550  \\$wg$aSpinal Curvatures
=550  \\$wh$aScheuermann Disease
=680  \\$iDeformities of the SPINE characterized by an exaggerated convexity of the vertebral column. The forward bending of the thoracic region usually is more than 40 degrees. This deformity sometimes is called round back or hunchback.
=750  \0$aKyphosis$0(DLC) sh 85073583$5IEN

=LDR  00396cz  a2200157n  4500
=001  9880363637102441
=005  20141212202738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007737
=035  \\$aCBA0941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x608
=150  \\$aKynurenine
=550  \\$wg$aAmino Acids
=667  \\$aan amino acid
=750  \0$aKynurenine$0(DLC) sh 88006234$5IEN

=LDR  00995cz  a2200181n  4500
=001  9880363637202441
=005  20141212202737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007732
=035  \\$aCBA0936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x708.$x626.$x505
=150  \\$aKwashiorkor
=450  \\$wnnna$aKwashiorkors
=550  \\$wg$aProtein-Energy Malnutrition
=667  \\$asevere form of protein malnutrition
=680  \\$iA syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning "displaced child". Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed)
=750  \0$aKwashiorkor$5IEN$0(DLC)sh 85073548

=LDR  01228cz  a2200205n  4500
=001  9880363637302441
=005  20141212202736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007729
=035  \\$aCBA0933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x800.$x435
=072  \\$aC10.$x574.$x843.$x625
=150  \\$aKuru
=450  \\$wnnna$aEncephalopathy, Kuru
=450  \\$aKuru Encephalopathy
=550  \\$wg$aPrion Diseases
=667  \\$ado not confuse with KORO, a depersonalization disord
=680  \\$iA prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. (From Adams et al., Principles of Neurology, 6th ed, p773)
=750  \0$aKuru$5IEN$0(DLC)sh 85073487

=LDR  00948cz  a2200253n  4500
=001  9880363637402441
=005  20141212202736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007728
=035  \\$aCBA0932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x372.$x588
=072  \\$aA11.$x627.$x482.$x588
=072  \\$aA11.$x733.$x397.$x588
=072  \\$aA15.$x382.$x680.$x397.$x588
=072  \\$aA15.$x382.$x812.$x522.$x588
=150  \\$aKupffer Cells
=450  \\$wnnna$aCells, Kupffer
=550  \\$wg$aMacrophages
=550  \\$aMononuclear Phagocyte System
=667  \\$aalso called reticuloendothelial cells of liver
=680  \\$iSpecialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood, and dispose of worn out red blood cells.
=688  \\$a73
=750  \0$aKupffer cells$5IEN$0(DLC)sh 85073457

=LDR  00785cz  a2200205n  4500
=001  9880363637502441
=005  20141212202736.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007727
=035  \\$aCBA0931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x540
=150  \\$aKrypton Radioisotopes
=450  \\$wnnna$aRadioisotopes, Krypton
=550  \\$wg$aRadioisotopes
=550  \\$aKrypton
=667  \\$aKr-74-77, 79, 81, 85, 87-94; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of krypton that decay or disintegrate emitting radiation. Kr atoms with atomic weights 74-77, 79, 81, 85, and 87-94 are radioactive krypton isotopes.
=688  \\$a88
=750  \0$aKrypton$xIsotopes$5IEN-M$0(DLC)sh 85073328

=LDR  00714cz  a2200181n  4500
=001  9880363637602441
=005  20141212202735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007726
=035  \\$aCBA0930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x613.$x425
=072  \\$aD1.$x362.$x641.$x468
=150  \\$aKrypton
=550  \\$wg$aNoble Gases
=667  \\$aa rare gas; Kr-84; Kr-78, 80, 82, 83, 86 = KRYPTON (IM) + ISOTOPES (NIM); Kr-74-77, 79, 81, 85, 87-94 = KRYPTON RADIOISOTOPES (IM)
=680  \\$iA noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.
=750  \0$aKrypton$5IEN$0(DLC)sh 85073327

=LDR  00710cz  a2200241n  4500
=001  9880363637702441
=005  20141212202734.0
=008  781219\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007720
=035  \\$aCBA0924HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x400.$x410
=150  \\$aKnee Prosthesis
=450  \\$aArtificial Knee$5IEN
=450  \\$wnnna$aKnee Prostheses
=450  \\$wnnna$aProstheses, Knee
=450  \\$wnnna$aProsthesis, Knee
=550  \\$wg$aJoint Prosthesis
=550  \\$aArthroplasty, Replacement, Knee
=667  \\$ado not use /util except by MeSH definition
=680  \\$iReplacement for a knee joint.
=688  \\$a80
=750  \0$aArtificial knee$5IEN$0(DLC)sh 85008186

=LDR  00918cz  a2200301n  4500
=001  9880363637802441
=005  20141212202733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007719
=035  \\$aCBA0923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x475
=150  \\$aKnee Joint
=450  \\$wnnna$aJoint, Knee
=450  \\$wnnna$aJoint, Superior Tibiofibular
=450  \\$wnnna$aJoints, Knee
=450  \\$wnnna$aJoints, Superior Tibiofibular
=450  \\$wnnna$aKnee Joints
=450  \\$wnnna$aSuperior Tibiofibular Joint
=450  \\$wnnna$aSuperior Tibiofibular Joints
=450  \\$wnnna$aTibiofibular Joint, Superior
=450  \\$wnnna$aTibiofibular Joints, Superior
=550  \\$wg$aJoints
=550  \\$wh$aMenisci, Tibial
=550  \\$wh$aPatellofemoral Joint
=667  \\$aprimates only; differentiate from KNEE
=688  \\$a65
=750  \0$aKnee$5IEN$0(DLC)sh 85072671

=LDR  00777cz  a2200265n  4500
=001  9880363637902441
=005  20141212202733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007718
=035  \\$aCBA0922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x558.$x554
=150  \\$aKnee Injuries
=450  \\$wnnna$aInjuries, Knee
=450  \\$wnnna$aInjury, Knee
=450  \\$aKnee$xinjuries
=450  \\$wnnna$aKnee Injury
=450  \\$aKnee Joint$xinjuries
=550  \\$wg$aLeg Injuries
=550  \\$wh$aIliotibial Band Syndrome
=550  \\$wh$aKnee Dislocation
=550  \\$wh$aPatellar Dislocation
=667  \\$aconsider also PATELLA /inj
=680  \\$iInjuries to the knee or the knee joint.
=750  \0$aKnee$xWounds and injuries$5IEN$0(DLC)sh 85072678

=LDR  00484cz  a2200157n  4500
=001  9880363638002441
=005  20141212202733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007717
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x450
=150  \\$aKnee
=450  \\$wnnna$aKnees
=550  \\$wg$aLower Extremity
=667  \\$aprimates only; / inj = KNEE INJURIES but PATELLA / inj is also available; differentiate from KNEE JOINT
=750  \0$aKnee$5IEN$0(DLC)sh 85072671

=LDR  00613cz  a2200205n  4500
=001  9880363638102441
=005  20141212202733.0
=008  850207\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007716
=035  \\$aCBA0920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x536
=072  \\$aB1.$x300.$x930.$x536
=150  \\$aKluyveromyces
=450  \\$wnnna$aKluyveromyce
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=680  \\$iAn ascomycetous yeast of the fungal family Saccharomycetaceae, order SACCHAROMYCETALES.
=688  \\$a91(86)
=750  \0$aKluyveromyces$5IEN$0(DLC)sh 90004030

=LDR  02680cz  a2200589n  4500
=001  9880363638202441
=005  20141212202732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007713
=035  \\$aCBA0917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x316.$x795.$x500
=072  \\$aC13.$x351.$x875.$x253.$x795.$x500
=072  \\$aC16.$x131.$x260.$x830.$x835.$x500
=072  \\$aC16.$x131.$x939.$x316.$x795.$x500
=072  \\$aC16.$x320.$x180.$x830.$x835.$x500
=072  \\$aC19.$x391.$x119.$x795.$x500
=072  \\$aC19.$x391.$x482.$x629
=150  \\$aKlinefelter Syndrome
=450  \\$wnnna$a48,XXYY Syndrome
=450  \\$wnnna$a49,XXXXY Syndrome
=450  \\$wnnna$aKlinefelter Syndrome, Variants
=450  \\$wnnna$aKlinefelter Syndromes
=450  \\$wnnna$aKlinefelter Syndromes, Variants
=450  \\$wnnna$aKlinefelter's Syndrome
=450  \\$wnnna$aKlinefelters Syndrome
=450  \\$wnnna$aSyndrome, 48,XXYY
=450  \\$wnnna$aSyndrome, Klinefelter
=450  \\$wnnna$aSyndrome, Klinefelter's
=450  \\$wnnna$aSyndrome, Variants Klinefelter
=450  \\$wnnna$aSyndrome, XXY
=450  \\$wnnna$aSyndrome, Xxyy
=450  \\$wnnna$aSyndromes, 49,XXXXY
=450  \\$wnnna$aSyndromes, Klinefelter
=450  \\$wnnna$aSyndromes, Variants Klinefelter
=450  \\$wnnna$aSyndromes, XXY
=450  \\$wnnna$aSyndromes, Xxyy
=450  \\$wnnna$aTrisomies, XXY
=450  \\$wnnna$aTrisomy, XXY
=450  \\$wnnna$aXXXY Male
=450  \\$wnnna$aXXXY Males
=450  \\$wnnna$aXXY Syndrome
=450  \\$wnnna$aXXY Syndromes
=450  \\$wnnna$aXXY Trisomies
=450  \\$wnnna$aXXY Trisomy
=450  \\$wnnna$aXxyy Syndrome
=450  \\$wnnna$aXxyy Syndromes
=550  \\$wg$aHypogonadism
=550  \\$wg$aSex Chromosome Disorders of Sex Development
=667  \\$aindex here karyotypes XXXY, XXXXY, XXYY, XXXYY, XX/XXY, XX/YY, XY/XXY, XXY/XXXY, XXY/XXYY, XY/XXY/XXXY if called KLINEFELTER SYNDROME by author but if not so named by author, index under SEX CHROMOSOME DISORDERS
=680  \\$iA form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).
=750  \0$aKlinefelter's syndrome$5IEN$0(DLC)sh 85072641

=LDR  00799cz  a2200217n  4500
=001  9880363638302441
=005  20141212202731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007711
=035  \\$aCBA0915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x425.$x600
=072  \\$aB3.$x660.$x250.$x150.$x400.$x590
=150  \\$aKlebsiella pneumoniae
=450  \\$wnnna$aKlebsiella rhinoscleromatis
=550  \\$wg$aKlebsiella
=550  \\$aEnterobacter aerogenes
=667  \\$ainfection: coord IM with KLEBSIELLA INFECTIONS (IM)
=680  \\$iGram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
=688  \\$a1974(1972)
=750  \0$aKlebsiella pneumoniae$5IEN$0(DLC)sh 88023267

=LDR  00946cz  a2200205n  4500
=001  9880363638402441
=005  20141212202731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007709
=035  \\$aCBA0913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x425
=072  \\$aB3.$x660.$x250.$x150.$x400
=150  \\$aKlebsiella
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aKlebsiella oxytoca
=550  \\$wh$aKlebsiella pneumoniae
=667  \\$aKLEBSIELLA AEROGENES and KLEBSIELLA MOBILUS see ENTEROBACTER AEROGENES are also available
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
=750  \0$aKlebsiella$5IEN$0(DLC)sh 88023266

=LDR  01214cz  a2200265n  4500
=001  9880363638502441
=005  20141212202729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007705
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x812
=072  \\$aD12.$x776.$x467.$x812
=072  \\$aD23.$x469.$x50.$x375
=072  \\$aD23.$x529.$x812
=150  \\$aKinins
=550  \\$wg$aAutacoids
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aBradykinin
=550  \\$wh$aKininogens
=550  \\$wh$aTachykinins
=550  \\$wh$aUrotensins
=667  \\$aa group of polypeptide autacoids
=680  \\$iA generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588)
=688  \\$a66(64)
=750  \0$aKinins$5IEN$0(DLC)sh 85072461

=LDR  01494cz  a2200337n  4500
=001  9880363638602441
=005  20141212202728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007703
=035  \\$aCBA0907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x350.$x687
=072  \\$aD23.$x50.$x301.$x264.$x35.$x585
=072  \\$aD23.$x101.$x100.$x110.$x585
=150  \\$aPeptidyl-Dipeptidase A
=450  \\$aAngiotensin Converting Enzyme
=450  \\$wnnna$aAngiotensin I-Converting Enzyme
=450  \\$wnnna$aAngiotensin I Converting Enzyme
=450  \\$aAntigens, CD143
=450  \\$wnnna$aCarboxycathepsin
=450  \\$aCD143 Antigens
=450  \\$wnnna$aDipeptidyl Peptidase A
=450  \\$wnnna$aKininase A
=450  \\$aKininase II
=450  \\$wnnna$aPeptidyl Dipeptidase A
=550  \\$wg$aAntigens, CD
=550  \\$wg$aDipeptidyl-Peptidases and Tripeptidyl-Peptidases
=667  \\$a/antag = ANGIOTENSIN-CONVERTING ENZYME INHIBITORS
=680  \\$iA peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl(-)-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. (From Enzyme Nomenclature, 1992) EC 3.4.15.1.
=688  \\$a94; was KININASE II 1973-93 (Prov 1973); TONIN was see KININASE II 1984-93
=750  \0$aAngiotensin converting enzyme$5IEN$0(DLC)sh 85005039

=LDR  00934cz  a2200301n  4500
=001  9880363638702441
=005  20141212202727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007702
=035  \\$aCBA0906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x450
=150  \\$aKinetocardiography
=450  \\$wnnna$aAccelographies
=450  \\$aAccelography
=450  \\$wnnna$aApex Cardiographies
=450  \\$aApex Cardiography
=450  \\$wnnna$aCardiographies, Apex
=450  \\$wnnna$aCardiography, Apex
=450  \\$aKinematocardiography$5IEN
=450  \\$wnnna$aKinetocardiographies
=450  \\$wnnna$aVibrocardiographies
=450  \\$aVibrocardiography
=550  \\$wg$aHeart Function Tests
=667  \\$aDF: KINETOCARDIOGR
=680  \\$iThe graphic recording of chest wall movement due to cardiac impulses.
=688  \\$a67(64)
=750  \0$aKinematocardiography$5IEN$0(DLC)sh 85072382

=LDR  00807cz  a2200217n  4500
=001  9880363638802441
=005  20170608144524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007700
=035  \\$aCBA0904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x661
=072  \\$aG2.$x111.$x490
=150  \\$aKinetics
=450  \\$aDynamics$5IEN
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMechanical Phenomena
=667  \\$aalmost never IM; do not confuse with KINESICS ("use of posture or gesture for communication") or KINESIS (a form of movement); pharmacokinetics of chemicals and drugs is PHARMACOKINETICS or better, specific drug term /pharmacokin
=680  \\$iThe rate dynamics in chemical or physical systems.
=688  \\$a66(64)
=750  \0$aDynamics$5IEN$0(DLC)sh 85040316

=LDR  00869cz  a2200265n  4500
=001  9880363638902441
=005  20141212202727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007699
=035  \\$aCBA0903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x541.$x504
=072  \\$aG11.$x561.$x600.$x810.$x541.$x587
=150  \\$aKinesthesis
=450  \\$wnnna$aKinestheses
=450  \\$aKinesthesia
=450  \\$wnnna$aKinesthesias
=450  \\$wnnna$aKinesthetic Sense
=450  \\$wnnna$aKinesthetic Senses
=450  \\$wnnna$aMovement Sensation
=450  \\$wnnna$aMovement Sensations
=550  \\$wg$aProprioception
=667  \\$ado not confuse with MOTION PERCEPTION
=680  \\$iSense of movement of a part of the body, such as movement of fingers, elbows, knees, limbs, or weights.
=750  \0$aMuscular sense$5IEN$0(DLC)sh 85088696

=LDR  00848cz  a2200253n  4500
=001  9880363639002441
=005  20141212202726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007697
=035  \\$aCBA0901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530.$x538
=150  \\$aKinesics
=450  \\$aBody Language
=450  \\$wnnna$aBody Languages
=450  \\$wnnna$aLanguage, Body
=450  \\$wnnna$aLanguages, Body
=550  \\$wg$aNonverbal Communication
=550  \\$wh$aGestures
=550  \\$aPosture
=667  \\$ano qualif; do not confuse with KINETICS or KINESIS: kinesics = "use of posture or gesture for communication"
=680  \\$iSystematic study of the body and the use of its static and dynamic position as a means of communication.
=688  \\$a68
=750  \0$aBody language$5IEN$0(DLC)sh 85092369

=LDR  00986cz  a2200265n  4500
=001  9880363639102441
=005  20141212202726.0
=008  810224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007696
=035  \\$aCBA0900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x480
=150  \\$aKindling, Neurologic
=450  \\$wnno$aKindling (Neurology)$5IEN-M
=450  \\$wnnna$aKindlings, Neurologic
=450  \\$wnnna$aNeurologic Kindling
=450  \\$wnnna$aNeurologic Kindlings
=550  \\$wg$aNervous System Physiological Processes
=550  \\$aModels, Neurological
=550  \\$aSeizures
=680  \\$iThe repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures.
=688  \\$a2007(1982)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Kindling (Neurology)
=688  \\$a82
=750  \0$aKindling (Neurology)$0(DLC) sh 85072375$5IEN

=LDR  00962cz  a2200241n  4500
=001  9880363639202441
=005  20141212202726.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007695
=035  \\$aCBA0899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x280.$x500
=150  \\$aKillifishes
=450  \\$aCyprinodon
=450  \\$wnnna$aCyprinodons
=450  \\$aCyprinodontidae
=450  \\$wnnoa$aKillifish$5IEN-HS
=450  \\$aPupfishes
=550  \\$wg$aCyprinodontiformes
=667  \\$aKILLIFISH; ATLANTIC KILLIFISH; GULF KILLIFISH see FUNDULIDAE and JAPANESE KILLIFISH see ORYZIAS are available; killifish unspecified goes here
=680  \\$iSmall oviparous fishes in the family Cyprinodontidae, usually striped or barred black. They are much used in mosquito control.
=688  \\$a2002(1975); was see under CYPRINODONTIFORMES 1987-90; was see under FISHES 1975-86
=750  \0$aKillifishes$5IEN$0(DLC)sh 85072331

=LDR  01622cz  a2200361n  4500
=001  9880363639302441
=005  20141212202725.0
=008  820429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007694
=035  \\$aCBA0898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x537
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x537
=072  \\$aA15.$x382.$x490.$x555.$x567.$x537
=150  \\$aKiller Cells, Natural
=450  \\$wnnna$aCell, Natural Killer
=450  \\$wnnna$aCell, NK
=450  \\$wnnna$aCells, Natural Killer
=450  \\$wnnna$aCells, NK
=450  \\$wnnna$aKiller Cell, Natural
=450  \\$wnnoa$aKiller Cells$5IEN-M
=450  \\$wnnna$aNatural Killer Cell
=450  \\$aNatural Killer Cells
=450  \\$wnnna$aNK Cell
=450  \\$aNK Cells
=550  \\$wg$aLymphocytes
=550  \\$wh$aKiller Cells, Lymphokine-Activated
=550  \\$aCytotoxicity, Immunologic
=667  \\$ado not confuse with NATURAL KILLER T-CELLS; if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM)
=680  \\$iBone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.
=688  \\$a1983
=688  \\$a83
=750  \0$aKiller cells$0(DLC) sh 85072328$5IEN-M

=LDR  01273cz  a2200325n  4500
=001  9880363639402441
=005  20141212202725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007692
=035  \\$aCBA0896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x750.$x300
=072  \\$aD1.$x650.$x550.$x825.$x400
=072  \\$aD1.$x837.$x725.$x400
=150  \\$aDiatomaceous Earth
=450  \\$wnnna$a545, Celite
=450  \\$wnnna$a560, Celite
=450  \\$wnnna$aCelite
=450  \\$wnnna$aCelite 545
=450  \\$wnnna$aCelite 560
=450  \\$wnnna$aChromosorb P
=450  \\$wnnna$aEarth, Diatomaceous
=450  \\$wnnna$aEarth, Infusorial
=450  \\$aInfusorial Earth
=450  \\$aKieselguhr
=450  \\$wnnna$aP, Chromosorb
=550  \\$wg$aSilicon Dioxide
=680  \\$iA form of SILICON DIOXIDE composed of skeletons of prehistoric aquatic plants which is used for its ABSORPTION quality, taking up 1.5-4 times its weight in water. The microscopic sharp edges are useful for insect control but can also be an inhalation hazard. It has been used in baked goods and animal feed. Kieselguhr is German for flint + earthy sediment.
=688  \\$a91(75); was see under SILICA 1975-90
=750  \0$aDiatomaceous earth$5IEN$0(DLC)sh 85037626

=LDR  01640cz  a2200397n  4500
=001  9880363639502441
=005  20141212202724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007690
=035  \\$aCBA0894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x403.$x875
=072  \\$aC13.$x351.$x968.$x419.$x403.$x875
=150  \\$aPolycystic Kidney Diseases
=450  \\$wnnna$aDisease, Polycystic Kidney
=450  \\$wnnna$aDisease, Polycystic Renal
=450  \\$wnnna$aDiseases, Polycystic Kidney
=450  \\$wnnna$aDiseases, Polycystic Renal
=450  \\$wnnna$aKidney Disease, Polycystic
=450  \\$wnnna$aKidney Diseases, Polycystic
=450  \\$wnnna$aKidney, Polycystic
=450  \\$wnnna$aKidneys, Polycystic
=450  \\$wnnna$aPolycystic Kidney
=450  \\$wnnna$aPolycystic Kidney Disease
=450  \\$wnnna$aPolycystic Kidneys
=450  \\$wnnna$aPolycystic Renal Disease
=450  \\$wnnna$aPolycystic Renal Diseases
=450  \\$wnnna$aRenal Disease, Polycystic
=450  \\$wnnna$aRenal Diseases, Polycystic
=550  \\$wg$aKidney Diseases, Cystic
=550  \\$wh$aPolycystic Kidney, Autosomal Dominant
=550  \\$wh$aPolycystic Kidney, Autosomal Recessive
=667  \\$aKIDNEY, CYSTIC and MULTICYSTIC DYSPLASTIC KIDNEY are also available; prefer specifics
=680  \\$iHereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
=688  \\$a1991
=750  \0$aPolycystic kidney disease$5IEN$0(DLC)sh 86002206

=LDR  01567cz  a2200457n  4500
=001  9880363639602441
=005  20141212202723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007688
=035  \\$aCBA0892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x82.$x585
=150  \\$aKidneys, Artificial
=450  \\$aArtificial Kidney
=450  \\$wnnna$aArtificial Kidneys
=450  \\$wnnna$aBlood Dialyser
=450  \\$wnnna$aBlood Dialysers
=450  \\$wnnna$aBlood Dialyzer
=450  \\$wnnna$aBlood Dialyzers
=450  \\$wnnna$aDialyser, Blood
=450  \\$wnnna$aDialysers, Blood
=450  \\$wnnna$aDialysis Machine, Renal
=450  \\$wnnna$aDialysis Machines, Renal
=450  \\$wnnna$aDialyzer, Blood
=450  \\$wnnna$aDialyzers, Blood
=450  \\$wnnna$aHemodialyser
=450  \\$wnnna$aHemodialysers
=450  \\$wnnna$aHemodialyzer
=450  \\$wnnna$aHemodialyzers
=450  \\$aKidney, Artificial
=450  \\$wnnna$aMachine, Renal Dialysis
=450  \\$wnnna$aMachines, Renal Dialysis
=450  \\$wnnna$aRenal Dialysis Machine
=450  \\$wnnna$aRenal Dialysis Machines
=550  \\$wg$aArtificial Organs
=550  \\$aPeritoneal Dialysis
=550  \\$aRenal Dialysis
=680  \\$iDevices which can substitute for normally functioning KIDNEYS in removing components from the blood by DIALYSIS that are normally eliminated in the URINE.
=688  \\$a2013 (1966)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Kidney, Artificial
=750  \0$aArtificial kidney$5IEN$0(DLC)sh 85008185

=LDR  01082cz  a2200253n  4500
=001  9880363639702441
=005  20141212202722.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007684
=035  \\$aCBA0888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x736.$x560
=150  \\$aKidney Tubules
=450  \\$wnnna$aKidney Tubule
=450  \\$wnnna$aTubule, Kidney
=450  \\$wnnna$aTubules, Kidney
=550  \\$wg$aNephrons
=550  \\$wh$aBowman Capsule
=550  \\$wh$aKidney Tubules, Collecting
=550  \\$wh$aKidney Tubules, Distal
=550  \\$wh$aKidney Tubules, Proximal
=550  \\$wh$aLoop of Henle
=680  \\$iLong convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER.
=750  \0$aKidney tubules$5IEN$0(DLC)sh 85072253

=LDR  00771cz  a2200217n  4500
=001  9880363639802441
=005  20141212202721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007682
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x537
=150  \\$aKidney Pelvis
=360  \\$iconsider also terms at$aPYEL-
=450  \\$wnnna$aPelvis, Kidney
=450  \\$wnnna$aPelvis, Renal
=450  \\$aRenal Pelvis
=550  \\$wg$aKidney
=550  \\$wh$aKidney Calices
=667  \\$ado not confuse with pelvic kidney ( = KIDNEY /abnorm); inflammation = PYELITIS; nephrostomy: consider NEPHROSTOMY, PERCUTANEOUS
=680  \\$iThe flattened, funnel-shaped expansion connecting the URETER to the KIDNEY CALICES.
=750  \0$aKidney pelvis$5IEN$0(DLC)sh 85072252

=LDR  01536cz  a2200481n  4500
=001  9880363639902441
=005  20141212202720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007680
=035  \\$aCBA0884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x947.$x535
=072  \\$aC12.$x758.$x820.$x750
=072  \\$aC12.$x777.$x419.$x473
=072  \\$aC13.$x351.$x937.$x820.$x535
=072  \\$aC13.$x351.$x968.$x419.$x473
=150  \\$aKidney Neoplasms
=450  \\$wnnna$aCancer, Kidney
=450  \\$aCancer of Kidney
=450  \\$wnnna$aCancer of the Kidney
=450  \\$wnnna$aCancer, Renal
=450  \\$wnnna$aCancers, Kidney
=450  \\$wnnna$aCancers, Renal
=450  \\$aKidney Cancer
=450  \\$wnnna$aKidney Cancers
=450  \\$wnnna$aKidney Neoplasm
=450  \\$wnnna$aNeoplasm, Kidney
=450  \\$wnnna$aNeoplasm, Renal
=450  \\$wnnna$aNeoplasms, Kidney
=450  \\$wnnna$aNeoplasms, Renal
=450  \\$aRenal Cancer
=450  \\$wnnna$aRenal Cancers
=450  \\$wnnna$aRenal Neoplasm
=450  \\$wnnna$aRenal Neoplasms
=550  \\$wg$aKidney Diseases
=550  \\$wg$aUrologic Neoplasms
=550  \\$wh$aCarcinoma, Renal Cell
=550  \\$wh$aNephroma, Mesoblastic
=550  \\$wh$aWilms Tumor
=667  \\$ageneral prefer specifics; coordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancers of the KIDNEY.
=750  \0$aKidneys$xCancer$5IEN-M$0(DLC)sh 85072260
=750  \0$aKidneys$xTumors$5IEN-HS$0(DLC)sh 85072275

=LDR  00925cz  a2200253n  4500
=001  9880363640002441
=005  20141212202720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007679
=035  \\$aCBA0883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x466
=150  \\$aKidney Medulla
=450  \\$wnnna$aKidney Medullas
=450  \\$aKidney Papilla
=450  \\$wnnna$aKidney Papillas
=450  \\$wnnna$aMedulla, Kidney
=450  \\$wnnna$aMedullas, Kidney
=450  \\$wnnna$aPapilla, Kidney
=450  \\$wnnna$aPapillas, Kidney
=550  \\$wg$aKidney
=680  \\$iThe internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.
=688  \\$a79(73); was see under KIDNEY 1975-78
=750  \0$aRenal papilla$5IEN$0(DLC)sh 85112820

=LDR  00849cz  a2200253n  4500
=001  9880363640102441
=005  20141212202720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007678
=035  \\$aCBA0882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x324.$x359
=072  \\$aA5.$x810.$x453.$x736.$x520
=150  \\$aKidney Glomerulus
=450  \\$wnnna$aGlomerulus, Kidney
=550  \\$wg$aKidney Cortex
=550  \\$wg$aNephrons
=550  \\$wh$aGlomerular Basement Membrane
=550  \\$wh$aGlomerular Filtration Barrier
=550  \\$wh$aJuxtaglomerular Apparatus
=550  \\$wh$aMesangial Cells
=550  \\$wh$aPodocytes
=680  \\$iA cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue.
=750  \0$aKidney glomerulus$5IEN$0(DLC)sh 85072250

=LDR  00763cz  a2200241n  4500
=001  9880363640202441
=005  20141212202719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007677
=035  \\$aCBA0881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x390.$x400
=150  \\$aKidney Function Tests
=450  \\$wnnna$aFunction Test, Kidney
=450  \\$wnnna$aFunction Tests, Kidney
=450  \\$wnnna$aKidney Function Test
=450  \\$wnnna$aTest, Kidney Function
=450  \\$wnnna$aTests, Kidney Function
=550  \\$wg$aDiagnostic Techniques, Urological
=550  \\$wh$aBlood Urea Nitrogen
=550  \\$wh$aGlomerular Filtration Rate
=550  \\$wh$aRadioisotope Renography
=750  \0$aKidney function tests$5IEN$0(DLC)sh 85072249

=LDR  01746cz  a2200421n  4500
=001  9880363640302441
=005  20141212202719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007676
=035  \\$aCBA0880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x780.$x750.$x500
=072  \\$aC13.$x351.$x968.$x419.$x780.$x750.$x500
=150  \\$aKidney Failure, Chronic
=450  \\$wnnna$aChronic Kidney Failure
=450  \\$wnnna$aChronic Renal Failure
=450  \\$wnnna$aDisease, End-Stage Kidney
=450  \\$wnnna$aDisease, End-Stage Renal
=450  \\$wnnna$aEnd-Stage Kidney Disease
=450  \\$wnnna$aEnd Stage Kidney Disease
=450  \\$aEnd-Stage Renal Disease
=450  \\$wnnna$aEnd Stage Renal Disease
=450  \\$wnnna$aEnd-Stage Renal Failure
=450  \\$aESRD
=450  \\$wnnna$aKidney Disease, End-Stage
=450  \\$aRenal Disease, End-Stage
=450  \\$wnnna$aRenal Disease, End Stage
=450  \\$aRenal Failure, Chronic
=450  \\$aRenal Failure, End-Stage
=450  \\$wnnna$aRenal Failure, End Stage
=550  \\$wg$aRenal Insufficiency, Chronic
=550  \\$wh$aFrasier Syndrome
=550  \\$aGlomerulonephritis
=550  \\$aPyelonephritis
=667  \\$aRENAL INSUFFICIENCY, CHRONIC is also available
=680  \\$iThe end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
=688  \\$a67(66)
=750  \0$aChronic renal failure$0(DLC) sh 85112814$5IEN

=LDR  01905cz  a2200565n  4500
=001  9880363640402441
=005  20180119101339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007674
=035  \\$aCBA0878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419
=072  \\$aC13.$x351.$x968.$x419
=150  \\$aKidney Diseases
=450  \\$wnnna$aDisease, Kidney
=450  \\$wnnna$aDiseases, Kidney
=450  \\$wnnna$aKidney Disease
=550  \\$wg$aUrologic Diseases
=550  \\$wh$aAIDS-Associated Nephropathy
=550  \\$wh$aAnuria
=550  \\$wh$aChronic Kidney Disease-Mineral and Bone Disorder
=550  \\$wh$aDiabetes Insipidus
=550  \\$wh$aDiabetic Nephropathies
=550  \\$wh$aFanconi Syndrome
=550  \\$wh$aHepatorenal Syndrome
=550  \\$wh$aHydronephrosis
=550  \\$wh$aHyperoxaluria
=550  \\$wh$aHypertension, Renal
=550  \\$wh$aKidney Cortex Necrosis
=550  \\$wh$aKidney Diseases, Cystic
=550  \\$wh$aKidney Neoplasms
=550  \\$wh$aKidney Papillary Necrosis
=550  \\$wh$aNephritis
=550  \\$wh$aNephrocalcinosis
=550  \\$wh$aNephrolithiasis
=550  \\$wh$aNephrosclerosis
=550  \\$wh$aNephrosis
=550  \\$wh$aPerinephritis
=550  \\$wh$aRenal Artery Obstruction
=550  \\$wh$aRenal Insufficiency
=550  \\$wh$aRenal Nutcracker Syndrome
=550  \\$wh$aRenal Tubular Transport, Inborn Errors
=550  \\$wh$aTuberculosis, Renal
=550  \\$wh$aUremia
=550  \\$wh$aZellweger Syndrome
=550  \\$aNephrology
=550  \\$aRenal Replacement Therapy
=667  \\$ageneral or unspecified: prefer specifics; inflammatory disease = NEPHRITIS; consider diseases under NEPHR- & RENAL; cyst = KIDNEY, CYSTIC or specifics
=680  \\$iPathological processes of the KIDNEY or its component tissues.
=750  \0$aKidneys$xDiseases$5IEN$0(DLC)sh 85072261

=LDR  00624cz  a2200193n  4500
=001  9880363640502441
=005  20141212202718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007672
=035  \\$aCBA0876M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453.$x324
=150  \\$aKidney Cortex
=450  \\$wnnna$aCortex, Kidney
=550  \\$wg$aKidney
=550  \\$wh$aKidney Glomerulus
=680  \\$iThe outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL.
=688  \\$a74(73)
=750  \0$aKidney cortex$5IEN-M$0(DLC)sh 98006695

=LDR  01373cz  a2200397n  4500
=001  9880363640602441
=005  20141212202717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007669
=035  \\$aCBA0873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x600.$x500
=072  \\$aC12.$x777.$x967.$x249.$x500
=072  \\$aC12.$x777.$x967.$x500.$x503
=072  \\$aC13.$x351.$x968.$x419.$x600.$x500
=072  \\$aC13.$x351.$x968.$x967.$x249.$x500
=072  \\$aC13.$x351.$x968.$x967.$x500.$x503
=072  \\$aC23.$x300.$x175.$x850.$x550
=150  \\$aKidney Calculi
=450  \\$wnnna$aCalculi, Kidney
=450  \\$wnnna$aCalculi, Renal
=450  \\$wnnna$aCalculus, Kidney
=450  \\$wnnna$aCalculus, Renal
=450  \\$wnnna$aKidney Calculus
=450  \\$wnnna$aKidney Stone
=450  \\$aKidney Stones
=450  \\$wnnna$aNephrolith
=450  \\$aRenal Calculi
=450  \\$wnnna$aRenal Calculus
=450  \\$wnnna$aStone, Kidney
=450  \\$wnnna$aStones, Kidney
=550  \\$wg$aNephrolithiasis
=550  \\$wg$aUrinary Calculi
=667  \\$achemical composition of calculi = KIDNEY CALCULI /chem
=680  \\$iStones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
=750  \0$aKidneys$xCalculi$0(DLC) sh 85072259$5IEN

=LDR  01407cz  a2200265n  4500
=001  9880363640702441
=005  20141212202716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007668
=035  \\$aCBA0872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x810.$x453
=150  \\$aKidney
=360  \\$iconsider also terms at$aGLOMERUL-$aNEPHR-$aPYEL-$aRENAL
=450  \\$wnnna$aKidneys
=550  \\$wg$aUrinary Tract
=550  \\$wh$aKidney Cortex
=550  \\$wh$aKidney Medulla
=550  \\$wh$aKidney Pelvis
=550  \\$wh$aNephrons
=550  \\$aRenal Replacement Therapy
=667  \\$akidney tissue or cells in cultures: Manual 18.6.15, 18.7.2, 26.23+; fetal or embryonic kidney tissue or cells in culture: do not use /embryol with KIDNEY; /blood supply: consider also RENAL CIRCULATION; /radionuclide: consider RADIOISOTOPE RENOGRAPHY, a specific kidney function test (see note there); /surg: consider NEPHRECTOMY; cyst = KIDNEY, CYSTIC but KIDNEY, POLYCYSTIC is also available; inflammation = NEPHRITIS; Goldblatt kidney = HYPERTENSION, GOLDBLATT see HYPERTENSION, RENOVASCULAR; nephrostomy: consider NEPHROSTOMY, PERCUTANEOUS
=680  \\$iBody organ that filters blood for the secretion of URINE and that regulates ion concentrations.
=688  \\$a/transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89
=750  \0$aKidneys$5IEN$0(DLC)sh 85072254

=LDR  05443cz  a2201201n  4500
=001  9880363782402441
=005  20141212192537.0
=008  860331\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013132
=035  \\$aCBA6454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x252.$x700
=072  \\$aC10.$x228.$x854.$x787
=072  \\$aC10.$x574.$x500.$x825
=072  \\$aC16.$x320.$x400.$x780
=150  \\$aSpinocerebellar Degenerations
=450  \\$wnnna$aAtaxia, Hereditary
=450  \\$aAtaxias, Hereditary
=450  \\$aCerebellar Ataxia, Early Onset
=450  \\$aCerebellar Ataxia, Late Onset
=450  \\$wnnna$aCerebellar Ataxia, Marie
=450  \\$wnnna$aCerebellar Ataxia, Marie's
=450  \\$wnnna$aCerebellar Degeneration, Primary
=450  \\$aCerebellar Degenerations, Primary
=450  \\$aCorticostriatal-Spinal Degeneration
=450  \\$wnnna$aCorticostriatal Spinal Degeneration
=450  \\$wnnna$aCorticostriatal-Spinal Degenerations
=450  \\$wnnna$aDegeneration, Corticostriatal-Spinal
=450  \\$wnnna$aDegeneration, Familial Spinocerebellar
=450  \\$wnnna$aDegeneration, Hereditary Spinocerebellar
=450  \\$wnnna$aDegeneration, Inherited Spinocerebellar
=450  \\$wnnna$aDegeneration, Primary Cerebellar
=450  \\$wnnna$aDegeneration, Spino Cerebellar
=450  \\$wnnna$aDegeneration, Spino-Cerebellar
=450  \\$wnnna$aDegeneration, Spinocerebellar
=450  \\$wnnna$aDegenerations, Corticostriatal-Spinal
=450  \\$wnnna$aDegenerations, Familial Spinocerebellar
=450  \\$wnnna$aDegenerations, Hereditary Spinocerebellar
=450  \\$wnnna$aDegenerations, Inherited Spinocerebellar
=450  \\$wnnna$aDegenerations, Primary Cerebellar
=450  \\$wnnna$aDegenerations, Spino Cerebellar
=450  \\$wnnna$aDegenerations, Spinocerebellar
=450  \\$wnnna$aEarly Onset Cerebellar Ataxia
=450  \\$wnnna$aFamilial Spinocerebellar Degeneration
=450  \\$wnnna$aFamilial Spinocerebellar Degenerations
=450  \\$wnnna$aGarland-Moorhouse Syndrome
=450  \\$wnnna$aGarland Moorhouse Syndrome
=450  \\$wnnna$aHereditary Ataxia
=450  \\$wnnna$aHereditary Ataxias
=450  \\$wnnna$aHereditary Oligophrenic Cerebello-Lental Degeneration
=450  \\$wnnna$aHereditary Oligophrenic Cerebello Lental Degeneration
=450  \\$wnnna$aHereditary Spinocerebellar Degeneration
=450  \\$wnnna$aHereditary Spinocerebellar Degenerations
=450  \\$wnnna$aHypogonadism, Marinesco-Sjogren Syndrome-Hypergonadotrophic
=450  \\$wnnna$aInherited Spinocerebellar Degeneration
=450  \\$wnnna$aInherited Spinocerebellar Degenerations
=450  \\$wnnna$aLate Onset Cerebellar Ataxia
=450  \\$aMarie Cerebellar Ataxia
=450  \\$wnnna$aMarie's Cerebellar Ataxia
=450  \\$wnnna$aMarinesco-Garland Syndrome
=450  \\$wnnna$aMarinesco Garland Syndrome
=450  \\$wnnna$aMarinesco-Sjögren Syndrome
=450  \\$wnnna$aMarinesco Sjögren Syndrome
=450  \\$wnnna$aMarinesco-Sjogren-Garland Syndrome
=450  \\$wnnna$aMarinesco Sjogren Garland Syndrome
=450  \\$aMarinesco-Sjogren Syndrome
=450  \\$wnnna$aMarinesco Sjogren Syndrome
=450  \\$wnnna$aMarinesco-Sjogren Syndrome-Hypergonadotrophic Hypogonadism
=450  \\$wnnna$aMarinesco Sjogren Syndrome Hypergonadotrophic Hypogonadism
=450  \\$wnnna$aMarinesco-Sjogren Syndrome-Myopathy
=450  \\$wnnna$aMarinesco Sjogren Syndrome Myopathy
=450  \\$wnnna$aPrimary Cerebellar Degeneration
=450  \\$wnnna$aPrimary Cerebellar Degenerations
=450  \\$wnnna$aSpino Cerebellar Degeneration
=450  \\$wnnna$aSpino-Cerebellar Degeneration
=450  \\$wnnna$aSpino Cerebellar Degenerations
=450  \\$wnnna$aSpino-Cerebellar Degenerations
=450  \\$aSpinocerebellar Degeneration
=450  \\$wnnna$aSpinocerebellar Degeneration, Familial
=450  \\$wnnna$aSpinocerebellar Degeneration, Hereditary
=450  \\$wnnna$aSpinocerebellar Degeneration, Inherited
=450  \\$wnnna$aSpinocerebellar Degenerations, Familial
=450  \\$wnnna$aSpinocerebellar Degenerations, Hereditary
=450  \\$wnnna$aSpinocerebellar Degenerations, Inherited
=450  \\$wnnna$aSpinocerebellar Disease
=450  \\$wnnna$aSpinocerebellar Diseases
=450  \\$wnnna$aSyndrome, Garland-Moorhouse
=450  \\$wnnna$aSyndrome-Hypergonadotrophic Hypogonadism, Marinesco-Sjogren
=450  \\$wnnna$aSyndrome, Marinesco-Garland
=450  \\$wnnna$aSyndrome, Marinesco-Sjögren
=450  \\$wnnna$aSyndrome, Marinesco-Sjogren
=450  \\$wnnna$aSyndrome, Marinesco-Sjogren-Garland
=450  \\$wnnna$aSyndrome-Myopathy, Marinesco-Sjogren
=550  \\$wg$aCerebellar Diseases
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wh$aFriedreich Ataxia
=550  \\$wh$aMyoclonic Cerebellar Dyssynergia
=550  \\$wh$aOlivopontocerebellar Atrophies
=550  \\$wh$aSpinocerebellar Ataxias
=680  \\$iA heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.
=688  \\$a2000(1987)
=750  \0$aCerebellum$xDegeneration$5IEN$0(DLC)sh 91005267

=LDR  01447cz  a2200385n  4500
=001  9880363782502441
=005  20141212205815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013131
=035  \\$aCBA6453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834
=150  \\$aSpine
=360  \\$iconsider also terms at$aSPONDYL-$aVERTEBRAL
=450  \\$wnnna$aColumn, Spinal
=450  \\$wnnna$aColumn, Vertebral
=450  \\$wnnna$aColumns, Spinal
=450  \\$wnnna$aColumns, Vertebral
=450  \\$aSpinal Column
=450  \\$wnnna$aSpinal Columns
=450  \\$wnnna$aVertebra
=450  \\$aVertebrae
=450  \\$aVertebral Column
=450  \\$wnnna$aVertebral Columns
=550  \\$wg$aBone and Bones
=550  \\$wh$aCervical Vertebrae
=550  \\$wh$aCoccyx
=550  \\$wh$aIntervertebral Disc
=550  \\$wh$aLumbar Vertebrae
=550  \\$wh$aSacrum
=550  \\$wh$aSpinal Canal
=550  \\$wh$aThoracic Vertebrae
=667  \\$aGEN or unspecified: specific groups of vertebrae are available; /inj = SPINAL INJURIES for GEN or unspecified vertebrae but specific vertebrae are available with /inj; /transpl of the whole spine is unlikely: use /transpl with specific vertebra terms instead; inflammation = SPONDYLITIS; spondylosis = SPONDYLOSIS (see SPINAL OSTEOPHYTOSIS) (IM) + specific vertebrae (IM)
=680  \\$iThe spinal or vertebral column.
=750  \0$aSpine$5IEN$0(DLC)sh 85126694

=LDR  00639cz  a2200217n  4500
=001  9880363782602441
=005  20141212205814.0
=008  820422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013130
=035  \\$aCBA6452HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x825
=150  \\$aSpinal Stenosis
=450  \\$wnnna$aSpinal Stenoses
=450  \\$wnnna$aStenoses, Spinal
=450  \\$wnnna$aStenosis, Spinal
=550  \\$wg$aSpinal Diseases
=667  \\$acoordinate with vertebrae headings if appropriate
=680  \\$iNarrowing of the spinal canal.
=688  \\$a83
=750  \0$aSpinal canal$xStenosis$5IEN$0(DLC)sh 85126665

=LDR  01282cz  a2200397n  4500
=001  9880363782702441
=005  20141212205814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013129
=035  \\$aCBA6451HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x54.$x790
=072  \\$aE1.$x370.$x376.$x700
=072  \\$aE4.$x74.$x790
=072  \\$aE4.$x665.$x700
=072  \\$aE5.$x200.$x998.$x54.$x790
=072  \\$aE5.$x200.$x998.$x683
=150  \\$aSpinal Puncture
=450  \\$aLumbar Puncture
=450  \\$wnnna$aLumbar Punctures
=450  \\$wnnna$aPuncture, Lumbar
=450  \\$wnnna$aPuncture, Spinal
=450  \\$wnnna$aPunctures, Lumbar
=450  \\$wnnna$aPunctures, Spinal
=450  \\$wnnna$aSpinal Punctures
=450  \\$wnnna$aSpinal Tap
=450  \\$wnnna$aSpinal Taps
=450  \\$wnnna$aTap, Spinal
=450  \\$wnnna$aTaps, Spinal
=550  \\$wg$aBiopsy
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aPunctures
=550  \\$wg$aSpecimen Handling
=667  \\$ado not use /util except by MeSH definition
=680  \\$iTapping fluid from the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebrae.
=750  \0$aSpine$xPuncture$5IEN$0(DLC)sh 85126700

=LDR  01054cz  a2200241n  4500
=001  9880363782802441
=005  20141212205814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013128
=035  \\$aCBA6450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900.$x815
=150  \\$aSpinal Osteophytosis
=450  \\$wnnna$aOsteophytoses, Spinal
=450  \\$aOsteophytosis, Spinal
=450  \\$wnnna$aSpinal Osteophytoses
=550  \\$wg$aSpinal Diseases
=550  \\$wh$aHyperostosis, Diffuse Idiopathic Skeletal
=667  \\$acoordinate with specific vertebra
=680  \\$iOutgrowth of immature bony processes or bone spurs (OSTEOPHYTE) from the VERTEBRAE, reflecting the presence of degenerative disease and calcification. It commonly occurs in cervical and lumbar SPONDYLOSIS.
=688  \\$a1965
=688  \\$a65; BARRE-LIEOU SYNDROME was heading 1967-96 (see under SPINAL OSTEOPHYTOSIS 1967-71); POSTERIOR CERVICAL SYMPATHETIC SYNDROME was see BARRE-LIEOU SYNDROME 1975-96
=750  \0$aSpinal osteophytosis$0(DLC) sh 85126685$5IEN

=LDR  00971cz  a2200265n  4500
=001  9880363782902441
=005  20141212205813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013127
=035  \\$aCBA6449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720
=150  \\$aSpinal Nerves
=450  \\$wnnna$aNerve, Spinal
=450  \\$wnnna$aNerves, Spinal
=450  \\$wnnna$aSpinal Nerve
=550  \\$wg$aPeripheral Nerves
=550  \\$wh$aBrachial Plexus
=550  \\$wh$aCervical Plexus
=550  \\$wh$aLumbosacral Plexus
=550  \\$wh$aSpinal Nerve Roots
=550  \\$wh$aThoracic Nerves
=667  \\$aperipheral nerves; do not use vertebra headings to locate area of spinal nerves
=680  \\$iThe 31 paired peripheral nerves formed by the union of the dorsal and ventral spinal roots from each spinal cord segment. The spinal nerve plexuses and the spinal roots are also included.
=750  \0$aSpinal nerves$5IEN$0(DLC)sh 85090910

=LDR  01921cz  a2200409n  4500
=001  9880363783002441
=005  20141212192535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013126
=035  \\$aCBA6448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x725
=150  \\$aSpinal Nerve Roots
=450  \\$wnnna$aDorsal Root
=450  \\$aDorsal Roots
=450  \\$wnnna$aNerve Root, Spinal
=450  \\$wnnna$aNerve Roots, Spinal
=450  \\$wnnna$aRoot, Dorsal
=450  \\$wnnna$aRoot, Spinal
=450  \\$wnnna$aRoot, Spinal Nerve
=450  \\$wnnna$aRoot, Ventral
=450  \\$wnnna$aRoots, Dorsal
=450  \\$wnnna$aRoots, Spinal
=450  \\$wnnna$aRoots, Spinal Nerve
=450  \\$wnnna$aRoots, Ventral
=450  \\$wnnna$aSpinal Nerve Root
=450  \\$wnnna$aSpinal Root
=450  \\$aSpinal Roots
=450  \\$wnnna$aVentral Root
=450  \\$aVentral Roots
=550  \\$wg$aSpinal Nerves
=550  \\$wh$aCauda Equina
=550  \\$wh$aGanglia, Spinal
=667  \\$a/surg: consider RHIZOTOMY; DORSAL ROOT GANGLIA see GANGLIA, SPINAL is also available; inflammation = RADICULITIS (single root) or POLYRADICULITIS (several roots) or POLYRADICULONEURITIS (nerve roots & peripheral nerves); do not use vertebra headings to locate area of spinal nerves; nerve root compression: coordinate IM with NERVE COMPRESSION SYNDROMES (IM), not SPINAL CORD COMPRESSION
=680  \\$iPaired bundles of NERVE FIBERS entering and leaving the SPINAL CORD at each segment. The dorsal and ventral nerve roots join to form the mixed segmental spinal nerves. The dorsal roots are generally afferent, formed by the central projections of the spinal (dorsal root) ganglia sensory cells, and the ventral roots are efferent, comprising the axons of spinal motor and PREGANGLIONIC AUTONOMIC FIBERS.
=688  \\$a73(70)
=750  \0$aSpinal nerve roots$5IEN-M$0(DLC)sh 85090912

=LDR  00845cz  a2200241n  4500
=001  9880363783102441
=005  20141212205813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013125
=035  \\$aCBA6447HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x828
=072  \\$aC5.$x116.$x231.$x828
=072  \\$aC5.$x116.$x900.$x801
=150  \\$aSpinal Neoplasms
=450  \\$wnnna$aNeoplasm, Spinal
=450  \\$wnnna$aNeoplasms, Spinal
=450  \\$wnnna$aSpinal Neoplasm
=550  \\$wg$aBone Neoplasms
=550  \\$wg$aSpinal Diseases
=667  \\$ado not confuse with SPINAL CORD NEOPLASMS; coord IM with specific vertebrae (IM) + histol type of neopl (IM); /blood supply /chem /second /secret /ultrastruct permitted
=750  \0$aSpine$xCancer$5IEN-M$0(DLC)sh 85126696
=750  \0$aSpine$xTumors$5IEN-M$0(IEN)380427

=LDR  00810cz  a2200265n  4500
=001  9880363783202441
=005  20141212205813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013124
=035  \\$aCBA6446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x117.$x500
=072  \\$aC26.$x831
=150  \\$aSpinal Injuries
=450  \\$wnnna$aInjuries, Spinal
=450  \\$wnnna$aInjury, Spinal
=450  \\$wnnna$aSpinal Injury
=450  \\$aSpine$xinjuries
=550  \\$wg$aBack Injuries
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aSpinal Fractures
=550  \\$aBack Injuries
=667  \\$ado not confuse with SPINAL CORD INJURIES; GEN only, vertebrae unspecified
=680  \\$iInjuries involving the vertebral column.
=750  \0$aSpine$xWounds and injuries$5IEN$0(DLC)sh 85126705

=LDR  01060cz  a2200253n  4500
=001  9880363783302441
=005  20141212205812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013123
=035  \\$aCBA6445HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x100.$x700
=150  \\$aSpinal Fusion
=450  \\$wnnna$aFusion, Spinal
=450  \\$wnnna$aFusions, Spinal
=450  \\$wnnna$aSpinal Fusions
=450  \\$wnnna$aSpondylodeses
=450  \\$aSpondylodesis
=450  \\$wnnna$aSpondylosyndeses
=450  \\$aSpondylosyndesis
=550  \\$wg$aArthrodesis
=667  \\$ado not use /util except by MeSH definition; X ref SPONDYLODESIS is found largely in lang of Germanic family as synonym for X ref SPONDYLOSYNDESIS
=680  \\$iOperative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. (From Blauvelt & Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed)
=750  \0$aSpinal fusion$5IEN$0(DLC)sh 85126682

=LDR  01056cz  a2200337n  4500
=001  9880363783402441
=005  20141212205812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013122
=035  \\$aCBA6444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x900
=150  \\$aSpinal Diseases
=450  \\$wnnna$aDisease, Spinal
=450  \\$wnnna$aDiseases, Spinal
=450  \\$wnnna$aSpinal Disease
=550  \\$wg$aBone Diseases
=550  \\$wh$aIntervertebral Disc Degeneration
=550  \\$wh$aIntervertebral Disc Displacement
=550  \\$wh$aOssification of Posterior Longitudinal Ligament
=550  \\$wh$aPlatybasia
=550  \\$wh$aPosterior Cervical Sympathetic Syndrome
=550  \\$wh$aSpinal Curvatures
=550  \\$wh$aSpinal Neoplasms
=550  \\$wh$aSpinal Osteochondrosis
=550  \\$wh$aSpinal Osteophytosis
=550  \\$wh$aSpinal Stenosis
=550  \\$wh$aSpondylitis
=550  \\$wh$aSpondylosis
=667  \\$acoord IM with specific vertebrae (IM)
=750  \0$aSpine$xDiseases$5IEN$0(DLC)sh 85126698

=LDR  02327cz  a2200457n  4500
=001  9880363783502441
=005  20141212205811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013120
=035  \\$aCBA6442HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x803
=072  \\$aC10.$x228.$x854.$x765
=072  \\$aC10.$x551.$x240.$x750
=150  \\$aSpinal Cord Neoplasms
=450  \\$aIntradural-Extramedullary Spinal Cord Neoplasms
=450  \\$wnnna$aIntradural Extramedullary Spinal Cord Neoplasms
=450  \\$aIntramedullary Spinal Cord Neoplasms
=450  \\$wnnna$aIntramedullary Spinal Cord Neoplasms, Primary
=450  \\$wnnna$aNeoplasm, Spinal Cord
=450  \\$wnnna$aNeoplasms, Spinal Cord
=450  \\$wnnna$aPrimary Intramedullary Spinal Cord Neoplasms
=450  \\$wnnna$aPrimary Spinal Cord Neoplasms, Intramedullary
=450  \\$wnnna$aSpinal Cord Neoplasm
=450  \\$wnnna$aSpinal Cord Neoplasms, Benign
=450  \\$wnnna$aSpinal Cord Neoplasms, Intradural-Extramedullary
=450  \\$wnnna$aSpinal Cord Neoplasms, Intradural Extramedullary
=450  \\$wnnna$aSpinal Cord Neoplasms, Intramedullary
=450  \\$wnnna$aSpinal Cord Neoplasms, Malignant
=450  \\$wnnna$aSpinal Cord Neoplasms, Primary Intramedullary
=450  \\$wnnna$aSpinal Cord Tumor
=450  \\$wnnna$aSpinal Cord Tumors
=450  \\$wnnna$aTumor, Spinal Cord
=450  \\$wnnna$aTumors, Spinal Cord
=550  \\$wg$aCentral Nervous System Neoplasms
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wh$aEpidural Neoplasms
=667  \\$acoord IM with histol type of neopl (IM); coord IM with specific vertebrae (NIM) to locate site on spinal cord
=680  \\$iBenign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
=750  \0$aSpinal cord$xTumors$5IEN-M$0(DLC)sh 85126680
=750  \0$aSpinal cord$xCancer$5IEN-HS$0(DLC)sh2010010331

=LDR  02726cz  a2200733n  4500
=001  9880363783602441
=005  20141212205811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013119
=035  \\$aCBA6441HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x854.$x770
=072  \\$aC10.$x900.$x850
=072  \\$aC26.$x819
=150  \\$aSpinal Cord Injuries
=450  \\$wnnna$aContusion, Spinal Cord
=450  \\$wnnna$aContusions, Spinal Cord
=450  \\$wnnna$aCord Contusion, Spinal
=450  \\$wnnna$aCord Contusions, Spinal
=450  \\$wnnna$aCord Injuries, Spinal
=450  \\$wnnna$aCord Injury, Spinal
=450  \\$wnnna$aCord Laceration, Spinal
=450  \\$wnnna$aCord Lacerations, Spinal
=450  \\$wnnna$aCord Transection, Spinal
=450  \\$wnnna$aCord Transections, Spinal
=450  \\$wnnna$aCord Trauma, Spinal
=450  \\$wnnna$aCord Traumas, Spinal
=450  \\$wnnna$aInjuries, Spinal Cord
=450  \\$wnnna$aInjury, Spinal Cord
=450  \\$wnnna$aLaceration, Spinal Cord
=450  \\$wnnna$aLacerations, Spinal Cord
=450  \\$wnnna$aMyelopathies, Post-Traumatic
=450  \\$wnnna$aMyelopathies, Traumatic
=450  \\$wnnna$aMyelopathy, Post-Traumatic
=450  \\$aMyelopathy, Traumatic
=450  \\$wnnna$aPost-Traumatic Myelopathies
=450  \\$wnnna$aPost-Traumatic Myelopathy
=450  \\$wnnna$aPost Traumatic Myelopathy
=450  \\$wnnna$aSpinal Cord Contusion
=450  \\$wnnna$aSpinal Cord Contusions
=450  \\$aSpinal Cord$xinjuries
=450  \\$wnnna$aSpinal Cord Injury
=450  \\$wnnna$aSpinal Cord Laceration
=450  \\$wnnna$aSpinal Cord Lacerations
=450  \\$wnnna$aSpinal Cord Transection
=450  \\$wnnna$aSpinal Cord Transections
=450  \\$wnnna$aSpinal Cord Trauma
=450  \\$wnnna$aSpinal Cord Traumas
=450  \\$wnnna$aTransection, Spinal Cord
=450  \\$wnnna$aTransections, Spinal Cord
=450  \\$wnnna$aTrauma, Spinal Cord
=450  \\$wnnna$aTraumas, Spinal Cord
=450  \\$wnnna$aTraumatic Myelopathies
=450  \\$wnnna$aTraumatic Myelopathy
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wg$aTrauma, Nervous System
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aAutonomic Dysreflexia
=550  \\$wh$aCentral Cord Syndrome
=550  \\$wh$aSpinal Cord Compression
=550  \\$aSpinal Cord Regeneration
=667  \\$acoordinate IM with specific vertebra (NIM) to locate site on spinal cord
=680  \\$iPenetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).
=750  \0$aSpinal cord$xWounds and injuries$5IEN$0(DLC)sh 85126681

=LDR  01646cz  a2200421n  4500
=001  9880363783702441
=005  20141212205810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013118
=035  \\$aCBA6440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x854
=150  \\$aSpinal Cord Diseases
=450  \\$wnnna$aMyelopathies
=450  \\$aMyelopathy
=450  \\$wnnna$aSpinal Cord Disease
=450  \\$wnnna$aSpinal Cord Disorder
=450  \\$wnnna$aSpinal Cord Disorders
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wh$aAmyotrophic Lateral Sclerosis
=550  \\$wh$aEpidural Abscess
=550  \\$wh$aMuscular Atrophy, Spinal
=550  \\$wh$aMyelitis
=550  \\$wh$aPneumorrhachis
=550  \\$wh$aPoliomyelitis
=550  \\$wh$aSpinal Cord Compression
=550  \\$wh$aSpinal Cord Injuries
=550  \\$wh$aSpinal Cord Neoplasms
=550  \\$wh$aSpinal Cord Vascular Diseases
=550  \\$wh$aSpinocerebellar Degenerations
=550  \\$wh$aStiff-Person Syndrome
=550  \\$wh$aSubacute Combined Degeneration
=550  \\$wh$aSyringomyelia
=550  \\$wh$aTabes Dorsalis
=667  \\$acoord IM with specific vertebrae (NIM) to locate site on spinal cord; inflamm dis of spinal cord= MYELITIS
=680  \\$iPathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.
=688  \\$a1966
=750  \0$aSpinal cord$xDiseases$5IEN$0(DLC)sh 85126670

=LDR  02731cz  a2200793n  4500
=001  9880363783802441
=005  20141212192534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013116
=035  \\$aCBA6438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x854
=150  \\$aSpinal Cord
=360  \\$iconsider also terms at$aMYEL-
=450  \\$wnnna$aCerebelli, Tentorium
=450  \\$wnnna$aCerebellus, Tentorium
=450  \\$wnnna$aCerebri, Falx
=450  \\$wnnna$aCerebrus, Falx
=450  \\$wnnna$aCoccygeal Cord
=450  \\$wnnna$aCoccygeal Cords
=450  \\$wnnna$aConus Medullari
=450  \\$wnnna$aConus Medullaris
=450  \\$wnnna$aConus Terminali
=450  \\$wnnna$aConus Terminalis
=450  \\$wnnna$aCord, Coccygeal
=450  \\$wnnna$aCord, Lumbar
=450  \\$wnnna$aCord, Sacral
=450  \\$wnnna$aCord, Spinal
=450  \\$wnnna$aCord, Thoracic
=450  \\$wnnna$aCords, Coccygeal
=450  \\$wnnna$aCords, Lumbar
=450  \\$wnnna$aCords, Sacral
=450  \\$wnnna$aCords, Spinal
=450  \\$wnnna$aCords, Thoracic
=450  \\$wnnna$aFalx Cerebri
=450  \\$wnnna$aFalx Cerebrus
=450  \\$wnnna$aLumbar Cord
=450  \\$wnnna$aLumbar Cords
=450  \\$wnnna$aMedulla Spinali
=450  \\$wnnna$aMedulla Spinalis
=450  \\$wnnna$aMedullari, Conus
=450  \\$wnnna$aMedullaris, Conus
=450  \\$wnnna$aMyelon
=450  \\$wnnna$aMyelons
=450  \\$wnnna$aSacral Cord
=450  \\$wnnna$aSacral Cords
=450  \\$wnnna$aSpinal Cords
=450  \\$wnnna$aSpinali, Medulla
=450  \\$wnnna$aSpinalis, Medulla
=450  \\$wnnna$aTentorium Cerebelli
=450  \\$wnnna$aTentorium Cerebellus
=450  \\$wnnna$aTerminali, Conus
=450  \\$wnnna$aTerminalis, Conus
=450  \\$wnnna$aThoracic Cord
=450  \\$wnnna$aThoracic Cords
=550  \\$wg$aCentral Nervous System
=550  \\$wh$aCervical Cord
=550  \\$wh$aExtrapyramidal Tracts
=550  \\$wh$aGray Matter
=550  \\$wh$aPyramidal Tracts
=550  \\$wh$aSpinal Cord Dorsal Horn
=550  \\$wh$aSpinal Cord Lateral Horn
=550  \\$wh$aSpinal Cord Ventral Horn
=550  \\$wh$aSpinothalamic Tracts
=550  \\$wh$aWhite Matter
=550  \\$aCauda Equina
=667  \\$a/radiogr permitted but consider MYELOGRAPHY; /surg: probably CORDOTOMY; inflammation = MYELITIS; coordinate IM with specific vertebrae (NIM) to locate site on spinal cord; do not confuse words containing "myel-" for spinal cord with "myel-" for bone marrow
=680  \\$iA cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.
=750  \0$aSpinal cord$5IEN$0(DLC)sh 85126666

=LDR  00903cz  a2200313n  4500
=001  9880363783902441
=005  20141212205740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013026
=035  \\$aCBA6346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285.$x850
=150  \\$aSpace Flight
=450  \\$wnnna$aExploration, Space
=450  \\$wnnna$aExplorations, Space
=450  \\$wnnna$aFlight, Space
=450  \\$wnnna$aFlights, Space
=450  \\$aSpace Exploration
=450  \\$wnnna$aSpace Explorations
=450  \\$wnnna$aSpace Flights
=450  \\$wnnna$aSpaceflight
=450  \\$wnnna$aSpaceflights
=550  \\$wg$aAviation
=550  \\$wh$aExtravehicular Activity
=550  \\$wh$aSpacecraft
=550  \\$aAerospace Medicine
=667  \\$aSPEC: SPEC qualif
=680  \\$iTravel beyond the earth's atmosphere.
=750  \0$aSpace flight$5IEN$0(DLC)sh 85125923

=LDR  00907cz  a2200313n  4500
=001  9880363784002441
=005  20141212205740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013025
=035  \\$aCBA6345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x750
=072  \\$aJ2.$x500.$x300.$x100.$x900
=072  \\$aJ2.$x500.$x850.$x500.$x700
=150  \\$aSoybeans
=450  \\$wnnna$aBean, Soy
=450  \\$wnnna$aBeans, Soy
=450  \\$aGlycine max
=450  \\$wnnna$aSoy Bean
=450  \\$aSoy Beans
=450  \\$wnnna$aSoybean
=550  \\$wg$aAnimal Feed
=550  \\$wg$aFabaceae
=550  \\$wh$aSoy Foods
=550  \\$aSoybean Proteins
=667  \\$aas plant & food
=680  \\$iAn annual legume or the seeds of this plant.
=688  \\$a86; was SOY BEANS 1963-85; was in Cat J only 1963-80
=750  \0$aSoybean$5IEN$0(DLC)sh 85125884

=LDR  01128cz  a2200385n  4500
=001  9880363784102441
=005  20141212205740.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013024
=035  \\$aCBA6344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x800
=072  \\$aD10.$x212.$x507.$x800
=072  \\$aD10.$x627.$x700.$x880
=072  \\$aD20.$x215.$x784.$x750.$x880
=072  \\$aJ2.$x500.$x375.$x400.$x750
=150  \\$aSoybean Oil
=450  \\$wnnna$aOil, Soy Bean
=450  \\$wnnna$aOil, Soya
=450  \\$wnnna$aOil, Soybean
=450  \\$wnnna$aOils, Soy Bean
=450  \\$wnnna$aOils, Soya
=450  \\$wnnna$aOils, Soybean
=450  \\$wnnna$aSoy Bean Oil
=450  \\$wnnna$aSoy Bean Oils
=450  \\$aSoy Oil$5IEN
=450  \\$aSoya Oil
=450  \\$wnnna$aSoya Oils
=450  \\$wnnna$aSoybean Oils
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=680  \\$iOil from soybean or soybean plant.
=688  \\$a91(87); was see under PLANT OILS 1987-90
=750  \0$aSoy oil$5IEN$0(DLC)sh 85125897

=LDR  00949cz  a2200277n  4500
=001  9880363784202441
=005  20141212205738.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013017
=035  \\$aCBA6335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x71.$x869
=150  \\$aSound Localization
=450  \\$aAuditory Localization
=450  \\$wnnna$aAuditory Localizations
=450  \\$aDirectional Hearing$5IEN
=450  \\$wnnna$aLocalization, Auditory
=450  \\$wnnna$aLocalization, Sound
=450  \\$wnnna$aLocalizations, Auditory
=450  \\$wnnna$aLocalizations, Sound
=450  \\$wnnna$aSound Localizations
=550  \\$wg$aAuditory Perception
=667  \\$ado not confuse with ECHOLOCATION (animal only)
=680  \\$iAbility to determine the specific location of a sound source.
=688  \\$a91(80); was see under AUDITORY PERCEPTION 1980-90
=750  \0$aDirectional hearing$5IEN$0(DLC)sh 85125378

=LDR  01524cz  a2200433n  4500
=001  9880363784302441
=005  20161123115633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013016
=035  \\$aCBA6334HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x770.$x776
=150  \\$aSound
=360  \\$iconsider also terms at$aPHON-
=450  \\$wnnna$aAcoustic Wave
=450  \\$wnnna$aAcoustic Waves
=450  \\$wnnna$aElastic Wave
=450  \\$wnnna$aElastic Waves
=450  \\$wnnna$aRadiation, Sonic
=450  \\$wnnna$aRadiations, Sonic
=450  \\$wnnna$aSonic Radiation
=450  \\$wnnna$aSonic Radiations
=450  \\$wnnna$aSound Wave
=450  \\$wnnna$aSound Waves
=450  \\$wnnna$aSounds
=450  \\$wnnna$aWave, Acoustic
=450  \\$wnnna$aWave, Elastic
=450  \\$wnnna$aWave, Sound
=450  \\$wnnna$aWaves, Acoustic
=450  \\$wnnna$aWaves, Elastic
=450  \\$wnnna$aWaves, Sound
=550  \\$wg$aRadiation, Nonionizing
=550  \\$wh$aHigh-Energy Shock Waves
=550  \\$wh$aNoise
=550  \\$wh$aPhonons
=550  \\$wh$aUltrasonic Waves
=680  \\$iA type of non-ionizing radiation in which energy is transmitted through solid, liquid, or gas as compression waves. Sound (acoustic or sonic) radiation with frequencies above the audible range is classified as ultrasonic. Sound radiation below the audible range is classified as infrasonic.
=750  \0$aSound$5IEN-M$0(DLC)sh 85125363
=750  \0$aSound-waves$5IEN-HS$0(DLC)sh 85125404

=LDR  01241cz  a2200313n  4500
=001  9880363784402441
=005  20141212205736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013012
=035  \\$aCBA6330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x813
=072  \\$aD9.$x853.$x813
=150  \\$aSorbitol
=450  \\$wnnna$aBaxter Brand of Sorbitol
=450  \\$aGlucitol
=450  \\$wnnna$aklysma Sorbit
=450  \\$wnnna$aMedefield Brand of Sorbitol
=450  \\$wnnna$aMedevac
=450  \\$wnnna$aPfizer Brand of Sorbitol
=450  \\$wnnna$aSorbilax
=450  \\$wnnna$aSorbitol Pfizer Brand
=450  \\$wnnna$aTrommsdorff Brand of Sorbitol
=450  \\$wnnna$aYal
=550  \\$wg$aSugar Alcohols
=550  \\$wh$aIsosorbide
=550  \\$wh$aMeglumine
=680  \\$iA polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications.
=750  \0$aSorbitol$5IEN$0(DLC)sh 85125297

=LDR  00934cz  a2200277n  4500
=001  9880363784502441
=005  20141212205736.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013011
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x840
=150  \\$aSorbic Acid
=450  \\$wnnna$aAcid, Hexadienoic
=450  \\$wnnna$aAcid, Propenylacrylic
=450  \\$wnnna$aAcid, Sorbic
=450  \\$aHexadienoic Acid
=450  \\$wnnna$aPotassium Sorbate
=450  \\$aPropenylacrylic Acid
=450  \\$wnnna$aSodium Sorbate
=450  \\$wnnna$aSorbate, Potassium
=450  \\$wnnna$aSorbate, Sodium
=550  \\$wg$aFatty Acids, Unsaturated
=667  \\$aD25-26 qualif; POLYSORBATES is available
=680  \\$iMold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses.
=688  \\$a91(75); was see under FATTY ACIDS, UNSATURATED 1975-90
=750  \0$aSorbic acid$5IEN$0(DLC)sh 89000456

=LDR  00612cz  a2200193n  4500
=001  9880363784602441
=005  20141212205735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013010
=035  \\$aCBA6328M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x848
=150  \\$aSonication
=450  \\$wnnna$aSonications
=550  \\$wg$aInvestigative Techniques
=550  \\$aHigh-Energy Shock Waves
=680  \\$iThe application of high intensity ultrasound to liquids.
=688  \\$a91(75); was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73
=750  \0$aSonication$0(DLC)sh2005006543$5IEN-M

=LDR  00977cz  a2200253n  4500
=001  9880363784702441
=005  20141212205735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013009
=035  \\$aCBA6327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x659.$x635.$x700
=072  \\$aF3.$x870.$x664.$x635.$x700
=150  \\$aSomnambulism
=450  \\$aNocturnal Wandering
=450  \\$wnnna$aSleep Walking
=450  \\$wnnna$aSleep Walking Disorder
=450  \\$wnnna$aSleep Walking Disorders
=450  \\$aSleepwalking
=450  \\$wnnna$aWandering, Nocturnal
=550  \\$wg$aSleep Arousal Disorders
=680  \\$iA parasomnia characterized by a partial arousal that occurs during stage IV of non-REM sleep. Affected individuals exhibit semipurposeful behaviors such as ambulation and are difficult to fully awaken. Children are primarily affected, with a peak age range of 4-6 years.
=688  \\$a69
=750  \0$aSleepwalking$5IEN$0(DLC)sh 85124805

=LDR  01144cz  a2200361n  4500
=001  9880363784802441
=005  20141212205735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013008
=035  \\$aCBA6326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x800
=072  \\$aG7.$x100.$x800
=150  \\$aSomatotypes
=450  \\$aBody Build
=450  \\$wnnna$aBody Builds
=450  \\$wnnna$aBody Type
=450  \\$aBody Types
=450  \\$wnnna$aBuild, Body
=450  \\$wnnna$aBuilds, Body
=450  \\$aEctomorph
=450  \\$wnnna$aEctomorphs
=450  \\$aEndomorph
=450  \\$wnnna$aEndomorphs
=450  \\$aMesomorph
=450  \\$wnnna$aMesomorphs
=450  \\$wnnna$aSomatotype
=450  \\$wnnna$aType, Body
=450  \\$wnnna$aTypes, Body
=550  \\$wg$aBody Constitution
=550  \\$aPhenotype
=680  \\$iParticular categories of body build, determined on the basis of certain physical characteristics. The three basic body types are ectomorph (thin physique), endomorph (rounded physique), and mesomorph (athletic physique).
=750  \0$aSomatotypes$5IEN$0(DLC)sh 85124785

=LDR  01856cz  a2200421n  4500
=001  9880363784902441
=005  20141212205734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013007
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x740.$x860
=072  \\$aD12.$x644.$x400.$x400.$x740.$x860
=072  \\$aD12.$x644.$x548.$x365.$x740.$x860
=072  \\$aD12.$x776.$x641.$x650.$x405.$x740.$x860
=150  \\$aGrowth Hormone-Releasing Hormone
=450  \\$wnnna$aGHRH 1-44
=450  \\$wnnna$aGRF 1-44
=450  \\$aGrowth Hormone-Releasing Factor
=450  \\$wnnna$aGrowth Hormone Releasing Factor
=450  \\$wnnna$aGrowth Hormone-Releasing Factor 44
=450  \\$wnnna$aGrowth Hormone Releasing Factor 44
=450  \\$wnnna$aGrowth Hormone Releasing Hormone
=450  \\$wnnna$ahpGRF 44
=450  \\$wnnna$aHuman Pancreatic Growth Hormone-Releasing Factor
=450  \\$aSomatocrinin
=450  \\$wnnna$aSomatoliberin
=450  \\$aSomatotropin-Releasing Factor 44
=450  \\$wnnna$aSomatotropin Releasing Factor 44
=450  \\$aSomatotropin-Releasing Hormone
=450  \\$wnnna$aSomatotropin Releasing Hormone
=550  \\$wg$aPituitary Hormone-Releasing Hormones
=550  \\$wh$aSermorelin
=667  \\$aDF: SRH
=680  \\$iA peptide of 44 amino acids in most species that stimulates the release and synthesis of GROWTH HORMONE. GHRF (or GRF) is synthesized by neurons in the ARCUATE NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, GHRF stimulates GH release by the SOMATOTROPHS in the PITUITARY GLAND.
=688  \\$a2007 (1974)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Somatotropin-Releasing Hormone
=688  \\$a91; was SOMATOTROPIN RELEASING HORMONE 1974-90
=750  \0$aGrowth hormone releasing factor$0(DLC) sh 90001973$5IEN

=LDR  01587cz  a2200373n  4500
=001  9880363785002441
=005  20141212205734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013006
=035  \\$aCBA6324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x525.$x425
=072  \\$aD12.$x644.$x548.$x691.$x525.$x425
=150  \\$aGrowth Hormone
=450  \\$wnnna$aGrowth Hormone, Pituitary
=450  \\$aGrowth Hormone, Recombinant
=450  \\$wnnna$aGrowth Hormones Pituitary, Recombinant
=450  \\$wnnna$aGrowth Hormones, Recombinant
=450  \\$aPituitary Growth Hormone
=450  \\$wnnna$aPituitary Growth Hormones, Recombinant
=450  \\$aRecombinant Growth Hormone
=450  \\$wnnna$aRecombinant Growth Hormones
=450  \\$wnnna$aRecombinant Pituitary Growth Hormones
=450  \\$wnnna$aRecombinant Somatotropin
=450  \\$wnnna$aRecombinant Somatotropins
=450  \\$aSomatotropin
=450  \\$aSomatotropin, Recombinant
=450  \\$wnnna$aSomatotropins, Recombinant
=550  \\$wg$aPituitary Hormones, Anterior
=550  \\$wh$aHuman Growth Hormone
=667  \\$adespite X ref, coord with RECOMBINANT PROTEINS for recombinant somatotropin; HUMAN GROWTH HORMONE is also available
=680  \\$iA polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.
=688  \\$a2003 (1966)
=750  \0$aSomatotropin$0(DLC) sh 85124783$5IEN

=LDR  01803cz  a2200385n  4500
=001  9880363785102441
=005  20141212205733.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013004
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x700.$x875
=072  \\$aD6.$x472.$x699.$x587.$x780
=072  \\$aD12.$x644.$x400.$x400.$x700.$x875
=072  \\$aD12.$x644.$x548.$x365.$x700.$x875
=072  \\$aD12.$x644.$x548.$x586.$x780
=072  \\$aD12.$x776.$x641.$x650.$x405.$x700.$x875
=150  \\$aSomatostatin
=450  \\$aCyclic Somatostatin
=450  \\$wnnna$aSomatofalk
=450  \\$aSomatostatin-14
=450  \\$wnnna$aSomatostatin 14
=450  \\$wnnna$aSomatostatin, Cyclic
=450  \\$wnnna$aSomatotropin Release-Inhibiting Factor
=450  \\$wnnna$aSomatotropin Release Inhibiting Factor
=450  \\$aSomatotropin Release-Inhibiting Hormone
=450  \\$wnnna$aSomatotropin Release Inhibiting Hormone
=450  \\$wnnna$aSRIH-14
=450  \\$wnnna$aStilamin
=550  \\$wg$aPancreatic Hormones
=550  \\$wg$aPituitary Hormone Release Inhibiting Hormones
=550  \\$wh$aSomatostatin-28
=550  \\$aReceptors, Somatostatin
=680  \\$iA 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
=688  \\$a99
=750  \0$aSomatostatin$0(DLC) sh 85124782$5IEN

=LDR  03243cz  a2200817n  4500
=001  9880363785202441
=005  20141212192531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013003
=035  \\$aCBA6321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x670.$x675
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814.$x906
=150  \\$aSomatosensory Cortex
=450  \\$wnnna$aAnterior Parietal Cortex
=450  \\$wnnna$aAnterior Parietal Cortices
=450  \\$wnnna$aArea, Primary Somatosensory
=450  \\$wnnna$aArea, Secondary Somatosensory
=450  \\$wnnna$aAreas, Primary Somatosensory
=450  \\$wnnna$aAreas, Secondary Somatosensory
=450  \\$wnnna$aCentral Gyrus, Post
=450  \\$wnnna$aCortex, Anterior Parietal
=450  \\$wnnna$aCortex, Primary Somatosensory
=450  \\$wnnna$aCortex, Secondary Sensory
=450  \\$wnnna$aCortex, Secondary Somatosensory
=450  \\$wnnna$aCortex, SI
=450  \\$wnnna$aCortex, Somatosensory
=450  \\$wnnna$aCortices, Anterior Parietal
=450  \\$wnnna$aCortices, Primary Somatosensory
=450  \\$wnnna$aCortices, Secondary Sensory
=450  \\$wnnna$aCortices, Secondary Somatosensory
=450  \\$wnnna$aCortices, SI
=450  \\$wnnna$aGyrus, Post Central
=450  \\$wnnna$aGyrus, Postcentral
=450  \\$wnnna$aGyrus Postcentrali
=450  \\$wnnna$aGyrus Postcentralis
=450  \\$wnnna$aParietal Cortex, Anterior
=450  \\$wnnna$aParietal Cortices, Anterior
=450  \\$wnnna$aPost Central Gyrus
=450  \\$wnnna$aPostcentral Gyrus
=450  \\$wnnna$aPostcentrali, Gyrus
=450  \\$wnnna$aPostcentralis, Gyrus
=450  \\$wnnna$aPrimary Somatic Sensory Area
=450  \\$wnnna$aPrimary Somatosensory Area
=450  \\$wnnna$aPrimary Somatosensory Areas
=450  \\$wnnna$aPrimary Somatosensory Cortex
=450  \\$wnnna$aPrimary Somatosensory Cortices
=450  \\$wnnna$aSecond Somatic Sensory Area
=450  \\$wnnna$aSecondary Sensory Cortex
=450  \\$wnnna$aSecondary Sensory Cortices
=450  \\$wnnna$aSecondary Somatosensory Area
=450  \\$wnnna$aSecondary Somatosensory Areas
=450  \\$wnnna$aSecondary Somatosensory Cortex
=450  \\$wnnna$aSecondary Somatosensory Cortices
=450  \\$wnnna$aSensory Cortex, Secondary
=450  \\$wnnna$aSensory Cortices, Secondary
=450  \\$wnnna$aSI Cortex
=450  \\$wnnna$aSI Cortices
=450  \\$wnnna$aSomatosensory Area, Primary
=450  \\$wnnna$aSomatosensory Area, Secondary
=450  \\$wnnna$aSomatosensory Areas, Primary
=450  \\$wnnna$aSomatosensory Areas, Secondary
=450  \\$wnnna$aSomatosensory Cortex, Primary
=450  \\$wnnna$aSomatosensory Cortex, Secondary
=450  \\$wnnna$aSomatosensory Cortices, Primary
=450  \\$wnnna$aSomatosensory Cortices, Secondary
=550  \\$wg$aParietal Lobe
=550  \\$wg$aSensorimotor Cortex
=680  \\$iArea of the parietal lobe concerned with receiving sensations such as movement, pain, pressure, position, temperature, touch, and vibration. It lies posterior to the central sulcus.
=688  \\$a71
=750  \0$aSomatosensory cortex$0(DLC)sh2012002724$5IEN-M

=LDR  01345cz  a2200325n  4500
=001  9880363785302441
=005  20141212205732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x937
=072  \\$aD12.$x776.$x124.$x862
=072  \\$aD12.$x776.$x467.$x937
=072  \\$aD23.$x529.$x937
=150  \\$aSomatomedins
=450  \\$wnnna$aFactor, Sulfation
=450  \\$wnnna$aFactors, Insulin-Like Growth
=450  \\$wnnna$aGrowth Factors, Insulin-Like
=450  \\$wnnna$aInsulin Like Growth Factors
=450  \\$aInsulin-Like Growth Factors
=450  \\$wnnna$aSomatomedin
=450  \\$aSulfation Factor
=550  \\$wg$aBlood Proteins
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aInsulin-Like Growth Factor I
=550  \\$wh$aInsulin-Like Growth Factor II
=550  \\$wh$aNonsuppressible Insulin-Like Activity
=680  \\$iInsulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism.
=688  \\$a82; was SOMATOMEDIN 1973-81, was SULFATION FACTOR 1971-72 (Prov)
=750  \0$aSomatomedin$5IEN$0(DLC)sh 85124781

=LDR  01359cz  a2200301n  4500
=001  9880363785402441
=005  20141212205732.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013001
=035  \\$aCBA6319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x875
=150  \\$aSomatoform Disorders
=450  \\$aBriquet Syndrome
=450  \\$aPain Disorder
=450  \\$aSomatization Disorder
=450  \\$wnnna$aSomatization Disorders
=450  \\$wnnna$aSomatoform Disorder
=450  \\$wnnna$aSyndrome, Briquet
=550  \\$wg$aMental Disorders
=550  \\$wh$aBody Dysmorphic Disorders
=550  \\$wh$aConversion Disorder
=550  \\$wh$aHypochondriasis
=550  \\$wh$aNeurasthenia
=667  \\$adifferentiate from FACTITIOUS DISORDERS and PSYCHOPHYSIOLOGIC DISORDERS
=680  \\$iDisorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-IV)
=688  \\$a81
=750  \0$aSomatoform disorders$5IEN$0(DLC)sh 85124779

=LDR  00643cz  a2200181n  4500
=001  9880363785502441
=005  20141212205731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012997
=035  \\$aCBA6315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x844
=150  \\$aSolvents
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aIonic Liquids
=667  \\$aD25-26 qualif
=680  \\$iLiquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aSolvents$0(DLC) sh 85124746$5IEN

=LDR  01212cz  a2200265n  4500
=001  9880363785602441
=005  20141212205731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012996
=035  \\$aCBA6314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x776
=150  \\$aSolutions
=550  \\$wg$aPharmaceutical Preparations
=550  \\$wh$aContact Lens Solutions
=550  \\$wh$aHypertonic Solutions
=550  \\$wh$aHypotonic Solutions
=550  \\$wh$aIsotonic Solutions
=550  \\$wh$aOrgan Preservation Solutions
=550  \\$wh$aPharmaceutical Solutions
=550  \\$wh$aRehydration Solutions
=550  \\$aPharmaceutical Solutions
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) when substance in solution is IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the substance in solution, not the "solution"
=680  \\$iThe homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aSolution (Chemistry)$5IEN-M$0(DLC)sh 85124730

=LDR  00668cz  a2200205n  4500
=001  9880363785702441
=005  20141212192530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012995
=035  \\$aCBA6313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x800
=150  \\$aSolubility
=450  \\$wnnna$aSolubilities
=550  \\$wg$aPhysicochemical Phenomena
=550  \\$aDrug Liberation
=667  \\$aNIM
=680  \\$iThe ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a65(64)
=750  \0$aSolubility$5IEN$0(DLC)sh 85124725

=LDR  00820cz  a2200265n  4500
=001  9880363785802441
=005  20141212205730.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012993
=035  \\$aCBA6311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x897
=072  \\$aN6.$x230.$x132.$x644.$x500
=150  \\$aSolar Energy
=450  \\$wnnna$aEnergies, Solar
=450  \\$wnnna$aEnergy, Solar
=450  \\$wnnna$aPower, Solar
=450  \\$wnnna$aSolar Energies
=450  \\$wnnna$aSolar Power
=550  \\$wg$aRadiation
=550  \\$wg$aRenewable Energy
=550  \\$aSolar Activity
=680  \\$iEnergy transmitted from the sun in the form of electromagnetic radiation.
=688  \\$a91(82); was see under ENERGY-GENERATING RESOURCES 1982-90
=750  \0$aSolar energy$5IEN$0(DLC)sh 85124500

=LDR  00682cz  a2200229n  4500
=001  9880363785902441
=005  20141212205730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012992
=035  \\$aCBA6310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x760.$x769
=072  \\$aD4.$x808.$x247.$x515.$x500.$x500
=072  \\$aD4.$x808.$x247.$x808.$x874
=072  \\$aD9.$x408.$x782.$x674
=150  \\$aSolanine
=550  \\$wg$aDiosgenin
=550  \\$wg$aSaponins
=550  \\$wg$aSolanaceous Alkaloids
=550  \\$wg$aSterols
=680  \\$iA mixture of alpha-chaconine and alpha-solanine, found in SOLANACEAE plants.
=750  \0$aSolanine$5IEN$0(DLC)sh 86007719

=LDR  00772cz  a2200217n  4500
=001  9880363786002441
=005  20141212205729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012988
=035  \\$aCBA6306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x274.$x555
=072  \\$aN6.$x850.$x425.$x300
=150  \\$aSoil Microbiology
=450  \\$wnnna$aMicrobiology, Soil
=450  \\$aSoil$xmicrobiology
=450  \\$aSoil$xvirology
=550  \\$wg$aEnvironmental Microbiology
=667  \\$aIM; coord IM with specific bact, virus or fungus (IM); DF: SOIL MICROBIOL
=680  \\$iThe presence of bacteria, viruses, and fungi in the soil. This term is not restricted to pathogenic organisms.
=750  \0$aSoil microbiology$5IEN$0(DLC)sh 85124357

=LDR  00890cz  a2200301n  4500
=001  9880363786102441
=005  20141212205728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012987
=035  \\$aCBA6305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x721
=072  \\$aG1.$x311.$x820
=072  \\$aG16.$x500.$x275.$x815
=072  \\$aN6.$x230.$x600
=150  \\$aSoil
=450  \\$wnnna$aCompost
=450  \\$wnnna$aHumus
=450  \\$aPeat
=450  \\$wnnna$aSoils
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aEnvironment
=550  \\$wg$aGeological Phenomena
=550  \\$wh$aHumic Substances
=550  \\$wh$aPermafrost
=680  \\$iThe unconsolidated mineral or organic matter on the surface of the earth that serves as a natural medium for the growth of land plants.
=688  \\$aPEAT was heading 1963-81
=750  \0$aSoils$5IEN$0(DLC)sh 85124396

=LDR  00865cz  a2200265n  4500
=001  9880363786202441
=005  20141212205728.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012986
=035  \\$aCBA6304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x868
=150  \\$aSoftware Validation
=450  \\$wnnna$aSoftware Validations
=450  \\$aSoftware Verification
=450  \\$wnnna$aSoftware Verifications
=450  \\$wnnna$aValidation, Software
=450  \\$wnnna$aValidations, Software
=450  \\$wnnna$aVerification, Software
=450  \\$wnnna$aVerifications, Software
=550  \\$wg$aSoftware
=667  \\$aIM; no qualif
=680  \\$iThe act of testing the software for compliance with a standard.
=688  \\$a91(87); was see under SOFTWARE 1987-90
=750  \0$aComputer software$xValidation$0(DLC) sh 85029536$5IEN

=LDR  02300cz  a2200625n  4500
=001  9880363786302441
=005  20141212205728.0
=008  820430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012984
=035  \\$aCBA6302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900
=150  \\$aSoftware
=450  \\$wnnna$aApplication, Computer Software
=450  \\$wnnna$aApplications, Computer Software
=450  \\$wnnna$aApplications Software, Computer
=450  \\$wnnna$aApplications Softwares, Computer
=450  \\$wnnna$aComputer Applications Software
=450  \\$wnnna$aComputer Applications Softwares
=450  \\$wnnna$aComputer Program
=450  \\$aComputer Programs
=450  \\$wnnna$aComputer Programs and Programming
=450  \\$aComputer Software
=450  \\$wnnna$aComputer Software Application
=450  \\$wnnna$aComputer Software Applications
=450  \\$wnnna$aEngineering, Software
=450  \\$wnnna$aProgram, Computer
=450  \\$wnnna$aPrograms, Computer
=450  \\$wnnna$aSoftware Application, Computer
=450  \\$wnnna$aSoftware Applications, Computer
=450  \\$wnnna$aSoftware, Computer
=450  \\$wnnna$aSoftware, Computer Applications
=450  \\$aSoftware Engineering
=450  \\$wnnna$aSoftware Tool
=450  \\$aSoftware Tools
=450  \\$wnnna$aSoftwares, Computer Applications
=450  \\$wnnna$aTool, Software
=450  \\$wnnna$aTools, Software
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aDatabase Management Systems
=550  \\$wh$aGrateful Med
=550  \\$wh$aHypermedia
=550  \\$wh$aMobile Applications
=550  \\$wh$aProgramming Languages
=550  \\$wh$aSoftware Design
=550  \\$wh$aSoftware Validation
=550  \\$wh$aSpeech Recognition Software
=550  \\$wh$aUser-Computer Interface
=550  \\$wh$aVideo Games
=550  \\$wh$aWeb Browser
=550  \\$wh$aWord Processing
=550  \\$aSearch Engine
=680  \\$iSequential operating programs and data which instruct the functioning of a digital computer.
=688  \\$a87(83); was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMIMG, COMPUTER see under COMPUTERS 1966-74
=750  \0$aComputer software$5IEN-HS$0(DLC)sh 85029534

=LDR  01128cz  a2200253n  4500
=001  9880363786402441
=005  20141212205727.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012983
=035  \\$aCBA6301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x839
=150  \\$aSoft Tissue Neoplasms
=450  \\$wnnna$aNeoplasm, Soft Tissue
=450  \\$wnnna$aNeoplasms, Soft Tissue
=450  \\$wnnna$aSoft Tissue Neoplasm
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aMuscle Neoplasms
=550  \\$wh$aVascular Neoplasms
=550  \\$aNeoplasms, Connective Tissue
=667  \\$aneoplasms located in soft (connective) tissue, NOT neoplasms composed of soft tissue; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term or site (IM)
=680  \\$iNeoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
=688  \\$a76
=750  \0$aSoft tissue tumors$0(DLC) sh 91000905$5IEN

=LDR  00812cz  a2200205n  4500
=001  9880363786502441
=005  20141212205726.0
=008  870323\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012982
=035  \\$aCBA6300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x857.$x700
=150  \\$aSodium, Dietary
=450  \\$aDietary Sodium
=550  \\$wg$aSodium Compounds
=550  \\$wh$aSodium Chloride, Dietary
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /defic = SODIUM /defic but consider also HYPONATREMIA; for intake of table salt index under SODIUM CHLORIDE, DIETARY
=680  \\$iSodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate.
=688  \\$a88
=750  \0$aFood$xSodium content$5IEN-M$0(DLC)sh 85050224

=LDR  01352cz  a2200385n  4500
=001  9880363786602441
=005  20141212192530.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012978
=035  \\$aCBA6296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x937.$x700
=072  \\$aD2.$x241.$x511.$x429.$x700
=150  \\$aSodium Oxybate
=450  \\$a4-Hydroxybutyrate Sodium
=450  \\$wnnna$a4 Hydroxybutyrate Sodium
=450  \\$agamma-Hydroxybutyrate
=450  \\$wnnna$agamma Hydroxybutyrate
=450  \\$wnnna$aGamma-OH
=450  \\$wnnna$aGamma OH
=450  \\$wnnna$aKöhler Brand of Sodium Oxybate
=450  \\$wnnna$aOrphan Brand of Sodium Oxybate
=450  \\$aOxybate Sodium
=450  \\$wnnna$aOxybate, Sodium
=450  \\$wnnna$aOxybutyrate, Sodium
=450  \\$wnnna$aSERB Brand of Sodium Oxybate
=450  \\$aSodium gamma-Hydroxybutyrate
=450  \\$wnnna$aSodium gamma Hydroxybutyrate
=450  \\$aSodium Oxybutyrate
=450  \\$wnnna$aSomsanit
=450  \\$wnnna$aXyrem
=550  \\$wg$aHydroxybutyrates
=680  \\$iThe sodium salt of 4-hydroxybutyric acid. Anesthetic used for both induction and maintenance. It may cause bradycardia and dyskinesias.
=688  \\$a91(75); was see under HYDROXYBUTYRATES 1975-90
=750  \0$aGamma-hydroxybutyrate$5IEN-M$0(DLC)sh 98004623

=LDR  00707cz  a2200193n  4500
=001  9880363786702441
=005  20141212205725.0
=008  780315\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012974
=035  \\$aCBA6292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x475.$x410.$x800
=072  \\$aD1.$x857.$x760
=150  \\$aSodium Iodide
=550  \\$wg$aIodides
=550  \\$wg$aSodium Compounds
=680  \\$iA compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function tests.
=688  \\$a91(79); was see under IODIDES 1979-90
=750  \0$aSodium iodide$5IEN$0(DLC)sh 88002051

=LDR  00944cz  a2200265n  4500
=001  9880363786802441
=005  20141212205724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012973
=035  \\$aCBA6291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x465.$x800
=072  \\$aD1.$x650.$x550.$x400.$x800
=072  \\$aD1.$x857.$x750
=150  \\$aSodium Hypochlorite
=450  \\$wnnna$aAntiformin
=450  \\$wnnna$aClorox
=450  \\$wnnna$aHypochlorite, Sodium
=450  \\$wnnna$aSodium Hypochlorite (Solution)
=550  \\$wg$aHypochlorous Acid
=550  \\$wg$aSodium Compounds
=667  \\$aneedle bleaching (as by intravenous drug users) is indexed under SODIUM HYPOCHLORITE + DISINFECTION + NEEDLES
=680  \\$iIt is used as an oxidizing and bleaching agent and as a disinfectant. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a65
=750  \0$aSodium hypochlorite$5IEN$0(DLC)sh 86006536

=LDR  00765cz  a2200253n  4500
=001  9880363786902441
=005  20141212205724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012972
=035  \\$aCBA6290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45.$x250.$x750
=072  \\$aD1.$x455.$x824
=072  \\$aD1.$x857.$x745
=150  \\$aSodium Hydroxide
=450  \\$wnnna$aCaustic Soda
=450  \\$wnnna$aHydroxide, Sodium
=450  \\$wnnna$aSoda, Caustic
=550  \\$wg$aHydroxides
=550  \\$wg$aSodium Compounds
=667  \\$aa caustic
=680  \\$iA highly caustic substance that is used to neutralize acids and make sodium salts. (From Merck Index, 11th ed)
=688  \\$a65(64)
=750  \0$aSodium hydroxide$5IEN$0(DLC)sh 85124265

=LDR  00742cz  a2200241n  4500
=001  9880363787002441
=005  20141212205723.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012970
=035  \\$aCBA6288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x67.$x625.$x349.$x850
=072  \\$aD12.$x125.$x119.$x409.$x349.$x575
=150  \\$aSodium Glutamate
=450  \\$wnnna$aAccent
=450  \\$wnnna$aGlutamate, Sodium
=450  \\$aMonosodium Glutamate
=450  \\$aMSG
=450  \\$wnnna$aVestin
=550  \\$wg$aGlutamic Acid
=680  \\$iOne of the FLAVORING AGENTS used to impart a meat-like flavor.
=688  \\$a91(75); was see under GLUTAMATES 1975-90
=750  \0$aMonosodium glutamate$0(DLC) sh 86006084$5IEN

=LDR  01136cz  a2200361n  4500
=001  9880363787102441
=005  20141212205723.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012969
=035  \\$aCBA6287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x303.$x350.$x300.$x875
=072  \\$aD1.$x857.$x725
=072  \\$aD25.$x223.$x716
=072  \\$aJ1.$x637.$x51.$x223.$x716
=150  \\$aSodium Fluoride
=450  \\$wnnna$aFluoride, Sodium
=450  \\$wnnna$aFluorides, Sodium
=450  \\$wnnna$aFluoristat
=450  \\$wnnna$aFluoristats
=450  \\$wnnna$aOssin
=450  \\$wnnna$aOssins
=450  \\$wnnna$aProcter & Gamble Brand of Sodium Fluoride
=450  \\$wnnna$aSodium Fluorides
=450  \\$wnnna$aZymafluor
=450  \\$wnnna$aZymafluors
=550  \\$wg$aCariostatic Agents
=550  \\$wg$aFluorides
=550  \\$wg$aSodium Compounds
=550  \\$wh$aAcidulated Phosphate Fluoride
=680  \\$iA source of inorganic fluoride which is used topically to prevent dental caries.
=688  \\$a84(77); was see under FLUORIDES 1977-83
=750  \0$aSodium fluoride$5IEN$0(DLC)sh 85124263

=LDR  02495cz  a2200637n  4500
=001  9880363787202441
=005  20171012131905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012968
=035  \\$aCBA6286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x429.$x500.$x830
=150  \\$aEtidronic Acid
=450  \\$wnnna$a1,1-hydroxyethylenediphosphonate
=450  \\$wnnna$a1,1 hydroxyethylenediphosphonate
=450  \\$wnnna$a1-Hydroxyethane-1,1-Diphosphonate
=450  \\$wnnna$a1 Hydroxyethane 1,1 Diphosphonate
=450  \\$wnnna$a1-Hydroxyethylene Diphosphonate, Disodium
=450  \\$wnnna$a(1-hydroxyethylene)diphosphonic acid
=450  \\$wnnna$a(1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt
=450  \\$wnnna$a1-Hydroxyethylidene-1,1-Bisphosphonate
=450  \\$wnnna$a1 Hydroxyethylidene 1,1 Bisphosphonate
=450  \\$wnnna$aDicalcium EHDP
=450  \\$wnnna$aDicalcium Etidronate
=450  \\$wnnna$aDidronel
=450  \\$wnnna$aDiphosphonate, Disodium 1-Hydroxyethylene
=450  \\$wnnna$aDiphosphonic Acid, Hydroxyethylidene
=450  \\$wnnna$aDisodium 1-Hydroxyethylene Diphosphonate
=450  \\$wnnna$aDisodium 1 Hydroxyethylene Diphosphonate
=450  \\$wnnna$aDisodium Etidronate
=450  \\$aEHDP
=450  \\$wnnna$aEHDP, Dicalcium
=450  \\$aEthanehydroxydiphosphonate
=450  \\$wnnna$aEthanehydroxyphosphate
=450  \\$aEtidronate
=450  \\$wnnna$aEtidronate, Dicalcium
=450  \\$aEtidronate Disodium
=450  \\$wnnna$aEtidronate, Disodium
=450  \\$wnnna$aEtidronate, Sodium
=450  \\$wnnna$aEtidronate, Tetrapotassium Salt
=450  \\$wnnna$aHEDP
=450  \\$wnnna$aHEDSPA
=450  \\$wnnna$aHydroxyethanediphosphonate
=450  \\$wnnna$aHydroxyethylidene Diphosphonic Acid
=450  \\$wnnna$aPhosphonic acid, (1-hydroxyethylidene)bis-, disodium salt
=450  \\$wnnna$aSalt Etidronate, Tetrapotassium
=450  \\$aSodium Etidronate
=450  \\$wnnna$aTetrapotassium Salt Etidronate
=450  \\$wnnna$aXidifon
=450  \\$wnnna$aXidiphon
=450  \\$wnnna$aXydiphone
=550  \\$wg$aDiphosphonates
=550  \\$wh$aRisedronate Sodium
=680  \\$iA diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
=688  \\$a2001(1973); for (1-HYDROXYETHLENE)DIPHOSPHONIC ACID use ETIDRONAT DISODIUM (NM) 1987-2000
=750  \0$aEtidronate$5IEN$0(DLC)sh 91002976

=LDR  00781cz  a2200217n  4500
=001  9880363787302441
=005  20141212205722.0
=008  780315\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012966
=035  \\$aCBA6284M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x400.$x100.$x875
=072  \\$aD1.$x857.$x660
=150  \\$aSodium Cyanide
=450  \\$wnnna$aCyanide, Sodium
=450  \\$wnnna$aCyanogran
=550  \\$wg$aCyanides
=550  \\$wg$aSodium Compounds
=680  \\$iA highly poisonous compound that is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. It is also used in many industrial processes.
=688  \\$a91(79); was see under CYANIDES 1979-90
=750  \0$aSodium cyanide$0(DLC)sh2006001698$5IEN-M

=LDR  00791cz  a2200253n  4500
=001  9880363787402441
=005  20141212205721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012965
=035  \\$aCBA6283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150.$x875
=072  \\$aD1.$x857.$x650
=150  \\$aSodium Chloride
=450  \\$wnnna$aSaline Solution
=450  \\$aSalt$5IEN
=450  \\$wnnna$aSodium Chloride, (22)Na
=450  \\$wnnna$aSodium Chloride, (24)NaCl
=550  \\$wg$aChlorides
=550  \\$wg$aSodium Compounds
=550  \\$wh$aSodium Chloride, Dietary
=667  \\$afor intake of table salt use SODIUM CHLORIDE, DIETARY
=680  \\$iA ubiquitous sodium salt that is commonly used to season food.
=750  \0$aSalt$5IEN$0(DLC)sh 85116850

=LDR  01367cz  a2200361n  4500
=001  9880363787502441
=005  20141212210923.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015222
=035  \\$aCBA6282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x875
=072  \\$aD12.$x776.$x543.$x550.$x425.$x875
=072  \\$aD12.$x776.$x543.$x585.$x400.$x875
=150  \\$aSodium Channels
=450  \\$wnnna$aChannel, Sodium
=450  \\$wnnna$aChannel, Sodium Ion
=450  \\$wnnna$aChannels, Sodium
=450  \\$wnnna$aChannels, Sodium Ion
=450  \\$wnnna$aIon Channel, Sodium
=450  \\$aIon Channels, Sodium
=450  \\$wnnna$aSodium Channel
=450  \\$wnnna$aSodium Ion Channel
=450  \\$wnnna$aSodium Ion Channels
=550  \\$wg$aIon Channels
=550  \\$wh$aAcid Sensing Ion Channels
=550  \\$wh$aDegenerin Sodium Channels
=550  \\$wh$aEpithelial Sodium Channels
=550  \\$wh$aVoltage-Gated Sodium Channels
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iIon channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.
=688  \\$a89
=750  \0$aSodium channels$0(DLC) sh 86007510$5IEN

=LDR  00923cz  a2200253n  4500
=001  9880363787602441
=005  20141212192529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012964
=035  \\$aCBA6281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549.$x750
=072  \\$aD1.$x268.$x557.$x650
=072  \\$aD1.$x552.$x528.$x850
=072  \\$aD1.$x552.$x547.$x725
=150  \\$aSodium
=450  \\$wnnna$aIon Level, Sodium
=450  \\$wnnna$aLevel, Sodium Ion
=450  \\$wnnna$aSodium Ion Level
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Light
=667  \\$a/blood: note also HYPERNATREMIA& HYPONATREMIA; /defic: consider also HYPONATREMIA; /urine: consider also NATRIURESIS; SODIUM, DIETARY is also available
=680  \\$iA member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
=750  \0$aSodium$5IEN-M$0(DLC)sh 85124249

=LDR  00902cz  a2200277n  4500
=001  9880363787702441
=005  20141212205721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012963
=035  \\$aCBA6280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x866
=150  \\$aSociometric Techniques
=450  \\$wnnna$aSociometric Technic
=450  \\$wnnna$aSociometric Technics
=450  \\$wnnna$aSociometric Technique
=450  \\$wnnna$aTechnic, Sociometric
=450  \\$wnnna$aTechnics, Sociometric
=450  \\$wnnna$aTechnique, Sociometric
=450  \\$wnnna$aTechniques, Sociometric
=550  \\$wg$aSociology
=550  \\$aStatistics as Topic
=667  \\$ano qualif
=680  \\$iMethods for quantitatively assessing and measuring interpersonal and group relationships.
=688  \\$a91; was SOCIOMETRIC TECHNICS 1968-90
=750  \0$aSociometry$5IEN$0(DLC)sh 85124236

=LDR  00927cz  a2200265n  4500
=001  9880363787802441
=005  20141212192529.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012962
=035  \\$aCBA6279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x879.$x757.$x400
=072  \\$aH2.$x790
=072  \\$aI1.$x880.$x859
=150  \\$aSociology, Medical
=450  \\$aMedical Sociologists$5IEN
=450  \\$aMedical Sociology
=450  \\$wnnna$aSociology of Medicine
=550  \\$wg$aHealth Occupations
=550  \\$wg$aSociology
=667  \\$ause for the specialty only
=680  \\$iThe study of the social determinants and social effects of health and disease, and of the social structure of medical institutions or professions.
=688  \\$a80(78); was see under SOCIOLOGY 1978-79
=750  \0$aMedical sociologists$5IEN-M$0(DLC)sh 85083029
=750  \0$aSocial medicine$5IEN-HS$0(DLC)sh 85123973

=LDR  01246cz  a2200337n  4500
=001  9880363787902441
=005  20190304103833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012961
=035  \\$aCBA6278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x879.$x757
=072  \\$aI1.$x880
=150  \\$aSociology
=450  \\$wnnna$aGeneral Social Development and Population
=450  \\$aSociologists$5IEN
=550  \\$wg$aSocial Sciences
=550  \\$wh$aSocial Control, Formal
=550  \\$wh$aSocial Control, Informal
=550  \\$wh$aSocial Planning
=550  \\$wh$aSocial Problems
=550  \\$wh$aSocial Welfare
=550  \\$wh$aSocial Work
=550  \\$wh$aSociological Factors
=550  \\$wh$aSociology, Medical
=550  \\$wh$aSociometric Techniques
=667  \\$aspecialty; use SOCIOLOGICAL FACTORS or specifics treed under it for sociological characteristics and phenomena; /methods: probably SOCIOMETRIC TECHNIQUES
=680  \\$iA social science dealing with group relationships, patterns of collective behavior, and social organization.
=688  \\$aRELIGION AND SOCIOLOGY was heading 1963-65
=750  \0$aSociologists$5IEN-M$0(DLC)sh 85124199
=750  \0$aSociology$5IEN-HS$0(DLC)sh 85124200

=LDR  00754cz  a2200205n  4500
=001  9880363788002441
=005  20141212205720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012958
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828.$x838
=150  \\$aSocieties, Scientific
=450  \\$wnnna$aAmerican Psychological Association
=450  \\$aScientific Societies
=450  \\$wnnna$aScientific Society
=450  \\$wnnna$aSociety, Scientific
=550  \\$wg$aSocieties
=667  \\$afor societies of scientists & professionals in disciplines not covered under SOCIETIES, MEDICAL; Manual 35.9.1; specify geog
=680  \\$iSocieties whose membership is limited to scientists.
=750  \0$aScience$xSocieties, etc.$5IEN$0(DLC)sh 85118586

=LDR  01010cz  a2200313n  4500
=001  9880363788102441
=005  20141212205720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012957
=035  \\$aCBA6274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828.$x755
=150  \\$aSocieties, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Societies
=450  \\$wnnna$aPharmaceutic Society
=450  \\$wnnna$aPharmaceutical Societies
=450  \\$wnnna$aPharmaceutical Society
=450  \\$wnnna$aPharmacy Societies
=450  \\$wnnna$aPharmacy Society
=450  \\$wnnna$aSocieties, Pharmaceutic
=450  \\$wnnna$aSocieties, Pharmacy
=450  \\$wnnna$aSociety, Pharmaceutic
=450  \\$wnnna$aSociety, Pharmaceutical
=450  \\$wnnna$aSociety, Pharmacy
=550  \\$wg$aSocieties
=667  \\$aspecify geog; DF: SOCIETIES PHARM
=680  \\$iSocieties whose membership is limited to pharmacists.
=688  \\$a68
=750  \0$aPharmacy$xSocieties, etc.$5IEN$0(IEN)378391

=LDR  00734cz  a2200241n  4500
=001  9880363788202441
=005  20141212205720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012956
=035  \\$aCBA6273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828.$x672
=150  \\$aSocieties, Nursing
=450  \\$wnnna$aNursing Societies
=450  \\$wnnna$aNursing Society
=450  \\$wnnna$aSociety, Nursing
=550  \\$wg$aSocieties
=550  \\$wh$aAmerican Nurses' Association
=550  \\$wh$aInternational Council of Nurses
=667  \\$aspecify geog; DF: SOCIETIES NURS
=680  \\$iSocieties whose membership is limited to nurses.
=688  \\$a66
=750  \0$aNursing$xSocieties, etc.$5IEN$0(IEN)378390

=LDR  00829cz  a2200217n  4500
=001  9880363788302441
=005  20141212205720.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012955
=035  \\$aCBA6272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828.$x589
=150  \\$aSocieties, Medical
=450  \\$wnnna$aMedical Societies
=450  \\$wnnna$aMedical Society
=450  \\$wnnna$aSociety, Medical
=550  \\$wg$aSocieties
=550  \\$wh$aAmerican Medical Association
=667  \\$afor conventional medical societies & soc of med specialties indented under spec in Cat G2; Manual 35.9.1; TN 174: scope; specify geog; "College of Physicians" goes here; DF: SOCIETIES MED
=680  \\$iSocieties whose membership is limited to physicians.
=750  \0$aMedicine$xSocieties, etc.$5IEN$0(DLC)sh 85083102

=LDR  00682cz  a2200229n  4500
=001  9880363788402441
=005  20141212205719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012953
=035  \\$aCBA6270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828.$x506
=150  \\$aSocieties, Dental
=450  \\$wnnna$aDental Societies
=450  \\$wnnna$aDental Society
=450  \\$wnnna$aSociety, Dental
=550  \\$wg$aSocieties
=550  \\$wh$aAmerican Dental Association
=667  \\$aspecify geog; DF: SOCIETIES DENT
=680  \\$iSocieties whose membership is limited to dentists.
=688  \\$a65
=750  \0$aDentistry$xSocieties, etc.$5IEN$0(IEN)378388

=LDR  01221cz  a2200325n  4500
=001  9880363788502441
=005  20141212205719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012952
=035  \\$aCBA6269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x828
=150  \\$aSocieties
=450  \\$wnnna$aOrganization, Professional
=450  \\$wnnna$aOrganizations, Professional
=450  \\$wnnna$aProfessional Organization
=450  \\$wnnna$aProfessional Organizations
=550  \\$wg$aOrganizations
=550  \\$wh$aAmerican Public Health Association
=550  \\$wh$aAmerican Speech-Language-Hearing Association
=550  \\$wh$aSocieties, Dental
=550  \\$wh$aSocieties, Hospital
=550  \\$wh$aSocieties, Medical
=550  \\$wh$aSocieties, Nursing
=550  \\$wh$aSocieties, Pharmaceutical
=550  \\$wh$aSocieties, Scientific
=550  \\$aOrganizations
=667  \\$aGEN or unspecified; prefer specific types of societies; do not confuse with ORGANIZATIONS: see note there; Manual 35.9+; specify geog; TN 174: scope
=680  \\$iOrganizations composed of members with common interests and whose professions may be similar.
=750  \0$aSocieties$5IEN$0(DLC)sh 85124175

=LDR  00700cz  a2200205n  4500
=001  9880363788602441
=005  20141212192528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012951
=035  \\$aCBA6268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x934
=150  \\$aSocialization
=450  \\$wnnna$aSocializations
=550  \\$wg$aSociological Factors
=550  \\$aPersonality Development
=667  \\$ano qualif
=680  \\$iThe training or molding of an individual through various relationships, educational agencies, and social controls, which enables him to become a member of a particular society.
=688  \\$a68
=750  \0$aSocialization$5IEN$0(DLC)sh 85124152

=LDR  00596cz  a2200181n  4500
=001  9880363788702441
=005  20141212205719.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012950
=035  \\$aCBA6267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696.$x798
=150  \\$aSocialism
=450  \\$wnnna$aSocialisms
=550  \\$wg$aPolitical Systems
=667  \\$aspecify country; do not confuse with NATIONAL SOCIALISM
=680  \\$iA system of government in which means of production and distribution of goods are controlled by the state.
=750  \0$aSocialism$5IEN$0(DLC)sh 85124118

=LDR  01284cz  a2200361n  4500
=001  9880363788802441
=005  20141212205718.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012949
=035  \\$aCBA6266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x408.$x823
=072  \\$aI1.$x880.$x792.$x410
=072  \\$aN2.$x421.$x461.$x798
=072  \\$aN2.$x421.$x849.$x673
=150  \\$aSocial Work, Psychiatric
=450  \\$wnnna$aPsychiatric Social Service
=450  \\$wnnna$aPsychiatric Social Services
=450  \\$aPsychiatric Social Work
=450  \\$wnnna$aPsychiatric Social Works
=450  \\$wnnna$aService, Psychiatric Social
=450  \\$wnnna$aServices, Psychiatric Social
=450  \\$aSocial Service, Psychiatric
=450  \\$wnnna$aSocial Services, Psychiatric
=450  \\$wnnna$aSocial Works, Psychiatric
=450  \\$wnnna$aWork, Psychiatric Social
=450  \\$wnnna$aWorks, Psychiatric Social
=550  \\$wg$aMental Health Services
=550  \\$wg$aSocial Work
=667  \\$aSPEC: SPEC qualif
=680  \\$iUse of all social work processes in the treatment of patients in a psychiatric or mental health setting.
=688  \\$a78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77
=750  \0$aPsychiatric social work$5IEN$0(DLC)sh 85108376

=LDR  00699cz   2200217n  4500
=001  9880363788902441
=005  20240216142417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012801
=035  \\$aCBA6114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x450
=150  \\$aSibling Relations
=450  \\$wnnna$aRelation, Sibling
=450  \\$wnnna$aRelations, Sibling
=450  \\$wnnna$aSibling Relation
=550  \\$wg$aFamily Relations
=667  \\$ahuman & animal; DF: SIBLING RELAT
=680  \\$iInteractions and relationships between sisters and/or brothers. The concept also applies to animal studies.
=688  \\$a68
=750  \0$aSiblings$5IEN$0(DLC)sh 85017225

=LDR  00615cz  a2200217n  4500
=001  9880363789002441
=005  20141212205632.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012798
=035  \\$aCBA6111HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x815.$x815
=150  \\$aSialorrhea
=450  \\$aDrooling
=450  \\$aHypersalivation
=550  \\$wg$aSalivary Gland Diseases
=550  \\$aSalivation
=667  \\$a"increased salivary flow"
=680  \\$iIncreased salivary flow.
=688  \\$a77; was see under SALIVARY GLAND DISEASES 1965-74
=750  \0$aDrooling$5IEN-M$0(DLC)sh 93005024

=LDR  00892cz  a2200277n  4500
=001  9880363789102441
=005  20141212205632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012796
=035  \\$aCBA6109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x720.$x793
=072  \\$aE1.$x370.$x372.$x700
=072  \\$aE6.$x342.$x764.$x793
=150  \\$aSialography
=450  \\$aSalivary Ducts$xradiography
=450  \\$aSalivary Glands$xradiography
=450  \\$wnnna$aSialographies
=450  \\$avon Ebner Glands$xradiography
=550  \\$wg$aDiagnostic Techniques, Digestive System
=550  \\$wg$aRadiography, Dental
=550  \\$aSalivary Glands
=667  \\$aDF: SIALOGR
=680  \\$iRadiography of the SALIVARY GLANDS or ducts following injection of contrast medium.
=688  \\$a65
=750  \0$aSalivary glands$xRadiography$5IEN$0(DLC)sh 85116810

=LDR  01073cz  a2200301n  4500
=001  9880363789202441
=005  20141212205631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012794
=035  \\$aCBA6107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x562.$x668
=072  \\$aD2.$x241.$x511.$x902.$x562.$x668
=072  \\$aD9.$x67.$x687.$x668
=072  \\$aD9.$x811.$x589.$x668
=150  \\$aSialic Acids
=450  \\$wnnna$aAcids, N-Acetylneuraminic
=450  \\$wnnna$aAcids, Sialic
=450  \\$aN-Acetylneuraminic Acids
=450  \\$wnnna$aN Acetylneuraminic Acids
=550  \\$wg$aNeuraminic Acids
=550  \\$wh$aCytidine Monophosphate N-Acetylneuraminic Acid
=550  \\$wh$aN-Acetylneuraminic Acid
=550  \\$wh$aZanamivir
=550  \\$aSialomucins
=680  \\$iA group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues.
=688  \\$a75; was see under NEURAMINIC ACIDS 1963-74
=750  \0$aSialic acids$5IEN$0(DLC)sh 85122186

=LDR  00641cz  a2200217n  4500
=001  9880363789302441
=005  20141212205630.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012792
=035  \\$aCBA6105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x617
=150  \\$aShyness
=450  \\$aBashfulness$5IEN
=450  \\$aTimidity
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iDiscomfort and partial inhibition of the usual forms of behavior when in the presence of others.
=688  \\$a87
=750  \0$aBashfulness$5IEN-M$0(DLC)sh 85012062
=750  \0$aTimidity$5IEN-HS$0(DLC)sh 85135452

=LDR  00531cz  a2200181n  4500
=001  9880363789402441
=005  20141212205629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012788
=035  \\$aCBA6101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x473.$x751
=150  \\$aShrews
=450  \\$wnnna$aShrew
=550  \\$wg$aInsectivora
=667  \\$aIM; qualif permitted; do not confuse SHREWS (insectivore) with TREE SHREWS see TUPAIIDAE
=688  \\$a72
=750  \0$aShrews$5IEN$0(DLC)sh 85122121

=LDR  00934cz  a2200265n  4500
=001  9880363789502441
=005  20141212205628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012785
=035  \\$aCBA6098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x748
=150  \\$aShoulder Joint
=450  \\$aGlenohumeral Joint
=450  \\$wnnna$aGlenohumeral Joints
=450  \\$wnnna$aJoint, Glenohumeral
=450  \\$wnnna$aJoint, Shoulder
=450  \\$wnnna$aJoints, Glenohumeral
=450  \\$wnnna$aJoints, Shoulder
=450  \\$wnnna$aShoulder Joints
=550  \\$wg$aJoints
=667  \\$aTN 117: use for human & other vertebrates; TN 238: differentiation from SHOULDER & indexing instructions
=680  \\$iThe articulation between the head of the HUMERUS and the glenoid cavity of the SCAPULA.
=688  \\$a65; SHOULDER ARTHROSES was heading 1963-64
=750  \0$aShoulder joint$5IEN$0(DLC)sh 85122093

=LDR  01194cz  a2200313n  4500
=001  9880363789602441
=005  20181210120957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012784
=035  \\$aCBA6097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x803.$x250
=072  \\$aC26.$x404.$x625
=150  \\$aShoulder Fractures
=450  \\$wnnna$aFracture, Proximal Humeral
=450  \\$wnnna$aFracture, Shoulder
=450  \\$wnnna$aFractures, Proximal Humeral
=450  \\$wnnna$aFractures, Shoulder
=450  \\$wnnna$aHumeral Fracture, Proximal
=450  \\$aHumeral Fractures, Proximal
=450  \\$wnnna$aProximal Humeral Fracture
=450  \\$wnnna$aProximal Humeral Fractures
=450  \\$wnnna$aShoulder Fracture
=550  \\$wg$aFractures, Bone
=550  \\$wg$aShoulder Injuries
=550  \\$wh$aBankart Lesions
=667  \\$arefers to SHOULDER, not SHOULDER JOINT; restricted to fract of proximal humerus (head, neck, tuberosities): do not confuse with HUMERAL FRACTURES (non-head, etc.)
=680  \\$iFractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities.
=750  \0$aShoulder$xFractures$5IEN$0(IEN)378299

=LDR  01160cz  a2200337n  4500
=001  9880363789702441
=005  20181210120446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012783
=035  \\$aCBA6096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x518.$x750
=072  \\$aC26.$x289.$x750
=072  \\$aC26.$x803.$x125
=150  \\$aShoulder Dislocation
=450  \\$wnnna$aDislocation, Glenohumeral
=450  \\$wnnna$aDislocation, Shoulder
=450  \\$wnnna$aDislocations, Glenohumeral
=450  \\$wnnna$aDislocations, Shoulder
=450  \\$aGlenohumeral Dislocation
=450  \\$wnnna$aGlenohumeral Dislocations
=450  \\$wnnna$aGlenohumeral Subluxation
=450  \\$wnnna$aGlenohumeral Subluxations
=450  \\$wnnna$aShoulder Dislocations
=450  \\$wnnna$aSubluxation, Glenohumeral
=450  \\$wnnna$aSubluxations, Glenohumeral
=550  \\$wg$aJoint Dislocations
=550  \\$wg$aShoulder Injuries
=667  \\$aacromioclavicular disloc = ACROMIOCLAVICULAR JOINT + DISLOCATIONS
=680  \\$iDisplacement of the HUMERUS from the SCAPULA.
=750  \0$aShoulder joint$xDislocation$5IEN$0(DLC)sh 85122095

=LDR  00558cz  a2200169n  4500
=001  9880363789802441
=005  20141212205627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x750
=150  \\$aShoulder
=450  \\$wnnna$aShoulders
=550  \\$wg$aUpper Extremity
=667  \\$aTN 117: use for human & other vertebrates; TN 238: differentiation from SHOULDER JOINT & indexing instructions
=688  \\$aSHOULDER ARTHROSES was heading 1963-64
=750  \0$aShoulder$5IEN$0(DLC)sh 85122089

=LDR  00445cz  a2200169n  4500
=001  9880363789902441
=005  20141212205627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012781
=035  \\$aCBA6094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x539.$x750
=150  \\$aShorthand
=450  \\$wnnna$aShorthands
=550  \\$wg$aHandwriting
=667  \\$ano qualif
=750  \0$aShorthand$5IEN$0(DLC)sh 85121977

=LDR  01219cz  a2200349n  4500
=001  9880363790002441
=005  20141212205627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012780
=035  \\$aCBA6093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x565.$x280.$x853
=072  \\$aE2.$x779.$x496.$x280.$x853
=150  \\$aShort-Wave Therapy
=450  \\$wnnna$aShort Wave Therapies
=450  \\$wnnna$aShort-Wave Therapies
=450  \\$wnnna$aShort Wave Therapy
=450  \\$wnnna$aShortwave Therapies
=450  \\$wnnna$aShortwave Therapy
=450  \\$wnnna$aTherapies, Short Wave
=450  \\$wnnna$aTherapies, Short-Wave
=450  \\$wnnna$aTherapies, Shortwave
=450  \\$wnnna$aTherapy, Short-Wave
=450  \\$wnnna$aTherapy, Short Wave
=450  \\$wnnna$aTherapy, Shortwave
=450  \\$wnnna$aWave Therapies, Short
=450  \\$wnnna$aWave Therapy, Short
=550  \\$wg$aDiathermy
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe use of focused short radio waves to produce local hyperthermia in an injured person or diseased body area.
=688  \\$a91(75); was see under DIATHERMY 1975-90
=750  \0$aShortwave therapy$5IEN$0(DLC)sh 85121974

=LDR  00447cz  a2200169n  4500
=001  9880363790102441
=005  20141212205625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012775
=035  \\$aCBA6088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x215.$x800
=150  \\$aShoes
=450  \\$wnnna$aShoe
=550  \\$wg$aClothing
=667  \\$ahorseshoes may be indexed here but only as NIM
=750  \0$aShoes$5IEN$0(DLC)sh 85121735

=LDR  00567cz  a2200205n  4500
=001  9880363790202441
=005  20141212205624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012774
=035  \\$aCBA6087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x835.$x888
=072  \\$aC26.$x797
=150  \\$aShock, Traumatic
=450  \\$wnnna$aTraumatic Shock
=550  \\$wg$aShock
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aCrush Syndrome
=680  \\$iShock produced as a result of trauma.
=750  \0$aTraumatic shock$5IEN$0(DLC)sh 85137140

=LDR  01348cz  a2200361n  4500
=001  9880363790302441
=005  20141212205624.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012772
=035  \\$aCBA6085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x757.$x800
=072  \\$aC23.$x550.$x470.$x790.$x500.$x800
=072  \\$aC23.$x550.$x835.$x900.$x712
=150  \\$aShock, Septic
=450  \\$wnnna$aEndotoxic Shock
=450  \\$aSeptic Shock
=450  \\$aShock, Endotoxic
=450  \\$wnnna$aShock Syndrome, Toxic
=450  \\$wnnna$aShock Syndromes, Toxic
=450  \\$aShock, Toxic
=450  \\$wnnna$aSyndrome, Toxic Shock
=450  \\$wnnna$aSyndromes, Toxic Shock
=450  \\$wnnna$aToxic Shock
=450  \\$aToxic Shock Syndrome
=450  \\$wnnna$aToxic Shock Syndromes
=550  \\$wg$aSepsis
=550  \\$wg$aSystemic Inflammatory Response Syndrome
=550  \\$aEndotoxemia
=667  \\$acoordinate (IM) with specific infection (IM)
=680  \\$iSepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include, but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
=688  \\$a77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76
=750  \0$aSeptic shock$5IEN$0(DLC)sh 85120117

=LDR  00642cz  a2200205n  4500
=001  9880363790402441
=005  20141212205624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012771
=035  \\$aCBA6084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x414.$x980
=072  \\$aC23.$x550.$x835.$x650
=150  \\$aShock, Hemorrhagic
=450  \\$aHemorrhagic Shock
=550  \\$wg$aHemorrhage
=550  \\$wg$aShock
=667  \\$aHYPOVOLEMIC SHOCK does not go here: it is a see ref to SHOCK
=680  \\$iAcute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA.
=750  \0$aHemorrhagic shock$5IEN$0(DLC)sh 85060234

=LDR  00652cz  a2200217n  4500
=001  9880363790502441
=005  20141212205623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012770
=035  \\$aCBA6083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x500.$x750
=072  \\$aC14.$x907.$x585.$x500.$x750
=072  \\$aC23.$x550.$x835.$x550
=150  \\$aShock, Cardiogenic
=450  \\$wnnna$aCardiogenic Shock
=550  \\$wg$aMyocardial Infarction
=550  \\$wg$aShock
=680  \\$iShock resulting from diminution of cardiac output in heart disease.
=688  \\$a71
=750  \0$aCardiogenic shock$5IEN$0(DLC)sh 85020206

=LDR  01108cz  a2200325n  4500
=001  9880363790602441
=005  20141212205623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012769
=035  \\$aCBA6082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x835
=150  \\$aShock
=450  \\$aCirculatory Collapse
=450  \\$aCirculatory Failure
=450  \\$wnnna$aCollapse, Circulatory
=450  \\$wnnna$aFailure, Circulatory
=450  \\$aHypovolemic Shock
=450  \\$wnnna$aShock, Hypovolemic
=550  \\$wg$aPathologic Processes
=550  \\$wh$aMultiple Organ Failure
=550  \\$wh$aShock, Cardiogenic
=550  \\$wh$aShock, Hemorrhagic
=550  \\$wh$aShock, Surgical
=550  \\$wh$aShock, Traumatic
=550  \\$wh$aSystemic Inflammatory Response Syndrome
=550  \\$aHypovolemia
=667  \\$ageneral or unspecified; prefer specifics; therapy of shock = SHOCK / ther, not SHOCK THERAPY see CONVULSIVE THERAPY
=680  \\$iA pathological condition manifested by failure to perfuse or oxygenate vital organs.
=750  \0$aShock$5IEN$0(DLC)sh 85121705

=LDR  01010cz  a2200265n  4500
=001  9880363790702441
=005  20141212205622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012767
=035  \\$aCBA6080HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x817
=150  \\$aShips
=450  \\$wnnna$aBoat
=450  \\$aBoats
=450  \\$wnnna$aHospital Ship
=450  \\$wnnna$aHospital Ships
=450  \\$wnnna$aShip
=450  \\$wnnna$aShip, Hospital
=450  \\$wnnna$aShips, Hospital
=550  \\$wg$aTransportation
=550  \\$aNaval Medicine
=667  \\$ause as a coordinate for non-medical aspects of sailors; for physiology, psychology, and diseases of sailors use NAVAL MEDICINE but see note there
=680  \\$iLarge vessels propelled by power or sail used for transportation on rivers, seas, oceans, or other navigable waters. Boats are smaller vessels propelled by oars, paddles, sail, or power; they may or may not have a deck.
=750  \0$aShips$5IEN$0(DLC)sh 85121591

=LDR  00749cz  a2200217n  4500
=001  9880363790802441
=005  20141212205622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012765
=035  \\$aCBA6078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x268.$x792
=072  \\$aD2.$x241.$x511.$x852
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x750
=150  \\$aShikimic Acid
=450  \\$wnnna$aAcid, Shikimic
=550  \\$wg$aCyclohexanecarboxylic Acids
=550  \\$wg$aCyclohexenes
=550  \\$wg$aHydroxy Acids
=680  \\$iA tri-hydroxy cyclohexene carboxylic acid important in biosynthesis of so many compounds that the shikimate pathway is named after it.
=750  \0$aShikimic acid$5IEN$0(DLC)sh 86002803

=LDR  00594cz  a2200193n  4500
=001  9880363790902441
=005  20141212205621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012764
=035  \\$aCBA6077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x850.$x800
=072  \\$aB3.$x660.$x250.$x150.$x730.$x710
=150  \\$aShigella sonnei
=550  \\$wg$aShigella
=667  \\$ainfection: coord IM with DYSENTERY, BACILLARY (IM)
=680  \\$iA lactose-fermenting bacterium causing dysentery.
=688  \\$a66(63)
=750  \0$aShigella sonnei$5IEN$0(DLC)sh 85121415

=LDR  00687cz  a2200193n  4500
=001  9880363791002441
=005  20141212205621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012763
=035  \\$aCBA6076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x850.$x450
=072  \\$aB3.$x660.$x250.$x150.$x730.$x210
=150  \\$aShigella flexneri
=550  \\$wg$aShigella
=667  \\$ainfection: coord IM with DYSENTERY, BACILLARY (IM)
=680  \\$iA bacterium which is one of the etiologic agents of bacillary dysentery (DYSENTERY, BACILLARY) and sometimes of infantile gastroenteritis.
=688  \\$a74(72)
=750  \0$aShigella flexneri$5IEN$0(DLC)sh 88023334

=LDR  00927cz  a2200229n  4500
=001  9880363791102441
=005  20141212205621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012760
=035  \\$aCBA6073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x850
=072  \\$aB3.$x660.$x250.$x150.$x730
=150  \\$aShigella
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aShigella boydii
=550  \\$wh$aShigella dysenteriae
=550  \\$wh$aShigella flexneri
=550  \\$wh$aShigella sonnei
=667  \\$aGEN; prefer specifics; infection = DYSENTERY, BACILLARY & specify species if pertinent (IM)
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).
=750  \0$aShigella$5IEN$0(DLC)sh 88023333

=LDR  00909cz  a2200229n  4500
=001  9880363791202441
=005  20141212205620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012759
=035  \\$aCBA6072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x808.$x860
=150  \\$aSheltered Workshops
=450  \\$wnnna$aSheltered Workshop
=450  \\$wnnna$aWorkshop, Sheltered
=450  \\$wnnna$aWorkshops, Sheltered
=550  \\$wg$aRehabilitation Centers
=550  \\$aRehabilitation, Vocational
=667  \\$ado not confuse with EMPLOYMENT, SUPPORTED which takes place in normal or regular work setting: a sheltered workshop is work in a controlled working environment
=680  \\$iProtective places of employment for disabled persons which provide training and employment on a temporary or permanent basis.
=688  \\$a67(65)
=750  \0$aSheltered workshops$5IEN$0(DLC)sh 85121315

=LDR  00780cz  a2200205n  4500
=001  9880363791302441
=005  20141212205620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012758
=035  \\$aCBA6071HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x600.$x875.$x700
=150  \\$aShellfish
=550  \\$wg$aSeafood
=550  \\$aAnimal Shells
=550  \\$aCrustacea
=550  \\$aMollusca
=667  \\$aas food, coordinate IM with specific shellfish (IM); shellfish as animal = CRUSTACEA or MOLLUSCA or specifics; shellfish poisoning usually due to toxins from marine flora or fauna = MARINE TOXINS
=680  \\$iAquatic invertebrates belonging to the phylum MOLLUSCA or the subphylum CRUSTACEA, and used as food.
=750  \0$aShellfish$5IEN$0(DLC)sh 85121291

=LDR  01316cz  a2200373n  4500
=001  9880363791402441
=005  20141212205620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012757
=035  \\$aCBA6070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x836
=150  \\$aSheep Diseases
=450  \\$wnnna$aDisease, Ovine
=450  \\$wnnna$aDisease, Sheep
=450  \\$wnnna$aDiseases, Ovine
=450  \\$wnnna$aDiseases, Sheep
=450  \\$wnnna$aOvine Disease
=450  \\$wnnna$aOvine Diseases
=450  \\$wnnna$aSheep Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aBluetongue
=550  \\$wh$aBorder Disease
=550  \\$wh$aEcthyma, Contagious
=550  \\$wh$aLouping Ill
=550  \\$wh$aNairobi Sheep Disease
=550  \\$wh$aPneumonia, Progressive Interstitial, of Sheep
=550  \\$wh$aPulmonary Adenomatosis, Ovine
=550  \\$wh$aScrapie
=550  \\$wh$aSwayback
=550  \\$wh$aVisna
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific sheep dis (IM); for abnormalities or injuries, index under SHEEP /abnorm or SHEEP /inj; don't forget also SHEEP (NIM) & check tag ANIMALS; DF: SHEEP DIS
=680  \\$iDiseases of domestic and mountain sheep of the genus Ovis.
=750  \0$aSheep$xDiseases$5IEN$0(DLC)sh 85121211

=LDR  00817cz  a2200229n  4500
=001  9880363791502441
=005  20141212205619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012756
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x791
=150  \\$aSheep
=450  \\$wnnna$aDall Sheep
=450  \\$aOvis
=450  \\$wnnna$aOvis dalli
=450  \\$aSheep, Dall
=550  \\$wg$aRuminants
=550  \\$wh$aSheep, Bighorn
=550  \\$wh$aSheep, Domestic
=667  \\$aSHEEP, DOMESTIC and SHEEP, BIGHORN are also available; SHEEP unspecified goes here
=680  \\$iAny of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.
=750  \0$aSheep$5IEN$0(DLC)sh 85121208

=LDR  00644cz  a2200193n  4500
=001  9880363791602441
=005  20141212205619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012754
=035  \\$aCBA6067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x370.$x853
=150  \\$aSharks
=450  \\$wnnna$aShark
=550  \\$wg$aElasmobranchii
=550  \\$wh$aDogfish
=667  \\$aelasmobranch fish; IM; qualif permitted; DOGFISH is also available
=680  \\$iA group of elongate elasmobranchs. Sharks are mostly marine fish, with certain species large and voracious.
=750  \0$aSharks$5IEN$0(DLC)sh 85121141

=LDR  01218cz  a2200337n  4500
=001  9880363791702441
=005  20141212192521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012753
=035  \\$aCBA6066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x750.$x700
=150  \\$aShared Paranoid Disorder
=450  \\$wnnna$aDisorder, Shared Paranoid
=450  \\$wnnna$aDisorder, Shared Psychotic
=450  \\$wnnna$aDisorders, Shared Paranoid
=450  \\$wnnna$aDisorders, Shared Psychotic
=450  \\$aFolie a Deux
=450  \\$aFolie a Trois
=450  \\$aParanoid Disorder, Shared
=450  \\$wnnna$aParanoid Disorders, Shared
=450  \\$wnnna$aPsychotic Disorder, Shared
=450  \\$wnnna$aPsychotic Disorders, Shared
=450  \\$wnnna$aShared Paranoid Disorders
=450  \\$aShared Psychotic Disorder
=450  \\$wnnna$aShared Psychotic Disorders
=550  \\$wg$aSchizophrenia
=667  \\$aspell FOLIE A DEUX as folie á deux (with accent) in translations
=680  \\$iA condition in which closely related persons, usually in the same family, share the same delusions.
=688  \\$a81; was FOLIE A DEUX 1968-80
=750  \0$aFolie �a deux$5IEN$0(DLC)sh 85049648

=LDR  00585cz  a2200205n  4500
=001  9880363791802441
=005  20141212205619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012752
=035  \\$aCBA6065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x483.$x666
=150  \\$aShame
=450  \\$wnnna$aShames
=550  \\$wg$aGuilt
=550  \\$aSocial Stigma
=667  \\$ano qualif
=680  \\$iAn emotional attitude excited by realization of a shortcoming or impropriety.
=688  \\$a91(75); was see under GUILT 1975-90
=750  \0$aShame$5IEN$0(DLC)sh 85121092

=LDR  01623cz  a2200397n  4500
=001  9880363791902441
=005  20141212205618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012749
=035  \\$aCBA6060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x778
=072  \\$aC2.$x800
=072  \\$aC12.$x294.$x668
=072  \\$aC13.$x351.$x500.$x711
=150  \\$aSexually Transmitted Diseases
=450  \\$wnnna$aDisease, Sexually Transmitted
=450  \\$wnnna$aDisease, Venereal
=450  \\$wnnna$aDiseases, Sexually Transmitted
=450  \\$wnnna$aDiseases, Venereal
=450  \\$wnnna$aSexually Transmitted Disease
=450  \\$aSTDs
=450  \\$wnnna$aVenereal Disease
=450  \\$aVenereal Diseases
=550  \\$wg$aGenital Diseases, Female
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aInfection
=550  \\$wg$aVirus Diseases
=550  \\$wh$aSexually Transmitted Diseases, Bacterial
=550  \\$wh$aSexually Transmitted Diseases, Viral
=550  \\$aReproductive Tract Infections
=550  \\$aVenereology
=667  \\$ageneral or unspecified; prefer specifics; SEXUALLY TRANSMITTED DISEASES, BACTERIAL & SEXUALLY TRANSMITTED DISEASES, VIRAL are also available; not all genital diseases are venereal or sexually transm & not all sexually transm diseases are genital; contact tracing: index under CONTACT TRACING (IM) + SEXUALLY TRANSMITTED DISEASES /epidemiol or /transm (IM)
=680  \\$iDiseases due to or propagated by sexual contact.
=688  \\$a87; was VENEREAL DISEASES 1963-86
=750  \0$aSexually transmitted diseases$5IEN$0(DLC)sh 85142634

=LDR  00710cz  a2200229n  4500
=001  9880363792002441
=005  20141212205618.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012746
=035  \\$aCBA6057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x900
=150  \\$aSexual Abstinence
=450  \\$wnnna$aAbstinence, Postpartum
=450  \\$wnnna$aAbstinence, Sexual
=450  \\$aCelibacy
=450  \\$wnnna$aPostpartum Abstinence
=450  \\$aVirginity
=550  \\$wg$aSexual Behavior
=680  \\$iRefraining from SEXUAL INTERCOURSE.
=688  \\$a91(75); was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67
=750  \0$aSexual abstinence$5IEN$0(DLC)sh 85120718

=LDR  00667cz  a2200241n  4500
=001  9880363792102441
=005  20141212205617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x815
=072  \\$aI1.$x240.$x800.$x815
=072  \\$aN1.$x224.$x803.$x815
=072  \\$aN6.$x850.$x505.$x400.$x850.$x815
=150  \\$aSex Ratio
=450  \\$wnnna$aRatio, Sex
=450  \\$wnnna$aRatios, Sex
=450  \\$wnnna$aSex Ratios
=550  \\$wg$aGenetic Phenomena
=550  \\$wg$aSex Distribution
=680  \\$iThe number of males per 100 females.
=688  \\$a68
=750  \0$aSex ratio$5IEN$0(DLC)sh 85120661

=LDR  00843cz  a2200253n  4500
=001  9880363792202441
=005  20141212205617.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012743
=035  \\$aCBA6054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x420.$x890
=150  \\$aSex Preselection
=450  \\$wnnna$aPredetermination, Sex
=450  \\$wnnna$aPreselection, Sex
=450  \\$wnnna$aSelection, Sex
=450  \\$aSex Predetermination
=450  \\$aSex Selection
=550  \\$wg$aGenetic Engineering
=550  \\$aSex Determination Processes
=667  \\$ado not confuse with SEX DETERMINATION ANALYSIS: analysis of sex genotype
=680  \\$iMethods for controlling genetic SEX of offspring.
=688  \\$a91(75); was see under GENETIC ENGINEERING 1975-90
=750  \0$aSex preselection$5IEN$0(DLC)sh 85120660

=LDR  00736cz  a2200169n  4500
=001  9880364034302441
=005  20141212210716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014820
=035  \\$aCBA8167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x621.$x440.$x895
=150  \\$aVitiligo
=550  \\$wg$aHypopigmentation
=667  \\$amacular depigmentation
=680  \\$iA disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
=750  \0$aVitiligo$5IEN$0(DLC)sh 85144023

=LDR  01182cz  a2200253n  4500
=001  9880364034402441
=005  20141212210715.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014819
=035  \\$aCBA8166M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x92.$x500.$x925
=072  \\$aD12.$x776.$x290.$x812.$x500
=072  \\$aD12.$x776.$x744.$x925
=150  \\$aVitellogenins
=450  \\$wnnna$aMicrovitellogenin
=450  \\$wnnna$aVitellogenin
=450  \\$wnnna$aVitellogenin II
=550  \\$wg$aInsect Proteins
=550  \\$wg$aPhosphoproteins
=550  \\$wg$aVitellins
=680  \\$iPhospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the regulation of steroid hormones, such as ESTRADIOL and JUVENILE HORMONES in insects.
=688  \\$a2005 (1986); use LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA use EGG PROTEINS 1990-2004
=750  \0$aVitellogenins$0(DLC)sh2008001262$5IEN-M

=LDR  00732cz  a2200181n  4500
=001  9880364034502441
=005  20141212210715.0
=008  830606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014818
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x650.$x249.$x880
=072  \\$aG8.$x686.$x785.$x760.$x310.$x500.$x880
=150  \\$aVitellogenesis
=450  \\$wnnna$aVitellogeneses
=550  \\$wg$aOogenesis
=680  \\$iThe active production and accumulation of VITELLINS (egg yolk proteins) in the non-mammalian OOCYTES from circulating precursors, VITELLOGENINS. Vitellogenesis usually begins after the first MEIOSIS and is regulated by estrogenic hormones.
=688  \\$a84
=750  \0$aVitellogenesis$0(DLC)sh2008001263$5IEN-M

=LDR  00941cz  a2200229n  4500
=001  9880364034602441
=005  20181130114806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014815
=035  \\$aCBA8162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x683.$x500.$x600.$x354
=072  \\$aG7.$x203.$x300.$x681.$x500.$x600
=072  \\$aJ2.$x500.$x631.$x600
=150  \\$aVitamins
=450  \\$wnnna$aVitamin
=550  \\$wg$aMicronutrients
=550  \\$wh$aProvitamins
=550  \\$wh$aVitamin B Complex
=667  \\$adeficiency = AVITAMINOSIS but prefer specific precoordinated vitamin deficiency terms (avitaminosis A = VITAMIN A DEFICIENCY etc); ther use: coordinate disease term with /drug ther, not /diet ther
=680  \\$iOrganic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.
=750  \0$aVitamins$5IEN$0(DLC)sh 85144006

=LDR  01309cz  a2200313n  4500
=001  9880364034702441
=005  20141212210714.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014814
=035  \\$aCBA8161HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x30.$x676.$x950
=072  \\$aD12.$x125.$x166.$x676.$x950
=150  \\$aVitamin U
=450  \\$wnnna$aChloride, Methionine Methylsulfonium
=450  \\$wnnna$aChloride, Methylmethioninesulfonium
=450  \\$aMethionine Methylsulfonium Chloride
=450  \\$wnnna$aMethylmethionine
=450  \\$wnnna$aMethylmethionine Sulfonium Chloride
=450  \\$aMethylmethioninesulfonium Chloride
=450  \\$wnnna$aMethylsulfonium Chloride, Methionine
=450  \\$wnnna$aS-Methylmethionine
=450  \\$wnnna$aS Methylmethionine
=450  \\$wnnna$aSulfonium, ((3S)-3-Amino-3-Carboxypropyl)Dimethyl-, Inner Salt
=550  \\$wg$aMethionine
=667  \\$a/ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract.
=688  \\$a91(77); was see under VITAMINS 1977-90
=750  \0$aVitamin U$5IEN$0(DLC)sh 85144005

=LDR  01168cz  a2200241n  4500
=001  9880364034802441
=005  20141212210713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014812
=035  \\$aCBA8159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x721.$x374
=072  \\$aD2.$x455.$x849.$x291.$x523.$x500
=072  \\$aD4.$x615.$x638.$x721.$x374
=150  \\$aVitamin K
=550  \\$wg$aNaphthoquinones
=550  \\$wg$aPhytol
=550  \\$wh$aVitamin K 1
=550  \\$wh$aVitamin K 2
=550  \\$wh$aVitamin K 3
=667  \\$a/ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
=750  \0$aVitamin K$5IEN$0(DLC)sh 85143994

=LDR  01274cz  a2200229n  4500
=001  9880364034902441
=005  20141212210713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014811
=035  \\$aCBA8158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x841
=150  \\$aVitamin E Deficiency
=450  \\$wnnna$aDeficiencies, Vitamin E
=450  \\$wnnna$aDeficiency, Vitamin E
=450  \\$wnnna$aVitamin E Deficiencies
=450  \\$aVitamin E$xdeficiency
=550  \\$wg$aAvitaminosis
=550  \\$wh$aSteatitis
=667  \\$aDF: VITAMIN E DEFIC
=680  \\$iA nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. (Cecil Textbook of Medicine, 19th ed, p1181)
=750  \0$aVitamin E deficiency$5IEN$0(DLC)sh 85143988

=LDR  00875cz  a2200205n  4500
=001  9880364035002441
=005  20141212210713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014810
=035  \\$aCBA8157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x909
=072  \\$aD3.$x830.$x219.$x909
=150  \\$aVitamin E
=550  \\$wg$aBenzopyrans
=550  \\$wh$aTocopherols
=550  \\$wh$aTocotrienols
=667  \\$a/ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.
=750  \0$aVitamin E$5IEN$0(DLC)sh 85143987

=LDR  01026cz  a2200229n  4500
=001  9880364035102441
=005  20141212210712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014808
=035  \\$aCBA8155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x770
=150  \\$aVitamin D Deficiency
=450  \\$wnnna$aDeficiencies, Vitamin D
=450  \\$wnnna$aDeficiency, Vitamin D
=450  \\$wnnna$aVitamin D Deficiencies
=450  \\$aVitamin D$xdeficiency
=550  \\$wg$aAvitaminosis
=550  \\$wh$aRickets
=667  \\$aDF: VITAMIN D DEFIC
=680  \\$iA nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)
=750  \0$aVitamin D deficiency$5IEN$0(DLC)sh 85143983

=LDR  00959cz  a2200193n  4500
=001  9880364035202441
=005  20141212210711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014807
=035  \\$aCBA8154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x812.$x768
=150  \\$aVitamin D
=550  \\$wg$aSecosteroids
=550  \\$wh$aCholecalciferol
=550  \\$wh$aErgocalciferols
=667  \\$a/defic = VITAMIN D DEFICIENCY or RICKETS; /ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
=750  \0$aVitamin D$5IEN$0(DLC)sh 85143982

=LDR  01409cz  a2200265n  4500
=001  9880364035302441
=005  20141212210711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014806
=035  \\$aCBA8153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x923
=150  \\$aVitamin B 12 Deficiency
=450  \\$wnnna$aDeficiencies, Vitamin B12
=450  \\$wnnna$aDeficiency, Vitamin B 12
=450  \\$wnnna$aDeficiency, Vitamin B12
=450  \\$aVitamin B 12$xdeficiency
=450  \\$wnnna$aVitamin B12 Deficiencies
=450  \\$wnnna$aVitamin B12 Deficiency
=550  \\$wg$aVitamin B Deficiency
=550  \\$wh$aAnemia, Pernicious
=550  \\$wh$aSubacute Combined Degeneration
=667  \\$acoord IM with specific B 12 vitamin /defic (IM); DF: VITAMIN B 12 DEFIC
=680  \\$iA nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p848)
=750  \0$aVitamin B12 deficiency$5IEN$0(DLC)sh 85143972

=LDR  01184cz  a2200301n  4500
=001  9880364035402441
=005  20141212210711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014805
=035  \\$aCBA8152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x437.$x777
=072  \\$aD3.$x549.$x909.$x437.$x777
=072  \\$aD4.$x345.$x783.$x437.$x777
=150  \\$aVitamin B 12
=450  \\$wnnna$aB 12, Vitamin
=450  \\$wnnna$aB12, Vitamin
=450  \\$aCobalamin
=450  \\$wnnna$aCobalamins
=450  \\$aCyanocobalamin
=450  \\$wnnna$aEritron
=450  \\$wnnna$aVitamin B12
=550  \\$wg$aCorrinoids
=550  \\$wh$aCobamides
=550  \\$wh$aHydroxocobalamin
=667  \\$atherapeutic use: coordinate disease with /drug ther, not /diet ther
=680  \\$iA cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12.
=750  \0$aVitamin B12$5IEN$0(DLC)sh 85143970

=LDR  01170cz  a2200301n  4500
=001  9880364035502441
=005  20141212210710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014804
=035  \\$aCBA8151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699
=150  \\$aVitamin B Deficiency
=450  \\$wnnna$aDeficiencies, Vitamin B
=450  \\$wnnna$aDeficiency, Vitamin B
=450  \\$aVitamin B Complex$xdeficiency
=450  \\$wnnna$aVitamin B Deficiencies
=550  \\$wg$aAvitaminosis
=550  \\$wh$aCholine Deficiency
=550  \\$wh$aFolic Acid Deficiency
=550  \\$wh$aHyperhomocysteinemia
=550  \\$wh$aPellagra
=550  \\$wh$aRiboflavin Deficiency
=550  \\$wh$aThiamine Deficiency
=550  \\$wh$aVitamin B 12 Deficiency
=550  \\$wh$aVitamin B 6 Deficiency
=680  \\$iA condition due to deficiency in any member of the VITAMIN B COMPLEX. These B vitamins are water-soluble and must be obtained from the diet because they are easily lost in the urine. Unlike the lipid-soluble vitamins, they cannot be stored in the body fat.
=750  \0$aVitamin B deficiency$5IEN$0(DLC)sh 85143959

=LDR  00719cz  a2200193n  4500
=001  9880364035602441
=005  20141212210710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014803
=035  \\$aCBA8150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x605.$x600.$x708
=150  \\$aVitamin B Complex
=450  \\$wnnna$aB Vitamins
=450  \\$wnnna$aNeurobion
=550  \\$wg$aVitamins
=667  \\$aGEN or unspecified B vitamins; prefer specific vitamin B; /defic = VITAMIN B DEFICIENCY or PELLAGRA; /ther use: coord disease with /drug ther, not /diet ther
=680  \\$iA group of water-soluble vitamins, some of which are COENZYMES.
=750  \0$aVitamin B complex$5IEN$0(DLC)sh 85143958

=LDR  01167cz  a2200217n  4500
=001  9880364035702441
=005  20141212210709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014802
=035  \\$aCBA8149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x628
=150  \\$aVitamin A Deficiency
=450  \\$wnnna$aDeficiencies, Vitamin A
=450  \\$wnnna$aDeficiency, Vitamin A
=450  \\$wnnna$aVitamin A Deficiencies
=450  \\$aVitamin A$xdeficiency
=550  \\$wg$aAvitaminosis
=667  \\$aDF: VITAMIN A DEFIC
=680  \\$iA nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (XEROPHTHALMIA). Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. (From Cecil Textbook of Medicine, 19th ed, p1179)
=750  \0$aVitamin A deficiency$5IEN$0(DLC)sh 85143953

=LDR  01458cz  a2200313n  4500
=001  9880364035802441
=005  20141212210709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014801
=035  \\$aCBA8148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x818
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700.$x860
=072  \\$aD2.$x455.$x849.$x131.$x495.$x818
=072  \\$aD23.$x767.$x261.$x700.$x860
=150  \\$aVitamin A
=450  \\$wnnna$a11-cis-Retinol
=450  \\$wnnna$a3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
=450  \\$wnnna$aAll-Trans-Retinol
=450  \\$wnnna$aAll Trans Retinol
=450  \\$wnnna$aAquasol A
=450  \\$aRetinol
=450  \\$wnnna$aVitamin A1
=550  \\$wg$aRetinoids
=550  \\$wh$aTretinoin
=667  \\$a/ther use: coordinate disease with /drug ther, not /diet ther
=680  \\$iRetinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of CAROTENOIDS found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.
=688  \\$aRETINOL was see under VITAMIN A 1971-76, was see VITAMIN A 1969-70
=750  \0$aVitamin A$0(DLC) sh 85143952$5IEN

=LDR  01185cz  a2200169n  4500
=001  9880364035902441
=005  20141212210708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014799
=035  \\$aCBA8146HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x935
=150  \\$aVitalism
=450  \\$wnnna$aVitalisms
=550  \\$wg$aPhilosophy
=680  \\$iThe metaphysical doctrine that the functions and processes of life are due to a vital principle distinct from physicochemical forces and that the laws of physics and chemistry alone cannot explain life functions and processes. Vitalism is opposed to mechanistic materialism. The belief was that matter was divided into two classes based on behavior with respect to heat: organic and inorganic. Inorganic material could be melted but could always be recovered by removing the heat source. Organic compounds changed form upon heating and could not be recovered by removing the heat source. The proposed explanation for the difference between organic and inorganic compounds was the Vitalism Theory, which stated that inorganic materials did not contain the "vital force" of life.
=750  \0$aVitalism$5IEN$0(DLC)sh 85143950

=LDR  01196cz  a2200361n  4500
=001  9880364036002441
=005  20141212210707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014798
=035  \\$aCBA8145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985
=072  \\$aL1.$x280.$x975
=072  \\$aN1.$x224.$x935
=072  \\$aN6.$x850.$x505.$x400.$x975
=072  \\$aN6.$x850.$x520.$x308.$x985
=150  \\$aVital Statistics
=450  \\$wnnna$aRegistration of Vital Statistics
=450  \\$wnnna$aRegistration, Vital Statistics
=450  \\$wnnna$aRegistrations, Vital Statistics
=450  \\$wnnna$aStatistics, Vital
=450  \\$wnnna$aVital Statistics Registration
=450  \\$wnnna$aVital Statistics Registrations
=550  \\$wg$aData Collection
=550  \\$wg$aDemography
=550  \\$wh$aLife Expectancy
=550  \\$wh$aLife Tables
=550  \\$wh$aMorbidity
=550  \\$wh$aMortality
=550  \\$wh$aPregnancy Rate
=667  \\$aGEN only: prefer specifics: no qualif; specify geog
=680  \\$iUsed for general articles concerning statistics of births, deaths, marriages, etc.
=750  \0$aVital statistics$5IEN$0(DLC)sh 85143949

=LDR  01367cz  a2200409n  4500
=001  9880364036102441
=005  20141212210707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014796
=035  \\$aCBA8143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932
=150  \\$aVisual Perception
=450  \\$wnnna$aPerception, Visual
=450  \\$wnnna$aPerceptions, Visual
=450  \\$wnnna$aVisual Perceptions
=550  \\$wg$aPerception
=550  \\$wh$aAfterimage
=550  \\$wh$aAttentional Blink
=550  \\$wh$aColor Perception
=550  \\$wh$aField Dependence-Independence
=550  \\$wh$aFigural Aftereffect
=550  \\$wh$aFlicker Fusion
=550  \\$wh$aMotion Perception
=550  \\$wh$aOptic Flow
=550  \\$wh$aPattern Recognition, Visual
=550  \\$wh$aPerceptual Closure
=550  \\$wh$aPerceptual Masking
=550  \\$wh$aSpace Perception
=550  \\$wh$aVision, Binocular
=550  \\$wh$aVision, Monocular
=550  \\$wh$aVisual Acuity
=550  \\$wh$aVisual Fields
=550  \\$aVision, Ocular
=667  \\$adifferentiate from VISION, OCULAR; visual perception takes place in the brain, ocular vision takes place in the eye
=680  \\$iThe selecting and organizing of visual stimuli based on the individual's past experience.
=750  \0$aVisual perception$5IEN$0(DLC)sh 85143926

=LDR  00712cz  a2200205n  4500
=001  9880364036202441
=005  20141212192621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014795
=035  \\$aCBA8142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x612.$x220.$x860
=150  \\$aVisual Pathways
=450  \\$wnnna$aPathway, Visual
=450  \\$wnnna$aPathways, Visual
=450  \\$wnnna$aVisual Pathway
=550  \\$wg$aAfferent Pathways
=680  \\$iSet of cell bodies and nerve fibers conducting impulses from the eyes to the cerebral cortex. It includes the RETINA; OPTIC NERVE; optic tract; and geniculocalcarine tract.
=688  \\$a72(71)
=750  \0$aVisual pathways$5IEN$0(DLC)sh 85143925

=LDR  00743cz  a2200229n  4500
=001  9880364036302441
=005  20141212210706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014794
=035  \\$aCBA8141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932.$x934
=072  \\$aG14.$x950
=150  \\$aVisual Fields
=450  \\$wnnna$aField, Visual
=450  \\$wnnna$aFields, Visual
=450  \\$wnnna$aVisual Field
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aVisual Perception
=667  \\$aVISUAL FIELD TESTS is also available
=680  \\$iThe total area or space visible in a person's peripheral vision with the eye looking straightforward.
=750  \0$aVisual fields$5IEN$0(DLC)sh 85143922

=LDR  01584cz  a2200433n  4500
=001  9880364036402441
=005  20141212192621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014793
=035  \\$aCBA8140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x571.$x735
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814.$x953
=150  \\$aVisual Cortex
=450  \\$wnnna$aCortex, Extrastriate
=450  \\$wnnna$aCortex Primaries, Visual
=450  \\$wnnna$aCortex Primary, Visual
=450  \\$wnnna$aCortex, Primary Visual
=450  \\$wnnna$aCortex, Striate
=450  \\$wnnna$aCortex, Visual
=450  \\$wnnna$aCortices, Extrastriate
=450  \\$wnnna$aCortices, Primary Visual
=450  \\$wnnna$aExtrastriate Cortex
=450  \\$wnnna$aExtrastriate Cortices
=450  \\$wnnna$aPrimaries, Visual Cortex
=450  \\$wnnna$aPrimary Visual Cortex
=450  \\$wnnna$aPrimary, Visual Cortex
=450  \\$wnnna$aPrimary Visual Cortices
=450  \\$aStriate Cortex
=450  \\$wnnna$aVisual Cortex Primaries
=450  \\$wnnna$aVisual Cortex Primary
=450  \\$wnnna$aVisual Cortex, Primary
=450  \\$wnnna$aVisual Cortices, Primary
=550  \\$wg$aOccipital Lobe
=550  \\$wg$aSensorimotor Cortex
=667  \\$ado not confuse entry term STRIATE CORTEX with CORPUS STRIATUM (basal ganglia)
=680  \\$iArea of the OCCIPITAL LOBE concerned with the processing of visual information relayed via VISUAL PATHWAYS.
=688  \\$a70(68)
=750  \0$aVisual cortex$5IEN$0(DLC)sh 85143918

=LDR  01167cz  a2200277n  4500
=001  9880364036502441
=005  20141212210706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014792
=035  \\$aCBA8139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850.$x950
=072  \\$aF2.$x463.$x593.$x932.$x901
=072  \\$aG14.$x940
=150  \\$aVisual Acuity
=450  \\$wnnna$aAcuities, Visual
=450  \\$wnnna$aAcuity, Visual
=450  \\$wnnna$aVisual Acuities
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aVision Tests
=550  \\$wg$aVisual Perception
=550  \\$wh$aContrast Sensitivity
=550  \\$wh$aEmmetropia
=680  \\$iClarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
=688  \\$a70(68)
=750  \0$aVisual acuity$5IEN$0(DLC)sh 85143915

=LDR  01365cz  a2200265n  4500
=001  9880364036602441
=005  20141212210706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014790
=035  \\$aCBA8137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x589.$x600.$x900
=072  \\$aB4.$x909.$x777.$x731.$x589.$x600.$x900
=150  \\$aVisna-maedi virus
=450  \\$aMaedi Virus
=450  \\$wnnna$aMaedi Viruses
=450  \\$aMaedi-Visna Virus
=450  \\$wnnna$aMaedi Visna Virus
=450  \\$wnnna$aVisna Maedi Virus
=450  \\$aVisna Virus
=550  \\$wg$aLentiviruses, Ovine-Caprine
=667  \\$ainfection = VISNA or MAEDI see PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP
=680  \\$iA species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), that can cause chronic pneumonia (maedi), mastitis, arthritis, and encephalomyelitis (visna) in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte (PULMONARY ADENOMATOSIS, OVINE). Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE.
=688  \\$a94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 (see under RNA VIRUSES 1975-77); VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93
=750  \0$aMaedi-visna virus$5IEN$0(DLC)sh 85143910

=LDR  00767cz  a2200265n  4500
=001  9880364036702441
=005  20141212210705.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014789
=035  \\$aCBA8136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x935
=150  \\$aVisitors to Patients
=450  \\$wnnna$aPatient Visitors
=450  \\$wnnna$aPatients' Visitor
=450  \\$aPatients' Visitors
=450  \\$wnnna$aPatient's Visitors
=450  \\$wnnna$aPatients Visitors
=450  \\$wnnna$aVisitor, Patients'
=450  \\$wnnna$aVisitors, Patients'
=450  \\$wnnna$aVisitors to Patient
=550  \\$wg$aPersons
=680  \\$iPatients' guests and rules for visiting.
=688  \\$a78
=750  \0$aVisiting the sick$5IEN$0(DLC)sh 85143902

=LDR  00488cz  a2200181n  4500
=001  9880364036802441
=005  20141212211011.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015349
=035  \\$aCBA8135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932.$x893
=150  \\$aVision, Monocular
=450  \\$aMonocular Vision
=550  \\$wg$aVisual Perception
=680  \\$iImages seen by one eye.
=688  \\$a89
=750  \0$aVision, Monocular$5IEN$0(DLC)sh 85143878

=LDR  01173cz  a2200301n  4500
=001  9880364036902441
=005  20141212211012.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015354
=035  \\$aCBA8134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941.$x905
=072  \\$aC11.$x966.$x905
=072  \\$aC23.$x888.$x592.$x763.$x941.$x848
=150  \\$aVision, Low
=450  \\$wnnna$aDiminished Vision
=450  \\$wnnna$aLow Vision
=450  \\$wnnna$aReduced Vision
=450  \\$wnnna$aSubnormal Vision
=450  \\$wnnna$aVision, Diminished
=450  \\$aVision, Reduced
=450  \\$aVision, Subnormal
=550  \\$wg$aVision Disorders
=550  \\$aBlindness
=667  \\$ado not make a diagnosis: use term of author
=680  \\$iVision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.).
=688  \\$a2000(1989)
=750  \0$aLow vision$5IEN$0(DLC)sh 86007792

=LDR  00538cz  a2200181n  4500
=001  9880364037002441
=005  20141212211010.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015348
=035  \\$aCBA8132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x932.$x885
=150  \\$aVision, Binocular
=450  \\$aBinocular Vision
=550  \\$wg$aVisual Perception
=680  \\$iThe blending of separate images seen by each eye into one composite image.
=688  \\$a89
=750  \0$aBinocular vision$5IEN$0(DLC)sh 85014109

=LDR  00790cz  a2200253n  4500
=001  9880364037102441
=005  20141212210705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014787
=035  \\$aCBA8131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850
=150  \\$aVision Tests
=450  \\$wnnna$aTest, Vision
=450  \\$wnnna$aTests, Vision
=450  \\$wnnna$aVision Test
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$wh$aColor Perception Tests
=550  \\$wh$aRefraction, Ocular
=550  \\$wh$aVision Screening
=550  \\$wh$aVisual Acuity
=550  \\$wh$aVisual Field Tests
=667  \\$afor an individual: differentiate from VISION SCREENING on a given population
=750  \0$aVision$xTesting$5IEN$0(DLC)sh 85143876

=LDR  02234cz  a2200625n  4500
=001  9880364037202441
=005  20141212210704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014786
=035  \\$aCBA8128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x941
=072  \\$aC11.$x966
=072  \\$aC23.$x888.$x592.$x763.$x941
=150  \\$aVision Disorders
=450  \\$wnnna$aBlindness, Day
=450  \\$wnnna$aDay Blindness
=450  \\$wnnna$aDisabilities, Vision
=450  \\$wnnna$aDisability, Vision
=450  \\$wnnna$aDisorder, Visual
=450  \\$wnnna$aDisorders, Visual
=450  \\$aHemeralopia
=450  \\$wnnna$aHemeralopias
=450  \\$wnnna$aImpairment, Visual
=450  \\$wnnna$aImpairments, Visual
=450  \\$aMacropsia
=450  \\$wnnna$aMacropsias
=450  \\$wnnna$aMetamorphopsia
=450  \\$wnnna$aMetamorphopsias
=450  \\$aMicropsia
=450  \\$wnnna$aMicropsias
=450  \\$wnnna$aVision Disabilities
=450  \\$wnnna$aVision Disability
=450  \\$wnnna$aVision Disorder
=450  \\$wnnna$aVisual Disorder
=450  \\$wnnna$aVisual Disorders
=450  \\$wnnna$aVisual Impairment
=450  \\$wnnna$aVisual Impairments
=550  \\$wg$aEye Diseases
=550  \\$wg$aSensation Disorders
=550  \\$wh$aAlice in Wonderland Syndrome
=550  \\$wh$aAmblyopia
=550  \\$wh$aBlindness
=550  \\$wh$aColor Vision Defects
=550  \\$wh$aDiplopia
=550  \\$wh$aHemianopsia
=550  \\$wh$aNight Blindness
=550  \\$wh$aPhotophobia
=550  \\$wh$aScotoma
=550  \\$wh$aSusac Syndrome
=550  \\$wh$aVision, Low
=667  \\$ageneral or unspecified: prefer specifics; / diag: consider also DlAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL
=680  \\$iVisual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132).
=688  \\$a1967
=750  \0$aVision disorders$5IEN$0(DLC)sh 85143879

=LDR  01760cz  a2200469n  4500
=001  9880364037302441
=005  20141212210704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014785
=035  \\$aCBA8127HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x964
=072  \\$aG2.$x111.$x87.$x800.$x480.$x900
=072  \\$aG2.$x149.$x115.$x800.$x480.$x900
=072  \\$aG4.$x299.$x880.$x480.$x900
=072  \\$aG11.$x561.$x600.$x810.$x964
=072  \\$aG14.$x640.$x816
=150  \\$aVision, Ocular
=450  \\$wnnna$aLight Signal Transduction, Visual
=450  \\$wnnna$aOcular Vision
=450  \\$wnnna$aPhototransduction, Visual
=450  \\$wnnna$aTransduction, Visual
=450  \\$aVision
=450  \\$wnnna$aVisual Light Signal Transduction
=450  \\$wnnna$aVisual Phototransduction
=450  \\$wnnna$aVisual Transduction
=550  \\$wg$aLight Signal Transduction
=550  \\$wg$aOcular Physiological Processes
=550  \\$wg$aSensation
=550  \\$wh$aColor Vision
=550  \\$wh$aMesopic Vision
=550  \\$wh$aNight Vision
=550  \\$wh$aPhosphenes
=550  \\$wh$aVision, Entoptic
=550  \\$aEye
=550  \\$aOphthalmology
=550  \\$aVisual Perception
=667  \\$adifferentiate from VISUAL PERCEPTION which takes place in the brain, vision takes place in the eye; visual stimulation: probably PHOTIC STIMULATION but check text for possible non-light (non-photic) stimulation
=680  \\$iThe process in which light signals are transformed by the PHOTORECEPTOR CELLS into electrical signals which can then be transmitted to the brain.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Vision
=750  \0$aVision$0(DLC) sh 85143872$5IEN

=LDR  01228cz  a2200217n  4500
=001  9880364037402441
=005  20141212210703.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014784
=035  \\$aCBA8126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x735
=150  \\$aMistletoe
=450  \\$wnnna$aMistletoes
=550  \\$wg$aAngiosperms
=550  \\$wh$aLoranthaceae
=550  \\$wh$aViscaceae
=667  \\$atraditional mistletoe = VISCUM ALBUM; prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iParasitic plants that form a bushy growth on branches of host trees which are in the order Santalales. It includes the Christmas mistletoe family (VISCACEAE), the showy mistletoe family (LORANTHACEAE) and the catkin mistletoe family (Eremolepidaceae). The composition of toxins, lectins, tyramine, phenethylamines, and other compounds may be affected by the host.
=688  \\$a2002(1963)
=750  \0$aMistletoes$5IEN-M$0(DLC)sh 85086250

=LDR  00618cz  a2200181n  4500
=001  9880364037502441
=005  20141212210703.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014783
=035  \\$aCBA8125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x925
=150  \\$aViscosity
=450  \\$wnnna$aViscosities
=550  \\$wg$aPhysicochemical Phenomena
=667  \\$aNIM
=680  \\$iThe resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aViscosity$5IEN$0(DLC)sh 85143858

=LDR  00617cz  a2200193n  4500
=001  9880364037602441
=005  20141212210702.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014781
=035  \\$aCBA8123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x960
=150  \\$aViscera
=360  \\$iconsider also terms at$aSPLANCHN-
=550  \\$wg$aBody Regions
=667  \\$aGEN & unspecified only: prefer specific organ term
=680  \\$iAny of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.
=688  \\$a87
=750  \0$aViscera$5IEN$0(DLC)sh 85143850

=LDR  02010cz  a2200505n  4500
=001  9880364037702441
=005  20160906105605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014780
=035  \\$aCBA8122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4
=150  \\$aViruses
=450  \\$wnnna$aAnimal Virus
=450  \\$aAnimal Viruses
=450  \\$wnno$aVertebrate Viruses$5IEN-M
=450  \\$wnnna$aVirus
=450  \\$wnnna$aVirus, Animal
=450  \\$wnnna$aViruses, Animal
=450  \\$aZoophaginae
=550  \\$wh$aArboviruses
=550  \\$wh$aArchaeal Viruses
=550  \\$wh$aBacteriophages
=550  \\$wh$aDefective Viruses
=550  \\$wh$aDNA Viruses
=550  \\$wh$aHelper Viruses
=550  \\$wh$aHepatitis Viruses
=550  \\$wh$aInsect Viruses
=550  \\$wh$aOncolytic Viruses
=550  \\$wh$aPlant Viruses
=550  \\$wh$aProviruses
=550  \\$wh$aReassortant Viruses
=550  \\$wh$aRNA Viruses
=550  \\$wh$aVertebrate Viruses
=550  \\$wh$aVirion
=550  \\$wh$aViroids
=550  \\$wh$aViruses, Unclassified
=550  \\$aAntiviral Agents
=550  \\$aGenetic Vectors
=550  \\$aInclusion Bodies, Viral
=550  \\$aReceptors, Virus
=667  \\$ageneral or unspecified; prefer specific taxonomic group or genus; do not confuse "slow viruses" with VIRUS LATENCY: slow cause disease with very long preclinical course & very slow progression, VIRUS LATENCY is the ability of a virus to lie dormant in a cell; presence of viruses in blood = VIREMIA; many pre-coordinated viral terms are available such as VIRAL PROTEINS; RNA, VIRAL, etc.; policy: Manual 22.18, 22.24+
=680  \\$iMinute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.
=688  \\$a1963; for ANIMAL VIRUSES & ZOOPHAGINAE use VERTEBRATE VIRUSES 1975-1991
=750  \0$aViruses$5IEN-M$0(DLC)sh 85143833

=LDR  00909cz  a2200253n  4500
=001  9880364037802441
=005  20141212210701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014779
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x590.$x875.$x780
=072  \\$aG6.$x920.$x875.$x780
=150  \\$aVirus Replication
=450  \\$wnnna$aReplication, Virus
=450  \\$wnnna$aReplications, Virus
=450  \\$wnnna$aVirus Replications
=550  \\$wg$aVirus Physiological Processes
=550  \\$wh$aVirus Activation
=550  \\$wh$aVirus Assembly
=550  \\$aDNA Replication
=667  \\$acoord with specific virus /physiol
=680  \\$iThe process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
=688  \\$a68
=750  \0$aViruses$xReproduction$5IEN$0(DLC)sh 85143840

=LDR  01537cz  a2200481n  4500
=001  9880364037902441
=005  20141212210701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014777
=035  \\$aCBA8119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2
=150  \\$aVirus Diseases
=450  \\$wnnna$aDisease, Viral
=450  \\$wnnna$aDisease, Virus
=450  \\$wnnna$aDiseases, Viral
=450  \\$wnnna$aDiseases, Virus
=450  \\$wnnna$aViral Disease
=450  \\$wnnna$aViral Diseases
=450  \\$wnnna$aVirus Disease
=550  \\$wh$aArbovirus Infections
=550  \\$wh$aBronchiolitis, Viral
=550  \\$wh$aCentral Nervous System Viral Diseases
=550  \\$wh$aCoinfection
=550  \\$wh$aDNA Virus Infections
=550  \\$wh$aEncephalitis, Viral
=550  \\$wh$aEye Infections, Viral
=550  \\$wh$aFatigue Syndrome, Chronic
=550  \\$wh$aHepatitis, Viral, Animal
=550  \\$wh$aHepatitis, Viral, Human
=550  \\$wh$aMeningitis, Viral
=550  \\$wh$aOpportunistic Infections
=550  \\$wh$aPneumonia, Viral
=550  \\$wh$aRNA Virus Infections
=550  \\$wh$aSexually Transmitted Diseases
=550  \\$wh$aSkin Diseases, Viral
=550  \\$wh$aSlow Virus Diseases
=550  \\$wh$aTumor Virus Infections
=550  \\$wh$aViremia
=550  \\$wh$aZoonoses
=667  \\$aGEN: prefer specifics; /drug ther: consider also ANTIVIRAL AGENTS
=680  \\$iA general term for diseases produced by viruses.
=750  \0$aVirus diseases$5IEN$0(DLC)sh 85143818

=LDR  00897cz  a2200277n  4500
=001  9880364038002441
=005  20141212210700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014776
=035  \\$aCBA8118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x970
=072  \\$aE5.$x200.$x875.$x970
=150  \\$aVirus Cultivation
=450  \\$wnnna$aCultivation, Viral
=450  \\$wnnna$aCultivation, Virus
=450  \\$wnnna$aCultivations, Viral
=450  \\$wnnna$aCultivations, Virus
=450  \\$wnnna$aViral Cultivation
=450  \\$wnnna$aViral Cultivations
=450  \\$wnnna$aVirus Cultivations
=550  \\$wg$aMicrobiological Techniques
=550  \\$wh$aViral Plaque Assay
=550  \\$aCulture Techniques
=667  \\$aNIM; relation to TISSUE CULTURE TECHNIQUES: Manual 26.23.3
=750  \0$aVirology$xCultures and culture media$5IEN$0(DLC)sh 85143802

=LDR  00803cz  a2200193n  4500
=001  9880364038102441
=005  20141212210659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014774
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x930
=150  \\$aVirulence
=450  \\$aPathogenicity
=550  \\$wg$aMicrobiological Phenomena
=550  \\$aVirulence Factors
=667  \\$acoord NIM with micro-organism or parasite /pathogen (IM)
=680  \\$iThe degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
=688  \\$a66(65)
=750  \0$aVirulence (Microbiology)$5IEN$0(DLC)sh 85143817

=LDR  00941cz  a2200229n  4500
=001  9880364038202441
=005  20141212210659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014773
=035  \\$aCBA8115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x859
=150  \\$aVirology
=450  \\$aMedical Virology$5IEN
=450  \\$aVirologists$5IEN
=550  \\$wg$aMicrobiology
=550  \\$aInfectious Disease Medicine
=667  \\$athe discipline (education, history, etc) only; use VIRUS PHYSIOLOGICAL PHENOMENA or specifics treed under it for biological processes and properties of viruses, or the qualifier /virology with specific anatomical terms, organisms & diseases
=680  \\$iThe study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
=688  \\$a67
=750  \0$aVirology$5IEN-M$0(DLC)sh 85143799
=750  \0$aVirologists$5IEN-HS$0(DLC)sh 85143798

=LDR  00829cz  a2200193n  4500
=001  9880364038302441
=005  20141212210659.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014772
=035  \\$aCBA8114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x956
=150  \\$aViroids
=450  \\$wnnna$aViroid
=550  \\$wg$aViruses
=667  \\$a"smallest known agents of infect dis"; read MeSH definition
=680  \\$iA group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected.
=688  \\$a81
=750  \0$aViroids$5IEN$0(DLC)sh 85143797

=LDR  00805cz  a2200229n  4500
=001  9880364038402441
=005  20141212210658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014770
=035  \\$aCBA8112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x971
=150  \\$aVirilism
=450  \\$aAndrogenization
=450  \\$aVirilization
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aHirsutism
=550  \\$aAdrenal Hyperplasia, Congenital
=550  \\$aHyperandrogenism
=667  \\$acheck the tag FEMALE
=680  \\$iDevelopment of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.
=750  \0$aVirilism$5IEN$0(DLC)sh 85143794

=LDR  01615cz  a2200481n  4500
=001  9880364038502441
=005  20141212210657.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014765
=035  \\$aCBA8107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899
=150  \\$aViral Vaccines
=450  \\$wnnna$aVaccines, Viral
=550  \\$wg$aVaccines
=550  \\$wh$aAdenovirus Vaccines
=550  \\$wh$aAIDS Vaccines
=550  \\$wh$aCytomegalovirus Vaccines
=550  \\$wh$aDengue Vaccines
=550  \\$wh$aEbola Vaccines
=550  \\$wh$aHerpesvirus Vaccines
=550  \\$wh$aInfluenza Vaccines
=550  \\$wh$aJapanese Encephalitis Vaccines
=550  \\$wh$aMeasles-Mumps-Rubella Vaccine
=550  \\$wh$aMeasles Vaccine
=550  \\$wh$aMumps Vaccine
=550  \\$wh$aPapillomavirus Vaccines
=550  \\$wh$aParainfluenza Vaccines
=550  \\$wh$aPoliovirus Vaccines
=550  \\$wh$aPseudorabies Vaccines
=550  \\$wh$aRabies Vaccines
=550  \\$wh$aRespiratory Syncytial Virus Vaccines
=550  \\$wh$aRotavirus Vaccines
=550  \\$wh$aRubella Vaccine
=550  \\$wh$aSAIDS Vaccines
=550  \\$wh$aSmallpox Vaccine
=550  \\$wh$aViral Hepatitis Vaccines
=550  \\$wh$aWest Nile Virus Vaccines
=550  \\$wh$aYellow Fever Vaccine
=667  \\$afor specifics not indented here coord IM with specific virus /immunol (IM)
=680  \\$iSuspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
=688  \\$a65
=750  \0$aViral vaccines$5IEN$0(DLC)sh 85143735

=LDR  00999cz  a2200289n  4500
=001  9880364038602441
=005  20141212210656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014764
=035  \\$aCBA8106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x964
=150  \\$aViral Proteins
=450  \\$aGene Products, Viral
=450  \\$wnnna$aProteins, Viral
=450  \\$aViral Gene Products
=450  \\$aViral Gene Proteins
=550  \\$wg$aProteins
=550  \\$wh$aOncogene Proteins, Viral
=550  \\$wh$aRetroviridae Proteins
=550  \\$wh$aViral Nonstructural Proteins
=550  \\$wh$aViral Regulatory and Accessory Proteins
=550  \\$wh$aViral Structural Proteins
=550  \\$aGenes, Viral
=667  \\$a/drug eff /ultrastruct permitted; /physiol permitted for function with the virus; IM; coord with specific protein (IM) + specific virus (IM)
=680  \\$iProteins found in any species of virus.
=750  \0$aViral Proteins$0(DLC) sh 94006884$5IEN-M

=LDR  00982cz  a2200277n  4500
=001  9880364038702441
=005  20141212210652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014756
=035  \\$aCBA8098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x875
=072  \\$aD12.$x644.$x641.$x875
=150  \\$aViomycin
=450  \\$wnnna$aCeliomycin
=450  \\$aFlorimycin
=450  \\$aTuberactinomycin B
=450  \\$wnnna$aVinactane
=450  \\$wnnna$aViocin
=450  \\$wnnna$aViomicin
=450  \\$wnnna$aViomycins
=550  \\$wg$aPeptides, Cyclic
=550  \\$wh$aEnviomycin
=680  \\$iA strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.
=688  \\$a94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80
=750  \0$aViomycin$5IEN$0(DLC)sh 85143716

=LDR  00920cz  a2200229n  4500
=001  9880364038902441
=005  20141212210651.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014752
=035  \\$aCBA8094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x884.$x750
=072  \\$aD2.$x455.$x526.$x439.$x975
=150  \\$aVinyl Chloride
=450  \\$wnnna$aChloride, Vinyl
=450  \\$aChloroethylene
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wg$aVinyl Compounds
=667  \\$aD25-26 qualif; POLYVINYL CHLORIDE is available
=680  \\$iA gas that has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms.
=688  \\$a91(75); was see under VINYL COMPOUNDS 1975-90; was in Cat D & J 1975-79
=750  \0$aVinyl chloride$5IEN$0(DLC)sh 85143414

=LDR  01176cz  a2200325n  4500
=001  9880364039002441
=005  20141212210651.0
=008  850424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014751
=035  \\$aCBA8093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827.$x830
=072  \\$aD3.$x438.$x473.$x402.$x681.$x827.$x830
=150  \\$aVindesine
=450  \\$wnnna$aCompound 112531
=450  \\$wnnna$aDesacetylvinblastine Amide
=450  \\$wnnna$aEG Labo Brand of Vindesine Sulfate
=450  \\$wnnna$aEldisine
=450  \\$wnnna$aEnison
=450  \\$wnnna$aLilly Brand of Vindesine Sulfate
=450  \\$wnnna$aNSC-245467
=450  \\$wnnna$aNSC 245467
=450  \\$wnnna$aNSC245467
=450  \\$wnnna$aSulfate, Vindesine
=450  \\$wnnna$aVindesin
=450  \\$wnnna$aVindesine Sulfate
=550  \\$wg$aVinca Alkaloids
=680  \\$iVinblastine derivative with antineoplastic activity against CANCER. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS).
=688  \\$a86
=750  \0$aVindesine$5IEN$0(DLC)sh 85143400

=LDR  01849cz  a2200529n  4500
=001  9880364039102441
=005  20141212210650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014750
=035  \\$aCBA8092HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827.$x817
=072  \\$aD3.$x438.$x473.$x402.$x681.$x827.$x817
=150  \\$aVincristine
=450  \\$wnnna$aBristol-Myers Squibb Brand of Vincristine Sulfate
=450  \\$wnnna$acell pharm Brand of Vincristine Sulfate
=450  \\$wnnna$acellcristin
=450  \\$wnnna$aCitomid
=450  \\$wnnna$aColumbia Brand of Vincristine Sulfate
=450  \\$wnnna$aEG Labo Brand of Vincristine Sulfate
=450  \\$wnnna$aFarmistin
=450  \\$wnnna$aIrisfarma Brand of Vincristine Sulfate
=450  \\$wnnna$aLemery Brand of Vincristine Sulfate
=450  \\$aLeurocristine
=450  \\$wnnna$aLilly Brand of Vincristine Sulfate
=450  \\$wnnna$amedac Brand of Vincristine Sulfate
=450  \\$wnnna$aOncovin
=450  \\$wnnna$aOncovine
=450  \\$wnnna$aOnkocristin
=450  \\$wnnna$aOnkoworks Brand of Vincristine Sulfate
=450  \\$wnnna$aPfizer Brand of Vincristine Sulfate
=450  \\$wnnna$aPFS, Vincasar
=450  \\$wnnna$aSulfate, Vincristine
=450  \\$wnnna$aTeva Brand of Vincristine Sulfate
=450  \\$wnnna$aVincasar
=450  \\$wnnna$aVincasar PFS
=450  \\$wnnna$aVincristin Bristol
=450  \\$wnnna$aVincristin Liquid, Lilly
=450  \\$wnnna$aVincristin medac
=450  \\$wnnna$aVincristine Sulfate
=450  \\$wnnna$aVincrisul
=450  \\$wnnna$aVintec
=550  \\$wg$aVinca Alkaloids
=667  \\$a/biosyn permitted if by plant
=680  \\$iAntitumor alkaloid isolated from Vinca Rosea. (Merck, 11th ed.)
=688  \\$a66(63)
=750  \0$aVincristine$5IEN$0(DLC)sh 85143399

=LDR  00897cz  a2200253n  4500
=001  9880364039202441
=005  20141212210650.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014749
=035  \\$aCBA8091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827.$x750
=072  \\$aD3.$x438.$x473.$x402.$x681.$x827.$x750
=150  \\$aVincamine
=450  \\$wnnna$aCerebroxine
=450  \\$wnnna$aDevincan
=450  \\$wnnna$aPervincamine
=450  \\$wnnna$aVincapront
=450  \\$wnnna$aVincimax
=550  \\$wg$aVinca Alkaloids
=667  \\$a/biosyn permitted if by plant
=680  \\$iA major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders.
=688  \\$a91(79); was see under VINCA ALKALOIDS 1979-90
=750  \0$aVincamine$5IEN$0(DLC)sh 85143390

=LDR  00978cz  a2200253n  4500
=001  9880364039302441
=005  20141212210649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014748
=035  \\$aCBA8090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827
=072  \\$aD3.$x438.$x473.$x402.$x681.$x827
=150  \\$aVinca Alkaloids
=450  \\$wnnna$aAlkaloids, Vinca
=550  \\$wg$aSecologanin Tryptamine Alkaloids
=550  \\$wh$aVinblastine
=550  \\$wh$aVincamine
=550  \\$wh$aVincristine
=550  \\$wh$aVindesine
=680  \\$iA group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS.
=688  \\$a73
=750  \0$81$wb$aVinca$5IEN$0(DLC)sh 85143388
=750  \0$81$wb$aAlkaloids$5IEN-HS$0(DLC)sh 85003598

=LDR  01407cz  a2200397n  4500
=001  9880364039402441
=005  20141212210649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014747
=035  \\$aCBA8089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827.$x650
=072  \\$aD3.$x438.$x473.$x402.$x681.$x827.$x650
=150  \\$aVinblastine
=450  \\$wnnna$acell pharm Brand of Vinblastine Sulfate
=450  \\$wnnna$acellblastin
=450  \\$wnnna$aEG Labo Brand of Vinblastine Sulfate
=450  \\$wnnna$aFaulding Brand of Vinblastine Sulfate
=450  \\$wnnna$aGastrozepin Brand of Vinblastine Sulfate
=450  \\$wnnna$aGry Brand of Vinblastine Sulfate
=450  \\$wnnna$aHexal Brand of Vinblastine Sulfate
=450  \\$wnnna$aLemblastine
=450  \\$wnnna$aLemery Brand of Vinblastine Sulfate
=450  \\$wnnna$aLilly Brand of Vinblastine Sulfate
=450  \\$wnnna$aSulfate, Vinblastine
=450  \\$wnnna$aVelban
=450  \\$wnnna$aVelbe
=450  \\$wnnna$aVinblastin Hexal
=450  \\$wnnna$aVinblastina Lilly
=450  \\$wnnna$aVinblastine Sulfate
=450  \\$wnnna$aVinblastinsulfat-Gry
=450  \\$aVincaleukoblastine
=550  \\$wg$aVinca Alkaloids
=667  \\$a/biosyn permitted if by plant
=680  \\$iAntitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)
=750  \0$aVinblastine$5IEN$0(DLC)sh 85143387

=LDR  01483cz  a2200445n  4500
=001  9880364039502441
=005  20141212210648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014743
=035  \\$aCBA8085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x846.$x734
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x840
=072  \\$aL1.$x178.$x590.$x875.$x840
=072  \\$aL1.$x178.$x820.$x90.$x846.$x734
=072  \\$aL1.$x178.$x820.$x90.$x898.$x840
=072  \\$aL1.$x240.$x940.$x840
=072  \\$aL1.$x240.$x960.$x880
=150  \\$aVideotape Recording
=450  \\$wnnna$aRecording, Video Tape
=450  \\$wnnna$aRecording, Videotape
=450  \\$wnnna$aRecordings, Video Tape
=450  \\$wnnna$aRecordings, Videotape
=450  \\$aTape Recording, Video
=450  \\$wnnna$aTape Recordings, Video
=450  \\$aVideo Tape Recorders and Recording$5IEN
=450  \\$wnnna$aVideo Tape Recording
=450  \\$wnnna$aVideo Tape Recordings
=450  \\$aVideo Tapes$5IEN
=450  \\$aVideocassettes$5IEN
=450  \\$wnnna$aVideotape
=450  \\$wnnna$aVideotape Recordings
=450  \\$wnnna$aVideotapes
=550  \\$wg$aTape Recording
=550  \\$wg$aTelevision
=550  \\$wg$aVideo Recording
=667  \\$aIM; do not confuse with VIDEO RECORDING or VIDEODISC RECORDING
=680  \\$iRecording of visual and sometimes sound signals on magnetic tape.
=688  \\$a74
=750  \0$aVideo tapes$5IEN-M$0(DLC)sh 85143214

=LDR  01335cz  a2200373n  4500
=001  9880364039602441
=005  20141212210647.0
=008  830613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014742
=035  \\$aCBA8084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x668.$x800
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x800
=072  \\$aL1.$x178.$x590.$x875.$x800
=072  \\$aL1.$x178.$x820.$x90.$x668.$x800
=072  \\$aL1.$x178.$x820.$x90.$x898.$x800
=072  \\$aL1.$x240.$x960.$x800
=150  \\$aVideodisc Recording
=450  \\$wnnna$aRecording, Videodisc
=450  \\$wnnna$aRecording, Videodisk
=450  \\$wnnna$aRecordings, Videodisc
=450  \\$wnnna$aRecordings, Videodisk
=450  \\$aVideo Discs$5IEN
=450  \\$wnnna$aVideodisc Recordings
=450  \\$wnnna$aVideodisk Recording
=450  \\$wnnna$aVideodisk Recordings
=550  \\$wg$aOptical Storage Devices
=550  \\$wg$aTelevision
=550  \\$wg$aVideo Recording
=550  \\$wh$aCompact Disks
=667  \\$aIM; do not confuse with VIDEO RECORDING or VIDEOTAPE RECORDING
=680  \\$iThe storing of visual and usually sound signals on discs for later reproduction on a television screen or monitor.
=688  \\$a91(84); was see under VIDEO RECORDING 1984-90
=750  \0$aVideodiscs$0(DLC)sh 85143198$5IEN-M

=LDR  00902cz  a2200253n  4500
=001  9880364039802441
=005  20141212210645.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014737
=035  \\$aCBA8079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900
=072  \\$aB3.$x660.$x250.$x830
=150  \\$aVibrionaceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wh$aAliivibrio
=550  \\$wh$aListonella
=550  \\$wh$aPhotobacterium
=550  \\$wh$aVibrio
=667  \\$ainfection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA family of gram-negative bacteria whose members predominate in the bacterial flora of PLANKTON; FISHES; and SEAWATER. Some members are important pathogens for humans and animals.
=688  \\$a76
=750  \0$aVibrionaceae$5IEN$0(DLC)sh 88023360

=LDR  00669cz  a2200193n  4500
=001  9880364039902441
=005  20141212210645.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014736
=035  \\$aCBA8078M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x859.$x550
=072  \\$aB3.$x660.$x250.$x830.$x830.$x590
=150  \\$aVibrio parahaemolyticus
=550  \\$wg$aVibrio
=667  \\$ainfection: coord IM with VIBRIO INFECTIONS (IM)
=680  \\$iA species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis.
=688  \\$a76
=750  \0$aVibrio parahaemolyticus$0(DLC) sh2004003308$5IEN-M

=LDR  00702cz  a2200229n  4500
=001  9880364040002441
=005  20141212210645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014735
=035  \\$aCBA8077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x959
=150  \\$aVibrio Infections
=450  \\$wnnna$aInfection, Vibrio
=450  \\$wnnna$aInfections, Vibrio
=450  \\$wnnna$aVibrio Infection
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wh$aCholera
=667  \\$agram-neg bact infect; V. comma infection = CHOLERA
=680  \\$iInfections with bacteria of the genus VIBRIO.
=688  \\$a68
=750  \0$aVibrio infections$5IEN$0(DLC)sh 89002992

=LDR  00729cz  a2200241n  4500
=001  9880364040102441
=005  20141212210645.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014734
=035  \\$aCBA8076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x859.$x225
=072  \\$aB3.$x660.$x250.$x830.$x830.$x100
=150  \\$aVibrio cholerae
=450  \\$aVibrio comma
=550  \\$wg$aVibrio
=550  \\$wh$aVibrio cholerae non-O1
=550  \\$wh$aVibrio cholerae O1
=550  \\$wh$aVibrio cholerae O139
=667  \\$ainfection = CHOLERA
=680  \\$iThe etiologic agent of CHOLERA.
=688  \\$a76; was VIBRIO COMMA 1972-75 (Prov 1972-73)
=750  \0$aVibrio cholerae$5IEN$0(DLC)sh 85143142

=LDR  01052cz  a2200253n  4500
=001  9880364040202441
=005  20141212210644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014733
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x859
=072  \\$aB3.$x660.$x250.$x830.$x830
=150  \\$aVibrio
=450  \\$aBeneckea
=550  \\$wg$aVibrionaceae
=550  \\$wh$aVibrio alginolyticus
=550  \\$wh$aVibrio cholerae
=550  \\$wh$aVibrio mimicus
=550  \\$wh$aVibrio parahaemolyticus
=550  \\$wh$aVibrio vulnificus
=667  \\$aGEN or unspecified; prefer specifics; VIBRIO MARINUS and VIBRIO VISCOSUS see MORITELLA are also available; infection = VIBRIO INFECTIONS
=680  \\$iA genus of VIBRIONACEAE, made up of short, slightly curved, motile, gram-negative rods. Various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle.
=688  \\$a90; BENECKEA was see under VIBRIONACEAE l978-89, was heading 1963-65
=750  \0$aVibrio$5IEN$0(DLC)sh 85143141

=LDR  00668cz  a2200193n  4500
=001  9880364040302441
=005  20141212210644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014732
=035  \\$aCBA8074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x676.$x930
=072  \\$aG1.$x595.$x540.$x930
=150  \\$aVibration
=450  \\$wnnna$aVibrations
=550  \\$wg$aMechanical Processes
=667  \\$abiological and non-biological application
=680  \\$iA continuing periodic change in displacement with respect to a fixed reference. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aVibration$5IEN$0(DLC)sh 85143117

=LDR  01587cz  a2200229n  4500
=001  9880364040402441
=005  20141212210644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014731
=035  \\$aCBA8073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x956.$x858
=150  \\$aVeterinary Service, Military
=450  \\$aMilitary Veterinary Service
=450  \\$wnnna$aMilitary Veterinary Services
=450  \\$wnnna$aService, Military Veterinary
=450  \\$wnnna$aServices, Military Veterinary
=450  \\$wnnna$aVeterinary Services, Military
=550  \\$wg$aVeterinary Medicine
=667  \\$aSPEC: SPEC qualif; specify country; DF: VET SERV MILITARY
=680  \\$iA corps of the armed services concerned with animal medicine, the chief interest of which is the care of government-owned working dogs (as in the military police units), working horses (as in state funerals), and working military dolphins (as in undersea exploration and other activities). In the United States Army Veterinary Corps animal medicine overlaps and interconnects with biomedical research using laboratory research animals. A related activity is laboratory animal care. The Corps provides limited care for privately owned animals of military personnel through non-appropriated funds. Military service veterinarians in the United States Army must be graduates of accredited veterinary schools and must have a state license. (Telephone communication with Lt. Col. William Inskeep II, U.S. Army Veterinary Corps, October 4, 1994)
=750  \0$aVeterinary service, Military$5IEN$0(DLC)sh 85143078

=LDR  00998cz  a2200241n  4500
=001  9880364040502441
=005  20141212210643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014730
=035  \\$aCBA8072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x956
=150  \\$aVeterinary Medicine
=450  \\$aMedicine, Veterinary
=550  \\$wg$aHealth Occupations
=550  \\$wh$aPathology, Veterinary
=550  \\$wh$aSurgery, Veterinary
=550  \\$wh$aVeterinary Service, Military
=550  \\$wh$aVeterinary Sports Medicine
=550  \\$aAnimal Husbandry
=667  \\$aSPEC only: SPEC qualif; prefer /vet with diseases & techniques: Manual 19.7+, 19.8.81; indexing policy: Manual 23.33+; /legislation & jurisprudence = LEGISLATION, VETERINARY or VETERINARY MEDICINE (IM) + JURISPRUDENCE (IM); DF: VET MED
=680  \\$iThe medical science concerned with the prevention, diagnosis, and treatment of diseases in animals.
=750  \0$aVeterinary medicine$5IEN-HS$0(DLC)sh 85143046

=LDR  00582cz  a2200217n  4500
=001  9880364040602441
=005  20141212192620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014728
=035  \\$aCBA8070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x930
=150  \\$aVeterans
=450  \\$wnnna$aVeteran
=550  \\$wg$aPersons
=550  \\$aMilitary Family
=550  \\$aMilitary Personnel
=550  \\$aVeterans Health
=680  \\$iFormer members of the armed services.
=688  \\$a81; was VETERANS AFFAIRS 1963-80
=750  \0$aVeterans$5IEN$0(DLC)sh 85142973

=LDR  00871cz  a2200205n  4500
=001  9880364040702441
=005  20141212210643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014727
=035  \\$aCBA8069HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x550.$x800
=072  \\$aE6.$x645.$x550.$x800
=150  \\$aVestibuloplasty
=450  \\$wnnna$aVestibuloplasties
=550  \\$wg$aOral Surgical Procedures, Preprosthetic
=667  \\$arefers to the oral cavity, not to the vestib appar; do not use /util except by MeSH definition
=680  \\$iThose procedures designed to widen the zone of attached gingiva and deepen the vestibular depth which will facilitate the clearance of the area for natural food passage, and provide access for toothbrushing and interdental stimulation.
=688  \\$a72(69)
=750  \0$aVestibuloplasty$5IEN$0(DLC)sh 85142956

=LDR  01143cz  a2200301n  4500
=001  9880364040802441
=005  20141212210643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014726
=035  \\$aCBA8068HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x800
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x800
=150  \\$aVestibular Nuclei
=450  \\$wnnna$aMedial Vestibular Nucleus
=450  \\$wnnna$aNuclei, Vestibular
=450  \\$wnnna$aNucleus, Medial Vestibular
=450  \\$wnnna$aNucleus, Schwalbe
=450  \\$wnnna$aNucleus, Schwalbe's
=450  \\$aSchwalbe Nucleus
=450  \\$wnnna$aSchwalbe's Nucleus
=450  \\$wnnna$aSchwalbes Nucleus
=450  \\$aVestibular Nucleus, Medial
=550  \\$wg$aPons
=550  \\$wh$aVestibular Nucleus, Lateral
=680  \\$iThe four cellular masses in the floor of the fourth ventricle giving rise to a widely dispersed special sensory system. Included is the superior, medial, inferior, and LATERAL VESTIBULAR NUCLEUS. (From Dorland, 27th ed)
=688  \\$a1967(1965)
=750  \0$aVestibular nuclei$5IEN$0(DLC)sh 85142955

=LDR  01281cz  a2200265n  4500
=001  9880364040902441
=005  20141212210642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014725
=035  \\$aCBA8067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x910.$x900
=150  \\$aVestibular Nerve
=450  \\$wnnna$aGanglion, Scarpa's
=450  \\$wnnna$aNerve, Vestibular
=450  \\$wnnna$aNerves, Vestibular
=450  \\$wnnna$aScarpa Ganglion
=450  \\$aScarpa's Ganglion
=450  \\$wnnna$aScarpas Ganglion
=450  \\$wnnna$aVestibular Nerves
=550  \\$wg$aVestibulocochlear Nerve
=667  \\$adis: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM); neopl: coord IM with VESTIBULOCOCHLEAR NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe vestibular part of the 8th cranial nerve (VESTIBULOCOCHLEAR NERVE). The vestibular nerve fibers arise from neurons of Scarpa's ganglion and project peripherally to vestibular hair cells and centrally to the VESTIBULAR NUCLEI of the BRAIN STEM. These fibers mediate the sense of balance and head position.
=688  \\$aSCARPA'S GANGLION was see under VESTIBULAR NERVE 1963-78
=750  \0$aVestibular apparatus$xInnervation$0(IEN)379849$5IEN

=LDR  00828cz  a2200253n  4500
=001  9880364041002441
=005  20141212210642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014724
=035  \\$aCBA8066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x900
=150  \\$aVestibular Function Tests
=450  \\$wnnna$aFunction Test, Vestibular
=450  \\$wnnna$aFunction Tests, Vestibular
=450  \\$wnnna$aTest, Vestibular Function
=450  \\$wnnna$aTests, Vestibular Function
=450  \\$wnnna$aVestibular Function Test
=550  \\$wg$aDiagnostic Techniques, Otological
=550  \\$wh$aCaloric Tests
=550  \\$wh$aElectronystagmography
=550  \\$wh$aHead Impulse Test
=550  \\$aVestibular Evoked Myogenic Potentials
=750  \0$aVestibular function tests$5IEN$0(DLC)sh 85142954

=LDR  01772cz  a2200421n  4500
=001  9880364041102441
=005  20141212210641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014722
=035  \\$aCBA8064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x909
=150  \\$aVestibule, Labyrinth
=450  \\$wnnna$aApparatus, Vestibular
=450  \\$wnnna$aEar Vestibule
=450  \\$wnnna$aEar Vestibules
=450  \\$wnnna$aLabyrinth, Vestibular
=450  \\$wnnna$aLabyrinth Vestibule
=450  \\$wnnna$aLabyrinth Vestibules
=450  \\$wnnna$aLabyrinths, Vestibular
=450  \\$aVestibular Apparatus
=450  \\$wnnna$aVestibular Labyrinth
=450  \\$wnnna$aVestibular Labyrinths
=450  \\$wnnna$aVestibule, Ear
=450  \\$wnnna$aVestibule of Ear
=450  \\$wnnna$aVestibules, Ear
=450  \\$wnnna$aVestibules, Labyrinth
=450  \\$wnnna$aVestibulum Auris
=550  \\$wg$aEar, Inner
=550  \\$wh$aOval Window, Ear
=550  \\$wh$aSaccule and Utricle
=550  \\$wh$aVestibular Aqueduct
=667  \\$adiseases = VESTIBULAR DISEASES
=680  \\$iAn oval, bony chamber of the inner ear, part of the bony labyrinth. It is continuous with bony COCHLEA anteriorly, and SEMICIRCULAR CANALS posteriorly. The vestibule contains two communicating sacs (utricle and saccule) of the balancing apparatus. The oval window on its lateral wall is occupied by the base of the STAPES of the MIDDLE EAR.
=688  \\$a2008 (1979)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Vestibule
=688  \\$a90; was VESTIBULAR APPARATUS 1963-89; ENDOLYMPHATIC DUCT was see under LABYRINTH 1979-89; ENDOLYMPHATIC SAC was see under LABYRINTH 1979-89
=750  \0$aVestibular apparatus$0(DLC) sh 85142952$5IEN

=LDR  00817cz  a2200229n  4500
=001  9880364041202441
=005  20141212210640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014720
=035  \\$aCBA8062HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x160.$x927
=072  \\$aC22.$x905.$x927
=150  \\$aVesicular Exanthema of Swine
=450  \\$wnnna$aSwine Vesicular Exanthema
=450  \\$wnnna$aSwine Vesicular Exanthemas
=550  \\$wg$aCaliciviridae Infections
=550  \\$wg$aSwine Diseases
=667  \\$acaused by a calicivirus; don't forget also SWINE (NIM) & check tag ANIMALS
=680  \\$iA calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia.
=688  \\$a71
=750  \0$aVesicular exanthema of swine$5IEN$0(DLC)sh 85142931

=LDR  01334cz  a2200373n  4500
=001  9880364041302441
=005  20141212192620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014719
=035  \\$aCBA8061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x894.$x767.$x500
=072  \\$aC13.$x351.$x875.$x881.$x312.$x733
=072  \\$aC13.$x351.$x968.$x829.$x548.$x733
=072  \\$aC23.$x300.$x575.$x825.$x250.$x775
=072  \\$aC23.$x300.$x575.$x925.$x816
=150  \\$aVesicovaginal Fistula
=450  \\$wnnna$aFistula, Vesico-Vaginal
=450  \\$wnnna$aFistula, Vesicovaginal
=450  \\$wnnna$aFistulae, Vesico-Vaginal
=450  \\$wnnna$aFistulae, Vesicovaginal
=450  \\$wnnna$aFistulas, Vesico-Vaginal
=450  \\$wnnna$aFistulas, Vesicovaginal
=450  \\$wnnna$aVesico-Vaginal Fistula
=450  \\$wnnna$aVesico Vaginal Fistula
=450  \\$wnnna$aVesico-Vaginal Fistulae
=450  \\$wnnna$aVesico Vaginal Fistulae
=450  \\$wnnna$aVesico-Vaginal Fistulas
=450  \\$wnnna$aVesicovaginal Fistulae
=450  \\$wnnna$aVesicovaginal Fistulas
=550  \\$wg$aUrinary Bladder Fistula
=550  \\$wg$aVaginal Fistula
=680  \\$iAn abnormal anatomical passage between the URINARY BLADDER and the VAGINA.
=750  \0$aFistula, Vesico-vaginal$5IEN$0(DLC)sh 85048906

=LDR  00881cz  a2200229n  4500
=001  9880364041402441
=005  20141212210640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014718
=035  \\$aCBA8060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829.$x920
=072  \\$aC13.$x351.$x968.$x829.$x920
=150  \\$aVesico-Ureteral Reflux
=450  \\$wnnna$aReflux, Vesico-Ureteral
=450  \\$wnnna$aReflux, Vesicoureteral
=450  \\$wnnna$aVesico Ureteral Reflux
=450  \\$wnnna$aVesicoureteral Reflux
=450  \\$wnnna$aVesicoureteral Reflux 1
=550  \\$wg$aUrinary Bladder Diseases
=680  \\$iRetrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve leading to ascending bacterial infection into the KIDNEY.
=750  \0$aVesico-ureteral reflux$5IEN$0(DLC)sh 85142929

=LDR  03422cz  a2200865n  4500
=001  9880364041502441
=005  20141212192619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014717
=035  \\$aCBA8059HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x568.$x900.$x883
=072  \\$aC10.$x597.$x951
=072  \\$aC23.$x888.$x592.$x958
=150  \\$aVertigo
=450  \\$wnnna$aBrain Stem Vertigo
=450  \\$wnnna$aBrain Stem Vertigos
=450  \\$wnnna$aBrainstem Vertigo
=450  \\$wnnna$aBrainstem Vertigos
=450  \\$wnnna$aCentral Nervous System Origin Vertigo
=450  \\$wnnna$aCentral Origin Vertigo
=450  \\$wnnna$aCentral Origin Vertigos
=450  \\$wnnna$aCNS Origin Vertigo
=450  \\$wnnna$aCNS Origin Vertigos
=450  \\$wnnna$aConstant Vertigo
=450  \\$wnnna$aConstant Vertigos
=450  \\$wnnna$aEssential Vertigo
=450  \\$wnnna$aEssential Vertigos
=450  \\$wnnna$aIntermittant Vertigo
=450  \\$wnnna$aIntermittant Vertigos
=450  \\$wnnna$aOrigin Vertigo, Central
=450  \\$wnnna$aOrigin Vertigo, CNS
=450  \\$wnnna$aOrigin Vertigos, Central
=450  \\$wnnna$aOrigin Vertigos, CNS
=450  \\$wnnna$aParoxysmal Vertigo
=450  \\$wnnna$aParoxysmal Vertigos
=450  \\$wnnna$aPeripheral Vertigo
=450  \\$wnnna$aPeripheral Vertigos
=450  \\$wnnna$aPositional Vertigo
=450  \\$wnnna$aSensation, Spinning
=450  \\$wnnna$aSensations, Spinning
=450  \\$wnnna$aSpinning Sensation
=450  \\$wnnna$aSpinning Sensations
=450  \\$wnnna$aSubjective Vertigo
=450  \\$wnnna$aSubjective Vertigos
=450  \\$wnnna$aVertigo, Brain Stem
=450  \\$wnnna$aVertigo, Brainstem
=450  \\$wnnna$aVertigo, Central Nervous System Origin
=450  \\$wnnna$aVertigo, Central Origin
=450  \\$wnnna$aVertigo, CNS Origin
=450  \\$wnnna$aVertigo, Constant
=450  \\$wnnna$aVertigo, Essential
=450  \\$wnnna$aVertigo, Intermittant
=450  \\$wnnna$aVertigo, Paroxysmal
=450  \\$wnnna$aVertigo, Peripheral
=450  \\$wnnna$aVertigo, Positional
=450  \\$wnnna$aVertigo, Subjective
=450  \\$wnnna$aVertigos
=450  \\$wnnna$aVertigos, Brain Stem
=450  \\$wnnna$aVertigos, Brainstem
=450  \\$wnnna$aVertigos, Central Origin
=450  \\$wnnna$aVertigos, CNS Origin
=450  \\$wnnna$aVertigos, Constant
=450  \\$wnnna$aVertigos, Essential
=450  \\$wnnna$aVertigos, Intermittant
=450  \\$wnnna$aVertigos, Paroxysmal
=450  \\$wnnna$aVertigos, Peripheral
=450  \\$wnnna$aVertigos, Subjective
=550  \\$wg$aNeurologic Manifestations
=550  \\$wg$aVestibular Diseases
=550  \\$wh$aBenign Paroxysmal Positional Vertigo
=550  \\$aDizziness
=667  \\$adifferentiate from DIZZINESS, "sensation of unsteadiness or lightheadedness", but use word of text
=680  \\$iAn illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
=750  \0$aVertigo$5IEN$0(DLC)sh 85142921

=LDR  04122cz  a2200961n  4500
=001  9880364041602441
=005  20141212210639.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014715
=035  \\$aCBA8057HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x150.$x956
=072  \\$aC14.$x907.$x253.$x92.$x956
=072  \\$aC14.$x907.$x253.$x956
=150  \\$aVertebrobasilar Insufficiency
=450  \\$wnnna$aArtery Insufficiencies, Basilar
=450  \\$wnnna$aArtery Insufficiencies, Vertebral
=450  \\$wnnna$aArtery Insufficiency, Basilar
=450  \\$wnnna$aArtery Insufficiency, Vertebral
=450  \\$wnnna$aArtery Ischemia, Basilar
=450  \\$wnnna$aArtery Ischemia, Vertebral
=450  \\$wnnna$aArtery Ischemias, Basilar
=450  \\$wnnna$aArtery Ischemias, Vertebral
=450  \\$wnnna$aArtery Stenoses, Basilar
=450  \\$wnnna$aArtery Stenoses, Vertebral
=450  \\$wnnna$aArtery Stenosis, Basilar
=450  \\$wnnna$aArtery Stenosis, Vertebral
=450  \\$wnnna$aBasilar Artery Insufficiencies
=450  \\$aBasilar Artery Insufficiency
=450  \\$wnnna$aBasilar Artery Ischemia
=450  \\$wnnna$aBasilar Artery Ischemias
=450  \\$wnnna$aBasilar Artery Stenoses
=450  \\$aBasilar Artery Stenosis
=450  \\$wnnna$aBasilar Insufficiencies
=450  \\$wnnna$aBasilar Insufficiency
=450  \\$wnnna$aDolichoectasia, Vertebrobasilar
=450  \\$wnnna$aDolichoectasias, Vertebrobasilar
=450  \\$wnnna$aInsufficiencies, Basilar
=450  \\$wnnna$aInsufficiencies, Basilar Artery
=450  \\$wnnna$aInsufficiencies, Vertebral Artery
=450  \\$wnnna$aInsufficiencies, Vertebro-Basilar
=450  \\$wnnna$aInsufficiencies, Vertebrobasilar
=450  \\$wnnna$aInsufficiency, Basilar
=450  \\$wnnna$aInsufficiency, Basilar Artery
=450  \\$wnnna$aInsufficiency, Vertebral Artery
=450  \\$wnnna$aInsufficiency, Vertebro-Basilar
=450  \\$wnnna$aInsufficiency, Vertebrobasilar
=450  \\$wnnna$aIschemia, Basilar Artery
=450  \\$wnnna$aIschemia, Vertebral Artery
=450  \\$wnnna$aIschemia, Vertebro-Basilar
=450  \\$wnnna$aIschemia, Vertebrobasilar
=450  \\$wnnna$aIschemias, Basilar Artery
=450  \\$wnnna$aIschemias, Vertebral Artery
=450  \\$wnnna$aIschemias, Vertebro-Basilar
=450  \\$wnnna$aIschemias, Vertebrobasilar
=450  \\$wnnna$aStenoses, Basilar Artery
=450  \\$wnnna$aStenoses, Vertebral Artery
=450  \\$wnnna$aStenosis, Basilar Artery
=450  \\$wnnna$aStenosis, Vertebral Artery
=450  \\$wnnna$aVertebral Artery Insufficiencies
=450  \\$aVertebral Artery Insufficiency
=450  \\$wnnna$aVertebral Artery Ischemia
=450  \\$wnnna$aVertebral Artery Ischemias
=450  \\$wnnna$aVertebral Artery Stenoses
=450  \\$aVertebral Artery Stenosis
=450  \\$wnnna$aVertebro-Basilar Insufficiencies
=450  \\$wnnna$aVertebro-Basilar Insufficiency
=450  \\$wnnna$aVertebro Basilar Insufficiency
=450  \\$wnnna$aVertebro-Basilar Ischemia
=450  \\$wnnna$aVertebro Basilar Ischemia
=450  \\$wnnna$aVertebro-Basilar Ischemias
=450  \\$wnnna$aVertebrobasilar Dolichoectasia
=450  \\$wnnna$aVertebrobasilar Dolichoectasias
=450  \\$wnnna$aVertebrobasilar Insufficiencies
=450  \\$wnnna$aVertebrobasilar Ischemia
=450  \\$wnnna$aVertebrobasilar Ischemias
=550  \\$wg$aBrain Ischemia
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wh$aSubclavian Steal Syndrome
=667  \\$aBRACHIAL-BASILAR INSUFFICIENCY SYNDROME see SUBCLAVIAN STEAL SYNDROME is available
=680  \\$iLocalized or diffuse reduction in blood flow through the vertebrobasilar arterial system, which supplies the BRAIN STEM; CEREBELLUM; OCCIPITAL LOBE; medial TEMPORAL LOBE; and THALAMUS. Characteristic clinical features include SYNCOPE; lightheadedness; visual disturbances; and VERTIGO. BRAIN STEM INFARCTIONS or other BRAIN INFARCTION may be associated.
=688  \\$a1980
=750  \0$aVertebrobasilar insufficiency$5IEN$0(DLC)sh 85142907

=LDR  00809cz  a2200241n  4500
=001  9880364041702441
=005  20141212210638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014714
=035  \\$aCBA8056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900
=150  \\$aVertebrates
=450  \\$wnnna$aVertebrate
=550  \\$wg$aChordata
=550  \\$wh$aAmphibians
=550  \\$wh$aBirds
=550  \\$wh$aFishes
=550  \\$wh$aMammals
=550  \\$wh$aReptiles
=667  \\$aavoid: too general; prefer specific classes, orders, families & genera; IM; qualif permitted
=680  \\$iAnimals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.
=750  \0$aVertebrates$5IEN$0(DLC)sh 85142902

=LDR  00668cz  a2200193n  4500
=001  9880364041902441
=005  20141212210637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014711
=035  \\$aCBA8053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x955
=150  \\$aVertebral Artery
=450  \\$wnnna$aArteries, Vertebral
=450  \\$wnnna$aArtery, Vertebral
=450  \\$wnnna$aVertebral Arteries
=550  \\$wg$aArteries
=680  \\$iThe first branch of the SUBCLAVIAN ARTERY with distribution to muscles of the NECK; VERTEBRAE; SPINAL CORD; CEREBELLUM; and interior of the CEREBRUM.
=750  \0$aVertebral artery$5IEN$0(DLC)sh 85142896

=LDR  00971cz  a2200277n  4500
=001  9880364042002441
=005  20141212210637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014710
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x996
=150  \\$aVersion, Fetal
=450  \\$wnnna$aCephalic Version, External
=450  \\$wnnna$aCephalic Versions, External
=450  \\$aExternal Cephalic Version
=450  \\$wnnna$aExternal Cephalic Versions
=450  \\$aFetal Version
=450  \\$wnnna$aFetal Versions
=450  \\$aVersion, External Cephalic
=450  \\$wnnna$aVersions, External Cephalic
=450  \\$wnnna$aVersions, Fetal
=550  \\$wg$aDelivery, Obstetric
=550  \\$aLabor Presentation
=680  \\$iThe artificial alteration of the fetal position to facilitate birth.
=688  \\$a91(81); was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80
=750  \0$aVersion (Obstetrics)$5IEN-M$0(DLC)sh 85142885

=LDR  00646cz  a2200217n  4500
=001  9880364042102441
=005  20141212210636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014706
=035  \\$aCBA8048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x952
=150  \\$aVerbal Learning
=450  \\$wnnna$aLearning, Verbal
=450  \\$wnnna$aLearnings, Verbal
=450  \\$wnnna$aVerbal Learnings
=550  \\$wg$aLearning
=550  \\$wh$aPaired-Associate Learning
=550  \\$wh$aSerial Learning
=680  \\$iLearning to respond verbally to a verbal stimulus cue.
=750  \0$aVerbal learning$5IEN$0(DLC)sh 85142799

=LDR  00663cz  a2200229n  4500
=001  9880364042202441
=005  20141212210636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014705
=035  \\$aCBA8047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x908
=150  \\$aVerbal Behavior
=450  \\$wnnna$aBehavior, Verbal
=450  \\$wnnna$aBehaviors, Verbal
=450  \\$wnnna$aVerbal Behaviors
=550  \\$wg$aCommunication
=550  \\$wh$aSpeech
=550  \\$aSpeech
=680  \\$iIncludes both producing and responding to words, either written or spoken.
=688  \\$a66(64)
=750  \0$aVerbal behavior$5IEN$0(DLC)sh 85142797

=LDR  01485cz  a2200325n  4500
=001  9880364042302441
=005  20180820132713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x615.$x625.$x920
=150  \\$aVeratrum
=450  \\$wnnna$aBlack Hellebore
=450  \\$wnnna$aBlack Hellebores
=450  \\$wnnna$aFalse Hellebore
=450  \\$wnnna$aFalse Hellebores
=450  \\$aHellebore, Black
=450  \\$aHellebore, False
=450  \\$aHellebore, White
=450  \\$wnnna$aHellebores, Black
=450  \\$wnnna$aHellebores, False
=450  \\$wnnna$aHellebores, White
=450  \\$wnnna$aVeratrums
=450  \\$wnnna$aWhite Hellebore
=450  \\$wnnna$aWhite Hellebores
=550  \\$wg$aMelanthiaceae
=667  \\$aplant only; VERATRUM ALKALOIDS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE with roots that contain VERATRUM ALKALOIDS used as emetics, parasiticides, antihypertensives. It is the main ingredient of Boicil.
=688  \\$a91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77
=750  \0$aFalse hellebores$0(DLC) sh 85142792$5IEN

=LDR  00509cz  a2200193n  4500
=001  9880364042402441
=005  20141212210635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014702
=035  \\$aCBA8044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x920.$x256.$x815
=072  \\$aD3.$x549.$x256.$x815
=150  \\$aVeratrine
=450  \\$wnnna$aCevadine
=550  \\$wg$aCevanes
=667  \\$ado not confuse with VERATRIDINE
=688  \\$a73(63)
=750  \0$aVeratrine$5IEN$0(DLC)sh 85142791

=LDR  01044cz  a2200349n  4500
=001  9880364042502441
=005  20141212210634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014700
=035  \\$aCBA8042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x953
=150  \\$aVerapamil
=450  \\$wnnna$aCalan
=450  \\$wnnna$aCordilox
=450  \\$wnnna$aDexverapamil
=450  \\$wnnna$aFalicard
=450  \\$wnnna$aFinoptin
=450  \\$wnnna$aHydrochloride, Verapamil
=450  \\$aIproveratril
=450  \\$wnnna$aIsoptin
=450  \\$wnnna$aIsoptine
=450  \\$wnnna$aIzoptin
=450  \\$wnnna$aLekoptin
=450  \\$wnnna$aSandoz Brand of Verapamil
=450  \\$wnnna$aVerapamil Hydrochloride
=450  \\$wnnna$aVerapamil Sandoz Brand
=550  \\$wg$aPhenethylamines
=550  \\$wh$aGallopamil
=680  \\$iA calcium channel blocker that is a class IV anti-arrhythmia agent.
=688  \\$a84; was IPROVERATRIL 1964-83 (Prov 1964-71)
=750  \0$aVerapamil$5IEN$0(DLC)sh 93000011

=LDR  00898cz  a2200253n  4500
=001  9880364042602441
=005  20141212210633.0
=008  870318\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014696
=035  \\$aCBA8038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x188.$x957
=072  \\$aE4.$x525.$x170.$x860
=150  \\$aVentriculostomy
=450  \\$wnnna$aVentriculocisternostomies
=450  \\$aVentriculocisternostomy
=450  \\$wnnna$aVentriculostomies
=550  \\$wg$aCerebrospinal Fluid Shunts
=550  \\$aCerebral Ventricles
=550  \\$aCisterna Magna
=667  \\$arefers to cerebral ventricles only, not heart nor stomach; do not use /util except by MeSH definition
=680  \\$iSurgical creation of an opening in a cerebral ventricle.
=688  \\$a91(88); was see under CEREBROSPINAL FLUID SHUNTS 1988-90
=750  \0$aVentriculocisternostomy$5IEN$0(DLC)sh 85142756

=LDR  01219cz  a2200277n  4500
=001  9880364042702441
=005  20141212210633.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014695
=035  \\$aCBA8037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x190
=072  \\$aE1.$x370.$x350.$x700.$x560.$x190
=072  \\$aE1.$x370.$x376.$x537.$x750.$x190
=072  \\$aE5.$x629.$x937.$x190
=150  \\$aCerebral Ventriculography
=450  \\$aCerebral Ventricles$xradiography
=450  \\$wnnna$aCerebral Ventriculographies
=450  \\$wnnna$aVentriculographies, Cerebral
=450  \\$aVentriculography, Cerebral
=550  \\$wg$aNeuroradiography
=550  \\$aCerebral Ventricles
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL VENTRICULOGR
=680  \\$iRadiography of the ventricular system of the brain after injection of air or other contrast medium directly into the cerebral ventricles. It is used also for x-ray computed tomography of the cerebral ventricles.
=688  \\$a90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76
=750  \0$aBrain$xVentricles$xRadiography$5IEN$0(DLC)sh 85022112

=LDR  01038cz  a2200217n  4500
=001  9880364042802441
=005  20141212210632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014693
=035  \\$aCBA8035HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x922
=072  \\$aC23.$x550.$x73.$x922
=150  \\$aVentricular Fibrillation
=450  \\$wnnna$aFibrillation, Ventricular
=450  \\$wnnna$aFibrillations, Ventricular
=450  \\$wnnna$aVentricular Fibrillations
=550  \\$wg$aArrhythmias, Cardiac
=667  \\$adoes not confuse with VENTRICULAR FLUTTER
=680  \\$iA potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
=750  \0$aVentricular fibrillation$5IEN$0(DLC)sh 85142753

=LDR  01212cz  a2200361n  4500
=001  9880364042902441
=005  20141212205306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012122
=035  \\$aCBA8034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x950
=150  \\$aVentilators, Mechanical
=450  \\$wnnna$aMechanical Ventilator
=450  \\$wnnna$aMechanical Ventilators
=450  \\$wnnna$aPulmonary Ventilator
=450  \\$wnnna$aPulmonary Ventilators
=450  \\$wnnna$aRespirator
=450  \\$aRespirators
=450  \\$wnnna$aVentilator
=450  \\$wnnna$aVentilator, Mechanical
=450  \\$wnnna$aVentilator, Pulmonary
=450  \\$wnnna$aVentilators
=450  \\$aVentilators, Pulmonary
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aVentilators, Negative-Pressure
=550  \\$aLiquid Ventilation
=550  \\$aRespiration, Artificial
=550  \\$aVentilator-Induced Lung Injury
=667  \\$aassociated with PNEUMONIA = PNEUMONIA, VENTILATOR-ASSOCIATED
=680  \\$iMechanical devices used to produce or assist pulmonary ventilation.
=688  \\$a89; was RESPIRATORS 1963-88
=750  \0$aRespirators (Medical equipment)$5IEN$0(DLC)sh 97008479

=LDR  00952cz  a2200265n  4500
=001  9880364043002441
=005  20141212210632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014692
=035  \\$aCBA8032HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x650.$x900
=072  \\$aG9.$x772.$x920
=150  \\$aVentilation-Perfusion Ratio
=450  \\$wnnna$aRatio, Ventilation-Perfusion
=450  \\$wnnna$aRatios, Ventilation-Perfusion
=450  \\$wnnna$aVentilation Perfusion Ratio
=450  \\$wnnna$aVentilation-Perfusion Ratios
=550  \\$wg$aPulmonary Gas Exchange
=550  \\$wg$aRespiratory Physiological Phenomena
=550  \\$aPulmonary Circulation
=667  \\$aa resp funct test
=680  \\$iThe ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. (Stedman, 25th ed)
=688  \\$a70(68)
=750  \0$aVentilation-perfusion ratio$5IEN$0(DLC)sh 85142750

=LDR  00745cz  a2200193n  4500
=001  9880364043102441
=005  20141212210632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014691
=035  \\$aCBA8031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x520
=150  \\$aVentilation
=450  \\$wnnna$aVentilations
=550  \\$wg$aEnvironment, Controlled
=550  \\$aConfined Spaces
=667  \\$aenvironment, not lungs ( = PULMONARY VENTILATION)
=680  \\$iSupplying a building or house, their rooms and corridors, with fresh air. The controlling of the environment thus may be in public or domestic sites and in medical or non-medical locales. (From Dorland, 28th ed)
=750  \0$aVentilation$5IEN$0(DLC)sh 85142747

=LDR  01216cz  a2200313n  4500
=001  9880364043202441
=005  20141212210631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014690
=035  \\$aCBA8030HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380.$x76.$x732
=150  \\$aVenous Pressure
=450  \\$aBlood Pressure, Venous
=450  \\$wnnna$aBlood Pressures, Venous
=450  \\$wnnna$aPressure, Venous
=450  \\$wnnna$aPressure, Venous Blood
=450  \\$wnnna$aPressures, Venous
=450  \\$wnnna$aPressures, Venous Blood
=450  \\$wnnna$aVenous Blood Pressure
=450  \\$wnnna$aVenous Blood Pressures
=450  \\$wnnna$aVenous Pressures
=550  \\$wg$aBlood Pressure
=550  \\$wh$aCentral Venous Pressure
=550  \\$wh$aPortal Pressure
=667  \\$aIM GEN only; NIM for pressure within a specific vessel; CENTRAL VENOUS PRESSURE & PORTAL PRESSURE are also available; venous hypertension: index under VENOUS PRESSURE (IM) & do not coord with HYPERTENSION
=680  \\$iThe blood pressure in the VEINS. It is usually measured to assess the filling PRESSURE to the HEART VENTRICLE.
=688  \\$a70
=750  \0$aVenous pressure$5IEN$0(DLC)sh 85142744

=LDR  01024cz  a2200241n  4500
=001  9880364043302441
=005  20141212210631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014689
=035  \\$aCBA8029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x952
=150  \\$aVenous Insufficiency
=450  \\$wnnna$aInsufficiencies, Venous
=450  \\$wnnna$aInsufficiency, Venous
=450  \\$wnnna$aVenous Insufficiencies
=550  \\$wg$aVascular Diseases
=550  \\$wh$aPostphlebitic Syndrome
=550  \\$wh$aPostthrombotic Syndrome
=667  \\$ageneral or unspecified but usually of the legs; coordinate IM with specific vein (IM) or organ /blood supply (IM) if pertinent
=680  \\$iImpaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.
=688  \\$a73
=750  \0$aVenous insufficiency$5IEN$0(DLC)sh 85142743

=LDR  01263cz  a2200301n  4500
=001  9880364043402441
=005  20141212210631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014688
=035  \\$aCBA8028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x935
=072  \\$aD20.$x888
=072  \\$aD23.$x946.$x833
=150  \\$aVenoms
=450  \\$wnnna$aVenom
=550  \\$wg$aBodily Secretions
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aToxins, Biological
=550  \\$wh$aAmphibian Venoms
=550  \\$wh$aArthropod Venoms
=550  \\$wh$aCnidarian Venoms
=550  \\$wh$aFish Venoms
=550  \\$wh$aMollusk Venoms
=550  \\$wh$aSnake Venoms
=667  \\$ageneral or unspecified only: prefer specifics; coordinate with the animal producing the venom but many specific precoordinated venom terms are available (AMPHIBIAN VENOMS; ARTHROPOD VENOMS; SNAKE VENOMS & its indentions, etc.)
=680  \\$iPoisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator.
=750  \0$aVenom$5IEN$0(DLC)sh 85142740

=LDR  00532cz  a2200181n  4500
=001  9880364043502441
=005  20141212210630.0
=008  820430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014686
=035  \\$aCBA8026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x909
=150  \\$aVenereology
=550  \\$wg$aMedicine
=667  \\$aSPEC: SPEC qualif; DF: VENEREOL
=680  \\$iA branch of medicine which deals with sexually transmitted disease.
=688  \\$a83
=750  \0$aSexually transmitted diseases$5IEN$0(DLC)sh 85142634

=LDR  00608cz  a2200205n  4500
=001  9880364043602441
=005  20141212210629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014684
=035  \\$aCBA8024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x949
=150  \\$aVenae Cavae
=450  \\$wnnna$aCavae, Venae
=550  \\$wg$aVeins
=550  \\$wh$aVena Cava, Inferior
=550  \\$wh$aVena Cava, Superior
=667  \\$atry to specify VENA CAVA, INFERIOR or VENA CAVA, SUPERIOR
=680  \\$iThe inferior and superior venae cavae.
=750  \0$aVenae cavae$5IEN$0(DLC)sh 85142597

=LDR  00622cz  a2200193n  4500
=001  9880364043702441
=005  20141212210629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014683
=035  \\$aCBA8023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x949.$x815
=150  \\$aVena Cava, Superior
=450  \\$wnnna$aSuperior Vena Cava
=450  \\$wnnna$aSuperior Vena Cavas
=450  \\$wnnna$aVena Cavas, Superior
=550  \\$wg$aVenae Cavae
=680  \\$iThe venous trunk which returns blood from the head, neck, upper extremities and chest.
=750  \0$aVena cava superior$5IEN$0(DLC)sh 85142600

=LDR  00642cz  a2200193n  4500
=001  9880364043802441
=005  20141212210629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014682
=035  \\$aCBA8022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x949.$x648
=150  \\$aVena Cava, Inferior
=450  \\$wnnna$aInferior Vena Cava
=450  \\$wnnna$aInferior Vena Cavas
=450  \\$wnnna$aVena Cavas, Inferior
=550  \\$wg$aVenae Cavae
=680  \\$iThe venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.
=750  \0$aVena cava inferior$5IEN$0(DLC)sh 85142599

=LDR  00901cz  a2200277n  4500
=001  9880364043902441
=005  20141212210601.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014604
=035  \\$aCBA7942M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x364.$x978
=072  \\$aC11.$x319.$x494
=072  \\$aC11.$x941.$x855
=150  \\$aUveal Neoplasms
=450  \\$wnnna$aNeoplasm, Uveal
=450  \\$wnnna$aNeoplasms, Uveal
=450  \\$wnnna$aUveal Neoplasm
=550  \\$wg$aEye Neoplasms
=550  \\$wg$aUveal Diseases
=550  \\$wh$aChoroid Neoplasms
=550  \\$wh$aIris Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); CHOROID NEOPLASMS & IRIS NEOPLASMS are also available
=680  \\$iTumors or cancer of the UVEA.
=688  \\$a81
=750  \0$aUvea$xCancer$0(DLC)sh2010010503$5IEN-M

=LDR  00743cz  a2200265n  4500
=001  9880364044002441
=005  20141212210600.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014603
=035  \\$aCBA7941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941
=150  \\$aUveal Diseases
=450  \\$wnnna$aDisease, Uveal
=450  \\$wnnna$aDiseases, Uveal
=450  \\$wnnna$aUveal Disease
=550  \\$wg$aEye Diseases
=550  \\$wh$aChoroid Diseases
=550  \\$wh$aIris Diseases
=550  \\$wh$aUveal Neoplasms
=550  \\$wh$aUveitis
=667  \\$ainflamm dis = UVEITIS & specifics
=680  \\$iDiseases of the uvea.
=688  \\$a76; was NON MESH before 1976
=750  \0$aUvea$xDiseases$5IEN$0(DLC)sh 85141647

=LDR  00978cz  a2200229n  4500
=001  9880364044102441
=005  20141212210600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014602
=035  \\$aCBA7940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x894
=150  \\$aUvea
=450  \\$wnnna$aUveas
=550  \\$wg$aEye
=550  \\$wh$aBlood-Aqueous Barrier
=550  \\$wh$aChoroid
=550  \\$wh$aCiliary Body
=550  \\$wh$aIris
=667  \\$aanterior uvea = IRIS + CILIARY BODY, posterior uvea = CHOROID; uveal neopl = UVEAL NEOPLASMS; anterior uveal neopl = UVEAL NEOPLASMS (IM) + CILIARY BODY (IM) + IRIS NEOPLASMS (IM), posterior uveal neopl = CHOROID NEOPLASMS; inflammation = UVEITIS & many specifics
=680  \\$iThe pigmented vascular coat of the eyeball, consisting of the CHOROID; CILIARY BODY; and IRIS, which are continuous with each other. (Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aUvea$5IEN$0(DLC)sh 85141646

=LDR  00386cz  a2200157n  4500
=001  9880364044202441
=005  20141212210600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014601
=035  \\$aCBA7939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x884
=150  \\$aUtopias
=450  \\$wnnna$aUtopia
=550  \\$wg$aPhilosophy
=750  \0$aUtopias$5IEN$0(DLC)sh 85141635

=LDR  01024cz  a2200277n  4500
=001  9880364044302441
=005  20141212210600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014600
=035  \\$aCBA7938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761.$x879
=072  \\$aN5.$x700.$x900
=150  \\$aUtilization Review
=450  \\$wnnna$aReview, Utilization
=450  \\$wnnna$aReviews, Utilization
=450  \\$wnnna$aUtilization Reviews
=550  \\$wg$aQuality Assurance, Health Care
=550  \\$wg$aQuality of Health Care
=550  \\$wh$aConcurrent Review
=550  \\$wh$aDrug Utilization Review
=550  \\$aProfessional Staff Committees
=667  \\$aDF: UTIL REV
=680  \\$iAn organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.
=688  \\$a68
=750  \0$aMedical care$xUtilization review$5IEN$0(DLC)sh 86004273

=LDR  01485cz  a2200361n  4500
=001  9880363913202441
=005  20141212205700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012886
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781
=150  \\$aSkull
=360  \\$iconsider also terms at$aCRANI-
=450  \\$aCalvaria
=450  \\$wnnna$aCalvarium
=450  \\$aCranium
=450  \\$wnnna$aSkulls
=550  \\$wg$aBone and Bones
=550  \\$wh$aCranial Fontanelles
=550  \\$wh$aCranial Sutures
=550  \\$wh$aEthmoid Bone
=550  \\$wh$aFacial Bones
=550  \\$wh$aFrontal Bone
=550  \\$wh$aOccipital Bone
=550  \\$wh$aParietal Bone
=550  \\$wh$aPterygopalatine Fossa
=550  \\$wh$aSkull Base
=550  \\$wh$aSphenoid Bone
=550  \\$wh$aTemporal Bone
=550  \\$aHead
=667  \\$abony part of head only; differentiate from HEAD & FACE; "cranial" is SKULL; /abnorm: consider also CRANIOFACIAL ABNORMALITIES; /anat: consider also CEPHALOMETRY; /inj "cranio-cerebral inj" is CRANIOCEREBRAL TRAUMA (or its specifics) only & not also here unless particularly discussed; /surg: consider also CRANIOTOMY & TREPHINING; "craniofacial dysmorphism" or "craniofacial fibrous dysplasia": index under FACIAL BONES (IM) + SKULL (IM) + FIBROUS DYSPLASIA, POLYOSTOTIC (IM)
=680  \\$iThe SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.
=750  \0$aSkull$0(DLC) sh 85123237$5IEN

=LDR  01411cz  a2200265n  4500
=001  9880363913302441
=005  20141212205700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012885
=035  \\$aCBA6201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x803
=072  \\$aE5.$x41.$x124.$x803
=072  \\$aG7.$x100.$x100.$x803
=150  \\$aSkinfold Thickness
=450  \\$wnnna$aSkinfold Thicknesses
=450  \\$wnnna$aThickness, Skinfold
=450  \\$wnnna$aThicknesses, Skinfold
=550  \\$wg$aBody Weights and Measures
=550  \\$aAdipose Tissue
=550  \\$aObesity
=667  \\$aa measurement of body fat; no qualif
=680  \\$iThe measurement of subcutaneous fat located directly beneath the skin by grasping a fold of skin and subcutaneous fat between the thumb and forefinger and pulling it away from the underlying muscle tissue. The thickness of the double layer of skin and subcutaneous tissue is then read with a caliper. The five most frequently measured sites are the upper arm, below the scapula, above the hip bone, the abdomen, and the thigh. Its application is the determination of relative fatness, of changes in physical conditioning programs, and of the percentage of body fat in desirable body weight. (From McArdle, et al., Exercise Physiology, 2d ed, p496-8)
=688  \\$a73(68)
=750  \0$aSkinfold thickness$5IEN$0(DLC)sh 85123200

=LDR  00602cz  a2200229n  4500
=001  9880363913402441
=005  20141212205659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012883
=035  \\$aCBA6199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x893
=150  \\$aSkin Ulcer
=450  \\$wnnna$aSkin Ulcers
=450  \\$wnnna$aUlcer, Skin
=450  \\$wnnna$aUlcers, Skin
=550  \\$wg$aSkin Diseases
=550  \\$wh$aBuruli Ulcer
=550  \\$wh$aLeg Ulcer
=550  \\$wh$aPressure Ulcer
=550  \\$wh$aPyoderma Gangrenosum
=750  \0$aSkin$xUlcers$5IEN$0(IEN)378322

=LDR  01023cz  a2200301n  4500
=001  9880363913502441
=005  20141212205659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012882
=035  \\$aCBA6198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x871
=072  \\$aE5.$x200.$x812.$x871
=072  \\$aE5.$x478.$x594.$x890
=150  \\$aSkin Tests
=450  \\$wnnna$aSkin Test
=450  \\$wnnna$aTest, Skin
=450  \\$wnnna$aTests, Skin
=550  \\$wg$aImmunologic Tests
=550  \\$wh$aIntradermal Tests
=550  \\$wh$aLocal Lymph Node Assay
=550  \\$wh$aPassive Cutaneous Anaphylaxis
=550  \\$wh$aPatch Tests
=550  \\$wh$aSkin Window Technique
=550  \\$wh$aTuberculin Test
=667  \\$aNIM
=680  \\$iEpicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.
=750  \0$aSkin tests$5IEN$0(DLC)sh 85123199

=LDR  00888cz  a2200289n  4500
=001  9880363913602441
=005  20161215104243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012880
=035  \\$aCBA6196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x450.$x500
=072  \\$aE1.$x370.$x600.$x620.$x750
=072  \\$aG7.$x100.$x175.$x500
=072  \\$aG13.$x750.$x829.$x833
=072  \\$aG16.$x690.$x890
=150  \\$aSkin Pigmentation
=450  \\$wnnna$aPigmentation, Skin
=450  \\$wnnna$aPigmentations, Skin
=450  \\$wnnna$aSkin Pigmentations
=550  \\$wg$aBody, Physical Appearance
=550  \\$wg$aPigmentation
=550  \\$wg$aSkin Physiological Processes
=550  \\$wh$aSuntan
=680  \\$iColoration of the skin.
=688  \\$a76(75); was see under PIGMENTATION 1963-75
=750  \0$aHuman skin color$5IEN$0(DLC)sh 85028612

=LDR  01820cz  a2200469n  4500
=001  9880363913702441
=005  20141212205658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012879
=035  \\$aCBA6195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG13.$x750
=150  \\$aSkin Physiological Phenomena
=450  \\$wnnna$aConcept, Skin Physiological
=450  \\$wnnna$aConcepts, Skin Physiological
=450  \\$wnnna$aPhenomena, Skin Physiological
=450  \\$wnnna$aPhenomenas, Skin Physiological
=450  \\$wnnna$aPhenomenon, Skin Physiological
=450  \\$wnnna$aPhenomenons, Skin Physiological
=450  \\$wnnna$aPhysiological Concept, Skin
=450  \\$wnnna$aPhysiological Concepts, Skin
=450  \\$wnnna$aPhysiological Phenomena, Skin
=450  \\$wnnna$aPhysiological Phenomenas, Skin
=450  \\$wnnna$aPhysiological Phenomenon, Skin
=450  \\$wnnna$aPhysiological Phenomenons, Skin
=450  \\$wnnna$aPhysiology, Skin
=450  \\$wnnna$aSkin Physiological Concept
=450  \\$wnnna$aSkin Physiological Concepts
=450  \\$wnnna$aSkin Physiological Phenomenas
=450  \\$wnnna$aSkin Physiological Phenomenon
=450  \\$wnnna$aSkin Physiological Phenomenons
=450  \\$aSkin Physiology
=450  \\$aSkin$xphysiology
=550  \\$wg$aIntegumentary System Physiological Phenomena
=550  \\$wh$aSkin Physiological Processes
=550  \\$wh$aSkin Temperature
=667  \\$ageneral or unspecified; prefer specifics; DF: SKIN PHYSIOL
=680  \\$iThe functions of the skin in the human and animal body. It includes the pigmentation of the skin.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Skin Physiology
=688  \\$a98; use explode 1970-97
=750  \0$aSkin$xPhysiology$0(DLC) sh 92003937$5IEN-M

=LDR  01179cz  a2200349n  4500
=001  9880363913802441
=005  20141212205657.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012878
=035  \\$aCBA6194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x805
=072  \\$aC17.$x800.$x882
=150  \\$aSkin Neoplasms
=450  \\$aCancer of Skin
=450  \\$wnnna$aCancer of the Skin
=450  \\$wnnna$aCancer, Skin
=450  \\$wnnna$aCancers, Skin
=450  \\$wnnna$aNeoplasm, Skin
=450  \\$wnnna$aNeoplasms, Skin
=450  \\$aSkin Cancer
=450  \\$wnnna$aSkin Cancers
=450  \\$wnnna$aSkin Neoplasm
=550  \\$wg$aNeoplasms by Site
=550  \\$wg$aSkin Diseases
=550  \\$wh$aAcanthoma
=550  \\$wh$aSebaceous Gland Neoplasms
=550  \\$wh$aSweat Gland Neoplasms
=667  \\$acoord IM with histol type of neoplasm (IM); coord also with site (NIM) if merely locational but for neoplasms of the head or neck, coord IM with HEAD AND NECK NEOPLASMS or specifics (IM)
=680  \\$iTumors or cancer of the SKIN.
=750  \0$aSkin$xTumors$5IEN-M$0(DLC)sh 85123187
=750  \0$aSkin$xCancer$5IEN-HS$0(DLC)sh 85123168

=LDR  01138cz  a2200361n  4500
=001  9880363913902441
=005  20180328092413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012877
=035  \\$aCBA6193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x885
=150  \\$aSkin Manifestations
=450  \\$wnnna$aManifestation, Skin
=450  \\$wnnna$aManifestations, Skin
=450  \\$wnnna$aSkin Manifestation
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aCafe-au-Lait Spots
=550  \\$wh$aCellulite
=550  \\$wh$aEcchymosis
=550  \\$wh$aJaundice
=550  \\$wh$aLivedo Reticularis
=550  \\$wh$aNecrolytic Migratory Erythema
=550  \\$wh$aPallor
=550  \\$wh$aPruritus
=550  \\$wh$aPurpura
=550  \\$wh$aStriae Distensae
=550  \\$aSkin
=550  \\$aSkin Diseases
=667  \\$anot used for indexing since 1989; prior to 1989 used for skin manifest of non-skin diseases
=680  \\$iDermatologic disorders attendant upon non-dermatologic disease or injury.
=688  \\$a65
=750  \0$aCutaneous manifestations of general diseases$5IEN$0(DLC)sh 85034995

=LDR  01334cz  a2200349n  4500
=001  9880363914002441
=005  20141212205656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012874
=035  \\$aCBA6190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800
=072  \\$aC17.$x800.$x838
=150  \\$aSkin Diseases, Infectious
=450  \\$wnnna$aDisease, Infectious Skin
=450  \\$wnnna$aDiseases, Infectious Skin
=450  \\$wnnna$aInfectious Skin Disease
=450  \\$wnnna$aInfectious Skin Diseases
=450  \\$wnnna$aSkin Disease, Infectious
=550  \\$wg$aInfection
=550  \\$wg$aSkin Diseases
=550  \\$wh$aCellulitis
=550  \\$wh$aDermatomycoses
=550  \\$wh$aParonychia
=550  \\$wh$aSkin Diseases, Bacterial
=550  \\$wh$aSkin Diseases, Parasitic
=550  \\$wh$aSkin Diseases, Viral
=550  \\$aSoft Tissue Infections
=667  \\$aGEN or unspecified; prefer specifics; coord IM with specific infect dis (IM) + site (NIM) but note precoord site terms in note on SKIN DISEASES; bacterial = SKIN DISEASES, BACTERIAL, viral = SKIN DISEASES, VIRAL, parasitic = SKIN DISEASES, PARASITIC, fungal = DERMATOMYCOSES
=680  \\$iSkin diseases caused by bacteria, fungi, parasites, or viruses.
=688  \\$a68
=750  \0$aSkin$xInfections$5IEN$0(DLC)sh 85123180

=LDR  02938cz  a2200817n  4500
=001  9880363914102441
=005  20141212205653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012871
=035  \\$aCBA6187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800
=150  \\$aSkin Diseases
=450  \\$aDermatoses
=450  \\$wnnna$aDermatosis
=450  \\$wnnna$aDisease, Skin
=450  \\$wnnna$aDiseases, Skin
=450  \\$wnnoa$aSkin Appendage Diseases$5IEN-HS
=450  \\$wnnna$aSkin Disease
=550  \\$wg$aSkin and Connective Tissue Diseases
=550  \\$wh$aAcneiform Eruptions
=550  \\$wh$aAngiolymphoid Hyperplasia with Eosinophilia
=550  \\$wh$aBreast Diseases
=550  \\$wh$aCutaneous Fistula
=550  \\$wh$aDermatitis
=550  \\$wh$aDermatomyositis
=550  \\$wh$aErythema
=550  \\$wh$aExanthema
=550  \\$wh$aFacial Dermatoses
=550  \\$wh$aFoot Diseases
=550  \\$wh$aHair Diseases
=550  \\$wh$aHand Dermatoses
=550  \\$wh$aKeratoacanthoma
=550  \\$wh$aKeratosis
=550  \\$wh$aLeg Dermatoses
=550  \\$wh$aLipomatosis
=550  \\$wh$aLupus Erythematosus, Cutaneous
=550  \\$wh$aMastocytosis
=550  \\$wh$aMorgellons Disease
=550  \\$wh$aNail Diseases
=550  \\$wh$aNecrobiotic Disorders
=550  \\$wh$aNecrolytic Migratory Erythema
=550  \\$wh$aNephrogenic Fibrosing Dermopathy
=550  \\$wh$aPanniculitis
=550  \\$wh$aPhotosensitivity Disorders
=550  \\$wh$aPigmentation Disorders
=550  \\$wh$aPrurigo
=550  \\$wh$aPruritus
=550  \\$wh$aPyoderma
=550  \\$wh$aRosacea
=550  \\$wh$aScalp Dermatoses
=550  \\$wh$aScleredema Adultorum
=550  \\$wh$aScleroderma, Localized
=550  \\$wh$aScleroderma, Systemic
=550  \\$wh$aSebaceous Gland Diseases
=550  \\$wh$aSkin Abnormalities
=550  \\$wh$aSkin Diseases, Eczematous
=550  \\$wh$aSkin Diseases, Genetic
=550  \\$wh$aSkin Diseases, Infectious
=550  \\$wh$aSkin Diseases, Metabolic
=550  \\$wh$aSkin Diseases, Papulosquamous
=550  \\$wh$aSkin Diseases, Vascular
=550  \\$wh$aSkin Diseases, Vesiculobullous
=550  \\$wh$aSkin Neoplasms
=550  \\$wh$aSkin Ulcer
=550  \\$wh$aSweat Gland Diseases
=550  \\$wh$aXanthogranuloma, Juvenile
=550  \\$aDermatology
=667  \\$aGEN: prefer specifics; X ref DERMATOSES is sometimes used loosely for "dermatitis", strictly speaking an inflamm dis: check text carefully; /drug ther: consider also DERMATOLOGIC AGENTS; inflamm dis = DERMATITIS & its specifics; dryness of skin goes here: do not interpret as XERODERMA see ICHTHYOSIS without clues from text; also available are FACIAL DERMATOSES; FOOT DERMATOSES; HAND DERMATOSES; LEG DERMATOSES & SCALP DERMATOSES
=688  \\$a65; was see under DERMATOLOGY 1963-64
=750  \0$aSkin$xDiseases$5IEN$0(DLC)sh 85123171

=LDR  01778cz  a2200517n  4500
=001  9880363914202441
=005  20141212192523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012869
=035  \\$aCBA6185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x23.$x500.$x750
=072  \\$aG3.$x787.$x24.$x500.$x750
=072  \\$aG7.$x690.$x725.$x15.$x500.$x750
=072  \\$aG13.$x750.$x829.$x820
=150  \\$aSkin Absorption
=450  \\$wnnna$aAbsorption, Intracutaneous
=450  \\$wnnna$aAbsorption, Intradermal
=450  \\$wnnna$aAbsorption, Percutaneous
=450  \\$aAbsorption, Skin
=450  \\$wnnna$aAbsorption, Transcutaneous
=450  \\$wnnna$aAbsorption, Transdermal
=450  \\$wnnna$aAbsorptions, Intracutaneous
=450  \\$wnnna$aAbsorptions, Intradermal
=450  \\$wnnna$aAbsorptions, Percutaneous
=450  \\$wnnna$aAbsorptions, Skin
=450  \\$wnnna$aAbsorptions, Transcutaneous
=450  \\$wnnna$aAbsorptions, Transdermal
=450  \\$wnnna$aIntracutaneous Absorption
=450  \\$wnnna$aIntracutaneous Absorptions
=450  \\$wnnna$aIntradermal Absorption
=450  \\$wnnna$aIntradermal Absorptions
=450  \\$wnnna$aPercutaneous Absorption
=450  \\$wnnna$aPercutaneous Absorptions
=450  \\$wnnna$aSkin Absorptions
=450  \\$wnnna$aTranscutaneous Absorption
=450  \\$wnnna$aTranscutaneous Absorptions
=450  \\$wnnna$aTransdermal Absorption
=450  \\$wnnna$aTransdermal Absorptions
=550  \\$wg$aAbsorption, Physiological
=550  \\$wg$aSkin Physiological Processes
=550  \\$aAbsorption
=550  \\$aAdministration, Cutaneous
=680  \\$iUptake of substances through the SKIN.
=688  \\$a65
=750  \0$aSkin absorption$5IEN$0(DLC)sh 85123190

=LDR  00992cz  a2200229n  4500
=001  9880363914302441
=005  20141212205652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012867
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA17.$x815
=150  \\$aSkin
=360  \\$iconsider also terms at$aCUTANEOUS$aCUTIS$aDERMAT-
=550  \\$wg$aIntegumentary System
=550  \\$wh$aDermis
=550  \\$wh$aEpidermis
=550  \\$wh$aSebaceous Glands
=550  \\$wh$aSweat Glands
=667  \\$afor animal tissue in wound ther see note on BIOLOGICAL DRESSINGS; inflammation = DERMATITIS & its specifics; dryness of skin: index under SKIN DISEASES & do not interpret as XERODERMA see ICHTHYOSIS without clues from text
=680  \\$iThe outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
=688  \\$a/transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89
=750  \0$aSkin$5IEN$0(DLC)sh 85123164

=LDR  00755cz  a2200217n  4500
=001  9880363914402441
=005  20141212205651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012865
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x787.$x500
=150  \\$aSkiing
=450  \\$wnnna$aSkiing, Snow
=450  \\$wnnna$aSkiings, Snow
=450  \\$wnnna$aSnow Skiing
=450  \\$wnnna$aSnow Skiings
=450  \\$aSnowboarding
=550  \\$wg$aSnow Sports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; does not include water-skiing (index under SPORTS)
=680  \\$iA snow sport which uses skis to glide over the snow. It does not include water-skiing.
=750  \0$aSkis and skiing$5IEN$0(DLC)sh 85123208

=LDR  00696cz  a2200205n  4500
=001  9880363914502441
=005  20141212205651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012863
=035  \\$aCBA6179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835
=150  \\$aSkeleton
=450  \\$wnnna$aSkeletons
=550  \\$wg$aMusculoskeletal System
=550  \\$wh$aBone and Bones
=550  \\$wh$aJoints
=667  \\$athe bony frame as a whole; avoid: use BONE AND BONES; "skeletal" in titles is probably "bone", "bone tissue" or "osseous" which = BONE AND BONES: TN 173; no qualif
=750  \0$aSkeleton$5IEN-M$0(DLC)sh 85123119
=750  \0$aHuman skeleton$5IEN-HS$0(DLC)sh 85062895

=LDR  00893cz  a2200277n  4500
=001  9880363914602441
=005  20141212205650.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012861
=035  \\$aCBA6177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x700
=150  \\$aSkating
=450  \\$aIce Skating
=450  \\$wnnna$aIce Skatings
=450  \\$aRoller-Skating$5IEN
=450  \\$aSkateboarding
=450  \\$wnnna$aSkateboardings
=450  \\$wnnna$aSkating, Ice
=450  \\$wnnna$aSkatings
=450  \\$wnnna$aSkatings, Ice
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iUsing ice skates, roller skates, or skateboards in racing or other competition or for recreation.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aSkating$5IEN-HS$0(DLC)sh 85123105

=LDR  01458cz  a2200313n  4500
=001  9880363914702441
=005  20141212205650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012859
=035  \\$aCBA6175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x154.$x774
=072  \\$aC5.$x799.$x114.$x774
=072  \\$aC7.$x465.$x815.$x929.$x669
=072  \\$aC11.$x496.$x260.$x719
=072  \\$aC17.$x300.$x775.$x99.$x774
=072  \\$aC20.$x111.$x199.$x774
=150  \\$aSjogren's Syndrome
=450  \\$aSicca Syndrome
=450  \\$wnnna$aSjogren Syndrome
=450  \\$wnnna$aSjogrens Syndrome
=450  \\$wnnna$aSyndrome, Sicca
=450  \\$wnnna$aSyndrome, Sjogren's
=550  \\$wg$aArthritis, Rheumatoid
=550  \\$wg$aDry Eye Syndromes
=550  \\$wg$aXerostomia
=667  \\$aa form of rheum arthritis; do not confuse with SJOGREN-LARSSON SYNDROME, a form of ichthyosis; in titles & translations, use diacrit: Sjogren
=680  \\$iChronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
=750  \0$aSjogren's syndrome$5IEN$0(DLC)sh 85123086

=LDR  00655cz  a2200217n  4500
=001  9880363914802441
=005  20141212205649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012858
=035  \\$aCBA6174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x725
=072  \\$aF2.$x463.$x593.$x932.$x869.$x794
=150  \\$aSize Perception
=450  \\$wnnna$aPerception, Size
=450  \\$wnnna$aPerceptions, Size
=450  \\$wnnna$aSize Perceptions
=550  \\$wg$aPerception
=550  \\$wg$aSpace Perception
=680  \\$iThe sensory interpretation of the dimensions of objects.
=750  \0$aSize perception$5IEN$0(DLC)sh 85123076

=LDR  01126cz  a2200241n  4500
=001  9880363914902441
=005  20141212205648.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012854
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x760.$x615.$x750
=150  \\$aSister Chromatid Exchange
=450  \\$wnnna$aChromatid Exchange, Sister
=450  \\$wnnna$aChromatid Exchanges, Sister
=450  \\$wnnna$aExchange, Sister Chromatid
=450  \\$wnnna$aExchanges, Sister Chromatid
=450  \\$wnnna$aSister Chromatid Exchanges
=550  \\$wg$aHomologous Recombination
=550  \\$aChromatids
=550  \\$aCrossing Over, Genetic
=680  \\$iAn exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME.
=688  \\$a85(80); was see under CROSSING OVER (GENETICS) 1980-84
=750  \0$aSister chromatid exchange$5IEN$0(DLC)sh 85123006

=LDR  01231cz  a2200373n  4500
=001  9880363915002441
=005  20141212205648.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012853
=035  \\$aCBA6169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x51.$x374.$x785
=150  \\$aSisomicin
=450  \\$wnnna$a4,5-Dehydrogentamicin
=450  \\$wnnna$a4,5 Dehydrogentamicin
=450  \\$wnnna$a6640, Antibiotic
=450  \\$wnnna$aAntibiotic 6640
=450  \\$wnnna$aExtramycin
=450  \\$wnnna$aPathomycin
=450  \\$wnnna$aRickamicin
=450  \\$wnnna$aSch-13475
=450  \\$wnnna$aSch 13475
=450  \\$wnnna$aSch13475
=450  \\$wnnna$aSiseptin
=450  \\$wnnna$aSisomicin Sulfate
=450  \\$wnnna$aSisomicin Sulfate (2:5) Salt
=450  \\$aSisomycin
=450  \\$aSissomicin
=450  \\$wnnna$aSizomycin
=550  \\$wg$aGentamicins
=550  \\$wh$aNetilmicin
=680  \\$iAntibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS).
=688  \\$a84(75); was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77
=750  \0$aSisomicin$5IEN$0(DLC)sh 90005005

=LDR  00873cz  a2200265n  4500
=001  9880363915102441
=005  20141212205648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012852
=035  \\$aCBA6168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x692.$x752
=072  \\$aC8.$x730.$x749
=072  \\$aC9.$x603.$x692.$x752
=150  \\$aSinusitis
=450  \\$wnnna$aSinusitides
=550  \\$wg$aParanasal Sinus Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aEthmoid Sinusitis
=550  \\$wh$aFrontal Sinusitis
=550  \\$wh$aMaxillary Sinusitis
=550  \\$wh$aSphenoid Sinusitis
=667  \\$ageneral or unspecified; prefer specifics; rhinosinusitis: index RHINITIS + SINUSITIS
=680  \\$iInflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.
=750  \0$aSinusitis$5IEN$0(DLC)sh 85122938

=LDR  02855cz  a2200649n  4500
=001  9880363915202441
=005  20141212205647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012851
=035  \\$aCBA6167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x525.$x425.$x500
=072  \\$aC14.$x907.$x253.$x566.$x350.$x500
=072  \\$aC14.$x907.$x355.$x590.$x213.$x350.$x500
=072  \\$aC14.$x907.$x355.$x830.$x850.$x213.$x350.$x500
=150  \\$aSinus Thrombosis, Intracranial
=450  \\$wnnna$aCranial Sinus Thromboses
=450  \\$aCranial Sinus Thrombosis
=450  \\$wnnna$aIntracranial Sinus Thrombophlebitides
=450  \\$aIntracranial Sinus Thrombophlebitis
=450  \\$wnnna$aIntracranial Sinus Thromboses
=450  \\$wnnna$aIntracranial Sinus Thrombosis
=450  \\$wnnna$aPetrous Sinus Thrombophlebitides
=450  \\$wnnna$aPetrous Sinus Thrombophlebitis
=450  \\$wnnna$aPetrous Sinus Thromboses
=450  \\$aPetrous Sinus Thrombosis
=450  \\$wnnna$aSinus Thrombophlebitides, Intracranial
=450  \\$wnnna$aSinus Thrombophlebitides, Petrous
=450  \\$wnnna$aSinus Thrombophlebitis, Intracranial
=450  \\$wnnna$aSinus Thrombophlebitis, Petrous
=450  \\$wnnna$aSinus Thromboses
=450  \\$wnnna$aSinus Thromboses, Cranial
=450  \\$wnnna$aSinus Thromboses, Intracranial
=450  \\$wnnna$aSinus Thromboses, Petrous
=450  \\$aSinus Thrombosis
=450  \\$wnnna$aSinus Thrombosis, Cranial
=450  \\$wnnna$aSinus Thrombosis, Petrous
=450  \\$wnnna$aThrombophlebitides, Intracranial Sinus
=450  \\$wnnna$aThrombophlebitides, Petrous Sinus
=450  \\$wnnna$aThrombophlebitis, Intracranial Sinus
=450  \\$wnnna$aThrombophlebitis, Petrous Sinus
=450  \\$wnnna$aThromboses, Cranial Sinus
=450  \\$wnnna$aThromboses, Intracranial Sinus
=450  \\$wnnna$aThromboses, Petrous Sinus
=450  \\$wnnna$aThromboses, Sinus
=450  \\$wnnna$aThrombosis, Cranial Sinus
=450  \\$wnnna$aThrombosis, Intracranial Sinus
=450  \\$wnnna$aThrombosis, Petrous Sinus
=450  \\$wnnna$aThrombosis, Sinus
=450  \\$aVenous Sinus Thrombosis, Cranial
=550  \\$wg$aIntracranial Thrombosis
=550  \\$wh$aCavernous Sinus Thrombosis
=550  \\$wh$aLateral Sinus Thrombosis
=550  \\$wh$aSagittal Sinus Thrombosis
=680  \\$iFormation or presence of a blood clot (THROMBUS) in the CRANIAL SINUSES, large endothelium-lined venous channels situated within the SKULL. Intracranial sinuses, also called cranial venous sinuses, include the superior sagittal, cavernous, lateral, petrous sinuses, and many others. Cranial sinus thrombosis can lead to severe HEADACHE; SEIZURE; and other neurological defects.
=688  \\$a2000(1964)
=750  \0$aSinus thrombosis$5IEN$0(DLC)sh 85122937

=LDR  01577cz  a2200409n  4500
=001  9880363915302441
=005  20141212205646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012849
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x409.$x819
=150  \\$aSinoatrial Node
=450  \\$wnnna$aNode, Sino-Atrial
=450  \\$wnnna$aNode, Sinoatrial
=450  \\$wnnna$aNode, Sinu-Atrial
=450  \\$wnnna$aNode, Sinuatrial
=450  \\$wnnna$aNode, Sinus
=450  \\$wnnna$aNodes, Sino-Atrial
=450  \\$wnnna$aNodes, Sinoatrial
=450  \\$wnnna$aNodes, Sinu-Atrial
=450  \\$wnnna$aNodes, Sinuatrial
=450  \\$wnnna$aNodes, Sinus
=450  \\$wnnna$aSino-Atrial Node
=450  \\$wnnna$aSino Atrial Node
=450  \\$wnnna$aSino-Atrial Nodes
=450  \\$wnnna$aSinoatrial Nodes
=450  \\$wnnna$aSinu-Atrial Node
=450  \\$wnnna$aSinu Atrial Node
=450  \\$wnnna$aSinu-Atrial Nodes
=450  \\$aSinuatrial Node
=450  \\$wnnna$aSinuatrial Nodes
=450  \\$aSinus Node
=450  \\$wnnna$aSinus Nodes
=550  \\$wg$aHeart Conduction System
=680  \\$iThe small mass of modified cardiac muscle fibers located at the junction of the superior vena cava (VENA CAVA, SUPERIOR) and right atrium. Contraction impulses probably start in this node, spread over the atrium (HEART ATRIUM) and are then transmitted by the atrioventricular bundle (BUNDLE OF HIS) to the ventricle (HEART VENTRICLE).
=688  \\$a78; was SINO-ATRIAL NODE 1964-77 (Prov 1964-69)
=750  \0$aSinoatrial node$5IEN$0(DLC)sh 85122927

=LDR  01129cz  a2200337n  4500
=001  9880363915402441
=005  20141212192523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012847
=035  \\$aCBA6163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500.$x725
=072  \\$aI1.$x240.$x361.$x500.$x725
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500.$x725
=072  \\$aM1.$x785
=072  \\$aN1.$x224.$x361.$x500.$x725
=072  \\$aN1.$x824.$x308.$x500.$x725
=150  \\$aSingle Person
=450  \\$wnnna$aMaritally Unattached
=450  \\$wnnna$aNever Married
=450  \\$wnnna$aPerson, Single
=450  \\$wnnna$aPersons, Single
=450  \\$wnnna$aSingle Persons
=450  \\$wnnna$aUnmarried
=550  \\$wg$aMarital Status
=550  \\$wg$aPersons
=550  \\$wh$aSingle Parent
=667  \\$a/psychol permitted; does not include "celibacy": CELIBACY see SEXUAL ABSTINENCE; "unwed parent" = PARENTS (IM) + ILLEGITIMACY (IM); SINGLE PARENT is also available
=680  \\$iThe unmarried man or woman.
=688  \\$a68
=750  \0$aSingle people$5IEN-HS$0(DLC)sh 85122849

=LDR  01642cz  a2200445n  4500
=001  9880363915502441
=005  20141212192640.0
=008  880607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015406
=035  \\$aCBA6162HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500.$x725.$x700
=072  \\$aF1.$x829.$x263.$x500.$x320.$x785
=072  \\$aI1.$x240.$x361.$x500.$x725.$x700
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500.$x725.$x700
=072  \\$aI1.$x880.$x853.$x150.$x500.$x340.$x785
=072  \\$aM1.$x620.$x785
=072  \\$aN1.$x224.$x361.$x500.$x725.$x700
=072  \\$aN1.$x824.$x308.$x500.$x725.$x700
=150  \\$aSingle Parent
=450  \\$aParent, Single
=450  \\$wnnna$aParents, Single
=450  \\$wnnna$aSingle Parents
=450  \\$wnnna$aSingle Step-Parent
=450  \\$wnnna$aSingle Step Parent
=450  \\$wnnna$aSingle Step-Parents
=450  \\$wnnna$aSingle Stepparent
=450  \\$wnnna$aSingle Stepparents
=450  \\$wnnna$aStep-Parent, Single
=450  \\$wnnna$aStep-Parents, Single
=450  \\$wnnna$aStepparent, Single
=450  \\$wnnna$aStepparents, Single
=550  \\$wg$aParents
=550  \\$wg$aSingle Person
=550  \\$aParents
=550  \\$aSingle-Parent Family
=667  \\$anever-married, divorced or widowed: read MeSH definition
=680  \\$iA natural, adoptive, or substitute parent of a dependent child, who lives with only one parent. The single parent may live with or visit the child. The concept includes the never-married, as well as the divorced and widowed.
=688  \\$a89
=750  \0$aSingle parents$5IEN-M$0(DLC)sh 85122845

=LDR  00942cz  a2200265n  4500
=001  9880363915602441
=005  20141212205645.0
=008  830606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x800
=150  \\$aSimuliidae
=450  \\$aBlack Flies
=450  \\$wnnna$aBlack Fly
=450  \\$wnnna$aBlackflies
=450  \\$wnnna$aBlackfly
=450  \\$wnnna$aFlies, Black
=450  \\$wnnna$aFly, Black
=450  \\$aSimulium
=450  \\$wnnna$aSimuliums
=550  \\$wg$aDiptera
=667  \\$aa family of flies, including black flies & buffalo gnats; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iSeveral species of the genus Simulium (family Simuliidae) that act as intermediate hosts (vectors) for the parasitic disease ONCHOCERCIASIS.
=688  \\$a84
=750  \0$aSimuliidae$5IEN$0(DLC)sh 85122769

=LDR  00744cz  a2200205n  4500
=001  9880363915702441
=005  20141212205644.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012840
=035  \\$aCBA6154M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x87.$x640.$x855
=072  \\$aB4.$x909.$x777.$x147.$x640.$x855
=150  \\$aSimbu virus
=450  \\$wnnna$aSimbu Group Viruses
=550  \\$wg$aOrthobunyavirus
=667  \\$ainfection: coord IM with BUNYAVIRIDAE INFECTIONS (IM)
=680  \\$iA species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE family. Previously a large group of serotypes, most are now considered separate species.
=688  \\$a2002 (1975)
=750  \0$aSimbu virus$5IEN-M$0(DLC)sh2002005814

=LDR  02011cz  a2200541n  4500
=001  9880363915802441
=005  20141212192522.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012837
=035  \\$aCBA6151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x755.$x800
=072  \\$aD2.$x92.$x146.$x807.$x755.$x800
=072  \\$aD2.$x886.$x590.$x700.$x725.$x755.$x800
=150  \\$aSilver Sulfadiazine
=450  \\$wnnna$aAbbott Brand of Silver Sulfadiazine
=450  \\$wnnna$aAldo Brand of Silver Sulfadiazine
=450  \\$wnnna$aBrandiazin
=450  \\$wnnna$aDermazin
=450  \\$wnnna$aFlamazine
=450  \\$wnnna$aFlammazine
=450  \\$wnnna$aMajor Brand of Silver Sulfadiazine
=450  \\$wnnna$amedphano Brand of Silver Sulfadiazine
=450  \\$wnnna$aMonarch Brand of Silver Sulfadiazine
=450  \\$wnnna$aPar Brand 1 of Silver Sulfadiazine
=450  \\$wnnna$aPar Brand 2 of Silver Sulfadiazine
=450  \\$wnnna$aPar Brand 3 of Silver Sulfadiazine
=450  \\$wnnna$aPharmascience Brand of Silver Sulfadiazine
=450  \\$wnnna$aRhône-Poulenc Rorer Brand of Silver Sulfadiazine
=450  \\$wnnna$aRhône Poulenc Rorer Brand of Silver Sulfadiazine
=450  \\$wnnna$aSherwood Brand of Silver Sulfadiazine
=450  \\$wnnna$aSicazine
=450  \\$wnnna$aSilvadene
=450  \\$wnnna$aSilvederma
=450  \\$wnnna$aSilver Sulfafdiazine
=450  \\$wnnna$aSmith & Nephew Brand of Silver Sulfadiazine
=450  \\$wnnna$aSolvay Brand of Silver Sulfadiazine
=450  \\$wnnna$aSSD
=450  \\$wnnna$aSSD AF
=450  \\$wnnna$aSulfadiazine, Silver
=450  \\$wnnna$aSulfafdiazine, Silver
=450  \\$wnnna$aSulfargen
=450  \\$wnnna$aThermazene
=450  \\$wnnna$aZenith Brand of Silver Sulfadiazine
=550  \\$wg$aSulfadiazine
=680  \\$iAntibacterial used topically in burn therapy.
=688  \\$a91(77); was see under SULFADIAZINE 1977-90
=750  \0$aSilver sulfadiazine$5IEN$0(DLC)sh 85122652

=LDR  00807cz  a2200229n  4500
=001  9880363915902441
=005  20141212205643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012835
=035  \\$aCBA6149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x525.$x550.$x850
=072  \\$aD1.$x847.$x900
=150  \\$aSilver Nitrate
=450  \\$wnnna$aAlcoholic Silver Nitrate
=450  \\$wnnna$aSilver Nitrate, Alcoholic
=450  \\$wnnna$aSilver Nitrate, Silver (2+) Salt (2:1)
=550  \\$wg$aNitrates
=550  \\$wg$aSilver Compounds
=667  \\$a/diag use: this is probably SILVER STAINING (see note there)
=680  \\$iA silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
=750  \0$aSilver nitrate$5IEN$0(DLC)sh 85122640

=LDR  00891cz  a2200205n  4500
=001  9880363916002441
=005  20141212205642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012834
=035  \\$aCBA6148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x812
=072  \\$aD1.$x268.$x956.$x843
=072  \\$aD1.$x552.$x544.$x812
=150  \\$aSilver
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aAg-107; Ag-109 = SILVER (IM) + ISOTOPES (NIM); Ag-102-106, 108, 110-117 = SILVER (IM) + RADIOISOTOPES (IM)
=680  \\$iSilver. An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.
=750  \0$aSilver$5IEN-M$0(DLC)sh 85122588

=LDR  00968cz  a2200313n  4500
=001  9880363916102441
=005  20141212205642.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012833
=035  \\$aCBA6147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x837.$x800
=072  \\$aD2.$x715.$x650
=072  \\$aD5.$x750.$x900
=072  \\$aD25.$x720.$x900
=072  \\$aJ1.$x637.$x51.$x720.$x900
=150  \\$aSiloxanes
=450  \\$wnnna$aPolysiloxane
=450  \\$wnnna$aPolysiloxanes
=450  \\$wnnna$aSiloxane
=550  \\$wg$aOrganosilicon Compounds
=550  \\$wg$aPolymers
=550  \\$wg$aSilicon Compounds
=550  \\$wh$aSilicones
=550  \\$wh$aSilorane Resins
=667  \\$asilicon polymers; D25-26 qualif
=680  \\$iSilicon polymers that contain alternate silicon and oxygen atoms in linear or cyclic molecular structures.
=688  \\$a91(75); was see under SILICONES 1975-90
=750  \0$aSiloxanes$5IEN$0(DLC)sh 85122576

=LDR  01187cz  a2200277n  4500
=001  9880363916202441
=005  20141212205641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012831
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x561.$x650.$x100
=150  \\$aBombyx
=450  \\$aBombyx mori
=450  \\$wnnna$aBombyx morus
=450  \\$wnnna$aBombyxs
=450  \\$wnnna$amori, Bombyx
=450  \\$wnnna$amorus, Bombyx
=450  \\$wnnna$aSilkmoth
=450  \\$aSilkmoths
=450  \\$wnnna$aSilkworm
=450  \\$aSilkworms
=550  \\$wg$aMoths
=550  \\$aSilk
=680  \\$iA genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree (on which it feeds). A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p519)
=688  \\$a2005 (1963)
=750  \0$aSilkworms$0(DLC) sh 85122562$5IEN

=LDR  00913cz  a2200253n  4500
=001  9880363916302441
=005  20141212205641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012830
=035  \\$aCBA6144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x899.$x669
=072  \\$aC8.$x381.$x483.$x581.$x760.$x750
=072  \\$aC8.$x381.$x520.$x702.$x760.$x750
=072  \\$aC8.$x381.$x922.$x669
=072  \\$aC8.$x730.$x939.$x669
=072  \\$aC24.$x800.$x834.$x752
=150  \\$aSilicotuberculosis
=450  \\$wnnna$aSilicotuberculoses
=550  \\$wg$aSilicosis
=550  \\$wg$aTuberculosis, Pulmonary
=667  \\$ado not coordinate with OCCUPATIONAL DISEASES
=680  \\$iPulmonary or extrapulmonary infection caused by MYCOBACTERIUM TUBERCULOSIS or nontuberculous mycobacteria in a patient with silicosis.
=750  \0$aSilicotuberculosis$5IEN$0(DLC)sh 85122540

=LDR  00989cz  a2200265n  4500
=001  9880363916402441
=005  20141212205641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012829
=035  \\$aCBA6143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x581.$x760
=072  \\$aC8.$x381.$x520.$x702.$x760
=072  \\$aC24.$x800.$x834
=150  \\$aSilicosis
=450  \\$wnnna$aSilicoses
=450  \\$aSilicotics$5IEN
=550  \\$wg$aPneumoconiosis
=550  \\$wh$aAnthracosilicosis
=550  \\$wh$aSilicotuberculosis
=550  \\$aCoal Mining
=667  \\$aANTHRACOSILICOSIS & SILICOTUBERCULOSIS are also available; do not coordinate with OCCUPATIONAL DISEASES
=680  \\$iA form of pneumoconiosis resulting from inhalation of dust containing crystalline form of SILICON DIOXIDE, usually in the form of quartz. Amorphous silica is relatively nontoxic.
=750  \0$aSilicosis$5IEN-M$0(DLC)sh 85122538
=750  \0$aSilicotics$5IEN-HS$0(DLC)sh 85122539

=LDR  01058cz  a2200265n  4500
=001  9880363916502441
=005  20141212205641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012828
=035  \\$aCBA6142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x715.$x650.$x700
=072  \\$aD5.$x750.$x900.$x850
=072  \\$aD25.$x720.$x900.$x850
=072  \\$aJ1.$x637.$x51.$x720.$x900.$x850
=150  \\$aSilicones
=450  \\$wnnna$aSilicone
=550  \\$wg$aSiloxanes
=550  \\$wh$aDimethylpolysiloxanes
=550  \\$wh$aSilicone Elastomers
=550  \\$wh$aSilicone Gels
=550  \\$wh$aSilicone Oils
=667  \\$ain breast implants use SILICONE GELS or SILICONE ELASTOMERS; do not confuse with SILICON
=680  \\$iA broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. (From Merck Index, 12th ed)
=750  \0$aSilicones$5IEN$0(DLC)sh 85122534

=LDR  01748cz  a2200421n  4500
=001  9880363916602441
=005  20141212205640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012826
=035  \\$aCBA6140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x900.$x850.$x900
=072  \\$aD25.$x720.$x327.$x900
=072  \\$aD25.$x720.$x900.$x850.$x900
=072  \\$aJ1.$x637.$x51.$x720.$x327.$x900
=072  \\$aJ1.$x637.$x51.$x720.$x900.$x850.$x900
=072  \\$aJ1.$x637.$x412.$x900
=150  \\$aSilicone Elastomers
=450  \\$aElastomers, Silicone
=450  \\$wnnna$aElastosil
=450  \\$wnnna$aElastosils
=450  \\$wnnna$aMicrofil
=450  \\$wnnna$aMicrofils
=450  \\$aRubber Silicone
=450  \\$wnnna$aSE-30
=450  \\$wnnna$aSE 30
=450  \\$wnnna$aSE30
=450  \\$wnnna$aSilicone Elastomer
=450  \\$aSilicone Rubber
=550  \\$wg$aElastomers
=550  \\$wg$aSilicones
=550  \\$aBreast Implants
=550  \\$aDental Impression Materials
=550  \\$aDenture Liners
=667  \\$asilicones in breast implants probably goes under SILICONE GELS or here if specified as elastomers; for prosthetic implants do not use /ther use; ELASTOMERS is available
=680  \\$iPolymers of silicone that are formed by crosslinking and treatment with amorphous silica to increase strength. They have properties similar to vulcanized natural rubber, in that they stretch under tension, retract rapidly, and fully recover to their original dimensions upon release. They are used in the encapsulation of surgical membranes and implants.
=688  \\$a72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was (NM) 1988-93
=750  \0$aSilicone rubber$5IEN$0(DLC)sh 85122533

=LDR  00815cz  a2200169n  4500
=001  9880363916702441
=005  20141212205639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012825
=035  \\$aCBA6139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x513.$x937
=150  \\$aSilicon
=550  \\$wg$aMetalloids
=667  \\$aSi-28; do not confuse with SILICA or SILICONES; Si-29, 30 = SILICON (IM) + ISOTOPES (NIM); Si-26, 27, 31, 32 = SILICON (IM) + RADIOISOTOPES (IM); lung disease from various silicon dusts = SILICOSIS
=680  \\$iA trace element that constitutes about 27.6% of the earth's crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight [28.084; 28.086].
=750  \0$aSilicon$5IEN-M$0(DLC)sh 85122512

=LDR  01094cz  a2200313n  4500
=001  9880363916802441
=005  20141212205639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012824
=035  \\$aCBA6138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x863
=072  \\$aD1.$x837.$x725.$x700
=150  \\$aSilicic Acid
=450  \\$wnnna$aGel, Hydrated Silica
=450  \\$wnnna$aHydrate, Silica
=450  \\$wnnna$aHydrate, Silicate
=450  \\$wnnna$aHydrated Silica Gel
=450  \\$wnnna$aSilica Gel, Hydrated
=450  \\$wnnna$aSilica Hydrate
=450  \\$wnnna$aSilicate Hydrate
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aSilicon Dioxide
=550  \\$wh$aSilica Gel
=550  \\$wh$aSilicates
=680  \\$iA hydrated form of silicon dioxide. It is commonly used in the manufacture of TOOTHPASTES and as a stationary phase for CHROMATOGRAPHY.
=688  \\$a1991(1975) use SILICA 1975-1990, for SILICATE HYDRATE use SILICATES 1993-2010
=688  \\$a91(75); was see under SILICA 1975-90
=750  \0$aSilicic acid$5IEN$0(DLC)sh 85122508

=LDR  01367cz  a2200397n  4500
=001  9880363916902441
=005  20141212192522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012822
=035  \\$aCBA6136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x750
=072  \\$aD1.$x650.$x550.$x825
=072  \\$aD1.$x837.$x725
=150  \\$aSilicon Dioxide
=450  \\$wnnna$a380, Aerosil
=450  \\$wnnna$aAerosil
=450  \\$wnnna$aAerosil 380
=450  \\$wnnna$aCristobalite
=450  \\$wnnna$aDioxide, Silicon
=450  \\$wnnna$aG32, Quso
=450  \\$wnnna$aQuso G-32
=450  \\$wnnna$aQuso G 32
=450  \\$wnnna$aQuso G32
=450  \\$aSilica
=450  \\$wnnna$aTridymite
=550  \\$wg$aMinerals
=550  \\$wg$aOxides
=550  \\$wg$aSilicon Compounds
=550  \\$wh$aDiatomaceous Earth
=550  \\$wh$aQuartz
=550  \\$wh$aSilicic Acid
=667  \\$anote X ref: do not confuse with SILICON; TN 172: differentiation among silic- terms; see MeSH definition for names of common forms of silicon dioxide
=680  \\$iTransparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid.
=688  \\$a94; was SILICA 1963-93
=750  \0$aSilica$5IEN-M$0(DLC)sh 85122495

=LDR  00748cz  a2200193n  4500
=001  9880363917002441
=005  20141212205639.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012821
=035  \\$aCBA6135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x837.$x700
=072  \\$aD2.$x715.$x625
=150  \\$aSilanes
=550  \\$wg$aOrganosilicon Compounds
=550  \\$wg$aSilicon Compounds
=680  \\$iCompounds similar to hydrocarbons in which a tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air, and form useful derivatives.
=688  \\$a91(75); was see under SILICON 1975-90; HYDROSILICONS, SILICANS & SILICOHYDRIDES were see SILANES 1975-93
=750  \0$aSilane compounds$5IEN$0(DLC)sh 90001656

=LDR  00786cz  a2200229n  4500
=001  9880363917102441
=005  20200511142844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012820
=035  \\$aCBA6134HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x200.$x750
=072  \\$aG7.203.$x300.$x300.$x100.$x800
=072  \\$aJ2.$x350.$x750
=072  \\$aJ2.$x500.$x300.$x100.$x800
=150  \\$aSilage
=550  \\$wg$aAnimal Feed
=550  \\$wg$aFermented Foods and Beverages
=667  \\$a"fodder converted into succulent feed for livestock"
=680  \\$iFodder converted into succulent feed for livestock through processes of anaerobic fermentation (as in a silo).
=688  \\$a91(64); was see under ANIMAL FEED 1964-90
=750  \0$aSilage$5IEN$0(DLC)sh 85122457

=LDR  02064cz  a2200637n  4500
=001  9880363917202441
=005  20200716175930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012816
=035  \\$aCBA6130HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888
=150  \\$aSigns and Symptoms
=450  \\$wnnna$aSymptoms and Signs
=550  \\$wg$aPathological Conditions, Signs and Symptoms
=550  \\$wh$aAging, Premature
=550  \\$wh$aAsthenia
=550  \\$wh$aBody Temperature Changes
=550  \\$wh$aBody Weight
=550  \\$wh$aCardiac Output, High
=550  \\$wh$aCardiac Output, Low
=550  \\$wh$aChills
=550  \\$wh$aCyanosis
=550  \\$wh$aEdema
=550  \\$wh$aEye Manifestations
=550  \\$wh$aFailure to Thrive
=550  \\$wh$aFatigue
=550  \\$wh$aFeminization
=550  \\$wh$aFetal Distress
=550  \\$wh$aFlushing
=550  \\$wh$aHeart Murmurs
=550  \\$wh$aHot Flashes
=550  \\$wh$aHypergammaglobulinemia
=550  \\$wh$aHyperlactatemia
=550  \\$wh$aHypertriglyceridemic Waist
=550  \\$wh$aIntermittent Claudication
=550  \\$wh$aMedically Unexplained Symptoms
=550  \\$wh$aMobility Limitation
=550  \\$wh$aMotion Sickness
=550  \\$wh$aNeurologic Manifestations
=550  \\$wh$aOral Manifestations
=550  \\$wh$aPain
=550  \\$wh$aPolydipsia
=550  \\$wh$aProdromal Symptoms
=550  \\$wh$aPseudophakia
=550  \\$wh$aReticulocytosis
=550  \\$wh$aSigns and Symptoms, Digestive
=550  \\$wh$aSigns and Symptoms, Respiratory
=550  \\$wh$aSkin Manifestations
=550  \\$wh$aTravel-Related Illness
=550  \\$wh$aUrological Manifestations
=550  \\$wh$aVirilism
=667  \\$aused for searching: indexers apply specifics; may be used by catalogers
=680  \\$iClinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.
=688  \\$a98; use pre-explosion 1970-97
=750  \0$aSymptoms$5IEN-M$0(DLC)sh 85131555

=LDR  03172cz  a2200601n  4500
=001  9880363917302441
=005  20180913104501.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015398
=035  \\$aCBA6129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x820
=072  \\$aG4.$x835
=150  \\$aSignal Transduction
=450  \\$wnnna$aPathway, Signal
=450  \\$wnnna$aPathway, Signal Transduction
=450  \\$wnnna$aPathways, Signal
=450  \\$wnnna$aPathways, Signal Transduction
=450  \\$wnnna$aReceptor Mediated Signal Transduction
=450  \\$aReceptor-Mediated Signal Transduction
=450  \\$wnnna$aReceptor-Mediated Signal Transductions
=450  \\$wnnna$aSignal Pathway
=450  \\$aSignal Pathways
=450  \\$wnnna$aSignal Transduction Pathway
=450  \\$wnnna$aSignal Transduction Pathways
=450  \\$wnnna$aSignal Transduction, Receptor-Mediated
=450  \\$wnnna$aSignal Transduction System
=450  \\$wnnna$aSignal Transduction Systems
=450  \\$wnnna$aSignal Transductions
=450  \\$wnnna$aSignal Transductions, Receptor-Mediated
=450  \\$wnnna$aSystem, Signal Transduction
=450  \\$wnnna$aSystems, Signal Transduction
=450  \\$wnnna$aTransduction, Signal
=450  \\$wnnna$aTransductions, Signal
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aExcitation Contraction Coupling
=550  \\$wh$aIon Channel Gating
=550  \\$wh$aLight Signal Transduction
=550  \\$wh$aMAP Kinase Signaling System
=550  \\$wh$aMechanotransduction, Cellular
=550  \\$wh$aNon-Neuronal Cholinergic System
=550  \\$wh$aSecond Messenger Systems
=550  \\$wh$aSynaptic Transmission
=550  \\$wh$aWnt Signaling Pathway
=550  \\$aCell Communication
=550  \\$aFeedback, Physiological
=550  \\$aGasotransmitters
=550  \\$aReceptor-CD3 Complex, Antigen, T-Cell
=550  \\$aReceptor Cross-Talk
=680  \\$iThe intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
=688  \\$a89
=750  \0$aCellular signal transduction$5IEN$0(DLC)sh 89002397

=LDR  01514cz  a2200385n  4500
=001  9880363917402441
=005  20141212205637.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012815
=035  \\$aCBA6128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x800
=150  \\$aSignal Processing, Computer-Assisted
=450  \\$wnnna$aComputer-Assisted Signal Interpretation
=450  \\$wnnna$aComputer-Assisted Signal Interpretations
=450  \\$wnnna$aComputer-Assisted Signal Processing
=450  \\$aDigital Signal Processing
=450  \\$wnnna$aInterpretation, Computer-Assisted Signal
=450  \\$wnnna$aInterpretations, Computer-Assisted Signal
=450  \\$aSignal Interpretation, Computer-Assisted
=450  \\$wnnna$aSignal Interpretation, Computer Assisted
=450  \\$wnnna$aSignal Interpretations, Computer-Assisted
=450  \\$wnnna$aSignal Processing, Computer Assisted
=450  \\$aSignal Processing, Digital
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aData Compression
=550  \\$wh$aFourier Analysis
=550  \\$wh$aWavelet Analysis
=550  \\$aData Compression
=550  \\$aFetal Monitoring
=550  \\$aMonitoring, Physiologic
=667  \\$aIM
=680  \\$iComputer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.
=688  \\$a87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88
=750  \0$aSignal processing$5IEN$0(DLC)sh 85122397

=LDR  00859cz  a2200253n  4500
=001  9880363917502441
=005  20141212205636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012813
=035  \\$aCBA6126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x200.$x609.$x668
=072  \\$aF1.$x145.$x209.$x530.$x702.$x668
=072  \\$aL1.$x143.$x649.$x526.$x668
=150  \\$aSign Language
=450  \\$wnnna$aLanguage, Sign
=450  \\$wnnna$aLanguages, Sign
=450  \\$wnnna$aSign Languages
=550  \\$wg$aManual Communication
=550  \\$aLanguage
=667  \\$ano qualif
=680  \\$iA system of hand gestures used for communication by the deaf or by people speaking different languages.
=688  \\$a91(75)63-65; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65
=750  \0$aSign language$5IEN$0(DLC)sh 85122390

=LDR  01408cz  a2200385n  4500
=001  9880363917602441
=005  20141212192521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012812
=035  \\$aCBA6125HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x200.$x700
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x160.$x800
=072  \\$aE4.$x210.$x240.$x250.$x160.$x800
=072  \\$aE4.$x502.$x250.$x250.$x250.$x160.$x800
=150  \\$aSigmoidoscopy
=450  \\$wnnna$aProcedure, Sigmoidoscopic Surgical
=450  \\$wnnna$aProcedures, Sigmoidoscopic Surgical
=450  \\$wnnna$aProctosigmoidoscopies
=450  \\$aProctosigmoidoscopy
=450  \\$wnnna$aSigmoidoscopic Surgeries
=450  \\$wnnna$aSigmoidoscopic Surgery
=450  \\$wnnna$aSigmoidoscopic Surgical Procedure
=450  \\$aSigmoidoscopic Surgical Procedures
=450  \\$wnnna$aSigmoidoscopies
=450  \\$wnnna$aSurgeries, Sigmoidoscopic
=450  \\$wnnna$aSurgery, Sigmoidoscopic
=450  \\$wnnna$aSurgical Procedure, Sigmoidoscopic
=450  \\$aSurgical Procedures, Sigmoidoscopic
=550  \\$wg$aColonoscopy
=550  \\$aColon, Sigmoid
=550  \\$aSigmoidoscopes
=667  \\$a/ instrum permitted but consider also SIGMOIDOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the sigmoid flexure.
=750  \0$aSigmoidoscopy$5IEN$0(DLC)sh 85122388

=LDR  01303cz  a2200301n  4500
=001  9880363917702441
=005  20141212205634.0
=008  781220\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012804
=035  \\$aCBA6117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x93.$x249
=072  \\$aC14.$x280.$x67.$x558.$x536
=072  \\$aC23.$x550.$x73.$x93.$x249
=072  \\$aC23.$x550.$x73.$x425.$x440
=150  \\$aSick Sinus Syndrome
=450  \\$wnnna$aDysfunction, Sinus Node
=450  \\$wnnna$aDysfunctions, Sinus Node
=450  \\$wnnna$aSick Sinus Node Syndrome
=450  \\$wnnna$aSinus Node Disease
=450  \\$wnnna$aSinus Node Diseases
=450  \\$aSinus Node Dysfunction
=450  \\$wnnna$aSyndrome, Sick Sinus
=550  \\$wg$aArrhythmia, Sinus
=550  \\$wg$aHeart Block
=680  \\$iA condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.
=688  \\$a80
=750  \0$aSick sinus syndrome$5IEN$0(DLC)sh 85122292

=LDR  01020cz  a2200253n  4500
=001  9880363917802441
=005  20141212205609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012723
=035  \\$aCBA6034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x810
=150  \\$aSex
=450  \\$wnnna$aGenotypic Sex
=450  \\$wnnna$aPhenotypic Sex
=450  \\$wnnna$aSex, Genotypic
=450  \\$wnnna$aSex, Phenotypic
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$aSex Characteristics
=550  \\$aSex Determination Analysis
=550  \\$aSexual Behavior
=667  \\$adifferentiate from SEX FACTORS, largely statist in concept; sex therapy: coord PSYCHOTHERAPY (IM) + SEXUAL DYSFUNCTION, PHYSIOLOGICAL /ther or PSYCHOSEXUAL DYSFUNCTIONS /ther or their indentions /ther (IM)
=680  \\$iThe totality of characteristics of reproductive structure, functions, PHENOTYPE, and GENOTYPE, differentiating the MALE from the FEMALE organism.
=750  \0$aSex$5IEN-M$0(DLC)sh 85120549

=LDR  00641cz  a2200193n  4500
=001  9880363917902441
=005  20141212205609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012722
=035  \\$aCBA6033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944.$x932.$x500
=150  \\$aSewage
=450  \\$aSludge
=550  \\$wg$aWaste Water
=667  \\$aX ref SLUDGE: usually mudlike ooze in sewage but non-sewage sludge is indexed under other specific waste term
=680  \\$iRefuse liquid or waste matter carried off by sewers.
=750  \0$aSewage disposal$5IEN-M$0(DLC)sh 85120499
=750  \0$aSewage$5IEN-HS$0(DLC)sh 85120457

=LDR  03461cz  a2200913n  4500
=001  9880363918002441
=005  20141212192520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012721
=035  \\$aCBA6032HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x150
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x162
=072  \\$aD4.$x615.$x638.$x162
=150  \\$aCarbaryl
=450  \\$wnnna$a1-Naphthyl-N-methylcarbamate
=450  \\$wnnna$a18, Concentrat VO
=450  \\$wnnna$aAntigale
=450  \\$wnnna$aAvicopharma Brand of Carbaril
=450  \\$wnnna$aBiové Brand of Carbaril
=450  \\$wnnna$aCarbaril
=450  \\$wnnna$aCarbaril Avicopharma Brand
=450  \\$wnnna$aCarbaril Biové Brand
=450  \\$wnnna$aCarbaril Clément Brand
=450  \\$wnnna$aCarbaril Coophavet Brand
=450  \\$wnnna$aCarbaril IntraVeno Brand
=450  \\$wnnna$aCarbaril Mavlab Brand
=450  \\$wnnna$aCarbaril Novartis Brand
=450  \\$wnnna$aCarbaril Ornis Brand
=450  \\$wnnna$aCarbaril Sanofi Brand
=450  \\$wnnna$aCarbaril Sogeval Brand
=450  \\$wnnna$aCarbaril Vétoquinol Brand
=450  \\$wnnna$aCarbaril Virbac Brand
=450  \\$wnnna$aCarbaryl, Manganese (2+) Salt
=450  \\$wnnna$aCarbaryl, Nickel (2+) Salt
=450  \\$wnnna$aCarbyl
=450  \\$wnnna$aCarylderm
=450  \\$wnnna$aClément Brand of Carbaril
=450  \\$wnnna$aConcentrat VO 18
=450  \\$wnnna$aCoophavet Brand of Carbaril
=450  \\$wnnna$aDavid Veterinary Laboratories Brand of Carbaril
=450  \\$wnnna$aDog-Net Insecticide Poudre
=450  \\$wnnna$aDog Net Insecticide Poudre
=450  \\$wnnna$aDogNet Insecticide Poudre
=450  \\$wnnna$aFido's Free-Itch
=450  \\$wnnna$aFido's Free Itch
=450  \\$wnnna$aFido's FreeItch
=450  \\$wnnna$aG-Wizz
=450  \\$wnnna$aG Wizz
=450  \\$wnnna$aGWizz
=450  \\$wnnna$ainsecticide Moureau, Poudre
=450  \\$wnnna$ainsecticide Vetoquinol, Poudre
=450  \\$wnnna$aIntraVeno Brand of Carbaril
=450  \\$wnnna$aJoseph Lyddy
=450  \\$wnnna$aLyddy, Joseph
=450  \\$wnnna$aMavlab Brand of Carbaril
=450  \\$wnnna$aMoureau, Poudre insecticide
=450  \\$wnnna$aNovartis Brand of Carbaril
=450  \\$wnnna$aOcécoxil
=450  \\$wnnna$aOrnis Brand of Carbaril
=450  \\$wnnna$aPoudre insecticide Moureau
=450  \\$wnnna$aPoudre insecticide Vetoquinol
=450  \\$wnnna$aPoutic
=450  \\$wnnna$aSépou
=450  \\$wnnna$aSanofi Brand of Carbaril
=450  \\$wnnna$aSevin
=450  \\$wnnna$aSkatta Tick Flea Louse Powder
=450  \\$wnnna$aSogeval Brand of Carbaril
=450  \\$wnnna$aTigal
=450  \\$wnnna$aVétoquinol Brand of Carbaril
=450  \\$wnnna$aVetoquinol, Poudre insecticide
=450  \\$wnnna$aVirbac Brand of Carbaril
=450  \\$wnnna$aVO 18, Concentrat
=550  \\$wg$aCarbamates
=550  \\$wg$aNaphthalenes
=667  \\$aTN 111 for eff on insects
=680  \\$iA carbamate insecticide and parasiticide. It is a potent anticholinesterase agent belonging to the carbamate group of reversible cholinesterase inhibitors. It has a particularly low toxicity from dermal absorption and is used for control of head lice in some countries.
=688  \\$a92; was SEVIN 1971-91 (Prov 1971-73); CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95
=750  \0$aCarbaryl$5IEN-M$0(DLC)sh 85020071

=LDR  00749cz  a2200277n  4500
=001  9880363918202441
=005  20141212205608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012717
=035  \\$aCBA6028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x765
=150  \\$aSesquiterpenes
=550  \\$wg$aTerpenes
=550  \\$wh$aAbscisic Acid
=550  \\$wh$aArtemisinins
=550  \\$wh$aFarnesol
=550  \\$wh$aGossypol
=550  \\$wh$aSantonin
=550  \\$wh$aSesquiterpenes, Eudesmane
=550  \\$wh$aSesquiterpenes, Germacrane
=550  \\$wh$aSesquiterpenes, Guaiane
=550  \\$wh$aTrichothecenes
=667  \\$aGEN; prefer specifics
=688  \\$a74
=750  \0$aSesquiterpenes$5IEN$0(DLC)sh 89006047

=LDR  00492cz  a2200181n  4500
=001  9880363918302441
=005  20141212205607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012716
=035  \\$aCBA6027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x730
=150  \\$aSesamoid Bones
=450  \\$wnnna$aBone, Sesamoid
=450  \\$wnnna$aBones, Sesamoid
=450  \\$wnnna$aSesamoid Bone
=550  \\$wg$aBone and Bones
=750  \0$aSesamoid bones$5IEN$0(DLC)sh 85120372

=LDR  01224cz  a2200289n  4500
=001  9880363918402441
=005  20141212205607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012715
=035  \\$aCBA6026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x775
=072  \\$aD10.$x212.$x507.$x775
=072  \\$aD10.$x627.$x700.$x865
=072  \\$aD20.$x215.$x784.$x750.$x865
=072  \\$aJ2.$x500.$x375.$x400.$x725
=150  \\$aSesame Oil
=450  \\$wnnna$aOil, Sesame
=450  \\$wnnna$aOils, Sesame
=450  \\$wnnna$aSesame Oils
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=667  \\$aan unsaturated fat
=680  \\$iThe refined fixed oil obtained from the seed of one or more cultivated varieties of Sesamum indicum. It is used as a solvent and oleaginous vehicle for drugs and has been used internally as a laxative and externally as a skin softener. It is used also in the manufacture of margarine, soap, and cosmetics. (Dorland, 28th ed & Random House Unabridged Dictionary, 2d ed)
=688  \\$a91(87)66; was see under PLANT OILS 1987-90; was heading 1966-86
=750  \0$aSesame oil$5IEN$0(DLC)sh 88006608

=LDR  01027cz  a2200253n  4500
=001  9880363918502441
=005  20141212205606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012713
=035  \\$aCBA6024HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x600.$x800
=072  \\$aC20.$x543.$x206.$x380.$x800
=072  \\$aC20.$x543.$x520.$x770
=072  \\$aC25.$x100.$x468.$x380.$x800
=150  \\$aSerum Sickness
=450  \\$wnnna$aSerum Sicknesses
=450  \\$wnnna$aSickness, Serum
=450  \\$wnnna$aSicknesses, Serum
=550  \\$wg$aDrug Eruptions
=550  \\$wg$aImmune Complex Diseases
=667  \\$aan immune complex dis
=680  \\$iImmune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses.
=750  \0$aSerum sickness$5IEN$0(DLC)sh 85120336

=LDR  00972cz  a2200301n  4500
=001  9880363918602441
=005  20200626121446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012709
=035  \\$aCBA6020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x34.$x841
=072  \\$aD12.$x776.$x124.$x50.$x700
=072  \\$aD12.$x776.$x124.$x727
=150  \\$aSerum Albumin
=450  \\$wnnna$aAlbumin, Serum
=450  \\$aAlbumins$xblood
=450  \\$aPlasma Albumin
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlbumins
=550  \\$wg$aBlood Proteins
=550  \\$wh$aMethemalbumin
=550  \\$wh$aPrealbumin
=550  \\$wh$aSerum Albumin, Bovine
=550  \\$wh$aSerum Albumin, Human
=550  \\$wh$aSerum Albumin, Radio-Iodinated
=680  \\$iA major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.
=750  \0$aSerum albumin$5IEN$0(DLC)sh 85120333

=LDR  00899cz  a2200217n  4500
=001  9880363918702441
=005  20141212205605.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012708
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x849.$x789
=072  \\$aA11.$x382.$x952
=072  \\$aA11.$x436.$x837
=150  \\$aSertoli Cells
=450  \\$wnnna$aCells, Sertoli
=550  \\$wg$aEndocrine Cells
=550  \\$wg$aEpithelial Cells
=550  \\$wg$aTestis
=680  \\$iSupporting cells projecting inward from the basement membrane of SEMINIFEROUS TUBULES. They surround and nourish the developing male germ cells and secrete ANDROGEN-BINDING PROTEIN and hormones such as ANTI-MULLERIAN HORMONE. The tight junctions of Sertoli cells with the SPERMATOGONIA and SPERMATOCYTES provide a BLOOD-TESTIS BARRIER.
=688  \\$a68(64)
=750  \0$aSertoli cells$0(DLC) sh 85120330$5IEN

=LDR  00806cz  a2200181n  4500
=001  9880363918802441
=005  20141212205604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012706
=035  \\$aCBA6017HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x814.$x664
=072  \\$aB3.$x660.$x250.$x150.$x720.$x500
=150  \\$aSerratia marcescens
=550  \\$wg$aSerratia
=667  \\$ain water, soil, dairy products, insects; do not use /blood-csf-urine; opportunistic; infection: coord IM with SERRATIA INFECTIONS (IM)
=680  \\$iA species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.
=750  \0$aSerratia marcescens$5IEN$0(DLC)sh 88023332

=LDR  00771cz  a2200205n  4500
=001  9880363918902441
=005  20141212205604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012705
=035  \\$aCBA6016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x814
=072  \\$aB3.$x660.$x250.$x150.$x720
=150  \\$aSerratia
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aSerratia liquefaciens
=550  \\$wh$aSerratia marcescens
=667  \\$ain water, soil, food; infection = SERRATIA INFECTIONS
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment (soil, water, and plant surfaces) or as an opportunistic human pathogen.
=750  \0$aSerratia$5IEN$0(DLC)sh 85120324

=LDR  02012cz  a2200493n  4500
=001  9880363919002441
=005  20190510161420.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012702
=035  \\$aCBA6013HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x850.$x850
=072  \\$aD27.$x505.$x696.$x577.$x850.$x850
=150  \\$aSerotonin Antagonists
=450  \\$a5-HT Antagonists
=450  \\$wnnna$a5 HT Antagonists
=450  \\$a5-Hydroxytryptamine Antagonists
=450  \\$wnnna$a5 Hydroxytryptamine Antagonists
=450  \\$wnnna$aAgents, Antiserotonergic
=450  \\$wnnna$aAntagonists, 5-HT
=450  \\$wnnna$aAntagonists, 5 HT
=450  \\$wnnna$aAntagonists, 5-Hydroxytryptamine
=450  \\$wnnna$aAntagonists, 5 Hydroxytryptamine
=450  \\$wnnna$aAntagonists, Serotonin
=450  \\$wnnna$aAntagonists, Serotonin Receptor
=450  \\$aAntiserotonergic Agents
=450  \\$wnnna$aBlockaders, Serotonin
=450  \\$wnnna$aBlockers, Serotonin Receptor
=450  \\$wnnna$aReceptor Antagonists, Serotonin
=450  \\$wnnna$aReceptor Blockers, Serotonin
=450  \\$aReceptors, Serotonin$xantagonists & inhibitors
=450  \\$aSerotonin$xantagonists & inhibitors
=450  \\$aSerotonin Blockaders
=450  \\$wnnna$aSerotonin Receptor Antagonists
=450  \\$wnnna$aSerotonin Receptor Blockers
=550  \\$wg$aSerotonin Agents
=550  \\$wh$aSerotonin 5-HT1 Receptor Antagonists
=550  \\$wh$aSerotonin 5-HT2 Receptor Antagonists
=550  \\$wh$aSerotonin 5-HT3 Receptor Antagonists
=550  \\$wh$aSerotonin 5-HT4 Receptor Antagonists
=667  \\$ageneral or unspecified; prefer specifics; differentiate from SEROTONIN UPTAKE INHIBITORS: do not confuse with SEROTONIN AGONISTS
=680  \\$iDrugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.
=688  \\$a78,64-67
=750  \0$aSerotonin$xAntagonists$0(DLC)sh 85120302$5IEN-M

=LDR  01518cz  a2200337n  4500
=001  9880363919102441
=005  20141212205603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012701
=035  \\$aCBA6012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x801.$x852
=072  \\$aD3.$x438.$x473.$x914.$x814
=072  \\$aD23.$x469.$x50.$x650
=150  \\$aSerotonin
=450  \\$wnnna$a3-(2-Aminoethyl)-1H-indol-5-ol
=450  \\$a5-HT
=450  \\$a5-Hydroxytryptamine
=450  \\$wnnna$a5 Hydroxytryptamine
=450  \\$wnnna$aEnteramine
=450  \\$wnnna$aHippophaine
=450  \\$wnnna$aHydroxytryptamine
=550  \\$wg$aAutacoids
=550  \\$wg$aTryptamines
=550  \\$wh$a5-Methoxytryptamine
=550  \\$wh$aBufotenin
=550  \\$aSerotonin Syndrome
=667  \\$a/antag = SEROTONIN ANTAGONISTS but consider also SEROTONIN UPTAKE INHIBITORS
=680  \\$iA biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.
=688  \\$aHYDROXYTRYPTAMINE was see SEROTONIN 1975-92
=750  \0$aSerotonin$5IEN$0(DLC)sh 85120301

=LDR  00600cz  a2200169n  4500
=001  9880363919202441
=005  20141212205602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012699
=035  \\$aCBA6010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x781
=150  \\$aSerology
=550  \\$wg$aHealth Occupations
=667  \\$afield of immunology dealing with in vitro antigen-antibody reactions; SPEC: SPEC qualif; do not confuse with SEROLOGIC TESTS; DF: SEROL
=680  \\$iThe study of serum, especially of antigen-antibody reactions in vitro.
=750  \0$aSerology$5IEN$0(DLC)sh 85120300

=LDR  01646cz  a2200457n  4500
=001  9880363919302441
=005  20141212205602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012698
=035  \\$aCBA6009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735
=072  \\$aE5.$x200.$x812.$x735
=072  \\$aE5.$x478.$x594.$x760
=150  \\$aSerologic Tests
=450  \\$wnnna$aSerodiagnoses
=450  \\$aSerodiagnosis
=450  \\$wnnna$aSerologic Test
=450  \\$wnnna$aSerological Test
=450  \\$wnnna$aSerological Tests
=450  \\$wnnna$aTest, Serologic
=450  \\$wnnna$aTest, Serological
=450  \\$wnnna$aTests, Serologic
=450  \\$wnnna$aTests, Serological
=550  \\$wg$aImmunologic Tests
=550  \\$wh$aAgglutination Tests
=550  \\$wh$aAIDS Serodiagnosis
=550  \\$wh$aComplement Fixation Tests
=550  \\$wh$aComplement Hemolytic Activity Assay
=550  \\$wh$aHemadsorption Inhibition Tests
=550  \\$wh$aHemagglutination Inhibition Tests
=550  \\$wh$aNeutralization Tests
=550  \\$wh$aPrecipitin Tests
=550  \\$wh$aRadioallergosorbent Test
=550  \\$wh$aRadioimmunoprecipitation Assay
=550  \\$wh$aSerum Bactericidal Antibody Assay
=550  \\$wh$aSyphilis Serodiagnosis
=667  \\$aGEN or unspecified; prefer specifics; NIM; Manual 26.9-26.9.2; restrict to determ of immune cpds (e.g., antibodies) in serum: do not confuse with SEROLOGY, the specialty; DF: SERODIAG
=680  \\$iDiagnostic procedures involving immunoglobulin reactions.
=688  \\$a98(63)
=750  \0$aSerodiagnosis$5IEN$0(DLC)sh 85120334

=LDR  01219cz  a2200325n  4500
=001  9880363919402441
=005  20141212205600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012695
=035  \\$aCBA6006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x232.$x400.$x600
=150  \\$aL-Serine Dehydratase
=450  \\$wnnna$aAmmonia-Lyase, L-Serine
=450  \\$wnnna$aDeaminase, Serine
=450  \\$wnnna$aDehydratase, L-Serine
=450  \\$wnnna$aDehydratase, Serine
=450  \\$wnnna$aDehydratase, Serine-Threonine
=450  \\$wnnna$aL-Serine Ammonia-Lyase
=450  \\$wnnna$aL Serine Ammonia Lyase
=450  \\$wnnna$aL Serine Dehydratase
=450  \\$aSerine Deaminase
=450  \\$aSerine Dehydratase
=450  \\$wnnna$aSerine-Threonine Dehydratase
=450  \\$wnnna$aSerine Threonine Dehydratase
=550  \\$wg$aAmmonia-Lyases
=667  \\$aspecific for L-serine
=680  \\$iA PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13.
=688  \\$a98(67); for SERINE DEAMINASE use HYDRO-LYASES 1963-71
=750  \0$aSerine dehydratase$5IEN$0(DLC)sh 89006968

=LDR  00867cz  a2200265n  4500
=001  9880363919502441
=005  20141212205600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012694
=035  \\$aCBA6005M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x154.$x800
=072  \\$aD12.$x125.$x837
=150  \\$aSerine
=450  \\$wnnna$aL-Serine
=450  \\$wnnna$aL Serine
=550  \\$wg$aAmino Acids
=550  \\$wg$aAmino Acids, Neutral
=550  \\$wh$aAzaserine
=550  \\$wh$aCycloserine
=550  \\$wh$aDroxidopa
=550  \\$wh$aEnterobactin
=550  \\$wh$aPhosphoserine
=680  \\$iA non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
=750  \0$aSerine$5IEN-M$0(DLC)sh 99001554

=LDR  00951cz  a2200241n  4500
=001  9880363919602441
=005  20141212205600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012693
=035  \\$aCBA6004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x829
=150  \\$aSerial Publications
=450  \\$wnnna$aPublication, Serial
=450  \\$wnnna$aPublications, Serial
=450  \\$wnnna$aSerial Publication
=550  \\$wg$aPublications
=550  \\$wh$aNewspapers
=550  \\$wh$aPeriodicals as Topic
=667  \\$aGEN or unspecified; prefer specifics; IM; coord with subject of the publication (IM)
=680  \\$iPublications in any medium issued in successive parts bearing numerical or chronological designations and intended to be continued indefinitely. (ALA Glossary of Library and Information Science, 1983, p203)
=688  \\$a98; use explode 1975-97
=750  \0$aSerial publications$5IEN-M$0(DLC)sh 85120228

=LDR  00639cz  a2200229n  4500
=001  9880363919702441
=005  20141212205558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012685
=035  \\$aCBA5996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x813
=150  \\$aSepharose
=450  \\$wnnna$a4B, Sepharose
=450  \\$wnnna$a4B, Sepharose C1
=450  \\$aAgarose
=450  \\$wnnna$aC1 4B, Sepharose
=450  \\$wnnna$aSepharose 4B
=450  \\$wnnna$aSepharose C1 4B
=550  \\$wg$aPolysaccharides
=688  \\$a84(75); was see under POLYSACCHARIDES 1975-83
=750  \0$aSepharose$5IEN$0(DLC)sh 85120107

=LDR  01266cz  a2200313n  4500
=001  9880363919802441
=005  20141212205558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012684
=035  \\$aCBA5995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x710
=150  \\$aSensory Thresholds
=450  \\$wnnna$aSensory Threshold
=450  \\$wnnna$aThreshold, Sensory
=450  \\$wnnna$aThresholds, Sensory
=550  \\$wg$aPerception
=550  \\$wh$aAuditory Threshold
=550  \\$wh$aDifferential Threshold
=550  \\$wh$aPain Threshold
=550  \\$wh$aSignal Detection, Psychological
=550  \\$wh$aSubliminal Stimulation
=550  \\$wh$aTaste Threshold
=550  \\$aPain Measurement
=550  \\$aSignal Detection, Psychological
=667  \\$aIM GEN or unspecified; AUDITORY THRESHOLD; DIFFERENTIAL THRESHOLD; PAIN THRESHOLD; SUBLIMINAL STIMULATION & TASTE THRESHOLD are also available; coord NIM with specific sensory concept (IM), e.g., visual threshold = SENSORY THRESHOLD (NIM) + VISUAL PERCEPTION (IM)
=680  \\$iThe minimum amount of stimulus energy necessary to elicit a sensory response.
=688  \\$a79; was THRESHOLD (NON MESH) before 1979
=750  \0$aThreshold (Perception)$5IEN$0(DLC)sh 85135045

=LDR  00663cz  a2200205n  4500
=001  9880363919902441
=005  20141212205557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012683
=035  \\$aCBA5994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x696
=150  \\$aSensory Deprivation
=450  \\$wnnna$aDeprivation, Sensory
=450  \\$wnnna$aDeprivations, Sensory
=450  \\$wnnna$aSensory Deprivations
=550  \\$wg$aPerception
=667  \\$ahuman & animal
=680  \\$iThe absence or restriction of the usual external sensory stimuli to which the individual responds.
=750  \0$aSensory deprivation$5IEN$0(DLC)sh 85120053

=LDR  01263cz  a2200337n  4500
=001  9880363920002441
=005  20141212205557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012681
=035  \\$aCBA5992HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x316.$x697
=072  \\$aF4.$x754.$x864.$x581.$x813
=150  \\$aSensitivity Training Groups
=450  \\$wnnna$aEncounter Group
=450  \\$aEncounter Groups
=450  \\$wnnna$aGroup, Encounter
=450  \\$wnnna$aGroup, Sensitivity Training
=450  \\$wnnna$aGroups, Encounter
=450  \\$wnnna$aGroups, Sensitivity Training
=450  \\$wnnna$aSensitivity Training Group
=450  \\$wnnna$aT-Group
=450  \\$aT-Groups
=450  \\$wnnna$aT Groups
=450  \\$wnnna$aTraining Group, Sensitivity
=450  \\$wnnna$aTraining Groups, Sensitivity
=550  \\$wg$aGroup Processes
=550  \\$wg$aPsychotherapy, Group
=680  \\$iA group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, and group processes and about larger social systems.
=688  \\$a72(69); ENCOUNTER GROUPS was heading 1975-96 (see under SENSITIVITY TRAINING GROUPS 1975-90)
=750  \0$aGroup relations training$5IEN$0(DLC)sh 85057495

=LDR  00587cz  a2200241n  4500
=001  9880363920102441
=005  20141212205556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012679
=035  \\$aCBA5990HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9
=150  \\$aSense Organs
=450  \\$wnnna$aOrgan, Sense
=450  \\$wnnna$aOrgans, Sense
=450  \\$wnnna$aSense Organ
=550  \\$wh$aEar
=550  \\$wh$aEye
=550  \\$wh$aNose
=550  \\$wh$aTaste Buds
=667  \\$aGEN: prefer specifics
=688  \\$a72
=750  \0$aSense organs$5IEN$0(DLC)sh 85120042

=LDR  01246cz  a2200349n  4500
=001  9880363920202441
=005  20141212205556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012678
=035  \\$aCBA5989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751
=072  \\$aC23.$x888.$x592.$x763
=150  \\$aSensation Disorders
=450  \\$wnnna$aSensation Disorder
=450  \\$wnnna$aSenses Disorder, Special
=450  \\$wnnna$aSenses Disorders, Special
=450  \\$wnnna$aSensory Disorder
=450  \\$aSensory Disorders
=450  \\$wnnna$aSpecial Senses Disorder
=450  \\$aSpecial Senses Disorders
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aDizziness
=550  \\$wh$aHearing Disorders
=550  \\$wh$aOlfaction Disorders
=550  \\$wh$aSomatosensory Disorders
=550  \\$wh$aTaste Disorders
=550  \\$wh$aVision Disorders
=667  \\$aGEN or unspecified: prefer specifics
=680  \\$iDisorders of the special senses (i.e., VISION; HEARING; TASTE; and SMELL) or somatosensory system (i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM).
=688  \\$a1993; was SENSATION DISORDERS (NON MESH) 1967-92
=750  \0$aSensory disorders$0(DLC) sh2005001956$5IEN-M

=LDR  01469cz  a2200433n  4500
=001  9880363920302441
=005  20141212205555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012677
=035  \\$aCBA5988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816
=072  \\$aG11.$x561.$x600.$x810
=150  \\$aSensation
=450  \\$wnnna$aFunction, Sensory
=450  \\$wnnna$aFunctions, Sensory
=450  \\$wnnna$aOrganoleptic
=450  \\$wnnna$aSensations
=450  \\$aSensory Function
=450  \\$wnnna$aSensory Functions
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aPsychophysiology
=550  \\$wh$aBreakthrough Pain
=550  \\$wh$aGravity Sensing
=550  \\$wh$aHearing
=550  \\$wh$aMastodynia
=550  \\$wh$aMusculoskeletal Pain
=550  \\$wh$aPain
=550  \\$wh$aPleasure
=550  \\$wh$aProprioception
=550  \\$wh$aSmell
=550  \\$wh$aTaste
=550  \\$wh$aThermosensing
=550  \\$wh$aTouch
=550  \\$wh$aVision, Ocular
=550  \\$aPerception
=667  \\$aSENSATION DISORDERS is available but burning, tingling or prickling sensations go under PARESTHESIA
=680  \\$iThe process in which specialized SENSORY RECEPTOR CELLS transduce peripheral stimuli (physical or chemical) into NERVE IMPULSES which are then transmitted to the various sensory centers in the CENTRAL NERVOUS SYSTEM.
=750  \0$aSenses and sensation$5IEN$0(DLC)sh 85120047

=LDR  00784cz  a2200229n  4500
=001  9880363920402441
=005  20141212205554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012674
=035  \\$aCBA5985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x800
=150  \\$aSenecio
=450  \\$aGroundsel
=450  \\$wnnna$aGroundsels
=450  \\$aRagwort
=450  \\$wnnna$aRagworts
=450  \\$wnnna$aSenecios
=550  \\$wg$aAsteraceae
=667  \\$apoisonous to livestock
=680  \\$iA species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals.
=750  \0$aSenecio$5IEN$0(DLC)sh 85119996

=LDR  00624cz  a2200193n  4500
=001  9880363920502441
=005  20141212205554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012672
=035  \\$aCBA5983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x850.$x54.$x840
=072  \\$aB4.$x909.$x777.$x923.$x54.$x840
=150  \\$aSemliki forest virus
=550  \\$wg$aAlphavirus
=667  \\$ainfection: coord IM with ALPHAVIRUS INFECTIONS (IM)
=680  \\$iA species of ALPHAVIRUS isolated in central, eastern, and southern Africa.
=688  \\$a66(64)
=750  \0$aSemliki Forest virus$5IEN$0(DLC)sh 85119971

=LDR  00750cz  a2200193n  4500
=001  9880363920602441
=005  20141212205553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012669
=035  \\$aCBA5980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x713
=150  \\$aSeminal Vesicles
=450  \\$wnnna$aSeminal Vesicle
=450  \\$wnnna$aVesicle, Seminal
=450  \\$wnnna$aVesicles, Seminal
=550  \\$wg$aGenitalia, Male
=680  \\$iA saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aSeminal vesicles$5IEN$0(DLC)sh 85119927

=LDR  00726cz  a2200205n  4500
=001  9880363920702441
=005  20141212205552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012666
=035  \\$aCBA5977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x625
=150  \\$aSemiconductors
=450  \\$wnnna$aSemiconductor
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wh$aTransistors, Electronic
=550  \\$aQuantum Dots
=680  \\$iMaterials that have a limited and usually variable electrical conductivity. They are particularly useful for the production of solid-state electronic devices.
=688  \\$a73(67); was in Cat H & J 1967-82
=750  \0$aSemiconductors$5IEN$0(DLC)sh 85119903

=LDR  00948cz  a2200205n  4500
=001  9880363920802441
=005  20141212205552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012665
=035  \\$aCBA5976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x631.$x663
=150  \\$aSemicircular Canals
=450  \\$wnnna$aCanal, Semicircular
=450  \\$wnnna$aCanals, Semicircular
=450  \\$wnnna$aSemicircular Canal
=550  \\$wg$aEar, Inner
=550  \\$wh$aSemicircular Ducts
=680  \\$iThree long canals (anterior, posterior, and lateral) of the bony labyrinth. They are set at right angles to each other and are situated posterosuperior to the vestibule of the bony labyrinth (VESTIBULAR LABYRINTH). The semicircular canals have five openings into the vestibule with one shared by the anterior and the posterior canals. Within the canals are the SEMICIRCULAR DUCTS.
=750  \0$aSemicircular canals$5IEN$0(DLC)sh 85119888

=LDR  01036cz  a2200277n  4500
=001  9880363920902441
=005  20141212205551.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012662
=035  \\$aCBA5973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x792.$x833.$x890
=072  \\$aE5.$x760.$x833.$x890
=150  \\$aSemen Preservation
=450  \\$aFrozen Semen
=450  \\$wnnna$aPreservation, Semen
=450  \\$wnnna$aPreservation, Sperm
=450  \\$wnnna$aSemen, Frozen
=450  \\$aSperm Preservation
=550  \\$wg$aTissue Preservation
=550  \\$aInsemination, Artificial
=550  \\$aTissue and Organ Harvesting
=667  \\$acryopreservation of semen: coord IM with CRYOPRESERVATION (IM)
=680  \\$iThe process by which semen is kept viable outside of the organism from which it was derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism).
=688  \\$a78
=750  \0$aFrozen semen$5IEN$0(DLC)sh 85119884

=LDR  00887cz  a2200193n  4500
=001  9880363921002441
=005  20141212205551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012661
=035  \\$aCBA5972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x732
=150  \\$aSemen
=450  \\$wnnna$aPlasma, Seminal
=450  \\$aSeminal Plasma
=550  \\$wg$aBodily Secretions
=667  \\$asemen donors: coord SEMEN (IM) + TISSUE DONORS (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) (IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) (IM) if pertinent; HEMOSPERMIA is available
=680  \\$iThe thick, yellowish-white, viscid fluid secretion of male reproductive organs discharged upon ejaculation. In addition to reproductive organ secretions, it contains SPERMATOZOA and their nutrient plasma.
=750  \0$aSemen$0(DLC) sh 85119883$5IEN

=LDR  00631cz  a2200193n  4500
=001  9880363921202441
=005  20141212205550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012658
=035  \\$aCBA5969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x802.$x662
=150  \\$aSella Turcica
=450  \\$wnnna$aSella Turcicas
=450  \\$wnnna$aTurcica, Sella
=450  \\$wnnna$aTurcicas, Sella
=550  \\$wg$aSphenoid Bone
=680  \\$iA bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.
=750  \0$aSella turcica$5IEN$0(DLC)sh 91001197

=LDR  01435cz  a2200361n  4500
=001  9880363921302441
=005  20141212205550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012657
=035  \\$aCBA5968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x540.$x782
=150  \\$aSelf-Help Groups
=450  \\$wnnna$aClub, Therapeutic Social
=450  \\$wnnna$aClubs, Therapeutic Social
=450  \\$wnnna$aGroup, Self-Help
=450  \\$wnnna$aGroup, Support
=450  \\$wnnna$aGroups, Self-Help
=450  \\$wnnna$aGroups, Support
=450  \\$wnnna$aSelf-Help Group
=450  \\$wnnna$aSelf Help Groups
=450  \\$wnnna$aSocial Club, Therapeutic
=450  \\$aSocial Clubs, Therapeutic
=450  \\$wnnna$aSupport Group
=450  \\$aSupport Groups
=450  \\$wnnna$aTherapeutic Social Club
=450  \\$wnnna$aTherapeutic Social Clubs
=550  \\$wg$aOrganizations
=550  \\$wh$aAlcoholics Anonymous
=550  \\$aSocial Support
=680  \\$iOrganizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs.
=688  \\$a79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 (Prov)
=750  \0$aSelf-help groups$5IEN$0(DLC)sh 85119757

=LDR  01183cz  a2200337n  4500
=001  9880363921402441
=005  20141212205549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012656
=035  \\$aCBA5967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x796
=150  \\$aSelf-Help Devices
=450  \\$wnnna$aAssistive Device
=450  \\$aAssistive Devices
=450  \\$wnnna$aAssistive Technologies
=450  \\$aAssistive Technology
=450  \\$wnnna$aDevice, Assistive
=450  \\$wnnna$aDevice, Self-Help
=450  \\$wnnna$aDevices, Assistive
=450  \\$wnnna$aDevices, Self-Help
=450  \\$wnnna$aSelf-Help Device
=450  \\$wnnna$aSelf Help Devices
=450  \\$wnnna$aTechnologies, Assistive
=450  \\$wnnna$aTechnology, Assistive
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aCommunication Aids for Disabled
=550  \\$wh$aWheelchairs
=550  \\$aDisabled Persons
=680  \\$iDevices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.
=750  \0$aSelf-help devices for people with disabilities$5IEN$0(DLC)sh 85119755

=LDR  00709cz  a2200205n  4500
=001  9880363921502441
=005  20141212205548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012652
=035  \\$aCBA5963HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x780
=072  \\$aF1.$x145.$x126.$x980.$x750
=150  \\$aSelf Mutilation
=450  \\$wnnna$aMutilation, Self
=550  \\$wg$aSelf-Injurious Behavior
=550  \\$wg$aWounds and Injuries
=667  \\$aSELF-INJURIOUS BEHAVIOR is also available
=680  \\$iThe act of injuring one's own body to the extent of cutting off or permanently destroying a limb or other essential part of a body.
=750  \0$aSelf-mutilation$0(DLC) sh 85119771$5IEN

=LDR  00788cz  a2200241n  4500
=001  9880363921602441
=005  20141212205548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012651
=035  \\$aCBA5962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x900
=072  \\$aE2.$x900.$x900
=150  \\$aSelf Medication
=450  \\$wnnna$aMedication, Self
=450  \\$wnnna$aMedications, Self
=450  \\$wnnna$aSelf Medications
=550  \\$wg$aDrug Therapy
=550  \\$wg$aSelf Care
=667  \\$adifferentiate from SELF ADMINISTRATION & SELF CARE (see note there)
=680  \\$iThe self administration of medication not prescribed by a physician or in a manner not directed by a physician.
=688  \\$a68(65)
=750  \0$aSelf medication$5IEN$0(DLC)sh 85119770

=LDR  00754cz  a2200229n  4500
=001  9880363921702441
=005  20141212205548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012650
=035  \\$aCBA5961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x792.$x662
=150  \\$aSelf Disclosure
=450  \\$wnnna$aDisclosure, Self
=450  \\$wnnna$aDisclosures, Self
=450  \\$wnnna$aSelf Disclosures
=550  \\$wg$aSelf Concept
=550  \\$aPrivacy
=667  \\$a"a willingness to reveal information about oneself to others"; no qualif
=680  \\$iA willingness to reveal information about oneself to others.
=688  \\$a79(75); was see under SELF CONCEPT 1969-78
=750  \0$aSelf-disclosure$5IEN$0(DLC)sh 85119736

=LDR  01279cz  a2200409n  4500
=001  9880363921802441
=005  20141212205547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012649
=035  \\$aCBA5960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x792
=150  \\$aSelf Concept
=450  \\$wnnna$aConcept, Self
=450  \\$wnnna$aConcepts, Self
=450  \\$wnnna$aEsteem, Self
=450  \\$wnnna$aEsteems, Self
=450  \\$wnnna$aPerception, Self
=450  \\$wnnna$aPerceptions, Self
=450  \\$wnnna$aSelf Concepts
=450  \\$aSelf Esteem
=450  \\$wnnna$aSelf Esteems
=450  \\$wnnna$aSelf-Perception
=450  \\$aSelf Perception
=450  \\$wnnna$aSelf Perceptions
=450  \\$wnnna$aSelf-Perceptions
=550  \\$wg$aPersonality Development
=550  \\$wh$aDiagnostic Self Evaluation
=550  \\$wh$aSelf-Assessment
=550  \\$wh$aSelf Disclosure
=550  \\$wh$aSelf Efficacy
=550  \\$wh$aSense of Coherence
=550  \\$aPersonal Autonomy
=667  \\$ado not confuse with SELF PSYCHOLOGY: see MeSH definition; no qualif
=680  \\$iA person's view of himself.
=688  \\$a69; SELF PERCEPTION was see under SELF CONCEPT 1969-78
=750  \0$aSelf-perception$5IEN$0(DLC)sh 85119775

=LDR  01236cz  a2200289n  4500
=001  9880363921902441
=005  20141212205547.0
=008  800519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012648
=035  \\$aCBA5959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x900
=072  \\$aN2.$x421.$x784.$x680
=150  \\$aSelf Care
=450  \\$wnnna$aCare, Self
=450  \\$wnnna$aSelf-Care
=450  \\$wnnna$aSelf-Management
=450  \\$wnnna$aSelf Management
=550  \\$wg$aRehabilitation
=550  \\$wg$aTherapeutics
=550  \\$wh$aBlood Glucose Self-Monitoring
=550  \\$wh$aSelf Administration
=550  \\$wh$aSelf Medication
=667  \\$a= care prescribed by MD or generated by person himself & includes care for self, family or friends; differentiate from SELF MEDICATION (medication not prescribed by MD) and SELF ADMINISTRATION (admin of medication prescribed by MD or self admin of substances by exper animals)
=680  \\$iPerformance of activities or tasks traditionally performed by professional health care providers. The concept includes care of oneself or one's family and friends.
=688  \\$a81; was see ACTIVITIES OF DAILY LIVING 1979-80
=750  \0$aSelf-care, Health$5IEN$0(DLC)sh 85119714

=LDR  00791cz  a2200205n  4500
=001  9880363922002441
=005  20141212205546.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012644
=035  \\$aCBA5955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x780
=150  \\$aSelenium Radioisotopes
=450  \\$wnnna$aRadioisotopes, Selenium
=550  \\$wg$aRadioisotopes
=550  \\$aSelenium
=667  \\$aSe-70-73, 75, 79, 81, 83-85; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of selenium that decay or disintegrate emitting radiation. Se atoms with atomic weights 70-73, 75, 79, 81, and 83-85 are radioactive selenium isotopes.
=688  \\$a88
=750  \0$aSelenium$xIsotopes$5IEN-M$0(DLC)sh 85119689

=LDR  00874cz  a2200193n  4500
=001  9880363922102441
=005  20141212205545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012643
=035  \\$aCBA5954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x185.$x850
=072  \\$aD1.$x578.$x700
=150  \\$aSelenium
=550  \\$wg$aChalcogens
=550  \\$wg$aMinerals
=667  \\$aSe-80; Se-74, 76-78, 82 = SELENIUM (IM) + ISOTOPES (NIM); Se-70-73, 75, 79, 81, 83-85 = SELENIUM RADIOISOTOPES (IM)
=680  \\$iAn element with the atomic symbol Se, atomic number 34, and atomic weight 78.96. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.
=750  \0$aSelenium$5IEN-M$0(DLC)sh 85119688

=LDR  01927cz  a2200481n  4500
=001  9880363922202441
=005  20141212205545.0
=008  771209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012642
=035  \\$aCBA5953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x915
=150  \\$aSelegiline
=450  \\$wnnna$aBristol-Myers Squibb Brand of Selegiline
=450  \\$wnnna$aBristol Myers Squibb Brand of Selegiline
=450  \\$aDeprenalin
=450  \\$aDeprenil
=450  \\$aDeprenyl
=450  \\$wnnna$aE-250
=450  \\$wnnna$aE 250
=450  \\$wnnna$aE250
=450  \\$wnnna$aEldepryl
=450  \\$wnnna$aEmsam
=450  \\$wnnna$aHumex
=450  \\$wnnna$aHydrochloride, Selegiline
=450  \\$wnnna$aJumex
=450  \\$wnnna$aL-Deprenyl
=450  \\$wnnna$aSelegiline Hydrochloride
=450  \\$wnnna$aSelegiline Hydrochloride, (R)-Isomer
=450  \\$wnnna$aSelegiline Hydrochloride, (R,S)-Isomer
=450  \\$wnnna$aSelegiline Hydrochloride, (S)-Isomer
=450  \\$wnnna$aSelegiline, (R)-Isomer
=450  \\$wnnna$aSelegiline, (R,S)-Isomer
=450  \\$wnnna$aSelegiline, (S)-Isomer
=450  \\$wnnna$aSelegiline Valeant Brand
=450  \\$wnnna$aSelegyline
=450  \\$wnnna$aValeant Brand of Selegiline
=450  \\$wnnna$aYumex
=450  \\$wnnna$aZelapar
=550  \\$wg$aPhenethylamines
=680  \\$iA selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.
=688  \\$a91(84); was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83
=750  \0$aSelegiline$5IEN$0(DLC)sh 87007222

=LDR  00904cz  a2200229n  4500
=001  9880363922302441
=005  20141212205544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x800
=150  \\$aSelection, Genetic
=450  \\$wnnna$aGenetic Selection
=450  \\$aNatural Selection
=450  \\$wnnna$aSelection, Natural
=550  \\$wg$aGenetic Processes
=550  \\$aGenetic Fitness
=680  \\$iDifferential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.
=688  \\$a68; NATURAL SELECTION was indexed under EVOLUTION 1978
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Selection (Genetics)
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20100901: 150:##:_{dollar}a Selection (Genetics)
=750  \0$aNatural selection$0(DLC) sh 85090264$5IEN

=LDR  04107cz  a2201141n  4500
=001  9880363922402441
=005  20141212205544.0
=008  780517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012640
=035  \\$aCBA5951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x631
=072  \\$aC10.$x597.$x742
=072  \\$aC23.$x888.$x592.$x742
=150  \\$aSeizures
=450  \\$wnnna$aAuditory Seizure
=450  \\$wnnna$aAuditory Seizures
=450  \\$wnnna$aClonic Seizure
=450  \\$wnnna$aClonic Seizures
=450  \\$wnnna$aConvulsion
=450  \\$wnnna$aConvulsion, Non-Epileptic
=450  \\$wnnna$aConvulsion, Non Epileptic
=450  \\$aConvulsions
=450  \\$wnnna$aConvulsions, Non-Epileptic
=450  \\$wnnna$aConvulsive Seizure
=450  \\$aConvulsive Seizures
=450  \\$wnnna$aFocal Seizure
=450  \\$wnnna$aFocal Seizures
=450  \\$wnnna$aGeneralized Seizure
=450  \\$wnnna$aGeneralized Seizures
=450  \\$wnnna$aGustatory Seizure
=450  \\$wnnna$aGustatory Seizures
=450  \\$aJacksonian Seizure
=450  \\$wnnna$aMotor Seizure
=450  \\$wnnna$aMotor Seizures
=450  \\$wnnna$aNon-Epileptic Convulsion
=450  \\$wnnna$aNon-Epileptic Convulsions
=450  \\$wnnna$aOlfactory Seizure
=450  \\$wnnna$aOlfactory Seizures
=450  \\$wnnna$aSeizure
=450  \\$wnnna$aSeizure, Auditory
=450  \\$wnnna$aSeizure, Clonic
=450  \\$wnnna$aSeizure, Convulsive
=450  \\$wnnna$aSeizure, Focal
=450  \\$wnnna$aSeizure, Generalized
=450  \\$wnnna$aSeizure, Gustatory
=450  \\$wnnna$aSeizure, Jacksonian
=450  \\$wnnna$aSeizure, Motor
=450  \\$wnnna$aSeizure, Olfactory
=450  \\$wnnna$aSeizure, Sensory
=450  \\$wnnna$aSeizure, Somatosensory
=450  \\$wnnna$aSeizure, Tonic
=450  \\$wnnna$aSeizure, Tonic-Clonic
=450  \\$wnnna$aSeizure, Vertiginous
=450  \\$wnnna$aSeizure, Vestibular
=450  \\$wnnna$aSeizure, Visual
=450  \\$wnnna$aSeizures, Auditory
=450  \\$wnnna$aSeizures, Clonic
=450  \\$aSeizures, Convulsive
=450  \\$aSeizures, Focal
=450  \\$aSeizures, Generalized
=450  \\$wnnna$aSeizures, Gustatory
=450  \\$aSeizures, Motor
=450  \\$wnnna$aSeizures, Olfactory
=450  \\$aSeizures, Sensory
=450  \\$wnnna$aSeizures, Somatosensory
=450  \\$wnnna$aSeizures, Tonic
=450  \\$wnnna$aSeizures, Tonic-Clonic
=450  \\$wnnna$aSeizures, Tonic Clonic
=450  \\$wnnna$aSeizures, Vertiginous
=450  \\$wnnna$aSeizures, Vestibular
=450  \\$wnnna$aSeizures, Visual
=450  \\$wnnna$aSensory Seizure
=450  \\$wnnna$aSensory Seizures
=450  \\$wnnna$aSomatosensory Seizure
=450  \\$wnnna$aSomatosensory Seizures
=450  \\$wnnna$aTonic-Clonic Seizure
=450  \\$wnnna$aTonic-Clonic Seizures
=450  \\$wnnna$aTonic Seizure
=450  \\$wnnna$aTonic Seizures
=450  \\$wnnna$aVertiginous Seizure
=450  \\$wnnna$aVertiginous Seizures
=450  \\$wnnna$aVestibular Seizure
=450  \\$wnnna$aVestibular Seizures
=450  \\$wnnna$aVisual Seizure
=450  \\$wnnna$aVisual Seizures
=550  \\$wg$aEpilepsy
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aAlcohol Withdrawal Seizures
=550  \\$aAnticonvulsants
=550  \\$aConvulsants
=550  \\$aEclampsia
=550  \\$aEpilepsy
=550  \\$aKindling, Neurologic
=667  \\$anote other specific seizure terms in MeSH; audiogenic or acoustic seizures = REFLEX EPILEPSY, AUDIOGENIC
=680  \\$iClinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder."
=688  \\$a1979; for CONVULSIVE SEIZURES & SEIZURES, CONVULSIVE use CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE use EPILEPSY, PARTIAL 1992-1999
=750  \0$aSpasms$5IEN$0(DLC)sh 85126339

=LDR  01353cz  a2200337n  4500
=001  9880363922502441
=005  20141212205543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012639
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x500.$x750
=072  \\$aJ2.$x500.$x775
=150  \\$aSeeds
=450  \\$wnnna$aEmbryo, Plant
=450  \\$aEmbryos, Plant
=450  \\$wnnna$aPlant Embryo
=450  \\$aPlant Embryos
=450  \\$wnnna$aPlant Zygote
=450  \\$aPlant Zygotes
=450  \\$wnnna$aSeed
=450  \\$wnnna$aZygote, Plant
=450  \\$aZygotes, Plant
=550  \\$wg$aFood
=550  \\$wg$aFruit
=550  \\$wh$aCotyledon
=550  \\$wh$aEndosperm
=550  \\$aPlants
=667  \\$aIM GEN or unspecified; for seed of specific plants, coord IM with plant (IM), as sunflower seeds = SEEDS (IM) + HELIANTHUS (IM); coord probably IM in genetics & space physiol, NIM in pharmacognosy, with specific plant (IM or NIM)
=680  \\$iThe encapsulated embryos of flowering plants. They are used as is or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are also produced for the oils (fats) they yield.
=688  \\$a63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94
=750  \0$aSeeds$5IEN$0(DLC)sh 85119543

=LDR  00788cz  a2200253n  4500
=001  9880363922602441
=005  20141212205542.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012637
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x910
=150  \\$aSecurity Measures
=450  \\$wnnna$aMeasure, Security
=450  \\$wnnna$aMeasures, Security
=450  \\$wnnna$aNational Security
=450  \\$wnnna$aSecurity Measure
=450  \\$wnnna$aSecurity, National
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aBiometric Identification
=550  \\$wh$aComputer Security
=667  \\$amed or non-med contexts
=680  \\$iRegulations to assure protection of property and equipment.
=688  \\$a78
=750  \0$aSecurity systems$5IEN$0(DLC)sh 85119483

=LDR  01358cz  a2200469n  4500
=001  9880363922702441
=005  20141212205541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012634
=035  \\$aCBA5945HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200
=150  \\$aBodily Secretions
=450  \\$wnnna$aBodily Secretion
=450  \\$wnnna$aSecretion
=450  \\$wnnna$aSecretion, Bodily
=450  \\$aSecretions
=450  \\$wnnna$aSecretions, Bodily
=550  \\$wg$aFluids and Secretions
=550  \\$wh$aBile
=550  \\$wh$aCerumen
=550  \\$wh$aColostrum
=550  \\$wh$aDander
=550  \\$wh$aGastric Juice
=550  \\$wh$aIntestinal Secretions
=550  \\$wh$aMilk
=550  \\$wh$aMilk, Human
=550  \\$wh$aMucus
=550  \\$wh$aPancreatic Juice
=550  \\$wh$aSaliva
=550  \\$wh$aSebum
=550  \\$wh$aSemen
=550  \\$wh$aSmegma
=550  \\$wh$aSputum
=550  \\$wh$aSweat
=550  \\$wh$aTears
=550  \\$wh$aVenoms
=550  \\$wh$aVernix Caseosa
=667  \\$ageneral or unspecified; prefer specific secretion or anatomical and chemical terms with / secret
=680  \\$iEndogenous substances produced through the activity of intact cells of glands, tissues, or organs.
=688  \\$a98; use explode 1967-97
=750  \0$aSecretion$5IEN-M$0(DLC)sh 85119448

=LDR  01182cz  a2200325n  4500
=001  9880363922802441
=005  20141212205452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012469
=035  \\$aCBA5778HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x760
=072  \\$aA10.$x336.$x779
=072  \\$aA14.$x549.$x760
=150  \\$aSalivary Glands
=360  \\$iconsider also terms at$aSIAL-
=450  \\$wnnna$aGland, Salivary
=450  \\$wnnna$aGlands, Salivary
=450  \\$wnnna$aSalivary Gland
=550  \\$wg$aExocrine Glands
=550  \\$wg$aMouth
=550  \\$wh$aParotid Gland
=550  \\$wh$aSalivary Ducts
=550  \\$wh$aSalivary Glands, Minor
=550  \\$wh$aSublingual Gland
=550  \\$wh$aSubmandibular Gland
=550  \\$wh$avon Ebner Glands
=667  \\$aGEN; /secret: see also SALIVATION; inflammation = SIALADENITIS; tuberc of salivary glands or tuberc sialadenitis = SIALADENITIS (IM) + TUBERCULOSIS, ORAL (IM)
=680  \\$iGlands that secrete SALIVA in the MOUTH. There are three pairs of salivary glands (PAROTID GLAND; SUBLINGUAL GLAND; SUBMANDIBULAR GLAND).
=750  \0$aSalivary glands$5IEN$0(DLC)sh 85116807

=LDR  01365cz  a2200385n  4500
=001  9880363922902441
=005  20141212205452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012468
=035  \\$aCBA5777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591.$x824
=072  \\$aC7.$x465.$x565.$x824
=072  \\$aC7.$x465.$x815.$x718
=150  \\$aSalivary Gland Neoplasms
=450  \\$aCancer of Salivary Gland
=450  \\$wnnna$aCancer of the Salivary Gland
=450  \\$wnnna$aCancer, Salivary Gland
=450  \\$wnnna$aCancers, Salivary Gland
=450  \\$wnnna$aGland Neoplasm, Salivary
=450  \\$wnnna$aGland Neoplasms, Salivary
=450  \\$wnnna$aNeoplasm, Salivary Gland
=450  \\$wnnna$aNeoplasms, Salivary Gland
=450  \\$aSalivary Gland Cancer
=450  \\$wnnna$aSalivary Gland Cancers
=450  \\$wnnna$aSalivary Gland Neoplasm
=550  \\$wg$aMouth Neoplasms
=550  \\$wg$aSalivary Gland Diseases
=550  \\$wh$aParotid Neoplasms
=550  \\$wh$aSublingual Gland Neoplasms
=550  \\$wh$aSubmandibular Gland Neoplasms
=667  \\$aGEN: prefer specific precoord; coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the SALIVARY GLANDS.
=750  \0$aSalivary glands$xCancer$5IEN-M$0(DLC)sh2010010287
=750  \0$aSalivary glands$xTumors$5IEN-M$0(IEN)380286

=LDR  01190cz  a2200349n  4500
=001  9880363923002441
=005  20141212205451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012466
=035  \\$aCBA5775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x815
=150  \\$aSalivary Gland Diseases
=450  \\$wnnna$aDisease, Salivary Gland
=450  \\$wnnna$aDiseases, Salivary Gland
=450  \\$wnnna$aGland Disease, Salivary
=450  \\$wnnna$aGland Diseases, Salivary
=450  \\$wnnna$aSalivary Gland Disease
=550  \\$wg$aMouth Diseases
=550  \\$wh$aMikulicz' Disease
=550  \\$wh$aParotid Diseases
=550  \\$wh$aSalivary Calculi
=550  \\$wh$aSalivary Gland Fistula
=550  \\$wh$aSalivary Gland Neoplasms
=550  \\$wh$aSialadenitis
=550  \\$wh$aSialometaplasia, Necrotizing
=550  \\$wh$aSialorrhea
=550  \\$wh$aSubmandibular Gland Diseases
=550  \\$wh$aXerostomia
=667  \\$aGEN: prefer specifics; inflamm dis = SIALADENITIS; tuberc sialadenitis or tuberc of salivary glands = SIALADENITIS (IM) + TUBERCULOSIS, ORAL (IM)
=688  \\$a65
=750  \0$aSalivary glands$xDiseases$5IEN$0(DLC)sh 85116808

=LDR  00709cz  a2200181n  4500
=001  9880363923102441
=005  20141212205450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012463
=035  \\$aCBA5771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x666
=150  \\$aSaliva
=450  \\$wnnna$aSalivas
=550  \\$wg$aBodily Secretions
=667  \\$aSALIVATION and SALIVARY GLANDS are also available; "salivary IMMUNOGLOBULIN A": index SALIVA/immunol (IM) + IMMUNOGLOBULIN A, SECRETORY (IM)
=680  \\$iThe clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.
=750  \0$aSaliva$5IEN$0(DLC)sh 85116804

=LDR  01239cz  a2200337n  4500
=001  9880363923202441
=005  20141212205449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012459
=035  \\$aCBA5767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x300.$x595
=072  \\$aD2.$x241.$x511.$x390.$x595
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x595
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x595
=150  \\$aSalicylates
=450  \\$wnnna$aAcids, Salicylic
=450  \\$aSalicylic Acid$xanalogs & derivatives
=450  \\$wnnna$aSalicylic Acids
=550  \\$wg$aHydroxybenzoates
=550  \\$wh$aAminosalicylic Acids
=550  \\$wh$aAnacardic Acids
=550  \\$wh$aAspirin
=550  \\$wh$aDicamba
=550  \\$wh$aDiflunisal
=550  \\$wh$aGentisates
=550  \\$wh$aSalicylic Acid
=680  \\$iThe salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.
=688  \\$a1963
=688  \\$a63; for BISMUTH SALICYLATE & MAGNESIUM SALICYLATE use SALICYLIC ACID (NM) 1981-98
=750  \0$aSalicylates$5IEN$0(DLC)sh 85116753

=LDR  01250cz  a2200385n  4500
=001  9880363943502441
=005  20141212204959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011593
=035  \\$aCBA4889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829
=072  \\$aF4.$x96.$x628.$x829
=150  \\$aPsychology, Social
=450  \\$wnnna$aPsychologies, Social
=450  \\$wnnna$aSocial Psychologies
=450  \\$aSocial Psychology
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wg$aPsychology
=550  \\$wh$aDouble Bind Interaction
=550  \\$wh$aFamily
=550  \\$wh$aGroup Processes
=550  \\$wh$aInternal-External Control
=550  \\$wh$aInterpersonal Relations
=550  \\$wh$aLife Style
=550  \\$wh$aMorale
=550  \\$wh$aMorals
=550  \\$wh$aPaternalism
=550  \\$wh$aPrejudice
=550  \\$wh$aPsychosocial Deprivation
=550  \\$wh$aSocial Norms
=550  \\$wh$aSocial Values
=667  \\$aSPEC: IM, SPEC qualif; NIM coord, no qualif; DF: PSYCHOL SOCIAL
=680  \\$iThe branch of psychology concerned with the effects of group membership upon the behavior, attitudes, and beliefs of an individual.
=750  \0$aSocial psychology$5IEN$0(DLC)sh 85123994

=LDR  00690cz  a2200181n  4500
=001  9880363943602441
=005  20141212204959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011592
=035  \\$aCBA4888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x754
=150  \\$aPsychology, Military
=450  \\$aMilitary Psychology
=550  \\$wg$aPsychology, Applied
=667  \\$aSPEC: SPEC qualif; consider also MILITARY PERSONNEL /psychol; DF: PSYCHOL MILITARY
=680  \\$iThe branch of applied psychology concerned with psychological aspects of selection, assignment, training, morale, etc., of Armed Forces personnel.
=750  \0$aPsychology, Military$5IEN$0(DLC)sh 85108477

=LDR  01118cz  a2200313n  4500
=001  9880363943702441
=005  20141212204958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011590
=035  \\$aCBA4886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x692
=072  \\$aF4.$x96.$x628.$x779
=150  \\$aPsychology, Industrial
=450  \\$wnnna$aIndustrial Psychologies
=450  \\$wnnna$aIndustrial Psychology
=450  \\$wnnna$aPsychologies, Industrial
=550  \\$wg$aPsychology
=550  \\$wg$aPsychology, Applied
=550  \\$wh$aAbsenteeism
=550  \\$wh$aEfficiency
=550  \\$wh$aJob Satisfaction
=550  \\$wh$aTask Performance and Analysis
=550  \\$wh$aTime Management
=550  \\$wh$aVocational Guidance
=550  \\$aHuman Engineering
=667  \\$aSPEC: SPEC qualif; DF: PSYCHOL INDUST
=680  \\$iThe branch of applied psychology concerned with the application of psychologic principles and methods to industrial problems including selection and training of workers, working conditions, etc.
=750  \0$aPsychology, Industrial$5IEN$0(DLC)sh 85108476

=LDR  00801cz  a2200205n  4500
=001  9880363943802441
=005  20141212204958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011589
=035  \\$aCBA4885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x729
=150  \\$aPsychology, Experimental
=450  \\$wnnna$aExperimental Psychologies
=450  \\$wnnna$aExperimental Psychology
=450  \\$wnnna$aPsychologies, Experimental
=550  \\$wg$aPsychology
=667  \\$aSPEC: SPEC qualif; avoid as NIM coord; DF: PSYCHOL EXPER
=680  \\$iThe branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations.
=750  \0$aPsychology, Experimental$5IEN$0(DLC)sh 85108474

=LDR  01195cz  a2200361n  4500
=001  9880363943902441
=005  20141212204958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011588
=035  \\$aCBA4884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629
=072  \\$aF4.$x96.$x628.$x679
=150  \\$aPsychology, Educational
=450  \\$wnnna$aEducational Psychologies
=450  \\$wnnna$aEducational Psychology
=450  \\$wnnna$aPsychologies, Educational
=550  \\$wg$aPsychology
=550  \\$wg$aPsychology, Applied
=550  \\$wh$aAchievement
=550  \\$wh$aAptitude
=550  \\$wh$aAspirations (Psychology)
=550  \\$wh$aChild, Exceptional
=550  \\$wh$aChild Guidance
=550  \\$wh$aEducation of Intellectually Disabled
=550  \\$wh$aLearning
=550  \\$wh$aRemedial Teaching
=550  \\$wh$aStudent Dropouts
=550  \\$wh$aUnderachievement
=550  \\$wh$aVocational Guidance
=667  \\$aSPEC: SPEC qualif; DF: PSYCHOL EDUC
=680  \\$iThe branch of psychology concerned with psychological aspects of teaching and the formal learning process in school.
=750  \0$aEducational psychology$5IEN$0(DLC)sh 85041141

=LDR  00943cz  a2200205n  4500
=001  9880363944002441
=005  20141212204957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011587
=035  \\$aCBA4883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x629
=150  \\$aPsychology, Comparative
=450  \\$wnnna$aComparative Psychologies
=450  \\$wnnna$aComparative Psychology
=450  \\$wnnna$aPsychologies, Comparative
=550  \\$wg$aPsychology
=667  \\$aSPEC: IM, SPEC qualif; NIM coord, no qualif; do not check COMPARATIVE STUDY for as a field it is not a substitute for a comparison of two or more psychol concepts ( = COMPARATIVE STUDY tag): Manual 18.13.4; DF: PSYCHOL COMPARATIVE
=680  \\$iThe branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples.
=750  \0$aPsychology, Comparative$5IEN$0(DLC)sh 85108473

=LDR  00704cz  a2200205n  4500
=001  9880363944102441
=005  20141212192452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011586
=035  \\$aCBA4882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628.$x579
=150  \\$aPsychology, Clinical
=450  \\$wnnna$aClinical Psychology
=550  \\$wg$aPsychology
=550  \\$aPsychotherapy
=667  \\$aSPEC: SPEC qualif; DF: PSYCHOL CLIN
=680  \\$iThe branch of psychology concerned with psychological methods of recognizing and treating behavior disorders.
=750  \0$aClinical psychologists$5IEN-M$0(DLC)sh 85027066
=750  \0$aClinical psychology$5IEN-HS$0(DLC)sh 85027067

=LDR  00949cz  a2200277n  4500
=001  9880363944202441
=005  20141212204957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011585
=035  \\$aCBA4881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784
=150  \\$aPsychology, Applied
=450  \\$wnnna$aApplied Psychologies
=450  \\$wnnna$aApplied Psychology
=450  \\$wnnna$aPsychologies, Applied
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aCounseling
=550  \\$wh$aCriminal Psychology
=550  \\$wh$aHuman Engineering
=550  \\$wh$aPsychology, Educational
=550  \\$wh$aPsychology, Industrial
=550  \\$wh$aPsychology, Military
=667  \\$aSPEC: SPEC qualif; DF: PSYCHOL APPLIED
=680  \\$iThe science which utilizes psychologic principles to derive more effective means in dealing with practical problems.
=750  \0$aPsychology, Applied$5IEN$0(DLC)sh 85108472

=LDR  01945cz  a2200529n  4500
=001  9880363944302441
=005  20170927143658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011584
=035  \\$aCBA4880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x628
=150  \\$aPsychology
=450  \\$wnnna$aFactor, Psychological
=450  \\$wnnna$aFactor, Psychosocial
=450  \\$wnnna$aFactors, Psychological
=450  \\$wnnna$aFactors, Psychosocial
=450  \\$wnnna$aPsychological Factor
=450  \\$wnnna$aPsychological Factors
=450  \\$wnnna$aPsychological Side Effect
=450  \\$wnnna$aPsychological Side Effects
=450  \\$wnnna$aPsychologist
=450  \\$wnnna$aPsychologists
=450  \\$wnnna$aPsychosocial Factor
=450  \\$wnnna$aPsychosocial Factors
=450  \\$wnnna$aSide Effect, Psychological
=450  \\$wnnna$aSide Effects, Psychological
=550  \\$wg$aBehavioral Sciences
=550  \\$wh$aCognitive Science
=550  \\$wh$aEconomics, Behavioral
=550  \\$wh$aEnvironmental Psychology
=550  \\$wh$aEthnopsychology
=550  \\$wh$aPsychology, Adolescent
=550  \\$wh$aPsychology, Child
=550  \\$wh$aPsychology, Clinical
=550  \\$wh$aPsychology, Comparative
=550  \\$wh$aPsychology, Developmental
=550  \\$wh$aPsychology, Educational
=550  \\$wh$aPsychology, Experimental
=550  \\$wh$aPsychology, Industrial
=550  \\$wh$aPsychology, Medical
=550  \\$wh$aPsychology, Social
=550  \\$wh$aPsychology, Sports
=667  \\$aSPEC: IM, SPEC qualif; prefer /psychol: Manual 19.7+, 19.8.59; NIM for "psychological aspects of" terms not in Cat C, E1-6 & F3: no qualif; as NIM: Manual 27.10 DF: PSYCHOL
=680  \\$iThe science dealing with the study of mental processes and behavior in man and animals.
=750  \0$aPsychology$5IEN-M$0(DLC)sh 85108459
=750  \0$aPsychologists$5IEN-HS$0(DLC)sh 85108453

=LDR  00782cz  a2200217n  4500
=001  9880363944402441
=005  20160826102514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011583
=035  \\$aCBA4879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x500.$x711
=150  \\$aPsychological Warfare
=450  \\$wnnna$aPsychologic Warfare
=450  \\$wnnna$aWarfare, Psychologic
=450  \\$wnnna$aWarfare, Psychological
=550  \\$wg$aWarfare
=550  \\$aPersuasive Communication
=667  \\$ano qualif; DF: PSYCHOL WARFARE
=680  \\$iThe manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one's own country and weaken the enemy.
=750  \0$aPsychological warfare$5IEN$0(DLC)sh 85108451

=LDR  01092cz  a2200337n  4500
=001  9880363944502441
=005  20141212204956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011582
=035  \\$aCBA4878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739
=150  \\$aPsychological Theory
=450  \\$wnnna$aPsychologic Theories
=450  \\$wnnna$aPsychologic Theory
=450  \\$wnnna$aPsychological Theories
=450  \\$wnnna$aTheories, Psychologic
=450  \\$wnnna$aTheories, Psychological
=450  \\$wnnna$aTheory, Psychologic
=450  \\$wnnna$aTheory, Psychological
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aBehaviorism
=550  \\$wh$aExistentialism
=550  \\$wh$aGestalt Theory
=550  \\$wh$aPersonal Construct Theory
=550  \\$wh$aPsychoanalytic Theory
=550  \\$wh$aTheory of Mind
=667  \\$ano qualif; DF: PSYCHOL THEORY
=680  \\$iPrinciples applied to the analysis and explanation of psychological or behavioral phenomena.
=688  \\$a69
=750  \0$aPsychology$5IEN$0(DLC)sh 85108459

=LDR  01150cz  a2200337n  4500
=001  9880363944602441
=005  20180419110217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011581
=035  \\$aCBA4877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711
=150  \\$aPsychological Tests
=450  \\$wnnna$aPsychologic Test
=450  \\$wnnna$aPsychologic Tests
=450  \\$wnnna$aPsychological Test
=450  \\$wnnna$aTest, Psychologic
=450  \\$wnnna$aTest, Psychological
=450  \\$wnnna$aTests, Psychologic
=450  \\$wnnna$aTests, Psychological
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wh$aAptitude Tests
=550  \\$wh$aBehavior Rating Scale
=550  \\$wh$aEcological Momentary Assessment
=550  \\$wh$aLanguage Tests
=550  \\$wh$aNeuropsychological Tests
=550  \\$wh$aPersonality Tests
=550  \\$wh$aPsychometrics
=667  \\$aDF: PSYCHOL TESTS
=680  \\$iStandardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits.
=750  \0$aPsychological tests$5IEN$0(DLC)sh 85108448

=LDR  01098cz  a2200265n  4500
=001  9880363944702441
=005  20141212204954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011578
=035  \\$aCBA4874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x694
=072  \\$aF4.$x96.$x586
=072  \\$aL1.$x143.$x506.$x598.$x628
=150  \\$aPsycholinguistics
=450  \\$wnnna$aPsycholinguistic
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aLinguistics
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aNeurolinguistic Programming
=550  \\$wh$aSemantic Differential
=667  \\$aSPEC: IM, SPEC qualif; coord with specific linguistic & psychol concepts (IM); NIM coord, no qualif
=680  \\$iA discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding (phonetics) and decoding (psychoacoustics) as they relate states of messages to states of communicators.
=688  \\$a67
=750  \0$aPsycholinguistics$5IEN$0(DLC)sh 85108432

=LDR  00793cz  a2200229n  4500
=001  9880363944802441
=005  20141212204954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011577
=035  \\$aCBA4873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x781
=072  \\$aF4.$x754.$x864.$x581.$x679
=150  \\$aPsychodrama
=450  \\$wnnna$aDrama Therapy
=450  \\$wnnna$aDramatherapy
=450  \\$wnnna$aTherapy, Drama
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPsychotherapy, Group
=550  \\$wh$aRole Playing
=680  \\$iPrimarily a technique of group psychotherapy which involves a structured, directed, and dramatized acting out of the patient's personal and emotional problems.
=750  \0$aDrama$xTherapeutic use$0(DLC) sh 85039334$5IEN-M

=LDR  01275cz  a2200385n  4500
=001  9880363944902441
=005  20141212204953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011576
=035  \\$aCBA4872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x781
=150  \\$aPsychodidae
=450  \\$wnnna$aFlies, Moth
=450  \\$wnnna$aFlies, Sand
=450  \\$wnnna$aFly, Moth
=450  \\$wnnna$aFly, Sand
=450  \\$aLutzomyia
=450  \\$wnnna$aLutzomyias
=450  \\$aMoth Flies
=450  \\$wnnna$aMoth Fly
=450  \\$aPhlebotominae
=450  \\$aPsychodinae
=450  \\$wnnna$aSand Flies
=450  \\$wnnna$aSand Fly
=450  \\$aSandflies
=450  \\$wnnna$aSandfly
=450  \\$aSergentomyia
=450  \\$wnnna$aSergentomyias
=550  \\$wg$aDiptera
=550  \\$wh$aPhlebotomus
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iSmall, hairy, moth-like flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia.
=688  \\$a85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72
=750  \0$aPsychodidae$5IEN$0(DLC)sh 85108428

=LDR  01292cz  a2200313n  4500
=001  9880363945002441
=005  20141212204953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011575
=035  \\$aCBA4871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x709
=150  \\$aPsychoanalytic Therapy
=450  \\$aBalint Psychoanalytic Therapy
=450  \\$wnnna$aPsychoanalytic Therapies
=450  \\$wnnna$aPsychoanalytic Therapy, Balint
=450  \\$wnnna$aPsychoanalytical Therapies
=450  \\$wnnna$aPsychoanalytical Therapy
=450  \\$wnnna$aTherapies, Psychoanalytic
=450  \\$wnnna$aTherapies, Psychoanalytical
=450  \\$wnnna$aTherapy, Balint Psychoanalytic
=450  \\$wnnna$aTherapy, Psychoanalytic
=450  \\$wnnna$aTherapy, Psychoanalytical
=550  \\$wg$aPsychotherapy
=550  \\$wh$aFree Association
=550  \\$wh$aTransactional Analysis
=667  \\$aa psychother technique; DF: PSYCHOANAL THER
=680  \\$iA form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior.
=750  \0$aPsychoanalysis$0(DLC) sh 85108411$5IEN

=LDR  01895cz  a2200505n  4500
=001  9880363945102441
=005  20201202114334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011574
=035  \\$aCBA4870HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794
=150  \\$aPsychoanalytic Theory
=450  \\$wnnna$aCharacter, Oral
=450  \\$wnnna$aCharacters, Oral
=450  \\$aOral Character
=450  \\$wnnna$aOral Characters
=450  \\$wnnna$aPsychoanalytic Theories
=450  \\$wnnna$aPsychoanalytical Theories
=450  \\$wnnna$aPsychoanalytical Theory
=450  \\$wnnna$aTheories, Psychoanalytic
=450  \\$wnnna$aTheories, Psychoanalytical
=450  \\$wnnna$aTheory, Psychoanalytic
=450  \\$wnnna$aTheory, Psychoanalytical
=550  \\$wg$aPsychological Theory
=550  \\$wh$aEgo
=550  \\$wh$aExtraversion, Psychological
=550  \\$wh$aFreudian Theory
=550  \\$wh$aId
=550  \\$wh$aInhibition, Psychological
=550  \\$wh$aIntroversion, Psychological
=550  \\$wh$aJungian Theory
=550  \\$wh$aLibido
=550  \\$wh$aNarcissism
=550  \\$wh$aObject Attachment
=550  \\$wh$aOedipus Complex
=550  \\$wh$aPleasure-Pain Principle
=550  \\$wh$aPsychosexual Development
=550  \\$wh$aSelf Psychology
=550  \\$wh$aSuperego
=550  \\$wh$aUnconscious, Psychology
=667  \\$aIM; no qualif; /hist = PSYCHOANALYSIS /hist; differentiate from PSYCHOANALYTIC INTERPRETATION in that the theory is on a more universal, less subjective level
=680  \\$iConceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior.
=688  \\$a66; ORAL CHARACTER was heading 1975-96 (see under PSYCHOANALYTIC THEORY 1975-90)
=750  \0$aPsychoanalysis$0(DLC) sh 85108411$5IEN

=LDR  01058cz  a2200253n  4500
=001  9880363945202441
=005  20141212204952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011573
=035  \\$aCBA4869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x628
=150  \\$aPsychoanalytic Interpretation
=450  \\$wnnna$aInterpretation, Psychoanalytic
=450  \\$wnnna$aInterpretation, Psychoanalytical
=450  \\$wnnna$aInterpretations, Psychoanalytic
=450  \\$wnnna$aInterpretations, Psychoanalytical
=450  \\$wnnna$aPsychoanalytic Interpretations
=450  \\$wnnna$aPsychoanalytical Interpretation
=450  \\$wnnna$aPsychoanalytical Interpretations
=550  \\$wg$aBehavioral Disciplines and Activities
=667  \\$aIM; no qualif; differentiate from PSYCHOANALYTIC THEORY in that the theory is on a more universal level
=680  \\$iUtilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc.
=750  \0$aPsychoanalytic interpretation$5IEN$0(DLC)sh 85108424

=LDR  01203cz  a2200241n  4500
=001  9880363945302441
=005  20141212192452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011572
=035  \\$aCBA4868HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x779
=150  \\$aPsychoanalysis
=450  \\$wnnna$aAnalyses, Psychodynamic
=450  \\$wnnna$aAnalysis, Psychodynamic
=450  \\$aPsychoanalysts$5IEN
=450  \\$wnnna$aPsychodynamic Analyses
=450  \\$wnnna$aPsychodynamic Analysis
=550  \\$wg$aPsychiatry
=667  \\$aspecialty; for therapy use PSYCHOANALYTIC THERAPY or specifics
=680  \\$iThe separation or resolution of the psyche into its constituent elements. The term has two separate meanings: 1. a procedure devised by Sigmund Freud, for investigating mental processes by means of free association, dream interpretation and interpretation of resistance and transference manifestations; and 2. a theory of psychology developed by Freud from his clinical experience with hysterical patients. (From Campbell, Psychiatric Dictionary, 1996).
=750  \0$aPsychoanalysts$0(DLC) sh 85108422$5IEN-M
=750  \0$aPsychoanalysis$0(DLC) sh 85108411$5IEN-M

=LDR  00799cz  a2200253n  4500
=001  9880363945402441
=005  20141212204952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011571
=035  \\$aCBA4867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x60.$x530
=072  \\$aE1.$x370.$x685.$x628
=072  \\$aF4.$x96.$x753.$x628
=072  \\$aF4.$x732.$x628
=150  \\$aPsychoacoustics
=450  \\$wnnna$aPsychoacoustic
=550  \\$wg$aAudiometry
=550  \\$wg$aPsychophysics
=550  \\$aAcoustics
=667  \\$aIM; no qualif
=680  \\$iThe science pertaining to the interrelationship of psychologic phenomena and the individual's response to the physical properties of sound.
=688  \\$a72(68)
=750  \0$aPsychoacoustics$5IEN$0(DLC)sh 85108410

=LDR  01207cz  a2200373n  4500
=001  9880363945502441
=005  20141212204951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011570
=035  \\$aCBA4866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544
=072  \\$aH2.$x403.$x690
=150  \\$aPsychiatry
=450  \\$wnnna$aPsychiatrist
=450  \\$wnnna$aPsychiatrists
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aMedicine
=550  \\$wh$aAdolescent Psychiatry
=550  \\$wh$aBiological Psychiatry
=550  \\$wh$aChild Psychiatry
=550  \\$wh$aCommunity Psychiatry
=550  \\$wh$aEthnopsychology
=550  \\$wh$aForensic Psychiatry
=550  \\$wh$aGeriatric Psychiatry
=550  \\$wh$aMilitary Psychiatry
=550  \\$wh$aNeuropsychiatry
=550  \\$wh$aOrthopsychiatry
=550  \\$wh$aPsychoanalysis
=550  \\$wh$aPsychosomatic Medicine
=667  \\$aspecialty only; do not confuse with MENTAL DISORDERS
=680  \\$iThe medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders.
=750  \0$aPsychiatry$5IEN-M$0(DLC)sh 85108381
=750  \0$aPsychiatrists$5IEN-HS$0(DLC)sh 85108377

=LDR  01591cz  a2200301n  4500
=001  9880363945602441
=005  20141212204951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011569
=035  \\$aCBA4865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x586
=150  \\$aPsychiatric Status Rating Scales
=450  \\$wnnna$aAdjustment Scales, Katz
=450  \\$aFactor Construct Rating Scales (FCRS)
=450  \\$aKatz Adjustment Scales
=450  \\$aLorr's Inpatient Multidimensional Psychiatric Rating Scale
=450  \\$aPsychiatric Rating Scales$5IEN
=450  \\$wnnna$aScales, Katz Adjustment
=450  \\$wnnna$aScales, Wittenborn
=450  \\$aWittenborn Scales
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wh$aBrief Psychiatric Rating Scale
=550  \\$wh$aMental Status Schedule
=667  \\$aDF: PSR SCALES
=680  \\$iStandardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
=688  \\$a69; KATZ ADJUSTMENT SCALES was heading 1975-96 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90); WITTENBORN SCALES was heading 1979-91 (see under PSYCHIATRIC STATUS RATING SCALES 1979-90), was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR'S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1975-91 (see under PSYCHIATRIC STATUS RATING SCALES 1975-90); FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78
=750  \0$aPsychiatric rating scales$5IEN$0(DLC)sh 85108375

=LDR  00871cz  a2200241n  4500
=001  9880363945702441
=005  20141212192451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011568
=035  \\$aCBA4864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x710
=072  \\$aN2.$x421.$x533.$x778
=150  \\$aPsychiatric Nursing
=450  \\$wnnna$aMental Health Nursing
=450  \\$wnnna$aNursing, Mental Health
=450  \\$wnnna$aNursing, Psychiatric
=450  \\$wnnna$aNursing, Psychosocial
=450  \\$wnnna$aPsychosocial Nursing
=550  \\$wg$aNursing Care
=550  \\$wg$aSpecialties, Nursing
=680  \\$iA specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient.
=750  \0$aPsychiatric nursing$5IEN$0(DLC)sh 85108372

=LDR  01001cz  a2200253n  4500
=001  9880363945802441
=005  20141212204950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011567
=035  \\$aCBA4863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x641
=072  \\$aN4.$x452.$x442.$x422.$x641
=150  \\$aPsychiatric Department, Hospital
=450  \\$wnnna$aDepartment, Hospital Psychiatric
=450  \\$wnnna$aDepartments, Hospital Psychiatric
=450  \\$aHospital Psychiatric Department
=450  \\$wnnna$aHospital Psychiatric Departments
=450  \\$wnnna$aPsychiatric Departments, Hospital
=550  \\$wg$aHospital Departments
=667  \\$aorderlies & ward attendants go under PSYCHIATRIC AIDES; DF: PSYCHIATR DEP
=680  \\$iHospital department responsible for the organization and administration of psychiatric services.
=688  \\$a78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77
=750  \0$aPsychiatric hospitals$5IEN-M$0(DLC)sh 85108356

=LDR  01508cz  a2200385n  4500
=001  9880363945902441
=005  20141212204950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011566
=035  \\$aCBA4862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x652.$x628
=072  \\$aN2.$x360.$x67.$x652.$x628
=150  \\$aPsychiatric Aides
=450  \\$wnnna$aAide, Psychiatric
=450  \\$wnnna$aAides, Psychiatric
=450  \\$wnnna$aAttendant, Psychiatric Ward
=450  \\$wnnna$aAttendants, Psychiatric Ward
=450  \\$wnnna$aHospital Orderlies, Psychiatric
=450  \\$wnnna$aHospital Orderly, Psychiatric
=450  \\$wnnna$aOrderlies, Psychiatric Hospital
=450  \\$wnnna$aOrderly, Psychiatric Hospital
=450  \\$wnnna$aPsychiatric Aide
=450  \\$aPsychiatric Hospital Orderlies
=450  \\$wnnna$aPsychiatric Hospital Orderly
=450  \\$wnnna$aPsychiatric Ward Attendant
=450  \\$aPsychiatric Ward Attendants
=450  \\$wnnna$aWard Attendant, Psychiatric
=450  \\$wnnna$aWard Attendants, Psychiatric
=550  \\$wg$aNurses' Aides
=667  \\$acoord IM with HOSPITALS, PSYCHIATRIC or PSYCHIATRIC DEPARTMENT, HOSPITAL (IM or NIM) if pertinent
=680  \\$iPersons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department.
=688  \\$a71
=750  \0$aAllied mental health personnel$5IEN-M$0(DLC)sh 85003684
=750  \0$aPsychiatric aides$5IEN-HS$0(DLC)sh 85108342

=LDR  01082cz  a2200241n  4500
=001  9880363946002441
=005  20141212204950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011565
=035  \\$aCBA4861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x859.$x675
=150  \\$aPsoriasis
=450  \\$aPalmoplantaris Pustulosis
=450  \\$wnnna$aPsoriases
=450  \\$aPustular Psoriasis of Palms and Soles
=450  \\$aPustulosis of Palms and Soles
=450  \\$aPustulosis Palmaris et Plantaris
=550  \\$wg$aSkin Diseases, Papulosquamous
=550  \\$wh$aArthritis, Psoriatic
=667  \\$aa papulosquamous skin dis; ARTHRITIS, PSORIATIC is also available
=680  \\$iA common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
=750  \0$aPsoriasis$5IEN$0(DLC)sh 85108334

=LDR  01192cz  a2200325n  4500
=001  9880363946102441
=005  20141212192446.0
=008  780313\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011564
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x446.$x794
=072  \\$aD3.$x494.$x770
=072  \\$aD3.$x830.$x219.$x446.$x794
=150  \\$aFurocoumarins
=450  \\$wnnna$aAngelicins
=450  \\$aFicusin$xanalogs & derivatives
=450  \\$aFuranocoumarins
=450  \\$aPsoralens
=550  \\$wg$aCoumarins
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wh$aFicusin
=550  \\$wh$aKhellin
=550  \\$wh$aMethoxsalen
=550  \\$wh$aTrioxsalen
=667  \\$ado not confuse entry term PSORALENS with the specific drug PSORALEN see FICUSIN; do not index here for psoralens in PUVA THERAPY unless particularly discussed
=680  \\$iPolycyclic compounds consisting of a furan ring fused with coumarin. They commonly occur in PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA.
=688  \\$a2015 (1979)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Psoralens
=688  \\$a79
=750  \0$aPsoralens$5IEN$0(DLC)sh 88001527

=LDR  01922cz  a2200421n  4500
=001  9880363946202441
=005  20141212192445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011561
=035  \\$aCBA4857M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x454.$x530
=072  \\$aC15.$x378.$x463.$x515.$x530
=072  \\$aC16.$x131.$x831.$x766
=072  \\$aC16.$x320.$x850.$x750
=072  \\$aC17.$x300.$x766
=072  \\$aC17.$x800.$x804.$x766
=072  \\$aC17.$x800.$x827.$x750
=150  \\$aPseudoxanthoma Elasticum
=450  \\$wnnna$aElasticum, Incomplete Pseudoxanthoma
=450  \\$wnnna$aElasticums, Incomplete Pseudoxanthoma
=450  \\$wnnna$aGroenblad-Strandberg Syndrome
=450  \\$aGronblad-Strandberg Syndrome
=450  \\$wnnna$aGronblad Strandberg Syndrome
=450  \\$wnnna$aIncomplete Pseudoxanthoma Elasticum
=450  \\$wnnna$aIncomplete Pseudoxanthoma Elasticums
=450  \\$wnnna$aPseudoxanthoma Elasticum, Autosomal Dominant
=450  \\$wnnna$aPseudoxanthoma Elasticum, Forme Fruste
=450  \\$wnnna$aPseudoxanthoma Elasticum, Incomplete
=450  \\$wnnna$aPseudoxanthoma Elasticums, Incomplete
=450  \\$wnnna$aSyndrome, Gronblad-Strandberg
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aHemostatic Disorders
=550  \\$wg$aSkin Abnormalities
=550  \\$wg$aSkin Diseases, Genetic
=667  \\$ain titles & translations use diacritic: Grönblad
=680  \\$iAn inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.
=750  \0$aPseudoxanthoma elasticum$0(DLC) sh2005005155$5IEN-M

=LDR  01306cz  a2200313n  4500
=001  9880363946302441
=005  20141212204948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011558
=035  \\$aCBA4854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x100.$x900.$x510
=072  \\$aB4.$x909.$x204.$x382.$x100.$x900.$x510
=150  \\$aHerpesvirus 1, Suid
=450  \\$wnnna$aAujeszky Disease Virus
=450  \\$aAujeszky's Disease Virus
=450  \\$wnnna$aAujeszkys Disease Virus
=450  \\$wnnna$aHerpesvirus 1 (alpha), Suid
=450  \\$wnnna$aHerpesvirus 1, Swine
=450  \\$wnnna$aHerpesvirus Suis
=450  \\$aPseudorabies virus
=450  \\$wnnna$aPseudorabies viruses
=450  \\$aSuid herpesvirus 1
=450  \\$aSwine Herpesvirus 1
=550  \\$wg$aVaricellovirus
=667  \\$ainfection = PSEUDORABIES
=680  \\$iA species of VARICELLOVIRUS producing a respiratory infection (PSEUDORABIES) in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink.
=688  \\$a94; was PSEUDORABIES VIRUS 1963-93 (see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74); HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93
=750  \0$aAujeszky's disease virus$5IEN$0(DLC)sh 85108296

=LDR  00850cz  a2200253n  4500
=001  9880363946402441
=005  20141212204948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011557
=035  \\$aCBA4853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182.$x710
=072  \\$aC2.$x256.$x466.$x793
=072  \\$aC10.$x228.$x228.$x210.$x710
=072  \\$aC22.$x742
=150  \\$aPseudorabies
=450  \\$wnnna$aAujeszky Disease
=450  \\$aAujeszky's Disease
=450  \\$wnnna$aAujeszkys Disease
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aCentral Nervous System Viral Diseases
=550  \\$wg$aHerpesviridae Infections
=680  \\$iA highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
=750  \0$aAujeszky's disease$5IEN$0(DLC)sh 85108295

=LDR  00826cz  a2200205n  4500
=001  9880363946502441
=005  20141212204947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011555
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x887
=150  \\$aPseudopregnancy
=450  \\$aPseudocyesis
=450  \\$wnnna$aPseudopregnancies
=550  \\$wg$aPregnancy
=550  \\$aPregnancy
=667  \\$ado NOT check tag PREGNANCY
=680  \\$iAn acyclic state that resembles PREGNANCY in that there is no ovarian cycle, ESTROUS CYCLE, or MENSTRUAL CYCLE. Unlike pregnancy, there is no EMBRYO IMPLANTATION. Pseudopregnancy can be experimentally induced to form DECIDUOMA in the UTERUS.
=688  \\$awas in Cat G only 1968-78, was in Cat F only 1963-67
=750  \0$aPseudocyesis$5IEN$0(DLC)sh 85108263

=LDR  00695cz  a2200205n  4500
=001  9880363946602441
=005  20141212204946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011552
=035  \\$aCBA4848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x739
=150  \\$aPseudomonas Infections
=450  \\$wnnna$aInfection, Pseudomonas
=450  \\$wnnna$aInfections, Pseudomonas
=450  \\$wnnna$aPseudomonas Infection
=550  \\$wg$aGram-Negative Bacterial Infections
=667  \\$agram-neg bact infect; see note under PSEUDOMONAS AERUGINOSA
=680  \\$iInfections with bacteria of the genus PSEUDOMONAS.
=750  \0$aPseudomonas infections$5IEN$0(DLC)sh 85108282

=LDR  00618cz  a2200181n  4500
=001  9880363946702441
=005  20141212204946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011551
=035  \\$aCBA4847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x625.$x325
=072  \\$aB3.$x660.$x250.$x580.$x590.$x210
=150  \\$aPseudomonas fluorescens
=550  \\$wg$aPseudomonas
=680  \\$iA species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.
=688  \\$a74(72)
=750  \0$aPseudomonas fluorescens$5IEN$0(DLC)sh 85108283

=LDR  00844cz  a2200193n  4500
=001  9880363946802441
=005  20141212204946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011550
=035  \\$aCBA4846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x625.$x100
=072  \\$aB3.$x660.$x250.$x580.$x590.$x50
=150  \\$aPseudomonas aeruginosa
=450  \\$aPseudomonas pyocyanea
=550  \\$wg$aPseudomonas
=667  \\$ainfections: coordinate IM with PSEUDOMONAS INFECTIONS (IM)
=680  \\$iA species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
=750  \0$aPseudomonas aeruginosa$5IEN$0(DLC)sh 85108281

=LDR  01142cz  a2200325n  4500
=001  9880363946902441
=005  20181130123013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011549
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x625
=072  \\$aB3.$x660.$x250.$x580.$x590
=150  \\$aPseudomonas
=450  \\$aChryseomonas
=450  \\$wnnna$aFlavimonas
=550  \\$wg$aPseudomonadaceae
=550  \\$wh$aPseudomonas aeruginosa
=550  \\$wh$aPseudomonas alcaligenes
=550  \\$wh$aPseudomonas chlororaphis
=550  \\$wh$aPseudomonas fluorescens
=550  \\$wh$aPseudomonas fragi
=550  \\$wh$aPseudomonas mendocina
=550  \\$wh$aPseudomonas oleovorans
=550  \\$wh$aPseudomonas pseudoalcaligenes
=550  \\$wh$aPseudomonas putida
=550  \\$wh$aPseudomonas stutzeri
=550  \\$wh$aPseudomonas syringae
=667  \\$ainfection = PSEUDOMONAS INFECTIONS
=680  \\$iA genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.
=750  \0$aPseudomonas$5IEN-M$0(DLC)sh 85108280

=LDR  00874cz  a2200277n  4500
=001  9880363947002441
=005  20141212204945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011548
=035  \\$aCBA4844HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625
=072  \\$aB3.$x660.$x250.$x580
=150  \\$aPseudomonadaceae
=450  \\$wnnna$aAzomonas
=450  \\$wnnna$aAzomonas agilis
=450  \\$wnnna$aAzotobacteraceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aAzotobacter
=550  \\$wh$aCellvibrio
=550  \\$wh$aPseudomonas
=680  \\$iA family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.
=688  \\$a1975
=688  \\$a75
=750  \0$aPseudomonadaceae$0(DLC)sh 85108278$5IEN

=LDR  01967cz  a2200433n  4500
=001  9880363947102441
=005  20141212204945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011547
=035  \\$aCBA4843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x709
=072  \\$aC16.$x320.$x565.$x618.$x815
=072  \\$aC18.$x452.$x174.$x766
=072  \\$aC18.$x452.$x648.$x618.$x815
=150  \\$aPseudohypoparathyroidism
=450  \\$wnnna$aAlbright Hereditary Osteodystrophy with Multiple Hormone Resistance
=450  \\$wnnna$aPHD Ib
=450  \\$wnnna$aPHD Ibs
=450  \\$wnnna$aPHD1b
=450  \\$wnnna$aPHP Ia
=450  \\$wnnna$aPseudohypoparathyroidism, Type Ia
=450  \\$wnnna$aPseudohypoparathyroidism, Type Ib
=450  \\$wnnna$aPseudohypoparathyroidisms
=450  \\$wnnna$aPseudohypoparathyroidisms, Type Ia
=450  \\$wnnna$aPseudohypoparathyroidisms, Type Ib
=450  \\$wnnna$aType Ia Pseudohypoparathyroidism
=450  \\$wnnna$aType Ia Pseudohypoparathyroidisms
=450  \\$wnnna$aType Ib Pseudohypoparathyroidism
=450  \\$wnnna$aType Ib Pseudohypoparathyroidisms
=550  \\$wg$aBone Diseases, Metabolic
=550  \\$wg$aCalcium Metabolism Disorders
=550  \\$wg$aMetal Metabolism, Inborn Errors
=550  \\$wh$aPseudopseudohypoparathyroidism
=550  \\$aGTP-Binding Protein alpha Subunits, Gs
=667  \\$ado not confuse with PSEUDOPSEUDOHYPOPARATHYROIDISM
=680  \\$iA hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.
=688  \\$a65(63)
=750  \0$aPseudohypoparathyroidism$5IEN$0(DLC)sh 85108274

=LDR  00893cz  a2200205n  4500
=001  9880363947202441
=005  20141212204943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011542
=035  \\$aCBA4838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x468.$x627
=150  \\$aPseudarthrosis
=450  \\$wnnna$aPseudarthroses
=450  \\$wnnna$aPseudoarthroses
=450  \\$wnnna$aPseudoarthrosis
=550  \\$wg$aFractures, Ununited
=667  \\$aa type of ununited fract; do not index under FRACTURES, UNUNITED unless particularly discussed
=680  \\$iA pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the "false joint" that gives the condition its name. (Dorland, 27th ed)
=750  \0$aPseudarthrosis$5IEN$0(DLC)sh 85108239

=LDR  00743cz  a2200253n  4500
=001  9880363947302441
=005  20141212204941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011537
=035  \\$aCBA4833HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x685
=072  \\$aC23.$x888.$x885.$x625
=150  \\$aPruritus
=450  \\$aItching
=450  \\$wnnna$aPruritis
=550  \\$wg$aSkin Diseases
=550  \\$wg$aSkin Manifestations
=550  \\$wh$aPruritus Ani
=550  \\$wh$aPruritus Vulvae
=550  \\$wh$aTinea Pedis
=667  \\$a/drug ther: consider also ANTIPRURITICS
=680  \\$iAn intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.
=750  \2$aItching$5IEN

=LDR  00655cz  a2200169n  4500
=001  9880363947402441
=005  20141212204941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011536
=035  \\$aCBA4832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x674
=150  \\$aPrurigo
=550  \\$wg$aSkin Diseases
=667  \\$aitchy skin eruptions
=680  \\$iA name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed)
=750  \0$aPrurigo$5IEN$0(DLC)sh 85108047

=LDR  01386cz  a2200361n  4500
=001  9880363947502441
=005  20141212204939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011529
=035  \\$aCBA4825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x688
=072  \\$aC3.$x752.$x625
=072  \\$aC22.$x674.$x710
=150  \\$aProtozoan Infections, Animal
=450  \\$wnnna$aAnimal Protozoan Infection
=450  \\$wnnna$aAnimal Protozoan Infections
=450  \\$wnnna$aInfection, Animal Protozoan
=450  \\$wnnna$aInfections, Animal Protozoan
=450  \\$wnnna$aProtozoan Infection, Animal
=450  \\$aProtozoan Infections$xveterinary
=550  \\$wg$aParasitic Diseases, Animal
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aBabesiosis
=550  \\$wh$aCryptosporidiosis
=550  \\$wh$aDourine
=550  \\$wh$aTheileriasis
=550  \\$wh$aToxoplasmosis, Animal
=550  \\$wh$aTrypanosomiasis, Bovine
=667  \\$aexper or vet; GEN or unspecified; prefer specific indentions or specific protozoan infect /vet; don't forget to check tag ANIMALS; DF: PROTOZOAN INFECT ANIMAL
=680  \\$iInfections with unicellular organisms formerly members of the subkingdom Protozoa. The infections may be experimental or veterinary.
=688  \\$a98; use explode 1971-97
=750  \0$aVeterinary protozoology$5IEN$0(DLC)sh 85143071

=LDR  01447cz  a2200421n  4500
=001  9880363947602441
=005  20141212204939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011528
=035  \\$aCBA4824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752
=150  \\$aProtozoan Infections
=450  \\$wnnna$aHistomoniases
=450  \\$aHistomoniasis
=450  \\$wnnna$aInfection, Protozoan
=450  \\$wnnna$aInfections, Protozoan
=450  \\$wnno$aMastigophora Infections$5IEN-M
=450  \\$wnnna$aProtozoan Infection
=450  \\$wnno$aSarcodina Infections$5IEN-M
=450  \\$wnno$aSarcomastigophora Infections$5IEN-M
=450  \\$wnno$aSporozoea Infections$5IEN-M
=550  \\$wg$aParasitic Diseases
=550  \\$wh$aAmebiasis
=550  \\$wh$aCentral Nervous System Protozoal Infections
=550  \\$wh$aCiliophora Infections
=550  \\$wh$aCoccidiosis
=550  \\$wh$aDientamoebiasis
=550  \\$wh$aEuglenozoa Infections
=550  \\$wh$aGiardiasis
=550  \\$wh$aMalaria
=550  \\$wh$aProtozoan Infections, Animal
=550  \\$wh$aTick-Borne Diseases
=550  \\$wh$aTrichomonas Infections
=667  \\$aGEN; prefer specifics; /drug ther: consider also ANTIPROTOZOAL AGENTS
=680  \\$iInfections with unicellular organisms formerly members of the subkingdom Protozoa.
=688  \\$aHISTOMONIASIS was heading 1968-85
=750  \0$aProtozoan diseases$0(DLC) sh 88003025$5IEN

=LDR  00439cz  a2200181n  4500
=001  9880363947702441
=005  20141212204937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011523
=035  \\$aCBA4819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x789
=150  \\$aProtoplasts
=450  \\$wnnna$aProtoplast
=550  \\$wg$aCells
=667  \\$aA 11 qualif
=688  \\$a66(64)
=750  \0$aProtoplasts$5IEN$0(DLC)sh 85107805

=LDR  01025cz  a2200301n  4500
=001  9880363947802441
=005  20180914113806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011522
=035  \\$aCBA4818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x300.$x459.$x700
=072  \\$aD1.$x268.$x406.$x750
=072  \\$aD1.$x362.$x340.$x750
=072  \\$aG1.$x249.$x660.$500
=150  \\$aProtons
=450  \\$wnnna$aHydrogen Ion
=450  \\$aHydrogen Ions
=450  \\$wnnna$aIon, Hydrogen
=450  \\$wnnna$aIons, Hydrogen
=450  \\$wnnna$aProton
=550  \\$wg$aCations, Monovalent
=550  \\$wg$aHydrogen
=550  \\$wg$aNucleons
=667  \\$aelementary particles; IM
=680  \\$iStable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.
=688  \\$a66
=750  \0$aProtons$5IEN$0(DLC)sh 85107796

=LDR  01343cz  a2200337n  4500
=001  9880363947902441
=005  20141212204937.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011521
=035  \\$aCBA4817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x374.$x725
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500.$x640.$x220.$x725
=072  \\$aD3.$x549.$x909.$x374.$x725
=072  \\$aD3.$x549.$x909.$x500.$x640.$x220.$x725
=072  \\$aD4.$x345.$x783.$x374.$x725
=072  \\$aD4.$x345.$x783.$x500.$x640.$x220.$x725
=072  \\$aD23.$x767.$x727.$x220.$x725
=072  \\$aD23.$x767.$x727.$x640.$x220.$x725
=150  \\$aProtochlorophyllide
=450  \\$wnnna$aA, Protochlorophyllide
=450  \\$wnnna$aMonovinyl Protochlorophyllide
=450  \\$wnnna$aMV-PChlide
=450  \\$wnnna$aMV PChlide
=450  \\$aProtochlorophyllide A
=450  \\$wnnna$aProtochlorophyllide, Monovinyl
=550  \\$wg$aChlorophyll
=667  \\$aa chlorophyll
=680  \\$iA photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll.
=688  \\$a91(75); was see under CHLOROPHYLL 1975-90
=750  \0$aProtochlorophyllide$5IEN$0(DLC)sh 85107776

=LDR  01365cz  a2200385n  4500
=001  9880363948002441
=005  20190304142222.0
=008  850320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011519
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791
=150  \\$aProto-Oncogenes
=450  \\$wnnna$aProto-Oncogene
=450  \\$wnnna$aProto Oncogene
=450  \\$wnnna$aProto Oncogenes
=550  \\$wg$aOncogenes
=550  \\$wh$aGenes, abl
=550  \\$wh$aGenes, bcl-1
=550  \\$wh$aGenes, bcl-2
=550  \\$wh$aGenes, erbA
=550  \\$wh$aGenes, erbB
=550  \\$wh$aGenes, fms
=550  \\$wh$aGenes, fos
=550  \\$wh$aGenes, jun
=550  \\$wh$aGenes, mos
=550  \\$wh$aGenes, myb
=550  \\$wh$aGenes, myc
=550  \\$wh$aGenes, ras
=550  \\$wh$aGenes, rel
=550  \\$wh$aGenes, sis
=550  \\$wh$aGenes, src
=667  \\$a"normal cellular genes homologous to viral oncogenes"
=680  \\$iNormal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc.
=688  \\$a86; was see ONCOGENES 1983-85
=750  \0$aProto-oncogenes$0(DLC)sh 90000342$5IEN

=LDR  01126cz  a2200289n  4500
=001  9880363948102441
=005  20141212204934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011516
=035  \\$aCBA4812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x622.$x709
=072  \\$aD12.$x776.$x124.$x125.$x800
=072  \\$aD23.$x119.$x945
=150  \\$aProthrombin
=450  \\$wnnna$aBlood Coagulation Factor II
=450  \\$aCoagulation Factor II
=450  \\$wnnna$aDifferentiation Reversal Factor
=450  \\$wnnna$aFactor, Differentiation Reversal
=450  \\$aFactor II
=450  \\$wnnna$aFactor II, Coagulation
=450  \\$wnnna$aII, Coagulation Factor
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aEnzyme Precursors
=667  \\$aa blood coag factor; an enzyme precursor
=680  \\$iA plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.
=750  \0$aProthrombin$5IEN$0(DLC)sh 85107736

=LDR  00956cz  a2200217n  4500
=001  9880363948202441
=005  20141212204933.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011511
=035  \\$aCBA4807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x600
=072  \\$aB3.$x660.$x250.$x150.$x590
=150  \\$aProteus
=550  \\$wg$aEnterobacteriaceae
=550  \\$wh$aProteus mirabilis
=550  \\$wh$aProteus penneri
=550  \\$wh$aProteus vulgaris
=667  \\$aGEN; infection = PROTEUS INFECTIONS
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
=750  \0$aProteus (Bacteria)$5IEN-M$0(DLC)sh 88023305

=LDR  00851cz  a2200265n  4500
=001  9880363948302441
=005  20181221105613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011509
=035  \\$aCBA4805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x735
=072  \\$aD12.$x776.$x395.$x650
=150  \\$aProteoglycans
=450  \\$wnnna$aProteoglycan
=450  \\$wnnna$aProteoglycan Type H
=550  \\$wg$aGlycoproteins
=550  \\$wg$aPolysaccharides
=550  \\$wh$aChondroitin Sulfate Proteoglycans
=550  \\$wh$aHeparan Sulfate Proteoglycans
=550  \\$wh$aSmall Leucine-Rich Proteoglycans
=667  \\$apolysaccharides
=680  \\$iGlycoproteins which have a very high polysaccharide content.
=688  \\$a77(75); was see under MUCOPOLYSACCHARIDES 1975-76
=750  \0$aProteoglycans$5IEN$0(DLC)sh 85107683

=LDR  00864cz  a2200253n  4500
=001  9880363948402441
=005  20141212204932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011507
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x734
=072  \\$aC13.$x351.$x968.$x934.$x734
=072  \\$aC23.$x888.$x942.$x750
=150  \\$aProteinuria
=450  \\$aProteins$xurine
=450  \\$wnnna$aProteinurias
=550  \\$wg$aUrination Disorders
=550  \\$wg$aUrological Manifestations
=550  \\$wh$aAlbuminuria
=550  \\$wh$aHemoglobinuria
=550  \\$aUrine
=667  \\$aEPH (Edema, Proteinuria, Hypertension) = GESTOSIS, EPH & do not index under PROTEINURIA unless it is particularly discussed
=680  \\$iThe presence of proteins in the urine, an indicator of KIDNEY DISEASES.
=750  \0$aProteinuria$5IEN$0(DLC)sh 85107680

=LDR  05503cz  a2201489n  4500
=001  9880363948502441
=005  20190130131644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011506
=035  \\$aCBA4802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776
=150  \\$aProteins
=450  \\$aGene Products, Protein
=450  \\$aGene Proteins
=450  \\$wnnna$aProtein Gene Products
=450  \\$wnnna$aProteins, Gene
=550  \\$wg$aAmino Acids, Peptides, and Proteins
=550  \\$wh$aAlbumins
=550  \\$wh$aAlgal Proteins
=550  \\$wh$aAmphibian Proteins
=550  \\$wh$aAmyloid
=550  \\$wh$aAntifreeze Proteins
=550  \\$wh$aApoproteins
=550  \\$wh$aAprotinin
=550  \\$wh$aArchaeal Proteins
=550  \\$wh$aArmadillo Domain Proteins
=550  \\$wh$aArthropod Proteins
=550  \\$wh$aAutophagy-Related Proteins
=550  \\$wh$aAvian Proteins
=550  \\$wh$aBacterial Proteins
=550  \\$wh$aBlood Proteins
=550  \\$wh$aCarrier Proteins
=550  \\$wh$aCell Cycle Proteins
=550  \\$wh$aCerebrospinal Fluid Proteins
=550  \\$wh$aChloroplast Proteins
=550  \\$wh$aCircadian Rhythm Signaling Peptides and Proteins
=550  \\$wh$aColipases
=550  \\$wh$aContractile Proteins
=550  \\$wh$aCRISPR-Associated Proteins
=550  \\$wh$aCystatins
=550  \\$wh$aCystine-Knot Miniproteins
=550  \\$wh$aCytoskeletal Proteins
=550  \\$wh$aDental Enamel Proteins
=550  \\$wh$aDietary Proteins
=550  \\$wh$aDNA-Binding Proteins
=550  \\$wh$aEgg Proteins
=550  \\$wh$aEpididymal Secretory Proteins
=550  \\$wh$aEye Proteins
=550  \\$wh$aFanconi Anemia Complementation Group Proteins
=550  \\$wh$aFetal Proteins
=550  \\$wh$aFish Proteins
=550  \\$wh$aFlavoproteins
=550  \\$wh$aFungal Proteins
=550  \\$wh$aGlobulins
=550  \\$wh$aGlycoproteins
=550  \\$wh$aGTP-Binding Protein Regulators
=550  \\$wh$aHelminth Proteins
=550  \\$wh$aHemeproteins
=550  \\$wh$aHuntingtin Protein
=550  \\$wh$aImmediate-Early Proteins
=550  \\$wh$aImmobilized Proteins
=550  \\$wh$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aIntracellular Signaling Peptides and Proteins
=550  \\$wh$aIntrinsically Disordered Proteins
=550  \\$wh$aIodoproteins
=550  \\$wh$aIron-Regulatory Proteins
=550  \\$wh$aLDL-Receptor Related Proteins
=550  \\$wh$aLectins
=550  \\$wh$aLIM Domain Proteins
=550  \\$wh$aLipoproteins
=550  \\$wh$aLithostathine
=550  \\$wh$aLuminescent Proteins
=550  \\$wh$aMembrane Proteins
=550  \\$wh$aMetalloproteins
=550  \\$wh$aMitochondrial Proteins
=550  \\$wh$aMolecular Chaperones
=550  \\$wh$aMutant Proteins
=550  \\$wh$aNeoplasm Proteins
=550  \\$wh$aNerve Tissue Proteins
=550  \\$wh$aNuclear Proteins
=550  \\$wh$aNucleoproteins
=550  \\$wh$aOxidative Phosphorylation Coupling Factors
=550  \\$wh$aParkinson Disease Associated Proteins
=550  \\$wh$aPeptones
=550  \\$wh$aPhosphoproteins
=550  \\$wh$aPhotoreceptors, Microbial
=550  \\$wh$aPlant Proteins
=550  \\$wh$aPolyproteins
=550  \\$wh$aPregnancy Proteins
=550  \\$wh$aPrions
=550  \\$wh$aProtein Corona
=550  \\$wh$aProtein Degradation End Products
=550  \\$wh$aProtein Hydrolysates
=550  \\$wh$aProtein Isoforms
=550  \\$wh$aProtein Precursors
=550  \\$wh$aProtein Subunits
=550  \\$wh$aProteinase Inhibitory Proteins, Secretory
=550  \\$wh$aProteolipids
=550  \\$wh$aProteome
=550  \\$wh$aProtozoan Proteins
=550  \\$wh$aPulmonary Surfactant-Associated Proteins
=550  \\$wh$aReceptors, Cytoplasmic and Nuclear
=550  \\$wh$aReceptors, Drug
=550  \\$wh$aRecombinant Proteins
=550  \\$wh$aReptilian Proteins
=550  \\$wh$aRibosomal Proteins
=550  \\$wh$aSalivary Proteins and Peptides
=550  \\$wh$aScleroproteins
=550  \\$wh$aSecretoglobins
=550  \\$wh$aSelenium-Binding Proteins
=550  \\$wh$aSelenoproteins
=550  \\$wh$aSeminal Plasma Proteins
=550  \\$wh$aSerpins
=550  \\$wh$aSilver Proteins
=550  \\$wh$aThioredoxins
=550  \\$wh$aThymosin
=550  \\$wh$aTranscription Factors
=550  \\$wh$aTripartite Motif Proteins
=550  \\$wh$aUbiquitinated Proteins
=550  \\$wh$aUbiquitins
=550  \\$wh$aViral Proteins
=550  \\$aMolecular Mechanisms of Pharmacological Action
=667  \\$ageneral only; prefer specific protein or specific precoordinated protein group terms such as EYE PROTEINS; BACTERIAL PROTEINS; DIETARY PROTEINS; etc.; primary protein structure = AMINO ACID SEQUENCE; protein structure referring to protein architecture = PROTEIN CONFORMATION or its specifics: PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; or PROTEIN STRUCTURE, QUATERNARY
=680  \\$iLinear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.
=688  \\$a/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64
=750  \0$aProteins$5IEN$0(DLC)sh 85107666

=LDR  02188cz  a2200565n  4500
=001  9880363948602441
=005  20190114114111.0
=008  850425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011505
=035  \\$aCBA4801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725
=150  \\$aProtein-Tyrosine Kinases
=450  \\$wnnna$aKinase, Protein-Tyrosine
=450  \\$wnnna$aKinase, Tyrosine
=450  \\$wnnna$aKinase, Tyrosine Protein
=450  \\$wnnna$aKinase, Tyrosine-Specific Protein
=450  \\$wnnna$aKinase, Tyrosylprotein
=450  \\$wnnna$aKinases, Protein-Tyrosine
=450  \\$wnnna$aKinases, Tyrosine Protein
=450  \\$wnnna$aKinases, Tyrosine-Specific Protein
=450  \\$wnnna$aProtein Kinase, Tyrosine-Specific
=450  \\$wnnna$aProtein Kinases, Tyrosine
=450  \\$wnnna$aProtein Kinases, Tyrosine-Specific
=450  \\$wnnna$aProtein-Tyrosine Kinase
=450  \\$wnnna$aProtein Tyrosine Kinase
=450  \\$wnnna$aProtein Tyrosine Kinases
=450  \\$wnnna$aTyrosine Kinase
=450  \\$aTyrosine Protein Kinase
=450  \\$wnnna$aTyrosine Protein Kinases
=450  \\$aTyrosine-Specific Protein Kinase
=450  \\$wnnna$aTyrosine Specific Protein Kinase
=450  \\$wnnna$aTyrosine-Specific Protein Kinases
=450  \\$wnnna$aTyrosine Specific Protein Kinases
=450  \\$wnnna$aTyrosylprotein Kinase
=550  \\$wg$aProtein Kinases
=550  \\$wh$aFocal Adhesion Protein-Tyrosine Kinases
=550  \\$wh$aJanus Kinases
=550  \\$wh$aMitogen-Activated Protein Kinase Kinases
=550  \\$wh$aProto-Oncogene Proteins c-abl
=550  \\$wh$aProto-Oncogene Proteins c-fes
=550  \\$wh$aReceptor Protein-Tyrosine Kinases
=550  \\$wh$asrc-Family Kinases
=550  \\$wh$aSyk Kinase
=550  \\$wh$aZAP-70 Protein-Tyrosine Kinase
=680  \\$iProtein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.
=688  \\$a2007(1986)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Protein-Tyrosine Kinase
=688  \\$a86
=750  \0$aProtein tyrosine kinase$0(DLC) 91006259$5IEN

=LDR  01772cz  a2200385n  4500
=001  9880363948702441
=005  20141212204928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011504
=035  \\$aCBA4800HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x818
=150  \\$aProtein-Losing Enteropathies
=450  \\$wnnna$aEnteropathies, Exudative
=450  \\$wnnna$aEnteropathies, Protein-Losing
=450  \\$aEnteropathy, Exudative
=450  \\$wnnna$aEnteropathy, Protein-Losing
=450  \\$wnnna$aExudative Enteropathies
=450  \\$wnnna$aExudative Enteropathy
=450  \\$wnnna$aHypercatabolic Hypoproteinemia, Idiopathic
=450  \\$wnnna$aHypercatabolic Hypoproteinemias, Idiopathic
=450  \\$wnnna$aHypoproteinemia, Idiopathic Hypercatabolic
=450  \\$wnnna$aHypoproteinemias, Idiopathic Hypercatabolic
=450  \\$aIdiopathic Hypercatabolic Hypoproteinemia
=450  \\$wnnna$aIdiopathic Hypercatabolic Hypoproteinemias
=450  \\$wnnna$aProtein Losing Enteropathies
=450  \\$wnnna$aProtein-Losing Enteropathy
=450  \\$wnnna$aProtein Losing Enteropathy
=550  \\$wg$aIntestinal Diseases
=550  \\$aAgammaglobulinemia
=550  \\$aHypoproteinemia
=550  \\$aLymphopenia
=680  \\$iPathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.
=688  \\$a66
=750  \0$aProtein-losing enteropathies$5IEN$0(DLC)sh 85107661

=LDR  01641cz  a2200277n  4500
=001  9880363948802441
=005  20141212204927.0
=008  850424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011503
=035  \\$aCBA4799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x50.$x200.$x800
=150  \\$aTransglutaminases
=450  \\$wnnna$aGamma-Glutamyltransferases, Glutaminyl-Peptide
=450  \\$wnnna$agamma-Glutamyltransferases, Protein-Glutamine
=450  \\$aGlutaminyl-Peptide Gamma-Glutamyltransferases
=450  \\$wnnna$aGlutaminyl Peptide Gamma Glutamyltransferases
=450  \\$wnnoa$aProtein-Glutamine gamma-Glutamyltransferase$5IEN-HS
=450  \\$aProtein-Glutamine gamma-Glutamyltransferases
=450  \\$wnnna$aProtein Glutamine gamma Glutamyltransferases
=550  \\$wg$aAminoacyltransferases
=550  \\$wh$aFactor XIIIa
=667  \\$adistinguish X refs GLUTAMINYL-PEPTIDE GAMMA-GLUTAMYLTRANSFERASES and TRANSGLUTAMINASES from GAMMA-GLUTAMYL TRANSPEPTIDASE which is involved with glutathione metabolism; PLASMA TRANSGLUTAMINASE see FACTOR XIIIA is also available
=680  \\$iTransglutaminases catalyze cross-linking of proteins at a GLUTAMINE in one chain with LYSINE in another chain. They include keratinocyte transglutaminase (TGM1 or TGK), tissue transglutaminase (TGM2 or TGC), plasma transglutaminase involved with coagulation (FACTOR XIII and FACTOR XIIIa), hair follicle transglutaminase, and prostate transglutaminase. Although structures differ, they share an active site (YGQCW) and strict CALCIUM dependence.
=688  \\$a2002(1986)
=750  \0$aTransglutaminases$5IEN-M$0(DLC)sh 85136921

=LDR  01161cz  a2200277n  4500
=001  9880363948902441
=005  20171012170255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011502
=035  \\$aCBA4798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x708.$x626
=150  \\$aProtein-Energy Malnutrition
=450  \\$wnnna$aMalnutrition, Protein-Calorie
=450  \\$wnnna$aMalnutrition, Protein-Energy
=450  \\$wnnna$aMalnutritions, Protein-Energy
=450  \\$aMarasmus
=450  \\$aProtein-Calorie Malnutrition
=450  \\$wnnna$aProtein Calorie Malnutrition
=450  \\$wnnna$aProtein Energy Malnutrition
=550  \\$wg$aProtein Deficiency
=550  \\$aEmaciation
=667  \\$aconsider also KWASHIORKOR
=680  \\$iThe lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses.
=688  \\$a92; was PROTEIN-CALORIE MALNUTRITION 1972-91 (Prov 1972-73)
=750  \0$aProtein-energy malnutrition$0(DLC) sh2009009525$5IEN-M

=LDR  03367cz  a2200673n  4500
=001  9880363949002441
=005  20141212204926.0
=008  820426\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011499
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x675.$x871.$x790.$x600
=072  \\$aG2.$x111.$x87.$x693.$x600
=072  \\$aG2.$x149.$x115.$x675.$x871.$x790.$x600
=072  \\$aG2.$x149.$x115.$x693.$x600
=072  \\$aG3.$x495.$x770.$x871.$x790.$x600
=072  \\$aG5.$x355.$x315.$x670.$x600
=150  \\$aProtein Processing, Post-Translational
=450  \\$aAmino Acid Modification, Post-Translational
=450  \\$wnnna$aAmino Acid Modification, Post Translational
=450  \\$wnnna$aAmino Acid Modification, Posttranslational
=450  \\$wnnna$aModification, Post-Translational
=450  \\$wnnna$aModification, Post-Translational Protein
=450  \\$wnnna$aModification, Posttranslational
=450  \\$wnnna$aModifications, Post-Translational
=450  \\$wnnna$aModifications, Post-Translational Protein
=450  \\$wnnna$aModifications, Posttranslational
=450  \\$wnnna$aPost-Translational Amino Acid Modification
=450  \\$wnnna$aPost Translational Amino Acid Modification
=450  \\$wnnna$aPost-Translational Modification
=450  \\$wnnna$aPost-Translational Modifications
=450  \\$wnnna$aPost Translational Modifications
=450  \\$aPost-Translational Protein Modification
=450  \\$wnnna$aPost Translational Protein Modification
=450  \\$wnnna$aPost-Translational Protein Modifications
=450  \\$wnnna$aPost-Translational Protein Processing
=450  \\$wnnna$aPost Translational Protein Processing
=450  \\$wnnna$aPosttranslational Amino Acid Modification
=450  \\$wnnna$aPosttranslational Modification
=450  \\$wnnna$aPosttranslational Modifications
=450  \\$wnnna$aPosttranslational Protein Processing
=450  \\$wnnna$aProcessing, Post-Translational Protein
=450  \\$wnnna$aProcessing, Posttranslational Protein
=450  \\$aProtein Modification, Post-Translational
=450  \\$wnnna$aProtein Modification, Post Translational
=450  \\$wnnna$aProtein Modifications, Post-Translational
=450  \\$wnnna$aProtein Processing, Post Translational
=450  \\$wnnna$aProtein Processing, Posttranslational
=550  \\$wg$aProtein Modification, Translational
=550  \\$wh$aProtein Prenylation
=550  \\$wh$aProtein Splicing
=550  \\$wh$aUbiquitination
=550  \\$wh$aUnfolded Protein Response
=550  \\$aGlycosylation
=550  \\$aHistone Code
=550  \\$aMetabolic Detoxication, Phase II
=667  \\$acoord IM with specific protein /metab (IM) and with specific modification, for example, ACYLATION; AMINATION; DEAMINATION; PROTEIN ISOPRENYLATION; etc.; do not confuse with PROTEIN MODIFICATION, TRANSLATIONAL; DF: PROTEIN PROC POST
=680  \\$iAny of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.
=688  \\$a83
=750  \0$aPost-translational modification$0(DLC) sh 88005292$5IEN-M

=LDR  00858cz  a2200313n  4500
=001  9880363949102441
=005  20141212204925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011498
=035  \\$aCBA4794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x811
=150  \\$aProtein Precursors
=450  \\$wnnna$aPrecursors, Protein
=550  \\$wg$aProteins
=550  \\$wh$aAmyloid beta-Protein Precursor
=550  \\$wh$aAngiotensinogen
=550  \\$wh$aChromogranins
=550  \\$wh$aFibrinogen
=550  \\$wh$aKininogens
=550  \\$wh$aPro-Opiomelanocortin
=550  \\$wh$aProcollagen
=550  \\$wh$aProglucagon
=550  \\$wh$aProinsulin
=550  \\$wh$aTropoelastin
=550  \\$aInteins
=667  \\$aIM; coord with specific protein (IM)
=688  \\$a73
=750  \0$aProtein precursors$5IEN$0(DLC)sh 92004698

=LDR  00951cz  a2200277n  4500
=001  9880363949202441
=005  20180718110753.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011494
=035  \\$aCBA4790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682
=150  \\$aProtein Kinases
=450  \\$wnnna$aKinase, Protein
=450  \\$wnnna$aKinases, Protein
=450  \\$wnnna$aProtein Kinase
=550  \\$wg$aPhosphotransferases (Alcohol Group Acceptor)
=550  \\$wh$aConnectin
=550  \\$wh$aHistidine Kinase
=550  \\$wh$aPhosphorylase Kinase
=550  \\$wh$aProtein-Serine-Threonine Kinases
=550  \\$wh$aProtein-Tyrosine Kinases
=550  \\$aCell Cycle Proteins
=680  \\$iA family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein.
=688  \\$a80; was PROTEIN KINASE 1973-79 (Prov 1973)
=750  \0$aProtein kinases$0(DLC) sh 85107660$5IEN

=LDR  01846cz  a2200349n  4500
=001  9880363949302441
=005  20200618132621.0
=008  850517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011493
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x725
=150  \\$aProtein Kinase C
=450  \\$aCalcium-Activated Phospholipid-Dependent Kinase
=450  \\$wnnna$aCalcium Activated Phospholipid Dependent Kinase
=450  \\$aCalcium Phospholipid-Dependent Protein Kinase
=450  \\$wnnna$aCalcium Phospholipid Dependent Protein Kinase
=450  \\$wnnna$aPhospholipid-Dependent Kinase, Calcium-Activated
=450  \\$wnnna$aPhospholipid-Sensitive Calcium-Dependent Protein Kinase
=450  \\$wnnna$aPhospholipid Sensitive Calcium Dependent Protein Kinase
=450  \\$aPKC Serine-Threonine Kinase
=450  \\$wnnna$aPKC Serine Threonine Kinase
=450  \\$wnnna$aProtein Kinase M
=450  \\$wnnna$aSerine-Threonine Kinase, PKC
=550  \\$wg$aProtein-Serine-Threonine Kinases
=550  \\$wh$aProtein Kinase C-alpha
=550  \\$wh$aProtein Kinase C beta
=550  \\$wh$aProtein Kinase C-delta
=550  \\$wh$aProtein Kinase C-epsilon
=550  \\$wh$aProtein Kinase C-theta
=680  \\$iAn serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.
=688  \\$a86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93
=750  \0$aProtein kinase C$0(DLC) sh 94007950$5IEN-M

=LDR  00591cz  a2200181n  4500
=001  9880363949402441
=005  20141212204922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011492
=035  \\$aCBA4788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x796
=150  \\$aProtein Hydrolysates
=450  \\$wnnna$aHydrolysates, Protein
=550  \\$wg$aProteins
=550  \\$aParenteral Nutrition, Total
=667  \\$aa ther agent & nutrient: do not confuse with the hydrolysis of proteins ( = PROTEINS + HYDROLYSIS (NIM))
=750  \0$aProtein hydrolysates$5IEN$0(DLC)sh 85107659

=LDR  01513cz  a2200325n  4500
=001  9880363949502441
=005  20141212210914.0
=008  880430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x420.$x601
=150  \\$aProtein Engineering
=450  \\$wnnna$aEngineering, Protein
=450  \\$wnnna$aEngineering, Protein Genetic
=450  \\$aGenetic Engineering of Proteins
=450  \\$wnnna$aGenetic Engineering, Protein
=450  \\$wnnna$aProtein Genetic Engineering
=450  \\$wnnna$aProteins, Genetic Engineering
=550  \\$wg$aGenetic Engineering
=550  \\$wh$aAmino Acid Substitution
=550  \\$wh$aCell Surface Display Techniques
=550  \\$wh$aMutagenesis, Insertional
=550  \\$wh$aMutagenesis, Site-Directed
=550  \\$aDirected Molecular Evolution
=550  \\$aDNA Shuffling
=550  \\$aGenetic Engineering
=550  \\$aMolecular Farming
=680  \\$iProcedures by which protein structure and function are changed or created in vitro by altering existing or synthesizing new structural genes that direct the synthesis of proteins with sought-after properties. Such procedures may include the design of MOLECULAR MODELS of proteins using COMPUTER GRAPHICS or other molecular modeling techniques; site-specific mutagenesis (MUTAGENESIS, SITE-SPECIFIC) of existing genes; and DIRECTED MOLECULAR EVOLUTION techniques to create new genes.
=688  \\$a89
=750  \0$aProtein engineering$0(DLC) sh 86007375$5IEN

=LDR  00911cz  a2200253n  4500
=001  9880363949602441
=005  20141212204922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011489
=035  \\$aCBA4784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x793.$x500
=072  \\$aG1.$x154.$x100.$x640.$x750.$x500
=072  \\$aG1.$x595.$x100.$x640.$x750.$x500
=072  \\$aG2.$x111.$x87.$x690.$x750.$x500
=072  \\$aG2.$x149.$x115.$x690.$x750.$x500
=150  \\$aProtein Denaturation
=450  \\$wnnna$aDenaturation, Protein
=450  \\$wnnna$aDenaturations, Protein
=450  \\$wnnna$aProtein Denaturations
=550  \\$wg$aProtein Unfolding
=680  \\$iDisruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein.
=688  \\$a66(64)
=750  \0$aProteins$xDenaturation$5IEN$0(DLC)sh 85107670

=LDR  01553cz  a2200253n  4500
=001  9880363949702441
=005  20141212204922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011488
=035  \\$aCBA4783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x708
=150  \\$aProtein Deficiency
=450  \\$wnnna$aDeficiencies, Protein
=450  \\$wnnna$aDeficiency, Protein
=450  \\$aDietary Proteins$xdeficiency
=450  \\$wnnna$aProtein Deficiencies
=450  \\$aProteins$xdeficiency
=550  \\$wg$aDeficiency Diseases
=550  \\$wh$aProtein-Energy Malnutrition
=550  \\$aDietary Proteins
=667  \\$adeficiency of dietary protein, not genetic defic of specific proteins; consider also PROTEIN-CALORIE MALNUTRITION; DF: PROTEIN DEFIC
=680  \\$iA nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization). (From Merck Manual, 16th ed; Harrison's Principles of Internal Medicine, 12th ed, p406)
=750  \0$aProtein deficiency$5IEN$0(DLC)sh 85107657

=LDR  01382cz  a2200301n  4500
=001  9880363949802441
=005  20181129143534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011487
=035  \\$aCBA4782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x820.$x709
=150  \\$aProtein Conformation
=450  \\$wnnna$aConformation, Protein
=450  \\$wnnna$aConformations, Protein
=450  \\$wnnna$aProtein Conformations
=550  \\$wg$aMolecular Conformation
=550  \\$wh$aProtein Structural Elements
=550  \\$wh$aProtein Structure, Quaternary
=550  \\$wh$aProtein Structure, Secondary
=550  \\$wh$aProtein Structure, Tertiary
=550  \\$wh$aStructural Homology, Protein
=550  \\$aProtein Folding
=550  \\$aProteins
=667  \\$aIM general; coord NIM with specific protein; peptide conformation = PEPTIDES or specific peptide (IM) + PROTEIN CONFORMATION (NIM); index protein architecture here or under its specifics
=680  \\$iThe characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
=688  \\$a72
=750  \0$aProteins$xConformation$5IEN$0(DLC)sh 89006335

=LDR  00858cz  a2200241n  4500
=001  9880363949902441
=005  20141212204921.0
=008  860602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011486
=035  \\$aCBA4781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x622.$x705
=072  \\$aD12.$x776.$x124.$x650
=072  \\$aD12.$x776.$x395.$x635
=072  \\$aD23.$x113.$x700
=150  \\$aProtein C
=550  \\$wg$aBlood Coagulation Factor Inhibitors
=550  \\$wg$aBlood Proteins
=550  \\$wg$aEnzyme Precursors
=550  \\$wg$aGlycoproteins
=680  \\$iA vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.
=688  \\$a87
=750  \0$aProtein C$5IEN$0(DLC)sh 85107656

=LDR  01240cz  a2200265n  4500
=001  9880363950002441
=005  20170608155514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011485
=035  \\$aCBA4780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x679
=072  \\$aG3.$x808
=150  \\$aProtein Binding
=450  \\$wnnna$aBinding, Protein
=450  \\$wnnna$aPlasma Protein Binding Capacity
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$aBinding Sites
=550  \\$aBlood Proteins
=550  \\$aProtein Interaction Mapping
=667  \\$aNIM; restrict to the chem or metab binding mechanism; coord NIM with substance being bound /metab (IM) + specific protein /metab (IM); do not use with receptors terms unless the substance bound to the receptor is a protein & the binding mechanism is discussed; do not confuse with BINDING PROTEINS see CARRIER PROTEINS
=680  \\$iThe process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
=688  \\$a70(66)
=750  \0$aProtein binding$5IEN$0(DLC)sh 85107654

=LDR  00747cz  a2200193n  4500
=001  9880363950102441
=005  20141212204919.0
=008  800512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011483
=035  \\$aCBA4778HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x630
=150  \\$aProteidae
=550  \\$wg$aUrodela
=550  \\$wh$aNecturus
=667  \\$anote category: a family of aquatic salamanders; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iThe Proteidae family of permanently larval aquatic salamanders. It consists of two living genera - Necturus (mudpuppy) of the eastern United States and Proteus (the European olm).
=688  \\$a81
=750  \0$aProteidae$5IEN$0(DLC)sh 85107653

=LDR  00825cz   2200265n  4500
=001  9880363950202441
=005  20240216143701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011481
=035  \\$aCBA4776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x600
=072  \\$aJ1.$x637.$x215.$x600
=072  \\$aJ1.$x637.$x708.$x560.$x675
=150  \\$aProtective Clothing
=450  \\$aClothing, Protective
=550  \\$wg$aClothing
=550  \\$wg$aPersonal Protective Devices
=550  \\$wg$aProtective Devices
=550  \\$wh$aEar Protective Devices
=550  \\$wh$aGloves, Protective
=550  \\$wh$aSpace Suits
=680  \\$iClothing designed to protect the individual against possible exposure to known hazards.
=688  \\$a70
=750  \0$aPersonal protective equipment$5IEN$0(DLC)sh 85027158

=LDR  01939cz  a2200505n  4500
=001  9880363950302441
=005  20141212204918.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011480
=035  \\$aCBA4775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745
=150  \\$aProtease Inhibitors
=450  \\$wnnna$aAntagonists, Protease
=450  \\$wnnna$aAntiproteases
=450  \\$aEndopeptidase Inhibitors
=450  \\$aEndopeptidases$xantagonists & inhibitors
=450  \\$aExopeptidases$xantagonists & inhibitors
=450  \\$wnnna$aHydrolase Inhibitors, Peptide
=450  \\$wnnna$aInhibitor, Protease
=450  \\$wnnna$aInhibitors, Endopeptidase
=450  \\$wnnna$aInhibitors, Peptidase
=450  \\$wnnna$aInhibitors, Peptide Hydrolase
=450  \\$wnnna$aInhibitors, Peptide Peptidohydrolase
=450  \\$wnnna$aInhibitors, Protease
=450  \\$aPeptidase Inhibitors
=450  \\$aPeptide Hydrolase Inhibitors
=450  \\$aPeptide Hydrolases$xantagonists & inhibitors
=450  \\$aPeptide Peptidohydrolase Inhibitors
=450  \\$wnnna$aPeptidohydrolase Inhibitors, Peptide
=450  \\$aProtease Antagonists
=450  \\$wnnna$aProtease Inhibitor
=550  \\$wg$aEnzyme Inhibitors
=550  \\$wh$aAngiotensin-Converting Enzyme Inhibitors
=550  \\$wh$aCysteine Proteinase Inhibitors
=550  \\$wh$aDipeptidyl-Peptidase IV Inhibitors
=550  \\$wh$aHIV Protease Inhibitors
=550  \\$wh$aMatrix Metalloproteinase Inhibitors
=550  \\$wh$aProteasome Inhibitors
=550  \\$wh$aSerine Proteinase Inhibitors
=550  \\$aProteinase Inhibitory Proteins, Secretory
=667  \\$aPROTEASE INHIBITORY PROTEINS, SECRETORY is also available; DF: PROTEASE INHIB
=680  \\$iCompounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).
=688  \\$a79
=750  \0$aProtease inhibitors$0(DLC) sh 85107684$5IEN

=LDR  00798cz  a2200229n  4500
=001  9880363950402441
=005  20141212204917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011478
=035  \\$aCBA4773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x725
=072  \\$aD1.$x268.$x271.$x100.$x725
=072  \\$aD1.$x268.$x556.$x750
=072  \\$aD1.$x552.$x20.$x778
=072  \\$aD1.$x552.$x544.$x750
=150  \\$aProtactinium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iProtactinium. A radioactive element of the actinide group of metals. It has the atomic symbol Pa, atomic number 91, and atomic weight 231. It decays by alpha-emission.
=750  \0$aProtactinium$5IEN$0(DLC)sh 85107634

=LDR  00813nz  a2200265n  4500
=001  9882256886802441
=005  20230831114157.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011477
=035  \\$a(DNLM)D011477
=035  \\$a(NLM)98196096940000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x802.$x790
=072  \\$aI1.$x880.$x735.$x679
=150  \\$aSex Work
=450  \\$wnnna$aSex Industry
=450  \\$aCommercial Sex
=450  \\$aProstitution
=450  \\$wnnna$aIndustries, Sex
=450  \\$wnnna$aSex Industries
=450  \\$wnnna$aSex, Commercial
=450  \\$wnnna$aWork, Sex
=680  \\$iThe act or practice of engaging in sexual relations for money or other benefit.
=750  \0$aSex work$0(DLC)sh2022006936$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  00978cz  a2200289n  4500
=001  9880363950602441
=005  20200619133856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011476
=035  \\$aCBA4771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780
=072  \\$aH2.$x163.$x876.$x708
=150  \\$aProsthodontics
=450  \\$wnnna$aProsthodontic
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aDental Casting Technique
=550  \\$wh$aDental Implantation
=550  \\$wh$aDental Marginal Adaptation
=550  \\$wh$aDental Prosthesis
=550  \\$wh$aResonance Frequency Analysis
=550  \\$wh$aTissue Conditioning (Dental)
=667  \\$aSPEC: SPEC qualif
=680  \\$iA dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing teeth and structures by artificial devices or prostheses.
=688  \\$a65
=750  \0$aProsthodontics$5IEN$0(DLC)sh 85107621

=LDR  00816cz  a2200265n  4500
=001  9880363950702441
=005  20141212204916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011474
=035  \\$aCBA4769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x320.$x550
=072  \\$aE7.$x695.$x680
=150  \\$aProsthesis Design
=450  \\$wnnna$aDesign, Prosthesis
=450  \\$wnnna$aDesigns, Prosthesis
=450  \\$wnnna$aProsthesis Designs
=550  \\$wg$aEquipment Design
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aProsthesis Coloring
=550  \\$aEquipment Design
=667  \\$acoordinate with specific prosthesis
=680  \\$iThe plan and delineation of prostheses in general or a specific prosthesis.
=688  \\$a74(71)
=750  \0$aProsthesis$xDesign$5IEN$0(IEN)369988

=LDR  01452cz  a2200337n  4500
=001  9880363950802441
=005  20141212204916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011472
=035  \\$aCBA4767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x565.$x750
=150  \\$aProstatitis
=450  \\$wnnna$aAcute Bacterial Prostatitides
=450  \\$wnnna$aAcute Bacterial Prostatitis
=450  \\$wnnna$aAsymptomatic Inflammatory Prostatitides
=450  \\$wnnna$aAsymptomatic Inflammatory Prostatitis
=450  \\$wnnna$aBacterial Prostatitides, Acute
=450  \\$wnnna$aBacterial Prostatitides, Chronic
=450  \\$wnnna$aBacterial Prostatitis, Acute
=450  \\$wnnna$aBacterial Prostatitis, Chronic
=450  \\$wnnna$aChronic Bacterial Prostatitides
=450  \\$wnnna$aChronic Bacterial Prostatitis
=450  \\$wnnna$aChronic Prostatitis with Chronic Pelvic Pain Syndrome
=450  \\$wnnna$aInflammatory Prostatitis, Asymptomatic
=450  \\$wnnna$aProstatitides
=450  \\$wnnna$aProstatitides, Chronic Bacterial
=550  \\$wg$aProstatic Diseases
=667  \\$acoordinate with appropriate infection term if pertinent; do not confuse with PROSTATISM
=680  \\$iInfiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
=750  \0$aProstatitis$5IEN$0(DLC)sh 85107613

=LDR  01594cz  a2200457n  4500
=001  9880363950902441
=005  20141212204915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011471
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x440.$x770
=072  \\$aC12.$x294.$x260.$x750
=072  \\$aC12.$x294.$x565.$x625
=072  \\$aC12.$x758.$x409.$x750
=150  \\$aProstatic Neoplasms
=450  \\$aCancer of Prostate
=450  \\$wnnna$aCancer of the Prostate
=450  \\$wnnna$aCancer, Prostate
=450  \\$wnnna$aCancer, Prostatic
=450  \\$wnnna$aCancers, Prostate
=450  \\$wnnna$aCancers, Prostatic
=450  \\$wnnna$aNeoplasm, Prostate
=450  \\$wnnna$aNeoplasm, Prostatic
=450  \\$wnnna$aNeoplasms, Prostate
=450  \\$wnnna$aNeoplasms, Prostatic
=450  \\$aProstate Cancer
=450  \\$wnnna$aProstate Cancers
=450  \\$wnnna$aProstate Neoplasm
=450  \\$wnnna$aProstate Neoplasms
=450  \\$wnnna$aProstatic Cancer
=450  \\$wnnna$aProstatic Cancers
=450  \\$wnnna$aProstatic Neoplasm
=550  \\$wg$aGenital Neoplasms, Male
=550  \\$wg$aProstatic Diseases
=550  \\$wh$aProstatic Neoplasms, Castration-Resistant
=550  \\$aProstate-Specific Antigen
=550  \\$aProstatic Hyperplasia
=667  \\$acoordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available
=680  \\$iTumors or cancer of the PROSTATE.
=750  \0$aProstate$xTumors$5IEN-M$0(IEN)369985
=750  \0$aProstate$xCancer$5IEN-HS$0(DLC)sh 85107606

=LDR  01393cz  a2200325n  4500
=001  9880363951002441
=005  20141212204915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011470
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x565.$x500
=150  \\$aProstatic Hyperplasia
=450  \\$aAdenoma, Prostatic
=450  \\$wnnna$aAdenomas, Prostatic
=450  \\$aBenign Prostatic Hyperplasia
=450  \\$wnnna$aBenign Prostatic Hypertrophy
=450  \\$wnnna$aHyperplasia, Prostatic
=450  \\$wnnna$aHypertrophy, Benign Prostatic
=450  \\$aProstatic Adenoma
=450  \\$wnnna$aProstatic Adenomas
=450  \\$aProstatic Hyperplasia, Benign
=450  \\$aProstatic Hypertrophy
=450  \\$aProstatic Hypertrophy, Benign
=550  \\$wg$aProstatic Diseases
=550  \\$aProstatic Neoplasms
=550  \\$aProstatism
=667  \\$anote category: non-neoplastic despite X refs ADENOMA, PROSTATIC & PROSTATIC ADENOMA
=680  \\$iIncrease in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
=688  \\$a96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95
=750  \0$aProstate$xHypertrophy$5IEN$0(DLC)sh 85107609

=LDR  00784cz  a2200253n  4500
=001  9880363951102441
=005  20141212204914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011469
=035  \\$aCBA4764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x565
=150  \\$aProstatic Diseases
=450  \\$wnnna$aDisease, Prostatic
=450  \\$wnnna$aDiseases, Prostatic
=450  \\$wnnna$aProstatic Disease
=550  \\$wg$aGenital Diseases, Male
=550  \\$wh$aProstatic Hyperplasia
=550  \\$wh$aProstatic Neoplasms
=550  \\$wh$aProstatitis
=667  \\$ainflammatory disease = PROSTATITIS
=680  \\$iPathological processes involving the PROSTATE or its component tissues.
=688  \\$a66
=750  \0$aProstate$xDiseases$5IEN$0(DLC)sh 85107607

=LDR  01304cz  a2200301n  4500
=001  9880363951202441
=005  20141212204914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011468
=035  \\$aCBA4763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x774.$x860.$x625
=150  \\$aProstatectomy
=450  \\$wnnna$aProstatectomies
=450  \\$wnnna$aProstatectomies, Retropubic
=450  \\$wnnna$aProstatectomies, Suprapubic
=450  \\$aProstatectomy, Retropubic
=450  \\$aProstatectomy, Suprapubic
=450  \\$wnnna$aRetropubic Prostatectomies
=450  \\$wnnna$aRetropubic Prostatectomy
=450  \\$wnnna$aSuprapubic Prostatectomies
=450  \\$wnnna$aSuprapubic Prostatectomy
=550  \\$wg$aUrologic Surgical Procedures, Male
=550  \\$wh$aTransurethral Resection of Prostate
=550  \\$wh$aUltrasound, High-Intensity Focused, Transrectal
=550  \\$aProstate
=680  \\$iComplete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE).
=750  \0$aProstatectomy$5IEN$0(DLC)sh 85107611

=LDR  01066cz  a2200205n  4500
=001  9880363951302441
=005  20141212204914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011467
=035  \\$aCBA4762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x575
=072  \\$aA10.$x336.$x707
=150  \\$aProstate
=450  \\$wnnna$aProstates
=550  \\$wg$aExocrine Glands
=550  \\$wg$aGenitalia, Male
=667  \\$aadenoma, hyperplasia & hypertrophy = PROSTATIC HYPERPLASIA; /surg: probably PROSTATECTOMY; inflammation = PROSTATITIS; PROSTATE-SPECIFIC ANTIGEN (a serine proteinase) is available: do not confuse with prostate-specific acid phosphatase ( = PROSTATE + ACID PHOSPHATASE)
=680  \\$iA gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.
=750  \0$aProstate$5IEN$0(DLC)sh 85107605

=LDR  01474cz  a2200313n  4500
=001  9880363951402441
=005  20141212204913.0
=008  770523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011464
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x100.$x637.$x550.$x500
=072  \\$aD10.$x251.$x355.$x255.$x550.$x550.$x500
=072  \\$aD23.$x469.$x50.$x175.$x725.$x895.$x500
=150  \\$aEpoprostenol
=450  \\$wnnna$aEpoprostanol
=450  \\$wnnna$aEpoprostenol Sodium
=450  \\$wnnna$aEpoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
=450  \\$wnnna$aFlolan
=450  \\$aPGI2
=450  \\$aPGX
=450  \\$aProstacyclin
=450  \\$wnnna$aProstaglandin I(2)
=450  \\$aProstaglandin I2
=450  \\$wnnoa$aProstaglandins X$5IEN-M
=550  \\$wg$aProstaglandins I
=667  \\$a/chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGX
=680  \\$iA prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
=688  \\$a91(78); was PROSTAGLANDINS X 1978-90 (see under PROSTAGLANDINS 1978-83); PROSTACYCLIN was PROSTACYCLINS 1978-93; PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93
=750  \0$aProstacyclin$5IEN$0(DLC)sh 85107601

=LDR  01197cz  a2200337n  4500
=001  9880363951502441
=005  20141212204911.0
=008  770523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011459
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x550.$x700.$x450
=072  \\$aD23.$x469.$x700.$x660
=150  \\$aProstaglandins E, Synthetic
=450  \\$wnnna$aAnalogs, Prostaglandin E
=450  \\$wnnna$aAnalogues, Prostaglandin E
=450  \\$aPGE Synthetic
=450  \\$aProstaglandin E Analogs
=450  \\$wnnna$aProstaglandin E Analogues
=450  \\$aProstaglandins E$xanalogs & derivatives
=450  \\$wnnna$aSynthetic, PGE
=450  \\$wnnna$aSynthetic Prostaglandins E
=550  \\$wg$aProstaglandins, Synthetic
=550  \\$wh$a16,16-Dimethylprostaglandin E2
=550  \\$wh$aArbaprostil
=550  \\$wh$aEnprostil
=550  \\$wh$aMisoprostol
=550  \\$wh$aRioprostil
=667  \\$aDF: PGE SYN
=680  \\$iAnalogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.
=688  \\$a78
=750  \0$aSynthetic prostaglandins E$5IEN$0(DLC)sh 85131672

=LDR  01313cz  a2200241n  4500
=001  9880363951602441
=005  20141212204910.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011458
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x100.$x637.$x250
=072  \\$aD10.$x251.$x355.$x255.$x550.$x250
=072  \\$aD23.$x469.$x50.$x175.$x725.$x780
=150  \\$aProstaglandins E
=450  \\$wnnna$aE, Prostaglandins
=450  \\$aPGE
=550  \\$wg$aProstaglandins
=550  \\$wh$aAlprostadil
=550  \\$wh$aDinoprostone
=667  \\$a/biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS E, SYNTHETIC: DF: PGE
=680  \\$i(11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.
=688  \\$a75
=750  \0$aProstaglandins E$5IEN$0(DLC)sh 85107604

=LDR  01144cz  a2200289n  4500
=001  9880363951702441
=005  20190423122716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x550
=072  \\$aD23.$x469.$x50.$x175.
=150  \\$aProstaglandins
=450  \\$wnnna$aProstanoids
=550  \\$wg$aEicosanoids
=550  \\$wh$aProstaglandin Endoperoxides
=550  \\$wh$aProstaglandins A
=550  \\$wh$aProstaglandins B
=550  \\$wh$aProstaglandins D
=550  \\$wh$aProstaglandins E
=550  \\$wh$aProstaglandins F
=550  \\$wh$aProstaglandins I
=550  \\$wh$aProstaglandins, Synthetic
=667  \\$aGEN or unspecified only: prefer specifics; /biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC
=680  \\$iA group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.
=688  \\$a66(63)
=750  \0$aProstaglandins$5IEN-M$0(DLC)sh 85107602

=LDR  02836cz  a2200709n  4500
=001  9880363951802441
=005  20141212204908.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011451
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x600.$x720
=072  \\$aD8.$x811.$x682.$x690.$x708.$x715
=150  \\$aProstaglandin-Endoperoxide Synthases
=450  \\$wnnna$aArachidonic Acid Cyclooxygenase
=450  \\$wnnna$aCyclase, Hydroperoxide
=450  \\$wnnna$aCyclo-Oxygenase
=450  \\$wnnna$aCyclo Oxygenase
=450  \\$wnnna$aCyclo-Oxygenase, Fatty Acid
=450  \\$wnnna$aCyclo-Oxygenase, Prostaglandin
=450  \\$wnnna$aCyclooxygenase
=450  \\$wnnna$aCyclooxygenase, Arachidonic Acid
=450  \\$wnnna$aCyclooxygenase, Prostaglandin
=450  \\$wnnna$aCyclooxygenases
=450  \\$wnnna$aEndoperoxide Synthetase, Prostaglandin
=450  \\$aFatty Acid Cyclo-Oxygenase
=450  \\$wnnna$aFatty Acid Cyclo Oxygenase
=450  \\$wnnna$aG-H Synthase, Prostaglandin
=450  \\$wnnna$aHydroperoxide Cyclase
=450  \\$aPGH Synthase
=450  \\$wnnna$aPGH2 Synthetase
=450  \\$wnnna$aProstaglandin Cyclo-Oxygenase
=450  \\$wnnna$aProstaglandin Cyclo Oxygenase
=450  \\$wnnna$aProstaglandin Cyclooxygenase
=450  \\$aProstaglandin-Endoperoxide Synthase
=450  \\$wnnna$aProstaglandin Endoperoxide Synthases
=450  \\$wnnna$aProstaglandin Endoperoxide Synthetase
=450  \\$wnnna$aProstaglandin G-H Synthase
=450  \\$wnnna$aProstaglandin G H Synthase
=450  \\$aProstaglandin H Synthase
=450  \\$wnnna$aProstaglandin H2 Synthetase
=450  \\$aProstaglandin Synthase
=450  \\$wnnna$aProstaglandin Synthetase
=450  \\$wnnna$aSynthase, PGH
=450  \\$wnnna$aSynthase, Prostaglandin
=450  \\$wnnna$aSynthase, Prostaglandin-Endoperoxide
=450  \\$wnnna$aSynthase, Prostaglandin G-H
=450  \\$wnnna$aSynthase, Prostaglandin H
=450  \\$wnnna$aSynthases, Prostaglandin-Endoperoxide
=450  \\$wnnna$aSynthetase, PGH2
=450  \\$wnnna$aSynthetase, Prostaglandin
=450  \\$wnnna$aSynthetase, Prostaglandin Endoperoxide
=450  \\$wnnna$aSynthetase, Prostaglandin H2
=550  \\$wg$aMixed Function Oxygenases
=550  \\$wg$aMultienzyme Complexes
=550  \\$wh$aCyclooxygenase 1
=550  \\$wh$aCyclooxygenase 2
=667  \\$aDF: PG SYNTHASE
=680  \\$iEnzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.
=688  \\$a2006(1992);
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Prostaglandin-Endoperoxide Synthase
=688  \\$a92; was PROSTAGLANDIN SYNTHASE 1975-91 (see under HYDROXYLASES 1975-77)
=750  \0$aCyclooxygenases$0(DLC) sh 96008414$5IEN-M

=LDR  01030cz  a2200301n  4500
=001  9880363951902441
=005  20141212204906.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011448
=035  \\$aCBA4742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x710
=072  \\$aD27.$x505.$x696.$x399.$x450.$x710
=150  \\$aProstaglandin Antagonists
=450  \\$wnnna$aAntagonist, Prostaglandin
=450  \\$wnnna$aAntagonists, Prostaglandin
=450  \\$wnnna$aInhibitor, Prostaglandin
=450  \\$wnnna$aInhibitors, Prostaglandin
=450  \\$wnnna$aProstaglandin Antagonist
=450  \\$wnnna$aProstaglandin Inhibitor
=450  \\$aProstaglandin Inhibitors
=450  \\$aProstaglandins$xantagonists & inhibitors
=550  \\$wg$aHormone Antagonists
=550  \\$aProstaglandins
=667  \\$a/biosyn /physiol permitted if by living organism; DF: PG ANTAG
=680  \\$iCompounds that inhibit the action of prostaglandins.
=688  \\$a75
=750  \0$aProstaglandins$xAntagonists$5IEN$0(IEN)369983

=LDR  00682cz  a2200253n  4500
=001  9880363952002441
=005  20141212204904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011437
=035  \\$aCBA4731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x831
=150  \\$aPropylamines
=550  \\$wg$aAmines
=550  \\$wh$aCitalopram
=550  \\$wh$aClorgyline
=550  \\$wh$aFluoxetine
=550  \\$wh$aMexiletine
=550  \\$wh$aPromethazine
=550  \\$wh$aTranylcypromine
=688  \\$a66
=750  \0$aIsopropylamine$5IEN-M$0(DLC)sh 85068666
=750  \0$aPropylamine$5IEN-HS$0(DLC)sh 85107557
=750  \0$aDipropylamine$5IEN-HS$0(DLC)sh 85038230

=LDR  00777cz  a2200217n  4500
=001  9880363952102441
=005  20141212204903.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011435
=035  \\$aCBA4729M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x300.$x200.$x600
=072  \\$aD2.$x241.$x511.$x390.$x200.$x600
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x200.$x600
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x200.$x600
=150  \\$aPropyl Gallate
=450  \\$wnnna$aGallate, Propyl
=550  \\$wg$aGallic Acid
=680  \\$iAntioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.
=688  \\$a91(75); was see under GALLIC ACID 1975-90
=750  \0$aPropyl gallate$0(DLC)sh2008008251$5IEN-M

=LDR  01224cz  a2200313n  4500
=001  9880363952202441
=005  20141212204903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011434
=035  \\$aCBA4728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x541
=072  \\$aG11.$x561.$x600.$x810.$x541
=150  \\$aProprioception
=450  \\$aPosition Sense
=450  \\$wnnna$aPosition Senses
=450  \\$wnnna$aProprioceptions
=450  \\$aProprioceptors$5IEN
=450  \\$wnnna$aSense of Position
=450  \\$wnnna$aSense, Position
=450  \\$wnnna$aSenses, Position
=550  \\$wg$aSensation
=550  \\$wh$aKinesthesis
=550  \\$wh$aPostural Balance
=550  \\$aMechanoreceptors
=680  \\$iSensory functions that transduce stimuli received by proprioceptive receptors in joints, tendons, muscles, and the INNER EAR into neural impulses to be transmitted to the CENTRAL NERVOUS SYSTEM. Proprioception provides sense of stationary positions and movements of one's body parts, and is important in maintaining KINESTHESIA and POSTURAL BALANCE.
=688  \\$a73
=750  \0$aProprioceptors$5IEN-M$0(DLC)sh 85107556
=750  \0$aProprioception$5IEN-HS$0(DLC)sh 85107555

=LDR  00751cz  a2200229n  4500
=001  9880363952302441
=005  20141212204901.0
=008  771209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x840.$x762
=072  \\$aD20.$x215.$x721.$x500.$x762
=150  \\$aPropolis
=450  \\$wnnna$aBee Bread
=450  \\$wnnna$aBee Glue
=450  \\$wnnna$aBread, Bee
=450  \\$wnnna$aGlue, Bee
=550  \\$wg$aResins, Plant
=550  \\$aBees
=680  \\$iA resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances.
=688  \\$a91(79); was see under RESINS 1979-90
=750  \0$aPropolis$5IEN$0(DLC)sh 85107536

=LDR  00591cz  a2200229n  4500
=001  9880363952402441
=005  20141212204901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011427
=035  \\$aCBA4721M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x818
=150  \\$aPropiophenones
=550  \\$wg$aKetones
=550  \\$wh$aBupropion
=550  \\$wh$aChalcones
=550  \\$wh$aHydroxypropiophenone
=550  \\$wh$aKynuramine
=550  \\$wh$aOxyfedrine
=550  \\$wh$aPropafenone
=550  \\$wh$aTolperisone
=750  \0$aPropiophenones$0(DLC)sh2010003589$5IEN-M

=LDR  00981cz  a2200205n  4500
=001  9880363952502441
=005  20141212204900.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011425
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x600.$x600.$x600
=072  \\$aB3.$x510.$x460.$x400.$x400.$x600.$x600.$x600
=150  \\$aPropionibacterium acnes
=450  \\$aCorynebacterium acnes
=450  \\$aCorynebacterium parvum
=550  \\$wg$aPropionibacterium
=667  \\$ainfection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM); DF: PROPIONIBACT ACNES
=680  \\$iA bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.
=688  \\$a76; CORYNEBACTERIUM ACNES & CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1972-75 (Provs 1972-74)
=750  \0$aPropionibacterium acnes$5IEN$0(DLC)sh 88023304

=LDR  00922cz  a2200193n  4500
=001  9880363952602441
=005  20181127093807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011424
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x600.$x600
=072  \\$aB3.$x510.$x460.$x400.$x400.$x600.$x600
=150  \\$aPropionibacterium
=550  \\$wg$aPropionibacteriaceae
=550  \\$wh$aPropionibacterium acnes
=550  \\$wh$aPropionibacterium freudenreichii
=667  \\$ado not confuse with PROPIONIGENIUM; DF: PROPIONIBACT
=680  \\$iA genus of gram-positive, rod-shaped bacteria whose cells occur singly, in pairs or short chains, in V or Y configurations, or in clumps resembling letters of the Chinese alphabet. Its organisms are found in cheese and dairy products as well as on human skin and can occasionally cause soft tissue infections.
=750  \0$aPropionibacterium$5IEN$0(DLC)sh 88023303

=LDR  00720cz  a2200205n  4500
=001  9880363952702441
=005  20141212204900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x600
=072  \\$aB3.$x510.$x460.$x400.$x400.$x600
=150  \\$aPropionibacteriaceae
=550  \\$wg$aActinomycetales
=550  \\$wg$aGram-Positive Asporogenous Rods, Irregular
=550  \\$wh$aPropionibacterium
=667  \\$ain dairy products or intestinal tracts of animals
=680  \\$iA family of gram-positive bacteria found in dairy products or in the intestinal tracts of animals.
=688  \\$a75
=750  \0$aPropionibacteriaceae$5IEN$0(DLC)sh 88023302

=LDR  02145cz  a2200529n  4500
=001  9880363952802441
=005  20210212102522.0
=008  850612\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010959
=035  \\$aCBA4249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x875
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x875
=072  \\$aD12.$x776.$x124.$x125.$x662.$x768
=072  \\$aD23.$x119.$x970
=150  \\$aTissue Plasminogen Activator
=450  \\$wnnna$aActilyse
=450  \\$wnnna$aActivase
=450  \\$aAlteplase
=450  \\$wnnna$aAlteplase Genentech Brand
=450  \\$wnnna$aAlteplase Promeco Brand
=450  \\$wnnna$aBoehringer Ingelheim Brand of Alteplase
=450  \\$wnnna$aGenentech Brand of Alteplase
=450  \\$wnnna$aHoffmann-La Roche Brand of Alteplase
=450  \\$wnnna$aHoffmann La Roche Brand of Alteplase
=450  \\$wnnna$aLysatec rt-PA
=450  \\$wnnna$aLysatec rt PA
=450  \\$wnnna$aLysatec rtPA
=450  \\$wnnna$aPlasminogen Activator, Tissue
=450  \\$aPlasminogen Activator, Tissue-Type
=450  \\$wnnna$aPlasminogen Activator, Tissue Type
=450  \\$wnnna$aPromeco Brand of Alteplase
=450  \\$aT-Plasminogen Activator
=450  \\$wnnna$aT Plasminogen Activator
=450  \\$wnnna$aTisokinase
=450  \\$wnnna$aTissue Activator D-44
=450  \\$wnnna$aTissue Activator D 44
=450  \\$aTissue-Type Plasminogen Activator
=450  \\$wnnna$aTissue Type Plasminogen Activator
=450  \\$wnnna$aTTPA
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aPlasminogen Activators
=550  \\$wg$aSerine Endopeptidases
=550  \\$wh$aTenecteplase
=680  \\$iA proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
=688  \\$a98(86)
=750  \0$aTissue plasminogen activator$5IEN-M$0(DLC)sh 87000090

=LDR  01377cz  a2200325n  4500
=001  9880363952902441
=005  20141212204627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010958
=035  \\$aCBA4248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x622.$x610
=072  \\$aD12.$x776.$x124.$x790.$x223.$x580
=072  \\$aD12.$x776.$x377.$x715.$x182.$x580
=150  \\$aPlasminogen
=450  \\$wnnna$a1-Plasminogen, Glutamic Acid
=450  \\$wnnna$aGlu-Plasminogen
=450  \\$wnnna$aGlu Plasminogen
=450  \\$wnnna$aGlutamic Acid 1-Plasminogen
=450  \\$wnnna$aGlutamic Acid 1 Plasminogen
=450  \\$wnnna$aGlutamyl Plasminogen
=450  \\$wnnna$aPlasminogen, Glutamyl
=450  \\$aProfibrinolysin
=550  \\$wg$aBeta-Globulins
=550  \\$wg$aEnzyme Precursors
=550  \\$wh$aAngiostatins
=667  \\$aan enzyme precursor & fibrinolytic agent; /antag: do not confuse with PLASMINOGEN INACTIVATORS which modulate PLASMINOGEN ACTIVATORS, not PLASMINOGEN
=680  \\$iPrecursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent.
=688  \\$a65(63)
=750  \0$aPlasminogen$5IEN$0(DLC)sh 87000088

=LDR  01247cz  a2200325n  4500
=001  9880363953002441
=005  20141212204627.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010957
=035  \\$aCBA4247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x600
=150  \\$aPlasmids
=450  \\$wnnna$aEpisome
=450  \\$aEpisomes
=450  \\$wnnna$aPlasmid
=550  \\$wg$aGenetic Structures
=550  \\$wh$aBacteriocin Plasmids
=550  \\$wh$aCosmids
=550  \\$wh$aF Factor
=550  \\$wh$aHemolysin Factors
=550  \\$wh$aLactose Factors
=550  \\$wh$aPlant Tumor-Inducing Plasmids
=550  \\$wh$aR Factors
=550  \\$aDNA Transposable Elements
=667  \\$aGEN; prefer specifics
=680  \\$iExtrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
=688  \\$a78(75); was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77
=750  \0$aPlasmids$5IEN-M$0(DLC)sh 85103093
=750  \0$aEpisomes$5IEN-HS$0(DLC)sh 85044449

=LDR  00807cz  a2200229n  4500
=001  9880363953102441
=005  20141212204626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010956
=035  \\$aCBA4246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x120.$x770
=072  \\$aE2.$x912.$x715
=150  \\$aPlasmapheresis
=450  \\$wnnna$aPlasmaphereses
=550  \\$wg$aBlood Component Removal
=550  \\$wg$aSorption Detoxification
=550  \\$aCell Separation
=667  \\$ado not use /util except by MeSH definition
=680  \\$iProcedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
=688  \\$a68(65)
=750  \0$aPlasmapheresis$5IEN$0(DLC)sh 85103092

=LDR  01125cz  a2200301n  4500
=001  9880363953202441
=005  20141212204626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010954
=035  \\$aCBA4244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x595.$x600
=072  \\$aC20.$x683.$x515.$x880
=150  \\$aPlasmacytoma
=450  \\$aPlasma Cell Tumor
=450  \\$wnnna$aPlasma Cell Tumors
=450  \\$wnnna$aPlasmacytomas
=450  \\$wnnna$aPlasmocytoma
=450  \\$wnnna$aPlasmocytomas
=450  \\$wnnna$aTumor, Plasma Cell
=450  \\$wnnna$aTumors, Plasma Cell
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wg$aNeoplasms, Plasma Cell
=550  \\$aInterleukin-6
=667  \\$asolitary = PLASMACYTOMA; multiple = MULTIPLE MYELOMA; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
=680  \\$iAny discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.
=688  \\$a65; was PLASMOCYTOMA 1963-64
=750  \0$aPlasmacytoma$5IEN$0(DLC)sh 85103091

=LDR  01043cz  a2200253n  4500
=001  9880363953302441
=005  20141212204625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010952
=035  \\$aCBA4242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x140.$x500
=150  \\$aPlasma Substitutes
=450  \\$aBlood Expanders
=450  \\$aBlood Plasma Substitutes$5IEN
=450  \\$wnnna$aExpanders, Blood
=450  \\$wnnna$aExpanders, Plasma Volume
=450  \\$aPlasma Volume Expanders
=450  \\$wnnna$aSubstitutes, Plasma
=450  \\$wnnna$aVolume Expanders, Plasma
=550  \\$wg$aBlood Substitutes
=667  \\$aBLOOD SUBSTITUTES is also available
=680  \\$iAny liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.
=750  \0$aBlood plasma substitutes$5IEN$0(DLC)sh 85015002

=LDR  00899cz  a2200217n  4500
=001  9880363953402441
=005  20141212204625.0
=008  800512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010951
=035  \\$aCBA4241HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x135.$x750
=150  \\$aPlasma Exchange
=450  \\$wnnna$aExchange, Plasma
=450  \\$wnnna$aExchanges, Plasma
=450  \\$wnnna$aPlasma Exchanges
=550  \\$wg$aBlood Transfusion
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRemoval of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
=688  \\$a81
=750  \0$aPlasma exchange (Therapeutics)$5IEN$0(DLC)sh 85103071

=LDR  01012cz  a2200325n  4500
=001  9880363852902441
=005  20180221134940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011056
=035  \\$aCBA4346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696
=150  \\$aPolitical Systems
=450  \\$aPolitical Science$5IEN
=450  \\$wnnna$aPolitical System
=450  \\$wnnna$aSystem, Political
=450  \\$wnnna$aSystems, Political
=550  \\$wg$aSocial Sciences
=550  \\$wh$aApartheid
=550  \\$wh$aCapitalism
=550  \\$wh$aColonialism
=550  \\$wh$aCommunism
=550  \\$wh$aDemocracy
=550  \\$wh$aFacism
=550  \\$wh$aNational Socialism
=550  \\$wh$aSocialism
=667  \\$aspecify geog
=680  \\$iThe units based on political theory and chosen by countries under which their governmental power is organized and administered to their citizens.
=688  \\$a80; was NON MESH before 1980
=750  \0$aPolitical science$5IEN$0(DLC)sh 85104440

=LDR  01115cz  a2200229n  4500
=001  9880363853002441
=005  20141212204700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011055
=035  \\$aCBA4345HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x623.$x750
=150  \\$aPoliovirus Vaccine, Oral
=450  \\$wnnna$aOral Poliovirus Vaccine
=450  \\$aPoliomyelitis Vaccine, Oral$5IEN
=450  \\$aSabin Vaccine
=450  \\$wnnna$aVaccine, Oral Poliovirus
=450  \\$wnnna$aVaccine, Sabin
=550  \\$wg$aPoliovirus Vaccines
=667  \\$aSABIN VACCINE is attenuated (live)
=680  \\$iA live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)
=750  \0$aPoliomyelitis vaccine, Oral$5IEN$0(DLC)sh 85104278

=LDR  00914cz  a2200253n  4500
=001  9880363853102441
=005  20141212204700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011054
=035  \\$aCBA4344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x830.$x614
=072  \\$aD20.$x215.$x894.$x899.$x623.$x500
=150  \\$aPoliovirus Vaccine, Inactivated
=450  \\$wnnna$aInactivated Poliovirus Vaccine
=450  \\$aPoliomyelitis Vaccine$5IEN
=450  \\$wnnoa$aPoliovirus Vaccine$5IEN-HS
=450  \\$aSalk Vaccine
=450  \\$wnnna$aVaccine, Inactivated Poliovirus
=450  \\$wnnna$aVaccine, Salk
=550  \\$wg$aPoliovirus Vaccines
=550  \\$wg$aVaccines, Inactivated
=680  \\$iA suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.
=750  \0$aPoliomyelitis vaccine$5IEN$0(DLC)sh 85104276

=LDR  02471cz  a2200529n  4500
=001  9880363853202441
=005  20141212204659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011051
=035  \\$aCBA4341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182.$x600.$x700
=072  \\$aC2.$x182.$x700
=072  \\$aC2.$x782.$x687.$x359.$x764
=072  \\$aC10.$x228.$x228.$x210.$x575.$x750
=072  \\$aC10.$x228.$x228.$x210.$x650
=072  \\$aC10.$x228.$x228.$x618.$x850
=072  \\$aC10.$x228.$x854.$x525.$x850
=072  \\$aC10.$x228.$x854.$x641
=072  \\$aC10.$x668.$x864
=150  \\$aPoliomyelitis
=450  \\$wnnna$aAcute Poliomyelitis
=450  \\$wnnna$aAcute Poliomyelitis, Epidemic
=450  \\$wnnna$aEncephalitis, Polio
=450  \\$wnnna$aEpidemic Acute Poliomyelitis
=450  \\$aInfantile Paralysis
=450  \\$wnnna$aNonpoliovirus Poliomyelitis
=450  \\$wnnna$aParalysis, Infantile
=450  \\$aPolio
=450  \\$wnnna$aPolio Encephalitis
=450  \\$wnnna$aPoliomyelitides, Preparalytic
=450  \\$wnnna$aPoliomyelitis, Acute
=450  \\$wnnna$aPoliomyelitis, Epidemic Acute
=450  \\$aPoliomyelitis, Nonpoliovirus
=450  \\$aPoliomyelitis, Preparalytic
=450  \\$wnnna$aPolios
=450  \\$wnnna$aPreparalytic Poliomyelitis
=550  \\$wg$aCentral Nervous System Viral Diseases
=550  \\$wg$aEnterovirus Infections
=550  \\$wg$aMyelitis
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wg$aSpinal Cord Diseases
=550  \\$wh$aPoliomyelitis, Bulbar
=550  \\$wh$aPostpoliomyelitis Syndrome
=550  \\$aPostpoliomyelitis Syndrome
=680  \\$iAn acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)
=750  \0$aPoliomyelitis$5IEN$0(DLC)sh 85104268

=LDR  01064cz  a2200325n  4500
=001  9880363853302441
=005  20141212204658.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011050
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x742
=150  \\$aPolicy Making
=450  \\$wnnna$aAnalyses, Policy
=450  \\$wnnna$aAnalysis, Policy
=450  \\$wnnna$aDevelopment, Policy
=450  \\$wnnna$aDevelopments, Policy
=450  \\$wnnna$aMaking, Policy
=450  \\$wnnna$aPolicy Analyses
=450  \\$wnnna$aPolicy Analysis
=450  \\$wnnna$aPolicy Development
=450  \\$wnnna$aPolicy Developments
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aAdvisory Committees
=550  \\$aDecision Making
=550  \\$aDecision Making, Organizational
=550  \\$aDissent and Disputes
=667  \\$ano qualif
=680  \\$iThe decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures.
=688  \\$a80
=750  \0$aPolicy sciences$0(DLC) sh 85104264$5IEN

=LDR  00987cz  a2200229n  4500
=001  9880363853402441
=005  20141212204658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011048
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x749
=072  \\$aE5.$x301.$x700
=150  \\$aPolarography
=450  \\$wnnna$aDC Polarography
=450  \\$wnnna$aPolarography, DC
=450  \\$wnnna$aPolarography, Pulse
=450  \\$wnnna$aPulse Polarography
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aElectrochemical Techniques
=667  \\$aDF: POLAROGR
=680  \\$iAn electrochemical technique for measuring the current that flows in solution as a function of an applied voltage. The observed polarographic wave, resulting from the electrochemical response, depends on the way voltage is applied (linear sweep or differential pulse) and the type of electrode used. Usually a mercury drop electrode is used.
=750  \0$aPolarography$5IEN$0(DLC)sh 85104165

=LDR  00907cz  a2200241n  4500
=001  9880363853502441
=005  20141212204657.0
=008  780503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011043
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x503.$x499.$x875
=072  \\$aD12.$x776.$x765.$x678.$x875
=150  \\$aPokeweed Mitogens
=450  \\$wnnna$aIsolectin, Pokeweed Mitogen
=450  \\$aLectins, Pokeweed
=450  \\$wnnna$aMitogen Isolectin, Pokeweed
=450  \\$wnnna$aMitogens, Pokeweed
=450  \\$aPokeweed Lectins
=450  \\$wnnna$aPokeweed Mitogen Isolectin
=550  \\$wg$aPlant Lectins
=680  \\$iProteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells.
=688  \\$a79
=750  \0$aPokeweed mitogens$5IEN$0(DLC)sh 85103972

=LDR  00799cz  a2200217n  4500
=001  9880363853602441
=005  20141212204656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011042
=035  \\$aCBA4332HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x777
=072  \\$aD27.$x888.$x569.$x612
=150  \\$aPoisons
=550  \\$wg$aNoxae
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$wh$aChemical Warfare Agents
=550  \\$aToxicology
=667  \\$aIM
=680  \\$iSubstances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed)
=750  \0$aPoisons$5IEN$0(DLC)sh 85103951

=LDR  01662cz  a2200445n  4500
=001  9880363853702441
=005  20200514121648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011041
=035  \\$aCBA4331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723
=150  \\$aPoisoning
=450  \\$aPharmaceutical Preparations$xpoisoning
=450  \\$wnnna$aPoisonings
=550  \\$wg$aChemically-Induced Disorders
=550  \\$wh$aArgyria
=550  \\$wh$aArsenic Poisoning
=550  \\$wh$aBites and Stings
=550  \\$wh$aCadmium Poisoning
=550  \\$wh$aCarbon Tetrachloride Poisoning
=550  \\$wh$aDrug-Induced Liver Injury
=550  \\$wh$aErgotism
=550  \\$wh$aFluoride Poisoning
=550  \\$wh$aFoodborne Diseases
=550  \\$wh$aGas Poisoning
=550  \\$wh$aHeavy Metal Poisoning
=550  \\$wh$aLead Poisoning
=550  \\$wh$aManganese Poisoning
=550  \\$wh$aMercury Poisoning
=550  \\$wh$aMycotoxicosis
=550  \\$wh$aNeurotoxicity Syndromes
=550  \\$wh$aOrganophosphate Poisoning
=550  \\$wh$aPlant Poisoning
=550  \\$wh$aPsychoses, Substance-Induced
=550  \\$wh$aWater Intoxication
=667  \\$aa disease concept: the discipline = TOXICOLOGY; general only; prefer /pois with Category D & J terms: Manual 19.7+, 19.8.57, 19.9+, 25.11.4; sometimes called "toxicoses" & often called "intoxication" in foreign literature.
=680  \\$iA condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.
=750  \0$aAccidental poisoning$5IEN-M$0(DLC)sh 85103939
=750  \0$aPoisoning$5IEN-HS$0(DLC)sh 85103938

=LDR  01664cz  a2200373n  4500
=001  9880363853802441
=005  20141212204656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011040
=035  \\$aCBA4330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x255.$x100.$x700
=072  \\$aC17.$x800.$x815.$x255.$x100.$x700
=072  \\$aC20.$x543.$x418.$x150.$x700
=150  \\$aDermatitis, Toxicodendron
=450  \\$wnnna$aDermatitides, Poison Ivy
=450  \\$wnnna$aDermatitides, Rhus
=450  \\$wnnna$aDermatitides, Toxicodendron
=450  \\$wnnna$aDermatitis, Poison Ivy
=450  \\$wnnna$aDermatitis, Rhus
=450  \\$wnnna$aPoison Ivy Dermatitides
=450  \\$aPoison Ivy Dermatitis
=450  \\$wnnna$aRhus Dermatitides
=450  \\$aRhus Dermatitis
=450  \\$wnnna$aToxicodendron Dermatitides
=450  \\$aToxicodendron Dermatitis
=550  \\$wg$aDermatitis, Allergic Contact
=550  \\$aToxicodendron
=667  \\$aToxicodendron or Rhus is the genus name for poison ivy; includes poison oak & poison sumac
=680  \\$iAn allergic contact dermatitis caused by exposure to plants of the genus Toxicodendron (formerly Rhus). These include poison ivy, poison oak, and poison sumac, all plants that contain the substance urushiol, a potent skin sensitizing agent. (From Dorland, 27th ed)
=688  \\$a93; was POISON IVY DERMATITIS 1963-92
=750  \0$81$wb$aToxicodendron$5IEN-M$0(DLC)sh 85136328
=750  \0$81$wb$aSkin$xInflammation$5IEN-HS$0(DLC)sh 85123181
=788  \0$iSearch also under the following headings used together in the same record$aToxicodendron$iand$aSkin--Inflammation$5IEN-M

=LDR  00839cz  a2200253n  4500
=001  9880363853902441
=005  20141212204655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011039
=035  \\$aCBA4329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x726
=072  \\$aN2.$x421.$x297.$x695
=150  \\$aPoison Control Centers
=450  \\$wnnna$aCenter, Poison Control
=450  \\$wnnna$aCenters, Poison Control
=450  \\$wnnna$aControl Centers, Poison
=450  \\$wnnna$aPoison Control Center
=550  \\$wg$aEmergency Medical Services
=550  \\$wg$aHealth Facilities
=667  \\$aspecify geog if pertinent
=680  \\$iFacilities which provide information concerning poisons and treatment of poisoning in emergencies.
=688  \\$a66(64)
=750  \0$aPoison control centers$0(DLC) sh 85103932$5IEN

=LDR  00821cz  a2200217n  4500
=001  9880363854002441
=005  20141212204654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011037
=035  \\$aCBA4327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x781
=150  \\$aPoetry as Topic
=550  \\$wg$aLiterature
=667  \\$acoordinate IM with LITERATURE, MEDIEVAL (IM) or LITERATURE, MODERN (IM) if pertinent; do not confuse with the Publication Type POETRY
=680  \\$iLiterary and oral genre expressing meaning via symbolism and following formal or informal patterns.
=688  \\$a2009(1966)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Poetry
=750  \0$aPoetry$0(DLC) sh 85103704$5IEN
=750  \0$aPoetics$0(DLC) sh 85103703$5IEN-M
=750  \0$aPoets$0(DLC) sh 85103733$5IEN-M

=LDR  00998cz  a2200253n  4500
=001  9880363854102441
=005  20141212204654.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011036
=035  \\$aCBA4326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x280.$x680
=150  \\$aPoecilia
=450  \\$wnnna$aGuppies
=450  \\$aGuppy
=450  \\$aLebistes
=450  \\$wnnna$aMollies
=450  \\$aMolly
=450  \\$wnnna$aPoecilias
=550  \\$wg$aCyprinodontiformes
=667  \\$anote X refs; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA genus of livebearing cyprinodont fish comprising the guppy and molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research.
=688  \\$a91(87); was see under CYPRINODONTIFORMES 1987-90
=750  \0$aPoecilia$5IEN$0(DLC)sh 85103694

=LDR  01203cz  a2200205n  4500
=001  9880363854202441
=005  20141212204654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011035
=035  \\$aCBA4325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x125.$x500
=150  \\$aPodophyllum
=450  \\$wnnna$aPodophyllums
=550  \\$wg$aBerberidaceae
=550  \\$wh$aPodophyllum peltatum
=667  \\$aplant only with PODOPHYLLIN the probable Cat D term; prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of poisonous American herbs, family BERBERIDACEAE. The roots yield PODOPHYLLOTOXIN and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA.
=688  \\$a91(86)63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B & D 1963-77
=750  \0$aPodophyllum$5IEN$0(DLC)sh 85103687

=LDR  02308cz  a2200505n  4500
=001  9880363854302441
=005  20141212204653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011034
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x140.$x450.$x777
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x960.$x675
=072  \\$aD4.$x615.$x638.$x960.$x675
=150  \\$aPodophyllotoxin
=450  \\$wnnna$aArdern Brand of Podophyllotoxin
=450  \\$wnnna$aCanderm Brand of Podophyllotoxin
=450  \\$wnnna$aCondyline
=450  \\$wnnna$aCondylox
=450  \\$wnnna$aCPH86
=450  \\$aEpipodophyllotoxin
=450  \\$wnnna$aFides Ecopharma Brand of Podophyllotoxin
=450  \\$wnnna$aHamilton Brand of Podophyllotoxin
=450  \\$wnnna$aNewport Brand of Podophyllotoxin
=450  \\$wnnna$aOclassen Brand of Podophyllotoxin
=450  \\$wnnna$aPaddock Brand of Podophyllotoxin
=450  \\$wnnna$aPaladin Brand of Podophyllotoxin
=450  \\$wnnna$aPodocon-25
=450  \\$wnnna$aPodofilm
=450  \\$wnnna$aPodofilox
=450  \\$wnnna$aPodophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer
=450  \\$wnnna$aPodophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer
=450  \\$wnnna$aPodophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer
=450  \\$wnnna$aPodophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer
=450  \\$wnnna$aStiefel Brand of Podophyllotoxin
=450  \\$wnnna$aWartec
=450  \\$wnnna$aWarticon
=450  \\$wnnna$aWolff Brand of Podophyllotoxin
=450  \\$wnnna$aYamanouchi Brand of Podophyllotoxin
=550  \\$wg$aLignans
=550  \\$wg$aTetrahydronaphthalenes
=550  \\$wh$aEtoposide
=667  \\$a/biosyn permitted if by plant
=680  \\$iA lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives.
=688  \\$a73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975
=750  \0$aPodophyllotoxin$5IEN$0(DLC)sh 85103686

=LDR  00799cz  a2200229n  4500
=001  9880363854402441
=005  20141212204652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011032
=035  \\$aCBA4322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x696
=150  \\$aPodiatry
=450  \\$aChiropody
=450  \\$aPodiatric Assistants$5IEN
=450  \\$aPodiatrists$5IEN
=550  \\$wg$aHealth Occupations
=667  \\$aSPEC: SPEC qualif; for /educ, coord with med educ terms permitted
=680  \\$iA specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot.
=750  \0$aPodiatry$5IEN-M$0(DLC)sh 85103669
=750  \0$aPodiatrists$5IEN-HS$0(DLC)sh 85103667
=750  \0$aPodiatric assistants$5IEN-HS$0(DLC)sh 85103666

=LDR  00768cz  a2200205n  4500
=001  9880363854502441
=005  20141212204652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011031
=035  \\$aCBA4321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928.$x600.$x220.$x620
=150  \\$aPneumothorax, Artificial
=450  \\$wnnna$aArtificial Pneumothorax
=450  \\$wnnna$aArtificial Pneumothoraxs
=450  \\$wnnna$aPneumothoraxs, Artificial
=550  \\$wg$aCollapse Therapy
=667  \\$acoordinate with disease /surg; do not confuse with PNEUMOTHORAX, a disease
=680  \\$iInjection of air or a more slowly absorbed gas such as nitrogen, into the PLEURAL CAVITY to collapse the lung.
=750  \0$aPneumothorax, Artificial$5IEN$0(DLC)sh 85103633

=LDR  01513cz  a2200373n  4500
=001  9880363854602441
=005  20141212204652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011030
=035  \\$aCBA4320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x778
=150  \\$aPneumothorax
=450  \\$wnnna$aPneumothorax, Pressure
=450  \\$wnnna$aPneumothorax, Spontaneous
=450  \\$wnnna$aPneumothorax, Tension
=450  \\$wnnna$aPneumothoraxs, Pressure
=450  \\$wnnna$aPneumothoraxs, Primary Spontaneous
=450  \\$wnnna$aPneumothoraxs, Spontaneous
=450  \\$wnnna$aPneumothoraxs, Tension
=450  \\$wnnna$aPressure Pneumothorax
=450  \\$wnnna$aPressure Pneumothoraxs
=450  \\$wnnna$aPrimary Spontaneous Pneumothorax
=450  \\$wnnna$aPrimary Spontaneous Pneumothoraxs
=450  \\$wnnna$aSpontaneous Pneumothorax
=450  \\$wnnna$aSpontaneous Pneumothorax, Primary
=450  \\$wnnna$aSpontaneous Pneumothoraxs
=450  \\$wnnna$aSpontaneous Pneumothoraxs, Primary
=450  \\$wnnna$aTension Pneumothorax
=450  \\$wnnna$aTension Pneumothoraxs
=550  \\$wg$aPleural Diseases
=667  \\$ado not confuse with PNEUMOTHORAX, ARTIFICIAL, a surgical procedure
=680  \\$iAn accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.
=750  \0$aPneumothorax$5IEN$0(DLC)sh 85103632

=LDR  01447cz  a2200385n  4500
=001  9880363854702441
=005  20141212204651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011029
=035  \\$aCBA4319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x625
=150  \\$aPneumoradiography
=450  \\$wnnna$aAir Radiographies
=450  \\$aAir Radiography
=450  \\$wnnna$aContrast Radiographies, Negative
=450  \\$wnnna$aContrast Radiography, Negative
=450  \\$wnnna$aInsufflation Radiographies
=450  \\$aInsufflation Radiography
=450  \\$wnnna$aNegative Contrast Radiographies
=450  \\$aNegative Contrast Radiography
=450  \\$aPneumomyelography$5IEN
=450  \\$wnnna$aPneumoradiographies
=450  \\$wnnna$aRadiographies, Air
=450  \\$wnnna$aRadiographies, Insufflation
=450  \\$wnnna$aRadiographies, Negative Contrast
=450  \\$wnnna$aRadiography, Air
=450  \\$aRadiography, Insufflation
=450  \\$wnnna$aRadiography, Negative Contrast
=550  \\$wg$aRadiography
=550  \\$wh$aPneumoencephalography
=667  \\$a"radiogr by air, oxygen or some other gas as the contrast medium": nothing to do with LUNG /radiogr; do not use /util except by MeSH definition; DF: PNEUMORADIOGR
=680  \\$iRadiography using air, oxygen, or some other gas as a contrast medium.
=688  \\$a74
=750  \0$aPneumomyelography$5IEN$0(DLC)sh 85103624

=LDR  00610cz  a2200181n  4500
=001  9880363854802441
=005  20141212204651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011028
=035  \\$aCBA4318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x605
=150  \\$aPneumoperitoneum, Artificial
=450  \\$wnnna$aArtificial Pneumoperitoneum
=550  \\$wg$aDiagnostic Techniques, Surgical
=667  \\$ado not use /util except by MeSH definition
=680  \\$iDeliberate introduction of air into the peritoneal cavity.
=750  \0$aPneumoperitoneum, Artificial$5IEN$0(DLC)sh 85103631

=LDR  00744cz  a2200241n  4500
=001  9880363854902441
=005  20141212204650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011024
=035  \\$aCBA4314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x705
=072  \\$aC8.$x381.$x677.$x807
=072  \\$aC8.$x730.$x610.$x763
=150  \\$aPneumonia, Viral
=450  \\$wnnna$aPneumonias, Viral
=450  \\$wnnna$aViral Pneumonia
=450  \\$wnnna$aViral Pneumonias
=550  \\$wg$aPneumonia
=550  \\$wg$aVirus Diseases
=667  \\$acoordinate IM with specific viral disease (IM)
=680  \\$iInflammation of the lung parenchyma that is caused by a viral infection.
=750  \0$aViral pneumonia$5IEN$0(DLC)sh 85143733

=LDR  01042cz  a2200253n  4500
=001  9880363855002441
=005  20141212204649.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011021
=035  \\$aCBA4311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x660
=072  \\$aC2.$x839.$x660
=072  \\$aC22.$x836.$x660
=150  \\$aPneumonia, Progressive Interstitial, of Sheep
=450  \\$aMaedi
=450  \\$aProgressive Interstitial Pneumonia of Sheep
=550  \\$wg$aLentivirus Infections
=550  \\$wg$aSheep Diseases
=550  \\$wg$aSlow Virus Diseases
=667  \\$acaused by a lentivirus; don't forget also SHEEP (NIM) & check tag ANIMALS; DF: note short X ref
=680  \\$iChronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity.
=688  \\$a76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74
=750  \0$aMaedi-visna disease$5IEN$0(DLC)sh 89004922

=LDR  01621cz  a2200385n  4500
=001  9880363855102441
=005  20141212204649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011020
=035  \\$aCBA4310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x534.$x700
=072  \\$aC1.$x703.$x770.$x700
=072  \\$aC8.$x381.$x472.$x700
=072  \\$aC8.$x381.$x677.$x675
=072  \\$aC8.$x730.$x435.$x700
=072  \\$aC8.$x730.$x610.$x675
=150  \\$aPneumonia, Pneumocystis
=450  \\$aInterstitial Plasma Cell Pneumonia$5IEN
=450  \\$wnnna$aPneumocystis carinii Pneumonia
=450  \\$aPneumocystis Pneumonia
=450  \\$wnnna$aPneumocystis Pneumonias
=450  \\$wnnna$aPneumocystoses
=450  \\$aPneumocystosis
=450  \\$aPneumonia, Interstitial Plasma Cell
=450  \\$wnnna$aPneumonia, Pneumocystis carinii
=450  \\$wnnna$aPneumonias, Pneumocystis
=450  \\$wnnna$aPneumonias, Pneumocystis carinii
=550  \\$wg$aLung Diseases, Fungal
=550  \\$wg$aPneumocystis Infections
=550  \\$wg$aPneumonia
=667  \\$acoordinate IM with species (IM) if pertinent
=680  \\$iA pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
=688  \\$a2004 (1963)
=750  \0$aPneumocystis carinii pneumonia$5IEN-M$0(DLC)sh 85067532

=LDR  01313cz  a2200325n  4500
=001  9880363855202441
=005  20141212204648.0
=008  781221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011019
=035  \\$aCBA4309M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x610.$x610.$x760
=072  \\$aC1.$x252.$x620.$x500
=072  \\$aC8.$x381.$x677.$x540.$x500
=072  \\$aC8.$x730.$x610.$x540.$x500
=150  \\$aPneumonia, Mycoplasma
=450  \\$wnnna$aAtypical Pneumonia, Primary
=450  \\$wnnna$aAtypical Pneumonias, Primary
=450  \\$aMycoplasma Pneumonia
=450  \\$wnnna$aMycoplasma Pneumonias
=450  \\$aPneumonia, Primary Atypical
=450  \\$wnnna$aPneumonias, Mycoplasma
=450  \\$wnnna$aPneumonias, Primary Atypical
=450  \\$wnnna$aPrimary Atypical Pneumonia
=450  \\$wnnna$aPrimary Atypical Pneumonias
=550  \\$wg$aMycoplasma Infections
=550  \\$wg$aPneumonia, Bacterial
=680  \\$iInterstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR.
=688  \\$a80
=750  \0$aMycoplasma pneumoniae infections$0(DLC)sh 99004181$5IEN-M

=LDR  00898cz  a2200253n  4500
=001  9880363855302441
=005  20141212204648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011018
=035  \\$aCBA4308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x890.$x670.$x750
=072  \\$aC1.$x252.$x620.$x550
=072  \\$aC8.$x381.$x677.$x540.$x550
=072  \\$aC8.$x730.$x610.$x540.$x550
=150  \\$aPneumonia, Pneumococcal
=450  \\$wnnna$aPneumococcal Pneumonia
=450  \\$wnnna$aPneumococcal Pneumonias
=450  \\$wnnna$aPneumonias, Pneumococcal
=550  \\$wg$aPneumococcal Infections
=550  \\$wg$aPneumonia, Bacterial
=680  \\$iA febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
=688  \\$a98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97
=750  \0$aPneumonia, Pneumococcal$5IEN$0(DLC)sh 85103628

=LDR  01383cz  a2200385n  4500
=001  9880363855402441
=005  20141212204647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011015
=035  \\$aCBA4305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x677.$x529
=072  \\$aC8.$x730.$x610.$x529
=150  \\$aPneumonia, Aspiration
=450  \\$aAcid Aspiration Syndrome
=450  \\$wnnna$aAcid Aspiration Syndromes
=450  \\$aAspiration Pneumonia
=450  \\$wnnna$aAspiration Pneumonias
=450  \\$wnnna$aGastric Acid Aspiration Syndrome
=450  \\$wnnna$aMendelson Syndrome
=450  \\$wnnna$aMendelson's Syndrome
=450  \\$wnnna$aMendelsons Syndrome
=450  \\$wnnna$aPneumonias, Aspiration
=450  \\$wnnna$aSyndrome, Acid Aspiration
=450  \\$wnnna$aSyndrome, Mendelson
=450  \\$wnnna$aSyndrome, Mendelson's
=450  \\$wnnna$aSyndromes, Acid Aspiration
=550  \\$wg$aPneumonia
=550  \\$wh$aPneumonia, Lipid
=550  \\$aRespiratory Aspiration
=550  \\$aRespiratory Aspiration of Gastric Contents
=667  \\$a/congen: consider also RESPIRATORY DISTRESS SYNDROME, NEWBORN
=680  \\$iA type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT.
=688  \\$a67(66)
=750  \0$aAspiration pneumonia$0(DLC) 85008730$5IEN

=LDR  01883cz  a2200517n  4500
=001  9880363855502441
=005  20181126094202.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011014
=035  \\$aCBA4304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x677
=072  \\$aC8.$x730.$x610
=150  \\$aPneumonia
=450  \\$aExperimental Lung Inflammation
=450  \\$wnnna$aExperimental Lung Inflammations
=450  \\$wnnna$aInflammation, Experimental Lung
=450  \\$wnnna$aInflammation, Lung
=450  \\$wnnna$aInflammation, Pulmonary
=450  \\$wnnna$aInflammations, Lung
=450  \\$wnnna$aInflammations, Pulmonary
=450  \\$aLobar Pneumonia
=450  \\$aLung Inflammation
=450  \\$wnnna$aLung Inflammation, Experimental
=450  \\$wnnna$aLung Inflammations
=450  \\$wnnna$aLung Inflammations, Experimental
=450  \\$aPneumonia, Lobar
=450  \\$wnnna$aPneumonias
=450  \\$wnnna$aPneumonitides
=450  \\$aPneumonitis
=450  \\$aPulmonary Inflammation
=450  \\$wnnna$aPulmonary Inflammations
=550  \\$wg$aLung Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aBronchopneumonia
=550  \\$wh$aPleuropneumonia
=550  \\$wh$aPneumonia, Aspiration
=550  \\$wh$aPneumonia, Bacterial
=550  \\$wh$aPneumonia, Necrotizing
=550  \\$wh$aPneumonia, Pneumocystis
=550  \\$wh$aPneumonia, Ventilator-Associated
=550  \\$wh$aPneumonia, Viral
=667  \\$ageneral or unspecified; prefer specifics; PNEUMONIA, INTERSTITIAL see LUNG DISEASES, INTERSTITIAL and IDIOPATHIC INTERSTITIAL PNEUMONIAS and its specifics are also available
=680  \\$iInflammation of any part, segment or lobe, of the lung parenchyma.
=688  \\$a1963; for LOBAR PNEUMONIA use PNEUMONIA, PNEUMOCOCCAL 1995-2008
=750  \0$aPneumonia$5IEN$0(DLC)sh 85103627

=LDR  00819cz  a2200253n  4500
=001  9880363855602441
=005  20141212204646.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011013
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928.$x600.$x600
=150  \\$aPneumonectomy
=450  \\$aLung Volume Reduction
=450  \\$wnnna$aLung Volume Reductions
=450  \\$wnnna$aPneumonectomies
=450  \\$wnnna$aReduction, Lung Volume
=450  \\$wnnna$aReductions, Lung Volume
=450  \\$wnnna$aVolume Reduction, Lung
=450  \\$wnnna$aVolume Reductions, Lung
=550  \\$wg$aPulmonary Surgical Procedures
=550  \\$aLung
=550  \\$aTuberculosis, Pulmonary
=680  \\$iThe excision of lung tissue including partial or total lung lobectomy.
=750  \0$aPneumonectomy$5IEN$0(DLC)sh 85103625

=LDR  01195cz  a2200301n  4500
=001  9880363855702441
=005  20141212204645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011011
=035  \\$aCBA4301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x620
=072  \\$aE1.$x370.$x350.$x700.$x560.$x620
=072  \\$aE1.$x370.$x350.$x700.$x625.$x620
=072  \\$aE1.$x370.$x376.$x537.$x750.$x620
=072  \\$aE5.$x629.$x937.$x620
=150  \\$aPneumoencephalography
=450  \\$wnnna$aCisternographies, Pneumoencephalographic
=450  \\$aCisternography, Pneumoencephalographic
=450  \\$wnnna$aPneumoencephalographic Cisternographies
=450  \\$wnnna$aPneumoencephalographic Cisternography
=450  \\$wnnna$aPneumoencephalographies
=550  \\$wg$aNeuroradiography
=550  \\$wg$aPneumoradiography
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PNEUMOENCEPHALOGR
=680  \\$iRadiographic visualization of the cerebral ventricles by injection of air or other gas.
=688  \\$a72(69); was see under VENTRICULOGRAPHY 1963-71
=750  \0$aPneumoencephalography$5IEN$0(DLC)sh 85103622

=LDR  01639cz  a2200373n  4500
=001  9880363855802441
=005  20141212204645.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011009
=035  \\$aCBA4299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x581
=072  \\$aC8.$x381.$x520.$x702
=072  \\$aC24.$x800
=150  \\$aPneumoconiosis
=450  \\$aBagassosis
=450  \\$wnnna$aPneumoconioses
=550  \\$wg$aLung Diseases, Interstitial
=550  \\$wg$aLung Injury
=550  \\$wg$aOccupational Diseases
=550  \\$wh$aAnthracosis
=550  \\$wh$aAsbestosis
=550  \\$wh$aBerylliosis
=550  \\$wh$aByssinosis
=550  \\$wh$aCaplan Syndrome
=550  \\$wh$aSiderosis
=550  \\$wh$aSilicosis
=550  \\$aCoal Mining
=550  \\$aDust
=550  \\$aMineral Fibers
=667  \\$ageneral or unspecified; prefer specifics; index specific pneumoconiosis for which there is no MeSH term here + substance yielding dust, as pneumoconiosis in gold mining: PNEUMOCONIOSIS (IM) + GOLD (IM) + MINING (IM); do not coordinate with OCCUPATIONAL DISEASES
=680  \\$iA diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.
=688  \\$a66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83
=750  \0$aLungs$xDust diseases$0(DLC) sh 85078909$5IEN

=LDR  00934cz  a2200229n  4500
=001  9880363855902441
=005  20141212204643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011005
=035  \\$aCBA4295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x700
=072  \\$aD1.$x268.$x271.$x100.$x700
=072  \\$aD1.$x268.$x556.$x700
=072  \\$aD1.$x552.$x20.$x734
=072  \\$aD1.$x552.$x544.$x700
=150  \\$aPlutonium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iPlutonium. A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, atomic number 94, and atomic weight 242. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
=750  \0$aPlutonium$5IEN$0(DLC)sh 85103582

=LDR  01114cz  a2200253n  4500
=001  9880363856002441
=005  20141212204642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011002
=035  \\$aCBA4292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x610.$x610.$x717
=072  \\$aC22.$x717
=150  \\$aPleuropneumonia, Contagious
=450  \\$aContagious Bovine Pleuropneumonia$5IEN
=450  \\$wnnna$aContagious Pleuropneumonia
=450  \\$wnnna$aContagious Pleuropneumonias
=450  \\$wnnna$aPleuropneumonias, Contagious
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aMycoplasma Infections
=667  \\$aMycoplasma infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term (IM) + animal (NIM) or with animal (IM) in absence of precoord
=680  \\$iA pleuropneumonia of cattle and goats caused by species of MYCOPLASMA.
=688  \\$a91(75); was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77
=750  \0$aContagious bovine pleuropneumonia$5IEN$0(DLC)sh 85103510

=LDR  00740cz  a2200229n  4500
=001  9880363856102441
=005  20141212204642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011001
=035  \\$aCBA4291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x677.$x473
=072  \\$aC8.$x528.$x735.$x473
=072  \\$aC8.$x730.$x582.$x473
=072  \\$aC8.$x730.$x610.$x473
=150  \\$aPleuropneumonia
=450  \\$wnnna$aPleuropneumonias
=550  \\$wg$aPleurisy
=550  \\$wg$aPneumonia
=667  \\$ain animals, consider also PLEUROPNEUMONIA, CONTAGIOUS
=680  \\$iInflammation of the lung parenchyma that is associated with PLEURISY, inflammation of the PLEURA.
=750  \0$aPleuropneumonia$5IEN$0(DLC)sh 85103509

=LDR  00841cz  a2200253n  4500
=001  9880363856202441
=005  20141212204641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010998
=035  \\$aCBA4288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x735
=072  \\$aC8.$x730.$x582
=150  \\$aPleurisy
=450  \\$wnnna$aPleurisies
=450  \\$wnnna$aPleuritides
=450  \\$wnnna$aPleuritis
=550  \\$wg$aPleural Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aPleuropneumonia
=550  \\$aPleura
=667  \\$apleuropericarditis: coordinate PLEUROPERICARDITIS see PERICARDITIS with PLEURITIS see PLEURISY
=680  \\$iINFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN.
=750  \0$aPleurisy$5IEN$0(DLC)sh 85103500

=LDR  01096cz  a2200265n  4500
=001  9880363856302441
=005  20141212204641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010997
=035  \\$aCBA4287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797.$x640
=072  \\$aC8.$x528.$x694
=072  \\$aC8.$x785.$x640
=150  \\$aPleural Neoplasms
=450  \\$wnnna$aNeoplasm, Pleural
=450  \\$wnnna$aNeoplasms, Pleural
=450  \\$wnnna$aPleural Neoplasm
=550  \\$wg$aPleural Diseases
=550  \\$wg$aRespiratory Tract Neoplasms
=550  \\$wh$aPleural Effusion, Malignant
=550  \\$wh$aSolitary Fibrous Tumor, Pleural
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iNeoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
=750  \0$aPleura$xCancer$5IEN-HS$0(DLC)sh2010009995

=LDR  01063cz  a2200265n  4500
=001  9880363856402441
=005  20141212204640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010996
=035  \\$aCBA4286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x652
=150  \\$aPleural Effusion
=450  \\$wnnna$aEffusion, Pleural
=450  \\$wnnna$aEffusions, Pleural
=450  \\$wnnna$aPleural Effusions
=550  \\$wg$aPleural Diseases
=550  \\$wh$aPleural Effusion, Malignant
=550  \\$aExudates and Transudates
=550  \\$aYellow Nail Syndrome
=667  \\$aPLEURAL EFFUSION, MALIGNANT is also available
=680  \\$iPresence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
=688  \\$a1968; was in Cat A & C 1968-1983, was PLEURAL EFFUSIONS in Cat A & C 1963-1967
=688  \\$a68; was in Cat A & C 1968-83, was PLEURAL EFFUSIONS in Cat A & C 1963-67
=750  \0$aPleural effusions$5IEN$0(DLC)sh 85103499

=LDR  00935cz  a2200337n  4500
=001  9880363856502441
=005  20141212204640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010995
=035  \\$aCBA4285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528
=150  \\$aPleural Diseases
=450  \\$wnnna$aDisease, Pleural
=450  \\$wnnna$aDiseases, Pleural
=450  \\$wnnna$aPleural Disease
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aChylothorax
=550  \\$wh$aEmpyema, Pleural
=550  \\$wh$aHemopneumothorax
=550  \\$wh$aHemothorax
=550  \\$wh$aHydropneumothorax
=550  \\$wh$aHydrothorax
=550  \\$wh$aPleural Effusion
=550  \\$wh$aPleural Neoplasms
=550  \\$wh$aPleurisy
=550  \\$wh$aPneumothorax
=550  \\$wh$aTuberculosis, Pleural
=667  \\$ainflamm dis = PLEURISY
=688  \\$a66
=750  \0$aPleura$xDiseases$5IEN$0(DLC)sh 85103494

=LDR  01003cz  a2200241n  4500
=001  9880363856602441
=005  20141212204640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010994
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x716
=072  \\$aA10.$x615.$x789.$x736
=150  \\$aPleura
=450  \\$wnnna$aParietal Pleura
=450  \\$wnnna$aPleura, Parietal
=450  \\$wnnna$aPleura, Visceral
=450  \\$wnnna$aVisceral Pleura
=550  \\$wg$aRespiratory System
=550  \\$wg$aSerous Membrane
=550  \\$aPleurisy
=667  \\$a/surg: consider also PNEUMONOLYSIS; inflammation = PLEURISY; PLEURAL CAVITY is also available
=680  \\$iThe thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid.
=750  \0$aPleura$5IEN$0(DLC)sh 85103493

=LDR  01250cz  a2200289n  4500
=001  9880363856702441
=005  20141212204639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010992
=035  \\$aCBA4282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x610.$x610
=072  \\$aE1.$x370.$x405.$x610
=072  \\$aE1.$x370.$x610.$x610
=150  \\$aPlethysmography, Impedance
=450  \\$wnnna$aImpedance Plethysmographies
=450  \\$wnnna$aImpedance Plethysmography
=450  \\$wnnna$aPlethysmographies, Impedance
=450  \\$wnnna$aRheographies
=450  \\$aRheography
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aPlethysmography
=550  \\$wh$aCardiography, Impedance
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; do not confuse X ref RHEOGRAPHY with "rheography" as a synonym for the study of flow dynamics of body & other fluids ( = RHEOLOGY); DF: PLETHYSMOGR IMPEDANCE
=680  \\$iRecording changes in electrical impedance between electrodes placed on opposite sides of a part of the body, as a measure of volume changes in the path of the current. (Stedman, 25th ed)
=688  \\$a66
=750  \0$aImpedance plethysmography$5IEN$0(DLC)sh 85064612

=LDR  00984cz  a2200253n  4500
=001  9880363856802441
=005  20141212204639.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010991
=035  \\$aCBA4281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x610
=072  \\$aE1.$x370.$x610
=150  \\$aPlethysmography
=450  \\$wnnna$aPlethysmographies
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wh$aPhotoplethysmography
=550  \\$wh$aPlethysmography, Impedance
=550  \\$wh$aPlethysmography, Whole Body
=550  \\$aBlood Circulation
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; "venous occlusion plethysmography" & "strain gauge plethysmography" go here; DF: PLETHYSMOGR
=680  \\$iRecording of change in the size of a part as modified by the circulation in it.
=750  \0$aPlethysmography$5IEN$0(DLC)sh 85103492

=LDR  00799cz  a2200229n  4500
=001  9880363856902441
=005  20141212204638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010990
=035  \\$aCBA4280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794.$x746
=150  \\$aPleasure-Pain Principle
=450  \\$wnnna$aPleasure Pain Principle
=450  \\$wnnna$aPleasure-Pain Principles
=450  \\$wnnna$aPrinciple, Pleasure-Pain
=450  \\$wnnna$aPrinciples, Pleasure-Pain
=550  \\$wg$aPsychoanalytic Theory
=667  \\$ano qualif
=680  \\$iThe psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure.
=688  \\$a73(64)
=750  \0$aPleasure principle (Psychology)$0(DLC) sh 85103437$5IEN-M

=LDR  01038cz  a2200313n  4500
=001  9880363857002441
=005  20141212204638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010989
=035  \\$aCBA4279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x888.$x625
=072  \\$aF4.$x754.$x664
=150  \\$aPlay Therapy
=450  \\$wnnna$aPlay Therapies
=450  \\$wnnna$aSandplay
=450  \\$wnnna$aSandplay Therapies
=450  \\$wnnna$aSandplay Therapy
=450  \\$wnnna$aSandplays
=450  \\$wnnna$aTherapies, Play
=450  \\$wnnna$aTherapies, Sandplay
=450  \\$wnnna$aTherapy, Play
=450  \\$wnnna$aTherapy, Sandplay
=550  \\$wg$aPsychotherapy
=550  \\$wg$aSensory Art Therapies
=667  \\$aDF: PLAY THER
=680  \\$iA treatment technique utilizing play as a medium for expression and communication between patient and therapist.
=688  \\$a69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67
=750  \0$aPlay therapy$5IEN$0(DLC)sh 85103375

=LDR  01082cz  a2200337n  4500
=001  9880363857102441
=005  20170324163131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010988
=035  \\$aCBA4278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x693
=150  \\$aPlay and Playthings
=450  \\$aGames$5IEN
=450  \\$wnnna$aPlay
=450  \\$wnnna$aPlays
=450  \\$wnnna$aPlaything
=450  \\$wnnna$aPlaythings
=450  \\$wnnna$aPlaythings and Play
=450  \\$wnnna$aPuppet
=450  \\$aPuppets
=450  \\$wnnna$aToy
=450  \\$aToys
=550  \\$wg$aRecreation
=550  \\$wh$aGames, Recreational
=550  \\$wh$aVideo Games
=667  \\$a/psychol permitted but do not confuse with PLAY THERAPY; includes games; DF: PLAY
=680  \\$iSpontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc.
=688  \\$a78; was PLAY 1963-77
=750  \0$aToys$5IEN-M$0(DLC)sh 85136372
=750  \0$aPlay$5IEN-HS$0(DLC)sh 85103365

=LDR  00699cz  a2200205n  4500
=001  9880363857202441
=005  20141212204638.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010987
=035  \\$aCBA4277HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x627.$x600
=150  \\$aPlatypus
=450  \\$aDuckbilled Platypus
=450  \\$wnnna$aPlatypus, Duckbilled
=550  \\$wg$aMonotremata
=667  \\$aIM; qualif permitted
=680  \\$iA small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania.
=688  \\$a91(75); was see under MONOTREMATA 1975-90; DUCKMOLE was see PLATYPUS 9175-95
=750  \0$aPlatypus$5IEN$0(DLC)sh 85103358

=LDR  00947cz  a2200265n  4500
=001  9880363857302441
=005  20141212204637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010986
=035  \\$aCBA4276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736
=150  \\$aPlatyhelminths
=450  \\$wnnna$aFlatworm
=450  \\$aFlatworms
=450  \\$wnnna$aPlatyhelminth
=450  \\$aPlatyhelminthes$5IEN
=550  \\$wg$aHelminths
=550  \\$wh$aCestoda
=550  \\$wh$aTrematoda
=550  \\$wh$aTurbellaria
=667  \\$ainfection = CESTODE INFECTIONS or TREMATODE INFECTIONS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda.
=688  \\$a65
=750  \0$aPlatyhelminthes$5IEN$0(DLC)sh 85103342

=LDR  01107cz  a2200301n  4500
=001  9880363857402441
=005  20141212204637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010985
=035  \\$aCBA4275HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x742
=072  \\$aC5.$x116.$x900.$x540
=072  \\$aC5.$x660.$x207.$x720
=072  \\$aC16.$x131.$x621.$x207.$x720
=150  \\$aPlatybasia
=450  \\$aBasilar Impression
=450  \\$wnnna$aBasilar Impressions
=450  \\$wnnna$aImpression, Basilar
=450  \\$wnnna$aImpressions, Basilar
=450  \\$wnnna$aPlatybasias
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aCraniofacial Abnormalities
=550  \\$wg$aSpinal Diseases
=667  \\$aoccipital bone abnorm; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. (Dorland, 27th ed)
=688  \\$a67
=750  \0$aPlatybasia$5IEN$0(DLC)sh 85103335

=LDR  01015cz  a2200217n  4500
=001  9880363857502441
=005  20141212204637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010984
=035  \\$aCBA4274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x690
=072  \\$aD1.$x268.$x956.$x734
=072  \\$aD1.$x552.$x544.$x690
=150  \\$aPlatinum
=450  \\$aPlatinum Black
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aPt-195; Pt-194, 196, 198 = PLATINUM (IM) + ISOTOPES (NIM); Pt-173-193, 197, 199, 200 = PLATINUM (IM) + RADIOISOTOPES (IM)
=680  \\$iPlatinum. A heavy, soft, whitish metal, resembling tin, atomic number 78, atomic weight 195.09, symbol Pt. (From Dorland, 28th ed) It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae".
=750  \0$aPlatinum$5IEN-M$0(DLC)sh 85103305

=LDR  01129cz  a2200277n  4500
=001  9880363857602441
=005  20141212204636.0
=008  830531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x910
=072  \\$aD12.$x776.$x124.$x625
=072  \\$aD12.$x776.$x467.$x910
=072  \\$aD23.$x529.$x910
=150  \\$aPlatelet-Derived Growth Factor
=450  \\$wnnna$aFactor, Platelet-Derived Growth
=450  \\$wnnna$aGrowth Factor, Platelet-Derived
=450  \\$wnnna$aPlatelet Derived Growth Factor
=550  \\$wg$aBlood Proteins
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aProto-Oncogene Proteins c-sis
=550  \\$aReceptors, Platelet-Derived Growth Factor
=667  \\$aDF: PDGF
=680  \\$iMitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication.
=688  \\$a84
=750  \0$aPlatelet-derived growth factor$5IEN$0(DLC)sh 92004606

=LDR  00853cz  a2200217n  4500
=001  9880363857702441
=005  20141212204633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010974
=035  \\$aCBA4264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x124.$x552.$x624
=072  \\$aG9.$x188.$x124.$x560.$x600.$x640
=150  \\$aPlatelet Aggregation
=450  \\$wnnna$aAggregation, Platelet
=550  \\$wg$aHemorheology
=550  \\$wg$aPlatelet Activation
=550  \\$aBlood Platelets
=680  \\$iThe attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS.
=688  \\$a76(75); was see under PLATELET ADHESIVENESS 1974-75
=750  \0$aBlood platelets$xAggregation$5IEN$0(DLC)sh 85015003

=LDR  00887cz  a2200253n  4500
=001  9880363857802441
=005  20141212204632.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010973
=035  \\$aCBA4263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x188.$x124.$x560.$x600.$x500
=072  \\$aG9.$x188.$x670
=150  \\$aPlatelet Adhesiveness
=450  \\$wnnna$aAdhesiveness, Platelet
=450  \\$wnnna$aAdhesivenesses, Platelet
=450  \\$wnnna$aPlatelet Adhesivenesses
=550  \\$wg$aBlood Physiological Phenomena
=550  \\$wg$aPlatelet Activation
=550  \\$aAdhesiveness
=550  \\$aBlood Platelets
=680  \\$iThe process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces.
=688  \\$a72(69)
=750  \0$aBlood platelets$xAggregation$5IEN$0(DLC)sh 85015003

=LDR  01815cz  a2200457n  4500
=001  9880363857902441
=005  20141212204632.0
=008  820511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010972
=035  \\$aCBA4262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x211.$x500
=072  \\$aD2.$x92.$x63.$x291.$x211.$x500
=072  \\$aD2.$x92.$x877.$x883.$x333.$x710
=072  \\$aD2.$x675.$x276.$x232.$x710
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x985.$x910
=072  \\$aD23.$x119.$x865
=072  \\$aD23.$x469.$x50.$x600
=150  \\$aPlatelet Activating Factor
=450  \\$wnnna$a1-Alkyl-2-acetyl-sn-glycerophosphocholine
=450  \\$wnnna$a1 Alkyl 2 acetyl sn glycerophosphocholine
=450  \\$aAcetyl Glyceryl Ether Phosphorylcholine
=450  \\$aAGEPC
=450  \\$wnnna$aAggregating Factor, Platelet
=450  \\$wnnna$aFactor, Platelet Activating
=450  \\$aPAF-Acether
=450  \\$wnnna$aPAF Acether
=450  \\$aPhosphorylcholine, Acetyl Glyceryl Ether
=450  \\$wnnna$aPlatelet-Activating Substance
=450  \\$wnnna$aPlatelet Activating Substance
=450  \\$wnnna$aPlatelet Aggregating Factor
=450  \\$wnnna$aPlatelet Aggregation Enhancing Factor
=450  \\$wnnna$aThrombocyte Aggregating Activity
=550  \\$wg$aAutacoids
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aCholine
=550  \\$wg$aPhospholipid Ethers
=680  \\$iA phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.
=688  \\$a1983(1979)
=688  \\$a83
=750  \0$aPlatelet activating factor$5IEN$0(DLC)sh 85103285

=LDR  00912cz  a2200241n  4500
=001  9880363858002441
=005  20141212204631.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010970
=035  \\$aCBA4260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x556.$x760
=072  \\$aD12.$x776.$x765.$x680
=150  \\$aPlastocyanin
=450  \\$wnnna$aPlastocyanin, Silver
=450  \\$wnnna$aPlastocyanine
=450  \\$wnnna$aSilver Plastocyanin
=550  \\$wg$aMetalloproteins
=550  \\$wg$aPlant Proteins
=667  \\$aa plant protein
=680  \\$iA copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.
=688  \\$a91(75); was see under PLANT PROTEINS 1975-90
=750  \0$aPlastocyanin$5IEN$0(DLC)sh 87005364

=LDR  01174cz  a2200313n  4500
=001  9880363858102441
=005  20141212204631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010969
=035  \\$aCBA4259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716
=072  \\$aD25.$x720.$x716
=072  \\$aJ1.$x637.$x51.$x720.$x716
=150  \\$aPlastics
=450  \\$wnnna$aPlastic
=550  \\$wg$aPolymers
=550  \\$wh$aBiodegradable Plastics
=550  \\$wh$aNylons
=550  \\$wh$aPolyethylenes
=550  \\$wh$aPolypropylenes
=550  \\$wh$aPolystyrenes
=550  \\$wh$aPolyurethanes
=550  \\$wh$aPolyvinyls
=550  \\$wh$aResins, Synthetic
=667  \\$aD25-26 qualif
=680  \\$iPolymeric materials (usually organic) of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included (versus the resin, the homogeneous polymeric starting material). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$awas in Cat D & J 1967-82, was in Cat J only 1963-66
=750  \0$aPlastics$5IEN$0(DLC)sh 85103153

=LDR  00671cz  a2200169n  4500
=001  9880363858202441
=005  20141212204631.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010968
=035  \\$aCBA4258HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x760
=150  \\$aPlasticizers
=550  \\$wg$aSpecialty Uses of Chemicals
=680  \\$iMaterials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment.
=688  \\$a77
=750  \0$aPlasticizers$5IEN$0(DLC)sh 85103152

=LDR  00749cz  a2200217n  4500
=001  9880363858302441
=005  20141212204630.0
=008  870310\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010967
=035  \\$aCBA4257M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611.$x780
=150  \\$aPlasmodium yoelii
=450  \\$wnnna$aPlasmodium yoelius
=450  \\$wnnna$ayoelii, Plasmodium
=450  \\$wnnna$ayoelius, Plasmodium
=550  \\$wg$aPlasmodium
=667  \\$ainfection: coordinate IM with MALARIA (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of PLASMODIUM causing malaria in rodents.
=688  \\$a88
=750  \0$aPlasmodium yoelii$0(DLC) sh2004009960$5IEN-M

=LDR  00854cz  a2200205n  4500
=001  9880363858402441
=005  20141212204630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010966
=035  \\$aCBA4256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611.$x761
=150  \\$aPlasmodium vivax
=450  \\$wnnna$aPlasmodium vivaxs
=450  \\$wnnna$avivax, Plasmodium
=450  \\$wnnna$avivaxs, Plasmodium
=550  \\$wg$aPlasmodium
=667  \\$ainfection = MALARIA, VIVAX; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.
=750  \0$aPlasmodium vivax$5IEN-M$0(DLC)sh 88021423

=LDR  00872cz  a2200217n  4500
=001  9880363858502441
=005  20141212204630.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010964
=035  \\$aCBA4254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611.$x576
=150  \\$aPlasmodium gallinaceum
=450  \\$wnnna$agallinaceum, Plasmodium
=450  \\$wnnna$agallinaceums, Plasmodium
=450  \\$wnnna$aPlasmodium gallinaceums
=550  \\$wg$aPlasmodium
=667  \\$ainfection = MALARIA, AVIAN; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA protozoan parasite that causes avian malaria (MALARIA, AVIAN), primarily in chickens, and is transmitted by the Aedes mosquito.
=688  \\$a91(86); was see under PLASMODIUM 1986-90
=750  \0$aPlasmodium gallinaceum$5IEN-M$0(DLC)sh 88021419

=LDR  00829cz  a2200205n  4500
=001  9880363858602441
=005  20141212204629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010963
=035  \\$aCBA4253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611.$x561
=150  \\$aPlasmodium falciparum
=450  \\$wnnna$afalciparum, Plasmodium
=450  \\$wnnna$afalciparums, Plasmodium
=450  \\$wnnna$aPlasmodium falciparums
=550  \\$wg$aPlasmodium
=667  \\$ainfection = MALARIA, FALCIPARUM; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics.
=750  \0$aPlasmodium falciparum$5IEN-M$0(DLC)sh 85103100

=LDR  01508cz  a2200301n  4500
=001  9880363858702441
=005  20141212204629.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010961
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x380.$x611
=150  \\$aPlasmodium
=450  \\$wnnna$aPlasmodiums
=550  \\$wg$aHaemosporida
=550  \\$wh$aPlasmodium berghei
=550  \\$wh$aPlasmodium chabaudi
=550  \\$wh$aPlasmodium cynomolgi
=550  \\$wh$aPlasmodium falciparum
=550  \\$wh$aPlasmodium gallinaceum
=550  \\$wh$aPlasmodium knowlesi
=550  \\$wh$aPlasmodium malariae
=550  \\$wh$aPlasmodium ovale
=550  \\$wh$aPlasmodium vivax
=550  \\$wh$aPlasmodium yoelii
=667  \\$ageneral; prefer specifics; infection = MALARIA; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.
=688  \\$aHAEMAMOEBA was see PLASMODIUM 1976-91
=750  \0$aPlasmodium$5IEN-M$0(DLC)sh 85103098

=LDR  01276cz  a2200313n  4500
=001  9880363858802441
=005  20141212204628.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010960
=035  \\$aCBA4250HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x635
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x635
=072  \\$aD12.$x776.$x124.$x125.$x662
=150  \\$aPlasminogen Activators
=450  \\$wnnna$aExtrinsic Plasminogen Activators
=450  \\$wnnna$aPlasminogen Activator
=450  \\$wnnna$aUterine-Tissue Plasminogen Activator
=450  \\$wnnna$aUterine Tissue Plasminogen Activator
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aSerine Endopeptidases
=550  \\$wh$aAnistreplase
=550  \\$wh$aStreptokinase
=550  \\$wh$aTissue Plasminogen Activator
=550  \\$wh$aUrokinase-Type Plasminogen Activator
=667  \\$a/antag: consider also PLASMINOGEN INACTIVATORS
=680  \\$iA heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.
=688  \\$a76
=750  \0$aPlasminogen activators$5IEN$0(DLC)sh 87000089

=LDR  00588cz  a2200169n  4500
=001  9880363858902441
=005  20141212204537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010792
=035  \\$aCBA4081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x799
=150  \\$aPhrenology
=550  \\$wg$aHistory
=667  \\$aDF: PHRENOL
=680  \\$iThe study of the conformation of the skull as indicative of mental faculties and traits of character, especially according to the hypothesis of F. J. Gall (1758-1828). (Webster 3d ed)
=750  \0$aPhrenology$5IEN$0(DLC)sh 85101440

=LDR  00845cz  a2200205n  4500
=001  9880363859002441
=005  20141212204537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010791
=035  \\$aCBA4080HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x150.$x700
=150  \\$aPhrenic Nerve
=450  \\$wnnna$aNerve, Phrenic
=450  \\$wnnna$aNerves, Phrenic
=450  \\$wnnna$aPhrenic Nerves
=550  \\$wg$aCervical Plexus
=667  \\$adis: coord IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neopl: coord IM with PERIPHERAL NERVE NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe motor nerve of the diaphragm. The phrenic nerve fibers originate in the cervical spinal column (mostly C4) and travel through the cervical plexus to the diaphragm.
=750  \0$aPhrenic nerve$5IEN$0(DLC)sh 85101439

=LDR  01337cz  a2200385n  4500
=001  9880363859102441
=005  20141212204537.0
=008  800409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010789
=035  \\$aCBA4078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x774
=150  \\$aPhototherapy
=450  \\$aLight$xtherapeutic use
=450  \\$wnnna$aLight Therapies
=450  \\$aLight Therapy
=450  \\$wnnna$aPhotoradiation Therapies
=450  \\$aPhotoradiation Therapy
=450  \\$wnnna$aPhototherapies
=450  \\$wnnna$aTherapies, Light
=450  \\$wnnna$aTherapies, Photoradiation
=450  \\$wnnna$aTherapy, Light
=450  \\$wnnna$aTherapy, Photoradiation
=550  \\$wg$aTherapeutics
=550  \\$wh$aColor Therapy
=550  \\$wh$aHeliotherapy
=550  \\$wh$aIntense Pulsed Light Therapy
=550  \\$wh$aLaser Therapy, Low-Level
=550  \\$wh$aPhotochemotherapy
=550  \\$wh$aUltraviolet Therapy
=550  \\$aLight
=667  \\$acoord disease with /ther, not /radiother; PHOTOCHEMOTHERAPY; COLOR THERAPY; & ULTRAVIOLET THERAPY are also available
=680  \\$iTreatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths.
=688  \\$a81; was LIGHT/therapeutic use 1966-80
=750  \0$aPhototherapy$5IEN$0(DLC)sh 85101417

=LDR  02372cz  a2200553n  4500
=001  9880363859202441
=005  20141212204536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010788
=035  \\$aCBA4077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x937
=072  \\$aG2.$x111.$x87.$x678.$x700
=072  \\$aG2.$x149.$x115.$x160.$x937
=072  \\$aG2.$x149.$x115.$x678.$x700
=072  \\$aG2.$x149.$x767.$x690.$x921
=072  \\$aG2.$x842.$x750.$x690.$x921
=072  \\$aG3.$x495.$x256.$x937
=072  \\$aG3.$x495.$x553.$x700
=072  \\$aG3.$x495.$x795.$x700
=072  \\$aG15.$x744.$x700
=150  \\$aPhotosynthesis
=450  \\$aCalvin-Benson-Bassham Cycle
=450  \\$wnnna$aCalvin Benson Bassham Cycle
=450  \\$aCalvin-Benson Cycle
=450  \\$wnnna$aCalvin Benson Cycle
=450  \\$aCalvin Cycle
=450  \\$aCarbon Fixation, Photosynthetic
=450  \\$wnnna$aCycle, Calvin
=450  \\$wnnna$aCycle, Calvin-Benson
=450  \\$wnnna$aCycle, Calvin-Benson-Bassham
=450  \\$wnnna$aDark Reactions of Photosynthesis
=450  \\$wnnna$aPhotosynthesis Dark Reaction
=450  \\$wnnna$aPhotosynthesis Dark Reactions
=450  \\$wnnna$aPhotosynthetic Carbon Fixation
=450  \\$aReductive Pentose Phosphate Cycle
=550  \\$wg$aCarbohydrate Metabolism
=550  \\$wg$aMetabolic Networks and Pathways
=550  \\$wg$aPhotochemical Processes
=550  \\$wg$aPhototrophic Processes
=550  \\$wg$aPlant Physiological Processes
=550  \\$wh$aPhotophosphorylation
=550  \\$aChlorophyll
=550  \\$aChloroplasts
=550  \\$aLight
=550  \\$aPhotobiology
=667  \\$ado not confuse REDUCTIVE PENTOSE PHOSPHATE CYCLE with PENTOSE PHOSPHATE PATHWAY; DF: PHOTOSYN
=680  \\$iThe synthesis by organisms of organic chemical compounds, especially carbohydrates, from carbon dioxide using energy obtained from light rather than from the oxidation of chemical compounds. Photosynthesis comprises two separate processes: the light reactions and the dark reactions. In higher plants; GREEN ALGAE; and CYANOBACTERIA; NADPH and ATP formed by the light reactions drive the dark reactions which result in the fixation of carbon dioxide. (from Oxford Dictionary of Biochemistry and Molecular Biology, 2001)
=750  \0$aPhotosynthesis$0(DLC) sh 85101413$5IEN

=LDR  02432cz  a2200529n  4500
=001  9880363859302441
=005  20141212204536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010787
=035  \\$aCBA4076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x600
=150  \\$aPhotosensitivity Disorders
=450  \\$wnnna$aActinic Dermatitides
=450  \\$wnnna$aActinic Dermatitides, Chronic
=450  \\$wnnna$aActinic Dermatitis
=450  \\$wnnna$aActinic Dermatitis, Chronic
=450  \\$aActinic Reticuloid Syndrome
=450  \\$wnnna$aActinic Reticuloid Syndromes
=450  \\$wnnna$aChronic Actinic Dermatitides
=450  \\$wnnna$aChronic Actinic Dermatitis
=450  \\$wnnna$aDermatitides, Actinic
=450  \\$wnnna$aDermatitides, Chronic Actinic
=450  \\$aDermatitis, Actinic
=450  \\$wnnna$aDermatitis, Chronic Actinic
=450  \\$wnnna$aDisorder, Photosensitivity
=450  \\$wnnna$aDisorders, Photosensitivity
=450  \\$wnnna$aPhotodermatitides
=450  \\$aPhotodermatitis
=450  \\$wnnna$aPhotosensitivity Disorder
=450  \\$wnnna$aPhotosensitization
=450  \\$wnnna$aReticuloid Syndrome, Actinic
=450  \\$wnnna$aReticuloid Syndromes, Actinic
=450  \\$wnnna$aSyndrome, Actinic Reticuloid
=450  \\$wnnna$aSyndromes, Actinic Reticuloid
=550  \\$wg$aSkin Diseases
=550  \\$wh$aDermatitis, Photoallergic
=550  \\$wh$aDermatitis, Phototoxic
=550  \\$wh$aHydroa Vacciniforme
=550  \\$wh$aSunburn
=550  \\$wh$aXeroderma Pigmentosum
=550  \\$aLight
=667  \\$aa skin disease entity: does not mean sensitivity to light of eye, plants, bacteria, etc. ( = LIGHT)
=680  \\$iAbnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
=688  \\$a80; was PHOTOSENSITIZATION 1963-79
=750  \0$aPhotosensitivity disorders$5IEN-M$0(DLC)sh 85101157
=750  \0$aPhotosensitization, Biological$5IEN-HS$0(DLC)sh 85101411

=LDR  02537cz  a2200601n  4500
=001  9880363859402441
=005  20141212192426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010786
=035  \\$aCBA4075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x850.$x625
=072  \\$aA8.$x675.$x650.$x915.$x937
=072  \\$aA8.$x800.$x950.$x937
=072  \\$aA9.$x371.$x729.$x831.$x625
=072  \\$aA11.$x671.$x650.$x850.$x625
=072  \\$aA11.$x671.$x650.$x915.$x937
=150  \\$aPhotoreceptor Cells
=450  \\$wnnna$aCell, Ciliary Photoreceptor
=450  \\$wnnna$aCell, Photoreceptor
=450  \\$wnnna$aCell, Rhabdomeric Photoreceptor
=450  \\$wnnna$aCells, Ciliary Photoreceptor
=450  \\$wnnna$aCells, Photoreceptor
=450  \\$wnnna$aCells, Rhabdomeric Photoreceptor
=450  \\$wnnna$aCiliary Photoreceptor
=450  \\$wnnna$aCiliary Photoreceptor Cell
=450  \\$wnnna$aCiliary Photoreceptor Cells
=450  \\$wnnna$aCiliary Photoreceptors
=450  \\$wnnna$aPhotoreceptor Cell
=450  \\$wnnna$aPhotoreceptor Cell, Ciliary
=450  \\$wnnna$aPhotoreceptor Cell, Rhabdomeric
=450  \\$wnnna$aPhotoreceptor Cells, Ciliary
=450  \\$wnnna$aPhotoreceptor Cells, Rhabdomeric
=450  \\$wnnna$aPhotoreceptor, Ciliary
=450  \\$wnnna$aPhotoreceptor, Rhabdomeric
=450  \\$wnno$aPhotoreceptors$5IEN-M
=450  \\$wnnna$aPhotoreceptors, Ciliary
=450  \\$wnnna$aPhotoreceptors, Rhabdomeric
=450  \\$wnnna$aRhabdomeric Photoreceptor
=450  \\$wnnna$aRhabdomeric Photoreceptor Cell
=450  \\$wnnna$aRhabdomeric Photoreceptor Cells
=450  \\$wnnna$aRhabdomeric Photoreceptors
=550  \\$wg$aRetinal Neurons
=550  \\$wg$aSensory Receptor Cells
=550  \\$wh$aPhotoreceptor Cells, Invertebrate
=550  \\$wh$aPhotoreceptor Cells, Vertebrate
=550  \\$aVision, Ocular
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iSpecialized cells that detect and transduce light. They are classified into two types based on their light reception structure, the ciliary photoreceptors and the rhabdomeric photoreceptors with MICROVILLI. Ciliary photoreceptor cells use OPSINS that activate a PHOSPHODIESTERASE phosphodiesterase cascade. Rhabdomeric photoreceptor cells use opsins that activate a PHOSPHOLIPASE C cascade.
=688  \\$a2009 (1971)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Photoreceptors
=688  \\$a71
=750  \0$aPhotoreceptors$0(DLC) sh 85101407$5IEN

=LDR  00810cz  a2200217n  4500
=001  9880363859502441
=005  20141212204534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010784
=035  \\$aCBA4073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x799
=072  \\$aE1.$x370.$x350.$x600.$x635
=072  \\$aE5.$x595.$x799
=150  \\$aPhotomicrography
=450  \\$wnnna$aPhotomicrographies
=550  \\$wg$aMicroscopy
=550  \\$wg$aPhotography
=667  \\$aavoid: read Manual 26.12.3; when IM, qualif permitted; do not confuse with "microphotography" (MICROFILMING or PHOTOMICROGRAPHY: be careful); DF: PHOTOMICROGR
=680  \\$iPhotography of objects viewed under a microscope using ordinary photographic methods.
=750  \0$aPhotomicrography$5IEN$0(DLC)sh 85101386

=LDR  00668cz  a2200229n  4500
=001  9880363859602441
=005  20141212204534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010783
=035  \\$aCBA4072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712
=150  \\$aPhotometry
=450  \\$wnnna$aPhotometries
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aDensitometry
=550  \\$wh$aLuminescent Measurements
=550  \\$wh$aNephelometry and Turbidimetry
=550  \\$wh$aSpectrophotometry
=550  \\$aLight
=680  \\$iMeasurement of the various properties of light.
=750  \0$aPhotometry$5IEN$0(DLC)sh 85101383

=LDR  00845cz  a2200277n  4500
=001  9880363859702441
=005  20141212204534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010781
=035  \\$aCBA4070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600
=072  \\$aE5.$x712
=150  \\$aPhotography
=450  \\$wnnna$aPhotographies
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aHolography
=550  \\$wh$aImage Enhancement
=550  \\$wh$aPhotofluorography
=550  \\$wh$aPhotogrammetry
=550  \\$wh$aPhotography, Dental
=550  \\$wh$aPhotomicrography
=550  \\$wh$aTime-Lapse Imaging
=680  \\$iMethod of making images on a sensitized surface by exposure to light or other radiant energy.
=750  \0$aPhotography$5IEN$0(DLC)sh 85101206

=LDR  00837cz  a2200253n  4500
=001  9880363859802441
=005  20141212204533.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010780
=035  \\$aCBA4069HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600.$x630
=150  \\$aPhotogrammetry
=450  \\$wnnna$aPhotogrammetries
=450  \\$wnnna$aStereophotogrammetries
=450  \\$aStereophotogrammetry
=550  \\$wg$aPhotography
=550  \\$wh$aMoire Topography
=550  \\$wh$aRadiostereometric Analysis
=667  \\$ameasurement by stereoscopic photographs
=680  \\$iMaking measurements by the use of stereoscopic photographs.
=688  \\$a88(75); was see under PHOTOGRAPHY 1975-87
=750  \0$aPhotogrammetrists$5IEN$0(DLC)sh 92003188
=750  \0$aPhotogrammetry$5IEN-HS$0(DLC)sh 85101174

=LDR  01150cz  a2200337n  4500
=001  9880363859902441
=005  20141212204533.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010778
=035  \\$aCBA4067HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x186.$x500
=072  \\$aE2.$x319.$x685
=072  \\$aE2.$x774.$x722
=150  \\$aPhotochemotherapy
=450  \\$wnnna$aPhotochemotherapies
=450  \\$wnnna$aPhotodynamic Therapies
=450  \\$aPhotodynamic Therapy
=450  \\$wnnna$aTherapies, Photodynamic
=450  \\$wnnna$aTherapy, Photodynamic
=550  \\$wg$aCombined Modality Therapy
=550  \\$wg$aDrug Therapy
=550  \\$wg$aPhototherapy
=550  \\$wh$aHematoporphyrin Photoradiation
=550  \\$aLight
=550  \\$aPhotosensitizing Agents
=550  \\$aUltraviolet Therapy
=667  \\$a"therapy using oral or topical photosensitizing agents with subsequent exposure to light"; IM; coord with disease /drug ther (IM)
=680  \\$iTherapy using oral or topical photosensitizing agents with subsequent exposure to light.
=688  \\$a78
=750  \0$aPhotochemotherapy$5IEN$0(DLC)sh 85101147

=LDR  00658cz  a2200205n  4500
=001  9880363860002441
=005  20141212204533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010777
=035  \\$aCBA4066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x529.$x711
=150  \\$aPhotochemistry
=450  \\$wnnna$aPhotochemistries
=550  \\$wg$aChemistry, Physical
=550  \\$aLight
=550  \\$aPhotobiology
=667  \\$athe discipline (education, history, etc) only; use PHOTOCHEMICAL PROCESSES or specifics treed under it for photochemical principles and processes
=688  \\$a71
=750  \0$aPhotochemistry$0(DLC) sh 85101143$5IEN

=LDR  00726cz  a2200169n  4500
=001  9880363860102441
=005  20141212204532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010776
=035  \\$aCBA4065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x900.$x604
=072  \\$aB3.$x660.$x250.$x830.$x590
=150  \\$aPhotobacterium
=550  \\$wg$aVibrionaceae
=680  \\$iA genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are common in the marine environment and on the surfaces and in the intestinal contents of marine animals. Some species are bioluminescent and are found as symbionts in specialized luminous organs of fish.
=750  \0$aPhotobacterium$5IEN$0(DLC)sh 88023300

=LDR  01572cz  a2200349n  4500
=001  9880363860202441
=005  20141212204531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010770
=035  \\$aCBA4059HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696
=150  \\$aPhosphotransferases
=450  \\$wnnna$aATP Phosphotransferases
=450  \\$wnnna$aKinase
=450  \\$aKinases
=450  \\$aPhosphotransferases, ATP
=450  \\$aTransphosphorylases
=550  \\$wg$aTransferases
=550  \\$wh$aDiphosphotransferases
=550  \\$wh$aMyosin Type III
=550  \\$wh$aNucleotidyltransferases
=550  \\$wh$aPhosphotransferases (Alcohol Group Acceptor)
=550  \\$wh$aPhosphotransferases (Carboxyl Group Acceptor)
=550  \\$wh$aPhosphotransferases (Nitrogenous Group Acceptor)
=550  \\$wh$aPhosphotransferases (Paired Acceptors)
=550  \\$wh$aPhosphotransferases (Phosphate Group Acceptor)
=550  \\$wh$aTransferases (Other Substituted Phosphate Groups)
=667  \\$aGEN or unspecified; prefer specific groups or specific phosphotransferases
=680  \\$iA rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7.
=688  \\$aPHOSPHOTRANSFERASES, ATP was heading 1974-93; KINASES was see PHOSPHOTRANSFERASES, ATP 1977-93, was see PHOSPHOTRANSFERASES 1963-76
=750  \0$aPhosphotransferases$5IEN$0(DLC)sh 85101133

=LDR  01127cz  a2200265n  4500
=001  9880363860302441
=005  20170608154949.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010766
=035  \\$aCBA4055HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x665
=072  \\$aG2.$x607.$x780
=072  \\$aG3.$x796
=150  \\$aPhosphorylation
=450  \\$wnnna$aPhosphorylations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$wh$aOxidative Phosphorylation
=550  \\$wh$aPhotophosphorylation
=667  \\$aalmost never IM; enzymatic phosphorylation: coord NIM with PHOSPHOTRANSFERASES (IM) + substrate (NIM) or specific phosphotransferase (particularly KINASES or PROTEIN KINASES) (IM); OXIDATIVE PHOSPHORYLATION & PHOTOPHOSPHORYLATION are also available
=680  \\$iThe introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.
=688  \\$a91(79); was see under CHEMISTRY, ORGANIC 1979-90
=750  \0$aPhosphorylation$5IEN$0(DLC)sh 85101132

=LDR  00961cz  a2200253n  4500
=001  9880363860402441
=005  20141212204529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010760
=035  \\$aCBA4049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x750
=150  \\$aPhosphorus Metabolism Disorders
=450  \\$wnnna$aDisorder, Phosphorus Metabolism
=450  \\$wnnna$aDisorders, Phosphorus Metabolism
=450  \\$wnnna$aMetabolism Disorder, Phosphorus
=450  \\$wnnna$aMetabolism Disorders, Phosphorus
=450  \\$wnnna$aPhosphorus Metabolism Disorder
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aHyperphosphatemia
=550  \\$wh$aHypophosphatemia
=667  \\$aHYPOPHOSPHATEMIA is also available; DF: PHOSPHORUS METAB DIS
=680  \\$iDisorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
=750  \0$aPhosphorus$xMetabolism$xDisorders$5IEN$0(DLC)sh 85101122

=LDR  00686cz  a2200205n  4500
=001  9880363860502441
=005  20141212204528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010759
=035  \\$aCBA4048HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x669
=150  \\$aPhosphorus Isotopes
=450  \\$wnnna$aIsotopes, Phosphorus
=550  \\$wg$aIsotopes
=550  \\$wh$aPhosphorus Radioisotopes
=550  \\$aPhosphorus
=667  \\$aP-31; NIM
=680  \\$iStable phosphorus atoms that have the same atomic number as the element phosphorus, but differ in atomic weight. P-31 is a stable phosphorus isotope.
=750  \0$aPhosphorus$xIsotopes$5IEN$0(DLC)sh 85101120

=LDR  00800cz  a2200217n  4500
=001  9880363860602441
=005  20141212204528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010758
=035  \\$aCBA4047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x666
=150  \\$aPhosphorus
=450  \\$aPhosphorus Compounds$5IEN
=450  \\$wnnna$aPhosphorus, Red
=450  \\$wnnna$aRed Phosphorus
=550  \\$wg$aElements
=667  \\$aP-31; PHOSPHORUS METABOLISM DISORDERS is available
=680  \\$iA non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.
=688  \\$a/metabolism was PHOSPHORUS METABOLISM 1965
=750  \0$aPhosphorus$5IEN-M$0(DLC)sh 85101119

=LDR  01003cz  a2200265n  4500
=001  9880363860702441
=005  20141212204528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010757
=035  \\$aCBA4046M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x700
=072  \\$aD1.$x695.$x625.$x700
=150  \\$aPhosphorous Acids
=450  \\$wnnna$aAcids, Phosphonic
=450  \\$wnnna$aAcids, Phosphorous
=450  \\$wnnna$aPhosphonic Acids
=550  \\$wg$aPhosphorus Acids
=550  \\$wh$aPhosphites
=667  \\$ado not confuse with PHOSPHORIC ACIDS
=680  \\$iInorganic derivatives of phosphorus trihydroxide (P(OH)3) and its tautomeric form dihydroxyphosphine oxide (HP=O(OH)2). Note that organic derivatives of phosphonic acids are listed under are ORGANOPHOSPHONATES.
=688  \\$a1968
=688  \\$a68
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Phosphonic Acids
=750  \0$aPhosphonic acids$0(DLC)sh 85101110$5IEN-M

=LDR  00884cz  a2200253n  4500
=001  9880363860802441
=005  20141212204528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010756
=035  \\$aCBA4045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675
=072  \\$aD1.$x695.$x625.$x675
=150  \\$aPhosphoric Acids
=450  \\$wnnna$aAcids, Phosphoric
=450  \\$wnnna$aAcids, Pyrophosphoric
=450  \\$aPyrophosphoric Acids
=550  \\$wg$aPhosphorus Acids
=550  \\$wh$aPhosphates
=550  \\$wh$aPhosphotungstic Acid
=667  \\$ado not confuse with PHOSPHORUS ACIDS
=680  \\$iInorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES.
=688  \\$a68; PYROPHOSPHORIC ACIDS was heading 1968-93
=750  \0$aPhosphoric acid$5IEN$0(DLC)sh 85101114

=LDR  02060cz  a2200553n  4500
=001  9880363860902441
=005  20141212204526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010751
=035  \\$aCBA4040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x520.$x241.$x300.$x500
=150  \\$aPhosphopyruvate Hydratase
=450  \\$wnnna$a2-Phospho-D-Glycerate Hydro-Lyase
=450  \\$wnnna$a2 Phospho D Glycerate Hydro Lyase
=450  \\$wnnna$a2-Phospho-D-Glycerate Hydrolase
=450  \\$wnnna$a2 Phospho D Glycerate Hydrolase
=450  \\$wnnna$a2-Phosphoglycerate Dehydratase
=450  \\$wnnna$a2 Phosphoglycerate Dehydratase
=450  \\$wnnna$aalpha-Enolase
=450  \\$wnnna$aalpha Enolase
=450  \\$wnnna$abeta-Enolase
=450  \\$wnnna$abeta Enolase
=450  \\$wnnna$aDehydratase, 2-Phosphoglycerate
=450  \\$aEnolase
=450  \\$wnnna$aEnolase 2
=450  \\$wnnna$aEnolase 3
=450  \\$wnnna$aEnolase, Muscle-Specific
=450  \\$wnnna$aEnolase, Nervous System-Specific
=450  \\$wnnna$aEnolase, Neuron-Specific
=450  \\$wnnna$aEnolase, Non-Neuronal
=450  \\$wnnna$agamma-Enolase
=450  \\$wnnna$agamma Enolase
=450  \\$wnnna$aHydratase, Phosphopyruvate
=450  \\$wnnna$aHydro-Lyase, 2-Phospho-D-Glycerate
=450  \\$wnnna$aMuscle-Specific Enolase
=450  \\$wnnna$aMuscle Specific Enolase
=450  \\$wnnna$aNervous System-Specific Enolase
=450  \\$wnnna$aNervous System Specific Enolase
=450  \\$aNeuron-Specific Enolase
=450  \\$wnnna$aNeuron Specific Enolase
=450  \\$wnnna$aNon-Neuronal Enolase
=450  \\$wnnna$aNon Neuronal Enolase
=450  \\$wnnna$aSystem-Specific Enolase, Nervous
=550  \\$wg$aHydro-Lyases
=550  \\$wh$atau-Crystallins
=680  \\$iA hydro-lyase that catalyzes the dehydration of 2-phosphoglycerate to form PHOSPHOENOLPYRUVATE. Several different isoforms of this enzyme exist, each with its own tissue specificity.
=688  \\$a73(64)
=750  \0$aEnolase$5IEN$0(DLC)sh 85044043

=LDR  01653cz  a2200505n  4500
=001  9880363861002441
=005  20141212204526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010750
=035  \\$aCBA4039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x744
=150  \\$aPhosphoproteins
=550  \\$wg$aProteins
=550  \\$wh$abcl-Associated Death Protein
=550  \\$wh$aBRCA1 Protein
=550  \\$wh$aCaseins
=550  \\$wh$aCaveolin 1
=550  \\$wh$aCaveolin 2
=550  \\$wh$aCDC2 Protein Kinase
=550  \\$wh$aCortactin
=550  \\$wh$aCrk-Associated Substrate Protein
=550  \\$wh$aDopamine and cAMP-Regulated Phosphoprotein 32
=550  \\$wh$aFanconi Anemia Complementation Group A Protein
=550  \\$wh$aFanconi Anemia Complementation Group D2 Protein
=550  \\$wh$aFanconi Anemia Complementation Group G Protein
=550  \\$wh$aFocal Adhesion Kinase 1
=550  \\$wh$aIntegrin-Binding Sialoprotein
=550  \\$wh$aInterferon Regulatory Factor-3
=550  \\$wh$aInterferon Regulatory Factor-7
=550  \\$wh$aPaxillin
=550  \\$wh$aPhosvitin
=550  \\$wh$aPlectin
=550  \\$wh$aRetinoblastoma-Like Protein p107
=550  \\$wh$aRetinoblastoma-Like Protein p130
=550  \\$wh$aRetinoblastoma Protein
=550  \\$wh$aSmad Proteins, Receptor-Regulated
=550  \\$wh$aStathmin
=550  \\$wh$aSynapsins
=550  \\$wh$aTumor Suppressor Protein p53
=550  \\$wh$aVitellogenins
=550  \\$wh$aZyxin
=667  \\$a/physiol permitted
=688  \\$a73(71); was see under PROTEINS 1963-72
=750  \0$aPhosphoproteins$0(DLC) sh 85101111$5IEN

=LDR  03668cz  a2200865n  4500
=001  9880363861102441
=005  20181127114711.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010749
=035  \\$aCBA4038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x625
=150  \\$aPhosphoprotein Phosphatases
=450  \\$wnnna$aCasein Phosphatase
=450  \\$wnnna$aEcto-Phosphoprotein Phosphatase
=450  \\$wnnna$aEcto Phosphoprotein Phosphatase
=450  \\$wnnna$aNuclear Protein Phosphatase
=450  \\$wnnna$aPhosphatase-2C, Phosphoprotein
=450  \\$wnnna$aPhosphatase C-I, Protein
=450  \\$wnnna$aPhosphatase C-II, Protein
=450  \\$wnnna$aPhosphatase C, Protein
=450  \\$wnnna$aPhosphatase, Casein
=450  \\$wnnna$aPhosphatase, Ecto-Phosphoprotein
=450  \\$wnnna$aPhosphatase H-II, Protein
=450  \\$wnnna$aPhosphatase, Nuclear Protein
=450  \\$wnnna$aPhosphatase, Phosphohistone
=450  \\$wnnna$aPhosphatase, Phosphoprotein
=450  \\$wnnna$aPhosphatase, Phosphoseryl-Protein
=450  \\$wnnna$aPhosphatase, Protein-Serine-Threonine
=450  \\$wnnna$aPhosphatase, Protein-Threonine
=450  \\$wnnna$aPhosphatase, Serine-Threonine
=450  \\$wnnna$aPhosphatase, Threonine
=450  \\$wnnna$aPhosphatases, Phosphoprotein
=450  \\$wnnna$aPhosphatases, Protein
=450  \\$wnnna$aPhosphohistone Phosphatase
=450  \\$wnnna$aPhosphohydrolase, Phosphoprotein
=450  \\$aPhosphoprotein Phosphatase
=450  \\$wnnna$aPhosphoprotein Phosphatase-2C
=450  \\$wnnna$aPhosphoprotein Phosphatase 2C
=450  \\$aPhosphoprotein Phosphohydrolase
=450  \\$wnnna$aPhosphoseryl-Protein Phosphatase
=450  \\$wnnna$aPhosphoseryl Protein Phosphatase
=450  \\$wnnna$aProtein Phosphatase C
=450  \\$wnnna$aProtein Phosphatase C-I
=450  \\$wnnna$aProtein Phosphatase C I
=450  \\$wnnna$aProtein Phosphatase C-II
=450  \\$wnnna$aProtein Phosphatase C II
=450  \\$wnnna$aProtein Phosphatase H-II
=450  \\$wnnna$aProtein Phosphatase H II
=450  \\$wnnna$aProtein Phosphatase, Nuclear
=450  \\$aProtein Phosphatases
=450  \\$wnnna$aProtein-Serine-Threonine Phosphatase
=450  \\$wnnna$aProtein Serine Threonine Phosphatase
=450  \\$wnnna$aProtein-Threonine Phosphatase
=450  \\$wnnna$aProtein Threonine Phosphatase
=450  \\$wnnna$aSerine-Threonine Phosphatase
=450  \\$wnnna$aSerine Threonine Phosphatase
=450  \\$wnnna$aThreonine Phosphatase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=550  \\$wh$aCalcineurin
=550  \\$wh$aDual-Specificity Phosphatases
=550  \\$wh$aGlycogen-Synthase-D Phosphatase
=550  \\$wh$aMyosin-Light-Chain Phosphatase
=550  \\$wh$aPhosphorylase Phosphatase
=550  \\$wh$aProtein Phosphatase 1
=550  \\$wh$aProtein Phosphatase 2
=550  \\$wh$aProtein Phosphatase 2c
=550  \\$wh$aPyruvate Dehydrogenase (Lipoamide)-Phosphatase
=550  \\$aCell Cycle Proteins
=667  \\$ageneral; prefer specifics
=680  \\$iA group of enzymes removing the SERINE- or THREONINE-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. (Enzyme Nomenclature, 1992)
=688  \\$a2008(1994)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Phosphoprotein Phosphatase
=688  \\$a94; was PHOSPHOPROTEIN PHOSPHATASES 1978-93; PHOSPHOPROTEIN PHOSPHOHYDROLASE was PHOSPHOPROTEIN PHOSPHOHYDROLASES 1978-93
=750  \0$aPhosphoprotein phosphatases$0(DLC) sh 86006524$5IEN

=LDR  01590cz  a2200409n  4500
=001  9880363861202441
=005  20181011122547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010744
=035  \\$aCBA4033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650
=150  \\$aPhosphoric Monoester Hydrolases
=450  \\$wnnna$aHydrolases, Phosphoric Monoester
=450  \\$aPhosphatases
=450  \\$aPhosphohydrolases
=450  \\$aPhosphomonoesterases
=550  \\$wg$aEsterases
=550  \\$wh$a4-Nitrophenylphosphatase
=550  \\$wh$a6-Phytase
=550  \\$wh$aAcid Phosphatase
=550  \\$wh$aAlkaline Phosphatase
=550  \\$wh$aFructose-Bisphosphatase
=550  \\$wh$aGlucose-6-Phosphatase
=550  \\$wh$aHistidinol-Phosphatase
=550  \\$wh$aMitogen-Activated Protein Kinase Phosphatases
=550  \\$wh$aNucleotidases
=550  \\$wh$aPhosphatidate Phosphatase
=550  \\$wh$aPhosphofructokinase-2
=550  \\$wh$aPhosphoinositide Phosphatases
=550  \\$wh$aPhosphoprotein Phosphatases
=550  \\$wh$aProtein Tyrosine Phosphatases
=550  \\$wh$aPTEN Phosphohydrolase
=667  \\$aDF: note short X ref
=680  \\$iA group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3.
=688  \\$a94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93
=750  \0$aPhosphatases$0sh 85101088$5IEN-M

=LDR  00982cz  a2200277n  4500
=001  9880363861402441
=005  20141212204522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010740
=035  \\$aCBA4029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x100.$x680
=072  \\$aD8.$x811.$x277.$x352.$x640.$x700
=150  \\$aPhospholipases
=450  \\$wnnna$aLecithinase
=450  \\$aLecithinases
=450  \\$wnnna$aPhospholipase
=550  \\$wg$aCarboxylic Ester Hydrolases
=550  \\$wg$aPhosphoric Diester Hydrolases
=550  \\$wh$aLysophospholipase
=550  \\$wh$aPhospholipase D
=550  \\$wh$aPhospholipases A
=550  \\$wh$aType C Phospholipases
=680  \\$iA class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.
=688  \\$a80; was PHOSPHOLIPASE 1963-79; LECITHINASES was LECITHINASE see under PHOSPHOLIPASE 1963-79
=750  \0$aPhospholipases$0(DLC) sh 87003052$5IEN

=LDR  01369cz  a2200289n  4500
=001  9880363861502441
=005  20141212204521.0
=008  790222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010738
=035  \\$aCBA4027M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x640.$x700.$x700
=150  \\$aType C Phospholipases
=450  \\$aLecithinase C
=450  \\$aPhospholipase C
=450  \\$wnnna$aPhospholipases C
=450  \\$aPhospholipases, Type C
=550  \\$wg$aPhospholipases
=550  \\$wh$aGlycosylphosphatidylinositol Diacylglycerol-Lyase
=550  \\$wh$aPhosphatidylinositol Diacylglycerol-Lyase
=550  \\$wh$aPhosphoinositide Phospholipase C
=667  \\$ageneral; many specifics are available
=680  \\$iA subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS.
=688  \\$a2007(1980)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Phospholipase C
=688  \\$a86(80); was see under PHOSPHOLIPASES 1980-85
=750  \0$aPhospholipase C$0(DLC) sh 96007147$5IEN-M

=LDR  01504cz  a2200301n  4500
=001  9880363861602441
=005  20141212204520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010732
=035  \\$aCBA4021HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x225.$x850.$x500
=150  \\$aPhosphofructokinase-1
=450  \\$wnnna$a6-Phosphofructo-1-kinase
=450  \\$a6-Phosphofructokinase
=450  \\$wnnna$a6 Phosphofructokinase
=450  \\$wnnna$aFructose-6-P 1-Kinase
=450  \\$wnnna$aFructose-6-phosphate 1-Phosphotransferase
=450  \\$wnnna$aPhosphofructokinase 1
=550  \\$wg$aPhosphofructokinases
=550  \\$wh$aPhosphofructokinase-1, Liver Type
=550  \\$wh$aPhosphofructokinase-1, Muscle Type
=550  \\$wh$aPhosphofructokinase-1, Type C
=550  \\$aPhosphofructokinase-2
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iAn allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, TYPE C; found in platelets, brain, and other tissues.
=688  \\$a2002
=750  \0$aPhosphofructokinase 1$5IEN-M$0(DLC)sh 97002380

=LDR  01183cz  a2200301n  4500
=001  9880363861702441
=005  20141212204518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010727
=035  \\$aCBA4016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x640
=150  \\$aPhosphoric Diester Hydrolases
=450  \\$wnnna$aHydrolases, Phosphoric Diester
=450  \\$aPhosphodiesterases
=550  \\$wg$aEsterases
=550  \\$wh$a2',3'-Cyclic-Nucleotide Phosphodiesterases
=550  \\$wh$a3',5'-Cyclic-AMP Phosphodiesterases
=550  \\$wh$a3',5'-Cyclic-GMP Phosphodiesterases
=550  \\$wh$aAnnexin A3
=550  \\$wh$aGlycerophosphoinositol Inositolphosphodiesterase
=550  \\$wh$aPhosphodiesterase I
=550  \\$wh$aPhospholipases
=550  \\$wh$aSphingomyelin Phosphodiesterase
=667  \\$a/antag = PHOSPHORIC DIESTER HYDROLASE INHIBITORS (see PHOSPHODIESTERASE INHIBITORS)
=680  \\$iA class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4.
=688  \\$a94; was PHOSPHODIESTERASES 1972-93 (Prov 1972-73)
=750  \0$aPhosphodiesterases$5IEN$0(DLC)sh 90000407

=LDR  01067cz  a2200265n  4500
=001  9880363861802441
=005  20141212204518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010725
=035  \\$aCBA4014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x373.$x603
=072  \\$aD12.$x125.$x740.$x675
=150  \\$aPhosphocreatine
=450  \\$aCreatine Phosphate
=450  \\$wnnna$aDisodium Salt Phosphocreatine
=450  \\$wnnna$aNeoton
=450  \\$wnnna$aPhosphate, Creatine
=450  \\$wnnna$aPhosphocreatine, Disodium Salt
=450  \\$wnnna$aPhosphorylcreatine
=550  \\$wg$aCreatine
=550  \\$wg$aPhosphoamino Acids
=680  \\$iAn endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996)
=688  \\$a66(63); was see under COENZYMES 1963-65
=750  \0$aPhosphocreatine$5IEN$0(DLC)sh 91004960

=LDR  00972cz  a2200289n  4500
=001  9880363861902441
=005  20141212204516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010721
=035  \\$aCBA4010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x600
=072  \\$aD1.$x695.$x625.$x600
=072  \\$aD2.$x705.$x629
=150  \\$aPhosphinic Acids
=450  \\$wnnna$aAcid, Phosphinic
=450  \\$wnnna$aAcids, Hypophosphorous
=450  \\$wnnna$aAcids, Phosphinic
=450  \\$aHypophosphorous Acids
=450  \\$wnnna$aPhosphinic Acid
=550  \\$wg$aOrganophosphorus Compounds
=550  \\$wg$aPhosphorus Acids
=550  \\$wh$aFosinopril
=667  \\$ado not confuse with PHOSPHONIC ACIDS
=680  \\$iInorganic or organic derivatives of phosphinic acid, H2PO(OH). They include phosphinates and phosphinic acid esters.
=688  \\$a65; was PHOSPHINIC ACID 1963-64
=750  \0$aPhosphinic acid$0(DLC)sh2005008190$5IEN-M

=LDR  00677cz  a2200205n  4500
=001  9880363862002441
=005  20141212204516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010720
=035  \\$aCBA4009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x695.$x525
=072  \\$aD2.$x705.$x621
=150  \\$aPhosphines
=550  \\$wg$aOrganophosphorus Compounds
=550  \\$wg$aPhosphorus Compounds
=667  \\$ado not confuse with PHOSPHENES
=680  \\$iInorganic or organic compounds derived from phosphine (PH3) by the replacement of H atoms. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a65(63)
=750  \0$aPhosphine$5IEN$0(DLC)sh 85101105

=LDR  00860cz  a2200217n  4500
=001  9880363862102441
=005  20141212204516.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010719
=035  \\$aCBA4008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x964.$x500
=072  \\$aG11.$x561.$x600.$x810.$x964.$x500
=072  \\$aG14.$x640.$x816.$x500
=150  \\$aPhosphenes
=450  \\$wnnna$aPhosphene
=550  \\$wg$aVision, Ocular
=667  \\$ado not confuse with PHOSPHINES
=680  \\$iA subjective visual sensation with the eyes closed and in the absence of light. Phosphenes can be spontaneous, or induced by chemical, electrical, or mechanical (pressure) stimuli which cause the visual field to light up without optical inputs.
=688  \\$a91(75); was see under VISION 1975-90
=750  \0$aPhosphenes$5IEN$0(DLC)sh 85101103

=LDR  00849cz  a2200205n  4500
=001  9880363862202441
=005  20141212204516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010718
=035  \\$aCBA4007M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x971
=150  \\$aPhosphatidylserines
=450  \\$wnnna$aPhosphoglycerides, Serine
=450  \\$aSerine Phosphoglycerides
=550  \\$wg$aGlycerophospholipids
=667  \\$a/biosyn /physiol permitted
=680  \\$iDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a serine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and serine and 2 moles of fatty acids.
=688  \\$a77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76
=750  \0$aPhosphatidylserines$5IEN-M$0(DLC)sh 99001549

=LDR  01402cz  a2200337n  4500
=001  9880363862302441
=005  20141212204515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010716
=035  \\$aCBA4005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x942
=150  \\$aPhosphatidylinositols
=450  \\$wnnna$aInositide Phospholipids
=450  \\$wnnna$aInositol, Phosphatidyl
=450  \\$aInositol Phosphoglycerides
=450  \\$wnnna$aInositol Phospholipids
=450  \\$wnnna$aPhosphatidyl Inositol
=450  \\$wnnna$aPhosphatidylinositol
=450  \\$wnnna$aPhosphoglycerides, Inositol
=450  \\$aPhosphoinositides
=450  \\$wnnna$aPhospholipids, Inositide
=450  \\$wnnna$aPhospholipids, Inositol
=450  \\$aPtdIns
=550  \\$wg$aGlycerophospholipids
=550  \\$wh$aGlycosylphosphatidylinositols
=550  \\$wh$aPhosphatidylinositol Phosphates
=667  \\$a/biosyn /physiol permitted
=680  \\$iDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids.
=688  \\$a77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93
=750  \0$aPhosphoinositides$0(DLC) sh 85101107$5IEN-M

=LDR  01005cz  a2200229n  4500
=001  9880363862402441
=005  20141212204514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010714
=035  \\$aCBA4003M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760.$x400.$x840
=150  \\$aPhosphatidylethanolamines
=450  \\$aCephalins
=450  \\$aEthanolamine Phosphoglycerides
=450  \\$wnnna$aEthanolamineglycerophospholipids
=450  \\$wnnna$aPhosphoglycerides, Ethanolamine
=550  \\$wg$aGlycerophospholipids
=667  \\$a/biosyn /physiol permitted
=680  \\$iDerivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.
=688  \\$a77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76
=750  \0$aPhosphatidylethanolamines$0(DLC)sh2007010969$5IEN-M

=LDR  01006cz  a2200265n  4500
=001  9880363862502441
=005  20141212204514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010712
=035  \\$aCBA4001M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x755.$x375.$x760
=150  \\$aPhosphatidic Acids
=450  \\$wnnna$aAcid, Phosphatidic
=450  \\$wnnna$aAcids, Phosphatidic
=450  \\$wnnna$aAmmonium Phosphatidate
=450  \\$wnnna$aDiacylglycerophosphates
=450  \\$wnnna$aPhosphatidate, Ammonium
=450  \\$wnnna$aPhosphatidic Acid
=550  \\$wg$aGlycerophosphates
=550  \\$wh$aGlycerophospholipids
=550  \\$wh$aLysophospholipids
=680  \\$iFatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.
=688  \\$a77(63)
=750  \0$aPhosphatidic acids$0(DLC)sh2006007078$5IEN-M

=LDR  01071cz  a2200253n  4500
=001  9880363862602441
=005  20141212204513.0
=008  780313\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010711
=035  \\$aCBA4000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x620
=150  \\$aPhosphatidate Phosphatase
=450  \\$wnnna$aPhosphatase, Phosphatidate
=450  \\$wnnna$aPhosphatase, Phosphatidic Acid
=450  \\$aPhosphatidate Phosphohydrolase
=450  \\$wnnna$aPhosphatidic Acid Phosphatase
=450  \\$wnnna$aPhosphatidic Acid Phosphohydrolase
=450  \\$wnnna$aPhosphohydrolase, Phosphatidate
=450  \\$wnnna$aPhosphohydrolase, Phosphatidic Acid
=550  \\$wg$aPhosphoric Monoester Hydrolases
=680  \\$iA phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4.
=688  \\$a91(79); was see under PHOSPHOMONOESTERASES 1979-90
=750  \0$aPhosphatidate phosphatase$0(DLC) sh 87004223$5IEN

=LDR  01213cz  a2200313n  4500
=001  9880363862702441
=005  20190107102446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010710
=035  \\$aCBA3999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374
=072  \\$aD1.$x248.$x497.$x158.$x730
=072  \\$aD1.$x695.$x625.$x675.$x650
=150  \\$aPhosphates
=450  \\$wnnna$aInorganic Phosphates
=450  \\$wnnna$aOrthophosphate
=450  \\$aPhosphates, Inorganic
=550  \\$wg$aAnions
=550  \\$wg$aPhosphoric Acids
=550  \\$wh$aAcidulated Phosphate Fluoride
=550  \\$wh$aCalcium Phosphates
=550  \\$wh$aPhosphoramides
=550  \\$wh$aPolyphosphates
=550  \\$wh$aStruvite
=667  \\$aPHOSPHATES, ORGANIC see ORGANOPHOSPHATES and POLYPHOSPHATES are also available; /blood: consider also HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIA, FAMILIAL or HYPERPHOSPHATEMIA; /defic: consider also HYPOPHOSPHATEMIA or HYPOPHOSPHATEMIA, FAMILIAL
=680  \\$iInorganic salts of phosphoric acid.
=688  \\$a/blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76
=750  \0$aPhosphates$5IEN$0(DLC)sh 85101098

=LDR  00908cz  a2200193n  4500
=001  9880363862802441
=005  20141212204512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010707
=035  \\$aCBA3996NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x700
=150  \\$aPhosphamidon
=450  \\$wnnna$aDimecron
=550  \\$wg$aOrganophosphates
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organophosphate cholinesterase inhibitor that is used as an insecticide.
=688  \\$a91(72); was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90
=750  \0$aPhosphamidon$5IEN-M$0(DLC)sh 94003428

=LDR  00360cz  a2200133n  4500
=001  9880364124902441
=005  20120717143441.0
=008  780519\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3797HS
=035  \\$a(DNLM)D003413Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aCricoid Cartilage$xsurgery
=450  \\$aCricothyrotomy$5IEN
=750  \0$aCricothyrotomy$5IEN$0(DLC)sh 85033989

=LDR  00319cz  a2200121n  4500
=001  9880364125002441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBE3530HS
=035  \\$a(DNLM)D011818Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aRabies$xveterinary
=750  \0$aRabies in animals$5IEN$0(DLC)sh 88003398

=LDR  00351cz  a2200121n  4500
=001  9880364125102441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3686HS
=035  \\$a(DNLM)D003141Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aCommunicable Diseases$xveterinary
=750  \0$aCommunicable diseases in animals$5IEN-M$0(DLC)sh 85029021

=LDR  00317cz  a2200121n  4500
=001  9880364125202441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3647HS
=035  \\$a(DNLM)D002987Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aClitoris$xsurgery
=750  \0$aClitoridectomy$5IEN-M$0(DLC)sh 85027085

=LDR  00382cz  a2200133n  4500
=001  9880364125302441
=005  20120717143448.0
=008  710101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE0413HS
=035  \\$a(DNLM)D000488Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aAllied Health Personnel$xeducation
=450  \\$aParamedical Education$5IEN
=750  \0$aParamedical education$5IEN$0(DLC)sh 85097847

=LDR  00319cz  a2200121n  4500
=001  9880364125402441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3601HS
=035  \\$a(DNLM)D002784Q000097
=040  \\$aDNLM$cDNLM
=150  \\$aCholesterol$xblood
=750  \0$aBlood cholesterol$5IEN$0(DLC)sh 85014971

=LDR  00373cz  a2200133n  4500
=001  9880364125602441
=005  20120717143440.0
=008  660101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3558HS
=035  \\$a(DNLM)D002675Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aChild, Preschool$xeducation
=450  \\$aEducation, Preschool$5IEN
=750  \0$aEducation, Preschool$5IEN$0(DLC)sh 85041072

=LDR  00417cz  a2200145n  4500
=001  9880364125702441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBE0164HS
=035  \\$a(DNLM)D000383Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aAgriculture$xeducation
=450  \\$aAgricultural Education$5IEN
=450  \\$aEducation, Agricultural$5IEN
=750  \0$aAgricultural education$5IEN$0(DLC)sh 85002310

=LDR  00329cz  a2200121n  4500
=001  9880364125802441
=005  20120717143440.0
=008  720101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3448HS
=035  \\$a(DNLM)D002477Q000648
=040  \\$aDNLM$cDNLM
=150  \\$aCells$xultrastructure
=750  \0$aUltrastructure (Biology)$5IEN$0(DLC)sh 85139504

=LDR  00325cz  a2200121n  4500
=001  9880364125902441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD9976HS
=035  \\$a(DNLM)D000375Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aAging$xdrug effects
=750  \0$aGeriatric pharmacology$5IEN$0(DLC)sh 85054310

=LDR  00319cz  a2200121n  4500
=001  9880364126002441
=005  20120717143440.0
=008  720101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3446HS
=035  \\$a(DNLM)D002477Q000473
=040  \\$aDNLM$cDNLM
=150  \\$aCells$xpathology
=750  \0$aPathology, Cellular$5IEN$0(DLC)sh 85098687

=LDR  00350cz  a2200121n  4500
=001  9880364126102441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3378HS
=035  \\$a(DNLM)D002309Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aCardiology$xinstrumentation
=750  \0$aCardiovascular instruments, Implanted$5IEN-M$0(DLC)sh 85020225

=LDR  00361cz  a2200133n  4500
=001  9880364126202441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD9601HS
=035  \\$a(DNLM)D000336Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aAerosols$xtherapeutic use
=450  \\$aAerosol Therapy$5IEN
=750  \0$aAerosol therapy$5IEN$0(DLC)sh 85001418

=LDR  00327cz  a2200121n  4500
=001  9880364126302441
=005  20120717143440.0
=008  740101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3357HS
=035  \\$a(DNLM)D002272Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aCarcinoembryonic Antigen$xgenetics
=750  \0$aCEA genes$5IEN$0(DLC)sh 89002393

=LDR  00326cz  a2200121n  4500
=001  9880364126402441
=005  20120717143448.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6669HS
=035  \\$a(DNLM)D011041Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aPoisoning$xveterinary
=750  \0$aVeterinary toxicology$5IEN$0(DLC)sh 85143082

=LDR  00307cz  a2200121n  4500
=001  9880364126502441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD3344HS
=035  \\$a(DNLM)D002244Q000652
=040  \\$aDNLM$cDNLM
=150  \\$aCarbon$xurine
=750  \0$aCarbonuria$5IEN$0(DLC)sh 85020142

=LDR  00331cz  a2200121n  4500
=001  9880364126602441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6668HS
=035  \\$a(DNLM)D011041Q000530
=040  \\$aDNLM$cDNLM
=150  \\$aPoisoning$xradiography
=750  \0$aRadiography in toxicology$5IEN$0(DLC)sh 85110707

=LDR  00342cz  a2200133n  4500
=001  9880364126702441
=005  20120717143440.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3342HS
=035  \\$a(DNLM)D002137Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aCalculi$xsurgery
=450  \\$aLithotomy$5IEN
=750  \0$aLithotomy$5IEN-M$0(DLC)sh 85077617

=LDR  00321cz  a2200121n  4500
=001  9880364126802441
=005  20010320224654.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6644HS
=035  \\$a(DNLM)D010944Q000528
=040  \\$aDNLM$cDNLM
=150  \\$aPlants$xradiation effects
=750  \0$aPlants, Effect of radiation on$5IEN

=LDR  00347cz  a2200133n  4500
=001  9880364126902441
=005  20120717143439.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3298HS
=035  \\$a(DNLM)D001940Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aBreast$xsurgery
=550  \\$aMammaplasty$5IEN-M
=750  \0$aMammaplasty$5IEN-M$0(DLC)sh 85080274

=LDR  00350cz  a2200133n  4500
=001  9880364127002441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD6642HS
=035  \\$a(DNLM)D010944Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aPlants$xgenetics
=450  \\$aPlant Genetics$5IEN
=750  \0$aPlant genetics$5IEN$0(DLC)sh 85102745

=LDR  00369cz  a2200133n  4500
=001  9880364127102441
=005  20110525082300.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD3089HS
=035  \\$a(DNLM)D001808Q000637
=040  \\$aDNLM$cDNLM
=150  \\$aBlood Vessels$xtransplantation
=450  \\$aVascular Grafts$5IEN
=750  \0$aVascular grafts$0(DLC) sh 85142360$5IEN-M

=LDR  00321cz  a2200121n  4500
=001  9880364127202441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6447HS
=035  \\$a(DNLM)D010100Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aOxygen$xtherapeutic use
=750  \0$aOxygen therapy$5IEN$0(DLC)sh 85096338

=LDR  00308cz  a2200121n  4500
=001  9880364127302441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6446HS
=035  \\$a(DNLM)D010053Q000601
=040  \\$aDNLM$cDNLM
=150  \\$aOvary$xsurgery
=750  \0$aOvariotomy$5IEN$0(DLC)sh 85096188

=LDR  00408cz  a2200145n  4500
=001  9880364127402441
=005  20120717143439.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD2834HS
=035  \\$a(DNLM)D001419Q000378
=040  \\$aDNLM$cDNLM
=150  \\$aBacteria$xmetabolism
=450  \\$aBacterial Metabolism$5IEN
=450  \\$aMicrobial Metabolism$5IEN
=750  \0$aMicrobial metabolism$5IEN$0(DLC)sh 85084763

=LDR  00355cz  a2200121n  4500
=001  9880364127502441
=005  20120717143447.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6442HS
=035  \\$a(DNLM)D010038Q000530
=040  \\$aDNLM$cDNLM
=150  \\$aOtorhinolaryngologic Diseases$xradiography
=750  \0$aRadiography in otolaryngology$5IEN$0(DLC)sh 85110706

=LDR  00320cz  a2200121n  4500
=001  9880364127602441
=005  20120717143439.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD2751HS
=035  \\$a(DNLM)D001419Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aBacteria$xgenetics
=750  \0$aBacterial genetics$5IEN$0(DLC)sh 85010849

=LDR  00347cz  a2200121n  4500
=001  9880364127702441
=005  20120717143447.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6440HS
=035  \\$a(DNLM)D010038Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aOtorhinolaryngologic Diseases$xnursing
=750  \0$aOtolaryngological nursing$5IEN$0(DLC)sh 85096047

=LDR  00398cz  a2200133n  4500
=001  9880364127802441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6430HS
=035  \\$a(DNLM)D010021Q000193
=040  \\$aDNLM$cDNLM
=150  \\$aOsteopathic Medicine$xeducation
=750  \0$aOsteopathic schools$5IEN-M$0(DLC)sh 85095973
=750  \0$aOsteopathic students$5IEN-M$0(DLC)sh 85095974

=LDR  00329cz  a2200121n  4500
=001  9880364127902441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6417HS
=035  \\$a(DNLM)D009985Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aOrthopedics$xveterinary
=750  \0$aVeterinary orthopedics$5IEN$0(DLC)sh 85143063

=LDR  02081cz  a2200409n  4500
=001  9880364128002441
=005  20141212211411.0
=008  900111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016133
=035  \\$aCBD0998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x620.$x500
=150  \\$aPolymerase Chain Reaction
=450  \\$aAnchored PCR
=450  \\$wnnna$aAnchored Polymerase Chain Reaction
=450  \\$aInverse PCR
=450  \\$wnnna$aInverse Polymerase Chain Reaction
=450  \\$aNested PCR
=450  \\$wnnna$aNested Polymerase Chain Reaction
=450  \\$aPCR
=450  \\$wnnna$aPCR, Anchored
=450  \\$wnnna$aPCR, Inverse
=450  \\$wnnna$aPCR, Nested
=450  \\$wnnna$aPolymerase Chain Reactions
=450  \\$wnnna$aReaction, Polymerase Chain
=450  \\$wnnna$aReactions, Polymerase Chain
=550  \\$wg$aNucleic Acid Amplification Techniques
=550  \\$wh$aAmplified Fragment Length Polymorphism Analysis
=550  \\$wh$aMultiplex Polymerase Chain Reaction
=550  \\$wh$aPrimed In Situ Labeling
=550  \\$wh$aRandom Amplified Polymorphic DNA Technique
=550  \\$wh$aReal-Time Polymerase Chain Reaction
=550  \\$wh$aReverse Transcriptase Polymerase Chain Reaction
=550  \\$aLigase Chain Reaction
=680  \\$iIn vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
=688  \\$a91(90); was see under GENE AMPLIFICATION 1990
=750  \0$aPolymerase chain reaction$5IEN-M$0(DLC)sh 89002539

=LDR  00359cz  a2200133n  4500
=001  9880364128102441
=005  20120717143447.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD6309HS
=035  \\$a(DNLM)D009622Q000517
=040  \\$aDNLM$cDNLM
=150  \\$aNoise$xprevention & control
=450  \\$aNoise Control$5IEN
=750  \0$aNoise control$5IEN$0(DLC)sh 85092183

=LDR  00381cz  a2200133n  4500
=001  9880364128202441
=005  20120717143447.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD6250HS
=035  \\$a(DNLM)D009422Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aNervous System Diseases$xveterinary
=450  \\$aVeterinary Neurology$5IEN
=750  \0$aVeterinary neurology$5IEN$0(DLC)sh 85143058

=LDR  00362cz  a2200133n  4500
=001  9880364128302441
=005  20120717143446.0
=008  731227\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD6241HS
=035  \\$a(DNLM)D009420Q000276
=040  \\$aDNLM$cDNLM
=150  \\$aNervous System$ximmunology
=450  \\$aNeuroimmunology$5IEN
=750  \0$aNeuroimmunology$5IEN$0(DLC)sh 85091127

=LDR  01582cz  a2200361n  4500
=001  9880364128402441
=005  20141212211347.0
=008  890714\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016049
=035  \\$aCBD0997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x590.$x616.$x130
=072  \\$aD13.$x570.$x230.$x500.$x90
=072  \\$aD13.$x570.$x583.$x616.$x130
=072  \\$aD13.$x570.$x800.$x573.$x130
=150  \\$aDidanosine
=450  \\$a2',3'-Dideoxyinosine
=450  \\$wnnna$a2',3' Dideoxyinosine
=450  \\$wnnna$aBristol-Myers Brand of Didanosine
=450  \\$wnnna$aBristol Myers Brand of Didanosine
=450  \\$wnnna$aBristol-Myers Squibb Brand of Didanosine
=450  \\$wnnna$aBristol Myers Squibb Brand of Didanosine
=450  \\$addI (Antiviral)
=450  \\$aDideoxyinosine
=450  \\$wnnna$aNSC-612049
=450  \\$wnnna$aNSC 612049
=450  \\$wnnna$aNSC612049
=450  \\$wnnna$aVidex
=550  \\$wg$aDideoxynucleosides
=550  \\$wg$aInosine
=680  \\$iA dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.
=688  \\$a92; was DIDEOXYINOSINE 1990-91
=750  \0$aDidanosine$0(DLC)sh2012002721$5IEN-M

=LDR  00474cz  a2200157n  4500
=001  9880364128502441
=005  20120717143446.0
=008  900713nn\ancnnbabn\\\\\\\\\\|n\ana\|||\d
=035  \\$a(DNLM)D009369Q000627
=035  \\$aCBD6214HS
=040  \\$aIEN-M$cIEN-M
=150  \\$aNeoplasms$xveterinary
=690  \\$aAMD:7/13/90
=750  \0$aVeterinary oncology$5IEN-M$0(DLC)sh 85143061
=750  \0$aTumors in animals$5IEN-M$0(DLC)sh 85138567
=750  \0$aCancer in animals$5IEN-M$0(DLC)sh 94001688

=LDR  00315cz  a2200121n  4500
=001  9880364128602441
=005  20120717143446.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6143HS
=035  \\$a(DNLM)D009206Q000166
=040  \\$aDNLM$cDNLM
=150  \\$aMyocardium$xcytology
=750  \0$aHeart cells$5IEN$0(DLC)sh 87004510

=LDR  00322cz  a2200121n  4500
=001  9880364128702441
=005  20120717143446.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6131HS
=035  \\$a(DNLM)D009181Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aMycoses$xveterinary
=750  \0$aVeterinary mycology$5IEN$0(DLC)sh 85143056

=LDR  00322cz  a2200121n  4500
=001  9880364128802441
=005  20120717143446.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6060HS
=035  \\$a(DNLM)D008903Q000378
=040  \\$aDNLM$cDNLM
=150  \\$aMinerals$xmetabolism
=750  \0$aMineral metabolism$5IEN$0(DLC)sh 85085566

=LDR  01142cz  a2200313n  4500
=001  9880364128902441
=005  20141212211344.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016040
=035  \\$aCBD0989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928.$x600.$x495
=072  \\$aE4.$x936.$x450.$x495
=150  \\$aLung Transplantation
=450  \\$aGrafting, Lung
=450  \\$wnnna$aGraftings, Lung
=450  \\$wnnna$aLung Grafting
=450  \\$wnnna$aLung Graftings
=450  \\$aLung$xtransplantation
=450  \\$wnnna$aLung Transplantations
=450  \\$aTransplantation, Lung
=450  \\$wnnna$aTransplantations, Lung
=550  \\$wg$aOrgan Transplantation
=550  \\$wg$aPulmonary Surgical Procedures
=550  \\$wh$aHeart-Lung Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; HEART-LUNG TRANSPLANTATION is also available
=680  \\$iThe transference of either one or both of the lungs from one human or animal to another.
=688  \\$a90; was LUNG/transplantation 1966-89
=750  \0$aLungs$xTransplantation$5IEN$0(DLC)sh 85078920

=LDR  00301cz  a2200121n  4500
=001  9880364129102441
=005  20010320183403.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6055HS
=035  \\$a(DNLM)D008867Q000295
=040  \\$aDNLM$cDNLM
=150  \\$aMicrotomy$xinstrumentation
=750  \0$aMicrotome$5IEN

=LDR  00331cz  a2200121n  4500
=001  9880364129202441
=005  20120717143446.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD6028HS
=035  \\$a(DNLM)D008691Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aMethadone$xtherapeutic use
=750  \0$aMethadone maintenance$5IEN$0(DLC)sh 85084374

=LDR  00331cz  a2200121n  4500
=001  9880364129302441
=005  20120717143446.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D008603Q000193
=035  \\$aCBD5961HS
=040  \\$aDNLM$cDNLM
=150  \\$aMental Health$xeducation
=750  \0$aMental health education$5IEN$0(DLC)sh 85083620

=LDR  00293cz  a2200109n  4500
=001  9880364129402441
=005  20120717143446.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D008511Q000639
=040  \\$aDNLM$cDNLM
=150  \\$aMedicine$xtrends
=750  \0$aMedical Innovations$5IEN$0(DLC)sh 85082946

=LDR  01662cz  a2200457n  4500
=001  9880364129502441
=005  20141212211343.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016039
=035  \\$aCBD0988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x825.$x374
=072  \\$aE4.$x936.$x580.$x225
=150  \\$aCorneal Transplantation
=450  \\$wnnna$aCornea Transplantation
=450  \\$aCornea$xtransplantation
=450  \\$wnnna$aCornea Transplantations
=450  \\$wnnna$aCorneal Grafting
=450  \\$wnnna$aCorneal Graftings
=450  \\$wnnna$aCorneal Transplantations
=450  \\$aGrafting, Corneal
=450  \\$wnnna$aGraftings, Corneal
=450  \\$wnnna$aKeratoplasties
=450  \\$wnnna$aKeratoplasties, Lamellar
=450  \\$aKeratoplasty
=450  \\$aKeratoplasty, Lamellar
=450  \\$wnnna$aLamellar Keratoplasties
=450  \\$wnnna$aLamellar Keratoplasty
=450  \\$wnnna$aTransplantation, Cornea
=450  \\$aTransplantation, Corneal
=450  \\$wnnna$aTransplantations, Cornea
=450  \\$wnnna$aTransplantations, Corneal
=550  \\$wg$aRefractive Surgical Procedures
=550  \\$wg$aTissue Transplantation
=550  \\$wh$aDescemet Stripping Endothelial Keratoplasty
=550  \\$wh$aEpikeratophakia
=550  \\$wh$aKeratoplasty, Penetrating
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed
=680  \\$iPartial or total replacement of the CORNEA from one human or animal to another.
=688  \\$a90; was CORNEA/transplantation 1966-89; was heading 1963-65
=750  \0$aCornea$xTransplantation$5IEN$0(DLC)sh 85032802

=LDR  00321cz  a2200121n  4500
=001  9880364129602441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5791HS
=035  \\$a(DNLM)D008074Q000097
=040  \\$aDNLM$cDNLM
=150  \\$aLipoproteins$xblood
=750  \0$aBlood lipoproteins$5IEN$0(DLC)sh 85014996

=LDR  00309cz  a2200121n  4500
=001  9880364129702441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5783HS
=035  \\$a(DNLM)D008055Q000097
=040  \\$aDNLM$cDNLM
=150  \\$aLipids$xblood
=750  \0$aBlood lipids$5IEN$0(DLC)sh 85014995

=LDR  00402cz  a2200133n  4500
=001  9880364129802441
=005  20091120084041.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5721HS
=035  \\$a(DNLM)D007674Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aKidney Diseases$xveterinary
=750  \0$aVeterinary nephrology$0(DLC) sh 85143057$5IEN
=750  \0$aKidney diseases in animals$0(DLC)sh2008009730$5IEN-M

=LDR  00331cz  a2200121n  4500
=001  9880364129902441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5714HS
=035  \\$a(DNLM)D007657Q000378
=040  \\$aDNLM$cDNLM
=150  \\$aKetone Bodies$xmetabolism
=750  \0$aKetone body metabolism$5IEN$0(DLC)sh 85072094

=LDR  01178cz  a2200325n  4500
=001  9880364130002441
=005  20141212211343.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016038
=035  \\$aCBD0987HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x680.$x275.$x850
=072  \\$aE4.$x936.$x580.$x700
=150  \\$aSkin Transplantation
=450  \\$wnnna$aDermatoplasties
=450  \\$aDermatoplasty
=450  \\$aGrafting, Skin
=450  \\$wnnna$aGraftings, Skin
=450  \\$wnnna$aSkin Grafting
=450  \\$wnnna$aSkin Graftings
=450  \\$aSkin$xtransplantation
=450  \\$wnnna$aSkin Transplantations
=450  \\$aTransplantation, Skin
=450  \\$wnnna$aTransplantations, Skin
=550  \\$wg$aDermatologic Surgical Procedures
=550  \\$wg$aTissue Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed
=680  \\$iThe grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.
=688  \\$a90; was SKIN/transplantation 1966-89; was heading 1963-65
=750  \2$aSkin-grafting$5IEN

=LDR  00325cz  a2200121n  4500
=001  9880364130102441
=005  20101130123759.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5704HS
=035  \\$a(DNLM)D007501Q000172
=040  \\$aDNLM$cDNLM
=150  \\$aIron$xdeficiency
=750  \0$aIron deficiency diseases$0(DLC) sh 85068189$5IEN

=LDR  00328cz  a2200121n  4500
=001  9880364130202441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5701HS
=035  \\$a(DNLM)D007455Q000172
=040  \\$aDNLM$cDNLM
=150  \\$aIodine$xdeficiency
=750  \0$aIodine deficiency diseases$5IEN$0(DLC)sh 87000668

=LDR  00329cz  a2200121n  4500
=001  9880364130302441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5595HS
=035  \\$a(DNLM)D007246Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aInfertility$xveterinary
=750  \0$aInfertility in animals$5IEN$0(DLC)sh 85128024

=LDR  00479cz  a2200145n  4500
=001  9880364130402441
=005  20050131130534.0
=008  710101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\\
=035  \\$a(DNLM)D007154Q000662
=035  \\$aCBD5566HS
=040  \\$aDNLM$cDNLM
=150  \\$aImmune System Diseases$xveterinary
=450  \\$wnnoa$aImmunologic Diseases$xveterinary$5IEN-HS
=750  \0$aImmunologic diseases in animals$0(DLC) sh 88004348$5IEN-M
=750  \0$aVeterinary immunology$0(DLC) sh 85143040$5IEN-M

=LDR  00326cz  a2200121n  4500
=001  9880364130502441
=005  20120717143445.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5422HS
=035  \\$a(DNLM)D006761Q000656
=040  \\$aDNLM$cDNLM
=150  \\$aHospitals$xutilization
=750  \0$aHospital utilization$5IEN$0(DLC)sh 85062266

=LDR  00324cz  a2200121n  4500
=001  9880364130602441
=005  20120717143444.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5390HS
=035  \\$a(DNLM)D006728Q000627
=040  \\$aDNLM$cDNLM
=150  \\$aHormones$xtherapeutic use
=750  \0$aHormone therapy$5IEN$0(DLC)sh 85061979

=LDR  00351cz  a2200121n  4500
=001  9880364130702441
=005  20120717143444.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5331HS
=035  \\$a(DNLM)D006566Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aHerpesviridae Infections$xveterinary
=750  \0$aHerpesvirus diseases in animals$5IEN$0(DLC)sh 85060460

=LDR  01155cz  a2200301n  4500
=001  9880364130802441
=005  20141212211342.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016035
=035  \\$aCBD0984HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x725
=072  \\$aE4.$x936.$x450.$x650
=150  \\$aPancreas Transplantation
=450  \\$aGrafting, Pancreas
=450  \\$wnnna$aGraftings, Pancreas
=450  \\$wnnna$aPancreas Grafting
=450  \\$wnnna$aPancreas Graftings
=450  \\$aPancreas$xtransplantation
=450  \\$wnnna$aPancreas Transplantations
=450  \\$aTransplantation, Pancreas
=450  \\$wnnna$aTransplantations, Pancreas
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wg$aOrgan Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; in therapy of diabetes mellitus, ISLETS OF LANGERHANS TRANSPLANTATION is probably the correct term
=680  \\$iThe transference of a pancreas from one human or animal to another.
=688  \\$a90; was PANCREAS/transplantation 1966-89
=750  \0$aPancreas$xTransplantation$5IEN

=LDR  00337cz  a2200121n  4500
=001  9880364130902441
=005  20120717143444.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5281HS
=035  \\$a(DNLM)D006402Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aHematologic Diseases$xveterinary
=750  \0$aVeterinary hematology$5IEN$0(DLC)sh 85143035

=LDR  01313cz  a2200373n  4500
=001  9880364131002441
=005  20141212211341.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016031
=035  \\$aCBD0981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x650
=072  \\$aE4.$x936.$x450.$x490
=072  \\$aE4.$x936.$x580.$x490
=150  \\$aLiver Transplantation
=450  \\$aGrafting, Liver
=450  \\$wnnna$aGraftings, Liver
=450  \\$aHepatic Transplantation
=450  \\$wnnna$aHepatic Transplantations
=450  \\$wnnna$aLiver Grafting
=450  \\$wnnna$aLiver Graftings
=450  \\$aLiver$xtransplantation
=450  \\$wnnna$aLiver Transplantations
=450  \\$aTransplantation, Hepatic
=450  \\$aTransplantation, Liver
=450  \\$wnnna$aTransplantations, Hepatic
=450  \\$wnnna$aTransplantations, Liver
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$wg$aOrgan Transplantation
=550  \\$wg$aTissue Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed
=680  \\$iThe transference of a part of or an entire liver from one human or animal to another.
=688  \\$a90; was LIVER/transplantation 1966-89
=750  \0$aLiver$xTransplantation$5IEN$0(DLC)sh 85077768

=LDR  00412cz  a2200133n  4500
=001  9880364131102441
=005  20120717143444.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D006358Q000627
=035  \\$aCBD5259HS
=040  \\$aDNLM$cDNLM
=150  \\$aHot Temperature$xtherapeutic use
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Heat _{dollar}x therapeutic use
=750  \0$aThermotherapy$5IEN$0(DLC)sh 85134823

=LDR  00331cz  a2200121n  4500
=001  9880364131202441
=005  20120717143444.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5253HS
=035  \\$a(DNLM)D006331Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aHeart Diseases$xveterinary
=750  \0$aVeterinary cardiology$5IEN$0(DLC)sh 85143011

=LDR  00333cz  a2200121n  4500
=001  9880364131302441
=005  20120717143444.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5143HS
=035  \\$a(DNLM)D005836Q000473
=040  \\$aDNLM$cDNLM
=150  \\$aGenitalia, Female$xpathology
=750  \0$aGynecologic pathology$5IEN$0(DLC)sh 85098690

=LDR  00386cz  a2200133n  4500
=001  9880364131402441
=005  20120717143444.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD5134HS
=035  \\$a(DNLM)D005831Q000473
=040  \\$aDNLM$cDNLM
=150  \\$aGenital Diseases, Female$xpathology
=450  \\$aPathology, Gynecological$5IEN
=750  \0$aGynecologic pathology$5IEN$0(DLC)sh 85098690

=LDR  01234cz  a2200349n  4500
=001  9880364131502441
=005  20141212211340.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016030
=035  \\$aCBD0980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x870.$x500
=072  \\$aE4.$x936.$x450.$x485
=072  \\$aE4.$x950.$x774.$x400
=150  \\$aKidney Transplantation
=450  \\$aGrafting, Kidney
=450  \\$wnnna$aKidney Grafting
=450  \\$aKidney$xtransplantation
=450  \\$wnnna$aKidney Transplantations
=450  \\$aRenal Transplantation
=450  \\$wnnna$aRenal Transplantations
=450  \\$aTransplantation, Kidney
=450  \\$aTransplantation, Renal
=450  \\$wnnna$aTransplantations, Kidney
=450  \\$wnnna$aTransplantations, Renal
=550  \\$wg$aOrgan Transplantation
=550  \\$wg$aRenal Replacement Therapy
=550  \\$wg$aUrologic Surgical Procedures
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed
=680  \\$iThe transference of a kidney from one human or animal to another.
=688  \\$a90; was KIDNEY/transplantation 1966-89; was heading 1963-65
=750  \0$aKidneys$xTransplantation$5IEN$0(DLC)sh 85072273

=LDR  01383cz  a2200385n  4500
=001  9880364131602441
=005  20141212211339.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016027
=035  \\$aCBD0977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x475
=072  \\$aE4.$x928.$x220.$x390
=072  \\$aE4.$x936.$x450.$x475
=150  \\$aHeart Transplantation
=450  \\$aCardiac Transplantation
=450  \\$wnnna$aCardiac Transplantations
=450  \\$aGrafting, Heart
=450  \\$wnnna$aGraftings, Heart
=450  \\$wnnna$aHeart Grafting
=450  \\$wnnna$aHeart Graftings
=450  \\$aHeart$xtransplantation
=450  \\$wnnna$aHeart Transplantations
=450  \\$aMyocardium$xtransplantation
=450  \\$aTransplantation, Cardiac
=450  \\$aTransplantation, Heart
=450  \\$wnnna$aTransplantations, Cardiac
=450  \\$wnnna$aTransplantations, Heart
=550  \\$wg$aCardiac Surgical Procedures
=550  \\$wg$aOrgan Transplantation
=550  \\$wh$aHeart-Lung Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; HEART-LUNG TRANSPLANTATION is also available
=680  \\$iThe transference of a heart from one human or animal to another.
=688  \\$a90; was HEART/transplantation 1966-89
=750  \0$aHeart$xTransplantation$5IEN$0(DLC)sh 85059721

=LDR  00377cz  a2200133n  4500
=001  9880364131702441
=005  20120717143444.0
=008  650101\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBD5133HS
=035  \\$a(DNLM)D005831Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aGenital Diseases, Female$xnursing
=450  \\$aGynecologic Nursing$5IEN
=750  \0$aGynecologic nursing$5IEN$0(DLC)sh 85058087

=LDR  01346cz  a2200289n  4500
=001  9880364131802441
=005  20141212211338.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016026
=035  \\$aCBD0976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x580.$x40
=150  \\$aBone Marrow Transplantation
=450  \\$aBone Marrow Cell Transplantation
=450  \\$aBone Marrow Cells$xtransplantation
=450  \\$wnnna$aBone Marrow Grafting
=450  \\$aBone Marrow$xtransplantation
=450  \\$aGrafting, Bone Marrow
=450  \\$aTransplantation, Bone Marrow
=450  \\$aTransplantation, Bone Marrow Cell
=550  \\$wg$aTissue Transplantation
=550  \\$aBone Marrow Purging
=550  \\$aHematopoietic Stem Cell Transplantation
=667  \\$ado not coordinate with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; coordinate with disease / surg; conditioning before transplantation of bone marrow: coordinate IM with TRANSPLANTATION CONDITIONING (IM)
=680  \\$iThe transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.
=688  \\$a90; was BONE MARROW/transplantation 1966-89; was heading 1964-65
=750  \0$aBone marrow$xTransplantation$5IEN$0(DLC)sh 85081543

=LDR  00348cz  a2200121n  4500
=001  9880364131902441
=005  20120717143443.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5110HS
=035  \\$a(DNLM)D005767Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aGastrointestinal Diseases$xveterinary
=750  \0$aVeterinary gastroenterology$5IEN$0(DLC)sh 85143030

=LDR  00320cz  a2200121n  4500
=001  9880364132002441
=005  20120717143443.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5082HS
=035  \\$a(DNLM)D005658Q000472
=040  \\$aDNLM$cDNLM
=150  \\$aFungi$xpathogenicity
=750  \0$aPathogenic fungi$5IEN$0(DLC)sh 85052464

=LDR  00999cz  a2200265n  4500
=001  9880364132102441
=005  20141212211337.0
=008  890906\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016025
=035  \\$aCBD0975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x130
=072  \\$aE4.$x936.$x580.$x52
=150  \\$aBone Transplantation
=450  \\$aBone and Bones$xtransplantation
=450  \\$wnnna$aBone Grafting
=450  \\$aGrafting, Bone
=450  \\$aTransplantation, Bone
=550  \\$wg$aOrthopedic Procedures
=550  \\$wg$aTissue Transplantation
=550  \\$wh$aSinus Floor Augmentation
=667  \\$amay refer to a whole bone or a segment of bone; do not coordinate with TRANSPLANTATION, AUTOLOGOUS or TRANSPLANTATION, HETEROTOPIC unless particularly discussed
=680  \\$iThe grafting of bone from a donor site to a recipient site.
=688  \\$a90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65
=750  \0$aBone-grafting$5IEN$0(DLC)sh 85015521

=LDR  01721cz  a2200277n  4500
=001  9880364132202441
=005  20141212211336.0
=008  890707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016023
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x408
=150  \\$aIntegrins
=550  \\$wg$aReceptors, Immunologic
=550  \\$wh$aIntegrin alpha Chains
=550  \\$wh$aIntegrin beta Chains
=550  \\$wh$aReceptors, Cytoadhesin
=550  \\$wh$aReceptors, Fibrinogen
=550  \\$wh$aReceptors, Fibronectin
=550  \\$wh$aReceptors, Leukocyte-Adhesion
=550  \\$wh$aReceptors, Very Late Antigen
=550  \\$wh$aReceptors, Vitronectin
=550  \\$aCell Adhesion Molecules
=667  \\$aprefer specifics
=680  \\$iA family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.
=688  \\$a90
=750  \0$aIntegrins$5IEN-M$0(DLC)sh 94001109

=LDR  00326cz  a2200121n  4500
=001  9880364132302441
=005  20120717143443.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5027HS
=035  \\$a(DNLM)D005392Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aFirst Aid$xveterinary
=750  \0$aFirst aid for animals$5IEN$0(DLC)sh 85048580

=LDR  00326cz  a2200121n  4500
=001  9880364132402441
=005  20120717143443.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD5024HS
=035  \\$a(DNLM)D005390Q000517
=040  \\$aDNLM$cDNLM
=150  \\$aFires$xprevention & control
=750  \0$aFire prevention$5IEN$0(DLC)sh 85048509

=LDR  00337cz  a2200121n  4500
=001  9880364132502441
=005  20120717143443.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBD4318HS
=035  \\$a(DNLM)D005131Q000628
=040  \\$aDNLM$cDNLM
=150  \\$aEye Injuries$xtherapy
=750  \0$aTherapeutics, Ophthalmological$5IEN-M$0(DLC)sh 85134728

=LDR  03060cz  a2200769n  4500
=001  9880364132602441
=005  20141212211336.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016022
=035  \\$aCBD0972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x760.$x500.$x500
=072  \\$aN5.$x715.$x360.$x775.$x175.$x200
=072  \\$aN6.$x850.$x520.$x450.$x500.$x500
=150  \\$aCase-Control Studies
=450  \\$aCase-Base Studies
=450  \\$wnnna$aCase Base Studies
=450  \\$wnnna$aCase-Base Study
=450  \\$aCase-Comparison Studies
=450  \\$wnnna$aCase Comparison Studies
=450  \\$wnnna$aCase-Comparison Study
=450  \\$wnnna$aCase-Compeer Studies
=450  \\$wnnna$aCase Compeer Studies
=450  \\$wnnna$aCase-Compeer Study
=450  \\$wnnna$aCase Control Studies
=450  \\$wnnna$aCase-Control Studies, Matched
=450  \\$wnnna$aCase-Control Studies, Nested
=450  \\$wnnna$aCase Control Study
=450  \\$wnnna$aCase-Control Study
=450  \\$wnnna$aCase-Control Study, Matched
=450  \\$wnnna$aCase-Control Study, Nested
=450  \\$aCase-Referent Studies
=450  \\$wnnna$aCase Referent Studies
=450  \\$wnnna$aCase-Referent Study
=450  \\$wnnna$aCase-Referrent Studies
=450  \\$wnnna$aCase Referrent Studies
=450  \\$wnnna$aCase-Referrent Study
=450  \\$aMatched Case-Control Studies
=450  \\$wnnna$aMatched Case Control Studies
=450  \\$wnnna$aMatched Case-Control Study
=450  \\$aNested Case-Control Studies
=450  \\$wnnna$aNested Case Control Studies
=450  \\$wnnna$aNested Case-Control Study
=450  \\$wnnna$aStudies, Case-Base
=450  \\$wnnna$aStudies, Case-Comparison
=450  \\$wnnna$aStudies, Case-Compeer
=450  \\$wnnna$aStudies, Case Control
=450  \\$wnnna$aStudies, Case-Control
=450  \\$wnnna$aStudies, Case-Referent
=450  \\$wnnna$aStudies, Case-Referrent
=450  \\$wnnna$aStudies, Matched Case-Control
=450  \\$wnnna$aStudies, Nested Case-Control
=450  \\$wnnna$aStudy, Case-Base
=450  \\$wnnna$aStudy, Case-Comparison
=450  \\$wnnna$aStudy, Case-Compeer
=450  \\$wnnna$aStudy, Case Control
=450  \\$wnnna$aStudy, Case-Control
=450  \\$wnnna$aStudy, Case-Referent
=450  \\$wnnna$aStudy, Case-Referrent
=450  \\$wnnna$aStudy, Matched Case-Control
=450  \\$wnnna$aStudy, Nested Case-Control
=550  \\$wg$aEpidemiologic Studies
=550  \\$wh$aRetrospective Studies
=667  \\$aIM GEN only; coord NIM with specific disease (IM); no qualif; specify geog if pertinent
=680  \\$iStudies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
=688  \\$a90
=750  \0$aCase-control method$0(DLC)sh2008007460$5IEN-M

=LDR  01237cz  a2200277n  4500
=001  9880364132702441
=005  20141212211334.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016019
=035  \\$aCBD0969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x998
=072  \\$aN5.$x715.$x360.$x750.$x795
=072  \\$aN6.$x850.$x520.$x830.$x998
=150  \\$aSurvival Analysis
=450  \\$wnnna$aAnalyses, Survival
=450  \\$wnnna$aAnalysis, Survival
=450  \\$wnnna$aSurvival Analyses
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aDisease-Free Survival
=550  \\$wh$aKaplan-Meier Estimate
=550  \\$wh$aProportional Hazards Models
=667  \\$aIM GEN only; coord NIM with specific disease (IM); DF: SURVIVAL ANAL
=680  \\$iA class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
=688  \\$a90
=750  \0$aSurvival analysis (Biometry)$5IEN$0(DLC)sh 90003967

=LDR  01226cz  a2200289n  4500
=001  9880364132802441
=005  20141212211333.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016018
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x750.$x400
=072  \\$aN5.$x715.$x360.$x750.$x695.$x440
=072  \\$aN6.$x850.$x520.$x830.$x750.$x400
=150  \\$aLeast-Squares Analysis
=450  \\$wnnna$aAnalyses, Least-Squares
=450  \\$wnnna$aAnalysis, Least-Squares
=450  \\$wnnna$aAnalysis, Least Squares
=450  \\$wnnna$aLeast Squares
=450  \\$wnnna$aLeast-Squares Analyses
=450  \\$wnnna$aLeast Squares Analysis
=450  \\$wnnna$aRefinement, Rietveld
=450  \\$aRietveld Refinement
=550  \\$wg$aRegression Analysis
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM);
=680  \\$iA principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model.
=688  \\$a91(90); was see under REGRESSION ANALYSIS 1990
=750  \0$aLeast squares$5IEN$0(DLC)sh 85075570

=LDR  02324cz  a2200625n  4500
=001  9880364132902441
=005  20141212211332.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016016
=035  \\$aCBD0966M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x500.$x700
=072  \\$aE5.$x318.$x740.$x600.$x700
=072  \\$aE5.$x318.$x740.$x750.$x725
=072  \\$aE5.$x318.$x740.$x998.$x825
=072  \\$aE5.$x599.$x835.$x900
=072  \\$aN5.$x715.$x360.$x750.$x530.$x650
=072  \\$aN5.$x715.$x360.$x750.$x625.$x650
=072  \\$aN5.$x715.$x360.$x750.$x695.$x650
=072  \\$aN5.$x715.$x360.$x750.$x795.$x825
=072  \\$aN6.$x850.$x520.$x830.$x500.$x700
=072  \\$aN6.$x850.$x520.$x830.$x600.$x700
=072  \\$aN6.$x850.$x520.$x830.$x750.$x725
=150  \\$aProportional Hazards Models
=450  \\$wnnna$aCox Models
=450  \\$wnnna$aCox Proportional Hazards Models
=450  \\$wnnna$aHazard Model
=450  \\$wnnna$aHazard Model, Proportional
=450  \\$wnnna$aHazard Models
=450  \\$wnnna$aHazard Models, Proportional
=450  \\$wnnna$aHazards Model
=450  \\$wnnna$aHazards Model, Proportional
=450  \\$aHazards Models
=450  \\$wnnna$aHazards Models, Proportional
=450  \\$wnnna$aModel, Hazard
=450  \\$wnnna$aModel, Hazards
=450  \\$wnnna$aModel, Proportional Hazard
=450  \\$wnnna$aModel, Proportional Hazards
=450  \\$wnnna$aModels, Cox
=450  \\$wnnna$aModels, Hazard
=450  \\$wnnna$aModels, Hazards
=450  \\$wnnna$aModels, Proportional Hazard
=450  \\$aModels, Proportional Hazards
=450  \\$wnnna$aProportional Hazard Model
=450  \\$wnnna$aProportional Hazard Models
=450  \\$wnnna$aProportional Hazards Model
=550  \\$wg$aModels, Statistical
=550  \\$wg$aProbability
=550  \\$wg$aRegression Analysis
=550  \\$wg$aSurvival Analysis
=550  \\$aSurvival Analysis
=667  \\$aIM general only; coordinate NIM with specific subject / statist (IM)
=680  \\$iStatistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
=688  \\$a90
=750  \2$aProportional hazards models$0(DLC)sh2008003951$5IEN-M

=LDR  01779cz  a2200445n  4500
=001  9880364133002441
=005  20141212211332.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016015
=035  \\$aCBD0965HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x500.$x525
=072  \\$aE5.$x318.$x740.$x600.$x800.$x450
=072  \\$aE5.$x318.$x740.$x750.$x450
=072  \\$aE5.$x599.$x835.$x875
=072  \\$aN5.$x715.$x360.$x750.$x530.$x480
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700.$x450
=072  \\$aN5.$x715.$x360.$x750.$x695.$x470
=072  \\$aN6.$x850.$x520.$x830.$x500.$x525
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800.$x450
=072  \\$aN6.$x850.$x520.$x830.$x750.$x450
=150  \\$aLogistic Models
=450  \\$wnnna$aLogistic Model
=450  \\$aLogistic Regression
=450  \\$wnnna$aLogistic Regressions
=450  \\$wnnna$aLogit Model
=450  \\$aLogit Models
=450  \\$wnnna$aModel, Logistic
=450  \\$wnnna$aModel, Logit
=450  \\$aModels, Logistic
=450  \\$wnnna$aModels, Logit
=450  \\$wnnna$aRegression, Logistic
=450  \\$wnnna$aRegressions, Logistic
=550  \\$wg$aModels, Statistical
=550  \\$wg$aRegression Analysis
=550  \\$wg$aRisk
=667  \\$aIM GEN only; coord NIM with specific subject /statist (IM); no qualif
=680  \\$iStatistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
=688  \\$a90
=750  \0$aLogits$5IEN$0(DLC)sh 85078131

=LDR  01534cz  a2200409n  4500
=001  9880364133102441
=005  20141212211331.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016014
=035  \\$aCBD0964HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x500.$x500
=072  \\$aE5.$x318.$x740.$x750.$x425
=072  \\$aE5.$x599.$x835.$x750
=072  \\$aN5.$x715.$x360.$x750.$x530.$x460
=072  \\$aN5.$x715.$x360.$x750.$x695.$x460
=072  \\$aN6.$x850.$x520.$x830.$x500.$x500
=072  \\$aN6.$x850.$x520.$x830.$x750.$x425
=150  \\$aLinear Models
=450  \\$wnnna$aLinear Model
=450  \\$aLinear Regression
=450  \\$wnnna$aLinear Regressions
=450  \\$wnnna$aLog-Linear Model
=450  \\$aLog-Linear Models
=450  \\$wnnna$aLog Linear Models
=450  \\$wnnna$aModel, Linear
=450  \\$wnnna$aModel, Log-Linear
=450  \\$aModels, Linear
=450  \\$wnnna$aModels, Log-Linear
=450  \\$wnnna$aRegression, Linear
=450  \\$wnnna$aRegressions, Linear
=550  \\$wg$aModels, Statistical
=550  \\$wg$aRegression Analysis
=667  \\$aIM GEN only; coord NIM with specific subject /statist (IM); no qualif
=680  \\$iStatistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
=688  \\$a90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93
=750  \0$aLinear models (Statistics)$5IEN$0(DLC)sh 85077177

=LDR  00968cz  a2200229n  4500
=001  9880364133202441
=005  20141212211330.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016012
=035  \\$aCBD0962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x994.$x750
=072  \\$aG17.$x820.$x750
=072  \\$aN5.$x715.$x360.$x750.$x750.$x620
=072  \\$aN6.$x850.$x520.$x830.$x994.$x750
=150  \\$aPoisson Distribution
=450  \\$wnnna$aDistribution, Poisson
=550  \\$wg$aStatistical Distributions
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iA distribution function used to describe the occurrence of rare events or to describe the sampling distribution of isolated counts in a continuum of time or space.
=688  \\$a90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78
=750  \0$aPoisson distribution$5IEN$0(DLC)sh 85103956

=LDR  01191cz  a2200277n  4500
=001  9880364133302441
=005  20141212211330.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016011
=035  \\$aCBD0961HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x994.$x500
=072  \\$aG17.$x820.$x500
=072  \\$aN5.$x715.$x360.$x750.$x750.$x565
=072  \\$aN6.$x850.$x520.$x830.$x994.$x500
=150  \\$aNormal Distribution
=450  \\$wnnna$aDistribution, Gaussian
=450  \\$wnnna$aDistribution, Normal
=450  \\$wnnna$aDistributions, Normal
=450  \\$aGaussian Distribution
=450  \\$wnnna$aNormal Distributions
=550  \\$wg$aStatistical Distributions
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iContinuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.
=688  \\$a90
=750  \0$aGaussian distribution$5IEN$0(DLC)sh 85053556

=LDR  01450cz  a2200349n  4500
=001  9880364133402441
=005  20141212211330.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016010
=035  \\$aCBD0960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x994.$x250
=072  \\$aG17.$x820.$x250
=072  \\$aN5.$x715.$x360.$x750.$x750.$x150
=072  \\$aN6.$x850.$x520.$x830.$x994.$x250
=150  \\$aBinomial Distribution
=450  \\$aBernoulli Distribution
=450  \\$wnnna$aBinomial Distribution, Negative
=450  \\$wnnna$aBinomial Distributions
=450  \\$wnnna$aBinomial Distributions, Negative
=450  \\$wnnna$aDistribution, Bernoulli
=450  \\$wnnna$aDistribution, Binomial
=450  \\$wnnna$aDistribution, Negative Binomial
=450  \\$wnnna$aDistributions, Binomial
=450  \\$wnnna$aDistributions, Negative Binomial
=450  \\$aNegative Binomial Distribution
=450  \\$wnnna$aNegative Binomial Distributions
=550  \\$wg$aStatistical Distributions
=667  \\$aIM GEN only, coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iThe probability distribution associated with two mutually exclusive outcomes; used to model cumulative incidence rates and prevalence rates. The Bernoulli distribution is a special case of binomial distribution.
=688  \\$a90
=750  \0$aBinomial distribution$5IEN$0(DLC)sh 85014113

=LDR  01496cz  a2200325n  4500
=001  9880364133502441
=005  20141212211329.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016009
=035  \\$aCBD0959HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x994.$x300
=072  \\$aG17.$x820.$x300
=072  \\$aN5.$x715.$x360.$x750.$x750.$x200
=072  \\$aN6.$x850.$x520.$x830.$x994.$x300
=150  \\$aChi-Square Distribution
=450  \\$wnnna$aChi Square Distribution
=450  \\$wnnna$aChi-Square Distributions
=450  \\$aChi-Square Test
=450  \\$wnnna$aChi Square Test
=450  \\$wnnna$aChi-Square Tests
=450  \\$wnnna$aDistribution, Chi-Square
=450  \\$wnnna$aDistributions, Chi-Square
=450  \\$wnnna$aTest, Chi-Square
=450  \\$wnnna$aTests, Chi-Square
=550  \\$wg$aStatistical Distributions
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iA distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.
=688  \\$a90
=750  \0$aChi-square test$5IEN$0(DLC)sh 85023209

=LDR  01507cz  a2200313n  4500
=001  9880364133602441
=005  20141212211329.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016008
=035  \\$aCBD0958HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x994
=072  \\$aG17.$x820
=072  \\$aN5.$x715.$x360.$x750.$x750
=072  \\$aN6.$x850.$x520.$x830.$x994
=150  \\$aStatistical Distributions
=450  \\$wnnna$aDistribution, Statistical
=450  \\$wnnna$aDistributions, Statistical
=450  \\$wnnna$aStatistical Distribution
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aBinomial Distribution
=550  \\$wh$aChi-Square Distribution
=550  \\$wh$aNormal Distribution
=550  \\$wh$aPoisson Distribution
=667  \\$ahow many or what proportion of a group has a given value: read MeSH definition; GEN or unspecified: prefer specifics; IM; coord with subject of data /epidemiol or /statist (IM); DF: STATIST DISTRIBUTIONS
=680  \\$iThe complete summaries of the frequencies of the values or categories of a measurement made on a group of items, a population, or other collection of data. The distribution tells either how many or what proportion of the group was found to have each value (or each range of values) out of all the possible values that the quantitative measure can have.
=688  \\$a98; use explode 1990-97
=750  \0$aDistribution (Probability theory)$5IEN-M$0(DLC)sh 85038545

=LDR  00952cz  a2200241n  4500
=001  9880364133702441
=005  20141212211328.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016002
=035  \\$aCBD0952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x350
=072  \\$aN5.$x715.$x360.$x750.$x325
=072  \\$aN6.$x850.$x520.$x830.$x350
=150  \\$aDiscriminant Analysis
=450  \\$wnnna$aAnalyses, Discriminant
=450  \\$wnnna$aAnalysis, Discriminant
=450  \\$wnnna$aDiscriminant Analyses
=550  \\$wg$aStatistics as Topic
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis.
=688  \\$a90
=750  \0$aDiscriminant analysis$5IEN$0(DLC)sh 85038374

=LDR  00941cz  a2200241n  4500
=001  9880364133802441
=005  20141212211328.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016001
=035  \\$aCBD0951HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x275
=072  \\$aN5.$x715.$x360.$x750.$x220
=072  \\$aN6.$x850.$x520.$x830.$x275
=150  \\$aConfidence Intervals
=450  \\$wnnna$aConfidence Interval
=450  \\$wnnna$aInterval, Confidence
=450  \\$wnnna$aIntervals, Confidence
=550  \\$wg$aStatistics as Topic
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.
=688  \\$a91(90); was see under STATISTICS 1990
=750  \0$aConfidence intervals$5IEN$0(DLC)sh 85030927

=LDR  01402cz  a2200337n  4500
=001  9880364133902441
=005  20141212211328.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016000
=035  \\$aCBD0950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x250
=072  \\$aN5.$x715.$x360.$x750.$x200
=072  \\$aN6.$x850.$x520.$x830.$x250
=150  \\$aCluster Analysis
=450  \\$wnnna$aAnalyses, Cluster
=450  \\$wnnna$aAnalysis, Cluster
=450  \\$wnnna$aCluster Analyses
=450  \\$aClustering
=450  \\$wnnna$aClustering, Disease
=450  \\$wnnna$aClusterings
=450  \\$wnnna$aClusterings, Disease
=450  \\$wnnna$aDisease Clustering
=450  \\$wnnna$aDisease Clusterings
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aSmall-Area Analysis
=550  \\$wh$aSpace-Time Clustering
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both.
=688  \\$a90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89
=750  \0$aCluster analysis$5IEN$0(DLC)sh 85027250

=LDR  01005cz  a2200241n  4500
=001  9880364134002441
=005  20141212211327.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015999
=035  \\$aCBD0949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x150.$x500
=072  \\$aN5.$x715.$x360.$x750.$x125.$x500
=072  \\$aN6.$x850.$x520.$x830.$x150.$x500
=150  \\$aMultivariate Analysis
=450  \\$wnnna$aAnalyses, Multivariate
=450  \\$wnnna$aAnalysis, Multivariate
=450  \\$wnnna$aMultivariate Analyses
=550  \\$wg$aAnalysis of Variance
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif
=680  \\$iA set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
=688  \\$a90
=750  \0$aMultivariate analysis$5IEN$0(DLC)sh 85088390

=LDR  01808cz  a2200493n  4500
=001  9880364134102441
=005  20141212211325.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015993
=035  \\$aCBD0943HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x475
=072  \\$aE5.$x318.$x740.$x100.$x500
=072  \\$aL1.$x280.$x975.$x475
=072  \\$aN1.$x224.$x935.$x530
=072  \\$aN6.$x850.$x505.$x400.$x975.$x475
=072  \\$aN6.$x850.$x520.$x308.$x985.$x475
=150  \\$aLife Tables
=450  \\$wnnna$aAnalyses, Life Table
=450  \\$wnnna$aAnalysis, Life Table
=450  \\$wnnna$aEstimate, Life Table
=450  \\$wnnna$aEstimates, Life Table
=450  \\$wnnna$aLife Table
=450  \\$wnnna$aLife Table Analyses
=450  \\$aLife Table Analysis
=450  \\$wnnna$aLife Table Estimate
=450  \\$wnnna$aLife Table Estimates
=450  \\$wnnna$aLife Table Method
=450  \\$aLife Table Methods
=450  \\$wnnna$aLife Table Model
=450  \\$aLife Table Models
=450  \\$wnnna$aMethod, Life Table
=450  \\$wnnna$aMethods, Life Table
=450  \\$wnnna$aModel, Life Table
=450  \\$wnnna$aModels, Life Table
=450  \\$aMortality,$xtables$5IEN
=450  \\$wnnna$aTables, Life
=550  \\$wg$aActuarial Analysis
=550  \\$wg$aVital Statistics
=550  \\$wh$aQuality-Adjusted Life Years
=667  \\$aIM; no qualif
=680  \\$iSummarizing techniques used to describe the pattern of mortality and survival in populations. These methods can be applied to the study not only of death, but also of any defined endpoint such as the onset of disease or the occurrence of disease complications.
=688  \\$a90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89
=750  \0$aMortality$xTables$5IEN

=LDR  01232cz  a2200277n  4500
=001  9880364134202441
=005  20141212211324.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015992
=035  \\$aCBD0942M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x115.$x100.$x125
=072  \\$aE5.$x41.$x124.$x125
=072  \\$aG7.$x100.$x100.$x125
=072  \\$aN6.$x850.$x505.$x200.$x100.$x175
=150  \\$aBody Mass Index
=450  \\$wnnna$aIndex, Body Mass
=450  \\$wnnna$aIndex, Quetelet
=450  \\$aQuetelet Index
=450  \\$wnnna$aQuetelet's Index
=450  \\$wnnna$aQuetelets Index
=550  \\$wg$aAnthropometry
=550  \\$wg$aBody Weights and Measures
=680  \\$iAn indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
=688  \\$a90
=750  \0$aBody mass index$0(DLC)sh2005007672$5IEN-M

=LDR  01132cz  a2200277n  4500
=001  9880364134302441
=005  20141212211318.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015978
=035  \\$aCBD0928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x710.$x500.$x500
=150  \\$aTrichosanthin
=450  \\$aalpha-Trichosanthin
=450  \\$wnnna$aalpha Trichosanthin
=450  \\$aCompound Q
=450  \\$wnnna$aGLQ-223
=450  \\$wnnna$aGLQ 223
=450  \\$wnnna$aGLQ223
=450  \\$wnnna$aTian-hua-fen
=450  \\$wnnna$aT'ien-hua-fen
=550  \\$wg$aRibosome Inactivating Proteins, Type 1
=667  \\$a/drug eff /ultrastruct permitted
=680  \\$iPlant-derived ribosome-inactivating protein (RIP) purified from the Chinese medicinal herb tian-hua-fen which is obtained from the root tubers of Trichosanthes kirilowii. It has been used as an abortifacient and in the treatment of trophoblastic tumors. GLQ223 (Compound Q), a highly purified form of trichosanthin, has been proposed as antiviral treatment for AIDS.
=688  \\$a90
=750  \0$aTrichosanthin$5IEN$0(DLC)sh 90002864

=LDR  00899cz  a2200277n  4500
=001  9880364134402441
=005  20141212211317.0
=008  890705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015974
=035  \\$aCBD0925HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x963
=072  \\$aN3.$x706.$x535.$x803
=150  \\$aWrongful Life
=450  \\$wnnna$aBirth, Wrongful
=450  \\$wnnna$aBirths, Wrongful
=450  \\$wnnna$aLife, Wrongful
=450  \\$wnnna$aLives, Wrongful
=450  \\$aWrongful Birth
=450  \\$wnnna$aWrongful Births
=450  \\$wnnna$aWrongful Lives
=550  \\$wg$aJurisprudence
=667  \\$alegal action alleging "that a defendant has wrongfully caused a child to be born"
=680  \\$iIn civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born.
=688  \\$a90
=750  \0$aWrongful birth$5IEN

=LDR  00819cz  a2200205n  4500
=001  9880364134502441
=005  20141212211316.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x315.$x330
=150  \\$aGene Expression Regulation, Fungal
=450  \\$aFungal Gene Expression Regulation
=450  \\$wnnna$aRegulation, Gene Expression, Fungal
=450  \\$aRegulation of Gene Expression, Fungal
=550  \\$wg$aGene Expression Regulation
=667  \\$acoord IM with specific fungus /genet (IM); DF: GENE EXPRESSION REG FUNGAL
=680  \\$iAny of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.
=688  \\$a90
=750  \0$aFungal gene expression$5IEN$0(DLC)sh 92001544

=LDR  01509cz  a2200301n  4500
=001  9880364134602441
=005  20141212211314.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015946
=035  \\$aCBD0913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x368.$x225
=150  \\$aEthylene Dibromide
=450  \\$a1,2-Dibromoethane
=450  \\$wnnna$a1,2 Dibromoethane
=450  \\$wnnna$aBromide, Ethylene
=450  \\$wnnna$aDibromide, Ethylene
=450  \\$wnnna$aDibromides, Ethylene
=450  \\$wnnna$aDowfume W 85
=450  \\$wnnna$aDowfume W85
=450  \\$wnnna$aEthylene Bromide
=450  \\$wnnna$aEthylene Dibromides
=450  \\$wnnna$asym-Dibromoethane
=450  \\$wnnna$asym Dibromoethane
=550  \\$wg$aHydrocarbons, Brominated
=680  \\$iAn effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.
=688  \\$a90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90
=750  \0$aEthylene dibromide$5IEN$0(DLC)sh 85045437

=LDR  00797cz  a2200241n  4500
=001  9880364134702441
=005  20160913105723.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015931
=035  \\$aCBD0899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x190.$x405
=072  \\$aN2.$x421.$x585.$x190.$x500
=150  \\$aIntensive Care, Neonatal
=450  \\$wnnna$aCare, Neonatal Intensive
=450  \\$aInfant, Newborn, Intensive Care
=450  \\$aNeonatal Intensive Care
=550  \\$wg$aCritical Care
=550  \\$aInfant Care
=667  \\$acheck also tags HUMANS & INFANT, NEWBORN
=680  \\$iContinuous care and monitoring of newborn infants with life-threatening conditions, in any setting.
=688  \\$a90
=750  \0$aNeonatal intensive care$5IEN$0(DLC)sh 85090799

=LDR  01395cz  a2200361n  4500
=001  9880364134902441
=005  20141212211307.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015925
=035  \\$aCBD0894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x760.$x160
=072  \\$aE1.$x370.$x225.$x750.$x600.$x760.$x160
=072  \\$aE2.$x792.$x156
=072  \\$aE5.$x200.$x500.$x620.$x760.$x160
=072  \\$aE5.$x200.$x750.$x600.$x760.$x160
=072  \\$aE5.$x760.$x156
=150  \\$aCryopreservation
=450  \\$aCryofixation
=450  \\$wnnna$aCryonic Suspension
=450  \\$wnnna$aCryonic Suspensions
=450  \\$wnnna$aSuspension, Cryonic
=450  \\$wnnna$aSuspensions, Cryonic
=550  \\$wg$aPreservation, Biological
=550  \\$wg$aTissue Preservation
=550  \\$wh$aFreeze Drying
=550  \\$aCold Temperature
=550  \\$aFreezing
=550  \\$aVitrification
=667  \\$acoordinate IM with specific organ, tissue or cell heading (IM with no qualifiers)
=680  \\$iPreservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens.
=688  \\$a90
=750  \0$aCryopreservation of organs, tissues, etc.$5IEN$0(DLC)sh 85034422

=LDR  01189cz  a2200337n  4500
=001  9880364135002441
=005  20141212211303.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015917
=035  \\$aCBD0886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x610
=150  \\$aPenile Prosthesis
=450  \\$aArtificial Penis
=450  \\$wnnna$aImplant, Penile
=450  \\$wnnna$aImplants, Penile
=450  \\$wnnna$aPenile Implant
=450  \\$wnnna$aPenile Implants
=450  \\$wnnna$aPenile Prostheses
=450  \\$aPenis, Artificial
=450  \\$wnnna$aPenis Prostheses
=450  \\$wnnna$aPenis Prosthesis
=450  \\$wnnna$aProstheses, Penile
=450  \\$wnnna$aProstheses, Penis
=450  \\$wnnna$aProsthesis, Penile
=450  \\$wnnna$aProsthesis, Penis
=550  \\$wg$aProstheses and Implants
=550  \\$aPenile Implantation
=680  \\$iRigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic ERECTILE DYSFUNCTION.
=688  \\$a90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990
=750  \0$aPenile prosthesis$5IEN

=LDR  00787cz  a2200217n  4500
=001  9880363620602441
=005  20141212203130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008187
=035  \\$aCBA1427HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x562
=072  \\$aD1.$x268.$x558.$x362.$x562
=072  \\$aD1.$x268.$x956.$x311
=072  \\$aD1.$x552.$x550.$x399.$x562
=150  \\$aLutetium
=550  \\$wg$aLanthanoid Series Elements
=550  \\$wg$aTransition Elements
=667  \\$aa rare earth metal; Lu-175; Lu-167-174, 176-180 = LUTETIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iLutetium. An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175.
=750  \0$aLutetium$5IEN$0(DLC)sh 85078994

=LDR  01122cz  a2200241n  4500
=001  9880363620702441
=005  20141212203128.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008183
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x605.$x410
=150  \\$aLuteal Phase
=450  \\$aMenstrual Cycle, Luteal Phase
=450  \\$aMenstrual Cycle, Secretory Phase
=450  \\$aMenstrual Secretory Phase
=450  \\$wnnna$aPhase, Luteal
=450  \\$wnnna$aPhase, Postovulatory
=450  \\$aPostovulatory Phase
=450  \\$wnnna$aSecretory Phase, Menstrual
=550  \\$wg$aMenstrual Cycle
=680  \\$iThe period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.
=688  \\$a1985(1975); was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE use MENSTRUAL CYCLE 1985-2002
=750  \0$aLuteal phase$5IEN$0(DLC)sh 85078983

=LDR  01170cz  a2200265n  4500
=001  9880363620802441
=005  20141212203128.0
=008  840413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008182
=035  \\$aCBA1422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x513.$x300
=150  \\$aLuria-Nebraska Neuropsychological Battery
=450  \\$wnnna$aBattery, Luria-Nebraska Neuropsychological
=450  \\$wnnna$aLuria Nebraska Neuropsychologic Battery
=450  \\$wnnna$aLuria-Nebraska Neuropsychologic Battery
=450  \\$wnnna$aLuria Nebraska Neuropsychological Battery
=450  \\$wnnna$aNeuropsychologic Battery, Luria-Nebraska
=450  \\$wnnna$aNeuropsychological Battery, Luria-Nebraska
=450  \\$wnnna$aNeuropsychological Battery, Luria Nebraska
=550  \\$wg$aNeuropsychological Tests
=667  \\$aDF: LURIA
=680  \\$iA series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization.
=688  \\$a91(85); was see under NEUROPSYCHOLOGICAL TESTS 1985-90
=750  \0$aLuria-Nebraska Neuropsychological Battery$5IEN$0(DLC)sh 85078946

=LDR  01447cz  a2200277n  4500
=001  9880363620902441
=005  20141212203127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008180
=035  \\$aCBA1420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x480
=072  \\$aC20.$x111.$x590
=150  \\$aLupus Erythematosus, Systemic
=450  \\$wnnna$aDisease, Libman-Sacks
=450  \\$aLibman-Sacks Disease
=450  \\$wnnna$aLibman Sacks Disease
=450  \\$aLupus Erythematosus Disseminatus
=450  \\$aSystemic Lupus Erythematosus
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wh$aLupus Nephritis
=550  \\$wh$aLupus Vasculitis, Central Nervous System
=667  \\$aif not specified as "systemic" it is still probably correct to index here, not also discoid; LE CELLS see NEUTROPHILS is also available
=680  \\$iA chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
=750  \0$aSystemic lupus erythematosus$5IEN$0(DLC)sh 85078942

=LDR  01124cz  a2200253n  4500
=001  9880363621002441
=005  20141212203126.0
=008  860404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008178
=035  \\$aCBA1418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x475
=072  \\$aC17.$x800.$x480
=150  \\$aLupus Erythematosus, Cutaneous
=450  \\$wnnna$aCutaneous Lupus Erythematosus
=450  \\$aLupus Erythematosus, Cutaneous, Subacute
=450  \\$aLupus Erythematosus, Subacute Cutaneous
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aSkin Diseases
=550  \\$wh$aLupus Erythematosus, Discoid
=667  \\$aacute: consider LUPUS ERYTHEMATOSUS, SYSTEMIC if skin lesions are paramount
=680  \\$iA form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
=688  \\$a87
=750  \0$aLupus erythematosus$5IEN$0(DLC)sh 85078941

=LDR  00861cz  a2200229n  4500
=001  9880363621102441
=005  20141212203126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008177
=035  \\$aCBA1417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x583.$x470
=072  \\$aC1.$x252.$x825.$x820.$x470
=072  \\$aC1.$x539.$x800.$x720.$x820.$x470
=072  \\$aC17.$x800.$x838.$x765.$x820.$x470
=150  \\$aLupus Vulgaris
=550  \\$wg$aTuberculosis, Cutaneous
=667  \\$ado not confuse with LUPUS ERYTHEMATOSUS, CUTANEOUS
=680  \\$iA form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the NASAL MUCOSA; BUCCAL MUCOSA; and conjunctival mucosa.
=688  \\$a2008
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Lupus
=750  \0$aLupus$0(DLC) 85078940$5IEN

=LDR  01586cz  a2200505n  4500
=001  9880363621202441
=005  20141212203125.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008175
=035  \\$aCBA1415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x797.$x520
=072  \\$aC8.$x381.$x540
=072  \\$aC8.$x785.$x520
=150  \\$aLung Neoplasms
=450  \\$wnnna$aCancer, Lung
=450  \\$aCancer of Lung
=450  \\$wnnna$aCancer of the Lung
=450  \\$wnnna$aCancer, Pulmonary
=450  \\$wnnna$aCancers, Lung
=450  \\$wnnna$aCancers, Pulmonary
=450  \\$aLung Cancer
=450  \\$wnnna$aLung Cancers
=450  \\$wnnna$aLung Neoplasm
=450  \\$wnnna$aNeoplasm, Lung
=450  \\$wnnna$aNeoplasm, Pulmonary
=450  \\$wnnna$aNeoplasms, Lung
=450  \\$wnnna$aNeoplasms, Pulmonary
=450  \\$aPulmonary Cancer
=450  \\$wnnna$aPulmonary Cancers
=450  \\$wnnna$aPulmonary Neoplasm
=450  \\$aPulmonary Neoplasms
=550  \\$wg$aLung Diseases
=550  \\$wg$aRespiratory Tract Neoplasms
=550  \\$wh$aBronchial Neoplasms
=550  \\$wh$aCarcinoma, Bronchogenic
=550  \\$wh$aMultiple Pulmonary Nodules
=550  \\$wh$aPancoast Syndrome
=550  \\$wh$aPulmonary Blastoma
=550  \\$wh$aPulmonary Sclerosing Hemangioma
=550  \\$wh$aSolitary Pulmonary Nodule
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the LUNG.
=750  \0$aLungs$xCancer$5IEN-M$0(DLC)sh 85078900
=750  \0$aLungs$xTumors$5IEN-HS$0(DLC)sh 85078921

=LDR  01146cz  a2200301n  4500
=001  9880363621302441
=005  20141212203124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008173
=035  \\$aCBA1413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x495
=150  \\$aLung Diseases, Obstructive
=450  \\$wnnna$aLung Disease, Obstructive
=450  \\$wnnna$aObstructive Lung Disease
=450  \\$wnnna$aObstructive Lung Diseases
=450  \\$wnnna$aObstructive Pulmonary Disease
=450  \\$wnnna$aObstructive Pulmonary Diseases
=450  \\$wnnna$aPulmonary Disease, Obstructive
=450  \\$wnnna$aPulmonary Diseases, Obstructive
=550  \\$wg$aLung Diseases
=550  \\$wh$aAsthma
=550  \\$wh$aBronchitis
=550  \\$wh$aPulmonary Disease, Chronic Obstructive
=667  \\$aPULMONARY DISEASE, CHRONIC OBSTRUCTIVE and AIRWAY OBSTRUCTION are also available
=680  \\$iAny disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
=688  \\$a72(71)
=750  \0$aLungs$xDiseases, Obstructive$5IEN$0(DLC)sh 85078908

=LDR  01346cz  a2200385n  4500
=001  9880363621402441
=005  20141212203124.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008172
=035  \\$aCBA1412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x534
=072  \\$aC8.$x381.$x472
=072  \\$aC8.$x730.$x435
=150  \\$aLung Diseases, Fungal
=450  \\$wnnna$aFungal Disease, Pulmonary
=450  \\$wnnna$aFungal Diseases, Pulmonary
=450  \\$wnnna$aFungal Infection, Pulmonary
=450  \\$wnnna$aFungal Infections, Pulmonary
=450  \\$wnnna$aFungal Lung Disease
=450  \\$aFungal Lung Diseases
=450  \\$wnnna$aLung Disease, Fungal
=450  \\$wnnna$aPulmonary Fungal Disease
=450  \\$wnnna$aPulmonary Fungal Diseases
=450  \\$wnnna$aPulmonary Fungal Infection
=450  \\$aPulmonary Fungal Infections
=550  \\$wg$aLung Diseases
=550  \\$wg$aMycoses
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wh$aAspergillosis, Allergic Bronchopulmonary
=550  \\$wh$aPneumonia, Pneumocystis
=550  \\$wh$aPulmonary Aspergillosis
=667  \\$acoordinate IM with specific fungal disease (IM)
=680  \\$iPulmonary diseases caused by fungal infections, usually through hematogenous spread.
=750  \0$aLungs$xDiseases, Fungal$5IEN$0(DLC)sh 85078907

=LDR  02068cz   2200601n  4500
=001  9880363621502441
=005  20220303090640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008171
=035  \\$aCBA1411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381
=150  \\$aLung Diseases
=450  \\$wnnna$aDisease, Lung
=450  \\$wnnna$aDisease, Pulmonary
=450  \\$wnnna$aDiseases, Lung
=450  \\$wnnna$aDiseases, Pulmonary
=450  \\$wnnna$aLung Disease
=450  \\$wnnna$aPulmonary Disease
=450  \\$aPulmonary Diseases
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aAcute Chest Syndrome
=550  \\$wh$aalpha 1-Antitrypsin Deficiency
=550  \\$wh$aCystic Adenomatoid Malformation of Lung, Congenital
=550  \\$wh$aCystic Fibrosis
=550  \\$wh$aHemoptysis
=550  \\$wh$aHepatopulmonary Syndrome
=550  \\$wh$aHypertension, Pulmonary
=550  \\$wh$aLung Abscess
=550  \\$wh$aLung Diseases, Fungal
=550  \\$wh$aLung Diseases, Interstitial
=550  \\$wh$aLung Diseases, Obstructive
=550  \\$wh$aLung Diseases, Parasitic
=550  \\$wh$aLung, Hyperlucent
=550  \\$wh$aLung Injury
=550  \\$wh$aLung Neoplasms
=550  \\$wh$aPlasma Cell Granuloma, Pulmonary
=550  \\$wh$aPneumonia
=550  \\$wh$aPulmonary Alveolar Proteinosis
=550  \\$wh$aPulmonary Atelectasis
=550  \\$wh$aPulmonary Edema
=550  \\$wh$aPulmonary Embolism
=550  \\$wh$aPulmonary Eosinophilia
=550  \\$wh$aPulmonary Fibrosis
=550  \\$wh$aPulmonary Veno-Occlusive Disease
=550  \\$wh$aRespiratory Distress Syndrome
=550  \\$wh$aRespiratory Distress Syndrome, Newborn
=550  \\$wh$aScimitar Syndrome
=550  \\$wh$aSolitary Pulmonary Nodule
=550  \\$wh$aTuberculosis, Pulmonary
=667  \\$ageneral; prefer specifics; inflammatory disease = PNEUMONIA; lung collapse = PULMONARY ATELECTASIS
=680  \\$iPathological processes involving any part of the LUNG.
=750  \0$aLungs$xDiseases$0(DLC) sh 85078904$5IEN

=LDR  01132cz  a2200301n  4500
=001  9880363621602441
=005  20141212203122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008169
=035  \\$aCBA1409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x25.$x490
=072  \\$aC8.$x381.$x450
=072  \\$aC8.$x730.$x407
=150  \\$aLung Abscess
=450  \\$wnnna$aAbscess, Lung
=450  \\$aAbscess, Pulmonary
=450  \\$wnnna$aAbscesses, Lung
=450  \\$wnnna$aAbscesses, Pulmonary
=450  \\$wnnna$aLung Abscesses
=450  \\$wnnna$aPulmonary Abscess
=450  \\$wnnna$aPulmonary Abscesses
=550  \\$wg$aAbscess
=550  \\$wg$aLung Diseases
=550  \\$wg$aRespiratory Tract Infections
=667  \\$acoordinate IM with precoordinated organism/infection term (IM); if unspecified bacterial abscess, do not coordinate with BACTERIAL INFECTIONS since most abscesses are bacterial
=680  \\$iSolitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.
=750  \0$aLungs$xAbscess$5IEN$0(DLC)sh 85078892

=LDR  01060cz  a2200217n  4500
=001  9880363621702441
=005  20141212203122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008168
=035  \\$aCBA1408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x411
=150  \\$aLung
=360  \\$iconsider also terms at$aPNEUMO-$aPULMON-
=450  \\$wnnna$aLungs
=550  \\$wg$aRespiratory System
=550  \\$wh$aBronchi
=550  \\$wh$aPulmonary Alveoli
=667  \\$a/abnorm: CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL is available; /blood supply: consider also PULMONARY CIRCULATION; /surg: consider also PNEUMONECTOMY but PULMONARY SURGICAL PROCEDURES is also available; /transpl = LUNG TRANSPLANTATION or HEART-LUNG TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; inflammation = PNEUMONIA; collapse of lung = PULMONARY ATELECTASIS
=680  \\$iEither of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
=750  \0$aLungs$5IEN$0(DLC)sh 85078891

=LDR  00788cz  a2200205n  4500
=001  9880363621802441
=005  20141212203122.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008167
=035  \\$aCBA1407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x650.$x160.$x150.$x500
=072  \\$aB4.$x909.$x204.$x783.$x160.$x150.$x500
=150  \\$aLumpy skin disease virus
=450  \\$aNeethling Virus
=550  \\$wg$aCapripoxvirus
=667  \\$ainfection = LUMPY SKIN DISEASE: see note there; DF: note short X ref or LUMPY SKIN DIS VIRUS
=680  \\$iA species of CAPRIPOXVIRUS causing a cattle disease occurring in Africa.
=688  \\$a91(75); was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80
=750  \0$aLumpy skin disease virus$5IEN$0(DLC)sh 85078848

=LDR  00999cz  a2200265n  4500
=001  9880363621902441
=005  20141212203122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008166
=035  \\$aCBA1406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x494
=072  \\$aC22.$x196.$x497
=150  \\$aLumpy Skin Disease
=450  \\$wnnna$aDisease, Lumpy Skin
=450  \\$wnnna$aDiseases, Lumpy Skin
=450  \\$wnnna$aLumpy Skin Diseases
=450  \\$wnnna$aSkin Disease, Lumpy
=450  \\$wnnna$aSkin Diseases, Lumpy
=550  \\$wg$aCattle Diseases
=550  \\$wg$aPoxviridae Infections
=667  \\$acaused by a poxvirus; usually animal; check tag ANIMALS; don't forget also CATTLE (NIM) but do not index under CATTLE DISEASES
=680  \\$iA poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin.
=688  \\$a91(90)70; was see under POXVIRUS INFECTIONS 1990
=750  \0$aLumpy skin disease$5IEN$0(DLC)sh 85078847

=LDR  03327cz  a2200865n  4500
=001  9880363622002441
=005  20141212203121.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008163
=035  \\$aCBA1403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x516
=150  \\$aLuminescent Measurements
=450  \\$wnnna$aAssay, Bioluminescent
=450  \\$wnnna$aAssay, Chemiluminescent
=450  \\$wnnna$aAssay, Luminescent
=450  \\$wnnna$aAssay, Phosphorescent
=450  \\$wnnna$aAssays, Bioluminescent
=450  \\$wnnna$aAssays, Chemiluminescent
=450  \\$wnnna$aAssays, Luminescent
=450  \\$wnnna$aAssays, Phosphorescent
=450  \\$wnnna$aBioluminescence Measurement
=450  \\$wnnna$aBioluminescence Measurements
=450  \\$wnnna$aBioluminescent Assay
=450  \\$wnnna$aBioluminescent Assays
=450  \\$wnnna$aBioluminescent Measurement
=450  \\$wnnna$aBioluminescent Measurements
=450  \\$wnnna$aChemiluminescence Measurement
=450  \\$wnnna$aChemiluminescence Measurements
=450  \\$wnnna$aChemiluminescent Assay
=450  \\$wnnna$aChemiluminescent Assays
=450  \\$wnnna$aChemiluminescent Measurement
=450  \\$wnnna$aChemiluminescent Measurements
=450  \\$wnnna$aChemoluminescence Measurement
=450  \\$wnnna$aChemoluminescence Measurements
=450  \\$wnnna$aLuminescence Measurement
=450  \\$wnnna$aLuminescence Measurements
=450  \\$wnnna$aLuminescent Assay
=450  \\$wnnna$aLuminescent Assays
=450  \\$wnnna$aLuminescent Measurement
=450  \\$wnnna$aLuminescent Technique
=450  \\$wnnna$aLuminescent Techniques
=450  \\$wnnna$aMeasurement, Bioluminescence
=450  \\$wnnna$aMeasurement, Bioluminescent
=450  \\$wnnna$aMeasurement, Chemiluminescence
=450  \\$wnnna$aMeasurement, Chemiluminescent
=450  \\$wnnna$aMeasurement, Chemoluminescence
=450  \\$wnnna$aMeasurement, Luminescence
=450  \\$wnnna$aMeasurement, Luminescent
=450  \\$wnnna$aMeasurement, Phosphorescence
=450  \\$wnnna$aMeasurement, Phosphorescent
=450  \\$wnnna$aMeasurements, Bioluminescence
=450  \\$wnnna$aMeasurements, Bioluminescent
=450  \\$wnnna$aMeasurements, Chemiluminescence
=450  \\$wnnna$aMeasurements, Chemiluminescent
=450  \\$wnnna$aMeasurements, Chemoluminescence
=450  \\$wnnna$aMeasurements, Luminescence
=450  \\$wnnna$aMeasurements, Luminescent
=450  \\$wnnna$aMeasurements, Phosphorescence
=450  \\$wnnna$aMeasurements, Phosphorescent
=450  \\$wnnna$aPhosphorescence Measurement
=450  \\$wnnna$aPhosphorescence Measurements
=450  \\$wnnna$aPhosphorescent Assay
=450  \\$wnnna$aPhosphorescent Assays
=450  \\$wnnna$aPhosphorescent Measurement
=450  \\$wnnna$aPhosphorescent Measurements
=450  \\$wnnna$aTechnique, Luminescent
=450  \\$wnnna$aTechniques, Luminescent
=550  \\$wg$aPhotometry
=550  \\$wh$aBioluminescence Resonance Energy Transfer Techniques
=550  \\$wh$aFluorometry
=550  \\$aLight
=680  \\$iTechniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE.
=688  \\$a2005(1963)
=750  \0$aChemiluminescence assay$0(DLC) sh 93005494$5IEN-M

=LDR  00804cz  a2200241n  4500
=001  9880363622102441
=005  20141212203119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008161
=035  \\$aCBA1401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x176.$x519
=150  \\$aLumbosacral Region
=450  \\$aLumbar Region
=450  \\$wnnna$aLumbar Regions
=450  \\$wnnna$aLumbosacral Regions
=450  \\$wnnna$aRegion, Lumbar
=450  \\$wnnna$aRegion, Lumbosacral
=450  \\$wnnna$aRegions, Lumbar
=450  \\$wnnna$aRegions, Lumbosacral
=550  \\$wg$aBack
=667  \\$ado not confuse with LUMBAR VERTEBRAE or SACROCOCCYGEAL REGION: use term in the text; NIM when merely locational; pain: note see related ref
=750  \0$aLumbosacral region$5IEN$0(DLC)sh 85078835

=LDR  00629cz  a2200169n  4500
=001  9880363622202441
=005  20141212203119.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008159
=035  \\$aCBA1399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x519
=150  \\$aLumbar Vertebrae
=450  \\$wnnna$aVertebrae, Lumbar
=550  \\$wg$aSpine
=667  \\$ado not confuse with LUMBOSACRAL REGION; IM when discussed as bones or as coord with specific spinal disease (IM); NIM when locational; inflammation = LUMBAR VERTEBRAE (IM) + SPONDYLITIS (IM)
=750  \0$aLumbar vertebrae$5IEN$0(DLC)sh 85142894

=LDR  00931cz  a2200253n  4500
=001  9880363622302441
=005  20141212203118.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008156
=035  \\$aCBA1396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x517
=072  \\$aD12.$x776.$x532.$x510
=150  \\$aLuciferases
=450  \\$aLuciferase
=550  \\$wg$aLuminescent Proteins
=550  \\$wg$aOxidoreductases
=550  \\$wh$aLuciferases, Bacterial
=550  \\$wh$aLuciferases, Firefly
=550  \\$wh$aLuciferases, Renilla
=667  \\$ageneral; prefer specifics; note species specific luciferases in SCR
=680  \\$iEnzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates.
=688  \\$a2005(1963)
=750  \0$aLuciferases$0(DLC)sh2007001349$5IEN-M

=LDR  00676cz  a2200193n  4500
=001  9880363622402441
=005  20141212192303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008153
=035  \\$aCBA1393M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x830.$x583
=150  \\$aLubrication
=450  \\$wnnna$aLubrications
=550  \\$wg$aRheology
=667  \\$acoordinate with lubricant; do not use for natural "lubrication" of joints: = probably SYNOVIAL FLUID
=680  \\$iThe application of LUBRICANTS to diminish FRICTION between two surfaces.
=688  \\$a91(64); was see under PHYSICS 1964-90
=750  \0$aLubrication and lubricants$0(DLC) sh 85078720$5IEN-M

=LDR  00989cz  a2200229n  4500
=001  9880363622502441
=005  20141212203117.0
=008  790308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008150
=035  \\$aCBA1390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x278.$x500
=150  \\$aLower Body Negative Pressure
=450  \\$aAbdominal Decompression
=450  \\$aDecompression, Abdominal
=450  \\$aLBNP
=550  \\$wg$aDecompression
=550  \\$aFluid Shifts
=667  \\$a"external decompression applied to the lower body"; used in physiol research & ther
=680  \\$iExternal decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated hemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth.
=688  \\$a91(80); was see under DECOMPRESSION 1980-90
=750  \0$aAbdominal decompression$5IEN$0(DLC)sh 85000110

=LDR  00573cz  a2200193n  4500
=001  9880363622602441
=005  20141212203117.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008149
=035  \\$aCBA1389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x734
=150  \\$aLove
=450  \\$wnnna$aLoves
=550  \\$wg$aEmotions
=550  \\$aCourtship
=667  \\$ano qualif
=680  \\$iAffection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between individuals.
=750  \0$aLove$5IEN$0(DLC)sh 85078519

=LDR  00869cz  a2200217n  4500
=001  9880363622702441
=005  20141212203116.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008146
=035  \\$aCBA1386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350.$x250.$x650
=072  \\$aC22.$x836.$x435
=150  \\$aLouping Ill
=450  \\$wnnna$aIll, Louping
=550  \\$wg$aFlavivirus Infections
=550  \\$wg$aSheep Diseases
=667  \\$acaused by a tick-transm flavivirus; usually animal, generally sheep; "louping" is Scottish dialect for "leaping" with ref to musc manifest of infected animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
=680  \\$iAn acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep.
=688  \\$a71
=750  \0$aLouping ill$5IEN$0(DLC)sh 85078511

=LDR  00840cz  a2200241n  4500
=001  9880363622802441
=005  20141212202906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007992
=035  \\$aCBA1227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x346.$x596.$x463
=072  \\$aN2.$x278.$x354.$x600
=072  \\$aN4.$x452.$x442.$x600
=150  \\$aLibraries, Hospital
=450  \\$aHospital Libraries
=450  \\$wnnna$aHospital Library
=450  \\$wnnna$aLibrary, Hospital
=550  \\$wg$aHospital Administration
=550  \\$wg$aLibraries
=667  \\$aIM; specify geog or other site; DF: LIBRARIES HOSP
=680  \\$iInformation centers primarily serving the needs of hospital medical staff and sometimes also providing patient education and other services.
=750  \0$aHospital libraries$5IEN$0(DLC)sh 85062246

=LDR  00581cz  a2200205n  4500
=001  9880363622902441
=005  20141212202905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007991
=035  \\$aCBA1226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x346.$x596.$x363
=150  \\$aLibraries, Dental
=450  \\$wnnna$aDental Libraries
=450  \\$wnnna$aDental Library
=450  \\$wnnna$aLibrary, Dental
=550  \\$wg$aLibraries
=667  \\$aIM; specify geog or other site; DF: LIBRARIES DENT
=688  \\$a65
=750  \0$aDental libraries$5IEN$0(DLC)sh 85036904

=LDR  00940cz  a2200277n  4500
=001  9880363623002441
=005  20170705100132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007990
=035  \\$aCBA1225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ3.$x400.$x596
=072  \\$aL1.$x346.$x596
=150  \\$aLibraries
=450  \\$wnnna$aLibrary
=550  \\$wg$aInformation Centers
=550  \\$wh$aLibraries, Dental
=550  \\$wh$aLibraries, Digital
=550  \\$wh$aLibraries, Hospital
=550  \\$wh$aLibraries, Medical
=550  \\$wh$aLibraries, Nursing
=550  \\$wh$aLibraries, Special
=550  \\$aInformation Services
=667  \\$aspecify geographic or other site
=680  \\$iCollections of systematically acquired and organized information resources, and usually providing assistance to users. (ERIC Thesaurus, http://www.eric.ed.gov/ accessed 2/1/2008)
=750  \0$aLibraries$5IEN$0(DLC)sh 85076502

=LDR  02474cz  a2200649n  4500
=001  9880363623102441
=005  20141212202904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007987
=035  \\$aCBA1222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x740.$x320
=072  \\$aD12.$x644.$x400.$x400.$x740.$x320
=072  \\$aD12.$x644.$x456.$x460
=072  \\$aD12.$x644.$x548.$x365.$x740.$x320
=072  \\$aD12.$x776.$x641.$x650.$x405.$x740.$x320
=150  \\$aGonadotropin-Releasing Hormone
=450  \\$wnnna$aCystorelin
=450  \\$wnnna$aDirigestran
=450  \\$wnnna$aFactrel
=450  \\$aFSH-Releasing Hormone
=450  \\$wnnna$aFSH Releasing Hormone
=450  \\$wnnna$aGn-RH
=450  \\$aGnRH
=450  \\$aGonadoliberin
=450  \\$aGonadorelin
=450  \\$wnnna$aGonadorelin Acetate
=450  \\$wnnna$aGonadorelin Hydrochloride
=450  \\$wnnna$aGonadotropin Releasing Hormone
=450  \\$wnnna$aKryptocur
=450  \\$wnnna$aLFRH
=450  \\$aLH-FSH Releasing Hormone
=450  \\$wnnna$aLH FSH Releasing Hormone
=450  \\$wnnna$aLH-Releasing Hormone
=450  \\$wnnna$aLH Releasing Hormone
=450  \\$wnnna$aLH-RH
=450  \\$wnnna$aLHFSH Releasing Hormone
=450  \\$wnnna$aLHFSHRH
=450  \\$aLHRH
=450  \\$aLuliberin
=450  \\$aLuteinizing Hormone-Releasing Hormone
=450  \\$wnnna$aLuteinizing Hormone Releasing Hormone
=450  \\$wnnna$aReleasing Hormone, LHFSH
=550  \\$wg$aOligopeptides
=550  \\$wg$aPituitary Hormone-Releasing Hormones
=550  \\$wh$aBuserelin
=550  \\$wh$aGoserelin
=550  \\$wh$aLeuprolide
=550  \\$wh$aNafarelin
=550  \\$wh$aTriptorelin Pamoate
=550  \\$aKallmann Syndrome
=550  \\$aReceptors, LHRH
=680  \\$iA decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
=688  \\$a2007 (1974)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Gonadorelin
=688  \\$a91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90
=750  \0$aLuteinizing hormone releasing hormone$0(DLC) sh 85078987$5IEN

=LDR  01277cz  a2200313n  4500
=001  9880363623202441
=005  20141212202903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007985
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x849.$x513
=072  \\$aA6.$x407.$x312.$x782.$x513
=072  \\$aA11.$x382.$x906
=072  \\$aA11.$x436.$x513
=150  \\$aLeydig Cells
=450  \\$wnnna$aCell, Testicular Interstitial
=450  \\$wnnna$aCells, Leydig
=450  \\$wnnna$aCells, Testicular Interstitial
=450  \\$wnnna$aInterstitial Cell, Testicular
=450  \\$aInterstitial Cells, Testicular
=450  \\$wnnna$aTesticular Interstitial Cell
=450  \\$aTesticular Interstitial Cells
=550  \\$wg$aEndocrine Cells
=550  \\$wg$aEpithelial Cells
=550  \\$wg$aTestis
=667  \\$ado not confuse X ref interstitial cells here with interstitial cells of connective tissue ( = CONNECTIVE TISSUE CELLS)
=680  \\$iSteroid-producing cells in the interstitial tissue of the TESTIS. They are under the regulation of PITUITARY HORMONES; LUTEINIZING HORMONE; or interstitial cell-stimulating hormone. TESTOSTERONE is the major androgen (ANDROGENS) produced.
=688  \\$a68(64)
=750  \0$aLeydig cells$5IEN$0(DLC)sh 85076366

=LDR  01225cz  a2200289n  4500
=001  9880363623402441
=005  20141212202901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007978
=035  \\$aCBA1214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x675.$x346
=072  \\$aD3.$x383.$x129.$x308.$x480
=072  \\$aD3.$x383.$x129.$x708.$x346
=150  \\$aLevamisole
=450  \\$wnnna$aDecaris
=450  \\$wnnna$aDekaris
=450  \\$wnnna$aHydrochloride, Levamisole
=450  \\$aL-Tetramisole
=450  \\$wnnna$aLevamisole Hydrochloride
=450  \\$aLevotetramisole
=450  \\$wnnna$aSolaskil
=550  \\$wg$aImidazoles
=550  \\$wg$aThiazoles
=680  \\$iAn antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
=688  \\$a74
=750  \0$aLevamisole$5IEN$0(DLC)sh 85076310

=LDR  01117cz  a2200229n  4500
=001  9880363623502441
=005  20141212210949.0
=008  880524\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015289
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x100.$x450
=072  \\$aD23.$x469.$x50.$x175.$x450
=150  \\$aLeukotrienes
=550  \\$wg$aArachidonic Acids
=550  \\$wg$aEicosanoids
=550  \\$wh$aLeukotriene A4
=550  \\$wh$aLeukotriene B4
=550  \\$wh$aSRS-A
=667  \\$aeicosanoids; GEN or unspecified; prefer specifics; /biosyn /physiol permitted
=680  \\$iA family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.
=688  \\$a89
=750  \0$aLeukotrienes$5IEN$0(DLC)sh 85076302

=LDR  01159cz  a2200325n  4500
=001  9880363623602441
=005  20141212202859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007972
=035  \\$aCBA1207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591.$x545
=072  \\$aC4.$x834.$x512.$x513
=072  \\$aC7.$x465.$x565.$x545
=072  \\$aC23.$x300.$x816.$x513
=150  \\$aLeukoplakia, Oral
=450  \\$aKeratosis, Oral
=450  \\$wnnna$aLeukokeratoses, Oral
=450  \\$wnnna$aLeukokeratosis, Oral
=450  \\$wnnna$aLeukoplakias, Oral
=450  \\$wnnna$aOral Leukokeratoses
=450  \\$wnnna$aOral Leukokeratosis
=450  \\$wnnna$aOral Leukoplakia
=450  \\$wnnna$aOral Leukoplakias
=550  \\$wg$aLeukoplakia
=550  \\$wg$aMouth Neoplasms
=550  \\$wh$aLeukoplakia, Hairy
=680  \\$iA white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).
=688  \\$a72(70)
=750  \0$aLeukoplakia, Oral$5IEN$0(DLC)sh 85076301

=LDR  01012cz  a2200277n  4500
=001  9880363623702441
=005  20141212202859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007971
=035  \\$aCBA1206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x834.$x512
=072  \\$aC23.$x300.$x816
=150  \\$aLeukoplakia
=450  \\$wnnna$aLesion, Leukoplakic
=450  \\$wnnna$aLesions, Leukoplakic
=450  \\$wnnna$aLeukokeratoses
=450  \\$wnnna$aLeukokeratosis
=450  \\$wnnna$aLeukoplakias
=450  \\$wnnna$aLeukoplakic Lesion
=450  \\$wnnna$aLeukoplakic Lesions
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wg$aPrecancerous Conditions
=550  \\$wh$aLeukoplakia, Oral
=680  \\$iA white patch lesion found on a MUCOUS MEMBRANE that cannot be scraped off. Leukoplakia is generally considered a precancerous condition, however its appearance may also result from a variety of HEREDITARY DISEASES.
=750  \0$aLeukoplakia$0(DLC) sh 85076300$5IEN

=LDR  05636cz  a2201153n  4500
=001  9880363623802441
=005  20141219145145.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007966
=035  \\$aCBA1201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x362.$x550
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x850.$x500
=072  \\$aC10.$x228.$x140.$x695.$x625.$x550
=072  \\$aC10.$x314.$x400.$x550
=072  \\$aC16.$x320.$x565.$x189.$x362.$x550
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x850.$x500
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x925.$x500
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x850.$x500
=072  \\$aC18.$x452.$x132.$x100.$x362.$x550
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x850.$x500
=072  \\$aC18.$x452.$x584.$x687.$x803.$x925.$x500
=072  \\$aC18.$x452.$x648.$x189.$x362.$x550
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x850.$x500
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x925.$x500
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x850.$x500
=150  \\$aLeukodystrophy, Metachromatic
=450  \\$wnnna$aAdult Metachromatic Leukodystrophies
=450  \\$wnnna$aAdult Metachromatic Leukodystrophy
=450  \\$wnnna$aAdult-Type Metachromatic Leukodystrophies
=450  \\$wnnna$aAdult-Type Metachromatic Leukodystrophy
=450  \\$wnnna$aARSA Deficiencies
=450  \\$wnnna$aARSA Deficiency
=450  \\$wnnna$aArylsulfatase A Deficiencies
=450  \\$wnnna$aArylsulfatase A Deficiency
=450  \\$aArylsulfatase A Deficiency Disease
=450  \\$wnnna$aCerebral sclerosis, Diffuse, Metachromatic Form
=450  \\$wnnna$aCerebroside Sulfatase Deficiencies
=450  \\$wnnna$aCerebroside Sulfatase Deficiency
=450  \\$aCerebroside Sulphatase Deficiency Disease
=450  \\$wnnna$aDeficiencies, ARSA
=450  \\$wnnna$aDeficiencies, Arylsulfatase A
=450  \\$wnnna$aDeficiencies, Cerebroside Sulfatase
=450  \\$wnnna$aDeficiency, ARSA
=450  \\$wnnna$aDeficiency, Arylsulfatase A
=450  \\$wnnna$aDeficiency, Cerebroside Sulfatase
=450  \\$wnnna$aGreenfield Disease
=450  \\$wnnna$aGreenfield's Disease
=450  \\$wnnna$aInfant Metachromatic Leukodystrophies
=450  \\$wnnna$aInfant Metachromatic Leukodystrophy
=450  \\$wnnna$aInfant-Type Metachromatic Leukodystrophies
=450  \\$wnnna$aInfant-Type Metachromatic Leukodystrophy
=450  \\$wnnna$aJuvenile Metachromatic Leukodystrophies
=450  \\$wnnna$aJuvenile Metachromatic Leukodystrophy
=450  \\$wnnna$aJuvenile-Type Metachromatic Leukodystrophies
=450  \\$wnnna$aJuvenile-Type Metachromatic Leukodystrophy
=450  \\$wnnna$aLeukodystrophies, Adult Metachromatic
=450  \\$wnnna$aLeukodystrophies, Adult-Type Metachromatic
=450  \\$wnnna$aLeukodystrophies, Juvenile Metachromatic
=450  \\$wnnna$aLeukodystrophies, Juvenile-Type Metachromatic
=450  \\$wnnna$aLeukodystrophies, Metachromatic
=450  \\$wnnna$aLeukodystrophy, Adult Metachromatic
=450  \\$wnnna$aLeukodystrophy, Adult-Type Metachromatic
=450  \\$wnnna$aLeukodystrophy, Juvenile Metachromatic
=450  \\$wnnna$aLeukodystrophy, Juvenile-Type Metachromatic
=450  \\$wnnna$aLeukodystrophy, Metachromatic, Adult
=450  \\$wnnna$aLeukodystrophy, Metachromatic, Juvenile
=450  \\$wnnna$aLeukoencephalopathies, Metachromatic
=450  \\$wnnna$aLeukoencephalopathy, Metachromatic
=450  \\$wnnna$aLipidosis, Sulfatide
=450  \\$wnnna$aMetachromatic Leukodystrophies
=450  \\$wnnna$aMetachromatic Leukodystrophies, Adult
=450  \\$wnnna$aMetachromatic Leukodystrophies, Adult-Type
=450  \\$wnnna$aMetachromatic Leukodystrophies, Infant
=450  \\$wnnna$aMetachromatic Leukodystrophies, Infant-Type
=450  \\$wnnna$aMetachromatic Leukodystrophies, Juvenile
=450  \\$wnnna$aMetachromatic Leukodystrophies, Juvenile-Type
=450  \\$wnnna$aMetachromatic Leukodystrophy
=450  \\$wnnna$aMetachromatic Leukodystrophy, Adult
=450  \\$wnnna$aMetachromatic Leukodystrophy, Adult-Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Adult Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Infant
=450  \\$wnnna$aMetachromatic Leukodystrophy, Infant-Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Infant Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Juvenile
=450  \\$wnnna$aMetachromatic Leukodystrophy, Juvenile-Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Juvenile Type
=450  \\$wnnna$aMetachromatic Leukodystrophy, Late Infantile
=450  \\$wnnna$aMetachromatic Leukoencephalopathies
=450  \\$wnnna$aMetachromatic Leukoencephalopathy
=450  \\$wnnna$aSulfatase Deficiencies, Cerebroside
=450  \\$wnnna$aSulfatase Deficiency, Cerebroside
=450  \\$wnnna$aSulfatide Lipidosis
=550  \\$wg$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wg$aSulfatidosis
=550  \\$aCerebroside-Sulfatase
=680  \\$iAn autosomal recessive metabolic disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to intralysosomal accumulation of cerebroside sulfate (SULFOGLYCOSPHINGOLIPIDS) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the GLIAL CELLS. There are several allelic and nonallelic forms with a variety of neurological symptoms.
=688  \\$a1974
=750  \0$aMetachromatic leukodystrophy$0(DLC) sh 85076299$5IEN-M

=LDR  05601cz  a2201165n  4500
=001  9880363623902441
=005  20141219145206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007965
=035  \\$aCBA1200HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x362.$x500
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825.$x590
=072  \\$aC10.$x228.$x140.$x695.$x625.$x500
=072  \\$aC10.$x314.$x400.$x500
=072  \\$aC16.$x320.$x565.$x189.$x362.$x500
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825.$x590
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803.$x585
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825.$x590
=072  \\$aC18.$x452.$x132.$x100.$x362.$x500
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825.$x590
=072  \\$aC18.$x452.$x584.$x687.$x803.$x585
=072  \\$aC18.$x452.$x648.$x189.$x362.$x500
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825.$x590
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803.$x585
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825.$x590
=150  \\$aLeukodystrophy, Globoid Cell
=450  \\$wnnna$abeta-Galactosidase Deficiencies, Galactosylceramide
=450  \\$wnnna$abeta-Galactosidase Deficiency, Galactosylceramide
=450  \\$wnnna$aCell Leukodystrophies, Globoid
=450  \\$wnnna$aCell Leukodystrophy, Globoid
=450  \\$wnnna$aCell Leukoencephalopathies, Globoid
=450  \\$wnnna$aCell Leukoencephalopathy, Globoid
=450  \\$wnnna$aClassic Globoid Cell Leukodystrophy
=450  \\$wnnna$aDeficiencies, Galactocerebrosidase
=450  \\$wnnna$aDeficiencies, Galactosylceramide beta-Galactosidase
=450  \\$wnnna$aDeficiencies, GALC
=450  \\$wnnna$aDeficiency Disease, Galactosylceramidase
=450  \\$wnnna$aDeficiency Disease, Galactosylceramide-beta-Galactosidase
=450  \\$wnnna$aDeficiency Diseases, Galactosylceramidase
=450  \\$wnnna$aDeficiency Diseases, Galactosylceramide-beta-Galactosidase
=450  \\$wnnna$aDeficiency, Galactocerebrosidase
=450  \\$wnnna$aDeficiency, Galactosylceramide beta-Galactosidase
=450  \\$wnnna$aDeficiency, GALC
=450  \\$aDiffuse Globoid Body Sclerosis
=450  \\$wnnna$aDisease, Galactosylceramidase Deficiency
=450  \\$wnnna$aDisease, Galactosylceramide-beta-Galactosidase Deficiency
=450  \\$wnnna$aDiseases, Galactosylceramidase Deficiency
=450  \\$wnnna$aDiseases, Galactosylceramide-beta-Galactosidase Deficiency
=450  \\$wnnna$aEarly-Onset Globoid Cell Leukodystrophy
=450  \\$wnnna$aEarly Onset Globoid Cell Leukodystrophy
=450  \\$wnnna$aGalactocerebrosidase Deficiencies
=450  \\$wnnna$aGalactocerebrosidase Deficiency
=450  \\$aGalactosylceramidase Deficiency Disease
=450  \\$wnnna$aGalactosylceramidase Deficiency Diseases
=450  \\$wnnna$aGalactosylceramide beta-Galactosidase Deficiencies
=450  \\$wnnna$aGalactosylceramide beta-Galactosidase Deficiency
=450  \\$wnnna$aGalactosylceramide beta Galactosidase Deficiency
=450  \\$wnnna$aGalactosylceramide-beta-Galactosidase Deficiency Disease
=450  \\$wnnna$aGalactosylceramide beta Galactosidase Deficiency Disease
=450  \\$wnnna$aGalactosylceramide-beta-Galactosidase Deficiency Diseases
=450  \\$wnnna$aGalactosylceramide Lipidosis
=450  \\$wnnna$aGalactosylcerebrosidase Deficiency
=450  \\$wnnna$aGalactosylsphingosine Lipidosis
=450  \\$wnnna$aGALC Deficiencies
=450  \\$wnnna$aGALC Deficiency
=450  \\$wnnna$aGloboid Body Sclerosis, Diffuse
=450  \\$wnnna$aGloboid Cell Leukodystrophies
=450  \\$wnnna$aGloboid Cell Leukodystrophy
=450  \\$wnnna$aGloboid Cell Leukoencephalopathies
=450  \\$wnnna$aGloboid Cell Leukoencephalopathy
=450  \\$wnnna$aGloboid Leukodystrophies
=450  \\$wnnna$aGloboid Leukodystrophy
=450  \\$wnnna$aInfantile Globoid Cell Leukodystrophy
=450  \\$aKrabbe Disease
=450  \\$wnnna$aKrabbe Leukodystrophy
=450  \\$wnnna$aKrabbe's Disease
=450  \\$wnnna$aKrabbes Disease
=450  \\$wnnna$aKrabbe's Leukodystrophy
=450  \\$wnnna$aKrabbes Leukodystrophy
=450  \\$wnnna$aLate-Onset Globoid Cell Leukodystrophy
=450  \\$wnnna$aLate Onset Globoid Cell Leukodystrophy
=450  \\$wnnna$aLeukodystrophies, Globoid
=450  \\$wnnna$aLeukodystrophies, Globoid Cell
=450  \\$wnnna$aLeukodystrophy, Globoid
=450  \\$wnnna$aLeukodystrophy, Globoid Cell, Classic
=450  \\$wnnna$aLeukodystrophy, Globoid Cell, Early-Onset
=450  \\$wnnna$aLeukodystrophy, Globoid Cell, Infantile
=450  \\$wnnna$aLeukodystrophy, Globoid Cell, Late-Onset
=450  \\$wnnna$aLeukodystrophy, Krabbe
=450  \\$wnnna$aLeukodystrophy, Krabbe's
=450  \\$wnnna$aLeukoencephalopathies, Globoid Cell
=450  \\$wnnna$aLeukoencephalopathy, Globoid Cell
=450  \\$wnnna$aPsychosine Lipidosis
=550  \\$wg$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wg$aSphingolipidoses
=550  \\$aGalactosylceramidase
=680  \\$iAn autosomal recessive metabolic disorder caused by a deficiency of GALACTOSYLCERAMIDASE leading to intralysosomal accumulation of galactolipids such as GALACTOSYLCERAMIDES and PSYCHOSINE. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of MYELIN disrupts normal conduction of nerve impulses.
=688  \\$a1974(1963)
=750  \0$aGloboid cell leukodystrophy$5IEN$0(DLC)sh 85076298

=LDR  01309cz  a2200349n  4500
=001  9880363624002441
=005  20141212202852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007962
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x118.$x637
=072  \\$aA15.$x145.$x229.$x637
=072  \\$aA15.$x382.$x490
=150  \\$aLeukocytes
=450  \\$wnnna$aBlood Cell, White
=450  \\$aBlood Cells, White
=450  \\$wnnna$aBlood Corpuscle, White
=450  \\$aBlood Corpuscles, White
=450  \\$wnnna$aCorpuscle, White Blood
=450  \\$wnnna$aCorpuscles, White Blood
=450  \\$wnnna$aLeukocyte
=450  \\$wnnna$aWhite Blood Cell
=450  \\$aWhite Blood Cells
=450  \\$wnnna$aWhite Blood Corpuscle
=450  \\$wnnna$aWhite Blood Corpuscles
=550  \\$wg$aBlood Cells
=550  \\$wg$aImmune System
=550  \\$wh$aGranulocytes
=550  \\$wh$aLeukocytes, Mononuclear
=667  \\$adecrease in no. of leukocytes: consider LEUKOPENIA; increase in number of leukocytes: consider LEUKOCYTOSIS; CELL MIGRATION ASSAYS, LEUKOCYTE is available
=680  \\$iWhite blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).
=750  \0$aLeucocytes$0(DLC) sh 85076269$5IEN

=LDR  01020cz  a2200301n  4500
=001  9880363624102441
=005  20141212202851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007960
=035  \\$aCBA1195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x553
=150  \\$aLeukocyte Disorders
=450  \\$wnnna$aDisorder, Leukocyte
=450  \\$wnnna$aDisorders, Leukocyte
=450  \\$wnnna$aLeukocyte Disorder
=550  \\$wg$aHematologic Diseases
=550  \\$wh$aEosinophilia
=550  \\$wh$aInfectious Mononucleosis
=550  \\$wh$aLeukocytosis
=550  \\$wh$aLeukopenia
=550  \\$wh$aLeukostasis
=550  \\$wh$aPelger-Huet Anomaly
=550  \\$wh$aPhagocyte Bactericidal Dysfunction
=667  \\$aGEN or unspecified; prefer specifics; DF: LEUKOCYTE DIS
=680  \\$iDisordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.
=688  \\$a98; use explode 1967-97
=750  \0$aLeucocyte disorders$5IEN-M$0(DLC)sh 85076268

=LDR  01839cz  a2200337n  4500
=001  9880363624202441
=005  20141212202851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007959
=035  \\$aCBA1194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x385.$x475
=072  \\$aE5.$x200.$x812.$x385.$x475
=072  \\$aE5.$x478.$x594.$x385.$x429
=150  \\$aLymphocyte Culture Test, Mixed
=450  \\$aLeukocyte Culture Test, Mixed
=450  \\$wnnna$aLeukocyte Reaction, Mixed
=450  \\$wnnna$aLeukocyte Reactions, Mixed
=450  \\$wnnna$aLymphocyte Reaction, Mixed
=450  \\$wnnna$aLymphocyte Reactions, Mixed
=450  \\$wnnna$aMixed Leukocyte Culture Test
=450  \\$wnnna$aMixed Leukocyte Reaction
=450  \\$wnnna$aMixed Leukocyte Reactions
=450  \\$aMixed Lymphocyte Culture Test
=450  \\$aMixed Lymphocyte Reaction
=450  \\$wnnna$aMixed Lymphocyte Reactions
=550  \\$wg$aHistocompatibility Testing
=667  \\$aNIM
=680  \\$iMeasure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
=688  \\$a93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92
=750  \0$aLymphocyte culture test, Mixed$5IEN-M$0(DLC)sh 85079145

=LDR  03159cz  a2200697n  4500
=001  9880363624302441
=005  20141212211049.0
=008  880609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015459
=035  \\$aCBA1187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x428.$x580.$x100
=072  \\$aC15.$x604.$x515.$x560.$x575.$x100
=072  \\$aC20.$x683.$x515.$x528.$x582.$x100
=150  \\$aLeukemia-Lymphoma, Adult T-Cell
=450  \\$wnnna$aAdult T-Cell Leukemia
=450  \\$wnnna$aAdult T-Cell Leukemia-Lymphoma
=450  \\$wnnna$aAdult T-Cell Leukemia-Lymphomas
=450  \\$wnnna$aAdult T-Cell Leukemias
=450  \\$wnnna$aATLL
=450  \\$wnnna$aHTLV-Associated Leukemia-Lymphoma
=450  \\$wnnna$aHTLV Associated Leukemia Lymphoma
=450  \\$wnnna$aHTLV-Associated Leukemia-Lymphomas
=450  \\$wnnna$aHTLV I Associated T Cell Leukemia Lymphoma
=450  \\$wnnna$aHTLV-I-Associated T-Cell Leukemia-Lymphoma
=450  \\$wnnna$aHTLV-I-Associated T-Cell Leukemia-Lymphomas
=450  \\$wnnna$aHuman T-Cell Leukemia-Lymphoma
=450  \\$wnnna$aHuman T Cell Leukemia Lymphoma
=450  \\$wnnna$aHuman T-Cell Leukemia-Lymphomas
=450  \\$wnnna$aHuman T Lymphotropic Virus Associated Leukemia Lymphoma
=450  \\$wnnna$aHuman T Lymphotropic Virus-Associated Leukemia-Lymphoma
=450  \\$wnnna$aLeukemia, Adult T-Cell
=450  \\$wnnna$aLeukemia, Adult T Cell
=450  \\$wnnna$aLeukemia Lymphoma, Adult T Cell
=450  \\$wnnna$aLeukemia-Lymphoma, HTLV-Associated
=450  \\$wnnna$aLeukemia-Lymphoma, HTLV-I-Associated T-Cell
=450  \\$wnnna$aLeukemia-Lymphoma, Human T-Cell
=450  \\$wnnna$aLeukemia Lymphoma, T Cell, Acute, HTLV I Associated
=450  \\$wnnna$aLeukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated
=450  \\$wnnna$aLeukemia-Lymphomas, Adult T-Cell
=450  \\$wnnna$aLeukemia-Lymphomas, HTLV-Associated
=450  \\$wnnna$aLeukemia-Lymphomas, HTLV-I-Associated T-Cell
=450  \\$wnnna$aLeukemia-Lymphomas, Human T-Cell
=450  \\$wnnna$aLeukemias, Adult T-Cell
=450  \\$wnnna$aT Cell Leukemia, Adult
=450  \\$wnnna$aT-Cell Leukemia, Adult
=450  \\$wnnna$aT-Cell Leukemia-Lymphoma, Adult
=450  \\$wnnna$aT Cell Leukemia Lymphoma, Adult
=450  \\$wnnna$aT Cell Leukemia Lymphoma, HTLV I Associated
=450  \\$wnnna$aT-Cell Leukemia-Lymphoma, HTLV-I-Associated
=450  \\$wnnna$aT-Cell Leukemia-Lymphoma, Human
=450  \\$wnnna$aT-Cell Leukemia-Lymphomas, Adult
=450  \\$wnnna$aT-Cell Leukemia-Lymphomas, HTLV-I-Associated
=450  \\$wnnna$aT-Cell Leukemia-Lymphomas, Human
=450  \\$wnnna$aT-Cell Leukemias, Adult
=550  \\$wg$aLeukemia, T-Cell
=680  \\$iAggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.
=688  \\$a2008 (1989)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, T-Cell, Acute
=688  \\$a89
=750  \0$aAdult T-cell leukemia$0(DLC) sh 94002377$5IEN-M

=LDR  01033cz  a2200289n  4500
=001  9880363624402441
=005  20141212202849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007953
=035  \\$aCBA1184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x650
=072  \\$aC4.$x682.$x512
=072  \\$aC26.$x733.$x345
=150  \\$aLeukemia, Radiation-Induced
=450  \\$wnnna$aLeukemia, Radiation Induced
=450  \\$wnnna$aLeukemias, Radiation-Induced
=450  \\$wnnna$aRadiation-Induced Leukemia
=450  \\$wnnna$aRadiation Induced Leukemia
=450  \\$wnnna$aRadiation-Induced Leukemias
=550  \\$wg$aLeukemia
=550  \\$wg$aNeoplasms, Radiation-Induced
=550  \\$wg$aRadiation Injuries
=550  \\$aNeoplasms, Radiation-Induced
=667  \\$acoordinate IM with specific type of LEUKEMIA (IM); solitary myeloma goes here
=680  \\$iLeukemia produced by exposure to IONIZING RADIATION or NON-IONIZING RADIATION.
=750  \0$aLeukemia, Radiation-induced$5IEN$0(DLC)sh 85076295

=LDR  01188cz  a2200313n  4500
=001  9880363624502441
=005  20141212202848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007952
=035  \\$aCBA1180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x595
=072  \\$aC4.$x557.$x595.$x500.$x500
=072  \\$aC20.$x683.$x515.$x845.$x500
=150  \\$aLeukemia, Plasma Cell
=450  \\$aLeukemia, Plasmacytic
=450  \\$wnnna$aLeukemias, Plasma Cell
=450  \\$wnnna$aLeukemias, Plasmacytic
=450  \\$aPlasma Cell Leukemia
=450  \\$wnnna$aPlasma Cell Leukemias
=450  \\$aPlasmacytic Leukemia
=450  \\$wnnna$aPlasmacytic Leukemias
=550  \\$wg$aLeukemia
=550  \\$wg$aMultiple Myeloma
=680  \\$iA rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.
=688  \\$a2008 (1967)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, Plasmacytic
=688  \\$a67
=750  \0$aPlasmacytic leukemia$0(DLC) sh 85103090$5IEN

=LDR  03577cz  a2200865n  4500
=001  9880363624602441
=005  20141212211054.0
=008  880609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015470
=035  \\$aCBA1178M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x539.$x275
=150  \\$aLeukemia, Myeloid, Acute
=450  \\$wnnna$aAcute Myeloblastic Leukemia
=450  \\$wnnna$aAcute Myeloblastic Leukemias
=450  \\$wnnna$aAcute Myelocytic Leukemia
=450  \\$wnnna$aAcute Myelocytic Leukemias
=450  \\$wnnna$aAcute Myelogenous Leukemia
=450  \\$wnnna$aAcute Myelogenous Leukemias
=450  \\$wnnna$aAcute Myeloid Leukemia
=450  \\$wnnna$aAcute Myeloid Leukemia with Maturation
=450  \\$wnnna$aAcute Myeloid Leukemia without Maturation
=450  \\$wnnna$aAcute Myeloid Leukemias
=450  \\$wnnna$aAcute Nonlymphoblastic Leukemia
=450  \\$wnnna$aAcute Nonlymphoblastic Leukemias
=450  \\$wnnna$aAcute Nonlymphocytic Leukemia
=450  \\$wnnna$aAcute Nonlymphocytic Leukemias
=450  \\$wnnna$aANLL
=450  \\$wnnna$aLeukemia, Acute Myeloblastic
=450  \\$wnnna$aLeukemia, Acute Myelocytic
=450  \\$wnnna$aLeukemia, Acute Myelogenous
=450  \\$wnnna$aLeukemia, Acute Myeloid
=450  \\$wnnna$aLeukemia, Acute Nonlymphoblastic
=450  \\$wnnna$aLeukemia, Acute Nonlymphocytic
=450  \\$wnnna$aLeukemia, Myeloblastic, Acute
=450  \\$wnnna$aLeukemia, Myelocytic, Acute
=450  \\$aLeukemia, Myelogenous, Acute
=450  \\$wnnna$aLeukemia, Myeloid, Acute, M1
=450  \\$wnnna$aLeukemia, Myeloid, Acute, M2
=450  \\$wnnna$aLeukemia, Nonlymphoblastic, Acute
=450  \\$aLeukemia, Nonlymphocytic, Acute
=450  \\$wnnna$aLeukemias, Acute Myeloblastic
=450  \\$wnnna$aLeukemias, Acute Myelocytic
=450  \\$wnnna$aLeukemias, Acute Myelogenous
=450  \\$wnnna$aLeukemias, Acute Myeloid
=450  \\$wnnna$aLeukemias, Acute Nonlymphoblastic
=450  \\$wnnna$aLeukemias, Acute Nonlymphocytic
=450  \\$wnnna$aMyeloblastic Leukemia, Acute
=450  \\$wnnna$aMyeloblastic Leukemias, Acute
=450  \\$wnnna$aMyelocytic Leukemia, Acute
=450  \\$wnnna$aMyelocytic Leukemias, Acute
=450  \\$wnnna$aMyelogenous Leukemia, Acute
=450  \\$wnnna$aMyelogenous Leukemias, Acute
=450  \\$aMyeloid Leukemia, Acute
=450  \\$wnnna$aMyeloid Leukemia, Acute, M1
=450  \\$wnnna$aMyeloid Leukemia, Acute, M2
=450  \\$wnnna$aMyeloid Leukemias, Acute
=450  \\$wnnna$aNonlymphoblastic Leukemia, Acute
=450  \\$wnnna$aNonlymphoblastic Leukemias, Acute
=450  \\$aNonlymphocytic Leukemia, Acute
=450  \\$wnnna$aNonlymphocytic Leukemias, Acute
=550  \\$wg$aLeukemia, Myeloid
=550  \\$wh$aLeukemia, Basophilic, Acute
=550  \\$wh$aLeukemia, Eosinophilic, Acute
=550  \\$wh$aLeukemia, Erythroblastic, Acute
=550  \\$wh$aLeukemia, Mast-Cell
=550  \\$wh$aLeukemia, Megakaryoblastic, Acute
=550  \\$wh$aLeukemia, Monocytic, Acute
=550  \\$wh$aLeukemia, Promyelocytic, Acute
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iClonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
=688  \\$a2008 (1989)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, Nonlymphocytic, Acute
=688  \\$a89
=750  \0$aAcute myeloid leukemia$0(DLC) sh 90001715$5IEN-M

=LDR  04384cz  a2200913n  4500
=001  9880363624702441
=005  20141212211051.0
=008  880609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015464
=035  \\$aCBA1173HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x539.$x250
=072  \\$aC15.$x378.$x190.$x636.$x370
=150  \\$aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
=450  \\$wnnna$aChronic Granulocytic Leukemia
=450  \\$wnnna$aChronic Granulocytic Leukemias
=450  \\$wnnna$aChronic Myelocytic Leukemia
=450  \\$wnnna$aChronic Myelocytic Leukemias
=450  \\$wnnna$aChronic Myelogenous Leukemia
=450  \\$wnnna$aChronic Myelogenous Leukemias
=450  \\$wnnna$aChronic Myeloid Leukemia
=450  \\$wnnna$aChronic Myeloid Leukemias
=450  \\$aGranulocytic Leukemia, Chronic
=450  \\$wnnna$aGranulocytic Leukemias, Chronic
=450  \\$wnnna$aLeukemia, Chronic Granulocytic
=450  \\$wnnna$aLeukemia, Chronic Myelocytic
=450  \\$wnnna$aLeukemia, Chronic Myelogenous
=450  \\$wnnna$aLeukemia, Chronic Myeloid
=450  \\$aLeukemia, Granulocytic, Chronic
=450  \\$aLeukemia, Myelocytic, Chronic
=450  \\$aLeukemia, Myelogenous, Chronic
=450  \\$wnnna$aLeukemia, Myelogenous, Ph1 Positive
=450  \\$wnnna$aLeukemia, Myelogenous, Ph1-Positive
=450  \\$aLeukemia, Myeloid, Chronic
=450  \\$wnnna$aLeukemia, Myeloid, Ph1 Positive
=450  \\$wnnna$aLeukemia, Myeloid, Ph1-Positive
=450  \\$wnnna$aLeukemia, Myeloid, Philadelphia Positive
=450  \\$wnnna$aLeukemia, Myeloid, Philadelphia-Positive
=450  \\$wnnna$aLeukemia, Ph1-Positive Myelogenous
=450  \\$wnnna$aLeukemia, Ph1-Positive Myeloid
=450  \\$wnnna$aLeukemia, Philadelphia-Positive Myeloid
=450  \\$wnnna$aLeukemias, Chronic Granulocytic
=450  \\$wnnna$aLeukemias, Chronic Myelocytic
=450  \\$wnnna$aLeukemias, Chronic Myelogenous
=450  \\$wnnna$aLeukemias, Chronic Myeloid
=450  \\$wnnna$aLeukemias, Ph1-Positive Myelogenous
=450  \\$wnnna$aLeukemias, Ph1-Positive Myeloid
=450  \\$wnnna$aLeukemias, Philadelphia-Positive Myeloid
=450  \\$aMyelocytic Leukemia, Chronic
=450  \\$wnnna$aMyelocytic Leukemias, Chronic
=450  \\$aMyelogenous Leukemia, Chronic
=450  \\$wnnna$aMyelogenous Leukemia, Ph1-Positive
=450  \\$wnnna$aMyelogenous Leukemia, Ph1 Positive
=450  \\$wnnna$aMyelogenous Leukemias, Chronic
=450  \\$wnnna$aMyelogenous Leukemias, Ph1-Positive
=450  \\$aMyeloid Leukemia, Chronic
=450  \\$wnnna$aMyeloid Leukemia, Ph1-Positive
=450  \\$wnnna$aMyeloid Leukemia, Ph1 Positive
=450  \\$wnnna$aMyeloid Leukemia, Philadelphia-Positive
=450  \\$wnnna$aMyeloid Leukemia, Philadelphia Positive
=450  \\$wnnna$aMyeloid Leukemias, Chronic
=450  \\$wnnna$aMyeloid Leukemias, Ph1-Positive
=450  \\$wnnna$aMyeloid Leukemias, Philadelphia-Positive
=450  \\$wnnna$aPh1-Positive Myelogenous Leukemia
=450  \\$wnnna$aPh1-Positive Myelogenous Leukemias
=450  \\$wnnna$aPh1-Positive Myeloid Leukemia
=450  \\$wnnna$aPh1-Positive Myeloid Leukemias
=450  \\$wnnna$aPhiladelphia-Positive Myeloid Leukemia
=450  \\$wnnna$aPhiladelphia-Positive Myeloid Leukemias
=550  \\$wg$aLeukemia, Myeloid
=550  \\$wg$aMyeloproliferative Disorders
=550  \\$wh$aBlast Crisis
=550  \\$wh$aLeukemia, Myeloid, Accelerated Phase
=550  \\$wh$aLeukemia, Myeloid, Chronic-Phase
=680  \\$iClonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
=688  \\$a2008 (1989); for LEUKEMIA, MYELOCYTIC, CHRONIC & LEUKEMIA, MYELOGENOUS, CHRONIC use LEUKEMIA, MYELOID 1974-1988
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, Myeloid, Chronic
=688  \\$a89; LEUKEMIA, MYELOCYTIC, CHRONIC & LEUKEMIA, MYELOGENOUS, CHRONIC were see LEUKEMIA, MYELOCYTIC 1974-88
=750  \0$aChronic myeloid leukemia$0(DLC) sh2004008307$5IEN-M

=LDR  02269cz  a2200553n  4500
=001  9880363624802441
=005  20141212202848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007951
=035  \\$aCBA1171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x539
=150  \\$aLeukemia, Myeloid
=450  \\$wnnna$aChronic Monocytic Leukemia
=450  \\$wnnna$aChronic Monocytic Leukemias
=450  \\$aGranulocytic Leukemia
=450  \\$wnnna$aGranulocytic Leukemias
=450  \\$wnnna$aLeukemia, Chronic Monocytic
=450  \\$aLeukemia, Granulocytic
=450  \\$wnnna$aLeukemia, Monocytic, Chronic
=450  \\$aLeukemia, Myelocytic
=450  \\$aLeukemia, Myelogenous
=450  \\$wnnna$aLeukemias, Chronic Monocytic
=450  \\$wnnna$aLeukemias, Granulocytic
=450  \\$wnnna$aLeukemias, Myelocytic
=450  \\$wnnna$aLeukemias, Myelogenous
=450  \\$wnnna$aLeukemias, Myeloid
=450  \\$wnnna$aMonocytic Leukemia, Chronic
=450  \\$wnnna$aMonocytic Leukemias, Chronic
=450  \\$aMyelocytic Leukemia
=450  \\$wnnna$aMyelocytic Leukemias
=450  \\$aMyelogenous Leukemia
=450  \\$wnnna$aMyelogenous Leukemias
=450  \\$aMyeloid Leukemia
=450  \\$wnnna$aMyeloid Leukemias
=550  \\$wg$aLeukemia
=550  \\$wh$aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
=550  \\$wh$aLeukemia, Myeloid, Acute
=550  \\$wh$aLeukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
=550  \\$wh$aLeukemia, Myelomonocytic, Acute
=550  \\$wh$aLeukemia, Myelomonocytic, Chronic
=550  \\$wh$aLeukemia, Myelomonocytic, Juvenile
=550  \\$wh$aSarcoma, Myeloid
=667  \\$ageneral or unspecified: prefer specifics; index here for CD4+/CD56+ hematodermic neoplasms
=680  \\$iForm of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
=688  \\$a1989
=688  \\$a89; LEUKEMIA, MYELOCYTIC was heading 1963-88; LEUKEMIA, GRANULOCYTIC was see LEUKEMIA, MYELOCYTIC 1974-88
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Leukemias, Chronic Monocytic
=750  \0$aMyeloid leukemia$0(DLC) sh 85089219$5IEN

=LDR  01437cz  a2200397n  4500
=001  9880363624902441
=005  20141212202846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007945
=035  \\$aCBA1160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x428
=072  \\$aC15.$x604.$x515.$x560
=072  \\$aC20.$x683.$x515.$x528
=150  \\$aLeukemia, Lymphoid
=450  \\$aLeukemia, Lymphocytic
=450  \\$wnnna$aLeukemias, Lymphocytic
=450  \\$wnnna$aLeukemias, Lymphoid
=450  \\$aLymphocytic Leukemia
=450  \\$wnnna$aLymphocytic Leukemias
=450  \\$aLymphoid Leukemia
=450  \\$wnnna$aLymphoid Leukemias
=550  \\$wg$aLeukemia
=550  \\$wg$aLymphoproliferative Disorders
=550  \\$wh$aLeukemia, B-Cell
=550  \\$wh$aLeukemia, Biphenotypic, Acute
=550  \\$wh$aLeukemia, Prolymphocytic
=550  \\$wh$aLeukemia, T-Cell
=550  \\$wh$aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
=550  \\$aLymphatic Diseases
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iLeukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, Lymphocytic
=688  \\$aLEUKEMIA, LYMPHOBLASTIC was heading 1967-88
=750  \0$aLymphocytic leukemia$0(DLC) sh 85079150$5IEN

=LDR  01376cz  a2200301n  4500
=001  9880363625002441
=005  20141212202845.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007943
=035  \\$aCBA1159HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x415
=072  \\$aC15.$x604.$x515.$x553
=072  \\$aC20.$x683.$x515.$x517
=150  \\$aLeukemia, Hairy Cell
=450  \\$aHairy Cell Leukemia
=450  \\$wnnna$aHairy Cell Leukemias
=450  \\$wnnna$aLeukemias, Hairy Cell
=450  \\$wnnna$aLeukemic Reticuloendothelioses
=450  \\$aLeukemic Reticuloendotheliosis
=450  \\$wnnna$aReticuloendothelioses, Leukemic
=450  \\$aReticuloendotheliosis, Leukemic
=550  \\$wg$aLeukemia
=550  \\$wg$aLymphoproliferative Disorders
=667  \\$asince the disease is chronic, do not coordinate with CHRONIC DISEASE; note entry term RETICULOENDOTHELIOSIS, LEUKEMIC;: RETICULOENDOTHELIOSIS, AVIAN is also available
=680  \\$iA neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow.
=688  \\$a78
=750  \0$aLeukemia, Hairy cell$5IEN$0(DLC)sh 85076294

=LDR  01203cz  a2200337n  4500
=001  9880363625102441
=005  20141212202845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007942
=035  \\$aCBA1158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x372
=072  \\$aC4.$x619.$x531
=072  \\$aE5.$x598.$x500.$x496.$x500
=150  \\$aLeukemia, Experimental
=450  \\$wnnna$aAnimal Leukemia Model
=450  \\$wnnna$aAnimal Leukemia Models
=450  \\$wnnna$aExperimental Leukemia
=450  \\$wnnna$aExperimental Leukemias
=450  \\$wnnna$aLeukemia Model, Animal
=450  \\$wnnna$aLeukemia Models, Animal
=450  \\$wnnna$aLeukemias, Experimental
=550  \\$wg$aLeukemia
=550  \\$wg$aNeoplasms, Experimental
=550  \\$wh$aAvian Leukosis
=550  \\$wh$aLeukemia L1210
=550  \\$wh$aLeukemia L5178
=550  \\$wh$aLeukemia P388
=667  \\$aincludes infection by LEUKEMOGENIC VIRUSES; DF: LEUKEMIA EXPER
=680  \\$iLeukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
=750  \0$aLeukemia, Experimental$5IEN$0(DLC)sh 85076293

=LDR  05159cz  a2201129n  4500
=001  9880363625202441
=005  20141212211046.0
=008  880609\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015451
=035  \\$aCBA1153HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x428.$x80.$x125
=072  \\$aC15.$x604.$x515.$x560.$x80.$x125
=072  \\$aC20.$x683.$x515.$x528.$x80.$x125
=150  \\$aLeukemia, Lymphocytic, Chronic, B-Cell
=450  \\$wnnna$aB-Cell Chronic Lymphocytic Leukemia
=450  \\$wnnna$aB Cell Chronic Lymphocytic Leukemia
=450  \\$aB-Cell Leukemia, Chronic
=450  \\$wnnna$aB Cell Leukemia, Chronic
=450  \\$wnnna$aB-Cell Leukemias, Chronic
=450  \\$wnnna$aB-Cell Malignancy, Low-Grade
=450  \\$aB-Lymphocytic Leukemia, Chronic
=450  \\$wnnna$aB Lymphocytic Leukemia, Chronic
=450  \\$wnnna$aB-Lymphocytic Leukemias, Chronic
=450  \\$wnnna$aChronic B-Cell Leukemia
=450  \\$wnnna$aChronic B-Cell Leukemias
=450  \\$wnnna$aChronic B-Lymphocytic Leukemia
=450  \\$wnnna$aChronic B-Lymphocytic Leukemias
=450  \\$wnnna$aChronic Lymphoblastic Leukemia
=450  \\$wnnna$aChronic Lymphoblastic Leukemias
=450  \\$aChronic Lymphocytic Leukemia
=450  \\$wnnna$aChronic Lymphocytic Leukemias
=450  \\$wnnna$aCLL Lymphoplasmacytoid Lymphoma
=450  \\$wnnna$aCLL Lymphoplasmacytoid Lymphomas
=450  \\$wnnna$aDiffuse Well-Differentiated Lymphocytic Lymphoma
=450  \\$wnnna$aDiffuse Well Differentiated Lymphocytic Lymphoma
=450  \\$wnnna$aDisrupted In B-Cell Malignancy
=450  \\$wnnna$aLeukemia, B Cell, Chronic
=450  \\$aLeukemia, B-Cell, Chronic
=450  \\$wnnna$aLeukemia, Chronic B-Cell
=450  \\$wnnna$aLeukemia, Chronic B-Lymphocytic
=450  \\$wnnna$aLeukemia, Chronic Lymphatic
=450  \\$wnnna$aLeukemia, Chronic Lymphocytic
=450  \\$wnnna$aLeukemia, Chronic Lymphocytic, B-Cell
=450  \\$wnnna$aLeukemia, Lymphoblastic, Chronic
=450  \\$aLeukemia, Lymphocytic, Chronic
=450  \\$wnnna$aLeukemia, Lymphocytic, Chronic, B Cell
=450  \\$wnnna$aLeukemias, Chronic B-Cell
=450  \\$wnnna$aLeukemias, Chronic B-Lymphocytic
=450  \\$wnnna$aLeukemias, Chronic Lymphoblastic
=450  \\$wnnna$aLymphoblastic Leukemia, Chronic
=450  \\$wnnna$aLymphoblastic Leukemias, Chronic
=450  \\$wnnna$aLymphocytic Leukemia, Chronic
=450  \\$wnnna$aLymphocytic Leukemia, Chronic, B Cell
=450  \\$aLymphocytic Leukemia, Chronic, B-Cell
=450  \\$wnnna$aLymphocytic Leukemias, Chronic
=450  \\$wnnna$aLymphocytic Lymphoma
=450  \\$wnnna$aLymphocytic Lymphoma, Diffuse, Well Differentiated
=450  \\$wnnna$aLymphocytic Lymphoma, Diffuse, Well-Differentiated
=450  \\$wnnna$aLymphocytic Lymphoma, Small
=450  \\$wnnna$aLymphocytic Lymphoma, Well Differentiated
=450  \\$wnnna$aLymphocytic Lymphoma, Well-Differentiated
=450  \\$wnnna$aLymphocytic Lymphomas
=450  \\$wnnna$aLymphocytic Lymphomas, Small
=450  \\$wnnna$aLymphocytic Lymphomas, Well-Differentiated
=450  \\$wnnna$aLymphoma, CLL Lymphoplasmacytoid
=450  \\$wnnna$aLymphoma, Lymphocytic
=450  \\$wnnna$aLymphoma, Lymphocytic, Diffuse, Well Differentiated
=450  \\$wnnna$aLymphoma, Lymphocytic, Diffuse, Well-Differentiated
=450  \\$wnnna$aLymphoma, Lymphocytic, Well Differentiated
=450  \\$wnnna$aLymphoma, Lymphocytic, Well-Differentiated
=450  \\$wnnna$aLymphoma, Lymphoplasmacytoid, CLL
=450  \\$wnnna$aLymphoma, Small-Cell
=450  \\$wnnna$aLymphoma, Small Cell
=450  \\$aLymphoma, Small Lymphocytic
=450  \\$wnnna$aLymphoma, Small Lymphocytic, Plasmacytoid
=450  \\$wnnna$aLymphoma, Well-Differentiated Lymphocytic
=450  \\$wnnna$aLymphomas, CLL Lymphoplasmacytoid
=450  \\$wnnna$aLymphomas, Lymphocytic
=450  \\$wnnna$aLymphomas, Small-Cell
=450  \\$wnnna$aLymphomas, Small Lymphocytic
=450  \\$wnnna$aLymphomas, Well-Differentiated Lymphocytic
=450  \\$wnnna$aLymphoplasmacytoid Lymphoma, CLL
=450  \\$wnnna$aLymphoplasmacytoid Lymphomas, CLL
=450  \\$wnnna$aSmall-Cell Lymphoma
=450  \\$wnnna$aSmall Cell Lymphoma
=450  \\$wnnna$aSmall-Cell Lymphomas
=450  \\$wnnna$aSmall Lymphocytic Lymphoma
=450  \\$wnnna$aSmall Lymphocytic Lymphomas
=450  \\$wnnna$aWell-Differentiated Lymphocytic Lymphoma
=450  \\$wnnna$aWell-Differentiated Lymphocytic Lymphomas
=550  \\$wg$aLeukemia, B-Cell
=680  \\$iA chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease.
=688  \\$a2008 (1989)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Leukemia, B-Cell, Chronic
=688  \\$a89
=750  \0$aChronic lymphocytic leukemia$0(DLC) sh 87004460$5IEN-M

=LDR  01609cz  a2200373n  4500
=001  9880363625302441
=005  20141212202844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007938
=035  \\$aCBA1145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337
=150  \\$aLeukemia
=450  \\$wnnna$aLeucocythaemia
=450  \\$wnnna$aLeucocythaemias
=450  \\$wnnna$aLeucocythemia
=450  \\$wnnna$aLeucocythemias
=450  \\$wnnna$aLeukemias
=450  \\$wnnoa$aLeumkemia, Subleukemic$5IEN-M
=550  \\$wg$aNeoplasms by Histologic Type
=550  \\$wh$aEnzootic Bovine Leukosis
=550  \\$wh$aLeukemia, Experimental
=550  \\$wh$aLeukemia, Feline
=550  \\$wh$aLeukemia, Hairy Cell
=550  \\$wh$aLeukemia, Lymphoid
=550  \\$wh$aLeukemia, Mast-Cell
=550  \\$wh$aLeukemia, Myeloid
=550  \\$wh$aLeukemia, Plasma Cell
=550  \\$wh$aLeukemia, Radiation-Induced
=550  \\$aHematologic Neoplasms
=550  \\$aMyeloproliferative Disorders
=667  \\$ageneral or unspecified; many specific leukemia types are available
=680  \\$iA progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
=750  \0$aLeukemia$5IEN$0(DLC)sh 85076285

=LDR  01274cz  a2200397n  4500
=001  9880363625402441
=005  20141212202843.0
=008  780126\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007937
=035  \\$aCBA1144HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x160.$x570
=072  \\$aE2.$x120.$x285.$x570
=072  \\$aE2.$x120.$x527.$x570
=072  \\$aE5.$x242.$x363.$x285.$x570
=150  \\$aLeukapheresis
=450  \\$wnnna$aLeukaphereses
=450  \\$wnnna$aLeukocytaphereses
=450  \\$aLeukocytapheresis
=450  \\$wnnna$aLeukocytophereses
=450  \\$wnnna$aLeukocytopheresis
=450  \\$wnnna$aLeukophereses
=450  \\$aLeukopheresis
=450  \\$wnnna$aLymphaphereses
=450  \\$aLymphapheresis
=450  \\$wnnna$aLymphocytaphereses
=450  \\$aLymphocytapheresis
=450  \\$wnnna$aLymphocytophereses
=450  \\$wnnna$aLymphocytopheresis
=450  \\$wnnna$aLymphophereses
=450  \\$wnnna$aLymphopheresis
=550  \\$wg$aCytapheresis
=550  \\$wg$aLeukocyte Reduction Procedures
=680  \\$iThe preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor.
=688  \\$a79; was see PLASMAPHERESIS 1978
=750  \0$aLeukapheresis$5IEN$0(DLC)sh 85076284

=LDR  00713cz  a2200193n  4500
=001  9880363625502441
=005  20180814122232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007934
=035  \\$aCBA1141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x550.$x475.$x450
=150  \\$aLeuconostoc
=450  \\$wnnna$aLeukonostoc
=550  \\$wg$aLeuconostocaceae
=550  \\$wh$aLeuconostoc mesenteroides
=667  \\$ain plant & dairy products
=680  \\$iA genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans.
=750  \0$aLeuconostoc$5IEN$0(DLC)sh 85076273

=LDR  01763cz  a2200373n  4500
=001  9880363625602441
=005  20141212202842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007931
=035  \\$aCBA1138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x350.$x100.$x511
=072  \\$aD8.$x811.$x277.$x656.$x350.$x555.$x700
=072  \\$aD8.$x811.$x277.$x656.$x675.$x555.$x700
=150  \\$aLeucyl Aminopeptidase
=450  \\$wnnna$aAminopeptidase, Cytosol
=450  \\$wnnna$aAminopeptidase, Leucine
=450  \\$wnnna$aAminopeptidase, Leucyl
=450  \\$wnnna$aAminopeptidase, Methoxyleucine
=450  \\$wnnna$aAminopeptidase, Zinc-Manganese-Leucine
=450  \\$aCytosol Aminopeptidase
=450  \\$wnnna$aL-Leucylnaphthylamidase
=450  \\$aLeucine Aminopeptidase
=450  \\$wnnna$aMethoxyleucine Aminopeptidase
=450  \\$wnnna$aPeptidase S
=450  \\$wnnna$aS, Peptidase
=450  \\$wnnna$aZinc-Manganese-Leucine Aminopeptidase
=450  \\$wnnna$aZinc Manganese Leucine Aminopeptidase
=550  \\$wg$aAminopeptidases
=550  \\$wg$aMetalloexopeptidases
=680  \\$iA zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. The activity of this enzyme is commonly assayed using a leucine arylamide chromogenic substrate such as leucyl beta-naphthylamide.
=688  \\$a1999(1965)
=688  \\$a99(65); for PEPTIDASE S use LEUCYL AMINOPEPTIDASE (NM) 1979-98
=750  \0$aLeucine aminopeptidase$0(DLC) sh 85076261$5IEN

=LDR  00752cz  a2200241n  4500
=001  9880363625702441
=005  20141212202842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007930
=035  \\$aCBA1137HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x70.$x637
=072  \\$aD12.$x125.$x142.$x441
=150  \\$aLeucine
=450  \\$wnnna$aL-Isomer Leucine
=450  \\$wnnna$aL-Leucine
=450  \\$wnnna$aLeucine, L-Isomer
=450  \\$wnnna$aLeucine, L Isomer
=550  \\$wg$aAmino Acids, Branched-Chain
=550  \\$wg$aAmino Acids, Essential
=667  \\$a/biosyn /defic /physiol permitted
=680  \\$iAn essential branched-chain amino acid important for hemoglobin formation.
=750  \0$aLeucine$5IEN$0(DLC)sh 85076260

=LDR  06566cz  a2201285n  4500
=001  9880363625802441
=005  20141212202841.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x425
=072  \\$aC10.$x574.$x500.$x536
=072  \\$aC10.$x597.$x606.$x643.$x455.$x625
=072  \\$aC16.$x320.$x322.$x500.$x625
=072  \\$aC16.$x320.$x400.$x500
=072  \\$aC16.$x320.$x400.$x525.$x625
=072  \\$aC16.$x320.$x565.$x189.$x425
=072  \\$aC16.$x320.$x565.$x798.$x594
=072  \\$aC18.$x452.$x132.$x100.$x425
=072  \\$aC18.$x452.$x648.$x189.$x425
=072  \\$aC18.$x452.$x648.$x798.$x594
=150  \\$aLesch-Nyhan Syndrome
=450  \\$aChoreoathetosis Self-Mutilation Hyperuricemia Syndrome
=450  \\$wnnna$aChoreoathetosis Self Mutilation Hyperuricemia Syndrome
=450  \\$wnnna$aChoreoathetosis Self-Mutilation Syndrome
=450  \\$wnnna$aChoreoathetosis Self Mutilation Syndrome
=450  \\$wnnna$aChoreoathetosis Self-Mutilation Syndromes
=450  \\$wnnna$aComplete HGPRT Deficiency Disease
=450  \\$wnnna$aComplete HPRT Deficiencies
=450  \\$wnnna$aComplete HPRT Deficiency
=450  \\$wnnna$aComplete Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency
=450  \\$wnnna$aComplete Hypoxanthine Guanine Phosphoribosyltransferase Deficiency
=450  \\$wnnna$aDeficiencies, Complete HPRT
=450  \\$wnnna$aDeficiencies, HGPRT
=450  \\$wnnna$aDeficiencies, Hypoxanthine Phosphoribosyltransferase
=450  \\$wnnna$aDeficiencies, Total HPRT
=450  \\$wnnna$aDeficiency, Complete HPRT
=450  \\$wnnna$aDeficiency Disease, Complete HGPRT
=450  \\$wnnna$aDeficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase
=450  \\$wnnna$aDeficiency Disease, Hypoxanthine Phosphoribosyl Transferase
=450  \\$wnnna$aDeficiency Diseases, Hypoxanthine-Phosphoribosyl-Transferase
=450  \\$wnnna$aDeficiency, HGPRT
=450  \\$wnnna$aDeficiency, Hypoxanthine Phosphoribosyltransferase
=450  \\$wnnna$aDeficiency of Guanine Phosphoribosyltransferase
=450  \\$wnnna$aDeficiency of Hypoxanthine Phosphoribosyltransferase
=450  \\$wnnna$aDeficiency, Total HPRT
=450  \\$wnnna$aGuanine Phosphoribosyltransferase Deficiencies
=450  \\$wnnna$aGuanine Phosphoribosyltransferase Deficiency
=450  \\$wnnna$aHGPRT Deficiencies
=450  \\$wnnna$aHGPRT Deficiency
=450  \\$wnnna$aHGPRT Deficiency Disease, Complete
=450  \\$wnnna$aHPRT Deficiencies, Complete
=450  \\$wnnna$aHPRT Deficiencies, Total
=450  \\$wnnna$aHPRT Deficiency, Complete
=450  \\$wnnna$aHPRT Deficiency, Total
=450  \\$wnnna$aHyperuricemia Syndrome, Juvenile
=450  \\$wnnna$aHyperuricemia Syndrome, Primary
=450  \\$wnnna$aHyperuricemia Syndromes, Juvenile
=450  \\$wnnna$aHyperuricemia Syndromes, Primary
=450  \\$wnnna$aHyperuricemia, X-Linked
=450  \\$wnnna$aHyperuricemia, X-Linked Primary
=450  \\$wnnna$aHyperuricemias, X-Linked
=450  \\$wnnna$aHyperuricemias, X-Linked Primary
=450  \\$wnnna$aHypoxanthine Guanine Phosphoribosyltransferase 1 Deficiency
=450  \\$wnnna$aHypoxanthine Guanine Phosphoribosyltransferase Deficiency
=450  \\$aHypoxanthine-Phosphoribosyl-Transferase Deficiency Disease
=450  \\$wnnna$aHypoxanthine Phosphoribosyl Transferase Deficiency Disease
=450  \\$wnnna$aHypoxanthine-Phosphoribosyl-Transferase Deficiency Diseases
=450  \\$wnnna$aHypoxanthine Phosphoribosyltransferase Deficiencies
=450  \\$wnnna$aHypoxanthine Phosphoribosyltransferase Deficiency
=450  \\$wnnna$aJuvenile Gout, Choreoathetosis, Mental Retardation Syndrome
=450  \\$wnnna$aJuvenile Hyperuricemia Syndrome
=450  \\$wnnna$aJuvenile Hyperuricemia Syndromes
=450  \\$wnnna$aLesch-Nyhan Disease
=450  \\$wnnna$aLesch Nyhan Disease
=450  \\$wnnna$aLesch Nyhan Syndrome
=450  \\$wnnna$aPhosphoribosyltransferase Deficiencies, Guanine
=450  \\$wnnna$aPhosphoribosyltransferase Deficiencies, Hypoxanthine
=450  \\$wnnna$aPhosphoribosyltransferase Deficiency, Guanine
=450  \\$wnnna$aPhosphoribosyltransferase Deficiency, Hypoxanthine
=450  \\$wnnna$aPrimary Hyperuricemia Syndrome
=450  \\$wnnna$aPrimary Hyperuricemia Syndromes
=450  \\$wnnna$aPrimary Hyperuricemia, X-Linked
=450  \\$wnnna$aPrimary Hyperuricemias, X-Linked
=450  \\$wnnna$aSelf-Mutilation Syndrome, Choreoathetosis
=450  \\$wnnna$aSelf-Mutilation Syndromes, Choreoathetosis
=450  \\$wnnna$aSyndrome, Choreoathetosis Self-Mutilation
=450  \\$wnnna$aSyndrome, Juvenile Hyperuricemia
=450  \\$wnnna$aSyndrome, Primary Hyperuricemia
=450  \\$wnnna$aSyndromes, Choreoathetosis Self-Mutilation
=450  \\$wnnna$aSyndromes, Juvenile Hyperuricemia
=450  \\$wnnna$aSyndromes, Primary Hyperuricemia
=450  \\$wnnna$aTotal HPRT Deficiencies
=450  \\$wnnna$aTotal HPRT Deficiency
=450  \\$wnnna$aTotal Hypoxanthine-Guanine Phosphoribosyl Transferase Deficiency
=450  \\$wnnna$aTotal Hypoxanthine Guanine Phosphoribosyl Transferase Deficiency
=450  \\$wnnna$aX-Linked Hyperuricemia
=450  \\$wnnna$aX Linked Hyperuricemia
=450  \\$wnnna$aX-Linked Hyperuricemias
=450  \\$wnnna$aX-Linked Primary Hyperuricemia
=450  \\$wnnna$aX Linked Primary Hyperuricemia
=450  \\$wnnna$aX-Linked Primary Hyperuricemias
=550  \\$wg$aBrain Diseases, Metabolic, Inborn
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aMental Retardation, X-Linked
=550  \\$wg$aPurine-Pyrimidine Metabolism, Inborn Errors
=550  \\$aHypoxanthine Phosphoribosyltransferase
=680  \\$iAn inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. (Menkes, Textbook of Child Neurology, 5th ed, pp127)
=688  \\$a1973(1971)
=750  \0$aLesch-Nyhan syndrome$5IEN$0(DLC)sh 85076163

=LDR  00673cz  a2200217n  4500
=001  9880363625902441
=005  20141212202838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007922
=035  \\$aCBA1129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x511
=072  \\$aC1.$x252.$x847.$x511
=150  \\$aLeptospirosis
=450  \\$wnnna$aLeptospiroses
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wg$aSpirochaetales Infections
=550  \\$wh$aWeil Disease
=667  \\$agram-neg bact infect; a spirochete infect
=680  \\$iInfections with bacteria of the genus LEPTOSPIRA.
=750  \0$aLeptospirosis$5IEN$0(DLC)sh 85076134

=LDR  00636cz  a2200193n  4500
=001  9880363626002441
=005  20141212202838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007919
=035  \\$aCBA1126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x475.$x475
=072  \\$aB3.$x851.$x475.$x475
=150  \\$aLeptospira
=550  \\$wg$aLeptospiraceae
=550  \\$wh$aLeptospira interrogans
=667  \\$ainfection = LEPTOSPIROSIS
=680  \\$iA genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic.
=750  \0$aLeptospira$5IEN$0(DLC)sh 88023276

=LDR  01299cz  a2200289n  4500
=001  9880363626102441
=005  20141212202838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007918
=035  \\$aCBA1122HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x386
=150  \\$aLeprosy
=450  \\$wnnna$aDisease, Hansen
=450  \\$wnnna$aDisease, Hansen's
=450  \\$wnnna$aHansen Disease
=450  \\$aHansen's Disease
=450  \\$wnnna$aHansens Disease
=450  \\$aLepers$5IEN
=450  \\$wnnna$aLeprosies
=550  \\$wg$aMycobacterium Infections
=550  \\$wh$aLeprosy, Multibacillary
=550  \\$wh$aLeprosy, Paucibacillary
=667  \\$ageneral or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent; rat leprosy = MYCOBACTERIUM INFECTIONS (IM) + MYCOBACTERIUM LEPRAEMURIUM (IM); ENL (erythema nodosum leprosum) = LEPROSY, LEPROMATOUS (IM) + ERYTHEMA NODOSUM (IM)
=680  \\$iA chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
=750  \0$aLeprosy$5IEN-M$0(DLC)sh 85076084
=750  \0$aLeprosy$xPatients$5IEN-HS$0(DLC)sh 85076050

=LDR  00924cz  a2200253n  4500
=001  9880363626202441
=005  20141212202837.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007917
=035  \\$aCBA1121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x85.$x777
=150  \\$aLeprostatic Agents
=450  \\$wnnna$aAgents, Antileprotic
=450  \\$wnnna$aAgents, Leprostatic
=450  \\$aAntileprotic Agents
=450  \\$wnnna$aLeprostatics
=550  \\$wg$aAnti-Bacterial Agents
=550  \\$aLeprosy
=550  \\$aMycobacterium leprae
=667  \\$a-static or -cidal; consider also MYCOBACTERIUM LEPRAE /drug eff & LEPROSY /drug ther
=680  \\$iSubstances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions.
=688  \\$a75
=750  \0$aLeprostatic agents$5IEN-M$0(DLC)sh 95004959

=LDR  00700cz  a2200217n  4500
=001  9880363626302441
=005  20200515133046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007915
=035  \\$aCBA1119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x937
=150  \\$aLepidoptera
=450  \\$wnnna$aLepidopteras
=550  \\$wg$aHolometabola
=550  \\$wh$aButterflies
=550  \\$wh$aMoths
=667  \\$aincludes BUTTERFLIES & MOTHS; don't forget SILKWORMS; /microbiol /parasitol /virol permitted
=680  \\$iA large order of insects comprising the butterflies and moths.
=688  \\$a75
=750  \0$aLepidoptera$5IEN$0(DLC)sh 85076067

=LDR  01280cz  a2200325n  4500
=001  9880363626402441
=005  20200529150032.0
=008  780126\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007910
=035  \\$aCBA1114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x500.$x460
=072  \\$aE7.$x695.$x460
=150  \\$aLenses, Intraocular
=450  \\$wnnna$aContact Lens, Implantable
=450  \\$wnnna$aImplantable Contact Lens
=450  \\$wnnna$aIntraocular Lens
=450  \\$wnnna$aIntraocular Lenses
=450  \\$wnnna$aLens, Implantable Contact
=450  \\$wnnna$aLens, Intraocular
=550  \\$wg$aLenses
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aMultifocal Intraocular Lenses
=550  \\$wh$aPhakic Intraocular Lenses
=550  \\$aCataract Extraction
=550  \\$aLens Implantation, Intraocular
=667  \\$aartificial lens: do not confuse with LENS, CRYSTALLINE (Category A); commonly used after cataract extraction but do not coordinate with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the state of the eye in the presence of an intraocular lens after cataract extraction
=680  \\$iArtificial implanted lenses.
=688  \\$a79
=750  \0$aIntraocular lenses$0(DLC) sh 85067622$5IEN

=LDR  00691cz  a2200193n  4500
=001  9880363626502441
=005  20141212202835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x500
=150  \\$aLenses
=550  \\$wg$aOptical Devices
=550  \\$wh$aContact Lenses
=550  \\$wh$aEyeglasses
=550  \\$wh$aLenses, Intraocular
=667  \\$afor microscopes, magnifying glasses, telescopes, etc. but not for eyeglasses or sunglasses ( = EYEGLASSES); see next entry
=680  \\$iPieces of glass or other transparent materials used for magnification or increased visual acuity.
=750  \0$aLenses$0(DLC) sh 85075999$5IEN

=LDR  01092cz  a2200229n  4500
=001  9880363626602441
=005  20141212202835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x500
=150  \\$aLens, Crystalline
=450  \\$wnnna$aCrystalline Lens
=450  \\$aEye Lens
=450  \\$aLens, Eye
=550  \\$wg$aAnterior Eye Segment
=550  \\$wh$aLens Capsule, Crystalline
=550  \\$wh$aLens Cortex, Crystalline
=550  \\$wh$aLens Nucleus, Crystalline
=667  \\$aof the eye; congenital absence = APHAKIA /congen; APHAKIA, POSTCATARACT is also available; replacement by intraocular lens = LENSES, INTRAOCULAR; extraction = probably CATARACT EXTRACTION
=680  \\$iA transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor (VITREOUS BODY). It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION.
=750  \0$aCrystalline lens$5IEN$0(DLC)sh 85034493

=LDR  00814cz  a2200265n  4500
=001  9880363626702441
=005  20141212202833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007902
=035  \\$aCBA1106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x400.$x480
=072  \\$aN2.$x421.$x585.$x400.$x480
=150  \\$aLength of Stay
=450  \\$wnnna$aHospital Stay
=450  \\$wnnna$aHospital Stays
=450  \\$wnnna$aStay, Hospital
=450  \\$wnnna$aStay Length
=450  \\$wnnna$aStay Lengths
=450  \\$wnnna$aStays, Hospital
=550  \\$wg$aHospitalization
=550  \\$aHospitalization
=680  \\$iThe period of confinement of a patient to a hospital or other health facility.
=688  \\$a72(69)
=750  \0$aHospital utilization$xLength of stay$5IEN$0(DLC)sh 85062269

=LDR  00913cz  a2200265n  4500
=001  9880363626802441
=005  20141212202833.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007901
=035  \\$aCBA1105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x700.$x508
=150  \\$aLemuridae
=450  \\$aHapalemur
=450  \\$wnnna$aHapalemurs
=450  \\$aLepilemur
=450  \\$wnnna$aLepilemurs
=450  \\$aVarecia
=450  \\$wnnna$aVarecias
=550  \\$wg$aStrepsirhini
=550  \\$wh$aLemur
=667  \\$aprosimians; IM; qualif permitted
=680  \\$iA family of the order PRIMATES, suborder Strepsirhini (PROSIMII), containing four genera which inhabit Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The four genera are Hapalemur, LEMUR, Lepilemur, and Varecia.
=688  \\$a81
=750  \0$aLemuridae$5IEN$0(DLC)sh 85075967

=LDR  00958cz  a2200193n  4500
=001  9880363626902441
=005  20141212202833.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007900
=035  \\$aCBA1104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x700.$x508.$x490
=150  \\$aLemur
=450  \\$wnnna$aLemurs
=550  \\$wg$aLemuridae
=667  \\$aa genus; do not confuse with LEMUR, DWARF see CHEIROGALEIDAE or LEMUR, MOUSE see CHEIROGALEIDAE; IM; qualif permitted
=680  \\$iA genus of the family Lemuridae consisting of five species: L. catta (ring-tailed lemur), L. fulvus, L. macaco (acoumba or black lemur), L. mongoz (mongoose lemur), and L. variegatus (white lemur). Most members of this genus occur in forested areas on Madagascar and the Comoro Islands.
=688  \\$a91(81); was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80
=750  \0$aLemur (Genus)$5IEN$0(DLC)sh 85075965

=LDR  00742cz  a2200265n  4500
=001  9880363627002441
=005  20141212202832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007899
=035  \\$aCBA1103HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450
=150  \\$aLeisure Activities
=450  \\$wnnna$aActivities, Leisure
=450  \\$wnnna$aActivity, Leisure
=450  \\$wnnna$aLeisure
=450  \\$wnnna$aLeisure Activity
=450  \\$wnnna$aLeisures
=550  \\$wg$aHuman Activities
=550  \\$wh$aHolidays
=550  \\$wh$aRecreation
=550  \\$wh$aRelaxation
=680  \\$iVoluntary use of free time for activities outside the daily routine.
=688  \\$a70
=750  \0$aLeisure$5IEN$0(DLC)sh 85075925

=LDR  01186cz  a2200229n  4500
=001  9880363627102441
=005  20141212202832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007898
=035  \\$aCBA1102HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x500.$x510
=150  \\$aLeishmaniasis, Visceral
=450  \\$aBlack Fever
=450  \\$wnnna$aFever, Black
=450  \\$aKala-Azar
=450  \\$wnnna$aKala Azar
=450  \\$wnnna$aVisceral Leishmaniasis
=550  \\$wg$aLeishmaniasis
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; do not confuse entry term BLACK FEVER with BLACKWATER FEVER or AMAZON BLACK FEVER see HEPATITIS D
=680  \\$iA chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
=750  \0$aK�ala-az�ar$5IEN$0(DLC)sh 85071321

=LDR  01093cz  a2200229n  4500
=001  9880363627202441
=005  20141212202832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007897
=035  \\$aCBA1101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x500.$x400.$x385
=072  \\$aC3.$x858.$x560.$x400.$x385
=072  \\$aC17.$x800.$x838.$x775.$x560.$x400.$x385
=150  \\$aLeishmaniasis, Mucocutaneous
=450  \\$wnnna$aLeishmaniases, Mucocutaneous
=450  \\$wnnna$aMucocutaneous Leishmaniases
=450  \\$wnnna$aMucocutaneous Leishmaniasis
=550  \\$wg$aLeishmaniasis, Cutaneous
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iA disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
=750  \0$aLeishmaniasis, Mucocutaneous$5IEN$0(DLC)sh 85075924

=LDR  01214cz  a2200241n  4500
=001  9880363627302441
=005  20141212202831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007896
=035  \\$aCBA1100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x500
=072  \\$aC3.$x858.$x560
=072  \\$aC17.$x800.$x838.$x775.$x560
=150  \\$aLeishmaniasis
=450  \\$wnnna$aLeishmaniases
=550  \\$wg$aEuglenozoa Infections
=550  \\$wg$aSkin Diseases, Parasitic
=550  \\$wh$aLeishmaniasis, Cutaneous
=550  \\$wh$aLeishmaniasis, Visceral
=667  \\$ageneral or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent; LEISHMANIASIS, AMERICAN see LEISHMANIASIS, CUTANEOUS is also available; tegumentary leishmaniasis = LEISHMANIASIS, CUTANEOUS
=680  \\$iA disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
=750  \0$aLeishmaniasis$0(DLC) sh 85075922$5IEN

=LDR  02124cz  a2200421n  4500
=001  9880363627402441
=005  20141212202828.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007891
=035  \\$aCBA1095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868.$x488
=150  \\$aLeishmania
=450  \\$wnnna$aLeishmania leishmania
=450  \\$aLeishmania (Leishmania)
=450  \\$wnnna$aleishmania, Leishmania
=450  \\$wnnna$aLeishmania leishmanias
=450  \\$wnnna$aLeishmania viannia
=450  \\$aLeishmania (Viannia)
=450  \\$wnnna$aLeishmania viannias
=450  \\$wnnna$aLeishmanias
=450  \\$wnnna$aLeishmanias (Leishmania)
=450  \\$wnnna$aleishmanias, Leishmania
=450  \\$wnnna$aLeishmanias (Viannia)
=450  \\$wnnna$aviannia, Leishmania
=450  \\$wnnna$aviannias, Leishmania
=550  \\$wg$aTrypanosomatina
=550  \\$wh$aLeishmania braziliensis
=550  \\$wh$aLeishmania donovani
=550  \\$wh$aLeishmania enriettii
=550  \\$wh$aLeishmania guyanensis
=550  \\$wh$aLeishmania infantum
=550  \\$wh$aLeishmania major
=550  \\$wh$aLeishmania mexicana
=550  \\$wh$aLeishmania tropica
=667  \\$ainfection = LEISHMANIASIS or its specifics; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; a virus infecting Leishmania is named LEISHMANIAVIRUS: see note there
=680  \\$iA genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.
=750  \0$aLeishmania$5IEN$0(DLC)sh 85075921

=LDR  01769cz  a2200457n  4500
=001  9880363627502441
=005  20141212202827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007889
=035  \\$aCBA1093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x590.$x450
=150  \\$aLeiomyoma
=450  \\$aFibroid
=450  \\$aFibroid Tumor
=450  \\$wnnna$aFibroid Tumors
=450  \\$wnnna$aFibroid, Uterine
=450  \\$aFibroid Uterus
=450  \\$wnnna$aFibroids
=450  \\$aFibroids, Uterine
=450  \\$aFibroma, Uterine
=450  \\$wnnna$aFibromas, Uterine
=450  \\$aFibromyoma
=450  \\$wnnna$aFibromyomas
=450  \\$wnnna$aLeiomyoma, Uterine
=450  \\$wnnna$aLeiomyomas
=450  \\$wnnna$aTumor, Fibroid
=450  \\$wnnna$aTumors, Fibroid
=450  \\$wnnna$aUterine Fibroid
=450  \\$wnnna$aUterine Fibroids
=450  \\$wnnna$aUterine Fibroma
=450  \\$wnnna$aUterine Fibromas
=450  \\$wnnna$aUterus, Fibroid
=550  \\$wg$aNeoplasms, Muscle Tissue
=550  \\$wh$aAngiomyoma
=550  \\$wh$aLeiomyoma, Epithelioid
=550  \\$wh$aLeiomyomatosis
=667  \\$asolitary; multiple = LEIOMYOMATOSIS; coord IM with precoord organ/neopl term (IM); for X refs FIBROID UTERUS; FIBROIDS, UTERINE & FIBROMA, UTERINE: coord with UTERINE NEOPLASMS (IM)
=680  \\$iA benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
=688  \\$aFIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93
=750  \0$aUterine fibroids$5IEN-M$0(DLC)sh 86005513

=LDR  03955cz  a2201345n  4500
=001  9880363627602441
=005  20190131140309.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007887
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401
=072  \\$aJ2.$x500.$x850.$x500
=150  \\$aFabaceae
=450  \\$aAfzelia
=450  \\$aAmorpha
=450  \\$aAndira
=450  \\$aBaptisia
=450  \\$aBeans
=450  \\$aCallerya
=450  \\$aCeratonia
=450  \\$aClathrotropis
=450  \\$aColophospermum
=450  \\$aCopaifera
=450  \\$aDelonix
=450  \\$aEuchresta
=450  \\$aGuibourtia
=450  \\$wnnna$aLegume
=450  \\$aLegumes
=450  \\$wnnna$aLeguminosae
=450  \\$aMachaerium
=450  \\$wnnna$aPithecellobium
=450  \\$aPithecolobium
=450  \\$aStryphnodendron
=450  \\$wnnna$aTachigalia
=550  \\$wg$aAngiosperms
=550  \\$wg$aVegetables
=550  \\$wh$aAbrus
=550  \\$wh$aAcacia
=550  \\$wh$aAlbizzia
=550  \\$wh$aArachis
=550  \\$wh$aAspalathus
=550  \\$wh$aAstragalus Plant
=550  \\$wh$aBauhinia
=550  \\$wh$aButea
=550  \\$wh$aCaesalpinia
=550  \\$wh$aCajanus
=550  \\$wh$aCanavalia
=550  \\$wh$aCaragana
=550  \\$wh$aCassia
=550  \\$wh$aCastanospermum
=550  \\$wh$aChamaecrista
=550  \\$wh$aCicer
=550  \\$wh$aClitoria
=550  \\$wh$aCrotalaria
=550  \\$wh$aCyamopsis
=550  \\$wh$aCyclopia Plant
=550  \\$wh$aCytisus
=550  \\$wh$aDalbergia
=550  \\$wh$aDerris
=550  \\$wh$aDioclea
=550  \\$wh$aDipteryx
=550  \\$wh$aDolichos
=550  \\$wh$aErythrina
=550  \\$wh$aFabaceae
=550  \\$wh$aGalega
=550  \\$wh$aGenista
=550  \\$wh$aGleditsia
=550  \\$wh$aGlycyrrhiza
=550  \\$wh$aGriffonia
=550  \\$wh$aHymenaea
=550  \\$wh$aIndigofera
=550  \\$wh$aLaburnum
=550  \\$wh$aLathyrus
=550  \\$wh$aLens Plant
=550  \\$wh$aLespedeza
=550  \\$wh$aLotus
=550  \\$wh$aLupinus
=550  \\$wh$aMaackia
=550  \\$wh$aMedicago
=550  \\$wh$aMelilotus
=550  \\$wh$aMillettia
=550  \\$wh$aMimosa
=550  \\$wh$aMucuna
=550  \\$wh$aMyroxylon
=550  \\$wh$aOnonis
=550  \\$wh$aOxytropis
=550  \\$wh$aPachyrhizus
=550  \\$wh$aPeas
=550  \\$wh$aPhaseolus
=550  \\$wh$aPhysostigma
=550  \\$wh$aPongamia
=550  \\$wh$aProsopis
=550  \\$wh$aPsoralea
=550  \\$wh$aPterocarpus
=550  \\$wh$aPueraria
=550  \\$wh$aRobinia
=550  \\$wh$aSenna Plant
=550  \\$wh$aSesbania
=550  \\$wh$aSophora
=550  \\$wh$aSoybeans
=550  \\$wh$aSpartium
=550  \\$wh$aSphenostylis
=550  \\$wh$aTamarindus
=550  \\$wh$aTephrosia
=550  \\$wh$aTetrapleura
=550  \\$wh$aTrifolium
=550  \\$wh$aTrigonella
=550  \\$wh$aUlex
=550  \\$wh$aVicia
=550  \\$wh$aVigna
=550  \\$wh$aWisteria
=667  \\$aX ref EUCHRESTA: for Euchresta tenuifolia use MAACKIA; prefer specific plant; X ref PONGAMIA: PONGAMIA PINNATA see MILLETTIA PINNATA and PONGAMIA ULIGINOSA see DERRIS are also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots.
=688  \\$a2002
=750  \0$aLegumes$0(DLC) sh 85075872$5IEN

=LDR  00833cz  a2200241n  4500
=001  9880363627702441
=005  20141212202824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007885
=035  \\$aCBA1089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x615
=150  \\$aLegislation, Pharmacy
=450  \\$wnnna$aLegislations, Pharmacy
=450  \\$wnnna$aPharmacy Legislation
=450  \\$aPharmacy$xlegislation & jurisprudence
=450  \\$wnnna$aPharmacy Legislations
=550  \\$wg$aLegislation as Topic
=550  \\$aPharmacy
=667  \\$aIM; specify country or state; DF: LEGIS PHARM
=680  \\$iLaws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body.
=688  \\$a68
=750  \0$aPharmacy$xLaw and legislation$5IEN$0(DLC)sh 85100606

=LDR  00871cz  a2200253n  4500
=001  9880363627802441
=005  20141212202823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007884
=035  \\$aCBA1088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x544
=150  \\$aLegislation, Nursing
=450  \\$wnnna$aLegislations, Nursing
=450  \\$aNursing Care$xlegislation & jurisprudence
=450  \\$wnnna$aNursing Legislation
=450  \\$aNursing$xlegislation & jurisprudence
=450  \\$wnnna$aNursing Legislations
=550  \\$wg$aLegislation as Topic
=550  \\$aNursing
=667  \\$aIM; specify country or state; DF: LEGIS NURS
=680  \\$iLaws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body.
=688  \\$a66
=750  \0$aNursing$xLaw and legislation$5IEN$0(DLC)sh 85093372

=LDR  00766cz  a2200217n  4500
=001  9880363627902441
=005  20141212202823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007883
=035  \\$aCBA1087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x473
=150  \\$aLegislation, Medical
=450  \\$wnnna$aMedical Legislation
=450  \\$aMedicine$xlegislation & jurisprudence
=550  \\$wg$aLegislation as Topic
=550  \\$wh$aMedical Device Legislation
=550  \\$aMedicine
=667  \\$aIM; specify country or state; DF: LEGIS MED
=680  \\$iLaws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body.
=750  \0$aMedical laws and legislation$5IEN$0(DLC)sh 85082964

=LDR  00888cz  a2200253n  4500
=001  9880363628002441
=005  20141212202823.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007882
=035  \\$aCBA1086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x420
=150  \\$aLegislation, Hospital
=450  \\$wnnna$aHospital Legislation
=450  \\$wnnna$aHospital Legislations
=450  \\$aHospitals$xlegislation & jurisprudence
=450  \\$wnnna$aLegislations, Hospital
=550  \\$wg$aLegislation as Topic
=550  \\$wh$aMedicare Part C
=550  \\$wh$aPatient Self-Determination Act
=667  \\$aIM; specify country or state; DF: LEGIS HOSP
=680  \\$iLaws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body.
=688  \\$a78
=750  \0$aHospitals$xLaw and legislation$5IEN$0(DLC)sh 85062337

=LDR  00930cz  a2200277n  4500
=001  9880363628102441
=005  20141212202822.0
=008  780504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007881
=035  \\$aCBA1085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x412
=150  \\$aLegislation, Food
=450  \\$wnnna$aFood Law
=450  \\$aFood Laws
=450  \\$wnnna$aFood Legislation
=450  \\$aFood$xlegislation & jurisprudence
=450  \\$wnnna$aFood Legislations
=450  \\$wnnna$aLaw, Food
=450  \\$wnnna$aLaws, Food
=450  \\$wnnna$aLegislations, Food
=550  \\$wg$aLegislation as Topic
=667  \\$aIM; specify country or state; DF: LEGIS FOOD
=680  \\$iLaws and regulations concerned with industrial processing and marketing of foods.
=688  \\$a79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78
=750  \0$aFood law and legislation$5IEN$0(DLC)sh 85050300

=LDR  01327cz  a2200373n  4500
=001  9880363628202441
=005  20141212202822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007880
=035  \\$aCBA1084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x605
=072  \\$aN3.$x706.$x615.$x402
=150  \\$aLegislation, Drug
=450  \\$wnnna$aDrug Law
=450  \\$aDrug Laws
=450  \\$wnnna$aDrug Legislation
=450  \\$aFood, Drug and Cosmetic Act
=450  \\$wnnna$aLaw, Drug
=450  \\$wnnna$aLaw, Narcotic
=450  \\$wnnna$aLaws, Drug
=450  \\$wnnna$aLaws, Narcotic
=450  \\$wnnna$aNarcotic Law
=450  \\$aNarcotic Laws
=450  \\$aPharmaceutical Preparations$xlegislation & jurisprudence
=550  \\$wg$aLegislation as Topic
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aDrug and Narcotic Control
=550  \\$aDrug Prescriptions
=667  \\$aspecify country or state; DF: LEGIS DRUG
=680  \\$iLaws concerned with manufacturing, dispensing, and marketing of drugs.
=688  \\$a68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78; FOOD, DRUG AND COSMETIC ACT was see under LEGISLATION, DRUG 1968-77
=750  \0$aNarcotic laws$5IEN-M$0(DLC)sh 85089814
=750  \0$aDrugs$xLaw and legislation$5IEN-HS$0(DLC)sh 85039735

=LDR  00729cz  a2200205n  4500
=001  9880363628302441
=005  20141212202822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007879
=035  \\$aCBA1083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x331
=150  \\$aLegislation, Dental
=450  \\$wnnna$aDental Legislation
=450  \\$aDentistry$xlegislation & jurisprudence
=550  \\$wg$aLegislation as Topic
=550  \\$aDentistry
=667  \\$aIM; specify country or state; DF: LEGIS DENT
=680  \\$iLaws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body.
=750  \0$aDental laws and legislation$5IEN$0(DLC)sh 85036903

=LDR  02537cz  a2200649n  4500
=001  9880363628402441
=005  20141212202821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007878
=035  \\$aCBA1082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615
=150  \\$aLegislation as Topic
=450  \\$wnnna$aAmendment, Constitutional
=450  \\$wnnna$aAmendments, Constitutional
=450  \\$wnnna$aConstitutional Amendment
=450  \\$wnnna$aConstitutional Amendments
=450  \\$aHealth Legislation
=450  \\$wnnna$aLaw, Population
=450  \\$wnnna$aLaws and Statutes
=450  \\$wnnna$aLaws, Population
=450  \\$wnnna$aLegislation, Health
=450  \\$wnnna$aLegislation, Model
=450  \\$wnnna$aModel Legislation
=450  \\$wnnna$aPopulation Law
=450  \\$wnnna$aPopulation Laws
=450  \\$wnnna$aStatutes and Laws
=550  \\$wg$aSocial Control, Formal
=550  \\$wh$aAmerican Recovery and Reinvestment Act
=550  \\$wh$aAntitrust Laws
=550  \\$wh$aEmployee Retirement Income Security Act
=550  \\$wh$aHealth Insurance Portability and Accountability Act
=550  \\$wh$aHealth Planning
=550  \\$wh$aLegislation, Dental
=550  \\$wh$aLegislation, Drug
=550  \\$wh$aLegislation, Food
=550  \\$wh$aLegislation, Hospital
=550  \\$wh$aLegislation, Medical
=550  \\$wh$aLegislation, Nursing
=550  \\$wh$aLegislation, Pharmacy
=550  \\$wh$aLegislation, Veterinary
=550  \\$wh$aMedicaid
=550  \\$wh$aMedicare
=550  \\$wh$aMedicare Part A
=550  \\$wh$aMedicare Part B
=550  \\$wh$aMedicare Part D
=550  \\$wh$aPatient Freedom of Choice Laws
=550  \\$wh$aPatient Protection and Affordable Care Act
=550  \\$wh$aPatient Self-Determination Act
=550  \\$wh$aPrivacy
=550  \\$wh$aTax Equity and Fiscal Responsibility Act
=550  \\$wh$aThreshold Limit Values
=667  \\$ageneral or unspecified; prefer specifics; prefer the qualifier / legis with a specific term; specify country or state; do not confuse with the Publication Type LEGISLATION
=680  \\$iThe enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific heading.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Legislation
=750  \0$aLegislation$0(DLC) sh 85075801$5IEN

=LDR  01412cz  a2200325n  4500
=001  9880363628502441
=005  20141212202820.0
=008  780215\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007877
=035  \\$aCBA1081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x500.$x501
=072  \\$aC8.$x730.$x382.$x380
=150  \\$aLegionnaires' Disease
=450  \\$wnnna$aDisease, Legionnaire
=450  \\$wnnna$aDisease, Legionnaires'
=450  \\$wnnna$aInfection, Legionella pneumophila
=450  \\$wnnna$aInfections, Legionella pneumophila
=450  \\$wnnna$aLegionella pneumophila Infection
=450  \\$aLegionella pneumophila Infections
=450  \\$wnnna$aLegionnaire Disease
=450  \\$wnnna$aLegionnaire's Disease
=450  \\$wnnna$aLegionnaires Disease
=450  \\$wnnna$apneumophila Infection, Legionella
=450  \\$wnnna$apneumophila Infections, Legionella
=550  \\$wg$aLegionellosis
=667  \\$acaused by Legionella pneumophila: infect by other Legionella species = LEGIONELLOSIS
=680  \\$iAn acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.
=688  \\$a79(78); was see under RESPIRATORY TRACT INFECTIONS 1978
=750  \0$aLegionnaires' disease$5IEN$0(DLC)sh 85075800

=LDR  00850cz  a2200217n  4500
=001  9880363628602441
=005  20141212192258.0
=008  800514\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007875
=035  \\$aCBA1079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x450.$x450
=072  \\$aB3.$x660.$x250.$x460.$x460
=150  \\$aLegionella
=550  \\$wg$aLegionellaceae
=550  \\$wh$aLegionella longbeachae
=550  \\$wh$aLegionella pneumophila
=667  \\$ainfection = LEGIONELLOSIS but Legionella pneumophila infection = LEGIONNAIRES' DISEASE
=680  \\$iGram-negative aerobic rods, isolated from surface water or thermally polluted lakes or streams. Member are pathogenic for man. Legionella pneumophila is the causative agent for LEGIONNAIRES' DISEASE.
=688  \\$a81
=750  \0$aLegionella$5IEN$0(DLC)sh 91002868

=LDR  01802cz  a2200433n  4500
=001  9880363628702441
=005  20141212192258.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007873
=035  \\$aCBA1077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x852.$x175.$x570
=150  \\$aLegg-Calve-Perthes Disease
=450  \\$aCoxa Plana
=450  \\$wnnna$aDisease, Legg-Calvé-Perthes
=450  \\$wnnna$aDisease, Legg-Calve-Perthes
=450  \\$wnnna$aDisease, Legg-Perthes
=450  \\$wnnna$aDisease, Perthes
=450  \\$wnnna$aLegg-Calvé-Perthes Disease
=450  \\$wnnna$aLegg Calvé Perthes Disease
=450  \\$wnnna$aLegg-Calvé-Perthes Syndrome
=450  \\$wnnna$aLegg Calvé Perthes Syndrome
=450  \\$wnnna$aLegg Calve Perthes Disease
=450  \\$wnnna$aLegg-Calve-Perthes Syndrome
=450  \\$wnnna$aLegg Calve Perthes Syndrome
=450  \\$aLegg-Perthes Disease
=450  \\$wnnna$aLegg Perthes Disease
=450  \\$wnnna$aOsteochondritis Deforman
=450  \\$wnnna$aOsteochondritis Deformans
=450  \\$aPerthes Disease
=450  \\$wnnna$aSyndrome, Legg-Calvé-Perthes
=450  \\$wnnna$aSyndrome, Legg-Calve-Perthes
=550  \\$wg$aFemur Head Necrosis
=680  \\$iA particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so.
=688  \\$a2012 (1963); for COXA PLANA see OSTEOCHRONDRITIS 1963-1978
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Legg-Perthes Disease
=688  \\$a1991(1963); for COXA PLANA use OSTEOCHONDRITIS 1963-1978
=688  \\$a91(75); was see under FEMUR HEAD NECROSIS 1979-90; was see under OSTEOCHONDRITIS 1963-78; COXA PLANA was see under OSTEOCHONDRITIS 1963-78
=750  \0$aLegg-Calv�e-Perthes disease$0(DLC) sh 85075795$5IEN

=LDR  00852cz  a2200229n  4500
=001  9880363628802441
=005  20141212202819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007871
=035  \\$aCBA1075HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x893.$x592
=150  \\$aLeg Ulcer
=450  \\$wnnna$aLeg Ulcers
=450  \\$wnnna$aUlcer, Leg
=450  \\$wnnna$aUlcers, Leg
=550  \\$wg$aSkin Ulcer
=550  \\$wh$aFoot Ulcer
=550  \\$wh$aVaricose Ulcer
=667  \\$aif varicose, index instead under VARICOSE ULCER; FOOT ULCER is also available
=680  \\$iUlceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
=750  \0$aLeg$xUlcers$5IEN$0(DLC)sh 85075713

=LDR  01065cz  a2200265n  4500
=001  9880363628902441
=005  20141212202819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007870
=035  \\$aCBA1074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x655
=072  \\$aC23.$x300.$x808
=150  \\$aLeg Length Inequality
=450  \\$wnnna$aInequalities, Leg Length
=450  \\$wnnna$aInequality, Leg Length
=450  \\$wnnna$aLeg Length Inequalities
=450  \\$wnnna$aLength Inequalities, Leg
=450  \\$wnnna$aLength Inequality, Leg
=550  \\$wg$aBone Diseases, Developmental
=550  \\$wg$aPathological Conditions, Anatomical
=667  \\$acorrection of inequality: coord IM with BONE LENGTHENING (IM) or specifically ILIZAROV TECHNIQUE (IM) if pertinent
=680  \\$iA condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.
=688  \\$a72; LEG LENGTHENING was heading 1964-71 (Prov 1964-66)
=750  \0$aLeg length inequality$5IEN$0(DLC)sh 85075714

=LDR  01006cz  a2200313n  4500
=001  9880363629002441
=005  20190128122022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007869
=035  \\$aCBA1073HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x558
=150  \\$aLeg Injuries
=450  \\$wnnna$aInjuries, Leg
=450  \\$wnnna$aInjury, Leg
=450  \\$aLeg$xinjuries
=450  \\$wnnna$aLeg Injury
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aAnkle Injuries
=550  \\$wh$aFemoral Fractures
=550  \\$wh$aFoot Injuries
=550  \\$wh$aKnee Injuries
=550  \\$wh$aMedial Tibial Stress Syndrome
=550  \\$wh$aTibial Fractures
=550  \\$aPeroneal Neuropathies
=550  \\$wh$aTibial Meniscus Injuries
=667  \\$aGEN or unspecified; consider also /inj with specific parts of the leg; /vet permitted for non-primates
=680  \\$iGeneral or unspecified injuries involving the leg.
=750  \0$aLeg$xWounds and injuries$5IEN$0(DLC)sh 85046608

=LDR  00668cz  a2200169n  4500
=001  9880363629102441
=005  20141212202818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x610.$x500
=150  \\$aLeg
=450  \\$wnnna$aLegs
=550  \\$wg$aLower Extremity
=667  \\$aprimates only but see note on LEG INJURIES; for whole leg or lower leg (THIGH is available for upper leg); for bones use TIBIA or FIBULA; Manual 21.58: table of human, primate & non-primate extremities
=680  \\$iThe inferior part of the lower extremity between the KNEE and the ANKLE.
=750  \0$aLeg$5IEN$0(DLC)sh 85075709

=LDR  00768cz  a2200217n  4500
=001  9880363629202441
=005  20141212202818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007865
=035  \\$aCBA1069HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x91.$x426
=150  \\$aLeeches
=450  \\$aHirudinea
=450  \\$wnnna$aHirudineas
=450  \\$wnnna$aLeeche
=550  \\$wg$aAnnelida
=550  \\$wh$aHirudo medicinalis
=550  \\$aLeeching
=680  \\$iAnnelids of the class Hirudinea. Some species, the bloodsuckers, may become temporarily parasitic upon animals, including man. Medicinal leeches (HIRUDO MEDICINALIS) have been used therapeutically for drawing blood since ancient times.
=750  \0$aLeeches$5IEN$0(DLC)sh 85075689

=LDR  02004cz   2200589n  4500
=001  9880363629402441
=005  20230831174300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007858
=035  \\$aCBA1062HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425
=072  \\$aF2.$x784.$x629.$x529
=150  \\$aLearning
=450  \\$wnnna$aMemory Training
=450  \\$aPhenomenography
=450  \\$wnnna$aTraining, Memory
=550  \\$wg$aMental Processes
=550  \\$wg$aPsychology, Educational
=550  \\$wh$aAssociation
=550  \\$wh$aAvoidance Learning
=550  \\$wh$aConditioning, Psychological
=550  \\$wh$aCritical Period (Psychology)
=550  \\$wh$aCues
=550  \\$wh$aDiscrimination Learning
=550  \\$wh$aFormative Feedback
=550  \\$wh$aGeneralization, Psychological
=550  \\$wh$aHabituation, Psychophysiologic
=550  \\$wh$aHelplessness, Learned
=550  \\$wh$aImprinting, Psychological
=550  \\$wh$aInhibition, Psychological
=550  \\$wh$aLearning Curve
=550  \\$wh$aMemory
=550  \\$wh$aNeurolinguistic Programming
=550  \\$wh$aOverlearning
=550  \\$wh$aPractice, Psychological
=550  \\$wh$aProbability Learning
=550  \\$wh$aProblem-Based Learning
=550  \\$wh$aProblem Solving
=550  \\$wh$aReinforcement, Psychology
=550  \\$wh$aReversal Learning
=550  \\$wh$aSelf-Directed Learning as Topic
=550  \\$wh$aSet, Psychology
=550  \\$wh$aSpatial Learning
=550  \\$wh$aTransfer, Psychology
=550  \\$wh$aVerbal Learning
=550  \\$aEducation
=667  \\$apolicy: Manual 30.12
=680  \\$iRelatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge.
=750  \0$aLearning, Psychology of$5IEN-M$0(DLC)sh 85075526
=750  \0$aLearning$5IEN-HS$0(DLC)sh 85075520
=750  \0$iNarrower mapping$aMeaningful learning$0(DLC)sh2022007197$4NM$5IEN-M

=LDR  00590cz  a2200181n  4500
=001  9880363629502441
=005  20141212202814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007857
=035  \\$aCBA1061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x609
=150  \\$aLeadership
=450  \\$wnnna$aInfluentials
=550  \\$wg$aPersonality
=667  \\$ano qualif
=680  \\$iThe function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers.
=750  \0$aLeadership$5IEN$0(DLC)sh 85075480

=LDR  00761cz  a2200205n  4500
=001  9880363629602441
=005  20141212202814.0
=008  870408\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007856
=035  \\$aCBA1060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x749.$x560
=150  \\$aLead Radioisotopes
=450  \\$wnnna$aRadioisotopes, Lead
=550  \\$wg$aRadioisotopes
=550  \\$aLead
=667  \\$aPb-194-203, 205, 209-214; /blood-csf-urine /metab permitted but not for tracer studies ( = /diag use)
=680  \\$iUnstable isotopes of lead that decay or disintegrate emitting radiation. Pb atoms with atomic weights 194-203, 205, and 209-214 are radioactive lead isotopes.
=688  \\$a88
=750  \0$aLead$xIsotopes$5IEN-M$0(DLC)sh 85075437

=LDR  00836cz  a2200217n  4500
=001  9880363629702441
=005  20141212202814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007855
=035  \\$aCBA1059HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x589
=150  \\$aLead Poisoning
=450  \\$aLead$xpoisoning
=450  \\$wnnna$aLead Poisonings
=450  \\$wnnna$aPoisoning, Lead
=450  \\$wnnna$aPoisonings, Lead
=550  \\$wg$aPoisoning
=550  \\$wh$aLead Poisoning, Nervous System
=667  \\$aoccup lead pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there); in infant or child = LEAD POISONING, NERVOUS SYSTEM, CHILDHOOD; in adolescent or adult, consider also LEAD POISONING, NERVOUS SYSTEM, ADULT
=750  \0$aLead poisoning$5IEN$0(DLC)sh 94009453

=LDR  00741cz  a2200205n  4500
=001  9880363629802441
=005  20141212202813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007854
=035  \\$aCBA1058HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x435
=072  \\$aD1.$x552.$x544.$x435
=150  \\$aLead
=450  \\$aLead Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=667  \\$aPb-208; Pb-204, 206, 207 = LEAD (IM) + ISOTOPES (NIM); Pb-194-203, 205, 209-214 = LEAD RADIOISOTOPES (IM)
=680  \\$iA soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.19, symbol Pb. (Dorland, 28th)
=750  \0$aLead compounds$5IEN-M$0(DLC)sh 85075452
=750  \0$aLead$5IEN-HS$0(DLC)sh 85075435

=LDR  00923cz  a2200265n  4500
=001  9880363629902441
=005  20141212202813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007852
=035  \\$aCBA1056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x500
=072  \\$aD1.$x268.$x271.$x100.$x500
=072  \\$aD1.$x268.$x556.$x423
=072  \\$aD1.$x268.$x956.$x295
=072  \\$aD1.$x552.$x20.$x507
=072  \\$aD1.$x552.$x544.$x423
=150  \\$aLawrencium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$anaturally radioactive; IM
=680  \\$iLawrencium. A radioactive actinide discovered in 1961. It has the atomic symbol Lr, atomic number 103, and atomic weight of 257. There are two isotopes with mass number 257 or 258, and mass number 256.
=688  \\$a75
=750  \0$aLawrencium$5IEN$0(DLC)sh 85075345

=LDR  00556cz  a2200205n  4500
=001  9880363630002441
=005  20141212202813.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007850
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x500
=150  \\$aLauric Acids
=450  \\$wnnna$aAcids, Dodecanoic
=450  \\$wnnna$aAcids, Lauric
=450  \\$aDodecanoic Acids
=550  \\$wg$aFatty Acids
=550  \\$wh$aLaurates
=680  \\$i12-Carbon saturated monocarboxylic acids.
=688  \\$a75
=750  \0$aLauric acid$5IEN$0(DLC)sh 85075089

=LDR  01265cz  a2200277n  4500
=001  9880363630102441
=005  20141212202812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007849
=035  \\$aCBA1053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x617.$x500
=072  \\$aC16.$x131.$x77.$x509
=150  \\$aLaurence-Moon Syndrome
=450  \\$aLaurence-Moon-Biedl Syndrome
=450  \\$wnnna$aLaurence Moon Biedl Syndrome
=450  \\$wnnna$aLaurence Moon Syndrome
=450  \\$wnnna$aSyndrome, Laurence-Moon
=450  \\$wnnna$aSyndrome, Laurence-Moon-Biedl
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aHypothalamic Diseases
=550  \\$aIntellectual Disability
=667  \\$anote X ref: do not confuse with LAURENCE-MOON-BARDET-BIEDL SYNDROME see BARDET-BIEDL SYNDROME
=680  \\$iAn autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. (From N Engl J Med. 1989 Oct 12;321(15):1002-9)
=688  \\$a2000 (1966)
=750  \0$aLaurence-Moon-Biedl syndrome$5IEN$0(DLC)sh 85075082

=LDR  00856cz  a2200253n  4500
=001  9880363630202441
=005  20141212202812.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007847
=035  \\$aCBA1051HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x428
=072  \\$aN4.$x452.$x442.$x422.$x428
=150  \\$aLaundry Service, Hospital
=450  \\$aHospital Laundry Service
=450  \\$wnnna$aHospital Laundry Services
=450  \\$wnnna$aLaundry Services, Hospital
=450  \\$wnnna$aService, Hospital Laundry
=450  \\$wnnna$aServices, Hospital Laundry
=550  \\$wg$aHospital Departments
=667  \\$aDF: LAUNDRY SERV HOSP
=680  \\$iHospital department which administers all activities pertaining to the hospital laundry service.
=688  \\$a80
=750  \0$aHospital laundries$5IEN$0(DLC)sh 85075064

=LDR  00428cz  a2200169n  4500
=001  9880363630302441
=005  20141212202811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007846
=035  \\$aCBA1050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x549
=150  \\$aLaundering
=450  \\$wnnna$aLaunderings
=550  \\$wg$aIndustry
=667  \\$aSPEC: SPEC qualif
=750  \0$aLaundries$5IEN$0(DLC)sh 85075063

=LDR  00700cz  a2200217n  4500
=001  9880363630402441
=005  20141212202811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007845
=035  \\$aCBA1049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530.$x614
=072  \\$aF1.$x470.$x693
=150  \\$aLaughter
=450  \\$wnnna$aLaughters
=550  \\$wg$aEmotions
=550  \\$wg$aNonverbal Communication
=550  \\$aLaughter Therapy
=550  \\$aWit and Humor as Topic
=680  \\$iAn involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization.
=750  \0$aLaughter$5IEN$0(DLC)sh 85075047

=LDR  00662cz  a2200181n  4500
=001  9880363630502441
=005  20141212202811.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007842
=035  \\$aCBA1046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x756.$x558
=150  \\$aLathyrism
=450  \\$wnnna$aNeurolathyrism
=550  \\$wg$aPlant Poisoning
=550  \\$aAminopropionitrile
=680  \\$iA paralytic condition of the legs caused by ingestion of lathyrogens, especially BETA-AMINOPROPIONITRILE or beta-N-oxalyl amino-L-alanine, which are found in the seeds of plants of the genus LATHYRUS.
=750  \0$aLathyrism$5IEN$0(DLC)sh 85074870

=LDR  01488cz  a2200337n  4500
=001  9880363630602441
=005  20141212202810.0
=008  800520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007840
=035  \\$aCBA1044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x625
=072  \\$aD20.$x215.$x721.$x124
=072  \\$aD25.$x720.$x99.$x625
=072  \\$aD25.$x720.$x99.$x750.$x500
=072  \\$aD25.$x720.$x327.$x840.$x239
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x625
=072  \\$aJ1.$x637.$x51.$x720.$x540
=150  \\$aLatex
=450  \\$wnnna$aLatice
=450  \\$wnnna$aLatices
=550  \\$wg$aBiopolymers
=550  \\$wg$aPlant Exudates
=550  \\$wg$aPolymers
=550  \\$wg$aRubber
=550  \\$aRubber
=667  \\$acoordinate with source plant (commonly HEVEA)
=680  \\$iA milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35% caoutchouc, 60-75% water, 2% protein, 2% resin, 1.5% sugar & 1% ash. RUBBER is made by the removal of water from latex.(From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed). Hevein proteins are responsible for LATEX HYPERSENSITIVITY. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS.
=688  \\$a1981(1963-1967); use LATEX RUBBER 1968-1980
=688  \\$a1981(1963-1967); use LATEX RUBBER 1968-1980; for CAOUTCHOUC use LATEX 1980-1999
=750  \0$aLatex$5IEN$0(DLC)sh 85074851

=LDR  01763cz  a2200397n  4500
=001  9880363630702441
=005  20141212202810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007839
=035  \\$aCBA1043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x297.$x425
=072  \\$aG11.$x561.$x225.$x425
=150  \\$aFunctional Laterality
=450  \\$aAmbidexterity
=450  \\$aBehavioral Laterality
=450  \\$aHandedness
=450  \\$wnno$aLaterality$5IEN-M
=450  \\$wnnna$aLaterality, Behavioral
=450  \\$wnnna$aLaterality, Functional
=450  \\$aLaterality of Motor Control
=450  \\$aMirror Writing
=450  \\$wnnna$aMirror Writings
=450  \\$wnnna$aMotor Control Laterality
=450  \\$wnnna$aWriting, Mirror
=450  \\$wnnna$aWritings, Mirror
=550  \\$wg$aDominance, Cerebral
=550  \\$wh$aDominance, Ocular
=550  \\$aSplit-Brain Procedure
=667  \\$arestrict to neurological & psychological sense; sidedness or laterality of disease, index the disease with /pathol or /physiopathol; for unilateral or bilateral surgery, index the surgical technique with /methods if pertinent
=680  \\$iBehavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.
=688  \\$a2007(1966); for MIRROR WRITING use DOMINANCE, CEREBRAL 1976-2006 & HANDWRITING 1963-1975
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Laterality
=688  \\$aAMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74
=750  \0$aLeft and right (Psychology)$0(DLC) sh 85075704$5IEN-M
=750  \0$aLaterality$0(DLC) sh 85074846$5IEN-HS

=LDR  03340cz  a2200889n  4500
=001  9880363327902441
=005  20200504111821.0
=008  880607\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015415
=035  \\$aCAZ4845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x101
=150  \\$aBiomarkers
=450  \\$wnno$aBiological Markers
=450  \\$wnnna$aBiochemical Marker
=450  \\$aBiochemical Markers
=450  \\$wnnna$aBiologic Marker
=450  \\$wnnna$aBiologic Markers
=450  \\$wnnna$aBiological Marker
=450  \\$wnnna$aClinical Marker
=450  \\$aClinical Markers
=450  \\$wnnna$aEnd Point, Surrogate
=450  \\$wnnna$aEnd Points, Surrogate
=450  \\$wnnna$aEndpoint, Surrogate
=450  \\$wnnna$aEndpoints, Surrogate
=450  \\$wnnna$aImmune Marker
=450  \\$wnnna$aImmune Markers
=450  \\$wnnna$aImmunologic Marker
=450  \\$aImmunologic Markers
=450  \\$wnnna$aLaboratory Marker
=450  \\$aLaboratory Markers
=450  \\$wnnna$aMarker, Biochemical
=450  \\$wnnna$aMarker, Biologic
=450  \\$wnnna$aMarker, Biological
=450  \\$wnnna$aMarker, Clinical
=450  \\$wnnna$aMarker, Immune
=450  \\$wnnna$aMarker, Immunologic
=450  \\$wnnna$aMarker, Laboratory
=450  \\$wnnna$aMarker, Serum
=450  \\$wnnna$aMarker, Surrogate
=450  \\$wnnna$aMarker, Viral
=450  \\$aMarkers, Biochemical
=450  \\$wnnna$aMarkers, Biologic
=450  \\$aMarkers, Biological
=450  \\$aMarkers, Clinical
=450  \\$wnnna$aMarkers, Immune
=450  \\$aMarkers, Immunologic
=450  \\$aMarkers, Laboratory
=450  \\$aMarkers, Serum
=450  \\$aMarkers, Surrogate
=450  \\$aMarkers, Viral
=450  \\$wnnna$aSerum Marker
=450  \\$aSerum Markers
=450  \\$wnnna$aSurrogate End Point
=450  \\$wnnna$aSurrogate End Points
=450  \\$wnnna$aSurrogate Endpoint
=450  \\$wnnna$aSurrogate Endpoints
=450  \\$wnnna$aSurrogate Marker
=450  \\$aSurrogate Markers
=450  \\$wnnna$aViral Marker
=450  \\$aViral Markers
=550  \\$wg$aBiological Factors
=550  \\$wh$aAntibodies, Antineutrophil Cytoplasmic
=550  \\$wh$aAntigens, Differentiation
=550  \\$wh$aBiomarkers, Pharmacological
=550  \\$wh$aChorionic Gonadotropin, beta Subunit, Human
=550  \\$wh$aEnvironmental Biomarkers
=550  \\$wh$aFibrinopeptide A
=550  \\$wh$aGenetic Markers
=550  \\$wh$aOligoclonal Bands
=550  \\$wh$aTumor Markers, Biological
=550  \\$aEndophenotypes
=550  \\$aMolecular Probes
=667  \\$aIM general only; coordinate NIM with specific substance (IM); note that many specific markers are available; DF: BIOL MARKERS
=680  \\$iMeasurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
=688  \\$a2016(1989)
=750  \0$aBiochemical markers$0(DLC) sh 85014122$5IEN

=LDR  02001cz  a2200541n  4500
=001  9880363328002441
=005  20141212192026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001761
=035  \\$aCAZ4922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x420.$x110
=072  \\$aD12.$x644.$x233.$x110
=150  \\$aBleomycin
=450  \\$wnnna$aAlmirall Brand of Bleomycin Sulfate
=450  \\$wnnna$aBellon, Bléomycine
=450  \\$wnnna$aBellon Brand of Bleomycin Sulfate
=450  \\$wnnna$aBléomycine Bellon
=450  \\$wnnna$aBlanoxan
=450  \\$wnnna$aBlenoxane
=450  \\$wnnna$aBLEO-cell
=450  \\$wnnna$aBLEO cell
=450  \\$wnnna$aBLEOcell
=450  \\$wnnna$aBleolem
=450  \\$wnnna$aBleomicina
=450  \\$wnnna$aBleomycin A(2)
=450  \\$wnnna$aBleomycin A2
=450  \\$wnnna$aBleomycin B(2)
=450  \\$wnnna$aBleomycin B2
=450  \\$wnnna$aBleomycin Sulfate
=450  \\$wnnna$aBleomycins
=450  \\$wnnna$aBleomycinum Mack
=450  \\$wnnna$aBristol-Myers Squibb Brand of Bleomycin Sulfate
=450  \\$wnnna$aBristol Myers Squibb Brand of Bleomycin Sulfate
=450  \\$wnnna$aBull Brand of Bleomycin Sulfate
=450  \\$wnnna$acell pharm Brand of Bleomycin Sulfate
=450  \\$wnnna$aLemery Brand of Bleomycin Sulfate
=450  \\$wnnna$aLundbeck Brand of Bleomycin Sulfate
=450  \\$wnnna$aMack, Bleomycinum
=450  \\$wnnna$aMack Brand of Bleomycin Sulfate
=450  \\$wnnna$aSulfate, Bleomycin
=550  \\$wg$aGlycopeptides
=550  \\$wh$aPeplomycin
=550  \\$wh$aPhleomycins
=667  \\$aa glycopeptide antineoplastic antibiotic
=680  \\$iA complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.
=688  \\$a96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 (Prov 1972-73)
=750  \0$aBleomycin$5IEN$0(DLC)sh 85014840

=LDR  01910cz  a2200565n  4500
=001  9880363328102441
=005  20141212195238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001683
=035  \\$aCAZ4842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x180.$x562.$x94
=150  \\$aBiological Clocks
=450  \\$wnnna$aBiologic Clock
=450  \\$wnnna$aBiologic Clocks
=450  \\$wnnna$aBiologic Oscillator
=450  \\$wnnna$aBiologic Oscillators
=450  \\$wnnna$aBiologic Pacemaker
=450  \\$wnnna$aBiologic Pacemakers
=450  \\$wnnna$aBiological Clock
=450  \\$wnnna$aBiological Oscillator
=450  \\$aBiological Oscillators
=450  \\$wnnna$aBiological Pacemaker
=450  \\$wnnna$aBiological Pacemakers
=450  \\$aBiological Rhythms$5IEN
=450  \\$wnnna$aClock, Biologic
=450  \\$wnnna$aClock, Biological
=450  \\$wnnna$aClocks, Biologic
=450  \\$wnnna$aClocks, Biological
=450  \\$wnnna$aEndogenous Oscillator
=450  \\$wnnna$aEndogenous Oscillators
=450  \\$wnnna$aOscillator, Biologic
=450  \\$wnnna$aOscillator, Biological
=450  \\$wnnna$aOscillator, Endogenous
=450  \\$wnnna$aOscillators, Biologic
=450  \\$wnnna$aOscillators, Biological
=450  \\$aOscillators, Endogenous
=450  \\$wnnna$aPacemaker, Biologic
=450  \\$wnnna$aPacemaker, Biological
=450  \\$wnnna$aPacemakers, Biologic
=450  \\$aPacemakers, Biological
=550  \\$wg$aPeriodicity
=550  \\$wh$aCircadian Clocks
=550  \\$aChronobiology Phenomena
=550  \\$aCircadian Rhythm
=550  \\$aPeriodicity
=550  \\$aSleep Disorders, Circadian Rhythm
=680  \\$iThe physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena.
=688  \\$a67(64)
=750  \0$aBiological rhythms$5IEN$0(DLC)sh 85014188

=LDR  01301cz  a2200289n  4500
=001  9880363328202441
=005  20141212195305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001759
=035  \\$aCAZ4920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x55
=072  \\$aC1.$x703.$x128
=072  \\$aC1.$x703.$x295.$x55
=072  \\$aC17.$x800.$x838.$x208.$x55
=150  \\$aBlastomycosis
=450  \\$wnnna$aBlastomycoses
=450  \\$aBlastomycosis, North American
=450  \\$wnnna$aGilchrist Disease
=450  \\$wnnna$aGilchrist's Disease
=450  \\$wnnna$aGilchrists Disease
=450  \\$wnnna$aNorth American Blastomycosis
=550  \\$wg$aDermatomycoses
=550  \\$wg$aMycoses
=667  \\$afungus dis; do not confuse X ref BLASTOMYCOSIS, NORTH AMERICAN with BLASTOMYCOSIS, SOUTH AMERICAN see PARACOCCIDIOIDOMYCOSIS
=680  \\$iA fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.
=750  \0$aBlastomycosis$5IEN$0(DLC)sh 85014805

=LDR  00938cz  a2200241n  4500
=001  9880363328302441
=005  20141212195305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001758
=035  \\$aCAZ4919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x125
=150  \\$aBlastomyces
=450  \\$wnnna$aBlastomyce
=450  \\$wnnna$aBlastomyces dermatitidi
=450  \\$wnnna$aBlastomyces dermatitidis
=450  \\$wnnna$adermatitidi, Blastomyces
=450  \\$wnnna$adermatitidis, Blastomyces
=550  \\$wg$aMitosporic Fungi
=550  \\$aOnygenales
=667  \\$ainfection = BLASTOMYCOSIS; BLASTOMYCES BRASILIENSIS see PARACOCCIDIOIDES is available
=680  \\$iA genus of onygenacetous mitosporic fungi whose perfect state is Ajellomyces (see ONYGENALES). The species Blastomyces dermatitidis (perfect state Ajellomyces dermatitidis) causes blastomycosis.
=750  \0$aBlastomyces$5IEN$0(DLC)sh 91005365

=LDR  00660cz  a2200181n  4500
=001  9880363328402441
=005  20141212195304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001756
=035  \\$aCAZ4917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x331.$x24
=150  \\$aBlastoderm
=450  \\$wnnna$aBlastoderms
=550  \\$wg$aEmbryo, Nonmammalian
=680  \\$iA layer of cells lining the fluid-filled cavity (blastocele) of a BLASTULA, usually developed from a fertilized insect, reptilian, or avian egg.
=688  \\$a80(75); was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74
=750  \0$aBlastoderm$5IEN$0(DLC)sh 85014802

=LDR  01194cz  a2200253n  4500
=001  9880363328502441
=005  20141212195304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001755
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x254.$x500
=150  \\$aBlastocyst
=450  \\$wnnna$aBlastocysts
=450  \\$aEmbryo, Preimplantation
=450  \\$wnnna$aEmbryos, Preimplantation
=450  \\$wnnna$aPreimplantation Embryo
=450  \\$wnnna$aPreimplantation Embryos
=550  \\$wg$aEmbryo, Mammalian
=550  \\$wh$aBlastocyst Inner Cell Mass
=550  \\$wh$aTrophoblasts
=667  \\$aMammalian only; non-mammalian, use BLASTULA; /transpl: coordinate BLASTOCYST (NIM with no qualifiers) + EMBRYO TRANSFER (IM); do not confuse with BLASTOCYTES see BLASTOMERES
=680  \\$iA post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper.
=688  \\$a74
=750  \0$aBlastocyst$0(DLC) sh 85014801$5IEN

=LDR  00631cz  a2200181n  4500
=001  9880363328602441
=005  20141212195304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001754
=035  \\$aCAZ4915HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x230.$x150
=150  \\$aBlastocladiella
=450  \\$wnnna$aBlastocladiellas
=550  \\$wg$aBlastocladiomycota
=680  \\$iA genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation.
=688  \\$a91; use CHYTRIDIOMYCOTA 1986-90, use FUNGI 1963-85
=750  \0$aBlastocladiella$0(DLC) sh 88021877$5IEN

=LDR  00990cz  a2200229n  4500
=001  9880363328702441
=005  20141212195303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001753
=035  \\$aCAZ4914HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x120.$x126
=150  \\$aBlast Injuries
=450  \\$wnnna$aBlast Injury
=450  \\$wnnna$aInjuries, Blast
=450  \\$wnnna$aInjury, Blast
=550  \\$wg$aBarotrauma
=550  \\$aExplosions
=667  \\$avarious body inj from waves of high-pressure velocity; /compl permitted but do not confuse with /pathol
=680  \\$iInjuries resulting when a person is struck by particles impelled with violent force from an explosion. Blast causes pulmonary concussion and hemorrhage, laceration of other thoracic and abdominal viscera, ruptured ear drums, and minor effects in the central nervous system. (From Dorland, 27th ed)
=688  \\$a73; was BLAST INJURY 1963-72
=750  \0$aBlast injuries$0(DLC)sh2007009825$5IEN-M

=LDR  02185cz  a2200517n  4500
=001  9880363328802441
=005  20141212195302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001750
=035  \\$aCAZ4911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x900
=072  \\$aC12.$x777.$x829.$x839
=072  \\$aC13.$x351.$x968.$x829.$x760
=072  \\$aC23.$x888.$x592.$x900
=150  \\$aUrinary Bladder, Neurogenic
=450  \\$wnnna$aAtonic Neurogenic Bladder
=450  \\$aBladder Disorder, Neurogenic
=450  \\$wnnna$aBladder Neurogenesis
=450  \\$wnnna$aBladder, Neurogenic
=450  \\$wnnna$aNeurogenesis, Bladder
=450  \\$wnnna$aNeurogenesis, Urinary Bladder
=450  \\$aNeurogenic Bladder
=450  \\$wnnna$aNeurogenic Bladder, Atonic
=450  \\$wnnna$aNeurogenic Bladder Disorder
=450  \\$wnnna$aNeurogenic Bladder Disorders
=450  \\$wnnna$aNeurogenic Bladder, Spastic
=450  \\$wnnna$aNeurogenic Bladder, Uninhibited
=450  \\$wnnna$aNeurogenic Dysfunction of the Urinary Bladder
=450  \\$wnnna$aNeurogenic Urinary Bladder
=450  \\$wnnna$aNeurogenic Urinary Bladder, Atonic
=450  \\$wnnna$aNeurogenic Urinary Bladder Disorder
=450  \\$wnnna$aNeurogenic Urinary Bladder, Spastic
=450  \\$wnnna$aNeurogenic Urinary Bladder, Uninhibited
=450  \\$wnnna$aNeuropathic Bladder
=450  \\$wnnna$aSpastic Neurogenic Bladder
=450  \\$wnnna$aUninhibited Neurogenic Bladder
=450  \\$wnnna$aUrinary Bladder Disorder, Neurogenic
=450  \\$wnnna$aUrinary Bladder Neurogenesis
=450  \\$wnnna$aUrinary Bladder Neurogenic Dysfunction
=550  \\$wg$aNeurologic Manifestations
=550  \\$wg$aUrinary Bladder Diseases
=680  \\$iDysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
=688  \\$a2007 (1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Bladder, Neurogenic
=750  \0$aNeurogenic bladder$0(DLC) sh 85091123$5IEN

=LDR  00917cz  a2200241n  4500
=001  9880363328902441
=005  20141212195014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001228
=035  \\$aCAZ4383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200.$x383.$x249
=072  \\$aC1.$x703.$x295.$x328.$x249
=072  \\$aC1.$x703.$x513.$x249
=072  \\$aC17.$x800.$x838.$x208.$x416.$x249
=150  \\$aAspergillosis
=450  \\$wnnna$aAspergilloses
=550  \\$wg$aHyalohyphomycosis
=550  \\$wh$aAspergillosis, Allergic Bronchopulmonary
=550  \\$wh$aNeuroaspergillosis
=667  \\$aspecify species (IM) if pertinent; coordinate IM with precoordinated organ/disease term (IM); note PULMONARY ASPERGILLOSIS and specifics and NEUROASPERGILLOSIS are also available
=680  \\$iInfections with fungi of the genus ASPERGILLUS.
=750  \0$aAspergillosis$5IEN$0(DLC)sh 88000751

=LDR  01266cz  a2200277n  4500
=001  9880363329002441
=005  20141212195014.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001227
=035  \\$aCAZ4382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x125
=150  \\$aAspartylglucosylaminase
=450  \\$wnnna$aAmidohydrolase, Aspartylglucosamine
=450  \\$wnnna$aAmidohydrolase, Aspartylglycosamine
=450  \\$wnnna$aAspartylglucosamine Amidohydrolase
=450  \\$aAspartylglucosaminidase
=450  \\$aAspartylglucosylamine Deaspartylase
=450  \\$aAspartylglycosamine Amidohydrolase
=450  \\$wnnna$aDeaspartylase, Aspartylglucosylamine
=450  \\$aGlycoasparaginase$5IEN-M
=450  \\$wnnna$aGlycosylasparaginase
=550  \\$wg$aAmidohydrolases
=680  \\$iAn enzyme that catalyzes the conversion of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine-oligosaccharides containing one amino acid, i.e. the ASPARAGINE has free alpha-amino and alpha-carboxyl groups. (From Enzyme Nomenclature, 1992)
=688  \\$a91(75); was see under AMIDOHYDROLASES 1975-90
=750  \0$aGlycoasparaginase$5IEN-M$0(DLC)sh 94002845

=LDR  03166cz  a2200841n  4500
=001  9880363329102441
=005  20141212195013.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001224
=035  \\$aCAZ4379HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x67.$x500
=072  \\$aD12.$x125.$x119.$x170
=072  \\$aD12.$x125.$x427.$x40
=150  \\$aAspartic Acid
=450  \\$wnnna$a(+-)-Aspartic Acid
=450  \\$wnnna$aAmmonium Aspartate
=450  \\$wnnna$aAspartate
=450  \\$wnnna$aAspartate, Ammonium
=450  \\$wnnna$aAspartate, Calcium
=450  \\$wnnna$aAspartate, Dipotassium
=450  \\$wnnna$aAspartate, Disodium
=450  \\$wnnna$aAspartate, Magnesium
=450  \\$wnnna$aAspartate Magnesium Hydrochloride
=450  \\$wnnna$aAspartate, Monopotassium
=450  \\$wnnna$aAspartate, Monosodium
=450  \\$wnnna$aAspartate, Potassium
=450  \\$wnnna$aAspartate, Sodium
=450  \\$wnnna$aAspartic Acid, Ammonium Salt
=450  \\$wnnna$aAspartic Acid, Calcium Salt
=450  \\$wnnna$aAspartic Acid, Dipotassium Salt
=450  \\$wnnna$aAspartic Acid, Disodium Salt
=450  \\$wnnna$aAspartic Acid, Hydrobromide
=450  \\$wnnna$aAspartic Acid, Hydrochloride
=450  \\$wnnna$aAspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate
=450  \\$wnnna$aAspartic Acid, Magnesium (2:1) Salt
=450  \\$wnnna$aAspartic Acid, Magnesium-Potassium (2:1:2) Salt
=450  \\$wnnna$aAspartic Acid, Monopotassium Salt
=450  \\$wnnna$aAspartic Acid, Monosodium Salt
=450  \\$wnnna$aAspartic Acid, Potassium Salt
=450  \\$wnnna$aAspartic Acid, Sodium Salt
=450  \\$wnnna$aCalcium Aspartate
=450  \\$wnnna$aDipotassium Aspartate
=450  \\$wnnna$aDisodium Aspartate
=450  \\$wnnna$aHydrobromide Aspartic Acid
=450  \\$wnnna$aHydrochloride, Aspartate Magnesium
=450  \\$wnnna$aHydrochloride Aspartic Acid
=450  \\$wnnna$aL-Aspartate
=450  \\$wnnna$aL Aspartate
=450  \\$wnnna$aL-Aspartic Acid
=450  \\$wnnna$aL Aspartic Acid
=450  \\$wnnna$aMagnesiocard
=450  \\$wnnna$aMagnesium Aspartate
=450  \\$aMagnesium Hydrochloride, Aspartate$5IEN-M
=450  \\$wnnna$aMg-5-Longoral
=450  \\$wnnna$aMg 5 Longoral
=450  \\$wnnna$aMg5Longoral
=450  \\$wnnna$aMonopotassium Aspartate
=450  \\$wnnna$aMonosodium Aspartate
=450  \\$wnnna$aPotassium Aspartate
=450  \\$wnnna$a(R,S)-Aspartic Acid
=450  \\$wnnna$aSodium Aspartate
=550  \\$wg$aAmino Acids, Acidic
=550  \\$wg$aAmino Acids, Dicarboxylic
=550  \\$wg$aExcitatory Amino Acids
=550  \\$wh$aD-Aspartic Acid
=550  \\$wh$aIsoaspartic Acid
=550  \\$wh$aN-Methylaspartate
=550  \\$wh$aPotassium Magnesium Aspartate
=667  \\$aD-ASPARTIC ACID is also available
=680  \\$iOne of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
=688  \\$a93; ISOASPARTIC ACID was (NM) 1990-92
=750  \0$aAspartic acid$5IEN$0(DLC)sh 85008689

=LDR  01886cz  a2200457n  4500
=001  9880363329202441
=005  20141212195011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001219
=035  \\$aCAZ4374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x477.$x700.$x225
=150  \\$aAspartate Aminotransferases
=450  \\$wnnna$aAminotransferase, Aspartate
=450  \\$wnnna$aAminotransferase, L-Aspartate-2-Oxoglutarate
=450  \\$wnnna$aAminotransferases, Aspartate
=450  \\$wnnna$aApoaminotransferase, Aspartate
=450  \\$aAspartate Aminotransferase
=450  \\$wnnna$aAspartate Apoaminotransferase
=450  \\$aAspartate Transaminase
=450  \\$wnnna$aGlutamate-Aspartate Transaminase
=450  \\$wnnna$aGlutamate Aspartate Transaminase
=450  \\$aGlutamic-Oxaloacetic Transaminase
=450  \\$wnnna$aGlutamic Oxaloacetic Transaminase
=450  \\$wnnna$aGlutamic-Oxaloacetic Transaminase, Serum
=450  \\$wnnna$aL-Aspartate-2-Oxoglutarate Aminotransferase
=450  \\$wnnna$aL Aspartate 2 Oxoglutarate Aminotransferase
=450  \\$wnnna$aSerum Glutamic-Oxaloacetic Transaminase
=450  \\$wnnna$aSerum Glutamic Oxaloacetic Transaminase
=450  \\$aSGOT
=450  \\$wnnna$aTransaminase, Aspartate
=450  \\$wnnna$aTransaminase, Glutamate-Aspartate
=450  \\$wnnna$aTransaminase, Glutamic-Oxaloacetic
=450  \\$wnnna$aTransaminase, Serum Glutamic-Oxaloacetic
=550  \\$wg$aTransaminases
=550  \\$wh$aAspartate Aminotransferase, Cytoplasmic
=550  \\$wh$aAspartate Aminotransferase, Mitochondrial
=667  \\$anote specifics
=680  \\$iEnzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
=688  \\$a2002(1963)
=750  \0$aAspartate aminotransferase$5IEN$0(DLC)sh 88007756

=LDR  01624cz  a2200493n  4500
=001  9880363329302441
=005  20141212192010.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001218
=035  \\$aCAZ4373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x345.$x190
=150  \\$aAspartame
=450  \\$wnnna$aAspartame Fuca Brand
=450  \\$wnnna$aAspartame Hermes Brand
=450  \\$wnnna$aAspartame Muro Brand
=450  \\$wnnna$aAspartame Prodes Brand
=450  \\$wnnna$aAspartylphenylalanine, Methyl
=450  \\$aAspartylphenylalanine Methyl Ester
=450  \\$wnnna$aCanderel
=450  \\$wnnna$aDiététiques et Santé Brand of Aspartame
=450  \\$wnnna$aFuca Brand of Aspartame
=450  \\$wnnna$aGold, Hermesetas
=450  \\$wnnna$aGoldswite
=450  \\$wnnna$aHermes Brand of Aspartame
=450  \\$wnnna$aHermesetas Gold
=450  \\$wnnna$aMethyl Aspartylphenylalanine
=450  \\$wnnna$aMethyl Ester, Aspartylphenylalanine
=450  \\$wnnna$aMilisucre
=450  \\$wnnna$aMuro Brand of Aspartame
=450  \\$wnnna$aNozucar
=450  \\$wnnna$aNutraSweet
=450  \\$wnnna$aProdes Brand of Aspartame
=450  \\$wnnna$aSC-18862
=450  \\$wnnna$aSC 18862
=450  \\$wnnna$aSC18862
=450  \\$wnnna$aTri-Sweet
=450  \\$wnnna$aTri Sweet
=450  \\$wnnna$aTriSweet
=550  \\$wg$aDipeptides
=667  \\$aD25-26 qualif
=680  \\$iFlavoring agent sweeter than sugar, metabolized as PHENYLALANINE and ASPARTIC ACID.
=688  \\$a91(75); was see under DIPEPTIDES 1975-90
=750  \0$aAspartame$5IEN$0(DLC)sh 85008688

=LDR  01862cz  a2200529n  4500
=001  9880363329402441
=005  20141212192009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001215
=035  \\$aCAZ4370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x116
=150  \\$aAsparaginase
=450  \\$wnnna$aAsparaginase Bayer Brand
=450  \\$wnnna$aAsparaginase Bellon Brand
=450  \\$wnnna$aAsparaginase Christiaens Brand
=450  \\$wnnna$aAsparaginase II
=450  \\$wnnna$aAsparaginase Ispen Brand
=450  \\$wnnna$aAsparaginase medac
=450  \\$wnnna$aAsparaginase medac Brand
=450  \\$wnnna$aAsparaginase Merck Brand
=450  \\$wnnna$aAsparaginase Sanfer Brand
=450  \\$wnnna$aAsparaginase Speywood Brand
=450  \\$wnnna$aAsparagine Deaminase
=450  \\$wnnna$aBayer Brand of Asparaginase
=450  \\$wnnna$aBellon Brand of Asparaginase
=450  \\$wnnna$aChristiaens Brand of Asparaginase
=450  \\$wnnna$aColaspase
=450  \\$wnnna$aCrasnitin
=450  \\$wnnna$aDeaminase, Asparagine
=450  \\$wnnna$aElspar
=450  \\$wnnna$aErwinase
=450  \\$wnnna$aIspen Brand of Asparaginase
=450  \\$wnnna$aKidrolase
=450  \\$wnnna$aLeunase
=450  \\$wnnna$amedac, Asparaginase
=450  \\$wnnna$amedac Brand of Asparaginase
=450  \\$wnnna$aMerck Brand of Asparaginase
=450  \\$wnnna$aParonal
=450  \\$wnnna$aRhône-Poulenc Rorer Brand of Asparaginase
=450  \\$wnnna$aRhône Poulenc Rorer Brand of Asparaginase
=450  \\$wnnna$aSanfer Brand of Asparaginase
=450  \\$wnnna$aSpeywood Brand of Asparaginase
=550  \\$wg$aAmidohydrolases
=680  \\$iA hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1.
=688  \\$a68
=750  \0$aAsparaginase$5IEN$0(DLC)sh 89006966

=LDR  02658nz  a2200577n  4500
=001  9882549680002441
=005  20250214141609.0
=008  800512\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001213
=035  \\$a(DNLM)D001213
=035  \\$a(NLM)98195895850000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x906.$x375
=072  \\$aM1.$x686.$x330.$x250
=072  \\$aM1.$x686.$x477.$x625.$x594.$x563
=150  \\$aAsian
=450  \\$wnnna$aAsian Indian Americans
=450  \\$wnnna$aCambodian Americans
=450  \\$wnnna$aFilipino Americans
=450  \\$wnnna$aHmong Americans
=450  \\$wnnna$aVietnamese Americans
=450  \\$aAsian Americans
=450  \\$aChinese Americans
=450  \\$aJapanese Americans
=450  \\$aKorean Americans
=450  \\$wnnna$aAmerican, Cambodian
=450  \\$wnnna$aAmerican, Korean
=450  \\$wnnna$aAmericans, Asian
=450  \\$wnnna$aAmericans, Cambodian
=450  \\$wnnna$aAmericans, Chinese
=450  \\$wnnna$aAmericans, Filipino
=450  \\$wnnna$aAmericans, Hmong
=450  \\$wnnna$aAmericans, Japanese
=450  \\$wnnna$aAmericans, Korean
=450  \\$wnnna$aAmericans, Vietnamese
=450  \\$wnnna$aAmerican, Vietnamese
=450  \\$wnnna$aAsian American
=450  \\$wnnna$aAsian Indian American
=450  \\$wnnna$aAsians
=450  \\$wnnna$aCambodian American
=450  \\$wnnna$aChinese American
=450  \\$wnnna$aFilipino American
=450  \\$wnnna$aHmong American
=450  \\$wnnna$aIndian American, Asian
=450  \\$wnnna$aJapanese American
=450  \\$wnnna$aKorean American
=450  \\$wnnna$aVietnamese American
=667  \\$adespite entry terms, specify CHINA /ethnol, JAPAN /ethnol, KOREA /ethnol, or other Asian country with /ethnol when pertinent
=680  \\$iA person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2023; use ASIAN AMERICANS 1981-2022
=750  \0$aAsian Americans$5IEN$0(DLC)sh 85008644

=LDR  01347cz  a2200289n  4500
=001  9880363329602441
=005  20141212195006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001206
=035  \\$aCAZ4361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133.$x115
=150  \\$aAscorbic Acid Deficiency
=450  \\$wnnna$aAscorbic Acid Deficiencies
=450  \\$aAscorbic Acid$xdeficiency
=450  \\$wnnna$aDeficiencies, Ascorbic Acid
=450  \\$wnnna$aDeficiencies, Vitamin C
=450  \\$wnnna$aDeficiency, Ascorbic Acid
=450  \\$wnnna$aDeficiency, Vitamin C
=450  \\$wnnna$aVitamin C Deficiencies
=450  \\$aVitamin C Deficiency
=550  \\$wg$aAvitaminosis
=550  \\$wh$aScurvy
=550  \\$aScurvy
=667  \\$anote X ref; DF: ASCORBIC ACID DEFIC
=680  \\$iA condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177)
=750  \0$aVitamin C deficiency$5IEN$0(DLC)sh 85143980

=LDR  01724cz  a2200433n  4500
=001  9880363329702441
=005  20141212195006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001205
=035  \\$aCAZ4360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x107
=072  \\$aD2.$x241.$x511.$x902.$x107
=072  \\$aD9.$x811.$x100
=150  \\$aAscorbic Acid
=450  \\$wnnna$aAcid, Ascorbic
=450  \\$wnnna$aAcid, L-Ascorbic
=450  \\$wnnna$aAscorbate, Ferrous
=450  \\$wnnna$aAscorbate, Magnesium
=450  \\$wnnna$aAscorbate, Sodium
=450  \\$wnnna$aAscorbic Acid, Monosodium Salt
=450  \\$wnnna$adi-L-Ascorbate, Magnesium
=450  \\$wnnna$aFerrous Ascorbate
=450  \\$wnnna$aHybrin
=450  \\$wnnna$aL-Ascorbic Acid
=450  \\$wnnna$aL Ascorbic Acid
=450  \\$wnnna$aMagnesium Ascorbate
=450  \\$wnnna$aMagnesium Ascorbicum
=450  \\$wnnna$aMagnesium di-L-Ascorbate
=450  \\$wnnna$aMagnesium di L Ascorbate
=450  \\$wnnna$aMagnorbin
=450  \\$wnnna$aSodium Ascorbate
=450  \\$aVitamin C
=550  \\$wg$aSugar Acids
=550  \\$wh$aDehydroascorbic Acid
=667  \\$a/defic = ASCORBIC ACID DEFICIENCY or SCURVY
=680  \\$iA six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
=688  \\$a/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965
=750  \0$aVitamin C$5IEN$0(DLC)sh 85143977

=LDR  01345cz  a2200397n  4500
=001  9880363329802441
=005  20170831101433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001203
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107
=150  \\$aAscomycota
=450  \\$wnnna$aAscomycete
=450  \\$aAscomycetes
=450  \\$wnnna$aAscomycotas
=450  \\$aCochliobolus
=450  \\$aSclerotinia
=450  \\$wnnna$aSclerotinias
=550  \\$wg$aFungi
=550  \\$wh$aEurotiales
=550  \\$wh$aHypocreales
=550  \\$wh$aMagnaporthe
=550  \\$wh$aOnygenales
=550  \\$wh$aOphiostomatales
=550  \\$wh$aParmeliaceae
=550  \\$wh$aPhyllachorales
=550  \\$wh$aPneumocystis
=550  \\$wh$aPseudallescheria
=550  \\$wh$aSaccharomycetales
=550  \\$wh$aSchizosaccharomyces
=550  \\$wh$aSordariales
=550  \\$wh$aXylariales
=667  \\$aGEN or unspecified; prefer specifics; infection coord IM with MYCOSES (IM) or specific mycosis (IM)
=680  \\$iA phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell (ascus) containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.
=688  \\$a99(75)
=750  \0$aAscomycetes$5IEN-M$0(DLC)sh 85008564

=LDR  00618cz  a2200169n  4500
=001  9880363329902441
=005  20141212195004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001201
=035  \\$aCAZ4356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x81
=150  \\$aAscites
=550  \\$wg$aPathologic Processes
=667  \\$ado not index here for routine liver cirrhosis or Ehrlich ascites tumor; text must discuss ascites especially; chylous ascites: index CHYLOPERITONEUM
=680  \\$iAccumulation or retention of free fluid within the peritoneal cavity.
=750  \0$aAscites$5IEN$0(DLC)sh 85008555

=LDR  00922cz  a2200205n  4500
=001  9880363330002441
=005  20141212195004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001200
=035  \\$aCAZ4355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x100.$x100.$x108
=150  \\$aAscaris
=450  \\$wnnna$aAscari
=550  \\$wg$aAscaridoidea
=550  \\$wh$aAscaris lumbricoides
=550  \\$wh$aAscaris suum
=667  \\$aa genus of nematodes; do not confuse with ASCARIDIA, another genus, both belonging to the superfamily of ASCARIDOIDEA; do not confuse with ACARI (mites & ticks) or ACARUS (mites); infection = ASCARIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine.
=750  \0$aAscaris$5IEN$0(DLC)sh 85008529

=LDR  00825cz  a2200181n  4500
=001  9880363330102441
=005  20141212195003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001196
=035  \\$aCAZ4351HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x700.$x100.$x70
=150  \\$aAscariasis
=450  \\$wnnna$aAscariases
=550  \\$wg$aAscaridida Infections
=667  \\$anematode infect caused by ASCARIS; do not confuse with ACARIASIS, mite infestation or ASCARIDIASIS, infection with ASCARIDIA; coord IM with species (IM)
=680  \\$iInfection by nematodes of the genus ASCARIS. Ingestion of infective eggs causes diarrhea and pneumonitis. Its distribution is more prevalent in areas of poor sanitation and where human feces are used for fertilizer.
=750  \0$aAscariasis$5IEN$0(DLC)sh 85008525

=LDR  01078cz  a2200229n  4500
=001  9880363330202441
=005  20141212195003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001195
=035  \\$aCAZ4350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x581.$x125
=072  \\$aC8.$x381.$x520.$x702.$x125
=072  \\$aC24.$x800.$x127
=150  \\$aAsbestosis
=450  \\$wnnna$aAsbestoses
=450  \\$aIdiopathic Interstitial Pneumonitis - from Asbestos Exposure
=450  \\$aPulmonary Fibrosis - from Asbestos Exposure
=550  \\$wg$aPneumoconiosis
=667  \\$ado not coordinate with OCCUPATIONAL DISEASES; for emphasis on presence of asbestos fibers, MINERAL FIBERS is available: see note there
=680  \\$iA form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium.
=750  \0$aAsbestosis$5IEN$0(DLC)sh 85008522

=LDR  01240cz  a2200241n  4500
=001  9880363330302441
=005  20141212195002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001194
=035  \\$aCAZ4349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x725.$x50
=072  \\$aD1.$x837.$x725.$x700.$x760.$x70
=150  \\$aAsbestos
=550  \\$wg$aSilicates
=550  \\$wh$aAsbestos, Amphibole
=550  \\$wh$aAsbestos, Serpentine
=667  \\$aa silicate used in insulation & fireproofing; carcinogenic; GEN or unspecified; prefer specifics; /adv eff: consider also ASBESTOSIS; disease coord with ASBESTOS /adv eff is dis /etiol, not dis /chem ind; for emphasis on asbestos fibers, MINERAL FIBERS is available: see note there
=680  \\$iAsbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms.
=688  \\$a70(69)
=750  \0$aAsbestos$5IEN-M$0(DLC)sh 85008511
=750  \0$aAsbestos industry$5IEN-HS$0(DLC)sh 85008518
=750  \0$aAsbestos mines and mining$5IEN-HS$0(DLC)sh 85008520

=LDR  00982cz  a2200241n  4500
=001  9880363330402441
=005  20141212195002.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001192
=035  \\$aCAZ4346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x827.$x70
=150  \\$aArylsulfatases
=450  \\$aArylsulfate Sulfohydrolases
=450  \\$wnnna$aArylsulphatases
=450  \\$wnnna$aPseudo Arylsulfatase A
=550  \\$wg$aSulfatases
=550  \\$wh$aCerebroside-Sulfatase
=550  \\$wh$aN-Acetylgalactosamine-4-Sulfatase
=550  \\$wh$aSteryl-Sulfatase
=680  \\$iEnzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1.
=688  \\$a91(75); was see under SULFATASES 1975-90
=750  \0$aArylsulfatases$5IEN$0(DLC)sh 85008503

=LDR  00742cz  a2200229n  4500
=001  9880363330502441
=005  20141212195001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001190
=035  \\$aCAZ4344M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50
=150  \\$aArylsulfonates
=450  \\$wnnna$aAryl Sulfonates
=450  \\$wnnna$aSulfonates, Aryl
=550  \\$wg$aArylsulfonic Acids
=550  \\$wh$aBenzenesulfonates
=550  \\$wh$aLissamine Green Dyes
=550  \\$wh$aNaphthalenesulfonates
=680  \\$iOrganic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical.
=688  \\$a94; was ARYL SULFONATES 1974-93
=750  \0$aArylsulfonates$0(DLC)sh2007001705$5IEN-M

=LDR  00739cz  a2200217n  4500
=001  9880363330602441
=005  20200508115045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001188
=035  \\$aCAZ4342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x500
=150  \\$aArtiodactyla
=450  \\$wnnna$aArtiodactylas
=550  \\$wg$aMammals
=550  \\$wh$aCamelidae
=550  \\$wh$aRuminants
=550  \\$wh$aSwine
=667  \\$aGEN or unspecified; prefer specifics; includes giraffe, hippopotamus, peccary; IM; qualif permitted
=680  \\$iAn order of mammals which consists of the even-toed ungulates and includes both RUMINANTS and SWINE.
=750  \0$aArtiodactyla$5IEN$0(DLC)sh 85008262

=LDR  01637cz  a2200337n  4500
=001  9880363330702441
=005  20141212195000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001187
=035  \\$aCAZ4341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x82
=150  \\$aArtificial Organs
=450  \\$wnnna$aArtificial Organ
=450  \\$wnnna$aOrgan, Artificial
=450  \\$wnnna$aOrgans, Artificial
=550  \\$wg$aSurgical Equipment
=550  \\$wh$aArtificial Limbs
=550  \\$wh$aBioartificial Organs
=550  \\$wh$aHeart, Artificial
=550  \\$wh$aHeart-Lung Machine
=550  \\$wh$aInfusion Pumps
=550  \\$wh$aKidneys, Artificial
=550  \\$wh$aLarynx, Artificial
=550  \\$wh$aLiver, Artificial
=550  \\$wh$aPancreas, Artificial
=550  \\$wh$aSkin, Artificial
=550  \\$wh$aUrinary Sphincter, Artificial
=667  \\$ausually to replace function, as HEART, ARTIFICIAL or KIDNEY, ARTIFICIAL: do not confuse with PROSTHESES AND IMPLANTS which is usually cosmetic; not for injections, like silicones, to replace substance; coord IM with specific organ (IM) with no qualif but note available precoords
=680  \\$iDevices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic (EYE, ARTIFICIAL) as well as functional (ARTIFICIAL LIMBS).
=750  \0$aArtificial organs$5IEN$0(DLC)sh 85008195

=LDR  01662cz  a2200541n  4500
=001  9880363330802441
=005  20141212194959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001186
=035  \\$aCAZ4340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695.$x50
=072  \\$aE7.$x858.$x82.$x50
=072  \\$aE7.$x858.$x442.$x50
=150  \\$aArtificial Limbs
=450  \\$aArm, Artificial
=450  \\$wnnna$aArm Prostheses
=450  \\$aArm Prosthesis
=450  \\$wnnna$aArms, Artificial
=450  \\$aArtificial Arm
=450  \\$wnnna$aArtificial Arms
=450  \\$wnnna$aArtificial Extremities
=450  \\$wnnna$aArtificial Extremity
=450  \\$aArtificial Leg
=450  \\$wnnna$aArtificial Legs
=450  \\$wnnna$aArtificial Limb
=450  \\$aExtremities, Artificial
=450  \\$wnnna$aExtremity, Artificial
=450  \\$aLeg, Artificial
=450  \\$wnnna$aLeg Prostheses
=450  \\$aLeg Prosthesis
=450  \\$wnnna$aLegs, Artificial
=450  \\$wnnna$aLimb, Artificial
=450  \\$wnnna$aLimb Prostheses
=450  \\$aLimb Prosthesis
=450  \\$aLimbs, Artificial
=450  \\$wnnna$aProstheses, Arm
=450  \\$wnnna$aProstheses, Leg
=450  \\$wnnna$aProstheses, Limb
=450  \\$wnnna$aProsthesis, Arm
=450  \\$wnnna$aProsthesis, Leg
=450  \\$wnnna$aProsthesis, Limb
=550  \\$wg$aArtificial Organs
=550  \\$wg$aOrthopedic Equipment
=550  \\$wg$aProstheses and Implants
=667  \\$acoord ARM or LEG (NIM) if pertinent
=680  \\$iProsthetic replacements for arms, legs, and parts thereof.
=750  \0$aArtificial limbs$0(DLC) sh 85008192$5IEN

=LDR  02291cz  a2200589n  4500
=001  9880363330902441
=005  20201216141312.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001185
=035  \\$aCAZ4339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG17.$x35.$x250
=072  \\$aL1.$x224.$x50.$x375
=150  \\$aArtificial Intelligence
=450  \\$wnnna$aAcquisition, Knowledge (Computer)
=450  \\$wnnna$aAcquisitions, Knowledge (Computer)
=450  \\$aAI (Artificial Intelligence)
=450  \\$wnnna$aAIs (Artificial Intelligence)
=450  \\$wnnna$aComputational Intelligence
=450  \\$wnnna$aComputational Intelligences
=450  \\$aComputer Reasoning
=450  \\$wnnna$aComputer Vision System
=450  \\$aComputer Vision Systems
=450  \\$wnnna$aIntelligence, Artificial
=450  \\$wnnna$aIntelligence, Computational
=450  \\$wnnna$aIntelligence, Machine
=450  \\$wnnna$aIntelligences, Computational
=450  \\$aKnowledge Acquisition (Computer)
=450  \\$wnnna$aKnowledge Acquisitions (Computer)
=450  \\$aKnowledge Representation (Computer)
=450  \\$wnnna$aKnowledge Representations (Computer)
=450  \\$wnnna$aLearning, Machine
=450  \\$aMachine Intelligence
=450  \\$wnnna$aReasoning, Computer
=450  \\$wnnna$aRepresentation, Knowledge (Computer)
=450  \\$wnnna$aRepresentations, Knowledge (Computer)
=450  \\$wnnna$aSystem, Computer Vision
=450  \\$wnnna$aSystems, Computer Vision
=450  \\$wnnna$aVision System, Computer
=450  \\$wnnna$aVision Systems, Computer
=550  \\$wg$aAlgorithms
=550  \\$wh$aComputer Heuristics
=550  \\$wh$aExpert Systems
=550  \\$wh$aFuzzy Logic
=550  \\$wh$aKnowledge Bases
=550  \\$wh$aMachine Learning
=550  \\$wh$aNatural Language Processing
=550  \\$wh$aNeural Networks, Computer
=550  \\$wh$aRobotics
=680  \\$iTheory and development of COMPUTER SYSTEMS which perform tasks that normally require human intelligence. Such tasks may include speech recognition, LEARNING; VISUAL PERCEPTION; MATHEMATICAL COMPUTING; reasoning, PROBLEM SOLVING, DECISION-MAKING, and translation of language.
=688  \\$a86
=750  \0$aArtificial intelligence$5IEN$0(DLC)sh 85008180

=LDR  02019cz  a2200517n  4500
=001  9880363331002441
=005  20141212194958.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001184
=035  \\$aCAZ4338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x150
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x150
=150  \\$aArticulation Disorders
=450  \\$wnnna$aArticulation Disorder
=450  \\$wnnna$aArticulation Disorder, Developmental
=450  \\$wnnna$aArticulation Disorder, Speech
=450  \\$wnnna$aArticulation Disorders, Developmental
=450  \\$wnnna$aArticulation Disorders, Speech
=450  \\$wnnna$aArticulation, Unintelligible
=450  \\$wnnna$aArticulations, Unintelligible
=450  \\$wnnna$aDevelopmental Articulation Disorder
=450  \\$wnnna$aDevelopmental Articulation Disorders
=450  \\$wnnna$aDisarticulation Disorder
=450  \\$wnnna$aDisarticulation Disorders
=450  \\$wnnna$aDisorder, Disarticulation
=450  \\$wnnna$aDisorders, Disarticulation
=450  \\$wnnna$aImpairment, Phonological
=450  \\$wnnna$aImpairment, Phonology
=450  \\$wnnna$aImpairments, Phonological
=450  \\$wnnna$aImpairments, Phonology
=450  \\$wnnna$aMisarticulation
=450  \\$wnnna$aPhonological Impairment
=450  \\$aPhonological Impairments
=450  \\$wnnna$aPhonology Impairment
=450  \\$wnnna$aPhonology Impairments
=450  \\$wnnna$aSpeech Articulation Disorder
=450  \\$aSpeech Articulation Disorders
=450  \\$wnnna$aUnintelligible Articulation
=450  \\$wnnna$aUnintelligible Articulations
=550  \\$wg$aSpeech Disorders
=550  \\$wh$aDysarthria
=667  \\$anote categories: "articulation" refers to speech, not to joints
=680  \\$iDisorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.
=688  \\$a1979
=750  \0$aArticulation disorders$5IEN$0(DLC)sh 85008159

=LDR  01269cz  a2200385n  4500
=001  9880363331102441
=005  20141212192008.0
=008  810415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001182
=035  \\$aCAZ4336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x70
=072  \\$aE4.$x502.$x250.$x70
=072  \\$aE4.$x555.$x113
=150  \\$aArthroscopy
=450  \\$wnnna$aArthroscopic Surgeries
=450  \\$wnnna$aArthroscopic Surgery
=450  \\$wnnna$aArthroscopic Surgical Procedure
=450  \\$aArthroscopic Surgical Procedures
=450  \\$wnnna$aArthroscopies
=450  \\$wnnna$aProcedure, Arthroscopic Surgical
=450  \\$wnnna$aProcedures, Arthroscopic Surgical
=450  \\$wnnna$aSurgeries, Arthroscopic
=450  \\$wnnna$aSurgery, Arthroscopic
=450  \\$wnnna$aSurgical Procedure, Arthroscopic
=450  \\$aSurgical Procedures, Arthroscopic
=550  \\$wg$aEndoscopy
=550  \\$wg$aOrthopedic Procedures
=550  \\$wh$aJoint Capsule Release
=550  \\$aArthroscopes
=550  \\$aJoints
=667  \\$a/ instrum permitted but consider also ARTHROSCOPES
=680  \\$iEndoscopic examination, therapy and surgery of the joint.
=688  \\$a82
=750  \0$aArthroscopy$5IEN$0(DLC)sh 85008141

=LDR  00867cz  a2200229n  4500
=001  9880363331202441
=005  20141212194957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001181
=035  \\$aCAZ4335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131
=150  \\$aArthropods
=450  \\$wnnna$aArthropod
=450  \\$wnnna$aArthropoda
=550  \\$wg$aInvertebrates
=550  \\$wh$aArachnida
=550  \\$wh$aCrustacea
=550  \\$wh$aHorseshoe Crabs
=550  \\$wh$aInsects
=680  \\$iMembers of the phylum Arthropoda, composed of organisms having a hard, jointed exoskeleton and paired jointed legs. It includes the class INSECTS and the subclass ARACHNIDA, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man.
=750  \0$aArthropoda$5IEN$0(DLC)sh 85008134

=LDR  01282cz  a2200289n  4500
=001  9880363331302441
=005  20141212194957.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001180
=035  \\$aCAZ4334HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x65
=072  \\$aD23.$x946.$x833.$x65
=150  \\$aArthropod Venoms
=450  \\$wnnna$aArthropod Venom
=450  \\$wnnna$aVenom, Arthropod
=450  \\$wnnna$aVenoms, Arthropod
=550  \\$wg$aVenoms
=550  \\$wh$aAnt Venoms
=550  \\$wh$aBee Venoms
=550  \\$wh$aScorpion Venoms
=550  \\$wh$aSpider Venoms
=550  \\$wh$aWasp Venoms
=667  \\$a/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific arachnid or insect (IM or NIM) but note available specifics: ANT VENOMS; BEE VENOMS; SCORPION VENOMS; SPIDER VENOMS & WASP VENOMS & their indentions
=680  \\$iVenoms from animals of the phylum Arthropoda. Those most investigated are from scorpions and spiders of the class Arachnidae and from ant, bee, and wasp families of the Insecta order Hymenoptera. The venoms contain protein toxins, enzymes, and other bioactive substances and may be lethal to man.
=688  \\$a78
=750  \0$aPoisonous arthropoda$xVenom$5IEN$0(DLC)sh 85008140

=LDR  00937cz  a2200241n  4500
=001  9880363331402441
=005  20141212194956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001179
=035  \\$aCAZ4333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x310.$x350.$x100
=150  \\$aArthropod Vectors
=450  \\$wnnna$aArthropod Vector
=450  \\$wnnna$aVector, Arthropod
=450  \\$wnnna$aVectors, Arthropod
=550  \\$wg$aDisease Vectors
=550  \\$wh$aArachnid Vectors
=550  \\$wh$aInsect Vectors
=667  \\$acoord IM with specific arthropod (IM); specify both infecting organism & vector if pertinent; ARACHNID VECTORS and INSECT VECTORS are also avail
=680  \\$iArthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
=688  \\$a64
=750  \0$aArthropod vectors$5IEN$0(DLC)sh 85008133

=LDR  01069cz  a2200277n  4500
=001  9880363331502441
=005  20141212192007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001178
=035  \\$aCAZ4332HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x110
=072  \\$aE4.$x680.$x101
=150  \\$aArthroplasty
=450  \\$wnnna$aArthroplasties
=550  \\$wg$aOrthopedic Procedures
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wh$aAnterior Cruciate Ligament Reconstruction
=550  \\$wh$aArthroplasty, Replacement
=550  \\$wh$aArthroplasty, Subchondral
=550  \\$aAcetabuloplasty
=550  \\$aJoints
=550  \\$aOsseointegration
=667  \\$asurg reconstruct of a joint; total or partial joint replacement = ARTHROPLASTY, REPLACEMENT or its specifics; joint revision (see REOPERATION) = ARTHROPLASTY (IM) + REOPERATION (NIM); do not use /util except by MeSH definition
=680  \\$iSurgical reconstruction of a joint to relieve pain or restore motion.
=750  \0$aArthroplasty$0(DLC) sh 85008130$5IEN

=LDR  01122cz  a2200265n  4500
=001  9880363331602441
=005  20141212194956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001177
=035  \\$aCAZ4331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x186
=150  \\$aArthropathy, Neurogenic
=450  \\$wnnna$aArthropathies, Neurogenic
=450  \\$wnnna$aCharcot Joint
=450  \\$aCharcot Joints$5IEN-M
=450  \\$aCharcot's Joint
=450  \\$wnnna$aCharcots Joint
=450  \\$wnnna$aJoint, Charcot's
=450  \\$aJoints, Charcot$5IEN-M
=450  \\$wnnna$aNeurogenic Arthropathies
=450  \\$wnnna$aNeurogenic Arthropathy
=550  \\$wg$aJoint Diseases
=680  \\$iChronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed)
=750  \0$aCharcot joints$5IEN$0(DLC)sh 85022640

=LDR  02835cz  a2200721n  4500
=001  9880363331702441
=005  20141212194956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001176
=035  \\$aCAZ4330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x150
=072  \\$aC5.$x651.$x102
=072  \\$aC5.$x660.$x77
=072  \\$aC16.$x131.$x621.$x77
=150  \\$aArthrogryposis
=450  \\$aAmyoplasia Congenita
=450  \\$wnnna$aArthrogryposes
=450  \\$wnnna$aArthrogryposes, Congenital Multiple
=450  \\$wnnna$aArthrogryposis, Congenital Multiple
=450  \\$wnnna$aArthrogryposis Multiplex Congenita
=450  \\$wnnna$aArthrogryposis Multiplex Congenita (AMC)
=450  \\$wnnna$aArthrogryposis Multiplex Congenitas
=450  \\$wnnna$aArthrogryposis Multiplex Congenitas (AMC)
=450  \\$aArthromyodysplasia, Congenital
=450  \\$wnnna$aArthromyodysplasias, Congenital
=450  \\$wnnna$aCongenita, Arthrogryposis Multiplex
=450  \\$wnnna$aCongenita, Arthrogryposis Multiplex (AMC)
=450  \\$wnnna$aCongenital Arthromyodysplasia
=450  \\$wnnna$aCongenital Arthromyodysplasias
=450  \\$wnnna$aCongenital Multiple Arthrogryposes
=450  \\$wnnna$aCongenital Multiple Arthrogryposis
=450  \\$wnnna$aCongenitas, Arthrogryposis Multiplex
=450  \\$wnnna$aCongenitas, Arthrogryposis Multiplex (AMC)
=450  \\$wnnna$aFibrous Ankylosis of Multiple Joints
=450  \\$wnnna$aGuérin-Stern Syndrome
=450  \\$wnnna$aGuérin Stern Syndrome
=450  \\$aGuerin-Stern Syndrome
=450  \\$wnnna$aGuerin Stern Syndrome
=450  \\$wnnna$aMultiple Arthrogryposes, Congenital
=450  \\$wnnna$aMultiple Arthrogryposis, Congenital
=450  \\$wnnna$aMultiplex Congenita, Arthrogryposis
=450  \\$wnnna$aMultiplex Congenita, Arthrogryposis (AMC)
=450  \\$wnnna$aMultiplex Congenitas, Arthrogryposis
=450  \\$wnnna$aMultiplex Congenitas, Arthrogryposis (AMC)
=450  \\$aMyodystrophia Fetalis Deformans
=450  \\$wnnna$aOtto Syndrome
=450  \\$wnnna$aRocher-Sheldon Syndrome
=450  \\$wnnna$aRocher Sheldon Syndrome
=450  \\$wnnna$aRossi Syndrome
=450  \\$wnnna$aSyndrome, Guérin-Stern
=450  \\$wnnna$aSyndrome, Guerin-Stern
=450  \\$wnnna$aSyndrome, Otto
=450  \\$wnnna$aSyndrome, Rocher-Sheldon
=450  \\$wnnna$aSyndrome, Rossi
=550  \\$wg$aJoint Diseases
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aMusculoskeletal Abnormalities
=550  \\$aReceptor, ErbB-3
=667  \\$a"persistent flexure or contracture of a joint"; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iPersistent flexure or contracture of a joint.�[MARC+A0]
=688  \\$a65(63)
=750  \0$aArthrogryposis$5IEN$0(DLC)sh 85008129

=LDR  00690cz  a2200217n  4500
=001  9880363331802441
=005  20141212194955.0
=008  850607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001175
=035  \\$aCAZ4329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x70
=150  \\$aArthrography
=450  \\$wnnna$aArthrographies
=450  \\$aJoints$xradiography
=550  \\$wg$aRadiography
=550  \\$aJoints
=667  \\$ado not use /util except by MeSH definition; DF: ARTHROGR
=680  \\$iRoentgenography of a joint, usually after injection of either positive or negative contrast medium.
=688  \\$a86
=750  \0$aJoints$xRadiography$5IEN$0(DLC)sh 85070663

=LDR  00787cz  a2200205n  4500
=001  9880363331902441
=005  20141212194954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001174
=035  \\$aCAZ4328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x555.$x100
=150  \\$aArthrodesis
=450  \\$wnnna$aArthrodeses
=550  \\$wg$aOrthopedic Procedures
=550  \\$wh$aSpinal Fusion
=550  \\$aBone and Bones
=667  \\$aa method of joint surg; do not use /util except by MeSH definition; vertebral or spinal arthrodesis = SPINAL FUSION
=680  \\$iThe surgical fixation of a joint by a procedure designed to accomplish fusion of the joint surfaces by promoting the proliferation of bone cells. (Dorland, 28th ed)
=750  \0$aArthrodesis$5IEN$0(DLC)sh 85008126

=LDR  00592cz  a2200181n  4500
=001  9880363332002441
=005  20141212194954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001173
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x475.$x50
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x74
=150  \\$aArthrobacter
=550  \\$wg$aActinobacteria
=550  \\$wg$aMicrococcaceae
=667  \\$ain soil
=680  \\$iA genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle.
=750  \0$aArthrobacter$5IEN$0(DLC)sh 86006604

=LDR  01357cz  a2200313n  4500
=001  9880363332102441
=005  20141212192007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001172
=035  \\$aCAZ4326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x154
=072  \\$aC5.$x799.$x114
=072  \\$aC17.$x300.$x775.$x99
=072  \\$aC20.$x111.$x199
=150  \\$aArthritis, Rheumatoid
=450  \\$aRheumatoid Arthritis
=550  \\$wg$aArthritis
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aRheumatic Diseases
=550  \\$wh$aCaplan Syndrome
=550  \\$wh$aFelty Syndrome
=550  \\$wh$aRheumatoid Nodule
=550  \\$wh$aRheumatoid Vasculitis
=550  \\$wh$aSjogren's Syndrome
=550  \\$wh$aStill's Disease, Adult-Onset
=667  \\$ain children = ARTHRITIS, JUVENILE RHEUMATOID; includes PCE: polyarthrite chronique évolutive; tends to be chronic so do not coord with CHRONIC DISEASE
=680  \\$iA chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
=750  \0$aRheumatoid arthritis$5IEN$0(DLC)sh 85113649

=LDR  02981cz  a2200649n  4500
=001  9880363332202441
=005  20141212194954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001171
=035  \\$aCAZ4325HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x122
=072  \\$aC5.$x799.$x56
=072  \\$aC17.$x300.$x775.$x49
=072  \\$aC20.$x111.$x198
=150  \\$aArthritis, Juvenile
=450  \\$aArthritis, Juvenile Chronic
=450  \\$wnnna$aArthritis, Juvenile Enthesitis-Related
=450  \\$aArthritis, Juvenile Idiopathic
=450  \\$wnnna$aArthritis, Juvenile Psoriatic
=450  \\$aArthritis, Juvenile Rheumatoid
=450  \\$wnnna$aArthritis, Juvenile Systemic
=450  \\$wnnna$aChronic Arthritis, Juvenile
=450  \\$wnnna$aEnthesitis-Related Arthritis, Juvenile
=450  \\$wnnna$aEnthesitis Related Arthritis, Juvenile
=450  \\$wnnna$aIdiopathic Arthritis, Juvenile
=450  \\$wnnna$aJuvenile Arthritis
=450  \\$wnnna$aJuvenile Chronic Arthritis
=450  \\$wnnna$aJuvenile Enthesitis-Related Arthritis
=450  \\$wnnna$aJuvenile Idiopathic Arthritis
=450  \\$wnnna$aJuvenile Oligoarthritis
=450  \\$wnnna$aJuvenile-Onset Still Disease
=450  \\$wnnna$aJuvenile Onset Still Disease
=450  \\$wnnna$aJuvenile-Onset Stills Disease
=450  \\$wnnna$aJuvenile Onset Stills Disease
=450  \\$wnnna$aJuvenile-Onset Still's Disease
=450  \\$wnnna$aJuvenile Psoriatic Arthritis
=450  \\$wnnna$aJuvenile Rheumatoid Arthritis
=450  \\$wnnna$aJuvenile Systemic Arthritis
=450  \\$wnnna$aOligoarthritis, Juvenile
=450  \\$wnnna$aPolyarthritis, Juvenile, Rheumatoid Factor Negative
=450  \\$wnnna$aPolyarthritis, Juvenile, Rheumatoid Factor Positive
=450  \\$wnnna$aPsoriatic Arthritis, Juvenile
=450  \\$wnnna$aRheumatoid Arthritis, Juvenile
=450  \\$wnnna$aStill Disease, Juvenile-Onset
=450  \\$wnnna$aStill Disease, Juvenile Onset
=450  \\$aStill's Disease, Juvenile-Onset
=450  \\$wnnna$aStill's Disease, Juvenile Onset
=450  \\$wnnna$aStills Disease, Juvenile-Onset
=450  \\$wnnna$aSystemic Arthritis, Juvenile
=550  \\$wg$aArthritis
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aRheumatic Diseases
=667  \\$anote entry term STILL'S DISEASE, JUVENILE-ONSET: STILL'S DISEASE, ADULT-ONSET is also available
=680  \\$iArthritis of children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Arthritis, Juvenile Rheumatoid
=750  \0$aRheumatoid arthritis in children$5IEN$0(DLC)sh 85113650

=LDR  01469cz  a2200445n  4500
=001  9880363332302441
=005  20141212194953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001170
=035  \\$aCAZ4324HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x100
=072  \\$aC5.$x550.$x114.$x99
=150  \\$aArthritis, Infectious
=450  \\$wnnna$aArthritides, Bacterial
=450  \\$wnnna$aArthritides, Infectious
=450  \\$wnnna$aArthritides, Septic
=450  \\$wnnna$aArthritides, Suppurative
=450  \\$wnnna$aArthritides, Viral
=450  \\$aArthritis, Bacterial
=450  \\$aArthritis, Septic
=450  \\$wnnna$aArthritis, Suppurative
=450  \\$aArthritis, Viral
=450  \\$wnnna$aBacterial Arthritides
=450  \\$wnnna$aBacterial Arthritis
=450  \\$wnnna$aInfectious Arthritides
=450  \\$wnnna$aInfectious Arthritis
=450  \\$wnnna$aSeptic Arthritides
=450  \\$wnnna$aSeptic Arthritis
=450  \\$wnnna$aSuppurative Arthritides
=450  \\$wnnna$aSuppurative Arthritis
=450  \\$wnnna$aViral Arthritides
=450  \\$wnnna$aViral Arthritis
=550  \\$wg$aArthritis
=550  \\$wg$aInfection
=550  \\$wh$aArthritis, Reactive
=667  \\$acoordinate IM with specific infection (IM) + site (IM)
=680  \\$iArthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.
=688  \\$a65
=750  \0$aInfectious arthritis$5IEN$0(DLC)sh 85066079

=LDR  01254cz  a2200337n  4500
=001  9880363332402441
=005  20141212192006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001168
=035  \\$aCAZ4322HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114
=150  \\$aArthritis
=450  \\$wnnna$aArthritides
=450  \\$wnnna$aPolyarthritides
=450  \\$aPolyarthritis
=550  \\$wg$aJoint Diseases
=550  \\$wh$aArthritis, Experimental
=550  \\$wh$aArthritis, Infectious
=550  \\$wh$aArthritis, Juvenile
=550  \\$wh$aArthritis, Psoriatic
=550  \\$wh$aArthritis, Rheumatoid
=550  \\$wh$aChondrocalcinosis
=550  \\$wh$aGout
=550  \\$wh$aOsteoarthritis
=550  \\$wh$aPeriarthritis
=550  \\$wh$aRheumatic Fever
=550  \\$wh$aSacroiliitis
=550  \\$wh$aSpondylarthritis
=667  \\$ainflamm: do not confuse with ARTHRALGIA which is non-inflamm; note X ref POLYARTHRITIS but polyarthrite chronique évolutive (PCE) = ARTHRITIS, RHEUMATOID; septic arthritis = ARTHRITIS, INFECTIOUS; tends to be chronic so do not coord with CHRONIC DISEASE; degenerative arthritis = OSTEOARTHRITIS; ARTHRITIS, PSORIATIC is also available
=750  \0$aArthritis$5IEN$0(DLC)sh 85008121

=LDR  00891cz  a2200289n  4500
=001  9880363332502441
=005  20141212194952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001167
=035  \\$aCAZ4321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x184
=072  \\$aC14.$x907.$x940.$x90
=150  \\$aArteritis
=450  \\$wnnna$aArterial Inflammation
=450  \\$wnnna$aArteritides
=450  \\$wnnna$aInflammation, Arterial
=550  \\$wg$aVascular Diseases
=550  \\$wg$aVasculitis
=550  \\$wh$aAIDS Arteritis, Central Nervous System
=550  \\$wh$aEndarteritis
=550  \\$wh$aGiant Cell Arteritis
=550  \\$wh$aPolyarteritis Nodosa
=550  \\$wh$aTakayasu Arteritis
=667  \\$ageneral, unspecified; coordinate IM with specific artery (IM)
=680  \\$iINFLAMMATION of any ARTERIES.
=750  \0$aArteritis$5IEN$0(DLC)sh 85008116

=LDR  00962cz  a2200265n  4500
=001  9880363332602441
=005  20141212194952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001166
=035  \\$aCAZ4320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x87
=072  \\$aE4.$x100.$x814.$x868.$x249
=150  \\$aArteriovenous Shunt, Surgical
=450  \\$wnnna$aArteriovenous Shunts, Surgical
=450  \\$wnnna$aShunt, Surgical Arteriovenous
=450  \\$wnnna$aShunts, Surgical Arteriovenous
=450  \\$wnnna$aSurgical Arteriovenous Shunt
=450  \\$wnnna$aSurgical Arteriovenous Shunts
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aVascular Grafting
=667  \\$ado not use /util except by MeSH definition; Manual 23.19.6.2
=680  \\$iSurgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed)
=688  \\$a70
=750  \0$aArteriovenous shunts, Surgical$5IEN$0(DLC)sh 85008115

=LDR  01441cz  a2200301n  4500
=001  9880363332702441
=005  20141212194951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001165
=035  \\$aCAZ4319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x850.$x750
=072  \\$aC14.$x907.$x150
=072  \\$aC16.$x131.$x240.$x850.$x750
=150  \\$aArteriovenous Malformations
=450  \\$aAngiodysplasia$xcongenital
=450  \\$wnnna$aArteriovenous Malformation
=450  \\$wnnna$aMalformation, Arteriovenous
=450  \\$wnnna$aMalformations, Arteriovenous
=550  \\$wg$aVascular Diseases
=550  \\$wg$aVascular Malformations
=550  \\$wh$aArteriovenous Fistula
=550  \\$wh$aIntracranial Arteriovenous Malformations
=550  \\$aArteriovenous Fistula
=667  \\$ageneral or unspecified; coordinate IM with specific artery /abnorm (IM) + specific vein /abnorm (IM) or use specific available precoordinated arterial or venous abnormalities (IM)
=680  \\$iAbnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
=688  \\$a73(69)
=750  \0$aBlood-vessels$xAbnormalities$5IEN$0(DLC)sh 85015022

=LDR  01755cz  a2200325n  4500
=001  9880363332802441
=005  20141212194951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001164
=035  \\$aCAZ4318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x850.$x750.$x147
=072  \\$aC14.$x240.$x850.$x984.$x750
=072  \\$aC14.$x907.$x150.$x125
=072  \\$aC14.$x907.$x933.$x555
=072  \\$aC16.$x131.$x240.$x850.$x750.$x125
=072  \\$aC23.$x300.$x575.$x950.$x250
=150  \\$aArteriovenous Fistula
=450  \\$aAneurysm, Arteriovenous
=450  \\$aArteriovenous Aneurysm
=450  \\$wnnna$aArteriovenous Fistulas
=450  \\$wnnna$aFistula, Arteriovenous
=450  \\$wnnna$aFistulas, Arteriovenous
=550  \\$wg$aArteriovenous Malformations
=550  \\$wg$aVascular Fistula
=550  \\$aArteriovenous Malformations
=667  \\$ado not confuse with ARTERIOVENOUS ANASTOMOSIS, an anatomical term; coordinate IM with specific artery /abnorm + specific vein /abnorm (IM) or precoordinate vessel/disease headings (IM); Manual 23.19.6+; congenital cerebral arteriovenous fistula = INTRACRANIAL ARTERIOVENOUS MALFORMATIONS (IM) + ARTERIOVENOUS FISTULA (IM); surgically created arteriovenous fistula = ARTERIOVENOUS SHUNT, SURGICAL
=680  \\$iAn abnormal direct communication between an artery and a vein without passing through the CAPILLARIES. An A-V fistula usually leads to the formation of a dilated sac-like connection, arteriovenous aneurysm. The locations and size of the shunts determine the degree of effects on the cardiovascular functions such as BLOOD PRESSURE and HEART RATE.
=688  \\$a67; was FISTULA, ARTERIOVENOUS 1963-66
=750  \0$aFistula, Arteriovenous$5IEN$0(DLC)sh 85048894

=LDR  00962cz  a2200241n  4500
=001  9880363332902441
=005  20141212194950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001163
=035  \\$aCAZ4317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x461.$x85
=150  \\$aArteriovenous Anastomosis
=450  \\$wnnna$aAnastomose, Arteriovenous
=450  \\$wnnna$aAnastomoses, Arteriovenous
=450  \\$wnnna$aAnastomosis, Arteriovenous
=450  \\$wnnna$aArteriovenous Anastomose
=450  \\$wnnna$aArteriovenous Anastomoses
=550  \\$wg$aMicrovessels
=667  \\$anote category: do not confuse with ARTERIOVENOUS FISTULA; Manual 23.19.6.2
=680  \\$iA vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed. Not to be confused with surgical anastomosis, nor with arteriovenous fistula.
=688  \\$a66(64)
=750  \0$aArteriovenous anastomosis$5IEN$0(DLC)sh 85008114

=LDR  00732cz  a2200157n  4500
=001  9880363333002441
=005  20141212194950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137.$x126.$x114
=150  \\$aArteriosclerosis Obliterans
=450  \\$wnnna$aObliterans, Arteriosclerosis
=550  \\$wg$aArteriosclerosis
=680  \\$iCommon occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
=750  \0$aArteriosclerosis obliterans$5IEN$0(DLC)sh 85008113

=LDR  01071cz  a2200265n  4500
=001  9880363333102441
=005  20141212194950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001161
=035  \\$aCAZ4315HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137.$x126
=150  \\$aArteriosclerosis
=450  \\$wnnna$aArterioscleroses
=550  \\$wg$aArterial Occlusive Diseases
=550  \\$wh$aArteriolosclerosis
=550  \\$wh$aArteriosclerosis Obliterans
=550  \\$wh$aAtherosclerosis
=550  \\$wh$aCoronary Artery Disease
=550  \\$wh$aIntermittent Claudication
=550  \\$wh$aIntracranial Arteriosclerosis
=667  \\$ageneral; prefer specifics; do not confuse with ARTERIOLOSCLEROSIS
=680  \\$iThickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
=688  \\$a1964
=750  \0$aArteriosclerosis$5IEN$0(DLC)sh 85008111

=LDR  02063cz  a2200589n  4500
=001  9880363333202441
=005  20141212194949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001158
=035  \\$aCAZ4312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114
=150  \\$aArteries
=450  \\$wnnna$aArtery
=550  \\$wg$aBlood Vessels
=550  \\$wh$aAorta
=550  \\$wh$aArterioles
=550  \\$wh$aAxillary Artery
=550  \\$wh$aBasilar Artery
=550  \\$wh$aBrachial Artery
=550  \\$wh$aBrachiocephalic Trunk
=550  \\$wh$aBronchial Arteries
=550  \\$wh$aCarotid Arteries
=550  \\$wh$aCeliac Artery
=550  \\$wh$aCerebral Arteries
=550  \\$wh$aCiliary Arteries
=550  \\$wh$aCoronary Vessels
=550  \\$wh$aEpigastric Arteries
=550  \\$wh$aFemoral Artery
=550  \\$wh$aGastroepiploic Artery
=550  \\$wh$aHepatic Artery
=550  \\$wh$aIliac Artery
=550  \\$wh$aMaxillary Artery
=550  \\$wh$aMeningeal Arteries
=550  \\$wh$aMesenteric Arteries
=550  \\$wh$aOphthalmic Artery
=550  \\$wh$aPopliteal Artery
=550  \\$wh$aPulmonary Artery
=550  \\$wh$aRadial Artery
=550  \\$wh$aRenal Artery
=550  \\$wh$aRetinal Artery
=550  \\$wh$aSplenic Artery
=550  \\$wh$aSubclavian Artery
=550  \\$wh$aThoracic Arteries
=550  \\$wh$aTibial Arteries
=550  \\$wh$aUlnar Artery
=550  \\$wh$aUmbilical Arteries
=550  \\$wh$aUterine Artery
=550  \\$wh$aVertebral Artery
=667  \\$aIM general only; NIM as coordinate to indicate a specific artery, as "pancreatic artery" = PANCREAS / blood supply (IM) + ARTERIES (NIM); / surg: consider also ENDARTERECTOMY; inflammation = ARTERITIS; arterial blood: index only if significant & coordinate BLOOD (NIM) + ARTERIES or specific artery (NIM); arterial pressure = BLOOD PRESSURE (IM) only: index specific artery only if pertinent
=680  \\$iThe vessels carrying blood away from the heart.
=750  \0$aArteries$5IEN$0(DLC)sh 85008101

=LDR  01910cz  a2200481n  4500
=001  9880363333302441
=005  20200526152501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001157
=035  \\$aCAZ4311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137
=150  \\$aArterial Occlusive Diseases
=450  \\$wnnna$aArterial Obstructive Disease
=450  \\$aArterial Obstructive Diseases
=450  \\$aArterial Occlusions$5IEN
=450  \\$wnnna$aArterial Occlusive Disease
=450  \\$wnnna$aDisease, Arterial Obstructive
=450  \\$wnnna$aDisease, Arterial Occlusive
=450  \\$wnnna$aDiseases, Arterial Obstructive
=450  \\$wnnna$aDiseases, Arterial Occlusive
=450  \\$wnnna$aObstructive Disease, Arterial
=450  \\$wnnna$aObstructive Diseases, Arterial
=450  \\$aOcclusions, Arterial$5IEN
=450  \\$wnnna$aOcclusive Disease, Arterial
=450  \\$wnnna$aOcclusive Diseases, Arterial
=550  \\$wg$aVascular Diseases
=550  \\$wh$aArteriosclerosis
=550  \\$wh$aCarotid Stenosis
=550  \\$wh$aFibromuscular Dysplasia
=550  \\$wh$aLeriche Syndrome
=550  \\$wh$aMalignant Atrophic Papulosis
=550  \\$wh$aMedian Arcuate Ligament Syndrome
=550  \\$wh$aMesenteric Vascular Occlusion
=550  \\$wh$aMoyamoya Disease
=550  \\$wh$aRenal Artery Obstruction
=550  \\$wh$aRetinal Artery Occlusion
=550  \\$wh$aStenosis, Pulmonary Artery
=550  \\$wh$aThromboangiitis Obliterans
=667  \\$ageneral; prefer specifics; coordinate IM with specific artery (IM) if pertinent
=680  \\$iPathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
=688  \\$a73
=750  \0$aArterial occlusions$5IEN$0(DLC)sh 85008100

=LDR  00908cz  a2200229n  4500
=001  9880363333402441
=005  20141212194948.0
=008  780320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001156
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x60.$x50
=150  \\$aArtemia
=450  \\$wnnna$aArtemias
=450  \\$aBrine Shrimp
=450  \\$wnnna$aBrine Shrimps
=450  \\$aShrimp, Brine
=450  \\$wnnna$aShrimps, Brine
=550  \\$wg$aAnostraca
=667  \\$anote X ref BRINE SHRIMP: several other shrimp terms are available; check text and MeSH; unspecified shrimp as food is probably PENAEIDAE
=680  \\$iA genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.
=688  \\$a79
=750  \0$aArtemia$5IEN$0(DLC)sh 88002326

=LDR  00903cz  a2200289n  4500
=001  9880363333502441
=005  20141212194947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001155
=035  \\$aCAZ4309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x888.$x124
=072  \\$aE2.$x831.$x100
=072  \\$aF4.$x754.$x70
=150  \\$aArt Therapy
=450  \\$wnnna$aArt Therapies
=450  \\$aArt Therapists$5IEN
=450  \\$wnnna$aTherapies, Art
=450  \\$wnnna$aTherapy, Art
=550  \\$wg$aPsychotherapy
=550  \\$wg$aRehabilitation
=550  \\$wg$aSensory Art Therapies
=667  \\$aa psychother technique; DF: ART THER
=680  \\$iThe use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders.
=688  \\$a74
=750  \0$aArt therapists$0sh 85008087$5IEN-M
=750  \0$aArt therapy$0(DLC) sh 85008088$5IEN-M

=LDR  01022cz  a2200349n  4500
=001  9880363333602441
=005  20200625135922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001154
=035  \\$aCAZ4308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93
=150  \\$aArt
=450  \\$aArtists$5IEN
=450  \\$wnnna$aArts
=550  \\$wg$aHumanities
=550  \\$wh$aCaricatures as Topic
=550  \\$wh$aEngraving and Engravings
=550  \\$wh$aHuman Body
=550  \\$wh$aMedical Illustration
=550  \\$wh$aMedicine in the Arts
=550  \\$wh$aMotion Pictures
=550  \\$wh$aNumismatics
=550  \\$wh$aPaintings
=550  \\$wh$aPhilately
=550  \\$wh$aPictorial Works as Topic
=550  \\$wh$aPortraits as Topic
=550  \\$wh$aScience in the Arts
=550  \\$wh$aSculpture
=667  \\$aworks of art, the field of fine arts, artistic production; art as therapy = ART THERAPY
=750  \0$aArt$5IEN-M$0(DLC)sh 85007461
=750  \0$aArtists$5IEN-HS$0(DLC)sh 85008276

=LDR  00569cz  a2200205n  4500
=001  9880363333702441
=005  20141212194947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001153
=035  \\$aCAZ4307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x88.$x50
=150  \\$aArsphenamine
=450  \\$wnnna$aArsenobenzol
=450  \\$wnnna$aArsenobenzol, Sodium
=450  \\$wnnna$aSalvarsan
=450  \\$wnnna$aSodium Arsenobenzol
=550  \\$wg$aArsenicals
=688  \\$a68; was ARSPHENAMINES 1963-67
=750  \0$aArsphenamine$5IEN$0(DLC)sh 85007460

=LDR  01055cz  a2200361n  4500
=001  9880363333802441
=005  20141212194946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001152
=035  \\$aCAZ4306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x75
=072  \\$aD2.$x691.$x88
=150  \\$aArsenicals
=450  \\$aArsenic Compounds
=450  \\$wnnna$aCompounds, Arsenic
=450  \\$aNeoarsphenamine$5IEN-M
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganometallic Compounds
=550  \\$wh$aArsanilic Acid
=550  \\$wh$aArsenamide
=550  \\$wh$aArsenates
=550  \\$wh$aArsenazo III
=550  \\$wh$aArsenites
=550  \\$wh$aArsphenamine
=550  \\$wh$aCacodylic Acid
=550  \\$wh$aMelarsoprol
=550  \\$wh$ap-Azobenzenearsonate
=550  \\$wh$aRoxarsone
=667  \\$ainorganic or organic arsenic cpds
=680  \\$iInorganic or organic compounds that contain arsenic.
=688  \\$aARSENIC COMPOUNDS was heading 1994-95
=750  \0$aArsenic compounds$5IEN-M$0(DLC)sh 85007453

=LDR  01485cz  a2200385n  4500
=001  9880363333902441
=005  20141212195106.0
=008  850614\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001398
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x500.$x44
=072  \\$aD2.$x886.$x108.$x500.$x44
=072  \\$aD3.$x383.$x411.$x350.$x44
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x500.$x44
=150  \\$aAztreonam
=450  \\$wnnna$aAz-threonam
=450  \\$wnnna$aAz threonam
=450  \\$wnnna$aAzactam
=450  \\$wnnna$aAzthreonam
=450  \\$wnnna$aAztreonam Esteve Brand
=450  \\$wnnna$aAztreonam Squibb Brand
=450  \\$wnnna$aBristol-Myers Squibb Brand of Aztreonam
=450  \\$wnnna$aBristol Myers Squibb Brand of Aztreonam
=450  \\$wnnna$aEsteve Brand of Aztreonam
=450  \\$wnnna$aSanofi Winthrop Brand of Aztreonam
=450  \\$wnnna$aSQ-26,776
=450  \\$wnnna$aSQ 26,776
=450  \\$wnnna$aSQ26,776
=450  \\$wnnna$aSquibb Brand of Aztreonam
=450  \\$wnnna$aUrobactam
=550  \\$wg$aMonobactams
=667  \\$ado not use /biosyn unless by living matter
=680  \\$iA monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
=688  \\$a86
=750  \0$aAztreonam$5IEN$0(DLC)sh 85010687

=LDR  01754cz  a2200373n  4500
=001  9880363334002441
=005  20141212195039.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001300
=035  \\$aCAZ4455HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x60.$x50
=150  \\$aAudiometry, Evoked Response
=450  \\$wnnna$aAudiometries, Electroencephalic Response
=450  \\$wnnna$aAudiometries, Evoked Response
=450  \\$aAudiometry, Electric Response$5IEN-M
=450  \\$aAudiometry, Electroencephalic Response
=450  \\$aElectric Response Audiometry$5IEN-M
=450  \\$wnnna$aElectrocochleographies
=450  \\$aElectrocochleography
=450  \\$wnnna$aElectroencephalic Response Audiometries
=450  \\$wnnna$aElectroencephalic Response Audiometry
=450  \\$wnnna$aEvoked Response Audiometries
=450  \\$aEvoked Response Audiometry
=450  \\$wnnna$aResponse Audiometries, Electroencephalic
=450  \\$wnnna$aResponse Audiometries, Evoked
=450  \\$wnnna$aResponse Audiometry, Electroencephalic
=450  \\$wnnna$aResponse Audiometry, Evoked
=550  \\$wg$aAudiometry
=550  \\$aEvoked Potentials, Auditory, Brain Stem
=667  \\$ado not use /util except by MeSH definition; also called "electric response audiometry"
=680  \\$iA form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.
=688  \\$a86(80); was see under AUDIOMETRY 1980-85
=750  \0$aAudiometry, Evoked response$5IEN$0(DLC)sh 85009473

=LDR  00691cz  a2200193n  4500
=001  9880363334102441
=005  20141212195105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001395
=035  \\$aCAZ4550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x50
=072  \\$aB3.$x660.$x250.$x580.$x22
=150  \\$aAzotobacter
=550  \\$wg$aPseudomonadaceae
=550  \\$wh$aAzotobacter vinelandii
=667  \\$ain soil & water
=680  \\$iA genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.
=750  \0$aAzotobacter$0(DLC) sh 85010665$5IEN

=LDR  00717cz  a2200265n  4500
=001  9880363334202441
=005  20170830161953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001393
=035  \\$aCAZ4548M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129
=150  \\$aAzoles
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aImidazoles
=550  \\$wh$aIsoxazoles
=550  \\$wh$aOxazoles
=550  \\$wh$aPaliperidone Palmitate
=550  \\$wh$aPyrazoles
=550  \\$wh$aPyrroles
=550  \\$wh$aTetrazoles
=550  \\$wh$aThiazoles
=550  \\$wh$aTriazoles
=680  \\$iFive membered rings containing a NITROGEN atom.
=750  \0$aAzoles$0(DLC)sh2007003939$5IEN-M

=LDR  01083cz  a2200241n  4500
=001  9880363334302441
=005  20141212195039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001299
=035  \\$aCAZ4454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x60
=150  \\$aAudiometry
=450  \\$wnnna$aAudiometries
=550  \\$wg$aHearing Tests
=550  \\$wh$aAudiometry, Evoked Response
=550  \\$wh$aAudiometry, Pure-Tone
=550  \\$wh$aAudiometry, Speech
=550  \\$wh$aPsychoacoustics
=550  \\$aAuditory Threshold
=667  \\$aa specific type of hearing test: do not use as a general term for "the measurement of hearing" ( = HEARING TESTS)
=680  \\$iThe testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds.
=750  \0$aAudiometry$5IEN$0(DLC)sh 85009472

=LDR  00767cz  a2200193n  4500
=001  9880363334402441
=005  20180223102621.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001298
=035  \\$aCAZ4453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x10.$x150
=150  \\$aAudiology
=550  \\$wg$aAllied Health Occupations
=550  \\$aOtolaryngology
=667  \\$ause for the specialty only; do not confuse with HEARING (physiologic process) or HEARING TESTS or AUDIOMETRY (a specific type of hearing test); AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available
=680  \\$iAllied medical specialty that studies hearing and hearing impairment.
=688  \\$a78; was see under HEARING 1963-74
=750  \0$aAudiology$0(DLC)sh 85009470$5IEN-M

=LDR  01014cz  a2200373n  4500
=001  9880363334502441
=005  20141212192015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001391
=035  \\$aCAZ4546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x172
=150  \\$aAzo Compounds
=450  \\$wnnna$aAzo Dyes
=450  \\$wnnna$aCompounds, Azo
=450  \\$wnnna$aDyes, Azo
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAmaranth Dye
=550  \\$wh$aAmido Black
=550  \\$wh$aArsenazo III
=550  \\$wh$aAzoxymethane
=550  \\$wh$aDiamide
=550  \\$wh$aDiazonium Compounds
=550  \\$wh$aDiazooxonorleucine
=550  \\$wh$aDithizone
=550  \\$wh$aEvans Blue
=550  \\$wh$aFormazans
=550  \\$wh$ao-Aminoazotoluene
=550  \\$wh$ap-Aminoazobenzene
=550  \\$wh$ap-Azobenzenearsonate
=550  \\$wh$aTartrazine
=550  \\$wh$aTrypan Blue
=667  \\$ado not confuse with AZA COMPOUNDS
=750  \0$aAzo compounds$5IEN$0(DLC)sh 85010652

=LDR  00997cz  a2200289n  4500
=001  9880363334602441
=005  20141212195104.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001388
=035  \\$aCAZ4543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x97.$x217
=150  \\$aAziridines
=450  \\$aApholate$5IEN-M
=450  \\$wnnna$aAzacyclopropanes, Saturated
=450  \\$wnnna$aDimethyleneimines
=450  \\$aEthyleneimines
=450  \\$wnnna$aSaturated Azacyclopropanes
=550  \\$wg$aAzirines
=550  \\$wh$aCarbazilquinone
=550  \\$wh$aTriaziquone
=550  \\$wh$aTriethylenemelamine
=550  \\$wh$aTriethylenephosphoramide
=667  \\$aAZACYCLOPROPANES, UNSATURATED see AZIRINES is available
=680  \\$iSaturated azacyclopropane compounds. They include compounds with substitutions on CARBON or NITROGEN atoms.
=688  \\$a90(75)66-67; was see under AZIRINES 1975-89; was heading 1966-67
=750  \0$aAziridines$0(DLC)sh2007004890$5IEN-M

=LDR  00532cz  a2200193n  4500
=001  9880363334702441
=005  20141212195103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001386
=035  \\$aCAZ4541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x100
=072  \\$aD2.$x159
=150  \\$aAzides
=550  \\$wg$aNitrogen Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aSodium Azide
=680  \\$iOrganic or inorganic compounds that contain the -N3 group.
=750  \0$aAzides$5IEN$0(DLC)sh 85010647

=LDR  01741cz  a2200553n  4500
=001  9880363334802441
=005  20141212195038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001296
=035  \\$aCAZ4451HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500
=072  \\$aL1.$x178.$x820.$x90
=150  \\$aAudiovisual Aids
=450  \\$wnnna$aAid, Audio-Visual
=450  \\$wnnna$aAid, Audiovisual
=450  \\$wnnna$aAid, Visual
=450  \\$wnnna$aAids, Audio-Visual
=450  \\$wnnna$aAids, Audiovisual
=450  \\$wnnna$aAids, Visual
=450  \\$wnnna$aAudio-Visual Aid
=450  \\$wnnna$aAudio-Visual Aids
=450  \\$wnnna$aAudio Visual Aids
=450  \\$aAudio-Visual Materials$5IEN
=450  \\$wnnna$aAudiovisual Aid
=450  \\$wnnna$aVisual Aid
=450  \\$aVisual Aids
=550  \\$wg$aEducational Technology
=550  \\$wg$aTeaching Materials
=550  \\$wh$aBooks, Illustrated
=550  \\$wh$aExhibits as Topic
=550  \\$wh$aMaps as Topic
=550  \\$wh$aMedical Illustration
=550  \\$wh$aModels, Structural
=550  \\$wh$aMotion Pictures as Topic
=550  \\$wh$aMP3-Player
=550  \\$wh$aMultimedia
=550  \\$wh$aOptical Storage Devices
=550  \\$wh$aPosters as Topic
=550  \\$wh$aRadio
=550  \\$wh$aTape Recording
=550  \\$wh$aTelevision
=550  \\$aTeaching Materials
=667  \\$aTEACHING MATERIALS is also available
=680  \\$iAuditory and visual instructional materials.
=688  \\$a96; was AUDIO-VISUAL AIDS 1963-95
=750  \0$aAudio-visual materials$5IEN-M$0(DLC)sh 85009466
=750  \0$aAudio-visual equipment$5IEN-HS$0(DLC)sh 85009463
=750  \0$aVisual aids$5IEN-M$0(DLC)sh 85143916

=LDR  00768cz  a2200277n  4500
=001  9880363334902441
=005  20141212195102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001381
=035  \\$aCAZ4536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x66
=150  \\$aAzepines
=450  \\$aHexamethyleneimines
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aCaprolactam
=550  \\$wh$aDilazep
=550  \\$wh$aMeptazinol
=550  \\$wh$aOxazepines
=550  \\$wh$aPentylenetetrazole
=550  \\$wh$aThiazepines
=550  \\$wh$aZolazepam
=550  \\$aBenzazepines
=550  \\$aDibenzazepines
=680  \\$iSeven membered heterocyclic rings containing a NITROGEN atom.
=750  \0$aAzepines$5IEN$0(DLC)sh 85010632

=LDR  01034cz  a2200325n  4500
=001  9880363335002441
=005  20200717113349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001294
=035  \\$aCAZ4449HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x100.$x150
=072  \\$aN5.$x300.$x150
=150  \\$aAttitude to Health
=450  \\$wnnna$aAttitude, Health
=450  \\$wnnna$aAttitudes, Health
=450  \\$wnnna$aHealth Attitude
=450  \\$wnnna$aHealth, Attitude to
=450  \\$wnnna$aHealth Attitudes
=550  \\$wg$aAttitude
=550  \\$wg$aDelivery of Health Care
=550  \\$wh$aHealth Knowledge, Attitudes, Practice
=550  \\$wh$aHealth Services Misuse
=550  \\$wh$aPatient Acceptance of Health Care
=550  \\$wh$aTreatment Adherence and Compliance
=550  \\$aPublic Opinion
=667  \\$aincludes attitude to disease
=680  \\$iPublic attitudes toward health, disease, and the medical care system.
=688  \\$a68
=750  \0$aHealth attitudes$5IEN$0(DLC)sh 85059529

=LDR  01105cz  a2200313n  4500
=001  9880363335102441
=005  20141212195100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001374
=035  \\$aCAZ4529M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x150
=072  \\$aD3.$x383.$x742.$x680.$x245.$x217
=072  \\$aD13.$x570.$x685.$x245.$x217
=072  \\$aD13.$x570.$x800.$x286.$x300
=150  \\$aAzacitidine
=450  \\$wnnna$a5-Azacytidine
=450  \\$wnnna$a5 Azacytidine
=450  \\$aAzacytidine
=450  \\$wnnna$aNSC-102816
=450  \\$wnnna$aNSC 102816
=450  \\$wnnna$aNSC102816
=450  \\$wnnna$aPharmion Brand of Azacitidine
=450  \\$wnnna$aVidaza
=550  \\$wg$aAza Compounds
=550  \\$wg$aCytidine
=680  \\$iA pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.
=688  \\$a96; was AZACYTIDINE 1972-95 (Prov 1972-73)
=750  \0$aAzacitidine$0(DLC)sh2010007274$5IEN-M

=LDR  00823cz  a2200253n  4500
=001  9880363335202441
=005  20141212195037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001293
=035  \\$aCAZ4448HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x100.$x125
=072  \\$aN5.$x300.$x125
=150  \\$aAttitude to Death
=450  \\$wnnna$aAttitudes to Death
=450  \\$wnnna$aDeath, Attitude to
=450  \\$wnnna$aDeath, Attitudes to
=450  \\$wnnna$aDeath$xpsychology$5IEN-M
=550  \\$wg$aAttitude
=550  \\$wg$aDelivery of Health Care
=550  \\$aDeath
=680  \\$iConceptual response of the person to the various aspects of death, which are based on individual psychosocial and cultural experience.
=688  \\$a74
=750  \0$aDeath$xPsychological aspects$5IEN$0(DLC)sh 85036094

=LDR  00959cz  a2200301n  4500
=001  9880363335302441
=005  20180208142735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001291
=035  \\$aCAZ4446HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x100.$x50
=072  \\$aN5.$x300.$x100
=150  \\$aAttitude of Health Personnel
=450  \\$wnnna$aAttitude, Staff
=450  \\$wnnna$aAttitudes, Staff
=450  \\$wnnna$aHealth Personnel Attitude
=450  \\$wnnna$aHealth Personnel Attitudes
=450  \\$wnnna$aStaff Attitude
=450  \\$wnnna$aStaff Attitudes
=550  \\$wg$aAttitude
=550  \\$wg$aDelivery of Health Care
=550  \\$wh$aAlert Fatigue, Health Personnel
=550  \\$wh$aNurse's Role
=550  \\$wh$aRefusal to Treat
=680  \\$iAttitudes of personnel toward their patients, other professionals, toward the medical care system, etc.
=688  \\$a68
=750  \0$aMedical personnel$xAttitudes$5IEN

=LDR  01273cz  a2200337n  4500
=001  9880363335402441
=005  20180402103011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001370
=035  \\$aCAZ4525HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x166.$x355.$x40
=072  \\$aG4.$x299.$x418.$x40
=072  \\$aG11.$x561.$x50
=150  \\$aAxonal Transport
=450  \\$wnnna$aAxonal Transports
=450  \\$aAxoplasmic Flow
=450  \\$wnnna$aAxoplasmic Flows
=450  \\$wnnna$aAxoplasmic Streaming
=450  \\$aAxoplasmic Transport
=450  \\$wnnna$aAxoplasmic Transports
=450  \\$wnnna$aStreaming, Axoplasmic
=450  \\$wnnna$aTransport, Axonal
=450  \\$wnnna$aTransport, Axoplasmic
=450  \\$wnnna$aTransports, Axonal
=450  \\$wnnna$aTransports, Axoplasmic
=550  \\$wg$aCytoplasmic Streaming
=550  \\$wg$aNervous System Physiological Phenomena
=680  \\$iThe directed transport of ORGANELLES and molecules along nerve cell AXONS. Transport can be anterograde (from the cell body) or retrograde (toward the cell body). (Alberts et al., Molecular Biology of the Cell, 3d ed, pG3)
=688  \\$a96; was AXOPLASMIC FLOW 1972-95 (Prov 1969-71)
=750  \0$aAxonal transport$5IEN$0(DLC)sh 85010596

=LDR  00993cz  a2200265n  4500
=001  9880363335502441
=005  20170914130100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001290
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x100
=150  \\$aAttitude
=450  \\$wnnna$aAttitudes
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aAttitude of Health Personnel
=550  \\$wh$aAttitude to Computers
=550  \\$wh$aAttitude to Death
=550  \\$wh$aAttitude to Health
=550  \\$wh$aCatastrophization
=550  \\$wh$aOptimism
=550  \\$wh$aPessimism
=550  \\$aIntention
=680  \\$iAn enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be.
=688  \\$a65(64); was see under BEHAVIOR 1963-64
=750  \0$aAttitude (Psychology)$5IEN$0(DLC)sh 85009407

=LDR  00947cz  a2200301n  4500
=001  9880363335602441
=005  20180226113043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001369
=035  \\$aCAZ4524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x542.$x145
=072  \\$aA11.$x284.$x180.$x75
=072  \\$aA11.$x671.$x137
=072  \\$aA11.$x671.$x501.$x145
=150  \\$aAxons
=450  \\$wnnna$aAxon
=550  \\$wg$aCell Surface Extensions
=550  \\$wg$aNerve Fibers
=550  \\$wg$aNeurons
=550  \\$wh$aAxon Initial Segment
=550  \\$wh$aGrowth Cones
=550  \\$wh$aMossy Fibers, Hippocampal
=550  \\$wh$aNeurites
=550  \\$wh$aPresynaptic Terminals
=667  \\$aNERVE FIBERS is available; giant squid axon: coord IM with SQUID (NIM)
=680  \\$iNerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.
=750  \0$aAxons$5IEN$0(DLC)sh 85010598

=LDR  00793cz  a2200265n  4500
=001  9880363335702441
=005  20160422101508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001368
=035  \\$aCAZ4523HS
=040  \\$aDNLM$beng$cDNLM
=060  \0$aWE 725
=072  \\$aA2.$x835.$x232.$x834.$x151.$x383
=150  \\$aAxis, Cervical Vertebra
=450  \\$wnnoa$aAxis
=450  \\$aEpistropheus
=450  \\$wnnna$aAxi, Cervical Vertebra
=450  \\$wnnna$aCervical Vertebra Axi
=450  \\$wnnna$aCervical Vertebra Axis
=450  \\$wnnna$aVertebra Axi, Cervical
=450  \\$wnnna$aVertebra Axis, Cervical
=550  \\$wg$aCervical Vertebrae
=550  \\$wh$aOdontoid Process
=680  \\$iThe second cervical vertebra.
=750  \0$aAxis (Vertebra)$5IEN$0(DLC)sh 85010591

=LDR  00453cz  a2200157n  4500
=001  9880363335802441
=005  20141212195058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001365
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x90
=150  \\$aAxilla
=450  \\$wnnna$aAxillas
=550  \\$wg$aUpper Extremity
=667  \\$a"axillary lymph nodes" = LYMPH NODES (IM) + AXILLA (NIM, no qualif)
=750  \0$aAxilla$5IEN$0(DLC)sh 85010583

=LDR  00775cz  a2200193n  4500
=001  9880363335902441
=005  20141212195058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001364
=035  \\$aCAZ4519HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x150
=150  \\$aAwareness
=450  \\$wnnna$aAwarenesses
=550  \\$wg$aCognition
=667  \\$ado not use for awareness (knowledge) of specific objects, awareness of health matters (= probably HEALTH KNOWLEDGE, ATTITUDES, PRACTICE)
=680  \\$iThe act of "taking account" of an object or state of affairs. It does not imply assessment of nor attention to the qualities or nature of the object.
=688  \\$a91(75); was see under COGNITION 1975-90
=750  \0$aAwareness$5IEN$0(DLC)sh 85010576

=LDR  02327cz  a2200421n  4500
=001  9880363336002441
=005  20141212195036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001289
=035  \\$aCAZ4444HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x550.$x150.$x150
=150  \\$aAttention Deficit Disorder with Hyperactivity
=450  \\$aAttention Deficit Disorder
=450  \\$wnnna$aAttention Deficit Disorders
=450  \\$wnnna$aAttention Deficit Disorders with Hyperactivity
=450  \\$wnnna$aAttention Deficit-Hyperactivity Disorder
=450  \\$aAttention Deficit Hyperactivity Disorder
=450  \\$wnnna$aAttention Deficit Hyperactivity Disorders
=450  \\$wnnna$aAttention Deficit-Hyperactivity Disorders
=450  \\$aBrain Dysfunction, Minimal
=450  \\$wnnna$aDeficit Disorder, Attention
=450  \\$wnnna$aDeficit Disorders, Attention
=450  \\$wnnna$aDeficit-Hyperactivity Disorder, Attention
=450  \\$wnnna$aDeficit-Hyperactivity Disorders, Attention
=450  \\$wnnna$aDisorder, Attention Deficit
=450  \\$wnnna$aDisorder, Attention Deficit-Hyperactivity
=450  \\$wnnna$aDisorders, Attention Deficit
=450  \\$wnnna$aDisorders, Attention Deficit-Hyperactivity
=450  \\$wnnna$aDysfunction, Minimal Brain
=450  \\$aHyperkinetic Syndrome
=450  \\$aMinimal Brain Dysfunction
=450  \\$wnnna$aSyndromes, Hyperkinetic
=550  \\$wg$aAttention Deficit and Disruptive Behavior Disorders
=667  \\$anot confined to children; do not confuse with HYPERKINESIS: note X refs under both; DF: ADDH or ADHD
=680  \\$iA behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV)
=688  \\$a84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 (Prov 1969-72)
=750  \0$aAttention-deficit hyperactivity disorder$5IEN$0(DLC)sh 85063661

=LDR  00711cz  a2200229n  4500
=001  9880363336102441
=005  20141212195058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001363
=035  \\$aCAZ4518HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x150
=150  \\$aAwards and Prizes
=450  \\$wnnna$aAward
=450  \\$wnnna$aAwards
=450  \\$wnnna$aPrize
=450  \\$wnnna$aPrizes
=450  \\$wnnna$aPrizes and Awards
=550  \\$wg$aHumanities
=550  \\$wh$aNobel Prize
=667  \\$aIM; no qualif; awards & prizes in field of medicine: do not coord with MEDICINE but coord with specific med specialty or other field (IM); DF: AWARDS
=750  \0$aAwards$5IEN$0(DLC)sh 85113526

=LDR  00689cz  a2200217n  4500
=001  9880363336202441
=005  20180223101553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001288
=035  \\$aCAZ4443HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x104.$x214
=150  \\$aAttention
=450  \\$wnnna$aAttentions
=450  \\$aConcentration
=450  \\$wnnna$aConcentrations
=550  \\$wg$aArousal
=550  \\$wh$aAttentional Bias
=550  \\$aExecutive Function
=680  \\$iFocusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating.
=750  \0$aAttention$5IEN$0(DLC)sh 85009391

=LDR  00604cz  a2200193n  4500
=001  9880363336302441
=005  20141212195058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001362
=035  \\$aCAZ4517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x97
=150  \\$aAvoidance Learning
=450  \\$wnnna$aAvoidance Learnings
=450  \\$wnnna$aLearning, Avoidance
=450  \\$wnnna$aLearnings, Avoidance
=550  \\$wg$aLearning
=680  \\$iA response to a cue that is instrumental in avoiding a noxious experience.
=750  \0$aAvoidance (Psychology)$5IEN$0(DLC)sh 85010555

=LDR  01119cz  a2200325n  4500
=001  9880363336402441
=005  20141212195057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001361
=035  \\$aCAZ4516HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500.$x133
=150  \\$aAvitaminosis
=450  \\$wnnna$aAvitaminoses
=450  \\$wnnna$aDeficiencies, Vitamin
=450  \\$wnnna$aDeficiency, Vitamin
=450  \\$aHypovitaminosis$5IEN-M
=450  \\$wnnna$aVitamin Deficiencies
=450  \\$aVitamin Deficiency
=450  \\$aVitamins$xdeficiency
=550  \\$wg$aDeficiency Diseases
=550  \\$wh$aAscorbic Acid Deficiency
=550  \\$wh$aVitamin A Deficiency
=550  \\$wh$aVitamin B Deficiency
=550  \\$wh$aVitamin D Deficiency
=550  \\$wh$aVitamin E Deficiency
=550  \\$wh$aVitamin K Deficiency
=667  \\$aincludes hypovitaminosis; GEN: prefer specifics: avitaminosis A = VITAMIN A DEFICIENCY, etc.
=680  \\$iA condition due to a deficiency of one or more essential vitamins. (Dorland, 27th ed)
=750  \0$aAvitaminosis$5IEN$0(DLC)sh 85010548

=LDR  01468cz  a2200409n  4500
=001  9880363336502441
=005  20141212192010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001285
=035  \\$aCAZ4440HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x74.$x722.$x229.$x199
=072  \\$aD3.$x132.$x760.$x180.$x572.$x199
=072  \\$aD3.$x132.$x889.$x180.$x648.$x199
=072  \\$aD3.$x605.$x869.$x229.$x199
=072  \\$aD4.$x75.$x80.$x875.$x99.$x722.$x229.$x199
=150  \\$aAtropine
=450  \\$wnnna$aAnhydrous, Atropine Sulfate
=450  \\$wnnna$aAtroPen
=450  \\$wnnna$aAtropin Augenöl
=450  \\$wnnna$aAtropine Chauvin Brand
=450  \\$wnnna$aAtropine Sulfate
=450  \\$wnnna$aAtropine Sulfate Anhydrous
=450  \\$wnnna$aAtropine Winzer Brand
=450  \\$wnnna$aAtropinol
=450  \\$wnnna$aAugenöl, Atropin
=450  \\$wnnna$aChauvin Brand of Atropine
=450  \\$wnnna$aSulfate Anhydrous, Atropine
=450  \\$wnnna$aSulfate, Atropine
=450  \\$wnnna$aSurvival Technology Brand of Atropine
=450  \\$wnnna$aWinzer Brand of Atropine
=550  \\$wg$aAtropine Derivatives
=550  \\$wh$aHyoscyamine
=680  \\$iAn alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
=688  \\$a1975
=688  \\$a75; for HYOSCYAMINE use BELLADONNA 1963-74
=750  \0$aAtropine$5IEN$0(DLC)sh 85009366

=LDR  00761cz  a2200229n  4500
=001  9880363336602441
=005  20141212195057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001360
=035  \\$aCAZ4515HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x34.$x614.$x300
=072  \\$aD12.$x776.$x256.$x317.$x663.$x300
=072  \\$aD12.$x776.$x290.$x663.$x100
=072  \\$aD12.$x776.$x395.$x175
=150  \\$aAvidin
=550  \\$wg$aGlycoproteins
=550  \\$wg$aOvalbumin
=550  \\$aBiotin
=680  \\$iA specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.
=688  \\$a87(73); was see under OVALBUMIN 1969-86
=750  \0$aAvidin$5IEN$0(DLC)sh 85010542

=LDR  00872cz  a2200265n  4500
=001  9880363336702441
=005  20141212195057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001359
=035  \\$aCAZ4514HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285
=150  \\$aAviation
=450  \\$aAeronautics$5IEN
=450  \\$wnnna$aAir Traffic Control
=450  \\$wnnna$aControl, Air Traffic
=450  \\$aParachuting
=450  \\$wnnna$aTraffic Control, Air
=550  \\$wg$aTransportation
=550  \\$wh$aAircraft
=550  \\$wh$aSpace Flight
=667  \\$afor medical, physiological, psychological aspect of flying index AEROSPACE MEDICINE: Manual 28.7
=680  \\$iDesign, development, manufacture, and operation of heavier-than-air AIRCRAFT.
=688  \\$aPARACHUTING was heading 1963-82
=750  \0$aAeronautics$5IEN-M$0(DLC)sh 85001319

=LDR  01340cz  a2200373n  4500
=001  9880363336802441
=005  20141212195033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001283
=035  \\$aCAZ4438HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x409.$x147
=150  \\$aAtrioventricular Node
=450  \\$wnnna$aA-V Node
=450  \\$wnnna$aA V Node
=450  \\$wnnna$aA-V Nodes
=450  \\$wnnna$aAtrio-Ventricular Node
=450  \\$wnnna$aAtrio Ventricular Node
=450  \\$wnnna$aAtrio-Ventricular Nodes
=450  \\$wnnna$aAtrioventricular Nodes
=450  \\$aAV Node
=450  \\$wnnna$aAV Nodes
=450  \\$wnnna$aNode, A-V
=450  \\$wnnna$aNode, Atrio-Ventricular
=450  \\$wnnna$aNode, Atrioventricular
=450  \\$wnnna$aNode, AV
=450  \\$wnnna$aNodes, A-V
=450  \\$wnnna$aNodes, Atrio-Ventricular
=450  \\$wnnna$aNodes, Atrioventricular
=450  \\$wnnna$aNodes, AV
=550  \\$wg$aHeart Conduction System
=680  \\$iA small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.
=688  \\$a91(75); was see under HEART CONDUCTION SYSTEM 1975-90
=750  \0$aAtrioventricular node$5IEN$0(DLC)sh 88002656

=LDR  01266cz  a2200349n  4500
=001  9880363336902441
=005  20141212195056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001357
=035  \\$aCAZ4512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x800
=072  \\$aC2.$x928.$x800
=072  \\$aC4.$x557.$x450.$x795.$x830.$x800
=072  \\$aC4.$x619.$x857.$x800
=072  \\$aC4.$x619.$x935.$x800
=072  \\$aC4.$x925.$x700
=072  \\$aC22.$x131.$x800
=150  \\$aSarcoma, Avian
=450  \\$aAvian Sarcoma
=450  \\$wnnna$aAvian Sarcomas
=450  \\$aRous Sarcoma
=450  \\$aSarcoma, Rous
=450  \\$wnnna$aSarcomas, Avian
=550  \\$wg$aBird Diseases
=550  \\$wg$aRetroviridae Infections
=550  \\$wg$aSarcoma, Experimental
=550  \\$wg$aTumor Virus Infections
=667  \\$acaused by a retrovirus; /blood supply /chem /second /secret /ultrastruct permitted; don't forget also BIRDS or POULTRY (NIM) or specific bird or fowl (IM); check tag ANIMALS
=680  \\$iConnective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses.
=688  \\$a94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82
=750  \0$aRous sarcoma$0(DLC) sh 85115545$5IEN

=LDR  01066cz  a2200313n  4500
=001  9880363337002441
=005  20141212195054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001353
=035  \\$aCAZ4508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x96
=072  \\$aC2.$x928.$x120
=072  \\$aC4.$x557.$x337.$x372.$x216
=072  \\$aC4.$x619.$x531.$x216
=072  \\$aC4.$x619.$x935.$x120
=072  \\$aC4.$x925.$x120
=072  \\$aC22.$x131.$x94
=150  \\$aAvian Leukosis
=450  \\$wnnna$aAvian Leukoses
=450  \\$wnnna$aLeukoses, Avian
=450  \\$aLeukosis, Avian
=550  \\$wg$aBird Diseases
=550  \\$wg$aLeukemia, Experimental
=550  \\$wg$aRetroviridae Infections
=550  \\$wg$aTumor Virus Infections
=667  \\$adon't forget also BIRDS (NIM) or specific bird (IM) & check tag ANIMALS
=680  \\$iA group of transmissible viral diseases of chickens and turkeys. Liver tumors are found in most forms, but tumors can be found elsewhere.
=750  \0$aAvian leukosis$0(DLC) sh 85010532$5IEN

=LDR  01327cz  a2200277n  4500
=001  9880363337102441
=005  20141212195033.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001282
=035  \\$aCAZ4437HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x248
=072  \\$aC23.$x550.$x73.$x248
=150  \\$aAtrial Flutter
=450  \\$wnnna$aAtrial Flutters
=450  \\$aAuricular Flutter
=450  \\$wnnna$aAuricular Flutters
=450  \\$wnnna$aFlutter, Atrial
=450  \\$wnnna$aFlutter, Auricular
=450  \\$wnnna$aFlutters, Atrial
=450  \\$wnnna$aFlutters, Auricular
=550  \\$wg$aArrhythmias, Cardiac
=667  \\$ado not confuse with ATRIAL FIBRILLATION
=680  \\$iRapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
=688  \\$a84; was AURICULAR FLUTTER 1963-83
=750  \0$aAtrial flutter$5IEN-M$0(DLC)sh 96000979

=LDR  00881cz  a2200265n  4500
=001  9880363337202441
=005  20141212195053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001348
=035  \\$aCAZ4503HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137.$x174
=150  \\$aAversive Therapy
=450  \\$wnnna$aAversion Therapies
=450  \\$wnnna$aAversion Therapy
=450  \\$wnnna$aAversive Therapies
=450  \\$wnnna$aTherapies, Aversion
=450  \\$wnnna$aTherapies, Aversive
=450  \\$wnnna$aTherapy, Aversion
=450  \\$wnnna$aTherapy, Aversive
=550  \\$wg$aBehavior Therapy
=667  \\$aa psychother technique; DF: AVERSIVE THER
=680  \\$iA treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences.
=688  \\$a70
=750  \0$aAversion therapy$5IEN$0(DLC)sh 85010520

=LDR  00819cz  a2200229n  4500
=001  9880363337302441
=005  20141212195052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001345
=035  \\$aCAZ4500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x750.$x132
=072  \\$aE5.$x200.$x750.$x132
=072  \\$aE5.$x799.$x256
=150  \\$aAutoradiography
=450  \\$aRadioautography
=550  \\$wg$aHistological Techniques
=550  \\$wg$aRadiometry
=667  \\$aNIM, usually no qualif; DF: AUTORADIOGR
=680  \\$iThe making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed)
=688  \\$a73; was RADIOAUTOGRAPHY 1963-72
=750  \0$aAutoradiography$5IEN$0(DLC)sh 85010463

=LDR  00787cz  a2200181n  4500
=001  9880363337502441
=005  20141212195032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001280
=035  \\$aCAZ4435HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x931.$x247
=150  \\$aAtrazine
=450  \\$wnnna$aGesamprim
=550  \\$wg$aTriazines
=680  \\$iA selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. (From The Merck Index, 11th ed)
=688  \\$a74(72)
=750  \0$aAtrazine$5IEN$0(DLC)sh 85009352

=LDR  01181cz  a2200337n  4500
=001  9880363337602441
=005  20141212195052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001344
=035  \\$aCAZ4499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x60
=072  \\$aE5.$x70
=072  \\$aI1.$x198.$x780.$x937.$x120
=150  \\$aAutopsy
=450  \\$wnnna$aAutopsies
=450  \\$wnnna$aExamination, Post-Mortem
=450  \\$wnnna$aExamination, Postmortem
=450  \\$wnnna$aExaminations, Post-Mortem
=450  \\$wnnna$aExaminations, Postmortem
=450  \\$wnnna$aPost-Mortem Examination
=450  \\$wnnna$aPost Mortem Examination
=450  \\$wnnna$aPost-Mortem Examinations
=450  \\$wnnna$aPostmortem Examination
=450  \\$wnnna$aPostmortem Examinations
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wg$aForensic Medicine
=550  \\$wg$aInvestigative Techniques
=667  \\$ano qualifiers when NIM; not a routine coordinate for postmortem pathology ( = /pathol): discussion must be on autopsy as a procedure
=680  \\$iPostmortem examination of the body.
=750  \0$aAutopsy$5IEN$0(DLC)sh 85010461

=LDR  01250cz  a2200337n  4500
=001  9880363337702441
=005  20141212195032.0
=008  860714\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001279
=035  \\$aCAZ4434HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x531.$x85.$x61
=150  \\$aAtracurium
=450  \\$wnnna$a33 A 74
=450  \\$wnnna$aA 74, 33
=450  \\$wnnna$aAtracurium Besilate
=450  \\$aAtracurium Besylate
=450  \\$aAtracurium Dibesylate
=450  \\$wnnna$aBesilate, Atracurium
=450  \\$wnnna$aBW-33A
=450  \\$wnnna$aBW 33A
=450  \\$wnnna$aBW33A
=450  \\$wnnna$aGlaxo Wellcome Brand of Atracurium Besilate
=450  \\$wnnna$aPisa Brand of Atracurium Besilate
=450  \\$wnnna$aRelatrac
=450  \\$wnnna$aTracrium
=450  \\$wnnna$aWellcome Brand of Atracurium Besilate
=550  \\$wg$aBenzylisoquinolines
=680  \\$iA non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
=688  \\$a87
=750  \0$aAtracurium$5IEN$0(DLC)sh 92005136

=LDR  01725cz  a2200397n  4500
=001  9880363337802441
=005  20141212195051.0
=008  780320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001343
=035  \\$aCAZ4498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x139.$x399
=072  \\$aG4.$x299.$x482.$x350.$x91
=150  \\$aAutophagy
=450  \\$wnnna$aAutophagic Cell Death
=450  \\$wnnna$aAutophagic Cell Deaths
=450  \\$wnnna$aAutophagic Programmed Cell Death
=450  \\$wnnna$aAutophagies
=450  \\$wnnna$aAutophagies, Cellular
=450  \\$aAutophagocytosis
=450  \\$wnnna$aAutophagy, Cellular
=450  \\$wnnna$aCell Death, Autophagic
=450  \\$wnnna$aCell Deaths, Autophagic
=450  \\$wnnna$aCellular Autophagies
=450  \\$wnnna$aCellular Autophagy
=450  \\$wnnna$aDeath, Autophagic Cell
=450  \\$wnnna$aDeaths, Autophagic Cell
=450  \\$wnnna$aProgrammed Cell Death, Type II
=550  \\$wg$aCell Death
=550  \\$wg$aPhagocytosis
=667  \\$aprogrammed cell death unspecified probably = APOPTOSIS, but check text
=680  \\$iThe segregation and degradation of damaged or unwanted cytoplasmic constituents by autophagic vacuoles (cytolysosomes) composed of LYSOSOMES containing cellular components in the process of digestion; it plays an important role in BIOLOGICAL METAMORPHOSIS of amphibians, in the removal of bone by osteoclasts, and in the degradation of normal cell components in nutritional deficiency states.
=688  \\$a2006(1979)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Autophagocytosis
=688  \\$a91(79); was see under PHAGOCYTOSIS 1979-90
=750  \0$aAutophagic vacuoles$0(DLC) sh 85010460$5IEN

=LDR  00854cz  a2200265n  4500
=001  9880363337902441
=005  20141212195030.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001274
=035  \\$aCAZ4429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x750.$x274
=072  \\$aN6.$x230.$x300.$x100.$x185
=150  \\$aAtmospheric Pressure
=450  \\$wnnna$aAtmospheric Pressures
=450  \\$wnnna$aPressure, Atmospheric
=450  \\$wnnna$aPressures, Atmospheric
=550  \\$wg$aAtmosphere
=550  \\$wg$aMeteorological Concepts
=550  \\$wh$aAir Pressure
=550  \\$wh$aVacuum
=550  \\$aPressure
=667  \\$ano qualif
=680  \\$iThe pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned.
=750  \0$aAtmospheric pressure$5IEN$0(DLC)sh 85009290

=LDR  00935cz  a2200229n  4500
=001  9880363358202441
=005  20141212194636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000576
=035  \\$aCAZ3725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x50
=072  \\$aD1.$x268.$x271.$x100.$x50
=072  \\$aD1.$x268.$x556.$x37
=072  \\$aD1.$x552.$x20.$x86
=072  \\$aD1.$x552.$x544.$x37
=150  \\$aAmericium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iAmericium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.
=750  \0$aAmericium$5IEN$0(DLC)sh 85004443

=LDR  00741cz  a2200217n  4500
=001  9880363358302441
=005  20141212194633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000568
=035  \\$aCAZ3717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x568.$x500
=150  \\$aAmenorrhea
=450  \\$wnnna$aAmenorrhea, Postpartum
=450  \\$wnnna$aPostpartum Amenorrhea
=450  \\$wnnna$aPostpartum Amenorrheas
=550  \\$wg$aMenstruation Disturbances
=550  \\$aOligomenorrhea
=667  \\$a"postpartum amenorrhea" is indexed under AMENORRHEA (IM) + PUERPERIUM (IM) & not LACTATION unless lactation is particularly discussed
=680  \\$iAbsence of menstruation.
=750  \0$aAmenorrhea$5IEN$0(DLC)sh 85004214

=LDR  01278cz  a2200361n  4500
=001  9880363358402441
=005  20141212194631.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000562
=035  \\$aCAZ3711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x49
=150  \\$aAmebiasis
=450  \\$aAbscess, Amebic
=450  \\$wnnna$aAbscesses, Amebic
=450  \\$wnnna$aAmebiases
=450  \\$wnnna$aAmebic Abscess
=450  \\$wnnna$aAmebic Abscesses
=450  \\$aAmeboma
=450  \\$wnnna$aAmebomas
=450  \\$wnnna$aAmoebiases
=450  \\$aAmoebiasis
=450  \\$wnnna$aIodamoebiases
=450  \\$aIodamoebiasis
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aAcanthamoeba Keratitis
=550  \\$wh$aBlastocystis Infections
=550  \\$wh$aDysentery, Amebic
=550  \\$wh$aEntamoebiasis
=550  \\$wh$aLiver Abscess, Amebic
=667  \\$acaused by "any of various amebae"; /drug ther: consider also AMEBICIDES; note X ref ABSCESS, AMEBIC: LIVER ABSCESS, AMEBIC is also available
=680  \\$iInfection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.
=750  \0$aAmebiasis$5IEN$0(DLC)sh 85004194

=LDR  00918cz  a2200253n  4500
=001  9880363358502441
=005  20141212194630.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000559
=035  \\$aCAZ3708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x80
=150  \\$aAmbystomatidae
=450  \\$aAmbystomidae$5IEN
=450  \\$wnnna$aMole Salamander
=450  \\$wnnna$aMole Salamanders
=450  \\$aSalamander, Mole
=450  \\$wnnna$aSalamanders, Mole
=550  \\$wg$aUrodela
=550  \\$wh$aAmbystoma
=667  \\$aa family of salamanders; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.
=688  \\$a81
=750  \0$aAmbystomatidae$5IEN$0(DLC)sh 85004192

=LDR  01085cz  a2200277n  4500
=001  9880363358602441
=005  20141212194630.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000558
=035  \\$aCAZ3707HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x80.$x68.$x525
=150  \\$aAmbystoma mexicanum
=450  \\$wnnna$aAmbystoma mexicanums
=450  \\$aAxolotl
=450  \\$wnnna$aAxolotls
=450  \\$wnnna$aMexican Salamander
=450  \\$wnnna$amexicanum, Ambystoma
=450  \\$wnnna$amexicanums, Ambystoma
=450  \\$wnnna$aSalamander, Mexican
=550  \\$wg$aAmbystoma
=667  \\$aNIM with no qualifiers when an experimental animal
=680  \\$iA salamander found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research. The axolotl remains in larval form throughout its life, a phenomenon known as neoteny.
=688  \\$a1991(1981); for AXOLOTL use AMBYSTOMA 1972-2009
=688  \\$a91(81); was see under AMBYSTOMA 1981-90
=750  \0$aAmbystoma mexicanum$5IEN$0(DLC)sh 85004189

=LDR  01183cz  a2200301n  4500
=001  9880363358702441
=005  20141212194630.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000557
=035  \\$aCAZ3706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x80.$x68
=150  \\$aAmbystoma
=450  \\$aAmblystoma
=450  \\$wnnna$aAmblystomas
=450  \\$aAmbystoma tigrinum
=450  \\$wnnna$aAmbystomas
=450  \\$wnnna$aSalamander, Tiger
=450  \\$wnnna$aSalamanders, Tiger
=450  \\$wnnna$aTiger Salamander
=450  \\$wnnna$aTiger Salamanders
=450  \\$wnnna$atigrinum, Ambystoma
=550  \\$wg$aAmbystomatidae
=550  \\$wh$aAmbystoma mexicanum
=667  \\$aNIM with no qualifiers when an experimental animal
=680  \\$iA genus of the Ambystomatidae family. The best known species are the axolotl AMBYSTOMA MEXICANUM and the closely related tiger salamander Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.
=688  \\$a72
=750  \0$aAmbystoma$5IEN$0(DLC)sh 85004185

=LDR  01496cz  a2200433n  4500
=001  9880363358802441
=005  20141212194629.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000556
=035  \\$aCAZ3705HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x30
=150  \\$aAmbulatory Surgical Procedures
=450  \\$wnnna$aAmbulatory Surgeries
=450  \\$aAmbulatory Surgery
=450  \\$wnnna$aAmbulatory Surgical Procedure
=450  \\$wnnna$aDay Surgeries
=450  \\$aDay Surgery
=450  \\$wnnna$aOffice Surgeries
=450  \\$aOffice Surgery
=450  \\$wnnna$aOutpatient Surgeries
=450  \\$aOutpatient Surgery
=450  \\$wnnna$aProcedure, Ambulatory Surgical
=450  \\$wnnna$aProcedures, Ambulatory Surgical
=450  \\$wnnna$aSurgeries, Ambulatory
=450  \\$wnnna$aSurgeries, Day
=450  \\$wnnna$aSurgeries, Office
=450  \\$wnnna$aSurgeries, Outpatient
=450  \\$wnnna$aSurgery, Ambulatory
=450  \\$wnnna$aSurgery, Day
=450  \\$aSurgery, Office
=450  \\$aSurgery, Outpatient
=450  \\$wnnna$aSurgical Procedure, Ambulatory
=450  \\$wnnna$aSurgical Procedures, Ambulatory
=550  \\$wg$aSurgical Procedures, Operative
=667  \\$aoutpatient surg performed in MD's office, surgicenter or hosp
=680  \\$iSurgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter.
=688  \\$a98(80)
=750  \0$aAmbulatory surgery$5IEN$0(DLC)sh 85130785

=LDR  03026cz  a2200829n  4500
=001  9880363358902441
=005  20141212194629.0
=008  780426\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000554
=035  \\$aCAZ3703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x35
=150  \\$aAmbulatory Care Facilities
=450  \\$wnnna$aAbortion Center
=450  \\$wnnna$aAbortion Centers
=450  \\$wnnna$aAbortion Clinic
=450  \\$wnnna$aAbortion Clinics
=450  \\$wnnna$aActivities, Clinic
=450  \\$wnnna$aActivity, Clinic
=450  \\$wnnna$aAmbulatory Care Facilities, Non Hospital
=450  \\$wnnna$aAmbulatory Care Facilities, Non-Hospital
=450  \\$wnnna$aAmbulatory Care Facilities, Nonhospital
=450  \\$wnnna$aAmbulatory Care Facility
=450  \\$wnnna$aAmbulatory Health Center
=450  \\$wnnna$aAmbulatory Health Centers
=450  \\$wnnna$aCare Center, Urgent
=450  \\$wnnna$aCare Centers, Urgent
=450  \\$wnnna$aCare Clinic, Urgent
=450  \\$wnnna$aCare Clinics, Urgent
=450  \\$wnnna$aCenter, Abortion
=450  \\$wnnna$aCenter, Ambulatory Health
=450  \\$wnnna$aCenter, Family Planning
=450  \\$wnnna$aCenter, Urgent Care
=450  \\$wnnna$aCenters, Abortion
=450  \\$wnnna$aCenters, Ambulatory Health
=450  \\$wnnna$aCenters, Family Planning
=450  \\$wnnna$aCenters, Urgent Care
=450  \\$wnnna$aClinic, Abortion
=450  \\$wnnna$aClinic Activities
=450  \\$wnnna$aClinic Activity
=450  \\$wnnna$aClinic, Free-Standing
=450  \\$wnnna$aClinic, Outpatient
=450  \\$wnnna$aClinic, Urgent Care
=450  \\$wnnna$aClinics, Abortion
=450  \\$aClinics, Free-Standing
=450  \\$wnnna$aClinics, Free Standing
=450  \\$wnnna$aClinics, Outpatient
=450  \\$wnnna$aClinics, Urgent Care
=450  \\$wnnna$aFacilities, Ambulatory Care
=450  \\$wnnna$aFacility, Ambulatory Care
=450  \\$wnnna$aFamily Planning Center
=450  \\$wnnna$aFamily Planning Centers
=450  \\$wnnna$aFree-Standing Clinic
=450  \\$wnnna$aFree-Standing Clinics
=450  \\$wnnna$aHealth Center, Ambulatory
=450  \\$aHealth Centers, Ambulatory
=450  \\$wnnna$aOutpatient Clinic
=450  \\$aOutpatient Clinics
=450  \\$wnnna$aUrgent Care Center
=450  \\$wnnna$aUrgent Care Centers
=450  \\$wnnna$aUrgent Care Clinic
=450  \\$wnnna$aUrgent Care Clinics
=550  \\$wg$aHealth Facilities
=550  \\$wh$aCommunity Health Centers
=550  \\$wh$aCommunity Mental Health Centers
=550  \\$wh$aMaternal-Child Health Centers
=550  \\$wh$aOutpatient Clinics, Hospital
=550  \\$wh$aPain Clinics
=550  \\$wh$aSurgicenters
=680  \\$iThose facilities which administer health services to individuals who do not require hospitalization or institutionalization.
=688  \\$a83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979
=750  \0$aClinics$5IEN$0(DLC)sh 85027070

=LDR  01538cz  a2200421n  4500
=001  9880363359002441
=005  20141212194627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000553
=035  \\$aCAZ3702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x106
=072  \\$aN2.$x421.$x585.$x106
=150  \\$aAmbulatory Care
=450  \\$wnnna$aCare, Ambulatory
=450  \\$wnnna$aCare, Outpatient
=450  \\$wnnna$aCare, Urgent
=450  \\$wnnna$aCares, Urgent
=450  \\$wnnna$aClinic Visit
=450  \\$wnnna$aClinic Visits
=450  \\$wnnna$aHealth Service, Outpatient
=450  \\$wnnna$aHealth Services, Outpatient
=450  \\$aOutpatient Care
=450  \\$wnnna$aOutpatient Health Service
=450  \\$aOutpatient Health Services
=450  \\$wnnna$aService, Outpatient Health
=450  \\$wnnna$aServices, Outpatient Health
=450  \\$wnnna$aUrgent Care
=450  \\$wnnna$aUrgent Cares
=450  \\$wnnna$aVisit, Clinic
=450  \\$wnnna$aVisits, Clinic
=550  \\$wg$aPatient Care
=550  \\$wh$aPeritoneal Dialysis, Continuous Ambulatory
=550  \\$aOutpatient Clinics, Hospital
=550  \\$aOutpatients
=680  \\$iHealth care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.
=688  \\$a68(66)
=750  \0$aAmbulatory medical care$5IEN$0(DLC)sh 85004180

=LDR  01190cz  a2200361n  4500
=001  9880363359102441
=005  20141212194627.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000552
=035  \\$aCAZ3701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x500.$x50
=072  \\$aN2.$x421.$x297.$x879.$x100
=150  \\$aAmbulances
=450  \\$wnnna$aAmbulance
=450  \\$wnnna$aEmergency Mobile Unit
=450  \\$aEmergency Mobile Units
=450  \\$wnnna$aEmergency Unit, Mobile
=450  \\$wnnna$aEmergency Units, Mobile
=450  \\$wnnna$aMobile Emergency Unit
=450  \\$aMobile Emergency Units
=450  \\$wnnna$aMobile Unit, Emergency
=450  \\$wnnna$aMobile Units, Emergency
=450  \\$wnnna$aUnit, Emergency Mobile
=450  \\$wnnna$aUnit, Mobile Emergency
=450  \\$wnnna$aUnits, Emergency Mobile
=450  \\$wnnna$aUnits, Mobile Emergency
=550  \\$wg$aMotor Vehicles
=550  \\$wg$aTransportation of Patients
=550  \\$wh$aAir Ambulances
=550  \\$aEmergency Medical Services
=680  \\$iA vehicle equipped for transporting patients in need of emergency care.
=750  \0$aAmbulances$5IEN-M$0(DLC)sh 85004178

=LDR  02336cz  a2200505n  4500
=001  9880363359202441
=005  20141212194626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000550
=035  \\$aCAZ3699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x55
=072  \\$aC10.$x597.$x751.$x941.$x73
=072  \\$aC11.$x966.$x73
=072  \\$aC23.$x888.$x592.$x763.$x941.$x73
=150  \\$aAmblyopia
=450  \\$wnnna$aAmblyopia, Anisometropic
=450  \\$wnnna$aAmblyopia, Developmental
=450  \\$wnnna$aAmblyopia, Stimulus Deprivation-Induced
=450  \\$wnnna$aAmblyopia, Stimulus Deprivation Induced
=450  \\$wnnna$aAmblyopia, Suppression
=450  \\$wnnna$aAmblyopias
=450  \\$wnnna$aAmblyopias, Anisometropic
=450  \\$wnnna$aAmblyopias, Developmental
=450  \\$wnnna$aAmblyopias, Stimulus Deprivation-Induced
=450  \\$wnnna$aAmblyopias, Suppression
=450  \\$aAnisometropic Amblyopia
=450  \\$wnnna$aAnisometropic Amblyopias
=450  \\$wnnna$aDeprivation-Induced Amblyopia, Stimulus
=450  \\$wnnna$aDeprivation-Induced Amblyopias, Stimulus
=450  \\$wnnna$aDevelopmental Amblyopia
=450  \\$wnnna$aDevelopmental Amblyopias
=450  \\$wnnna$aEye, Lazy
=450  \\$wnnna$aEyes, Lazy
=450  \\$aLazy Eye
=450  \\$wnnna$aLazy Eyes
=450  \\$wnnna$aStimulus Deprivation-Induced Amblyopia
=450  \\$wnnna$aStimulus Deprivation Induced Amblyopia
=450  \\$wnnna$aStimulus Deprivation-Induced Amblyopias
=450  \\$wnnna$aSuppression Amblyopia
=450  \\$wnnna$aSuppression Amblyopias
=550  \\$wg$aBrain Diseases
=550  \\$wg$aVision Disorders
=680  \\$iA nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.
=750  \0$aAmblyopia$5IEN$0(DLC)sh 85004156

=LDR  01075cz  a2200277n  4500
=001  9880363359302441
=005  20141212194625.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000548
=035  \\$aCAZ3697M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x172.$x25
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x555.$x200
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50.$x650.$x12
=072  \\$aD4.$x615.$x638.$x555.$x200
=150  \\$aAmaranth Dye
=450  \\$wnnoa$aAmaranth$5IEN-HS
=450  \\$wnnna$aDye, Amaranth
=450  \\$wnnna$aFD & C Red No. 2
=450  \\$aRed Dye No. 2
=550  \\$wg$aAzo Compounds
=550  \\$wg$aNaphthalenesulfonates
=667  \\$aAMARANTH PLANT see AMARANTHUS is also available; D25-26 qualif
=680  \\$iA sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. (From Merck Index, 11th ed)
=688  \\$a1991(1975)
=750  \0$aAmaranth products$5IEN-M$0(DLC)sh 93007926

=LDR  04522cz  a2201141n  4500
=001  9880363359402441
=005  20141212194625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000547
=035  \\$aCAZ3696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x100.$x50.$x35
=150  \\$aAmantadine
=450  \\$wnnna$a1-Aminoadamantane
=450  \\$wnnna$a1 Aminoadamantane
=450  \\$wnnna$aAbZ Brand of Amantadine Hydrochloride
=450  \\$wnnna$aAdamantylamine
=450  \\$wnnna$aAdekin
=450  \\$wnnna$aAL, Amantadin
=450  \\$wnnna$aAliud Brand of Amantadine Sulfate
=450  \\$wnnna$aAlliance Brand of Amantadine Hydrochloride
=450  \\$wnnna$aAman
=450  \\$wnnna$aAmanta
=450  \\$wnnna$aAmanta-HCI-AZU
=450  \\$wnnna$aAmanta HCI AZU
=450  \\$wnnna$aAmanta-Sulfate-AZU
=450  \\$wnnna$aAmanta Sulfate AZU
=450  \\$wnnna$aAmantadin AL
=450  \\$wnnna$aAmantadin AZU
=450  \\$wnnna$aAmantadin-neuraxpharm
=450  \\$wnnna$aAmantadin neuraxpharm
=450  \\$wnnna$aAmantadin-ratiopharm
=450  \\$wnnna$aAmantadin ratiopharm
=450  \\$wnnna$aAmantadin Stada
=450  \\$wnnna$aAmantadina Juventus
=450  \\$wnnna$aAmantadina Llorente
=450  \\$wnnna$aAmantadine Hydrochloride
=450  \\$wnnna$aAmantadine Sulfate
=450  \\$wnnna$aAmantadinneuraxpharm
=450  \\$wnnna$aAmantadinratiopharm
=450  \\$wnnna$aAmantaHCIAZU
=450  \\$wnnna$aAmantaSulfateAZU
=450  \\$wnnna$aAmixx
=450  \\$wnnna$aAZU, Amantadin
=450  \\$wnnna$aAzupharma Brand of Amantadine Hydrochloride
=450  \\$wnnna$aAzupharma Brand of Amantadine Sulfate
=450  \\$wnnna$aCerebramed
=450  \\$wnnna$aCiba-Geigy Brand of Amantadine Hydrochloride
=450  \\$wnnna$aCiba Geigy Brand of Amantadine Hydrochloride
=450  \\$wnnna$aDesitin Brand of Amantadine Hydrochloride
=450  \\$wnnna$aDu Pont Brand of Amantadine Hydrochloride
=450  \\$wnnna$aEndantadine
=450  \\$wnnna$aEndo Brand of Amantadine Hydrochloride
=450  \\$wnnna$aGen-Amantadine
=450  \\$wnnna$aGen Amantadine
=450  \\$wnnna$aGenAmantadine
=450  \\$wnnna$aGenpharm Brand of Amantadine Hydrochloride
=450  \\$wnnna$aHexal Brand of Amantadine Sulfate
=450  \\$wnnna$aHormosan Brand of Amantadine Sulfate
=450  \\$wnnna$aHydrochloride, Amantadine
=450  \\$wnnna$aInfecto-Flu
=450  \\$wnnna$aInfecto Flu
=450  \\$wnnna$aInfectoFlu
=450  \\$wnnna$aInfectopharm Brand of Amantadine Hydrochloride
=450  \\$wnnna$aInfex
=450  \\$wnnna$aJuventus, Amantadina
=450  \\$wnnna$aJuventus Brand of Amantadine Hydrochloride
=450  \\$wnnna$aKrewel Brand of Amantadine Hydrochloride
=450  \\$wnnna$aLlorente, Amantadina
=450  \\$wnnna$aLlorente Brand of Amantadine Hydrochloride
=450  \\$wnnna$aMantadix
=450  \\$wnnna$aMerz Brand of Amantadine Sulfate
=450  \\$wnnna$aMidantan
=450  \\$wnnna$aneuraxpharm Brand of Amantadine Sulfate
=450  \\$wnnna$aNeuro Hexal Brand of Amantadine Sulfate
=450  \\$wnnna$aNovartis Brand of Amantadine Hydrochloride
=450  \\$wnnna$aOrion Brand of Amantadine Hydrochloride
=450  \\$wnnna$aPharmascience Brand of Amantadine Hydrochloride
=450  \\$wnnna$aPMS-Amantadine
=450  \\$wnnna$aPMS Amantadine
=450  \\$wnnna$aPMSAmantadine
=450  \\$wnnna$aratiopharm Brand of Amantadine Hydrochloride
=450  \\$wnnna$aSolvay Brand of Amantadine Hydrochloride
=450  \\$wnnna$aStada, Amantadin
=450  \\$wnnna$aStada Brand of Amantadine Hydrochloride
=450  \\$wnnna$aStada Brand of Amantadine Sulfate
=450  \\$wnnna$aSulfate, Amantadine
=450  \\$wnnna$aSymadine
=450  \\$wnnna$aSymmetrel
=450  \\$wnnna$aThiemann Brand of Amantadine Hydrochloride
=450  \\$wnnna$atregor
=450  \\$wnnna$aViregyt
=450  \\$wnnna$aWiregyt
=550  \\$wg$aAdamantane
=550  \\$wh$aMemantine
=680  \\$iAn antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
=688  \\$a68(65)
=750  \0$aAmantadine$5IEN$0(DLC)sh 89000746

=LDR  01055cz  a2200253n  4500
=001  9880363359502441
=005  20141212194623.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000546
=035  \\$aCAZ3695HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x50
=072  \\$aD12.$x644.$x456.$x50
=072  \\$aD12.$x644.$x641.$x50
=072  \\$aD23.$x946.$x587.$x175
=150  \\$aAmanitins
=550  \\$wg$aMycotoxins
=550  \\$wg$aOligopeptides
=550  \\$wg$aPeptides, Cyclic
=550  \\$wh$aAlpha-Amanitin
=667  \\$a/antag permitted but consider also ANTITOXINS
=680  \\$iCyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.
=688  \\$a75
=750  \0$aAmanitins$0(DLC) sh 85004102$5IEN

=LDR  00690cz  a2200193n  4500
=001  9880363359602441
=005  20141212194623.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000545
=035  \\$aCAZ3694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x110
=150  \\$aAmanita
=450  \\$wnnna$aAmanitas
=550  \\$wg$aAgaricales
=667  \\$aa poisonous basidiomycete; coord NIM for MUSHROOM POISONING (IM) by Amanita
=680  \\$iA genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.
=688  \\$a91(75); was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85
=750  \0$aAmanita$5IEN$0(DLC)sh 85004099

=LDR  02681cz  a2200589n  4500
=001  9880363359702441
=005  20141212194623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000544
=035  \\$aCAZ3693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x380.$x100
=072  \\$aC10.$x574.$x945.$x249
=072  \\$aF3.$x87.$x400.$x100
=150  \\$aAlzheimer Disease
=450  \\$aAcute Confusional Senile Dementia
=450  \\$wnnna$aAlzheimer Dementia (AD)
=450  \\$wnnna$aAlzheimer Disease, Early Onset
=450  \\$wnnna$aAlzheimer Disease, Late Onset
=450  \\$wnnna$aAlzheimer Sclerosis
=450  \\$wnnna$aAlzheimer Syndrome
=450  \\$wnnna$aAlzheimer Type Dementia
=450  \\$wnnna$aAlzheimer-Type Dementia (ATD)
=450  \\$wnnna$aAlzheimer Type Dementia (ATD)
=450  \\$wnnna$aAlzheimer Type Senile Dementia
=450  \\$wnnna$aAlzheimer's Disease
=450  \\$wnnna$aAlzheimer's Disease, Focal Onset
=450  \\$wnnna$aDementia, Alzheimer (AD)
=450  \\$aDementia, Alzheimer Type
=450  \\$wnnna$aDementia, Alzheimer-Type (ATD)
=450  \\$wnnna$aDementia, Presenile
=450  \\$wnnna$aDementia, Primary Senile Degenerative
=450  \\$aDementia, Senile
=450  \\$wnnna$aDisease, Alzheimer
=450  \\$wnnna$aDisease, Alzheimer's
=450  \\$wnnna$aEarly Onset Alzheimer Disease
=450  \\$wnnna$aFamilial Alzheimer Disease (FAD)
=450  \\$wnnna$aFocal Onset Alzheimer's Disease
=450  \\$wnnna$aLate Onset Alzheimer Disease
=450  \\$aPresenile Alzheimer Dementia
=450  \\$wnnna$aPresenile Dementia
=450  \\$wnnna$aPrimary Senile Degenerative Dementia
=450  \\$wnnna$aSclerosis, Alzheimer
=450  \\$wnnna$aSenile Dementia
=450  \\$wnnna$aSenile Dementia, Acute Confusional
=450  \\$aSenile Dementia, Alzheimer Type
=450  \\$wnnna$aSyndrome, Alzheimer
=550  \\$wg$aDementia
=550  \\$wg$aTauopathies
=680  \\$iA degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
=688  \\$a1998(1963); for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999
=750  \0$aAlzheimer's disease$5IEN$0(DLC)sh 85004080

=LDR  00814cz  a2200217n  4500
=001  9880363359802441
=005  20141212194622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000543
=035  \\$aCAZ3692HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x550.$x120
=072  \\$aE6.$x645.$x550.$x120
=150  \\$aAlveoloplasty
=450  \\$wnnna$aAlveoloplasties
=550  \\$wg$aOral Surgical Procedures, Preprosthetic
=550  \\$aAlveolar Process
=667  \\$arefers to ALVEOLAR PROCESS (see note there); do not confuse with ALVEOLECTOMY; do not use /util except by MeSH definition
=680  \\$iConservative contouring of the alveolar process, in preparation for immediate or future denture construction. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aAlveoloplasty$5IEN$0(DLC)sh 85004069

=LDR  01476cz  a2200361n  4500
=001  9880363359902441
=005  20141212194622.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000542
=035  \\$aCAZ3691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x483.$x125
=072  \\$aC8.$x674.$x55
=072  \\$aC20.$x543.$x480.$x680.$x75
=150  \\$aAlveolitis, Extrinsic Allergic
=450  \\$wnnna$aAllergic Alveolitides, Extrinsic
=450  \\$aAllergic Alveolitis, Extrinsic
=450  \\$wnnna$aAlveolitides, Extrinsic Allergic
=450  \\$wnnna$aExtrinsic Allergic Alveolitides
=450  \\$wnnna$aExtrinsic Allergic Alveolitis
=450  \\$wnnna$aHypersensitivity Pneumonitides
=450  \\$aHypersensitivity Pneumonitis
=450  \\$wnnna$aPneumonitides, Hypersensitivity
=450  \\$aPneumonitis, Hypersensitivity
=550  \\$wg$aLung Diseases, Interstitial
=550  \\$wg$aRespiratory Hypersensitivity
=550  \\$wh$aBird Fancier's Lung
=550  \\$wh$aFarmer's Lung
=550  \\$wh$aSilo Filler's Disease
=550  \\$wh$aTrichosporonosis
=680  \\$iA common interstitial lung disease caused by hypersensitivity reactions of PULMONARY ALVEOLI after inhalation of and sensitization to environmental antigens of microbial, animal, or chemical sources. The disease is characterized by lymphocytic alveolitis and granulomatous pneumonitis.
=688  \\$a77
=750  \0$aHypersensitivity pneumonitis$5IEN$0(DLC)sh 89001803

=LDR  00798cz  a2200217n  4500
=001  9880363360002441
=005  20141212194621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000541
=035  \\$aCAZ3690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x550.$x110
=072  \\$aE6.$x645.$x550.$x110
=150  \\$aAlveolectomy
=450  \\$wnnna$aAlveolectomies
=550  \\$wg$aOral Surgical Procedures, Preprosthetic
=550  \\$aAlveolar Process
=667  \\$aexcision of part of the ALVEOLAR PROCESS (see note there); do not confuse with ALVEOLOPLASTY; do not use /util except by MeSH definition
=680  \\$iSubtotal or complete excision of the alveolar process of the maxilla or mandible. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aAlveolectomy$5IEN$0(DLC)sh 85004067

=LDR  00993cz  a2200289n  4500
=001  9880363360102441
=005  20141212194620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000539
=035  \\$aCAZ3688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x125
=072  \\$aA14.$x521.$x125
=072  \\$aA14.$x549.$x167.$x646.$x94
=150  \\$aAlveolar Process
=450  \\$wnnna$aAlveolar Processes
=450  \\$aAlveolar Ridge
=450  \\$wnnna$aProcess, Alveolar
=450  \\$wnnna$aProcesses, Alveolar
=450  \\$wnnna$aRidge, Alveolar
=550  \\$wg$aJaw
=550  \\$wg$aPeriodontium
=550  \\$wh$aTooth Socket
=667  \\$adis: coord with JAW DISEASES or specific precoord jaw dis (IM); for /surg, prefer ALVEOLECTOMY or ALVEOLOPLASTY
=680  \\$iThe thickest and spongiest part of the maxilla and mandible hollowed out into deep cavities for the teeth.
=688  \\$a65
=750  \0$aAlveolar process$5IEN$0(DLC)sh 85004064

=LDR  00973cz  a2200265n  4500
=001  9880363360202441
=005  20141212194620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000538
=035  \\$aCAZ3687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x50.$x75
=072  \\$aD1.$x578.$x725.$x25
=072  \\$aD1.$x650.$x550.$x50.$x75
=072  \\$aD1.$x837.$x725.$x700.$x760.$x50
=150  \\$aAluminum Silicates
=450  \\$wnnna$aSilicates, Aluminum
=550  \\$wg$aAluminum Oxide
=550  \\$wg$aSilicates
=550  \\$wh$aBentonite
=550  \\$wh$aKaolin
=550  \\$wh$aZeolites
=667  \\$a"numerous types of clay"
=680  \\$iAny of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=750  \0$aAluminum silicates$5IEN$0(DLC)sh 85004034

=LDR  01129cz  a2200325n  4500
=001  9880363360302441
=005  20141212194620.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000537
=035  \\$aCAZ3686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x50
=072  \\$aD1.$x650.$x550.$x50
=150  \\$aAluminum Oxide
=450  \\$aAlumina
=450  \\$wnnna$aAlumina Ceramic
=450  \\$wnnna$aAluminum Oxide (Al130O40)
=450  \\$wnnna$aAluminum Oxide (Al2O)
=450  \\$wnnna$aAluminum Oxide (AlO2)
=450  \\$wnnna$aBauxite
=450  \\$wnnna$aCeramic, Alumina
=450  \\$wnnna$aCorundum
=450  \\$wnnna$aOxide, Aluminum
=450  \\$wnnna$aSapphire
=550  \\$wg$aAluminum Compounds
=550  \\$wg$aOxides
=550  \\$wh$aAluminum Silicates
=680  \\$iAn oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.
=688  \\$a91(78); was see under ALUMINUM 1978-90
=750  \0$aAluminum oxide$5IEN$0(DLC)sh 85004029

=LDR  02175cz  a2200589n  4500
=001  9880363360402441
=005  20141212191942.0
=008  770516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000536
=035  \\$aCAZ3685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45.$x250.$x50
=072  \\$aD1.$x56.$x37
=072  \\$aD1.$x455.$x150
=150  \\$aAluminum Hydroxide
=450  \\$wnnna$aAldrox
=450  \\$wnnna$aAlgeldrate
=450  \\$wnnna$aAlgeldrate Atlas Brand
=450  \\$wnnna$aAlgeldrate Axcan Brand
=450  \\$wnnna$aAlgeldrate Chefaro Brand
=450  \\$wnnna$aAlgeldrate Roques Brand
=450  \\$wnnna$aAlgeldrate Stiefel Brand
=450  \\$wnnna$aAlgeldrate Whitehall Brand
=450  \\$wnnna$aAlgeldrate Wyeth Brand
=450  \\$wnnna$aAlhydrogel
=450  \\$wnnna$aAlugel
=450  \\$wnnna$aAlumina, Hydrated
=450  \\$wnnna$aAmphojel
=450  \\$wnnna$aAtlas Brand of Algeldrate
=450  \\$wnnna$aAxcan Brand of Algeldrate
=450  \\$wnnna$aBasalgel
=450  \\$wnnna$aBrasivil
=450  \\$wnnna$aChefaro Brand of Algeldrate
=450  \\$wnnna$aDialume
=450  \\$aHydrated Alumina
=450  \\$wnnna$aHydroxide, Aluminum
=450  \\$wnnna$aNephrox
=450  \\$wnnna$aPepsamer
=450  \\$wnnna$aRhône-Poulenc Rorer Brand of Algeldrate
=450  \\$wnnna$aRhône Poulenc Rorer Brand of Algeldrate
=450  \\$wnnna$aRocgel
=450  \\$wnnna$aRoques Brand of Algeldrate
=450  \\$wnnna$aSanofi Winthrop Brand of Algeldrate
=450  \\$wnnna$aSmithKline Beecham Brand of Algeldrate
=450  \\$wnnna$aStiefel Brand of Algeldrate
=450  \\$wnnna$aWhitehall Brand of Algeldrate
=450  \\$wnnna$aWyeth Brand of Algeldrate
=550  \\$wg$aAluminum Compounds
=550  \\$wg$aHydroxides
=680  \\$iA compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
=688  \\$a78; ALUMINUM HYDROXIDE GEL was heading 1972-77 (Prov 1972); ALUMINUM GELS was see under ANTACIDS 1963-72
=750  \0$aAluminum hydroxide$5IEN$0(DLC)sh 85004013

=LDR  00590cz  a2200181n  4500
=001  9880363360502441
=005  20141212194619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000535
=035  \\$aCAZ3684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x557.$x50
=072  \\$aD1.$x552.$x547.$x50
=150  \\$aAluminum
=550  \\$wg$aMetals, Light
=667  \\$aAl-27; Al-23-26, 28-30 = ALUMINUM (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.
=750  \0$aAluminum$5IEN-M$0(DLC)sh 85003956

=LDR  00993cz  a2200217n  4500
=001  9880363360602441
=005  20141212194619.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000534
=035  \\$aCAZ3683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x25
=072  \\$aD1.$x875.$x800.$x800.$x850.$x25
=150  \\$aAlum Compounds
=450  \\$wnnna$aCompounds, Alum
=550  \\$wg$aAluminum Compounds
=550  \\$wg$aSulfates
=667  \\$aastringents; also many indust uses; used also in vet med; D25-26 qualif; DF: ALUM CPDS
=680  \\$iAluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.
=688  \\$a91(75); was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE & ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93
=750  \0$aAlum$5IEN-HS$0(DLC)sh 85003949

=LDR  00602cz  a2200205n  4500
=001  9880363360702441
=005  20141212194619.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000533
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x90
=150  \\$aAltruism
=450  \\$aHumanitarianism
=550  \\$wg$aSocial Behavior
=550  \\$aBeneficence
=550  \\$aGift Giving
=667  \\$ano qualif
=680  \\$iConsideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.
=688  \\$a78
=750  \0$aAltruism$5IEN$0(DLC)sh 85003944

=LDR  00751cz  a2200229n  4500
=001  9880363360802441
=005  20141212194618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000531
=035  \\$aCAZ3680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x58
=072  \\$aN6.$x230.$x58
=150  \\$aAltitude
=450  \\$wnnna$aAltitudes
=550  \\$wg$aEnvironment
=550  \\$aAerospace Medicine
=550  \\$aAtmospheric Pressure
=550  \\$aMountaineering
=667  \\$aconsider also ATMOSPHERIC PRESSURE; /adv eff = probably ALTITUDE SICKNESS
=680  \\$iA vertical distance measured from a known level on the surface of a planet or other celestial body.
=750  \0$aAltitude, Influence of$5IEN$0(DLC)sh 85003930

=LDR  02262cz  a2200541n  4500
=001  9880363360902441
=005  20200618113531.0
=008  850225\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000529
=035  \\$aCAZ3678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190
=150  \\$aComplementary Therapies
=450  \\$aAlternative Medicine
=450  \\$wnnna$aAlternative Therapies
=450  \\$aComplementary Medicine
=450  \\$aMedicine, Alternative
=450  \\$aMedicine, Complementary
=450  \\$wnnna$aTherapies, Alternative
=450  \\$wnnna$aTherapies, Complementary
=450  \\$wnnna$aTherapy, Alternative
=450  \\$wnnna$aTherapy, Complementary
=550  \\$wg$aTherapeutics
=550  \\$wh$aAcupuncture Therapy
=550  \\$wh$aAnthroposophy
=550  \\$wh$aAuriculotherapy
=550  \\$wh$aDiffuse Noxious Inhibitory Control
=550  \\$wh$aHolistic Health
=550  \\$wh$aHomeopathy
=550  \\$wh$aHorticultural Therapy
=550  \\$wh$aIntegrative Oncology
=550  \\$wh$aMedicine, Traditional
=550  \\$wh$aMesotherapy
=550  \\$wh$aMind-Body Therapies
=550  \\$wh$aMusculoskeletal Manipulations
=550  \\$wh$aNaturopathy
=550  \\$wh$aOrganotherapy
=550  \\$wh$aPhytotherapy
=550  \\$wh$aProlotherapy
=550  \\$wh$aReflexotherapy
=550  \\$wh$aRejuvenation
=550  \\$wh$aSensory Art Therapies
=550  \\$wh$aSpeleotherapy
=550  \\$wh$aSpiritual Therapies
=667  \\$aGeneral or unspecified; prefer specifics; not for "alternative health care delivery system" (= DELIVERY OF HEALTH CARE) or specific health service.
=680  \\$iTherapeutic practices which are not currently considered an integral part of conventional allopathic medical practice. They may lack biomedical explanations but as they become better researched some (PHYSICAL THERAPY MODALITIES; DIET; ACUPUNCTURE) become widely accepted whereas others (humors, radium therapy) quietly fade away, yet are important historical footnotes. Therapies are termed as Complementary when used in addition to conventional treatments and as Alternative when used instead of conventional treatment.
=688  \\$a2002(1986)
=750  \0$aAlternative medicine$5IEN$0(DLC)sh 85134721

=LDR  00664cz  a2200193n  4500
=001  9880363361002441
=005  20141212194617.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000528
=035  \\$aCAZ3677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x75
=150  \\$aAlternaria
=450  \\$wnnna$aAlternarias
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection = ALTERNARIOSIS
=680  \\$iA mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.
=688  \\$a91(75)
=750  \0$aAlternaria$5IEN$0(DLC)sh 85003913

=LDR  01780cz  a2200529n  4500
=001  9880363361102441
=005  20141212194617.0
=008  850308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000527
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x550.$x250.$x50
=072  \\$aD10.$x251.$x355.$x325.$x50
=072  \\$aD23.$x469.$x50.$x175.$x725.$x780.$x50
=150  \\$aAlprostadil
=450  \\$wnnna$aAbbott Brand of Alprostadil
=450  \\$wnnna$aAllphar Brand of Alprostadil
=450  \\$wnnna$aAstra Brand of Alprostadil
=450  \\$wnnna$aAstraZeneca Brand of Alprostadil
=450  \\$wnnna$aCaverject
=450  \\$wnnna$aEdex
=450  \\$wnnna$aHoyer Brand of Alprostadil
=450  \\$wnnna$aJanssen Brand of Alprostadil
=450  \\$wnnna$aLipo-PGE1
=450  \\$wnnna$aLipo PGE1
=450  \\$wnnna$aMinprog
=450  \\$wnnna$aMuse
=450  \\$wnnna$aPaladin Brand of Alprostadil
=450  \\$aPGE1
=450  \\$wnnna$aPGE1alpha
=450  \\$wnnna$aPharmacia Brand 1 of Alprostadil
=450  \\$wnnna$aPharmacia Brand 2 of Alprostadil
=450  \\$aProstaglandin E1
=450  \\$wnnna$aProstaglandin E1alpha
=450  \\$wnnna$aProstavasin
=450  \\$wnnna$aProstin VR
=450  \\$wnnna$aProstine VR
=450  \\$wnnna$aSchwarz Brand of Alprostadil
=450  \\$wnnna$aSchwarz Pharma Brand of Alprostadil
=450  \\$wnnna$aSugiran
=450  \\$wnnna$aVasaprostan
=450  \\$wnnna$aViridal
=450  \\$wnnna$aVivus Brand of Alprostadil
=550  \\$wg$aFatty Acids, Monounsaturated
=550  \\$wg$aProstaglandins E
=680  \\$iA potent vasodilator agent that increases peripheral blood flow.
=688  \\$a86; see VASOPROSTAN (NM) 1995-97
=750  \0$aProstaglandin E1$5IEN-M$0(DLC)sh 94005574

=LDR  02244cz  a2200649n  4500
=001  9880363361202441
=005  20141212194616.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000525
=035  \\$aCAZ3674HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x30
=150  \\$aAlprazolam
=450  \\$wnnna$aAlphapharm Brand of Alprazolam
=450  \\$wnnna$aAlprazolam Alphapharm Brand
=450  \\$wnnna$aAlprazolam Apotex Brand
=450  \\$wnnna$aAlprazolam Kenral Brand
=450  \\$wnnna$aAlprazolam Novopharm Brand
=450  \\$wnnna$aAlprazolam Nu-Pharm Brand
=450  \\$wnnna$aAlprazolam Orion Brand
=450  \\$wnnna$aAlprazolam Pfizer Brand
=450  \\$wnnna$aAlprazolam Temmler Brand
=450  \\$aAlprazolan
=450  \\$wnnna$aAlprox
=450  \\$wnnna$aApo-Alpraz
=450  \\$wnnna$aApo Alpraz
=450  \\$wnnna$aApoAlpraz
=450  \\$wnnna$aApotex Brand of Alprazolam
=450  \\$wnnna$aArzneimittelwerk Dresden Brand of Alprazolam
=450  \\$wnnna$aCassadan
=450  \\$wnnna$aD-65MT
=450  \\$wnnna$aD65MT
=450  \\$wnnna$aEsparon
=450  \\$wnnna$aKalma
=450  \\$wnnna$aKenral Brand of Alprazolam
=450  \\$wnnna$aNovo-Alprazol
=450  \\$wnnna$aNovo Alprazol
=450  \\$wnnna$aNovoAlprazol
=450  \\$wnnna$aNovopharm Brand of Alprazolam
=450  \\$wnnna$aNu-Alpraz
=450  \\$wnnna$aNu Alpraz
=450  \\$wnnna$aNu-Pharm Brand of Alprazolam
=450  \\$wnnna$aNu Pharm Brand of Alprazolam
=450  \\$wnnna$aNuAlpraz
=450  \\$wnnna$aOrion Brand of Alprazolam
=450  \\$wnnna$aPfizer Brand of Alprazolam
=450  \\$wnnna$aRalozam
=450  \\$wnnna$aTafil
=450  \\$wnnna$aTemmler Brand of Alprazolam
=450  \\$wnnna$aTrankimazin
=450  \\$wnnna$aU-31,889
=450  \\$wnnna$aU31,889
=450  \\$wnnna$aXanax
=550  \\$wg$aBenzodiazepines
=680  \\$iA triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
=688  \\$a87
=750  \0$aAlprazolam$5IEN$0(DLC)sh 85003838

=LDR  01747cz  a2200505n  4500
=001  9880363361302441
=005  20141212194612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000515
=035  \\$aCAZ3664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x822.$x750.$x35
=072  \\$aD12.$x644.$x861.$x35
=072  \\$aD12.$x776.$x124.$x50.$x70
=072  \\$aD12.$x776.$x124.$x790.$x106.$x85
=072  \\$aD12.$x776.$x377.$x715.$x85.$x85
=072  \\$aD12.$x776.$x395.$x68
=072  \\$aD12.$x776.$x645.$x750.$x35
=072  \\$aD12.$x776.$x872.$x35
=150  \\$aalpha 1-Antitrypsin
=450  \\$wnnna$a1-Antiproteinase, alpha
=450  \\$wnnna$aA1PI
=450  \\$wnnna$aalpha 1 Antiprotease
=450  \\$wnnna$aalpha 1-Antiproteinase
=450  \\$wnnna$aalpha 1 Antiproteinase
=450  \\$wnnna$aalpha 1 Antitrypsin
=450  \\$aalpha 1-Protease Inhibitor
=450  \\$wnnna$aalpha 1 Protease Inhibitor
=450  \\$aalpha 1-Proteinase Inhibitor
=450  \\$wnnna$aalpha 1 Proteinase Inhibitor
=450  \\$wnnna$aAntiprotease, alpha 1
=450  \\$wnnna$aInhibitor, alpha 1-Protease
=450  \\$wnnna$aInhibitor, alpha 1-Proteinase
=450  \\$wnnna$aProlastin
=450  \\$wnnna$aSerpin A1
=450  \\$aTrypsin Inhibitor, alpha 1-Antitrypsin
=450  \\$wnnna$aTrypsin Inhibitor, alpha 1 Antitrypsin
=450  \\$wnnna$aZemaira
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aGlycoproteins
=550  \\$wg$aSerpins
=680  \\$iPlasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES.
=688  \\$a74
=750  \0$aAlpha 1-antitrypsin$5IEN$0(DLC)sh 85003808

=LDR  00932cz  a2200241n  4500
=001  9880363361402441
=005  20141212194611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000513
=035  \\$aCAZ3662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x300.$x150.$x374
=072  \\$aE1.$x370.$x405.$x245.$x287.$x374
=072  \\$aG7.$x265.$x87.$x500
=072  \\$aG11.$x561.$x127.$x500
=150  \\$aAlpha Rhythm
=450  \\$wnnna$aAlpha Rhythms
=450  \\$wnnna$aRhythm, Alpha
=450  \\$wnnna$aRhythms, Alpha
=550  \\$wg$aBrain Waves
=680  \\$iBrain waves characterized by a relatively high voltage or amplitude and a frequency of 8-13 Hz. They constitute the majority of waves recorded by EEG registering the activity of the parietal and occipital lobes when the individual is awake, but relaxed with the eyes closed.
=688  \\$a74(72)
=750  \0$aAlpha rhythm$5IEN$0(DLC)sh 85003818

=LDR  00966cz  a2200277n  4500
=001  9880363361502441
=005  20141212194611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000512
=035  \\$aCAZ3661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x750.$x55
=150  \\$aAlpha Particles
=450  \\$wnnna$aAlpha Particle
=450  \\$wnnna$aAlpha Radiation
=450  \\$wnnna$aAlpha Ray
=450  \\$aAlpha Rays
=450  \\$wnnna$aParticle, Alpha
=450  \\$wnnna$aParticles, Alpha
=450  \\$wnnna$aRadiation, Alpha
=450  \\$wnnna$aRay, Alpha
=450  \\$wnnna$aRays, Alpha
=550  \\$wg$aRadiation, Ionizing
=680  \\$iPositively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability.
=688  \\$a66
=750  \0$aAlpha rays$5IEN$0(DLC)sh 85003816

=LDR  01397cz  a2200397n  4500
=001  9880363361602441
=005  20141212194427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000203
=035  \\$aCAZ3350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x67
=072  \\$aI3.$x50
=072  \\$aN2.$x421.$x784.$x110
=150  \\$aActivities of Daily Living
=450  \\$wnnna$aActivities, Daily Living
=450  \\$wnnna$aActivity, Daily Living
=450  \\$aADL
=450  \\$wnnna$aCare, Self (Rehabilitation)
=450  \\$wnnna$aCares, Self (Rehabilitation)
=450  \\$aChronic Limitation of Activity
=450  \\$wnnna$aDaily Living Activities
=450  \\$wnnna$aDaily Living Activity
=450  \\$aLimitation of Activity, Chronic
=450  \\$wnnna$aLiving Activities, Daily
=450  \\$wnnna$aLiving Activity, Daily
=450  \\$aSelf Care (Rehabilitation)
=450  \\$wnnna$aSelf Cares (Rehabilitation)
=550  \\$wg$aHuman Activities
=550  \\$wg$aRehabilitation
=550  \\$wh$aIndependent Living
=550  \\$wh$aSocial Participation
=550  \\$aKarnofsky Performance Status
=680  \\$iThe performance of the basic activities of self care, such as dressing, ambulation, or eating.
=688  \\$a68; SELF CARE (REHABILITATION) was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80
=750  \0$aLife skills$5IEN$0(DLC)sh 85076844

=LDR  02668cz  a2200661n  4500
=001  9880363361702441
=005  20141212194611.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000511
=035  \\$aCAZ3660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x50.$x80
=072  \\$aD12.$x776.$x124.$x790.$x106.$x100
=072  \\$aD12.$x776.$x124.$x790.$x720.$x100
=072  \\$aD12.$x776.$x377.$x715.$x85.$x100
=072  \\$aD12.$x776.$x377.$x715.$x647.$x100
=150  \\$aalpha-Macroglobulins
=450  \\$wnnna$a45S RNP
=450  \\$wnnna$aAcute-Phase alpha 1-Protein
=450  \\$wnnna$aAcute Phase alpha 1 Protein
=450  \\$wnnna$aalpha 1-Acute Phase Globulin
=450  \\$wnnna$aalpha 1 Acute Phase Globulin
=450  \\$wnnna$aalpha 1-Acute Phase Protein
=450  \\$wnnna$aalpha 1 Acute Phase Protein
=450  \\$wnnna$aalpha 1-Macroglobulin
=450  \\$wnnna$aalpha 1 Macroglobulin
=450  \\$wnnna$aalpha 1-Protein, Acute-Phase
=450  \\$wnnna$aalpha 2-Acute Phase Globulin
=450  \\$wnnna$aalpha 2 Acute Phase Globulin
=450  \\$aalpha 2-Acute Phase Globulins
=450  \\$wnnna$aalpha 2 Acute Phase Globulins
=450  \\$wnnna$aalpha 2-Globulin, Slow
=450  \\$wnnna$aalpha 2-Glucoprotein
=450  \\$wnnna$aalpha 2 Glucoprotein
=450  \\$aalpha 2-Glucoproteins
=450  \\$wnnna$aalpha 2 Glucoproteins
=450  \\$wnnna$aalpha 2-Macroglobulin
=450  \\$wnnna$aalpha 2 Macroglobulin
=450  \\$wnnna$aalpha 2-Macroglobulins, Slow
=450  \\$wnnna$aalpha-Macrofetoprotein
=450  \\$wnnna$aalpha Macrofetoprotein
=450  \\$aalpha-Macrofetoproteins
=450  \\$wnnna$aalpha Macrofetoproteins
=450  \\$wnnna$aalpha Macroglobulins
=450  \\$wnnna$aalpha2-Macroglobulin
=450  \\$wnnna$aalpha2 Macroglobulin
=450  \\$wnnna$aRNP, 45S
=450  \\$wnnna$aSlow alpha 2-Globulin
=450  \\$wnnna$aSlow alpha 2 Globulin
=450  \\$aSlow alpha 2-Macroglobulins
=450  \\$wnnna$aSlow alpha 2 Macroglobulins
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aMacroglobulins
=550  \\$wh$aPregnancy-Associated alpha 2-Macroglobulins
=680  \\$iGlycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters.
=688  \\$a96; was ALPHA MACROGLOBULINS 1976-95
=750  \0$aAlpha macroglobulins$5IEN$0(DLC)sh 85003814

=LDR  01184cz  a2200349n  4500
=001  9880363361802441
=005  20141212194425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000200
=035  \\$aCAZ3347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x580.$x100
=072  \\$aG7.$x265.$x750.$x100
=072  \\$aG11.$x561.$x570.$x100
=150  \\$aAction Potentials
=450  \\$wnnna$aAction Potential
=450  \\$wnnna$aImpulse, Nerve
=450  \\$wnnna$aImpulses, Nerve
=450  \\$wnnna$aNerve Impulse
=450  \\$wnnna$aNerve Impulses
=450  \\$wnnna$aPotential, Action
=450  \\$wnnna$aPotential, Spike
=450  \\$wnnna$aPotentials, Action
=450  \\$wnnna$aPotentials, Spike
=450  \\$wnnna$aSpike Potential
=450  \\$aSpike Potentials
=550  \\$wg$aMembrane Potentials
=550  \\$aNeural Conduction
=667  \\$ado not confuse with SYNAPTIC POTENTIALS see SYNAPTIC TRANSMISSION
=680  \\$iAbrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
=688  \\$a68(67)
=750  \0$aAction potentials (Electrophysiology)$5IEN$0(DLC)sh 85000721

=LDR  01373cz  a2200397n  4500
=001  9880363361902441
=005  20141212194610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000510
=035  \\$aCAZ3659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x790.$x106
=072  \\$aD12.$x776.$x377.$x715.$x85
=150  \\$aAlpha-Globulins
=450  \\$wnnna$aAlpha-Globulin
=450  \\$wnnna$aAlpha Globulin
=450  \\$wnnna$aAlpha Globulins
=550  \\$wg$aSerum Globulins
=550  \\$wh$aalpha 1-Antichymotrypsin
=550  \\$wh$aalpha 1-Antitrypsin
=550  \\$wh$aalpha-2-Antiplasmin
=550  \\$wh$aalpha-Fetoproteins
=550  \\$wh$aalpha-Macroglobulins
=550  \\$wh$aAntithrombin III
=550  \\$wh$aCeruloplasmin
=550  \\$wh$aFetuins
=550  \\$wh$aHaptoglobins
=550  \\$wh$aHeparin Cofactor II
=550  \\$wh$aOrosomucoid
=550  \\$wh$aProgesterone-Binding Globulin
=550  \\$wh$aRetinol-Binding Proteins, Plasma
=550  \\$wh$aTranscortin
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iSerum proteins that have the most rapid migration during ELECTROPHORESIS. This subgroup of globulins is divided into faster and slower alpha(1)- and alpha(2)-globulins.
=688  \\$a75; was ALPHA GLOBULIN 1964-74 (Prov 1964)
=750  \0$aAlpha globulins$5IEN$0(DLC)sh 85003812

=LDR  01036cz  a2200289n  4500
=001  9880363362002441
=005  20160425095650.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000509
=035  \\$aCAZ3658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x790.$x106.$x92
=072  \\$aD12.$x776.$x320.$x525.$x500
=072  \\$aD12.$x776.$x377.$x228.$x500
=072  \\$aD12.$x776.$x377.$x715.$x85.$x92
=072  \\$aD23.$x101.$x840.$x50
=150  \\$aalpha-Fetoproteins
=450  \\$wnnna$aalpha-Fetoprotein
=450  \\$wnnna$aalpha Fetoprotein
=450  \\$wnnna$aalpha Fetoproteins
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aFetal Globulins
=550  \\$wg$aBiomarkers, Tumor
=550  \\$aAnencephaly
=680  \\$iThe first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
=688  \\$a96; was ALPHA FETOPROTEINS 1975-95 (see under FETAL GLOBULINS 1975-76)
=750  \0$aAlpha fetoproteins$0(DLC) sh 85003811$5IEN

=LDR  01549cz  a2200421n  4500
=001  9880363362102441
=005  20141212194425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000199
=035  \\$aCAZ3346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x730.$x250
=072  \\$aD12.$x776.$x210.$x500.$x100
=072  \\$aD12.$x776.$x220.$x525.$x255
=150  \\$aActins
=450  \\$wnnna$aActin
=450  \\$wnnna$aalpha-Actin
=450  \\$wnnna$aalpha Actin
=450  \\$wnnna$aalpha-Isoactin
=450  \\$wnnna$aalpha Isoactin
=450  \\$wnnna$abeta-Actin
=450  \\$wnnna$abeta Actin
=450  \\$aF-Actin
=450  \\$wnnna$aF Actin
=450  \\$aFilamentous Actin$5IEN-M
=450  \\$aG-Actin
=450  \\$wnnna$aG Actin
=450  \\$wnnna$agamma-Actin
=450  \\$wnnna$agamma Actin
=450  \\$aGlobular Actin$5IEN-M
=450  \\$wnnna$aIsoactin
=450  \\$wnnna$aN-Actin
=450  \\$wnnna$aN Actin
=550  \\$wg$aMicrofilament Proteins
=550  \\$wg$aMuscle Proteins
=680  \\$iFilamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.
=688  \\$a82; was ACTIN 1971-81 (Prov 1971-72)
=750  \0$aActin$5IEN$0(DLC)sh 85000687

=LDR  01054cz  a2200241n  4500
=001  9880363362202441
=005  20141212194609.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000508
=035  \\$aCAZ3657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x75.$x50.$x75
=150  \\$aAlouatta
=450  \\$wnnna$aAlouattas
=450  \\$wnnna$aHowler Monkey
=450  \\$wnnna$aHowler Monkeys
=450  \\$aMonkey, Howler
=450  \\$wnnna$aMonkeys, Howler
=550  \\$wg$aAlouattinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the subfamily ALOUATTINAE, family ATELIDAE, inhabiting the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.
=688  \\$a91(81); was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80
=750  \0$aHowler monkeys$5IEN$0(DLC)sh 85062666

=LDR  01022cz  a2200253n  4500
=001  9880363362302441
=005  20141212194424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000196
=035  \\$aCAZ3343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x137
=150  \\$aActinomycosis
=450  \\$wnnna$aActinomyces Infection
=450  \\$aActinomyces Infections
=450  \\$wnnna$aActinomycoses
=450  \\$wnnna$aInfection, Actinomyces
=450  \\$wnnna$aInfections, Actinomyces
=550  \\$wg$aActinomycetales Infections
=550  \\$wh$aActinomycosis, Cervicofacial
=550  \\$wh$aWhipple Disease
=667  \\$abact infect, not fungal despite "-mycosis": = infection by genus ACTINOMYCES; do not confuse with ACTINOMYCETALES INFECTIONS, infection by order ACTINOMYCETALES; pulm actinomycosis = ACTINOMYCOSIS (IM) + LUNG DISEASES (IM), not LUNG DISEASES, FUNGAL
=680  \\$iInfections with bacteria of the genus ACTINOMYCES.
=750  \0$aActinomycosis$5IEN$0(DLC)sh 85000715

=LDR  01282cz  a2200373n  4500
=001  9880363362402441
=005  20141212194423.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000192
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49
=150  \\$aActinomycetales
=450  \\$aCorynebacteriaceae
=450  \\$aCoryneform Group
=450  \\$wnno$aNocardioform Group$5IEN-HS
=550  \\$wg$aActinobacteria
=550  \\$wh$aActinomycetaceae
=550  \\$wh$aBrevibacterium
=550  \\$wh$aCellulomonas
=550  \\$wh$aCorynebacterium
=550  \\$wh$aFrankia
=550  \\$wh$aGordonia Bacterium
=550  \\$wh$aMicrococcaceae
=550  \\$wh$aMicromonosporaceae
=550  \\$wh$aMycobacteriaceae
=550  \\$wh$aNocardiaceae
=550  \\$wh$aPropionibacteriaceae
=550  \\$wh$aSaccharopolyspora
=550  \\$wh$aStreptomycetaceae
=550  \\$wh$aTropheryma
=667  \\$ainfection = ACTINOMYCETALES INFECTIONS
=680  \\$iAn order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.
=688  \\$a67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 (see under CORYNEFORM GROUP 1976-90); CORYNEFORM GROUP was heading 1976-91
=750  \0$aActinomycetales$5IEN$0(DLC)sh 85000712

=LDR  01316cz  a2200409n  4500
=001  9880363362502441
=005  20141212194608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000505
=035  \\$aCAZ3654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x329.$x937.$x122
=072  \\$aC23.$x300.$x35
=150  \\$aAlopecia
=450  \\$aAlopecia, Androgenetic
=450  \\$wnnna$aAlopecia, Androgenetic, 1
=450  \\$wnnna$aAlopecia Cicatrisata
=450  \\$wnnna$aAlopecia Cicatrisatas
=450  \\$wnnna$aAlopecia, Male Pattern
=450  \\$wnnna$aAndrogenetic Alopecia
=450  \\$wnnna$aAndrogenic Alopecia
=450  \\$aBaldness
=450  \\$wnnna$aBaldness, Male Pattern
=450  \\$wnnna$aCicatrisata, Alopecia
=450  \\$wnnna$aCicatrisatas, Alopecia
=450  \\$wnnna$aFemale Pattern Baldness
=450  \\$wnnna$aMale Pattern Alopecia
=450  \\$aMale Pattern Baldness
=450  \\$wnnna$aPattern Baldness
=450  \\$aPseudopelade
=550  \\$wg$aHypotrichosis
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aAlopecia Areata
=550  \\$wh$aLoose Anagen Hair Syndrome
=550  \\$wh$aMucinosis, Follicular
=680  \\$iAbsence of hair from areas where it is normally present.
=750  \0$aBaldness$5IEN$0(DLC)sh 85011156

=LDR  00707cz  a2200229n  4500
=001  9880363362602441
=005  20141212194422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000191
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x50
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x49
=150  \\$aActinomycetaceae
=550  \\$wg$aActinobacteria
=550  \\$wg$aActinomycetales
=550  \\$wh$aActinomyces
=550  \\$wh$aArcanobacterium
=550  \\$wh$aMobiluncus
=667  \\$aa family of the order ACTINOMYCETALES
=680  \\$iA family of bacteria including numerous parasitic and pathogenic forms.
=688  \\$a75
=750  \0$aActinomycetaceae$5IEN$0(DLC)sh 85000711

=LDR  01136cz  a2200229n  4500
=001  9880363362702441
=005  20190626115236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000504
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x970.$x500
=150  \\$aAloe
=450  \\$aAloe vera
=450  \\$wnnna$aAloe veras
=450  \\$wnnna$aAloes
=450  \\$wnnna$avera, Aloe
=450  \\$wnnna$averas, Aloe
=550  \\$wg$aXanthorrhoeaceae
=667  \\$afor HESPERALOE see AGAVACEAE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Xanthorrhoeaceae is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin (EMODIN).
=688  \\$a91(78)63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B & D 1963-77
=750  \0$aAloe$5IEN$0(DLC)sh 85003788

=LDR  00778cz  a2200181n  4500
=001  9880363362802441
=005  20141212194422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000190
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x50.$x50
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x49.$x178
=150  \\$aActinomyces
=550  \\$wg$aActinomycetaceae
=550  \\$wh$aActinomyces viscosus
=667  \\$aa genus of the family ACTINOMYCETACEAE of the order ACTINOMYCETALES; infection = ACTINOMYCOSIS
=680  \\$iA genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.
=750  \0$aActinomyces$5IEN$0(DLC)sh 88023205

=LDR  01107cz  a2200205n  4500
=001  9880363362902441
=005  20141212194607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000503
=035  \\$aCAZ3652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x72
=150  \\$aAlmanacs as Topic
=450  \\$wnnna$aAlmanacs as Topics
=550  \\$wg$aReference Books
=667  \\$afor medical almanacs, do not coordinate with MEDICINE; do not confuse with Publication Type ALMANACS
=680  \\$iPublications, usually annual, containing a calendar for the coming year, the times of such events and phenomena as anniversaries, sunrises, sunsets, phases of the moon, tides, meteorological, and other statistical information and related topics. Almanacs are also annual reference books of useful and interesting facts relating to countries of the world, sports, entertainment, population groups, etc. (Random House Unabridged Dictionary, 2d ed)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Almanacs
=750  \0$aAlmanacs$0(DLC) sh 85003744$5IEN-M

=LDR  00998cz  a2200241n  4500
=001  9880363363002441
=005  20141212194422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000188
=035  \\$aCAZ3335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x9
=072  \\$aB3.$x660.$x250.$x550.$x50
=150  \\$aActinobacillus
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wg$aPasteurellaceae
=550  \\$wh$aActinobacillus equuli
=550  \\$wh$aActinobacillus pleuropneumoniae
=550  \\$wh$aActinobacillus seminis
=550  \\$wh$aActinobacillus suis
=667  \\$ainfection = ACTINOBACILLUS INFECTIONS or ACTINOBACILLOSIS: see notes there
=680  \\$iA genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.
=750  \0$aActinobacillus$5IEN$0(DLC)sh 85000708

=LDR  00578cz  a2200217n  4500
=001  9880363363102441
=005  20141212194606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000498
=035  \\$aCAZ3647HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x122
=150  \\$aAllyl Compounds
=450  \\$wnnna$aCompounds, Allyl
=550  \\$wg$aAlkenes
=550  \\$wh$aAllylamine
=550  \\$wh$aAllylglycine
=550  \\$wh$aAllylisopropylacetamide
=667  \\$aDF: ALLYL CPDS
=688  \\$a73(71)
=750  \0$aAllyl halides$5IEN$0(DLC)sh 85003738

=LDR  00795cz  a2200277n  4500
=001  9880363363202441
=005  20141212194606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000497
=035  \\$aCAZ3646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x552.$x33
=072  \\$aD25.$x58
=072  \\$aJ1.$x637.$x51.$x58
=150  \\$aAlloys
=450  \\$wnnna$aAlloy
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aMetals
=550  \\$wh$aChromium Alloys
=550  \\$wh$aGold Alloys
=550  \\$wh$aMetal Ceramic Alloys
=550  \\$wh$aSteel
=667  \\$aD25-26 qualif
=680  \\$iA mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.
=688  \\$a65
=750  \0$aAlloys$5IEN$0(DLC)sh 85003721

=LDR  00508cz  a2200157n  4500
=001  9880363363302441
=005  20141212194606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000496
=035  \\$aCAZ3645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x122
=150  \\$aAlloxan
=550  \\$wg$aPyrimidinones
=667  \\$aALLOXAN DIABETES indexed as DIABETES MELLITUS, EXPERIMENTAL (IM) + ALLOXAN (NIM) only if chem is particularly discussed
=750  \0$aAlloxan$5IEN$0(DLC)sh 85003718

=LDR  00854cz  a2200229n  4500
=001  9880363363402441
=005  20141212194421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000186
=035  \\$aCAZ3333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x33
=072  \\$aD1.$x268.$x271.$x100.$x33
=072  \\$aD1.$x268.$x556.$x25
=072  \\$aD1.$x552.$x20.$x42
=072  \\$aD1.$x552.$x544.$x25
=150  \\$aActinium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iActinium. A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, atomic number 89, and atomic weight 227.0278. Its principal isotope is 227 and decays primarily by beta-emission.
=750  \0$aActinium$5IEN$0(DLC)sh 85000706

=LDR  00580cz  a2200193n  4500
=001  9880363363502441
=005  20141212194420.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000184
=035  \\$aCAZ3331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x47
=150  \\$aActing Out
=550  \\$wg$aDefense Mechanisms
=550  \\$aPsychodrama
=667  \\$ano qualif
=680  \\$iExpressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior.
=688  \\$a68
=750  \0$aActing out (Psychology)$5IEN$0(DLC)sh 85000697

=LDR  00847cz  a2200229n  4500
=001  9880363363602441
=005  20170608114946.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000494
=035  \\$aCAZ3643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x44
=150  \\$aAllosteric Regulation
=450  \\$wnnna$aAllosteric Regulations
=450  \\$wnnna$aRegulation, Allosteric
=450  \\$wnnna$aRegulations, Allosteric
=550  \\$wg$aBiochemical Phenomena
=550  \\$aAllosteric Site
=667  \\$aalmost never IM; DF: ALLOSTERIC REG
=680  \\$iThe modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES.
=688  \\$a78(71); was see under BIOCHEMISTRY 1975-77
=750  \0$aAllosteric regulation$5IEN$0(DLC)sh 88005221

=LDR  00576cz  a2200193n  4500
=001  9880363363702441
=005  20141212194420.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000181
=035  \\$aCAZ3328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x626.$x95
=150  \\$aAcrylonitrile
=450  \\$wnnna$aCyanide, Vinyl
=450  \\$aVinyl Cyanide
=550  \\$wg$aNitriles
=680  \\$iA highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber.
=688  \\$a91(77)
=750  \0$aAcrylonitrile$5IEN$0(DLC)sh 87000843

=LDR  00789cz  a2200229n  4500
=001  9880363363802441
=005  20180212094315.0
=008  850503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000490
=035  \\$aCAZ3639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x50.$x60
=150  \\$aAllium
=450  \\$aAlliaceae
=550  \\$wg$aAmaryllidaceae
=550  \\$wh$aChive
=550  \\$wh$aGarlic
=550  \\$wh$aOnions
=550  \\$wh$aShallots
=680  \\$iA genus of the plant family Amaryllidaceae. Many produce pungent, often bacteriostatic and physiologically active compounds and are used as VEGETABLES; CONDIMENTS; and medicament, the latter in traditional medicine.
=688  \\$a86
=750  \0$aAllium$5IEN-M$0(DLC)sh 85003696

=LDR  00723cz  a2200241n  4500
=001  9880363363902441
=005  20141212194419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000180
=035  \\$aCAZ3327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x716.$x822.$x111
=072  \\$aD25.$x720.$x716.$x822.$x111
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x111
=150  \\$aAcrylic Resins
=450  \\$wnnna$aResins, Acrylic
=550  \\$wg$aResins, Synthetic
=550  \\$wh$aPolymethacrylic Acids
=550  \\$aDental Restoration, Permanent
=550  \\$aDental Restoration, Temporary
=550  \\$aTooth, Artificial
=667  \\$aD25-26 qualif
=750  \0$aAcrylic resins$5IEN$0(DLC)sh 85000675

=LDR  00599cz  a2200229n  4500
=001  9880363364002441
=005  20141212194419.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000179
=035  \\$aCAZ3326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x69
=150  \\$aAcrylates
=450  \\$aBromebric Acid$5IEN-M
=550  \\$wg$aAcids, Acyclic
=550  \\$wh$aAcrylamides
=550  \\$wh$aCyanoacrylates
=550  \\$wh$aMethacrylates
=550  \\$wh$aPolymethacrylic Acids
=550  \\$wh$aUrocanic Acid
=688  \\$a66
=750  \0$aAcrylates$0(DLC) sh 91004852$5IEN

=LDR  00927cz  a2200301n  4500
=001  9880363364102441
=005  20141212194604.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000489
=035  \\$aCAZ3638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x100
=150  \\$aAlligators and Crocodiles
=450  \\$wnnna$aAlligator
=450  \\$wnnna$aAlligators
=450  \\$wnnna$aCaiman
=450  \\$aCaimans
=450  \\$wnnna$aCayman
=450  \\$wnnna$aCaymans
=450  \\$wnnna$aCrocodile
=450  \\$aCrocodiles
=450  \\$wnnna$aCrocodiles and Alligators
=550  \\$wg$aReptiles
=667  \\$aIM; qualif permitted; DF: ALLIGATORS
=680  \\$iLarge, long-tailed reptiles, including caimans, of the order Loricata.
=688  \\$a91(75); was see under REPTILES 1975-90
=750  \0$aAlligators$5IEN-M$0(DLC)sh 85003688
=750  \0$aCrocodiles$5IEN-HS$0(DLC)sh 85034208

=LDR  01560cz  a2200301n  4500
=001  9880363364202441
=005  20141212194417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000172
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x132.$x82
=072  \\$aC10.$x228.$x140.$x617.$x738.$x250.$x100
=072  \\$aC19.$x700.$x355.$x179
=150  \\$aAcromegaly
=450  \\$wnnna$aHypersecretion Syndrome, Somatotropin (Acromegaly)
=450  \\$wnnna$aHypersecretion Syndromes, Somatotropin (Acromegaly)
=450  \\$wnnna$aInappropriate GH Secretion Syndrome (Acromegaly)
=450  \\$aInappropriate Growth Hormone Secretion Syndrome (Acromegaly)
=450  \\$aSomatotropin Hypersecretion Syndrome (Acromegaly)
=450  \\$wnnna$aSomatotropin Hypersecretion Syndromes (Acromegaly)
=450  \\$wnnna$aSyndrome, Somatotropin Hypersecretion (Acromegaly)
=450  \\$wnnna$aSyndromes, Somatotropin Hypersecretion (Acromegaly)
=550  \\$wg$aBone Diseases, Endocrine
=550  \\$wg$aHyperpituitarism
=550  \\$aAdenoma, Acidophil
=667  \\$acoordinate with GROWTH HORMONE/secret in animals or HUMAN GROWTH HORMONE/secret in humans if pertinent
=680  \\$iA condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)
=750  \0$aAcromegaly$5IEN$0(DLC)sh 85000666

=LDR  01998cz  a2200517n  4500
=001  9880363364302441
=005  20141212194604.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000488
=035  \\$aCAZ3637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67
=072  \\$aN2.$x360.$x67
=150  \\$aAllied Health Personnel
=450  \\$aAllied Health Occupations$xmanpower
=450  \\$wnnna$aHealth Personnel, Allied
=450  \\$wnnna$aParamedic
=450  \\$aParamedical Personnel
=450  \\$aParamedics
=450  \\$wnnna$aPersonnel, Allied Health
=450  \\$wnnna$aPersonnel, Paramedical
=450  \\$wnnna$aPopulation Program Specialist
=450  \\$wnnna$aPopulation Program Specialists
=450  \\$wnnna$aProgram Specialist, Population
=450  \\$wnnna$aProgram Specialists, Population
=450  \\$wnnna$aSpecialist, Population Program
=450  \\$wnnna$aSpecialists, Population Program
=550  \\$wg$aHealth Personnel
=550  \\$wh$aAnimal Technicians
=550  \\$wh$aCommunity Health Workers
=550  \\$wh$aDental Auxiliaries
=550  \\$wh$aEmergency Medical Technicians
=550  \\$wh$aHome Health Aides
=550  \\$wh$aLicensed Practical Nurses
=550  \\$wh$aMedical Record Administrators
=550  \\$wh$aMedical Secretaries
=550  \\$wh$aNurses' Aides
=550  \\$wh$aNutritionists
=550  \\$wh$aOperating Room Technicians
=550  \\$wh$aPharmacists' Aides
=550  \\$wh$aPhysical Therapist Assistants
=550  \\$wh$aPhysical Therapists
=550  \\$wh$aPhysician Assistants
=680  \\$iHealth care workers specially trained and licensed to assist and support the work of health professionals. Often used synonymously with paramedical personnel, the term generally refers to all health care workers who perform tasks which must otherwise be performed by a physician or other health professional.
=688  \\$a71
=750  \0$aAllied health personnel$5IEN$0(DLC)sh 85003678

=LDR  00816cz  a2200289n  4500
=001  9880363364402441
=005  20141212194417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000171
=035  \\$aCAZ3318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x122
=150  \\$aAcrolein
=450  \\$wnnna$a2-Propenal
=450  \\$wnnna$a2 Propenal
=450  \\$wnnna$aAcraldehyde
=450  \\$wnnna$aAcrylaldehyde
=450  \\$wnnna$aAcrylic Aldehyde
=450  \\$wnnna$aAldehyde, Acrylic
=450  \\$wnnna$aAldehyde, Allyl
=450  \\$wnnna$aAldehyde, Ethylene
=450  \\$wnnna$aAllyl Aldehyde
=450  \\$wnnna$aAqualin
=450  \\$wnnna$aEthylene Aldehyde
=550  \\$wg$aAldehydes
=688  \\$a91(73); was see under ALDEHYDES 1973-90
=750  \0$aAcrolein$5IEN-M$0(DLC)sh 00009449

=LDR  01418cz  a2200313n  4500
=001  9880363364602441
=005  20180212091233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000486
=035  \\$aCAZ3635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x44
=150  \\$aAllergy and Immunology
=450  \\$aAllergists$5IEN
=450  \\$wnnna$aAllergy, Immunology
=450  \\$wnnna$aAllergy Specialty
=450  \\$aImmunologists$5IEN
=450  \\$aImmunology
=450  \\$wnnna$aImmunology, Allergy
=450  \\$wnnna$aImmunology and Allergy
=450  \\$wnnna$aSpecialty, Allergy
=550  \\$wg$aMedicine
=550  \\$wh$aImmunochemistry
=667  \\$athe discipline (education, history, etc) only; use IMMUNE SYSTEM PHENOMENA or specifics treed under it for immunologic processes and properties; use HYPERSENSITIVITY or specifics treed under it for allergic conditions; the qualifier / immunol is available for use with specific anatomical terms, organisms, diseases, etc
=680  \\$iA medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.
=688  \\$a80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66
=750  \0$aImmunology$5IEN-M$0(DLC)sh 85064579
=750  \0$aAllergy$5IEN-HS$0(DLC)sh 85003662
=750  \0$aImmunologists$5IEN-HS$0(DLC)sh 85064578

=LDR  01555cz  a2200361n  4500
=001  9880363364702441
=005  20141212194417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000170
=035  \\$aCAZ3317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x25
=072  \\$aC10.$x720.$x475.$x600.$x150
=072  \\$aC25.$x723.$x647.$x500.$x100
=150  \\$aAcrodynia
=450  \\$wnnna$aAcrodynic Erythema
=450  \\$wnnna$aChildhood Mercurialism, Chronic
=450  \\$wnnna$aChildhood Mercurialisms, Chronic
=450  \\$wnnna$aChronic Childhood Mercurialism
=450  \\$wnnna$aChronic Childhood Mercurialisms
=450  \\$wnnna$aErythema, Acrodynic
=450  \\$aFeer Disease
=450  \\$wnnna$aFeer's Disease
=450  \\$wnnna$aFeers Disease
=450  \\$wnnna$aMercurialism, Chronic Childhood
=450  \\$aPink Disease
=450  \\$aSwift Disease
=450  \\$wnnna$aSwift's Disease
=450  \\$wnnna$aSwifts Disease
=550  \\$wg$aMercury Poisoning, Nervous System
=550  \\$wg$aPeripheral Nervous System Diseases
=680  \\$iA condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. (From Menkes, Textbook of Child Neurology, 5th ed, p603)
=750  \0$aAcrodynia$5IEN$0(DLC)sh 85000661

=LDR  00614cz  a2200193n  4500
=001  9880363364802441
=005  20141212194603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000485
=035  \\$aCAZ3634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x63
=150  \\$aAllergens
=550  \\$wg$aAntigens
=550  \\$aPollen
=667  \\$acoord IM with specific allergen (IM), e.g., pollen as an allergen = ALLERGENS + POLLEN
=680  \\$iAntigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
=688  \\$a65
=750  \0$aAllergens$5IEN$0(DLC)sh 85003659

=LDR  00978cz  a2200313n  4500
=001  9880363364902441
=005  20141212194602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000481
=035  \\$aCAZ3630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x948.$x58
=072  \\$aD3.$x383.$x129.$x308.$x432.$x555.$x105
=150  \\$aAllantoin
=450  \\$wnnna$aAllantoin Campbell Brand
=450  \\$wnnna$aAllantoin Sween Brand
=450  \\$wnnna$aCampbell Brand of Allantoin
=450  \\$wnnna$aHerpecin-L
=450  \\$wnnna$aHerpecin L
=450  \\$wnnna$aHerpecinL
=450  \\$wnnna$aReed & Carnrick Brand of Allantoin
=450  \\$wnnna$aSebical
=450  \\$wnnna$aSween Brand of Allantoin
=450  \\$wnnna$aWoun'dres
=550  \\$wg$aHydantoins
=550  \\$wg$aUrea
=680  \\$iA urea hydantoin that is found in URINE and PLANTS and is used in dermatological preparations.
=688  \\$a72(64)
=750  \0$aAllantoin$5IEN$0(DLC)sh 85003625

=LDR  00803cz  a2200253n  4500
=001  9880363365002441
=005  20201021122023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000480
=035  \\$aCAZ3629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x397
=150  \\$aAlkynes
=450  \\$wnnna$aAcetylenes
=450  \\$aAcetylenic Compounds
=550  \\$wg$aHydrocarbons, Acyclic
=550  \\$wh$a(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
=550  \\$wh$aAcetylene
=550  \\$wh$aCarbocyanines
=550  \\$wh$aPolyynes
=550  \\$wh$aPolyunsaturated Alkamides
=680  \\$iHydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2.
=688  \\$a66
=750  \0$aAlkynes$5IEN-M$0(DLC)sh 97007297

=LDR  02315cz  a2200517n  4500
=001  9880363365102441
=005  20141212194416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000169
=035  \\$aCAZ3316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x831.$x66
=072  \\$aC17.$x800.$x174.$x100
=072  \\$aC17.$x800.$x804.$x66
=150  \\$aAcrodermatitis
=450  \\$wnnna$aAcrodermatitides
=450  \\$wnnna$aAcrodermatitis Papulosa Infantum
=450  \\$wnnna$aAcrodermatitis Papulosa Infantums
=450  \\$wnnna$aAcropapulo-Vesicular Syndrome
=450  \\$wnnna$aAcropapulo Vesicular Syndrome
=450  \\$wnnna$aAcropapulo-Vesicular Syndromes
=450  \\$wnnna$aChildhood Papular Acrodermatitides
=450  \\$wnnna$aChildhood Papular Acrodermatitis
=450  \\$wnnna$aErythemato-Vesiculo-Papulous Eruptive Syndrome
=450  \\$wnnna$aErythemato Vesiculo Papulous Eruptive Syndrome
=450  \\$wnnna$aErythemato-Vesiculo-Papulous Eruptive Syndromes
=450  \\$aGianotti-Crosti Syndrome
=450  \\$wnnna$aGianotti Crosti Syndrome
=450  \\$wnnna$aInfantile Papular Acrodermatitides
=450  \\$aInfantile Papular Acrodermatitis
=450  \\$wnnna$aPapular Acrodermatitides, Infantile
=450  \\$wnnna$aPapular Acrodermatitis, Infantile
=450  \\$wnnna$aPapular Acrodermatitis of Childhood
=450  \\$wnnna$aPapulovesicular Acrolocated Syndrome
=450  \\$wnnna$aPapulovesicular Acrolocated Syndromes
=450  \\$wnnna$aSyndrome, Acropapulo-Vesicular
=450  \\$wnnna$aSyndrome, Erythemato-Vesiculo-Papulous Eruptive
=450  \\$wnnna$aSyndrome, Gianotti-Crosti
=450  \\$wnnna$aSyndromes, Acropapulo-Vesicular
=450  \\$wnnna$aSyndromes, Erythemato-Vesiculo-Papulous Eruptive
=450  \\$wnnna$aSyndromes, Papulovesicular Acrolocated
=550  \\$wg$aDermatitis
=550  \\$wg$aSkin Abnormalities
=667  \\$adermatitis of hands or feet so do not bother to coord with HAND DERMATOSES or FOOT DERMATOSES unless particularly discussed
=680  \\$iInflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. The infantile form is called Gianotti-Crosti syndrome.
=750  \0$aAcrodermatitis$5IEN$0(DLC)sh 85000660

=LDR  00917cz  a2200253n  4500
=001  9880363365202441
=005  20170608114203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000478
=035  \\$aCAZ3627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x35
=072  \\$aG2.$x607.$x94
=072  \\$aG3.$x59
=150  \\$aAlkylation
=450  \\$wnnna$aAlkylations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$wh$aMethylation
=667  \\$aalmost never IM; enzymatic alkylation: coord NIM with TRANSFERASES (IM) + substrate (NIM); METHYLATION & METHYLTRANSFERASES are also available
=680  \\$iThe covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group.
=688  \\$a66
=750  \0$aAlkylation$5IEN$0(DLC)sh 85003606

=LDR  00523cz  a2200181n  4500
=001  9880363365302441
=005  20141212194414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000166
=035  \\$aCAZ3313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x46
=150  \\$aAcridines
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wh$aAcridones
=550  \\$wh$aAminoacridines
=667  \\$aD25-26 qualif; acridinamines & acridinylamines = AMINOACRIDINES
=750  \0$aAcridine$0(DLC) sh 85000650$5IEN

=LDR  01005cz  a2200241n  4500
=001  9880363365402441
=005  20141212194600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000477
=035  \\$aCAZ3626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x124
=072  \\$aD27.$x888.$x569.$x35
=150  \\$aAlkylating Agents
=450  \\$wnnna$aAgents, Alkylating
=450  \\$wnnna$aAlkylators
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wg$aNoxae
=550  \\$wh$aAntineoplastic Agents, Alkylating
=550  \\$aMutagens
=680  \\$iHighly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.
=688  \\$a66(64)
=750  \0$aAlkylating agents$5IEN$0(DLC)sh 88002246

=LDR  00726cz  a2200217n  4500
=001  9880363365502441
=005  20141212194413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000164
=035  \\$aCAZ3311HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x25
=150  \\$aAcremonium
=450  \\$wnnna$aAcremoniums
=450  \\$aCephalosporium
=450  \\$wnnna$aCephalosporiums
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)
=680  \\$iA mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.
=688  \\$a86(63)
=750  \0$aAcremonium$5IEN$0(DLC)sh 88022015

=LDR  00786cz  a2200265n  4500
=001  9880363365602441
=005  20141212194600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000475
=035  \\$aCAZ3624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271
=150  \\$aAlkenes
=450  \\$aOlefins
=450  \\$aPentenes
=550  \\$wg$aHydrocarbons, Acyclic
=550  \\$wh$aAllyl Compounds
=550  \\$wh$aEnediynes
=550  \\$wh$aEthylenes
=550  \\$wh$aPolyenes
=550  \\$wh$aPolyunsaturated Alkamides
=550  \\$wh$aVinyl Compounds
=680  \\$iUnsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408)
=688  \\$a66
=750  \0$aAlkenes$5IEN$0(DLC)sh 85094589

=LDR  01251cz  a2200385n  4500
=001  9880363365702441
=005  20141212194347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x199.$x92.$x40
=150  \\$aAcetaminophen
=450  \\$wnnna$aAcamol
=450  \\$wnnna$aAcephen
=450  \\$wnnna$aAcetaco
=450  \\$aAcetamidophenol
=450  \\$wnnna$aAcetominophen
=450  \\$wnnna$aAlgotropyl
=450  \\$wnnna$aAnacin-3
=450  \\$wnnna$aAnacin 3
=450  \\$wnnna$aAnacin3
=450  \\$wnnna$aAPAP
=450  \\$wnnna$aDatril
=450  \\$aHydroxyacetanilide
=450  \\$wnnna$aN-(4-Hydroxyphenyl)acetanilide
=450  \\$wnnna$aN-Acetyl-p-aminophenol
=450  \\$wnnna$ap-Acetamidophenol
=450  \\$wnnna$ap-Hydroxyacetanilide
=450  \\$wnnna$aPanadol
=450  \\$aParacetamol
=450  \\$wnnna$aTylenol
=550  \\$wg$aAcetanilides
=680  \\$iAnalgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
=688  \\$a1965; for ACEPHEN use MECLOFENOXATE 1990-2002
=750  \0$aAcetaminophen$5IEN$0(DLC)sh 85000454

=LDR  00957cz  a2200325n  4500
=001  9880363365802441
=005  20141212194559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000473
=035  \\$aCAZ3622HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146
=150  \\$aAlkanes
=550  \\$wg$aHydrocarbons, Acyclic
=550  \\$wh$aAcetogenins
=550  \\$wh$aAlkanesulfonic Acids
=550  \\$wh$aButanes
=550  \\$wh$aEthane
=550  \\$wh$aFumonisins
=550  \\$wh$aHeptanes
=550  \\$wh$aHexanes
=550  \\$wh$aMethane
=550  \\$wh$aNitroparaffins
=550  \\$wh$aOctanes
=550  \\$wh$aPentanes
=550  \\$wh$aPropane
=667  \\$acycloalkanes = CYCLOPARAFFINS
=680  \\$iThe generic name for the group of aliphatic hydrocarbons Cn-H2n+2. They are denoted by the suffix -ane. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a66
=750  \0$aAlkanes$5IEN$0(DLC)sh 85097763

=LDR  00837cz  a2200289n  4500
=001  9880363365902441
=005  20170705105448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000081
=035  \\$aCAZ3227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x64
=072  \\$aD2.$x241.$x81.$x18.$x110
=150  \\$aAcetamides
=550  \\$wg$aAcetates
=550  \\$wg$aAmides
=550  \\$wh$a2-Acetylaminofluorene
=550  \\$wh$aAllylisopropylacetamide
=550  \\$wh$aBenzeneacetamides
=550  \\$wh$aIodoacetamide
=550  \\$wh$aLinezolid
=550  \\$wh$aOseltamivir
=550  \\$wh$aPiracetam
=550  \\$wh$aThioacetamide
=680  \\$iDerivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
=688  \\$a73(71)
=750  \0$aAcetamide$5IEN$0(DLC)sh 85000453

=LDR  00975cz  a2200205n  4500
=001  9880363366002441
=005  20141212194412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000162
=035  \\$aCAZ3310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x31
=150  \\$aAcoustics
=450  \\$wnnna$aAcoustic
=550  \\$wg$aPhysics
=550  \\$wh$aUltrasonics
=667  \\$ain speech & hearing research & for the environment (home, hospital, facilities, theater, etc.)
=680  \\$iThe branch of physics that deals with sound and sound waves. In medicine it is often applied in procedures in speech and hearing studies. With regard to the environment, it refers to the characteristics of a room, auditorium, theatre, building, etc. that determines the audibility or fidelity of sounds in it. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aBioacoustics$5IEN-M$0(DLC)sh 85014119
=750  \0$aAcoustical engineering$5IEN-HS$0(DLC)sh 85000596

=LDR  00985cz  a2200253n  4500
=001  9880363366102441
=005  20141212191913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000077
=035  \\$aCAZ3223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x825.$x108
=150  \\$aAcetabulum
=450  \\$wnnna$aAcetabula
=450  \\$wnnna$aAcetabulas
=450  \\$wnnna$aAcetabulums
=450  \\$wnnna$aCavities, Cotyloid
=450  \\$wnnna$aCavity, Cotyloid
=450  \\$wnnna$aCotyloid Cavities
=450  \\$wnnna$aCotyloid Cavity
=550  \\$wg$aPelvic Bones
=667  \\$apoint of union of the 3 pelvic bones; do not confuse with HIP or HIP JOINT; fractures = ACETABULUM /inj (IM) + FRACTURES, BONE (IM);  /surg: consider also ACETABULOPLASTY
=680  \\$iThe part of the pelvis that comprises the pelvic socket where the head of FEMUR joins to form HIP JOINT (acetabulofemoral joint).
=750  \0$aAcetabulum (Anatomy)$0(DLC) sh 85000450$5IEN-M

=LDR  00851cz  a2200193n  4500
=001  9880363366202441
=005  20141212194346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000076
=035  \\$aCAZ3222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x133
=150  \\$aAcetabularia
=450  \\$wnnna$aAcetabularias
=550  \\$wg$aChlorophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of green algae found in the Mediterranean and other warm seas.
=688  \\$a91(72); was see under ALGAE, GREEN 1972-90
=750  \0$aAcetabularia$5IEN$0(DLC)sh 88022300

=LDR  00728cz  a2200217n  4500
=001  9880363366302441
=005  20141212191910.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000069
=035  \\$aCAZ3215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x50
=072  \\$aI1.$x880.$x853.$x100.$x79
=150  \\$aAcculturation
=450  \\$wnnna$aAssimilation, Cultural
=450  \\$wnnna$aCultural Assimilation
=550  \\$wg$aCulture
=680  \\$iProcess of cultural change in which one group or members of a group assimilate various cultural patterns from another.
=688  \\$a1963
=688  \\$aASSIMILATION was see under ACCULTURATION 1968-82
=750  \0$aAcculturation$5IEN$0(DLC)sh 85000442

=LDR  00877cz  a2200241n  4500
=001  9880363366402441
=005  20141212194345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000068
=035  \\$aCAZ3214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x110.$x70
=072  \\$aN5.$x700.$x200.$x100
=150  \\$aAccreditation
=450  \\$wnnna$aAccreditations
=550  \\$wg$aCredentialing
=550  \\$wh$aJoint Commission on Accreditation of Healthcare Organizations
=550  \\$aCertification
=550  \\$aLicensure
=667  \\$aby the profession; do not confuse with LICENSURE (by the state)
=680  \\$iCertification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.
=688  \\$a66(64)
=750  \0$aAccreditation (Education)$5IEN$0(DLC)sh 85000437

=LDR  00809cz  a2200253n  4500
=001  9880363366502441
=005  20161208102026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000066
=035  \\$aCAZ3212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x463.$x30
=150  \\$aAccounting
=450  \\$wnnna$aAccountings
=550  \\$wg$aFinancial Management
=550  \\$wh$aAccounts Payable and Receivable
=550  \\$wh$aBanking, Personal
=550  \\$wh$aDepreciation
=550  \\$wh$aFinancial Audit
=550  \\$wh$aPatient Credit and Collection
=667  \\$aIM; coord with SPEC (IM) or specific financial endeavor (IM)
=680  \\$iSystem of recording financial transactions.
=750  \0$aAccounting$5IEN-M$0(DLC)sh 85000411
=750  \0$aAccountants$5IEN-HS$0(DLC)sh 85000405

=LDR  01268cz  a2200253n  4500
=001  9880363366602441
=005  20141212194344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000065
=035  \\$aCAZ3211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x640.$x79
=150  \\$aAccommodation, Ocular
=450  \\$wnnna$aAccommodation, Lens
=450  \\$wnnna$aAccommodation, Ocular Distance
=450  \\$wnnna$aDistance Accommodation, Ocular
=450  \\$wnnna$aLens Accommodation
=450  \\$wnnna$aOcular Accommodation
=450  \\$wnnna$aOcular Distance Accommodation
=450  \\$wnnna$aOcular Distance Accommodations
=550  \\$wg$aOcular Physiological Processes
=667  \\$ado not confuse with ADAPTATION, OCULAR, adjustment of eye to light
=680  \\$iThe dioptric adjustment of the EYE (to attain maximal sharpness of retinal imagery for an object of regard) referring to the ability, to the mechanism, or to the process. Ocular accommodation is the effecting of refractive changes by changes in the shape of the CRYSTALLINE LENS. Loosely, it refers to ocular adjustments for VISION, OCULAR at various distances. (Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aEye$xAccommodation and refraction$5IEN$0(DLC)sh 85046644

=LDR  00725cz  a2200229n  4500
=001  9880363366702441
=005  20190128114656.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000064
=035  \\$aCAZ3210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x25.$x133
=072  \\$aG16.$x12.$x500.$x133
=150  \\$aAcclimatization
=450  \\$aAcclimation
=550  \\$wg$aAdaptation, Physiological
=550  \\$wh$aSalt Tolerance
=550  \\$wh$aThermotolerance
=550  \\$aClimate
=667  \\$aincludes to climate, altitude, weather but not to gravity ( = ADAPTATION, PHYSIOLOGICAL)
=680  \\$iAdaptation to a new environment or to a change in the old.
=750  \0$aAcclimatization$5IEN$0(DLC)sh 85000377

=LDR  02217cz  a2200517n  4500
=001  9880363366802441
=005  20141212194412.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000160
=035  \\$aCAZ3308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x807.$x800
=072  \\$aC10.$x292.$x910
=150  \\$aVestibulocochlear Nerve Diseases
=450  \\$wnnna$aAcoustic Nerve Disease
=450  \\$aAcoustic Nerve Diseases
=450  \\$wnnna$aAcoustic Nerve Disorder
=450  \\$wnnna$aAcoustic Nerve Disorders
=450  \\$wnnna$aCochlear Nerve Disease
=450  \\$aCochlear Nerve Diseases
=450  \\$wnnna$aCochlear Nerve Disorder
=450  \\$wnnna$aCochlear Nerve Disorders
=450  \\$wnnna$aCochlear Neuritides
=450  \\$wnnna$aCochlear Neuritis
=450  \\$aCranial Nerve VIII Diseases
=450  \\$wnnna$aCranial Nerve VIII Disorders
=450  \\$wnnna$aEighth Cranial Nerve Diseases
=450  \\$wnnna$aNeuritides, Cochlear
=450  \\$wnnna$aNeuritis, Cochlear
=450  \\$wnnna$aVestibular Nerve Disease
=450  \\$aVestibular Nerve Diseases
=450  \\$wnnna$aVestibular Nerve Disorder
=450  \\$wnnna$aVestibular Nerve Disorders
=450  \\$wnnna$aVestibulocochlear Nerve Disease
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aRetrocochlear Diseases
=550  \\$wh$aCogan Syndrome
=550  \\$wh$aNeuroma, Acoustic
=550  \\$wh$aVestibular Neuronitis
=550  \\$wh$aVestibulocochlear Nerve Injuries
=550  \\$aCranial Nerve Injuries
=550  \\$aHearing Loss, Central
=667  \\$acoordinate IM with COCHLEAR NERVE (IM) for cochlear nerve disease or with VESTIBULAR NERVE (IM) for vestibular nerve disease: neoplasms: coordinate IM with CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM); DF: ACOUSTIC NERVE DIS
=680  \\$iPathological processes of the VESTIBULOCOCHLEAR NERVE, including the branches of COCHLEAR NERVE and VESTIBULAR NERVE. Common examples are VESTIBULAR NEURITIS, cochlear neuritis, and ACOUSTIC NEUROMA. Clinical signs are varying degree of HEARING LOSS; VERTIGO; and TINNITUS.
=688  \\$a2000(1979)
=750  \0$aAcoustic nerve$xDiseases$0(IEN)372283$5IEN-M

=LDR  01170cz  a2200229n  4500
=001  9880363366902441
=005  20141212194344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000063
=035  \\$aCAZ3209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x392
=150  \\$aAccidents, Traffic
=450  \\$wnnna$aAccident, Traffic
=450  \\$wnnna$aTraffic Accident
=450  \\$wnnna$aTraffic Accidents
=550  \\$wg$aAccidents
=550  \\$aAutomobile Driving
=550  \\$aMotor Vehicles
=667  \\$aimplies automobile accid so do not coord with AUTOMOBILES unless the auto is especially discussed; coord IM with BICYCLING (IM) or MOTORCYCLES (IM) if pertinent; not for railroad accidents ( = RAILROADS + ACCIDENTS) or all-terrain vehicles, motorbikes or snowmobiles ( = OFF-ROAD MOTOR VEHICLES + ACCIDENTS)
=680  \\$iAccidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES (passenger cars, buses, and trucks), BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.
=750  \0$aTraffic accidents$5IEN$0(DLC)sh 85136758

=LDR  01042cz  a2200289n  4500
=001  9880363367002441
=005  20141212194343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000062
=035  \\$aCAZ3208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x240
=150  \\$aAccidents, Occupational
=450  \\$wnnna$aAccident, Industrial
=450  \\$wnnna$aAccident, Occupational
=450  \\$aAccidents, Industrial
=450  \\$wnnna$aIndustrial Accident
=450  \\$wnnna$aIndustrial Accidents
=450  \\$wnnna$aOccupational Accident
=450  \\$wnnna$aOccupational Accidents
=550  \\$wg$aAccidents
=550  \\$aOccupational Diseases
=550  \\$aOccupational Injuries
=667  \\$acoordinate IM with specific occupation (IM)
=680  \\$iUnforeseen occurrences, especially injuries in the course of work-related activities.
=688  \\$a79; was in Cat G & J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G & J 1967-78 & Cat G & I 1963-66
=750  \0$aIndustrial accidents$5IEN$0(DLC)sh 85065821

=LDR  00553cz  a2200205n  4500
=001  9880363367102441
=005  20141212194343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000061
=035  \\$aCAZ3207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x217
=150  \\$aAccidents, Home
=450  \\$wnnna$aAccident, Home
=450  \\$wnnna$aHome Accident
=450  \\$aHome Accidents
=550  \\$wg$aAccidents
=667  \\$aIM; coord with specific inj (IM)
=688  \\$a70(69)
=750  \0$aHome accidents$5IEN$0(DLC)sh 85061658

=LDR  02080cz  a2200457n  4500
=001  9880363367202441
=005  20141212191920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000159
=035  \\$aCAZ3307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x910
=150  \\$aVestibulocochlear Nerve
=450  \\$wnnna$aCochleovestibular Nerve
=450  \\$wnnna$aCochleovestibular Nerves
=450  \\$wnnna$aCranial Nerve, Eighth
=450  \\$aCranial Nerve VIII
=450  \\$wnnna$aCranial Nerve VIIIs
=450  \\$wnnna$aCranial Nerves, Eighth
=450  \\$aEighth Cranial Nerve
=450  \\$wnnna$aEighth Cranial Nerves
=450  \\$wnnna$aNerve, Cochleovestibular
=450  \\$wnnna$aNerve, Eighth Cranial
=450  \\$wnnna$aNerve, Statoacoustic
=450  \\$wnnna$aNerve, Vestibulocochlear
=450  \\$wnnna$aNerve VIIIs, Cranial
=450  \\$wnnna$aNerves, Cochleovestibular
=450  \\$wnnna$aNerves, Eighth Cranial
=450  \\$wnnna$aNerves, Statoacoustic
=450  \\$wnnna$aNerves, Vestibulocochlear
=450  \\$wnnna$aStatoacoustic Nerve
=450  \\$wnnna$aStatoacoustic Nerves
=450  \\$wnnna$aVestibulocochlear Nerves
=450  \\$wnnna$aVIIIs, Cranial Nerve
=550  \\$wg$aCranial Nerves
=550  \\$wh$aCochlear Nerve
=550  \\$wh$aVestibular Nerve
=667  \\$aneoplasm = VESTIBULOCOCHLEAR NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM) but note that NEUROMA, ACOUSTIC is also available
=680  \\$iThe 8th cranial nerve. The vestibulocochlear nerve has a cochlear part (COCHLEAR NERVE) which is concerned with hearing and a vestibular part (VESTIBULAR NERVE) which mediates the sense of balance and head position. The fibers of the cochlear nerve originate from neurons of the SPIRAL GANGLION and project to the cochlear nuclei (COCHLEAR NUCLEUS). The fibers of the vestibular nerve arise from neurons of Scarpa's ganglion and project to the VESTIBULAR NUCLEI.
=688  \\$a2000(1963)
=750  \0$aAcoustic nerve$0(DLC) sh 85000584$5IEN

=LDR  00593cz  a2200205n  4500
=001  9880363367302441
=005  20141212194343.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000060
=035  \\$aCAZ3206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x185
=150  \\$aAccidents, Aviation
=450  \\$wnnna$aAccident, Aviation
=450  \\$wnnna$aAviation Accident
=450  \\$wnnna$aAviation Accidents
=550  \\$wg$aAccidents
=550  \\$aAerospace Medicine
=667  \\$aIM; coord with specific inj (IM)
=750  \0$aAircraft accidents$0(DLC)sh 85001323$5IEN-M

=LDR  00832cz  a2200289n  4500
=001  9880363367402441
=005  20141212194342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000059
=035  \\$aCAZ3205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135
=150  \\$aAccidents
=450  \\$wnnna$aAccident
=550  \\$wg$aPublic Health
=550  \\$wh$aAccident Prevention
=550  \\$wh$aAccidental Falls
=550  \\$wh$aAccidents, Aviation
=550  \\$wh$aAccidents, Home
=550  \\$wh$aAccidents, Occupational
=550  \\$wh$aAccidents, Traffic
=550  \\$wh$aBiohazard Release
=550  \\$wh$aChemical Hazard Release
=550  \\$wh$aDrowning
=550  \\$wh$aRadioactive Hazard Release
=667  \\$aGEN or unspecified; prefer specifics
=750  \0$aAccidents$5IEN$0(DLC)sh 85000368

=LDR  01640cz  a2200373n  4500
=001  9880363367502441
=005  20141212194411.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000158
=035  \\$aCAZ3306HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x50
=150  \\$aAcoustic Impedance Tests
=450  \\$wnnna$aAcoustic Impedance Test
=450  \\$aAudiometry, Impedance
=450  \\$wnnna$aElectroacoustic Impedance Test
=450  \\$aElectroacoustic Impedance Tests
=450  \\$wnnna$aImpedance Audiometry
=450  \\$wnnna$aImpedance Test, Acoustic
=450  \\$wnnna$aImpedance Test, Electroacoustic
=450  \\$aImpedance Tests, Acoustic
=450  \\$wnnna$aImpedance Tests, Electroacoustic
=450  \\$wnnna$aTest, Acoustic Impedance
=450  \\$wnnna$aTest, Electroacoustic Impedance
=450  \\$wnnna$aTests, Acoustic Impedance
=450  \\$wnnna$aTests, Electroacoustic Impedance
=450  \\$aTympanometry
=550  \\$wg$aHearing Tests
=550  \\$aAudiometry
=550  \\$aEar, Middle
=667  \\$ado not use /util except by MeSH definition
=680  \\$iObjective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. These include static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). This term is used also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance).
=688  \\$a78
=750  \0$aAudiometry, Impedance$5IEN$0(DLC)sh 85009474

=LDR  00686cz  a2200217n  4500
=001  9880363367602441
=005  20141212194342.0
=008  860624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000058
=035  \\$aCAZ3204M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x122
=150  \\$aAccidental Falls
=450  \\$wnnna$aAccidental Fall
=450  \\$wnnna$aFall, Accidental
=450  \\$aFalls, Accidental
=550  \\$wg$aAccidents
=667  \\$acoord IM with specific inj (IM) if pertinent
=680  \\$iFalls due to slipping or tripping which result in injury.
=688  \\$a91(87); was see under ACCIDENTS 1987-90
=750  \0$aFalls (Accidents)$0(DLC) sh 85046985$5IEN-M

=LDR  00926cz  a2200241n  4500
=001  9880363367702441
=005  20141212194409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000152
=035  \\$aCAZ3300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x30.$x150
=072  \\$aC17.$x800.$x271.$x125.$x200
=072  \\$aC17.$x800.$x794.$x111
=150  \\$aAcne Vulgaris
=450  \\$aAcne
=550  \\$wg$aAcneiform Eruptions
=550  \\$wg$aSebaceous Gland Diseases
=550  \\$aHidradenitis Suppurativa
=667  \\$aan acneiform eruption
=680  \\$iA chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.
=688  \\$a93; was ACNE 1963-92
=750  \0$aAcne$5IEN$0(DLC)sh 85000560

=LDR  00697cz  a2200217n  4500
=001  9880363367802441
=005  20141212194342.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000057
=035  \\$aCAZ3203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x15
=150  \\$aAccident Proneness
=450  \\$wnnna$aAccident Pronenesses
=450  \\$wnnna$aProneness, Accident
=450  \\$wnnna$aPronenesses, Accident
=550  \\$wg$aBehavior
=667  \\$ano qualif
=680  \\$iTendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents.
=688  \\$a75
=750  \0$aAccidents$xPsychological aspects$5IEN$0(DLC)sh 85000372

=LDR  00724cz  a2200217n  4500
=001  9880363367902441
=005  20141212194342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000056
=035  \\$aCAZ3202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x135.$x60
=150  \\$aAccident Prevention
=450  \\$wnnna$aAccident Preventions
=450  \\$aAccidents$xprevention & control
=450  \\$wnnna$aPrevention, Accident
=450  \\$wnnna$aPreventions, Accident
=550  \\$wg$aAccidents
=550  \\$wh$aSafety
=680  \\$iEfforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.
=750  \0$aAccidents$xPrevention$5IEN$0(DLC)sh 85000371

=LDR  00864cz  a2200265n  4500
=001  9880363368002441
=005  20141212194409.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000151
=035  \\$aCAZ3298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x560.$x22
=150  \\$aAcinetobacter Infections
=450  \\$wnnna$aAcinetobacter Infection
=450  \\$wnnna$aInfection, Acinetobacter
=450  \\$wnnna$aInfection, Mimae
=450  \\$wnnna$aInfections, Acinetobacter
=450  \\$wnnna$aInfections, Mimae
=450  \\$wnnna$aMimae Infection
=450  \\$aMimae Infections
=550  \\$wg$aMoraxellaceae Infections
=667  \\$agram-neg bact infect
=680  \\$iInfections with bacteria of the genus ACINETOBACTER.
=688  \\$a77; was MIMAE INFECTIONS 1968-76
=750  \0$aAcinetobacter infections$5IEN-M$0(DLC)sh 95004928

=LDR  00973cz  a2200241n  4500
=001  9880363368102441
=005  20141212194408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000150
=035  \\$aCAZ3297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x537.$x50
=072  \\$aB3.$x660.$x250.$x530.$x50
=150  \\$aAcinetobacter
=450  \\$aHerellea
=450  \\$aMima
=550  \\$wg$aMoraxellaceae
=550  \\$wh$aAcinetobacter baumannii
=550  \\$wh$aAcinetobacter calcoaceticus
=667  \\$ainfection = ACINETOBACTER INFECTIONS
=680  \\$iA genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.
=688  \\$a76(75); was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91
=750  \0$aAcinetobacter$5IEN$0(DLC)sh 91001451

=LDR  00879cz  a2200193n  4500
=001  9880363368202441
=005  20141212194406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000143
=035  \\$aCAZ3290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29
=150  \\$aAcids
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aAcids, Noncarboxylic
=550  \\$wh$aLewis Acids
=667  \\$aGEN; avoid; do not use for specific acids, acid-fast bacteria, acid reactions, etc.
=680  \\$iChemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAcids$5IEN$0(DLC)sh 85000532

=LDR  00978cz  a2200229n  4500
=001  9880364104802441
=005  20141212212213.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017661
=035  \\$aCRE6636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x670
=150  \\$aReceptors, Presynaptic
=450  \\$wnnna$aPresynaptic Receptor
=450  \\$aPresynaptic Receptors
=450  \\$wnnna$aReceptor, Presynaptic
=550  \\$wg$aReceptors, Neurotransmitter
=550  \\$wh$aAutoreceptors
=667  \\$acell surface receptors: do not confuse with NEURORECEPTORS see SENSORY rRECEPTOR CELLS or with RECEPTORS, NEUROTRANSMITTER; DF: RECEPT PRESYNAPTIC
=680  \\$iNeurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed AUTORECEPTORS.
=688  \\$a94
=750  \0$aPresynaptic receptors$5IEN-M$0(DLC)sh 90003438

=LDR  01421cz  a2200373n  4500
=001  9880364104902441
=005  20141212212129.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017494
=035  \\$aCRE2656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x450.$x250.$x875
=072  \\$aD12.$x776.$x543.$x585.$x450.$x250.$x875
=150  \\$aProton Pumps
=450  \\$aH(+) Pump
=450  \\$wnnna$aH+ Pump
=450  \\$wnnna$aProton Pump
=450  \\$wnnna$aPump, H+
=450  \\$wnnna$aPump, Proton
=450  \\$wnnna$aPumps, Proton
=550  \\$wg$aCation Transport Proteins
=550  \\$wh$aBacteriorhodopsins
=550  \\$wh$aCytochrome b6f Complex
=550  \\$wh$aElectron Transport Complex I
=550  \\$wh$aElectron Transport Complex III
=550  \\$wh$aElectron Transport Complex IV
=550  \\$wh$aInorganic Pyrophosphatase
=550  \\$wh$aPhotosystem I Protein Complex
=550  \\$wh$aProton-Translocating ATPases
=550  \\$aProton-Motive Force
=667  \\$a/antag - consider also POTASSIUM HYDROGEN ATPASE /antag
=680  \\$iIntegral membrane proteins that transport protons across a membrane. This transport can be linked to the hydrolysis of ADENOSINE TRIPHOSPHATE. What is referred to as proton pump inhibitors frequently is about POTASSIUM HYDROGEN ATPASE.
=688  \\$a2002(1993)
=750  \0$aProton pump inhibitors$5IEN$0(DLC)sh 98006912

=LDR  00940cz  a2200241n  4500
=001  9880364105002441
=005  20141212212212.0
=008  930630\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017660
=035  \\$aCRE6635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x50
=072  \\$aD12.$x776.$x543.$x750.$x720.$x670.$x100
=150  \\$aAutoreceptors
=450  \\$wnnna$aAutoreceptor
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aReceptors, Presynaptic
=550  \\$wh$aReceptor, Serotonin, 5-HT1B
=550  \\$wh$aReceptor, Serotonin, 5-HT1D
=667  \\$apresynaptic receptors; DF: AUTORECEPT
=680  \\$iTransmitter receptors on or near presynaptic terminals (or varicosities) which are sensitive to the transmitter(s) released by the terminal itself. Receptors for the hormones released by hormone-releasing cells are also included.
=688  \\$a94
=750  \0$aAutoreceptors$5IEN$0(DLC)sh 90003437

=LDR  00707cz  a2200229n  4500
=001  9880364105102441
=005  20141212212212.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017655
=035  \\$aCRE6634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x837
=150  \\$aSilicon Compounds
=450  \\$wnnna$aCompounds, Silicon
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aSilanes
=550  \\$wh$aSilicon Dioxide
=550  \\$wh$aSiloxanes
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: SILICON CPDS
=680  \\$iInorganic compounds that contain silicon as an integral part of the molecule.
=688  \\$a94
=750  \0$aSilicon compounds$5IEN$0(DLC)sh 85122521

=LDR  00715cz  a2200241n  4500
=001  9880364105202441
=005  20141212212212.0
=008  921228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017646
=035  \\$aCRE6633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x715
=150  \\$aOrganosilicon Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aOrganically Modified Ceramics
=550  \\$wh$aSilanes
=550  \\$wh$aSiloxanes
=550  \\$wh$aTrimethylsilyl Compounds
=550  \\$aSilicon
=667  \\$aDF: ORGANOSILICON CPDS
=680  \\$iOrganic compounds that contain silicon as an integral part of the molecule.
=688  \\$a94
=750  \0$aOrganosilicon compounds$5IEN-M$0(DLC)sh 85095574

=LDR  01011cz  a2200229n  4500
=001  9880364105302441
=005  20141212212211.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017641
=035  \\$aCRE6632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x56.$x50.$x75.$x975
=072  \\$aD1.$x578.$x725.$x25.$x975
=072  \\$aD1.$x650.$x550.$x50.$x75.$x975
=072  \\$aD1.$x837.$x725.$x700.$x760.$x50.$x950
=150  \\$aZeolites
=450  \\$wnnna$aZeolite
=550  \\$wg$aAluminum Silicates
=667  \\$aaluminum silicates; cation exchangers, molecular sieves, water softeners & adsorbents
=680  \\$iZeolites. A group of crystalline, hydrated alkali-aluminum silicates. They occur naturally in sedimentary and volcanic rocks, altered basalts, ores, and clay deposits. Some 40 known zeolite minerals and a great number of synthetic zeolites are available commercially. (From Merck Index, 11th ed)
=688  \\$a94; was ZEOLITE (NM) 1972-93
=750  \0$aZeolites$0(DLC) sh 85149750$5IEN-M

=LDR  00885cz  a2200253n  4500
=001  9880364105402441
=005  20141212212211.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017640
=035  \\$aCRE6631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x725
=072  \\$aD1.$x837.$x725.$x700.$x760
=150  \\$aSilicates
=450  \\$wnnna$aSilicate
=550  \\$wg$aMinerals
=550  \\$wg$aSilicic Acid
=550  \\$wh$aAluminum Silicates
=550  \\$wh$aAsbestos
=550  \\$wh$aMagnesium Silicates
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe generic term for salts derived from silica or the silicic acids. They contain silicon, oxygen, and one or more metals, and may contain hydrogen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th Ed)
=688  \\$a94
=750  \0$aSilicates$5IEN-M$0(DLC)sh 85122503

=LDR  01089cz  a2200289n  4500
=001  9880364105502441
=005  20141212212211.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017639
=035  \\$aCRE6630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x524.$x500.$x40
=072  \\$aD1.$x578.$x725.$x50.$x50.$x50
=072  \\$aD1.$x578.$x725.$x500.$x40
=072  \\$aD1.$x837.$x725.$x700.$x760.$x70.$x50.$x60
=072  \\$aD1.$x837.$x725.$x700.$x760.$x535.$x40
=150  \\$aAsbestos, Amosite
=450  \\$wnnna$aAmosite
=450  \\$aAmosite Asbestos
=450  \\$wnnna$aCummingtonite-Grunerite
=450  \\$wnnna$aCummingtonite Grunerite
=550  \\$wg$aAsbestos, Amphibole
=550  \\$wg$aMagnesium Silicates
=667  \\$aan amphibole asbestos; D25-26 qualif
=680  \\$iAsbestos, grunerite. A monoclinic amphibole form of asbestos having long fibers and a high iron content. It is used in insulation. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a94; was AMOSITE (NM) 1974-93
=750  \0$aAmosite$5IEN-M$0(DLC)sh 85004586

=LDR  00858cz  a2200265n  4500
=001  9880364105602441
=005  20141212212211.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017638
=035  \\$aCRE6629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x725.$x50.$x50.$x100
=072  \\$aD1.$x837.$x725.$x700.$x760.$x70.$x50.$x90
=150  \\$aAsbestos, Crocidolite
=450  \\$wnnna$aAsbestos, Blue
=450  \\$wnnna$aAsbestos, Crocidolite (Fe2Mg3Na2(SiO3)8)
=450  \\$wnnna$aAsbestos, Crocidolite (Fe5Na2(SiO3)8)
=450  \\$wnnna$aBlue Asbestos
=450  \\$wnnna$aCrocidolite
=450  \\$aCrocidolite Asbestos
=550  \\$wg$aAsbestos, Amphibole
=667  \\$aD25-26 qualif
=680  \\$iA lavender, acid-resistant asbestos.
=688  \\$a94; was CROCIDOLITE (NM) 1975-93
=750  \0$aRiebeckite$5IEN-M$0(DLC)sh 85114030

=LDR  03538cz  a2200829n  4500
=001  9880364105702441
=005  20190507165530.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017483
=035  \\$aCRE2645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x910
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x925
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x925
=072  \\$aD12.$x776.$x543.$x750.$x750.$x660.$x900
=150  \\$aReceptors, Vasopressin
=450  \\$wnnna$a8-Arg-Vasopressin Receptor
=450  \\$wnnna$a8 Arg Vasopressin Receptor
=450  \\$wnnna$aAntidiuretic Hormone Receptor
=450  \\$wnnna$aAntidiuretic Hormone Receptor 1a
=450  \\$wnnna$aAntidiuretic Hormone Receptor 1b
=450  \\$aAntidiuretic Hormone Receptors
=450  \\$wnnna$aArginine Vasopressin Receptor
=450  \\$wnnna$aArgipressin Receptor
=450  \\$wnnna$aArgipressin Receptors
=450  \\$wnnna$aHormone Receptor, Antidiuretic
=450  \\$wnnna$aHormone Receptors, Antidiuretic
=450  \\$wnnna$aReceptor, Antidiuretic Hormone
=450  \\$wnnna$aReceptor, Arginine(8)-Vasopressin
=450  \\$wnnna$aReceptor, Arginine Vasopressin
=450  \\$wnnna$aReceptor, Argipressin
=450  \\$wnnna$aReceptor, V1
=450  \\$wnnna$aReceptor, V2
=450  \\$wnnna$aReceptor, Vasopressin
=450  \\$wnnna$aReceptor, Vasopressin V1b
=450  \\$wnnna$aReceptor, Vasopressin V3
=450  \\$wnnna$aReceptors, Antidiuretic Hormone
=450  \\$wnnna$aReceptors, Argipressin
=450  \\$aReceptors, V1
=450  \\$aReceptors, V2
=450  \\$wnnna$aRenal-Type Arginine Vasopressin Receptor
=450  \\$wnnna$aRenal Type Arginine Vasopressin Receptor
=450  \\$wnnna$aV1 Receptor
=450  \\$aV1 Receptors
=450  \\$wnnna$aV1a Vasopressin Receptor
=450  \\$wnnna$aV1b Receptor, Vasopressin
=450  \\$wnnna$aV1b Vasopressin Receptor
=450  \\$wnnna$aV2 Receptor
=450  \\$aV2 Receptors
=450  \\$wnnna$aVascular-Hepatic Type Arginine Vasopressin Receptor
=450  \\$wnnna$aVascular Hepatic Type Arginine Vasopressin Receptor
=450  \\$wnnna$aVasopressin Receptor
=450  \\$wnnna$aVasopressin Receptor 1
=450  \\$wnnna$aVasopressin Receptor, V1b
=450  \\$aVasopressin Receptors
=450  \\$wnnna$aVasopressin Type 1A Receptor
=450  \\$wnnna$aVasopressin V1a Receptor
=450  \\$wnnna$aVasopressin V1b Receptor
=450  \\$wnnna$aVasopressin V2 Receptor
=450  \\$wnnna$aVasopressin V3 Receptor
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aDiabetes Insipidus, Nephrogenic
=550  \\$aVasopressins
=667  \\$acoordinate IM with specific vasopressin (IM)
=680  \\$iSpecific molecular sites or proteins on or in cells to which VASOPRESSINS bind or interact in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor in the vascular smooth muscle and the V2 receptor in the kidneys. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors.
=688  \\$a1993 (1981)
=688  \\$a93; was VASOPRESSIN RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aVasopressin$0(DLC)sh 85142404$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aVasopressin--Receptors$5IEN-M

=LDR  01496cz  a2200337n  4500
=001  9880364105802441
=005  20190507154016.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017482
=035  \\$aCRE2644HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x200.$x800
=150  \\$aReceptors, Thromboxane
=450  \\$wnnna$aReceptor, Thromboxane
=450  \\$wnnna$aReceptor, TP
=450  \\$wnnna$aReceptors, Thromboxanes
=450  \\$wnnna$aReceptors, TP
=450  \\$wnnna$aThromboxane Receptor
=450  \\$aThromboxane Receptors
=450  \\$wnnna$aThromboxanes Receptors
=450  \\$wnnna$aTP Receptor
=450  \\$aTP Receptors
=550  \\$wg$aReceptors, Eicosanoid
=550  \\$wh$aReceptors, Thromboxane A2, Prostaglandin H2
=550  \\$aThromboxanes
=667  \\$acoord IM with specific thromboxane (IM); RECEPTORS, THROMBOXANE A2 is also available; DF: TP RECEPT
=680  \\$iCell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.
=688  \\$a93; was THROMBOXANE RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aThromboxanes$0(DLC)sh 85135081$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThromboxanes--Receptors$5IEN-M

=LDR  01890cz  a2200373n  4500
=001  9880364105902441
=005  20190507142814.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017481
=035  \\$aCRE2643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x850
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x760
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x760
=072  \\$aD12.$x776.$x543.$x750.$x750.$x580.$x720
=072  \\$aD12.$x776.$x543.$x750.$x750.$x700.$x800
=150  \\$aReceptors, Somatostatin
=450  \\$wnnna$aReceptor, Somatostatin
=450  \\$aReceptors, Somatotropin Release Inhibiting Hormone
=450  \\$wnnna$aReceptors, SRIH
=450  \\$wnnna$aSomatostatin Receptor
=450  \\$aSomatostatin Receptors
=450  \\$wnnna$aSRIH Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$wg$aReceptors, Pancreatic Hormone
=550  \\$wg$aReceptors, Pituitary Hormone
=550  \\$aSomatostatin
=667  \\$aDF: RECEPT SRIH
=680  \\$iCell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter.
=688  \\$a93; was SOMATOSTATIN RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aSomatostatin$0(DLC)sh 85124782$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aSomatostatin--Receptors$5IEN-M

=LDR  01388cz  a2200289n  4500
=001  9880364106002441
=005  20141212212122.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017480
=035  \\$aCRE2642M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x620.$x775
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x610.$x775
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x610.$x775
=150  \\$aReceptors, sigma
=450  \\$aOpioid Receptors, sigma
=450  \\$wnnna$aReceptor, sigma
=450  \\$aReceptors, Opioid, sigma
=450  \\$aReceptors, sigma Opioid
=450  \\$wnnna$asigma Opioid Receptors
=450  \\$wnnna$asigma Receptor
=450  \\$asigma Receptors
=550  \\$wg$aReceptors, Opioid
=667  \\$aopioid receptors; DF: RECEPT SIGMA
=680  \\$iA class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.
=688  \\$a93; was SIGMA RECEPTOR (NM) 1981-92
=750  \0$aSigma receptors$0(DLC)sh2007000716$5IEN-M

=LDR  02101cz  a2200373n  4500
=001  9880364106102441
=005  20190506113812.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017479
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x400.$x900
=072  \\$aD12.$x776.$x543.$x750.$x630.$x625
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x630
=150  \\$aReceptors, Platelet-Derived Growth Factor
=450  \\$wnnna$aPDGF Receptor
=450  \\$aPDGF Receptors
=450  \\$wnnna$aPlatelet-Derived Growth Factor Receptor
=450  \\$wnnna$aPlatelet Derived Growth Factor Receptor
=450  \\$aPlatelet-Derived Growth Factor Receptors
=450  \\$wnnna$aPlatelet Derived Growth Factor Receptors
=450  \\$wnnna$aReceptor, PDGF
=450  \\$aReceptors, PDGF
=450  \\$wnnna$aReceptors, Platelet Derived Growth Factor
=550  \\$wg$aReceptor Protein-Tyrosine Kinases
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aReceptor, Platelet-Derived Growth Factor alpha
=550  \\$wh$aReceptor, Platelet-Derived Growth Factor beta
=550  \\$aPlatelet-Derived Growth Factor
=667  \\$aDF: RECEPT PDGF
=680  \\$iSpecific receptors on cell membranes that react with PLATELET-DERIVED GROWTH FACTOR, its analogs, or antagonists. The alpha PDGF receptor (RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA) and the beta PDGF receptor (RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA) are the two principle types of PDGF receptors. Activation of the protein-tyrosine kinase activity of the receptors occurs by ligand-induced dimerization or heterodimerization of PDGF receptor types.
=688  \\$a93; was PLATELET-DERIVED GROWTH FACTOR RECEPTOR (NM) 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was NM 1989-92
=750  \0$81$wb$iBroader mapping$aPlatelet-derived growth factor$0(DLC)sh 92004606$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aPlatelet-derived growth factor--Receptors$5IEN-M

=LDR  01054cz  a2200265n  4500
=001  9880364106202441
=005  20141212212210.0
=008  930621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017636
=035  \\$aCRE6627HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x725.$x50.$x50
=072  \\$aD1.$x837.$x725.$x700.$x760.$x70.$x50
=150  \\$aAsbestos, Amphibole
=450  \\$aAmphibole Asbestos
=450  \\$wnnna$aAmphiboles
=450  \\$wnnna$aAsbestos, Amphibole-group Minerals
=450  \\$wnnna$aAsbestos, Amphibole group Minerals
=550  \\$wg$aAsbestos
=550  \\$wh$aAsbestos, Amosite
=550  \\$wh$aAsbestos, Crocidolite
=667  \\$aD25-26 qualif
=680  \\$iA class of asbestos that includes silicates of magnesium, iron, calcium, and sodium. The fibers are generally brittle and cannot be spun, but are more resistant to chemicals and heat than ASBESTOS, SERPENTINE. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=688  \\$a94; was AMPHIBOLES (NM) 1979-93
=750  \0$aAmphiboles$5IEN-M$0(DLC)sh 85004612

=LDR  01230cz  a2200301n  4500
=001  9880364106302441
=005  20141212212209.0
=008  930616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017632
=035  \\$aCRE6623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x524.$x500.$x50
=072  \\$aD1.$x578.$x725.$x50.$x75
=072  \\$aD1.$x578.$x725.$x500.$x50
=072  \\$aD1.$x837.$x725.$x700.$x760.$x70.$x110
=072  \\$aD1.$x837.$x725.$x700.$x760.$x535.$x400
=150  \\$aAsbestos, Serpentine
=450  \\$wnnna$aAntigorite
=450  \\$wnnna$aAsbestos, Serpentine, Chrysotile (Mg3(OH)4(Si2O5))
=450  \\$aChrysotile
=450  \\$aSerpentine Asbestos
=450  \\$aSerpentine (Mineral)
=550  \\$wg$aAsbestos
=550  \\$wg$aMagnesium Silicates
=667  \\$aserpentine refers to the mottled or spotted surface resembling a serpent's skin
=680  \\$iA type of asbestos that occurs in nature as the dihydrate of magnesium silicate. It exists in two forms: antigorite, a plated variety, and chrysotile, a fibrous variety. The latter makes up 95% of all asbestos products. (From Merck Index, 11th ed, p.893)
=688  \\$a94; CHRYSOTILE was (NM) 1974-93
=750  \0$aSerpentine$5IEN-M$0(DLC)sh 85120306

=LDR  01125cz  a2200253n  4500
=001  9880364106402441
=005  20141212212208.0
=008  930806\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017629
=035  \\$aCRE6621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x420.$x471
=150  \\$aGap Junctions
=450  \\$wnnna$aGap Junction
=450  \\$wnnna$aJunction, Gap
=450  \\$wnnna$aJunctions, Gap
=550  \\$wg$aIntercellular Junctions
=550  \\$wh$aElectrical Synapses
=550  \\$aSynapses
=550  \\$aSynaptic Transmission
=667  \\$aintercellular junctions; A 11 qualif except /cytol /transpl; /genet permitted
=680  \\$iConnections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow (1-2 nm) gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions.
=688  \\$a94
=750  \0$aGap junctions (Cell biology)$5IEN-M$0(DLC)sh 90002710

=LDR  01133cz  a2200193n  4500
=001  9880364106502441
=005  20141212212208.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017628
=035  \\$aCRE6620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637.$x400
=072  \\$aA11.$x650.$x400
=150  \\$aMicroglia
=550  \\$wg$aNeuroglia
=667  \\$aa type of neuroglia; A 11 qualif
=680  \\$iThe third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling.
=688  \\$a94
=750  \0$aMicroglia$5IEN-M$0(DLC)sh 85084845

=LDR  01099cz  a2200217n  4500
=001  9880364106602441
=005  20141212212207.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017626
=035  \\$aCRE6619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x135
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x135
=150  \\$aCochlear Nucleus
=450  \\$wnnna$aCochlear Nuclei
=450  \\$wnnna$aNuclei, Cochlear
=450  \\$wnnna$aNucleus, Cochlear
=550  \\$wg$aPons
=680  \\$iThe brain stem nucleus that receives the central input from the cochlear nerve. The cochlear nucleus is located lateral and dorsolateral to the inferior cerebellar peduncles and is functionally divided into dorsal and ventral parts. It is tonotopically organized, performs the first stage of central auditory processing, and projects (directly or indirectly) to higher auditory areas including the superior olivary nuclei, the medial geniculi, the inferior colliculi, and the auditory cortex.
=688  \\$a94
=750  \0$aCochlear nucleus$5IEN$0(DLC)sh 85027593

=LDR  00844cz  a2200265n  4500
=001  9880364106702441
=005  20190107102052.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017616
=035  \\$aCRE6615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x524
=150  \\$aMagnesium Compounds
=450  \\$wnnna$aCompounds, Magnesium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aMagnesium Chloride
=550  \\$wh$aMagnesium Hydroxide
=550  \\$wh$aMagnesium Oxide
=550  \\$wh$aMagnesium Silicates
=550  \\$wh$aMagnesium Sulfate
=550  \\$wh$aStruvite
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: MAGNESIUM CPDS
=680  \\$iInorganic compounds that contain magnesium as an integral part of the molecule.
=688  \\$a94
=750  \0$aMagnesium compounds$5IEN-M$0(DLC)sh 90000932

=LDR  01474cz  a2200265n  4500
=001  9880364106802441
=005  20141212212205.0
=008  930618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017615
=035  \\$aCRE6614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x150
=150  \\$aEnteric Nervous System
=450  \\$wnnna$aEnteric Nervous Systems
=450  \\$wnnna$aNervous System, Enteric
=450  \\$wnnna$aNervous Systems, Enteric
=450  \\$wnnna$aSystem, Enteric Nervous
=450  \\$wnnna$aSystems, Enteric Nervous
=550  \\$wg$aAutonomic Nervous System
=550  \\$wh$aMyenteric Plexus
=550  \\$wh$aSubmucous Plexus
=667  \\$aa major division of the autonomic nerv syst
=680  \\$iTwo ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)
=688  \\$a94
=750  \0$aDigestive organs$xInnervation$5IEN-M$0(DLC)sh 85037963

=LDR  00729cz  a2200241n  4500
=001  9880364106902441
=005  20141212212204.0
=008  930604\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017613
=035  \\$aCRE6612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x475
=150  \\$aIodine Compounds
=450  \\$wnnna$aCompounds, Iodine
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aIodates
=550  \\$wh$aIodides
=550  \\$wh$aIodophors
=550  \\$wh$aPeriodic Acid
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: IODINE CPDS
=680  \\$iInorganic compounds that contain iodine as an integral part of the molecule.
=688  \\$a94
=750  \0$aIodine compounds$5IEN-M$0(DLC)sh 85067777

=LDR  01431cz  a2200301n  4500
=001  9880364107002441
=005  20190502120212.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017478
=035  \\$aCRE2640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x827.$x550
=150  \\$aReceptors, Phencyclidine
=450  \\$wnnna$aPCP Receptor
=450  \\$aPCP Receptors
=450  \\$aPhencyclidine Receptors
=450  \\$wnnna$aPhencylidine Receptor
=450  \\$wnnna$aReceptor, PCP
=450  \\$wnnna$aReceptor, Phencylidine
=450  \\$aReceptors, PCP
=550  \\$wg$aReceptors, Drug
=550  \\$aPhencyclidine
=667  \\$aDF: RECEPT PCP
=680  \\$iSpecific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs.
=688  \\$a93; was PHENCYCLIDINE RECEPTOR (NM) 1981-92
=750  \0$81$wb$iBroader mapping$aPhencyclidine$0(DLC)sh 85100665$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aPhencyclidine--Receptors$5IEN-M

=LDR  01215cz  a2200289n  4500
=001  9880364107102441
=005  20190501104857.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017476
=035  \\$aCRE2638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x500
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x540
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x540
=150  \\$aReceptors, Neuropeptide Y
=450  \\$wnnna$aNeuropeptide Y Receptor
=450  \\$aNeuropeptide Y Receptors
=450  \\$wnnna$aReceptor, Neuropeptide Y
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Neuropeptide
=550  \\$aNeuropeptide Y
=667  \\$aDF: RECEPT NEUROPEPTIDE Y
=680  \\$iCell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells.
=688  \\$a93; was NEUROPEPTIDE Y RECEPTOR (NM) 1985-92
=750  \0$81$wb$iBroader mapping$aNeuropeptide Y$0(DLC)sh 90000480)$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNeuropeptide Y--Receptors$5IEN-M

=LDR  01805cz  a2200409n  4500
=001  9880364107202441
=005  20190426122104.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017472
=035  \\$aCRE2635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x300
=150  \\$aReceptors, Interleukin-1
=450  \\$aIL-1 Receptors
=450  \\$wnnna$aIL 1 Receptors
=450  \\$wnnna$aIL1 Receptors
=450  \\$wnnna$aInterleukin 1 Receptor
=450  \\$aInterleukin-1 Receptors
=450  \\$wnnna$aInterleukin 1 Receptors
=450  \\$wnnna$aReceptor, Interleukin 1
=450  \\$aReceptors, IL-1
=450  \\$wnnna$aReceptors, IL 1
=450  \\$wnnna$aReceptors, IL1
=450  \\$wnnna$aReceptors, Interleukin 1
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aInterleukin-1 Receptor Accessory Protein
=550  \\$wh$aInterleukin-1 Receptor-Like 1 Protein
=550  \\$wh$aReceptors, Interleukin-1 Type I
=550  \\$wh$aReceptors, Interleukin-1 Type II
=550  \\$aInterleukin-1
=667  \\$aDF: RECEPT IL 1 or RECEPT IL1
=680  \\$iCell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
=688  \\$a1993(1985)
=688  \\$a93; use INTERLEUKIN 1 RECEPTOR (NM) 1985-92
=750  \0$80$wb$iBroader mapping$aInterleukin-1$0(DLC)sh 89004301$4BM$5IEN-M
=780  \0$80$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$aSearch also under the Library of Congress Subject heading:$aInterleukin-1--Receptors

=LDR  01359cz  a2200265n  4500
=001  9880364107302441
=005  20190426130157.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017471
=035  \\$aCRE2634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x400
=150  \\$aReceptors, Interferon
=450  \\$wnnna$aInterferon Receptor
=450  \\$aInterferon Receptors
=450  \\$wnnna$aReceptor, Interferon
=550  \\$wg$aReceptors, Cytokine
=550  \\$wh$aReceptor, Interferon alpha-beta
=550  \\$aInterferons
=667  \\$acoord IM with specific interferon (IM); DF: RECEPT INTERFERON
=680  \\$iSpecific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system.
=688  \\$a93; was INTERFERON RECEPTOR (NM) 1980-92
=750  \0$81$wb$iBroader mapping$aInterferon$0(DLC)sh 850672604BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterferon--Receptors$5IEN-M

=LDR  01635cz  a2200313n  4500
=001  9880364107402441
=005  20141212212118.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017470
=035  \\$aCRE2633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x720.$x200.$x450
=150  \\$aReceptors, Glutamate
=450  \\$wnnna$aExcitatory Amino Acid Receptor
=450  \\$aExcitatory Amino Acid Receptors
=450  \\$wnnna$aGlutamate Receptor
=450  \\$aGlutamate Receptors
=450  \\$wnnna$aReceptor, Glutamate
=450  \\$aReceptors, Excitatory Amino Acid
=550  \\$wg$aReceptors, Amino Acid
=550  \\$wh$aReceptors, Ionotropic Glutamate
=550  \\$wh$aReceptors, Metabotropic Glutamate
=550  \\$aExcitatory Amino Acids
=550  \\$aGlutamates
=550  \\$aGlutamic Acid
=667  \\$aGEN; prefer specifics; DF: RECEPT GLUTAMATE
=680  \\$iCell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.
=688  \\$a93; was GLUTAMATE RECEPTOR (NM) 1980-92; EXCITATORY AMINO ACID RECEPTORS & RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993
=750  \0$aExcitatory amino acids$xReceptors$5IEN-M

=LDR  01314cz  a2200265n  4500
=001  9880364107502441
=005  20190423163527.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017469
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x408.$x530
=150  \\$aReceptors, Fibronectin
=450  \\$aFibronectin Receptors
=550  \\$wg$aIntegrins
=550  \\$wh$aIntegrin alpha2beta1
=550  \\$wh$aIntegrin alpha4beta1
=550  \\$wh$aIntegrin alpha5beta1
=550  \\$aAntigens, CD29
=550  \\$aFibronectins
=667  \\$adp not confuse with FIBRONECTIN RECEPTOR see INTEGRIN ALPHA5BETA1, DF: RECEPT FIBRONECTIN
=680  \\$iSpecific cell surface receptors which bind to FIBRONECTINS. Studies have shown that these receptors function in certain types of adhesive contact as well as playing a major role in matrix assembly. These receptors include the traditional fibronectin receptor, also called INTEGRIN ALPHA5BETA1 and several other integrins.
=688  \\$a1993; use FIBRONECTIN RECEPTOR (NM) 1981-1992
=750  \0$81$wb$iBroader mapping$aFibronectins$0(DLC)sh 85048036$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \\$iSearch also under the Library of Congress Subject Heading:$aFibronectins--Receptors$5IEN-M

=LDR  01873cz  a2200373n  4500
=001  9880364107602441
=005  20190423162917.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017468
=035  \\$aCRE2631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x370
=150  \\$aReceptors, Fibroblast Growth Factor
=450  \\$wnnna$aFGF Receptor
=450  \\$aFGF Receptors
=450  \\$wnnna$aFibroblast Growth Factor Receptor
=450  \\$aFibroblast Growth Factor Receptors
=450  \\$wnnna$aHeparin-Binding Growth Factor Receptor
=450  \\$wnnna$aHeparin Binding Growth Factor Receptor
=450  \\$wnnna$aReceptor, FGF
=450  \\$aReceptors, FGF
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 1
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 2
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 3
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 4
=550  \\$wh$aReceptor, Fibroblast Growth Factor, Type 5
=550  \\$aFibroblast Growth Factors
=667  \\$acoord IM with specific FIBROBLAST GROWTH FACTORS (IM); DF: note short X ref
=680  \\$iSpecific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.
=688  \\$a2004; use FIBROBLAST GROWTH FACTOR RECEPTOR (NM) 1985-1992
=750  \0$81$wb$iBroader mapping$aFibroblast growth factors$0(DLC)sh 91005352$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aFibroblast growth factors--Receptors$5IEN-M

=LDR  01137cz  a2200265n  4500
=001  9880364107702441
=005  20190423154841.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017467
=035  \\$aCRE2630HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x150.$x200
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x200.$x340
=150  \\$aReceptors, Erythropoietin
=450  \\$wnnna$aErythropoietin Receptor
=450  \\$aErythropoietin Receptors
=450  \\$wnnna$aReceptor, Erythropoietin
=550  \\$wg$aReceptors, Colony-Stimulating Factor
=550  \\$aErythropoietin
=667  \\$aDF: RECEPT ERYTHROPOIETIN
=680  \\$iCell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells.
=688  \\$a93; was ERYTHROPOIETIN RECEPTOR (NM) 1985-92
=750  \0$81$wb$iBroader mapping$aErythropoietin$0(DLC)sh 85044756$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aErythropoietin--Receptors$5IEN-M

=LDR  00924cz  a2200217n  4500
=001  9880364107802441
=005  20141212211912.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017084
=035  \\$aCRE2301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x810.$x263.$x570
=150  \\$aOtoacoustic Emissions, Spontaneous
=450  \\$wnnna$aOtoacoustic Emission, Spontaneous
=450  \\$wnnna$aSpontaneous Otoacoustic Emission
=450  \\$wnnna$aSpontaneous Otoacoustic Emissions
=550  \\$wg$aHearing
=550  \\$aCochlea
=680  \\$iSelf-generated faint acoustic signals from the inner ear (COCHLEA) without external stimulation. These faint signals can be recorded in the EAR CANAL and are indications of active OUTER AUDITORY HAIR CELLS. Spontaneous otoacoustic emissions are found in all classes of land vertebrates.
=688  \\$a93
=750  \0$aOtoacoustic Emissions, Spontaneous$5IEN-M

=LDR  01334cz  a2200325n  4500
=001  9880364107902441
=005  20141212211911.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017078
=035  \\$aCRE2298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x475
=072  \\$aE5.$x830.$x500
=150  \\$aLaser-Doppler Flowmetry
=450  \\$aDoppler-Laser Flowmetry
=450  \\$wnnna$aDoppler Laser Flowmetry
=450  \\$wnnna$aFlowmetry, Doppler-Laser
=450  \\$aFlowmetry, Laser-Doppler
=450  \\$wnnna$aFlowmetry, Laser Doppler
=450  \\$wnnna$aLaser Doppler Flowmetry
=450  \\$aLaser-Doppler Velocimetry
=450  \\$wnnna$aLaser Doppler Velocimetry
=450  \\$aVelocimetry, Laser-Doppler
=450  \\$wnnna$aVelocimetry, Laser Doppler
=550  \\$wg$aDiagnostic Techniques, Cardiovascular
=550  \\$wg$aRheology
=667  \\$aindex laser velocimeters & Doppler velocimeters here with / instrum & do not coordinate with LASERS or DOPPLER EFFECT
=680  \\$iA method of non-invasive, continuous measurement of MICROCIRCULATION. The technique is based on the values of the DOPPLER EFFECT of low-power laser light scattered randomly by static structures and moving tissue particulates.
=688  \\$a93
=750  \0$aLaser Doppler blood flowmetry$0(DLC) sh 89005188$5IEN-M

=LDR  01444cz  a2200397n  4500
=001  9880364108002441
=005  20141212211910.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017076
=035  \\$aCRE2296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x108.$x150
=072  \\$aL1.$x296.$x110.$x150
=150  \\$aComputer-Aided Design
=450  \\$aCAD-CAM
=450  \\$wnnna$aComputer Aided Design
=450  \\$wnnna$aComputer-Aided Designs
=450  \\$aComputer-Aided Manufacturing
=450  \\$wnnna$aComputer Aided Manufacturing
=450  \\$aComputer-Assisted Design
=450  \\$wnnna$aComputer Assisted Design
=450  \\$wnnna$aComputer-Assisted Designs
=450  \\$aComputer-Assisted Manufacturing
=450  \\$wnnna$aComputer Assisted Manufacturing
=450  \\$wnnna$aDesign, Computer-Aided
=450  \\$wnnna$aDesign, Computer-Assisted
=450  \\$wnnna$aDesigns, Computer-Aided
=450  \\$wnnna$aDesigns, Computer-Assisted
=450  \\$wnnna$aManufacturing, Computer-Aided
=450  \\$wnnna$aManufacturing, Computer-Assisted
=550  \\$wg$aComputer Graphics
=550  \\$wh$aPrinting, Three-Dimensional
=667  \\$ain design of equipment or drugs
=680  \\$iThe use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics.
=688  \\$a93
=750  \0$aComputer-aided design$5IEN-M$0(DLC)sh 85029476

=LDR  01258cz  a2200337n  4500
=001  9880364108102441
=005  20141212211910.0
=008  920520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017075
=035  \\$aCRE2295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x520.$x745.$x410
=072  \\$aE2.$x594.$x530
=072  \\$aE4.$x14.$x520.$x530
=072  \\$aE4.$x350.$x750.$x410
=072  \\$aE4.$x540.$x630.$x410
=150  \\$aLaser Coagulation
=450  \\$wnnna$aCoagulation, Laser
=450  \\$wnnna$aCoagulations, Laser
=450  \\$wnnna$aLaser Coagulations
=450  \\$aLaser Thermocoagulation
=450  \\$wnnna$aLaser Thermocoagulations
=450  \\$aThermocoagulation, Laser
=450  \\$wnnna$aThermocoagulations, Laser
=550  \\$wg$aLaser Therapy
=550  \\$wg$aLight Coagulation
=550  \\$aArgon Plasma Coagulation
=667  \\$ado not confuse with LIGHT COAGULATION or with LASER SURGERY; coordinate IM with disease /surg (IM)
=680  \\$iThe use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
=688  \\$a93; was see LIGHT COAGULATION 1992; was heading 1968-85
=750  \0$aLaser coagulation$5IEN-M$0(DLC)sh 85074772

=LDR  00774cz  a2200217n  4500
=001  9880364108202441
=005  20141212211909.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017072
=035  \\$aCRE2292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x487.$x550
=150  \\$aNeostriatum
=550  \\$wg$aCorpus Striatum
=550  \\$wh$aCaudate Nucleus
=550  \\$wh$aHigh Vocal Center
=550  \\$wh$aPutamen
=667  \\$athe newer part of the corpus striatum, hence neo-; also called "striatum"
=680  \\$iThe phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.
=688  \\$a93
=750  \0$aNeostriatum$5IEN-M$0(DLC)sh 85090814

=LDR  00973cz  a2200229n  4500
=001  9880364108302441
=005  20141212211733.0
=008  920507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016754
=035  \\$aCRE2290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x722.$x500.$x100
=150  \\$aBoron Neutron Capture Therapy
=450  \\$wnnna$aBoron-Neutron Capture Therapy
=450  \\$wnnna$aNeutron Capture Therapy, Boron
=450  \\$wnnna$aTherapy, Boron Neutron Capture
=450  \\$wnnna$aTherapy, Boron-Neutron Capture
=550  \\$wg$aNeutron Capture Therapy
=667  \\$ado not use /util except by MeSH definition; coord IM with disease /radiother (IM); DF: BNCT
=680  \\$iA technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.
=688  \\$a93
=750  \0$aBoron-neutron capture therapy$5IEN-M$0(DLC)sh 86005080

=LDR  01732cz  a2200313n  4500
=001  9880364108402441
=005  20190506114506.0
=008  760503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011982
=035  \\$aCBT8301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x200.$x700
=150  \\$aReceptors, Prostaglandin
=450  \\$wnnna$aProstaglandin Receptor
=450  \\$aProstaglandin Receptors
=450  \\$wnnna$aProstaglandins Receptors
=450  \\$wnnna$aReceptor, Prostaglandin
=450  \\$wnnna$aReceptors, Prostaglandins
=550  \\$wg$aReceptors, Eicosanoid
=550  \\$wh$aReceptors, Epoprostenol
=550  \\$wh$aReceptors, Prostaglandin E
=550  \\$wh$aReceptors, Thromboxane A2, Prostaglandin H2
=550  \\$aProstaglandins
=667  \\$acoord IM with specific natural or synthetic prostaglandin (IM); RECEPTORS, PROSTAGLANDIN E is available; DF: RECEPT PG
=680  \\$iCell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors).
=688  \\$a87(77); was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86
=750  \0$81$wb$iBroader mapping$aProstaglandins$0(DLC)sh 85107602 4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aProstaglandins--Receptors$5IEN-M

=LDR  01908cz  a2200469n  4500
=001  9880364108502441
=005  20141212212638.0
=008  940624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018504
=035  \\$aCBT4255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x240
=072  \\$aN6.$x230.$x124.$x240
=072  \\$aN6.$x230.$x150.$x225
=150  \\$aEcological Systems, Closed
=450  \\$wnnna$aBreadboard Project
=450  \\$wnnna$aBreadboard Projects
=450  \\$wnnna$aCabin Ecologies, Sealed
=450  \\$wnnna$aCabin Ecology, Sealed
=450  \\$aCELSS
=450  \\$aClosed Ecologic Life Support Systems
=450  \\$wnnna$aClosed Ecological System
=450  \\$wnnna$aClosed Ecological Systems
=450  \\$wnnna$aEcological System, Closed
=450  \\$wnnna$aEcologies, Sealed Cabin
=450  \\$wnnna$aEcology, Sealed Cabin
=450  \\$aLife Support Systems, Regenerative
=450  \\$wnnna$aProject, Breadboard
=450  \\$wnnna$aProjects, Breadboard
=450  \\$wnnna$aSealed Cabin Ecologies
=450  \\$aSealed Cabin Ecology
=450  \\$wnnna$aSystem, Closed Ecological
=450  \\$wnnna$aSystems, Closed Ecological
=550  \\$wg$aEcosystem
=550  \\$wg$aEnvironment, Controlled
=550  \\$aConfined Spaces
=550  \\$aSpace Flight
=550  \\$aSubmarine Medicine
=667  \\$aIM; coord with SPACE FLIGHT (IM) or SUBMARINE MEDICINE (IM), if pertinent
=680  \\$iSystems that provide for the maintenance of life in an isolated living chamber through reutilization of the material available, in particular, by means of a cycle wherein exhaled carbon dioxide, urine, and other waste matter are converted chemically or by photosynthesis into oxygen, water, and food. (NASA Thesaurus, 1988)
=688  \\$a95; SEALED CABIN ECOLOGY was heading 1963-94
=750  \0$aClosed Ecological Systems$5IEN-M$0(DLC)sh 85027137

=LDR  01796cz  a2200397n  4500
=001  9880364108602441
=005  20190501094836.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017475
=035  \\$aCBT4254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x550.$x500
=150  \\$aReceptors, Nerve Growth Factor
=450  \\$aNerve Growth Factor Receptors
=450  \\$aNeurotrophic Factor Receptor
=450  \\$wnnna$aNeurotrophic Factor Receptors
=450  \\$wnnna$aNeurotrophin Receptors
=450  \\$aNGF Receptors
=450  \\$wnnna$aReceptor, Neurotrophic Factor
=450  \\$wnnna$aReceptors, Neurotrophic Factor
=450  \\$aReceptors, Neurotrophin
=450  \\$aReceptors, NGF
=550  \\$wg$aReceptors, Growth Factor
=550  \\$wh$aGlial Cell Line-Derived Neurotrophic Factor Receptors
=550  \\$wh$aReceptor, Ciliary Neurotrophic Factor
=550  \\$wh$aReceptor, Nerve Growth Factor
=550  \\$wh$aReceptor, trkA
=550  \\$wh$aReceptor, trkB
=550  \\$wh$aReceptor, trkC
=550  \\$aNerve Growth Factors
=667  \\$acoord IM with specific nerve growth factor (IM) but note RECEPTOR, NERVE GROWTH FACTOR and other specifics are available
=680  \\$iCell surface receptors that bind NERVE GROWTH FACTOR; (NGF) and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR.
=688  \\$a93; was NERVE GROWTH FACTORS RECEPTOR (NM) 1980-92
=750  \0$81$wb$iBroader mapping$aNerve growth factor$0(DLC)sh 85090895$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aNerve growth factor--Receptors$5IEN-M

=LDR  01213cz  a2200337n  4500
=001  9880364108702441
=005  20141212211920.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017108
=035  \\$aCBT4239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x850
=150  \\$aStreptococcus Phages
=450  \\$wnnna$aBacteriophage, Streptococcus
=450  \\$wnnna$aBacteriophages, Streptococcus
=450  \\$wnnna$aPhage, Streptococcal
=450  \\$wnnna$aPhage, Streptococcus
=450  \\$wnnna$aPhages, Streptococcal
=450  \\$wnnna$aPhages, Streptococcus
=450  \\$wnnna$aStreptococcal Phage
=450  \\$aStreptococcal Phages
=450  \\$wnnna$aStreptococcus Bacteriophage
=450  \\$wnnna$aStreptococcus Bacteriophages
=450  \\$wnnna$aStreptococcus Phage
=550  \\$wg$aBacteriophages
=667  \\$acoord IM with specific Streptococcus (NIM)
=680  \\$iViruses whose host is Streptococcus.
=688  \\$a93
=750  \0$81$wb$aStreptococcus$5IEN-M$0(DLC)sh 85128678
=750  \0$81$wb$aBacteriophages$5IEN-HS$0(DLC)sh 85010874
=788  \0$iSearch also under the following headings used together in the same record:$aStreptococcus$iand$aBacteriophages$5IEN

=LDR  01085cz  a2200289n  4500
=001  9880364108802441
=005  20141212211920.0
=008  920526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017105
=035  \\$aCBT4140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x123.$x660
=150  \\$aPseudomonas Phages
=450  \\$wnnna$aBacteriophage, Pseudomonas
=450  \\$wnnna$aBacteriophages, Pseudomonas
=450  \\$wnnna$aPseudomonas Bacteriophage
=450  \\$wnnna$aPseudomonas Bacteriophages
=450  \\$wnnna$aPseudomonas Phage
=550  \\$wg$aBacteriophages
=550  \\$wh$aBacteriophage Pf1
=550  \\$wh$aBacteriophage phi 6
=667  \\$acoord IM with specific Pseudomonas (NIM)
=680  \\$iViruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6.
=688  \\$a93
=750  \0$81$wb$aPseudomonas$5IEN-M$0(DLC)sh 85108280
=750  \0$81$wb$aBacteriophages$5IEN-HS$0(DLC)sh 85010874
=788  \0$iSearch also under the following headings used together in the same record:$aPseudomonas$iand$aBacteriophages$5IEN-M

=LDR  00856cz  a2200241n  4500
=001  9880364108902441
=005  20141212211911.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017082
=035  \\$aCBT4136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380.$x76.$x732.$x650
=150  \\$aPortal Pressure
=450  \\$wnnna$aPortal Venous Pressure
=450  \\$wnnna$aPressure, Portal
=450  \\$wnnna$aPressure, Portal Venous
=450  \\$wnnna$aVenous Pressure, Portal
=550  \\$wg$aVenous Pressure
=680  \\$iThe venous pressure measured in the PORTAL VEIN.
=688  \\$a93
=750  \0$81$wb$aVenous pressure$5IEN-M$0(DLC)sh 85142744
=750  \0$81$wb$aPortal vein$5IEN-HS$0(DLC)sh 85105068
=788  \2$iSearch also under the following headings used together in the same record:$aVenous pressure$iand$aPortal vein$5IEN-M

=LDR  00861cz  a2200217n  4500
=001  9880364109002441
=005  20141212211915.0
=008  920522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017090
=035  \\$aCBT4061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x453.$x510
=150  \\$aOcclusal Splints
=450  \\$wnnna$aOcclusal Splint
=450  \\$wnnna$aSplint, Occlusal
=450  \\$aSplints, Occlusal
=550  \\$wg$aOrthodontic Appliances
=667  \\$arigid or flexible splint used in orthodontics & treatment of clenching & bruxism
=680  \\$iRigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to treat clenching and bruxism and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain.
=688  \\$a93
=750  \0$aSplints, Bite plane$5IEN-M$0(DLC)sh 85126832

=LDR  01303cz  a2200337n  4500
=001  9880364109102441
=005  20141212211946.0
=008  920511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017195
=035  \\$aCBT0198HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x220.$x60
=150  \\$aAdolescent Nutritional Physiological Phenomena
=450  \\$wnno$aAdolescent Nutrition$5IEN-M
=450  \\$aAdolescent Nutrition Physiology
=450  \\$wnnna$aAdolescent Nutritional Physiological Phenomenon
=450  \\$wnnna$aAdolescent Nutritional Physiology
=450  \\$wnnna$aNutrition Physiology, Adolescent
=450  \\$wnnna$aNutritional Physiology, Adolescent
=450  \\$wnnna$aPhysiology, Adolescent Nutrition
=450  \\$wnnna$aPhysiology, Adolescent Nutritional
=550  \\$wg$aChild Nutritional Physiological Phenomena
=550  \\$aChild Nutritional Physiological Phenomena
=667  \\$acheck the tag ADOLESCENCE
=680  \\$iNutritional physiology of children aged 13-18 years.
=688  \\$a2009 (1993)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Adolescent Nutrition Physiology
=688  \\$a2007(1993)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Adolescent Nutrition
=688  \\$a93
=750  \0$aYouth$xNutrition$0(DLC) sh 85149335$5IEN-M

=LDR  00450cz  a2200181n  4500
=001  9880364109202441
=005  20141212201609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D005662
=035  \\$aCBS1357NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47.$x466
=072  \\$aD3.$x383.$x312.$x355
=150  \\$aFuraldehyde
=450  \\$aFurfural
=550  \\$wg$aAldehydes
=550  \\$wg$aFurans
=750  \0$aFurfural$5IEN-M$0(DLC)sh 99011536

=LDR  00998cz  a2200241n  4500
=001  9880364109302441
=005  20141212211605.0
=008  910103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016482
=035  \\$aCBP9025HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x810
=072  \\$aE1.$x370.$x390.$x810
=072  \\$aE5.$x200.$x124.$x810
=150  \\$aUrinalysis
=450  \\$wnnna$aUrinalyses
=450  \\$aUrine$xanalysis$5IEN-M
=550  \\$wg$aClinical Chemistry Tests
=550  \\$wg$aDiagnostic Techniques, Urological
=667  \\$aGEN only; for urinalysis of specific substances in the urine prefer /urine
=680  \\$iExamination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically.
=688  \\$a92
=750  \0$aUrine$xAnalysis$5IEN-M$0(DLC)sh 85141421

=LDR  01133cz  a2200253n  4500
=001  9880364109402441
=005  20141212211618.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016524
=035  \\$aCBP3639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417.$x700.$x162.$x500
=072  \\$aN4.$x452.$x677.$x800.$x162.$x500
=150  \\$aParental Leave
=450  \\$wnnna$aLeave, Maternity
=450  \\$wnnna$aLeave, Parental
=450  \\$wnnna$aLeave, Paternity
=450  \\$aMaternity Leave
=450  \\$aPaternity Leave
=550  \\$wg$aFamily Leave
=667  \\$aprenatal & postnatal leave, leave for illness of a child or leave for adoption procedures; do not confuse with FAMILY LEAVE: see MeSH definition
=680  \\$iThe authorized absence from work of either parent prior to and after the birth of their child. It includes also absence because of the illness of a child or at the time of the adoption of a child. It does not include leave for care of siblings, parents, or other family members: for this FAMILY LEAVE is available.
=688  \\$a92
=750  \0$aParental leave$5IEN-M$0(DLC)sh 87002518

=LDR  00379cz  a2200133n  4500
=001  9880364109502441
=005  20120717143521.0
=008  910620\n\ancnnbabn\\\\\\\\\\|n\ana\\\\|b
=035  \\$a(DNLM)D017055Q000451
=035  \\$aCBP1003HS
=040  \\$aIEN-M$cIEN-M
=150  \0$aIntensive Care$xnursing
=450  \0$aIntensive Care Nursing$5IEN-M
=750  \0$aIntensive care nursing$5IEN-M$0(DLC)sh 85067185

=LDR  00326cz  a2200121n  4500
=001  9880364109602441
=005  20120717143521.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBP0838HS
=035  \\$a(DNLM)D008113Q000556
=040  \\$aDNLM$cDNLM
=150  \\$aLiver Neoplasms$xsecondary
=750  \0$aLiver metastasis$5IEN$0(DLC)sh 93000008

=LDR  00408cz  a2200133n  4500
=001  9880364109702441
=005  20120717143521.0
=008  790425\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCBP0833HS
=035  \\$a(DNLM)D000556Q000451
=040  \\$aDNLM$cDNLM
=150  \\$aAmbulatory Surgical Procedures$xnursing
=450  \0$wnnoa$aAmbulatory Surgery$xnursing$5IEN-HS
=750  \0$aAmbulatory surgical nursing$5IEN$0(DLC)sh 92006592

=LDR  00754cz  a2200241n  4500
=001  9880364109802441
=005  20141212211820.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016902
=035  \\$aCBN9240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x100.$x80
=150  \\$aAir Pollution, Indoor
=450  \\$aAir Quality, Indoor
=450  \\$aIndoor Air Pollution
=450  \\$aIndoor Air Quality
=450  \\$wnnna$aPollution, Indoor Air
=550  \\$wg$aAir Pollution
=667  \\$aIM; specify environ if pertinent (IM)
=680  \\$iThe contamination of indoor air.
=688  \\$a92
=750  \0$aIndoor air pollution$5IEN-M$0(DLC)sh 85002587
=750  \0$aIndoor air quality$0(DLC)sh2007001498$5IEN-M$0(DLC)sh2007001498

=LDR  00337cz  a2200121n  4500
=001  9880364109902441
=005  20120717143520.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBN0692HS
=035  \\$a(DNLM)D014621Q000736
=040  \\$aDNLM$cDNLM
=150  \\$aVagina$xultrasonography
=750  \0$aTransvaginal ultrasonography$5IEN-M$0(DLC)sh 92004376

=LDR  01633cz  a2200397n  4500
=001  9880364110002441
=005  20141212211631.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016564
=035  \\$aCBN0679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x49.$x407.$x249
=072  \\$aD12.$x776.$x543.$x39
=072  \\$aD12.$x776.$x645.$x468.$x500
=072  \\$aD12.$x776.$x811.$x50
=150  \\$aAmyloid beta-Protein Precursor
=450  \\$aAmyloid A4 Protein Precursor
=450  \\$wnnna$aAmyloid beta Precursor Protein
=450  \\$wnnna$aAmyloid beta Protein Precursor
=450  \\$aAmyloid Protein Precursor
=450  \\$abeta-Amyloid Protein Precursor
=450  \\$wnnna$abeta Amyloid Protein Precursor
=450  \\$wnnna$abeta-Protein Precursor, Amyloid
=450  \\$wnnna$aNexin 2, Protease
=450  \\$wnnna$aNexin II, Protease
=450  \\$wnnna$aProtease Nexin 2
=450  \\$wnnna$aProtease Nexin II
=550  \\$wg$aAmyloidogenic Proteins
=550  \\$wg$aMembrane Proteins
=550  \\$wg$aProtease Nexins
=550  \\$wg$aProtein Precursors
=550  \\$wh$aAmyloid beta-Peptides
=550  \\$aAlzheimer Disease
=680  \\$iA single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES.
=688  \\$a92; was AMYLOID BETA PROTEIN PRECURSOR (NM) 1988-91; AMYLOID A4 PROTEIN PRECURSOR was NM 1987-94
=750  \0$aAmyloid beta-protein precursor$5IEN$0(DLC)sh 92004713

=LDR  00349cz  a2200121n  4500
=001  9880364110102441
=005  20120717143520.0
=008  650101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBN0667HS
=035  \\$a(DNLM)D001102Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aArbovirus Infections$xveterinary
=750  \0$aArbovirus infections in animals$5IEN-M$0(DLC)sh 92002401

=LDR  00338cz  a2200121n  4500
=001  9880364110202441
=005  20120717143520.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCBN0666HS
=035  \\$a(DNLM)D013518Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aSurgery, Plastic$xveterinary
=750  \0$aVeterinary plastic surgery$5IEN$0(DLC)sh 92002064

=LDR  02112cz  a2200469n  4500
=001  9880364110302441
=005  20201217120939.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017063
=035  \\$aCBM5941HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x431
=072  \\$aN4.$x761.$x559.$x590
=072  \\$aN5.$x715.$x360.$x575.$x575
=150  \\$aOutcome Assessment (Health Care)
=450  \\$wnnna$aAssessment, Outcome (Health Care)
=450  \\$wnnna$aAssessment, Outcomes
=450  \\$wnnna$aAssessments, Outcome (Health Care)
=450  \\$wnnna$aAssessments, Outcomes
=450  \\$wnnna$aMeasure, Outcome
=450  \\$wnnna$aMeasures, Outcome
=450  \\$wnnna$aOutcome Assessments (Health Care)
=450  \\$wnnna$aOutcome Measure
=450  \\$wnnna$aOutcome Measures
=450  \\$wnnna$aOutcome Studies
=450  \\$wnnna$aOutcome Study
=450  \\$wnnna$aOutcomes Assessment
=450  \\$wnnna$aOutcomes Assessments
=450  \\$aOutcomes Research
=450  \\$wnnna$aResearch, Outcomes
=450  \\$wnnna$aStudies, Outcome
=450  \\$wnnna$aStudy, Outcome
=550  \\$wg$aBiomedical Research
=550  \\$wg$aOutcome and Process Assessment, Health Care
=550  \\$wh$aCritical Care Outcomes
=550  \\$wh$aPatient Outcome Assessment
=550  \\$wh$aTreatment Outcome
=550  \\$wh$aWatchful Waiting
=667  \\$anote category: for admin aspects of patient assessment; outcome only: for outcome assessment with process assessment, OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) and TREATMENT OUTCOME are available; DF: OUTCOME ASSESS
=680  \\$iResearch aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).
=688  \\$a92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE) 1979-91
=750  \0$aOutcome assessment (Medical care)$5IEN-M$0(DLC)sh 94002382

=LDR  00962cz  a2200253n  4500
=001  9880364110402441
=005  20141212192717.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017060
=035  \\$aCBM5938HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x822.$x700
=072  \\$aN5.$x300.$x150.$x600.$x630
=072  \\$aN5.$x715.$x360.$x600
=150  \\$aPatient Satisfaction
=450  \\$wnnna$aSatisfaction, Patient
=550  \\$wg$aHealth Care Evaluation Mechanisms
=550  \\$wg$aPatient Acceptance of Health Care
=550  \\$wg$aPublic Relations
=550  \\$wh$aPatient Preference
=667  \\$aPATIENT PREFERENCE is also available
=680  \\$iThe degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial.
=688  \\$a92; was see CONSUMER SATISFACTION 1982-91
=750  \0$aPatient satisfaction$5IEN-M$0(DLC)sh 85098708

=LDR  01028cz  a2200253n  4500
=001  9880364110502441
=005  20141212211906.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017059
=035  \\$aCBM5937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x500.$x600.$x500
=072  \\$aE5.$x599.$x835.$x890.$x500
=072  \\$aN5.$x715.$x360.$x750.$x530.$x500.$x500
=072  \\$aN6.$x850.$x520.$x830.$x500.$x600.$x500
=150  \\$aModels, Econometric
=450  \\$wnnna$aEconometric Model
=450  \\$aEconometric Models
=450  \\$wnnna$aModel, Econometric
=550  \\$wg$aModels, Economic
=667  \\$amodels of econ theory & for solution of econ problems: a type of MODELS, ECONOMIC; no qualif; apply TN 128 for relation to MODELS, THEORETICAL
=680  \\$iThe application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.
=688  \\$a92
=750  \0$aEconometric models$5IEN-M$0(DLC)sh 85040762

=LDR  00848cz  a2200265n  4500
=001  9880364110602441
=005  20141212211906.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017058
=035  \\$aCBM5936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x686.$x754.$x441.$x500
=150  \\$aMexican Americans
=450  \\$wnnna$aAmerican, Mexican
=450  \\$wnnna$aAmericans, Mexican
=450  \\$wnnna$aChicana
=450  \\$wnnna$aChicanas
=450  \\$wnnna$aChicano
=450  \\$aChicanos
=450  \\$wnnna$aMexican American
=550  \\$wg$aHispanic Americans
=667  \\$aspecify geog if relevant
=680  \\$iPersons living in the United States of Mexican descent.
=688  \\$a92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91
=750  \0$aMexican Americans$5IEN-M$0(DLC)sh 85084498

=LDR  00966cz  a2200253n  4500
=001  9880364110702441
=005  20141212211905.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017057
=035  \\$aCBM5935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x385
=150  \\$aMedically Uninsured
=450  \\$aMedically Underinsured
=450  \\$wnnna$aUnderinsured
=450  \\$wnnna$aUninsured
=550  \\$wg$aPersons
=550  \\$aInsurance, Health
=550  \\$aMedical Indigency
=550  \\$aUncompensated Care
=667  \\$auninsured or underinsured; DF: MED UNINSURED
=680  \\$iIndividuals or groups with no or inadequate health insurance coverage. Those falling into this category usually comprise three primary groups: the medically indigent (MEDICAL INDIGENCY); those whose clinical condition makes them medically uninsurable; and the working uninsured.
=688  \\$a92
=750  \0$aMedically uninsured persons$5IEN-M$0(DLC)sh 88002475

=LDR  03386cz  a2200793n  4500
=001  9880364110802441
=005  20141212211905.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017056
=035  \\$aCBM5934HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x510
=072  \\$aM1.$x526.$x502.$x500
=072  \\$aN2.$x360.$x510
=150  \\$aMedical Laboratory Personnel
=450  \\$wnnna$aAssistant, Medical Laboratory
=450  \\$wnnna$aAssistants, Medical Laboratory
=450  \\$wnnna$aClinical Laboratory Personnel
=450  \\$wnnna$aClinical Laboratory Personnels
=450  \\$wnnna$aClinical Laboratory Scientist
=450  \\$wnnna$aClinical Laboratory Scientists
=450  \\$wnnna$aClinical Laboratory Technician
=450  \\$wnnna$aClinical Laboratory Technicians
=450  \\$wnnna$aLaboratory Assistant, Medical
=450  \\$wnnna$aLaboratory Assistants, Medical
=450  \\$wnnna$aLaboratory Personnel, Clinical
=450  \\$wnnna$aLaboratory Personnel, Medical
=450  \\$wnnna$aLaboratory Personnels, Clinical
=450  \\$wnnna$aLaboratory Personnels, Medical
=450  \\$wnnna$aLaboratory Scientist, Clinical
=450  \\$wnnna$aLaboratory Scientist, Medical
=450  \\$wnnna$aLaboratory Scientists, Clinical
=450  \\$wnnna$aLaboratory Scientists, Medical
=450  \\$wnnna$aLaboratory Technician, Clinical
=450  \\$wnnna$aLaboratory Technician, Medical
=450  \\$wnnna$aLaboratory Technicians, Clinical
=450  \\$wnnna$aLaboratory Technicians, Medical
=450  \\$wnnna$aMedical Laboratory Assistant
=450  \\$wnnna$aMedical Laboratory Assistants
=450  \\$wnnna$aMedical Laboratory Personnels
=450  \\$wnnna$aMedical Laboratory Scientist
=450  \\$wnnna$aMedical Laboratory Scientists
=450  \\$wnnna$aMedical Laboratory Technician
=450  \\$wnnna$aMedical Laboratory Technicians
=450  \\$wnnna$aMedical Technologist
=450  \\$wnnna$aMedical Technologists
=450  \\$wnnna$aPersonnel, Clinical Laboratory
=450  \\$wnnna$aPersonnel, Medical Laboratory
=450  \\$wnnna$aPersonnels, Clinical Laboratory
=450  \\$wnnna$aPersonnels, Medical Laboratory
=450  \\$wnnna$aScientist, Clinical Laboratory
=450  \\$wnnna$aScientist, Medical Laboratory
=450  \\$wnnna$aScientists, Clinical Laboratory
=450  \\$wnnna$aScientists, Medical Laboratory
=450  \\$wnnna$aTechnician, Clinical Laboratory
=450  \\$wnnna$aTechnician, Medical Laboratory
=450  \\$wnnna$aTechnicians, Clinical Laboratory
=450  \\$wnnna$aTechnicians, Medical Laboratory
=450  \\$wnnna$aTechnologist, Medical
=450  \\$wnnna$aTechnologists, Medical
=550  \\$wg$aHealth Personnel
=550  \\$wg$aLaboratory Personnel
=550  \\$aMedical Laboratory Science
=667  \\$acoord IM with type of lab or occup (IM), as hosp lab personnel = MEDICAL LABORATORY PERSONNEL (IM) + LABORATORIES, HOSPITAL (IM) or hematol lab personnel = MEDICAL LABORATORY PERSONNEL (IM) + HEMATOLOGY (IM)
=680  \\$iHealth care professionals, technicians, and assistants staffing LABORATORIES in research or health care facilities.
=688  \\$a2012 (1992)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Laboratory Personnel
=688  \\$a92
=750  \0$aMedical technologists$0(DLC) sh 85083045$5IEN-M

=LDR  01058cz  a2200253n  4500
=001  9880364110902441
=005  20141212211904.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017054
=035  \\$aCBM5932HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x539
=150  \\$aInsurance, Medigap
=450  \\$aMedigap Insurance
=450  \\$wnnna$aMedigap Policies
=450  \\$wnnna$aMedigap Policy
=450  \\$wnnna$aPolicies, Medigap
=450  \\$wnnna$aPolicy, Medigap
=550  \\$wg$aInsurance, Health
=550  \\$aMedicare
=667  \\$ainsures the gap between payments by private insurers & Medicare; specify geog
=680  \\$iA supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. (From Facts on File Dictionary of Health Care Management, 1988)
=688  \\$a92
=750  \0$aMedigap$5IEN-M$0(DLC)sh 85083205

=LDR  01351cz  a2200301n  4500
=001  9880364111002441
=005  20141212211903.0
=008  910719\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017053
=035  \\$aCBM5931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x450
=150  \\$aInfection Control
=450  \\$wnnna$aControl, Infection
=450  \\$aInfection$xprevention & control
=550  \\$wg$aCommunicable Disease Control
=550  \\$wh$aAntisepsis
=550  \\$wh$aBlood Safety
=550  \\$wh$aInfection Control, Dental
=550  \\$wh$aPatient Isolation
=550  \\$wh$aQuarantine
=550  \\$wh$aSterilization
=550  \\$aCommunicable Disease Control
=550  \\$aCross Infection
=667  \\$adifferentiate from COMMUNICABLE DISEASE CONTROL which tends to be on a large geog, demog or social level (e.g., city, underprivileged, elementary school, prison) while INFECTION CONTROL tends to be restricted within hosp or other health care facilities; if in doubt, use term of author; DF: INFECT CONTROL
=680  \\$iPrograms of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms.
=688  \\$a92; was INFECTION/prevention & control 1966-91
=750  \0$aInfection$xPrevention$5IEN-M

=LDR  01768cz  a2200493n  4500
=001  9880364111102441
=005  20141212211903.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017052
=035  \\$aCBM5930HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x400
=072  \\$aL1.$x280.$x975.$x550.$x400
=072  \\$aN1.$x224.$x935.$x698.$x400
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x400
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x400
=150  \\$aHospital Mortality
=450  \\$wnnna$aHospital Mortalities
=450  \\$wnnna$aHospital Mortalities, In
=450  \\$wnnna$aHospital Mortality, In
=450  \\$wnnna$aIn Hospital Mortalities
=450  \\$wnnna$aIn-Hospital Mortalities
=450  \\$wnnna$aIn Hospital Mortality
=450  \\$aIn-Hospital Mortality
=450  \\$wnnna$aIn-house Mortalities
=450  \\$wnnna$aIn-house Mortality
=450  \\$wnnna$aInhospital Mortalities
=450  \\$wnnna$aInhospital Mortality
=450  \\$wnnna$aMortalities, Hospital
=450  \\$wnnna$aMortalities, In Hospital
=450  \\$wnnna$aMortalities, In-Hospital
=450  \\$wnnna$aMortalities, In-house
=450  \\$wnnna$aMortalities, In house
=450  \\$wnnna$aMortalities, Inhospital
=450  \\$aMortality, Hospital
=450  \\$wnnna$aMortality, In-Hospital
=450  \\$wnnna$aMortality, In Hospital
=450  \\$wnnna$aMortality, In-house
=450  \\$wnnna$aMortality, Inhospital
=550  \\$wg$aMortality
=667  \\$adeath statist from any cause in hosp patients; DF: HOSP MORTAL
=680  \\$iA vital statistic measuring or recording the rate of death from any cause in hospitalized populations.
=688  \\$a92
=750  \0$aHospital patients$xMortality$5IEN-M

=LDR  01379cz  a2200301n  4500
=001  9880364111202441
=005  20141212211902.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017051
=035  \\$aCBM5929HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x905.$x400
=072  \\$aN2.$x421.$x585.$x905.$x400
=150  \\$aHospice Care
=450  \\$aBereavement Care
=450  \\$wnnna$aCare, Bereavement
=450  \\$wnnna$aCare, Hospice
=450  \\$wnnna$aHospice Program
=450  \\$aHospice Programs
=450  \\$wnnna$aProgram, Hospice
=450  \\$wnnna$aPrograms, Hospice
=550  \\$wg$aTerminal Care
=550  \\$aHospice and Palliative Care Nursing
=550  \\$aTerminal Care
=667  \\$afor the dying; /psychol permitted
=680  \\$iSpecialized health care, supportive in nature, provided to a dying person. A holistic approach is often taken, providing patients and their families with legal, financial, emotional, or spiritual counseling in addition to meeting patients' immediate physical needs. Care may be provided in the home, in the hospital, in specialized facilities (HOSPICES), or in specially designated areas of long-term care facilities. The concept also includes bereavement care for the family. (From Dictionary of Health Services Management, 2d ed)
=688  \\$a92
=750  \0$aHospice care$5IEN-M$0(DLC)sh 85062231

=LDR  02043cz  a2200493n  4500
=001  9880364111302441
=005  20141212211901.0
=008  910620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017048
=035  \\$aCBM5926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x400
=072  \\$aN5.$x300.$x375
=150  \\$aHealth Care Costs
=450  \\$wnnna$aCost, Health
=450  \\$wnnna$aCost, Health Care
=450  \\$wnnna$aCost, Healthcare
=450  \\$wnnna$aCost, Medical Care
=450  \\$wnnna$aCost, Treatment
=450  \\$wnnna$aCosts, Health
=450  \\$wnnna$aCosts, Health Care
=450  \\$wnnna$aCosts, Healthcare
=450  \\$wnnna$aCosts, Medical Care
=450  \\$wnnna$aCosts, Treatment
=450  \\$wnnna$aHealth Care Cost
=450  \\$wnnna$aHealth Cost
=450  \\$wnnna$aHealth Costs
=450  \\$wnnna$aHealthcare Cost
=450  \\$wnnna$aHealthcare Costs
=450  \\$wnnna$aMedical Care Cost
=450  \\$aMedical Care Costs
=450  \\$wnnna$aTreatment Cost
=450  \\$aTreatment Costs
=550  \\$wg$aCosts and Cost Analysis
=550  \\$wg$aDelivery of Health Care
=550  \\$wh$aDirect Service Costs
=550  \\$wh$aDrug Costs
=550  \\$wh$aEmployer Health Costs
=550  \\$wh$aHospital Costs
=550  \\$aHealth Expenditures
=667  \\$aactual cost of providing care: do not confuse with HEALTH EXPENDITURES (the amount paid for the service) or with FEES AND CHARGES (the amount charged regardless of cost); do not confuse with COST OF ILLNESS which is a personal cost (psychol, social, etc.) as well as a monetary cost for services
=680  \\$iThe actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.
=688  \\$a92
=750  \0$aMedical care, Cost of$5IEN-M$0(DLC)sh 85082888

=LDR  00844cz  a2200205n  4500
=001  9880364111402441
=005  20141212211900.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017045
=035  \\$aCBM5923HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x800.$x500
=072  \\$aB3.$x510.$x550.$x737.$x500
=150  \\$aLactococcus
=550  \\$wg$aStreptococcaceae
=550  \\$wh$aLactococcus lactis
=667  \\$ausually non-pathogenic; in milk & milk products
=680  \\$iA genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS (group N), it is now recognized as a separate genus.
=688  \\$a92
=750  \0$aLactococcus$5IEN-M$0(DLC)sh 91001168

=LDR  00650cz  a2200241n  4500
=001  9880364111502441
=005  20141212211859.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017043
=035  \\$aCBM5921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x197
=072  \\$aC11.$x338.$x300
=150  \\$aChalazion
=450  \\$wnnna$aChalazia
=450  \\$wnnna$aCyst, Meibomian
=450  \\$aMeibomian Cyst
=550  \\$wg$aCysts
=550  \\$wg$aEyelid Diseases
=550  \\$aMeibomian Glands
=680  \\$iA non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.
=688  \\$a92
=750  \0$aMeibomian Glands$xCysts$5IEN-M

=LDR  01947cz  a2200445n  4500
=001  9880364111602441
=005  20141212211858.0
=008  910726\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017041
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x173
=072  \\$aN4.$x452.$x758.$x788.$x300
=072  \\$aN5.$x350.$x268
=072  \\$aN5.$x700.$x685.$x300
=150  \\$aEthics Committees
=450  \\$wnnna$aCommittee, Ethics
=450  \\$wnnna$aCommittee, Institutional Ethics
=450  \\$wnnna$aCommittee, Regional Ethics
=450  \\$wnnna$aCommittees, Ethics
=450  \\$wnnna$aCommittees, Institutional Ethics
=450  \\$wnnna$aCommittees, Regional Ethics
=450  \\$wnnna$aEthics Committee
=450  \\$wnnna$aEthics Committee, Institutional
=450  \\$wnnna$aEthics Committee, Regional
=450  \\$wnnna$aEthics Committees, Institutional
=450  \\$wnnna$aEthics Committees, Regional
=450  \\$wnnna$aInstitutional Ethics Committee
=450  \\$aInstitutional Ethics Committees
=450  \\$wnnna$aRegional Ethics Committee
=450  \\$wnnna$aRegional Ethics Committees
=550  \\$wg$aEthics
=550  \\$wg$aProfessional Staff Committees
=550  \\$wh$aEthics Committees, Clinical
=550  \\$wh$aEthics Committees, Research
=550  \\$aAdvisory Committees
=550  \\$aAnimal Care Committees
=550  \\$aEthical Review
=680  \\$iCommittees established by professional societies, health facilities, or other institutions to consider decisions that have bioethical implications. The role of these committees may include consultation, education, mediation, and/or review of policies and practices. Committees that consider the ethical dimensions of patient care are ETHICS COMMITTEES, CLINICAL; committees established to protect the welfare of research subjects are ETHICS COMMITTEES, RESEARCH.
=688  \\$a92
=750  \0$aEthics committees$5IEN-M$0(DLC)sh 85045123

=LDR  02558cz  a2200745n  4500
=001  9880364111702441
=005  20141212211856.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017035
=035  \\$aCBM5915M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x930
=072  \\$aD4.$x615.$x638.$x930
=150  \\$aPravastatin
=450  \\$wnnna$aApo-Pravastatin
=450  \\$wnnna$aApo Pravastatin
=450  \\$wnnna$aApotex Brand of Pravastatin Sodium
=450  \\$wnnna$aAventis Brand of Pravastatin Sodium
=450  \\$wnnna$aBristacol
=450  \\$wnnna$aBristol-Myers Squibb Brand of Pravastatin Sodium
=450  \\$wnnna$aCS-514
=450  \\$wnnna$aCS 514
=450  \\$wnnna$aCS514
=450  \\$wnnna$aElisor
=450  \\$aEptastatin
=450  \\$wnnna$aEsteve Brand of Pravastatin Sodium
=450  \\$wnnna$aJuste Brand of Pravastatin Sodium
=450  \\$wnnna$aLin-Pravastatin
=450  \\$wnnna$aLin Pravastatin
=450  \\$wnnna$aLinson Pharma Brand of Pravastatin Sodium
=450  \\$wnnna$aLipemol
=450  \\$wnnna$aLiplat
=450  \\$wnnna$aLipostat
=450  \\$wnnna$aMevalotin
=450  \\$wnnna$aNu-Pharma Brand of Pravastatin Sodium
=450  \\$wnnna$aNu-Pravastatin
=450  \\$wnnna$aNu Pravastatin
=450  \\$wnnna$aPrareduct
=450  \\$wnnna$aPravachol
=450  \\$wnnna$aPravacol
=450  \\$wnnna$aPravasin
=450  \\$wnnna$aPravastatin, (6 beta)-Isomer
=450  \\$wnnna$aPravastatin Monosodium Salt, (6 beta)-Isomer
=450  \\$wnnna$aPravastatin Sodium
=450  \\$wnnna$aPravastatin Sodium Salt
=450  \\$wnnna$aPravastatin tert-Octylamine Salt
=450  \\$wnnna$aPravastatin tert Octylamine Salt
=450  \\$wnnna$aRMS-431
=450  \\$wnnna$aRMS 431
=450  \\$wnnna$aRMS431
=450  \\$wnnna$aSankyo Brand of Pravastatin Sodium
=450  \\$wnnna$aSelektine
=450  \\$wnnna$aSodium Salt, Pravastatin
=450  \\$wnnna$aSQ-31,000
=450  \\$wnnna$aSQ 31,000
=450  \\$wnnna$aSQ-31000
=450  \\$wnnna$aSQ 31000
=450  \\$wnnna$aSQ31,000
=450  \\$wnnna$aSQ31000
=450  \\$wnnna$aSquibb Brand of Pravastatin Sodium
=450  \\$wnnna$aVasten
=550  \\$wg$aNaphthalenes
=680  \\$iAn antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).
=688  \\$a92; was PRAVASTATIN (NM) 1986-91
=750  \0$aPravastatin$5IEN-M$0(DLC)sh2002000834

=LDR  01074cz  a2200253n  4500
=001  9880364111802441
=005  20180904125230.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017033
=035  \\$aCBM5913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x100
=072  \\$aB3.$x440.$x475.$x100.$x100
=072  \\$aB3.$x585.$x51
=150  \\$aAnabaena
=550  \\$wg$aCyanobacteria
=550  \\$wg$aNitrogen-Fixing Bacteria
=550  \\$wh$aAnabaena cylindrica
=550  \\$wh$aAnabaena flos-aquae
=550  \\$wh$aAnabaena variabilis
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater PLANKTON and also of many saline lakes. The species ANABAENA FLOS-AQUAE is responsible for acute poisonings of various animals.
=688  \\$a92
=750  \0$aAnabaena$5IEN-M$0(DLC)sh 89004372

=LDR  01565cz  a2200373n  4500
=001  9880364111902441
=005  20141212192715.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017028
=035  \\$aCBM5909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x85
=072  \\$aM1.$x526.$x485.$x200
=072  \\$aN2.$x360.$x200
=150  \\$aCaregivers
=450  \\$wnnna$aCare Giver
=450  \\$wnnna$aCare Givers
=450  \\$wnnna$aCaregiver
=450  \\$wnnna$aCaregiver, Family
=450  \\$wnnna$aCaregiver, Spouse
=450  \\$wnnna$aCaregivers, Family
=450  \\$wnnna$aCaregivers, Spouse
=450  \\$wnnna$aCarer
=450  \\$wnnna$aCarers
=450  \\$wnnna$aFamily Caregiver
=450  \\$aFamily Caregivers
=450  \\$wnnna$aSpouse Caregiver
=450  \\$aSpouse Caregivers
=550  \\$wg$aHealth Personnel
=550  \\$wg$aPersons
=667  \\$ageneral or unspecified; prefer specific caregiver as NURSES; PHYSICIANS; etc.; coordinate IM with specific field if pertinent (IM): "the teacher as caregiver" = CAREGIVERS (IM) + TEACHING (IM)
=680  \\$iPersons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients.
=688  \\$a92
=750  \0$aCaregivers$0(DLC)sh 88007577$5IEN-M

=LDR  01986cz  a2200433n  4500
=001  9880364112002441
=005  20141212211854.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017027
=035  \\$aCBM5908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x775
=150  \\$aProtein Tyrosine Phosphatases
=450  \\$wnnna$aPhosphatase, Phosphotyrosine
=450  \\$wnnna$aPhosphatase, Phosphotyrosyl Protein
=450  \\$wnnna$aPhosphatase, Protein-Tyrosine
=450  \\$wnnna$aPhosphatase, Tyrosyl Phosphoprotein
=450  \\$wnnna$aPhosphatases, Protein Tyrosine
=450  \\$wnnna$aPhosphoprotein Phosphatase, Tyrosyl
=450  \\$aPhosphotyrosine Phosphatase
=450  \\$wnnna$aPhosphotyrosyl Protein Phosphatase
=450  \\$wnnna$aProtein Phosphatase, Phosphotyrosyl
=450  \\$wnnna$aProtein-Tyrosine Phosphatase
=450  \\$aProtein-Tyrosine-Phosphatase
=450  \\$wnnna$aProtein Tyrosine Phosphatase
=450  \\$wnnna$aPTPase
=450  \\$wnnna$aTyrosine Phosphatases, Protein
=450  \\$aTyrosyl Phosphoprotein Phosphatase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=550  \\$wh$aDual-Specificity Phosphatases
=550  \\$wh$aProtein Tyrosine Phosphatases, Non-Receptor
=550  \\$wh$aReceptor-Like Protein Tyrosine Phosphatases
=550  \\$wh$aSH2 Domain-Containing Protein Tyrosine Phosphatases
=667  \\$ageneral; prefer specifics
=680  \\$iAn enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis.
=688  \\$a2008(1985)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Protein-Tyrosine-Phosphatase
=688  \\$a92; was PROTEIN-TYROSINE PHOSPHATASE (NM) 1985-91
=750  \0$aProtein-tyrosine phosphatase$0(DLC) sh 96008310$5IEN-M

=LDR  00920cz  a2200229n  4500
=001  9880364112102441
=005  20141212211854.0
=008  910712\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017026
=035  \\$aCBM5907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x830
=150  \\$aSwainsonine
=450  \\$wnnna$aSwainsonine, (1R-(2 beta,8a alpha))-Isomer
=450  \\$wnnna$aSwainsonine, (2 beta,8a alpha)-Isomer
=450  \\$wnnna$aSwainsonine, (8 alpha,8a alpha)-Isomer
=450  \\$wnnna$aSwainsonine, (8 alpha)-Isomer
=450  \\$wnnna$aSwainsonine, (8a alpha)-Isomer
=550  \\$wg$aAlkaloids
=680  \\$iAn indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.
=688  \\$a92; was SWAINSONINE (NM) 1981-91
=750  \0$aSwainsonine$5IEN-M$0(DLC)sh 89003351

=LDR  01016cz  a2200277n  4500
=001  9880364112202441
=005  20141212211853.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017023
=035  \\$aCBM5904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x625
=072  \\$aE1.$x370.$x350.$x700.$x60.$x200
=072  \\$aE1.$x370.$x370.$x50.$x200
=072  \\$aE1.$x370.$x370.$x380.$x200
=150  \\$aCoronary Angiography
=450  \\$wnnna$aAngiographies, Coronary
=450  \\$aAngiography, Coronary
=450  \\$wnnna$aCoronary Angiographies
=550  \\$wg$aAngiography
=550  \\$wg$aCardiac Imaging Techniques
=550  \\$wg$aHeart Function Tests
=667  \\$afor radiography of coronary vessels using non-contrast methods, index CORONARY VESSELS / radiogr + specific radiographic technique
=680  \\$iRadiography of the vascular system of the heart muscle after injection of a contrast medium.
=688  \\$a92
=750  \0$aHeart$xBlood vessels$xRadiography$5IEN-M

=LDR  01031cz  a2200241n  4500
=001  9880364112302441
=005  20141212211853.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017022
=035  \\$aCBM5903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x460
=150  \\$aFlow Injection Analysis
=450  \\$wnnna$aAnalyses, Flow Injection
=450  \\$wnnna$aAnalysis, Flow Injection
=450  \\$wnnna$aFlow Injection Analyses
=450  \\$wnnna$aInjection Analyses, Flow
=450  \\$wnnna$aInjection Analysis, Flow
=550  \\$wg$aChemistry Techniques, Analytical
=667  \\$aan anal chem technique; NIM; DF: FLOW INJECT ANAL
=680  \\$iThe analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device.
=688  \\$a92
=750  \0$aFlow injection analysis$5IEN-M$0(DLC)sh 90005310

=LDR  00859cz  a2200181n  4500
=001  9880364112402441
=005  20141212211851.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017014
=035  \\$aCBM5895M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2.$x200.$x492.$x500.$x500
=150  \\$aMethanobacterium
=550  \\$wg$aMethanobacteriaceae
=667  \\$aa genus of methanogens found throughout nature & in gastrointestinal tract of animals: do not confuse with plural see ref METHANOBACTERIA see EURYARCHAEOTA; DF: METHANOBACT
=680  \\$iA genus of anaerobic, rod-shaped METHANOBACTERIACEAE. Its organisms are nonmotile and use ammonia as the sole source of nitrogen. These methanogens are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals.
=688  \\$a92
=750  \0$aMethanobacterium$5IEN-M$0(DLC)sh 86005198

=LDR  00795cz  a2200217n  4500
=001  9880364112502441
=005  20141212211851.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017013
=035  \\$aCBM5894HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2.$x200.$x492.$x500
=150  \\$aMethanobacteriaceae
=450  \\$aMethanosphaera
=450  \\$aMethanothermobacter
=550  \\$wg$aMethanobacteriales
=550  \\$wh$aMethanobacterium
=550  \\$wh$aMethanobrevibacter
=680  \\$iA family of anaerobic, coccoid to rod-shaped METHANOBACTERIALES. Cell membranes are composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature.
=688  \\$a92
=750  \0$aMethanobacteriaceae$5IEN-M$0(DLC)sh 86005196

=LDR  00929cz  a2200241n  4500
=001  9880364112602441
=005  20141212211850.0
=008  910726\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017009
=035  \\$aCBM5890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x752
=150  \\$aProfessional Autonomy
=450  \\$wnnna$aAutonomy, Professional
=450  \\$wnnna$aProfessional Self Regulation
=450  \\$wnnna$aRegulation, Professional Self
=450  \\$wnnna$aSelf Regulation, Professional
=550  \\$wg$aProfessional Practice
=550  \\$aPersonal Autonomy
=680  \\$iThe quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.
=688  \\$a92
=750  \0$81$wb$aAutonomy$5IEN-M$0(DLC)sh 85010457
=750  \0$81$wb$aProfessional employees$5IEN-HS$0(DLC)sh 85107253

=LDR  01490cz  a2200385n  4500
=001  9880364112702441
=005  20170104104315.0
=008  910530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D017008
=035  \\$aCBM5889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x520
=072  \\$aF1.$x829.$x401.$x520
=072  \\$aF2.$x463.$x785.$x373.$x520
=072  \\$aL1.$x143.$x620
=072  \\$aN4.$x452.$x677.$x430
=150  \\$aNegotiating
=450  \\$aArbitrating
=450  \\$wnnna$aArbitration
=450  \\$wnnna$aConflict Resolution
=450  \\$wnnna$aConflict Resolutions
=450  \\$aMediating
=450  \\$wnnna$aMediation
=450  \\$wnnna$aNegotiation
=450  \\$wnnna$aNegotiations
=450  \\$wnnna$aResolution, Conflict
=550  \\$wg$aCommunication
=550  \\$wg$aDecision Making
=550  \\$wh$aDiplomacy
=550  \\$wg$aInterpersonal Relations
=550  \\$wg$aPersonnel Management
=667  \\$anot restricted to labor unions: used also for interpersonal communications, personnel management, business transactions, etc.
=680  \\$iThe process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy.
=688  \\$a92
=750  \0$aNegotiation$5IEN-M$0(DLC)sh 85090650

=LDR  00788cz  a2200205n  4500
=001  9880364112802441
=005  20141212211800.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016847
=035  \\$aCBM5731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x700
=150  \\$aSchizopyrenida
=450  \\$wnnna$aSchizopyrenidas
=550  \\$wg$aLobosea
=550  \\$wh$aNaegleria
=667  \\$ainfection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of ameboid protozoa commonly having a monopodial cylindrically shaped body. Nuclear division is promitotic and most species have a temporary flagellate stage.
=688  \\$a92
=750  \0$aSchizopyrenida$5IEN-M$0(DLC)sh 88021429

=LDR  00846cz  a2200253n  4500
=001  9880364112902441
=005  20141212211758.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016841
=035  \\$aCBM5725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x500.$x100
=150  \\$aAmoebida
=450  \\$wnnna$aAmebida
=450  \\$wnnna$aAmebidas
=450  \\$wnnna$aAmoebidas
=550  \\$wg$aLobosea
=550  \\$wh$aAcanthopodina
=550  \\$wh$aBlastocystina
=550  \\$wh$aTubulina
=667  \\$ainfection: coordinate IM with AMEBIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of ameboid protozoa that is commonly uninucleate and possess mitochondria. Most organisms are nonpathogenic.
=688  \\$a92
=750  \0$aAmoebida$5IEN-M$0(DLC)sh 85004570

=LDR  00892cz  a2200217n  4500
=001  9880364113002441
=005  20141212211757.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016839
=035  \\$aCBM5723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x550.$x550.$x600.$x700.$x550
=150  \\$aPhysarum polycephalum
=450  \\$wnnna$aPhysarum polycephalums
=450  \\$wnnna$apolycephalum, Physarum
=450  \\$wnnna$apolycephalums, Physarum
=550  \\$wg$aPhysarum
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA protozoan, previously also considered a fungus. Characteristics include sporangia that are stalked and multilobed. It is widely used in biomedical research.
=688  \\$a92
=750  \0$aPhysarum polycephalum$5IEN-M$0(DLC)sh 86002265

=LDR  00914cz  a2200229n  4500
=001  9880364113102441
=005  20141212211756.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016834
=035  \\$aCBM5718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x630.$x800
=150  \\$aTrichomonadida
=450  \\$wnnna$aTrichomonadidas
=550  \\$wg$aParabasalidea
=550  \\$wh$aDientamoeba
=550  \\$wh$aTrichomonas
=550  \\$wh$aTritrichomonas
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
=680  \\$iAn order of parasitic EUKARYOTES typically having four to six flagella. True cysts are known in very few species. Trichomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm.
=688  \\$a92
=750  \0$aTrichomonadida$5IEN-M$0(DLC)sh 88021468

=LDR  00836cz  a2200205n  4500
=001  9880364113202441
=005  20141212211755.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016830
=035  \\$aCBM5714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475
=150  \\$aKinetoplastida
=450  \\$wnnna$aKinetoplastidas
=550  \\$wg$aEuglenozoa
=550  \\$wh$aTrypanosomatina
=667  \\$ainfection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of flagellate protozoa. Characteristics include the presence of one or two flagella arising from a depression in the cell body and a single mitochondrion that extends the length of the body.
=688  \\$a92
=750  \0$aKinetoplastida$5IEN-M$0(DLC)sh 85072389

=LDR  00989cz  a2200229n  4500
=001  9880364113302441
=005  20141212211755.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016829
=035  \\$aCBM5713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x237.$x385.$x400
=150  \\$aGiardia lamblia
=450  \\$aGiardia duodenalis
=450  \\$aGiardia intestinalis
=450  \\$wnnna$aGiardia lamblias
=450  \\$aLamblia intestinalis
=550  \\$wg$aGiardia
=667  \\$ainfection: coordinate IM with GIARDIASIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent; a virus infecting Giardia lamblia is named GIARDIAVIRUS
=680  \\$iA species of parasitic EUKARYOTES that attaches itself to the intestinal mucosa and feeds on mucous secretions. The organism is roughly pear-shaped and motility is somewhat erratic, with a slow oscillation about the long axis.
=688  \\$a92
=750  \0$aGiardia lamblia$5IEN-M$0(DLC)sh 86001441

=LDR  01028cz  a2200229n  4500
=001  9880364113402441
=005  20141212211754.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016828
=035  \\$aCBM5712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x237
=150  \\$aDiplomonadida
=450  \\$wnnna$aDiplomonad
=450  \\$wnnna$aDiplomonadidas
=450  \\$wnnna$aDiplomonads
=550  \\$wg$aEukaryota
=550  \\$wh$aGiardia
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
=680  \\$iA group of flagellated, mostly symbiotic EUKARYOTES characterized by twofold symmetry associated with the presence of a pair of karyomastigont organellar systems. Two nuclei are attached by fibers to the flagella and there are no MITOCHONDRIA. Diplomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm.
=688  \\$a92
=750  \0$aDiplomonadida$5IEN-M$0(DLC)sh 85038205

=LDR  00936cz  a2200205n  4500
=001  9880364113502441
=005  20141212211753.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016823
=035  \\$aCBM5707HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x925
=150  \\$aVolvocida
=450  \\$aChlamydomonadales
=550  \\$wg$aChlorophyta
=550  \\$wh$aChlamydomonas
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iAn order of CHLOROPHYTA commonly found in freshwater habitats. Characteristics include the presence of a cellulose wall and two to four equal, smooth, apical flagella.
=688  \\$a92
=750  \0$aVolvocales$5IEN-M$0(DLC)sh 85144379

=LDR  01111cz  a2200253n  4500
=001  9880364113602441
=005  20141212211753.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016822
=035  \\$aCBM5706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x250
=150  \\$aEuglenida
=450  \\$wnnna$aEuglenid
=450  \\$wnnna$aEuglenidas
=450  \\$wnnna$aEuglenids
=450  \\$aEuglenophyta
=450  \\$wnnna$aEuglenophytas
=550  \\$wg$aEuglenozoa
=550  \\$wh$aEuglena
=667  \\$ainfection; coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA phylum of unicellular flagellates of ancient eukaryotic lineage with unclear taxonomy. They lack a CELL WALL but are covered by a proteinaceous flexible coat, the pellicle, that allows the cell to change shape. Historically some authorities considered them to be an order of protozoa and others classed them as ALGAE (some members have CHLOROPLASTS and some don't).
=688  \\$a92
=750  \0$aEuglenales$5IEN-HS$0(DLC)sh 88022364

=LDR  00925cz  a2200193n  4500
=001  9880364113702441
=005  20141212211752.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016818
=035  \\$aCBM5702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x360.$x500.$x500.$x100.$x400
=150  \\$aNosema
=450  \\$wnnna$aNosemas
=550  \\$wg$aApansporoblastina
=667  \\$anote NOSEMA CUNICULI see ENCEPHALITOZOON CUNICULI and NOSEMA CORNEUM see VITTAFORMA; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent
=680  \\$iA genus of parasitic FUNGI in the family Nosematidae. Some species are pathogenic for invertebrates of economic importance while others are being researched for possible roles in controlling pest INSECTS. They are also pathogenic in humans.
=688  \\$a1992
=750  \0$aNosema$5IEN-M$0(DLC)sh 85092763

=LDR  00899cz  a2200217n  4500
=001  9880364113802441
=005  20141212211751.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016816
=035  \\$aCBM5700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x360.$x500.$x500
=150  \\$aMicrosporida
=450  \\$wnnna$aMicrosporidas
=550  \\$wg$aMicrosporea
=550  \\$wh$aApansporoblastina
=550  \\$wh$aPansporablastina
=667  \\$ado not confuse with the fungal phylum MICROSPORIDIA; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent
=680  \\$iAn order of parasitic FUNGI found mostly in ARTHROPODS; FISHES; and in some VERTEBRATES including humans. It comprises two suborders: Pansporoblastina and APANSPOROBLASTINA.
=688  \\$a1992
=750  \0$aMicrosporida$5IEN-M$0(DLC)sh 88021374

=LDR  00842cz  a2200205n  4500
=001  9880364113902441
=005  20141212211751.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016815
=035  \\$aCBM5699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x360.$x500
=150  \\$aMicrosporea
=450  \\$wnnna$aMicrosporeas
=550  \\$wg$aMicrosporidia
=550  \\$wh$aMicrosporida
=667  \\$ado not confuse with fungal phylum MICROSPORA see MICROSPORIDIA; infection: coordinate IM with MICROSPORIDIOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent
=680  \\$iA class of parasitic FUNGI. Characteristics include spores that are spherical, oval, or tubular in shape and sporoplasm which is uninuclear or binuclear.
=688  \\$a1992
=750  \0$aMicrosporea$5IEN-M$0(DLC)sh 88021373

=LDR  01199cz  a2200265n  4500
=001  9880364114002441
=005  20141212211751.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016814
=035  \\$aCBM5698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x360
=150  \\$aMicrosporidia
=450  \\$aMicrospora
=450  \\$wnnna$aMicrosporas
=450  \\$wnnna$aMicrosporidias
=550  \\$wg$aFungi
=550  \\$wh$aMicrosporea
=550  \\$wh$aMicrosporidia, Unclassified
=667  \\$ado not confuse with the class MICROSPOREA, the order MICROSPORIDA, or with MICROSPORUM, a dermatophyte; MICROSPORIDIA, UNCLASSIFIED is also available, see annotation there; infection = MICROSPORIDIOSIS; coordinate with specific fungal term (ANTIGENS, FUNGAL, etc) if pertinent
=680  \\$iA phylum of fungi comprising minute intracellular PARASITES with FUNGAL SPORES of unicellular origin. It has two classes: Rudimicrosporea and MICROSPOREA.
=688  \\$a2006 (1992); use MICROSPORIDA 1991-2000
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Microspora
=688  \\$a1992; for MICROSPORIDIA use MICROSPORIDA 1991-2000
=750  \0$aMicrosporidia$0(DLC) sh 85084925$5IEN-M

=LDR  00751cz  a2200193n  4500
=001  9880364114102441
=005  20141212211750.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016812
=035  \\$aCBM5696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x700.$x400.$x750.$x375
=150  \\$aEuplotes
=450  \\$wnnna$aEuplote
=550  \\$wg$aSporadotrichina
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of ciliate protozoa having a dorsoventrally flattened body with widely spaced rows of short bristle-like cilia on the dorsal surface.
=688  \\$a92
=750  \0$aEuplotes$5IEN-M$0(DLC)sh 88021331

=LDR  00869cz  a2200217n  4500
=001  9880364114202441
=005  20141212211748.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016803
=035  \\$aCBM5688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375
=150  \\$aHymenostomatida
=450  \\$wnnna$aHymenostomatidas
=550  \\$wg$aOligohymenophorea
=550  \\$wh$aPeniculina
=550  \\$wh$aTetrahymenina
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of ciliate protozoa. Characteristics include a ventral oral area and a well-defined buccal cavity. It comprises three suborders: TETRAHYMENINA, Ophryoglenina, and PENICULINA.
=688  \\$a92
=750  \0$aHymenostomatida$5IEN-M$0(DLC)sh 85063595

=LDR  00800cz  a2200205n  4500
=001  9880364114302441
=005  20141212211748.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016800
=035  \\$aCBM5685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x375.$x650
=150  \\$aTrichostomatida
=450  \\$wnnna$aTrichostomatidas
=550  \\$wg$aKinetofragminophorea
=550  \\$wh$aTrichostomatina
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of ciliate protozoa in which the cytostome is usually situated at the base of an oral groove, the wall of which bears dense cilia.
=688  \\$a92
=750  \0$aTrichostomatida$5IEN-M$0(DLC)sh 88021475

=LDR  00930cz  a2200229n  4500
=001  9880364114402441
=005  20141212211747.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016799
=035  \\$aCBM5684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x375
=150  \\$aKinetofragminophorea
=450  \\$wnnna$aKinetofragminophoreas
=450  \\$aSuctoria
=450  \\$wnnna$aSuctorias
=550  \\$wg$aCiliophora
=550  \\$wh$aTrichostomatida
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia.
=688  \\$a92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84
=750  \0$aKinetofragminophora$5IEN-M$0(DLC)sh 88021360

=LDR  00970cz  a2200253n  4500
=001  9880364114502441
=005  20141212211747.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016798
=035  \\$aCBM5683HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185
=150  \\$aCiliophora
=450  \\$aCiliata
=450  \\$wnnna$aCiliatas
=450  \\$wnnna$aCiliophoras
=550  \\$wg$aAlveolata
=550  \\$wh$aKinetofragminophorea
=550  \\$wh$aOligohymenophorea
=550  \\$wh$aPolymenophorea
=667  \\$ageneral; prefer specifics; infection = CILIOPHORA INFECTIONS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA phylum of EUKARYOTES characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA; OLIGOHYMENOPHOREA; and POLYMENOPHOREA.
=688  \\$a92; CILIATA was heading 1963-91
=750  \0$aCiliata$5IEN-M$0(DLC)sh 85025977

=LDR  00906cz  a2200217n  4500
=001  9880364114602441
=005  20141212211747.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016797
=035  \\$aCBM5682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x600.$x580.$x700.$x500
=150  \\$aTheileria parva
=450  \\$wnnna$aparva, Theileria
=450  \\$wnnna$aparvas, Theileria
=450  \\$wnnna$aTheileria parvas
=550  \\$wg$aTheileria
=667  \\$ainfection: coordinate IM with THEILERIASIS (IM) + check tags ANIMALS & CATTLE but not also CATTLE DISEASES; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA protozoan parasite that is the etiologic agent of East Coast fever (THEILERIASIS). Transmission is by ticks of the Physicephalus and Hyalomma genera.
=688  \\$a92
=750  \0$aTheileria parva$5IEN-M$0(DLC)sh 88021460

=LDR  00899cz  a2200217n  4500
=001  9880364114702441
=005  20141212211746.0
=008  910502\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016794
=035  \\$aCBM5680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x600.$x580.$x700
=150  \\$aTheileria
=450  \\$wnnna$aTheilerias
=550  \\$wg$aPiroplasmida
=550  \\$wh$aTheileria annulata
=550  \\$wh$aTheileria parva
=667  \\$ainfection = THEILERIASIS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick.
=688  \\$a92
=750  \0$aTheileria$5IEN-M$0(DLC)sh 88021459

=LDR  00687nz  a2200217n  4500
=001  9880679770102441
=005  20180712121707.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070677
=035  \\$a(NLM)987390765000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x456
=150  \\$aGentianales
=550  \\$wg$aAngiosperms
=550  \\$wh$aApocynaceae
=550  \\$wh$aGentianaceae
=550  \\$wh$aLoganiaceae
=550  \\$wh$aRubiaceae
=680  \\$iAn angiosperm plant order that includes the APOCYNACEAE; ASCLEPIADACEAE; GENTIANACEAE; LOGANIACEAE; and RUBIACEAE  families.
=688  \\$a2017
=750  \0$aGentianales$0(DLC) sh 85053945$5IEN-M

=LDR  01286nz  a2200337n  4500
=001  9880679770702441
=005  20200513111640.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D051858
=035  \\$a(NLM)98195463720000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x260.$x950.$x249
=072  \\$aD12.$x776.$x930.$x977.$x249
=150  \\$aForkhead Transcription Factors
=450  \\$wnnna$aForkhead Box Proteins
=450  \\$wnnna$aForkhead Box Transcription Factors
=450  \\$wnnna$aForkhead Proteins
=450  \\$wnnna$aFox Transcription Factors
=450  \\$wnnna$aTranscription Factors, Forkhead
=450  \\$wnnna$aTranscription Factors, Fox
=550  \\$wg$aWinged-Helix Transcription Factors
=550  \\$wh$aForkhead Box Protein L2
=550  \\$wh$aForkhead Box Protein M1
=550  \\$wh$aForkhead Box Protein O1
=550  \\$wh$aForkhead Box Protein O3
=550  \\$wh$aHepatocyte Nuclear Factor 3-alpha
=550  \\$wh$aHepatocyte Nuclear Factor 3-beta
=550  \\$wh$aHepatocyte Nuclear Factor 3-gamma
=680  \\$iA subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.
=688  \\$a2006(1989)
=750  \0$aForkhead transcription factors$0(DLC)sh2007010081$5IEN-M

=LDR  00593nz  a2200205n  4500
=001  9880679773102441
=005  20180711102736.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070586
=035  \\$a(NLM)987390713900041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x655.$x125
=150  \\$aFiscal Policy
=450  \\$wnnna$aFiscal Policies
=450  \\$wnnna$aPolicies, Fiscal
=450  \\$wnnna$aPolicy, Fiscal
=550  \\$wg$aPolicy
=680  \\$iUse of government spending and taxation to influence the economy.
=688  \\$a2017
=750  \0$aFiscal policy$0(DLC)sh 85048601$5IEN-M

=LDR  00755nz  a2200229n  4500
=001  9880679773502441
=005  20180711102910.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072669
=035  \\$a(NLM)987391757900041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x393.$x420.$x270
=150  \\$aGene Editing
=450  \\$wnnna$aGenome Editing
=450  \\$wnnna$aEditing, Gene
=450  \\$wnnna$aEditing, Genome
=550  \\$wg$aGenetic Engineering
=550  \\$aMutagenesis, Site-Directed
=550  \\$aCRISPR-Cas Systems
=680  \\$iGenetic engineering techniques that involve DNA REPAIR mechanisms for incorporating site-specific  modifications into a cell's genome.
=688  \\$a2017
=750  \0$aGene editing$0(DLC)sh2018000093$5IEN-M

=LDR  00662nz  a2200217n  4500
=001  9880679773702441
=005  20180711095918.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072102
=035  \\$a(NLM)987391487900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x438
=072  \\$aN2.$x360.$x810.$x438
=150  \\$aGastroenterologists
=450  \\$wnnna$aHepatologists
=450  \\$wnnna$aGastroenterologist
=450  \\$wnnna$aHepatologist
=550  \\$wh$aPhysicians
=680  \\$iPhysicians who specialize in treating diseases of the DIGESTIVE SYSTEM.
=688  \\$a2017
=750  \0$aGastroenterologists$0(DLC)sh 85053478$5IEN-M

=LDR  00812nz  a2200253n  4500
=001  9880680267902441
=005  20180712181649.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071296
=035  \\$a(NLM)987391094600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x446
=150  \\$aGovernment Employees
=450  \\$wnnna$aGovernment Officials
=450  \\$wnnna$aEmployee, Government
=450  \\$wnnna$aEmployees, Government
=450  \\$wnnna$aGovernment Employee
=450  \\$wnnna$aGovernment Official
=450  \\$wnnna$aOfficial, Government
=450  \\$wnnna$aOfficials, Government
=550  \\$wh$aOccupational Groups
=680  \\$iPersons employed by the GOVERNMENT.
=688  \\$a2017; see OCCUPATIONAL GROUPS 1998-2016
=750  \0$aGovernment employees$0(DLC)sh 85056061$5IEN-M

=LDR  00779nz  a2200229n  4500
=001  9880680269502441
=005  20180712133612.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072219
=035  \\$a(NLM)987391453600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x533
=072  \\$aN2.$x360.$x810.$x533
=150  \\$aGeriatricians
=450  \\$wnnna$aGerontologists
=450  \\$wnnna$aGeriatrician
=450  \\$wnnna$aGerontologist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in physiological and pathological aspects of aging and the aged, including the clinical problems of senescence and senility.
=688  \\$a2017
=750  \0$aGeriatricians$0(DLC)sh 93000077$5IEN-M
=750  \0$aGerontologists$0(DLC)sh 85054692$5IEN-M

=LDR  01201cz  a2200241n  4500
=001  9880681169702441
=005  20180713162336.0
=008  780519\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009334
=035  \\$a(NLM)98198632790000041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 708
=072  \\$aA2.$x633.$x567.$x650
=150  \\$aNeck Muscles
=450  \\$wnnna$aMuscle, Neck
=450  \\$wnnna$aMuscles, Neck
=450  \\$wnnna$aNeck Muscle
=550  \\$wg$aMuscle, Skeletal
=550  \\$aNeck
=667  \\$arestrict to muscles of the neck as specified by MeSH definition: do not use for or include muscles of organs located in the neck, as the larynx (LARYNGEAL MUSCLES) or pharynx (PHARYNGEAL MUSCLES); /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent
=680  \\$iThe neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus).
=688  \\$a91(79); was see under MUSCLES 1979-90
=750  \0$aNeck$xMuscles$0(DLC)sh 91001389$5IEN-M

=LDR  02068nz  a2200625n  4500
=001  9880681173802441
=005  20180716104741.0
=008  940607\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D018482
=035  \\$a(NLM)98195306710000041
=040  \\$aDNLM$cDNLM
=072  \\$aA2.$x633.$x567
=072  \\$aA10.$x690.$x552.$x500
=150  \\$aMuscle, Skeletal
=450  \\$aAnterior Tibial Muscle
=450  \\$aGastrocnemius Muscle
=450  \\$aMuscle, Voluntary
=450  \\$aPlantaris Muscle
=450  \\$aSkeletal Muscle
=450  \\$aSoleus Muscle
=450  \\$wnnna$aMuscle, Anterior Tibial
=450  \\$wnnna$aMuscle, Gastrocnemius
=450  \\$wnnna$aMuscle, Plantaris
=450  \\$wnnna$aMuscle, Soleus
=450  \\$wnnna$aMuscles, Skeletal
=450  \\$wnnna$aMuscles, Voluntary
=450  \\$wnnna$aSkeletal Muscles
=450  \\$wnnna$aTibial Muscle, Anterior
=450  \\$wnnna$aVoluntary Muscle
=450  \\$wnnna$aVoluntary Muscles
=550  \\$wg$aMuscles
=550  \\$wg$aMuscle, Striated
=550  \\$wh$aAbdominal Muscles
=550  \\$wh$aBack Muscles
=550  \\$wh$aDeltoid Muscle
=550  \\$wh$aFacial Muscles
=550  \\$wh$aGracilis Muscle
=550  \\$wh$aHamstring Muscles
=550  \\$wh$aLaryngeal Muscles
=550  \\$wh$aMasticatory Muscles
=550  \\$wh$aMuscle Fibers, Skeletal
=550  \\$wh$aMuscle Spindles
=550  \\$wh$aNeck Muscles
=550  \\$wh$aOculomotor Muscles
=550  \\$wh$aPalatal Muscles
=550  \\$wh$aPharyngeal Muscles
=550  \\$wh$aPsoas Muscles
=550  \\$wh$aQuadriceps Muscle
=550  \\$wh$aRespiratory Muscles
=550  \\$wh$aRotator Cuff
=550  \\$wh$aStapedius
=550  \\$wh$aTensor Tympani
=667  \\$a/growth: coordinate with MUSCLE DEVELOPMENT; /embryol: coordinate with MUSCLE DEVELOPMENT if pertinent
=680  \\$iA subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
=688  \\$a95

=LDR  00483nz  a2200145n  4500
=001  9880681761002441
=005  20160901000000.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070476
=035  \\$a(NLM)987390827900041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x230
=150  \\$aHypoxidaceae
=680  \\$iA family of perennial herbaceous plants, in the order Asparagales, with the underground storage organs, rhizomes or corms.
=688  \\$a2017

=LDR  01293nz  a2200325n  4500
=001  9880681762202441
=005  20180718105910.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072696
=035  \\$a(NLM)987391906100041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x410.$x698.$x277.$x187
=072  \\$aI3.$x350.$x187
=150  \\$aHigh-Intensity Interval Training
=450  \\$wnnna$aHigh-Intensity Intermittent Exercise
=450  \\$wnnna$aSprint Interval Training
=450  \\$wnnna$aExercise, High-Intensity Intermittent
=450  \\$wnnna$aExercises, High-Intensity Intermittent
=450  \\$wnnna$aHigh Intensity Interval Training
=450  \\$wnnna$aHigh-Intensity Intermittent Exercises
=450  \\$wnnna$aHigh-Intensity Interval Trainings
=450  \\$wnnna$aInterval Training, High-Intensity
=450  \\$wnnna$aInterval Trainings, High-Intensity
=450  \\$wnnna$aSprint Interval Trainings
=450  \\$wnnna$aTraining, High-Intensity Interval
=450  \\$wnnna$aTrainings, High-Intensity Interval
=550  \\$wg$aExercise
=680  \\$iA cardiovascular exercise strategy with alternating short periods of intense anaerobic exercise with less-intense recovery periods.
=688  \\$a2017
=750  \2$aInterval training$0(DLC)sh2010009475$5IEN-M

=LDR  00939nz  a2200277n  4500
=001  9880681768202441
=005  20180717114617.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070276
=035  \\$a(NLM)987390550300041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x425
=072  \\$aE1.$x370.$x600.$x315
=150  \\$aHeart Rate Determination
=450  \\$wnnna$aPulse Rate Determination
=450  \\$wnnna$aDetermination, Heart Rate
=450  \\$wnnna$aDetermination, Pulse Rate
=450  \\$wnnna$aPulse Rate Determinations
=450  \\$wnnna$aRate Determination, Heart
=450  \\$wnnna$aRate Determination, Pulse
=450  \\$wnnna$aRate Determinations, Pulse
=550  \\$wg$aHeart Function Tests
=550  \\$wg$aPhysical Examination
=680  \\$iMethods, techniques, and processes by which HEART RATE is measured.
=688  \\$a2017
=750  \0$aHeart rate monitoring$0(DLC)sh 92004812$5IEN-M

=LDR  00941nz  a2200241n  4500
=001  9880681768902441
=005  20180717102259.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071277
=035  \\$a(NLM)987391095700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x213
=150  \\$aHarassment, Non-Sexual
=450  \\$wnnna$aNon-Sexual Harassment
=450  \\$wnnna$aNonsexual Harassment
=450  \\$aHarassment, Nonsexual
=450  \\$wnnna$aHarassment, Non Sexual
=450  \\$wnnna$aNon Sexual Harassment
=550  \\$wg$aSocial Behavior
=667  \\$aSEXUAL HARASSMENT is also available
=680  \\$iThe act of systematic and/or continuous unwanted and irritating actions of a non-sexual nature, by a party or group against another. This behavior may include threats, BULLYING, taunts, blackmail, and demands.
=688  \\$a2017; use SOCIAL BEHAVIOR 1992-2016
=750  \0$aHarassment$0(DLC)sh 97007082$5IEN-M

=LDR  00823nz  a2200253n  4500
=001  9880681769202441
=005  20180717093342.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070633
=035  \\$a(NLM)987390776400041
=040  \\$aDNLM$cDNLM
=072  \\$aA2.$x633.$x567.$x450
=072  \\$aA10.$x690.$x552.$x500.$x250
=150  \\$aHamstring Muscles
=450  \\$wnnna$aBiceps Femoris
=450  \\$wnnna$aSemimembranosus
=450  \\$wnnna$aSemitendinosus
=450  \\$wnnna$aHamstring Muscle
=450  \\$wnnna$aMuscle, Hamstring
=450  \\$wnnna$aMuscles, Hamstring
=550  \\$wh$aMuscle, Skeletal
=680  \\$iA group of muscles in the posterior THIGH area that are involved in connecting the KNEE JOINT and the PELVIS.
=688  \\$a2017
=750  \2$aHamstring muscle$0(DLC)sh2003011096$5IEN-M

=LDR  01076nz  a2200289n  4500
=001  9880682958002441
=005  20180725112646.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070716
=035  \\$a(NLM)987390649900041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x700.$x375
=072  \\$aG7.$x203.$x300.$x350.$x300.$x666
=072  \\$aG7.$x203.$x300.$x350.$x525.$x375
=072  \\$aJ2.$x200.$x700.$x375
=072  \\$aJ2.$x500.$x350.$x300.$x666
=072  \\$aJ2.$x500.$x350.$x525.$x375
=150  \\$aKefir
=450  \\$wnnna$aKefir Grains
=450  \\$wnnna$aGrain, Kefir
=450  \\$wnnna$aGrains, Kefir
=450  \\$wnnna$aKefir Grain
=550  \\$wg$aCultured Milk Products
=550  \\$wg$aMilk
=680  \\$iA beverage made from milk fermented by a mixture of endogenous LACTIC ACID-producing yeast and bacteria (KEFIR GRAINS), many of which are PROBIOTICS. It should not be confused with KAFFIR LIME or KAFFIR CORN.
=688  \\$a2017; use MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016
=750  \0$aKefir$0(DLC)sh 85072025$5IEN-M

=LDR  00689nz  a2200181n  4500
=001  9880682973302441
=005  20180719111324.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070100
=035  \\$a(NLM)987390565100041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x791.$x500
=150  \\$aInformal Sector
=450  \\$wnnna$aSector, Informal
=550  \\$wg$aPrivate Sector
=680  \\$iA component of the private sector characterized by ease of entry; reliance on indigenous resources; family ownership; small scale operations;  skills acquired outside of the formal sector; and unregulated markets.
=688  \\$a2017
=750  \0$aInformal sector (Economics)$0(DLC)sh 8506613$5IEN-M

=LDR  00708nz  a2200205n  4500
=001  9880686319502441
=005  20180822115237.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072138
=035  \\$a(NLM)987391609200041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x310.$x350.$x100.$x500.$x500
=150  \\$aMosquito Vectors
=450  \\$wnnna$aMosquito Vector
=450  \\$wnnna$aVector, Mosquito
=450  \\$wnnna$aVectors, Mosquito
=550  \\$wg$aInsect Vectors
=680  \\$iMosquitoes (members of the family CULICIDAE) that transmit pathogens or their intermediate forms from one host to another.
=688  \\$a2017
=750  \0$aMosquitoes as carriers of disease$0(DLC)sh 85087482$5IEN-M

=LDR  00793nz  a2200265n  4500
=001  9880686320302441
=005  20180821164220.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072896
=035  \\$a(NLM)987391864400041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x216.$x500.$x968.$x467
=072  \\$aN2.$x278.$x590
=072  \\$aN4.$x452.$x442.$x422.$x467
=150  \\$aMorgue
=450  \\$wnnna$aMorgue, Hospital
=450  \\$wnnna$aHospital Morgue
=450  \\$wnnna$aHospital Morgues
=450  \\$wnnna$aMorgues
=450  \\$wnnna$aMorgues, Hospital
=550  \\$wg$aHealth Facilities
=550  \\$wg$aHospital Departments
=680  \\$iLocation where dead bodies are kept until they are buried or cremated.
=688  \\$a2017
=750  \0$aMorgues$0(DLC)sh 85087265

=LDR  00537cz  a2200193n  4500
=001  9880686333402441
=005  20180820145147.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071253
=035  \\$a(NLM)987391103100041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x399.$x250.$x590
=150  \\$aMetadata
=450  \\$wnnna$aMetatags
=450  \\$wnnna$aMetatag
=550  \\$wg$aInformation Science
=680  \\$iStructured data elements used to describe other data.
=688  \\$a2017
=750  \0$aMetadata$0(DLC)sh 96000740$5IEN-M

=LDR  00641nz  a2200205n  4500
=001  9880686333702441
=005  20180820142503.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071252
=035  \\$a(NLM)987391104300041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x358.$x859
=072  \\$aI2.$x588
=150  \\$aMentoring
=450  \\$wnnna$aCoaching
=550  \\$wg$aEducation
=550  \\$wg$aEducation, Professional
=680  \\$iThe art and practice of training, guiding, COUNSELING, and providing support to a less experienced, trained, or knowledgeable person.
=688  \\$a2017
=750  \0$aMentoring$0(DLC)sh 95001844$5IEN-M

=LDR  00581cz  a2200193n  4500
=001  9880686334402441
=005  20180820134436.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072600
=035  \\$a(NLM)987391785800041
=040  \\$aDNLM$cDNLM
=072  \\$aA2.$x165.$x308.$x538
=072  \\$aA10.$x165.$x382.$x350.$x163
=150  \\$aMeniscus
=450  \\$wnnna$aMenisci
=550  \\$wh$aFibrocartilage
=680  \\$iCrescent-shaped cartilaginous tissue interposed between two articulating bones.
=688  \\$a2017
=750  \0$aMeniscus (Anatomy)$0(DLC)sh 85083575$5IEN-M

=LDR  00469cz  a2200145n  4500
=001  9880686335202441
=005  20170901000000.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070556
=035  \\$a(NLM)987390823400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x875.$x625
=150  \\$aMelanthiaceae
=680  \\$iA family in the order Liliales, of bulbous or rhizomatous woodland and alpine perennial herbs.
=688  \\$a2017

=LDR  00726nz  a2200241n  4500
=001  9880686349902441
=005  20180816130016.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069997
=035  \\$a(NLM)987390587100041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x215.$x721.$x500.$x626
=150  \\$aMastic Resin
=450  \\$wnnna$aGum Mastic
=450  \\$wnnna$aMastic Gum
=450  \\$wnnna$aMastisol
=450  \\$wnnna$aGum, Mastic
=450  \\$wnnna$aMastic, Gum
=450  \\$wnnna$aResin, Mastic
=550  \\$wg$aResins, Plant
=680  \\$iDried tree sap from the MASTIC TREE that is used in TRADITIONAL MEDICINE and chewed as gum.
=688  \\$a2017 (1985)
=750  \2$aMastic$0(DLC)sh2008000735$5IEN-M

=LDR  01817nz  a2200517n  4500
=001  9880686350102441
=005  20180816130240.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072499
=035  \\$a(NLM)987391650200041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x540
=150  \\$aManufacturing and Industrial Facilities
=450  \\$wnnna$aIndustrial Facilities
=450  \\$wnnna$aIndustrial Factories
=450  \\$wnnna$aIndustrial Plants
=450  \\$wnnna$aManufacturing Facilities
=450  \\$wnnna$aManufacturing Factories
=450  \\$wnnna$aManufacturing Plants
=450  \\$wnnna$aManufacturing and Industrial Plants
=450  \\$wnnna$aFacilities, Industrial
=450  \\$wnnna$aFacilities, Manufacturing
=450  \\$wnnna$aFacility, Industrial
=450  \\$wnnna$aFacility, Manufacturing
=450  \\$wnnna$aFactories, Industrial
=450  \\$wnnna$aFactories, Manufacturing
=450  \\$wnnna$aFactory, Industrial
=450  \\$wnnna$aFactory, Manufacturing
=450  \\$wnnna$aIndustrial Facility
=450  \\$wnnna$aIndustrial Factory
=450  \\$wnnna$aIndustrial Plant
=450  \\$wnnna$aManufacturing Facility
=450  \\$wnnna$aManufacturing Factory
=450  \\$wnnna$aManufacturing Plant
=450  \\$wnnna$aPlant, Industrial
=450  \\$wnnna$aPlant, Manufacturing
=450  \\$wnnna$aPlants, Industrial
=450  \\$wnnna$aPlants, Manufacturing
=550  \\$wg$aNon-Medical Public and Private Facilities
=550  \\$wh$aAbattoirs
=550  \\$wh$aFarms
=550  \\$wh$aFisheries
=550  \\$wh$aPower Plants
=680  \\$iPlaces provided for the processing, fabrication, assembly, and production of a line of products, services, commodities, or merchandise.
=688  \\$a2017
=750  \0$aFactories$0(DLC)sh 85046823$5IEN-M

=LDR  00741cz  a2200253n  4500
=001  9880686358802441
=005  20180820130934.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070396
=035  \\$a(NLM)987390537900041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x615.$x625
=150  \\$aLiliales
=450  \\$wnnna$aAlstroemeriaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aAlstroemeria
=550  \\$wh$aColchicaceae
=550  \\$wh$aCorsiaceae
=550  \\$wh$aLiliaceae
=550  \\$wh$aMelanthiaceae
=550  \\$wh$aSmilacaceae
=680  \\$iAn order of monocots that grow from bulbs or corms to become herbs or vines.
=688  \\$a2016
=750  \0$aLiliales$0(DLC)sh 85076963$5IEN-M

=LDR  00582nz  a2200193n  4500
=001  9880690254802441
=005  20180829120925.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072141
=035  \\$a(NLM)987391476300041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x652
=072  \\$aN2.$x360.$x810.$x652
=150  \\$aNeurologists
=450  \\$wnnna$aNeurologist
=550  \\$wg$aPhysicians
=680  \\$iQualified medical professionals who specialize in treating NERVOUS SYSTEM DISEASES.
=688  \\$a2017
=750  \0$aNeurologists$0(DLC)sh 85091135$5IEN-M

=LDR  00569cz  a2200193n  4500
=001  9880690255902441
=005  20180829114519.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072104
=035  \\$a(NLM)987391485100041
=040  \\$aDNLM$cDNLM
=060  \0$aWJ 21
=072  \\$aM1.$x526.$x485.$x810.$x628
=072  \\$aN2.$x360.$x810.$x628
=150  \\$aNephrologists
=450  \\$wnnna$aNephrologist
=680  \\$iQualified medical professionals who specialize in treating KIDNEY DISEASES.
=688  \\$a2017
=750  \0$aNephrologists$0(DLC)sh 85090859$5IEN-M

=LDR  00673nz  a2200205n  4500
=001  9880690256202441
=005  20180829112339.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072143
=035  \\$a(NLM)987391473500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x758
=072  \\$aN2.$x360.$x810.$x758
=150  \\$aPediatricians
=450  \\$wnnna$aPediatrician
=550  \\$wg$aPhysicians
=550  \\$wh$aNeonatologists
=680  \\$iQualified medical professionals specializing in maintaining health and providing medical care to children from birth through adolescence.
=688  \\$a2017
=750  \0$aPediatricians$0(DLC)sh 85099183$5IEN-M

=LDR  00613cz  a2200205n  4500
=001  9880690256302441
=005  20180829112941.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072156
=035  \\$a(NLM)987391472100041
=040  \\$aDNLM$cDNLM
=060  \0$aWS 21
=072  \\$aM1.$x526.$x485.$x810.$x758.$x500
=072  \\$aN2.$x360.$x810.$x758.$x500
=150  \\$aNeonatologists
=450  \\$wnnna$aNeonatologist
=550  \\$wg$aPediatricians
=680  \\$iPhysicians who specialize in providing medical care to newborn infants.
=688  \\$a2017
=750  \0$aNeonatologists$(DLC) sh 86002899$5IEN-M

=LDR  00865cz  a2200229n  4500
=001  9880692185702441
=005  20180926143641.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D031339
=035  \\$a(NLM)98194942420000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x520.$x647
=150  \\$aOcimum
=450  \\$wnnna$aOcimum gratissimum
=450  \\$wnnna$aOcimum gratissimums
=450  \\$wnnna$aOcimums
=450  \\$wnnna$agratissimum, Ocimum
=550  \\$wg$aLamiaceae
=550  \\$wh$aOcimum basilicum
=550  \\$wh$aOcimum sanctum
=680  \\$iA plant genus of the family Lamiaceae which occurs in tropical and warm temperate regions worldwide. It includes the aromatic herb OCIMUM BASILICUM (Sweet Basil) and the MEDICINAL PLANT Ocimum tenuiflorum (Holy Basil).
=688  \\$a2003; use OCIMUM BASILICUM 1998-2002

=LDR  00738cz  a2200229n  4500
=001  9880692185902441
=005  20180926143847.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070004
=035  \\$a(NLM)987390575400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x583.$x520.$x647.$x750
=150  \\$aOcimum sanctum
=450  \\$wnnna$aHoly Basil
=450  \\$wnnna$aOcimum tenuiflorum
=450  \\$wnnna$aBasil, Holy
=450  \\$wnnna$aBasils, Holy
=450  \\$wnnna$aHoly Basils
=550  \\$wg$aOcimum
=680  \\$iA plant species of the genus OCIMUM, family LAMIACEAE that has been used in TRADITIONAL MEDICINE.
=688  \\$a2017
=750  \0$aOcimum sanctum$0(DLC)sh 85093969$5IEN-M

=LDR  00753cz  a2200229n  4500
=001  9880692186702441
=005  20180926135702.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072087
=035  \\$a(NLM)987391498700041
=040  \\$aDNLM$cDNLM
=060  \0$aW 21
=072  \\$aM1.$x526.$x485.$x710
=072  \\$aN2.$x360.$x710
=150  \\$aOccupational Therapists
=450  \\$wnnna$aOccupational Therapist
=450  \\$wnnna$aTherapist, Occupational
=450  \\$wnnna$aTherapists, Occupational
=550  \\$wg$aHealth Personnel
=680  \\$iProfessionals trained to help individuals develop or regain skills needed to achieve independence in their lives.
=688  \\$a2017
=750  \0$aOccupational therapists$0(DLC)sh 85093849$5IEN-M

=LDR  01390cz  a2200385n  4500
=001  9880692198102441
=005  20180921140652.0
=008  890526\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D015921
=035  \\$a(NLM)98195049970000041
=040  \\$aDNLM$cDNLM
=060  \0$aWU 640
=072  \\$aD25.$x339.$x312
=072  \\$aE6.$x780.$x346.$x593
=072  \\$aE7.$x695.$x185
=072  \\$aJ1.$x637.$x51.$x339.$x312
=150  \\$aDental Implants
=450  \\$wnnna$aDental Implant
=450  \\$wnnna$aDental Prostheses, Surgical
=450  \\$wnnna$aImplant, Dental
=450  \\$wnnna$aProstheses, Surgical Dental
=450  \\$wnnna$aProsthesis, Surgical Dental
=450  \\$wnnna$aSurgical Dental Prostheses
=450  \\$wnnna$aSurgical Dental Prosthesis
=450  \\$aDental Prosthesis, Surgical
=450  \\$aImplants, Dental
=550  \\$wg$aDental Materials
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aProstheses and Implants
=550  \\$wh$aDental Implants, Single-Tooth
=550  \\$aDental Implantation
=667  \\$aDF: DENT IMPLANTS
=680  \\$iBiocompatible materials placed into (endosseous) or onto (subperiosteal) the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth.
=688  \\$a90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89
=750  \0$aDental implants$0(DLC)sh 85064641$5IEN-M

=LDR  00772nz  a2200253n  4500
=001  9880692227702441
=005  20180914154616.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072184
=035  \\$a(NLM)987391582500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x650.$x648
=072  \\$aN2.$x360.$x650.$x648
=150  \\$aNurse Specialists
=450  \\$wnnna$aNurse Specialist
=450  \\$wnnna$aSpecialist, Nurse
=450  \\$wnnna$aSpecialists, Nurse
=550  \\$wg$aNurses
=550  \\$wh$aNurse Anesthetists
=550  \\$wh$aNurse Clinicians
=550  \\$wh$aNurse Midwives
=550  \\$wh$aNurses, Pediatric
=680  \\$iNursing professionals whose practice is limited to A particular area or discipline of medicine.
=688  \\$a2017

=LDR  00509nz  a2200193n  4500
=001  9880692228802441
=005  20180914114911.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071940
=035  \\$a(NLM)987391279900041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x249.$x660
=150  \\$aNucleons
=450  \\$wnnna$aNucleon
=550  \\$wg$aElementary Particles
=550  \\$wh$aNeutrons
=550  \\$wh$aProtons
=680  \\$iSubatomic particles that are either protons or neutrons.
=688  \\$a2017

=LDR  00989nz  a2200349n  4500
=001  9880692268502441
=005  20180912112103.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072738
=035  \\$a(NLM)987391884000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x585
=150  \\$aNitrogen-Fixing Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aAnabaena
=550  \\$wh$aAzoarcus
=550  \\$wh$aAzorhizobium
=550  \\$wh$aAzospirillum brasilense
=550  \\$wh$aAzospirillum lipoferumh
=550  \\$wh$aBeijerinckiaceae
=550  \\$wh$aFrankia
=550  \\$wh$aHerbaspirillum
=550  \\$wh$aNodularia
=550  \\$wh$aNostoc commune
=550  \\$wh$aNostoc muscorum
=550  \\$wh$aPaenibacillus polymyxa
=550  \\$wh$aPlectonema
=550  \\$wh$aRhizobium
=550  \\$wh$aTrichodesmium
=680  \\$iBacteria that are capable of NITROGEN FIXATION.
=688  \\$a2017
=750  \0$aNitrogen-fixing microorganisms$0(DLC) sh 85084743$5IEN-M

=LDR  01452cz  a2200373n  4500
=001  9880702155302441
=005  20181002122138.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072638
=035  \\$a(NLM)987391927700041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x968.$x249.$x750
=150  \\$aPatient Portals
=450  \\$wnnna$aPatient Internet Portals
=450  \\$wnnna$aPatient Portal
=450  \\$wnnna$aPatient Web Portal
=450  \\$wnnna$aPatient Web Portals
=450  \\$wnnna$aInternet Portal, Patient
=450  \\$wnnna$aInternet Portals, Patient
=450  \\$wnnna$aPatient Internet Portal
=450  \\$wnnna$aPortal, Patient
=450  \\$wnnna$aPortal, Patient Internet
=450  \\$wnnna$aPortal, Patient Web
=450  \\$wnnna$aPortals, Patient Internet
=450  \\$wnnna$aPortals, Patient Web
=450  \\$wnnna$aWeb Portal, Patient
=450  \\$wnnna$aWeb Portals, Patient
=550  \\$wg$aElectronic Health Records
=550  \\$wg$aHealth Records, Personal
=680  \\$iA secure online website that provides patients convenient 24-hour access to personal health information via an Internet connection.
=688  \\$a2017
=750  \0$81$wb$aPatients$0(DLC)sh 85098709$5IEN-M
=750  \0$81$wb$iBroader mapping$aWeb portals$4BM$0(DLC)sh 99005116$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record:$aPatients$iand$aWeb Portals$5IEN-M

=LDR  00604nz  a2200193n  4500
=001  9880702156102441
=005  20181002114557.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072142
=035  \\$a(NLM)987391474900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x746
=072  \\$aN2.$x360.$x810.$x746
=150  \\$aPathologists
=450  \\$wnnna$aPathologist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians who assess changes in cellular or tissue structure and function to diagnose disease processes.
=688  \\$a2017
=750  \0$aPathologists$0(DLC)sh 85098684$5IEN-M

=LDR  00813nz  a2200229n  4500
=001  9880702170602441
=005  20180928124300.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072376
=035  \\$a(NLM)987391545600041
=040  \\$aDNLM$cDNLM
=072  \\$aD4.$x210.$x500.$x247.$x222.$x284.$x800
=072  \\$aD4.$x210.$x500.$x247.$x808.$x197.$x800
=072  \\$aD10.$x570.$x938.$x208.$x825
=150  \\$aOxysterols
=450  \\$wnnna$aOxysterol
=550  \\$wg$aCholesterol
=550  \\$wh$aHydroxycholesterols
=550  \\$wh$aKetocholesterols
=680  \\$iOxygenated derivatives of cholesterol or its sterol precursors. They are generated from sterol metabolism and the interaction of cholesterol with REACTIVE OXYGEN SPECIES.
=688  \\$a2017
=750  \0$aOxysterols$0(DLC)sh 89005379$5IEN-M

=LDR  00662nz  a2200217n  4500
=001  9880702171202441
=005  20180928122023.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072220
=035  \\$a(NLM)987391452200041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x734
=072  \\$aN2.$x360.$x810.$x734
=150  \\$aOtolaryngologists
=450  \\$wnnna$aOtologists
=450  \\$wnnna$aOtolaryngologist
=450  \\$wnnna$aOtologist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in the treatment of disorders of the ear, nose, and throat.
=688  \\$a2017
=750  \0$aOtolaryngologists$0(DLC)sh 85096048$5IEN-M

=LDR  00876nz  a2200241n  4500
=001  9880702171302441
=005  20180928121209.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072161
=035  \\$a(NLM)987391594500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x910.$x875
=072  \\$aN2.$x360.$x810.$x910.$x875
=150  \\$aOrthopedic Surgeons
=450  \\$wnnna$aOrthopedists
=450  \\$wnnna$aOrthopedic Surgeon
=450  \\$wnnna$aOrthopedist
=450  \\$wnnna$aSurgeon, Orthopedic
=450  \\$wnnna$aSurgeons, Orthopedic
=550  \\$wg$aSurgeons
=680  \\$iPhysicians specializing in medical, surgical, and physical methods used to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.
=688  \\$a2017
=750  \0$aOrthopedists$5IEN-HS$0(DLC)sh 85095815

=LDR  00766nz  a2200193n  4500
=001  9880702172002441
=005  20180928110519.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072162
=035  \\$a(NLM)987391593100041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x725
=072  \\$aN2.$x360.$x725
=150  \\$aOptometrists
=450  \\$wnnna$aOptometrist
=550  \\$wg$aHealth Personnel
=680  \\$iQualified professionals trained in primary eye and vision care, including measurement of visual abilities, diagnosing disorders of the visual system and provision of treatment such as prescriptions for correction of visual defects with lenses or glasses and vision therapy.
=688  \\$a2017
=750  \0$aOptometrists$5IEN-M$0(DLC)sh 85095205

=LDR  00625nz  a2200193n  4500
=001  9880702172202441
=005  20180928105110.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072163
=035  \\$a(NLM)987391591700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x705
=072  \\$aN2.$x360.$x810.$x705
=150  \\$aOphthalmologists
=450  \\$wnnna$aOphthalmologist
=550  \\$wg$aPhysicians
=680  \\$iQualified medical professionals specializing in medical and surgical treatment of defects and diseases of the eye.
=688  \\$a2017
=750  \0$aOphthalmologists$5IEN-M$0(DLC)sh 85095069

=LDR  00731nz  a2200229n  4500
=001  9880702172702441
=005  20180928103634.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072977
=035  \\$a(NLM)987391740400041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x872.$x677
=150  \\$aOogonial Stem Cells
=450  \\$wnnna$aFemale Germline Stem Cells
=450  \\$wnnna$aOvarian Germline Stem Cells
=450  \\$wnnna$aOogonial Stem Cell
=450  \\$wnnna$aStem Cell, Oogonial
=450  \\$wnnna$aStem Cells, Oogonial
=550  \\$wg$aStem Cells
=680  \\$iPrimordial germ cells found in embryonic OOGONIA and postnatal OVARIES.
=688  \\$a2017(2014)
=750  \0$aAdult stem cells$0(DLC)sh2016002116$5IEN-M

=LDR  00647nz  a2200205n  4500
=001  9880702172802441
=005  20180928102516.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072103
=035  \\$a(NLM)987391486500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x699
=072  \\$aN2.$x360.$x810.$x699
=150  \\$aOncologists
=450  \\$wnnna$aOncologist
=550  \\$wg$aPhysicians
=550  \\$wh$aRadiation Oncologists
=680  \\$iPhysicians specializing in MEDICAL ONCOLOGY or its sub-specialties of RADIATION ONCOLOGY or SURGICAL ONCOLOGY.
=688  \\$a2017
=750  \0$aOncologists$0(DLC)sh 85094723$5IEN-M

=LDR  00798nz  a2200229n  4500
=001  9880707870702441
=005  20181008120503.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071059
=035  \\$a(NLM)987390996000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x95.$x841
=150  \\$aPhage Therapy
=450  \\$wnnna$aBacteriophage Therapy
=450  \\$wnnna$aBacteriophage Therapies
=450  \\$wnnna$aPhage Therapies
=550  \\$wh$aBiological Therapy
=680  \\$iTherapeutic use of BACTERIOPHAGES to treat diseases.
=688  \\$a2017
=750  \0$81$wb$aBacteriophages$0(DLC)sh 85010874$5IEN-M
=780  \0$81$wb$aTherapeutic use$0(DLC)sh2001008985$5IEN
=788  \0$iSearch also under the following Library of Congress Subject Heading$aBacteriophages--Therapeutic use$5IEN-M

=LDR  00686cz  a2200181n  4500
=001  9880707872402441
=005  20181008105035.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072639
=035  \\$a(NLM)987391932500041
=040  \\$aDNLM$cDNLM
=060  \0$aBF 698.35.P47
=072  \\$aF1.$x752.$x823
=150  \\$aPerfectionism
=550  \\$wh$aPersonality
=680  \\$iA personality trait characterized by a person's striving for flawlessness and setting excessively high performance standards, accompanied by overly critical self-evaluations and concerns regarding others' evaluations.
=688  \\$a2017
=750  \0$aPerfectionism (Personality trait)$0(DLC)sh 87000286$5IEN-M

=LDR  00834cz  a2200241n  4500
=001  9880707872902441
=005  20181008101911.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070316
=035  \\$a(NLM)987390548200041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 105
=072  \\$aH2.$x403.$x250.$x500
=072  \\$aH2.$x403.$x670.$x450
=150  \\$aPediatric Emergency Medicine
=450  \\$wnnna$aEmergency Medicine, Pediatric
=450  \\$wnnna$aMedicine, Pediatric Emergency
=550  \\$wg$aEmergency Medicine
=550  \\$wg$aPediatrics
=680  \\$iBranch of EMERGENCY MEDICINE dealing with the emergency care of children.
=688  \\$a2017
=750  \\$0Related mapping$aPediatric emergencies$0(DLC)sh 85099149$4RM$5IEN-M
=750  \0$iRelated mapping$aPediatric emergency services$0(DLC)sh 91003386$4RM$5IEN-M

=LDR  00992cz  a2200301n  4500
=001  9880708258502441
=005  20181011121431.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072861
=035  \\$a(NLM)987391869900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 178
=072  \\$aF3.$x80.$x725.$x500
=150  \\$aPhobia, Social
=450  \\$wnnna$aSocial Anxiety Disorder
=450  \\$wnnna$aAnxiety Disorder, Social
=450  \\$wnnna$aAnxiety Disorders, Social
=450  \\$wnnna$aDisorder, Social Anxiety
=450  \\$wnnna$aDisorders, Social Anxiety
=450  \\$wnnna$aPhobias, Social
=450  \\$wnnna$aSocial Anxiety Disorders
=450  \\$wnnna$aSocial Phobia
=450  \\$wnnna$aSocial Phobias
=550  \\$wg$aPhobic Disorders
=550  \\$aAnxiety
=680  \\$iAnxiety disorder characterized by the persistent and irrational fear, anxiety, or avoidance of social or performance situations.
=688  \\$a2017
=750  \0$aSocial phobia$0(DLC)sh 92004280

=LDR  00784nz  a2200217n  4500
=001  9880708258802441
=005  20181011114900.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070838
=035  \\$a(NLM)987390926300041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x452
=072  \\$aH2.$x646.$x375
=150  \\$aPharmacy Research
=450  \\$wnnna$aResearch, Pharmacy
=550  \\$wg$aBiomedical Research
=550  \\$wg$aPharmacy
=667  \\$apharmacy research as a field or the progress or status of pharmacy research; do not add routinely for specific pharmacy research studies; do not confuse with PHARMACEUTICAL RESEARCH
=680  \\$iRESEARCH activity focused on PHARMACY.
=688  \\$a2017
=750  \0$aPharmacy$xResearch$0(DLC)sh 85100608$5IEN-M

=LDR  00798cz  a2200205n  4500
=001  9880708259402441
=005  20181011105739.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071220
=035  \\$a(NLM)987391214700041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 20.5
=072  \\$aH1.$x770.$x644.$x145.$x442
=150  \\$aPharmaceutical Research
=450  \\$wnnna$aResearch, Pharmaceutical
=550  \\$wg$aBiomedical Research
=667  \\$apharmaceutical research as a field or the progress or status of pharmaceutical research; do not add routinely for specific pharmaceutical research studies; do not confuse with PHARMACY RESEARCH
=680  \\$iRESEARCH activity focused on pharmaceutical products and services.
=688  \\$a2017
=750  \0$aDrugs$xResearch$0(DLC)sh 85039745$5IEN-M

=LDR  00677cz  a2200205n  4500
=001  9880730373702441
=005  20181121124709.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072157
=035  \\$a(NLM)987391603900041
=040  \\$aDNLM$cDNLM
=060  \0$aW 21
=072  \\$aM1.$x526.$x485.$x810.$x764
=072  \\$aN2.$x360.$x810.$x764
=150  \\$aPhysiatrists
=450  \\$wnnna$aPhysiatrist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in treating physical disorders and injuries affecting the brain, spinal cord, nerves, bones, joints, ligaments, muscles, and tendons.
=688  \\$a2017
=750  \0$aPhysiatrists$0(DLC)sh 85101511$5IEN-M

=LDR  01294nz  a2200409n  4500
=001  9880730373802441
=005  20181121123004.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071442
=035  \\$a(NLM)987391070700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x113.$x780
=072  \\$aF1.$x145.$x875.$x439.$x500
=072  \\$aG7.$x568.$x500.$x590
=072  \\$aG11.$x427.$x410.$x568.$x850
=150  \\$aTaxis Response
=450  \\$wnnna$aCompass Orientation
=450  \\$wnnna$aGalvanotaxis
=450  \\$wnnna$aHeat Avoidance
=450  \\$wnnna$aThermal Avoidance
=450  \\$wnnna$aThermotaxis
=450  \\$wnnna$aTropotaxis
=450  \\$wnnna$aAvoidance, Heat
=450  \\$wnnna$aAvoidance, Thermal
=450  \\$wnnna$aOrientation, Compass
=450  \\$wnnna$aResponse, Taxis
=450  \\$wnnna$aResponses, Taxis
=450  \\$wnnna$aTaxis Responses
=550  \\$wg$aBehavior, Animal
=550  \\$wg$aLocomotion
=550  \\$wg$aOrientation, Spatial
=550  \\$wh$aChemotaxis
=550  \\$wh$aEscape Reaction
=550  \\$wh$aPhototaxis
=680  \\$iA behavior in free-moving organism that results in motion or orientation toward or away from an external stimulus.
=688  \\$a2017
=750  \0$aTaxes (Biology)$0(DLC)sh 85132884$5IEN-M

=LDR  00774nz  a2200241n  4500
=001  9880730374102441
=005  20181121104910.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071444
=035  \\$a(NLM)987391150000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x113.$x780.$x875
=072  \\$aF1.$x145.$x875.$x439.$x500.$x875
=072  \\$aG7.$x568.$x500.$x590.$x875
=072  \\$aG11.$x427.$x410.$x568.$x850.$x875
=150  \\$aPhototaxis
=450  \\$wnnna$aPhotokinesis
=450  \\$wnnna$aPhotokineses
=550  \\$wg$aTaxis Response
=550  \\$aPhototropism
=680  \\$iA behavioral change that results in an organism moving or orienting toward or away from the light source.
=688  \\$a2017
=750  \0$aPhototaxis$0(DLC)sh 85101415$5IEN-M

=LDR  00754nz  a2200253n  4500
=001  9880730550302441
=005  20181130120921.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072664
=035  \\$a(NLM)987391761500041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x605.$x600.$x354
=072  \\$aG7.$x203.$x300.$x631.$x600.$x500
=072  \\$aJ2.$x500.$x631.$x600.$x500
=150  \\$aProvitamins
=450  \\$wnnna$aVitamin Precursors
=450  \\$wnnna$aPrecursor, Vitamin
=450  \\$wnnna$aPrecursors, Vitamin
=450  \\$wnnna$aProvitamin
=450  \\$wnnna$aVitamin Precursor
=550  \\$wg$aVitamins
=680  \\$iPrecursor forms of vitamins.
=688  \\$a2017
=750  \0$aProvitamins$0(DLC)sh 85108021$5IEN-M

=LDR  01328nz  a2200361n  4500
=001  9880730552802441
=005  20181129144328.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072416
=035  \\$a(NLM)987391680500041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x570.$x820.$x709.$x275
=150  \\$aProtein Structural Elements
=450  \\$wnnna$aProtein Structural Units
=450  \\$wnnna$aProtein Structure Elements
=450  \\$wnnna$aElement, Protein Structural
=450  \\$wnnna$aElements, Protein Structural
=450  \\$wnnna$aProtein Structural Element
=450  \\$wnnna$aProtein Structural Unit
=450  \\$wnnna$aProtein Structure Element
=450  \\$wnnna$aStructural Element, Protein
=450  \\$wnnna$aStructural Elements, Protein
=450  \\$wnnna$aStructural Unit, Protein
=450  \\$wnnna$aStructural Units, Protein
=450  \\$wnnna$aStructure Element, Protein
=450  \\$wnnna$aStructure Elements, Protein
=550  \\$wg$aProtein Conformation
=550  \\$wh$aAmino Acid Motifs
=550  \\$wh$aProtein Domains
=550  \\$wh$aRepetitive Sequences, Amino Acid
=680  \\$iDistinguishing three-dimensional structures characteristically formed by homologous protein sequences.
=688  \\$a2017
=750  \0$aProteins$xStructure$0(DLC)sh2008110122$5IEN-M

=LDR  00733cz  a2200193n  4500
=001  9880730572902441
=005  20181126134519.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072439
=035  \\$a(NLM)987391540100041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x731
=150  \\$aPostcards as Topic
=450  \\$wnnna$aPostcards as Topics
=550  \\$wg$aInformation Science
=667  \\$ado not confuse with Publication Type POSTCARDS
=680  \\$iWorks about cards on which a message may be written or printed for mailing without an envelope. Art & Architectural Thesaurus Online www.getty.edu/research/conducting_research/vocabularies/aat/ accessed 12/18/2008
=688  \\$a2017
=750  \0$aPostcards$0(DLC)sh 85105462

=LDR  00847cz  a2200229n  4500
=001  9880730573902441
=005  20181126103930.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071228
=035  \\$a(NLM)987391123900041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 270
=072  \\$aD1.$x248.$x249
=072  \\$aD5.$x750.$x230
=150  \\$aPolyelectrolytes
=450  \\$wnnna$aConjugated Polyelectrolytes
=450  \\$wnnna$aPolyelectrolytes, Conjugated
=550  \\$wg$aElectrolytes
=550  \\$wg$aPolymers
=680  \\$iNaturally-occurring or artificially made water-soluble POLYMERS whose repeating units are ionizable. Polyelectrolytes demonstrate attributes that are typical of salts, such as electrical conductivity, and typical of  polymers, such as viscosity.
=688  \\$a2017
=750  \0$aPolyelectrolytes$0(DLC)sh 85104617

=LDR  00767nz  a2200253n  4500
=001  9880730574302441
=005  20181126085453.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070356
=035  \\$a(NLM)987390728000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x727
=150  \\$aPilots
=450  \\$wnnna$aAviators
=450  \\$wnnna$aCo-Pilot
=450  \\$wnnna$aPilot
=450  \\$wnnna$aAviator
=450  \\$wnnna$aCo PilotIEN-M
=450  \\$wnnna$aCo-Pilots
=550  \\$wg$aOccupational Groups
=680  \\$iPersons skilled and/or qualified to operate an aircraft or ship.
=688  \\$a2017
=750  \0$iNarrower mapping$aPilots and pilotage$0(DLC)sh 85102165$4NM
=750  \0$iNarrower mapping$aAir pilots$0(DLC)sh 85002673$4NM$5IEN-M

=LDR  00588cz  a2200205n  4500
=001  9880732259102441
=005  20181206130428.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072140
=035  \\$a(NLM)987391605900041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 21
=072  \\$aM1.$x526.$x485.$x810.$x888
=072  \\$aN2.$x360.$x810.$x888
=150  \\$aRheumatologists
=450  \\$wnnna$aRheumatologist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians who specialize in treating RHEUMATIC DISEASES.
=688  \\$a2017
=750  \0$aRheumatologists$0(DLC) sh 85113652$5IEN-M

=LDR  00615nz  a2200193n  4500
=001  9880732259402441
=005  20181206093700.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072177
=035  \\$a(NLM)987391589800041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x877
=072  \\$aN2.$x360.$x810.$x877
=150  \\$aRadiologists
=450  \\$wnnna$aRadiologist
=550  \\$wh$aPhysicians
=680  \\$iPhysicians specializing in the use of x-ray and other forms of radiant energy to diagnosis and treatment of disease.
=688  \\$a2017
=750  \0$aRadiologists$0(DLC)sh 85110772$5IEN-M

=LDR  00741nz  a2200241n  4500
=001  9880732269502441
=005  20181204101101.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072232
=035  \\$a(NLM)987391445000041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x710.$x725
=150  \\$aRadiation Dosimeters
=450  \\$wnnna$aDosimeters
=450  \\$wnnna$aRadiation Dosimeter
=450  \\$wnnna$aDosimeter
=450  \\$wnnna$aDosimeter, Radiation
=450  \\$wnnna$aDosimeters, Radiation
=450  \\$aIn Vivo Dosimetry$xinstrumentation
=550  \\$wh$aRadiation Equipment and Supplies
=680  \\$iDevices that measure exposure to IONIZING RADIATION.
=688  \\$a2017
=750  \0$aDosimeters$0(DLC)sh 85039138$5IEN-M

=LDR  00658nz  a2200181n  4500
=001  9880732273702441
=005  20181203112347.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072440
=035  \\$a(NLM)987391539000041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x608
=072  \\$aN5.$x632
=150  \\$aPublic Health Systems Research
=550  \\$wg$aResearch
=680  \\$iA field of study that examines the organization, financing, and delivery of public health services within communities, and the impact of these services on public health.
=688  \\$a2017
=750  \0$aPublic health administration$xResearch$0(DLC)sh 85108654$5IEN-M

=LDR  01220cz  a2200337n  4500
=001  9880735564602441
=005  20181211123939.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013275
=035  \\$a(NLM)98197736960000041
=040  \\$aDNLM$cDNLM
=060  \0$aWI 306
=072  \\$aC6.$x405.$x748.$x824
=072  \\$aC26.$x17.$x809
=072  \\$aC26.$x761.$x684
=150  \\$aStomach Rupture
=450  \\$wnnna$aGastric Rupture
=450  \\$wnnna$aGastric Ruptures
=450  \\$wnnna$aRupture, Gastric
=450  \\$wnnna$aRupture, Stomach
=450  \\$wnnna$aRuptures, Gastric
=450  \\$wnnna$aRuptures, Stomach
=450  \\$wnnna$aStomach Ruptures
=550  \\$wg$aAbdominal Injuries
=550  \\$wg$aRupture
=550  \\$wg$aStomach Diseases
=667  \\$atraumatic or spontaneous; if spontaneous coord IM with RUPTURE, SPONTANEOUS (NIM); differentiate from traumatic stomach perforation ( = STOMACH /inj)
=680  \\$iBursting of the STOMACH.
=750  \0$81$wb$iRelated mapping$aStomach$0(DLC)sh 85128254$4RM$5IEN-M
=750  \0$81$wb$iRelated mapping$xRupture$0(DLC)sh00007669$4RM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aStomach--Rupture$5IEN-M

=LDR  01098cz  a2200301n  4500
=001  9880735564702441
=005  20181211121650.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D013161
=035  \\$a(NLM)98199461580000041
=040  \\$aDNLM$cDNLM
=060  \0$aWH 600
=072  \\$aC15.$x604.$x744.$x742
=072  \\$aC26.$x17.$x680
=072  \\$aC26.$x761.$x555
=150  \\$aSplenic Rupture
=450  \\$wnnna$aRupture, Splenic
=450  \\$wnnna$aRuptures, Splenic
=450  \\$wnnna$aSplenic Ruptures
=550  \\$wg$aAbdominal Injuries
=550  \\$wg$aRupture
=550  \\$wg$aSplenic Diseases
=550  \\$wh$aSplenosis
=667  \\$aspontaneous rupture: coordinate IM with RUPTURE, SPONTANEOUS (NIM); differentiate from traumatic spleen perforation ( = SPLEEN /inj)
=680  \\$iRupture of the SPLEEN due to trauma or disease.
=750  \0$81$wb$iRelated mapping$aSpleen$0(DLC)sh 85126812$4RM$5IEN-M
=780  \0$81$wb$iRelated mapping$xRupture$0(DLC)sh00007669$4RM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aSpleen--Rupture$5IEN-M

=LDR  01450cz  a2200361n  4500
=001  9880735564802441
=005  20181211121735.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001019
=035  \\$a(NLM)98197410530000041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 410
=072  \\$aC14.$x907.$x55.$x185.$x125
=072  \\$aC14.$x907.$x55.$x239.$x175
=072  \\$aC14.$x907.$x109.$x139.$x175
=072  \\$aC26.$x761.$x125
=150  \\$aAortic Rupture
=450  \\$wnnna$aRuptured Aortic Aneurysm
=450  \\$aAortic Aneurysm, Ruptured
=450  \\$wnnna$aAneurysm, Ruptured Aortic
=450  \\$wnnna$aAneurysms, Ruptured Aortic
=450  \\$wnnna$aAortic Aneurysms, Ruptured
=450  \\$wnnna$aAortic Ruptures
=450  \\$wnnna$aRupture, Aortic
=450  \\$wnnna$aRuptured Aortic Aneurysms
=450  \\$wnnna$aRuptures, Aortic
=550  \\$wg$aAortic Aneurysm
=550  \\$wg$aRupture
=667  \\$ado not coordinate with RUPTURE, SPONTANEOUS unless particularly discussed & then only NIM
=680  \\$iThe tearing or bursting of the wall along any portion of the AORTA, such as thoracic or abdominal. It may result from the rupture of an aneurysm or it may be due to TRAUMA.
=750  \0$81$wb$iRelated mapping$aAorta$0(DLC)sh 85005856$4RM$5IEN-M
=780  \0$81$wb$iRelated mapping$xRupture$0(DLC)sh00007669$4RM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aAorta--Rupture$5IEN-M

=LDR  00856cz  a2200253n  4500
=001  9880735565002441
=005  20181211122726.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012421
=035  \\$a(NLM)98197124540000041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x761
=150  \\$aRupture
=450  \\$wnnna$aRuptures
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aAortic Rupture
=550  \\$wh$aRotator Cuff Injuries
=550  \\$wh$aSplenic Rupture
=550  \\$wh$aStomach Rupture
=550  \\$wh$aUterine Rupture
=667  \\$atraumatic only: differentiate from RUPTURE, SPONTANEOUS; coordinate with organ /inj or precoordinated injury term
=680  \\$iForcible or traumatic tear or break of an organ or other soft part of the body.
=688  \\$a68(66)
=750  \0$aRupture of organs, tissues, etc.$0(DLC)sh 94000201$5IEN-M

=LDR  00954cz  a2200325n  4500
=001  9880735572302441
=005  20181210121318.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070599
=035  \\$a(NLM)987390805400041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 810
=072  \\$aC26.$x803
=150  \\$aShoulder Injuries
=450  \\$wnnna$aSLAP Tears
=450  \\$wnnna$aSuperior Labrum from Anterior to Posterior Injuries
=450  \\$wnnna$aInjuries, Shoulder
=450  \\$wnnna$aInjury, Shoulder
=450  \\$wnnna$aSLAP Tear
=450  \\$wnnna$aShoulder Injury
=450  \\$wnnna$aTear, SLAP
=450  \\$wnnna$aTears, SLAP
=450  \\$aShoulder$xinjuries
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aRotator Cuff Injuries
=550  \\$wh$aShoulder Dislocation
=550  \\$wh$aShoulder Fractures
=550  \\$wh$aShoulder Impingement Syndrome
=680  \\$iInjuries involving the SHOULDERS.
=688  \\$a2017

=LDR  01877nz  a2200517n  4500
=001  9880735572802441
=005  20181211121919.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070636
=035  \\$a(NLM)987390669700041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x761.$x340
=072  \\$aC26.$x803.$x63
=072  \\$aC26.$x874.$x400
=150  \\$aRotator Cuff Injuries
=450  \\$wnnna$aGlenoid Labral Tears
=450  \\$wnnna$aRotator Cuff Tears
=450  \\$wnnna$aRotator Cuff Tendinitis
=450  \\$wnnna$aRotator Cuff Tendinosis
=450  \\$wnnna$aCuff Injury, Rotator
=450  \\$wnnna$aGlenoid Labral Tear
=450  \\$wnnna$aInjuries, Rotator Cuff
=450  \\$wnnna$aInjury, Rotator Cuff
=450  \\$wnnna$aLabral Tear, Glenoid
=450  \\$wnnna$aLabral Tears, Glenoid
=450  \\$wnnna$aRotator Cuff Injury
=450  \\$wnnna$aRotator Cuff Tear
=450  \\$wnnna$aRotator Cuff Tendinitides
=450  \\$wnnna$aRotator Cuff Tendinoses
=450  \\$wnnna$aTear, Glenoid Labral
=450  \\$wnnna$aTear, Rotator Cuff
=450  \\$wnnna$aTears, Glenoid Labral
=450  \\$wnnna$aTears, Rotator Cuff
=450  \\$wnnna$aTendinitis, Rotator Cuff
=450  \\$wnnna$aTendinoses, Rotator Cuff
=450  \\$wnnna$aTendinosis, Rotator Cuff
=450  \\$aRotator Cuff$xinjuries
=550  \\$wg$aShoulder Injuries
=550  \\$wg$aRupture
=550  \\$wg$aTendon Injuries
=550  \\$aRotator Cuff Tear Arthropathy
=680  \\$iInjuries to the ROTATOR CUFF of the shoulder joint.
=688  \\$a2017
=750  \0$81$wb$iRelated mapping$aShoulder joint$xRotator cuff$0(DLC)sh 86001426$5IEN
=780  \0$81$wb$iRelated mapping$xWounds and injuries$0(DLC)sh 99004991$4RM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading$aShoulder joint--Rotator cuff--Wounds and injuries

=LDR  00819cz  a2200241n  4500
=001  9880737040902441
=005  20181221103240.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072776
=035  \\$a(NLM)987391877500041
=040  \\$aDNLM$cDNLM
=060  \0$aWW 143
=072  \\$aE1.$x370.$x380.$x727
=150  \\$aSlit Lamp Microscopy
=450  \\$wnnna$aSlit Lamp Examination
=450  \\$wnnna$aExamination, Slit Lamp
=450  \\$wnnna$aExaminations, Slit Lamp
=450  \\$wnnna$aMicroscopy, Slit Lamp
=450  \\$wnnna$aSlit Lamp Examinations
=550  \\$aSlit Lamp
=680  \\$iA procedure that uses a SLIT LAMP to examine structures in the front of the EYE, such as the CONJUNCTIVA; CORNEA; IRIS; and AQUEOUS HUMOR.
=688  \\$a2017
=750  \0$aOcular biomicroscopy$0(DLC)sh 85094050$5IEN-M

=LDR  01409nz  a2200409n  4500
=001  9880737051502441
=005  20181219121331.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072227
=035  \\$a(NLM)987391564900041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x695.$x400.$x852
=150  \\$aShoulder Prosthesis
=450  \\$wnnna$aArtificial Shoulder Joint
=450  \\$wnnna$aHumeral Head Prosthesis
=450  \\$wnnna$aProsthetic Shoulder
=450  \\$wnnna$aArtificial Shoulder Joints
=450  \\$wnnna$aHead Prostheses, Humeral
=450  \\$wnnna$aHead Prosthesis, Humeral
=450  \\$wnnna$aHumeral Head Prostheses
=450  \\$wnnna$aJoint, Artificial Shoulder
=450  \\$wnnna$aJoints, Artificial Shoulder
=450  \\$wnnna$aProstheses, Humeral Head
=450  \\$wnnna$aProstheses, Shoulder
=450  \\$wnnna$aProsthesis, Humeral Head
=450  \\$wnnna$aProsthesis, Shoulder
=450  \\$wnnna$aProsthetic Shoulders
=450  \\$wnnna$aShoulder Joint, Artificial
=450  \\$wnnna$aShoulder Joints, Artificial
=450  \\$wnnna$aShoulder Prostheses
=450  \\$wnnna$aShoulder, Prosthetic
=450  \\$wnnna$aShoulders, Prosthetic
=550  \\$wg$aJoint Prosthesis
=550  \\$aArthroplasty, Replacement, Shoulder
=680  \\$iReplacement for a SHOULDER JOINT.
=688  \\$a2017
=750  \0$aArtificial shoulder joints$0(DLC)sh 87001567$5IEN-M

=LDR  03144cz  a2200889n  4500
=001  9880737061302441
=005  20181217133824.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072339
=035  \\$a(NLM)987391698300041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x777
=150  \\$aSexual and Gender Minorities
=450  \\$wnnna$aBisexuals
=450  \\$wnnna$aGLBT Persons
=450  \\$wnnna$aGLBTQ Persons
=450  \\$wnnna$aGender Minorities
=450  \\$wnnna$aHomosexuals
=450  \\$wnnna$aLBG Persons
=450  \\$wnnna$aLGBT Persons
=450  \\$wnnna$aLGBTQ Persons
=450  \\$wnnna$aLesbians
=450  \\$wnnna$aLesbigay Persons
=450  \\$wnnna$aMen Who Have Sex With Men
=450  \\$wnnna$aNon-Heterosexual Persons
=450  \\$wnnna$aNon-Heterosexuals
=450  \\$wnnna$aQueers
=450  \\$wnnna$aSexual Dissidents
=450  \\$wnnna$aSexual Minorities
=450  \\$wnnna$aWomen Who Have Sex With Women
=450  \\$aGays
=450  \\$wnnna$aBisexual
=450  \\$wnnna$aDissident, Sexual
=450  \\$wnnna$aDissidents, Sexual
=450  \\$wnnna$aGLBT Person
=450  \\$wnnna$aGLBTQ Person
=450  \\$wnnna$aGay
=450  \\$wnnna$aGender Minority
=450  \\$wnnna$aHomosexual
=450  \\$wnnna$aLBG Person
=450  \\$wnnna$aLGBT Person
=450  \\$wnnna$aLGBTQ Person
=450  \\$wnnna$aLesbian
=450  \\$wnnna$aLesbigay Person
=450  \\$wnnna$aMinorities, Gender
=450  \\$wnnna$aMinorities, Sexual
=450  \\$wnnna$aMinority, Gender
=450  \\$wnnna$aMinority, Sexual
=450  \\$wnnna$aNon Heterosexual Persons
=450  \\$wnnna$aNon Heterosexuals
=450  \\$wnnna$aNon-Heterosexual
=450  \\$wnnna$aNon-Heterosexual Person
=450  \\$wnnna$aPerson, GLBT
=450  \\$wnnna$aPerson, GLBTQ
=450  \\$wnnna$aPerson, LBG
=450  \\$wnnna$aPerson, LGBT
=450  \\$wnnna$aPerson, LGBTQ
=450  \\$wnnna$aPerson, Lesbigay
=450  \\$wnnna$aPerson, Non-Heterosexual
=450  \\$wnnna$aPersons, GLBT
=450  \\$wnnna$aPersons, GLBTQ
=450  \\$wnnna$aPersons, LBG
=450  \\$wnnna$aPersons, LGBT
=450  \\$wnnna$aPersons, LGBTQ
=450  \\$wnnna$aPersons, Lesbigay
=450  \\$wnnna$aQueer
=450  \\$wnnna$aSexual Dissident
=450  \\$wnnna$aSexual Minority
=550  \\$wg$aPersons
=550  \\$wh$aTransgender Persons
=550  \\$aBisexuality
=550  \\$aHomosexuality
=550  \\$aHomosexuality, Male
=550  \\$aHomosexuality, Female
=680  \\$iIndividuals including lesbian, gay, bisexual, transgender, queer, intersex, gender non-conforming people, and other populations whose sexual orientation or GENDER IDENTITY and reproductive development is considered outside cultural, societal, or physiological norms.
=688  \\$a2018; was SEXUAL MINORITIES 2017; for BISEXUALS use BISEXUALITY 1996-2016; for LESBIANS see HOMOSEXUALITY, FEMALE 1995-2016; for HOMOSEXUALS see HOMOSEXUALITY 1989-2016; for QUEERS see HOMOSEXALITY 2016-2017; for GAYS see HOMOSEXUALITY 1995-2016
=750  \0$aSexual minorities$0(DLC)sh2004003385$5IEN-M

=LDR  00867cz  a2200217n  4500
=001  9880737061702441
=005  20181217104934.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072739
=035  \\$a(NLM)987391882400041
=040  \\$aDNLM$cDNLM
=072  \\$aB5.$x698
=150  \\$aSentinel Species
=450  \\$wnnna$aBioindicator Species
=450  \\$wnnna$aSentinel Animals
=450  \\$wnnna$aSentinel Organisms
=450  \\$wnnna$aSentinel Plants
=550  \\$wg$aOrganism Forms
=680  \\$iOrganisms used to determine measurable environmental risks or hazards to human health and or well-being, thereby serving as advance or early warning signs of impending danger to humans. Examples of sentinel species are monkeys, guinea pigs, and the fabled canary in the coal mine.
=688  \\$a2017
=750  \0$aIndicators (Biology)$0(DLC)sh 85065657$5IEN-M

=LDR  00993cz  a2200313n  4500
=001  9880737068702441
=005  20181213113320.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072039
=035  \\$a(NLM)987391509700041
=040  \\$aDNLM$cDNLM
=072  \\$aC5.$x550.$x518.$x336
=072  \\$aC26.$x289.$x336
=072  \\$aC26.$x404.$x26
=150  \\$aFracture Dislocation
=450  \\$wnnna$aDislocation Fracture
=450  \\$wnnna$aDislocation Fractures
=450  \\$wnnna$aDislocation, Fracture
=450  \\$wnnna$aDislocations, Fracture
=450  \\$wnnna$aFracture Dislocations
=450  \\$wnnna$aFracture, Dislocation
=450  \\$wnnna$aFractures, Dislocation
=550  \\$wg$aFractures, Bone
=550  \\$wg$aJoint Dislocations
=550  \\$wh$aColles' Fracture
=550  \\$wh$aMonteggia's Fracture
=550  \\$wh$aSalter-Harris Fractures
=680  \\$iFracture of a bone near an articulation with concomitant dislocation of that joint.
=688  \\$a2017

=LDR  01166cz  a2200325n  4500
=001  9880737068802441
=005  20181213114008.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072042
=035  \\$a(NLM)987391627700041
=040  \\$aDNLM$cDNLM
=072  \\$aC5.$x550.$x518.$x336.$x875
=072  \\$aC26.$x289.$x336.$x875
=072  \\$aC26.$x404.$x26.$x500
=150  \\$aSalter-Harris Fractures
=450  \\$wnnna$aGrowth Plate Fractures
=450  \\$wnnna$aGrowth Plate Injuries
=450  \\$wnnna$aFracture, Growth Plate
=450  \\$wnnna$aFractures, Growth Plate
=450  \\$wnnna$aFractures, Salter-Harris
=450  \\$wnnna$aGrowth Plate Fracture
=450  \\$wnnna$aGrowth Plate Injury
=450  \\$wnnna$aSalter Harris Fractures
=450  \\$aGrowth Plate$xinjuries
=550  \\$wg$aFracture Dislocation
=680  \\$iFractures involving a GROWTH PLATE.
=688  \\$a2017
=750  \0$81$wb$iBroader mapping$aGrowth plate$0(DLCsh 88001051$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xFractures$0(DLC)sh00005813$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aGrowth plate--Fractures$5IEN-M

=LDR  00912cz  a2200253n  4500
=001  9880741169402441
=005  20190103114346.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066530
=035  \\$a(NLM)985399330100041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x760.$x169.$x63.$x500.$x477
=072  \\$aE2.$x831.$x477
=072  \\$aH2.$x403.$x680.$x600.$x750
=072  \\$aN2.$x421.$x784.$x511
=150  \\$aNeurological Rehabilitation
=450  \\$wnnna$aNeurologic Rehabilitation
=450  \\$wnnna$aNeurorehabilitation
=450  \\$wnnna$aRehabilitation, Neurologic
=450  \\$wnnna$aRehabilitation, Neurological
=550  \\$wg$aRehabilitation
=680  \\$iPhysician-supervised programs designed to rehabilitate people with diseases, trauma, or disorders of the NERVOUS SYSTEM.
=688  \\$a2016
=750  \0$aNervous system$xDiseases$xPatients$xRehabilitation$0(DLC)sh2010103647$5IEN-M

=LDR  00900cz  a2200253n  4500
=001  9880741169902441
=005  20190103111746.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071939
=035  \\$a(NLM)987391286700041
=035  \\$a(NLM)987391286700041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 356
=072  \\$aE2.$x760.$x169.$x63.$x500.$x477.$x500
=072  \\$aE2.$x831.$x477.$x500
=072  \\$aH2.$x403.$x680.$x600.$x750.$x500
=072  \\$aN2.$x421.$x784.$x511.$x500
=150  \\$aStroke Rehabilitation
=450  \\$wnnna$aRehabilitation, Stroke
=450  \\$aStroke$xrehabilitation
=550  \\$wg$aNeurological Rehabilitation
=680  \\$iRestoration of functions to the maximum degree possible in a person or persons suffering from a stroke.
=688  \\$a2017
=750  \0$iBroader mapping$aCerebrovascular disease$xPatients$xRehabilitation$0(DLC)sh2008100287$4BM$5IEN-M

=LDR  00863cz  a2200193n  4500
=001  9880741173702441
=005  20190102114635.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070001
=035  \\$a(NLM)987390580200041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x353.$x750.$x737.$x872.$x663
=072  \\$aB3.$x510.$x400.$x800.$x872.$x663
=072  \\$aB3.$x510.$x550.$x737.$x872.$x663
=150  \\$aStreptococcus salivarius
=550  \\$wg$aStreptococcus
=680  \\$iA species of Streptococcus that occurs in the human oral cavity and upper respiratory tract. It is a constituent of DENTAL PLAQUE and some strains may be pathogenic if they enter the bloodstream. However, other strains such as Streptococcus salivarius K12 produce BACTERIOCINS and are used as PROBIOTICS.
=688  \\$a2017
=750  \0$aStreptococcus salivarius$0(DLC)sh 85128687$5IEN-M

=LDR  00608cz  a2200181n  4500
=001  9880741174002441
=005  20190102111359.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070318
=035  \\$a(NLM)987390730000041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x452.$x718.$x500
=150  \\$aStrategic Planning
=450  \\$wnnna$aPlanning, Strategic
=550  \\$wg$aPlanning Techniques
=680  \\$iA rigorous and systematic process which entails defining plans, decisions, and sequence of steps to be taken in the future.
=688  \\$a2017
=750  \0$aStrategic planning$0(DLC)sh 85128511$5IEN-M

=LDR  01219cz  a2200325n  4500
=001  9880743773702441
=005  20190107110741.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072176
=035  \\$a(NLM)987391590300041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x358.$x500.$x875
=150  \\$aSuperconductivity
=450  \\$wnnna$aMeissner Effect
=450  \\$wnnna$aSuperconducting Coil
=450  \\$wnnna$aSuperconducting Magnets
=450  \\$wnnna$aSuperconductors
=450  \\$wnnna$aCoil, Superconducting
=450  \\$wnnna$aCoils, Superconducting
=450  \\$wnnna$aEffect, Meissner
=450  \\$wnnna$aMagnet, Superconducting
=450  \\$wnnna$aMagnets, Superconducting
=450  \\$wnnna$aSuperconducting Coils
=450  \\$wnnna$aSuperconducting Magnet
=450  \\$wnnna$aSuperconductivities
=450  \\$wnnna$aSuperconductor
=550  \\$wg$aElectromagnetic Phenomena
=680  \\$iThe ability of an element or metallic alloy to allow the passage of ELECTRONS without ELECTRICAL RESISTANCE and expel MAGNETIC FIELDS below a certain threshold temperature called superconducting transition temperature.
=688  \\$a2017
=750  \0$aSuperconductivity$0(DLC)sh 85130584$5IEN-M

=LDR  01008cz  a2200277n  4500
=001  9880745362002441
=005  20190110142126.0
=008  991108\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020834
=035  \\$a(NLM)98198726400000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 752
=072  \\$aH1.$x158.$x703.$x15
=072  \\$aH2.$x628.$x100
=072  \\$aI1.$x76.$x201.$x450.$x654.$x252
=150  \\$aEthnopharmacology
=550  \\$wg$aMedicine, Traditional
=550  \\$aPhytotherapy
=550  \\$aPharmacognosy
=550  \\$aPlants
=550  \\$aPlants, Medicinal
=550  \\$aEthnobotany
=667  \\$aspecialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant (IM) for ethnopharmacologic aspects of the drug or plant
=680  \\$iThe study of the actions and properties of medicinal agents, often derived from PLANTS, indigenous to populations or ETHNIC GROUPS.
=688  \\$a2000
=750  \0$aEthnopharmacology$0(DLC)sh2005008277$5IEN-M

=LDR  01987cz  a2200529n  4500
=001  9880745367102441
=005  20190110143443.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008519
=035  \\$a(NLM)98195279120000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x190.$x488
=072  \\$aI1.$x76.$x201.$x450.$x654
=150  \\$aMedicine, Traditional
=450  \\$wnnna$aIndigenous Medicine
=450  \\$wnnna$aPrimitive Medicine
=450  \\$wnnna$aTraditional Medicine
=450  \\$aEthnomedicine
=450  \\$aFolk Medicine
=450  \\$aFolk Remedies
=450  \\$aHome Remedies
=450  \\$aMedicine, Folk
=450  \\$aMedicine, Indigenous
=450  \\$aMedicine, Primitive
=450  \\$wnnna$aFolk Remedy
=450  \\$wnnna$aHome Remedy
=450  \\$wnnna$aRemedies, Folk
=450  \\$wnnna$aRemedies, Home
=450  \\$wnnna$aRemedy, Folk
=450  \\$wnnna$aRemedy, Home
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aCulture
=550  \\$wh$aEthnopharmacology
=550  \\$wh$aMedicine, African Traditional
=550  \\$wh$aMedicine, Arabic
=550  \\$wh$aMedicine, Ayurvedic
=550  \\$wh$aMedicine, East Asian Traditional
=550  \\$wh$aShamanism
=550  \\$aTraditional Pulse Diagnosis
=550  \\$aMateria Medica
=550  \\$aNostrums
=550  \\$aPharmacognosy
=550  \\$aPlants, Medicinal
=667  \\$aincludes medicine among aborigines & other primitive cultures & folk medicine among non-primitive cultures; specify geographical term; DF: MED TRADITIONAL
=680  \\$iSystems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals (SPIRITUAL THERAPIES); PHYTOTHERAPY; and other treatments which may not be explained by modern medicine.
=688  \\$a81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77
=750  \0$aTraditional medicine$0(DLC)sh 85083164$5IEN-M

=LDR  00599cz  a2200205n  4500
=001  9880746971602441
=005  20190114101619.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071077
=035  \\$a(NLM)987390879500041
=040  \\$aDNLM$cDNLM
=060  \0$aQZ 21
=072  \\$aH2.$x403.$x429.$x515.$x750
=072  \\$aH2.$x403.$x810.$x796
=150  \\$aSurgical Oncology
=450  \\$wnnna$aOncology, Surgical
=550  \\$wg$aMedical Oncology
=680  \\$iA surgical specialty concerned with management of cancer.
=688  \\$a2017
=750  \0$aCancer$xSurgery$0(DLC)sh 85019545$5IEN-M

=LDR  01093cz  a2200289n  4500
=001  9880749674002441
=005  20190121175030.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071057
=035  \\$a(NLM)987390896100041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 390
=072  \\$aC10.$x228.$x662.$x262.$x500.$x500
=072  \\$aC10.$x597.$x350.$x275.$x500
=072  \\$aC23.$x888.$x592.$x350.$x275.$x500
=150  \\$aTardive Dyskinesia
=450  \\$wnnna$aTardive Dystonia
=450  \\$wnnna$aDyskinesia, Tardive
=450  \\$wnnna$aDyskinesias, Tardive
=450  \\$wnnna$aDystonia, Tardive
=450  \\$wnnna$aDystonias, Tardive
=450  \\$wnnna$aTardive Dyskinesias
=450  \\$wnnna$aTardive Dystonias
=550  \\$wg$aDyskinesia, Drug-Induced
=680  \\$iDrug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).
=688  \\$a2017; use MOVEMENT DISORDERS 2010-2016
=750  \0$aTardive dyskinesia$0(DLC)sh 85132478$5IEN-M

=LDR  01037cz  a2200265n  4500
=001  9880749674302441
=005  20190121122909.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005804
=035  \\$a(NLM)98197707430000041
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x350
=150  \\$aGenes, Lethal
=450  \\$wnnna$aAlleles, Lethal
=450  \\$wnnna$aAllele, Lethal
=450  \\$wnnna$aGene, Lethal
=450  \\$wnnna$aLethal Allele
=450  \\$wnnna$aLethal Alleles
=450  \\$wnnna$aLethal Gene
=450  \\$wnnna$aLethal Genes
=550  \\$wg$aGenes
=550  \\$aSynthetic Lethal Mutations
=680  \\$iGenes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability.
=688  \\$a68
=750  \0$aLethal mutation$0(DLC)sh 85076205$5IEN-M

=LDR  00822cz  a2200241n  4500
=001  9880750272502441
=005  20190124114603.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070260
=035  \\$a(NLM)987390730300041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x358.$x984
=150  \\$aTeacher Training
=450  \\$wnnna$aTeacher Education
=450  \\$wnnna$aTraining of Trainers
=450  \\$wnnna$aEducation, Teacher
=450  \\$wnnna$aTrainers Training
=450  \\$wnnna$aTraining, Teacher
=450  \\$aSchool Teachers$xeducation
=550  \\$wg$aEducation, Professional
=680  \\$iA curriculum-centered process of equipping individuals with professional knowledge and skills required to become effective teachers.
=688  \\$a2017
=750  \0$aTeachers$xTraining of$0(DLC) sh 85132999$5IEN-M

=LDR  00920cz  a2200313n  4500
=001  9880751048702441
=005  20190201163548.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072797
=035  \\$a(NLM)987391872100041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x600.$x250.$x500
=072  \\$aG11.$x427.$x410.$x568.$x900.$x750.$x500
=150  \\$aWalking Speed
=450  \\$wnnna$aGait Speed
=450  \\$wnnna$aWalking Pace
=450  \\$wnnna$aGait Speeds
=450  \\$wnnna$aPace, Walking
=450  \\$wnnna$aPaces, Walking
=450  \\$wnnna$aSpeed, Gait
=450  \\$wnnna$aSpeed, Walking
=450  \\$wnnna$aSpeeds, Gait
=450  \\$wnnna$aSpeeds, Walking
=450  \\$wnnna$aWalking Paces
=450  \\$wnnna$aWalking Speeds
=550  \\$wg$aGait
=680  \\$iThe rate at which steps are made while walking.
=688  \\$a2017
=750  \0$aWalking speed$0(DLC)sh2014000692$5IEN-M

=LDR  01552cz  a2200541n  4500
=001  9880751053802441
=005  20190131140458.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070658
=035  \\$a(NLM)987390652100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x401.$x976
=150  \\$aVigna
=450  \\$wnnna$aAdzuki Bean
=450  \\$wnnna$aBlack Gram
=450  \\$wnnna$aBlackeyed Pea
=450  \\$wnnna$aCowpeas
=450  \\$wnnna$aMoth Bean
=450  \\$wnnna$aMung Beans
=450  \\$wnnna$aPhaseolus mungo
=450  \\$wnnna$aRice Bean
=450  \\$wnnna$aVigna aconitifolia
=450  \\$wnnna$aVigna angularis
=450  \\$wnnna$aVigna mungo
=450  \\$wnnna$aVigna radiata
=450  \\$wnnna$aVigna umbellata
=450  \\$wnnna$aVigna unguiculata
=450  \\$wnnna$aAdzuki Beans
=450  \\$wnnna$aBean, Adzuki
=450  \\$wnnna$aBean, Moth
=450  \\$wnnna$aBean, Mung
=450  \\$wnnna$aBean, Rice
=450  \\$wnnna$aBeans, Adzuki
=450  \\$wnnna$aBeans, Moth
=450  \\$wnnna$aBeans, Mung
=450  \\$wnnna$aBeans, Rice
=450  \\$wnnna$aBlackeyed Peas
=450  \\$wnnna$aCowpea
=450  \\$wnnna$aGram, Black
=450  \\$wnnna$aMoth Beans
=450  \\$wnnna$aMung Bean
=450  \\$wnnna$aPea, Blackeyed
=450  \\$wnnna$aPeas, Blackeyed
=450  \\$wnnna$aRice Beans
=550  \\$wg$aFabaceae
=680  \\$iPlant genus in the pea family (Fabaceae).
=688  \\$a2017
=750  \0$aVigna$0(DLC)sh 85143324$5IEN-M

=LDR  01223cz  a2200409n  4500
=001  9880751054602441
=005  20190131135205.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072137
=035  \\$a(NLM)987391477700041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 295
=072  \\$aF1.$x145.$x805.$x500
=150  \\$aVaping
=150  \\$aSmoking
=450  \\$wnnna$aE-Cig Use
=450  \\$wnnna$aE-Cigarette Use
=450  \\$wnnna$aElectronic Cigarette Use
=450  \\$wnnna$aVape
=450  \\$wnnna$aCigarette Use, Electronic
=450  \\$wnnna$aCigarette Uses, Electronic
=450  \\$wnnna$aE Cig Use
=450  \\$wnnna$aE Cigarette Use
=450  \\$wnnna$aE-Cig Uses
=450  \\$wnnna$aE-Cigarette Uses
=450  \\$wnnna$aElectronic Cigarette Uses
=450  \\$wnnna$aUse, E-Cig
=450  \\$wnnna$aUse, E-Cigarette
=450  \\$wnnna$aUse, Electronic Cigarette
=450  \\$wnnna$aUses, E-Cig
=450  \\$wnnna$aUses, E-Cigarette
=450  \\$wnnna$aUses, Electronic Cigarette
=450  \\$wnnna$aVapes
=550  \\$wg$aSmoking
=680  \\$iSMOKING vapors produced from ELECTRONIC NICOTINE DELIVERY SYSTEMS.
=688  \\$a2017
=750  \0$aVaping$0(DLC)sh2016002039$5IEN-M

=LDR  01758cz  a2200481n  4500
=001  9880751055502441
=005  20190131125913.0
=008  900529\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D016312
=035  \\$a(NLM)98199368920000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x150.$x750.$x750
=072  \\$aF1.$x145.$x488.$x887.$x750
=072  \\$aI1.$x880.$x604.$x473.$x650.$x968
=072  \\$aN3.$x706.$x437.$x650.$x875
=072  \\$aN5.$x300.$x150.$x800.$x750
=150  \\$aTreatment Refusal
=450  \\$wnnna$aAnesthesia Refusal
=450  \\$wnnna$aPatient Elopement
=450  \\$aPatient Refusal of Treatment
=450  \\$aRefusal of Treatment
=450  \\$wnnna$aAnesthesia Refusals
=450  \\$wnnna$aElopement, Patient
=450  \\$wnnna$aElopements, Patient
=450  \\$wnnna$aPatient Elopements
=450  \\$wnnna$aRefusal, Anesthesia
=450  \\$wnnna$aRefusal, Treatment
=450  \\$wnnna$aRefusals, Anesthesia
=450  \\$wnnna$aRefusals, Treatment
=450  \\$wnnna$aTreatment Refusals
=550  \\$wg$aPatient Rights
=550  \\$wh$aVaccination Refusal
=550  \\$aInformed Consent
=550  \\$aPatient Compliance
=550  \\$aMental Competency
=550  \\$aProxy
=550  \\$aThird-Party Consent
=550  \\$aRefusal to Participate
=550  \\$aMedication Adherence
=667  \\$afor patient non-compliance index PATIENT NON-COMPLIANCE see PATIENT COMPLIANCE; do not confuse with PHYSICIAN REFUSAL TO TREAT see REFUSAL TO TREAT
=680  \\$iPatient or client refusal of or resistance to medical, psychological, or psychiatric treatment. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a1991
=750  \0$aPatient refusal of treatment$0(DLC)sh2004009953$5IEN-M

=LDR  00653cz  a2200205n  4500
=001  9880751055702441
=005  20190131123307.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072178
=035  \\$a(NLM)987391588400041
=040  \\$aDNLM$cDNLM
=060  \0$aWJ 21
=072  \\$aM1.$x526.$x485.$x810.$x955
=072  \\$aN2.$x360.$x810.$x955
=150  \\$aUrologists
=450  \\$wnnna$aUrologist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in the diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male.
=688  \\$a2017
=750  \0$aUrologists$0(DLC)sh 85141450$5IEN-M

=LDR  00860cz  a2200253n  4500
=001  9880751055902441
=005  20190131114757.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071218
=035  \\$a(NLM)987391216500041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x180.$x562.$x797
=150  \\$aUltradian Rhythm
=450  \\$wnnna$aUltradian Cycle
=450  \\$aUltradian Cycles
=450  \\$wnnna$aCycle, Ultradian
=450  \\$wnnna$aCycles, Ultradian
=450  \\$wnnna$aRhythm, Ultradian
=450  \\$wnnna$aRhythms, Ultradian
=450  \\$wnnna$aUltradian Rhythms
=550  \\$wg$aPeriodicity
=680  \\$iA biological rhythm with a period shorter than 24 hours.
=688  \\$a2017; for ULTRADIAN RHYTHMS use CIRCADIAN RHYTHM 2016; for ULTRADIAN CYCLES use ACTIVITY CYCLES 1985-2016
=750  \0$aUltradian rhythms$0(DLC)sh 85139466$5IEN-M

=LDR  00639cz  a2200205n  4500
=001  9880751056002441
=005  20190130130715.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072359
=035  \\$a(NLM)987391547200041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x875
=072  \\$aB3.$x440.$x475.$x100.$x875
=072  \\$aB3.$x585.$x950
=150  \\$aTrichodesmium
=550  \\$wg$aCyanobacteria
=550  \\$wg$aNitrogen-Fixing Bacteria
=680  \\$iA nitrogen-fixing genus of filamentous cyanobacteria that occurs in tropical and subtropical oceans.
=688  \\$a2017
=750  \0$aTrichodesmium$0(DLC)sh 88023354$5IEN-M

=LDR  00871cz  a2200229n  4500
=001  9880751056302441
=005  20190130105616.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072436
=035  \\$a(NLM)987391679300041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x970
=150  \\$aTransportation Facilities
=450  \\$wnnna$aFacilities, Transportation
=450  \\$wnnna$aFacility, Transportation
=450  \\$wnnna$aTransportation Facility
=550  \\$wg$aNon-Medical Public and Private Facilities
=550  \\$wh$aAirports
=550  \\$wh$aParking Facilities
=680  \\$iPlaces such as AIRPORTS, bus stations, and train stations that are used for managing arriving and departing transport vehicles, and included facilities for handling passengers.
=688  \\$a2017
=750  \0$iRelated mapping$aTransportation buildings$0(DLC)sh 85137067$4RM$5IEN-M

=LDR  00724cz  a2200229n  4500
=001  9880751068602441
=005  20190128115241.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071436
=035  \\$a(NLM)987391156500041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x25.$x133.$x500
=072  \\$aG16.$x12.$x500.$x133.$x500
=150  \\$aThermotolerance
=450  \\$wnnna$aHeat Adaptation
=450  \\$wnnna$aHeat Tolerance
=450  \\$wnnna$aTolerance, Heat
=450  \\$wnnna$aTolerances, Heat
=550  \\$wg$aAcclimatization
=680  \\$iThe ability of an organism to reduce susceptibility to heat shock, and adapt to HOT TEMPERATURE.
=688  \\$a2017
=750  \0$aHeat adaptation$0(DLC)sh2003011688$5IEN-M

=LDR  01053nz  a2200301n  4500
=001  9882549679102441
=005  20250214144537.0
=008  160708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000070380
=035  \\$a(DNLM)D000070380
=035  \\$a(NLM)987390542100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x618.$x100.$x970
=150  \\$aAsphodelaceae
=450  \\$wnnna$aXanthorrhoeaceae
=450  \\$aAloeaceae
=450  \\$aAsphodeloideae
=450  \\$aAsphodelus
=450  \\$aBulbine
=450  \\$aFlax, New Zealand
=450  \\$aPhormium
=450  \\$wnnna$aNew Zealand Flax
=450  \\$wnnna$aZealand Flax, New
=680  \\$iA plant genus of the family ASPHODELACEAE.
=680  \\$iA plant genus of Xanthorrhoeaceae.
=680  \\$iA family of flowering plants in the order Asparagales.
=688  \\$a2023; for PHORMIUM use ASPARAGACEAE 2003-2016; for ASPHODELACEAE use LLILIACEAE 2007-2016; for BULBINE use LILIACEAE 2003-2016
=750  \0$aXanthorrhoeaceae$0(DLC)sh 95005018$5IEN-M

=LDR  00735cz  a2200205n  4500
=001  9880752570302441
=005  20190204134623.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072358
=035  \\$a(NLM)987391548700041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x940
=072  \\$aI3.$x946.$x225.$x438
=072  \\$aN4.$x452.$x677.$x650.$x438
=150  \\$aWork-Life Balance
=150  \\$wg$aSocial Sciences
=450  \\$wnnna$aLife-Work Imbalance
=680  \\$iThe optimal arrangement of an individual's on-the-job and private time to facilitate health and personal satisfaction without negatively impacting productivity and professional success.
=688  \\$a2017
=750  \\$aWork-life balance$0(DLC)sh2009010770$5IEN-M

=LDR  00819cz  a2200265n  4500
=001  9880752570902441
=005  20190204132943.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070660
=035  \\$a(NLM)987390763300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x760.$x845
=150  \\$aWolfiporia
=450  \\$wnnna$aFu Ling
=450  \\$wnnna$aFu-Ling
=450  \\$wnnna$aFuling
=450  \\$wnnna$aPoria cocos
=450  \\$wnnna$aTuckahoe Fungus
=450  \\$wnnna$aWolfiporia cocos
=450  \\$wnnna$aWolfiporia extensa
=450  \\$wnnna$aFungus, Tuckahoe
=550  \\$wg$aPolyporaceae
=680  \\$iA genus of wood-decaying, edible fungi in the Polyporaceae family. Its type species is Wolfiporia extensa.
=688  \\$a2017
=750  \0$aPoria cocos$0(DLC)sh 85104998$5IEN-M

=LDR  00859cz  a2200265n  4500
=001  9880363903202441
=005  20170228163031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013110
=035  \\$aCBA6432HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x700
=072  \\$aD2.$x33.$x455.$x843
=072  \\$aD2.$x92.$x63.$x700
=150  \\$aSphingosine
=450  \\$wnnna$a4-Sphingenine
=450  \\$wnnna$a4 Sphingenine
=550  \\$wg$aAmino Alcohols
=550  \\$wg$aGlycols
=550  \\$wh$aPsychosine
=550  \\$wh$aFingolimod Hydrochloride
=550  \\$aSphingolipids
=680  \\$iAn amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)
=688  \\$a72
=750  \0$aSphingosine$0(DLC) sh 85126607$5IEN

=LDR  00975cz  a2200229n  4500
=001  9880363903302441
=005  20141212205807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013107
=035  \\$aCBA6429HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570.$x877
=072  \\$aD10.$x808
=150  \\$aSphingolipids
=450  \\$aLysosphingolipids
=550  \\$wg$aLipids
=550  \\$wg$aMembrane Lipids
=550  \\$wh$aGlycosphingolipids
=550  \\$aSphingosine
=680  \\$iA class of membrane lipids that have a polar head and two nonpolar tails. They are composed of one molecule of the long-chain amino alcohol sphingosine (4-sphingenine) or one of its derivatives, one molecule of a long-chain acid, a polar head alcohol and sometimes phosphoric acid in diester linkage at the polar head group. (Lehninger et al, Principles of Biochemistry, 2nd ed)
=688  \\$a72(71); was see under LIPIDS 1963-71
=750  \0$aSphingolipids$5IEN$0(DLC)sh 85126606

=LDR  01904cz  a2200445n  4500
=001  9880363903402441
=005  20141212205806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013106
=035  \\$aCBA6428HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x435.$x825
=072  \\$aC16.$x320.$x565.$x189.$x435.$x825
=072  \\$aC16.$x320.$x565.$x398.$x641.$x803
=072  \\$aC16.$x320.$x565.$x595.$x554.$x825
=072  \\$aC18.$x452.$x132.$x100.$x435.$x825
=072  \\$aC18.$x452.$x584.$x687.$x803
=072  \\$aC18.$x452.$x648.$x189.$x435.$x825
=072  \\$aC18.$x452.$x648.$x398.$x641.$x803
=072  \\$aC18.$x452.$x648.$x595.$x554.$x825
=150  \\$aSphingolipidoses
=450  \\$wnnna$aSphingolipid Storage Disease
=450  \\$wnnna$aSphingolipid Storage Diseases
=450  \\$wnnna$aSphingolipidosis
=450  \\$wnnna$aStorage Disease, Sphingolipid
=450  \\$wnnna$aStorage Diseases, Sphingolipid
=550  \\$wg$aLipidoses
=550  \\$wg$aLysosomal Storage Diseases, Nervous System
=550  \\$wh$aFabry Disease
=550  \\$wh$aFarber Lipogranulomatosis
=550  \\$wh$aGangliosidoses
=550  \\$wh$aGaucher Disease
=550  \\$wh$aLeukodystrophy, Globoid Cell
=550  \\$wh$aNiemann-Pick Diseases
=550  \\$wh$aSea-Blue Histiocyte Syndrome
=550  \\$wh$aSulfatidosis
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA group of inherited metabolic disorders characterized by the intralysosomal accumulation of SPHINGOLIPIDS primarily in the CENTRAL NERVOUS SYSTEM and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.
=688  \\$a1992(1974)
=750  \0$aSphingolipidoses$5IEN-M$0(DLC)sh 85126605

=LDR  00747cz  a2200229n  4500
=001  9880363903502441
=005  20141212205805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013104
=035  \\$aCBA6426HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x868
=072  \\$aB3.$x110.$x761
=072  \\$aB5.$x110.$x761
=150  \\$aSpheroplasts
=450  \\$wnnna$aSpheroplast
=550  \\$wg$aAtypical Bacterial Forms
=550  \\$wg$aCells
=667  \\$ain micro-organisms only; coord IM with specific micro-organism (IM)
=680  \\$iCells, usually bacteria or yeast, which have partially lost their cell wall, lost their characteristic shape and become round.
=688  \\$a74(72)
=750  \0$aSpheroplasts$5IEN$0(DLC)sh 85126602

=LDR  00848cz  a2200181n  4500
=001  9880363903602441
=005  20141212205805.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013101
=035  \\$aCBA6423HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x531.$x621.$x827
=150  \\$aSphenoid Sinus
=450  \\$wnnna$aSinus, Sphenoid
=550  \\$wg$aParanasal Sinuses
=667  \\$ainflammation or sinusitis = SPHENOID SINUSITIS; fractures: coordinate SPHENOID SINUS /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with PARANASAL SINUS NEOPLASMS (IM)
=680  \\$iOne of the paired air spaces located in the body of the SPHENOID BONE behind the ETHMOID BONE in the middle of the skull. Sphenoid sinus communicates with the posterosuperior part of NASAL CAVITY on the same side.
=750  \0$aSphenoid sinus$5IEN$0(DLC)sh 85126586

=LDR  01028cz  a2200217n  4500
=001  9880363903702441
=005  20141212205804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013100
=035  \\$aCBA6422HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x802
=150  \\$aSphenoid Bone
=450  \\$wnnna$aBone, Sphenoid
=450  \\$wnnna$aBones, Sphenoid
=450  \\$wnnna$aSphenoid Bones
=550  \\$wg$aSkull
=550  \\$wh$aSella Turcica
=667  \\$afractures: coordinate SPHENOID BONE /inj (IM) + SKULL FRACTURES (IM); neoplasms: coordinate IM with SKULL NEOPLASMS (IM)
=680  \\$iAn irregular unpaired bone situated at the SKULL BASE and wedged between the frontal, temporal, and occipital bones (FRONTAL BONE; TEMPORAL BONE; OCCIPITAL BONE). Sphenoid bone consists of a median body and three pairs of processes resembling a bat with spread wings. The body is hollowed out in its inferior to form two large cavities (SPHENOID SINUS).
=750  \0$aSphenoid bone$5IEN$0(DLC)sh 85126585

=LDR  00751cz  a2200229n  4500
=001  9880363903802441
=005  20141212205804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013098
=035  \\$aCBA6420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x950
=150  \\$aXylariales
=450  \\$wnnna$aSphaeriale
=450  \\$aSphaeriales
=450  \\$wnnna$aXylariale
=550  \\$wg$aAscomycota
=680  \\$iAn order of ascomycetous FUNGI which includes many economically important plant parasites as well as saprophytes.
=688  \\$a2006 (1975)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Sphaeriales
=688  \\$a91(75); was see under ASCOMYCETES 1975-90
=750  \0$aXylariales$0(DLC) sh 85148850$5IEN-M

=LDR  00781cz  a2200181n  4500
=001  9880363903902441
=005  20141212205804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013096
=035  \\$aCBA6418HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x415.$x701.$x801.$x821
=072  \\$aD2.$x92.$x782.$x802
=150  \\$aSpermine
=550  \\$wg$aPolyamines
=550  \\$wg$aSpermidine
=680  \\$iA biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.
=750  \0$aSpermine$5IEN$0(DLC)sh 85126550

=LDR  00768cz  a2200205n  4500
=001  9880363904002441
=005  20141212205803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013095
=035  \\$aCBA6417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x415.$x701.$x801
=072  \\$aD2.$x92.$x782.$x677
=150  \\$aSpermidine
=550  \\$wg$aPolyamines
=550  \\$wg$aPutrescine
=550  \\$wh$aSpermine
=680  \\$iA polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.
=688  \\$a73(71)
=750  \0$aSpermidine$5IEN$0(DLC)sh 85126549

=LDR  02430cz  a2200529n  4500
=001  9880363904102441
=005  20141212205803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013094
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490.$x890
=072  \\$aA11.$x497.$x760
=150  \\$aSpermatozoa
=450  \\$aSperm
=450  \\$wnnna$aSperm, X-Bearing
=450  \\$wnnna$aSperm, X-Chromosome-Bearing
=450  \\$wnnna$aSperm, Y-Bearing
=450  \\$wnnna$aSperm, Y-Chromosome-Bearing
=450  \\$wnnna$aSpermatozoon
=450  \\$wnnna$aSperms, X-Bearing
=450  \\$wnnna$aSperms, X-Chromosome-Bearing
=450  \\$wnnna$aSperms, Y-Bearing
=450  \\$wnnna$aSperms, Y-Chromosome-Bearing
=450  \\$wnnna$aX-Bearing Sperm
=450  \\$wnnna$aX Bearing Sperm
=450  \\$wnnna$aX-Bearing Sperms
=450  \\$wnnna$aX-Chromosome-Bearing Sperm
=450  \\$wnnna$aX Chromosome Bearing Sperm
=450  \\$wnnna$aX-Chromosome-Bearing Sperms
=450  \\$wnnna$aY-Bearing Sperm
=450  \\$wnnna$aY Bearing Sperm
=450  \\$wnnna$aY-Bearing Sperms
=450  \\$wnnna$aY-Chromosome-Bearing Sperm
=450  \\$wnnna$aY Chromosome Bearing Sperm
=450  \\$wnnna$aY-Chromosome-Bearing Sperms
=550  \\$wg$aGerm Cells
=550  \\$wh$aSperm Head
=550  \\$wh$aSperm Midpiece
=550  \\$wh$aSperm Tail
=550  \\$wh$aSpermatids
=550  \\$wh$aSpermatocytes
=550  \\$wh$aSpermatogonia
=550  \\$aSemen
=667  \\$apolyspermia & polyspermy = SPERMATOZOA if excessive sperm or = FERTILIZATION if fertilization of ovum by more than one sperm; sperm donors: coordinate SPERMATOZOA (IM) + TISSUE DONORS (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband)(IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband)(IM) if pertinent but note SPERM BANKS is available; SPERM PRESERVATION is available; HEMOSPERMIA is available
=680  \\$iMature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.
=688  \\$a1963; for X-BEARING SPERM use X CHROMOSOME 1980-2005; for Y-BEARING SPERM use Y CHROMOSOME 1980-2005
=750  \0$aSpermatozoa$5IEN$0(DLC)sh 85126546

=LDR  00849cz  a2200205n  4500
=001  9880363904202441
=005  20141212205802.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013093
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x490.$x890.$x900
=072  \\$aA11.$x497.$x760.$x800
=150  \\$aSpermatogonia
=450  \\$wnnna$aSpermatogonias
=450  \\$wnnna$aSpermatophore
=450  \\$aSpermatophores
=550  \\$wg$aSpermatozoa
=680  \\$iEuploid male germ cells of an early stage of SPERMATOGENESIS, derived from prespermatogonia. With the onset of puberty, spermatogonia at the basement membrane of the seminiferous tubule proliferate by mitotic then meiotic divisions and give rise to the haploid SPERMATOCYTES.
=688  \\$a91(75); was see under SPERMATOZOA 1975-90
=750  \0$aSpermatophores$5IEN$0(DLC)sh 85126544

=LDR  00719cz  a2200205n  4500
=001  9880363904302441
=005  20141212205802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x151.$x650.$x624
=072  \\$aG8.$x686.$x785.$x760.$x310.$x760
=150  \\$aSpermatogenesis
=450  \\$aSpermatocytogenesis
=450  \\$aSpermiogenesis
=550  \\$wg$aGametogenesis
=550  \\$wh$aSperm Maturation
=680  \\$iThe process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA.
=688  \\$a73(71)
=750  \0$aSpermatogenesis$5IEN$0(DLC)sh 85126541

=LDR  01581cz  a2200433n  4500
=001  9880363904402441
=005  20141212205801.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013089
=035  \\$aCBA6411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x138.$x569
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276.$x827
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276.$x827
=072  \\$aD27.$x888.$x569.$x71.$x569
=150  \\$aSpermatocidal Agents
=450  \\$wnnna$aAgents, Spermatocidal
=450  \\$wnnna$aAgents, Spermatocidal Contraceptive
=450  \\$wnnna$aAgents, Spermicidal
=450  \\$wnnna$aAgents, Spermicidal Contraceptive
=450  \\$wnnna$aContraceptive Agents, Spermatocidal
=450  \\$wnnna$aContraceptive Agents, Spermicidal
=450  \\$wnnna$aDrugs, Spermatocidal
=450  \\$wnnna$aSpermatocidal Contraceptive Agents
=450  \\$wnnna$aSpermatocidal Drugs
=450  \\$wnnna$aSpermatocides
=450  \\$aSpermicidal Agents
=450  \\$wnnna$aSpermicidal Contraceptive Agents
=450  \\$aSpermicides$5IEN
=450  \\$wnnna$aSpermicides, Vaginal
=450  \\$wnnna$aVaginal Spermicides
=550  \\$wg$aAntispermatogenic Agents
=550  \\$wg$aContraceptive Agents, Female
=550  \\$aSpermatozoa
=550  \\$aVaginal Creams, Foams, and Jellies
=667  \\$aconsider also SPERMATOZOA /drug eff
=680  \\$iChemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.
=688  \\$a75
=750  \0$aSpermicides$5IEN$0(DLC)sh 85126548

=LDR  01196cz  a2200253n  4500
=001  9880363904502441
=005  20141212205800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013086
=035  \\$aCBA6408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x693
=150  \\$aSpermatic Cord Torsion
=450  \\$wnnna$aSpermatic Cord Torsions
=450  \\$aTesticular Torsion
=450  \\$wnnna$aTesticular Torsions
=450  \\$wnnna$aTorsion Of Testicular Cord
=450  \\$wnnna$aTorsion, Spermatic Cord
=450  \\$wnnna$aTorsion, Testicular
=450  \\$wnnna$aTorsions, Spermatic Cord
=450  \\$wnnna$aTorsions, Testicular
=550  \\$wg$aGenital Diseases, Male
=680  \\$iThe twisting of the SPERMATIC CORD due to an anatomical abnormality that left the TESTIS mobile and dangling in the SCROTUM. The initial effect of testicular torsion is obstruction of venous return. Depending on the duration and degree of cord rotation, testicular symptoms range from EDEMA to interrupted arterial flow and testicular pain. If blood flow to testis is absent for 4 to 6 h, SPERMATOGENESIS may be permanently lost.
=750  \0$aSpermatic cord torsion$5IEN$0(DLC)sh 85126540

=LDR  00851cz  a2200217n  4500
=001  9880363904602441
=005  20141212205800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013085
=035  \\$aCBA6407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x777
=150  \\$aSpermatic Cord
=450  \\$wnnna$aCord, Spermatic
=450  \\$wnnna$aCords, Spermatic
=450  \\$wnnna$aFuniculus Spermaticus
=450  \\$wnnna$aSpermatic Cords
=550  \\$wg$aGenitalia, Male
=667  \\$adiseases: coord IM with GENITAL DISEASES, MALE (IM)
=680  \\$iEither of a pair of tubular structures formed by DUCTUS DEFERENS; ARTERIES; VEINS; LYMPHATIC VESSELS; and nerves. The spermatic cord extends from the deep inguinal ring through the INGUINAL CANAL to the TESTIS in the SCROTUM.
=750  \0$aSpermatic cord$5IEN$0(DLC)sh 85126538

=LDR  02233cz  a2200577n  4500
=001  9880363904702441
=005  20141212205800.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013084
=035  \\$aCBA6406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x277.$x800
=150  \\$aSperm-Ovum Interactions
=450  \\$wnnna$aEgg-Sperm Interaction
=450  \\$wnnna$aEgg-Sperm Interactions
=450  \\$wnnna$aEgg Sperm Interactions
=450  \\$wnnna$aGamete Interaction
=450  \\$wnnna$aGamete Interactions
=450  \\$wnnna$aOocyte-Sperm Interaction
=450  \\$wnnna$aOocyte-Sperm Interactions
=450  \\$wnnna$aOocyte Sperm Interactions
=450  \\$wnnna$aOvum-Sperm Interaction
=450  \\$aOvum-Sperm Interactions
=450  \\$wnnna$aOvum Sperm Interactions
=450  \\$wnnna$aSperm-Egg Interaction
=450  \\$wnnna$aSperm-Egg Interactions
=450  \\$wnnna$aSperm Egg Interactions
=450  \\$wnnna$aSperm-Egg Penetration
=450  \\$wnnna$aSperm Egg Penetration
=450  \\$wnnna$aSperm-Egg Penetrations
=450  \\$wnnna$aSperm-Oocyte Interaction
=450  \\$wnnna$aSperm-Oocyte Interactions
=450  \\$wnnna$aSperm Oocyte Interactions
=450  \\$wnnna$aSperm-Oocyte Penetration
=450  \\$wnnna$aSperm Oocyte Penetration
=450  \\$wnnna$aSperm-Oocyte Penetrations
=450  \\$wnnna$aSperm-Ovum Interaction
=450  \\$wnnna$aSperm Ovum Interactions
=450  \\$wnnna$aSperm-Ovum Penetration
=450  \\$wnnna$aSperm Ovum Penetration
=450  \\$wnnna$aSperm-Ovum Penetrations
=450  \\$aSperm Penetration
=450  \\$wnnna$aSperm Penetrations
=450  \\$wnnna$aSperm-Zona Pellucida Penetration
=450  \\$wnnna$aSperm Zona Pellucida Penetration
=450  \\$wnnna$aSperm-Zona Pellucida Penetrations
=550  \\$wg$aFertilization
=550  \\$wh$aAcrosome Reaction
=680  \\$iInteractive processes between the oocyte (OVUM) and the sperm (SPERMATOZOA) including sperm adhesion, ACROSOME REACTION, sperm penetration of the ZONA PELLUCIDA, and events leading to FERTILIZATION.
=688  \\$a85(75); was see under FERTILIZATION 1975-84
=750  \0$aSperm-ovum interactions$5IEN$0(DLC)sh 90002688

=LDR  00729cz  a2200253n  4500
=001  9880363904802441
=005  20141212205756.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013074
=035  \\$aCBA6396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x65.$x700
=150  \\$aSperm Banks
=450  \\$wnnna$aBank, Sperm
=450  \\$wnnna$aBanks, Sperm
=450  \\$wnnna$aSperm Bank
=550  \\$wg$aBiological Specimen Banks
=550  \\$aInsemination, Artificial
=550  \\$aSemen
=550  \\$aSemen Preservation
=550  \\$aSpermatozoa
=680  \\$iCenters for acquiring and storing semen.
=688  \\$a91(82); was see under TISSUE BANKS 1982-90
=750  \0$aSperm banks$5IEN$0(DLC)sh 85126534

=LDR  00902cz  a2200217n  4500
=001  9880363904902441
=005  20141212205756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013072
=035  \\$aCBA6394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x727.$x541.$x677
=150  \\$aSpeech, Esophageal
=450  \\$wnnna$aEsophageal Speech
=450  \\$wnnna$aEsophageal Speechs
=450  \\$wnnna$aSpeechs, Esophageal
=550  \\$wg$aSpeech, Alaryngeal
=667  \\$apost-laryngectomy speech
=680  \\$iA method of speech used after laryngectomy, with sound produced by vibration of the column of air in the esophagus against the contracting cricopharyngeal sphincter. (Dorland, 27th ed)
=688  \\$a91(75)(65-67); was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1965-79 (Prov 1965-67)
=750  \0$aEsophageal speech$5IEN$0(DLC)sh 85044846

=LDR  01073cz  a2200277n  4500
=001  9880363905002441
=005  20141212205756.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013071
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x727.$x541
=150  \\$aSpeech, Alaryngeal
=450  \\$wnnna$aAlaryngeal Speech
=450  \\$wnnna$aAlaryngeal Voice Production
=450  \\$wnnna$aAlaryngeal Voice Productions
=450  \\$wnnna$aProduction, Alaryngeal Voice
=450  \\$wnnna$aProductions, Alaryngeal Voice
=450  \\$wnnna$aVoice Production, Alaryngeal
=450  \\$wnnna$aVoice Productions, Alaryngeal
=550  \\$wg$aRehabilitation of Speech and Language Disorders
=550  \\$wh$aSpeech, Esophageal
=550  \\$aLaryngectomy
=550  \\$aLarynx, Artificial
=680  \\$iMethods of enabling a patient without a larynx or with a non-functional larynx to produce voice or speech. The methods may be pneumatic or electronic.
=688  \\$a80; was VOICE PRODUCTION, ALARYNGEAL 1968-79
=750  \0$aSpeech, Alaryngeal$5IEN$0(DLC)sh 85126438

=LDR  00935cz  a2200229n  4500
=001  9880363905102441
=005  20141212205755.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013070
=035  \\$aCBA6392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x727.$x552
=150  \\$aSpeech Therapy
=450  \\$wnnna$aSpeech Therapies
=450  \\$aSpeech Therapists$5IEN
=450  \\$wnnna$aTherapies, Speech
=450  \\$wnnna$aTherapy, Speech
=550  \\$wg$aRehabilitation of Speech and Language Disorders
=667  \\$ado not confuse with LANGUAGE THERAPY: SPEECH THERAPY is for SPEECH DISORDERS; LANGUAGE THERAPY is for LANGUAGE DISORDERS; coord IM with specific speech disord /ther (IM), not /rehabil
=688  \\$a66(64); was in Cat E & G 1973-79, was in Cat G only 1968-72, was in Cat E only 1964-67
=750  \0$aSpeech therapists$5IEN-M$0(DLC)sh 85126454
=750  \0$aSpeech therapy$5IEN-HS$0(DLC)sh 85126455

=LDR  00966cz  a2200253n  4500
=001  9880363905202441
=005  20141212205755.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013068
=035  \\$aCBA6390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x760
=150  \\$aSpeech Production Measurement
=450  \\$wnnna$aMeasurement, Speech Production
=450  \\$wnnna$aMeasurements, Speech Production
=450  \\$wnnna$aProduction Measurement, Speech
=450  \\$wnnna$aProduction Measurements, Speech
=450  \\$wnnna$aSpeech Production Measurements
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aSpeech Articulation Tests
=550  \\$aSpeech Intelligibility
=680  \\$iMeasurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody.
=688  \\$a79
=750  \0$aSpeech$xMeasurement$5IEN$0(IEN)378590

=LDR  00741cz  a2200205n  4500
=001  9880363905302441
=005  20141212205755.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013067
=035  \\$aCBA6389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x71.$x875
=150  \\$aSpeech Perception
=450  \\$wnnna$aDiscrimination, Speech
=450  \\$wnnna$aPerception, Speech
=450  \\$aSpeech Discrimination
=550  \\$wg$aAuditory Perception
=680  \\$iThe process whereby an utterance is decoded into a representation in terms of linguistic units (sequences of phonetic segments which combine to form lexical and grammatical morphemes).
=688  \\$a79
=750  \0$aSpeech perception$5IEN$0(DLC)sh 85126447

=LDR  01502cz  a2200445n  4500
=001  9880363905402441
=005  20141212205754.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013064
=035  \\$aCBA6386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800
=150  \\$aSpeech Disorders
=450  \\$aAprosodia
=450  \\$wnnna$aAprosodias
=450  \\$wnnna$aAprosodic Speech
=450  \\$wnnna$aCluttering
=450  \\$wnnna$aClutterings
=450  \\$wnnna$aDysglossia
=450  \\$wnnna$aDysglossias
=450  \\$wnnna$aDyslalia
=450  \\$wnnna$aDyslalias
=450  \\$wnnna$aRhinolalia
=450  \\$wnnna$aRhinolalias
=450  \\$wnnna$aSpeech, Aprosodic
=450  \\$wnnna$aVerbal Fluency Disorder
=450  \\$wnnna$aVerbal Fluency Disorders
=550  \\$wg$aLanguage Disorders
=550  \\$wh$aAphasia
=550  \\$wh$aArticulation Disorders
=550  \\$wh$aEcholalia
=550  \\$wh$aMutism
=550  \\$wh$aStuttering
=550  \\$aLanguage Disorders
=550  \\$aVelopharyngeal Insufficiency
=550  \\$aVerbal Behavior
=667  \\$a/ther: consider also SPEECH THERAPY; do not confuse with LANGUAGE DISORDERS: read differentiation of SPEECH & LANGUAGE under SPEECH
=680  \\$iAcquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.
=750  \0$aSpeech disorders$5IEN$0(DLC)sh 85126439

=LDR  01027cz  a2200241n  4500
=001  9880363905502441
=005  20141212205753.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013063
=035  \\$aCBA6385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x60.$x60.$x750
=150  \\$aSpeech Discrimination Tests
=450  \\$wnnna$aDiscrimination Test, Speech
=450  \\$wnnna$aDiscrimination Tests, Speech
=450  \\$wnnna$aSpeech Discrimination Test
=450  \\$wnnna$aTest, Speech Discrimination
=450  \\$wnnna$aTests, Speech Discrimination
=550  \\$wg$aAudiometry, Speech
=667  \\$athe examinee hears & understands the examiner's speech; do not confuse with SPEECH INTELLIGIBILITY (the speaker speaks in such a way that the hearer understands him)
=680  \\$iTests of the ability to hear and understand speech as determined by scoring the number of words in a word list repeated correctly.
=688  \\$a1979
=750  \0$aSpeech perception$xTesting$5IEN$0(DLC)sh 85126448

=LDR  01055cz  a2200301n  4500
=001  9880363905602441
=005  20141212205752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013060
=035  \\$aCBA6382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x908.$x677
=072  \\$aG11.$x561.$x600.$x825
=072  \\$aL1.$x143.$x506.$x423.$x676
=150  \\$aSpeech
=450  \\$aPublic Speaking
=450  \\$wnnna$aSpeaking, Public
=550  \\$wg$aLanguage Arts
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aVerbal Behavior
=550  \\$wh$aSpeech Acoustics
=550  \\$wh$aSpeech Intelligibility
=550  \\$aLanguage Development
=550  \\$aPhonation
=550  \\$aVoice
=667  \\$a= LANGUAGE as it comes out of the mouth; VERBAL BEHAVIOR is how it comes out; PHONETICS is the sounds making up SPEECH; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available
=680  \\$iCommunication through a system of conventional vocal symbols.
=750  \0$aSpeech$5IEN$0(DLC)sh 85126434

=LDR  00938cz  a2200277n  4500
=001  9880363905702441
=005  20141212205752.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013059
=035  \\$aCBA6381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x822.$x860
=072  \\$aE5.$x196.$x867.$x890
=150  \\$aSpectrum Analysis, Raman
=450  \\$wnnna$aAnalysis, Raman Spectrum
=450  \\$wnnna$aRaman Optical Activity Spectroscopy
=450  \\$wnnna$aRaman Scattering
=450  \\$aRaman Spectroscopy
=450  \\$wnnna$aRaman Spectrum Analysis
=450  \\$wnnna$aScattering, Raman
=450  \\$wnnna$aSpectroscopy, Raman
=550  \\$wg$aScattering, Radiation
=550  \\$wg$aSpectrum Analysis
=680  \\$iAnalysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light.
=688  \\$a77
=750  \0$aRaman spectroscopy$5IEN$0(DLC)sh 85111278

=LDR  01447cz  a2200373n  4500
=001  9880363905802441
=005  20141212205752.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013058
=035  \\$aCBA6380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x566
=150  \\$aMass Spectrometry
=450  \\$wnnna$aAnalyses, Mass Spectrum
=450  \\$wnnna$aAnalysis, Mass Spectrum
=450  \\$aMass Spectroscopy
=450  \\$wnnna$aMass Spectrum Analyses
=450  \\$wnnna$aMass Spectrum Analysis
=450  \\$aSpectrometry, Mass
=450  \\$aSpectroscopy, Mass
=450  \\$wnnna$aSpectrum Analyses, Mass
=450  \\$aSpectrum Analysis, Mass
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aGas Chromatography-Mass Spectrometry
=550  \\$wh$aSpectrometry, Mass, Electrospray Ionization
=550  \\$wh$aSpectrometry, Mass, Fast Atom Bombardment
=550  \\$wh$aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
=550  \\$wh$aSpectrometry, Mass, Secondary Ion
=550  \\$wh$aTandem Mass Spectrometry
=680  \\$iAn analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers.
=688  \\$a2007 (1971)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Spectrum Analysis, Mass
=688  \\$a74; was MASS SPECTRUM ANALYSIS 1971-73 (Prov)
=750  \0$aMass spectrometry$0(DLC) sh 85081907$5IEN

=LDR  01624cz   2200421n  4500
=001  9880363905902441
=005  20230901100059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013057
=035  \\$aCBA6379HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867
=150  \\$aSpectrum Analysis
=450  \\$wnnna$aAnalysis, Spectrum
=450  \\$wnnna$aSpectrometry
=450  \\$aSpectroscopy
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aCircular Dichroism
=550  \\$wh$aDielectric Spectroscopy
=550  \\$wh$aIon Mobility Spectrometry
=550  \\$wh$aMagnetic Resonance Spectroscopy
=550  \\$wh$aOptical Rotatory Dispersion
=550  \\$wh$aPhotoelectron Spectroscopy
=550  \\$wh$aPulse Radiolysis
=550  \\$wh$aSpectrometry, Fluorescence
=550  \\$wh$aSpectrometry, Gamma
=550  \\$wh$aSpectrometry, X-Ray Emission
=550  \\$wh$aSpectrophotometry
=550  \\$wh$aSpectroscopy, Electron Energy-Loss
=550  \\$wh$aSpectroscopy, Near-Infrared
=550  \\$wh$aSpectrum Analysis, Raman
=550  \\$wh$aSun Protection Factor
=550  \\$wh$aTerahertz Spectroscopy
=550  \\$wh$aX-Ray Absorption Spectroscopy
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aSpectrum analysis$5IEN$0(DLC)sh 85126423
=750  \0$iNarrower mapping$aCyclotron radiation emission spectroscopy$0(DLC)sh2022007526$4NM$5IEN-M

=LDR  01145cz  a2200205n  4500
=001  9880363906002441
=005  20141212210915.0
=008  880430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015204
=035  \\$aCBA6378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x776.$x751
=150  \\$aSpectroscopy, Mossbauer
=450  \\$aMossbauer Spectroscopy
=450  \\$aNuclear Gamma Resonance Spectroscopy
=550  \\$wg$aSpectrometry, Gamma
=667  \\$aa type of spectrum anal; NIM
=680  \\$iA spectroscopic technique which uses the Mossbauer effect (inelastic scattering of gamma radiation resulting from interaction with heavy nuclei) to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.
=688  \\$a89
=750  \0$aM�ossbauer spectroscopy$5IEN$0(DLC)sh 85087488

=LDR  01018cz  a2200241n  4500
=001  9880363906102441
=005  20141212205751.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013056
=035  \\$aCBA6377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726.$x802
=072  \\$aE5.$x196.$x867.$x826.$x802
=150  \\$aSpectrophotometry, Ultraviolet
=450  \\$aUltraviolet Spectrometry$5IEN
=450  \\$aUltraviolet Spectrophotometry
=450  \\$aUltraviolet Spectroscopy$5IEN
=550  \\$wg$aSpectrophotometry
=667  \\$aa type of spectrum anal; NIM; 180-390 millimus
=680  \\$iDetermination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a73
=750  \0$aUltraviolet spectroscopy$5IEN-M$0(DLC)sh 85139510
=750  \0$aUltraviolet spectrometry$5IEN-HS$0(DLC)sh 85139509

=LDR  00965cz  a2200229n  4500
=001  9880363906202441
=005  20141212205750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013055
=035  \\$aCBA6376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726.$x676
=072  \\$aE5.$x196.$x867.$x826.$x676
=150  \\$aSpectrophotometry, Infrared
=450  \\$aInfrared Spectrophotometry
=450  \\$aInfrared Spectroscopy$5IEN
=550  \\$wg$aSpectrophotometry
=550  \\$wh$aSpectroscopy, Fourier Transform Infrared
=667  \\$aa type of spectrum anal; NIM; 770-1500 millimus
=680  \\$iSpectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a73
=750  \0$aInfrared spectroscopy$5IEN$0(DLC)sh 85066329

=LDR  01571cz  a2200397n  4500
=001  9880363906302441
=005  20141212192533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013054
=035  \\$aCBA6375HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726.$x551
=072  \\$aE5.$x196.$x867.$x826.$x551
=150  \\$aSpectrophotometry, Atomic
=450  \\$wnnna$aAA Spectrophotometries
=450  \\$wnnna$aAA Spectrophotometry
=450  \\$wnnna$aAbsorption Spectrophotometry, Atomic
=450  \\$wnnna$aAE Spectrophotometries
=450  \\$wnnna$aAE Spectrophotometry
=450  \\$wnnna$aAtomic Absorption Spectrophotometry
=450  \\$wnnna$aAtomic Emission Spectrophotometry
=450  \\$wnnna$aAtomic Spectrophotometry
=450  \\$wnnna$aEmission Spectrophotometry, Atomic
=450  \\$wnnna$aInductively Coupled Plasma Atomic Emission Spectrophotometry
=450  \\$wnnna$aInductively Coupled Plasma Atomic Emission Spectroscopy
=450  \\$wnnna$aSpectrophotometries, AA
=450  \\$wnnna$aSpectrophotometries, AE
=450  \\$wnnna$aSpectrophotometry, AA
=450  \\$wnnna$aSpectrophotometry, AE
=450  \\$aSpectrophotometry, Atomic Absorption
=450  \\$wnnna$aSpectrophotometry, Atomic Emission
=550  \\$wg$aSpectrophotometry
=550  \\$aAbsorption, Radiation
=680  \\$iSpectrophotometric techniques by which the absorption or emmision spectra of radiation from atoms are produced and analyzed.
=688  \\$a2004 (1972)
=750  \0$aAtomic absorption spectroscopy$5IEN$0(DLC)sh 85009307

=LDR  00824cz  a2200241n  4500
=001  9880363906402441
=005  20141212205750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013053
=035  \\$aCBA6374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x726
=072  \\$aE5.$x196.$x867.$x826
=150  \\$aSpectrophotometry
=550  \\$wg$aPhotometry
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aMicrospectrophotometry
=550  \\$wh$aSpectrophotometry, Atomic
=550  \\$wh$aSpectrophotometry, Infrared
=550  \\$wh$aSpectrophotometry, Ultraviolet
=667  \\$aa type of spectrum anal; NIM
=680  \\$iThe art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.
=750  \0$aSpectrophotometry$5IEN$0(DLC)sh 85126418

=LDR  04055cz  a2200805n  4500
=001  9880363906502441
=005  20141212205750.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013052
=035  \\$aCBA6373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x800
=072  \\$aE5.$x799.$x830
=150  \\$aSpectrometry, X-Ray Emission
=450  \\$wnnna$aEmission Spectrometry, X-Ray
=450  \\$wnnna$aEmission Spectrometry, Xray
=450  \\$wnnna$aEmission Spectroscopy, X-Ray
=450  \\$wnnna$aEmission Spectroscopy, Xray
=450  \\$wnnna$aEnergy Dispersive X-Ray Fluorescence Spectrometry
=450  \\$wnnna$aEnergy Dispersive X Ray Fluorescence Spectrometry
=450  \\$wnnna$aEnergy Dispersive X-Ray Fluorescence Spectroscopy
=450  \\$wnnna$aEnergy Dispersive X Ray Fluorescence Spectroscopy
=450  \\$wnnna$aEnergy Dispersive X-Ray Spectrometry
=450  \\$wnnna$aEnergy Dispersive X Ray Spectrometry
=450  \\$wnnna$aEnergy Dispersive X-Ray Spectroscopy
=450  \\$wnnna$aEnergy Dispersive X Ray Spectroscopy
=450  \\$wnnna$aFluorescence Spectrometry, X-Ray
=450  \\$wnnna$aFluorescence Spectroscopy, X-Ray
=450  \\$wnnna$aParticle Induced X Ray Emission Spectrometry
=450  \\$aParticle-Induced X-Ray Emission Spectrometry
=450  \\$wnnna$aProton Induced X Ray Emission Spectrometry
=450  \\$aProton-Induced X-Ray Emission Spectrometry
=450  \\$wnnna$aSpectrometry, Particle Induced X Ray Emission
=450  \\$aSpectrometry, Particle-Induced X-Ray Emission
=450  \\$wnnna$aSpectrometry, Proton Induced X Ray Emission
=450  \\$aSpectrometry, Proton-Induced X-Ray Emission
=450  \\$wnnna$aSpectrometry, X Ray Emission
=450  \\$aSpectrometry, X-Ray Fluorescence
=450  \\$wnnna$aSpectrometry, X Ray Fluorescence
=450  \\$wnnna$aSpectrometry, Xray Emission
=450  \\$wnnna$aSpectroscopy, X-Ray Emission
=450  \\$wnnna$aSpectroscopy, X-Ray Fluorescence
=450  \\$wnnna$aSpectroscopy, Xray Emission
=450  \\$wnnna$aWavelength Dispersive X-Ray Fluorescence Spectrometry
=450  \\$wnnna$aWavelength Dispersive X Ray Fluorescence Spectrometry
=450  \\$wnnna$aWavelength Dispersive X-Ray Fluorescence Spectroscopy
=450  \\$wnnna$aWavelength Dispersive X Ray Fluorescence Spectroscopy
=450  \\$wnnna$aWavelength Dispersive X-Ray Spectrometry
=450  \\$wnnna$aWavelength Dispersive X Ray Spectrometry
=450  \\$wnnna$aWavelength Dispersive X-Ray Spectroscopy
=450  \\$wnnna$aWavelength Dispersive X Ray Spectroscopy
=450  \\$aX-Ray Emission Spectrometry
=450  \\$wnnna$aX Ray Emission Spectrometry
=450  \\$aX-Ray Emission Spectroscopy
=450  \\$wnnna$aX Ray Emission Spectroscopy
=450  \\$aX-Ray Fluorescence Spectrometry
=450  \\$wnnna$aX Ray Fluorescence Spectrometry
=450  \\$wnnna$aX-Ray Fluorescence Spectroscopies
=450  \\$wnnna$aX-Ray Fluorescence Spectroscopy
=450  \\$wnnna$aX Ray Fluorescence Spectroscopy
=450  \\$aX-Ray Spectroscopy$5IEN
=450  \\$wnnna$aXray Emission Spectrometry
=450  \\$wnnna$aXray Emission Spectroscopy
=550  \\$wg$aRadiometry
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aElectron Probe Microanalysis
=667  \\$ado not confuse with entry terms at ELECTRON PROBE MICROANALYSIS; do not confuse entry term SPECTROMETRY, X-RAY FLUORESCENCE with SPECTROMETRY, FLUORESCENCE
=680  \\$iThe spectrometric analysis of fluorescent X-RAYS, i.e. X-rays emitted after bombarding matter with high energy particles such as PROTONS; ELECTRONS; or higher energy X-rays. Identification of ELEMENTS by this technique is based on the specific type of X-rays that are emitted which are characteristic of the specific elements in the material being analyzed. The characteristic X-rays are distinguished and/or quantified by either wavelength dispersive or energy dispersive methods.
=688  \\$a1978
=750  \0$aX-ray spectroscopy$5IEN$0(DLC)sh 85148744

=LDR  00933cz  a2200265n  4500
=001  9880363906602441
=005  20141212205749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013051
=035  \\$aCBA6372HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x776
=072  \\$aE5.$x799.$x801
=150  \\$aSpectrometry, Gamma
=450  \\$aGamma Ray Spectrometry$5IEN
=450  \\$wnnna$aGamma Spectrometry
=450  \\$aGamma Spectrophotometry
=450  \\$wnnna$aSpectrophotometry, Gamma
=550  \\$wg$aRadiometry
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aSpectroscopy, Mossbauer
=667  \\$aa type of spectrum anal; NIM
=680  \\$iDetermination of the energy distribution of gamma rays emitted by nuclei. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a74; was GAMMA SPECTROMETRY (Prov 1969-73)
=750  \0$aGamma ray spectrometry$5IEN$0(DLC)sh 85052988

=LDR  01096cz  a2200289n  4500
=001  9880363906702441
=005  20141212205748.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013050
=035  \\$aCBA6371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x516.$x600.$x676
=072  \\$aE5.$x196.$x867.$x726
=150  \\$aSpectrometry, Fluorescence
=450  \\$wnnna$aFluorescence Spectrometry
=450  \\$aFluorescence Spectrophotometry
=450  \\$aFluorescence Spectroscopy
=450  \\$aSpectrofluorometry
=450  \\$wnnna$aSpectrophotometry, Fluorescence
=450  \\$wnnna$aSpectroscopy, Fluorescence
=550  \\$wg$aFluorometry
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aFluorescence Resonance Energy Transfer
=667  \\$aa type of spectrum anal; NIM; do not confuse with SPECTROMETRY, X-RAY FLUORESCENCE see SPECTROMETRY, X-RAY EMISSION
=680  \\$iMeasurement of the intensity and quality of fluorescence.
=688  \\$a74; was FLUORESCENCE SPECTROPHOTOMETRY (Prov 1972-73)
=750  \0$aFluorescence Spectroscopy$5IEN$0(DLC)sh 85049411

=LDR  01210cz  a2200349n  4500
=001  9880363906802441
=005  20141212205747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013048
=035  \\$aCBA6369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998
=072  \\$aE5.$x200.$x998
=150  \\$aSpecimen Handling
=450  \\$wnnna$aCollection, Specimen
=450  \\$wnnna$aCollections, Specimen
=450  \\$wnnna$aHandling, Specimen
=450  \\$wnnna$aHandlings, Specimen
=450  \\$wnnna$aSpecimen Collection
=450  \\$wnnna$aSpecimen Collections
=450  \\$wnnna$aSpecimen Handlings
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wh$aBiopsy
=550  \\$wh$aBlood Specimen Collection
=550  \\$wh$aChorionic Villi Sampling
=550  \\$wh$aDissection
=550  \\$wh$aDNA Contamination
=550  \\$wh$aParacentesis
=550  \\$wh$aSpinal Puncture
=550  \\$wh$aUrine Specimen Collection
=680  \\$iProcedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation.
=750  \0$aDiagnostic specimens$5IEN$0(DLC)sh 85037511

=LDR  00861cz  a2200265n  4500
=001  9880363906902441
=005  20141212205747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013046
=035  \\$aCBA6367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x810
=150  \\$aSpecific Gravity
=450  \\$wnnna$aDensities, Relative
=450  \\$wnnna$aDensity, Relative
=450  \\$wnnna$aGravities, Specific
=450  \\$wnnna$aGravity, Specific
=450  \\$wnnna$aRelative Densities
=450  \\$wnnna$aRelative Density
=450  \\$wnnna$aSpecific Gravities
=550  \\$wg$aPhysicochemical Phenomena
=667  \\$aNIM
=680  \\$iThe ratio of the density of a material to the density of some standard material, such as water or air, at a specified temperature.
=688  \\$a68
=750  \0$aSpecific gravity$5IEN$0(DLC)sh 85126388

=LDR  01839cz  a2200565n  4500
=001  9880363907002441
=005  20181206092901.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013041
=035  \\$aCBA6362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676
=150  \\$aSpecialties, Nursing
=450  \\$wnnna$aNursing Specialties
=450  \\$wnnna$aNursing Specialty
=450  \\$wnnna$aSpecialty, Nursing
=550  \\$wg$aNursing
=550  \\$wh$aAdvanced Practice Nursing
=550  \\$wh$aCardiovascular Nursing
=550  \\$wh$aCommunity Health Nursing
=550  \\$wh$aCritical Care Nursing
=550  \\$wh$aEmergency Nursing
=550  \\$wh$aFamily Nursing
=550  \\$wh$aForensic Nursing
=550  \\$wh$aGeriatric Nursing
=550  \\$wh$aHolistic Nursing
=550  \\$wh$aHospice and Palliative Care Nursing
=550  \\$wh$aMaternal-Child Nursing
=550  \\$wh$aMidwifery
=550  \\$wh$aMilitary Nursing
=550  \\$wh$aNephrology Nursing
=550  \\$wh$aNeuroscience Nursing
=550  \\$wh$aObstetric Nursing
=550  \\$wh$aOccupational Health Nursing
=550  \\$wh$aOncology Nursing
=550  \\$wh$aOrthopedic Nursing
=550  \\$wh$aPediatric Nursing
=550  \\$wh$aPerioperative Nursing
=550  \\$wh$aPsychiatric Nursing
=550  \\$wh$aPublic Health Nursing
=550  \\$wh$aRehabilitation Nursing
=550  \\$wh$aRural Nursing
=550  \\$wh$aSchool Nursing
=550  \\$wh$aRadiologic and Imaging Nursing
=550  \\$wh$aTranscultural Nursing
=550  \\$aEducation, Nursing, Continuing
=667  \\$aSPEC: SPEC qualif; coord IM with type of nursing or subject
=680  \\$iVarious branches of nursing practice limited to specialized areas.
=688  \\$a73(71)
=750  \0$aNursing specialties$5IEN$0(DLC)sh 86007197

=LDR  00972cz  a2200313n  4500
=001  9880363907102441
=005  20141212205745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013039
=035  \\$aCBA6360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x163.$x876
=150  \\$aSpecialties, Dental
=450  \\$wnnna$aDental Specialties
=450  \\$wnnna$aDental Specialty
=450  \\$wnnna$aSpecialty, Dental
=550  \\$wg$aDentistry
=550  \\$wh$aEndodontics
=550  \\$wh$aOrthodontics
=550  \\$wh$aPathology, Oral
=550  \\$wh$aPediatric Dentistry
=550  \\$wh$aPeriodontics
=550  \\$wh$aProsthodontics
=550  \\$wh$aPublic Health Dentistry
=550  \\$wh$aSurgery, Oral
=667  \\$aSPEC: SPEC qualif; coord IM with field or subject (IM); DF: SPECIALTIES DENT
=680  \\$iVarious branches of dental practice limited to specialized areas.
=688  \\$a68
=750  \0$aDental specialties$5IEN$0(DLC)sh 85036934

=LDR  00704cz  a2200229n  4500
=001  9880363907202441
=005  20141212205744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013038
=035  \\$aCBA6359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x811
=150  \\$aSpecialization
=450  \\$aSpecialism
=450  \\$wnnna$aSpecialist
=450  \\$wnnna$aSpecialists
=550  \\$wg$aHealth Occupations
=667  \\$acoordinate IM with field or subject (IM)
=680  \\$iAn occupation limited in scope to a subsection of a broader field.
=688  \\$a2010 (1966)
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Specialism
=750  \0$aSpecialists$0(DLC) sh 89004538$5IEN-M

=LDR  01058cz  a2200313n  4500
=001  9880363907302441
=005  20180928112939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013037
=035  \\$aCBA6358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x875
=150  \\$aSpatial Behavior
=450  \\$wnnna$aBehavior, Spatial
=450  \\$wnnna$aBehaviors, Spatial
=450  \\$wnnna$aSpatial Behaviors
=550  \\$wg$aBehavior
=550  \\$wh$aCrowding
=550  \\$wh$aPersonal Space
=550  \\$wh$aSpatial Learning
=550  \\$wh$aSpatial Navigation
=550  \\$wh$aSpatial Processing
=550  \\$wh$aOrientation, Spatial
=550  \\$wh$aTerritoriality
=667  \\$ahuman & animal
=680  \\$iReactions of an individual or groups of individuals with relation to the immediate surrounding area including the animate or inanimate objects within that area.
=688  \\$a1968
=688  \\$a68; PROXEMICS was heading 1975-96 (see under SPATIAL BEHAVIOR 1975-90)
=750  \0$aSpatial behavior$5IEN$0(DLC)sh 85126348

=LDR  03097cz  a2200697n  4500
=001  9880363907402441
=005  20200824123250.0
=008  760505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013036
=035  \\$aCBA6356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x375.$x760
=072  \\$aC10.$x228.$x140.$x490.$x493.$x875
=150  \\$aSpasms, Infantile
=450  \\$wnnna$aAttack, Lightning
=450  \\$wnnna$aAttacks, Lightning
=450  \\$wnnna$aAttacks, Salaam
=450  \\$wnnna$aCryptogenic Infantile Spasm
=450  \\$aCryptogenic Infantile Spasms
=450  \\$wnnna$aCryptogenic West Syndrome
=450  \\$aHypsarrhythmia
=450  \\$wnnna$aHypsarrhythmias
=450  \\$wnnna$aInfantile Spasm
=450  \\$wnnna$aInfantile Spasm, Cryptogenic
=450  \\$wnnna$aInfantile Spasm, Symptomatic
=450  \\$aInfantile Spasms
=450  \\$wnnna$aInfantile Spasms, Cryptogenic
=450  \\$wnnna$aInfantile Spasms, Symptomatic
=450  \\$wnnna$aJackknife Seizure
=450  \\$aJackknife Seizures
=450  \\$wnnna$aLightning Attack
=450  \\$wnnna$aLightning Attacks
=450  \\$aNodding Spasm
=450  \\$wnnna$aNodding Spasms
=450  \\$wnnna$aSalaam Attacks
=450  \\$aSalaam Seizures
=450  \\$wnnna$aSeizure, Jackknife
=450  \\$wnnna$aSeizures, Jackknife
=450  \\$wnnna$aSeizures, Salaam
=450  \\$wnnna$aSpasm, Cryptogenic Infantile
=450  \\$wnnna$aSpasm, Nodding
=450  \\$wnnna$aSpasm, Symptomatic Infantile
=450  \\$wnnna$aSpasms, Cryptogenic Infantile
=450  \\$wnnna$aSpasms, Nodding
=450  \\$wnnna$aSpasms, Symptomatic Infantile
=450  \\$aSpasmus Nutans
=450  \\$wnnna$aSymptomatic Infantile Spasm
=450  \\$aSymptomatic Infantile Spasms
=450  \\$wnnna$aSymptomatic West Syndrome
=450  \\$wnnna$aSyndrome, Cryptogenic West
=450  \\$wnnna$aSyndrome, Symptomatic West
=450  \\$wnnna$aSyndrome, West
=450  \\$aWest Syndrome
=450  \\$wnnna$aWest Syndrome, Cryptogenic
=450  \\$wnnna$aWest Syndrome, Symptomatic
=550  \\$wg$aEpilepsy, Generalized
=550  \\$wg$aEpileptic Syndromes
=667  \\$aepileptic seizures only: do not confuse with SPASM + INFANT for non-epileptic seizures in inf such as in tetany or vitamin defic; check tag INFANT or INFANT, NEWBORN
=680  \\$iAn epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8)
=688  \\$a1977(1963)
=750  \0$aInfantile spasms$0(DLC)sh 85126340$5IEN-M

=LDR  01725cz  a2200433n  4500
=001  9880363907502441
=005  20141212205743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013035
=035  \\$aCBA6355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x750
=072  \\$aC23.$x888.$x592.$x608.$x750
=150  \\$aSpasm
=450  \\$wnnna$aCiliary Body Spasm
=450  \\$wnnna$aCiliary Body Spasms
=450  \\$wnnna$aGeneralized Spasm
=450  \\$wnnna$aGeneralized Spasms
=450  \\$aMuscle Spasm
=450  \\$wnnna$aMuscle Spasms
=450  \\$wnnna$aMuscular Spasm
=450  \\$wnnna$aMuscular Spasms
=450  \\$wnnna$aSpasm, Ciliary Body
=450  \\$wnnna$aSpasm, Generalized
=450  \\$wnnna$aSpasm, Muscle
=450  \\$wnnna$aSpasm, Muscular
=450  \\$wnnna$aSpasms
=450  \\$wnnna$aSpasms, Ciliary Body
=450  \\$wnnna$aSpasms, Generalized
=450  \\$wnnna$aSpasms, Muscle
=450  \\$wnnna$aSpasms, Muscular
=550  \\$wg$aNeuromuscular Manifestations
=550  \\$wh$aHemifacial Spasm
=550  \\$wh$aTrismus
=550  \\$aMuscle Cramp
=550  \\$aMuscle Spasticity
=667  \\$aGEN or unspecified only; coord IM with specific organ/dis (IM); spasms in infants: index SPASMS, INFANTILE if an epileptic seizure (see MeSH definition) or SPASM + INFANT if non-epileptic such as in tetany or vitamin defic; "facial spasm" = SPASM (IM) + FACIAL MUSCLES (IM) but "hemifacial spasm" = HEMIFACIAL SPASM; also available are BRONCHIAL SPASM & ESOPHAGEAL SPASM, DIFFUSE
=680  \\$iAn involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
=750  \0$aSpasms$5IEN$0(DLC)sh 85126339

=LDR  02484cz  a2200517n  4500
=001  9880363907602441
=005  20141212205743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013034
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x786
=072  \\$aD3.$x438.$x834.$x737.$x500
=150  \\$aSparteine
=450  \\$wnnna$aalpha-Isosparteine
=450  \\$wnnna$aalpha Isosparteine
=450  \\$wnnna$aAnhydrous, Sparteine Sulfate
=450  \\$wnnna$abeta-Isosparteine
=450  \\$wnnna$abeta Isosparteine
=450  \\$wnnna$aD-sparteine
=450  \\$wnnna$aDepasan Retard
=450  \\$wnnna$aGenisteine Alkaloid
=450  \\$wnnna$aL-Sparteine
=450  \\$aPachycarpine
=450  \\$wnnna$aPachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine, (+)-Isomer
=450  \\$wnnna$aSparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer
=450  \\$wnnna$aSparteine, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine, (-)-Isomer
=450  \\$wnnna$aSparteine Monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Sulfate
=450  \\$wnnna$aSparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer
=450  \\$wnnna$aSparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer
=450  \\$wnnna$aSparteine Sulfate Anhydrous
=450  \\$wnnna$aSulfate Anhydrous, Sparteine
=550  \\$wg$aAlkaloids
=550  \\$wg$aQuinolizidines
=680  \\$iA quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.
=688  \\$a1963; for PACHYCARPINE use SPARTEINE(NM) 1973-2001
=750  \0$aSparteine$5IEN$0(DLC)sh 85126333

=LDR  00814cz  a2200265n  4500
=001  9880363907702441
=005  20141212192532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013028
=035  \\$aCBA6348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x778
=072  \\$aF2.$x463.$x593.$x932.$x869
=150  \\$aSpace Perception
=450  \\$wnnna$aPerception, Space
=450  \\$wnnna$aPerceptions, Space
=450  \\$wnnna$aSpace Perceptions
=550  \\$wg$aPerception
=550  \\$wg$aVisual Perception
=550  \\$wh$aDepth Perception
=550  \\$wh$aForm Perception
=550  \\$wh$aSize Perception
=550  \\$aSpatial Learning
=680  \\$iThe awareness of the spatial properties of objects; includes physical space.
=750  \0$aSpace perception$5IEN$0(DLC)sh 85125945

=LDR  00962cz  a2200277n  4500
=001  9880363907802441
=005  20161123104955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012947
=035  \\$aCBA6264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x792
=072  \\$aN2.$x421.$x849
=150  \\$aSocial Work
=450  \\$aService, Social
=450  \\$wnnna$aServices, Social
=450  \\$aSocial Service
=450  \\$wnnna$aSocial Services
=450  \\$wnnna$aWork, Social
=550  \\$wg$aHealth Services
=550  \\$wg$aSociology
=550  \\$wh$aSocial Work, Psychiatric
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe use of community resources, individual case work, or group work to promote the adaptive capacities of individuals in relation to their social and economic environments. It includes social service agencies.
=688  \\$a78; was SOCIAL SERVICE 1963-77
=750  \0$aSocial service$5IEN-HS$0(DLC)sh 85124049

=LDR  00723cz  a2200241n  4500
=001  9880363907902441
=005  20141212192528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012945
=035  \\$aCBA6262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x873
=150  \\$aSocial Values
=450  \\$wnnna$aValue Orientation
=450  \\$wnnna$aValue Orientations
=450  \\$wnnna$aValues, Social
=550  \\$wg$aPsychology, Social
=550  \\$aSocial Norms
=550  \\$aValue of Life
=550  \\$aVirtues
=680  \\$iAbstract standards or empirical variables in social life which are believed to be important and/or desirable.
=688  \\$a69
=750  \0$aSocial values$5IEN$0(DLC)sh 85124083

=LDR  01396cz  a2200325n  4500
=001  9880363908002441
=005  20181203104618.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012944
=035  \\$aCBA6261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x500.$x600
=150  \\$aSocial Support
=450  \\$wnnna$aNetwork, Social
=450  \\$wnnna$aNetworks, Social
=450  \\$wnnna$aPsychosocial Support System
=450  \\$aPsychosocial Support Systems
=450  \\$wnnna$aSocial Network
=450  \\$wnnna$aSocial Networks
=450  \\$wnnna$aSupport, Social
=450  \\$wnnna$aSupport System, Psychosocial
=450  \\$wnnna$aSupport Systems, Psychosocial
=450  \\$wnnna$aSystem, Psychosocial Support
=450  \\$wnnna$aSystems, Psychosocial Support
=550  \\$wg$aSocial Environment
=550  \\$wh$aPsychosocial Support Systems
=667  \\$ahuman only; do not confuse entry term SOCIAL NETWORKS with SOCIAL NETWORKING
=680  \\$iSupport systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while formal assistance is provided by churches, groups, etc.
=688  \\$a91(83); was see under SOCIAL ENVIRONMENT 1983-90
=750  \0$aSocial networks$0(DLC) sh 87002172$5IEN-M

=LDR  01090cz  a2200313n  4500
=001  9880363908102441
=005  20141212205717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012943
=035  \\$aCBA6260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x849
=072  \\$aN3.$x219.$x521.$x576.$x823
=150  \\$aSocial Security
=450  \\$aAid to the Blind
=450  \\$aAid to the Totally Disabled
=450  \\$wnnna$aAid to Totally Disabled Persons
=450  \\$wnnna$aAid to Visually Impaired
=450  \\$wnnna$aAid to Visually Impaired Persons
=450  \\$wnnna$aInsurance, Social
=450  \\$wnnna$aSecurity, Social
=450  \\$aSocial Insurance
=550  \\$wg$aInsurance
=550  \\$wg$aPublic Assistance
=550  \\$wh$aAid to Families with Dependent Children
=667  \\$aspecify country, including U.S.
=680  \\$iGovernment sponsored social insurance programs.
=688  \\$aAID TO THE BLIND & AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77
=750  \0$aSocial security$5IEN$0(DLC)sh 85124036

=LDR  01294cz  a2200421n  4500
=001  9880363908202441
=005  20190204134319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012942
=035  \\$aCBA6259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x879
=072  \\$aI1
=150  \\$aSocial Sciences
=450  \\$wnnna$aScience, Social
=450  \\$wnnna$aSciences, Social
=450  \\$wnnna$aSocial Science
=550  \\$wg$aBehavioral Sciences
=550  \\$wh$aAnthropology
=550  \\$wh$aCriminology
=550  \\$wh$aDemography
=550  \\$wh$aEconomics
=550  \\$wh$aEnvironment Design
=550  \\$wh$aForecasting
=550  \\$wh$aGovernment
=550  \\$wh$aGovernment Programs
=550  \\$wh$aInternationality
=550  \\$wh$aPolicy
=550  \\$wh$aPolitical Systems
=550  \\$wh$aPolitics
=550  \\$wh$aPrivate Sector
=550  \\$wh$aPublic Sector
=550  \\$wh$aQuality of Life
=550  \\$wh$aSociology
=550  \\$wh$aWork-Life Balance
=667  \\$aSPEC: SPEC qualif
=680  \\$iDisciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology.
=750  \0$aSocial sciences$5IEN$0(DLC)sh 85124003

=LDR  01290cz  a2200397n  4500
=001  9880363908302441
=005  20141212205716.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x595
=072  \\$aK1.$x752.$x566.$x599
=150  \\$aSocial Responsibility
=450  \\$wnnna$aAccountability
=450  \\$wnnna$aAccountability, Social
=450  \\$wnnna$aCommunitarianism
=450  \\$wnnna$aFuture Generation
=450  \\$wnnna$aFuture Generations
=450  \\$wnnna$aGeneration, Future
=450  \\$wnnna$aGenerations, Future
=450  \\$aObligation, Social
=450  \\$wnnna$aObligations, Social
=450  \\$wnnna$aObligations to Society
=450  \\$wnnna$aResponsibilities, Social
=450  \\$aResponsibility, Social
=450  \\$wnnna$aSocial Accountability
=450  \\$wnnna$aSocial Obligation
=450  \\$wnnna$aSocial Obligations
=450  \\$wnnna$aSocial Responsibilities
=450  \\$wnnna$aSociety, Obligations to
=550  \\$wg$aMorals
=550  \\$wh$aMoral Obligations
=667  \\$ano qualif
=680  \\$iThe obligations and accountability assumed in carrying out actions or ideas on behalf of others.
=688  \\$a78
=750  \0$aResponsibility$5IEN$0(DLC)sh 85113235

=LDR  01535cz  a2200505n  4500
=001  9880363908402441
=005  20200516145534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012940
=035  \\$aCBA6257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735
=150  \\$aSocial Problems
=450  \\$wnnna$aProblem, Social
=450  \\$wnnna$aProblems, Social
=450  \\$wnnna$aSocial Problem
=550  \\$wg$aSociology
=550  \\$wh$aCivil Disorders
=550  \\$wh$aCrime
=550  \\$wh$aDangerous Behavior
=550  \\$wh$aDivorce
=550  \\$wh$aDoping in Sports
=550  \\$wh$aHomicide
=550  \\$wh$aHuman Rights Abuses
=550  \\$wh$aIllegitimacy
=550  \\$wh$aIncest
=550  \\$wh$aIncivility
=550  \\$wh$aJuvenile Delinquency
=550  \\$wh$aNeedle Sharing
=550  \\$wh$aParental Death
=550  \\$wh$aPoverty
=550  \\$wh$aQuackery
=550  \\$wh$aRace Relations
=550  \\$wh$aRunaway Behavior
=550  \\$wh$aSex Work
=550  \\$wh$aSocial Behavior Disorders
=550  \\$wh$aSocial Segregation
=550  \\$wh$aSuicide
=550  \\$wh$aUnderage Drinking
=550  \\$wh$aViolence
=550  \\$wh$aWar
=667  \\$aspecify geographic term if pertinent
=680  \\$iSituations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration.
=688  \\$a68
=750  \0$aSocial problems$5IEN$0(DLC)sh 85123988

=LDR  01527cz  a2200421n  4500
=001  9880363908502441
=005  20141212205715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012939
=035  \\$aCBA6256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x709
=150  \\$aSocial Planning
=450  \\$wnnna$aDevelopment Planning
=450  \\$wnnna$aDevelopment Plannings
=450  \\$wnnna$aDevelopment, Rural
=450  \\$wnnna$aDevelopments, Rural
=450  \\$wnnna$aFive-Year Plan
=450  \\$wnnna$aFive-Year Plans
=450  \\$wnnna$aFive Year Plans
=450  \\$wnnna$aPlan, Five-Year
=450  \\$wnnna$aPlanning, Development
=450  \\$wnnna$aPlanning, Social
=450  \\$wnnna$aPlannings, Development
=450  \\$wnnna$aPlannings, Social
=450  \\$wnnna$aPlans, Five-Year
=450  \\$wnnna$aRural Development
=450  \\$wnnna$aRural Developments
=450  \\$wnnna$aSocial Plannings
=550  \\$wg$aSociology
=550  \\$wh$aCity Planning
=550  \\$wh$aEnvironment Design
=550  \\$wh$aUrban Renewal
=550  \\$aPlanning Techniques
=667  \\$ano qualif
=680  \\$iInteractional process combining investigation, discussion, and agreement by a number of people in the preparation and carrying out of a program to ameliorate conditions of need or social pathology in the community. It usually involves the action of a formal political, legal, or recognized voluntary body.
=688  \\$a68
=750  \0$aSocial planning$5IEN$0(DLC)sh 90001138

=LDR  00661cz  a2200217n  4500
=001  9880363908602441
=005  20141212205715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012938
=035  \\$aCBA6255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x752
=150  \\$aSocial Perception
=450  \\$aPerception, Social
=450  \\$wnnna$aPerceptions, Social
=450  \\$wnnna$aSocial Perceptions
=550  \\$wg$aPerception
=667  \\$ano qualif
=680  \\$iThe perceiving of attributes, characteristics, and behaviors of one's associates or social groups.
=688  \\$a69
=750  \0$aSocial perception$5IEN$0(DLC)sh 85123982

=LDR  00712cz  a2200229n  4500
=001  9880363908702441
=005  20141212192527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012937
=035  \\$aCBA6254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x755.$x673
=072  \\$aN1.$x824.$x782.$x673
=150  \\$aSocial Mobility
=450  \\$wnnna$aMobilities, Social
=450  \\$wnnna$aMobility, Social
=450  \\$wnnna$aSocial Mobilities
=550  \\$wg$aSocial Class
=667  \\$ano qualif
=680  \\$iThe movement or shifting of membership between or within social classes by individuals or by groups.
=688  \\$a68
=750  \0$aSocial mobility$5IEN$0(DLC)sh 85123976

=LDR  00638cz  a2200193n  4500
=001  9880363908802441
=005  20141212205714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012936
=035  \\$aCBA6253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x800
=150  \\$aSocial Medicine
=450  \\$wnnna$aMedicine, Social
=550  \\$wg$aMedicine
=550  \\$aPublic Health
=667  \\$aSPEC: SPEC qualif; DF: SOCIAL MED
=680  \\$iA branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease.
=750  \0$aSocial medicine$5IEN$0(DLC)sh 85123973

=LDR  00944cz  a2200277n  4500
=001  9880363908902441
=005  20141212205714.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012935
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x700
=072  \\$aK1.$x559.$x411.$x756.$x750
=072  \\$aK1.$x752.$x566.$x479.$x830.$x750
=072  \\$aN3.$x706.$x437.$x700
=150  \\$aSocial Justice
=450  \\$wnnna$aCommon Good
=450  \\$wnnna$aGood, Common
=450  \\$wnnna$aJustice
=450  \\$wnnna$aJustice, Social
=450  \\$wnnna$aObligations of Society
=550  \\$wg$aHuman Rights
=550  \\$wg$aPrinciple-Based Ethics
=667  \\$aspecify geographic term if pertinent
=680  \\$iAn interactive process whereby members of a community are concerned for the equality and rights of all.
=688  \\$a91(78); was see under HUMAN RIGHTS 1978-90
=750  \0$aSocial justice$5IEN$0(DLC)sh 85123969

=LDR  01072cz  a2200277n  4500
=001  9880363909002441
=005  20141212192527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012934
=035  \\$aCBA6251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x781
=072  \\$aI1.$x880.$x853.$x748
=150  \\$aSocial Isolation
=450  \\$aIsolation, Social
=450  \\$wnnna$aIsolations, Social
=450  \\$wnnna$aSocial Isolations
=550  \\$wg$aSocial Behavior
=550  \\$wg$aSociological Factors
=550  \\$wh$aLoneliness
=550  \\$wh$aSocial Alienation
=550  \\$aPopulation Density
=667  \\$ahuman & animal
=680  \\$iThe separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication.
=688  \\$a69; was ISOLATION, SOCIAL 1968
=750  \0$aSocial isolation$5IEN$0(DLC)sh 85123967

=LDR  01178cz  a2200313n  4500
=001  9880363909102441
=005  20141212205714.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012933
=035  \\$aCBA6250M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x708
=150  \\$aSocial Identification
=450  \\$aGroup Identification
=450  \\$wnnna$aGroup Identifications
=450  \\$wnnna$aIdentification, Group
=450  \\$aIdentification, Social
=450  \\$wnnna$aIdentifications, Group
=450  \\$wnnna$aIdentifications, Social
=450  \\$wnnna$aIdentities, Social
=450  \\$wnnna$aIdentity, Social
=450  \\$wnnna$aSocial Identifications
=450  \\$wnnna$aSocial Identities
=450  \\$wnnna$aSocial Identity
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iThe process by which an aspect of self image is developed based on in-group preference or ethnocentrism and a perception of belonging to a social or cultural group. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a91(78); was see under SOCIAL BEHAVIOR 1978-90
=750  \0$aGroup identity$5IEN-M$0(DLC)sh 85057485

=LDR  00745cz  a2200217n  4500
=001  9880363909202441
=005  20141212205714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012932
=035  \\$aCBA6249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x655
=150  \\$aSocial Facilitation
=450  \\$wnnna$aFacilitation, Social
=450  \\$wnnna$aFacilitations, Social
=450  \\$wnnna$aSocial Facilitations
=550  \\$wg$aSocial Behavior
=667  \\$ahuman & animal; no qualif
=680  \\$iAny enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination.
=688  \\$a68
=750  \0$aGroup facilitation$5IEN$0(DLC)sh 85123942

=LDR  00847cz  a2200241n  4500
=001  9880363909302441
=005  20141212205713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012930
=035  \\$aCBA6247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x650
=150  \\$aSocial Dominance
=450  \\$wnnna$aDominance Hierarchies
=450  \\$aDominance Hierarchy
=450  \\$aDominance, Social
=450  \\$wnnna$aHierarchy, Dominance
=550  \\$wg$aSocial Behavior
=550  \\$wh$aDominance-Subordination
=667  \\$ahuman & animal
=680  \\$iSocial structure of a group as it relates to the relative social rank of dominance status of its members. (APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a69; was DOMINANCE, SOCIAL 1968
=750  \0$aDominance (Psychology)$5IEN$0(DLC)sh 85038960

=LDR  00899cz  a2200289n  4500
=001  9880363909402441
=005  20141212205713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012929
=035  \\$aCBA6246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x630
=072  \\$aF1.$x829.$x316.$x777
=150  \\$aSocial Distance
=450  \\$wnnna$aAcceptance, Social
=450  \\$wnnna$aDistance, Social
=450  \\$wnnna$aDistances, Social
=450  \\$wnnna$aRejection, Social
=450  \\$wnnna$aSocial Acceptance
=450  \\$wnnna$aSocial Rejection
=450  \\$wnnna$aSocial Rejections
=550  \\$wg$aGroup Processes
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iThe degree of closeness or acceptance an individual or group feels toward another individual or group.
=688  \\$a69
=750  \0$aSocial distance$5IEN$0(DLC)sh 85123938

=LDR  00910cz  a2200241n  4500
=001  9880363909502441
=005  20141212205713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012928
=035  \\$aCBA6245HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x628
=150  \\$aSocial Desirability
=450  \\$wnnna$aDesirabilities, Social
=450  \\$wnnna$aDesirability, Social
=450  \\$wnnna$aSocial Desirabilities
=450  \\$wnnna$aSocial Worth
=450  \\$wnnna$aWorth, Social
=550  \\$wg$aSocial Behavior
=667  \\$ano qualif
=680  \\$iA personality trait rendering the individual acceptable in social or interpersonal relations. It is related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion.
=688  \\$a65
=750  \0$aSocial desirability$5IEN$0(DLC)sh 85123936

=LDR  00995cz  a2200301n  4500
=001  9880363909602441
=005  20201218172306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012927
=035  \\$aCBA6244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x630
=150  \\$aSocial Control, Informal
=450  \\$wnnna$aControl, Informal Social
=450  \\$wnnna$aControls, Informal Social
=450  \\$wnnna$aInformal Social Control
=450  \\$wnnna$aInformal Social Controls
=450  \\$wnnna$aSocial Controls, Informal
=550  \\$wg$aSociology
=550  \\$wh$aBehavior Control
=550  \\$wh$aCoercion
=550  \\$wh$aPublic Opinion
=550  \\$wh$aPunishment
=550  \\$aPower,(Psychological
=550  \\$aSocial Conformity
=680  \\$iThose forms of control which are exerted in less concrete and tangible ways, as through folkways, mores, conventions, and public sentiment.
=688  \\$a68
=750  \0$aSocial influence$5IEN-HS$0(DLC)sh 91001924

=LDR  01759cz  a2200529n  4500
=001  9880363909702441
=005  20200520114434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604
=150  \\$aSocial Control, Formal
=450  \\$wnnna$aControl, Social
=450  \\$wnnna$aControls, Social
=450  \\$wnnna$aFormal Social Control
=450  \\$wnnna$aFormal Social Controls
=450  \\$wnnna$aRegulation
=450  \\$wnnna$aRegulations
=450  \\$wnnna$aSocial Control
=450  \\$wnnna$aSocial Controls
=550  \\$wg$aHealth Care Economics and Organizations
=550  \\$wg$aSociology
=550  \\$wh$aAnimal Welfare
=550  \\$wh$aCapital Punishment
=550  \\$wh$aCensorship, Research
=550  \\$wh$aCoercion
=550  \\$wh$aCredentialing
=550  \\$wh$aFacility Regulation and Control
=550  \\$wh$aGovernment Regulation
=550  \\$wh$aHuman Rights
=550  \\$wh$aInvoluntary Treatment
=550  \\$wh$aJurisprudence
=550  \\$wh$aLaw Enforcement
=550  \\$wh$aLegislation as Topic
=550  \\$wh$aLegislation, Drug
=550  \\$wh$aMandatory Programs
=550  \\$wh$aPatient Advocacy
=550  \\$wh$aPeer Review
=550  \\$wh$aPolice
=550  \\$wh$aPolicy Making
=550  \\$wh$aPrisons
=550  \\$wh$aSocial Control Policies
=550  \\$aPublic Policy
=667  \\$aX ref REGULATION: not for regulation in biological processes
=680  \\$iControl which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written.
=688  \\$a68
=750  \0$aSocial control$5IEN$0(DLC)sh 85123931

=LDR  00648cz  a2200217n  4500
=001  9880363909802441
=005  20141212192526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012925
=035  \\$aCBA6242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x625
=150  \\$aSocial Conformity
=450  \\$wnnna$aConformities, Social
=450  \\$aConformity, Social
=450  \\$wnnna$aSocial Conformities
=550  \\$wg$aSocial Behavior
=550  \\$aSocial Norms
=680  \\$iBehavioral or attitudinal compliance with recognized social patterns or standards.
=688  \\$a68
=750  \0$aConformity$5IEN$0(DLC)sh 85031062

=LDR  01035cz  a2200289n  4500
=001  9880363909902441
=005  20141212192526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012924
=035  \\$aCBA6241HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x450
=072  \\$aN1.$x824.$x827
=150  \\$aSocial Conditions
=450  \\$wnnna$aCondition, Living
=450  \\$wnnna$aCondition, Social
=450  \\$wnnna$aConditions, Living
=450  \\$wnnna$aConditions, Social
=450  \\$wnnna$aLiving Condition
=450  \\$wnnna$aLiving Conditions
=450  \\$wnnna$aSocial Condition
=550  \\$wg$aSocioeconomic Factors
=550  \\$wg$aSociological Factors
=550  \\$wh$aAnomie
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society.
=750  \0$aSocial history$5IEN$0(DLC)sh 85123948

=LDR  01237cz  a2200361n  4500
=001  9880363910002441
=005  20141212192525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012923
=035  \\$aCBA6240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x755
=072  \\$aN1.$x824.$x782
=150  \\$aSocial Class
=450  \\$aCaste
=450  \\$wnnna$aCastes
=450  \\$wnnna$aClass Population, Middle
=450  \\$wnnna$aClass Populations, Middle
=450  \\$wnnna$aClass, Social
=450  \\$wnnna$aClasses, Social
=450  \\$wnnna$aMiddle Class Population
=450  \\$wnnna$aMiddle Class Populations
=450  \\$wnnna$aPopulation, Middle Class
=450  \\$wnnna$aPopulations, Middle Class
=450  \\$wnnna$aSocial Classes
=450  \\$aSocioeconomic Status
=450  \\$wnnna$aStatus, Socioeconomic
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aSocial Mobility
=680  \\$iA stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income.
=688  \\$a68
=750  \0$aCaste$5IEN-M$0(DLC)sh 85020649
=750  \0$aSocial classes$5IEN-HS$0(DLC)sh 85123921

=LDR  01639cz  a2200469n  4500
=001  9880363910102441
=005  20141212192525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012922
=035  \\$aCBA6239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x400
=072  \\$aN1.$x824.$x737
=150  \\$aSocial Change
=450  \\$wnnna$aChange, Social
=450  \\$wnnna$aChanges, Social
=450  \\$wnnna$aCommunity Development
=450  \\$wnnna$aCommunity Developments
=450  \\$wnnna$aDevelopment, Community
=450  \\$wnnna$aDevelopment Plan
=450  \\$wnnna$aDevelopment Plans
=450  \\$wnnna$aDevelopment, Social
=450  \\$wnnna$aDevelopments, Community
=450  \\$wnnna$aDevelopments, Social
=450  \\$wnnna$aImpact, Social
=450  \\$wnnna$aImpacts, Social
=450  \\$wnnna$aModernization
=450  \\$wnnna$aPlan, Development
=450  \\$wnnna$aPlans, Development
=450  \\$wnnna$aSocial Changes
=450  \\$wnnna$aSocial Development
=450  \\$wnnna$aSocial Developments
=450  \\$wnnna$aSocial Impact
=450  \\$wnnna$aSocial Impacts
=550  \\$wg$aSocioeconomic Factors
=550  \\$wg$aSociological Factors
=550  \\$wh$aUrbanization
=550  \\$aGroup Processes
=667  \\$aspecify geog if pertinent
=680  \\$iSocial process whereby the values, attitudes, or institutions of society, such as education, family, religion, and industry become modified. It includes both the natural process and action programs initiated by members of the community.
=688  \\$a68
=750  \0$aSocial change$5IEN$0(DLC)sh 85123918

=LDR  00761cz  a2200241n  4500
=001  9880363910202441
=005  20141212205711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012920
=035  \\$aCBA6237HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x784
=150  \\$aSocial Behavior Disorders
=450  \\$wnnna$aBehavior Disorders, Social
=450  \\$aDeviant Behavior$5IEN
=450  \\$wnnna$aDisorders, Social Behavior
=550  \\$wg$aSocial Problems
=550  \\$wh$aGeneral Adaptation Syndrome
=550  \\$aAnomie
=667  \\$ahuman only
=680  \\$iBehaviors which are at variance with the expected social norm and which affect other individuals.
=688  \\$a69
=750  \0$aDeviant behavior$5IEN$0(DLC)sh 85037372

=LDR  02541cz  a2200817n  4500
=001  9880363910302441
=005  20201222174355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012919
=035  \\$aCBA6236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813
=150  \\$aSocial Behavior
=450  \\$wnnna$aBehavior, Social
=450  \\$wnnna$aBehaviors, Social
=450  \\$wnnna$aHarassment, Non-Sexual
=450  \\$wnnna$aHarassment, Non Sexual
=450  \\$aHarassment, Nonsexual
=450  \\$wnnna$aHarassments, Non-Sexual
=450  \\$wnnna$aHarassments, Nonsexual
=450  \\$wnnna$aNon-Sexual Harassment
=450  \\$wnnna$aNon Sexual Harassment
=450  \\$wnnna$aNon-Sexual Harassments
=450  \\$wnnna$aNonsexual Harassment
=450  \\$wnnna$aNonsexual Harassments
=450  \\$wnnna$aSocial Behaviors
=550  \\$wg$aBehavior
=550  \\$wh$aAggression
=550  \\$wh$aAltruism
=550  \\$wh$aAnomie
=550  \\$wh$aCell Phone Use
=550  \\$wh$aCeremonial Behavior
=550  \\$wh$aCompetitive Behavior
=550  \\$wh$aCooperative Behavior
=550  \\$wh$aDeception
=550  \\$wh$aDehumanization
=550  \\$wh$aFemininity
=550  \\$wh$aGift Giving
=550  \\$wh$aHarassment, Non-Sexual
=550  \\$wh$aHelping Behavior
=550  \\$wh$aHelp-Seeking Behavior
=550  \\$wh$aIncivility
=550  \\$wh$aMasculinity
=550  \\$wh$aMass Behavior
=550  \\$wh$aPermissiveness
=550  \\$wh$aPrejudice
=550  \\$wh$aProfessional Misconduct
=550  \\$wh$aRejection, Psychology
=550  \\$wh$aScapegoating
=550  \\$wh$aSelf-Control
=550  \\$wh$aShyness
=550  \\$wh$aSocial Adjustment
=550  \\$wh$aSocial Conformity
=550  \\$wh$aSocial Desirability
=550  \\$wh$aSocial Discrimination
=550  \\$wh$aSocial Distance
=550  \\$wh$aSocial Dominance
=550  \\$wh$aSocial Facilitation
=550  \\$wh$aSocial Identification
=550  \\$wh$aSocial Isolation
=550  \\$wh$aSocial Marginalization
=550  \\$wh$aSocial Skills
=550  \\$wh$aSocial Stigma
=550  \\$wh$aStereotyping
=550  \\$wh$aWhistleblowing
=667  \\$ahuman & animal
=680  \\$iAny behavior caused by or affecting another individual, usually of the same species.
=688  \\$a69
=750  \0$aSocial behavior in animals$5IEN-M$0(DLC)sh 85123911
=750  \0$aSocial skills$5IEN-HS$0(DLC)sh 85124073
=750  \0$aInterpersonal relations$5IEN-HS$0(DLC)sh 85067484

=LDR  00973cz  a2200277n  4500
=001  9880363910402441
=005  20141212192524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012918
=035  \\$aCBA6235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x748.$x755
=150  \\$aSocial Alienation
=450  \\$aAlienation, Social
=450  \\$wnnna$aAlienations, Social
=450  \\$wnnna$aBreakdown Syndrome, Social
=450  \\$wnnna$aBreakdown Syndromes, Social
=450  \\$wnnna$aSocial Alienations
=450  \\$aSocial Breakdown Syndrome
=450  \\$wnnna$aSocial Breakdown Syndromes
=450  \\$wnnna$aSyndrome, Social Breakdown
=450  \\$wnnna$aSyndromes, Social Breakdown
=550  \\$wg$aSocial Isolation
=680  \\$iThe state of estrangement individuals feel in cultural settings that they view as foreign, unpredictable, or unacceptable.
=688  \\$a73
=750  \0$aAlienation (Social psychology)$5IEN$0(DLC)sh 85003540

=LDR  00940cz  a2200265n  4500
=001  9880363910502441
=005  20141212205710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012917
=035  \\$aCBA6234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x621
=150  \\$aSocial Adjustment
=450  \\$wnnna$aAdjustment
=450  \\$aAdjustment, Social
=450  \\$wnnna$aAdjustments
=450  \\$wnnna$aAdjustments, Social
=450  \\$wnnna$aSocial Adjustments
=550  \\$wg$aSocial Behavior
=550  \\$aAdaptation, Psychological
=667  \\$ano qualif
=680  \\$iAdaptation of the person to the social environment. Adjustment may take place by adapting the self to the environment or by changing the environment. (From Campbell, Psychiatric Dictionary, 1996)
=688  \\$a69
=750  \0$aAdjustment (Psychology)$5IEN-M$0(DLC)sh 85000892
=750  \0$aSocial adjustment$5IEN-HS$0(DLC)sh 85123908

=LDR  00827cz  a2200193n  4500
=001  9880363910602441
=005  20141212205710.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012916
=035  \\$aCBA6233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x800
=150  \\$aSoccer
=450  \\$wnnna$aSoccers
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1; includes non-North American "football"; does not include rugby (RUGBY see FOOTBALL)
=680  \\$iA game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. The object of the game is to place the ball in opposite goals.
=688  \\$a90(76); was see under SPORTS 1976-89
=750  \0$aSoccer$5IEN$0(DLC)sh 85123840

=LDR  01086cz  a2200265n  4500
=001  9880363910702441
=005  20141212205710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012915
=035  \\$aCBA6232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x877.$x265.$x861
=072  \\$aJ1.$x516.$x872
=150  \\$aSoaps
=450  \\$wnnna$aSoap
=450  \\$wnnna$aSoap Solution
=450  \\$wnnna$aSoap Solutions
=450  \\$wnnna$aSolution, Soap
=450  \\$wnnna$aSolutions, Soap
=550  \\$wg$aDetergents
=550  \\$wg$aHousehold Products
=667  \\$aD25-26 qualif
=680  \\$iSodium or potassium salts of long chain fatty acids. These detergent substances are obtained by boiling natural oils or fats with caustic alkali. Sodium soaps are harder and are used as topical anti-infectives and vehicles in pills and liniments; potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials.
=688  \\$a91(81)63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80
=750  \0$aSoap$5IEN$0(DLC)sh 85123820

=LDR  00755cz  a2200253n  4500
=001  9880363910802441
=005  20141212205709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012914
=035  \\$aCBA6231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x135.$x867
=072  \\$aG16.$x500.$x275.$x63.$x725.$x480
=072  \\$aG16.$x500.$x750.$x775.$x480
=072  \\$aN6.$x230.$x300.$x100.$x725.$x480
=150  \\$aSnow
=450  \\$wnnna$aBlizzard
=450  \\$wnnna$aBlizzards
=450  \\$wnnna$aSnows
=550  \\$wg$aClimatic Processes
=550  \\$wg$aWeather
=680  \\$iFrozen water crystals that fall from the ATMOSPHERE.
=688  \\$a91(75); was see under WEATHER 1975-90
=750  \0$aSnow$5IEN$0(DLC)sh 85123771

=LDR  00627cz  a2200193n  4500
=001  9880363910902441
=005  20141212205709.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012913
=035  \\$aCBA6230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x852.$x779.$x850
=150  \\$aSnoring
=450  \\$wnnna$aSnorings
=550  \\$wg$aRespiratory Sounds
=667  \\$anote category
=680  \\$iRough, noisy breathing during sleep, due to vibration of the uvula and soft palate.
=688  \\$a85(79); was see under RESPIRATORY SOUNDS 1980-84 & MOUTH BREATHING 1979
=750  \0$aSnoring$5IEN$0(DLC)sh 85123769

=LDR  00682cz  a2200193n  4500
=001  9880363911002441
=005  20141212205709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012912
=035  \\$aCBA6229M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x852.$x889
=072  \\$aG9.$x772.$x770.$x820
=150  \\$aSneezing
=450  \\$wnnna$aSneezings
=550  \\$wg$aRespiratory Physiological Processes
=550  \\$wg$aSigns and Symptoms, Respiratory
=680  \\$iThe sudden, forceful, involuntary expulsion of air from the NOSE and MOUTH caused by irritation to the MUCOUS MEMBRANES of the upper RESPIRATORY TRACT.
=750  \0$aSneezing$0(DLC) sh 85123748$5IEN-M

=LDR  00865cz   2200277n  4500
=001  9880363911102441
=005  20220926164326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012911
=035  \\$aCBA6228HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x672
=150  \\$aSnakes
=450  \\$wnnna$aOphidia
=450  \\$aSerpentes
=450  \\$wnnna$aSnake
=550  \\$wg$aReptiles
=550  \\$wh$aBoidae
=550  \\$wh$aColubridae
=550  \\$wh$aElapidae
=550  \\$wh$aViperidae
=667  \\$ageneral or unspecified; prefer specific families or genera
=680  \\$iLimbless REPTILES of the suborder Serpentes.
=750  \0$aSnakes$5IEN$0(DLC)sh 85123727
=750  \0$iNarrower mapping$aLamprophiidae$0(DLC)sh2021008677$4NM$5IEN-M
=750  \0$iNarrower mapping$aPsammophis schokari$0(DLC)sh2021008676$4NM$5IEN-M

=LDR  01289cz  a2200277n  4500
=001  9880363911202441
=005  20141212205709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012910
=035  \\$aCBA6227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x888.$x850
=072  \\$aD23.$x946.$x833.$x850
=150  \\$aSnake Venoms
=450  \\$wnnna$aSnake Venom
=450  \\$wnnna$aVenom, Snake
=450  \\$wnnna$aVenoms, Snake
=550  \\$wg$aVenoms
=550  \\$wh$aElapid Venoms
=550  \\$wh$aViper Venoms
=550  \\$aSnake Bites
=550  \\$aSnakes
=667  \\$aGEN or unspecified only: prefer the many specifics: common & scientific names of venomous snakes to identify specific SNAKE VENOMS term: TN 241; coord IM with specific available snake family or genus (IM); /antag permitted but consider also ANTIVENINS; /enzymol permitted; do not use qualif when coord with ANTIVENINS
=680  \\$iSolutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors.
=688  \\$a76(75); was see under VENOMS 1975
=750  \0$aPoisonous snakes$xVenom$5IEN$0(DLC)sh 85103950

=LDR  01187cz  a2200301n  4500
=001  9880363911302441
=005  20141212205708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012909
=035  \\$aCBA6226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x127.$x442
=072  \\$aC26.$x176.$x724
=150  \\$aSnake Bites
=450  \\$wnnna$aBite, Snake
=450  \\$wnnna$aBites, Snake
=450  \\$wnnna$aEnvenomation, Snake
=450  \\$wnnna$aEnvenomations, Snake
=450  \\$wnnna$aSnake Bite
=450  \\$aSnake Envenomation
=450  \\$wnnna$aSnake Envenomations
=450  \\$wnnna$aSnakebite
=450  \\$wnnna$aSnakebites
=550  \\$wg$aBites and Stings
=550  \\$aSnakes
=667  \\$aCoordinate IM with specific snake family or genus (IM); therapy with antivenins is /ther, not /drug ther
=680  \\$iBites by snakes. Bite by a venomous snake is characterized by stinging pain at the wound puncture. The venom injected at the site of the bite is capable of producing a deleterious effect on the blood or on the nervous system. (Webster's 3d ed; from Dorland, 27th ed, at snake, venomous)
=750  \0$aSnakebites$5IEN-M$0(DLC)sh 94005707

=LDR  00850cz  a2200229n  4500
=001  9880363911402441
=005  20201125151355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012908
=035  \\$aCBA6225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x750
=150  \\$aSnails
=450  \\$wnnna$aSnail
=550  \\$wg$aGastropoda
=550  \\$wh$aBiomphalaria
=550  \\$wh$aBulinus
=550  \\$wh$aHelix, Snail)
=550  \\$wh$aLymnaea
=667  \\$aas animal & food; IM; GEN or unspecified; prefer specifics; as food, coord IM with SHELLFISH (IM); /microbiol /parasitol /virol permitted
=680  \\$iMarine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man.
=750  \0$aSnails$5IEN$0(DLC)sh 85123719

=LDR  01291cz  a2200349n  4500
=001  9880363911502441
=005  20200423124114.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012907
=035  \\$aCBA6224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x805
=150  \\$aSmoking
=450  \\$wnnna$aHookah Smoking
=450  \\$wnnna$aHookah Smokings
=450  \\$wnnna$aSmoking, Hookah
=450  \\$wnnna$aSmoking, Waterpipe
=450  \\$wnnna$aSmokings, Hookah
=450  \\$wnnna$aSmokings, Waterpipe
=450  \\$wnnna$aWaterpipe Smoking
=450  \\$wnnna$aWaterpipe Smokings
=550  \\$wg$aBehavior
=550  \\$wh$aPipe Smoking
=550  \\$wh$aSmoking Reduction
=550  \\$wh$aSmoking, Non-Tobacco Products
=550  \\$wh$aTobacco Smoking
=550  \\$wh$aVaping
=550  \\$aMarijuana Smoking
=550  \\$aTobacco
=667  \\$aMARIJUANA SMOKING is also available; smokers' patches, smokers' tongue = LEUKOPLAKIA, ORAL; cancer caused by smoking = organ/neoplasm term with /etiol (not /chem ind) + SMOKING /adv eff (not TOBACCO USE DISORDER); PASSIVE SMOKING see TOBACCO SMOKE POLLUTION and SMOKING CESSATION are also available
=680  \\$iInhaling and exhaling the smoke of burning TOBACCO.
=750  \0$aSmoking$5IEN$0(DLC)sh 85123693

=LDR  00945cz  a2200205n  4500
=001  9880363911602441
=005  20141212205708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012906
=035  \\$aCBA6222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x937
=150  \\$aSmoke
=450  \\$wnnna$aSmokes
=550  \\$wg$aParticulate Matter
=550  \\$wh$aSoot
=550  \\$wh$aTobacco Smoke Pollution
=667  \\$asmoke in any environment, not restricted to industrial smokes; can refer to smoke-filled rooms, elevators, trains, aircraft, from any source including fires, tobacco, etc.; coord IM or NIM with source of smoke (tobacco smoke = TOBACCO + SMOKE but remember TOBACCO SMOKE POLLUTION is available) provided emphasis is on the nature, composition or eff of the smoke; /adv eff: consider also SMOKE INHALATION INJURY
=688  \\$a74(71); was see under AIR POLLUTION 1963-73
=750  \0$aSmoke$5IEN$0(DLC)sh 85123681

=LDR  00527cz  a2200181n  4500
=001  9880363911702441
=005  20141212205707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012905
=035  \\$aCBA6221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x875
=150  \\$aSmog
=550  \\$wg$aParticulate Matter
=667  \\$aIM
=680  \\$iA mixture of smoke and fog polluting the atmosphere. (Dorland, 27th ed)
=688  \\$a74(71); was see under AIR POLLUTION 1969-73
=750  \0$aSmog$5IEN$0(DLC)sh 85123680

=LDR  00791cz  a2200241n  4500
=001  9880363911802441
=005  20141212205707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012903
=035  \\$aCBA6219HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x816.$x643
=072  \\$aG11.$x561.$x600.$x810.$x643
=150  \\$aSmell
=450  \\$aOlfaction
=450  \\$wnnna$aSense of Smell
=450  \\$wnnna$aSmell Sense
=550  \\$wg$aSensation
=550  \\$aOdors
=550  \\$aOlfactometry
=667  \\$adifferentiate from OLFACTORY PERCEPTION: SMELL takes place in the nose, OLFACTORY PERCEPTION takes place in the brain
=680  \\$iThe ability to detect scents or odors, such as the function of OLFACTORY RECEPTOR NEURONS.
=750  \0$aSmell$5IEN$0(DLC)sh 85123629

=LDR  00848cz  a2200169n  4500
=001  9880363911902441
=005  20141212205706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012900
=035  \\$aCBA6216HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x859
=150  \\$aSmallpox Vaccine
=450  \\$wnnna$aVaccine, Smallpox
=550  \\$wg$aViral Vaccines
=680  \\$iA live VACCINIA VIRUS vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. (Dorland, 28th ed)
=750  \0$aSmallpox vaccine$5IEN$0(DLC)sh 85123618

=LDR  00993cz  a2200253n  4500
=001  9880363912002441
=005  20141212205706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012899
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x826
=150  \\$aSmallpox
=450  \\$aAlastrim
=450  \\$wnnna$aMinor, Variola
=450  \\$wnnna$aMinors, Variola
=450  \\$aVariola
=450  \\$aVariola Minor
=450  \\$wnnna$aVariola Minors
=450  \\$wnnna$aVariolas
=550  \\$wg$aPoxviridae Infections
=667  \\$acaused by a poxvirus
=680  \\$iAn acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. (Dorland, 28th ed)
=688  \\$aALASTRIM was heading 1975-96 (see under SMALLPOX 1975-90); VARIOLA MINOR was see ALASTRIM 1979-96
=750  \0$aSmallpox$5IEN$0(DLC)sh 85123612

=LDR  01891cz  a2200361n  4500
=001  9880363912102441
=005  20141212205705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012897
=035  \\$aCBA6213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x839
=150  \\$aSlow Virus Diseases
=450  \\$wnnna$aDisease, Slow Virus
=450  \\$wnnna$aDiseases, Slow Virus
=450  \\$wnnna$aSlow Virus Disease
=450  \\$wnnna$aVirus Disease, Slow
=450  \\$wnnna$aVirus Diseases, Slow
=550  \\$wg$aVirus Diseases
=550  \\$wh$aAcquired Immunodeficiency Syndrome
=550  \\$wh$aAIDS-Related Complex
=550  \\$wh$aAleutian Mink Disease
=550  \\$wh$aEquine Infectious Anemia
=550  \\$wh$aFeline Acquired Immunodeficiency Syndrome
=550  \\$wh$aLeukoencephalopathy, Progressive Multifocal
=550  \\$wh$aPneumonia, Progressive Interstitial, of Sheep
=550  \\$wh$aSimian Acquired Immunodeficiency Syndrome
=550  \\$wh$aSubacute Sclerosing Panencephalitis
=550  \\$wh$aVisna
=667  \\$acaused by viruses incubating months to years; some dis formerly called slow virus dis are now considered prion dis: see note there; GEN or unspecified: prefer specifics
=680  \\$iDiseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL), and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES.
=688  \\$a72(68)
=750  \0$aSlow virus diseases$5IEN$0(DLC)sh 85143823

=LDR  00618cz  a2200193n  4500
=001  9880363912202441
=005  20201104120429.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012896
=035  \\$aCBA6212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x900.$x750
=150  \\$aSloths
=450  \\$wnnna$aSloth
=550  \\$wg$aCingulata
=667  \\$aIM; qualif permitted
=680  \\$iSlow-moving exclusively arboreal mammals that inhabit the tropical forests of South and Central America.
=688  \\$a91(75); was see under EDENTATA 1975-90
=750  \0$aSloths$5IEN$0(DLC)sh 85123466

=LDR  01222cz  a2200373n  4500
=001  9880363912302441
=005  20141212205704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012895
=035  \\$aCBA6211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x855.$x796.$x671
=072  \\$aG11.$x561.$x600.$x815.$x754.$x671
=150  \\$aSleep, REM
=450  \\$wnnna$aEye Movement, Rapid
=450  \\$wnnna$aEye Movements, Rapid
=450  \\$aFast-Wave Sleep
=450  \\$wnnna$aFast Wave Sleep
=450  \\$wnnna$aMovement, Rapid Eye
=450  \\$wnnna$aMovements, Rapid Eye
=450  \\$aParadoxical Sleep
=450  \\$wnnna$aRapid Eye Movement
=450  \\$aRapid Eye Movements
=450  \\$wnnna$aREM Sleep
=450  \\$aRhombencephalic Sleep
=450  \\$aSleep, Fast-Wave
=450  \\$wnnna$aSleep, Fast Wave
=450  \\$wnnna$aSleep, Paradoxical
=450  \\$wnnna$aSleep, Rhombencephalic
=550  \\$wg$aSleep Stages
=550  \\$aEye Movements
=680  \\$iA stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.
=688  \\$a69
=750  \0$aRapid eye movement sleep$5IEN-M$0(DLC)sh 00009418

=LDR  00904cz  a2200265n  4500
=001  9880363912402441
=005  20141212205704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012894
=035  \\$aCBA6210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x855.$x796
=072  \\$aG11.$x561.$x600.$x815.$x754
=150  \\$aSleep Stages
=450  \\$aDrowsiness
=450  \\$wnnna$aDrowsinesses
=450  \\$wnnna$aSleep Stage
=450  \\$wnnna$aStage, Sleep
=450  \\$wnnna$aStages, Sleep
=550  \\$wg$aSleep
=550  \\$wh$aSleep, REM
=550  \\$aStupor
=680  \\$iPeriods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep.
=688  \\$a72(69)
=750  \0$aSleep$xStages$5IEN$0(DLC)sh 85123401

=LDR  02665cz  a2200661n  4500
=001  9880363912502441
=005  20160801130839.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012893
=035  \\$aCBA6209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886
=072  \\$aC23.$x888.$x592.$x796
=072  \\$aF3.$x870
=150  \\$aSleep Wake Disorders
=450  \\$wnno$aSleep Disorders
=450  \\$wnnna$aDisorder, Sleep
=450  \\$wnnna$aDisorder, Sleep Wake
=450  \\$wnnna$aDisorders, Sleep Wake
=450  \\$wnnna$aDisorders, Sleep
=450  \\$wnnna$aLong Sleeper Syndrome
=450  \\$wnnna$aLong Sleeper Syndromes
=450  \\$wnnna$aNeurogenic Tachypnea, Sleep-Related
=450  \\$wnnna$aNeurogenic Tachypneas, Sleep-Related
=450  \\$wnnna$aPhenotype, Short Sleep
=450  \\$wnnna$aPhenotypes, Short Sleep
=450  \\$wnnna$aShort Sleep Phenotype
=450  \\$wnnna$aShort Sleep Phenotypes
=450  \\$wnnna$aShort Sleeper Syndrome
=450  \\$wnnna$aShort Sleeper Syndromes
=450  \\$wnnna$aSleep Disorder
=450  \\$wnnna$aSleep Phenotypes, Short
=450  \\$wnnna$aSleep-Related Neurogenic Tachypnea
=450  \\$wnnna$aSleep Related Neurogenic Tachypnea
=450  \\$wnnna$aSleep-Related Neurogenic Tachypneas
=450  \\$wnnna$aSleep Wake Disorder
=450  \\$wnnna$aSleeper Syndrome, Long
=450  \\$wnnna$aSleeper Syndrome, Short
=450  \\$wnnna$aSleeper Syndromes, Long
=450  \\$wnnna$aSleeper Syndromes, Short
=450  \\$wnnna$aSubwakefullness Syndrome
=450  \\$wnnna$aSubwakefullness Syndromes
=450  \\$wnnna$aSyndrome, Long Sleeper
=450  \\$wnnna$aSyndrome, Short Sleeper
=450  \\$wnnna$aSyndrome, Subwakefullness
=450  \\$wnnna$aSyndromes, Long Sleeper
=450  \\$wnnna$aSyndromes, Short Sleeper
=450  \\$wnnna$aSyndromes, Subwakefullness
=450  \\$wnnna$aTachypnea, Sleep-Related Neurogenic
=450  \\$wnnna$aTachypneas, Sleep-Related Neurogenic
=550  \\$wg$aMental Disorders
=550  \\$wg$aNervous System Diseases
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aDyssomnias
=550  \\$wh$aParasomnias
=550  \\$wh$aSleep Deprivation
=680  \\$iConditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
=750  \0$aSleep disorders$0(DLC) sh 85123404$5IEN

=LDR  01733cz  a2200457n  4500
=001  9880363912602441
=005  20141212205703.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012892
=035  \\$aCBA6208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x425.$x175
=072  \\$aC23.$x888.$x592.$x796.$x772
=072  \\$aF2.$x830.$x855.$x671
=072  \\$aF3.$x870.$x400.$x99
=072  \\$aG11.$x561.$x600.$x815.$x587
=150  \\$aSleep Deprivation
=450  \\$wnnna$aDeprivation, REM Sleep
=450  \\$wnnna$aDeprivation, Sleep
=450  \\$wnnna$aDeprivations, REM Sleep
=450  \\$wnnna$aDeprivations, Sleep
=450  \\$wnnna$aFragmentation, Sleep
=450  \\$wnnna$aFragmentations, Sleep
=450  \\$aInsufficient Sleep Syndrome
=450  \\$wnnna$aInsufficient Sleep Syndromes
=450  \\$aREM Sleep Deprivation
=450  \\$wnnna$aREM Sleep Deprivations
=450  \\$wnnna$aSleep Deprivation, REM
=450  \\$wnnna$aSleep Deprivations
=450  \\$wnnna$aSleep Deprivations, REM
=450  \\$aSleep Fragmentation
=450  \\$wnnna$aSleep Fragmentations
=450  \\$wnnna$aSyndrome, Insufficient Sleep
=450  \\$wnnna$aSyndromes, Insufficient Sleep
=550  \\$wg$aDyssomnias
=550  \\$wg$aSleep
=550  \\$wg$aSleep Disorders
=667  \\$ado not confuse with SLEEP INITIATION AND MAINTENANCE DISORDERS, inability to fall asleep or sleep
=680  \\$iThe state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder.
=688  \\$a67(64)
=750  \0$aSleep deprivation$5IEN$0(DLC)sh 85123403

=LDR  01840cz  a2200481n  4500
=001  9880363912702441
=005  20141212205702.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012891
=035  \\$aCBA6207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x85.$x852
=072  \\$aC10.$x886.$x425.$x800.$x750
=150  \\$aSleep Apnea Syndromes
=450  \\$aApnea, Sleep
=450  \\$wnnna$aApnea Syndrome, Sleep
=450  \\$wnnna$aApnea Syndromes, Sleep
=450  \\$wnnna$aApneas, Sleep
=450  \\$wnnna$aBreathing, Sleep-Disordered
=450  \\$aHypersomnia with Periodic Respiration
=450  \\$wnnna$aHypopnea, Sleep
=450  \\$wnnna$aHypopneas, Sleep
=450  \\$wnnna$aMixed Central and Obstructive Sleep Apnea
=450  \\$wnnna$aMixed Sleep Apnea
=450  \\$wnnna$aMixed Sleep Apneas
=450  \\$wnnna$aSleep Apnea
=450  \\$wnnna$aSleep Apnea, Mixed
=450  \\$wnnna$aSleep Apnea, Mixed Central and Obstructive
=450  \\$wnnna$aSleep Apnea Syndrome
=450  \\$wnnna$aSleep Apneas
=450  \\$wnnna$aSleep Apneas, Mixed
=450  \\$aSleep-Disordered Breathing
=450  \\$wnnna$aSleep Disordered Breathing
=450  \\$wnnna$aSleep Hypopnea
=450  \\$wnnna$aSleep Hypopneas
=550  \\$wg$aApnea
=550  \\$wg$aSleep Disorders, Intrinsic
=550  \\$wh$aSleep Apnea, Central
=550  \\$wh$aSleep Apnea, Obstructive
=667  \\$aDF: SLEEP APNEA
=680  \\$iDisorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
=688  \\$a80
=750  \0$aSleep apnea syndromes$0(DLC) sh 85123402$5IEN

=LDR  00869cz  a2200277n  4500
=001  9880363912802441
=005  20200629164825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012890
=035  \\$aCBA6206HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x855
=072  \\$aG11.$x561.$x803
=150  \\$aSleep
=450  \\$aSleep, Slow-Wave
=450  \\$wnnna$aSleep, Slow Wave
=450  \\$wnnna$aSlow-Wave Sleep
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aPsychophysiology
=550  \\$wh$aDreams
=550  \\$wh$aSleep Deprivation
=550  \\$wh$aSleep Hygiene
=550  \\$wh$aSleep Latency
=550  \\$wh$aSleep Stages
=680  \\$iA readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.
=750  \0$aSleep$5IEN$0(DLC)sh 85123396

=LDR  01356cz  a2200433n  4500
=001  9880363912902441
=005  20141212205702.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012889
=035  \\$aCBA6205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x500
=150  \\$aMephitidae
=450  \\$aConepatus
=450  \\$wnnna$aHog-nosed Skunk
=450  \\$aHog-nosed Skunks
=450  \\$wnnna$aHog nosed Skunks
=450  \\$wnnna$aHooded Skunk
=450  \\$aHooded Skunks
=450  \\$aMephitis
=450  \\$wnnna$aSkunk
=450  \\$wnnna$aSkunk, Hog-nosed
=450  \\$wnnna$aSkunk, Hooded
=450  \\$wnnna$aSkunk, Spotted
=450  \\$wnnna$aSkunk, Striped
=450  \\$aSkunks
=450  \\$wnnna$aSkunks, Hog-nosed
=450  \\$wnnna$aSkunks, Hooded
=450  \\$wnnna$aSkunks, Spotted
=450  \\$wnnna$aSkunks, Striped
=450  \\$aSpilogalae
=450  \\$wnnna$aSpotted Skunk
=450  \\$aSpotted Skunks
=450  \\$wnnna$aStriped Skunk
=450  \\$aStriped Skunks
=550  \\$wg$aCarnivora
=680  \\$iThe family of omnivorous New World skunks, showing typical warning coloration of patterned black and white and able to eject a malodorous secretion when the animal is startled or in danger.
=688  \\$a2005 (1975)
=750  \0$aSkunks$0(DLC) sh 85123249$5IEN

=LDR  01074cz  a2200265n  4500
=001  9880363913002441
=005  20141212205701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012888
=035  \\$aCBA6204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721
=072  \\$aC5.$x116.$x231.$x754
=150  \\$aSkull Neoplasms
=450  \\$wnnna$aNeoplasm, Skull
=450  \\$wnnna$aNeoplasms, Skull
=450  \\$wnnna$aSkull Neoplasm
=550  \\$wg$aBone Neoplasms
=550  \\$wh$aJaw Neoplasms
=550  \\$wh$aNose Neoplasms
=550  \\$wh$aOrbital Neoplasms
=550  \\$wh$aSkull Base Neoplasms
=667  \\$aof bony part of skull only: do not confuse with HEAD AND NECK NEOPLASMS or FACIAL NEOPLASMS; "intracranial tumors" is probably BRAIN NEOPLASMS, not SKULL NEOPLASMS; GEN: prefer specifics; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM); SKULL BASE NEOPLASMS is also available
=680  \\$iNeoplasms of the bony part of the skull.
=750  \0$aSkull$xTumors$5IEN-M$0(IEN)380403

=LDR  01914cz  a2200469n  4500
=001  9880363913102441
=005  20141212205701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012887
=035  \\$aCBA6203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x900.$x300.$x918
=072  \\$aC26.$x260.$x836
=072  \\$aC26.$x404.$x750
=072  \\$aC26.$x915.$x300.$x745
=150  \\$aSkull Fractures
=450  \\$wnnna$aFracture, Non-Depressed Skull
=450  \\$wnnna$aFracture, Skull
=450  \\$wnnna$aFractures, Linear Skull
=450  \\$wnnna$aFractures, Non-Depressed Skull
=450  \\$wnnna$aFractures, Skull
=450  \\$aLinear Skull Fracture
=450  \\$wnnna$aLinear Skull Fractures
=450  \\$wnnna$aNon-Depressed Skull Fracture
=450  \\$wnnna$aNon Depressed Skull Fracture
=450  \\$wnnna$aNon-Depressed Skull Fractures
=450  \\$wnnna$aSkull Fracture
=450  \\$aSkull Fracture, Linear
=450  \\$aSkull Fracture, Non-Depressed
=450  \\$wnnna$aSkull Fracture, Non Depressed
=450  \\$wnnna$aSkull Fractures, Linear
=450  \\$wnnna$aSkull Fractures, Non-Depressed
=550  \\$wg$aCraniocerebral Trauma
=550  \\$wg$aFractures, Bone
=550  \\$wh$aJaw Fractures
=550  \\$wh$aOrbital Fractures
=550  \\$wh$aSkull Fracture, Basilar
=550  \\$wh$aSkull Fracture, Depressed
=550  \\$wh$aZygomatic Fractures
=667  \\$aGEN; fractures of specific bones of the skull: coord IM with specific bone/inj (IM)
=680  \\$iFractures of the skull which may result from penetrating or nonpenetrating head injuries or rarely BONE DISEASES (see also FRACTURES, SPONTANEOUS). Skull fractures may be classified by location (e.g., SKULL FRACTURE, BASILAR), radiographic appearance (e.g., linear), or based upon cranial integrity (e.g., SKULL FRACTURE, DEPRESSED).
=750  \0$aSkull$xFractures$5IEN$0(DLC)sh 85123241

=LDR  02313cz  a2200613n  4500
=001  9880364358002441
=005  20141212213914.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020732
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x385
=072  \\$aE5.$x200.$x500.$x385
=072  \\$aE5.$x242.$x385
=072  \\$aE5.$x393.$x285
=150  \\$aCytogenetic Analysis
=450  \\$wnnna$aAnalyses, Cytogenetic
=450  \\$wnnna$aAnalysis, Cytogenetic
=450  \\$wnnna$aCytogenetic Analyses
=450  \\$wnnna$aCytogenetic Technic
=450  \\$wnnna$aCytogenetic Technic, Molecular
=450  \\$wnnna$aCytogenetic Technics
=450  \\$wnnna$aCytogenetic Technics, Molecular
=450  \\$wnnna$aCytogenetic Technique
=450  \\$wnnna$aCytogenetic Technique, Molecular
=450  \\$aCytogenetic Techniques
=450  \\$wnnna$aCytogenetic Techniques, Molecular
=450  \\$wnnna$aMolecular Cytogenetic Technic
=450  \\$wnnna$aMolecular Cytogenetic Technics
=450  \\$wnnna$aMolecular Cytogenetic Technique
=450  \\$aMolecular Cytogenetic Techniques
=450  \\$wnnna$aTechnic, Cytogenetic
=450  \\$wnnna$aTechnic, Molecular Cytogenetic
=450  \\$wnnna$aTechnics, Cytogenetic
=450  \\$wnnna$aTechnics, Molecular Cytogenetic
=450  \\$wnnna$aTechnique, Cytogenetic
=450  \\$wnnna$aTechnique, Molecular Cytogenetic
=450  \\$wnnna$aTechniques, Cytogenetic
=450  \\$wnnna$aTechniques, Molecular Cytogenetic
=550  \\$wg$aCytological Techniques
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aChromosome Banding
=550  \\$wh$aComparative Genomic Hybridization
=550  \\$wh$aIn Situ Hybridization, Fluorescence
=550  \\$wh$aKaryotyping
=550  \\$wh$aMitotic Index
=550  \\$wh$aSex Determination Analysis
=550  \\$aChromosome Aberrations
=550  \\$aChromosome Mapping
=550  \\$aCytogenetics
=550  \\$aKaryometry
=550  \\$aMolecular Diagnostic Techniques
=680  \\$iExamination of CHROMOSOMES to diagnose, classify, screen for, or manage genetic diseases and abnormalities. Following preparation of the sample, KARYOTYPING is performed and/or the specific chromosomes are analyzed.
=688  \\$a2000
=750  \0$aCytogenetics$xTechnique$5IEN-M

=LDR  02292cz  a2200553n  4500
=001  9880364358102441
=005  20141212213623.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020220
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x262.$x500
=072  \\$aC10.$x292.$x300.$x500
=072  \\$aC10.$x900.$x300.$x218.$x300
=072  \\$aC26.$x260.$x237.$x325
=072  \\$aC26.$x915.$x300.$x400.$x300
=150  \\$aFacial Nerve Injuries
=450  \\$wnnna$aAvulsion, Facial Nerve
=450  \\$wnnna$aAvulsions, Facial Nerve
=450  \\$wnnna$aCranial Nerve VII Injuries
=450  \\$wnnna$aFacial Nerve Avulsion
=450  \\$wnnna$aFacial Nerve Avulsions
=450  \\$aFacial Nerve$xinjuries
=450  \\$wnnna$aFacial Nerve Injury
=450  \\$aFacial Nerve Trauma
=450  \\$wnnna$aFacial Nerve Traumas
=450  \\$wnnna$aFacial Neuropathies, Traumatic
=450  \\$aFacial Neuropathy, Traumatic
=450  \\$wnnna$aInjuries, Cranial Nerve VII
=450  \\$wnnna$aInjuries, Facial Nerve
=450  \\$wnnna$aInjuries, Seventh Cranial Nerve
=450  \\$wnnna$aInjury, Facial Nerve
=450  \\$wnnna$aNerve Avulsion, Facial
=450  \\$wnnna$aNerve Avulsions, Facial
=450  \\$wnnna$aNerve Injuries, Facial
=450  \\$wnnna$aNerve Injury, Facial
=450  \\$wnnna$aNerve Trauma, Facial
=450  \\$wnnna$aNerve Traumas, Facial
=450  \\$wnnna$aNeuropathies, Traumatic Facial
=450  \\$wnnna$aNeuropathy, Traumatic Facial
=450  \\$wnnna$aSeventh Cranial Nerve Injuries
=450  \\$wnnna$aTrauma, Facial Nerve
=450  \\$wnnna$aTraumas, Facial Nerve
=450  \\$wnnna$aTraumatic Facial Neuropathies
=450  \\$wnnna$aTraumatic Facial Neuropathy
=550  \\$wg$aCranial Nerve Injuries
=550  \\$wg$aFacial Nerve Diseases
=680  \\$iTraumatic injuries to the facial nerve. This may result in FACIAL PARALYSIS, decreased lacrimation and salivation, and loss of taste sensation in the anterior tongue. The nerve may regenerate and reform its original pattern of innervation, or regenerate aberrantly, resulting in inappropriate lacrimation in response to gustatory stimuli (e.g., "crocodile tears") and other syndromes.
=688  \\$a2000
=750  \0$aFacial nerve$xWounds and injuries$5IEN-M

=LDR  01399cz  a2200313n  4500
=001  9880364358202441
=005  20141212213908.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x915.$x162.$x249
=072  \\$aD2.$x241.$x152.$x811.$x162.$x500
=072  \\$aD2.$x241.$x511.$x902.$x915.$x162.$x500
=072  \\$aD9.$x811.$x922.$x162.$x500
=150  \\$aGlucuronic Acid
=450  \\$aGlucuronate
=450  \\$wnnna$aGlucuronate, Monopotassium
=450  \\$wnnna$aGlucuronate, Monosodium
=450  \\$wnnna$aGlucuronic Acid, 6-(14)C-labeled, (D)-isomer
=450  \\$wnnna$aGlucuronic Acid, Monopotassium Salt
=450  \\$wnnna$aGlucuronic Acid, Monosodium Salt
=450  \\$wnnna$aMonopotassium Glucuronate
=450  \\$wnnna$aMonosodium Glucuronate
=550  \\$wg$aGlucuronates
=667  \\$afor glycoside-linked compounds use GLUCURONIDES
=680  \\$iA sugar acid formed by the oxidation of the C-6 carbon of GLUCOSE. In addition to being a key intermediate metabolite of the uronic acid pathway, glucuronic acid also plays a role in the detoxification of certain drugs and toxins by conjugating with them to form GLUCURONIDES.
=688  \\$a2000; for GLUCURONATE use GLUCURONIC ACID 2000-2012
=688  \\$a2000; use GLUCURONIC ACID (NM) 1981-1999
=750  \0$aGlucuronic acid$5IEN-M$0(DLC)sh 85055368

=LDR  00990cz  a2200217n  4500
=001  9880364358302441
=005  20141212213907.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020719
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x844.$x915.$x162.$x500
=072  \\$aD2.$x241.$x152.$x811.$x162.$x750
=072  \\$aD2.$x241.$x511.$x902.$x915.$x162.$x750
=072  \\$aD9.$x811.$x922.$x162.$x750
=150  \\$aGlucuronides
=550  \\$wg$aGlucuronates
=550  \\$aGlucuronic Acid
=550  \\$aUridine Diphosphate Glucuronic Acid
=680  \\$iGlycosides of GLUCURONIC ACID formed by the reaction of URIDINE DIPHOSPHATE GLUCURONIC ACID with certain endogenous and exogenous substances. Their formation is important for the detoxification of drugs, steroid excretion and BILIRUBIN metabolism to a more water-soluble compound that can be eliminated in the URINE and BILE.
=688  \\$a2000; use GLUCURONATES 1977-1999
=750  \0$aGlucuronides$5IEN-M$0(DLC)sh 85055371

=LDR  00295cz  a2200109n  4500
=001  9880364358402441
=005  20040909090933.0
=008  860602\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D011486Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aProtein C$xgenetics
=750  \0$aProtein C gene$0(DLC) sh2003001498$5IEN-M

=LDR  00314cz  a2200109n  4500
=001  9880364358502441
=005  20130401175327.0
=008  970714\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D020018Q000628
=040  \\$aDNLM$cDNLM
=150  \\$aSexual Dysfunctions, Psychological$xtherapy
=750  \0$aSex therapy$0(DLC)sh 85120674$5IEN-M

=LDR  00332cz  a2200109n  4500
=001  9880364358602441
=005  20120717143638.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D006330Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aHeart Defects, Congenital$xveterinary
=750  \0$aCongenital heart disease in animals$5IEN-M$0(DLC)sh 00000246

=LDR  01354cz  a2200301n  4500
=001  9880364358702441
=005  20141212213827.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020557
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x599.$x395.$x642.$x550
=072  \\$aE5.$x599.$x695.$x550
=072  \\$aF2.$x463.$x425.$x575
=072  \\$aF2.$x694.$x550
=072  \\$aF2.$x784.$x629.$x529.$x550
=072  \\$aF4.$x96.$x586.$x550
=072  \\$aL1.$x143.$x506.$x598.$x628.$x550
=150  \\$aNeurolinguistic Programming
=450  \\$wnnna$aNeuro-linguistic Programming
=450  \\$wnnna$aProgramming, Neuro-linguistic
=450  \\$wnnna$aProgramming, Neurolinguistic
=550  \\$wg$aLearning
=550  \\$wg$aModels, Neurological
=550  \\$wg$aModels, Psychological
=550  \\$wg$aPsycholinguistics
=680  \\$iA set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone's internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.
=688  \\$a2000
=750  \0$aNeurolinguistic programming$5IEN-M$0(DLC)sh 85091129

=LDR  00317cz  a2200109n  4500
=001  9880364358802441
=005  20120717143638.0
=008  770516\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004723Q000037
=040  \\$aDNLM$cDNLM
=150  \\$aEndorphins$xantagonists & inhibitors
=750  \0$aEndorphin antagonists$5IEN-M$0(DLC)sh 85043093

=LDR  00292cz  a2200109n  4500
=001  9880364358902441
=005  20051109082955.0
=008  920513\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D017280Q000656
=040  \\$aDNLM$cDNLM
=150  \\$aCondoms$xutilization
=750  \0$aCondom use$0(DLC) sh2005020286$5IEN-M

=LDR  00331cz  a2200109n  4500
=001  9880364359002441
=005  20130401110233.0
=008  720101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004064Q000531
=040  \\$aDNLM$cDNLM
=150  \\$aDigestive System$xradionuclide imaging
=750  \0$aRadioisotopes in gastroenterology$0(DLC)sh 85110734$5IEN-M

=LDR  00302cz  a2200109n  4500
=001  9880364359102441
=005  20040917131929.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D008223Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aLymphoma$xveterinary
=750  \0$aLymphomas in animals$0(DLC) sh2004000639$5IEN-M

=LDR  00304cz  a2200109n  4500
=001  9880364359202441
=005  20040930182151.0
=008  980101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D001523Q000175
=040  \\$aDNLM$cDNLM
=150  \\$aMental Disorders$xdiagnosis
=750  \0$aPsychodiagnostics$0(DLC) sh85108427$5IEN-M

=LDR  01709cz  a2200385n  4500
=001  9880364359302441
=005  20141212213633.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020238
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762.$x100.$x650
=072  \\$aC23.$x888.$x592.$x604.$x764.$x100.$x650
=072  \\$aF1.$x700.$x750.$x100.$x650
=150  \\$aProsopagnosia
=450  \\$wnnna$aAcquired Prosopagnosia
=450  \\$wnnna$aAcquired Prosopagnosias
=450  \\$wnnna$aAgnosia, Facial Recognition
=450  \\$wnnna$aAgnosia for Face
=450  \\$aAgnosia for Faces
=450  \\$wnnna$aAgnosias, Facial Recognition
=450  \\$wnnna$aDevelopmental Prosopagnosia
=450  \\$wnnna$aDevelopmental Prosopagnosias
=450  \\$aFacial Recognition Agnosia
=450  \\$wnnna$aFacial Recognition Agnosias
=450  \\$wnnna$aProsopagnosia, Acquired
=450  \\$wnnna$aProsopagnosia, Developmental
=450  \\$wnnna$aProsopagnosias
=450  \\$wnnna$aProsopagnosias, Acquired
=450  \\$wnnna$aProsopagnosias, Developmental
=450  \\$wnnna$aRecognition Agnosia, Facial
=450  \\$wnnna$aRecognition Agnosias, Facial
=550  \\$wg$aAgnosia
=680  \\$iThe inability to recognize a familiar face or to learn to recognize new faces. This visual agnosia is most often associated with lesions involving the junctional regions between the temporal and occipital lobes. The majority of cases are associated with bilateral lesions, however unilateral damage to the right occipito-temporal cortex has also been associated with this condition. (From Cortex 1995 Jun;31(2):317-29)
=688  \\$a2000
=750  \0$aProsopagnosia$5IEN-M$0(DLC)sh 85107586

=LDR  00328cz  a2200109n  4500
=001  9880364359402441
=005  20120717143638.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D002653Q000175
=040  \\$aDNLM$cDNLM
=150  \\$aChild Behavior Disorders$xdiagnosis
=750  \0$aBehavioral assessment of children$5IEN-M$0(DLC)sh 85012902

=LDR  00296cz  a2200109n  4500
=001  9880364359502441
=005  20120717143637.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D010944Q000737
=040  \\$aDNLM$cDNLM
=150  \\$aPlants$xchemistry
=750  \0$aBotanical chemistry$5IEN-M$0(DLC)sh 85015961

=LDR  00296cz  a2200109n  4500
=001  9880364359602441
=005  20100803213844.0
=008  921228\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D017747Q000506
=040  \\$aDNLM$cDNLM
=150  \\$aSeafood$xpoisoning
=750  \2$aSeafood poisoning$0(DLC) sh 89006927$5IEN-M

=LDR  00313cz  a2200109n  4500
=001  9880364359702441
=005  20091123102347.0
=008  930628\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D018035Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aReceptors, Odorant$xgenetics
=750  \0$aOlfactory receptor genes$0(DLC)sh2009000175$5IEN-M

=LDR  00309cz  a2200109n  4500
=001  9880364359802441
=005  20070105122929.0
=008  840525\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D001057Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aApolipoproteins E$xgenetics
=750  \0$aApolipoprotein E gene$0(DLC)sh2006007988$5IEN-M

=LDR  00297cz  a2200109n  4500
=001  9880364359902441
=005  20011212121216.0
=008  910211\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D016695Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aGlycosyltransferases$xgenetics
=750  \2$aGlycosyltransferase genes$5IEN-M

=LDR  00321cz  a2200109n  4500
=001  9880364360002441
=005  20080508093302.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D008659Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aMetabolic Diseases$xveterinary
=750  \0$aMetabolic disorders in animals$0(DLC)sh2007004647$5IEN-M

=LDR  00307cz  a2200109n  4500
=001  9880364360102441
=005  20080327104118.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D009536Q000172
=040  \\$aDNLM$cDNLM
=150  \\$aNiacinamide$xdeficiency
=750  \0$aNicotinamide deficiency$0(DLC) sh 85144001$5IEN-M

=LDR  00309cz  a2200109n  4500
=001  9880364360202441
=005  20120717143637.0
=008  741111\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D003422Q000656
=040  \\$aDNLM$cDNLM
=150  \\$aCritical Care$xveterinary
=750  \0$aVeterinary critical care$5IEN-M$0(DLC)sh 85143015

=LDR  00296cz  a2200109n  4500
=001  9880364360302441
=005  20091120085032.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D014511Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aUremia$xveterinary
=750  \0$aUremia in animals$0(DLC)sh2008009226$5IEN-M

=LDR  00336cz  a2200121n  4500
=001  9880364360402441
=005  20120717143637.0
=008  650401\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$a(DNLM)D005914Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aGlobins$xgenetics
=450  \\$wnnoa$aGlobin$xgenetics$5IEN-HS
=750  \0$aGlobin genes$5IEN-M$0(DLC)sh 88003266

=LDR  00345cz  a2200109n  4500
=001  9880364360502441
=005  20120717143637.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D001694Q000331
=040  \\$aDNLM$cDNLM
=150  \\$aBiological Warfare$xlegislation & jurisprudence
=750  \0$aBiological warfare (International law)$5IEN-M$0(DLC)sh 86002987

=LDR  00324cz  a2200109n  4500
=001  9880364360602441
=005  20091119132409.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D014802Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aVitamin A Deficiency$xveterinary
=750  \0$aVitamin A deficiency in animals$0(DLC)sh2008008494$5IEN-M

=LDR  00328cz  a2200109n  4500
=001  9880364360702441
=005  20091119132730.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D001206Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aAscorbic Acid Deficiency$xveterinary
=750  \0$aVitamin C deficiency in animals$0(DLC)sh2008008498$5IEN-M

=LDR  00467cz  a2200133n  4500
=001  9880364360802441
=005  20080306095809.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D011431Q000031
=040  \\$aDNLM$cDNLM
=150  \\$aDextropropoxyphene$xanalogs & derivatives
=450  \\$aPropoxyphene Napsylate$5IEN-M
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Propoxyphene _{dollar}x analogs & derivatives
=750  \0$aPropoxyphene napsylate$0(DLC) sh 85107554$5IEN-M

=LDR  00312cz  a2200109n  4500
=001  9880364360902441
=005  20091120083343.0
=008  680101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004011Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDicrocoeliasis$xveterinary
=750  \0$aDicrocoeliasis in animals$0(DLC)sh2008009231$5IEN-M

=LDR  00394cz  a2200121n  4500
=001  9880364361002441
=005  20100201152515.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D014235Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aTrichinellosis$xveterinary
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Trichinosis _{dollar}x veterinary
=750  \0$aTrichinosis in animals$0(DLC) sh 85137448$5IEN-M

=LDR  00335cz  a2200109n  4500
=001  9880364361102441
=005  20120717143637.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D004927Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aEscherichia coli Infections$xveterinary
=750  \0$aEscherichia coli infections in animals$5IEN$0(DLC)sh 88003834

=LDR  00326cz  a2200109n  4500
=001  9880364361202441
=005  20070511140228.0
=008  680101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D003015Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aClostridium Infections$xveterinary
=750  \0$aClostridium diseases in animals$0(DLC) sh 93002697$5IEN-M

=LDR  00306cz  a2200109n  4500
=001  9880364361302441
=005  20120717143637.0
=008  900525\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D016292Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aConscious Sedation$xveterinary
=750  \0$aAnimal sedation$5IEN-M$0(DLC)sh2002011190

=LDR  00308cz  a2200109n  4500
=001  9880364361402441
=005  20040917133917.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D005759Q000821
=040  \\$aDNLM$cDNLM
=150  \\$aGastroenteritis$xvirology
=750  \0$aViral gastroenteritis$0(DLC) sh2004000705$5IEN-M

=LDR  00295cz  a2200109n  4500
=001  9880364361502441
=005  20120717143637.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D010031Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aOtitis$xveterinary
=750  \0$aOtitis in animals$5IEN-M$0(DLC)sh 99005560

=LDR  00336cz  a2200121n  4500
=001  9880364361602441
=005  20120717143636.0
=008  910211\n\ancnnbabn\\\\\\\\\\\b\ana\\\\\\
=035  \\$a(DNLM)D016678Q000187
=040  \\$aDNLM$cDNLM
=150  \\$aGenome$xdrug effects
=450  \\$aPharmacogenomics$5IEN-M
=750  \0$aPharmacogenomics$5IEN-M$0(DLC)sh 99000126

=LDR  00566cz  a2200169n  4500
=001  9880364361702441
=005  20141212213801.0
=008  980618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020462
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x385
=150  \\$aGliocladium
=450  \\$wnnna$aGliocladiums
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic fungal genus occurring in soil or decaying plant matter. It is structurally similar to Penicillium.
=688  \\$a99; use MITOSPORIC FUNGI 1975-98
=750  \0$aGliocladium$5IEN-M$0(DLC)sh 98007339

=LDR  00653cz  a2200217n  4500
=001  9880364361802441
=005  20141212213341.0
=008  980618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019727
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x380.$x600
=150  \\$aProxy
=450  \\$wnnna$aAgent, Patient
=450  \\$wnnna$aAgents, Patient
=450  \\$aPatient Agent
=450  \\$wnnna$aProxies
=550  \\$wg$aLegal Guardians
=550  \\$aThird-Party Consent
=680  \\$iA person authorized to decide or act for another person, for example, a person having durable power of attorney.
=688  \\$a99
=750  \0$aProxy$5IEN-M$0(DLC)sh 85108030

=LDR  01059cz  a2200325n  4500
=001  9880364361902441
=005  20141212213638.0
=008  980616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x767.$x859
=072  \\$aC23.$x888.$x821.$x712.$x700
=072  \\$aC23.$x888.$x821.$x937.$x59
=150  \\$aPostoperative Nausea and Vomiting
=450  \\$wnnna$aEmeses, Postoperative
=450  \\$wnnna$aEmesis, Postoperative
=450  \\$aNausea and Vomiting, Postoperative
=450  \\$wnnna$aNausea, Postoperative
=450  \\$aPONV
=450  \\$wnnna$aPostoperative Emeses
=450  \\$wnnna$aPostoperative Emesis
=450  \\$wnnna$aPostoperative Nausea
=450  \\$wnnna$aPostoperative Vomiting
=450  \\$wnnna$aVomiting, Postoperative
=550  \\$wg$aNausea
=550  \\$wg$aPostoperative Complications
=550  \\$wg$aVomiting
=680  \\$iEmesis and queasiness occurring after anesthesia.
=688  \\$a99
=750  \0$aPostoperative nausea and vomiting$5IEN-M$0(DLC)sh 99001642

=LDR  00773cz  a2200229n  4500
=001  9880364362002441
=005  20141212213715.0
=008  980612\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x355
=150  \\$aFinite Element Analysis
=450  \\$wnnna$aAnalyses, Finite Element
=450  \\$wnnna$aAnalysis, Finite Element
=450  \\$wnnna$aElement Analyses, Finite
=450  \\$wnnna$aElement Analysis, Finite
=450  \\$wnnna$aFinite Element Analyses
=550  \\$wg$aInvestigative Techniques
=667  \\$aDF: Finite Element Anal
=680  \\$iA computer based method of simulating or analyzing the behavior of structures or components.
=688  \\$a99
=750  \0$aFinite element method$5IEN-M$0(DLC)sh 85048349

=LDR  02837cz  a2200565n  4500
=001  9880364362102441
=005  20141212213520.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020071
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x708.$x330
=072  \\$aG5.$x360.$x80.$x708.$x330
=072  \\$aG5.$x360.$x340.$x24.$x425
=150  \\$aInterspersed Repetitive Sequences
=450  \\$wnnna$aDispersed Repetitive Sequence
=450  \\$aDispersed Repetitive Sequences
=450  \\$wnnna$aElement, Interspersed Repetitive
=450  \\$wnnna$aElement, Mobile Genetic
=450  \\$wnnna$aElements, Interspersed Repetitive
=450  \\$wnnna$aElements, Mobile Genetic
=450  \\$wnnna$aGene, Jumping
=450  \\$aGenes, Jumping
=450  \\$wnnna$aGenetic Element, Mobile
=450  \\$wnnna$aGenetic Elements, Mobile
=450  \\$wnnna$aInterspersed Repetitive Element
=450  \\$aInterspersed Repetitive Elements
=450  \\$wnnna$aInterspersed Repetitive Sequence
=450  \\$wnnna$aJumping Gene
=450  \\$aJumping Genes
=450  \\$wnnna$aMobile Genetic Element
=450  \\$aMobile Genetic Elements
=450  \\$wnnna$aRepetitive Element, Interspersed
=450  \\$wnnna$aRepetitive Elements, Interspersed
=450  \\$wnnna$aRepetitive Sequence, Dispersed
=450  \\$wnnna$aRepetitive Sequence, Interspersed
=450  \\$aRepetitive Sequences, Dispersed
=450  \\$aRepetitive Sequences, Interspersed
=450  \\$wnnna$aSequence, Dispersed Repetitive
=450  \\$wnnna$aSequence, Interspersed Repetitive
=450  \\$wnnna$aSequences, Dispersed Repetitive
=450  \\$wnnna$aSequences, Interspersed Repetitive
=550  \\$wg$aGenome Components
=550  \\$wg$aRepetitive Sequences, Nucleic Acid
=550  \\$wh$aDNA Transposable Elements
=550  \\$wh$aGenomic Islands
=550  \\$wh$aRetroelements
=667  \\$aGEN: prefer specifics - DNA TRANSPOSABLE ELEMENTS or RETROELEMENTS or its indentions
=680  \\$iCopies of transposable elements interspersed throughout the genome, some of which are still active and often referred to as "jumping genes". There are two classes of interspersed repetitive elements. Class I elements (or RETROELEMENTS - such as retrotransposons, retroviruses, LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS) transpose via reverse transcription of an RNA intermediate. Class II elements (or DNA TRANSPOSABLE ELEMENTS - such as transposons, Tn elements, insertion sequence elements and mobile gene cassettes of bacterial integrons) transpose directly from one site in the DNA to another.
=688  \\$a99; for MOBILE GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1986-98; for SELFISH DNA use DNA (1983-2003)
=750  \0$aMobile genetic elements$5IEN-M$0(DLC)sh 88007588

=LDR  01243cz  a2200337n  4500
=001  9880364362202441
=005  20141212213759.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020457
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x879.$x750.$x500
=150  \\$aTrichechus manatus
=450  \\$aCaribbean Manatee
=450  \\$wnnna$aCaribbean Manatees
=450  \\$aFlorida Manatee
=450  \\$wnnna$aFlorida Manatees
=450  \\$wnnna$aIndian Manatee, West
=450  \\$wnnna$aIndian Manatees, West
=450  \\$aManatee, Caribbean
=450  \\$aManatee, Florida
=450  \\$aManatee, West Indian
=450  \\$wnnna$aManatees, Caribbean
=450  \\$wnnna$aManatees, Florida
=450  \\$wnnna$aManatees, West Indian
=450  \\$wnnna$amanatus, Trichechus
=450  \\$aWest Indian Manatee
=450  \\$wnnna$aWest Indian Manatees
=550  \\$wg$aTrichechus
=680  \\$iMember of the genus Trichechus inhabiting the coast and coastal rivers of the southeastern United States as well as the West Indies and the adjacent mainland from Vera Cruz, Mexico to northern South America. (From Scott, Concise Encyclopedia Biology, 1996)
=688  \\$a99
=750  \0$aTrichechus manatus$5IEN-M

=LDR  00975cz  a2200289n  4500
=001  9880364362302441
=005  20141212213703.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020305
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x815.$x550
=072  \\$aB1.$x50.$x150.$x900.$x248.$x870
=150  \\$aStrigiformes
=450  \\$wnnna$aBarn Owl
=450  \\$aBarn Owls
=450  \\$wnnna$aGreat Horned Owl
=450  \\$aGreat Horned Owls
=450  \\$wnnna$aOwl
=450  \\$wnnna$aOwl, Great Horned
=450  \\$aOwls
=450  \\$wnnna$aOwls, Great Horned
=450  \\$wnnna$aTyto alba
=550  \\$wg$aBirds
=550  \\$wg$aRaptors
=680  \\$iAn order of BIRDS with the common name owls characterized by strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks. While considered nocturnal RAPTORS, some owls do hunt by day.
=688  \\$a2005 (1999)
=750  \0$aOwls$0(DLC) sh 85096279$5IEN-M

=LDR  00887cz  a2200217n  4500
=001  9880364362402441
=005  20141212213534.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020116
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x622.$x509.$x700
=150  \\$aPepsinogen A
=450  \\$aPepsinogen
=450  \\$aPepsinogen 3, Group I
=450  \\$aPepsinogen 5, Group I
=450  \\$aPepsinogen I
=450  \\$aUropepsinogen
=550  \\$wg$aPepsinogens
=680  \\$iThis is one of 2 related pepsinogen systems in humans and is also known as pepsinogen. (The other is PEPSINOGEN C.) This includes isozymogens Pg1-Pg5 (pepsinogens 1-5, group I or products of PGA1-PGA5 genes). This is the main pepsinogen found in urine.
=688  \\$a99; for PEPSINOGEN use PEPSINOGENS 1972-98; for UROPEPSINOGEN use PEPSINOGEN A (NM) 1978-98
=750  \0$aPepsinogen$5IEN-M$0(DLC)sh 85099680

=LDR  01037cz  a2200253n  4500
=001  9880364362502441
=005  20141212213724.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020376
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x400
=072  \\$aB3.$x440.$x450.$x342.$x550
=072  \\$aB3.$x660.$x250.$x80.$x550
=150  \\$aDichelobacter nodosus
=450  \\$aBacteroides nodosus
=450  \\$aDichelobacter
=550  \\$wg$aCardiobacteriaceae
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$aDigital Dermatitis
=550  \\$aFoot Rot
=667  \\$ainfection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS and FOOT ROT or DIGITAL DERMATITIS if pertinent
=680  \\$iA gram-negative, obligate anaerobe of the family Cardiobacteriaceae. It has polar fimbriae and is the causative agent of FOOT ROT and DIGITAL DERMATITIS. It is the lone species in the genus Dichelobacter.
=688  \\$a99
=750  \0$aBacteroides nodosus$5IEN-M$0(DLC)sh 88023215

=LDR  02363cz  a2200553n  4500
=001  9880364362602441
=005  20141212213640.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020257
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x985
=072  \\$aG9.$x330.$x190.$x962.$x975
=150  \\$aVentricular Remodeling
=450  \\$aCardiac Remodeling, Ventricular
=450  \\$wnnna$aCardiac Remodelings, Ventricular
=450  \\$wnnna$aLeft Ventricle Remodeling
=450  \\$wnnna$aLeft Ventricle Remodelings
=450  \\$aLeft Ventricular Remodeling
=450  \\$wnnna$aLeft Ventricular Remodelings
=450  \\$aMyocardial Remodeling, Ventricular
=450  \\$wnnna$aMyocardial Remodelings, Ventricular
=450  \\$wnnna$aRemodeling, Left Ventricle
=450  \\$wnnna$aRemodeling, Left Ventricular
=450  \\$wnnna$aRemodeling, Ventricle
=450  \\$wnnna$aRemodeling, Ventricular
=450  \\$wnnna$aRemodeling, Ventricular Cardiac
=450  \\$wnnna$aRemodeling, Ventricular Myocardial
=450  \\$wnnna$aRemodelings, Left Ventricle
=450  \\$wnnna$aRemodelings, Left Ventricular
=450  \\$wnnna$aRemodelings, Ventricle
=450  \\$wnnna$aRemodelings, Ventricular
=450  \\$wnnna$aRemodelings, Ventricular Cardiac
=450  \\$wnnna$aRemodelings, Ventricular Myocardial
=450  \\$wnnna$aVentricle Remodeling
=450  \\$wnnna$aVentricle Remodeling, Left
=450  \\$wnnna$aVentricle Remodelings
=450  \\$wnnna$aVentricle Remodelings, Left
=450  \\$wnnna$aVentricular Cardiac Remodeling
=450  \\$wnnna$aVentricular Cardiac Remodelings
=450  \\$wnnna$aVentricular Myocardial Remodeling
=450  \\$wnnna$aVentricular Myocardial Remodelings
=450  \\$wnnna$aVentricular Remodeling, Left
=450  \\$wnnna$aVentricular Remodelings
=450  \\$wnnna$aVentricular Remodelings, Left
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wg$aVentricular Function
=680  \\$iThe geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.
=688  \\$a99
=750  \0$aVentricular remodeling$0(DLC) sh2005005706$5IEN-M

=LDR  01132cz  a2200325n  4500
=001  9880364362702441
=005  20141212213734.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020397
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x369.$x320
=072  \\$aA4.$x329.$x597.$x320
=072  \\$aA4.$x531.$x520.$x320
=072  \\$aA4.$x760.$x259
=072  \\$aA10.$x615.$x550.$x444.$x321
=072  \\$aA10.$x615.$x550.$x760.$x520.$x320
=072  \\$aA10.$x615.$x550.$x760.$x600.$x320
=072  \\$aA11.$x436.$x298
=150  \\$aGoblet Cells
=450  \\$wnnna$aCell, Goblet
=450  \\$wnnna$aCells, Goblet
=450  \\$wnnna$aGoblet Cell
=550  \\$wg$aEpithelial Cells
=550  \\$wg$aIntestinal Mucosa
=550  \\$wg$aLaryngeal Mucosa
=550  \\$wg$aNasal Mucosa
=550  \\$wg$aRespiratory Mucosa
=680  \\$iA glandular epithelial cell or a unicellular gland. Goblet cells secrete MUCUS. They are scattered in the epithelial linings of many organs, especially the SMALL INTESTINE and the RESPIRATORY TRACT.
=688  \\$a99
=750  \0$aExfoliative cytology$5IEN-M$0(DLC)sh 85046343

=LDR  00634cz  a2200181n  4500
=001  9880364362802441
=005  20141212213737.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020405
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA17.$x815.$x180
=150  \\$aDermis
=450  \\$aCorium
=550  \\$wg$aSkin
=550  \\$wh$aAcellular Dermis
=680  \\$iA layer of vascularized connective tissue underneath the EPIDERMIS. The surface of the dermis contains innervated papillae. Embedded in or beneath the dermis are SWEAT GLANDS; HAIR FOLLICLES; and SEBACEOUS GLANDS.
=688  \\$a99
=750  \0$aDermis$5IEN-M$0(DLC)sh 85037109

=LDR  01113cz  a2200265n  4500
=001  9880364362902441
=005  20190503152142.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020024
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x565
=072  \\$aD27.$x505.$x696.$x399.$x450.$x565
=150  \\$aLeukotriene Antagonists
=450  \\$wnnna$aAntagonists, Leukotriene
=450  \\$wnnna$aAntagonists, Leukotriene Receptor
=450  \\$aLeukotriene Receptor Antagonists
=450  \\$aLeukotrienes$xantagonists & inhibitors
=450  \\$wnnna$aReceptor Antagonists, Leukotriene
=450  \\$aReceptors, Leukotriene$xantagonists & inhibitors
=550  \\$wg$aHormone Antagonists
=680  \\$iA class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
=688  \\$a99
=750  \0$81$wb$iBroader mappingi$aLeukotrienes$0(DLC)sh 85076302$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAntagonists$0(DLC)(DLC) sh 99002348$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLeukotrienes--Antagonists$5IEN-M

=LDR  01225cz  a2200313n  4500
=001  9880364363102441
=005  20141212213531.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x80.$x85.$x543
=072  \\$aD3.$x383.$x725.$x50.$x85.$x543
=150  \\$aMilrinone
=450  \\$wnnna$aCorotrop
=450  \\$wnnna$aCorotrope
=450  \\$wnnna$aLactate, Milrinone
=450  \\$wnnna$aMilrinone Lactate
=450  \\$wnnna$aPrimacor
=450  \\$wnnna$aSanofi Brand of Milrinone Lactate
=450  \\$wnnna$aSanofi Synthelabo Brand of Milrinone
=450  \\$wnnna$aSanofi Synthelabo Brand of Milrinone Lactate
=450  \\$wnnna$aSanofi Winthrop Brand of Milrinone Lactate
=450  \\$wnnna$aWin-47203
=450  \\$wnnna$aWin 47203
=450  \\$wnnna$aWin47203
=550  \\$wg$aAmrinone
=680  \\$iA positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.
=688  \\$a99; use MILRINONE (NM) 1983-98
=750  \0$aMilrinone$5IEN-M$0(DLC)sh 85085440

=LDR  01272cz  a2200325n  4500
=001  9880364363202441
=005  20141212213534.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020117
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x277.$x135
=072  \\$aD2.$x241.$x223.$x100.$x50.$x500.$x700
=072  \\$aD2.$x241.$x223.$x100.$x100.$x135
=072  \\$aD2.$x241.$x223.$x100.$x200.$x374
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x20.$x937.$x700
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x85.$x135
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x250.$x374
=072  \\$aD3.$x383.$x621.$x135
=150  \\$aCisapride
=450  \\$wnnna$aPropulsid
=450  \\$wnnna$aR-51619
=450  \\$wnnna$aR 51619
=450  \\$wnnna$aR51619
=550  \\$wg$aBenzamides
=550  \\$wg$aChlorobenzoates
=550  \\$wg$apara-Aminobenzoates
=550  \\$wg$aPiperidines
=680  \\$iA substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
=688  \\$a99; use CISAPRIDE (NM) 1984-98
=750  \0$aCisapride$5IEN-M$0(DLC)sh 87006695

=LDR  00965cz  a2200229n  4500
=001  9880364363302441
=005  20141212213522.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020076
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x650
=150  \\$aPleurotus
=450  \\$wnnna$aMushroom, Oyster
=450  \\$wnnna$aMushrooms, Oyster
=450  \\$wnnna$aostreatus, Pleurotus
=450  \\$wnnna$aOyster Mushroom
=450  \\$aOyster Mushrooms
=450  \\$wnnna$aPleurotus ostreatus
=550  \\$wg$aAgaricales
=680  \\$iA genus of basidiomycetous fungi, family POLYPORACEAE, order POLYPORALES, that grows on logs or tree stumps in shelflike layers. The species P. ostreatus, the oyster mushroom, is a choice edible species and is the most frequently encountered member of the genus in eastern North America. (Alexopoulos et al., Introductory Mycology, 4th ed, p531)
=688  \\$a99
=750  \0$aPleurotus$5IEN-M$0(DLC)sh 85103514

=LDR  01736cz  a2200409n  4500
=001  9880364363402441
=005  20141212213707.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020315
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x600
=150  \\$aLatex Hypersensitivity
=450  \\$wnnna$aAllergies, Latex
=450  \\$wnnna$aAllergies, Rubber
=450  \\$wnnna$aAllergies, Rubber Latex
=450  \\$aAllergy, Latex
=450  \\$wnnna$aAllergy, Rubber
=450  \\$wnnna$aAllergy, Rubber Latex
=450  \\$wnnna$aHypersensitivities, Latex
=450  \\$aHypersensitivity, Latex
=450  \\$wnnna$aLatex Allergies
=450  \\$aLatex Allergy
=450  \\$wnnna$aLatex Hypersensitivities
=450  \\$wnnna$aNatural Rubber Latex Allergy
=450  \\$wnnna$aRubber Allergies
=450  \\$aRubber Allergy
=450  \\$wnnna$aRubber Latex Allergies
=450  \\$wnnna$aRubber Latex Allergy
=550  \\$wg$aHypersensitivity
=550  \\$aDermatitis, Allergic Contact
=550  \\$aHypersensitivity, Immediate
=550  \\$aLatex
=550  \\$aRubber
=667  \\$acoord with HYPERSENSITIVITY, IMMEDIATE or HYPERSENSITIVITY, DELAYED if pertinent
=680  \\$iAllergic reaction to products containing processed natural rubber latex such as rubber gloves, condoms, catheters, dental dams, balloons, and sporting equipment. Both T-cell mediated (HYPERSENSITIVITY, DELAYED) and IgE antibody-mediated (HYPERSENSITIVITY, IMMEDIATE) allergic responses are possible. Delayed hypersensitivity results from exposure to antioxidants present in the rubber; immediate hypersensitivity results from exposure to a latex protein.
=688  \\$a2002
=750  \0$aLatex allergy$0(DLC) sh2004000501$5IEN-M

=LDR  01084cz  a2200253n  4500
=001  9880364363502441
=005  20141212213735.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020400
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x800.$x875
=072  \\$aN4.$x590.$x374.$x142.$x600
=072  \\$aN4.$x590.$x374.$x410.$x875
=072  \\$aN5.$x300.$x262.$x600
=150  \\$aProvider-Sponsored Organizations
=450  \\$wnnna$aOrganization, Provider-Sponsored
=450  \\$wnnna$aOrganizations, Provider-Sponsored
=450  \\$wnnna$aProvider-Sponsored Organization
=450  \\$wnnna$aProvider Sponsored Organizations
=550  \\$wg$aDelivery of Health Care, Integrated
=550  \\$wg$aManaged Care Programs
=680  \\$iEntities sponsored by local hospitals, physician groups, and other licensed providers which are affiliated through common ownership or control and share financial risk whose purpose is to deliver health care services.
=688  \\$a99
=750  \0$aProvider-sponsored organizations (Medical care)$5IEN-M$0(DLC)sh 98003437

=LDR  01335cz  a2200337n  4500
=001  9880364363602441
=005  20141212213726.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020380
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x594
=072  \\$aN3.$x349.$x380.$x565
=072  \\$aN5.$x300.$x537
=150  \\$aNeeds Assessment
=450  \\$wnnna$aAssessment, Educational Needs
=450  \\$aAssessment of Health Care Needs
=450  \\$wnnna$aAssessment of Healthcare Needs
=450  \\$aDetermination of Health Care Needs
=450  \\$wnnna$aDetermination of Healthcare Needs
=450  \\$aEducational Needs Assessment
=450  \\$wnnna$aNeeds Assessment, Educational
=450  \\$wnnna$aNeeds Assessment, Healthcare
=450  \\$wnnna$aNeeds Assessments
=450  \\$wnnna$aNeeds Assessments, Educational
=450  \\$wnnna$aNeeds Assessments, Healthcare
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aEducation
=550  \\$wg$aHealth Services Research
=680  \\$iSystematic identification of a population's needs or the assessment of individuals to determine the proper level of services needed.
=688  \\$a99; ASSESSMENT OF HEALTH CARE NEEDS & DETERMINATION OF HEALTH CARE NEEDS use HEALTH SERVICES NEEDS AND DEMAND 1980-98
=750  \0$aNeeds assessment$5IEN-M$0(DLC)sh 87004128

=LDR  01519cz  a2200397n  4500
=001  9880364363702441
=005  20190528151329.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x300.$x250
=150  \\$aGinkgo biloba
=450  \\$wnnna$abiloba, Gingko
=450  \\$wnnna$abiloba, Ginkgo
=450  \\$wnnna$abilobas, Gingko
=450  \\$wnnna$abilobas, Ginkgo
=450  \\$aGingko
=450  \\$aGingko biloba
=450  \\$wnnna$aGingko bilobas
=450  \\$wnnna$aGingkos
=450  \\$aGinkgo
=450  \\$wnnna$aGinkgo bilobas
=450  \\$aGinkgophyta
=450  \\$wnnna$aGinkgophytas
=450  \\$wnnna$aGinkgos
=450  \\$wnnna$aGinko
=450  \\$wnnna$aGinkos
=450  \\$aMaidenhair Tree
=450  \\$wnnna$aMaidenhair Trees
=450  \\$wnnna$aTree, Maidenhair
=450  \\$wnnna$aTrees, Maidenhair
=550  \\$wg$aEmbryophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe only specie of the genus Ginkgo, family Ginkgoacea. It is the source of extracts of medicinal interest, especially Egb 761. Ginkgo may refer to the genus or species.
=688  \\$a99; for GINKGOPHYTA see GYMNOSPERMS 1998
=750  \0$aGinkgo$5IEN-M$0(DLC)sh 85054984

=LDR  00930cz  a2200241n  4500
=001  9880364363802441
=005  20141212213724.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020375
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x195
=150  \\$aEducation, Distance
=450  \\$wnnna$aCorrespondence Course
=450  \\$aCorrespondence Courses
=450  \\$wnnna$aCourse, Correspondence
=450  \\$aDistance Education
=450  \\$aDistance Learning
=450  \\$wnnna$aLearning, Distance
=550  \\$wg$aEducation
=667  \\$ado not confuse with COMPUTER-ASSISTED INSTRUCTION
=680  \\$iEducation via communication media (correspondence, radio, television, computer networks) with little or no in-person face-to-face contact between students and teachers. (ERIC Thesaurus, 1997)
=688  \\$a99; for CORRESPONDENCE COURSES see EDUCATION 1978-98
=750  \0$aDistance education$5IEN-M$0(DLC)sh 85038507

=LDR  00721cz  a2200205n  4500
=001  9880364363902441
=005  20141212213410.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019826
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x105.$x225.$x130
=072  \\$aD4.$x808.$x221.$x430.$x130
=150  \\$aCholic Acid
=450  \\$wnnna$aAcid, Cholic
=550  \\$wg$aCholic Acids
=550  \\$wh$aCholates
=667  \\$aCHOLIC ACIDS is available
=680  \\$iA major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.
=688  \\$a99; use CHOLIC ACID (NM) 1981-98
=750  \0$aCholic acid$5IEN-M$0(DLC)sh 85024655

=LDR  00899cz  a2200265n  4500
=001  9880364364002441
=005  20141212213527.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x300
=150  \\$aEntomophthorales
=450  \\$aBasidiobolus
=450  \\$aEntomophaga
=450  \\$wnnna$aEntomophagas
=450  \\$wnnna$aEntomophthorale
=450  \\$aZoophthora
=450  \\$wnnna$aZoophthoras
=550  \\$wg$aFungi, Unclassified
=550  \\$wh$aConidiobolus
=550  \\$wh$aEntomophthora
=667  \\$ainfection: coord IM with ZYGOMYCOSIS (IM)
=680  \\$iAn order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.
=688  \\$a99
=750  \0$aEntomophthorales$5IEN-M$0(DLC)sh 85044136

=LDR  00762cz  a2200205n  4500
=001  9880364364102441
=005  20141212213724.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020372
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x338
=150  \\$aDexfenfluramine
=450  \\$wnnna$aDexfenfluramine Hydrochloride
=450  \\$wnnna$aHydrochloride, Dexfenfluramine
=450  \\$wnnna$aRedux
=450  \\$wnnna$aWyeth Brand of Dexfenfluramine Hydrochloride
=550  \\$wg$aPhenethylamines
=680  \\$iThe S-isomer of FENFLURAMINE. It is a serotonin agonist and is used as an anorectic. Unlike fenfluramine, it does not possess any catecholamine agonist activity.
=688  \\$a99
=750  \0$aDexfenfluramine$5IEN-M$0(DLC)sh 96007010

=LDR  00880cz  a2200229n  4500
=001  9880364364202441
=005  20141212213518.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020064
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x700
=150  \\$aReduviidae
=450  \\$wnnna$aAssassin Bug
=450  \\$aAssassin Bugs
=450  \\$wnnna$aBug, Assassin
=450  \\$wnnna$aBugs, Assassin
=550  \\$wg$aHeteroptera
=550  \\$wh$aTriatominae
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iA family of winged insects of the suborder HETEROPTERA, called assassin bugs, because most prey on other insects. However one subfamily, TRIATOMINAE, attacks humans and other vertebrates and transmits Chagas disease.
=688  \\$a99; use TRIATOMINAE 1979-98
=750  \0$aAssassin bugs$5IEN-M$0(DLC)sh 85112151

=LDR  00706cz  a2200181n  4500
=001  9880364364302441
=005  20141212213517.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020063
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x150
=150  \\$aCimicidae
=550  \\$wg$aHeteroptera
=550  \\$wh$aBedbugs
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iA family of wingless, blood-sucking insects of the suborder HETEROPTERA, including the bedbugs and related forms. Cimex (BEDBUGS), Heamatosiphon, and Oeciacus are medically important genera. (From Dorland, 28th ed)
=688  \\$a99
=750  \0$aCimicidae$5IEN-M$0(DLC)sh 87020107

=LDR  00707cz  a2200193n  4500
=001  9880364364402441
=005  20141212213716.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020345
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x596.$x700
=072  \\$aC6.$x405.$x469.$x363.$x700
=150  \\$aEnterocolitis, Necrotizing
=450  \\$wnnna$aNecrotizing Enterocolitis
=550  \\$wg$aEnterocolitis
=550  \\$aTyphlitis
=680  \\$iENTEROCOLITIS with extensive ulceration (ULCER) and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT.
=688  \\$a99; use ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98
=750  \0$aEnterocolitis, Neonatal necrotizing$5IEN-M$0(DLC)sh 85044081

=LDR  02986cz  a2200673n  4500
=001  9880364364502441
=005  20141212213407.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019815
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x337.$x593.$x750
=150  \\$aOxalic Acid
=450  \\$wnnna$aAcid, Oxalic
=450  \\$wnnna$aAluminum Oxalate
=450  \\$wnnna$aAmmonium Oxalate
=450  \\$wnnna$aChromium (2+) Oxalate
=450  \\$wnnna$aChromium (3+) Oxalate (3:2)
=450  \\$wnnna$aChromium Oxalate
=450  \\$wnnna$aDiammonium Oxalate
=450  \\$wnnna$aDilithium Oxalate
=450  \\$wnnna$aDipotassium Oxalate
=450  \\$wnnna$aDisodium Oxalate
=450  \\$wnnna$aFerric Oxalate
=450  \\$wnnna$aIron (2+) Oxalate (1:1)
=450  \\$wnnna$aIron (3+) Oxalate
=450  \\$wnnna$aIron Oxalate
=450  \\$wnnna$aMagnesium Oxalate
=450  \\$wnnna$aMagnesium Oxalate (1:1)
=450  \\$wnnna$aManganese (2+) Oxalate (1:1)
=450  \\$wnnna$aMonoammonium Oxalate
=450  \\$wnnna$aMonohydrogen Monopotassium Oxalate
=450  \\$wnnna$aMonopotassium Oxalate
=450  \\$wnnna$aMonosodium Oxalate
=450  \\$wnnna$aOxalate, Aluminum
=450  \\$wnnna$aOxalate, Chromium
=450  \\$wnnna$aOxalate, Diammonium
=450  \\$wnnna$aOxalate, Dilithium
=450  \\$wnnna$aOxalate, Dipotassium
=450  \\$wnnna$aOxalate, Disodium
=450  \\$wnnna$aOxalate, Ferric
=450  \\$wnnna$aOxalate, Iron
=450  \\$wnnna$aOxalate, Magnesium
=450  \\$wnnna$aOxalate, Monoammonium
=450  \\$wnnna$aOxalate, Monohydrogen Monopotassium
=450  \\$wnnna$aOxalate, Monopotassium
=450  \\$wnnna$aOxalate, Monosodium
=450  \\$wnnna$aOxalate, Potassium
=450  \\$wnnna$aOxalate, Potassium Chromium
=450  \\$wnnna$aOxalate, Sodium
=450  \\$wnnna$aPotassium Chromium Oxalate
=450  \\$wnnna$aPotassium Oxalate
=450  \\$wnnna$aPotassium Oxalate (2:1)
=450  \\$wnnna$aSodium Oxalate
=550  \\$wg$aOxalates
=550  \\$wh$aCalcium Oxalate
=680  \\$iA strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.
=688  \\$a1999; for ALUMINUM OXALATE, CHROMIUM OXALATE, DIPOTASSIUM OXALATE, POTASSIUM CHROMIUM OXALATE, and SODIUM OXALATE use OXALATES 1992-2012; for AMMONIUM OXALATE, CHROMIUM (2+) OXALATE, CHROMIUM (3+) OXALATE (3:2), DIAMMONIUM OXALATE, DILITHIUM OXALATE, DISODIUM OXALATE, IRON (2+) OXALATE (1:1), IRON (3+) OXALATE, IRON OXALATE, MAGNESIUM OXALATE (1:1), MANGANESE (2+) OXALATE (1:1), MONOAMMONIUM OXALATE, MONOPOTASSIUM OXALATE, MONOSODIUM OXALATE, POTASSIUM OXALATE, and POTASSIUM OXALATE (2:1) use OXALATES 1999-2012
=688  \\$a99; use OXALIC ACID (NM) 1981-98
=750  \0$aOxalic acid$5IEN-M$0(DLC)sh 85096288

=LDR  01674cz  a2200397n  4500
=001  9880364364602441
=005  20141212213729.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020387
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x250
=072  \\$aN6.$x230.$x124.$x250
=150  \\$aFood Chain
=450  \\$wnnna$aChain, Food
=450  \\$wnnna$aChain, Parasite
=450  \\$wnnna$aChain, Predator
=450  \\$wnnna$aChain, Saprophytic
=450  \\$wnnna$aChains, Food
=450  \\$wnnna$aChains, Parasite
=450  \\$wnnna$aChains, Predator
=450  \\$wnnna$aChains, Saprophytic
=450  \\$wnnna$aFood Chains
=450  \\$aFood Web
=450  \\$wnnna$aFood Webs
=450  \\$aParasite Chain
=450  \\$wnnna$aParasite Chains
=450  \\$aPredator Chain
=450  \\$wnnna$aPredator Chains
=450  \\$aSaprophytic Chain
=450  \\$wnnna$aSaprophytic Chains
=450  \\$wnnna$aWeb, Food
=450  \\$wnnna$aWebs, Food
=550  \\$wg$aEcosystem
=680  \\$iThe sequence of transfers of matter and energy from organism to organism in the form of FOOD. Food chains intertwine locally into a food web because most organisms consume more than one type of animal or plant. PLANTS, which convert SOLAR ENERGY to food by PHOTOSYNTHESIS, are the primary food source. In a predator chain, a plant-eating animal is eaten by a larger animal. In a parasite chain, a smaller organism consumes part of a larger host and may itself be parasitized by smaller organisms. In a saprophytic chain, microorganisms live on dead organic matter.
=688  \\$a99
=750  \0$aFood chains (Ecology)$5IEN-M$0(DLC)sh 85050265

=LDR  00931cz  a2200253n  4500
=001  9880364364702441
=005  20141212213755.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x630.$x490.$x400
=072  \\$aM1.$x526.$x485.$x740.$x422.$x400
=072  \\$aM1.$x526.$x485.$x810.$x580
=072  \\$aN2.$x360.$x630.$x490.$x400
=072  \\$aN2.$x360.$x740.$x422.$x400
=072  \\$aN2.$x360.$x810.$x580
=150  \\$aHospitalists
=450  \\$wnnna$aHospitalist
=550  \\$wg$aMedical Staff, Hospital
=550  \\$wg$aPhysicians
=550  \\$aHospital Medicine
=680  \\$iPhysicians who are employed to work exclusively in hospital settings, primarily for managed care organizations. They are the attending or primary responsible physician for the patient during hospitalization.
=688  \\$a99
=750  \0$aHospitalists$0(DLC)sh2007007319$5IEN-M

=LDR  00795cz  a2200181n  4500
=001  9880364364802441
=005  20200508134839.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x998
=150  \\$aSirenia
=550  \\$wg$aEutheria
=550  \\$wh$aDugong
=550  \\$wh$aTrichechus
=680  \\$iAn order of heavy-bodied, slow-moving, completely aquatic, herbivorous mammals. The body is fusiform, plump, and hairless, except for bristles on the snout. Hindlimbs are absent, the forelimbs are modified to flippers, and the tail is a horizontal fluke. (From Scott, Concise Encyclopedia Biology, 1996)
=688  \\$a99; 63-97; use MAMMALS 1998; use SIRENIA 1963-67
=750  \0$aSirenia$5IEN-M$0(DLC)sh 85122967

=LDR  01007cz  a2200313n  4500
=001  9880364364902441
=005  20141212213716.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020346
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x500.$x40
=072  \\$aD12.$x776.$x543.$x550.$x425.$x730.$x40
=072  \\$aD12.$x776.$x543.$x585.$x400.$x730.$x40
=150  \\$aAquaporins
=450  \\$wnnna$aChannel Proteins, Water
=450  \\$wnnna$aChannels, Water
=450  \\$wnnna$aProteins, Water Channel
=450  \\$aWater Channel Proteins
=450  \\$aWater Channels
=550  \\$wg$aPorins
=550  \\$wh$aAquaglyceroporins
=550  \\$wh$aAquaporin 1
=550  \\$wh$aAquaporin 2
=550  \\$wh$aAquaporin 4
=550  \\$wh$aAquaporin 5
=667  \\$ageneral; prefer specifics
=680  \\$iA class of porins that allow the passage of WATER and other small molecules across CELL MEMBRANES.
=688  \\$a99
=750  \0$aAquaporins$5IEN-M$0(DLC)sh2001010899

=LDR  00957cz  a2200181n  4500
=001  9880364365002441
=005  20141212213758.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020452
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x498
=150  \\$aJournalism
=550  \\$wg$aPublishing
=550  \\$wh$aJournalism, Dental
=550  \\$wh$aJournalism, Medical
=680  \\$iThe collection, preparation, and distribution of news and related commentary and feature materials through such media as pamphlets, newsletters, newspapers, magazines, radio, motion pictures, television, and books. While originally applied to the reportage of current events in printed form, specifically newspapers, with the advent of radio and television the use of the term has broadened to include all printed and electronic communication dealing with current affairs.
=688  \\$a99; see JOURNALISM, MEDICAL 1994-97
=750  \0$aJournalism$5IEN-M$0(DLC)sh 85070736

=LDR  01034cz  a2200301n  4500
=001  9880364365102441
=005  20141212213544.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020148
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x750
=072  \\$aD10.$x251.$x400.$x143.$x500
=150  \\$aButyric Acid
=450  \\$wnnna$aAcid, Butanoic
=450  \\$wnnna$aAcid, Butyric
=450  \\$wnnna$aButanoic Acid
=450  \\$wnnna$aButyrate, Magnesium
=450  \\$wnnna$aButyrate, Sodium
=450  \\$wnnna$aButyric Acid Magnesium Salt
=450  \\$wnnna$aButyric Acid, Sodium Salt
=450  \\$wnnna$aDibutyrate, Magnesium
=450  \\$wnnna$aMagnesium Butyrate
=450  \\$wnnna$aMagnesium Dibutyrate
=450  \\$wnnna$aSodium Butyrate
=550  \\$wg$aButyrates
=680  \\$iA four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
=688  \\$a99; use BUTYRIC ACID (NM) 1981-98
=750  \0$aButyric acid$5IEN$0(DLC)sh 85018405

=LDR  01035cz  a2200205n  4500
=001  9880364365202441
=005  20141212213515.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x214.$x600
=150  \\$aPfiesteria piscicida
=450  \\$wnnna$aPfiesteria piscicidas
=450  \\$wnnna$apiscicida, Pfiesteria
=450  \\$wnnna$apiscicidas, Pfiesteria
=550  \\$wg$aDinoflagellida
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA dinoflagellate with a life cycle that includes numerous flagellated, amoeboid, and encysted stages. Both the flagellated and amoeboid forms produce toxins which cause open wounds on fish. Pfiesteria piscicida feeds on tissue sloughed from these wounds, as well as on bacteria and algae. It is found in Atlantic estuaries of the United States.
=688  \\$a99
=750  \0$aPfiesteria piscicida$5IEN-M$0(DLC)sh 98004253

=LDR  01287cz  a2200325n  4500
=001  9880364365302441
=005  20141212213727.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020382
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x518
=072  \\$aD12.$x776.$x467.$x374.$x465.$x518
=072  \\$aD23.$x529.$x374.$x465.$x518
=150  \\$aInterleukin-18
=450  \\$wnnna$aIFN-gamma Inducing Factor
=450  \\$aIFN-gamma-Inducing Factor
=450  \\$wnnna$aIFN gamma Inducing Factor
=450  \\$aIL-18
=450  \\$wnnna$aIL18
=450  \\$wnnna$aInducing Factor, IFN-gamma
=450  \\$wnnna$aInducing Factor, Interferon-gamma
=450  \\$wnnna$aInterferon-gamma Inducing Factor
=450  \\$aInterferon-gamma-Inducing Factor
=450  \\$wnnna$aInterferon gamma Inducing Factor
=450  \\$wnnna$aInterleukin 18
=550  \\$wg$aInterleukins
=667  \\$aDF: IL18
=680  \\$iA cytokine which resembles IL-1 structurally and IL-12 functionally. It enhances the cytotoxic activity of NK CELLS and CYTOTOXIC T-LYMPHOCYTES, and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity.
=688  \\$a99; use INTERLEUKIN-18 (NM) 1995-98
=750  \0$aInterleukin-18$0(DLC)sh2011005577$5IEN-M

=LDR  00721cz  a2200181n  4500
=001  9880364365402441
=005  20141212213549.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020160
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x120.$x500
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x117.$x500
=150  \\$aSodium Benzoate
=450  \\$wnnna$aBenzoate, Sodium
=550  \\$wg$aBenzoic Acid
=680  \\$iThe sodium salt of BENZOIC ACID. It is used as an antifungal preservative in pharmaceutical preparations and foods. It may also be used as a test for liver function.
=688  \\$a99; for SODIUM BENZOATE use BENZOIC ACID (NM) 1980-98
=750  \0$aSodium benzoate$5IEN-M$0(DLC)sh 85124256

=LDR  00796cz  a2200205n  4500
=001  9880364365502441
=005  20141212213704.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020307
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x250.$x200
=072  \\$aB1.$x50.$x150.$x900.$x248.$x815.$x350.$x200
=150  \\$aEagles
=450  \\$aAquila
=450  \\$wnnna$aEagle
=450  \\$aHaliaeetus
=550  \\$wg$aFalconiformes
=680  \\$iLarge members of the FALCONIFORMES order of birds, family Accipitridae, most especially the genera Aquila, Haliaeetus, Harpia, and Circaetus. They are characterized by their powerful talons, which carry long, curved, pointed claws and by their opposable hindtoe.
=688  \\$a1999
=750  \0$aEagles$0(DLC) sh 85040377$5IEN-M

=LDR  00718cz  a2200217n  4500
=001  9880364365602441
=005  20141212213707.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020317
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x705.$x790
=150  \\$aSalmo salar
=450  \\$aAtlantic Salmon
=450  \\$wnnna$aAtlantic Salmons
=450  \\$wnnna$asalar, Salmo
=450  \\$aSalmon, Atlantic
=450  \\$wnnna$aSalmons, Atlantic
=550  \\$wg$aSalmon
=680  \\$iA commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.
=688  \\$a1999
=750  \0$aAtlantic salmon$5IEN-M$0(DLC)sh 85009204

=LDR  00997cz  a2200277n  4500
=001  9880364365702441
=005  20141212213736.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020402
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x170.$x650
=072  \\$aN3.$x219.$x521.$x576.$x90.$x650
=072  \\$aN3.$x219.$x521.$x576.$x343.$x830
=072  \\$aN3.$x219.$x559.$x500
=150  \\$aMedical Savings Accounts
=450  \\$wnnna$aAccount, Medical Savings
=450  \\$wnnna$aAccounts, Medical Savings
=450  \\$wnnna$aMedical Savings Account
=450  \\$wnnna$aSavings Account, Medical
=450  \\$aSavings Accounts, Medical
=550  \\$wg$aCost Sharing
=550  \\$wg$aFinancing, Personal
=550  \\$wg$aInsurance, Health
=680  \\$iTax-exempt trusts or custodial accounts established by individuals with financial institutions for saving money for future medical expenses.
=688  \\$a99
=750  \0$aMedical savings accounts$5IEN-M$0(DLC)sh 97006820

=LDR  00685cz  a2200229n  4500
=001  9880364365802441
=005  20141212213741.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020415
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x245.$x600
=072  \\$aN4.$x452.$x677.$x450
=150  \\$aPersonnel Downsizing
=450  \\$wnnna$aDownsizing, Personnel
=450  \\$aDownsizing, Staff
=450  \\$aRightsizing
=450  \\$aStaff Downsizing
=550  \\$wg$aEmployment
=550  \\$wg$aPersonnel Management
=680  \\$iReducing staff to cut costs or to achieve greater efficiency.
=688  \\$a99
=750  \0$aDownsizing of organizations$5IEN-M$0(DLC)sh 94001979

=LDR  00767cz  a2200229n  4500
=001  9880364365902441
=005  20141212213519.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x91.$x700
=072  \\$aC23.$x888.$x646.$x130.$x700
=072  \\$aC23.$x888.$x646.$x793
=150  \\$aShoulder Pain
=450  \\$wnnna$aPain, Shoulder
=450  \\$wnnna$aPains, Shoulder
=450  \\$wnnna$aShoulder Pains
=550  \\$wg$aArthralgia
=550  \\$wg$aPain
=680  \\$iUnilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.
=688  \\$a99
=750  \0$aShoulder pain$5IEN-M$0(DLC)sh 90002048

=LDR  00669cz  a2200217n  4500
=001  9880364366002441
=005  20141212213733.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020393
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x779.$x867.$x466
=150  \\$aManipulation, Spinal
=450  \\$aCervical Manipulation
=450  \\$aLumbar Manipulation
=450  \\$wnnna$aManipulation, Cervical
=450  \\$wnnna$aManipulation, Lumbar
=450  \\$aSpinal Manipulation
=550  \\$wg$aMusculoskeletal Manipulations
=680  \\$iAdjustment and manipulation of the vertebral column.
=688  \\$a1999
=750  \0$aSpinal adjustment$5IEN-M$0(DLC)sh 85126662

=LDR  02077cz  a2200553n  4500
=001  9880364366102441
=005  20141212213654.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020280
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x705.$x800
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x845.$x800
=072  \\$aD4.$x615.$x638.$x845.$x800
=150  \\$aSertraline
=450  \\$wnnna$aAltruline
=450  \\$wnnna$aApo-Sertraline
=450  \\$wnnna$aApo Sertraline
=450  \\$wnnna$aApotex Brand of Sertraline Hydrochloride
=450  \\$wnnna$aAremis
=450  \\$wnnna$aBesitran
=450  \\$wnnna$aBoehringer Ingelheim Brand of Sertraline Hydrochloride
=450  \\$wnnna$aEsteve Brand of Sertraline Hydrochloride
=450  \\$wnnna$aGen-Sertraline
=450  \\$wnnna$aGen Sertraline
=450  \\$wnnna$aGenpharm Brand of Sertraline Hydrochloride
=450  \\$wnnna$aGladem
=450  \\$wnnna$aHydrochloride, Sertraline
=450  \\$wnnna$aLacer Brand of Sertraline Hydrochloride
=450  \\$wnnna$aLustral
=450  \\$wnnna$aNovo-Sertraline
=450  \\$wnnna$aNovo Sertraline
=450  \\$wnnna$aNovopharm Brand of Sertraline Hydrochloride
=450  \\$wnnna$aParke Davis Brand of Sertraline Hydrochloride
=450  \\$wnnna$aPfizer Brand of Sertraline Hydrochloride
=450  \\$wnnna$aratio-Sertraline
=450  \\$wnnna$aratio Sertraline
=450  \\$wnnna$aRatiopharm Brand of Sertraline Hydrochloride
=450  \\$wnnna$aRhoxal-sertraline
=450  \\$wnnna$aRhoxal sertraline
=450  \\$wnnna$aRhoxalpharma Brand of Sertraline Hydrochloride
=450  \\$wnnna$aRoerig Brand of Sertraline Hydrochloride
=450  \\$wnnna$aSealdin
=450  \\$wnnna$aSertraline Hydrochloride
=450  \\$wnnna$aSertraline Hydrochloride (1S-cis)-Isomer
=450  \\$wnnna$aZoloft
=550  \\$wg$a1-Naphthylamine
=680  \\$iA selective serotonin uptake inhibitor that is used in the treatment of depression.
=688  \\$a99; use SERTRALINE (NM) 1983-98
=750  \0$aSertraline$5IEN-M$0(DLC)sh 93006171

=LDR  01246cz  a2200313n  4500
=001  9880364366202441
=005  20141212213655.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020285
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x402.$x150
=072  \\$aE5.$x595.$x402.$x150
=150  \\$aCryoelectron Microscopy
=450  \\$wnnna$aCryo-electron Microscopies
=450  \\$wnnna$aCryo-electron Microscopy
=450  \\$wnnna$aCryo electron Microscopy
=450  \\$wnnna$aCryoelectron Microscopies
=450  \\$wnnna$aCryomicroscopies, Electron
=450  \\$wnnna$aCryomicroscopy, Electron
=450  \\$wnnna$aElectron Cryomicroscopies
=450  \\$aElectron Cryomicroscopy
=450  \\$wnnna$aMicroscopies, Cryo-electron
=450  \\$wnnna$aMicroscopies, Cryoelectron
=450  \\$wnnna$aMicroscopy, Cryo-electron
=450  \\$wnnna$aMicroscopy, Cryoelectron
=550  \\$wg$aMicroscopy, Electron
=680  \\$iElectron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains.
=688  \\$a99
=750  \0$aCryomicroscopy$5IEN-M$0(DLC)sh 91006257

=LDR  00542cz  a2200169n  4500
=001  9880364366302441
=005  20141212213554.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020171
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x128
=150  \\$aBotrytis
=450  \\$wnnna$aBotryti
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic Leotiales fungal genus of plant pathogens. It has teleomorphs in the genus Botryotina.
=688  \\$a99; use MITOSPORIC FUNGI 1975-98
=750  \0$aBotrytis$5IEN-M$0(DLC)sh 85016033

=LDR  00925cz  a2200289n  4500
=001  9880364366402441
=005  20141212213756.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x207
=150  \\$aFitness Centers
=450  \\$wnnna$aCenter, Fitness
=450  \\$wnnna$aCenter, Wellness
=450  \\$wnnna$aCenters, Fitness
=450  \\$wnnna$aCenters, Wellness
=450  \\$wnnna$aClub, Health
=450  \\$wnnna$aClubs, Health
=450  \\$wnnna$aFitness Center
=450  \\$wnnna$aHealth Club
=450  \\$aHealth Clubs
=450  \\$wnnna$aWellness Center
=450  \\$aWellness Centers
=550  \\$wg$aHealth Facilities
=680  \\$iFacilities having programs intended to promote and maintain a state of physical well-being for optimal performance and health.
=688  \\$a99
=750  \0$aPhysical fitness centers$5IEN-M$0(DLC)sh 85101545

=LDR  01158cz  a2200301n  4500
=001  9880364366502441
=005  20141212213545.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020151
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x100.$x100.$x690
=072  \\$aC15.$x378.$x147.$x880
=072  \\$aC15.$x378.$x925.$x795
=072  \\$aC16.$x320.$x99.$x690
=150  \\$aProtein C Deficiency
=450  \\$wnnna$aDeficiencies, Protein C
=450  \\$wnnna$aDeficiency, Protein C
=450  \\$wnnna$aHereditary Thrombophilia Due To Protein C Deficiency
=450  \\$wnnna$aProtein C Deficiencies
=450  \\$aProtein C$xdeficiency
=550  \\$wg$aBlood Coagulation Disorders, Inherited
=550  \\$wg$aBlood Protein Disorders
=550  \\$wg$aThrombophilia
=550  \\$aActivated Protein C Resistance
=667  \\$aDF: PROTEIN C DEFIC
=680  \\$iAn absence or deficiency in PROTEIN C which leads to impaired regulation of blood coagulation. It is associated with an increased risk of severe or premature thrombosis. (Stedman's Med. Dict., 26th ed.)
=688  \\$a99
=750  \0$aProtein C deficiency$5IEN-M$0(DLC)sh 87007324

=LDR  00618cz  a2200181n  4500
=001  9880364366602441
=005  20141212213705.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020310
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x600.$x800
=150  \\$aStruthioniformes
=450  \\$aOstriches
=550  \\$wg$aPalaeognathae
=667  \\$aOSTRICH, AMERICAN see RHEIFORMES is available
=680  \\$iAn order of flightless birds comprising the ostriches, which naturally inhabit open, low rainfall areas of Africa.
=688  \\$a2005 (1999)
=750  \0$aOstriches$0(DLC) sh 85096012$5IEN-M

=LDR  00652cz  a2200169n  4500
=001  9880364366702441
=005  20141212213622.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020219
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377.$x625.$x180
=072  \\$aG11.$x427.$x590.$x560.$x180
=150  \\$aChondrogenesis
=550  \\$wg$aMusculoskeletal Development
=680  \\$iThe formation of cartilage. This process is directed by CHONDROCYTES which continually divide and lay down matrix during development. It is sometimes a precursor to OSTEOGENESIS.
=688  \\$a99
=750  \0$aChondrogenesis$5IEN-M$0(DLC)sh 85024681

=LDR  00964cz  a2200241n  4500
=001  9880364366802441
=005  20161116104721.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x110.$x500
=150  \\$aInternet
=450  \\$wnnna$aInternets
=450  \\$wnnna$aMessaging, Twitter
=450  \\$wnnna$aWeb, World Wide
=450  \\$wnnna$aWide Web, World
=450  \\$aWorld Wide Web
=550  \\$wg$aComputer Communication Networks
=550  \\$wh$aBlogging
=550  \\$wh$aSocial Media
=680  \\$iA loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.
=688  \\$a99; see COMPUTER COMMUNICATION NETWORKS 1996-98
=750  \0$aInternet (Computer network)$5IEN-M

=LDR  01606cz  a2200481n  4500
=001  9880364366902441
=005  20141212213704.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020308
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750
=150  \\$aSongbirds
=450  \\$aEremophila alpestris
=450  \\$wnnna$aFlycatcher
=450  \\$aFlycatchers
=450  \\$aHorned Lark
=450  \\$wnnna$aHorned Larks
=450  \\$wnnna$aLark, Horned
=450  \\$wnnna$aLarks, Horned
=450  \\$wnnna$aOscine
=450  \\$aOscines
=450  \\$wnnna$aRobin
=450  \\$aRobins
=450  \\$wnnna$aSongbird
=450  \\$aThrushes
=450  \\$wnnna$aTroglodytidae
=450  \\$wnnna$aTroglodytinae
=450  \\$aTurdidae
=450  \\$wnnna$aWarbler
=450  \\$wnnna$aWarblers
=450  \\$wnnna$aWren
=450  \\$aWrens
=550  \\$wg$aPasseriformes
=550  \\$wh$aCrows
=550  \\$wh$aFinches
=550  \\$wh$aSparrows
=550  \\$wh$aStarlings
=550  \\$wh$aSwallows
=550  \\$aHigh Vocal Center
=667  \\$aprefer specifics; X ref EREMOPHILA ALPESTRIS: EREMOPHILA PLANT and EREMOPHILUS MUTISII see CATFISHES are also available
=680  \\$iPASSERIFORMES of the suborder, Oscines, in which the flexor tendons of the toes are separate, and the lower syrinx has 4 to 9 pairs of tensor muscles inserted at both ends of the tracheal half rings. They include many commonly recognized birds such as CROWS; FINCHES; robins; SPARROWS; and SWALLOWS.
=688  \\$a1999
=750  \0$aSongbirds$5IEN-M$0(DLC)sh 92001070

=LDR  00692cz  a2200193n  4500
=001  9880364367002441
=005  20141212213705.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020312
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x600.$x200
=150  \\$aDromaiidae
=450  \\$wnnna$aDromaius novaehollandiae
=450  \\$wnnna$aEmu
=450  \\$aEmus
=550  \\$wg$aPalaeognathae
=680  \\$iA family of flightless, running BIRDS, in the order Casuariiformes. The emu is the only surviving member of the family. They naturally inhabit forests, open plains, and grasslands in Australia.
=688  \\$a2005 (1999)
=750  \0$aEmus$0(DLC) sh 85042952$5IEN-M

=LDR  01004cz  a2200265n  4500
=001  9880364367102441
=005  20141212213758.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020454
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x879.$x125
=150  \\$aDugong
=450  \\$wnnna$aCow, Sea
=450  \\$wnnna$aCows, Sea
=450  \\$wnnna$adugon, Dugong
=450  \\$aDugong dugon
=450  \\$wnnna$aDugong dugong
=450  \\$wnnna$adugong, Dugong
=450  \\$aDugongs
=450  \\$wnnna$aSea Cow
=450  \\$aSea Cows
=550  \\$wg$aSirenia
=680  \\$iA genus of the order Sirenia characterized by a notched tail, the presence of nasal bones and a long nasal cavity, and large columnar teeth lacking enamel. Dugongs inhabit the coastal waters of the Indian Ocean, Red Sea, and the Malay Archipelago. (From Scott, Concise Encyclopedia Biology, 1996)
=688  \\$a99; for DUGONGS & SEA COWS use MAMMALS 1998
=750  \0$aDugong$5IEN-M$0(DLC)sh 85039921

=LDR  00710cz  a2200181n  4500
=001  9880364367202441
=005  20141212213528.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020094
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x500.$x480
=150  \\$aMortierella
=450  \\$wnnna$aMortierellas
=550  \\$wg$aMucorales
=667  \\$ainfection: coord IM with MUCORMYCOSIS (IM)
=680  \\$iA genus of zygomycetous fungi of the family Mortierellaceae, order MUCORALES. Its species are abundant in soil and can cause rare infections in humans and animals. Mortierella alpinais is used for production of arachidonic acid.
=688  \\$a99
=750  \0$aMortierella$5IEN-M$0(DLC)sh 88021895

=LDR  01215cz  a2200325n  4500
=001  9880364367302441
=005  20141212213533.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020113
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x625.$x555
=150  \\$aPhenolphthalein
=450  \\$wnnna$aAp-La-Day
=450  \\$wnnna$aEx-Lax
=450  \\$wnnna$aFeen-A-Mint
=450  \\$wnnna$aKey Brand of Phenolphthalein
=450  \\$wnnna$aLaxatone
=450  \\$wnnna$aLaxettes
=450  \\$wnnna$aManesco Brand of Phenolphthalein
=450  \\$wnnna$aMentholatum Brand of Phenolphthalein
=450  \\$wnnna$aModane
=450  \\$wnnna$aNovartis Brand of Phenolphthalein
=450  \\$wnnna$aSchering-Plough Brand of Phenolphthalein
=450  \\$wnnna$aThalinol
=450  \\$wnnna$aThompson Brand of Phenolphthalein
=550  \\$wg$aPhenolphthaleins
=667  \\$aPHENOLPHTHALEINS is also available
=680  \\$iAn acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.
=688  \\$a99; use PHENOLPHTHALEIN (NM) 1983-98
=750  \0$aPhenolphthalein$5IEN$0(DLC)sh 85100674

=LDR  00673cz  a2200193n  4500
=001  9880364367402441
=005  20141212213521.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020074
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x100.$x515
=150  \\$aLentinula
=450  \\$wnnna$aLentinulas
=450  \\$aLentinus
=550  \\$wg$aAgaricales
=550  \\$wh$aShiitake Mushrooms
=680  \\$iA genus of fungi of the family Tricholomataceae, order AGARICALES. The commonly known SHIITAKE MUSHROOMS are Lentinula edodes (also seen as Lentinus edodes).
=688  \\$a2005 (1999); use POLYPORACEAE 1986-98
=750  \0$aLentinus$0(DLC) sh 85076012$5IEN-M

=LDR  00817cz  a2200217n  4500
=001  9880364367502441
=005  20141212213521.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020075
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120.$x760.$x649
=150  \\$aPhanerochaete
=450  \\$wnnna$achrysosporium, Phanerochaete
=450  \\$wnnna$achrysosporiums, Phanerochaete
=450  \\$wnnna$aPhanerochaete chrysosporium
=450  \\$wnnna$aPhanerochaete chrysosporiums
=450  \\$wnnna$aPhanerochaetes
=550  \\$wg$aPolyporaceae
=680  \\$iA genus of fungi in the family Corticiaceae, order Stereales, that degrades lignin. The white-rot fungus Phanerochaete chrysosporium is a frequently used species in research.
=688  \\$a99
=750  \0$aPhanerochaete$0(DLC) sh 85100569$5IEN-M

=LDR  00763cz  a2200181n  4500
=001  9880364367602441
=005  20141212213532.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x122.$x15
=072  \\$aD2.$x241.$x81.$x69.$x94.$x15
=150  \\$aAcrylamide
=550  \\$wg$aAcrylamides
=667  \\$aACRYLAMIDES is also available
=680  \\$iA colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile. It is primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries.
=688  \\$a99; use ACRYLAMIDE (NM) 1982-98
=750  \0$aAcrylamide$5IEN-M$0(DLC)sh 87000368

=LDR  02798cz  a2200589n  4500
=001  9880364367702441
=005  20141212192932.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020419
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x850.$x625.$x670
=072  \\$aA8.$x675.$x650.$x915.$x937.$x670
=072  \\$aA8.$x800.$x950.$x937.$x670
=072  \\$aA9.$x371.$x729.$x831.$x625.$x670
=072  \\$aA11.$x671.$x650.$x850.$x625.$x670
=072  \\$aA11.$x671.$x650.$x915.$x937.$x670
=150  \\$aPhotoreceptor Cells, Vertebrate
=450  \\$wnnna$aCell, Retinal Photoreceptor
=450  \\$wnnna$aCell, Vertebrate Photoreceptor
=450  \\$wnnna$aCells, Retinal Photoreceptor
=450  \\$wnnna$aCells, Vertebrate Photoreceptor
=450  \\$wnnna$aCones and Rods
=450  \\$wnnna$aPhotoreceptor Cell, Retinal
=450  \\$wnnna$aPhotoreceptor Cell, Vertebrate
=450  \\$wnnna$aPhotoreceptor Cells, Retinal
=450  \\$wnnna$aPhotoreceptor, Retinal
=450  \\$wnnna$aPhotoreceptor, Vertebrate
=450  \\$wnnna$aPhotoreceptors, Retinal
=450  \\$wnnna$aPhotoreceptors, Vertebrate
=450  \\$wnnna$aRetinal Photoreceptor
=450  \\$wnnna$aRetinal Photoreceptor Cell
=450  \\$aRetinal Photoreceptor Cells
=450  \\$wnnna$aRetinal Photoreceptors
=450  \\$aRods and Cones
=450  \\$wnnna$aVertebrate Photoreceptor
=450  \\$wnnna$aVertebrate Photoreceptor Cell
=450  \\$wnnna$aVertebrate Photoreceptor Cells
=450  \\$wnnna$aVertebrate Photoreceptors
=550  \\$wg$aPhotoreceptor Cells
=550  \\$wh$aPhotoreceptor Connecting Cilium
=550  \\$wh$aRetinal Cone Photoreceptor Cells
=550  \\$wh$aRetinal Photoreceptor Cell Inner Segment
=550  \\$wh$aRetinal Photoreceptor Cell Outer Segment
=550  \\$wh$aRetinal Rod Photoreceptor Cells
=550  \\$aVision, Ocular
=680  \\$iSpecialized PHOTOTRANSDUCTION neurons in the vertebrates, such as the RETINAL ROD CELLS and the RETINAL CONE CELLS. Non-visual photoreceptor neurons have been reported in the deep brain, the PINEAL GLAND and organs of the circadian system.
=688  \\$a2009 (1999); use PHOTORECEPTORS 1997-1998; for RODS AND CONES use PHOTORECEPTORS 1966-1998; for RETINAL PHOTORECEPTORS use PHOTORECEPTORS 1997-2008
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Photoreceptors, Vertebrate
=688  \\$a99; use PHOTORECEPTORS 1997-98; for RODS AND CONES use PHOTORECEPTORS 1966-98
=750  \0$81$wb$aVertebrates$xPhysiology$0(DLC) sh sh 85142905$5IEN-M$0(DLC)sh 85142905
=750  \0$81$wb$aPhotoreceptors$0(DLC) sh 85101407$5IEN-M$0(DLC)sh 85101407
=788  \0$iSearch also under the following headings used together in the same record:$aPhotoreceptors$iand$aVertebrates--Physiology$5IEN-M

=LDR  01018cz  a2200277n  4500
=001  9880364367802441
=005  20141212213407.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019817
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x120
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x117
=150  \\$aBenzoic Acid
=450  \\$wnnna$aAcid, Benzoic
=450  \\$wnnna$aBenzoate, Potassium
=450  \\$wnnna$aKendall Brand of Benzoic Acid Sodium Salt
=450  \\$wnnna$aPotassium Benzoate
=450  \\$wnnna$aUcephan
=550  \\$wg$aBenzoates
=550  \\$wh$aSodium Benzoate
=550  \\$aLindera
=667  \\$aBENZOIC ACIDS see BENZOATES is also available
=680  \\$iA fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid.
=688  \\$a1999; for POTASSIUM BENZOATE use BENZOATES 1999-2012
=688  \\$a99; use BENZOIC ACID (NM) 1980-98
=750  \0$aBenzoic acid$5IEN-M$0(DLC)sh2003009190

=LDR  00931cz  a2200229n  4500
=001  9880364367902441
=005  20141212213520.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020072
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x179.$x120
=150  \\$aPolyporales
=450  \\$wnnna$aAphyllophorale
=450  \\$aAphyllophorales
=450  \\$wnnna$aPolyporale
=550  \\$wg$aBasidiomycota
=550  \\$wh$aCoriolaceae
=550  \\$wh$aGanoderma
=550  \\$wh$aPolyporaceae
=680  \\$iAn order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. (From Alexopoulos, Introductory Mycology, 4th ed, pp504-68)
=688  \\$a2005 (1999)
=750  \0$aPolyporiales$0(DLC) sh 99001392$5IEN-M

=LDR  00768cz  a2200205n  4500
=001  9880364368002441
=005  20141212213530.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020101
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x277.$x800.$x100
=150  \\$aAcrosome Reaction
=450  \\$wnnna$aAcrosome Reactions
=450  \\$wnnna$aReaction, Acrosome
=450  \\$wnnna$aReactions, Acrosome
=550  \\$wg$aSperm-Ovum Interactions
=550  \\$aAcrosome
=680  \\$iChanges that occur to liberate the enzymes of the ACROSOME of a sperm (SPERMATOZOA). Acrosome reaction allows the sperm to penetrate the ZONA PELLUCIDA and enter the OVUM during FERTILIZATION.
=688  \\$a99
=750  \0$aAcrosome reaction$0(DLC)sh2005004311$5IEN-M

=LDR  01043cz  a2200301n  4500
=001  9880363651102441
=005  20141212202348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007047
=035  \\$aCBA0234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x325
=072  \\$aE1.$x370.$x378.$x325
=150  \\$aHysterosalpingography
=450  \\$aFallopian Tubes$xradiography
=450  \\$wnnna$aHysterosalpingographies
=450  \\$wnnna$aSalpingographies
=450  \\$aSalpingography
=450  \\$aUterus$xradiography
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wg$aRadiography
=550  \\$aFallopian Tubes
=550  \\$aGenitalia, Female
=550  \\$aHysteroscopy
=550  \\$aUterus
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: HYSTEROSALPINGOGR
=680  \\$iRadiography of the uterus and fallopian tubes after the injection of a contrast medium.
=750  \0$aHysterosalpingography$5IEN$0(DLC)sh 87003899

=LDR  00791cz  a2200193n  4500
=001  9880363651202441
=005  20141212202347.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007046
=035  \\$aCBA0233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x400.$x500
=150  \\$aHysteria
=450  \\$wnnna$aHysterical Neuroses
=450  \\$wnnna$aNeuroses, Hysterical
=550  \\$wg$aHistrionic Personality Disorder
=680  \\$iHistorical term for a chronic, but fluctuating, disorder beginning in early life and characterized by recurrent and multiple somatic complaints not apparently due to physical illness. This diagnosis is not used in contemporary practice.
=688  \\$aHYSTERICAL NEUROSES was see under HYSTERIA 1969-78
=750  \0$aHysteria$5IEN$0(DLC)sh 85063851

=LDR  00784cz  a2200241n  4500
=001  9880363651302441
=005  20141212202347.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007045
=035  \\$aCBA0232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x300.$x399.$x380
=150  \\$aHysterectomy, Vaginal
=450  \\$wnnna$aColpohysterectomies
=450  \\$aColpohysterectomy
=450  \\$wnnna$aHysterectomies, Vaginal
=450  \\$wnnna$aVaginal Hysterectomies
=450  \\$wnnna$aVaginal Hysterectomy
=550  \\$wg$aHysterectomy
=667  \\$ado not use /util except by MeSH definition
=680  \\$iRemoval of the uterus through the vagina.
=688  \\$a91(75); was see under HYSTERECTOMY 1975-90
=750  \0$aVaginal hysterectomy$5IEN$0(DLC)sh 85063847

=LDR  00665cz  a2200217n  4500
=001  9880363651402441
=005  20171102175712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007044
=035  \\$aCBA0231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x950.$x300.$x399
=150  \\$aHysterectomy
=450  \\$wnnna$aHysterectomies
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$wh$aHysterectomy, Vaginal
=550  \\$wh$aTrachelectomy
=550  \\$aUterus
=667  \\$ado not use /util except by MeSH definition; abdominal: do not coord with ABDOMEN
=680  \\$iExcision of the uterus.
=750  \0$aHysterectomy$5IEN$0(DLC)sh 85063844

=LDR  00643cz  a2200205n  4500
=001  9880363651502441
=005  20200508120608.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007043
=035  \\$aCBA0230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x957
=150  \\$aHyraxes
=450  \\$wnnna$aHyraces
=450  \\$wnnna$aHyrax
=550  \\$wg$aEutheria
=667  \\$aIM; qualif permitted
=680  \\$iAny of certain small hoofed mammals of the order Hyracoidea native to Africa and southwestern Asia.
=688  \\$a91(75); was see under MAMMALS 1975-90
=750  \0$aHyraxes$5IEN$0(DLC)sh 85063841

=LDR  00796cz  a2200205n  4500
=001  9880363651602441
=005  20141212202345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007037
=035  \\$aCBA0224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874.$x482
=150  \\$aHypothyroidism
=450  \\$wnnna$aHypothyroidisms
=550  \\$wg$aThyroid Diseases
=550  \\$wh$aCongenital Hypothyroidism
=550  \\$wh$aMyxedema
=550  \\$aThyroid Hormones
=680  \\$iA syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.
=750  \0$aHypothyroidism$0(DLC) sh 85063828$5IEN

=LDR  01485cz  a2200349n  4500
=001  9880363651702441
=005  20141212192244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007036
=035  \\$aCBA0223HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x258.$x750
=150  \\$aHypothermia, Induced
=450  \\$wnnna$aHypothermia, Therapeutic
=450  \\$wnnna$aInduced Hypothermia
=450  \\$wnnna$aInduced Mild Hypothermia
=450  \\$wnnna$aInduced Mild Hypothermias
=450  \\$wnnna$aInduced Moderate Hypothermia
=450  \\$wnnna$aInduced Moderate Hypothermias
=450  \\$wnnna$aMild Hypothermia, Induced
=450  \\$wnnna$aMild Hypothermias, Induced
=450  \\$wnnna$aModerate Hypothermia, Induced
=450  \\$wnnna$aModerate Hypothermias, Induced
=450  \\$wnnna$aTherapeutic Hypothermia
=550  \\$wg$aCryotherapy
=550  \\$wh$aGastric Hypothermia
=550  \\$aCold Temperature
=550  \\$aCryotherapy
=550  \\$aRefrigeration
=680  \\$iAbnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries.
=688  \\$aANESTHESIA, REFRIGERATION & HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1964-83 (Prov 1964-65)
=750  \0$aHypothermia, Induced$0(DLC) sh 85063826$5IEN-M

=LDR  00946cz  a2200265n  4500
=001  9880363651802441
=005  20141212202345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007035
=035  \\$aCBA0222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x119.$x565
=150  \\$aHypothermia
=450  \\$wnnna$aAccidental Hypothermia
=450  \\$wnnna$aAccidental Hypothermias
=450  \\$wnnna$aHypothermia, Accidental
=450  \\$wnnna$aHypothermias
=450  \\$wnnna$aHypothermias, Accidental
=550  \\$wg$aBody Temperature Changes
=550  \\$aCold-Shock Response
=550  \\$aCold Temperature
=550  \\$aRewarming
=667  \\$ado not confuse with HYPOTHERMIA, INDUCED for cooling of organs during surgery or for therapy; relation to BODY TEMPERATURE: see Manual 23.27+
=680  \\$iLower than normal body temperature, especially in warm-blooded animals.
=750  \0$aHypothermia$5IEN$0(DLC)sh 85063825

=LDR  01497cz  a2200361n  4500
=001  9880363651902441
=005  20141212192243.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007033
=035  \\$aCBA0220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x497.$x352
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x352
=150  \\$aHypothalamus, Middle
=450  \\$wnnna$aHypothalamic Region, Intermediate
=450  \\$wnnna$aHypothalamic Regions, Intermediate
=450  \\$aHypothalamus, Medial
=450  \\$aIntermediate Hypothalamic Region
=450  \\$wnnna$aIntermediate Hypothalamic Regions
=450  \\$wnnna$aMedial Hypothalamus
=450  \\$wnnna$aMiddle Hypothalamus
=450  \\$wnnna$aRegion, Intermediate Hypothalamic
=450  \\$wnnna$aRegions, Intermediate Hypothalamic
=550  \\$wg$aHypothalamus
=550  \\$wh$aArcuate Nucleus of Hypothalamus
=550  \\$wh$aDorsomedial Hypothalamic Nucleus
=550  \\$wh$aHypothalamo-Hypophyseal System
=550  \\$wh$aTuber Cinereum
=550  \\$wh$aVentromedial Hypothalamic Nucleus
=667  \\$adiseases: coordinate IM with HYPOTHALAMIC DISEASES (IM); HYPOTHALAMIC AREA, LATERAL is also available
=680  \\$iMiddle portion of the hypothalamus containing the arcuate, dorsomedial, ventromedial nuclei, the TUBER CINEREUM and the PITUITARY GLAND.
=688  \\$a83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82
=750  \0$aInfundibulum (Brain)$5IEN$0(DLC)sh 85066334

=LDR  01314cz  a2200313n  4500
=001  9880363652002441
=005  20141212192242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007031
=035  \\$aCBA0218HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x497
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357
=150  \\$aHypothalamus
=450  \\$wnnna$aArea, Preoptico-Hypothalamic
=450  \\$wnnna$aAreas, Preoptico-Hypothalamic
=450  \\$aLamina Terminalis
=450  \\$wnnna$aPreoptico-Hypothalamic Area
=450  \\$wnnna$aPreoptico Hypothalamic Area
=450  \\$wnnna$aPreoptico-Hypothalamic Areas
=550  \\$wg$aDiencephalon
=550  \\$wg$aLimbic System
=550  \\$wh$aHypothalamic Area, Lateral
=550  \\$wh$aHypothalamus, Anterior
=550  \\$wh$aHypothalamus, Middle
=550  \\$wh$aHypothalamus, Posterior
=667  \\$ageneral or unspecified; prefer specific structures & areas in the hypothalamus; HYPOTHALAMO-HYPOPHYSEAL SYSTEM is available for the hypothalamus-pituitary relationship
=680  \\$iVentral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE.
=750  \0$aHypothalamus$5IEN$0(DLC)sh 85063824

=LDR  01572cz  a2200289n  4500
=001  9880363652102441
=005  20190318135544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007030
=035  \\$aCBA0217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x688.$x357
=072  \\$aA8.$x186.$x211.$x180.$x497.$x352.$x435
=072  \\$aA8.$x186.$x211.$x200.$x317.$x357.$x352.$x435
=072  \\$aA8.$x713.$x357
=150  \\$aHypothalamo-Hypophyseal System
=450  \\$wnnna$aHypothalamic-Pituitary Unit
=450  \\$wnnna$aHypothalamic Pituitary Unit
=450  \\$wnnna$aHypothalamo Hypophyseal System
=550  \\$wg$aHypothalamus, Middle
=550  \\$wg$aNeurosecretory Systems
=550  \\$wh$aMedian Eminence
=550  \\$wh$aPituitary Gland
=667  \\$ahypothalamo-pituitary-adrenal axis: coordinate HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; emphasis here is on interrelation between hypothalamus & pituitary: do not use as a substitute for HYPOTHALAMUS & PITUITARY GLAND as entities; diseases: coordinate IM with HYPOTHALAMIC DISEASES (IM)
=680  \\$iA collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.
=688  \\$a65
=750  \0$aHypothalamo-hypophyseal system$5IEN$0(DLC)sh 85063823

=LDR  01814cz  a2200385n  4500
=001  9880363652202441
=005  20141212202343.0
=008  780516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007028
=035  \\$aCBA0215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327
=072  \\$aD12.$x644.$x400.$x400
=072  \\$aD12.$x644.$x548.$x365
=072  \\$aD12.$x776.$x641.$x650.$x405
=150  \\$aHypothalamic Hormones
=450  \\$wnnna$aHormones, Hypothalamic
=450  \\$wnnna$aHormones, Hypothalamic Pituitary-Regulating
=450  \\$wnnna$aHypothalamic Pituitary-Regulating Hormones
=450  \\$wnnna$aHypothalamic Pituitary Regulating Hormones
=450  \\$wnnna$aHypothalamic Pituitary-Regulating Peptides
=450  \\$wnnna$aHypothalamic Pituitary Regulating Peptides
=450  \\$wnnna$aPeptides, Hypothalamic Pituitary-Regulating
=450  \\$wnnna$aPituitary-Regulating Hormones, Hypothalamic
=450  \\$wnnna$aPituitary-Regulating Peptides, Hypothalamic
=550  \\$wg$aNeuropeptides
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aPituitary Hormone Release Inhibiting Hormones
=550  \\$wh$aPituitary Hormone-Releasing Hormones
=550  \\$wh$aPro-Opiomelanocortin
=550  \\$wh$aProlactin-Releasing Hormone
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iPeptide hormones produced by NEURONS of various regions in the HYPOTHALAMUS. They are released into the pituitary portal circulation to stimulate or inhibit PITUITARY GLAND functions. VASOPRESSIN and OXYTOCIN, though produced in the hypothalamus, are not included here for they are transported down the AXONS to the POSTERIOR LOBE OF PITUITARY before being released into the portal circulation.
=688  \\$a79
=750  \0$aHypothalamic hormones$5IEN$0(DLC)sh 85063822

=LDR  00995cz  a2200229n  4500
=001  9880363652302441
=005  20141212202341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007024
=035  \\$aCBA0211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177.$x575.$x600.$x450
=072  \\$aC14.$x907.$x514.$x482
=150  \\$aHypotension, Orthostatic
=450  \\$aHypotension, Postural
=450  \\$wnnna$aOrthostatic Hypotension
=450  \\$wnnna$aPostural Hypotension
=550  \\$wg$aHypotension
=550  \\$wg$aOrthostatic Intolerance
=550  \\$aPosture
=680  \\$iA significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE.
=750  \0$aHypotension, Orthostatic$0(DLC) sh 85063819$5IEN

=LDR  00529cz  a2200169n  4500
=001  9880363652402441
=005  20141212202341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007023
=035  \\$aCBA0210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x545
=150  \\$aHypotension, Controlled
=450  \\$wnnna$aControlled Hypotension
=550  \\$wg$aAnesthesia and Analgesia
=667  \\$anote category: a technique; do not use /util except by MeSH definition
=750  \0$aHypotension, Controlled$5IEN$0(DLC)sh 85063818

=LDR  01103cz  a2200265n  4500
=001  9880363652502441
=005  20141212202341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007022
=035  \\$aCBA0209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x514
=150  \\$aHypotension
=450  \\$aBlood Pressure, Low
=450  \\$wnnna$aHypotension, Vascular
=450  \\$wnnna$aLow Blood Pressure
=450  \\$wnnna$aVascular Hypotension
=550  \\$wg$aVascular Diseases
=550  \\$wh$aHypotension, Orthostatic
=550  \\$wh$aPost-Exercise Hypotension
=550  \\$wh$aShy-Drager Syndrome
=550  \\$aBlood Pressure
=667  \\$aonly blood pressure; INTRACRANIAL HYPOTENSION and OCULAR HYPOTENSION are also available; relation to BLOOD PRESSURE: Manual 23.27+
=680  \\$iAbnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
=750  \0$aHypotension$5IEN$0(DLC)sh 85063817

=LDR  00860cz  a2200217n  4500
=001  9880363652602441
=005  20141212202341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007021
=035  \\$aCBA0208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x494.$x400
=072  \\$aC12.$x706.$x516
=072  \\$aC13.$x351.$x875.$x466
=072  \\$aC16.$x131.$x939.$x516
=150  \\$aHypospadias
=450  \\$wnnna$aHypospadia
=550  \\$wg$aPenile Diseases
=550  \\$wg$aUrogenital Abnormalities
=680  \\$iA birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.
=750  \0$aHypospadias$0(DLC) sh 85063812$5IEN

=LDR  00745cz  a2200229n  4500
=001  9880363652702441
=005  20141212202339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007016
=035  \\$aCBA0203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x270.$x532
=072  \\$aE4.$x525.$x400
=150  \\$aHypophysectomy
=450  \\$wnnna$aHypophysectomies
=550  \\$wg$aEndocrine Surgical Procedures
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wh$aHypophysectomy, Chemical
=550  \\$aPituitary Gland
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed)
=750  \0$aHypophysectomy$5IEN$0(DLC)sh 85063807

=LDR  00890cz  a2200205n  4500
=001  9880363652802441
=005  20141212202314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006945
=035  \\$aCBA0131HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x946.$x350
=150  \\$aHyperhidrosis
=550  \\$wg$aSweat Gland Diseases
=550  \\$wh$aSweating, Gustatory
=550  \\$aSweating
=667  \\$aexcessive sweating; do not confuse with HYPOHIDROSIS, reduced sweating
=680  \\$iExcessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.
=688  \\$a76; was see under SWEATING 1963-75
=750  \0$aHyperhidrosis$5IEN$0(DLC)sh 85063699

=LDR  01212cz  a2200277n  4500
=001  9880363652902441
=005  20141212202314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006943
=035  \\$aCBA0129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x952
=150  \\$aHyperglycemia
=450  \\$wnnna$aHyperglycemia, Postprandial
=450  \\$wnnna$aHyperglycemias
=450  \\$wnnna$aHyperglycemias, Postprandial
=450  \\$aPostprandial Hyperglycemia
=450  \\$wnnna$aPostprandial Hyperglycemias
=550  \\$wg$aGlucose Metabolism Disorders
=550  \\$wh$aGlucose Intolerance
=550  \\$aBlood Glucose
=550  \\$aGlucose
=550  \\$aPrediabetic State
=667  \\$ado not confuse with HYPOGLYCEMIA; HYPERGLYCEMIC MICE see MICE, OBESE is available: do not add HYPERGLYCEMIA or OBESITY unless disease is particularly discussed; Somogyi effect or rebound hyperglycemia: index HYPERGLYCEMIA / chem ind + DIABETES MELLITUS / drug ther + INSULIN / adv eff; "induced hyperglycemia" in disease states or physiologic studies: index BLOOD GLUCOSE, not HYPERGLYCEMIA
=680  \\$iAbnormally high BLOOD GLUCOSE level.
=750  \0$aHyperglycemia$5IEN$0(DLC)sh 85063696

=LDR  01044cz  a2200301n  4500
=001  9880363653002441
=005  20200706114037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006942
=035  \\$aCBA0128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x147.$x542
=072  \\$aC20.$x683.$x460
=072  \\$aC23.$x888.$x512
=150  \\$aHypergammaglobulinemia
=450  \\$wnnna$aHypergammaglobulinemias
=450  \\$aHyperimmunoglobulinemia
=450  \\$wnnna$aHyperimmunoglobulinemias
=550  \\$wg$aBlood Protein Disorders
=550  \\$wg$aImmunoproliferative Disorders
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aMevalonate Kinase Deficiency
=550  \\$wh$aMonoclonal Gammopathy of Undetermined Significance
=550  \\$wh$aSmoldering Multiple Myeloma
=667  \\$acoord IM with specific immunoglobulin (IM)
=680  \\$iAn excess of GAMMA-GLOBULINS in the serum due to chronic infections or PARAPROTEINEMIAS.
=688  \\$a72(69)
=750  \0$aHypergammaglobulinemia$0(DLC) sh 85063693$5IEN

=LDR  01379cz  a2200361n  4500
=001  9880363653102441
=005  20141212202312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006940
=035  \\$aCBA0126HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x474
=150  \\$aHyperemia
=450  \\$wnnna$aActive Hyperemia
=450  \\$wnnna$aArterial Hyperemia
=450  \\$wnnna$aCongestion, Venous
=450  \\$wnnna$aEngorgement, Venous
=450  \\$wnnna$aHyperemia, Active
=450  \\$wnnna$aHyperemia, Arterial
=450  \\$wnnna$aHyperemia, Passive
=450  \\$wnnna$aHyperemia, Reactive
=450  \\$wnnna$aHyperemias
=450  \\$wnnna$aHyperemias, Reactive
=450  \\$wnnna$aPassive Hyperemia
=450  \\$wnnna$aReactive Hyperemia
=450  \\$wnnna$aReactive Hyperemias
=450  \\$wnnna$aVenous Congestion
=450  \\$wnnna$aVenous Engorgement
=550  \\$wg$aVascular Diseases
=550  \\$aBlood Circulation
=680  \\$iThe presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
=688  \\$a1966; for VENOUS ENGORGEMENT use VEINS 1978-2006
=750  \0$aHyperemia$5IEN$0(DLC)sh 85063686

=LDR  00972cz  a2200241n  4500
=001  9880363653202441
=005  20141212202310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006937
=035  \\$aCBA0123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x584.$x500.$x500.$x396
=150  \\$aHypercholesterolemia
=450  \\$wnnna$aElevated Cholesterol
=450  \\$aHypercholesteremia
=450  \\$wnnna$aHypercholesteremias
=450  \\$wnnna$aHypercholesterolemias
=550  \\$wg$aHyperlipidemias
=550  \\$aCholesterol
=550  \\$aCholesterol, Dietary
=680  \\$iA condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
=688  \\$a80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 (see note under HYPERLIPIDEMIA for former cross refs to it)
=750  \0$aHypercholesteremia$0(DLC) sh 85063682$5IEN

=LDR  00615cz  a2200193n  4500
=001  9880363653302441
=005  20141212202309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006935
=035  \\$aCBA0121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x852.$x544
=150  \\$aHypercapnia
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$aCarbon Dioxide
=667  \\$aCARBON DIOXIDE/blood is also available
=680  \\$iA clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
=688  \\$a68(66)
=750  \0$aHypercapnia$5IEN$0(DLC)sh 85063681

=LDR  01183cz  a2200325n  4500
=001  9880363653402441
=005  20141212202309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006934
=035  \\$aCBA0120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174.$x451
=072  \\$aC18.$x452.$x950.$x340
=150  \\$aHypercalcemia
=450  \\$aBurnett's Syndrome$5IEN-M
=450  \\$wnnna$aHypercalcemias
=450  \\$aMilk-Alkali Syndrome
=450  \\$wnnna$aMilk Alkali Syndrome
=450  \\$aMilk-Drinker's Syndrome$5IEN-M
=450  \\$aSyndrome, Burnett's$5IEN-M
=450  \\$wnnna$aSyndrome, Milk-Alkali
=450  \\$aSyndrome, Milk-Drinker's$5IEN-M
=550  \\$wg$aCalcium Metabolism Disorders
=550  \\$wg$aWater-Electrolyte Imbalance
=550  \\$aAlkalies
=550  \\$aCalcium
=667  \\$ahigh blood calcium levels; do not confuse with HYPOCALCEMIA; X ref is also called Burnett's syndrome or milk-drinker's syndrome
=680  \\$iAbnormally high level of calcium in the blood.
=688  \\$aMILK-ALKALI SYNDROME was see under HYPERCALCEMIA 1978-83, was see under CALCINOSIS 1975-77
=750  \0$aHypercalcemia$5IEN$0(DLC)sh 85063679

=LDR  00882cz  a2200241n  4500
=001  9880363653502441
=005  20141212202308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006932
=035  \\$aCBA0118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x429
=150  \\$aHyperbilirubinemia
=450  \\$aBilirubinemia
=450  \\$wnnna$aBilirubinemias
=450  \\$wnnna$aHyperbilirubinemias
=550  \\$wg$aPathologic Processes
=550  \\$wh$aHyperbilirubinemia, Neonatal
=550  \\$wh$aJaundice
=550  \\$wh$aKernicterus
=550  \\$aBilirubin
=680  \\$iA condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.
=750  \0$aHyperbilirubinemia$5IEN$0(DLC)sh 85063672

=LDR  01376cz  a2200301n  4500
=001  9880363653602441
=005  20141212202308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006931
=035  \\$aCBA0117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x880.$x690.$x490
=150  \\$aHyperbaric Oxygenation
=450  \\$wnnna$aHyperbaric Oxygen Therapies
=450  \\$wnnna$aHyperbaric Oxygen Therapy
=450  \\$wnnna$aHyperbaric Oxygenations
=450  \\$wnnna$aOxygen Therapies, Hyperbaric
=450  \\$wnnna$aOxygen Therapy, Hyperbaric
=450  \\$aOxygenation, Hyperbaric
=450  \\$wnnna$aOxygenations, Hyperbaric
=450  \\$wnnna$aTherapies, Hyperbaric Oxygen
=450  \\$wnnna$aTherapy, Hyperbaric Oxygen
=550  \\$wg$aOxygen Inhalation Therapy
=550  \\$aAtmospheric Pressure
=667  \\$acoord IM with disease /ther (IM), not /drug ther
=680  \\$iThe therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures (three atmospheres). It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. (From Segen, Dictionary of Modern Medicine, 1992). The list of treatment modalities includes stroke.
=688  \\$a65(64)
=750  \0$aHyperbaric oxygenation$5IEN$0(DLC)sh 85063671

=LDR  01769cz  a2200493n  4500
=001  9880363653702441
=005  20141212202308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006930
=035  \\$aCBA0116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x751.$x791.$x400
=072  \\$aC23.$x888.$x592.$x763.$x770.$x400
=150  \\$aHyperalgesia
=450  \\$wnnna$aAllodynia
=450  \\$wnnna$aAllodynia, Mechanical
=450  \\$wnnna$aAllodynia, Tactile
=450  \\$wnnna$aAllodynia, Thermal
=450  \\$wnnna$aAllodynias, Mechanical
=450  \\$wnnna$aAllodynias, Tactile
=450  \\$wnnna$aAllodynias, Thermal
=450  \\$wnnna$aHyperalgesia, Mechanical
=450  \\$wnnna$aHyperalgesia, Primary
=450  \\$wnnna$aHyperalgesia, Secondary
=450  \\$aHyperalgesia, Tactile
=450  \\$aHyperalgesia, Thermal
=450  \\$wnnna$aHyperalgesias
=450  \\$wnnna$aHyperalgesias, Mechanical
=450  \\$wnnna$aHyperalgesias, Primary
=450  \\$wnnna$aHyperalgesias, Secondary
=450  \\$wnnna$aHyperalgesias, Tactile
=450  \\$wnnna$aHyperalgesias, Thermal
=450  \\$wnnna$aHyperalgesic Sensations
=450  \\$wnnna$aMechanical Allodynia
=450  \\$wnnna$aMechanical Hyperalgesia
=450  \\$wnnna$aTactile Allodynia
=450  \\$wnnna$aThermal Allodynia
=450  \\$wnnna$aThermal Hyperalgesia
=550  \\$wg$aSomatosensory Disorders
=550  \\$aPain
=667  \\$acoordinate with TOUCH or HOT TEMPERATURE if pertinent
=680  \\$iAn increased sensation of pain or discomfort produced by mimimally noxious stimuli due to damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve.
=688  \\$a1991(1975)
=750  \0$aHyperalgesia$5IEN$0(DLC)sh 92000586

=LDR  01100cz  a2200289n  4500
=001  9880363653802441
=005  20141212202307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006929
=035  \\$aCBA0115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53.$x800.$x604
=150  \\$aHyperaldosteronism
=450  \\$aAldosteronism
=450  \\$wnnna$aConn Syndrome
=450  \\$wnnna$aConn's Syndrome
=450  \\$wnnna$aConns Syndrome
=450  \\$wnnna$aHyperaldosteronism, Primary
=450  \\$wnnna$aPrimary Hyperaldosteronism
=450  \\$wnnna$aSyndrome, Conn
=450  \\$wnnna$aSyndrome, Conn's
=550  \\$wg$aAdrenocortical Hyperfunction
=550  \\$wh$aBartter Syndrome
=550  \\$aAldosterone
=667  \\$ado not confuse with HYPOALDOSTERONISM; do not confuse X ref CONN SYNDROME with CONN DISEASE see ADRENOCORTICAL ADENOMA
=680  \\$iA condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
=750  \0$aHyperaldosteronism$5IEN$0(DLC)sh 85063665

=LDR  00882cz  a2200241n  4500
=001  9880363653902441
=005  20141212202307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006928
=035  \\$aCBA0114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x409
=150  \\$aHyoid Bone
=450  \\$wnnna$aBone, Hyoid
=450  \\$wnnna$aBone, Lingual
=450  \\$wnnna$aBones, Hyoid
=450  \\$wnnna$aBones, Lingual
=450  \\$wnnna$aHyoid Bones
=450  \\$aLingual Bone
=450  \\$wnnna$aLingual Bones
=550  \\$wg$aBone and Bones
=680  \\$iA mobile U-shaped bone that lies in the anterior part of the neck at the level of the third CERVICAL VERTEBRAE. The hyoid bone is suspended from the processes of the TEMPORAL BONES by ligaments, and is firmly bound to the THYROID CARTILAGE by muscles.
=750  \0$aHyoid bone$5IEN$0(DLC)sh 85063652

=LDR  00709cz  a2200229n  4500
=001  9880363654002441
=005  20200515132830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006927
=035  \\$aCBA0113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x875
=150  \\$aHymenoptera
=450  \\$wnnna$aHymenopteras
=550  \\$wg$aHolmetabola
=550  \\$wh$aAnts
=550  \\$wh$aBees
=550  \\$wh$aWasps
=667  \\$aincludes ANTS; BEES; WASPS; /microbiol /parasitol /virol permitted
=680  \\$iAn extensive order of highly specialized insects including bees, wasps, and ants.
=688  \\$a75
=750  \0$aHymenoptera$5IEN$0(DLC)sh 85063592

=LDR  00783cz  a2200217n  4500
=001  9880363654102441
=005  20141212202306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006926
=035  \\$aCBA0112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x454
=150  \\$aHymenolepis
=450  \\$wnnna$aHymenolepi
=550  \\$wg$aCestoda
=550  \\$wh$aHymenolepis diminuta
=550  \\$wh$aHymenolepis nana
=667  \\$ainfection = HYMENOLEPIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of small tapeworms of birds and mammals.
=688  \\$a79(75); was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64
=750  \0$aHymenolepis$5IEN$0(DLC)sh 85063586

=LDR  00720cz  a2200241n  4500
=001  9880363654202441
=005  20141212202306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006925
=035  \\$aCBA0111HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x519
=150  \\$aHymenolepiasis
=450  \\$wnnna$aHymenolepiases
=450  \\$wnnna$aHymenolepis Infection
=450  \\$wnnna$aHymenolepis Infections
=450  \\$wnnna$aInfection, Hymenolepis
=450  \\$wnnna$aInfections, Hymenolepis
=550  \\$wg$aCestode Infections
=667  \\$atapeworm infect
=680  \\$iInfection with tapeworms of the genus Hymenolepis.
=688  \\$a68
=750  \0$aHymenolepiasis$5IEN$0(DLC)sh 88002786

=LDR  01621cz  a2200265n  4500
=001  9880363654302441
=005  20141212202305.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006922
=035  \\$aCBA0108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x420.$x390
=150  \\$aHylobates
=450  \\$wnnna$aGibbon
=450  \\$aGibbons
=450  \\$wnnna$aHylobate
=450  \\$aNomascus
=450  \\$aSiamang
=450  \\$wnnna$aSiamangs
=450  \\$aSymphalangus
=550  \\$wg$aHylobatidae
=667  \\$agibbon, not monkey & not ape; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with specific dis /vet (IM)
=680  \\$iA genus of the family HYLOBATIDAE consisting of six species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Some authors refer to Symphalangus and Nomascus as Hylobates. The six genera include: H. concolor (crested or black gibbon), H. hoolock (Hoolock gibbon), H. klossii (Kloss's gibbon; dwarf siamang), H. lar (common gibbon), H. pileatus (pileated gibbon), and H. syndactylus (siamang). H. lar is also known as H. agilis (lar gibbon), H. moloch (agile gibbon), and H. muelleri (silvery gibbon).
=688  \\$a91(81); was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80
=750  \0$aHylobates$0(DLC)sh2014000040$5IEN-M

=LDR  00979cz  a2200229n  4500
=001  9880363654402441
=005  20141212202305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006920
=035  \\$aCBA0106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x547
=072  \\$aN6.$x850.$x670
=150  \\$aHygiene
=550  \\$wg$aPublic Health
=550  \\$wg$aTherapeutics
=550  \\$wh$aMilitary Hygiene
=550  \\$wh$aOral Hygiene
=550  \\$wh$aSkin Care
=667  \\$ahygiene as a principle & personal hygiene go here; dental hygiene = DENTAL HYGIENE see ORAL HYGIENE; industrial hygiene = INDUSTRIAL HYGIENE see OCCUPATIONAL HEALTH; mental hygiene = MENTAL HYGIENE see MENTAL HEALTH; MILITARY HYGIENE is also available
=680  \\$iThe science dealing with the establishment and maintenance of health in the individual and the group. It includes the conditions and practices conducive to health. (Webster, 3d ed)
=750  \0$aHygiene$5IEN$0(DLC)sh 85063519

=LDR  00910cz  a2200265n  4500
=001  9880363654502441
=005  20141212202304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006916
=035  \\$aCBA0102HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x850.$x479
=150  \\$a5-Hydroxytryptophan
=450  \\$a5-HTP
=450  \\$wnnna$a5-Hydroxy- Tryptophan
=450  \\$wnnna$a5 Hydroxytryptophan
=450  \\$wnnna$aHydroxytryptophan
=450  \\$wnnna$aOxitriptan
=450  \\$wnnna$aOxytryptophan
=450  \\$wnnna$aTryptophan, 5-Hydroxy-
=450  \\$wnnna$aTryptophan, 5 Hydroxy
=550  \\$wg$aTryptophan
=680  \\$iThe immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
=688  \\$a90; was HYDROXYTRYPTOPHAN 1963-89 (Prov 1963-65)
=750  \0$aHydroxytryptophan$5IEN-M$0(DLC)sh 97008890

=LDR  00673cz  a2200193n  4500
=001  9880363654602441
=005  20141212202302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006908
=035  \\$aCBA0094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x829.$x395
=072  \\$aD6.$x472.$x334.$x851.$x687.$x750.$x478
=150  \\$aHydroxyprogesterones
=550  \\$wg$aProgesterone
=550  \\$wh$a17-alpha-Hydroxyprogesterone
=680  \\$iMetabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
=688  \\$a78; was HYDROXYPROGESTERONE 1963-77
=750  \0$aHydroxyprogesterone$5IEN$0(DLC)sh 85063511

=LDR  01348cz  a2200301n  4500
=001  9880363654702441
=005  20141212202301.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006903
=035  \\$aCBA0089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x820.$x150.$x415
=150  \\$aHydroxymethylglutaryl CoA Reductases
=450  \\$wnnna$a3-Hydroxy-3-methylglutaryl CoA Reductase
=450  \\$wnnna$a3 Hydroxy 3 methylglutaryl CoA Reductase
=450  \\$wnnna$aCoA Reductase, 3-Hydroxy-3-methylglutaryl
=450  \\$wnnna$aHMG CoA Reductase
=450  \\$aHMG CoA Reductases
=450  \\$wnnna$aHydroxymethylglutaryl CoA Reductase
=450  \\$aHydroxymethylglutaryl Coenzyme A Reductases$5IEN
=450  \\$wnnna$aReductase, 3-Hydroxy-3-methylglutaryl CoA
=550  \\$wg$a3-Hydroxyacyl CoA Dehydrogenases
=550  \\$wh$aHydroxymethylglutaryl-CoA Reductases, NAD-Dependent
=550  \\$wh$aHydroxymethylglutaryl-CoA-Reductases, NADP-dependent
=550  \\$aHydroxymethylglutaryl-CoA Reductase Inhibitors
=680  \\$iEnzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID.
=688  \\$a78(75); was see under ALCOHOL OXIDOREDUCTASES 1975-77
=750  \0$aHydroxymethylglutaryl coenzyme A reductases$5IEN$0(DLC)sh 85063510

=LDR  00863cz  a2200229n  4500
=001  9880363654802441
=005  20170608144227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006900
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x385
=072  \\$aG2.$x607.$x348
=072  \\$aG3.$x425
=150  \\$aHydroxylation
=450  \\$wnnna$aHydroxylations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic hydroxylation: coord NIM with MIXED FUNCTION OXYGENASES (IM) + substrate (NIM) or specific hydroxylase (IM)
=680  \\$iPlacing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed)
=688  \\$a91(71); was see under CHEMISTRY, ORGANIC 1971-90
=750  \0$aHydroxylation$5IEN$0(DLC)sh 85063509

=LDR  02116cz  a2200469n  4500
=001  9880363654902441
=005  20141212202259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006899
=035  \\$aCBA0085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x708
=150  \\$aMixed Function Oxygenases
=450  \\$aHydroxylases
=450  \\$wnnna$aMixed Function Oxidases
=450  \\$aMonooxygenases
=450  \\$wnnna$aOxidases, Mixed Function
=450  \\$wnnna$aOxygenases, Mixed Function
=550  \\$wg$aOxygenases
=550  \\$wh$a4-Hydroxybenzoate-3-Monooxygenase
=550  \\$wh$aBenzoate 4-Monooxygenase
=550  \\$wh$aCatechol Oxidase
=550  \\$wh$aCytochrome P-450 Enzyme System
=550  \\$wh$aDopamine beta-Hydroxylase
=550  \\$wh$aFatty Acid Desaturases
=550  \\$wh$agamma-Butyrobetaine Dioxygenase
=550  \\$wh$aHeme Oxygenase (Decyclizing)
=550  \\$wh$aKynurenine 3-Monooxygenase
=550  \\$wh$aPhenylalanine Hydroxylase
=550  \\$wh$aProcollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase
=550  \\$wh$aProlyl Hydroxylases
=550  \\$wh$aProstaglandin-Endoperoxide Synthases
=550  \\$wh$aSqualene Monooxygenase
=550  \\$wh$aSteroid Hydroxylases
=550  \\$wh$aTrans-Cinnamate 4-Monooxygenase
=550  \\$wh$aTryptophan Hydroxylase
=550  \\$wh$aTyrosine 3-Monooxygenase
=550  \\$wh$aVitamin K Epoxide Reductases
=667  \\$ado not confuse with HYDRO-LYASES
=680  \\$iWidely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation.
=688  \\$a2003 (1966)
=750  \0$aMonooxygenases$5IEN-M$0(DLC)sh 91000967

=LDR  01877cz  a2200481n  4500
=001  9880363655002441
=005  20141212192239.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006895
=035  \\$aCBA0081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x365.$x855.$x500
=150  \\$aHydroxyethyl Starch Derivatives
=450  \\$wnnna$a2-Hydroxyethyl Starches
=450  \\$wnnna$aBraun Brand of Pentastarch
=450  \\$wnnna$aBristol-Myers Squibb Brand of Pentastarch
=450  \\$wnnna$aDerivatives, Hydroxyethyl Starch
=450  \\$wnnna$aElohes
=450  \\$wnnna$aFresenius Brand of Pentastarch
=450  \\$wnnna$aFresenius Kabi Brand of Hydroxyethylstarch
=450  \\$wnnna$aHAES-steril
=450  \\$wnnna$aHemohes
=450  \\$wnnna$aHespan
=450  \\$aHetastarch
=450  \\$wnnna$aHydroxyethyl Starch 130-0.4
=450  \\$wnnna$aHydroxyethyl Starch 130 0.4
=450  \\$wnnna$aHydroxyethyl Starch (130 KD-0.4 Substitution)
=450  \\$wnnna$aHydroxyethylated Starches
=450  \\$wnnna$aPentafraction
=450  \\$wnnna$aPentaspan
=450  \\$wnnna$aPentastarch
=450  \\$wnnna$aPlasmasteril
=450  \\$wnnna$aRhône-Poulenc Rorer Brand of Pentastarch
=450  \\$wnnna$aStarch Derivatives, Hydroxyethyl
=450  \\$wnnna$aStarches, 2-Hydroxyethyl
=450  \\$wnnna$aStarches, 2 Hydroxyethyl
=450  \\$wnnna$aStarches, Hydroxyethylated
=550  \\$wg$aStarch
=680  \\$iStarches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups.
=688  \\$a2014(1975); was HYDROXYETHYL STARCH 1975-2013; was HETASTARCH 1996-2013
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Hetastarch
=688  \\$a96; was HYDROXYETHYL STARCH 1975-95 (see under STARCH 1975-90)
=750  \0$aHydroxyethyl starch$5IEN$0(DLC)sh 85063505

=LDR  00977cz  a2200349n  4500
=001  9880363655102441
=005  20141212202255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006880
=035  \\$aCBA0066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x511
=150  \\$aHydroxy Acids
=450  \\$wnnna$aAcids, Hydroxy
=550  \\$wg$aCarboxylic Acids
=550  \\$wh$aBenzilates
=550  \\$wh$aGlycolates
=550  \\$wh$aHydroxamic Acids
=550  \\$wh$aHydroxybenzoates
=550  \\$wh$aHydroxybutyrates
=550  \\$wh$aLactates
=550  \\$wh$aMalates
=550  \\$wh$aMandelic Acids
=550  \\$wh$aMevalonic Acid
=550  \\$wh$aMycolic Acids
=550  \\$wh$aPhosphoenolpyruvate
=550  \\$wh$aQuinic Acid
=550  \\$wh$aShikimic Acid
=550  \\$wh$aSugar Acids
=680  \\$iOrganic compounds containing both the hydroxyl and carboxyl radicals.
=688  \\$a75
=750  \0$aHydroxy Acids$5IEN-M$0(DLC)sh 97005617

=LDR  00882cz  a2200313n  4500
=001  9880363655202441
=005  20141212202254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006878
=035  \\$aCBA0064HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45.$x250
=072  \\$aD1.$x248.$x497.$x158.$x459
=072  \\$aD1.$x455
=150  \\$aHydroxides
=550  \\$wg$aAlkalies
=550  \\$wg$aAnions
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aAluminum Hydroxide
=550  \\$wh$aAmmonium Hydroxide
=550  \\$wh$aCalcium Hydroxide
=550  \\$wh$aHydroxyl Radical
=550  \\$wh$aLye
=550  \\$wh$aMagnesium Hydroxide
=550  \\$wh$aSodium Hydroxide
=550  \\$wh$aWater
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iInorganic compounds that contain the OH- group.
=750  \0$aHydroxides$5IEN$0(DLC)sh 85063504

=LDR  00784cz  a2200265n  4500
=001  9880363655302441
=005  20141212202254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006877
=035  \\$aCBA0063HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x570.$x394
=072  \\$aD2.$x241.$x511.$x372
=150  \\$aHydroxamic Acids
=450  \\$wnnna$aAcid, Hydroxamic
=450  \\$wnnna$aAcids, Hydroxamic
=450  \\$wnnna$aHydroxamic Acid
=550  \\$wg$aHydroxy Acids
=550  \\$wg$aHydroxylamines
=550  \\$wh$aBufexamac
=550  \\$wh$aDeferoxamine
=550  \\$wh$aFerrichrome
=680  \\$iA class of weak acids with the general formula R-CONHOH.
=688  \\$a75; was HYDROXAMIC ACID 1963-74
=750  \0$aHydroxamic acids$5IEN$0(DLC)sh 90003600

=LDR  00498cz  a2200169n  4500
=001  9880363655402441
=005  20141212202254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006876
=035  \\$aCBA0062HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x528.$x476
=150  \\$aHydrothorax
=550  \\$wg$aPleural Diseases
=667  \\$afluid in pleural cavity
=680  \\$iA collection of watery fluid in the pleural cavity. (Dorland, 27th ed)
=750  \0$aHydrothorax$5IEN$0(DLC)sh 85063500

=LDR  00994cz  a2200265n  4500
=001  9880363655502441
=005  20141212202254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006875
=035  \\$aCBA0061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x533
=072  \\$aE2.$x779.$x492
=150  \\$aHydrotherapy
=450  \\$wnnna$aBath, Whirlpool
=450  \\$wnnna$aBaths, Whirlpool
=450  \\$wnnna$aHydrotherapies
=450  \\$wnnna$aWhirlpool Bath
=450  \\$aWhirlpool Baths
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aTherapeutics
=550  \\$wh$aTherapeutic Irrigation
=667  \\$ado not use /util except by MeSH definition; external with natural water only, with emphasis on water temperature & motion of water (note X ref WHIRLPOOL BATHS); do not confuse with BALNEOLOGY (see note there); if in doubt, use word of text
=680  \\$iExternal application of water for therapeutic purposes.
=750  \0$aHydrotherapy$5IEN$0(DLC)sh 85063494

=LDR  00652cz  a2200217n  4500
=001  9880363655602441
=005  20141212202253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006874
=035  \\$aCBA0060HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x715.$x352
=150  \\$aHydrostatic Pressure
=450  \\$wnnna$aHydrostatic Pressures
=450  \\$wnnna$aPressure, Hydrostatic
=450  \\$wnnna$aPressures, Hydrostatic
=550  \\$wg$aPressure
=667  \\$aNIM
=680  \\$iThe pressure due to the weight of fluid.
=688  \\$a91(73); was see under PRESSURE 1973-90
=750  \0$aHydrostatic pressure$5IEN$0(DLC)sh 85063491

=LDR  00635cz  a2200217n  4500
=001  9880363655702441
=005  20141212202253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006873
=035  \\$aCBA0059HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x393
=150  \\$aHydroquinones
=450  \\$ap-Dihydroxybenzenes
=450  \\$wnnna$ap Dihydroxybenzenes
=450  \\$apara-Dihydroxybenzenes
=450  \\$wnnna$apara Dihydroxybenzenes
=450  \\$wnnna$aQuinols
=550  \\$wg$aPhenols
=688  \\$a66(63); was see under PHENOLS 1963-65
=750  \0$aHydroquinone$5IEN$0(DLC)sh 85063488

=LDR  00764cz  a2200193n  4500
=001  9880363655802441
=005  20141212202252.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006869
=035  \\$aCBA0054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x307
=072  \\$aC13.$x351.$x968.$x419.$x307
=150  \\$aHydronephrosis
=450  \\$wnnna$aHydronephroses
=550  \\$wg$aKidney Diseases
=550  \\$wh$aPyonephrosis
=680  \\$iAbnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
=750  \0$aHydronephrosis$5IEN$0(DLC)sh 85063477

=LDR  00563cz  a2200181n  4500
=001  9880363655902441
=005  20170609092658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006868
=035  \\$aCBA0053HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x380
=150  \\$aHydrolysis
=550  \\$wg$aChemical Phenomena
=667  \\$aalmost never IM
=680  \\$iThe process of cleaving a chemical compound by the addition of a molecule of water.
=688  \\$a91(71); was see under CHEMISTRY, PHYSICAL 1971-90
=750  \0$aHydrolysis$5IEN$0(DLC)sh 85063464

=LDR  01231cz  a2200325n  4500
=001  9880363656002441
=005  20200618133608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006867
=035  \\$aCBA0052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277
=150  \\$aHydrolases
=550  \\$wg$aEnzymes
=550  \\$wh$aAcid Anhydride Hydrolases
=550  \\$wh$aAdenosylhomocysteinase
=550  \\$wh$aAmidohydrolases
=550  \\$wh$aAminohydrolases
=550  \\$wh$aComplement Activating Enzymes
=550  \\$wh$aEpoxide Hydrolases
=550  \\$wh$aEsterases
=550  \\$wh$aGlycoside Hydrolases
=550  \\$wh$aPancreatin
=550  \\$wh$aPeptide Hydrolases
=550  \\$wh$aProtein-Arginine Deiminases
=550  \\$wh$aProtein Deglycase DJ-1
=550  \\$wh$aUreohydrolases
=667  \\$ado not confuse with HYDRO-LYASES
=680  \\$iAny member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3.
=750  \0$aHydrolases$5IEN$0(DLC)sh 85063449

=LDR  00851cz  a2200241n  4500
=001  9880363656102441
=005  20170608143911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006865
=035  \\$aCBA0050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x380
=072  \\$aG2.$x607.$x324
=072  \\$aG3.$x409
=150  \\$aHydrogenation
=450  \\$wnnna$aHydrogenations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic hydrogenation: coord NIM with specific enzyme (IM) + substrate (NIM)
=680  \\$iAddition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. (From Stedman, 26th ed)
=688  \\$a91(71); was see under CHEMISTRY, ORGANIC 1971-90
=750  \0$aHydrogenation$5IEN$0(DLC)sh 85063436

=LDR  00880cz  a2200241n  4500
=001  9880363656202441
=005  20141212202251.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006864
=035  \\$aCBA0049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x400
=150  \\$aHydrogenase
=450  \\$wnnna$aFerredoxin Hydrogenase
=450  \\$wnnna$aH2-Oxidizing Hydrogenase
=450  \\$wnnna$aH2 Oxidizing Hydrogenase
=450  \\$wnnna$aHydrogenase, Ferredoxin
=450  \\$wnnna$aHydrogenase, H2-Oxidizing
=450  \\$wnnna$aHydrogenlyase
=550  \\$wg$aOxidoreductases
=680  \\$iAn enzyme found in bacteria. It catalyzes the reduction of FERREDOXIN and other substances in the presence of molecular hydrogen and is involved in the electron transport of bacterial photosynthesis.
=688  \\$a85
=750  \0$aHydrogenase$5IEN$0(DLC)sh 85063435

=LDR  01035cz  a2200253n  4500
=001  9880363656302441
=005  20170629111832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x300
=150  \\$aHydrogen-Ion Concentration
=450  \\$wnnna$aConcentration, Hydrogen-Ion
=450  \\$wnnna$aConcentrations, Hydrogen-Ion
=450  \\$wnnna$aHydrogen Ion Concentration
=450  \\$wnnna$aHydrogen-Ion Concentrations
=450  \\$apH
=550  \\$wg$aChemical Phenomena
=550  \\$wh$aAcid-Base Equilibrium
=550  \\$wh$aIsoelectric Point
=550  \\$aProton-Motive Force
=667  \\$aNIM
=680  \\$iThe normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aHydrogen-ion concentration$5IEN$0(DLC)sh 85063427

=LDR  01059cz  a2200301n  4500
=001  9880363656402441
=005  20141212202250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006862
=035  \\$aCBA0047HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x340
=072  \\$aD1.$x362.$x350
=072  \\$aD1.$x875.$x350
=150  \\$aHydrogen Sulfide
=450  \\$wnnna$aHydrogen Sulfide (H2(Sx))
=450  \\$wnnna$aHydrogen Sulfide (H2S2)
=450  \\$wnnna$aHydrogen Sulfide (H2S3)
=450  \\$aHydrogen Sulphide$5IEN
=450  \\$wnnna$aSulfide, Hydrogen
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aGases
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aSulfides
=667  \\$a/analogs = SULFIDES or SULFHYDRYL COMPOUNDS or specifics
=680  \\$iA flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
=688  \\$a73(71)
=750  \0$aHydrogen sulfide$5IEN$0(DLC)sh 85063433

=LDR  00967cz  a2200253n  4500
=001  9880363656502441
=005  20141212202250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006861
=035  \\$aCBA0046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x685.$x750.$x424
=072  \\$aD1.$x339.$x431.$x374.$x424
=072  \\$aD1.$x650.$x550.$x750.$x400
=150  \\$aHydrogen Peroxide
=450  \\$wnnna$aHydrogen Peroxide (H2O2)
=450  \\$wnnna$aHydroperoxide
=450  \\$wnnna$aOxydol
=450  \\$wnnna$aPerhydrol
=450  \\$wnnna$aPeroxide, Hydrogen
=450  \\$wnnna$aSuperoxol
=550  \\$wg$aPeroxides
=680  \\$iA strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.
=750  \0$aHydrogen peroxide$5IEN$0(DLC)sh 85063431

=LDR  00761cz  a2200217n  4500
=001  9880363656602441
=005  20170628163821.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006860
=035  \\$aCBA0045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x282
=150  \\$aHydrogen Bonding
=450  \\$wnnna$aBonding, Hydrogen
=450  \\$wnnna$aBondings, Hydrogen
=450  \\$wnnna$aHydrogen Bondings
=550  \\$wg$aChemical Phenomena
=667  \\$aNIM
=680  \\$iA low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds.
=688  \\$a91(75); was see under CHEMISTRY, PHYSICAL 1975-90
=750  \0$aHydrogen bonding$5IEN$0(DLC)sh 85063424

=LDR  01086cz  a2200253n  4500
=001  9880363656702441
=005  20141212202250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006859
=035  \\$aCBA0044HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x406
=072  \\$aD1.$x362.$x340
=072  \\$aD1.$x435
=150  \\$aHydrogen
=550  \\$wg$aElements
=550  \\$wg$aGases
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aDeuterium
=550  \\$wh$aProtons
=550  \\$wh$aTritium
=667  \\$aH or H1; H2 or 2H (superscript) = DEUTERIUM; H2 (subscript) = HYDROGEN; H3 or 3H = TRITIUM; prod of H ions = probably PH
=680  \\$iThe first chemical element in the periodic table. It has the atomic symbol H, atomic number 1, and atomic weight [1.00784; 1.00811]. It exists, under normal conditions, as a colorless, odorless, tasteless, diatomic gas. Hydrogen ions are PROTONS. Besides the common H1 isotope, hydrogen exists as the stable isotope DEUTERIUM and the unstable, radioactive isotope TRITIUM.
=750  \0$aHydrogen$5IEN$0(DLC)sh 85063416

=LDR  01028cz  a2200301n  4500
=001  9880363656802441
=005  20141212202249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006858
=035  \\$aCBA0043HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x328
=072  \\$aD1.$x303.$x350
=150  \\$aHydrofluoric Acid
=450  \\$wnnna$aAcid, Fluohydric
=450  \\$wnnna$aAcid, Fluorhydric
=450  \\$wnnna$aAcid, Hydrofluoric
=450  \\$wnnna$aFluohydric Acid
=450  \\$wnnna$aFluorhydric Acid
=450  \\$wnnna$aFluoride, Hydrogen
=450  \\$aHydrogen Fluoride
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aFluorine Compounds
=550  \\$wh$aFluorides
=667  \\$ahydrogen fluoride in water; can cause burns; /analogs = FLUORIDES or specific fluoride
=680  \\$iHydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns.
=688  \\$a77(72)
=750  \0$aHydrofluoric acid$5IEN$0(DLC)sh 85063411

=LDR  00983cz  a2200265n  4500
=001  9880363656902441
=005  20141212202249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006856
=035  \\$aCBA0041HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x330
=072  \\$aD1.$x625.$x400
=150  \\$aHydrogen Cyanide
=450  \\$wnnna$aAcid, Hydrocyanic
=450  \\$wnnna$aCyanide, Hydrogen
=450  \\$aHydrocyanic Acid
=450  \\$wnnna$aZyklon B
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aNitrogen Compounds
=550  \\$wh$aCyanides
=667  \\$atoxic liquid or gas; /analogs = CYANIDES
=680  \\$iHydrogen cyanide (HCN); A toxic liquid or colorless gas. It is found in the smoke of various tobacco products and released by combustion of nitrogen-containing organic materials.
=688  \\$a94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93
=750  \0$aHydrocyanic acid$5IEN$0(DLC)sh 85063385

=LDR  01289cz  a2200325n  4500
=001  9880363657002441
=005  20141212202248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006854
=035  \\$aCBA0039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x600
=072  \\$aD6.$x472.$x40.$x585.$x353.$x476
=072  \\$aD6.$x472.$x40.$x585.$x478.$x392
=150  \\$aHydrocortisone
=450  \\$wnnna$a11-Epicortisol
=450  \\$wnnna$a11 Epicortisol
=450  \\$wnnna$aCortifair
=450  \\$aCortisol
=450  \\$wnnna$aCortril
=450  \\$wnnna$aEpicortisol
=450  \\$wnnna$aHydrocortisone, (11 alpha)-Isomer
=450  \\$wnnna$aHydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer
=550  \\$wg$a11-Hydroxycorticosteroids
=550  \\$wg$a17-Hydroxycorticosteroids
=550  \\$wg$aPregnenediones
=550  \\$wh$aFludrocortisone
=680  \\$iThe main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.
=688  \\$a/adv eff-pois-tox was HYDROCORTISONE TOXICOLOGY 1963-65
=750  \0$aHydrocortisone$5IEN$0(DLC)sh 85063384

=LDR  01167cz  a2200289n  4500
=001  9880363657102441
=005  20141212202247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006851
=035  \\$aCBA0036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x326
=072  \\$aD1.$x210.$x450
=150  \\$aHydrochloric Acid
=450  \\$wnnna$aAcid, Hydrochloric
=450  \\$wnnna$aAcid, Muriatic
=450  \\$wnnna$aChloride, Hydrogen
=450  \\$aHydrogen Chloride
=450  \\$wnnna$aMuriatic Acid
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aChlorine Compounds
=550  \\$wh$aChlorides
=550  \\$aGastric Acid
=667  \\$aHCl; not for gastric HCl ( = GASTRIC ACID); /analogs = CHLORIDES or specific chloride; = "chlorhydrate" in foreign texts: translate as "hydrochloric acid", not "chlorhydrate"
=680  \\$iA strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.
=750  \0$aHydrochloric acid$5IEN$0(DLC)sh 85063381
=750  \0$aHydrogen chloride$5IEN-HS$0(DLC)sh 92002991

=LDR  02192cz  a2200565n  4500
=001  9880363657202441
=005  20141212192238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006849
=035  \\$aCBA0034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x602
=072  \\$aC10.$x228.$x140.$x631.$x450
=150  \\$aHydrocephalus
=450  \\$wnnna$aAqueductal Stenoses
=450  \\$wnnna$aAqueductal Stenosis
=450  \\$wnnna$aCerebral Ventriculomegalies
=450  \\$wnnna$aCerebral Ventriculomegalies, Fetal
=450  \\$wnnna$aCerebral Ventriculomegaly
=450  \\$wnnna$aCerebral Ventriculomegaly, Fetal
=450  \\$aCommunicating Hydrocephalus
=450  \\$aCongenital Hydrocephalus
=450  \\$wnnna$aFetal Cerebral Ventriculomegalies
=450  \\$wnnna$aFetal Cerebral Ventriculomegaly
=450  \\$wnnna$aHydrocephalus, Communicating
=450  \\$wnnna$aHydrocephalus, Congenital
=450  \\$wnnna$aHydrocephalus Ex-Vacuo
=450  \\$wnnna$aHydrocephalus Ex Vacuo
=450  \\$wnnna$aHydrocephalus Ex-Vacuos
=450  \\$wnnna$aHydrocephalus, Obstructive
=450  \\$wnnna$aHydrocephalus, Post-Traumatic
=450  \\$wnnna$aHydrocephaly
=450  \\$aObstructive Hydrocephalus
=450  \\$aPost-Traumatic Hydrocephalus
=450  \\$wnnna$aPost Traumatic Hydrocephalus
=450  \\$wnnna$aStenoses, Aqueductal
=450  \\$wnnna$aStenosis, Aqueductal
=450  \\$wnnna$aVentriculomegalies, Cerebral
=450  \\$wnnna$aVentriculomegalies, Fetal Cerebral
=450  \\$wnnna$aVentriculomegaly, Cerebral
=450  \\$wnnna$aVentriculomegaly, Fetal Cerebral
=550  \\$wg$aBrain Diseases
=550  \\$wg$aIntracranial Hypertension
=550  \\$wh$aDandy-Walker Syndrome
=550  \\$wh$aHydrocephalus, Normal Pressure
=550  \\$aCerebral Ventriculitis
=550  \\$aIntracranial Hypertension
=550  \\$aMegalencephaly
=680  \\$iExcessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA.
=750  \0$aHydrocephalus$5IEN$0(DLC)sh 85063378

=LDR  01320cz  a2200325n  4500
=001  9880363657302441
=005  20141212202246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006848
=035  \\$aCBA0033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x882
=150  \\$aTesticular Hydrocele
=450  \\$wnnna$aHydrocele, Scrotal
=450  \\$wnnna$aHydrocele, Testicular
=450  \\$wnnna$aHydrocele, Vaginal
=450  \\$wnnna$aHydroceles, Scrotal
=450  \\$wnnna$aHydroceles, Testicular
=450  \\$wnnna$aHydroceles, Vaginal
=450  \\$wnnna$aScrotal Hydrocele
=450  \\$wnnna$aScrotal Hydroceles
=450  \\$wnnna$aTesticular Hydroceles
=450  \\$wnnna$aVaginal Hydrocele
=450  \\$wnnna$aVaginal Hydroceles
=550  \\$wg$aGenital Diseases, Male
=667  \\$a"vaginal hydrocele" is of the tunica vaginalis of the testis, not of the vagina; in females, hydrocele of Nuck's canal is a watery dilatation of the processus vaginalis peritonei: index under PERITONEAL DISEASES
=680  \\$iAccumulation of serous fluid between the layers of membrane (tunica vaginalis) covering the TESTIS in the SCROTUM.
=688  \\$a2007; use HYDROCELE 1966-2006
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Hydrocele
=750  \0$aHydrocele$0(DLC) sh 85063377$5IEN

=LDR  00828cz  a2200277n  4500
=001  9880363657402441
=005  20141212202246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006846
=035  \\$aCBA0031HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526
=150  \\$aHydrocarbons, Halogenated
=450  \\$aHalocarbons$5IEN
=450  \\$aHalogenated Hydrocarbons
=550  \\$wg$aHydrocarbons
=550  \\$wh$aHalothane
=550  \\$wh$aHydrocarbons, Brominated
=550  \\$wh$aHydrocarbons, Chlorinated
=550  \\$wh$aHydrocarbons, Fluorinated
=550  \\$wh$aHydrocarbons, Iodinated
=550  \\$wh$aMustard Compounds
=550  \\$wh$aTrihalomethanes
=667  \\$aGEN; note specific halogenated hydrocarbon groups available
=688  \\$a66
=750  \0$aHalocarbons$5IEN$0(DLC)sh 85058504

=LDR  00686cz  a2200229n  4500
=001  9880363657502441
=005  20141212202245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006845
=035  \\$aCBA0030HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x510
=150  \\$aHydrocarbons, Fluorinated
=450  \\$aFluorinated Hydrocarbons
=550  \\$wg$aHydrocarbons, Halogenated
=550  \\$wh$aChlorofluorocarbons
=550  \\$wh$aFluoroacetates
=550  \\$wh$aFluorobenzenes
=550  \\$wh$aFluorocarbons
=667  \\$ado not confuse with FLUOROCARBONS nor with CHLOROFLUOROCARBONS
=688  \\$a74
=750  \0$aFluorohydrocarbons$5IEN$0(DLC)sh 85049439

=LDR  02009cz  a2200649n  4500
=001  9880363657602441
=005  20201016144157.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006843
=035  \\$aCBA0028HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439
=150  \\$aHydrocarbons, Chlorinated
=450  \\$aChlorinated Hydrocarbons
=450  \\$wnnna$aChlorine Compounds, Organic
=450  \\$wnnna$aCompounds, Organic Chlorine
=450  \\$wnnna$aCompounds, Organochlorine
=450  \\$wnnna$aOrganic Chlorine Compounds
=450  \\$wnnna$aOrganochlorine Compounds
=550  \\$wg$aHydrocarbons, Halogenated
=550  \\$wh$aAldrin
=550  \\$wh$aCarbon Tetrachloride
=550  \\$wh$aChlordan
=550  \\$wh$aChlordecone
=550  \\$wh$aChloroacetates
=550  \\$wh$aChlorobenzenes
=550  \\$wh$aChlorofluorocarbons
=550  \\$wh$aChloroform
=550  \\$wh$aDDT
=550  \\$wh$aDichlorodiphenyl Dichloroethylene
=550  \\$wh$aDichlorodiphenyldichloroethane
=550  \\$wh$aDichloroethylenes
=550  \\$wh$aDieldrin
=550  \\$wh$aEndrin
=550  \\$wh$aEthyl Chloride
=550  \\$wh$aEthylene Dichlorides
=550  \\$wh$aHeptachlor
=550  \\$wh$aHexachlorocyclohexane
=550  \\$wh$aMethoxychlor
=550  \\$wh$aMethyl Chloride
=550  \\$wh$aMethylene Chloride
=550  \\$wh$aMirex
=550  \\$wh$aMitotane
=550  \\$wh$aPicryl Chloride
=550  \\$wh$aPolychlorinated Biphenyls
=550  \\$wh$aPolychloroterphenyl Compounds
=550  \\$wh$aTetrachloroethylene
=550  \\$wh$aToxaphene
=550  \\$wh$aTrichloroepoxypropane
=550  \\$wh$aTrichloroethanes
=550  \\$wh$aTrichloroethylene
=550  \\$wh$aVinyl Chloride
=550  \\$aChlorine Compounds
=667  \\$ageneral; prefer specifics
=680  \\$iHydrocarbon compounds with one or more of the hydrogens replaced by CHLORINE.
=688  \\$a74
=750  \0$aChlorohydrocarbons$5IEN$0(DLC)sh 85024567

=LDR  00895cz  a2200229n  4500
=001  9880363657702441
=005  20141212202244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006841
=035  \\$aCBA0026HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559
=150  \\$aHydrocarbons, Aromatic
=450  \\$aAromatic Hydrocarbons
=550  \\$wg$aHydrocarbons, Cyclic
=550  \\$wh$aBenzene Derivatives
=550  \\$wh$aDiarylheptanoids
=550  \\$wh$aPolycyclic Hydrocarbons, Aromatic
=667  \\$aGEN; prefer specifics; used for mapping supplementary chemicals
=680  \\$iOrganic compounds containing carbon and hydrogen in the form of an unsaturated, usually hexagonal ring structure. The compounds can be single ring, or double, triple, or multiple fused rings.
=688  \\$a98; use explode 1967-97
=750  \0$aAromatic compounds$5IEN-M$0(DLC)sh 85007397

=LDR  00744cz  a2200229n  4500
=001  9880363657802441
=005  20141212202243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006838
=035  \\$aCBA0023HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455
=150  \\$aHydrocarbons
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aHydrocarbons, Acyclic
=550  \\$wh$aHydrocarbons, Cyclic
=550  \\$wh$aHydrocarbons, Halogenated
=550  \\$wh$aParaffin
=550  \\$wh$aPetrolatum
=550  \\$wh$aTerpenes
=667  \\$aGEN or unspecified; prefer specific hydrocarbon groups or specific hydrocarbons; POLYCYCLIC COMPOUNDS (D4) & CYCLOPARAFFINS (D2) are also available
=750  \0$aHydrocarbons$5IEN$0(DLC)sh 85063372

=LDR  00805cz  a2200193n  4500
=001  9880363657902441
=005  20141212202243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006837
=035  \\$aCBA0022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x600.$x425
=072  \\$aC17.$x800.$x865.$x575
=150  \\$aHydroa Vacciniforme
=550  \\$wg$aPhotosensitivity Disorders
=550  \\$wg$aSkin Diseases, Vesiculobullous
=667  \\$aa vesiculobullous skin dis on sun-exposed skin
=680  \\$iA vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. (From Dorland, 27th ed)
=750  \0$aHydroa vacciniforme$5IEN$0(DLC)sh 85063366

=LDR  00738cz  a2200205n  4500
=001  9880363658002441
=005  20141212202242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006835
=035  \\$aCBA0020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x442.$x288
=150  \\$aHydrazones
=550  \\$wg$aHydrazines
=550  \\$wh$aCarbonyl Cyanide m-Chlorophenyl Hydrazone
=550  \\$wh$aCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone
=667  \\$ado not confuse with HYDRAZINES
=680  \\$iCompounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a74(72)
=750  \0$aHydrazones$5IEN$0(DLC)sh 92001500

=LDR  00693cz  a2200265n  4500
=001  9880363658102441
=005  20141212202242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006834
=035  \\$aCBA0019HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x442
=150  \\$aHydrazines
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aBenserazide
=550  \\$wh$aCarbidopa
=550  \\$wh$aHydrazones
=550  \\$wh$aIproniazid
=550  \\$wh$aIsoniazid
=550  \\$wh$aMethylhydrazines
=550  \\$wh$aPhenelzine
=550  \\$wh$aPhenylhydrazines
=550  \\$wh$aTodralazine
=667  \\$ado not confuse with HYDRAZONES
=750  \0$aHydrazines$5IEN$0(DLC)sh 85063356

=LDR  00956cz  a2200301n  4500
=001  9880363658202441
=005  20141212202241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006830
=035  \\$aCBA0015HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x710.$x605.$x500
=150  \\$aHydralazine
=450  \\$wnnna$aApresoline
=450  \\$wnnna$aApressin
=450  \\$wnnna$aApressoline
=450  \\$wnnna$aHydralazine Hydrochloride
=450  \\$wnnna$aHydralazine mono-Hydrochloride
=450  \\$wnnna$aHydralazine mono Hydrochloride
=450  \\$aHydrallazin
=450  \\$wnnna$aHydrazinophthalazine
=450  \\$wnnna$aHydrochloride, Hydralazine
=450  \\$wnnna$amono-Hydrochloride, Hydralazine
=450  \\$wnnna$aNepresol
=550  \\$wg$aPhthalazines
=550  \\$wh$aDihydralazine
=680  \\$iA direct-acting vasodilator that is used as an antihypertensive agent.
=750  \0$aHydralazine$5IEN$0(DLC)sh 85063289

=LDR  00650cz  a2200169n  4500
=001  9880363658302441
=005  20141212202241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006829
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x485.$x400
=150  \\$aHydra
=450  \\$wnnna$aHydras
=550  \\$wg$aHydrozoa
=680  \\$iA genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
=688  \\$a72
=750  \0$aHydra$5IEN$0(DLC)sh 85063283

=LDR  02038cz  a2200469n  4500
=001  9880363658402441
=005  20141212202240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x955.$x416.$x812
=072  \\$aC4.$x850.$x908.$x416.$x750
=072  \\$aC13.$x703.$x720.$x949.$x416.$x875
=150  \\$aHydatidiform Mole
=450  \\$wnnna$aComplete Hydatidiform Mole
=450  \\$wnnna$aComplete Hydatidiform Moles
=450  \\$wnnna$aHydatid Mole
=450  \\$wnnna$aHydatid Moles
=450  \\$wnnna$aHydatidiform Mole, Complete
=450  \\$wnnna$aHydatidiform Mole, Partial
=450  \\$wnnna$aHydatidiform Moles
=450  \\$wnnna$aHydatidiform Moles, Complete
=450  \\$wnnna$aHydatidiform Moles, Partial
=450  \\$wnnna$aMolar Pregnancies
=450  \\$aMolar Pregnancy
=450  \\$wnnna$aMole, Complete Hydatidiform
=450  \\$wnnna$aMole, Hydatid
=450  \\$wnnna$aMole, Hydatidiform
=450  \\$wnnna$aMole, Partial Hydatidiform
=450  \\$wnnna$aMoles, Complete Hydatidiform
=450  \\$wnnna$aMoles, Hydatid
=450  \\$wnnna$aMoles, Hydatidiform
=450  \\$wnnna$aMoles, Partial Hydatidiform
=450  \\$wnnna$aPartial Hydatidiform Mole
=450  \\$wnnna$aPartial Hydatidiform Moles
=450  \\$wnnna$aPregnancies, Molar
=450  \\$aPregnancy, Molar
=550  \\$wg$aGestational Trophoblastic Disease
=550  \\$wh$aHydatidiform Mole, Invasive
=667  \\$ado not confuse with HYDATID CYST see ECHINOCOCCOSIS or specifics; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE and PREGNANCY
=680  \\$iTrophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype.
=750  \0$aMolar pregnancy$5IEN$0(DLC)sh 85106289

=LDR  00725cz  a2200241n  4500
=001  9880363658502441
=005  20141212202240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006827
=035  \\$aCBA0012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x432.$x555
=150  \\$aHydantoins
=450  \\$wnnna$aImidazolidine-2,4-Diones
=450  \\$wnnna$aImidazolidine 2,4 Diones
=550  \\$wg$aImidazolidines
=550  \\$wh$aAllantoin
=550  \\$wh$aDantrolene
=550  \\$wh$aMephenytoin
=550  \\$wh$aPhenytoin
=550  \\$wh$aThiohydantoins
=680  \\$iCompounds based on imidazolidine dione. Some derivatives are ANTICONVULSANTS.
=750  \0$aHydantoin$5IEN$0(DLC)sh 85063279

=LDR  00979cz  a2200241n  4500
=001  9880363658602441
=005  20141212202239.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006825
=035  \\$aCBA0010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x251.$x353.$x485
=072  \\$aA11.$x251.$x600.$x485
=150  \\$aHybridomas
=450  \\$wnnna$aHybridoma
=550  \\$wg$aClone Cells
=550  \\$wg$aHybrid Cells
=550  \\$aAntibodies, Monoclonal
=550  \\$aInterleukin-6
=667  \\$anote category: not a tumor but "cells artificially created by fusion of activated lymphocytes with neoplastic cells"; A 11 qualif
=680  \\$iCells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell.
=688  \\$a82
=750  \0$aHybridomas$5IEN$0(DLC)sh 85063278

=LDR  01100cz  a2200325n  4500
=001  9880363658702441
=005  20141212202239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006824
=035  \\$aCBA0009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x820.$x150.$x390
=072  \\$aG5.$x355.$x90.$x390
=150  \\$aHybridization, Genetic
=450  \\$aCrossbreeding
=450  \\$wnnna$aCrossbreedings
=450  \\$wnnna$aGenetic Hybridization
=450  \\$wnnna$aGenetic Hybridizations
=450  \\$wnnoa$aHybridization$5IEN-HS
=450  \\$wnnna$aHybridization, Intraspecies
=450  \\$wnnna$aHybridizations, Genetic
=450  \\$wnnna$aHybridizations, Intraspecies
=450  \\$wnnna$aIntraspecies Hybridization
=450  \\$wnnna$aIntraspecies Hybridizations
=550  \\$wg$aBreeding
=550  \\$aCrosses, Genetic
=550  \\$aHybrid Vigor
=667  \\$aNUCLEIC ACID HYBRIDIZATION is also available
=680  \\$iThe genetic process of crossbreeding between genetically dissimilar parents to produce a hybrid.
=750  \0$aHybridization$5IEN$0(DLC)sh 85063276

=LDR  00687cz  a2200205n  4500
=001  9880363658802441
=005  20141212202239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006823
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x400
=150  \\$aHybrid Vigor
=450  \\$aHeterosis
=450  \\$wnnna$aVigor, Hybrid
=550  \\$wg$aGenetic Phenomena
=550  \\$aGenetic Load
=550  \\$aHybridization, Genetic
=680  \\$iThe adaptive superiority of the heterozygous GENOTYPE with respect to one or more characters in comparison with the corresponding HOMOZYGOTE.
=688  \\$a91(68); was see under HYBRIDIZATION 1968-90
=750  \0$aHeterosis$5IEN$0(DLC)sh 85060546

=LDR  00867cz  a2200301n  4500
=001  9880363658902441
=005  20141212202238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006822
=035  \\$aCBA0007HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x251.$x600
=150  \\$aHybrid Cells
=450  \\$wnnna$aCell, Hybrid
=450  \\$wnnna$aCell Hybrid, Somatic
=450  \\$wnnna$aCell Hybrids, Somatic
=450  \\$wnnna$aCells, Hybrid
=450  \\$wnnna$aHybrid Cell
=450  \\$wnnna$aHybrid, Somatic Cell
=450  \\$wnnna$aHybrids, Somatic Cell
=450  \\$wnnna$aSomatic Cell Hybrid
=450  \\$aSomatic Cell Hybrids
=550  \\$wg$aCells, Cultured
=550  \\$wh$aHybridomas
=550  \\$aCell Fusion
=667  \\$aA 11 qualif; not for micro-organisms
=688  \\$a72
=750  \0$aCell hybridization$5IEN$0(DLC)sh 85021648

=LDR  01509cz  a2200385n  4500
=001  9880363659002441
=005  20141212202238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006820
=035  \\$aCBA0005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x373.$x475
=150  \\$aHyaluronic Acid
=450  \\$wnnna$aAcid, Hyaluronic
=450  \\$wnnna$aAdvanced Medical Optics Brand of Sodium Hyaluronidate
=450  \\$wnnna$aAdvanced Medical Optics, Inc. Brand of Sodium Hyaluronate
=450  \\$wnnna$aAkorn, Inc. Brand of Sodium Hyaluronate
=450  \\$wnnna$aAmo Vitrax
=450  \\$wnnna$aAmvisc
=450  \\$wnnna$aAnika Therapeutics Brand of Sodium Hyaluronidate
=450  \\$wnnna$aBausch and Lomb Brand of Sodium Hyaluronate
=450  \\$wnnna$aBiolon
=450  \\$wnnna$aEtamucine
=450  \\$wnnna$aHealon
=450  \\$wnnna$aHyaluronan
=450  \\$wnnna$aHyaluronate Sodium
=450  \\$wnnna$aHyaluronate, Sodium
=450  \\$wnnna$aHyvisc
=450  \\$wnnna$aLuronit
=450  \\$wnnna$aSodium Hyaluronate
=450  \\$wnnna$aVitrax, Amo
=550  \\$wg$aGlycosaminoglycans
=680  \\$iA natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA.
=688  \\$a2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001
=750  \0$aHyaluronic acid$5IEN$0(DLC)sh 85063257

=LDR  01110cz  a2200241n  4500
=001  9880363659102441
=005  20141212202237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006819
=035  \\$aCBA0004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x842.$x475
=072  \\$aC8.$x618.$x842.$x475
=072  \\$aC16.$x614.$x521.$x563.$x475
=150  \\$aHyaline Membrane Disease
=450  \\$wnnna$aDisease, Hyaline Membrane
=450  \\$wnnna$aDiseases, Hyaline Membrane
=450  \\$wnnna$aHyaline Membrane Diseases
=550  \\$wg$aRespiratory Distress Syndrome, Newborn
=550  \\$aHyalinosis, Systemic
=667  \\$ado not confuse with INFANTILE SYSTEMIC HYALINOSIS see HYALINOSIS, SYSTEMIC
=680  \\$iA respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
=750  \0$aHyaline membrane disease$5IEN$0(DLC)sh 85063253

=LDR  02861cz  a2200577n  4500
=001  9880363659202441
=005  20141212202237.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006816
=035  \\$aCBA0001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x545
=072  \\$aC10.$x228.$x140.$x380.$x278
=072  \\$aC10.$x228.$x662.$x262.$x249.$x750
=072  \\$aC10.$x574.$x500.$x497
=072  \\$aC16.$x320.$x400.$x430
=072  \\$aF3.$x87.$x250.$x400
=072  \\$aF3.$x87.$x400.$x390
=150  \\$aHuntington Disease
=450  \\$wnnna$aAkinetic-Rigid Variant of Huntington Disease
=450  \\$wnnna$aAkinetic Rigid Variant of Huntington Disease
=450  \\$wnnna$aChorea, Chronic Progressive Hereditary (Huntington)
=450  \\$wnnna$aChorea, Huntington
=450  \\$wnnna$aChorea, Huntington's
=450  \\$wnnna$aChronic Progressive Hereditary Chorea (Huntington)
=450  \\$aHuntington Chorea
=450  \\$wnnna$aHuntington Chronic Progressive Hereditary Chorea
=450  \\$wnnna$aHuntington Disease, Akinetic-Rigid Variant
=450  \\$wnnna$aHuntington Disease, Akinetic Rigid Variant
=450  \\$wnnna$aHuntington Disease, Juvenile
=450  \\$wnnna$aHuntington Disease, Juvenile-Onset
=450  \\$wnnna$aHuntington Disease, Juvenile Onset
=450  \\$wnnna$aHuntington Disease, Late Onset
=450  \\$wnnna$aHuntington Disease, Late-Onset
=450  \\$wnnna$aHuntington's Chorea
=450  \\$wnnna$aHuntington's Disease
=450  \\$aJuvenile Huntington Disease
=450  \\$wnnna$aJuvenile-Onset Huntington Disease
=450  \\$wnnna$aJuvenile Onset Huntington Disease
=450  \\$wnnna$aLate-Onset Huntington Disease
=450  \\$wnnna$aLate Onset Huntington Disease
=450  \\$wnnna$aProgressive Chorea, Chronic Hereditary (Huntington)
=450  \\$wnnna$aProgressive Chorea, Hereditary, Chronic (Huntington)
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aChorea
=550  \\$wg$aCognition Disorders
=550  \\$wg$aDementia
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=680  \\$iA familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
=688  \\$a2000(1963)
=750  \0$aHuntington's disease$5IEN$0(DLC)sh 85063158

=LDR  00753cz  a2200253n  4500
=001  9880363659302441
=005  20141212202236.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006815
=035  \\$aCBA0000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x293.$x391
=072  \\$aG7.$x610.$x390
=072  \\$aG10.$x261.$x390
=150  \\$aHunger
=550  \\$wg$aDigestive System Physiological Phenomena
=550  \\$wg$aDrive
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aAppetite
=550  \\$aFasting
=550  \\$aFood Deprivation
=550  \\$aStarvation
=680  \\$iThe desire for FOOD generated by a sensation arising from the lack of food in the STOMACH.
=750  \0$aHunger$5IEN$0(DLC)sh 85063084

=LDR  00647cz  a2200217n  4500
=001  9880363659402441
=005  20141212202235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006813
=035  \\$aCAZ9998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x63.$x725.$x310
=072  \\$aG16.$x500.$x750.$x775.$x310
=072  \\$aN6.$x230.$x150.$x372
=072  \\$aN6.$x230.$x300.$x100.$x725.$x310
=150  \\$aHumidity
=450  \\$wnnna$aHumidities
=550  \\$wg$aEnvironment, Controlled
=550  \\$wg$aWeather
=680  \\$iA measure of the amount of WATER VAPOR in the air.
=750  \0$aHumidity$5IEN$0(DLC)sh 85062931

=LDR  01080cz  a2200277n  4500
=001  9880363659502441
=005  20141212202235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006812
=035  \\$aCAZ9997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x444
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x377
=072  \\$aD20.$x721.$x500
=150  \\$aHumic Substances
=450  \\$wnnna$aAcids, Humic
=450  \\$aHumic Acids
=450  \\$wnnna$aHuminate, Sodium
=450  \\$wnnna$aSodium Huminate
=450  \\$wnnna$aSubstances, Humic
=550  \\$wg$aCarboxylic Acids
=550  \\$wg$aPhenols
=550  \\$wg$aSoil
=680  \\$iOrganic matter in a state of advanced decay, after passing through the stages of COMPOST and PEAT and before becoming lignite (COAL). It is composed of a heterogenous mixture of compounds including phenolic radicals and acids that polymerize and are not easily separated nor analyzed. (E.A. Ghabbour & G. Davies, eds. Humic Substances, 2001).
=688  \\$a2005(1963)
=750  \0$aHumic acid$0(DLC) sh 85062929$5IEN

=LDR  00482cz  a2200169n  4500
=001  9880363659602441
=005  20141212202235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006811
=035  \\$aCAZ9996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x90.$x400
=150  \\$aHumerus
=550  \\$wg$aArm Bones
=550  \\$wh$aHumeral Head
=667  \\$adisloc at shoulder = SHOULDER DISLOCATION: do not add HUMERUS
=750  \0$aHumerus$5IEN$0(DLC)sh 85062928

=LDR  00693cz  a2200289n  4500
=001  9880363659702441
=005  20171012140732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006809
=035  \\$aCAZ9994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1
=150  \\$aHumanities
=550  \\$wh$aArt
=550  \\$wh$aAwards and Prizes
=550  \\$wh$aHistory
=550  \\$wh$aKnowledge
=550  \\$wh$aLiterature
=550  \\$wh$aMorals
=550  \\$wh$aMusic
=550  \\$wh$aNature
=550  \\$wh$aOccultism
=550  \\$wh$aPhilosophy
=550  \\$wh$aRomanticism
=550  \\$wh$aReligion
=550  \\$wh$aSecularism
=750  \0$aHumanities$0(DLC) sh 85062913$5IEN

=LDR  00619cz  a2200193n  4500
=001  9880363659802441
=005  20141212202234.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006808
=035  \\$aCAZ9993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x400
=072  \\$aK1.$x752.$x566.$x479.$x120
=150  \\$aHumanism
=550  \\$wg$aEthics
=550  \\$wh$aFeminism
=680  \\$iAn ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind.
=688  \\$a78
=750  \0$aHumanism$5IEN$0(DLC)sh 85062902

=LDR  01272cz  a2200349n  4500
=001  9880363660002441
=005  20141212202234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x445
=072  \\$aH1.$x770.$x644.$x145.$x365
=072  \\$aH1.$x770.$x644.$x302
=150  \\$aHuman Experimentation
=450  \\$wnnna$aExperimentation, Human
=450  \\$wnnna$aHuman Research Subject Protection
=550  \\$wg$aBiomedical Research
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aResearch
=550  \\$wh$aAutoexperimentation
=550  \\$wh$aNontherapeutic Human Experimentation
=550  \\$wh$aTherapeutic Human Experimentation
=550  \\$aBioethical Issues
=550  \\$aEmbryo Research
=550  \\$aEthics, Research
=550  \\$aFetal Research
=550  \\$aHelsinki Declaration
=550  \\$aResearch Subjects
=667  \\$aIM for moral, legal, ethical, sociologic, religious aspect of experiments on humans; coordinate IM with aspect (IM); do not routinely add for research involving human disease, therapy or physiology
=680  \\$iThe use of humans as investigational subjects.
=688  \\$a66
=750  \0$aHuman experimentation in medicine$5IEN$0(DLC)sh 85062870

=LDR  01308cz  a2200337n  4500
=001  9880363660202441
=005  20141212211016.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015367
=035  \\$aCAZ9983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x200.$x730.$x404
=072  \\$aB4.$x909.$x574.$x807.$x200.$x730.$x399
=072  \\$aB4.$x909.$x777.$x731.$x200.$x730.$x404
=150  \\$aHuman T-lymphotropic virus 2
=450  \\$aHTLV-2
=450  \\$aHTLV-II
=450  \\$wnnna$aHuman T Cell Leukemia Virus II
=450  \\$aHuman T-Cell Leukemia Virus II
=450  \\$wnnna$aHuman T lymphotropic virus 2
=450  \\$wnnna$aHuman T Lymphotropic Virus II
=450  \\$aHuman T-Lymphotropic Virus II
=450  \\$wnnna$aLeukemia Virus II, Human T Cell
=450  \\$aLeukemia Virus II, Human T-Cell
=450  \\$wnnna$aT Cell Leukemia Virus II, Human
=450  \\$aT-Cell Leukemia Virus II, Human
=550  \\$wg$aPrimate T-lymphotropic virus 2
=667  \\$ainfection = HTLV-II INFECTIONS
=680  \\$iA strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1.
=688  \\$a2002 (1989)
=750  \0$aHTLV-II (Virus)$0(DLC)sh2010007849$5IEN-M

=LDR  00865cz  a2200253n  4500
=001  9880363660302441
=005  20141212211101.0
=008  880610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015490
=035  \\$aCAZ9982HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x200.$x470
=072  \\$aC20.$x673.$x483.$x470
=150  \\$aHTLV-I Infections
=450  \\$wnnna$aHTLV-I Infection
=450  \\$wnnna$aHTLV I Infections
=450  \\$wnnna$aInfection, HTLV-I
=450  \\$wnnna$aInfections, HTLV-I
=450  \\$wnnna$aInfections, HTLV I
=550  \\$wg$aDeltaretrovirus Infections
=550  \\$wh$aParaparesis, Tropical Spastic
=667  \\$aGEN or unspecified; consider also LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED & PARAPARESIS, TROPICAL SPASTIC; DF: HTLV I INFECT
=688  \\$a89
=750  \0$aHTLV-I infections$5IEN$0(DLC)sh 88007038

=LDR  01682cz  a2200361n  4500
=001  9880363660402441
=005  20141212211016.0
=008  880602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015368
=035  \\$aCAZ9981HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x200.$x725.$x400
=072  \\$aB4.$x909.$x574.$x807.$x200.$x725.$x400
=072  \\$aB4.$x909.$x777.$x731.$x200.$x725.$x400
=150  \\$aHuman T-lymphotropic virus 1
=450  \\$wnnna$aAdult T Cell Leukemia Lymphoma Virus I
=450  \\$aAdult T-Cell Leukemia-Lymphoma Virus I
=450  \\$aATLV
=450  \\$aHTLV-1
=450  \\$aHTLV-I
=450  \\$wnnna$aHuman T Cell Leukemia Virus I
=450  \\$aHuman T-Cell Leukemia Virus I
=450  \\$wnnna$aHuman T lymphotropic virus 1
=450  \\$wnnna$aLeukemia Lymphoma Virus I, Adult T Cell
=450  \\$wnnna$aLeukemia Virus I, Human T Cell
=450  \\$aLeukemia Virus I, Human T-Cell
=450  \\$wnnna$aT Cell Leukemia Virus I, Human
=450  \\$aT-Cell Leukemia Virus I, Human
=550  \\$wg$aPrimate T-lymphotropic virus 1
=667  \\$ainfection = HTLV-I INFECTIONS or its specifics; t-cell lymphoma caused by this virus = LYMPHOMA, T-CELL + HTLV-I INFECTIONS
=680  \\$iA strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC).
=688  \\$a2001 (1989)
=750  \0$aHTLV-I (Virus)$5IEN-M$0(DLC)sh 88007035

=LDR  01371cz  a2200361n  4500
=001  9880363660502441
=005  20141212202232.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006800
=035  \\$aCAZ9979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x200
=072  \\$aC20.$x673.$x483
=150  \\$aDeltaretrovirus Infections
=450  \\$wnnna$aBLV Infection
=450  \\$aBLV Infections
=450  \\$wnnna$aDeltaretrovirus Infection
=450  \\$wnnna$aHTLV-BLV Infection
=450  \\$aHTLV-BLV Infections
=450  \\$wnnna$aHTLV BLV Infections
=450  \\$wnnna$aHTLV Infection
=450  \\$aHTLV Infections
=450  \\$wnnna$aInfection, Deltaretrovirus
=450  \\$wnnna$aInfections, Deltaretrovirus
=550  \\$wg$aImmunologic Deficiency Syndromes
=550  \\$wg$aRetroviridae Infections
=550  \\$wh$aEnzootic Bovine Leukosis
=550  \\$wh$aHTLV-I Infections
=550  \\$wh$aHTLV-II Infections
=667  \\$aGEN or unspecified only: prefer specifics; do not confuse X ref BLV INFECTIONS with ENZOOTIC BOVINE LEUKOSIS (see MeSH definition); DF: HTLV INFECT
=680  \\$iInfections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).
=688  \\$a2002 (1987)
=750  \0$aHTLV infections$5IEN$0(DLC)sh 88007037

=LDR  00551cz  a2200205n  4500
=001  9880363660602441
=005  20141212202232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006799
=035  \\$aCAZ9978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x360.$x250
=150  \\$aHousing, Animal
=450  \\$wnnna$aAnimal Housing
=450  \\$wnnna$aAnimal Housings
=450  \\$wnnna$aHousings, Animal
=550  \\$wg$aHousing
=550  \\$wh$aHospitals, Animal
=688  \\$a72
=750  \0$aAnimal housing$5IEN$0(DLC)sh 85005196

=LDR  01260cz  a2200397n  4500
=001  9880363660702441
=005  20200619131450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006798
=035  \\$aCAZ9977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ3.$x340
=072  \\$aN1.$x224.$x791.$x400
=072  \\$aN6.$x230.$x150.$x360
=072  \\$aN6.$x850.$x505.$x400.$x800.$x400
=150  \\$aHousing
=450  \\$aFamily-Patient Lodging
=450  \\$wnnna$aFamily Patient Lodging
=450  \\$wnnna$aFamily-Patient Lodgings
=450  \\$wnnna$aLodging, Family-Patient
=450  \\$wnnna$aLodging, Patient-Family
=450  \\$wnnna$aLodgings, Family-Patient
=450  \\$wnnna$aLodgings, Patient-Family
=450  \\$aPatient-Family Lodging
=450  \\$wnnna$aPatient Family Lodging
=450  \\$wnnna$aPatient-Family Lodgings
=550  \\$wg$aEnvironment, Controlled
=550  \\$wg$aResidence Characteristics
=550  \\$wh$aHousing, Animal
=550  \\$wh$aHousing for the Elderly
=550  \\$wh$aPublic Housing
=550  \\$wh$aRefugee Camps
=550  \\$aUrban Renewal
=667  \\$afor persons; for animals use HOUSING, ANIMAL
=680  \\$iLiving facilities for humans.
=750  \0$aHousing$5IEN$0(DLC)sh 85062603

=LDR  00826cz  a2200241n  4500
=001  9880363660802441
=005  20141212202231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006797
=035  \\$aCAZ9976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x412
=072  \\$aN2.$x508.$x472
=072  \\$aN4.$x452.$x442.$x422.$x412
=150  \\$aHousekeeping, Hospital
=450  \\$aHospital Housekeeping
=450  \\$wnnna$aHospital Housekeepings
=450  \\$wnnna$aHousekeepings, Hospital
=550  \\$wg$aHospital Departments
=550  \\$wg$aHousekeeping
=680  \\$iHospital department which manages and provides the required housekeeping functions in all areas of the hospital.
=688  \\$a78; was HOSPITAL HOUSEKEEPING 1963-77
=750  \0$aHospital housekeeping$5IEN$0(DLC)sh 85062244

=LDR  01005nz  a2200289n  4500
=001  9882116471902441
=005  20230127144624.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006796
=035  \\$a(DNLM)D006796
=035  \\$a(NLM)98194212810000041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x508
=150  \\$aHousehold Work
=450  \\$wnnna$aHousework
=450  \\$aHousehold Activity
=450  \\$aHousekeeping
=450  \\$wnnna$aActivities, Household
=450  \\$wnnna$aActivity, Household
=450  \\$wnnna$aHousehold Activities
=450  \\$wnnna$aHousehold Works
=450  \\$wnnna$aWork, Household
=450  \\$wnnna$aWorks, Household
=667  \\$anot restricted to domestic housekeeping; HOUSEKEEPING, HOSPITAL is also available
=680  \\$iHousehold work including physical, emotional, and spiritual integrating household work with care work whether on a paid or unpaid basis.
=688  \\$a73
=750  \0$aHome economics$5IEN$0(DLC)sh 85061673

=LDR  00941cz  a2200277n  4500
=001  9880363661002441
=005  20141212202231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006795
=035  \\$aCAZ9974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x516
=150  \\$aHousehold Products
=450  \\$wnnna$aHousehold Product
=450  \\$aHousehold Supplies
=450  \\$wnnna$aProduct, Household
=450  \\$wnnna$aProducts, Household
=450  \\$wnnna$aSupplies, Household
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aCosmetics
=550  \\$wh$aDetergents
=550  \\$wh$aSoaps
=667  \\$athese are consumable (like housecleaning products): differentiate from HOUSEHOLD ARTICLES, more or less permanent (like rugs)
=680  \\$iSubstances or materials used in the course of housekeeping or personal routine.
=688  \\$a75
=750  \0$aHousehold supplies$5IEN$0(DLC)sh 85062592

=LDR  00944cz  a2200229n  4500
=001  9880363661102441
=005  20141212202230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D006793
=035  \\$aCAZ9972HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x642.$x470
=150  \\$aHouseflies
=450  \\$wnnna$adomestica, Musca
=450  \\$wnnna$adomesticas, Musca
=450  \\$wnnna$aHousefly
=450  \\$aMusca domestica
=450  \\$wnnna$aMusca domesticas
=550  \\$wg$aMuscidae
=667  \\$a/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111; note X ref MUSCA DOMESTICA but other Musca species & genera of family Muscidae go under MUSCIDAE
=680  \\$iFlies of the species Musca domestica (family MUSCIDAE), which infest human habitations throughout the world and often act as carriers of pathogenic organisms.
=750  \0$aHousefly$5IEN$0(DLC)sh 85062571

=LDR  01314cz  a2200277n  4500
=001  9880363862902441
=005  20141212204512.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010706
=035  \\$aCBA3995M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x670
=072  \\$aD2.$x705.$x539.$x345.$x670
=072  \\$aD2.$x886.$x300.$x692.$x670
=072  \\$aD3.$x438.$x513.$x750.$x625
=150  \\$aPhosmet
=450  \\$wnnna$aImidan
=450  \\$wnnna$aN-(Mercaptomethyl)phthalimide S-(O,O-dimethyl phosphorothionate)
=450  \\$aPhthalophos
=450  \\$wnnna$aProlate
=550  \\$wg$aOrganothiophosphates
=550  \\$wg$aPhthalimides
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iAn organothiophosphorus insecticide that has been used to control pig mange.
=688  \\$a91(75); was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93
=750  \0$aPhosmet$0(DLC)sh2008020261$5IEN-M

=LDR  00569cz  a2200193n  4500
=001  9880363863002441
=005  20141212204511.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010704
=035  \\$aCBA3993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291.$x500
=150  \\$aPhorbols
=550  \\$wg$aDiterpenes
=550  \\$wh$aPhorbol Esters
=667  \\$acarcinogens; D25-26 qualif
=680  \\$iThe parent alcohol of the tumor promoting compounds from CROTON OIL (Croton tiglium).
=688  \\$a75
=750  \0$aPhorbols$5IEN$0(DLC)sh 85101079

=LDR  01011cz  a2200253n  4500
=001  9880363863102441
=005  20141212204511.0
=008  741114\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010703
=035  \\$aCBA3991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x291.$x500.$x510
=150  \\$aPhorbol Esters
=450  \\$wnnna$aDiesters, Phorbol
=450  \\$wnnna$aEsters, Phorbol
=450  \\$wnnna$aPhorbol Diesters
=550  \\$wg$aPhorbols
=550  \\$wh$aPhorbol 12,13-Dibutyrate
=550  \\$wh$aTetradecanoylphorbol Acetate
=550  \\$aCroton Oil
=667  \\$aa group of tumor-promoting cpds; GEN or unspecified: prefer specifics; index here only for a specific phorbol ester not in MeSH; D25-26 qualif
=680  \\$iTumor-promoting compounds obtained from CROTON OIL (Croton tiglium). Some of these are used in cell biological experiments as activators of protein kinase C.
=688  \\$a86(75); was see under PHORBOLS 1975-85
=750  \0$aPhorbol esters$5IEN$0(DLC)sh 85101078

=LDR  01076cz  a2200217n  4500
=001  9880363863202441
=005  20141212204511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010701
=035  \\$aCBA3989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x400.$x500
=150  \\$aPhonocardiography
=450  \\$wnnna$aPhonocardiographies
=550  \\$wg$aHeart Auscultation
=550  \\$aHeart Auscultation
=550  \\$aHeart Murmurs
=550  \\$aHeart Sounds
=667  \\$aNIM; consider also HEART AUSCULTATION; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PHONOCARDIOGR
=680  \\$iGraphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine.
=750  \0$aPhonocardiography$5IEN$0(DLC)sh 85101058

=LDR  00742cz  a2200217n  4500
=001  9880363863302441
=005  20141212204510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010700
=035  \\$aCBA3988HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x518
=150  \\$aPhonetics
=450  \\$wnnna$aSound, Speech
=450  \\$wnnna$aSounds, Speech
=450  \\$wnnna$aSpeech Sound
=450  \\$aSpeech Sounds
=550  \\$wg$aLinguistics
=667  \\$ano qualif
=680  \\$iThe science or study of speech sounds and their production, transmission, and reception, and their analysis, classification, and transcription. (Random House Unabridged Dictionary, 2d ed)
=750  \0$aPhonetics$5IEN$0(DLC)sh 85101053

=LDR  01403cz  a2200397n  4500
=001  9880363863402441
=005  20181011115800.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010698
=035  \\$aCBA3986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x725
=150  \\$aPhobic Disorders
=450  \\$aClaustrophobia
=450  \\$wnnna$aClaustrophobias
=450  \\$wnnna$aDisorder, Phobic
=450  \\$wnnna$aDisorders, Phobic
=450  \\$aNeuroses, Phobic
=450  \\$wnnna$aPhobia
=450  \\$aPhobia, School
=450  \\$aPhobia, Social
=450  \\$aPhobias
=450  \\$wnnna$aPhobias, School
=450  \\$wnnna$aPhobias, Social
=450  \\$wnnna$aPhobic Disorder
=450  \\$aPhobic Neuroses
=450  \\$wnnna$aSchool Phobia
=450  \\$wnnna$aSchool Phobias
=450  \\$wnnna$aSocial Phobia
=450  \\$wnnna$aSocial Phobias
=550  \\$wg$aAnxiety Disorders
=550  \\$wh$aPhobia, Social
=550  \\$aFear
=680  \\$iAnxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
=688  \\$a81; was PHOBIAS 1963-80; PHOBIC NEUROSES was see under PHOBIAS 1969-80; CLAUSTROPHOBIA was see under PHOBIAS 1968-78
=750  \0$aPhobias$5IEN$0(DLC)sh 85101017

=LDR  00824cz  a2200169n  4500
=001  9880363863502441
=005  20141212204508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010691
=035  \\$aCBA3979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x781.$x602
=150  \\$aPhlebotomus
=550  \\$wg$aPsychodidae
=667  \\$ablood-sucking fly, the vector of PAPPATACI FEVER see PHLEBOTOMUS FEVER & other dis; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI; LEISHMANIA TROPICA; Bartonella bacilliformis, and the Pappataci fever virus (SANDFLY FEVER NAPLES VIRUS).
=750  \0$aPhlebotomus$5IEN$0(DLC)sh 85101010

=LDR  00861cz  a2200253n  4500
=001  9880363863602441
=005  20141212204508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010690
=035  \\$aCBA3978HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x60.$x600
=072  \\$aE1.$x370.$x370.$x50.$x600
=150  \\$aPhlebography
=450  \\$wnnna$aPhlebographies
=450  \\$aVeins$xradiography
=450  \\$wnnna$aVenographies
=450  \\$aVenography
=550  \\$wg$aAngiography
=550  \\$aVeins
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PHLEBOGR
=680  \\$iRadiographic visualization or recording of a vein after the injection of contrast medium.
=688  \\$a66(63); was see under ANGIOGRAPHY 1963-65
=750  \0$aVeins$xRadiography$5IEN$0(DLC)sh 85142548

=LDR  00897cz  a2200265n  4500
=001  9880363863702441
=005  20141212204507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010689
=035  \\$aCBA3977HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x617.$x718
=072  \\$aC14.$x907.$x940.$x740
=150  \\$aPhlebitis
=450  \\$wnnna$aPeriphlebitides
=450  \\$aPeriphlebitis
=450  \\$wnnna$aPhlebitides
=550  \\$wg$aPeripheral Vascular Diseases
=550  \\$wg$aVasculitis
=550  \\$wh$aPostphlebitic Syndrome
=550  \\$wh$aThrombophlebitis
=667  \\$ado not coordinate with LEG; THROMBOPHLEBITIS is also available
=680  \\$iInflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).
=688  \\$aPERIPHLEBITIS was heading 1963-83
=750  \0$aPhlebitis$5IEN$0(DLC)sh 85101009

=LDR  00592cz  a2200181n  4500
=001  9880363863802441
=005  20141212204507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010688
=035  \\$aCBA3976HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x494.$x684
=150  \\$aPhimosis
=450  \\$wnnna$aPhimoses
=550  \\$wg$aPenile Diseases
=550  \\$wh$aParaphimosis
=680  \\$iA condition in which the FORESKIN cannot be retracted to reveal the GLANS PENIS. It is due to tightness or narrowing of the foreskin opening.
=750  \0$aPhimosis$5IEN$0(DLC)sh 85101006

=LDR  01354cz  a2200385n  4500
=001  9880363863902441
=005  20141212204414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010519
=035  \\$aCBA3805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x646
=150  \\$aPeriodontium
=450  \\$aParadentium
=450  \\$wnnna$aParadentiums
=450  \\$aParodontium
=450  \\$wnnna$aParodontiums
=450  \\$wnnna$aPeriodontiums
=450  \\$wnnna$aStructure, Tooth Supporting
=450  \\$wnnna$aStructures, Tooth Supporting
=450  \\$wnnna$aSupporting Structure, Tooth
=450  \\$wnnna$aSupporting Structures, Tooth
=450  \\$wnnna$aTooth Supporting Structure
=450  \\$aTooth Supporting Structures
=550  \\$wg$aDentition
=550  \\$wh$aAlveolar Process
=550  \\$wh$aDental Cementum
=550  \\$wh$aEpithelial Attachment
=550  \\$wh$aGingiva
=550  \\$wh$aPeriapical Tissue
=550  \\$wh$aPeriodontal Ligament
=667  \\$ainflammation = PERIODONTITIS
=680  \\$iThe structures surrounding and supporting the tooth. Periodontium includes the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.
=688  \\$aTOOTH SUPPORTING STRUCTURES was heading 1965-67
=750  \0$aPeriodontium$5IEN$0(DLC)sh 85099926

=LDR  01225cz  a2200277n  4500
=001  9880363864002441
=005  20141212204413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010518
=035  \\$aCBA3804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x533
=150  \\$aPeriodontitis
=450  \\$wnnna$aPericementitides
=450  \\$aPericementitis
=450  \\$wnnna$aPeriodontitides
=550  \\$wg$aPeriodontal Diseases
=550  \\$wh$aAggressive Periodontitis
=550  \\$wh$aChronic Periodontitis
=550  \\$wh$aPeriapical Periodontitis
=550  \\$wh$aPeriodontal Abscess
=550  \\$wh$aPeriodontal Pocket
=667  \\$ageneral; prefer specifics
=680  \\$iInflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)
=688  \\$a65; PERICEMENTITIS was see under PERIODONTITIS 1969-78
=750  \0$aPeriodontitis$0(DLC)  sh 85099925$5IEN

=LDR  01163cz  a2200337n  4500
=001  9880363864102441
=005  20141212204413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010517
=035  \\$aCBA3803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721
=072  \\$aH2.$x163.$x876.$x623
=150  \\$aPeriodontics
=450  \\$wnnna$aPeriodontic
=450  \\$aPeriodontists$5IEN
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aDental Prophylaxis
=550  \\$wh$aGingivectomy
=550  \\$wh$aGingivoplasty
=550  \\$wh$aGuided Tissue Regeneration, Periodontal
=550  \\$wh$aPeriodontal Dressings
=550  \\$wh$aPeriodontal Index
=550  \\$wh$aPeriodontal Prosthesis
=550  \\$wh$aSubgingival Curettage
=667  \\$aSPEC: SPEC qualif
=680  \\$iA dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth, and of the treatment and prevention of disease affecting these tissues.
=688  \\$a65
=750  \0$aPeriodontists$5IEN-M$0(DLC)sh 85099924
=750  \0$aPeriodontics$5IEN-HS$0(DLC)sh 85099922

=LDR  00715cz  a2200205n  4500
=001  9880363864202441
=005  20141212204413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010516
=035  \\$aCBA3802HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x721.$x680
=150  \\$aPeriodontal Splints
=450  \\$wnnna$aPeriodontal Splint
=450  \\$wnnna$aSplint, Periodontal
=450  \\$aSplints, Periodontal
=550  \\$wg$aPeriodontal Prosthesis
=667  \\$ado not use /util except by MeSH definition
=688  \\$a91(80); was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79
=750  \0$aSplints, Periodontal$5IEN$0(DLC)sh 85126833

=LDR  00998cz  a2200253n  4500
=001  9880363864302441
=005  20141212204412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010515
=035  \\$aCBA3801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x721
=072  \\$aE7.$x695.$x190.$x610
=150  \\$aPeriodontal Prosthesis
=450  \\$wnnna$aPeriodontal Prostheses
=450  \\$wnnna$aProstheses, Periodontal
=450  \\$wnnna$aProsthesis, Periodontal
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aPeriodontics
=550  \\$wh$aPeriodontal Splints
=667  \\$ado not use /util except by MeSH definition
=680  \\$iAny restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. (Boucher's Clinical Dental Terminology, 3d ed)
=688  \\$a66
=750  \0$aPeriodontal prosthesis$5IEN$0(DLC)sh 85099921

=LDR  00827cz  a2200229n  4500
=001  9880363864402441
=005  20141212204412.0
=008  780228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010514
=035  \\$aCBA3800HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714.$x533.$x750
=150  \\$aPeriodontal Pocket
=450  \\$wnnna$aPeriodontal Pockets
=450  \\$aPocket, Periodontal
=450  \\$wnnna$aPockets, Periodontal
=550  \\$wg$aPeriodontitis
=550  \\$aGingival Pocket
=667  \\$ado not confuse with GINGIVAL POCKET: read MeSH definition
=680  \\$iAn abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption.
=688  \\$a91(79); was see under PERIODONTITIS 1979-90
=750  \0$aPeriodontal pockets$5IEN$0(DLC)sh 85099918

=LDR  01184cz  a2200313n  4500
=001  9880363864502441
=005  20141212204412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010513
=035  \\$aCBA3799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x646.$x771
=150  \\$aPeriodontal Ligament
=450  \\$aAlveolodental Ligament
=450  \\$wnnna$aAlveolodental Ligaments
=450  \\$aAlveolodental Membrane
=450  \\$wnnna$aAlveolodental Membranes
=450  \\$wnnna$aLigament, Alveolodental
=450  \\$wnnna$aLigament, Periodontal
=450  \\$wnnna$aLigaments, Alveolodental
=450  \\$wnnna$aLigaments, Periodontal
=450  \\$wnnna$aMembrane, Alveolodental
=450  \\$wnnna$aMembranes, Alveolodental
=450  \\$wnnna$aPeriodontal Ligaments
=550  \\$wg$aPeriodontium
=667  \\$aintraligamental anesthesia or periodontal ligament injection (PDLI): coord IM with ANESTHESIA, DENTAL (IM)
=680  \\$iThe fibrous CONNECTIVE TISSUE surrounding the TOOTH ROOT, separating it from and attaching it to the alveolar bone (ALVEOLAR PROCESS).
=688  \\$a73(72)
=750  \0$aPeriodontal ligament$5IEN$0(DLC)sh 85099915

=LDR  00802cz  a2200217n  4500
=001  9880363864602441
=005  20141212204411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010511
=035  \\$aCBA3797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x721.$x595
=150  \\$aPeriodontal Dressings
=450  \\$wnnna$aDressing, Periodontal
=450  \\$aDressings, Periodontal
=450  \\$wnnna$aPeriodontal Dressing
=550  \\$wg$aPeriodontics
=667  \\$aafter periodontal surg; D25-26 qualif
=680  \\$iSurgical dressings, after periodontal surgery, applied to the necks of teeth and the adjacent tissue to cover and protect the surgical wound. (Boucher's Clinical Dental Terminology, 4th ed, p218)
=688  \\$a73(71)
=750  \0$aPeriodontal dressings$5IEN$0(DLC)sh 85099914

=LDR  01466cz  a2200373n  4500
=001  9880363864702441
=005  20141212204411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010510
=035  \\$aCBA3796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x714
=150  \\$aPeriodontal Diseases
=450  \\$wnnna$aDisease, Periodontal
=450  \\$wnnna$aDiseases, Periodontal
=450  \\$wnnna$aParodontoses
=450  \\$aParodontosis
=450  \\$wnnna$aPeriodontal Disease
=450  \\$aPyorrhea Alveolaris
=550  \\$wg$aMouth Diseases
=550  \\$wh$aFurcation Defects
=550  \\$wh$aGingival Diseases
=550  \\$wh$aPeri-Implantitis
=550  \\$wh$aPeriapical Diseases
=550  \\$wh$aPeriodontal Atrophy
=550  \\$wh$aPeriodontal Cyst
=550  \\$wh$aPeriodontitis
=550  \\$wh$aTooth Loss
=550  \\$wh$aTooth Migration
=550  \\$wh$aTooth Mobility
=667  \\$aentry term PARODONTOSIS occurs in foreign literature; "periodontosis" also seen in foreign literature, meaning "periodontal disease", should not be confused with PERIODONTOSIS see AGGRESSIVE PERIODONTITIS; inflammatory disease = PERIODONTITIS
=680  \\$iPathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT.
=688  \\$a65; was PERIODONTAL DISEASE 1963-64
=750  \0$aPeriodontal disease$5IEN$0(DLC)sh 85099910

=LDR  01295cz  a2200361n  4500
=001  9880363864802441
=005  20190131114209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010507
=035  \\$aCBA3793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x910.$x645
=072  \\$aG7.$x180.$x562
=150  \\$aPeriodicity
=450  \\$wnnna$aBioperiodicities
=450  \\$aBioperiodicity
=450  \\$wnnna$aBiorhythm
=450  \\$aBiorhythms
=450  \\$aCycles$5IEN
=450  \\$wnnna$aCyclicities
=450  \\$aCyclicity
=450  \\$wnnna$aPeriodicities
=450  \\$wnnna$aRhythmicities
=450  \\$aRhythmicity
=550  \\$wg$aChronobiology Phenomena
=550  \\$wg$aTime
=550  \\$wh$aBiological Clocks
=550  \\$wh$aCircadian Rhythm
=550  \\$wh$aSeasons
=550  \\$wh$aUltadian Rhythm
=667  \\$aIM + coord with specific dis for periodically occurring dis (IM); no qualif; do not confuse with PERIODIC DISEASE, a specific clin entity: see Dorland
=680  \\$iThe tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian).
=750  \0$aCycles$5IEN$0(DLC)sh 85035062

=LDR  01099cz  a2200265n  4500
=001  9880363864902441
=005  20141212204409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010506
=035  \\$aCBA3792HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x829.$x678
=150  \\$aPeriodicals as Topic
=450  \\$aJournals as Topic
=450  \\$wnnna$aMagazine
=450  \\$wnnna$aMagazines
=450  \\$wnnna$aNewsletter
=450  \\$wnnna$aNewsletters
=550  \\$wg$aSerial Publications
=550  \\$aPublishing
=667  \\$ado not confuse with the Publication Type PERIODICALS; medical periodicals, medical journals, medical newsletters: do not coordinate with MEDICINE; writing for periodicals goes here but see note on WRITING; note entry term NEWSLETTERS: for articles from newsletters, the Publication Type NEWSPAPER ARTICLE is available
=680  \\$iA publication issued at stated, more or less regular, intervals.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Periodicals
=750  \0$aPeriodicals$0(DLC) sh 85099890$5IEN

=LDR  02656cz  a2200589n  4500
=001  9880363865002441
=005  20141212204409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010505
=035  \\$aCBA3791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x382.$x625
=150  \\$aFamilial Mediterranean Fever
=450  \\$wnnna$aBenign Paroxysmal Peritonitides
=450  \\$wnnna$aBenign Paroxysmal Peritonitis
=450  \\$wnnna$aDisease, Periodic
=450  \\$wnnna$aDisease, Wolff Periodic
=450  \\$wnnna$aDisease, Wolff's Periodic
=450  \\$wnnna$aDiseases, Periodic
=450  \\$wnnna$aFamilial Mediterranean Fever, Autosomal Recessive
=450  \\$wnnna$aFamilial Paroxysmal Polyserositides
=450  \\$wnnna$aFamilial Paroxysmal Polyserositis
=450  \\$aMediterranean Fever, Familial
=450  \\$wnnna$aParoxysmal Peritonitides, Benign
=450  \\$wnnna$aParoxysmal Peritonitis, Benign
=450  \\$wnnna$aParoxysmal Polyserositides, Familial
=450  \\$wnnna$aParoxysmal Polyserositis, Familial
=450  \\$aPeriodic Disease
=450  \\$wnnna$aPeriodic Disease, Wolff
=450  \\$aPeriodic Disease, Wolff's
=450  \\$wnnna$aPeriodic Disease, Wolffs
=450  \\$wnnna$aPeriodic Diseases
=450  \\$wnnna$aPeriodic Peritonitides
=450  \\$wnnna$aPeriodic Peritonitis
=450  \\$wnnna$aPeritonitides, Benign Paroxysmal
=450  \\$wnnna$aPeritonitides, Periodic
=450  \\$wnnna$aPeritonitis, Benign Paroxysmal
=450  \\$wnnna$aPeritonitis, Periodic
=450  \\$wnnna$aPolyserositides, Familial Paroxysmal
=450  \\$wnnna$aPolyserositides, Recurrent
=450  \\$wnnna$aPolyserositis, Familial Paroxysmal
=450  \\$wnnna$aPolyserositis, Recurrent
=450  \\$wnnna$aRecurrent Polyserositides
=450  \\$wnnna$aRecurrent Polyserositis
=450  \\$aWolff Periodic Disease
=450  \\$aWolff's Periodic Disease
=450  \\$wnnna$aWolffs Periodic Disease
=550  \\$wg$aHereditary Autoinflammatory Diseases
=667  \\$aa specific disease entity: do not use entry term PERIODIC DISEASE for periodically occurring disease (= PERIODICITY (IM) + disease (IM))
=680  \\$iA group of HEREDITARY AUTOINFLAMMATION DISEASES, characterized by recurrent fever, abdominal pain, headache, rash, PLEURISY; and ARTHRITIS. ORCHITIS; benign MENINGITIS; and AMYLOIDOSIS may also occur. Homozygous or compound heterozygous mutations in marenostrin gene result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease.
=688  \\$a2000 (1966)
=750  \0$aPeriodic peritonitis$5IEN$0(DLC)sh 85099886

=LDR  00808cz  a2200265n  4500
=001  9880363865102441
=005  20141212204408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010504
=035  \\$aCBA3790HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x675
=072  \\$aD1.$x475.$x705
=150  \\$aPeriodic Acid
=450  \\$wnnna$aAcid, Paraperiodic
=450  \\$wnnna$aAcid, Periodic
=450  \\$wnnna$aAcids, Periodic
=450  \\$wnnna$aParaperiodic Acid
=450  \\$wnnna$aPeriodic Acid (HIO4)
=450  \\$wnnna$aPeriodic Acids
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aIodine Compounds
=680  \\$iA strong oxidizing agent.
=688  \\$a94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was NM 1987-93
=750  \0$aPeriodic acid$5IEN-M$0(DLC)sh 89006199

=LDR  00705cz  a2200169n  4500
=001  9880363865202441
=005  20141212204407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010502
=035  \\$aCBA3788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x719
=150  \\$aPerineum
=450  \\$wnnna$aPerineums
=550  \\$wg$aBody Regions
=680  \\$iThe body region lying between the genital area and the ANUS on the surface of the trunk, and to the shallow compartment lying deep to this area that is inferior to the PELVIC DIAPHRAGM. The surface area is between the VULVA and the anus in the female, and between the SCROTUM and the anus in the male.
=750  \0$aPerineum$5IEN$0(DLC)sh 85099875

=LDR  00753cz  a2200181n  4500
=001  9880363865302441
=005  20141212204407.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010500
=035  \\$aCBA3786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x670.$x500
=150  \\$aPerinatology
=550  \\$wg$aPediatrics
=667  \\$a= fetus + newborn inf: differentiate from NEONATOLOGY, the newborn inf only; SPEC: SPEC qualif; DF: PERINATOL
=680  \\$iThe branch of medicine dealing with the fetus and infant during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth. (From Dorland, 27th ed)
=688  \\$a77
=750  \0$aPerinatology$5IEN$0(DLC)sh 86003112

=LDR  00795cz  a2200193n  4500
=001  9880363865402441
=005  20141212204406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010498
=035  \\$aCBA3784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x270.$x517.$x678
=150  \\$aPerilymph
=450  \\$wnnna$aPerilymphs
=550  \\$wg$aLabyrinthine Fluids
=667  \\$aa labyrinthine fluid
=680  \\$iThe fluid separating the membranous labyrinth from the osseous labyrinth of the ear. It is entirely separate from the ENDOLYMPH which is contained in the membranous labyrinth. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1396, 642)
=688  \\$a91(75); was see under LABYRINTHINE FLUIDS 1975-90
=750  \0$aPerilymph$5IEN$0(DLC)sh 85099871

=LDR  01443cz  a2200313n  4500
=001  9880363865502441
=005  20170831164432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010496
=035  \\$aCBA3782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x795
=072  \\$aA10.$x615.$x789.$x470
=150  \\$aPericardium
=450  \\$aEpicardium
=450  \\$wnnna$aFibrous Pericardium
=450  \\$wnnna$aParietal Pericardium
=450  \\$wnnna$aPericardium, Fibrous
=450  \\$wnnna$aPericardium, Parietal
=450  \\$wnnna$aPericardium, Visceral
=450  \\$wnnna$aPericardiums, Fibrous
=450  \\$wnnna$aSerous Pericardium
=450  \\$wnnna$aVisceral Pericardium
=550  \\$wg$aHeart
=550  \\$wg$aSerous Membrane
=550  \\$wh$aPericardial Fluid
=667  \\$ainflammation = PERICARDITIS or its specifics; simple mediastinal cyst adjacent to pericardium = MEDIASTINAL CYST (do not coordinate with PERICARDIUM)
=680  \\$iA conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs, the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
=750  \0$aPericardium$5IEN$0(DLC)sh 85099851

=LDR  00846cz  a2200205n  4500
=001  9880363865602441
=005  20141212204405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010493
=035  \\$aCBA3779HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x720
=150  \\$aPericarditis
=450  \\$wnnna$aPleuropericarditis
=550  \\$wg$aHeart Diseases
=550  \\$wh$aPericarditis, Constrictive
=550  \\$wh$aPericarditis, Tuberculous
=667  \\$anote entry term PLEUROPERICARDITIS: coordinate with PLEURITIS see PLEURISY for pleuropericarditis
=680  \\$iInflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
=750  \0$aPericarditis$5IEN$0(DLC)sh 85099850

=LDR  00608cz  a2200205n  4500
=001  9880363865702441
=005  20141212204404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010489
=035  \\$aCBA3775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x550.$x114.$x678
=072  \\$aC5.$x550.$x251.$x595
=150  \\$aPeriarthritis
=450  \\$wnnna$aPeriarthritides
=550  \\$wg$aArthritis
=550  \\$wg$aBursitis
=667  \\$a"inflamm of tissues around a joint"
=680  \\$iInflammation of the tissues around a joint. (Dorland, 27th ed)
=750  \0$aPeriarthritis$5IEN$0(DLC)sh 85099849

=LDR  01567cz  a2200349n  4500
=001  9880363865802441
=005  20141212204403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010488
=035  \\$aCBA3774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x184.$x595
=072  \\$aC14.$x907.$x940.$x90.$x720
=072  \\$aC14.$x907.$x940.$x897.$x500
=072  \\$aC17.$x800.$x862.$x625
=150  \\$aPolyarteritis Nodosa
=450  \\$wnnna$aArteritides, Necrotizing
=450  \\$wnnna$aArteritis, Necrotizing
=450  \\$wnnna$aEssential Polyarteritides
=450  \\$aEssential Polyarteritis
=450  \\$wnnna$aNecrotizing Arteritides
=450  \\$aNecrotizing Arteritis
=450  \\$aPeriarteritis Nodosa
=450  \\$wnnna$aPolyarteritides, Essential
=450  \\$wnnna$aPolyarteritis, Essential
=550  \\$wg$aArteritis
=550  \\$wg$aSkin Diseases, Vascular
=550  \\$wg$aSystemic Vasculitis
=680  \\$iA form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.
=688  \\$a1995; was PERIARTERITIS NODOSA 1963-1994; for POLYARTERITIS NODOSA use PERIARTERITIS NODOSA 1968-1994
=688  \\$a95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94
=750  \0$aPolyarteritis nodosa$5IEN$0(DLC)sh 85099848

=LDR  01117cz  a2200301n  4500
=001  9880363865902441
=005  20141212204402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010484
=035  \\$aCBA3770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x320.$x830.$x700.$x740
=072  \\$aC7.$x465.$x714.$x306.$x700.$x740
=072  \\$aC7.$x465.$x714.$x533.$x487.$x740
=150  \\$aPeriapical Granuloma
=450  \\$aDental Granuloma
=450  \\$wnnna$aDental Granulomas
=450  \\$wnnna$aGranuloma, Dental
=450  \\$aGranuloma, Periapical
=450  \\$wnnna$aGranulomas, Dental
=450  \\$wnnna$aGranulomas, Periapical
=450  \\$wnnna$aPeriapical Granulomas
=450  \\$aPeriapical Periodontitis, Chronic Nonsuppurative
=450  \\$aPeriodontitis, Apical, Chronic Nonsuppurative
=550  \\$wg$aPeriapical Periodontitis
=680  \\$iChronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.
=688  \\$a80; was GRANULOMA, PERIAPICAL 1965-79
=750  \0$aGranuloma, Periapical$5IEN$0(DLC)sh 85056444

=LDR  00941cz  a2200277n  4500
=001  9880363866002441
=005  20141212204402.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010483
=035  \\$aCBA3769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x320.$x830
=072  \\$aC7.$x465.$x714.$x306
=150  \\$aPeriapical Diseases
=450  \\$wnnna$aDisease, Periapical
=450  \\$wnnna$aDiseases, Periapical
=450  \\$wnnna$aPeriapical Disease
=550  \\$wg$aJaw Diseases
=550  \\$wg$aPeriodontal Diseases
=550  \\$wh$aPeriapical Periodontitis
=550  \\$wh$aRadicular Cyst
=550  \\$aDental Pulp Diseases
=667  \\$ainflammatory disease = PERIAPICAL PERIODONTITIS
=680  \\$iDiseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the TOOTH ROOT.
=688  \\$a80
=750  \0$aPeriapical diseases$5IEN$0(DLC)sh 85099847

=LDR  00687cz  a2200193n  4500
=001  9880363866102441
=005  20141212204401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010480
=035  \\$aCBA3766HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x644
=150  \\$aPerhexiline
=450  \\$wnnna$aPerhexilene
=550  \\$wg$aPiperidines
=667  \\$aa vasodilator calcium channel blocker
=680  \\$i2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.
=688  \\$a84(73); was see under PIPERIDINES 1975-83, was Prov 1973-74
=750  \0$aPerhexiline$5IEN$0(DLC)sh 85099846

=LDR  00664cz  a2200181n  4500
=001  9880363866202441
=005  20141212204359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010477
=035  \\$aCBA3763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x680
=150  \\$aPerfusion
=450  \\$wnnna$aPerfusions
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aReperfusion
=667  \\$anote category; a technique: not for perfusion of blood through a vessel ( = a circulation concept); REPERFUSION is available for restoration of blood supply to tissue & MYOCARDIAL REPERFUSION for heart
=750  \0$aPerfusion (Physiology)$5IEN$0(DLC)sh 85099843

=LDR  00721cz  a2200169n  4500
=001  9880363866302441
=005  20141212204359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010476
=035  \\$aCBA3762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x269.$x700
=150  \\$aPerfume
=550  \\$wg$aCosmetics
=667  \\$aIM; coord with specific substance if pertinent (IM); D25-26 qualif
=680  \\$iA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed)
=750  \0$aPerfumes$5IEN$0(DLC)sh 85099839

=LDR  00604cz  a2200181n  4500
=001  9880363866402441
=005  20141212204359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010474
=035  \\$aCBA3760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x610
=150  \\$aPercussion
=450  \\$wnnna$aPercussions
=550  \\$wg$aPhysical Examination
=667  \\$adiag from sound obtained by short sharp blows
=680  \\$iAct of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.
=750  \0$aPercussion$5IEN$0(DLC)sh 85099737

=LDR  01250cz  a2200409n  4500
=001  9880363866502441
=005  20141212204359.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010473
=035  \\$aCBA3759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602
=150  \\$aPerciformes
=450  \\$aBluegill
=450  \\$wnnna$aBluegills
=450  \\$wnnna$aCentrarchidae
=450  \\$wnnna$aCroaker
=450  \\$aCroakers
=450  \\$aDolphin Fish
=450  \\$wnnna$aFish, Sparid
=450  \\$wnnna$aMackerel
=450  \\$wnnna$aMackerels
=450  \\$wnnna$aMahi-Mahi
=450  \\$aPorgies
=450  \\$aSparid Fish
=450  \\$aSparus
=450  \\$aSunfishes
=550  \\$wg$aFishes
=550  \\$wh$aBass
=550  \\$wh$aCichlids
=550  \\$wh$aPerches
=550  \\$wh$aSea Bream
=550  \\$wh$aTuna
=667  \\$aGEN; prefer specifics; do not confuse X ref DOLPHIN FISH with DOLPHINS which are mammals
=680  \\$iThe most diversified of all fish orders and the largest vertebrate order. It includes many of the commonly known fish such as porgies, croakers, sunfishes, dolphin fish, mackerels, TUNA, etc.
=688  \\$a87
=750  \0$aPerciformes$5IEN$0(DLC)sh 85099726

=LDR  00989cz  a2200253n  4500
=001  9880363866602441
=005  20141212204358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010472
=035  \\$aCBA3758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x650
=072  \\$aD1.$x210.$x675
=150  \\$aPerchlorates
=450  \\$wnnna$aAcids, Perchloric
=450  \\$wnnna$aPerchloric Acid Derivatives
=450  \\$wnnna$aPerchloric Acids
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aChlorine Compounds
=680  \\$iCompounds that contain the Cl(=O)(=O)(=O)O- structure. Included under this heading is perchoric acid and the salts and ester forms of perchorate.
=688  \\$a1994(2014); was PERCHLORIC ACIDS 1963-1993; was PERCHLORIC ACID 1994-2013
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Perchloric Acid
=688  \\$a94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was NM 1981-93
=750  \0$aPerchlorates$0(DLC)sh 89001746$5IEN-M

=LDR  00627cz  a2200205n  4500
=001  9880363866702441
=005  20141212204358.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010471
=035  \\$aCBA3757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x600
=150  \\$aPerches
=450  \\$aPerca
=450  \\$aPerch
=450  \\$aPercidae
=550  \\$wg$aPerciformes
=680  \\$iA common name for fish of the family Percidae, belonging to the suborder Percoidei, order PERCIFORMES.
=688  \\$a91(87); was see under PERCIFORMES 1987-90
=750  \0$aPerch$5IEN-M$0(DLC)sh 85099721

=LDR  01797cz  a2200469n  4500
=001  9880363866802441
=005  20141212204357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010468
=035  \\$aCBA3754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762
=072  \\$aC23.$x888.$x592.$x604.$x764
=072  \\$aF1.$x700.$x750
=150  \\$aPerceptual Disorders
=450  \\$wnnna$aDiscrimination Disorder, Somatosensory
=450  \\$wnnna$aDiscrimination Disorders, Somatosensory
=450  \\$wnnna$aHemisensory Neglect
=450  \\$wnnna$aHemisensory Neglects
=450  \\$aHemispatial Neglect
=450  \\$wnnna$aHemispatial Neglects
=450  \\$wnnna$aNeglect, Hemisensory
=450  \\$wnnna$aNeglect, Hemispatial
=450  \\$wnnna$aNeglect, Sensory
=450  \\$wnnna$aNeglects, Hemisensory
=450  \\$wnnna$aPerceptual Disorder
=450  \\$wnnna$aSensory Neglect
=450  \\$wnnna$aSensory Neglects
=450  \\$wnnna$aSomatosensory Discrimination Disorder
=450  \\$wnnna$aSomatosensory Discrimination Disorders
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wh$aAgnosia
=550  \\$wh$aAlice in Wonderland Syndrome
=550  \\$wh$aAllesthesia
=550  \\$wh$aAuditory Perceptual Disorders
=550  \\$wh$aHallucinations
=550  \\$wh$aIllusions
=550  \\$wh$aPhantom Limb
=550  \\$aPerceptual Distortion
=680  \\$iCognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
=688  \\$a1969
=750  \0$aPerceptual disorders$0(DLC) sh 85099710$5IEN

=LDR  00746cz  a2200205n  4500
=001  9880363866902441
=005  20141212204357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010467
=035  \\$aCBA3753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x628
=150  \\$aPerceptual Defense
=450  \\$wnnna$aDefense, Perceptual
=450  \\$wnnna$aDefenses, Perceptual
=550  \\$wg$aDefense Mechanisms
=667  \\$ano qualif
=680  \\$iSelective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately.
=688  \\$a70(65)
=750  \0$aPerceptual defense$5IEN$0(DLC)sh 85099715

=LDR  01494cz  a2200481n  4500
=001  9880363867002441
=005  20141212204356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010465
=035  \\$aCBA3751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593
=150  \\$aPerception
=450  \\$wnnna$aPerceptions
=550  \\$wg$aMental Processes
=550  \\$wh$aAuditory Perception
=550  \\$wh$aBody Image
=550  \\$wh$aDepth Perception
=550  \\$wh$aDifferential Threshold
=550  \\$wh$aDiscrimination (Psychology)
=550  \\$wh$aEidetic Imagery
=550  \\$wh$aField Dependence-Independence
=550  \\$wh$aForm Perception
=550  \\$wh$aIllusions
=550  \\$wh$aInteroception
=550  \\$wh$aOlfactory Perception
=550  \\$wh$aPain Perception
=550  \\$wh$aPattern Recognition, Physiological
=550  \\$wh$aPerceptual Distortion
=550  \\$wh$aSensory Deprivation
=550  \\$wh$aSensory Thresholds
=550  \\$wh$aSize Perception
=550  \\$wh$aSocial Perception
=550  \\$wh$aSpace Perception
=550  \\$wh$aTaste Perception
=550  \\$wh$aTime Perception
=550  \\$wh$aTouch Perception
=550  \\$wh$aVisual Perception
=550  \\$wh$aWeight Perception
=550  \\$aSensation
=667  \\$ageneral; prefer specifics
=680  \\$iThe process by which the nature and meaning of sensory stimuli are recognized and interpreted.
=750  \0$aPerception$0(DLC) sh 85099708$5IEN

=LDR  01132cz  a2200349n  4500
=001  9880363867102441
=005  20141212204355.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010463
=035  \\$aCBA3749M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x664
=150  \\$aPeracetic Acid
=450  \\$aAcetyl Hydroperoxide
=450  \\$wnnna$aAcid, Peracetic
=450  \\$wnnna$aAcid, Peroxyacetic
=450  \\$wnnna$aAcid, Peroxyethanoic
=450  \\$wnnna$aDesoxone-1
=450  \\$wnnna$aDesoxone 1
=450  \\$wnnna$aDesoxone1
=450  \\$wnnna$aDialax
=450  \\$wnnna$aPeracetate, Sodium
=450  \\$wnnna$aPeracetate, Zinc
=450  \\$wnnna$aPeracetic Acid, Sodium Salt
=450  \\$aPeroxyacetic Acid
=450  \\$wnnna$aPeroxyethanoic Acid
=450  \\$wnnna$aSodium Peracetate
=450  \\$wnnna$aZinc Peracetate
=550  \\$wg$aAcetates
=680  \\$iA liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.
=688  \\$a91(75); was see under ACETIC ACIDS 1975-90
=750  \0$aPeracetic acid$5IEN-M$0(DLC)sh2002009500

=LDR  00713cz  a2200181n  4500
=001  9880363867202441
=005  20141212204355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010461
=035  \\$aCBA3747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x719
=150  \\$aPeptones
=450  \\$wnnna$aPeptone
=550  \\$wg$aProteins
=667  \\$aproteins
=680  \\$iDerived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. (Dorland, 28th ed)
=750  \0$aPeptones$5IEN$0(DLC)sh 85099695

=LDR  00699cz  a2200169n  4500
=001  9880363867302441
=005  20141212204354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010460
=035  \\$aCBA3746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x562.$x593
=150  \\$aPeptococcus
=550  \\$wg$aPeptococcaceae
=667  \\$ainfection: coord IM with GRAM-POSITIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.
=750  \0$aPeptococcus$5IEN$0(DLC)sh 88023298

=LDR  00701cz  a2200193n  4500
=001  9880363867402441
=005  20141212204354.0
=008  750721\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010459
=035  \\$aCBA3745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x400.$x562
=150  \\$aPeptococcaceae
=550  \\$wg$aGram-Positive Cocci
=550  \\$wh$aPeptococcus
=667  \\$ain man, animals, soil
=680  \\$iA family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains.
=688  \\$a76
=750  \0$aPeptococcaceae$5IEN$0(DLC)sh 88023297

=LDR  00801cz  a2200265n  4500
=001  9880363867502441
=005  20141212204354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010457
=035  \\$aCBA3743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x400.$x420.$x700
=072  \\$aD9.$x698.$x718.$x594
=072  \\$aD12.$x644.$x233.$x594
=072  \\$aD12.$x776.$x395.$x560.$x800
=072  \\$aD23.$x50.$x161.$x616.$x594
=150  \\$aPeptidoglycan
=450  \\$aMurein
=450  \\$wnnna$aPseudomurein
=550  \\$wg$aGlycopeptides
=550  \\$wg$aMucoproteins
=550  \\$wg$aPolysaccharides, Bacterial
=667  \\$acoord IM with specific bacterium (IM) & do not coord with POLYSACCHARIDES, BACTERIAL
=688  \\$a73(71)
=750  \0$aPeptidoglycans$5IEN$0(DLC)sh 85099694

=LDR  01531cz  a2200505n  4500
=001  9880363867602441
=005  20141212204353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010456
=035  \\$aCBA3742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566
=072  \\$aD12.$x644.$x641
=150  \\$aPeptides, Cyclic
=450  \\$aCyclic Peptides
=450  \\$wnnna$aCyclopeptides
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wg$aPeptides
=550  \\$wh$aAlamethicin
=550  \\$wh$aAmanitins
=550  \\$wh$aBacitracin
=550  \\$wh$aCapreomycin
=550  \\$wh$aCyclosporins
=550  \\$wh$aCyclotides
=550  \\$wh$aDactinomycin
=550  \\$wh$aDaptomycin
=550  \\$wh$aDepsipeptides
=550  \\$wh$aEchinocandins
=550  \\$wh$aEchinomycin
=550  \\$wh$aEnterobactin
=550  \\$wh$aFerrichrome
=550  \\$wh$aMicrocystins
=550  \\$wh$aMycobacillin
=550  \\$wh$aNanotubes, Peptide
=550  \\$wh$aNisin
=550  \\$wh$aOctreotide
=550  \\$wh$aPhalloidine
=550  \\$wh$aPolymyxins
=550  \\$wh$aStreptogramins
=550  \\$wh$aThiostrepton
=550  \\$wh$aTyrothricin
=550  \\$wh$aViomycin
=680  \\$iPeptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).
=688  \\$a73(71)
=750  \0$aCyclic peptides$5IEN$0(DLC)sh 89002721

=LDR  02687cz  a2200685n  4500
=001  9880363867702441
=005  20190130111144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010455
=035  \\$aCBA3741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644
=150  \\$aPeptides
=450  \\$aPolypeptides
=550  \\$wg$aAmino Acids, Peptides, and Proteins
=550  \\$wh$aAmyloid beta-Peptides
=550  \\$wh$aAntimicrobial Cationic Peptides
=550  \\$wh$aAptamers, Peptide
=550  \\$wh$aCell-Penetrating Peptides
=550  \\$wh$aCharybdotoxin
=550  \\$wh$aCholecystokinin
=550  \\$wh$aCircadian Rhythm Signaling Peptides and Proteins
=550  \\$wh$aCystine-Knot Miniproteins
=550  \\$wh$aDiazepam Binding Inhibitor
=550  \\$wh$aDisintegrins
=550  \\$wh$aDistamycins
=550  \\$wh$aEdeine
=550  \\$wh$aErabutoxins
=550  \\$wh$aFibrinopeptide A
=550  \\$wh$aFibrinopeptide B
=550  \\$wh$aGlatiramer Acetate
=550  \\$wh$aGlycopeptides
=550  \\$wh$aIntercellular Signaling Peptides and Proteins
=550  \\$wh$aIntracellular Signaling Peptides and Proteins
=550  \\$wh$aLipopeptides
=550  \\$wh$aMating Factor
=550  \\$wh$aMyocardial Depressant Factor
=550  \\$wh$aNeuropeptides
=550  \\$wh$aOligopeptides
=550  \\$wh$aOpioid Peptides
=550  \\$wh$aPeptaibols
=550  \\$wh$aPeptide Fragments
=550  \\$wh$aPeptide Hormones
=550  \\$wh$aPeptide Library
=550  \\$wh$aPeptides, Cyclic
=550  \\$wh$aPeptoids
=550  \\$wh$aPhosphopeptides
=550  \\$wh$aPolygeline
=550  \\$wh$aPolyglutamic Acid
=550  \\$wh$aPolylysine
=550  \\$wh$aProtein Sorting Signals
=550  \\$wh$aProteinase Inhibitory Proteins, Secretory
=550  \\$wh$aSalivary Proteins and Peptides
=550  \\$wh$aSerpins
=550  \\$wh$aTissue Polypeptide Antigen
=550  \\$wh$aTrefoil Factors
=550  \\$wh$aTyrothricin
=667  \\$ageneral; prefer specifics; fewer than 13 amino acids = oligopeptides; "primary structure" = PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE; peptide structure other than primary: coordinate IM with PROTEIN CONFORMATION or its specifics
=680  \\$iMembers of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
=750  \0$aPeptides$0(DLC) sh 85099692$5IEN

=LDR  01383cz  a2200277n  4500
=001  9880363867802441
=005  20170608154559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010452
=035  \\$aCBA3738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x660
=072  \\$aG3.$x734
=150  \\$aPeptide Biosynthesis
=450  \\$wnnna$aBiosynthesis, Peptide
=450  \\$wnnoa$aPeptide Synthesis$5IEN-HS
=450  \\$aPeptides$xbiosynthesis
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wh$aAminoacylation
=550  \\$wh$aPeptide Biosynthesis, Nucleic Acid-Independent
=550  \\$wh$aProtein Biosynthesis
=667  \\$ageneral or unspecified; prefer specific peptide/biosyn; PROTEIN BIOSYNTHESIS and PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT are also available
=680  \\$iThe production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.
=688  \\$a2005 (1998)
=750  \0$aPeptides$xSynthesis$0(DLC) sh 85099691$5IEN-M

=LDR  00989cz  a2200301n  4500
=001  9880363867902441
=005  20141212204350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010450
=035  \\$aCBA3736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300
=150  \\$aEndopeptidases
=450  \\$aPeptide Peptidohydrolases
=550  \\$wg$aPeptide Hydrolases
=550  \\$wh$aAmyloid Precursor Protein Secretases
=550  \\$wh$aAspartic Acid Endopeptidases
=550  \\$wh$aATP-Dependent Endopeptidases
=550  \\$wh$aBrinolase
=550  \\$wh$aCoagulase
=550  \\$wh$aCysteine Endopeptidases
=550  \\$wh$aMetalloendopeptidases
=550  \\$wh$aSerine Endopeptidases
=550  \\$wh$aStreptokinase
=550  \\$wh$aUbiquitin-Specific Proteases
=680  \\$iA subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.
=688  \\$a2000(1963)
=750  \0$aEndopeptidases$0(DLC) sh 94006903$5IEN-M

=LDR  01260cz  a2200361n  4500
=001  9880363868002441
=005  20141212204349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010447
=035  \\$aCBA3733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656
=150  \\$aPeptide Hydrolases
=450  \\$wnnna$aEsteroproteases
=450  \\$aPeptidases
=450  \\$aProteases
=450  \\$aProteinases
=450  \\$aProteolytic Enzymes
=550  \\$wg$aHydrolases
=550  \\$wh$aAspartic Acid Proteases
=550  \\$wh$aATP-Dependent Proteases
=550  \\$wh$aCathepsins
=550  \\$wh$aCysteine Proteases
=550  \\$wh$aEndopeptidases
=550  \\$wh$aExopeptidases
=550  \\$wh$aMetalloproteases
=550  \\$wh$aProprotein Convertases
=550  \\$wh$aProteasome Endopeptidase Complex
=550  \\$wh$aSerine Proteases
=550  \\$aGene Products, pol
=680  \\$iHydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES.
=688  \\$a1966; for PROTEINASES use ENDOPEPTIDASES 1979-2000; for PROTEASES use ENDOPEPTIDASES 1987-2004
=750  \0$aProteolytic enzymes$5IEN$0(DLC)sh 85107685

=LDR  00987cz  a2200253n  4500
=001  9880363868102441
=005  20141212204346.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010439
=035  \\$aCBA3725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x275.$x800.$x698
=072  \\$aC6.$x405.$x608.$x698
=072  \\$aC6.$x405.$x748.$x586.$x698
=150  \\$aPeptic Ulcer Perforation
=450  \\$wnnna$aPeptic Ulcer Perforations
=450  \\$wnnna$aPerforation, Peptic Ulcer
=450  \\$wnnna$aPerforations, Peptic Ulcer
=450  \\$wnnna$aUlcer Perforation, Peptic
=450  \\$wnnna$aUlcer Perforations, Peptic
=550  \\$wg$aPeptic Ulcer
=667  \\$acoord IM with STOMACH ULCER /compl (IM) or DUODENAL ULCER /compl (IM) if pertinent
=680  \\$iPenetration of a PEPTIC ULCER through the wall of DUODENUM or STOMACH allowing the leakage of luminal contents into the PERITONEAL CAVITY.
=750  \0$aPeptic ulcer perforation$5IEN$0(DLC)sh 85099687

=LDR  01828cz  a2200433n  4500
=001  9880363868202441
=005  20141212204345.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010437
=035  \\$aCBA3723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x275.$x800
=072  \\$aC6.$x405.$x608
=072  \\$aC6.$x405.$x748.$x586
=150  \\$aPeptic Ulcer
=450  \\$aGastroduodenal Ulcer
=450  \\$wnnna$aGastroduodenal Ulcers
=450  \\$aMarginal Ulcer
=450  \\$wnnna$aMarginal Ulcers
=450  \\$wnnna$aPeptic Ulcers
=450  \\$wnnna$aUlcer, Gastroduodenal
=450  \\$wnnna$aUlcer, Marginal
=450  \\$wnnna$aUlcer, Peptic
=450  \\$wnnna$aUlcers, Gastroduodenal
=450  \\$wnnna$aUlcers, Marginal
=450  \\$wnnna$aUlcers, Peptic
=550  \\$wg$aDuodenal Diseases
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wg$aStomach Diseases
=550  \\$wh$aDuodenal Ulcer
=550  \\$wh$aEsophagitis, Peptic
=550  \\$wh$aPeptic Ulcer Perforation
=550  \\$wh$aStomach Ulcer
=550  \\$wh$aZollinger-Ellison Syndrome
=550  \\$aPeptic Ulcer Hemorrhage
=667  \\$aGEN: prefer STOMACH ULCER or DUODENAL ULCER but note GASTRODUODENAL ULCER = PEPTIC ULCER; stress ulcer: coord with STRESS, PHYSIOLOGICAL or STRESS, PSYCHOLOGICAL (IM or NIM)
=680  \\$iUlcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
=688  \\$aMARGINAL ULCER was heading 1964-96 (see under PEPTIC ULCER 1964-90)
=750  \0$aPeptic ulcer$5IEN$0(DLC)sh 85099682

=LDR  00970cz  a2200241n  4500
=001  9880363868302441
=005  20141212204344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010434
=035  \\$aCBA3720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x74.$x500.$x700
=072  \\$aD8.$x811.$x277.$x656.$x300.$x48.$x700
=150  \\$aPepsin A
=450  \\$aPepsin
=450  \\$wnnna$aPepsin 1
=450  \\$wnnna$aPepsin 3
=550  \\$wg$aAspartic Acid Endopeptidases
=550  \\$aGastric Juice
=667  \\$a/biosyn /physiol permitted
=680  \\$iFormed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice.
=688  \\$a91; was PEPSIN 1964-90
=750  \0$aPepsin$5IEN$0(DLC)sh 85099679

=LDR  00966cz  a2200265n  4500
=001  9880363868402441
=005  20141212204343.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010431
=035  \\$aCBA3717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x758.$x824.$x651.$x700
=150  \\$aPentoxifylline
=450  \\$wnnna$aAgapurin
=450  \\$wnnna$aBL-191
=450  \\$wnnna$aBL 191
=450  \\$wnnna$aBL191
=450  \\$wnnna$aOxpentifylline
=450  \\$wnnna$aPentoxil
=450  \\$wnnna$aTorental
=450  \\$wnnna$aTrental
=550  \\$wg$aTheobromine
=680  \\$iA METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.
=688  \\$a91(77)
=750  \0$aPentoxifylline$5IEN$0(DLC)sh 89005578

=LDR  00608cz  a2200217n  4500
=001  9880363868502441
=005  20190304142138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010429
=035  \\$aCBA3715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x947.$x875.$x627
=150  \\$aPentoses
=550  \\$wg$aMonosaccharides
=550  \\$wh$aArabinose
=550  \\$wh$aRibose
=550  \\$wh$aXylose
=550  \\$wh$aXylulose
=667  \\$amonosaccharides; GEN; prefer specifics
=680  \\$iA class of carbohydrates that contains five carbon atoms.
=750  \0$aPentoses$0(DLC)sh 85099648$5IEN

=LDR  02376cz  a2200589n  4500
=001  9880363868602441
=005  20141212204342.0
=008  840529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010427
=035  \\$aCBA3713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x87.$x160.$x875
=072  \\$aG2.$x149.$x115.$x160.$x875
=072  \\$aG3.$x495.$x256.$x875
=072  \\$aG3.$x495.$x335.$x693
=072  \\$aG3.$x495.$x553.$x695
=150  \\$aPentose Phosphate Pathway
=450  \\$aHexose Monophosphate Shunt
=450  \\$wnnna$aHexose Monophosphate Shunts
=450  \\$wnnna$aPathway, Pentose Phosphate
=450  \\$wnnna$aPathway, Pentose-Phosphate
=450  \\$wnnna$aPathway, Pentosephosphate
=450  \\$wnnna$aPathways, Pentose Phosphate
=450  \\$wnnna$aPathways, Pentose-Phosphate
=450  \\$wnnna$aPathways, Pentosephosphate
=450  \\$wnnna$aPentose-Phosphate Pathway
=450  \\$wnnna$aPentose Phosphate Pathways
=450  \\$wnnna$aPentose-Phosphate Pathways
=450  \\$aPentose Phosphate Shunt
=450  \\$wnnna$aPentose Phosphate Shunts
=450  \\$aPentose Shunt
=450  \\$wnnna$aPentose Shunts
=450  \\$aPentosephosphate Pathway
=450  \\$wnnna$aPentosephosphate Pathways
=450  \\$wnnna$aPentosephosphate Shunt
=450  \\$wnnna$aPentosephosphate Shunts
=450  \\$wnnna$aShunt, Hexose Monophosphate
=450  \\$wnnna$aShunt, Pentose
=450  \\$wnnna$aShunt, Pentose Phosphate
=450  \\$wnnna$aShunt, Pentosephosphate
=450  \\$wnnna$aShunts, Hexose Monophosphate
=450  \\$wnnna$aShunts, Pentose
=450  \\$wnnna$aShunts, Pentose Phosphate
=450  \\$wnnna$aShunts, Pentosephosphate
=550  \\$wg$aCarbohydrate Metabolism
=550  \\$wg$aEnergy Metabolism
=550  \\$wg$aMetabolic Networks and Pathways
=680  \\$iAn oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.
=688  \\$a2006 (1985)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Pentosephosphate Pathway
=688  \\$a85
=750  \0$aPentose phosphate pathway$0(DLC) sh 85099647$5IEN

=LDR  01153cz  a2200289n  4500
=001  9880363868702441
=005  20141212204341.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010424
=035  \\$aCBA3710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x253.$x593
=150  \\$aPentobarbital
=450  \\$wnnna$aDiabutal
=450  \\$wnnna$aEtaminal
=450  \\$wnnna$aEthaminal
=450  \\$aMebubarbital
=450  \\$aMebumal
=450  \\$wnnna$aMonosodium Salt Pentobarbital
=450  \\$wnnna$aNembutal
=450  \\$wnnna$aPentobarbital, Monosodium Salt
=450  \\$wnnna$aPentobarbital Sodium
=450  \\$wnnna$aPentobarbitone
=450  \\$wnnna$aSagatal
=550  \\$wg$aBarbiturates
=680  \\$iA short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
=750  \0$aPentobarbital$5IEN$0(DLC)sh 85099645

=LDR  00960cz  a2200265n  4500
=001  9880363868802441
=005  20141212204340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010423
=035  \\$aCBA3709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x106.$x700
=072  \\$aD4.$x615.$x723.$x795.$x106.$x700
=150  \\$aPentazocine
=450  \\$wnnna$aFortral
=450  \\$wnnna$aHydrochloride, Pentazocine
=450  \\$wnnna$aLactate, Pentazocine
=450  \\$wnnna$aLexir
=450  \\$wnnna$aPentazocine Hydrochloride
=450  \\$wnnna$aPentazocine Lactate
=450  \\$wnnna$aTalwin
=550  \\$wg$aBenzomorphans
=680  \\$iThe first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97)
=688  \\$a66(64)
=750  \0$aPentazocine$5IEN$0(DLC)sh 85099626

=LDR  00655cz  a2200217n  4500
=001  9880363868902441
=005  20141212204316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010333
=035  \\$aCBA3618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x380
=150  \\$aPaternal Deprivation
=450  \\$wnnna$aDeprivation, Paternal
=450  \\$wnnna$aDeprivations, Paternal
=450  \\$wnnna$aPaternal Deprivations
=550  \\$wg$aFamily Relations
=667  \\$ahuman & animal
=680  \\$iProlonged separation of the offspring from the father.
=688  \\$a69
=750  \0$aPaternal deprivation$5IEN$0(DLC)sh 85098669

=LDR  00785cz  a2200241n  4500
=001  9880363869002441
=005  20141212204316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010330
=035  \\$aCBA3615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x458.$x650
=072  \\$aN3.$x706.$x535.$x518.$x650
=150  \\$aPatents as Topic
=450  \\$wnnna$aPatents as Topics
=450  \\$wnnna$aTrademark
=450  \\$aTrademarks
=550  \\$wg$aIntellectual Property
=667  \\$ado not confuse with the Publication Type PATENTS
=680  \\$iExclusive legal rights or privileges applied to inventions, plants, etc.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Patents
=750  \0$aPatents$0(DLC) sh 85098655$5IEN

=LDR  00553cz  a2200181n  4500
=001  9880363869102441
=005  20141212204315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010329
=035  \\$aCBA3614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x650.$x624
=150  \\$aPatella
=450  \\$wnnna$aPatellas
=550  \\$wg$aLeg Bones
=667  \\$a/inj permitted: do not convert to KNEE INJURIES
=680  \\$iThe flat, triangular bone situated at the anterior part of the KNEE.
=750  \0$aPatella$5IEN$0(DLC)sh 85098636

=LDR  00810cz  a2200241n  4500
=001  9880363869202441
=005  20141212204315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010327
=035  \\$aCBA3612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x176.$x560
=072  \\$aF2.$x880.$x410
=150  \\$aPastoral Care
=450  \\$wnnna$aCare, Pastoral
=450  \\$wnnna$aPastoral Psychology
=450  \\$aPsychology, Pastoral
=550  \\$wg$aCounseling
=550  \\$wg$aReligion and Psychology
=667  \\$aSPEC: SPEC qualif
=680  \\$iCounseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations.
=688  \\$a79; was PSYCHOLOGY, PASTORAL 1963-78
=750  \0$aPastoral care$5IEN-M$0(DLC)sh2001010409

=LDR  00870cz  a2200205n  4500
=001  9880363869302441
=005  20141212204315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010325
=035  \\$aCBA3610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x600
=072  \\$aB3.$x660.$x250.$x550.$x590
=150  \\$aPasteurella
=550  \\$wg$aPasteurellaceae
=550  \\$wh$aPasteurella multocida
=550  \\$wh$aPasteurella pneumotropica
=667  \\$ainfection = PASTEURELLA INFECTIONS or its specifics
=680  \\$iThe oldest recognized genus of the family PASTEURELLACEAE. It consists of several species. Its organisms occur most frequently as coccobacillus or rod-shaped and are gram-negative, nonmotile, facultative anaerobes. Species of this genus are found in both animals and humans.
=750  \0$aPasteurella$5IEN$0(DLC)sh 85098555

=LDR  02094cz  a2200409n  4500
=001  9880363869402441
=005  20141212204314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010324
=035  \\$aCBA3609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x625
=150  \\$aPassive-Aggressive Personality Disorder
=450  \\$wnnna$aDisorder, Negativistic Personality
=450  \\$wnnna$aDisorder, Passive-Aggressive Personality
=450  \\$wnnna$aDisorders, Negativistic Personality
=450  \\$wnnna$aDisorders, Passive-Aggressive Personality
=450  \\$aNegativistic Personality Disorder
=450  \\$wnnna$aNegativistic Personality Disorders
=450  \\$wnnna$aPassive-Aggressive Personalities
=450  \\$wnnna$aPassive-Aggressive Personality
=450  \\$wnnna$aPassive Aggressive Personality
=450  \\$wnnna$aPassive Aggressive Personality Disorder
=450  \\$wnnna$aPassive Aggressive Personality Disorders
=450  \\$wnnna$aPassive-Aggressive Personality Disorders
=450  \\$wnnna$aPersonalities, Passive-Aggressive
=450  \\$wnnna$aPersonality Disorder, Negativistic
=450  \\$aPersonality Disorder, Passive-Aggressive
=450  \\$wnnna$aPersonality Disorder, Passive Aggressive
=450  \\$wnnna$aPersonality Disorders, Negativistic
=450  \\$wnnna$aPersonality Disorders, Passive Aggressive
=450  \\$wnnna$aPersonality Disorders, Passive-Aggressive
=450  \\$wnnna$aPersonality, Passive-Aggressive
=550  \\$wg$aPersonality Disorders
=680  \\$iA personality disorder characterized by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency. (Dorland, 27th ed)
=688  \\$a91(81); was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80
=750  \0$aPassive-aggressive personality$5IEN$0(DLC)sh 85098527

=LDR  01034cz  a2200313n  4500
=001  9880363869502441
=005  20141212204313.0
=008  830615\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010322
=035  \\$aCBA3607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x700
=150  \\$aParvoviridae Infections
=450  \\$wnnna$aInfection, Parvoviridae
=450  \\$wnnna$aInfection, Parvovirus
=450  \\$wnnna$aInfections, Parvoviridae
=450  \\$wnnna$aInfections, Parvovirus
=450  \\$wnnna$aParvoviridae Infection
=450  \\$wnnna$aParvovirus Infection
=450  \\$aParvovirus Infections
=550  \\$wg$aDNA Virus Infections
=550  \\$wh$aAleutian Mink Disease
=550  \\$wh$aErythema Infectiosum
=550  \\$wh$aFeline Panleukopenia
=550  \\$wh$aMink Viral Enteritis
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus infections caused by the PARVOVIRIDAE.
=688  \\$a94; was PARVOVIRUS INFECTIONS 1984-93
=750  \0$aParvovirus infections$5IEN$0(DLC)sh 87004435

=LDR  00816cz  a2200229n  4500
=001  9880363869602441
=005  20141212204313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010321
=035  \\$aCBA3606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x580
=072  \\$aB4.$x909.$x204.$x671
=150  \\$aParvoviridae
=450  \\$aPicodnaviruses
=550  \\$wg$aDNA Viruses
=550  \\$wh$aDensovirinae
=550  \\$wh$aParvovirinae
=667  \\$ainfection = PARVOVIRIDAE INFECTIONS
=680  \\$iA family of very small DNA viruses containing a single molecule of single-stranded DNA and consisting of two subfamilies: PARVOVIRINAE and DENSOVIRINAE. They infect both vertebrates and invertebrates.
=688  \\$a81; was PARVOVIRUSES 1974-80
=750  \0$aParvoviruses$5IEN-M$0(DLC)sh 85098419

=LDR  01091cz  a2200253n  4500
=001  9880363869702441
=005  20141212204312.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010319
=035  \\$aCBA3604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x695
=150  \\$aParturient Paresis
=450  \\$wnnna$aAnimal Milk Fever
=450  \\$wnnna$aFever, Animal Milk
=450  \\$aMilk Fever, Animal
=450  \\$wnnna$aPareses, Parturient
=450  \\$wnnna$aParesis, Parturient
=450  \\$wnnna$aParturient Pareses
=550  \\$wg$aAnimal Diseases
=667  \\$aanimal only, exper or vet; in cows & ewes: check tags ANIMALS + FEMALE + PREGNANCY & don't forget CATTLE DISEASES (IM) + CATTLE (NIM) or SHEEP DISEASES (IM) + SHEEP (NIM)
=680  \\$iA disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes.
=688  \\$a75
=750  \0$aMilk fever in animals$5IEN$0(DLC)sh 85085355

=LDR  01441cz  a2200325n  4500
=001  9880363869802441
=005  20141212204312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010318
=035  \\$aCBA3603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x671.$x589
=150  \\$aPartnership Practice, Dental
=450  \\$aAssociateship Practice, Dental
=450  \\$wnnna$aAssociateship Practices, Dental
=450  \\$wnnna$aDental Associateship Practice
=450  \\$wnnna$aDental Associateship Practices
=450  \\$aDental Partnership$5IEN
=450  \\$wnnna$aDental Partnership Practice
=450  \\$wnnna$aDental Partnership Practices
=450  \\$wnnna$aPartnership Practices, Dental
=450  \\$wnnna$aPractice, Dental Associateship
=450  \\$wnnna$aPractice, Dental Partnership
=450  \\$wnnna$aPractices, Dental Associateship
=450  \\$wnnna$aPractices, Dental Partnership
=550  \\$wg$aPartnership Practice
=667  \\$acoord IM with specific dent specialty (IM); do not confuse with GROUP PRACTICE, DENTAL but do not interpret: use word of text; DF: PARTNERSHIP PRACTICE DENT
=680  \\$iA voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.
=688  \\$a91(72); was see under PARTNERSHIP PRACTICE 1972-90
=750  \0$aDental partnership$5IEN$0(DLC)sh 85036909

=LDR  00953cz  a2200241n  4500
=001  9880363869902441
=005  20141212204312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010317
=035  \\$aCBA3602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x671
=150  \\$aPartnership Practice
=450  \\$aMedical Partnership$5IEN
=450  \\$wnnna$aPartnership Practices
=450  \\$wnnna$aPractice, Partnership
=450  \\$wnnna$aPractices, Partnership
=550  \\$wg$aProfessional Practice
=550  \\$wh$aPartnership Practice, Dental
=667  \\$acoord IM with med or other specialty (IM); do not confuse with GROUP PRACTICE but do not interpret: use word of text
=680  \\$iA voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.
=688  \\$a68
=750  \0$aMedical partnership$5IEN$0(DLC)sh 85082981

=LDR  01082cz  a2200313n  4500
=001  9880363870002441
=005  20141212204311.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010315
=035  \\$aCBA3600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x710.$x680
=150  \\$aParticle Accelerators
=450  \\$wnnna$aAccelerator, Linear
=450  \\$wnnna$aAccelerator, Particle
=450  \\$wnnna$aAccelerators, Linear
=450  \\$wnnna$aAccelerators, Particle
=450  \\$wnnna$aBetatron
=450  \\$aBetatrons
=450  \\$wnnna$aLinear Accelerator
=450  \\$aLinear Accelerators
=450  \\$wnnna$aParticle Accelerator
=550  \\$wg$aRadiation Equipment and Supplies
=550  \\$wh$aCyclotrons
=550  \\$wh$aSynchrotrons
=667  \\$aCYCLOTRONS & SYNCHROTRONS are also available
=680  \\$iDevices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy.
=688  \\$a78
=750  \0$aParticle accelerators$5IEN$0(DLC)sh 85098356

=LDR  00714cz  a2200169n  4500
=001  9880363870102441
=005  20141212204310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010312
=035  \\$aCBA3597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x830.$x500
=150  \\$aParthenogenesis
=450  \\$wnnna$aParthenogeneses
=550  \\$wg$aReproduction, Asexual
=680  \\$iA unisexual reproduction without the fusion of a male and a female gamete (FERTILIZATION). In parthenogenesis, an individual is formed from an unfertilized OVUM that did not complete MEIOSIS. Parthenogenesis occurs in nature and can be artificially induced.
=750  \0$aParthenogenesis$5IEN$0(DLC)sh 85098337

=LDR  00728cz  a2200241n  4500
=001  9880363870302441
=005  20141212204309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010309
=035  \\$aCBA3594HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x815.$x470.$x800
=072  \\$aC7.$x465.$x815.$x793.$x500
=150  \\$aParotitis
=450  \\$wnnna$aParotiditides
=450  \\$wnnna$aParotiditis
=450  \\$wnnna$aParotitides
=550  \\$wg$aParotid Diseases
=550  \\$wg$aSialadenitis
=550  \\$wh$aMumps
=667  \\$ain translations use "parotitis", not "parotiditis" despite form of vernacular
=680  \\$iINFLAMMATION of the PAROTID GLAND.
=750  \0$aParotitis$5IEN$0(DLC)sh 85098273

=LDR  01036cz  a2200325n  4500
=001  9880363870402441
=005  20141212204309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010307
=035  \\$aCBA3592HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x591.$x824.$x695
=072  \\$aC7.$x465.$x565.$x824.$x695
=072  \\$aC7.$x465.$x815.$x470.$x770
=072  \\$aC7.$x465.$x815.$x718.$x589
=150  \\$aParotid Neoplasms
=450  \\$aCancer of Parotid
=450  \\$wnnna$aCancer of the Parotid
=450  \\$wnnna$aCancer, Parotid
=450  \\$wnnna$aCancers, Parotid
=450  \\$wnnna$aNeoplasm, Parotid
=450  \\$wnnna$aNeoplasms, Parotid
=450  \\$aParotid Cancer
=450  \\$wnnna$aParotid Cancers
=450  \\$wnnna$aParotid Neoplasm
=550  \\$wg$aParotid Diseases
=550  \\$wg$aSalivary Gland Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the PAROTID GLAND.
=750  \0$aParotid glands$xTumors$5IEN-M$0(DLC)sh 85098271

=LDR  00760cz  a2200229n  4500
=001  9880363870502441
=005  20141212204309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010306
=035  \\$aCBA3591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x500.$x760.$x464
=072  \\$aA10.$x336.$x779.$x464
=072  \\$aA14.$x549.$x760.$x464
=150  \\$aParotid Gland
=450  \\$wnnna$aGland, Parotid
=450  \\$wnnna$aGlands, Parotid
=450  \\$wnnna$aParotid Glands
=550  \\$wg$aSalivary Glands
=667  \\$ainflammation = PAROTITIS
=680  \\$iThe largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR.
=750  \0$aParotid glands$5IEN$0(DLC)sh 85098268

=LDR  00644cz  a2200229n  4500
=001  9880363870602441
=005  20141212204309.0
=008  790427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010305
=035  \\$aCBA3590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x815.$x470
=150  \\$aParotid Diseases
=450  \\$wnnna$aDisease, Parotid
=450  \\$wnnna$aDiseases, Parotid
=450  \\$wnnna$aParotid Disease
=550  \\$wg$aSalivary Gland Diseases
=550  \\$wh$aParotid Neoplasms
=550  \\$wh$aParotitis
=667  \\$ainflamm dis = PAROTITIS
=688  \\$a80
=750  \0$aParotid glands$xDiseases$5IEN$0(DLC)sh 85098269

=LDR  01123cz  a2200217n  4500
=001  9880363870702441
=005  20141212204308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010304
=035  \\$aCBA3589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x460
=072  \\$aC17.$x800.$x529.$x639
=072  \\$aC17.$x800.$x838.$x486
=150  \\$aParonychia
=450  \\$wnnna$aParonychias
=550  \\$wg$aNail Diseases
=550  \\$wg$aSkin Diseases, Infectious
=667  \\$ainfect dis of skin surrounding nail; coord IM with specific infect (IM)
=680  \\$iAn inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. (Andrews' Diseases of the Skin, 8th ed, p271)
=750  \0$aParonychia$5IEN$0(DLC)sh 85098260

=LDR  01789cz  a2200349n  4500
=001  9880363870802441
=005  20141212204308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010302
=035  \\$aCBA3587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x862.$x800
=072  \\$aC10.$x228.$x662.$x600.$x700
=150  \\$aParkinson Disease, Secondary
=450  \\$aAtherosclerotic Parkinsonism
=450  \\$wnnna$aParkinson Disease, Secondary Vascular
=450  \\$wnnna$aParkinson Disease, Symptomatic
=450  \\$wnnna$aParkinsonism, Atherosclerotic
=450  \\$wnnna$aParkinsonism, Secondary
=450  \\$wnnna$aParkinsonism, Symptomatic
=450  \\$wnnna$aSecondary Parkinson Disease
=450  \\$aSecondary Parkinsonism
=450  \\$wnnna$aSecondary Vascular Parkinson Disease
=450  \\$aSymptomatic Parkinson Disease
=450  \\$wnnna$aSymptomatic Parkinsonism
=550  \\$wg$aParkinsonian Disorders
=550  \\$wh$aMPTP Poisoning
=550  \\$wh$aParkinson Disease, Postencephalitic
=667  \\$a/chem ind permitted: coord IM with drug /adv eff-pois-tox (IM); coord IM with other cause (IM)
=680  \\$iConditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
=688  \\$a2000(1973)
=750  \0$aSymptomatic Parkinson's disease$5IEN$0(DLC)sh 85098118

=LDR  02348cz  a2200421n  4500
=001  9880363870902441
=005  20141212204307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010301
=035  \\$aCBA3586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x862.$x800.$x600
=072  \\$aC10.$x228.$x662.$x600.$x700.$x500
=150  \\$aParkinson Disease, Postencephalitic
=450  \\$wnnna$aEconomo-Type Parkinsonism, Postencephalitic
=450  \\$aEncephalitis Lethargica Type Parkinsonism
=450  \\$wnnna$aMeningoencephalitic Parkinsonism, Viral
=450  \\$wnnna$aParkinson Disease, Post-Encephalitic
=450  \\$wnnna$aParkinson Disease, Post Encephalitic
=450  \\$wnnna$aParkinsonian Syndrome, Postencephalitis
=450  \\$wnnna$aParkinsonism, Postencephalitic
=450  \\$wnnna$aParkinsonism, Postencephalitic Economo-Type
=450  \\$aParkinsonism, Viral Meningoencephalitic
=450  \\$wnnna$aParkinsonisms, Viral Meningoencephalitic
=450  \\$wnnna$aPost-Encephalitic Parkinson Disease
=450  \\$wnnna$aPost Encephalitic Parkinson Disease
=450  \\$wnnna$aPostencephalitic Economo-Type Parkinsonism
=450  \\$wnnna$aPostencephalitic Economo Type Parkinsonism
=450  \\$wnnna$aPostencephalitic Parkinson Disease
=450  \\$aPostencephalitic Parkinsonism
=450  \\$wnnna$aPostencephalitis Parkinsonian Syndrome
=450  \\$wnnna$aViral Meningoencephalitic Parkinsonism
=450  \\$wnnna$avon Economo Encephalitis Type Parkinsonism
=550  \\$wg$aParkinson Disease, Secondary
=667  \\$aDF: PARKINSON DIS POSTENCEPH
=680  \\$iParkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)
=688  \\$a1979(1967)
=750  \0$aPostencephalitic Parkinson's disease$5IEN$0(DLC)sh 85098117

=LDR  01922cz  a2200373n  4500
=001  9880363871002441
=005  20141212204306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010300
=035  \\$aCBA3585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x862.$x500
=072  \\$aC10.$x228.$x662.$x600.$x400
=072  \\$aC10.$x574.$x812
=150  \\$aParkinson Disease
=450  \\$aIdiopathic Parkinson Disease
=450  \\$wnnna$aIdiopathic Parkinson's Disease
=450  \\$aLewy Body Parkinson Disease
=450  \\$wnnna$aLewy Body Parkinson's Disease
=450  \\$aParalysis Agitans
=450  \\$wnnna$aParkinson Disease, Idiopathic
=450  \\$wnnna$aParkinsonism, Primary
=450  \\$wnnna$aParkinson's Disease
=450  \\$wnnna$aParkinson's Disease, Idiopathic
=450  \\$wnnna$aParkinson's Disease, Lewy Body
=450  \\$aPrimary Parkinsonism
=550  \\$wg$aNeurodegenerative Diseases
=550  \\$wg$aParkinsonian Disorders
=550  \\$aLewy Bodies
=550  \\$aManganese Poisoning
=667  \\$adrug ther: consider also ANTIPARKINSON AGENTS; /chem ind = PARKINSON DISEASE, SECONDARY/chem ind
=680  \\$iA progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
=688  \\$a1979(1963)
=750  \0$aParkinson's disease$5IEN$0(DLC)sh 85098115

=LDR  00683cz  a2200205n  4500
=001  9880363871102441
=005  20190130104623.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010299
=035  \\$aCBA3584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x490
=150  \\$aParking Facilities
=450  \\$wnnna$aFacilities, Parking
=450  \\$wnnna$aFacility, Parking
=450  \\$wnnna$aParking Facility
=550  \\$wg$aTransportation Facilities
=680  \\$iIndoor or outdoor areas designated for the parking of vehicles.
=688  \\$a91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
=750  \0$aAutomobile parking$5IEN$0(DLC)sh 85010172

=LDR  01112cz  a2200325n  4500
=001  9880363871202441
=005  20141212204306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010298
=035  \\$aCBA3583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x677
=072  \\$aG8.$x686.$x785.$x760.$x769.$x472
=072  \\$aN6.$x850.$x490.$x812.$x600
=150  \\$aParity
=450  \\$aMultiparity
=450  \\$aNulliparity
=450  \\$wnnna$aParity Progression Ratio
=450  \\$wnnna$aParity Progression Ratios
=450  \\$aPrimiparity
=450  \\$wnnna$aRatio, Parity Progression
=450  \\$wnnna$aRatios, Parity Progression
=550  \\$wg$aPregnancy
=550  \\$wg$aReproductive History
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$aGravidity
=667  \\$ahuman & animal; relation to PREGNANCY: Manual 28.16.4
=680  \\$iThe number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome.
=688  \\$a70(65)
=750  \0$aParity (Obstetrics)$0(DLC)sh2010012915$5IEN-M

=LDR  02916cz  a2200805n  4500
=001  9880363871302441
=005  20141212192414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010296
=035  \\$aCBA3581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x670
=150  \\$aParietal Lobe
=450  \\$wnnna$aAngular Gyrus
=450  \\$wnnna$aAngulari, Gyrus
=450  \\$wnnna$aAngularis, Gyrus
=450  \\$wnnna$aCortex, Parietal
=450  \\$wnnna$aCortex, Posterior Parietal
=450  \\$wnnna$aCortex, Precuneus
=450  \\$wnnna$aCortices, Parietal
=450  \\$wnnna$aCortices, Posterior Parietal
=450  \\$wnnna$aCortices, Precuneus
=450  \\$wnnna$aGyrus, Angular
=450  \\$wnnna$aGyrus Angulari
=450  \\$wnnna$aGyrus Angularis
=450  \\$wnnna$aGyrus, Prelunate
=450  \\$wnnna$aGyrus, Supramarginal
=450  \\$wnnna$aGyrus Supramarginali
=450  \\$wnnna$aGyrus Supramarginalis
=450  \\$wnnna$aIntraparietal Sulcus
=450  \\$wnnna$aLobe, Parietal
=450  \\$wnnna$aLobes, Parietal
=450  \\$wnnna$aLobule, Parietal
=450  \\$wnnna$aLobule, Posterior Paracentral
=450  \\$wnnna$aLobules, Parietal
=450  \\$wnnna$aLobules, Posterior Paracentral
=450  \\$wnnna$aMarginal Sulcus
=450  \\$wnnna$aParacentral Lobule, Posterior
=450  \\$wnnna$aParacentral Lobules, Posterior
=450  \\$wnnna$aParietal Cortex
=450  \\$wnnna$aParietal Cortex, Posterior
=450  \\$wnnna$aParietal Cortices
=450  \\$wnnna$aParietal Cortices, Posterior
=450  \\$wnnna$aParietal Lobes
=450  \\$wnnna$aParietal Lobule
=450  \\$wnnna$aParietal Lobules
=450  \\$wnnna$aParietal Region
=450  \\$wnnna$aParietal Regions
=450  \\$wnnna$aPosterior Paracentral Lobule
=450  \\$wnnna$aPosterior Paracentral Lobules
=450  \\$wnnna$aPosterior Parietal Cortex
=450  \\$wnnna$aPosterior Parietal Cortices
=450  \\$wnnna$aPraecuneus
=450  \\$wnnna$aPrecuneus
=450  \\$wnnna$aPrecuneus Cortex
=450  \\$wnnna$aPrecuneus Cortices
=450  \\$wnnna$aPrelunate Gyrus
=450  \\$wnnna$aRegion, Parietal
=450  \\$wnnna$aRegions, Parietal
=450  \\$wnnna$aSulcus, Intraparietal
=450  \\$wnnna$aSulcus, Marginal
=450  \\$wnnna$aSupramarginal Gyrus
=450  \\$wnnna$aSupramarginali, Gyrus
=450  \\$wnnna$aSupramarginalis, Gyrus
=550  \\$wg$aCerebral Cortex
=550  \\$wh$aSomatosensory Cortex
=550  \\$wh$aWernicke Area
=667  \\$adiseases: coordinate IM with BRAIN DISEASES (IM); neoplasms: coordinate IM with BRAIN NEOPLASMS (IM)
=680  \\$iUpper central part of the cerebral hemisphere. It is located posterior to central sulcus, anterior to the OCCIPITAL LOBE, and superior to the TEMPORAL LOBES.
=750  \0$aParietal lobes$5IEN$0(DLC)sh 85098035

=LDR  01523cz  a2200349n  4500
=001  9880363871502441
=005  20141212204303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010288
=035  \\$aCBA3573HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x421.$x505
=072  \\$aE2.$x642.$x500.$x505
=150  \\$aParenteral Nutrition
=450  \\$wnnna$aFeeding, Intravenous
=450  \\$wnnna$aFeeding, Parenteral
=450  \\$wnnna$aFeedings, Intravenous
=450  \\$wnnna$aFeedings, Parenteral
=450  \\$aIntravenous Feeding
=450  \\$wnnna$aIntravenous Feedings
=450  \\$aNutrition, Parenteral
=450  \\$aParenteral Feeding
=450  \\$wnnna$aParenteral Feedings
=550  \\$wg$aFeeding Methods
=550  \\$wg$aNutritional Support
=550  \\$wh$aParenteral Nutrition, Home
=550  \\$wh$aParenteral Nutrition, Total
=550  \\$aParenteral Nutrition Solutions
=667  \\$afor nourishment: differentiate from FLUID THERAPY (to replace fluids) or ENTERAL NUTRITION or INFUSIONS, PARENTERAL (a method of administering drugs & chemicals); coordinate IM with disease / ther (IM), not / diet ther
=680  \\$iThe administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously).
=688  \\$a92; was PARENTERAL FEEDING 1966-91
=750  \0$aParenteral feeding$5IEN-M$0(DLC)sh 85097999

=LDR  01305cz  a2200373n  4500
=001  9880363871602441
=005  20141212204302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010287
=035  \\$aCBA3572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x290
=150  \\$aParent-Child Relations
=450  \\$wnnna$aChild Relationship, Parent
=450  \\$wnnna$aChild Relationships, Parent
=450  \\$aParent and Child$5IEN
=450  \\$wnnna$aParent-Child Relation
=450  \\$wnnna$aParent Child Relations
=450  \\$wnnna$aParent Child Relationship
=450  \\$wnnna$aParent-Child Relationship
=450  \\$wnnna$aParent Child Relationships
=450  \\$wnnna$aParent-Child Relationships
=450  \\$wnnna$aRelation, Parent-Child
=450  \\$wnnna$aRelations, Parent-Child
=450  \\$wnnna$aRelationship, Parent Child
=450  \\$wnnna$aRelationship, Parent-Child
=450  \\$wnnna$aRelationships, Parent Child
=450  \\$wnnna$aRelationships, Parent-Child
=550  \\$wg$aFamily Relations
=550  \\$wh$aFather-Child Relations
=550  \\$wh$aMother-Child Relations
=667  \\$ahuman only; DF: PARENT CHILD RELAT
=680  \\$iThe interactions between parent and child.
=750  \0$aParent and child$5IEN-HS$0(DLC)sh 85097980

=LDR  00790cz  a2200205n  4500
=001  9880363871702441
=005  20141212204302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010284
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x821.$x438
=150  \\$aParatyphoid Fever
=450  \\$wnnna$aFever, Paratyphoid
=450  \\$wnnna$aFevers, Paratyphoid
=450  \\$wnnna$aParatyphoid Fevers
=550  \\$wg$aSalmonella Infections
=667  \\$aspecify Salmonella paratyphi species if possible (IM)
=680  \\$iA prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.
=688  \\$a92; was PARATYPHOID FEVERS 1963-91
=750  \0$aParatyphoid fever$5IEN-M$0(DLC)sh 85097945

=LDR  00887cz  a2200265n  4500
=001  9880363871802441
=005  20141212204301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010283
=035  \\$aCBA3568HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x588
=072  \\$aC22.$x688
=150  \\$aParatuberculosis
=450  \\$wnnna$aDisease, Johne
=450  \\$wnnna$aDisease, Johne's
=450  \\$wnnna$aJohne Disease
=450  \\$aJohne's Disease
=450  \\$wnnna$aJohnes Disease
=450  \\$wnnna$aParatuberculoses
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aMycobacterium Infections
=667  \\$acaused by Mycobacterium avium subsp. paratuberculosis; usually animal
=680  \\$iA chronic GASTROENTERITIS in RUMINANTS caused by MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS.
=750  \0$aParatuberculosis$5IEN$0(DLC)sh 85070623

=LDR  01551cz  a2200433n  4500
=001  9880363871902441
=005  20141212204301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010282
=035  \\$aCBA3567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x525
=072  \\$aC4.$x588.$x443.$x680
=072  \\$aC19.$x344.$x525
=072  \\$aC19.$x642.$x713
=150  \\$aParathyroid Neoplasms
=450  \\$wnnna$aAdenoma, Parathyroid
=450  \\$wnnna$aAdenomas, Parathyroid
=450  \\$aCancer of Parathyroid
=450  \\$wnnna$aCancer of the Parathyroid
=450  \\$wnnna$aCancer, Parathyroid
=450  \\$wnnna$aCancers, Parathyroid
=450  \\$wnnna$aCarcinoma, Parathyroid
=450  \\$wnnna$aCarcinomas, Parathyroid
=450  \\$wnnna$aNeoplasm, Parathyroid
=450  \\$wnnna$aNeoplasms, Parathyroid
=450  \\$wnnna$aParathyroid Adenoma
=450  \\$wnnna$aParathyroid Adenomas
=450  \\$aParathyroid Cancer
=450  \\$wnnna$aParathyroid Cancers
=450  \\$wnnna$aParathyroid Carcinoma
=450  \\$wnnna$aParathyroid Carcinomas
=450  \\$wnnna$aParathyroid Neoplasm
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aHead and Neck Neoplasms
=550  \\$wg$aParathyroid Diseases
=667  \\$acoordinate IM with histological type of neoplasm (IM); parathyroid adenoma: coordinate IM with ADENOMA in spite of entry term PARATHYROID ADENOMA
=680  \\$iTumors or cancer of the PARATHYROID GLANDS.
=750  \0$aParathyroid glands$xTumors$5IEN-M$0(DLC)sh 85097937

=LDR  01498cz  a2200325n  4500
=001  9880363872002441
=005  20141212204300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x590
=072  \\$aD12.$x644.$x548.$x587
=150  \\$aParathyroid Hormone
=450  \\$wnnna$aHormone, Parathyroid
=450  \\$wnnna$aParathormone
=450  \\$wnnna$aParathyrin
=450  \\$wnnna$aParathyroid Hormone (1-34)
=450  \\$wnnna$aParathyroid Hormone (1-84)
=450  \\$wnnna$aParathyroid Hormone Peptide (1-34)
=450  \\$wnnoa$aParathyroid Hormones$5IEN-HS
=450  \\$wnnna$aPTH(1-34)
=450  \\$wnnna$aPTH (1-84)
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aTeriparatide
=550  \\$aParathyroid Hormone-Related Protein
=667  \\$a/defic: consider also HYPOPARATHYROIDISM
=680  \\$iA polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.
=688  \\$a2004(1963-1981); for PARATHYROID HORMONE PEPTIDE (1-34) use TERIPARATIDE 1997-2007
=688  \\$a2004(1963-1981);
=750  \0$aParathyroid hormone$5IEN$0(DLC)sh 85097938

=LDR  00822cz  a2200205n  4500
=001  9880363872102441
=005  20141212204300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010280
=035  \\$aCBA3565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x560
=150  \\$aParathyroid Glands
=450  \\$wnnna$aGland, Parathyroid
=450  \\$wnnna$aGlands, Parathyroid
=450  \\$wnnna$aParathyroid Gland
=550  \\$wg$aEndocrine Glands
=667  \\$a/surg: consider also PARATHYROIDECTOMY
=680  \\$iTwo pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.
=750  \0$aParathyroid glands$5IEN$0(DLC)sh 85097934

=LDR  01124cz  a2200301n  4500
=001  9880363872202441
=005  20141212204300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010279
=035  \\$aCBA3564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x642
=150  \\$aParathyroid Diseases
=450  \\$wnnna$aDisease, Parathyroid
=450  \\$wnnna$aDiseases, Parathyroid
=450  \\$wnnna$aDisorder, Parathyroid
=450  \\$wnnna$aDisorders, Parathyroid
=450  \\$wnnna$aParathyroid Disease
=450  \\$wnnna$aParathyroid Disorder
=450  \\$wnnna$aParathyroid Disorders
=550  \\$wg$aEndocrine System Diseases
=550  \\$wh$aHyperparathyroidism
=550  \\$wh$aHypoparathyroidism
=550  \\$wh$aParathyroid Neoplasms
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iPathological processes of the PARATHYROID GLANDS. They usually manifest as hypersecretion or hyposecretion of PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body.
=688  \\$a66
=750  \0$aParathyroid glands$xDiseases$5IEN$0(DLC)sh 85097935

=LDR  01148cz  a2200277n  4500
=001  9880363872302441
=005  20141212204259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010278
=035  \\$aCBA3563M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x400.$x625.$x600
=072  \\$aD2.$x705.$x539.$x345.$x600
=072  \\$aD2.$x886.$x300.$x692.$x600
=150  \\$aParathion
=450  \\$wnnna$aE-605
=450  \\$wnnna$aEthyl Parathion
=450  \\$wnnna$aParathion, Ethyl
=450  \\$wnnna$aPhosphostigmine
=450  \\$wnnna$aThiofos
=450  \\$wnnna$aThiophos
=550  \\$wg$aOrganothiophosphates
=550  \\$wh$aMethyl Parathion
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect; for poisoning, coordinate with ORGANOPHOSPHATE POISONING
=680  \\$iA highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide.
=750  \0$aParathion$0(DLC)sh2008020211$5IEN-M

=LDR  01421cz  a2200289n  4500
=001  9880363872402441
=005  20141212204259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010277
=035  \\$aCBA3562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x675
=150  \\$aParasympathomimetics
=450  \\$wnnna$aAgents, Parasympathomimetic
=450  \\$wnnna$aDrugs, Parasympathomimetic
=450  \\$wnnna$aEffect, Parasympathomimetic
=450  \\$wnnna$aEffects, Parasympathomimetic
=450  \\$wnnna$aParasympathomimetic Agents
=450  \\$wnnna$aParasympathomimetic Drugs
=450  \\$wnnna$aParasympathomimetic Effect
=450  \\$wnnna$aParasympathomimetic Effects
=550  \\$wg$aAutonomic Agents
=550  \\$aMiotics
=550  \\$aParasympathetic Nervous System
=667  \\$anote entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance
=680  \\$iDrugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
=750  \0$aParasympathomimetic agents$5IEN$0(DLC)sh 85097931

=LDR  00925cz  a2200265n  4500
=001  9880363872502441
=005  20141212204250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010254
=035  \\$aCBA3538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460.$x692
=072  \\$aC9.$x603.$x692
=150  \\$aParanasal Sinus Diseases
=450  \\$wnnna$aDisease, Paranasal Sinus
=450  \\$wnnna$aDiseases, Paranasal Sinus
=450  \\$wnnna$aParanasal Sinus Disease
=450  \\$wnnna$aSinus Disease, Paranasal
=450  \\$wnnna$aSinus Diseases, Paranasal
=550  \\$wg$aNose Diseases
=550  \\$wh$aParanasal Sinus Neoplasms
=550  \\$wh$aSinusitis
=680  \\$iDiseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.
=688  \\$a77; was NON MESH before 1977
=750  \0$aParanasal sinuses$xDiseases$5IEN$0(DLC)sh 85097870

=LDR  01963cz  a2200493n  4500
=001  9880363872602441
=005  20141212204259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010276
=035  \\$aCBA3561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x650
=150  \\$aParasympatholytics
=450  \\$wnnna$aAgents, Antispasmodic
=450  \\$wnnna$aAgents, Parasympathetic-Blocking
=450  \\$wnnna$aAgents, Parasympatholytic
=450  \\$wnnna$aAntispasmodic Agents
=450  \\$wnnna$aAntispasmodic Drugs
=450  \\$wnnna$aAntispasmodic Effect
=450  \\$wnnna$aAntispasmodic Effects
=450  \\$aAntispasmodics
=450  \\$wnnna$aDrugs, Antispasmodic
=450  \\$wnnna$aDrugs, Parasympatholytic
=450  \\$wnnna$aEffect, Antispasmodic
=450  \\$wnnna$aEffect, Parasympatholytic
=450  \\$wnnna$aEffects, Antispasmodic
=450  \\$wnnna$aEffects, Parasympatholytic
=450  \\$aParasympathetic-Blocking Agents
=450  \\$wnnna$aParasympathetic Blocking Agents
=450  \\$wnnna$aParasympatholytic Agents
=450  \\$wnnna$aParasympatholytic Drugs
=450  \\$wnnna$aParasympatholytic Effect
=450  \\$wnnna$aParasympatholytic Effects
=450  \\$aSpasmolytics
=550  \\$wg$aAutonomic Agents
=550  \\$aMuscarinic Antagonists
=550  \\$aMuscle Relaxants, Central
=550  \\$aParasympathetic Nervous System
=550  \\$aSolanaceous Alkaloids
=667  \\$anote entry term PARASYMPATHOLYTIC EFFECT: use only for the parasympatholyic effect of a chemical substance
=680  \\$iAgents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
=688  \\$aANTISPASMODICS & SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69
=750  \0$aAntispasmodics$5IEN-M$0(DLC)sh 85005773
=750  \0$aParasympatholytic agents$5IEN-HS$0(DLC)sh 85097930

=LDR  00863cz  a2200217n  4500
=001  9880363872702441
=005  20141212204249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010252
=035  \\$aCBA3536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600
=072  \\$aB4.$x909.$x777.$x455.$x600
=150  \\$aParamyxoviridae
=550  \\$wg$aMononegavirales
=550  \\$wh$aParamyxovirinae
=550  \\$wh$aPneumovirinae
=667  \\$aa family of the order Mononegavirales; infection = PARAMYXOVIRIDAE INFECTIONS
=680  \\$iA family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE.
=688  \\$a81; was PARAMYXOVIRUSES 1971-80 (Prov 1971-72)
=750  \0$aParamyxoviruses$5IEN$0(DLC)sh 85097864

=LDR  01458cz  a2200301n  4500
=001  9880363872802441
=005  20141212204258.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010275
=035  \\$aCBA3560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x600
=150  \\$aParasympathetic Nervous System
=450  \\$wnnna$aNervous System, Parasympathetic
=450  \\$wnnna$aNervous Systems, Parasympathetic
=450  \\$wnnna$aParasympathetic Nervous Systems
=450  \\$wnnna$aSystem, Parasympathetic Nervous
=450  \\$wnnna$aSystems, Parasympathetic Nervous
=550  \\$wg$aAutonomic Nervous System
=550  \\$wh$aFacial Nerve
=550  \\$wh$aGanglia, Parasympathetic
=550  \\$wh$aGlossopharyngeal Nerve
=550  \\$wh$aOculomotor Nerve
=550  \\$wh$aParasympathetic Fibers, Postganglionic
=550  \\$wh$aVagus Nerve
=667  \\$a/drug eff: consider also PARASYMPATHOMIMETICS & PARASYMPATHOLYTICS
=680  \\$iThe craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system.
=750  \0$aParasympathetic nervous system$5IEN$0(DLC)sh 85090942

=LDR  01103cz  a2200313n  4500
=001  9880364286902441
=005  20141212215937.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x600.$x670
=150  \\$aSea Lions
=450  \\$aCalifornia Sea Lion
=450  \\$wnnna$aCalifornia Sea Lions
=450  \\$wnnna$aLion, California Sea
=450  \\$wnnna$aLion, Sea
=450  \\$wnnna$aLions, California Sea
=450  \\$wnnna$aLions, Sea
=450  \\$wnnna$aSea Lion
=450  \\$aSea Lion, California
=450  \\$wnnna$aSea Lions, California
=450  \\$wnnna$aSealion
=450  \\$wnnna$aSealions
=450  \\$aZalophus
=450  \\$wnnna$aZalophus californianus
=550  \\$wg$aPinnipedia
=680  \\$iA group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair.
=688  \\$a2005; use SEALS, EARLESS 1980-2004, use PINNIPEDIA 1968-1979
=750  \0$aSea lions$0(DLC) sh 85119233$5IEN-M

=LDR  00957cz  a2200277n  4500
=001  9880364287002441
=005  20141212215937.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x600.$x288
=150  \\$aFur Seals
=450  \\$aArctocephalus
=450  \\$aCallorhinus
=450  \\$wnnna$aEared Seal
=450  \\$wnnna$aEared Seals
=450  \\$wnnna$aFur Seal
=450  \\$wnnna$aSeal, Eared
=450  \\$wnnna$aSeal, Fur
=450  \\$aSeals, Eared
=450  \\$wnnna$aSeals, Fur
=550  \\$wg$aPinnipedia
=667  \\$aSEALS, EARLESS and SEA LIONS are also available
=680  \\$iA group comprised of several species of eared seals found in two genera, in the family Otariidae. In comparison to SEA LIONS, they have an especially dense wooly undercoat.
=688  \\$a2005; use SEALS, EARLESS 1990-2004
=750  \0$aEared seals$0(DLC) sh 85040406$5IEN-M

=LDR  01095cz  a2200229n  4500
=001  9880364287102441
=005  20141212215936.0
=008  040719\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046068
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x300
=150  \\$aCaulerpa
=450  \\$wnnna$aCaulerpa taxifolia
=450  \\$wnnna$aCaulerpa taxifolias
=450  \\$wnnna$aCaulerpas
=450  \\$wnnna$ataxifolia, Caulerpa
=450  \\$wnnna$ataxifolias, Caulerpa
=550  \\$wg$aChlorophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of toxic marine GREEN ALGAE found throughout tropical and subtropical seas. One species, Caulerpa taxifolia, is highly invasive and produces the poison caulerpenyne, deadly to marine organisms though not humans.
=688  \\$a2005
=750  \0$aCaulerpa$0(DLC) sh 85021446$5IEN-M

=LDR  00729cz  a2200229n  4500
=001  9880364287202441
=005  20141212215936.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046049
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x600.$x700.$x600
=150  \\$aPhoca
=450  \\$wnnna$aHarbor Seal
=450  \\$wnnna$aHarbor Seals
=450  \\$wnnna$aPhoca vitulina
=450  \\$wnnna$aPhocas
=450  \\$aSeal, Harbor
=450  \\$wnnna$aSeals, Harbor
=550  \\$wg$aSeals, Earless
=680  \\$iA genus in the family of EARLESS SEALS (Phocidae) and collectively the most abundant PINNIPEDS in the Northern Hemisphere.
=688  \\$a2005
=750  \0$aPhoca$0(DLC) sh 90003961$5IEN-M

=LDR  00860cz  a2200229n  4500
=001  9880364287402441
=005  20141212215934.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046031
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x700
=150  \\$aRaccoon Dogs
=450  \\$wnnna$aDog, Raccoon
=450  \\$wnnna$aDogs, Raccoon
=450  \\$aNyctereutes
=450  \\$wnnna$aNyctereutes procyonoides
=450  \\$wnnna$aRaccoon Dog
=550  \\$wg$aCanidae
=667  \\$ado not confuse with RACCOONS
=680  \\$iThe lone species in the genus Nyctereutes, family CANIDAE. It is found in the woodland zone from southeastern Siberia to Vietnam and on the main islands of Japan.
=688  \\$a2005; use CARNIVORA 1990-2004; for NYCTEREUTES use CARNIVORA 1998-2004
=750  \0$aRaccoon dog$0(DLC) sh 85110227$5IEN-M

=LDR  00622cz  a2200169n  4500
=001  9880364287502441
=005  20141212215934.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046030
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x400
=150  \\$aJackals
=450  \\$wnnna$aJackal
=550  \\$wg$aCanidae
=680  \\$iMedium-sized terrestrial carnivores, in the genus Canis, family CANIDAE. Three species are recognized, two found only in Africa and one found in Africa, Europe, and Asia.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aJackals$0(DLC) sh 85069185$5IEN-M

=LDR  00624cz  a2200181n  4500
=001  9880364287602441
=005  20141212215934.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046029
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153.$x150
=150  \\$aCoyotes
=450  \\$aCanis latrans
=450  \\$wnnna$aCoyote
=550  \\$wg$aCanidae
=680  \\$iThe species Canis latrans in the family CANIDAE, a smaller relative of WOLVES. It is found in the Western hemisphere from Costa Rica to Alaska.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aCoyote$0(DLC) sh 85033677$5IEN-M

=LDR  00842cz  a2200265n  4500
=001  9880364287702441
=005  20141212215933.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046028
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x153
=150  \\$aCanidae
=450  \\$wnnna$aChrysocyon brachyurus
=450  \\$wnnna$aManed Wolf
=450  \\$wnnna$aWolf, Maned
=550  \\$wg$aCarnivora
=550  \\$wh$aCoyotes
=550  \\$wh$aDogs
=550  \\$wh$aFoxes
=550  \\$wh$aJackals
=550  \\$wh$aRaccoon Dogs
=550  \\$wh$aWolves
=680  \\$iA family of terrestrial carnivores with long snouts and non-retractable claws. Members include COYOTES; DOGS; FOXES; JACKALS; RACCOON DOGS; and WOLVES.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aCanidae$0(DLC) sh 85019594$5IEN-M

=LDR  00755cz  a2200205n  4500
=001  9880364287802441
=005  20141212215718.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044044
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x19
=072  \\$aB3.$x660.$x250.$x17
=150  \\$aAeromonadaceae
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wh$aAeromonas
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA family of gram-negative facultatively anaerobic bacteria, ubiquitous in fresh and brackish water, and associated with GASTROINTESTINAL DISEASES.
=688  \\$a2004
=750  \0$aAeromonadaceae$0(DLC) sh2005020185$5IEN-M

=LDR  01463cz  a2200373n  4500
=001  9880364287902441
=005  20190423153646.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044006
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x200.$x700.$x299
=150  \\$aReceptors, Epoprostenol
=450  \\$wnnna$aEpoprostenol Receptors
=450  \\$aPGI2 Receptor
=450  \\$wnnna$aPGI2 Receptors
=450  \\$aProstacyclin Receptor
=450  \\$wnnna$aProstacyclin Receptors
=450  \\$wnnna$aProstaglandin I2 Receptor
=450  \\$wnnna$aProstaglandin I2 Receptors
=450  \\$wnnna$aProstaglandins X Receptors
=450  \\$wnnna$aReceptor, PGI2
=450  \\$wnnna$aReceptor, Prostacyclin
=450  \\$wnnna$aReceptor, Prostaglandin I2
=450  \\$wnnna$aReceptors, PGI2
=450  \\$aReceptors, Prostacyclin
=450  \\$wnnna$aReceptors, Prostaglandin I2
=450  \\$wnnna$aReceptors, Prostaglandins X
=550  \\$wg$aReceptors, Prostaglandin
=667  \\$aDF: PGI2 RECEPT
=680  \\$iCell surface receptors for EPOPROSTENOL. They are coupled to HETEROTRIMERIC G-PROTEINS.
=688  \\$a2004; use RECEPTORS, EPOPROSTENOL (NM) 1981-2002
=750  \0$81$wb$iBroader mapping$aProstacyclin$0(DLC)sh 85107601$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \\$iSearch also under the Library of Congress Subject Heading:$aProstacyclin--Receptors$5IEN-M

=LDR  00909cz  a2200253n  4500
=001  9880364288002441
=005  20210217182045.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x531.$x820
=150  \\$aTetrahydroisoquinolines
=450  \\$wnnna$a1,2,3,4-Tetrahydroisoquinolines
=450  \\$wnnna$aTetrahydro-Isoquinolines
=450  \\$wnnna$aTetrahydro Isoquinolines
=550  \\$wg$aIsoquinolines
=550  \\$wh$aSalsoline Alkaloids
=550  \\$wh$aSolifenacin Succinate
=550  \\$wh$aToxiferine
=550  \\$wh$aTubocurarine
=550  \\$wh$aTrabectedin
=680  \\$iA group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES.
=688  \\$a2004
=750  \0$aTetrahydroisoquinolines$0(DLC) sh 85134201$5IEN-M

=LDR  01246cz  a2200325n  4500
=001  9880364288102441
=005  20141212215715.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044003
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x137.$x750
=150  \\$aSphagnopsida
=450  \\$wnnna$aMoss, Peat
=450  \\$aMoss, Sphagnum
=450  \\$wnnna$aMosse, Peat
=450  \\$aMosses, Peat
=450  \\$wnnna$aMosses, Sphagnum
=450  \\$wnnna$aPeat Moss
=450  \\$wnnna$aPeat Mosse
=450  \\$wnnna$aPeat Mosses
=450  \\$wnnna$aSphagnopsidas
=450  \\$aSphagnum
=450  \\$wnnna$aSphagnum Moss
=450  \\$wnnna$aSphagnum Mosses
=450  \\$wnnna$aSphagnums
=550  \\$wg$aBryophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA class of BRYOPHYTA which is best known for Sphagnum forming PEAT bogs.
=688  \\$a2004; for SPHAGNUM use BRYOPSIDA 1996-2003, use PLANTS 1986-1995
=750  \0$aPeat mosses$0(DLC) sh 85099088$5IEN-M

=LDR  01267cz  a2200325n  4500
=001  9880364288202441
=005  20141212215714.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x137
=150  \\$aBryophyta
=450  \\$aAndreaeopsida
=450  \\$wnnna$aAndreaeopsidas
=450  \\$wnnna$aBryophytas
=450  \\$wnnna$aGranite Mosse
=450  \\$wnnna$aGranite Mosses
=450  \\$wnnna$aMosse
=450  \\$wnnna$aMosse, Granite
=450  \\$wnnna$aMosses
=450  \\$aMosses, Granite
=450  \\$aMusci
=450  \\$wnnna$aMuscus
=550  \\$wg$aEmbryophyta
=550  \\$wh$aBryopsida
=550  \\$wh$aSphagnopsida
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA division of the plant kingdom. Bryophyta contains the subdivision, Musci, which contains the classes: Andreaeopsida, BRYOPSIDA, and SPHAGNOPSIDA.
=688  \\$a2004; for MUSCI use BRYOPSIDA 1996-2003
=750  \0$aBryophytes$0(DLC) sh 85017380$5IEN-M

=LDR  01578cz  a2200409n  4500
=001  9880364288302441
=005  20141212215714.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043982
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x841
=150  \\$aRhizophoraceae
=450  \\$wnnna$aAmerican Mangrove
=450  \\$aBruguiera
=450  \\$wnnna$aBruguieras
=450  \\$aCassipourea
=450  \\$wnnna$aCassipoureas
=450  \\$wnnna$aCeriop
=450  \\$aCeriops
=450  \\$aKandelia
=450  \\$wnnna$aKandelias
=450  \\$wnnna$amangle, Rhizophora
=450  \\$wnnna$amangles, Rhizophora
=450  \\$aMangrove, American
=450  \\$aMangrove, Red
=450  \\$wnnna$aMangroves, Red
=450  \\$wnnna$aRed Mangrove
=450  \\$wnnna$aRed Mangroves
=450  \\$aRhizophora
=450  \\$aRhizophora mangle
=450  \\$wnnna$aRhizophora mangles
=450  \\$wnnna$aRhizophoras
=550  \\$wg$aAngiosperms
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29; note entry terms MANGROVE, AMERICAN and MANGROVE, RED: MANGROVE SWAMPS see WETLANDS is also available
=680  \\$iA plant family of the order Rhizophorales, subclass Rosidae, class Magnoliopsida, that includes mangrove trees.
=688  \\$a2004
=750  \0$aRhizophoraceae$0(DLC) sh 88023067$5IEN-M

=LDR  01207cz  a2200289n  4500
=001  9880364288402441
=005  20141212215713.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043964
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x461
=150  \\$aMarsileaceae
=450  \\$aClover, Water
=450  \\$wnnna$aClovers, Water
=450  \\$aMarsilea
=450  \\$wnnna$aMarsileas
=450  \\$aPepperwort
=450  \\$wnnna$aPepperworts
=450  \\$wnnna$aWater Clover
=450  \\$wnnna$aWater Clovers
=450  \\$aWaterclover
=450  \\$wnnna$aWaterclovers
=550  \\$wg$aFerns
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Hydropteridales, class Filicopsida, division PTERIDOPHYTA. They are aquatic ferns with quatrifoliate leaves resembling four leaf clover, creeping rhizome, and bean shaped sporocarps.
=688  \\$a2004
=750  \0$aMarsileaceae$5IEN-M$0(DLC)sh 85081604

=LDR  00671cz  a2200217n  4500
=001  9880364288502441
=005  20141212215712.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x850
=150  \\$aNanotubes
=450  \\$wnnna$aNanorod
=450  \\$aNanorods
=450  \\$wnnna$aNanotube
=550  \\$wg$aNanostructures
=550  \\$wh$aNanotubes, Carbon
=550  \\$wh$aNanotubes, Peptide
=680  \\$iNanometer-sized tubes composed of various substances including carbon (CARBON NANOTUBES), boron nitride, or nickel vanadate.
=688  \\$a2004
=750  \0$aNanotubes$0(DLC)sh2001008062$5IEN-M

=LDR  00991cz  a2200241n  4500
=001  9880364288602441
=005  20141212215711.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043922
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x750.$x850
=072  \\$aH1.$x158.$x703.$x52.$x850
=072  \\$aH1.$x158.$x703.$x795.$x850
=072  \\$aH2.$x628.$x479.$x850
=072  \\$aH2.$x628.$x795.$x850
=150  \\$aToxicogenetics
=450  \\$aToxicogenomics
=550  \\$wg$aPharmacogenetics
=550  \\$wg$aToxicology
=667  \\$aSPEC or GEN; prefer specific drug or toxic substance and specific genetic aspect
=680  \\$iThe study of existing genetic knowledge, and the generation of new genetic data, to understand and thus avoid DRUG TOXICITY and adverse effects from toxic substances from the environment.
=688  \\$a2004; use PHARMACOGENETICS 2003; for TOXICOGENOMICS use PHARMACOGENETICS 2003
=750  \0$aGenetic toxicology$0(DLC) sh 85053871$5IEN-M

=LDR  01805cz  a2200457n  4500
=001  9880364288702441
=005  20141212215711.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043887
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x170.$x200
=072  \\$aD12.$x776.$x543.$x750.$x720.$x600.$x270.$x200
=072  \\$aD12.$x776.$x543.$x750.$x750.$x360.$x200.$x200
=072  \\$aD12.$x776.$x543.$x750.$x750.$x555.$x270.$x200
=150  \\$aReceptor, Cholecystokinin B
=450  \\$wnnna$aB Receptor, Cholecystokinin
=450  \\$aCCK-B Receptor
=450  \\$wnnna$aCCK B Receptor
=450  \\$wnnna$aCCK-B Receptors
=450  \\$wnnna$aCCK B Receptors
=450  \\$wnnna$aCCK2 Receptor
=450  \\$wnnna$aCholecystokinin-2 Receptor
=450  \\$wnnna$aCholecystokinin 2 Receptor
=450  \\$wnnna$aCholecystokinin B Receptor
=450  \\$wnnna$aCKK-2 Receptor
=450  \\$wnnna$aCKK 2 Receptor
=450  \\$wnnna$aGastrin Receptor
=450  \\$wnnna$aGastrin Receptors
=450  \\$wnnna$aReceptor, CCK-B
=450  \\$wnnna$aReceptor, CCK B
=450  \\$wnnna$aReceptor, CCK2
=450  \\$wnnna$aReceptor, Cholecystokinin-2
=450  \\$wnnna$aReceptor, CKK-2
=450  \\$wnnna$aReceptor, Gastrin
=450  \\$wnnna$aReceptors, CCK-B
=450  \\$aReceptors, Gastrin
=550  \\$wg$aReceptors, Cholecystokinin
=667  \\$aDF: CCK B RECEPT
=680  \\$iA subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.
=688  \\$a2004; use RECEPTOR, CHOLECYSTOKININ B (NM) 1993-2003
=750  \0$aGastrin$xReceptors$0(DLC)sh 85053468$5IEN-M

=LDR  01345cz  a2200277n  4500
=001  9880364288802441
=005  20190422163354.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x125
=150  \\$aReceptors, Cannabinoid
=450  \\$aCannabinoid Receptor
=450  \\$aCannabinoid Receptors
=450  \\$wnnna$aReceptor, Cannabinoid
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptor, Cannabinoid, CB1
=550  \\$wh$aReceptor, Cannabinoid, CB2
=550  \\$aCannabinoid Receptor Agonists
=550  \\$aCannabinoids
=667  \\$anote specific subtypes
=680  \\$iA class of G-protein-coupled receptors that are specific for CANNABINOIDS such as those derived from CANNABIS. They also bind a structurally distinct class of endogenous factors referred to as ENDOCANNABINOIDS. The receptor class may play a role in modulating the release of signaling molecules such as NEUROTRANSMITTERS and CYTOKINES.
=688  \\$a2004; use RECEPTORS, CANNABINOID (NM) 1988-2003
=750  \0$81$wb$iBroader mapping$aCannabinoids$0(DLC)sh 85019609$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:i$aCannabinoids--Receptors$5IEN-M

=LDR  00647cz  a2200193n  4500
=001  9880364288902441
=005  20141212215708.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x251
=150  \\$aCatenanes
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aDNA, Catenated
=550  \\$aRotaxanes
=667  \\$acoord with specific Cat D chemical structure term if pertinent
=680  \\$iComplex compounds where two cyclic molecules are interlaced together as links in a chain. They have potential use in NANOTECHNOLOGY.
=688  \\$a2004
=750  \0$aCatenanes$5IEN-M$0(DLC)sh 96010896

=LDR  00923cz  a2200217n  4500
=001  9880364289002441
=005  20141212215708.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043862
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x825
=150  \\$aRotaxanes
=450  \\$aPolyrotaxanes
=450  \\$aPseudorotaxanes
=450  \\$wnnna$aRotaxane
=550  \\$wg$aOrganic Chemicals
=550  \\$aCatenanes
=667  \\$acoord with specific Cat D chemical structure term if pertinent; TAXANES is also available
=680  \\$iComplex compounds in which a dumbbell shaped molecule is encircled by a macrocycle. They are named after rota (wheel) and axis (axle). Notation with a prefix is used to indicate the number of interlocked components. They have potential use in NANOTECHNOLOGY. Rotaxanes have been made with CYCLODEXTRINS and CYCLIC ETHERS.
=688  \\$a2004
=750  \0$aRotaxanes$0(DLC) sh 96010897$5IEN-M

=LDR  01315cz  a2200325n  4500
=001  9880364289102441
=005  20141212215708.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x355.$x291.$x308
=072  \\$aD4.$x345.$x51.$x500
=072  \\$aD4.$x345.$x241.$x308
=150  \\$aCrown Ethers
=450  \\$aAza-Oxa Crown Ethers
=450  \\$wnnna$aAza Oxa Crown Ethers
=450  \\$wnnna$aCrown Ethers, Aza-Oxa
=450  \\$wnnna$aCrown Ethers, Oxa-Thia
=450  \\$aCryptands
=450  \\$aCryptates
=450  \\$wnnna$aEthers, Aza-Oxa Crown
=450  \\$wnnna$aEthers, Crown
=450  \\$wnnna$aEthers, Oxa-Thia Crown
=450  \\$wnnna$aOxa-Thia Crown Ethers
=450  \\$wnnna$aOxa Thia Crown Ethers
=550  \\$wg$aCrown Compounds
=550  \\$wg$aEthers, Cyclic
=680  \\$iMacrocyclic polyethers with the repeating unit of (-CH2-CH2-O)n where n is greater than 2 and some oxygens may be replaced by nitrogen, sulfur or phosphorus. These compounds are useful for coordinating CATIONS. The nomenclature uses a prefix to indicate the size of the ring and a suffix for the number of heteroatoms.
=688  \\$a2004; use ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was NM 1976-1992
=750  \0$aCrown ethers$5IEN-M$0(DLC)sh 89006653

=LDR  01282cz  a2200301n  4500
=001  9880364289202441
=005  20141212215707.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x506
=150  \\$aLeuzea
=450  \\$wnnna$acarthamoide, Leuzea
=450  \\$wnnna$acarthamoide, Rhaponticum
=450  \\$wnnna$acarthamoides, Leuzea
=450  \\$wnnna$acarthamoides, Rhaponticum
=450  \\$wnnna$aLeuzea carthamoide
=450  \\$wnnna$aLeuzea carthamoides
=450  \\$wnnna$aLeuzeas
=450  \\$wnnna$aRhaponticum
=450  \\$wnnna$aRhaponticum carthamoide
=450  \\$wnnna$aRhaponticum carthamoides
=450  \\$wnnna$aRhaponticums
=550  \\$wg$aAsteraceae
=667  \\$aX ref RHAPONTICUM: RHEUM RHAPONTICUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. ECDYSONE has been found in seeds of some members.
=688  \\$a2004
=750  \0$aRhaponticum$5IEN-M$0(DLC)sh 96008848

=LDR  00962cz  a2200241n  4500
=001  9880364289302441
=005  20141212215707.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043842
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x779
=150  \\$aOchnaceae
=450  \\$aOchna
=450  \\$wnnna$aOchnas
=450  \\$aOuratea
=450  \\$wnnna$aOurateas
=450  \\$aSauvagesia
=450  \\$wnnna$aSauvagesias
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida that have evergreen, alternate leaves.
=688  \\$a2004
=750  \0$aOchnaceae$5IEN-M$0(DLC)sh 88022948

=LDR  00689cz  a2200205n  4500
=001  9880364289402441
=005  20141212215653.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043563
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x660
=072  \\$aD12.$x776.$x543.$x750.$x775
=150  \\$aReceptors, Pheromone
=450  \\$wnnna$aPheromone Receptors
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wh$aReceptors, Mating Factor
=680  \\$iCell surface receptors that respond to PHEROMONES.
=688  \\$a2004; use CHEMORECEPTORS 1991-2003
=750  \0$aPheromones$xReceptors$0(DLC) sh 85100708$5IEN-M

=LDR  01018cz  a2200289n  4500
=001  9880364289502441
=005  20141212215651.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x308.$x574
=072  \\$aG2.$x111.$x570.$x790.$x486.$x493
=072  \\$aG5.$x360.$x580.$x493
=150  \\$aDNA, Z-Form
=450  \\$wnnna$aDNA, Left-Handed
=450  \\$wnnna$aDNA, Z Form
=450  \\$wnnna$aLeft-Handed DNA
=450  \\$wnnna$aLeft Handed DNA
=450  \\$aZ-DNA
=450  \\$wnnna$aZ-Form DNA
=550  \\$wg$aDNA
=550  \\$wg$aNucleic Acid Conformation
=550  \\$aDNA, A-Form
=550  \\$aDNA, C-Form
=680  \\$iA left-handed double helix of DNA. Its name derives from its narrow zigzag structure that is the least twisted and thinnest form of DNA. Z-DNA forming regions within the GENOME may play an important role in GENE EXPRESSION REGULATION.
=688  \\$a2004; use DNA 1985-2003
=750  \0$aZ-DNA$0(DLC)sh2013002109$5IEN-M

=LDR  00734cz  a2200241n  4500
=001  9880364289602441
=005  20141212215821.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x49
=072  \\$aN6.$x230.$x124.$x49
=150  \\$aBiodiversity
=450  \\$aBiological Diversity
=450  \\$wnnna$aDiversity, Biological
=550  \\$wg$aEcosystem
=550  \\$wh$aBiota
=550  \\$wh$aEcotype
=550  \\$wh$aEndangered Species
=550  \\$wh$aIntroduced Species
=680  \\$iThe variety of all native living organisms and their various forms and interrelationships.
=688  \\$a2004; use ECOSYSTEM 1996-2003
=750  \2$aBiodiversity$5IEN-M

=LDR  02438cz  a2200589n  4500
=001  9880364289702441
=005  20181127103355.0
=008  030722\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043484
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x837
=150  \\$aProprotein Convertases
=450  \\$wnnna$aConvertase, POMC
=450  \\$wnnna$aConvertase, Prohormone
=450  \\$wnnna$aConvertase, Proopiomelanocortin
=450  \\$wnnna$aConvertase, Proprotein
=450  \\$wnnna$aConvertases, Prohormone
=450  \\$wnnna$aConvertases, Proprotein
=450  \\$wnnna$aConvertases, Subtilisin-Like Proprotein
=450  \\$wnnna$aConverting Enzyme, Pro-Opiocortin
=450  \\$wnnna$aConverting Enzyme, Pro-Opiomelanocortin
=450  \\$wnnna$aConverting Protease, Pro-Opiocortin
=450  \\$wnnna$aPOMC Convertase
=450  \\$wnnna$aPOMC-Converting Enzyme
=450  \\$wnnna$aPOMC Converting Enzyme
=450  \\$wnnna$aPOMC Enzyme
=450  \\$wnnna$aPro-Opiocortin Converting Enzyme
=450  \\$wnnna$aPro Opiocortin Converting Enzyme
=450  \\$wnnna$aPro-Opiocortin Converting Protease
=450  \\$wnnna$aPro Opiocortin Converting Protease
=450  \\$aPro-Opiomelanocortin Converting Enzyme
=450  \\$wnnna$aPro Opiomelanocortin Converting Enzyme
=450  \\$wnnna$aProhormone Convertase
=450  \\$aProhormone Convertases
=450  \\$wnnna$aProopiomelanocortin Convertase
=450  \\$aProprotein Convertase
=450  \\$wnnna$aProprotein Convertases, Subtilisin-Like
=450  \\$wnnna$aSubtilisin-Like Proprotein Convertases
=450  \\$wnnna$aSubtilisin Like Proprotein Convertases
=550  \\$wg$aPeptide Hydrolases
=550  \\$wh$aCarboxypeptidase B
=550  \\$wh$aCarboxypeptidase B2
=550  \\$wh$aCarboxypeptidase H
=550  \\$wh$aFurin
=550  \\$wh$aProprotein Convertase 1
=550  \\$wh$aProprotein Convertase 2
=550  \\$wh$aProprotein Convertase 5
=550  \\$wh$aProprotein Convertase 9
=550  \\$wh$aRenin
=680  \\$iProteolytic enzymes that are involved in the conversion of protein precursors such as peptide prohormones into PEPTIDE HORMONES. Some are ENDOPEPTIDASES, some are EXOPEPTIDASES.
=688  \\$a2004; use PROPROTEIN CONVERTASES (NM) 2002-2003; for PRO-OPIOMELANOCORTIN CONVERTING ENZYME use PROPROTEIN CONVERTASES (NM) 1982-2003
=750  \0$aProprotein convertases$0(DLC)sh2013000892$5IEN-M

=LDR  00861cz  a2200181n  4500
=001  9880364289802441
=005  20141212215820.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044784
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x150.$x150
=150  \\$aChara
=450  \\$wnnna$aCharas
=550  \\$wg$aCharaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of green plants in the family CHARACEAE, phylum STREPTOPHYTA. They have a strong garlic-like odor and are an important food source for waterfowl.
=688  \\$a2004
=750  \0$aChara$5IEN-M$0(DLC)sh 88022321

=LDR  00584cz  a2200181n  4500
=001  9880364289902441
=005  20141212215817.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x825
=150  \\$aSaprolegnia
=450  \\$wnnna$aSaprolegnias
=550  \\$wg$aOomycetes
=667  \\$ainfection: coordinate IM with INFECTION (IM)
=680  \\$iA genus of OOMYCETES in the family Saprolegniaceae. It is a parasite and pathogen of freshwater FISHES.
=688  \\$a2004
=750  \0$aSaprolegnia$0(DLC) sh 88021913$5IEN-M

=LDR  00997cz  a2200277n  4500
=001  9880364290002441
=005  20141212215644.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043371
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x343
=150  \\$aFatty Acids, Omega-6
=450  \\$wnnna$aAcids, N-6 Fatty
=450  \\$wnnna$aAcids, Omega-6 Fatty
=450  \\$wnnna$aFatty Acids, N-6
=450  \\$wnnna$aFatty Acids, Omega 6
=450  \\$wnnna$aN-6 Fatty Acids
=450  \\$wnnna$aN 6 Fatty Acids
=450  \\$aOmega-6 Fatty Acids
=450  \\$wnnna$aOmega 6 Fatty Acids
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$wh$agamma-Linolenic Acid
=550  \\$wh$aLinoleic Acids
=680  \\$iFATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.
=688  \\$a2004
=750  \0$aOmega-6 fatty acids$5IEN-M$0(DLC)sh 89002538

=LDR  00591cz  a2200181n  4500
=001  9880364290102441
=005  20141212215817.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x75
=150  \\$aAphanomyces
=450  \\$wnnna$aAphanomyce
=550  \\$wg$aOomycetes
=667  \\$ainfection: coordinate IM with INFECTION (IM)
=680  \\$iA genus of OOMYCETES in the family Saprolegniaceae. It causes root rot in plants and is also a pathogen of FISHES.
=688  \\$a2004
=750  \0$aAphanomyces$5IEN-M$0(DLC)sh 88021872

=LDR  00557cz  a2200181n  4500
=001  9880364290202441
=005  20141212215817.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044743
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x50
=150  \\$aAchlya
=450  \\$wnnna$aAchlyas
=550  \\$wg$aOomycetes
=667  \\$ainfection: coordinate IM with INFECTION (IM)
=680  \\$iA genus of OOMYCETES in the family Saprolegniaceae. They are pathogens of FISHES and INSECTS.
=688  \\$a2004
=750  \0$aAchlya$5IEN-M$0(DLC)sh 88021866

=LDR  00686cz  a2200193n  4500
=001  9880364290302441
=005  20141212215643.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043368
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x251.$x650.$x750
=072  \\$aB3.$x660.$x75.$x77.$x650.$x750
=150  \\$aRalstonia solanacearum
=450  \\$wnnna$aBurkholderia solanacearum
=450  \\$wnnna$aPseudomonas solanacearum
=550  \\$wg$aRalstonia
=680  \\$iA species of Ralstonia previously classed in the genera PSEUDOMONAS and BURKHOLDERIA. It is an important plant pathogen.
=688  \\$a2004
=750  \0$aRalstonia solanacearum$0(DLC)sh 88023313$5IEN-M

=LDR  00538cz  a2200169n  4500
=001  9880364290402441
=005  20141212215817.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x710
=150  \\$aPeronospora
=450  \\$wnnna$aPeronosporas
=550  \\$wg$aOomycetes
=680  \\$iA genus of OOMYCETES in the family Peronosporaceae. Most species are obligatory parasites and many are plant pathogens.
=688  \\$a2004
=750  \2$aPeronospora$0(DLC)sh 85100026$5IEN-M

=LDR  00787cz  a2200205n  4500
=001  9880364290502441
=005  20141212215643.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x251.$x650
=072  \\$aB3.$x660.$x75.$x77.$x650
=150  \\$aRalstonia
=550  \\$wg$aBurkholderiaceae
=550  \\$wh$aRalstonia pickettii
=550  \\$wh$aRalstonia solanacearum
=667  \\$ainfection: coordinate IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus in the family BURKHOLDERIACEAE, comprised of many species. They are associated with a variety of infections including MENINGITIS; PERITONITIS; and URINARY TRACT INFECTIONS.
=688  \\$a2004
=750  \0$aRalstonia$0(DLC)sh 98000068$5IEN-M

=LDR  00707cz  a2200181n  4500
=001  9880364290602441
=005  20141212215816.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044726
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x500
=150  \\$aLagenidium
=450  \\$wnnna$aLagenidiums
=550  \\$wg$aOomycetes
=667  \\$ainfection: coordinate IM with INFECTION (IM)
=680  \\$iA genus of OOMYCETES in the family Lagenidiaceae. One species (L. giganteum) parasitizes the larval stage of MOSQUITOES and is used in its biological control (PEST CONTROL, BIOLOGICAL); it also causes disease in freshwater FISHES.
=688  \\$a2004
=750  \0$aLagenidium$5IEN-M$0(DLC)sh 85073938

=LDR  00812cz  a2200181n  4500
=001  9880364290702441
=005  20141212215816.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044724
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700.$x325
=150  \\$aGracilaria
=450  \\$wnnna$aGracilarias
=550  \\$wg$aRhodophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of RED ALGAE in the family Gracilariaceae. It is a highly commercial SEAWEED and a source of AGAR.
=688  \\$a2004
=750  \0$aGracilaria$5IEN-M$0(DLC)sh 88022381

=LDR  01540cz  a2200349n  4500
=001  9880364290802441
=005  20141212215643.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043366
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x420.$x200.$x400
=150  \\$aCellulose 1,4-beta-Cellobiosidase
=450  \\$wnnna$a1,4-beta-Cellobiosidase, Cellulose
=450  \\$wnnna$a1,4-beta-D-Glucan Cellobiohydrolase
=450  \\$wnnna$a1,4 beta D Glucan Cellobiohydrolase
=450  \\$wnnna$aBeta-Glucancellobiohydrolase
=450  \\$wnnna$aBeta Glucancellobiohydrolase
=450  \\$wnnna$aCbhI Protein
=450  \\$wnnna$aCEL1 Protein
=450  \\$wnnna$aCellobiohydrolase
=450  \\$wnnna$aCellobiohydrolase, 1,4-beta-D-Glucan
=450  \\$wnnna$aCellobiohydrolase A
=450  \\$wnnna$aCellobiohydrolase I
=450  \\$wnnna$aCellobiohydrolase II
=450  \\$wnnna$aCellulose 1,4 beta Cellobiosidase
=450  \\$aExo-Cellobiohydrolase
=450  \\$wnnna$aExo Cellobiohydrolase
=450  \\$wnnna$aExoglucanase II
=550  \\$wg$aCellulases
=680  \\$iAn exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.
=688  \\$a2004; use CELLULOSE 1,4-BETA-CELLOBIOSIDASE (NM) 1974-2003; for EXOGLUCANASE II use GLUCAN 1,3-BETA-GLUCOSIDASE (NM) 1992-2003
=750  \0$aCellulose 1,4-beta-cellobiosidase$5IEN-M$0(DLC)sh 87007094

=LDR  01061cz  a2200277n  4500
=001  9880364290902441
=005  20141212215815.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700.$x150
=150  \\$aChondrus
=450  \\$wnnna$aCarrageen
=450  \\$wnnna$aCarrageens
=450  \\$wnnna$aChondrus crispus
=450  \\$wnnna$acrispus, Chondrus
=450  \\$wnnna$aIrish Moss
=450  \\$wnnna$aIrish Mosses
=450  \\$aMoss, Irish
=450  \\$wnnna$aMosses, Irish
=550  \\$wg$aRhodophyta
=550  \\$aCarrageenan
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of RED ALGAE, in the family Gigartinaceae. The species Chondrus crispus is a source of CARRAGEENAN.
=688  \\$a2004
=750  \2$aChondrus$5IEN-M

=LDR  00877cz  a2200181n  4500
=001  9880364291002441
=005  20141212215815.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700.$x500
=150  \\$aLaurencia
=450  \\$wnnna$aLaurencias
=550  \\$wg$aRhodophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of RED ALGAE in the family Rhodomelaceae. Some species are a rich source of chlorine-and bromine-containing metabolites which show significant antibacterial activity.
=688  \\$a2004
=750  \0$aLaurencia$5IEN-M$0(DLC)sh 96008778

=LDR  00743cz  a2200205n  4500
=001  9880364291102441
=005  20141212215641.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043344
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150
=150  \\$aChordata
=450  \\$wnnna$aChordate
=450  \\$aChordates
=550  \\$wg$aAnimals
=550  \\$wh$aChordata, Nonvertebrate
=550  \\$wh$aVertebrates
=680  \\$iPhylum in the domain Eukarya, comprised of animals either with fully developed backbones (VERTEBRATES), or those with notochords only during some developmental stage (CHORDATA, NONVERTEBRATE).
=688  \\$a2004, 1966-1999; use CHORDATA, NON-VERTEBRATE 2000-2003
=750  \0$aChordata$5IEN-M$0(DLC)sh 85024735

=LDR  00988cz  a2200241n  4500
=001  9880364291202441
=005  20141212215815.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x780.$x760
=150  \\$aForensic Ballistics
=450  \\$wnnna$aBallistic, Forensic
=450  \\$aBallistics
=450  \\$wnnna$aBallistics, Forensic
=450  \\$aBallistics, Wound
=450  \\$wnnna$aForensic Ballistic
=450  \\$wnnna$aWound Ballistics
=550  \\$wg$aForensic Sciences
=550  \\$aWounds, Gunshot
=680  \\$iThe science of studying projectiles in motion, ballistics, being applied to law. Ballistics on firearm projectiles, such as bullets, include the study of what happens inside the weapon, during the flight of the projectile, and when the projectile strikes the target, such as body tissue.
=688  \\$a2004; for BALLISTICS, WOUND see WOUNDS, GUNSHOT 1987-2003
=750  \2$aForensic ballistics$5IEN-M

=LDR  00939cz  a2200265n  4500
=001  9880364291302441
=005  20141212215814.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044707
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x780
=150  \\$aForensic Sciences
=450  \\$wnnna$aForensic Science
=450  \\$wnnna$aScience, Forensic
=450  \\$wnnna$aSciences, Forensic
=550  \\$wg$aCriminology
=550  \\$wh$aForensic Anthropology
=550  \\$wh$aForensic Ballistics
=550  \\$wh$aForensic Dentistry
=550  \\$wh$aForensic Medicine
=550  \\$wh$aForensic Nursing
=550  \\$wh$aForensic Toxicology
=680  \\$iDisciplines that apply sciences to law. Forensic sciences include a wide range of disciplines, such as FORENSIC TOXICOLOGY; FORENSIC ANTHROPOLOGY; FORENSIC MEDICINE; FORENSIC DENTISTRY; and others.
=688  \\$a2004
=750  \0$aForensic sciences$5IEN-M$0(DLC)sh 90001487

=LDR  01209cz  a2200337n  4500
=001  9880364291402441
=005  20141212215640.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x114
=150  \\$abeta-Fructofuranosidase
=450  \\$wnnna$a6-Phosphate Hydrolase, Sucrose
=450  \\$wnnna$aAcid Invertase
=450  \\$abeta-D-Fructofuranosidase
=450  \\$wnnna$abeta D Fructofuranosidase
=450  \\$wnnna$abeta Fructofuranosidase
=450  \\$wnnna$abeta-Fructosidase
=450  \\$wnnna$abeta Fructosidase
=450  \\$wnnna$aHydrolase, Sucrose 6-Phosphate
=450  \\$wnnna$aInvertase
=450  \\$wnnna$aInvertase, Acid
=450  \\$wnnna$aSaccharase
=450  \\$wnnna$aSacrosidase
=450  \\$wnnna$aSucraid
=450  \\$wnnna$aSucrose 6-Phosphate Hydrolase
=450  \\$wnnna$aSucrose 6 Phosphate Hydrolase
=550  \\$wg$aGlycoside Hydrolases
=680  \\$iA glycoside hydrolase found primarily in PLANTS and YEASTS. It has specificity for beta-D-fructofuranosides such as SUCROSE.
=688  \\$a2004; use BETA-FRUCTOFURANOSIDASE (NM) 1980-2003
=750  \0$aInvertase$5IEN-M$0(DLC)sh 85067689

=LDR  00841cz  a2200181n  4500
=001  9880364291502441
=005  20141212215811.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700.$x610
=150  \\$aPorphyridium
=450  \\$wnnna$aPorphyridiums
=550  \\$wg$aRhodophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of RED ALGAE in the family Porphyridiaceae. A single stellate CHLOROPLAST is present in each cell which has no CELL WALL.
=688  \\$a2004
=750  \0$aPorphyridium$0(DLC)sh 88022448$5IEN-M

=LDR  00871cz  a2200205n  4500
=001  9880364291602441
=005  20141212215811.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044664
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700.$x600
=150  \\$aPorphyra
=450  \\$aNori
=450  \\$wnnna$aNorus
=450  \\$wnnna$aPorphyras
=550  \\$wg$aRhodophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of RED ALGAE in the family Bangiaceae. It is the most widely consumed SEAWEED in the world and especially in Asia.
=688  \\$a2004
=750  \0$aPorphyra$0(DLC)sh 85105020$5IEN-M

=LDR  00558cz  a2200169n  4500
=001  9880364291702441
=005  20141212215810.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x150.$x600
=150  \\$aOchromonas
=450  \\$wnnna$aOchromona
=550  \\$wg$aChrysophyta
=680  \\$iA genus of GOLDEN-BROWN ALGAE in the family Ochromonadaceae, found mostly in freshwater. They bear two unequal FLAGELLA and are heterotrophic.
=688  \\$a2004
=750  \0$aOchromonas$5IEN-M$0(DLC)sh 88022427

=LDR  00906cz  a2200265n  4500
=001  9880364291802441
=005  20141212215810.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044662
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x480
=150  \\$aMacrocystis
=450  \\$wnnna$aGiant Kelp
=450  \\$wnnna$aGiant Kelps
=450  \\$aKelp, Giant
=450  \\$wnnna$aKelps, Giant
=450  \\$wnnna$aMacrocysti
=450  \\$wnnna$aMacrocystis pyrifera
=450  \\$wnnna$aMacrocystis pyriferas
=450  \\$wnnna$apyrifera, Macrocystis
=450  \\$wnnna$apyriferas, Macrocystis
=550  \\$wg$aPhaeophyta
=680  \\$iA genus of BROWN ALGAE in the family Lessoniaceae, and one of the major forms of KELP. The species Macrocystis pyrifera, also known as giant kelp, is the largest of the marine algae.
=688  \\$a2004
=750  \0$aMacrocystis$5IEN-M$0(DLC)sh 86003725

=LDR  02320cz  a2200493n  4500
=001  9880364291902441
=005  20141212215639.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043303
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x660.$x500
=150  \\$aAryldialkylphosphatase
=450  \\$wnnna$aAcid Anhydrase, Organophosphorus
=450  \\$wnnna$aAcid Anhydrolase, Organophosphorus
=450  \\$wnnna$aAcid Hydrolase, Organophosphorus
=450  \\$wnnna$aAnhydrase, OPA
=450  \\$wnnna$aAnhydrase, Organophosphorus Acid
=450  \\$wnnna$aAnhydrolase, Organophosphorus Acid
=450  \\$wnnna$aAryl-dialkyl Phosphatase
=450  \\$wnnna$aAryl dialkyl Phosphatase
=450  \\$wnnna$aArylalkylphosphatase
=450  \\$wnnna$aEnzyme, OPH
=450  \\$wnnna$aHomocysteine Thiolactone Hydrolase
=450  \\$wnnna$aHydrolase, Homocysteine Thiolactone
=450  \\$wnnna$aHydrolase, Organophosphorus
=450  \\$wnnna$aHydrolase, Organophosphorus Acid
=450  \\$wnnna$aOPA Anhydrase
=450  \\$wnnna$aOPH Enzyme
=450  \\$wnnna$aOrganophosphorus Acid Anhydrase
=450  \\$wnnna$aOrganophosphorus Acid Anhydrolase
=450  \\$wnnna$aOrganophosphorus Acid Hydrolase
=450  \\$wnnna$aOrganophosphorus Hydrolase
=450  \\$wnnna$aParaoxonase
=450  \\$wnnna$aParaoxonase-1
=450  \\$wnnna$aParaoxonase 1
=450  \\$wnnna$aParaoxonase-2
=450  \\$wnnna$aParaoxonase 2
=450  \\$wnnna$aPhosphatase, Aryl-dialkyl
=450  \\$wnnna$aThiolactone Hydrolase, Homocysteine
=550  \\$wg$aPhosphoric Triester Hydrolases
=667  \\$aX refs PARAOXONASE-1 and PARAOXONASE-2 see SCR for organism specific terms
=680  \\$iAn enzyme which catalyzes the hydrolysis of an aryl-dialkyl phosphate to form dialkyl phosphate and an aryl alcohol. It can hydrolyze a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may also mediate an enzymatic protection of LOW DENSITY LIPOPROTEINS against oxidative modification and the consequent series of events leading to ATHEROMA formation. The enzyme was previously regarded to be identical with Arylesterase (EC 3.1.1.2).
=688  \\$a2004; use ARYLDIALKYLPHOSPHATASE (NM) 1980 - 2003
=750  \0$aParaoxonase$5IEN-M$0(DLC)sh2002008729

=LDR  00589cz  a2200181n  4500
=001  9880364292002441
=005  20141212215810.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044648
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x800
=150  \\$aUndaria
=450  \\$wnnna$aUndaria pinnatifida
=450  \\$aWakame
=550  \\$wg$aPhaeophyta
=680  \\$iA genus of BROWN ALGAE, in the family Alariaceae, native to Japan, Korea, and China. The edible SEAWEED Undaria pinnatifida is also called wakame.
=688  \\$a2004
=750  \0$aUndaria$0(DLC) sh 88022481$5IEN-M

=LDR  00710cz  a2200157n  4500
=001  9880364292102441
=005  20141212215809.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x725
=150  \\$aSargassum
=550  \\$wg$aPhaeophyta
=680  \\$iOne of the largest genera of BROWN ALGAE, comprised of more than 150 species found in tropical, subtropical, and temperate zones of both hemispheres. Some species are attached (benthic) but most float in the open sea (pelagic). Sargassum provides a critical habitat for hundreds of species of FISHES; TURTLES; and INVERTEBRATES.
=688  \\$a2004
=750  \0$aSargassum$0(DLC) sh 88022470$5IEN-M

=LDR  00526cz  a2200157n  4500
=001  9880364292202441
=005  20141212215809.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044646
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x40
=150  \\$aAscophyllum
=550  \\$wg$aPhaeophyta
=680  \\$iA BROWN ALGAE closely related to FUCUS. It is found attached to rocks and boulders on the middle shore, primarily in the North Atlantic basin.
=688  \\$a2004
=750  \0$aAscophyllum$5IEN-M$0(DLC)sh 88022309

=LDR  01543cz  a2200445n  4500
=001  9880364292302441
=005  20200511121307.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x200.$x500
=072  \\$aG7.$x203.$x300.$x350.$x300
=072  \\$aJ2.$x350.$x500
=072  \\$aJ2.$x500.$x350.$x300.
=150  \\$aCultured Milk Products
=450  \\$wnnna$aCultured Milk Product
=450  \\$wnnna$aDiary Product, Fermented
=450  \\$wnnna$aDiary Products, Fermented
=450  \\$wnnna$aFermented Diary Product
=450  \\$wnnna$aFermented Milk Product
=450  \\$wnnna$aFermented Milk Products
=450  \\$wnnna$aMilk Product, Cultured
=450  \\$wnnna$aMilk Product, Fermented
=450  \\$wnnna$aMilk Products, Cultured
=450  \\$wnnna$aMilk Products, Fermented
=450  \\$wnnna$aProduct, Cultured Milk
=450  \\$wnnna$aProduct, Fermented Milk
=450  \\$wnnna$aProducts, Cultured Milk
=450  \\$wnnna$aProducts, Fermented Diary
=450  \\$wnnna$aProducts, Fermented Milk
=550  \\$wg$aDiary Products
=550  \\$wg$aFermented Foods and Beverages
=550  \\$wh$aButtermilk
=550  \\$wh$aCheese
=550  \\$wh$aKefir
=550  \\$wh$aKoumiss
=550  \\$wh$aYogurt
=680  \\$iMilk modified with controlled FERMENTATION. This should not be confused with KAFFIR LIME or with KAFFIR CORN.
=688  \\$a2004; for BUTTERMILK and KEFIR use MILK 1998-2003
=750  \0$aCultured milk$0(DLC)sh 91004696$xIEN-M

=LDR  00676cz  a2200193n  4500
=001  9880364292402441
=005  20141212193052.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044645
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x212
=150  \\$aFucus
=450  \\$wnnna$aBladder Wrack
=450  \\$wnnna$aBladderwrack
=450  \\$wnnna$aFucus vesiculosus
=550  \\$wg$aPhaeophyta
=680  \\$iA genus of BROWN ALGAE in the family Fucaceae. It is found in temperate, marine intertidal areas along rocky coasts and is a source of ALGINATES. Some species of Fucus are referred to as KELP.
=688  \\$a2004
=750  \0$aFucus$5IEN-M$0(DLC)sh 88022368

=LDR  01108cz  a2200265n  4500
=001  9880364292502441
=005  20141212215805.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x150
=150  \\$aChrysophyta
=450  \\$wnnna$aAlgae, Golden
=450  \\$aAlgae, Golden-Brown
=450  \\$wnnna$aAlgae, Golden Brown
=450  \\$aChrysophyceae
=450  \\$aGolden Algae
=450  \\$wnnna$aGolden-Brown Algae
=550  \\$wg$aStramenopiles
=550  \\$wh$aOchromonas
=680  \\$iA family of microscopic freshwater EUKARYOTA, commonly known as golden algae. They share many features with the BROWN ALGAE but are planktonic rather than benthic. Though most are photosynthetic, they are not considered truly autotrophic since they can become facultatively heterotrophic in the absence of adequate light. In this state they can feed on BACTERIA or DIATOMS.
=688  \\$a2011 (2004)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Algae, Golden-Brown
=688  \\$a2004
=750  \0$aChrysophyceae$0(DLC) sh 85025447$5IEN-M

=LDR  01062cz  a2200265n  4500
=001  9880364292602441
=005  20141212215630.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043183
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x158.$x272.$x608
=150  \\$aIrritable Bowel Syndrome
=450  \\$wnnna$aColitides, Mucous
=450  \\$aColitis, Mucous
=450  \\$aColon, Irritable
=450  \\$wnnna$aIrritable Bowel Syndromes
=450  \\$wnnna$aIrritable Colon
=450  \\$wnnna$aMucous Colitides
=450  \\$wnnna$aMucous Colitis
=450  \\$wnnna$aSyndrome, Irritable Bowel
=450  \\$wnnna$aSyndromes, Irritable Bowel
=550  \\$wg$aColonic Diseases, Functional
=680  \\$iA disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
=688  \\$a2004; use COLONIC DISEASES, FUNCTIONAL 1979-2003
=750  \0$aIrritable colon$5IEN-M$0(DLC)sh 85068314

=LDR  00865cz  a2200193n  4500
=001  9880364292702441
=005  20141212215804.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044522
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x150
=150  \\$aCharaceae
=550  \\$wg$aCharophyceae
=550  \\$wh$aChara
=550  \\$wh$aNitella
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iFamily of slender threadlike aquatic plants, in the order CHARALES, phylum STREPTOPHYTA, that are closely related to LAND PLANTS.
=688  \\$a2004
=750  \0$aCharaceae$5IEN-M$0(DLC)sh 88022324

=LDR  00743cz  a2200193n  4500
=001  9880364292802441
=005  20141212215627.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D043167
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x840
=072  \\$aB3.$x660.$x75.$x710
=150  \\$aSpirillaceae
=550  \\$wg$aBetaproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aSpirillum
=680  \\$iA family of gram-negative bacteria in the order Nitrosomonadales. It formerly included the genera CAMPYLOBACTER and SPIRILLUM, then was abandoned, and is now reinstated as a family with a single genus SPIRILLUM.
=688  \\$a2004, 1975-1991; use BACTERIA 1992-2003
=750  \0$aSpirillaceae$0(DLC) sh 88023337$5IEN-M

=LDR  01174cz  a2200253n  4500
=001  9880364292902441
=005  20141212215624.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042965
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x662.$x290
=072  \\$aD12.$x776.$x331.$x775
=150  \\$aMethylenetetrahydrofolate Reductase (NADPH2)
=450  \\$wnnna$a5,10-Methylenetetrahydrofolate Reductase (NADPH)
=450  \\$wnnna$aMethylene Tetrahydrofolate Reductase
=450  \\$aMethylene-THF Reductase (NADPH)
=450  \\$wnnna$aMethylenetetrahydrofolate Reductase
=450  \\$wnnna$aMethylenetetrahydrofolate Reductase (NADPH)
=450  \\$wnnna$aTetrahydrofolate Reductase, Methylene
=550  \\$wg$aFlavoproteins
=550  \\$wg$aOxidoreductases Acting on CH-NH Group Donors
=680  \\$iA flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate. This enzyme was formerly classified as EC 1.1.1.171.
=688  \\$a2004; use METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2) (NM) 1986-2003
=750  \0$aMethylenetetrahydrofolate reductase$0(DLC) sh2005003812$5IEN-M

=LDR  01609cz  a2200301n  4500
=001  9882116471402441
=005  20230127153137.0
=008  030709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044468
=035  \\$a(DNLM)D044468
=035  \\$a(NLM)98198555710000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x906.$x750
=072  \\$aM1.$x270.$x968.$x750
=072  \\$aM1.$x686.$x477.$x625.$x594.$x625
=072  \\$aM1.$x686.$x493.$x500.$x800.$x500
=150  \\$aNative Hawaiian or Other Pacific Islander
=450  \\$wnnna$aNative Hawaiians
=450  \\$wnnna$aPacific Islander Americans
=450  \\$aPacific Island Americans
=450  \\$wnnna$aHawaiian, Native
=450  \\$wnnna$aNative Hawaiian
=450  \\$wnnna$aPacific Island American
=450  \\$wnnna$aPacific Islander American
=680  \\$iA person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2022
=750  \0$iNarrower mapping$aHawaiians$0(DLC)sh85059379$4NM$5IEN-M
=750  \0$iNarrower mapping$aPacific Islander Americans$0(DLC)sh85093915$4NM$5IEN-M

=LDR  01263cz  a2200337n  4500
=001  9880364293102441
=005  20141212215619.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x130.$x409.$x633
=072  \\$aC6.$x130.$x564.$x332.$x500
=072  \\$aC23.$x300.$x175.$x525
=150  \\$aGallstones
=450  \\$aBiliary Calculi
=450  \\$wnnna$aBiliary Calculi, Common Bile Duct
=450  \\$wnnna$aCalculi, Biliary
=450  \\$wnnna$aCommon Bile Duct Calculi
=450  \\$wnnna$aCommon Bile Duct Gall Stones
=450  \\$wnnna$aCommon Bile Duct Gallstones
=450  \\$wnnna$aGall Stone
=450  \\$wnnna$aGall Stones
=450  \\$wnnna$aGall Stones, Common Bile Duct
=450  \\$wnnna$aGallstone
=450  \\$wnnna$aGallstones, Common Bile Duct
=550  \\$wg$aCalculi
=550  \\$wg$aCholecystolithiasis
=550  \\$wg$aCholelithiasis
=680  \\$iSolid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin.
=688  \\$a2004; use CHOLELITHIASIS 1975-2003
=750  \0$aGallstones$5IEN-M$0(DLC)sh 85052869

=LDR  01056cz  a2200265n  4500
=001  9880364293202441
=005  20141212215618.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x494
=150  \\$aLaccase
=450  \\$wnnna$aLaccase B
=450  \\$wnnna$aLaccase I
=450  \\$wnnna$aLaccase II
=450  \\$wnnna$aLaccase III
=450  \\$wnnna$aOxidase, p-Diphenol
=450  \\$wnnna$aOxidase, Urishiol
=450  \\$wnnna$ap-Diphenol Oxidase
=450  \\$wnnna$ap Diphenol Oxidase
=450  \\$wnnna$aUrishiol Oxidase
=550  \\$wg$aOxidoreductases
=680  \\$iA copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products.
=688  \\$a2004; use LACCASE (NM) 1980-2003
=750  \0$aLaccase$5IEN-M$0(DLC)sh 85073800

=LDR  01566cz  a2200313n  4500
=001  9882104696802441
=005  20230109154819.0
=008  030709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044466
=035  \\$a(DNLM)D044466
=035  \\$a(NLM)98198555890000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x330
=150  \\$aAsian People
=450  \\$wnnna$aAsiatic Race
=450  \\$wnnna$aMongoloid Race
=450  \\$aAsian Continental Ancestry Group
=450  \\$aAsian Person
=450  \\$wnnna$aAsian Peoples
=450  \\$wnnna$aAsian Persons
=450  \\$wnnna$aAsiatic Races
=450  \\$wnnna$aMongoloid Races
=450  \\$wnnna$aPeople, Asian
=450  \\$wnnna$aPerson, Asian
=450  \\$wnnna$aRace, Asiatic
=450  \\$wnnna$aRace, Mongoloid
=680  \\$iPersons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2023; use MONGOLOID RACE 1966-2003, ASIAN CONTINENTAL ANCESTRY GROUP 2004-2021, ASIANS 2022
=750  \0$aMongoloid race$5IEN-M$0(DLC)sh 85086833

=LDR  00605cz  a2200181n  4500
=001  9880364293402441
=005  20141212215615.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042808
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x550.$x550.$x800
=072  \\$aB3.$x660.$x75.$x525.$x520.$x760
=150  \\$aNeisseria sicca
=550  \\$wg$aNeisseria
=667  \\$ainfection: coord IM with NEISSERIACEAE INFECTIONS (IM)
=680  \\$iA species of gram-negative, aerobic BACTERIA found in the human NASOPHARYNX; SALIVA; and SPUTUM.
=688  \\$a2004
=750  \2$aNeisseria sicca$5IEN

=LDR  01592cz  a2200337n  4500
=001  9882104696102441
=005  20230109164057.0
=008  030714\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044465
=035  \\$a(DNLM)D044465
=035  \\$a(NLM)98198555980000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x877
=150  \\$aWhite People
=450  \\$wnnna$aCaucasian Race
=450  \\$wnnna$aCaucasoid Race
=450  \\$aEuropean Continental Ancestry Group
=450  \\$aWhite Person
=450  \\$wnnna$aCaucasian Races
=450  \\$wnnna$aCaucasoid Races
=450  \\$wnnna$aPeople, White
=450  \\$wnnna$aPerson, White
=450  \\$wnnna$aRace, Caucasian
=450  \\$wnnna$aRace, Caucasoid
=450  \\$wnnna$aWhite Peoples
=450  \\$wnnna$aWhite Persons
=667  \\$aspecify geographic location if relevant
=680  \\$iPersons having origins in any of the white racial groups of  Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2023; use CAUCASIAN RACE 1963-1977, WHITES 1978-2003, CAUCASOID RACE 1978-2003, EUROPEAN CONTINENTAL ANCESTRY GROUP 2004-2021, WHTIES 2022
=750  \0$aCaucasian race$5IEN-M$0(DLC)sh 85021431
=750  \0$aWhite people$5IEN-M$0(DLC)sh85146547

=LDR  01964cz  a2200469n  4500
=001  9880364293602441
=005  20170914134849.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x275
=150  \\$aEndothelial Cells
=450  \\$wnnna$aCapillary Endothelial Cell
=450  \\$wnnna$aCapillary Endothelial Cells
=450  \\$wnnna$aCell, Capillary Endothelial
=450  \\$wnnna$aCell, Endothelial
=450  \\$wnnna$aCell, Lymphatic Endothelial
=450  \\$wnnna$aCell, Vascular Endothelial
=450  \\$wnnna$aCells, Capillary Endothelial
=450  \\$wnnna$aCells, Endothelial
=450  \\$wnnna$aCells, Lymphatic Endothelial
=450  \\$wnnna$aCells, Vascular Endothelial
=450  \\$wnnna$aEndothelial Cell
=450  \\$wnnna$aEndothelial Cell, Capillary
=450  \\$wnnna$aEndothelial Cell, Lymphatic
=450  \\$wnnna$aEndothelial Cell, Vascular
=450  \\$wnnna$aEndothelial Cells, Capillary
=450  \\$wnnna$aEndothelial Cells, Lymphatic
=450  \\$wnnna$aEndothelial Cells, Vascular
=450  \\$wnnna$aLymphatic Endothelial Cell
=450  \\$wnnna$aLymphatic Endothelial Cells
=450  \\$wnnna$aVascular Endothelial Cell
=450  \\$wnnna$aVascular Endothelial Cells
=550  \\$wg$aEpithelial Cells
=550  \\$wh$aEndothelial Progenitor Cells
=550  \\$wh$aHemangioblasts
=550  \\$wh$aHuman Umbilical Vein Endothelial Cells
=550  \\$wh$aPodosomes
=667  \\$acoordinate with specific tissue type if pertinent
=680  \\$iHighly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.
=688  \\$a2004
=750  \0$aEndothelial cells$5IEN-M$0(DLC)sh2012001927

=LDR  01871cz  a2200361n  4500
=001  9880364293702441
=005  20190419144226.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044464
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x100.$x35
=072  \\$aD12.$x776.$x543.$x750.$x792.$x249
=150  \\$aReceptor, PAR-2
=450  \\$aPAR-2 Receptor
=450  \\$wnnna$aPAR 2 Receptor
=450  \\$wnnna$aPAR2 Receptor
=450  \\$wnnna$aProtease-Activated Receptor 2
=450  \\$wnnna$aProtease Activated Receptor 2
=450  \\$aProteinase Activated Receptor 2
=450  \\$wnnna$aReceptor 2, Protease-Activated
=450  \\$wnnna$aReceptor, PAR 2
=450  \\$wnnna$aReceptor, PAR2
=450  \\$wnnna$aReceptor, Trypsin
=450  \\$wnnna$aReceptors, Trypsin
=450  \\$wnnna$aTrypsin Receptor
=450  \\$wnnna$aTrypsin Receptors
=550  \\$wg$aReceptors, G-Protein-Coupled
=550  \\$wg$aReceptors, Proteinase-Activated
=680  \\$iA G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.
=688  \\$a2004; use RECEPTOR, PAR-2 (NM) 1994-2003; for TRYPSIN RECEPTOR use RECEPTOR, PAR-2 (NM) 1986-2003
=750  \0$81$wb$iBroader mapping$aTrypsin$0(DLC)sh 85138301$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aTrpsin--Receptors$5IEN-M

=LDR  00652cz  a2200181n  4500
=001  9880364293802441
=005  20141212215610.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x292.$x750
=072  \\$aB3.$x660.$x75.$x102.$x750
=150  \\$aSphaerotilus
=550  \\$wg$aComamonadaceae
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE. They are closely related to LEPTOTHRIX.
=688  \\$a2004
=750  \0$aSphaerotilus$0(DLC) sh 88023335$5IEN-M

=LDR  00866cz  a2200169n  4500
=001  9880364293902441
=005  20141212215758.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x950
=150  \\$aVolvox
=550  \\$wg$aChlorophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of GREEN ALGAE in the family Volvocaceae. They form spherical colonies of hundreds or thousands of bi-flagellated cells in a semi-transparent gelatinous ball.
=688  \\$a2004; use ALGAE, GREEN 1998-2003
=750  \0$aVolvox$0(DLC) sh 88022489$5IEN-M

=LDR  00682cz  a2200193n  4500
=001  9880364294002441
=005  20141212215610.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042726
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x251.$x100.$x477
=072  \\$aB3.$x660.$x75.$x77.$x100.$x477
=150  \\$aBurkholderia mallei
=450  \\$aPseudomonas mallei
=550  \\$wg$aBurkholderia
=667  \\$ainfection = GLANDERS
=680  \\$iA species of gram-negative bacteria parasitic on HORSES and DONKEYS causing GLANDERS, which can be transmitted to humans.
=688  \\$a2004; use PSEUDOMONAS 2003
=750  \0$aPseudomonas mallei$5IEN-M$0(DLC)sh 88023309

=LDR  01118cz  a2200265n  4500
=001  9880364294102441
=005  20141212215601.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042442
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x100.$x800
=072  \\$aD12.$x776.$x467.$x100.$x800
=072  \\$aD23.$x529.$x100.$x800
=150  \\$aVascular Endothelial Growth Factors
=450  \\$wnnna$aVEGFs
=550  \\$wg$aAngiogenic Proteins
=550  \\$wh$aVascular Endothelial Growth Factor A
=550  \\$wh$aVascular Endothelial Growth Factor B
=550  \\$wh$aVascular Endothelial Growth Factor C
=550  \\$wh$aVascular Endothelial Growth Factor D
=550  \\$wh$aVascular Endothelial Growth Factor, Endocrine-Gland-Derived
=667  \\$ageneral; prefer specifics
=680  \\$iA family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
=688  \\$a2004
=750  \0$aVascular endothelial growth factors$0(DLC) sh 2004000517$5IEN-M

=LDR  01153cz  a2200277n  4500
=001  9880364294202441
=005  20141212215758.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044445
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x900
=150  \\$aUlva
=450  \\$wnnna$aarasakii, Ulva
=450  \\$wnnna$aarasakius, Ulva
=450  \\$wnnna$aLettuce, Sea
=450  \\$wnnna$aLettuces, Sea
=450  \\$wnnna$aSea Lettuce
=450  \\$aSea Lettuces
=450  \\$wnnna$aUlva arasakii
=450  \\$wnnna$aUlva arasakius
=450  \\$wnnna$aUlvas
=550  \\$wg$aChlorophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of GREEN ALGAE in the family Ulvaceae. Commonly know as sea lettuces, they grow attached to rocks and KELP in marine and estuarine waters.
=688  \\$a2004; use ALGAE, GREEN 2000-2003
=750  \0$aUlva$0(DLC) sh2002000229$5IEN-M

=LDR  00875cz  a2200169n  4500
=001  9880364294302441
=005  20141212215758.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150.$x800
=150  \\$aScenedesmus
=550  \\$wg$aChlorophyta
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL.
=688  \\$a2004; use ALGAE, GREEN 1998-2003
=750  \0$aScenedesmus$0(DLC) sh 87002271$5IEN-M

=LDR  00890cz  a2200181n  4500
=001  9880364294402441
=005  20141212215757.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x150.$x150.$x575
=150  \\$aNitella
=450  \\$wnnna$aNitellas
=550  \\$wg$aCharaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus of green plants in the family CHARACEAE, phylum STREPTOPHYTA. They are found in shallow to deep waters of soft water or acid lakes and bogs.
=688  \\$a2004; use ALGAE, GREEN 1998-2003
=750  \0$aNitella$5IEN-M$0(DLC)sh 88022415

=LDR  00875cz  a2200193n  4500
=001  9880364294502441
=005  20141212215757.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600.$x425
=072  \\$aB5.$x80.$x750.$x450
=150  \\$aKelp
=550  \\$wg$aPhaeophyta
=550  \\$wg$aSeaweed
=667  \\$acoordinate with specific organism if pertinent
=680  \\$iLarge, robust forms of brown algae (PHAEOPHYCEAE) in the order Laminariales. They are a major component of the lower intertidal and sublittoral zones on rocky coasts in temperate and polar waters. Kelp, a kind of SEAWEED, usually refers to species in the genera LAMINARIA or MACROCYSTIS, but the term may also be used for species in FUCUS or Nereocystis.
=688  \\$a2004; use SEAWEED 2000-2003
=750  \0$aKelps$5IEN-M$0(DLC)sh 85071892

=LDR  01425cz  a2200313n  4500
=001  9882095282602441
=005  20230104140251.0
=008  030714\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044383
=035  \\$a(DNLM)D044383
=035  \\$a(NLM)98199390110000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x372
=150  \\$aBlack People
=450  \\$wnnna$aNegroid Race
=450  \\$aAfrican Continental Ancestry Group
=450  \\$aBlack Person
=450  \\$wnnna$aBlack Peoples
=450  \\$wnnna$aBlack Persons
=450  \\$wnnna$aNegroid Races
=450  \\$wnnna$aPeople, Black
=450  \\$wnnna$aPerson, Black
=450  \\$wnnna$aPersons, Black
=450  \\$wnnna$aRace, Negroid
=667  \\$aspecify geographic location if pertinent
=680  \\$iPersons having origins in any of the black racial groups of AFRICA. Note that OMB category BLACK OR AFRICAN AMERICAN is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2023; use AFRICAN CONTINENTAL ANCESTRY GROUP 2004-2021, use BLACKS 2022
=750  \0$aBlack people$5IEN-M$0(DLC)sh 85014672
=750  \0$aBlack race$5IEN-M$0(DLC)sh 85014604

=LDR  02112cz  a2200565n  4500
=001  9880364294702441
=005  20141212215558.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x236.$x249
=072  \\$aA10.$x336.$x532
=150  \\$aMammary Glands, Human
=450  \\$wnnna$aAlveoli, Human Mammary
=450  \\$wnnna$aAlveolus, Human Mammary
=450  \\$wnnna$aDuct, Human Mammary
=450  \\$wnnna$aDucts, Human Mammary
=450  \\$wnnna$aEpithelia, Human Mammary
=450  \\$wnnna$aEpithelium, Human Mammary
=450  \\$wnnna$aGland, Human Mammary
=450  \\$wnnna$aGland, Mammary
=450  \\$wnnna$aGlands, Human Mammary
=450  \\$wnnna$aGlands, Mammary
=450  \\$wnnna$aHuman Mammary Alveoli
=450  \\$wnnna$aHuman Mammary Alveolus
=450  \\$wnnna$aHuman Mammary Duct
=450  \\$wnnna$aHuman Mammary Ducts
=450  \\$wnnna$aHuman Mammary Epithelia
=450  \\$wnnna$aHuman Mammary Epithelium
=450  \\$wnnna$aHuman Mammary Gland
=450  \\$wnnna$aHuman Mammary Glands
=450  \\$wnnna$aHuman Mammary Lobule
=450  \\$wnnna$aHuman Mammary Lobules
=450  \\$wnnna$aMammary Alveoli, Human
=450  \\$wnnna$aMammary Alveolus, Human
=450  \\$wnnna$aMammary Duct, Human
=450  \\$wnnna$aMammary Ducts, Human
=450  \\$wnnna$aMammary Epithelia, Human
=450  \\$wnnna$aMammary Epithelium, Human
=450  \\$wnnna$aMammary Gland
=450  \\$wnnna$aMammary Gland, Human
=450  \\$wnnna$aMammary Glands
=450  \\$wnnna$aMammary Lobule, Human
=450  \\$wnnna$aMammary Lobules, Human
=550  \\$wg$aBreast
=550  \\$wg$aExocrine Glands
=667  \\$afor animals use MAMMARY GLANDS, ANIMAL
=680  \\$iGlandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young.
=688  \\$a2004; use BREAST 1975-2003
=750  \0$aMammary Glands$5IEN-M$0(DLC)sh 85080275

=LDR  00588cz  a2200169n  4500
=001  9880364294802441
=005  20141212215557.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x40.$x50.$x500
=072  \\$aB3.$x660.$x50.$x20.$x50.$x500
=150  \\$aAnaplasma marginale
=550  \\$wg$aAnaplasma
=680  \\$iA species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.
=688  \\$a2004
=750  \0$aAnaplasma marginale$5IEN-M$0(DLC)sh 98004435

=LDR  00924cz  a2200289n  4500
=001  9880364294902441
=005  20141212215556.0
=008  030722\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x620.$x520
=072  \\$aE1.$x370.$x225.$x750.$x600.$x520
=072  \\$aE1.$x370.$x225.$x998.$x221.$x580
=072  \\$aE4.$x221.$x580
=072  \\$aE5.$x200.$x750.$x600.$x520
=072  \\$aE5.$x200.$x998.$x221.$x580
=072  \\$aE5.$x591.$x560
=150  \\$aMicrodissection
=450  \\$wnnna$aMicrodissections
=550  \\$wg$aDissection
=550  \\$wg$aHistocytological Preparation Techniques
=550  \\$wg$aMicromanipulation
=550  \\$wh$aLaser Capture Microdissection
=550  \\$aMicrosurgery
=680  \\$iThe performance of dissections with the aid of a microscope.
=688  \\$a2004
=750  \0$aMicrodissection$5IEN-M$0(DLC)sh 87005977

=LDR  01594cz  a2200433n  4500
=001  9880364295002441
=005  20200706175816.0
=008  030725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x645
=072  \\$aG2.$x734
=150  \\$aPhase Transition
=450  \\$wnnna$aGas-Liquid-Solid Phase Transition
=450  \\$wnnna$aGas-Liquid-Solid Phase Transitions
=450  \\$wnnna$aGas Liquid Solid Phase Transitions
=450  \\$wnnna$aPhase Transition, Gas-Liquid-Solid
=450  \\$wnnna$aPhase Transition, Sol-Gel
=450  \\$wnnna$aPhase Transitions
=450  \\$wnnna$aPhase Transitions, Gas-Liquid-Solid
=450  \\$wnnna$aPhase Transitions, Sol-Gel
=450  \\$wnnna$aSol-Gel Phase Transition
=450  \\$wnnna$aSol Gel Phase Transition
=450  \\$wnnna$aSol-Gel Phase Transitions
=450  \\$wnnna$aTransition, Gas-Liquid-Solid Phase
=450  \\$wnnna$aTransition, Sol-Gel Phase
=450  \\$wnnna$aTransitions, Gas-Liquid-Solid Phase
=450  \\$wnnna$aTransitions, Sol-Gel Phase
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPhysical PHenomena
=550  \\$wh$aFreezing
=550  \\$wh$aSublimation, Chemical
=550  \\$wh$aVitrification
=550  \\$wh$aVolatilization
=550  \\$aTransition Temperature
=667  \\$anote X refs: restrict to physical chemical change; not for physiologic phase transition
=680  \\$iA change of a substance from one form or state to another.
=688  \\$a2004
=750  \0$aPhase transformations (Statistical physics)$0(DLC)sh 85100646$5IEN-M

=LDR  00874cz  a2200253n  4500
=001  9880364295102441
=005  20141212215555.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x560.$x500
=150  \\$aRetinoscopy
=450  \\$wnnna$aRetinoscopies
=450  \\$wnnna$aShadow Test
=450  \\$wnnna$aShadow Tests
=450  \\$wnnna$aSkiametries
=450  \\$wnnna$aSkiametry
=450  \\$wnnna$aSkiascopies
=450  \\$wnnna$aSkiascopy
=550  \\$wg$aOphthalmoscopy
=550  \\$aRefraction, Ocular
=680  \\$iAn objective determination of the refractive state of the eye (NEARSIGHTEDNESS; FARSIGHTEDNESS; ASTIGMATISM). By using a RETINOSCOPE, the amount of correction and the power of lens needed can be determined.
=688  \\$a2004
=750  \0$aRetinoscopy$0(DLC) sh 85123144$5IEN-M

=LDR  00630cz  a2200181n  4500
=001  9880364295202441
=005  20141212215554.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x708.$x500
=072  \\$aB3.$x660.$x50.$x663.$x750.$x500
=150  \\$aMagnetospirillum
=550  \\$wg$aRhodospirillaceae
=550  \\$aMagnetosomes
=680  \\$iA genus of microaerophilic, gram-negative bacteria that forms crystals of the mineral magnetite in special organelles called MAGNETOSOMES.
=688  \\$a2004
=750  \0$aMagnetospirillum$0(DLC)sh2008020098$5IEN-M

=LDR  01264cz  a2200349n  4500
=001  9880364295302441
=005  20141212215749.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044366
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x595.$x850
=150  \\$aTransition Temperature
=450  \\$wnnna$aBoiling Point Temperature
=450  \\$wnnna$aBoiling Point Temperatures
=450  \\$wnnna$aFreezing Point Temperature
=450  \\$wnnna$aFreezing Point Temperatures
=450  \\$wnnna$aMelting Point Temperature
=450  \\$wnnna$aMelting Point Temperatures
=450  \\$wnnna$aTemperature, Boiling Point
=450  \\$wnnna$aTemperature, Freezing Point
=450  \\$wnnna$aTemperature, Melting Point
=450  \\$aTemperature, Transition
=450  \\$wnnna$aTemperatures, Boiling Point
=450  \\$wnnna$aTemperatures, Freezing Point
=450  \\$wnnna$aTemperatures, Melting Point
=450  \\$wnnna$aTemperatures, Transition
=450  \\$wnnna$aTransition Temperatures
=550  \\$wg$aTemperature
=550  \\$aPhase Transition
=680  \\$iThe temperature at which a substance changes from one state or conformation of matter to another.
=688  \\$a2004
=750  \0$aTransition temperature$0(DLC) sh 85136955$5IEN-M

=LDR  00720cz  a2200217n  4500
=001  9880364295402441
=005  20141212215552.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x487
=072  \\$aB3.$x660.$x50.$x500
=150  \\$aMethylobacteriaceae
=450  \\$aProtomonas
=450  \\$aRoseomonas
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aMethylobacterium
=680  \\$iA family of gram-negative bacteria in the order Rhizobiales. Genera include METHYLOBACTERIUM, Protomonas, and Roseomonas.
=688  \\$a2004
=750  \0$aMethylobacteriaceae$0(DLC)sh2004009989$5IEN-M

=LDR  00731cz  a2200181n  4500
=001  9880364295502441
=005  20141212215746.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044347
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x837
=150  \\$aSexology
=550  \\$wg$aBehavioral Sciences
=550  \\$wh$aSex Counseling
=550  \\$wh$aSex Education
=680  \\$iThis discipline concerns the study of SEXUALITY, and the application of sexual knowledge such as sexual attitudes, psychology, and SEXUAL BEHAVIOR. Scope of application generally includes educational (SEX EDUCATION), clinical (SEX COUNSELING), and other settings.
=688  \\$a2004; use SEX 1991-2003
=750  \0$aSexology$0(DLC) sh 90004841$5IEN-M

=LDR  00837cz  a2200217n  4500
=001  9880364295602441
=005  20141212215551.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D042021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x215
=072  \\$aB3.$x660.$x50.$x70
=150  \\$aBrucellaceae
=550  \\$wg$aAlphaproteobacteria
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aBrucella
=550  \\$wh$aOchrobactrum
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA family of gram-negative coccoid to rod-shaped bacteria in the order Rhizobiales. They are obligate parasites chiefly of warm-blooded VERTEBRATES. Many are pathogenic.
=688  \\$a2004, 1975-1991; use BRUCELLA 1992-2003
=750  \0$aBrucellaceae$5IEN-M$0(DLC)sh 85017287

=LDR  00873cz  a2200253n  4500
=001  9880364295702441
=005  20171012165637.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521
=150  \\$aMalnutrition
=450  \\$wnnna$aNutritional Deficiencies
=450  \\$wnnna$aNutritional Deficiency
=450  \\$wnnna$aUndernutrition
=550  \\$wg$aNutrition Disorders
=550  \\$wh$aDeficiency Diseases
=550  \\$wh$aFetal Nutrition Disorders
=550  \\$wh$aRefeeding Syndrome
=550  \\$wh$aSevere Acute Malnutrition
=550  \\$wh$aStarvation
=680  \\$iAn imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.
=688  \\$a2004; use NUTRITION DISORDERS 1975-2003
=750  \0$aMalnutrition$5IEN-M$0(DLC)sh 85080176

=LDR  00925cz  a2200277n  4500
=001  9880364295802441
=005  20141212215549.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556
=150  \\$aGastrointestinal Tract
=450  \\$aDigestive Tract
=450  \\$wnnna$aDigestive Tracts
=450  \\$wnnna$aGastrointestinal Tracts
=450  \\$wnnna$aGI Tract
=450  \\$wnnna$aGI Tracts
=550  \\$wg$aDigestive System
=550  \\$wh$aIntestines
=550  \\$wh$aLower Gastrointestinal Tract
=550  \\$wh$aMouth
=550  \\$wh$aPharynx
=550  \\$wh$aUpper Gastrointestinal Tract
=680  \\$iGenerally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).
=688  \\$a2004
=750  \0$aGastrointestinal System$5IEN-M$0(DLC)sh 85053487

=LDR  01029cz  a2200229n  4500
=001  9880364295902441
=005  20141212215741.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x920
=150  \\$aTrans Fatty Acids
=450  \\$wnnna$aAcids, Trans Fatty
=450  \\$wnnna$aAcids, Trans-Fatty
=450  \\$wnnna$aFatty Acids, Trans
=450  \\$wnnna$aTrans-Fatty Acids
=550  \\$wg$aFatty Acids, Unsaturated
=550  \\$aLinoleic Acids, Conjugated
=667  \\$acoord with specific fatty acid if pertinent
=680  \\$iUNSATURATED FATTY ACIDS that contain at least one double bond in the trans configuration, which results in a greater bond angle than the cis configuration. This results in a more extended fatty acid chain similar to SATURATED FATTY ACIDS, with closer packing and reduced fluidity. HYDROGENATION of unsaturated fatty acids increases the trans content.
=688  \\$a2004
=750  \0$aTrans fatty acids$0(DLC) sh 96001154$5IEN-M

=LDR  00867cz  a2200253n  4500
=001  9880364296002441
=005  20141212215549.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041964
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x130
=072  \\$aB3.$x440.$x400.$x425.$x300
=150  \\$aCytophagaceae
=450  \\$wnnna$aFlexibacteraceae
=550  \\$wg$aBacteroidetes
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=550  \\$wh$aCytophaga
=550  \\$wh$aFlexibacter
=667  \\$ainfection = CYTOPHAGACEAE INFECTIONS
=680  \\$iA family of gram-negative, gliding bacteria in the order Cytophagales, class Cytophagia. They are found in SOIL and SEA WATER.
=688  \\$a2012 (2004)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Flexibacteraceae
=688  \\$a2004
=750  \0$aCytophagaceae$0(DLC) sh 85035248$5IEN-M

=LDR  00676cz  a2200169n  4500
=001  9880364296102441
=005  20141212215740.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044224
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x625.$x625.$x770
=072  \\$aB3.$x660.$x250.$x580.$x590.$x770
=150  \\$aPseudomonas syringae
=550  \\$wg$aPseudomonas
=680  \\$iA species of gram-negative, fluorescent, phytopathogenic bacteria in the genus PSEUDOMONAS. It is differentiated into approximately 50 pathovars with different plant pathogenicities and host specificities.
=688  \\$a2004
=750  \0$aPseudomonas syringae$0(DLC)sh 88023314$5IEN-M

=LDR  00742cz  a2200253n  4500
=001  9880364296202441
=005  20190121173123.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041963
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140
=150  \\$aBacteroidetes
=450  \\$aCytophagales
=550  \\$wg$aBacteria
=550  \\$wh$aBacteroidaceae
=550  \\$wh$aCytophagaceae
=550  \\$wh$aFlavobacteriaceae
=550  \\$wh$aPedobacter
=550  \\$wh$aRhodothermus
=550  \\$wh$aSphingobacterium
=550  \\$wh$aTannerella forsythia
=680  \\$iA phylum of bacteria comprised of three classes: Bacteroides, Flavobacteria, and Sphingobacteria.
=688  \\$a2004
=750  \0$aCytophagales$5IEN-M$0(DLC)sh 85035249

=LDR  01167cz  a2200349n  4500
=001  9880364296302441
=005  20141212215547.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041943
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x700.$x249
=072  \\$aJ2.$x200.$x712.$x249
=072  \\$aJ2.$x500.$x350.$x525.$x332
=072  \\$aJ2.$x500.$x525.$x350.$x500
=072  \\$aJ2.$x500.$x525.$x500.$x500
=150  \\$aInfant Formula
=450  \\$wnnna$aBaby Formula
=450  \\$wnnna$aBaby Formulas
=450  \\$wnnna$aFormula, Baby
=450  \\$wnnna$aFormula, Infant
=450  \\$wnnna$aFormulas, Baby
=450  \\$wnnna$aFormulas, Infant
=450  \\$wnnna$aInfant Formulas
=550  \\$wg$aFood, Formulated
=550  \\$wg$aInfant Food
=550  \\$wg$aMilk
=550  \\$wg$aMilk Substitutes
=550  \\$aInfant Food
=667  \\$acoordinate with major ingredient
=680  \\$iLiquid formulations for the nutrition of INFANTS, useful for those with special needs or MILK HYPERSENSITIVITY or those whose mothers are unable to breastfeed (BREAST FEEDING).
=688  \\$a2004
=750  \0$aInfant formulas$5IEN-M$0(DLC)sh 85066001

=LDR  00672cz  a2200241n  4500
=001  9880364296402441
=005  20141212215547.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041942
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x712.$x500
=072  \\$aJ2.$x500.$x850.$x500.$x700.$x500.$x500
=150  \\$aSoy Milk
=450  \\$wnnna$aBeverage, Soy
=450  \\$wnnna$aBeverages, Soy
=450  \\$aMilk, Soy
=450  \\$wnnna$aSoy Beverage
=450  \\$wnnna$aSoy Beverages
=550  \\$wg$aMilk Substitutes
=550  \\$wg$aSoy Foods
=680  \\$iA beverage prepared from SOYBEANS.
=688  \\$a2004
=750  \0$aSoymilk$5IEN-M$0(DLC)sh 85125893

=LDR  00657cz  a2200193n  4500
=001  9880364296602441
=005  20141212215546.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D041923
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x525.$x49
=072  \\$aG7.$x700.$x320.$x374.$x500
=150  \\$aAdolescent Development
=450  \\$wnnna$aDevelopment, Adolescent
=550  \\$wg$aHuman Development
=550  \\$aAdolescent Behavior
=680  \\$iThe continuous sequential physiological and psychological changes during ADOLESCENCE, approximately between the age of 13 and 18.
=688  \\$a2004
=750  \0$aYouth development$5IEN-M$0(DLC)sh2002010586

=LDR  01961cz  a2200433n  4500
=001  9880364296702441
=005  20141212215734.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x591
=072  \\$aD12.$x644.$x276.$x908
=072  \\$aD12.$x644.$x548.$x588
=072  \\$aD12.$x776.$x467.$x890
=072  \\$aD23.$x529.$x890
=150  \\$aParathyroid Hormone-Related Protein
=450  \\$wnnna$aHormone-Related Protein, Parathyroid
=450  \\$wnnna$aHypercalcemic Factor, Tumor
=450  \\$wnnna$aHypercalcemic Hormone of Malignancy
=450  \\$wnnna$aParathyroid Hormone-Like Protein
=450  \\$wnnna$aParathyroid Hormone Like Protein
=450  \\$wnnna$aParathyroid Hormone Like Tumor Factor
=450  \\$wnnna$aParathyroid Hormone-Related Peptide
=450  \\$wnnna$aParathyroid Hormone Related Peptide
=450  \\$wnnna$aParathyroid Hormone Related Protein
=450  \\$wnnna$aPTH-Like Protein
=450  \\$wnnna$aPTH Like Protein
=450  \\$wnnna$aPTH Like Tumor Factor
=450  \\$wnnna$aPTH-Related Peptide
=450  \\$wnnna$aPTH Related Peptide
=450  \\$wnnna$aPTHrP
=450  \\$wnnna$aTumor Hypercalcemic Factor
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wg$aPeptide Hormones
=550  \\$aParathyroid Hormone
=667  \\$asee SCR for organism specific terms
=680  \\$iA ubiquitously expressed, secreted protein with bone resorption and renal calcium reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate in appreciable amounts in normal subjects, but rather exerts its biological actions locally. Overexpression of parathyroid hormone-related protein by tumor cells results in humoral calcemia of malignancy.
=688  \\$a2004; use PARATHYROID HORMONE-RELATED PROTEIN (NM) 1987-2003
=750  \0$aParathyroid hormone-related protein$0(DLC)sh 91006183$5IEN-M

=LDR  00836cz  a2200241n  4500
=001  9880364296802441
=005  20141212215733.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044148
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x451
=072  \\$aC16.$x131.$x482
=150  \\$aLymphatic Abnormalities
=450  \\$wnnna$aAbnormalities, Lymphatic
=450  \\$wnnna$aAbnormality, Lymphatic
=450  \\$wnnna$aLymphatic Abnormality
=550  \\$wg$aCongenital Abnormalities
=550  \\$wg$aLymphatic Diseases
=550  \\$wh$a22q11 Deletion Syndrome
=550  \\$wh$aLymphangiectasis, Intestinal
=680  \\$iCongenital or acquired structural abnormalities of the lymphatic system (LYMPHOID TISSUE) including the lymph vessels.
=688  \\$a2004
=750  \0$aLymphatics$xAbnormalities$5IEN-HS$0(DLC)sh 85079133

=LDR  00783cz  a2200193n  4500
=001  9880364296902441
=005  20141212215730.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044135
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600.$x450.$x675
=072  \\$aB3.$x660.$x250.$x550.$x290.$x675
=150  \\$aHaemophilus parainfluenzae
=450  \\$aHemophilius parainfluenzae
=550  \\$wg$aHaemophilus
=667  \\$ainfection: coord IM with HAEMOPHILUS INFECTIONS (IM)
=680  \\$iA species of gram-negative bacteria in the genus HAEMOPHILUS, ubiquitous in the human ORAL CAVITY and PHARYNX. It has low pathogenicity but is occasionally implicated in ENDOCARDITIS in humans.
=688  \\$a2004
=750  \0$aHaemophilus parainfluenzae$0(DLC)sh2006002256$5IEN-M

=LDR  00813cz  a2200241n  4500
=001  9880363691702441
=005  20141212204008.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009739
=035  \\$aCBA3012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x539
=150  \\$aNursing Services
=450  \\$wnnna$aNursing Service
=450  \\$wnnna$aService, Nursing
=450  \\$wnnna$aServices, Nursing
=550  \\$wg$aHealth Services
=550  \\$wh$aHome Care Services
=550  \\$wh$aNursing Service, Hospital
=667  \\$aGEN or unspecified as hosp nurs services ( = NURSING SERVICES, HOSPITAL); IM; DF: NURS SERV
=680  \\$iA general concept referring to the organization and administration of nursing activities.
=688  \\$a78
=750  \0$aNursing services$5IEN$0(DLC)sh 86006194

=LDR  01063cz  a2200301n  4500
=001  9880363691802441
=005  20141212211026.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015399
=035  \\$aCBA3010HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x390
=072  \\$aH2.$x478.$x395
=072  \\$aN4.$x590.$x233.$x508.$x613
=150  \\$aNursing Research
=450  \\$aResearch, Nursing
=550  \\$wg$aBiomedical Research
=550  \\$wg$aNursing
=550  \\$wg$aNursing Process
=550  \\$wh$aClinical Nursing Research
=550  \\$wh$aNursing Administration Research
=550  \\$wh$aNursing Education Research
=550  \\$wh$aNursing Evaluation Research
=550  \\$wh$aNursing Methodology Research
=667  \\$aSPEC: SPEC qualif; DF: NURS RESEARCH
=680  \\$iResearch carried out by nurses, generally in clinical settings, in the areas of clinical practice, evaluation, nursing education, nursing administration, and methodology.
=688  \\$a89
=750  \0$aNursing$xResearch$5IEN$0(DLC)sh 85093375

=LDR  00936cz  a2200265n  4500
=001  9880363691902441
=005  20141212204008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009737
=035  \\$aCBA3009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x984
=072  \\$aL1.$x280.$x900.$x984
=072  \\$aN4.$x452.$x859.$x675
=072  \\$aN5.$x715.$x360.$x300.$x715.$x550
=072  \\$aN6.$x850.$x520.$x308.$x940.$x984
=150  \\$aNursing Records
=450  \\$wnnna$aNursing Record
=450  \\$wnnna$aRecord, Nursing
=450  \\$wnnna$aRecords, Nursing
=550  \\$wg$aRecords as Topic
=667  \\$aFORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: NURS RECORDS
=680  \\$iData recorded by nurses concerning the nursing care given to the patient, including judgment of the patient's progress.
=688  \\$a67
=750  \0$aNursing records$5IEN$0(DLC)sh 85093417

=LDR  00961cz  a2200241n  4500
=001  9880363692002441
=005  20141212204007.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009736
=035  \\$aCBA3008HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x508
=150  \\$aNursing Process
=450  \\$wnnna$aNursing Processes
=450  \\$wnnna$aProcess, Nursing
=450  \\$wnnna$aProcesses, Nursing
=550  \\$wg$aComprehensive Health Care
=550  \\$wh$aNursing Assessment
=550  \\$wh$aNursing Research
=667  \\$a"total of nursing care activities"; do not confuse with NURSING (the profession), NURSING CARE (the patient), NURSING SERVICES; DF: NURS PROCESS
=680  \\$iThe sum total of nursing activities which includes assessment (identifying needs), intervention (ministering to needs), and evaluation (validating the effectiveness of the help given).
=688  \\$a80
=750  \0$aNursing$5IEN$0(DLC)sh 85093362

=LDR  00882cz  a2200241n  4500
=001  9880363692102441
=005  20141212204007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009735
=035  \\$aCBA3006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x825.$x610
=150  \\$aNursing Homes
=450  \\$wnnna$aHome, Nursing
=450  \\$wnnna$aHomes, Nursing
=450  \\$wnnna$aNursing Home
=550  \\$wg$aResidential Facilities
=550  \\$wh$aIntermediate Care Facilities
=550  \\$wh$aSkilled Nursing Facilities
=667  \\$anursing homes for the aged: coord IM with HOMES FOR THE AGED (IM); DF: NURS HOMES
=680  \\$iFacilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.
=750  \0$aNursing home care$5IEN-M$0(DLC)sh 85093392
=750  \0$aNursing homes$5IEN-HS$0(DLC)sh 85093396

=LDR  01523cz  a2200361n  4500
=001  9880363692202441
=005  20141212211028.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015402
=035  \\$aCBA3003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145.$x390.$x413
=072  \\$aH2.$x478.$x395.$x413
=072  \\$aI2.$x358.$x462.$x612
=072  \\$aN4.$x590.$x233.$x508.$x613.$x413
=150  \\$aNursing Education Research
=450  \\$aEducation Research, Nursing
=450  \\$wnnna$aEducation Researchs, Nursing
=450  \\$wnnna$aEducational Nursing Research
=450  \\$wnnna$aEducational Nursing Researchs
=450  \\$wnnna$aNursing Education Researchs
=450  \\$aNursing Research, Educational
=450  \\$wnnna$aNursing Researchs, Educational
=450  \\$wnnna$aResearch, Educational Nursing
=450  \\$aResearch, Nursing Education
=450  \\$wnnna$aResearchs, Educational Nursing
=450  \\$wnnna$aResearchs, Nursing Education
=550  \\$wg$aEducation, Nursing
=550  \\$wg$aNursing Research
=667  \\$aSPEC: SPEC qualif; DF: NURS EDUC RESEARCH
=680  \\$iInvestigations into the problems of integrating research findings into nursing curricula, developing problem solving skills, finding approaches to clinical teaching, determining the level of practice by graduates from different basic preparations, etc.
=688  \\$a91(89); was see under NURSING RESEARCH 1989-90
=750  \0$aNursing$xStudy and teaching$xResearch$5IEN$0(IEN)369558

=LDR  01772cz  a2200517n  4500
=001  9880363692302441
=005  20141212204006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009732
=035  \\$aCBA3001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x611
=072  \\$aN2.$x421.$x533
=150  \\$aNursing Care
=450  \\$wnnna$aCare, Nursing
=450  \\$aDisease$xnursing
=450  \\$wnnna$aManagement, Nursing Care
=450  \\$wnnna$aNursing Care Management
=450  \\$aPatient Care$xnursing
=550  \\$wg$aHealth Services
=550  \\$wg$aPatient Care
=550  \\$wh$aCardiovascular Nursing
=550  \\$wh$aCritical Care Nursing
=550  \\$wh$aEmergency Nursing
=550  \\$wh$aGeriatric Nursing
=550  \\$wh$aHolistic Nursing
=550  \\$wh$aHome Nursing
=550  \\$wh$aHospice and Palliative Care Nursing
=550  \\$wh$aMaternal-Child Nursing
=550  \\$wh$aNephrology Nursing
=550  \\$wh$aNeuroscience Nursing
=550  \\$wh$aNursing, Practical
=550  \\$wh$aObstetric Nursing
=550  \\$wh$aOccupational Health Nursing
=550  \\$wh$aOncology Nursing
=550  \\$wh$aOrthopedic Nursing
=550  \\$wh$aPediatric Nursing
=550  \\$wh$aPerioperative Nursing
=550  \\$wh$aPrimary Care Nursing
=550  \\$wh$aPrimary Nursing
=550  \\$wh$aPsychiatric Nursing
=550  \\$wh$aRehabilitation Nursing
=667  \\$aGEN & for patients only: NURSING is for the nursing profession; /legislation & jurisprudence = LEGISLATION, NURSING or NURSING (IM) + JURISPRUDENCE (IM); prefer /nursing: Manual 19.7+, 19.8.48; DF: NURS CARE
=680  \\$iCare given to patients by nursing service personnel.
=688  \\$a66
=750  \0$aNursing$5IEN$0(DLC)sh 85093362

=LDR  00859cz  a2200229n  4500
=001  9880363692402441
=005  20141212204005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009731
=035  \\$aCBA3000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761.$x700.$x250.$x520
=072  \\$aN5.$x700.$x175.$x520
=150  \\$aNursing Audit
=450  \\$wnnna$aAudit, Nursing
=450  \\$wnnna$aAudits, Nursing
=450  \\$wnnna$aNursing Audits
=550  \\$wg$aClinical Audit
=667  \\$ato evaluate quality of nurs care; do not confuse with NURSING ASSESSMENT (to evaluate nurs problems of patient to plan care); DF: NURS AUDIT
=680  \\$iA detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care.
=688  \\$a68
=750  \0$aNursing audit$0sh 85093386$5IEN

=LDR  01147cz  a2200277n  4500
=001  9880363692502441
=005  20141212204005.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009730
=035  \\$aCBA2999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x508.$x480
=150  \\$aNursing Assessment
=450  \\$wnnna$aAssessment, Nursing
=450  \\$wnnna$aAssessments, Nursing
=450  \\$wnnna$aNursing Assessments
=450  \\$wnnna$aNursing Protocol
=450  \\$aNursing Protocols
=450  \\$wnnna$aProtocol, Nursing
=450  \\$wnnna$aProtocols, Nursing
=550  \\$wg$aNursing Process
=550  \\$wh$aNursing Diagnosis
=667  \\$ato evaluate nature & extent of nurs problems of patient to plan patient care; do not confuse with NURSING AUDIT (to evaluate quality of nurs care); DF: NURS ASSESS
=680  \\$iEvaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning.
=688  \\$a87(80); was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79
=750  \0$aNursing assessment$5IEN$0(DLC)sh 88007597

=LDR  01129cz  a2200313n  4500
=001  9880363692602441
=005  20141212204005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009729
=035  \\$aCBA2997HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478
=072  \\$aN4.$x452.$x758.$x377
=150  \\$aNursing
=450  \\$wnnna$aNursings
=550  \\$wg$aHealth Occupations
=550  \\$wg$aProfessional Practice
=550  \\$wh$aEvidence-Based Nursing
=550  \\$wh$aNursing, Private Duty
=550  \\$wh$aNursing Research
=550  \\$wh$aNursing, Supervisory
=550  \\$wh$aNursing Theory
=550  \\$wh$aOffice Nursing
=550  \\$wh$aSpecialties, Nursing
=550  \\$wh$aTelenursing
=550  \\$wh$aTravel Nursing
=667  \\$athe nursing profession only: NURSING CARE is for patients; /legislation & jurisprudence = LEGISLATION, NURSING or NURSING (IM) + JURISPRUDENCE (IM); available is /nurs: Manual 19.7+, 19.8.48; DF: NURS
=680  \\$iThe field of nursing care concerned with the promotion, maintenance, and restoration of health.
=750  \0$aNursing$5IEN$0(DLC)sh 85093362

=LDR  00750cz  a2200265n  4500
=001  9880363692802441
=005  20141212204004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009727
=035  \\$aCBA2995HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x390.$x660
=072  \\$aM1.$x526.$x485.$x650.$x670
=072  \\$aN2.$x360.$x650.$x670
=150  \\$aNurses, Male
=450  \\$wnnna$aMale Nurse
=450  \\$wnnna$aMale Nurses
=450  \\$aMen Nurses$5IEN
=450  \\$wnnna$aNurse, Male
=550  \\$wg$aMen
=550  \\$wg$aNurses
=667  \\$arelation to nurs specialties: Manual 34.11.3; use of check tags: Manual 34.6
=680  \\$iNurses of the male sex.
=688  \\$a67
=750  \0$aMale nurses$5IEN$0(DLC)sh 85083530

=LDR  01308cz  a2200361n  4500
=001  9880363692902441
=005  20180914121110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009726
=035  \\$aCBA2994HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x650
=072  \\$aN2.$x360.$x650
=150  \\$aNurses
=450  \\$wnnna$aNurse
=450  \\$wnnna$aNurse, Registered
=450  \\$wnnna$aNurses, Registered
=450  \\$wnnna$aNursing Personnel
=450  \\$wnnna$aPersonnel, Nursing
=450  \\$wnnna$aRegistered Nurse
=450  \\$wnnna$aRegistered Nurses
=550  \\$wg$aHealth Personnel
=550  \\$wh$aNurse Administrators
=550  \\$wh$aNurse Practitioners
=550  \\$wh$aNurse Specialists
=550  \\$wh$aNurses, Community Health
=550  \\$wh$aNurses, International
=550  \\$wh$aNurses, Male
=550  \\$wh$aNurses, Public Health
=667  \\$arelation to nursing specialties: Manual 34.11.3
=680  \\$iProfessionals qualified by graduation from an accredited school of nursing and by passage of a national licensing examination to practice nursing. They provide services to patients requiring assistance in recovering or maintaining their physical or mental health.
=688  \\$a67(65)
=750  \0$aNurses$5IEN$0(DLC)sh 85093349

=LDR  00717cz  a2200229n  4500
=001  9880363693002441
=005  20201216180509.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009725
=035  \\$aCBA2993HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x388.$x540
=072  \\$aN2.$x278.$x617.$x473
=150  \\$aNurseries, Hospital
=450  \\$aHospital Nurseries
=450  \\$wnnna$aHospital Nursery
=450  \\$wnnna$aNursery, Hospital
=550  \\$wg$aHospital Units
=667  \\$acheck also tag INFANT, NEWBORN
=680  \\$iHospital facilities which provide care for newborn infants.
=688  \\$a78; was HOSPITAL NURSERIES 1972-77
=750  \0$aHospitals$xNurseries$5IEN$0(DLC)sh 85062345

=LDR  01044cz  a2200301n  4500
=001  9880363693202441
=005  20141212204003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009723
=035  \\$aCBA2991HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x650.$x600
=072  \\$aN5.$x300.$x660.$x560
=150  \\$aNurse-Patient Relations
=450  \\$wnnna$aNurse-Patient Relation
=450  \\$wnnna$aNurse Patient Relations
=450  \\$wnnna$aNurse Patient Relationship
=450  \\$wnnna$aNurse Patient Relationships
=450  \\$wnnna$aPatient Relations, Nurse
=450  \\$wnnna$aPatient Relationship, Nurse
=450  \\$wnnna$aPatient Relationships, Nurse
=450  \\$wnnna$aRelations, Nurse Patient
=450  \\$wnnna$aRelations, Nurse-Patient
=450  \\$wnnna$aRelationship, Nurse Patient
=450  \\$wnnna$aRelationships, Nurse Patient
=550  \\$wg$aProfessional-Patient Relations
=680  \\$iInteraction between the patient and nurse.
=750  \0$aNurse and patient$5IEN$0(DLC)sh 85093312

=LDR  00838cz  a2200241n  4500
=001  9880363693302441
=005  20141212204003.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009722
=035  \\$aCBA2990HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x650.$x640
=072  \\$aN2.$x360.$x650.$x640
=150  \\$aNurse Practitioners
=450  \\$wnnna$aNurse Practitioner
=450  \\$wnnna$aPractitioner, Nurse
=450  \\$wnnna$aPractitioners, Nurse
=550  \\$wg$aNurses
=550  \\$wh$aFamily Nurse Practitioners
=550  \\$wh$aPediatric Nurse Practitioners
=680  \\$iNurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician.
=688  \\$a76; was NURSE PRACTITIONER 1973-75
=750  \0$aNurse practitioners$5IEN$0(DLC)sh 85093316

=LDR  00762cz  a2200241n  4500
=001  9880363693402441
=005  20180914153414.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009721
=035  \\$aCBA2989HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x650.$x648.$x762
=072  \\$aN2.$x360.$x650.$x648.$x762
=150  \\$aNurse Midwives
=450  \\$wnnna$aNurse-Midwife
=450  \\$wnnna$aNurse Midwife
=450  \\$wnnna$aNurse-Midwives
=550  \\$wg$aNurse Specialists
=550  \\$aMidwifery
=667  \\$acheck also tag PREGNANCY
=680  \\$iProfessional nurses who have received postgraduate training in midwifery.
=688  \\$a77; was NURSE MIDWIFE see under NURSES 1975-76
=750  \0$aMidwives$5IEN$0(DLC)sh 85085055

=LDR  00931cz  a2200253n  4500
=001  9880363693502441
=005  20180914135717.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009719
=035  \\$aCBA2987HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x140.$x650
=072  \\$aM1.$x526.$x485.$x650.$x648.$x500
=072  \\$aN2.$x360.$x140.$x650
=072  \\$aN2.$x360.$x650.$x648.$x500
=150  \\$aNurse Anesthetists
=450  \\$wnnna$aAnesthetist, Nurse
=450  \\$wnnna$aAnesthetists, Nurse
=450  \\$wnnna$aNurse Anesthetist
=550  \\$wg$aAnesthetists
=550  \\$wg$aNurse Specialists
=680  \\$iProfessional nurses who have completed postgraduate training in the administration of anesthetics and who function under the responsibility of the operating surgeon.
=688  \\$a77; was NURSE ANESTHETIST see under NURSES 1975-76
=750  \0$aNurse anesthetists$5IEN$0(DLC)sh 85093314

=LDR  01250cz  a2200349n  4500
=001  9880363693602441
=005  20180914122708.0
=008  810302\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009718
=035  \\$aCBA2986HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70.$x140.$x670
=072  \\$aM1.$x526.$x485.$x650.$x580
=072  \\$aN2.$x360.$x650.$x580
=150  \\$aNurse Administrators
=450  \\$wnnna$aAdministrator, Nurse
=450  \\$wnnna$aAdministrators, Nurse
=450  \\$wnnna$aExecutive, Nurse
=450  \\$wnnna$aExecutives, Nurse
=450  \\$wnnna$aManager, Nurse
=450  \\$wnnna$aManagers, Nurse
=450  \\$wnnna$aNurse Administrator
=450  \\$wnnna$aNurse Executive
=450  \\$wnnna$aNurse Executives
=450  \\$wnnna$aNurse Manager
=450  \\$wnnna$aNurse Managers
=550  \\$wg$aAdministrative Personnel
=550  \\$wg$aNurses
=667  \\$ado not confuse with HEAD NURSES see NURSING, SUPERVISORY; in British journals "matron" goes here but nursing "sisters" go under NURSING, SUPERVISORY
=680  \\$iNurses professionally qualified in administration.
=688  \\$a91(82); was see under ADMINISTRATIVE PERSONNEL 1982-90
=750  \0$aNurse administrators$5IEN$0(DLC)sh 85093311

=LDR  00921cz  a2200229n  4500
=001  9880363693702441
=005  20141212204002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009717
=035  \\$aCBA2985HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x560
=150  \\$aNumismatics
=450  \\$wnnna$aCoin
=450  \\$aCoins
=450  \\$wnnna$aMedal
=450  \\$aMedals
=550  \\$wg$aArt
=667  \\$aSPEC: SPEC qualif; note X ref MEDALS: do not confuse a medal as a piece of metal (usually in the form of a coin) with a medal awarded for an accomplishment ( = AWARDS AND PRIZES); coin collecting as a hobby: coord IM with HOBBIES (IM); indexing policy: TN 245
=680  \\$iStudy of coins, tokens, medals, etc. However, it usually refers to medals pertaining to the history of medicine.
=688  \\$awas in Cat I 1975-82, was in Cat E 1963-74
=750  \0$aNumismatics$5IEN$0(DLC)sh 85093255

=LDR  00468cz  a2200169n  4500
=001  9880363693802441
=005  20141212204001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009715
=035  \\$aCBA2983HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x548
=150  \\$aNudism
=450  \\$wnnna$aNudisms
=550  \\$wg$aHuman Activities
=680  \\$iThe practice of living unclothed for reasons of comfort or health.
=750  \0$aNudism$5IEN$0(DLC)sh 85093173

=LDR  01238cz  a2200277n  4500
=001  9880363693902441
=005  20150518164233.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009714
=035  \\$aCBA2982M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x487.$x775.$x500
=150  \\$aNucleus Accumbens
=450  \\$wnnna$aAccumbens Nucleus
=450  \\$wnnna$aAccumbens, Nucleus
=450  \\$wnnna$aAccumbens Septi, Nucleus
=450  \\$wnnna$aAccumbens Septus, Nucleus
=450  \\$wnnna$aNucleus, Accumbens
=450  \\$wnnna$aNucleus Accumbens Septi
=450  \\$wnnna$aNucleus Accumbens Septus
=450  \\$wnnna$aSepti, Nucleus Accumbens
=450  \\$wnnna$aSeptus, Nucleus Accumbens
=550  \\$wg$aVentral Striatum
=680  \\$iCollection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA.
=688  \\$a91(78); was see under SEPTAL NUCLEI 1978-90
=750  \0$aNucleus accumbens$0(DLC)sh 98004436$5IEN-M

=LDR  00562cz  a2200217n  4500
=001  9880363694002441
=005  20141212204000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009712
=035  \\$aCBA2980HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x695.$x462
=150  \\$aNucleotides, Cyclic
=450  \\$wnnna$aCyclic Nucleotides
=550  \\$wg$aNucleotides
=550  \\$wh$aCyclic AMP
=550  \\$wh$aCyclic CMP
=550  \\$wh$aCyclic GMP
=550  \\$wh$aCyclic IMP
=688  \\$a74
=750  \0$aCyclic nucleotides$5IEN$0(DLC)sh 85035068

=LDR  01217cz  a2200325n  4500
=001  9880363694102441
=005  20141212204000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009711
=035  \\$aCBA2979HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x620
=072  \\$aD13.$x695
=150  \\$aNucleotides
=550  \\$wg$aGlycosides
=550  \\$wg$aNucleic Acids, Nucleotides, and Nucleosides
=550  \\$wh$aArabinonucleotides
=550  \\$wh$aDeoxyribonucleotides
=550  \\$wh$aDideoxynucleotides
=550  \\$wh$aDinucleoside Phosphates
=550  \\$wh$aNucleoside Diphosphate Sugars
=550  \\$wh$aNucleotides, Cyclic
=550  \\$wh$aPolynucleotides
=550  \\$wh$aPurine Nucleotides
=550  \\$wh$aPyrimidine Nucleotides
=550  \\$wh$aRibonucleotides
=550  \\$wh$aThionucleotides
=667  \\$apyridine nucleotides are probably NAD or NADP; /anal: consider also NUCLEOTIDE MAPPING
=680  \\$iThe monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
=750  \0$aNucleotides$5IEN$0(DLC)sh 85093160

=LDR  00873cz  a2200265n  4500
=001  9880363694202441
=005  20141212203958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009705
=035  \\$aCBA2973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x595
=072  \\$aD13.$x570
=150  \\$aNucleosides
=550  \\$wg$aGlycosides
=550  \\$wg$aNucleic Acids, Nucleotides, and Nucleosides
=550  \\$wh$aArabinonucleosides
=550  \\$wh$aDeoxyribonucleosides
=550  \\$wh$aPurine Nucleosides
=550  \\$wh$aPyrimidine Nucleosides
=550  \\$wh$aRibonucleosides
=550  \\$wh$aThionucleosides
=667  \\$anucleoside phosphates = NUCLEOTIDES
=680  \\$iPurine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
=750  \0$aNucleosides$5IEN$0(DLC)sh 85093157

=LDR  01202cz  a2200337n  4500
=001  9880363694302441
=005  20141212203956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009699
=035  \\$aCBA2967HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x430
=150  \\$aN-Glycosyl Hydrolases
=450  \\$aGlycoside Hydrolases, Nitrogen-linked
=450  \\$wnnna$aGlycoside Hydrolases, Nitrogen linked
=450  \\$aHydrolases, N-Glycosyl
=450  \\$wnnna$aHydrolases, N Glycosyl
=450  \\$wnnna$aHydrolases, Nitrogen-linked Glycoside
=450  \\$wnnna$aHydrolases, Nucleoside
=450  \\$wnnna$aN Glycosyl Hydrolases
=450  \\$wnnna$aNitrogen-linked Glycoside Hydrolases
=450  \\$wnnna$aNitrogen linked Glycoside Hydrolases
=450  \\$aNucleosidases
=450  \\$wnnna$aNucleoside Hydrolases
=550  \\$wg$aGlycoside Hydrolases
=550  \\$wh$aDNA Glycosylases
=550  \\$wh$aNAD+ Nucleosidase
=550  \\$wh$aRibosome Inactivating Proteins
=680  \\$iA class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars.
=688  \\$a2003(1966)
=750  \0$aNucleosidases$5IEN$0(DLC)sh 85093156

=LDR  00809cz  a2200253n  4500
=001  9880363694402441
=005  20141212203956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009698
=035  \\$aCBA2966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x664
=150  \\$aNucleoproteins
=450  \\$wnnna$aNucleoprotein
=550  \\$wg$aProteins
=550  \\$wh$aChromatin
=550  \\$wh$aChromosomal Proteins, Non-Histone
=550  \\$wh$aDeoxyribonucleoproteins
=550  \\$wh$aHistones
=550  \\$wh$aProtamines
=550  \\$wh$aRNA-Binding Proteins
=667  \\$aproteins conjugated with nucleic acids: do not confuse with NUCLEAR PROTEINS (proteins in the cell nucleus)
=680  \\$iProteins conjugated with nucleic acids.
=750  \0$aNucleoproteins$5IEN$0(DLC)sh 85093155

=LDR  00816cz  a2200229n  4500
=001  9880363694502441
=005  20141212203955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009696
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444
=150  \\$aNucleic Acids
=450  \\$wnnna$aAcids, Nucleic
=550  \\$wg$aNucleic Acids, Nucleotides, and Nucleosides
=550  \\$wh$aDNA
=550  \\$wh$aImmobilized Nucleic Acids
=550  \\$wh$aNucleic Acid Heteroduplexes
=550  \\$wh$aNucleic Acid Probes
=550  \\$wh$aRNA
=667  \\$aGEN: prefer RNA & DNA whether Priority 1, 2 or 3 article;
=680  \\$iHigh molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages.
=750  \0$aNucleic acids$5IEN$0(DLC)sh 85093144

=LDR  01031cz  a2200289n  4500
=001  9880363694602441
=005  20141212211008.0
=008  880601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015341
=035  \\$aCBA2962HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x600
=072  \\$aD27.$x505.$x259.$x750.$x600
=072  \\$aD27.$x720.$x470.$x530.$x600
=150  \\$aNucleic Acid Probes
=450  \\$wnnna$aAcid Probes, Nucleic
=450  \\$wnnna$aProbes, Nucleic Acid
=550  \\$wg$aMolecular Probes
=550  \\$wg$aNucleic Acids
=550  \\$wh$aAntisense Elements (Genetics)
=550  \\$wh$aDNA Probes
=550  \\$wh$aOligonucleotide Probes
=550  \\$wh$aRNA Probes
=667  \\$aGEN: prefer specific DNA & RNA probes; usually no qualif
=680  \\$iNucleic acid which complements a specific mRNA or DNA molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies.
=688  \\$a89
=750  \0$aNucleic acid probes$5IEN$0(DLC)sh 89005128

=LDR  02033cz  a2200433n  4500
=001  9880363694702441
=005  20170608152845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009693
=035  \\$aCBA2960HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x393.$x661
=072  \\$aG2.$x111.$x611
=150  \\$aNucleic Acid Hybridization
=450  \\$wnnna$aAcid Hybridization, Nucleic
=450  \\$wnnna$aAcid Hybridizations, Nucleic
=450  \\$aGenomic Hybridization
=450  \\$wnnna$aGenomic Hybridizations
=450  \\$wnnna$aHybridization, Genomic
=450  \\$wnnna$aHybridization, Nucleic Acid
=450  \\$wnnna$aHybridizations, Genomic
=450  \\$wnnna$aHybridizations, Nucleic Acid
=450  \\$wnnna$aNucleic Acid Hybridizations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aGenetic Techniques
=550  \\$wh$aBase Pairing
=550  \\$wh$aBranched DNA Signal Amplification Assay
=550  \\$wh$aComparative Genomic Hybridization
=550  \\$wh$aHeteroduplex Analysis
=550  \\$wh$aIn Situ Hybridization
=550  \\$wh$aOligonucleotide Array Sequence Analysis
=550  \\$wh$aSubtractive Hybridization Techniques
=550  \\$aDNA
=550  \\$aNucleic Acid Probes
=550  \\$aOligonucleotide Probes
=667  \\$aIM general only; coord NIM with DNA or RNA or specific (IM); IN SITU HYBRIDIZATION & IN SITU HYBRIDIZATION, FLUORESCENCE are available
=680  \\$iWidely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503)
=688  \\$a72(71)
=750  \0$aNucleic acid hybridization$5IEN$0(DLC)sh 85093143

=LDR  01691cz  a2200529n  4500
=001  9880363694802441
=005  20141212203953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009690
=035  \\$aCBA2957HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x790.$x486
=072  \\$aG5.$x360.$x580
=150  \\$aNucleic Acid Conformation
=450  \\$wnnna$aConformation, DNA
=450  \\$wnnna$aConformation, Nucleic Acid
=450  \\$wnnna$aConformation, RNA
=450  \\$wnnna$aConformations, DNA
=450  \\$wnnna$aConformations, Nucleic Acid
=450  \\$wnnna$aConformations, RNA
=450  \\$wnnna$aDNA Conformation
=450  \\$wnnna$aDNA Conformations
=450  \\$wnnna$aNucleic Acid Conformations
=450  \\$wnnna$aRNA Conformation
=450  \\$wnnna$aRNA Conformations
=550  \\$wg$aGenetic Structures
=550  \\$wg$aMolecular Conformation
=550  \\$wh$aBase Pairing
=550  \\$wh$aDNA, A-Form
=550  \\$wh$aDNA, B-Form
=550  \\$wh$aDNA, C-Form
=550  \\$wh$aDNA, Circular
=550  \\$wh$aDNA, Concatenated
=550  \\$wh$aDNA, Cruciform
=550  \\$wh$aDNA, Single-Stranded
=550  \\$wh$aDNA, Z-Form
=550  \\$wh$aG-Quadruplexes
=550  \\$wh$aNucleotide Motifs
=550  \\$wh$aRNA, Double-Stranded
=550  \\$wh$aRNA Folding
=550  \\$aDNA, A-Form
=550  \\$aDNA, C-Form
=550  \\$aRNA Folding
=667  \\$acoord with DNA or RNA or specific
=680  \\$iThe spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape.
=688  \\$a72
=750  \0$aNucleic acids$xConformation$5IEN$0(IEN)369550

=LDR  00631cz  a2200217n  4500
=001  9880363694902441
=005  20160826102433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009689
=035  \\$aCBA2956HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x500.$x600
=150  \\$aNuclear Warfare
=450  \\$aAtomic Warfare
=450  \\$wnnna$aWarfare, Atomic
=450  \\$wnnna$aWarfare, Nuclear
=550  \\$wg$aWarfare
=550  \\$aRadiation
=680  \\$iWarfare involving the use of NUCLEAR WEAPONS.
=688  \\$a82; was ATOMIC WARFARE 1963-81
=750  \0$aNuclear warfare$5IEN$0(DLC)sh 85093115

=LDR  01118cz  a2200253n  4500
=001  9880363695002441
=005  20141212203952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009688
=035  \\$aCBA2955HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x710.$x600
=150  \\$aNuclear Reactors
=450  \\$wnnna$aNuclear Reactor
=450  \\$wnnna$aReactor, Nuclear
=450  \\$wnnna$aReactors, Nuclear
=550  \\$wg$aRadiation Equipment and Supplies
=550  \\$wh$aNuclear Power Plants
=550  \\$aChernobyl Nuclear Accident
=550  \\$aNuclear Energy
=667  \\$aRADIONUCLIDE GENERATORS and NUCLEAR POWER PLANTS are also available
=680  \\$iDevices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining NUCLEAR FISSION chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a68(64)
=750  \0$aNuclear reactors$5IEN$0(DLC)sh 85093071

=LDR  02813cz  a2200709n  4500
=001  9880363695102441
=005  20200716165216.0
=008  870403\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009687
=035  \\$aCBA2954HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x660
=150  \\$aNuclear Proteins
=450  \\$wnnna$aNuclear Protein
=450  \\$aNucleolar Proteins
=450  \\$wnnna$aProtein, Nuclear
=450  \\$wnnna$aProteins, Nuclear
=450  \\$wnnna$aProteins, Nucleolar
=550  \\$wg$aProteins
=550  \\$wh$aAntennapedia Homeodomain Protein
=550  \\$wh$aAntigens, Nuclear
=550  \\$wh$aBRCA1 Protein
=550  \\$wh$aBRCA2 Protein
=550  \\$wh$aCCAAT-Enhancer-Binding Proteins
=550  \\$wh$aChromosomal Proteins, Non-Histone
=550  \\$wh$aFanconi Anemia Complementation Group A Protein
=550  \\$wh$aFanconi Anemia Complementation Group D2 Protein
=550  \\$wh$aFanconi Anemia Complementation Group E Protein
=550  \\$wh$aFanconi Anemia Complementation Group F Protein
=550  \\$wh$aFanconi Anemia Complementation Group N Protein
=550  \\$wh$aHepatocyte Nuclear Factors
=550  \\$wh$aHistones
=550  \\$wh$aImmunoglobulin J Recombination Signal Sequence-Binding Protein
=550  \\$wh$aInhibitor of Growth Protein 1
=550  \\$wh$aKaryopherins
=550  \\$wh$aMad2 Proteins
=550  \\$wh$aMediator Complex
=550  \\$wh$aNF-kappa B
=550  \\$wh$aNuclear Matrix-Associated Proteins
=550  \\$wh$aNuclear Receptor Coactivators
=550  \\$wh$aOncogene Protein p55(v-myc)
=550  \\$wh$aPoly-ADP-Ribose Binding Proteins
=550  \\$wh$aProliferating Cell Nuclear Antigen
=550  \\$wh$aPromyelocytic Leukemia Protein
=550  \\$wh$aProtamines
=550  \\$wh$aProto-Oncogene Proteins c-fos
=550  \\$wh$aProto-Oncogene Proteins c-jun
=550  \\$wh$aProto-Oncogene Proteins c-mdm2
=550  \\$wh$aProto-Oncogene Proteins c-myc
=550  \\$wh$aProto-Oncogene Proteins c-rel
=550  \\$wh$aran GTP-Binding Protein
=550  \\$wh$aRetinoblastoma Binding Proteins
=550  \\$wh$aRetinoblastoma-Like Protein p107
=550  \\$wh$aRetinoblastoma-Like Protein p130
=550  \\$wh$aRetinoblastoma Protein
=550  \\$wh$aSilent Information Regulator Proteins, Saccharomyces cerevisiae
=550  \\$wh$aThyroid Nuclear Factor
=550  \\$wh$aTumor Protein p73
=667  \\$aproteins in the cell nucleus: do not confuse with NUCLEOPROTEINS (proteins conjugated with nucleic acids)
=680  \\$iProteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
=688  \\$a88
=750  \0$aNuclear proteins$0(DLC)sh2008009187$5IEN-M

=LDR  00806cz  a2200217n  4500
=001  9880363695202441
=005  20141212203951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009686
=035  \\$aCBA2953HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x579
=150  \\$aNuclear Physics
=450  \\$wnnna$aNuclear Physic
=450  \\$wnnna$aPhysic, Nuclear
=450  \\$wnnna$aPhysics, Nuclear
=550  \\$wg$aPhysics
=550  \\$wh$aQuantum Theory
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the characteristics, behavior, and internal structures of the atomic nucleus and its interactions with other nuclei. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aNuclear physics$5IEN$0(DLC)sh 85093024

=LDR  01317cz  a2200361n  4500
=001  9880363695302441
=005  20141212203950.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009685
=035  \\$aCBA2952HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x630
=072  \\$aA11.$x284.$x149.$x450.$x700
=072  \\$aA11.$x284.$x430.$x106.$x279.$x692
=072  \\$aA11.$x284.$x835.$x514.$x700
=150  \\$aNuclear Envelope
=450  \\$wnnna$aEnvelope, Nuclear
=450  \\$wnnna$aEnvelopes, Nuclear
=450  \\$wnnna$aMembrane, Nuclear
=450  \\$wnnna$aMembranes, Nuclear
=450  \\$wnnna$aNuclear Envelopes
=450  \\$aNuclear Membrane
=450  \\$wnnna$aNuclear Membranes
=550  \\$wg$aCell Membrane Structures
=550  \\$wg$aCell Nucleus Structures
=550  \\$wg$aIntracellular Membranes
=550  \\$wh$aNuclear Lamina
=550  \\$wh$aNuclear Pore
=550  \\$aCell Membrane
=550  \\$aMembranes
=680  \\$iThe membrane system of the CELL NUCLEUS that surrounds the nucleoplasm. It consists of two concentric membranes separated by the perinuclear space. The structures of the envelope where it opens to the cytoplasm are called the nuclear pores (NUCLEAR PORE).
=688  \\$a2001
=750  \0$aNuclear membranes$5IEN$0(DLC)sh 85093016

=LDR  00825cz  a2200253n  4500
=001  9880363695402441
=005  20141212203950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009683
=035  \\$aCBA2950HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x740.$x500
=150  \\$aNuclear Medicine
=450  \\$aAtomic Medicine
=450  \\$wnnna$aMedicine, Atomic
=450  \\$wnnna$aMedicine, Nuclear
=450  \\$aNuclear Radiology
=450  \\$wnnna$aRadiology, Nuclear
=550  \\$wg$aRadiology
=550  \\$aRadiobiology
=667  \\$aSPEC: SPEC qualif; DF: NUCLEAR MED
=680  \\$iA specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.
=688  \\$a67
=750  \0$aNuclear medicine$5IEN$0(DLC)sh 85093011

=LDR  02113cz  a2200457n  4500
=001  9880363695502441
=005  20141212203949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009682
=035  \\$aCBA2949HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x519
=150  \\$aMagnetic Resonance Spectroscopy
=450  \\$aIn Vivo NMR Spectroscopy
=450  \\$aMagnetic Resonance
=450  \\$wnnna$aMagnetic Resonance, Nuclear
=450  \\$wnnna$aMagnetic Resonance Spectroscopies
=450  \\$aMR Spectroscopy
=450  \\$wnnna$aNMR Spectroscopies
=450  \\$aNMR Spectroscopy
=450  \\$aNMR Spectroscopy, In Vivo
=450  \\$aNuclear Magnetic Resonance
=450  \\$wnnna$aResonance, Magnetic
=450  \\$wnnna$aResonance, Nuclear Magnetic
=450  \\$wnnna$aResonance Spectroscopy, Magnetic
=450  \\$wnnna$aSpectroscopies, NMR
=450  \\$aSpectroscopy, Magnetic Resonance
=450  \\$wnnna$aSpectroscopy, MR
=450  \\$aSpectroscopy, NMR
=450  \\$aSpectroscopy, Nuclear Magnetic Resonance
=550  \\$wg$aSpectrum Analysis
=550  \\$wh$aCarbon-13 Magnetic Resonance Spectroscopy
=550  \\$wh$aElectron Spin Resonance Spectroscopy
=550  \\$wh$aNuclear Magnetic Resonance, Biomolecular
=550  \\$wh$aProton Magnetic Resonance Spectroscopy
=550  \\$aMagnetic Resonance Imaging
=667  \\$aindex under element or isotope used in performing the NMR spectroscopy only if discussed (probably NIM); do not confuse with MAGNETIC RESONANCE IMAGING: check text; coordinate with disease, organ or tissue using pertinent qualifiers; for diagnostic use coordinate with disease / diag (not / radiogr nor /radionuclide); DF: NMR
=680  \\$iSpectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
=688  \\$a66(65)
=750  \0$aNuclear magnetic resonance$5IEN-M$0(DLC)sh 85093005
=750  \0$aNuclear magnetic resonance spectroscopy$5IEN-M$0(DLC)sh 85093008

=LDR  00928cz  a2200229n  4500
=001  9880363695602441
=005  20141212203949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009681
=035  \\$aCBA2948HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x630.$x652
=072  \\$aN6.$x230.$x132.$x580.$x520
=150  \\$aNuclear Fusion
=450  \\$wnnna$aFusion, Nuclear
=450  \\$wnnna$aFusions, Nuclear
=450  \\$wnnna$aNuclear Fusions
=550  \\$wg$aNuclear Energy
=667  \\$ano qualif; do not confuse with NUCLEAR FISSION
=680  \\$iThermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom.
=688  \\$a91(71); was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was Prov 1971-74; was in Cat H only 1971-81
=750  \0$aNuclear fusion$5IEN$0(DLC)sh 85092995

=LDR  00842cz  a2200229n  4500
=001  9880363695702441
=005  20141212203949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009680
=035  \\$aCBA2947HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x630.$x485
=072  \\$aN6.$x230.$x132.$x580.$x500
=150  \\$aNuclear Fission
=450  \\$wnnna$aFission, Nuclear
=450  \\$wnnna$aFissions, Nuclear
=450  \\$wnnna$aNuclear Fissions
=550  \\$wg$aNuclear Energy
=667  \\$ano qualif; do not confuse with NUCLEAR FUSION
=680  \\$iNuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon.
=688  \\$a74(71); was in Cat H only 1971-81
=750  \0$aNuclear fission$5IEN$0(DLC)sh 85092983

=LDR  00862cz  a2200277n  4500
=001  9880363695802441
=005  20141212203948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009678
=035  \\$aCBA2945HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x630
=072  \\$aN6.$x230.$x132.$x580
=150  \\$aNuclear Energy
=450  \\$aAtomic Energy
=450  \\$wnnna$aEnergy, Atomic
=450  \\$wnnna$aEnergy, Nuclear
=550  \\$wg$aEnergy-Generating Resources
=550  \\$wg$aPhysical Processes
=550  \\$wh$aNuclear Fission
=550  \\$wh$aNuclear Fusion
=550  \\$aNuclear Reactors
=667  \\$aNUCLEAR POWER PLANTS is also available
=680  \\$iEnergy released by nuclear fission or nuclear fusion.
=688  \\$a82; was ATOMIC ENERGY (Cat H heading only) 1963-81
=750  \0$aNuclear energy$5IEN$0(DLC)sh 85092958

=LDR  01266cz  a2200301n  4500
=001  9880363695902441
=005  20141212203947.0
=008  800512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009673
=035  \\$aCBA2940HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x700.$x500.$x480
=150  \\$aNotophthalmus viridescens
=450  \\$aDiemictylus viridescens
=450  \\$aNewt, Red-Spotted
=450  \\$wnnna$aNewt, Red Spotted
=450  \\$wnnna$aNewts, Red-Spotted
=450  \\$wnnna$aRed-Spotted Newt
=450  \\$wnnna$aRed-Spotted Newts
=450  \\$aTriturus viridescens
=450  \\$wnnna$aviridescens, Diemictylus
=450  \\$wnnna$aviridescens, Notophthalmus
=450  \\$wnnna$aviridescens, Triturus
=550  \\$wg$aNotophthalmus
=667  \\$aa species of newt; NIM as exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of newt in the Salamandridae family in which the larvae transform into terrestrial eft stage and later into an aquatic adult. They occur from Canada to southern United States. Viridescens refers to the greenish color often found in this species.
=688  \\$a91(81); was see under SALAMANDRIDAE 1981-90
=750  \0$aNotophthalmus viridescens$5IEN$0(DLC)sh 85092817

=LDR  00932cz  a2200205n  4500
=001  9880363696002441
=005  20141212203946.0
=008  771205\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009672
=035  \\$aCBA2939HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x660
=150  \\$aNotochord
=450  \\$wnnna$aChordamesoderm
=450  \\$wnnna$aChordamesoderms
=450  \\$wnnna$aNotochords
=550  \\$wg$aEmbryonic Structures
=680  \\$iA cartilaginous rod of mesodermal cells at the dorsal midline of all CHORDATE embryos. In lower vertebrates, notochord is the backbone of support. In the higher vertebrates, notochord is a transient structure, and segments of the vertebral column will develop around it. Notochord is also a source of midline signals that pattern surrounding tissues including the NEURAL TUBE development.
=688  \\$a91(79); was see under EMBRYO 1979-90
=750  \0$aNotochord$5IEN$0(DLC)sh 85092813

=LDR  01202cz  a2200265n  4500
=001  9880363696102441
=005  20141212203946.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009670
=035  \\$aCBA2937HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x360.$x500.$x500.$x100.$x175.$x175
=150  \\$aEncephalitozoon cuniculi
=450  \\$wnnna$acuniculi, Encephalitozoon
=450  \\$wnnna$acuniculi, Nosema
=450  \\$wnnna$acuniculus, Encephalitozoon
=450  \\$wnnna$acuniculus, Nosema
=450  \\$wnnna$aEncephalitozoon cuniculus
=450  \\$aNosema cuniculi
=450  \\$wnnna$aNosema cuniculus
=550  \\$wg$aEncephalitozoon
=667  \\$ainfection: coordinate IM with ENCEPHALITOZOONOSIS (IM); coordinate with specific fungal terms (ANTIGENS, FUNGAL, etc) if pertinent
=680  \\$iA species of parasitic FUNGI. This intracellular parasite is found in the BRAIN; HEART; and KIDNEYS of several MAMMALS. Transmission is probably by ingestion of the spores (SPORES, FUNGAL).
=688  \\$a92; was NOSEMA CUNICULI 1982-91 (see under SPOROZOA 1982-90); ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91
=750  \0$aNosema cuniculi$5IEN-M$0(DLC)sh 88021386

=LDR  01602cz  a2200505n  4500
=001  9880363696202441
=005  20141212203945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009669
=035  \\$aCBA2936HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x149.$x721.$x600
=072  \\$aC4.$x588.$x443.$x665.$x650
=072  \\$aC5.$x116.$x231.$x754.$x600
=072  \\$aC8.$x460.$x669
=072  \\$aC8.$x785.$x600
=072  \\$aC9.$x603.$x669
=072  \\$aC9.$x647.$x685
=150  \\$aNose Neoplasms
=450  \\$wnnna$aCancer, Nasal
=450  \\$wnnna$aCancer, Nose
=450  \\$aCancer of Nose
=450  \\$wnnna$aCancer of the Nose
=450  \\$wnnna$aCancers, Nasal
=450  \\$wnnna$aCancers, Nose
=450  \\$wnnna$aNasal Cancer
=450  \\$wnnna$aNasal Cancers
=450  \\$wnnna$aNasal Neoplasm
=450  \\$aNasal Neoplasms
=450  \\$wnnna$aNeoplasm, Nasal
=450  \\$wnnna$aNeoplasm, Nose
=450  \\$wnnna$aNeoplasms, Nasal
=450  \\$wnnna$aNeoplasms, Nose
=450  \\$aNose Cancer
=450  \\$wnnna$aNose Cancers
=450  \\$wnnna$aNose Neoplasm
=550  \\$wg$aNose Diseases
=550  \\$wg$aOtorhinolaryngologic Neoplasms
=550  \\$wg$aRespiratory Tract Neoplasms
=550  \\$wg$aSkull Neoplasms
=550  \\$wh$aParanasal Sinus Neoplasms
=667  \\$asoft or bony tissue; coordinate IM with specific site in nose (IM) + histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the NOSE.
=750  \0$aNose$xCancer$5IEN-M$0(DLC)sh2010009866
=750  \0$aNose$xTumors$5IEN-HS$0(DLC)sh 85092759

=LDR  01439cz  a2200481n  4500
=001  9880363696302441
=005  20141212203945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009668
=035  \\$aCBA2935HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x460
=072  \\$aC9.$x603
=150  \\$aNose Diseases
=450  \\$wnnna$aDisease, Nasal
=450  \\$wnnna$aDisease, Nose
=450  \\$wnnna$aDiseases, Nasal
=450  \\$wnnna$aDiseases, Nose
=450  \\$wnnna$aDisorder, Nasal
=450  \\$wnnna$aDisorders, Nasal
=450  \\$wnnna$aNasal Disease
=450  \\$aNasal Diseases
=450  \\$wnnna$aNasal Disorder
=450  \\$wnnna$aNasal Disorders
=450  \\$wnnna$aNose Disease
=550  \\$wg$aOtorhinolaryngologic Diseases
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aChoanal Atresia
=550  \\$wh$aEpistaxis
=550  \\$wh$aGranuloma, Lethal Midline
=550  \\$wh$aNasal Obstruction
=550  \\$wh$aNasal Polyps
=550  \\$wh$aNasal Septal Perforation
=550  \\$wh$aNose Deformities, Acquired
=550  \\$wh$aNose Neoplasms
=550  \\$wh$aParanasal Sinus Diseases
=550  \\$wh$aRhinitis
=550  \\$wh$aRhinoscleroma
=550  \\$aOtorhinolaryngologic Diseases
=667  \\$ainflammatory disease = RHINITIS
=680  \\$iDisorders of the nose, general or unspecified.
=688  \\$a66
=750  \0$aNose$xDiseases$5IEN$0(DLC)sh 85092750

=LDR  01437cz  a2200409n  4500
=001  9880363696402441
=005  20141212203944.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009666
=035  \\$aCBA2933HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x733
=072  \\$aA4.$x531
=072  \\$aA9.$x531
=150  \\$aNose
=360  \\$iconsider also terms at$aNAS-$aRHIN-
=450  \\$wnnna$aExternal Nose
=450  \\$wnnna$aExternal Noses
=450  \\$wnnna$aNose, External
=450  \\$wnnna$aNoses
=450  \\$wnnna$aNoses, External
=550  \\$wg$aFace
=550  \\$wg$aRespiratory System
=550  \\$wg$aSense Organs
=550  \\$wh$aNasal Bone
=550  \\$wh$aNasal Cartilages
=550  \\$wh$aNasal Cavity
=550  \\$wh$aNasal Mucosa
=550  \\$wh$aNasal Septum
=550  \\$wh$aOlfactory Mucosa
=550  \\$wh$aParanasal Sinuses
=550  \\$wh$aTurbinates
=550  \\$wh$aVomeronasal Organ
=550  \\$aRhinoplasty
=667  \\$anose unspecified, but note specific nasal terms are available; / abnorm permitted for congenital deformities but acquired deformities = NOSE DEFORMITIES, ACQUIRED; / surg = probably NASAL SURGICAL PROCEDURES or RHINOPLASTY
=680  \\$iA part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES.
=750  \0$aNose$5IEN$0(DLC)sh 85092748

=LDR  01246cz  a2200337n  4500
=001  9880363696502441
=005  20141212203939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009644
=035  \\$aCBA2910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x668.$x651.$x693.$x762
=150  \\$aNorgestrel
=450  \\$wnnna$aDL-Norgestrel
=450  \\$wnnna$aDL Norgestrel
=450  \\$wnnna$aNeogest
=450  \\$wnnna$aNorgestrel Schering Brand
=450  \\$wnnna$aNorgestrel Wyeth Brand
=450  \\$wnnna$aOvrette
=450  \\$wnnna$aPostinor
=450  \\$wnnna$aSchering Brand of Norgestrel
=450  \\$wnnna$aWy-3707
=450  \\$wnnna$aWy 3707
=450  \\$wnnna$aWy3707
=450  \\$wnnna$aWyeth Brand of Norgestrel
=550  \\$wg$aNorpregnenes
=550  \\$wh$aEthinyl Estradiol-Norgestrel Combination
=550  \\$wh$aLevonorgestrel
=680  \\$iA synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.
=688  \\$a72
=750  \0$aNorgestrel$5IEN$0(DLC)sh 85092414

=LDR  01059cz  a2200337n  4500
=001  9880363696602441
=005  20141212203938.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009643
=035  \\$aCBA2909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x835.$x322.$x374
=150  \\$aNorfloxacin
=450  \\$wnnna$aAM-0715
=450  \\$wnnna$aAM 0715
=450  \\$wnnna$aAM-715
=450  \\$wnnna$aAM 715
=450  \\$wnnna$aAM0715
=450  \\$wnnna$aMerck Brand of Norfloxacin
=450  \\$wnnna$aMK-0366
=450  \\$wnnna$aMK 0366
=450  \\$wnnna$aMK-366
=450  \\$wnnna$aMK 366
=450  \\$wnnna$aMK0366
=450  \\$wnnna$aMK366
=450  \\$wnnna$aNorfloxacin Merck Brand
=450  \\$wnnna$aNoroxin
=550  \\$wg$aFluoroquinolones
=680  \\$iA synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
=688  \\$a86
=750  \0$aNorfloxacin$5IEN$0(DLC)sh 85092409

=LDR  01141cz  a2200313n  4500
=001  9880363696702441
=005  20141212203938.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009640
=035  \\$aCBA2906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x668.$x651.$x693.$x651
=150  \\$aNorethindrone
=450  \\$wnnna$aConceplan
=450  \\$aEthinylnortestosterone
=450  \\$wnnna$aMicronor
=450  \\$wnnna$aMonogest
=450  \\$wnnna$aNor-QD
=450  \\$wnnna$aNor QD
=450  \\$wnnna$aNorcolut
=450  \\$wnnna$aNorcolute
=450  \\$wnnna$aNorethindrone, (1 beta)-Isomer
=450  \\$aNorethisterone
=450  \\$wnnna$aNorlutin
=450  \\$aNorpregneninolone
=450  \\$wnnna$aNorQD
=550  \\$wg$aNorpregnenes
=680  \\$iA synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
=750  \0$aNorethindrone$5IEN$0(DLC)sh 85092408

=LDR  02830cz  a2200661n  4500
=001  9880363696802441
=005  20141212192359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009638
=035  \\$aCBA2904HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x502
=072  \\$aD2.$x92.$x63.$x480
=072  \\$aD2.$x92.$x211.$x215.$x311.$x560
=072  \\$aD2.$x92.$x311.$x461.$x484
=150  \\$aNorepinephrine
=450  \\$wnnna$aAbbott Brand of Levophed Bitartrate
=450  \\$wnnna$aArterenol
=450  \\$wnnna$aAventis Brand of Norepinephrine Hydrochloride
=450  \\$wnnna$aBitartrate, Levophed
=450  \\$wnnna$aBitartrate, Noradrenaline
=450  \\$wnnna$aBitartrate, Norepinephrine
=450  \\$wnnna$aHydrochloride, Norepinephrine
=450  \\$aLevarterenol
=450  \\$wnnna$aLevonor
=450  \\$aLevonorepinephrine
=450  \\$wnnna$aLevophed
=450  \\$wnnna$aLevophed Bitartrate
=450  \\$wnnna$aNoradrénaline tartrate renaudin
=450  \\$aNoradrenaline
=450  \\$wnnna$aNoradrenaline Bitartrate
=450  \\$wnnna$aNorepinephrin d-Tartrate (1:1)
=450  \\$wnnna$aNorepinephrine, (+)-Isomer
=450  \\$wnnna$aNorepinephrine, (+,-)-Isomer
=450  \\$wnnna$aNorepinephrine Bitartrate
=450  \\$wnnna$aNorepinephrine d-Tartrate (1:1)
=450  \\$wnnna$aNorepinephrine Hydrochloride
=450  \\$wnnna$aNorepinephrine Hydrochloride, (+)-Isomer
=450  \\$wnnna$aNorepinephrine Hydrochloride, (+,-)-Isomer
=450  \\$wnnna$aNorepinephrine l-Tartrate, (+)-Isomer
=450  \\$wnnna$aNorepinephrine l-Tartrate (1:1)
=450  \\$wnnna$aNorepinephrine l-Tartrate (1:1), (+,-)-Isomer
=450  \\$wnnna$aNorepinephrine l-Tartrate (1:1), Monohydrate
=450  \\$wnnna$aNorepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer
=450  \\$wnnna$aNorepinephrine l-Tartrate (1:2)
=450  \\$wnnna$aRenaudin Brand of Norepinephrine Bitartrate
=450  \\$wnnna$arenaudin, Noradrénaline tartrate
=450  \\$wnnna$atartrate renaudin, Noradrénaline
=550  \\$wg$aAmino Alcohols
=550  \\$wg$aCatecholamines
=550  \\$wg$aEpinephrine
=550  \\$wg$aEthanolamines
=550  \\$wh$aDroxidopa
=550  \\$wh$aNordefrin
=550  \\$wh$aNormetanephrine
=680  \\$iPrecursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
=688  \\$aARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65
=750  \0$aNoradrenaline$5IEN$0(DLC)sh 85092392

=LDR  01045cz  a2200301n  4500
=001  9880363696902441
=005  20141212203935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009633
=035  \\$aCBA2899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209.$x530
=072  \\$aL1.$x143.$x649
=150  \\$aNonverbal Communication
=450  \\$wnnna$aCommunication, Nonverbal
=450  \\$wnnna$aCommunications, Nonverbal
=450  \\$wnnna$aNonverbal Communications
=550  \\$wg$aCommunication
=550  \\$wh$aBlushing
=550  \\$wh$aCrying
=550  \\$wh$aFacial Expression
=550  \\$wh$aKinesics
=550  \\$wh$aLaughter
=550  \\$wh$aManual Communication
=667  \\$ahuman only; for animals use ANIMAL COMMUNICATION or VOCALIZATION, ANIMAL; consider also MANUAL COMMUNICATION & SIGN LANGUAGE
=680  \\$iTransmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language.
=688  \\$a71(70)
=750  \0$aNonverbal communication$5IEN$0(DLC)sh 85092368

=LDR  01054cz  a2200241n  4500
=001  9880363697002441
=005  20141212203934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009631
=035  \\$aCBA2897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x89.$x530.$x660
=072  \\$aC5.$x500.$x470.$x660
=072  \\$aC7.$x320.$x450.$x640
=150  \\$aNonodontogenic Cysts
=450  \\$wnnna$aCyst, Nonodontogenic
=450  \\$wnnna$aCysts, Nonodontogenic
=450  \\$wnnna$aNonodontogenic Cyst
=550  \\$wg$aJaw Cysts
=667  \\$anon-neoplastic; of jaw; /blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/dis term (IM)
=680  \\$iCysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.
=688  \\$a65
=750  \0$aJaws$xCysts$5IEN$0(DLC)sh 85069810

=LDR  01141cz  a2200277n  4500
=001  9880363697202441
=005  20141212203933.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009627
=035  \\$aCBA2893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x531.$x535
=150  \\$aNomifensine
=450  \\$wnnna$aHoe-984
=450  \\$wnnna$aHoe 984
=450  \\$wnnna$aHoe984
=450  \\$wnnna$aLinamiphen
=450  \\$wnnna$aMaleate, Nomifensine
=450  \\$wnnna$aMerital
=450  \\$wnnna$aNomifensin
=450  \\$wnnna$aNomifensine Maleate
=450  \\$wnnna$aNomifensine Maleate (1:1)
=550  \\$wg$aIsoquinolines
=680  \\$iAn isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
=688  \\$a86(78); was see under ISOQUINOLINES 1978-85
=750  \0$aNomifensine$5IEN$0(DLC)sh 85092209

=LDR  01238cz  a2200301n  4500
=001  9880363697302441
=005  20190102103258.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009626
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x598.$x400
=150  \\$aTerminology as Topic
=450  \\$wnnna$aEtymologies
=450  \\$aEtymology
=450  \\$aNomenclature as Topic
=550  \\$wg$aLinguistics
=550  \\$wh$aNames
=550  \\$wh$aRxNorm
=550  \\$wh$aStandardized Nursing Terminology
=550  \\$aDictionaries as Topic
=550  \\$aUnified Medical Language System
=667  \\$a"medical nomenclature": do not coordinate with MEDICINE; do not confuse with the Publication Type TERMINOLOGY
=680  \\$iThe terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.
=688  \\$a2008(1966)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Terminology
=688  \\$a99(66)
=750  \0$81$wb$aTerminology$0(DLC) sh 85134029$5IEN-M$0(DLC)sh 85134029
=788  \0$iSearch for subdivision$aTerminology$iunder topical headings for works that list or discuss words and expressions found in those works or used in those fields$5IEN-M

=LDR  00851cz  a2200229n  4500
=001  9880363697402441
=005  20141212203932.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009624
=035  \\$aCBA2890HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x400.$x550
=072  \\$aN6.$x850.$x460.$x610.$x680
=150  \\$aNoise, Transportation
=450  \\$wnnna$aNoises, Transportation
=450  \\$wnnna$aTransportation Noise
=450  \\$wnnna$aTransportation Noises
=550  \\$wg$aNoise
=667  \\$acoord IM with specific mode of transport (AIRCRAFT; AUTOMOBILES; RAILROADS; etc.) (IM); consider also HEARING LOSS, NOISE-INDUCED
=680  \\$iNoise associated with transportation, particularly aircraft and automobiles.
=688  \\$a91(79); was see under NOISE 1979-90
=750  \0$aTransportation noise$5IEN$0(DLC)sh 85137079

=LDR  01129cz  a2200313n  4500
=001  9880363697502441
=005  20141212203932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009622
=035  \\$aCBA2888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x750.$x770.$x776.$x567
=072  \\$aG16.$x500.$x275.$x600
=072  \\$aN6.$x230.$x400
=072  \\$aN6.$x850.$x460.$x610
=150  \\$aNoise
=450  \\$wnnna$aNoise Pollution
=450  \\$wnnna$aNoises
=450  \\$wnnna$aPollution, Noise
=550  \\$wg$aEnvironment
=550  \\$wg$aEnvironmental Pollution
=550  \\$wg$aSound
=550  \\$wh$aNoise, Occupational
=550  \\$wh$aNoise, Transportation
=550  \\$aSound
=667  \\$arestrict to noise as a type of sound: do not use for "noise" as artifacts or interference with data in various techniques or electrical interference ( = ELECTRICITY); /adv eff: consider also HEARING LOSS, NOISE-INDUCED/
=680  \\$iAny sound which is unwanted or interferes with HEARING other sounds.
=750  \0$aNoise pollution$5IEN-M$0(DLC)sh 85092188
=750  \0$aNoise$5IEN-HS$0(DLC)sh 85092179

=LDR  01186cz  a2200301n  4500
=001  9880363697602441
=005  20141212192358.0
=008  770411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009619
=035  \\$aCBA2885HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x875
=072  \\$aA8.$x800.$x950.$x875
=072  \\$aA11.$x671.$x650.$x915.$x875
=150  \\$aNociceptors
=450  \\$wnnna$aNeuron, Nociceptive
=450  \\$wnnna$aNeurons, Nociceptive
=450  \\$wnnna$aNociceptive Neuron
=450  \\$wnnna$aNociceptive Neurons
=450  \\$wnnna$aNociceptor
=450  \\$wnnna$aPain Receptor
=450  \\$aPain Receptors
=450  \\$aReceptors, Pain
=550  \\$wg$aSensory Receptor Cells
=667  \\$aDF: NOCICEPT
=680  \\$iPeripheral AFFERENT NEURONS which are sensitive to injuries or pain, usually caused by extreme thermal exposures, mechanical forces, or other noxious stimuli. Their cell bodies reside in the DORSAL ROOT GANGLIA. Their peripheral terminals (NERVE ENDINGS) innervate target tissues and transduce noxious stimuli via axons to the CENTRAL NERVOUS SYSTEM.
=688  \\$a78
=750  \0$aNociceptors$0(DLC) sh 85092154$5IEN

=LDR  00634cz  a2200193n  4500
=001  9880363697702441
=005  20141212203931.0
=008  750718\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009618
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x537
=150  \\$aNocardiaceae
=550  \\$wg$aActinomycetales
=550  \\$wh$aNocardia
=550  \\$wh$aRhodococcus
=667  \\$ain soil, animals & man
=680  \\$iA family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.
=688  \\$a76
=750  \0$aNocardiaceae$0(DLC)sh2005002566$5IEN-M

=LDR  00730cz  a2200193n  4500
=001  9880363697802441
=005  20141212203930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009615
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x537.$x550
=150  \\$aNocardia
=450  \\$aMicropolyspora
=550  \\$wg$aNocardiaceae
=550  \\$wh$aNocardia asteroides
=667  \\$ainfection = NOCARDIA INFECTIONS
=680  \\$iA genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals.
=688  \\$a1963; for MICROPOLYSPORA use MICROMONOSPORACEAE 1993-2009
=750  \0$aNocardia$5IEN$0(DLC)sh 85092151

=LDR  00774cz  a2200229n  4500
=001  9880363697902441
=005  20141212203930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009614
=035  \\$aCBA2880M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x575
=072  \\$aD1.$x268.$x271.$x100.$x575
=072  \\$aD1.$x268.$x556.$x620
=072  \\$aD1.$x552.$x20.$x659
=072  \\$aD1.$x552.$x544.$x620
=150  \\$aNobelium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$aman-made radioactive element; IM
=680  \\$iNobelium. A man-made radioactive element of the actinide metal series. It has the atomic symbol No, atomic number 102, and atomic weight 259.
=750  \0$aNobelium$0(DLC)sh2012003649$5IEN-M

=LDR  00510cz  a2200169n  4500
=001  9880363698002441
=005  20141212203929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009613
=035  \\$aCBA2879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x150.$x567
=150  \\$aNobel Prize
=450  \\$wnnna$aPrize, Nobel
=550  \\$wg$aAwards and Prizes
=667  \\$aaward for medicine: coordinate with specific field or specialty but not with MEDICINE
=750  \0$aNobel prizes$5IEN$0(DLC)sh 85092136

=LDR  00957cz  a2200241n  4500
=001  9880363698102441
=005  20141212203928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009609
=035  \\$aCBA2875HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x635.$x625
=072  \\$aD1.$x625.$x550.$x550
=072  \\$aD1.$x650.$x550.$x587.$x650
=150  \\$aNitrous Oxide
=450  \\$wnnna$aGas, Laughing
=450  \\$wnnna$aLaughing Gas
=450  \\$wnnna$aNitrogen Protoxide
=450  \\$wnnna$aOxide, Nitrous
=550  \\$wg$aNitrogen Oxides
=680  \\$iNitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
=688  \\$a1963; for NITROGEN PROTOXIDE use NITRIC OXIDE 1982-2008
=750  \0$aNitrous oxide$5IEN$0(DLC)sh 85092097

=LDR  00817cz  a2200241n  4500
=001  9880363698202441
=005  20141212203928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009608
=035  \\$aCBA2874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x575
=072  \\$aD1.$x625.$x600
=150  \\$aNitrous Acid
=450  \\$wnnna$aAcid, Nitrous
=550  \\$wg$aAcids, Noncarboxylic
=550  \\$wg$aNitrogen Compounds
=550  \\$wh$aNitrites
=550  \\$wh$aPeroxynitrous Acid
=667  \\$ado not confuse with NITRIC ACID
=680  \\$iNitrous acid (HNO2). A weak acid that exists only in solution. It can form water-soluble nitrites and stable esters. (From Merck Index, 11th ed)
=688  \\$a91(75); was see under NITRITES 1975-90
=750  \0$aNitrous acid$5IEN$0(DLC)sh 85092096

=LDR  00736cz  a2200277n  4500
=001  9880363698302441
=005  20141212203928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009607
=035  \\$aCBA2873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x654.$x692
=072  \\$aD2.$x948.$x594
=150  \\$aNitrosourea Compounds
=450  \\$wnnna$aCompounds, Nitrosourea
=550  \\$wg$aNitroso Compounds
=550  \\$wg$aUrea
=550  \\$wh$aCarmustine
=550  \\$wh$aEthylnitrosourea
=550  \\$wh$aLomustine
=550  \\$wh$aMethylnitrosourea
=550  \\$wh$aNimustine
=550  \\$wh$aStreptozocin
=667  \\$aDF: NITROSOUREA CPDS
=688  \\$a73(71)
=750  \0$aNitrosoureas$5IEN$0(DLC)sh 85092094

=LDR  00648cz  a2200229n  4500
=001  9880363698402441
=005  20141212203927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009603
=035  \\$aCBA2869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x654
=150  \\$aNitroso Compounds
=450  \\$wnnna$aCompounds, Nitroso
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aNitrosamines
=550  \\$wh$aNitrosoguanidines
=550  \\$wh$aNitrosomethylurethane
=550  \\$wh$aNitrosourea Compounds
=550  \\$wh$aReactive Nitrogen Species
=667  \\$aDF: NITROSO CPDS
=750  \0$aNitroso compounds$5IEN$0(DLC)sh 85092091

=LDR  00750cz  a2200229n  4500
=001  9880363698502441
=005  20141212203927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009602
=035  \\$aCBA2868HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x654.$x442
=150  \\$aNitrosamines
=450  \\$aNitrosoamines$5IEN
=550  \\$wg$aNitroso Compounds
=550  \\$wh$aButylhydroxybutylnitrosamine
=550  \\$wh$aDiethylnitrosamine
=550  \\$wh$aDimethylnitrosamine
=550  \\$wh$aN-Nitrosopyrrolidine
=667  \\$acarcinogens
=680  \\$iA class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.
=750  \0$aNitrosoamines$5IEN$0(DLC)sh 85092093

=LDR  01725cz  a2200457n  4500
=001  9880363698602441
=005  20141212203926.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009599
=035  \\$aCBA2865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x291.$x350.$x550
=072  \\$aD1.$x490.$x100.$x300.$x550
=072  \\$aD1.$x625.$x400.$x100.$x325.$x550
=150  \\$aNitroprusside
=450  \\$wnnna$aAbbott Brand of Sodium Nitroprusside
=450  \\$wnnna$aBayer Brand of Sodium Nitroprusside
=450  \\$wnnna$aCyanonitrosylferrate
=450  \\$wnnna$aDisodium Salt Nitroprusside
=450  \\$wnnna$aFaulding Brand of Sodium Nitroprusside
=450  \\$wnnna$aFides Ecopharma Brand of Sodium Nitroprusside
=450  \\$wnnna$aKetostix
=450  \\$wnnna$aNaniprus
=450  \\$wnnna$aNipride
=450  \\$wnnna$aNipruton
=450  \\$wnnna$aNitriate
=450  \\$aNitroferricyanide
=450  \\$wnnna$aNitropress
=450  \\$wnnna$aNitroprussiat Fides
=450  \\$wnnna$aNitroprusside, Disodium Salt
=450  \\$wnnna$aNitroprusside, Disodium Salt, Dihydrate
=450  \\$wnnna$aNitroprusside, Sodium
=450  \\$wnnna$aRoche Brand of Sodium Nitroprusside
=450  \\$wnnna$aSERB Brand of Sodium Nitroprusside
=450  \\$aSodium Nitroferricyanide$5IEN
=450  \\$aSodium Nitroprusside
=550  \\$wg$aFerricyanides
=667  \\$aD25-26 qualif
=680  \\$iA powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.
=688  \\$a91(75); was see under FERRICYANIDES 1975-90
=750  \0$aSodium nitroferricyanide$5IEN$0(DLC)sh 85124268

=LDR  00707cz  a2200253n  4500
=001  9880363698702441
=005  20210217133955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009596
=035  \\$aCBA2862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x566
=072  \\$aD2.$x640.$x743
=150  \\$aNitrophenols
=550  \\$wg$aNitro Compounds
=550  \\$wg$aPhenols
=550  \\$wh$a2-Hydroxy-5-nitrobenzyl Bromide
=550  \\$wh$aDinitrophenols
=550  \\$wh$aNiclofolan
=550  \\$wh$aNitrohydroxyiodophenylacetate
=550  \\$wh$aNitroxinil
=550  \\$wh$aPicrates
=550  \\$wh$aTolcapone
=750  \0$aNitrophenols$5IEN-M$0(DLC)sh 93006725

=LDR  00535cz  a2200193n  4500
=001  9880363698802441
=005  20141212203924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009595
=035  \\$aCBA2861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x672
=072  \\$aD2.$x640.$x720
=150  \\$aNitroparaffins
=550  \\$wg$aAlkanes
=550  \\$wg$aNitro Compounds
=550  \\$wh$aTetranitromethane
=688  \\$a91(75); was see under ALKANES 1975-90
=750  \0$aNitroalkanes$5IEN$0(DLC)sh 85092088

=LDR  00886cz  a2200277n  4500
=001  9880363698902441
=005  20200619133531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009416
=035  \\$aCBA2679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x585.$x250
=072  \\$aG16.$x762.$x611.$250
=150  \\$aNerve Regeneration
=450  \\$wnnna$aNerve Regenerations
=450  \\$wnnna$aRegeneration, Nerve
=450  \\$wnnna$aRegenerations, Nerve
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aRegeneration
=550  \\$wh$aRemyelination
=550  \\$wh$aSpinal Cord Regeneration
=550  \\$aNerve Transfer
=667  \\$acoord IM with specific nerve /physiol (IM or NIM)
=680  \\$iRenewal or physiological repair of damaged nerve tissue.
=688  \\$a66
=750  \0$aNervous system$xRegeneration$5IEN$0(DLC)sh 85090933

=LDR  01203cz  a2200277n  4500
=001  9880363699002441
=005  20141212203822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009415
=035  \\$aCBA2678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x511
=150  \\$aNerve Net
=450  \\$wnnna$aNerve Nets
=450  \\$wnnna$aNet, Nerve
=450  \\$wnnna$aNets, Nerve
=450  \\$wnnna$aNetwork, Neural (Anatomic)
=450  \\$wnnna$aNetworks, Neural (Anatomic)
=450  \\$wnnna$aNeural Network (Anatomic)
=450  \\$aNeural Networks (Anatomic)
=550  \\$wg$aNervous System
=550  \\$wh$aCentral Pattern Generators
=667  \\$ado not confuse X ref on anat neural networks with NEURAL NETWORKS (COMPUTER)
=680  \\$iA meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction.
=688  \\$a91(64); was see under NERVOUS SYSTEM 1964-90
=750  \0$aNeural networks (Neurobiology)$5IEN$0(DLC)sh 93002348

=LDR  02025cz  a2200529n  4500
=001  9880363699102441
=005  20200605172608.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009414
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x860
=072  \\$aD12.$x776.$x467.$x860
=072  \\$aD12.$x776.$x631.$x600
=072  \\$aD23.$x529.$x850
=150  \\$aNerve Growth Factors
=450  \\$wnnna$aFactors, Nerve Growth
=450  \\$wnnna$aFactors, Neurite Outgrowth
=450  \\$wnnna$aFactors, Neuronotrophic
=450  \\$wnnna$aFactors, Neurotrophic
=450  \\$wnnna$aGrowth-Associated Proteins, Neuronal
=450  \\$wnnna$aGrowth Associated Proteins, Neuronal
=450  \\$aNeurite Outgrowth Factors
=450  \\$wnnna$aNeuronal Growth-Associated Proteins
=450  \\$wnnna$aNeuronal Growth Associated Proteins
=450  \\$wnnna$aNeuronotrophic Factors
=450  \\$aNeurotrophic Factors
=450  \\$wnnna$aNeurotrophic Protein
=450  \\$wnnna$aNeurotrophic Proteins
=450  \\$aNeurotrophins
=450  \\$wnnna$aOutgrowth Factors, Neurite
=450  \\$wnnna$aProteins, Neuronal Growth-Associated
=550  \\$wg$aIntercellular Signaling Peptides and Proteins
=550  \\$wg$aNerve Tissue Proteins
=550  \\$wh$aBrain-Derived Neurotrophic Factor
=550  \\$wh$aCiliary Neurotrophic Factor
=550  \\$wh$aGlia Maturation Factor
=550  \\$wh$aGlial Cell Line-Derived Neurotrophic Factors
=550  \\$wh$aNerve Growth Factor
=550  \\$wh$aNetrins
=550  \\$wh$aNeuregulins
=550  \\$wh$aNeurotrophin 3
=550  \\$wh$aPituitary Adenylate Cyclase-Activating Polypeptide
=550  \\$aNeurites
=667  \\$aNERVE GROWTH FACTOR is also available
=680  \\$iFactors which enhance the growth potentialities of sensory and sympathetic nerve cells.
=688  \\$a1980; use NERVE GROWTH FACTOR 1966-1979; for NEUROTROPHIC PROTEIN use NERVE GROWTH FACTORS (NM) 1978-1999
=750  \0$aNerve growth factor$5IEN$0(DLC)sh 85090895

=LDR  00919cz  a2200217n  4500
=001  9880363699202441
=005  20141212203821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009411
=035  \\$aCBA2674HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x550
=150  \\$aNerve Endings
=450  \\$wnnna$aEnding, Nerve
=450  \\$wnnna$aEndings, Nerve
=450  \\$wnnna$aNerve Ending
=550  \\$wg$aPeripheral Nervous System
=550  \\$wh$aNeuroeffector Junction
=667  \\$ado not confuse with MOTOR ENDPLATE
=680  \\$iBranch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS.
=750  \0$aNerve endings$5IEN$0(DLC)sh 85090893

=LDR  01425cz  a2200301n  4500
=001  9880363699302441
=005  20141212203821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009410
=035  \\$aCBA2673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x737
=150  \\$aNerve Degeneration
=450  \\$wnnna$aDegeneration, Nerve
=450  \\$wnnna$aDegeneration, Neuron
=450  \\$wnnna$aDegenerations, Nerve
=450  \\$wnnna$aDegenerations, Neuron
=450  \\$wnnna$aNerve Degenerations
=450  \\$aNeuron Degeneration
=450  \\$wnnna$aNeuron Degenerations
=550  \\$wg$aPathologic Processes
=550  \\$wh$aRetrograde Degeneration
=550  \\$wh$aSubacute Combined Degeneration
=550  \\$wh$aWallerian Degeneration
=667  \\$aIM as a pathol process; coord with specific neurol dis /pathol (IM) or specific nerve /pathol (IM or NIM) if pertinent
=680  \\$iLoss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
=688  \\$a67(64)
=750  \0$aNervous system$xDegeneration$5IEN$0(DLC)sh 85090923

=LDR  01981cz  a2200457n  4500
=001  9880363699402441
=005  20141212203820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009408
=035  \\$aCBA2671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x550
=150  \\$aNerve Compression Syndromes
=450  \\$wnnna$aCompression Syndrome, Nerve
=450  \\$wnnna$aCompression Syndromes, Nerve
=450  \\$wnnna$aEntrapment, Nerve
=450  \\$aEntrapment Neuropathies
=450  \\$wnnna$aEntrapments, Nerve
=450  \\$wnnna$aExternal Nerve Compression Syndromes
=450  \\$wnnna$aInternal Nerve Compression Syndromes
=450  \\$wnnna$aNerve Compression Syndrome
=450  \\$wnnna$aNerve Compression Syndromes, External
=450  \\$wnnna$aNerve Compression Syndromes, Internal
=450  \\$wnnna$aNerve Entrapment
=450  \\$aNerve Entrapments
=450  \\$wnnna$aNeuropathies, Entrapment
=450  \\$wnnna$aNeuropathy, Entrapment
=450  \\$wnnna$aSyndrome, Nerve Compression
=450  \\$wnnna$aSyndromes, Nerve Compression
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wh$aCarpal Tunnel Syndrome
=550  \\$wh$aPiriformis Muscle Syndrome
=550  \\$wh$aPudendal Neuralgia
=550  \\$wh$aTarsal Tunnel Syndrome
=550  \\$wh$aThoracic Outlet Syndrome
=550  \\$wh$aUlnar Nerve Compression Syndromes
=550  \\$aCompartment Syndromes
=667  \\$acoord IM with specific nerve disease (IM) or specific nerve (IM); cauda equina syndrome: coord IM with CAUDA EQUINA (IM)
=680  \\$iMechanical compression of nerves or nerve roots from internal or external causes. These may result in a conduction block to nerve impulses (due to MYELIN SHEATH dysfunction) or axonal loss. The nerve and nerve sheath injuries may be caused by ISCHEMIA; INFLAMMATION; or a direct mechanical effect.
=688  \\$a1973(1972)
=750  \0$aEntrapment neuropathies$0(DLC) sh 85044147$5IEN

=LDR  01496cz  a2200397n  4500
=001  9880363699502441
=005  20141212203819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009407
=035  \\$aCBA2670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x86.$x711
=072  \\$aE4.$x525.$x210.$x550
=150  \\$aNerve Block
=450  \\$wnnna$aBlock, Nerve
=450  \\$wnnna$aBlockade, Nerve
=450  \\$wnnna$aBlockades, Nerve
=450  \\$wnnna$aBlocks, Nerve
=450  \\$wnnna$aChemical Neurolyses
=450  \\$wnnna$aChemical Neurolysis
=450  \\$wnnna$aChemodenervation
=450  \\$wnnna$aChemodenervations
=450  \\$wnnna$aNerve Blockade
=450  \\$wnnna$aNerve Blockades
=450  \\$wnnna$aNerve Blocks
=450  \\$wnnna$aNeurolyses, Chemical
=450  \\$wnnna$aNeurolysis, Chemical
=550  \\$wg$aAnesthesia, Conduction
=550  \\$wg$aDenervation
=550  \\$wh$aAutonomic Nerve Block
=550  \\$wh$aBrachial Plexus Block
=550  \\$wh$aCervical Plexus Block
=667  \\$adifferentiate from NEUROMUSCULAR BLOCKADE; coordinate with substance used to induce the block with no qualifiers if particularly discussed; AUTONOMIC NERVE BLOCK is also available
=680  \\$iInterruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain.
=688  \\$a74
=750  \0$aNerve block$5IEN$0(DLC)sh 85090892

=LDR  00758cz  a2200229n  4500
=001  9880363699602441
=005  20141212203819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009405
=035  \\$aCBA2669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x550
=072  \\$aD1.$x268.$x271.$x100.$x550
=072  \\$aD1.$x268.$x556.$x600
=072  \\$aD1.$x552.$x20.$x621
=072  \\$aD1.$x552.$x544.$x600
=150  \\$aNeptunium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iNeptunium. A radioactive element of the actinide metals family. It has the atomic symbol Np, atomic number 93, and atomic weight 237.
=750  \0$aNeptunium$5IEN$0(DLC)sh 85090879

=LDR  00888cz  a2200193n  4500
=001  9880363699702441
=005  20141212203819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009404
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x630.$x643
=072  \\$aC13.$x351.$x968.$x419.$x630.$x643
=150  \\$aNephrotic Syndrome
=450  \\$wnnna$aNephrotic Syndromes
=450  \\$wnnna$aSyndrome, Nephrotic
=450  \\$wnnna$aSyndromes, Nephrotic
=550  \\$wg$aNephrosis
=680  \\$iA condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
=750  \0$aNephrotic syndrome$5IEN$0(DLC)sh 85090863

=LDR  01406cz  a2200313n  4500
=001  9880363699802441
=005  20141212203818.0
=008  850228\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009403
=035  \\$aCBA2667HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x390.$x550
=072  \\$aE4.$x579.$x642
=072  \\$aE4.$x950.$x774.$x852.$x642
=150  \\$aNephrostomy, Percutaneous
=450  \\$wnnna$aNephrolithotomies, Percutaneous
=450  \\$aNephrolithotomy, Percutaneous
=450  \\$wnnna$aNephrostomies, Percutaneous
=450  \\$wnnna$aPercutaneous Nephrolithotomies
=450  \\$aPercutaneous Nephrolithotomy
=450  \\$wnnna$aPercutaneous Nephrostomies
=450  \\$aPercutaneous Nephrostomy
=550  \\$wg$aDiagnostic Techniques, Urological
=550  \\$wg$aOstomy
=550  \\$wg$aUrinary Diversion
=667  \\$ado not use /util except by MeSH definition; X ref NEPHROLITHOTOMY, PERCUTANEOUS is not a substitute for LITHOTRIPSY: coord NEPHROSTOMY, PERCUTANEOUS + LITHOTRIPSY for lithotripsy of urinary calculi by percutaneous nephrolithotomy
=680  \\$iThe insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional. It is used also to remove or dissolve renal calculi and to diagnose ureteral obstruction.
=688  \\$a86
=750  \0$aNephrostomy$5IEN$0(DLC)sh 85090862

=LDR  00674cz  a2200181n  4500
=001  9880363699902441
=005  20141212203817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009400
=035  \\$aCBA2664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x610
=072  \\$aC13.$x351.$x968.$x419.$x610
=150  \\$aNephrosclerosis
=450  \\$wnnna$aNephroscleroses
=550  \\$wg$aKidney Diseases
=680  \\$iHardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.
=750  \0$aNephrosclerosis$5IEN$0(DLC)sh 85090861

=LDR  00563cz  a2200181n  4500
=001  9880363700002441
=005  20141212203817.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009398
=035  \\$aCBA2662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x580
=150  \\$aNephrology
=550  \\$wg$aInternal Medicine
=667  \\$aSPEC; SPEC qualif; DF: NEPHROL
=680  \\$iA subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.
=688  \\$a80
=750  \0$aNephrology$5IEN$0(DLC)sh 85090860

=LDR  00821cz  a2200205n  4500
=001  9880363700102441
=005  20141212203816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009397
=035  \\$aCBA2661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x590
=072  \\$aC13.$x351.$x968.$x419.$x590
=072  \\$aC18.$x452.$x174.$x130.$x560
=150  \\$aNephrocalcinosis
=450  \\$wnnna$aNephrocalcinoses
=550  \\$wg$aCalcinosis
=550  \\$wg$aKidney Diseases
=680  \\$iA condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
=750  \0$aKidneys$xCalcification$5IEN$0(DLC)sh 87007206

=LDR  02075cz  a2200493n  4500
=001  9880363700202441
=005  20141212203816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009396
=035  \\$aCBA2660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x435.$x595
=072  \\$aC4.$x588.$x945.$x947.$x535.$x585
=072  \\$aC4.$x700.$x635
=072  \\$aC12.$x758.$x820.$x750.$x585
=072  \\$aC12.$x777.$x419.$x473.$x585
=072  \\$aC13.$x351.$x937.$x820.$x535.$x585
=072  \\$aC13.$x351.$x968.$x419.$x473.$x585
=072  \\$aC16.$x320.$x700.$x642
=150  \\$aWilms Tumor
=450  \\$aBilateral Wilms Tumor
=450  \\$aNephroblastoma
=450  \\$wnnna$aNephroblastomas
=450  \\$wnnna$aTumor, Bilateral Wilms
=450  \\$wnnna$aTumor, Wilms
=450  \\$wnnna$aTumor, Wilms'
=450  \\$wnnna$aWilm Tumor
=450  \\$wnnna$aWilms' Tumor
=450  \\$wnnna$aWilm's Tumor
=450  \\$wnnna$aWilms Tumor 1
=450  \\$wnnna$aWilms Tumor, Bilateral
=550  \\$wg$aKidney Neoplasms
=550  \\$wg$aNeoplasms, Complex and Mixed
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wh$aDenys-Drash Syndrome
=550  \\$wh$aWAGR Syndrome
=550  \\$aGenes, Wilms Tumor
=550  \\$aWT1 Proteins
=667  \\$acoordinate IM with KIDNEY NEOPLASMS (IM); /genet: consider also GENES, WILMS TUMOR
=680  \\$iA malignant kidney tumor, caused by the uncontrolled multiplication of renal stem (blastemal), stromal (STROMAL CELLS), and epithelial (EPITHELIAL CELLS) elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child's side or ABDOMEN.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Nephroblastoma
=688  \\$a94; was WILMS TUMOR 1991-93, was NEPHROBLASTOMA 1963-90; NEPHROBLASTOMA was see WILMS TUMOR 1991-93; WILMS TUMOR was see NEPHROBLASTOMA 1963-90
=750  \0$aNephroblastoma$0(DLC) sh 85090858$5IEN

=LDR  01286cz  a2200289n  4500
=001  9880363700302441
=005  20141212203816.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009395
=035  \\$aCBA2659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570.$x643
=072  \\$aC13.$x351.$x968.$x419.$x570.$x643
=150  \\$aNephritis, Interstitial
=450  \\$wnnna$aInterstitial Nephritides
=450  \\$aInterstitial Nephritis
=450  \\$wnnna$aNephritides, Interstitial
=450  \\$wnnna$aNephritides, Tubulointerstitial
=450  \\$aNephritis, Tubulointerstitial
=450  \\$wnnna$aTubulointerstitial Nephritides
=450  \\$aTubulointerstitial Nephritis
=550  \\$wg$aNephritis
=550  \\$wh$aBalkan Nephropathy
=550  \\$wh$aPyelonephritis
=680  \\$iInflammation of the interstitial tissue of the kidney. This term is generally used for primary inflammation of KIDNEY TUBULES and/or surrounding interstitium. For primary inflammation of glomerular interstitium, see GLOMERULONEPHRITIS. Infiltration of the inflammatory cells into the interstitial compartment results in EDEMA, increased spaces between the tubules, and tubular renal dysfunction.
=688  \\$a64
=750  \0$aNephritis, Interstitial$5IEN$0(DLC)sh 85090857

=LDR  02417cz  a2200565n  4500
=001  9880363700402441
=005  20141212203815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009394
=035  \\$aCBA2658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x742
=072  \\$aC12.$x777.$x419.$x570.$x620
=072  \\$aC13.$x351.$x875.$x742
=072  \\$aC13.$x351.$x968.$x419.$x570.$x620
=072  \\$aC16.$x131.$x939.$x742
=072  \\$aC17.$x300.$x200.$x517
=150  \\$aNephritis, Hereditary
=450  \\$wnnna$aAlport Syndrome
=450  \\$wnnna$aAlport Syndrome, Autosomal Dominant
=450  \\$wnnna$aAlport Syndrome, Autosomal Recessive
=450  \\$wnnna$aAlport Syndrome, X-Linked
=450  \\$wnnna$aAlport Syndrome, X Linked
=450  \\$aAlport's Syndrome
=450  \\$wnnna$aCongenital Hereditary Hematuria
=450  \\$wnnna$aFamilial Nephritis
=450  \\$wnnna$aHematuria, Congenital Hereditary
=450  \\$wnnna$aHematuria-Nephropathy-Deafness Syndrome
=450  \\$wnnna$aHematuria Nephropathy Deafness Syndrome
=450  \\$wnnna$aHematuric Hereditary Nephritis
=450  \\$wnnna$aHemorrhagic Familial Nephritis
=450  \\$wnnna$aHemorrhagic Hereditary Nephritis
=450  \\$wnnna$aHereditary Familial Congenital Hemorrhagic Nephritis
=450  \\$wnnna$aHereditary Hematuria Syndrome
=450  \\$wnnna$aHereditary Interstitial Pyelonephritis
=450  \\$wnnna$aHereditary Nephritis
=450  \\$aNephritis, Familial
=450  \\$wnnna$aNephritis, Hematuric Hereditary
=450  \\$wnnna$aNephritis, Hemorrhagic Familial
=450  \\$wnnna$aNephritis, Hemorrhagic Hereditary
=450  \\$wnnna$aPyelonephritis, Hereditary Interstitial
=450  \\$wnnna$aSyndrome, Alport
=450  \\$wnnna$aSyndrome, Hematuria-Nephropathy-Deafness
=450  \\$wnnna$aX-Linked Alport Syndrome
=550  \\$wg$aCollagen Diseases
=550  \\$wg$aNephritis
=550  \\$wg$aUrogenital Abnormalities
=680  \\$iA group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome (hereditary nephritis with HEARING LOSS) which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.
=688  \\$a77; was ALPORT'S SYNDROME 1964-76 (Prov 1964-69)
=750  \0$aAlport's syndrome$5IEN$0(DLC)sh 85003837

=LDR  00727cz  a2200241n  4500
=001  9880363700502441
=005  20141212203814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009393
=035  \\$aCBA2657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x570
=072  \\$aC13.$x351.$x968.$x419.$x570
=150  \\$aNephritis
=450  \\$wnnna$aNephritides
=550  \\$wg$aKidney Diseases
=550  \\$wh$aGlomerulonephritis
=550  \\$wh$aNephritis, Hereditary
=550  \\$wh$aNephritis, Interstitial
=550  \\$wh$aPyelitis
=667  \\$afamilial: consider also NEPHRITIS, HEREDITARY
=680  \\$iInflammation of any part of the KIDNEY.
=750  \0$aKidneys$xDiseases$5IEN$0(DLC)sh 85072261

=LDR  01255cz  a2200301n  4500
=001  9880363700602441
=005  20141212192344.0
=008  790423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009389
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x589.$x500
=150  \\$aNeovascularization, Pathologic
=450  \\$aAngiogenesis, Pathologic
=450  \\$wnnna$aAngiogenesis, Pathological
=450  \\$wnnna$aNeovascularization, Pathological
=450  \\$wnnna$aPathologic Angiogenesis
=450  \\$wnnna$aPathologic Neovascularization
=450  \\$wnnna$aPathological Angiogenesis
=450  \\$wnnna$aPathological Neovascularization
=550  \\$wg$aMetaplasia
=550  \\$wh$aChoroidal Neovascularization
=550  \\$wh$aRetinal Neovascularization
=550  \\$aNeovascularization, Physiologic
=550  \\$aVascular Remodeling
=667  \\$acoordinate with organ / blood supply; NEOVASCULARIZATION, PHYSIOLOGIC is also available
=680  \\$iA pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
=688  \\$a96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85; was in Cat G 1980-82
=750  \0$aNeovascularization$5IEN$0(DLC)sh 87002299

=LDR  00944cz  a2200301n  4500
=001  9880363700702441
=005  20141212203813.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009387
=035  \\$aCBA2651HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x480
=072  \\$aD25.$x720.$x327.$x390
=072  \\$aJ1.$x637.$x51.$x720.$x327.$x840.$x480
=072  \\$aJ1.$x637.$x412.$x767.$x480
=150  \\$aNeoprene
=450  \\$aChloroprene Polymer
=450  \\$wnnna$aChloroprene Polymers
=450  \\$wnnna$aDuprene
=450  \\$aPolychloroprene
=450  \\$wnnna$aPolychloroprenes
=450  \\$aRubber, Artificial$5IEN
=550  \\$wg$aElastomers
=550  \\$wg$aPolyenes
=550  \\$wg$aRubber
=680  \\$iAn oil-resistant synthetic rubber made by the polymerization of chloroprene.
=688  \\$a91(75); was see under POLYENES 1975-90
=750  \0$aRubber, Artificial$5IEN$0(DLC)sh 85115640

=LDR  01641cz  a2200361n  4500
=001  9880363700802441
=005  20141212203812.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009384
=035  \\$aCBA2648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x490
=072  \\$aC4.$x730.$x713
=072  \\$aC19.$x344.$x473
=150  \\$aParaneoplastic Endocrine Syndromes
=450  \\$wnnna$aEctopic Hormone Syndrome
=450  \\$aEctopic Hormone Syndromes
=450  \\$wnnna$aEndocrine Syndrome, Paraneoplastic
=450  \\$wnno$aNeoplastic Endocrine-Like Syndromes$5IEN-HS
=450  \\$wnnna$aParaneoplastic Endocrine Syndrome
=450  \\$wnnna$aSyndrome, Ectopic Hormone
=450  \\$wnnna$aSyndrome, Paraneoplastic Endocrine
=450  \\$wnnna$aSyndromes, Ectopic Hormone
=450  \\$wnnna$aSyndromes, Paraneoplastic Endocrine
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aParaneoplastic Syndromes
=550  \\$wh$aACTH Syndrome, Ectopic
=550  \\$wh$aZollinger-Ellison Syndrome
=550  \\$aHormones, Ectopic
=667  \\$acoordinate IM with pre-coordinated organ/neoplasm term with /secret (IM) + histological type of neoplasm /secret (IM) + specific hormone /secret (IM); but ACTH SYNDROME, ECTOPIC is also available
=680  \\$iSyndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion.
=688  \\$a2005 (1973)
=750  \0$aNeoplastic endocrine-like syndromes$0(DLC) sh 85090805$5IEN

=LDR  01572cz  a2200421n  4500
=001  9880363700902441
=005  20141212203811.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009382
=035  \\$aCBA2646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x650.$x895
=072  \\$aC23.$x550.$x727.$x650.$x895
=150  \\$aNeoplasms, Unknown Primary
=450  \\$aNeoplasm Metastasis, Unknown Primary
=450  \\$wnnna$aNeoplasm, Occult Primary
=450  \\$wnnna$aNeoplasm, Unknown Primary
=450  \\$aNeoplasms, Occult Primary
=450  \\$wnnna$aOccult Primary Neoplasm
=450  \\$aOccult Primary Neoplasms
=450  \\$wnnna$aPrimary Neoplasm, Occult
=450  \\$wnnna$aPrimary Neoplasm, Unknown
=450  \\$wnnna$aPrimary Neoplasms, Occult
=450  \\$wnnna$aPrimary Neoplasms, Unknown
=450  \\$wnnna$aPrimary Tumor, Unknown
=450  \\$wnnna$aPrimary Tumors, Unknown
=450  \\$wnnna$aTumor, Unknown Primary
=450  \\$wnnna$aTumors, Unknown Primary
=450  \\$wnnna$aUnknown Primary Neoplasm
=450  \\$wnnna$aUnknown Primary Neoplasm Metastasis
=450  \\$wnnna$aUnknown Primary Neoplasms
=450  \\$wnnna$aUnknown Primary Tumor
=450  \\$aUnknown Primary Tumors
=550  \\$wg$aNeoplasm Metastasis
=667  \\$aIM; do not use /second; coord IM with organ/neopl term with /second (IM) + histol type /second (IM); Manual 24.4.1.8
=680  \\$iMetastases in which the tissue of origin is unknown.
=688  \\$a87
=750  \0$aCancer of unknown primary origin$0(DLC) sh2004003310$5IEN-M

=LDR  01311cz  a2200349n  4500
=001  9880363701002441
=005  20141212203810.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009381
=035  \\$aCBA2645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x682
=072  \\$aC26.$x733.$x476
=150  \\$aNeoplasms, Radiation-Induced
=450  \\$wnnna$aCancer, Radiation-Induced
=450  \\$wnnna$aCancer, Radiation Induced
=450  \\$wnnna$aCancers, Radiation-Induced
=450  \\$wnnna$aNeoplasm, Radiation-Induced
=450  \\$wnnna$aNeoplasms, Radiation Induced
=450  \\$aRadiation-Induced Cancer
=450  \\$wnnna$aRadiation Induced Cancer
=450  \\$wnnna$aRadiation-Induced Cancers
=450  \\$wnnna$aRadiation-Induced Neoplasm
=450  \\$wnnna$aRadiation-Induced Neoplasms
=450  \\$wnnna$aRadiation Induced Neoplasms
=450  \\$aTumors, Radiation-Induced$5IEN
=550  \\$wg$aNeoplasms
=550  \\$wg$aRadiation Injuries
=550  \\$wh$aLeukemia, Radiation-Induced
=667  \\$aIM; coord with specific histol type (IM) + organ/neopl term (IM); Manual 24.4.3.2+; DF: NEOPL RAD IND
=680  \\$iTumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.
=750  \0$aRadiation carcinogenesis$5IEN$0(DLC)sh 85138566

=LDR  01927cz  a2200373n  4500
=001  9880363701102441
=005  20141212203809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009378
=035  \\$aCBA2642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x651
=150  \\$aNeoplasms, Multiple Primary
=450  \\$wnnna$aMultiple Primary Neoplasm
=450  \\$wnnna$aMultiple Primary Neoplasms
=450  \\$wnnna$aMultiple Primary Neoplasms, Synchronous
=450  \\$wnnna$aNeoplasm, Multiple Primary
=450  \\$wnnna$aNeoplasm, Synchronous
=450  \\$aNeoplasms, Synchronous
=450  \\$aNeoplasms, Synchronous Multiple Primary
=450  \\$wnnna$aPrimary Neoplasm, Multiple
=450  \\$wnnna$aPrimary Neoplasms, Multiple
=450  \\$wnnna$aSynchronous Multiple Primary Neoplasms
=450  \\$wnnna$aSynchronous Neoplasm
=450  \\$wnnna$aSynchronous Neoplasms
=550  \\$wg$aNeoplasms
=550  \\$wh$aHamartoma Syndrome, Multiple
=550  \\$wh$aMultiple Endocrine Neoplasia
=550  \\$wh$aTuberous Sclerosis
=550  \\$aNeoplasms, Second Primary
=667  \\$a2 or more neoplasms occurring simultaneously: do not confuse with NEOPLASMS, SECOND PRIMARY, a neoplasm following an earlier neoplasm but not its metastasis; coordinate with histological type(s) (IM) & each precoordinated organ/neoplasm term(s) (IM); do not use /compl with specific multiple neoplasm terms to show multiplicity; differentiate from NEOPLASM METASTASIS & NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5, 24.4.1.6; MULTIPLE ENDOCRINE NEOPLASIA & its specifics are also available; DF: NEOPL MULTIPLE PRIMARY
=680  \\$iTwo or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
=688  \\$a65
=750  \0$aMultiple tumors$5IEN$0(DLC)sh 85088379

=LDR  02879cz  a2200589n  4500
=001  9880363701202441
=005  20141212203809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009377
=035  \\$aCBA2641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x400
=072  \\$aC4.$x651.$x600
=072  \\$aC4.$x700.$x630
=072  \\$aC16.$x320.$x700.$x630
=072  \\$aC19.$x344.$x400
=150  \\$aMultiple Endocrine Neoplasia
=450  \\$wnnna$aAdenomatoses, Familial Endocrine
=450  \\$wnnna$aAdenomatoses, Multiple Endocrine
=450  \\$aAdenomatosis, Familial Endocrine
=450  \\$wnnna$aAdenomatosis, Multiple Endocrine
=450  \\$wnnna$aAdenopathies, Multiple Endocrine
=450  \\$wnnna$aAdenopathy, Multiple Endocrine
=450  \\$wnnna$aEndocrine Adenomatoses, Familial
=450  \\$wnnna$aEndocrine Adenomatoses, Multiple
=450  \\$wnnna$aEndocrine Adenomatosis, Familial
=450  \\$wnnna$aEndocrine Adenomatosis, Multiple
=450  \\$wnnna$aEndocrine Adenopathies, Multiple
=450  \\$wnnna$aEndocrine Adenopathy, Multiple
=450  \\$aEndocrine Neoplasia, Multiple
=450  \\$wnnna$aEndocrine Neoplasms, Multiple
=450  \\$wnnna$aFamilial Endocrine Adenomatoses
=450  \\$wnnna$aFamilial Endocrine Adenomatosis
=450  \\$wnnna$aMultiple Endocrine Adenomatoses
=450  \\$wnnna$aMultiple Endocrine Adenomatosis
=450  \\$wnnna$aMultiple Endocrine Adenopathies
=450  \\$wnnna$aMultiple Endocrine Adenopathy
=450  \\$wnnna$aMultiple Endocrine Neoplasia Syndromes
=450  \\$wnnna$aMultiple Endocrine Neoplasms
=450  \\$aNeoplasia, Multiple Endocrine
=450  \\$aNeoplasms, Multiple Endocrine
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aNeoplasms, Multiple Primary
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wh$aMultiple Endocrine Neoplasia Type 1
=550  \\$wh$aMultiple Endocrine Neoplasia Type 2a
=550  \\$wh$aMultiple Endocrine Neoplasia Type 2b
=550  \\$aApudoma
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific endocrine/neoplasm pre-coordinates (IM) + specific histological type (IM) if pertinent; DF MULTIPLE ENDOCRINE NEOPL
=680  \\$iA group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.
=688  \\$a95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 (Prov 1964)
=750  \0$aAdenomatosis, Familial endocrine$5IEN$0(DLC)sh 85000844

=LDR  01013cz  a2200241n  4500
=001  9880363701302441
=005  20141212203808.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009376
=035  \\$aCBA2640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x626
=150  \\$aNeoplasms, Hormone-Dependent
=450  \\$wnnna$aHormone-Dependent Neoplasm
=450  \\$aHormone-Dependent Neoplasms
=450  \\$wnnna$aHormone Dependent Neoplasms
=450  \\$wnnna$aNeoplasm, Hormone-Dependent
=450  \\$wnnna$aNeoplasms, Hormone Dependent
=550  \\$wg$aNeoplasms
=667  \\$aIM general only; prefer specific neoplasm term(s) and do not routinely add Neoplasms, Hormone, Dependent; coordinate with specific hormone if pertinent
=680  \\$iCertain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
=688  \\$a79
=750  \0$aCancer$xEndocrine aspects$5IEN$0(DLC)sh 85019508

=LDR  01396cz  a2200361n  4500
=001  9880363701402441
=005  20141212203807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009374
=035  \\$aCBA2638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x619
=072  \\$aE5.$x598.$x500.$x496
=150  \\$aNeoplasms, Experimental
=450  \\$wnnna$aExperimental Neoplasm
=450  \\$wnnna$aExperimental Neoplasms
=450  \\$wnnna$aNeoplasm, Experimental
=550  \\$wg$aDisease Models, Animal
=550  \\$wg$aNeoplasms
=550  \\$wh$aCarcinoma 256, Walker
=550  \\$wh$aCarcinoma, Brown-Pearce
=550  \\$wh$aCarcinoma, Ehrlich Tumor
=550  \\$wh$aCarcinoma, Krebs 2
=550  \\$wh$aCarcinoma, Lewis Lung
=550  \\$wh$aLeukemia, Experimental
=550  \\$wh$aLiver Neoplasms, Experimental
=550  \\$wh$aMammary Neoplasms, Experimental
=550  \\$wh$aMelanoma, Experimental
=550  \\$wh$aSarcoma, Experimental
=550  \\$wh$aTumor Virus Infections
=667  \\$aIM general only; not a routine coordinate for specific neoplasms in experimental animals; policy: Manual 24.5+; /chem ind: Manual 24.5.6+; spontaneous: Manual 24.5.5; DF: NEOPL EXPER
=680  \\$iExperimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
=750  \0$aOncology, Experimental$5IEN$0(DLC)sh 85094726

=LDR  02284cz  a2200577n  4500
=001  9880363701502441
=005  20141212203806.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009373
=035  \\$aCBA2637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465
=150  \\$aNeoplasms, Germ Cell and Embryonal
=450  \\$wnnna$aCancer, Embryonal
=450  \\$wnnna$aCancer, Embryonal and Mixed
=450  \\$wnnna$aCancer, Germ Cell
=450  \\$wnnna$aCancers, Embryonal
=450  \\$wnnna$aCancers, Germ Cell
=450  \\$wnnna$aEmbryonal Cancer
=450  \\$wnnna$aEmbryonal Cancers
=450  \\$wnnna$aEmbryonal Neoplasm
=450  \\$wnnna$aEmbryonal Neoplasms
=450  \\$wnnna$aGerm Cell and Embryonal Neoplasms
=450  \\$wnnna$aGerm Cell and Embryonic Neoplasms
=450  \\$aGerm Cell Cancer
=450  \\$wnnna$aGerm Cell Cancers
=450  \\$wnnna$aGerm Cell Neoplasms
=450  \\$aGerm Cell Tumor
=450  \\$wnnna$aGerm Cell Tumors
=450  \\$wnnna$aNeoplasm, Embryonal
=450  \\$wnnna$aNeoplasms, Embryonal
=450  \\$aNeoplasms, Embryonal and Mixed
=450  \\$wnnna$aNeoplasms, Germ Cell
=450  \\$wnnna$aNeoplasms, Germ Cell and Embryonic
=450  \\$wnnna$aTumor, Germ Cell
=450  \\$wnnna$aTumors, Germ Cell
=550  \\$wg$aNeoplasms by Histologic Type
=550  \\$wh$aCarcinoma, Embryonal
=550  \\$wh$aChordoma
=550  \\$wh$aGerminoma
=550  \\$wh$aGonadoblastoma
=550  \\$wh$aMesonephroma
=550  \\$wh$aNeuroectodermal Tumors
=550  \\$wh$aTeratocarcinoma
=550  \\$wh$aTeratoma
=550  \\$wh$aTrophoblastic Neoplasms
=667  \\$aneoplasms composed of germ cells or embryonic tissue, NOT neoplasms located in germ cells or embryonic tissue; coordinate IM with precoordinated organ/neoplasm term (IM); DF: NEOPL GERM CELL
=680  \\$iNeoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.
=688  \\$a1994 (1963); for GERM CELL TUMOR use GERMINOMA 1994-2005
=688  \\$a94; was NEOPLASMS, EMBRYONAL AND MIXED 1963-93
=750  \0$aEmbryonal tumors$5IEN$0(DLC)sh 85138564

=LDR  02197cz  a2200517n  4500
=001  9880363701602441
=005  20190320163939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009369
=035  \\$aCBA2633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4
=150  \\$aNeoplasms
=360  \\$iconsider also terms at$aCANCER$aCARCINO-$aONCO-$aTUMOR
=450  \\$wnnna$aBenign Neoplasm
=450  \\$wnnna$aBenign Neoplasms
=450  \\$aCancer
=450  \\$wnnna$aCancers
=450  \\$wnnna$aNeoplasia
=450  \\$wnnna$aNeoplasm
=450  \\$wnnna$aNeoplasm, Benign
=450  \\$wnnna$aNeoplasms, Benign
=450  \\$wnnna$aTumor
=450  \\$aTumors
=550  \\$wh$aCysts
=550  \\$wh$aHamartoma
=550  \\$wh$aNeoplasms by Histologic Type
=550  \\$wh$aNeoplasms by Site
=550  \\$wh$aNeoplasms, Experimental
=550  \\$wh$aNeoplasms, Hormone-Dependent
=550  \\$wh$aNeoplasms, Multiple Primary
=550  \\$wh$aNeoplasms, Post-Traumatic
=550  \\$wh$aNeoplasms, Radiation-Induced
=550  \\$wh$aNeoplasms, Second Primary
=550  \\$wh$aNeoplastic Processes
=550  \\$wh$aNeoplastic Syndromes, Hereditary
=550  \\$wh$aParaneoplastic Syndromes
=550  \\$wh$aPrecancerous Conditions
=550  \\$wh$aPregnancy Complications, Neoplastic
=550  \\$wh$aTumor Virus Infections
=550  \\$aMedical Oncology
=667  \\$ageneral; prefer specifics; policy: see Manual Chapter 24; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS
=680  \\$iNew abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
=688  \\$a/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977
=750  \0$aTumors$0(DLC)sh 85138553$5IEN-M
=750  \0$iNarrower mapping$aCancer$0(DLC)sh 85019492$4NM$5IEN-M

=LDR  00847cz  a2200253n  4500
=001  9880363701702441
=005  20141212203804.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009368
=035  \\$aCBA2632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x624
=150  \\$aNeoplasm Transplantation
=450  \\$wnnna$aNeoplasm Transplantations
=450  \\$wnnna$aTransplantation, Neoplasm
=450  \\$wnnna$aTransplantations, Neoplasm
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aXenograft Model Antitumor Assays
=550  \\$aNeoplasms, Experimental
=550  \\$aTransplantation
=667  \\$aNIM; Manual 24.5.4; DF: NEOPL TRANSPL
=680  \\$iExperimental transplantation of neoplasms in laboratory animals for research purposes.
=688  \\$a67(64)
=750  \0$aTumors$xTransplantation$5IEN$0(DLC)sh 85138563

=LDR  00995cz  a2200277n  4500
=001  9880363701802441
=005  20141212203804.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009367
=035  \\$aCBA2631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x789.$x625
=150  \\$aNeoplasm Staging
=450  \\$aCancer Staging
=450  \\$wnnna$aStaging, Cancer
=450  \\$aStaging, Neoplasm
=450  \\$wnnna$aStaging, TNM
=450  \\$wnnna$aStaging, Tumor
=450  \\$wnnna$aTNM Staging
=450  \\$aTumor Staging
=550  \\$wg$aPrognosis
=550  \\$aNomograms
=667  \\$aIM general only; coordinate NIM with no qualifers with neoplasm terms/pathol (IM); do not confuse with NEOPLASM GRADING; staging is given in Roman numerals, grading in Arabic numerals; Manual 24.4.1.12+
=680  \\$iMethods which attempt to express in replicable terms the extent of the neoplasm in the patient.
=688  \\$a78
=750  \0$aTumors$vClassification$5IEN$0(DLC)sh 85138555

=LDR  01119cz  a2200289n  4500
=001  9880363701902441
=005  20141212203803.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009365
=035  \\$aCBA2629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x670
=072  \\$aC23.$x550.$x727.$x670
=072  \\$aG16.$x100.$x870.$x500
=150  \\$aNeoplasm Regression, Spontaneous
=450  \\$aCancer Regression, Spontaneous$5IEN
=450  \\$aNeoplasm Remission, Spontaneous
=450  \\$wnnna$aRegression, Spontaneous Neoplasm
=450  \\$aRemission, Spontaneous Neoplasm
=450  \\$wnnna$aSpontaneous Neoplasm Regression
=450  \\$wnnna$aSpontaneous Neoplasm Remission
=550  \\$wg$aNeoplastic Processes
=550  \\$wg$aRemission, Spontaneous
=667  \\$aIM; must be spontaneous: for regression or remission after ther, use REMISSION INDUCTION; Manual 24.4.1.9; DF: NEOPL REGRESSION SPONTANEOUS
=680  \\$iDisappearance of a neoplasm or neoplastic state without the intervention of therapy.
=688  \\$a64
=750  \0$aCancer regression, Spontaneous$5IEN$0(DLC)sh 85019555

=LDR  01198cz  a2200277n  4500
=001  9880363953502441
=005  20141212204625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010950
=035  \\$aCBA4240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x63.$x438.$x725
=072  \\$aA11.$x118.$x637.$x555.$x567.$x562.$x725
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x562.$x725
=072  \\$aA15.$x382.$x32.$x438.$x725
=072  \\$aA15.$x382.$x490.$x555.$x567.$x562.$x725
=150  \\$aPlasma Cells
=450  \\$wnnna$aCell, Plasma
=450  \\$wnnna$aCells, Plasma
=450  \\$wnnna$aPlasma Cell
=450  \\$wnnna$aPlasmacyte
=450  \\$aPlasmacytes
=550  \\$wg$aB-Lymphocytes
=667  \\$anot for BLOOD CELLS: they are antibody-producing cells; A 11 qualif
=680  \\$iSpecialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20)
=750  \0$aPlasma cells$5IEN$0(DLC)sh 85103058

=LDR  01415cz  a2200361n  4500
=001  9880363953602441
=005  20141212204624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010949
=035  \\$aCBA4239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152.$x693
=072  \\$aA12.$x207.$x270.$x695
=072  \\$aA15.$x145.$x693
=150  \\$aPlasma
=450  \\$aBlood Plasma
=450  \\$wnnna$aBlood Plasmas
=450  \\$aFresh Frozen Plasma
=450  \\$wnnna$aFresh Frozen Plasmas
=450  \\$wnnna$aFrozen Plasma, Fresh
=450  \\$wnnna$aFrozen Plasmas, Fresh
=450  \\$wnnna$aPlasma, Blood
=450  \\$wnnna$aPlasma, Fresh Frozen
=450  \\$wnnna$aPlasmas
=450  \\$wnnna$aPlasmas, Blood
=450  \\$wnnna$aPlasmas, Fresh Frozen
=550  \\$wg$aBlood
=550  \\$wg$aExtracellular Fluid
=550  \\$wh$aPlatelet-Rich Plasma
=550  \\$aSerum
=667  \\$arestrict to plasma for transfusions or plasma when compared with serum or blood cells or whole blood; substances in plasma = /blood, not PLASMA; policy: Manual 21.47, 25.14.5; for entry term FRESH FROZEN PLASMA do not coordinate with FREEZING or BLOOD PRESERVATION; PLATELET-RICH PLASMA is also available
=680  \\$iThe residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.
=750  \0$aBlood plasma$5IEN$0(DLC)sh 85015001

=LDR  01734cz  a2200361n  4500
=001  9880363953702441
=005  20141212204624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010948
=035  \\$aCBA4238M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x970.$x790
=072  \\$aE5.$x200.$x875.$x970.$x790
=150  \\$aViral Plaque Assay
=450  \\$wnnna$aAssay, Bacteriophage Plaque
=450  \\$wnnna$aAssay, Viral Plaque
=450  \\$wnnna$aAssays, Bacteriophage Plaque
=450  \\$wnnna$aAssays, Viral Plaque
=450  \\$wnnna$aBacteriophage Plaque Assay
=450  \\$wnnna$aBacteriophage Plaque Assays
=450  \\$wnnna$aPlaque Assay, Bacteriophage
=450  \\$wnnna$aPlaque Assay, Viral
=450  \\$wnnna$aPlaque Assays, Bacteriophage
=450  \\$wnnna$aPlaque Assays, Viral
=450  \\$wnnna$aViral Plaque Assays
=550  \\$wg$aVirus Cultivation
=550  \\$aCytopathogenic Effect, Viral
=667  \\$afor viruses; coord IM or NIM with specific virus /growth (IM); do not confuse with HEMOLYTIC PLAQUE TECHNIQUE in immunol
=680  \\$iMethod for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
=688  \\$a2012 (1973)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Plaque Assay
=688  \\$a73
=750  \0$aPlaque assay technique$0(DLC) sh 85103043$5IEN-M

=LDR  00763cz  a2200253n  4500
=001  9880363953802441
=005  20141212204623.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x660
=150  \\$aPlants, Toxic
=450  \\$wnnna$aPlant, Poisonous
=450  \\$wnnna$aPlant, Toxic
=450  \\$wnnna$aPlants, Poisonous
=450  \\$wnnna$aPoisonous Plant
=450  \\$wnnna$aPoisonous Plants
=450  \\$wnnna$aToxic Plant
=450  \\$wnnna$aToxic Plants
=550  \\$wg$aPlants
=667  \\$aIM general only
=680  \\$iPlants or plant parts which are harmful to man or other animals.
=688  \\$a1976; was NON MESH before 1976;
=750  \0$aPoisonous plants$5IEN$0(DLC)sh 85103946

=LDR  01795cz  a2200421n  4500
=001  9880363953902441
=005  20141212204623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010946
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x560
=150  \\$aPlants, Medicinal
=450  \\$wnnna$aHealing Plant
=450  \\$wnnna$aHealing Plants
=450  \\$wnnna$aHerb, Medicinal
=450  \\$aHerbs, Medicinal
=450  \\$wnnna$aMedicinal Herb
=450  \\$aMedicinal Herbs
=450  \\$wnnna$aMedicinal Plant
=450  \\$wnnna$aMedicinal Plants
=450  \\$wnnna$aPharmaceutical Plant
=450  \\$wnnna$aPharmaceutical Plants
=450  \\$wnnna$aPlant, Healing
=450  \\$wnnna$aPlant, Medicinal
=450  \\$wnnna$aPlant, Pharmaceutical
=450  \\$wnnna$aPlants, Healing
=450  \\$wnnna$aPlants, Pharmaceutical
=550  \\$wg$aPlants
=550  \\$aEthnopharmacology
=550  \\$aHerbal Medicine
=550  \\$aMedicine, Traditional
=550  \\$aPharmaceutical Preparations
=550  \\$aPharmacognosy
=550  \\$aPhytotherapy
=667  \\$aIM general only; specify geographic term if pertinent
=680  \\$iPlants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals.
=688  \\$aAESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX & TAMARIND were headings 1963-85; ADONIS, ASPIDIUM & OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85
=750  \0$aMedicinal plants$0(DLC) sh 85083063$5IEN-HS

=LDR  01358cz  a2200289n  4500
=001  9880363954002441
=005  20160422112316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010945
=035  \\$aCBA4235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x510
=150  \\$aPlants, Edible
=450  \\$wnnna$aEdible Plant
=450  \\$wnnna$aEdible Plants
=450  \\$wnnna$aFood Plant
=450  \\$aFood Plants
=450  \\$wnnna$aPlant, Edible
=450  \\$wnnna$aPlant, Food
=450  \\$wnnna$aPlants, Food
=550  \\$wg$aPlants
=550  \\$wh$aCrops, Agricultural
=550  \\$wh$aVegetables
=550  \\$aFood
=667  \\$aas plants & food; prefer FRUIT (J) or VEGETABLES (J) if ascertainable; specify geog if pertinent; use qualif available to PLANTS with discretion
=680  \\$iAn organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES.
=750  \0$aPlants, Edible$5IEN$0(DLC)sh 85102891

=LDR  01656cz  a2200349n  4500
=001  9880363954102441
=005  20141212204622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010944
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650
=150  \\$aPlants
=450  \\$wnnna$aPlant
=550  \\$wg$aEukaryota
=550  \\$wh$aChimera
=550  \\$wh$aGlaucophyta
=550  \\$wh$aPlant Weeds
=550  \\$wh$aPlants, Edible
=550  \\$wh$aPlants, Genetically Modified
=550  \\$wh$aPlants, Medicinal
=550  \\$wh$aPlants, Toxic
=550  \\$wh$aRhodophyta
=550  \\$wh$aSalt-Tolerant Plants
=550  \\$wh$aTrees
=550  \\$wh$aViridiplantae
=550  \\$aBotany
=550  \\$aEthnopharmacology
=550  \\$aPlant Proteins
=667  \\$ageneral only: prefer specific groups or specific plants; plants or "plant tissue": Manual 31.10; /anat: consider also PLANT COMPONENTS; /embryol: consider also SEEDS; policy 22.30, 36.25; plants used in therapy = PHYTOTHERAPY: Manual 26.29
=680  \\$iMulticellular, eukaryotic life forms of kingdom Plantae (sensu lato), comprising the VIRIDIPLANTAE; RHODOPHYTA; and GLAUCOPHYTA; all of which acquired chloroplasts by direct endosymbiosis of CYANOBACTERIA. They are characterized by a mainly photosynthetic mode of nutrition; essentially unlimited growth at localized regions of cell divisions (MERISTEMS); cellulose within cells providing rigidity; the absence of organs of locomotion; absence of nervous and sensory systems; and an alternation of haploid and diploid generations.
=688  \\$aPYRETHRUM was heading 1963-85
=750  \0$aPlants$5IEN$0(DLC)sh 85102839

=LDR  01272cz  a2200205n  4500
=001  9880363954202441
=005  20161117141215.0
=008  770329\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010943
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x818
=150  \\$aPlantago
=450  \\$wnnna$aPlantagos
=450  \\$aPlantain
=450  \\$wnnna$aPlantains
=550  \\$wg$aAngiosperms
=667  \\$aXref PLANTAIN: for the banana-like fruit or green plantain flour use MUSA; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Plantaginaceae, order Plantaginales, subclass Asteridae, class Magnoliopsida. The small plants usually have a dense tuft of basal leaves and long, leafless stalks bearing a terminal spike of small flowers. The seeds, known as PSYLLIUM, swell in water and are used as laxatives. The leaves have been used medicinally.
=688  \\$a91(78); was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 (Cat B & D heading)
=750  \0$aPlantago$5IEN-M$0(DLC)sh 91003316

=LDR  01309cz  a2200445n  4500
=001  9880363954302441
=005  20141212204621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010942
=035  \\$aCBA4232HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715
=150  \\$aPlant Viruses
=450  \\$aPhytophagineae
=450  \\$wnnna$aPlant Virus
=450  \\$wnnna$aVirus, Plant
=450  \\$wnnna$aViruses, Plant
=550  \\$wg$aViruses
=550  \\$wh$aBadnavirus
=550  \\$wh$aBromoviridae
=550  \\$wh$aCaulimoviridae
=550  \\$wh$aClosteroviridae
=550  \\$wh$aComoviridae
=550  \\$wh$aFlexiviridae
=550  \\$wh$aGeminiviridae
=550  \\$wh$aLuteoviridae
=550  \\$wh$aMosaic Viruses
=550  \\$wh$aNanoviridae
=550  \\$wh$aPhycodnaviridae
=550  \\$wh$aPotyviridae
=550  \\$wh$aSequiviridae
=550  \\$wh$aTenuivirus
=550  \\$wh$aTombusviridae
=550  \\$wh$aTospovirus
=550  \\$wh$aTungrovirus
=550  \\$wh$aTymoviridae
=667  \\$aGEN or unspecified; prefer specifics; coord IM with specific plant /virol (IM or NIM)
=680  \\$iViruses parasitic on plants higher than bacteria.
=688  \\$aPHYTOPHAGINEAE was see under PLANT VIRUSES 1963-78
=750  \0$aPlant viruses$5IEN$0(DLC)sh 85102820

=LDR  01048cz  a2200289n  4500
=001  9880363954402441
=005  20141212204621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010941
=035  \\$aCBA4231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x556.$x700
=150  \\$aPlant Tumors
=450  \\$aCrown Gall
=450  \\$wnnna$aCrown Galls
=450  \\$wnnna$aGall, Crown
=450  \\$wnnna$aGall, Plant
=450  \\$wnnna$aGalls, Crown
=450  \\$aGalls, Plant
=450  \\$wnnna$aPlant Gall
=450  \\$aPlant Galls
=450  \\$wnnna$aPlant Tumor
=450  \\$wnnna$aTumor, Plant
=450  \\$wnnna$aTumors, Plant
=550  \\$wg$aPlant Diseases
=680  \\$iA localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls usually form in response to the action of a pathogen or a pest. (Holliday, P., A Dictionary of Plant Pathology, 1989, p330)
=750  \0$aTumors, Plant$5IEN$0(DLC)sh 85138565

=LDR  01610cz  a2200421n  4500
=001  9880363954502441
=005  20201028132344.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010940
=035  \\$aCBA4230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765
=150  \\$aPlant Proteins
=450  \\$wnnna$aProteins, Plant
=550  \\$wg$aProteins
=550  \\$wh$aArabidopsis Proteins
=550  \\$wh$aChloroplast Proteins
=550  \\$wh$aDEFICIENS Protein
=550  \\$wh$aFerredoxins
=550  \\$wh$aFlorigen
=550  \\$wh$aG-Box Binding Factors
=550  \\$wh$aLeghemoglobin
=550  \\$wh$aPeriplasmic Proteins
=550  \\$wh$aPhotoreceptors, Plant
=550  \\$wh$aPhycocyanin
=550  \\$wh$aPhycoerythrin
=550  \\$wh$aPhytochrome
=550  \\$wh$aPlant Lectins
=550  \\$wh$aPlant Proteins, Dietary
=550  \\$wh$aPlastocyanin
=550  \\$wh$aRibosome Inactivating Proteins
=550  \\$wh$aSeed Storage Proteins
=550  \\$wh$aSoybean Proteins
=550  \\$aEndosperm
=550  \\$aPlants
=667  \\$adietary plant proteins: coord IM with specific plant (IM) + specific protein (IM) + DIETARY PROTEINS (IM) but note that VEGETABLE PROTEINS is available (see note there); nutritive value of plant proteins: coord IM with specific protein (IM) + NUTRITIVE VALUE (NIM) but not also DIETARY PROTEINS
=680  \\$iProteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which VEGETABLE PROTEINS is available.
=750  \0$aPlant proteins$5IEN$0(DLC)sh 85102804

=LDR  01249cz  a2200265n  4500
=001  9880363954602441
=005  20141212204620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010939
=035  \\$aCBA4229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x756
=150  \\$aPlant Poisoning
=450  \\$wnnna$aPlant Poisonings
=450  \\$wnnna$aPoisoning, Plant
=450  \\$wnnna$aPoisonings, Plant
=550  \\$wg$aPoisoning
=550  \\$wh$aErgotism
=550  \\$wh$aFavism
=550  \\$wh$aLathyrism
=550  \\$wh$aMilk Sickness
=550  \\$aPlants, Toxic
=667  \\$ahuman & animal; coord IM with specific plant (IM) + specific dis /etiol (IM); do not coord with food plants in Cat J: index under specific Cat J2 food plant /pois (IM), as FRUIT /pois or GARLIC /pois but not also here; Jamaican vomiting sickness: index PLANT POISONING + HYPOGLYCINS /pois
=680  \\$iPoisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage.
=750  \0$aPoisonous plants$xToxicology$5IEN$0(DLC)sh 85103947

=LDR  01329cz  a2200469n  4500
=001  9880363954702441
=005  20200710121804.0
=008  860603\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010938
=035  \\$aCBA4228M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627.$x700
=072  \\$aD20.$x215.$x784.$x750
=150  \\$aPlant Oils
=450  \\$aOils, Plant
=450  \\$aOils, Vegetable
=450  \\$aVegetable Oils
=550  \\$wg$aOils
=550  \\$wg$aPlant Preparations
=550  \\$wh$aCastor Oil
=550  \\$wh$aClove Oil
=550  \\$wh$aCoconut Oil
=550  \\$wh$aCorn Oil
=550  \\$wh$aCottonseed Oil
=550  \\$wh$aCroton Oil
=550  \\$wh$aIodized Oil
=550  \\$wh$aLinseed Oil
=550  \\$wh$aOlive Oil
=550  \\$wh$aPalm Oil
=550  \\$wh$aPeanut Oil
=550  \\$wh$aRapeseed Oil
=550  \\$wh$aRice Bran Oil
=550  \\$wh$aSafflower Oil
=550  \\$wh$aSesame Oil
=550  \\$wh$aSoybean Oil
=550  \\$wh$aSunflower Oil
=550  \\$wh$aTea Tree Oil
=550  \\$aEndosperm
=667  \\$aD25-26 qualif; coord IM with specific plant source of oil (IM or NIM) but not PLANTS; "yusho poisoning": see note on RICE
=680  \\$iOils derived from plants or plant products.
=688  \\$a87
=750  \0$aVegetable oils$5IEN-M$0(DLC)sh 94004802

=LDR  00881cz  a2200241n  4500
=001  9880363954802441
=005  20141212204619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010937
=035  \\$aCBA4227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x377.$x760
=150  \\$aPlant Growth Regulators
=450  \\$wnnna$aGrowth Regulators, Plant
=450  \\$wnnna$aHormones, Plant
=450  \\$aPhytohormones
=450  \\$aPlant Hormones
=450  \\$wnnna$aRegulators, Plant Growth
=550  \\$wg$aGrowth Substances
=667  \\$aDF: PLANT GROWTH REG
=680  \\$iAny of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.
=750  \0$aPlant hormones$5IEN-M$0(DLC)sh 85102750
=750  \0$aPlant regulators$5IEN-HS$0(DLC)sh 85102807

=LDR  00679cz  a2200229n  4500
=001  9880363954902441
=005  20141212204619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010935
=035  \\$aCBA4225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x556
=150  \\$aPlant Diseases
=450  \\$wnnna$aDisease, Plant
=450  \\$wnnna$aDiseases, Plant
=450  \\$wnnna$aPlant Disease
=550  \\$wg$aPlant Physiological Phenomena
=550  \\$wh$aPlant Tumors
=667  \\$acoord with specific causative organism if pertinent but not with infection term
=680  \\$iDiseases of plants.
=688  \\$a68
=750  \0$aPlant diseases$5IEN$0(DLC)sh 85102732

=LDR  01204cz  a2200373n  4500
=001  9880363955002441
=005  20190102111215.0
=008  790601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010934
=035  \\$aCBA4224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x718
=150  \\$aPlanning Techniques
=450  \\$wnnna$aMethodologies, Planning
=450  \\$wnnna$aMethodology, Planning
=450  \\$wnnna$aPlanning Methodologies
=450  \\$wnnna$aPlanning Methodology
=450  \\$wnnna$aPlanning Technic
=450  \\$wnnna$aPlanning Technics
=450  \\$wnnna$aPlanning Technique
=450  \\$aPlanning Theories
=450  \\$wnnna$aPlanning Theory
=450  \\$wnnna$aTechnic, Planning
=450  \\$wnnna$aTechnics, Planning
=450  \\$wnnna$aTechnique, Planning
=450  \\$wnnna$aTechniques, Planning
=450  \\$wnnna$aTheories, Planning
=450  \\$wnnna$aTheory, Planning
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aStrategic Planning
=667  \\$aNIM; no qualif
=680  \\$iProcedures, strategies, and theories of planning.
=688  \\$a91; was PLANNING TECHNICS 1980-90
=750  \0$aPlanning$xTechnique$0(DLC)sh2008008472$5IEN

=LDR  00957cz  a2200205n  4500
=001  9880363955102441
=005  20141212204618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010933
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80.$x500
=150  \\$aPlankton
=550  \\$wg$aAquatic Organisms
=550  \\$wh$aPhytoplankton
=550  \\$wh$aZooplankton
=550  \\$aAquatic Organisms
=550  \\$aMarine Biology
=667  \\$acoordinate with specific organism; PHYTOPLANKTON and ZOOPLANKTON are also available; non-phototrophic bacterioplankton: index PLANKTON + BACTERIA or specific; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific
=680  \\$iCommunity of tiny aquatic PLANTS and ANIMALS, and photosynthetic BACTERIA, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON.
=750  \0$aPlankton$5IEN$0(DLC)sh 85102688

=LDR  00840cz  a2200217n  4500
=001  9880363955202441
=005  20141212204618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010932
=035  \\$aCBA4222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x847.$x610
=150  \\$aPlanarians
=450  \\$aDugesia
=450  \\$wnnna$aDugesias
=450  \\$wnnna$aPlanarian
=550  \\$wg$aTurbellaria
=667  \\$anon-parasitic flatworms used in regeneration experiments
=680  \\$iNonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which lives in water, and Bipalium, which lives on land. Geoplana occurs in South America and California.
=688  \\$a91(75); was see under TURBELLARIA 1975-90
=750  \0$aDugesia$5IEN$0(DLC)sh 85039918

=LDR  00539cz  a2200169n  4500
=001  9880363955302441
=005  20141212204618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010931
=035  \\$aCBA4221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x609
=150  \\$aPlague Vaccine
=450  \\$wnnna$aVaccine, Plague
=550  \\$wg$aBacterial Vaccines
=680  \\$iA suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas.
=750  \0$aPlague vaccines$5IEN$0(DLC)sh 85102598

=LDR  01821cz  a2200469n  4500
=001  9880363955402441
=005  20141212204617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010930
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x980.$x745
=150  \\$aPlague
=450  \\$wnnna$aBlack Death
=450  \\$wnnna$aBlack Deaths
=450  \\$wnnna$aBlack Plague
=450  \\$wnnna$aBlack Plagues
=450  \\$aBubonic Plague
=450  \\$wnnna$aDeath, Black
=450  \\$wnnna$aDeaths, Black
=450  \\$aMeningeal Plague
=450  \\$wnnna$aMeningeal Plagues
=450  \\$wnnna$aPlague, Black
=450  \\$wnnna$aPlague, Bubonic
=450  \\$wnnna$aPlague, Meningeal
=450  \\$wnnna$aPlague, Pneumonic
=450  \\$wnnna$aPlague, Pulmonic
=450  \\$wnnna$aPlague, Septicemic
=450  \\$wnnna$aPlagues, Black
=450  \\$wnnna$aPlagues, Meningeal
=450  \\$wnnna$aPlagues, Pneumonic
=450  \\$wnnna$aPlagues, Pulmonic
=450  \\$wnnna$aPlagues, Septicemic
=450  \\$aPneumonic Plague
=450  \\$wnnna$aPneumonic Plagues
=450  \\$aPulmonic Plague
=450  \\$wnnna$aPulmonic Plagues
=450  \\$wnnna$aSepticemic Plague
=450  \\$wnnna$aSepticemic Plagues
=550  \\$wg$aYersinia Infections
=667  \\$aPasteurella pestis or Yersinia pestis infection only; swine plague = HEMORRHAGIC SEPTICEMIA /vet (IM) + SWINE DISEASES (IM) but do not confuse with African swine plague ( = AFRICAN SWINE FEVER)
=680  \\$iAn acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.
=750  \0$aPlague$5IEN$0(DLC)sh 85102591

=LDR  00812cz  a2200205n  4500
=001  9880363955502441
=005  20141212204616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x649
=072  \\$aD12.$x644.$x548.$x726
=150  \\$aPlacental Hormones
=450  \\$wnnna$aHormones, Placental
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aChorionic Gonadotropin
=550  \\$wh$aGonadotropins, Equine
=550  \\$wh$aPlacental Lactogen
=680  \\$iHormones produced by the placenta include CHORIONIC GONADOTROPIN, and PLACENTAL LACTOGEN as well as steroids (ESTROGENS; PROGESTERONE), and neuropeptide hormones similar to those found in the hypothalamus (HYPOTHALAMIC HORMONES).
=750  \0$aPlacental hormones$5IEN$0(DLC)sh 85102573

=LDR  01086cz  a2200313n  4500
=001  9880363955602441
=005  20141212204615.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010925
=035  \\$aCBA4215HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x610
=150  \\$aPlacental Function Tests
=450  \\$wnnna$aFetoplacental Function Test
=450  \\$aFetoplacental Function Tests
=450  \\$wnnna$aFunction Test, Fetoplacental
=450  \\$wnnna$aFunction Test, Placental
=450  \\$wnnna$aFunction Tests, Fetoplacental
=450  \\$wnnna$aFunction Tests, Placental
=450  \\$wnnna$aPlacental Function Test
=450  \\$wnnna$aTest, Fetoplacental Function
=450  \\$wnnna$aTest, Placental Function
=450  \\$wnnna$aTests, Fetoplacental Function
=450  \\$wnnna$aTests, Placental Function
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=667  \\$aNIM
=680  \\$iMethods used for the assessment of placental function.
=688  \\$a75
=750  \0$aPlacental function tests$5IEN$0(DLC)sh 85102572

=LDR  00793cz  a2200181n  4500
=001  9880363955702441
=005  20141212204615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010924
=035  \\$aCBA4214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x777.$x608
=150  \\$aPlacental Extracts
=450  \\$wnnna$aExtracts, Placental
=550  \\$wg$aTissue Extracts
=667  \\$aextracts of placenta or placental fractions; do not confuse with chemical substances "extracted" from the placenta, as "peptides extracted from the mouse placenta" ( = PEPTIDES /anal + PLACENTA /chem)
=680  \\$iExtracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities.
=750  \0$aPlacental extracts$5IEN$0(DLC)sh 85102571

=LDR  00928cz  a2200229n  4500
=001  9880363955802441
=005  20141212204615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010923
=035  \\$aCBA4213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x420.$x714
=072  \\$aC13.$x703.$x590.$x734
=150  \\$aPlacenta Previa
=450  \\$wnnna$aPlacenta Praevia
=550  \\$wg$aObstetric Labor Complications
=550  \\$wg$aPlacenta Diseases
=667  \\$acheck the tags FEMALE & PREGNANCY
=680  \\$iAbnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Placenta Praevia
=750  \0$aPlacenta praevia$0(DLC) sh 85102570$5IEN

=LDR  01293cz  a2200385n  4500
=001  9880363955902441
=005  20141212204615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010922
=035  \\$aCBA4212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x590
=150  \\$aPlacenta Diseases
=450  \\$wnnna$aDisease, Placenta
=450  \\$wnnna$aDisease, Placental
=450  \\$wnnna$aDiseases, Placenta
=450  \\$wnnna$aDiseases, Placental
=450  \\$wnnna$aDisorder, Placenta
=450  \\$wnnna$aDisorders, Placenta
=450  \\$wnnna$aPlacenta Disease
=450  \\$wnnna$aPlacenta Disorder
=450  \\$wnnna$aPlacenta Disorders
=450  \\$wnnna$aPlacental Disease
=450  \\$wnnna$aPlacental Diseases
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aAbruptio Placentae
=550  \\$wh$aChorioamnionitis
=550  \\$wh$aPlacenta Accreta
=550  \\$wh$aPlacenta Previa
=550  \\$wh$aPlacenta, Retained
=550  \\$wh$aPlacental Insufficiency
=667  \\$acheck the tags FEMALE & PREGNANCY; FETAL MALNUTRITION is available
=680  \\$iPathological processes or abnormal functions of the PLACENTA.
=688  \\$a80; was PLACENTA DISORDERS 1969-79 (Prov 1969-72)
=750  \0$aPlacenta$xDiseases$5IEN$0(DLC)sh 85102566

=LDR  01231cz  a2200277n  4500
=001  9880363956002441
=005  20141212204614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010920
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x710
=150  \\$aPlacenta
=450  \\$wnnna$aNormal Placentoma
=450  \\$wnnna$aNormal Placentomas
=450  \\$wnnna$aPlacentas
=450  \\$aPlacentoma, Normal
=450  \\$wnnna$aPlacentomas, Normal
=450  \\$aPlacentome
=450  \\$wnnna$aPlacentomes
=550  \\$wg$aEmbryonic Structures
=550  \\$wh$aChorionic Villi
=550  \\$wh$aDecidua
=550  \\$wh$aTrophoblasts
=667  \\$amammals only; check the tags FEMALE & PREGNANCY; /blood supply: consider PLACENTAL CIRCULATION; placental serum or placental blood = PLACENTA + BLOOD
=680  \\$iA highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).
=750  \0$aPlacenta$5IEN$0(DLC)sh 85102565

=LDR  01069cz  a2200217n  4500
=001  9880363956102441
=005  20141212204613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010919
=035  \\$aCBA4209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x660
=072  \\$aE2.$x785
=150  \\$aPlacebos
=450  \\$wnnna$aSham Treatment
=550  \\$wg$aPharmaceutical Preparations
=550  \\$wg$aTherapeutics
=550  \\$aMind-Body Therapies
=667  \\$ausually NIM; do not index routinely for articles on CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; etc., unless particularly discussed; Manual 18.12.13
=680  \\$iAny dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
=750  \0$aPlacebos (Medicine)$5IEN$0(DLC)sh 85102563

=LDR  01057cz  a2200241n  4500
=001  9880363956202441
=005  20141212204612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010913
=035  \\$aCBA4203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x691
=150  \\$aPituitary-Adrenal System
=450  \\$wnnna$aPituitary Adrenal System
=450  \\$wnnna$aPituitary-Adrenal Systems
=450  \\$wnnna$aSystem, Pituitary-Adrenal
=450  \\$wnnna$aSystems, Pituitary-Adrenal
=550  \\$wg$aEndocrine Glands
=667  \\$ahypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM
=680  \\$iThe interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary.
=688  \\$a68(66); was in Cat G only 1966-74
=750  \0$81$wb$aPituitary gland$5IEN$0(DLC)sh 85102519
=750  \0$81$wb$aAdrenal glands$5IEN-HS$0(DLC)sh 85000998

=LDR  00956cz  a2200241n  4500
=001  9880363956302441
=005  20141212204612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010912
=035  \\$aCBA4202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x374.$x600
=150  \\$aPituitary-Adrenal Function Tests
=450  \\$wnnna$aFunction Test, Pituitary-Adrenal
=450  \\$wnnna$aFunction Tests, Pituitary-Adrenal
=450  \\$wnnna$aPituitary-Adrenal Function Test
=450  \\$wnnna$aPituitary Adrenal Function Tests
=450  \\$wnnna$aTest, Pituitary-Adrenal Function
=450  \\$wnnna$aTests, Pituitary-Adrenal Function
=550  \\$wg$aDiagnostic Techniques, Endocrine
=667  \\$apituit funct in relation to adrenal funct or corticoid production: differentiate from PITUITARY FUNCTION TESTS, test of pituit funct or hormonal secretion
=688  \\$a68
=750  \0$aPituitary-adrenal function tests$5IEN$0(DLC)sh 85102518

=LDR  02770cz  a2200613n  4500
=001  9880363956402441
=005  20141212204611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010911
=035  \\$aCBA4201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x609
=072  \\$aC4.$x588.$x614.$x250.$x195.$x885.$x500.$x600
=072  \\$aC10.$x228.$x140.$x211.$x885.$x500.$x600
=072  \\$aC10.$x228.$x140.$x617.$x477.$x600
=072  \\$aC10.$x228.$x140.$x617.$x738.$x675
=072  \\$aC10.$x551.$x240.$x250.$x700.$x500.$x500
=072  \\$aC19.$x344.$x609
=072  \\$aC19.$x700.$x734
=150  \\$aPituitary Neoplasms
=450  \\$wnnna$aAdenoma, Pituitary
=450  \\$wnnna$aAdenomas, Pituitary
=450  \\$wnnna$aCancer of Pituitary
=450  \\$wnnna$aCancer of the Pituitary
=450  \\$wnnna$aCancer, Pituitary
=450  \\$wnnna$aCancers, Pituitary
=450  \\$wnnna$aCarcinoma, Pituitary
=450  \\$wnnna$aCarcinomas, Pituitary
=450  \\$wnnna$aNeoplasm, Pituitary
=450  \\$wnnna$aNeoplasms, Pituitary
=450  \\$wnnna$aPituitary Adenoma
=450  \\$wnnna$aPituitary Adenomas
=450  \\$aPituitary Cancer
=450  \\$wnnna$aPituitary Cancers
=450  \\$wnnna$aPituitary Carcinoma
=450  \\$wnnna$aPituitary Carcinomas
=450  \\$wnnna$aPituitary Neoplasm
=450  \\$wnnna$aPituitary Tumor
=450  \\$wnnna$aPituitary Tumors
=450  \\$wnnna$aTumor, Pituitary
=450  \\$wnnna$aTumors, Pituitary
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aHypothalamic Neoplasms
=550  \\$wg$aPituitary Diseases
=550  \\$wh$aACTH-Secreting Pituitary Adenoma
=550  \\$wh$aGrowth Hormone-Secreting Pituitary Adenoma
=550  \\$wh$aProlactinoma
=550  \\$aAdenoma, Acidophil
=550  \\$aAdenoma, Basophil
=550  \\$aAdenoma, Chromophobe
=667  \\$acoordinate IM with histological type of neoplasm (IM); pituitary adenoma: coordinate IM with ADENOMA (IM) in spite of entry term PITUITARY ADENOMA
=680  \\$iNeoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
=750  \0$aPituitary gland$xCancer$5IEN-M$0(DLC)sh2010009989
=750  \0$aPituitary gland$xTumors$5IEN-HS$0(DLC)sh 85102525

=LDR  01294cz  a2200289n  4500
=001  9880363956502441
=005  20141212204610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x692
=072  \\$aD12.$x644.$x548.$x691.$x692
=150  \\$aPituitary Hormones, Posterior
=450  \\$aNeurohypophyseal Hormones
=450  \\$wnnna$aNeurohypophyseal Peptides
=450  \\$aPituitrin
=450  \\$wnnna$aPosterior Pituitary Hormones
=550  \\$wg$aPituitary Hormones
=550  \\$wh$aOxytocin
=550  \\$wh$aVasopressins
=550  \\$wh$aVasotocin
=550  \\$aHypothalamic Hormones
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iHormones released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). They include a number of peptides which are formed in the NEURONS in the HYPOTHALAMUS, bound to NEUROPHYSINS, and stored in the nerve terminals in the posterior pituitary. Upon stimulation, these peptides are released into the hypophysial portal vessel blood.
=688  \\$aPITUITRIN was heading 1975-95 (see under PITUITARY HORMONES, POSTERIOR 1975-90)
=750  \0$81$wb$aPituitary hormones$5IEN$0(DLC)sh 85102529
=750  \0$81$wb$aNeurohypophysis$5IEN-HS$0(DLC)sh 85091126

=LDR  01068cz  a2200289n  4500
=001  9880363956602441
=005  20141212204610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x525
=072  \\$aD12.$x644.$x548.$x691.$x525
=150  \\$aPituitary Hormones, Anterior
=450  \\$aAdenohypophyseal Hormones
=450  \\$wnnna$aAnterior Pituitary Hormones
=450  \\$wnnna$aHormones, Adenohypophyseal
=450  \\$wnnna$aHormones, Anterior Pituitary
=550  \\$wg$aPituitary Hormones
=550  \\$wh$aGonadotropins, Pituitary
=550  \\$wh$aGrowth Hormone
=550  \\$wh$aPro-Opiomelanocortin
=550  \\$wh$aProlactin
=550  \\$wh$aThyrotropin
=667  \\$aGEN; prefer specifics
=680  \\$iHormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Structurally, they include polypeptide, protein, and glycoprotein molecules.
=750  \0$81$wb$aPituitary hormones$5IEN$0(DLC)sh 85102529
=750  \0$81$wb$aAdenohypophysis$5IEN-HS$0(DLC)sh 85000837

=LDR  01193cz  a2200217n  4500
=001  9880363956702441
=005  20141212204609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010907
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631
=072  \\$aD12.$x644.$x548.$x691
=150  \\$aPituitary Hormones
=450  \\$wnnna$aHormones, Pituitary
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aPituitary Hormones, Anterior
=550  \\$wh$aPituitary Hormones, Posterior
=667  \\$aGEN or unspecified; prefer specific groups or specific hormone; /defic: consider also HYPOPITUITARISM & its specifics
=680  \\$iHormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS.
=688  \\$a72
=750  \0$aPituitary hormones$5IEN$0(DLC)sh 85102529

=LDR  01993cz  a2200409n  4500
=001  9880363956802441
=005  20141212204609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x740
=072  \\$aD12.$x644.$x400.$x400.$x740
=072  \\$aD12.$x644.$x548.$x365.$x740
=072  \\$aD12.$x776.$x641.$x650.$x405.$x740
=150  \\$aPituitary Hormone-Releasing Hormones
=450  \\$wnnna$aHormone, Hypothalamic Hypophysiotropic
=450  \\$wnnna$aHormones, Hypophysiotropic
=450  \\$wnnna$aHormones, Pituitary Hormone Releasing
=450  \\$wnnna$aHypophysiotropic Hormone, Hypothalamic
=450  \\$wnnna$aHypophysiotropic Hormones
=450  \\$wnnna$aHypothalamic Hypophysiotropic Hormone
=450  \\$wnnna$aHypothalamic Releasing Factor
=450  \\$wnnna$aHypothalamic Releasing Hormone
=450  \\$wnnna$aHypothalamic Releasing Hormones
=450  \\$wnnna$aPituitary Hormone Releasing Hormones
=450  \\$wnnna$aReleasing Hormone, Hypothalamic
=550  \\$wg$aHypothalamic Hormones
=550  \\$wh$aCorticotropin-Releasing Hormone
=550  \\$wh$aGonadotropin-Releasing Hormone
=550  \\$wh$aGrowth Hormone-Releasing Hormone
=550  \\$wh$aThyrotropin-Releasing Hormone
=550  \\$aHypothalamo-Hypophyseal System
=550  \\$aNeurosecretion
=667  \\$ageneral, prefer specifics
=680  \\$iPeptides, natural or synthetic, that stimulate the release of PITUITARY HORMONES. They were first isolated from the extracts of the HYPOTHALAMUS; MEDIAN EMINENCE; PITUITARY STALK; and NEUROHYPOPHYSIS. In addition, some hypophysiotropic hormones control pituitary cell differentiation, cell proliferation, and hormone synthesis. Some can act on more than one pituitary hormone.
=688  \\$a91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73
=750  \0$aPituitary hormone releasing factors$5IEN$0(DLC)sh 85102528

=LDR  02198cz  a2200493n  4500
=001  9880363956902441
=005  20141212192431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010904
=035  \\$aCBA4194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x747.$x875
=072  \\$aA6.$x688.$x178.$x875
=072  \\$aA6.$x688.$x357.$x750.$x875
=072  \\$aA8.$x186.$x211.$x464.$x497.$x352.$x435.$x500.$x875
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x352.$x435.$x500.$x875
=072  \\$aA8.$x713.$x49.$x875
=072  \\$aA8.$x713.$x357.$x750.$x875
=150  \\$aPituitary Gland, Posterior
=450  \\$wnnna$aGland, Posterior Pituitary
=450  \\$wnnna$aInfundibular Process
=450  \\$wnnna$aInfundibular Processes
=450  \\$wnnna$aLobe, Neural
=450  \\$wnnna$aLobes, Neural
=450  \\$wnnna$aLobus Nervosus
=450  \\$wnnna$aNervosus, Lobus
=450  \\$wnnna$aNeural Lobe
=450  \\$wnnna$aNeural Lobes
=450  \\$aNeurohypophysis
=450  \\$wnnna$aPars Nervosa of Pituitary
=450  \\$wnnna$aPituitary Pars Nervosa
=450  \\$wnnna$aPituitary Posterior Lobe
=450  \\$wnnna$aPosterior Lobe of Pituitary
=450  \\$wnnna$aPosterior Pituitary Gland
=450  \\$wnnna$aPosterior Pituitary Glands
=450  \\$wnnna$aProcess, Infundibular
=450  \\$wnnna$aProcesses, Infundibular
=550  \\$wg$aCircumventricular Organs
=550  \\$wg$aPituitary Gland
=667  \\$adiseases: coordinate IM with PITUITARY DISEASES (IM) or specifics (IM)
=680  \\$iNeural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland.
=688  \\$a1963; for HYPOTHALAMUS, INFUNDIBULAR use HYPOTHALAMUS, MIDDLE 1983-1999; for INFUNDIBULAR STALK use PITUITARY GLAND 2000-2007
=688  \\$a1963; for HYPOTHALAMUS, INFUNDIBULAR use HYPOTHALAMUS, MIDDLE 1983-1999
=750  \0$aNeurohypophysis$5IEN$0(DLC)sh 85091126

=LDR  01710cz  a2200445n  4500
=001  9880363957002441
=005  20141212192430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010903
=035  \\$aCBA4193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x747.$x500
=072  \\$aA6.$x688.$x357.$x750.$x500
=072  \\$aA8.$x186.$x211.$x464.$x497.$x352.$x435.$x500.$x500
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x352.$x435.$x500.$x500
=072  \\$aA8.$x713.$x357.$x750.$x500
=150  \\$aPituitary Gland, Anterior
=450  \\$wnnna$aAdenohypophyses
=450  \\$aAdenohypophysis
=450  \\$wnnna$aAnterior Lobe of Pituitary
=450  \\$wnnna$aAnterior, Lobus
=450  \\$wnnna$aAnterior Pituitary Gland
=450  \\$wnnna$aAnterior Pituitary Glands
=450  \\$wnnna$aAnteriors, Lobus
=450  \\$wnnna$aLobus Anterior
=450  \\$wnnna$aLobus Anteriors
=450  \\$wnnna$aPars Distalis of Pituitary
=450  \\$wnnna$aPituitary Anterior Lobe
=450  \\$wnnna$aPituitary Glands, Anterior
=450  \\$wnnna$aPituitary Pars Distalis
=550  \\$wg$aPituitary Gland
=550  \\$wh$aCorticotrophs
=550  \\$wh$aGonadotrophs
=550  \\$wh$aLactotrophs
=550  \\$wh$aSomatotrophs
=550  \\$wh$aThyrotrophs
=667  \\$adiseases: coordinate IM with PITUITARY DISEASES (IM) or specifics (IM)
=680  \\$iThe anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION.
=688  \\$a78(75)63-67; was see under PITUITARY GLAND 1968-77
=750  \0$aAdenohypophysis$5IEN$0(DLC)sh 85000837

=LDR  02263cz  a2200601n  4500
=001  9880363957102441
=005  20141212192430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010902
=035  \\$aCBA4192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x747
=072  \\$aA6.$x688.$x357.$x750
=072  \\$aA8.$x186.$x211.$x464.$x497.$x352.$x435.$x500
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x352.$x435.$x500
=072  \\$aA8.$x713.$x357.$x750
=150  \\$aPituitary Gland
=360  \\$iconsider also terms at$aHYPOPHYS-
=450  \\$wnnna$aCerebri, Hypophysis
=450  \\$wnnna$aCerebrus, Hypophysis
=450  \\$wnnna$aGland, Pituitary
=450  \\$wnnna$aGlands, Pituitary
=450  \\$wnnna$aHypophyseal Infundibulum
=450  \\$wnnna$aHypophyseal Stalk
=450  \\$wnnna$aHypophyseal Stalks
=450  \\$wnnna$aHypophyses
=450  \\$aHypophysis
=450  \\$wnnna$aHypophysis Cerebri
=450  \\$wnnna$aHypophysis Cerebrus
=450  \\$aHypothalamus, Infundibular
=450  \\$wnnna$aInfundibular Hypothalamus
=450  \\$aInfundibular Stalk
=450  \\$wnnna$aInfundibular Stalks
=450  \\$aInfundibular Stem
=450  \\$wnnna$aInfundibulum
=450  \\$aInfundibulum, Hypophyseal
=450  \\$aInfundibulum (Hypophysis)
=450  \\$wnnna$aInfundibulums
=450  \\$wnnna$aPituitary Glands
=450  \\$aPituitary Stalk
=450  \\$wnnna$aPituitary Stalks
=450  \\$wnnna$aStalk, Hypophyseal
=450  \\$wnnna$aStalk, Infundibular
=450  \\$wnnna$aStalks, Hypophyseal
=450  \\$wnnna$aStalks, Infundibular
=550  \\$wg$aEndocrine Glands
=550  \\$wg$aHypothalamo-Hypophyseal System
=550  \\$wh$aPituitary Gland, Anterior
=550  \\$wh$aPituitary Gland, Intermediate
=550  \\$wh$aPituitary Gland, Posterior
=667  \\$ageneral or unspecified: prefer specific lobes; /rad eff: consider also PITUITARY IRRADIATION; /surg: probably HYPOPHYSECTOMY; consider also PITUITARY-ADRENAL SYSTEM & HYPOTHALAMO-HYPOPHYSEAL SYSTEM
=680  \\$iA small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.
=750  \0$aPituitary gland$5IEN$0(DLC)sh 85102519

=LDR  02838cz  a2200721n  4500
=001  9880363957202441
=005  20180718115443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010900
=035  \\$aCBA4190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x617.$x738
=072  \\$aC19.$x700
=150  \\$aPituitary Diseases
=450  \\$wnnna$aAdenohypophyseal Disease
=450  \\$aAdenohypophyseal Diseases
=450  \\$wnnna$aAnterior Pituitary Disease
=450  \\$wnnna$aAnterior Pituitary Diseases
=450  \\$wnnna$aDisease, Adenohypophyseal
=450  \\$wnnna$aDisease, Anterior Pituitary
=450  \\$wnnna$aDisease, Neurohypophyseal
=450  \\$wnnna$aDisease, Pituitary
=450  \\$wnnna$aDisease, Pituitary Gland
=450  \\$wnnna$aDisease, Posterior Pituitary
=450  \\$wnnna$aDiseases, Adenohypophyseal
=450  \\$wnnna$aDiseases, Anterior Pituitary
=450  \\$wnnna$aDiseases, Neurohypophyseal
=450  \\$wnnna$aDiseases, Pituitary
=450  \\$wnnna$aDiseases, Pituitary Gland
=450  \\$wnnna$aDiseases, Posterior Pituitary
=450  \\$wnnna$aDisorder, Hypophyseal
=450  \\$wnnna$aDisorder, Pituitary
=450  \\$wnnna$aDisorders, Hypophyseal
=450  \\$wnnna$aDisorders, Pituitary
=450  \\$wnnna$aHypophyseal Disorder
=450  \\$aHypophyseal Disorders
=450  \\$wnnna$aNeurohypophyseal Disease
=450  \\$aNeurohypophyseal Diseases
=450  \\$wnnna$aPituitary Disease
=450  \\$wnnna$aPituitary Disease, Anterior
=450  \\$wnnna$aPituitary Disease, Posterior
=450  \\$wnnna$aPituitary Diseases, Anterior
=450  \\$wnnna$aPituitary Diseases, Posterior
=450  \\$wnnna$aPituitary Disorder
=450  \\$wnnna$aPituitary Disorders
=450  \\$wnnna$aPituitary Gland Disease
=450  \\$wnnna$aPituitary Gland Diseases
=450  \\$wnnna$aPosterior Pituitary Disease
=450  \\$wnnna$aPosterior Pituitary Diseases
=550  \\$wg$aEndocrine System Diseases
=550  \\$wg$aHypothalamic Diseases
=550  \\$wh$aDiabetes Insipidus
=550  \\$wh$aEmpty Sella Syndrome
=550  \\$wh$aHyperpituitarism
=550  \\$wh$aHypophysitis
=550  \\$wh$aHypopituitarism
=550  \\$wh$aInappropriate ADH Syndrome
=550  \\$wh$aPituitary Apoplexy
=550  \\$wh$aPituitary Neoplasms
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific part of pituitary (IM) if pertinent
=680  \\$iDisorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.
=688  \\$a66
=750  \0$aPituitary gland$xDiseases$5IEN$0(DLC)sh 85102520

=LDR  01014cz  a2200301n  4500
=001  9880363957302441
=005  20141212204606.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010895
=035  \\$aCBA4185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339.$x773
=072  \\$aJ1.$x637.$x51.$x339.$x773
=150  \\$aPit and Fissure Sealants
=450  \\$aDental Sealants
=450  \\$aFissure Sealants
=450  \\$wnnna$aFissure Sealants, Pit
=450  \\$wnnna$aPit Fissure Sealants
=450  \\$wnnna$aSealants, Dental
=450  \\$wnnna$aSealants, Fissure
=450  \\$wnnna$aSealants, Pit Fissure
=450  \\$aSealants, Tooth
=450  \\$wnnna$aTooth Sealants
=550  \\$wg$aDental Materials
=667  \\$aD25-26 qualif; DF: PIT SEALANTS
=680  \\$iAgents used to occlude dental enamel pits and fissures in the prevention of dental caries.
=688  \\$a80(72); was see under DENTAL MATERIALS 1975-79
=750  \0$aPit and fissure sealants (Dentistry)$5IEN$0(DLC)sh 85102478

=LDR  00852cz  a2200229n  4500
=001  9880363957402441
=005  20141212204606.0
=008  860602\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010894
=035  \\$aCBA4184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x665.$x500
=072  \\$aD3.$x383.$x855.$x500
=150  \\$aPiroxicam
=450  \\$wnnna$aCP-16171
=450  \\$wnnna$aCP 16171
=450  \\$wnnna$aCP16171
=450  \\$wnnna$aFeldene
=550  \\$wg$aThiazines
=680  \\$iA cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
=688  \\$a87
=750  \0$aPiroxicam$0(DLC) sh 85102442$5IEN

=LDR  01950cz  a2200445n  4500
=001  9880363957502441
=005  20141212204604.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010890
=035  \\$aCBA4180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x70.$x750
=150  \\$aPirenzepine
=450  \\$wnnna$aAzupharma Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$aBoehringer Ingelheim Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$act-Arzneimittel Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$aDihydrochloride, Pirenzepine
=450  \\$wnnna$aDolorgiet Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$aGastrotsepin
=450  \\$wnnna$aGastrozepin
=450  \\$wnnna$aL-S 519
=450  \\$wnnna$aLS-519
=450  \\$wnnna$aLS 519
=450  \\$wnnna$aLS519
=450  \\$wnnna$aPiren-basan
=450  \\$wnnna$aPiren basan
=450  \\$wnnna$aPirenzepin
=450  \\$wnnna$aPirenzepin-ratiopharm
=450  \\$wnnna$aPirenzepin ratiopharm
=450  \\$wnnna$apirenzepin von ct
=450  \\$wnnna$aPirenzepine Dihydrochloride
=450  \\$wnnna$aPyrenzepine
=450  \\$wnnna$aratiopharm Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$aSagitta Brand of Pirenzepine Dihydrochloride
=450  \\$wnnna$aUlcoprotect
=450  \\$wnnna$aUlgescum
=550  \\$wg$aBenzodiazepinones
=680  \\$iAn antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
=688  \\$a87
=750  \0$aPirenzepine$5IEN$0(DLC)sh 92002473

=LDR  00753cz  a2200193n  4500
=001  9880363957602441
=005  20141212204603.0
=008  800512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010884
=035  \\$aCBA4174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x610
=150  \\$aPipidae
=550  \\$wg$aAnura
=550  \\$wh$aXenopus
=667  \\$atongueless frogs; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA family of the order Anura, distinguished by the lack of a tongue. It includes four living genera of aquatic "toads". Two of the most familiar pipids are the popularly called Surinam "toad" (Pipa pipa) and XENOPUS LAEVIS.
=688  \\$a81
=750  \0$aPipidae$5IEN$0(DLC)sh 85102408

=LDR  00632cz  a2200229n  4500
=001  9880363957702441
=005  20141212204602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010881
=035  \\$aCBA4171HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x808
=150  \\$aPiperidones
=550  \\$wg$aPiperidines
=550  \\$wh$aCycloheximide
=550  \\$wh$aDexetimide
=550  \\$wh$aGlutethimide
=550  \\$wh$aNaphthalimides
=550  \\$wh$aThalidomide
=550  \\$wh$aTriacetoneamine-N-Oxyl
=688  \\$a91(71); was see under PIPERIDINES 1971-90
=750  \0$aPiperidones$5IEN$0(DLC)sh 90001414

=LDR  01603cz  a2200601n  4500
=001  9880363957802441
=005  20141212204602.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010880
=035  \\$aCBA4170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621
=150  \\$aPiperidines
=450  \\$aDanitracen$5IEN-M
=450  \\$aTibric Acid$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aAlphaprodine
=550  \\$wh$aAnabasine
=550  \\$wh$aBetalains
=550  \\$wh$aBiperiden
=550  \\$wh$aCisapride
=550  \\$wh$aClopamide
=550  \\$wh$aCyproheptadine
=550  \\$wh$aDomperidone
=550  \\$wh$aFentanyl
=550  \\$wh$aFlecainide
=550  \\$wh$aFluspirilene
=550  \\$wh$aImino Pyranoses
=550  \\$wh$aIndoramin
=550  \\$wh$aIsonipecotic Acids
=550  \\$wh$aKetanserin
=550  \\$wh$aKetotifen
=550  \\$wh$aLobeline
=550  \\$wh$aLoperamide
=550  \\$wh$aMepivacaine
=550  \\$wh$aMethylphenidate
=550  \\$wh$aMinoxidil
=550  \\$wh$aNipecotic Acids
=550  \\$wh$aParoxetine
=550  \\$wh$aPempidine
=550  \\$wh$aPenfluridol
=550  \\$wh$aPerhexiline
=550  \\$wh$aPhencyclidine
=550  \\$wh$aPipecolic Acids
=550  \\$wh$aPiperidones
=550  \\$wh$aPiperoxan
=550  \\$wh$aRitanserin
=550  \\$wh$aTerfenadine
=550  \\$wh$aTrihexyphenidyl
=550  \\$aPyridines
=680  \\$iA family of hexahydropyridines.
=688  \\$aAZACYCLONOL was heading 1963-84
=750  \0$aPiperidine$5IEN-M$0(DLC)sh 85102400

=LDR  02211cz  a2200601n  4500
=001  9880363958002441
=005  20141212204601.0
=008  830311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010878
=035  \\$aCBA4168HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x750.$x50.$x650
=072  \\$aD2.$x886.$x108.$x750.$x750.$x50.$x650
=072  \\$aD3.$x438.$x260.$x825.$x750.$x50.$x650
=072  \\$aD3.$x605.$x84.$x737.$x750.$x50.$x650
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x750.$x50.$x650
=150  \\$aPiperacillin
=450  \\$wnnna$aAB-Piperacillin
=450  \\$wnnna$aAB Piperacillin
=450  \\$wnnna$aAHP Brand of Piperacillin Sodium
=450  \\$wnnna$aAstrapin Brand of Piperacillin Sodium
=450  \\$wnnna$aCl-227193
=450  \\$wnnna$aCl 227193
=450  \\$wnnna$aCl227193
=450  \\$wnnna$acurasan Brand of Piperacillin Sodium
=450  \\$wnnna$aFresenius Brand of Piperacillin Sodium
=450  \\$wnnna$aHexal Brand of Piperacillin Sodium
=450  \\$wnnna$aLederle Brand of Pipracillin Sodium
=450  \\$wnnna$aMonosodium Salt, Piperacillin
=450  \\$wnnna$aPipcil
=450  \\$wnnna$aPipera-hameln
=450  \\$wnnna$aPipera hameln
=450  \\$wnnna$aPiperacillin curasan
=450  \\$wnnna$aPiperacillin Fresenius
=450  \\$wnnna$aPiperacillin Hexal
=450  \\$wnnna$aPiperacillin Monosodium Salt
=450  \\$wnnna$aPiperacillin-ratiopharm
=450  \\$wnnna$aPiperacillin ratiopharm
=450  \\$wnnna$aPiperacillin Sodium
=450  \\$wnnna$aPipercillin
=450  \\$wnnna$aPipracil
=450  \\$wnnna$aPipril
=450  \\$wnnna$aratiopharm Brand of Piperacillin Sodium
=450  \\$wnnna$aSalt, Piperacillin Monosodium
=450  \\$wnnna$aSodium, Piperacillin
=450  \\$wnnna$aT-1220
=450  \\$wnnna$aT 1220
=450  \\$wnnna$aT1220
=450  \\$wnnna$aWyeth Brand of Piperacillin Sodium
=550  \\$wg$aAmpicillin
=680  \\$iSemisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
=688  \\$a84
=750  \0$aPiperacillin$5IEN$0(DLC)sh 85102397

=LDR  00949cz  a2200229n  4500
=001  9880363958102441
=005  20141212204600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010874
=035  \\$aCBA4164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x840.$x558
=072  \\$aC1.$x252.$x825.$x630
=072  \\$aC1.$x252.$x847.$x840.$x558
=072  \\$aC1.$x539.$x800.$x720.$x630
=072  \\$aC17.$x800.$x838.$x765.$x630
=150  \\$aPinta
=550  \\$wg$aSkin Diseases, Bacterial
=550  \\$wg$aTreponemal Infections
=667  \\$aa nonvenereal treponemal skin infect
=680  \\$iAn infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.
=750  \0$aPinta$5IEN$0(DLC)sh 85102277

=LDR  00572cz  a2200181n  4500
=001  9880363958202441
=005  20141212204600.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010873
=035  \\$aCBA4163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x482.$x370
=150  \\$aPinocytosis
=450  \\$wnnna$aPinocytoses
=550  \\$wg$aEndocytosis
=680  \\$iThe engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles.
=688  \\$a66(64)
=750  \0$aPinocytosis$5IEN$0(DLC)sh 85102268

=LDR  02618cz  a2200565n  4500
=001  9880363958402441
=005  20141212204559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010871
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x657
=072  \\$aC4.$x557.$x470.$x670.$x657
=072  \\$aC4.$x557.$x580.$x625.$x600.$x657
=072  \\$aC4.$x588.$x614.$x250.$x195.$x766
=072  \\$aC10.$x228.$x140.$x211.$x788
=072  \\$aC10.$x551.$x240.$x250.$x625
=150  \\$aPinealoma
=450  \\$wnnna$aMixed Pineocytoma-Pineoblastoma
=450  \\$wnnna$aMixed Pineocytoma Pineoblastoma
=450  \\$wnnna$aMixed Pineocytoma-Pineoblastomas
=450  \\$wnnna$aNeoplasm, Pineal
=450  \\$aNeoplasms, Pineal
=450  \\$wnnna$aPineal Gland Tumor
=450  \\$wnnna$aPineal Gland Tumors
=450  \\$wnnna$aPineal Neoplasm
=450  \\$aPineal Neoplasms
=450  \\$wnnna$aPineal Parenchymal Tumor
=450  \\$wnnna$aPineal Parenchymal Tumors
=450  \\$wnnna$aPineal Tumor
=450  \\$wnnna$aPineal Tumors
=450  \\$aPinealocytoma
=450  \\$wnnna$aPinealocytomas
=450  \\$wnnna$aPinealomas
=450  \\$aPineoblastoma
=450  \\$wnnna$aPineoblastomas
=450  \\$aPineocytoma
=450  \\$wnnna$aPineocytoma-Pineoblastoma, Mixed
=450  \\$wnnna$aPineocytoma-Pineoblastomas, Mixed
=450  \\$wnnna$aPineocytomas
=450  \\$wnnna$aTumor, Pineal
=450  \\$wnnna$aTumor, Pineal Gland
=450  \\$wnnna$aTumor, Pineal Parenchymal
=450  \\$wnnna$aTumors, Pineal
=450  \\$wnnna$aTumors, Pineal Gland
=450  \\$wnnna$aTumors, Pineal Parenchymal
=550  \\$wg$aBrain Neoplasms
=550  \\$wg$aNeoplasms, Neuroepithelial
=667  \\$acoord IM with BRAIN NEOPLASMS + PINEAL GLAND (IM)
=680  \\$iNeoplasms which originate from pineal parenchymal cells that tend to enlarge the gland and be locally invasive. The two major forms are pineocytoma and the more malignant pineoblastoma. Pineocytomas have moderate cellularity and tend to form rosette patterns. Pineoblastomas are highly cellular tumors containing small, poorly differentiated cells. These tumors occasionally seed the neuroaxis or cause obstructive HYDROCEPHALUS or Parinaud's syndrome. GERMINOMA; CARCINOMA, EMBRYONAL; GLIOMA; and other neoplasms may arise in the pineal region with germinoma being the most common pineal region tumor. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2064; Adams et al., Principles of Neurology, 6th ed, p670)
=750  \0$aPineal gland$xTumors$5IEN-HS$0(DLC)sh 85102234

=LDR  01414cz  a2200397n  4500
=001  9880363958502441
=005  20141212192429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010870
=035  \\$aCBA4160HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x635
=072  \\$aA6.$x688.$x733
=072  \\$aA8.$x186.$x211.$x464.$x200.$x680
=072  \\$aA8.$x186.$x211.$x730.$x317.$x200.$x620
=072  \\$aA8.$x713.$x733
=150  \\$aPineal Gland
=450  \\$wnnna$aBodies, Pineal
=450  \\$wnnna$aBody, Pineal
=450  \\$wnnna$aCerebri, Epiphysis
=450  \\$wnnna$aCorpus Pineale
=450  \\$wnnna$aCorpus Pineales
=450  \\$aEpiphysis Cerebri
=450  \\$wnnna$aGland, Pineal
=450  \\$wnnna$aGlands, Pineal
=450  \\$wnnna$aPineal Bodies
=450  \\$aPineal Body
=450  \\$wnnna$aPineal Glands
=450  \\$wnnna$aPineale, Corpus
=450  \\$wnnna$aPineales, Corpus
=550  \\$wg$aEndocrine Glands
=550  \\$wg$aEpithalamus
=550  \\$wg$aNeurosecretory Systems
=667  \\$aneoplasms: coordinate PINEAL GLAND (IM) with BRAIN NEOPLASMS (IM) + histological type of neoplasm (IM); consider PINEALOMA
=680  \\$iA light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES.
=750  \0$aPineal gland$5IEN$0(DLC)sh 85102232

=LDR  00976cz  a2200241n  4500
=001  9880363958602441
=005  20141212204557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010864
=035  \\$aCBA4154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x710
=150  \\$aPilonidal Sinus
=450  \\$wnnna$aCyst, Pilonidal
=450  \\$wnnna$aCysts, Pilonidal
=450  \\$aPilonidal Cyst
=450  \\$wnnna$aPilonidal Cysts
=450  \\$wnnna$aSinus, Pilonidal
=550  \\$wg$aCysts
=667  \\$anon-neoplastic; a hair-containing cyst or sinus usually in the coccygeal region: no organ coord needed; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; /blood supply /chem /secret /ultrastruct permitted
=680  \\$iA hair-containing cyst or sinus, occurring chiefly in the coccygeal region.
=688  \\$a97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96
=750  \0$aPilonidal cyst$5IEN$0(DLC)sh 85102155

=LDR  01006cz  a2200289n  4500
=001  9880363958702441
=005  20141212204556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010862
=035  \\$aCBA4152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x672
=150  \\$aPilocarpine
=450  \\$wnnna$aHydrochloride, Pilocarpine
=450  \\$wnnna$aIsopilocarpine
=450  \\$wnnna$aIsoptocarpine
=450  \\$wnnna$aNitrate, Pilocarpine
=450  \\$wnnna$aOcusert
=450  \\$wnnna$aPilocarpine Hydrochloride
=450  \\$wnnna$aPilocarpine, Monohydrochloride, (3S-cis)-Isomer
=450  \\$wnnna$aPilocarpine Mononitrate, (3S-cis)-Isomer
=450  \\$wnnna$aPilocarpine Nitrate
=450  \\$wnnna$aSalagen
=550  \\$wg$aAlkaloids
=667  \\$a/biosyn permitted if by plant
=680  \\$iA slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
=750  \0$aPilocarpine$5IEN$0(DLC)sh 85102153

=LDR  01913cz  a2200397n  4500
=001  9880363958802441
=005  20141212204556.0
=008  790104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x180.$x285
=072  \\$aA20.$x843
=150  \\$aFimbriae, Bacterial
=450  \\$wnnna$aBacterial Fimbria
=450  \\$aBacterial Fimbriae
=450  \\$aBacterial Pili
=450  \\$wnnna$aBacterial Pilus
=450  \\$wnnna$aCommon Fimbria
=450  \\$aCommon Fimbriae
=450  \\$aCommon Pili
=450  \\$wnnna$aCommon Pilus
=450  \\$wnnna$aFimbria, Bacterial
=450  \\$wnnna$aFimbria, Common
=450  \\$wnnna$aFimbriae, Common
=450  \\$aPili, Bacterial
=450  \\$aPili, Common
=450  \\$wnnna$aPilus, Bacterial
=450  \\$wnnna$aPilus, Common
=550  \\$wg$aBacterial Structures
=550  \\$wg$aCell Surface Extensions
=550  \\$aBacteria
=550  \\$aFimbriae Proteins
=667  \\$aappendages of gram-neg bact; coord IM with specific bacterium (IM or NIM) if pertinent; A 11 qualif except /cytol; /genet permitted; DF: FIMBRIAE BACT
=680  \\$iThin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX).
=688  \\$a95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94
=750  \0$aPili (Microbiology)$5IEN-M$0(DLC)sh 85102135

=LDR  01220cz  a2200421n  4500
=001  9880363958902441
=005  20190716132109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010860
=035  \\$aCBA4150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x767
=150  \\$aPigments, Biological
=450  \\$wnnna$aBiological Pigments
=550  \\$wg$aBiological Factors
=550  \\$wh$aAdrenochrome
=550  \\$wh$aAnthocyanins
=550  \\$wh$aBile Pigments
=550  \\$wh$aCarotenoids
=550  \\$wh$aCeroid
=550  \\$wh$aFlavins
=550  \\$wh$aHemocyanins
=550  \\$wh$aLipofuscin
=550  \\$wh$aMelanins
=550  \\$wh$aPhycocyanin
=550  \\$wh$aPhycoerythrin
=550  \\$wh$aPhytochrome
=550  \\$wh$aPorphyrins
=550  \\$wh$aProdigiosin
=550  \\$wh$aPterins
=550  \\$wh$aPyocyanine
=550  \\$wh$aRetinal Pigments
=550  \\$aColoring Agents
=667  \\$adifferentiate from COLORING AGENTS
=680  \\$iAny normal or abnormal coloring matter in PLANTS; ANIMALS or micro-organisms.
=688  \\$a2006(1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Pigments
=750  \0$aPigments (Biology)$0(DLC) sh 85102094$5IEN-HS

=LDR  01365cz  a2200397n  4500
=001  9880363959002441
=005  20141212204555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010859
=035  \\$aCBA4149HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x621
=150  \\$aPigmentation Disorders
=450  \\$wnnna$aDisease, Schamberg
=450  \\$wnnna$aDisease, Schamberg's
=450  \\$wnnna$aDisorder, Pigmentation
=450  \\$wnnna$aDisorders, Pigmentation
=450  \\$aIncontinentia Pigmenti Achromians
=450  \\$aIto Syndrome
=450  \\$wnnna$aPigmentation Disorder
=450  \\$wnnna$aSchamberg Disease
=450  \\$aSchamberg's Disease
=450  \\$wnnna$aSchambergs Disease
=450  \\$wnnna$aSyndrome, Ito
=550  \\$wg$aSkin Diseases
=550  \\$wh$aArgyria
=550  \\$wh$aCafe-au-Lait Spots
=550  \\$wh$aHyperpigmentation
=550  \\$wh$aHypopigmentation
=550  \\$wh$aIncontinentia Pigmenti
=550  \\$wh$aUrticaria Pigmentosa
=550  \\$wh$aXeroderma Pigmentosum
=550  \\$wh$aYellow Nail Syndrome
=667  \\$ado not restrict to skin despite category; do not confuse X ref INCONTINENTIA PIGMENTI ACHROMIANS with INCONTINENTIA PIGMENTI
=688  \\$aSCHAMBERG'S DISEASE was see under PIGMENTATION DISORDERS 1965-85
=750  \0$aPigmentation disorders$5IEN$0(DLC)sh 85102092

=LDR  00818cz  a2200265n  4500
=001  9880363959102441
=005  20141212204554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010858
=035  \\$aCBA4148HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x620
=072  \\$aG16.$x690
=150  \\$aPigmentation
=450  \\$wnnna$aPigmentations
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aPhysical Examination
=550  \\$wh$aEye Color
=550  \\$wh$aHair Color
=550  \\$wh$aSkin Pigmentation
=550  \\$aChromatophores
=550  \\$aPigments, Biological
=667  \\$adifferentiate from COLOR in that PIGMENTATION is related to PIGMENTS, BIOLOGICAL
=680  \\$iColoration or discoloration of a part by a pigment.
=750  \0$aAnimals$xColor$5IEN-M$0(DLC)sh 85028609

=LDR  00784cz  a2200241n  4500
=001  9880363959202441
=005  20141212204554.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010857
=035  \\$aCBA4147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x670
=072  \\$aA10.$x272.$x640
=150  \\$aPigment Epithelium of Eye
=450  \\$wnnna$aEye Pigment Epithelium
=550  \\$wg$aEpithelium
=550  \\$wg$aEye
=550  \\$wh$aRetinal Pigment Epithelium
=667  \\$adetachment = RETINAL DETACHMENT
=680  \\$iThe layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye.
=688  \\$a76
=750  \0$81$wb$aVisual pigments$5IEN$0(DLC)sh 85143930
=750  \0$81$wb$aEpithelium$5IEN-HS$0(DLC)sh 85044466

=LDR  00776cz  a2200181n  4500
=001  9880363959402441
=005  20141212204553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010852
=035  \\$aCBA4142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x800
=072  \\$aD2.$x540.$x552
=150  \\$aPicrotoxin
=550  \\$wg$aCyclohexanes
=550  \\$wg$aLactones
=680  \\$iA noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates.
=750  \0$aPicrotoxin$5IEN$0(DLC)sh 85101980

=LDR  01102cz  a2200313n  4500
=001  9880363959502441
=005  20141212204552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010850
=035  \\$aCBA4140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687
=150  \\$aPicornaviridae Infections
=450  \\$wnnna$aInfection, Picornaviridae
=450  \\$wnnna$aInfection, Picornavirus
=450  \\$wnnna$aInfections, Picornaviridae
=450  \\$wnnna$aInfections, Picornavirus
=450  \\$wnnna$aPicornaviridae Infection
=450  \\$wnnna$aPicornavirus Infection
=450  \\$aPicornavirus Infections
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aCardiovirus Infections
=550  \\$wh$aCommon Cold
=550  \\$wh$aEnterovirus Infections
=550  \\$wh$aFoot-and-Mouth Disease
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iVirus diseases caused by the PICORNAVIRIDAE.
=688  \\$a94; was PICORNAVIRUS INFECTIONS 1980-93; was PICORNAVIRUS INFECTIONS (NON MESH) before 1980
=750  \0$aPicornavirus infections$5IEN$0(DLC)sh 88007036

=LDR  01177cz  a2200325n  4500
=001  9880363959602441
=005  20141212204552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010849
=035  \\$aCBA4139HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565
=072  \\$aB4.$x909.$x777.$x618
=150  \\$aPicornaviridae
=450  \\$wnnna$aPicornaviruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aAphthovirus
=550  \\$wh$aCardiovirus
=550  \\$wh$aEnterovirus
=550  \\$wh$aErbovirus
=550  \\$wh$aHepatitis Virus, Duck
=550  \\$wh$aHepatovirus
=550  \\$wh$aKobuvirus
=550  \\$wh$aParechovirus
=550  \\$wh$aRhinovirus
=550  \\$wh$aTeschovirus
=667  \\$ainfection = PICORNAVIRIDAE INFECTIONS
=680  \\$iA family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are nine genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; ERBOVIRUS; HEPATOVIRUS; KOBUVIRUS; PARECHOVIRUS; RHINOVIRUS; and TESCHOVIRUS.
=688  \\$a81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74
=750  \0$aPicornaviruses$0(DLC) sh 85101976$5IEN

=LDR  00578cz  a2200193n  4500
=001  9880363959702441
=005  20141212204551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010846
=035  \\$aCBA4136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x66.$x707.$x523
=072  \\$aD3.$x383.$x725.$x705.$x523
=150  \\$aPicloram
=450  \\$wnnna$aChloramp
=550  \\$wg$aPicolinic Acids
=680  \\$iA picolinic acid derivative that is used as a herbicide.
=688  \\$a91(71); was see under PICOLINIC ACIDS 1971-90
=750  \0$aPicloram$5IEN$0(DLC)sh 87005017

=LDR  01476cz  a2200313n  4500
=001  9880363959802441
=005  20141212204551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010845
=035  \\$aCBA4135HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x85.$x852.$x850.$x500
=072  \\$aC8.$x618.$x846.$x565.$x500
=072  \\$aC10.$x886.$x425.$x800.$x750.$x850.$x500
=072  \\$aC18.$x654.$x726.$x500.$x695
=150  \\$aObesity Hypoventilation Syndrome
=450  \\$wnnna$aHypoventilation Syndrome, Obesity
=450  \\$wnnna$aObesity-Hypoventilation Syndrome
=450  \\$aPickwickian Syndrome
=450  \\$wnnna$aSyndrome, Obesity Hypoventilation
=450  \\$wnnna$aSyndrome, Pickwickian
=550  \\$wg$aHypoventilation
=550  \\$wg$aObesity
=550  \\$wg$aSleep Apnea, Obstructive
=680  \\$iHYPOVENTILATION syndrome in very obese persons with excessive ADIPOSE TISSUE around the ABDOMEN and DIAPHRAGM. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic HYPOXIA; HYPERCAPNIA; POLYCYTHEMIA; and long periods of sleep during day and night (HYPERSOMNOLENCE). It is a condition often related to OBSTRUCTIVE SLEEP APNEA but can occur separately.
=688  \\$a2006 (1970); use PICKWICK SYNDROME 1964-1969
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Pickwickian Syndrome
=688  \\$a70; was PICKWICK SYNDROME 1964-69 (Prov)
=750  \0$aPickwickian syndrome$0(DLC) sh 85101970$5IEN

=LDR  00686cz  a2200229n  4500
=001  9880363959902441
=005  20141212204550.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010843
=035  \\$aCBA4133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795.$x700
=072  \\$aB1.$x300.$x930.$x600
=150  \\$aPichia
=450  \\$aHansenula
=450  \\$wnnna$aHansenulas
=450  \\$wnnna$aPichias
=550  \\$wg$aSaccharomycetales
=550  \\$wg$aYeasts
=680  \\$iYeast-like ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES isolated from exuded tree sap.
=688  \\$a91(75)
=750  \0$aPichia$5IEN-M$0(DLC)sh 98001688

=LDR  00579cz  a2200193n  4500
=001  9880363960002441
=005  20160429145110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010842
=035  \\$aCBA4132M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x375.$x600
=150  \\$aPica
=450  \\$wnnna$aAllotriophagy
=450  \\$aGeophagia
=550  \\$wg$aFeeding and Eating Disorders
=680  \\$iThe persistent eating of nonnutritive substances for a period of at least one month. (DSM-IV)
=688  \\$a72(68)
=750  \0$aPica (Pathology)$0(DLC) sh 85101913$5IEN-M

=LDR  01041cz  a2200229n  4500
=001  9880363960102441
=005  20141212204550.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010839
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB5.$x80.$x500.$x600
=150  \\$aPhytoplankton
=550  \\$wg$aPlankton
=550  \\$wh$aMicroalgae
=550  \\$aChlorophyta
=550  \\$aCyanobacteria
=550  \\$aDiatoms
=550  \\$aDinoflagellida
=667  \\$acoordinate with specific organism; phototrophic bacterioplankton: index PHYTOPLANKTON + BACTERIA or specific
=680  \\$iFree-floating minute organisms that are photosynthetic. The term is non-taxonomic and refers to a lifestyle (energy utilization and motility), rather than a particular type of organism. Most, but not all, are unicellular algae. Important groups include DIATOMS; DINOFLAGELLATES; CYANOBACTERIA; CHLOROPHYTA; HAPTOPHYTA; CRYPTOMONADS; and silicoflagellates.
=688  \\$a91(71); was see under PLANKTON 1971-90
=750  \0$aPhytoplankton$5IEN$0(DLC)sh 85101706

=LDR  01478cz  a2200361n  4500
=001  9880363960202441
=005  20141212204549.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010838
=035  \\$aCBA4128HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x937.$x715
=150  \\$aPhytophthora
=450  \\$wnnna$acinnamomi, Phytophthora
=450  \\$wnnna$acinnamomus, Phytophthora
=450  \\$wnnna$aparasitica, Phytophthora
=450  \\$wnnna$aparasiticas, Phytophthora
=450  \\$wnnna$aPhytophthora cinnamomi
=450  \\$wnnna$aPhytophthora cinnamomus
=450  \\$wnnna$aPhytophthora parasitica
=450  \\$wnnna$aPhytophthora parasiticas
=450  \\$wnnna$aPhytophthora ramorum
=450  \\$wnnna$aPhytophthora ramorums
=450  \\$wnnna$aPhytophthora sojae
=450  \\$wnnna$aPhytophthoras
=450  \\$wnnna$aramorum, Phytophthora
=450  \\$wnnna$aramorums, Phytophthora
=450  \\$wnnna$asojae, Phytophthora
=550  \\$wg$aOomycetes
=550  \\$wh$aPhytophthora infestans
=680  \\$iA genus of destructive parasitic OOMYCETES in the family Peronosporaceae, order Peronosporales, affecting numerous fruit, vegetable, and other crops. Differentiation of zoospores usually takes place in the sporangium and no vesicle is formed. It was previously considered a fungus.
=688  \\$a91(75); was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85
=750  \0$aPhytophthora$0(DLC) sh 85101696$5IEN

=LDR  01086cz  a2200265n  4500
=001  9880363960302441
=005  20141212204548.0
=008  780503\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010835
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x560.$x825
=072  \\$aD12.$x776.$x503.$x499.$x750
=072  \\$aD12.$x776.$x765.$x678.$x750
=150  \\$aPhytohemagglutinins
=450  \\$wnnna$aBean Lectins, Kidney
=450  \\$aKidney Bean Lectins
=450  \\$aLectins, Kidney Bean
=450  \\$wnnna$aLectins, Phaseolus vulgaris
=450  \\$aPhaseolus vulgaris Lectins
=450  \\$wnnna$avulgaris Lectins, Phaseolus
=550  \\$wg$aMucoproteins
=550  \\$wg$aPlant Lectins
=680  \\$iMucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture.
=688  \\$a79; was indexed under PLANT AGGLUTININS 1968-78
=750  \0$aPhytohemagglutinins$5IEN$0(DLC)sh 85101691

=LDR  00721cz  a2200229n  4500
=001  9880363960402441
=005  20141212204548.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010834
=035  \\$aCBA4124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x765.$x675
=072  \\$aD23.$x767.$x712
=150  \\$aPhytochrome
=550  \\$wg$aPigments, Biological
=550  \\$wg$aPlant Proteins
=550  \\$wh$aPhytochrome A
=550  \\$wh$aPhytochrome B
=667  \\$aa blue-green pigment of plants; a plant protein
=680  \\$iA blue-green biliprotein widely distributed in the plant kingdom.
=688  \\$a91(75); was see under PLANT PROTEINS 1975-90
=750  \0$aPhytochrome$5IEN$0(DLC)sh 85101688

=LDR  01101cz  a2200325n  4500
=001  9880363960502441
=005  20141212204548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010833
=035  \\$aCBA4123HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x519.$x400.$x700
=072  \\$aD9.$x853.$x519.$x400.$x700
=072  \\$aD9.$x894.$x480.$x700
=150  \\$aPhytic Acid
=450  \\$wnnna$aAcid, Phytic
=450  \\$wnnna$aCalcium Phytate
=450  \\$wnnna$aHexakisphosphate, Inositol
=450  \\$wnnna$aHexaphosphate, Inositol
=450  \\$wnnna$aInositol Hexakisphosphate
=450  \\$aInositol Hexaphosphate
=450  \\$wnnna$aPhytate
=450  \\$wnnna$aPhytate, Calcium
=450  \\$wnnna$aPhytate, Sodium
=450  \\$aPhytin
=450  \\$wnnna$aSodium Phytate
=550  \\$wg$aInositol Phosphates
=680  \\$iComplexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.
=688  \\$a78(75); was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77
=750  \0$aPhytic acid$5IEN$0(DLC)sh 85101685

=LDR  00747cz  a2200193n  4500
=001  9880363960602441
=005  20141212204548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010832
=035  \\$aCBA4122M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x700
=150  \\$a6-Phytase
=450  \\$wnnna$a6 Phytase
=450  \\$wnnna$aPhytase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=680  \\$iAn enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26.
=688  \\$a94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93
=750  \0$aPhytases$5IEN-M$0(DLC)sh2003003455

=LDR  00835cz  a2200205n  4500
=001  9880363960702441
=005  20141212204547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010830
=035  \\$aCBA4120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x583.$x682
=072  \\$aD3.$x132.$x436.$x545
=072  \\$aD3.$x438.$x473.$x402.$x545
=150  \\$aPhysostigmine
=450  \\$wnnna$aEserine
=550  \\$wg$aIndole Alkaloids
=550  \\$wg$aPhenylcarbamates
=680  \\$iA cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.
=750  \0$aPhysostigmine$0(DLC)sh2010009087$5IEN-M

=LDR  00812cz  a2200181n  4500
=001  9880363960802441
=005  20141212204546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010828
=035  \\$aCBA4118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x782.$x688
=150  \\$aPhysiology, Comparative
=450  \\$wnnna$aComparative Physiology
=550  \\$wg$aPhysiology
=667  \\$athe discipline (education, history, etc) only; for comparative physiological studies, use the qualifier/ physiol with specific anatomical term, process or organism + the Publication Type COMPARATIVE STUDY
=680  \\$iThe biological science concerned with similarities or differences in the life-supporting functions and processes of different species.
=750  \0$aPhysiology, Comparative$5IEN$0(DLC)sh 85101681

=LDR  01159cz  a2200265n  4500
=001  9880363960902441
=005  20141212204546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010827
=035  \\$aCBA4117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x782
=150  \\$aPhysiology
=450  \\$aPhysiologists$5IEN
=550  \\$wg$aBiological Science Disciplines
=550  \\$wh$aElectrophysiology
=550  \\$wh$aEndocrinology
=550  \\$wh$aNeurophysiology
=550  \\$wh$aPhysiology, Comparative
=550  \\$wh$aPsychophysiology
=667  \\$athe discipline (education, history, etc) only; use PHYSIOLOGICAL PHENOMENA or specifics treed under it for functions and processes of organisms, or the qualifier / physiology with specific anatomical terms, organisms, and physiological and psychological processes; DF: PHYSIOL
=680  \\$iThe biological science concerned with the life-supporting properties, functions, and processes of living organisms or their parts.
=750  \0$aPhysiologists$5IEN-M$0(DLC)sh 85101678
=750  \0$aHuman physiology$5IEN-HS$0(DLC)sh 85062884
=750  \0$aPhysiology$5IEN-HS$0(DLC)sh 85101679

=LDR  00435cz  a2200169n  4500
=001  9880363961002441
=005  20141212204546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010826
=035  \\$aCBA4116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x734
=150  \\$aPhysiognomy
=450  \\$wnnna$aPhysiognomies
=550  \\$wg$aInvestigative Techniques
=667  \\$ano qualif
=750  \0$aPhysiognomy$5IEN$0(DLC)sh 85101673

=LDR  01178cz   2200325n  4500
=001  9880363961102441
=005  20230901093427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010825
=035  \\$aCBA4115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671
=150  \\$aPhysics
=450  \\$wnnna$aPhysic
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aAcoustics
=550  \\$wh$aAstronomy
=550  \\$wh$aBiophysics
=550  \\$wh$aElectronics
=550  \\$wh$aHealth Physics
=550  \\$wh$aMagnetics
=550  \\$wh$aMechanics
=550  \\$wh$aMeteorology
=550  \\$wh$aNuclear Physics
=550  \\$wh$aOptics and Photonics
=550  \\$wh$aRheology
=667  \\$athe discipline (education, history, etc) only; use PHYSICAL PHENOMENA or its specifics for physical processes and principles related to matter and energy
=680  \\$iThe study of those aspects of energy and matter in terms of elementary principles and laws. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aPhysics$5IEN$0(DLC)sh 85101653
=750  \0$iNarrower mapping$aComputational physics$0(DLC)sh2022007579$4NM$5IEN-M

=LDR  01341cz  a2200325n  4500
=001  9880363961202441
=005  20141212204545.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010824
=035  \\$aCBA4114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x692
=150  \\$aPhysicians' Offices
=450  \\$aMedical Offices$5IEN
=450  \\$wnnna$aOffice, Physician's
=450  \\$wnnna$aOffice, Physicians'
=450  \\$wnnna$aOffices, Physician's
=450  \\$wnnna$aOffices, Physicians'
=450  \\$wnnna$aPhysician Office
=450  \\$wnnna$aPhysician Offices
=450  \\$wnnna$aPhysician's Office
=450  \\$wnnna$aPhysicians Office
=450  \\$wnnna$aPhysicians' Office
=450  \\$wnnna$aPhysician's Offices
=450  \\$wnnna$aPhysicians Offices
=550  \\$wg$aHealth Facilities
=667  \\$arestrict to physical office: includes reception rooms, examining rooms, treatment rooms, office, labs, etc.; not for articles with title reading, e.g., "office assessment of nutrition disord" or "office use of microscopes in otology"
=680  \\$iThe room or rooms in which the physician and staff provide patient care. The offices include all rooms in the physician's office suite.
=688  \\$a91(80); was see under HEALTH FACILITIES 1980-90
=750  \0$aMedical offices$5IEN$0(DLC)sh 85082978

=LDR  02149cz  a2200517n  4500
=001  9880363961302441
=005  20141212204545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010823
=035  \\$aCBA4113HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x740
=072  \\$aN2.$x360.$x67.$x740
=150  \\$aPhysician Assistants
=450  \\$wnnna$aAnesthesia Assistant
=450  \\$aAnesthesia Assistants
=450  \\$wnnna$aAssistant, Anesthesia
=450  \\$wnnna$aAssistant, Doctor's
=450  \\$wnnna$aAssistant, Physicians'
=450  \\$wnnna$aAssistants, Anesthesia
=450  \\$wnnna$aAssistants, Doctor's
=450  \\$wnnna$aAssistants, Physician
=450  \\$wnnna$aAssistants, Physicians'
=450  \\$wnnna$aDoctor Assistants
=450  \\$wnnna$aDoctor's Assistant
=450  \\$wnnna$aDoctor's Assistants
=450  \\$wnnna$aExtender, Physicians'
=450  \\$wnnna$aExtenders, Physicians'
=450  \\$wnnna$aFeldsher
=450  \\$aFeldshers
=450  \\$wnnna$aPhysician Assistant
=450  \\$wnnna$aPhysician Extenders
=450  \\$wnnna$aPhysicians' Assistant
=450  \\$aPhysicians' Assistants
=450  \\$wnnna$aPhysician's Assistants
=450  \\$wnnna$aPhysicians Assistants
=450  \\$wnnna$aPhysicians' Extender
=450  \\$aPhysicians' Extenders
=450  \\$wnnna$aPhysician's Extenders
=550  \\$wg$aAllied Health Personnel
=550  \\$wh$aOphthalmic Assistants
=550  \\$wh$aPediatric Assistants
=667  \\$acoordinate IM with specialty (IM); PARAMEDICS see ALLIED HEALTH PERSONNEL is available
=680  \\$iHealth professionals who practice medicine as members of a team with their supervising physicians. They deliver a broad range of medical and surgical services to diverse populations in rural and urban settings. Duties may include physical exams, diagnosis and treatment of disease, interpretation of tests, assist in surgery, and prescribe medications. (from http://www.aapa.orglabout-pas accessed 2114/2011)
=688  \\$a95; was PHYSICIANS' ASSISTANTS 1971-94
=750  \0$aPhysicians' assistants$5IEN$0(DLC)sh 85101641

=LDR  00799cz  a2200265n  4500
=001  9880363961402441
=005  20141212204544.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010822
=035  \\$aCBA4112HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x820
=072  \\$aM1.$x975.$x790
=072  \\$aN2.$x360.$x810.$x820
=150  \\$aPhysicians, Women
=450  \\$wnnna$aPhysician, Woman
=450  \\$wnnna$aPhysicians, Woman
=450  \\$wnnna$aWoman Physician
=450  \\$wnnna$aWoman Physicians
=450  \\$aWomen Physicians
=550  \\$wg$aPhysicians
=550  \\$wg$aWomen
=667  \\$a/educ = EDUCATION, MEDICAL or its specifics; Manual 34.1l.2
=680  \\$iWomen licensed to practice medicine.
=750  \0$aWomen physicians$5IEN$0(DLC)sh 85147674

=LDR  01663cz  a2200517n  4500
=001  9880363961502441
=005  20190131123149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010820
=035  \\$aCBA4110HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x810
=072  \\$aN2.$x360.$x810
=150  \\$aPhysicians
=450  \\$wnnna$aPhysician
=550  \\$wg$aHealth Personnel
=550  \\$wh$aAllergists
=550  \\$wh$aAnesthesiologists
=550  \\$wh$aCardiologists
=550  \\$wh$aDermatologists
=550  \\$wh$aEndocrinologists
=550  \\$wh$aForeign Medical Graduates
=550  \\$wh$aGastroenterologists
=550  \\$wh$aGeneral Practitioners
=550  \\$wh$aGeriatricians
=550  \\$wh$aHospitalists
=550  \\$wh$aNeurologists
=550  \\$wh$aOccupational Health Physicians
=550  \\$wh$aOncologists
=550  \\$wh$aOphthalmologists
=550  \\$wh$aOsteopathic Physicians
=550  \\$wh$aOtolaryngologists
=550  \\$wh$aPathologists
=550  \\$wh$aPediatricians
=550  \\$wh$aPhysiatrists
=550  \\$wh$aPhysicians, Family
=550  \\$wh$aPhysicians, Primary Care
=550  \\$wh$aPhysicians, Women
=550  \\$wh$aPulmonologists
=550  \\$wh$aRadiologists
=550  \\$wh$aRheumatologists
=550  \\$wh$aSurgeons
=550  \\$wh$aUrologists
=667  \\$a/educ = EDUCATION, MEDICAL or its specifics; Manual 35.2.3; in biographies: Manual 32.16.7; when not to use: Manual 34.11.1; "role of physician in ..." = PHYSICIAN'S ROLE: see note there
=680  \\$iIndividuals licensed to practice medicine.
=750  \0$aPhysicians$5IEN$0(DLC)sh 85101610

=LDR  01460cz  a2200397n  4500
=001  9880363961602441
=005  20141212204543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010817
=035  \\$aCBA4107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x650.$x675
=072  \\$aN5.$x300.$x660.$x625
=150  \\$aPhysician-Patient Relations
=450  \\$wnnna$aDoctor Patient Relation
=450  \\$wnnna$aDoctor-Patient Relation
=450  \\$wnnna$aDoctor Patient Relations
=450  \\$aDoctor-Patient Relations
=450  \\$wnnna$aPhysician Patient Relation
=450  \\$wnnna$aPhysician-Patient Relation
=450  \\$wnnna$aPhysician Patient Relations
=450  \\$wnnna$aPhysician Patient Relationship
=450  \\$wnnna$aPhysician Patient Relationships
=450  \\$wnnna$aRelation, Doctor Patient
=450  \\$wnnna$aRelation, Doctor-Patient
=450  \\$wnnna$aRelation, Physician Patient
=450  \\$wnnna$aRelation, Physician-Patient
=450  \\$wnnna$aRelations, Doctor Patient
=450  \\$wnnna$aRelations, Doctor-Patient
=450  \\$wnnna$aRelations, Physician Patient
=450  \\$wnnna$aRelations, Physician-Patient
=450  \\$wnnna$aRelationship, Physician Patient
=450  \\$wnnna$aRelationships, Physician Patient
=550  \\$wg$aProfessional-Patient Relations
=680  \\$iThe interactions between physician and patient.
=750  \0$aPhysician and patient$5IEN$0(DLC)sh 85101608

=LDR  01450cz  a2200445n  4500
=001  9880363961702441
=005  20200526132559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010811
=035  \\$aCBA4100HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1
=150  \\$aNatural Science Disciplines
=450  \\$wnnna$aDiscipline, Natural Science
=450  \\$wnnna$aDisciplines, Natural Science
=450  \\$wnnna$aNatural Science
=450  \\$wnnna$aNatural Science Discipline
=450  \\$aNatural Sciences
=450  \\$wnnna$aPhysical Science
=450  \\$aPhysical Sciences
=450  \\$wnnna$aScience, Natural
=450  \\$wnnna$aScience, Physical
=450  \\$wnnna$aSciences, Natural
=450  \\$wnnna$aSciences, Physical
=550  \\$wh$aBiological Science Disciplines
=550  \\$wh$aChemistry
=550  \\$wh$aEarth Sciences
=550  \\$wh$aMaterials Science
=550  \\$wh$aMathematics
=550  \\$wh$aMicrotechnology
=550  \\$wh$aNanotechnology
=550  \\$wh$aPhysics
=550  \\$wh$aScience
=667  \\$aGEN or unspecified; prefer specifics; SPEC: SPEC qualif
=680  \\$iThe sciences dealing with processes observable in nature.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Natural Sciences
=688  \\$a98; was Physical Sciences 1998-2001
=750  \0$aScience$0(DLC) sh 85118553$5IEN-M
=750  \0$aScientists$0(DLC) sh 85118696$5IEN-M

=LDR  01093cz  a2200277n  4500
=001  9880363961802441
=005  20181121124847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010810
=035  \\$aCBA4099HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x680
=150  \\$aPhysical and Rehabilitation Medicine
=450  \\$wnnna$aMedicine, Physical
=450  \\$wnnna$aPhysiatrics
=450  \\$aPhysiatrists$5IEN
=450  \\$aPhysiatry
=450  \\$aPhysical Medicine
=450  \\$wnnna$aPhysical Medicine and Rehabilitation
=550  \\$wg$aMedicine
=550  \\$wh$aRehabilitation
=667  \\$athe specialty; for therapy consider REHABILITATION or PHYSICAL THERAPY MODALITIES and their specifics and /rehabil with specific disease
=680  \\$iA medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients.
=688  \\$a2013 (1966)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Physical Medicine
=750  \0$aMedicine, Physical$5IEN-M$0(DLC)sh 85083159

=LDR  00897cz  a2200253n  4500
=001  9880363961902441
=005  20180326143242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010809
=035  \\$aCBA4098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x685
=072  \\$aI3.$x450.$x642.$x845.$x54.$x800
=072  \\$aN1.$x400.$x545
=150  \\$aPhysical Fitness
=450  \\$wnnna$aFitness, Physical
=550  \\$wg$aAthletic Performance
=550  \\$wg$aHealth
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wg$aCardiorespiratory Fitness
=550  \\$aExercise
=680  \\$iThe ability to carry out daily tasks and perform physical activities in a highly functional state, often as a result of physical conditioning.
=688  \\$aPHYSICAL CONDITIONING, HUMAN was see EXERCISE THERAPY 1986-96
=750  \0$aPhysical fitness$5IEN$0(DLC)sh 85101540

=LDR  01562cz  a2200469n  4500
=001  9880363962002441
=005  20180717113446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010808
=035  \\$aCBA4097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600
=150  \\$aPhysical Examination
=450  \\$wnnna$aExamination, Physical
=450  \\$wnnna$aExaminations, Physical
=450  \\$wnnna$aPhysical Examinations
=450  \\$wnnna$aPhysical Examinations and Diagnoses
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aAnthropometry
=550  \\$wh$aApgar Score
=550  \\$wh$aAuscultation
=550  \\$wh$aBlood Pressure Determination
=550  \\$wh$aBody Constitution
=550  \\$wh$aFacial Expression
=550  \\$wh$aFacies
=550  \\$wh$aGait
=550  \\$wh$aGynecological Examination
=550  \\$wh$aHeart Rate Determination
=550  \\$wh$aMetabolic Equivalent
=550  \\$wh$aMuscle Strength
=550  \\$wh$aNeurologic Examination
=550  \\$wh$aPalpation
=550  \\$wh$aPercussion
=550  \\$wh$aPigmentation
=550  \\$wh$aPulse
=550  \\$wh$aRange of Motion, Articular
=550  \\$wh$aSelf-Examination
=550  \\$wh$aVital Signs
=667  \\$aNEUROLOGIC EXAMINATION is also available; DF: PHYSICAL EXAM
=680  \\$iSystematic and thorough inspection of the patient for physical signs of disease or abnormality.
=750  \0$aPhysical diagnosis$5IEN-M$0(DLC)sh 85101514
=750  \0$aPeriodic health examinations$5IEN-HS$0(DLC)sh 85099884

=LDR  00974cz  a2200277n  4500
=001  9880363962102441
=005  20141212204540.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010807
=035  \\$aCBA4096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x680
=072  \\$aI3.$x450.$x642.$x845.$x54.$x600
=150  \\$aPhysical Endurance
=450  \\$wnnna$aEndurance, Physical
=450  \\$wnnna$aEndurances, Physical
=450  \\$wnnna$aPhysical Endurances
=550  \\$wg$aAthletic Performance
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wh$aAnaerobic Threshold
=550  \\$wh$aExercise Tolerance
=550  \\$aPhysical Fitness
=667  \\$adiffers from PHYSICAL FITNESS in that here the emphasis is on "endurance"
=680  \\$iThe time span between the beginning of physical activity by an individual and the termination because of exhaustion.
=688  \\$a77
=750  \0$aPhysical fitness$5IEN$0(DLC)sh 85101540

=LDR  01023cz  a2200217n  4500
=001  9880363962202441
=005  20141212204540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010806
=035  \\$aCBA4095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x543
=150  \\$aPhysical Education and Training
=450  \\$wnnna$aEducation, Physical
=450  \\$wnnna$aPhysical Education
=450  \\$wnnna$aPhysical Education, Training
=550  \\$wg$aEducation, Nonprofessional
=550  \\$wh$aGymnastics
=667  \\$a"instructional" & "often in schools": differentiate from EXERCISE (see MeSH definition there), from GYMNASTICS (see note there) & from EXERCISE THERAPY (prescribed exercise & physical activity); DF: PHYS ED or PHYSICAL EDUC or PHYSICAL EDUCATION
=680  \\$iInstructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY.
=750  \0$aPhysical education and training$5IEN$0(DLC)sh 85101517

=LDR  00761cz  a2200205n  4500
=001  9880363962302441
=005  20141212204539.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010804
=035  \\$aCBA4093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x46.$x550.$x550.$x600.$x700
=150  \\$aPhysarum
=450  \\$wnnna$aPhysarums
=550  \\$wg$aPhysarida
=550  \\$wh$aPhysarum polycephalum
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoa, formerly also considered a fungus. Characteristics include the presence of violet to brown spores.
=688  \\$a79(75)
=750  \0$aPhysarum$5IEN$0(DLC)sh 85101506

=LDR  00726cz  a2200241n  4500
=001  9880363962402441
=005  20141212204539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010802
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x697
=072  \\$aG16.$x100.$x178.$x605
=072  \\$aL1.$x100.$x697
=150  \\$aPhylogeny
=450  \\$wnnna$aPhylogenies
=550  \\$wg$aBiological Evolution
=550  \\$wg$aClassification
=550  \\$wg$aGenetic Phenomena
=550  \\$aClassification
=550  \\$aPhylogeography
=680  \\$iThe relationships of groups of organisms as reflected by their genetic makeup.
=688  \\$a78(75); was see under EVOLUTION 1967-77
=750  \0$aPhylogeny$5IEN$0(DLC)sh 85101498

=LDR  00606cz  a2200181n  4500
=001  9880363962502441
=005  20141212204539.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010800
=035  \\$aCBA4089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x500.$x750
=150  \\$aPhycomyces
=450  \\$wnnna$aPhycomyce
=550  \\$wg$aMucorales
=680  \\$iA genus of zygomycetous fungi in the family Mucoraceae, order MUCORALES, forming mycelia having a metallic sheen. It has been used for research on phototropism.
=688  \\$a91(75)
=750  \0$aPhycomyces$5IEN$0(DLC)sh 86007262

=LDR  00739cz  a2200205n  4500
=001  9880363962602441
=005  20141212204538.0
=008  771215\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010796
=035  \\$aCBA4085M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x113.$x600
=072  \\$aD2.$x241.$x223.$x805.$x800
=150  \\$aPhthalic Anhydrides
=450  \\$wnnna$aAnhydrides, Phthalic
=550  \\$wg$aAnhydrides
=550  \\$wg$aPhthalic Acids
=680  \\$iPhthalic acid anhydrides. Can be substituted on any carbon atom. Used extensively in industry and as a reagent in the acylation of amino- and hydroxyl groups.
=688  \\$a91(79); was see under PHTHALIC ACIDS 1979-90
=750  \0$aPhthalic anhydride$0(DLC)sh2011001273$5IEN-M

=LDR  00835cz  a2200241n  4500
=001  9880363962702441
=005  20141212204538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010795
=035  \\$aCBA4084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x805
=150  \\$aPhthalic Acids
=450  \\$wnnna$aAcids, Phthalic
=550  \\$wg$aAcids, Carbocyclic
=550  \\$wh$aDibutyl Phthalate
=550  \\$wh$aDiethylhexyl Phthalate
=550  \\$wh$ao-Phthalaldehyde
=550  \\$wh$aPhthalic Anhydrides
=550  \\$wh$aPhthalimides
=680  \\$iA group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. (Dorland, 28th ed)
=688  \\$a75; was PHTHALIC ACID 1963-74
=750  \0$aPhthalic acid$5IEN$0(DLC)sh 85101458

=LDR  00603cz  a2200217n  4500
=001  9880363962802441
=005  20141212204507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010687
=035  \\$aCBA3975HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x712
=150  \\$aPhilosophy, Nursing
=450  \\$wnnna$aNursing Philosophies
=450  \\$wnnna$aNursing Philosophy
=450  \\$wnnna$aPhilosophies, Nursing
=550  \\$wg$aPhilosophy
=550  \\$wh$aEthics, Nursing
=550  \\$wh$aHolistic Nursing
=688  \\$a74(69)
=750  \0$aNursing$xPhilosophy$5IEN$0(DLC)sh 90003890

=LDR  00633cz  a2200229n  4500
=001  9880363962902441
=005  20141212204507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010686
=035  \\$aCBA3974HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x667
=150  \\$aPhilosophy, Medical
=450  \\$wnnna$aMedical Philosophy
=550  \\$wg$aPhilosophy
=550  \\$wh$aEmpiricism
=550  \\$wh$aGerm Theory of Disease
=550  \\$wh$aHolistic Health
=550  \\$wh$aHumoralism
=550  \\$wh$aHygiene Hypothesis
=667  \\$aDF: PHILOSOPHY MED
=750  \0$aMedicine$xPhilosophy$5IEN$0(DLC)sh 85083087

=LDR  00595cz  a2200217n  4500
=001  9880363963002441
=005  20141212204507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010685
=035  \\$aCBA3973HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x622
=150  \\$aPhilosophy, Dental
=450  \\$wnnna$aDental Philosophies
=450  \\$wnnna$aDental Philosophy
=450  \\$wnnna$aPhilosophies, Dental
=550  \\$wg$aPhilosophy
=550  \\$wh$aEthics, Dental
=667  \\$aDF: PHILOSOPHY DENT
=688  \\$a74(71)
=750  \0$aDentistry$xPhilosophy$5IEN$0(IEN)369828

=LDR  00692cz  a2200181n  4500
=001  9880363963202441
=005  20141212204506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010683
=035  \\$aCBA3971HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x732.$x727
=150  \\$aPhilology, Romance
=450  \\$wnnna$aRomance Philology
=550  \\$wg$aPhilology
=667  \\$aIM; DF: PHILOL ROMANCE
=680  \\$iThe study of literature written in the Romance languages (French, Spanish, Italian, and others descended from Latin), including grammar, etymology, criticism, literary history, and language and linguistic history.
=750  \0$aRomance philology$5IEN$0(DLC)sh 85114963

=LDR  00649cz  a2200181n  4500
=001  9880363963302441
=005  20141212204506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010682
=035  \\$aCBA3970HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x732.$x602
=150  \\$aPhilology, Oriental
=450  \\$wnnna$aOriental Philology
=550  \\$wg$aPhilology
=667  \\$aIM; DF: PHILOL ORIENTAL
=680  \\$iThe study of literature written in languages of Asia and the Far East, including grammar, etymology, criticism, literary history, and language and linguistic history.
=750  \0$aOriental philology$5IEN$0(DLC)sh 85095620

=LDR  00631cz  a2200181n  4500
=001  9880363963402441
=005  20141212204505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010681
=035  \\$aCBA3969HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x732.$x477
=150  \\$aPhilology, Classical
=450  \\$wnnna$aClassical Philology
=550  \\$wg$aPhilology
=667  \\$aIM; DF: PHILOL CLASSICAL
=680  \\$iThe study of ancient Greek and Roman literature, including grammar, etymology, criticism, literary history, and language and linguistic history.
=750  \0$aClassical philology$5IEN$0(DLC)sh 85026710

=LDR  00982cz  a2200205n  4500
=001  9880363963502441
=005  20141212204505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010680
=035  \\$aCBA3968HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x732
=150  \\$aPhilology
=550  \\$wg$aLiterature
=550  \\$wh$aPhilology, Classical
=550  \\$wh$aPhilology, Oriental
=550  \\$wh$aPhilology, Romance
=667  \\$astudy of literature or language as used in literature; do not confuse with LITERATURE, literary works; GEN or unspecified; prefer specifics; DF: PHILOL
=680  \\$iThe study of literature in its widest sense, including grammar, etymology, criticism, literary history, language history, linguistic history, systems of writing, and anything else that is relevant to literature or language viewed as literature. Philology as a discipline has both philosophical and scientific overtones.
=750  \0$aPhilology$5IEN$0(DLC)sh 85100821

=LDR  00835cz  a2200241n  4500
=001  9880363963602441
=005  20141212204505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010678
=035  \\$aCBA3966HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x93.$x660
=150  \\$aPhilately
=450  \\$wnnna$aPhilatelies
=450  \\$wnnna$aPostage Stamp
=450  \\$aPostage Stamps
=450  \\$wnnna$aStamp, Postage
=450  \\$wnnna$aStamps, Postage
=550  \\$wg$aArt
=667  \\$aSPEC: SPEC qualif; stamp collecting as a hobby: coord IM with HOBBIES (IM); indexing policy: TN 245
=680  \\$iStudy of stamps or postal markings. It usually refers to the design and commemorative aspects of the stamp.
=688  \\$awas in Cat I 1975-82, was in Cat E 1963-74
=750  \0$aStamp collecting$5IEN$0(DLC)sh 85105432

=LDR  00856cz  a2200181n  4500
=001  9880364175302441
=005  20141212220041.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x157.$x249
=072  \\$aG8.$x686.$x785.$x880.$x249.$x249
=150  \\$aAndropause
=450  \\$wnnna$aChange of Life, Male
=550  \\$wg$aClimacteric
=680  \\$iAn endocrine state in men, characterized by a significant decline in the production of TESTOSTERONE; DEHYDROEPIANDROSTERONE; and other hormones such as HUMAN GROWTH HORMONE. Andropause symptoms are related to the lack of androgens including DEPRESSION, sexual dysfunction, and OSTEOPOROSIS. Andropause may also result from hormonal ablation therapy for malignant diseases.
=688  \\$a2005
=750  \0$aClimacteric, Male$0(DLC) sh 85027035$5IEN-M

=LDR  00747cz  a2200169n  4500
=001  9880364175402441
=005  20141212220040.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047648
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x157.$x500.$x562
=072  \\$aG8.$x686.$x785.$x880.$x249.$x500.$x562
=150  \\$aPerimenopause
=550  \\$wg$aMenopause
=680  \\$iThe transitional period before and after MENOPAUSE. Perimenopausal symptoms are associated with irregular MENSTRUAL CYCLE and widely fluctuated hormone levels. They may appear 6 years before menopause and subside 2 to 5 years after menopause.
=688  \\$a2005; use CLIMACTERIC 2002-2004, use PREMENOPAUSE 1995-2001
=750  \0$aPerimenopause$0(DLC) sh 97009027$5IEN-M

=LDR  00766cz  a2200229n  4500
=001  9880364175502441
=005  20150602164732.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x297
=072  \\$aD12.$x644.$x641.$x297
=150  \\$aDepsipeptides
=450  \\$wnnna$aCryptophycins
=450  \\$wnnna$aCyclic Depsipeptides
=450  \\$wnnna$aCyclodepsipeptides
=450  \\$wnnna$aDepsipeptides, Cyclic
=550  \\$wg$aPeptides, Cyclic
=550  \\$wh$aValinomycin
=680  \\$iCompounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized.
=688  \\$a2005
=750  \0$aDepsipeptides$0(DLC)sh2014002614$5IEN-M

=LDR  00737cz  a2200229n  4500
=001  9880364175602441
=005  20141212220038.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047568
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x987
=150  \\$aUnsafe Sex
=450  \\$aHigh-Risk Sex
=450  \\$wnnna$aHigh Risk Sex
=450  \\$wnnna$aSex, High-Risk
=450  \\$wnnna$aSex, Unprotected
=450  \\$wnnna$aSex, Unsafe
=450  \\$wnnna$aUnprotected Sex
=550  \\$wg$aSexual Behavior
=680  \\$iSexual behaviors which are high-risk for contracting SEXUALLY TRANSMITTED DISEASES or for producing PREGNANCY.
=688  \\$a2005; use SAFE SEX 2001-2004
=750  \0$aUnsafe sex$0(DLC)sh2005008000$5IEN-M

=LDR  01717cz  a2200337n  4500
=001  9880364175702441
=005  20141212220038.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047548
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250.$x159
=150  \\$aDefibrillators
=450  \\$wnnna$aAutomated External Defibrillator
=450  \\$wnnna$aAutomated External Defibrillators
=450  \\$wnnna$aDefibrillator
=450  \\$wnnna$aDefibrillator, Automated External
=450  \\$wnnna$aDefibrillator, External
=450  \\$wnnna$aDefibrillators, Automated External
=450  \\$wnnna$aDefibrillators, External
=450  \\$wnnna$aElectric Shock Cardiac Stimulators
=450  \\$wnnna$aExternal Defibrillator
=450  \\$wnnna$aExternal Defibrillator, Automated
=450  \\$wnnna$aExternal Defibrillators
=450  \\$wnnna$aExternal Defibrillators, Automated
=450  \\$wnnna$aStimulators, Electrical, Cardiac, Shock
=550  \\$wg$aElectrodes
=550  \\$wh$aDefibrillators, Implantable
=550  \\$aElectric Countershock
=680  \\$iCardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia (TACHYCARDIA, VENTRICULAR) that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias (called synchronized defibrillation or CARDIOVERSION), using relatively low-level discharges synchronized to the patient's ECG waveform. (UMDNS, 2003)
=688  \\$a2005
=750  \0$aDefibrillators$0(DLC) sh 85036450$5IEN-M

=LDR  01320cz  a2200325n  4500
=001  9880364175802441
=005  20141212220033.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047390
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x140.$x600
=072  \\$aD12.$x776.$x476.$x150.$x600
=150  \\$aCasein Kinase II
=450  \\$wnnna$a2alpha', Casein Kinase
=450  \\$wnnna$aCasein Kinase 2
=450  \\$wnnna$aCasein Kinase-2
=450  \\$wnnna$aCasein Kinase 2 alpha Subunit
=450  \\$wnnna$aCasein Kinase 2 alpha' Subunit
=450  \\$wnnna$aCasein Kinase 2 beta Subunit
=450  \\$wnnna$aCasein Kinase 2alpha
=450  \\$wnnna$aCasein Kinase 2alpha'
=450  \\$wnnna$aCasein Kinase TS
=450  \\$wnnna$aKinase 2alpha', Casein
=450  \\$wnnna$aKinase CKII, Protein
=450  \\$wnnna$aProtein Kinase CK2
=450  \\$wnnna$aProtein Kinase CKII
=550  \\$wg$aCasein Kinases
=680  \\$iA ubiquitous casein kinase that is comprised of two distinct catalytic subunits and dimeric regulatory subunit. Casein kinase II has been shown to phosphorylate a large number of substrates, many of which are proteins involved in the regulation of gene expression.
=688  \\$a2005(1992)
=750  \0$aProtein kinase CK2$0(DLC) sh 98003320$5IEN-M

=LDR  00567cz  a2200169n  4500
=001  9880364175902441
=005  20141212220031.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047332
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x560.$x400
=150  \\$aHolothuria
=450  \\$wnnna$aHolothurias
=550  \\$wg$aSea Cucumbers
=680  \\$iA genus of large SEA CUCUMBERS in the family Holothuriidae possessing thick body walls, a warty body surface, and microscopic ossicles.
=688  \\$a2005
=750  \0$aHolothuria$0(DLC) sh 88021522$5IEN-M

=LDR  00676cz  a2200205n  4500
=001  9880364176002441
=005  20141212220031.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047331
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x578.$x500
=150  \\$aLytechinus
=450  \\$wnnna$aLytechinus variegatus
=450  \\$wnnna$avariegatus, Lytechinus
=550  \\$wg$aSea Urchins
=680  \\$iA genus of SEA URCHINS in the family Toxopneustidae possessing trigeminate ambulacral plating.
=688  \\$a2007 (2005)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Lytechnius
=688  \\$a2005
=750  \0$aLytechinus$0(DLC) sh 88021524$5IEN-M

=LDR  00773cz  a2200217n  4500
=001  9880364176102441
=005  20141212220030.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047308
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x578.$x70
=150  \\$aArbacia
=450  \\$wnnna$aArbacia punctulata
=450  \\$wnnna$aArbacia punctulatas
=450  \\$wnnna$aArbacias
=450  \\$wnnna$apunctulata, Arbacia
=450  \\$wnnna$apunctulatas, Arbacia
=550  \\$wg$aSea Urchins
=680  \\$iA genus of SEA URCHINS in the family Arbaciidae. They have only one spheridium (stalked body) per ambulacral area (contains tube feet); most sea urchins have several spheridia per area.
=688  \\$a2005
=750  \0$aArbacia$0(DLC) sh 88021500$5IEN-M

=LDR  00745cz  a2200217n  4500
=001  9880364176202441
=005  20141212220029.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047288
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x765.$x75
=150  \\$aAsterina
=450  \\$wnnna$aAsterina pectinifera
=450  \\$wnnna$aAsterina pectiniferas
=450  \\$wnnna$aAsterinas
=450  \\$wnnna$apectinifera, Asterina
=450  \\$wnnna$apectiniferas, Asterina
=550  \\$wg$aStarfish
=680  \\$iA genus of STARFISH in the family Asterinidae. They externally hold developing embryos (EMBRYO, NON-MAMMALIAN) among the spines below the oral surface.
=688  \\$a2005
=750  \0$aAsterina$0(DLC) sh 88021924$5IEN

=LDR  00547cz  a2200169n  4500
=001  9880364176302441
=005  20141212220029.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047271
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x765.$x70
=150  \\$aAsterias
=450  \\$wnnna$aAsteria
=550  \\$wg$aStarfish
=680  \\$iA genus of STARFISH in the family Asteriidae. One species, Asterias rubens, is the most common in the north-east Atlantic region.
=688  \\$a2005
=750  \0$aAsterias$0(DLC) sh 88021503$5IEN-M

=LDR  00960cz  a2200241n  4500
=001  9880364176402441
=005  20141212220029.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047270
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x578.$x800.$x600
=150  \\$aStrongylocentrotus purpuratus
=450  \\$wnnna$aPurple Sea Urchin
=450  \\$wnnna$aPurple Sea Urchins
=450  \\$wnnna$apurpuratus, Strongylocentrotus
=450  \\$wnnna$aSea Urchin, Purple
=450  \\$wnnna$aSea Urchins, Purple
=450  \\$wnnna$aUrchin, Purple Sea
=450  \\$wnnna$aUrchins, Purple Sea
=550  \\$wg$aStrongylocentrotus
=680  \\$iA species of SEA URCHINS in the family Strongylocentrotidae found on the Pacific coastline from Alaska to Mexico. This species serves as a major research model for molecular developmental biology and other fields.
=688  \\$a2005
=750  \0$aStrongylocentrotus purpuratus$0(DLC) sh 88023383$5IEN-M

=LDR  00654cz  a2200169n  4500
=001  9880364176502441
=005  20141212220029.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047269
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408.$x578.$x800
=150  \\$aStrongylocentrotus
=550  \\$wg$aSea Urchins
=550  \\$wh$aStrongylocentrotus purpuratus
=680  \\$iA genus of SEA URCHINS in the family Strongylocentrotidae. They possess more than three pore pairs per ambulacral plate. The species STRONGYLOCENTROTUS PURPURATUS is commonly used for research.
=688  \\$a2005
=750  \0$aStrongylocentrotus$0(DLC) sh 88023382$5IEN-M

=LDR  00644cz  a2200181n  4500
=001  9880364176602441
=005  20141212220028.0
=008  040708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x25
=150  \\$aCalixarenes
=450  \\$wnnna$aCalix(n)Arenes
=450  \\$aCalixarene
=550  \\$wg$aMacrocyclic Compounds
=680  \\$iPhenolic metacyclophanes derived from condensation of PHENOLS and ALDEHYDES. The name derives from the vase-like molecular structures. A bracketed [n] indicates the number of aromatic rings.
=688  \\$a2005
=750  \0$aCalixarenes$0(DLC) sh 90000799$5IEN-M

=LDR  00535cz  a2200169n  4500
=001  9880364176702441
=005  20141212220024.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047129
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x802.$x380
=150  \\$aHaliclona
=450  \\$wnnna$aHaliclonas
=550  \\$wg$aPorifera
=680  \\$iA genus of SPONGES in the family Chalinidae characterized by unispicular secondary lines in the choanosomal skeleton.
=688  \\$a2005
=750  \0$aHaliclona$0(DLC) sh 88021492$5IEN-M

=LDR  01030cz  a2200313n  4500
=001  9880364176802441
=005  20141212220024.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047109
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x235
=072  \\$aG8.$x686.$x785.$x760.$x170.$x157
=150  \\$aFetal Development
=450  \\$wnnna$aDevelopment, Fetal
=450  \\$wnnna$aFetal Growth
=450  \\$aFetal Programming
=450  \\$wnnna$aFetal Programmings
=450  \\$aFetus$xgrowth & development
=450  \\$wnnna$aGrowth, Fetal
=550  \\$wg$aEmbryonic and Fetal Development
=550  \\$wh$aFetal Movement
=550  \\$wh$aFetal Organ Maturity
=550  \\$wh$aFetal Viability
=550  \\$wh$aFetal Weight
=550  \\$wh$aGestational Age
=667  \\$amammalian only
=680  \\$iMorphological and physiological development of FETUSES.
=688  \\$a2005, 1985-2002; use EMBRYONIC AND FETAL DEVELOPMENT 2003-2004
=750  \0$aFetus$xDevelopment$0(DLC)sh2005008659$5IEN

=LDR  01213cz  a2200313n  4500
=001  9880364176902441
=005  20141212220022.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047090
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99
=072  \\$aD2.$x886.$x108
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221
=150  \\$abeta-Lactams
=450  \\$wnnna$a4-Thia-1-Azabicyclo(3.2.0)Heptanes
=450  \\$wnnna$a4-Thia-1-Azabicyclo(4.2.0)Octanes
=450  \\$wnnna$abeta Lactams
=550  \\$wg$aAzabicyclo Compounds
=550  \\$wg$aLactams
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aCarbapenems
=550  \\$wh$aCephalosporins
=550  \\$wh$aClavulanic Acids
=550  \\$wh$aMonobactams
=550  \\$wh$aMoxalactam
=550  \\$wh$aPenicillins
=680  \\$iFour-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
=688  \\$a2005; use LACTAMS 1996-2004
=750  \0$aBeta lactam antibiotics$0(DLC) sh 86002798$5IEN-M

=LDR  00773cz  a2200217n  4500
=001  9880364177002441
=005  20141212193057.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047072
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x870.$x300
=072  \\$aD27.$x505.$x696.$x399.$x450.$x327.$x149
=072  \\$aD27.$x505.$x696.$x399.$x450.$x855.$x300
=150  \\$aAromatase Inhibitors
=450  \\$aAromatase$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, Aromatase
=550  \\$wg$aEstrogen Antagonists
=550  \\$wg$aSteroid Synthesis Inhibitors
=680  \\$iCompounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
=688  \\$a2005
=750  \0$aAromatase$xInhibitors$0(IEN)7237494$5IEN-M

=LDR  01204cz  a2200301n  4500
=001  9880364177102441
=005  20141212220021.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x101.$x74
=150  \\$aBandages, Hydrocolloid
=450  \\$wnnna$aBandage, Hydrocolloid
=450  \\$wnnna$aBandage, Hydrogel
=450  \\$aBandages, Hydrogel
=450  \\$wnnna$aDressing, Hydrocolloid
=450  \\$wnnna$aDressings, Hydrocolloid
=450  \\$wnnna$aDuoderm
=450  \\$wnnna$aHydrocolloid Bandage
=450  \\$wnnna$aHydrocolloid Bandages
=450  \\$wnnna$aHydrocolloid Dressing
=450  \\$wnnna$aHydrocolloid Dressings
=450  \\$wnnna$aHydrogel Bandage
=450  \\$wnnna$aHydrogel Bandages
=550  \\$wg$aBandages
=680  \\$iDressings comprised of a self-adhesive matrix to which hydrophilic absorbent particles are embedded. The particles consist of CELLULOSE derivatives; calcium ALGINATES; PECTINS; or GELS. The utility is based on providing a moist environment for WOUND HEALING.
=688  \\$a2005; use BANDAGES, HYDROCOLLOID (NM) 1988-2004
=750  \0$aHydrocolloid surgical dressings$0(DLC) sh 85063383$5IEN-M

=LDR  00695cz  a2200217n  4500
=001  9880364177202441
=005  20141212220021.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x850
=150  \\$aPyrazolones
=450  \\$wnnna$aPyrazolin-5-Ones
=450  \\$wnnna$aPyrazolin 5 Ones
=550  \\$wg$aPyrazoles
=550  \\$wh$aAminopyrine
=550  \\$wh$aAntipyrine
=550  \\$wh$aPhenylbutazone
=680  \\$iCompounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.
=688  \\$a2005
=750  \0$aPyrazolones$0(DLC) sh 85109309$5IEN-M

=LDR  00882cz  a2200217n  4500
=001  9880364177302441
=005  20141212220020.0
=008  040715\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047030
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x92.$x500.$x809.$x750
=150  \\$aSericins
=450  \\$wnnna$aProteins, Silk Gum
=450  \\$wnnna$aSericin
=450  \\$wnnna$aSericin-1
=450  \\$wnnna$aSericin 1
=450  \\$wnnna$aSilk Gum Proteins
=550  \\$wg$aSilk
=680  \\$iA serine-rich sticky protein secreted by MOTHS. Generally, the term refers to silkworm silk gum protein secreted in the middle section of silk gland cells of SILKWORMS, Bombyx mori. Sericin acts as a cement and coating for the two fibroin filaments in a silk strand and is readily soluble in mild alkaline solution.
=688  \\$a2005 (1974)
=750  \0$aSericin$0(DLC) sh 85120234$5IEN-M

=LDR  01089cz  a2200349n  4500
=001  9880364177402441
=005  20141212220019.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047028
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345
=150  \\$aMacrocyclic Compounds
=450  \\$wnnna$aCompounds, Macrocycle
=450  \\$wnnna$aCompounds, Macrocyclic
=450  \\$wnnna$aMacrocycle Compounds
=450  \\$wnnna$aSpherands
=450  \\$wnnna$aTorands
=550  \\$wg$aPolycyclic Compounds
=550  \\$wh$aCalixarenes
=550  \\$wh$aCrown Compounds
=550  \\$wh$aCyclodextrins
=550  \\$wh$aCycloparaffins
=550  \\$wh$aEthers, Cyclic
=550  \\$wh$aLactams, Macrocyclic
=550  \\$wh$aPeptides, Cyclic
=550  \\$wh$aPolyketides
=550  \\$wh$aTetrapyrroles
=550  \\$wh$aTrichothecenes
=667  \\$ageneral or unspecified; prefer specific group or specific compound
=680  \\$iCyclic compounds with a ring size of approximately 1-4 dozen atoms.
=688  \\$a2005
=750  \0$aMacrocyclic compounds$0(DLC) sh 92002788$5IEN-M

=LDR  00724cz  a2200229n  4500
=001  9880364177502441
=005  20141212220019.0
=008  040715\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047011
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x875
=072  \\$aD12.$x776.$x92.$x500.$x809
=072  \\$aD12.$x776.$x92.$x750
=150  \\$aSilk
=550  \\$wg$aArthropod Proteins
=550  \\$wg$aBiopolymers
=550  \\$wg$aInsect Proteins
=550  \\$wh$aFibroins
=550  \\$wh$aSericins
=680  \\$iA continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.
=688  \\$a2005; use SILK (NM) 1980 -2004
=750  \0$aSilk$0(DLC) sh 85122543$5IEN-M

=LDR  00601cz  a2200169n  4500
=001  9880364177602441
=005  20141212220018.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047010
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x493
=072  \\$aB3.$x510.$x415.$x400.$x200.$x493
=150  \\$aClostridium kluyveri
=550  \\$wg$aClostridium
=680  \\$iA species of gram-positive bacteria in the family Clostridiaceae. It is distinctive for its ability to ferment ETHANOL to caproic acid.
=688  \\$a2005
=750  \0$aClostridium kluyveri$0(DLC) sh 88023237$5IEN-M

=LDR  00860cz  a2200181n  4500
=001  9880364177702441
=005  20141212220018.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047008
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x462.$x750
=150  \\$aMarchantia
=450  \\$wnnna$aMarchantias
=550  \\$wg$aHepatophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA liverwort plant genus of the family Marchantiaceae, order Marchantiales, subclass MARCHANTIAE. Members contain brassinosteroids and DITERPENES.
=688  \\$a2005
=750  \0$aMarchantia$0(DLC) sh 88022278$5IEN-M

=LDR  00746cz  a2200181n  4500
=001  9880364177802441
=005  20141212220017.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046975
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x215
=072  \\$aB3.$x510.$x415.$x400.$x200.$x215
=150  \\$aClostridium chauvoei
=550  \\$wg$aClostridium
=667  \\$ainfection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)
=680  \\$iA species of gram-positive bacteria in the family Clostridiaceae isolated from infected CATTLE; SHEEP; and other animals. It causes blackleg in cattle and sheep and is transmitted through soil-borne spores.
=688  \\$a2005
=750  \0$aClostridium chauvoei$0(DLC) sh 88023235$5IEN-M

=LDR  00673cz  a2200181n  4500
=001  9880364177902441
=005  20141212220017.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046972
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x180
=072  \\$aB3.$x510.$x415.$x400.$x200.$x180
=150  \\$aClostridium butyricum
=550  \\$wg$aClostridium
=667  \\$ainfection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)
=680  \\$iType species of the genus CLOSTRIDIUM, a gram-positive bacteria in the family Clostridiaceae. It is used as a source of PROBIOTICS.
=688  \\$a2005
=750  \0$aClostridium butyricum$0(DLC) sh 88023234$5IEN-M

=LDR  00663cz  a2200181n  4500
=001  9880364178002441
=005  20141212220016.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046969
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x200.$x25
=072  \\$aB3.$x510.$x415.$x400.$x200.$x25
=150  \\$aClostridium acetobutylicum
=550  \\$wg$aClostridium
=667  \\$ainfection: coordinate IM with CLOSTRIDIUM INFECTIONS (IM)
=680  \\$iA species of gram-positive bacteria in the family Clostridiaceae, used for the industrial production of SOLVENTS.
=688  \\$a2005
=750  \0$aClostridium acetobutylicum$0(DLC) sh 88023232$5IEN-M

=LDR  01840cz  a2200457n  4500
=001  9880364178102441
=005  20141212220015.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046948
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681
=072  \\$aD3.$x438.$x473.$x402.$x681
=150  \\$aSecologanin Tryptamine Alkaloids
=450  \\$wnnna$aAlkaloids, Monoterpenoid Indole
=450  \\$wnnna$aAlkaloids, Rauvolfia
=450  \\$wnnna$aAlkaloids, Rauwolfia
=450  \\$wnnna$aAlkaloids, Secologanin Indole
=450  \\$wnnna$aAlkaloids, Secologanin Tryptamine
=450  \\$wnnna$aAlkaloids, Terpenoid Indole
=450  \\$wnnna$aAlseroxylon
=450  \\$wnnna$aIndole Alkaloids, Monoterpenoid
=450  \\$wnnna$aIndole Alkaloids, Secologanin
=450  \\$wnnna$aIndole Alkaloids, Terpenoid
=450  \\$wnnna$aMonoterpenoid Indole Alkaloids
=450  \\$wnnna$aRauvolfia Alkaloids
=450  \\$wnnna$aRauwolfia Alkaloids
=450  \\$wnnna$aSecologanin Indole Alkaloids
=450  \\$wnnna$aTerpenoid Indole Alkaloids
=450  \\$wnnna$aTryptamine Alkaloids, Secologanin
=450  \\$wnnna$aYohimbans
=550  \\$wg$aIndole Alkaloids
=550  \\$wh$aAjmaline
=550  \\$wh$aEllipticines
=550  \\$wh$aIbogaine
=550  \\$wh$aStrychnine
=550  \\$wh$aVinca Alkaloids
=550  \\$wh$aYohimbine
=550  \\$aRauwolfia
=680  \\$iCompounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds. These are especially found in plants of the APOCYNACEAE; LOGANIACEAE; and RUBIACEAE families.
=688  \\$a2005; for YOHIMBANS use YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS use RAUWOLFIA ALKALOIDS 1975-2004
=750  \0$aRauwolfia (Drug)$0(DLC)sh 85111571$5IEN-M

=LDR  00729cz  a2200193n  4500
=001  9880364178202441
=005  20180912110844.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046938
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x650
=072  \\$aB3.$x440.$x475.$x100.$x650
=072  \\$aB3.$x585.$x900
=150  \\$aPlectonema
=550  \\$wg$aCyanobacteria
=550  \\$wg$aNitrogen-Fixing Bacteria
=680  \\$iA form-genus of CYANOBACTERIA in the order Oscillatoriales. They are non-heterocystous but may carry out NITROGEN FIXATION under microaerobic conditions. Some smaller members have undergone transfer to the form-genus Leptolyngbya.
=688  \\$a2005
=750  \0$aPlectonema$0(DLC) sh 85103451$5IEN-M

=LDR  00791cz  a2200217n  4500
=001  9880364178302441
=005  20141212220014.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046937
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x575
=072  \\$aB3.$x440.$x475.$x100.$x575
=150  \\$aNostoc
=450  \\$wnnna$aNostoc ellipsosporum
=450  \\$wnnna$aNostoc punctiforme
=550  \\$wg$aCyanobacteria
=550  \\$wh$aNostoc commune
=550  \\$wh$aNostoc muscorum
=680  \\$iA form-genus of CYANOBACTERIA in the order Nostocales. Trichomes composed of spherical or ovoid vegetative cells along with heterocysts and akinetes. The species form symbiotic associations with a wide range of eukaryotes.
=688  \\$a2005
=750  \0$aNostoc$0(DLC) sh 85092774$5IEN-M

=LDR  01879cz  a2200445n  4500
=001  9880364178402441
=005  20141212220014.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046936
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x522
=150  \\$aPhotinia
=450  \\$wnnna$aAronia
=450  \\$wnnna$aAronia melanocarpa
=450  \\$wnnna$aAronia melanocarpas
=450  \\$wnnna$aAronias
=450  \\$wnnna$aBlack Chokeberry Tree
=450  \\$wnnna$aBlack Chokeberry Trees
=450  \\$wnnna$aBlack Chokecherry Tree
=450  \\$wnnna$aBlack Chokecherry Trees
=450  \\$wnnna$aChokeberry Tree, Black
=450  \\$wnnna$aChokeberry Trees, Black
=450  \\$wnnna$aChokecherry Tree, Black
=450  \\$wnnna$aChokecherry Trees, Black
=450  \\$wnnna$amelanocarpa, Aronia
=450  \\$wnnna$amelanocarpa, Photinia
=450  \\$wnnna$amelanocarpas, Aronia
=450  \\$wnnna$amelanocarpas, Photinia
=450  \\$wnnna$aPhotinia melanocarpa
=450  \\$wnnna$aPhotinia melanocarpas
=450  \\$wnnna$aPhotinias
=450  \\$wnnna$aTree, Black Chokeberry
=450  \\$wnnna$aTree, Black Chokecherry
=450  \\$wnnna$aTrees, Black Chokeberry
=450  \\$wnnna$aTrees, Black Chokecherry
=550  \\$wg$aRosaceae
=667  \\$aX ref BLACK CHOKECHERRY TREE: CHOKECHERRY TREE see PRUNUS is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ROSACEAE. The common names of chokeberry or chokecherry are also used for some species of PRUNUS.
=688  \\$a2005
=750  \0$aAronia$0(DLC) sh 93000308$5IEN-M

=LDR  00582cz  a2200181n  4500
=001  9880364178502441
=005  20141212220012.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046931
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x500
=072  \\$aB3.$x440.$x475.$x100.$x500
=150  \\$aMicrocystis
=450  \\$wnnna$aMicrocystis aeruginosa
=550  \\$wg$aCyanobacteria
=680  \\$iA form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles.
=688  \\$a2005
=750  \0$aMicrocystis$0(DLC) sh 88023286$5IEN-M

=LDR  01085cz  a2200277n  4500
=001  9880364178602441
=005  20141212220012.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046930
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x974
=150  \\$aThymus Plant
=450  \\$wnnna$aPlant, Thymus
=450  \\$wnnna$aPlants, Thymus
=450  \\$wnnna$aThyme
=450  \\$wnnna$aThymes
=450  \\$wnnna$aThymus Plants
=450  \\$wnnna$aThymus vulgari
=450  \\$wnnna$aThymus vulgaris
=450  \\$wnnna$avulgari, Thymus
=450  \\$wnnna$avulgaris, Thymus
=550  \\$wg$aLamiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE best known for the thyme spice added to foods.
=688  \\$a2005
=750  \0$aThymes$0(DLC) sh 85135135$5IEN-M

=LDR  01287cz  a2200337n  4500
=001  9880364178702441
=005  20141212220010.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046914
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x194
=150  \\$aDipteryx
=450  \\$wnnna$aBean, Tonka
=450  \\$wnnna$aBeans, Tonka
=450  \\$wnnna$aCoumarouna odorata
=450  \\$wnnna$aCoumarouna odoratas
=450  \\$wnnna$aDipteryx odorata
=450  \\$wnnna$aDipteryx odoratas
=450  \\$wnnna$aDipteryxs
=450  \\$wnnna$aodorata, Coumarouna
=450  \\$wnnna$aodorata, Dipteryx
=450  \\$wnnna$aodoratas, Coumarouna
=450  \\$wnnna$aodoratas, Dipteryx
=450  \\$aTonka Bean
=450  \\$wnnna$aTonka Beans
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members contain COUMARINS.
=688  \\$a2005
=750  \0$aTonka bean$0(DLC) sh 85136005$5IEN-M
=750  \0$aDipteryx$0(DLC)sh2007008907$5IEN-M

=LDR  01270cz  a2200301n  4500
=001  9880364178802441
=005  20141212220009.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046911
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5
=150  \\$aMacromolecular Substances
=450  \\$wnnna$aComplexes, Macromolecular
=450  \\$wnnna$aCompounds, Macromolecular
=450  \\$wnnna$aMacromolecular Complexes
=450  \\$wnnna$aMacromolecular Compounds
=450  \\$wnnna$aMacromolecular Compounds and Complexes
=450  \\$wnno$aMacromolecular Systems$5IEN-M
=450  \\$wnnna$aSubstances, Macromolecular
=550  \\$wh$aMicelles
=550  \\$wh$aMultiprotein Complexes
=550  \\$wh$aPolymers
=550  \\$wh$aProtein Aggregates
=550  \\$aNanostructures
=667  \\$ageneral only; do not use as a routine coordinate with specific macromolecular substances
=680  \\$iCompounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.
=688  \\$a2005
=750  \0$aMacromolecules$0(DLC) sh 85079449$5IEN-M

=LDR  01061cz  a2200301n  4500
=001  9880364178902441
=005  20141212215933.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046011
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x630
=150  \\$aPuma
=450  \\$wnnna$aCougar
=450  \\$aCougars
=450  \\$wnnna$aFelis concolor
=450  \\$aFlorida Panther
=450  \\$wnnna$aLion, Mountain
=450  \\$wnnna$aLions, Mountain
=450  \\$aMountain Lion
=450  \\$wnnna$aMountain Lions
=450  \\$wnnna$aPanther, Florida
=450  \\$aPuma concolor
=450  \\$wnnna$aPuma concolor coryi
=450  \\$wnnna$aPumas
=550  \\$wg$aFelidae
=680  \\$iA genus in the family FELIDAE comprising one species, Puma concolor. It is a large, long-tailed, feline of uniform color. The names puma, cougar, and mountain lion are used interchangeably for this species. There are more than 20 subspecies.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aPuma$0(DLC) sh 85109054$5IEN-M

=LDR  00621cz  a2200181n  4500
=001  9880364179002441
=005  20141212215932.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046010
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x600.$x800
=150  \\$aTigers
=450  \\$aPanthera tigris
=450  \\$wnnna$aTiger
=550  \\$wg$aPanthera
=680  \\$iThe species Panthera tigris, a large feline inhabiting Asia. Several subspecies exist including the Siberian tiger and Sumatran tiger.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aTiger$0(DLC) sh 85135318$5IEN-M

=LDR  00878cz  a2200277n  4500
=001  9880364179102441
=005  20141212215932.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046009
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x600
=150  \\$aPanthera
=450  \\$wnnna$aBlack Panther
=450  \\$wnnna$aJaguar
=450  \\$aJaguars
=450  \\$aLeopard
=450  \\$wnnna$aPanther, Black
=450  \\$wnnna$aPanthera onca
=450  \\$wnnna$aPanthera pardus
=550  \\$wg$aFelidae
=550  \\$wh$aLions
=550  \\$wh$aTigers
=667  \\$ado not confuse X ref LEOPARD with leopards in other genera
=680  \\$iGenus in the family FELIDAE comprised of big felines including LIONS; TIGERS; jaguars; and the leopard.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aPanthera$0(DLC) sh 86005489$5IEN-M

=LDR  00563cz  a2200181n  4500
=001  9880364179202441
=005  20141212215932.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D046008
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x500
=150  \\$aLynx
=450  \\$wnnna$aBobcat
=450  \\$aBobcats
=550  \\$wg$aFelidae
=680  \\$iA genus in the family FELIDAE comprising felines with long legs, ear tufts, and a short tail.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aLynx$0(DLC) sh 85079162$5IEN-M

=LDR  00593cz  a2200169n  4500
=001  9880364179302441
=005  20141212215932.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045991
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x250
=150  \\$aFelis
=550  \\$wg$aFelidae
=550  \\$wh$aCats
=680  \\$iGenus in the family FELIDAE comprised of small felines including the domestic cat, Felis catus (CATS) and its ancestor the wild cat, Felis silvestris.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aFelis$0(DLC) sh 85047702$5IEN-M

=LDR  01117cz  a2200373n  4500
=001  9880364179402441
=005  20141212215931.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045989
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354
=150  \\$aFelidae
=450  \\$wnnna$aClouded Leopard
=450  \\$wnnna$aClouded Leopards
=450  \\$wnnna$aLeopard, Clouded
=450  \\$wnnna$aLeopard, Snow
=450  \\$wnnna$aLeopards, Clouded
=450  \\$aLeopards, Snow
=450  \\$aLeopardus pardalis
=450  \\$wnnna$aOcelot
=450  \\$aOcelots
=450  \\$wnnna$aSnow Leopard
=450  \\$aSnow Leopards
=450  \\$wnnna$aUncia
=450  \\$wnnna$aUncia uncia
=550  \\$wg$aCarnivora
=550  \\$wh$aAcinonyx
=550  \\$wh$aFelis
=550  \\$wh$aLynx
=550  \\$wh$aPanthera
=550  \\$wh$aPuma
=680  \\$iThe cat family in the order CARNIVORA comprised of muscular, deep-chested terrestrial carnivores with a highly predatory lifestyle.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aFelidae$0(DLC) sh 85047696$5IEN-M

=LDR  00866cz  a2200277n  4500
=001  9880364179502441
=005  20141212215931.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045988
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x650
=150  \\$aProcyonidae
=450  \\$wnnna$aBassariscus astutus
=450  \\$wnnna$aCoati
=450  \\$wnnna$aCoatimundi
=450  \\$aCoatimundis
=450  \\$wnnna$aCoatis
=450  \\$wnnna$aNasua
=450  \\$wnnna$aRingtail
=450  \\$aRingtails
=550  \\$wg$aCarnivora
=550  \\$wh$aRaccoons
=680  \\$iA family of long-tailed terrestrial omnivores including RACCOONS, ringtails, and coatimundis.
=688  \\$a2005; use CARNIVORA 1998
=688  \\$a2005; use CARNIVORA 1998; for PANDAS, LESSER use CARNIVORA 1997-2004
=750  \0$aProcyonidae$0(DLC) sh 85107178

=LDR  01062cz  a2200361n  4500
=001  9880364179602441
=005  20141212215931.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045969
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x550
=150  \\$aMustelidae
=450  \\$wnnna$aBadger
=450  \\$aBadgers
=450  \\$aGulo
=450  \\$wnnna$aGulos
=450  \\$wnnna$aMarten
=450  \\$aMartens
=450  \\$aMartes
=450  \\$aMartes zibellina
=450  \\$wnnna$aSable
=450  \\$aSables
=450  \\$wnnna$aWeasel
=450  \\$aWeasels
=450  \\$wnnna$aWolverine
=450  \\$aWolverines
=550  \\$wg$aCarnivora
=550  \\$wh$aFerrets
=550  \\$wh$aMink
=550  \\$wh$aOtters
=680  \\$iA family of terrestrial carnivores with long, slender bodies, long tails, and anal scent glands. They include badgers, weasels, martens, FERRETS; MINKS; wolverines, polecats, and OTTERS.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aMustelidae$0(DLC) sh 85089120$5IEN-M

=LDR  00728cz  a2200229n  4500
=001  9880364179702441
=005  20141212215930.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045968
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x410
=150  \\$aHyaenidae
=450  \\$wnnna$aAardwolve
=450  \\$aAardwolves
=450  \\$wnnna$aHyena
=450  \\$aHyenas
=450  \\$wnnna$aProtele
=450  \\$aProteles
=550  \\$wg$aCarnivora
=680  \\$iA family of large terrestrial carnivores possessing long legs, coarse guard hairs and a busy tail. It is comprised of hyenas and aardwolves.
=688  \\$a2005; use CARNIVORA 1998-2004
=750  \0$aHyaenidae$0(DLC) sh 93004306$5IEN-M

=LDR  00884cz  a2200253n  4500
=001  9880364179802441
=005  20141212215930.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045949
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x900
=150  \\$aViverridae
=450  \\$wnnna$aCat, Civet
=450  \\$wnnna$aCats, Civet
=450  \\$wnnna$aCivet
=450  \\$wnnna$aCivet Cat
=450  \\$aCivet Cats
=450  \\$aCivets
=450  \\$aGenets
=550  \\$wg$aCarnivora
=667  \\$anote entry terms: CIVET, MALAGASY see EUPLERIDAE and AFRICAN PALM CIVET see NANDINIIDAE are also available
=680  \\$iThe family of civets which are small and medium-sized Old World carnivores, often striped or spotted.
=688  \\$a2005; use CARNIVORA 1998-2004; for CIVET CATS use CARNIVORA 2004
=750  \0$aViverridae$0(DLC) sh 85144037$5IEN-M

=LDR  01272cz  a2200373n  4500
=001  9882104696602441
=005  20230109155853.0
=008  030714\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044469
=035  \\$a(DNLM)D044469
=035  \\$a(NLM)98198555620000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x477.$x625.$x594
=150  \\$aRacial Groups
=450  \\$wnnna$aRace
=450  \\$wnnna$aRacial Stocks
=450  \\$aContinental Population Groups
=450  \\$wnnna$aContinental Population Group
=450  \\$wnnna$aGroup, Continental Population
=450  \\$wnnna$aGroup, Racial
=450  \\$wnnna$aGroups, Continental Population
=450  \\$wnnna$aGroups, Racial
=450  \\$wnnna$aPopulation Group, Continental
=450  \\$wnnna$aPopulation Groups, Continental
=450  \\$wnnna$aRaces
=450  \\$wnnna$aRacial Group
=450  \\$wnnna$aRacial Stock
=450  \\$wnnna$aStock, Racial
=450  \\$wnnna$aStocks, Racial
=550  \\$aRace Factors
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iGroups of individuals with similar physical appearances often reinforced by cultural, social and/or linguistic similarities.
=688  \\$a2022(1968)
=750  \0$aRace$5IEN-M$0(DLC)sh 85110232

=LDR  00944cz  a2200253n  4500
=001  9880364180002441
=005  20251029104449.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045930
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x80
=150  \\$aAnabolic Agents
=450  \\$wnnna$aAgents, Anabolic
=450  \\$wnnna$aAnabolic Effect
=450  \\$wnnna$aAnabolic Effects
=450  \\$wnno$aAnabolic Steroids$5IEN-M
=450  \\$wnnna$aEffect, Anabolic
=450  \\$wnnna$aEffects, Anabolic
=550  \\$wg$aHormones
=667  \\$anote entry term ANABOLIC EFFECT: use only for the anabolic effect of a chemical substance
=680  \\$iThese compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power.
=688  \\$a2004
=750  \0$iNarrower mapping$aAnabolic steroids$0(DLC)sh 85004733$4NM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/05/22

=LDR  00974cz  a2200229n  4500
=001  9880364180102441
=005  20141212215929.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045908
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x615
=072  \\$aC22.$x735.$x750
=072  \\$aC22.$x795.$x600
=150  \\$aMonkeypox
=450  \\$wnnna$aMonkey Pox
=550  \\$wg$aPoxviridae Infections
=550  \\$wg$aPrimate Diseases
=550  \\$wg$aRodent Diseases
=667  \\$ahuman & animal; if in animal, use/vet
=680  \\$iA viral disease infecting PRIMATES and RODENTS. Its clinical presentation in humans is similar to SMALLPOX including FEVER; HEADACHE; COUGH; and a painful RASH. It is caused by MONKEYPOX VIRUS and is usually transmitted to humans through BITES or via contact with an animal's BLOOD. Interhuman transmission is relatively low (significantly less than smallpox).
=688  \\$a2004
=750  \0$aMonkeypox$5IEN-M$0(DLC)sh 88003281

=LDR  01522cz  a2200397n  4500
=001  9880364180202441
=005  20141212215929.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045868
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x894
=150  \\$aSorghum
=450  \\$wnnna$abicolor, Sorghum
=450  \\$wnnna$abicolors, Sorghum
=450  \\$wnnna$aCorn, Kaffir
=450  \\$wnnna$aCorns, Kaffir
=450  \\$wnnna$ahalepense, Sorghum
=450  \\$wnnna$ahalepenses, Sorghum
=450  \\$wnnna$aJohnsongrass
=450  \\$wnnna$aJohnsongrasses
=450  \\$wnnna$aKaffir Corn
=450  \\$wnnna$aKaffir Corns
=450  \\$wnnna$aKafir
=450  \\$wnnna$aKafirs
=450  \\$wnnna$aSorghum bicolor
=450  \\$wnnna$aSorghum bicolors
=450  \\$wnnna$aSorghum halepense
=450  \\$wnnna$aSorghum halepenses
=450  \\$wnnna$aSorghums
=450  \\$wnnna$aSudangrass
=450  \\$wnnna$aSudangrasses
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The grain is used for FOOD and for ANIMAL FEED. This should not be confused with KAFFIR LIME or with KEFIR milk product.
=688  \\$a2004
=750  \0$aSorghum$0(DLC) sh 85125316$5IEN-M

=LDR  00673cz  a2200181n  4500
=001  9880364180302441
=005  20141212215928.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045859
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x415.$x400.$x230
=072  \\$aB3.$x900.$x300
=150  \\$aDesulfotomaculum
=550  \\$wg$aGram-Positive Endospore-Forming Rods
=550  \\$wg$aSulfur-Reducing Bacteria
=680  \\$iA genus of anaerobic bacteria in the family PEPTOCOCCACEAE, widely distributed in SOIL and the RUMEN of animals. Stains gram-negative but cell wall is gram-positive type.
=688  \\$a2004
=750  \0$aDesulfotomaculum$0(DLC)sh2013003014$5IEN-M

=LDR  00775cz  a2200241n  4500
=001  9880364180402441
=005  20170317163103.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045854
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x353.$x984
=072  \\$aB3.$x440.$x425.$x410.$x800
=150  \\$aVeillonellaceae
=450  \\$aAcidaminococcaceae
=550  \\$wg$aFirmicutes
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$wh$aPectinatus
=550  \\$wh$aSelenomonas
=550  \\$wh$aVeillonella
=680  \\$iA family of  gram-negative bacteria, in the phylum FIRMICUTES.
=688  \\$a2004
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Acidaminococcaceae
=750  \0$aVeillonellaceae$0(DLC) sh 88023357$5IEN-M

=LDR  00718cz  a2200217n  4500
=001  9880364180502441
=005  20141212215924.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x531.$x568
=072  \\$aC23.$x300.$x970.$x500
=150  \\$aIntestinal Volvulus
=450  \\$wnnna$aVolvulus
=450  \\$wnnna$aVolvulus, Intestinal
=450  \\$wnnna$aVolvulus, Intestine
=550  \\$wg$aIntestinal Obstruction
=550  \\$wg$aTorsion Abnormality
=680  \\$iA twisting in the intestine (INTESTINES) that can cause INTESTINAL OBSTRUCTION.
=688  \\$a2004; use INTESTINAL OBSTRUCTION 1975-2003
=750  \0$aVolvulus$5IEN-M$0(DLC)sh 85144380

=LDR  00988cz  a2200277n  4500
=001  9880364180602441
=005  20141212215922.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045792
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x309
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x375
=072  \\$aD2.$x455.$x849.$x131.$x309
=150  \\$aNorisoprenoids
=450  \\$wnnna$aDamascones
=450  \\$wnnna$aIonones
=450  \\$wnnna$aIrones
=450  \\$wnnna$aMegastigmanes
=450  \\$wnnna$aNor-Isoprenoids
=450  \\$wnnna$aNor Isoprenoids
=450  \\$wnnna$aTheaspiranes
=450  \\$wnnna$aVitispiranes
=550  \\$wg$aCarotenoids
=680  \\$iThirteen-carbon butene cyclohexene degradation products formed by the cleavage of CAROTENOIDS. They contribute to the flavor of some FRUIT. Ionone should not be confused with the similarly named ionol.
=688  \\$a2004
=750  \0$aIonones$5IEN-M$0(DLC)sh 85067831

=LDR  01803cz  a2200577n  4500
=001  9880364180702441
=005  20200511112810.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045730
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x203.$x200.$x775
=072  \\$aG7.$x203.$x300.$x850.$x450.$x500
=072  \\$aJ2.$x350.$x775
=072  \\$aJ2.$x500.$x850.$x800.$x500
=150  \\$aSoy Foods
=450  \\$aBean Curd, Soy
=450  \\$wnnna$aBean Curds, Soy
=450  \\$wnnna$aCheese, Soy
=450  \\$wnnna$aCheeses, Soy
=450  \\$wnnna$aCurd, Soy Bean
=450  \\$wnnna$aCurds, Soy Bean
=450  \\$wnnna$aFood, Soy
=450  \\$wnnna$aFoods, Soy
=450  \\$aMiso
=450  \\$aNatto
=450  \\$wnnna$aProtein, Texturized Soy
=450  \\$wnnna$aProtein, Texturized Vegetable
=450  \\$wnnna$aProteins, Texturized Soy
=450  \\$wnnna$aSauce, Soy
=450  \\$wnnna$aSoy Bean Curd
=450  \\$wnnna$aSoy Bean Curds
=450  \\$aSoy Cheese
=450  \\$wnnna$aSoy Cheeses
=450  \\$wnnna$aSoy Food
=450  \\$wnnna$aSoy Protein, Texturized
=450  \\$wnnna$aSoy Proteins, Texturized
=450  \\$aSoy Sauce
=450  \\$wnnna$aTempeh
=450  \\$aTexturized Soy Protein
=450  \\$wnnna$aTexturized Soy Proteins
=450  \\$aTexturized Vegetable Protein
=450  \\$aTofu
=450  \\$wnnna$aVegetable Protein, Texturized
=450  \\$wnnna$aVegetable Proteins, Texturized
=550  \\$wg$aFermented Foods and Beverages
=550  \\$wg$aVegetable Products
=550  \\$wh$aSoy Milk
=550  \\$wh$aSoybean Proteins
=680  \\$iFoods made from SOYBEANS. Health benefits are ascribed to the high levels of DIETARY PROTEINS and ISOFLAVONES.
=688  \\$a2004
=750  \0$aSoyfoods$0(DLC) sh 85125887$5IEN-M

=LDR  00586cz  a2200193n  4500
=001  9880364180802441
=005  20141212215917.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045728
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x437
=072  \\$aD3.$x549.$x909.$x437
=072  \\$aD4.$x345.$x783.$x437
=150  \\$aCorrinoids
=550  \\$wg$aTetrapyrroles
=550  \\$wh$aVitamin B 12
=680  \\$iCyclic TETRAPYRROLES based on the corrin skeleton.
=688  \\$a2004; use CORRINOIDS (NM) 1975-2003
=750  \0$aCorrinoids$0(DLC)sh2006004546$5IEN-M

=LDR  00771cz  a2200217n  4500
=001  9880364180902441
=005  20141212215916.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045726
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x675
=150  \\$aMetalloproteases
=450  \\$wnnna$aMetallopeptidases
=450  \\$aMetalloproteinases
=550  \\$wg$aPeptide Hydrolases
=550  \\$wh$aMetalloendopeptidases
=550  \\$wh$aMetalloexopeptidases
=667  \\$aGEN; prefer specifics
=680  \\$iProteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS.
=688  \\$a2004; use METALLOENDOPEPTIDASES 1988-2003
=750  \0$aMetalloproteinases$0(DLC) sh 94005070$5IEN-M

=LDR  00894cz  a2200265n  4500
=001  9880364181002441
=005  20141212215916.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045725
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840
=072  \\$aD3.$x549.$x909
=072  \\$aD4.$x345.$x783
=150  \\$aTetrapyrroles
=550  \\$wg$aHeterocyclic Compounds with 4 or More Rings
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wg$aPyrroles
=550  \\$wh$aBile Pigments
=550  \\$wh$aChlorophyll
=550  \\$wh$aCorrinoids
=550  \\$wh$aPhycobilins
=550  \\$wh$aPorphyrins
=680  \\$iFour PYRROLES joined by one-carbon units linking position 2 of one to position 5 of the next. The conjugated bond system results in PIGMENTATION.
=688  \\$a2004; use TETRAPYRROLES (NM) 1978-2003
=750  \0$aTetrapyrroles$0(DLC) sh 85134221$5IEN-M

=LDR  00580cz  a2200169n  4500
=001  9880364181102441
=005  20141212215913.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x860.$x580.$x553.$x553.$x345
=150  \\$aMycoplasma gallisepticum
=550  \\$wg$aMycoplasma
=667  \\$ainfection: coord IM with MYCOPLASMA INFECTIONS (IM)
=680  \\$iA species of gram-negative bacteria causing chronic respiratory disease in POULTRY.
=688  \\$a2004
=750  \0$aMycoplasma gallisepticum$5IEN-M$0(DLC)sh 88023293

=LDR  01222cz  a2200313n  4500
=001  9880364181202441
=005  20141212215911.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x705
=072  \\$aJ1.$x637.$x512.$x600.$x650
=150  \\$aQuantum Dots
=450  \\$wnnna$aDot, Quantum
=450  \\$wnnna$aDots, Quantum
=450  \\$aNanocrystals, Semiconductor
=450  \\$wnnna$aNanoparticle, Semiconductor
=450  \\$wnnna$aNanoparticles, Semiconductor
=450  \\$wnnna$aQuantum Dot
=450  \\$aSemiconductor Nanocrystals
=450  \\$wnnna$aSemiconductor Nanoparticle
=450  \\$wnnna$aSemiconductor Nanoparticles
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aNanoparticles
=550  \\$aSemiconductors
=667  \\$ado not confuse with microscopic fluorescent bar codes which are micrometer sized
=680  \\$iNanometer sized fragments of semiconductor crystalline material which emit PHOTONS. The wavelength is based on the quantum confinement size of the dot. They can be embedded in MICROBEADS for high throughput ANALYTICAL CHEMISTRY TECHNIQUES.
=688  \\$a2004
=750  \0$aQuantum dots$0(DLC)sh 98002716$5IEN-M

=LDR  01473cz  a2200433n  4500
=001  9880364181302441
=005  20170831164643.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x295.$x260
=072  \\$aA12.$x207.$x270
=150  \\$aExtracellular Fluid
=450  \\$wnnna$aExtracellular Fluids
=450  \\$wnnna$aFluid, Extracellular
=450  \\$wnnna$aFluid, Intercellular
=450  \\$wnnna$aFluid, Interstitial
=450  \\$wnnna$aFluids, Extracellular
=450  \\$wnnna$aFluids, Intercellular
=450  \\$wnnna$aFluids, Interstitial
=450  \\$wnnna$aIntercellular Fluid
=450  \\$wnnna$aIntercellular Fluids
=450  \\$aInterstitial Fluid
=450  \\$wnnna$aInterstitial Fluids
=550  \\$wg$aBody Fluids
=550  \\$wg$aExtracellular Space
=550  \\$wh$aAqueous Humor
=550  \\$wh$aCerebrospinal Fluid
=550  \\$wh$aExtravascular Lung Water
=550  \\$wh$aFollicular Fluid
=550  \\$wh$aLabyrinthine Fluids
=550  \\$wh$aLymph
=550  \\$wh$aPericardial Fluid
=550  \\$wh$aPlasma
=550  \\$wh$aSynovial Fluid
=667  \\$ado not confuse EXTRACELLULAR FLUID with BODY WATER
=680  \\$iThe fluid of the body that is outside of CELLS. It is the external environment for the cells.
=688  \\$a2004; use EXTRACELLULAR SPACE 1975-2003, use BODY FLUIDS 1963-1974
=750  \0$aExtracellular fluid$5IEN-M$0(DLC)sh 85046576

=LDR  00596cz  a2200169n  4500
=001  9880364181402441
=005  20141212215908.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045602
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637.$x887
=072  \\$aC18.$x452.$x603.$x887
=150  \\$aSteatorrhea
=550  \\$wg$aMalabsorption Syndromes
=680  \\$iA condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.
=688  \\$a2004; use CELIAC DISEASE 1975-2003
=750  \0$aSprue$0(DLC) sh 85127047$5IEN-M

=LDR  01216cz  a2200349n  4500
=001  9880364181502441
=005  20141212215906.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045567
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x739.$x900
=072  \\$aD8.$x811.$x913.$x696.$x445.$x950
=150  \\$aVDJ Recombinases
=450  \\$wnnna$aImmunoglobulin Recombinase
=450  \\$aImmunoglobulin Recombinases
=450  \\$wnnna$aRecombinase, Immunoglobulin
=450  \\$wnnna$aRecombinase, V-D-J
=450  \\$wnnna$aRecombinase, VDJ
=450  \\$wnnna$aRecombinases, Immunoglobulin
=450  \\$wnnna$aV(D)J Recombinase
=450  \\$wnnna$aV-(D)-J Recombinase
=450  \\$wnnna$aV-D-J Recombinase
=450  \\$wnnna$aV D J Recombinase
=450  \\$aVDJ Recombinase
=550  \\$wg$aNucleotidyltransferases
=550  \\$wg$aRecombinases
=550  \\$aGene Rearrangement
=550  \\$aV(D)J Recombination
=550  \\$aVDJ Exons
=680  \\$iRecombinases involved in the rearrangement of immunity-related GENES such as IMMUNOGLOBULIN GENES and T-CELL RECEPTOR GENES.
=688  \\$a2004; use VDJ RECOMBINASES (NM) 1986-2003
=750  \0$aVDJ recombinases$0(DLC)sh2007009104$5IEN-M

=LDR  01325cz  a2200349n  4500
=001  9880364181602441
=005  20141212215904.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x835.$x661
=072  \\$aD8.$x211.$x682
=150  \\$aPQQ Cofactor
=450  \\$wnnna$a2,7,9-Tricarboxy-1H-Pyrrolo-(2,3-f)Quinoline-4,5-Dione
=450  \\$wnnna$a2,7,9-Tricarboxypyrroloquinoline Quinone
=450  \\$wnnna$a4,5-Dihydro-4,5-Dioxo-1-H-Pyrrolo(2,3-f)Quinoline-2,7,9-Tricarboxylic Acid
=450  \\$wnnna$aCoenzyme PQQ
=450  \\$wnnna$aCoenzyme, PQQ
=450  \\$wnnna$aCofactor, PQQ
=450  \\$aMethoxatin
=450  \\$wnnna$aPQQ Coenzyme
=450  \\$wnnna$aPQQ, Coenzyme
=450  \\$wnnna$aPyrrolo-Quinoline Quinone
=450  \\$wnnna$aPyrrolo Quinoline Quinone
=450  \\$wnnna$aPyrroloquinoline Quinone
=450  \\$wnnna$aQuinone, Pyrrolo-Quinoline
=450  \\$wnnna$aQuinone, Pyrroloquinoline
=550  \\$wg$aCoenzymes
=550  \\$wg$aQuinolones
=680  \\$iA pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
=688  \\$a2004; use PQQ COFACTOR (NM) 1981-2003
=750  \0$aPQQ (Biochemistry)$0(DLC)sh 89001700$5IEN-M

=LDR  00910cz  a2200217n  4500
=001  9880364181702441
=005  20141212215904.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045524
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x695
=072  \\$aD5.$x500.$x562.$x488.$x490.$x500
=072  \\$aD8.$x811.$x600.$x710.$x490.$x500
=150  \\$aPhycobilisomes
=450  \\$wnnna$aPhycobilisome
=550  \\$wg$aCell Membrane Structures
=550  \\$wg$aLight-Harvesting Protein Complexes
=550  \\$wh$aPhycobiliproteins
=680  \\$iLight energy harvesting structures attached to the THYLAKOID MEMBRANES of CYANOBACTERIA and RED ALGAE. These multiprotein complexes contain pigments (PHYCOBILIPROTEINS) that transfer light energy to chlorophyll a.
=688  \\$a2004; use PHYCOBILISOMES (NM) 1980-2003; use PROTEINS 1978-1979
=750  \0$aPhycobilisomes$0(DLC)sh2004010855$5IEN-M

=LDR  00700cz  a2200229n  4500
=001  9880364181802441
=005  20141212215902.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x750
=072  \\$aG16.$x500.$x275.$x280.$x650
=072  \\$aN6.$x230.$x232.$x650
=150  \\$aRivers
=450  \\$wnnna$aRiver
=450  \\$wnnna$aStream
=450  \\$wnnna$aStreams
=550  \\$wg$aFresh Water
=550  \\$wg$aGeological Phenomena
=680  \\$iLarge natural streams of FRESH WATER formed by converging tributaries and which empty into a body of water (lake or ocean).
=688  \\$a2004
=750  \0$aRivers$0(DLC) sh 85114250$5IEN

=LDR  01016cz  a2200301n  4500
=001  9880364181902441
=005  20141212215901.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x311.$x355.$x750.$x500
=150  \\$aHot Springs
=450  \\$wnnna$aGeothermal Spring
=450  \\$wnnna$aGeothermal Springs
=450  \\$wnnna$aHot Spring
=450  \\$wnnna$aSpring, Geothermal
=450  \\$wnnna$aSpring, Hot
=450  \\$wnnna$aSpring, Warm
=450  \\$wnnna$aSprings, Geothermal
=450  \\$wnnna$aSprings, Hot
=450  \\$wnnna$aSprings, Warm
=450  \\$wnnna$aWarm Spring
=450  \\$wnnna$aWarm Springs
=550  \\$wg$aNatural Springs
=550  \\$wh$aHydrothermal Vents
=680  \\$iHabitat of hot water naturally heated by underlying geologic processes. Surface hot springs have been used for BALNEOLOGY. Underwater hot springs are called HYDROTHERMAL VENTS.
=688  \\$a2004
=750  \0$aHot springs$5IEN-M$0(DLC)sh 85062446

=LDR  01103cz  a2200277n  4500
=001  9880364182002441
=005  20141212215901.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045471
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875.$x77
=150  \\$aAegle
=450  \\$wnnna$aAegle marmelo
=450  \\$aAegle marmelos
=450  \\$wnnna$aAegles
=450  \\$wnnna$aCrateva marmelo
=450  \\$wnnna$aCrateva marmelos
=450  \\$wnnna$amarmelo, Aegle
=450  \\$wnnna$amarmelo, Crateva
=450  \\$wnnna$amarmelos, Aegle
=450  \\$wnnna$amarmelos, Crateva
=550  \\$wg$aRutaceae
=667  \\$aX ref CRATEVA MARMELOS: CRATEVA see CAPPARACEAE is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RUTACEAE.
=688  \\$a2004
=750  \0$aAegle$5IEN-M$0(DLC)sh 85001238

=LDR  00952cz  a2200229n  4500
=001  9880364182102441
=005  20141212215900.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045469
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x110
=150  \\$aChrysobalanaceae
=450  \\$wnnna$aChrysobalanus
=450  \\$wnnna$aHirtella
=450  \\$wnnna$aHirtellas
=450  \\$wnnna$aLicania
=450  \\$wnnna$aLicanias
=550  \\$wg$aRosales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.
=688  \\$a2004; use ROSALES 2003-2004
=750  \0$aChrysobalanaceae$5IEN-M$0(DLC)sh 85025438

=LDR  00984cz  a2200289n  4500
=001  9880364182202441
=005  20160429142546.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045468
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x825.$x359.$x500
=150  \\$aFallopia japonica
=450  \\$wnno$aPolygonum cuspidatum
=450  \\$wnnna$acuspidatum, Polygonum
=450  \\$wnnna$acuspidatums, Polygonum
=450  \\$wnnna$aFallopia japonicas
=450  \\$wnnna$aJapanese Knotweed
=450  \\$wnnna$aJapanese Knotweeds
=450  \\$wnnna$ajaponica, Fallopia
=450  \\$wnnna$ajaponicas, Fallopia
=450  \\$wnnna$aKnotweed, Japanese
=450  \\$wnnna$aKnotweeds, Japanese
=450  \\$wnnna$aPolygonum cuspidatums
=550  \\$wg$aFallopia
=680  \\$iA plant species of the family POLYGONACEAE. Itadori tea is prepared from the root of this genus.
=688  \\$a2004
=750  \0$aJapanese knotweed$0(DLC)sh 96010870$5IEN-M

=LDR  00802cz  a2200181n  4500
=001  9880364182302441
=005  20141212215859.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045467
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x339
=150  \\$aElaeocarpaceae
=450  \\$wnnna$aElaeocarpus
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2004
=750  \0$aElaeocarpaceae$5IEN-M$0(DLC)sh 85041485

=LDR  00897cz  a2200217n  4500
=001  9880364182402441
=005  20190617135759.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045466
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x318
=150  \\$aDilleniaceae
=450  \\$wnnna$aCuratella
=450  \\$wnnna$aCuratellas
=450  \\$wnnna$aDillenia
=450  \\$wnnna$aDillenias
=550  \\$wg$aMagnoliopsida
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Dilleniales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2004
=750  \0$aDilleniaceae$5IEN-M$0(DLC)sh 95002235

=LDR  01174cz  a2200265n  4500
=001  9880364182502441
=005  20141212215859.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045465
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x270
=150  \\$aCorsiaceae
=450  \\$wnnna$aArachnitis Plant
=450  \\$wnnna$aArachnitis Plants
=450  \\$wnnna$aCorsia
=450  \\$wnnna$aCorsias
=450  \\$wnnna$aCorsiopses
=450  \\$wnnna$aCorsiopsis
=450  \\$wnnna$aPlant, Arachnitis
=450  \\$wnnna$aPlants, Arachnitis
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Liliales (or by some as Dioscoreales or Burmanniales), subclass Liliidae, class Liliopsida (monocotyledons). They are perennial saprophytic plants obtaining their carbon from FUNGI.
=688  \\$a2004
=750  \0$aCorsiaceae$5IEN-M$0(DLC)sh 87004672

=LDR  01242cz  a2200265n  4500
=001  9880364182602441
=005  20141212215857.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x553
=150  \\$aMicrobubbles
=450  \\$wnnna$aAphron, Colloidal Gas
=450  \\$wnnna$aAphrons, Colloidal Gas
=450  \\$wnnna$aColloidal Gas Aphron
=450  \\$wnnna$aColloidal Gas Aphrons
=450  \\$wnnna$aGas Aphron, Colloidal
=450  \\$wnnna$aGas Aphrons, Colloidal
=450  \\$wnnna$aMicrobubble
=550  \\$wg$aEquipment and Supplies
=550  \\$aMicrospheres
=667  \\$acoordinate with CONTRAST MEDIA, specific diagnostic technique or therapeutic technique if pertinent
=680  \\$iSmall encapsulated gas bubbles (diameters of micrometers) that can be used as CONTRAST MEDIA, and in other diagnostic and therapeutic applications. Upon exposure to sufficiently intense ultrasound, microbubbles will cavitate, rupture, disappear, release gas content. Such characteristics of the microbubbles can be used to enhance diagnostic tests, dissolve blood clots, and deliver drugs or genes for therapy.
=688  \\$a2004
=750  \0$aMicrobubbles$0(DLC)sh2007006028$5IEN-M

=LDR  00946cz  a2200217n  4500
=001  9880364182702441
=005  20141212215856.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045405
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x400.$x550
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x400.$x550
=150  \\$aNipah Virus
=450  \\$wnnna$aNipah Viruses
=450  \\$wnnna$aVirus, Nipah
=450  \\$wnnna$aViruses, Nipah
=550  \\$wg$aHenipavirus
=667  \\$ainfection: coordinate IM with HENIPAVIRUS INFECTIONS (IM)
=680  \\$iA species of HENIPAVIRUS, closely related to HENDRA VIRUS, which emerged in Peninsular Malaysia in 1998. It causes a severe febrile VIRAL ENCEPHALITIS in humans and also encephalitis and RESPIRATORY TRACT INFECTIONS in pigs. Fruit bats (PTEROPUS) are the natural host.
=688  \\$a2004; use PARAMYXOVIRINAE 2000-2003
=750  \0$aNipah virus$5IEN-M$0(DLC)sh 00005427

=LDR  01327cz  a2200277n  4500
=001  9880364182802441
=005  20180117153809.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045363
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x730.$x650
=150  \\$aPneumocystis carinii
=450  \\$wnno$aPneumocystis jirovecii
=450  \\$wnnna$acarini, Pneumocystis
=450  \\$wnnna$acarinii, Pneumocystis
=450  \\$wnnna$acarinius, Pneumocystis
=450  \\$wnnna$acarinus, Pneumocystis
=450  \\$wnnna$aPneumocystis carini
=450  \\$wnnna$aPneumocystis carinius
=450  \\$wnnna$aPneumocystis carinus
=450  \\$wnnna$aPneumocystis
=550  \\$wg$aPneumocystis jiroveci
=667  \\$ainfection: coordinate IM with probably PNEUMONIA, PNEUMOCYSTIS (IM) but if not of lungs, coordinate with PNEUMOCYSTIS INFECTIONS (IM) + precoordinated organ/disease term (IM)
=680  \\$iThe prototype species of PNEUMOCYSTIS infecting the laboratory rat, Rattus norvegicus (RATS). It was formerly called Pneumocystis carinii f. sp. carinii. Strains that infect humans and cause PNEUMOCYSTIS PNEUMONIA were originally classified as Pneumocystis jirovecii or Pneumocystis carinii f. sp. hominis.
=688  \\$a2004; use PNEUMOCYSTIS 1974-2003
=750  \0$aPneumocystis carinii$0(DLC)sh 85103621$5IEN

=LDR  01376cz  a2200313n  4500
=001  9880364182902441
=005  20141212215849.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x562.$x488
=072  \\$aD8.$x811.$x600.$x710
=072  \\$aD12.$x776.$x183.$x750.$x750
=072  \\$aD12.$x776.$x543.$x983.$x500
=072  \\$aD12.$x776.$x765.$x199.$x750.$x750
=150  \\$aPhotosynthetic Reaction Center Complex Proteins
=450  \\$wnnna$aComplexes, Photosynthetic
=450  \\$wnnna$aPhotosynthetic Complexes
=450  \\$wnnna$aPhotosynthetic Reaction Centers
=450  \\$wnnna$aReaction Centers, Photosynthetic
=550  \\$wg$aMultienzyme Complexes
=550  \\$wg$aThylakoid Membrane Proteins
=550  \\$wh$aCytochrome b6f Complex
=550  \\$wh$aLight-Harvesting Protein Complexes
=550  \\$wh$aPhotosystem I Protein Complex
=550  \\$wh$aPhotosystem II Protein Complex
=680  \\$iProtein complexes that take part in the process of PHOTOSYNTHESIS. They are located within the THYLAKOID MEMBRANES of plant CHLOROPLASTS and a variety of structures in more primitive organisms. There are two major complexes involved in the photosynthetic process called PHOTOSYSTEM I and PHOTOSYSTEM II.
=688  \\$a2004
=750  \0$aPhotosynthetic reaction centers$0(DLC)sh 90006184$5IEN-M

=LDR  00667cz  a2200181n  4500
=001  9880364183002441
=005  20141212215846.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045268
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x380
=150  \\$aFlowmeters
=450  \\$wnnna$aFlowmeter
=550  \\$wg$aDiagnostic Equipment
=667  \\$aconsider also RHEOLOGY /instrum or LASER-DOPPLER FLOWMETRY /instrum;
=680  \\$iDevices used to measure the flow of fluids (see RHEOLOGY) or the AIR to measure RESPIRATION.
=688  \\$a2004, 1974-1992; use RHEOLOGY 1993-2003, use BLOOD FLOW VELOCITY 1963-1971
=750  \0$aFlow meters$5IEN-5$0(DLC)sh 85049289

=LDR  00651cz  a2200181n  4500
=001  9880364183102441
=005  20141212215845.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045248
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x140.$x130.$x200
=072  \\$aB3.$x440.$x400.$x425.$x300.$x200
=150  \\$aFlexibacter
=550  \\$wg$aCytophagaceae
=667  \\$ainfection: coord IM with CYTOPHAGACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative, chemoorganotrophic bacteria in the family CYTOPHAGACEAE. In some species there is a cyclic change in cell morphology.
=688  \\$a2004
=750  \0$aFlexibacter$5IEN-M$0(DLC)sh 88023258

=LDR  02116cz  a2200529n  4500
=001  9880364183202441
=005  20141212215842.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045170
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x534
=072  \\$aG5.$x360.$x80.$x534
=150  \\$aMatrix Attachment Regions
=450  \\$wnnna$aElement, MAR
=450  \\$wnnna$aElement, SAR
=450  \\$wnnna$aElements, MAR
=450  \\$wnnna$aElements, SAR
=450  \\$wnnna$aMAR Element
=450  \\$wnnna$aMAR Elements
=450  \\$wnnna$aMAR-SAR Recognition Signature Sequence
=450  \\$wnnna$aMAR SAR Recognition Signature Sequence
=450  \\$wnnna$aMatrix-Attached Region
=450  \\$wnnna$aMatrix-Attached Regions
=450  \\$wnnna$aMatrix Attached Regions
=450  \\$wnnna$aMatrix Attachment Region
=450  \\$aMRS Sequence
=450  \\$wnnna$aMRS Sequences
=450  \\$wnnna$aRegion, Matrix-Attached
=450  \\$wnnna$aRegion, Matrix Attachment
=450  \\$wnnna$aRegion, Scaffold-Attached
=450  \\$wnnna$aRegion, Scaffold Attachment
=450  \\$wnnna$aRegions, Matrix-Attached
=450  \\$wnnna$aRegions, Matrix Attachment
=450  \\$wnnna$aRegions, Scaffold-Attached
=450  \\$wnnna$aRegions, Scaffold Attachment
=450  \\$wnnna$aSAR Element
=450  \\$wnnna$aSAR Elements
=450  \\$wnnna$aScaffold-Attached Region
=450  \\$wnnna$aScaffold-Attached Regions
=450  \\$wnnna$aScaffold Attached Regions
=450  \\$wnnna$aScaffold Attachment Region
=450  \\$aScaffold Attachment Regions
=450  \\$wnnna$aSequences, MRS
=550  \\$wg$aBase Sequence
=680  \\$iRegions of the CHROMATIN or DNA that bind to the NUCLEAR MATRIX. They are found in INTERGENIC DNA, especially flanking the 5' ends of genes or clusters of genes. Many of the regions that have been isolated contain a bipartite sequence motif called the MAR/SAR recognition signature sequence that binds to MATRIX ATTACHMENT REGION BINDING PROTEINS.
=688  \\$a2004
=750  \0$aMatrix attachment regions$5IEN-M$0(DLC)sh 99010676

=LDR  01390cz  a2200337n  4500
=001  9880364183302441
=005  20141212215841.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045167
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x851.$x687
=150  \\$aProgesterone Congeners
=450  \\$wnnna$aProgestagens, Synthetic
=450  \\$wnnna$aProgestational Hormone Analogs
=450  \\$wnnna$aProgestational Hormone Analogues
=450  \\$wnnna$aProgestational Hormones, Synthetic
=450  \\$wnnna$aProgestin Analogs
=450  \\$wnnna$aProgestin Analogues
=450  \\$wnnna$aProgestins, Synthetic
=450  \\$wnnna$aProgestogens, Synthetic
=450  \\$wnnna$aSynthetic Progestagens
=450  \\$wnnna$aSynthetic Progestational Hormones
=450  \\$wnnna$aSynthetic Progestins
=450  \\$wnnna$aSynthetic Progestogens
=550  \\$wg$aGonadal Steroid Hormones
=550  \\$wh$aPregnenolone
=550  \\$wh$aProgesterone
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iSteroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
=688  \\$a2004
=750  \0$aProgestational hormones, Synthetic$5IEN$0(DLC)sh 85107293

=LDR  00773cz  a2200217n  4500
=001  9880364183402441
=005  20141212215836.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D045022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x551
=150  \\$aLactate Dehydrogenases
=450  \\$wnnna$aDehydrogenases, Lactate
=550  \\$wg$aAlcohol Oxidoreductases
=550  \\$wh$aepsilon-Crystallins
=550  \\$wh$aL-Lactate Dehydrogenase
=550  \\$wh$aL-Lactate Dehydrogenase (Cytochrome)
=667  \\$aL-LACTATE DEHYDROGENASE and L-LACTATE DEHYDROGENASE (CYTOCHROME) are also available
=680  \\$iAlcohol oxidoreductases with substrate specificity for LACTIC ACID.
=688  \\$a2004
=750  \0$aLactate dehydrogenase$5IEN$0(DLC)sh 85073861

=LDR  00903cz  a2200217n  4500
=001  9880364183502441
=005  20141212215834.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044968
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x750
=150  \\$aRegenerative Medicine
=450  \\$wnnna$aMedicine, Regenerative
=450  \\$wnnna$aMedicines, Regenerative
=450  \\$wnnna$aRegenerative Medicines
=550  \\$wg$aMedicine
=550  \\$aCell- and Tissue-Based Therapy
=667  \\$ause for the specialty only
=680  \\$iA field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.
=688  \\$a2004
=750  \0$aRegenerative medicine$0(DLC)sh2008001685$5IEN-M

=LDR  00662cz  a2200229n  4500
=001  9880364183602441
=005  20141212215834.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044967
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152.$x846
=072  \\$aA15.$x145.$x846
=150  \\$aSerum
=450  \\$wnnna$aBlood Serum
=450  \\$wnnna$aSerum, Blood
=450  \\$wnnna$aSerums
=550  \\$wg$aBlood
=550  \\$wh$aImmune Sera
=550  \\$aPlasma
=680  \\$iThe clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.
=688  \\$a2004
=750  \0$aSerum$0(DLC) sh 85120332$5IEN-M

=LDR  00737cz  a2200229n  4500
=001  9880364183702441
=005  20141212215834.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x388.$x77
=150  \\$aAnti-Retroviral Agents
=450  \\$wnnna$aAgents, Anti-Retroviral
=450  \\$wnnna$aAgents, Antiretroviral
=450  \\$wnnna$aAnti Retroviral Agents
=450  \\$wnnna$aAntiretroviral Agents
=550  \\$wg$aAntiviral Agents
=550  \\$wh$aAnti-HIV Agents
=550  \\$wh$aReverse Transcriptase Inhibitors
=680  \\$iAgents used to treat RETROVIRIDAE INFECTIONS.
=688  \\$a2004
=750  \0$aAntiretroviral agents$5IEN-M$0(DLC)sh2003006231

=LDR  01051cz  a2200241n  4500
=001  9880364183802441
=005  20141212215832.0
=008  030709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D044962
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x308.$x189
=072  \\$aL1.$x224.$x800.$x500
=072  \\$aL1.$x470.$x500
=150  \\$aData Compression
=450  \\$wnnna$aCompression, Data
=450  \\$wnnna$aCompression, Image
=450  \\$wnnna$aImage Compression
=550  \\$wg$aImage Processing, Computer-Assisted
=550  \\$wg$aInformation Storage and Retrieval
=550  \\$wg$aSignal Processing, Computer-Assisted
=680  \\$iInformation application based on a variety of coding methods to minimize the amount of data to be stored, retrieved, or transmitted. Data compression can be applied to various forms of data, such as images and signals. It is used to reduce costs and increase efficiency in the maintenance of large volumes of data.
=688  \\$a2004
=750  \0$aData compression (Computer science)$5IEN-M$0(DLC)sh 85035850

=LDR  00871cz  a2200205n  4500
=001  9880364183902441
=005  20141212215433.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039323
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x229
=150  \\$aCoptis
=450  \\$wnnna$aCopti
=450  \\$aGoldthread
=450  \\$wnnna$aGoldthreads
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain BERBERINE and other isoquinoline ALKALOIDS.
=688  \\$a2003
=750  \0$aCoptis$5IEN-M$0(DLC)sh 85032424

=LDR  01541cz  a2200373n  4500
=001  9880364184002441
=005  20141212193038.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x337
=150  \\$aHelleborus
=450  \\$wnnna$aChristmas-Rose
=450  \\$wnnna$aChristmas Rose
=450  \\$wnnna$aChristmas-Roses
=450  \\$wnnna$aGreen Hellebore
=450  \\$wnnna$aGreen Hellebores
=450  \\$aHeleborus
=450  \\$aHellebore
=450  \\$aHellebore, Green
=450  \\$aHellebore, Stinking
=450  \\$wnnna$aHellebores
=450  \\$wnnna$aHellebores, Green
=450  \\$wnnna$aHellebores, Stinking
=450  \\$wnnna$aHelleborus foetidus
=450  \\$wnnna$aHelleborus niger
=450  \\$wnnna$aHelleborus viridis
=450  \\$wnnna$aStinking Hellebore
=450  \\$wnnna$aStinking Hellebores
=550  \\$wg$aRanunculaceae
=667  \\$aHELLEBORE,BLACK, HELLEBORE,FALSE and HELLERBORE, WHITE see VERATRUM is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain hellebrin (BUFANOLIDES). The extract is the basis of Boicil preparation used to treat rheumatism.
=688  \\$a2003
=750  \2$aHellebores$5IEN-M

=LDR  01161cz  a2200301n  4500
=001  9880364184102441
=005  20141212215433.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x838.$x397
=150  \\$aHydrastis
=450  \\$wnnna$acanadenses, Hydrastis
=450  \\$wnnna$acanadensis, Hydrastis
=450  \\$wnnna$aGolden Seal
=450  \\$wnnna$aGolden Seals
=450  \\$aGoldenseal
=450  \\$wnnna$aGoldenseals
=450  \\$wnnna$aHydrasti
=450  \\$wnnna$aHydrastis canadenses
=450  \\$wnnna$aHydrastis canadensis
=450  \\$wnnna$aSeal, Golden
=450  \\$wnnna$aSeals, Golden
=550  \\$wg$aRanunculaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family RANUNCULACEAE. Members contain BERBERINE.
=688  \\$a2003
=750  \0$aHydrastis$5IEN-M$0(DLC)sh 88022840

=LDR  01593cz  a2200469n  4500
=001  9880364184202441
=005  20141212215432.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x315
=072  \\$aL1.$x224.$x300
=150  \\$aComputers, Molecular
=450  \\$wnnna$aComputation, DNA
=450  \\$wnnna$aComputation, Molecular
=450  \\$wnnna$aComputation, RNA
=450  \\$wnnna$aComputations, DNA
=450  \\$wnnna$aComputations, Molecular
=450  \\$wnnna$aComputations, RNA
=450  \\$wnnna$aComputer, DNA
=450  \\$wnnna$aComputer, Molecular
=450  \\$wnnna$aComputer, RNA
=450  \\$wnnna$aComputers, DNA
=450  \\$wnnna$aComputers, RNA
=450  \\$wnnna$aDNA Computation
=450  \\$wnnna$aDNA Computations
=450  \\$wnnna$aDNA Computer
=450  \\$aDNA Computers
=450  \\$wnnna$aMolecular Computation
=450  \\$wnnna$aMolecular Computations
=450  \\$wnnna$aMolecular Computer
=450  \\$wnnna$aMolecular Computers
=450  \\$wnnna$aRNA Computation
=450  \\$wnnna$aRNA Computations
=450  \\$wnnna$aRNA Computer
=450  \\$aRNA Computers
=550  \\$wg$aComputers
=550  \\$wg$aComputing Methodologies
=667  \\$ado not confuse DNA Computers with DNA MICROCHIPS see OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS
=680  \\$iComputers whose input, output and state transitions are carried out by biochemical interactions and reactions.
=688  \\$a2003
=750  \0$aMolecular computers$5IEN-M$0(DLC)sh 96004522

=LDR  00877cz  a2200181n  4500
=001  9880364184302441
=005  20141212215431.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x775.$x500
=150  \\$aMirabilis
=450  \\$wnnna$aMirabili
=550  \\$wg$aNyctaginaceae
=667  \\$ado not confuse with PROTEUS MIRABILIS; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NYCTAGINACEAE. Members contain Mirabilis antiviral protein (a ribosome-inactivating protein).
=688  \\$a2003
=750  \0$aMirabilis$5IEN-M$0(DLC)sh 88022923

=LDR  01096cz  a2200277n  4500
=001  9880364184402441
=005  20200422104814.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x750
=150  \\$aNyctaginaceae
=450  \\$aAbronia
=450  \\$wnnna$aAbronias
=450  \\$wnnna$aBoerhaavia
=450  \\$wnnna$aBoerhaavias
=450  \\$aBoerhavia
=450  \\$wnnna$aBoerhavias
=450  \\$aBougainvillea
=450  \\$wnnna$aBougainvilleas
=550  \\$wg$aCaryophyllales
=550  \\$wh$aMirabilis
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aNyctaginaceae$5IEN-M$0(DLC)sh 85093505

=LDR  00814cz  a2200181n  4500
=001  9880364184502441
=005  20141212215430.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x344
=150  \\$aEriocaulaceae
=450  \\$aPaepalanthus
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Commelinales, subclass Commelinidae, class Liliopsida (monocotyledons).
=688  \\$a2003
=750  \0$aEriocaulaceae$5IEN-M$0(DLC)sh 85044631

=LDR  00971cz  a2200229n  4500
=001  9880364184602441
=005  20141212215424.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x831.$x500
=150  \\$aMacadamia
=450  \\$wnnna$aMacadamia Nut
=450  \\$wnnna$aMacadamia Nuts
=450  \\$wnnna$aMacadamias
=450  \\$wnnna$aNut, Macadamia
=450  \\$wnnna$aNuts, Macadamia
=550  \\$wg$aProteaceae
=667  \\$acoord with FOOD if pertinent; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PROTEACEAE that is the source of edible NUTS.
=688  \\$a2003
=750  \0$aMacadamia nut$5IEN-M$0(DLC)sh 85079244

=LDR  01122cz  a2200253n  4500
=001  9880364184702441
=005  20141212215424.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D039105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x831
=150  \\$aProteaceae
=450  \\$aGrevillea
=450  \\$wnnna$aGrevilleas
=450  \\$wnnna$aPlant, Protea
=450  \\$wnnna$aPlants, Protea
=450  \\$aProtea Plant
=450  \\$wnnna$aProtea Plants
=550  \\$wg$aAngiosperms
=550  \\$wh$aMacadamia
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Proteales, subclass Rosidae class Magnoliopsida. Cluster roots, bottlebrush-like clusters of rootlets which form in response to poor soil, are common in this family.
=688  \\$a2003
=750  \0$aProteaceae$5IEN-M$0(DLC)sh 85107642

=LDR  01412cz  a2200265n  4500
=001  9880364184802441
=005  20190422171807.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x685
=150  \\$aReceptors, Collagen
=450  \\$wnnna$aCollagen Receptor
=450  \\$aCollagen Receptors
=450  \\$wnnna$aReceptor, Collagen
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aDiscoidin Domain Receptors
=550  \\$wh$aIntegrin alpha1beta1
=550  \\$wh$aIntegrin alpha2beta1
=550  \\$wh$aIntegrin alpha3beta1
=680  \\$iCollagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI.
=688  \\$a2003; use RECEPTORS, COLLAGEN (NM) 1983-2002
=750  \0$81$wb$iBroader mapping$aCollagen$0(DLC)sh 85027969$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aCollagen--Receptors$5IEN-M

=LDR  01819cz  a2200433n  4500
=001  9880364184902441
=005  20141212215417.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x455
=072  \\$aC16.$x320.$x322.$x500
=072  \\$aC16.$x320.$x400.$x525
=150  \\$aMental Retardation, X-Linked
=450  \\$wnnna$aMental Retardation, X Linked
=450  \\$wnnna$aRetardation, X-Linked Mental
=450  \\$aX-Linked Mental Retardation
=450  \\$wnnna$aX Linked Mental Retardation
=450  \\$wnnna$aX-Linked Mental Retardation Disorders
=450  \\$wnnna$aX Linked Mental Retardation Disorders
=450  \\$wnnna$aX-Linked Mental Retardation Syndromes
=450  \\$wnnna$aX Linked Mental Retardation Syndromes
=450  \\$wnnna$aX-Linked Mental Retardations
=550  \\$wg$aGenetic Diseases, X-Linked
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aIntellectual Disability
=550  \\$wh$aAdrenoleukodystrophy
=550  \\$wh$aClassical Lissencephalies and Subcortical Band Heterotopias
=550  \\$wh$aCoffin-Lowry Syndrome
=550  \\$wh$aFragile X Syndrome
=550  \\$wh$aGlycogen Storage Disease Type IIb
=550  \\$wh$aLesch-Nyhan Syndrome
=550  \\$wh$aMenkes Kinky Hair Syndrome
=550  \\$wh$aMucopolysaccharidosis II
=550  \\$wh$aPyruvate Dehydrogenase Complex Deficiency Disease
=550  \\$wh$aRett Syndrome
=680  \\$iA class of genetic disorders resulting in INTELLECTUAL DISABILITY that is associated either with mutations of GENES located on the X CHROMOSOME or aberrations in the structure of the X chromosome (SEX CHROMOSOME ABERRATIONS).
=688  \\$a2003
=750  \0$aX-linked mental retardation$5IEN-M$0(DLC)sh 99002289

=LDR  00846cz  a2200229n  4500
=001  9880364185002441
=005  20141212215416.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x800
=150  \\$aMedicine, Tibetan Traditional
=450  \\$wnnna$aMedicine, Traditional Tibetan
=450  \\$wnnna$aTibetan Medicine, Traditional
=450  \\$wnnna$aTibetan Traditional Medicine
=450  \\$aTraditional Medicine, Tibetan
=450  \\$wnnna$aTraditional Tibetan Medicine
=550  \\$wg$aMedicine, East Asian Traditional
=550  \\$aMedicine, Chinese Traditional
=680  \\$iA system of traditional medicine which is based on the beliefs and practices of the Tibetan culture.
=688  \\$a2003
=750  \0$aMedicine, Tibetan$5IEN-M$0(DLC)sh 85083182

=LDR  01505cz  a2200385n  4500
=001  9880364185102441
=005  20141212215416.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x400.$x525
=072  \\$aA19.$x690
=072  \\$aB1.$x300.$x655
=072  \\$aB5.$x550
=150  \\$aMycorrhizae
=450  \\$aArbuscular Mycorrhizae
=450  \\$aEctomycorrhizae
=450  \\$aEndomycorrhizae
=450  \\$wnnna$aMycorrhiza
=450  \\$aMycorrhizae, Arbuscular
=450  \\$aMycorrhizae, Vesicular-Arbuscular
=450  \\$wnnna$aMycorrhizae, Vesicular Arbuscular
=450  \\$wnnna$aMycorrhizas
=450  \\$aVesicular-Arbuscular Mycorrhizae
=450  \\$wnnna$aVesicular Arbuscular Mycorrhizae
=550  \\$wg$aFungal Structures
=550  \\$wg$aFungi
=550  \\$wg$aOrganism Forms
=550  \\$wg$aPlant Roots
=550  \\$aRoot Nodules, Plant
=550  \\$aSymbiosis
=667  \\$acoordinate with specific plant and specific fungus if pertinent
=680  \\$iSymbiotic combination (dual organism) of the MYCELIUM of FUNGI with the roots of plants (PLANT ROOTS). The roots of almost all higher plants exhibit this mutually beneficial relationship, whereby the fungus supplies water and mineral salts to the plant, and the plant supplies CARBOHYDRATES to the fungus. There are two major types of mycorrhizae: ectomycorrhizae and endomycorrhizae.
=688  \\$a2003
=750  \0$aMycorrhizas$5IEN-M$0(DLC)sh 85089197

=LDR  00486cz  a2200169n  4500
=001  9880364185202441
=005  20141212215415.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x637
=150  \\$aOtoscopy
=550  \\$wg$aDiagnostic Techniques, Otological
=550  \\$aOtoscopes
=680  \\$iExamination of the EAR CANAL and eardrum with an OTOSCOPE.
=688  \\$a2003
=750  \0$aOtoscopy$5IEN-M$0(DLC)sh 85096077

=LDR  01190cz  a2200277n  4500
=001  9880363872902441
=005  20141212204249.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010250
=035  \\$aCBA3534HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x600
=150  \\$aParamphistomatidae
=450  \\$aAmphistomidae
=450  \\$wnnna$aGastrodiscoide
=450  \\$wnnna$aGastrodiscoides
=450  \\$aParamphistomata
=450  \\$wnnna$aParamphistomatas
=450  \\$aParamphistomum
=450  \\$wnnna$aParamphistomums
=450  \\$wnnna$aWatsonius
=550  \\$wg$aTrematoda
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of flukes of the class Trematoda found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron.
=688  \\$a82
=750  \0$aParamphistomidae$5IEN$0(DLC)sh 88021784

=LDR  00954cz  a2200265n  4500
=001  9880363873002441
=005  20141212204257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010274
=035  \\$aCBA3559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x688
=150  \\$aParasitology
=450  \\$wnnna$aMedical Parasitology
=450  \\$aParasitologists$5IEN
=450  \\$wnnna$aParasitology, Medical
=550  \\$wg$aBiology
=550  \\$wh$aFood Parasitology
=550  \\$aInfectious Disease Medicine
=667  \\$athe discipline (education, history, etc) only; for parasitological studies, use the qualifier/ parasitol with specific anatomical terms, organisms & diseases
=680  \\$iThe study of parasites and PARASITIC DISEASES.
=688  \\$a67
=750  \0$aMedical parasitology$5IEN-M$0(DLC)sh 85082980
=750  \0$aParasitology$5IEN-HS$0(DLC)sh 85097922
=750  \0$aParasitologists$5IEN-HS$0(DLC)sh 85097921

=LDR  00867cz  a2200217n  4500
=001  9880363873102441
=005  20141212204248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010247
=035  \\$aCBA3531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x185.$x650.$x375.$x550.$x637
=150  \\$aParamecium
=450  \\$wnnna$aParameciums
=550  \\$wg$aPeniculina
=550  \\$wh$aParamecium aurelia
=550  \\$wh$aParamecium caudatum
=550  \\$wh$aParamecium tetraurelia
=667  \\$ainfection: coordinate IM with CILIOPHORA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of ciliate protozoa that is often large enough to be seen by the naked eye. Paramecia are commonly used in genetic, cytological, and other research.
=750  \0$aParamecium$5IEN$0(DLC)sh 85097846

=LDR  01225cz  a2200313n  4500
=001  9880363873202441
=005  20141212204257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010273
=035  \\$aCBA3558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701
=072  \\$aC22.$x674
=150  \\$aParasitic Diseases, Animal
=450  \\$wnnna$aAnimal Parasitic Disease
=450  \\$wnnna$aAnimal Parasitic Diseases
=450  \\$wnnna$aDisease, Animal Parasitic
=450  \\$wnnna$aDiseases, Animal Parasitic
=450  \\$wnnna$aParasitic Disease, Animal
=450  \\$aParasitic Diseases$xveterinary
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aParasitic Diseases
=550  \\$wh$aBabesiosis
=550  \\$wh$aHelminthiasis, Animal
=550  \\$wh$aProtozoan Infections, Animal
=667  \\$aexper or vet; GEN or unspecified; prefer specific indentions or specific parasitic dis /vet; indexing policy: Manual 22.12-.20; don't forget to check tag ANIMAL; DF: PARASITIC DIS ANIMALS
=680  \\$iInfections or infestations with parasitic organisms. The infestation may be experimental or veterinary.
=688  \\$a98; use explode 1975-97
=750  \0$aVeterinary parasitology$5IEN$0(DLC)sh 85143064

=LDR  00988cz  a2200265n  4500
=001  9880363873302441
=005  20141212204248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010246
=035  \\$aCBA3530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x131.$x587
=072  \\$aC26.$x141.$x587
=150  \\$aParalysis, Obstetric
=450  \\$wnnna$aObstetric Paralyses
=450  \\$wnnna$aObstetric Paralysis
=450  \\$wnnna$aObstetrical Paralyses
=450  \\$wnnna$aObstetrical Paralysis
=450  \\$wnnna$aParalyses, Obstetric
=450  \\$wnnna$aParalyses, Obstetrical
=450  \\$wnnna$aParalysis, Obstetrical
=550  \\$wg$aBirth Injuries
=667  \\$arefers to neonate; coord IM with specific paralysis or birth inj (IM); do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iParalysis of an infant resulting from injury received at birth. (From Dorland, 27th ed)
=750  \0$aObstetrical paralysis$5IEN$0(DLC)sh 85093762

=LDR  01607cz  a2200385n  4500
=001  9880363873402441
=005  20141212204257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010272
=035  \\$aCBA3557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3
=150  \\$aParasitic Diseases
=450  \\$wnnna$aDisease, Parasitic
=450  \\$wnnna$aDiseases, Parasitic
=450  \\$wnnna$aParasitic Disease
=550  \\$wh$aCentral Nervous System Parasitic Infections
=550  \\$wh$aCoinfection
=550  \\$wh$aEye Infections, Parasitic
=550  \\$wh$aHelminthiasis
=550  \\$wh$aIntestinal Diseases, Parasitic
=550  \\$wh$aLiver Diseases, Parasitic
=550  \\$wh$aLung Diseases, Parasitic
=550  \\$wh$aMesomycetozoea Infections
=550  \\$wh$aOpportunistic Infections
=550  \\$wh$aParasitemia
=550  \\$wh$aParasitic Diseases, Animal
=550  \\$wh$aPregnancy Complications, Parasitic
=550  \\$wh$aProtozoan Infections
=550  \\$wh$aSkin Diseases, Parasitic
=550  \\$wh$aZoonoses
=667  \\$aGEN: prefer specifics; relation to parasites: Manual 22.12-.20; parasitic dis not in MeSH: Manual 22.17, 22.18; parasitic dis of heart = PARASITIC DISEASES or specific parasitic dis (IM) + CARDIOMYOPATHIES (IM), not HEART DISEASES; DF: PARASITIC DIS
=680  \\$iInfections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure.
=688  \\$aPARASITICIDES was heading 1963-66
=750  \0$aParasitic diseases$5IEN$0(DLC)sh 85097912

=LDR  01058cz  a2200205n  4500
=001  9880363873502441
=005  20141212204256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010271
=035  \\$aCBA3556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x714
=150  \\$aParasites
=450  \\$wnnna$aParasite
=550  \\$wg$aInvertebrates
=550  \\$aParasite Load
=667  \\$ageneral or unspecified only: prefer specifics; in lower animals: Manual 22.20; relation to parasitic diseases: Manual 22.12-.20; parasites in food or parasitic contamination of food is indexed under FOOD PARASITOLOGY (IM) + specific parasite (IM) + specific food item /parasitol (IM) or (NIM)
=680  \\$iInvertebrate organisms that live on or in another organism (the host), and benefit at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically.
=688  \\$aPARASITICIDES was heading 1963-66
=750  \0$aParasites$5IEN$0(DLC)sh 85097907

=LDR  01730cz  a2200421n  4500
=001  9880363873602441
=005  20141212204246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010243
=035  \\$aCBA3527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x622
=072  \\$aC23.$x888.$x592.$x636
=150  \\$aParalysis
=450  \\$wnnna$aPalsies
=450  \\$aPalsy
=450  \\$wnnna$aParalyses
=450  \\$wnnna$aParalysis, Todd
=450  \\$wnnna$aParalysis, Todd's
=450  \\$aPlegia
=450  \\$wnnna$aPlegias
=450  \\$wnnna$aTodd Paralysis
=450  \\$wnnna$aTodd's Paralysis
=450  \\$wnnna$aTodds Paralysis
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aFacial Paralysis
=550  \\$wh$aGastroparesis
=550  \\$wh$aHemiplegia
=550  \\$wh$aOphthalmoplegia
=550  \\$wh$aParaplegia
=550  \\$wh$aPseudobulbar Palsy
=550  \\$wh$aQuadriplegia
=550  \\$wh$aRespiratory Paralysis
=550  \\$wh$aVocal Cord Paralysis
=667  \\$asevere loss of motor function as compared with PARESIS, a slight loss; GENERAL PARALYSIS see NEUROSYPHILIS does not mean "generalized paralysis" ( = PARALYSIS); spastic paralysis = PARALYSIS (IM) + MUSCLE SPASTICITY (NIM); flaccid paralysis = PARALYSIS (IM) + MUSCLE FLACCIDITY (NIM)
=680  \\$iA general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
=688  \\$aPARALYSIS, SPASTIC was heading 1963-78
=750  \0$aParalysis$5IEN$0(DLC)sh 85097834

=LDR  00761cz  a2200217n  4500
=001  9880363873702441
=005  20141212204256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010269
=035  \\$aCBA3554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x762.$x621
=150  \\$aParaquat
=450  \\$wnnna$aGramoxone
=450  \\$aMethyl Viologen
=450  \\$wnnna$aParagreen A
=450  \\$wnnna$aViologen, Methyl
=550  \\$wg$aPyridinium Compounds
=680  \\$iA poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds.
=688  \\$a73(71)
=750  \0$aParaquat$5IEN$0(DLC)sh 85097905

=LDR  01417cz  a2200385n  4500
=001  9880363873802441
=005  20141212204255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010268
=035  \\$aCBA3553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x550
=072  \\$aF4.$x96.$x462
=072  \\$aH1.$x770.$x644.$x364
=150  \\$aParapsychology
=450  \\$aClairvoyance
=450  \\$aExtrasensory Perception
=450  \\$wnnna$aExtrasensory Perceptions
=450  \\$wnnna$aPerception, Extrasensory
=450  \\$wnnna$aPerceptions, Extrasensory
=450  \\$wnnna$aPsychic Research
=450  \\$aPsychical Research
=450  \\$wnnna$aResearch, Psychic
=450  \\$wnnna$aResearch, Psychical
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wg$aResearch
=550  \\$wh$aTelepathy
=550  \\$aSpiritual Therapies
=550  \\$aTelepathy
=667  \\$aDF: PARAPSYCHOL
=680  \\$iBranch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day "natural laws".
=688  \\$aCLAIRVOYANCE was see under PARAPSYCHOLOGY 1965-78; EXTRASENSORY PERCEPTION & PSYCHICAL RESEARCH were see under PARAPSYCHOLOGY 1963-78
=750  \0$aParapsychology$5IEN$0(DLC)sh 85108405
=750  \0$aParapsychologists$5IEN-HS$0(DLC)sh 94002314

=LDR  01927cz  a2200505n  4500
=001  9880363873902441
=005  20200706114240.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010265
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x147.$x780
=072  \\$aC20.$x683.$x780
=150  \\$aParaproteinemias
=450  \\$wnnna$aCell Dyscrasia, Plasma
=450  \\$wnnna$aCell Dyscrasias, Plasma
=450  \\$wnnna$aDyscrasia, Plasma Cell
=450  \\$wnnna$aDyscrasias, Plasma Cell
=450  \\$wnnna$aGammapathies, Monoclonal
=450  \\$aGammapathy, Monoclonal
=450  \\$wnnna$aGammopathies, Monoclonal
=450  \\$aGammopathy, Monoclonal
=450  \\$wnnna$aMonoclonal Gammapathies
=450  \\$wnnna$aMonoclonal Gammapathy
=450  \\$aMonoclonal Gammopathies
=450  \\$wnnna$aMonoclonal Gammopathy
=450  \\$wnnna$aParaimmunoglobulinemia
=450  \\$aParaimmunoglobulinemias
=450  \\$wnnna$aParaproteinemia
=450  \\$wnnna$aPlasma Cell Dyscrasia
=450  \\$aPlasma Cell Dyscrasias
=550  \\$wg$aBlood Protein Disorders
=550  \\$wh$aImmunoglobulin Light-chain Amyloidosis
=550  \\$wg$aImmunoproliferative Disorders
=550  \\$wh$aCryoglobulinemia
=550  \\$wh$aHeavy Chain Disease
=550  \\$wh$aMonoclonal Gammopathy of Undetermined Significance
=550  \\$wh$aMultiple Myeloma
=550  \\$wh$aPOEMS Syndrome
=550  \\$wh$aWaldenstrom Macroglobulinemia
=550  \\$wh$aSmoldering Multiple Myeloma
=550  \\$aAmyloidosis
=550  \\$aImmunoglobulins
=680  \\$iA group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
=688  \\$a76
=750  \0$aParaproteinemia$0(DLC) sh 85097892$5IEN

=LDR  01919cz  a2200493n  4500
=001  9880363874002441
=005  20141212204253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010264
=035  \\$aCBA3549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x622.$x669
=072  \\$aC23.$x888.$x592.$x636.$x637
=150  \\$aParaplegia
=450  \\$wnnna$aAtaxic Paraplegia
=450  \\$wnnna$aAtaxic Paraplegias
=450  \\$wnnna$aCerebral Paraplegia
=450  \\$wnnna$aCerebral Paraplegias
=450  \\$wnnna$aFlaccid Paraplegia
=450  \\$wnnna$aFlaccid Paraplegias
=450  \\$wnnna$aParalysis, Legs
=450  \\$aParalysis, Lower Extremities
=450  \\$wnnna$aParalysis, Lower Limbs
=450  \\$wnnna$aParaplegia, Ataxic
=450  \\$wnnna$aParaplegia, Cerebral
=450  \\$wnnna$aParaplegia, Flaccid
=450  \\$aParaplegia, Spastic
=450  \\$wnnna$aParaplegia, Spinal
=450  \\$wnnna$aParaplegias
=450  \\$wnnna$aParaplegias, Ataxic
=450  \\$wnnna$aParaplegias, Cerebral
=450  \\$wnnna$aParaplegias, Flaccid
=450  \\$wnnna$aParaplegias, Spastic
=450  \\$wnnna$aParaplegias, Spinal
=450  \\$aSpastic Paraplegia
=450  \\$wnnna$aSpastic Paraplegias
=450  \\$wnnna$aSpinal Paraplegia
=450  \\$wnnna$aSpinal Paraplegias
=550  \\$wg$aParalysis
=550  \\$wh$aBrown-Sequard Syndrome
=667  \\$aalso available is QUADRIPLEGIA; note X ref spastic paraplegia: SPASTIC PARAPLEGIA, HEREDITARY is also available
=680  \\$iSevere or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.
=688  \\$a1963
=750  \0$aParaplegia$5IEN$0(DLC)sh 85097887

=LDR  00783cz  a2200181n  4500
=001  9880363874102441
=005  20141212204245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010238
=035  \\$aCBA3522HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x800.$x610
=150  \\$aParagonimus
=550  \\$wg$aTroglotrematidae
=550  \\$wh$aParagonimus westermani
=667  \\$ainfection = PARAGONIMIASIS; coordinate with specific helminth terms (for example, ANTIGENS, HELMINTH) if pertinent
=680  \\$iA genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans.
=750  \0$aParagonimus$5IEN$0(DLC)sh 88021783

=LDR  00861cz  a2200253n  4500
=001  9880363874202441
=005  20141212204245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010237
=035  \\$aCBA3521HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x865.$x741
=150  \\$aParagonimiasis
=450  \\$wnnna$aInfection, Paragonimus westermani
=450  \\$wnnna$aInfections, Paragonimus westermani
=450  \\$wnnna$aParagonimiases
=450  \\$wnnna$aParagonimus westermani Infection
=450  \\$wnnna$aParagonimus westermani Infections
=450  \\$wnnna$awestermani Infection, Paragonimus
=450  \\$wnnna$awestermani Infections, Paragonimus
=550  \\$wg$aTrematode Infections
=667  \\$atrematode infect
=680  \\$iInfection with TREMATODA of the genus PARAGONIMUS.
=750  \0$aParagonimiasis$5IEN$0(DLC)sh 85097768

=LDR  02002cz  a2200433n  4500
=001  9880363874302441
=005  20141212204245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D010236
=035  \\$aCBA3520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x700.$x705
=072  \\$aC4.$x557.$x580.$x625.$x650.$x700.$x705
=150  \\$aParaganglioma, Extra-Adrenal
=450  \\$aChemodectoma
=450  \\$wnnna$aChemodectomas
=450  \\$wnnna$aExtra-Adrenal Paraganglioma
=450  \\$wnnna$aExtra-Adrenal Paragangliomas
=450  \\$wnnna$aNon-Chromaffin Paraganglioma
=450  \\$wnnna$aNon-Chromaffin Paragangliomas
=450  \\$wnnna$aNonchromaffin Paraganglioma
=450  \\$wnnna$aNonchromaffin Paragangliomas
=450  \\$wnnna$aParaganglioma, Extra Adrenal
=450  \\$wnnna$aParaganglioma, Non-Chromaffin
=450  \\$wnnna$aParaganglioma, Non Chromaffin
=450  \\$aParaganglioma, Nonchromaffin
=450  \\$wnnna$aParagangliomas, Extra-Adrenal
=450  \\$wnnna$aParagangliomas, Familial Nonchromaffin, 1
=450  \\$wnnna$aParagangliomas, Non-Chromaffin
=450  \\$wnnna$aParagangliomas, Nonchromaffin
=550  \\$wg$aParaganglioma
=550  \\$wh$aCarotid Body Tumor
=550  \\$wh$aGlomus Jugulare Tumor
=550  \\$wh$aGlomus Tympanicum Tumor
=550  \\$aGlomus Tumor
=667  \\$acoordinate IM with precoordinated organ/neoplasm term (IM)
=680  \\$iA relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the CAROTID BODY; GLOMUS JUGULARE; GLOMUS TYMPANICUM; AORTIC BODIES; and the female genital tract. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. (From Stedman, 27th ed)
=688  \\$a94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93
=750  \0$aNonchromaffin paraganglioma$5IEN$0(DLC)sh 85092239

=LDR  00962cz  a2200229n  4500
=001  9880363874402441
=005  20141212192614.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014295
=035  \\$aCBA7631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x906
=150  \\$aTrimethoprim
=450  \\$wnnna$aProloprim
=450  \\$wnnna$aTrimpex
=550  \\$wg$aPyrimidines
=550  \\$wh$aTrimethoprim-Sulfamethoxazole Combination
=550  \\$aTrimethoprim Resistance
=667  \\$aconsider TRIMETHOPRIM RESISTANCE for nonsusceptibility of bacteria
=680  \\$iA pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
=688  \\$a74(72)
=750  \0$aTrimethoprim$5IEN$0(DLC)sh 85137542

=LDR  00958cz  a2200241n  4500
=001  9880363874502441
=005  20141212210419.0
=008  780208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014290
=035  \\$aCBA7626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x542
=072  \\$aD2.$x33.$x755.$x624.$x698.$x542
=072  \\$aD2.$x92.$x63.$x624.$x698.$x542
=150  \\$aMetipranolol
=450  \\$wnnna$a1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol
=450  \\$wnnna$aDisorat
=450  \\$wnnna$aMethypranol
=450  \\$aTrimepranol
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.
=688  \\$a95; was TRIMEPRANOL 1979-94 (see under PROPANOLAMINES 1979-90); METIPRANOLOL was see TRIMEPRANOL 1986-94
=750  \0$aMetipranolol$5IEN$0(DLC)sh 85084432

=LDR  00959cz  a2200229n  4500
=001  9880363874602441
=005  20141212210417.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014284
=035  \\$aCBA7620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x931.$x740.$x385
=072  \\$aD12.$x125.$x72.$x50.$x767.$x741.$x894
=150  \\$aTriiodothyronine
=450  \\$wnnna$aCytomel
=450  \\$aLiothyronine
=450  \\$aT3 Thyroid Hormone
=450  \\$wnnna$aThyroid Hormone, T3
=550  \\$wg$aThyronines
=680  \\$iA T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
=688  \\$aLIOTHYRONINE was heading 1963-66
=750  \0$aTriiodothyronine$5IEN$0(DLC)sh 85137530

=LDR  00751cz  a2200217n  4500
=001  9880363874702441
=005  20141212210415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014280
=035  \\$aCBA7616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x351.$x801
=150  \\$aTriglycerides
=450  \\$aTriacylglycerol
=450  \\$aTriacylglycerols
=550  \\$wg$aGlycerides
=550  \\$wh$aTriacetin
=550  \\$wh$aTriolein
=667  \\$a/blood: consider also HYPERTRIGLYCERIDEMIA & the hypertriglyceridemias in HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV & HYPERLIPOPROTEINEMIA TYPE V
=688  \\$a2001(1966); for TRIACYLGLYCEROL use TRIGLYCERIDES (NM) 1976-2000
=750  \0$aTriglycerides$5IEN$0(DLC)sh 85137515

=LDR  02174cz  a2200493n  4500
=001  9880363874802441
=005  20141212210415.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014277
=035  \\$aCBA7613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x292.$x775.$x700
=150  \\$aTrigeminal Neuralgia
=450  \\$wnnna$aDisease, Fothergill
=450  \\$wnnna$aEpileptiform Neuralgia
=450  \\$wnnna$aEpileptiform Neuralgias
=450  \\$wnnna$aFothergill Disease
=450  \\$wnnna$aIdiopathic Trigeminal Neuralgia
=450  \\$wnnna$aIdiopathic Trigeminal Neuralgias
=450  \\$wnnna$aNeuralgia, Epileptiform
=450  \\$wnnna$aNeuralgia, Idiopathic Trigeminal
=450  \\$wnnna$aNeuralgia, Secondary Trigeminal
=450  \\$wnnna$aNeuralgia, Trifacial
=450  \\$wnnna$aNeuralgia, Trigeminal
=450  \\$wnnna$aNeuralgias, Epileptiform
=450  \\$wnnna$aNeuralgias, Idiopathic Trigeminal
=450  \\$wnnna$aNeuralgias, Secondary Trigeminal
=450  \\$wnnna$aNeuralgias, Trifacial
=450  \\$wnnna$aNeuralgias, Trigeminal
=450  \\$wnnna$aSecondary Trigeminal Neuralgia
=450  \\$wnnna$aSecondary Trigeminal Neuralgias
=450  \\$aTic Douloureux
=450  \\$wnnna$aTrifacial Neuralgia
=450  \\$wnnna$aTrifacial Neuralgias
=450  \\$wnnna$aTrigeminal Neuralgia, Idiopathic
=450  \\$wnnna$aTrigeminal Neuralgia, Secondary
=450  \\$wnnna$aTrigeminal Neuralgias
=450  \\$wnnna$aTrigeminal Neuralgias, Idiopathic
=450  \\$wnnna$aTrigeminal Neuralgias, Secondary
=550  \\$wg$aTrigeminal Nerve Diseases
=550  \\$aFacial Pain
=550  \\$aTrigeminal Nerve
=680  \\$iA syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
=750  \0$aNeuralgia, Trigeminal$5IEN$0(DLC)sh 85091105

=LDR  01933cz  a2200433n  4500
=001  9880363874902441
=005  20141212192612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014276
=035  \\$aCBA7612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x120.$x760
=150  \\$aTrigeminal Nerve
=450  \\$wnnna$aCranial Nerve, Fifth
=450  \\$aCranial Nerve V
=450  \\$wnnna$aCranial Nerves, Fifth
=450  \\$aFifth Cranial Nerve
=450  \\$wnnna$aFifth Cranial Nerves
=450  \\$wnnna$aNerve, Fifth Cranial
=450  \\$wnnna$aNerve, Trigeminal
=450  \\$wnnna$aNerve V
=450  \\$wnnna$aNerve V, Cranial
=450  \\$wnnna$aNerve Vs
=450  \\$wnnna$aNerves, Fifth Cranial
=450  \\$wnnna$aNerves, Trigeminal
=450  \\$wnnna$aNervus Trigeminus
=450  \\$wnnna$aTrigeminal Nerves
=450  \\$wnnna$aTrigeminus, Nervus
=450  \\$wnnna$aV, Cranial Nerve
=550  \\$wg$aCranial Nerves
=550  \\$wh$aMandibular Nerve
=550  \\$wh$aMaxillary Nerve
=550  \\$wh$aOphthalmic Nerve
=550  \\$wh$aTrigeminal Ganglion
=550  \\$aPontine Tegmentum
=550  \\$aTrigeminal Neuralgia
=667  \\$aneoplasm = TRIGEMINAL NERVE DISEASES (IM) + CRANIAL NERVE NEOPLASMS (IM) + histological type of neoplasm (IM)
=680  \\$iThe 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the TRIGEMINAL GANGLION and project to the TRIGEMINAL NUCLEUS of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.
=750  \0$aTrigeminal nerve$0(DLC) sh 85137510$5IEN

=LDR  00613cz  a2200205n  4500
=001  9880363875002441
=005  20141212210414.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014274
=035  \\$aCBA7610M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x146.$x859.$x717
=072  \\$aD2.$x455.$x426.$x559.$x389.$x832.$x767
=150  \\$aTrifluralin
=450  \\$wnnna$aTreflan
=550  \\$wg$aToluene
=550  \\$wg$aToluidines
=680  \\$iA microtubule-disrupting pre-emergence herbicide.
=688  \\$a91(72); was see under TOLUIDINES 1972-90
=750  \0$aTrifluralin$5IEN-M$0(DLC)sh 00006154

=LDR  01006cz  a2200265n  4500
=001  9880363875102441
=005  20141212210412.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014266
=035  \\$aCBA7602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782.$x258.$x368.$x880
=150  \\$aTrientine
=450  \\$wnnna$aMerck Brand of Trientine Hydrochloride
=450  \\$wnnna$aSyprine
=450  \\$wnnna$aTrien
=450  \\$wnnna$aTrientine Dihydrochloride
=450  \\$wnnna$aTrientine Hydrochloride
=450  \\$aTriethylenetetramine
=550  \\$wg$aEthylenediamines
=680  \\$iAn ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
=688  \\$a2011(1978)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Triethylenetetramine
=688  \\$a91(78); was see under ETHYLENEDIAMINES 1978-90
=750  \0$aTriethylenetetramine$0(DLC) sh 94008141$5IEN-M

=LDR  01189cz  a2200313n  4500
=001  9880363875202441
=005  20141212210411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014262
=035  \\$aCBA7598HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x856
=150  \\$aTricuspid Valve Insufficiency
=450  \\$wnnna$aIncompetence, Tricuspid
=450  \\$wnnna$aIncompetence, Tricuspid Valve
=450  \\$wnnna$aInsufficiency, Tricuspid Valve
=450  \\$wnnna$aRegurgitation, Tricuspid
=450  \\$wnnna$aRegurgitation, Tricuspid Valve
=450  \\$aTricuspid Incompetence
=450  \\$aTricuspid Regurgitation
=450  \\$aTricuspid Valve Incompetence
=450  \\$wnnna$aTricuspid Valve Regurgitation
=450  \\$wnnna$aValve Incompetence, Tricuspid
=450  \\$wnnna$aValve Insufficiency, Tricuspid
=450  \\$wnnna$aValve Regurgitation, Tricuspid
=550  \\$wg$aHeart Valve Diseases
=680  \\$iBackflow of blood from the RIGHT VENTRICLE into the RIGHT ATRIUM due to imperfect closure of the TRICUSPID VALVE.
=688  \\$a67; was TRICUSPID INSUFFICIENCY 1963-66
=750  \0$aTricuspid valve insufficiency$5IEN$0(DLC)sh 85137497

=LDR  00756cz  a2200205n  4500
=001  9880363875302441
=005  20141212210411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014261
=035  \\$aCBA7597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510.$x893
=150  \\$aTricuspid Valve
=450  \\$wnnna$aTricuspid Valves
=450  \\$wnnna$aValve, Tricuspid
=450  \\$wnnna$aValves, Tricuspid
=550  \\$wg$aHeart Valves
=667  \\$adis: coord IM with HEART VALVE DISEASES (IM) but note specific tricuspid valve dis; /abnorm = probably TRICUSPID ATRESIA
=680  \\$iThe valve consisting of three cusps situated between the right atrium and right ventricle of the heart.
=750  \0$aTricuspid valve$5IEN$0(DLC)sh 85137494

=LDR  01088cz  a2200253n  4500
=001  9880363875402441
=005  20141212210409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014258
=035  \\$aCBA7594M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275.$x780.$x628
=150  \\$aTrichuris
=450  \\$wnnna$atrichiura, Trichuris
=450  \\$wnnna$atrichiuras, Trichuris
=450  \\$aTrichocephalus
=450  \\$wnnna$aTrichuri
=450  \\$aTrichuris trichiura
=450  \\$wnnna$aTrichuris trichiuras
=550  \\$wg$aTrichuroidea
=667  \\$aa genus of nematodes called whipworms; infection = TRICHURIASIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of nematode worms comprising the whipworms.
=688  \\$a72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHURIS 1974-78, was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66
=750  \0$aWhipworms$0(DLC)sh2006002913$5IEN-M

=LDR  00723cz  a2200205n  4500
=001  9880363875502441
=005  20141212210409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014257
=035  \\$aCBA7593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x100.$x275.$x895
=150  \\$aTrichuriasis
=450  \\$wnnna$aTrichocephaliases
=450  \\$aTrichocephaliasis
=450  \\$wnnna$aTrichuriases
=550  \\$wg$aEnoplida Infections
=667  \\$anematode infect caused by Trichuris: do not confuse with TRICHINELLOSIS, caused by Trichina or Trichinella
=680  \\$iInfection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.
=750  \0$aTrichuriasis$5IEN$0(DLC)sh 85137482

=LDR  01126cz  a2200277n  4500
=001  9880363875602441
=005  20141212210409.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014255
=035  \\$aCBA7591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x765.$x850
=072  \\$aD4.$x345.$x891
=072  \\$aD23.$x946.$x587.$x933
=150  \\$aTrichothecenes
=450  \\$wnnna$aEpoxides, Trichothecene
=450  \\$aEpoxytrichothecenes
=450  \\$aTrichothecene Epoxides
=550  \\$wg$aMacrocyclic Compounds
=550  \\$wg$aMycotoxins
=550  \\$wg$aSesquiterpenes
=550  \\$wh$aT-2 Toxin
=550  \\$wh$aTrichodermin
=680  \\$iUsually 12,13-epoxytrichothecenes, produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition.
=688  \\$a91(81); was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80
=750  \0$aTrichothecenes$5IEN$0(DLC)sh 85137481

=LDR  00799cz  a2200169n  4500
=001  9880363875702441
=005  20141212210408.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014254
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x700.$x775.$x746.$x610
=150  \\$aTrichostrongylus
=550  \\$wg$aTrichostrongyloidea
=667  \\$ainfection = TRICHOSTRONGYLOSIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of parasitic nematodes found in the digestive tract of herbivorous animals. They cause incidental infections in humans from the following species: Trichostrongylus colubriformis, T. orientalis, T. axei, and T. probolurus.
=688  \\$a86
=750  \0$aTrichostrongylus$5IEN$0(DLC)sh 87020022

=LDR  00801cz  a2200229n  4500
=001  9880363875802441
=005  20141212210407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014249
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x928
=150  \\$aTrichophyton
=450  \\$aEndodermophyton
=450  \\$wnnna$aEndodermophytons
=450  \\$wnnna$aTrichophytons
=450  \\$wnnna$aTrychophyton
=450  \\$wnnna$aTrychophytons
=550  \\$wg$aMitosporic Fungi
=550  \\$aArthrodermataceae
=667  \\$ado not confuse with TRICHOPHYTIN, a fungal antigen; infection = TRICHOPHYTOSIS see TINEA
=680  \\$iA mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair.
=750  \0$aTrichophyton$5IEN$0(DLC)sh 88022097

=LDR  00986cz  a2200217n  4500
=001  9880363875902441
=005  20141212210406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014246
=035  \\$aCBA7582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x630.$x800.$x808.$x717
=150  \\$aTrichomonas vaginalis
=450  \\$wnnna$aTrichomonas vaginali
=450  \\$wnnna$avaginali, Trichomonas
=450  \\$wnnna$avaginalis, Trichomonas
=550  \\$wg$aTrichomonas
=667  \\$ado not confuse with the disease TRICHOMONAS VAGINITIS; infection = probably TRICHOMONAS VAGINITIS but if not, coordinate IM with TRICHOMONAS INFECTIONS (IM) + precoord organ/dis term (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males.
=688  \\$a72
=750  \0$aTrichomonas vaginalis$5IEN$0(DLC)sh 85137471

=LDR  00901cz  a2200241n  4500
=001  9880363876002441
=005  20141212210406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014245
=035  \\$aCBA7581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x890
=150  \\$aTrichomonas Infections
=450  \\$wnnna$aInfection, Trichomonas
=450  \\$wnnna$aInfections, Trichomonas
=450  \\$wnnna$aTrichomonas Infection
=450  \\$aTrichomoniasis$5IEN
=550  \\$wg$aProtozoan Infections
=550  \\$wh$aTrichomonas Vaginitis
=667  \\$aprotozoan infect; /drug ther: consider also ANTITRICHOMONAL AGENTS
=680  \\$iInfections in birds and mammals produced by various species of Trichomonas.
=688  \\$aTRICHOMONAS CYSTITIS, TRICHOMONAS PROSTATO-SEMINO-VESICULITIS & TRICHOMONAS URETHRITIS were headings 1963-71
=750  \0$aTrichomoniasis$5IEN$0(DLC)sh 85137472

=LDR  00790cz  a2200193n  4500
=001  9880363876102441
=005  20141212210406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014244
=035  \\$aCBA7580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x630.$x800.$x808
=150  \\$aTrichomonas
=450  \\$wnnna$aTrichomona
=550  \\$wg$aTrichomonadida
=550  \\$wh$aTrichomonas vaginalis
=667  \\$ainfection = TRICHOMONAS INFECTIONS; trichomonicides = ANTITRICHOMONAL AGENTS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of parasitic flagellate EUKARYOTES distinguished by the presence of four anterior flagella, an undulating membrane, and a trailing flagellum.
=750  \0$aTrichomonas$5IEN$0(DLC)sh 88021470

=LDR  00634cz  a2200181n  4500
=001  9880363876202441
=005  20141212210405.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x910
=150  \\$aTrichoderma
=450  \\$wnnna$aTrichodermas
=550  \\$wg$aMitosporic Fungi
=667  \\$ainfection: coord IM with MYCOSES or specifics
=680  \\$iA mitosporic fungal genus frequently found in soil and on wood. It is sometimes used for controlling pathogenic fungi. Its teleomorph is HYPOCREA.
=688  \\$a91(75)
=750  \0$aTrichoderma$5IEN$0(DLC)sh 85137461

=LDR  00888cz  a2200217n  4500
=001  9880363876302441
=005  20141212210405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014241
=035  \\$aCBA7577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x939
=150  \\$aTrichloroethylene
=450  \\$aEthinyl Trichloride
=450  \\$wnnna$aTrichloride, Ethinyl
=450  \\$wnnna$aTrichloroethene
=450  \\$wnnna$aTrielina
=450  \\$wnnna$aTrilene
=550  \\$wg$aHydrocarbons, Chlorinated
=680  \\$iA highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment.
=750  \0$aTrichloroethylene$5IEN$0(DLC)sh 85137453

=LDR  00814cz  a2200169n  4500
=001  9880363876402441
=005  20141212210405.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014240
=035  \\$aCBA7576HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x927
=150  \\$aTrichloroethanes
=550  \\$wg$aHydrocarbons, Chlorinated
=680  \\$iChlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers.
=688  \\$a91(77); was see under HYDROCARBONS, CHLORINATED 1977-90
=750  \0$aTrichloroethane$5IEN$0(DLC)sh 85137452

=LDR  01343cz  a2200289n  4500
=001  9880363876502441
=005  20141212210403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014235
=035  \\$aCBA7571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x508.$x100.$x275.$x882
=150  \\$aTrichinellosis
=450  \\$wnnna$aHuman Trichinelloses
=450  \\$aHuman Trichinellosis
=450  \\$wnnna$aTrichinelliases
=450  \\$aTrichinelliasis
=450  \\$wnnna$aTrichinelloses
=450  \\$wnnna$aTrichinelloses, Human
=450  \\$wnnna$aTrichinellosis, Human
=450  \\$wnnna$aTrichinoses
=450  \\$aTrichinosis
=550  \\$wg$aEnoplida Infections
=667  \\$anematode infect caused by Trichina or Trichinella: do not confuse with TRICHURIASIS, caused by Trichuris
=680  \\$iAn infection with TRICHINELLA. It is caused by eating raw or undercooked meat that is infected with larvae of nematode worms TRICHINELLA genus. All members of the TRICHINELLA genus can infect human in addition to TRICHINELLA SPIRALIS, the traditional etiological agent. It is distributed throughout much of the world and is re-emerging in some parts as a public health hazard and a food safety problem.
=688  \\$aHeading changed 20090831 from: 150:##:_{dollar}a Trichinosis
=750  \0$aTrichinosis$0(DLC) sh 85137447$5IEN

=LDR  00791cz  a2200217n  4500
=001  9880363876602441
=005  20141212210403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014234
=035  \\$aCBA7570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275.$x780.$x608
=150  \\$aTrichinella
=450  \\$aTrichina
=450  \\$wnnna$aTrichinas
=450  \\$wnnna$aTrichinellas
=550  \\$wg$aTrichuroidea
=550  \\$wh$aTrichinella spiralis
=667  \\$aa genus of nematodes; infection =TRICHINELLOSIS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of parasitic nematodes that causes TRICHINELLOSIS in man and other animal.
=750  \0$aTrichinella$5IEN$0(DLC)sh 85137443

=LDR  00673cz  a2200193n  4500
=001  9880363876702441
=005  20141212210402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014231
=035  \\$aCBA7567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x69.$x799
=150  \\$aTribolium
=450  \\$wnnna$aTriboliums
=550  \\$wg$aBeetles
=667  \\$a"confused flour beetle"; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of small beetles of the family Tenebrionidae; T. confusum is the "confused flour beetle".
=688  \\$a72
=750  \0$aTribolium$5IEN$0(DLC)sh 85137425

=LDR  00636cz  a2200241n  4500
=001  9880363876802441
=005  20171024154532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014230
=035  \\$aCBA7566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x799
=150  \\$aTriazoles
=550  \\$wg$aAzoles
=550  \\$wh$aAmitrole
=550  \\$wh$aFluconazole
=550  \\$wh$aGuanazole
=550  \\$wh$aItraconazole
=550  \\$wh$aSitagliptin Phosphate
=550  \\$wh$aTrapidil
=550  \\$wh$aVoriconazole
=667  \\$aincludes triazolines, triazolidines
=750  \0$aTriazoles$5IEN$0(DLC)sh 85137417

=LDR  01342cz  a2200337n  4500
=001  9880363876902441
=005  20141212210402.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014229
=035  \\$aCBA7565M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x79.$x80.$x900
=150  \\$aTriazolam
=450  \\$wnnna$aApo-Triazo
=450  \\$wnnna$aApo Triazo
=450  \\$wnnna$aApotex Brand of Triazolam
=450  \\$wnnna$aGen-Triazolam
=450  \\$wnnna$aGen Triazolam
=450  \\$wnnna$aGenpharm Brand of Triazolam
=450  \\$wnnna$aGerard Brand of Triazolam
=450  \\$wnnna$aHalcion
=450  \\$wnnna$aPfizer Brand of Triazolam
=450  \\$wnnna$aTriazolam Pfizer Brand
=450  \\$wnnna$aTrilam
=450  \\$wnnna$aU-33,030
=450  \\$wnnna$aU 33,030
=450  \\$wnnna$aU33,030
=550  \\$wg$aBenzodiazepines
=680  \\$iA short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
=688  \\$a86(77); was see under BENZODIAZEPINE TRANQUILIZERS 1977-85
=750  \0$aTriazolam$5IEN-M$0(DLC)sh 98003091

=LDR  00986cz  a2200325n  4500
=001  9880363877002441
=005  20210217132334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014227
=035  \\$aCBA7563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x931
=150  \\$aTriazines
=450  \\$wnnna$aBenzotriazines
=450  \\$aCycloguanil Pamoate$5IEN-M
=450  \\$aMelamine$5IEN-M
=550  \\$wg$aHeterocyclic Compounds, 1-Ring
=550  \\$wh$aAlmitrine
=550  \\$wh$aAltretamine
=550  \\$wh$aApazone
=550  \\$wh$aAtrazine
=550  \\$wh$aFerrozine
=550  \\$wh$aOxonic Acid
=550  \\$wh$aPrometryne
=550  \\$wh$aSimazine
=550  \\$wh$aTriethylenemelamine
=550  \\$wh$aTirapazamine
=667  \\$ado not confuse with TRIAZENES
=680  \\$iHeterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.
=750  \0$aTriazines$0(DLC) sh 85137416$5IEN

=LDR  00699cz  a2200229n  4500
=001  9880363877102441
=005  20141212210401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014226
=035  \\$aCBA7562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x925
=150  \\$aTriazenes
=450  \\$wnnna$aCompounds, Diazoamino
=450  \\$wnnna$aDiazoamino Compounds
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aDacarbazine
=550  \\$wh$aDiminazene
=667  \\$ado not confuse with TRIAZINES
=680  \\$iCompounds with three contiguous nitrogen atoms in linear format, H2N-N=NH, and hydrocarbyl derivatives.
=688  \\$a73(72)
=750  \0$aTriazenes$5IEN$0(DLC)sh 90004537

=LDR  00851cz  a2200217n  4500
=001  9880363877202441
=005  20141212210401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014225
=035  \\$aCBA7561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x700.$x850
=150  \\$aTriatominae
=550  \\$wg$aReduviidae
=550  \\$wh$aPanstrongylus
=550  \\$wh$aRhodnius
=550  \\$wh$aTriatoma
=667  \\$avectors of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111
=680  \\$iA subfamily of assassin bugs (REDUVIIDAE) that are obligate blood-suckers of vertebrates. Included are the genera TRIATOMA; RHODNIUS; and PANSTRONGYLUS, which are vectors of TRYPANOSOMA CRUZI, the agent of CHAGAS DISEASE in humans.
=688  \\$a91(67)
=750  \0$aConenoses$0(DLC) sh 87020124$5IEN

=LDR  00721cz  a2200193n  4500
=001  9880363877302441
=005  20141212210400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014224
=035  \\$aCBA7560HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x420.$x700.$x850.$x800
=150  \\$aTriatoma
=450  \\$wnnna$aTriatomas
=550  \\$wg$aTriatominae
=667  \\$avector of Trypanosoma cruzi; do not use /drug eff for insecticides: TN 111
=680  \\$iA genus of the subfamily TRIATOMINAE. Several species are vectors of TRYPANOSOMA CRUZI.
=688  \\$a91(75); was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78
=750  \0$aTriatoma$5IEN$0(DLC)sh 85137415

=LDR  00834cz  a2200253n  4500
=001  9880363877402441
=005  20141212210400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014223
=035  \\$aCBA7559HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x733.$x900
=150  \\$aTriamterene
=450  \\$wnnna$aDyrenium
=450  \\$wnnna$aDytac
=450  \\$wnnna$aGoldshield Brand of Triamterene
=450  \\$wnnna$aJorba Brand of Triamterene
=450  \\$wnnna$aSmithKline Beecham Brand of Triamterene
=450  \\$wnnna$aUrocaudal
=450  \\$wnnna$aWellspring Brand of Triamterene
=550  \\$wg$aPteridines
=680  \\$iA pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
=688  \\$a65(63)
=750  \0$aTriamterene$5IEN$0(DLC)sh 85137406

=LDR  01087cz  a2200301n  4500
=001  9880363877502441
=005  20141212210400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014222
=035  \\$aCBA7558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x915.$x715
=072  \\$aD4.$x808.$x908.$x891.$x927
=150  \\$aTriamcinolone Acetonide
=450  \\$wnnna$a40, Kenalog
=450  \\$wnnna$aA, Kenacort
=450  \\$wnnna$aAcetonide, Triamcinolone
=450  \\$wnnna$aAzmacort
=450  \\$wnnna$aCinonide
=450  \\$wnnna$aKenacort A
=450  \\$wnnna$aKenalog
=450  \\$wnnna$aKenalog 40
=450  \\$wnnna$aTricort-40
=450  \\$wnnna$aTricort 40
=450  \\$wnnna$aTricort40
=550  \\$wg$aTriamcinolone
=680  \\$iAn esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.
=750  \0$aTriamcinolone acetonide$5IEN$0(DLC)sh 85137405

=LDR  00866cz  a2200217n  4500
=001  9880363877602441
=005  20141212210359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014221
=035  \\$aCBA7557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x915
=072  \\$aD4.$x808.$x908.$x891
=150  \\$aTriamcinolone
=450  \\$wnnna$aAristocort
=450  \\$wnnna$aVolon
=550  \\$wg$aPregnadienes
=550  \\$wg$aSteroids, Fluorinated
=550  \\$wh$aTriamcinolone Acetonide
=680  \\$iA glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p739)
=750  \0$aTriamcinolone$5IEN$0(DLC)sh 85137404

=LDR  00678cz  a2200181n  4500
=001  9880363877702441
=005  20141212210359.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014218
=035  \\$aCBA7554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x297.$x900
=150  \\$aTriage
=450  \\$wnnna$aTriages
=550  \\$wg$aEmergency Medical Services
=680  \\$iThe sorting out and classification of patients or casualties to determine priority of need and proper place of treatment.
=688  \\$a91(76); was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79
=750  \0$aTriage (Medicine)$5IEN$0(DLC)sh 85137323

=LDR  00589cz  a2200193n  4500
=001  9880363877802441
=005  20141212210231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013965
=035  \\$aCBA7297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x270.$x856
=150  \\$aThyroidectomy
=450  \\$wnnna$aThyroidectomies
=550  \\$wg$aEndocrine Surgical Procedures
=550  \\$aThyroid Gland
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal of the thyroid gland. (Dorland, 28th ed)
=750  \0$aThyroidectomy$5IEN$0(DLC)sh 85135176

=LDR  01550cz  a2200469n  4500
=001  9880363877902441
=005  20210212075909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013964
=035  \\$aCBA7296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x894
=072  \\$aC4.$x588.$x443.$x915
=072  \\$aC19.$x344.$x894
=072  \\$aC19.$x874.$x788
=150  \\$aThyroid Neoplasms
=450  \\$wnnna$aAdenoma, Thyroid
=450  \\$wnnna$aAdenomas, Thyroid
=450  \\$wnnna$aCancer of the Thyroid
=450  \\$aCancer of Thyroid
=450  \\$wnnna$aCancer, Thyroid
=450  \\$wnnna$aCancers, Thyroid
=450  \\$wnnna$aCarcinoma, Thyroid
=450  \\$wnnna$aCarcinomas, Thyroid
=450  \\$wnnna$aNeoplasm, Thyroid
=450  \\$wnnna$aNeoplasms, Thyroid
=450  \\$wnnna$aThyroid Adenoma
=450  \\$wnnna$aThyroid Adenomas
=450  \\$aThyroid Cancer
=450  \\$wnnna$aThyroid Cancers
=450  \\$wnnna$aThyroid Carcinoma
=450  \\$wnnna$aThyroid Carcinomas
=450  \\$wnnna$aThyroid Neoplasm
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wg$aHead and Neck Neoplasms
=550  \\$wg$aThyroid Diseases
=550  \\$wh$aThyroid Nodule
=550  \\$wh$aThyroid Cancer, Papillary
=667  \\$acoordinate IM with histological type of neoplasm (IM); THYROID NODULE is also available
=680  \\$iTumors or cancer of the THYROID GLAND.
=750  \0$aThyroid gland$xTumors$5IEN-M$0(DLC)sh 85135172
=750  \0$aThyroid gland$xCancer$5IEN-HS$0(DLC)sh 85135165

=LDR  00856cz  a2200253n  4500
=001  9880363878002441
=005  20141212210231.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013963
=035  \\$aCBA7295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x931
=150  \\$aThyroid Hormones
=450  \\$wnnna$aHormones, Thyroid
=550  \\$wg$aHormones
=550  \\$wh$aDextrothyroxine
=550  \\$wh$aDiiodotyrosine
=550  \\$wh$aMonoiodotyrosine
=550  \\$wh$aThyroid (USP)
=550  \\$wh$aThyronines
=550  \\$wh$aThyroxine
=667  \\$ageneral or unspecified: prefer specifics; T3 = TRIIODOTHYRONINE; T4 = THYROXINE; /defic: consider also HYPOTHYROIDISM
=680  \\$iNatural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs.
=750  \0$aThyroid hormones$5IEN$0(DLC)sh 85135174

=LDR  01083cz  a2200229n  4500
=001  9880363878102441
=005  20141212210230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013961
=035  \\$aCBA7293HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x900
=150  \\$aThyroid Gland
=450  \\$wnnna$aGland, Thyroid
=450  \\$wnnna$aGlands, Thyroid
=450  \\$wnnna$aThyroid
=450  \\$wnnna$aThyroid Glands
=450  \\$wnnna$aThyroids
=550  \\$wg$aEndocrine Glands
=667  \\$a/surg: probably THYROIDECTOMY; inflammation = THYROIDITIS; nodule = THYROID NODULE; /abnorm: consider also THYROID DYSGENESIS; THYROID (USP), a dehydrated extract of thyroid glands is available
=680  \\$iA highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.
=750  \0$aThyroid gland$5IEN$0(DLC)sh 85135163

=LDR  01185cz  a2200325n  4500
=001  9880363878202441
=005  20141212210230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013960
=035  \\$aCBA7292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x374.$x750
=150  \\$aThyroid Function Tests
=450  \\$wnnna$aFunction Test, Thyroid
=450  \\$wnnna$aFunction Tests, Thyroid
=450  \\$wnnna$aIodine Test, Protein-Bound
=450  \\$wnnna$aIodine Tests, Protein-Bound
=450  \\$aProtein-Bound Iodine Test
=450  \\$wnnna$aProtein Bound Iodine Test
=450  \\$wnnna$aProtein-Bound Iodine Tests
=450  \\$wnnna$aTest, Protein-Bound Iodine
=450  \\$wnnna$aTest, Thyroid Function
=450  \\$wnnna$aTests, Protein-Bound Iodine
=450  \\$wnnna$aTests, Thyroid Function
=450  \\$wnnna$aThyroid Function Test
=450  \\$wnnna$aThyroid Gland Function Tests
=550  \\$wg$aDiagnostic Techniques, Endocrine
=550  \\$wh$aBasal Metabolism
=688  \\$a77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95
=750  \0$aThyroid gland function tests$5IEN$0(DLC)sh 85135173

=LDR  01007cz  a2200313n  4500
=001  9880363878302441
=005  20141212210230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013959
=035  \\$aCBA7291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x874
=150  \\$aThyroid Diseases
=450  \\$wnnna$aDisease, Thyroid
=450  \\$wnnna$aDiseases, Thyroid
=450  \\$wnnna$aThyroid Disease
=550  \\$wg$aEndocrine System Diseases
=550  \\$wh$aEuthyroid Sick Syndromes
=550  \\$wh$aGoiter
=550  \\$wh$aHyperthyroidism
=550  \\$wh$aHyperthyroxinemia
=550  \\$wh$aHypothyroidism
=550  \\$wh$aThyroid Dysgenesis
=550  \\$wh$aThyroid Neoplasms
=550  \\$wh$aThyroiditis
=550  \\$wh$aThyrotoxicosis
=667  \\$ageneral or unspecified; prefer specifics; inflammatory disease (-itis) = THYROIDITIS or specifics
=680  \\$iPathological processes involving the THYROID GLAND.
=750  \0$aThyroid gland$xDiseases$5IEN$0(DLC)sh 85135167

=LDR  01298cz  a2200337n  4500
=001  9880363878402441
=005  20141212210229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013956
=035  \\$aCBA7288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x100
=072  \\$aD27.$x505.$x696.$x399.$x450.$x100
=150  \\$aAntithyroid Agents
=450  \\$wnnna$aAgents, Antithyroid
=450  \\$wnnna$aAntagonists, Thyroid
=450  \\$wnnna$aAntithyroid Drugs
=450  \\$wnnna$aAntithyroid Effect
=450  \\$wnnna$aAntithyroid Effects
=450  \\$wnnna$aDrugs, Antithyroid
=450  \\$wnnna$aEffect, Antithyroid
=450  \\$wnnna$aEffects, Antithyroid
=450  \\$aGoitrogens
=450  \\$aThyroid Antagonists
=450  \\$aThyroid Hormones$xantagonists & inhibitors
=550  \\$wg$aHormone Antagonists
=550  \\$aHyperthyroidism
=667  \\$anote entry term ANTITHYROID EFFECT: use only for the antithyroid effect of a chemical substance
=680  \\$iAgents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
=688  \\$a96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95
=750  \0$aThyroid antagonists$5IEN$0(DLC)sh 85135161

=LDR  00592cz  a2200217n  4500
=001  9880363878502441
=005  20141212210228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013954
=035  \\$aCBA7286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x377.$x856
=072  \\$aD12.$x776.$x395.$x768
=072  \\$aD12.$x776.$x486.$x706
=150  \\$aThyroglobulin
=550  \\$wg$aGlobulins
=550  \\$wg$aGlycoproteins
=550  \\$wg$aIodoproteins
=550  \\$aThyroid Hormones
=667  \\$a/biosyn /physiol permitted
=750  \0$aThyroglobulin$5IEN$0(DLC)sh 85135158

=LDR  01575cz  a2200517n  4500
=001  9880363878602441
=005  20141212210228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013953
=035  \\$aCBA7285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x949
=072  \\$aC15.$x604.$x861
=150  \\$aThymus Neoplasms
=450  \\$wnnna$aCancer of the Thymus
=450  \\$aCancer of Thymus
=450  \\$wnnna$aCancer, Thymic
=450  \\$wnnna$aCancer, Thymus
=450  \\$wnnna$aCancers, Thymic
=450  \\$wnnna$aCancers, Thymus
=450  \\$wnnna$aNeoplasm, Thymic
=450  \\$wnnna$aNeoplasm, Thymus
=450  \\$wnnna$aNeoplasms, Thymic
=450  \\$wnnna$aNeoplasms, Thymus
=450  \\$wnnna$aThymic Cancer
=450  \\$wnnna$aThymic Cancers
=450  \\$wnnna$aThymic Neoplasm
=450  \\$wnnna$aThymic Neoplasms
=450  \\$wnnna$aThymic Tumor
=450  \\$wnnna$aThymic Tumors
=450  \\$aThymus Cancer
=450  \\$wnnna$aThymus Cancers
=450  \\$wnnna$aThymus Neoplasm
=450  \\$wnnna$aThymus Tumor
=450  \\$aThymus Tumors
=450  \\$wnnna$aTumor, Thymic
=450  \\$wnnna$aTumor, Thymus
=450  \\$wnnna$aTumors, Thymic
=450  \\$wnnna$aTumors, Thymus
=550  \\$wg$aLymphatic Diseases
=550  \\$wg$aThoracic Neoplasms
=550  \\$wh$aThymoma
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the THYMUS GLAND.
=750  \0$aThymus$xCancer$5IEN-M$0(DLC)sh2010010407
=750  \0$aThymus$xTumors$5IEN-HS$0(DLC)sh 85135150

=LDR  00823cz  a2200253n  4500
=001  9880363878702441
=005  20141212210227.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013951
=035  \\$aCBA7283HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x910
=150  \\$aThymus Hormones
=450  \\$wnnna$aHormones, Thymic
=450  \\$wnnna$aHormones, Thymus
=450  \\$aThymic Hormones
=550  \\$wg$aHormones
=550  \\$wh$aThymic Factor, Circulating
=550  \\$wh$aThymopoietins
=550  \\$wh$aThymosin
=667  \\$a/biosyn /physiol permitted
=680  \\$iHumoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response.
=688  \\$a77
=750  \0$aThymic hormones$5IEN$0(DLC)sh 85135139

=LDR  01126cz  a2200229n  4500
=001  9880363878802441
=005  20141212210227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013950
=035  \\$aCBA7282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x549.$x750
=072  \\$aA15.$x382.$x520.$x604.$x750
=150  \\$aThymus Gland
=450  \\$wnnna$aGland, Thymus
=450  \\$wnnna$aGlands, Thymus
=450  \\$wnnna$aThymus
=450  \\$wnnna$aThymus Glands
=550  \\$wg$aLymphoid Tissue
=667  \\$adiseases: coordinate IM with LYMPHATIC DISEASES (IM); / surg: probably THYMECTOMY; agenesis, aplasia, dysplasia = DIGEORGE SYNDROME; cyst = THYMIC CYST see MEDIASTINAL CYST; THYMOCYTES is available
=680  \\$iA single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.
=750  \0$aThymus$5IEN$0(DLC)sh 85135147

=LDR  00889cz  a2200193n  4500
=001  9880363878902441
=005  20141212210226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013949
=035  \\$aCBA7281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x777.$x871
=150  \\$aThymus Extracts
=450  \\$wnnna$aExtracts, Thymus
=550  \\$wg$aTissue Extracts
=667  \\$aextracts of thymus or thymus fractions containing uncharacterized factors; do not confuse with chemical substances "extracted" from the thymus, as "peptides extracted from the mouse thymus" ( = PEPTIDES /anal + THYMUS GLAND /anal)
=680  \\$iExtracts of the thymus that contain specific, but uncharacterized factors or proteins with specific activities; three distinct substances are already known: thymotoxin, thymin and thymosin.
=688  \\$a74
=750  \0$aThymus extract$5IEN$0(DLC)sh 85135146

=LDR  01122cz  a2200253n  4500
=001  9880363879002441
=005  20210212080042.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x910.$x850
=072  \\$aD12.$x644.$x548.$x869
=072  \\$aD12.$x776.$x922
=150  \\$aThymosin
=450  \\$wnnna$aThymosin Fs
=450  \\$wnnna$aThymosins
=550  \\$wg$aPeptide Hormones
=550  \\$wg$aProteins
=550  \\$wg$aThymus Hormones
=550  \\$wh$aThymalfasin
=667  \\$a/biosyn /physiol permitted
=680  \\$iThymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging.
=688  \\$a84(75); was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76
=750  \0$aThymosin$5IEN$0(DLC)sh 85135144

=LDR  00740cz  a2200205n  4500
=001  9880363879102441
=005  20141212210225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013943
=035  \\$aCBA7275HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x575.$x875
=150  \\$aThymol
=450  \\$wnnna$aApiguard
=450  \\$wnnna$aSwarm Brand of Thymol
=450  \\$wnnna$aThymol Swarm Brand
=550  \\$wg$aMonoterpenes
=550  \\$wh$aBromthymol Blue
=680  \\$iA phenol obtained from thyme oil or other volatile oils used as a stabilizer in pharmaceutical preparations, and as an antiseptic (antibacterial or antifungal) agent. It was formerly used as a vermifuge.
=750  \0$aThymol$5IEN$0(DLC)sh 85135143

=LDR  00547cz  a2200181n  4500
=001  9880363879202441
=005  20141212210224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013941
=035  \\$aCBA7273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x698.$x875.$x899
=150  \\$aThymine
=450  \\$wnnna$a5-Methyluracil
=450  \\$wnnna$a5 Methyluracil
=550  \\$wg$aUracil
=667  \\$a/biosyn /physiol permitted; thymine deoxyriboside, thymine deoxyribonucleoside = THYMIDINE
=750  \0$aThymine$0sh 85135141$5IEN

=LDR  00824cz  a2200205n  4500
=001  9880363879302441
=005  20141212210224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013940
=035  \\$aCBA7272M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x555.$x500.$x862
=150  \\$aThymidylate Synthase
=450  \\$wnnna$aSynthase, Thymidylate
=450  \\$wnnna$aSynthetase, Thymidylate
=450  \\$wnnna$aThymidylate Synthetase
=550  \\$wg$aMethyltransferases
=680  \\$iAn enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45.
=688  \\$a98; see METHYLTRANSFERASES 1975-85
=750  \0$aThymidylate synthase$0(DLC)sh2008009589$5IEN-M

=LDR  00864cz  a2200277n  4500
=001  9880363879402441
=005  20210212103845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013936
=035  \\$aCBA7268HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x705
=072  \\$aD13.$x570.$x230.$x855
=072  \\$aD13.$x570.$x685.$x705
=150  \\$aThymidine
=450  \\$wnnna$a2'-Deoxythymidine
=450  \\$wnnna$a2' Deoxythymidine
=450  \\$wnnna$aDeoxythymidine
=550  \\$wg$aDeoxyribonucleosides
=550  \\$wg$aPyrimidine Nucleosides
=550  \\$wh$aStavudine
=550  \\$wh$aTrifluridine
=550  \\$wh$aZidovudine
=550  \\$wh$aTelbivudine
=667  \\$a/biosyn /physiol permitted; "tritiated thymidine" as a research technique is probably NIM if indexed at all
=750  \0$aThymidine$5IEN$0(DLC)sh 85135140

=LDR  00600cz  a2200205n  4500
=001  9880363879502441
=005  20141212210222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013934
=035  \\$aCBA7266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x928.$x770
=150  \\$aThymectomy
=450  \\$wnnna$aThymectomies
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$aThymus Gland
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal of the thymus gland. (Dorland, 28th ed)
=688  \\$a65(64)
=750  \0$aThymectomy$5IEN$0(DLC)sh 85135136

=LDR  00452cz  a2200157n  4500
=001  9880363879602441
=005  20141212210222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013933
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x667.$x430.$x705
=150  \\$aThumb
=450  \\$wnnna$aThumbs
=550  \\$wg$aFingers
=667  \\$aprimates only; /inj permitted: do not convert to FINGER INJURIES
=750  \0$aThumb$5IEN$0(DLC)sh 85135107

=LDR  00710cz  a2200193n  4500
=001  9880363879702441
=005  20141212210222.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013932
=035  \\$aCBA7264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x984
=072  \\$aD1.$x268.$x558.$x362.$x984
=072  \\$aD1.$x552.$x550.$x399.$x984
=150  \\$aThulium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Tm-169; Tm-161-168, 170-176 = THULIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iThulium. An element of the rare earth family of metals. It has the atomic symbol Tm, atomic number 69, and atomic weight 168.93.
=750  \0$aThulium$5IEN$0(DLC)sh 85135103

=LDR  00960cz  a2200229n  4500
=001  9880363879802441
=005  20141212210222.0
=008  770523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013931
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x255.$x100.$x825
=072  \\$aD10.$x251.$x355.$x255.$x775
=072  \\$aD23.$x469.$x50.$x175.$x800
=150  \\$aThromboxanes
=550  \\$wg$aArachidonic Acids
=550  \\$wg$aEicosanoids
=550  \\$wh$aThromboxane A2
=550  \\$wh$aThromboxane B2
=667  \\$a/biosyn /physiol permitted
=680  \\$iPhysiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase.
=688  \\$a78
=750  \0$aThromboxanes$5IEN$0(DLC)sh 85135081

=LDR  00938cz  a2200241n  4500
=001  9880363879902441
=005  20141212210220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013927
=035  \\$aCBA7259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x830
=150  \\$aThrombosis
=450  \\$wnnna$aThromboses
=450  \\$aThrombus
=550  \\$wg$aEmbolism and Thrombosis
=550  \\$wh$aCoronary Thrombosis
=550  \\$wh$aThromboembolism
=550  \\$wh$aVenous Thrombosis
=550  \\$aThrombotic Microangiopathies
=667  \\$ageneral; prefer specifics; mural thrombus: if in the heart wall, coordinate IM with HEART DISEASES (IM); if in the wall of a blood vessel, coordinate IM with specific blood vessel (IM) or precoordinated blood vessel disease term (IM)
=680  \\$iFormation and development of a thrombus or blood clot in the blood vessel.
=750  \0$aThrombosis$5IEN$0(DLC)sh 85135077

=LDR  01476cz  a2200349n  4500
=001  9880363880002441
=005  20141212210220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x750
=072  \\$aD12.$x776.$x395.$x240.$x750
=072  \\$aD12.$x776.$x395.$x720
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x750
=072  \\$aD23.$x529.$x374.$x410.$x240.$x750
=150  \\$aThrombopoietin
=450  \\$ac-mpl Ligand
=450  \\$wnnna$aLigand, c-mpl
=450  \\$wnnna$aLigand, mpl
=450  \\$wnnna$aMegakaryocyte Colony Stimulating Factor
=450  \\$aMegakaryocyte Growth and Development Factor
=450  \\$wnnna$aMGDF Factor
=450  \\$wnnna$ampl Ligand
=450  \\$wnnna$aMyeloproliferative Leukemia Virus Oncogene Ligand
=450  \\$wnnna$aThrombocytopoiesis-Stimulating Factor
=450  \\$wnnna$aThrombocytopoiesis Stimulating Factor
=450  \\$wnnna$aThrombocytopoietin
=550  \\$wg$aColony-Stimulating Factors
=550  \\$wg$aGlycoproteins
=680  \\$iA humoral factor that stimulates the production of thrombocytes (BLOOD PLATELETS). Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.
=688  \\$a91(66); was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975
=750  \0$aThrombopoietin$0(DLC) sh 96010009$5IEN-M

=LDR  01362cz  a2200373n  4500
=001  9880363880102441
=005  20141212210220.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013925
=035  \\$aCBA7257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x125.$x900
=072  \\$aD23.$x119.$x965
=150  \\$aThromboplastin
=450  \\$wnnna$aActivity, Glomerular Procoagulant
=450  \\$aAntigens, CD142
=450  \\$wnnna$aBlood Coagulation Factor III
=450  \\$aCD142 Antigens
=450  \\$aCoagulation Factor III
=450  \\$wnnna$aCoagulin
=450  \\$aFactor III
=450  \\$wnnna$aFactor III, Coagulation
=450  \\$wnnna$aGlomerular Procoagulant Activity
=450  \\$wnnna$aProcoagulant Activity, Glomerular
=450  \\$wnnna$aProcoagulant, Tissue Factor
=450  \\$wnnna$aProthrombinase
=450  \\$wnnna$aThromboplastin, Tissue
=450  \\$aTissue Factor
=450  \\$wnnna$aTissue Factor Procoagulant
=450  \\$aTissue Thromboplastin
=450  \\$wnnna$aUrothromboplastin
=550  \\$wg$aBlood Coagulation Factors
=680  \\$iConstituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.
=750  \0$aThromboplastin$5IEN$0(DLC)sh 85135076

=LDR  00884cz  a2200253n  4500
=001  9880363880202441
=005  20141212210219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013924
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x830.$x925.$x770
=072  \\$aC14.$x907.$x617.$x718.$x788
=072  \\$aC14.$x907.$x940.$x740.$x910
=150  \\$aThrombophlebitis
=450  \\$wnnna$aDolens, Phlegmasia Alba
=450  \\$aPhlegmasia Alba Dolens
=450  \\$wnnna$aThrombophlebitides
=550  \\$wg$aPhlebitis
=550  \\$wg$aVenous Thrombosis
=550  \\$wh$aLemierre Syndrome
=667  \\$aassume to be of the legs so do not coordinate with LEG
=680  \\$iInflammation of a vein associated with a blood clot (THROMBUS).
=688  \\$aPHLEGMASIA ALBA DOLENS was see under THROMBOPHLEBITIS 1963-78
=750  \0$aThrombophlebitis$5IEN$0(DLC)sh 85135075

=LDR  00751cz  a2200229n  4500
=001  9880363880302441
=005  20141212210219.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013923
=035  \\$aCBA7255HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x590
=072  \\$aC14.$x907.$x355.$x830.$x850
=150  \\$aThromboembolism
=450  \\$wnnna$aThromboembolisms
=550  \\$wg$aEmbolism and Thrombosis
=550  \\$wg$aThrombosis
=550  \\$wh$aEmbolism, Paradoxical
=550  \\$wh$aIntracranial Embolism and Thrombosis
=550  \\$wh$aVenous Thromboembolism
=680  \\$iObstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
=750  \0$aThromboembolism$0(DLC) sh 85135071$5IEN

=LDR  00840cz  a2200265n  4500
=001  9880363880402441
=005  20141212210218.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013921
=035  \\$aCBA7253HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x140.$x855
=150  \\$aThrombocytopenia
=450  \\$wnnna$aThrombocytopenias
=450  \\$aThrombopenia
=450  \\$wnnna$aThrombopenias
=550  \\$wg$aBlood Platelet Disorders
=550  \\$wh$aJacobsen Distal 11q Deletion Syndrome
=550  \\$wh$aKasabach-Merritt Syndrome
=550  \\$wh$aThrombocytopenia, Neonatal Alloimmune
=550  \\$wh$aThrombotic Microangiopathies
=550  \\$aBlood Platelets
=680  \\$iA subnormal level of BLOOD PLATELETS.
=688  \\$a85; was THROMBOPENIA 1963-84
=750  \0$aThrombocytopenia$0(DLC) sh 85135069$5IEN

=LDR  01083cz  a2200253n  4500
=001  9880363880502441
=005  20141212210217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013919
=035  \\$aCBA7251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x137.$x870
=072  \\$aC14.$x907.$x940.$x905
=150  \\$aThromboangiitis Obliterans
=450  \\$aBuerger Disease
=450  \\$wnnna$aBuerger's Disease
=450  \\$wnnna$aBuergers Disease
=450  \\$wnnna$aDisease, Buerger
=450  \\$wnnna$aDisease, Buerger's
=450  \\$wnnna$aThromboangitis Obliterans
=550  \\$wg$aArterial Occlusive Diseases
=550  \\$wg$aVasculitis
=680  \\$iA non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.
=750  \0$aThromboangiitis obliterans$5IEN$0(DLC)sh 85135068

=LDR  01418cz  a2200433n  4500
=001  9880363880602441
=005  20141212210217.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013917
=035  \\$aCBA7249HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x855
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x855
=072  \\$aD12.$x776.$x124.$x125.$x890
=072  \\$aD23.$x119.$x960
=150  \\$aThrombin
=450  \\$wnnna$aalpha-Thrombin
=450  \\$wnnna$abeta,gamma-Thrombin
=450  \\$wnnna$abeta-Thrombin
=450  \\$wnnna$aEthicon Brand of Thrombin
=450  \\$wnnna$agamma-Thrombin
=450  \\$wnnna$aJMI, Thrombin
=450  \\$wnnna$aJones Brand of Thrombin
=450  \\$wnnna$aPark Davis Brand of Thrombin
=450  \\$wnnna$aPfizer Brand of Thrombin
=450  \\$aThrombase
=450  \\$wnnna$aThrombin Ethicon Brand
=450  \\$wnnna$aThrombin JMI
=450  \\$wnnna$aThrombin-JMI
=450  \\$wnnna$aThrombin Jones Brand
=450  \\$wnnna$aThrombin Pfizer Brand
=450  \\$wnnna$aThrombinar
=450  \\$wnnna$aThrombostat
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aSerine Endopeptidases
=550  \\$aCoagulants
=667  \\$a/antag permitted: not same as ANTITHROMBINS
=680  \\$iAn enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.
=750  \0$aThrombin$5IEN$0(DLC)sh 85135066

=LDR  00695cz  a2200193n  4500
=001  9880363880702441
=005  20141212210216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013916
=035  \\$aCBA7248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x625.$x115.$x830
=072  \\$aE5.$x200.$x625.$x115.$x830
=150  \\$aThrombelastography
=450  \\$aThromboelastography
=450  \\$wnnna$aThromboelastometry
=550  \\$wg$aBlood Coagulation Tests
=680  \\$iUse of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.
=750  \0$aThrombelastography$5IEN$0(DLC)sh 85135065

=LDR  00888cz  a2200253n  4500
=001  9880363880802441
=005  20141212210215.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013911
=035  \\$aCBA7243HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x650.$x550.$x875
=072  \\$aD1.$x930.$x930
=150  \\$aThorium Dioxide
=450  \\$wnnna$aDioxide, Thorium
=450  \\$wnnna$aOxide, Thorium
=450  \\$aThorium Oxide
=450  \\$wnnna$aThorotrast
=550  \\$wg$aOxides
=550  \\$wg$aThorium Compounds
=667  \\$aan early (1930-50) contrast medium; D25-26 qualif
=680  \\$iThorium oxide (ThO2). A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.
=688  \\$a65
=750  \0$aThorium dioxide$0(DLC)sh2012003207$5IEN-M

=LDR  00949cz  a2200229n  4500
=001  9880363880902441
=005  20141212210214.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013910
=035  \\$aCBA7242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x900
=072  \\$aD1.$x268.$x271.$x100.$x900
=072  \\$aD1.$x268.$x556.$x850
=072  \\$aD1.$x552.$x20.$x889
=072  \\$aD1.$x552.$x544.$x850
=150  \\$aThorium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM
=680  \\$iThorium. A radioactive element of the actinide series of metals. It has an atomic symbol Th, atomic number 90, and atomic weight 232.04. It is used as fuel in nuclear reactors to produce fissionable uranium isotopes. Because of its radioopacity, various thorium compounds are used to facilitate visualization in roentgenography.
=750  \0$aThorium$5IEN$0(DLC)sh 85134957

=LDR  00936cz  a2200241n  4500
=001  9880363881002441
=005  20181210103655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013909
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x761
=150  \\$aThorax
=450  \\$aChest
=450  \\$wnnna$aChests
=450  \\$wnnna$aThorace
=450  \\$wnnna$aThoraces
=550  \\$wg$aTorso
=550  \\$wh$aThoracic Cavity
=550  \\$wh$aThoracic Wall
=667  \\$a/surg = THORACIC SURGERY, the specialty (Cat G2) or THORACIC SURGICAL PROCEDURES (Cat E4); "intrathoracic" could be THORAX or HEART or LUNG or RIBS: check text; chest pain = CHEST PAIN
=680  \\$iThe upper part of the trunk between the NECK and the ABDOMEN. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed)
=688  \\$a/surgery was used for indexing 1966-79
=750  \0$aChest$0(DLC)sh 85023136$5IEN-M

=LDR  01398cz  a2200421n  4500
=001  9880363881102441
=005  20141212192603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013906
=035  \\$aCBA7238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x840
=072  \\$aE4.$x502.$x250.$x840
=072  \\$aE4.$x928.$x752
=150  \\$aThoracoscopy
=450  \\$wnnna$aEndoscopies, Pleural
=450  \\$aEndoscopy, Pleural
=450  \\$wnnna$aPleural Endoscopies
=450  \\$aPleural Endoscopy
=450  \\$wnnna$aPleuroscopies
=450  \\$aPleuroscopy
=450  \\$wnnna$aSurgeries, Thoracoscopic
=450  \\$wnnna$aSurgery, Thoracoscopic
=450  \\$wnnna$aSurgical Procedure, Thoracoscopic
=450  \\$aSurgical Procedures, Thoracoscopic
=450  \\$wnnna$aThoracoscopic Surgeries
=450  \\$wnnna$aThoracoscopic Surgery
=450  \\$wnnna$aThoracoscopic Surgical Procedure
=450  \\$aThoracoscopic Surgical Procedures
=450  \\$wnnna$aThoracoscopies
=550  \\$wg$aEndoscopy
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$wh$aThoracic Surgery, Video-Assisted
=550  \\$aThoracoscopes
=550  \\$aThorax
=667  \\$a/ instrum permitted but consider also THORACOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the pleural cavity.
=750  \0$aThoracoscopy$5IEN$0(DLC)sh 85134952

=LDR  00599cz  a2200169n  4500
=001  9880363881202441
=005  20141212210213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013904
=035  \\$aCBA7236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x892
=150  \\$aThoracic Vertebrae
=450  \\$wnnna$aVertebrae, Thoracic
=550  \\$wg$aSpine
=667  \\$aIM when discussed as bones or as coord with specific spinal disease (IM); NIM when locational; inflammation = THORACIC VERTEBRAE (IM) + SPONDYLITIS (IM)
=750  \0$aThoracic vertebrae$0(DLC)sh 85142895$5IEN-M

=LDR  01265cz  a2200289n  4500
=001  9880363881302441
=005  20141212210213.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013903
=035  \\$aCBA7235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x810.$x803
=150  \\$aThoracic Surgery
=450  \\$aCardiac Surgery
=450  \\$aHeart Surgery
=450  \\$wnnna$aSurgery, Cardiac
=450  \\$wnnna$aSurgery, Heart
=450  \\$wnnna$aSurgery, Thoracic
=550  \\$wg$aSpecialties, Surgical
=550  \\$aCardiac Surgical Procedures
=550  \\$aCardiovascular Surgical Procedures
=550  \\$aThoracic Surgical Procedures
=550  \\$aThorax
=667  \\$aa surg specialty: do not confuse with THORACIC SURGICAL PROCEDURES (Cat E4); SPEC qualif; do not use for surg of specific thoracic organs ( = organ /surg) or specific thoracic dis ( = disease /surg); DF: THORACIC SURG
=680  \\$iA surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular.
=688  \\$a80; was THORAX /surgery 1966-79 & SURGERY, THORACIC (NON MESH) before 1980
=750  \0$aChest$xSurgery$5IEN$0(DLC)sh 85023143

=LDR  01247cz  a2200265n  4500
=001  9880363881402441
=005  20141212210212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x730
=150  \\$aRadiography, Thoracic
=450  \\$wnnna$aRadiographies, Thoracic
=450  \\$aThoracic Cavity$xradiography
=450  \\$wnnna$aThoracic Radiographies
=450  \\$wnnna$aThoracic Radiography
=450  \\$aThorax$xradiography
=550  \\$wg$aRadiography
=550  \\$wh$aBronchography
=550  \\$wh$aMass Chest X-Ray
=550  \\$aThorax
=667  \\$aGEN only: not a synonym for LUNG /radiogr; only for "thoracic" when the enclosed organs are not specified or are irrelevant & for THORAX /radiogr; do not use as coord with lung, heart, bronchial, etc. diseases when /radiogr with the specific organ or chest dis is given; /drug eff /rad eff permitted; do not use /util except by MeSH definition; MASS CHEST X-RAY also exists; DF: RADIOGR THORACIC
=680  \\$iX-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
=688  \\$a98(63)
=750  \0$aChest$xRadiography$5IEN$0(DLC)sh 85023142

=LDR  02508cz  a2200505n  4500
=001  9880363881502441
=005  20141212210212.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013901
=035  \\$aCBA7233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x550.$x850
=072  \\$aC14.$x907.$x863
=150  \\$aThoracic Outlet Syndrome
=450  \\$wnnna$aAperture Syndrome, Thoracic Outlet
=450  \\$wnnna$aArterial Thoracic Outlet Syndrome
=450  \\$aCostoclavicular Syndrome
=450  \\$wnnna$aCostoclavicular Syndromes
=450  \\$wnnna$aNerve Compression Syndrome, Thoracic Outlet
=450  \\$wnnna$aNeurogenic Thoracic Outlet Syndrome
=450  \\$wnnna$aNeurologic Syndrome, Thoracic Outlet
=450  \\$aNeurovascular Syndrome, Thoracic Outlet
=450  \\$wnnna$aOutlet Syndrome, Thoracic
=450  \\$wnnna$aOutlet Syndromes, Thoracic
=450  \\$aScalenus Anticus Syndrome
=450  \\$wnnna$aSuperior Thoracic Aperture Syndrome
=450  \\$wnnna$aSyndrome, Costoclavicular
=450  \\$wnnna$aSyndrome, Scalenus Anticus
=450  \\$wnnna$aSyndrome, Thoracic Outlet
=450  \\$wnnna$aSyndromes, Costoclavicular
=450  \\$wnnna$aSyndromes, Thoracic Outlet
=450  \\$aThoracic Outlet Nerve Compression Syndrome
=450  \\$wnnna$aThoracic Outlet Neurologic Syndrome
=450  \\$wnnna$aThoracic Outlet Neurovascular Syndrome
=450  \\$wnnna$aThoracic Outlet Syndrome, Neurogenic
=450  \\$wnnna$aThoracic Outlet Syndromes
=450  \\$wnnna$aVenous Thoracic Outlet Syndrome
=550  \\$wg$aNerve Compression Syndromes
=550  \\$wg$aVascular Diseases
=550  \\$wh$aCervical Rib Syndrome
=550  \\$aBrachial Plexus
=550  \\$aCervical Rib
=680  \\$iA neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a CERVICAL RIB, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. (Adams et al., Principles of Neurology, 6th ed, pp214-5).
=688  \\$a1983(1963)
=750  \0$aThoracic outlet syndrome$5IEN$0(DLC)sh 85134950

=LDR  00923cz  a2200253n  4500
=001  9880363881602441
=005  20141212210211.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013899
=035  \\$aCBA7231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894
=150  \\$aThoracic Neoplasms
=450  \\$wnnna$aNeoplasm, Thoracic
=450  \\$wnnna$aNeoplasms, Thoracic
=450  \\$wnnna$aThoracic Neoplasm
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aHeart Neoplasms
=550  \\$wh$aMediastinal Neoplasms
=550  \\$wh$aRespiratory Tract Neoplasms
=550  \\$wh$aThymus Neoplasms
=667  \\$aGEN or unspecified only; prefer specifics like HEART NEOPLASMS; LUNG NEOPLASMS; etc; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=750  \0$aChest$xCancer$5IEN-M$0(DLC)sh2010008992
=750  \0$aChest$xTumors$5IEN-HS$0(DLC)sh 85023144

=LDR  01034cz  a2200313n  4500
=001  9880363881702441
=005  20141212192603.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013898
=035  \\$aCBA7230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x891
=150  \\$aThoracic Injuries
=450  \\$aChest Injuries
=450  \\$wnnna$aChest Injury
=450  \\$wnnna$aInjuries, Chest
=450  \\$wnnna$aInjuries, Thoracic
=450  \\$wnnna$aInjury, Chest
=450  \\$wnnna$aInjury, Thoracic
=450  \\$wnnna$aThoracic Injury
=450  \\$aThorax$xinjuries
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aFlail Chest
=550  \\$wh$aHeart Injuries
=550  \\$wh$aLung Injury
=550  \\$wh$aRib Fractures
=667  \\$ageneral or unspecified only: prefer specifics like HEART INJURIES; LUNG INJURIES, etc.; consider also / inj with specific parts of the chest
=680  \\$iGeneral or unspecified injuries to the chest area.
=750  \0$aChest$xWounds and injuries$5IEN$0(DLC)sh 85023145

=LDR  00826cz  a2200253n  4500
=001  9880363881802441
=005  20141212210210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013897
=035  \\$aCBA7229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x382.$x520.$x301.$x750
=150  \\$aThoracic Duct
=450  \\$wnnna$aChyli, Cisterna
=450  \\$wnnna$aChylus, Cisterna
=450  \\$aCisterna Chyli
=450  \\$wnnna$aCisterna Chylus
=450  \\$wnnna$aDuct, Thoracic
=450  \\$wnnna$aDucts, Thoracic
=450  \\$wnnna$aThoracic Ducts
=550  \\$wg$aLymphatic Vessels
=680  \\$iThe largest lymphatic vessel that passes through the chest and drains into the SUBCLAVIAN VEIN.
=688  \\$aCISTERNA CHYLI was see under THORACIC DUCT 1963-78
=750  \0$aThoracic duct$5IEN$0(DLC)sh 85134948

=LDR  00670cz  a2200217n  4500
=001  9880363881902441
=005  20141212210210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013896
=035  \\$aCBA7228HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x846
=150  \\$aThoracic Diseases
=450  \\$wnnna$aDisease, Thoracic
=450  \\$wnnna$aDiseases, Thoracic
=450  \\$wnnna$aThoracic Disease
=550  \\$wg$aRespiratory Tract Diseases
=550  \\$wh$aMediastinal Diseases
=667  \\$aGEN: prefer specifics; CHEST PAIN is available
=680  \\$iDisorders affecting the organs of the thorax.
=750  \0$aChest$xDiseases$5IEN$0(DLC)sh 85023137

=LDR  00771cz  a2200205n  4500
=001  9880363882002441
=005  20141212210210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013895
=035  \\$aCBA7227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x891
=150  \\$aThoracic Arteries
=450  \\$wnnna$aArteries, Thoracic
=450  \\$wnnna$aArtery, Thoracic
=450  \\$wnnna$aThoracic Artery
=550  \\$wg$aArteries
=550  \\$wh$aMammary Arteries
=680  \\$iArteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall.
=750  \0$aThoracic arteries$5IEN$0(DLC)sh 85134946

=LDR  00545cz  a2200205n  4500
=001  9880363882102441
=005  20141212210210.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013894
=035  \\$aCBA7226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x293.$x787
=150  \\$aThirst
=450  \\$wnnna$aThirsts
=550  \\$wg$aDrive
=550  \\$aDehydration
=550  \\$aPolydipsia
=550  \\$aWater Deprivation
=680  \\$iA drive stemming from a physiological need for WATER.
=750  \0$aThirst$5IEN$0(DLC)sh 85134902

=LDR  00792cz  a2200277n  4500
=001  9880363882202441
=005  20141212210209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013892
=035  \\$aCBA7224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x952
=072  \\$aD3.$x494.$x953.$x704
=150  \\$aThioxanthenes
=450  \\$aThioxanthene$5IEN
=550  \\$wg$aSulfur Compounds
=550  \\$wg$aXanthenes
=550  \\$wh$aChlorprothixene
=550  \\$wh$aClopenthixol
=550  \\$wh$aFlupenthixol
=550  \\$wh$aHycanthone
=550  \\$wh$aLucanthone
=550  \\$wh$aThiothixene
=680  \\$iCompounds with three aromatic rings in linear arrangement with a SULFUR in the center ring.
=688  \\$a74
=750  \0$aThioxanthenes$5IEN$0(DLC)sh 85134891

=LDR  01105cz  a2200313n  4500
=001  9880363882302441
=005  20141212210209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013890
=035  \\$aCBA7222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x904
=072  \\$aD2.$x948.$x898
=150  \\$aThiourea
=550  \\$wg$aSulfur Compounds
=550  \\$wg$aUrea
=550  \\$wh$abeta-Aminoethyl Isothiourea
=550  \\$wh$aBurimamide
=550  \\$wh$aDimaprit
=550  \\$wh$aEthylenethiourea
=550  \\$wh$aGuanylthiourea
=550  \\$wh$aIsothiuronium
=550  \\$wh$aMethallibure
=550  \\$wh$aMetiamide
=550  \\$wh$aNoxythiolin
=550  \\$wh$aPhenylthiourea
=667  \\$aa thyroid antag
=680  \\$iA photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
=750  \0$aThiourea$5IEN$0(DLC)sh 88002082

=LDR  00777cz  a2200241n  4500
=001  9880363882402441
=005  20141212210208.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013888
=035  \\$aCBA7220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x952.$x787
=072  \\$aD3.$x494.$x953.$x704.$x787
=150  \\$aThiothixene
=450  \\$wnnna$aNavane
=450  \\$wnnna$aPfizer Brand of Tiotixene
=450  \\$wnnna$aPfizer Brand of Tiotixene Dihydrochloride
=450  \\$aTiotixene
=450  \\$wnnna$aTiotixene Pfizer Brand
=550  \\$wg$aThioxanthenes
=680  \\$iA thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.
=688  \\$a73(70)
=750  \0$aThiothixene$0(DLC) sh 85134890$5IEN

=LDR  00602cz  a2200193n  4500
=001  9880363882502441
=005  20141212210208.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013885
=035  \\$aCBA7217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x248.$x497.$x158.$x845.$x703
=072  \\$aD1.$x875.$x800.$x800.$x850.$x900
=150  \\$aThiosulfates
=450  \\$aThiosulphates$5IEN
=550  \\$wg$aSulfates
=550  \\$wh$aGold Sodium Thiosulfate
=680  \\$iInorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
=750  \0$aThiosulfates$5IEN$0(DLC)sh 87003117

=LDR  00589cz  a2200217n  4500
=001  9880363882602441
=005  20141212210207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013882
=035  \\$aCBA7214HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x845.$x746.$x703
=072  \\$aD2.$x886.$x803
=150  \\$aThiosemicarbazones
=450  \\$aGloxazone$5IEN-M
=550  \\$wg$aSemicarbazones
=550  \\$wg$aSulfur Compounds
=550  \\$wh$aMethisazone
=550  \\$wh$aThioacetazone
=667  \\$aantituberc agents
=750  \0$aThiosemicarbazones$5IEN-M$0(DLC)sh 93006562

=LDR  01880cz  a2200517n  4500
=001  9880363882702441
=005  20141212210207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013881
=035  \\$aCBA7212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x369.$x843
=072  \\$aD3.$x494.$x741.$x843
=150  \\$aThioridazine
=450  \\$wnnna$aAldazine
=450  \\$wnnna$aAlphapharm Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aApo-Thioridazine
=450  \\$wnnna$aApo Thioridazine
=450  \\$wnnna$aApotex Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aApoThioridazine
=450  \\$wnnna$aArzneimittelwerk Dresden Brand of Thioridazine
=450  \\$wnnna$aAWD.pharma Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aClonmel Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aDDSA Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aMeleril
=450  \\$wnnna$aMellaril
=450  \\$wnnna$aMelleretten
=450  \\$wnnna$aMelleril
=450  \\$wnnna$aMelleryl
=450  \\$wnnna$aMelzine
=450  \\$wnnna$aneurazpharm Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aNovartis Brand of Thioridazine
=450  \\$wnnna$aPinewood Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aRideril
=450  \\$wnnna$aRoxane Brand of Thioridazine Hydrochloride
=450  \\$wnnna$aSonapax
=450  \\$wnnna$aThioridazine HCL
=450  \\$wnnna$aThioridazine Hydrochloride
=450  \\$wnnna$aThioridazine-neurazpharm
=450  \\$wnnna$aThioridazine neurazpharm
=450  \\$wnnna$aThioridazine Novartis Brand
=450  \\$wnnna$aThioridazineneurazpharm
=450  \\$wnnna$aThiozine
=550  \\$wg$aPhenothiazines
=680  \\$iA phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
=750  \0$aThioridazine$5IEN$0(DLC)sh 85134889

=LDR  01592cz  a2200385n  4500
=001  9880363882802441
=005  20141212210136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013759
=035  \\$aCBA7090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x90.$x810
=150  \\$aDronabinol
=450  \\$wnnna$a9-ene-Tetrahydrocannabinol
=450  \\$wnnna$a9 ene Tetrahydrocannabinol
=450  \\$wnnna$adelta(1)-Tetrahydrocannabinol
=450  \\$wnnna$adelta(1)-THC
=450  \\$wnnna$adelta(9)-Tetrahydrocannabinol
=450  \\$adelta(9)-THC
=450  \\$wnnna$aMarinol
=450  \\$wnnna$aSolvay Brand of Tetrahydrocannabinol
=450  \\$aTetrahydrocannabinol
=450  \\$wnnna$aTetrahydrocannabinol, (6a-trans)-Isomer
=450  \\$wnnna$aTetrahydrocannabinol, (6aR-cis)-Isomer
=450  \\$wnnna$aTetrahydrocannabinol, (6aS-cis)-Isomer
=450  \\$wnnna$aTetrahydrocannabinol, Trans-(+-)-Isomer
=450  \\$wnnna$aTetrahydrocannabinol, Trans-Isomer
=450  \\$wnnna$aTetrahydrocannabinol, Trans Isomer
=450  \\$aTHC
=550  \\$wg$aCannabinoids
=680  \\$iA psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
=688  \\$a2014(1971);
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Tetrahydrocannabinol
=688  \\$a77(71); was see under CANNABIS 1975-76
=750  \0$aTetrahydrocannabinol$5IEN$0(DLC)sh 85134199

=LDR  01847cz  a2200421n  4500
=001  9880364256802441
=005  20141212192904.0
=008  960624\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019392
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x453.$x300
=072  \\$aD8.$x811.$x682.$x662.$x582.$x338
=072  \\$aD8.$x811.$x682.$x690.$x708.$x170.$x200
=072  \\$aD12.$x776.$x422.$x220.$x453.$x300
=150  \\$aCytochrome P-450 CYP2E1
=450  \\$a4-Nitrophenol-2-Hydroxylase
=450  \\$wnnna$a4 Nitrophenol 2 Hydroxylase
=450  \\$wnnna$aCYP 2E1
=450  \\$wnnna$aCYP IIE1
=450  \\$aCYP2E1
=450  \\$wnnna$aCYPIIE1
=450  \\$wnnna$aCytochrome P-450 (ALC)
=450  \\$wnnna$aCytochrome P 450 CYP2E1
=450  \\$wnnna$aCytochrome P-450 IIE1
=450  \\$wnnna$aCytochrome P 450 IIE1
=450  \\$wnnna$aCytochrome P-450-J
=450  \\$wnnna$aCytochrome P 450 J
=450  \\$wnnna$aCytochrome P450 2E1
=450  \\$aDimethylnitrosamine N-Demethylase
=450  \\$wnnna$aDimethylnitrosamine N Demethylase
=450  \\$wnnna$aN-Nitrosodimethylamine Demethylase
=450  \\$wnnna$aN Nitrosodimethylamine Demethylase
=550  \\$wg$aCytochrome P-450 Enzyme System
=550  \\$wg$aOxidoreductases, N-Demethylating
=667  \\$ado not confuse with other cytochrome P-450 CYP's
=680  \\$iAn ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Substrates include ETHANOL; INHALATION ANESTHETICS; BENZENE; ACETAMINOPHEN and other low molecular weight compounds. CYP2E1 has been used as an enzyme marker in the study of alcohol abuse.
=688  \\$a97; was DIMETHYLNITROSAMIME N-DEMETHYLASE (NM) 1972-96 & was 4-NITROPHENOL-2-HYDROXYLASE (NM) 1984-96
=750  \0$aCytochrome P-450 CYP2E1$0(DLC) sh 99002450$5IEN-M

=LDR  02343cz  a2200877n  4500
=001  9880364256902441
=005  20141212213058.0
=008  960620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019216
=035  \\$aCTL9408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556
=072  \\$aD1.$x552.$x544
=150  \\$aMetals, Heavy
=450  \\$aHeavy Metals
=550  \\$wg$aElements
=550  \\$wg$aMetals
=550  \\$wh$aActinium
=550  \\$wh$aAmericium
=550  \\$wh$aAntimony
=550  \\$wh$aBarium
=550  \\$wh$aBerkelium
=550  \\$wh$aBismuth
=550  \\$wh$aCadmium
=550  \\$wh$aCalifornium
=550  \\$wh$aCesium
=550  \\$wh$aChromium
=550  \\$wh$aCobalt
=550  \\$wh$aCopper
=550  \\$wh$aCurium
=550  \\$wh$aEinsteinium
=550  \\$wh$aFermium
=550  \\$wh$aFrancium
=550  \\$wh$aGallium
=550  \\$wh$aGermanium
=550  \\$wh$aGold
=550  \\$wh$aHafnium
=550  \\$wh$aIndium
=550  \\$wh$aIridium
=550  \\$wh$aIron
=550  \\$wh$aLawrencium
=550  \\$wh$aLead
=550  \\$wh$aManganese
=550  \\$wh$aMendelevium
=550  \\$wh$aMercury
=550  \\$wh$aMolybdenum
=550  \\$wh$aNeptunium
=550  \\$wh$aNickel
=550  \\$wh$aNiobium
=550  \\$wh$aNobelium
=550  \\$wh$aOsmium
=550  \\$wh$aPalladium
=550  \\$wh$aPlatinum
=550  \\$wh$aPlutonium
=550  \\$wh$aProtactinium
=550  \\$wh$aRadium
=550  \\$wh$aRhenium
=550  \\$wh$aRhodium
=550  \\$wh$aRubidium
=550  \\$wh$aRuthenium
=550  \\$wh$aSilver
=550  \\$wh$aStrontium
=550  \\$wh$aTantalum
=550  \\$wh$aTechnetium
=550  \\$wh$aThallium
=550  \\$wh$aThorium
=550  \\$wh$aTin
=550  \\$wh$aTungsten
=550  \\$wh$aUranium
=550  \\$wh$aVanadium
=550  \\$wh$aZinc
=550  \\$wh$aZirconium
=667  \\$aGEN: prefer specifics
=680  \\$iMetals with high specific gravity, typically larger than 5. They have complex spectra, form colored salts and double salts, have a low electrode potential, are mainly amphoteric, yield weak bases and weak acids, and are oxidizing or reducing agents (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a97
=750  \0$aHeavy metals$5IEN-M$0(DLC)sh 85059851

=LDR  00965cz  a2200301n  4500
=001  9880364257002441
=005  20141212213248.0
=008  960620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019565
=035  \\$aCTL9407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x557
=072  \\$aD1.$x552.$x547
=150  \\$aMetals, Light
=450  \\$aLight Metals
=550  \\$wg$aElements
=550  \\$wg$aMetals
=550  \\$wh$aAluminum
=550  \\$wh$aBeryllium
=550  \\$wh$aLithium
=550  \\$wh$aMagnesium
=550  \\$wh$aPotassium
=550  \\$wh$aSodium
=550  \\$wh$aTitanium
=667  \\$aGEN: prefer specifics
=680  \\$iMetals with low specific gravity, typically smaller than 5, characterized by a single valence (1, 2, or 3), a simple spectrum, strong electromotive force (positive), and colorless compounds. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a97
=750  \0$aLight metals$5IEN-M$0(DLC)sh 85076899

=LDR  00839cz  a2200181n  4500
=001  9880364257102441
=005  20141212213248.0
=008  960620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019563
=035  \\$aCTL9405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x515
=150  \\$aMechanics
=550  \\$wg$aPhysics
=667  \\$athe discipline (education, history, etc) only; use MECHANICAL PHENOMENA or specifics treed under it for mechanical properties and processes of materials
=680  \\$iThe branch of physics which deals with the motions of material bodies, including kinematics, dynamics, and statics. When the laws of mechanics are applied to living structures, as to the locomotor system, it is referred to as BIOMECHANICAL PHENOMENA. (From Dorland, 28th ed)
=688  \\$a97
=750  \0$aMechanics$5IEN-M$0(DLC)sh 85082767

=LDR  00695cz  a2200205n  4500
=001  9880364257202441
=005  20141212213206.0
=008  960620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019415
=035  \\$aCTL9404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x676.$x860.$x500
=072  \\$aG1.$x595.$x540.$x860.$x500
=150  \\$aTorque
=450  \\$wnnna$aTorques
=550  \\$wg$aTorsion, Mechanical
=667  \\$aa principle of mechanics; not restricted to space flight
=680  \\$iThe rotational force about an axis that is equal to the product of a force times the distance from the axis where the force is applied.
=688  \\$a97
=750  \0$aTorque$5IEN-M$0(DLC)sh 85136134

=LDR  00867cz  a2200205n  4500
=001  9880364257302441
=005  20141212213123.0
=008  960619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019266
=035  \\$aCTL9402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x490.$x600
=072  \\$aD2.$x691.$x550.$x600
=150  \\$aIron, Dietary
=450  \\$aDietary Iron
=550  \\$wg$aIron Compounds
=667  \\$a/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther
=680  \\$iIron or iron compounds used in foods or as food. Dietary iron is important in oxygen transport and the synthesis of the iron-porphyrin proteins hemoglobin, myoglobin, cytochromes, and cytochrome oxidase. Insufficient amounts of dietary iron can lead to iron-deficiency anemia.
=688  \\$a97
=750  \0$aFood$xIron content$5IEN-M$0(DLC)sh 85050200

=LDR  01212cz  a2200241n  4500
=001  9880364257402441
=005  20141212213217.0
=008  960614\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019453
=035  \\$aCTL9397M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x425.$x325.$x300.$x800.$x250.$x500
=072  \\$aB3.$x660.$x250.$x150.$x180.$x100.$x800.$x250.$x500
=150  \\$aEscherichia coli O157
=450  \\$aE coli O157
=450  \\$aE coli O157-H7
=450  \\$aEscherichia coli O157-H7
=550  \\$wg$aEnterohemorrhagic Escherichia coli
=550  \\$aShiga Toxin 1
=667  \\$ainfection: coordinate IM with ESCHERICHIA COLI INFECTIONS (IM); consider also HEMOLYTIC-UREMIC SYNDROME; in titles & translations use O157 (the letter O), not 0157 (the number zero)
=680  \\$iA verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. A strain from this serogroup, serotype H7, which produces SHIGA TOXINS, has been linked to human disease outbreaks resulting from contamination of foods by E. coli O157 from bovine origin.
=688  \\$a97
=750  \0$aEscherichia coli O157:H7$0(DLC) sh 99001739$5IEN-M

=LDR  01750cz  a2200421n  4500
=001  9880364257502441
=005  20141212192903.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019389
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x453.$x40.$x600
=072  \\$aD8.$x811.$x682.$x690.$x708.$x170.$x40.$x600
=072  \\$aD12.$x776.$x422.$x220.$x453.$x40.$x600
=150  \\$aCytochrome P-450 CYP2D6
=450  \\$wnnna$a2-Hydroxylase, Imipramine
=450  \\$wnnna$a4-Hydroxylase, Debrisoquine
=450  \\$wnnna$a4-Monooxygenase, Debrisoquine
=450  \\$wnnna$aCYP 2D6
=450  \\$aCYP2D6
=450  \\$wnnna$aCYP2D6, Cytochrome P-450
=450  \\$wnnna$aCytochrome P 450 CYP2D6
=450  \\$wnnna$aCytochrome P450 2D6
=450  \\$aDebrisoquine 4-Hydroxylase
=450  \\$wnnna$aDebrisoquine 4 Hydroxylase
=450  \\$wnnna$aDebrisoquine 4-Monooxygenase
=450  \\$wnnna$aDebrisoquine 4 Monooxygenase
=450  \\$aDebrisoquine Hydroxylase
=450  \\$wnnna$aHydroxylase, Debrisoquine
=450  \\$wnnna$aImipramine 2-Hydroxylase
=450  \\$wnnna$aImipramine 2 Hydroxylase
=450  \\$wnnna$aMonooxygenase, Sparteine
=450  \\$wnnna$aP-450 CYP2D6, Cytochrome
=450  \\$wnnna$aP450 2D6, Cytochrome
=450  \\$wnnna$aSparteine Monooxygenase
=550  \\$wg$aAryl Hydrocarbon Hydroxylases
=680  \\$iA cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.
=688  \\$a97; was DEBRISOQUINE 4-HYDROXYLASE (NM) 1982-96
=750  \0$aCytochrome P-450 CYP2D6$0(DLC)sh2011005901$5IEN-M

=LDR  01432cz  a2200385n  4500
=001  9880364257602441
=005  20141212213213.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019440
=035  \\$aCTL9392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x140
=150  \\$aAnti-Obesity Agents
=450  \\$wnnna$aAgents, Anti-Obesity
=450  \\$wnnna$aAgents, Antiobesity
=450  \\$wnnna$aAgents, Weight-Loss
=450  \\$wnnna$aAnti Obesity Agents
=450  \\$wnnna$aAnti-Obesity Drugs
=450  \\$wnnna$aAnti Obesity Drugs
=450  \\$wnnna$aAntiobesity Agents
=450  \\$wnnna$aAntiobesity Drugs
=450  \\$wnnna$aDrugs, Anti-Obesity
=450  \\$wnnna$aDrugs, Antiobesity
=450  \\$wnnna$aDrugs, Weight-Loss
=450  \\$aWeight-Loss Agents
=450  \\$wnnna$aWeight Loss Agents
=450  \\$wnnna$aWeight-Loss Drugs
=450  \\$wnnna$aWeight Loss Drugs
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wh$aAppetite Depressants
=550  \\$aObesity
=667  \\$aconsider also OBESITY /drug ther
=680  \\$iAgents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity.
=688  \\$a97
=750  \0$aWeight loss preparations$5IEN-M$0(DLC)sh 85145959

=LDR  00935cz  a2200253n  4500
=001  9880364257702441
=005  20141212213231.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019496
=035  \\$aCTL9389M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x200
=150  \\$aCancer Vaccines
=450  \\$aNeoplasm Vaccines
=450  \\$aTumor Vaccines
=450  \\$aVaccines, Cancer
=450  \\$aVaccines, Neoplasm
=450  \\$aVaccines, Tumor
=550  \\$wg$aVaccines
=550  \\$aPapillomavirus Vaccines
=667  \\$acoord IM with specific cancer histol type (IM) + organ/neopl precoord (IM)
=680  \\$iVaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.
=688  \\$a97
=750  \0$aCancer vaccines$5IEN-M$0(DLC)sh2003001408

=LDR  00941cz  a2200205n  4500
=001  9880364257802441
=005  20141212213218.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019455
=035  \\$aCTL9388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x739.$x794.$x837
=150  \\$aSelf Psychology
=450  \\$aPsychology, Self
=550  \\$wg$aPsychoanalytic Theory
=550  \\$aEgo
=667  \\$apsychoanal theory; normal or pathol; do not confuse with SELF CONCEPT; no qualif; DF: SELF PSYCHOL
=680  \\$iPsychoanalytic theory focusing on interpretation of behavior in reference to self. (From APA, Thesaurus of Psychological Terms, 1994) This elaboration of the psychoanalytic concepts of narcissism and the self, was developed by Heinz Kohut, and stresses the importance of the self-awareness of excessive needs for approval and self-gratification.
=688  \\$a97
=750  \0$aSelf psychology$5IEN-M$0(DLC)sh 88002287

=LDR  01541cz  a2200397n  4500
=001  9880364257902441
=005  20181004124646.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019538
=035  \\$aCTL9386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x980.$x344
=072  \\$aN3.$x349.$x380.$x210
=072  \\$aN5.$x425.$x210
=072  \\$aN5.$x715.$x360.$x300.$x800.$x344
=072  \\$aN6.$x850.$x520.$x308.$x980.$x344
=150  \\$aHealth Care Surveys
=450  \\$wnnna$aCare Survey, Health
=450  \\$wnnna$aCare Surveys, Health
=450  \\$wnnna$aHealth Care Survey
=450  \\$wnnna$aHealthcare Survey
=450  \\$aHealthcare Surveys
=450  \\$aNational Ambulatory Medical Care Survey
=450  \\$aNational Hospital Discharge Survey
=450  \\$wnnna$aSurvey, Health Care
=450  \\$wnnna$aSurvey, Healthcare
=450  \\$wnnna$aSurveys, Health Care
=450  \\$wnnna$aSurveys, Healthcare
=550  \\$wg$aHealth Services Research
=550  \\$wg$aSurveys and Questionnaires
=550  \\$wh$aHealth Impact Assessment
=550  \\$wh$aPatient Reported Outcome Measures
=667  \\$ado not confuse with HEALTH SURVEYS: health care surveys are on health services provided, health surveys are on health statist; specify geog if pertinent
=680  \\$iStatistical measures of utilization and other aspects of the provision of health care services including hospitalization and ambulatory care.
=688  \\$a97
=750  \0$aMedical care surveys$5IEN-M$0(DLC)sh 86006709

=LDR  00858cz  a2200217n  4500
=001  9880364258002441
=005  20141212213221.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019464
=035  \\$aCTL9381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x900.$x940
=150  \\$aTax Exemption
=450  \\$wnnna$aExemption, Tax
=450  \\$wnnna$aExemptions, Tax
=450  \\$wnnna$aTax Exemptions
=550  \\$wg$aTaxes
=667  \\$acoord IM with subject of tax (IM); specify geog
=680  \\$iStatus not subject to taxation; as the income of a philanthropic organization. Tax-exempt organizations may also qualify to receive tax-deductible donations if they are considered to be nonprofit corporations under Section 501(c)3 of the United States Internal Revenue Code.
=688  \\$a97
=750  \0$aTax exemption$5IEN-M$0(DLC)sh 85132865

=LDR  01164cz  a2200385n  4500
=001  9880364258102441
=005  20170607100447.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019445
=035  \\$aCTL9380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x800
=150  \\$aSolar Activity
=450  \\$wnnna$aActivities, Solar
=450  \\$wnnna$aActivity, Solar
=450  \\$wnnna$aEvent, Solar Particle
=450  \\$wnnna$aEvents, Solar Particle
=450  \\$wnnna$aFlare, Solar
=450  \\$wnnna$aFlares, Solar
=450  \\$wnnna$aParticle Event, Solar
=450  \\$wnnna$aParticle Events, Solar
=450  \\$wnnna$aSolar Activities
=450  \\$wnnna$aSolar Flare
=450  \\$aSolar Flares
=450  \\$wnnna$aSolar Particle Event
=450  \\$aSolar Particle Events
=450  \\$wnnna$aSunspot
=450  \\$aSunspots
=550  \\$wg$aAstronomical Phenomena
=550  \\$aCosmic Radiation
=550  \\$aSolar Energy
=667  \\$ano qualif
=680  \\$iAny type of variation in the appearance of energy output of the sun. (NASA Thesaurus, 1994)
=688  \\$a97
=750  \0$aSolar activity$5IEN-M$0(DLC)sh 85124483

=LDR  01534cz  a2200253n  4500
=001  9880364258202441
=005  20141212213246.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019558
=035  \\$aCTL9378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x658.$x578.$x200
=150  \\$aOcclusal Adjustment
=450  \\$wnnna$aAdjustment, Occlusal
=450  \\$wnnna$aAdjustments, Occlusal
=450  \\$wnnna$aEquilibrations, Occlusal
=450  \\$wnnna$aOcclusal Adjustments
=450  \\$aOcclusal Equilibration
=550  \\$wg$aOrthodontics, Corrective
=550  \\$aDental Occlusion, Balanced
=667  \\$agrinding of occlusal surfaces of teeth to achieve optimal occlusion
=680  \\$iSelective grinding of occlusal surfaces of the teeth in an effort to eliminate premature contacts and occlusal interferences; to establish optimal masticatory effectiveness, stable occlusal relationships, direction of main occlusal forces, and efficient multidirectional patterns, to improve functional relations and to induce physiologic stimulation of the masticatory system; to eliminate occlusal trauma; to eliminate abnormal muscle tension; to aid in the stabilization of orthodontic results; to treat periodontal and temporomandibular joint problems; and in restorative procedures. (From Jablonski, Dictionary of Dentistry, 1992)
=688  \\$a97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74
=750  \0$aOcclusal adjustment$5IEN-M$0(DLC)sh 86004126

=LDR  01626cz  a2200385n  4500
=001  9880364258302441
=005  20141212213241.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019544
=035  \\$aCTL9377M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x325.$x192
=150  \\$aEquipment Failure Analysis
=450  \\$wnnna$aAnalyses, Equipment Failure
=450  \\$wnnna$aAnalyses, Materials Failure
=450  \\$wnnna$aAnalyses, Prosthesis Failure
=450  \\$wnnna$aAnalysis, Equipment Failure
=450  \\$wnnna$aAnalysis, Materials Failure
=450  \\$wnnna$aAnalysis, Prosthesis Failure
=450  \\$wnnna$aEquipment Failure Analyses
=450  \\$wnnna$aFailure Analyses, Equipment
=450  \\$wnnna$aFailure Analyses, Materials
=450  \\$wnnna$aFailure Analyses, Prosthesis
=450  \\$wnnna$aFailure Analysis, Equipment
=450  \\$wnnna$aFailure Analysis, Materials
=450  \\$wnnna$aFailure Analysis, Prosthesis
=450  \\$wnnna$aMaterials Failure Analyses
=450  \\$aMaterials Failure Analysis
=450  \\$wnnna$aProsthesis Failure Analyses
=450  \\$aProsthesis Failure Analysis
=550  \\$wg$aEquipment Failure
=667  \\$acoordinate with specific equipment or specific technique / instrum
=680  \\$iThe evaluation of incidents involving the loss of function of a device. These evaluations are used for a variety of purposes such as to determine the failure rates, the causes of failures, costs of failures, and the reliability and maintainability of devices.
=688  \\$a97
=750  \0$aFailure analysis (Engineering)$5IEN-M$0(DLC)sh2012001097

=LDR  00815cz  a2200205n  4500
=001  9880364258402441
=005  20141212213055.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019212
=035  \\$aCTL9376NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x633
=072  \\$aL1.$x178.$x820.$x90.$x633
=150  \\$aMultimedia
=450  \\$wnnna$aMultimedium
=550  \\$wg$aAudiovisual Aids
=667  \\$arestrict to a combination of audiovisual aids: do not use for a multiplicity of media such as newspapers, radio, TV
=680  \\$iMaterials, frequently computer applications, that combine some or all of text, sound, graphics, animation, and video into integrated packages. (Thesaurus of ERIC Descriptors, 1994)
=688  \\$a97
=750  \0$aMultimedia systems$5IEN-M$0(DLC)sh 92002381

=LDR  00822cz  a2200205n  4500
=001  9880364258502441
=005  20141212213021.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019146
=035  \\$aCTL9373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x590
=150  \\$aHypermedia
=450  \\$wnnna$aHypermedium
=450  \\$aHypertext
=550  \\$wg$aSoftware
=667  \\$aa type of computer software
=680  \\$iComputerized compilations of information units (text, sound, graphics, and/or video) interconnected by logical nonlinear linkages that enable users to follow optimal paths through the material and also the systems used to create and display this information. (From Thesaurus of ERIC Descriptors, 1994)
=688  \\$a97
=750  \0$aInteractive multimedia$5IEN-M$0(DLC)sh 90004922

=LDR  00672cz  a2200217n  4500
=001  9880364258602441
=005  20170607100750.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019419
=035  \\$aCTL9370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x275
=072  \\$aG1.$x311.$x290
=150  \\$aEvolution, Planetary
=450  \\$aPlanetary Evolution
=550  \\$wg$aAstronomical Phenomena
=550  \\$wg$aGeological Phenomena
=550  \\$wh$aEvolution, Chemical
=680  \\$iCreation and development of bodies within solar systems, includes study of early planetary geology.
=688  \\$a97
=750  \0$aPlanets$xOrigin$5IEN-M$0(DLC)sh 85102667

=LDR  00774cz  a2200241n  4500
=001  9880364258702441
=005  20141212213243.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019548
=035  \\$aCTL9366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x135
=150  \\$aCrime Victims
=450  \\$wnnna$aCrime Victim
=450  \\$wnnna$aVictim, Crime
=450  \\$aVictimization
=450  \\$wnnna$aVictims, Crime
=550  \\$wg$aPersons
=550  \\$wh$aAdult Survivors of Child Abuse
=667  \\$acoord IM with specific crime if pertinent (IM)
=680  \\$iIndividuals subjected to and adversely affected by criminal activity. (APA, Thesaurus of Psychological Index Terms, 1994)
=688  \\$a97
=750  \0$aVictims of crimes$5IEN-M$0(DLC)sh 85143177

=LDR  01553cz  a2200385n  4500
=001  9880364258802441
=005  20141212192856.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019295
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x180
=072  \\$aL1.$x313.$x124
=150  \\$aComputational Biology
=450  \\$wnnna$aBio-Informatic
=450  \\$wnnna$aBio-Informatics
=450  \\$wnnna$aBio Informatics
=450  \\$wnnna$aBioinformatic
=450  \\$aBioinformatics
=450  \\$wnnna$aBiologies, Computational Molecular
=450  \\$wnnna$aBiology, Computational
=450  \\$wnnna$aBiology, Computational Molecular
=450  \\$wnnna$aComputational Molecular Biologies
=450  \\$wnnna$aComputational Molecular Biology
=450  \\$wnnna$aMolecular Biologies, Computational
=450  \\$aMolecular Biology, Computational
=550  \\$wg$aBiology
=550  \\$wg$aInformatics
=550  \\$wh$aGenomics
=550  \\$wh$aMetabolomics
=550  \\$wh$aSystems Biology
=550  \\$aGenomics
=667  \\$ause for the discipline and as a coordinate for bioinformatics studies
=680  \\$iA field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories for solving biological problems including manipulation of models and datasets.
=688  \\$a97
=750  \0$aComputational biology$5IEN-M$0(DLC)no 00094896

=LDR  01656cz  a2200385n  4500
=001  9880364258902441
=005  20141212213236.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019521
=035  \\$aCTL9364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x100
=150  \\$aBody Patterning
=450  \\$aAxial Patterning (Embryology)
=450  \\$wnnna$aBody Pattern Formation
=450  \\$wnnna$aBody Pattern Specification
=450  \\$wnnna$aDevelopment Polarity
=450  \\$aEmbryonic Pattern Formation
=450  \\$wnnna$aEmbryonic Pattern Formations
=450  \\$wnnna$aEmbryonic Pattern Specification
=450  \\$wnnna$aFormation, Embryonic Pattern
=450  \\$wnnna$aPattern Formation, Body
=450  \\$wnnna$aPattern Formation, Embryonic
=450  \\$wnnna$aPattern Specification, Body
=450  \\$wnnna$aPattern Specification, Embryonic
=450  \\$wnnna$aPatterning, Axial (Embryology)
=450  \\$wnnna$aPatterning, Body
=450  \\$aPolarity of Development
=450  \\$wnnna$aSpecification, Body Pattern
=450  \\$wnnna$aSpecification, Embryonic Pattern
=550  \\$wg$aMorphogenesis
=550  \\$wh$aEmbryonic Induction
=680  \\$iThe processes occurring in early development that direct morphogenesis. They specify the body plan ensuring that cells will proceed to differentiate, grow, and diversify in size and shape at the correct relative positions. Included are axial patterning, segmentation, compartment specification, limb position, organ boundary patterning, blood vessel patterning, etc.
=688  \\$a97
=750  \0$aPolarity (Biology)$5IEN-M$0(DLC)sh 85104151

=LDR  00733cz  a2200217n  4500
=001  9880364259002441
=005  20141212213206.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019414
=035  \\$aCTL9360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x250
=150  \\$aChlorobi
=450  \\$aBacteria, Green Sulfur
=450  \\$aChlorobiaceae
=450  \\$aGreen Sulfur Bacteria
=550  \\$wg$aBacteria
=550  \\$wh$aChlorobium
=680  \\$iA phylum of anoxygenic, phototrophic bacteria including the family Chlorobiaceae. They occur in aquatic sediments, sulfur springs, and hot springs and utilize reduced sulfur compounds instead of oxygen.
=688  \\$a97
=750  \0$aChlorobiaceae$5IEN-M$0(DLC)sh 88023225

=LDR  01039cz  a2200289n  4500
=001  9880364259102441
=005  20141212213222.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019467
=035  \\$aCTL9359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x850
=072  \\$aN2.$x421.$x585.$x850
=150  \\$aSubacute Care
=450  \\$wnnna$aCare, Sub-Acute
=450  \\$wnnna$aCare, Subacute
=450  \\$wnnna$aCares, Sub-Acute
=450  \\$wnnna$aCares, Subacute
=450  \\$wnnna$aSub-Acute Care
=450  \\$wnnna$aSub Acute Care
=450  \\$wnnna$aSub-Acute Cares
=450  \\$wnnna$aSubacute Cares
=550  \\$wg$aPatient Care
=667  \\$amed & nurs care for patient out of acute phase of dis
=680  \\$iMedical and skilled nursing services provided to patients who are not in an acute phase of an illness but who require a level of care higher than that provided in a long-term care setting. (JCAHO, Lexikon, 1994)
=688  \\$a97
=750  \0$aSubacute care facilities$5IEN-M$0(DLC)sh 95006501

=LDR  00693cz  a2200193n  4500
=001  9880364259202441
=005  20141212213222.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019466
=035  \\$aCTL9358HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x590.$x540.$x333
=072  \\$aG14.$x400
=150  \\$aGlare
=550  \\$wg$aLight
=550  \\$wg$aOcular Physiological Phenomena
=680  \\$iRelatively bright light, or the dazzling sensation of relatively bright light, which produces unpleasantness or discomfort, or which interferes with optimal VISION, OCULAR. (Cline et al., Dictionary of Visual Science, 4th ed)
=688  \\$a97
=750  \0$aGlare$5IEN-M$0(DLC)sh 89005243

=LDR  01001cz  a2200277n  4500
=001  9880364259302441
=005  20141212213242.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019546
=035  \\$aCTL9357M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x581.$x136
=150  \\$aCouples Therapy
=450  \\$wnnna$aCouple Therapies
=450  \\$wnnna$aCouple Therapy
=450  \\$wnnna$aCouples Therapies
=450  \\$wnnna$aTherapies, Couple
=450  \\$wnnna$aTherapies, Couples
=450  \\$wnnna$aTherapy, Couple
=450  \\$wnnna$aTherapy, Couples
=550  \\$wg$aPsychotherapy, Group
=550  \\$aMarital Therapy
=667  \\$aa psychother technique for unmarried couples: for married couples index under MARITAL THERAPY; DF: COUPLES THER
=680  \\$iPsychotherapy used specifically for unmarried couples, of mixed or same sex. (From APA, Thesaurus of Psychological Index Terms, 1994)
=688  \\$a97
=750  \0$aCouples therapy$0(DLC)sh2008009473$5IEN-M

=LDR  02514cz  a2200685n  4500
=001  9880364259402441
=005  20141212192857.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x100
=150  \\$aArtemisia
=450  \\$wnnna$aabrotanum, Artemisia
=450  \\$wnnna$aabrotanums, Artemisia
=450  \\$wnnna$aArtemisia abrotanum
=450  \\$wnnna$aArtemisia abrotanums
=450  \\$wnnna$aArtemisia capillari
=450  \\$wnnna$aArtemisia capillaris
=450  \\$wnnna$aArtemisia dracunculus
=450  \\$wnnna$aArtemisia judaica
=450  \\$wnnna$aArtemisia judaicas
=450  \\$aArtemisia maritima
=450  \\$wnnna$aArtemisia maritimas
=450  \\$wnnna$aArtemisia vulgari
=450  \\$aArtemisia vulgaris
=450  \\$wnnna$aArtemisias
=450  \\$wnnna$acapillari, Artemisia
=450  \\$wnnna$acapillaris, Artemisia
=450  \\$wnnna$adracunculus, Artemisia
=450  \\$wnnna$ajudaica, Artemisia
=450  \\$wnnna$ajudaicas, Artemisia
=450  \\$wnnna$aLevant Wormseed
=450  \\$wnnna$aLevant Wormseeds
=450  \\$wnnna$amaritima, Artemisia
=450  \\$wnnna$amaritimas, Artemisia
=450  \\$aMugwort
=450  \\$wnnna$aMugworts
=450  \\$wnnna$aPlant, Tarragon
=450  \\$wnnna$aPlants, Tarragon
=450  \\$aSagebrush
=450  \\$wnnna$aSagebrushs
=450  \\$aSagewort
=450  \\$wnnna$aSageworts
=450  \\$aSouthernwood
=450  \\$wnnna$aSouthernwoods
=450  \\$wnnna$aTarragon Plant
=450  \\$wnnna$aTarragon Plants
=450  \\$wnnna$avulgari, Artemisia
=450  \\$wnnna$avulgaris, Artemisia
=450  \\$aWormseed, Levant
=450  \\$wnnna$aWormseeds, Levant
=450  \\$aWormwood
=450  \\$wnnna$aWormwoods
=550  \\$wg$aAsteraceae
=550  \\$wh$aArtemisia absinthium
=550  \\$wh$aArtemisia annua
=667  \\$anote entry term WORMSEED, LEVANT: WORMSEED see CHENOPODIUM AMBROSIOIDES is also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM)+ PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.
=688  \\$a97
=750  \0$aArtemisia$0(DLC) sh 85008094$5IEN-M

=LDR  01339cz  a2200289n  4500
=001  9880364259502441
=005  20141212213205.0
=008  960613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019412
=035  \\$aCTL9353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x185
=150  \\$aAnatomy, Cross-Sectional
=450  \\$wnnna$aAnatomy, Cross Sectional
=450  \\$aAnatomy, Sectional
=450  \\$wnnna$aCross-Sectional Anatomy
=450  \\$wnnna$aCross Sectional Anatomy
=450  \\$wnnna$aSectional Anatomy
=550  \\$wg$aAnatomy
=550  \\$wh$aVisible Human Projects
=550  \\$aMagnetic Resonance Imaging
=550  \\$aTomography
=550  \\$aUltrasonography
=667  \\$acoordinate with organ/anat (IM); DF: ANAT CROSS SECTION
=680  \\$iDescriptive anatomy based on three-dimensional imaging (IMAGING, THREE-DIMENSIONAL) of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, MAGNETIC RESONANCE IMAGING, and computed tomography (TOMOGRAPHY, X-RAY COMPUTED). (From Lane & Sharfaei, Modern Sectional Anatomy, 1992, Preface)
=688  \\$a97
=750  \0$aCross-sectional imaging$0(DLC) sh2005005696$5IEN-M

=LDR  02394cz  a2200517n  4500
=001  9880364259602441
=005  20141212213103.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019222
=035  \\$aCTL9350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x509
=150  \\$aMind-Body Relations, Metaphysical
=450  \\$wnnna$aBody-Mind Relation
=450  \\$wnnna$aBody-Mind Relations
=450  \\$wnnna$aBody Mind Relations
=450  \\$wnnna$aMetaphysical Mind-Body Relation
=450  \\$wnnna$aMetaphysical Mind-Body Relations
=450  \\$wnnna$aMind-Body Relation, Metaphysical
=450  \\$wnnna$aMind-Body Relation (Metaphysics)
=450  \\$wnnna$aMind-Body Relation (Non-Physiology)
=450  \\$wnnna$aMind Body Relations, Metaphysical
=450  \\$aMind-Body Relations (Metaphysics)
=450  \\$wnnna$aMind Body Relations (Metaphysics)
=450  \\$aMind-Body Relations (Non-Physiology)
=450  \\$wnnna$aMind Body Relations (Non Physiology)
=450  \\$wnnna$aRelation, Body-Mind
=450  \\$wnnna$aRelation, Metaphysical Mind-Body
=450  \\$wnnna$aRelation, Mind-Body (Metaphysics)
=450  \\$wnnna$aRelation, Mind-Body (Non-Physiology)
=450  \\$wnnna$aRelation, Soul-Body
=450  \\$wnnna$aRelations, Body-Mind
=450  \\$wnnna$aRelations, Metaphysical Mind-Body
=450  \\$wnnna$aRelations, Mind-Body (Metaphysics)
=450  \\$wnnna$aRelations, Mind-Body (Non-Physiology)
=450  \\$wnnna$aRelations, Soul-Body
=450  \\$wnnna$aSoul-Body Relation
=450  \\$wnnna$aSoul-Body Relations
=450  \\$wnnna$aSoul Body Relations
=550  \\$wg$aMental Processes
=667  \\$aimportant in alternative medicine; do not confuse with MIND-BODY RELATIONS (PHYSIOLOGY) see PSYCHOPHYSIOLOGY where emphasis is on physiology
=680  \\$iThe relation between the mind and the body in a religious, social, spiritual, behavioral, and metaphysical context. This concept is significant in the field of alternative medicine. It differs from the relationship between physiologic processes and behavior where the emphasis is on the body's physiology ( = PSYCHOPHYSIOLOGY).
=688  \\$a2011; 1997-2010 use Mind-Body Relations (Metaphysics)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Mind-Body Relations (Metaphysics)
=688  \\$a97
=750  \0$aMind and body$0(DLC) sh 85085488$5IEN-M

=LDR  01987cz  a2200493n  4500
=001  9880364259702441
=005  20141212192858.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019337
=035  \\$aCTL9348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x448
=072  \\$aC15.$x378.$x400
=150  \\$aHematologic Neoplasms
=450  \\$aHematologic Malignancies
=450  \\$wnnna$aHematologic Malignancy
=450  \\$wnnna$aHematologic Neoplasm
=450  \\$wnnna$aHematological Malignancies
=450  \\$wnnna$aHematological Malignancy
=450  \\$wnnna$aHematological Neoplasm
=450  \\$wnnna$aHematological Neoplasms
=450  \\$wnnna$aHematopoietic Malignancies
=450  \\$wnnna$aHematopoietic Malignancy
=450  \\$wnnna$aHematopoietic Neoplasm
=450  \\$aHematopoietic Neoplasms
=450  \\$wnnna$aMalignancies, Hematologic
=450  \\$wnnna$aMalignancies, Hematological
=450  \\$wnnna$aMalignancies, Hematopoietic
=450  \\$wnnna$aMalignancy, Hematologic
=450  \\$wnnna$aMalignancy, Hematological
=450  \\$wnnna$aMalignancy, Hematopoietic
=450  \\$wnnna$aNeoplasm, Hematologic
=450  \\$wnnna$aNeoplasm, Hematological
=450  \\$wnnna$aNeoplasm, Hematopoietic
=450  \\$wnnna$aNeoplasms, Hematologic
=450  \\$wnnna$aNeoplasms, Hematological
=450  \\$wnnna$aNeoplasms, Hematopoietic
=550  \\$wg$aHematologic Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aBone Marrow Neoplasms
=667  \\$ageneral or unspecified only;  consider instead LEUKEMIA or LYMPHOMA or their specifics and  do not coordinate here
=680  \\$iNeoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
=688  \\$a97
=750  \0$aHematopoietic system$xCancer$5IEN-M$0(DLC)sh 85060141

=LDR  01861cz  a2200481n  4500
=001  9880364259802441
=005  20141212213053.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019207
=035  \\$aCTL9345M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x123
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x50
=072  \\$aD2.$x455.$x849.$x131.$x123
=072  \\$aD23.$x767.$x261.$x50
=150  \\$abeta Carotene
=450  \\$wnnna$a3M Brand of Betacarotene
=450  \\$wnnna$aBellaCarotin
=450  \\$wnnna$abeta-Carotene
=450  \\$aBetacarotene
=450  \\$wnnna$aBetacarotene 3M Brand
=450  \\$wnnna$aBetacarotene Hermal Brand
=450  \\$wnnna$aBetacarotene Marlyn Brand
=450  \\$wnnna$aBetacarotene Merck Brand
=450  \\$wnnna$aBetacarotene Roche Brand
=450  \\$wnnna$aBetacarotene Solgar Brand
=450  \\$wnnna$aCarotaben
=450  \\$wnnna$aCarotene, beta
=450  \\$wnnna$aHermal Brand of Betacarotene
=450  \\$wnnna$aMarlyn Brand of Betacarotene
=450  \\$wnnna$aMax-Caro
=450  \\$wnnna$aMax Caro
=450  \\$wnnna$aMaxCaro
=450  \\$wnnna$aMerck Brand of Betacarotene
=450  \\$wnnna$aProvatene
=450  \\$wnnna$aRoche Brand of Betacarotene
=450  \\$wnnna$aSolatene
=450  \\$wnnna$aSolgar Brand of Betacarotene
=450  \\$wnnna$aVetoron
=550  \\$wg$aCarotenoids
=680  \\$iA carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria (PORPHYRIA, ERYTHROPOIETIC). (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Engewood, CO, 1995.)
=688  \\$a97; was BETA-CAROTENE (NM) 1980-96
=750  \0$aBeta Carotene$0(DLC)sh2008007530$5IEN-M

=LDR  01026cz  a2200241n  4500
=001  9880364259902441
=005  20141212213216.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019446
=035  \\$aCTL9341M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x757.$x100.$x275
=072  \\$aC1.$x539.$x861.$x375
=072  \\$aC23.$x550.$x470.$x790.$x500.$x100.$x275
=150  \\$aEndotoxemia
=450  \\$wnnna$aEndotoxemias
=550  \\$wg$aBacteremia
=550  \\$wg$aToxemia
=550  \\$aBacteremia
=667  \\$acoordinate IM with specific bacterial infection heading (IM) or specific bacterium (IM) if precoordinated bacterial infection heading is not in MeSH; do not use /blood to cover -emia
=680  \\$iA condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
=688  \\$a97
=750  \0$aEndotoxemia$0(DLC)sh2007000009$5IEN-M

=LDR  01072cz  a2200229n  4500
=001  9880364260002441
=005  20141212213111.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019242
=035  \\$aCTL9337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x640
=072  \\$aH2.$x163.$x670
=150  \\$aOral Medicine
=450  \\$wnnna$aMedicine, Oral
=450  \\$aStomatology
=550  \\$wg$aDentistry
=550  \\$aDentistry
=667  \\$a"a branch of dentistry dealing with dis of the oral & paraoral struct & the oral management of system dis"; SPEC: SPEC qualif; X ref STOMATOLOGY: seen most often in foreign lit: translate as "oral medicine"; "stomatol dis" = MOUTH DISEASES
=680  \\$iA branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. (Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8)
=688  \\$a97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96
=750  \0$aOral medicine$5IEN-M$0(DLC)sh 85128280

=LDR  00592cz  a2200205n  4500
=001  9880364260102441
=005  20141212213133.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019296
=035  \\$aCTL9335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x386.$x700.$x150
=150  \\$aCapnography
=450  \\$wnnna$aCapnographies
=550  \\$wg$aRespiratory Function Tests
=550  \\$aCarbon Dioxide
=667  \\$aDF: CAPNOGR
=680  \\$iContinuous recording of the carbon dioxide content of expired air.
=688  \\$a97
=750  \0$aCapnography$5IEN-M$0(DLC)sh 85019989

=LDR  01578cz  a2200349n  4500
=001  9880364260202441
=005  20141212213228.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019485
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x954.$x200
=072  \\$aD12.$x776.$x467.$x942.$x200
=072  \\$aD23.$x529.$x942.$x200
=150  \\$aBone Morphogenetic Proteins
=450  \\$wnnna$aBone Morphogenetic Protein
=450  \\$wnnna$aMorphogenetic Protein, Bone
=450  \\$wnnna$aMorphogenetic Proteins, Bone
=550  \\$wg$aTGF-beta Superfamily Proteins
=550  \\$wh$aBone Morphogenetic Protein 1
=550  \\$wh$aBone Morphogenetic Protein 15
=550  \\$wh$aBone Morphogenetic Protein 2
=550  \\$wh$aBone Morphogenetic Protein 3
=550  \\$wh$aBone Morphogenetic Protein 4
=550  \\$wh$aBone Morphogenetic Protein 5
=550  \\$wh$aBone Morphogenetic Protein 6
=550  \\$wh$aBone Morphogenetic Protein 7
=550  \\$wh$aGrowth Differentiation Factor 10
=550  \\$wh$aGrowth Differentiation Factor 2
=667  \\$ageneral; prefer specifics
=680  \\$iBone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
=688  \\$a97; was BONE MORPHOGENETIC PROTEIN (NM) 1981-96
=750  \0$aBone morphogenetic proteins$0(DLC) sh 96003251$5IEN-M

=LDR  00654cz  a2200205n  4500
=001  9880364260302441
=005  20141212213039.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019187
=035  \\$aCTL9321HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x142
=150  \\$aCadmium Compounds
=450  \\$wnnna$aCompounds, Cadmium
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCadmium Chloride
=667  \\$ainorganic; GEN or unspecified; prefer specifics; DF: CADMIUM CPDS
=680  \\$iInorganic compounds that contain cadmium as an integral part of the molecule.
=688  \\$a97
=750  \0$aCadmium compounds$5IEN-M$0(DLC)sh 85018645

=LDR  00964cz  a2200301n  4500
=001  9880364260402441
=005  20141212213131.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019291
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x830
=072  \\$aA2.$x835.$x232.$x781.$x750
=150  \\$aSkull Base
=450  \\$wnnna$aBase, Cranial
=450  \\$wnnna$aBase of Skull
=450  \\$wnnna$aBase, Skull
=450  \\$aBasicranium
=450  \\$wnnna$aBasis cranii
=450  \\$aCranial Base
=550  \\$wg$aHead
=550  \\$wg$aSkull
=550  \\$wh$aCranial Fossa, Anterior
=550  \\$wh$aCranial Fossa, Middle
=550  \\$wh$aCranial Fossa, Posterior
=667  \\$aGEN: prefer specifics; NIM when merely locational; neopl = SKULL BASE NEOPLASMS
=680  \\$iThe inferior region of the skull consisting of an internal (cerebral), and an external (basilar) surface.
=688  \\$a97
=750  \0$aSkull base$5IEN-M$0(DLC)sh 85012083

=LDR  01808cz  a2200385n  4500
=001  9880364260502441
=005  20170712130128.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019300
=035  \\$aCTL9318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x450
=150  \\$aMedical Errors
=450  \\$wnnna$aError, Medical
=450  \\$wnnna$aError, Surgical
=450  \\$wnnna$aErrors, Medical
=450  \\$wnnna$aErrors, Surgical
=450  \\$wnnna$aMedical Error
=450  \\$wnnna$aMedical Mistake
=450  \\$aMedical Mistakes
=450  \\$wnnna$aMistake, Medical
=450  \\$wnnna$aMistakes, Medical
=450  \\$wnnna$aSurgical Error
=450  \\$aSurgical Errors
=550  \\$wg$aHealth Services
=550  \\$wh$aDiagnostic Errors
=550  \\$wh$aMedication Errors
=550  \\$wh$aNear Miss, Healthcare
=550  \\$wh$aObserver Variation
=550  \\$wh$aRadiotherapy Setup Errors
=550  \\$aIatrogenic Disease
=667  \\$acoordinate IM with specific disease or procedure (IM); do not confuse with MALPRACTICE; DIAGNOSTIC ERRORS & MEDICATION ERRORS are also available
=680  \\$iErrors or mistakes committed by health professionals which result in harm to the patient. They include errors in diagnosis (DIAGNOSTIC ERRORS), errors in the administration of drugs and other medications (MEDICATION ERRORS), errors in the performance of surgical procedures, in the use of other types of therapy, in the use of equipment, and in the interpretation of laboratory findings. Medical errors are differentiated from MALPRACTICE in that the former are regarded as honest mistakes or accidents while the latter is the result of negligence, reprehensible ignorance, or criminal intent.
=688  \\$a97
=750  \0$aMedical errors$5IEN-M$0(DLC)sh 85082928

=LDR  01087cz  a2200277n  4500
=001  9880364260602441
=005  20141212213112.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019243
=035  \\$aCTL9317HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x420.$x500
=150  \\$aEnamel Microabrasion
=450  \\$aDental Microabrasion
=450  \\$wnnna$aDental Microabrasions
=450  \\$wnnna$aEnamel Microabrasions
=450  \\$aMicroabrasion, Dental
=450  \\$aMicroabrasion, Enamel
=450  \\$wnnna$aMicroabrasions, Dental
=450  \\$wnnna$aMicroabrasions, Enamel
=550  \\$wg$aEsthetics, Dental
=550  \\$aTooth Discoloration
=667  \\$ato remove surface discoloration
=680  \\$iMechanical removal of a small amount of tooth structure (not more than a few tenths of a millimeter in depth) to eliminate superficial enamel discoloration defects not successfully removed by bleaching techniques. A common abrasive is a mixture of pumice and hydrochloric acid.
=688  \\$a97
=750  \0$aDental enamel microabrasion$5IEN-M$0(DLC)sh 91000137

=LDR  01466cz  a2200277n  4500
=001  9880364260702441
=005  20141212213154.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019352
=035  \\$aCTL9310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x205
=072  \\$aN1.$x224.$x175
=072  \\$aN6.$x850.$x505.$x400.$x225
=150  \\$aCensuses
=450  \\$wnnna$aCensus
=450  \\$wnnna$aCensus Method
=450  \\$wnnna$aCensus Methods
=450  \\$wnnna$aMethod, Census
=450  \\$wnnna$aMethods, Census
=450  \\$wnnna$aMicrocensus
=550  \\$wg$aDemography
=667  \\$afor modern & hist censuses; IM; specify geog
=680  \\$iEnumerations of populations usually recording identities of all persons in every place of residence with age or date of birth, sex, occupation, national origin, language, marital status, income, relation to head of household, information on the dwelling place, education, literacy, health-related data (e.g., permanent disability), etc. The census or "numbering of the people" is mentioned several times in the Old Testament. Among the Romans, censuses were intimately connected with the enumeration of troops before and after battle and probably a military necessity. (From Last, A Dictionary of Epidemiology, 3d ed; Garrison, An Introduction to the History of Medicine, 4th ed, p66, p119)
=688  \\$a97; CENSUS was see DEMOGRAPHY 1990-96
=750  \0$aCensus$5IEN-M$0(DLC)sh 85021832

=LDR  01274cz  a2200193n  4500
=001  9880364260802441
=005  20170104092825.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019338
=035  \\$aCTL9305M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x698
=150  \\$aPolypharmacy
=550  \\$wg$aDrug Therapy
=550  \\$wh$aDeprescriptions
=667  \\$anote category: do not confuse with POLYPHARMACOLOGY, the design or use of drugs acting on multiple targets or pathways or with PHARMACOLOGY, the discipline or with DRUG COMBINATIONS or with POLYCHEMOTHERAPY see DRUG THERAPY, COMBINATION
=680  \\$iThe use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)
=688  \\$a97
=750  \0$aPolypharmacy$0(DLC)sh2011000398$5IEN-M

=LDR  00956cz  a2200253n  4500
=001  9880364260902441
=005  20141212213248.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019564
=035  \\$aCTL9303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x380.$x900
=072  \\$aN5.$x300.$x150.$x395.$x900
=150  \\$aUnnecessary Procedures
=450  \\$wnnna$aProcedure, Unnecessary
=450  \\$wnnna$aProcedures, Unnecessary
=450  \\$aSurgery, Unnecessary
=450  \\$wnnna$aUnnecessary Procedure
=450  \\$aUnnecessary Surgery
=550  \\$wg$aHealth Services Misuse
=667  \\$aIM; coord with specific procedure (IM) with probably /util
=680  \\$iDiagnostic, therapeutic, and investigative procedures prescribed and performed by health professionals, the results of which do not justify the benefits or hazards and costs to the patient.
=688  \\$a97
=750  \0$aSurgery, Unnecessary$5IEN-M$0(DLC)sh 85130791

=LDR  01533cz  a2200337n  4500
=001  9880364261002441
=005  20141212213151.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019341
=035  \\$aCTL9302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x61
=072  \\$aE2.$x190.$x755.$x100
=072  \\$aE2.$x190.$x888.$x61
=072  \\$aF4.$x754.$x35
=150  \\$aAromatherapy
=450  \\$wnnna$aAroma Therapies
=450  \\$wnnna$aAroma Therapy
=450  \\$wnnna$aAromatherapies
=450  \\$wnnna$aTherapies, Aroma
=450  \\$wnnna$aTherapy, Aroma
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPhytotherapy
=550  \\$wg$aPsychotherapy
=550  \\$wg$aSensory Art Therapies
=550  \\$aOdors
=550  \\$aOils, Volatile
=667  \\$ause of essential oils to treat dis in alternative med; coord IM with disease /ther (IM) & specific plant or essential oil /ther use (IM) if available & if pertinent; DF: AROMATHER
=680  \\$iThe use of fragrances and essences from plants to affect or alter a person's mood or behavior and to facilitate physical, mental, and emotional well-being. The chemicals comprising essential oils in plants has a host of therapeutic properties and has been used historically in Africa, Asia, and India. Its greatest application is in the field of alternative medicine. (From Random House Unabridged Dictionary, 2d ed; from Dr. Atiba Vheir, Dove Center, Washington, D.C.)
=688  \\$a97
=750  \0$aAromatherapy$5IEN-M$0(DLC)sh 88005874

=LDR  01153cz  a2200337n  4500
=001  9880364261102441
=005  20141212213214.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019443
=035  \\$aCTL9297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x222.$x200
=072  \\$aG1.$x60.$x249.$x159.$x200
=072  \\$aG16.$x500.$x275.$x240.$x200
=150  \\$aCosmic Dust
=450  \\$wnnna$aCosmic Dusts
=450  \\$wnnna$aDust, Cosmic
=450  \\$wnnna$aDust, Interplanetary
=450  \\$wnnna$aDust, Interstellar
=450  \\$wnnna$aDusts, Cosmic
=450  \\$wnnna$aDusts, Interplanetary
=450  \\$wnnna$aDusts, Interstellar
=450  \\$aInterplanetary Dust
=450  \\$wnnna$aInterplanetary Dusts
=450  \\$aInterstellar Dust
=450  \\$wnnna$aInterstellar Dusts
=550  \\$wg$aDust
=550  \\$wg$aExtraterrestrial Environment
=680  \\$iFinely divided solid matter with particle sizes smaller than a micrometeorite, thus with diameters much smaller than a millimeter, moving in interplanetary space. (NASA Thesaurus, 1994)
=688  \\$a97
=750  \0$aCosmic dust$5IEN-M$0(DLC)sh 85033146

=LDR  00736cz  a2200217n  4500
=001  9880364261202441
=005  20141212192912.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019460
=035  \\$aCTL9296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x968
=150  \\$aTobacco Industry
=450  \\$wnnna$aIndustries, Tobacco
=450  \\$wnnna$aIndustry, Tobacco
=450  \\$wnnna$aTobacco Industries
=550  \\$wg$aManufacturing Industry
=667  \\$aSPEC; SPEC qualif; DF: TOBACCO INDUST
=680  \\$iThe aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.
=688  \\$a97
=750  \0$aTobacco industry$5IEN-M$0(DLC)sh 85135735

=LDR  00689cz  a2200217n  4500
=001  9880364261302441
=005  20141212213207.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019416
=035  \\$aCTL9295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x478
=150  \\$aHead Movements
=450  \\$wnnna$aHead Movement
=450  \\$wnnna$aMovement, Head
=450  \\$wnnna$aMovements, Head
=550  \\$wg$aMovement
=667  \\$anote HEAD BANGING see STEREOTYPED BEHAVIOR
=680  \\$iVoluntary or involuntary motion of head that may be relative to or independent of body; includes animals and humans.
=688  \\$a97
=750  \0$aHead$xMovements$5IEN-M

=LDR  01279cz  a2200241n  4500
=001  9880364261402441
=005  20141212213224.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019471
=035  \\$aCTL9294HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x595.$x240
=150  \\$aElementary Particle Interactions
=450  \\$wnnna$aElementary Particle Interaction
=450  \\$wnnna$aInteraction, Elementary Particle
=450  \\$wnnna$aInteractions, Elementary Particle
=450  \\$wnnna$aParticle Interaction, Elementary
=450  \\$aParticle Interactions, Elementary
=550  \\$wg$aPhysical Processes
=667  \\$aa concept in nuclear physics; sub-atomic particles only
=680  \\$iThe interactions of particles responsible for their scattering and transformations (decays and reactions). Because of interactions, an isolated particle may decay into other particles. Two particles passing near each other may transform, perhaps into the same particles but with changed momenta (elastic scattering) or into other particles (inelastic scattering). Interactions fall into three groups: strong, electromagnetic, and weak. (From McGraw-Hill Encyclopedia of Science & Technology, 7th ed)
=688  \\$a97
=750  \0$aNuclear reactions$5IEN-M$0(DLC)sh 85093069

=LDR  00770cz  a2200205n  4500
=001  9880364261502441
=005  20141212213217.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019451
=035  \\$aCTL9293HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x399
=150  \\$aInformation Management
=450  \\$wnnna$aManagement, Information
=550  \\$wg$aInformation Science
=550  \\$wh$aHealth Information Management
=667  \\$amanagement of acquis, organiz, storage & retrieval of information; SPEC qualif
=680  \\$iManagement of the acquisition, organization, storage, retrieval, and dissemination of information. (From Thesaurus of ERIC Descriptors, 1994)
=688  \\$a97
=750  \0$aInformation resources management$0(DLC) sh 85066147$5IEN-M

=LDR  01459cz  a2200265n  4500
=001  9880364261602441
=005  20141212213219.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019456
=035  \\$aCTL9292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x600.$x400
=072  \\$aN1.$x224.$x625.$x400
=072  \\$aN6.$x850.$x505.$x400.$x700.$x400
=072  \\$aN6.$x850.$x650
=150  \\$aHealth Transition
=450  \\$wnnna$aHealth Transitions
=450  \\$wnnna$aTransition, Health
=450  \\$wnnna$aTransitions, Health
=550  \\$wg$aPopulation Dynamics
=550  \\$wg$aPublic Health
=667  \\$ademogr & epidemiol changes in health picture in a population
=680  \\$iDemographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterized by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition. (From Ann Intern Med 1992 Mar 15;116(6):499-504)
=688  \\$a97
=750  \0$aHealth transition$5IEN-M$0(DLC)sh 92005908

=LDR  01183cz  a2200241n  4500
=001  9880364261802441
=005  20200609110305.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019468
=035  \\$aCTL9290M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x607
=150  \\$aDisease Management
=450  \\$wnnna$aDisease Managements
=450  \\$wnnna$aManagement, Disease
=450  \\$wnnna$aManagements, Disease
=550  \\$wg$aPatient Care Management
=550  \\$wh$aObesity Management
=550  \\$wh$aPain Management
=667  \\$aselection of appropriate dis ther processes in relation to cost & clin outcome; DF: DIS MANAGEMENT
=680  \\$iA broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596)
=688  \\$a97
=750  \0$aDisease management$5IEN-M$0(DLC)sh 98004266

=LDR  00769cz  a2200193n  4500
=001  9880364261902441
=005  20141212213217.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019452
=035  \\$aCTL9289HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x873
=150  \\$aTerminally Ill
=450  \\$wnnna$aIll, Terminally
=550  \\$wg$aPersons
=667  \\$athe terminal patient himself; care of the terminal patient = TERMINAL CARE
=680  \\$iPersons with an incurable or irreversible illness at the end stage that will result in death within a short time. (From O'Leary et al., Lexikon: Dictionary of Health Care Terms, Organizations, and Acronyms for the Era of Reform, 1994, p780)
=688  \\$a97
=750  \0$aTerminally ill$5IEN-M$0(DLC)sh 85134022

=LDR  01348cz  a2200361n  4500
=001  9880364262002441
=005  20141212213245.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019555
=035  \\$aCTL9288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x205.$x500
=150  \\$aPhysician-Nurse Relations
=450  \\$wnnna$aNurse-Physician Relation
=450  \\$aNurse-Physician Relations
=450  \\$wnnna$aNurse Physician Relations
=450  \\$wnnna$aNurse Relationship, Physician
=450  \\$wnnna$aNurse Relationships, Physician
=450  \\$wnnna$aPhysician-Nurse Relation
=450  \\$wnnna$aPhysician Nurse Relations
=450  \\$wnnna$aPhysician Nurse Relationship
=450  \\$wnnna$aPhysician Nurse Relationships
=450  \\$wnnna$aRelation, Nurse-Physician
=450  \\$wnnna$aRelation, Physician-Nurse
=450  \\$wnnna$aRelations, Nurse-Physician
=450  \\$wnnna$aRelations, Physician-Nurse
=450  \\$wnnna$aRelationship, Physician Nurse
=450  \\$wnnna$aRelationships, Physician Nurse
=550  \\$wg$aInterprofessional Relations
=667  \\$ano qualif; IM; coord with med & nurs spec (IM) if pertinent; DF: PHYSICIAN NURSE RELAT
=680  \\$iThe reciprocal interaction of physicians and nurses.
=688  \\$a97
=750  \0$aNurse and physician$5IEN-M$0(DLC)sh 85093313

=LDR  01151cz  a2200265n  4500
=001  9880364262102441
=005  20141212213105.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019226
=035  \\$aCTL9278HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x465.$x672
=150  \\$aOral Ulcer
=450  \\$aMouth Ulcer
=450  \\$wnnna$aMouth Ulcers
=450  \\$wnnna$aOral Ulcers
=450  \\$wnnna$aUlcer, Mouth
=450  \\$wnnna$aUlcer, Oral
=450  \\$wnnna$aUlcers, Mouth
=450  \\$wnnna$aUlcers, Oral
=550  \\$wg$aMouth Diseases
=667  \\$acoord IM with cause (IM) if pertinent; not a synonym for STOMATITIS, APHTHOUS
=680  \\$iA loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis (STOMATITIS, APHTHOUS); NOMA; necrotizing gingivitis (GINGIVITIS, NECROTIZING ULCERATIVE); TOOTHBRUSHING; and various irritants. (From Jablonski, Dictionary of Dentistry, 1992, p842)
=688  \\$a97
=750  \0$aMouth$xUlcers$5IEN-M$0(DLC)sh 85088005

=LDR  01109cz  a2200265n  4500
=001  9880364262202441
=005  20141212213213.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019439
=035  \\$aCTL9276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x224.$x161
=072  \\$aA11.$x299
=150  \\$aChromaffin Cells
=450  \\$wnnna$aCell, Chromaffin
=450  \\$wnnna$aCells, Chromaffin
=450  \\$wnnna$aChromaffin Cell
=550  \\$wg$aCells
=550  \\$wg$aChromaffin System
=550  \\$wh$aChromaffin Granules
=550  \\$wh$aPC12 Cells
=667  \\$alocated in adrenal medulla & sympath paraganglia; store epinephrine
=680  \\$iCells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia (PARAGANGLIA, CHROMAFFIN) of the sympathetic nervous system.
=688  \\$a97
=750  \0$aChromaffin cells$5IEN-M$0(DLC)sh 85025330

=LDR  01491cz  a2200313n  4500
=001  9880364262302441
=005  20141212213206.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019413
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x520.$x300
=072  \\$aK1.$x752.$x730
=150  \\$aQi
=450  \\$aCh'i
=450  \\$wnnna$aEnergies, Vital (Philosophy)
=450  \\$wnnna$aEnergy, Vital (Philosophy)
=450  \\$aLife-Breath (Philosophy)
=450  \\$wnnna$aLife Breath (Philosophy)
=450  \\$aVital Energy (Philosophy)
=550  \\$wg$aMedicine, Chinese Traditional
=550  \\$wg$aPhilosophy
=550  \\$wh$aMeridians
=550  \\$aYang Deficiency
=550  \\$aYin Deficiency
=550  \\$aYin-Yang
=667  \\$aQi defic goes here
=680  \\$iThe vital life force in the body, supposedly able to be regulated by acupuncture. It corresponds roughly to the Greek pneuma, the Latin spiritus, and the ancient Indian prana. The concept of life-breath or vital energy was formulated as an indication of the awareness of man, originally directed externally toward nature or society but later turned inward to the self or life within. (From Comparison between Concepts of Life-Breath in East and West, 15th International Symposium on the Comparative History of Medicine - East and West, August 26-September 3, 1990, Shizuoka, Japan, pp. ix-x)
=688  \\$a2002(1997)
=750  \0$aQi (Chinese philosophy)$5IEN-M$0(DLC)sh 85023202

=LDR  01530cz  a2200337n  4500
=001  9880364262402441
=005  20141212213215.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019444
=035  \\$aCTL9272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x828.$x868.$x910
=072  \\$aD20.$x215.$x894.$x865.$x910
=072  \\$aD23.$x50.$x865.$x910
=150  \\$aVaccines, DNA
=450  \\$aDNA Vaccines
=450  \\$wnnna$aDNA Vaccines, Naked
=450  \\$wnnna$aDNA Vaccines, Recombinant
=450  \\$aNaked DNA Vaccines
=450  \\$aNucleic Acid Vaccines
=450  \\$aPolynucleotide Vaccines
=450  \\$aRecombinant DNA Vaccines
=450  \\$wnnna$aVaccines, Naked DNA
=450  \\$wnnna$aVaccines, Nucleic Acid
=450  \\$wnnna$aVaccines, Polynucleotide
=450  \\$aVaccines, Recombinant DNA
=550  \\$wg$aVaccines, Synthetic
=667  \\$avaccines composed of recombinant DNA vectors encoding antigens
=680  \\$iRecombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
=688  \\$a97
=750  \0$aDNA vaccines$5IEN-M$0(DLC)sh 95007398

=LDR  01050cz  a2200253n  4500
=001  9880364262502441
=005  20141212213216.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019448
=035  \\$aCTL9270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x118.$x299
=150  \\$aEthnobotany
=550  \\$wg$aBotany
=550  \\$aBotany
=550  \\$aEthnopharmacology
=550  \\$aMedicine, Traditional
=550  \\$aPhytotherapy
=550  \\$aPlants
=550  \\$aPlants, Medicinal
=667  \\$aspecialty; coordinate with geographic term or ethnic group if pertinent; coordinate NIM with specific drug or plant (IM) for ethnobotany aspects of the plant
=680  \\$iThe study of plant lore and agricultural customs of a people. In the fields of ETHNOMEDICINE and ETHNOPHARMACOLOGY, the emphasis is on traditional medicine and the existence and medicinal uses of PLANTS and PLANT EXTRACTS and their constituents, both historically and in modern times.
=688  \\$a97
=750  \0$aEthnobotany$5IEN-M$0(DLC)sh 85045192

=LDR  01042cz  a2200313n  4500
=001  9880364262602441
=005  20141212213214.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019442
=035  \\$aCTL9269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x600.$x700
=072  \\$aJ1.$x637.$x215.$x600.$x700
=072  \\$aJ1.$x637.$x708.$x600.$x700
=150  \\$aSpace Suits
=450  \\$wnnna$aFlight Suit
=450  \\$aFlight Suits
=450  \\$wnnna$aSpace Suit
=450  \\$wnnna$aSpacesuit
=450  \\$wnnna$aSpacesuits
=450  \\$wnnna$aSuit, Flight
=450  \\$wnnna$aSuit, Space
=450  \\$wnnna$aSuits, Flight
=450  \\$wnnna$aSuits, Space
=550  \\$wg$aProtective Clothing
=667  \\$aGRAVITY SUITS is also available
=680  \\$iPressure suits for wear in space or at very low ambient pressures within the atmosphere, designed to permit the wearer to leave the protection of a pressurized cabin. (NASA Thesaurus, 1994)
=688  \\$a97
=750  \0$aSpace suits$5IEN-M$0(DLC)sh 85125966

=LDR  01625cz  a2200229n  4500
=001  9880364262702441
=005  20141212213208.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019423
=035  \\$aCTL9266HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x830
=072  \\$aE2.$x190.$x901.$x788
=072  \\$aI1.$x76.$x201.$x450.$x654.$x830
=150  \\$aShamanism
=550  \\$wg$aMedicine, Traditional
=550  \\$wg$aSpiritual Therapies
=550  \\$aMedicine, Traditional
=667  \\$aa form of traditional medicine; specify geog; not for African witch doctors: use instead MEDICINE, AFRICAN TRADITIONAL
=680  \\$iAn intermediate stage between polytheism and monotheism, which assumes a "Great Spirit", with lesser deities subordinated. With the beginnings of shamanism there was the advent of the medicine man or witch doctor, who assumed a supervisory relation to disease and its cure. Formally, shamanism is a religion of Ural-Altaic peoples of Northern Asia and Europe, characterized by the belief that the unseen world of gods, demons, ancestral spirits is responsive only to shamans. The Indians of North and South America entertain religious practices similar to the Ural-Altaic shamanism. The word shaman comes from the Tungusic (Manchuria and Siberia) saman, meaning Buddhist monk. The shaman handles disease almost entirely by psychotherapeutic means; he frightens away the demons of disease by assuming a terrifying mien. (From Garrison, An Introduction to the History of Medicine, 4th ed, p22; from Webster, 3d ed)
=688  \\$a97
=750  \0$aShamanism$5IEN-M$0(DLC)sh 85121085

=LDR  01466cz  a2200397n  4500
=001  9880364262802441
=005  20141212213200.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019380
=035  \\$aCTL9264M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x388.$x77.$x88
=150  \\$aAnti-HIV Agents
=450  \\$wnnna$aAgents, Anti-AIDS
=450  \\$wnnna$aAgents, Anti-HIV
=450  \\$aAIDS Drugs
=450  \\$aAnti-AIDS Agents
=450  \\$wnnna$aAnti AIDS Agents
=450  \\$wnnna$aAnti-AIDS Drugs
=450  \\$wnnna$aAnti AIDS Drugs
=450  \\$wnnna$aAnti HIV Agents
=450  \\$wnnna$aAnti-HIV Drugs
=450  \\$wnnna$aAnti HIV Drugs
=450  \\$wnnna$aDrugs, AIDS
=450  \\$wnnna$aDrugs, Anti-AIDS
=450  \\$wnnna$aDrugs, Anti-HIV
=550  \\$wg$aAnti-Retroviral Agents
=550  \\$wh$aCCR5 Receptor Antagonists
=550  \\$wh$aHIV Fusion Inhibitors
=550  \\$wh$aHIV Integrase Inhibitors
=550  \\$wh$aHIV Protease Inhibitors
=550  \\$aAntiretroviral Therapy, Highly Active
=667  \\$aconsider also AIDS /drug ther; may be used for articles on simian acquired immunodefic syndrome & simian immunodefic virus
=680  \\$iAgents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
=688  \\$a97
=750  \0$aAntiretroviral agents$5IEN-M$0(DLC)sh2003006231

=LDR  00898cz  a2200253n  4500
=001  9880364262902441
=005  20141212213138.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019308
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x694.$x750
=150  \\$aPalmitic Acid
=450  \\$wnnna$aAcid, Hexadecanoic
=450  \\$wnnna$aAcid, Palmitic
=450  \\$wnnna$aCalcium Palmitate
=450  \\$aHexadecanoic Acid
=450  \\$wnnna$aPalmitate, Calcium
=450  \\$wnnna$aPalmitate, Sodium
=450  \\$wnnna$aSodium Palmitate
=550  \\$wg$aPalmitic Acids
=667  \\$ado not confuse with PALMITIC ACIDS
=680  \\$iA common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
=688  \\$a97; was PALMITIC ACID (NM) 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96
=750  \0$aPalmitic acid$5IEN-M$0(DLC)sh 85097244

=LDR  01004cz  a2200265n  4500
=001  9880364263002441
=005  20141212213134.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x325.$x600.$x525
=150  \\$aOleic Acid
=450  \\$a9-Octadecenoic Acid
=450  \\$wnnna$a9 Octadecenoic Acid
=450  \\$wnnna$aAcid, 9-Octadecenoic
=450  \\$wnnna$aAcid, cis-9-Octadecenoic
=450  \\$wnnna$aAcid, Oleic
=450  \\$wnnna$acis-9-Octadecenoic Acid
=450  \\$wnnna$acis 9 Octadecenoic Acid
=450  \\$aOleate
=550  \\$wg$aOleic Acids
=667  \\$ado not confuse with OLEIC ACIDS
=680  \\$iAn unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. (Stedman, 26th ed)
=688  \\$a97; was OLEIC ACID (NM) 1981-96
=750  \0$aOleic acid$5IEN-M$0(DLC)sh 87004196

=LDR  01054cz  a2200289n  4500
=001  9880364263102441
=005  20141212192859.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019343
=035  \\$aCTL9248HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x901.$x434.$x249
=150  \\$aCitric Acid
=450  \\$wnnna$aAcid Monohydrate, Citric
=450  \\$wnnna$aAnhydrous Citric Acid
=450  \\$aCitrate
=450  \\$wnnna$aCitric Acid, Anhydrous
=450  \\$wnnna$aCitric Acid Monohydrate
=450  \\$wnnna$aMonohydrate, Citric Acid
=450  \\$wnnna$aUralyt U
=550  \\$wg$aCitrates
=550  \\$wh$aCalcium Citrate
=550  \\$wh$aPotassium Citrate
=667  \\$ado not confuse entry term CITRATE with CITRATES
=680  \\$iA key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
=688  \\$a97; was CITRIC ACID (NM) 1979-96
=750  \0$aCitric acid$5IEN-M$0(DLC)sh 85026216

=LDR  01895cz  a2200469n  4500
=001  9880364263202441
=005  20141212213049.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019204
=035  \\$aCTL9246M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x330.$x300
=072  \\$aD12.$x776.$x157.$x325
=150  \\$aGTP-Binding Proteins
=450  \\$wnnna$aG-Protein
=450  \\$wnnna$aG Protein
=450  \\$aG-Proteins
=450  \\$wnnna$aG Proteins
=450  \\$wnnna$aGTP-Binding Protein
=450  \\$wnnna$aGTP Binding Protein
=450  \\$wnnna$aGTP Binding Proteins
=450  \\$wnnna$aGTP-Regulatory Protein
=450  \\$wnnna$aGTP Regulatory Protein
=450  \\$aGTP-Regulatory Proteins
=450  \\$wnnna$aGTP Regulatory Proteins
=450  \\$wnnna$aGuanine Nucleotide Coupling Protein
=450  \\$aGuanine Nucleotide Regulatory Proteins
=450  \\$wnnna$aProtein, GTP-Binding
=450  \\$wnnna$aProtein, GTP-Regulatory
=450  \\$wnnna$aProteins, GTP-Binding
=450  \\$wnnna$aProteins, GTP-Regulatory
=550  \\$wg$aCarrier Proteins
=550  \\$wg$aGTP Phosphohydrolases
=550  \\$wh$aGTP Phosphohydrolase-Linked Elongation Factors
=550  \\$wh$aHeterotrimeric GTP-Binding Proteins
=550  \\$wh$aMonomeric GTP-Binding Proteins
=550  \\$wh$aMyxovirus Resistance Proteins
=550  \\$wh$aSeptins
=667  \\$aGEN or unspecified; prefer specifics; GTP stands for Guanosine TriPhosphate
=680  \\$iRegulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-.
=688  \\$a1997(1985)
=750  \0$aG proteins$0(DLC) sh 89000191$5IEN-M

=LDR  00746cz  a2200217n  4500
=001  9880364263302441
=005  20141212213243.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019551
=035  \\$aCTL9235HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x425.$x300
=072  \\$aD27.$x720.$x274.$x300
=150  \\$aDental Disinfectants
=450  \\$aDisinfectants, Dental
=550  \\$wg$aDisinfectants
=550  \\$wh$aRoot Canal Irrigants
=667  \\$aDF: DENT DISINFECTANTS
=680  \\$iChemicals especially for use on instruments to destroy pathogenic organisms. (Boucher, Clinical Dental Terminology, 4th ed)
=688  \\$a97
=750  \0$aDental instruments and apparatus$xSterilization$5IEN$0(DLC)sh 85036899

=LDR  00554cz  a2200181n  4500
=001  9880364263402441
=005  20141212213241.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019545
=035  \\$aCTL9234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x675
=150  \\$aIntuition
=550  \\$wg$aCognition
=667  \\$aknowing without conscious reasoning
=680  \\$iKnowing or understanding without conscious use of reasoning. (Thesaurus of ERIC Descriptors, 1994)
=688  \\$a97
=750  \0$aIntuition$5IEN-M$0(DLC)sh 85067653

=LDR  01260cz  a2200313n  4500
=001  9880364263502441
=005  20141212213021.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019147
=035  \\$aCTL9231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x531.$x940
=150  \\$aVomeronasal Organ
=450  \\$wnnna$aJacobson Organ
=450  \\$wnnna$aJacobson's Organ
=450  \\$wnnna$aJacobsons Organ
=450  \\$aOrganum Vomeronasale
=450  \\$wnnna$aOrganum Vomeronasales
=450  \\$aVomeronasal Nerve
=450  \\$wnnna$aVomeronasal Nerves
=450  \\$wnnna$aVomeronasal Organs
=450  \\$aVomeronasal System
=450  \\$wnnna$aVomeronasal Systems
=450  \\$wnnna$aVomeronasale, Organum
=550  \\$wg$aNose
=550  \\$aOlfactory Mucosa
=680  \\$iAn accessory chemoreceptor organ that is separated from the main OLFACTORY MUCOSA. It is situated at the base of nasal septum close to the VOMER and NASAL BONES. It forwards chemical signals (such as PHEROMONES) to the CENTRAL NERVOUS SYSTEM, thus influencing reproductive and social behavior. In humans, most of its structures except the vomeronasal duct undergo regression after birth.
=688  \\$a97
=750  \0$aJacobson's organ$5IEN-M$0(DLC)sh 85069227

=LDR  00842cz  a2200241n  4500
=001  9880364263602441
=005  20141212192852.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019178
=035  \\$aCTL9230M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x81.$x50
=072  \\$aB4.$x715.$x464.$x40
=072  \\$aB4.$x820.$x81.$x50
=150  \\$aAlfamovirus
=450  \\$wnnna$aAlfamoviruses
=550  \\$wg$aBromoviridae
=550  \\$wg$aMosaic Viruses
=550  \\$wh$aAlfalfa mosaic virus
=667  \\$aa genus of mosaic viruses; from ALFAlfa MOsaic virus; coord IM with specific plant /virol (IM or NIM)
=680  \\$iA genus of the family BROMOVIRIDAE with a wide host range. Transmission is by aphids and the type species is ALFALFA MOSAIC VIRUS.
=688  \\$a97
=750  \0$aAlfamoviruses$0(DLC) sh2004003305$5IEN-M

=LDR  01265cz  a2200325n  4500
=001  9880364263702441
=005  20141212213125.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019272
=035  \\$aCTL9226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x560.$x500
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x560.$x500
=150  \\$aLeukocyte Elastase
=450  \\$wnnna$aElastase, Granulocyte
=450  \\$wnnna$aElastase, Leukocyte
=450  \\$wnnna$aElastase, Lysosomal
=450  \\$wnnna$aElastase, Neutrophil
=450  \\$wnnna$aElastase, PMN
=450  \\$wnnna$aElastase, Polymorphonuclear Leukocyte
=450  \\$wnnna$aGranulocyte Elastase
=450  \\$wnnna$aLeukocyte Elastase, Polymorphonuclear
=450  \\$aLysosomal Elastase
=450  \\$aNeutrophil Elastase
=450  \\$aPMN Elastase
=450  \\$aPolymorphonuclear Leukocyte Elastase
=550  \\$wg$aPancreatic Elastase
=680  \\$iAn enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.
=688  \\$a97; was LEUKOCYTE ELASTASE (NM) 1988-96
=750  \0$aLeucocyte elastase$5IEN-M$0(DLC)sh 91005159

=LDR  00941cz  a2200241n  4500
=001  9880364263802441
=005  20141212213152.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019346
=035  \\$aCTL9224HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x165.$x500
=150  \\$aSodium Acetate
=450  \\$wnnna$aAcetate, Sodium
=450  \\$wnnna$aAcetate Trihydrate, Sodium
=450  \\$wnnna$aAnhydrous Sodium Acetate
=450  \\$wnnna$aSodium Acetate, Anhydrous
=450  \\$wnnna$aSodium Acetate Trihydrate
=450  \\$wnnna$aTrihydrate, Sodium Acetate
=550  \\$wg$aAcetic Acid
=680  \\$iThe trihydrate sodium salt of acetic acid, which is used as a source of sodium ions in solutions for dialysis and as a systemic and urinary alkalizer, diuretic, and expectorant.
=688  \\$a97; SODIUM ACETATE was SY to ACETIC ACID GLACIAL (NM) 1981-96
=750  \0$aSodium acetate$5IEN-M$0(DLC)sh 85124254

=LDR  00356cz  a2200133n  4500
=001  9880364263902441
=005  20120717143611.0
=008  900711nn\ancnnbabn\\\\\\\\\\|n\ana\|||\d
=035  \\$a(DNLM)D008405Q000627
=035  \\$aCTG0811HS
=040  \\$aIEN-M$cIEN-M
=150  \0$aMassage$xtherapeutic use
=690  \\$aAJO:11/27/96
=750  \0$aMassage therapy$5IEN-M$0(DLC)sh 95008240

=LDR  00332cz  a2200121n  4500
=001  9880364264002441
=005  20120717143611.0
=008  950526\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTG0809HS
=035  \\$a(DNLM)D019050Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aAcupressure$xveterinary
=750  \0$aAcupressure for animals$5IEN-M$0(DLC)sh 93007502

=LDR  00333cz  a2200121n  4500
=001  9880364264102441
=005  20120717143611.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTF4610HS
=035  \\$a(DNLM)D004035Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDiet Therapy$xveterinary
=750  \0$aVeterinary diet therapy$5IEN-M$0(DLC)sh 93005975

=LDR  00321cz  a2200121n  4500
=001  9880364264202441
=005  20120717143611.0
=008  731227\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTE9748HS
=035  \\$a(DNLM)D009439Q000172
=040  \\$aDNLM$cDNLM
=150  \\$aNeuraminidase$xdeficiency
=750  \0$aSialidoses$5IEN-M$0(DLC)sh 93004739

=LDR  00333cz  a2200121n  4500
=001  9880364264302441
=005  20120717143611.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTE9716HS
=035  \\$a(DNLM)D000820Q000628
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Diseases$xtherapy
=750  \0$aVeterinary therapeutics$5IEN-M$0(DLC)sh 91004924

=LDR  00338cz  a2200121n  4500
=001  9880364264402441
=005  20120717143610.0
=008  660101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTE9715HS
=035  \\$a(DNLM)D000820Q000188
=040  \\$aDNLM$cDNLM
=150  \\$aAnimal Diseases$xdrug therapy
=750  \0$aVeterinary chemotherapy$5IEN-M$0(DLC)sh 86004774

=LDR  00347cz  a2200121n  4500
=001  9880364264502441
=005  20120717143610.0
=008  670101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$aCTE4528HS
=035  \\$a(DNLM)D002690Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aChlamydia Infections$xveterinary
=750  \0$aChlamydia infections in animals$5IEN$0(DLC)sh 92005429

=LDR  00493cz  a2200157n  4500
=001  9880364264602441
=005  20120717143610.0
=008  950524\n\ancnnbabn\\\\\\\\\\\a\ana\\\\\b
=035  \\$aCTC8607HS
=035  \\$a(DNLM)D019005Q000235
=040  \\$aDNLM$cDNLM
=150  \\$aCystic Fibrosis Transmembrane Conductance Regulator$xgenetics
=450  \\$aCFTR Gene$5IEN-M
=450  \\$aCystic Fibrosis Gene$5IEN-M
=550  \\$aCystic Fibrosis$xgenetics$5IEN-M
=750  \0$aCystic fibrosis gene$5IEN-M$0(DLC)sh 91001900

=LDR  02158cz  a2200565n  4500
=001  9880364264702441
=005  20170827172043.0
=008  940601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018377
=035  \\$aCSK6100M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625
=072  \\$aD27.$x505.$x696.$x577
=150  \\$aNeurotransmitter Agents
=450  \\$wnne$aAmino Acid Neurotransmitters$5IEN
=450  \\$wnnna$aNerve Transmitter Substances
=450  \\$wnnna$aNeurohormones
=450  \\$wnnna$aNeurohumors
=450  \\$wnnna$aNeuromodulator
=450  \\$wnnna$aNeuromodulators
=450  \\$wnnna$aNeuroregulator
=450  \\$wnnna$aNeuroregulators
=450  \\$wnnna$aNeurosteroids
=450  \\$wnnna$aNeurotransmitter
=450  \\$wnnna$aNeurotransmitters
=450  \\$wnnna$aSubstances, Nerve Transmitter
=450  \\$wnnna$aTransmitter Substances, Nerve
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAdrenergic Agents
=550  \\$wh$aCannabinoid Receptor Modulators
=550  \\$wh$aCholinergic Agents
=550  \\$wh$aDopamine Agents
=550  \\$wh$aExcitatory Amino Acid Agents
=550  \\$wh$aGABA Agents
=550  \\$wh$aGasotransmitters
=550  \\$wh$aGlycine Agents
=550  \\$wh$aHistamine Agents
=550  \\$wh$aNeurokinin-1 Receptor Antagonists
=550  \\$wh$aNeurotransmitter Uptake Inhibitors
=550  \\$wh$aOrexin Receptor Antagonists
=550  \\$wh$aPurinergic Agents
=550  \\$wh$aSerotonin Agents
=550  \\$aNeurotoxins
=667  \\$ageneral; prefer specifics
=680  \\$iSubstances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
=688  \\$a1998; use explode 1995-1997
=688  \\$a98; use explode 1995-97
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20061114: 150:##:_{dollar}a Neurotransmitters
=750  \0$aNeurotransmitters$0(DLC) sh 85091183$5IEN-M

=LDR  01287cz  a2200217n  4500
=001  9880364264802441
=005  20141212212924.0
=008  950629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019016
=035  \\$aCSK6095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x578.$x500
=150  \\$aMineral Fibers
=450  \\$wnnna$aFiber, Mineral
=450  \\$wnnna$aFibers, Mineral
=450  \\$wnnna$aMineral Fiber
=550  \\$wg$aMinerals
=667  \\$arestrict to minerals; emphasis is on the filamentous structure; IM GEN or unspecified only; coord NIM with specific mineral or material (IM), as asbestos fibers = MINERAL FIBERS (NIM) + ASBESTOS (IM); not for textile fibers ( = TEXTILES or specific textile such as COTTON FIBER; WOOL; or NYLON); not for fiberglass ( = GLASS); /adv eff: consider also specific pneumoconioses, such as ASBESTOSIS
=680  \\$iLong, pliable, cohesive natural or manufactured filaments of various lengths. They form the structure of some minerals. The medical significance lies in their potential ability to cause various types of PNEUMOCONIOSIS (e.g., ASBESTOSIS) after occupational or environmental exposure. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p708)
=688  \\$a96
=750  \0$aMetal fibers$5IEN-M$0(DLC)sh 85084055

=LDR  01882cz  a2200433n  4500
=001  9880364264902441
=005  20141212213007.0
=008  950629\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019094
=035  \\$aCSK6093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x630
=072  \\$aE7.$x695.$x190.$x185
=150  \\$aDental Prosthesis, Implant-Supported
=450  \\$wnnna$aDental, Implant-Supported Prosthesis
=450  \\$wnnna$aDental Prostheses, Implant-Supported
=450  \\$wnnna$aDental Prosthesis, Implant Supported
=450  \\$wnnna$aDentals, Implant-Supported Prosthesis
=450  \\$aDenture, Implant-Supported
=450  \\$wnnna$aDenture, Implant Supported
=450  \\$wnnna$aDentures, Implant-Supported
=450  \\$wnnna$aImplant-Supported Dental Prostheses
=450  \\$aImplant-Supported Dental Prosthesis
=450  \\$wnnna$aImplant Supported Dental Prosthesis
=450  \\$wnnna$aImplant-Supported Denture
=450  \\$wnnna$aImplant Supported Denture
=450  \\$wnnna$aImplant-Supported Dentures
=450  \\$wnnna$aImplant-Supported Prosthesis Dental
=450  \\$wnnna$aImplant-Supported Prosthesis Dentals
=450  \\$wnnna$aProstheses, Implant-Supported Dental
=450  \\$wnnna$aProsthesis Dental, Implant-Supported
=450  \\$wnnna$aProsthesis Dental, Implant Supported
=450  \\$wnnna$aProsthesis Dentals, Implant-Supported
=450  \\$wnnna$aProsthesis, Implant-Supported Dental
=550  \\$wg$aDental Prosthesis
=667  \\$aDF: DENT PROSTHESIS IMPLANT SUP
=680  \\$iA prosthesis that gains its support, stability, and retention from a substructure that is implanted under the soft tissues of the basal seat of the device and is in contact with bone. (From Boucher's Clinical Dental Terminology, 4th ed)
=688  \\$a96
=750  \0$aImplant-supported dentures$5IEN-M$0(DLC)sh 97001644

=LDR  01364cz  a2200313n  4500
=001  9880364265102441
=005  20141212212903.0
=008  950616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018969
=035  \\$aCSK6042HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x420
=150  \\$aInsulin-Like Growth Factor Binding Proteins
=450  \\$aIGF-Binding Proteins
=450  \\$wnnna$aIGF Binding Proteins
=450  \\$aIGFBP
=450  \\$aSomatomedin-Binding Proteins
=450  \\$wnnna$aSomatomedin Binding Proteins
=550  \\$wg$aCarrier Proteins
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 1
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 2
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 3
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 4
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 5
=550  \\$wh$aInsulin-Like Growth Factor Binding Protein 6
=667  \\$aGEN or unspecified; prefer specifics; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs
=680  \\$iA family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (Int J Gynaecol Obstet 1992;39(1):3-9)
=688  \\$a2005(1996)
=750  \0$aInsulin-like growth factor-binding proteins$0(DLC) sh 90000055$5IEN-M

=LDR  01091cz  a2200253n  4500
=001  9880364265202441
=005  20141212213016.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019122
=035  \\$aCSK6039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x374
=072  \\$aE2.$x190.$x901.$x455
=072  \\$aF4.$x754.$x137.$x750.$x500
=150  \\$aMeditation
=450  \\$wnnna$aMeditation, Transcendental
=450  \\$aTranscendental Meditation
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aRelaxation Therapy
=550  \\$wg$aSpiritual Therapies
=667  \\$aa relaxation technique
=680  \\$iA state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress. A wide variety of techniques are used to clear the mind of stressful outside interferences. It includes meditation therapy. (Mosby's Medical, Nursing, and Allied Health Dictionary, 4th ed)
=688  \\$a96
=750  \0$aMeditation$0(DLC) sh 85083210$5IEN-M

=LDR  01741cz  a2200337n  4500
=001  9880364265302441
=005  20141212212925.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019018
=035  \\$aCSK6036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x249
=072  \\$aF4.$x754.$x462
=150  \\$aImagery (Psychotherapy)
=450  \\$wnnna$aDirected Reverie Therapies
=450  \\$aDirected Reverie Therapy
=450  \\$aGuided Imagery
=450  \\$wnnna$aImageries (Psychotherapy)
=450  \\$wnnna$aImagery
=450  \\$aImagery, Guided
=450  \\$wnnna$aReverie Therapies, Directed
=450  \\$wnnna$aReverie Therapy, Directed
=450  \\$wnnna$aTherapies, Directed Reverie
=450  \\$wnnna$aTherapy, Directed Reverie
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPsychotherapy
=550  \\$aImagination
=667  \\$aa psychother technique; do not confuse with the imagery or mental images produced by the imagination ( = IMAGINATION); DF: IMAGERY
=680  \\$iThe use of mental images produced by the imagination as a form of psychotherapy. It can be classified by the modality of its content: visual, verbal, auditory, olfactory, tactile, gustatory, or kinesthetic. Common themes derive from nature imagery (e.g., forests and mountains), water imagery (e.g., brooks and oceans), travel imagery, etc. Imagery is used in the treatment of mental disorders and in helping patients cope with other diseases. Imagery often forms a part of HYPNOSIS, of AUTOGENIC TRAINING, of RELAXATION TECHNIQUES, and of BEHAVIOR THERAPY. (From Encyclopedia of Human Behavior, vol. 4, pp29-30, 1994)
=688  \\$a96
=750  \0$aImagery (Psychology)$xTherapeutic use$5IEN-M$0(DLC)sh2008104270

=LDR  01420cz  a2200349n  4500
=001  9880364265402441
=005  20141212192839.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018862
=035  \\$aCSK6022M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x750.$x425
=072  \\$aA8.$x800.$x950.$x750.$x425
=072  \\$aA11.$x436.$x660
=072  \\$aA11.$x671.$x650.$x915.$x750.$x425
=150  \\$aMerkel Cells
=450  \\$wnnna$aCells, Merkel
=450  \\$wnnna$aMerkel Receptor
=450  \\$wnnna$aMerkel Receptors
=450  \\$aMerkel's Receptor
=450  \\$wnnna$aMerkels Receptor
=450  \\$wnnna$aMerkel's Receptors
=450  \\$wnnna$aReceptor, Merkel
=450  \\$wnnna$aReceptor, Merkel's
=450  \\$wnnna$aReceptors, Merkel
=450  \\$wnnna$aReceptors, Merkel's
=450  \\$wnnna$aReceptors, Merkels
=550  \\$wg$aEpithelial Cells
=550  \\$wg$aMechanoreceptors
=680  \\$iModified epidermal cells located in the stratum basale. They are found mostly in areas where sensory perception is acute, such as the fingertips. Merkel cells are closely associated with an expanded terminal bulb of an afferent myelinated nerve fiber. Do not confuse with Merkel's corpuscle which is a combination of a neuron and an epidermal cell.
=688  \\$a96; MERKEL'S RECEPTOR was see MECHANORECEPTORS 1994-95
=750  \0$aMerkel cells$5IEN-M$0(DLC)sh 00000072

=LDR  02294cz  a2200685n  4500
=001  9880364265502441
=005  20141212213242.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019547
=035  \\$aCTL9218NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x576
=072  \\$aC23.$x888.$x592.$x612.$x553
=072  \\$aC23.$x888.$x646.$x501
=150  \\$aNeck Pain
=450  \\$wnnna$aAche, Neck
=450  \\$wnnna$aAches, Neck
=450  \\$wnnna$aAnterior Cervical Pain
=450  \\$wnnna$aAnterior Cervical Pains
=450  \\$wnnna$aAnterior Neck Pain
=450  \\$wnnna$aAnterior Neck Pains
=450  \\$aCervical Pain
=450  \\$wnnna$aCervical Pain, Anterior
=450  \\$wnnna$aCervical Pain, Posterior
=450  \\$wnnna$aCervical Pains
=450  \\$wnnna$aCervical Pains, Anterior
=450  \\$wnnna$aCervical Pains, Posterior
=450  \\$wnnna$aCervicalgia
=450  \\$wnnna$aCervicalgias
=450  \\$wnnna$aCervicodynia
=450  \\$wnnna$aCervicodynias
=450  \\$wnnna$aNeck Ache
=450  \\$wnnna$aNeck Aches
=450  \\$wnnna$aNeck Pain, Anterior
=450  \\$wnnna$aNeck Pain, Posterior
=450  \\$wnnna$aNeck Pains
=450  \\$wnnna$aNeck Pains, Anterior
=450  \\$wnnna$aNeck Pains, Posterior
=450  \\$aNeckache
=450  \\$wnnna$aNeckaches
=450  \\$wnnna$aPain, Anterior Cervical
=450  \\$wnnna$aPain, Anterior Neck
=450  \\$wnnna$aPain, Cervical
=450  \\$wnnna$aPain, Neck
=450  \\$wnnna$aPain, Posterior Cervical
=450  \\$wnnna$aPain, Posterior Neck
=450  \\$wnnna$aPains, Anterior Cervical
=450  \\$wnnna$aPains, Anterior Neck
=450  \\$wnnna$aPains, Cervical
=450  \\$wnnna$aPains, Neck
=450  \\$wnnna$aPains, Posterior Cervical
=450  \\$wnnna$aPains, Posterior Neck
=450  \\$wnnna$aPosterior Cervical Pain
=450  \\$wnnna$aPosterior Cervical Pains
=450  \\$wnnna$aPosterior Neck Pain
=450  \\$wnnna$aPosterior Neck Pains
=550  \\$wg$aPain
=680  \\$iDiscomfort or more intense forms of pain that are localized to the cervical region. This term generally refers to pain in the posterior or lateral regions of the neck.
=688  \\$a1997
=750  \0$aNeck pain$5IEN-M$0(DLC)sh 85090564

=LDR  01008cz  a2200205n  4500
=001  9880364265602441
=005  20141212212827.0
=008  950606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018868
=035  \\$aCSK6020HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x300
=150  \\$aInsurance, Disability
=450  \\$aDisability Insurance
=550  \\$wg$aInsurance
=550  \\$wh$aWorkers' Compensation
=667  \\$aIM; coord with specific disability if pertinent (IM); specific geog if possible
=680  \\$iInsurance designed to compensate persons who lose wages because of illness or injury; insurance providing periodic payments that partially replace lost wages, salary, or other income when the insured is unable to work because of illness, injury, or disease. Individual and group disability insurance are two types of such coverage. (From Facts on File Dictionary of Health Care Management, 1988, p207)
=688  \\$a96
=750  \0$aDisability insurance$5IEN-M$0(DLC)sh 85066881

=LDR  00865cz  a2200241n  4500
=001  9880364265702441
=005  20141212213044.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019193
=035  \\$aCTL9186M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x715.$x750.$x900
=072  \\$aB4.$x820.$x750.$x900
=150  \\$aWaikavirus
=450  \\$aAnthriscus yellow virus
=450  \\$aMaize chlorotic dwarf virus
=450  \\$aRice tungro spherical virus
=450  \\$wnnna$aWaikaviruses
=550  \\$wg$aSequiviridae
=667  \\$acoord IM with specific plant (often RICE) /virol
=680  \\$iA genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by leafhoppers or APHIDS and depends on a self-encoded helper protein. The type species is Rice tungro spherical virus.
=688  \\$a97
=750  \0$aWaikaviruses$0(DLC)sh2007002924$5IEN-M

=LDR  00743cz  a2200229n  4500
=001  9880364265802441
=005  20141212213020.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019143
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x44.$x250
=072  \\$aG16.$x100.$x178.$x250
=150  \\$aEvolution, Molecular
=450  \\$wnnna$aEvolution, Genetic
=450  \\$wnnna$aGenetic Evolution
=450  \\$aMolecular Evolution
=550  \\$wg$aBiological Evolution
=550  \\$wh$aMutation Rate
=550  \\$aDirected Molecular Evolution
=680  \\$iThe process of cumulative change at the level of DNA; RNA; and PROTEINS, over successive generations.
=688  \\$a96
=750  \0$aMolecular evolution$5IEN-M$0(DLC)sh 85022912

=LDR  01062cz  a2200301n  4500
=001  9880364265902441
=005  20170620112020.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019069
=035  \\$aCSK6009HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x197
=072  \\$aG4.$x270
=150  \\$aCell Respiration
=450  \\$wnnna$aCell Respirations
=450  \\$aCellular Respiration
=450  \\$wnnna$aCellular Respirations
=450  \\$aRespiration, Cell
=450  \\$wnnna$aRespiration, Cellular
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wg$aMetabolism
=550  \\$wh$aCell Hypoxia
=550  \\$wh$aRespiratory Burst
=550  \\$aRespiration
=667  \\$aNIM; not for micro-organisms; for plant resp, coord NIM with PLANTS /metab (IM) or specific plant /metab (IM); CELL HYPOXIA is also available
=680  \\$iThe metabolic process of all living cells (animal and plant) in which oxygen is used to provide a source of energy for the cell.
=688  \\$a96
=750  \0$aCell respiration$5IEN-M$0(DLC)sh 85021667

=LDR  01748cz  a2200361n  4500
=001  9880364266002441
=005  20141212213122.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019265
=035  \\$aCTL9181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x750
=072  \\$aE5.$x196.$x867.$x851
=150  \\$aSpectroscopy, Near-Infrared
=450  \\$wnnna$aNear-Infrared Spectrometries
=450  \\$wnnna$aNear-Infrared Spectrometry
=450  \\$wnnna$aNear-Infrared Spectroscopies
=450  \\$wnnna$aNear-Infrared Spectroscopy
=450  \\$wnnna$aNIR Spectroscopies
=450  \\$aNIR Spectroscopy
=450  \\$wnnna$aSpectrometries, Near-Infrared
=450  \\$aSpectrometry, Near-Infrared
=450  \\$wnnna$aSpectrometry, Near Infrared
=450  \\$wnnna$aSpectroscopies, Near-Infrared
=450  \\$wnnna$aSpectroscopies, NIR
=450  \\$wnnna$aSpectroscopy, Near Infrared
=450  \\$wnnna$aSpectroscopy, NIR
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aSpectrum Analysis
=667  \\$aa type of spectrum anal; DF: note short X ref
=680  \\$iA noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light (NIR) can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.
=688  \\$a97
=750  \0$aNear infrared spectroscopy$5IEN-M$0(DLC)sh 88002315

=LDR  00796cz  a2200217n  4500
=001  9880364266102441
=005  20141212213020.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019142
=035  \\$aCSK6000HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x417.$x415
=072  \\$aC2.$x782.$x580.$x250.$x400
=150  \\$aHemorrhagic Fever, Ebola
=450  \\$aEbola Hemorrhagic Fever
=450  \\$aEbola Virus Disease
=550  \\$wg$aFiloviridae Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=680  \\$iA highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.
=688  \\$a96
=750  \0$aEbola virus disease$5IEN-M$0(DLC)sh 85040654

=LDR  01066cz  a2200301n  4500
=001  9880364266202441
=005  20141212213151.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x165
=072  \\$aD10.$x251.$x400.$x45.$x500
=150  \\$aAcetic Acid
=450  \\$wnnna$aAcetic Acid Glacial
=450  \\$wnnna$aAcetic Acid, Glacial
=450  \\$wnnna$aAcid, Acetic
=450  \\$wnnna$aAcid Glacial, Acetic
=450  \\$wnnna$aAcid, Glacial Acetic
=450  \\$aGlacial Acetic Acid
=450  \\$wnnna$aGlacial, Acetic Acid
=450  \\$aVinegar
=550  \\$wg$aAcetates
=550  \\$wh$aPotassium Acetate
=550  \\$wh$aSodium Acetate
=550  \\$wh$aZinc Acetate
=680  \\$iProduct of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
=688  \\$a97; was ACETIC ACID GLACIAL (NM) 1981-96
=750  \0$aAcetic acid$5IEN-M$0(DLC)sh 85000460

=LDR  01191cz  a2200337n  4500
=001  9880364266302441
=005  20141212213012.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019110
=035  \\$aCSK5998HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x60.$x249.$x500
=150  \\$aMeteoroids
=450  \\$wnnna$aCarbonaceous Chondrite
=450  \\$aCarbonaceous Chondrites
=450  \\$wnnna$aChondrite
=450  \\$wnnna$aChondrite, Carbonaceous
=450  \\$wnnna$aChondrites
=450  \\$wnnna$aChondrites, Carbonaceous
=450  \\$wnnna$aComet (Astronomy)
=450  \\$aComets (Astronomy)
=450  \\$wnnna$aMeteor
=450  \\$wnnna$aMeteorite
=450  \\$aMeteorites
=450  \\$wnnna$aMeteoroid
=450  \\$aMeteors
=550  \\$wg$aAstronomical Objects
=667  \\$ano qualif
=680  \\$iAny solid objects moving in interplanetary space that are smaller than a planet or asteroid but larger than a molecule. Meteorites are any meteoroid that has fallen to a planetary surface. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a96; was see SOLAR SYSTEM 1995
=750  \0$aMeteoroids$5IEN-M$0(DLC)sh 87007639

=LDR  01360cz  a2200301n  4500
=001  9880364266402441
=005  20141212213142.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019317
=035  \\$aCTL9177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x249.$x750
=072  \\$aH2.$x403.$x200.$x400
=150  \\$aEvidence-Based Medicine
=450  \\$wnnna$aEvidence Based Medicine
=450  \\$aMedicine, Evidence-Based
=450  \\$wnnna$aMedicine, Evidence Based
=550  \\$wg$aClinical Medicine
=550  \\$wg$aEvidence-Based Practice
=550  \\$wh$aEvidence-Based Emergency Medicine
=550  \\$aClinical Medicine
=550  \\$aDecision Support Techniques
=550  \\$aEvidence-Based Dentistry
=550  \\$aEvidence-Based Nursing
=667  \\$aDF: EVIDENCE BASED MED
=680  \\$iAn approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006)
=688  \\$a97
=750  \0$aEvidence-based medicine$5IEN-M$0(DLC)sh 97007984

=LDR  00723cz  a2200229n  4500
=001  9880364266502441
=005  20141212213141.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019315
=035  \\$aCTL9176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x675.$x700
=072  \\$aC23.$x550.$x414.$x960
=150  \\$aRetrobulbar Hemorrhage
=450  \\$aHemorrhage, Retrobulbar
=450  \\$wnnna$aRetrobulbar Hemorrhages
=550  \\$wg$aHemorrhage
=550  \\$wg$aOrbital Diseases
=667  \\$ado not confuse with EYE HEMORRHAGE or its specifics, hemorrh of eye tissue
=680  \\$iHemorrhage within the orbital cavity, posterior to the eyeball.
=688  \\$a97
=750  \0$aEye-sockets$xHemorrhage$5IEN-M

=LDR  01110cz  a2200325n  4500
=001  9880364266602441
=005  20141212212950.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019064
=035  \\$aCSK5996HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x761
=150  \\$aProduct Packaging
=450  \\$wnnna$aContainer, Product
=450  \\$wnnna$aContainers, Product
=450  \\$wnnna$aPackaging
=450  \\$aPackaging, Product
=450  \\$wnnna$aPackagings
=450  \\$wnnna$aPackagings, Product
=450  \\$wnnna$aProduct Container
=450  \\$aProduct Containers
=450  \\$wnnna$aProduct Packagings
=550  \\$wg$aIndustry
=550  \\$wh$aDrug Packaging
=550  \\$wh$aFood Packaging
=550  \\$wh$aProduct Labeling
=667  \\$aincludes containers, packaging methods, packaging materials; IM; coord with specific product (IM); FOOD PACKAGING & DRUG PACKAGING are also available
=680  \\$iForm in which product is processed or wrapped and labeled. PRODUCT LABELING is also available.
=688  \\$a96
=750  \0$aPackaging$5IEN-M$0(DLC)sh 85096514

=LDR  01258cz  a2200169n  4500
=001  9880364266702441
=005  20141212213152.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019348
=035  \\$aCTL9175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x752.$x667.$x400
=150  \\$aEmpiricism
=550  \\$wg$aPhilosophy, Medical
=680  \\$iOne of the principal schools of medical philosophy in ancient Greece and Rome. It developed in Alexandria between 270 and 220 B.C., the only one to have any success in reviving the essentials of the Hippocratic concept. The Empiricists declared that the search for ultimate causes of phenomena was vain, but they were active in endeavoring to discover immediate causes. The "tripod of the Empirics" was their own chance observations (experience), learning obtained from contemporaries and predecessors (experience of others), and, in the case of new diseases, the formation of conclusions from other diseases which they resembled (analogy). Empiricism enjoyed sporadic continuing popularity in later centuries up to the nineteenth. (From Castiglioni, A History of Medicine, 2d ed, p186; Dr. James H. Cassedy, NLM History of Medicine Division)
=688  \\$a97
=750  \0$aEmpiricism$5IEN-M$0(DLC)sh 85042851

=LDR  01090cz  a2200229n  4500
=001  9880364307302441
=005  20141212215044.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x920.$x777
=150  \\$aStyrax
=450  \\$wnnna$abenzoide, Styrax
=450  \\$wnnna$abenzoides, Styrax
=450  \\$wnnna$aStyrax benzoide
=450  \\$wnnna$aStyrax benzoides
=450  \\$wnnna$aStyraxs
=550  \\$wg$aStyracaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family STYRACACEAE. Sap of these Asian trees are a source of a balsam (BALSAMS). This styrax balsam is 3/4 coniferyl benzoate, 1/8 free BENZOIC ACID, along with benzyl cinnamate, vanillin, and TRITERPENES.
=688  \\$a2003
=750  \0$aStyrax$5IEN-M$0(DLC)sh 88023139

=LDR  01192cz  a2200241n  4500
=001  9880364307402441
=005  20200929171840.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x915.$x583
=150  \\$aSterculia
=450  \\$aKaraya
=450  \\$wnnna$aKarayas
=450  \\$wnnna$aSterculia uren
=450  \\$wnnna$aSterculia urens
=450  \\$wnnna$aSterculias
=450  \\$wnnna$auren, Sterculia
=450  \\$wnnna$aurens, Sterculia
=667  \\$asource of TRAGACANTH, INDIAN see KARAYA GUM; source of true tragacanth is ASTRAGALUS GUMMIFER; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family STERCULIACEAE. S. urens is the source of KARAYA GUM which is sometimes called Indian tragacanth, which is different from the true TRAGACANTH which comes from ASTRAGALUS GUMMIFER.
=688  \\$a2003
=750  \0$aSterculia$5IEN-M$0(DLC)sh 85127993

=LDR  01158cz  a2200313n  4500
=001  9880364307502441
=005  20141212215043.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x620
=150  \\$aMuscle Cells
=450  \\$wnnna$aMature Muscle Cell
=450  \\$wnnna$aMature Muscle Cells
=450  \\$wnnna$aMuscle Cell
=450  \\$wnnna$aMuscle Cell, Mature
=450  \\$aMuscle Cells, Mature
=450  \\$wnnna$aMyocyte
=450  \\$aMyocytes
=550  \\$wg$aCells
=550  \\$wh$aInterstitial Cells of Cajal
=550  \\$wh$aMuscle Fibers, Skeletal
=550  \\$wh$aMyocytes, Cardiac
=550  \\$wh$aMyocytes, Smooth Muscle
=550  \\$aMyoblasts
=667  \\$aprefer specifics
=680  \\$iMature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.
=688  \\$a2003
=750  \0$aMuscle Cells$5IEN-M$0(DLC)sh 85088676

=LDR  01010cz  a2200229n  4500
=001  9880364307602441
=005  20141212215043.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x950
=150  \\$aWithania
=450  \\$wnnna$asomnifera, Withania
=450  \\$wnnna$asomniferas, Withania
=450  \\$wnnna$aWithania somnifera
=450  \\$wnnna$aWithania somniferas
=450  \\$wnnna$aWithanias
=550  \\$wg$aSolanaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family SOLANACEAE. Members contain withanolides. Withania somnifera is the source of ashwagandha and aswal.
=688  \\$a2003
=750  \0$aWithania$0(DLC) sh 85147154$5IEN-M

=LDR  01050cz  a2200253n  4500
=001  9880364307702441
=005  20141212215042.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D032324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x725.$x699
=150  \\$aSolanum nigrum
=450  \\$aBlack Nightshade
=450  \\$wnnna$aBlack Nightshades
=450  \\$aNightshade, Black
=450  \\$wnnna$aNightshades, Black
=450  \\$wnnna$anigrum, Solanum
=450  \\$wnnna$anigrums, Solanum
=450  \\$wnnna$aSolanum nigrums
=550  \\$wg$aSolanum
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the genus SOLANUM, family SOLANACEAE that contains steroidal glycosides.
=688  \\$a2003
=750  \0$aSolanum nigrum$5IEN-M$0(DLC)sh 85124480

=LDR  01025cz  a2200253n  4500
=001  9880364307802441
=005  20141212214954.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x744
=150  \\$aPaspalum
=450  \\$aBahiagrass
=450  \\$wnnna$aBahiagrasses
=450  \\$wnnna$aKodo Millet
=450  \\$wnnna$aKodo Millets
=450  \\$aMillet, Kodo
=450  \\$wnnna$aMillets, Kodo
=450  \\$wnnna$aPaspalums
=550  \\$wg$aPoaceae
=667  \\$aX ref MILLET, KODO: other millet terms are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that is used for forage.
=688  \\$a2003
=750  \0$aPaspalum$5IEN-M$0(DLC)sh 85098445

=LDR  00818cz  a2200193n  4500
=001  9880364307902441
=005  20141212214954.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031752
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x463
=150  \\$aHolcus
=450  \\$aVelvetgrass
=450  \\$wnnna$aVelvetgrasses
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that contains Hol l 1 and Hol l 5 allergens.
=688  \\$a2003
=750  \0$aHolcus$5IEN-M$0(DLC)sh 88022837

=LDR  00807cz  a2200181n  4500
=001  9880364308002441
=005  20141212214954.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031751
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x427
=150  \\$aFestuca
=450  \\$wnnna$aFestucas
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The common name of fescue is also used with some other grasses.
=688  \\$a2003
=750  \0$aFescue$0(DLC) sh 85047923$5IEN-M

=LDR  00779cz  a2200205n  4500
=001  9880364308102441
=005  20141212214953.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031750
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x355
=150  \\$aEragrostis
=450  \\$wnnna$aEragrosti
=450  \\$aTeff
=450  \\$wnnna$aTeffs
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE.
=688  \\$a2003
=750  \2$aLove grass$5IEN

=LDR  00770cz  a2200169n  4500
=001  9880364308202441
=005  20141212214953.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031749
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x344
=150  \\$aElymus
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The common name of wildrye is used with some other grasses.
=688  \\$a2003
=750  \0$aElymus$5IEN-M$0(DLC)sh 88022766

=LDR  01774cz  a2200481n  4500
=001  9880364308302441
=005  20141212214953.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031748
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x333
=150  \\$aEleusine
=450  \\$wnnna$acoracana, Eleusine
=450  \\$wnnna$acoracanas, Eleusine
=450  \\$wnnna$aEleusine coracana
=450  \\$wnnna$aEleusine coracanas
=450  \\$wnnna$aEleusine indica
=450  \\$wnnna$aEleusine indicas
=450  \\$wnnna$aEleusines
=450  \\$wnnna$aFinger Millet
=450  \\$wnnna$aFinger Millet, Indian
=450  \\$wnnna$aFinger Millets
=450  \\$wnnna$aGoose Grass
=450  \\$wnnna$aGoose Grasses
=450  \\$aGoosegrass
=450  \\$wnnna$aGoosegrasses
=450  \\$aGrass, Goose
=450  \\$wnnna$aGrasses, Goose
=450  \\$aIndian Finger Millet
=450  \\$wnnna$aindica, Eleusine
=450  \\$wnnna$aindicas, Eleusine
=450  \\$wnnna$aKoracan Millet
=450  \\$wnnna$aKoracan Millets
=450  \\$aMillet, Finger
=450  \\$aMillet, Indian Finger
=450  \\$aMillet, Koracan
=450  \\$wnnna$aMillets, Finger
=450  \\$wnnna$aMillets, Koracan
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. Finger millet or raggee (E. coracana) is an important food grain in southern Asia and parts of Africa.
=688  \\$a2003
=750  \0$aEleusine$5IEN-M$0(DLC)sh 96009668

=LDR  01386cz  a2200373n  4500
=001  9880364308402441
=005  20141212214952.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031747
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x322
=150  \\$aEchinochloa
=450  \\$wnnna$aBarnyard Grass
=450  \\$wnnna$aBarnyard Grasses
=450  \\$wnnna$aBarnyard Millet
=450  \\$wnnna$aBarnyard Millets
=450  \\$wnnna$aCockspur Grass
=450  \\$wnnna$aCockspur Grasses
=450  \\$wnnna$aEchinochloas
=450  \\$aGrass, Barnyard
=450  \\$aGrass, Cockspur
=450  \\$wnnna$aGrasses, Barnyard
=450  \\$wnnna$aGrasses, Cockspur
=450  \\$wnnna$aJapanese Millet
=450  \\$wnnna$aJapanese Millets
=450  \\$aMillet, Barnyard
=450  \\$aMillet, Japanese
=450  \\$wnnna$aMillets, Barnyard
=450  \\$wnnna$aMillets, Japanese
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that is grown mainly as a hay crop.
=688  \\$a2003
=750  \0$aEchinochloa$5IEN-M$0(DLC)sh 88022756

=LDR  00978cz  a2200253n  4500
=001  9880364308502441
=005  20141212214952.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031746
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x311
=150  \\$aDigitaria
=450  \\$wnnna$aCrab Grass
=450  \\$wnnna$aCrab Grasses
=450  \\$aCrabgrass
=450  \\$wnnna$aCrabgrasses
=450  \\$wnnna$aDigitarias
=450  \\$aGrass, Crab
=450  \\$wnnna$aGrasses, Crab
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that many people consider to be a weed.
=688  \\$a2003
=750  \0$aCrabgrass$5IEN$0(DLC)sh 85033699

=LDR  00985cz  a2200253n  4500
=001  9880364308602441
=005  20141212214951.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031745
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x299
=150  \\$aDactylis
=450  \\$wnnna$aDactyli
=450  \\$aGrass, Orchard
=450  \\$wnnna$aGrasses, Orchard
=450  \\$wnnna$aOrchard Grass
=450  \\$wnnna$aOrchard Grasses
=450  \\$aOrchardgrass
=450  \\$wnnna$aOrchardgrasses
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that contains allergen Dac g I.
=688  \\$a2003
=750  \0$aDactylis$5IEN-M$0(DLC)sh 87006510

=LDR  01043cz  a2200253n  4500
=001  9880364308702441
=005  20141212214951.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031744
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x288
=150  \\$aCynodon
=450  \\$wnnna$aBermuda Grass
=450  \\$wnnna$aBermuda Grasses
=450  \\$aBermudagrass
=450  \\$wnnna$aBermudagrasses
=450  \\$wnnna$aCynodons
=450  \\$aGrass, Bermuda
=450  \\$wnnna$aGrasses, Bermuda
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE that is considered a lawngrass by some and a weed by others. It contains allergen Cyn d 7.
=688  \\$a2003
=750  \0$aCynodon$5IEN-M$0(DLC)sh 88022730

=LDR  01235cz  a2200325n  4500
=001  9880364308802441
=005  20141212214951.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031743
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x266
=150  \\$aCymbopogon
=450  \\$wnnna$aAndropogon nardus
=450  \\$aCitronella
=450  \\$wnnna$aCitronellas
=450  \\$wnnna$aCymbopogon nardus
=450  \\$wnnna$aCymbopogons
=450  \\$wnnna$aGrass, Lemon
=450  \\$wnnna$aGrasses, Lemon
=450  \\$wnnna$aLemon Grass
=450  \\$wnnna$aLemon Grasses
=450  \\$aLemongrass
=450  \\$wnnna$aLemongrasses
=450  \\$wnnna$anardus, Andropogon
=450  \\$wnnna$anardus, Cymbopogon
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE which is a source of citronella oil and lemongrass oil.
=688  \\$a2003
=750  \0$aCymbopogon$0(DLC) sh 85035146$5IEN-M

=LDR  01520cz  a2200409n  4500
=001  9880364308902441
=005  20141212214950.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x227
=150  \\$aCoix
=450  \\$aAdlay Seed Plant
=450  \\$wnnna$aAdlay Seed Plants
=450  \\$wnnna$aCoices
=450  \\$wnnna$aCoicis Semen
=450  \\$wnnna$aCoicis Semens
=450  \\$wnnna$aCoix lachryma-jobi
=450  \\$wnnna$aCoix lachryma jobi
=450  \\$wnnna$aCoix lachryma-jobus
=450  \\$wnnna$aJob Tears
=450  \\$aJob's Tears
=450  \\$wnnna$aJobs Tears
=450  \\$wnnna$alachryma-jobi, Coix
=450  \\$wnnna$alachryma-jobus, Coix
=450  \\$wnnna$aPlant, Adlay Seed
=450  \\$wnnna$aPlants, Adlay Seed
=450  \\$wnnna$aSeed Plant, Adlay
=450  \\$wnnna$aSeed Plants, Adlay
=450  \\$wnnna$aSemen, Coicis
=450  \\$wnnna$aSemens, Coicis
=450  \\$wnnna$aTears, Job's
=550  \\$wg$aPoaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The seed is used in folk medicine (DRUGS, CHINESE HERBAL).
=688  \\$a2003
=750  \0$aCoix$5IEN-M$0(DLC)sh 88022689

=LDR  00829cz  a2200193n  4500
=001  9880364309002441
=005  20141212214950.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x151
=150  \\$aCenchrus
=450  \\$aSandbur
=450  \\$wnnna$aSandburs
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The common name of buffelgrass is also used for PENNISETUM.
=688  \\$a2003
=750  \0$aCenchrus$5IEN-M$0(DLC)sh 87006620

=LDR  01010cz  a2200217n  4500
=001  9880364309102441
=005  20141212214949.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031724
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x77
=150  \\$aBromus
=450  \\$aBrome
=450  \\$aBromegrass
=450  \\$wnnna$aBromegrasses
=450  \\$wnnna$aBromes
=550  \\$wg$aPoaceae
=667  \\$ado not confuse with Broom terms in MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The name is similar to Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM).
=688  \\$a2003
=750  \0$aBromegrasses$0(DLC) sh 85017045$5IEN-M

=LDR  00967cz  a2200181n  4500
=001  9880364309202441
=005  20141212214949.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x66
=150  \\$aBambusa
=450  \\$wnnna$aBambusas
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. Young shoots are eaten in Asian foods while the stiff mature stems are used for construction of many things. The common name of bamboo is also used for other genera of Poaceae including Phyllostachys, SASA, and Dendrocalamus.
=688  \\$a2003
=750  \0$aBambusa$0(DLC)sh2007003075$5IEN

=LDR  01033cz  a2200181n  4500
=001  9880364309302441
=005  20141212214949.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x55
=150  \\$aAndropogon
=450  \\$wnnna$aAndropogons
=550  \\$wg$aPoaceae
=667  \\$aANDROPOGON NARDUS see CYMBOPOGON and ANDROPOGON ZIZANIOIDES see VETIVERIA are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The common name of bluestem is also used for other plants in this family. Andropogon nardus has been reclassified as CYMBOPOGON nardus and Andropogon zizanioides to VETIVERIA zizanioides.
=688  \\$a2003
=750  \0$aAndropogon$5IEN-M$0(DLC)sh 88022549

=LDR  01087cz  a2200205n  4500
=001  9880364309402441
=005  20141212214948.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031721
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812.$x666.$x374
=150  \\$aPiper betle
=450  \\$wnnna$abetle, Piper
=450  \\$wnnna$abetles, Piper
=450  \\$wnnna$aPiper betles
=550  \\$wg$aPiper
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PIPERACEAE that is indigenous in the Indian Malay region and cultivated in Madagascar, and the West Indies. It contains chavibetol, chavicol and cadinene. The leaf is chewed as a stimulant, antiseptic and sialogogue. The common name of betel is also used for ARECA.
=688  \\$a2003
=750  \0$aPiper betle$5IEN-M$0(DLC)sh 85102393

=LDR  00803cz  a2200205n  4500
=001  9880364309502441
=005  20141212214948.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x44
=150  \\$aAgrostis
=450  \\$wnnna$aAgrosti
=450  \\$aBentgrass
=450  \\$wnnna$aBentgrasses
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE.
=688  \\$a2003
=750  \0$aAgrostis$5IEN-M$0(DLC)sh 99011626

=LDR  00826cz  a2200181n  4500
=001  9880364309602441
=005  20141212214948.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031702
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x33
=150  \\$aAgropyron
=450  \\$wnnna$aAgropyrons
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE. The common name of wheatgrass is also used for other plants in the family.
=688  \\$a2003
=750  \0$aWheatgrasses$5IEN-M$0(DLC)sh 88022532

=LDR  01800cz  a2200505n  4500
=001  9880364309702441
=005  20141212214948.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812.$x666
=150  \\$aPiper
=450  \\$wnnna$aAshanti Pepper
=450  \\$wnnna$aAshanti Peppers
=450  \\$aCubeb Pepper
=450  \\$wnnna$aCubeb Peppers
=450  \\$wnnna$acubeba, Piper
=450  \\$wnnna$acubebas, Piper
=450  \\$wnnna$aguineense, Piper
=450  \\$wnnna$aguineenses, Piper
=450  \\$wnnna$aJaborandi Pepper
=450  \\$wnnna$aJaborandi Peppers
=450  \\$wnnna$alongum, Piper
=450  \\$wnnna$alongums, Piper
=450  \\$aPepper, Ashanti
=450  \\$aPepper, Cubeb
=450  \\$aPepper, Jaborandi
=450  \\$wnnna$aPeppers, Ashanti
=450  \\$wnnna$aPeppers, Cubeb
=450  \\$wnnna$aPeppers, Jaborandi
=450  \\$wnnna$aPiper cubeba
=450  \\$wnnna$aPiper cubebas
=450  \\$wnnna$aPiper guineense
=450  \\$wnnna$aPiper guineenses
=450  \\$wnnna$aPiper longum
=450  \\$wnnna$aPiper longums
=450  \\$wnnna$aPipers
=550  \\$wg$aPiperaceae
=550  \\$wh$aKava
=550  \\$wh$aPiper betle
=550  \\$wh$aPiper nigrum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.
=688  \\$a2003
=750  \0$aPiper (Genus)$5IEN-M$0(DLC)sh 85102391

=LDR  00866cz  a2200205n  4500
=001  9880364309802441
=005  20141212214947.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x853
=150  \\$aTagetes
=450  \\$wnnna$aPericon
=450  \\$wnnna$aPericons
=450  \\$wnnna$aTagete
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The common name of marigold is also used for CALENDULA.
=688  \\$a2003
=750  \0$aMarigolds$5IEN-M$0(DLC)sh 85081088

=LDR  00857cz  a2200205n  4500
=001  9880364309902441
=005  20141212214947.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x806.$x750
=150  \\$aSesamum
=450  \\$aSesame
=450  \\$wnnna$aSesames
=450  \\$wnnna$aSesamums
=550  \\$wg$aPedaliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PEDALIACEAE that is the source of the edible seed and SESAME OIL.
=688  \\$a2003
=750  \0$aSesamum$5IEN-M$0(DLC)sh 85120373

=LDR  01316cz  a2200325n  4500
=001  9880364310002441
=005  20141212214946.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031684
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x806.$x500
=150  \\$aHarpagophytum
=450  \\$wnnna$aClaw, Devils
=450  \\$wnnna$aClaws, Devils
=450  \\$aDevils Claw
=450  \\$wnnna$aDevils Claws
=450  \\$wnnna$aHarpagophytum procumben
=450  \\$wnnna$aHarpagophytum procumbens
=450  \\$wnnna$aHarpagophytums
=450  \\$wnnna$aprocumben, Harpagophytum
=450  \\$wnnna$aprocumben, Uncaria
=450  \\$wnnna$aprocumbens, Harpagophytum
=450  \\$wnnna$aprocumbens, Uncaria
=450  \\$wnnna$aUncaria procumben
=450  \\$aUncaria procumbens
=550  \\$wg$aPedaliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PEDALIACEAE. Members contain harpagoside and are the source of extract WS 1531.
=688  \\$a2003
=750  \0$aHarpagophytum$5IEN-M$0(DLC)sh 90002770

=LDR  01075cz  a2200181n  4500
=001  9880364310102441
=005  20141212214946.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031683
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x803
=150  \\$aPassifloraceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aPassiflora
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida that are herbaceous or woody vines, shrubs, and trees, mostly of warm regions. Many have tendrils in leaf axils. Leaves are alternate. Flowers have 3-5 sepals, petals and stamens. Nearly all species have seeds that bear a fleshy appendage called an aril.
=688  \\$a2003
=750  \0$aPassifloraceae$5IEN-M$0(DLC)sh 85098514

=LDR  01354cz  a2200325n  4500
=001  9880364310202441
=005  20141212214945.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795.$x750
=150  \\$aSanguinaria
=450  \\$aBloodroot
=450  \\$wnnna$aBloodroots
=450  \\$wnnna$acanadenses, Sanguinaria
=450  \\$wnnna$acanadensis, Sanguinaria
=450  \\$wnnna$aPuccoon, Red
=450  \\$wnnna$aPuccoons, Red
=450  \\$wnnna$aRed Puccoon
=450  \\$wnnna$aRed Puccoons
=450  \\$wnnna$aRedroot
=450  \\$wnnna$aRedroots
=450  \\$wnnna$aSanguinaria canadenses
=450  \\$wnnna$aSanguinaria canadensis
=450  \\$wnnna$aSanguinarias
=550  \\$wg$aPapaveraceae
=667  \\$aX ref REDROOT: REDROOT PIGWEED see AMARANTHUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PAPAVERACEAE. S. canadensis is the source of sanguinarine extract used in MOUTHWASHES.
=688  \\$a2003
=750  \0$aSanguinaria (Genus)$0(DLC)sh2006020023$5IEN-M

=LDR  01163cz  a2200277n  4500
=001  9880364310302441
=005  20141212214945.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031675
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795.$x374
=150  \\$aEschscholzia
=450  \\$wnnna$aCalifornia Poppies
=450  \\$wnnna$aCalifornia Poppy
=450  \\$wnnna$acalifornica, Eschscholzia
=450  \\$wnnna$acalifornicas, Eschscholzia
=450  \\$wnnna$aEschscholzia californica
=450  \\$wnnna$aEschscholzia californicas
=450  \\$wnnna$aEschscholzias
=450  \\$wnnna$aPoppies, California
=450  \\$aPoppy, California
=550  \\$wg$aPapaveraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PAPAVERACEAE that contains benzo[c]phenanthridine alkaloids.
=688  \\$a2003
=750  \0$aEschscholzia$5IEN-M$0(DLC)sh 85044802

=LDR  01095cz  a2200277n  4500
=001  9880364310402441
=005  20141212214945.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031674
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x795.$x124
=150  \\$aArgemone
=450  \\$wnnna$aArgemone mexicana
=450  \\$wnnna$aArgemone mexicanas
=450  \\$wnnna$aArgemones
=450  \\$wnnna$amexicana, Argemone
=450  \\$wnnna$amexicanas, Argemone
=450  \\$wnnna$aPoppies, Prickly
=450  \\$aPoppy, Prickly
=450  \\$wnnna$aPrickly Poppies
=450  \\$aPrickly Poppy
=550  \\$wg$aPapaveraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PAPAVERACEAE that contains isoquinoline alkaloids.
=688  \\$a2003
=750  \0$aArgemone$5IEN-M$0(DLC)sh 88022566

=LDR  00823cz  a2200181n  4500
=001  9880364310502441
=005  20141212214944.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031673
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x792
=150  \\$aPandanaceae
=450  \\$aPandanus
=550  \\$wg$aAngiosperms
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Pandanales, subclass Arecidae, class Liliopsida (monocotyledons).
=688  \\$a2003
=750  \0$aPandanaceae$5IEN-M$0(DLC)sh 85097393

=LDR  01267cz  a2200253n  4500
=001  9880364310602441
=005  20141212214944.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x788.$x750
=150  \\$aOrobanche
=450  \\$aBroom Rape
=450  \\$wnnna$aBroom Rapes
=450  \\$aBroomrape
=450  \\$wnnna$aBroomrapes
=450  \\$wnnna$aOrobanches
=450  \\$wnnna$aRape, Broom
=450  \\$wnnna$aRapes, Broom
=550  \\$wg$aOrobanchaceae
=667  \\$aX ref BROOM RAPE: several other Broom terms are also available; check text and MeSH; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OROBANCHACEAE. Lacking chlorophyll, they are nonphotosynthetic parasitic plants. The common name is similar to Broom or Scotch Broom (CYTISUS) or Butcher's Broom (RUSCUS) or Desert Broom (BACCHARIS) or Spanish Broom (SPARTIUM) or Brome (BROMUS).
=688  \\$a2003
=750  \0$aBroomrapes$5IEN-M$0(DLC)sh 88022957

=LDR  00701cz  a2200253n  4500
=001  9880364310702441
=005  20161117134917.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031670
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x583.$x670
=150  \\$aOrobanchaceae
=450  \\$aCastilleja
=450  \\$aIndian Paintbrush
=450  \\$aPaintbrush, Indian
=550  \\$wg$aLamiales
=550  \\$wh$aCistanche
=550  \\$wh$aEuphrasia
=550  \\$wh$aOrobanche
=550  \\$wh$aPedicularis
=550  \\$wh$aStriga
=680  \\$iThe broom-rape plant family of the order Lamiales.
=688  \\$a2003
=750  \0$aOrobanchaceae$5IEN-M$0(DLC)sh 85095732

=LDR  00843cz  a2200181n  4500
=001  9880364310802441
=005  20141212214943.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031669
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x787.$x888
=150  \\$aVanilla
=450  \\$wnnna$aVanillas
=550  \\$wg$aOrchidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines (FLAVORING AGENTS).
=688  \\$a2003
=750  \0$aVanilla$5IEN-M$0(DLC)sh 85142052

=LDR  01453cz  a2200349n  4500
=001  9880364310902441
=005  20141212214943.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031668
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x787.$x500
=150  \\$aGastrodia
=450  \\$wnnna$aElata Extract, Gastrodia
=450  \\$wnnna$aElata Extracts, Gastrodia
=450  \\$wnnna$aelata, Gastrodia
=450  \\$wnnna$aelatas, Gastrodia
=450  \\$wnnna$aExtract, Gastrodia Elata
=450  \\$wnnna$aExtracts, Gastrodia Elata
=450  \\$wnnna$aGastrodia elata
=450  \\$wnnna$aGastrodia Elata Extract
=450  \\$wnnna$aGastrodia Elata Extracts
=450  \\$wnnna$aGastrodia elatas
=450  \\$wnnna$aGastrodias
=450  \\$wnnna$ama, Tien
=450  \\$wnnna$amas, Tien
=450  \\$aTien ma
=450  \\$wnnna$aTien mas
=550  \\$wg$aOrchidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ORCHIDACEAE which depends on the fungus Armillaria mellea to complete its life cycle. It is an ingredient of Zhenxuanyin (DRUGS, CHINESE HERBAL).
=688  \\$a2003(2002)
=750  \0$aGastrodia$5IEN-M$0(DLC)sh 85053471

=LDR  00823cz  a2200181n  4500
=001  9880364311002441
=005  20141212214942.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031667
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x787.$x222
=150  \\$aDendrobium
=450  \\$wnnna$aDendrobiums
=550  \\$wg$aOrchidaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ORCHIDACEAE that contains dihydroayapin (COUMARINS) and phenanthraquinones.
=688  \\$a2003
=750  \0$aDendrobium$5IEN-M$0(DLC)sh 85036707

=LDR  00815cz  a2200181n  4500
=001  9880364311102441
=005  20141212214942.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031666
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x786.$x416
=150  \\$aEpilobium
=450  \\$wnnna$aEpilobiums
=550  \\$wg$aOnagraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ONAGRACEAE. The common name of fireweed is also used with other plants.
=688  \\$a2003
=750  \0$aEpilobium$5IEN-M$0(DLC)sh 85044412

=LDR  01074cz  a2200253n  4500
=001  9880364311202441
=005  20141212214942.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x786.$x611.$x500
=150  \\$aOenothera biennis
=450  \\$wnnna$abienni, Oenothera
=450  \\$wnnna$abiennis, Oenothera
=450  \\$aEvening Primrose
=450  \\$wnnna$aEvening Primroses
=450  \\$wnnna$aOenothera bienni
=450  \\$aPrimrose, Evening
=450  \\$wnnna$aPrimroses, Evening
=550  \\$wg$aOenothera
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species, of the genus OENOTHERA, family ONAGRACEAE, that is the source of evening primrose oil.
=688  \\$a2003
=750  \0$aEvening primrose$5IEN-M$0(DLC)sh 85045966

=LDR  00820cz  a2200193n  4500
=001  9880364311302441
=005  20141212214941.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031664
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x786.$x611
=150  \\$aOenothera
=450  \\$wnnna$aOenotheras
=550  \\$wg$aOnagraceae
=550  \\$wh$aOenothera biennis
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ONAGRACEAE. Members contain oenotheins.
=688  \\$a2003
=750  \0$aOenothera$5IEN-M$0(DLC)sh 85094141

=LDR  00861cz  a2200181n  4500
=001  9880364311402441
=005  20141212214941.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031663
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x786.$x222
=150  \\$aClarkia
=450  \\$wnnna$aClarkias
=550  \\$wg$aOnagraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus, of the family ONAGRACEAE, which is the subject of genetic studies. The floral aroma is attributed to benzenoid esters and benzylacetate.
=688  \\$a2003
=750  \0$aClarkia$5IEN-M$0(DLC)sh 85026673

=LDR  00793cz  a2200181n  4500
=001  9880364311502441
=005  20141212214941.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031662
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x833
=150  \\$aSyringa
=450  \\$wnnna$aSyringas
=550  \\$wg$aOleaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. Oleuropein has been identified in the stem bark.
=688  \\$a2003
=750  \0$aLilacs$5IEN-M$0(DLC)sh 85076957

=LDR  00990cz  a2200265n  4500
=001  9880364311602441
=005  20141212214940.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x374
=150  \\$aFraxinus
=450  \\$aAsh, Common
=450  \\$aAsh Tree
=450  \\$wnnna$aAsh Trees
=450  \\$wnnna$aAshs, Common
=450  \\$wnnna$aCommon Ash
=450  \\$wnnna$aCommon Ashs
=450  \\$wnnna$aTree, Ash
=450  \\$wnnna$aTrees, Ash
=550  \\$wg$aOleaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. Members contain secoiridoid glucosides.
=688  \\$a2003
=750  \0$aFraxinus$5IEN-M

=LDR  00883cz  a2200205n  4500
=001  9880364311702441
=005  20141212214940.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031660
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x416
=150  \\$aJasminum
=450  \\$aJasmine
=450  \\$wnnna$aJasmines
=450  \\$wnnna$aJasminums
=550  \\$wg$aOleaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. Members contain secoiridoid glucosides and this is the source of oil of jasmine.
=688  \\$a2003
=750  \0$aJasmine$5IEN-M$0(DLC)sh 85069764

=LDR  01187cz  a2200301n  4500
=001  9880364311802441
=005  20141212214940.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031659
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x499
=150  \\$aLigustrum
=450  \\$wnnna$aLigustri lucidi
=450  \\$wnnna$aLigustri lucidus
=450  \\$aLigustrum lucidum
=450  \\$wnnna$aLigustrum lucidums
=450  \\$wnnna$aLigustrums
=450  \\$wnnna$alucidi, Ligustri
=450  \\$wnnna$alucidum, Ligustrum
=450  \\$wnnna$alucidums, Ligustrum
=450  \\$wnnna$alucidus, Ligustri
=450  \\$aPrivet
=450  \\$wnnna$aPrivets
=550  \\$wg$aOleaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. Oleuropein, a phenolic secoiridoid glycoside, is found in the leaves.
=688  \\$a2003
=750  \0$aPrivets$0(DLC)sh2008020090$5IEN-M

=LDR  01010cz  a2200253n  4500
=001  9880364311902441
=005  20141212214939.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031658
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x666
=150  \\$aOlea
=450  \\$wnnna$aOleas
=450  \\$wnnna$aOlive
=450  \\$aOlive Tree
=450  \\$wnnna$aOlive Trees
=450  \\$aOlives
=450  \\$wnnna$aTree, Olive
=450  \\$wnnna$aTrees, Olive
=550  \\$wg$aOleaceae
=667  \\$aOLIVE, RUSSIAN see ELAEAGNUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. The olive fruit is the source of olive oil.
=688  \\$a2003
=750  \0$aOlive$5IEN-M$0(DLC)sh 85094612

=LDR  00968cz  a2200253n  4500
=001  9880364312002441
=005  20141212214939.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031657
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x782.$x333
=150  \\$aForsythia
=450  \\$wnnna$aForsythias
=450  \\$wnnna$aGoldenbell
=450  \\$aGoldenbells
=450  \\$aLian qiao
=450  \\$wnnna$aLian qiaos
=450  \\$wnnna$aqiao, Lian
=450  \\$wnnna$aqiaos, Lian
=550  \\$wg$aOleaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family OLEACEAE. Members contain suspensaside.
=688  \\$a2003
=750  \0$aForsythia$5IEN-M$0(DLC)sh 85050854

=LDR  01165cz  a2200313n  4500
=001  9880364312102441
=005  20141212214939.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031656
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x780
=150  \\$aOlacaceae
=450  \\$aMuira Puama
=450  \\$wnnna$aMuira Puamas
=450  \\$wnnna$aOchanostachy
=450  \\$aOchanostachys
=450  \\$aPtychopetalum
=450  \\$wnnna$aPtychopetalums
=450  \\$wnnna$aPuama, Muira
=450  \\$wnnna$aPuamas, Muira
=450  \\$aSchoepfia
=450  \\$wnnna$aSchoepfias
=450  \\$aXimenia
=450  \\$wnnna$aXimenias
=550  \\$wg$aAngiosperms
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA small plant family of the order Santalales, subclass Rosidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aOlacaceae$5IEN-M$0(DLC)sh 85094500

=LDR  00818cz  a2200205n  4500
=001  9880364312202441
=005  20141212214938.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031655
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x778.$x594
=150  \\$aNyssa
=450  \\$wnnna$aNyssas
=450  \\$aTupelo
=450  \\$wnnna$aTupelos
=550  \\$wg$aNyssaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NYSSACEAE (or Cornaceae by some).
=688  \\$a2003
=750  \0$aTupelo$5IEN-M$0(DLC)sh 96009973

=LDR  01027cz  a2200253n  4500
=001  9880364312302441
=005  20141212214938.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031654
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x776.$x488
=150  \\$aNuphar
=450  \\$wnnna$aLilies, Yellow Pond
=450  \\$aLily, Yellow Pond
=450  \\$wnnna$aNuphars
=450  \\$wnnna$aPond Lilies, Yellow
=450  \\$aPond Lily, Yellow
=450  \\$wnnna$aYellow Pond Lilies
=450  \\$wnnna$aYellow Pond Lily
=550  \\$wg$aNymphaeaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NYMPHAEACEAE. Members contain sesquiterpene thioalkaloids.
=688  \\$a2003
=750  \0$aNuphar$5IEN-M$0(DLC)sh 85093299

=LDR  00812cz  a2200181n  4500
=001  9880364312402441
=005  20141212214938.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031653
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x774.$x500
=150  \\$aNelumbo
=450  \\$wnnna$aNelumbos
=550  \\$wg$aNelumbonaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family NELUMBONACEAE. The common name of lotus is also for LOTUS and NYMPHAEA.
=688  \\$a2003
=750  \0$aNelumbo$5IEN-M$0(DLC)sh 85090690

=LDR  00846cz  a2200181n  4500
=001  9880364312502441
=005  20141212214937.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031652
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x774
=150  \\$aNelumbonaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aNelumbo
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. They are aquatic plants.
=688  \\$a2003
=750  \0$aNelumbonaceae$0(DLC) sh2005020472$5IEN-M

=LDR  01792cz  a2200421n  4500
=001  9880364312602441
=005  20141212214937.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031650
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x745
=150  \\$aMelaleuca
=450  \\$wnnna$aalternifolia, Melaleuca
=450  \\$wnnna$aalternifolias, Melaleuca
=450  \\$aCajuput
=450  \\$wnnna$acajuputi, Melaleuca
=450  \\$wnnna$aCajuputs
=450  \\$wnnna$acajuputus, Melaleuca
=450  \\$wnnna$aleucadendra, Melaleuca
=450  \\$wnnna$aleucadendras, Melaleuca
=450  \\$wnnna$aMelaleuca alternifolia
=450  \\$wnnna$aMelaleuca alternifolias
=450  \\$wnnna$aMelaleuca cajuputi
=450  \\$wnnna$aMelaleuca cajuputus
=450  \\$wnnna$aMelaleuca leucadendra
=450  \\$wnnna$aMelaleuca leucadendras
=450  \\$wnnna$aMelaleuca vindifolia
=450  \\$wnnna$aMelaleuca vindifolias
=450  \\$wnnna$aMelaleucas
=450  \\$aNiaouli
=450  \\$wnnna$aNiaoulus
=450  \\$wnnna$avindifolia, Melaleuca
=450  \\$wnnna$avindifolias, Melaleuca
=550  \\$wg$aMyrtaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYRTACEAE. M. alternifolia foliage is a source of TEA TREE OIL. The common name of tea tree also refers to LEPTOSPERMUM or KUNZEA. M. vindifolia is a source of niaouli oil. M. cajuputi and M. leucadendra are sources of cajuput oil.
=688  \\$a2003
=750  \0$aMelaleuca$5IEN-M$0(DLC)sh 85083360

=LDR  00942cz  a2200217n  4500
=001  9880364312702441
=005  20141212214936.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x713
=150  \\$aLeptospermum
=450  \\$wnnna$aLeptospermums
=450  \\$aManuka, New Zealand
=450  \\$aNew Zealand Manuka
=450  \\$wnnna$aZealand Manuka, New
=550  \\$wg$aMyrtaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYRTACEAE. The common name of tea tree is also used for MELALEUCA and KUNZEA.
=688  \\$a2003
=750  \0$aLeptospermum$5IEN-M$0(DLC)sh 99000520

=LDR  01147cz  a2200277n  4500
=001  9880364312802441
=005  20141212214936.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031647
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x888
=150  \\$aPsidium
=450  \\$wnnna$aGoiaba
=450  \\$wnnna$aGoiabas
=450  \\$wnnna$aguajava, Psidium
=450  \\$wnnna$aguajavas, Psidium
=450  \\$aGuava
=450  \\$wnnna$aGuavas
=450  \\$wnnna$aPsidium guajava
=450  \\$wnnna$aPsidium guajavas
=450  \\$wnnna$aPsidiums
=550  \\$wg$aMyrtaceae
=667  \\$aX ref GUAVA: PINEAPPLE GUAVA see FEIJOA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYRTACEAE that bears an edible fruit and contains guavin B and quercetin glycosides.
=688  \\$a2003
=750  \0$aPsidium$0(DLC) sh 85108314$5IEN-M

=LDR  00975cz  a2200205n  4500
=001  9880364312902441
=005  20141212214934.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031643
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x756.$x500
=150  \\$aMyoporum
=450  \\$aBoobialla
=450  \\$wnnna$aBoobiallas
=450  \\$wnnna$aMyoporums
=550  \\$wg$aMyoporaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYOPORACEAE. Members contain dehydrongaione, deisopropylngaione, dehydromyodesmone and other furanoid sesquiterpene essential oils. It is the source of Ngaio oil and ngaione.
=688  \\$a2003
=750  \0$aMyoporum$5IEN-M$0(DLC)sh 85089273

=LDR  00854cz  a2200193n  4500
=001  9880364313002441
=005  20141212214934.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x756
=150  \\$aMyoporaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aEremophila Plant
=550  \\$wh$aMyoporum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aMyoporaceae$5IEN-M$0(DLC)sh 85089272

=LDR  01240cz  a2200301n  4500
=001  9880364313102441
=005  20141212214934.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x760.$x500
=150  \\$aMyrica
=450  \\$wnnna$aBayberries
=450  \\$aBayberry
=450  \\$aBog Myrtle
=450  \\$wnnna$aBog Myrtles
=450  \\$wnnna$aGale, Sweet
=450  \\$wnnna$aGales, Sweet
=450  \\$wnnna$aMyricas
=450  \\$aMyrtle, Bog
=450  \\$wnnna$aMyrtles, Bog
=450  \\$aSweet Gale
=450  \\$wnnna$aSweet Gales
=550  \\$wg$aMyricaceae
=667  \\$aX ref BOG MYRTLE: MYRTLE see MYRTUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MYRICACEAE. Members contain myricanol. The common name of bayberry is similar to the name barberry which is used for BERBERIS and MAHONIA.
=688  \\$a2003
=750  \0$aMyrica$5IEN-M$0(DLC)sh 85089294

=LDR  00804cz  a2200193n  4500
=001  9880364313202441
=005  20141212214933.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031625
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x633
=150  \\$aMorus
=450  \\$wnnna$aMulberries
=450  \\$aMulberry
=550  \\$wg$aMoraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE that is widely planted for shade.
=688  \\$a2003
=750  \0$aMulberry$5IEN-M$0(DLC)sh 85088306

=LDR  00951cz  a2200229n  4500
=001  9880364313302441
=005  20141212214933.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031624
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x599
=150  \\$aMaclura
=450  \\$wnnna$aMacluras
=450  \\$aOrange, Osage
=450  \\$wnnna$aOranges, Osage
=450  \\$aOsage Orange
=450  \\$wnnna$aOsage Oranges
=550  \\$wg$aMoraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE. Members contain maclurin, antifungal chalcones, and other compounds.
=688  \\$a2003
=750  \0$aOsage orange$5IEN-M$0(DLC)sh 85095865

=LDR  00790cz  a2200181n  4500
=001  9880364313402441
=005  20141212214933.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x144
=150  \\$aBroussonetia
=450  \\$wnnna$aBroussonetias
=550  \\$wg$aMoraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE. Members contain PYRROLIDINES.
=688  \\$a2003
=750  \0$aBroussonetia$5IEN-M$0(DLC)sh 88022611

=LDR  00934cz  a2200217n  4500
=001  9880364313502441
=005  20141212214933.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x88
=150  \\$aArtocarpus
=450  \\$aBreadfruit
=450  \\$wnnna$aBreadfruits
=450  \\$aJackfruit
=450  \\$wnnna$aJackfruits
=550  \\$wg$aMoraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE. Puag-haad extract, from A. lakoocha, contains STILBENES and related 4-substituted RESORCINOLS.
=688  \\$a2003
=750  \0$aArtocarpus$5IEN-M$0(DLC)sh 00008715

=LDR  00789cz  a2200181n  4500
=001  9880364313602441
=005  20141212214932.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x750.$x55
=150  \\$aAntiaris
=450  \\$wnnna$aAntiari
=550  \\$wg$aMoraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MORACEAE. Members have been used as an arrow poison.
=688  \\$a2003
=750  \0$aAntiaris$5IEN-M$0(DLC)sh2001004232

=LDR  01497cz  a2200325n  4500
=001  9880364313702441
=005  20141212214929.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031601
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x715.$x124
=150  \\$aAzadirachta
=450  \\$wnnna$aAzadirachta indica
=450  \\$wnnna$aAzadirachta indicas
=450  \\$wnnna$aazadirachta, Melia
=450  \\$wnnna$aAzadirachtas
=450  \\$wnnna$aazadirachtas, Melia
=450  \\$wnnna$aindica, Azadirachta
=450  \\$wnnna$aindicas, Azadirachta
=450  \\$aMelia azadirachta
=450  \\$wnnna$aMelia azadirachtas
=450  \\$aNeem Tree
=450  \\$wnnna$aNeem Trees
=450  \\$wnnna$aTree, Neem
=450  \\$wnnna$aTrees, Neem
=550  \\$wg$aMeliaceae
=667  \\$aX ref MELIA AZADIRACHTA: MELIA AZEDARACH is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MELIACEAE. Members contain azadirachtin A (a limonoid commonly referred to as azadirachtin) and other TRITERPENES. They have been used in PESTICIDES. The old name of Melia azadirachta is very similar to a related plant, MELIA AZEDARACH.
=688  \\$a2003
=750  \0$aAzadirachta$5IEN-M$0(DLC)sh 92001439

=LDR  00778cz  a2200181n  4500
=001  9880364313802441
=005  20141212214929.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031587
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x715.$x249
=150  \\$aCedrela
=450  \\$wnnna$aCedrelas
=550  \\$wg$aMeliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MELIACEAE. Members contain cedrelanolide.
=688  \\$a2003
=750  \0$aCedrela$5IEN-M$0(DLC)sh 85021600

=LDR  00833cz  a2200193n  4500
=001  9880364313902441
=005  20141212214928.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x715.$x500
=150  \\$aMelia
=450  \\$wnnna$aMelias
=550  \\$wg$aMeliaceae
=550  \\$wh$aMelia azedarach
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MELIACEAE. Members contain meliavolkinin, melianin C and limonoids.
=688  \\$a2003
=750  \0$aMelia$5IEN-M$0(DLC)sh 85083410

=LDR  00934cz  a2200217n  4500
=001  9880364314002441
=005  20141212214928.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031584
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x700.$x288
=150  \\$aHibiscus
=450  \\$wnnna$acannabinus, Hibiscus
=450  \\$wnnna$aHibiscus cannabinus
=450  \\$aKenaf
=450  \\$wnnna$aKenafs
=550  \\$wg$aMalvaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MALVACEAE. Members contain LIGNANS. H. cannabinus is a source of textile fiber (TEXTILES).
=688  \\$a2003
=750  \0$aHibiscus$5IEN-M$0(DLC)sh 85060602

=LDR  00948cz  a2200205n  4500
=001  9880364314102441
=005  20141212214928.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031581
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x690.$x99
=150  \\$aBanisteriopsis
=450  \\$aAyahuasca
=450  \\$wnnna$aAyahuascas
=450  \\$wnnna$aBanisteriopses
=550  \\$wg$aMalpighiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MALPIGHIACEAE which includes an Amazonian psychoactive plant that contains the beta-carboline harmine and N,N-dimethyltryptamine.
=688  \\$a2003
=750  \0$aBanisteriopsis$5IEN-M$0(DLC)sh 85011538

=LDR  01388cz  a2200325n  4500
=001  9880364314202441
=005  20141212214927.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031567
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x680.$x249
=150  \\$aLiriodendron
=450  \\$wnnna$aLiriodendron tulipifera
=450  \\$wnnna$aLiriodendron tulipiferas
=450  \\$wnnna$aLiriodendrons
=450  \\$aPoplar, Yellow
=450  \\$wnnna$aPoplars, Yellow
=450  \\$wnnna$aTree, Tulip
=450  \\$wnnna$aTrees, Tulip
=450  \\$aTulip Tree
=450  \\$wnnna$aTulip Trees
=450  \\$wnnna$atulipifera, Liriodendron
=450  \\$wnnna$atulipiferas, Liriodendron
=450  \\$wnnna$aYellow Poplar
=450  \\$wnnna$aYellow Poplars
=550  \\$wg$aMagnoliaceae
=667  \\$aX ref YELLOW POPLAR: POPLAR, TRUE see POPULUS is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MAGNOLIACEAE. Members include hardwood trees of eastern North America with distinct large tuliplike flowers.
=688  \\$a2003
=750  \0$aLiriodendron$5IEN-M$0(DLC)sh 85077426

=LDR  01544cz  a2200349n  4500
=001  9880364314302441
=005  20141212214927.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031566
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x680.$x500
=150  \\$aMagnolia
=450  \\$aBay, Sweet
=450  \\$wnnna$agrandiflora, Magnolia
=450  \\$wnnna$agrandifloras, Magnolia
=450  \\$wnnna$aMagnolia grandiflora
=450  \\$wnnna$aMagnolia grandifloras
=450  \\$wnnna$aMagnolia officinali
=450  \\$wnnna$aMagnolia officinalis
=450  \\$wnnna$aMagnolia virginiana
=450  \\$wnnna$aMagnolia virginianas
=450  \\$wnnna$aMagnolias
=450  \\$wnnna$aofficinali, Magnolia
=450  \\$wnnna$aofficinalis, Magnolia
=450  \\$aSweet Bay
=450  \\$wnnna$avirginiana, Magnolia
=450  \\$wnnna$avirginianas, Magnolia
=550  \\$wg$aMagnoliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.
=688  \\$a2003
=750  \0$aMagnolias$5IEN-M$0(DLC)sh 85079802

=LDR  01187cz  a2200301n  4500
=001  9880364314402441
=005  20141212214926.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031564
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x665.$x437
=150  \\$aLawsonia Plant
=450  \\$aHenna Plant
=450  \\$wnnna$aHenna Plants
=450  \\$wnnna$ainermi, Lawsonia
=450  \\$wnnna$ainermis, Lawsonia
=450  \\$wnnna$aLawsonia inermi
=450  \\$wnnna$aLawsonia inermis
=450  \\$wnnna$aLawsonia Plants
=450  \\$wnnna$aPlant, Henna
=450  \\$wnnna$aPlant, Lawsonia
=450  \\$wnnna$aPlants, Henna
=450  \\$wnnna$aPlants, Lawsonia
=550  \\$wg$aLythraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LYTHRACEAE that is the source of henna and has cytotoxic activity.
=688  \\$a2003
=750  \0$aLawsonia$0(DLC) sh 88022874$5IEN-M

=LDR  00826cz  a2200181n  4500
=001  9880364314502441
=005  20141212214926.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031563
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x665.$x374
=150  \\$aLagerstroemia
=450  \\$wnnna$aLagerstroemias
=550  \\$wg$aLythraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LYTHRACEAE. Members contain lagertannin and have hypoglycemic effects.
=688  \\$a2003
=750  \0$aLagerstroemia$5IEN-M$0(DLC)sh 85073944

=LDR  00787cz  a2200181n  4500
=001  9880364314602441
=005  20141212214926.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x665.$x249
=150  \\$aCuphea
=450  \\$wnnna$aCupheas
=550  \\$wg$aLythraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LYTHRACEAE. Members contain lauric acid and cuphiin.
=688  \\$a2003
=750  \0$aCuphea$5IEN-M$0(DLC)sh 88022725

=LDR  01004cz  a2200253n  4500
=001  9880364314702441
=005  20141212214925.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x665.$x500
=150  \\$aLythrum
=450  \\$aLoosestrife
=450  \\$wnnna$aLoosestrife, Purple
=450  \\$wnnna$aLoosestrifes
=450  \\$wnnna$aLoosestrifes, Purple
=450  \\$wnnna$aLythrums
=450  \\$wnnna$aPurple Loosestrife
=450  \\$wnnna$aPurple Loosestrifes
=550  \\$wg$aLythraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LYTHRACEAE that contains ALKALOIDS.
=688  \\$a2003
=750  \0$aLythrum$5IEN-M$0(DLC)sh 85079201

=LDR  00805cz  a2200205n  4500
=001  9880364314802441
=005  20141212214925.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x155.$x500
=150  \\$aFractionation, Field Flow
=450  \\$aField Flow Fractionation
=450  \\$wnnna$aSdFFF
=450  \\$aSedimentation Field Flow Fractionation
=550  \\$wg$aChemical Fractionation
=667  \\$aDOSE FRACTIONATION and CELL FRACTIONATION are also available
=680  \\$iSeparation of molecules and particles by a simultaneous action of carrier liquid flow and focusing field forces (electrical, sedimentation, or thermal), without a stationary phase.
=688  \\$a2003
=750  \0$aField-flow fractionation$5IEN-M$0(DLC)sh 87004532

=LDR  01237cz  a2200277n  4500
=001  9880364314902441
=005  20141212214924.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x275
=150  \\$aGleditsia
=450  \\$aFagara horrida
=450  \\$wnnna$aFagara horridas
=450  \\$aGleditsia japonica
=450  \\$wnnna$aGleditsia japonicas
=450  \\$wnnna$aGleditsias
=450  \\$wnnna$ahorrida, Fagara
=450  \\$wnnna$ahorridas, Fagara
=450  \\$wnnna$ajaponica, Gleditsia
=450  \\$wnnna$ajaponicas, Gleditsia
=550  \\$wg$aFabaceae
=667  \\$aX ref FAGARA HORRIDA: FAGARA, unspecified index RUTACEAE; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that contains gleditsiosides (triterpenoid SAPONINS).
=688  \\$a2003
=750  \0$aHoney locust$5IEN-M$0(DLC)sh 85061852

=LDR  00876cz  a2200181n  4500
=001  9880364315002441
=005  20141212214924.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031485
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x177.$x750
=150  \\$aCleome
=450  \\$wnnna$aCleomes
=550  \\$wg$aCapparaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CAPPARACEAE that contains cleogynol and 15alpha-acetoxycleomblynol (dammaranes) and 1-epibrachyacarpone (a triterpene), and ISOTHIOCYANATES.
=688  \\$a2003
=750  \0$aCleome$5IEN-M$0(DLC)sh 88022680

=LDR  00837cz  a2200205n  4500
=001  9880364315102441
=005  20141212214924.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031484
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x177.$x500
=150  \\$aCapparis
=450  \\$aCaper
=450  \\$aCapers
=450  \\$wnnna$aCappari
=550  \\$wg$aCapparaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CAPPARACEAE that contains mabinlin, a sweet protein.
=688  \\$a2003
=750  \0$aCapparis$5IEN-M$0(DLC)sh 88022639

=LDR  01134cz  a2200241n  4500
=001  9880364315202441
=005  20141212214923.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x177
=150  \\$aCapparaceae
=450  \\$wnnna$aCrataeva
=450  \\$wnnna$aCrataevas
=450  \\$aCrateva
=450  \\$wnnna$aCratevas
=550  \\$wg$aAngiosperms
=550  \\$wh$aCapparis
=550  \\$wh$aCleome
=667  \\$aX ref CRATEVA: Crateva marmelos see AEGLE MARMELOS is also available; prefer specific plant; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida, that are mostly herbs and shrubs growing in warm arid regions. Several produce GLUCOSINOLATES.
=688  \\$a2003
=750  \0$aCapparaceae$5IEN-M$0(DLC)sh 88022638

=LDR  00949cz  a2200205n  4500
=001  9880364315302441
=005  20141212214923.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031461
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x638.$x750.$x500
=150  \\$aStrychnos nux-vomica
=450  \\$aNux Vomica
=450  \\$aStrychninetree
=450  \\$wnnna$aVomica, Nux
=550  \\$wg$aStrychnos
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.
=688  \\$a2003; for NUX-VOMICA use STRYCHNINE 1979-2001, use NUX VOMICA 1963-1978
=750  \0$aNux vomica$5IEN-M$0(DLC)sh 85093484

=LDR  00866cz  a2200193n  4500
=001  9880364315402441
=005  20141212214923.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031451
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x638.$x750
=150  \\$aStrychnos
=450  \\$wnnna$aStrychno
=550  \\$wg$aLoganiaceae
=550  \\$wh$aStrychnos nux-vomica
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LOGANIACEAE (classified by some botanists as Strychnaceae).
=688  \\$a2003
=750  \0$aStrychnos$5IEN-M$0(DLC)sh2001004251

=LDR  01259cz  a2200313n  4500
=001  9880364315502441
=005  20141212214922.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031450
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x638.$x500
=150  \\$aGelsemium
=450  \\$wnnna$aGelsemiums
=450  \\$aHu-man-teng
=450  \\$wnnna$aHu man teng
=450  \\$wnnna$aHu-man-tengs
=450  \\$aJessamine, Yellow
=450  \\$wnnna$aJessamines, Yellow
=450  \\$aWoodbine
=450  \\$wnnna$aWoodbines
=450  \\$aYellow-Jessamine
=450  \\$wnnna$aYellow Jessamine
=450  \\$wnnna$aYellow Jessamines
=450  \\$wnnna$aYellow-Jessamines
=550  \\$wg$aLoganiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LOGANIACEAE (classified by some botanists as Gelsemiaceae). The sometimes used common name of trumpet flower is also used for DATURA.
=688  \\$a2003
=750  \0$aGelsemium$5IEN-M$0(DLC)sh 85053701

=LDR  01017cz  a2200229n  4500
=001  9880364315602441
=005  20180820132918.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031449
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x615.$x625.$x960
=150  \\$aZigadenus
=450  \\$wnnna$aCama, Death
=450  \\$aCamas, Death
=450  \\$wnnna$aDeath Cama
=450  \\$aDeath Camas
=450  \\$aZygadenus
=550  \\$wg$aLiliaceae
=667  \\$aCAMAS see CAMASSIA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE that is fatally toxic to grazing animals. The name is similar to another plant called Camas (CAMASSIA).
=688  \\$a2003
=750  \0$aZigadenus$5IEN-M$0(DLC)sh 85150077

=LDR  01329cz  a2200289n  4500
=001  9880364315702441
=005  20141212214845.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031263
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x336
=150  \\$aElaeagnaceae
=450  \\$wnnna$aBuffaloberries
=450  \\$aBuffaloberry
=450  \\$aElaeagnus
=450  \\$aOlive, Russian
=450  \\$wnnna$aOlives, Russian
=450  \\$wnnna$aRussian Olive
=450  \\$wnnna$aRussian Olives
=450  \\$aShepherdia
=450  \\$wnnna$aShepherdias
=550  \\$wg$aAngiosperms
=550  \\$wh$aHippophae
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Rhamnales, subclass Rosidae class Magnoliopsida. The plants have a characteristic silvery or rusty-colored sheen, caused by tiny distinctive scales. Flowers have a tubular structure of four sepals. Root nodules host the Frankia (ACTINOMYCETES) nitrogen-fixing symbionts.
=688  \\$a2003
=750  \0$aElaeagnaceae$5IEN-M$0(DLC)sh 85041484

=LDR  00911cz  a2200205n  4500
=001  9880364315902441
=005  20190702123337.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031262
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x341.$x875
=150  \\$aEbenaceae
=450  \\$aEuclea
=450  \\$wnnna$aEucleas
=550  \\$wg$aEricales
=550  \\$wh$aDiospyros
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA small plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida. Members contain NAPHTHOQUINONES.
=688  \\$a2003
=750  \0$aEbenaceae$5IEN-M$0(DLC)sh 85040645

=LDR  00909cz  a2200205n  4500
=001  9880364316002441
=005  20141212214921.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031447
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x786
=150  \\$aTulipa
=450  \\$aTulip
=450  \\$wnnna$aTulipas
=450  \\$wnnna$aTulips
=550  \\$wg$aLiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE. Members contain tuliposides and tulipalins and have been associated with allergic contact dermatitis in florists.
=688  \\$a2003
=750  \0$aTulips$5IEN-M$0(DLC)sh 85138521

=LDR  01181cz  a2200253n  4500
=001  9880364316102441
=005  20200422103905.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031257
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x350
=150  \\$aDroseraceae
=450  \\$aDionaea
=450  \\$wnnna$aDionaeas
=450  \\$wnnna$aFlytrap, Venus
=450  \\$wnnna$aFlytraps, Venus
=450  \\$aVenus Flytrap
=450  \\$wnnna$aVenus Flytraps
=550  \\$wg$aCaryophyllales
=550  \\$wh$aDrosera
=667  \\$aX ref VENUS FLYTRAP: FLYTRAP see SARRACENIACEAE is also available; prefer specific plant; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Nepenthales, subclass Dilleniidae, class Magnoliopsida, notable for leaves with sticky gland-tipped hairs that entrap insects.
=688  \\$a2003
=750  \0$aDroseraceae$5IEN-M$0(DLC)sh 85039636

=LDR  00882cz  a2200205n  4500
=001  9880364316202441
=005  20180820131451.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031446
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x615.$x625.$x860
=150  \\$aTrillium
=450  \\$wnnna$aTrilliums
=450  \\$aWakerobin
=450  \\$wnnna$aWakerobins
=550  \\$wg$aMelanthiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LILIACEAE that is a short plant with a distinct whorl of 3 broad leaves.
=688  \\$a2003
=750  \0$aTrilliums$5IEN-M$0(DLC)sh 96008268

=LDR  01027cz  a2200265n  4500
=001  9880364316302441
=005  20141212214843.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031256
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x312.$x299
=150  \\$aEleocharis
=450  \\$wnnna$aChestnut, Chinese Water
=450  \\$aChestnut, Water
=450  \\$wnnna$aChestnuts, Water
=450  \\$aChinese Water Chestnut
=450  \\$wnnna$aEleochari
=450  \\$wnnna$aWater Chestnut
=450  \\$aWater Chestnut, Chinese
=450  \\$wnnna$aWater Chestnuts
=550  \\$wg$aCyperaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CYPERACEAE.
=688  \\$a2003
=750  \0$aEleocharis$5IEN-M$0(DLC)sh 85042519

=LDR  00802cz  a2200181n  4500
=001  9880364316402441
=005  20170524141745.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x800
=150  \\$aSansevieria
=450  \\$wnnna$aSansevierias
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE that contains steroidal saponins.
=688  \\$a2003
=750  \0$aSansevieria$5IEN-M$0(DLC)sh 85117321

=LDR  00871cz  a2200205n  4500
=001  9880364316502441
=005  20141212214842.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031255
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x312.$x99
=150  \\$aCarex Plant
=450  \\$wnnna$aCarex Plants
=450  \\$wnnna$aPlant, Carex
=450  \\$wnnna$aPlants, Carex
=550  \\$wg$aCyperaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CYPERACEAE. The seed contains oligostilbenes (STILBENES).
=688  \\$a2003
=750  \0$aCarex$5IEN-M$0(DLC)sh 85020259

=LDR  01014cz  a2200217n  4500
=001  9880364316602441
=005  20141212214842.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031254
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238.$x374
=150  \\$aConvolvulus
=450  \\$aBindweed, Field
=450  \\$wnnna$aBindweeds, Field
=450  \\$wnnna$aField Bindweed
=450  \\$wnnna$aField Bindweeds
=550  \\$wg$aConvolvulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CONVOLVULACEAE. The common name of morning glory also refers to IPOMOEA. The common name of bindweed also refers to IPOMOEA; CALYSTEGIA; or POLYGONUM.
=688  \\$a2003
=750  \0$aBindweeds$0(DLC) sh 85014093$5IEN-M

=LDR  01121cz  a2200253n  4500
=001  9880364316702441
=005  20170524141129.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x600
=150  \\$aOphiopogon
=450  \\$wnnna$ajaponicus, Ophiopogon
=450  \\$wnnna$amaidon, Ophiopogon
=450  \\$wnnna$amaidons, Ophiopogon
=450  \\$wnnna$aOphiopogon japonicus
=450  \\$wnnna$aOphiopogon maidon
=450  \\$wnnna$aOphiopogon maidons
=450  \\$wnnna$aOphiopogons
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE. Members contain steroidal glycosides and provide an ingredient of shengmaisan (DRUGS, CHINESE HERBAL).
=688  \\$a2003
=750  \0$aOphiopogon$5IEN-M$0(DLC)sh2002004593

=LDR  00963cz  a2200229n  4500
=001  9880364316802441
=005  20141212214842.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031253
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x238.$x249
=150  \\$aCalystegia
=450  \\$aBindweed, False
=450  \\$wnnna$aBindweeds, False
=450  \\$wnnna$aCalystegias
=450  \\$wnnna$aFalse Bindweed
=450  \\$wnnna$aFalse Bindweeds
=550  \\$wg$aConvolvulaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CONVOLVULACEAE. Members contain calystegine and calystegins.
=688  \\$a2003
=750  \0$aFalse bindweeds$0(DLC)sh2006005631$5IEN-M

=LDR  00559cz  a2200181n  4500
=001  9880364316902441
=005  20180212104429.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x50.$x600
=150  \\$aNarcissus
=450  \\$aDaffodil
=450  \\$wnnna$aDaffodils
=550  \\$wg$aAmaryllidaceae
=680  \\$iA plant genus of the family Amaryllidaceae. Members contain ungiminorine and LECTINS.
=688  \\$a2003
=750  \2$aNarcissus (Plants)$5IEN-M

=LDR  00792cz  a2200181n  4500
=001  9880364317002441
=005  20141212214841.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031251
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x249.$x249
=150  \\$aClusia
=450  \\$wnnna$aClusias
=550  \\$wg$aClusiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CLUSIACEAE. Members contain benzophenones.
=688  \\$a2003
=750  \0$aClusia (Plants)$5IEN-M$0(DLC)sh 88022683

=LDR  00649cz  a2200157n  4500
=001  9880364317102441
=005  20141212214919.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031425
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x420.$x625
=150  \\$aPlasmodesmata
=550  \\$wg$aIntercellular Junctions
=680  \\$iMembrane-like channels of cytoplasm connecting adjacent plant cells. Plasmodesmata connect through pores in the CELL WALL and associate with the CYTOSKELETON machinery. They are essential for intercellular transport and communication.
=688  \\$a2003
=750  \0$aPlasmodesmata$5IEN-M$0(DLC)sh 85103096

=LDR  00894cz  a2200217n  4500
=001  9880364317202441
=005  20141212214841.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031250
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x216
=150  \\$aClethraceae
=450  \\$wnnna$aClethra
=450  \\$wnnna$aClethras
=450  \\$aSweetpepperbush
=450  \\$wnnna$aSweetpepperbushs
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aClethraceae$5IEN-M$0(DLC)sh 85027002

=LDR  00887cz  a2200193n  4500
=001  9880364317302441
=005  20170524135045.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D031423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x400
=150  \\$aHyacinthus
=450  \\$aHyacinth
=450  \\$wnnna$aHyacinths
=550  \\$wg$aAsparagaceae
=667  \\$aHYACINTH, WATER see EICHHORNIA is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASPARAGACEAE. Do not confuse with water hyacinth (EICHHORNIA).
=688  \\$a2003
=750  \0$aHyacinths$5IEN-M$0(DLC)sh 85063250

=LDR  00888cz  a2200289n  4500
=001  9880363812402441
=005  20141212205301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012109
=035  \\$aCBA5412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x483.$x645
=150  \\$aResearch Support as Topic
=450  \\$aGrants and Subsidies, Research
=450  \\$aResearch Grants$5IEN
=450  \\$wnnna$aResearch Subsidies
=450  \\$wnnna$aResearch Subsidy
=450  \\$aSubsidies, Research
=450  \\$wnnna$aSubsidy, Research
=550  \\$wg$aFinancial Support
=550  \\$aEducation
=667  \\$aResearch Support as Topic
=680  \\$iFinancial support of research activities.
=688  \\$a2008(1964)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Research Support
=688  \\$a66(64)
=750  \0$aResearch grants$0(DLC) sh 85113042$5IEN

=LDR  00992cz  a2200349n  4500
=001  9880363812502441
=005  20141212205301.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012108
=035  \\$aCBA5411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x839
=072  \\$aM1.$x770
=150  \\$aResearch Personnel
=450  \\$aClinical Investigator
=450  \\$aClinical Investigators
=450  \\$wnnna$aInvestigator
=450  \\$wnnna$aInvestigator, Clinical
=450  \\$wnnna$aInvestigators
=450  \\$wnnna$aInvestigators, Clinical
=450  \\$wnnna$aPersonnel, Research
=450  \\$wnnna$aPersonnel, Survey
=450  \\$wnnna$aResearcher
=450  \\$aResearchers
=450  \\$wnnna$aSurvey Personnel
=550  \\$wg$aOccupational Groups
=550  \\$wg$aPersons
=550  \\$wh$aAstronauts
=667  \\$aIM
=680  \\$iThose individuals engaged in research.
=688  \\$a68
=750  \0$aMedical research personnel$5IEN$0(DLC)sh 85083020

=LDR  02651cz  a2200793n  4500
=001  9880363812602441
=005  20161122162047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012107
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x581.$x500
=072  \\$aH1.$x770.$x644.$x728
=150  \\$aResearch Design
=450  \\$wnnna$aData Adjustment
=450  \\$wnnna$aData Adjustments
=450  \\$wnnna$aData Reporting
=450  \\$wnnna$aDesign, Experimental
=450  \\$wnnna$aDesign, Research
=450  \\$wnnna$aDesigns, Experimental
=450  \\$wnnna$aDesigns, Research
=450  \\$wnnna$aError Source
=450  \\$wnnna$aError Sources
=450  \\$aExperimental Design
=450  \\$wnnna$aExperimental Designs
=450  \\$wnnna$aFormulation, Problem
=450  \\$wnnna$aFormulations, Problem
=450  \\$wnnna$aGroup, Matched
=450  \\$wnnna$aGroups, Matched
=450  \\$wnnna$aMatched Group
=450  \\$wnnna$aMatched Groups
=450  \\$wnnna$aMethod, Scoring
=450  \\$wnnna$aMethodology, Research
=450  \\$wnnna$aMethods, Scoring
=450  \\$wnnna$aProblem Formulation
=450  \\$wnnna$aProblem Formulations
=450  \\$wnnna$aProposal, Research
=450  \\$wnnna$aProposals, Research
=450  \\$wnnna$aReporting, Data
=450  \\$wnnna$aResearch Designs
=450  \\$wnnna$aResearch Methodology
=450  \\$aResearch$xmethods
=450  \\$wnnna$aResearch Proposal
=450  \\$wnnna$aResearch Proposals
=450  \\$wnnna$aResearch Technic
=450  \\$wnnna$aResearch Technics
=450  \\$wnnna$aResearch Technique
=450  \\$wnnna$aResearch Techniques
=450  \\$wnnna$aScoring Method
=450  \\$wnnna$aScoring Methods
=450  \\$wnnna$aSource, Error
=450  \\$wnnna$aSources, Error
=450  \\$wnnna$aTechnic, Research
=450  \\$wnnna$aTechnics, Research
=450  \\$wnnna$aTechnique, Research
=450  \\$wnnna$aTechniques, Research
=550  \\$wg$aMethods
=550  \\$wg$aResearch
=550  \\$wh$aControl Groups
=550  \\$wh$aDouble-Blind Method
=550  \\$wh$aEarly Termination of Clinical Trials
=550  \\$wh$aMeta-Analysis as Topic
=550  \\$wh$aNumbers Needed To Treat
=550  \\$wh$aPatient Selection
=550  \\$wh$aRandom Allocation
=550  \\$wh$aSample Size
=550  \\$aClinical Trials Data Monitoring Committees
=680  \\$iA plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
=688  \\$a73
=750  \0$aExperimental design$5IEN$0(DLC)sh 85046441

=LDR  02120cz  a2200517n  4500
=001  9880363812702441
=005  20200618114501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644
=150  \\$aResearch
=450  \\$wnnna$aActivities, Research
=450  \\$wnnna$aActivity, Research
=450  \\$wnnna$aDevelopment and Research
=450  \\$wnnna$aLaboratory Research
=450  \\$wnnna$aPriorities, Research
=450  \\$wnnna$aPriority, Research
=450  \\$wnnna$aResearch Activities
=450  \\$wnnna$aResearch Activity
=450  \\$wnnna$aResearch and Development
=450  \\$wnnna$aResearch, Laboratory
=450  \\$aResearch Priorities
=450  \\$wnnna$aResearch Priority
=550  \\$wg$aScience
=550  \\$wh$aAnimal Experimentation
=550  \\$wh$aBehavioral Research
=550  \\$wh$aBiomedical Research
=550  \\$wh$aCommunity-Based Participatory Research
=550  \\$wh$aData Anonymization
=550  \\$wh$aDual Use Research
=550  \\$wh$aEmpirical Research
=550  \\$wh$aHuman Experimentation
=550  \\$wh$aInterdisciplinary Research
=550  \\$wh$aOperations Research
=550  \\$wh$aParapsychology
=550  \\$wh$aPeer Review, Research
=550  \\$wh$aProof of Concept Study
=550  \\$wh$aPublic Health Systems Research
=550  \\$wh$aResearch Design
=550  \\$wh$aResearch Report
=550  \\$wh$aSocial Validity, Research
=550  \\$aEthics, Research
=667  \\$ageneral or unspecified; prefer specifics; research as a field or the progress or status of research in a particular field; do not add routinely for specific studies involving "research"
=680  \\$iCritical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)
=750  \0$aResearch$5IEN$0(DLC)sh 85113021

=LDR  00814cz  a2200265n  4500
=001  9880363812802441
=005  20141212205259.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012104
=035  \\$aCBA5407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833
=150  \\$aReptiles
=450  \\$wnnna$aReptile
=450  \\$aReptilia
=550  \\$wg$aVertebrates
=550  \\$wh$aAlligators and Crocodiles
=550  \\$wh$aDinosaurs
=550  \\$wh$aLizards
=550  \\$wh$aSnakes
=550  \\$wh$aTurtles
=550  \\$aReptilian Proteins
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iCold-blooded, air-breathing VERTEBRATES belonging to the class Reptilia, usually covered with external scales or bony plates.
=750  \0$aReptiles$5IEN$0(DLC)sh 85112964

=LDR  00982cz  a2200241n  4500
=001  9880363812902441
=005  20141212205257.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012100
=035  \\$aCBA5403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x830
=150  \\$aReproduction, Asexual
=450  \\$wnnna$aAsexual Reproduction
=450  \\$wnnna$aAsexual Reproductions
=450  \\$wnnna$aReproductions, Asexual
=550  \\$wg$aReproduction
=550  \\$wh$aApomixis
=550  \\$wh$aParthenogenesis
=550  \\$aCloning, Organism
=680  \\$iReproduction without fusion of two types of cells, mostly found in ALGAE; FUNGI; and PLANTS. Asexual reproduction occurs in several ways, such as budding, fission, or splitting from "parent" cells. Only few groups of ANIMALS reproduce asexually or unisexually (PARTHENOGENESIS).
=688  \\$a91(75); was see under REPRODUCTION 1975-90
=750  \0$aReproduction, Asexual$5IEN$0(DLC)sh 85112956

=LDR  02071cz  a2200529n  4500
=001  9880363813002441
=005  20141212205257.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012099
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875
=072  \\$aE5.$x820
=150  \\$aReproductive Techniques
=450  \\$wnnna$aReproduction Technic
=450  \\$wnnna$aReproduction Technics
=450  \\$wnnna$aReproduction Technique
=450  \\$wnnna$aReproduction Techniques
=450  \\$wnnna$aReproductive Technique
=450  \\$wnnna$aReproductive Technologies
=450  \\$aReproductive Technology
=450  \\$wnnna$aTechnic, Reproduction
=450  \\$wnnna$aTechnics, Reproduction
=450  \\$wnnna$aTechnique, Reproduction
=450  \\$wnnna$aTechnique, Reproductive
=450  \\$wnnna$aTechniques, Reproduction
=450  \\$wnnna$aTechniques, Reproductive
=450  \\$wnnna$aTechnologies, Reproductive
=450  \\$wnnna$aTechnology, Reproductive
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aTherapeutics
=550  \\$wh$aBreeding
=550  \\$wh$aCloning, Organism
=550  \\$wh$aContraception
=550  \\$wh$aEmbryo Disposition
=550  \\$wh$aFallopian Tube Patency Tests
=550  \\$wh$aInsemination, Artificial
=550  \\$wh$aNuclear Transfer Techniques
=550  \\$wh$aOvulation Detection
=550  \\$wh$aOvulation Prediction
=550  \\$wh$aReproductive Techniques, Assisted
=550  \\$wh$aTocolysis
=550  \\$aReproductive Health Services
=550  \\$aReproductive Medicine
=667  \\$aGEN only; prefer REPRODUCTIVE TECHNIQUES, ASSISTED and its specifics (human & animal) or BREEDING and its specifics (animal only)
=680  \\$iMethods pertaining to the generation of new individuals, including techniques used in selective BREEDING, cloning (CLONING, ORGANISM), and assisted reproduction (REPRODUCTIVE TECHNIQUES, ASSISTED).
=688  \\$a91; was REPRODUCTION TECHNICS 1988-90; was non-MeSH before 1988
=750  \0$aReproductive technology$5IEN-M$0(DLC)sh 88005586

=LDR  01709cz  a2200481n  4500
=001  9880363813102441
=005  20141212205256.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012098
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760
=150  \\$aReproduction
=450  \\$wnnna$aHuman Reproductive Index
=450  \\$wnnna$aHuman Reproductive Indexes
=450  \\$wnnna$aHuman Reproductive Indices
=450  \\$wnnna$aIndex, Human Reproductive
=450  \\$wnnna$aIndexes, Human Reproductive
=450  \\$wnnna$aIndices, Human Reproductive
=450  \\$wnnna$aPeriod, Reproductive
=450  \\$wnnna$aPeriods, Reproductive
=450  \\$wnnna$aReproductive Index, Human
=450  \\$wnnna$aReproductive Indices, Human
=450  \\$wnnna$aReproductive Period
=450  \\$wnnna$aReproductive Periods
=550  \\$wg$aReproductive Physiological Processes
=550  \\$wh$aCoitus
=550  \\$wh$aEjaculation
=550  \\$wh$aEmbryonic and Fetal Development
=550  \\$wh$aFertilization
=550  \\$wh$aGametogenesis
=550  \\$wh$aInsemination
=550  \\$wh$aOrgasm
=550  \\$wh$aOviposition
=550  \\$wh$aOvulation
=550  \\$wh$aPenile Erection
=550  \\$wh$aPollination
=550  \\$wh$aPregnancy
=550  \\$wh$aReproduction, Asexual
=550  \\$wh$aReproductive Behavior
=667  \\$aIM for human, other mammals, birds & fish; NIM for other vertebrates, invertebrates & plants; REPRODUCTIVE BEHAVIOR is also available
=680  \\$iThe total process by which organisms produce offspring. (Stedman, 25th ed)
=750  \0$aHuman reproduction$5IEN-M$0(DLC)sh 85062887
=750  \0$aReproduction$5IEN-HS$0(DLC)sh 85112953

=LDR  01165cz  a2200337n  4500
=001  9880363813202441
=005  20141212205254.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012094
=035  \\$aCBA5396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x821
=150  \\$aRepression, Psychology
=450  \\$wnnna$aDelayed Memories
=450  \\$aDelayed Memory
=450  \\$aFalse Memory Syndrome
=450  \\$wnnna$aFalse Memory Syndromes
=450  \\$wnnna$aMemories, Delayed
=450  \\$wnnna$aMemories, Repressed
=450  \\$wnnna$aMemory, Delayed
=450  \\$wnnna$aMemory, Repressed
=450  \\$wnnna$aMemory Syndrome, False
=450  \\$wnnna$aPsychology Repression
=450  \\$aRepressed Memory
=450  \\$aRepression
=450  \\$wnnna$aSyndrome, False Memory
=550  \\$wg$aDefense Mechanisms
=550  \\$wh$aRepression-Sensitization
=680  \\$iThe active mental process of keeping out and ejecting, banishing from consciousness, ideas or impulses that are unacceptable to it.
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Repression
=750  \0$aRepression (Psychology)$0(DLC) sh 85112948$5IEN

=LDR  00994cz  a2200289n  4500
=001  9880363813302441
=005  20141212205253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012092
=035  \\$aCBA5394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x936.$x494
=150  \\$aReplantation
=450  \\$aReimplantation
=450  \\$wnnna$aReimplantations
=450  \\$wnnna$aReplantation, Surgical
=450  \\$wnnna$aReplantations
=450  \\$wnnna$aReplantations, Surgical
=450  \\$aSurgical Replantation
=450  \\$wnnna$aSurgical Replantations
=550  \\$wg$aTransplantation
=550  \\$wh$aTooth Replantation
=550  \\$aAmputation, Traumatic
=667  \\$ado not use /util except by MeSH definition; differentiate from transpl; coord with organ /surg: Manual 19.8.75
=680  \\$iRestoration of an organ or other structure to its original site.
=688  \\$a82; was REIMPLANTATION 1965-81
=750  \0$aReimplantation (Surgery)$5IEN$0(DLC)sh 85112428

=LDR  02408cz  a2200565n  4500
=001  9880363813402441
=005  20141212205252.0
=008  870430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012090
=035  \\$aCBA5392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x844.$x150
=150  \\$aCumulative Trauma Disorders
=450  \\$wnnna$aCumulative Trauma Disorder
=450  \\$wnnna$aDisorder, Cumulative Trauma
=450  \\$wnnna$aDisorder, Repetitive Motion
=450  \\$wnnna$aDisorders, Cumulative Trauma
=450  \\$wnnna$aDisorders, Repetitive Motion
=450  \\$wnnna$aInjuries, Overuse
=450  \\$wnnna$aInjuries, Repetition Strain
=450  \\$wnnna$aInjuries, Repetitive Strain
=450  \\$wnnna$aInjury, Overuse
=450  \\$wnnna$aInjury, Repetition Strain
=450  \\$wnnna$aInjury, Repetitive Strain
=450  \\$wnnna$aMotion Disorder, Repetitive
=450  \\$wnnna$aMotion Disorders, Repetitive
=450  \\$wnnna$aOveruse Injuries
=450  \\$wnnna$aOveruse Injury
=450  \\$aOveruse Syndrome
=450  \\$wnnna$aOveruse Syndromes
=450  \\$wnnna$aRepetition Strain Injuries
=450  \\$aRepetition Strain Injury
=450  \\$wnnna$aRepetitive Motion Disorder
=450  \\$wnnna$aRepetitive Motion Disorders
=450  \\$wnnna$aRepetitive Strain Injuries
=450  \\$wnnna$aRepetitive Strain Injury
=450  \\$wnnna$aStrain Injuries, Repetition
=450  \\$wnnna$aStrain Injuries, Repetitive
=450  \\$wnnna$aStrain Injury, Repetition
=450  \\$wnnna$aStrain Injury, Repetitive
=450  \\$wnnna$aTrauma Disorder, Cumulative
=450  \\$aTrauma Disorders, Cumulative
=550  \\$wg$aSprains and Strains
=550  \\$wh$aCarpal Tunnel Syndrome
=550  \\$wh$aIliotibial Band Syndrome
=550  \\$wh$aUlnar Nerve Compression Syndromes
=667  \\$apainful conditions from overuse or overexertion of any activity; DF: CUMULATIVE TRAUMA DIS
=680  \\$iHarmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system, often resulting from work-related physical activities. It is characterized by inflammation, pain, or dysfunction of the involved joints, bones, ligaments, and nerves.
=688  \\$a97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996
=750  \0$aOveruse injuries$5IEN$0(DLC)sh 86007498

=LDR  01479cz  a2200373n  4500
=001  9880363813502441
=005  20141212211037.0
=008  880608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015427
=035  \\$aCBA5391HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x725
=072  \\$aC23.$x550.$x767.$x877
=150  \\$aReperfusion Injury
=450  \\$wnnna$aDamage, Reperfusion
=450  \\$wnnna$aDamages, Reperfusion
=450  \\$wnnna$aInjuries, Ischemia-Reperfusion
=450  \\$wnnna$aInjuries, Reperfusion
=450  \\$wnnna$aInjury, Ischemia-Reperfusion
=450  \\$wnnna$aInjury, Ischemia Reperfusion
=450  \\$wnnna$aInjury, Reperfusion
=450  \\$wnnna$aIschemia-Reperfusion Injuries
=450  \\$aIschemia-Reperfusion Injury
=450  \\$wnnna$aIschemia Reperfusion Injury
=450  \\$wnnna$aReperfusion Damage
=450  \\$wnnna$aReperfusion Damages
=450  \\$wnnna$aReperfusion Injuries
=550  \\$wg$aPostoperative Complications
=550  \\$wg$aVascular Diseases
=550  \\$wh$aMyocardial Reperfusion Injury
=550  \\$wh$aPrimary Graft Dysfunction
=680  \\$iAdverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.
=688  \\$a89
=750  \0$aReperfusion injury$0(DLC) sh 91002062$5IEN

=LDR  01203cz  a2200229n  4500
=001  9880363813602441
=005  20141212211037.0
=008  880607\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015424
=035  \\$aCBA5390HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x700
=072  \\$aE5.$x680.$x730
=150  \\$aReperfusion
=450  \\$wnnna$aReperfusions
=550  \\$wg$aCardiovascular Surgical Procedures
=550  \\$wg$aPerfusion
=550  \\$wh$aMyocardial Reperfusion
=667  \\$anote category: a technique; /adv eff permitted but consider also REPERFUSION INJURY; MYOCARDIAL REPERFUSION is also available
=680  \\$iRestoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY.
=688  \\$a89
=750  \0$aReperfusion (Physiology)$5IEN$0(DLC)sh 92002150

=LDR  02060cz  a2200553n  4500
=001  9880363813702441
=005  20141212205251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012087
=035  \\$aCBA5387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x630
=072  \\$aB4.$x909.$x777.$x714
=150  \\$aReoviridae
=450  \\$aAquareovirus
=450  \\$wnnna$aAquareoviruses
=450  \\$wnnna$aAquatic Reovirus
=450  \\$wnnna$aAquatic Reoviruses
=450  \\$aCypovirus
=450  \\$wnnna$aCypoviruses
=450  \\$wnnna$aCytoplasmic Polyhedrosis Virus
=450  \\$aCytoplasmic Polyhedrosis Viruses
=450  \\$aFijivirus
=450  \\$wnnna$aFijiviruses
=450  \\$aIdnoreovirus
=450  \\$wnnna$aIdnoreoviruses
=450  \\$aMycoreovirus
=450  \\$wnnna$aMycoreoviruses
=450  \\$aOryzavirus
=450  \\$wnnna$aOryzaviruses
=450  \\$aPhytoreovirus
=450  \\$wnnna$aPhytoreoviruses
=450  \\$wnnna$aPolyhedrosis Virus, Cytoplasmic
=450  \\$wnnna$aPolyhedrosis Viruses, Cytoplasmic
=450  \\$wnnna$aReovirus, Aquatic
=450  \\$aReoviruses, Aquatic
=450  \\$aRespiratory Enteric Orphan Viruses
=450  \\$aSeadornavirus
=450  \\$wnnna$aSeadornaviruses
=550  \\$wg$aRNA Viruses
=550  \\$wh$aColtivirus
=550  \\$wh$aOrbivirus
=550  \\$wh$aOrthoreovirus
=550  \\$wh$aRotavirus
=550  \\$aArboviruses
=667  \\$ainfection = REOVIRIDAE INFECTIONS
=680  \\$iA family of unenveloped RNA viruses with cubic symmetry. The twelve genera include ORTHOREOVIRUS; ORBIVIRUS; COLTIVIRUS; ROTAVIRUS; Aquareovirus, Cypovirus, Phytoreovirus, Fijivirus, Seadornavirus, Idnoreovirus, Mycoreovirus, and Oryzavirus.
=688  \\$a81; was REOVIRUSES 1975-80, was REOVIRUS 1964-74 (Prov 1964-65); RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993
=750  \0$aReoviruses$0(DLC) sh 85112894$5IEN

=LDR  01204cz  a2200289n  4500
=001  9880363813802441
=005  20141212205250.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012086
=035  \\$aCBA5386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x690
=150  \\$aReoperation
=450  \\$wnnna$aJoint Revision
=450  \\$wnnna$aRepeat Surgery
=450  \\$aRevision, Joint
=450  \\$aRevision, Surgical
=450  \\$aSurgery, Repeat
=450  \\$aSurgical Revision
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aRetreatment
=550  \\$aSecond-Look Surgery
=550  \\$aSurgical Procedures, Operative
=667  \\$aIM general only; coord NIM with specific type of surgery (IM); re-transplantation: coord with appropriate transplantation term; does not include staged surg ( = specific organ /surg, dis /surg or surg technique)
=680  \\$iA repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.
=688  \\$a91(82); was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92
=750  \0$aReoperation$5IEN$0(DLC)sh 89001259

=LDR  01946cz  a2200313n  4500
=001  9880363813902441
=005  20141212205249.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012084
=035  \\$aCBA5384HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x805
=072  \\$aG9.$x330.$x190.$x400.$x750
=150  \\$aRenin-Angiotensin System
=450  \\$aRenin-Angiotensin-Aldosterone System
=450  \\$wnnna$aRenin Angiotensin Aldosterone System
=450  \\$wnnna$aRenin Angiotensin System
=450  \\$wnnna$aSystem, Renin-Angiotensin
=450  \\$wnnna$aSystem, Renin-Angiotensin-Aldosterone
=550  \\$wg$aHemodynamics
=550  \\$wg$aMetabolism
=550  \\$aAldosterone
=550  \\$aAngiotensin II
=550  \\$aAngiotensins
=550  \\$aKallikrein-Kinin System
=667  \\$anote X ref but do not index under ALDOSTERONE unless particularly discussed; DF: RA SYSTEM
=680  \\$iA BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.
=688  \\$a82
=750  \0$aRenin-angiotensin system$5IEN-M$0(DLC)sh2002004485

=LDR  01484cz  a2200373n  4500
=001  9880363814002441
=005  20141212205249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012083
=035  \\$aCBA5383HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x74.$x500.$x780
=072  \\$aD8.$x811.$x277.$x656.$x300.$x48.$x780
=072  \\$aD8.$x811.$x277.$x656.$x837.$x750
=150  \\$aRenin
=450  \\$aAngiotensin-Forming Enzyme
=450  \\$wnnna$aAngiotensin Forming Enzyme
=450  \\$aAngiotensinogenase
=450  \\$wnnna$aBig Renin
=450  \\$wnnna$aCryorenin
=450  \\$wnnna$aInactive Renin
=450  \\$wnnna$aPre-Prorenin
=450  \\$wnnna$aPre Prorenin
=450  \\$wnnna$aPreprorenin
=450  \\$wnnna$aProrenin
=450  \\$wnnna$aRenin, Big
=450  \\$wnnna$aRenin, Inactive
=550  \\$wg$aAspartic Acid Endopeptidases
=550  \\$wg$aProprotein Convertases
=550  \\$aJuxtaglomerular Apparatus
=667  \\$ado not confuse with RENNIN see CHYMOSIN
=680  \\$iA highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19.
=688  \\$a1963; for PRORENIN use RENIN (NM) 1977-2003, for PREPRORENIN use RENIN (NM) 1980-2003
=750  \0$aRenin$5IEN$0(DLC)sh 85112852

=LDR  00567cz  a2200193n  4500
=001  9880363814102441
=005  20141212205248.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012082
=035  \\$aCBA5382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x752
=150  \\$aRenal Veins
=450  \\$wnnna$aRenal Vein
=450  \\$wnnna$aVein, Renal
=450  \\$wnnna$aVeins, Renal
=550  \\$wg$aVeins
=680  \\$iShort thick veins which return blood from the kidneys to the vena cava.
=750  \0$aKidneys$xBlood-vessels$5IEN$0(DLC)sh 85072256

=LDR  01525cz  a2200409n  4500
=001  9880363814202441
=005  20141212211104.0
=008  640701\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015499
=035  \\$aCBA5381HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x815
=072  \\$aC13.$x351.$x968.$x419.$x815
=072  \\$aC16.$x320.$x565.$x861
=072  \\$aC18.$x452.$x648.$x861
=150  \\$aRenal Tubular Transport, Inborn Errors
=450  \\$wnnna$aKidney Tubular Transport, Inborn Error
=450  \\$aKidney Tubular Transport, Inborn Errors
=450  \\$wnnna$aRenal Tubular Transport Errors
=450  \\$wnnna$aRenal Tubular Transport, Inborn Error
=550  \\$wg$aKidney Diseases
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aAcidosis, Renal Tubular
=550  \\$wh$aBartter Syndrome
=550  \\$wh$aDent Disease
=550  \\$wh$aFanconi Syndrome
=550  \\$wh$aGitelman Syndrome
=550  \\$wh$aGlycosuria, Renal
=550  \\$wh$aHypophosphatemia, Familial
=550  \\$wh$aLiddle Syndrome
=550  \\$wh$aOculocerebrorenal Syndrome
=550  \\$wh$aPseudohypoaldosteronism
=550  \\$wh$aRenal Aminoacidurias
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with specific metabolite/metab (IM); DF: RENAL TUB TRANSP INBORN ERR
=680  \\$iGenetic defects in the selective or non-selective transport functions of the KIDNEY TUBULES.
=688  \\$a65
=750  \0$aRenal tubular transport, Disorders of$5IEN$0(DLC)sh 85112823

=LDR  01493cz  a2200361n  4500
=001  9880363814302441
=005  20180119102508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012080
=035  \\$aCBA5380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x198.$x816.$x750
=072  \\$aC12.$x777.$x419.$x795
=072  \\$aC13.$x351.$x968.$x419.$x795
=072  \\$aC18.$x452.$x104.$x816.$x750
=072  \\$aC18.$x452.$x174.$x845.$x750
=072  \\$aC18.$x654.$x521.$x500.$x133.$x770.$x734.$x750
=072  \\$aC19.$x642.$x355.$x480.$x500
=150  \\$aChronic Kidney Disease-Mineral and Bone Disorder
=450  \\$wnno$aRenal Osteodystrophy
=450  \\$wnnna$aCKD-MBD
=450  \\$wnnna$aChronic Kidney Disease Mineral and Bone Disorder
=450  \\$wnnna$aOsteodystrophies, Renal
=450  \\$wnnna$aOsteodystrophy, Renal
=450  \\$wnnna$aRenal Osteodystrophies
=450  \\$aRenal Rickets
=450  \\$aRickets, Renal
=550  \\$wg$aHyperparathyroidism, Secondary
=550  \\$wg$aKidney Diseases
=550  \\$wg$aRickets
=680  \\$iDecalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
=688  \\$a2017(1963); was RICKETS, RENAL 1963-1971
=750  \0$aRenal osteodystrophy$0(DLC)sh 85112819$5IEN-M

=LDR  01058cz  a2200325n  4500
=001  9880363814402441
=005  20170609124521.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012079
=035  \\$aCBA5379M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x852.$x725
=072  \\$aG9.$x330.$x100.$x812
=150  \\$aRenal Circulation
=450  \\$wnnna$aBlood Flow, Renal
=450  \\$wnnna$aCirculation, Kidney
=450  \\$wnnna$aCirculation, Renal
=450  \\$wnnna$aFlow, Renal Blood
=450  \\$aKidney Circulation
=450  \\$aRenal Blood Flow
=550  \\$wg$aBlood Circulation
=550  \\$wg$aUrinary Tract Physiological Phenomena
=550  \\$wh$aRenal Blood Flow, Effective
=550  \\$wh$aRenal Plasma Flow
=550  \\$wh$aRenal Plasma Flow, Effective
=550  \\$aKidney
=667  \\$anote specific indentions; consider also KIDNEY /blood supply; DF: RENAL CIRC
=680  \\$iThe circulation of the BLOOD through the vessels of the KIDNEY.
=688  \\$a82
=750  \0$aRenal circulation$5IEN-M$0(DLC)sh 00008697

=LDR  01392cz  a2200301n  4500
=001  9880363814502441
=005  20141212205247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012078
=035  \\$aCBA5378HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x775
=072  \\$aC13.$x351.$x968.$x419.$x775
=072  \\$aC14.$x907.$x137.$x727
=150  \\$aRenal Artery Obstruction
=450  \\$wnnna$aObstruction, Renal Artery
=450  \\$wnnna$aObstructions, Renal Artery
=450  \\$wnnna$aRenal Artery Obstructions
=450  \\$wnnna$aRenal Artery Stenoses
=450  \\$aRenal Artery Stenosis
=450  \\$wnnna$aStenoses, Renal Artery
=450  \\$wnnna$aStenosis, Renal Artery
=550  \\$wg$aArterial Occlusive Diseases
=550  \\$wg$aKidney Diseases
=667  \\$arenal artery thrombosis: coordinate IM with THROMBOSIS (IM); consider also HYPERTENSION, RENOVASCULAR (hypertension caused by renal artery obstruction or compression)
=680  \\$iNarrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR).
=688  \\$aRENAL ARTERY STENOSIS was see under RENAL ARTERY OBSTRUCTION 1963-83
=750  \0$aRenal artery obstruction$5IEN$0(DLC)sh 85112812

=LDR  00674cz  a2200205n  4500
=001  9880363814602441
=005  20141212205247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012077
=035  \\$aCBA5377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x745
=150  \\$aRenal Artery
=450  \\$wnnna$aArteries, Renal
=450  \\$wnnna$aArtery, Renal
=450  \\$wnnna$aRenal Arteries
=550  \\$wg$aArteries
=667  \\$athrombosis: index under RENAL ARTERY OBSTRUCTION (IM) + THROMBOSIS (IM)
=680  \\$iA branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.
=750  \0$aRenal artery$5IEN$0(DLC)sh 85112810

=LDR  00666cz  a2200217n  4500
=001  9880363814702441
=005  20141212205246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012073
=035  \\$aCBA5373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x709
=072  \\$aI2.$x903.$x694
=150  \\$aRemedial Teaching
=450  \\$wnnna$aRemedial Teachings
=450  \\$wnnna$aTeaching, Remedial
=450  \\$wnnna$aTeachings, Remedial
=550  \\$wg$aPsychology, Educational
=550  \\$wg$aTeaching
=680  \\$iSpecialized instruction for students deviating from the expected norm.
=750  \0$aRemedial teaching$5IEN$0(DLC)sh 85112781

=LDR  00498cz  a2200181n  4500
=001  9880363814802441
=005  20141212205245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012071
=035  \\$aCBA5371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x754
=150  \\$aReligion and Sex
=450  \\$wnnna$aSex and Religion
=550  \\$wg$aReligion
=550  \\$aSex
=667  \\$ano qualif; coord IM with sexual aspect (IM)
=750  \0$aSex$xReligious aspects$5IEN$0(DLC)sh 85120553

=LDR  00495cz  a2200181n  4500
=001  9880363814902441
=005  20141212205245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012070
=035  \\$aCBA5370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x709
=150  \\$aReligion and Science
=450  \\$wnnna$aScience and Religion
=550  \\$wg$aReligion
=550  \\$aScience
=667  \\$ano qualif; usually general; IM
=750  \0$aReligion and science$5IEN$0(DLC)sh 85112579

=LDR  00906cz  a2200265n  4500
=001  9880363815002441
=005  20141212205245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012069
=035  \\$aCBA5369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x880
=072  \\$aK1.$x844.$x664
=150  \\$aReligion and Psychology
=450  \\$wnnna$aPsychology and Religion
=450  \\$wnnna$aPsychology, Religion
=450  \\$wnnna$aReligion, Psychology
=450  \\$aReligion$xpsychology
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wg$aReligion
=550  \\$wh$aPastoral Care
=550  \\$wh$aSpirituality
=667  \\$ano qualif; coord IM with psychol aspect (IM); X ref PRAYER HEALING see MENTAL HEALING is available; DF: RELIGION PSYCHOL
=680  \\$iThe interrelationship of psychology and religion.
=750  \0$aPsychology and religion$5IEN$0(DLC)sh 85108487

=LDR  00611cz  a2200193n  4500
=001  9880363815102441
=005  20141212205245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012068
=035  \\$aCBA5368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x844.$x619
=150  \\$aReligion and Medicine
=450  \\$wnnna$aMedicine and Religion
=550  \\$wg$aReligion
=550  \\$aParish Nursing
=667  \\$acoordinate IM with medical aspect (IM); FAITH HEALING is available
=680  \\$iThe interrelationship of medicine and religion.
=750  \0$aMedicine$xReligious aspects$5IEN$0(DLC)sh 85083091

=LDR  00885cz  a2200217n  4500
=001  9880363815302441
=005  20141212205244.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x734.$x769
=072  \\$aD6.$x472.$x699.$x715
=072  \\$aD12.$x644.$x548.$x762
=150  \\$aRelaxin
=450  \\$wnnna$aB, Relaxin
=450  \\$wnnna$aRelaxin B
=550  \\$wg$aCorpus Luteum Hormones
=550  \\$wg$aPeptide Hormones
=667  \\$a/biosyn /physiol permitted
=680  \\$iA water-soluble polypeptide (molecular weight approximately 8,000) extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. (Dorland, 28th ed)
=750  \0$aRelaxin$5IEN$0(DLC)sh 85112505

=LDR  01092cz  a2200277n  4500
=001  9880363815402441
=005  20141212205243.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012064
=035  \\$aCBA5364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x875
=072  \\$aF4.$x754.$x137.$x750
=150  \\$aRelaxation Therapy
=450  \\$wnnna$aRelaxation Technics
=450  \\$aRelaxation Techniques
=450  \\$wnnna$aTherapy, Relaxation
=550  \\$wg$aBehavior Therapy
=550  \\$wg$aMind-Body Therapies
=550  \\$wh$aMeditation
=667  \\$aRELAXATION is also available; MUSCLE RELAXATION is available for the physiological relaxation of muscles
=680  \\$iTreatment to improve one's health condition by using techniques that can reduce PHYSIOLOGICAL STRESS; PSYCHOLOGICAL STRESS; or both.
=688  \\$a2009 (1991); use RELAXATION TECHNICS 1976-1990
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Relaxation Techniques
=688  \\$a91; was RELAXATION TECHNICS 1976-90
=750  \0$aRelaxation$xtherapeutic use$0(IEN) 8576822$5IEN-M

=LDR  00587cz  a2200193n  4500
=001  9880363815502441
=005  20141212205243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012063
=035  \\$aCBA5363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x769
=150  \\$aRelaxation
=450  \\$wnnna$aRelaxations
=550  \\$wg$aLeisure Activities
=550  \\$wh$aRest
=667  \\$aMUSCLE RELAXATION is also available
=680  \\$iActivity which reduces the feelings of tension and the effects of STRESS, PHYSIOLOGICAL.
=750  \0$aRelaxation$0(DLC) sh 85112498$5IEN

=LDR  01231cz  a2200301n  4500
=001  9880363815602441
=005  20141212205243.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012062
=035  \\$aCBA5362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x810.$x250.$x275
=150  \\$aRelative Biological Effectiveness
=450  \\$wnnna$aBiologic Effectiveness, Relative
=450  \\$wnnna$aBiologic Relative Effectiveness
=450  \\$wnnna$aBiological Effectiveness, Relative
=450  \\$wnnna$aBiological Relative Effectiveness
=450  \\$wnnna$aEffectiveness, Biologic Relative
=450  \\$wnnna$aEffectiveness, Biological Relative
=450  \\$wnnna$aEffectiveness, Relative Biologic
=450  \\$wnnna$aEffectiveness, Relative Biological
=450  \\$wnnna$aRelative Biologic Effectiveness
=450  \\$wnnna$aRelative Effectiveness, Biologic
=550  \\$wg$aRadiation Dosage
=667  \\$aNIM; no qualif; DF: RBE
=680  \\$iThe ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
=688  \\$a77
=750  \0$aRelative biological effectiveness (Radiobiology)$5IEN$0(DLC)sh 85112490

=LDR  01323cz  a2200241n  4500
=001  9880363815702441
=005  20141212205242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012061
=035  \\$aCBA5361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x155.$x644
=072  \\$aC1.$x252.$x400.$x825.$x750
=072  \\$aC1.$x252.$x847.$x193.$x644
=150  \\$aRelapsing Fever
=450  \\$wnnna$aFever, Relapsing
=450  \\$wnnna$aFevers, Relapsing
=450  \\$wnnna$aRelapsing Fevers
=550  \\$wg$aBorrelia Infections
=550  \\$wg$aTick-Borne Diseases
=667  \\$anot for "recurrent fever" ( = FEVER (IM) + RECURRENCE (NIM) ); infections by Borrelia species other than B. burgdorferi or B. burgdorferi group (which cause LYME DISEASE) probably go here, otherwise index under BORRELIA INFECTIONS
=680  \\$iAn acute infection characterized by recurrent episodes of PYREXIA alternating with asymptomatic intervals of apparent recovery. This condition is caused by SPIROCHETES of the genus BORRELIA. It is transmitted by the BITES of either the body louse (PEDICULUS humanus corporis), for which humans are the reservoir, or by soft ticks of the genus ORNITHODOROS, for which rodents and other animals are the principal reservoirs.
=750  \0$aRelapsing fever$5IEN$0(DLC)sh 85112485

=LDR  00597cz  a2200181n  4500
=001  9880363815802441
=005  20141212205242.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012060
=035  \\$aCBA5360HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x822
=072  \\$aE2.$x849
=150  \\$aRejuvenation
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aTherapeutics
=680  \\$iThe phenomenon of youthfulness, vitality, and freshness being restored. This can apply to appearance, TISSUES, organ functions, or other areas.
=750  \0$aRejuvenation$5IEN$0(DLC)sh 85112481

=LDR  00717cz  a2200217n  4500
=001  9880363816002441
=005  20141212205241.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012056
=035  \\$aCBA5356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x770.$x706
=150  \\$aReinforcement, Social
=450  \\$wnnna$aReinforcements, Social
=450  \\$aSocial Reinforcement
=450  \\$wnnna$aSocial Reinforcements
=550  \\$wg$aReinforcement (Psychology)
=667  \\$ano qualif
=680  \\$iThe strengthening of a response with a social reward such as a nod of approval, a parent's love or attention.
=688  \\$a1969
=750  \0$aReinforcement (Psychology)$5IEN$0(DLC)sh 85112459

=LDR  01142cz  a2200193n  4500
=001  9880363816202441
=005  20141212205240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012053
=035  \\$aCBA5353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x373.$x644
=150  \\$aReindeer
=450  \\$aCaribou
=550  \\$wg$aDeer
=667  \\$aIM; qualif permitted
=680  \\$iA genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. (From Webster, 3d ed; Walker's Mammals of the World, 5th ed, p1397)
=688  \\$a68; CARIBOU was heading 1975-94 (see under REINDEER 1975-90)
=750  \0$aReindeer$5IEN$0(DLC)sh 85112433

=LDR  00789cz  a2200229n  4500
=001  9880363816302441
=005  20141212205240.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012050
=035  \\$aCBA5350HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x782
=072  \\$aN2.$x421.$x784.$x644
=150  \\$aRehabilitation, Vocational
=450  \\$wnnna$aRehabilitations, Vocational
=450  \\$aVocational Rehabilitation
=450  \\$wnnna$aVocational Rehabilitations
=550  \\$wg$aRehabilitation
=550  \\$wh$aEmployment, Supported
=680  \\$iTraining of the mentally or physically disabled in work skills so they may be returned to regular employment utilizing these skills.
=688  \\$a67(66)
=750  \0$aVocational rehabilitation$5IEN$0(DLC)sh 85144196

=LDR  03473cz  a2200853n  4500
=001  9880363816402441
=005  20141212205239.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012048
=035  \\$aCBA5348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x831.$x200
=072  \\$aH2.$x403.$x680.$x600.$x500
=072  \\$aN2.$x421.$x784.$x377
=150  \\$aCorrection of Hearing Impairment
=450  \\$wnnna$aAudiologic Habilitation
=450  \\$wnnna$aAudiologic Habilitations
=450  \\$wnnna$aAudiologic Rehabilitation
=450  \\$wnnna$aAudiologic Rehabilitations
=450  \\$wnnna$aAuditory Perception Correction
=450  \\$wnnna$aAuditory Perception Corrections
=450  \\$wnnna$aAural Habilitation
=450  \\$wnnna$aAural Habilitations
=450  \\$wnnna$aAural Rehabilitation
=450  \\$wnnna$aAural Rehabilitations
=450  \\$aCorrection of Auditory Perception
=450  \\$wnnna$aCorrection of Hearing Loss
=450  \\$wnnna$aHabilitation, Audiologic
=450  \\$wnnna$aHabilitation, Aural
=450  \\$wnnna$aHabilitation of Hearing Impaired
=450  \\$aHabilitation of Hearing Impairment
=450  \\$wnnna$aHabilitations, Audiologic
=450  \\$wnnna$aHabilitations, Aural
=450  \\$aHearing Disorders$xrehabilitation
=450  \\$wnnna$aHearing Impaired Habilitation
=450  \\$wnnna$aHearing Impaired Habilitations
=450  \\$aHearing Impaired Rehabilitation
=450  \\$wnnna$aHearing Impairment Correction
=450  \\$wnnna$aHearing Impairment Corrections
=450  \\$wnnna$aHearing Impairment Habilitation
=450  \\$wnnna$aHearing Impairment Habilitations
=450  \\$wnnna$aHearing Impairment Rehabilitation
=450  \\$wnnna$aHearing Impairment Rehabilitations
=450  \\$wnnna$aHearing Loss Correction
=450  \\$wnnna$aHearing Loss Corrections
=450  \\$wnnna$aImpaired Habilitation, Hearing
=450  \\$wnnna$aImpaired Habilitations, Hearing
=450  \\$wnnna$aImpairment Correction, Hearing
=450  \\$wnnna$aImpairment Corrections, Hearing
=450  \\$wnnna$aImpairment Habilitation, Hearing
=450  \\$wnnna$aImpairment Habilitations, Hearing
=450  \\$wnnna$aImpairment Rehabilitation, Hearing
=450  \\$wnnna$aImpairment Rehabilitations, Hearing
=450  \\$wnnna$aLoss Correction, Hearing
=450  \\$wnnna$aLoss Corrections, Hearing
=450  \\$wnnna$aPerception Correction, Auditory
=450  \\$wnnna$aPerception Corrections, Auditory
=450  \\$wnnna$aRehabilitation, Audiologic
=450  \\$wnnna$aRehabilitation, Aural
=450  \\$wnnna$aRehabilitation, Hearing Impaired
=450  \\$aRehabilitation of Hearing Impaired
=450  \\$wnnna$aRehabilitation of Hearing Impairment
=450  \\$wnnna$aRehabilitations, Audiologic
=450  \\$wnnna$aRehabilitations, Aural
=550  \\$wg$aRehabilitation
=550  \\$wh$aCommunication Methods, Total
=550  \\$wh$aLipreading
=550  \\$wh$aManual Communication
=667  \\$ageneral or unspecified; prefer specifics; coordinate IM with type of hearing disorder/ rehabil (IM)
=680  \\$iProcedures for correcting HEARING DISORDERS.
=688  \\$a2013; (1998); use Rehabilitation of Hearing Impaired 2000-2012
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Rehabilitation of Hearing Impaired
=688  \\$a98; use explode 1975-97
=750  \0$aHearing impaired$xRehabilitation$5IEN-M$0(DLC)sh2008121493

=LDR  00777cz  a2200241n  4500
=001  9880363816502441
=005  20141212205238.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012047
=035  \\$aCBA5347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x808
=150  \\$aRehabilitation Centers
=450  \\$wnnna$aCenter, Rehabilitation
=450  \\$wnnna$aCenters, Rehabilitation
=450  \\$wnnna$aRehabilitation Center
=550  \\$wg$aHealth Facilities
=550  \\$wh$aSheltered Workshops
=550  \\$wh$aSubstance Abuse Treatment Centers
=667  \\$aIM
=680  \\$iFacilities which provide programs for rehabilitating the mentally or physically disabled individuals.
=688  \\$a68
=750  \0$aRehabilitation centers$5IEN$0(DLC)sh 85112405

=LDR  01970cz  a2200577n  4500
=001  9880363816602441
=005  20200625180633.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012046
=035  \\$aCBA5346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x169.$x63.$x500
=072  \\$aE2.$x831
=072  \\$aH2.$x403.$x680.$x600
=072  \\$aN2.$x421.$x784
=150  \\$aRehabilitation
=450  \\$aDisease$xrehabilitation
=450  \\$aHabilitation
=550  \\$wg$aAfter Care
=550  \\$wh$aHealth Services
=550  \\$wg$aPhysical and Rehabilitation Medicine
=550  \\$wg$aTherapeutics
=550  \\$wh$aActivities of Daily Living
=550  \\$wh$aAnimal Assisted Therapy
=550  \\$wh$aArt Therapy
=550  \\$wh$aBibliotherapy
=550  \\$wh$aCardiac Rehabilitation
=550  \\$wh$aCorrection of Hearing Impairment
=550  \\$wh$aDance Therapy
=550  \\$wh$aEarly Ambulation
=550  \\$wh$aExercise Therapy
=550  \\$wh$aMental Health Recovery
=550  \\$wh$aMusic Therapy
=550  \\$wh$aMyofunctional Therapy
=550  \\$wh$aNeurological Rehabilitation
=550  \\$wh$aOccupational Therapy
=550  \\$wh$aPhysical Therapy Modalities
=550  \\$wh$aPsychiatric Rehabilitation
=550  \\$wh$aRecreation Therapy
=550  \\$wh$aRehabilitation of Speech and Language Disorders
=550  \\$wh$aRehabilitation, Vocational
=550  \\$wh$aSelf Care
=550  \\$wh$aSelf-Management
=550  \\$wh$aTelerehabilitation
=550  \\$aDisabled Persons
=550  \\$aRecovery of Function
=550  \\$aReturn to Work
=550  \\$aSports for Persons with Disabilities
=667  \\$ageneral only: prefer /rehabil with diseases: Manual 19.7+, 19.8.64; differentiate from AFTERCARE
=680  \\$iRestoration of human functions to the maximum degree possible in a person or persons suffering from disease or injury.
=750  \0$aRehabilitation$5IEN$0(DLC)sh 85112401

=LDR  01871cz  a2200373n  4500
=001  9880363816702441
=005  20171031092929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012044
=035  \\$aCBA5344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x750
=072  \\$aN5.$x715.$x360.$x750.$x695
=072  \\$aN6.$x850.$x520.$x830.$x750
=150  \\$aRegression Analysis
=450  \\$wnnna$aAnalyses, Regression
=450  \\$wnnna$aAnalysis, Regression
=450  \\$wnnna$aDiagnostics, Regression
=450  \\$wnnna$aRegression Analyses
=450  \\$aRegression Diagnostics
=450  \\$wnnna$aRegression, Statistical
=450  \\$wnnna$aRegressions, Statistical
=450  \\$aStatistical Regression
=450  \\$wnnna$aStatistical Regressions
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aLeast-Squares Analysis
=550  \\$wh$aLinear Models
=550  \\$wh$aLogistic Models
=550  \\$wh$aProportional Hazards Models
=550  \\$wh$aSpatial Regression
=667  \\$aIM GEN only; coord NIM with specific disease or other concept (IM); no qualif; specify geog if pertinent
=680  \\$iProcedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.
=688  \\$a80(73); was see under STATISTICS 1975-79
=750  \0$aRegression analysis$5IEN$0(DLC)sh 85112392

=LDR  00983cz  a2200229n  4500
=001  9880363816902441
=005  20141212205235.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012041
=035  \\$aCBA5341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x400
=150  \\$aRegional Medical Programs
=450  \\$wnnna$aMedical Program, Regional
=450  \\$wnnna$aMedical Programs, Regional
=450  \\$wnnna$aProgram, Regional Medical
=450  \\$wnnna$aPrograms, Regional Medical
=550  \\$wg$aRegional Health Planning
=667  \\$aspecify geog; TN 163: restricted definition & use; DF: REGIONAL MED PROGRAMS
=680  \\$iCoordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under U.S. Public Law 89-239.
=688  \\$a68(67)
=750  \0$aRegional medical programs$5IEN$0(DLC)sh 85112364

=LDR  01177cz  a2200241n  4500
=001  9880363817002441
=005  20141212205234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012039
=035  \\$aCBA5339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x190.$x163.$x780
=150  \\$aRegional Blood Flow
=450  \\$wnnna$aBlood Flow, Regional
=450  \\$wnnna$aBlood Flows, Regional
=450  \\$wnnna$aFlow, Regional Blood
=450  \\$wnnna$aFlows, Regional Blood
=450  \\$wnnna$aRegional Blood Flows
=550  \\$wg$aBlood Circulation
=667  \\$acoordinate with organ / blood supply or specific artery or vein / physiol; Manual 19.8.11; specifics available are CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; LIVER CIRCULATION; PLACENTAL CIRCULATION; PULMONARY CIRCULATION; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; also available are COLLATERAL CIRCULATION; MICROCIRCULATION & PORTAL SYSTEM; Manual 21.4.2, 21.6; taking of pulse at wrist is not REGIONAL BLOOD FLOW: it is PULSE
=680  \\$iThe flow of BLOOD through or around an organ or region of the body.
=688  \\$a67(64)
=750  \0$aRegional blood flow$5IEN$0(DLC)sh 85112359

=LDR  00857cz  a2200241n  4500
=001  9880363817102441
=005  20170609110413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012038
=035  \\$aCBA5338HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x762
=150  \\$aRegeneration
=450  \\$wnnna$aRegenerations
=550  \\$wg$aBiological Phenomena
=550  \\$wh$aBone Remodeling
=550  \\$wh$aLiver Regeneration
=550  \\$wh$aNerve Regeneration
=550  \\$wh$aWound Healing
=550  \\$aGuided Tissue Regeneration
=667  \\$acoordinate IM with organ / physiol (IM), not / growth; available also are BONE REGENERATION; LIVER REGENERATION; NERVE REGENERATION & SPINAL CORD REGENERATION
=680  \\$iThe physiological renewal, repair, or replacement of tissue.
=750  \0$aRegeneration (Biology)$5IEN$0(DLC)sh 85112343

=LDR  01225cz  a2200361n  4500
=001  9880363817202441
=005  20200424123705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012037
=035  \\$aCBA5337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x700
=072  \\$aN6.$x850.$x860.$x510.$x900.$x600
=150  \\$aRefuse Disposal
=450  \\$wnnna$aDisposal, Refuse
=450  \\$wnnna$aDisposal, Solid Waste
=450  \\$wnnna$aDisposals, Refuse
=450  \\$wnnna$aDisposals, Solid Waste
=450  \\$wnnna$aRefuse Disposals
=450  \\$wnnna$aSolid Waste Disposal
=450  \\$wnnna$aSolid Waste Disposals
=450  \\$aWaste Disposal, Solid
=450  \\$wnnna$aWaste Disposals, Solid
=550  \\$wg$aSanitary Engineering
=550  \\$wg$aWaste Management
=550  \\$wh$aComposting
=550  \\$wh$aGarbage
=550  \\$wh$aIncineration
=550  \\$wh$aMedical Waste Disposal
=550  \\$wh$aWaste Disposal, Fluid
=550  \\$aSolid Waste
=680  \\$iThe discarding or destroying of garbage, sewage, or other waste matter or its transformation into something useful or innocuous.
=750  \0$aRefuse and refuse disposal$5IEN$0(DLC)sh 85112316

=LDR  00803cz  a2200229n  4500
=001  9880363817302441
=005  20141212205233.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012036
=035  \\$aCBA5336HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x755
=150  \\$aRefugees
=450  \\$wnnna$aCamp, Refugee
=450  \\$wnnna$aCamps, Refugee
=450  \\$wnnna$aRefugee
=450  \\$wnnna$aRefugee Camp
=450  \\$wnnna$aRefugee Camps
=550  \\$wg$aPersons
=667  \\$aspecify geog
=680  \\$iPersons fleeing to a place of safety, especially those who flee to a foreign country or power to escape danger or persecution in their own country or habitual residence because of race, religion, or political belief. (Webster, 3d ed)
=750  \0$aRefugees$5IEN$0(DLC)sh 85112299

=LDR  00698cz  a2200241n  4500
=001  9880363817402441
=005  20141212205232.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012034
=035  \\$aCBA5335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x792.$x643
=072  \\$aE5.$x760.$x643
=150  \\$aRefrigeration
=450  \\$wnnna$aChain, Cold
=450  \\$wnnna$aChains, Cold
=450  \\$aCold Chain
=450  \\$wnnna$aCold Chains
=550  \\$wg$aPreservation, Biological
=550  \\$aCold Temperature
=550  \\$aFreezing
=688  \\$awas in Cat E & J 1967-81, was in Cat G only 1963-66
=750  \0$aRefrigeration and refrigerating machinery$5IEN$0(DLC)sh 85112278

=LDR  00942cz  a2200253n  4500
=001  9880363817502441
=005  20141212205230.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012031
=035  \\$aCBA5332HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x808
=072  \\$aH1.$x671.$x617.$x755
=150  \\$aRefractometry
=450  \\$wnnna$aIndex, Refractive
=450  \\$wnnna$aIndices, Refractive
=450  \\$aRefractive Index
=450  \\$wnnna$aRefractive Indices
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aOptics and Photonics
=667  \\$aan anal chem technique; do not use for refractometry in REFRACTION, OCULAR
=680  \\$iMeasurement of the index of refraction (the ratio of the velocity of light or other radiation in the first of two media to its velocity in the second as it passes from one into the other).
=688  \\$a79
=750  \0$aRefractive index$5IEN$0(DLC)sh 85112261

=LDR  01203cz  a2200373n  4500
=001  9880363817602441
=005  20141212205230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012030
=035  \\$aCBA5331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744
=150  \\$aRefractive Errors
=450  \\$aAmetropia
=450  \\$wnnna$aAmetropias
=450  \\$wnnna$aDisorder, Refractive
=450  \\$wnnna$aDisorders, Refractive
=450  \\$wnnna$aError, Refractive
=450  \\$wnnna$aErrors, Refractive
=450  \\$wnnna$aRefractive Disorder
=450  \\$wnnna$aRefractive Disorders
=450  \\$wnnna$aRefractive Error
=550  \\$wg$aEye Diseases
=550  \\$wh$aAniseikonia
=550  \\$wh$aAnisometropia
=550  \\$wh$aAstigmatism
=550  \\$wh$aCorneal Wavefront Aberration
=550  \\$wh$aHyperopia
=550  \\$wh$aMyopia
=550  \\$wh$aPresbyopia
=550  \\$aVisual Acuity
=667  \\$adeviations from standard refraction of eye; DF: REFRACTIVE ERR
=680  \\$iDeviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.
=750  \0$aEye$xRefractive errors$0(DLC) sh 85046676$5IEN

=LDR  00860cz  a2200289n  4500
=001  9880363817702441
=005  20141212205230.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012029
=035  \\$aCBA5330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x850.$x700
=072  \\$aG1.$x590.$x770.$x760
=072  \\$aG1.$x595.$x640.$x760
=072  \\$aG14.$x760
=150  \\$aRefraction, Ocular
=450  \\$aOcular Refraction
=450  \\$wnnna$aOcular Refractions
=450  \\$wnnna$aRefractions, Ocular
=550  \\$wg$aOcular Physiological Phenomena
=550  \\$wg$aOptical Processes
=550  \\$wg$aVision Tests
=550  \\$aEye
=550  \\$aRetinoscopy
=550  \\$aVisual Acuity
=680  \\$iRefraction of LIGHT effected by the media of the EYE.
=750  \0$aEye$xAccommodation and refraction$5IEN$0(DLC)sh 85046644

=LDR  00766cz  a2200193n  4500
=001  9880363817802441
=005  20141212205229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012028
=035  \\$aCBA5329HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x799
=150  \\$aReflexotherapy
=450  \\$aReflex Therapy
=450  \\$wnnna$aTherapy, Reflex
=550  \\$wg$aComplementary Therapies
=667  \\$ado not confuse with REFLEXOLOGY see MASSAGE; do not use /util except by MeSH definition; DF: REFLEXOTHER
=680  \\$iTreatment of some morbid condition by producing a reflex action, as in the household treatment of nosebleed by a piece of ice applied to the cervical spine. (Stedman, 27th ed)
=750  \0$aReflexotherapy$5IEN$0(DLC)sh 85112221

=LDR  01275cz  a2200289n  4500
=001  9880363817902441
=005  20150325104359.0
=008  860328\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012027
=035  \\$aCBA5328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x600.$x765.$x795
=150  \\$aReflex, Vestibulo-Ocular
=450  \\$wnnna$aReflex, Vestibulo Ocular
=450  \\$wnnna$aReflex, Vestibuloocular
=450  \\$wnnna$aReflexes, Vestibo-Ocular
=450  \\$wnnna$aReflexes, Vestibo Ocular
=450  \\$wnnna$aReflexes, Vestibuloocular
=450  \\$wnnna$aVestibo-Ocular Reflexes
=450  \\$aVestibulo-Ocular Reflex
=450  \\$wnnna$aVestibulo Ocular Reflex
=450  \\$wnnna$aVestibuloocular Reflex
=450  \\$wnnna$aVestibuloocular Reflexes
=550  \\$wg$aReflex
=680  \\$iA reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS.
=688  \\$a87
=750  \0$aVestibulo-ocular reflex$0(DLC)sh 92002984$5IEN-M

=LDR  00776cz  a2200241n  4500
=001  9880363818002441
=005  20141212205229.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012026
=035  \\$aCBA5327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x550.$x650.$x700
=072  \\$aE1.$x370.$x600.$x550.$x650.$x700
=072  \\$aG11.$x561.$x600.$x765.$x768
=150  \\$aReflex, Stretch
=450  \\$aReflex, Tendon
=450  \\$wnnna$aStretch Reflex
=450  \\$wnnna$aTendon Reflex
=550  \\$wg$aReflex
=550  \\$aMuscle Spindles
=680  \\$iReflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors.
=688  \\$a82; was REFLEX, TENDON 1965-81
=750  \0$aStretch reflex$5IEN$0(DLC)sh 85128716

=LDR  00606cz  a2200193n  4500
=001  9880363818102441
=005  20141212205228.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x550.$x650.$x670
=072  \\$aE1.$x370.$x600.$x550.$x650.$x670
=072  \\$aG11.$x561.$x600.$x765.$x594
=150  \\$aReflex, Acoustic
=450  \\$wnnna$aAcoustic Reflex
=550  \\$wg$aReflex
=680  \\$iIntra-aural contraction of tensor tympani and stapedius in response to sound.
=688  \\$a80
=750  \0$aAcoustic reflex$5IEN$0(DLC)sh 85000589

=LDR  02781cz  a2200757n  4500
=001  9880363818202441
=005  20141212192502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012021
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x704
=072  \\$aC23.$x888.$x592.$x717
=072  \\$aE1.$x370.$x376.$x550.$x650.$x655
=072  \\$aE1.$x370.$x600.$x550.$x650.$x655
=072  \\$aG11.$x561.$x600.$x765.$x587
=150  \\$aReflex, Abnormal
=450  \\$wnnna$aAbnormal Deep Tendon Reflex
=450  \\$wnnna$aAbnormal Reflex
=450  \\$wnnna$aAbnormal Reflexes
=450  \\$wnnna$aAbsent Reflex
=450  \\$wnnna$aBulbocavernosus Reflex, Decreased
=450  \\$wnnna$aBulbocavernousus Reflex Absent
=450  \\$wnnna$aDecreased Bulbocavernosus Reflex
=450  \\$wnnna$aDecreased Reflex
=450  \\$wnnna$aHoffman's Reflex
=450  \\$aHyperreflexia
=450  \\$aHyporeflexia
=450  \\$wnnna$aPalmo-Mental Reflex
=450  \\$wnnna$aPalmo Mental Reflex
=450  \\$wnnna$aPendular Reflex
=450  \\$wnnna$aReflex, Absent
=450  \\$wnnna$aReflex Absent, Bulbocavernousus
=450  \\$wnnna$aReflex, Acoustic, Abnormal
=450  \\$wnnna$aReflex, Anal, Absent
=450  \\$wnnna$aReflex, Anal, Decreased
=450  \\$wnnna$aReflex, Ankle, Abnormal
=450  \\$wnnna$aReflex, Ankle, Absent
=450  \\$wnnna$aReflex, Ankle, Decreased
=450  \\$wnnna$aReflex, Biceps, Abnormal
=450  \\$wnnna$aReflex, Biceps, Absent
=450  \\$wnnna$aReflex, Biceps, Decreased
=450  \\$wnnna$aReflex, Corneal, Absent
=450  \\$wnnna$aReflex, Corneal, Decreased
=450  \\$wnnna$aReflex, Decreased
=450  \\$wnnna$aReflex, Decreased Bulbocavernosus
=450  \\$wnnna$aReflex, Deep Tendon, Abnormal
=450  \\$wnnna$aReflex, Deep Tendon, Absent
=450  \\$wnnna$aReflex, Gag, Absent
=450  \\$wnnna$aReflex, Gag, Decreased
=450  \\$wnnna$aReflex, Hoffman's
=450  \\$wnnna$aReflex, Knee, Abnormal
=450  \\$wnnna$aReflex, Knee, Decreased
=450  \\$wnnna$aReflex, Moro, Asymmetric
=450  \\$wnnna$aReflex, Palmo-Mental
=450  \\$wnnna$aReflex, Pendular
=450  \\$wnnna$aReflex, Triceps, Abnormal
=450  \\$wnnna$aReflex, Triceps, Absent
=450  \\$wnnna$aReflex, Triceps, Decreased
=450  \\$wnnna$aReflexes, Abnormal
=550  \\$wg$aNeurologic Manifestations
=550  \\$wg$aReflex
=550  \\$aAutonomic Dysreflexia
=550  \\$aReflex, Babinski
=667  \\$ado not use Cat C or E qualif
=680  \\$iAn abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.
=750  \0$aAbnormal reflexes$5IEN$0(DLC)sh 85112220

=LDR  03282cz  a2200721n  4500
=001  9880363818302441
=005  20141212205227.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012019
=035  \\$aCBA5320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177.$x195.$x800
=072  \\$aC10.$x668.$x829.$x250.$x800
=150  \\$aReflex Sympathetic Dystrophy
=450  \\$wnnna$aAlgodystrophic Syndrome
=450  \\$wnnna$aAlgodystrophies
=450  \\$aAlgodystrophy
=450  \\$wnnna$aAtrophies, Sudek's
=450  \\$wnnna$aAtrophy, Sudek
=450  \\$wnnna$aAtrophy, Sudek's
=450  \\$wnnna$aCervical Sympathetic Dystrophies
=450  \\$wnnna$aCervical Sympathetic Dystrophy
=450  \\$aComplex Regional Pain Syndrome, Type I
=450  \\$wnnna$aCPRS Type I
=450  \\$wnnna$aCPRS Type Is
=450  \\$wnnna$aDystrophies, Cervical Sympathetic
=450  \\$wnnna$aDystrophies, Reflex Sympathetic
=450  \\$wnnna$aDystrophy, Cervical Sympathetic
=450  \\$wnnna$aDystrophy, Reflex Sympathetic
=450  \\$wnnna$aI, CPRS Type
=450  \\$wnnna$aIs, CPRS Type
=450  \\$wnnna$aPain Syndrome Type I, Complex Regional
=450  \\$aPain Syndrome Type I, Regional, Complex
=450  \\$wnnna$aReflex Dystrophia, Sympathetic
=450  \\$wnnna$aReflex Sympathetic Dystrophies
=450  \\$wnnna$aReflex Sympathetic Dystrophy Syndrome
=450  \\$wnnna$aRSD (Reflex Sympathetic Dystrophy)
=450  \\$wnnna$aRSDs (Reflex Sympathetic Dystrophy)
=450  \\$aShoulder-Hand Syndrome
=450  \\$wnnna$aShoulder Hand Syndrome
=450  \\$wnnna$aShoulder-Hand Syndromes
=450  \\$aSudek Atrophy
=450  \\$wnnna$aSudek's Atrophies
=450  \\$wnnna$aSudek's Atrophy
=450  \\$wnnna$aSudeks Atrophy
=450  \\$wnnna$aSympathetic Dystrophies, Cervical
=450  \\$wnnna$aSympathetic Dystrophies, Reflex
=450  \\$wnnna$aSympathetic Dystrophy, Cervical
=450  \\$wnnna$aSympathetic Dystrophy, Reflex
=450  \\$wnnna$aSympathetic Reflex Dystrophia
=450  \\$wnnna$aSympathetic Reflex Dystrophias
=450  \\$wnnna$aSyndrome, Algodystrophic
=450  \\$wnnna$aSyndrome, Reflex Sympathetic Dystrophy
=450  \\$wnnna$aSyndrome, Shoulder-Hand
=450  \\$wnnna$aSyndromes, Shoulder-Hand
=450  \\$wnnna$aType I Complex Regional Pain Syndrome
=450  \\$wnnna$aType I, CPRS
=450  \\$wnnna$aType Is, CPRS
=550  \\$wg$aComplex Regional Pain Syndromes
=667  \\$aDF: CRPS TYPE I
=680  \\$iA syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. This condition is most often precipitated by trauma to soft tissue or nerve complexes. The skin over the affected region is usually erythematous and demonstrates hypersensitivity to tactile stimuli and erythema. (Adams et al., Principles of Neurology, 6th ed, p1360; Pain 1995 Oct;63(1):127-33)
=688  \\$a1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME & SUDECK'S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK'S ATROPHY 1992-95
=750  \0$aReflex sympathetic dystrophy$5IEN$0(DLC)sh 85112217

=LDR  01577cz  a2200445n  4500
=001  9880363818402441
=005  20141212205226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012018
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x550.$x650
=072  \\$aE1.$x370.$x600.$x550.$x650
=072  \\$aF2.$x830.$x702
=072  \\$aG11.$x561.$x600.$x765
=150  \\$aReflex
=550  \\$wg$aNervous System Physiological Processes
=550  \\$wg$aNeurologic Examination
=550  \\$wg$aPsychophysiology
=550  \\$wh$aBaroreflex
=550  \\$wh$aBlinking
=550  \\$wh$aDiving Reflex
=550  \\$wh$aGagging
=550  \\$wh$aGalvanic Skin Response
=550  \\$wh$aPiloerection
=550  \\$wh$aReflex, Abdominal
=550  \\$wh$aReflex, Abnormal
=550  \\$wh$aReflex, Acoustic
=550  \\$wh$aReflex, Babinski
=550  \\$wh$aReflex, Monosynaptic
=550  \\$wh$aReflex, Oculocardiac
=550  \\$wh$aReflex, Pupillary
=550  \\$wh$aReflex, Righting
=550  \\$wh$aReflex, Startle
=550  \\$wh$aReflex, Stretch
=550  \\$wh$aReflex, Trigeminocardiac
=550  \\$wh$aReflex, Vestibulo-Ocular
=667  \\$aareflexia, hyporeflexia, hyperreflexia, loss of reflex: index under REFLEX, ABNORMAL
=680  \\$iAn involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.
=688  \\$aREFLEX, BABINSKI was BABINSKI REFLEX see under REFLEX, ABNORMAL 1968-89
=750  \0$aReflexes$5IEN$0(DLC)sh 85112218

=LDR  01581cz  a2200469n  4500
=001  9880363818502441
=005  20141212205226.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012017
=035  \\$aCBA5318HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x849
=150  \\$aReferral and Consultation
=450  \\$aConsultation
=450  \\$wnnna$aConsultation and Referral
=450  \\$wnnna$aConsultations
=450  \\$wnnna$aGatekeeper, Health Service
=450  \\$aGatekeepers, Health Service
=450  \\$wnnna$aHealth Service Gatekeeper
=450  \\$wnnna$aHealth Service Gatekeepers
=450  \\$aHospital Referral
=450  \\$wnnna$aHospital Referrals
=450  \\$wnnna$aOpinion, Second
=450  \\$wnnna$aOpinions, Second
=450  \\$wnnna$aReferral
=450  \\$wnnna$aReferral, Hospital
=450  \\$wnnna$aReferrals
=450  \\$wnnna$aReferrals, Hospital
=450  \\$aSecond Opinion
=450  \\$wnnna$aSecond Opinions
=550  \\$wg$aProfessional Practice
=550  \\$wh$aEthics Consultation
=550  \\$wh$aGatekeeping
=550  \\$wh$aPhysician Self-Referral
=550  \\$wh$aRemote Consultation
=550  \\$wh$aSecondary Care
=550  \\$wh$aTertiary Healthcare
=550  \\$aTertiary Care Centers
=680  \\$iThe practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide.
=688  \\$a68
=750  \0$aMedical consultation$5IEN-M$0(DLC)sh 85082909
=750  \0$aMedical referral$5IEN-HS$0(DLC)sh 85083019

=LDR  01347cz  a2200325n  4500
=001  9880363818602441
=005  20141212205225.0
=008  780324\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012015
=035  \\$aCBA5316HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x978.$x808
=150  \\$aReference Standards
=450  \\$wnnna$aPreparation, Standard
=450  \\$wnnna$aPreparations, Standard
=450  \\$wnnna$aReference Standard
=450  \\$wnnna$aStandard Preparation
=450  \\$aStandard Preparations
=450  \\$wnnna$aStandard, Reference
=450  \\$wnnna$aStandardization
=450  \\$wnnna$aStandards
=450  \\$aStandards, Reference
=550  \\$wg$aWeights and Measures
=550  \\$wh$aFiducial Markers
=550  \\$wh$aGrowth Charts
=550  \\$aQuality Control
=667  \\$aNIM with specific subject (IM) with /stand if permitted by category; no qualif; differentiate from REFERENCE VALUES: REFERENCE STANDARDS = basis of value or standard for a measurement, REFERENCE VALUES = range or frequency distribution of a measurement
=680  \\$iA basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.
=688  \\$a79
=750  \0$aStandardization$5IEN$0(DLC)sh 85127309

=LDR  01258cz  a2200337n  4500
=001  9880363818702441
=005  20201012173601.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012013
=035  \\$aCBA5314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836
=150  \\$aReference Books
=450  \\$wnnna$aBook, Reference
=450  \\$wnnna$aBooks, Reference
=450  \\$wnnna$aReference Book
=550  \\$wg$aBooks
=550  \\$wh$aAlmanacs as Topic
=550  \\$wh$aAtlases as Topic
=550  \\$wh$aDictionaries as Topic
=550  \\$wh$aDirectories as Topic
=550  \\$wh$aDispensatories as Topic
=550  \\$wh$aEncyclopedias as Topic
=550  \\$wh$aFormularies as Topic
=550  \\$wh$aHerbals as Topic
=550  \\$wh$aPharmacopoeias as Topic
=550  \\$wh$aReference Books, Medical
=550  \\$aTextbooks as Topic
=667  \\$aIM
=680  \\$iBooks designed by the arrangement and treatment of their subject matter to be consulted for definite terms of information rather than to be read consecutively. Reference books include DICTIONARIES; ENCYCLOPEDIAS; ATLASES; etc. (From the ALA Glossary of Library and Information Science, 1983)
=750  \0$aReference books$5IEN$0(DLC)sh 85112186

=LDR  00799cz  a2200193n  4500
=001  9880363818802441
=005  20141212192501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D012012
=035  \\$aCBA5313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659.$x413.$x875.$x642
=072  \\$aA8.$x186.$x211.$x653.$x413.$x500.$x642
=150  \\$aRed Nucleus
=450  \\$wnnna$aNucleus, Red
=450  \\$aNucleus Ruber
=550  \\$wg$aTegmentum Mesencephali
=680  \\$iA pinkish-yellow portion of the midbrain situated in the rostral mesencephalic tegmentum. It receives a large projection from the contralateral half of the CEREBELLUM via the superior cerebellar peduncle and a projection from the ipsilateral MOTOR CORTEX.
=750  \0$aRed nucleus$5IEN$0(DLC)sh 85112073

=LDR  01886cz  a2200373n  4500
=001  9880363818902441
=005  20141212205153.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011941
=035  \\$aCBA5242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x70.$x300.$x300
=072  \\$aD12.$x776.$x543.$x750.$x100.$x150.$x300
=072  \\$aD12.$x776.$x543.$x750.$x720.$x300.$x300.$x300
=150  \\$aReceptors, Adrenergic
=450  \\$wnnna$aAdrenergic Receptor
=450  \\$aAdrenergic Receptors
=450  \\$aAdrenoceptors
=450  \\$wnnna$aEpinephrine Receptors
=450  \\$wnnna$aNorepinephrine Receptors
=450  \\$wnnna$aReceptor, Adrenergic
=450  \\$aReceptors, Epinephrine
=450  \\$aReceptors, Norepinephrine
=550  \\$wg$aReceptors, Catecholamine
=550  \\$wh$aReceptors, Adrenergic, alpha
=550  \\$wh$aReceptors, Adrenergic, beta
=550  \\$aEpinephrine
=550  \\$aNorepinephrine
=550  \\$aRacepinephrine
=550  \\$aSympathomimetics
=667  \\$aGEN; prefer specifics; coord IM with specific adrenergic agent (IM); DF: RECEPT ADREN
=680  \\$iCell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
=688  \\$a73(71); RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, & RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993
=750  \0$aAdrenaline$xReceptors$5IEN$0(DLC)sh 85001011

=LDR  00591cz  a2200193n  4500
=001  9880363819002441
=005  20141212205152.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011939
=035  \\$aCBA5240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x641
=150  \\$aMental Recall
=450  \\$wnnna$aRecall, Mental
=550  \\$wg$aMemory
=550  \\$aComprehension
=680  \\$iThe process whereby a representation of past experience is elicited.
=688  \\$a2003 (1966); use MEMORY 1966-1990
=750  \0$aRecollection (Psychology)$5IEN$0(DLC)sh 85111844

=LDR  00897cz  a2200217n  4500
=001  9880363819102441
=005  20141212205151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011937
=035  \\$aCBA5238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x804
=150  \\$aReality Therapy
=450  \\$wnnna$aReality Therapies
=450  \\$wnnna$aTherapies, Reality
=450  \\$wnnna$aTherapy, Reality
=550  \\$wg$aPsychotherapy
=667  \\$aa psychother technique; DF: REALITY THER
=680  \\$iMethod of psychotherapeutic treatment based on assumption of patients' personal responsibility for their own behavior. The therapist actively guides patients to accurate self-perception for fulfillment of needs of self-worth and respect for others. (From APA, Thesaurus of Psychological Index Terms, 8th ed.)
=688  \\$a74
=750  \0$aReality therapy$5IEN$0(DLC)sh 85111775

=LDR  01717cz  a2200445n  4500
=001  9880363819202441
=005  20141212205150.0
=008  770422\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011933
=035  \\$aCBA5234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x259.$x875
=072  \\$aD27.$x720.$x470.$x410.$x680
=072  \\$aE7.$x720
=150  \\$aReagent Kits, Diagnostic
=450  \\$wnnna$aDiagnostic Reagent Kit
=450  \\$aDiagnostic Reagent Kits
=450  \\$wnnna$aDiagnostic Reagents and Test Kits
=450  \\$wnnna$aDiagnostic Test Kit
=450  \\$wnnna$aDiagnostic Test Kits
=450  \\$wnnna$aIn Vitro Diagnostic Device
=450  \\$wnnna$aIn Vitro Diagnostic Devices
=450  \\$wnnna$aIn Vitro Diagnostic Medical Device
=450  \\$wnnna$aIn Vitro Diagnostic Medical Devices
=450  \\$wnnna$aKit, Diagnostic Reagent
=450  \\$wnnna$aKit, Diagnostic Test
=450  \\$wnnna$aKits, Diagnostic Reagent
=450  \\$wnnna$aKits, Diagnostic Test
=450  \\$wnnna$aReagent Kit, Diagnostic
=450  \\$wnnna$aTest Kit, Diagnostic
=450  \\$wnnna$aTest Kits, Diagnostic
=550  \\$wg$aDiagnostic Uses of Chemicals
=550  \\$wg$aEquipment and Supplies
=550  \\$wg$aIndicators and Reagents
=550  \\$wh$aReagent Strips
=550  \\$aDiagnostic Tests, Routine
=550  \\$aIndicators and Reagents
=680  \\$iCommercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.
=688  \\$a78
=750  \0$aDiagnostic reagents and test kits$5IEN$0(DLC)sh 85037509

=LDR  00488cz  a2200169n  4500
=001  9880363819302441
=005  20141212205150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011932
=035  \\$aCBA5233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x557
=150  \\$aReading
=450  \\$wnnna$aReadings
=550  \\$wg$aLanguage Arts
=667  \\$ano qualif; Braille: coord IM with BLINDNESS (IM) + SENSORY AIDS (IM)
=750  \0$aReading$5IEN$0(DLC)sh 85111662

=LDR  01194cz  a2200373n  4500
=001  9880363819402441
=005  20141212205149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011930
=035  \\$aCBA5231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x650
=072  \\$aF4.$x669.$x817
=072  \\$aG11.$x561.$x677
=150  \\$aReaction Time
=450  \\$wnnna$aLatencies, Response
=450  \\$wnnna$aLatency, Response
=450  \\$wnnna$aReaction Times
=450  \\$wnnna$aResponse Latencies
=450  \\$aResponse Latency
=450  \\$aResponse Time
=450  \\$wnnna$aResponse Times
=450  \\$wnnna$aTime, Reaction
=450  \\$wnnna$aTime, Response
=450  \\$wnnna$aTimes, Reaction
=450  \\$wnnna$aTimes, Response
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wg$aPsychological Techniques
=550  \\$wg$aPsychophysiology
=550  \\$wh$aRefractory Period, Psychological
=667  \\$aphysiol processes only
=680  \\$iThe time from the onset of a stimulus until a response is observed.
=688  \\$aRESPONSE LATENCY was see under REACTION TIME 1970-76
=750  \0$aReaction time$5IEN$0(DLC)sh 85111631

=LDR  00814cz  a2200229n  4500
=001  9880363819502441
=005  20141212205149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011928
=035  \\$aCBA5229HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x617.$x812
=150  \\$aRaynaud Disease
=450  \\$wnnna$aCold Fingers, Hereditary
=450  \\$wnnna$aRaynaud Phenomenon
=450  \\$wnnna$aRaynaud's Disease
=450  \\$wnnna$aRaynauds Disease
=550  \\$wg$aPeripheral Vascular Diseases
=550  \\$wh$aCREST Syndrome
=680  \\$iAn idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
=688  \\$a2004 (1966)
=750  \0$aRaynaud's disease$0(DLC) sh 85111603$5IEN

=LDR  01429cz  a2200313n  4500
=001  9880363819602441
=005  20141212205148.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011926
=035  \\$aCBA5227HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x81.$x777
=150  \\$aRauwolfia
=450  \\$wnnna$aRauvolfia
=450  \\$wnnna$aRauvolfia serpentina
=450  \\$wnnna$aRauvolfia serpentinas
=450  \\$wnnna$aRauvolfias
=450  \\$wnnna$aRauwolfia serpentina
=450  \\$wnnna$aRauwolfia serpentinas
=450  \\$wnnna$aRauwolfias
=450  \\$wnnna$aserpentina, Rauvolfia
=450  \\$wnnna$aserpentina, Rauwolfia
=450  \\$wnnna$aserpentinas, Rauvolfia
=450  \\$wnnna$aserpentinas, Rauwolfia
=550  \\$wg$aApocynaceae
=667  \\$aplant only; deriv alkaloids = RAUWOLFIA ALKALOIDS or specifics; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the APOCYNACEAE or dogbane family. Alkaloids from plants in this genus have been used as tranquilizers and antihypertensive agents. RESERPINE is derived from R. serpentina.
=688  \\$awas in Cat B & D 1963-77
=750  \0$aRauvolfia$5IEN$0(DLC)sh 85111569

=LDR  02615cz  a2200685n  4500
=001  9880363819702441
=005  20141212205146.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011919
=035  \\$aCBA5220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x157.$x760
=072  \\$aB1.$x50.$x50.$x199.$x520.$x760
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x700.$x400
=150  \\$aRats, Inbred Strains
=450  \\$wnnna$aAugust Rat
=450  \\$aAugust Rats
=450  \\$wnnna$aInbred Rat Strain
=450  \\$wnnna$aInbred Rat Strains
=450  \\$wnnna$aInbred Strain of Rat
=450  \\$wnnna$aInbred Strain of Rats
=450  \\$wnnna$aInbred Strain Rat
=450  \\$wnnna$aInbred Strain Rats
=450  \\$wnnna$aInbred Strains of Rats
=450  \\$wnnna$aInbred Strains Rat
=450  \\$wnnna$aInbred Strains Rats
=450  \\$wnnna$aRat, August
=450  \\$wnnna$aRat, Inbred Strain
=450  \\$wnnna$aRat Inbred Strain
=450  \\$wnnna$aRat Inbred Strains
=450  \\$wnnna$aRat, Inbred Strains
=450  \\$wnnna$aRat Strain, Inbred
=450  \\$wnnna$aRat Strains, Inbred
=450  \\$wnnna$aRats, August
=450  \\$wnnna$aRats Inbred Strain
=450  \\$wnnna$aRats, Inbred Strain
=450  \\$wnnna$aRats Inbred Strains
=450  \\$wnnna$aStrain, Inbred Rat
=450  \\$wnnna$aStrain Rat, Inbred
=450  \\$wnnna$aStrain Rats, Inbred
=450  \\$wnnna$aStrains, Inbred Rat
=550  \\$wg$aAnimals, Inbred Strains
=550  \\$wg$aRats
=550  \\$wh$aRats, Inbred ACI
=550  \\$wh$aRats, Inbred BB
=550  \\$wh$aRats, Inbred BN
=550  \\$wh$aRats, Inbred BUF
=550  \\$wh$aRats, Inbred Dahl
=550  \\$wh$aRats, Inbred F344
=550  \\$wh$aRats, Inbred LEC
=550  \\$wh$aRats, Inbred Lew
=550  \\$wh$aRats, Inbred OLETF
=550  \\$wh$aRats, Inbred SHR
=550  \\$wh$aRats, Inbred WF
=550  \\$wh$aRats, Inbred WKY
=667  \\$aGEN or unspecified; prefer specifics; NIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS: Manual 18.6.14, 22.36; X ref AUGUST RATS is seen often in Russian lit
=680  \\$iGenetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
=688  \\$a72
=750  \0$81$wb$aInbreeding$5IEN$0(DLC)sh 85064709
=750  \0$81$wb$aRats$5IEN-HS$0(DLC)sh 85111538

=LDR  00804cz  a2200193n  4500
=001  9880363819802441
=005  20141212205142.0
=008  820428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011910
=035  \\$aCBA5211HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x505.$x700.$x550.$x110
=150  \\$aRats, Brattleboro
=450  \\$wnnna$aBrattleboro Rats
=550  \\$wg$aRats, Mutant Strains
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted; do not forget also to check tag RATS
=680  \\$iA mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus.
=688  \\$a91(83); was see under RATS, MUTANT STRAINS 1983-90
=750  \0$aBrattleboro rat$5IEN$0(DLC)sh 85016500

=LDR  00713cz  a2200181n  4500
=001  9880363819902441
=005  20141212205142.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011908
=035  \\$aCBA5209M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x746
=150  \\$aRationalization
=550  \\$wg$aDefense Mechanisms
=667  \\$ano qualif
=680  \\$iA defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable.
=688  \\$a91(75); was see under DEFENSE MECHANISMS 1975-90
=750  \0$aRationalization (Psychology)$0(DLC) sh 85111522$5IEN-M

=LDR  01142cz  a2200313n  4500
=001  9880363820002441
=005  20141212205141.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011906
=035  \\$aCBA5207HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x388.$x750
=072  \\$aC1.$x252.$x400.$x771
=150  \\$aRat-Bite Fever
=450  \\$wnnna$aFever, Rat-Bite
=450  \\$wnnna$aFever, Ratbite
=450  \\$wnnna$aFevers, Rat-Bite
=450  \\$wnnna$aFevers, Ratbite
=450  \\$wnnna$aRat Bite Fever
=450  \\$wnnna$aRat-Bite Fevers
=450  \\$wnnna$aRatbite Fever
=450  \\$wnnna$aRatbite Fevers
=450  \\$aSodoku
=550  \\$wg$aFusobacteriaceae Infections
=550  \\$wg$aGram-Negative Bacterial Infections
=667  \\$aa disease entity caused by a gram-neg bact
=680  \\$iA syndrome characterized by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either Streptobacillus moniliformis or Spirillum minus.
=688  \\$aRAT-BITE FEVER, SPIRILLARY was heading 1963-67
=750  \0$aRat-bite fever$5IEN$0(DLC)sh 85111497

=LDR  04795cz  a2201357n  4500
=001  9880363820102441
=005  20141212205141.0
=008  870509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011905
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x24.$x340.$x375.$x500.$x791.$x550
=150  \\$aGenes, ras
=450  \\$wnnna$ac-H-ras Gene
=450  \\$wnnna$ac-H-ras Genes
=450  \\$wnnna$ac H ras Genes
=450  \\$wnnna$ac-H-ras Proto-Oncogene
=450  \\$wnnna$ac-H-ras Proto-Oncogenes
=450  \\$wnnna$ac H ras Proto Oncogenes
=450  \\$wnnna$ac-Ha-ras Gene
=450  \\$ac-Ha-ras Genes
=450  \\$wnnna$ac Ha ras Genes
=450  \\$wnnna$ac-Ha-ras Proto-Oncogene
=450  \\$wnnna$ac-Ha-ras Proto-Oncogenes
=450  \\$wnnna$ac Ha ras Proto Oncogenes
=450  \\$wnnna$ac-K-ras Gene
=450  \\$wnnna$ac-K-ras Genes
=450  \\$wnnna$ac K ras Genes
=450  \\$wnnna$ac-K-ras Proto-Oncogene
=450  \\$wnnna$ac-K-ras Proto-Oncogenes
=450  \\$wnnna$ac K ras Proto Oncogenes
=450  \\$wnnna$ac-Ki-ras Gene
=450  \\$ac-Ki-ras Genes
=450  \\$wnnna$ac Ki ras Genes
=450  \\$wnnna$ac-Ki-ras Proto-Oncogene
=450  \\$wnnna$ac-Ki-ras Proto-Oncogenes
=450  \\$wnnna$ac Ki ras Proto Oncogenes
=450  \\$wnnna$ac-N-ras Gene
=450  \\$ac-N-ras Genes
=450  \\$wnnna$ac N ras Genes
=450  \\$wnnna$ac-N-ras Proto-Oncogene
=450  \\$wnnna$ac-N-ras Proto-Oncogenes
=450  \\$wnnna$ac N ras Proto Oncogenes
=450  \\$wnnna$aGene, Ha-ras
=450  \\$wnnna$aGene, Ki-ras
=450  \\$wnnna$aGene, v-Ha-ras
=450  \\$wnnna$aGene, v-Ki-ras
=450  \\$wnnna$aGenes, Ha-ras
=450  \\$wnnna$aGenes, Ki-ras
=450  \\$wnnna$aGenes, N-ras
=450  \\$wnnna$aGenes, v-Ha-ras
=450  \\$wnnna$aGenes, v-Ki-ras
=450  \\$wnnna$aH-ras Gene
=450  \\$wnnna$aH-ras Genes
=450  \\$wnnna$aH ras Genes
=450  \\$wnnna$aH-ras Oncogene
=450  \\$wnnna$aH-ras Oncogenes
=450  \\$wnnna$aH ras Oncogenes
=450  \\$wnnna$aHa-ras Gene
=450  \\$aHa-ras Genes
=450  \\$wnnna$aHa ras Genes
=450  \\$wnnna$aHa-ras Oncogene
=450  \\$wnnna$aHa-ras Oncogenes
=450  \\$wnnna$aHa ras Oncogenes
=450  \\$wnnna$aK-ras Gene
=450  \\$wnnna$aK-ras Genes
=450  \\$wnnna$aK ras Genes
=450  \\$wnnna$aK-ras Oncogene
=450  \\$wnnna$aK-ras Oncogenes
=450  \\$wnnna$aK ras Oncogenes
=450  \\$wnnna$aKi-ras Gene
=450  \\$aKi-ras Genes
=450  \\$wnnna$aKi ras Genes
=450  \\$wnnna$aKi-ras Oncogene
=450  \\$wnnna$aKi-ras Oncogenes
=450  \\$wnnna$aKi ras Oncogenes
=450  \\$wnnna$aN-ras Gene
=450  \\$aN-ras Genes
=450  \\$wnnna$aN ras Genes
=450  \\$wnnna$aN-ras Oncogene
=450  \\$wnnna$aN-ras Oncogenes
=450  \\$wnnna$aN ras Oncogenes
=450  \\$wnnna$aras Gene
=450  \\$aras Genes
=450  \\$wnnna$aras Oncogene
=450  \\$wnnna$aras Oncogenes
=450  \\$wnnna$av-H-ras Gene
=450  \\$wnnna$av-H-ras Genes
=450  \\$wnnna$av H ras Genes
=450  \\$wnnna$av-H-ras Oncogene
=450  \\$wnnna$av-H-ras Oncogenes
=450  \\$wnnna$av H ras Oncogenes
=450  \\$wnnna$av-Ha-ras Gene
=450  \\$av-Ha-ras Genes
=450  \\$wnnna$av Ha ras Genes
=450  \\$wnnna$av-Ha-ras Oncogene
=450  \\$wnnna$av-Ha-ras Oncogenes
=450  \\$wnnna$av Ha ras Oncogenes
=450  \\$wnnna$av-K-ras Gene
=450  \\$wnnna$av-K-ras Genes
=450  \\$wnnna$av K ras Genes
=450  \\$wnnna$av-K-ras Oncogene
=450  \\$wnnna$av-K-ras Oncogenes
=450  \\$wnnna$av K ras Oncogenes
=450  \\$wnnna$av-Ki-ras Gene
=450  \\$av-Ki-ras Genes
=450  \\$wnnna$av Ki ras Genes
=450  \\$wnnna$av-Ki-ras Oncogene
=450  \\$wnnna$av-Ki-ras Oncogenes
=450  \\$wnnna$av Ki ras Oncogenes
=550  \\$wg$aProto-Oncogenes
=550  \\$aCostello Syndrome
=550  \\$aras Proteins
=680  \\$iFamily of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.
=688  \\$a1991; was RAS GENES 1988-1990; was RAS GENES see ONCOGENES 1985-1987
=688  \\$a91; was RAS GENES 1988-90; was RAS GENES see ONCOGENES 1985-87
=750  \0$aRas oncogenes$5IEN$0(DLC)sh 89002595

=LDR  00469cz  a2200181n  4500
=001  9880363820202441
=005  20141212205139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011904
=035  \\$aCBA5205HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x779
=150  \\$aRare Books
=450  \\$wnnna$aBook, Rare
=450  \\$wnnna$aBooks, Rare
=450  \\$wnnna$aRare Book
=550  \\$wg$aBooks
=750  \0$aRare books$5IEN$0(DLC)sh 85111445

=LDR  00638cz  a2200217n  4500
=001  9880363820302441
=005  20141212205139.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011902
=035  \\$aCBA5203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x748.$x640
=150  \\$aRape
=450  \\$aRape Victims$5IEN
=450  \\$wnnna$aRapes
=450  \\$aRapists$5IEN
=550  \\$wg$aSex Offenses
=680  \\$iUnlawful sexual intercourse without consent of the victim.
=750  \0$aRape victims$5IEN-M$0(DLC)sh 85111415
=750  \0$aRape$5IEN-HS$0(DLC)sh 85111402
=750  \0$aRapists$5IEN-HS$0(DLC)sh 85111432

=LDR  01260cz  a2200325n  4500
=001  9880363820402441
=005  20141212192457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011901
=035  \\$aCBA5202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637.$x800.$x500.$x700
=072  \\$aA8.$x675.$x542.$x512.$x560.$x700
=072  \\$aA8.$x800.$x800.$x690.$x500.$x700
=072  \\$aA10.$x755.$x503.$x700
=072  \\$aA11.$x284.$x149.$x165.$x760
=072  \\$aA11.$x650.$x800.$x500.$x700
=072  \\$aA11.$x671.$x501.$x512.$x560.$x700
=072  \\$aA11.$x671.$x514.$x553.$x640
=150  \\$aRanvier's Nodes
=450  \\$aNodes of Ranvier
=450  \\$wnnna$aNodes, Ranvier's
=450  \\$wnnna$aRanvier Nodes
=450  \\$wnnna$aRanviers Nodes
=550  \\$wg$aCell Membrane Structures
=550  \\$wg$aMyelin Sheath
=667  \\$aregular gaps in myelin sheath; A 11 qualif except /cytol; /genet permitted
=680  \\$iRegularly spaced gaps in the myelin sheaths of peripheral axons. Ranvier's nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction.
=688  \\$a73(65)
=750  \0$aNodes of Ranvier$5IEN$0(DLC)sh 85092164

=LDR  01034cz  a2200313n  4500
=001  9880363820502441
=005  20141212205138.0
=008  830613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011899
=035  \\$aCBA5200HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x312.$x750
=150  \\$aRanitidine
=450  \\$wnnna$aAH-19065
=450  \\$wnnna$aAH 19065
=450  \\$wnnna$aAH19065
=450  \\$wnnna$aBiotidin
=450  \\$wnnna$aHydrochloride, Ranitidine
=450  \\$wnnna$aN (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
=450  \\$wnnna$aRanisen
=450  \\$wnnna$aRanitidin
=450  \\$wnnna$aRanitidine Hydrochloride
=450  \\$wnnna$aSostril
=450  \\$wnnna$aZantac
=450  \\$wnnna$aZantic
=550  \\$wg$aFurans
=680  \\$iA non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
=688  \\$a84
=750  \0$aRanitidine$5IEN$0(DLC)sh 85111377

=LDR  01016cz  a2200313n  4500
=001  9880363820602441
=005  20141212205138.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011898
=035  \\$aCBA5199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708
=150  \\$aRanidae
=450  \\$wnnna$aFrog, True
=450  \\$aFrogs, True
=450  \\$aRana
=450  \\$wnnna$aTrue Frog
=450  \\$wnnna$aTrue Frogs
=550  \\$wg$aAnura
=550  \\$wh$aRana catesbeiana
=550  \\$wh$aRana clamitans
=550  \\$wh$aRana esculenta
=550  \\$wh$aRana pipiens
=550  \\$wh$aRana ridibunda
=550  \\$wh$aRana temporaria
=667  \\$afamily of true frogs; GEN or unspecified; prefer specific genera; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iThe family of true frogs of the order Anura. The family occurs worldwide except in Antarctica.
=688  \\$a81; was RANA 1972-80
=750  \0$aRanidae$5IEN$0(DLC)sh 85111376

=LDR  00894cz  a2200253n  4500
=001  9880363820702441
=005  20141212205137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011896
=035  \\$aCBA5197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x420
=150  \\$aRana temporaria
=450  \\$wnnna$aCommon European Frog
=450  \\$wnnna$aCommon Frog, European
=450  \\$aEuropean Common Frog
=450  \\$wnnna$aEuropean Frog, Common
=450  \\$aFrog, Common European
=450  \\$wnnna$aFrog, European Common
=550  \\$wg$aRanidae
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc.
=688  \\$a72
=750  \0$aRana temporaria$5IEN$0(DLC)sh 85111314

=LDR  00672cz  a2200181n  4500
=001  9880363820802441
=005  20141212205137.0
=008  800512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011895
=035  \\$aCBA5196HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x360
=150  \\$aRana ridibunda
=550  \\$wg$aRanidae
=667  \\$alaughing frog; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research.
=688  \\$a91(81); was see under RANIDAE 1981-90
=750  \0$aPelophylax ridibundus$5IEN$0(DLC)sh 85111312

=LDR  00841cz  a2200241n  4500
=001  9880363820902441
=005  20141212205137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011894
=035  \\$aCBA5195HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x310
=150  \\$aRana pipiens
=450  \\$aFrog, Leopard
=450  \\$wnnna$aFrogs, Leopard
=450  \\$aLeopard Frog
=450  \\$wnnna$aLeopard Frogs
=450  \\$wnnna$aLithobates pipiens
=550  \\$wg$aRanidae
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research.
=688  \\$a72
=750  \0$aNorthern leopard frog$5IEN$0(DLC)sh 85111311

=LDR  00709cz  a2200205n  4500
=001  9880363821002441
=005  20141212205137.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011893
=035  \\$aCBA5194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x240
=150  \\$aRana esculenta
=450  \\$aEdible Frog$5IEN
=450  \\$aPelophylax esculentus
=550  \\$wg$aRanidae
=667  \\$aNIM with no qualifiers when experimental animal
=680  \\$iAn edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as "edible frog".
=688  \\$a72
=750  \0$aEdible frog$0(DLC) sh 85040964$5IEN

=LDR  00855cz  a2200241n  4500
=001  9880363821102441
=005  20141212205136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011892
=035  \\$aCBA5193HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x180
=150  \\$aRana catesbeiana
=450  \\$aBullfrog
=450  \\$wnnna$aBullfrogs
=450  \\$wnnna$acatesbeiana, Rana
=450  \\$wnnna$acatesbeianas, Rana
=450  \\$wnnna$aRana catesbeianas
=550  \\$wg$aRanidae
=667  \\$abullfrog; NIM when exper animal: no qualif; when IM, qualif permitted
=680  \\$iA species of the family Ranidae (true frogs). The only anuran properly referred to by the common name "bullfrog", it is the largest native anuran in North America.
=688  \\$a72
=750  \0$aBullfrog$5IEN$0(DLC)sh 85017962

=LDR  00869cz  a2200193n  4500
=001  9880363821202441
=005  20141212205136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011890
=035  \\$aCBA5191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x690
=150  \\$aRailroads
=450  \\$wnnna$aRailroad
=450  \\$wnnna$aSubway
=450  \\$aSubways
=550  \\$wg$aTransportation
=680  \\$iPermanent roads having a line of rails fixed to ties and laid to gage, usually on a leveled or graded ballasted roadbed and providing a track for freight cars, passenger cars, and other rolling stock. Cars are designed to be drawn by locomotives or sometimes propelled by self-contained motors. (From Webster's 3d) The concept includes the organizational and administrative aspects of railroads as well.
=750  \0$aRailroads$5IEN$0(DLC)sh 85110904

=LDR  00637cz  a2200205n  4500
=001  9880363821302441
=005  20141212205135.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011887
=035  \\$aCBA5188HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x629.$x802.$x700
=150  \\$aRaffinose
=450  \\$aGossypose
=450  \\$aMelitose
=450  \\$aMelitriose
=550  \\$wg$aTrisaccharides
=680  \\$iA trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal.
=688  \\$a91(75); was see under OLIGOSACCHARIDES 1975-90
=750  \0$aRaffinose$5IEN$0(DLC)sh 85110835

=LDR  00920cz  a2200253n  4500
=001  9880363821402441
=005  20141212205135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011886
=035  \\$aCBA5187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x800
=072  \\$aD1.$x268.$x613.$x700
=072  \\$aD1.$x362.$x641.$x745
=150  \\$aRadon
=450  \\$wnnna$aActinon
=450  \\$wnnna$aThoron (Element)
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aNoble Gases
=550  \\$wh$aRadon Daughters
=667  \\$aRADON DAUGHTERS is also available
=680  \\$iA naturally radioactive element with atomic symbol Rn, atomic number 86, and atomic weight 222. It is a member of the noble gas family found in soil, and is released during the decay of radium.
=688  \\$aACTINON was see RADON 1978-93; THORON (ELEMENT) was (NM) 1974-93
=750  \0$aRadon$5IEN$0(DLC)sh 85110814

=LDR  00613cz  a2200217n  4500
=001  9880363821502441
=005  20141212205135.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011885
=035  \\$aCBA5186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x88.$x268.$x556
=072  \\$aC26.$x404.$x562
=150  \\$aRadius Fractures
=450  \\$wnnna$aFracture, Radius
=450  \\$wnnna$aFractures, Radius
=450  \\$wnnna$aRadius Fracture
=550  \\$wg$aForearm Injuries
=550  \\$wg$aFractures, Bone
=550  \\$wh$aColles' Fracture
=750  \0$aRadius (Anatomy)$xFractures$5IEN$0(IEN)376400

=LDR  00380cz  a2200145n  4500
=001  9880363821602441
=005  20141212205134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011884
=035  \\$aCBA5185HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x90.$x700
=150  \\$aRadius
=550  \\$wg$aArm Bones
=750  \0$aRadius (Anatomy)$5IEN$0(DLC)sh 85110812

=LDR  01070cz  a2200241n  4500
=001  9880363821702441
=005  20141212205134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011883
=035  \\$aCBA5184HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x770
=072  \\$aD1.$x268.$x552.$x775
=072  \\$aD1.$x268.$x556.$x775
=072  \\$aD1.$x552.$x539.$x745
=072  \\$aD1.$x552.$x544.$x775
=150  \\$aRadium
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aMetals, Alkaline Earth
=550  \\$wg$aMetals, Heavy
=667  \\$anaturally radioactive; IM; /ther use: for curietherapy consider also BRACHYTHERAPY
=680  \\$iRadium. A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra, atomic number 88, and atomic weight 226. Radium is the product of the disintegration of uranium and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY.
=750  \0$aRadium$5IEN$0(DLC)sh 85110804

=LDR  01183cz  a2200265n  4500
=001  9880363821802441
=005  20141212205134.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011882
=035  \\$aCBA5183HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x722
=150  \\$aRadiotherapy, High-Energy
=450  \\$wnnna$aHigh-Energy Radiotherapy
=450  \\$wnnna$aHigh Energy Radiotherapy
=450  \\$aMegavolt Radiotherapy
=450  \\$wnnna$aRadiotherapy, High Energy
=450  \\$wnnna$aRadiotherapy, Megavolt
=550  \\$wg$aRadiotherapy
=550  \\$wh$aNeutron Capture Therapy
=550  \\$wh$aRadioisotope Teletherapy
=667  \\$aionizing only
=680  \\$iRadiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
=688  \\$a64
=750  \0$aRadiotherapy, High energy$5IEN-M$0(DLC)sh 85110799

=LDR  01571cz  a2200385n  4500
=001  9880363821902441
=005  20141212205134.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011881
=035  \\$aCBA5182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x635
=072  \\$aL1.$x700.$x508.$x100.$x710.$x600
=150  \\$aRadiotherapy, Computer-Assisted
=450  \\$wnnna$aComputer-Assisted Radiation Therapies
=450  \\$wnnna$aComputer-Assisted Radiation Therapy
=450  \\$wnnna$aComputer Assisted Radiation Therapy
=450  \\$wnnna$aComputer-Assisted Radiotherapies
=450  \\$aComputer-Assisted Radiotherapy
=450  \\$wnnna$aComputer Assisted Radiotherapy
=450  \\$wnnna$aRadiation Therapies, Computer-Assisted
=450  \\$aRadiation Therapy, Computer-Assisted
=450  \\$wnnna$aRadiation Therapy, Computer Assisted
=450  \\$wnnna$aRadiotherapies, Computer-Assisted
=450  \\$wnnna$aRadiotherapy, Computer Assisted
=450  \\$wnnna$aTherapies, Computer-Assisted Radiation
=450  \\$wnnna$aTherapy, Computer-Assisted Radiation
=550  \\$wg$aRadiotherapy
=550  \\$wg$aTherapy, Computer-Assisted
=550  \\$wh$aRadiotherapy, Conformal
=550  \\$wh$aRadiotherapy Planning, Computer-Assisted
=667  \\$aRADIOTHERAPY PLANNING, COMPUTER-ASSISTED is also available: see note there
=680  \\$iComputer systems or programs used in accurate computations for providing radiation dosage treatment to patients.
=688  \\$a87
=750  \0$aRadiotherapy$xData processing$5IEN$0(IEN)376397

=LDR  01047cz  a2200289n  4500
=001  9880363822002441
=005  20201013151613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011879
=035  \\$aCBA5180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x639
=150  \\$aRadiotherapy Dosage
=450  \\$wnnna$aDosage, Radiotherapy
=450  \\$wnnna$aDosages, Radiotherapy
=450  \\$wnnna$aRadiotherapy Dosages
=550  \\$wg$aRadiotherapy
=550  \\$wh$aDose Fractionation, Radiation
=550  \\$wh$aDose Hypofractionation
=550  \\$aRadiation Dosage
=550  \\$aRadiotherapy, Conformal
=667  \\$aNIM
=680  \\$iThe total amount of radiation absorbed by tissues as a result of radiotherapy.
=688  \\$a64
=750  \0$81$wb$iBroader mapping$aRadiotherapy$4BM$0(DLC)sh 85110795$5IEN-M
=750  \0$81$wb$iBroader mapping$aRadiation$xDosage$4BM$0(DLC)sh 85110341$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record$aRadiotherapy$iand$aRadiation$xDosage

=LDR  01710cz  a2200481n  4500
=001  9880363822102441
=005  20170927165016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011878
=035  \\$aCBA5179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815
=150  \\$aRadiotherapy
=450  \\$aDisease$xradiotherapy
=450  \\$aRadiation$xtherapeutic use
=450  \\$wnnna$aRadiotherapies
=450  \\$wnnna$aRadiotherapies, Targeted
=450  \\$aRadiotherapy, Targeted
=450  \\$wnnna$aTargeted Radiotherapies
=450  \\$aTargeted Radiotherapy
=550  \\$wg$aTherapeutics
=550  \\$wh$aBrachytherapy
=550  \\$wh$aChemoradiotherapy
=550  \\$wh$aCranial Irradiation
=550  \\$wh$aCraniospinal Irradiation
=550  \\$wh$aHeavy Ion Radiotherapy
=550  \\$wh$aHemibody Irradiation
=550  \\$wh$aLymphatic Irradiation
=550  \\$wh$aProton Therapy
=550  \\$wh$aRadioimmunotherapy
=550  \\$wh$aRadiosurgery
=550  \\$wh$aRadiotherapy, Adjuvant
=550  \\$wh$aRadiotherapy, Computer-Assisted
=550  \\$wh$aRadiotherapy Dosage
=550  \\$wh$aRadiotherapy, High-Energy
=550  \\$wh$aRadiotherapy, Image-Guided
=550  \\$wh$aRadiotherapy Setup Errors
=550  \\$wh$aRe-Irradiation
=550  \\$wh$aWhole-Body Irradiation
=550  \\$wh$aX-Ray Therapy
=667  \\$ageneral only: prefer / radiother with diseases: Manual 19.7+, 19.8.63; / adv eff: consider also RADIATION INJURIES or its specifics; many specific types of radiotherapy are available
=680  \\$iThe use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.
=750  \0$aRadiotherapy$5IEN$0(DLC)sh 85110795

=LDR  01540cz  a2200349n  4500
=001  9880363822202441
=005  20141212205132.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011877
=035  \\$aCBA5178HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x710
=072  \\$aE1.$x370.$x384.$x730
=150  \\$aRadionuclide Imaging
=450  \\$aGamma Camera Imaging
=450  \\$wnnna$aImaging, Gamma Camera
=450  \\$wnnna$aImaging, Radionuclide
=450  \\$aRadioisotope Scanning
=450  \\$aScanning, Radioisotope
=450  \\$aScintigraphy
=450  \\$aScintiphotography
=550  \\$wg$aDiagnostic Imaging
=550  \\$wg$aDiagnostic Techniques, Radioisotope
=550  \\$wh$aLymphoscintigraphy
=550  \\$wh$aPerfusion Imaging
=550  \\$wh$aRadioimmunodetection
=550  \\$wh$aRadionuclide Angiography
=550  \\$wh$aTomography, Emission-Computed
=667  \\$aIM general or unspecified only: prefer / radionuclide with disease or anatomical term: Manual 19.7+, 19.8.62
=680  \\$iThe production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
=688  \\$a77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963
=750  \0$aRadioisotope scanning$5IEN$0(DLC)sh 85110710

=LDR  01008cz  a2200265n  4500
=001  9880363822302441
=005  20141212205131.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011876
=035  \\$aCBA5177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x710.$x770
=150  \\$aRadionuclide Generators
=450  \\$wnnna$aGenerator, Radioisotope
=450  \\$wnnna$aGenerator, Radionuclide
=450  \\$wnnna$aGenerators, Radioisotope
=450  \\$wnnna$aGenerators, Radionuclide
=450  \\$wnnna$aRadioisotope Generator
=450  \\$aRadioisotope Generators
=450  \\$wnnna$aRadionuclide Generator
=550  \\$wg$aRadiation Equipment and Supplies
=667  \\$aIM
=680  \\$iSeparation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted (milked) by means of an appropriate eluting agent.
=688  \\$a79
=750  \0$aRadionuclide generators$5IEN$0(DLC)sh 85110788

=LDR  02837cz  a2200709n  4500
=001  9880363822402441
=005  20141212205130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011874
=035  \\$aCBA5175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x799
=150  \\$aRadiometry
=450  \\$wnnna$aCounter, Geiger
=450  \\$wnnna$aCounter, Radiation
=450  \\$wnnna$aCounter Tube, Geiger-Mueller
=450  \\$wnnna$aCounter Tubes, Geiger-Mueller
=450  \\$wnnna$aCounters, Geiger
=450  \\$wnnna$aCounters, Geiger-Mueller
=450  \\$wnnna$aCounters, Radiation
=450  \\$wnnna$aDetection, Nuclear Track
=450  \\$wnnna$aDosimetries, Radiation
=450  \\$wnnna$aDosimetry, Radiation
=450  \\$wnnna$aGeiger Counter
=450  \\$wnnna$aGeiger Counters
=450  \\$wnnna$aGeiger-Mueller Counter Tube
=450  \\$wnnna$aGeiger Mueller Counter Tube
=450  \\$wnnna$aGeiger-Mueller Counter Tubes
=450  \\$aGeiger-Mueller Counters
=450  \\$wnnna$aGeiger Mueller Counters
=450  \\$wnnna$aGeiger-Mueller Probe
=450  \\$wnnna$aGeiger Mueller Probe
=450  \\$wnnna$aGeiger-Mueller Probes
=450  \\$wnnna$aGeiger-Mueller Tube
=450  \\$wnnna$aGeiger Mueller Tube
=450  \\$wnnna$aGeiger-Mueller Tubes
=450  \\$aNuclear Track Detection
=450  \\$wnnna$aProbe, Geiger-Mueller
=450  \\$wnnna$aProbes, Geiger-Mueller
=450  \\$wnnna$aRadiation Counter
=450  \\$wnnna$aRadiation Counters
=450  \\$wnnna$aRadiation Dosimetries
=450  \\$aRadiation Dosimetry
=450  \\$wnnna$aTube, Geiger-Mueller
=450  \\$wnnna$aTube, Geiger-Mueller Counter
=450  \\$wnnna$aTubes, Geiger-Mueller
=450  \\$wnnna$aTubes, Geiger-Mueller Counter
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aAutoradiography
=550  \\$wh$aRadiation Dosage
=550  \\$wh$aRadiation Monitoring
=550  \\$wh$aRadiometric Dating
=550  \\$wh$aScintillation Counting
=550  \\$wh$aSpectrometry, Gamma
=550  \\$wh$aSpectrometry, X-Ray Emission
=550  \\$wh$aSun Protection Factor
=550  \\$wh$aWhole-Body Counting
=550  \\$aHealth Physics
=667  \\$aIM general only for measurement of radiation & techniques & equipment related to it; NIM as coordinate with specific radiation (IM) for measurement of its radiations; do not use with radioisotope tracers for measurement of amount of radiation emitted by the tracer: Manual 29.14; ionization chambers: index under RADIOMETRY / instrum
=680  \\$iThe measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.
=688  \\$aGEIGER-MUELLER COUNTER was see under RADIOMETRY 1963-77
=750  \0$aRadiation dosimetry$5IEN-HS$0(DLC)sh 85110354

=LDR  02632cz  a2200625n  4500
=001  9880363822502441
=005  20141212205129.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011873
=035  \\$aCBA5174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300.$x680.$x850
=072  \\$aL1.$x700.$x508.$x300.$x780
=072  \\$aN4.$x452.$x442.$x452.$x760
=072  \\$aN4.$x452.$x515.$x360.$x750
=072  \\$aN4.$x452.$x515.$x825
=150  \\$aRadiology Information Systems
=450  \\$wnnna$aArchiving, Radiologic Picture
=450  \\$wnnna$aInformation System, Radiologic
=450  \\$wnnna$aInformation System, Radiology
=450  \\$wnnna$aInformation System, X-Ray
=450  \\$wnnna$aInformation System, Xray
=450  \\$wnnna$aInformation Systems, Radiologic
=450  \\$wnnna$aInformation Systems, Radiology
=450  \\$wnnna$aInformation Systems, X-Ray
=450  \\$wnnna$aInformation Systems, Xray
=450  \\$aPACS (Radiology)
=450  \\$wnnna$aPACSs (Radiology)
=450  \\$aPicture Archiving and Communication Systems
=450  \\$aPicture Archiving, Radiologic
=450  \\$wnnna$aRadiologic Information System
=450  \\$wnnna$aRadiologic Information Systems
=450  \\$wnnna$aRadiologic Picture Archiving
=450  \\$wnnna$aRadiology Information System
=450  \\$wnnna$aSystem, Radiologic Information
=450  \\$wnnna$aSystem, Radiology Information
=450  \\$wnnna$aSystem, X-Ray Information
=450  \\$wnnna$aSystem, Xray Information
=450  \\$wnnna$aSystems, Radiologic Information
=450  \\$wnnna$aSystems, Radiology Information
=450  \\$wnnna$aSystems, X-Ray Information
=450  \\$wnnna$aSystems, Xray Information
=450  \\$wnnna$aX-Ray Information System
=450  \\$aX-Ray Information Systems
=450  \\$wnnna$aX Ray Information Systems
=450  \\$wnnna$aXray Information System
=450  \\$wnnna$aXray Information Systems
=550  \\$wg$aHospital Information Systems
=550  \\$wg$aInformation Systems
=550  \\$wg$aManagement Information Systems
=550  \\$wh$aTeleradiology
=667  \\$aDF: RADIOL INFORMATION SYSTEMS
=680  \\$iInformation systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of radiology services and facilities.
=688  \\$a91(87); was see under HOSPITAL INFORMATION SYSTEMS 1987-90
=750  \0$aPicture archiving and communication systems in medicine$5IEN$0(DLC)sh 91005239

=LDR  01419cz  a2200349n  4500
=001  9880363822602441
=005  20141212205128.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011872
=035  \\$aCBA5173HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x695
=072  \\$aN4.$x452.$x442.$x422.$x695
=150  \\$aRadiology Department, Hospital
=450  \\$wnnna$aDepartment, Hospital Radiology
=450  \\$wnnna$aDepartment, X-Ray
=450  \\$wnnna$aDepartment, X Ray
=450  \\$wnnna$aDepartments, Hospital Radiology
=450  \\$wnnna$aDepartments, X-Ray
=450  \\$wnnna$aDepartments, X Ray
=450  \\$aHospital Radiology Department
=450  \\$wnnna$aHospital Radiology Departments
=450  \\$wnnna$aRadiology Departments, Hospital
=450  \\$wnnna$aX-Ray Department
=450  \\$wnnna$aX Ray Department
=450  \\$aX-Ray Departments
=450  \\$wnnna$aX Ray Departments
=550  \\$wg$aHospital Departments
=667  \\$arestricted to x-ray & radiocobalt diag & ther serv: does not include other radioisotopes ( = NUCLEAR MEDICINE DEPARTMENT, HOSPITAL); DF: RADIOL DEP
=680  \\$iHospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services.
=688  \\$a91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
=750  \0$aHospitals$xRadiological services$5IEN$0(DLC)sh 85062356

=LDR  00888cz  a2200241n  4500
=001  9880364368102441
=005  20141212213703.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x815
=150  \\$aRaptors
=450  \\$wnnna$aBird of Prey
=450  \\$aBirds of Prey
=450  \\$wnnna$aPrey Bird
=450  \\$wnnna$aPrey Birds
=450  \\$wnnna$aRaptor
=550  \\$wg$aBirds
=550  \\$wh$aFalconiformes
=550  \\$wh$aStrigiformes
=680  \\$iBIRDS that hunt and kill other animals, especially higher vertebrates, for food. They include the FALCONIFORMES order, or diurnal birds of prey, comprised of EAGLES, falcons, HAWKS, and others, as well as the STRIGIFORMES order, or nocturnal birds of prey, which includes OWLS.
=688  \\$a99
=750  \0$aBirds of prey$5IEN-M$0(DLC)sh 85014346

=LDR  00631cz  a2200181n  4500
=001  9880364368202441
=005  20141212213628.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020231
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x235
=150  \\$aColletotrichum
=450  \\$wnnna$aColletotrichums
=550  \\$wg$aMitosporic Fungi
=550  \\$aPhyllachorales
=680  \\$iA genus of mitosporic Phyllachoraceae fungi which contains at least 40 species of plant parasites. They have teleomorphs in the genus Glomerella (see PHYLLACHORALES).
=688  \\$a99
=750  \0$aColletotrichum$0(DLC) sh 85028423$5IEN-M

=LDR  00581cz  a2200169n  4500
=001  9880364368402441
=005  20141212213554.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020172
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x950
=150  \\$aVerticillium
=450  \\$wnnna$aVerticilliums
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic fungal genus commonly isolated from soil. Some species are the cause of wilt diseases in many different plants.
=688  \\$a99; use MITOSPORIC FUNGI 1975-98
=750  \0$aVerticillium$5IEN-M$0(DLC)sh 88022099

=LDR  00724cz  a2200205n  4500
=001  9880364368502441
=005  20141212213757.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020450
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x467
=150  \\$aHeavy Ions
=450  \\$wnnna$aHeavy Ion
=450  \\$wnnna$aIon, Heavy
=450  \\$aIons, Heavy
=550  \\$wg$aElementary Particles
=667  \\$acoord with specific element
=680  \\$iPositively-charged atomic nuclei that have been stripped of their electrons. These particles have one or more units of electric charge and a mass exceeding that of the Helium-4 nucleus (alpha particle).
=688  \\$a99
=750  \0$aHeavy ions$5IEN-M$0(DLC)sh 85059849

=LDR  01056cz  a2200277n  4500
=001  9880364368602441
=005  20170209085539.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020123
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x540.$x505.$x760
=150  \\$aSirolimus
=450  \\$wnnna$aAY 22-989
=450  \\$wnnna$aAY 22 989
=450  \\$wnnna$aAY 22989
=450  \\$wnnna$aI-2190A
=450  \\$wnnna$aI 2190A
=450  \\$wnnna$aI2190A
=450  \\$wnnna$aRapamune
=450  \\$aRapamycin
=450  \\$wnnna$aWyeth Brand of Sirolimus
=550  \\$wg$aMacrolides
=550  \\$wh$aEverolimus
=680  \\$iA macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
=688  \\$a99; use SIROLIMUS (NM) 1980-97
=750  \0$aRapamycin$5IEN-M$0(DLC)sh2001005861

=LDR  00579cz  a2200181n  4500
=001  9880364368702441
=005  20141212213528.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020095
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x300.$x500.$x30
=150  \\$aAbsidia
=450  \\$wnnna$aAbsidias
=550  \\$wg$aMucorales
=667  \\$ainfection: coord IM with MUCORMYCOSIS (IM)
=680  \\$iA genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.
=688  \\$a99
=750  \0$aAbsidia$5IEN-M$0(DLC)sh 88021865

=LDR  01485cz  a2200289n  4500
=001  9880364368802441
=005  20141212213509.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020019
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x105.$x250.$x550
=072  \\$aC3.$x335.$x190.$x902.$x185.$x550
=072  \\$aC10.$x228.$x228.$x205.$x250.$x550
=150  \\$aNeurocysticercosis
=450  \\$wnnna$aBrain Cysticercosis
=450  \\$aCentral Nervous System Cysticercosis
=450  \\$aCysticercosis, Brain
=450  \\$aCysticercosis, Central Nervous System
=450  \\$wnnna$aNeurocysticercoses
=550  \\$wg$aCentral Nervous System Helminthiasis
=550  \\$wg$aCysticercosis
=550  \\$aTaenia
=550  \\$aTaeniasis
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; coordinate IM with specific site/disease term (IM) if pertinent
=680  \\$iInfection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
=688  \\$a1999
=750  \0$aNeurocysticercosis$0(DLC) sh 85035208$5IEN-M

=LDR  00910cz  a2200253n  4500
=001  9880364368902441
=005  20141212213534.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020118
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x251.$x200.$x200
=072  \\$aB3.$x660.$x75.$x77.$x200.$x200
=150  \\$aCupriavidus necator
=450  \\$wnnna$aAlcaligenes eutropha
=450  \\$aRalstonia eutropha
=450  \\$aWautersia eutropha
=550  \\$wg$aCupriavidus
=680  \\$iA gram-negative, facultatively chemoautotrophic bacterium, formerly called Wautersia eutropha, found in water and soil.
=688  \\$a2007 (1999)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Wautersia eutropha
=688  \\$a2006 (1999)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Ralstonia eutropha
=688  \\$a99
=750  \0$aAlcaligenes eutrophus$0(DLC) sh 93005950$5IEN-M

=LDR  01029cz  a2200277n  4500
=001  9880364369002441
=005  20141212213705.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020311
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x600.$x750
=150  \\$aRheiformes
=450  \\$wnnna$aAmerican Ostrich
=450  \\$wnnna$aAmerican Ostriches
=450  \\$wnnna$aAmerican Ostrichs
=450  \\$wnnna$aOstrich, American
=450  \\$aOstriches, American
=450  \\$wnnna$aOstrichs, American
=450  \\$wnnna$aRhea
=450  \\$wnnna$aRhea americana
=450  \\$aRheas
=550  \\$wg$aPalaeognathae
=667  \\$anote X ref OSTRICH, AMERICAN: OSTRICHES see STRUTHIONIFORMES is available
=680  \\$iAn order of large, long-necked, long-legged, flightless birds, found in South America. Known as rheas, they are sometimes called American ostriches, though they are in a separate order from true OSTRICHES.
=688  \\$a2005 (1999)
=750  \0$aRheiformes$0(DLC) sh 92001448$5IEN-M

=LDR  01311cz  a2200337n  4500
=001  9880364369102441
=005  20141212213546.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020156
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x300.$x595.$x608
=072  \\$aD2.$x241.$x511.$x390.$x595.$x608
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x595.$x608
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x595.$x608
=150  \\$aSalicylic Acid
=450  \\$wnnna$a2-Hydroxybenzoic Acid
=450  \\$wnnna$a2 Hydroxybenzoic Acid
=450  \\$wnnna$aAcid, 2-Hydroxybenzoic
=450  \\$wnnna$aAcid, o-Hydroxybenzoic
=450  \\$wnnna$aAcid, ortho-Hydroxybenzoic
=450  \\$wnnna$aAcid, Salicylic
=450  \\$wnnna$ao-Hydroxybenzoic Acid
=450  \\$wnnna$ao Hydroxybenzoic Acid
=450  \\$wnnna$aortho-Hydroxybenzoic Acid
=450  \\$wnnna$aortho Hydroxybenzoic Acid
=550  \\$wg$aSalicylates
=550  \\$wh$aSodium Salicylate
=667  \\$aSALICYLIC ACIDS see SALICYLATES is also available
=680  \\$iA compound obtained from the bark of the white willow and wintergreen leaves. It has bacteriostatic, fungicidal, and keratolytic actions.
=688  \\$a99; use SALICYLIC ACID (NM) 1981-98
=750  \0$aSalicylic acid$5IEN$0(DLC)sh 85116754

=LDR  00944cz  a2200265n  4500
=001  9880364369202441
=005  20141212213516.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020050
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x590
=150  \\$aMantodea
=450  \\$wnnna$aManti, Praying
=450  \\$wnnna$aMantid
=450  \\$aMantidae
=450  \\$aMantids
=450  \\$wnnna$aMantis, Praying
=450  \\$wnnna$aMantodeas
=450  \\$wnnna$aPraying Manti
=450  \\$aPraying Mantis
=550  \\$wg$aInsects
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iAn order of insects, comprising a single family (Mantidae), restricted almost entirely to the tropics. Only one species, the praying mantis (Mantis religiosa), is found in temperate habitats.
=688  \\$a99; for MANTIDS & PRAYING MANTIS use ORTHOPTERA 1986-98
=750  \0$aMantodea$5IEN-M$0(DLC)sh2001008516

=LDR  00795cz  a2200229n  4500
=001  9880364369302441
=005  20141212213515.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020048
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x140.$x100
=150  \\$aBlattellidae
=450  \\$wnnna$aCockroach, German
=450  \\$wnnna$aCockroachs, German
=450  \\$wnnna$aEctobiidae
=450  \\$wnnna$aGerman Cockroach
=450  \\$wnnna$aGerman Cockroachs
=550  \\$wg$aCockroaches
=667  \\$afor killing Blattellidae with insecticides, see note at INSECTICIDES
=680  \\$iA family of insects in the order Dictyoptera (COCKROACHES), including genera Blattella, Parcoblatta, and Symploce.
=688  \\$a99
=750  \0$aBlattellidae$5IEN-M$0(DLC)sh 85014814

=LDR  00766cz  a2200229n  4500
=001  9880364369402441
=005  20141212213516.0
=008  980611\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020058
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x150.$x750.$x800
=150  \\$aStyrene
=450  \\$wnnna$aMonomer, Styrene
=450  \\$aStyrene Monomer
=450  \\$wnnna$aStyrol
=450  \\$wnnna$aVinylbenzene
=550  \\$wg$aStyrenes
=550  \\$wh$aPolystyrenes
=667  \\$aSTYRENES is also available
=680  \\$iA colorless, toxic liquid with a strong aromatic odor. It is used to make rubbers, polymers and copolymers, and polystyrene plastics.
=688  \\$a99; use STYRENE (NM) 1981-98
=750  \0$aStyrene$5IEN-M$0(DLC)sh 85129392

=LDR  01373cz  a2200349n  4500
=001  9880364369502441
=005  20141212213511.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020031
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x466.$x313
=072  \\$aC2.$x928.$x313
=072  \\$aC4.$x619.$x935.$x313
=072  \\$aC4.$x925.$x313
=150  \\$aEpstein-Barr Virus Infections
=450  \\$wnnna$aEBV Infection
=450  \\$aEBV Infections
=450  \\$wnnna$aEpstein Barr Virus Infections
=450  \\$wnnna$aHerpesvirus 4 Infections, Human
=450  \\$wnnna$aHuman Herpes Virus 4 Infections
=450  \\$wnnna$aHuman Herpesvirus 4 Infections
=450  \\$wnnna$aInfections, EBV
=450  \\$wnnna$aInfections, Epstein-Barr Virus
=450  \\$wnnna$aVirus Infections, Epstein-Barr
=550  \\$wg$aHerpesviridae Infections
=550  \\$wg$aTumor Virus Infections
=550  \\$wh$aBurkitt Lymphoma
=550  \\$wh$aInfectious Mononucleosis
=550  \\$wh$aLeukoplakia, Hairy
=680  \\$iInfection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).
=688  \\$a99
=750  \0$aEpstein-Barr virus diseases$5IEN-M$0(DLC)sh 87003642

=LDR  00729cz  a2200205n  4500
=001  9880364369602441
=005  20141212213524.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x715
=150  \\$aPhyllachorales
=450  \\$aGlomerella
=450  \\$wnnna$aGlomerellas
=450  \\$wnnna$aPhyllachorale
=550  \\$wg$aAscomycota
=550  \\$aColletotrichum
=680  \\$iAn order of fungi in the phylum ASCOMYCOTA characterized by stromatic perithecial forms in most species. Notable genera are Magnaporthe and Glomerella, the latter having the anamorph (mitosporic form) COLLETOTRICHUM.
=688  \\$a99
=750  \0$aGlomerella$5IEN-M$0(DLC)sh 88021958

=LDR  00683cz  a2200205n  4500
=001  9880364369702441
=005  20141212213515.0
=008  980610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020049
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x485
=150  \\$aIsoptera
=450  \\$wnnna$aIsopteras
=450  \\$wnnna$aTermite
=450  \\$aTermites
=550  \\$wg$aInsects
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iAn order of insects, restricted mostly to the tropics, containing at least eight families. A few species occur in temperate regions of North America.
=688  \\$a99
=750  \0$aTermites$5IEN-M$0(DLC)sh 85134031

=LDR  00767cz  a2200241n  4500
=001  9880364369802441
=005  20141212192922.0
=008  970722\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019829
=035  \\$aCVE6292M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x506
=150  \\$aNevirapine
=450  \\$wnnna$aBI-RG-587
=450  \\$wnnna$aBI RG 587
=450  \\$wnnna$aBIRG587
=450  \\$wnnna$aHemihydrate, Nevirapine
=450  \\$wnnna$aNevirapine Hemihydrate
=450  \\$wnnna$aViramune
=550  \\$wg$aPyridines
=680  \\$iA potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
=688  \\$a98
=750  \0$aNevirapine$0(DLC)sh2010013984$5IEN-M

=LDR  02060cz  a2200553n  4500
=001  9880364369902441
=005  20160609133020.0
=008  970714\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020018
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x835
=150  \\$aSexual Dysfunctions, Psychological
=450  \\$wnnna$aArousal Disorders, Sexual
=450  \\$wnnna$aAversion Disorders, Sexual
=450  \\$wnnna$aDisorder, Psychosexual
=450  \\$wnnna$aDisorders, Orgasmic
=450  \\$wnnna$aDisorders, Psychosexual
=450  \\$wnnna$aDisorders, Sexual Arousal
=450  \\$wnnna$aDisorders, Sexual Aversion
=450  \\$wnnna$aDysfunction, Psychological Sexual
=450  \\$wnnna$aDysfunction, Psychosexual
=450  \\$wnnna$aDysfunctions, Psychological Sexual
=450  \\$wnnna$aDysfunctions, Psychosexual
=450  \\$aFrigidity
=450  \\$aHypoactive Sexual Desire Disorder
=450  \\$aOrgasmic Disorder
=450  \\$wnnna$aOrgasmic Disorders
=450  \\$wnnna$aPsychological Sexual Dysfunction
=450  \\$wnnna$aPsychological Sexual Dysfunctions
=450  \\$wnnna$aPsychosexual Disorder
=450  \\$aPsychosexual Disorders
=450  \\$wnnna$aPsychosexual Dysfunction
=450  \\$aPsychosexual Dysfunctions
=450  \\$aSexual Arousal Disorder
=450  \\$wnnna$aSexual Arousal Disorders
=450  \\$aSexual Aversion Disorder
=450  \\$wnnna$aSexual Aversion Disorders
=450  \\$wnnna$aSexual Dysfunction, Psychological
=550  \\$wg$aMental Disorders
=550  \\$wh$aDyspareunia
=550  \\$wh$aErectile Dysfunction
=550  \\$wh$aGender Dysphoria
=550  \\$wh$aPremature Ejaculation
=550  \\$wh$aSexual and Gender Disorders
=550  \\$wh$aTranssexualism
=550  \\$wh$aVaginismus
=680  \\$iDisturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. (APA, DSM-IV, 1994)
=688  \\$a99(81)
=750  \0$aPsychosexual disorders$5IEN-M$0(DLC)sh 85108504

=LDR  01593cz  a2200445n  4500
=001  9880364370002441
=005  20160405150626.0
=008  970707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019965
=035  \\$aCVE6287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x615
=150  \\$aNeurocognitive Disorders
=450  \\$aClerambault Syndrome
=450  \\$wnno$aDelirium, Dementia, Amnestic, Cognitive Disorders
=450  \\$wnnna$aDisorder, Neurocognitive
=450  \\$wnnna$aDisorders, Neurocognitive
=450  \\$wnnna$aNeurocognitive Disorder
=450  \\$wnnna$aDisorders, Organic Mental
=450  \\$aKandinsky Syndrome
=450  \\$wnnna$aMental Disorder, Organic
=450  \\$aMental Disorders, Organic
=450  \\$wnnna$aNonpsychotic Organic Brain Syndrome
=450  \\$aOrganic Brain Syndrome, Nonpsychotic
=450  \\$wnnna$aOrganic Mental Disorder
=450  \\$aOrganic Mental Disorders
=450  \\$aOrganic Mental Disorders, Psychotic
=450  \\$aPsychoses, Traumatic
=450  \\$wnnna$aTraumatic Psychoses
=550  \\$wg$aMental Disorders
=550  \\$wh$aAmnesia
=550  \\$wh$aCognition Disorders
=550  \\$wh$aConsciousness Disorders
=550  \\$wh$aDelirium
=550  \\$wh$aDementia
=550  \\$wh$aDyslexia, Acquired
=667  \\$aavoid, prefer specifics, but use for see refs; DF: ORG MENTAL DIS
=680  \\$iDiagnosis of DEMENTIA and AMNESTIC DISORDER are subsumed here. (DSM-5)
=688  \\$a98(63) for NON PSYCHOTIC BRAIN SYNDROME use MENTAL DISORDERS 1969-74
=750  \0$aTraumatic psychoses$5IEN$0(DLC)sh 85137139

=LDR  02925cz  a2200769n  4500
=001  9880364370102441
=005  20141212192920.0
=008  970702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019793
=035  \\$aCVE6286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x779.$x347.$x390
=072  \\$aD3.$x494.$x953.$x275.$x390
=072  \\$aD4.$x711.$x347.$x390
=150  \\$aFluorescein
=450  \\$wnnna$aAlcon Brand of Fluorescein Sodium
=450  \\$wnnna$aAllergan Brand of Fluorescein Sodium
=450  \\$wnnna$aC.I. 45350
=450  \\$wnnna$aCahill May Roberts Brand of Fluorescein Sodium
=450  \\$wnnna$aChauvin Brand of Fluorescein Sodium
=450  \\$wnnna$aColircusi Fluoresceina
=450  \\$wnnna$aD & C Yellow No. 7
=450  \\$wnnna$aD & C Yellow No. 8
=450  \\$wnnna$aD and C Yellow No. 7
=450  \\$wnnna$aD and C Yellow No. 8
=450  \\$wnnna$aD&C Yellow No. 7
=450  \\$wnnna$aD&C Yellow No. 8
=450  \\$wnnna$aDiba Brand of Fluorescein Sodium
=450  \\$wnnna$aDiofluor
=450  \\$wnnna$aDioptic Brand of Fluorescein Sodium
=450  \\$wnnna$aDipotassium Salt, Fluorescein
=450  \\$wnnna$aDisodium Fluorescein
=450  \\$wnnna$aDisodium Salt, Fluorescein
=450  \\$wnnna$aFluor-I-Strip A.T.
=450  \\$wnnna$aFluor I Strip A.T.
=450  \\$wnnna$aFluorescéine sodique Faure
=450  \\$wnnna$aFluorescein Dipotassium Salt
=450  \\$wnnna$aFluorescein, Disodium
=450  \\$wnnna$aFluorescein Disodium Salt
=450  \\$wnnna$aFluorescein Monosodium Salt
=450  \\$aFluorescein Sodium
=450  \\$wnnna$aFluorescein, Sodium
=450  \\$wnnna$aFluorescein Sodium, Minims
=450  \\$wnnna$aFluoresceina, Colircusi
=450  \\$wnnna$aFluoresceine, Minims
=450  \\$wnnna$aFluorescite
=450  \\$wnnna$aFluorets
=450  \\$wnnna$aFul-Glo
=450  \\$wnnna$aFul Glo
=450  \\$wnnna$aFunduscein
=450  \\$wnnna$aMinims Fluorescein Sodium
=450  \\$wnnna$aMinims Fluoresceine
=450  \\$wnnna$aMinims Stains
=450  \\$wnnna$aMonosodium Salt, Fluorescein
=450  \\$wnnna$aNovartis Brand of Fluorescein Sodium
=450  \\$wnnna$aOptifluor Diba
=450  \\$wnnna$aSmith & Nephew Brand of Fluorescein Sodium
=450  \\$aSodium Fluorescein
=450  \\$wnnna$aSodium, Fluorescein
=450  \\$wnnna$aSola-Barnes-Hind Brand of Fluorescein Sodium
=450  \\$wnnna$aSola Barnes Hind Brand of Fluorescein Sodium
=450  \\$wnnna$aUranine
=450  \\$wnnna$aWyeth Brand of Fluorescein Sodium
=550  \\$wg$aFluoresceins
=680  \\$iA phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor, used as a diagnostic aid in corneal injuries and corneal trauma.
=688  \\$a98; see FLUORESCEIN (NM) 1981-97
=750  \0$aFluorescein$5IEN-M$0(DLC)sh 85049406

=LDR  01495cz  a2200289n  4500
=001  9880364370202441
=005  20141212192924.0
=008  970626\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019992
=035  \\$aCVE6271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x470.$x750
=072  \\$aL1.$x700.$x508.$x300.$x188
=150  \\$aDatabases as Topic
=450  \\$wnnna$aData Banks as Topic
=450  \\$wnnna$aData Bases as Topic
=450  \\$wnnna$aDatabanks as Topic
=550  \\$wg$aInformation Storage and Retrieval
=550  \\$wg$aInformation Systems
=550  \\$wh$aDatabases, Bibliographic
=550  \\$wh$aDatabases, Factual
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with Publication Type DATABASE
=680  \\$iOrganized collections of computer records, standardized in format and content, that are stored in any of a variety of computer-readable modes. They are the basic sets of data from which computer-readable files are created. (from ALA Glossary of Library and Information Science, 1983)
=688  \\$a2008(1998); for DATABASES use INFORMATION SYSTEMS 1994-1996; for DATABANKS use DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Databases
=688  \\$a1998; DATABASES was see INFORMATION SYSTEMS 1994-1996; for DATABANKS use DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90
=750  \0$aDatabases$0(DLC) sh 86007767$5IEN-M

=LDR  02207cz  a2200529n  4500
=001  9880364370302441
=005  20141212213436.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019904
=035  \\$aCVE6261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x69.$x800.$x550.$x500
=072  \\$aD5.$x750.$x716.$x822.$x111.$x650.$x605.$x500
=072  \\$aD25.$x720.$x716.$x822.$x111.$x650.$x605.$x500
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x822.$x111.$x650.$x605.$x500
=150  \\$aPolymethyl Methacrylate
=450  \\$wnnna$aAcron
=450  \\$wnnna$aAcrylic Bone Cement
=450  \\$wnnna$aCMW Bone Cement
=450  \\$wnnna$aImplast
=450  \\$wnnna$aIsostatic Polymethyl Methacrylate
=450  \\$wnnna$aKallocryl K
=450  \\$wnnna$aLucite
=450  \\$wnnna$aMethacrylate, Polymethyl
=450  \\$wnnna$aMethacrylate, Syndiostatic Polymethyl
=450  \\$wnnna$aMethyl Acrylic Plastic
=450  \\$wnnna$aPalacos R
=450  \\$wnnna$aPalavit
=450  \\$wnnna$aPerspex
=450  \\$wnnna$aPlexiglas
=450  \\$wnnna$aPlexiglass
=450  \\$aPMMA
=450  \\$wnnna$aPoly(methyl methacrylate)
=450  \\$wnnna$aPolymethyl Methacrylate, Isostatic
=450  \\$wnnna$aPolymethyl Methacrylate, Simplex Opaque
=450  \\$wnnna$aPolymethyl Methacrylate, Surgical Simplex Bone Cement, Ammonium Salt
=450  \\$wnnna$aPolymethyl Methacrylate, Surgical Simplex P
=450  \\$wnnna$aPolymethyl Methacrylate, Syndiostatic
=450  \\$wnnna$aPolymethylmetacrylate
=450  \\$aPolymethylmethacrylate
=450  \\$wnnna$aSol
=450  \\$wnnna$aSuperacryl
=450  \\$wnnna$aSyndiostatic Polymethyl Methacrylate
=550  \\$wg$aMethylmethacrylates
=680  \\$iPolymerized methyl methacrylate monomers which are used as sheets, moulding, extrusion powders, surface coating resins, emulsion polymers, fibers, inks, and films (From International Labor Organization, 1983). This material is also used in tooth implants, bone cements, and hard corneal contact lenses.
=688  \\$a98; use METHYLMETHACRYLATE (NM) 1977-97; for POLYMETHYLMETHACRYLATE use METHYLMETHACRYLATES 1981-97
=750  \0$aLucite$5IEN-M$0(DLC)sh 85078742

=LDR  00980cz  a2200301n  4500
=001  9880364370402441
=005  20141212213502.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019987
=035  \\$aCVE6259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150.$x850
=150  \\$aVisually Impaired Persons
=450  \\$wnnna$aBlind Person
=450  \\$aBlind Persons
=450  \\$wnnna$aImpaired Person, Visually
=450  \\$wnnna$aImpaired Persons, Visually
=450  \\$wnnna$aPerson, Blind
=450  \\$wnnna$aPerson, Visually Impaired
=450  \\$wnnna$aPersons, Blind
=450  \\$wnnna$aPersons, Visually Impaired
=450  \\$wnnna$aVisually Impaired Person
=550  \\$wg$aDisabled Persons
=550  \\$aDeaf-Blind Disorders
=550  \\$aVision Disorders
=680  \\$iPersons with loss of vision such that there is an impact on activities of daily living.
=688  \\$a98
=750  \0$aPeople with visual disabilities$0(DLC) sh 85143940$5IEN-M

=LDR  00826cz  a2200241n  4500
=001  9880364370502441
=005  20141212213414.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019840
=035  \\$aCVE6258M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x755.$x615
=150  \\$a2-Propanol
=450  \\$wnnna$a2 Propanol
=450  \\$wnnna$aAlcohol, Isopropyl
=450  \\$wnnna$aAlcohol, Rubbing
=450  \\$aIsopropanol
=450  \\$aIsopropyl Alcohol
=450  \\$wnnna$aRubbing Alcohol
=550  \\$wg$aPropanols
=680  \\$iAn isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
=688  \\$a98
=750  \0$aIsopropyl alcohol$5IEN-M$0(DLC)sh2003005845

=LDR  00559cz  a2200205n  4500
=001  9880364370602441
=005  20141212213435.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019902
=035  \\$aCVE6257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x329.$x171
=150  \\$aChondrocytes
=450  \\$wnnna$aChondroblast
=450  \\$aChondroblasts
=450  \\$wnnna$aChondrocyte
=550  \\$wg$aConnective Tissue Cells
=680  \\$iPolymorphic cells that form cartilage.
=688  \\$a98
=750  \0$aCartilage cells$5IEN-M$0(DLC)sh 85020512

=LDR  02682cz  a2200805n  4500
=001  9880364370702441
=005  20201209104833.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019966
=035  \\$aCVE6242HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775
=072  \\$aF3.$x900
=150  \\$aSubstance-Related Disorders
=450  \\$wnnna$aAbuse, Drug
=450  \\$wnnna$aAbuse, Substance
=450  \\$wnnna$aAbuses, Substance
=450  \\$wnnna$aAddiction, Drug
=450  \\$wnnna$aAddiction, Substance
=450  \\$wnnna$aDependence, Drug
=450  \\$wnnna$aDependence, Substance
=450  \\$wnnna$aDisorder, Drug Use
=450  \\$wnnna$aDisorder, Substance Use
=450  \\$aDrug Abuse
=450  \\$aDrug Addiction
=450  \\$aDrug Dependence
=450  \\$aDrug Habituation
=450  \\$wnnna$aDrug Use Disorder
=450  \\$aDrug Use Disorders
=450  \\$wnnna$aHabituation, Drug
=450  \\$aOrganic Mental Disorders, Substance-Induced
=450  \\$wnnna$aOrganic Mental Disorders, Substance Induced
=450  \\$aSubstance Abuse
=450  \\$wnnna$aSubstance Abuses
=450  \\$wnnna$aSubstance Addiction
=450  \\$aSubstance Dependence
=450  \\$wnnna$aSubstance Use Disorder
=450  \\$aSubstance Use Disorders
=450  \\$aDisruptive, Impulse Control, and Conduct Disorders
=550  \\$wg$aChemically-Induced Disorders
=550  \\$wg$aMental Disorders
=550  \\$wh$aAlcohol-Related Disorders
=550  \\$wh$aAmphetamine-Related Disorders
=550  \\$wh$aCocaine-Related Disorders
=550  \\$wh$aDrug Overdose
=550  \\$wh$aInhalant Abuse
=550  \\$wh$aMarijuana Abuse
=550  \\$wh$aMarijuana Use
=550  \\$wh$aNeonatal Abstinence Syndrome
=550  \\$wh$aOpioid-Related Disorders
=550  \\$wh$aPhencyclidine Abuse
=550  \\$wh$aPsychoses, Substance-Induced
=550  \\$wh$aSubstance Abuse, Oral
=550  \\$wh$aSubstance Abuse, Intravenous
=550  \\$wh$aSubstance Withdrawal Syndrome
=550  \\$wh$aTobacco Use Disorder
=550  \\$aAlcohol-Related Disorders
=550  \\$aBehavior, Addictive
=550  \\$aCodependency, Psychology
=550  \\$aDesigner Drugs
=550  \\$aDrug and Narcotic Control
=550  \\$aPrescription Drug Misuse
=550  \\$aPsychoses, Alcoholic
=550  \\$aSocial Problems
=550  \\$aIllicit Drugs
=667  \\$ageneral or unspecified; prefer specifics; / diag: consider SUBSTANCE ABUSE DETECTION
=680  \\$iDisorders related to substance abuse.
=688  \\$a98(63)
=750  \0$aSubstance abuse$5IEN$0(DLC)sh 85129539
=750  \0$aDrug abuse$5IEN-M$0(DLC)sh 85039675

=LDR  00932cz  a2200289n  4500
=001  9880364370802441
=005  20141212213458.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019969
=035  \\$aCVE6240M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x225
=072  \\$aF3.$x900.$x225
=150  \\$aAmphetamine-Related Disorders
=450  \\$wnnna$aAbuse, Amphetamine
=450  \\$wnnna$aAddiction, Amphetamine
=450  \\$aAmphetamine Abuse
=450  \\$aAmphetamine Addiction
=450  \\$aAmphetamine Dependence
=450  \\$wnnna$aAmphetamine Related Disorders
=450  \\$wnnna$aDependence, Amphetamine
=450  \\$wnnna$aDisorder, Amphetamine-Related
=450  \\$wnnna$aDisorders, Amphetamine-Related
=550  \\$wg$aSubstance-Related Disorders
=680  \\$iDisorders related or resulting from use of amphetamines.
=688  \\$a98
=750  \0$aAmphetamine abuse$5IEN-M$0(DLC)sh 85004593

=LDR  01102cz  a2200301n  4500
=001  9880364370902441
=005  20161215093122.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019964
=035  \\$aCVE6239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x600
=150  \\$aMood Disorders
=450  \\$wnnna$aAffective Disorder
=450  \\$aAffective Disorders
=450  \\$wnnna$aDisorder, Affective
=450  \\$wnnna$aDisorder, Mood
=450  \\$wnnna$aDisorders, Affective
=450  \\$wnnna$aDisorders, Mood
=450  \\$wnnna$aMood Disorder
=550  \\$wg$aMental Disorders
=550  \\$wh$aCyclothymic Disorder
=550  \\$wh$aDepressive Disorder
=680  \\$iA major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
=667  \\$ahuman only; do not confuse with AFFECTIVE SYMPTOMS: read MeSH definitions & follow text
=680  \\$iThose disorders that have a disturbance in mood as their predominant feature.
=688  \\$a98(81)
=750  \0$aAffective disorders$5IEN$0(DLC)sh 85001494

=LDR  02620cz  a2200721n  4500
=001  9880364371002441
=005  20200619134101.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019937
=035  \\$aCVE6238HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370
=150  \\$aDiagnostic Techniques and Procedures
=450  \\$aDiagnosis$xmethods
=450  \\$wnnna$aDiagnostic Technics and Procedures
=450  \\$wnnna$aTechnics and Procedures, Diagnostic
=450  \\$wnnna$aTechniques and Procedures, Diagnostic
=550  \\$wg$aDiagnosis
=550  \\$wh$aAge Determination by Skeleton
=550  \\$wh$aAutopsy
=550  \\$wh$aBreath Tests
=550  \\$wh$aClinical Laboratory Techniques
=550  \\$wh$aDiagnostic Imaging
=550  \\$wh$aDiagnostic Self Evaluation
=550  \\$wh$aDiagnostic Techniques, Cardiovascular
=550  \\$wh$aDiagnostic Techniques, Digestive System
=550  \\$wh$aDiagnostic Techniques, Endocrine
=550  \\$wh$aDiagnostic Techniques, Neurological
=550  \\$wh$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wh$aDiagnostic Techniques, Ophthalmological
=550  \\$wh$aDiagnostic Techniques, Otological
=550  \\$wh$aDiagnostic Techniques, Radioisotope
=550  \\$wh$aDiagnostic Techniques, Respiratory System
=550  \\$wh$aDiagnostic Techniques, Surgical
=550  \\$wh$aDiagnostic Techniques, Urological
=550  \\$wh$aDiagnostic Tests, Routine
=550  \\$wh$aDirect-To-Consumer Screening and Testing
=550  \\$wh$aDisability Evaluation
=550  \\$wh$aElectrodiagnosis
=550  \\$wh$aInsufflation
=550  \\$wh$aKymography
=550  \\$wh$aMass Screening
=550  \\$wh$aMedical History Taking
=550  \\$wh$aMonitoring, Physiologic
=550  \\$wh$aMyography
=550  \\$wh$aPhotoacoustic Techniques
=550  \\$wh$aPhysical Examination
=550  \\$wh$aPlethysmography
=550  \\$wh$aPremarital Examinations
=550  \\$wh$aPsychophysics
=550  \\$wh$aResonance Frequency Analysis
=550  \\$wh$aSex Determination Analysis
=550  \\$wh$aSpeech Production Measurement
=550  \\$wh$aSurgical Clearance
=550  \\$wh$aSymptom Assessment
=550  \\$wh$aTraditional Pulse Techniques
=550  \\$wh$aVisual Analog Scale
=550  \\$wh$aXenodiagnosis
=550  \\$aSensitivity and Specificity
=667  \\$ageneral: prefer specifics
=680  \\$iMethods, procedures, and tests performed to diagnose disease, disordered function, or disability.
=688  \\$a98
=750  \0$aDiagnosis, Laboratory$0(DLC) sh 85037496$5IEN-M

=LDR  00988cz  a2200265n  4500
=001  9880364371102441
=005  20141212213503.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019988
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x150.$x200
=150  \\$aDisabled Children
=450  \\$aChild, Disabled
=450  \\$aChildren, Disabled
=450  \\$wnnna$aChildren, Handicapped
=450  \\$aChildren with Disabilities
=450  \\$wnnna$aChildren with Disability
=450  \\$wnnna$aDisability, Children with
=450  \\$wnnna$aDisabled Child
=450  \\$aHandicapped Children
=550  \\$wg$aDisabled Persons
=667  \\$acoord with type of disability if given (e.g. HEARING IMPAIRED PERSONS) + appropriate check tag
=680  \\$iChildren with mental or physical disabilities that interfere with usual activities of daily living and that may require accommodation or intervention.
=688  \\$a98
=750  \0$aChildren with disabilities$5IEN-M$0(DLC)sh 85058689

=LDR  01016cz  a2200229n  4500
=001  9880364371202441
=005  20170717165732.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019956
=035  \\$aCVE6234HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x984
=150  \\$aStereotypic Movement Disorder
=450  \\$aBody Rocking
=450  \\$aHead Banging
=450  \\$aMovement Disorder, Stereotypic
=450  \\$wnnna$aStereotypic Movement Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=550  \\$aStereotyped Behavior
=680  \\$iMotor behavior that is repetitive, often seemingly driven, and nonfunctional. This behavior markedly interferes with normal activities or results in severe bodily self-injury. The behavior is not due to the direct physiological effects of a substance or a general medical condition. (DSM-IV, 1994)
=688  \\$a98; for HEAD BANGING & BODY ROCKING use STEREOTYPED BEHAVIOR 1981-97
=750  \0$aStereotypic movement disorder$0(DLC)sh2005001004$5IEN-M

=LDR  00707cz  a2200205n  4500
=001  9880364371302441
=005  20141212213303.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019617
=035  \\$aCVE6217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2.$x200.$x400.$x400.$x410.$x450
=150  \\$aHalobacterium salinarum
=450  \\$aHalobacterium halobium
=450  \\$wnnoa$aHalobacterium salinarium$5IEN-HS
=550  \\$wg$aHalobacterium
=667  \\$aDF: HALOBACT SALINARUM
=680  \\$iA species of halophilic archaea found in salt lakes. Some strains form a PURPLE MEMBRANE under anaerobic conditions.
=688  \\$a2003 (1998)
=750  \0$aHalobacterium salinarium$5IEN-M$0(DLC)sh 87006188

=LDR  00650cz  a2200205n  4500
=001  9880364371402441
=005  20141212213506.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020010
=035  \\$aCVE6209HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x802.$x975.$x400
=072  \\$aG8.$x686.$x867.$x400
=150  \\$aHeterosexuality
=450  \\$wnnna$aHeterosexual
=450  \\$wnnna$aHeterosexuals
=550  \\$wg$aSexuality
=680  \\$iThe sexual attraction or relationship between members of the opposite SEX.
=688  \\$a98; use SEXUALITY 1997; use SEX BEHAVIOR 1990-96
=750  \0$aHeterosexuality$5IEN-M$0(DLC)sh 93008585

=LDR  00733cz  a2200229n  4500
=001  9880364371502441
=005  20141212213428.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019882
=035  \\$aCVE6204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x104
=072  \\$aE4.$x680.$x275.$x90
=150  \\$aBlepharoplasty
=450  \\$wnnna$aBlepharoplasties
=550  \\$wg$aDermatologic Surgical Procedures
=550  \\$wg$aOphthalmologic Surgical Procedures
=550  \\$aBlepharoptosis
=667  \\$ado not use /util except by MeSH definition
=680  \\$iPlastic surgery of the eyelid. (Cline et al., Dictionary of Visual Science, 4th ed)
=688  \\$a98
=750  \0$aBlepharoplasty$5IEN-M$0(DLC)sh 85014842

=LDR  01667cz  a2200505n  4500
=001  9880364371602441
=005  20141212213305.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019635
=035  \\$aCVE6201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525
=150  \\$aNeurosurgical Procedures
=450  \\$aNervous System$xsurgery
=450  \\$wnnna$aNeurologic Surgical Procedure
=450  \\$wnnna$aNeurologic Surgical Procedures
=450  \\$wnnna$aNeurosurgical Procedure
=450  \\$wnnna$aProcedure, Neurologic Surgical
=450  \\$wnnna$aProcedure, Neurosurgical
=450  \\$wnnna$aProcedures, Neurologic Surgical
=450  \\$wnnna$aProcedures, Neurosurgical
=450  \\$wnnna$aSurgical Procedure, Neurologic
=450  \\$wnnna$aSurgical Procedures, Neurologic
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$wh$aAnterior Temporal Lobectomy
=550  \\$wh$aBrain Tissue Transplantation
=550  \\$wh$aCerebral Decortication
=550  \\$wh$aCerebrospinal Fluid Shunts
=550  \\$wh$aCraniotomy
=550  \\$wh$aDenervation
=550  \\$wh$aForaminotomy
=550  \\$wh$aHypophysectomy
=550  \\$wh$aLaminectomy
=550  \\$wh$aLaminoplasty
=550  \\$wh$aMicrovascular Decompression Surgery
=550  \\$wh$aNerve Transfer
=550  \\$wh$aNeuroendoscopy
=550  \\$wh$aPallidotomy
=550  \\$wh$aPsychosurgery
=550  \\$wh$aSplit-Brain Procedure
=550  \\$wh$aStereotaxic Techniques
=550  \\$aNeurosurgery
=680  \\$iSurgery performed on the nervous system or its parts.
=688  \\$a98
=750  \0$aNervous system$xSurgery$5IEN-M$0(DLC)sh 85090934

=LDR  01145cz  a2200325n  4500
=001  9880364371702441
=005  20141212213433.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019896
=035  \\$aCVE6199HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x74
=072  \\$aC8.$x381.$x112
=072  \\$aC16.$x320.$x60
=072  \\$aC23.$x550.$x325.$x500.$x500
=150  \\$aalpha 1-Antitrypsin Deficiency
=450  \\$wnnna$aalpha 1-Antitrypsin Deficiencies
=450  \\$wnnna$aalpha 1 Antitrypsin Deficiency
=450  \\$aalpha 1-Antitrypsin$xdeficiency
=450  \\$wnnna$aDeficiencies, alpha 1-Antitrypsin
=450  \\$wnnna$aDeficiency, alpha 1-Antitrypsin
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aLiver Diseases
=550  \\$wg$aLung Diseases
=550  \\$wg$aSubcutaneous Emphysema
=550  \\$aalpha 1-Antitrypsin
=667  \\$aPi or PiZZ goes here + PHENOTYPE
=680  \\$iDeficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.
=688  \\$a98
=750  \0$aAlpha 1-antitrypsin deficiency$5IEN-M$0(DLC)sh 95007971

=LDR  01852cz  a2200421n  4500
=001  9880364371802441
=005  20141212213357.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019787
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x355.$x310.$x515.$x500
=072  \\$aD10.$x251.$x355.$x343.$x500.$x500
=150  \\$aLinoleic Acid
=450  \\$a9,12-Octadecadienoic Acid
=450  \\$wnnna$a9,12 Octadecadienoic Acid
=450  \\$wnnna$a9-trans,12-trans-Octadecadienoic Acid
=450  \\$wnnna$a9 trans,12 trans Octadecadienoic Acid
=450  \\$wnnna$aAcid, 9,12-Octadecadienoic
=450  \\$wnnna$acis,cis-9,12-Octadecadienoic Acid
=450  \\$wnnna$aLinoelaidic Acid
=450  \\$wnnna$aLinoelaidic Acid, (E,Z)-Isomer
=450  \\$aLinoleate
=450  \\$wnnna$aLinoleic Acid, Ammonium Salt, (Z,Z)-Isomer
=450  \\$wnnna$aLinoleic Acid, Calcium Salt, (Z,Z)-Isomer
=450  \\$wnnna$aLinoleic Acid, (E,E)-Isomer
=450  \\$wnnna$aLinoleic Acid, Potassium Salt, (Z,Z)-Isomer
=450  \\$wnnna$aLinoleic Acid, Sodium Salt, (E,E)-Isomer
=450  \\$wnnna$aLinoleic Acid, Sodium Salt, (Z,Z)-Isomer
=450  \\$wnnna$aLinoleic Acid, (Z,E)-Isomer
=450  \\$wnnna$aLinoleic Acid, (Z,Z)-Isomer
=450  \\$wnnna$aLinoleic Acid, (Z,Z)-Isomer, 14C-Labeled
=450  \\$wnnna$aLinolelaidic Acid
=450  \\$wnnna$atrans,trans-9,12-Octadecadienoic Acid
=550  \\$wg$aLinoleic Acids
=667  \\$aLINOLEIC ACIDS and LINOLEIC ACIDS, CONJUGATED are also available
=680  \\$iA doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. (From Stedman, 26th ed)
=688  \\$a98; use LINOLEIC ACID (NM) 1981-97
=750  \0$aLinoleic acid$0(DLC) sh 98004643$5IEN-M

=LDR  01240cz  a2200289n  4500
=001  9880364371902441
=005  20141212213401.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019802
=035  \\$aCVE6191HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x337.$x759.$x625
=150  \\$aSuccinic Acid
=450  \\$wnnna$a1,2-Ethanedicarboxylic Acid
=450  \\$wnnna$a1,2 Ethanedicarboxylic Acid
=450  \\$wnnna$a1,4-Butanedioic Acid
=450  \\$wnnna$a1,4 Butanedioic Acid
=450  \\$wnnna$aAmmonium Succinate
=450  \\$wnnna$aButanedioic Acid
=450  \\$aPotassium Succinate
=450  \\$aSuccinate
=450  \\$wnnna$aSuccinate, Ammonium
=450  \\$wnnna$aSuccinate, Potassium
=550  \\$wg$aSuccinates
=680  \\$iA water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
=688  \\$a98; use SUCCINIC ACID (NM) 1981-97
=750  \0$aSuccinic acid$5IEN-M$0(DLC)sh 85129593

=LDR  02327cz  a2200517n  4500
=001  9880364372002441
=005  20141212213335.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019704
=035  \\$aCVE6183HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x475.$x800.$x550
=150  \\$aProtein Disulfide-Isomerases
=450  \\$wnnna$aDisulfide Interchange Enzyme
=450  \\$wnnna$aDisulfide Isomerase
=450  \\$wnnna$aDisulfide Isomerase, Protein
=450  \\$wnnna$aDisulfide-Isomerase, Protein
=450  \\$wnnna$aDisulfide-Isomerases, Protein
=450  \\$wnnna$aEnzyme, Disulfide Interchange
=450  \\$wnnna$aEnzyme, Sulfhydryl-Disulfide Interchange
=450  \\$wnnna$aGlycosylation Site-Binding Protein
=450  \\$wnnna$aGlycosylation Site Binding Protein
=450  \\$wnnna$aInterchange Enzyme, Disulfide
=450  \\$wnnna$aInterchange Enzyme, Sulfhydryl-Disulfide
=450  \\$wnnna$aIsomerase, Disulfide
=450  \\$wnnna$aIsomerase, Protein Disulfide
=450  \\$aProtein Disulfide Isomerase
=450  \\$aProtein Disulfide-Isomerase
=450  \\$wnnna$aProtein Disulfide Isomerases
=450  \\$wnnna$aProtein, Glycosylation Site-Binding
=450  \\$wnnna$aSite-Binding Protein, Glycosylation
=450  \\$wnnna$aSulfhydryl-Disulfide Interchange Enzyme
=450  \\$wnnna$aSulfhydryl Disulfide Interchange Enzyme
=450  \\$wnnna$aThiol-Disulfide Transhydrogenase
=450  \\$wnnna$aThiol Disulfide Transhydrogenase
=450  \\$wnnna$aThioltransferase, Trypanothione-Glutathione
=450  \\$wnnna$aTranshydrogenase, Thiol-Disulfide
=450  \\$wnnna$aTrypanothione-Glutathione Thioltransferase
=450  \\$wnnna$aTrypanothione Glutathione Thioltransferase
=550  \\$wg$aSulfur-Sulfur Bond Isomerases
=550  \\$aProcollagen-Proline Dioxygenase
=680  \\$iSulfur-sulfur bond isomerases that catalyze the rearrangement of disulfide bonds within proteins during folding. Specific protein disulfide-isomerase isoenzymes also occur as subunits of PROCOLLAGEN-PROLINE DIOXYGENASE.
=688  \\$a2008(1998);
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Protein Disulfide-Isomerase
=688  \\$a98; use PROTEIN DISULFIDE-ISOMERASE (NM) 1980-97
=750  \0$aProtein disulfide isomerase$0(DLC) sh 90002771$5IEN-M

=LDR  01261cz  a2200289n  4500
=001  9880364372102441
=005  20141212213353.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019774
=035  \\$aCVE6182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x113
=150  \\$aBlood Coagulation Factor Inhibitors
=450  \\$aBlood Coagulation Factors$xantagonists & inhibitors$5IEN-M
=450  \\$wnnna$aInhibitor, Blood Coagulation Factor
=450  \\$wnnna$aInhibitor, Coagulation Factor, Blood
=450  \\$wnnna$aInhibitors, Blood Coagulation Factor
=450  \\$wnnna$aInhibitors, Coagulation Factor, Blood
=550  \\$wg$aBiological Factors
=550  \\$wh$aAntithrombin III
=550  \\$wh$aLupus Coagulation Inhibitor
=550  \\$wh$aProtein C
=550  \\$wh$aProtein S
=667  \\$aDF: BLOOD COAG FACTOR INHIB
=680  \\$iSubstances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.
=688  \\$a98
=750  \0$aBlood coagulation factors$xInhibitors$5IEN-M

=LDR  00896cz  a2200217n  4500
=001  9880364372202441
=005  20141212213426.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019876
=035  \\$aCVE6176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x825
=150  \\$aSports Equipment
=450  \\$aAthletic Equipment
=450  \\$wnnna$aEquipment, Athletic
=450  \\$wnnna$aEquipment, Sports
=550  \\$wg$aManufactured Materials
=667  \\$acoord IM with specific sport (IM); for protective equipment coord with PROTECTIVE DEVICES (IM) or specific protective device (IM)
=680  \\$iEquipment required for engaging in a sport (such as balls, bats, rackets, skis, skates, ropes, weights) and devices for the protection of athletes during their performance (such as masks, gloves, mouth pieces).
=688  \\$a98
=750  \0$aSporting goods$5IEN-M$0(DLC)sh 85126880

=LDR  01726cz  a2200421n  4500
=001  9880364372302441
=005  20190426151846.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019947
=035  \\$aCVE6175HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x400
=150  \\$aReceptors, Interleukin-6
=450  \\$wnnna$aIL-6 Receptor
=450  \\$wnnna$aIL 6 Receptor
=450  \\$aIL-6 Receptors
=450  \\$wnnna$aIL 6 Receptors
=450  \\$wnnna$aIL6 Receptor
=450  \\$wnnna$aIL6 Receptors
=450  \\$wnnna$aInterleukin 6 Receptor
=450  \\$aInterleukin-6 Receptors
=450  \\$wnnna$aInterleukin 6 Receptors
=450  \\$wnnna$aReceptor, IL-6
=450  \\$wnnna$aReceptor, IL6
=450  \\$wnnna$aReceptor, Interleukin 6
=450  \\$aReceptors, IL-6
=450  \\$wnnna$aReceptors, IL 6
=450  \\$wnnna$aReceptors, IL6
=450  \\$wnnna$aReceptors, Interleukin 6
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aCytokine Receptor gp130
=550  \\$wh$aInterleukin-6 Receptor alpha Subunit
=667  \\$aDF: RECEPT IL 6
=680  \\$iCell surface receptors that are specific for INTERLEUKIN-6. They are present on T-LYMPHOCYTES, mitogen-activated B-LYMPHOCYTES, and peripheral MONOCYTES. The receptors are heterodimers of the INTERLEUKIN-6 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130.
=688  \\$a98; use RECEPTORS, INTERLEUKIN-6 (NM) 1988-97
=750  \0$81$wb$iBroader mapping$aInterleukin-6$0(DLC) sh 92001229$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-6--Receptors$5IEN-M

=LDR  02295cz  a2200469n  4500
=001  9880364372402441
=005  20190426135212.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019948
=035  \\$aCVE6174HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x360
=150  \\$aReceptors, Interleukin-4
=450  \\$wnnna$aB Cell-Activating Factor Receptor
=450  \\$wnnna$aB Cell Activating Factor Receptor
=450  \\$wnnna$aIL-4 Receptor
=450  \\$wnnna$aIL 4 Receptor
=450  \\$aIL-4 Receptors
=450  \\$wnnna$aIL 4 Receptors
=450  \\$wnnna$aIL4 Receptor
=450  \\$wnnna$aIL4 Receptors
=450  \\$wnnna$aInterleukin 4 Receptor
=450  \\$aInterleukin-4 Receptors
=450  \\$wnnna$aInterleukin 4 Receptors
=450  \\$wnnna$aReceptor, B Cell-Activating Factor
=450  \\$wnnna$aReceptor, B Cell Activating Factor
=450  \\$wnnna$aReceptor, IL-4
=450  \\$wnnna$aReceptor, IL4
=450  \\$wnnna$aReceptor, Interleukin 4
=450  \\$aReceptors, IL-4
=450  \\$wnnna$aReceptors, IL 4
=450  \\$wnnna$aReceptors, IL4
=450  \\$wnnna$aReceptors, Interleukin 4
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aReceptors, Interleukin-4, Type I
=550  \\$wh$aReceptors, Interleukin-4, Type II
=667  \\$aDF: RECEPT IL 4; RECEPTORS, INTERLEUKIN-4 TYPE I and RECEPTORS, INTERLEUKIN-4 TYPE II are also available
=680  \\$iReceptors present on a wide variety of hematopoietic and non-hematopoietic cell types that are specific for INTERLEUKIN-4. They are involved in signaling a variety of immunological responses related to allergic INFLAMMATION including the differentiation of TH2 CELLS and the regulation of IMMUNOGLOBULIN E production. Two subtypes of receptors exist and are referred to as the TYPE I INTERLEUKIN-4 RECEPTOR and the TYPE II INTERLEUKIN-4 RECEPTOR. Each receptor subtype is defined by its unique subunit composition.
=688  \\$a98; use RECEPTORS, INTERLEUKIN-4 (NM) 1986-97
=750  \0$81$wb$iBroader mapping$aInterleukin-4$0(DLC)sh 91004837$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-4--Receptors$5IEN-M

=LDR  02675cz  a2200697n  4500
=001  9880364372502441
=005  20181204093631.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019736
=035  \\$aCVE6170HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x695
=150  \\$aProstheses and Implants
=450  \\$wnnna$aArtificial Implant
=450  \\$wnnna$aArtificial Implants
=450  \\$wnnna$aImplant, Artificial
=450  \\$wnnna$aImplants and Prostheses
=450  \\$aImplants, Artificial
=450  \\$wnnna$aProstheses
=450  \\$aProsthesis
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aAbsorbable Implants
=550  \\$wh$aArtificial Limbs
=550  \\$wh$aAuditory Brain Stem Implants
=550  \\$wh$aBioprosthesis
=550  \\$wh$aBlood Vessel Prosthesis
=550  \\$wh$aBreast Implants
=550  \\$wh$aCochlear Implants
=550  \\$wh$aDefibrillators, Implantable
=550  \\$wh$aDental Implants
=550  \\$wh$aDental Prosthesis
=550  \\$wh$aElectrodes, Implanted
=550  \\$wh$aEmbolic Protection Devices
=550  \\$wh$aEye, Artificial
=550  \\$wh$aFiducial Markers
=550  \\$wh$aGlaucoma Drainage Implants
=550  \\$wh$aHeart, Artificial
=550  \\$wh$aHeart Valve Prosthesis
=550  \\$wh$aImplants, Experimental
=550  \\$wh$aInternal Fixators
=550  \\$wh$aJoint Prosthesis
=550  \\$wh$aLarynx, Artificial
=550  \\$wh$aLenses, Intraocular
=550  \\$wh$aMaxillofacial Prosthesis
=550  \\$wh$aOrbital Implants
=550  \\$wh$aOssicular Prosthesis
=550  \\$wh$aPenile Prosthesis
=550  \\$wh$aProsthesis Design
=550  \\$wh$aPunctal Plugs
=550  \\$wh$aSeptal Occluder Device
=550  \\$wh$aStents
=550  \\$wh$aSuburethral Slings
=550  \\$wh$aTissue Expansion Devices
=550  \\$wh$aTissue Scaffolds
=550  \\$wh$aUrinary Sphincter, Artificial
=550  \\$wh$aVisual Prosthesis
=550  \\$aProsthesis Retention
=667  \\$aGEN: prefer specifics; coord IM with prosthetic or implant material (IM or NIM); adv eff: consider PROSTHESIS-RELATED INFECTIONS; BIOPROSTHESIS is also available
=680  \\$iArtificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.
=688  \\$a98
=750  \0$aProsthesis$5IEN-M$0(DLC)sh 85107615

=LDR  00862cz  a2200193n  4500
=001  9880364372602441
=005  20141212213412.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019833
=035  \\$aCVE6169M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x150.$x266.$x450.$x400.$x375
=072  \\$aD3.$x830.$x219.$x266.$x450.$x400.$x375
=150  \\$aGenistein
=450  \\$wnnna$aGenestein
=550  \\$wg$aIsoflavones
=680  \\$iAn isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.
=688  \\$a98; use GENISTEIN (NM) 1980-97
=750  \0$aGenistein$0(DLC)sh2010008163$5IEN-M

=LDR  01898cz  a2200445n  4500
=001  9880364372702441
=005  20141212213413.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019837
=035  \\$aCVE6167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x150.$x800
=072  \\$aD12.$x776.$x210.$x500.$x800
=072  \\$aD12.$x776.$x543.$x550.$x425.$x150.$x800
=072  \\$aD12.$x776.$x543.$x585.$x400.$x150.$x800
=150  \\$aRyanodine Receptor Calcium Release Channel
=450  \\$wnnna$aCa Release Channel-Ryanodine Receptor
=450  \\$wnnna$aCa Release Channel Ryanodine Receptor
=450  \\$aCalcium-Ryanodine Receptor Complex
=450  \\$wnnna$aCalcium Ryanodine Receptor Complex
=450  \\$wnnna$aComplex, Calcium-Ryanodine Receptor
=450  \\$wnnna$aReceptor 1, Ryanodine
=450  \\$wnnna$aReceptor 2, Ryanodine
=450  \\$wnnna$aReceptor 3, Ryanodine
=450  \\$wnnna$aReceptor Complex, Calcium-Ryanodine
=450  \\$wnnna$aReceptor, Ryanodine
=450  \\$wnnna$aReceptors, Ryanodine
=450  \\$wnnna$aRyanodine Receptor
=450  \\$aRyanodine Receptor 1
=450  \\$aRyanodine Receptor 2
=450  \\$aRyanodine Receptor 3
=450  \\$aRyanodine Receptors
=450  \\$aRyR1
=450  \\$wnnna$aRyR2
=450  \\$wnnna$aRyR3
=550  \\$wg$aCalcium Channels
=550  \\$wg$aMuscle Proteins
=680  \\$iA tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.
=688  \\$a98; use RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL (NM) 1985-97
=750  \0$aRyanodine$xReceptors$0sh2004000526$5IEN-M

=LDR  01157cz  a2200301n  4500
=001  9880364372802441
=005  20141212213011.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019108
=035  \\$aCSK5909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x420.$x820
=150  \\$aTight Junctions
=450  \\$wnnna$aJunction, Occluding
=450  \\$wnnna$aJunction, Tight
=450  \\$wnnna$aJunctions, Occluding
=450  \\$wnnna$aJunctions, Tight
=450  \\$wnnna$aOccluden, Zonula
=450  \\$wnnna$aOccludens, Zonula
=450  \\$wnnna$aOccluding Junction
=450  \\$aOccluding Junctions
=450  \\$wnnna$aTight Junction
=450  \\$wnnna$aZonula Occluden
=450  \\$wnnna$aZonula Occludens
=550  \\$wg$aIntercellular Junctions
=680  \\$iCell-cell junctions that seal adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. (Alberts et al., Molecular Biology of the Cell, 2nd ed, p22)
=688  \\$a96; was see INTERCELLULAR JUNCTIONS 1995
=750  \0$aTight junctions (Cell biology)$5IEN-M$0(DLC)sh 91000984

=LDR  01211cz  a2200313n  4500
=001  9880364372902441
=005  20141212213009.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019098
=035  \\$aCSK5906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x445.$x308.$x300.$x750.$x750
=072  \\$aD12.$x776.$x157.$x725.$x500.$x921
=072  \\$aD12.$x776.$x664.$x962.$x500.$x921
=150  \\$aTelomerase
=450  \\$wnnna$aCatalytic Subunit, Telomerase
=450  \\$wnnna$aReverse Transcriptase, Telomerase
=450  \\$wnnna$aSubunit, Telomerase Catalytic
=450  \\$wnnna$aTelomerase Catalytic Subunit
=450  \\$wnnna$aTelomerase Reverse Transcriptase
=450  \\$wnnna$aTelomerase Reverse Transcriptase Catalytic Subunit
=450  \\$wnnna$aTranscriptase, Telomerase Reverse
=550  \\$wg$aRibonucleoproteins
=550  \\$wg$aRNA-Directed DNA Polymerase
=550  \\$aTelomere Homeostasis
=680  \\$iAn essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.
=688  \\$a1996(1989); use DNA NUCLEOTIDYLEXOTRANSFERASE 1989-1995
=688  \\$a96
=750  \0$aTelomerase$5IEN-M$0(DLC)sh 97007324

=LDR  00911cz  a2200253n  4500
=001  9880364373002441
=005  20141212212838.0
=008  950608\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018894
=035  \\$aCSK5900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x675.$x850
=072  \\$aD27.$x505.$x954.$x122.$x388.$x77.$x750
=150  \\$aReverse Transcriptase Inhibitors
=450  \\$wnnna$aInhibitors, Reverse Transcriptase
=450  \\$aRNA-Directed DNA Polymerase$xantagonists & inhibitors
=550  \\$wg$aAnti-Retroviral Agents
=550  \\$wg$aNucleic Acid Synthesis Inhibitors
=550  \\$aAntiviral Agents
=550  \\$aHIV
=667  \\$aDF: REVERSE TRANSCRIPTASE INHIB
=680  \\$iInhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.
=688  \\$a96
=750  \0$aReverse transcriptase$xInhibitors$5IEN-M

=LDR  01496cz  a2200373n  4500
=001  9880364373102441
=005  20141212212658.0
=008  940419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018575
=035  \\$aCSK5897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x524.$x403
=150  \\$aHome Care Services, Hospital-Based
=450  \\$wnnna$aCare, Hospital-Based Home
=450  \\$wnnna$aCare, Hospital Based Home
=450  \\$wnnna$aCares, Hospital-Based Home
=450  \\$wnnna$aCares, Hospital Based Home
=450  \\$wnnna$aHome Care, Hospital-Based
=450  \\$wnnna$aHome Care, Hospital Based
=450  \\$wnnna$aHome Care Services, Hospital Based
=450  \\$wnnna$aHome Cares, Hospital-Based
=450  \\$wnnna$aHome Cares, Hospital Based
=450  \\$aHospital-Based Home Care
=450  \\$wnnna$aHospital Based Home Care
=450  \\$wnnna$aHospital-Based Home Care Services
=450  \\$wnnna$aHospital Based Home Care Services
=450  \\$wnnna$aHospital Based Home Cares
=450  \\$wnnna$aHospital-Based Home Cares
=450  \\$wnnna$aHospital Home Care Services
=550  \\$wg$aHome Care Services
=667  \\$aIM; DF: HOME CARE SERV HOSP BASED
=680  \\$iHospital-sponsored provision of health services, such as nursing, therapy, and health-related homemaker or social services, in the patient's home. (Hospital Administration Terminology, 2d ed)
=688  \\$a95
=750  \0$aHospitals$xHome care programs$5IEN-M$0(DLC)sh 85062334

=LDR  01002cz  a2200217n  4500
=001  9880364373202441
=005  20141212213012.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019111
=035  \\$aCSK5893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x190.$x250.$x260
=150  \\$aCondoms, Female
=450  \\$wnnna$aCondom, Female
=450  \\$wnnna$aFemale Condom
=450  \\$aFemale Condoms
=550  \\$wg$aContraceptive Devices, Female
=667  \\$ado not use /util except by MeSH definition
=680  \\$iA soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. (Med Lett Drugs Ther 1993 Dec 24;35(12):123)
=688  \\$a96
=750  \0$aFemale condoms$5IEN-M$0(DLC)sh 95003209

=LDR  01084cz  a2200325n  4500
=001  9880364373302441
=005  20141212212744.0
=008  940416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018715
=035  \\$aCSK5889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x690
=072  \\$aE5.$x595.$x690
=072  \\$aJ1.$x897.$x280.$x500.$x898.$x475
=072  \\$aL1.$x178.$x820.$x90.$x898.$x475
=072  \\$aL1.$x178.$x847.$x823.$x475
=150  \\$aMicroscopy, Video
=450  \\$wnnna$aMicroscopies, Video
=450  \\$wnnna$aVideo Microscopies
=450  \\$aVideo Microscopy
=450  \\$wnnna$aVideomicrographies
=450  \\$aVideomicrography
=450  \\$wnnna$aVideomicroscopies
=450  \\$aVideomicroscopy
=550  \\$wg$aMicroscopy
=550  \\$wg$aTelevision
=667  \\$aNIM
=680  \\$iMicroscopy in which television cameras are used to brighten magnified images that are otherwise too dark to be seen with the naked eye. It is used frequently in TELEPATHOLOGY.
=688  \\$a95
=750  \0$aVideo microscopy$5IEN-M$0(DLC)sh 86000510

=LDR  01870cz  a2200409n  4500
=001  9880364373402441
=005  20190102103149.0
=008  950605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018875
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x453.$x245.$x945
=150  \\$aVocabulary, Controlled
=450  \\$wnnna$aControlled Thesauri
=450  \\$wnnna$aControlled Thesaurus
=450  \\$wnnna$aControlled Vocabularies
=450  \\$aControlled Vocabulary
=450  \\$wnnna$aThesauri
=450  \\$wnnna$aThesauri, Controlled
=450  \\$aThesaurus
=450  \\$wnnna$aThesaurus, Controlled
=450  \\$wnnna$aVocabularies, Controlled
=550  \\$wg$aDocumentation
=550  \\$wh$aBiological Ontologies
=550  \\$wh$aCommon Data Elements
=550  \\$wh$aCurrent Procedural Terminology
=550  \\$wh$aDiagnostic and Statistical Manual of Mental Disorders
=550  \\$wh$aHealthcare Common Procedure Coding System
=550  \\$wh$aInternational Classification of Diseases
=550  \\$wh$aInternational Classification of Functioning, Disability and Health
=550  \\$wh$aLogical Observation Identifiers Names and Codes
=550  \\$wh$aStandardized Nursing Terminology
=550  \\$wh$aSubject Headings
=550  \\$wh$aSystematized Nomenclature of Medicine
=550  \\$wh$aUnified Medical Language System
=680  \\$iA specified list of terms with a fixed and unalterable meaning, and from which a selection is made when CATALOGING; ABSTRACTING AND INDEXING; or searching BOOKS; JOURNALS AS TOPIC; and other documents. The control is intended to avoid the scattering of related subjects under different headings (SUBJECT HEADINGS). The list may be altered or extended only by the publisher or issuing agency. (From Harrod's Librarians' Glossary, 7th ed, p163)
=688  \\$a96
=750  \0$aThesauri$5IEN-M$0(DLC)sh 85134827

=LDR  01138cz  a2200241n  4500
=001  9880364373502441
=005  20141212212926.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019021
=035  \\$aCSK5884HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x602
=072  \\$aH1.$x770.$x552
=072  \\$aK1.$x400.$x703
=150  \\$aNatural History
=450  \\$wnnna$aHistory, Natural
=550  \\$wg$aBiology
=550  \\$wg$aHistory
=550  \\$wg$aScience
=667  \\$arestrict to the hist science: not for the "natural history" or natural course or develop of a dis; DF: NATURAL HIST
=680  \\$iA former branch of knowledge embracing the study, description, and classification of natural objects (as animals, plants, and minerals) and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalized pursuit of certain areas of science. (Webster, 3d ed; from Dr. James H. Cassedy, NLM History of Medicine Division)
=688  \\$a96
=750  \0$aNatural history$5IEN-M$0(DLC)sh 85090222

=LDR  00601cz  a2200193n  4500
=001  9880364373602441
=005  20141212212927.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019023
=035  \\$aCSK5879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x230.$x750
=150  \\$aStethoscopes
=450  \\$wnnna$aStethoscope
=550  \\$wg$aDiagnostic Equipment
=550  \\$aAuscultation
=680  \\$iInstruments intended to detect and study sound produced by the heart, lungs, or other parts of the body. (from UMDNS, 1999)
=688  \\$a96
=750  \0$aStethoscopes$5IEN-M$0(DLC)sh 85128062

=LDR  01014cz  a2200181n  4500
=001  9880364373702441
=005  20141212213004.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019090
=035  \\$aCSK5871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x624.$x250
=150  \\$aCase Management
=550  \\$wg$aPatient Care Planning
=667  \\$aall health professionals' activities to insure coord of services for the patient
=680  \\$iA traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. (From Slee & Slee, Health Care Terms, 2nd ed)
=688  \\$a96
=750  \0$aHospitals$xCase management services$5IEN-M$0(DLC)sh 86003663

=LDR  01205cz  a2200325n  4500
=001  9880364373802441
=005  20141212212901.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018962
=035  \\$aCSK5868HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x998.$x110.$x625
=072  \\$aE2.$x800.$x558
=072  \\$aE4.$x665.$x150.$x625
=072  \\$aE5.$x200.$x998.$x110.$x625
=150  \\$aPhlebotomy
=450  \\$wnnna$aPhlebotomies
=450  \\$aVenesection
=450  \\$wnnna$aVenesections
=450  \\$aVenipuncture
=450  \\$wnnna$aVenipunctures
=550  \\$wg$aBlood Specimen Collection
=550  \\$wg$aPunctures
=550  \\$wh$aBloodletting
=550  \\$aBloodletting
=550  \\$aHemorrhage
=667  \\$afor hist articles & hist contexts use BLOODLETTING
=680  \\$iThe techniques used to draw blood from a vein for diagnostic purposes or for treatment of certain blood disorders such as erythrocytosis, hemochromatosis, polycythemia vera, and porphyria cutanea tarda.
=688  \\$a1996; use BLOODLETTING 1987-1995; VENESECTION use BLOODLETTING 1987-1995; VENIPUNCTURE use BLOODLETTING 1989-1995
=750  \0$aPhlebotomy$5IEN-M$0(DLC)sh 85015033

=LDR  01318cz  a2200325n  4500
=001  9880364373902441
=005  20141212212939.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019042
=035  \\$aCSK5865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x839.$x500
=072  \\$aC5.$x651.$x494
=150  \\$aMuscle Neoplasms
=450  \\$wnnna$aCancer, Muscle
=450  \\$aCancer of Muscle
=450  \\$wnnna$aCancer of the Muscle
=450  \\$wnnna$aCancers, Muscle
=450  \\$aMuscle Cancer
=450  \\$wnnna$aMuscle Cancers
=450  \\$wnnna$aMuscle Neoplasm
=450  \\$wnnna$aNeoplasm, Muscle
=450  \\$wnnna$aNeoplasms, Muscle
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aSoft Tissue Neoplasms
=667  \\$aneopl located in muscles: do not confuse with NEOPLASMS, MUSCLE TISSUE, neopl composed of muscle tissue; coord IM with specific muscle (IM) + histol type of neopl (IM); DF: MUSCLE NEOPL
=680  \\$iTumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.
=688  \\$a96
=750  \0$aMuscles$xCancer$0(DLC)sh2010009786$5IEN-M
=750  \0$aMuscles$xTumors$0(DLC) sh 85088691$5IEN-M

=LDR  01434cz  a2200385n  4500
=001  9880364374102441
=005  20141212212849.0
=008  950526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D018926
=035  \\$aCSK5862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x16
=150  \\$aAnti-Allergic Agents
=450  \\$wnnna$aAgents, Anti-Allergic
=450  \\$wnnna$aAgents, Antiallergic
=450  \\$wnnna$aAgents, Antiallergy
=450  \\$wnnna$aAnti Allergic Agents
=450  \\$wnnna$aAnti-Allergics
=450  \\$wnnna$aAnti Allergics
=450  \\$wnnna$aAnti-Allergy Drugs
=450  \\$wnnna$aAnti Allergy Drugs
=450  \\$wnnna$aAntiallergic Agents
=450  \\$wnnna$aAntiallergic Drugs
=450  \\$wnnna$aAntiallergics
=450  \\$wnnna$aAntiallergy Agents
=450  \\$wnnna$aDrugs, Anti-Allergy
=450  \\$wnnna$aDrugs, Antiallergic
=550  \\$wg$aTherapeutic Uses
=550  \\$aHistamine H1 Antagonists
=550  \\$aHistamine H1 Antagonists, Non-Sedating
=550  \\$aHypersensitivity
=667  \\$aconsider also HYPERSENSITIVITY /drug ther
=680  \\$iAgents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)
=688  \\$a96
=750  \0$aAntiallergic agents$5IEN-M$0(DLC)sh 85005627

=LDR  02103cz  a2200589n  4500
=001  9880364421602441
=005  20200706140912.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066330
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x564
=072  \\$aL1.$x224.$x108.$x150.$x500
=072  \\$aL1.$x296.$x110.$x150.$x500
=150  \\$aPrinting, Three-Dimensional
=450  \\$wnnna$a3-D Printing
=450  \\$wnnna$a3 D Printing
=450  \\$wnnna$a3-D Printings
=450  \\$wnnna$a3 Dimensional Printing
=450  \\$wnnna$a3-Dimensional Printing
=450  \\$wnnna$a3 Dimensional Printings
=450  \\$wnnna$a3-Dimensional Printings
=450  \\$wnnna$a3D Printer
=450  \\$wnnna$a3D Printers
=450  \\$wnnna$a3D Printing
=450  \\$wnnna$a3D Printings
=450  \\$wnnna$aDimensional Printing, 3
=450  \\$wnnna$aDimensional Printing, Three
=450  \\$wnnna$aDimensional Printings, 3
=450  \\$wnnna$aDimensional Printings, Three
=450  \\$wnnna$aPrinter, 3D
=450  \\$wnnna$aPrinters, 3D
=450  \\$wnnna$aPrinting, 3-D
=450  \\$wnnna$aPrinting, 3 Dimensional
=450  \\$wnnna$aPrinting, 3-Dimensional
=450  \\$wnnna$aPrinting, 3D
=450  \\$wnnna$aPrinting, Three Dimensional
=450  \\$wnnna$aPrintings, 3-D
=450  \\$wnnna$aPrintings, 3 Dimensional
=450  \\$wnnna$aPrintings, 3-Dimensional
=450  \\$wnnna$aPrintings, 3D
=450  \\$wnnna$aPrintings, Three Dimensional
=450  \\$wnnna$aPrintings, Three-Dimensional
=450  \\$wnnna$aThree Dimensional Printing
=450  \\$wnnna$aThree-Dimensional Printing
=450  \\$wnnna$aThree Dimensional Printings
=450  \\$wnnna$aThree-Dimensional Printings
=550  \\$wg$aComputer-Aided Design
=550  \\$wg$aTechnology
=550  \\$wh$aStereolithography
=680  \\$iProcess for making, building or constructing a physical object from a three-dimensional digital model by laying down many successive thin layers of building material.
=688  \\$a2015
=750  \0$aThree-dimensional printing$0(DLC)sh2009006799$5IEN-M

=LDR  00630cz  a2200169n  4500
=001  9880364421802441
=005  20150413140858.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066297
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x241.$x850.$x750
=150  \\$aHermeneutics
=450  \\$wnnna$aHermeneutic
=550  \\$wg$aQualitative Research
=680  \\$iThe art, theory, and philosophy of interpreting the meaning of an object (a text, work of art, social action, utterances of another speaker, etc.) (Dictionary of Qualitative Inquiry, 2nd ed..)
=688  \\$a2015
=750  \0$aHermeneutics$0(DLC)sh 85060402$5IEN-M

=LDR  00500cz  a2200169n  4500
=001  9880364421902441
=005  20150406105802.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066296
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x241.$x424
=150  \\$aGrounded Theory
=450  \\$wnnna$aTheory, Grounded
=550  \\$wg$aEmpirical Research
=680  \\$iThe generation of theories from analysis of empirical data.
=688  \\$a2015
=750  \0$aGrounded theory$0(DLC)sh 90004682$5IEN-M

=LDR  01967cz  a2200457n  4500
=001  9880364422002441
=005  20150311135317.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066280
=040  \\$aDNLM$cDNLM
=072  \\$aA6.$x688.$x178
=072  \\$aA8.$x713.$x49
=150  \\$aCircumventricular Organs
=450  \\$wnnna$aCircumventricular Organ
=450  \\$wnnna$aCircumventricular Organ, Secretory
=450  \\$wnnna$aCircumventricular Organ, Sensory
=450  \\$wnnna$aCircumventricular Organs, Secretory
=450  \\$wnnna$aCircumventricular Organs, Sensory
=450  \\$aNeurohemal Organ
=450  \\$wnnna$aNeurohemal Organs
=450  \\$wnnna$aOrgan, Circumventricular
=450  \\$wnnna$aOrgan, Neurohemal
=450  \\$wnnna$aOrgan, Secretory Circumventricular
=450  \\$wnnna$aOrgan, Sensory Circumventricular
=450  \\$wnnna$aOrgans, Circumventricular
=450  \\$wnnna$aOrgans, Neurohemal
=450  \\$wnnna$aOrgans, Secretory Circumventricular
=450  \\$wnnna$aOrgans, Sensory Circumventricular
=450  \\$wnnna$aSecretory Circumventricular Organ
=450  \\$wnnna$aSecretory Circumventricular Organs
=450  \\$wnnna$aSensory Circumventricular Organ
=450  \\$wnnna$aSensory Circumventricular Organs
=550  \\$wg$aNeurosecretory Systems
=550  \\$wh$aArea Postrema
=550  \\$wh$aMedian Eminence
=550  \\$wh$aPituitary Gland, Posterior
=550  \\$wh$aSubcommissural Organ
=550  \\$wh$aSubfornical Organ
=680  \\$iHighly vascularized and specialized tissues distributed principally along the midline of the VENTRICULAR SYSTEM from the FOREBRAIN to the HINDBRAIN. They are distinguished by their lack of normal BLOOD-BRAIN BARRIER and fenestrated capillaries and contain either neurosecretory neurons or chemoreceptors.
=688  \\$a2015; for NEUROHEMAL ORGAN use NEUROSECRETORY SYSTEMS (1984-2014)
=750  \0$aCircumventricular organs$0(DLC)sh 85026079$5IEN-M

=LDR  00548cz  a2200193n  4500
=001  9880364422102441
=005  20150320160625.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066279
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x257
=150  \\$aCourage
=450  \\$wnnna$aBravery
=450  \\$wnnna$aHeroism
=550  \\$wg$aEmotions
=550  \\$aMorale
=680  \\$iState of mind or spirit that enables one to act in the face of perceived danger, difficulty, or pain.
=688  \\$a2015
=750  \0$aCourage$0(DLC)sh 85033527$5IEN-M

=LDR  01220cz  a2200301n  4500
=001  9880364422202441
=005  20150422110948.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066278
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x464.$x497.$x342.$x231
=072  \\$aA8.$x186.$x211.$x730.$x317.$x357.$x342.$x315
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x620.$x374.$x500
=150  \\$aOrganum Vasculosum
=450  \\$wnnna$aCrest, Supraoptic
=450  \\$wnnna$aCrests, Supraoptic
=450  \\$aOrganum Vasculosum Laminae Terminalis
=450  \\$wnnna$aOrganum Vasculosum of Lamina Terminalis
=450  \\$wnnna$aOrganum Vasculosums
=450  \\$wnnna$aSupraoptic Crest
=450  \\$wnnna$aSupraoptic Crests
=450  \\$wnnna$aVasculosum, Organum
=450  \\$wnnna$aVasculosums, Organum
=550  \\$wg$aBasal Forebrain
=550  \\$wg$aHypothalamus, Anterior
=680  \\$iCircumventricular cellular structure in the anterior hypothalamic region. It is located in the optic recess at the anteroventral end of the THIRD VENTRICLE and forms the ventral part of the midline anterior wall.
=688  \\$a2015
=750  \0$aOrganon vasculosum laminae terminalis$0(DLC)sh 85095564

=LDR  00528cz  a2200169n  4500
=001  9880364422302441
=005  20150501104252.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066270
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x375
=150  \\$aSocial Capital
=450  \\$wnnna$aCapital, Social
=550  \\$wg$aSociological Factors
=680  \\$iThe expected benefits derived from the cooperation between individuals and groups.
=688  \\$a2015
=750  \0$aSocial capital (Sociology)$0(DLC)sh 00009986$5IEN-M

=LDR  00808cz  a2200253n  4500
=001  9880364422402441
=005  20190304142352.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066269
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x970
=150  \\$aSocial Theory
=450  \\$wnnna$aSocial Theories
=450  \\$wnnna$aSociological Theories
=450  \\$wnnna$aSociological Theory
=450  \\$wnnna$aTheories, Social
=450  \\$wnnna$aTheories, Sociological
=450  \\$wnnna$aTheory, Social
=450  \\$wnnna$aTheory, Sociological
=550  \\$wg$aPsychological Phenomena
=550  \\$wh$aSymbolic Interactionism
=680  \\$iFrameworks of empirical evidence used to study and interpret social phenomena.
=688  \\$a2015
=750  \0$aSocial sciences$xPhilosophy$0(DLC)sh 85124013$5IEN-M

=LDR  00993cz  a2200265n  4500
=001  9880364422502441
=005  20200907142047.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066264
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x308.$x56
=072  \\$aL1.$x280.$x224
=072  \\$aL1.$x470.$x750.$x750.$x431
=072  \\$aL1.$x700.$x508.$x300.$x188.$x400.$x500
=072  \\$aN5.$x715.$x360.$x300.$x224
=072  \\$aN6.$x850.$x520.$x308.$x56
=150  \\$aDatasets as Topic
=450  \\$wnnna$aData Sets as Topic
=450  \\$aDataset as Topic
=550  \\$wg$aData Collection
=550  \\$wg$aDatabases, Factual
=667  \\$ause only for datasets as a subject; do not confuse with Publication Type DATASET
=680  \\$iDescription or design of an organized collection of data from research projects, stored permanently in a formalized manner suitable for communication, interpretation, or processing.
=688  \\$a2015
=750  \0$aData sets$0(DLC)sh2018002256$5IEN-M

=LDR  01001cz  a2200289n  4500
=001  9880364422602441
=005  20150501104453.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066262
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x750
=072  \\$aI1.$x880.$x853.$x903
=150  \\$aSocial Norms
=450  \\$wnnna$aNorm, Social
=450  \\$wnnna$aNorm, Societal
=450  \\$wnnna$aNorms, Social
=450  \\$wnnna$aNorms, Societal
=450  \\$wnnna$aSocial Norm
=450  \\$wnnna$aSocietal Norm
=450  \\$wnnna$aSocietal Norms
=550  \\$wg$aPsychology, Social
=550  \\$wg$aSociological Factors
=550  \\$aSocial Conformity
=550  \\$aSocial Values
=680  \\$iCustomary standards that govern behavior in groups, cultures, or societies. They reflect what a group deems acceptable in a social context in terms of appropriate and inappropriate values, beliefs, attitudes, and behaviors.
=688  \\$a2015
=750  \0$aSocial norms$0(DLC)sh 85123980$5IEN-M

=LDR  00663cz  a2200241n  4500
=001  9880364422702441
=005  20150430150212.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066256
=040  \\$aDNLM$cDNLM
=072  \\$aJ2.$x500.$x737
=150  \\$aRaw Foods
=450  \\$wnnna$aFood, Raw
=450  \\$wnnna$aFood, Uncooked
=450  \\$wnnna$aFoods, Raw
=450  \\$wnnna$aFoods, Uncooked
=450  \\$wnnna$aRaw Food
=450  \\$wnnna$aUncooked Food
=450  \\$wnnna$aUncooked Foods
=550  \\$wg$aFood
=680  \\$iFood prepared for consumption without exposure to heat.
=688  \\$a2015
=750  \0$aRaw foods$0(DLC)sh 85050250$5IEN-M

=LDR  01235cz  a2200313n  4500
=001  9880364422802441
=005  20150413142458.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066248
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x301.$x662
=150  \\$aHigh Fructose Corn Syrup
=450  \\$wnnna$aCorn Sugar
=450  \\$wnnna$aGlucose-Fructose Syrup
=450  \\$wnnna$aGlucose Fructose Syrup
=450  \\$wnnna$aHigh-Fructose Maize Syrup
=450  \\$wnnna$aHigh Fructose Maize Syrup
=450  \\$wnnna$aIsoglucose
=450  \\$wnnna$aMaize Syrup
=450  \\$wnnna$aMaize Syrup, High-Fructose
=450  \\$wnnna$aSugar, Corn
=450  \\$wnnna$aSyrup, Glucose-Fructose
=450  \\$wnnna$aSyrup, High-Fructose Maize
=450  \\$wnnna$aSyrup, Maize
=550  \\$wg$aDietary Carbohydrates
=680  \\$iSyrup made from corn used widely in foods and beverages as a cheaper alternative sweetener to SUCROSE (common table sugar). It is generated by enzymatic processing of natural corn syrup to produce a liquid most widely composed of 42 or 55% FRUCTOSE, GLUCOSE, and various POLYSACCHARIDES.
=688  \\$a2015
=750  \0$aCorn syrup$0(DLC)sh 85032791$5IEN-M
=750  \0$aCorn sugar$0(DLC)sh 85032790$5IEN-M

=LDR  00679cz  a2200193n  4500
=001  9880364422902441
=005  20150430142325.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066244
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x867.$x519.$x775
=150  \\$aProton Magnetic Resonance Spectroscopy
=450  \\$wnnna$a1H-MRS
=450  \\$wnnna$a1H NMR
=450  \\$wnnna$a1H-NMR
=550  \\$wg$aMagnetic Resonance Spectroscopy
=680  \\$iSpectroscopy technique which measures changes in organic compounds by tracking the spectral energy of absorption of HYDROGEN atoms.
=688  \\$a2015
=750  \0$aProton magnetic resonance spectroscopy$0(DLC)sh 85107792$5IEN-M

=LDR  00855cz  a2200217n  4500
=001  9880364423102441
=005  20150430142809.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066233
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x96.$x628.$x270
=150  \\$aPsychology, Developmental
=450  \\$aDevelopmental Psychology
=550  \\$wg$aPsychology
=550  \\$aHuman Development
=550  \\$aPsychology, Adolescent
=550  \\$aPsychology, Child
=667  \\$ause for the specialty only
=680  \\$iField of study concerned with age-related changes in BEHAVIOR that occur in human beings over the course of life, from birth to death. It includes all aspects of human growth, including emotional, intellectual, social, perceptual and personality development.
=688  \\$a2015
=750  \0$aDevelopmental psychology$0(DLC)sh 85037359$5IEN-M

=LDR  00607cz  a2200217n  4500
=001  9880364423202441
=005  20170807104346.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066231
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x910
=072  \\$aN2.$x360.$x810.$x910
=150  \\$aSurgeons
=450  \\$wnnna$aSurgeon
=550  \\$wg$aPhysicians
=550  \\$wh$aBarber Surgeons
=550  \\$wh$aNeurosurgeons
=550  \\$wh$aOrthopedic Surgeons
=680  \\$iMedical practitioners qualified to practice surgery.
=688  \\$a2015
=750  \0$aSurgeons$0(DLC) sh 85130761$5IEN-M

=LDR  00821cz  a2200241n  4500
=001  9880364423302441
=005  20150416165401.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066209
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x654
=150  \\$aMedical Writing
=450  \\$wnnna$aMedical Writer
=450  \\$wnnna$aMedical Writers
=450  \\$wnnna$aMedical Writings
=450  \\$wnnna$aWriter, Medical
=450  \\$wnnna$aWriters, Medical
=450  \\$wnnna$aWriting, Medical
=450  \\$wnnna$aWritings, Medical
=550  \\$wg$aWriting
=680  \\$iThe practice of writing usually by a skilled or specialized writer focused on the reporting or dissemination of medical information for a target audience.
=688  \\$a2015
=750  \0$aMedical writing$0(DLC)sh 85083051$5IEN-M

=LDR  02736cz  a2200733n  4500
=001  9880364423402441
=005  20150420165736.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066194
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x620
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814.$x695
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x750
=150  \\$aOlfactory Cortex
=450  \\$wnnna$aAmygdala, Cortical
=450  \\$wnnna$aAmygdalas, Cortical
=450  \\$wnnna$aAnterior Olfactory Nucleus
=450  \\$wnnna$aBrain, Olfactory
=450  \\$wnnna$aBrains, Olfactory
=450  \\$wnnna$aCortex, Lateral Entorhineal
=450  \\$wnnna$aCortex, Olfactory
=450  \\$wnnna$aCortex, Primary Olfactory
=450  \\$wnnna$aCortical Amygdala
=450  \\$wnnna$aCortical Amygdalas
=450  \\$wnnna$aCortices, Lateral Entorhineal
=450  \\$wnnna$aCortices, Primary Olfactory
=450  \\$wnnna$aEntorhineal Cortex, Lateral
=450  \\$wnnna$aEntorhineal Cortices, Lateral
=450  \\$wnnna$aLateral Entorhineal Cortex
=450  \\$wnnna$aLateral Entorhineal Cortices
=450  \\$wnnna$aLobe, Olfactory
=450  \\$wnnna$aLobes, Olfactory
=450  \\$wnnna$aNucleus, Anterior Olfactory
=450  \\$wnnna$aOlfactoria, Regio
=450  \\$wnnna$aOlfactorias, Regio
=450  \\$wnnna$aOlfactory Brain
=450  \\$wnnna$aOlfactory Brains
=450  \\$wnnna$aOlfactory Cortex, Primary
=450  \\$wnnna$aOlfactory Cortices, Primary
=450  \\$wnnna$aOlfactory Lobe
=450  \\$wnnna$aOlfactory Lobes
=450  \\$wnnna$aOlfactory Nucleus, Anterior
=450  \\$wnnna$aOlfactory Peduncle
=450  \\$wnnna$aOlfactory Peduncles
=450  \\$wnnna$aPaleopallium
=450  \\$wnnna$aPaleopalliums
=450  \\$wnnna$aPeduncle, Olfactory
=450  \\$wnnna$aPeduncles, Olfactory
=450  \\$wnnna$aPrimary Olfactory Cortex
=450  \\$wnnna$aPrimary Olfactory Cortices
=450  \\$wnnna$aRegio Olfactoria
=450  \\$wnnna$aRegio Olfactorias
=450  \\$aRhinencephalon
=450  \\$wnnna$aRhinencephalons
=550  \\$wg$aCerebral Cortex
=550  \\$wg$aCerebrum
=550  \\$wg$aSensorimotor Cortex
=550  \\$wh$aBasal Forebrain
=550  \\$wh$aEntorhinal Cortex
=550  \\$wh$aOlfactory Tubercle
=550  \\$wh$aPiriform Cortex
=680  \\$iBasal forebrain and medial part of temporal lobe areas that receive synaptic inputs from the OLFACTORY BULB.
=688  \\$a2015; use CENTRAL NERVOUS SYSTEM 1972-1990 and OLFACTORY PATHWAYS 1991-2014; for RHINENCEPHALON use LIMBIC SYSTEM 1963-1999 and OLFACTORY PATHWAYS 2000-2014
=750  \0$aRhinencephalon$0(DLC)sh 85113667$5IEN-M

=LDR  01026cz  a2200301n  4500
=001  9880364423502441
=005  20150416163919.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066192
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x655
=150  \\$aManufacturing Industry
=450  \\$wnnna$aFabrication Industries
=450  \\$wnnna$aFabrication Industry
=450  \\$wnnna$aIndustries, Fabrication
=450  \\$wnnna$aIndustry, Fabrication
=450  \\$wnnna$aManufacturing Industries
=550  \\$wg$aIndustry
=550  \\$wh$aBook Industry
=550  \\$wh$aChemical Industry
=550  \\$wh$aConstruction Industry
=550  \\$wh$aDrug Industry
=550  \\$wh$aExtraction and Processing Industry
=550  \\$wh$aTextile Industry
=550  \\$wh$aTobacco Industry
=680  \\$iAn INDUSTRY which specializes in the fabrication or manufacture of products from raw or intermediate materials.
=688  \\$a2015; use INDUSTRY 2012-2014
=750  \0$aManufacturing industries$0(DLC)sh 97001369$5IEN-M

=LDR  02002cz  a2200541n  4500
=001  9880364423602441
=005  20150501100138.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066191
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814
=150  \\$aSensorimotor Cortex
=450  \\$wnnna$aArea, Sensorimotor
=450  \\$wnnna$aArea, Sensory Motor
=450  \\$wnnna$aArea, Sensory-Motor
=450  \\$wnnna$aAreas, Sensorimotor
=450  \\$wnnna$aAreas, Sensory Motor
=450  \\$wnnna$aAreas, Sensory-Motor
=450  \\$wnnna$aCortex, Sensorimotor
=450  \\$wnnna$aCortex, Sensory Motor
=450  \\$wnnna$aCortex, Sensory-Motor
=450  \\$wnnna$aCortices, Sensorimotor
=450  \\$wnnna$aCortices, Sensory Motor
=450  \\$wnnna$aCortices, Sensory-Motor
=450  \\$wnnna$aMotor Area, Sensory
=450  \\$wnnna$aMotor Areas, Sensory
=450  \\$wnnna$aMotor Cortex, Sensory
=450  \\$wnnna$aMotor Cortices, Sensory
=450  \\$wnnna$aSensorimotor Area
=450  \\$wnnna$aSensorimotor Areas
=450  \\$wnnna$aSensorimotor Cortices
=450  \\$wnnna$aSensory Motor Area
=450  \\$wnnna$aSensory-Motor Area
=450  \\$wnnna$aSensory Motor Areas
=450  \\$wnnna$aSensory-Motor Areas
=450  \\$wnnna$aSensory Motor Cortex
=450  \\$wnnna$aSensory-Motor Cortex
=450  \\$wnnna$aSensory Motor Cortices
=450  \\$wnnna$aSensory-Motor Cortices
=550  \\$wg$aCerebral Cortex
=550  \\$wh$aAuditory Cortex
=550  \\$wh$aMotor Cortex
=550  \\$wh$aOlfactory Cortex
=550  \\$wh$aSomatosensory Cortex
=550  \\$wh$aVisual Cortex
=680  \\$iA composite area of the cerebral cortex concerned with motor control and sensory perception comprising the motor cortex areas, the somatosensory areas, the gustatory cortex, the olfactory areas, the auditory cortex, and the visual cortex.
=688  \\$a2015
=750  \0$aSensorimotor cortex$0(DLC)sh 87006733$5IEN-M

=LDR  00850cz  a2200229n  4500
=001  9880364423702441
=005  20150216162635.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066189
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x427
=150  \\$aMissionaries
=450  \\$wnnna$aMissionary
=450  \\$wnnoa$aMissions and Missionaries$5IEN-M
=550  \\$wg$aPersons
=550  \\$aMedical Missions, Official
=550  \\$aReligious Missions
=667  \\$aRELIGIOUS MISSIONS and MEDICAL MISSIONS, OFFICIAL are also available
=680  \\$iPersons sent into an area to evangelize or to perform acts of service, such as medical care, EDUCATION, or SOCIAL JUSTICE.
=688  \\$a2015(1991); use MISSIONS AND MISSIONARIES 1990-2014
=750  \0$aMissionaries$0(DLC)sh 85086017$5IEN-M
=750  \0$aMissionaries, Medical$0(DLC)sh 85086024$5IEN-M

=LDR  00724cz  a2200229n  4500
=001  9880364423802441
=005  20150518095840.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066188
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x437.$x750
=072  \\$aN6.$x230.$x124.$x343.$x750
=150  \\$aTaiga
=450  \\$wnnna$aBoreal Forest
=450  \\$wnnna$aBoreal Forests
=450  \\$wnnna$aForest, Boreal
=450  \\$wnnna$aForests, Boreal
=450  \\$wnnna$aTaigas
=550  \\$wg$aForests
=680  \\$iAn ecosystem dominated by coniferous forests including the tree line bordered by TUNDRA to the north and STEPPE to the south.
=688  \\$a2015
=750  \0$aTaigas$0(DLC)sh 85131940$5IEN-M

=LDR  00801cz  a2200205n  4500
=001  9880364423902441
=005  20141212222720.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064210
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x553.$x875
=150  \\$aSecondary Metabolism
=450  \\$wnnna$aMetabolism, Secondary
=450  \\$wnnna$aMetabolisms, Secondary
=450  \\$wnnna$aSecondary Metabolisms
=550  \\$wg$aMetabolic Networks and Pathways
=550  \\$aBasal Metabolism
=680  \\$iA physiochemical process which occurs in a wide range of organisms which unlike BASAL METABOLISM is not required for or essential to short-term survivability but to long-term general well-being of the organism.
=688  \\$a2014
=750  \0$aMetabolism, Secondary$0(DLC)sh 85084020$5IEN-M

=LDR  01143cz  a2200313n  4500
=001  9880364424002441
=005  20141212222720.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064209
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x787
=072  \\$aD20.$x663
=150  \\$aPhytochemicals
=450  \\$wnnna$aChemicals, Plant-Derived
=450  \\$wnnna$aCompounds, Plant-Derived
=450  \\$wnnna$aDietary Phytochemicals
=450  \\$wnnna$aPhytochemicals, Dietary
=450  \\$wnnna$aPhytonutrients
=450  \\$wnnna$aPlant-Derived Chemicals
=450  \\$wnnna$aPlant Derived Chemicals
=450  \\$wnnna$aPlant-Derived Compounds
=450  \\$wnnna$aPlant Derived Compounds
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aHeterocyclic Compounds
=550  \\$aSecondary Metabolism
=667  \\$ageneral or unspecified; prefer specific chemical; note PLANT ALKALOIDS see ALKALOIDS is available
=680  \\$iA broad range of biologically active compounds which occur naturally in plants having important medicinal and nutritional properties.
=688  \\$a2014
=750  \0$aPhytochemicals$0(DLC)sh 99001233$5IEN-M

=LDR  00771cz  a2200217n  4500
=001  9880364424102441
=005  20141212222718.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x917
=072  \\$aA18.$x24.$x750.$x825
=150  \\$aTrichomes
=450  \\$wnnna$aIndumentum
=450  \\$wnnna$aIndumentums
=450  \\$wnnna$aTrichome
=550  \\$wg$aCellular Structures
=550  \\$wg$aPlant Epidermis
=680  \\$iHair-like extensions on specialized epidermal surfaces of plants which protect against damage from insects, animals, light degradation and fungal infection. Trichomes may also occur on certain unicellular EUKARYOTES.
=688  \\$a2014
=750  \0$aTrichomes$0(DLC)sh 85137469$5IEN-M

=LDR  01485cz  a2200397n  4500
=001  9880364424202441
=005  20141212222714.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064186
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x332.$x500.$x500
=072  \\$aN2.$x421.$x143.$x827.$x407.$x680.$x500
=072  \\$aN2.$x421.$x726.$x407.$x680.$x500
=150  \\$aPrenatal Education
=450  \\$aAntenatal Education
=450  \\$wnnna$aAntenatal Parenthood Education
=450  \\$wnnna$aAntenatal Parenthood Educations
=450  \\$wnnna$aChildbirth Classes
=450  \\$wnnna$aChildbirth Education
=450  \\$wnnna$aChildbirth Educations
=450  \\$wnnna$aClasses, Childbirth
=450  \\$wnnna$aClasses, Expectant Parent
=450  \\$wnnna$aEducation, Antenatal
=450  \\$wnnna$aEducation, Antenatal Parenthood
=450  \\$wnnna$aEducation, Childbirth
=450  \\$wnnna$aEducation, Prenatal
=450  \\$wnnna$aEducations, Antenatal Parenthood
=450  \\$wnnna$aEducations, Childbirth
=450  \\$wnnna$aExpectant Parent Classes
=450  \\$wnnna$aParent Classes, Expectant
=450  \\$wnnna$aParenthood Education, Antenatal
=450  \\$wnnna$aParenthood Educations, Antenatal
=550  \\$wg$aPatient Education as Topic
=680  \\$iTraining for pregnant women and parents-to-be to prepare for CHILDBIRTH; CHILD CARE; and parenthood.
=688  \\$a2014
=750  \0$aChildbirth$xStudy and teaching$0(DLC)sh 85023409$5IEN-M

=LDR  01898cz  a2200541n  4500
=001  9880364424302441
=005  20141212222713.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064175
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x199.$x500
=072  \\$aB1.$x50.$x500.$x272.$x199.$x500
=150  \\$aLancelets
=450  \\$wnnna$aAmphioxi
=450  \\$wnnna$aAmphioxus
=450  \\$wnnna$aAmphioxus lanceolatus
=450  \\$wnnna$aAmphioxus, Mediterranean
=450  \\$wnnna$abelcheri, Branchiostoma
=450  \\$wnnna$abelcherus, Branchiostoma
=450  \\$wnnna$aBranchiostoma
=450  \\$wnnna$aBranchiostoma belcheri
=450  \\$wnnna$aBranchiostoma belcherus
=450  \\$wnnna$aBranchiostoma floridae
=450  \\$wnnna$aBranchiostoma japonicum
=450  \\$wnnna$aBranchiostoma japonicums
=450  \\$wnnna$aBranchiostoma lanceolatum
=450  \\$wnnna$aBranchiostoma lanceolatums
=450  \\$wnnna$aBranchiostoma nigeriense
=450  \\$wnnna$aBranchiostoma nigerienses
=450  \\$wnnna$aBranchiostomas
=450  \\$wnnna$aFlorida Lancelet
=450  \\$wnnna$aFlorida Lancelets
=450  \\$wnnna$afloridae, Branchiostoma
=450  \\$wnnna$ajaponicum, Branchiostoma
=450  \\$wnnna$ajaponicums, Branchiostoma
=450  \\$wnnna$aLancelet
=450  \\$wnnna$aLancelet, Florida
=450  \\$wnnna$aLancelets, Florida
=450  \\$wnnna$alanceolatum, Branchiostoma
=450  \\$wnnna$alanceolatums, Branchiostoma
=450  \\$wnnna$alanceolatus, Amphioxus
=450  \\$wnnna$aMediterranean Amphioxus
=450  \\$wnnna$anigeriense, Branchiostoma
=450  \\$wnnna$anigerienses, Branchiostoma
=550  \\$wg$aCephalochordata
=680  \\$iSmall fish-like marine creatures often used in phylogenetic comparative studies of CHORDATES.
=688  \\$a2014
=750  \0$aAmphioxus$0(DLC)sh 87020395$5IEN-M

=LDR  00723cz  a2200193n  4500
=001  9880364424402441
=005  20141212222712.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064174
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x200.$x199
=072  \\$aB1.$x50.$x500.$x272.$x199
=150  \\$aCephalochordata
=450  \\$wnnna$aCephalochordatas
=550  \\$wg$aChordata, Nonvertebrate
=550  \\$wh$aLancelets
=680  \\$iA subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the LANCELETS. Its members are characterized by a NOTOCHORD which extends into the adult stage head.
=688  \\$a2014
=750  \0$aCephalochordata$0(DLC)sh 87020394$5IEN-M

=LDR  01420cz  a2200397n  4500
=001  9880364424502441
=005  20141212222711.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064171
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x633.$x567.$x175.$x875
=150  \\$aSuperficial Back Muscles
=450  \\$wnnna$aBack Muscle, Superficial
=450  \\$wnnna$aBack Muscles, Superficial
=450  \\$wnnna$aDorsi, Latissimus
=450  \\$wnnna$aDorsus, Latissimus
=450  \\$wnnna$aLatissimus Dorsi
=450  \\$wnnna$aLatissimus Dorsus
=450  \\$wnnna$aLevator Scapulae
=450  \\$wnnna$aMuscle, Superficial Back
=450  \\$wnnna$aMuscle, Trapezius
=450  \\$wnnna$aMuscles, Superficial Back
=450  \\$wnnna$aMuscles, Trapezius
=450  \\$wnnna$aRhomboid Major
=450  \\$wnnna$aRhomboid Majors
=450  \\$wnnna$aRhomboid Minor
=450  \\$wnnna$aRhomboid Minors
=450  \\$wnnna$aScapulae, Levator
=450  \\$wnnna$aSuperficial Back Muscle
=450  \\$wnnna$aTrapezius
=450  \\$wnnna$aTrapezius Muscle
=450  \\$wnnna$aTrapezius Muscles
=550  \\$wg$aBack Muscles
=680  \\$iThe top layer of the back muscles whose function is to move the SCAPULA. This group of muscles consists of the trapezius, latissimus dorsi, rhomboid major, rhomboid minor and levator scapulae.
=688  \\$a2014
=750  \0$aTrapezius muscle$0(DLC)sh 85137115$5IEN-M

=LDR  01228cz  a2200289n  4500
=001  9880364424602441
=005  20141212222707.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x504.$x968.$x450
=150  \\$aInfluenza Pandemic, 1918-1919
=450  \\$wnnna$a1918-1919 Influenza Pandemic
=450  \\$wnnna$a1918-1919 Influenza Pandemics
=450  \\$wnnna$aH1N1 Influenza Pandemic, 1918-1919
=450  \\$wnnna$aH1N1 Influenza Pandemic, 1918 1919
=450  \\$wnnna$aInfluenza Pandemic, 1918 1919
=450  \\$wnnna$aInfluenza Pandemics, 1918-1919
=450  \\$wnnna$aPandemics, 1918-1919 Influenza
=450  \\$wnnna$aSpanish Flu Pandemic, 1918-1919
=450  \\$wnnna$aSpanish Flu Pandemic, 1918 1919
=550  \\$wg$aHistory, 20th Century
=550  \\$aInfluenza A Virus, H1N1 Subtype
=550  \\$aInfluenza, Human
=680  \\$iThe influenza outbreaks of 1918 to 1919 also known as Spanish flu pandemic. First reported in Haskell County in Kansas in March of 1918 the disease spread throughout the world and may have killed as many as 25 million people.
=688  \\$a2014
=750  \0$aInfluenza Epidemic, 1918-1919$0(DLC)sh2003011372$5IEN-M

=LDR  00685cz  a2200205n  4500
=001  9880364424702441
=005  20141212222707.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x553.$x546.$x184.$x564.$x750
=150  \\$aFebrile Neutropenia
=450  \\$wnnna$aFebrile Neutropenias
=450  \\$wnnna$aNeutropenia, Febrile
=450  \\$wnnna$aNeutropenias, Febrile
=550  \\$wg$aNeutropenia
=550  \\$wh$aChemotherapy-Induced Febrile Neutropenia
=680  \\$iFever accompanied by a significant reduction in the number of NEUTROPHILS.
=688  \\$a2014
=750  \0$aFebrile neutropenia$0(DLC)sh 96005503$5IEN-M

=LDR  01641cz  a2200397n  4500
=001  9880364424802441
=005  20141212222706.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064133
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x830
=150  \\$aSports Nutritional Physiological Phenomena
=450  \\$wnnna$aExercise Nutrition Physiology
=450  \\$wnnna$aExercise Nutritional Physiological Phenomena
=450  \\$wnnna$aExercise Nutritional Physiological Phenomenon
=450  \\$wnnna$aExercise Nutritional Physiology
=450  \\$wnnna$aExercise Nutritional Physiology Phenomena
=450  \\$wnnna$aExercise Nutritional Physiology Phenomenon
=450  \\$wnnna$aNutrition Physiology, Exercise
=450  \\$wnnna$aNutrition Physiology, Sports
=450  \\$wnnna$aNutritional Physiology, Exercise
=450  \\$wnnna$aNutritional Physiology, Sports
=450  \\$wnnna$aPhysiology, Exercise Nutrition
=450  \\$wnnna$aPhysiology, Exercise Nutritional
=450  \\$wnnna$aPhysiology, Sports Nutrition
=450  \\$wnnna$aPhysiology, Sports Nutritional
=450  \\$wnnna$aSports Nutrition Physiology
=450  \\$wnnna$aSports Nutritional Physiological Phenomenon
=450  \\$wnnna$aSports Nutritional Physiology
=450  \\$wnnna$aSports Nutritional Physiology Phenomena
=450  \\$wnnna$aSports Nutritional Physiology Phenomenon
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$aSports Nutritional Sciences
=680  \\$iNutritional physiology related to EXERCISE or ATHLETIC PERFORMANCE.
=688  \\$a2014
=750  \0$aAthletes$xNutrition$0(DLC)sh 85009139$5IEN-M

=LDR  02156cz  a2200613n  4500
=001  9880364424902441
=005  20141212222657.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064091
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x900.$x449
=072  \\$aN6.$x850.$x860.$x510.$x900.$x700
=150  \\$aWaste Disposal Facilities
=450  \\$wnnna$aDisposal Facilities, Waste
=450  \\$wnnna$aDisposal Facility, Waste
=450  \\$wnnna$aDisposal Site, Waste
=450  \\$wnnna$aDisposal Sites, Waste
=450  \\$wnnna$aDump Site, Waste
=450  \\$wnnna$aDump Sites, Waste
=450  \\$wnnna$aDump, Waste
=450  \\$wnnna$aDumping Ground, Waste
=450  \\$wnnna$aDumping Grounds, Waste
=450  \\$wnnna$aDumping Site, Waste
=450  \\$wnnna$aDumping Sites, Waste
=450  \\$wnnna$aDumps, Waste
=450  \\$wnnna$aFacilities, Waste Disposal
=450  \\$wnnna$aFacility, Waste Disposal
=450  \\$wnnna$aGround, Waste Dumping
=450  \\$wnnna$aGrounds, Waste Dumping
=450  \\$wnnna$aLandfill
=450  \\$wnnna$aLandfills
=450  \\$wnnna$aSite, Waste Disposal
=450  \\$wnnna$aSite, Waste Dump
=450  \\$wnnna$aSite, Waste Dumping
=450  \\$wnnna$aSites, Waste Disposal
=450  \\$wnnna$aSites, Waste Dump
=450  \\$wnnna$aSites, Waste Dumping
=450  \\$wnnna$aWaste Disposal Facility
=450  \\$wnnna$aWaste Disposal Site
=450  \\$wnnna$aWaste Disposal Sites
=450  \\$wnnna$aWaste Dump
=450  \\$wnnna$aWaste Dump Site
=450  \\$wnnna$aWaste Dump Sites
=450  \\$wnnna$aWaste Dumping Ground
=450  \\$wnnna$aWaste Dumping Grounds
=450  \\$wnnna$aWaste Dumping Site
=450  \\$wnnna$aWaste Dumping Sites
=450  \\$wnnna$aWaste Dumps
=550  \\$wg$aWaste Management
=550  \\$wh$aHazardous Waste Sites
=667  \\$aspecify geographic location if pertinent
=680  \\$iSites that receive and store WASTE PRODUCTS. Some facilities also sort, process, and recycle specific waste products.
=688  \\$a2014
=750  \0$aWaste Disposal Facilities$0(DLC)sh 85112330$5IEN-M

=LDR  00634cz  a2200169n  4500
=001  9880364425002441
=005  20141212222656.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064089
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x24
=150  \\$aAllelopathy
=450  \\$wnnna$aAllelopathies
=550  \\$wg$aBiological Phenomena
=680  \\$iThe process by which organisms release chemical compounds known as ALLELOCHEMICALS which influence the physiology, growth, survival, colonization, and reproductive activities of other species usually located nearby.
=688  \\$a2014
=750  \0$aAllelopathy$0(DLC)sh 85003645$5IEN-M

=LDR  01608cz  a2200397n  4500
=001  9880364425102441
=005  20141212222656.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064088
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x500.$x750
=072  \\$aN4.$x452.$x884.$x249
=072  \\$aN6.$x850.$x135.$x60.$x75.$x299
=072  \\$aN6.$x850.$x601.$x500.$x750
=150  \\$aHazard Analysis and Critical Control Points
=450  \\$wnnna$aAnalyses, Food Safety
=450  \\$wnnna$aAnalysis, Food Safety
=450  \\$wnnna$aFood Safety Analyses
=450  \\$wnnna$aFood Safety Analysis
=450  \\$wnnna$aFood Safety System
=450  \\$wnnna$aFood Safety Systems
=450  \\$wnnna$aHACCP
=450  \\$wnnna$aHACCPs
=450  \\$wnnna$aHazard Analysis Critical Control Points
=450  \\$wnnna$aSafety Analyses, Food
=450  \\$wnnna$aSafety Analysis, Food
=450  \\$wnnna$aSafety System, Food
=450  \\$wnnna$aSafety Systems, Food
=450  \\$wnnna$aSystem, Food Safety
=450  \\$wnnna$aSystems, Food Safety
=550  \\$wg$aFood Safety
=550  \\$wg$aSafety
=550  \\$wg$aSafety Management
=680  \\$iA system of safety management (abbreviated HACCP) applied mainly to the food industry. It involves the analysis and control of biological, chemical, and physical hazards, from raw material production, procurement and handling, to manufacturing, distribution and consumption of finished products.
=688  \\$a2014
=750  \0$aHazard Analysis and Critical Control Point (Food safety system)$0(DLC)sh2001009897$5IEN-M

=LDR  00923cz  a2200265n  4500
=001  9880364425202441
=005  20141212222655.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064086
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x528
=150  \\$aMedical Marijuana
=450  \\$wnnna$aCannabis, Medical
=450  \\$wnnna$aCannabis, Medicinal
=450  \\$wnnna$aMarijuana, Medical
=450  \\$wnnna$aMarijuana, Medicinal
=450  \\$wnnna$aMarijuana Treatment
=450  \\$wnnna$aMedical Cannabis
=450  \\$wnnna$aMedicinal Cannabis
=450  \\$wnnna$aMedicinal Marijuana
=450  \\$wnnna$aTreatment, Marijuana
=550  \\$wg$aPharmaceutical Preparations
=680  \\$iProduct of the CANNABIS plant, CANNABINOIDS, or synthetic derivatives thereof, used in the treatment of a wide range of clinical symptoms.
=688  \\$a2014
=750  \0$aMarijuana$xTherapeutic use$0(DLC)sh 99010191$5IEN-M

=LDR  00677cz  a2200181n  4500
=001  9880364425602441
=005  20141212222644.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x729.$x500
=150  \\$aPrisoners of War
=450  \\$wnnna$aWar Prisoner
=450  \\$wnnna$aWar Prisoners
=550  \\$wg$aPrisoners
=680  \\$iMembers held prisoner of the armed forces, members of militias of such armed forces, members of other militias, members of other volunteer corps, and organized resistance movements. (Geneva Convention of 1929 and 1949)
=688  \\$a2014
=750  \0$aPrisoners of war$0(DLC)sh 85106971$5IEN-M

=LDR  00703cz  a2200205n  4500
=001  9880364425702441
=005  20141212222643.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063867
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x300.$x249
=150  \\$aIdentity Theft
=450  \\$wnnna$aIdentity Thefts
=450  \\$wnnna$aTheft, Identity
=450  \\$wnnna$aThefts, Identity
=550  \\$wg$aFraud
=550  \\$wh$aMedical Identity Theft
=680  \\$iAll types of crime in which personal data is obtained wrongfully, typically for economic gain.(from www.justice.gov/criminal/fraud/websites/idtheft.html)
=688  \\$a2014
=750  \0$aIdentity theft$0(DLC)sh2004003368$5IEN-M

=LDR  01079cz  a2200253n  4500
=001  9880364425802441
=005  20141212222642.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063809
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x925.$x500.$x500
=072  \\$aL1.$x178.$x847.$x550.$x500
=072  \\$aL1.$x178.$x847.$x675.$x500.$x500
=150  \\$aSatellite Imagery
=450  \\$wnnna$aImageries, Satellite
=450  \\$wnnna$aImagery, Satellite
=450  \\$wnnna$aModerate Resolution Imaging Spectroradiometer
=450  \\$wnnna$aSatellite Imageries
=550  \\$wg$aRemote Sensing Technology
=550  \\$wg$aSatellite Communications
=550  \\$aGeographic Information Systems
=680  \\$iComposition of images of EARTH or other planets from data collected during SPACE FLIGHT by remote sensing instruments onboard SPACECRAFT. The satellite sensor systems measure and record absorbed, emitted, or reflected energy across the spectra, as well as global position and time.
=688  \\$a2014
=750  \0$aMODIS (Spectroradiometer)$0(DLC)sh2007004873$5IEN-M

=LDR  00587cz  a2200205n  4500
=001  9880364425902441
=005  20141212222642.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063807
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x146
=072  \\$aC17.$x800.$x738.$x353
=150  \\$aDandruff
=450  \\$wnnna$aScurf
=550  \\$wg$aDermatitis
=550  \\$wg$aScalp Dermatoses
=550  \\$aDermatitis, Seborrheic
=680  \\$iExcessive shedding of dry scaly material from the scalp in humans.
=688  \\$a2014
=750  \0$aDandruff$0(DLC)sh 85035700$5IEN-M

=LDR  00923cz  a2200313n  4500
=001  9880364426002441
=005  20141212222642.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063806
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x542
=072  \\$aC10.$x597.$x617.$x231.$x249
=072  \\$aC10.$x668.$x491.$x525
=072  \\$aF2.$x830.$x816.$x353.$x500
=072  \\$aG11.$x561.$x600.$x810.$x353.$x500
=150  \\$aMyalgia
=450  \\$wnnna$aMuscle Pain
=450  \\$aMuscle Soreness
=450  \\$wnnna$aMuscle Sorenesses
=450  \\$wnnna$aMuscle Tenderness
=450  \\$wnnna$aPain, Muscle
=450  \\$wnnna$aPains, Muscle
=450  \\$wnnna$aSoreness, Muscle
=450  \\$wnnna$aTenderness, Muscle
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aMusculoskeletal Pain
=680  \\$iPainful sensation in the muscles.
=688  \\$a2014
=750  \0$aMyalgia$0(DLC)sh 85089171$5IEN-M

=LDR  01109cz  a2200313n  4500
=001  9880364426102441
=005  20141212222641.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063766
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x726.$x500.$x720
=150  \\$aPediatric Obesity
=450  \\$wnnna$aAdolescent Obesity
=450  \\$wnnna$aChild Obesity
=450  \\$aChildhood Obesity
=450  \\$wnnna$aChildhood Onset Obesity
=450  \\$wnnna$aObesity, Adolescent
=450  \\$wnnna$aObesity, Child
=450  \\$wnnna$aObesity, Childhood
=450  \\$wnnna$aObesity, Childhood Onset
=450  \\$wnnna$aObesity in Adolescence
=450  \\$wnnna$aObesity in Childhood
=450  \\$wnnna$aObesity, Pediatric
=450  \\$wnnna$aOnset Obesity, Childhood
=550  \\$wg$aObesity
=680  \\$iBODY MASS INDEX in children (ages 2-12) and adolescents (ages 13-18) that is grossly above the recommended cut-off for a specific age and sex.
=688  \\$a2014
=750  \0$aObesity in adolescence$0(DLC)sh 90005200$5IEN-M
=750  \0$aObesity in children$0(DLC)sh 85093649$5IEN-M

=LDR  02023cz  a2200517n  4500
=001  9880363722002441
=005  20141212203335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008569
=035  \\$aCBA1820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x525
=072  \\$aC23.$x888.$x592.$x604.$x529
=072  \\$aF1.$x700.$x625
=150  \\$aMemory Disorders
=450  \\$wnnna$aAge-Related Memory Disorder
=450  \\$wnnna$aAge-Related Memory Disorders
=450  \\$wnnna$aAge Related Memory Disorders
=450  \\$wnnna$aCognitive Retention Disorder
=450  \\$wnnna$aCognitive Retention Disorders
=450  \\$wnnna$aDeficit, Memory
=450  \\$wnnna$aDeficits, Memory
=450  \\$wnnna$aMemory Deficit
=450  \\$wnnna$aMemory Deficits
=450  \\$wnnna$aMemory Disorder
=450  \\$wnnna$aMemory Disorder, Age-Related
=450  \\$wnnna$aMemory Disorder, Semantic
=450  \\$wnnna$aMemory Disorder, Spatial
=450  \\$wnnna$aMemory Disorders, Age-Related
=450  \\$wnnna$aMemory Disorders, Age Related
=450  \\$wnnna$aMemory Disorders, Semantic
=450  \\$wnnna$aMemory Disorders, Spatial
=450  \\$aMemory Loss
=450  \\$wnnna$aMemory Losses
=450  \\$wnnna$aRetention Disorder, Cognitive
=450  \\$wnnna$aRetention Disorders, Cognitive
=450  \\$wnnna$aSemantic Memory Disorder
=450  \\$wnnna$aSemantic Memory Disorders
=450  \\$wnnna$aSpatial Memory Disorder
=450  \\$wnnna$aSpatial Memory Disorders
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wh$aAmnesia
=550  \\$wh$aKorsakoff Syndrome
=680  \\$iDisturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
=688  \\$a1969
=750  \0$aMemory disorders$0(DLC) sh 85083500$5IEN

=LDR  00986cz  a2200253n  4500
=001  9880363722102441
=005  20141212203411.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008668
=035  \\$aCBA1920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x556.$x670
=150  \\$aMetallothionein
=450  \\$wnnna$aIsometallothionein
=450  \\$wnnna$aMetallothionein A
=450  \\$wnnna$aMetallothionein B
=450  \\$wnnna$aMetallothionein I
=450  \\$wnnna$aMetallothionein II
=450  \\$wnnna$aMetallothionein IIA
=550  \\$wg$aMetalloproteins
=667  \\$a/biosyn /physiol permitted
=680  \\$iA low-molecular-weight (approx. 10 kD) protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals.
=688  \\$a84(75); was see under METALLOPROTEINS 1975-83
=750  \0$aMetallothionein$5IEN$0(DLC)sh 85084134

=LDR  00979cz  a2200289n  4500
=001  9880363722202441
=005  20141212203335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008568
=035  \\$aCBA1819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540
=150  \\$aMemory
=550  \\$wg$aLearning
=550  \\$wh$aDeja Vu
=550  \\$wh$aMemory, Episodic
=550  \\$wh$aMemory, Long-Term
=550  \\$wh$aMemory, Short-Term
=550  \\$wh$aMental Recall
=550  \\$wh$aRecognition (Psychology)
=550  \\$wh$aRepetition Priming
=550  \\$wh$aRetention (Psychology)
=550  \\$wh$aSpatial Memory
=550  \\$aExecutive Function
=667  \\$ahuman & animal
=680  \\$iComplex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
=750  \0$aMemory$5IEN$0(DLC)sh 85083497

=LDR  01091cz  a2200289n  4500
=001  9880363722302441
=005  20141212203334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008567
=035  \\$aCBA1818HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x479
=072  \\$aJ1.$x637.$x51.$x479
=072  \\$aJ1.$x637.$x87.$x500
=150  \\$aMembranes, Artificial
=450  \\$wnnna$aArtificial Membrane
=450  \\$aArtificial Membranes
=450  \\$wnnna$aMembrane, Artificial
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aBiomimetic Materials
=550  \\$wh$aArtificial Cells
=550  \\$wh$aLipid Bilayers
=550  \\$wh$aLiposomes
=550  \\$wh$aVirosomes
=680  \\$iArtificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.
=688  \\$a68(66)
=750  \0$aMembranes (Technology)$5IEN$0(DLC)sh 85083476

=LDR  00827cz  a2200277n  4500
=001  9880363722402441
=005  20190716132047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008667
=035  \\$aCBA1919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x556
=150  \\$aMetalloproteins
=550  \\$wg$aProteins
=550  \\$wh$aAzurin
=550  \\$wh$aCeruloplasmin
=550  \\$wh$aHemocyanins
=550  \\$wh$aHemosiderin
=550  \\$wh$aIron-Binding Proteins
=550  \\$wh$aMetallothionein
=550  \\$wh$aPlastocyanin
=550  \\$aProtein Binding
=667  \\$acoord IM with specific metal (IM)
=680  \\$iProteins that have one or more tightly bound metal ions forming part of their structure. (Dorland, 28th ed)
=688  \\$a73
=750  \0$aMetalloproteins$0(DLC) sh 85084133$5IEN

=LDR  00912cz  a2200289n  4500
=001  9880363722502441
=005  20141212203334.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008566
=035  \\$aCBA1817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x615
=150  \\$aMembranes
=450  \\$wnnna$aMembrane
=450  \\$wnnna$aMembrane Tissue
=450  \\$wnnna$aMembrane Tissues
=450  \\$wnnna$aTissue, Membrane
=450  \\$wnnna$aTissues, Membrane
=550  \\$wg$aTissues
=550  \\$wh$aBasement Membrane
=550  \\$wh$aExtraembryonic Membranes
=550  \\$wh$aMucous Membrane
=550  \\$wh$aSerous Membrane
=667  \\$ageneral; prefer specifics; almost never IM
=680  \\$iThin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.
=688  \\$a68(66)
=750  \0$aMembranes (Biology)$5IEN$0(DLC)sh 85083472

=LDR  00987cz  a2200277n  4500
=001  9880363722602441
=005  20141212203410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008664
=035  \\$aCBA1916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x618
=072  \\$aC18.$x452.$x648.$x618
=150  \\$aMetal Metabolism, Inborn Errors
=450  \\$wnnna$aMetal Metabolism, Inborn Error
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aHemochromatosis
=550  \\$wh$aHepatolenticular Degeneration
=550  \\$wh$aHypophosphatasia
=550  \\$wh$aHypophosphatemia, Familial
=550  \\$wh$aMenkes Kinky Hair Syndrome
=550  \\$wh$aParalyses, Familial Periodic
=550  \\$wh$aPseudohypoparathyroidism
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific metal /metab (IM); DF: METAL METAB INBORN ERR
=688  \\$a65
=750  \0$aMetals$xMetabolism$xDisorders$5IEN-M$0(IEN)369258

=LDR  03815cz  a2201009n  4500
=001  9880363722702441
=005  20200611174306.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008565
=035  \\$aCBA1816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543
=150  \\$aMembrane Proteins
=450  \\$aCell Membrane Proteins
=450  \\$aCell Surface Proteins
=450  \\$wnnna$aIntegral Membrane Protein
=450  \\$aIntegral Membrane Proteins
=450  \\$wnnna$aMembrane-Associated Proteins
=450  \\$wnnna$aMembrane Associated Proteins
=450  \\$wnnna$aMembrane Protein
=450  \\$wnnna$aMembrane Protein, Integral
=450  \\$wnnna$aMembrane Proteins, Integral
=450  \\$wnnna$aProtein, Integral Membrane
=450  \\$wnnna$aProtein, Membrane
=450  \\$wnnna$aProteins, Cell Membrane
=450  \\$wnnna$aProteins, Cell Surface
=450  \\$wnnna$aProteins, Integral Membrane
=450  \\$wnnna$aProteins, Membrane
=450  \\$wnnna$aProteins, Membrane-Associated
=450  \\$wnnna$aProteins, Surface
=450  \\$aSurface Proteins
=550  \\$wg$aProteins
=550  \\$wh$aBcl-2-Like Protein 11
=550  \\$wh$a5-Lipoxygenase-Activating Proteins
=550  \\$wh$aAmphiregulin
=550  \\$wh$aAmyloid beta-Protein Precursor
=550  \\$wh$aAnkyrins
=550  \\$wh$aArrestins
=550  \\$wh$aB7 Antigens
=550  \\$wh$aBacterial Outer Membrane Proteins
=550  \\$wh$aCadherin Related Proteins
=550  \\$wh$aCalnexin
=550  \\$wh$aCarbonic Anhydrase IX
=550  \\$wh$aChemokine CX3CL1
=550  \\$wh$aCornified Envelope Proline-Rich Proteins
=550  \\$wh$aDysferlin
=550  \\$wh$aDystrophin
=550  \\$wh$aDystrophin-Associated Proteins
=550  \\$wh$aElectron Transport Chain Complex Proteins
=550  \\$wh$aEphrins
=550  \\$wh$agp100 Melanoma Antigen
=550  \\$wh$aHeterotrimeric GTP-Binding Proteins
=550  \\$wh$aLDL-Receptor Related Protein-Associated Protein
=550  \\$wh$aLipid-Linked Proteins
=550  \\$wh$aMARVEL Domain-Containing Proteins
=550  \\$wh$aMatrix Metalloproteinases, Membrane-Associated
=550  \\$wh$aMembrane Fusion Proteins
=550  \\$wh$aMembrane Glycoproteins
=550  \\$wh$aMembrane Transport Proteins
=550  \\$wh$aMitochondrial Trifunctional Protein
=550  \\$wh$aMyelin Proteins
=550  \\$wh$aMyristoylated Alanine-Rich C Kinase Substrate
=550  \\$wh$aNeurofibromin 2
=550  \\$wh$aPeroxisomal Biogenesis Factor 2
=550  \\$wh$aPhospholipid Transfer Proteins
=550  \\$wh$aPore Forming Cytotoxic Proteins
=550  \\$wh$aPresenilins
=550  \\$wh$aProtoporphyrinogen Oxidase
=550  \\$wh$aPulmonary Surfactant-Associated Protein B
=550  \\$wh$aPulmonary Surfactant-Associated Protein C
=550  \\$wh$aReceptor Activity-Modifying Proteins
=550  \\$wh$aReceptor-Like Protein Tyrosine Phosphatases
=550  \\$wh$aReceptors, Cell Surface
=550  \\$wh$aSerrate-Jagged Proteins
=550  \\$wh$aSpectrin
=550  \\$wh$aStromal Interaction Molecules
=550  \\$wh$aTetraspanins
=550  \\$wh$aThylakoid Membrane Proteins
=550  \\$wh$aTight Junction Proteins
=550  \\$wh$aUtrophin
=550  \\$wh$aVesicular Transport Proteins
=550  \\$aCell Membrane
=550  \\$aMembranes
=667  \\$a/biosyn /drug eff /physiol /ultrastruct permitted
=680  \\$iProteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
=688  \\$a77
=750  \0$aMembrane proteins$5IEN$0(DLC)sh 85083471

=LDR  02228cz  a2200577n  4500
=001  9880363722802441
=005  20141212203409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008661
=035  \\$aCBA1913HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565
=072  \\$aC18.$x452.$x648
=150  \\$aMetabolism, Inborn Errors
=450  \\$wnnna$aError, Inborn Metabolism
=450  \\$wnnna$aErrors, Inborn Metabolism
=450  \\$wnnna$aErrors Metabolism, Inborn
=450  \\$wnnna$aErrors Metabolisms, Inborn
=450  \\$wnnna$aInborn Errors Metabolism
=450  \\$wnnna$aInborn Errors Metabolisms
=450  \\$aInborn Errors of Metabolism
=450  \\$wnnna$aInborn Metabolism Error
=450  \\$wnnna$aInborn Metabolism Errors
=450  \\$aMetabolic Diseases$xcongenital
=450  \\$wnnna$aMetabolism Error, Inborn
=450  \\$wnnna$aMetabolism Errors, Inborn
=450  \\$wnnna$aMetabolism Inborn Error
=450  \\$wnnna$aMetabolism Inborn Errors
=450  \\$wnnna$aMetabolisms, Inborn Errors
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aAmino Acid Metabolism, Inborn Errors
=550  \\$wh$aAmino Acid Transport Disorders, Inborn
=550  \\$wh$aAmyloidosis, Familial
=550  \\$wh$aBrain Diseases, Metabolic, Inborn
=550  \\$wh$aCarbohydrate Metabolism, Inborn Errors
=550  \\$wh$aCytochrome-c Oxidase Deficiency
=550  \\$wh$aHyperbilirubinemia, Hereditary
=550  \\$wh$aLipid Metabolism, Inborn Errors
=550  \\$wh$aLysosomal Storage Diseases
=550  \\$wh$aMetal Metabolism, Inborn Errors
=550  \\$wh$aPeroxisomal Disorders
=550  \\$wh$aPorphyrias
=550  \\$wh$aProgeria
=550  \\$wh$aPurine-Pyrimidine Metabolism, Inborn Errors
=550  \\$wh$aRenal Tubular Transport, Inborn Errors
=550  \\$wh$aSteroid Metabolism, Inborn Errors
=667  \\$aGEN: prefer specific types; differentiate from DEFICIENCY DISEASES; DF: METAB INBORN ERR
=680  \\$iErrors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.
=688  \\$a65
=750  \0$aMetabolism, Inborn errors of$5IEN$0(DLC)sh 85084017

=LDR  03030cz  a2200637n  4500
=001  9880363722902441
=005  20160425095542.0
=008  880518\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015260
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x480.$x600
=072  \\$aD8.$x811.$x277.$x656.$x675.$x374.$x600
=072  \\$aD23.$x50.$x285.$x550
=072  \\$aD23.$x50.$x301.$x264.$x35.$x550
=072  \\$aD23.$x101.$x100.$x110.$x550
=072  \\$aD23.$x101.$x840.$x500
=150  \\$aNeprilysin
=450  \\$wnnna$aAntigen, CD10
=450  \\$aAntigens, CD10
=450  \\$aAntigens, Leukemia, Common Acute Lymphoblastic
=450  \\$wnnna$aAtriopeptidase
=450  \\$aCALLA Antigen
=450  \\$wnnna$aCarboxypeptidase, Enkephalin Dipeptidyl
=450  \\$wnnna$aCD10 Antigen
=450  \\$aCD10 Antigens
=450  \\$aCommon Acute Lymphoblastic Leukemia Antigens
=450  \\$wnnna$aDipeptidyl Carboxypeptidase, Enkephalin
=450  \\$aEndopeptidase-24.11
=450  \\$wnnna$aEndopeptidase 24.11
=450  \\$wnnna$aEndopeptidase 24.11, Neutral
=450  \\$wnnna$aEndopeptidase, Neutral
=450  \\$aEnkephalin Dipeptidyl Carboxypeptidase
=450  \\$aEnkephalinase
=450  \\$wnnna$aEnkephalinase-24.11
=450  \\$wnnna$aEnkephalinase 24.11
=450  \\$wnnna$aEnzyme, YGG-Forming
=450  \\$aKidney-Brush-Border Neutral Proteinase
=450  \\$wnnna$aKidney Brush Border Neutral Proteinase
=450  \\$aMembrane Metallo-Endopeptidase
=450  \\$wnnna$aMembrane Metallo Endopeptidase
=450  \\$wnnna$aMetallo-Endopeptidase, Membrane
=450  \\$wnnna$aMetalloendopeptidase, Thermolysin-Like
=450  \\$wnnna$aNeutral Endopeptidase
=450  \\$wnnna$aNeutral Endopeptidase 24.11
=450  \\$wnnna$aNeutral Proteinase, Kidney-Brush-Border
=450  \\$wnnna$aThermolysin-Like Metalloendopeptidase
=450  \\$wnnna$aThermolysin Like Metalloendopeptidase
=450  \\$wnnna$aYGG-Forming Enzyme
=450  \\$wnnna$aYGG Forming Enzyme
=550  \\$wg$aAntigens, CD
=550  \\$wg$aAntigens, Neoplasm
=550  \\$wg$aMetalloendopeptidases
=550  \\$wg$aBiomarkers, Tumor
=680  \\$iEnzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.
=688  \\$a97; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS (NM) 1983-92
=750  \0$aEnkephalinase$5IEN$0(DLC)sh 85044027

=LDR  01223cz  a2200313n  4500
=001  9880363723002441
=005  20141212203332.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008563
=035  \\$aCBA1813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x570
=150  \\$aMembrane Lipids
=450  \\$aCell Membrane Lipids
=450  \\$wnnna$aLipids, Cell Membrane
=450  \\$wnnna$aLipids, Membrane
=450  \\$wnnna$aMembrane Lipids, Cell
=550  \\$wg$aLipids
=550  \\$wh$aLipid Bilayers
=550  \\$wh$aPhospholipids
=550  \\$wh$aProteolipids
=550  \\$wh$aSphingolipids
=550  \\$wh$aSterols
=550  \\$aCell Membrane
=550  \\$aMembranes
=667  \\$a/biosyn /physiol permitted
=680  \\$iLipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation.
=688  \\$a77
=750  \0$aMembrane lipids$5IEN$0(DLC)sh 87004580

=LDR  00875cz  a2200241n  4500
=001  9880363723102441
=005  20170620114552.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008561
=035  \\$aCBA1811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x575
=150  \\$aMembrane Fusion
=450  \\$wnnna$aFusion, Membrane
=450  \\$wnnna$aFusions, Membrane
=450  \\$wnnna$aMembrane Fusions
=550  \\$wg$aCell Physiological Phenomena
=550  \\$aCell Membrane
=550  \\$aHIV Fusion Inhibitors
=550  \\$aN-Ethylmaleimide-Sensitive Proteins
=680  \\$iThe adherence and merging of cell membranes, intracellular membranes, or artificial membranes to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes.
=688  \\$a82
=750  \0$aMembrane fusion$0(DLC) sh 85083469$5IEN-M

=LDR  03347cz  a2200985n  4500
=001  9880363723202441
=005  20180109105207.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008660
=035  \\$aCBA1912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3
=150  \\$aMetabolism
=450  \\$aAnabolism
=450  \\$aCatabolism
=450  \\$wnnna$aConcept, Metabolic
=450  \\$wnnna$aConcept, Metabolism
=450  \\$wnnna$aConcepts, Metabolic
=450  \\$wnnna$aConcepts, Metabolism
=450  \\$wnnna$aMetabolic Concept
=450  \\$aMetabolic Concepts
=450  \\$wnnna$aMetabolic Process
=450  \\$aMetabolic Processes
=450  \\$wnnna$aMetabolism Concept
=450  \\$wnnna$aMetabolism Concepts
=450  \\$wnnna$aProcess, Metabolic
=450  \\$wnnna$aProcesses, Metabolic
=450  \\$wnnna$aPhenomena, Metabolic
=450  \\$wnnna$aPhenomena, Metabolism
=450  \\$wnnna$aPhenomenon, Metabolic
=450  \\$wnno$aMetabolic Phenomena
=550  \\$wh$aAbsorption
=550  \\$wh$aAcid-Base Equilibrium
=550  \\$wh$aAcylation
=550  \\$wh$aAerobiosis
=550  \\$wh$aAlkylation
=550  \\$wh$aAmination
=550  \\$wh$aAnaerobiosis
=550  \\$wh$aAutotrophic Processes
=550  \\$wh$aBiocatalysis
=550  \\$wh$aBiological Transport
=550  \\$wh$aBiotinylation
=550  \\$wh$aBiotransformation
=550  \\$wh$aBody Composition
=550  \\$wh$aBrain Chemistry
=550  \\$wh$aCarbohydrate Metabolism
=550  \\$wh$aCatabolite Repression
=550  \\$wh$aCell Respiration
=550  \\$wh$aCyclization
=550  \\$wh$aDealkylation
=550  \\$wh$aDeamination
=550  \\$wh$aDecarboxylation
=550  \\$wh$aDimerization
=550  \\$wh$aEnergy Metabolism
=550  \\$wh$aEnterohepatic Circulation
=550  \\$wh$aEnzyme Activation
=550  \\$wh$aEsterification
=550  \\$wh$aHalogenation
=550  \\$wh$aHeterotrophic Processes
=550  \\$wh$aHydrogenation
=550  \\$wh$aHydroxylation
=550  \\$wh$aLipid Metabolism
=550  \\$wh$aMetabolic Clearance Rate
=550  \\$wh$aMetabolic Networks and Pathways
=550  \\$wh$aMetabolome
=550  \\$wh$aNitrosation
=550  \\$wh$aOsmoregulation
=550  \\$wh$aOxidative Stress
=550  \\$wh$aOxygen Consumption
=550  \\$wh$aPeptide Biosynthesis
=550  \\$wh$aPharmacokinetics
=550  \\$wh$aPhosphorylation
=550  \\$wh$aPhototrophic Processes
=550  \\$wh$aPrenylation
=550  \\$wh$aProtein Binding
=550  \\$wh$aProteolysis
=550  \\$wh$aProteostasis
=550  \\$wh$aRenin-Angiotensin System
=550  \\$wh$aRNA Processing, Post-Transcriptional
=550  \\$wh$aSecretory Rate
=550  \\$wh$aToxicokinetics
=667  \\$ageneral only as the metabolic process irrespective of substance; prefer /metab with organs, organisms, diseases, substances: Manual 19.7+, 19.8.44, 19.10+; DF: METAB
=680  \\$iThe chemical reactions that occur within the cells, tissues, or an organism. These processes include both the biosynthesis (ANABOLISM) and the breakdown (CATABOLISM) of organic materials utilized by the living organism.
=688  \\$aMETABOLIC PROCESSES was NON MESH 1992-97; TISSUE METABOLISM was heading 1963-65
=750  \0$aMetabolism$0(DLC) sh 85084013$5IEN

=LDR  00733cz  a2200181n  4500
=001  9880363723302441
=005  20141212203328.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008554
=035  \\$aCBA1804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x170.$x531
=150  \\$aMelioidosis
=450  \\$wnnna$aMelioidoses
=550  \\$wg$aBurkholderia Infections
=667  \\$acaused by Burkholderia pseudomallei; in India, Malay & Indonesia
=680  \\$iA disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia.
=750  \0$aMelioidosis$5IEN$0(DLC)sh 85083417

=LDR  00751cz  a2200181n  4500
=001  9880363723402441
=005  20141212203327.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008550
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x914.$x481
=072  \\$aD6.$x472.$x506
=150  \\$aMelatonin
=550  \\$wg$aHormones
=550  \\$wg$aTryptamines
=680  \\$iA biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
=688  \\$a68(65)
=750  \0$aMelatonin$5IEN$0(DLC)sh 85083394

=LDR  00916cz  a2200301n  4500
=001  9880363723502441
=005  20141212203326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008548
=035  \\$aCBA1798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x621.$x430.$x530
=150  \\$aMelanosis
=450  \\$aChloasma
=450  \\$wnnna$aChloasmas
=450  \\$wnnna$aFreckle
=450  \\$aFreckles
=450  \\$aMelanism
=450  \\$wnnna$aMelanoses
=450  \\$aMelasma
=450  \\$wnnna$aMelasmas
=550  \\$wg$aHyperpigmentation
=550  \\$wh$aAcanthosis Nigricans
=550  \\$wh$aLentigo
=667  \\$afor neurocutaneous melanosis, coord with NEUROCUTANEOUS SYNDROMES
=680  \\$iDisorders of increased melanin pigmentation that develop without preceding inflammatory disease.
=688  \\$aFRECKLES was see LENTIGO 1963-79
=750  \0$aMelanosis$5IEN$0(DLC)sh 85083389

=LDR  00920cz  a2200205n  4500
=001  9880363723602441
=005  20141212203326.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008547
=035  \\$aCBA1797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x265.$x531
=150  \\$aMelanophores
=450  \\$wnnna$aMelanophore
=550  \\$wg$aChromatophores
=550  \\$wh$aMelanosomes
=667  \\$ado not confuse with MELANOCYTES
=680  \\$iChromatophores (large pigment cells of fish, amphibia, reptiles and many invertebrates) which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles (MELANOSOMES). Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES.
=688  \\$a78(75); was see under CHROMATOPHORES 1963-77
=750  \0$aMelanophores$5IEN$0(DLC)sh 85083385

=LDR  01635cz  a2200301n  4500
=001  9880363723702441
=005  20141212203325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008545
=035  \\$aCBA1795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x510
=072  \\$aC4.$x557.$x580.$x625.$x650.$x510
=072  \\$aC4.$x557.$x665.$x510
=150  \\$aMelanoma
=450  \\$aMalignant Melanoma
=450  \\$wnnna$aMalignant Melanomas
=450  \\$wnnna$aMelanoma, Malignant
=450  \\$wnnna$aMelanomas
=450  \\$wnnna$aMelanomas, Malignant
=550  \\$wg$aNeuroendocrine Tumors
=550  \\$wg$aNevi and Melanomas
=550  \\$wh$aHutchinson's Melanotic Freckle
=550  \\$wh$aMelanoma, Amelanotic
=550  \\$wh$aMelanoma, Experimental
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM); MELANOMA, EXPERIMENTAL is also available
=680  \\$iA malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
=750  \0$aMelanoma$5IEN$0(DLC)sh 85083381

=LDR  00893cz  a2200205n  4500
=001  9880363723802441
=005  20141212203325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008544
=035  \\$aCBA1794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x613
=150  \\$aMelanocytes
=450  \\$wnnna$aMelanocyte
=550  \\$wg$aEpithelial Cells
=550  \\$wh$aMelanosomes
=667  \\$ado not confuse with MELANOPHORES
=680  \\$iMammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES.
=688  \\$a72(69)
=750  \0$aMelanocytes$5IEN$0(DLC)sh 85083380

=LDR  00830cz  a2200229n  4500
=001  9880363723902441
=005  20141212203325.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008543
=035  \\$aCBA1793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x875.$x379
=072  \\$aD23.$x767.$x620
=150  \\$aMelanins
=450  \\$wnnna$aAllomelanins
=450  \\$wnnna$aMelanin
=450  \\$wnnna$aPhaeomelanins
=550  \\$wg$aPigments, Biological
=550  \\$wg$aTyrosine
=680  \\$iInsoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration.
=688  \\$a78; was MELANIN 1963-77
=750  \0$aMelanins$5IEN$0(DLC)sh 85083376

=LDR  00829cz  a2200217n  4500
=001  9880363724002441
=005  20141212203324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008540
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x134.$x220.$x220.$x687
=072  \\$aG5.$x355.$x105.$x220.$x687
=150  \\$aMeiosis
=450  \\$aM Phase, Meiotic
=450  \\$wnnna$aMeioses
=450  \\$wnnna$aMeiotic M Phase
=550  \\$wg$aCell Nucleus Division
=550  \\$wh$aMeiotic Prophase I
=680  \\$iA type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication (S PHASE) result in daughter cells with half the number of CHROMOSOMES as the parent cells.
=688  \\$a68
=750  \0$aMeiosis$5IEN$0(DLC)sh 85083346

=LDR  01021cz  a2200289n  4500
=001  9880363724102441
=005  20141212203322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008537
=035  \\$aCBA1787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x337.$x614
=072  \\$aA10.$x336.$x827.$x600
=150  \\$aMeibomian Glands
=450  \\$wnnna$aGland, Meibomian
=450  \\$wnnna$aGland, Tarsal
=450  \\$wnnna$aGlands, Meibomian
=450  \\$wnnna$aGlands, Tarsal
=450  \\$wnnna$aMeibomian Gland
=450  \\$wnnna$aTarsal Gland
=450  \\$wnnna$aTarsal Glands
=550  \\$wg$aEyelids
=550  \\$wg$aSebaceous Glands
=667  \\$adis: coord IM with EYELID DISEASES (IM); neopl: coord IM with EYELID NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iThe sebaceous glands situated on the inner surface of the eyelids between the tarsal plates and CONJUNCTIVA.
=688  \\$a91(75); was see under EYELIDS 1975-90
=750  \0$aMeibomian glands$0(DLC) sh 85083334$5IEN

=LDR  00647cz  a2200193n  4500
=001  9880363724202441
=005  20141212203321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008533
=035  \\$aCBA1783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x148.$x479
=072  \\$aA15.$x378.$x316.$x479
=150  \\$aMegakaryocytes
=450  \\$wnnna$aMegakaryocyte
=550  \\$wg$aBone Marrow Cells
=667  \\$aMEGAKARYOCYTE PROGENITOR CELLS and MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS are also available
=680  \\$iVery large BONE MARROW CELLS which release mature BLOOD PLATELETS.
=750  \0$aMegakaryocytes$5IEN$0(DLC)sh 85083275

=LDR  01773cz  a2200445n  4500
=001  9880363724302441
=005  20190607145455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008659
=035  \\$aCBA1911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452
=150  \\$aMetabolic Diseases
=450  \\$wnnna$aDisease, Metabolic
=450  \\$wnnna$aDiseases, Metabolic
=450  \\$wnnna$aMetabolic Disease
=450  \\$wnnna$aThesaurismoses
=450  \\$aThesaurismosis
=550  \\$wg$aNutritional and Metabolic Diseases
=550  \\$wh$aAcid-Base Imbalance
=550  \\$wh$aBrain Diseases, Metabolic
=550  \\$wh$aCalcium Metabolism Disorders
=550  \\$wh$aDNA Repair-Deficiency Disorders
=550  \\$wh$aGlucose Metabolism Disorders
=550  \\$wh$aHyperlactatemia
=550  \\$wh$aIron Metabolism Disorders
=550  \\$wh$aLipid Metabolism Disorders
=550  \\$wh$aMalabsorption Syndromes
=550  \\$wh$aMetabolic Syndrome
=550  \\$wh$aMetabolism, Inborn Errors
=550  \\$wh$aMitochondrial Diseases
=550  \\$wh$aPhosphorus Metabolism Disorders
=550  \\$wh$aPorphyrias
=550  \\$wh$aProteostasis Deficiencies
=550  \\$wh$aSkin Diseases, Metabolic
=550  \\$wh$aWasting Syndrome
=550  \\$wh$aWater-Electrolyte Imbalance
=667  \\$aGEN: prefer specifics; TN 194: differentiate from DEFICIENCY DISEASES; DF: METAB DIS
=680  \\$iGeneric term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
=750  \0$aMetabolism$xDisorders$0(DLC) sh 85084014$5IEN

=LDR  00711cz  a2200193n  4500
=001  9880363724402441
=005  20141212203321.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008531
=035  \\$aCBA1781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x158.$x701
=150  \\$aMegacolon
=450  \\$wnnna$aMegacolons
=550  \\$wg$aColonic Diseases
=550  \\$wh$aHirschsprung Disease
=550  \\$wh$aMegacolon, Toxic
=680  \\$iDilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.
=750  \0$aMegacolon$5IEN$0(DLC)sh 85083274

=LDR  01954cz  a2200433n  4500
=001  9880363724502441
=005  20141212192322.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008658
=035  \\$aCBA1910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x244.$x450
=072  \\$aG3.$x787.$x225.$x450
=072  \\$aG7.$x690.$x725.$x225.$x450
=150  \\$aInactivation, Metabolic
=450  \\$aDetoxication, Drug, Metabolic
=450  \\$wnnna$aDetoxication, Drug Metabolic
=450  \\$wnnna$aDetoxication, Metabolic Drug
=450  \\$wnnna$aDetoxification, Drug, Metabolic
=450  \\$wnnna$aDetoxification, Drug Metabolic
=450  \\$aDrug Detoxication, Metabolic
=450  \\$wnnna$aDrug Inactivation, Metabolic
=450  \\$wnnna$aDrug Metabolic Detoxication
=450  \\$wnnna$aDrug Metabolic Detoxification
=450  \\$wnnna$aInactivation, Metabolic Drug
=450  \\$aMetabolic Detoxication, Drug
=450  \\$wnnna$aMetabolic Detoxification, Drug
=450  \\$wnnna$aMetabolic Drug Detoxication
=450  \\$wnnna$aMetabolic Drug Inactivation
=450  \\$wnnna$aMetabolic Inactivation
=550  \\$wg$aBiotransformation
=550  \\$wh$aMetabolic Detoxication, Phase I
=550  \\$wh$aMetabolic Detoxication, Phase II
=667  \\$arestrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab
=680  \\$iReduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion.
=688  \\$a2015 (1970); use BIOTRANSFORMATION 1970-1979
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Metabolic Detoxication, Drug
=688  \\$a80(75); was see under BIOTRANSFORMATION 1970-79
=750  \0$aMetabolic detoxification$0(DLC) sh 85084010$5IEN

=LDR  01668cz  a2200397n  4500
=001  9880363724602441
=005  20180829120350.0
=008  880430\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015201
=035  \\$aCBA1908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x780.$x500
=072  \\$aE5.$x581.$x500.$x501
=072  \\$aN5.$x715.$x360.$x780.$x515
=072  \\$aN6.$x850.$x520.$x445.$x500
=150  \\$aMeta-Analysis as Topic
=450  \\$wnnna$aClinical Trial Overview
=450  \\$aClinical Trial Overviews
=450  \\$aData Pooling
=450  \\$wnnna$aData Poolings
=450  \\$wnnna$aMeta Analysis as Topic
=450  \\$wnnna$aOverview, Clinical Trial
=450  \\$wnnna$aOverviews, Clinical Trial
=550  \\$wg$aEpidemiologic Research Design
=550  \\$wg$aResearch Design
=550  \\$wh$aNetwork Meta-Analysis
=550  \\$aClinical Trials as Topic
=550  \\$aModels, Statistical
=550  \\$aReview Literature as Topic
=550  \\$aStatistics as Topic
=667  \\$afor general design, methodology, economics, etc. of meta-analysis studies; a different heading META-ANALYSIS is used for reports of a specific meta-analysis study
=680  \\$iA quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.
=688  \\$a2008(1989)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Meta-Analysis
=688  \\$a89
=750  \0$aMeta-analysis$0(DLC) sh 85084006$5IEN

=LDR  00766cz  a2200205n  4500
=001  9880363724702441
=005  20141212203407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008656
=035  \\$aCBA1907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x668.$x651.$x568.$x291.$x500
=072  \\$aD6.$x472.$x334.$x851.$x437.$x968.$x500.$x500
=150  \\$aMestranol
=450  \\$aEthinyl Estradiol 3-Methyl Ether
=450  \\$wnnna$aEthinyl Estradiol 3 Methyl Ether
=550  \\$wg$aEthinyl Estradiol
=680  \\$iThe 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
=688  \\$a65(64)
=750  \0$aMestranol$5IEN$0(DLC)sh 85084004

=LDR  01059cz  a2200217n  4500
=001  9880363724802441
=005  20141212203406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008654
=035  \\$aCBA1905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x35.$x510
=072  \\$aC4.$x557.$x470.$x660.$x510
=150  \\$aMesothelioma
=450  \\$wnnna$aMesotheliomas
=550  \\$wg$aAdenoma
=550  \\$wg$aNeoplasms, Mesothelial
=550  \\$wh$aMesothelioma, Cystic
=667  \\$abenign or malignant; coordinate IM with precoordinated organ/neoplasm term (IM); LOCALIZED MESOTHELIOMA and FIBROUS MESOTHELIOMA see SOLITARY FIBROUS TUMOR, PLEURAL is also available
=680  \\$iA tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
=750  \0$aMesothelioma$0(DLC) sh 85083965$5IEN

=LDR  02638cz  a2200745n  4500
=001  9880363724902441
=005  20141212192319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008528
=035  \\$aCBA1778HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x50.$x400.$x200.$x555
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x20.$x906.$x750.$x555
=150  \\$aMefenamic Acid
=450  \\$wnnna$aAcid, Mefenamic
=450  \\$wnnna$aAcid, Mefenaminic
=450  \\$wnnna$aAntigen Brand of Mefenamic Acid
=450  \\$wnnna$aApo-Mefenamic
=450  \\$wnnna$aApo Mefenamic
=450  \\$wnnna$aApoMefenamic
=450  \\$wnnna$aApotex Brand of Mefenamic Acid
=450  \\$wnnna$aAPS Brand of Mefenamic Acid
=450  \\$wnnna$aAshbourne Brand of Mefenamic Acid
=450  \\$wnnna$aChemidex Brand of Mefenamic Acid
=450  \\$wnnna$aClonmel Brand of Mefenamic Acid
=450  \\$wnnna$aContraflam
=450  \\$wnnna$aCoslan
=450  \\$wnnna$aDysman
=450  \\$wnnna$aElan Brand of Mefenamic Acid
=450  \\$wnnna$aFarmasierra Brand of Mefenamic Acid
=450  \\$wnnna$aFirst Horizon Brand of Mefenamic Acid
=450  \\$wnnna$aForte, Ponstan
=450  \\$wnnna$aGödecke Brand of Mefenamic Acid
=450  \\$wnnna$aMefac
=450  \\$wnnna$aMefacit
=450  \\$wnnna$aMefenaminic Acid
=450  \\$wnnna$aMefic
=450  \\$wnnna$aNu-Mefenamic
=450  \\$wnnna$aNu Mefenamic
=450  \\$wnnna$aNu-Pharm Brand of Mefenamic Acid
=450  \\$wnnna$aNu Pharm Brand of Mefenamic Acid
=450  \\$wnnna$aNuMefenamic
=450  \\$wnnna$aParke Davis Brand of Mefenamic Acid
=450  \\$wnnna$aParkemed
=450  \\$wnnna$aPfizer Brand of Mefenamic Acid
=450  \\$wnnna$aPharmascience Brand of Mefenamic Acid
=450  \\$wnnna$aPinalgesic
=450  \\$wnnna$aPinewood Brand of Mefenamic Acid
=450  \\$wnnna$aPMS-Mefenamic Acid
=450  \\$wnnna$aPMS Mefenamic Acid
=450  \\$wnnna$aPonalar
=450  \\$wnnna$aPonalgic
=450  \\$wnnna$aPonmel
=450  \\$wnnna$aPonstan
=450  \\$wnnna$aPonstan Forte
=450  \\$wnnna$aPonstel
=450  \\$wnnna$aPonsyl
=450  \\$wnnna$aPontal
=450  \\$wnnna$aRowa Brand of Mefenamic Acid
=450  \\$wnnna$aWarner-Lambert Brand of Mefenamic Acid
=450  \\$wnnna$aWarner Lambert Brand of Mefenamic Acid
=550  \\$wg$aFenamates
=680  \\$iA non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
=688  \\$a72(65)
=750  \0$aMefenamic acid$5IEN$0(DLC)sh 85083269

=LDR  01277cz  a2200313n  4500
=001  9880363725002441
=005  20141212203405.0
=008  840224\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008651
=035  \\$aCBA1902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x600
=150  \\$aMesons
=450  \\$wnnna$aMeson
=450  \\$wnnna$amu-Meson
=450  \\$amu-Mesons
=450  \\$wnnna$amu Mesons
=450  \\$wnnna$aMuon
=450  \\$aMuons
=450  \\$wnnna$api-Meson
=450  \\$api-Mesons
=450  \\$wnnna$api Mesons
=450  \\$wnnna$aPion
=450  \\$aPions
=550  \\$wg$aElementary Particles
=667  \\$aelementary particles; IM
=680  \\$iShort-lived elementary particles found in cosmic radiation or produced from nuclear disintegration. Their mass is between that of protons and electrons and they can be negative, positive, or neutral. pi-Mesons (pions) are heavier than mu-mesons (muons) and are proposed for cancer radiotherapy because their capture and disintegration by matter produces powerful, but short-lived, secondary radiation.
=688  \\$a91(85); was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84
=750  \0$aMesons$5IEN$0(DLC)sh 85083949

=LDR  00844cz  a2200205n  4500
=001  9880363725102441
=005  20141212203405.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008650
=035  \\$aCBA1901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x599
=150  \\$aMesonephros
=450  \\$wnnna$aBody, Wolffian
=450  \\$wnnna$aMesonephroi
=450  \\$aWolffian Body
=550  \\$wg$aEmbryonic Structures
=680  \\$iOne of a pair of excretory organs (mesonephroi) which grows caudally to the first pair (PRONEPHROI) during development. Mesonephroi are the permanent kidneys in adult amphibians and fish. In higher vertebrates, proneprhoi and most of mesonephroi degenerate with the appearance of metanephroi. The remaining ducts become WOLFFIAN DUCTS.
=688  \\$a75
=750  \0$aWolffian body$5IEN$0(DLC)sh 85147231

=LDR  02414cz  a2200493n  4500
=001  9880363725202441
=005  20141212203320.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008527
=035  \\$aCBA1777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x380.$x515
=072  \\$aC4.$x557.$x465.$x625.$x600.$x590.$x500
=072  \\$aC4.$x557.$x470.$x670.$x380.$x515
=072  \\$aC4.$x557.$x470.$x670.$x590.$x500
=072  \\$aC4.$x557.$x580.$x625.$x600.$x380.$x515
=072  \\$aC4.$x557.$x580.$x625.$x600.$x590.$x500
=150  \\$aMedulloblastoma
=450  \\$wnnna$aAdult Medulloblastoma
=450  \\$wnnna$aAdult Medulloblastomas
=450  \\$aArachnoidal Cerebellar Sarcoma, Circumscribed
=450  \\$wnnna$aChildhood Medulloblastoma
=450  \\$wnnna$aChildhood Medulloblastomas
=450  \\$wnnna$aDesmoplastic Medulloblastoma
=450  \\$wnnna$aDesmoplastic Medulloblastomas
=450  \\$wnnna$aMedulloblastoma, Adult
=450  \\$wnnna$aMedulloblastoma, Childhood
=450  \\$aMedulloblastoma, Desmoplastic
=450  \\$wnnna$aMedulloblastoma, Melanocytic
=450  \\$wnnna$aMedulloblastomas
=450  \\$wnnna$aMedulloblastomas, Adult
=450  \\$wnnna$aMedulloblastomas, Childhood
=450  \\$wnnna$aMedulloblastomas, Desmoplastic
=450  \\$wnnna$aMedulloblastomas, Melanocytic
=450  \\$aMedullomyoblastoma
=450  \\$wnnna$aMedullomyoblastomas
=450  \\$wnnna$aMelanocytic Medulloblastoma
=450  \\$wnnna$aMelanocytic Medulloblastomas
=450  \\$aSarcoma, Cerebellar, Circumscribed Arachnoidal
=550  \\$wg$aGlioma
=550  \\$wg$aNeuroectodermal Tumors, Primitive
=667  \\$acoord IM with CEREBELLAR NEOPLASMS (IM)
=680  \\$iA malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)
=750  \0$aMedulloblastoma$5IEN$0(DLC)sh 85083247

=LDR  01466cz  a2200445n  4500
=001  9880363725302441
=005  20141212203404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008648
=035  \\$aCBA1899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x504.$x660
=150  \\$aMesoderm
=450  \\$wnnna$aDorsal Mesoderm
=450  \\$wnnna$aDorsal Mesoderms
=450  \\$wnnna$aIntermediate Mesoderm
=450  \\$wnnna$aIntermediate Mesoderms
=450  \\$wnnna$aLateral Plate Mesoderm
=450  \\$wnnna$aLateral Plate Mesoderms
=450  \\$wnnna$aMesenchyma
=450  \\$wnnna$aMesenchymas
=450  \\$aMesenchyme
=450  \\$wnnna$aMesoderm, Dorsal
=450  \\$wnnna$aMesoderm, Intermediate
=450  \\$wnnna$aMesoderm, Lateral Plate
=450  \\$wnnna$aMesoderm, Paraxial
=450  \\$wnnna$aMesoderms, Dorsal
=450  \\$wnnna$aMesoderms, Intermediate
=450  \\$wnnna$aMesoderms, Lateral Plate
=450  \\$wnnna$aMesoderms, Paraxial
=450  \\$wnnna$aParaxial Mesoderm
=450  \\$wnnna$aParaxial Mesoderms
=450  \\$wnnna$aPlate Mesoderm, Lateral
=450  \\$wnnna$aPlate Mesoderms, Lateral
=550  \\$wg$aGerm Layers
=550  \\$wh$aPericytes
=550  \\$wh$aSomites
=680  \\$iThe middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube.
=750  \0$aMesenchyme$5IEN-M$0(DLC)sh 85083914
=750  \0$aMesoderm$5IEN-HS$0(DLC)sh 85083937

=LDR  01756cz  a2200457n  4500
=001  9880363725402441
=005  20141212192318.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008526
=035  \\$aCBA1776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x406
=072  \\$aA8.$x186.$x211.$x865.$x467.$x500
=150  \\$aMedulla Oblongata
=450  \\$wnnna$aAccessory Cuneate Nucleus
=450  \\$wnnna$aAmbiguous Nucleus
=450  \\$wnnna$aAmbiguus, Nucleus
=450  \\$wnnna$aArcuate Nucleus-1
=450  \\$wnnna$aArcuate Nucleus 1
=450  \\$wnnna$aArcuate Nucleus-1s
=450  \\$wnnna$aArcuate Nucleus of the Medulla
=450  \\$wnnna$aCuneate Nucleus, Accessory
=450  \\$wnnna$aCuneate Nucleus, External
=450  \\$wnnna$aCuneate Nucleus, Lateral
=450  \\$wnnna$aExternal Cuneate Nucleus
=450  \\$wnnna$aLateral Cuneate Nucleus
=450  \\$wnnna$aMedulla Oblongatas
=450  \\$wnnna$aNucleus, Accessory Cuneate
=450  \\$wnnna$aNucleus, Ambiguous
=450  \\$wnnna$aNucleus Ambiguus
=450  \\$wnnna$aNucleus, External Cuneate
=450  \\$wnnna$aNucleus, Lateral Cuneate
=550  \\$wg$aMyelencephalon
=550  \\$wg$aRhombencephalon
=550  \\$wh$aArea Postrema
=550  \\$wh$aOlivary Nucleus
=550  \\$wh$aRaphe Nuclei
=550  \\$wh$aSolitary Nucleus
=550  \\$wh$aTrigeminal Nucleus, Spinal
=680  \\$iThe lower portion of the BRAIN STEM. It is inferior to the PONS and anterior to the CEREBELLUM. Medulla oblongata serves as a relay station between the brain and the spinal cord, and contains centers for regulating respiratory, vasomotor, cardiac, and reflex activities.
=750  \0$aMedulla Oblongata$5IEN$0(DLC)sh 85083246

=LDR  01053cz  a2200265n  4500
=001  9880363725502441
=005  20141212203319.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008525
=035  \\$aCBA1775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x829.$x614
=150  \\$aMedroxyprogesterone
=450  \\$wnnna$a17 alpha-Hydroxy-6 alpha-Methylprogesterone
=450  \\$wnnna$a17 alpha Hydroxy 6 alpha Methylprogesterone
=450  \\$wnnna$aAdgyn Medro
=450  \\$wnnna$aMedroxyprogesterone Strakan Brand
=450  \\$aMethylhydroxyprogesterone
=450  \\$wnnna$aStrakan Brand of Medroxyprogesterone
=550  \\$wg$aProgesterone
=550  \\$wh$aMedroxyprogesterone Acetate
=667  \\$aa synthetic progestational hormone
=680  \\$i(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
=688  \\$aMETHYPREGNONE was see MEDROXYPROGESTERONE 1977-93
=750  \0$aMedroxyprogesterone$0(DLC) sh 85083245$5IEN-M

=LDR  01150cz  a2200301n  4500
=001  9880363725602441
=005  20141212203404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008647
=035  \\$aCBA1898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x635.$x150.$x500
=150  \\$aMesocricetus
=450  \\$wnnna$aGolden Hamster
=450  \\$wnnna$aGolden Hamsters
=450  \\$wnnna$aGolden Syrian Hamsters
=450  \\$wnnna$aHamster, Golden
=450  \\$aHamsters, Golden
=450  \\$aHamsters, Golden Syrian
=450  \\$aHamsters, Syrian
=450  \\$aMesocricetus auratus
=450  \\$wnnna$aSyrian Hamsters
=450  \\$wnnna$aSyrian Hamsters, Golden
=550  \\$wg$aCricetinae
=667  \\$aNIM when exper animal: no qualif; when IM, qualif permitted; do not forget to apply check tag
=680  \\$iA genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.
=688  \\$a91(75); was see under HAMSTERS 1975-90
=750  \0$aMesocricetus$5IEN$0(DLC)sh 85083936

=LDR  01017cz  a2200193n  4500
=001  9880363725702441
=005  20141212203403.0
=008  850315\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008645
=035  \\$aCBA1896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x520
=150  \\$aMesocestoides
=450  \\$wnnna$aMesocestoide
=550  \\$wg$aCestoda
=667  \\$ainfection: coord IM with CESTODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium.
=688  \\$a91(87); was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986
=750  \0$aMesocestoides$5IEN$0(DLC)sh 85083933

=LDR  00799cz  a2200181n  4500
=001  9880363725802441
=005  20141212203403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008643
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x47.$x25.$x600.$x451
=150  \\$aMesentery
=450  \\$wnnna$aMesenteries
=550  \\$wg$aPeritoneum
=550  \\$wh$aMesocolon
=667  \\$aavoid /blood supply: prefer MESENTERIC ARTERIES or MESENTERIC VEINS but for mesenteric circulation use SPLANCHNIC CIRCULATION; diseases: coord IM with PERITONEAL DISEASES (IM); neopl: coord IM with PERITONEAL NEOPLASMS (IM)
=680  \\$iA layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves.
=750  \0$aMesentery$5IEN$0(DLC)sh 85083916

=LDR  01545cz  a2200289n  4500
=001  9880363725902441
=005  20141212203319.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008523
=035  \\$aCBA1773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x280.$x710
=072  \\$aL1.$x700.$x508.$x300.$x710
=150  \\$aMEDLARS
=450  \\$wnnna$aInformation System, MEDLARS-MEDLINE
=450  \\$aMedical Literature Analysis and Retrieval System
=450  \\$wnnna$aMEDLARS-MEDLINE Information System
=450  \\$wnnna$aMEDLARS MEDLINE Information System
=450  \\$wnnna$aSystem, MEDLARS-MEDLINE Information
=550  \\$wg$aInformation Storage and Retrieval
=550  \\$wg$aInformation Systems
=550  \\$wh$aMEDLINE
=550  \\$aNational Library of Medicine (U.S.)
=667  \\$aIM CATALOG: use NAF entry
=680  \\$iA computerized biomedical bibliographic storage and retrieval system operated by the NATIONAL LIBRARY OF MEDICINE. MEDLARS stands for Medical Literature Analysis and Retrieval System, which was first introduced in 1964 and evolved into an online system in 1971 called MEDLINE (MEDLARS Online). As other online databases were developed, MEDLARS became the name of the entire NLM information system while MEDLINE became the name of the premier database. MEDLARS was used to produce the former printed Cumulated Index Medicus, and the printed monthly Index Medicus, until that publication ceased in December 2004.
=688  \\$a1991 (1978)
=750  \0$aMEDLARS$5IEN$0(DLC)sh 85083239

=LDR  00923cz  a2200205n  4500
=001  9880363726002441
=005  20141212203403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008642
=035  \\$aCBA1893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x670.$x385
=150  \\$aMesenteric Veins
=450  \\$wnnna$aMesenteric Vein
=450  \\$wnnna$aVein, Mesenteric
=450  \\$wnnna$aVeins, Mesenteric
=550  \\$wg$aPortal System
=667  \\$aocclusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM); venous thrombosis: index under MESENTERIC VASCULAR OCCLUSION (IM) + VENOUS THROMBOSIS (IM) + MESENTERIC VEINS (NIM)
=680  \\$iVeins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein.
=750  \0$aMesentery$xBlood-vessels$5IEN$0(DLC)sh 85083917

=LDR  02655cz  a2200613n  4500
=001  9880363726102441
=005  20141212203317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008518
=035  \\$aCBA1768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x585
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558
=150  \\$aMedicine, East Asian Traditional
=450  \\$wnnna$aAsia Medicines, East
=450  \\$wnnna$aEast Asia Medicine
=450  \\$wnnna$aEast Asia Medicines
=450  \\$wnnna$aEast Asian Medicine
=450  \\$wnnna$aEast Asian Medicines
=450  \\$wnnna$aEast Asian Traditional Medicine
=450  \\$wnnna$aEast Medicine, Far
=450  \\$wnnna$aEast Medicines, Far
=450  \\$wnnna$aFar East Medicine
=450  \\$wnnna$aFar East Medicines
=450  \\$wnnna$aMedicine, East Asia
=450  \\$wnnna$aMedicine, East Asian
=450  \\$wnnna$aMedicine, Far East
=450  \\$wnnna$aMedicine, Oriental
=450  \\$wnnna$aMedicine, Oriental Traditional
=450  \\$wnnna$aMedicine, Traditional, East Asia
=450  \\$wnnna$aMedicine, Traditional Oriental
=450  \\$wnnna$aMedicines, East Asia
=450  \\$wnnna$aMedicines, Far East
=450  \\$wnnna$aOriental Medicine
=450  \\$wnnna$aOriental Medicine, Traditional
=450  \\$wnnna$aOriental Traditional Medicine
=450  \\$wnnna$aTraditional East Asian Medicine
=450  \\$wnnna$aTraditional Far Eastern Medicine
=450  \\$aTraditional Medicine, East Asia
=450  \\$wnnna$aTraditional Medicine, Oriental
=450  \\$wnnna$aTraditional Oriental Medicine
=450  \\$wnnna$aTraditional Oriental Medicines
=550  \\$wg$aMedicine, Traditional
=550  \\$wh$aMedicine, Chinese Traditional
=550  \\$wh$aMedicine, Kampo
=550  \\$wh$aMedicine, Korean Traditional
=550  \\$wh$aMedicine, Mongolian Traditional
=550  \\$wh$aMedicine, Tibetan Traditional
=667  \\$aadd country; MEDICINE, CHINESE TRADITIONAL; MEDICINE, KOREAN TRADITIONAL; and MEDICINE, TIBETAN TRADITIONAL; are also available; do not use for "medicine in East Asian Countries" ( = MEDICINE (IM) + country); Manual 32.13; taking of pulse in traditional East Asian medicine = PULSE + appropriate acupuncture or traditional East Asian medicine terms
=680  \\$iMedical practice or discipline that is based on the knowledge, cultures, and beliefs of the people in EAST ASIA.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Medicine, Oriental Traditional
=688  \\$a84; was MEDICINE, ORIENTAL 1966-83
=750  \0$aMedicine, Oriental$0(DLC) sh 85083157$5IEN

=LDR  01271cz  a2200373n  4500
=001  9880363726202441
=005  20141212192317.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008517
=035  \\$aCBA1767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x755
=150  \\$aPhytotherapy
=450  \\$aHerb Therapy
=450  \\$wnnna$aHerbal Therapy
=450  \\$wnno$aHerbs$xtherapeutic use$5IEN-HS
=550  \\$wg$aComplementary Therapies
=550  \\$wh$aAromatherapy
=550  \\$wh$aEclecticism, Historical
=550  \\$aEthnobotany
=550  \\$aEthnopharmacology
=550  \\$aFlower Essences
=550  \\$aHerbal Medicine
=550  \\$aMateria Medica
=550  \\$aMedical Marijuana
=550  \\$aMedicine, Mongolian Traditional
=550  \\$aPharmacognosy
=550  \\$aPlant Extracts
=550  \\$aPlants
=550  \\$aPlants, Medicinal
=667  \\$acoordinate IM disease /drug ther (IM) + specific plant (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific chemical /ther use (IM) if pertinent;  Medical Botany: index under BOTANY
=680  \\$iUse of plants or herbs to treat diseases or to alleviate pain.
=688  \\$a2002(1963)
=750  \0$aHerbs$xTherapeutic use$0(DLC) sh 85060354$5IEN

=LDR  01611cz  a2200325n  4500
=001  9880363726302441
=005  20141212203316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008516
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x585.$x520
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x520
=150  \\$aMedicine, Chinese Traditional
=450  \\$aChinese Medicine, Traditional
=450  \\$wnnna$aChinese Traditional Medicine
=450  \\$aChung I Hsueh
=450  \\$wnnna$aHsueh, Chung I
=450  \\$wnnna$aTraditional Chinese Medicine
=450  \\$aTraditional Medicine, Chinese
=450  \\$aZhong Yi Xue
=550  \\$wg$aMedicine, East Asian Traditional
=550  \\$wh$aQi
=550  \\$wh$aYin-Yang
=550  \\$aAcupuncture Therapy
=550  \\$aMedicine, Kampo
=550  \\$aMedicine, Tibetan Traditional
=667  \\$ais not medicine in China ( = MEDICINE + CHINA); Manual 32.13; medicinal plants in Chinese med: consider DRUGS, CHINESE HERBAL; index differentiation of signs & symptoms (bianzheng shizhi) under MEDICINE, CHINESE TRADITIONAL (IM) + DIAGNOSIS, DIFFERENTIAL (IM); Oriental taking of pulses = PULSE + appropriate acupuncture or Oriental medicine terms; DF: MED CHINESE TRADITIONAL
=680  \\$iA system of traditional medicine which is based on the beliefs and practices of the Chinese culture.
=688  \\$a88(84); was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80
=750  \0$aMedicine, Chinese$5IEN$0(DLC)sh 85083125

=LDR  00938cz  a2200265n  4500
=001  9880363726402441
=005  20141212203315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008515
=035  \\$aCBA1765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x515
=072  \\$aI1.$x76.$x201.$x450.$x654.$x515
=150  \\$aMedicine, Ayurvedic
=450  \\$aAyurvedic Medicine
=450  \\$wnnna$aHindu Medicine
=450  \\$aMedicine, Hindu
=450  \\$wnnna$aMedicine, Siddha
=450  \\$aSiddha Medicine
=550  \\$wg$aMedicine, Traditional
=550  \\$aHinduism
=667  \\$aManual 32.13; DF: MED AYURVEDIC
=680  \\$iThe traditional Hindu system of medicine which is based on customs, beliefs, and practices of the Hindu culture. Ayurveda means "the science of Life": veda - science, ayur - life.
=688  \\$a81; was MEDICINE, HINDU 1964-80
=750  \0$aMedicine, Ayurvedic$5IEN$0(DLC)sh 85083119

=LDR  00841cz  a2200217n  4500
=001  9880363726502441
=005  20141212203315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008514
=035  \\$aCBA1764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x510
=072  \\$aI1.$x76.$x201.$x450.$x654.$x510
=072  \\$aK1.$x400.$x552.$x643
=150  \\$aMedicine, Arabic
=450  \\$wnnna$aArabic Medicine
=550  \\$wg$aHistory of Medicine
=550  \\$wg$aMedicine, Traditional
=550  \\$wh$aMedicine, Unani
=667  \\$ais not medicine in Arab countries ( = MEDICINE + specific country); no qualif; Manual 32.13; Avicenna (also called Ibn Sina) is indexed as Avicenna in field 15 + check tags BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL: TN 12; DF: MED ARABIC
=750  \0$aMedicine, Arab$5IEN$0(DLC)sh 85083116

=LDR  01104cz  a2200229n  4500
=001  9880363726602441
=005  20141212203401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008638
=035  \\$aCBA1889HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x565
=150  \\$aMesenteric Arteries
=450  \\$wnnna$aArteries, Mesenteric
=450  \\$wnnna$aArtery, Mesenteric
=450  \\$wnnna$aMesenteric Artery
=550  \\$wg$aArteries
=550  \\$wh$aMesenteric Artery, Inferior
=550  \\$wh$aMesenteric Artery, Superior
=667  \\$aGEN or unspecified; prefer MESENTERIC ARTERY, INFERIOR or MESENTERIC ARTERY, SUPERIOR; occlusion or obstruction: coord NIM with MESENTERIC VASCULAR OCCLUSION (IM); embolism or thrombosis: index under MESENTERIC VASCULAR OCCLUSION (IM) + EMBOLISM or THROMBOSIS (IM) + MESENTERIC ARTERIES (NIM); duodenal compression by superior mesenteric artery = SUPERIOR MESENTERIC ARTERY SYNDROME
=680  \\$iArteries which arise from the abdominal aorta and distribute to most of the intestines.
=750  \0$aMesenteric artery$5IEN$0(DLC)sh 85083915

=LDR  01041cz  a2200253n  4500
=001  9880363726702441
=005  20141212203401.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008636
=035  \\$aCBA1887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x659
=072  \\$aA8.$x186.$x211.$x653
=150  \\$aMesencephalon
=450  \\$wnnna$aMesencephalons
=450  \\$aMidbrain
=450  \\$wnnna$aMidbrains
=550  \\$wg$aBrain
=550  \\$wg$aBrain Stem
=550  \\$wh$aCerebral Peduncle
=550  \\$wh$aLocus Coeruleus
=550  \\$wh$aTectum Mesencephali
=680  \\$iThe middle of the three primitive cerebral vesicles of the embryonic brain. Without further subdivision, midbrain develops into a short, constricted portion connecting the PONS and the DIENCEPHALON. Midbrain contains two major parts, the dorsal TECTUM MESENCEPHALI and the ventral TEGMENTUM MESENCEPHALI, housing components of auditory, visual, and other sensorimoter systems.
=750  \0$aMesencephalon$5IEN$0(DLC)sh 85083912

=LDR  00833cz  a2200241n  4500
=001  9880363726802441
=005  20170927135954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008513
=035  \\$aCBA1763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x584
=150  \\$aMedicine in Literature
=450  \\$wnnna$ain Literature, Medicine
=450  \\$wnnna$ain Literature, Science
=450  \\$wnnna$aLiterature, Medicine in
=450  \\$wnnna$aLiterature, Science in
=450  \\$wnnna$aScience in Literature
=550  \\$wg$aLiterature
=550  \\$wg$aPsychiatry in Literature
=550  \\$aLiterature
=667  \\$acoordinate IM with medical aspect (IM) + specific literature heading (IM) + literary type if pertinent (as POETRY; DRAMA, etc.) (IM)
=750  \0$aMedicine in literature$5IEN$0(DLC)sh 85083194

=LDR  01123cz  a2200253n  4500
=001  9880363726902441
=005  20141212203400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008635
=035  \\$aCBA1886HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x635
=072  \\$aD3.$x132.$x524
=150  \\$aMescaline
=450  \\$wnnna$a3,4,5-Trimethoxyphenethylamine
=450  \\$aMezcalin
=450  \\$aPeyote
=450  \\$aTrimethoxyphenethylamine
=550  \\$wg$aAlkaloids
=550  \\$wg$aPhenethylamines
=667  \\$aa peyote alkaloid from Mexican cactus called mescal
=680  \\$iHallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church.
=688  \\$aPEYOTE was see under MESCALINE 1963-78
=750  \0$aMescaline$5IEN$0(DLC)sh 85083910

=LDR  01077cz  a2200241n  4500
=001  9880363727002441
=005  20141212203400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008632
=035  \\$aCBA1883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275.$x570
=150  \\$aMermithoidea
=450  \\$aMermithid
=450  \\$aMermithida$5IEN
=450  \\$wnnna$aMermithids
=450  \\$wnnna$aMermithoideas
=450  \\$wnnna$aRomanomermi
=450  \\$aRomanomermis
=550  \\$wg$aEnoplida
=667  \\$aa superfamily of nematodes; infection (probably accidental through food contam): coord IM with ENOPLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA superfamily of nematodes of the order ENOPLIDA. Characteristics include a reduced alimentary tract and the presence of a trophosome. Its organisms can be present in the human intestine through ingestion of unwashed or contaminated raw vegetables.
=750  \0$aMermithida$5IEN$0(DLC)sh 88021636

=LDR  00780cz  a2200217n  4500
=001  9880363727202441
=005  20141212203359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008630
=035  \\$aCBA1881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x647
=150  \\$aMercury Poisoning
=450  \\$aMercury$xpoisoning
=450  \\$wnnna$aMercury Poisonings
=450  \\$wnnna$aPoisoning, Mercury
=450  \\$wnnna$aPoisonings, Mercury
=550  \\$wg$aPoisoning
=550  \\$wh$aMercury Poisoning, Nervous System
=667  \\$aGEN only: consider also /pois with specific mercury terms; occup mercury pois: coord IM with OCCUPATIONAL DISEASES (IM) but not also ENVIRONMENTAL EXPOSURE (see note there)
=750  \0$aMercury$xToxicology$5IEN$0(DLC)sh 85083801

=LDR  00719cz  a2200217n  4500
=001  9880363727302441
=005  20141212203359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008629
=035  \\$aCBA1880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x532
=150  \\$aMercury Isotopes
=450  \\$wnnna$aIsotopes, Mercury
=550  \\$wg$aIsotopes
=550  \\$wh$aMercury Radioisotopes
=550  \\$aMercury
=667  \\$aHg-196,198-201,204; NIM
=680  \\$iStable mercury atoms that have the same atomic number as the element mercury, but differ in atomic weight. Hg-196, 198-201, and 204 are stable mercury isotopes.
=688  \\$a68(67)
=750  \0$aMercury$xIsotopes$5IEN$0(DLC)sh 85083797

=LDR  01034cz  a2200205n  4500
=001  9880363727402441
=005  20141212203359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008628
=035  \\$aCBA1879HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x504
=072  \\$aD1.$x268.$x956.$x437
=072  \\$aD1.$x552.$x544.$x504
=150  \\$aMercury
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aHg-202
=680  \\$iA silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.
=750  \0$aMercury$5IEN-M$0(DLC)sh 85083794

=LDR  02922cz  a2200793n  4500
=001  9880363727502441
=005  20171102162838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008511
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403
=150  \\$aMedicine
=450  \\$wnnna$aMedical Specialities
=450  \\$wnnna$aMedical Speciality
=450  \\$wnnna$aMedical Specialties
=450  \\$wnnna$aMedical Specialty
=450  \\$wnnna$aSpecialities, Medical
=450  \\$wnnna$aSpeciality, Medical
=450  \\$wnnna$aSpecialties, Medical
=450  \\$wnnna$aSpecialty, Medical
=550  \\$wg$aHealth Occupations
=550  \\$wh$aAdolescent Medicine
=550  \\$wh$aAerospace Medicine
=550  \\$wh$aAllergy and Immunology
=550  \\$wh$aAndrology
=550  \\$wh$aAnesthesiology
=550  \\$wh$aBariatric Medicine
=550  \\$wh$aBehavioral Medicine
=550  \\$wh$aClinical Medicine
=550  \\$wh$aCommunity Medicine
=550  \\$wh$aDermatology
=550  \\$wh$aDisaster Medicine
=550  \\$wh$aEmergency Medicine
=550  \\$wh$aForensic Medicine
=550  \\$wh$aGeneral Practice
=550  \\$wh$aGenetics, Medical
=550  \\$wh$aGeography, Medical
=550  \\$wh$aGeriatrics
=550  \\$wh$aGlobal Health
=550  \\$wh$aHospital Medicine
=550  \\$wh$aIntegrative Medicine
=550  \\$wh$aInternal Medicine
=550  \\$wh$aMilitary Medicine
=550  \\$wh$aMolecular Medicine
=550  \\$wh$aNaval Medicine
=550  \\$wh$aNeurology
=550  \\$wh$aOsteopathic Medicine
=550  \\$wh$aPalliative Medicine
=550  \\$wh$aPathology
=550  \\$wh$aPediatrics
=550  \\$wh$aPhysical and Rehabilitation Medicine
=550  \\$wh$aPsychiatry
=550  \\$wh$aPublic Health
=550  \\$wh$aRadiology
=550  \\$wh$aRegenerative Medicine
=550  \\$wh$aReproductive Medicine
=550  \\$wh$aSocial Medicine
=550  \\$wh$aSpecialties, Surgical
=550  \\$wh$aSports Medicine
=550  \\$wh$aTelemedicine
=550  \\$wh$aTheranostic Nanomedicine
=550  \\$wh$aTravel Medicine
=550  \\$wh$aTropical Medicine
=550  \\$wh$aVenereology
=550  \\$wh$aWilderness Medicine
=667  \\$amedicine only as a field, profession or discipline: differentiate from DELIVERY OF HEALTH CARE where the patient is emphasized; very general; it is divided broadly into experimental medicine ( = BIOMEDICAL RESEARCH) & CLINICAL MEDICINE, a specialty devoted to the diagnosis & management of human patients; / legislation & jurisprudence = LEGISLATION, MEDICAL or JURISPRUDENCE or FORENSIC MEDICINE; LEGAL MEDICINE see FORENSIC MEDICINE is also available
=680  \\$iThe art and science of studying, performing research on, preventing, diagnosing, and treating disease, as well as the maintenance of health.
=688  \\$a1963
=750  \0$aMedicine$0(DLC) sh 85083064$5IEN-HS

=LDR  00725cz  a2200229n  4500
=001  9880363727602441
=005  20180820143332.0
=008  870314\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008611
=035  \\$aCBA1862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x588
=072  \\$aM1.$x395
=150  \\$aMentors
=450  \\$wnnna$aMentor
=450  \\$wnnna$aMentorship
=450  \\$aMentorships
=550  \\$wg$aEducation
=550  \\$wg$aPersons
=680  \\$iSenior professionals who provide guidance, direction and support to those persons desirous of improvement in academic positions, administrative positions or other career development situations.
=688  \\$a88
=750  \0$aMentoring$0(DLC)sh 95001844$5IEN-M

=LDR  00584cz  a2200193n  4500
=001  9880363727702441
=005  20141212203353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008610
=035  \\$aCBA1861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x480.$x300.$x605
=072  \\$aD2.$x455.$x849.$x575.$x750
=150  \\$aMenthol
=450  \\$wnnna$aMenthol, (1alpha,2beta,5alpha)-Isomer
=550  \\$wg$aCyclohexanols
=550  \\$wg$aMonoterpenes
=680  \\$iAn alcohol produced from mint oils or prepared synthetically.
=750  \0$aMenthol$5IEN$0(DLC)sh 85083726

=LDR  02312cz  a2200505n  4500
=001  9880363727802441
=005  20141212203313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008510
=035  \\$aCBA1760HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x675
=072  \\$aN4.$x452.$x442.$x675
=072  \\$aN4.$x452.$x528.$x473
=150  \\$aMedication Systems, Hospital
=450  \\$wnnna$aDrug Distribution System, Hospital
=450  \\$wnnna$aDrug Distribution Systems, Hospital
=450  \\$aHospital Drug Distribution Systems
=450  \\$aHospital Medication System
=450  \\$wnnna$aHospital Medication, System
=450  \\$aHospital Medication Systems
=450  \\$wnnna$aHospital Medications, System
=450  \\$wnnna$aHospital System, Medication
=450  \\$wnnna$aHospital Systems, Medication
=450  \\$wnnna$aHospital Unit Dose Drug Distribution System
=450  \\$wnnna$aHospital Unit Dose Drug Distribution Systems
=450  \\$wnnna$aMedication Hospital System
=450  \\$wnnna$aMedication Hospital Systems
=450  \\$aMedication System, Hospital
=450  \\$wnnna$aMedication, System Hospital
=450  \\$wnnna$aMedications, System Hospital
=450  \\$wnnna$aSystem Hospital Medication
=450  \\$wnnna$aSystem, Hospital Medication
=450  \\$wnnna$aSystem Hospital Medications
=450  \\$wnnna$aSystem, Medication Hospital
=450  \\$wnnna$aSystems, Hospital Medication
=450  \\$wnnna$aSystems, Medication Hospital
=550  \\$wg$aHospital Administration
=550  \\$wg$aMedication Systems
=550  \\$aClinical Pharmacy Information Systems
=550  \\$aMedical Order Entry Systems
=667  \\$aan organizational concept in hospital patient care for providing medication; do not confuse with DRUG DELIVERY SYSTEMS; DF: MEDICATION SYSTEMS HOSP
=680  \\$iOverall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient.
=688  \\$a78; was HOSPITAL MEDICATION SYSTEMS 1968-77
=750  \0$aHospitals$xDrug distribution stystems$0(DLC) sh 85062316$5IEN

=LDR  02834cz   2200709n  4500
=001  9880363727902441
=005  20220303084947.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008607
=035  \\$aCBA1858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643
=072  \\$aC23.$x888.$x592.$x604.$x646
=072  \\$aF1.$x700.$x687
=072  \\$aF3.$x625.$x539
=150  \\$aIntellectual Disability
=450  \\$wnnna$aDeficiencies, Mental
=450  \\$wnnna$aDeficiency, Mental
=450  \\$wnnna$aDisabilities, Intellectual
=450  \\$aDisability, Intellectual
=450  \\$aIdiocy
=450  \\$wnnna$aIntellectual Disabilities
=450  \\$wnnna$aMental Deficiencies
=450  \\$wnnna$aMental Deficiency
=450  \\$aMental Retardation
=450  \\$wnnna$aMental Retardation, Psychosocial
=450  \\$wnnna$aMental Retardations, Psychosocial
=450  \\$wnnna$aPsychosocial Mental Retardation
=450  \\$wnnna$aPsychosocial Mental Retardations
=450  \\$aRetardation, Mental
=450  \\$wnnna$aRetardation, Psychosocial Mental
=450  \\$wnnna$aRetardations, Psychosocial Mental
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wh$aCri-du-Chat Syndrome
=550  \\$wh$aDe Lange Syndrome
=550  \\$wh$aDown Syndrome
=550  \\$wh$aMental Retardation, X-Linked
=550  \\$wh$aPrader-Willi Syndrome
=550  \\$wh$aRubinstein-Taybi Syndrome
=550  \\$wh$aTrisomy 13 Syndrome
=550  \\$wh$aWAGR Syndrome
=550  \\$wh$aWilliams Syndrome
=550  \\$aAbnormalities, Multiple
=550  \\$aAngelman Syndrome
=550  \\$aBardet-Biedl Syndrome
=550  \\$aBrain Diseases, Metabolic, Inborn
=550  \\$aCockayne Syndrome
=550  \\$aCri-du-Chat Syndrome
=550  \\$aDe Lange Syndrome
=550  \\$aFragile X Syndrome
=550  \\$aLaurence-Moon Syndrome
=550  \\$aPersons with Mental Disabilities
=550  \\$aPrader-Willi Syndrome
=550  \\$aRett Syndrome
=550  \\$aRubinstein-Taybi Syndrome
=550  \\$aWilliams Syndrome
=650  \\$wg$aNeurodevelopmental Disorders
=667  \\$ado not equate /rehabil with EDUCATION OF INTELLECTUALLY DISABLED
=680  \\$iSubnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabiled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
=688  \\$a1967(1963)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Mental Retardation
=750  \0$aIntellectual disability$0(DLC) sh 85083658$5IEN-M

=LDR  01066cz  a2200349n  4500
=001  9880363728002441
=005  20200618112916.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008606
=035  \\$aCBA1857HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463
=150  \\$aMental Processes
=450  \\$wnnna$aHuman Information Processing
=450  \\$aInformation Processing, Human
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aAnticipation, Psychological
=550  \\$wh$aCognition
=550  \\$wh$aExecutive Function
=550  \\$wh$aHigher Nervous Activity
=550  \\$wh$aIntention
=550  \\$wh$aLearning
=550  \\$wh$aMind-Body Relations, Metaphysical
=550  \\$wh$aMindfulness
=550  \\$wh$aPerception
=550  \\$wh$aProcrastination
=550  \\$wh$aSpatial Navigation
=550  \\$wh$aTheory of Mind
=550  \\$wh$aThinking
=550  \\$wh$aVolition
=680  \\$iConceptual functions or thinking in all its forms.
=750  \0$aHuman information processing$5IEN-HS$0(DLC)sh 85062880

=LDR  01437cz  a2200397n  4500
=001  9880363728102441
=005  20141212203352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008605
=035  \\$aCBA1856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x408
=072  \\$aN2.$x421.$x461
=150  \\$aMental Health Services
=450  \\$wnnna$aHealth Service, Mental
=450  \\$wnnna$aHealth Services, Mental
=450  \\$wnnna$aHygiene Service, Mental
=450  \\$wnnna$aHygiene Services, Mental
=450  \\$wnnna$aMental Health Service
=450  \\$wnnna$aMental Hygiene Service
=450  \\$aMental Hygiene Services
=450  \\$wnnna$aService, Mental Health
=450  \\$wnnna$aService, Mental Hygiene
=450  \\$wnnna$aServices, Mental Health
=450  \\$wnnna$aServices, Mental Hygiene
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wg$aHealth Services
=550  \\$wh$aChild Guidance
=550  \\$wh$aCommunity Mental Health Services
=550  \\$wh$aCounseling
=550  \\$wh$aEmergency Services, Psychiatric
=550  \\$wh$aSocial Work, Psychiatric
=667  \\$aCOMMUNITY MENTAL HEALTH SERVICES & specifics are also available; Public Laws 89-105 & 89-164; DF: MENTAL HEALTH SERV
=680  \\$iOrganized services to provide mental health care.
=688  \\$a67; was MENTAL HYGIENE SERVICES 1963-66
=750  \0$aMental health services$5IEN$0(DLC)sh 85083636

=LDR  00695cz  a2200241n  4500
=001  9880363728202441
=005  20141212203351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008603
=035  \\$aCBA1854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x418
=072  \\$aN1.$x400.$x500
=150  \\$aMental Health
=450  \\$wnnna$aHealth, Mental
=450  \\$wnnna$aHygiene, Mental
=450  \\$aMental Hygiene
=550  \\$wg$aHealth
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$aOrthopsychiatry
=680  \\$iThe state wherein the person is well adjusted.
=688  \\$a67; was MENTAL HYGIENE 1963-66
=750  \0$aMental health$5IEN$0(DLC)sh 85083615

=LDR  00608cz  a2200205n  4500
=001  9880363728302441
=005  20141212203351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008602
=035  \\$aCBA1853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x500
=072  \\$aE2.$x190.$x901.$x500
=150  \\$aMental Healing
=450  \\$wnnna$aHealing, Mental
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aSpiritual Therapies
=550  \\$aReligion
=680  \\$iThe use of mind to cure disease, particularly physical illness.
=750  \0$aMental healing$5IEN-HS$0(DLC)sh 85083614

=LDR  01133cz  a2200277n  4500
=001  9880363728402441
=005  20141212203350.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008600
=035  \\$aCBA1851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x875.$x360.$x276.$x500
=072  \\$aD27.$x505.$x696.$x875.$x650
=072  \\$aD27.$x505.$x954.$x705.$x360.$x276.$x500
=072  \\$aD27.$x505.$x954.$x705.$x650
=150  \\$aMenstruation-Inducing Agents
=450  \\$wnnna$aAgents, Menstruation-Inducing
=450  \\$aEmmenagogues
=450  \\$wnnna$aMenstruation Inducing Agents
=550  \\$wg$aContraceptive Agents, Female
=550  \\$wg$aReproductive Control Agents
=550  \\$aMenstruation
=667  \\$aconsider also MENSTRUATION /drug eff
=680  \\$iChemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)
=688  \\$a94; was MENSTRUATION INDUCING AGENTS 1975-93
=750  \0$aEmmenagogues$5IEN$0(DLC)sh 85042808

=LDR  01387cz  a2200421n  4500
=001  9880363728502441
=005  20141212203350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008599
=035  \\$aCBA1850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x568
=150  \\$aMenstruation Disturbances
=450  \\$wnnna$aDisorder, Menstruation
=450  \\$wnnna$aDisorders, Menstruation
=450  \\$wnnna$aDisturbance, Menstruation
=450  \\$wnnna$aDisturbances, Menstruation
=450  \\$aHypomenorrhea
=450  \\$wnnna$aHypomenorrheas
=450  \\$wnnna$aMenstruation Disorder
=450  \\$aMenstruation Disorders
=450  \\$wnnna$aMenstruation Disturbance
=450  \\$aMenstruation, Retrograde
=450  \\$wnnna$aMenstruations, Retrograde
=450  \\$aPolymenorrhea
=450  \\$wnnna$aPolymenorrheas
=450  \\$wnnna$aRetrograde Menstruation
=450  \\$wnnna$aRetrograde Menstruations
=550  \\$wg$aPathologic Processes
=550  \\$wh$aAmenorrhea
=550  \\$wh$aDysmenorrhea
=550  \\$wh$aMenorrhagia
=550  \\$wh$aOligomenorrhea
=550  \\$wh$aPremenstrual Syndrome
=667  \\$ahuman only; GEN or unspecified: prefer specifics; note X refs
=680  \\$iVariations of menstruation which may be indicative of disease.
=688  \\$a2000(1963)
=750  \0$aMenstruation disorders$5IEN$0(DLC)sh 85083607

=LDR  00964cz  a2200217n  4500
=001  9880363728602441
=005  20141212203350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008598
=035  \\$aCBA1849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x605.$x428
=072  \\$aG8.$x686.$x785.$x560
=150  \\$aMenstruation
=450  \\$wnnna$aMenstruations
=550  \\$wg$aMenstrual Cycle
=550  \\$wg$aReproductive Physiological Processes
=667  \\$ahuman & other primates only; non-primates = ESTRUS; do not confuse with MENSTRUAL CYCLE
=680  \\$iThe periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
=750  \0$aMenstrual regulation$5IEN-M$0(DLC)sh 85083603
=750  \0$aMenstruation$5IEN-HS$0(DLC)sh 85083604

=LDR  01597cz  a2200349n  4500
=001  9880363728702441
=005  20141212203349.0
=008  840531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008597
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x605
=150  \\$aMenstrual Cycle
=450  \\$wnnna$aCycle, Endometrial
=450  \\$wnnna$aCycle, Menstrual
=450  \\$wnnna$aCycle, Ovarian
=450  \\$wnnna$aCycles, Endometrial
=450  \\$wnnna$aCycles, Menstrual
=450  \\$wnnna$aCycles, Ovarian
=450  \\$aEndometrial Cycle
=450  \\$wnnna$aEndometrial Cycles
=450  \\$wnnna$aMenstrual Cycles
=450  \\$aOvarian Cycle
=450  \\$wnnna$aOvarian Cycles
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wh$aFertile Period
=550  \\$wh$aFollicular Phase
=550  \\$wh$aLuteal Phase
=550  \\$wh$aMenstruation
=667  \\$ahuman & other primates only; for non-primates use ESTROUS CYCLE; do not confuse with MENSTRUATION
=680  \\$iThe period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
=688  \\$a85
=750  \0$aMenstrual cycle$5IEN$0(DLC)sh 85083601

=LDR  00654cz  a2200217n  4500
=001  9880363728802441
=005  20141212203348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008595
=035  \\$aCBA1846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x691.$x449
=072  \\$aC23.$x550.$x568.$x875
=150  \\$aMenorrhagia
=450  \\$aHypermenorrhea
=550  \\$wg$aMenstruation Disturbances
=550  \\$wg$aUterine Hemorrhage
=550  \\$aUterine Hemorrhage
=667  \\$ado not confuse with METRORRHAGIA
=680  \\$iExcessive uterine bleeding during MENSTRUATION.
=750  \0$aMenorrhagia$5IEN$0(DLC)sh 85083593

=LDR  01307cz  a2200373n  4500
=001  9880363728902441
=005  20170712130332.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008508
=035  \\$aCBA1758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x529
=072  \\$aN2.$x421.$x450.$x500
=150  \\$aMedication Errors
=450  \\$wnnna$aDrug Use Error
=450  \\$wnnna$aDrug Use Errors
=450  \\$wnnna$aError, Drug Use
=450  \\$wnnna$aError, Medication
=450  \\$wnnna$aErrors, Drug Use
=450  \\$wnnna$aErrors, Medication
=450  \\$wnnna$aMedication Error
=450  \\$wnnna$aUse Error, Drug
=450  \\$wnnna$aUse Errors, Drug
=550  \\$wg$aDrug Therapy
=550  \\$wg$aMedical Errors
=550  \\$wh$aInappropriate Prescribing
=550  \\$wh$aMedication Reconciliation
=550  \\$wh$aNear Miss, Healthcare
=550  \\$aDrug Therapy
=550  \\$aPrescription Drug Misuse
=667  \\$acoordinate IM with specific disease / drug ther (IM) & specific drug / ther use (IM)
=680  \\$iErrors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.
=688  \\$a67(66)
=750  \0$aMedication errors$5IEN$0(DLC)sh 85083061

=LDR  01377cz  a2200361n  4500
=001  9880363729002441
=005  20141212203312.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008507
=035  \\$aCBA1756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x340
=072  \\$aN5.$x300.$x450.$x520
=150  \\$aMedically Underserved Area
=450  \\$wnnna$aArea, Medically Underserved
=450  \\$wnnna$aArea, Physician Shortage
=450  \\$wnnna$aAreas, Medically Underserved
=450  \\$wnnna$aAreas, Physician Shortage
=450  \\$wnnna$aHealth Service Corps, National
=450  \\$wnnna$aMedically Underserved Areas
=450  \\$aNational Health Service Corps
=450  \\$aPhysician Shortage Area
=450  \\$wnnna$aPhysician Shortage Areas
=450  \\$wnnna$aShortage Area, Physician
=450  \\$wnnna$aShortage Areas, Physician
=450  \\$wnnna$aUnderserved Area, Medically
=450  \\$wnnna$aUnderserved Areas, Medically
=550  \\$wg$aHealth Services Needs and Demand
=550  \\$wg$aRegional Health Planning
=667  \\$ano qualif; specify geog; DF: MED UNDERSERV AREA
=680  \\$iA geographic location which has insufficient health resources (manpower and/or facilities) to meet the medical needs of the resident population.
=688  \\$a78
=750  \0$aMedically underserved areas$5IEN$0(DLC)sh 85083052

=LDR  01062cz  a2200301n  4500
=001  9880363729102441
=005  20141212203311.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008506
=035  \\$aCBA1755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944.$x460
=072  \\$aN6.$x850.$x460.$x710.$x460
=150  \\$aMedical Waste
=450  \\$wnnna$aMedical Wastes
=450  \\$aPathological Waste
=450  \\$wnnna$aPathological Wastes
=450  \\$wnnna$aWaste, Medical
=450  \\$wnnna$aWaste, Pathological
=450  \\$wnnna$aWastes, Medical
=450  \\$wnnna$aWastes, Pathological
=550  \\$wg$aWaste Products
=550  \\$wh$aDental Waste
=550  \\$wh$aMedical Waste Disposal
=667  \\$anote next heading; DENTAL WASTE is also available; DF: MED WASTE
=680  \\$iBlood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures.
=688  \\$a91(78); was see under WASTE PRODUCTS 1978-90
=750  \0$aMedical wastes$5IEN$0(DLC)sh 88007401

=LDR  01623cz  a2200445n  4500
=001  9880363729202441
=005  20141212203311.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008505
=035  \\$aCBA1754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x630.$x490
=072  \\$aM1.$x526.$x485.$x740.$x422
=072  \\$aN2.$x360.$x630.$x490
=072  \\$aN2.$x360.$x740.$x422
=150  \\$aMedical Staff, Hospital
=450  \\$wnnna$aAttending Physician, Hospital
=450  \\$aAttending Physicians, Hospital
=450  \\$wnnna$aHospital Attending Physician
=450  \\$wnnna$aHospital Attending Physicians
=450  \\$aHospital Medical Staff
=450  \\$wnnna$aHospital Medical Staffs
=450  \\$wnnna$aHospital Registrar
=450  \\$wnnna$aHospital Registrars
=450  \\$wnnna$aJunior Physician
=450  \\$wnnna$aJunior Physicians
=450  \\$wnnna$aMedical Staffs, Hospital
=450  \\$wnnna$aPhysician, Junior
=450  \\$aPhysicians, Junior
=450  \\$wnnna$aRegistrar, Hospital
=450  \\$aRegistrars, Hospital
=450  \\$wnnna$aStaff, Hospital Medical
=450  \\$wnnna$aStaffs, Hospital Medical
=550  \\$wg$aMedical Staff
=550  \\$wg$aPersonnel, Hospital
=550  \\$wh$aHospitalists
=667  \\$ahosp only: non-hosp med staff = MEDICAL STAFF; X ref REGISTRARS, HOSPITAL refers to British hosp; DF: MED STAFF HOSP
=680  \\$iProfessional medical personnel approved to provide care to patients in a hospital.
=688  \\$a78; was HOSPITAL MEDICAL STAFF 1963-77
=750  \0$aHospitals$xMedical staff$5IEN$0(DLC)sh 85062341

=LDR  01090cz  a2200277n  4500
=001  9880363729302441
=005  20141212203310.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008504
=035  \\$aCBA1753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x458.$x500
=072  \\$aN4.$x452.$x442.$x530.$x500
=072  \\$aN4.$x452.$x758.$x275.$x500
=150  \\$aMedical Staff Privileges
=450  \\$wnnna$aMedical Staff Privilege
=450  \\$aMedical Staff Privileges, Nonphysician
=450  \\$wnnna$aPrivilege, Medical Staff
=450  \\$wnnna$aPrivileges, Medical Staff
=450  \\$wnnna$aStaff Privilege, Medical
=450  \\$wnnna$aStaff Privileges, Medical
=550  \\$wg$aHospital-Physician Relations
=667  \\$aDF: MED STAFF PRIVILEGES
=680  \\$iThose rights or activities which are specific to members of the institution's medical staff, including the right to admit private patients.
=688  \\$a91(Aug 77); was see under MEDICAL STAFF, HOSPITAL 1977-90
=750  \0$aHospitals$xMedical staff$xClinical privileges$5IEN$0(DLC)sh 86005038

=LDR  00707cz  a2200217n  4500
=001  9880363729402441
=005  20141212203310.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008502
=035  \\$aCBA1751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x600
=072  \\$aN2.$x360.$x67.$x600
=150  \\$aMedical Secretaries
=450  \\$wnnna$aMedical Secretary
=450  \\$wnnna$aSecretaries, Medical
=450  \\$wnnna$aSecretary, Medical
=550  \\$wg$aAllied Health Personnel
=550  \\$wh$aMedical Receptionists
=680  \\$iIndividuals responsible for various duties pertaining to the medical office routine.
=750  \0$aMedical secretaries$5IEN$0(DLC)sh 85083026

=LDR  01709cz  a2200433n  4500
=001  9880363729502441
=005  20141212203309.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008499
=035  \\$aCBA1748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x968
=072  \\$aL1.$x280.$x900.$x968
=072  \\$aN4.$x452.$x859.$x564
=072  \\$aN5.$x715.$x360.$x300.$x715.$x500
=072  \\$aN6.$x850.$x520.$x308.$x940.$x968
=150  \\$aMedical Records
=450  \\$wnnna$aDiaries, Health
=450  \\$wnnna$aDiary, Health
=450  \\$aHealth Diaries
=450  \\$wnnna$aHealth Diary
=450  \\$wnnna$aMedical Record
=450  \\$aMedical Transcription
=450  \\$wnnna$aMedical Transcriptions
=450  \\$wnnna$aRecord, Medical
=450  \\$wnnna$aRecords, Medical
=450  \\$wnnna$aTranscription, Medical
=450  \\$wnnna$aTranscriptions, Medical
=550  \\$wg$aRecords as Topic
=550  \\$wh$aClinical Coding
=550  \\$wh$aHealth Records, Personal
=550  \\$wh$aMedical Record Linkage
=550  \\$wh$aMedical Records, Problem-Oriented
=550  \\$wh$aMedical Records Systems, Computerized
=550  \\$wh$aPatient Discharge Summaries
=550  \\$wh$aTrauma Severity Indices
=667  \\$aveterinary records = RECORDS AS TOPIC (IM) + VETERINARY MEDICINE (IM); case reports as a form of medical presentation goes here or specific RECORDS AS TOPIC term (IM); FORMS AND RECORDS CONTROL, also available, is probably NIM when coordinate; HEALTH RECORDS, PERSONAL is also available
=680  \\$iRecording of pertinent information concerning patient's illness or illnesses.
=750  \0$aMedical records$5IEN$0(DLC)sh 85083010

=LDR  01244cz  a2200301n  4500
=001  9880363729602441
=005  20141212192317.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008498
=035  \\$aCBA1747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x968.$x500
=072  \\$aL1.$x280.$x900.$x968.$x500
=072  \\$aN4.$x452.$x859.$x564.$x550
=072  \\$aN5.$x715.$x360.$x300.$x715.$x500.$x500
=072  \\$aN6.$x850.$x520.$x308.$x940.$x968.$x500
=150  \\$aMedical Record Linkage
=450  \\$wnnna$aLinkage, Medical Record
=450  \\$wnnna$aLinkages, Medical Record
=450  \\$wnnna$aMedical Record Linkages
=450  \\$aRecord Linkage, Medical
=450  \\$wnnna$aRecord Linkages, Medical
=550  \\$wg$aMedical Records
=550  \\$aElectronic Health Records
=667  \\$arecords in multiple institutions for combined use of a patient's records; IM; DF: MED RECORD LINKAGE
=680  \\$iThe creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals.
=688  \\$a91(75); was see under MEDICAL RECORDS 1975-90
=750  \0$aMedical record linkage$5IEN$0(DLC)sh 85083008

=LDR  01757cz  a2200409n  4500
=001  9880363729702441
=005  20141212203308.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008497
=035  \\$aCBA1746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x550
=072  \\$aN2.$x360.$x67.$x550
=150  \\$aMedical Record Administrators
=450  \\$wnnna$aAdministrator, Medical Record
=450  \\$wnnna$aAdministrators, Medical Record
=450  \\$wnnna$aLibrarian, Medical Record
=450  \\$wnnna$aLibrarians, Medical Record
=450  \\$wnnna$aMedical Record Administrator
=450  \\$wnnna$aMedical Record Librarian
=450  \\$wnnna$aMedical Record Librarians
=450  \\$aMedical Record Personnel$5IEN
=450  \\$wnnna$aMedical Record Technician
=450  \\$wnnna$aMedical Record Technicians
=450  \\$wnnna$aRecord Administrator, Medical
=450  \\$wnnna$aRecord Administrators, Medical
=450  \\$wnnna$aRecord Librarian, Medical
=450  \\$wnnna$aRecord Librarians, Medical
=450  \\$wnnna$aRecord Technician, Medical
=450  \\$wnnna$aRecord Technicians, Medical
=450  \\$wnnna$aTechnician, Medical Record
=450  \\$wnnna$aTechnicians, Medical Record
=550  \\$wg$aAllied Health Personnel
=667  \\$aincludes med rec librarians & med rec technicians
=680  \\$iIndividuals professionally qualified in the management of patients' records. Duties may include planning, designing, and managing systems for patient administrative and clinical data, as well as patient medical records. The concept includes medical record technicians.
=688  \\$a77; was MEDICAL RECORDS LIBRARIANS 1963-76
=750  \0$aMedical record personnel$5IEN$0(DLC)sh 85083009

=LDR  00797cz  a2200253n  4500
=001  9880363729802441
=005  20200618134918.0
=008  780509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008495
=035  \\$aCBA1744HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x429.$x515
=150  \\$aMedical Oncology
=450  \\$wnnna$aClinical Oncology
=450  \\$wnnna$aOncology, Clinical
=450  \\$aOncology, Medical
=550  \\$wg$aInternal Medicine
=550  \\$wh$aRadiation Oncology
=550  \\$wh$aPsycho-Oncology
=550  \\$wh$aSurgical Oncology
=667  \\$ause for the specialty only RADIATION ONCOLOGY is also available
=680  \\$iA subspecialty of internal medicine concerned with the study of neoplasms.
=688  \\$a79
=750  \0$aOncology$5IEN-M$0(DLC)sh 85094724

=LDR  00839cz  a2200241n  4500
=001  9880363729902441
=005  20141212203307.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008494
=035  \\$aCBA1743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x562
=150  \\$aMedical Office Buildings
=450  \\$wnnna$aBuilding, Medical Office
=450  \\$wnnna$aBuildings, Medical Office
=450  \\$wnnna$aMedical Office Building
=450  \\$wnnna$aOffice Building, Medical
=450  \\$aOffice Buildings, Medical
=550  \\$wg$aHealth Facilities
=667  \\$aDF: MED OFFICE BUILDINGS
=680  \\$iOffice and laboratory facilities constructed for the use of physicians and other health personnel.
=688  \\$a91(80); was see under HEALTH FACILITIES 1980-90
=750  \0$aMedical offices$5IEN$0(DLC)sh 85082978

=LDR  01721cz  a2200457n  4500
=001  9880363730102441
=005  20141212203306.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008490
=035  \\$aCBA1739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x313.$x500
=072  \\$aL1.$x700
=150  \\$aMedical Informatics
=450  \\$aClinical Informatics
=450  \\$wnnna$aComputer Science, Medical
=450  \\$wnnna$aHealth Information Technologies
=450  \\$wnnna$aHealth Information Technology
=450  \\$wnnna$aInformatics, Clinical
=450  \\$wnnna$aInformatics, Medical
=450  \\$wnnna$aInformation Science, Medical
=450  \\$wnnna$aInformation Technologies, Health
=450  \\$wnnna$aInformation Technology, Health
=450  \\$aMedical Computer Science
=450  \\$wnnna$aMedical Computer Sciences
=450  \\$aMedical Information Science
=450  \\$wnnna$aMedical Information Sciences
=450  \\$wnnna$aScience, Medical Computer
=450  \\$wnnna$aTechnologies, Health Information
=450  \\$wnnna$aTechnology, Health Information
=550  \\$wg$aInformatics
=550  \\$wg$aInformation Science
=550  \\$wh$aHealth Information Exchange
=550  \\$wh$aMedical Informatics Applications
=550  \\$wh$aMedical Informatics Computing
=550  \\$aAmerican Recovery and Reinvestment Act
=550  \\$aBiomedical Technology
=550  \\$aComputational Biology
=680  \\$iThe field of information science concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine.
=688  \\$a87
=750  \0$aMedical informatics$0(DLC) sh 89005069$5IEN-HS

=LDR  01278cz  a2200301n  4500
=001  9880363730202441
=005  20141212203306.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008488
=035  \\$aCBA1737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x385
=072  \\$aJ1.$x897.$x280.$x500.$x480
=072  \\$aK1.$x93.$x410
=072  \\$aL1.$x178.$x820.$x90.$x480
=150  \\$aMedical Illustration
=450  \\$aIllustration, Medical
=450  \\$wnnna$aIllustrations, Medical
=450  \\$wnnna$aMedical Illustrations
=550  \\$wg$aArt
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aHealth Occupations
=550  \\$wh$aAnatomy, Artistic
=550  \\$aArt
=667  \\$aMODELS, ANATOMIC is also available; anatomical atlases go here (IM) + ANATOMY, ARTISTIC (IM) if general; if specific coord IM with specific subject illustrated (IM) + illus medium (IM or NIM); DF: MED ILLUSTRATION
=680  \\$iThe field which deals with illustrative clarification of biomedical concepts, as in the use of diagrams and drawings. The illustration may be produced by hand, photography, computer, or other electronic or mechanical methods.
=750  \0$aMedical illustration$5IEN$0(DLC)sh 85082944
=750  \0$aMedical illustrators$5IEN-HS$0(DLC)sh 91002495

=LDR  00631cz  a2200217n  4500
=001  9880363730302441
=005  20141212203305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008487
=035  \\$aCBA1736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x510
=150  \\$aMedical History Taking
=450  \\$wnnna$aHistory Taking, Medical
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aCornell Medical Index
=550  \\$wh$aReproductive History
=550  \\$aMedical Records
=667  \\$aDF: MED HIST TAKING
=688  \\$a70(67)
=750  \0$aMedical history taking$5IEN$0(DLC)sh 85082943

=LDR  01122cz  a2200301n  4500
=001  9880363730402441
=005  20141212203305.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008486
=035  \\$aCBA1735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70.$x700
=072  \\$aM1.$x526.$x485.$x800
=072  \\$aN2.$x360.$x800
=150  \\$aPhysician Executives
=450  \\$wnnna$aDirector, Medical
=450  \\$wnnna$aDirectors, Medical
=450  \\$wnnna$aExecutive, Physician
=450  \\$wnnna$aExecutives, Physician
=450  \\$wnnna$aMedical Director
=450  \\$aMedical Directors
=450  \\$wnnna$aPhysician Executive
=550  \\$wg$aAdministrative Personnel
=550  \\$wg$aHealth Personnel
=667  \\$anote X ref MEDICAL DIRECTORS; DF: MED DIRECTORS
=680  \\$iPhysicians who serve in a medical and administrative capacity as head of an organized medical staff and who also may serve as liaison for the medical staff with the administration and governing board.
=688  \\$a97; was MEDICAL DIRECTORS 1978-96
=750  \0$aPhysician executives$5IEN-M$0(DLC)sh 92003676

=LDR  00802cz  a2200241n  4500
=001  9880363730502441
=005  20141212203305.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008485
=035  \\$aCBA1734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761.$x700.$x250.$x500
=072  \\$aN5.$x700.$x175.$x500
=150  \\$aMedical Audit
=450  \\$wnnna$aAudit, Medical
=450  \\$wnnna$aAudits, Medical
=450  \\$wnnna$aMedical Audits
=550  \\$wg$aClinical Audit
=550  \\$wh$aCommission on Professional and Hospital Activities
=667  \\$aDF: MED AUDIT
=680  \\$iA detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.
=688  \\$a68
=750  \0$aMedical audit$0sh 92006749$5IEN

=LDR  01410cz  a2200289n  4500
=001  9880363730602441
=005  20141212203304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008484
=035  \\$aCBA1733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x564.$x655
=072  \\$aN3.$x706.$x615.$x693
=150  \\$aMedicaid
=450  \\$aDental Medicaid Program
=450  \\$wnnna$aDental Medicaid Programs
=450  \\$wnnna$aMedicaid Program, Dental
=450  \\$wnnna$aMedicaid Programs, Dental
=450  \\$aMedical Assistance, Title 19
=450  \\$wnnna$aProgram, Dental Medicaid
=450  \\$wnnna$aPrograms, Dental Medicaid
=550  \\$wg$aLegislation as Topic
=550  \\$wg$aMedical Assistance
=667  \\$aspecify geog; Public Law 89-97
=680  \\$iFederal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons.
=688  \\$a91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73
=750  \0$aMedicaid$5IEN$0(DLC)sh 85082855

=LDR  00654cz  a2200217n  4500
=001  9880363730702441
=005  20141212203304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008483
=035  \\$aCBA1732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x564
=150  \\$aMedical Assistance
=450  \\$wnnna$aAssistance, Medical
=550  \\$wg$aPublic Assistance
=550  \\$wh$aMedicaid
=550  \\$wh$aMedicare
=667  \\$aspecify geog; DF: MED ASSISTANCE
=680  \\$iFinancing of medical care provided to public assistance recipients.
=688  \\$a68
=750  \0$aMedical assistance$5IEN$0(DLC)sh 85082862

=LDR  00452cz  a2200145n  4500
=001  9880363730802441
=005  20141212203304.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x923.$x761.$x800.$x500
=150  \\$aMediastinum
=550  \\$wg$aThoracic Cavity
=667  \\$aradiogr is probably PNEUMOMEDIASTINUM, DIAGNOSTIC; inflammation = MEDIASTINITIS
=750  \0$aMediastinum$5IEN$0(DLC)sh 85082838

=LDR  01339cz  a2200373n  4500
=001  9880363730902441
=005  20141212192316.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008481
=035  \\$aCBA1730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x560
=072  \\$aE4.$x502.$x250.$x560
=072  \\$aE4.$x928.$x490
=150  \\$aMediastinoscopy
=450  \\$wnnna$aMediastinoscopic Surgeries
=450  \\$wnnna$aMediastinoscopic Surgery
=450  \\$wnnna$aMediastinoscopic Surgical Procedure
=450  \\$aMediastinoscopic Surgical Procedures
=450  \\$wnnna$aMediastinoscopies
=450  \\$wnnna$aProcedure, Mediastinoscopic Surgical
=450  \\$wnnna$aProcedures, Mediastinoscopic Surgical
=450  \\$wnnna$aSurgeries, Mediastinoscopic
=450  \\$wnnna$aSurgery, Mediastinoscopic
=450  \\$wnnna$aSurgical Procedure, Mediastinoscopic
=450  \\$aSurgical Procedures, Mediastinoscopic
=550  \\$wg$aEndoscopy
=550  \\$wg$aThoracic Surgical Procedures
=550  \\$aMediastinoscopes
=550  \\$aMediastinum
=667  \\$a/ instrum permitted but consider also MEDIASTINOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.
=688  \\$a74
=750  \0$aMediastinoscopy$5IEN$0(DLC)sh 85082837

=LDR  01309cz  a2200397n  4500
=001  9880363731002441
=005  20141212203303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008479
=035  \\$aCBA1728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x894.$x479
=072  \\$aC8.$x846.$x187.$x580
=150  \\$aMediastinal Neoplasms
=450  \\$wnnna$aCancer, Mediastinal
=450  \\$wnnna$aCancer, Mediastinum
=450  \\$aCancer of Mediastinum
=450  \\$wnnna$aCancer of the Mediastinum
=450  \\$wnnna$aCancers, Mediastinal
=450  \\$wnnna$aCancers, Mediastinum
=450  \\$aMediastinal Cancer
=450  \\$wnnna$aMediastinal Cancers
=450  \\$wnnna$aMediastinal Neoplasm
=450  \\$wnnna$aMediastinum Cancer
=450  \\$wnnna$aMediastinum Cancers
=450  \\$wnnna$aMediastinum Neoplasm
=450  \\$wnnna$aMediastinum Neoplasms
=450  \\$wnnna$aNeoplasm, Mediastinal
=450  \\$wnnna$aNeoplasm, Mediastinum
=450  \\$wnnna$aNeoplasms, Mediastinal
=450  \\$wnnna$aNeoplasms, Mediastinum
=550  \\$wg$aMediastinal Diseases
=550  \\$wg$aThoracic Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the MEDIASTINUM.
=750  \0$aMediastinum$xTumors$5IEN-M$0(DLC)sh 85082845

=LDR  00869cz  a2200241n  4500
=001  9880363731102441
=005  20141212203303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008478
=035  \\$aCBA1727HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x846.$x187.$x290
=072  \\$aC23.$x550.$x325.$x250
=150  \\$aMediastinal Emphysema
=450  \\$aEmphysema, Mediastinal
=450  \\$wnnna$aEmphysemas, Mediastinal
=450  \\$wnnna$aMediastinal Emphysemas
=450  \\$aPneumomediastinum
=550  \\$wg$aEmphysema
=550  \\$wg$aMediastinal Diseases
=667  \\$ado not confuse with radiogr pneumomediastinum ( = PNEUMOMEDIASTINUM, DIAGNOSTIC)
=680  \\$iPresence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma.
=750  \0$aPneumomediastinum$5IEN$0(DLC)sh 85103623

=LDR  00804cz  a2200265n  4500
=001  9880363731202441
=005  20141212203303.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008477
=035  \\$aCBA1726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x846.$x187
=150  \\$aMediastinal Diseases
=450  \\$wnnna$aDisease, Mediastinal
=450  \\$wnnna$aDiseases, Mediastinal
=450  \\$wnnna$aMediastinal Disease
=550  \\$wg$aThoracic Diseases
=550  \\$wh$aMediastinal Cyst
=550  \\$wh$aMediastinal Emphysema
=550  \\$wh$aMediastinal Neoplasms
=550  \\$wh$aMediastinitis
=667  \\$ainflamm dis = MEDIASTINITIS
=680  \\$iDisorders of the mediastinum, general or unspecified.
=688  \\$a66
=750  \0$aMediastinum$xDiseases$5IEN$0(DLC)sh 85082841

=LDR  01720cz  a2200421n  4500
=001  9880363731302441
=005  20141212203302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008476
=035  \\$aCBA1725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x182.$x444
=072  \\$aC8.$x846.$x187.$x145
=150  \\$aMediastinal Cyst
=450  \\$wnnna$aCyst, Mediastinal
=450  \\$wnnna$aCyst, Pericardial
=450  \\$wnnna$aCyst, Thoracic
=450  \\$wnnna$aCyst, Thymic
=450  \\$wnnna$aCyst, Tracheal
=450  \\$wnnna$aCysts, Mediastinal
=450  \\$wnnna$aCysts, Pericardial
=450  \\$wnnna$aCysts, Thoracic
=450  \\$wnnna$aCysts, Thymic
=450  \\$wnnna$aCysts, Tracheal
=450  \\$wnnna$aMediastinal Cysts
=450  \\$aPericardial Cyst
=450  \\$wnnna$aPericardial Cysts
=450  \\$aThoracic Cyst
=450  \\$wnnna$aThoracic Cysts
=450  \\$aThymic Cyst
=450  \\$wnnna$aThymic Cysts
=450  \\$aTracheal Cyst
=450  \\$wnnna$aTracheal Cysts
=550  \\$wg$aCysts
=550  \\$wg$aMediastinal Diseases
=667  \\$anon-neoplastic; simple mediastinal cysts commonly adjacent to pericardium; note X refs: do not coord pericardial, thoracic, thymic or tracheal cysts with respective organs or organ/dis precoord: index only under MEDIASTINAL CYST
=680  \\$iCysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.
=750  \0$aMediastinum$xCysts$5IEN-M$0(IEN)369117

=LDR  00932cz  a2200205n  4500
=001  9880363731402441
=005  20141212203302.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008475
=035  \\$aCBA1724HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x50.$x500
=150  \\$aMedian Nerve
=450  \\$wnnna$aMedian Nerves
=450  \\$wnnna$aNerve, Median
=450  \\$wnnna$aNerves, Median
=550  \\$wg$aBrachial Plexus
=667  \\$adis = MEDIAN NEUROPATHY (IM); neopl = MEDIAN NEUROPATHY (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iA major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord (usually C6 to T1), travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand.
=750  \0$aMedian nerve$5IEN$0(DLC)sh 85082833

=LDR  01342cz  a2200337n  4500
=001  9880363731502441
=005  20141212203301.0
=008  870325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008471
=035  \\$aCBA1720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x520.$x687
=072  \\$aC8.$x618.$x580
=072  \\$aC13.$x703.$x277.$x785
=072  \\$aC16.$x300.$x580
=072  \\$aC16.$x614.$x580
=150  \\$aMeconium Aspiration Syndrome
=450  \\$wnnna$aAspiration, Meconium
=450  \\$wnnna$aAspiration Syndrome, Meconium
=450  \\$wnnna$aMeconium Aspiration
=450  \\$wnnna$aMeconium Inhalation
=450  \\$wnnna$aSyndrome, Meconium Aspiration
=550  \\$wg$aFetal Diseases
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aLung Injury
=550  \\$wg$aRespiration Disorders
=680  \\$iA condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.
=688  \\$a2006 (1988)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Meconium Aspiration
=688  \\$a88
=750  \0$aMeconium aspiration syndrome$0(DLC) sh 89006255$5IEN

=LDR  00773cz  a2200205n  4500
=001  9880363731602441
=005  20141212203300.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008470
=035  \\$aCBA1719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x459.$x529
=072  \\$aA16.$x378.$x529
=150  \\$aMeconium
=450  \\$wnnna$aMeconiums
=550  \\$wg$aFeces
=550  \\$wg$aFetus
=667  \\$acheck the tag INFANT, NEWBORN
=680  \\$iThe thick green-to-black mucilaginous material found in the intestines of a full-term fetus. It consists of secretions of the INTESTINAL GLANDS; BILE PIGMENTS; FATTY ACIDS; AMNIOTIC FLUID; and intrauterine debris. It constitutes the first stools passed by a newborn.
=750  \0$aMeconium$5IEN$0(DLC)sh 85082793

=LDR  02795cz  a2200649n  4500
=001  9880363731702441
=005  20141212192315.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008465
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x750
=072  \\$aA8.$x800.$x950.$x750
=072  \\$aA11.$x671.$x650.$x915.$x750
=150  \\$aMechanoreceptors
=450  \\$wnnna$aBulbs, Krause's End
=450  \\$wnnna$aCell, Mechanoreceptor
=450  \\$wnnna$aCells, Mechanoreceptor
=450  \\$wnnna$aCorpuscle, Meissner's
=450  \\$wnnna$aCorpuscles, Ruffini's
=450  \\$wnnna$aEnd Bulbs, Krause's
=450  \\$aGolgi Tendon Organs
=450  \\$wnnna$aKrause End Bulbs
=450  \\$aKrause's End Bulbs
=450  \\$wnnna$aKrauses End Bulbs
=450  \\$wnnna$aMechanoreceptor
=450  \\$wnnna$aMechanoreceptor Cell
=450  \\$wnnna$aMechanoreceptor Cells
=450  \\$wnnna$aMeissner Corpuscle
=450  \\$aMeissner's Corpuscle
=450  \\$wnnna$aMeissners Corpuscle
=450  \\$wnnna$aNeurotendinous Spindle
=450  \\$aNeurotendinous Spindles
=450  \\$wnnna$aOrgans, Golgi Tendon
=450  \\$wnnna$aReceptor, Stretch
=450  \\$aReceptors, Stretch
=450  \\$wnnna$aRuffini Corpuscles
=450  \\$aRuffini's Corpuscles
=450  \\$wnnna$aRuffinis Corpuscles
=450  \\$wnnna$aSpindle, Neurotendinous
=450  \\$wnnna$aSpindles, Neurotendinous
=450  \\$wnnna$aStretch Receptor
=450  \\$aStretch Receptors
=450  \\$wnnna$aTendon Organs, Golgi
=550  \\$wg$aSensory Receptor Cells
=550  \\$wh$aGolgi-Mazzoni Corpuscles
=550  \\$wh$aMerkel Cells
=550  \\$wh$aMuscle Spindles
=550  \\$wh$aNeuroepithelial Cells
=550  \\$wh$aPacinian Corpuscles
=550  \\$wh$aPressoreceptors
=550  \\$wh$aPulmonary Stretch Receptors
=550  \\$aMechanotransduction, Cellular
=550  \\$aSensilla
=667  \\$aDF: MECHANORECEPT
=680  \\$iCells specialized to transduce mechanical stimuli and relay that information centrally in the nervous system. Mechanoreceptor cells include the INNER EAR hair cells, which mediate hearing and balance, and the various somatosensory receptors, often with non-neural accessory structures.
=688  \\$a71; NEUROTENDINOUS SPINDLES was heading 1975-96 (see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76), was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE'S END BULBS & RUFFINI'S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71
=750  \0$aMechanoreceptors$5IEN$0(DLC)sh 85082782

=LDR  00789cz  a2200241n  4500
=001  9880363731802441
=005  20141212203257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008462
=035  \\$aCBA1711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x700
=150  \\$aMeat-Packing Industry
=450  \\$wnnna$aIndustries, Meat-Packing
=450  \\$wnnna$aIndustry, Meat-Packing
=450  \\$wnnna$aIndustry, Meat Packing
=450  \\$wnnna$aMeat-Packing Industries
=450  \\$wnnna$aMeat Packing Industry
=550  \\$wg$aFood Handling
=550  \\$wh$aAbattoirs
=667  \\$aSPEC: SPEC qualif; DF: MEAT PACKING INDUST
=680  \\$iThe aggregate enterprise of technically producing packaged meat.
=750  \0$aPacking-houses$5IEN$0(DLC)sh 85096532

=LDR  00970cz  a2200229n  4500
=001  9880363731902441
=005  20170927170613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008460
=035  \\$aCBA1709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x600
=150  \\$aMeat
=450  \\$wnnna$aMeats
=550  \\$wg$aFood
=550  \\$wh$aMeat Products
=550  \\$wh$aPoultry
=550  \\$wh$aRed Meat
=550  \\$wh$aSeafood
=667  \\$acoordinate IM with animal source of meat (NIM), as beef = MEAT (IM) + CATTLE (NIM), pork = MEAT (IM) + SWINE (NIM): canned meat = MEAT (IM) + source (NIM) + FOOD, CANNED see FOOD, PRESERVED (IM); note MEAT PRODUCTS; FISH PRODUCTS & POULTRY PRODUCTS are available: see notes there
=680  \\$iThe edible portions of any animal used for food including domestic mammals (the major ones being cattle, swine, and sheep) along with poultry, fish, shellfish, and game.
=750  \0$aMeat$5IEN$0(DLC)sh 85082715

=LDR  00805cz  a2200205n  4500
=001  9880363732002441
=005  20141212203257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008459
=035  \\$aCBA1708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x455.$x600.$x650.$x500.$x500
=072  \\$aB4.$x909.$x777.$x455.$x600.$x650.$x500.$x500
=150  \\$aMeasles virus
=450  \\$aEdmonston virus
=550  \\$wg$aMorbillivirus
=550  \\$wh$aSSPE Virus
=667  \\$a"morbilli virus" sometimes refers to the MEASLES VIRUS & sometimes to the genus Morbillivirus: check text; infection = MEASLES
=680  \\$iThe type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.
=750  \0$aMeasles virus$5IEN$0(DLC)sh 85082699

=LDR  00876cz  a2200193n  4500
=001  9880363732102441
=005  20141212203257.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008458
=035  \\$aCBA1707HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x404
=150  \\$aMeasles Vaccine
=450  \\$wnnna$aVaccine, Measles
=550  \\$wg$aViral Vaccines
=550  \\$wh$aMeasles-Mumps-Rubella Vaccine
=680  \\$iA live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)
=688  \\$a64
=750  \0$aMeasles vaccine$5IEN$0(DLC)sh 85082698

=LDR  00784cz  a2200217n  4500
=001  9880363832702441
=005  20141212205006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011616
=035  \\$aCBA4912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x766
=150  \\$aPsychotherapy, Multiple
=450  \\$wnnna$aMultiple Psychotherapies
=450  \\$wnnna$aMultiple Psychotherapy
=450  \\$wnnna$aPsychotherapies, Multiple
=550  \\$wg$aPsychotherapy
=667  \\$adifferentiate from group: multiple = more than one therapist, group = more than one patient; DF: PSYCHOTHER MULTIPLE
=680  \\$iThe use of more than one therapist at one time in individual or group psychotherapy.
=688  \\$a73
=750  \0$aMultiple psychotherapy$5IEN$0(DLC)sh 85088371

=LDR  01052cz  a2200265n  4500
=001  9880363832802441
=005  20141212205006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011615
=035  \\$aCBA4911HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x864.$x581
=150  \\$aPsychotherapy, Group
=450  \\$wnnna$aGroup Psychotherapy
=450  \\$aGroup Therapy
=450  \\$wnnna$aTherapy, Group
=550  \\$wg$aSocioenvironmental Therapy
=550  \\$wh$aCouples Therapy
=550  \\$wh$aFamily Therapy
=550  \\$wh$aMarital Therapy
=550  \\$wh$aPsychodrama
=550  \\$wh$aSensitivity Training Groups
=667  \\$adifferentiate from multiple: group = more than one patient, multiple = more than one therapist; DF: PSYCHOTHER GROUP
=680  \\$iA form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments, and psychotic states.
=750  \0$aGroup psychotherapy$5IEN$0(DLC)sh 85057493

=LDR  01006cz  a2200289n  4500
=001  9880363832902441
=005  20141212205006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011614
=035  \\$aCBA4910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x738
=150  \\$aPsychotherapy, Brief
=450  \\$wnnna$aBrief Psychotherapies
=450  \\$wnnna$aBrief Psychotherapy
=450  \\$wnnna$aPsychotherapies, Brief
=450  \\$wnnna$aPsychotherapies, Short-Term
=450  \\$wnnna$aPsychotherapy, Short-Term
=450  \\$wnnna$aPsychotherapy, Short Term
=450  \\$wnnna$aShort-Term Psychotherapies
=450  \\$aShort-Term Psychotherapy
=450  \\$wnnna$aShort Term Psychotherapy
=550  \\$wg$aPsychotherapy
=667  \\$aDF: PSYCHOTHER BRIEF
=680  \\$iAny form of psychotherapy designed to produce therapeutic change within a minimal amount of time, generally not more than 20 sessions.
=688  \\$a73
=750  \0$aBrief psychotherapy$5IEN$0(DLC)sh 85108524

=LDR  02227cz   2200661n  4500
=001  9880363833002441
=005  20220810160250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011613
=035  \\$aCBA4909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754
=150  \\$aPsychotherapy
=450  \\$wnnna$aClinical Psychotherapist
=450  \\$wnnna$aClinical Psychotherapists
=450  \\$wnnna$aLogotherapies
=450  \\$wnnna$aLogotherapy
=450  \\$wnnna$aPsychotherapies
=450  \\$wnnna$aPsychotherapist
=450  \\$wnnna$aPsychotherapist, Clinical
=450  \\$wnnna$aPsychotherapists
=450  \\$wnnna$aPsychotherapists, Clinical
=450  \\$aPsychotherapy Patients$5IEN
=550  \\$wg$aBehavioral Disciplines and Activities
=550  \\$wh$aAnimal Assisted Therapy
=550  \\$wh$aAromatherapy
=550  \\$wh$aArt Therapy
=550  \\$wh$aAutogenic Training
=550  \\$wh$aBehavior Therapy
=550  \\$wh$aBibliotherapy
=550  \\$wh$aColor Therapy
=550  \\$wh$aCrisis Intervention
=550  \\$wh$aDance Therapy
=550  \\$wh$aEmotion-Focused Therapy
=550  \\$wh$aFeedback, Psychological
=550  \\$wh$aFeedback, Sensory
=550  \\$wh$aGestalt Therapy
=550  \\$wh$aHorticultural Therapy
=550  \\$wh$aHypnosis
=550  \\$wh$aImagery (Psychotherapy)
=550  \\$wh$aMusic Therapy
=550  \\$wh$aNarrative Therapy
=550  \\$wh$aPerson-Centered Therapy
=550  \\$wh$aPlay Therapy
=550  \\$wh$aPsychoanalytic Therapy
=550  \\$wh$aPsychotherapeutic Processes
=550  \\$wh$aPsychotherapy, Brief
=550  \\$wh$aPsychotherapy, Multiple
=550  \\$wh$aPsychotherapy, Psychodynamic
=550  \\$wh$aPsychotherapy, Rational-Emotive
=550  \\$wh$aReality Therapy
=550  \\$wh$aSocioenvironmental Therapy
=550  \\$wh$aTherapeutic Alliance
=550  \\$aNeurolinguistic Programming
=550  \\$aSensory Art Therapies
=680  \\$iA generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.
=750  \0$aPsychotherapy patients$0(DLC) sh 85108526$5IEN-M
=750  \0$aPsychotherapy$0(DLC) sh 85108516$5IEN-M

=LDR  01091cz  a2200337n  4500
=001  9880363833102441
=005  20141212205005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011612
=035  \\$aCBA4908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x600
=072  \\$aF4.$x570.$x630
=150  \\$aPsychosurgery
=450  \\$wnnna$aGyrectomies
=450  \\$aGyrectomy
=450  \\$wnnna$aLeucotomies
=450  \\$aLeucotomy
=450  \\$wnnna$aLeukotomies
=450  \\$aLeukotomy
=450  \\$wnnna$aLobotomies
=450  \\$aLobotomy
=450  \\$wnnna$aPsychosurgeries
=450  \\$wnnna$aTopectomies
=450  \\$aTopectomy
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wg$aPsychiatric Somatic Therapies
=550  \\$aBrain
=667  \\$acoord IM with specific lobe /surg (NIM); DF: PSYCHOSURG
=680  \\$iTreatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes.
=750  \0$aPsychosurgery$5IEN$0(DLC)sh 85108505

=LDR  00875cz  a2200193n  4500
=001  9880363833202441
=005  20141212205005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011611
=035  \\$aCBA4907HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x830
=150  \\$aPsychosomatic Medicine
=450  \\$wnnna$aMedicine, Psychosomatic
=550  \\$wg$aPsychiatry
=550  \\$aPsychophysiology
=667  \\$aSPEC: SPEC qualif; differentiate from PSYCHOPHYSIOLOGIC DISORDERS, the patient; MIND-BODY RELATIONS (PHYSIOLOGY) see PSYCHOPHYSIOLOGY is available; also Manual 27.12; DF: PSYCHOSOMATIC MED
=680  \\$iA system of medicine which aims at discovering the exact nature of the relationship between the emotions and bodily function, affirming the principle that the mind and body are one.
=750  \0$aMedicine, Psychosomatic$5IEN$0(DLC)sh 85083173

=LDR  00844cz  a2200241n  4500
=001  9880363833302441
=005  20141212192452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011610
=035  \\$aCBA4906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x628
=072  \\$aI1.$x880.$x853.$x100.$x806
=150  \\$aPsychosocial Deprivation
=450  \\$wnnna$aDeprivation, Psychosocial
=450  \\$wnnna$aDeprivations, Psychosocial
=450  \\$wnnna$aPsychosocial Deprivations
=550  \\$wg$aCulture
=550  \\$wg$aPsychology, Social
=667  \\$ano qualif
=680  \\$iThe absence of appropriate stimuli in the physical or social environment which are necessary for the emotional, social, and intellectual development of the individual.
=688  \\$a72(69)
=750  \0$aEmotional deprivation$5IEN$0(DLC)sh 91004289

=LDR  01445cz  a2200385n  4500
=001  9880363833402441
=005  20201207170721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011606
=035  \\$aCBA4902HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x722
=072  \\$aF2.$x739.$x794.$x793
=150  \\$aPsychosexual Development
=450  \\$aAnal Stage
=450  \\$wnnna$aAnal Stages
=450  \\$wnnna$aDevelopment, Psychosexual
=450  \\$wnnna$aDevelopments, Psychosexual
=450  \\$aPhallic Stage
=450  \\$wnnna$aPhallic Stages
=450  \\$wnnna$aPsychosexual Developments
=450  \\$wnnna$aStage, Anal
=450  \\$wnnna$aStage, Phallic
=450  \\$wnnna$aStages, Anal
=450  \\$wnnna$aStages, Phallic
=550  \\$wg$aPersonality Development
=550  \\$wg$aPsychoanalytic Theory
=550  \\$wh$aGender Identity
=550  \\$wh$aLatency Period, Psychological
=550  \\$wh$aOral Stage
=550  \\$aSex
=550  \\$aSexuality
=680  \\$iThe stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods.
=688  \\$a68; ANAL STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90); was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 (see under PSYCHOSEXUAL DEVELOPMENT 1975-90)
=750  \0$aPsychosexual development$5IEN$0(DLC)sh 87005879

=LDR  01192cz  a2200349n  4500
=001  9880363833502441
=005  20141212205004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011605
=035  \\$aCBA4901HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x809
=072  \\$aC25.$x775.$x746
=072  \\$aF3.$x700.$x675.$x600
=072  \\$aF3.$x900.$x746
=150  \\$aPsychoses, Substance-Induced
=450  \\$wnnna$aDrug Psychoses
=450  \\$aPsychoses, Drug
=450  \\$wnnna$aPsychoses, Substance Induced
=450  \\$aPsychoses, Toxic
=450  \\$aPsychotic Disorders$xchemically induced
=450  \\$wnnna$aSubstance-Induced Psychoses
=450  \\$wnnna$aSubstance Induced Psychoses
=450  \\$wnnna$aToxic Psychoses
=550  \\$wg$aPoisoning
=550  \\$wg$aPsychotic Disorders
=550  \\$wg$aSubstance-Related Disorders
=550  \\$wh$aPsychoses, Alcoholic
=667  \\$aPSYCHOSES, ALCOHOLIC is available
=680  \\$iPsychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
=688  \\$a81; was PSYCHOSES, TOXIC 1963-80
=750  \0$aToxic psychoses$5IEN$0(DLC)sh 85136324

=LDR  00894cz  a2200265n  4500
=001  9880363833602441
=005  20141212205004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011604
=035  \\$aCBA4900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x809.$x750
=072  \\$aC25.$x775.$x100.$x87.$x750
=072  \\$aF3.$x700.$x675.$x600.$x750
=072  \\$aF3.$x900.$x100.$x750
=150  \\$aPsychoses, Alcoholic
=450  \\$wnnna$aAlcoholic Psychoses
=550  \\$wg$aAlcohol-Induced Disorders
=550  \\$wg$aAlcohol-Related Disorders
=550  \\$wg$aPsychoses, Substance-Induced
=550  \\$aAlcohol-Related Disorders
=550  \\$aAlcoholism
=550  \\$aSubstance-Related Disorders
=680  \\$iA group of mental disorders associated with organic brain damage and caused by poisoning from alcohol.
=750  \0$aAlcoholic psychoses$5IEN$0(DLC)sh 85003286

=LDR  02666cz  a2200685n  4500
=001  9880363833702441
=005  20141212205003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011603
=035  \\$aCBA4899HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x812
=072  \\$aF2.$x830
=072  \\$aF4.$x96.$x795
=072  \\$aH1.$x158.$x782.$x795
=150  \\$aPsychophysiology
=450  \\$wnnna$aMind-Body Relation (Physiology)
=450  \\$aMind-Body Relations (Physiology)
=450  \\$wnnna$aMind Body Relations (Physiology)
=450  \\$wnnna$aMind-Body Relationship (Physiology)
=450  \\$wnnna$aMind Body Relationship (Physiology)
=450  \\$wnnna$aMind-Body Relationships (Physiology)
=450  \\$wnnna$aPhysiologic Psychologies
=450  \\$wnnna$aPhysiologic Psychology
=450  \\$wnnna$aPhysiological Psychology
=450  \\$wnnna$aPsychologies, Physiologic
=450  \\$wnnna$aPsychology, Physiologic
=450  \\$aPsychology, Physiological
=450  \\$wnnna$aRelation, Mind-Body (Physiology)
=450  \\$wnnna$aRelations, Mind-Body (Physiology)
=450  \\$wnnna$aRelationship, Mind-Body (Physiology)
=450  \\$wnnna$aRelationships, Mind-Body (Physiology)
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aMind-Body Therapies
=550  \\$wg$aPhysiology
=550  \\$wg$aPsychological Phenomena and Processes
=550  \\$wh$aAppetite
=550  \\$wh$aArousal
=550  \\$wh$aBiofeedback, Psychology
=550  \\$wh$aBlushing
=550  \\$wh$aConsciousness
=550  \\$wh$aDominance, Cerebral
=550  \\$wh$aHabituation, Psychophysiologic
=550  \\$wh$aLie Detection
=550  \\$wh$aNeuropsychology
=550  \\$wh$aOrientation
=550  \\$wh$aPsychoneuroimmunology
=550  \\$wh$aReaction Time
=550  \\$wh$aReflex
=550  \\$wh$aSatiation
=550  \\$wh$aSelf Stimulation
=550  \\$wh$aSensation
=550  \\$wh$aSleep
=550  \\$wh$aStress, Psychological
=550  \\$aMind-Body Relations, Metaphysical
=550  \\$aPsychosomatic Medicine
=667  \\$aIM for the discipline (education, history, etc); NIM as a coordinate in psychophysiological studies; use / physiol with behavior and psychological phenomena terms & / psychol with diseases & mental disorder terms; do not confuse entry term MIND-BODY RELATIONS (PHYSIOLOGY) with MIND-BODY RELATIONS, METAPHYSICAL; Manual 27.12
=680  \\$iThe study of the physiological basis of human and animal behavior.
=688  \\$aMIND-BODY RELATIONS (PHYSIOLOGY) was MIND-BODY RELATIONS see PSYCHOPHYSIOLOGY 1996
=750  \0$aPsychophysiology$5IEN$0(DLC)sh 85108484

=LDR  01098cz  a2200253n  4500
=001  9880363833802441
=005  20141212205002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011602
=035  \\$aCBA4898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x592.$x700
=150  \\$aPsychophysiologic Disorders
=450  \\$wnnna$aPsychophysiologic Disorder
=450  \\$wnnna$aPsychophysiological Disorder
=450  \\$wnnna$aPsychophysiological Disorders
=450  \\$wnnna$aPsychosomatic Disorder
=450  \\$aPsychosomatic Disorders
=550  \\$wg$aNeurologic Manifestations
=550  \\$aPsychosomatic Medicine
=667  \\$adifferentiate from PSYCHOSOMATIC MEDICINE which is the field; coord IM with specific dis /psychol (IM); Manual 27.12; DF: PSYCHOPHYSIOL DIS
=680  \\$iA group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)
=688  \\$a68
=750  \0$aMedicine, Psychosomatic$5IEN$0(DLC)sh 85083173

=LDR  01379cz  a2200385n  4500
=001  9880363833902441
=005  20190311105058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011422
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x583
=072  \\$aD2.$x491.$x485
=072  \\$aD12.$x125.$x72.$x401
=150  \\$aPropionates
=450  \\$wnnna$aAcids, Propanoic
=450  \\$wnnna$aAcids, Propionic
=450  \\$wnnna$aDerivatives, Propanoic Acid
=450  \\$wnnna$aDerivatives, Propionic Acid
=450  \\$wnnna$aPropanoates
=450  \\$wnnna$aPropanoic Acid Derivatives
=450  \\$wnnna$aPropanoic Acids
=450  \\$wnnna$aPropionic Acid Derivatives
=450  \\$wnnna$aPropionic Acids
=550  \\$wg$aAcids, Acyclic
=550  \\$wg$aFatty Acids, Volatile
=550  \\$wh$a3-Mercaptopropionic Acid
=550  \\$wh$aDextropropoxyphene
=550  \\$wh$aFlurbiprofen
=550  \\$wh$aLevopropoxyphene
=550  \\$wh$aNafenopin
=667  \\$a/blood: consider also PROPIONIC ACIDEMIA
=680  \\$iDerivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure.
=688  \\$a1966
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20130903: 150:##:_{dollar}a Propionic Acids
=750  \0$aPropionates$0(DLC) sh 85107534$5IEN

=LDR  01079cz  a2200385n  4500
=001  9880363834002441
=005  20141212204856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011412
=035  \\$aCBA4706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624
=072  \\$aD2.$x33.$x755.$x624
=072  \\$aD2.$x92.$x63.$x624
=150  \\$aPropanolamines
=450  \\$aAminopropanols
=450  \\$aToliprolol$5IEN-M
=550  \\$wg$aAmino Alcohols
=550  \\$wg$aPropanols
=550  \\$wh$aEphedrine
=550  \\$wh$aHistidinol
=550  \\$wh$aIsoxsuprine
=550  \\$wh$aMethoxamine
=550  \\$wh$aMetoprolol
=550  \\$wh$aNylidrin
=550  \\$wh$aOxyfedrine
=550  \\$wh$aPhenoxypropanolamines
=550  \\$wh$aPhenylpropanolamine
=550  \\$wh$aPseudoephedrine
=550  \\$wh$aRitodrine
=550  \\$wh$aSuloctidil
=550  \\$wh$aTimolol
=680  \\$iAMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.
=688  \\$a74
=750  \0$aPropanolamines$5IEN-M$0(DLC)sh 94005221

=LDR  00385cz  a2200157n  4500
=001  9880363834102441
=005  20141212204855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011407
=035  \\$aCBA4701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x800
=150  \\$aPropane
=550  \\$wg$aAlkanes
=688  \\$a73
=750  \0$aPropane$5IEN$0(DLC)sh 85107478

=LDR  00605cz  a2200193n  4500
=001  9880363834202441
=005  20141212204855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011406
=035  \\$aCBA4700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x790
=150  \\$aPropaganda
=550  \\$wg$aCommunication
=550  \\$aPersuasive Communication
=550  \\$aPsychological Warfare
=667  \\$ano qualif
=680  \\$iThe deliberate attempt to influence attitudes and beliefs for furthering one's cause or damaging an opponent's cause.
=750  \0$aPropaganda$5IEN$0(DLC)sh 85107443

=LDR  02332cz  a2200649n  4500
=001  9880363834302441
=005  20141212204855.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011405
=035  \\$aCBA4699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522.$x818.$x830
=150  \\$aPropafenone
=450  \\$wnnna$aAbbott Brand of Propafenone Hydrochloride
=450  \\$wnnna$aAliud Brand of Propafenone Hydrochloride
=450  \\$wnnna$aAlpharma Brand of Propafenone Hydrochloride
=450  \\$wnnna$aApo-Propafenone
=450  \\$wnnna$aApotex Brand of Propafenone Hydrochloride
=450  \\$wnnna$aArythmol
=450  \\$wnnna$aAzupharma Brand of Propafenone Hydrochloride
=450  \\$wnnna$aBaxarytmon
=450  \\$wnnna$aCuxafenon
=450  \\$wnnna$aFenoprain
=450  \\$wnnna$aHexal Brand of Propafenone
=450  \\$wnnna$aHydrochloride, Propafenone
=450  \\$wnnna$aJuta Brand of Propafenone Hydrochloride
=450  \\$wnnna$aJutanorm
=450  \\$wnnna$aKendrick Brand of Propafenone Hydrochloride
=450  \\$wnnna$aKnoll Brand of Propafenone Hydrochloride
=450  \\$wnnna$aMerck dura Brand of Propafenone Hydrochloride
=450  \\$wnnna$aNistaken
=450  \\$wnnna$aNorfenon
=450  \\$wnnna$aPintoform
=450  \\$wnnna$aProlecofen
=450  \\$wnnna$aPropafenon AL
=450  \\$wnnna$aPropafenon Hexal
=450  \\$wnnna$aPropafenon Minden
=450  \\$wnnna$aPropafenone, (+-)-Isomer
=450  \\$wnnna$aPropafenone Hydrochloride
=450  \\$wnnna$aPropafenone Hydrochloride, (R)-Isomer
=450  \\$wnnna$aPropafenone Hydrochloride, (S)-Isomer
=450  \\$wnnna$aPropafenone, (R)-Isomer
=450  \\$wnnna$aPropafenone, (S)-Isomer
=450  \\$wnnna$aPropamerck
=450  \\$wnnna$aQ-Pharm Brand of Propafenone Hydrochloride
=450  \\$wnnna$aRythmol
=450  \\$wnnna$aRytmo-Puren
=450  \\$wnnna$aRytmogenat
=450  \\$wnnna$aRytmonorm
=450  \\$wnnna$aSA-79
=450  \\$wnnna$aSA 79
=450  \\$wnnna$aSA79
=450  \\$wnnna$aTAD Brand of Propafenone Hydrochloride
=550  \\$wg$aPropiophenones
=680  \\$iAn antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
=688  \\$a87
=750  \0$aPropafenone$5IEN$0(DLC)sh 85107442

=LDR  02925cz  a2200721n  4500
=001  9880363834402441
=005  20141212204853.0
=008  840417\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x570.$x80.$x689.$x675
=072  \\$aG5.$x360.$x80.$x689.$x675
=072  \\$aG5.$x360.$x340.$x24.$x340.$x137.$x750.$x680
=150  \\$aPromoter Regions, Genetic
=450  \\$wnnna$aEarly Promoter, Genetic
=450  \\$wnnna$aEarly Promoters, Genetic
=450  \\$wnnna$aGenetic Late Promoter
=450  \\$wnnna$aGenetic Middle Promoters
=450  \\$wnnna$aGenetic Promoter
=450  \\$wnnna$aGenetic Promoter Region
=450  \\$wnnna$aGenetic Promoter Regions
=450  \\$wnnna$aGenetic Promoters
=450  \\$wnnna$aGenetic Promotor
=450  \\$wnnna$aGenetic Promotors
=450  \\$wnnna$aGenetic Pseudopromoter
=450  \\$wnnna$aGenetic Pseudopromoters
=450  \\$wnnna$aLate Promoter, Genetic
=450  \\$wnnna$aLate Promoters, Genetic
=450  \\$wnnna$aMiddle Promoter, Genetic
=450  \\$wnnna$aMiddle Promoters, Genetic
=450  \\$wnnna$aPromoter, Genetic
=450  \\$wnnna$aPromoter, Genetic Early
=450  \\$wnnna$aPromoter Region
=450  \\$wnnna$aPromoter Region, Genetic
=450  \\$wnnna$aPromoter Regions
=450  \\$wnnoa$aPromoter Regions (Genetics)$5IEN-M
=450  \\$wnnna$aPromoter, rRNA
=450  \\$wnnna$aPromoters, Genetic
=450  \\$wnnna$aPromoters, Genetic Middle
=450  \\$wnnna$aPromoters, rRNA
=450  \\$wnnna$aPromotor, Genetic
=450  \\$wnnna$aPromotor Region
=450  \\$wnnna$aPromotor Regions
=450  \\$wnnna$aPromotors, Genetic
=450  \\$wnnna$aPseudopromoter, Genetic
=450  \\$wnnna$aPseudopromoters, Genetic
=450  \\$wnnna$aRegion, Genetic Promoter
=450  \\$wnnna$aRegion, Promoter
=450  \\$wnnna$aRegion, Promotor
=450  \\$wnnna$aRegions, Genetic Promoter
=450  \\$wnnna$aRegions, Promoter
=450  \\$wnnna$aRegions, Promotor
=450  \\$arRNA Promoter
=450  \\$wnnna$arRNA Promoters
=550  \\$wg$aRegulatory Elements, Transcriptional
=550  \\$wg$aRegulatory Sequences, Nucleic Acid
=550  \\$wh$aResponse Elements
=550  \\$wh$aTATA Box
=680  \\$iDNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
=688  \\$a2009 (1985); for PROMOTER, GENETIC use OPERON 1980-1984; for rRNA PROMOTER use rRNA OPERON 1990-1998
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Promoter Regions (Genetics)
=688  \\$a85; for rRNA PROMOTER use rRNA OPERON 1990-98; for PROMOTER (GENETICS) use OPERON 1980-84
=750  \0$aPromoters (Genetics)$0(DLC) sh 85107419$5IEN

=LDR  00924cz  a2200217n  4500
=001  9880363834502441
=005  20141212204852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011399
=035  \\$aCBA4693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x720
=072  \\$aD1.$x268.$x477.$x875
=072  \\$aD1.$x268.$x558.$x362.$x875
=072  \\$aD1.$x552.$x550.$x399.$x875
=150  \\$aPromethium
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aLanthanoid Series Elements
=667  \\$anaturally radioactive; a rare earth metal; IM
=680  \\$iPromethium. A radioactive element of the rare earth family of metals. It has the atomic symbol Pm, atomic number 61, and atomic weight 147. It has been used in the construction of atomic batteries, in the preparation of self-luminous compounds, and as a beta-particle source for thickness gauges.
=750  \0$aPromethium$5IEN$0(DLC)sh 85107404

=LDR  01296cz  a2200409n  4500
=001  9880363834602441
=005  20141212204852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011398
=035  \\$aCBA4692M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x831.$x690
=072  \\$aD2.$x886.$x369.$x670
=072  \\$aD3.$x494.$x741.$x670
=150  \\$aPromethazine
=450  \\$wnnna$aAtosil
=450  \\$wnnna$aDiphergan
=450  \\$wnnna$aDiprazin
=450  \\$wnnna$aHydrochloride, Promethazine
=450  \\$wnnna$aIsopromethazine
=450  \\$wnnna$aPhenargan
=450  \\$wnnna$aPhenergan
=450  \\$wnnna$aPhensedyl
=450  \\$wnnna$aPipolfen
=450  \\$wnnna$aPipolphen
=450  \\$aProazamine
=450  \\$wnnna$aPromet
=450  \\$wnnna$aPrometazin
=450  \\$wnnna$aPromethazine Hydrochloride
=450  \\$wnnna$aProthazin
=450  \\$wnnna$aPyrethia
=450  \\$wnnna$aRemsed
=450  \\$wnnna$aRumergan
=550  \\$wg$aPhenothiazines
=550  \\$wg$aPropylamines
=680  \\$iA phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
=750  \0$aPromethazine$0(DLC)sh2007005455$5IEN-M

=LDR  00764cz  a2200229n  4500
=001  9880363834702441
=005  20141212204850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011392
=035  \\$aCBA4686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x401.$x623
=150  \\$aProline
=450  \\$wnnna$aL-Proline
=450  \\$wnnna$aL Proline
=550  \\$wg$aImino Acids
=550  \\$wh$aCaptopril
=550  \\$wh$aFosinopril
=550  \\$wh$aHydroxyproline
=667  \\$a/biosyn /defic /physiol permitted
=680  \\$iA non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons.
=750  \0$aProline$5IEN$0(DLC)sh 85107396

=LDR  02298cz  a2200565n  4500
=001  9880363834802441
=005  20141212210904.0
=008  880413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015175
=035  \\$aCBA4684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x35.$x625
=072  \\$aC4.$x588.$x322.$x609.$x792
=072  \\$aC10.$x228.$x140.$x617.$x738.$x675.$x800
=072  \\$aC19.$x344.$x609.$x792
=072  \\$aC19.$x700.$x734.$x792
=150  \\$aProlactinoma
=450  \\$wnnna$aAdenoma, Lactotroph
=450  \\$aAdenoma, Prolactin-Secreting, Pituitary
=450  \\$wnnna$aAdenomas, Lactotroph
=450  \\$wnnna$aLactotroph Adenoma
=450  \\$wnnna$aLactotroph Adenomas
=450  \\$wnnna$aMacroprolactinoma
=450  \\$wnnna$aMacroprolactinomas
=450  \\$wnnna$aMicroprolactinoma
=450  \\$wnnna$aMicroprolactinomas
=450  \\$wnnna$aPituitary Adenoma, PRL-Secreting
=450  \\$wnnna$aPituitary Adenoma, Prolactin-Producing
=450  \\$aPituitary Adenoma, Prolactin-Secreting
=450  \\$wnnna$aPituitary Adenoma, Prolactin Secreting
=450  \\$wnnna$aPituitary Adenomas, PRL-Secreting
=450  \\$wnnna$aPituitary Adenomas, Prolactin-Producing
=450  \\$wnnna$aPituitary Adenomas, Prolactin-Secreting
=450  \\$aPRL-Secreting Pituitary Adenoma
=450  \\$wnnna$aPRL Secreting Pituitary Adenoma
=450  \\$wnnna$aPRL-Secreting Pituitary Adenomas
=450  \\$wnnna$aProlactin-Producing Pituitary Adenoma
=450  \\$wnnna$aProlactin Producing Pituitary Adenoma
=450  \\$wnnna$aProlactin-Producing Pituitary Adenomas
=450  \\$wnnna$aProlactin-Secreting Pituitary Adenoma
=450  \\$wnnna$aProlactin Secreting Pituitary Adenoma
=450  \\$wnnna$aProlactin-Secreting Pituitary Adenomas
=450  \\$wnnna$aProlactinoma, Familial
=450  \\$wnnna$aProlactinomas
=550  \\$wg$aAdenoma
=550  \\$wg$aPituitary Neoplasms
=667  \\$acoordinate IM with PITUITARY NEOPLASMS (IM)
=680  \\$iA pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.
=688  \\$a1989
=750  \0$aProlactinoma$0(DLC) sh 85107392$5IEN

=LDR  01353cz  a2200289n  4500
=001  9880363834902441
=005  20141212204849.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011388
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x322.$x576.$x773
=072  \\$aD6.$x472.$x699.$x631.$x525.$x525
=072  \\$aD12.$x644.$x548.$x691.$x525.$x525
=150  \\$aProlactin
=450  \\$wnnna$aHormone, Pituitary Lactogenic
=450  \\$wnnna$aHormone, Pituitary Mammotropic
=450  \\$aLactogenic Hormone, Pituitary
=450  \\$aMammotropic Hormone, Pituitary
=450  \\$aMammotropin
=450  \\$wnnna$aPituitary Lactogenic Hormone
=450  \\$wnnna$aPituitary Mammotropic Hormone
=450  \\$wnnna$aPRL (Prolactin)
=550  \\$wg$aGonadotropins, Pituitary
=550  \\$wg$aPituitary Hormones, Anterior
=667  \\$a/blood: consider also HYPERPROLACTINEMIA
=680  \\$iA lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.
=750  \0$aProlactin$5IEN$0(DLC)sh 85107391

=LDR  00781cz  a2200229n  4500
=001  9880363835002441
=005  20141212204849.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011387
=035  \\$aCBA4680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x760
=150  \\$aProkaryotic Cells
=450  \\$wnnna$aCell, Prokaryotic
=450  \\$wnnna$aCells, Prokaryotic
=450  \\$aProkaryotes$5IEN
=450  \\$wnnna$aProkaryotic Cell
=550  \\$wg$aCells
=667  \\$ageneral: prefer BACTERIA or ARCHAEA or specifics
=680  \\$iCells lacking a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region.
=688  \\$a91(78); was see under CELLS 1978-90
=750  \0$aProkaryotes$5IEN$0(DLC)sh 85107388

=LDR  01416cz  a2200373n  4500
=001  9880363835102441
=005  20141212204848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011386
=035  \\$aCBA4679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x647.$x622
=150  \\$aProjective Techniques
=450  \\$wnnna$aFrustration Study, Picture
=450  \\$aPicture Frustration Study
=450  \\$wnnna$aProjective Technic
=450  \\$wnnna$aProjective Technics
=450  \\$wnnna$aProjective Technique
=450  \\$wnnna$aRosenzweig Picture Frustration Study
=450  \\$aRosenzweig Picture-Frustration Study
=450  \\$wnnna$aStudy, Picture Frustration
=450  \\$wnnna$aStudy, Rosenzweig Picture-Frustration
=450  \\$aSzondi Test
=450  \\$wnnna$aTechnic, Projective
=450  \\$wnnna$aTechnics, Projective
=450  \\$wnnna$aTechnique, Projective
=450  \\$wnnna$aTechniques, Projective
=450  \\$wnnna$aTest, Szondi
=550  \\$wg$aPersonality Tests
=550  \\$wh$aInk Blot Tests
=550  \\$wh$aThematic Apperception Test
=680  \\$iTechniques whereby personality attributes are revealed through the subject's responses to relatively unstructured, ambiguous, or vague stimuli. These responses represent projections of the subject's own fears and needs.
=688  \\$a1991(1963)
=750  \0$aProjective techniques$5IEN$0(DLC)sh 85107384

=LDR  00632cz  a2200193n  4500
=001  9880363835202441
=005  20141212204848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011385
=035  \\$aCBA4678HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393.$x693
=150  \\$aProjection
=550  \\$wg$aDefense Mechanisms
=550  \\$wh$aScapegoating
=667  \\$ano qualif
=680  \\$iA defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed (projected) to others.
=688  \\$a69
=750  \0$aProjection (Psychology)$5IEN$0(DLC)sh 85107378

=LDR  01118cz  a2200229n  4500
=001  9880363835302441
=005  20141212204848.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011384
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x587.$x200.$x500
=072  \\$aD12.$x644.$x548.$x586.$x200.$x500
=072  \\$aD12.$x776.$x811.$x706
=150  \\$aProinsulin
=550  \\$wg$aInsulins
=550  \\$wg$aProtein Precursors
=550  \\$wh$aC-Peptide
=550  \\$wh$aInsulin
=550  \\$aInsulin
=680  \\$iA pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
=688  \\$a72
=750  \0$aProinsulin$5IEN$0(DLC)sh 85107335

=LDR  00934cz  a2200241n  4500
=001  9880363835402441
=005  20141212204847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011383
=035  \\$aCBA4676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x799
=150  \\$aProgressive Patient Care
=450  \\$wnnna$aCare, Progressive Patient
=450  \\$wnnna$aCares, Progressive Patient
=450  \\$wnnna$aPatient Care, Progressive
=450  \\$wnnna$aPatient Cares, Progressive
=450  \\$wnnna$aProgressive Patient Cares
=550  \\$wg$aComprehensive Health Care
=667  \\$aIM
=680  \\$iOrganization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organized home care.
=688  \\$a66(64)
=750  \0$aProgressive patient care$0(DLC)sh2006004611$5IEN-M

=LDR  01242cz  a2200193n  4500
=001  9880363835502441
=005  20141212204847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011382
=035  \\$aCBA4675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x906.$x575.$x748
=150  \\$aProgramming, Linear
=450  \\$wnnna$aLinear Programming
=550  \\$wg$aOperations Research
=667  \\$aIM
=680  \\$iA technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.
=688  \\$a91(75); was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH & PROGRAMMED INSTRUCTION 1966-68
=750  \0$aLinear programming$5IEN$0(DLC)sh 85077181

=LDR  00663cz  a2200217n  4500
=001  9880363835602441
=005  20141212204847.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011381
=035  \\$aCBA4674HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x780
=150  \\$aProgramming Languages
=450  \\$wnnna$aLanguage, Programming
=450  \\$wnnna$aLanguages, Programming
=450  \\$wnnna$aProgramming Language
=550  \\$wg$aSoftware
=667  \\$aIM; no qualif
=680  \\$iSpecific languages used to prepare computer programs.
=688  \\$a87
=750  \0$aProgramming languages (Electronic computers)$5IEN$0(DLC)sh 85107313

=LDR  01007cz  a2200265n  4500
=001  9880363835802441
=005  20141212204846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011379
=035  \\$aCBA4671HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x789
=150  \\$aPrognosis
=450  \\$wnnna$aPrognoses
=550  \\$wg$aDiagnosis
=550  \\$wh$aDisease-Free Survival
=550  \\$wh$aMedical Futility
=550  \\$wh$aNeoplasm Grading
=550  \\$wh$aNeoplasm Staging
=550  \\$wh$aNomograms
=550  \\$wh$aPregnancy Outcome
=550  \\$wh$aTreatment Outcome
=667  \\$aalmost never IM; IM only when GEN; NIM with progn of specific dis /diag (IM); Manual 19.8.22; despite category, do not restrict to diagnosis: progn after ther or surg is PROGNOSIS (NIM)
=680  \\$iA prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
=750  \0$aPrognosis$5IEN$0(DLC)sh 85107299

=LDR  01089cz  a2200301n  4500
=001  9880363835902441
=005  20141212204846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011378
=035  \\$aCBA4670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x500.$x460.$x655
=072  \\$aC5.$x500.$x607.$x655
=072  \\$aC5.$x660.$x207.$x540.$x460.$x655
=072  \\$aC7.$x320.$x440.$x655
=072  \\$aC7.$x320.$x610.$x655
=072  \\$aC7.$x650.$x500.$x460.$x655
=072  \\$aC16.$x131.$x621.$x207.$x540.$x460.$x655
=072  \\$aC16.$x131.$x850.$x500.$x460.$x655
=150  \\$aPrognathism
=450  \\$wnnna$aPrognathisms
=550  \\$wg$aJaw Abnormalities
=550  \\$wg$aMandibular Diseases
=550  \\$aMalocclusion
=550  \\$aMalocclusion, Angle Class III
=667  \\$aabnormal protrusion of mandible; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES; consider also MALOCCLUSION, ANGLE CLASS III
=680  \\$iA condition marked by abnormal protrusion of the mandible. (Dorland, 27th ed)
=750  \0$aPrognathism$5IEN$0(DLC)sh 85107298

=LDR  00743cz  a2200217n  4500
=001  9880363836002441
=005  20141212204845.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011377
=035  \\$aCBA4669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x68.$x330.$x700
=072  \\$aD12.$x125.$x95.$x461.$x700
=150  \\$aProglumide
=450  \\$wnnna$aMilid
=450  \\$wnnna$aXilamide
=450  \\$aXylamide
=550  \\$wg$aGlutamine
=680  \\$iA drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
=688  \\$a91(75); was see under GLUTAMINE 1975-90
=750  \0$aProglumide$5IEN$0(DLC)sh 85107297

=LDR  01473cz  a2200325n  4500
=001  9880363836102441
=005  20141212204844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011374
=035  \\$aCBA4666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x829
=072  \\$aD6.$x472.$x334.$x734.$x623
=072  \\$aD6.$x472.$x334.$x851.$x687.$x750
=150  \\$aProgesterone
=450  \\$wnnna$aPregnenedione
=450  \\$wnnna$aProgesterone, (13 alpha,17 alpha)-(+-)-Isomer
=450  \\$wnnna$aProgesterone, (17 alpha)-Isomer
=450  \\$wnnna$aProgesterone, (9 beta,10 alpha)-Isomer
=550  \\$wg$aCorpus Luteum Hormones
=550  \\$wg$aPregnenediones
=550  \\$wg$aProgesterone Congeners
=550  \\$wh$a20-alpha-Dihydroprogesterone
=550  \\$wh$a5-alpha-Dihydroprogesterone
=550  \\$wh$aAlgestone
=550  \\$wh$aHydroxyprogesterones
=550  \\$wh$aMedroxyprogesterone
=550  \\$wh$aPregnanediol
=680  \\$iThe major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
=750  \0$aProgesterone$5IEN$0(DLC)sh 85107294

=LDR  01805cz  a2200469n  4500
=001  9880363836202441
=005  20141212204844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011372
=035  \\$aCBA4664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x399.$x472.$x858
=150  \\$aProgestins
=450  \\$wnnna$aEffect, Gestagen
=450  \\$wnnna$aEffect, Gestagenic
=450  \\$wnnna$aEffect, Progestin
=450  \\$wnnna$aEffect, Progestogen
=450  \\$wnnna$aEffects, Gestagen
=450  \\$wnnna$aEffects, Gestagenic
=450  \\$wnnna$aEffects, Progestin
=450  \\$wnnna$aEffects, Progestogen
=450  \\$wnnna$aGestagen Effect
=450  \\$wnnna$aGestagen Effects
=450  \\$wnnna$aGestagenic Agents
=450  \\$wnnna$aGestagenic Effect
=450  \\$wnnna$aGestagenic Effects
=450  \\$wnnna$aGestagens
=450  \\$wnnna$aProgestagenic Agents
=450  \\$wnnna$aProgestagens
=450  \\$wnnna$aProgestational Agents
=450  \\$wnnna$aProgestational Compounds
=450  \\$wnnna$aProgestational Hormones
=450  \\$wnnna$aProgestin Effect
=450  \\$wnnna$aProgestin Effects
=450  \\$wnnna$aProgestogen Effect
=450  \\$wnnna$aProgestogen Effects
=450  \\$aProgestogens
=550  \\$wg$aHormones
=667  \\$anote entry term PROGESTIN EFFECT: use only for the progestin effect of a chemical substance
=680  \\$iCompounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
=688  \\$a2004 (1963)
=750  \0$aProgestational hormones$5IEN$0(DLC)sh 85107292

=LDR  01345cz  a2200253n  4500
=001  9880363836302441
=005  20141212204843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011371
=035  \\$aCBA4663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x753
=072  \\$aC18.$x452.$x648.$x753
=150  \\$aProgeria
=450  \\$wnnna$aHutchinson Gilford Progeria Syndrome
=450  \\$wnnna$aHutchinson-Gilford Progeria Syndrome
=450  \\$wnnna$aHutchinson-Gilford Progeria Syndromes
=450  \\$aHutchinson-Gilford Syndrome
=450  \\$wnnna$aHutchinson Gilford Syndrome
=450  \\$wnnna$aProgeria Syndrome, Hutchinson-Gilford
=450  \\$wnnna$aProgeria Syndromes, Hutchinson-Gilford
=550  \\$wg$aMetabolism, Inborn Errors
=680  \\$iAn abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature greying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
=750  \0$aProgeria$5IEN$0(DLC)sh 85107291

=LDR  01520cz  a2200433n  4500
=001  9880363836402441
=005  20210212074542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011369
=035  \\$aCBA4661HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x650
=072  \\$aN5.$x300.$x660
=150  \\$aProfessional-Patient Relations
=450  \\$wnnna$aClient, Contacting
=450  \\$wnnna$aClients, Contacting
=450  \\$wnnna$aContacting Client
=450  \\$wnnna$aContacting Clients
=450  \\$wnnna$aProfessional-Patient Relation
=450  \\$wnnna$aProfessional Patient Relations
=450  \\$wnnna$aProfessional Patient Relationship
=450  \\$wnnna$aProfessional Patient Relationships
=450  \\$wnnna$aRelation, Professional-Patient
=450  \\$wnnna$aRelations, Professional-Patient
=450  \\$wnnna$aRelationship, Professional Patient
=450  \\$wnnna$aRelationships, Professional Patient
=550  \\$wg$aDelivery of Health Care
=550  \\$wg$aInterpersonal Relations
=550  \\$wh$aDentist-Patient Relations
=550  \\$wh$aDuty to Recontact
=550  \\$wh$aNurse-Patient Relations
=550  \\$wh$aPhysician-Patient Relations
=550  \\$wh$aResearcher-Subject Relations
=550  \\$aTeach-Back Communication
=550  \\$aTruth Disclosure
=550  \\$wh$aTherapeutic Alliance
=680  \\$iInteractions between health personnel and patients.
=688  \\$a68
=750  \0$aMedical personnel and patient$5IEN$0(DLC)sh 85083000

=LDR  01206cz  a2200313n  4500
=001  9880363836502441
=005  20141212204842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011367
=035  \\$aCBA4659HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x788
=072  \\$aN5.$x700.$x685
=150  \\$aProfessional Staff Committees
=450  \\$wnnna$aCommittee, Professional Staff
=450  \\$wnnna$aCommittees, Professional Staff
=450  \\$wnnna$aProfessional Staff Committee
=450  \\$wnnna$aStaff Committee, Professional
=450  \\$wnnna$aStaff Committees, Professional
=550  \\$wg$aProfessional Practice
=550  \\$wg$aQuality Assurance, Health Care
=550  \\$wh$aClinical Trials Data Monitoring Committees
=550  \\$wh$aEthics Committees
=550  \\$wh$aPharmacy and Therapeutics Committee
=550  \\$aHospital Administration
=550  \\$aQuality of Health Care
=680  \\$iCommittees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities.
=688  \\$a68
=750  \0$aInstitutional review boards (Medicine)$5IEN-M$0(DLC)sh2001010894

=LDR  01564cz  a2200349n  4500
=001  9880363836602441
=005  20141212204841.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011366
=035  \\$aCBA4658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x761.$x673
=072  \\$aN5.$x700.$x675
=150  \\$aProfessional Review Organizations
=450  \\$wnnna$aOrganization, Peer Review
=450  \\$wnnna$aOrganization, Professional Review
=450  \\$wnnna$aOrganizations, Peer Review
=450  \\$wnnna$aOrganizations, Professional Review
=450  \\$wnnna$aPeer Review Organization
=450  \\$aPeer Review Organizations
=450  \\$aPRO Professional Review Organizations
=450  \\$wnnna$aProfessional Review Organization
=450  \\$aProfessional Standards Review Organizations
=450  \\$aPSRO
=450  \\$wnnna$aReview Organizations, Professional
=450  \\$aUtilization and Quality Control Peer Review Organizations
=550  \\$wg$aQuality Assurance, Health Care
=550  \\$wg$aQuality of Health Care
=667  \\$aDF: note short X ref
=680  \\$iOrganizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982.
=688  \\$a86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85, was PSRO 1973 (Prov)
=750  \0$aProfessional standards review organizations (Medicine)$5IEN$0(DLC)sh 85107264

=LDR  01132cz  a2200265n  4500
=001  9880363836702441
=005  20141212204840.0
=008  780509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011362
=035  \\$aCBA4654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x760
=150  \\$aProfessional Corporations
=450  \\$aCorporate Practice
=450  \\$wnnna$aCorporate Practices
=450  \\$wnnna$aCorporation, Professional
=450  \\$wnnna$aCorporations, Professional
=450  \\$wnnna$aPractice, Corporate
=450  \\$wnnna$aPractices, Corporate
=450  \\$wnnna$aProfessional Corporation
=550  \\$wg$aProfessional Practice
=667  \\$acoord IM with PRACTICE MANAGEMENT, MEDICAL or PRACTICE MANAGEMENT, DENTAL (IM) for med or dent profess corp
=680  \\$iLegally authorized corporations owned and managed by one or more professionals (medical, dental, legal) in which the income is ascribed primarily to the professional activities of the owners or stockholders.
=688  \\$a91(79); was see under PROFESSIONAL PRACTICE 1979-90
=750  \0$aProfessional corporations$5IEN$0(DLC)sh 85107249

=LDR  00885cz  a2200253n  4500
=001  9880363836802441
=005  20141212204838.0
=008  780428\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011356
=035  \\$aCBA4648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x761.$x700
=150  \\$aProduct Labeling
=450  \\$wnnna$aInsert, Package
=450  \\$wnnna$aInserts, Package
=450  \\$aLabeling, Product
=450  \\$wnnna$aLabelling, Product
=450  \\$wnnna$aPackage Insert
=450  \\$aPackage Inserts
=450  \\$wnnna$aProduct Labelling
=550  \\$wg$aProduct Packaging
=680  \\$iUse of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information.
=688  \\$a79
=750  \0$aLabels$5IEN$0(DLC)sh 85073623

=LDR  00951cz  a2200229n  4500
=001  9880363836902441
=005  20141212204838.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011355
=035  \\$aCBA4647HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x675
=150  \\$aProdrugs
=450  \\$aDrug Precursors
=450  \\$wnnna$aPrecursors, Drug
=450  \\$wnnna$aPro-Drugs
=450  \\$wnnna$aPro Drugs
=550  \\$wg$aPharmaceutical Preparations
=667  \\$a"a cpd that on admin must undergo chem conversion by metab processes before becoming the pharmacologically active drug for which it is a prodrug"; D25-26 qualif; coord IM with specific drug (IM)
=680  \\$iA compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
=688  \\$a89(88); was see under DRUGS 1988
=750  \0$aProdrugs$5IEN$0(DLC)sh 85107186

=LDR  01325cz  a2200373n  4500
=001  9880363837002441
=005  20171102181454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011351
=035  \\$aCBA4643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x372.$x250.$x250.$x600
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x680
=072  \\$aE4.$x210.$x240.$x250.$x680
=072  \\$aE4.$x502.$x250.$x250.$x250.$x680
=150  \\$aProctoscopy
=450  \\$wnnna$aProcedure, Proctoscopic Surgical
=450  \\$wnnna$aProcedures, Proctoscopic Surgical
=450  \\$wnnna$aProctoscopic Surgeries
=450  \\$wnnna$aProctoscopic Surgery
=450  \\$wnnna$aProctoscopic Surgical Procedure
=450  \\$aProctoscopic Surgical Procedures
=450  \\$wnnna$aProctoscopies
=450  \\$wnnna$aSurgeries, Proctoscopic
=450  \\$wnnna$aSurgery, Proctoscopic
=450  \\$wnnna$aSurgical Procedure, Proctoscopic
=450  \\$aSurgical Procedures, Proctoscopic
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$wh$aTransanal Endoscopic Surgery
=550  \\$aAnal Canal
=550  \\$aProctoscopes
=667  \\$a/ instrum permitted but consider also PROCTOSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the rectum.
=750  \0$aProctoscopy$5IEN$0(DLC)sh 85107172

=LDR  04768cz  a2201357n  4500
=001  9880363837102441
=005  20141212192443.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011345
=035  \\$aCBA4637M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x968.$x500.$x625
=072  \\$aD2.$x355.$x726.$x305.$x625
=072  \\$aD2.$x455.$x426.$x559.$x389.$x115.$x124.$x750
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x654.$x305.$x625
=072  \\$aD2.$x522.$x223.$x750
=150  \\$aFenofibrate
=450  \\$wnnna$aAbbott Brand of Procetofen
=450  \\$wnnna$aAbZ Brand of Procetofen
=450  \\$wnnna$aAliud Brand of Procetofen
=450  \\$wnnna$aAntara Micronized Procetofen
=450  \\$wnnna$aAnto Brand of Procetofen
=450  \\$wnnna$aApo-Feno-Micro
=450  \\$wnnna$aApo Feno Micro
=450  \\$wnnna$aApo-Fenofibrate
=450  \\$wnnna$aApo Fenofibrate
=450  \\$wnnna$aApotex Brand of Procetofen
=450  \\$wnnna$aAZU, Fenofibrat
=450  \\$wnnna$aAzupharma Brand of Procetofen
=450  \\$wnnna$abetapharm Brand of Procetofen
=450  \\$wnnna$aBouchara Brand of Procetofen
=450  \\$wnnna$aCiL
=450  \\$wnnna$aControlip
=450  \\$wnnna$act-Arzneimittel Brand of Procetofen
=450  \\$wnnna$act Arzneimittel Brand of Procetofen
=450  \\$wnnna$aDebat, Fénofibrate
=450  \\$wnnna$adurafenat
=450  \\$wnnna$aFénofibrate Debat
=450  \\$wnnna$aFénofibrate MSD
=450  \\$wnnna$aFenobeta
=450  \\$wnnna$aFenofanton
=450  \\$wnnna$aFenofibrat AbZ
=450  \\$wnnna$aFenofibrat AL
=450  \\$wnnna$aFenofibrat AZU
=450  \\$wnnna$aFenofibrat FPh
=450  \\$wnnna$aFenofibrat Heumann
=450  \\$wnnna$aFenofibrat Hexal
=450  \\$wnnna$aFenofibrat-ratiopharm
=450  \\$wnnna$aFenofibrat ratiopharm
=450  \\$wnnna$aFenofibrat Stada
=450  \\$wnnna$afenofibrat von ct
=450  \\$wnnna$aFournier Brand of Procetofen
=450  \\$wnnna$aGate Brand of Procetofen
=450  \\$wnnna$aGen-Fenofibrate
=450  \\$wnnna$aGen Fenofibrate
=450  \\$wnnna$aGenpharm Brand of Procetofen
=450  \\$wnnna$aGNR-Pharma Brand of Procetofen
=450  \\$wnnna$aGNR Pharma Brand of Procetofen
=450  \\$wnnna$aHeumann Brand of Procetofen
=450  \\$wnnna$aHeumann, Fenofibrat
=450  \\$wnnna$aHexal Brand of Procetofen
=450  \\$wnnna$aHexal, Fenofibrat
=450  \\$wnnna$aKnoll Brand of Procetofen
=450  \\$wnnna$aLF-178
=450  \\$wnnna$aLF 178
=450  \\$wnnna$aLF178
=450  \\$wnnna$aLichtenstein Brand of Procetofen
=450  \\$wnnna$aLipanthyl
=450  \\$wnnna$aLipantil
=450  \\$wnnna$aLiparison
=450  \\$wnnna$aLipidil
=450  \\$wnnna$aLipidil-Ter
=450  \\$wnnna$aLipidil Ter
=450  \\$wnnna$aLivesan
=450  \\$wnnna$aLofibra
=450  \\$wnnna$aMerck dura Brand of Procetofen
=450  \\$wnnna$aMicronized Procetofen, Antara
=450  \\$wnnna$aMTW Brand of Procetofen
=450  \\$wnnna$aMTW-Fenofibrat
=450  \\$wnnna$aMTW Fenofibrat
=450  \\$wnnna$aNormalip
=450  \\$wnnna$aNovartis Brand of Procetofen
=450  \\$wnnna$aNovo-Fenofibrate
=450  \\$wnnna$aNovo Fenofibrate
=450  \\$wnnna$aNovopharm Brand of Procetofen
=450  \\$wnnna$aNu-Fenofibrate
=450  \\$wnnna$aNu Fenofibrate
=450  \\$wnnna$aNu-Pharm Brand of Procetofen
=450  \\$wnnna$aNu Pharm Brand of Procetofen
=450  \\$wnnna$aPharmascience Brand of Procetofen
=450  \\$wnnna$aPhenofibrate
=450  \\$wnnna$aPMS-Fenofibrate Micro
=450  \\$wnnna$aPMS Fenofibrate Micro
=450  \\$aProcetofen
=450  \\$wnnna$aProcetofen, Antara Micronized
=450  \\$wnnna$aProcetofen Reliant Brand
=450  \\$wnnna$aProcetofene
=450  \\$wnnna$aQ-Pharm Brand of Procetofen
=450  \\$wnnna$aQ Pharm Brand of Procetofen
=450  \\$wnnna$aratiopharm Brand of Procetofen
=450  \\$wnnna$aReliant Brand of Procetofen
=450  \\$wnnna$aSchering-Plough Brand of Procetofen
=450  \\$wnnna$aSchering Plough Brand of Procetofen
=450  \\$wnnna$aSecalip
=450  \\$wnnna$aStada, Fenofibrat
=450  \\$wnnna$aStadapharm Brand of Procetofen
=450  \\$wnnna$aSupralip
=450  \\$wnnna$aTricor
=450  \\$wnnna$aUnited Drug Brand of Procetofen
=550  \\$wg$aBenzophenones
=550  \\$wg$aFibric Acids
=680  \\$iAn antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.
=688  \\$a2011(1980)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Procetofen
=688  \\$a91(80); was see under PROPIONATES 1980-90
=750  \0$aFenofibrate$0(DLC) sh 95008680$5IEN-M

=LDR  02205cz  a2200541n  4500
=001  9880363837202441
=005  20141212192441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011343
=035  \\$aCBA4635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x50.$x500.$x906
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x20.$x937.$x906
=150  \\$aProcaine
=450  \\$wnnna$aAbbott Brand of Procaine Hydrochloride
=450  \\$wnnna$aAnuject
=450  \\$wnnna$aAventis Brand of Procaine Hydrochloride
=450  \\$wnnna$aBraun Brand of Procaine Hydrochloride
=450  \\$wnnna$aChaix et du Marais Brand of Procaine Hydrochloride
=450  \\$wnnna$acurasan Brand of Procaine Hydrochloride
=450  \\$wnnna$aGeriocaine
=450  \\$wnnna$aGerokit
=450  \\$wnnna$aHevert Brand of Procaine Hydrochloride
=450  \\$wnnna$aHewedolor-Procain
=450  \\$wnnna$aHydrochloride, Procaine
=450  \\$wnnna$aJenapharm Brand of Procaine Hydrochloride
=450  \\$wnnna$aLoges Brand of Procaine Hydrochloride
=450  \\$wnnna$aLomapharm Brand of Procaine Hydrochloride
=450  \\$wnnna$aLophakomp-Procain N
=450  \\$wnnna$aNovocain
=450  \\$wnnna$aNovocaine
=450  \\$wnnna$aPharmakon Brand of Procaine Hydrochloride
=450  \\$wnnna$aPröcaine chlorhydrate Lavoisier
=450  \\$wnnna$aProcain Braun
=450  \\$wnnna$aProcain curasan
=450  \\$wnnna$aProcain Jenapharm
=450  \\$wnnna$aprocain-loges
=450  \\$wnnna$aProcain Rödler
=450  \\$wnnna$aProcain Steigerwald
=450  \\$wnnna$aProcaina Serra
=450  \\$wnnna$aProcaine Hydrochloride
=450  \\$wnnna$aRöwo Procain
=450  \\$wnnna$aSerra Pamies Brand of Procaine Hydrochloride
=450  \\$wnnna$aSteigerwald Brand of Procaine Hydrochloride
=550  \\$wg$apara-Aminobenzoates
=550  \\$wh$aPenicillin G Procaine
=680  \\$iA local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
=750  \0$aProcaine$5IEN$0(DLC)sh 85092906

=LDR  01007cz  a2200301n  4500
=001  9880363837302441
=005  20141212204834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011341
=035  \\$aCBA4633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x746
=150  \\$aProbucol
=450  \\$wnnna$aAlmirall Brand of Probucol
=450  \\$wnnna$aAventis Brand of Probucol
=450  \\$wnnna$aBiphenabid
=450  \\$wnnna$aDH-581
=450  \\$wnnna$aDH 581
=450  \\$wnnna$aDH581
=450  \\$wnnna$aHoechst Brand of Probucol
=450  \\$wnnna$aLorelco
=450  \\$wnnna$aLurselle
=450  \\$wnnna$aPanavir
=450  \\$wnnna$aSuperlipid
=550  \\$wg$aPhenols
=680  \\$iA drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
=688  \\$a91(73); was see under PHENOLS 1973-90
=750  \0$aProbucol$5IEN$0(DLC)sh 85107119

=LDR  00678cz  a2200217n  4500
=001  9880363837402441
=005  20170331155411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011340
=035  \\$aCBA4632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x725
=072  \\$aF2.$x463.$x785.$x810
=150  \\$aProblem Solving
=550  \\$wg$aLearning
=550  \\$wg$aThinking
=550  \\$wh$aHeuristics
=550  \\$aExecutive Function
=667  \\$ahuman & animal
=680  \\$iA learning situation involving more than one alternative from which a selection is made in order to attain a specific goal.
=750  \0$aProblem solving$5IEN$0(DLC)sh 85107109

=LDR  00876cz  a2200229n  4500
=001  9880363837502441
=005  20141212204833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011337
=035  \\$aCBA4629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x701
=150  \\$aProbability Learning
=450  \\$wnnna$aLearning, Probability
=450  \\$wnnna$aLearnings, Probability
=450  \\$wnnna$aProbability Learnings
=550  \\$wg$aLearning
=550  \\$aModels, Psychological
=667  \\$ano qualif
=680  \\$iUsually refers to the use of mathematical models in the prediction of learning to perform tasks based on the theory of probability applied to responses; it may also refer to the frequency of occurrence of the responses observed in the particular study.
=688  \\$a69(66)
=750  \0$aProbability learning$5IEN$0(DLC)sh 85107092

=LDR  01234cz  a2200337n  4500
=001  9880363837602441
=005  20141212204832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011336
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600
=072  \\$aG17.$x680
=072  \\$aN5.$x715.$x360.$x750.$x625
=072  \\$aN6.$x850.$x520.$x830.$x600
=150  \\$aProbability
=450  \\$wnnna$aProbabilities
=550  \\$wg$aMathematical Concepts
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aBayes Theorem
=550  \\$wh$aLikelihood Functions
=550  \\$wh$aMarkov Chains
=550  \\$wh$aOdds Ratio
=550  \\$wh$aPosition-Specific Scoring Matrices
=550  \\$wh$aPropensity Score
=550  \\$wh$aProportional Hazards Models
=550  \\$wh$aRisk
=550  \\$wh$aUncertainty
=667  \\$aIM for probability as a statist concept; NIM as coord for relative frequency of occur of specific dis, physiol response, etc.; see note under RISK & RISK FACTORS; coord NIM with specific disease or other concept (IM)
=680  \\$iThe study of chance processes or the relative frequency characterizing a chance process.
=688  \\$a68(64)
=750  \0$aProbabilities$5IEN$0(DLC)sh 85107090

=LDR  02665cz  a2200685n  4500
=001  9880363837702441
=005  20141212204831.0
=008  840530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011333
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x935
=072  \\$aD6.$x472.$x699.$x631.$x525.$x600
=072  \\$aD12.$x644.$x400.$x400.$x935
=072  \\$aD12.$x644.$x548.$x365.$x935
=072  \\$aD12.$x644.$x548.$x691.$x525.$x690
=072  \\$aD12.$x776.$x641.$x650.$x405.$x935
=072  \\$aD12.$x776.$x811.$x800
=150  \\$aPro-Opiomelanocortin
=450  \\$wnnna$aACTH-beta-Lipotropin Precursor
=450  \\$wnnna$aACTH beta Lipotropin Precursor
=450  \\$wnnna$aACTH-Endorphin Precursor
=450  \\$wnnna$aACTH Endorphin Precursor
=450  \\$wnnna$aCorticotropin-beta-Lipotropin Precursor
=450  \\$wnnna$aCorticotropin beta Lipotropin Precursor
=450  \\$wnnna$aEndorphin-ACTH Precursor
=450  \\$wnnna$aEndorphin ACTH Precursor
=450  \\$wnnna$aOpiocortin
=450  \\$aPOMC
=450  \\$wnnna$aPre-POMC
=450  \\$wnnna$aPre POMC
=450  \\$wnnna$aPre-pro-opiocortin
=450  \\$wnnna$aPre pro opiocortin
=450  \\$wnnna$aPreproopiomelanocortin
=450  \\$wnnna$aPro-ACTH-Endorphin
=450  \\$wnnna$aPro ACTH Endorphin
=450  \\$wnnna$aPro-Opio-Melanocortin
=450  \\$wnnna$aPro Opio Melanocortin
=450  \\$aPro-Opiocortin
=450  \\$wnnna$aPro Opiocortin
=450  \\$wnnna$aPro Opiomelanocortin
=450  \\$wnnna$aProopiocortin
=450  \\$wnnna$aProopiomelanocortin
=550  \\$wg$aHypothalamic Hormones
=550  \\$wg$aPituitary Hormones, Anterior
=550  \\$wg$aProtein Precursors
=550  \\$wh$aAdrenocorticotropic Hormone
=550  \\$wh$aalpha-Endorphin
=550  \\$wh$aalpha-MSH
=550  \\$wh$abeta-Endorphin
=550  \\$wh$abeta-Lipotropin
=550  \\$wh$abeta-MSH
=550  \\$wh$aCorticotropin-Like Intermediate Lobe Peptide
=550  \\$wh$agamma-Endorphin
=550  \\$wh$agamma-Lipotropin
=550  \\$wh$agamma-MSH
=550  \\$wh$aMelanocortins
=680  \\$iA 30-kDa protein synthesized primarily in the ANTERIOR PITUITARY GLAND and the HYPOTHALAMUS. It is also found in the skin and other peripheral tissues. Depending on species and tissues, POMC is cleaved by PROHORMONE CONVERTASES yielding various active peptides including ACTH; BETA-LIPOTROPIN; ENDORPHINS; MELANOCYTE-STIMULATING HORMONES; and others (GAMMA-LPH; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; N-terminal peptide of POMC or NPP).
=688  \\$a1985
=688  \\$a85
=750  \0$aProopiomelanocortin$5IEN$0(DLC)sh 90005378

=LDR  00627cz  a2200193n  4500
=001  9880363837802441
=005  20141212204830.0
=008  870504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011332
=035  \\$aCBA4624HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x633.$x780
=150  \\$aPrivatization
=450  \\$wnnna$aPrivatizations
=550  \\$wg$aOwnership
=667  \\$amed or non-med services or facilities
=680  \\$iProcess of shifting publicly controlled services and/or facilities to the private sector.
=688  \\$a91(88); was see under OWNERSHIP 1988-90
=750  \0$aPrivatization$5IEN$0(DLC)sh 85107058

=LDR  00932cz  a2200277n  4500
=001  9880363837902441
=005  20141212204830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011331
=035  \\$aCBA4623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x758.$x745
=150  \\$aPrivate Practice
=450  \\$wnnna$aPractice, Private
=450  \\$wnnna$aPractice, Solo
=450  \\$wnnna$aPractices, Private
=450  \\$wnnna$aPractices, Solo
=450  \\$wnnna$aPrivate Practices
=450  \\$aSolo Practice
=450  \\$wnnna$aSolo Practices
=550  \\$wg$aProfessional Practice
=550  \\$wh$aFee-for-Service Plans
=550  \\$wh$aIndependent Practice Associations
=680  \\$iPractice of a health profession by an individual, offering services on a person-to-person basis, as opposed to group or partnership practice.
=688  \\$a73(69)
=750  \0$aMedicine$xPractice$5IEN$0(DLC)sh 85083088

=LDR  01365cz  a2200253n  4500
=001  9880363838202441
=005  20181126154324.0
=008  850510\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x785
=150  \\$aPrions
=450  \\$wnnna$aEncephalopathy Virus, Mink
=450  \\$aMink Encephalopathy Virus
=450  \\$aPrP Proteins
=550  \\$wg$aProteins
=550  \\$wh$aPrion Proteins
=550  \\$wh$aPrPC Proteins
=550  \\$wh$aPrPSc Proteins
=550  \\$aScrapie
=667  \\$a/pathogen permitted
=680  \\$iSmall proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL.
=688  \\$a86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED (now VIRUSES, UNCLASSIFIED) 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92
=750  \0$aPrions$5IEN-M$0(DLC)sh 86005911

=LDR  00426cz  a2200169n  4500
=001  9880363838302441
=005  20141212204829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011327
=035  \\$aCBA4619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x787
=150  \\$aPrinting
=550  \\$wg$aPublishing
=667  \\$aIM
=688  \\$aLITHOGRAPHY was heading 1963-65
=750  \0$aPrinting$5IEN$0(DLC)sh 85106751

=LDR  00619cz  a2200217n  4500
=001  9880363838402441
=005  20141212204829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011326
=035  \\$aCBA4618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x122.$x622
=150  \\$aPrinters' Marks
=450  \\$wnnna$aMark, Printers'
=450  \\$wnnna$aMarks, Printers'
=450  \\$wnnna$aPrinter Marks
=450  \\$wnnna$aPrinters' Mark
=450  \\$wnnna$aPrinter's Marks
=450  \\$wnnna$aPrinters Marks
=550  \\$wg$aBook Imprints
=750  \0$aPrinters' marks$5IEN$0(DLC)sh 85106748

=LDR  00995cz  a2200205n  4500
=001  9880363838502441
=005  20200508132807.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011323
=035  \\$aCBA4615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988
=150  \\$aPrimates
=450  \\$wnnna$aPrimate
=550  \\$wg$aEutheria
=550  \\$wh$aHaplorhini
=550  \\$wh$aStrepsirhini
=667  \\$aGEN or unspecified; prefer specific family, subfamily or genus; IM; qualif permitted; only human primate is HOMINIDAE
=680  \\$iAn order of mammals consisting of more than 300 species that include LEMURS; LORISIDAE; TARSIERS; MONKEYS; and HOMINIDS. They are characterized by a relatively large brain when compared with other terrestrial mammals, forward-facing eyes, the presence of a CALCARINE SULCUS, and specialized MECHANORECEPTORS in the hands and feet which allow the perception of light touch.
=750  \0$aPrimates$5IEN$0(DLC)sh 85106668

=LDR  01140cz  a2200265n  4500
=001  9880363838602441
=005  20141212192441.0
=008  780509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011322
=035  \\$aCBA4614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x726.$x758
=072  \\$aN6.$x850.$x780.$x680
=150  \\$aPrimary Prevention
=450  \\$aPrevention, Primary
=550  \\$wg$aPreventive Health Services
=550  \\$wg$aPublic Health Practice
=550  \\$wh$aImmunization
=550  \\$wh$aPre-Exposure Prophylaxis
=550  \\$aPreventive Dentistry
=550  \\$aPreventive Health Services
=550  \\$aProphylactic Surgical Procedures
=680  \\$iSpecific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.
=688  \\$a79
=750  \0$aMedicine, Preventive$5IEN$0(DLC)sh 85083162

=LDR  00948cz  a2200241n  4500
=001  9880363838702441
=005  20141212204828.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011321
=035  \\$aCBA4613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x533.$x760
=150  \\$aPrimary Nursing
=450  \\$wnnna$aCare, Primary Nursing
=450  \\$wnnna$aNursing Care, Primary
=450  \\$wnnna$aNursing, Primary
=450  \\$aPrimary Nursing Care
=550  \\$wg$aNursing Care
=667  \\$ado not confuse with PRIMARY CARE NURSING which refers to methods of patient care by nurses as primary care providers
=680  \\$iThe primary responsibility of one nurse for the planning, evaluation, and care of a patient throughout the course of illness, convalescence, and recovery.
=688  \\$a77
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Primary Nursing Care
=750  \0$aPrimary nursing$0(DLC) sh 88007928$5IEN

=LDR  01108cz  a2200289n  4500
=001  9880363838802441
=005  20141212204827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011320
=035  \\$aCBA4612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x233.$x727
=150  \\$aPrimary Health Care
=450  \\$wnnna$aCare, Primary
=450  \\$wnnna$aCare, Primary Health
=450  \\$wnnna$aHealth Care, Primary
=450  \\$wnnna$aHealthcare, Primary
=450  \\$aPrimary Care
=450  \\$wnnna$aPrimary Healthcare
=550  \\$wg$aComprehensive Health Care
=550  \\$wh$aContinuity of Patient Care
=550  \\$wh$aPatient-Centered Care
=550  \\$wh$aRefusal to Treat
=667  \\$aIM
=680  \\$iCare which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. (JAMA 1995;273(3):192)
=688  \\$a74(72)
=750  \0$aPrimary health care$5IEN-M$0(DLC)sh 92006809

=LDR  01099cz  a2200229n  4500
=001  9880363838902441
=005  20141212204827.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011319
=035  \\$aCBA4611HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x50.$x650
=150  \\$aPrimaquine
=450  \\$wnnna$aBoucher & Muir Brand of Primaquine Phosphate
=450  \\$wnnna$aDiphosphate, Primaquine
=450  \\$wnnna$aPhosphate, Primaquine
=450  \\$wnnna$aPrimacin
=450  \\$wnnna$aPrimaquine Diphosphate
=450  \\$wnnna$aPrimaquine Phosphate
=550  \\$wg$aAminoquinolines
=680  \\$iAn aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
=750  \0$aPrimaquine$5IEN$0(DLC)sh 86003969

=LDR  00626cz  a2200169n  4500
=001  9880363839002441
=005  20141212204826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011317
=035  \\$aCBA4609HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x494.$x786
=150  \\$aPriapism
=450  \\$wnnna$aPriapisms
=550  \\$wg$aPenile Diseases
=680  \\$iA prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.
=750  \0$aPriapism$5IEN$0(DLC)sh 85106605

=LDR  01008cz  a2200253n  4500
=001  9880363839102441
=005  20141212204826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011316
=035  \\$aCBA4608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x215.$x508
=072  \\$aH2.$x403.$x690.$x150.$x580
=072  \\$aH2.$x403.$x720.$x750.$x550
=150  \\$aPreventive Psychiatry
=450  \\$wnnna$aPsychiatry, Preventive
=550  \\$wg$aCommunity Psychiatry
=550  \\$wg$aPreventive Medicine
=550  \\$aPreventive Health Services
=550  \\$aPrimary Prevention
=667  \\$aspecialty; do not confuse with MENTAL DISORDERS /prev or specific ment disord /prev or with MENTAL HEALTH
=680  \\$iA discipline concerned with the prevention of mental illness and the promotion of mental health.
=688  \\$a91(75); was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79
=750  \0$aMental illness$xPrevention$5IEN-M$0(DLC)sh 92002346

=LDR  01037cz  a2200265n  4500
=001  9880363839202441
=005  20141212204826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011315
=035  \\$aCBA4607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x720.$x750
=150  \\$aPreventive Medicine
=450  \\$aDisease$xprevention & control
=450  \\$wnnna$aMedicine, Preventive
=550  \\$wg$aPublic Health
=550  \\$wh$aEnvironmental Medicine
=550  \\$wh$aOccupational Medicine
=550  \\$wh$aPreventive Psychiatry
=550  \\$aPreventive Health Services
=550  \\$aPrimary Prevention
=550  \\$aPublic Health
=667  \\$afor specific disease, use / prev: Manual 19.7+, 19.8.58; PRIMARY PREVENTION, SECONDARY PREVENTION and TERTIARY PREVENTION are also available
=680  \\$iA medical specialty primarily concerned with prevention of disease (PRIMARY PREVENTION) and the promotion and preservation of health in the individual.
=750  \0$aMedicine, Preventive$5IEN$0(DLC)sh 85083162

=LDR  01512cz  a2200457n  4500
=001  9880363839302441
=005  20201123173957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011314
=035  \\$aCBA4606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x827
=072  \\$aN2.$x421.$x726
=150  \\$aPreventive Health Services
=450  \\$wnnna$aHealth Service, Preventive
=450  \\$wnnna$aHealth Services, Preventive
=450  \\$wnnna$aPreventive Health Service
=450  \\$wnnna$aService, Preventive Health
=450  \\$wnnna$aServices, Preventive Health
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aHealth Services
=550  \\$wh$aDiagnostic Services
=550  \\$wh$aEarly Intervention, Educational
=550  \\$wh$aEarly Medical Intervention
=550  \\$wh$aHealth Education
=550  \\$wh$aHealth Promotion
=550  \\$wh$aImmunization Programs
=550  \\$wh$aNeedle-Exchange Programs
=550  \\$wh$aPost-Exposure Prophylaxis
=550  \\$wh$aPrimary Prevention
=550  \\$wh$aSchool Health Services
=550  \\$wh$aSecondary Prevention
=550  \\$wh$aTertiary Prevention
=550  \\$aPreventive Medicine
=550  \\$aPreventive Psychiatry
=550  \\$wh$aVaccination Coverage
=550  \\$aPrimary Prevention
=667  \\$aDF: PREV HEALTH SERV
=680  \\$iServices designed for HEALTH PROMOTION and prevention of disease.
=688  \\$a68
=750  \0$aPreventive health services$5IEN$0(DLC)sh 85106598

=LDR  01215cz  a2200301n  4500
=001  9880363839402441
=005  20141212204825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011313
=035  \\$aCBA4605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x761
=072  \\$aH2.$x163.$x721
=150  \\$aPreventive Dentistry
=450  \\$wnnna$aDentistries, Preventive
=450  \\$wnnna$aDentistry, Preventive
=450  \\$wnnna$aPreventive Dentistries
=550  \\$wg$aDentistry
=550  \\$wh$aDental Prophylaxis
=550  \\$wh$aFluoridation
=550  \\$wh$aMouth Protectors
=550  \\$wh$aOral Hygiene
=550  \\$aPreventive Health Services
=550  \\$aPrimary Prevention
=667  \\$aSPEC only: SPEC qualif; spec concerned with prev of tooth & mouth dis: do not confuse with TOOTH DISEASES /prev or MOUTH DISEASES /prev; see note under DENTAL CARE; for "see your dentist twice a year"; do not confuse with DENTAL PROPHYLAXIS (see note there) or ORAL HYGIENE (see note there)
=680  \\$iThe branch of dentistry concerned with the prevention of disease and the maintenance and promotion of oral health.
=688  \\$a65
=750  \0$aPreventive dentistry$5IEN$0(DLC)sh 85106595

=LDR  00958cz  a2200265n  4500
=001  9880363839502441
=005  20141212204825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011312
=035  \\$aCBA4603HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x715
=150  \\$aPressure
=450  \\$wnnna$aPressures
=550  \\$wg$aMechanical Phenomena
=550  \\$wh$aDecompression
=550  \\$wh$aHydrostatic Pressure
=550  \\$wh$aOsmotic Pressure
=550  \\$wh$aPartial Pressure
=550  \\$wh$aVacuum
=550  \\$wh$aVapor Pressure
=667  \\$aspinal or cerebrospinal fluid pressure = CEREBROSPINAL FLUID PRESSURE; pressure within heart ventricles = VENTRICULAR PRESSURE
=680  \\$iA type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a68(64)
=750  \0$aPressure$0(DLC) sh 85106531$5IEN

=LDR  01610cz  a2200445n  4500
=001  9880363839602441
=005  20141212192440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011311
=035  \\$aCBA4602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x750.$x750
=072  \\$aA8.$x800.$x50.$x800.$x900.$x700
=072  \\$aA8.$x800.$x950.$x750.$x750
=072  \\$aA11.$x671.$x650.$x915.$x750.$x750
=150  \\$aPressoreceptors
=450  \\$wnnna$aArterial Stretch Receptor
=450  \\$wnnna$aArterial Stretch Receptors
=450  \\$wnnna$aBaroreceptor
=450  \\$aBaroreceptors
=450  \\$wnnna$aPressoreceptor
=450  \\$wnnna$aReceptor, Arterial Stretch
=450  \\$wnnna$aReceptor, Vascular Stretch
=450  \\$wnnna$aReceptors, Arterial Stretch
=450  \\$aReceptors, Stretch, Arterial
=450  \\$aReceptors, Stretch, Vascular
=450  \\$wnnna$aReceptors, Vascular Stretch
=450  \\$wnnna$aStretch Receptor, Arterial
=450  \\$wnnna$aStretch Receptor, Vascular
=450  \\$aStretch Receptors, Arterial
=450  \\$aStretch Receptors, Vascular
=450  \\$wnnna$aVascular Stretch Receptor
=450  \\$wnnna$aVascular Stretch Receptors
=550  \\$wg$aMechanoreceptors
=550  \\$wg$aVasomotor System
=550  \\$aCarotid Sinus
=667  \\$amechanoreceptors of the vasomotor system; DF: PRESSORECEPT
=680  \\$iReceptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.
=688  \\$a65
=750  \0$aBaroreceptors$5IEN$0(DLC)sh 90003540

=LDR  01129cz  a2200289n  4500
=001  9880363839702441
=005  20141212204824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011310
=035  \\$aCBA4601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x650.$x702
=072  \\$aD27.$x720.$x744.$x771
=150  \\$aPreservatives, Pharmaceutical
=450  \\$aPharmaceutic Aids (Preservatives)
=450  \\$wnnna$aPharmaceutic Preservative
=450  \\$wnnna$aPharmaceutic Preservatives
=450  \\$wnnna$aPharmaceutical Preservative
=450  \\$wnnna$aPharmaceutical Preservatives
=450  \\$wnnna$aPreservative, Pharmaceutic
=450  \\$wnnna$aPreservative, Pharmaceutical
=450  \\$wnnna$aPreservatives, Pharmaceutic
=550  \\$wg$aPharmaceutic Aids
=667  \\$aD25-26 qualif; DF: PRESERVATIVES PHARM
=680  \\$iSubstances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants.
=688  \\$a91(75); was see under PHARMACEUTIC AIDS 1975-90
=750  \0$aDrugs$xPreservation$5IEN$0(DLC)sh 85039744

=LDR  00904cz  a2200265n  4500
=001  9880363839802441
=005  20141212204824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011309
=035  \\$aCBA4600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x792
=072  \\$aE5.$x760
=150  \\$aPreservation, Biological
=450  \\$wnnna$aBiologic Preservation
=450  \\$wnnna$aBiological Preservation
=450  \\$wnnna$aPreservation, Biologic
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aTherapeutics
=550  \\$wh$aCryopreservation
=550  \\$wh$aRefrigeration
=550  \\$wh$aTissue Preservation
=667  \\$aBLOOD PRESERVATION; ORGAN PRESERVATION and TISSUE PRESERVATION are also available; CRYOPRESERVATION is also available; DF: PRESERVATION BIOL
=688  \\$a67(64)
=750  \0$aBiological specimens$xCollection and preservation$5IEN$0(DLC)sh 85014192

=LDR  01427cz  a2200325n  4500
=001  9880363839902441
=005  20141212204824.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011307
=035  \\$aCBA4598HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x307
=072  \\$aN2.$x421.$x668.$x778.$x500
=150  \\$aDrug Prescriptions
=450  \\$wnnna$aDrug Prescription
=450  \\$wnno$aPrescriptions, Drug$5IEN-M
=550  \\$wg$aDrug Therapy
=550  \\$wg$aPrescriptions
=550  \\$wh$aDrug Substitution
=550  \\$wh$aOff-Label Use
=550  \\$aLegislation, Drug
=550  \\$aPharmacy
=667  \\$ageneral; do not confuse the concept of "prescription" with the drug prescribed; do not index here routinely for every "prescribed" drug; do not confuse with DRUG COMPOUNDING: prescribing is by the MD, compounding is by the pharmacist or drug company; note category: do not confuse with PRESCRIPTION DRUGS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed
=680  \\$iDirections written for the obtaining and use of DRUGS.
=688  \\$a2009(1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Prescriptions, Drug
=688  \\$a1978 (1963)
=688  \\$a78; was PRESCRIPTIONS 1963-77
=750  \0$aPrescription writing$0(DLC) sh 85106439$5IEN-M
=750  \0$aDrugs$xPrescribing$0sh 85039743$5IEN-HS

=LDR  01170cz  a2200301n  4500
=001  9880363840002441
=005  20141212204823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011306
=035  \\$aCBA4597M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x442.$x551.$x621
=072  \\$aN3.$x219.$x442.$x675
=150  \\$aPrescription Fees
=450  \\$wnnna$aDispensing Fee
=450  \\$aDispensing Fees
=450  \\$wnnna$aFee, Dispensing
=450  \\$wnnna$aFee, Prescription
=450  \\$wnnna$aFees, Dispensing
=450  \\$aFees, Prescription
=450  \\$wnnna$aPrescription Fee
=550  \\$wg$aFees and Charges
=550  \\$wg$aFees, Pharmaceutical
=550  \\$aEconomics, Pharmaceutical
=667  \\$afor drug & non-drug prescriptions; costs to the patient or 3d-party payer: do not confuse with DRUG COSTS, which are costs to a health care facility or organiz
=680  \\$iThe charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional.
=688  \\$a91(75); was see under FEES, PHARMACEUTICAL 1975-90
=750  \0$aPrescription pricing$5IEN-HS$0(DLC)sh 85106437

=LDR  00515cz  a2200169n  4500
=001  9880363840102441
=005  20141212204823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011305
=035  \\$aCBA4596HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744.$x786
=150  \\$aPresbyopia
=450  \\$wnnna$aPresbyopias
=550  \\$wg$aRefractive Errors
=680  \\$iThe normal decreasing elasticity of the crystalline lens that leads to loss of accommodation.
=750  \0$aPresbyopia$5IEN$0(DLC)sh 87002717

=LDR  00906cz  a2200193n  4500
=001  9880363840202441
=005  20141212204823.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011304
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x458.$x341.$x887.$x772
=072  \\$aC10.$x597.$x751.$x418.$x341.$x887.$x772
=072  \\$aC23.$x888.$x592.$x763.$x393.$x341.$x887.$x772
=150  \\$aPresbycusis
=450  \\$wnnna$aPresbycuses
=550  \\$wg$aHearing Loss, Sensorineural
=680  \\$iGradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.
=688  \\$a91(72); was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78
=750  \0$aPresbycusis$5IEN$0(DLC)sh 85106395

=LDR  01210cz  a2200277n  4500
=001  9880363840302441
=005  20141212204822.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011300
=035  \\$aCBA4591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x795
=072  \\$aE4.$x604.$x750
=072  \\$aN2.$x421.$x585.$x795
=150  \\$aPreoperative Care
=450  \\$wnnna$aCare, Preoperative
=450  \\$wnnna$aPreoperative Procedure
=450  \\$wnnna$aPreoperative Procedures
=450  \\$wnnna$aProcedure, Preoperative
=450  \\$wnnna$aProcedures, Preoperative
=550  \\$wg$aPatient Care
=550  \\$wg$aPerioperative Care
=550  \\$wh$aPreanesthetic Medication
=667  \\$apreop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS & not here; DF: PREOP CARE
=680  \\$iCare given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed)
=750  \0$aPreoperative care$5IEN$0(DLC)sh 85106377

=LDR  00787cz  a2200205n  4500
=001  9880363840402441
=005  20141212204821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011299
=035  \\$aCBA4590HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x471.$x683.$x825
=150  \\$aPrenylamine
=450  \\$wnnna$aCorontin
=450  \\$wnnna$aDifril
=450  \\$wnnna$aSegontin
=550  \\$wg$aPhenethylamines
=680  \\$iA drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1406)
=688  \\$a66; was SEGONTIN 1963-65
=750  \0$aPrenylamine$0(DLC) sh 87006727$5IEN

=LDR  01077cz  a2200217n  4500
=001  9880363840502441
=005  20141212204821.0
=008  810519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011297
=035  \\$aCBA4588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x824.$x500
=150  \\$aPrenatal Exposure Delayed Effects
=450  \\$aDelayed Effects, Prenatal Exposure
=450  \\$wnnna$aLate Effects, Prenatal Exposure
=550  \\$wg$aPrenatal Injuries
=550  \\$aMaternal Exposure
=667  \\$afor mammals only; note PRECONCEPTION INJURIES; MATERNAL EXPOSURE & PATERNAL EXPOSURE are available for environmental exposure of mother or father; check tags FEMALE & PREGNANCY
=680  \\$iThe consequences of exposing the FETUS in utero to certain factors, such as NUTRITION PHYSIOLOGICAL PHENOMENA; PHYSIOLOGICAL STRESS; DRUGS; RADIATION; and other physical or chemical factors. These consequences are observed later in the offspring after BIRTH.
=688  \\$a82; PRENATAL INFLUENCES was heading 1963-72
=750  \0$aPrenatal influences$0(DLC) sh 85106376$5IEN

=LDR  01848cz  a2200505n  4500
=001  9880363840602441
=005  20141212204820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011296
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x630
=150  \\$aPrenatal Diagnosis
=450  \\$wnnna$aAntenatal Diagnoses
=450  \\$wnnna$aAntenatal Diagnosis
=450  \\$wnnna$aAntenatal Screening
=450  \\$wnnna$aAntenatal Screenings
=450  \\$wnnna$aDiagnoses, Antenatal
=450  \\$wnnna$aDiagnoses, Intrauterine
=450  \\$wnnna$aDiagnoses, Prenatal
=450  \\$wnnna$aDiagnosis, Antenatal
=450  \\$wnnna$aDiagnosis, Intrauterine
=450  \\$aDiagnosis, Prenatal
=450  \\$wnnna$aIntrauterine Diagnoses
=450  \\$aIntrauterine Diagnosis
=450  \\$wnnna$aPrenatal Diagnoses
=450  \\$wnnna$aPrenatal Screening
=450  \\$wnnna$aPrenatal Screenings
=450  \\$wnnna$aScreening, Antenatal
=450  \\$wnnna$aScreening, Prenatal
=450  \\$wnnna$aScreenings, Antenatal
=450  \\$wnnna$aScreenings, Prenatal
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wh$aAmniocentesis
=550  \\$wh$aChorionic Villi Sampling
=550  \\$wh$aFetoscopy
=550  \\$wh$aMaternal Serum Screening Tests
=550  \\$wh$aUltrasonography, Prenatal
=550  \\$aGenetic Services
=550  \\$aGenetic Testing
=550  \\$aNeonatal Screening
=550  \\$aPreimplantation Diagnosis
=667  \\$acheck tags FEMALE & PREGNANCY; coordinate with FETAL DISEASES only if the article discusses the fetal aspect
=680  \\$iDetermination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth.
=688  \\$a73
=750  \0$aPrenatal diagnosis$5IEN$0(DLC)sh 85106375

=LDR  00821cz  a2200241n  4500
=001  9880363840702441
=005  20141212204820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011295
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x786
=072  \\$aN2.$x421.$x143.$x620.$x704
=072  \\$aN2.$x421.$x585.$x786
=150  \\$aPrenatal Care
=450  \\$wnnna$aCare, Prenatal
=550  \\$wg$aMaternal Health Services
=550  \\$wg$aPatient Care
=550  \\$aPreconception Care
=550  \\$aPregnancy
=550  \\$aPrenatal Nutritional Physiological Phenomena
=667  \\$acheck tags FEMALE & PREGNANCY
=680  \\$iCare provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.
=750  \0$aPrenatal care$5IEN$0(DLC)sh 85106374

=LDR  01161cz  a2200277n  4500
=001  9880363840802441
=005  20141212204819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011293
=035  \\$aCBA4584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x568.$x968
=150  \\$aPremenstrual Syndrome
=450  \\$wnnna$aPremenstrual Syndromes
=450  \\$aPremenstrual Tension
=450  \\$wnnna$aPremenstrual Tensions
=450  \\$wnnna$aSyndrome, Premenstrual
=450  \\$wnnna$aSyndromes, Premenstrual
=450  \\$wnnna$aTension, Premenstrual
=450  \\$wnnna$aTensions, Premenstrual
=550  \\$wg$aMenstruation Disturbances
=550  \\$wh$aPremenstrual Dysphoric Disorder
=550  \\$aMenstruation
=680  \\$iA combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
=688  \\$a86; was PREMENSTRUAL TENSION 1963-85
=750  \0$aPremenstrual syndrome$5IEN$0(DLC)sh 85106325

=LDR  00618cz  a2200205n  4500
=001  9880363840902441
=005  20141212204819.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011291
=035  \\$aCBA4582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x620
=150  \\$aPremarital Examinations
=450  \\$wnnna$aExamination, Premarital
=450  \\$wnnna$aExaminations, Premarital
=450  \\$wnnna$aPremarital Examination
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$aMarriage
=667  \\$aIM; DF: PREMARITAL EXAM
=750  \0$aPremarital examinations$5IEN$0(DLC)sh 85106320

=LDR  00855cz  a2200217n  4500
=001  9880363841002441
=005  20141212204818.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011289
=035  \\$aCBA4580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x834.$x770
=072  \\$aC15.$x378.$x800
=150  \\$aPreleukemia
=450  \\$wnnna$aPreleukemias
=550  \\$wg$aHematologic Diseases
=550  \\$wg$aPrecancerous Conditions
=667  \\$ado not use /compl for develop into leukemia
=680  \\$iConditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.
=688  \\$a77
=750  \0$aPreleukemia$5IEN$0(DLC)sh 85106315

=LDR  00996cz  a2200265n  4500
=001  9880363841202441
=005  20141212204817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011284
=035  \\$aCBA4575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x725
=072  \\$aD6.$x472.$x40.$x585.$x745
=072  \\$aD6.$x472.$x334.$x851.$x687.$x500
=150  \\$aPregnenolone
=450  \\$wnnna$a5-Pregnen-3-beta-ol-20-one
=450  \\$wnnna$a5 Pregnen 3 beta ol 20 one
=550  \\$wg$aHydroxycorticosteroids
=550  \\$wg$aPregnenes
=550  \\$wg$aProgesterone Congeners
=550  \\$wh$a17-alpha-Hydroxypregnenolone
=550  \\$wh$aPregnenolone Carbonitrile
=667  \\$ado not confuse with PREGNANOLONE
=680  \\$iA 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.
=750  \0$aPregnenolone$5IEN-M$0(DLC)sh 97009184

=LDR  00878cz  a2200277n  4500
=001  9880363841302441
=005  20141212204815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011278
=035  \\$aCBA4569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745
=150  \\$aPregnanes
=550  \\$wg$aSteroids
=550  \\$wh$aPregnadienes
=550  \\$wh$aPregnanediol
=550  \\$wh$aPregnanediones
=550  \\$wh$aPregnanetriol
=550  \\$wh$aPregnanolone
=550  \\$wh$aPregnatrienes
=550  \\$wh$aPregnenes
=550  \\$wh$aTetrahydrocortisol
=667  \\$ado not confuse with PREGNENES
=680  \\$iSaturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.
=688  \\$a68
=750  \0$aPregnane$5IEN$0(DLC)sh 85106296

=LDR  00718cz  a2200181n  4500
=001  9880363841402441
=005  20141212204814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011276
=035  \\$aCBA4567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x495
=072  \\$aD6.$x472.$x334.$x851.$x687.$x750.$x739
=150  \\$aPregnanediol
=550  \\$wg$aPregnanes
=550  \\$wg$aProgesterone
=680  \\$iAn inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.
=750  \0$aPregnanediol$5IEN$0(DLC)sh 85106297

=LDR  00822cz  a2200229n  4500
=001  9880363841502441
=005  20190322115243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011275
=035  \\$aCBA4566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x784.$x769.$x580
=150  \\$aPregnancy, Unwanted
=450  \\$wnnna$aPregnancies, Unwanted
=450  \\$wnnna$aUnwanted Pregnancies
=450  \\$wnnna$aUnwanted Pregnancy
=550  \\$wg$aPregnancy
=550  \\$aPregnancy, Unplanned
=667  \\$aPREGNANCY, UNPLANNED is also available; check tags HUMANS & FEMALE & PREGNANCY; DF: PREGN UNWANTED
=680  \\$iPregnancy, usually accidental, that is not desired by the parent or parents.
=688  \\$a91(73); was see under PREGNANCY 1973-90
=750  \0$aUnwanted pregnancy$0(DLC)sh 85106293$5IEN-M

=LDR  00877cz  a2200205n  4500
=001  9880363841602441
=005  20141212204814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011274
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x733.$x703
=150  \\$aPregnancy, Tubal
=450  \\$wnnna$aPregnancies, Tubal
=450  \\$wnnna$aTubal Pregnancies
=450  \\$aTubal Pregnancy
=550  \\$wg$aPregnancy, Ectopic
=550  \\$wh$aPregnancy, Interstitial
=667  \\$acheck the tags FEMALE & PREGNANCY; heterotopic or combined uterine & tubal pregnancy: see note on PREGNANCY, ECTOPIC; DF: PREGN TUBAL
=680  \\$iThe most common (>96%) type of ectopic pregnancy in which the extrauterine EMBRYO IMPLANTATION occurs in the FALLOPIAN TUBE, usually in the ampullary region where FERTILIZATION takes place.
=750  \0$aTubal pregnancy$5IEN-M$0(DLC)sh 85106292

=LDR  00953cz  a2200217n  4500
=001  9880363841702441
=005  20141212204814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011273
=035  \\$aCBA4564HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x805
=150  \\$aPregnancy, Prolonged
=450  \\$wnnna$aPregnancies, Prolonged
=450  \\$wnnna$aProlonged Pregnancies
=450  \\$wnnna$aProlonged Pregnancy
=550  \\$wg$aPregnancy Complications
=550  \\$aPregnancy Complications
=667  \\$acheck tags FEMALE & PREGNANCY; DF: PREGN PROLONGED
=680  \\$iA term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks (294 days) after the first day of the last menstrual period (MENSTRUATION), or birth with gestational age of 41 weeks or more.
=750  \0$aProlonged pregnancy$5IEN$0(DLC)sh 85106291

=LDR  01170cz  a2200301n  4500
=001  9880363841802441
=005  20141212204813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011272
=035  \\$aCBA4563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x710
=072  \\$aG8.$x686.$x785.$x760.$x769.$x525
=150  \\$aPregnancy, Multiple
=450  \\$wnnna$aMultiple Pregnancies
=450  \\$wnnna$aMultiple Pregnancy
=450  \\$wnnna$aPregnancies, Multiple
=550  \\$wg$aPregnancy
=550  \\$wg$aReproductive Physiological Phenomena
=550  \\$wh$aPregnancy, Quadruplet
=550  \\$wh$aPregnancy, Quintuplet
=550  \\$wh$aPregnancy, Triplet
=550  \\$wh$aPregnancy, Twin
=550  \\$wh$aSuperfetation
=550  \\$aPregnancy Reduction, Multifetal
=667  \\$ahuman & animal; in reference to animals, do not use PREGNANCY, MULTIPLE for animals naturally having litters; consider LITTER SIZE; not for "heterotopic pregnancy": see note at PREGNANCY, ECTOPIC; check tags FEMALE & PREGNANCY
=680  \\$iThe condition of carrying two or more FETUSES simultaneously.
=750  \0$aMultiple Pregnancy$0(DLC) sh 85106290$5IEN

=LDR  01318cz  a2200313n  4500
=001  9880363841902441
=005  20141212192439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011271
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x733
=150  \\$aPregnancy, Ectopic
=450  \\$wnnna$aEctopic Pregnancies
=450  \\$aEctopic Pregnancy
=450  \\$wnnna$aExtrauterine Pregnancies
=450  \\$wnnna$aExtrauterine Pregnancy
=450  \\$wnnna$aPregnancies, Ectopic
=450  \\$wnnna$aPregnancies, Extrauterine
=450  \\$wnnna$aPregnancy, Extrauterine
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aPregnancy, Abdominal
=550  \\$wh$aPregnancy, Angular
=550  \\$wh$aPregnancy, Cornual
=550  \\$wh$aPregnancy, Heterotopic
=550  \\$wh$aPregnancy, Ovarian
=550  \\$wh$aPregnancy, Tubal
=667  \\$acheck the tags FEMALE & PREGNANCY; PREGNANCY, HETEROTOPIC is also available
=680  \\$iA potentially life-threatening condition in which EMBRYO IMPLANTATION occurs outside the cavity of the UTERUS. Most ectopic pregnancies (>96%) occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity (PREGNANCY, ABDOMINAL).
=750  \0$aEctopic pregnancy$5IEN$0(DLC)sh 85106288

=LDR  00935cz  a2200217n  4500
=001  9880363842002441
=005  20141212204813.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011270
=035  \\$aCBA4561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x498
=150  \\$aPregnancy, Animal
=450  \\$wnnna$aAnimal Pregnancies
=450  \\$wnnna$aAnimal Pregnancy
=450  \\$wnnna$aPregnancies, Animal
=550  \\$wg$aPregnancy
=550  \\$wh$aLitter Size
=667  \\$aIM for articles on normal animal pregn but check also tag PREGNANCY; for NIM animal pregnancy do not index PREGNANCY, ANIMAL: merely check tag PREGNANCY; check tags ANIMALS & FEMALE also; Manual 18.4.6; DF: PREGN ANIMAL
=680  \\$iThe process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH.
=750  \0$aPregnancy in animals$5IEN-M$0(DLC)sh 93008329

=LDR  00693cz  a2200193n  4500
=001  9880363842102441
=005  20141212192439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011269
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x733.$x536
=150  \\$aPregnancy, Abdominal
=450  \\$wnnna$aAbdominal Pregnancies
=450  \\$aAbdominal Pregnancy
=450  \\$wnnna$aPregnancies, Abdominal
=550  \\$wg$aPregnancy, Ectopic
=680  \\$iA type of ectopic pregnancy in which the EMBRYO, MAMMALIAN implants in the ABDOMINAL CAVITY instead of in the ENDOMETRIUM of the UTERUS.
=750  \0$aPregnancy, Abdominal$5IEN
=750  \0$aAbdominal pregnancy$5IEN-M$0(DLC)sh 85106285

=LDR  01396cz  a2200361n  4500
=001  9880363842202441
=005  20141212204811.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011263
=035  \\$aCBA4554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x707.$x520
=150  \\$aPregnancy Trimester, Third
=450  \\$wnnna$aLast Trimester
=450  \\$wnnna$aLast Trimesters
=450  \\$wnnna$aPregnancies, Third Trimester
=450  \\$aPregnancy, Third Trimester
=450  \\$wnnna$aPregnancy Trimesters, Third
=450  \\$wnnna$aThird Pregnancy Trimester
=450  \\$wnnna$aThird Pregnancy Trimesters
=450  \\$wnnna$aThird Trimester
=450  \\$wnnna$aThird Trimester Pregnancies
=450  \\$wnnna$aThird Trimester Pregnancy
=450  \\$wnnna$aThird Trimesters
=450  \\$wnnna$aTrimester, Last
=450  \\$aTrimester, Third
=450  \\$wnnna$aTrimesters, Last
=450  \\$wnnna$aTrimesters, Third
=550  \\$wg$aPregnancy Trimesters
=667  \\$ahuman only; check tags HUMANS & FEMALE & PREGNANCY; "at term": consider better LABOR, OBSTETRIC; DF: PREGN TRIMESTER THIRD
=680  \\$iThe last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation.
=688  \\$a76; was PREGNANCY, THIRD TRIMESTER 1975
=750  \0$aPregnancy$xTrimester, Third$5IEN$0(DLC)sh 85106284

=LDR  01280cz  a2200337n  4500
=001  9880363842302441
=005  20141212204810.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011262
=035  \\$aCBA4553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x707.$x490
=150  \\$aPregnancy Trimester, Second
=450  \\$aMidtrimester
=450  \\$wnnna$aMidtrimesters
=450  \\$wnnna$aPregnancies, Second Trimester
=450  \\$aPregnancy, Second Trimester
=450  \\$wnnna$aPregnancy Trimesters, Second
=450  \\$wnnna$aSecond Pregnancy Trimester
=450  \\$wnnna$aSecond Pregnancy Trimesters
=450  \\$wnnna$aSecond Trimester
=450  \\$wnnna$aSecond Trimester Pregnancies
=450  \\$wnnna$aSecond Trimester Pregnancy
=450  \\$wnnna$aSecond Trimesters
=450  \\$aTrimester, Second
=450  \\$wnnna$aTrimesters, Second
=550  \\$wg$aPregnancy Trimesters
=667  \\$ahuman only; check tags HUMANS & FEMALE & PREGNANCY; DF: PREGN TRIMESTER SECOND
=680  \\$iThe middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation.
=688  \\$a76; was PREGNANCY, SECOND TRIMESTER 1975
=750  \0$aPregnancy$xTrimester, Second$5IEN$0(DLC)sh 85106283

=LDR  01503cz  a2200385n  4500
=001  9880363842402441
=005  20141212204810.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011261
=035  \\$aCBA4552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x707.$x408
=150  \\$aPregnancy Trimester, First
=450  \\$aEarly Placental Phase
=450  \\$wnnna$aEarly Placental Phases
=450  \\$wnnna$aFirst Pregnancy Trimester
=450  \\$wnnna$aFirst Pregnancy Trimesters
=450  \\$wnnna$aFirst Trimester
=450  \\$wnnna$aFirst Trimester Pregnancies
=450  \\$wnnna$aFirst Trimester Pregnancy
=450  \\$wnnna$aFirst Trimesters
=450  \\$wnnna$aPhase, Early Placental
=450  \\$wnnna$aPhases, Early Placental
=450  \\$wnnna$aPlacental Phase, Early
=450  \\$wnnna$aPlacental Phases, Early
=450  \\$wnnna$aPregnancies, First Trimester
=450  \\$aPregnancy, First Trimester
=450  \\$wnnna$aPregnancy Trimesters, First
=450  \\$aTrimester, First
=450  \\$wnnna$aTrimesters, First
=550  \\$wg$aPregnancy Trimesters
=667  \\$ahuman only; check tags HUMANS & FEMALE & PREGNANCY; DF: PREGN TRIMESTER FIRST
=680  \\$iThe beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation.
=688  \\$a76; was PREGNANCY, FIRST TRIMESTER 1975
=750  \0$aPregnancy$xTrimester, First$5IEN$0(DLC)sh 85106282

=LDR  01247cz  a2200313n  4500
=001  9880363842502441
=005  20180712175759.0
=008  790222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011257
=035  \\$aCBA4548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x780
=150  \\$aPregnancy Proteins
=450  \\$aPlacental Proteins
=450  \\$wnno$aPregnancy Zone Proteins$5IEN-M
=450  \\$wnnna$aProteins, Placental
=450  \\$wnnna$aProteins, Pregnancy
=550  \\$wg$aProteins
=550  \\$wh$aChorionic Gonadotropin
=550  \\$wh$aGlycodelin
=550  \\$wh$aGonadotropins, Equine
=550  \\$wh$aPlacental Lactogen
=550  \\$wh$aPregnancy-Associated alpha 2-Macroglobulins
=550  \\$wh$aPregnancy-Associated Plasma Protein-A
=550  \\$wh$aPregnancy-Specific beta 1-Glycoproteins
=667  \\$aGEN; prefer specifics; DF: PREGN PROTEINS
=680  \\$iProteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.)
=688  \\$a80
=750  \0$aPregnancy proteins$5IEN$0(DLC)sh 85106295

=LDR  01016cz  a2200241n  4500
=001  9880363842602441
=005  20141212204808.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011254
=035  \\$aCBA4545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x726
=150  \\$aPregnancy in Diabetics
=450  \\$wnnna$aPregnancy in Diabete
=450  \\$wnnna$aPregnancy in Diabetes
=450  \\$wnnna$aPregnancy in Diabetic
=550  \\$wg$aPregnancy Complications
=550  \\$wh$aFetal Macrosomia
=550  \\$aDiabetes, Gestational
=667  \\$aDIABETES MELLITUS, not DIABETES INSIPIDUS; coordinate IM with specific type of diabetes mellitus (IM) if pertinent; DF: PREGN IN DIABETES
=680  \\$iThe state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy.
=688  \\$a2001(1965)
=750  \0$aDiabetes in pregnancy$5IEN$0(DLC)sh 85037466

=LDR  01466cz  a2200373n  4500
=001  9880363842702441
=005  20141212204808.0
=008  780320\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D011253
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x494
=150  \\$aPregnancy in Adolescence
=450  \\$wnnna$aAdolescence, Pregnancy in
=450  \\$wnnna$aAdolescent Pregnancies
=450  \\$aAdolescent Pregnancy
=450  \\$wnnna$aPregnancies, Adolescent
=450  \\$wnnna$aPregnancies, Preteen
=450  \\$wnnna$aPregnancies, Teen
=450  \\$wnnna$aPregnancies, Teenage
=450  \\$aPregnancy, Adolescent
=450  \\$wnnna$aPregnancy, Preteen
=450  \\$wnnna$aPregnancy, Teen
=450  \\$aPregnancy, Teenage
=450  \\$wnnna$aPreteen Pregnancies
=450  \\$aPreteen Pregnancy
=450  \\$wnnna$aTeen Pregnancies
=450  \\$wnnna$aTeen Pregnancy
=450  \\$wnnna$aTeenage Pregnancies
=450  \\$aTeenage Pregnancy
=550  \\$wg$aPregnancy
=667  \\$aIM; use only for pregnancy as a social, cultural, or psychological problem in adolescents; for other aspects of PREGNANCY (IM) in adolescents, use PREGNANCY (IM) + ADOLESCENT (check tag); includes pregnancy in children under 13; check tags HUMAN; FEMALE; PREGNANCY & ADOLESCENT or CHILD if under 13
=680  \\$iPregnancy in human adolescent females under the age of 19.
=688  \\$a79
=750  \0$aTeenage pregnancy$5IEN$0(DLC)sh 85106286

=LDR  00641nz  a2200193n  4500
=001  9880485048702441
=005  20161221104127.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067508
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x50.$x375.$x95
=150  \\$aComputer Heuristics
=450  \\$wnnna$aComputer Heuristic
=450  \\$wnnna$aHeuristic, Computer
=450  \\$wnnna$aHeuristics, Computer
=550  \\$wg$aArtificial Intelligence
=550  \\$aHeuristics
=680  \\$iTrial-and-error methods of problem-solving used when an algorithmic approach is impractical
=750  \\$aHeuristic algorithms$0(DLC)sh2009010989$5IEN-M

=LDR  00719cz  a2200193n  4500
=001  9880485215102441
=005  20170105150302.0
=008  080708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D055553
=040  \\$aDNLM$cDNLM
=060  \0$aQV 55
=072  \\$aD26.$x670
=150  \\$aPrescription Drugs
=550  \\$wg$aPharmaceutical Preparations
=550  \\$aBehind-the-Counter Drugs
=667  \\$anote category: do not confuse with DRUG PRESCRIPTIONS; DRUG PRESCRIPTIONS are the written directions for obtaining drugs; PRESCRIPTION DRUGS are the drugs that are prescribed
=680  \\$iDrugs that cannot be sold legally without a prescription.
=688  \\$a2009
=750  \0$iBroader mapping$aDrugs$4BM$0(DLC)sh 85039719$5IEN-M

=LDR  00496nz  a2200169n  4500
=001  9880486266402441
=005  20170106114128.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067636
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x310.$x250.$x750
=150  \\$aDrosophila simulans
=450  \\$wnnna$asimulans, Drosophila
=550  \\$wg$aDrosophila
=680  \\$iA species of fruit fly.
=688  \\$a2016
=750  \0$aDrosophila simulans$0(DLC) sh2004000414$5IEN-M

=LDR  01100nz  a2200313n  4500
=001  9880486269002441
=005  20170106112907.0
=008  150702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066448
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x250.$x250
=072  \\$aF1.$x145.$x263.$x500
=072  \\$aI1.$x880.$x735.$x223.$x250
=072  \\$aI3.$x125.$x649
=150  \\$aDriving Under the Influence
=450  \\$wnnna$aDrinking and Driving
=450  \\$wnnna$aDriving While Intoxicated
=450  \\$wnnna$aDrunk Driving
=450  \\$wnnna$aDrunken Driving
=450  \\$wnnna$aDriving and Drinking
=450  \\$wnnna$aDriving, Drunk
=450  \\$wnnna$aDriving, Drunken
=450  \\$wnnna$aWhile Intoxicated, Driving
=550  \\$wg$aAutomobile Driving
=550  \\$aBlood Alcohol Content
=680  \\$iOperating a motor vehicle while impaired by alcohol or other drugs including those prescribed by physicians.
=688  \\$a2016
=750  \0$iNarrower mapping$aDrugged driving$4NM$0(DLC)sh 97006562$5IEN-M
=750  \0$iNarrower mapping$aDrunk driving$4NM$0(DLC)sh 85039787$5IEN-M

=LDR  01936cz  a2200493n  4500
=001  9880487812002441
=005  20170113125019.0
=008  800402\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005786
=040  \\$aDNLM$cDNLM
=060  \0$aQU 475
=072  \\$aG5.$x308
=150  \\$aGene Expression Regulation
=450  \\$wnnna$aExpression Regulation, Gene
=450  \\$wnnna$aRegulation, Gene Action
=450  \\$wnnna$aRegulation, Gene Expression
=450  \\$aGene Action Regulation
=450  \\$aRegulation of Gene Expression
=550  \\$wg$aGenetic Processes
=550  \\$wh$aChromatin Assembly and Disassembly
=550  \\$wh$aDown-Regulation
=550  \\$wh$aEctopic Gene Expression
=550  \\$wh$aEpigenesis, Genetic
=550  \\$wh$aEpistasis, Genetic
=550  \\$wh$aFrameshifting, Ribosomal
=550  \\$wh$aGene Amplification
=550  \\$wh$aGene Expression Regulation, Archaeal
=550  \\$wh$aGene Expression Regulation, Bacterial
=550  \\$wh$aGene Expression Regulation, Developmental
=550  \\$wh$aGene Expression Regulation, Enzymologic
=550  \\$wh$aGene Expression Regulation, Fungal
=550  \\$wh$aGene Expression Regulation, Neoplastic
=550  \\$wh$aGene Expression Regulation, Viral
=550  \\$wh$aProtein Modification, Translational
=550  \\$wh$aRNA Processing, Post-Transcriptional
=550  \\$wh$aTranscriptional Activation
=550  \\$wh$aUp-Regulation
=550  \\$wh$aGene Expression Regulation, Plant
=550  \\$aRNAi Therapeutics
=550  \\$aGene Regulatory Networks
=667  \\$ageneral or unspecified; prefer specifics; DF: GENE EXPRESSION REG
=680  \\$iAny of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
=688  \\$a81
=750  \0$aGenetic regulation$0(DLC)sh 85053870$5IEN-M

=LDR  00788nz  a2200229n  4500
=001  9880495258302441
=005  20170209104117.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066499
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x593.$x524.$x500.$x500
=072  \\$aF2.$x463.$x593.$x932.$x622.$x500
=150  \\$aFacial Recognition
=450  \\$wnnna$aFace Perception
=450  \\$wnnna$aIdentity Recognition
=450  \\$wnnna$aPerception, Face
=450  \\$wnnna$aRecognition, Facial
=450  \\$wnnna$aRecognition, Identity
=550  \\$wg$aPattern Recognition, Visual
=680  \\$iAbility to identify an individual and interpret their feelings and emotions based on their facial expressions.
=688  \\$a2016
=750  \0$aFace perception$0(DLC)sh 85046798$5IEN-M

=LDR  00879nz  a2200253n  4500
=001  9880495259802441
=005  20170209093405.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067190
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x341
=150  \\$aExoskeleton Device
=450  \\$wnnna$aRobotic Exoskeleton
=450  \\$wnnna$aDevice, Exoskeleton
=450  \\$wnnna$aDevices, Exoskeleton
=450  \\$wnnna$aExoskeleton Devices
=450  \\$wnnna$aExoskeleton, Robotic
=450  \\$wnnna$aExoskeletons, Robotic
=450  \\$wnnna$aRobotic Exoskeletons
=550  \\$aRobotics
=550  \\$wg$aEquipment and Supplies
=680  \\$iDevice designed to wear externally to support muscular skeletal system in various movements such as RANGE OF MOTIONS; WEIGHT-BEARING; GAIT; and LOCOMOTION.
=688  \\$a2016
=750  \0$aRobotic exoskeletons$0(DLC)sh2010011967$5IEN-M

=LDR  01193nz  a2200229n  4500
=001  9880495260102441
=005  20170209091929.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067013
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x200.$x252
=150  \\$aEvidence-Based Facility Design
=450  \\$wnnna$aDesign, Evidence-Based Facility
=450  \\$wnnna$aDesigns, Evidence-Based Facility
=450  \\$wnnna$aEvidence Based Facility Design
=450  \\$wnnna$aEvidence-Based Facility Designs
=450  \\$wnnna$aFacility Design, Evidence-Based
=450  \\$wnnna$aFacility Designs, Evidence-Based
=550  \\$wg$aFacility Design and Construction
=680  \\$iAn approach, process, or methodology which emphasizes credible evidence and the best available scientific knowledge, judiciously integrated to achieve the best possible outcomes in structural design. For example, the design of a new OUTPATIENT CLINIC might incorporate a review of published research on outpatient clinic design, decisions on similar past projects, along with interviews with staff and consumers.
=688  \\$a2016
=750  \0$iBroader mapping$aEvidence-based design$4BM$0(DLC)sh2008002680$5IEN-M

=LDR  01405nz  a2200361n  4500
=001  9880495263502441
=005  20170208144328.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068817
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x150.$x500
=072  \\$aD12.$x776.$x395.$x240.$x150.$x750
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x150.$x500
=072  \\$aD23.$x529.$x374.$x410.$x240.$x150.$x750
=150  \\$aEpoetin Alfa
=450  \\$wnnna$aBinocrit
=450  \\$wnnna$aEpoetin Alfa Hexal
=450  \\$wnnna$aEpogen
=450  \\$wnnna$aEprex
=450  \\$wnnna$aHX575
=450  \\$wnnna$aHX575 Compound
=450  \\$wnnna$aHeberitro
=450  \\$wnnna$aProcrit
=450  \\$wnnna$aRecombinant 1-165 Erythropoietin, Glycoform Alpha
=450  \\$wnnna$aAlfa Hexal, Epoetin
=450  \\$wnnna$aAlfa, Epoetin
=450  \\$wnnna$aCompound, HX575
=450  \\$wnnna$aHexal, Epoetin Alfa
=450  \\$wnnna$aRecombinant 1 165 Erythropoietin, Glycoform Alpha
=550  \\$wg$aErythropoietin
=680  \\$iA recombinant glycosylated form of erythropoietin which stimulates the differentiation and proliferation of erythroid precursors. It is used for the treatment of ANEMIA associated with CHRONIC RENAL FAILURE in dialysis and predialysis patients.
=688  \\$a2016 (2011)
=750  \0$aRecombinant erythropoietin$0(DLC)sh 89006947$5IEN-M

=LDR  00761cz  a2200193n  4500
=001  9880495264002441
=005  20170208142548.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069551
=040  \\$aDNLM$cDNLM
=060  \0$aBF 353
=072  \\$aF4.$x96.$x628.$x33
=150  \\$aEnvironmental Psychology
=450  \\$wnnna$aPsychology, Environmental
=550  \\$wg$aPsychology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe field that studies interactions between individuals and the built and natural environment. It includes investigating behaviors that inhibit or foster sustainable, climate-healthy, and nature-enhancing choices.
=688  \\$a2016
=750  \0$aEnvironmental psychology$0(DLC)sh 85044210$5IEN-M

=LDR  01454nz  a2200409n  4500
=001  9880498474202441
=005  20181008115807.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D001691
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x95
=150  \\$aBiological Therapy
=450  \\$wnnna$aBiologic Therapy
=450  \\$wnnna$aBiotherapy
=450  \\$wnnna$aTherapy, Biological
=450  \\$wnnna$aBiologic Therapies
=450  \\$wnnna$aBiological Therapies
=450  \\$wnnna$aBiotherapies
=450  \\$wnnna$aTherapies, Biologic
=450  \\$wnnna$aTherapies, Biological
=450  \\$wnnna$aTherapy, Biologic
=550  \\$wg$aTherapeutics
=550  \\$wh$aBlood Patch, Epidural
=550  \\$wh$aBlood Transfusion
=550  \\$wh$aCell- and Tissue-Based Therapy
=550  \\$wh$aCytapheresis
=550  \\$wh$aFecal Microbiota Transplantation
=550  \\$wh$aGenetic Therapy
=550  \\$wh$aHematopoietic Stem Cell Mobilization
=550  \\$wh$aImmunomagnetic Separation
=550  \\$wh$aImmunomodulation
=550  \\$wh$aOrganotherapy
=550  \\$wh$aPhage Therapy
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iTreatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
=688  \\$a98; use explode 1976-97
=750  \0$aBiological products$xTherapeutic use$0(DLC)sh 90001152$5IEN-M

=LDR  01915nz  a2200577n  4500
=001  9880498654602441
=005  20170228162057.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067571
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x463.$x30.$x140
=150  \\$aFinancial Statements
=450  \\$wnnna$aAssets, Financial
=450  \\$wnnna$aBalance Sheet
=450  \\$wnnna$aCash Flow Statement
=450  \\$wnnna$aEquity, Financial
=450  \\$wnnna$aExpense Statement
=450  \\$wnnna$aIncome Statement
=450  \\$wnnna$aLiabilities, Financial
=450  \\$wnnna$aNet Worth
=450  \\$wnnna$aAsset, Financial
=450  \\$wnnna$aBalance Sheets
=450  \\$wnnna$aCash Flow Statements
=450  \\$wnnna$aEquities, Financial
=450  \\$wnnna$aExpense Statements
=450  \\$wnnna$aFinancial Asset
=450  \\$wnnna$aFinancial Assets
=450  \\$wnnna$aFinancial Equities
=450  \\$wnnna$aFinancial Equity
=450  \\$wnnna$aFinancial Liabilities
=450  \\$wnnna$aFinancial Liability
=450  \\$wnnna$aFinancial Statement
=450  \\$wnnna$aFlow Statement, Cash
=450  \\$wnnna$aFlow Statements, Cash
=450  \\$wnnna$aIncome Statements
=450  \\$wnnna$aLiability, Financial
=450  \\$wnnna$aSheet, Balance
=450  \\$wnnna$aSheets, Balance
=450  \\$wnnna$aStatement, Cash Flow
=450  \\$wnnna$aStatement, Expense
=450  \\$wnnna$aStatement, Financial
=450  \\$wnnna$aStatement, Income
=450  \\$wnnna$aStatements, Cash Flow
=450  \\$wnnna$aStatements, Expense
=450  \\$wnnna$aStatements, Financial
=450  \\$wnnna$aStatements, Income
=450  \\$wnnna$aWorth, Net
=550  \\$wg$aAccounting
=680  \\$iFormal and structured record of financial activities of a business, person, or other entity.
=688  \\$a2016
=750  \0$aFinancial statements$0(DLC)sh 85048313$5IEN-M

=LDR  01259nz  a2200289n  4500
=001  9880498654802441
=005  20170228161353.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069585
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x410.$x240.$x350.$x500
=072  \\$aD12.$x776.$x395.$x240.$x200.$x500
=072  \\$aD12.$x776.$x467.$x374.$x410.$x240.$x350.$x500
=072  \\$aD23.$x529.$x374.$x410.$x240.$x350.$x500
=150  \\$aFilgrastim
=450  \\$wnnna$aG-CSF Recombinant, Human Methionyl
=450  \\$wnnna$aNeupogen
=450  \\$wnnna$aR-metHuG-CSF
=450  \\$wnnna$aRecombinant-Methionyl Human Granulocyte Colony-Stimulating Factor
=450  \\$wnnna$aTopneuter
=450  \\$wnnna$aG CSF Recombinant, Human Methionyl
=450  \\$wnnna$aR metHuG CSF
=450  \\$wnnna$aRecombinant Methionyl Human Granulocyte Colony Stimulating Factor
=550  \\$wg$aGranulocyte Colony-Stimulating Factor
=680  \\$iA recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, and to prepare blood progenitor cells for collection and use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.
=688  \\$a2016 (2011)
=750  \0$aFilgrastim$0(DLC)sh 93005046$5IEN-M

=LDR  00636nz  a2200193n  4500
=001  9880501882502441
=005  20170324164559.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068957
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x693.$x465
=150  \\$aGames, Recreational
=450  \\$wnnna$aGame, Recreational
=450  \\$wnnna$aRecreational Game
=450  \\$wnnna$aRecreational Games
=550  \\$wg$aPlay and Playthings
=680  \\$iActivity typically involving several individuals for the purpose of leisure, amusement, entertainment or pleasure.
=688  \\$a2016
=750  \0$aGames$0(DLC)sh 85052948$5IEN-M

=LDR  00639nz  a2200229n  4500
=001  9880501906302441
=005  20170322173314.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067148
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x352
=150  \\$aFungal Viruses
=450  \\$wnnna$aMycoviruses
=450  \\$wnnna$aFungal Virus
=450  \\$wnnna$aMycovirus
=450  \\$wnnna$aVirus, Fungal
=450  \\$wnnna$aViruses, Fungal
=550  \\$wg$aViruses
=667  \\$acoordinate with specific fungus/ virol
=680  \\$iViruses infecting species of FUNGI.
=688  \\$a2016
=750  \0$aFungal viruses$0(DLC)sh 85052432$5IEN-M

=LDR  00877nz  a2200289n  4500
=001  9880501906502441
=005  20170322171909.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067030
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x606
=072  \\$aJ2.$x200.$x606
=150  \\$aFruit and Vegetable Juices
=450  \\$wnnna$aFruit Juices
=450  \\$wnnna$aVegetable Juices
=450  \\$wnnna$aFruit Juice
=450  \\$wnnna$aJuice, Fruit
=450  \\$wnnna$aJuice, Vegetable
=450  \\$wnnna$aJuices, Fruit
=450  \\$wnnna$aJuices, Vegetable
=450  \\$wnnna$aVegetable Juice
=550  \\$wg$aBeverages
=667  \\$acoordinate with specific fruit or vegetable
=680  \\$iThe liquids extracted from plants.
=688  \\$a2016
=750  \0$aFruit juices$0(DLC)sh 85052173$5IEN-M
=750  \0$aVegetable juices$0(DLC)sh 85142484$5IEN-M

=LDR  01247nz  a2200325n  4500
=001  9880501918302441
=005  20170322105347.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068759
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x425
=072  \\$aD2.$x92.$x63.$x291.$x425
=150  \\$aFormoterol Fumarate
=450  \\$wnnna$a3-Formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
=450  \\$wnnna$aArformoterol
=450  \\$wnnna$aBD 40A
=450  \\$wnnna$aEformoterol
=450  \\$wnnna$aForadil
=450  \\$wnnna$aFormoterol
=450  \\$wnnna$aFormoterol Fumarate, ((R*,R*)-(+-))-isomer
=450  \\$wnnna$aFormoterol, ((R*,R*)-(+-))-isomer
=450  \\$wnnna$aOxis
=550  \\$wg$aEthanolamines
=550  \\$wh$aBudesonide, Formoterol Fumarate Drug Combination
=550  \\$wh$aMometasone Furoate, Formoterol Fumarate Drug Combination
=550  \\$aMometasone Furoate
=550  \\$aAlbuterol
=680  \\$iAn ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
=688  \\$a2016 (1976)
=750  \0$aFormoterol$0(DLC)sh 88004892$5IEN

=LDR  00891nz  a2200229n  4500
=001  9880501922302441
=005  20170322093124.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068299
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x57.$x750
=072  \\$aD2.$x92.$x63.$x291.$x57.$x750
=072  \\$aD2.$x92.$x471.$x683.$x61.$x750
=150  \\$aSalmeterol Xinafoate
=450  \\$wnnna$aSalmeterol
=450  \\$wnnna$aSerevent
=450  \\$wnnna$aXinafoate, Salmeterol
=550  \\$wg$aAlbuterol
=550  \\$wh$aFluticasone Propionate, Salmeterol Xinafoate Drug Combination
=680  \\$iA selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
=688  \\$a2016 (1989)
=750  \0$aSalmeterol$0(DLC)sh2012000859$5IEN-M

=LDR  00954cz  a2200277n  4500
=001  9880501961702441
=005  20170322102219.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068298
=040  \\$aDNLM$cDNLM
=072  \\$aD4.$x210.$x500.$x54.$x79.$x129.$x114
=150  \\$aFluticasone
=450  \\$wnnna$aCutivate
=450  \\$wnnna$aFlixonase
=450  \\$wnnna$aFlixotide
=450  \\$wnnna$aFlonase
=450  \\$wnnna$aFlovent
=450  \\$wnnna$aFlovent HFA
=450  \\$wnnna$aFluticasone Propionate
=450  \\$wnnna$aHFA, Flovent
=450  \\$wnnna$aPropionate, Fluticasone
=550  \\$wg$aAndrostadienes
=550  \\$wh$aFluticasone Propionate, Salmeterol Xinafoate Drug Combination
=680  \\$iA STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.
=688  \\$a2016 (1990)
=750  \0$aFluticasone propionate$0(DLC)sh2012000861$5IEN-M

=LDR  00950nz  a2200241n  4500
=001  9880502358402441
=005  20170329112544.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067495
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x800.$x715.$x500
=072  \\$aN4.$x452.$x871.$x715.$x400
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700.$x690.$x400
=072  \\$aN6.$x850.$x505.$x715.$x500
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800.$x715.$x500
=150  \\$aHealthcare Failure Mode and Effect Analysis
=450  \\$wnnna$aFailure Mode and Effect Analysis
=450  \\$wnnna$aFailure Mode and Effect Analysis, Healthcare
=450  \\$wnnna$aHFMEA
=550  \\$wg$aRisk Assessment
=680  \\$iProspective risk assessment tool aimed at identifying potential risks and their impact in healthcare settings.
=688  \\$a2016
=750  \0$iBroader mapping$aFailure mode and effects analysis$0(DLC)sh2012001105$4BM$5IEN-M

=LDR  00702nz  a2200253n  4500
=001  9880502360402441
=005  20170329104101.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066502
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x403
=072  \\$aI1.$x880.$x853.$x150.$x452
=072  \\$aM1.$x264
=150  \\$aGrandparents
=450  \\$wnnna$aGrandfather
=450  \\$wnnna$aGrandmother
=450  \\$wnnna$aGrandparent
=450  \\$wnnna$aGrandfathers
=450  \\$wnnna$aGrandmothers
=550  \\$wg$aFamily
=550  \\$wg$aPersons
=680  \\$iMember of a family who has children and grandchildren.
=688  \\$a2016
=750  \0$aGrandparents$0(DLC)sh 85056410$5IEN-M

=LDR  00581nz  a2200193n  4500
=001  9880502361002441
=005  20170329094843.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068276
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x443
=150  \\$aGiraffes
=450  \\$wnnna$aOkapis
=450  \\$wnnna$aGiraffe
=450  \\$wnnna$aOkapi
=550  \\$wg$aRuminants
=680  \\$iFour-legged hoofed mammals with extremely long necks and legs belonging to the family Giraffidae.
=688  \\$a2016
=750  \0$aGiraffe$0(DLC)sh 85055000$5IEN-M

=LDR  00633nz  a2200169n  4500
=001  9880502363302441
=005  20251029105131.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068116
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x835.$x550
=150  \\$aGender Dysphoria
=550  \\$wg$aSexual Dysfunctions, Psychological
=680  \\$iA marked difference between the individual's expressed/experienced gender and the gender others would assign him or her, and it must continue for at least six months. (from DSM-5)
=688  \\$a2016
=750  \0$aGender dysphoria$0(DLC)sh 85053731$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  00963cz  a2200205n  4500
=001  9880502862702441
=005  20170331161039.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067836
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x80.$x600.$x250
=150  \\$aHoarding Disorder
=450  \\$aObsessive Hoarding
=450  \\$wnnna$aDisorders, Hoarding
=450  \\$wnnna$aHoarding Disorders
=450  \\$wnnna$aHoarding, Obsessive
=550  \\$wg$aObsessive-Compulsive Disorder
=680  \\$iDisordered behavior associated with clinically significant distress or impairment in social, occupational or other important areas of functioning and persistent difficulty parting with possessions due to a perceived need to save the items and distress associated with discarding them. (from DSM-V) The quantity of collected items sets the behavior apart from normal collecting behaviors.
=688  \\$a2016
=750  \2$aCompulsive hoarding$0(DLC)sh2008001071$5IEN-M

=LDR  00751nz  a2200217n  4500
=001  9880502862902441
=005  20170331155527.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066506
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x725.$x500
=072  \\$aF2.$x463.$x785.$x810.$x500
=150  \\$aHeuristics
=450  \\$wnnna$aRule of Thumb
=450  \\$wnnna$aHeuristic
=550  \\$wg$aProblem Solving
=550  \\$aComputer Heuristics
=550  \\$aArtificial Intelligence
=680  \\$iExperience-based techniques for problem-solving, learning, and discovery that find a solution which is not guaranteed to be optimal, but sufficient for a given set of goals.
=688  \\$a2016
=750  \0$aHeuristic$0(DLC)sh 85060556$5IEN-M

=LDR  00654nz  a2200205n  4500
=001  9880502863602441
=005  20170331152752.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066505
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x217
=150  \\$aHelp-Seeking Behavior
=450  \\$wnnna$aBehavior, Help-Seeking
=450  \\$wnnna$aBehaviors, Help-Seeking
=450  \\$wnnna$aHelp Seeking Behavior
=450  \\$wnnna$aHelp-Seeking Behaviors
=550  \\$wg$aSocial Behavior
=680  \\$iForm of social behavior in which assistance is sought from others.
=688  \\$a2016
=750  \0$aHelp-seeking behavior$0(DLC)sh 85060101$5IEN-M

=LDR  01055nz  a2200265n  4500
=001  9880503327302441
=005  20170406093950.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066511
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x575
=072  \\$aI1.$x880.$x735.$x900.$x688
=150  \\$aIntimate Partner Violence
=450  \\$wnnna$aDating Violence
=450  \\$wnnna$aIntimate Partner Abuse
=450  \\$wnnna$aAbuse, Intimate Partner
=450  \\$wnnna$aPartner Abuse, Intimate
=450  \\$wnnna$aPartner Violence, Intimate
=450  \\$wnnna$aViolence, Dating
=450  \\$wnnna$aViolence, Intimate Partner
=550  \\$wg$aViolence
=550  \\$wh$aSpouse Abuse
=680  \\$iA pattern of assaultive and coercive behavior by an individual against their partner or spouse that may include physical injury, psychological abuse, sexual assault, progressive isolation, stalking, deprivation, intimidation, and reproductive coercion.
=688  \\$a2016
=750  \0$aIntimate partner violence$0(DLC)sh2009000032$5IEN-M

=LDR  00977cz  a2200277n  4500
=001  9880503342702441
=005  20170405113656.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011154
=040  \\$aDNLM$cDNLM
=072  \\$aN1
=150  \\$aPopulation Characteristics
=450  \\$wnnna$aPopulation Heterogeneity
=450  \\$wnnna$aPopulation Statistics
=450  \\$wnnna$aCharacteristic, Population
=450  \\$wnnna$aCharacteristics, Population
=450  \\$wnnna$aHeterogeneity, Population
=450  \\$wnnna$aPopulation Characteristic
=450  \\$wnnna$aStatistics, Population
=550  \\$wh$aDemography
=550  \\$wh$aHealth
=550  \\$wh$aPopulation
=550  \\$wh$aSocioeconomic Factors
=667  \\$aINDEXER: Do not use
=680  \\$iQualities and characterization of various types of populations within a social or geographic group, with emphasis on demography, health status, and socioeconomic factors.
=688  \\$a98; use explode 1970-97

=LDR  00915nz  a2200241n  4500
=001  9880503347802441
=005  20170404154923.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069285
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x608
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x537
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x642
=150  \\$aInfliximab
=450  \\$wnnna$aMAb cA2
=450  \\$wnnna$aMonoclonal Antibody cA2
=450  \\$wnnna$aRemicade
=450  \\$wnnna$aAntibody cA2, Monoclonal
=450  \\$wnnna$acA2, Monoclonal Antibody
=550  \\$wg$aAntibodies, Monoclonal
=680  \\$iA chimeric monoclonal antibody to TNF ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.
=688  \\$a2016 (1997)
=750  \0$aInfliximab$0(DLC) sh2002010978$5IEN-M

=LDR  01536nz  a2200421n  4500
=001  9880503349602441
=005  20170404152645.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068877
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x277.$x456
=072  \\$aD2.$x241.$x223.$x100.$x100.$x435
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x85.$x465
=072  \\$aD3.$x383.$x606.$x405
=072  \\$aD3.$x383.$x742.$x349
=150  \\$aImatinib Mesylate
=450  \\$wnnna$aAlpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
=450  \\$wnnna$aCGP 57148
=450  \\$wnnna$aCGP-57148
=450  \\$wnnna$aCGP57148B
=450  \\$wnnna$aGleevec
=450  \\$wnnna$aGlivec
=450  \\$wnnna$aImatinib
=450  \\$wnnna$aImatinib Methanesulfonate
=450  \\$wnnna$aST 1571
=450  \\$wnnna$aST1571
=450  \\$wnnna$aSTI 571
=450  \\$wnnna$aSTI-571
=450  \\$wnnna$aSTI571
=450  \\$wnnna$aCGP57148
=450  \\$wnnna$aMesylate, Imatinib
=450  \\$wnnna$aMethanesulfonate, Imatinib
=550  \\$wg$aBenzamides
=550  \\$wg$aPiperazines
=550  \\$wg$aPyrimidines
=680  \\$iA tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
=688  \\$a2016 (1996)
=750  \0$aImatinib$0(DLC)sh2002008739$5IEN-M

=LDR  01430nz  a2200385n  4500
=001  9880503350002441
=005  20170404150053.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066388
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x750
=150  \\$aOil and Gas Industry
=450  \\$wnnna$aCrude Oil Industry
=450  \\$wnnna$aGas and Oil Industry
=450  \\$wnnna$aIndustry, Natural Gas
=450  \\$wnnna$aNatural Gas Industry
=450  \\$wnnna$aPetroleum Industry
=450  \\$wnnna$aCrude Oil Industries
=450  \\$wnnna$aGas Industries, Natural
=450  \\$wnnna$aGas Industry, Natural
=450  \\$wnnna$aIndustries, Crude Oil
=450  \\$wnnna$aIndustries, Natural Gas
=450  \\$wnnna$aIndustries, Petroleum
=450  \\$wnnna$aIndustry, Crude Oil
=450  \\$wnnna$aIndustry, Petroleum
=450  \\$wnnna$aNatural Gas Industries
=450  \\$wnnna$aOil Industries, Crude
=450  \\$wnnna$aOil Industry, Crude
=450  \\$wnnna$aPetroleum Industries
=550  \\$wg$aExtraction and Processing Industry
=550  \\$wh$aHydraulic Fracking
=680  \\$iINDUSTRY concerned with the extraction, processing, distribution, marketing and storage of PETROLEUM and NATURAL GAS.
=688  \\$a2015
=750  \0$iNarrower mapping$aPetroleum industry and trade$0(DLC) sh 85100430$4NM$5IEN-M
=750  \0$iNarrower mapping$aGas industry$0(DLC)sh 85053304$4NM$5IEN-M

=LDR  01140nz  a2200253n  4500
=001  9880503350202441
=005  20170404150615.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067071
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x655.$x875.$x750.$x500
=150  \\$aHydraulic Fracking
=450  \\$wnnna$aFraccing
=450  \\$wnnna$aFracking
=450  \\$wnnna$aHydraulic Fracturing
=450  \\$wnnna$aHydrofracking
=450  \\$wnnna$aHydrofracturing
=450  \\$wnnna$aFracking, Hydraulic
=450  \\$wnnna$aFracturing, Hydraulic
=450  \\$wnnna$aHydrofracturings
=550  \\$wg$aOil and Gas Industry
=680  \\$iA drilling technology in which NATURAL GAS is extracted from large deposits of impermeable rock formations known as shale, deep within the earth’s crust. This drilling technique involves injecting large volumes of high-pressure fracturing fluid (a mixture of water, sand, and chemicals) several thousand feet underground, thereby creating cracks or fissures in the shale formation, and releasing trapped gas.
=688  \\$a2016
=750  \0$aHydraulic fracturing$0(DLC)sh 85063317$5IEN-M

=LDR  00525nz  a2200193n  4500
=001  9880503350402441
=005  20170404143552.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068998
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x451
=072  \\$aJ1.$x494.$x650
=150  \\$aHumidifiers
=450  \\$wnnna$aHumidifier
=550  \\$wg$aEquipment and Supplies
=550  \\$aRespiration, Artificial
=680  \\$iMachines that add moisture to the air.
=688  \\$a2016
=750  \0$aHumidifiers$0(DLC)sh 85062930$5IEN-M

=LDR  00755nz  a2200253n  4500
=001  9880511061902441
=005  20200511122452.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068858
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x215.$x784.$x844.$x500
=072  \\$aG7.$x203.$x100.$x831..$x500
=072  \\$aG7.$x203.$x200.$x625
=072  \\$aJ2.$x200.$x831.$x500
=072  \\$aJ2.$x350.$x625
=150  \\$aKombucha Tea
=450  \\$wnnna$aKombucha Teas
=450  \\$wnnna$aTea, Kombucha
=450  \\$wnnna$aTeas, Kombucha
=550  \\$wg$aFermented Foods and Beverages
=550  \\$wg$aTea
=680  \\$iA beverage made by FERMENTATION of black tea and/or green tea.
=688  \\$a2016
=750  \0$aKombucha tea$0(DLC) sh 96005234$5IEN-M

=LDR  00823nz  a2200241n  4500
=001  9880511063402441
=005  20170516161102.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068897
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x590.$x310
=150  \\$aIridescence
=450  \\$wnnna$aGoniochromism
=450  \\$wnnna$aIridescent Coloring
=450  \\$wnnna$aOpalescence
=450  \\$wnnna$aPearlescence
=450  \\$wnnna$aColoring, Iridescent
=450  \\$wnnna$aColorings, Iridescent
=450  \\$wnnna$aIridescent Colorings
=550  \\$wg$aOptical Phenomena
=680  \\$iThe changing of the color of an object due to variations in the angle of illumination or observation.
=688  \\$a2016; for OPALESCENCE (NM) use CARBAMIDE PEROXIDE (NM) 1969-2015
=750  \0$aIridescence$0(DLC) sh 85068066$5IEN-M

=LDR  00674cz  a2200205n  4500
=001  9880520649502441
=005  20170524132401.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D031448
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x313
=150  \\$aDrimia
=450  \\$wnnna$aDrimia maritima
=450  \\$wnnna$aScilla maritima
=450  \\$wnnna$aUrginea maritima
=450  \\$aUrginea
=550  \\$wh$aAsparagaceae
=680  \\$iA plant genus of the family Asparagaceae that contains bufadienolides (BUFANOLIDES). The common name of squill is also used for SCILLA.
=688  \\$a2003
=750  \0$aDrimia$0(DLC)sh 88023178$5IEN-M

=LDR  01346nz  a2200469n  4500
=001  9880520650602441
=005  20180222103902.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070357
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60
=150  \\$aAsparagaceae
=450  \\$wnnna$aAnemarrhenaceae
=450  \\$wnnna$aHesperaloe
=450  \\$wnnna$aNolinoideae
=450  \\$wnnna$aPolianthes
=450  \\$aAgavaceae
=450  \\$aConvallariaceae
=450  \\$aHyacinthaceae
=450  \\$aMuscari
=550  \\$wg$aAsperagales
=550  \\$wh$aAgave
=550  \\$wh$aAnemarrhena
=550  \\$wh$aAsparagus Plant
=550  \\$wh$aCamassia
=550  \\$wh$aConvallaria
=550  \\$wh$aCordyline
=550  \\$wh$aDracaena
=550  \\$wh$aDrimia
=550  \\$wh$aHosta
=550  \\$wh$aHyacinthus
=550  \\$wh$aLiriope Plant
=550  \\$wh$aMaianthemum
=550  \\$wh$aOphiopogon
=550  \\$wh$aPolygonatum
=550  \\$wh$aRuscus
=550  \\$wh$aSansevieria
=550  \\$wh$aScilla
=550  \\$wh$aYucca
=680  \\$iA family of flowering subshrubs and shrubs in the class Magnoliopsida.
=688  \\$a2017; for AGAVACEAE use AGAVACEAE 2002-2016; for CONVALLARIACEAE and MUSCARI use LILIACEAE 2003-2016
=750  \2$aAsparagaceae$0(DLC)sh2003011151$5IEN-M

=LDR  01122cz  a2200253n  4500
=001  9880532558502441
=005  20170628114011.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D004735
=040  \\$aDNLM$cDNLM
=060  \0$aQU 34
=072  \\$aG1.$x154.$x240
=072  \\$aG2.$x111.$x255
=072  \\$aG2.$x216
=150  \\$aEnergy Transfer
=450  \\$wnnna$aTransfer, Energy
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aBiophysical Phenomena
=550  \\$wg$aChemical Phenomena
=550  \\$wh$aFluorescence Resonance Energy Transfer
=550  \\$wh$aLinear Energy Transfer
=680  \\$iThe transfer of energy of a given form among different scales of motion. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed). It includes the transfer of kinetic energy and the transfer of chemical energy. The transfer of chemical energy from one molecule to another depends on proximity of molecules so it is often used as in techniques to measure distance such as the use of FORSTER RESONANCE ENERGY TRANSFER.
=688  \\$a68(65)
=750  \0$aEnergy transfer$0(DLC)sh 85043154$5IEN-M

=LDR  01216cz  a2200325n  4500
=001  9880532572602441
=005  20170607102640.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003359
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x60.$x185
=072  \\$aG1.$x750.$x750.$x235
=072  \\$aG16.$x500.$x200
=072  \\$aN6.$x230.$x300.$x100.$x300
=150  \\$aCosmic Radiation
=450  \\$wnnna$aRadiation, Cosmic
=450  \\$aHZE Particles
=450  \\$wnnna$aCosmic Radiations
=450  \\$wnnna$aHZE Particle
=450  \\$wnnna$aParticle, HZE
=450  \\$wnnna$aParticles, HZE
=450  \\$wnnna$aRadiations, Cosmic
=550  \\$wg$aAstronomical Phenomena
=550  \\$wg$aAtmosphere
=550  \\$wg$aEcological and Environmental Phenomena
=550  \\$wg$aRadiation, Ionizing
=550  \\$aSolar Activity
=667  \\$aentry term HZE PARTICLES stands for High atomic number (Z) Energy particles
=680  \\$iHigh-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft.
=750  \0$aExtraterrestrial radiation$0(DLC)sh 85046592$5IEN-M

=LDR  00822nz  a2200157n  4500
=001  9880534062302441
=005  20170616111718.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071194
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x190
=150  \\$aCamelidae
=550  \\$wg$aArtiodactyla
=680  \\$iThe only extant family of the suborder Tylopoda (order Artiodactyla). Currently living members include domesticated species, DROMEDARIES (with one-hump); BACTRIAN CAMELS (with two humps); LLAMAS; ALPACAS, and wild feral camels; VICUNAS; and GUANACOS. Although they get nutrients from plants by rumination, they evolved separately from the RUMINANTS which have four-chambered stomachs. Camelidae have three-chambered stomachs.
=688  \\$a2017
=750  \0$aCamelidae$0(DLC)sh 85019112$5IEN-M

=LDR  00888cz  a2200205n  4500
=001  9880535758602441
=005  20170628102014.0
=008  960613\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D019418
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x60.$x275.$x500
=072  \\$aG2.$x225
=150  \\$aEvolution, Chemical
=450  \\$aChemical Evolution
=450  \\$wnnna$aChemical Evolutions
=450  \\$wnnna$aEvolutions, Chemical
=550  \\$wg$aChemical Phenomena
=680  \\$iChemical and physical transformation of the biogenic elements from their nucleosynthesis in stars to their incorporation and subsequent modification in planetary bodies and terrestrial biochemistry. It includes the mechanism of incorporation of biogenic elements into complex molecules and molecular systems, leading up to the origin of life.
=688  \\$a97
=750  \0$aMolecular evolution$0(DLC)sh 85022912$5IEN-M

=LDR  00622cz  a2200181n  4500
=001  9880535759002441
=005  20170628102829.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003343
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x165
=150  \\$aCorrosion
=450  \\$wnnna$aCorrosions
=550  \\$wg$aChemical Phenomena
=667  \\$aalmost never IM
=680  \\$iThe gradual destruction of a metal or alloy due to oxidation or action of a chemical agent. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a73(70)
=750  \0$aCorrosion and anti-corrosives$0(DLC)sh 85033050$5IEN-M

=LDR  03326cz  a2200985n  4500
=001  9880535766002441
=005  20170725163839.0
=008  080708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D055598
=040  \\$aDNLM$cDNLM
=072  \\$aG2
=150  \\$aChemical Phenomena
=450  \\$wnnna$aChemical Phenomenon
=450  \\$wnnna$aChemical Process
=450  \\$wnnna$aPhysical Chemistry Phenomena
=450  \\$wnnna$aPhysical Chemistry Process
=450  \\$wnnna$aPhysicochemical Phenomenon
=450  \\$wnnna$aPhysicochemical Process
=450  \\$aChemical Concepts
=450  \\$wnno$aChemical Processes
=450  \\$aPhysical Chemistry Concepts
=450  \\$aPhysical Chemistry Processes
=450  \\$aPhysicochemical Concepts
=450  \\$aPhysicochemical Phenomena
=450  \\$aPhysicochemical Processes
=450  \\$wnnna$aChemical Concept
=450  \\$wnnna$aChemistry Process, Physical
=450  \\$wnnna$aChemistry Processes, Physical
=450  \\$wnnna$aConcept, Chemical
=450  \\$wnnna$aConcept, Physical Chemistry
=450  \\$wnnna$aConcept, Physicochemical
=450  \\$wnnna$aConcepts, Chemical
=450  \\$wnnna$aConcepts, Physical Chemistry
=450  \\$wnnna$aConcepts, Physicochemical
=450  \\$wnnna$aPhenomena, Chemical
=450  \\$wnnna$aPhenomena, Physical Chemistry
=450  \\$wnnna$aPhenomena, Physicochemical
=450  \\$wnnna$aPhenomenon, Chemical
=450  \\$wnnna$aPhenomenon, Physicochemical
=450  \\$wnnna$aPhysical Chemistry Concept
=450  \\$wnnna$aPhysicochemical Concept
=450  \\$wnnna$aProcess, Chemical
=450  \\$wnnna$aProcess, Physical Chemistry
=450  \\$wnnna$aProcess, Physicochemical
=450  \\$wnnna$aProcesses, Chemical
=450  \\$wnnna$aProcesses, Physical Chemistry
=450  \\$wnnna$aProcesses, Physicochemical
=550  \\$wh$aAbsorption
=550  \\$wh$aAdsorption
=550  \\$wh$aAir Ionization
=550  \\$wh$aAnisotropy
=550  \\$wh$aBiochemical Phenomena
=550  \\$wh$aCatalysis
=550  \\$wh$aChemical Precipitation
=550  \\$wh$aCorrosion
=550  \\$wh$aCrystallization
=550  \\$wh$aDesiccation
=550  \\$wh$aDialysis
=550  \\$wh$aDiffusion
=550  \\$wh$aDimerization
=550  \\$wh$aDrug Liberation
=550  \\$wh$aEnergy Transfer
=550  \\$wh$aEvolution, Chemical
=550  \\$wh$aFiltration
=550  \\$wh$aHydrogen Bonding
=550  \\$wh$aHydrogen-Ion Concentration
=550  \\$wh$aHydrolysis
=550  \\$wh$aHydrophobic and Hydrophilic Interactions
=550  \\$wh$aIon Exchange
=550  \\$wh$aMolecular Structure
=550  \\$wh$aMolecular Weight
=550  \\$wh$aNeutron Diffraction
=550  \\$wh$aOrganic Chemistry Phenomena
=550  \\$wh$aOsmolar Concentration
=550  \\$wh$aOsmosis
=550  \\$wh$aOxidation-Reduction
=550  \\$wh$aParticle Size
=550  \\$wh$aPermeability
=550  \\$wh$aPhase Transition
=550  \\$wh$aPolymerization
=550  \\$wh$aX-Ray Diffraction
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes.
=688  \\$a2009
=750  \0$aChemical processes$0(DLC) sh 85022948$5IEN-M

=LDR  00659cz  a2200205n  4500
=001  9880537172902441
=005  20170705100246.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066290
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x400.$x596.$x831
=072  \\$aL1.$x346.$x596.$x831
=150  \\$aLibraries, Special
=450  \\$wnnna$aLibrary, Special
=450  \\$wnnna$aSpecial Libraries
=450  \\$wnnna$aSpecial Library
=550  \\$wg$aLibraries
=680  \\$iCollections covering specialized subjects, containing materials in a special format, or serving a specialized clientele.
=688  \\$a2015
=750  \0$aSpecial libraries$0(DLC)sh 85076573

=LDR  01486nz  a2200433n  4500
=001  9880537173402441
=005  20170705094756.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068636
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x515.$x500
=150  \\$aLegendary Creatures
=450  \\$wnnna$aBigfoot
=450  \\$wnnna$aMermaids
=450  \\$wnnna$aMythical Animals
=450  \\$wnnna$aMythical Creatures
=450  \\$wnnna$aSasquatch
=450  \\$wnnna$aUnicorns
=450  \\$wnnna$aVampires
=450  \\$wnnna$aWerewolves
=450  \\$wnnna$aYeti, Himalayan
=450  \\$wnnna$aAnimal, Mythical
=450  \\$wnnna$aAnimals, Mythical
=450  \\$wnnna$aBigfoots
=450  \\$wnnna$aCreature, Legendary
=450  \\$wnnna$aCreature, Mythical
=450  \\$wnnna$aCreatures, Legendary
=450  \\$wnnna$aCreatures, Mythical
=450  \\$wnnna$aHimalayan Yeti
=450  \\$wnnna$aLegendary Creature
=450  \\$wnnna$aMermaid
=450  \\$wnnna$aMythical Animal
=450  \\$wnnna$aMythical Creature
=450  \\$wnnna$aUnicorn
=450  \\$wnnna$aVampire
=550  \\$wg$aFolklore
=680  \\$iAn unverified animal or humanoid, sometimes supernatural, often believed to be real and described in MYTHOLOGY, FOLKLORE, or legends. Some legendary creatures, such as the unicorn, were documented in scholarly antiquarian accounts of natural history.
=688  \\$a2016
=750  \0$aAnimals, Mythical$0(DLC)sh 85005269$5IEN-M

=LDR  00560nz  a2200193n  4500
=001  9880537174102441
=005  20170705084702.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067408
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x482
=150  \\$aLegal Services
=450  \\$wnnna$aLegal Service
=450  \\$wnnna$aService, Legal
=450  \\$wnnna$aServices, Legal
=550  \\$wg$aJurisprudence
=680  \\$iServices provided by ATTORNEYS and paralegal staff.
=688  \\$a2016
=750  \0$aLegal services$0(DLC)sh 85075770$5IEN-M

=LDR  00706cz  a2200229n  4500
=001  9880539459102441
=005  20170712135745.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067397
=040  \\$aDNLM$cDNLM
=060  \0$aQV 663
=072  \\$aD27.$x720.$x599
=072  \\$aD27.$x720.$x777.$x300.$x500
=150  \\$aNerve Agents
=450  \\$wnnna$aNerve Gas
=450  \\$wnnna$aAgents, Nerve
=450  \\$wnnna$aGas, Nerve
=550  \\$wg$aChemical Warfare Agents
=550  \\$hg$aSpecialty Uses of Chemicals
=680  \\$iA class of compounds that adversely affect the transmission of impulses through the NERVOUS SYSTEM.
=688  \\$a2016
=750  \0$aNerve gases$0(DLC)sh 00010095$5IEN-M

=LDR  00783nz  a2200229n  4500
=001  9880558171102441
=005  20170807104825.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069471
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x910.$x750
=072  \\$aN2.$x360.$x810.$x910.$x750
=150  \\$aNeurosurgeons
=450  \\$wnnna$aNeurological Surgeons
=450  \\$wnnna$aNeurological Surgeon
=450  \\$wnnna$aNeurosurgeon
=450  \\$wnnna$aSurgeon, Neurological
=450  \\$wnnna$aSurgeons, Neurological
=550  \\$wg$aSurgeons
=680  \\$iQualified medical professionals who specialize in surgical treatment of diseases of the BRAIN and other parts of the NERVOUS SYSTEM.
=688  \\$a2016
=750  \0$aNeurosurgeons$0(DLC)sh 85091176$5IEN-M

=LDR  00729nz  a2200229n  4500
=001  9880566034402441
=005  20170827172809.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066792
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x330.$x655
=072  \\$aN2.$x360.$x330.$x655
=150  \\$aOrthodontists
=450  \\$wnnna$aDentofacial Orthopedists
=450  \\$wnnna$aDentofacial Orthopedist
=450  \\$wnnna$aOrthodontist
=450  \\$wnnna$aOrthopedist, Dentofacial
=450  \\$wnnna$aOrthopedists, Dentofacial
=550  \\$wg$aDentists
=680  \\$iDentists who specialize in the treatment of misaligned TEETH and MALOCCLUSION.
=688  \\$a2016
=750  \0$aOrthodontists$0(DLC)sh 85095776$5IEN-M

=LDR  00863cz  a2200277n  4500
=001  9880566034502441
=005  20170827171337.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068797
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x400.$x360
=072  \\$aD12.$x776.$x631.$x650.$x363
=150  \\$aOrexins
=450  \\$wnnna$aHypocretin-1
=450  \\$wnnna$aHypocretin-2
=450  \\$wnnna$aHypocretins
=450  \\$wnnna$aOrexin-A
=450  \\$wnnna$aOrexin-B
=450  \\$wnnna$aHypocretin 1
=450  \\$wnnna$aHypocretin 2
=450  \\$wnnna$aOrexin A
=450  \\$wnnna$aOrexin B
=550  \\$wg$aNeuropeptides
=680  \\$iNeuropeptide hormones that play a role in regulating a variety of behavioral and physiological processes in response to motivational stimuli.
=688  \\$a2016
=750  \0$aOrexins$0(DLC)sh2005000100$5IEN-M

=LDR  00911nz  a2200277n  4500
=001  9880566034702441
=005  20170827165113.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066794
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x330.$x483
=072  \\$aN2.$x360.$x330.$x483
=150  \\$aOral and Maxillofacial Surgeons
=450  \\$wnnna$aExodontists
=450  \\$wnnna$aMaxillofacial Surgeons
=450  \\$wnnna$aOral Surgeons
=450  \\$wnnna$aExodontist
=450  \\$wnnna$aMaxillofacial Surgeon
=450  \\$wnnna$aOral Surgeon
=450  \\$wnnna$aSurgeon, Maxillofacial
=450  \\$wnnna$aSurgeon, Oral
=450  \\$wnnna$aSurgeons, Maxillofacial
=450  \\$wnnna$aSurgeons, Oral
=550  \\$wg$aDentists
=680  \\$iDentists who specialize in the surgical treatment of injuries, diseases, and abnormalities of the oral and maxillofacial regions.
=688  \\$a2016

=LDR  00481cz  a2200169n  4500
=001  9880566034802441
=005  20170827153746.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067656
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x787
=150  \\$aOptimism
=450  \\$wnnna$aPositive Thinking
=550  \\$wg$aAttitude
=680  \\$iMental attitude that interprets life events as generally being positive.
=688  \\$a2016
=750  \0$aOptimism$0(DLC)sh 85095193$5IEN-M

=LDR  01403nz  a2200169n  4500
=001  9880566035002441
=005  20170827154404.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066295
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x737.$x569
=150  \\$aOpen Access Publishing
=450  \\$wnnna$aPublishing, Open Access
=550  \\$wg$aPublishing
=680  \\$iAgreement in which author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use. A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving. (from Bethesda Statement on Open Access Publishing)
=688  \\$a2016
=750  \0$aOpen access publishing$0(DLC)sh2005002533$5IEN-M

=LDR  00792nz  a2200265n  4500
=001  9880566035302441
=005  20170826162904.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069463
=040  \\$aDNLM$cDNLM
=072  \\$aD10.$x212.$x302.$x380.$x580
=072  \\$aD10.$x212.$x507.$x650
=072  \\$aD10.$x627.$x700.$x728
=072  \\$aG7.$x203.$x300.$x375.$x400.$x500
=072  \\$aJ2.$x500.$x375.$x400.$x500
=150  \\$aOlive Oil
=450  \\$wnnna$aOlive Oils
=450  \\$wnnna$aOil, Olive
=450  \\$wnnna$aOils, Olive
=550  \\$wg$aDietary Fats, Unsaturated
=550  \\$wg$aFats, Unsaturated
=550  \\$wg$aPlant Oils
=680  \\$iOil extracted from fruit of the OLIVE TREE (genus Olea).
=688  \\$a2016
=750  \0$aOlive oil$0(DLC)sh 85094619$5IEN-M

=LDR  00720nz  a2200193n  4500
=001  9880568752202441
=005  20170831104845.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067074
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x316.$x483.$x750
=150  \\$aPeer Influence
=450  \\$wnnna$aPeer Pressure
=450  \\$wnnna$aInfluence, Peer
=450  \\$wnnna$aPressure, Peer
=550  \\$wg$aPeer Group
=680  \\$iThe effect or sway that a PEER GROUP exerts on the beliefs, value systems and behavior of each member of a group. The social expectations for individuals to conform to peer group influence is known as peer pressure.
=688  \\$a2016
=750  \0$aPeer pressure$0(DLC)sh 88002571$0IEN-M

=LDR  01015cz  a2200253n  4500
=001  9880364236202441
=005  20190624104423.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027923
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x500.$x500
=150  \\$aSambucus
=450  \\$wnnna$aElder Plant
=450  \\$wnnna$aElder Plants
=450  \\$wnnna$aElderberries
=450  \\$aElderberry
=450  \\$wnnna$aPlant, Elder
=450  \\$wnnna$aPlants, Elder
=550  \\$wg$aAdoxaceae
=550  \\$wh$aSambucus nigra
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family CAPRIFOLIACEAE best known for elderberries.
=688  \\$a2002
=750  \0$aElders (Plants)$5IEN-M$0(DLC)sh 85117016

=LDR  00840cz  a2200193n  4500
=001  9880364236302441
=005  20200430130604.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027922
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x328.$x750
=150  \\$aCaprifoliaceae
=550  \\$wg$aDipsacales
=550  \\$wh$aLonicera
=550  \\$wh$aSymphoricarpos
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida.
=688  \\$a2002
=750  \0$aCaprifoliaceae$5IEN-M$0(DLC)sh 85020003

=LDR  01239cz  a2200253n  4500
=001  9880364236702441
=005  20170524124704.0
=008  010803\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x32
=150  \\$aAgave
=450  \\$wnnna$aAgaves
=450  \\$aCentury Plant
=450  \\$wnnna$aCentury Plants
=450  \\$aMaguey
=450  \\$wnnna$aMagueys
=450  \\$wnnna$aPlant, Century
=450  \\$wnnna$aPlants, Century
=550  \\$wg$aAsparagaceae
=667  \\$aX ref CENTURY PLANT: CENTAURIUM is also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA genus known for fibers obtained from their leaves: sisal from A. sisalana, henequen from A. fourcroyoides and A. cantala, or Manila-Maguey fiber from A. cantala. Some species provide a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.
=688  \\$a2002
=750  \0$aAgaves$5IEN-M$0(DLC)sh 85002066

=LDR  01261cz  a2200289n  4500
=001  9880364236902441
=005  20161121142106.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x625
=150  \\$aPrunus
=450  \\$aChokecherry Tree
=450  \\$wnnna$aChokecherry Trees
=450  \\$wnnna$aTree, Chokecherry
=450  \\$wnnna$aTrees, Chokecherry
=550  \\$wg$aRosaceae
=550  \\$wh$aPrunus africana
=550  \\$wh$aPrunus armeniaca
=550  \\$wh$aPrunus avium
=550  \\$wh$aPrunus domestica
=550  \\$wh$aPrunus dulcis
=550  \\$wg$aPrunus persica
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of edible fruits such as apricot, plum, peach, cherry, and almond.
=688  \\$a2002; for APRICOT use ROSALES 1998-2001, use FRUIT 1963-1997;
=750  \0$aPrunus$5IEN-M$0(DLC)sh 85108043

=LDR  01119cz  a2200241n  4500
=001  9880364237002441
=005  20141212214430.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x444
=150  \\$aMalus
=450  \\$aApple
=450  \\$wnnna$aApples
=450  \\$wnnna$adomestica, Malus
=450  \\$wnnna$adomesticas, Malus
=450  \\$wnnna$aMalus domestica
=450  \\$wnnna$aMalus domesticas
=550  \\$wg$aRosaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of the edible fruit (apple) and is cultivated in temperate climates worldwide.
=688  \\$a2002; for APPLE use Rosales 1998-2001, use FRUIT 1963-1997
=750  \0$aApples$5IEN-M$0(DLC)sh 85006106

=LDR  00910cz  a2200205n  4500
=001  9880364237102441
=005  20141212214429.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x965
=150  \\$aVitaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aAmpelopsis
=550  \\$wh$aCissus
=550  \\$wh$aVitis
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Rhamnales, subclass Rosidae, class Magnoliopsida, best known for the VITIS genus, the source of grapes.
=688  \\$a2002
=750  \0$aVitaceae$5IEN-M$0(DLC)sh 85143945

=LDR  01079cz  a2200229n  4500
=001  9880364237202441
=005  20141212214429.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x965.$x500
=150  \\$aVitis
=450  \\$wnnna$aGrape
=450  \\$aGrapes
=450  \\$wnnna$aRaisin
=450  \\$aRaisins
=450  \\$wnnna$aVitides
=550  \\$wg$aVitaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family VITACEAE, order Rhamnales, subclass Rosidae. It is a woody vine cultivated worldwide. It is best known for grapes, the edible fruit and used to make WINE and raisins.
=688  \\$a2002; for GRAPES use Rosales 1998-2001, use FRUIT 1983-1997, use GRAPES 1963-1982
=750  \0$aGrapes$5IEN-M$0(DLC)sh 85056460

=LDR  01799cz  a2200517n  4500
=001  9880364237302441
=005  20160815112744.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027842
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773.$x900
=150  \\$aSyzygium
=450  \\$aCaryophyllus
=450  \\$wnnna$aCaryophyllus aromaticus
=450  \\$wnnna$aCleistocalyx
=450  \\$aClove
=450  \\$wnnna$aCloves
=450  \\$wnnna$aEugenia aromatica
=450  \\$wnnna$aEugenia caryophyllata
=450  \\$wnnna$aEugenia cumini
=450  \\$wnnna$aEugenia jambolana
=450  \\$wnnna$aEugenia jambos
=450  \\$wnnna$aEugenia malaccensis
=450  \\$wnnna$aEugenia sandwicensis
=450  \\$wnnna$aJambolan Plum Tree
=450  \\$wnnna$aJambolan Plum Trees
=450  \\$wnnna$aJava Plum Tree
=450  \\$wnnna$aJava Plum Trees
=450  \\$wnnna$aPlum Tree, Jambolan
=450  \\$wnnna$aPlum Tree, Java
=450  \\$wnnna$aPlum Trees, Jambolan
=450  \\$wnnna$aPlum Trees, Java
=450  \\$wnnna$aSyzygium aromaticum
=450  \\$wnnna$aSyzygium cumini
=450  \\$wnnna$aSyzygium jambolanum
=450  \\$wnnna$aSyzygium jambos
=450  \\$wnnna$aSyzygium malaccense
=450  \\$wnnna$aSyzygium sandwicense
=450  \\$wnnna$aTree, Jambolan Plum
=450  \\$wnnna$aTree, Java Plum
=450  \\$wnnna$aTrees, Jambolan Plum
=450  \\$wnnna$aTrees, Java Plum
=550  \\$wg$aMyrtaceae
=680  \\$iA plant genus in the family MYRTACEAE. It is known for cloves, which is the flower bud of Syzygium aromaticum and is the source of an oil rich in EUGENOL.
=688  \\$a2016 (2002); for CLOVE use ROSALES 1998-2001, for CLOVE use SPICES 1993-1997
=750  \0$aSyzygium$0(DLC)sh 87006096$5IEN-M

=LDR  00832nz  a2200229n  4500
=001  9881821164602441
=005  20220303090123.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D027841
=035  \\$a(DNLM)D027841
=035  \\$a(NLM)98195324620000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x773.$x777
=150  \\$aPimenta
=450  \\$wnnna$aPimenta officinalis
=450  \\$aAllspice
=450  \\$aPimenta dioica
=450  \\$aPimenta pseudocaryophyllus
=450  \\$wnnna$aPimentas
=680  \\$iA plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae. It is best known for allspice from the dried berry of PIMENTA dioica.
=688  \\$a2021; use Pimenta 2002-2020, Rosales 1998-2001, SPICES 1993-1997
=750  \0$aAllspice$5IEN-M$0(DLC)sh 85003727

=LDR  01049cz  a2200229n  4500
=001  9880364237502441
=005  20141212214428.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027826
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x750
=150  \\$aRosa
=450  \\$wnnna$aRosas
=450  \\$aRose
=450  \\$wnnna$aRosehip
=450  \\$aRosehips
=450  \\$wnnna$aRoses
=550  \\$wg$aRosaceae
=667  \\$ado not confuse with roseroot = Rhodiola; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family ROSACEAE and order Rosales. This should not be confused with the genus RHODIOLA which is sometimes called roseroot.
=688  \\$a2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997
=750  \0$aRoses$5IEN-M$0(DLC)sh 85115443

=LDR  01154cz  a2200241n  4500
=001  9880364237602441
=005  20141212193011.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027825
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500.$x177
=150  \\$aCrataegus
=450  \\$wnnna$aCrataegus monogyna
=450  \\$wnnna$aCrataegus monogynas
=450  \\$aHawthorn
=450  \\$wnnna$aHawthorns
=450  \\$wnnna$amonogyna, Crataegus
=450  \\$wnnna$amonogynas, Crataegus
=550  \\$wg$aRosaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA genus in the family ROSACEAE of shrubs and small trees native to the North Temperate Zone. It is best known for a traditional medication for the heart.
=688  \\$a2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997; for HAWTHORN use ROSALES 1998-2001
=750  \0$aHawthorns$5IEN-M$0(DLC)sh 85059400

=LDR  02317cz  a2200733n  4500
=001  9880364237702441
=005  20141212214428.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027824
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x842.$x500
=150  \\$aRosaceae
=450  \\$aAmelanchier
=450  \\$wnnna$aAmelanchiers
=450  \\$aCercocarpus
=450  \\$wnnna$aChaenomele
=450  \\$aChaenomeles
=450  \\$aColeogyne
=450  \\$wnnna$aColeogynes
=450  \\$aCotoneaster
=450  \\$wnnna$aCotoneasters
=450  \\$aCydonia
=450  \\$wnnna$aCydonias
=450  \\$wnnna$aDryas Plant
=450  \\$wnnna$aDryas Plants
=450  \\$wnnna$aFlowering Quince
=450  \\$wnnna$aFlowering Quinces
=450  \\$wnnna$aMahoganies, Mountain
=450  \\$aMahogany, Mountain
=450  \\$wnnna$aMountain Mahoganies
=450  \\$aMountain Mahogany
=450  \\$wnnna$aPlant, Dryas
=450  \\$wnnna$aPlants, Dryas
=450  \\$aQuince
=450  \\$aQuince, Flowering
=450  \\$wnnna$aQuinces
=450  \\$wnnna$aQuinces, Flowering
=450  \\$wnnna$aServiceberries
=450  \\$aServiceberry
=550  \\$wg$aRosales
=550  \\$wh$aAgrimonia
=550  \\$wh$aAlchemilla
=550  \\$wh$aCrataegus
=550  \\$wh$aEriobotrya
=550  \\$wh$aFilipendula
=550  \\$wh$aFragaria
=550  \\$wh$aGeum
=550  \\$wh$aMalus
=550  \\$wh$aPhotinia
=550  \\$wh$aPotentilla
=550  \\$wh$aPrunus
=550  \\$wh$aPygeum
=550  \\$wh$aPyracantha
=550  \\$wh$aPyrus
=550  \\$wh$aQuillaja
=550  \\$wh$aRosa
=550  \\$wh$aRubus
=550  \\$wh$aSanguisorba
=550  \\$wh$aSorbus
=550  \\$wh$aSpiraea
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.
=688  \\$a2002
=750  \0$aRosaceae$5IEN-M$0(DLC)sh 85115400

=LDR  01177cz  a2200313n  4500
=001  9880364237802441
=005  20141212214427.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027823
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x840
=150  \\$aRhamnaceae
=450  \\$wnnna$aAlphitonia
=450  \\$wnnna$aAlphitonias
=450  \\$aDiscaria
=450  \\$wnnna$aDiscarias
=450  \\$aVentilago
=450  \\$wnnna$aVentilagos
=550  \\$wg$aAngiosperms
=550  \\$wh$aCeanothus
=550  \\$wh$aColubrina
=550  \\$wh$aFrangula
=550  \\$wh$aKarwinskia
=550  \\$wh$aRhamnus
=550  \\$wh$aZiziphus
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe buckthorn plant family, of the order Rhamnales, includes some species with edible fruits and some that are medicinal.
=688  \\$a2002
=750  \0$aRhamnaceae$5IEN-M$0(DLC)sh 85113588

=LDR  01111cz  a2200301n  4500
=001  9880364237902441
=005  20141212214426.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x773
=150  \\$aMyrtaceae
=450  \\$wnnna$aHeteropyxidaceae
=450  \\$wnnna$aMirtaceae
=550  \\$wg$aAngiosperms
=550  \\$wh$aEucalyptus
=550  \\$wh$aEugenia
=550  \\$wh$aFeijoa
=550  \\$wh$aKunzea
=550  \\$wh$aLeptospermum
=550  \\$wh$aMelaleuca
=550  \\$wh$aMyrtus
=550  \\$wh$aPimenta
=550  \\$wh$aPsidium
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iThe myrtle plant family of the order Myrtales. It includes several aromatic medicinal plants such as EUCALYPTUS.
=688  \\$a2002
=750  \0$aMyrtaceae$5IEN-M$0(DLC)sh 85089317

=LDR  02376cz  a2200745n  4500
=001  9880364238002441
=005  20190617140541.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x875
=150  \\$aRutaceae
=450  \\$aAcronychia
=450  \\$wnnna$aAcronychias
=450  \\$wnnna$aAgathosma
=450  \\$wnnna$aAgathosmas
=450  \\$aAtalantia
=450  \\$wnnna$aAtalantias
=450  \\$aAustralian Wild Lime
=450  \\$aBauerella
=450  \\$wnnna$aBauerellas
=450  \\$aFortunella
=450  \\$wnnna$aFortunellas
=450  \\$wnnna$aGlycosmi
=450  \\$aGlycosmis
=450  \\$aHaplophyllum
=450  \\$wnnna$aHaplophyllums
=450  \\$aKumquat
=450  \\$wnnna$aKumquats
=450  \\$aLime, Australian Wild
=450  \\$aMelicope
=450  \\$wnnna$aMelicopes
=450  \\$aMicrocitrus
=450  \\$aRaulinoa
=450  \\$wnnna$aRaulinoas
=450  \\$aSarcomelicope
=450  \\$wnnna$aSarcomelicopes
=450  \\$aSeverinia
=450  \\$wnnna$aSeverinias
=450  \\$aSwinglea
=450  \\$wnnna$aSwingleas
=450  \\$aTeclea
=450  \\$wnnna$aTecleas
=450  \\$wnnna$aVepri
=450  \\$aVepris
=450  \\$wnnna$aWild Lime, Australian
=450  \\$aZieria
=450  \\$wnnna$aZierias
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAegle
=550  \\$wh$aCasimiroa
=550  \\$wh$aCitrus
=550  \\$wh$aClausena
=550  \\$wh$aDictamnus
=550  \\$wh$aEvodia
=550  \\$wh$aMurraya
=550  \\$wh$aPhellodendron
=550  \\$wh$aPilocarpus
=550  \\$wh$aPoncirus
=550  \\$wh$aRuta
=550  \\$wh$aZanthoxylum
=667  \\$aunspecified FAGARA goes here: note FAGARA HORRIDA see GLEDITSIA and FAGARA BONINENSIS, FAGARA RHETZA, FAGARA XANTHOXYLOIDES and FAGARA ZANTHOXYLOIDES see ZANTHOXYLUM are also available; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.
=688  \\$a2002
=750  \0$aRutaceae$5IEN-M$0(DLC)sh 85116078

=LDR  00769cz  a2200169n  4500
=001  9880364238102441
=005  20141212214426.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027807
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x375
=150  \\$aLathyrus
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family FABACEAE known for LATHYRISM poisoning.
=688  \\$a2002; use FABACEAE 1986-2001
=750  \0$aLathyrus$5IEN-M$0(DLC)sh 85074871

=LDR  01079cz  a2200277n  4500
=001  9880364238202441
=005  20141212214426.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027806
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x450
=150  \\$aLens Plant
=450  \\$wnnna$aculinari, Lens
=450  \\$wnnna$aculinaris, Lens
=450  \\$wnnna$aLens culinari
=450  \\$aLens culinaris
=450  \\$wnnna$aLens Plants
=450  \\$wnnna$aLentil
=450  \\$aLentils
=450  \\$wnnna$aPlant, Lens
=450  \\$wnnna$aPlants, Lens
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the FABACEAE family known for the seeds used as food.
=688  \\$a2005(2002); use FABACEAE 1978-2001
=750  \0$aLentils$0(DLC) sh 85076011$5IEN-M

=LDR  01809cz  a2200481n  4500
=001  9880364238302441
=005  20141212193009.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x649
=150  \\$aPhaseolus
=450  \\$wnnna$aacutifolius, Phaseolus
=450  \\$aBean, Kidney
=450  \\$wnnna$aBean Plant, Common
=450  \\$wnnna$aBean Plant, French
=450  \\$wnnna$aBean Plants, Common
=450  \\$wnnna$aBean Plants, French
=450  \\$aBean, Tepary
=450  \\$wnnna$aBeans, Kidney
=450  \\$wnnna$aBeans, Tepary
=450  \\$wnnna$aCommon Bean Plant
=450  \\$wnnna$aCommon Bean Plants
=450  \\$wnnna$aFrench Bean Plant
=450  \\$wnnna$aFrench Bean Plants
=450  \\$aKidney Bean
=450  \\$wnnna$aKidney Beans
=450  \\$wnnna$aPhaseolus acutifolius
=450  \\$wnnna$aPhaseolus vulgari
=450  \\$wnnna$aPhaseolus vulgaris
=450  \\$wnnna$aPlant, Common Bean
=450  \\$wnnna$aPlant, French Bean
=450  \\$wnnna$aPlants, Common Bean
=450  \\$wnnna$aPlants, French Bean
=450  \\$aTepary Bean
=450  \\$wnnna$aTepary Beans
=450  \\$wnnna$avulgari, Phaseolus
=450  \\$wnnna$avulgaris, Phaseolus
=550  \\$wg$aFabaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus in the family FABACEAE which is the source of edible beans and the lectin PHYTOHEMAGGLUTININS.
=688  \\$a2002; use FABACEAE 1978-2001
=750  \0$aBeans$5IEN-M$0(DLC)sh 85012651

=LDR  00705cz  a2200229n  4500
=001  9880364238402441
=005  20180212095709.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x50.$x295
=150  \\$aGalanthus
=450  \\$wnnna$aGalanthus nivali
=450  \\$aGalanthus nivalis
=450  \\$wnnna$anivali, Galanthus
=450  \\$wnnna$anivalis, Galanthus
=450  \\$wnnna$aSnowdrop
=450  \\$aSnowdrops
=550  \\$wg$aAmaryllidaceae
=680  \\$iA plant genus in the family Amaryllidaceae) that contains ALKALOIDS.
=688  \\$a2002
=750  \0$aSnowdrops$5IEN-M$0(DLC)sh 88022798

=LDR  01066cz  a2200277n  4500
=001  9880364238502441
=005  20141212214425.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x100.$x149
=072  \\$aJ2.$x500.$x850.$x243
=150  \\$aChive
=450  \\$aAllium schoenoprasum
=450  \\$wnnna$aAllium tuberosum
=450  \\$wnnna$aChinese Chive
=450  \\$wnnna$aChinese Chives
=450  \\$wnnna$aChive, Chinese
=450  \\$wnnna$aChives
=450  \\$wnnna$aChives, Chinese
=550  \\$wg$aAllium
=550  \\$wg$aVegetables
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant in the genus ALLIUM, similar to ONIONS.
=688  \\$a2002; use Allium 1998-2001
=750  \0$aChive$5IEN-M$0(DLC)sh2002004404

=LDR  01046cz  a2200253n  4500
=001  9880364238602441
=005  20141212214424.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x100.$x800
=072  \\$aJ2.$x500.$x850.$x750
=150  \\$aShallots
=450  \\$aAllium ascalonicum
=450  \\$wnnna$aAllium ascalonicums
=450  \\$wnnna$aascalonicum, Allium
=450  \\$wnnna$aascalonicums, Allium
=450  \\$wnnna$aShallot
=550  \\$wg$aAllium
=550  \\$wg$aVegetables
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iMildly aromatic herb in the Allium genus related to ONIONS and garlic used in SPICES.
=688  \\$a2002; use Allium 1998-2001
=750  \0$aShallot$5IEN$0(DLC)sh 85121079

=LDR  01088cz  a2200205n  4500
=001  9880364238702441
=005  20141212214424.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027762
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x610.$x500
=150  \\$aLilium
=450  \\$wnnna$aLilies
=450  \\$wnnna$aLiliums
=450  \\$aLily
=550  \\$wg$aLiliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family LILIACEAE generally growing in temperate areas. The word lily is also used in the common names of many plants of other genera that resemble true lilies. True lilies are erect perennial plants with leafy stems, scaly bulbs, usually narrow leaves, and solitary or clustered flowers.
=688  \\$a2002; use Liliaceae 1998-2001
=750  \0$aLilies$5IEN-M$0(DLC)sh 85076964

=LDR  01237cz  a2200265n  4500
=001  9880364238802441
=005  20170524130828.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D027761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x99.$x60.$x63
=150  \\$aAsparagus Plant
=450  \\$wnnoa$aAsparagus$5IEN-HS
=450  \\$wnnna$aAsparagus officinali
=450  \\$wnnna$aAsparagus officinalis
=450  \\$wnnna$aAsparagus Plants
=450  \\$wnnna$aofficinali, Asparagus
=450  \\$wnnna$aofficinalis, Asparagus
=450  \\$wnnna$aPlant, Asparagus
=450  \\$wnnna$aPlants, Asparagus
=550  \\$wg$aAsparagaceae
=667  \\$acoord with specific PLANT STRUCTURES and FOOD term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus in the family ASPARAGACEAE that contains ECDYSTEROIDS and is an ingredient of Siotone. The shoots are used as a vegetable and the roots are used in FOLK MEDICINE.
=688  \\$a2002; use Liliaceae 1998-2001
=750  \0$aAsparagus$5IEN-M$0(DLC)sh 85008678

=LDR  00644cz  a2200241n  4500
=001  9880364238902441
=005  20141212214227.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D024301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x750.$x200
=150  \\$aPlant Bark
=450  \\$aBark, Plant
=450  \\$aBark, Tree
=450  \\$wnnna$aBarks, Plant
=450  \\$wnnna$aBarks, Tree
=450  \\$wnnna$aPlant Barks
=450  \\$aTree Bark
=450  \\$wnnna$aTree Barks
=550  \\$wg$aPlant Epidermis
=680  \\$iThe outer layer of the woody parts of plants.
=688  \\$a2002
=750  \0$aBark$5IEN-M$0(DLC)sh 85011862

=LDR  01184cz  a2200337n  4500
=001  9880364239002441
=005  20141212214215.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x337.$x539.$x775
=072  \\$aC4.$x557.$x450.$x795.$x853
=150  \\$aSarcoma, Myeloid
=450  \\$aChloroma
=450  \\$wnnna$aChloromas
=450  \\$wnnna$aExtramedullary Myeloid Cell Tumor
=450  \\$wnnna$aGranulocytic Sarcoma
=450  \\$wnnna$aGranulocytic Sarcomas
=450  \\$wnnna$aMyeloid Cell Tumor, Extramedullary
=450  \\$aMyeloid Sarcoma
=450  \\$wnnna$aMyeloid Sarcomas
=450  \\$aSarcoma, Granulocytic
=450  \\$wnnna$aSarcomas, Granulocytic
=450  \\$wnnna$aSarcomas, Myeloid
=550  \\$wg$aLeukemia, Myeloid
=550  \\$wg$aSarcoma
=680  \\$iAn extramedullary tumor of immature MYELOID CELLS or MYELOBLASTS. Granulocytic sarcoma usually occurs with or follows the onset of ACUTE MYELOID LEUKEMIA.
=688  \\$a2008 (2002)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Sarcoma, Granulocytic
=688  \\$a2002
=750  \0$aChloroma$0(DLC) sh 85024568$5IEN-M

=LDR  01032cz  a2200301n  4500
=001  9880364239102441
=005  20141212214214.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x250.$x285
=072  \\$aC14.$x907.$x585.$x250.$x285
=150  \\$aCoronary Stenosis
=450  \\$wnnna$aArtery Stenoses, Coronary
=450  \\$wnnna$aArtery Stenosis, Coronary
=450  \\$wnnna$aCoronary Artery Stenoses
=450  \\$wnnna$aCoronary Artery Stenosis
=450  \\$wnnna$aCoronary Stenoses
=450  \\$wnnna$aStenoses, Coronary
=450  \\$wnnna$aStenoses, Coronary Artery
=450  \\$wnnna$aStenosis, Coronary
=450  \\$wnnna$aStenosis, Coronary Artery
=550  \\$wg$aCoronary Disease
=550  \\$wh$aCoronary Restenosis
=550  \\$aConstriction, Pathologic
=680  \\$iNarrowing or constriction of a coronary artery.
=688  \\$a2002; use CORONARY DISEASE 1995-2001
=750  \0$aCoronary arteries$xStenosis$0(DLC) sh 90003178$5IEN-M

=LDR  00784cz  a2200217n  4500
=001  9880364239202441
=005  20141212214214.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x647.$x250.$x285.$x200
=072  \\$aC14.$x907.$x585.$x250.$x285.$x200
=150  \\$aCoronary Restenosis
=450  \\$wnnna$aCoronary Restenoses
=450  \\$wnnna$aRestenoses, Coronary
=450  \\$wnnna$aRestenosis, Coronary
=550  \\$wg$aCoronary Stenosis
=550  \\$aNo-Reflow Phenomenon
=680  \\$iRecurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
=688  \\$a2002
=750  \0$aCoronary arteries$xStenosis$xRelapse$0(DLC) sh 98007400$5IEN-M

=LDR  00900cz  a2200277n  4500
=001  9880364239302441
=005  20141212214213.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600.$x631
=072  \\$aE5.$x712.$x315
=072  \\$aE6.$x342.$x488
=150  \\$aPhotography, Dental
=450  \\$wnnna$aDental Photography
=450  \\$wnnna$aIntraoral Photographies
=450  \\$wnnna$aIntraoral Photography
=450  \\$wnnna$aOrthodontic Photography
=450  \\$wnnna$aPhotographies, Intraoral
=450  \\$aPhotography, Intraoral
=450  \\$wnnna$aPhotography, Orthodontic
=550  \\$wg$aDiagnosis, Oral
=550  \\$wg$aPhotography
=680  \\$iPhotographic techniques used in ORTHODONTICS; DENTAL ESTHETICS; and patient education.
=688  \\$a2002
=750  \0$aDental photography$5IEN-M$0(DLC)sh 85101276

=LDR  00914cz  a2200241n  4500
=001  9880364239402441
=005  20141212193000.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x481.$x500.$x311.$x500
=072  \\$aJ1.$x293.$x69.$x249.$x500
=150  \\$aTissue Engineering
=450  \\$wnnna$aEngineering, Tissue
=550  \\$wg$aCell Engineering
=550  \\$aCell- and Tissue-Based Therapy
=550  \\$aGuided Tissue Regeneration
=550  \\$aOrgan Culture Techniques
=550  \\$aRegenerative Medicine
=550  \\$aTissue Expansion
=680  \\$iGenerating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures.
=688  \\$a2002
=750  \0$aTissue engineering$5IEN-M$0(DLC)sh2003001133

=LDR  00839cz  a2200217n  4500
=001  9880364239502441
=005  20141212214212.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x603
=072  \\$aE4.$x555.$x400
=072  \\$aE4.$x680.$x350
=150  \\$aLimb Salvage
=450  \\$wnnna$aSalvage, Limb
=550  \\$wg$aOrthopedic Procedures
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wg$aVascular Surgical Procedures
=680  \\$iAn alternative to amputation in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.
=688  \\$a2002
=750  \0$aLimb salvage$5IEN-M$0(DLC)sh 89000814

=LDR  01176cz  a2200289n  4500
=001  9880364239602441
=005  20141212214211.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x280.$x214
=150  \\$aFundulidae
=450  \\$wnnna$aAtlantic Killifish
=450  \\$aFundulus
=450  \\$wnnna$aFundulus grandis
=450  \\$aFundulus heteroclitus
=450  \\$aGulf Killifish
=450  \\$aKillifish
=450  \\$aKillifish, Gulf
=450  \\$aMummichog
=450  \\$wnnna$aMummichogs
=450  \\$wnnna$aTopminnows
=550  \\$wg$aCyprinodontiformes
=667  \\$ado not confuse X ref TOPMINNOWS with gila topminnows in the family Poeciliidae = CYPRINODONTIFORMES; do not confuse X refs KILLIFISH (Fundulus heteroclitus), GULF KILLIFISH (Fundulus grandis), or ATLANTIC KILLIFISH with KILLIFISHES or with JAPANESE KILLIFISH see ORYZIAS; killifish unspecified goes under KILLIFISHES
=680  \\$iFamily of small, surface-dwelling fish that inhabit fresh and brackish waters, and coastal marine areas.
=688  \\$a2002
=750  \0$aFundulidae$5IEN-M$0(DLC)sh2005001481

=LDR  00661cz  a2200205n  4500
=001  9880364239702441
=005  20141212214211.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850.$x139
=150  \\$aBeloniformes
=450  \\$wnnna$aBelonidae
=450  \\$wnnna$aNeedlefish
=450  \\$aNeedlefishes
=550  \\$wg$aSmegmamorpha
=550  \\$wh$aOryzias
=680  \\$iAn order of fish in the group SMEGMAMORPHA, comprising adrianichthyids, medakas (ORYZIAS), needlefishes, halfbeaks, and flying fishes.
=688  \\$a2002
=750  \0$aBeloniformes$5IEN-M$0(DLC)sh 95004632

=LDR  00582cz  a2200205n  4500
=001  9880364239802441
=005  20141212214211.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x875.$x800
=150  \\$aTakifugu
=450  \\$wnnna$aFugu
=450  \\$wnnna$aFugu rubripes
=450  \\$wnnna$aTakifugu rubripes
=450  \\$wnnna$aTorafugu
=550  \\$wg$aTetraodontiformes
=680  \\$iA genus of pufferfish commonly used for research.
=688  \\$a2002
=750  \0$aFugu$5IEN-M$0(DLC)sh 85052248

=LDR  00805cz  a2200253n  4500
=001  9880364239902441
=005  20141212214210.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023721
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x875
=150  \\$aTetraodontiformes
=450  \\$aBoxfishes
=450  \\$wnnna$aFish, Puffer
=450  \\$wnnna$aOstraciidae
=450  \\$wnnna$aPuffer Fish
=450  \\$aPufferfish
=450  \\$wnnna$aPuffers
=450  \\$wnnna$aTetraodontidae
=550  \\$wg$aFishes
=550  \\$wh$aTakifugu
=680  \\$iA small order of primarily marine fish containing 340 species. Most have a rotund or box-like shape. TETRODOTOXIN is found in their liver and ovaries.
=688  \\$a2002
=750  \0$aTetraodontiformes$5IEN-M$0(DLC)sh 85134216

=LDR  00906cz  a2200229n  4500
=001  9880364240002441
=005  20141212214210.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023702
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x378.$x430
=150  \\$aGymnotiformes
=450  \\$aEigenmannia
=450  \\$wnnna$aEigenmannias
=450  \\$aGymnotid
=450  \\$aGymnotidae
=450  \\$wnnna$aGymnotids
=550  \\$wg$aElectric Fish
=550  \\$wh$aElectrophorus
=680  \\$iAn order of neotropical electric fish found chiefly in the waters of South America. They continually emit weak electric discharges, which they use in object location and communication. A most popular species of research interest is the electric eel, ELECTROPHORUS electricus.
=688  \\$a2002; for GYMNOTID use ELECTRIC FISH 1987-2001
=750  \0$aGymnotiformes$5IEN-M$0(DLC)sh 93000034

=LDR  01331cz  a2200349n  4500
=001  9880364240102441
=005  20141212214210.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x850
=150  \\$aSmegmamorpha
=450  \\$wnnna$aEel, Swamp
=450  \\$wnnna$aEels, Swamp
=450  \\$aGasterosteidae
=450  \\$wnnna$aGasterosteiformes
=450  \\$wnnna$aMullet
=450  \\$aMullets
=450  \\$wnnna$aSeahorse
=450  \\$aSeahorses
=450  \\$wnnna$aStickleback
=450  \\$aSticklebacks
=450  \\$wnnna$aSwamp Eel
=450  \\$aSwamp Eels
=450  \\$wnnna$aSynbranchidae
=550  \\$wg$aFishes
=550  \\$wh$aBeloniformes
=550  \\$wh$aCyprinodontiformes
=667  \\$anote X ref SWAMP EELS; EELS is also available
=680  \\$iGroup of fish under the superorder Acanthopterygii, separate from the PERCIFORMES, which includes swamp eels, mullets, sticklebacks, seahorses, spiny eels, rainbowfishes, and KILLIFISHES. The name is derived from the six taxa which comprise the group. (From http://www.nanfa.org/articles/Elassoma/elassoma.htm, 8/4/2000)
=688  \\$a2002; for STICKLEBACKS use FISHES 1975-2001; for MULLETS use PERCIFORMES 1987-2001
=750  \0$aSynbranchidae$5IEN-M$0(DLC)sh 85131601

=LDR  00968cz  a2200277n  4500
=001  9880364240202441
=005  20141212214209.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x200
=150  \\$aCichlids
=450  \\$wnnna$aCichlid
=450  \\$aCichlid Fish
=450  \\$wnnna$aCichlidae
=450  \\$wnnna$aFish, Cichlid
=450  \\$wnnna$aNile Tilapia
=450  \\$wnnna$aOreochromis nilotica
=450  \\$aOreochromis niloticus
=450  \\$aTilapia nilotica
=550  \\$wg$aPerciformes
=550  \\$wh$aTilapia
=667  \\$anote X refs TILAPIA NILOTICA and NILE TILAPIA; TILAPIA is also available
=680  \\$iCommon name for perch-like fish of the family Cichlidae, belonging to the suborder Labroidei, order PERCIFORMES.
=688  \\$a2002; use PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001
=750  \0$aCichlids$5IEN-M$0(DLC)sh 85025926

=LDR  00509cz  a2200169n  4500
=001  9880364240302441
=005  20141212214208.0
=008  010725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x67
=150  \\$aAlzheimer Vaccines
=450  \\$wnnna$aVaccines, Alzheimer
=550  \\$wg$aVaccines
=680  \\$iVaccines or candidate vaccines used to prevent or treat ALZHEIMER DISEASE.
=688  \\$a2002
=750  \0$aAlzheimer's disease$xVaccination$5IEN-M

=LDR  01027cz  a2200325n  4500
=001  9880364240402441
=005  20141212214132.0
=008  010727\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x352.$x500.$x30
=072  \\$aL1.$x143.$x24
=072  \\$aL1.$x737.$x30
=150  \\$aAccess to Information
=450  \\$wnnna$aFOIA Request
=450  \\$aFOIA Requests
=450  \\$aFreedom of Information Act Requests
=450  \\$wnnna$aInformation, Access to
=450  \\$aOpen Access to Information
=450  \\$aPublic Access to Information
=450  \\$wnnna$aRequest, FOIA
=450  \\$wnnna$aRequests, FOIA
=550  \\$wg$aCommunication
=550  \\$wg$aPrivacy
=550  \\$wg$aPublishing
=550  \\$wh$aPatient Access to Records
=550  \\$aTruth Disclosure
=680  \\$iIndividual's rights to obtain and use information collected or generated by others.
=688  \\$a2001
=750  \0$aFreedom of information$5IEN-M$0(DLC)sh 85051702

=LDR  00697cz  a2200217n  4500
=001  9880364240502441
=005  20141212214208.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023521
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x210.$x250
=150  \\$aChlamydophila Infections
=450  \\$wnnna$aChlamydophila Infection
=450  \\$wnnna$aInfection, Chlamydophila
=450  \\$wnnna$aInfections, Chlamydophila
=550  \\$wg$aChlamydiaceae Infections
=550  \\$wh$aChlamydial Pneumonia
=550  \\$wh$aPsittacosis
=680  \\$iInfections with bacteria of the genus CHLAMYDOPHILA.
=688  \\$a2001
=750  \0$aChlamydophila infections$0(DLC) sh2003009926$5IEN-M

=LDR  00769cz  a2200193n  4500
=001  9880364240602441
=005  20141212214207.0
=008  000623\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x190.$x190.$x230
=150  \\$aChlamydophila
=550  \\$wg$aChlamydiaceae
=550  \\$wh$aChlamydophila pneumoniae
=550  \\$wh$aChlamydophila psittaci
=667  \\$ainfection = CHLAMYDOPHILA INFECTIONS
=680  \\$iA genus of the family CHLAMYDIACEAE comprising gram-negative non CHLAMYDIA TRACHOMATIS-like species infecting vertebrates. Chlamydophila do not produce detectable quantities of glycogen. The type species is CHLAMYDOPHILA PSITTACI.
=688  \\$a2001
=750  \0$aChlamydophila$0(DLC) sh2003009925$5IEN-M

=LDR  00775cz  a2200217n  4500
=001  9880364240702441
=005  20141212214207.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x800.$x100
=072  \\$aI1.$x880.$x735.$x900.$x800.$x100
=072  \\$aI1.$x880.$x735.$x944.$x226.$x100
=150  \\$aBioterrorism
=450  \\$aBiological Terrorism
=450  \\$wnnna$aTerrorism, Biological
=550  \\$wg$aBiological Warfare
=550  \\$wg$aTerrorism
=680  \\$iThe use of biological agents in TERRORISM. This includes the malevolent use of BACTERIA; VIRUSES; or other BIOLOGICAL TOXINS against people, ANIMALS; or PLANTS.
=688  \\$a2001
=750  \0$aBioterrorism$5IEN-M$0(DLC)sh 00006846

=LDR  00905cz  a2200241n  4500
=001  9880364240802441
=005  20141212214207.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023481
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x800
=072  \\$aI1.$x880.$x735.$x900.$x800
=150  \\$aTerrorism
=450  \\$wnnna$aRadioactive Terrorism
=450  \\$wnnna$aTerrorism, Radioactive
=550  \\$wg$aViolence
=550  \\$wh$aBioterrorism
=550  \\$wh$aChemical Terrorism
=550  \\$wh$aMass Casualty Incidents
=550  \\$wh$aSeptember 11 Terrorist Attacks
=680  \\$iThe use or threatened use of force or violence against persons or property in violation of criminal laws for purposes of intimidation, coercion, or ransom, in support of political or social objectives.
=688  \\$a2001; use VIOLENCE 1981-2000
=750  \0$aTerrorism$5IEN-M$0(DLC)sh 85134112

=LDR  01278cz  a2200361n  4500
=001  9880364240902441
=005  20141212214205.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x598
=150  \\$aModels, Animal
=450  \\$wnnna$aAnimal Model
=450  \\$wnnna$aAnimal Model, Experimental
=450  \\$wnnna$aAnimal Model, Laboratory
=450  \\$wnnna$aAnimal Models
=450  \\$wnnna$aAnimal Models, Experimental
=450  \\$wnnna$aAnimal Models, Laboratory
=450  \\$wnnna$aExperimental Animal Model
=450  \\$aExperimental Animal Models
=450  \\$wnnna$aLaboratory Animal Model
=450  \\$aLaboratory Animal Models
=450  \\$wnnna$aModel, Animal
=450  \\$wnnna$aModel, Experimental Animal
=450  \\$wnnna$aModel, Laboratory Animal
=450  \\$wnnna$aModels, Experimental Animal
=450  \\$wnnna$aModels, Laboratory Animal
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aDisease Models, Animal
=550  \\$aAnimal Experimentation
=680  \\$iNon-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.
=688  \\$a2001
=750  \0$aAnimal models in research$5IEN-M$0(DLC)sh 85005212

=LDR  00940cz  a2200265n  4500
=001  9880364241002441
=005  20141212214204.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023382
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x940.$x790
=150  \\$aToxicity Tests, Acute
=450  \\$wnnna$aAcute Toxicity Test
=450  \\$aAcute Toxicity Tests
=450  \\$wnnna$aTest, Acute Toxicity
=450  \\$wnnna$aTests, Acute Toxicity
=450  \\$wnnna$aToxicity Test, Acute
=550  \\$wg$aToxicity Tests
=550  \\$wh$aSkin Irritancy Tests
=667  \\$aTOXICITY TESTS, SUBACUTE is also available
=680  \\$iExperiments designed to determine the potential toxic effects of one-time, short-term exposure to a chemical or chemicals.
=688  \\$a2012 (2001)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Acute Toxicity Tests
=688  \\$a2001
=750  \0$aAcute toxicity testing$0DLC sh 88001077$5IEN-M

=LDR  00857cz  a2200301n  4500
=001  9880364241102441
=005  20141212214201.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D023281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x350
=072  \\$aH1.$x158.$x273.$x343.$x350
=150  \\$aGenomics
=550  \\$wg$aComputational Biology
=550  \\$wg$aGenetics
=550  \\$wh$aEpigenomics
=550  \\$wh$aGlycomics
=550  \\$wh$aHapMap Project
=550  \\$wh$aHuman Genome Project
=550  \\$wh$aMetagenomics
=550  \\$wh$aNutrigenomics
=550  \\$wh$aProteomics
=550  \\$aGenome
=550  \\$aHuman Genome Project
=550  \\$aProteomics
=680  \\$iThe systematic study of the complete DNA sequences (GENOME) of organisms.
=688  \\$a2001
=750  \0$aGenomics$5IEN-M$0(DLC)sh2002000809

=LDR  00601cz  a2200181n  4500
=001  9880364241202441
=005  20141212214153.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022882
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x913
=150  \\$aTrihalomethanes
=450  \\$wnnna$aTrihalomethane
=550  \\$wg$aHydrocarbons, Halogenated
=550  \\$wh$aChloroform
=680  \\$iMethanes substituted with three halogen atoms, which may be the same or different.
=688  \\$a2001; use CHLOROFLUOROCARBONS, METHANE 1984-2000
=750  \0$aTrihalomethanes$5IEN-M$0(DLC)sh 85137529

=LDR  01400cz  a2200385n  4500
=001  9880364241302441
=005  20160418102853.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x37.$x800
=072  \\$aB4.$x909.$x204.$x99.$x800
=072  \\$aB4.$x970.$x60.$x800
=150  \\$aTorque teno virus
=450  \\$wnnna$aSEN-V
=450  \\$aSEN virus
=450  \\$wnnna$aSEN viruses
=450  \\$wnnna$aSENV
=450  \\$wnnna$aTorque teno viruses
=450  \\$aTransfusion-Transmitted Virus
=450  \\$wnnna$aTransfusion Transmitted Virus
=450  \\$aTT Virus
=450  \\$wnnna$aTT Viruses
=450  \\$wnnna$avirus, SEN
=450  \\$wnnna$aVirus, Transfusion-Transmitted
=450  \\$wnnna$aVirus, TT
=450  \\$wnnna$aviruses, SEN
=450  \\$wnnna$aViruses, TT
=550  \\$wg$aAnelloviridae
=667  \\$aa specific virus, not any virus transmitted by transfusion; infection: coord IM with DNA VIRUS INFECTIONS (IM)
=680  \\$iA species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.
=688  \\$a2006 (2001)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Transfusion-Transmitted Virus
=688  \\$a2001
=750  \0$aTorque teno virus$0(DLC)sh2010013163$5IEN-M

=LDR  00733cz  a2200229n  4500
=001  9880364241402441
=005  20141212214150.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x436.$x348
=150  \\$aHepatocytes
=450  \\$wnnna$aCell, Hepatic
=450  \\$wnnna$aCells, Hepatic
=450  \\$wnnna$aHepatic Cell
=450  \\$aHepatic Cells
=450  \\$wnnna$aHepatocyte
=550  \\$wg$aEpithelial Cells
=550  \\$wh$aHep G2 Cells
=680  \\$iThe main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules.
=688  \\$a2001
=750  \0$aLiver cells$0(DLC) sh 85077772$5IEN-M

=LDR  01471cz  a2200397n  4500
=001  9880364241502441
=005  20141212214147.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x735.$x790
=150  \\$aRNA, Untranslated
=450  \\$wnnna$aNon-Coding RNA
=450  \\$wnnna$aNon-Peptide-Coding RNA
=450  \\$wnnna$aNon-Protein-Coding RNA
=450  \\$wnnna$aNoncoding RNA
=450  \\$wnnna$aNontranslated RNA
=450  \\$wnnna$anpcRNA
=450  \\$wnnna$aRNA, Non-Coding
=450  \\$wnnna$aRNA, Non Coding
=450  \\$wnnna$aRNA, Non-Peptide-Coding
=450  \\$wnnna$aRNA, Non Peptide Coding
=450  \\$wnnna$aRNA, Non-Protein-Coding
=450  \\$wnnna$aRNA, Non Protein Coding
=450  \\$wnnna$aRNA, Noncoding
=450  \\$wnnna$aRNA, Nontranslated
=450  \\$wnnna$aUntranslated RNA
=550  \\$wg$aRNA
=550  \\$wh$aRNA, Catalytic
=550  \\$wh$aRNA, Long Noncoding
=550  \\$wh$aRNA, Small Untranslated
=550  \\$wh$aUntranslated Regions
=667  \\$ageneral: prefer specifics; do not confuse with RNA, MESSENGER, STORED
=680  \\$iRNA which does not code for protein but has some enzymatic, structural or regulatory function. Although ribosomal RNA (RNA, RIBOSOMAL) and transfer RNA (RNA, TRANSFER) are also untranslated RNAs they are not included in this scope.
=688  \\$a2001
=750  \0$aNon-coding RNA$0(DLC)sh2006003525$5IEN-M

=LDR  00682cz  a2200205n  4500
=001  9880364241602441
=005  20141212214146.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x818
=150  \\$aVaccines, Contraceptive
=450  \\$wnnna$aAntifertility Vaccines
=450  \\$aContraceptive Vaccines
=450  \\$wnnna$aVaccines, Antifertility
=550  \\$wg$aVaccines
=550  \\$aContraception, Immunologic
=680  \\$iVaccines or candidate vaccines used to prevent conception.
=688  \\$a2001; use CONTRACEPTION, IMMUNOLOGIC (1996-2000)
=750  \0$aAntifertility vaccines$5IEN-M$0(DLC)sh 90004638

=LDR  01880cz  a2200481n  4500
=001  9880364241702441
=005  20141212214145.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022603
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x430.$x700.$x750.$x750
=072  \\$aD23.$x946.$x123.$x794
=072  \\$aD23.$x946.$x330.$x575
=150  \\$aShiga Toxins
=450  \\$wnnna$aCell Cytotoxins, Vero
=450  \\$wnnna$aCytotoxin, Vero
=450  \\$wnnna$aCytotoxin, Vero Cell
=450  \\$wnnna$aCytotoxins, Vero Cell
=450  \\$wnnna$aCytoxins, Vero
=450  \\$wnnna$aShiga-Like Toxins
=450  \\$wnnna$aShiga Like Toxins
=450  \\$wnnna$aToxin, Vero
=450  \\$wnnna$aToxins, Shiga
=450  \\$wnnna$aToxins, Shiga-Like
=450  \\$wnnna$aToxins, Vero
=450  \\$wnnna$aVero Cell Cytotoxin
=450  \\$wnnna$aVero Cell Cytotoxins
=450  \\$wnnna$aVero Cytotoxin
=450  \\$wnnna$aVero Cytoxins
=450  \\$aVero Toxin
=450  \\$aVero Toxins
=450  \\$wnnna$aVerotoxin
=450  \\$wnnna$aVerotoxins
=550  \\$wg$aBacterial Toxins
=550  \\$wg$aEnterotoxins
=550  \\$wg$aRibosome Inactivating Proteins, Type 2
=550  \\$wh$aShiga Toxin
=550  \\$wh$aShiga Toxin 1
=550  \\$wh$aShiga Toxin 2
=667  \\$aSHIGA TOXIN is also available
=680  \\$iA class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; (RNA, RIBOSOMAL) with PEPTIDE ELONGATION FACTORS. They include SHIGA TOXIN which is produced by SHIGELLA DYSENTERIAE and a variety of shiga-like toxins that are produced by pathologic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157.
=688  \\$a2001; for VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN & VERO TOXIN use SHIGA-LIKE TOXIN I (NM) 1980-2000
=750  \0$aVerocytotoxins$0(DLC) sh 89005883$5IEN-M

=LDR  00944cz  a2200217n  4500
=001  9880364241802441
=005  20141212214144.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x685
=150  \\$aSalmonella Vaccines
=450  \\$wnnna$aSalmonellosis Vaccines
=450  \\$aVaccines, Salmonella
=450  \\$wnnna$aVaccines, Salmonellosis
=550  \\$wg$aBacterial Vaccines
=550  \\$wh$aTyphoid-Paratyphoid Vaccines
=667  \\$acoord IM with specific Salmonella species /immunol (IM) but note TYPHOID-PARATYPHOID VACCINES is also available
=680  \\$iVaccines or candidate vaccines used to prevent infection with SALMONELLA. This includes vaccines used to prevent TYPHOID FEVER or PARATYPHOID FEVER; (TYPHOID-PARATYPHOID VACCINES), and vaccines used to prevent nontyphoid salmonellosis.
=688  \\$a2001
=750  \0$aSalmonellosis$xVaccination$5IEN-M

=LDR  01486cz  a2200421n  4500
=001  9880364241902441
=005  20141212214143.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x815.$x500
=072  \\$aD20.$x215.$x894.$x899.$x390
=072  \\$aD20.$x215.$x894.$x899.$x404.$x500
=072  \\$aD20.$x215.$x894.$x899.$x488.$x500
=072  \\$aD20.$x215.$x894.$x899.$x779.$x500
=150  \\$aMeasles-Mumps-Rubella Vaccine
=450  \\$wnnna$aBerna, Triviraten
=450  \\$wnnna$aMeasles, Mumps, Rubella Vaccine
=450  \\$wnnna$aMeasles Mumps Rubella Vaccine
=450  \\$aMMR Vaccine
=450  \\$wnnna$aMumps-Measles-Rubella Vaccine
=450  \\$wnnna$aMumps Measles Rubella Vaccine
=450  \\$wnnna$aPluserix
=450  \\$wnnna$aPriorix
=450  \\$wnnna$aTrimovax
=450  \\$wnnna$aTriviraten Berna
=450  \\$wnnna$aVaccine, Measles-Mumps-Rubella
=450  \\$wnnna$aVaccine, MMR
=450  \\$wnnna$aVaccine, Mumps-Measles-Rubella
=450  \\$wnnna$aVirivac
=550  \\$wg$aMeasles Vaccine
=550  \\$wg$aMumps Vaccine
=550  \\$wg$aRubella Vaccine
=550  \\$wg$aVaccines, Combined
=550  \\$wg$aViral Vaccines
=680  \\$iA combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
=688  \\$a2001; use MEASLES-MUMPS-RUBELLA VACCINE (NM) to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000
=750  \0$aMMR vaccine$0(DLC) sh2005000940$5IEN-M

=LDR  00653cz  a2200193n  4500
=001  9880364242002441
=005  20141212214143.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022541
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x750
=150  \\$aStreptococcal Vaccines
=450  \\$wnnna$aVaccines, Streptococcal
=550  \\$wg$aBacterial Vaccines
=550  \\$wh$aPneumococcal Vaccines
=667  \\$acoord IM with specific Streptococcus species /immunol (IM)
=680  \\$iVaccines or candidate vaccines used to prevent STREPTOCOCCAL INFECTIONS.
=688  \\$a2001
=750  \0$aStreptococcal infections$xVaccination$5IEN-M

=LDR  00754cz  a2200217n  4500
=001  9880364242102441
=005  20141212214142.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x290.$x500
=150  \\$aMarek Disease Vaccines
=450  \\$wnnna$aDisease Vaccines, Marek
=450  \\$wnnna$aMarek's Disease Vaccines
=450  \\$wnnna$aMareks Disease Vaccines
=450  \\$wnnna$aVaccines, Marek Disease
=450  \\$wnnna$aVaccines, Marek's Disease
=550  \\$wg$aHerpesvirus Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent MAREK DISEASE, an avian disease caused by a herpesvirus.
=688  \\$a2001
=750  \0$aMarek's disease$xVaccination$5IEN-M

=LDR  00545cz  a2200169n  4500
=001  9880364242202441
=005  20141212214142.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022482
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x120
=150  \\$aCytomegalovirus Vaccines
=450  \\$wnnna$aVaccines, Cytomegalovirus
=550  \\$wg$aViral Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent infection with CYTOMEGALOVIRUS.
=688  \\$a2001
=750  \0$aCytomegalovirus infections$xVaccination$5IEN-M

=LDR  00750cz  a2200193n  4500
=001  9880364242302441
=005  20141212214140.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x632
=150  \\$aPseudorabies Vaccines
=450  \\$wnnna$aPseudorabies Vaccine
=450  \\$wnnna$aVaccine, Pseudorabies
=450  \\$wnnna$aVaccines, Pseudorabies
=550  \\$wg$aViral Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent PSEUDORABIES (Aujeszky's disease), a herpesvirus of swine and other animals.
=688  \\$a2001; use PSEUDORABIES VACCINES (NM) to search PSEUDORABIES VACCINE 1992-2000
=750  \0$aAujeszky's disease vaccines$5IEN-M$0(DLC)sh 89001513

=LDR  00854cz  a2200241n  4500
=001  9880364242402441
=005  20141212214140.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x955.$x395
=150  \\$aHepatitis A Vaccines
=450  \\$wnnna$aHavrix
=450  \\$wnnna$aHepatitis A Vaccine
=450  \\$wnnna$aHepatovirus Vaccines
=450  \\$wnnna$aVaccine, Hepatitis A
=450  \\$wnnna$aVaccines, Hepatitis A
=450  \\$wnnna$aVaccines, Hepatovirus
=450  \\$wnnna$aVaqta
=550  \\$wg$aViral Hepatitis Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
=688  \\$a2001; use HEPATITIS A VACCINES (NM) to search HEPATITIS A VACCINE 1992-2000
=750  \0$aHepatitis A$xVaccination$5IEN-M

=LDR  00847cz  a2200217n  4500
=001  9880364242502441
=005  20141212214139.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x390
=150  \\$aEscherichia coli Vaccines
=450  \\$aE coli Vaccines
=450  \\$wnnna$aEscherichia coli Vaccine
=450  \\$wnnna$aVaccine, Escherichia coli
=450  \\$wnnna$aVaccines, E coli
=450  \\$wnnna$aVaccines, Escherichia coli
=550  \\$wg$aBacterial Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.
=688  \\$a2001; use ESCHERICHIA COLI VACCINES (NM) to search ESCHERICHIA COLI VACCINE 1983-2000
=750  \0$aEscherichia coli infections$xVaccination$5IEN-M

=LDR  00610cz  a2200181n  4500
=001  9880364242602441
=005  20141212214139.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x970
=150  \\$aYellow Fever Vaccine
=450  \\$wnnna$aFever Vaccine, Yellow
=450  \\$wnnna$aVaccine, Yellow Fever
=550  \\$wg$aViral Vaccines
=680  \\$iVaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.
=688  \\$a2001
=750  \0$aYellow fever vaccine$5IEN-M$0(DLC)sh 85149095

=LDR  00794cz  a2200193n  4500
=001  9880364242702441
=005  20141212214139.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x320
=150  \\$aJapanese Encephalitis Vaccines
=450  \\$wnnna$aEncephalitis Vaccines, Japanese
=450  \\$wnnna$aVaccines, Japanese Encephalitis
=550  \\$wg$aViral Vaccines
=667  \\$avaccines to prevent infections caused by ENCEPHALITIS VIRUS, JAPANESE only, not ENCEPHALITIS VIRUSES, JAPANESE.
=680  \\$iVaccines or candidate vaccines used to prevent infection with Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE).
=688  \\$a2001
=750  \0$aJapanese B encephalitis vaccine$5IEN-M$0(DLC)sh 85069622

=LDR  00786cz  a2200217n  4500
=001  9880364242802441
=005  20141212214139.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x290.$x400
=150  \\$aHerpes Simplex Virus Vaccines
=450  \\$aHSV Vaccines
=450  \\$wnnna$aSimplexvirus Vaccines
=450  \\$wnnna$aVaccines, HSV
=450  \\$wnnna$aVaccines, Simplexvirus
=550  \\$wg$aHerpesvirus Vaccines
=667  \\$acoord IM with specific simplexvirus /immunol (IM)
=680  \\$iVaccines or candidate vaccines used to prevent infection with viruses from the genus SIMPLEXVIRUS. This includes vaccines for HSV-1 and HSV-2.
=688  \\$a2001
=750  \0$aHerpes simplex$xVaccination$5IEN-M

=LDR  00771cz  a2200217n  4500
=001  9880364242902441
=005  20141212214138.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022283
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x290
=150  \\$aHerpesvirus Vaccines
=450  \\$wnnna$aVaccines, Herpesvirus
=550  \\$wg$aViral Vaccines
=550  \\$wh$aChickenpox Vaccine
=550  \\$wh$aHerpes Simplex Virus Vaccines
=550  \\$wh$aMarek Disease Vaccines
=667  \\$acoord IM with specific herpesvirus /immunol (IM) but note specifics
=680  \\$iVaccines or candidate vaccines used to prevent infection by any virus from the family HERPESVIRIDAE.
=688  \\$a2001
=750  \0$aHerpesvirus vaccines$5IEN-M$0(DLC)sh 85060461

=LDR  00669cz  a2200193n  4500
=001  9880364243002441
=005  20141212214138.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x720
=150  \\$aShigella Vaccines
=450  \\$wnnna$aVaccines, Shigella
=550  \\$wg$aBacterial Vaccines
=550  \\$aShigella dysenteriae
=667  \\$acoord IM with specific Shigella species /immunol (IM)
=680  \\$iVaccines or candidate vaccines used to prevent bacillary dysentery (DYSENTERY, BACILLARY) caused by species of SHIGELLA.
=688  \\$a2001
=750  \0$aShigellosis$xVaccination$5IEN-M

=LDR  00521cz  a2200169n  4500
=001  9880364243102441
=005  20141212214138.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022243
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x760
=150  \\$aRotavirus Vaccines
=450  \\$wnnna$aVaccines, Rotavirus
=550  \\$wg$aViral Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent infection with ROTAVIRUS.
=688  \\$a2001
=750  \0$aRotavirus infections$xVaccination$5IEN-M

=LDR  01007cz  a2200265n  4500
=001  9880364243202441
=005  20170331154647.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022242
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x750.$x600
=150  \\$aPneumococcal Vaccines
=450  \\$aPneumococcal Polysaccharide Vaccine
=450  \\$wnnna$aPneumovax
=450  \\$wnnna$aPnu-Imune Vaccine
=450  \\$wnnna$aPnu Imune Vaccine
=450  \\$wnnna$aPnuImune Vaccine
=450  \\$wnnna$aPolysaccharide Vaccine, Pneumococcal
=450  \\$wnnna$aVaccine, Pneumococcal Polysaccharide
=450  \\$wnnna$aVaccines, Pneumococcal
=550  \\$wg$aStreptococcal Vaccines
=550  \\$wh$aHeptavalent Pneumococcal Conjugate Vaccine
=680  \\$iVaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
=688  \\$a2001; use PNEUMOCOCCAL VACCINES (NM) to search PNEUMOVAX 1978-2000
=750  \0$aPneumococcal vaccine$5IEN-M$0(DLC)sh 85103620

=LDR  01507cz  a2200337n  4500
=001  9880364243302441
=005  20141212214136.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022221
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x178.$x190
=072  \\$aA11.$x284.$x187.$x520.$x190
=072  \\$aG5.$x360.$x162.$x178.$x190
=072  \\$aG5.$x360.$x162.$x520.$x190
=072  \\$aG5.$x360.$x337.$x249.$x190
=150  \\$aChromosomes, Artificial, Mammalian
=450  \\$wnnna$aArtificial Chromosome, Mammalian
=450  \\$aArtificial Chromosomes, Mammalian
=450  \\$wnnna$aChromosome, Mammalian Artificial
=450  \\$aChromosomes, Mammalian Artificial
=450  \\$wnnna$aMAC (Chromosome)
=450  \\$wnnna$aMACs (Chromosomes)
=450  \\$wnnna$aMammalian Artificial Chromosome
=450  \\$aMammalian Artificial Chromosomes
=550  \\$wg$aChromosomes, Artificial
=550  \\$wg$aChromosomes, Mammalian
=550  \\$wh$aChromosomes, Artificial, Human
=667  \\$acoord with specific animal /genet only if particularly discussed
=680  \\$iDNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintainance in progeny mammalian cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.
=688  \\$a2002(2001)
=750  \0$aMammalian artificial chromosomes$5IEN-M$0(DLC)sh2003008395

=LDR  01474cz  a2200337n  4500
=001  9880364243402441
=005  20141212214136.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022202
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x178.$x170
=072  \\$aA11.$x284.$x187.$x190.$x170
=072  \\$aA20.$x812.$x170
=072  \\$aG5.$x360.$x162.$x178.$x170
=072  \\$aG5.$x360.$x162.$x190.$x170
=072  \\$aG5.$x360.$x337.$x249.$x170
=150  \\$aChromosomes, Artificial, Bacterial
=450  \\$wnnna$aArtificial Chromosome, Bacterial
=450  \\$aArtificial Chromosomes, Bacterial
=450  \\$wnnna$aBAC (Chromosome)
=450  \\$wnnna$aBACs (Chromosomes)
=450  \\$wnnna$aBacterial Artificial Chromosome
=450  \\$aBacterial Artificial Chromosomes
=450  \\$wnnna$aChromosome, Bacterial Artificial
=450  \\$wnnna$aChromosomes, Bacterial Artificial
=550  \\$wg$aChromosomes, Artificial
=550  \\$wg$aChromosomes, Bacterial
=667  \\$acoord with specific bacterium /genet only if particularly discussed
=680  \\$iDNA constructs that are composed of, at least, a REPLICATION ORIGIN, for successful replication, propagation to and maintenance as an extra chromosome in bacteria. In addition, they can carry large amounts (about 200 kilobases) of other sequence for a variety of bioengineering purposes.
=688  \\$a2002(2001)
=750  \0$aBacterial artificial chromosomes$0(DLC) sh2003008306$5IEN-M

=LDR  01327cz  a2200289n  4500
=001  9880364243502441
=005  20141212214135.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187.$x178
=072  \\$aG5.$x360.$x162.$x178
=072  \\$aG5.$x360.$x337.$x249
=150  \\$aChromosomes, Artificial
=450  \\$wnnna$aArtificial Chromosome
=450  \\$aArtificial Chromosomes
=450  \\$wnnna$aChromosome, Artificial
=550  \\$wg$aChromosomes
=550  \\$wg$aGenetic Vectors
=550  \\$wh$aChromosomes, Artificial, Bacterial
=550  \\$wh$aChromosomes, Artificial, Mammalian
=550  \\$wh$aChromosomes, Artificial, P1 Bacteriophage
=550  \\$wh$aChromosomes, Artificial, Yeast
=667  \\$acoord with specific organism /genet only if particularly discussed; for insertion of the artificial chromosome, coord with GENE TRANSFER TECHNIQUES
=680  \\$iDNA constructs that are composed of, at least, elements such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintenance in progeny cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.
=688  \\$a2001
=750  \0$aArtificial chromosomes$5IEN-M$0(DLC)sh2003008390

=LDR  00919cz  a2200253n  4500
=001  9880364243602441
=005  20141212214133.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022143
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x218
=150  \\$aFamily Nursing
=450  \\$wnnna$aFamily-Centered Nursing
=450  \\$wnnna$aFamily Centered Nursing
=450  \\$wnnna$aFamily-Centered Nursings
=450  \\$wnnna$aFamily Nursings
=450  \\$wnnna$aNursing, Family
=450  \\$wnnna$aNursing, Family-Centered
=450  \\$wnnna$aNursings, Family
=450  \\$wnnna$aNursings, Family-Centered
=550  \\$wg$aSpecialties, Nursing
=680  \\$iThe provision of care involving the nursing process, to families and family members in health and illness situations. From Lippincott Manual of Nursing Practice. 6th ed.
=688  \\$a2001
=750  \0$aFamily nursing$5IEN-M$0(DLC)sh 88002062

=LDR  00505cz  a2200169n  4500
=001  9880364243702441
=005  20141212214132.0
=008  000622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022123
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x492
=150  \\$aLyme Disease Vaccines
=450  \\$aVaccines, Lyme Disease
=550  \\$wg$aBacterial Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent LYME DISEASE.
=688  \\$a2001
=750  \0$aLyme disease$xVaccination$5IEN-M

=LDR  00502cz  a2200169n  4500
=001  9880364243802441
=005  20141212214131.0
=008  000621\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D022122
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x63
=150  \\$aAnthrax Vaccines
=450  \\$aVaccines, Anthrax
=550  \\$wg$aBacterial Vaccines
=680  \\$iVaccines or candidate vaccines used to prevent ANTHRAX.
=688  \\$a2001
=750  \0$aAnthrax$xVaccination$5IEN-M$0(DLC)sh 85005564

=LDR  00321cz  a2200109n  4500
=001  9880364243902441
=005  20040909085110.0
=008  900507\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\b
=035  \\$a(DNLM)D016172Q000662
=040  \\$aDNLM$cDNLM
=150  \\$aDNA Fingerprinting$xveterinary
=750  \0$aDNA fingerprinting of animals$0(DLC) sh2003011280$5IEN-M

=LDR  01286cz  a2200253n  4500
=001  9880364244002441
=005  20141212214004.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x360.$x827
=072  \\$aD27.$x505.$x696.$x399.$x450.$x360.$x827
=150  \\$aSelective Estrogen Receptor Modulators
=450  \\$wnnna$aEstrogen Receptor Modulator, Selective
=450  \\$aEstrogen Receptor Modulators, Selective
=450  \\$wnnna$aSelective Estrogen Receptor Modulator
=450  \\$wnnna$aSERM
=450  \\$aSERMs
=550  \\$wg$aEstrogen Receptor Modulators
=550  \\$aBone Density Conservation Agents
=667  \\$ado not confuse with ESTROGEN RECEPTOR MODULATORS
=680  \\$iA structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
=688  \\$a2000
=750  \0$aSelective estrogen receptor modulators$5IEN-M$0(DLC)sh 98005058

=LDR  00773cz  a2200181n  4500
=001  9880364244102441
=005  20141212213856.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020675
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x585.$x600
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x755.$x600
=150  \\$aPeroxisomes
=450  \\$wnnna$aPeroxisome
=550  \\$wg$aMicrobodies
=680  \\$iMicrobodies which occur in animal and plant cells and in certain fungi and protozoa. They contain peroxidase, catalase, and allied enzymes. (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed)
=688  \\$a2000; use MICROBODIES 1976-1999
=750  \0$aPeroxisomes$5IEN-M$0(DLC)sh 90001242

=LDR  02325cz  a2200505n  4500
=001  9880364244202441
=005  20141212213745.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020426
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x675
=150  \\$aSciatic Neuropathy
=450  \\$wnnna$aLesion of Sciatic Nerve
=450  \\$wnnna$aNerve Disease, Sciatic
=450  \\$wnnna$aNerve Diseases, Sciatic
=450  \\$wnnna$aNerve Lesion, Sciatic
=450  \\$wnnna$aNerve Lesions, Sciatic
=450  \\$wnnna$aNerve Palsies, Sciatic
=450  \\$wnnna$aNerve Palsy, Sciatic
=450  \\$wnnna$aNeuralgia-Neuritides, Sciatic Nerve
=450  \\$wnnna$aNeuralgia-Neuritis, Sciatic Nerve
=450  \\$wnnna$aNeuralgia Neuritis, Sciatic Nerve
=450  \\$wnnna$aNeuritides, Sciatic
=450  \\$wnnna$aNeuritis, Sciatic
=450  \\$wnnna$aNeuropathies, Sciatic
=450  \\$wnnna$aNeuropathy, Sciatic
=450  \\$wnnna$aPalsies, Sciatic Nerve
=450  \\$wnnna$aPalsy, Sciatic Nerve
=450  \\$wnnna$aSciatic Nerve Disease
=450  \\$aSciatic Nerve Diseases
=450  \\$wnnna$aSciatic Nerve Lesion
=450  \\$wnnna$aSciatic Nerve Lesions
=450  \\$wnnna$aSciatic Nerve Neuralgia-Neuritides
=450  \\$wnnna$aSciatic Nerve Neuralgia-Neuritis
=450  \\$wnnna$aSciatic Nerve Palsies
=450  \\$wnnna$aSciatic Nerve Palsy
=450  \\$wnnna$aSciatic Neuritides
=450  \\$wnnna$aSciatic Neuritis
=450  \\$wnnna$aSciatic Neuropathies
=550  \\$wg$aMononeuropathies
=550  \\$wh$aPiriformis Muscle Syndrome
=550  \\$wh$aSciatica
=680  \\$iDisease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE (see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY). Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. (From Adams et al., Principles of Neurology, 6th ed, p1363)
=688  \\$a2000
=750  \0$aSciatic nerve$xDiseases$5IEN-M$0(DLC)sh 85118548

=LDR  03456cz  a2200949n  4500
=001  9880364244302441
=005  20141212213630.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020233
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x404
=072  \\$aC23.$x888.$x592.$x413
=150  \\$aGait Disorders, Neurologic
=450  \\$wnnna$aAmbulation Disorder, Neurologic
=450  \\$aAmbulation Disorders, Neurologic
=450  \\$wnnna$aAthetotic Gait
=450  \\$wnnna$aBroadened Gait
=450  \\$wnnna$aCharcot Gait
=450  \\$wnnna$aCharcot Gaits
=450  \\$wnnna$aCharcot's Gait
=450  \\$wnnna$aCharcots Gait
=450  \\$wnnna$aDrop Foot Gait
=450  \\$wnnna$aDuck Gait
=450  \\$wnnna$aFestinating Gait
=450  \\$wnnna$aFoot Gait, Drop
=450  \\$wnnna$aFrontal Gait
=450  \\$wnnna$aGait, Athetotic
=450  \\$wnnna$aGait, Broadened
=450  \\$wnnna$aGait, Charcot
=450  \\$wnnna$aGait, Charcot's
=450  \\$wnnna$aGait Disorder, Neurologic
=450  \\$wnnna$aGait Disorder, Sensorimotor
=450  \\$wnnna$aGait Disorders, Sensorimotor
=450  \\$wnnna$aGait, Drop Foot
=450  \\$wnnna$aGait, Duck
=450  \\$wnnna$aGait Dysfunction, Neurologic
=450  \\$wnnna$aGait Dysfunctions, Neurologic
=450  \\$wnnna$aGait, Festinating
=450  \\$wnnna$aGait, Frontal
=450  \\$wnnna$aGait, Hemiplegic
=450  \\$wnnna$aGait, Hysterical
=450  \\$wnnna$aGait, Reeling
=450  \\$wnnna$aGait, Rigid
=450  \\$wnnna$aGait, Scissors
=450  \\$wnnna$aGait, Shuffling
=450  \\$wnnna$aGait, Spastic
=450  \\$wnnna$aGait, Stumbling
=450  \\$wnnna$aGait, Unsteady
=450  \\$wnnna$aGait, Widebased
=450  \\$wnnna$aGaits, Charcot
=450  \\$wnnna$aHemiplegic Gait
=450  \\$wnnna$aHysterical Gait
=450  \\$wnnna$aLocomotion Disorder, Neurologic
=450  \\$wnnna$aLocomotion Disorders, Neurologic
=450  \\$wnnna$aMarche a Petit Pas
=450  \\$wnnna$aNeurologic Ambulation Disorder
=450  \\$wnnna$aNeurologic Ambulation Disorders
=450  \\$wnnna$aNeurologic Gait Disorder
=450  \\$wnnna$aNeurologic Gait Disorders
=450  \\$wnnna$aNeurologic Gait Dysfunction
=450  \\$wnnna$aNeurologic Gait Dysfunctions
=450  \\$wnnna$aNeurologic Locomotion Disorder
=450  \\$wnnna$aNeurologic Locomotion Disorders
=450  \\$wnnna$aRapid Fatigue of Gait
=450  \\$wnnna$aReeling Gait
=450  \\$wnnna$aRigid Gait
=450  \\$wnnna$aScissors Gait
=450  \\$wnnna$aSensorimotor Gait Disorder
=450  \\$wnnna$aSensorimotor Gait Disorders
=450  \\$wnnna$aShuffling Gait
=450  \\$wnnna$aShuffling Gaits
=450  \\$wnnna$aSpastic Gait
=450  \\$wnnna$aStumbling Gait
=450  \\$wnnna$aUnsteady Gait
=450  \\$wnnna$aWidebased Gait
=550  \\$wg$aNeurologic Manifestations
=550  \\$wh$aGait Apraxia
=550  \\$wh$aGait Ataxia
=667  \\$aLAMENESS, ANIMAL is also available
=680  \\$iGait abnormalities that are a manifestation of nervous system dysfunction. These conditions may be caused by a wide variety of disorders which affect motor control, sensory feedback, and muscle strength including: CENTRAL NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; or MUSCULAR DISEASES.
=688  \\$a2000
=750  \0$aGait disorders$5IEN-M$0(DLC)sh 85077991

=LDR  01784cz  a2200373n  4500
=001  9880364244402441
=005  20141212213646.0
=008  991108\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020267
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x862.$x800.$x300
=072  \\$aC10.$x228.$x662.$x600.$x700.$x250
=072  \\$aC10.$x720.$x606
=072  \\$aC25.$x723.$x705.$x400
=150  \\$aMPTP Poisoning
=450  \\$a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine$xpoisoning
=450  \\$a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine$xtoxicity
=450  \\$wnnna$aMPTP-Induced Degeneration of the Striatum
=450  \\$wnnna$aMPTP Induced Degeneration of the Striatum
=450  \\$wnnna$aMPTP-Induced Parkinsonism
=450  \\$wnnna$aMPTP Induced Parkinsonism
=450  \\$aMPTP Neurotoxicity Syndrome
=450  \\$wnnna$aMPTP Neurotoxicity Syndromes
=450  \\$wnnna$aNeurotoxicity Syndrome, MPTP
=450  \\$wnnna$aNeurotoxicity Syndromes, MPTP
=450  \\$wnnna$aParkinsonism, MPTP-Induced
=450  \\$wnnna$aPoisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
=450  \\$wnnna$aPoisoning, MPTP
=550  \\$wg$aNeurotoxicity Syndromes
=550  \\$wg$aParkinson Disease, Secondary
=550  \\$a1-Methyl-4-phenylpyridinium
=680  \\$iA condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8)
=688  \\$a2000
=750  \0$aMethylphenyltetrahydropyridine$xToxicology$5IEN-M

=LDR  00797cz  a2200229n  4500
=001  9880364244502441
=005  20141212214046.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627.$x675.$x775
=072  \\$aD10.$x627.$x700.$x940
=072  \\$aD20.$x215.$x784.$x750.$x940
=150  \\$aTea Tree Oil
=450  \\$aMelaleuca alternifolia Oil
=450  \\$wnnna$aOil, Melaleuca alternifolia
=450  \\$wnnna$aOil, Tea Tree
=550  \\$wg$aOils, Volatile
=550  \\$wg$aPlant Oils
=680  \\$iEssential oil extracted from Melaleuca alternifolia (tea tree). It is used as a topical antimicrobial due to the presence of terpineol.
=688  \\$a2000; use TEA TREE OIL (NM) 1993-1999
=750  \0$aMelaleuca alternifolia oil$5IEN-M

=LDR  05121cz  a2201381n  4500
=001  9880364244602441
=005  20141212214025.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020912
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x277.$x600
=072  \\$aD2.$x241.$x223.$x100.$x100.$x600
=072  \\$aD2.$x241.$x223.$x100.$x200.$x875
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x85.$x600
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x250.$x875
=150  \\$aMoclobemide
=450  \\$wnnna$a1A Brand of Moclobemide
=450  \\$wnnna$aAlphapharm Brand of Moclobemide
=450  \\$wnnna$aAlpharma Brand of Moclobemide
=450  \\$wnnna$aApo-Moclobemide
=450  \\$wnnna$aApo Moclobemide
=450  \\$wnnna$aApotex Brand of Moclobemide
=450  \\$wnnna$aArima
=450  \\$wnnna$aAurorex
=450  \\$wnnna$aAurorix
=450  \\$wnnna$aAZU, Moclobemid
=450  \\$wnnna$aAzupharma Brand of Moclobemide
=450  \\$wnnna$aBC Brand of Moclobemide
=450  \\$wnnna$abetapharm Brand of Moclobemide
=450  \\$wnnna$aBull Brand of Moclobemide
=450  \\$wnnna$aChem mart Brand of Moclobemide
=450  \\$wnnna$aChem mart Moclobemide
=450  \\$wnnna$act-Arzneimittel Brand of Moclobemide
=450  \\$wnnna$act Arzneimittel Brand of Moclobemide
=450  \\$wnnna$aDBL Moclobemide
=450  \\$wnnna$aDeprenorm
=450  \\$wnnna$aesparma Brand of Moclobemide
=450  \\$wnnna$aFaulding Brand of Moclobemide
=450  \\$wnnna$aFeraken
=450  \\$wnnna$aGenRX Moclobemide
=450  \\$wnnna$aHealthsense Brand of Moclobemide
=450  \\$wnnna$aHealthsense Moclobemide
=450  \\$wnnna$aHexal Brand of Moclobemide
=450  \\$wnnna$aHoffmann-La Roche Brand of Moclobemide
=450  \\$wnnna$aHoffmann La Roche Brand of Moclobemide
=450  \\$wnnna$aKendrick Brand of Moclobemide
=450  \\$wnnna$aManerix
=450  \\$wnnna$aMerck dura Brand of Moclobemide
=450  \\$wnnna$aMoclamine
=450  \\$wnnna$aMoclix
=450  \\$wnnna$aMoclobamide
=450  \\$wnnna$aMoclobemid-1A Pharma
=450  \\$wnnna$aMoclobemid 1A Pharma
=450  \\$wnnna$aMoclobemid AZU
=450  \\$wnnna$aMoclobemid-Puren
=450  \\$wnnna$aMoclobemid Puren
=450  \\$wnnna$aMoclobemid-ratiopharm
=450  \\$wnnna$aMoclobemid ratiopharm
=450  \\$wnnna$aMoclobemid Stada
=450  \\$wnnna$aMoclobemid von ct
=450  \\$wnnna$aMoclobemid1A Pharma
=450  \\$wnnna$aMoclobemide 1A Brand
=450  \\$wnnna$aMoclobemide Alphapharm Brand
=450  \\$wnnna$aMoclobemide Alpharma Brand
=450  \\$wnnna$aMoclobemide Apotex Brand
=450  \\$wnnna$aMoclobemide Azupharma Brand
=450  \\$wnnna$aMoclobemide BC Brand
=450  \\$wnnna$aMoclobemide betapharm Brand
=450  \\$wnnna$aMoclobemide Bull Brand
=450  \\$wnnna$aMoclobemide, Chem mart
=450  \\$wnnna$aMoclobemide ct-Arzneimittel Brand
=450  \\$wnnna$aMoclobemide, DBL
=450  \\$wnnna$aMoclobemide esparma Brand
=450  \\$wnnna$aMoclobemide Faulding Brand
=450  \\$wnnna$aMoclobemide, GenRX
=450  \\$wnnna$aMoclobemide, Healthsense
=450  \\$wnnna$aMoclobemide Healthsense Brand
=450  \\$wnnna$aMoclobemide Hexal Brand
=450  \\$wnnna$aMoclobemide Kendrick Brand
=450  \\$wnnna$aMoclobemide Novopharm Brand
=450  \\$wnnna$aMoclobemide Nu-Pharm Brand
=450  \\$wnnna$aMoclobemide Pharmascience Brand
=450  \\$wnnna$aMoclobemide ratiopharm Brand
=450  \\$wnnna$aMoclobemide Roche Brand
=450  \\$wnnna$aMoclobemide Stadapharm Brand
=450  \\$wnnna$aMoclobemide Temmler Brand
=450  \\$wnnna$aMoclobeta
=450  \\$wnnna$aMoclodura
=450  \\$wnnna$aMoclonorm
=450  \\$wnnna$aNovo-Moclobemide
=450  \\$wnnna$aNovo Moclobemide
=450  \\$wnnna$aNovoMoclobemide
=450  \\$wnnna$aNovopharm Brand of Moclobemide
=450  \\$wnnna$aNu-Moclobemide
=450  \\$wnnna$aNu Moclobemide
=450  \\$wnnna$aNu-Pharm Brand of Moclobemide
=450  \\$wnnna$aNu Pharm Brand of Moclobemide
=450  \\$wnnna$aNuMoclobemide
=450  \\$wnnna$aPharmascience Brand of Moclobemide
=450  \\$wnnna$aPMS-Moclobemide
=450  \\$wnnna$aPMS Moclobemide
=450  \\$wnnna$aratiopharm Brand of Moclobemide
=450  \\$wnnna$aRimoc
=450  \\$wnnna$aRo 11-1163
=450  \\$wnnna$aRo-11-1163
=450  \\$wnnna$aRo 11 1163
=450  \\$wnnna$aRoche Brand of Moclobemide
=450  \\$wnnna$aStada, Moclobemid
=450  \\$wnnna$aStadapharm Brand of Moclobemide
=450  \\$wnnna$aTemmler Brand of Moclobemide
=450  \\$wnnna$aTerry White Chemists Brand of Moclobemide
=450  \\$wnnna$aTerry White Chemists Moclobemide
=450  \\$wnnna$avon ct, Moclobemid
=550  \\$wg$aBenzamides
=550  \\$wg$aChlorobenzoates
=680  \\$iA reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
=688  \\$a2000; use MOCLOBEMIDE (NM) 1982-1999
=750  \0$aMoclobemide$5IEN-M$0(DLC)sh 87007396

=LDR  00732cz  a2200181n  4500
=001  9880364244702441
=005  20141212213856.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020676
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x585.$x250
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x755.$x250
=150  \\$aGlyoxysomes
=450  \\$wnnna$aGlyoxysome
=550  \\$wg$aMicrobodies
=680  \\$iMicrobodies which occur in plant cells, and in some eukaryotic microorganisms, and which contain enzymes of the glyoxylate cycle. (Singleton and Stainsbury, Dictionary of Microbiology and Molecular Biology, 2nd ed)
=688  \\$a2000
=750  \0$aGlyoxysomes$5IEN-M$0(DLC)sh 85055418

=LDR  01349cz  a2200301n  4500
=001  9880364244802441
=005  20141212213812.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020511
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x758
=150  \\$aNeuromuscular Junction Diseases
=450  \\$wnnna$aNeuromuscular Junction Disease
=450  \\$wnnna$aNeuromuscular Junction Disorder
=450  \\$wnnna$aNeuromuscular Junction Disorders
=450  \\$wnnna$aNeuromuscular Junction Toxic Disorders
=450  \\$wnnna$aNeuromuscular Transmission Disorder
=450  \\$wnnna$aNeuromuscular Transmission Disorders
=450  \\$wnnna$aToxic Disorders, Neuromuscular Junction
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wh$aBotulism
=550  \\$wh$aLambert-Eaton Myasthenic Syndrome
=550  \\$wh$aMyasthenia Gravis
=550  \\$wh$aMyasthenic Syndromes, Congenital
=550  \\$aChannelopathies
=680  \\$iConditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
=688  \\$a2000
=750  \0$aMyoneural junction$xDiseases$5IEN-M

=LDR  01667cz  a2200397n  4500
=001  9880364244902441
=005  20141212213905.0
=008  991109\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020711
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x706.$x615.$x917
=072  \\$aN6.$x850.$x460.$x350.$x600.$x807
=150  \\$aThreshold Limit Values
=450  \\$aShort-Term Exposure Limit
=450  \\$wnnna$aSTEL
=450  \\$wnnna$aSTELs
=450  \\$wnnna$aTLV-Biological Limit Value
=450  \\$wnnna$aTLV-BLV
=450  \\$wnnna$aTLV BLV
=450  \\$wnnna$aTLV-BLVs
=450  \\$wnnna$aTLV-Ceiling
=450  \\$wnnna$aTLV Ceiling
=450  \\$wnnna$aTLV-Ceilings
=450  \\$wnnna$aTLV-STEL
=450  \\$wnnna$aTLV STEL
=450  \\$wnnna$aTLV-STELs
=450  \\$wnnna$aTLV-Time Weighted Average
=450  \\$wnnna$aTLV-TWA
=450  \\$wnnna$aTLV TWA
=450  \\$wnnna$aTLV-TWAs
=550  \\$wg$aLegislation as Topic
=550  \\$wg$aOccupational Exposure
=667  \\$aDF: STEL
=680  \\$iStandards for limiting worker exposure to airborne contaminants. They are the maximum concentration in air at which it is believed that a particular substance will not produce adverse health effects with repeated daily exposure. It can be a time-weighted average (TLV-TWA), a short-term value (TLV-STEL), or an instantaneous value (TLV-Ceiling). They are expressed either as parts per million (ppm) or milligram per cubic meter (mg/m3).
=688  \\$a2000; use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999; for TLV use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999
=750  \0$aThreshold limit values (Industrial toxicology)$5IEN-M$0(DLC)sh 85135047

=LDR  00937cz  a2200217n  4500
=001  9880364245002441
=005  20141212213846.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x110
=072  \\$aB3.$x440.$x400.$x425.$x200.$x40
=072  \\$aB3.$x660.$x50.$x35.$x40
=150  \\$aAfipia
=450  \\$aAfipia felis
=550  \\$wg$aBradyrhizobiaceae
=550  \\$wg$aGram-Negative Aerobic Rods and Cocci
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM) or CAT-SCRATCH DISEASE (IM)
=680  \\$iA genus of gram-negative, oxidase-positive, nonfermentative rods which are motile by means of a single flagellum. Afipia felis and BARTONELLA HENSELAE are causative agents of CAT-SCRATCH DISEASE. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
=688  \\$a2000
=750  \0$aAfipia infections$5IEN-M$0(DLC)sh 98002721

=LDR  02181cz  a2200541n  4500
=001  9880364245102441
=005  20141212213709.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020323
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x700
=072  \\$aC23.$x888.$x592.$x350.$x700
=150  \\$aTics
=450  \\$wnnna$aChorea, Habit
=450  \\$wnnna$aChoreas, Habit
=450  \\$wnnna$aGestural Tic
=450  \\$wnnna$aGestural Tics
=450  \\$wnnna$aHabit Chorea
=450  \\$wnnna$aHabit Choreas
=450  \\$aHabit Spasm
=450  \\$wnnna$aHabit Spasms
=450  \\$wnnna$aHabituation Spasm
=450  \\$wnnna$aHabituation Spasms
=450  \\$wnnna$aMotor Tic
=450  \\$wnnna$aMotor Tics
=450  \\$wnnna$aSpasm, Habit
=450  \\$wnnna$aSpasm, Habituation
=450  \\$wnnna$aSpasms, Habit
=450  \\$wnnna$aSpasms, Habituation
=450  \\$wnnna$aTic
=450  \\$wnnna$aTic, Gestural
=450  \\$aTic, Motor
=450  \\$wnnna$aTic, Transient
=450  \\$aTic, Vocal
=450  \\$wnnna$aTics, Gestural
=450  \\$wnnna$aTics, Motor
=450  \\$wnnna$aTics, Transient
=450  \\$wnnna$aTics, Vocal
=450  \\$wnnna$aTransient Tic
=450  \\$wnnna$aTransient Tics
=450  \\$wnnna$aVocal Tic
=450  \\$wnnna$aVocal Tics
=550  \\$wg$aDyskinesias
=550  \\$aTourette Syndrome
=667  \\$aTIC DISORDERS is available
=680  \\$iHabitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, pp109-10)
=688  \\$a2000
=750  \0$aTic disorders$5IEN-M$0(DLC)sh 85135241

=LDR  00753cz  a2200205n  4500
=001  9880364245202441
=005  20141212213840.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020592
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x690
=072  \\$aB3.$x660.$x250.$x21.$x755
=150  \\$aShewanella
=550  \\$wg$aAlteromonadaceae
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wh$aShewanella putrefaciens
=667  \\$ainfection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish.
=688  \\$a2000
=750  \0$aShewanella$5IEN-M$0(DLC)sh 98005961

=LDR  01369cz  a2200229n  4500
=001  9880364245302441
=005  20141212213704.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x570
=072  \\$aC10.$x228.$x228.$x180.$x850
=150  \\$aTuberculosis, Central Nervous System
=450  \\$wnnna$aCentral Nervous System Tuberculosis
=550  \\$wg$aCentral Nervous System Bacterial Infections
=550  \\$wg$aTuberculosis
=550  \\$wh$aTuberculoma, Intracranial
=550  \\$wh$aTuberculosis, Meningeal
=667  \\$aDF: TUBERCULOSIS CNS
=680  \\$iTuberculosis of the brain, spinal cord, or meninges (TUBERCULOSIS, MENINGEAL), most often caused by MYCOBACTERIUM TUBERCULOSIS and rarely by MYCOBACTERIUM BOVIS. The infection may be limited to the nervous system or coexist in other organs (e.g., TUBERCULOSIS, PULMONARY). The organism tends to seed the meninges causing a diffuse meningitis and leads to the formation of TUBERCULOMA, which may occur within the brain, spinal cord, or perimeningeal spaces. Tuberculous involvement of the vertebral column (TUBERCULOSIS, SPINAL) may result in nerve root or spinal cord compression. (From Adams et al., Principles of Neurology, 6th ed, pp717-20)
=688  \\$a2000
=750  \0$aCentral nervous system$xTuberculosis$5IEN-M

=LDR  01483cz  a2200361n  4500
=001  9880364245402441
=005  20141212192957.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020950
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x960.$x888
=150  \\$aVitex
=450  \\$wnnna$aagnus-castus, Vitex
=450  \\$wnnna$aChaste Tree
=450  \\$wnnna$aChaste Trees
=450  \\$wnnna$aChasteberries
=450  \\$wnnna$aChasteberry
=450  \\$wnnna$aChasteberry Tree
=450  \\$wnnna$aChasteberry Trees
=450  \\$wnnna$aChastetree
=450  \\$wnnna$aChastetrees
=450  \\$wnnna$aTree, Chaste
=450  \\$wnnna$aTree, Chasteberry
=450  \\$wnnna$aTrees, Chaste
=450  \\$wnnna$aTrees, Chasteberry
=450  \\$aVitex agnus-castus
=450  \\$wnnna$aVitex agnus castus
=450  \\$wnnna$aVitices
=550  \\$wg$aVerbenaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA genus of trees in the VERBENACEAE (sometimes classified in the LAMIACEAE) family containing assorted flavonoids with possible analgesic and antineoplastic properties. The fruit of these trees is used in herbal preparations.
=688  \\$a2000
=750  \0$aVitex$5IEN-M$0(DLC)sh 97008690

=LDR  01031cz  a2200253n  4500
=001  9880364245502441
=005  20141212213951.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020809
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x105.$x250
=072  \\$aC10.$x228.$x228.$x205.$x250
=150  \\$aCentral Nervous System Helminthiasis
=450  \\$aCerebral Helminthiasis
=450  \\$aHelminthiasis, Central Nervous System
=450  \\$wnnna$aHelminthiasis, Cerebral
=550  \\$wg$aCentral Nervous System Parasitic Infections
=550  \\$wh$aNeurocysticercosis
=550  \\$wh$aNeuroschistosomiasis
=680  \\$iInfections of the BRAIN; SPINAL CORD; or MENINGES caused by HELMINTHS (parasitic worms).
=688  \\$a2000
=750  \0$81$wb$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632
=750  \0$81$wb$aHelminthiasis$5IEN-M$0(DLC)sh 85060073
=788  \0$iSearch also under the following headings used together in the same record:$aCentral nervous system--Infections$iand$aHelminthiasis$5IEN-M

=LDR  01541cz  a2200289n  4500
=001  9880364245602441
=005  20141212213706.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020314
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x181
=072  \\$aC10.$x228.$x228.$x198
=150  \\$aCentral Nervous System Fungal Infections
=450  \\$wnnna$aCentral Nervous System Mycoses
=450  \\$aFungal Infections, Central Nervous System
=450  \\$wnnna$aInfections, Fungal, Central Nervous System
=450  \\$aMycoses, Central Nervous System
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aMycoses
=550  \\$wh$aMeningitis, Fungal
=550  \\$wh$aNeuroaspergillosis
=667  \\$acoord IM with precoord fungal infection (IM) and specific site/dis term (IM) if pertinent; DF: CNS FUNGAL INFECT
=680  \\$iMYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).
=688  \\$a2000
=750  \0$81$wb$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632
=750  \0$81$wb$aMycoses$5IEN-M$0(DLC)sh 85089198
=788  \0$iSearch also under the following headings used together in the same record:$aCentral nervous system--Infections$iand$aMycoses$5IEN-M

=LDR  03091cz  a2200697n  4500
=001  9880364245702441
=005  20141212213748.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020429
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x700
=150  \\$aTibial Neuropathy
=450  \\$wnnna$aInternal Popliteal Neuropathies
=450  \\$wnnna$aInternal Popliteal Neuropathy
=450  \\$wnnna$aLateral Plantar Neuropathies
=450  \\$wnnna$aLateral Plantar Neuropathy
=450  \\$wnnna$aMedial Plantar Nerve Disease
=450  \\$wnnna$aMedial Plantar Neuropathies
=450  \\$aMedial Plantar Neuropathy
=450  \\$wnnna$aMedial Popliteal Neuropathies
=450  \\$wnnna$aMedial Popliteal Neuropathy
=450  \\$wnnna$aNerve Disease, Tibial
=450  \\$wnnna$aNerve Diseases, Tibial
=450  \\$wnnna$aNeuropathies, Internal Popliteal
=450  \\$wnnna$aNeuropathies, Lateral Plantar
=450  \\$wnnna$aNeuropathies, Medial Plantar
=450  \\$wnnna$aNeuropathies, Medial Popliteal
=450  \\$wnnna$aNeuropathies, Posterior Tibial
=450  \\$wnnna$aNeuropathies, Tibial
=450  \\$wnnna$aNeuropathy, Internal Popliteal
=450  \\$wnnna$aNeuropathy, Lateral Plantar
=450  \\$wnnna$aNeuropathy, Medial Plantar
=450  \\$wnnna$aNeuropathy, Medial Popliteal
=450  \\$wnnna$aNeuropathy, Post-Traumatic Tibial
=450  \\$wnnna$aNeuropathy, Posterior Tibial
=450  \\$wnnna$aNeuropathy, Tibial
=450  \\$wnnna$aPlantar Neuropathy, Lateral
=450  \\$wnnna$aPlantar Neuropathy, Medial
=450  \\$wnnna$aPopliteal Neuropathies, Internal
=450  \\$wnnna$aPopliteal Neuropathies, Medial
=450  \\$wnnna$aPopliteal Neuropathy, Internal
=450  \\$wnnna$aPopliteal Neuropathy, Medial
=450  \\$wnnna$aPost-Traumatic Tibial Neuropathies
=450  \\$wnnna$aPost-Traumatic Tibial Neuropathy
=450  \\$wnnna$aPosterior Tibial Nerve Diseases
=450  \\$wnnna$aPosterior Tibial Neuropathies
=450  \\$aPosterior Tibial Neuropathy
=450  \\$wnnna$aTibial Nerve Disease
=450  \\$aTibial Nerve Diseases
=450  \\$wnnna$aTibial Neuropathies
=450  \\$wnnna$aTibial Neuropathies, Post-Traumatic
=450  \\$wnnna$aTibial Neuropathies, Posterior
=450  \\$wnnna$aTibial Neuropathy, Post-Traumatic
=450  \\$wnnna$aTibial Neuropathy, Post Traumatic
=450  \\$wnnna$aTibial Neuropathy, Posterior
=550  \\$wg$aMononeuropathies
=550  \\$wh$aTarsal Tunnel Syndrome
=550  \\$aLeg Injuries
=680  \\$iDisease of the TIBIAL NERVE (also referred to as the posterior tibial nerve). The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions (e.g., COLLAGEN DISEASES) may also affect the nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. (From Joynt, Clinical Neurology, 1995, Ch51, p32)
=688  \\$a2000
=750  \0$aTibial nerve$xDiseases$5IEN-M

=LDR  01696cz  a2200385n  4500
=001  9880364245802441
=005  20141212213744.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020424
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x500.$x850
=150  \\$aUlnar Neuropathies
=450  \\$wnnna$aNerve Disease, Ulnar
=450  \\$wnnna$aNerve Diseases, Ulnar
=450  \\$wnnna$aNerve Palsies, Ulnar
=450  \\$wnnna$aNerve Palsy, Ulnar
=450  \\$wnnna$aNeuritides, Ulnar
=450  \\$wnnna$aNeuritis, Ulnar
=450  \\$wnnna$aNeuropathies, Ulnar
=450  \\$wnnna$aNeuropathy, Ulnar
=450  \\$wnnna$aPalsies, Ulnar Nerve
=450  \\$wnnna$aPalsy, Ulnar Nerve
=450  \\$wnnna$aUlnar Nerve Disease
=450  \\$aUlnar Nerve Diseases
=450  \\$wnnna$aUlnar Nerve Palsies
=450  \\$wnnna$aUlnar Nerve Palsy
=450  \\$wnnna$aUlnar Neuritides
=450  \\$wnnna$aUlnar Neuritis
=450  \\$wnnna$aUlnar Neuropathy
=550  \\$wg$aMononeuropathies
=550  \\$wh$aCubital Tunnel Syndrome
=550  \\$wh$aUlnar Nerve Compression Syndromes
=680  \\$iDisease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon's canal at the wrist. (From Joynt, Clinical Neurology, 1995, Ch51 pp43-5)
=688  \\$a2000
=750  \0$aUlnar nerve$xDiseases$5IEN-M

=LDR  01808cz  a2200361n  4500
=001  9880364245902441
=005  20141212213933.0
=008  991105\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020774
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x380.$x266.$x299.$x500
=072  \\$aF3.$x87.$x400.$x380.$x299.$x500
=150  \\$aPick Disease of the Brain
=450  \\$wnnna$aAtrophies, Lobar (Brain)
=450  \\$wnnna$aAtrophy, Lobar (Brain)
=450  \\$wnnna$aBrain Atrophy, Circumscribed Lobar
=450  \\$aCircumscribed Lobar Atrophy of the Brain
=450  \\$wnnna$aDementia with Lobar Atrophy and Neuronal Cytoplasmic Inclusions
=450  \\$wnnna$aDisease, Pick
=450  \\$wnnna$aDisease, Pick's
=450  \\$wnnna$aLobar Atrophies (Brain)
=450  \\$aLobar Atrophy (Brain)
=450  \\$wnnna$aLobar Atrophy Of Brain
=450  \\$aLobar Atrophy of the Brain
=450  \\$wnnna$aPick Disease
=450  \\$wnnna$aPick Disease Of Brain
=450  \\$wnnna$aPick's Disease
=450  \\$wnnna$aPicks Disease
=450  \\$wnnna$aPicks Disease of Brain
=550  \\$wg$aFrontotemporal Dementia
=680  \\$iA rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)
=688  \\$a2000; for PICKS DISEASE OF BRAIN use DEMENTIA 1992-1999
=750  \0$aPresenile dementia$5IEN-M$0(DLC)sh 85106442

=LDR  01582cz  a2200397n  4500
=001  9880364246002441
=005  20141212213949.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020805
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x182
=072  \\$aC10.$x228.$x228.$x210
=150  \\$aCentral Nervous System Viral Diseases
=450  \\$wnnna$aCentral Nervous System Viral Infections
=450  \\$wnnna$aCNS Infection, Viral
=450  \\$wnnna$aCNS Infections, Viral
=450  \\$wnnna$aInfection, Viral CNS
=450  \\$wnnna$aInfections, CNS, Viral
=450  \\$wnnna$aInfections, Viral CNS
=450  \\$wnnna$aViral CNS Infection
=450  \\$wnnna$aViral CNS Infections
=450  \\$aViral Diseases, Central Nervous System
=450  \\$wnnna$aViral Infections, Central Nervous System
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aVirus Diseases
=550  \\$wh$aEncephalitis
=550  \\$wh$aMeningitis, Viral
=550  \\$wh$aMyelitis
=550  \\$wh$aPoliomyelitis
=550  \\$wh$aPseudorabies
=667  \\$acoord IM with specific virus disease (IM) and specific site/dis term if pertinent; DF: CNS VIRAL DIS
=680  \\$iViral infections of the brain, spinal cord, meninges, or perimeningeal spaces.
=688  \\$a2000
=750  \0$81$wb$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632
=750  \0$81$wb$aVirus diseases$5IEN-M$0(DLC)sh 85143818
=788  \0$iSearch also under the following headings used together in the same record:$aCentral nervous system--Infections$iand$aVirus diseases$5IEN-M

=LDR  01382cz  a2200325n  4500
=001  9880364246102441
=005  20141212214049.0
=008  991109\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020959
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x550.$x500
=072  \\$aD5.$x750.$x716.$x507.$x500
=072  \\$aD25.$x720.$x716.$x507.$x500
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x507.$x500
=150  \\$aPolyethylene
=450  \\$aHDPE
=450  \\$aHigh-Density Polyethylene
=450  \\$wnnna$aHigh Density Polyethylene
=450  \\$wnnna$aLDPE
=450  \\$wnnna$aLow-Density Polyethylene
=450  \\$wnnna$aLow Density Polyethylene
=450  \\$wnnna$aPolyethylene, High-Density
=450  \\$wnnna$aPolyethylene, Low-Density
=450  \\$aPolyethylenes$xanalogs & derivatives
=450  \\$aPolythene
=550  \\$wg$aPolyethylenes
=667  \\$aPOLYETHYLENES is available
=680  \\$iA vinyl polymer made from ethylene. It can be branched or linear. Branched or low-density polyethylene is tough and pliable but not to the same degree as linear polyethylene. Linear or high-density polyethylene has a greater hardness and tensile strength. Polyethylene is used in a variety of products, including implants and prostheses.
=688  \\$a2000; for POLYTHENE use PLASTIPORE (NM) 1978-1999
=750  \0$aPolyethylene$5IEN-M$0(DLC)sh 85104624

=LDR  01043cz  a2200241n  4500
=001  9880364246202441
=005  20141212214001.0
=008  991103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020835
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x585.$x600
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x600
=150  \\$aMedicine, Kampo
=450  \\$wnnna$aKampo
=450  \\$aKampo Medicine
=450  \\$wnnna$aKanpo
=450  \\$wnnna$aKanpo Medicine
=450  \\$wnnna$aMedicine, Kanpo
=550  \\$wg$aMedicine, East Asian Traditional
=667  \\$acoord with DRUGS, CHINESE HERBAL or MATERIA MEDICA if pertinent; MEDICINE, CHINESE TRADITIONAL is also available
=680  \\$iSystem of herbal medicine practiced in Japan by both herbalists and practitioners of modern medicine. Kampo originated in China and is based on Chinese herbal medicine (MEDICINE, CHINESE TRADITIONAL).
=688  \\$a2000; for KAMPO & KANPO use MEDICINE, CHINESE TRADITIONAL 1994-1999
=750  \0$aHerbs$xTherapeutic use$zJapan$5IEN-M$0(DLC)sh 98007489

=LDR  02558cz  a2200553n  4500
=001  9880364246302441
=005  20190419105542.0
=008  991104\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D020746
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x150.$x400
=072  \\$aD12.$x776.$x543.$x550.$x425.$x150.$x400
=072  \\$aD12.$x776.$x543.$x585.$x400.$x150.$x400
=150  \\$aCalcium Channels, L-Type
=450  \\$wnnna$aCalcium Channel, L-Type
=450  \\$wnnna$aCalcium Channels, L Type
=450  \\$wnnna$aCalcium Channels, Long-Lasting
=450  \\$wnnna$aDihydropyridine Receptor
=450  \\$aDihydropyridine Receptors
=450  \\$wnnna$aL-Type Calcium Channel
=450  \\$wnnna$aL Type Calcium Channel
=450  \\$aL-Type Calcium Channels
=450  \\$wnnna$aL Type Calcium Channels
=450  \\$wnnna$aL-Type VDCC
=450  \\$wnnna$aL Type VDCC
=450  \\$aL-Type VDCC alpha-1 Subunit
=450  \\$wnnna$aL Type VDCC alpha 1 Subunit
=450  \\$wnnna$aL-Type VDCC alpha-2 Subunit
=450  \\$wnnna$aL Type VDCC alpha 2 Subunit
=450  \\$wnnna$aL-Type VDCC beta Subunit
=450  \\$wnnna$aL Type VDCC beta Subunit
=450  \\$wnnna$aL-Type VDCC delta Subunit
=450  \\$wnnna$aL Type VDCC delta Subunit
=450  \\$wnnna$aL-Type VDCC gamma Subunit
=450  \\$wnnna$aL Type VDCC gamma Subunit
=450  \\$wnnna$aL-Type Voltage-Dependent Calcium Channels
=450  \\$wnnna$aL Type Voltage Dependent Calcium Channels
=450  \\$aLong-Lasting Calcium Channels
=450  \\$wnnna$aLong Lasting Calcium Channels
=450  \\$wnnna$aReceptor, Dihydropyridine
=450  \\$aReceptors, Dihydropyridine
=450  \\$wnnna$aVDCC, L-Type
=550  \\$wg$aCalcium Channels
=667  \\$aDF: VDCC L
=680  \\$iLong-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.
=688  \\$a2000; use L-TYPE CALCIUM CHANNELS (NM) 1993-1999
=750  \0$81$wb$iBroader mapping$aDihydropyridine$0(DLC)sh 85037998$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC) sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aDihydropyridine--Receptors$5IEN-M

=LDR  01822cz  a2200481n  4500
=001  9880363469102441
=005  20141212195749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002635
=035  \\$aCAZ5794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x105.$x225.$x272.$x150
=072  \\$aD4.$x808.$x221.$x430.$x342.$x300
=150  \\$aChenodeoxycholic Acid
=450  \\$wnnna$aAcid, Chenic
=450  \\$wnnna$aAcid, Chenique
=450  \\$wnnna$aAcid, Chenodeoxycholic
=450  \\$wnnna$aAcid, Gallodesoxycholic
=450  \\$wnnna$aAntigen Brand of Chenodeoxycholic Acid
=450  \\$aChenic Acid
=450  \\$wnnna$aChenique Acid
=450  \\$wnnna$aChenix
=450  \\$aChenodeoxycholate
=450  \\$wnnna$aChenodeoxycholate, Sodium
=450  \\$aChenodiol
=450  \\$wnnna$aChenofalk
=450  \\$wnnna$aChenophalk
=450  \\$wnnna$aEstedi Brand of Chenodeoxycholic Acid
=450  \\$wnnna$aFalk Brand of Chenodeoxycholic Acid
=450  \\$aGallodesoxycholic Acid
=450  \\$wnnna$aHenohol
=450  \\$wnnna$aQuenobilan
=450  \\$wnnna$aQuenocol
=450  \\$wnnna$aSodium Chenodeoxycholate
=450  \\$wnnna$aSolvay Brand of Chenodeoxycholic Acid
=450  \\$wnnna$aTramedico Brand of Chenodeoxycholic Acid
=450  \\$wnnna$aZambon Brand of Chenodeoxycholic Acid
=550  \\$wg$aDeoxycholic Acid
=550  \\$wh$aGlycochenodeoxycholic Acid
=550  \\$wh$aTaurochenodeoxycholic Acid
=680  \\$iA bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.
=688  \\$a74(73)
=750  \0$aChenodeoxycholic acid$5IEN$0(DLC)sh 85023056

=LDR  00789cz  a2200241n  4500
=001  9880363469202441
=005  20141212195748.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002634
=035  \\$aCAZ5793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x283.$x424.$x233
=150  \\$aChemotaxis, Leukocyte
=450  \\$wnnna$aLeukocyte Chemotaxis
=450  \\$aLeukotaxis
=550  \\$wg$aChemotaxis
=550  \\$wh$aLeukocyte Rolling
=550  \\$aChemokines
=550  \\$aNeutrophil Infiltration
=667  \\$acoord IM with specific type of leukocyte (IM)
=680  \\$iThe movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction.
=688  \\$a77
=750  \0$81$wb$aLeucocytes$5IEN$0(DLC)sh 85076269

=LDR  00848cz  a2200265n  4500
=001  9880363469302441
=005  20181121122314.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002633
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x780.$x500
=072  \\$aF1.$x145.$x875.$x439.$x500.$x500
=072  \\$aG4.$x198.$x424
=072  \\$aG7.$x568.$x500.$x590.$x500
=072  \\$aG11.$x427.$x410.$x568.$x850.$x500
=150  \\$aChemotaxis
=450  \\$aHaptotaxis
=550  \\$wg$aCell Movement
=550  \\$wg$aTaxis Response
=550  \\$wh$aChemotaxis, Leukocyte
=550  \\$aChemoreceptor Cells
=550  \\$aChemotactic Factors
=680  \\$iThe movement of cells or organisms toward or away from a substance in response to its concentration gradient.
=688  \\$a70(65)
=750  \0$aChemotaxis$5IEN$0(DLC)sh 85023039

=LDR  01565cz  a2200397n  4500
=001  9880363469402441
=005  20141212192059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002628
=035  \\$aCAZ5787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x650.$x915.$x500
=072  \\$aA8.$x800.$x950.$x500
=072  \\$aA11.$x671.$x650.$x915.$x500
=150  \\$aChemoreceptor Cells
=450  \\$wnnna$aCell, Chemoreceptive
=450  \\$wnnna$aCell, Chemoreceptor
=450  \\$wnnna$aCells, Chemoreceptive
=450  \\$wnnna$aCells, Chemoreceptor
=450  \\$wnnna$aChemoreceptive Cell
=450  \\$wnnna$aChemoreceptive Cells
=450  \\$wnnna$aChemoreceptor Cell
=450  \\$wnno$aChemoreceptors$5IEN-M
=550  \\$wg$aSensory Receptor Cells
=550  \\$wh$aNeuroepithelial Cells
=550  \\$wh$aOlfactory Receptor Neurons
=550  \\$wh$aParaganglia, Nonchromaffin
=550  \\$wh$aTaste Buds
=550  \\$aChemotaxis
=550  \\$aSensilla
=667  \\$anote category: do not confuse with chemoreceptor proteins
=680  \\$iCells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptor cells may monitor external stimuli, as in TASTE and OLFACTION, or internal stimuli, such as the concentrations of OXYGEN and CARBON DIOXIDE in the blood.
=688  \\$a2009 (1968)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Chemoreceptors
=688  \\$a68; was see under RECEPTORS, NEURAL 1963-67
=750  \0$aChemoreceptors$0(DLC) sh 85023035$5IEN

=LDR  01013cz  a2200265n  4500
=001  9880363469502441
=005  20141212195747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002627
=035  \\$aCAZ5786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x529
=150  \\$aChemistry, Physical
=450  \\$wnnna$aChemistries, Physical
=450  \\$wnnna$aPhysical Chemistries
=450  \\$wnnna$aPhysical Chemistry
=550  \\$wg$aChemistry
=550  \\$wh$aCrystallography
=550  \\$wh$aElectrochemistry
=550  \\$wh$aPhotochemistry
=550  \\$wh$aRadiochemistry
=667  \\$athe discipline (education, history, etc) only; use PHYSICOCHEMICAL PHENOMENA or specifics treed under it for physical phenomena related to the structure and interactive processes of chemicals
=680  \\$iThe study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes.
=688  \\$a65
=750  \0$aChemistry, Physical and theoretical$5IEN$0(DLC)sh 85023027

=LDR  01155cz  a2200313n  4500
=001  9880363469602441
=005  20141212195747.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002626
=035  \\$aCAZ5785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x7
=072  \\$aH1.$x181.$x466
=150  \\$aChemistry, Pharmaceutical
=450  \\$wnnna$aChemistry, Medicinal
=450  \\$wnnna$aChemistry, Pharmaceutic
=450  \\$aDrug Formulation
=450  \\$wnnna$aDrug Formulations
=450  \\$wnnna$aFormulation, Drug
=450  \\$wnnna$aFormulations, Drug
=450  \\$aMedicinal Chemistry
=450  \\$wnnna$aPharmaceutic Chemistry
=450  \\$wnnna$aPharmaceutical Chemistry
=550  \\$wg$aChemistry
=550  \\$wg$aPharmacology
=550  \\$wh$aDrug Discovery
=667  \\$ause for the specialty and as an NIM coordinate; Manual 29.7; do not confuse the entry term DRUG FORMULATION with DRUG COMPOUNDING; DF: CHEM PHARM
=680  \\$iChemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.
=750  \0$aPharmaceutical chemistry$0(DLC) sh 85023026$5IEN

=LDR  00845cz  a2200205n  4500
=001  9880363469702441
=005  20141212195746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002625
=035  \\$aCAZ5784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x404
=150  \\$aChemistry, Organic
=450  \\$wnnna$aOrganic Chemistry
=450  \\$aOrganic Compounds$5IEN
=550  \\$wg$aChemistry
=667  \\$athe discipline (education, history, etc) only; use ORGANIC CHEMISTRY PHENOMENA or specifics treed under it for properties and reaction processes of organic compounds; DF: CHEM ORG
=680  \\$iThe study of the structure, preparation, properties, and reactions of carbon compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a66
=750  \0$aChemistry, Organic$5IEN-M$0(DLC)sh 85023022

=LDR  00971cz  a2200229n  4500
=001  9880363469802441
=005  20141212211022.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015392
=035  \\$aCAZ5783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x370
=150  \\$aChemistry, Inorganic
=450  \\$wnnna$aChemistries, Inorganic
=450  \\$wnnna$aInorganic Chemistries
=450  \\$aInorganic Chemistry
=550  \\$wg$aChemistry
=550  \\$wh$aChemistry, Bioinorganic
=667  \\$aSPEC: TN 37; do not use as NIM coord for chemistry or chem struct of an inorganic chemical ( = CHEMISTRY (NIM)); as SPEC, qualif permitted; DF: CHEM INORG
=680  \\$iA field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon (with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate).
=688  \\$a89
=750  \0$aChemistry, Inorganic$5IEN$0(DLC)sh 85023017

=LDR  00849cz  a2200217n  4500
=001  9880363469902441
=005  20141212195746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002624
=035  \\$aCAZ5782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x341
=150  \\$aChemistry, Clinical
=450  \\$aClinical Chemistry
=550  \\$wg$aChemistry
=550  \\$aChemistry, Analytic
=550  \\$aClinical Chemistry Tests
=667  \\$aSPEC: TN 37; SPEC qualif; do not use as NIM coord; DF: CLIN CHEM
=680  \\$iThe specialty of ANALYTIC CHEMISTRY applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy.
=688  \\$a67(66)
=750  \0$aClinical chemistry$5IEN$0(DLC)sh 85023014

=LDR  01557cz  a2200373n  4500
=001  9880363470002441
=005  20141212211023.0
=008  880606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015393
=035  \\$aCAZ5781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x214
=072  \\$aH1.$x181.$x122.$x253
=072  \\$aH1.$x181.$x370.$x310
=150  \\$aChemistry, Bioinorganic
=450  \\$wnnna$aBiochemistries, Inorganic
=450  \\$aBiochemistry, Inorganic
=450  \\$wnnna$aBioinorganic Chemistries
=450  \\$aBioinorganic Chemistry
=450  \\$wnnna$aBiological Inorganic Chemistries
=450  \\$wnnna$aBiological Inorganic Chemistry
=450  \\$wnnna$aChemistries, Bioinorganic
=450  \\$wnnna$aChemistries, Biological Inorganic
=450  \\$wnnna$aChemistry, Biological Inorganic
=450  \\$wnnna$aInorganic Biochemistries
=450  \\$wnnna$aInorganic Biochemistry
=450  \\$wnnna$aInorganic Chemistries, Biological
=450  \\$wnnna$aInorganic Chemistry, Biological
=550  \\$wg$aBiochemistry
=550  \\$wg$aChemistry, Inorganic
=667  \\$aThe discipline (education, history, etc) only; use CHEMICAL PHENOMENA or BIOCHEMICAL PHENOMENA or specifics treed under them for characteristics of inorganic substances interacting with biological substances.
=680  \\$iField of chemistry pertaining to the study of inorganic compounds or ions and their interactions with biological ligands at the molecular level.
=688  \\$a89
=750  \0$aBioinorganic chemistry$5IEN$0(DLC)sh 85014166

=LDR  02793cz  a2200805n  4500
=001  9880363470102441
=005  20141212195746.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002623
=035  \\$aCAZ5780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196
=150  \\$aChemistry Techniques, Analytical
=450  \\$wnnna$aAnalytical Chemistry Method
=450  \\$wnnna$aAnalytical Chemistry Methods
=450  \\$wnnna$aAnalytical Chemistry Technique
=450  \\$aAnalytical Chemistry Techniques
=450  \\$wnno$aChemistry, Analytical$5IEN-M
=450  \\$wnnoa$aChemistry, Analytical$xmethods$5IEN-M
=450  \\$wnnna$aChemistry Method, Analytical
=450  \\$wnnna$aChemistry Methods, Analytical
=450  \\$wnnna$aChemistry Technique, Analytical
=450  \\$wnnna$aMethod, Analytical Chemistry
=450  \\$wnnna$aMethods, Analytical Chemistry
=450  \\$wnnna$aTechnique, Analytical Chemistry
=450  \\$wnnna$aTechniques, Analytical Chemistry
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aActivation Analysis
=550  \\$wh$aAnalytic Sample Preparation Methods
=550  \\$wh$aBinding, Competitive
=550  \\$wh$aBiuret Reaction
=550  \\$wh$aCalorimetry
=550  \\$wh$aChemical Fractionation
=550  \\$wh$aChemical Precipitation
=550  \\$wh$aChromatography
=550  \\$wh$aCountercurrent Distribution
=550  \\$wh$aCrystallization
=550  \\$wh$aCrystallography
=550  \\$wh$aDesiccation
=550  \\$wh$aDeuterium Exchange Measurement
=550  \\$wh$aDialysis
=550  \\$wh$aDifferential Thermal Analysis
=550  \\$wh$aElectroosmosis
=550  \\$wh$aElectrophoresis
=550  \\$wh$aEnzyme Assays
=550  \\$wh$aFiltration
=550  \\$wh$aFlow Injection Analysis
=550  \\$wh$aGlucose Clamp Technique
=550  \\$wh$aMass Spectrometry
=550  \\$wh$aMicrochemistry
=550  \\$wh$aMicrochip Analytical Procedures
=550  \\$wh$aMolecular Imprinting
=550  \\$wh$aNucleotide Mapping
=550  \\$wh$aOsmometry
=550  \\$wh$aPeptide Mapping
=550  \\$wh$aPhotometry
=550  \\$wh$aPolarography
=550  \\$wh$aQuartz Crystal Microbalance Techniques
=550  \\$wh$aRefractometry
=550  \\$wh$aScattering, Radiation
=550  \\$wh$aSpectrum Analysis
=550  \\$wh$aSpin Trapping
=550  \\$wh$aSurface Plasmon Resonance
=550  \\$wh$aThermogravimetry
=550  \\$wh$aTitrimetry
=550  \\$wh$aUltracentrifugation
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iMethodologies used for the isolation, identification, detection, and quantitation of chemical substances.
=688  \\$a2010 (1963)
=750  \0$aChemistry, Analytic$xTechnique$0(DLC) sh 90006087$5IEN-M

=LDR  00817cz  a2200205n  4500
=001  9880363470202441
=005  20141212195745.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002622
=035  \\$aCAZ5779HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x216
=150  \\$aChemistry, Agricultural
=450  \\$wnnna$aAgricultural Chemistries
=450  \\$aAgricultural Chemistry
=450  \\$wnnna$aChemistries, Agricultural
=550  \\$wg$aChemistry
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe science of the chemical composition and reactions of chemicals involved in the production, protection and use of crops and livestock. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aAgricultural chemistry$5IEN$0(DLC)sh 85002284

=LDR  01401cz  a2200337n  4500
=001  9880363470302441
=005  20141212195744.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002621
=035  \\$aCAZ5778HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181
=150  \\$aChemistry
=450  \\$aChemicals$5IEN
=450  \\$aChemistry, Technical$5IEN
=450  \\$aChemists$5IEN
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aBiochemistry
=550  \\$wh$aChemistry, Agricultural
=550  \\$wh$aChemistry, Analytic
=550  \\$wh$aChemistry, Clinical
=550  \\$wh$aChemistry, Inorganic
=550  \\$wh$aChemistry, Organic
=550  \\$wh$aChemistry, Pharmaceutical
=550  \\$wh$aChemistry, Physical
=550  \\$wh$aMicrochemistry
=667  \\$athe discipline (education, history, etc) only; use CHEMICAL PHENOMENA or specifics treed under it for characteristics of chemicals and their reactions; the qualifier / chemistry is available for use with specific anatomical terms, lower organisms and chemicals; DF: CHEM
=680  \\$iA basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
=750  \0$aChemicals$5IEN-M$0(DLC)sh 85022963
=750  \0$aChemists$5IEN-HS$0(DLC)sh 85023033
=750  \0$aChemistry$5IEN-HS$0(DLC)sh 85022986

=LDR  00695cz  a2200217n  4500
=001  9880363470402441
=005  20160826102324.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002618
=035  \\$aCAZ5775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x500.$x340
=150  \\$aChemical Warfare
=450  \\$wnnna$aChemical Warfares
=450  \\$wnnna$aWarfare, Chemical
=450  \\$wnnna$aWarfares, Chemical
=550  \\$wg$aWarfare
=550  \\$wh$aChemical Terrorism
=667  \\$aDF: CHEM WARFARE
=680  \\$iTactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases.
=750  \0$aChemical warfare$5IEN$0(DLC)sh 85022958

=LDR  00815cz  a2200229n  4500
=001  9880363470502441
=005  20141212192058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002617
=035  \\$aCAZ5774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x576.$x655.$x437
=150  \\$aChemical Industry
=450  \\$wnnna$aChemical Industries
=450  \\$aChemical Workers$5IEN
=450  \\$wnnna$aIndustries, Chemical
=450  \\$wnnna$aIndustry, Chemical
=550  \\$wg$aManufacturing Industry
=667  \\$aSPEC: SPEC qualif; DF: CHEM INDUST
=680  \\$iThe aggregate enterprise of manufacturing and technically producing chemicals. (From Random House Unabridged Dictionary, 2d ed)
=750  \0$aChemical industry$5IEN-M$0(DLC)sh 85022913
=750  \0$aChemical workers$5IEN-HS$0(DLC)sh 85022962

=LDR  00518cz  a2200181n  4500
=001  9880363470602441
=005  20141212195743.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002616
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x293.$x257
=150  \\$aChemical Engineering
=450  \\$wnnna$aEngineering, Chemical
=550  \\$wg$aEngineering
=667  \\$aSPEC: SPEC qualif
=688  \\$a66
=750  \0$aChemical engineers$5IEN-M$0(DLC)sh 85022908
=750  \0$aChemical engineering$5IEN-HS$0(DLC)sh 85022900

=LDR  00854cz  a2200241n  4500
=001  9880363470702441
=005  20141212195743.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002615
=035  \\$aCAZ5772HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x218.$x170
=072  \\$aE4.$x680.$x275.$x200
=150  \\$aChemexfoliation
=450  \\$wnnna$aChemexfoliations
=450  \\$aChemical Face Peeling
=450  \\$aChemical Peel$5IEN
=450  \\$wnnna$aFace Peeling, Chemical
=550  \\$wg$aCosmetic Techniques
=550  \\$wg$aDermatologic Surgical Procedures
=680  \\$iApplication of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium.
=688  \\$a77
=750  \0$aChemical peel$5IEN$0(DLC)sh 88005348

=LDR  01151cz  a2200337n  4500
=001  9880363470802441
=005  20141212192058.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002614
=035  \\$aCAZ5771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x914.$x500
=072  \\$aD27.$x720.$x832.$x500
=150  \\$aChelating Agents
=450  \\$wnnna$aAgents, Chelating
=450  \\$wnnna$aAgents, Metal Chelating
=450  \\$wnnna$aAntagonists, Metal
=450  \\$wnnna$aChelating Agents, Metal
=450  \\$wnnna$aChelators
=450  \\$aComplexons
=450  \\$aMetal Antagonists
=450  \\$wnnna$aMetal Chelating Agents
=550  \\$wg$aSequestering Agents
=550  \\$wh$aCalcium Chelating Agents
=550  \\$wh$aIron Chelating Agents
=550  \\$aAntidotes
=550  \\$aCoordination Complexes
=550  \\$aIndicators and Reagents
=680  \\$iChemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.
=688  \\$aHEAVY METAL DETOXICANTS was heading 1963-65
=750  \0$aChelates$5IEN$0(DLC)sh 85022866

=LDR  00605cz  a2200193n  4500
=001  9880363470902441
=005  20141212195742.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002612
=035  \\$aCAZ5769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x354.$x30
=150  \\$aAcinonyx
=450  \\$wnnna$aCheetah
=450  \\$aCheetahs
=550  \\$wg$aFelidae
=680  \\$iA genus of long-legged, swift-moving felines (FELIDAE) from Africa (and formerly Asia) about the size of a small leopard.
=688  \\$a2005 (1975)
=750  \0$aCheetah$0(DLC) sh 85022857$5IEN

=LDR  00518cz  a2200169n  4500
=001  9880363471002441
=005  20141212195742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002611
=035  \\$aCAZ5768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x350.$x200
=150  \\$aCheese
=450  \\$wnnna$aCheeses
=550  \\$wg$aDairy Products
=680  \\$iA nutritious food consisting primarily of the curd or the semisolid substance formed when milk coagulates.
=750  \0$aCheese$5IEN$0(DLC)sh 85022845

=LDR  00705cz  a2200217n  4500
=001  9880363471102441
=005  20141212195742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002610
=035  \\$aCAZ5767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x505.$x173
=072  \\$aA14.$x194
=150  \\$aCheek
=450  \\$aBucca
=450  \\$wnnna$aBuccas
=450  \\$wnnna$aCheeks
=550  \\$wg$aFace
=550  \\$wg$aStomatognathic System
=667  \\$afor that external portion of face or that internal portion of mouth; NIM for hamster cheek pouch; buccal mucosa = MOUTH MUCOSA (IM) + CHEEK (NIM); cheek bone fracture = ZYGOMATIC FRACTURES
=750  \0$aCheek$5IEN$0(DLC)sh 85022839

=LDR  00596cz  a2200205n  4500
=001  9880363471202441
=005  20141212195741.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x190
=072  \\$aN3.$x540.$x125
=150  \\$aCharities
=450  \\$wnnna$aCharity
=550  \\$wg$aOrganizations
=550  \\$wg$aSocial Welfare
=550  \\$wh$aAlmshouses
=550  \\$aGift Giving
=680  \\$iSocial welfare organizations with programs designed to assist individuals in need.
=750  \0$aCharities$5IEN$0(DLC)sh 85022665

=LDR  02501cz  a2200637n  4500
=001  9880363471302441
=005  20141212192057.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002606
=035  \\$aCAZ5765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x150
=150  \\$aCharcoal
=450  \\$wnnna$aActidose
=450  \\$wnnna$aActidose-Aqua
=450  \\$aActivated Charcoal
=450  \\$wnnna$aAdsorba
=450  \\$wnnna$aCambridge Laboratories Brand of Activated Charcoal
=450  \\$wnnna$aCarbomix
=450  \\$wnnna$aCentral Brand of Activated Charcoal
=450  \\$wnnna$aCharbon
=450  \\$wnnna$aCharcoAid
=450  \\$wnnna$aCharcoal, Activated
=450  \\$wnnna$aCharcoCaps
=450  \\$wnnna$aCharcodote
=450  \\$wnnna$aChefaro Brand of Activated Charcoal
=450  \\$wnnna$aCheplapharm Brand of Activated Charcoal
=450  \\$wnnna$aFormocarbine
=450  \\$wnnna$aGambro Brand of Activated Charcoal
=450  \\$wnnna$aGlaxoSmithKline Brand of Activated Charcoal
=450  \\$wnnna$aHevert Brand of Activated Charcoal
=450  \\$wnnna$aInsta-Char
=450  \\$wnnna$aKöhler Brand of Activated Charcoal
=450  \\$wnnna$aKerr Brand of Activated Charcoal
=450  \\$wnnna$aKohle-Compretten
=450  \\$wnnna$aKohle-Hevert
=450  \\$wnnna$aKohle-Pulvis
=450  \\$wnnna$aKohle-Tabletten Boxo-Pharm
=450  \\$wnnna$aLiqui-Char
=450  \\$wnnna$aLittle Remedies Brand of Activated Charcoal
=450  \\$wnnna$aMerck Brand of Activated Charcoal
=450  \\$wnnna$aMerck Selbstmedikation Brand of Activated Charcoal
=450  \\$wnnna$aMonarch Brand of Activated Charcoal
=450  \\$wnnna$aNorit
=450  \\$wnnna$aPaddock Brand 1 of Activated Charcoal
=450  \\$wnnna$aPaddock Brand 2 of Activated Charcoal
=450  \\$wnnna$aPenn Brand of Activated Charcoal
=450  \\$wnnna$aPharmascience Brand of Activated Charcoal
=450  \\$wnnna$aPharmygiène Brand of Activated Charcoal
=450  \\$wnnna$aRequa Brand of Activated Charcoal
=450  \\$wnnna$aUltracarbon
=550  \\$wg$aCarbon
=667  \\$aD25-26 qualif only
=680  \\$iAn amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed)
=688  \\$a1994; for NORIT use CARBON 1982-1993
=750  \0$aCharcoal$5IEN$0(DLC)sh 85022633

=LDR  00903cz  a2200265n  4500
=001  9880363471402441
=005  20141212195731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002579
=035  \\$aCAZ5738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x593.$x112
=150  \\$aUterine Cervical Erosion
=450  \\$wnnna$aCervical Erosion, Uterine
=450  \\$aCervix Erosion
=450  \\$wnnna$aCervix Erosion, Uterine
=450  \\$wnnna$aErosion, Cervix
=450  \\$wnnna$aErosion, Uterine Cervical
=450  \\$wnnna$aErosion, Uterine Cervix
=450  \\$wnnna$aUterine Cervix Erosion
=550  \\$wg$aUterine Cervical Diseases
=680  \\$iLoss or destruction of the epithelial lining of the UTERINE CERVIX.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Cervix Erosion
=750  \0$aCervix erosion$0(DLC) sh 85022183$5IEN

=LDR  00596cz  a2200181n  4500
=001  9880363471502441
=005  20141212195739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002605
=035  \\$aCAZ5764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x190
=150  \\$aCharacter
=450  \\$wnnna$aCharacters
=550  \\$wg$aPersonality
=667  \\$ano qualif
=680  \\$iIn current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual.
=750  \0$aCharacter$5IEN$0(DLC)sh 85022615

=LDR  01303cz  a2200385n  4500
=001  9880363471602441
=005  20141212195730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002577
=035  \\$aCAZ5736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x593
=150  \\$aUterine Cervical Diseases
=450  \\$wnnna$aCervical Disease, Uterine
=450  \\$wnnna$aCervical Diseases, Uterine
=450  \\$wnnna$aCervix Disease
=450  \\$aCervix Diseases
=450  \\$aCervix Hypertrophy$5IEN-M
=450  \\$wnnna$aDisease, Cervix
=450  \\$wnnna$aDisease, Uterine Cervical
=450  \\$wnnna$aDiseases, Cervix
=450  \\$wnnna$aDiseases, Uterine Cervical
=450  \\$wnnna$aUterine Cervical Disease
=550  \\$wg$aUterine Diseases
=550  \\$wh$aUterine Cervical Dysplasia
=550  \\$wh$aUterine Cervical Erosion
=550  \\$wh$aUterine Cervical Incompetence
=550  \\$wh$aUterine Cervical Neoplasms
=550  \\$wh$aUterine Cervicitis
=667  \\$ainflammatory disease = UTERINE CERVICITIS
=680  \\$iPathological processes of the UTERINE CERVIX.
=688  \\$a2006 (1966)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Cervix Diseases
=688  \\$a66
=750  \0$aCervix uteri$xDiseases$0(DLC) sh 85022188$5IEN

=LDR  01354cz  a2200337n  4500
=001  9880363471702441
=005  20141212195739.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002604
=035  \\$aCAZ5763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x270
=072  \\$aN4.$x452.$x442.$x422.$x270
=150  \\$aChaplaincy Service, Hospital
=450  \\$wnnna$aChaplaincy Hospital Service
=450  \\$wnnna$aChaplaincy Hospital Services
=450  \\$wnnna$aChaplaincy Services, Hospital
=450  \\$aChaplains, Hospital$5IEN
=450  \\$aHospital Chaplaincy Service
=450  \\$wnnna$aHospital Chaplaincy Services
=450  \\$wnnna$aHospital Service, Chaplaincy
=450  \\$wnnna$aHospital Services, Chaplaincy
=450  \\$wnnna$aService, Chaplaincy Hospital
=450  \\$wnnna$aService, Hospital Chaplaincy
=450  \\$wnnna$aServices, Chaplaincy Hospital
=450  \\$wnnna$aServices, Hospital Chaplaincy
=550  \\$wg$aHospital Departments
=667  \\$aIM; coord with specific religion (IM) if pertinent; DF: CHAPLAINCY SERV HOSP
=680  \\$iHospital department which administers religious activities within the hospital, e.g., pastoral care, religious services.
=688  \\$a91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
=750  \0$aChaplains, Hospital$5IEN$0(DLC)sh 85022588

=LDR  00695cz  a2200205n  4500
=001  9880363471802441
=005  20160422101842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002574
=035  \\$aCAZ5733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x151
=150  \\$aCervical Vertebrae
=450  \\$wnnna$aVertebrae, Cervical
=550  \\$wg$aSpine
=550  \\$wh$aAxis, Cervical Vertebra
=550  \\$wh$aCervical Atlas
=550  \\$aNeck
=667  \\$aIM when discussed as bones or as coord with specific spinal disease (IM); NIM when locational; inflammation = CERVICAL VERTEBRAE (IM) + SPONDYLITIS (IM)
=750  \0$aCervical Vertebrae$5IEN$0(DLC)sh 85142888

=LDR  01096cz  a2200253n  4500
=001  9880363471902441
=005  20141212195738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002602
=035  \\$aCAZ5761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x700.$x433.$x257
=072  \\$aC1.$x252.$x810.$x201
=072  \\$aC1.$x539.$x778.$x281.$x201
=072  \\$aC12.$x294.$x668.$x281.$x201
=072  \\$aC13.$x351.$x500.$x711.$x281.$x201
=150  \\$aChancroid
=450  \\$wnnna$aChancroids
=550  \\$wg$aHaemophilus Infections
=550  \\$wg$aSexually Transmitted Diseases, Bacterial
=550  \\$aHaemophilus ducreyi
=667  \\$acaused by Haemophilus ducreyi; do not confuse with CHANCRE, the primary lesion of syphilis
=680  \\$iAcute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
=750  \0$aChancroid$5IEN$0(DLC)sh 85022494

=LDR  00622cz  a2200217n  4500
=001  9880363472002441
=005  20141212195729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002571
=035  \\$aCAZ5730HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x147
=150  \\$aCerumen
=450  \\$aEar Wax
=450  \\$aEarwax$5IEN-M
=450  \\$wnnna$aWax, Ear
=550  \\$wg$aBodily Secretions
=550  \\$aEar Canal
=550  \\$aWaxes
=680  \\$iThe yellow or brown waxy secretions produced by vestigial apocrine sweat glands in the external ear canal.
=750  \0$aEarwax$5IEN-M$0(DLC)sh 96008503

=LDR  00626cz  a2200181n  4500
=001  9880363472102441
=005  20141212195737.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002597
=035  \\$aCAZ5756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x800.$x150
=150  \\$aChaetomium
=450  \\$wnnna$aChaetomiums
=550  \\$wg$aSordariales
=680  \\$iA genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.
=688  \\$a91(75)
=750  \0$aChaetomium$5IEN$0(DLC)sh 88021932

=LDR  01170cz  a2200385n  4500
=001  9880363472202441
=005  20141212195728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002570
=035  \\$aCAZ5729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x226
=072  \\$aD12.$x776.$x124.$x50.$x130
=072  \\$aD12.$x776.$x124.$x790.$x106.$x214
=072  \\$aD12.$x776.$x157.$x160
=072  \\$aD12.$x776.$x377.$x715.$x85.$x214
=072  \\$aD12.$x776.$x556.$x151
=150  \\$aCeruloplasmin
=450  \\$wnnna$aalpha(2)-Ceruloplasmin
=450  \\$aCaeruloplasmin
=450  \\$wnnna$aCeruloplasmin Ferroxidase
=450  \\$wnnna$aCeruloplasmin Oxidase
=450  \\$aFerroxidase
=450  \\$wnnna$aFerroxidase, Ceruloplasmin
=450  \\$wnnna$aFerroxidase I
=450  \\$wnnna$aOxidase, Ceruloplasmin
=550  \\$wg$aAcute-Phase Proteins
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aCarrier Proteins
=550  \\$wg$aMetalloproteins
=550  \\$wg$aOxidoreductases
=550  \\$aCopper
=550  \\$aMenkes Kinky Hair Syndrome
=667  \\$aan alpha-globulin
=750  \0$aCeruloplasmin$5IEN$0(DLC)sh 85022174

=LDR  00950cz  a2200217n  4500
=001  9880363472302441
=005  20141212195728.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002567
=035  \\$aCAZ5726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x349.$x650.$x120
=150  \\$aCertificate of Need
=450  \\$wnnna$aNeed Certificate
=450  \\$wnnna$aNeed Certificates
=450  \\$aNeed Certification, Health Care
=550  \\$wg$aRegional Health Planning
=667  \\$aregional or area needs, not personal or financial need; specify geog
=680  \\$iA certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included.
=688  \\$a91(Aug 77); was see under REGIONAL HEALTH PLANNING 1977-90
=750  \0$aHealth facilities$xCertificates of need$5IEN$0(DLC)sh 85059547

=LDR  00682cz  a2200205n  4500
=001  9880363472402441
=005  20141212195727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002564
=035  \\$aCAZ5723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x156
=150  \\$aCerium Isotopes
=450  \\$wnnna$aIsotopes, Cerium
=550  \\$wg$aIsotopes
=550  \\$wh$aCerium Radioisotopes
=550  \\$aCerium
=667  \\$aCe-136, 138, 142; NIM
=680  \\$iStable cerium atoms that have the same atomic number as the element cerium, but differ in atomic weight. Ce-136, 138, and 142 are stable cerium isotopes.
=750  \0$aCerium$xIsotopes$5IEN$0(DLC)sh 85022139

=LDR  01782cz  a2200469n  4500
=001  9880363472502441
=005  20141212195736.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002594
=035  \\$aCAZ5753M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x762.$x232
=150  \\$aCetylpyridinium
=450  \\$wnnna$aAngifonil
=450  \\$wnnna$aAnhydrous, Cetylpyridinium Chloride
=450  \\$wnnna$aAventis Pharma Brand of Cetylpyridinium Chloride
=450  \\$wnnna$aBiosept
=450  \\$wnnna$aBoots Brand of Cetylpyridinium Chloride
=450  \\$wnnna$aCatamium
=450  \\$wnnna$aCeepryn Chloride
=450  \\$wnnna$aCetamium
=450  \\$wnnna$aCetylpyridinium Chloride
=450  \\$wnnna$aCetylpyridinium Chloride Anhydrous
=450  \\$wnnna$aCetylpyridium
=450  \\$wnnna$aCetylyre
=450  \\$wnnna$aChloride Anhydrous, Cetylpyridinium
=450  \\$wnnna$aChloride, Ceepryn
=450  \\$wnnna$aChloride, Cetylpyridinium
=450  \\$wnnna$aDiviser Aquilea Brand of Cetylpyridinium Chloride
=450  \\$wnnna$aDobendan
=450  \\$wnnna$aHexadecylpyridinium
=450  \\$wnnna$aIntra Veno Brand of Cetylpyridinium Chloride
=450  \\$wnnna$aMerocets
=450  \\$wnnna$aPristacin
=450  \\$wnnna$aPyrisept
=450  \\$wnnna$aSterogenol
=450  \\$wnnna$aUPSA Conseil Brand of Cetylpyridinium Chloride
=550  \\$wg$aPyridinium Compounds
=667  \\$aan anti-infective; = Cepacol
=680  \\$iCationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
=688  \\$a91(72); was see under PYRIDINIUM COMPOUNDS 1972-90
=750  \0$aCetylpyridinium chloride$0(DLC)sh2009008069$5IEN-M

=LDR  00703cz  a2200193n  4500
=001  9880363472602441
=005  20141212195727.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002563
=035  \\$aCAZ5722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x249
=072  \\$aD1.$x268.$x558.$x362.$x249
=072  \\$aD1.$x552.$x550.$x399.$x249
=150  \\$aCerium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Ce-140
=680  \\$iAn element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.
=750  \0$aCerium$5IEN$0(DLC)sh 85022138

=LDR  00987cz  a2200217n  4500
=001  9880363472702441
=005  20200508115726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002591
=035  \\$aCAZ5750HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x875
=150  \\$aCetacea
=450  \\$wnnna$aCetaceas
=550  \\$wg$aEutheria
=550  \\$wh$aDolphins
=550  \\$wh$aPorpoises
=550  \\$wh$aWhales
=667  \\$ageneral or unspecified; prefer DOLPHINS; PORPOISES; or WHALES; or specifics
=680  \\$iAn order of wholly aquatic MAMMALS occurring in all the OCEANS and adjoining seas of the world, as well as in certain river systems. They feed generally on FISHES, cephalopods, and crustaceans. Most are gregarious and most have a relatively long period of parental care and maturation. Included are DOLPHINS; PORPOISES; and WHALES. (From Walker's Mammals of the World, 5th ed, pp969-70)
=750  \0$aCetacea$5IEN$0(DLC)sh 85022218

=LDR  01200cz  a2200337n  4500
=001  9880363472802441
=005  20141212195734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002589
=035  \\$aCAZ5748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215
=150  \\$aCestoda
=450  \\$wnnna$aCestodas
=450  \\$wnnna$aCestode
=450  \\$wnnna$aCestodes
=450  \\$aRaillietina
=450  \\$wnnna$aRaillietinas
=450  \\$wnnna$aTapeworm
=450  \\$aTapeworms
=550  \\$wg$aPlatyhelminths
=550  \\$wh$aDiphyllobothrium
=550  \\$wh$aEchinococcus
=550  \\$wh$aHymenolepis
=550  \\$wh$aMesocestoides
=550  \\$wh$aSpirometra
=550  \\$wh$aTaenia
=667  \\$aGEN; IM; infection = CESTODE INFECTIONS; /drug eff: consider also ANTICESTODAL AGENTS; for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA subclass of segmented worms comprising the tapeworms.
=688  \\$a65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85
=750  \0$aTapeworms$5IEN-M$0(DLC)sh 85022214

=LDR  00664cz  a2200205n  4500
=001  9880363472902441
=005  20141212195733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002587
=035  \\$aCAZ5746HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x180
=150  \\$aCesium Isotopes
=450  \\$wnnna$aIsotopes, Cesium
=550  \\$wg$aIsotopes
=550  \\$wh$aCesium Radioisotopes
=550  \\$aCesium
=667  \\$aCs-133; NIM
=680  \\$iStable cesium atoms that have the same atomic number as the element cesium, but differ in atomic weight. Cs-133 is a naturally occurring isotope.
=750  \0$aCesium$xIsotopes$5IEN$0(DLC)sh 85022201

=LDR  00796cz  a2200217n  4500
=001  9880363473002441
=005  20141212195733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002586
=035  \\$aCAZ5745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x549.$x125
=072  \\$aD1.$x268.$x556.$x165
=072  \\$aD1.$x552.$x528.$x160
=072  \\$aD1.$x552.$x544.$x165
=150  \\$aCesium
=550  \\$wg$aMetals, Alkali
=550  \\$wg$aMetals, Heavy
=667  \\$aan alkali metal; Cs-133
=680  \\$iA member of the alkali metals. It has an atomic symbol Cs, atomic number 50, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency.
=750  \0$aCesium$5IEN$0(DLC)sh 85022200

=LDR  01067cz  a2200313n  4500
=001  9880363473102441
=005  20141212195733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002585
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252.$x500
=150  \\$aCesarean Section
=450  \\$wnnna$aAbdominal Deliveries
=450  \\$aAbdominal Delivery
=450  \\$wnnna$aC-Section (OB)
=450  \\$wnnna$aC Section (OB)
=450  \\$wnnna$aC-Sections (OB)
=450  \\$wnnna$aCaesarean Section
=450  \\$wnnna$aCaesarean Sections
=450  \\$wnnna$aCesarean Sections
=450  \\$wnnna$aDeliveries, Abdominal
=450  \\$aDelivery, Abdominal
=450  \\$wnnna$aPostcesarean Section
=550  \\$wg$aDelivery, Obstetric
=550  \\$wh$aCesarean Section, Repeat
=550  \\$aTrial of Labor
=667  \\$acheck the tags FEMALE & PREGNANCY; anesthesia in cesareans: coord IM with ANESTHESIA, OBSTETRICAL (IM)
=680  \\$iExtraction of the FETUS by means of abdominal HYSTEROTOMY.
=750  \0$aCesarean section$5IEN$0(DLC)sh 85022196

=LDR  00755cz  a2200217n  4500
=001  9880363473202441
=005  20141212195733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002584
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x679.$x256
=150  \\$aCervix Uteri
=450  \\$wnnna$aCervix
=450  \\$wnnna$aCervix, Uterine
=450  \\$wnnna$aCervixes
=450  \\$wnnna$aUterine Cervix
=550  \\$wg$aUterus
=667  \\$ainflammation = CERVICITIS; conization = CERVIX UTERI /pathol (IM) + CONIZATION (IM)
=680  \\$iThe neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.
=688  \\$aCERVIX HYPERTROPHY was heading 1963-96
=750  \0$aCervix uteri$5IEN$0(DLC)sh 85022185

=LDR  02784cz  a2200685n  4500
=001  9880363473302441
=005  20141212195726.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002561
=035  \\$aCAZ5721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300
=072  \\$aC14.$x907.$x253
=150  \\$aCerebrovascular Disorders
=450  \\$wnnna$aBrain Vascular Disorder
=450  \\$aBrain Vascular Disorders
=450  \\$aCerebrovascular Disease$5IEN
=450  \\$wnnna$aCerebrovascular Disorder
=450  \\$wnnna$aCerebrovascular Insufficiencies
=450  \\$wnnna$aCerebrovascular Insufficiency
=450  \\$wnnna$aCerebrovascular Occlusion
=450  \\$wnnna$aCerebrovascular Occlusions
=450  \\$wnnna$aInsufficiencies, Cerebrovascular
=450  \\$wnnna$aInsufficiency, Cerebrovascular
=450  \\$wnnna$aIntracranial Vascular Disease
=450  \\$wnnna$aIntracranial Vascular Diseases
=450  \\$wnnna$aIntracranial Vascular Disorder
=450  \\$aIntracranial Vascular Disorders
=450  \\$wnnna$aOcclusion, Cerebrovascular
=450  \\$wnnna$aOcclusions, Cerebrovascular
=450  \\$wnnna$aVascular Disease, Intracranial
=450  \\$aVascular Diseases, Intracranial
=450  \\$wnnna$aVascular Disorder, Brain
=450  \\$wnnna$aVascular Disorder, Intracranial
=450  \\$wnnna$aVascular Disorders, Brain
=450  \\$wnnna$aVascular Disorders, Intracranial
=550  \\$wg$aBrain Diseases
=550  \\$wg$aVascular Diseases
=550  \\$wh$aBasal Ganglia Cerebrovascular Disease
=550  \\$wh$aBrain Ischemia
=550  \\$wh$aCarotid Artery Diseases
=550  \\$wh$aCerebral Small Vessel Diseases
=550  \\$wh$aCerebrovascular Trauma
=550  \\$wh$aDementia, Vascular
=550  \\$wh$aIntracranial Arterial Diseases
=550  \\$wh$aIntracranial Arteriovenous Malformations
=550  \\$wh$aIntracranial Embolism and Thrombosis
=550  \\$wh$aIntracranial Hemorrhages
=550  \\$wh$aLeukomalacia, Periventricular
=550  \\$wh$aSneddon Syndrome
=550  \\$wh$aStroke
=550  \\$wh$aSusac Syndrome
=550  \\$wh$aVascular Headaches
=550  \\$wh$aVasculitis, Central Nervous System
=550  \\$wh$aVasospasm, Intracranial
=550  \\$wh$aVertebral Artery Dissection
=550  \\$wh$aVertebrobasilar Insufficiency
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES; or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
=750  \0$aCerebrovascular disease$5IEN$0(DLC)sh 85022123

=LDR  00709cz  a2200217n  4500
=001  9880363473402441
=005  20170807112006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002560
=035  \\$aCAZ5720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x100.$x159
=150  \\$aCerebrovascular Circulation
=450  \\$aCerebral Circulation$5IEN
=450  \\$wnnna$aCirculation, Cerebrovascular
=550  \\$wg$aBlood Circulation
=550  \\$wh$aNeurovascular couplings
=667  \\$aconsider also BRAIN /blood supply; DF: CEREBROVASCULAR CIRC
=680  \\$iThe circulation of blood through the vessels of the BRAIN.
=688  \\$a64
=750  \0$aCerebral circulation$5IEN$0(DLC)sh 87001148

=LDR  01126cz  a2200265n  4500
=001  9880363473502441
=005  20141212195725.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002557
=035  \\$aCAZ5717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x35.$x188
=072  \\$aE4.$x525.$x170
=150  \\$aCerebrospinal Fluid Shunts
=450  \\$wnnna$aCerebrospinal Fluid Shunt
=450  \\$wnnna$aShunt, Cerebrospinal Fluid
=450  \\$wnnna$aShunts, Cerebrospinal Fluid
=550  \\$wg$aAnastomosis, Surgical
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wh$aVentriculoperitoneal Shunt
=550  \\$wh$aVentriculostomy
=667  \\$ado not use /util except by MeSH definition; NIM destination of shunt; VENTRICULOPERITONEAL SHUNT is available
=680  \\$iTubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles.
=688  \\$a72(69)
=750  \0$aCerebrospinal fluid shunts$5IEN$0(DLC)sh 85022122

=LDR  00857cz  a2200205n  4500
=001  9880363473602441
=005  20141212195724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002556
=035  \\$aCAZ5716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x178
=150  \\$aCerebrospinal Fluid Proteins
=450  \\$wnnna$aFluid Proteins, Cerebrospinal
=450  \\$wnnna$aProteins, Cerebrospinal Fluid
=450  \\$aProteins$xcerebrospinal fluid
=550  \\$wg$aProteins
=667  \\$aIM & coord with specific protein /csf (IM)
=680  \\$iProteins in the cerebrospinal fluid, normally albumin and globulin present in the ratio of 8 to 1. Increases in protein levels are of diagnostic value in neurological diseases. (Brain and Bannister's Clinical Neurology, 7th ed, p221)
=750  \0$aCerebrospinal fluid proteins$5IEN$0(DLC)sh 87001758

=LDR  02121cz  a2200589n  4500
=001  9880363473702441
=005  20141212195732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002583
=035  \\$aCAZ5742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x945.$x418.$x948.$x850
=072  \\$aC13.$x351.$x500.$x852.$x593.$x131
=072  \\$aC13.$x351.$x500.$x852.$x762.$x850
=072  \\$aC13.$x351.$x937.$x418.$x875.$x850
=150  \\$aUterine Cervical Neoplasms
=450  \\$wnnna$aCancer, Cervix
=450  \\$wnnna$aCancer of Cervix
=450  \\$wnnna$aCancer of the Cervix
=450  \\$wnnna$aCancer of the Uterine Cervix
=450  \\$wnnna$aCancer, Uterine Cervical
=450  \\$wnnna$aCancers, Cervix
=450  \\$wnnna$aCancers, Uterine Cervical
=450  \\$wnnna$aCervical Cancer
=450  \\$wnnna$aCervical Cancer, Uterine
=450  \\$wnnna$aCervical Cancers, Uterine
=450  \\$wnnna$aCervical Neoplasm
=450  \\$wnnna$aCervical Neoplasm, Uterine
=450  \\$wnnna$aCervical Neoplasms
=450  \\$wnnna$aCervical Neoplasms, Uterine
=450  \\$wnnna$aCervix Cancer
=450  \\$wnnna$aCervix Neoplasm
=450  \\$wnnna$aCervix Neoplasms
=450  \\$wnnna$aNeoplasm, Cervical
=450  \\$wnnna$aNeoplasm, Cervix
=450  \\$wnnna$aNeoplasm, Uterine Cervical
=450  \\$wnnna$aNeoplasms, Cervical
=450  \\$wnnna$aNeoplasms, Cervix
=450  \\$wnnna$aNeoplasms, Uterine Cervical
=450  \\$wnnna$aUterine Cervical Cancer
=450  \\$wnnna$aUterine Cervical Cancers
=450  \\$wnnna$aUterine Cervical Neoplasm
=550  \\$wg$aUterine Cervical Diseases
=550  \\$wg$aUterine Neoplasms
=550  \\$aCervical Intraepithelial Neoplasia
=550  \\$aUterine Cervical Dysplasia
=667  \\$acoordinate IM with histologic type of neoplasm (IM)
=680  \\$iTumors or cancer of the UTERINE CERVIX.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Cervix Neoplasms
=750  \0$aCervix uteri$xTumors$0(IEN)366893$5IEN-M
=750  \0$aCervix uteri$xCancer$0(DLC) sh 85022186$5IEN-M

=LDR  01244cz  a2200301n  4500
=001  9880363473802441
=005  20141212195732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002582
=035  \\$aCAZ5741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x200.$x503.$x339
=150  \\$aCervix Mucus
=450  \\$wnnna$aCervical Mucus
=450  \\$aFern Test
=450  \\$wnnna$aFern Tests
=450  \\$wnnna$aMucus, Cervical
=450  \\$wnnna$aMucus, Cervix
=450  \\$aPalm-Leaf Reaction
=450  \\$wnnna$aPalm Leaf Reaction
=450  \\$wnnna$aPalm-Leaf Reactions
=450  \\$wnnna$aReaction, Palm-Leaf
=450  \\$wnnna$aReactions, Palm-Leaf
=450  \\$wnnna$aTest, Fern
=450  \\$wnnna$aTests, Fern
=550  \\$wg$aMucus
=680  \\$iA slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. (From Dictionary of Obstetrics and Gynecology, 1988)
=750  \0$aCervix mucus$5IEN$0(DLC)sh 85022184

=LDR  01464cz  a2200325n  4500
=001  9880363473902441
=005  20141212195731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002581
=035  \\$aCAZ5740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x852.$x593.$x120
=072  \\$aC13.$x703.$x39.$x89.$x339
=150  \\$aUterine Cervical Incompetence
=450  \\$wnnna$aCervical Incompetence, Uterine
=450  \\$wnnna$aCervices, Incompetent
=450  \\$aCervix Incompetence
=450  \\$wnnna$aCervix, Incompetent
=450  \\$wnnna$aIncompetence, Cervix
=450  \\$wnnna$aIncompetence, Uterine Cervical
=450  \\$wnnna$aIncompetent Cervices
=450  \\$wnnna$aIncompetent Cervix
=550  \\$wg$aAbortion, Habitual
=550  \\$wg$aUterine Cervical Diseases
=667  \\$acheck the tags FEMALE & PREGNANCY
=680  \\$iIncompetent UTERINE CERVIX is usually diagnosed in the second trimester of PREGNANCY. It is characterized by passive painless cervical dilation in the absence of UTERINE CONTRACTION; BLEEDING; INFECTION; and sometimes with the amniotic sac (AMNIOTIC MEMBRANE) bulging through the partially dilated cervix. Left untreated, this condition may lead to premature pregnancy loss, such as HABITUAL ABORTION.
=688  \\$a2006 (1973)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Cervix Incompetence
=688  \\$a73
=750  \0$aUterine cervix incompetence$0(DLC) sh 92005325$5IEN-M

=LDR  01239cz  a2200325n  4500
=001  9880363474002441
=005  20141212210902.0
=008  880412\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015170
=035  \\$aCAZ5715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG11.$x561.$x170
=150  \\$aCerebrospinal Fluid Pressure
=450  \\$wnnna$aCerebrospinal Fluid Pressures
=450  \\$wnnna$aFluid Pressure, Cerebrospinal
=450  \\$wnnna$aFluid Pressure, Spinal
=450  \\$wnnna$aFluid Pressures, Cerebrospinal
=450  \\$wnnna$aFluid Pressures, Spinal
=450  \\$wnnna$aPressure, Cerebrospinal Fluid
=450  \\$wnnna$aPressure, Spinal Fluid
=450  \\$wnnna$aPressures, Cerebrospinal Fluid
=450  \\$wnnna$aPressures, Spinal Fluid
=450  \\$aSpinal Fluid Pressure
=450  \\$wnnna$aSpinal Fluid Pressures
=550  \\$wg$aNervous System Physiological Phenomena
=550  \\$wh$aIntracranial Pressure
=667  \\$aDF: CSF PRESSURE
=680  \\$iManometric pressure of the CEREBROSPINAL FLUID as measured by lumbar, cerebroventricular, or cisternal puncture. Within the cranial cavity it is called INTRACRANIAL PRESSURE.
=688  \\$a89
=750  \0$aCerebrospinal fluid pressure$5IEN$0(DLC)sh 85022121

=LDR  01178cz  a2200277n  4500
=001  9880363474102441
=005  20141212192054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002555
=035  \\$aCAZ5714HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x270.$x210
=150  \\$aCerebrospinal Fluid
=450  \\$wnnna$aCerebro Spinal Fluid
=450  \\$wnnna$aCerebro Spinal Fluids
=450  \\$wnnna$aCerebrospinal Fluids
=450  \\$wnnna$aFluid, Cerebro Spinal
=450  \\$wnnna$aFluid, Cerebrospinal
=450  \\$wnnna$aFluids, Cerebro Spinal
=450  \\$wnnna$aFluids, Cerebrospinal
=450  \\$wnnna$aSpinal Fluid, Cerebro
=450  \\$wnnna$aSpinal Fluids, Cerebro
=550  \\$wg$aExtracellular Fluid
=667  \\$aIM as substance only: use the qualifier / csf with diseases & drugs; CSF production = / physiol, not / secret;  CEREBROSPINAL FLUID PRESSURE and CEREBROSPINAL FLUID PROTEINS are also  available
=680  \\$iA watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.
=750  \0$aCerebrospinal fluid$5IEN$0(DLC)sh 85022119

=LDR  01126cz  a2200217n  4500
=001  9880363474202441
=005  20141212195724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002554
=035  \\$aCAZ5713HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x313.$x250
=072  \\$aD9.$x400.$x410.$x420.$x525.$x200.$x250
=072  \\$aD10.$x390.$x470.$x675.$x200.$x250
=072  \\$aD10.$x570.$x877.$x360.$x612.$x200.$x250
=150  \\$aCerebrosides
=550  \\$wg$aCeramides
=550  \\$wh$aGalactosylceramides
=550  \\$wh$aGlucosylceramides
=680  \\$iNeutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)
=750  \0$aCerebrosides$5IEN$0(DLC)sh 85022116

=LDR  01259cz  a2200361n  4500
=001  9880363474302441
=005  20141212192054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002552
=035  \\$aCAZ5711HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x276
=150  \\$aCerebral Ventricles
=450  \\$wnnna$aCerebral Ventricle
=450  \\$wnnna$aCerebral Ventricular System
=450  \\$aForamen of Monro
=450  \\$wnnna$aMonro Foramen
=450  \\$wnnna$aVentricle, Cerebral
=450  \\$wnnna$aVentricles, Cerebral
=550  \\$wg$aBrain
=550  \\$wh$aCerebral Aqueduct
=550  \\$wh$aChoroid Plexus
=550  \\$wh$aEpendyma
=550  \\$wh$aFourth Ventricle
=550  \\$wh$aLateral Ventricles
=550  \\$wh$aSeptum Pellucidum
=550  \\$wh$aThird Ventricle
=550  \\$aCerebral Ventriculography
=550  \\$aInjections, Intraventricular
=550  \\$aVentriculostomy
=667  \\$ainflammation = CEREBRAL VENTRICULITIS
=680  \\$iFour CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE).
=750  \0$aBrain$xVentricles$5IEN$0(DLC)sh 85022111

=LDR  01115cz  a2200313n  4500
=001  9880363474402441
=005  20141212202442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007186
=035  \\$aCBA0377HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x325.$x569
=072  \\$aE7.$x461.$x487
=150  \\$aIncubators, Infant
=450  \\$wnnna$aIncubator, Infant
=450  \\$wnnna$aInfant Incubator
=450  \\$wnnna$aInfant Incubators
=450  \\$wnnna$aInfant Radiant Warmer
=450  \\$aInfant Radiant Warmers
=450  \\$wnnna$aRadiant Warmer, Infant
=450  \\$aRadiant Warmers, Infant
=450  \\$wnnna$aWarmer, Infant Radiant
=450  \\$wnnna$aWarmers, Infant Radiant
=550  \\$wg$aEquipment and Supplies, Hospital
=550  \\$wg$aIncubators
=550  \\$aInfant Care
=680  \\$iElectrically powered devices that are intended to assist in the maintenance of the thermal balance of infants, principally by controlling the air temperature and humidity in an enclosure. (from UMDNS, 1999)
=688  \\$a74
=750  \0$aIncubators (Pediatrics)$5IEN$0(DLC)sh 85064808

=LDR  00838cz  a2200229n  4500
=001  9880363474502441
=005  20141212202442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007185
=035  \\$aCBA0376HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x461
=150  \\$aIncubators
=450  \\$wnnna$aIncubator
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aIncubators, Infant
=550  \\$aEnvironment, Controlled
=550  \\$aLife Support Systems
=667  \\$afor eggs, microbial cultures, cell cultures, etc.; INCUBATORS, INFANT is also available
=680  \\$iInsulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.
=688  \\$a73
=750  \0$aIncubators$5IEN$0(DLC)sh 85064807

=LDR  00585cz  a2200205n  4500
=001  9880363474602441
=005  20141212202441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007183
=035  \\$aCBA0374HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x900.$x250
=150  \\$aIncome Tax
=450  \\$wnnna$aIncome Taxes
=450  \\$wnnna$aTax, Income
=450  \\$wnnna$aTaxes, Income
=550  \\$wg$aTaxes
=667  \\$aIM; specify geog
=680  \\$iTax on the net income of an individual, organization, or business.
=750  \0$aIncome tax$5IEN$0(DLC)sh 85064772

=LDR  01200cz  a2200349n  4500
=001  9880363474702441
=005  20141212202441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007182
=035  \\$aCBA0373HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417
=150  \\$aIncome
=450  \\$wnnna$aDistribution, Income
=450  \\$wnnna$aDistributions, Income
=450  \\$wnnna$aIncome Distribution
=450  \\$wnnna$aIncome Distributions
=450  \\$wnnna$aIncome Generation Program
=450  \\$wnnna$aIncome Generation Programs
=450  \\$wnnna$aIncomes
=450  \\$wnnna$aProgram, Income Generation
=450  \\$wnnna$aPrograms, Income Generation
=450  \\$wnnna$aSavings
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aPensions
=550  \\$wh$aRemuneration
=550  \\$wh$aSalaries and Fringe Benefits
=550  \\$aFinancial Management
=667  \\$aincludes income from salaries, annuities, stocks, etc.; does not include fees charged by a professional ( = FEES AND CHARGES)
=680  \\$iRevenues or receipts accruing from business enterprise, labor, or invested capital.
=688  \\$a68
=750  \0$aIncome$5IEN$0(DLC)sh 85064759

=LDR  00868cz  a2200193n  4500
=001  9880363474802441
=005  20141212202440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007180
=035  \\$aCBA0371HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x860.$x425
=150  \\$aIncisor
=450  \\$wnnna$aIncisors
=550  \\$wg$aTooth
=667  \\$aone of the 8 front teeth; NIM when merely locational; "incisive papilla", a projection on the palate posterior to the central incisors: index under PALATE & do not add INCISOR
=680  \\$iAny of the eight frontal teeth (four maxillary and four mandibular) having a sharp incisal edge for cutting food and a single root, which occurs in man both as a deciduous and a permanent tooth. (Jablonski, Dictionary of Dentistry, 1992, p820)
=688  \\$a65
=750  \0$aIncisors$5IEN$0(DLC)sh 85064750

=LDR  00598cz  a2200193n  4500
=001  9880363474902441
=005  20141212202440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007179
=035  \\$aCBA0369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x442
=150  \\$aIncest
=550  \\$wg$aSocial Problems
=667  \\$a/ethnol /psychol permitted
=680  \\$iSexual intercourse between persons so closely related that they are forbidden by law to marry.
=688  \\$a67
=750  \0$aIncest$5IEN-M$0(DLC)sh 85064740
=750  \0$aIncest victims$5IEN-HS$0(DLC)sh 85064744

=LDR  01156cz  a2200337n  4500
=001  9880363475002441
=005  20141212202440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007178
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x820.$x150.$x520
=072  \\$aG5.$x355.$x90.$x403
=150  \\$aInbreeding
=450  \\$aBackcrossing
=450  \\$wnnna$aBackcrossings
=450  \\$aHalf-Sib Mating
=450  \\$wnnna$aHalf Sib Mating
=450  \\$wnnna$aHalf-Sib Matings
=450  \\$wnnna$aMating, Half-Sib
=450  \\$wnnna$aMating, Sib
=450  \\$wnnna$aMatings, Half-Sib
=450  \\$wnnna$aMatings, Sib
=450  \\$aSib Mating
=450  \\$wnnna$aSib Matings
=550  \\$wg$aBreeding
=550  \\$wh$aConsanguinity
=550  \\$wh$aSelf-Fertilization
=667  \\$aanimals or plants only: for humans use CONSANGUINITY; restrict to inbreeding as a genetic concept or a technique: not a routine term for inbred animals (= ANIMALS, INBRED STRAINS or specifics)
=680  \\$iThe mating of plants or non-human animals which are closely related genetically.
=688  \\$a68
=750  \0$aInbreeding$5IEN$0(DLC)sh 85064709

=LDR  00795cz  a2200253n  4500
=001  9880363475102441
=005  20141212192246.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007175
=035  \\$aCBA0365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x527
=150  \\$aImpulsive Behavior
=450  \\$wnnna$aBehavior, Impulsive
=450  \\$wnnna$aBehaviors, Impulsive
=450  \\$wnnna$aImpulsive Behaviors
=450  \\$wnnna$aImpulsivities
=450  \\$wnnna$aImpulsivity
=550  \\$wg$aBehavior
=550  \\$wh$aCompulsive Behavior
=550  \\$aDelay Discounting
=680  \\$iAn act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.
=688  \\$a68
=750  \0$aImpulsive personality$5IEN$0(DLC)sh 85064680

=LDR  01364cz  a2200313n  4500
=001  9880363475202441
=005  20160428153522.0
=008  800520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007174
=035  \\$aCBA0364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x250
=150  \\$aDisruptive, Impulse Control, and Conduct Disorders
=450  \\$wnno$aImpulse Control Disorders
=450  \\$wnnna$aDisorders, Impulse Control
=450  \\$wnnna$aDisorders, Intermittent Explosive
=450  \\$wnnna$aExplosive Disorder, Intermittent
=450  \\$wnnna$aImpulse-Control Disorders
=450  \\$aIntermittent Explosive Disorder
=450  \\$wnnna$aIntermittent Explosive Disorders
=450  \\$aKleptomania
=550  \\$wg$aMental Disorders
=550  \\$wh$aFiresetting Behavior
=550  \\$wh$aGambling
=550  \\$wh$aTrichotillomania
=550  \\$aSubstance-Related Disorders
=680  \\$iDisorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
=688  \\$aKLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80
=750  \0$aImpulse control disorders$5IEN$0(DLC)sh 92006420

=LDR  01023cz  a2200301n  4500
=001  9880363475402441
=005  20141212202438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007172
=035  \\$aCBA0362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x294.$x644.$x486
=072  \\$aF3.$x800.$x800.$x400
=150  \\$aErectile Dysfunction
=450  \\$wnnna$aDysfunction, Erectile
=450  \\$aImpotence
=450  \\$wnnna$aImpotence, Male
=450  \\$wnnna$aImpotence, Male Sexual
=450  \\$wnnna$aMale Impotence
=450  \\$wnnna$aMale Sexual Impotence
=450  \\$wnnna$aSexual Impotence, Male
=550  \\$wg$aSexual Dysfunction, Physiological
=550  \\$wg$aSexual Dysfunctions, Psychological
=550  \\$wh$aImpotence, Vasculogenic
=680  \\$iThe inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Impotence
=750  \0$aImpotence$0(DLC) sh 85064658$5IEN

=LDR  01054cz  a2200241n  4500
=001  9880363475502441
=005  20141212202437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007169
=035  \\$aCBA0359HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x868.$x820.$x504
=072  \\$aC1.$x252.$x410.$x890.$x485
=072  \\$aC1.$x252.$x825.$x770.$x360
=072  \\$aC1.$x539.$x800.$x720.$x770.$x360
=072  \\$aC17.$x800.$x838.$x765.$x770.$x360
=150  \\$aImpetigo
=450  \\$aImpetigo Contagiosa
=550  \\$wg$aStaphylococcal Skin Infections
=550  \\$wg$aStreptococcal Infections
=667  \\$aa staph or strep infect of the skin
=680  \\$iA common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.
=750  \0$aImpetigo$5IEN$0(DLC)sh 85064638

=LDR  01028cz  a2200253n  4500
=001  9880363475602441
=005  20141212202437.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007168
=035  \\$aCBA0358M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x820.$x450
=150  \\$aIMP Dehydrogenase
=450  \\$wnnna$aAcid Dehydrogenase, Inosinic
=450  \\$wnnna$aDehydrogenase, IMP
=450  \\$wnnna$aDehydrogenase, Inosine-5-Monophosphate
=450  \\$wnnna$aDehydrogenase, Inosinic Acid
=450  \\$wnnna$aInosine-5-Monophosphate Dehydrogenase
=450  \\$wnnna$aInosine 5 Monophosphate Dehydrogenase
=450  \\$aInosinic Acid Dehydrogenase
=550  \\$wg$aNAD (+) and NADP (+) Dependent Alcohol Oxidoreductases
=680  \\$iAn enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205.
=688  \\$a91(75); was see under KETONE OXIDOREDUCTASES 1975-90
=750  \0$aIMP dehydrogenase$5IEN-M$0(DLC)sh2002008734

=LDR  00958cz  a2200253n  4500
=001  9880363475702441
=005  20141212202437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007167
=035  \\$aCBA0357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465.$x425
=150  \\$aImmunotherapy
=450  \\$wnnna$aImmunotherapies
=550  \\$wg$aImmunomodulation
=550  \\$wh$aImmunization
=550  \\$wh$aImmunosuppression
=550  \\$wh$aRadioimmunotherapy
=550  \\$aImmunity, Active
=550  \\$aImmunologic Techniques
=667  \\$aGEN only; do not use /util except by MeSH definition; for ther: coord IM with dis /ther (IM)
=680  \\$iManipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
=688  \\$a73; VACCINE THERAPY was heading 1963-82
=750  \0$aImmunotherapy$5IEN$0(DLC)sh 85064592

=LDR  01129cz  a2200229n  4500
=001  9880363475802441
=005  20141212202436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007166
=035  \\$aCBA0356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x656
=150  \\$aImmunosuppressive Agents
=450  \\$wnnna$aAgents, Immunosuppressive
=450  \\$wnnna$aImmunosuppressants
=550  \\$wg$aImmunologic Factors
=550  \\$wh$aComplement Inactivating Agents
=550  \\$wh$aMyeloablative Agonists
=550  \\$aAntirheumatic Agents
=680  \\$iAgents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
=688  \\$a66(64)
=750  \0$aImmunosuppressive agents$5IEN$0(DLC)sh 85064589

=LDR  01738cz  a2200421n  4500
=001  9882116471802441
=005  20230127144901.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007165
=035  \\$a(DNLM)D007165
=035  \\$a(NLM)98194889120000041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 955
=072  \\$aE2.$x95.$x465.$x425.$x450
=072  \\$aE5.$x478.$x610
=150  \\$aImmunosuppression Therapy
=450  \\$wnnna$aAnti-Rejection Therapy
=450  \\$wnnna$aTherapy, Anti-Rejection
=450  \\$wnnna$aTherapy, Antirejection
=450  \\$aAntirejection Therapy
=450  \\$aImmunosuppression
=450  \\$aImmunosuppressive Therapy
=450  \\$wnnna$aAnti Rejection Therapy
=450  \\$wnnna$aAnti-Rejection Therapies
=450  \\$wnnna$aAntirejection Therapies
=450  \\$wnnna$aImmunosuppression Therapies
=450  \\$wnnna$aImmunosuppressions
=450  \\$wnnna$aImmunosuppressive Therapies
=450  \\$wnnna$aTherapies, Immunosuppression
=450  \\$wnnna$aTherapies, Immunosuppressive
=450  \\$wnnna$aTherapy, Immunosuppression
=450  \\$wnnna$aTherapy, Immunosuppressive
=550  \\$aImmune Tolerance
=550  \\$aTransplantation Immunology
=667  \\$anote category: do not confuse with IMMUNOSUPPRESSION (PHYSIOLOGY) see IMMUNE TOLERANCE
=680  \\$iDeliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
=688  \\$a2022 (1971)
=750  \0$aImmunosuppression$5IEN$0(DLC)sh 85064588

=LDR  02128cz  a2200625n  4500
=001  9880363476002441
=005  20141212202434.0
=008  860401\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007159
=035  \\$aCBA0349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812
=072  \\$aE5.$x200.$x812
=072  \\$aE5.$x478.$x594
=150  \\$aImmunologic Tests
=450  \\$wnnna$aDiagnoses, Immunologic
=450  \\$wnnna$aDiagnoses, Immunological
=450  \\$wnnna$aDiagnosis, Immunologic
=450  \\$aDiagnosis, Immunological
=450  \\$wnnna$aImmunodiagnoses
=450  \\$aImmunodiagnosis
=450  \\$wnnna$aImmunologic Diagnoses
=450  \\$wnnna$aImmunologic Diagnosis
=450  \\$wnnna$aImmunologic Test
=450  \\$wnnna$aImmunological Diagnoses
=450  \\$wnnna$aImmunological Diagnosis
=450  \\$wnnna$aImmunological Test
=450  \\$wnnna$aImmunological Tests
=450  \\$wnnna$aTest, Immunologic
=450  \\$wnnna$aTest, Immunological
=450  \\$wnnna$aTests, Immunologic
=450  \\$wnnna$aTests, Immunological
=550  \\$wg$aClinical Laboratory Techniques
=550  \\$wg$aImmunologic Techniques
=550  \\$wh$aAntibody-Coated Bacteria Test, Urinary
=550  \\$wh$aBasophil Degranulation Test
=550  \\$wh$aCell Migration Assays
=550  \\$wh$aCytotoxicity Tests, Immunologic
=550  \\$wh$aHemolytic Plaque Technique
=550  \\$wh$aHistocompatibility Testing
=550  \\$wh$aImmune Adherence Reaction
=550  \\$wh$aImmunophenotyping
=550  \\$wh$aInterferon-gamma Release Tests
=550  \\$wh$aLeukocyte Adherence Inhibition Test
=550  \\$wh$aLymphocyte Activation
=550  \\$wh$aMonitoring, Immunologic
=550  \\$wh$aPregnancy Tests, Immunologic
=550  \\$wh$aRosette Formation
=550  \\$wh$aSerologic Tests
=550  \\$wh$aSerotyping
=550  \\$wh$aSkin Tests
=667  \\$ageneral; prefer specifics; do not confuse with IMMUNOLOGIC TECHNIQUES
=680  \\$iImmunologic techniques involved in diagnosis.
=688  \\$a87
=750  \0$aImmunodiagnosis$5IEN$0(DLC)sh 85064553

=LDR  02134cz  a2200565n  4500
=001  9880363476102441
=005  20141212202433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007158
=035  \\$aCBA0348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x478
=150  \\$aImmunologic Techniques
=450  \\$aAllergy and Immunology$xmethods
=450  \\$wnnna$aAntibody Dissociation
=450  \\$wnnna$aAntibody Dissociations
=450  \\$wnnna$aDissociation, Antibody
=450  \\$wnnna$aDissociations, Antibody
=450  \\$wnnna$aImmunologic Technic
=450  \\$wnnna$aImmunologic Technics
=450  \\$wnnna$aImmunologic Technique
=450  \\$wnnna$aImmunological Technic
=450  \\$wnnna$aImmunological Technics
=450  \\$wnnna$aImmunological Technique
=450  \\$wnnna$aImmunological Techniques
=450  \\$wnnna$aTechnic, Immunologic
=450  \\$wnnna$aTechnic, Immunological
=450  \\$wnnna$aTechnics, Immunologic
=450  \\$wnnna$aTechnics, Immunological
=450  \\$wnnna$aTechnique, Immunologic
=450  \\$wnnna$aTechnique, Immunological
=450  \\$wnnna$aTechniques, Immunologic
=450  \\$wnnna$aTechniques, Immunological
=550  \\$wg$aInvestigative Techniques
=550  \\$wh$aEpitope Mapping
=550  \\$wh$aFluorescent Antibody Technique
=550  \\$wh$aImmunization
=550  \\$wh$aImmunoassay
=550  \\$wh$aImmunohistochemistry
=550  \\$wh$aImmunologic Tests
=550  \\$wh$aImmunoprecipitation
=550  \\$wh$aImmunosuppression
=550  \\$wh$aInterferon-gamma Release Tests
=550  \\$wh$aRadioimmunodetection
=550  \\$aImmunity
=550  \\$aImmunochemistry
=667  \\$aGEN: prefer specifics; NIM; do not confuse with IMMUNOLOGIC TESTS ( = immunol techniques applied to diag); DF: IMMUNOL TECHNIQUES
=680  \\$iTechniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies.
=688  \\$a91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1971-82 (Prov 1971-72)
=750  \0$aImmunology$xTechnique$5IEN$0(DLC)sh 85064581

=LDR  00964cz  a2200253n  4500
=001  9880363476202441
=005  20141212202432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007156
=035  \\$aCBA0346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x50.$x500
=150  \\$aImmunologic Memory
=450  \\$wnnna$aImmunologic Memories
=450  \\$wnnna$aImmunological Memories
=450  \\$wnnna$aImmunological Memory
=450  \\$wnnna$aMemories, Immunologic
=450  \\$wnnna$aMemories, Immunological
=450  \\$wnnna$aMemory, Immunologic
=450  \\$wnnna$aMemory, Immunological
=550  \\$wg$aAdaptive Immunity
=680  \\$iThe altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus.
=688  \\$a73(71)
=750  \0$aImmunologic memory$5IEN$0(DLC)sh 85064573

=LDR  01434cz  a2200373n  4500
=001  9880363476302441
=005  20141212202432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007155
=035  \\$aCBA0345M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x477
=150  \\$aImmunologic Factors
=450  \\$wnnna$aBiological Response Modifiers
=450  \\$wnnna$aBiomodulators
=450  \\$wnnna$aFactors, Immune
=450  \\$wnnna$aFactors, Immunologic
=450  \\$wnnna$aFactors, Immunological
=450  \\$wnnna$aImmune Factors
=450  \\$wnnna$aImmunological Factors
=450  \\$aImmunomodulators
=450  \\$wnnna$aModifiers, Biological Response
=450  \\$wnnna$aResponse Modifiers, Biological
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAdjuvants, Immunologic
=550  \\$wh$aAgglutinins
=550  \\$wh$aImmunosuppressive Agents
=550  \\$wh$aInterferon Inducers
=550  \\$aMolecular Mechanisms of Pharmacological Action
=550  \\$aReceptors, Immunologic
=680  \\$iBiologically active substances whose activities affect or play a role in the functioning of the immune system.
=688  \\$a1998; for IMMUNOMODULATORS use ADJUVANTS, IMMUNOLOGIC 1980-2004
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Biological Response Modifiers
=750  \0$aBiological response modifiers$0(DLC) sh 85014187$5IEN-M

=LDR  01992cz  a2200565n  4500
=001  9880363476402441
=005  20141212202431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007154
=035  \\$aCBA0344HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20
=150  \\$aImmune System Diseases
=450  \\$aDevelopmental Immunology$5IEN
=450  \\$wnnna$aDisease, Immune
=450  \\$wnnna$aDisease, Immune System
=450  \\$wnnna$aDisease, Immunologic
=450  \\$wnnna$aDisease, Immunological
=450  \\$wnnna$aDiseases, Immune
=450  \\$wnnna$aDiseases, Immune System
=450  \\$wnnna$aDiseases, Immunologic
=450  \\$wnnna$aDiseases, Immunological
=450  \\$wnnna$aDiseases of Immune System
=450  \\$wnnna$aDisorder, Immune
=450  \\$wnnna$aDisorders, Immune
=450  \\$wnnna$aImmune Disease
=450  \\$wnnna$aImmune Diseases
=450  \\$wnnna$aImmune Disorder
=450  \\$aImmune Disorders
=450  \\$wnnna$aImmune System Disease
=450  \\$wnnna$aImmunologic Disease
=450  \\$aImmunologic Diseases
=450  \\$wnnna$aImmunological Disease
=450  \\$wnnna$aImmunological Diseases
=450  \\$aImmunopathology$5IEN
=550  \\$wh$aAutoimmune Diseases
=550  \\$wh$aErythroblastosis, Fetal
=550  \\$wh$aGlomerulonephritis, Membranoproliferative
=550  \\$wh$aGraft vs Host Disease
=550  \\$wh$aHypersensitivity
=550  \\$wh$aImmune Reconstitution Inflammatory Syndrome
=550  \\$wh$aImmunologic Deficiency Syndromes
=550  \\$wh$aImmunoproliferative Disorders
=550  \\$wh$aPurpura, Thrombocytopenic
=550  \\$wh$aTransfusion Reaction
=667  \\$aGEN: prefer specifics
=680  \\$iDisorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.
=688  \\$a2005 (1971)
=750  \0$aImmunopathology$5IEN-M$0(DLC)sh 85064585
=750  \0$aImmunologic diseases$0(DLC) sh 85064571$5IEN-HS$0(DLC)sh 85064571

=LDR  02371cz  a2200529n  4500
=001  9880363476502441
=005  20141212202430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007153
=035  \\$aCBA0343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x673
=150  \\$aImmunologic Deficiency Syndromes
=450  \\$aAntibodies$xdeficiency
=450  \\$aAntibody Deficiency Syndrome
=450  \\$wnnna$aAntibody Deficiency Syndromes
=450  \\$wnnna$aDeficiency Syndrome, Antibody
=450  \\$wnnna$aDeficiency Syndrome, Immunologic
=450  \\$wnnna$aDeficiency Syndrome, Immunological
=450  \\$wnnna$aDeficiency Syndromes, Antibody
=450  \\$wnnna$aDeficiency Syndromes, Immunologic
=450  \\$wnnna$aDeficiency Syndromes, Immunological
=450  \\$wnnna$aImmunologic Deficiency Syndrome
=450  \\$wnnna$aImmunological Deficiency Syndrome
=450  \\$wnnna$aImmunological Deficiency Syndromes
=450  \\$wnnna$aSyndrome, Antibody Deficiency
=450  \\$wnnna$aSyndrome, Immunologic Deficiency
=450  \\$wnnna$aSyndrome, Immunological Deficiency
=450  \\$wnnna$aSyndromes, Antibody Deficiency
=450  \\$wnnna$aSyndromes, Immunologic Deficiency
=450  \\$wnnna$aSyndromes, Immunological Deficiency
=550  \\$wg$aImmune System Diseases
=550  \\$wh$aAgammaglobulinemia
=550  \\$wh$aAtaxia Telangiectasia
=550  \\$wh$aCommon Variable Immunodeficiency
=550  \\$wh$aDeltaretrovirus Infections
=550  \\$wh$aDysgammaglobulinemia
=550  \\$wh$aHIV Infections
=550  \\$wh$aLeukocyte-Adhesion Deficiency Syndrome
=550  \\$wh$aLymphopenia
=550  \\$wh$aPhagocyte Bactericidal Dysfunction
=550  \\$wh$aSevere Combined Immunodeficiency
=550  \\$wh$aWiskott-Aldrich Syndrome
=667  \\$aGEN or unspecified; for defic of specific immunoprotein, IMMUNOGLOBULINS or specific immunoglobulin, use specific with /defic; TN 223: definition & use; TN 225: differentiation from immunoglobulin defic; Manual 23.25.2; DF: IMMUNOL DEFIC SYNDROMES
=680  \\$iSyndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
=688  \\$a70(68); ANTIBODY DEFICIENCY SYNDROME was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77
=750  \0$aImmunological deficiency syndromes$5IEN-M$0(DLC)sh 85064574

=LDR  02561cz  a2200685n  4500
=001  9880363476602441
=005  20141212202429.0
=008  870508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007150
=035  \\$aCBA0340HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x607.$x512
=072  \\$aE1.$x370.$x225.$x750.$x551.$x512
=072  \\$aE5.$x200.$x500.$x607.$x512
=072  \\$aE5.$x200.$x750.$x551.$x512
=072  \\$aE5.$x478.$x583
=072  \\$aH1.$x158.$x100.$x656.$x234.$x512
=072  \\$aH1.$x158.$x201.$x344.$x512
=072  \\$aH1.$x158.$x201.$x486.$x512
=072  \\$aH1.$x181.$x122.$x573.$x512
=072  \\$aH1.$x181.$x122.$x605.$x512
=150  \\$aImmunohistochemistry
=450  \\$aDiagnostic Immunohistochemistry$5IEN
=450  \\$aImmunocytochemistry
=450  \\$wnnna$aImmunogold-Silver Technic
=450  \\$wnnna$aImmunogold-Silver Technics
=450  \\$wnnna$aImmunogold Silver Technics
=450  \\$wnnna$aImmunogold-Silver Technique
=450  \\$aImmunogold-Silver Techniques
=450  \\$wnnna$aImmunogold Silver Techniques
=450  \\$wnnna$aImmunogold Technic
=450  \\$wnnna$aImmunogold Technics
=450  \\$wnnna$aImmunogold Technique
=450  \\$aImmunogold Techniques
=450  \\$aImmunohistocytochemistry
=450  \\$wnnna$aImmunolabeling Technic
=450  \\$wnnna$aImmunolabeling Technics
=450  \\$wnnna$aImmunolabeling Technique
=450  \\$aImmunolabeling Techniques
=450  \\$wnnna$aTechnic, Immunogold
=450  \\$wnnna$aTechnic, Immunogold-Silver
=450  \\$wnnna$aTechnic, Immunolabeling
=450  \\$wnnna$aTechnics, Immunogold
=450  \\$wnnna$aTechnics, Immunogold-Silver
=450  \\$wnnna$aTechnics, Immunolabeling
=450  \\$wnnna$aTechnique, Immunogold
=450  \\$wnnna$aTechnique, Immunogold-Silver
=450  \\$wnnna$aTechnique, Immunolabeling
=450  \\$wnnna$aTechniques, Immunogold
=450  \\$wnnna$aTechniques, Immunogold-Silver
=450  \\$wnnna$aTechniques, Immunolabeling
=550  \\$wg$aHistocytochemistry
=550  \\$wg$aImmunochemistry
=550  \\$wg$aImmunologic Techniques
=550  \\$wh$aFluorescent Antibody Technique
=550  \\$wh$aImmunoenzyme Techniques
=667  \\$aGEN; avoid as coord; SPEC qualif when IM; no qualif when NIM; immunohistochem of disease is disease /diag or /metab
=680  \\$iHistochemical localization of immunoreactive substances using labeled antibodies as reagents.
=688  \\$a88
=750  \0$aImmunohistochemistry$5IEN-M$0(DLC)sh 85064570

=LDR  02087cz  a2200361n  4500
=001  9880363476702441
=005  20141212202421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007136
=035  \\$aCBA0326HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485
=072  \\$aD12.$x776.$x124.$x790.$x651
=072  \\$aD12.$x776.$x377.$x715.$x548
=150  \\$aImmunoglobulins
=450  \\$aGlobulins, Immune
=450  \\$aImmune Globulins
=450  \\$wnnna$aImmunoglobulin
=550  \\$wg$aImmunoproteins
=550  \\$wg$aSerum Globulins
=550  \\$wh$aAntibodies
=550  \\$wh$agamma-Globulins
=550  \\$wh$aImmunoglobulin Constant Regions
=550  \\$wh$aImmunoglobulin Fragments
=550  \\$wh$aImmunoglobulin Subunits
=550  \\$wh$aImmunoglobulin Variable Region
=550  \\$wh$aParaproteins
=550  \\$wh$aReceptors, Antigen, B-Cell
=550  \\$aGenes, Immunoglobulin
=667  \\$ageneral: prefer specifics; /admin: consider also IMMUNOGLOBULINS, INTRAVENOUS; /defic permitted but consider also IMMUNOLOGIC DEFICIENCY SYNDROMES ; /ther use: consider also IMMUNOGLOBULIN THERAPY see IMMUNIZATION, PASSIVE; allotypes = IMMUNOGLOBULIN ALLOTYPES or specifics
=680  \\$iMulti-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.
=688  \\$a72(70); IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE & IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93
=750  \0$aImmunoglobulins$5IEN$0(DLC)sh 85064568

=LDR  01476cz  a2200313n  4500
=001  9880363476802441
=005  20141212202418.0
=008  780127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007130
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x541.$x500.$x745
=072  \\$aD12.$x776.$x124.$x486.$x485.$x680.$x745
=072  \\$aD12.$x776.$x124.$x790.$x651.$x680.$x745
=072  \\$aD12.$x776.$x377.$x715.$x548.$x680.$x745
=072  \\$aD23.$x50.$x550.$x750
=072  \\$aG2.$x111.$x570.$x60.$x425.$x580
=072  \\$aG12.$x500.$x450
=150  \\$aImmunoglobulin Idiotypes
=450  \\$wnnna$aIdiotype, Immunoglobulin
=450  \\$aIdiotypes, Immunoglobulin
=450  \\$wnnna$aImmunoglobulin Idiotype
=550  \\$wg$aEpitopes
=550  \\$wg$aImmunogenetic Phenomena
=550  \\$wg$aImmunoglobulin Fragments
=550  \\$wg$aImmunoglobulin Variable Region
=550  \\$aAntibodies, Anti-Idiotypic
=680  \\$iUnique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains.
=688  \\$a79
=750  \0$aImmunoglobulin idiotypes$5IEN$0(DLC)sh 85064566

=LDR  01476cz  a2200385n  4500
=001  9880363476902441
=005  20141212202416.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x606
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x606
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x606
=072  \\$aG12.$x500.$x400
=150  \\$aImmunoglobulin Allotypes
=450  \\$wnnna$aAllotype, Ig
=450  \\$wnnna$aAllotype, Immunoglobulin
=450  \\$wnnna$aAllotypes, Ig
=450  \\$aAllotypes, Immunoglobulin
=450  \\$aAllotypic Antibodies
=450  \\$wnnna$aAllotypic Antibody
=450  \\$aAntibodies, Allotypic
=450  \\$wnnna$aAntibody, Allotypic
=450  \\$wnnna$aIg Allotype
=450  \\$wnnna$aIg Allotypes
=450  \\$wnnna$aImmunoglobulin Allotype
=550  \\$wg$aAntibodies
=550  \\$wg$aImmunogenetic Phenomena
=550  \\$wh$aImmunoglobulin Gm Allotypes
=550  \\$wh$aImmunoglobulin Km Allotypes
=550  \\$aGenes, Immunoglobulin
=667  \\$ageneral or unspecified; prefer specifics; Am allotype goes here (IM) + IMMUNOGLOBULIN A (IM); DF: IG ALLOTYPES
=680  \\$iAllelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES.
=688  \\$a75
=750  \0$aImmunoglobulin allotypes$5IEN$0(DLC)sh 85064562

=LDR  00704cz  a2200193n  4500
=001  9880363477002441
=005  20141212202416.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007125
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x420
=150  \\$aImmunogenetics
=450  \\$wnnna$aImmunogenetic
=550  \\$wg$aGenetics
=550  \\$aGenes, Immunoglobulin
=667  \\$athe discipline (education, history, etc) only; use IMMUNOGENETIC PHENOMENA for genetic phenomena related to the immune system
=680  \\$iA subdiscipline of genetics which deals with the genetic basis of the immune response (IMMUNITY).
=688  \\$a71
=750  \0$aImmunogenetics$5IEN$0(DLC)sh 85064560

=LDR  04366cz  a2200949n  4500
=001  9880363477102441
=005  20141212202415.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007124
=035  \\$aCBA0314HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x478.$x566.$x350
=072  \\$aE5.$x478.$x583.$x400
=072  \\$aE5.$x601.$x495.$x350
=150  \\$aImmunoenzyme Techniques
=450  \\$wnnna$aAntibody Enzyme Technic, Unlabeled
=450  \\$aAntibody Enzyme Technique, Unlabeled
=450  \\$wnnna$aAntibody Technic, Enzyme-Labeled
=450  \\$wnnna$aAntibody Technic, Peroxidase-Labeled
=450  \\$wnnna$aAntibody Technics, Enzyme-Labeled
=450  \\$wnnna$aAntibody Technics, Peroxidase-Labeled
=450  \\$wnnna$aAntibody Technique, Enzyme-Labeled
=450  \\$wnnna$aAntibody Technique, Peroxidase-Labeled
=450  \\$wnnna$aAntibody Techniques, Enzyme-Labeled
=450  \\$wnnna$aAntibody Techniques, Peroxidase-Labeled
=450  \\$aEnzyme Immunoassay
=450  \\$wnnna$aEnzyme Immunoassays
=450  \\$wnnna$aEnzyme-Labeled Antibody Technic
=450  \\$wnnna$aEnzyme Labeled Antibody Technic
=450  \\$wnnna$aEnzyme-Labeled Antibody Technics
=450  \\$aEnzyme-Labeled Antibody Technique
=450  \\$wnnna$aEnzyme Labeled Antibody Technique
=450  \\$wnnna$aEnzyme-Labeled Antibody Techniques
=450  \\$aImmunoassay, Enzyme
=450  \\$wnnna$aImmunoassays, Enzyme
=450  \\$wnnna$aImmunoenzyme Technic
=450  \\$wnnna$aImmunoenzyme Technics
=450  \\$wnnna$aImmunoenzyme Technique
=450  \\$wnnna$aImmunoperoxidase Technic
=450  \\$wnnna$aImmunoperoxidase Technics
=450  \\$wnnna$aImmunoperoxidase Technique
=450  \\$aImmunoperoxidase Techniques
=450  \\$wnnna$aPeroxidase-Antiperoxidase Complex Technic
=450  \\$wnnna$aPeroxidase Antiperoxidase Complex Technic
=450  \\$wnnna$aPeroxidase-Antiperoxidase Complex Technics
=450  \\$aPeroxidase-Antiperoxidase Complex Technique
=450  \\$wnnna$aPeroxidase Antiperoxidase Complex Technique
=450  \\$wnnna$aPeroxidase-Antiperoxidase Complex Techniques
=450  \\$wnnna$aPeroxidase-Labeled Antibody Technic
=450  \\$wnnna$aPeroxidase Labeled Antibody Technic
=450  \\$wnnna$aPeroxidase-Labeled Antibody Technics
=450  \\$aPeroxidase-Labeled Antibody Technique
=450  \\$wnnna$aPeroxidase Labeled Antibody Technique
=450  \\$wnnna$aPeroxidase-Labeled Antibody Techniques
=450  \\$wnnna$aTechnic, Enzyme-Labeled Antibody
=450  \\$wnnna$aTechnic, Immunoenzyme
=450  \\$wnnna$aTechnic, Immunoperoxidase
=450  \\$wnnna$aTechnic, Peroxidase-Antiperoxidase Complex
=450  \\$wnnna$aTechnic, Peroxidase-Labeled Antibody
=450  \\$wnnna$aTechnics, Enzyme-Labeled Antibody
=450  \\$wnnna$aTechnics, Immunoenzyme
=450  \\$wnnna$aTechnics, Immunoperoxidase
=450  \\$wnnna$aTechnics, Peroxidase-Antiperoxidase Complex
=450  \\$wnnna$aTechnics, Peroxidase-Labeled Antibody
=450  \\$wnnna$aTechnique, Enzyme-Labeled Antibody
=450  \\$wnnna$aTechnique, Immunoenzyme
=450  \\$wnnna$aTechnique, Immunoperoxidase
=450  \\$wnnna$aTechnique, Peroxidase-Antiperoxidase Complex
=450  \\$wnnna$aTechnique, Peroxidase-Labeled Antibody
=450  \\$wnnna$aTechniques, Enzyme-Labeled Antibody
=450  \\$wnnna$aTechniques, Immunoenzyme
=450  \\$wnnna$aTechniques, Immunoperoxidase
=450  \\$wnnna$aTechniques, Peroxidase-Antiperoxidase Complex
=450  \\$wnnna$aTechniques, Peroxidase-Labeled Antibody
=550  \\$wg$aImmunoassay
=550  \\$wg$aImmunohistochemistry
=550  \\$wh$aEnzyme-Linked Immunosorbent Assay
=550  \\$wh$aEnzyme Multiplied Immunoassay Technique
=667  \\$acoord with specific enzyme with no qualif (NIM) but do not bother to add PEROXIDASES or specific; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE is available
=680  \\$iImmunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
=688  \\$a91; was IMMUNOENZYME TECHNICS 1977-90
=750  \0$aImmunoenzyme technique$5IEN$0(DLC)sh 85064558

=LDR  01657cz  a2200349n  4500
=001  9880363477202441
=005  20141212202414.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007123
=035  \\$aCBA0313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x645.$x350.$x350.$x350
=072  \\$aE5.$x196.$x401.$x568.$x520
=072  \\$aE5.$x200.$x812.$x735.$x645.$x350.$x350.$x350
=072  \\$aE5.$x301.$x300.$x568.$x520
=072  \\$aE5.$x478.$x594.$x760.$x645.$x350.$x350.$x350
=072  \\$aE5.$x478.$x605.$x492.$x350.$x350.$x350
=150  \\$aImmunoelectrophoresis, Two-Dimensional
=450  \\$wnnna$a2-D Immunoelectrophoresis
=450  \\$wnnna$a2D Immunoelectrophoresis
=450  \\$wnnna$aCrossed Immunoelectrophoresis
=450  \\$wnnna$aImmunoelectrophoresis, 2-D
=450  \\$wnnna$aImmunoelectrophoresis, 2 D
=450  \\$wnnna$aImmunoelectrophoresis, 2D
=450  \\$aImmunoelectrophoresis, Crossed
=450  \\$wnnna$aImmunoelectrophoresis, Two Dimensional
=450  \\$wnnna$aTwo-Dimensional Immunoelectrophoresis
=550  \\$wg$aImmunoelectrophoresis
=667  \\$aNIM; do not confuse X ref IMMUNOELECTROPHORESIS, CROSSED with IMMUNOELECTROPHORESIS, CROSSOVER see COUNTERIMMUNOELECTROPHORESIS; DF: IMMUNOELECTROPHORESIS 2D
=680  \\$iImmunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis.
=688  \\$a91(76); was see under IMMUNOELECTROPHORESIS 1976-90
=750  \0$aCrossed immunoelectrophoresis$5IEN$0(DLC)sh 85034289

=LDR  01232cz  a2200277n  4500
=001  9880363477302441
=005  20141212202413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007122
=035  \\$aCBA0312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x735.$x645.$x350.$x350
=072  \\$aE5.$x196.$x401.$x568
=072  \\$aE5.$x200.$x812.$x735.$x645.$x350.$x350
=072  \\$aE5.$x301.$x300.$x568
=072  \\$aE5.$x478.$x594.$x760.$x645.$x350.$x350
=072  \\$aE5.$x478.$x605.$x492.$x350.$x350
=150  \\$aImmunoelectrophoresis
=550  \\$wg$aElectrophoresis
=550  \\$wg$aImmunodiffusion
=550  \\$wh$aCounterimmunoelectrophoresis
=550  \\$wh$aImmunoelectrophoresis, Two-Dimensional
=550  \\$aBlood Protein Electrophoresis
=667  \\$aGEN or unspecified; prefer specifics; NIM
=680  \\$iA technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
=750  \0$aImmunoelectrophoresis$5IEN$0(DLC)sh 85064557

=LDR  00927cz  a2200241n  4500
=001  9880363477402441
=005  20141212202413.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007120
=035  \\$aCBA0310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x201.$x486
=072  \\$aH1.$x181.$x122.$x605
=072  \\$aH2.$x403.$x44.$x500
=150  \\$aImmunochemistry
=550  \\$wg$aAllergy and Immunology
=550  \\$wg$aBiochemistry
=550  \\$wh$aImmunohistochemistry
=550  \\$aImmunoblotting
=667  \\$aIM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate
=680  \\$iField of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.
=688  \\$a66(64)
=750  \0$aImmunochemistry$5IEN$0(DLC)sh 85064550

=LDR  01338cz  a2200373n  4500
=001  9880363477502441
=005  20141212210856.0
=008  880322\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015151
=035  \\$aCBA0309HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x478.$x566.$x320
=072  \\$aE5.$x601.$x495.$x320
=150  \\$aImmunoblotting
=450  \\$aDot Immunoblotting
=450  \\$wnnna$aDot Immunoblottings
=450  \\$aElectroimmunoblotting
=450  \\$wnnna$aElectroimmunoblottings
=450  \\$wnnna$aImmunoblotting, Dot
=450  \\$wnnna$aImmunoblotting, Reverse
=450  \\$wnnna$aImmunoblottings
=450  \\$wnnna$aImmunoblottings, Dot
=450  \\$wnnna$aImmunoblottings, Reverse
=450  \\$aImmunoelectroblotting
=450  \\$wnnna$aImmunoelectroblottings
=450  \\$aReverse Immunoblotting
=450  \\$wnnna$aReverse Immunoblottings
=550  \\$wg$aImmunoassay
=550  \\$wh$aBlotting, Western
=550  \\$aImmunochemistry
=667  \\$aGEN or unspecified: prefer specifics; DF: IMMUNOBLOT
=680  \\$iImmunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.
=688  \\$a89
=750  \0$aImmunoblotting$5IEN$0(DLC)sh 87004870

=LDR  01067cz  a2200301n  4500
=001  9880363477602441
=005  20200516143709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007118
=035  \\$aCBA0307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x478.$x566
=072  \\$aE5.$x601.$x470
=150  \\$aImmunoassay
=450  \\$wnnna$aImmunoassays
=550  \\$wg$aImmunologic Techniques
=550  \\$wg$aMolecular Probe Techniques
=550  \\$wh$aFluoroimmunoassay
=550  \\$wh$aImmunoblotting
=550  \\$wh$aImmunochromatography
=550  \\$wh$aImmunoenzyme Techniques
=550  \\$wh$aImmunosorbent Techniques
=550  \\$wh$aImmunoturbidimetry
=550  \\$wh$aRadioimmunoassay
=667  \\$aGEN or unspecified; prefer specifics; NIM
=680  \\$iA technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.
=688  \\$a67(66)
=750  \0$aImmunoassay$5IEN$0(DLC)sh 85064549

=LDR  02217cz  a2200493n  4500
=001  9880363477702441
=005  20141212202411.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007116
=035  \\$aCBA0305HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465.$x425.$x400.$x330
=072  \\$aE5.$x478.$x550.$x520
=150  \\$aImmunization, Passive
=450  \\$wnnna$aAntibody Transfer, Passive
=450  \\$wnnna$aAntibody Transfers, Passive
=450  \\$aImmune Sera$xtherapeutic use
=450  \\$wnnna$aImmunizations, Passive
=450  \\$wnnna$aImmunoglobulin Therapies
=450  \\$aImmunoglobulin Therapy
=450  \\$wnnna$aImmunotherapies, Passive
=450  \\$aImmunotherapy, Passive
=450  \\$aNormal Serum Globulin Therapy
=450  \\$aPassive Antibody Transfer
=450  \\$wnnna$aPassive Antibody Transfers
=450  \\$wnnna$aPassive Immunization
=450  \\$wnnna$aPassive Immunizations
=450  \\$wnnna$aPassive Immunotherapies
=450  \\$wnnna$aPassive Immunotherapy
=450  \\$aPassive Transfer of Immunity
=450  \\$wnnna$aSerotherapies
=450  \\$aSerotherapy
=450  \\$wnnna$aTherapies, Immunoglobulin
=450  \\$wnnna$aTherapy, Immunoglobulin
=450  \\$wnnna$aTransfer, Passive Antibody
=450  \\$wnnna$aTransfers, Passive Antibody
=550  \\$wg$aImmunization
=550  \\$wh$aAdoptive Transfer
=550  \\$aImmune Sera
=550  \\$aImmunity, Maternally-Acquired
=667  \\$aIM; note category: do not confuse with IMMUNITY, MATERNALLY-ACQUIRED (Cat G) nor X ref PASSIVE TRANSFER OF IMMUNITY with passive transfer of immune tolerance ( = IMMUNOSUPPRESSION) nor X ref IMMUNOGLOBULIN THERAPY with IMMUNOGLOBULINS, INTRAVENOUS
=680  \\$iTransfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
=688  \\$a80; was PASSIVE TRANSFER 1970-79 (Prov 1970-72); IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82
=750  \0$aSerotherapy$5IEN$0(DLC)sh 85120337

=LDR  01986cz  a2200505n  4500
=001  9880363477802441
=005  20141212202410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007114
=035  \\$aCBA0303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465.$x425.$x400
=072  \\$aE5.$x478.$x550
=072  \\$aN2.$x421.$x726.$x758.$x310
=072  \\$aN6.$x850.$x780.$x200.$x425
=072  \\$aN6.$x850.$x780.$x680.$x310
=150  \\$aImmunization
=450  \\$wnnna$aImmunizations
=450  \\$wnnna$aImmunologic Sensitization
=450  \\$aImmunologic Stimulation
=450  \\$wnnna$aImmunological Sensitization
=450  \\$wnnna$aImmunological Sensitizations
=450  \\$wnnna$aImmunological Stimulation
=450  \\$wnnna$aImmunological Stimulations
=450  \\$aImmunostimulation
=450  \\$aSensitization, Immunologic
=450  \\$wnnna$aSensitization, Immunological
=450  \\$wnnna$aSensitizations, Immunological
=450  \\$wnnna$aStimulation, Immunologic
=450  \\$wnnna$aStimulation, Immunological
=450  \\$wnnna$aStimulations, Immunological
=450  \\$aVariolation
=450  \\$wnnna$aVariolations
=550  \\$wg$aCommunicable Disease Control
=550  \\$wg$aImmunologic Techniques
=550  \\$wg$aImmunotherapy
=550  \\$wg$aPrimary Prevention
=550  \\$wh$aImmunization, Passive
=550  \\$wh$aImmunization Schedule
=550  \\$wh$aImmunization, Secondary
=550  \\$wh$aImmunotherapy, Active
=550  \\$wh$aVaccination
=550  \\$aPreventive Health Services
=680  \\$iDeliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
=750  \0$aImmunization$5IEN$0(DLC)sh 85064545

=LDR  01575cz  a2200421n  4500
=001  9880363477902441
=005  20141212202410.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007113
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x564
=150  \\$aImmunity, Innate
=450  \\$wnnna$aImmune Response, Innate
=450  \\$wnnna$aImmune Responses, Innate
=450  \\$aImmunity, Native
=450  \\$aImmunity, Natural
=450  \\$aImmunity, Non-Specific
=450  \\$wnnna$aImmunity, Non Specific
=450  \\$wnnna$aInnate Immune Response
=450  \\$wnnna$aInnate Immune Responses
=450  \\$wnnna$aInnate Immunity
=450  \\$wnnna$aNative Immunity
=450  \\$wnnna$aNatural Immunity
=450  \\$wnnna$aNatural Resistance
=450  \\$wnnna$aNon-Specific Immunity
=450  \\$aResistance, Natural
=550  \\$wg$aImmunity
=550  \\$wh$aBlood Bactericidal Activity
=550  \\$wh$aDisease Resistance
=550  \\$wh$aPhagocytosis
=550  \\$aAdaptive Immunity
=550  \\$aInflammasomes
=667  \\$acoordinate with specific disease/ immunol
=680  \\$iThe capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
=688  \\$a2009(1978)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Immunity, Natural
=688  \\$a78
=750  \0$aNatural immunity$0(DLC) sh 85090243$5IEN

=LDR  02047cz  a2200433n  4500
=001  9880363478002441
=005  20141212202409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007112
=035  \\$aCBA0301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x570
=150  \\$aImmunity, Maternally-Acquired
=450  \\$wnnna$aFetal Immunities, Maternally-Acquired
=450  \\$aFetal Immunity, Maternally-Acquired
=450  \\$wnnna$aFetal Immunity, Maternally Acquired
=450  \\$wnnna$aImmunities, Maternally Acquired
=450  \\$wnnna$aImmunities, Maternally-Acquired
=450  \\$wnnna$aImmunities, Maternally-Acquired Fetal
=450  \\$wnnna$aImmunities, Maternally-Acquired Neonatal
=450  \\$wnnna$aImmunity, Maternally Acquired
=450  \\$wnnna$aImmunity, Maternally-Acquired Fetal
=450  \\$wnnna$aImmunity, Maternally-Acquired Neonatal
=450  \\$wnnna$aMaternally-Acquired Fetal Immunities
=450  \\$wnnna$aMaternally-Acquired Fetal Immunity
=450  \\$wnnna$aMaternally Acquired Immunities
=450  \\$wnnna$aMaternally-Acquired Immunities
=450  \\$aMaternally-Acquired Immunity
=450  \\$wnnna$aMaternally Acquired Immunity
=450  \\$wnnna$aMaternally-Acquired Neonatal Immunities
=450  \\$wnnna$aMaternally-Acquired Neonatal Immunity
=450  \\$wnnna$aNeonatal Immunities, Maternally-Acquired
=450  \\$aNeonatal Immunity, Maternally-Acquired
=450  \\$wnnna$aNeonatal Immunity, Maternally Acquired
=550  \\$wg$aImmunity
=667  \\$aof fetus by transplacental transfer or of neonate through colostrum or milk; do not add MATERNAL-FETAL EXCHANGE; note category: do not confuse with IMMUNIZATION, PASSIVE (Cat E); TN 242
=680  \\$iResistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk.
=688  \\$a83; was IMMUNITY, PASSIVE 1966-82 (Prov 1966)
=750  \0$aMaternally acquired immunity$5IEN$0(DLC)sh 85082106

=LDR  01526cz  a2200409n  4500
=001  9880363478102441
=005  20141212202409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007111
=035  \\$aCBA0300HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450.$x50.$x400
=150  \\$aImmunity, Cellular
=450  \\$wnnna$aCell-Mediated Immunities
=450  \\$aCell-Mediated Immunity
=450  \\$wnnna$aCell Mediated Immunity
=450  \\$wnnna$aCellular Immune Response
=450  \\$wnnna$aCellular Immune Responses
=450  \\$wnnna$aCellular Immunities
=450  \\$wnnna$aCellular Immunity
=450  \\$wnnna$aImmune Response, Cellular
=450  \\$wnnna$aImmune Responses, Cellular
=450  \\$wnnna$aImmunities, Cell-Mediated
=450  \\$wnnna$aImmunities, Cellular
=450  \\$wnnna$aImmunity, Cell-Mediated
=450  \\$wnnna$aResponse, Cellular Immune
=550  \\$wg$aAdaptive Immunity
=550  \\$wh$aAntigen Presentation
=550  \\$wh$aImmunologic Surveillance
=550  \\$wh$aLymphocyte Activation
=550  \\$aInterleukin-12
=550  \\$aLymphokines
=550  \\$aT-Lymphocytes
=667  \\$acoordinate with specific disease / immunol
=680  \\$iManifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.
=688  \\$a72(70)
=750  \0$aCellular immunity$5IEN$0(DLC)sh 85021695

=LDR  01343cz  a2200337n  4500
=001  9880363478202441
=005  20141212202408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007109
=035  \\$aCBA0298HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x450
=150  \\$aImmunity
=450  \\$aDisease$ximmunology
=550  \\$wg$aImmune System Phenomena
=550  \\$wh$aAdaptive Immunity
=550  \\$wh$aAutoimmunity
=550  \\$wh$aCross Protection
=550  \\$wh$aImmunity, Herd
=550  \\$wh$aImmunity, Heterologous
=550  \\$wh$aImmunity, Innate
=550  \\$wh$aImmunity, Maternally-Acquired
=550  \\$wh$aImmunity, Mucosal
=550  \\$wh$aPlant Immunity
=550  \\$wh$aT-Cell Antigen Receptor Specificity
=550  \\$aImmunoglobulins
=667  \\$aIM GEN only for "immunity" or "immune process"; NIM with specific disease /immunol (IM); "immune response": index under ANTIBODY FORMATION (usually discusses B-lymphocytes) or IMMUNITY, CELLULAR (usually discusses T-lymphocytes); TN 242
=680  \\$iNonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.
=688  \\$aRADIATION IMMUNOLOGY was heading 1964-66
=750  \0$aImmune response$5IEN-M$0(DLC)sh 85064537
=750  \0$aImmunity$5IEN-HS$0(DLC)sh 85064541

=LDR  01382cz  a2200325n  4500
=001  9880363478302441
=005  20200515150724.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007108
=035  \\$aCBA0297HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x535.$x425
=150  \\$aImmune Tolerance
=450  \\$aImmunological Tolerance$5IEN
=450  \\$aImmunosuppression (Physiology)
=450  \\$wnnna$aImmunosuppressions (Physiology)
=450  \\$wnnna$aTolerance, Immune
=550  \\$wg$aImmunomodulation
=550  \\$wh$aClonal Anergy
=550  \\$wh$aClonal Deletion
=550  \\$wh$aImmune Privilege
=550  \\$wh$aSelf Tolerance
=550  \\$wh$aTachyphylaxis
=550  \\$wh$aTransplantation Tolerance
=550  \\$aImmunosuppression
=550  \\$aTumor Escape
=667  \\$ado not confuse X ref IMMUNOSUPPRESSION (PHYSIOLOGY) with the Cat E immunol technique IMMUNOSUPPRESSION: Manual 28.21.1
=680  \\$iThe specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
=688  \\$a66(64)
=750  \0$aImmunological tolerance$5IEN$0(DLC)sh 85064577

=LDR  01244cz  a2200337n  4500
=001  9880363478402441
=005  20141212202407.0
=008  840530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007107
=035  \\$aCBA0296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA15.$x382
=150  \\$aImmune System
=450  \\$wnnna$aImmune Systems
=450  \\$wnnna$aSystem, Immune
=450  \\$wnnna$aSystems, Immune
=550  \\$wg$aHemic and Immune Systems
=550  \\$wh$aAntibody-Producing Cells
=550  \\$wh$aAntigen-Presenting Cells
=550  \\$wh$aBone Marrow
=550  \\$wh$aEnterochromaffin Cells
=550  \\$wh$aImmunological Synapses
=550  \\$wh$aLeukocytes
=550  \\$wh$aLymphatic System
=550  \\$wh$aMast Cells
=550  \\$wh$aMononuclear Phagocyte System
=550  \\$wh$aPhagocytes
=667  \\$aGEN: prefer specifics; /physiol: consider also IMMUNITY & its indentions
=680  \\$iThe body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.
=688  \\$a85
=750  \0$aImmune system$5IEN$0(DLC)sh 86006453

=LDR  01120cz  a2200313n  4500
=001  9880363478502441
=005  20141212202407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007106
=035  \\$aCBA0295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152.$x846.$x500
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x573
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x573
=072  \\$aD20.$x215.$x401
=150  \\$aImmune Sera
=450  \\$aAntisera
=450  \\$wnnna$aImmune Serums
=450  \\$wnnna$aSera, Immune
=450  \\$wnnna$aSerums, Immune
=550  \\$wg$aAntibodies
=550  \\$wg$aBiological Products
=550  \\$wg$aSerum
=550  \\$wh$aAntilymphocyte Serum
=550  \\$wh$aAntitoxins
=680  \\$iSerum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen.
=688  \\$a80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965
=750  \0$aImmune serums$5IEN$0(DLC)sh 85064539

=LDR  01576cz  a2200325n  4500
=001  9880363478602441
=005  20141212202406.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007105
=035  \\$aCBA0294HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x543.$x520
=150  \\$aImmune Complex Diseases
=450  \\$wnnna$aDisease, Immune Complex
=450  \\$wnnna$aDiseases, Immune Complex
=450  \\$wnnna$aHypersensitivities, Type III
=450  \\$aHypersensitivity, Type III
=450  \\$wnnna$aImmune Complex Disease
=450  \\$wnnna$aType III Hypersensitivities
=450  \\$aType III Hypersensitivity
=550  \\$wg$aHypersensitivity
=550  \\$wh$aArthus Reaction
=550  \\$wh$aPurpura, Schoenlein-Henoch
=550  \\$wh$aSerum Sickness
=550  \\$wh$aVasculitis, Leukocytoclastic, Cutaneous
=550  \\$aAntigen-Antibody Complex
=667  \\$adis caused by deposition of antigen-antibody complexes with resultant damage to tissue; "immune complex" = IMMUNE COMPLEX see ANTIGEN-ANTIBODY COMPLEX
=680  \\$iGroup of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.
=688  \\$a93; was IMMUNE COMPLEX DISEASE 1972-92 (Prov 1972-73)
=750  \0$aImmune complex diseases$5IEN$0(DLC)sh 85064534

=LDR  01271cz  a2200265n  4500
=001  9880363478702441
=005  20141212202405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007102
=035  \\$aCBA0291M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x321.$x500
=150  \\$aImmersion Foot
=450  \\$wnnna$aFeet, Immersion
=450  \\$wnnna$aFeet, Trench
=450  \\$wnnna$aFoot, Immersion
=450  \\$wnnna$aFoot, Trench
=450  \\$wnnna$aImmersion Feet
=450  \\$wnnna$aTrench Feet
=450  \\$aTrench Foot
=550  \\$wg$aFoot Diseases
=550  \\$aCold Temperature
=680  \\$iA condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27)
=688  \\$aTRENCH FOOT was heading 1963-94
=750  \0$aTrench foot$0(DLC)sh2014000203

=LDR  00568cz  a2200205n  4500
=001  9880363478802441
=005  20141212202404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007101
=035  \\$aCBA0290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x466
=150  \\$aImmersion
=450  \\$wnnna$aImmersions
=450  \\$aSubmersion
=450  \\$wnnna$aSubmersions
=550  \\$wg$aInvestigative Techniques
=680  \\$iThe placing of a body or a part thereof into a liquid.
=688  \\$a67
=750  \0$aImmersion in liquids$0(DLC) sh2004005298$5IEN-M

=LDR  01776cz  a2200385n  4500
=001  9880363478902441
=005  20141212202339.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007015
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x815.$x647
=072  \\$aC13.$x351.$x968.$x419.$x815.$x647
=072  \\$aC16.$x320.$x565.$x618.$x544
=072  \\$aC16.$x320.$x565.$x861.$x647
=072  \\$aC18.$x452.$x648.$x618.$x544
=072  \\$aC18.$x452.$x648.$x861.$x647
=072  \\$aC18.$x452.$x750.$x400.$x500
=150  \\$aHypophosphatemia, Familial
=450  \\$wnnna$aDiabetes, Phosphate
=450  \\$wnnna$aFamilial Hypophosphatemia
=450  \\$wnnna$aFamilial Hypophosphatemias
=450  \\$wnnna$aHyperphosphaturia
=450  \\$aHypophosphatemia$xcongenital
=450  \\$wnnna$aHypophosphatemias, Familial
=450  \\$wnnna$aPhosphate Diabetes
=450  \\$wnnna$aPhosphaturia
=550  \\$wg$aHypophosphatemia
=550  \\$wg$aMetal Metabolism, Inborn Errors
=550  \\$wg$aRenal Tubular Transport, Inborn Errors
=550  \\$wh$aFamilial Hypophosphatemic Rickets
=667  \\$aa clinical entity: not for decreased blood phosphate levels ( = PHOSPHATES /blood)
=680  \\$iAn inherited condition of abnormally low serum levels of PHOSPHATES (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the PROXIMAL RENAL TUBULES. This leads to phosphaturia, HYPOPHOSPHATEMIA, and disturbances of cellular and organ functions such as those in X-LINKED HYPOPHOSPHATEMIC RICKETS; OSTEOMALACIA; and FANCONI SYNDROME.
=688  \\$a1965
=688  \\$a65; RICKETS, VITAMIN D-RESISTANT was heading 1972-93
=750  \0$aHypophosphatemia, Familial$5IEN$0(DLC)sh 85063805

=LDR  01180cz  a2200217n  4500
=001  9880363479002441
=005  20141212202338.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007014
=035  \\$aCBA0201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x618.$x482
=072  \\$aC18.$x452.$x648.$x618.$x482
=150  \\$aHypophosphatasia
=450  \\$wnnna$aHypophosphatasias
=550  \\$wg$aMetal Metabolism, Inborn Errors
=550  \\$aAlkaline Phosphatase
=667  \\$adefic of blood phosphatases; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iA genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)
=688  \\$a72(66)
=750  \0$aHypophosphatasia$5IEN$0(DLC)sh 85063804

=LDR  00886cz  a2200253n  4500
=001  9880363479102441
=005  20141212202338.0
=008  780519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007013
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA4.$x623.$x490
=072  \\$aA14.$x724.$x490
=150  \\$aHypopharynx
=450  \\$wnnna$aHypopharynges
=450  \\$wnnna$aHypopharynxes
=450  \\$wnnna$aLaryngopharynges
=450  \\$aLaryngopharynx
=450  \\$wnnna$aLaryngopharynxes
=550  \\$wg$aPharynx
=550  \\$wh$aPyriform Sinus
=667  \\$ainflammation: coordinate IM with PHARYNGITIS (IM)
=680  \\$iThe bottom portion of the pharynx situated below the OROPHARYNX and posterior to the LARYNX. The hypopharynx communicates with the larynx through the laryngeal inlet, and is also called laryngopharynx.
=688  \\$a79
=750  \0$aHypopharynx$5IEN$0(DLC)sh 85063801

=LDR  00394nz  a2200157n  4500
=001  9880568753302441
=005  20170831103750.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069636
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x665
=150  \\$aPedestrians
=550  \\$wg$aPersons
=680  \\$iPersons traveling on foot.
=688  \\$a2016
=750  \0$aPedestrians$0(DLC)sh 85099135$5IEN-M

=LDR  00866nz  a2200277n  4500
=001  9880568753502441
=005  20230831154038.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068837
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x685
=072  \\$aB1.$x300.$x340.$x458
=150  \\$aParmeliaceae
=450  \\$wnnna$aCetraria
=450  \\$wnnna$aCetraria islandica
=450  \\$wnnna$aIceland Moss
=450  \\$wnnna$aIceland Mosses
=450  \\$wnnna$aMoss, Iceland
=450  \\$wnnna$aMosses, Iceland
=550  \\$wg$aAscomycota
=550  \\$wg$aLichens
=680  \\$iThe largest family of lichen-forming fungi.
=688  \\$a2016
=750  \0$aParmeliaceae$0(DLC)sh 85098231$0IEN-M
=750  \0$iNarrower mapping$aCetraria$0(DLC)sh2022006384$4NM$5IEN-M
=750  \0$iNarrower mapping$aCetraria islandica$0(DLC)sh2022006376$4NM$5IEN-M

=LDR  01010cz  a2200337n  4500
=001  9880568756202441
=005  20170830171749.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068316
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x925.$x680
=150  \\$aParks, Recreational
=450  \\$wnnna$aCommunity Parks
=450  \\$wnnna$aNational Parks
=450  \\$wnnna$aUrban Parks
=450  \\$wnnna$aCommunity Park
=450  \\$wnnna$aNational Park
=450  \\$wnnna$aPark, Community
=450  \\$wnnna$aPark, National
=450  \\$wnnna$aPark, Recreational
=450  \\$wnnna$aPark, Urban
=450  \\$wnnna$aParks, Community
=450  \\$wnnna$aParks, National
=450  \\$wnnna$aParks, Urban
=450  \\$wnnna$aRecreational Park
=450  \\$wnnna$aRecreational Parks
=450  \\$wnnna$aUrban Park
=550  \\$wg$aSports and Recreational Facilities
=680  \\$iAn area of land open to the public for enjoyment.
=688  \\$a2016
=750  \0$aParks$0(DLC)sh 85098119$5IEN-M

=LDR  02099cz  a2200517n  4500
=001  9880568757002441
=005  20170830165742.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069289
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x345.$x500.$x550.$x875
=150  \\$aParasite Encystment
=450  \\$wnnna$aParasite Encystation
=450  \\$wnnna$aProtozoan Encystation
=450  \\$wnnna$aProtozoan Encystment
=450  \\$wnnna$aProtozoan Parasite Encysment
=450  \\$wnnna$aProtozoan Parasite Encystation
=450  \\$wnnna$aEncysment, Protozoan Parasite
=450  \\$wnnna$aEncysments, Protozoan Parasite
=450  \\$wnnna$aEncystation, Parasite
=450  \\$wnnna$aEncystation, Protozoan
=450  \\$wnnna$aEncystation, Protozoan Parasite
=450  \\$wnnna$aEncystations, Parasite
=450  \\$wnnna$aEncystations, Protozoan
=450  \\$wnnna$aEncystations, Protozoan Parasite
=450  \\$wnnna$aEncystment, Parasite
=450  \\$wnnna$aEncystment, Protozoan
=450  \\$wnnna$aEncystments, Parasite
=450  \\$wnnna$aEncystments, Protozoan
=450  \\$wnnna$aParasite Encysment, Protozoan
=450  \\$wnnna$aParasite Encysments, Protozoan
=450  \\$wnnna$aParasite Encystation, Protozoan
=450  \\$wnnna$aParasite Encystations
=450  \\$wnnna$aParasite Encystations, Protozoan
=450  \\$wnnna$aParasite Encystments
=450  \\$wnnna$aProtozoan Encystations
=450  \\$wnnna$aProtozoan Encystments
=450  \\$wnnna$aProtozoan Parasite Encysments
=450  \\$wnnna$aProtozoan Parasite Encystations
=550  \\$wg$aMetamorphosis, Biological
=550  \\$aTrophozoites
=680  \\$iProcess by which certain parasites such as GIARDIA and ENTAMOEBA convert from the TROPHOZOITE to SCHIZONT when exposed to stress.
=688  \\$a2016
=750  \0$81$wb$iBroader mapping$aEncystment (Zoology)$0(DLC)sh 85043037$4BM$5IEN-M
=750  \0$81$wb$aParasites$0(DLC)sh 85097907$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record:$aEncystment (Zoology)$iand$aParasites$5IEN-M

=LDR  01087nz  a2200289n  4500
=001  9880568757302441
=005  20170830162645.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069455
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x60.$x860
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x60.$x860
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x200.$x860
=150  \\$aPalivizumab
=450  \\$wnnna$aMEDI 493
=450  \\$wnnna$aMEDI-493
=450  \\$wnnna$aMonoclonal Antibody MEDI-493
=450  \\$wnnna$aSynagis
=450  \\$wnnna$a493, MEDI
=450  \\$wnnna$aAntibody MEDI-493, Monoclonal
=450  \\$wnnna$aMEDI-493, Monoclonal Antibody
=450  \\$wnnna$aMEDI493
=450  \\$wnnna$aMonoclonal Antibody MEDI 493
=550  \\$wg$aAntibodies, Monoclonal, Humanized
=680  \\$iA humanized monoclonal antibody and ANTIVIRAL AGENT  that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.
=688  \\$a2016 (1998)
=750  \0$aPalivizumab$0(DLC)sh2009005023$5IEN-M

=LDR  00786nz  a2200241n  4500
=001  9880573662402441
=005  20170914131253.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067563
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x110
=150  \\$aPhakopsora pachyrhizi
=450  \\$wnnna$aAsian Soybean Rust
=450  \\$wnnna$aPhakopsora pachyrhizus
=450  \\$wnnna$aRust, Asian Soybean
=450  \\$wnnna$aSoybean Rust, Asian
=450  \\$wnnna$aSoybean Rusts, Asian
=450  \\$wnnna$apachyrhizi, Phakopsora
=450  \\$wnnna$apachyrhizus, Phakopsora
=550  \\$wg$aBasidiomycota
=680  \\$iFungal pathogen which causes Soybean Rust disease in Soybeans (Glycine max).
=688  \\$a2016
=750  \0$aPhakopsora pachyrhizi$0(DLC)sh 85100555$5IEN-M

=LDR  00524cz  a2200181n  4500
=001  9880573663102441
=005  20170914130311.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067657
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x893
=150  \\$aPessimism
=450  \\$wnnna$aNegative Thinking
=450  \\$wnnna$aThinking, Negative
=550  \\$wg$aAttitude
=680  \\$iMental attitude that interprets life events as generally being negative.
=688  \\$a2016
=750  \0$aPessimism$0(DLC)sh 85100264$5IEN-M

=LDR  01135nz  a2200301n  4500
=001  9880576407902441
=005  20170925113708.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069583
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x81.$x114.$x500.$x350.$x500
=072  \\$aD12.$x125.$x190.$x350.$x450
=150  \\$aPregabalin
=450  \\$wnnna$a(R-)-3-isobutyl GABA
=450  \\$wnnna$a(S)-3-(aminomethyl)-5-methylhexanoic acid
=450  \\$wnnna$a(S+)-3-isobutyl GABA
=450  \\$wnnna$a3-(aminomethyl)-5-methylhexanoic acid
=450  \\$wnnna$a3-isobutyl GABA
=450  \\$wnnna$aCI 1008
=450  \\$wnnna$aCI-1008
=450  \\$wnnna$aLyrica
=450  \\$wnnna$a1008, CI
=450  \\$wnnna$a3 isobutyl GABA
=450  \\$wnnna$aCI1008
=450  \\$wnnna$aGABA, 3-isobutyl
=680  \\$iA gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.
=688  \\$a2016 (1993)
=750  \0$aPregabalin$0(DLC)sh2011002275$5IEN-M

=LDR  00813nz  a2200253n  4500
=001  9880577968802441
=005  20170928090421.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069466
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x300.$x600.$x813
=072  \\$aJ2.$x500.$x600.$x813
=150  \\$aRed Meat
=450  \\$wnnna$aBeef
=450  \\$wnnna$aPork
=450  \\$wnnna$aMeat, Red
=450  \\$wnnna$aMeats, Red
=450  \\$wnnna$aRed Meats
=550  \\$wh$aMeat
=680  \\$iMeat such as beef, pork, or lamb which contains more MYOGLOBIN than POULTRY or SEAFOOD.
=688  \\$a2016
=750  \0$iNarrower mapping$aBeef$0(DLC)sh 85012809$4NM$5IEN-M
=750  \0$iNarrower mapping$aLamb (Meat)$0(DLC)sh 85074167$4NM$5IEN-M
=750  \0$iNarrower mapping$aPork$0(DLC)sh 85105003$4NM$5IEN-M

=LDR  00308nz  a2200109n  4500
=001  9880577971102441
=005  20170927144338.0
=008  990101\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D013177Q000523
=040  \\$aDNLM$cDNLM
=150  \\$aSports$xpsychology
=750  \0$aSports$xPsychological aspects$0(DLC) sh 85126899$5IEN-M

=LDR  00644nz  a2200193n  4500
=001  9880577971202441
=005  20170927143917.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067450
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x96.$x628.$x914
=150  \\$aPsychology, Sports
=450  \\$wnnna$aSport Psychology
=450  \\$wnnna$aSports Psychology
=450  \\$wnnna$aPsychology, Sport
=550  \\$wg$aPsychology
=680  \\$iField of research that studies mental factors influencing the attainment of athletic skills and athletic performance.
=688  \\$a2016
=750  \0$aSports$xPsychological aspects$0(DLC) sh 85126899$5IEN-M

=LDR  00536nz  a2200169n  4500
=001  9880577972002441
=005  20170927141941.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067073
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x950.$x750.$x375
=150  \\$aPsychological Trauma
=450  \\$wnnna$aTrauma, Psychological
=550  \\$wg$aStress Disorders, Traumatic
=680  \\$iOverwhelming emotional damage caused by a distressful event or series of events.
=688  \\$a2016
=750  \0$aPsychic trauma$0(DLC)sh 85108403$5IEN-M

=LDR  00954nz  a2200229n  4500
=001  9880577972402441
=005  20170927140139.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066291
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x517.$x584.$x500
=150  \\$aPsychiatry in Literature
=450  \\$wnnna$aLiterature, Psychiatry in
=450  \\$wnnna$aLiteratures, Psychiatry in
=450  \\$wnnna$aPsychiatry in Literatures
=450  \\$wnnna$ain Literature, Psychiatry
=450  \\$wnnna$ain Literatures, Psychiatry
=550  \\$wh$aMedicine in Literature
=667  \\$acoordinate IM with psychiatric aspect (IM) + specific literature heading (IM) + literary type if pertinent (as POETRY; DRAMA, etc.) (IM)
=680  \\$iWritten or other literary works whose subject matter is related to mental disorders or psychiatry from the lay or practitioner perspective. .
=688  \\$a2016
=750  \0$aPsychiatry in literature$0(DLC)sh 85108400$5IEN-M

=LDR  00630cz  a2200181n  4500
=001  9880580162102441
=005  20171002163159.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066768
=040  \\$aDNLM$cDNLM
=060  \0$aWB 320.5
=072  \\$aH1.$x770.$x644.$x145.$x472
=150  \\$aRehabilitation Research
=450  \\$wnnna$aResearch, Rehabilitation
=550  \\$wg$aBiomedical Research
=680  \\$iStudies and research concerning the psychological, educational, social, vocational, industrial, and economic aspects of REHABILITATION.
=688  \\$a2016
=750  \0$aRehabilitation$xResearch$0(DLC)sh 85112404$5IEN-M

=LDR  01728cz  a2200505n  4500
=001  9880581102202441
=005  20171012172412.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068677
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x884.$x675
=072  \\$aD2.$x886.$x590.$x700.$x675
=072  \\$aD3.$x383.$x606.$x854
=072  \\$aD3.$x633.$x100.$x759.$x824
=150  \\$aSildenafil Citrate
=450  \\$wnnna$a1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
=450  \\$wnnna$aAcetildenafil
=450  \\$wnnna$aDesmethyl Sildenafil
=450  \\$wnnna$aDesmethylsildenafil
=450  \\$wnnna$aHomosildenafil
=450  \\$wnnna$aHydroxyhomosildenafil
=450  \\$wnnna$aNCX-911
=450  \\$wnnna$aRevatio
=450  \\$wnnna$aSildenafil
=450  \\$wnnna$aSildenafil Lactate
=450  \\$wnnna$aSildenafil Nitrate
=450  \\$wnnna$aUK 92480-10
=450  \\$wnnna$aUK-92,480-10
=450  \\$wnnna$aViagra
=450  \\$wnnna$aCitrate, Sildenafil
=450  \\$wnnna$aLactate, Sildenafil
=450  \\$wnnna$aNCX 911
=450  \\$wnnna$aNCX911
=450  \\$wnnna$aNitrate, Sildenafil
=450  \\$wnnna$aSildenafil, Desmethyl
=450  \\$wnnna$aUK 92,480 10
=450  \\$wnnna$aUK 92480 10
=450  \\$wnnna$aUK 9248010
=550  \\$wg$aPiperazines
=550  \\$wg$aPurines
=550  \\$wg$aSulfonamides
=550  \\$aTadalafil
=680  \\$iA PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT  that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION.
=688  \\$a2016 (1997)
=750  \0$aSildenafil$0(DLC)sh 98000937$5IEN-M

=LDR  00758cz  a2200217n  4500
=001  9880581102702441
=005  20171012161729.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068618
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x820.$x150.$x760
=072  \\$aG5.$x90.$x701
=150  \\$aSelective Breeding
=450  \\$wnnna$aBreeding, Selective
=450  \\$wnnna$aBreedings, Selective
=450  \\$wnnna$aSelective Breedings
=550  \\$wg$aBreeding
=680  \\$iA process in which offspring possessing desired genetic traits are produced.
=688  \\$a2016
=750  \0$iNarrower mapping$aSelection indexes (Animal breeding)$0(DLC)sh 93003761$4NM
=750  \0$iNarrower mapping$aSelection indexes (Plant breeding)$0(DLC)sh 86006942$4NM$5IEN-M

=LDR  01058nz  a2200301n  4500
=001  9880581103602441
=005  20171012154758.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068098
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x65.$x650
=150  \\$aSeed Bank
=450  \\$wnnna$aGermplasm Bank
=450  \\$wnnna$aSeedbank
=450  \\$wnnna$aSeeds Bank
=450  \\$wnnna$aBank, Germplasm
=450  \\$wnnna$aBank, Seed
=450  \\$wnnna$aBank, Seeds
=450  \\$wnnna$aBanks, Germplasm
=450  \\$wnnna$aBanks, Seed
=450  \\$wnnna$aGermplasm Banks
=450  \\$wnnna$aSeed Banks
=450  \\$wnnna$aSeedbanks
=550  \\$wg$aBiological Specimen Banks
=680  \\$iA repository of seeds maintained under optimal conditions that ensure long term storage, intended for use as a source of replenishment of seed stock or plant genetic material.
=688  \\$a2016
=750  \0$iBroader mapping$aGene banks, Plant$0(DLC)sh 85053733$4BM$5IEN-M
=750  \0$iNarrower mapping$aSoil seed banks$0(DLC)sh 88005747$4NM$5IEN-M

=LDR  00788nz  a2200253n  4500
=001  9880581105002441
=005  20171012150151.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068357
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x725
=150  \\$aSaline Waters
=450  \\$wnnna$aBrackish Water
=450  \\$wnnna$aBrackish Waters
=450  \\$wnnna$aSaline Water
=450  \\$wnnna$aWater, Brackish
=450  \\$wnnna$aWater, Saline
=450  \\$wnnna$aWaters, Brackish
=450  \\$wnnna$aWaters, Saline
=550  \\$wg$aEnvironment
=550  \\$wh$aSeawater
=680  \\$iWater from natural sources which contain significant concentrations of dissolved salts such as sodium chloride.
=688  \\$a2016
=750  \0$aSaline waters$0(DLC)sh 85116786$5IEN-M

=LDR  00596nz  a2200157n  4500
=001  9880581105502441
=005  20171012140901.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D066288
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x883
=150  \\$aRomanticism
=550  \\$wg$aHumanities
=680  \\$iThe attitude or intellectual orientation that characterized many works of literature, painting, music, architecture, criticism, and historiography in Western civilization over a period from the late 18th to the mid-19th century.
=688  \\$a2016
=750  \0$aRomanticism$0(DLC)sh 85115078$5IEN-M

=LDR  01210nz  a2200325n  4500
=001  9880581106502441
=005  20171012132637.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069283
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x75.$x785
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x75.$x785
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x284.$x785
=150  \\$aRituximab
=450  \\$wnnna$aCD20 Antibody, Rituximab
=450  \\$wnnna$aGP2013
=450  \\$wnnna$aIDEC-C2B8
=450  \\$wnnna$aIDEC-C2B8 Antibody
=450  \\$wnnna$aMabthera
=450  \\$wnnna$aRituxan
=450  \\$wnnna$aAntibody, Rituximab CD20
=450  \\$wnnna$aIDEC C2B8
=450  \\$wnnna$aIDEC C2B8 Antibody
=450  \\$wnnna$aIDECC2B8
=450  \\$wnnna$aIDECC2B8 Antibody
=450  \\$wnnna$aRituximab CD20 Antibody
=550  \\$wg$aAntibodies, Monoclonal, Murine-Derived
=680  \\$iA murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
=688  \\$a2016 (1995)
=750  \0$aRituximab$0(DLC) sh2002007324$5IEN-M

=LDR  01023nz  a2200289n  4500
=001  9880585800602441
=005  20171102174950.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069436
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x690.$x936
=150  \\$aToxicological Phenomena
=450  \\$wnnna$aToxicologic Phenomena
=450  \\$wnnna$aToxicologic Phenomenon
=450  \\$wnnna$aToxicological Concepts
=450  \\$wnnna$aToxicological Phenomenon
=450  \\$wnnna$aConcept, Toxicological
=450  \\$wnnna$aConcepts, Toxicological
=450  \\$wnnna$aPhenomena, Toxicologic
=450  \\$wnnna$aPhenomena, Toxicological
=450  \\$wnnna$aPhenomenon, Toxicologic
=450  \\$wnnna$aPhenomenon, Toxicological
=450  \\$wnnna$aToxicological Concept
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe nature and effects of chemical, physical or biological poisons on living organisms.
=688  \\$a2016
=750  \0$aPoisons$xPhysiological effect$0(DLC)sh 94005582$5IEN-M

=LDR  01259cz  a2200385n  4500
=001  9880585801002441
=005  20171102164505.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069258
=040  \\$aDNLM$cDNLM
=060  \0$aWF 980
=072  \\$aE1.$x370.$x225.$x998.$x329.$x810
=072  \\$aE2.$x800.$x550.$x810
=072  \\$aE4.$x665.$x600.$x810
=072  \\$aE5.$x200.$x998.$x329.$x810
=150  \\$aThoracentesis
=450  \\$wnnna$aChest Aspiration
=450  \\$wnnna$aPleural Aspiration
=450  \\$wnnna$aPleurocentesis
=450  \\$wnnna$aThoracocentesis
=450  \\$wnnna$aAspiration, Chest
=450  \\$wnnna$aAspiration, Pleural
=450  \\$wnnna$aAspirations, Chest
=450  \\$wnnna$aAspirations, Pleural
=450  \\$wnnna$aChest Aspirations
=450  \\$wnnna$aPleural Aspirations
=450  \\$wnnna$aPleurocenteses
=450  \\$wnnna$aThoracenteses
=450  \\$wnnna$aThoracocenteses
=550  \\$wg$aParacentesis
=550  \\$aPleural Effusion
=550  \\$aPneumothorax
=550  \0$aChest$xParacentesis$0(DLC) sh 85023141$5IEN-M
=680  \\$iAspiration of fluid or air from the THORACIC CAVITY. It is coupled sometimes  with the administration of drugs into the PLEURAL CAVITY.
=688  \\$a2016

=LDR  01319nz  a2200337n  4500
=001  9880585806102441
=005  20171102144931.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069553
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x35.$x250.$x500.$x500
=072  \\$aL1.$x224.$x50.$x375.$x530.$x500
=150  \\$aSupervised Machine Learning
=450  \\$wnnna$aActive Machine Learning
=450  \\$wnnna$aInductive Machine Learning
=450  \\$wnnna$aLearning from Labeled Data
=450  \\$wnnna$aMachine Learning with a Teacher
=450  \\$wnnna$aSemi-supervised Learning
=450  \\$wnnna$aLearning, Active Machine
=450  \\$wnnna$aLearning, Inductive Machine
=450  \\$wnnna$aLearning, Semi-supervised
=450  \\$wnnna$aLearning, Supervised Machine
=450  \\$wnnna$aMachine Learning, Active
=450  \\$wnnna$aMachine Learning, Inductive
=450  \\$wnnna$aMachine Learning, Supervised
=450  \\$wnnna$aSemi supervised Learning
=550  \\$wg$aMachine Learning
=550  \\$aUnsupervised Machine Learning
=680  \\$iA MACHINE LEARNING paradigm used to make predictions about future instances based on a given set of labeled paired input-output training (sample) data.
=688  \\$a2016
=750  \0$aSupervised learning (Machine learning)$0(DLC)sh 94008290$5IEN-M

=LDR  01125nz  a2200289n  4500
=001  9880585831202441
=005  20171031100859.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067496
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x844.$x619.$x500
=150  \\$aSpirit Possession
=450  \\$wnnna$aDemon Possession
=450  \\$wnnna$aDemonic Possession
=450  \\$wnnna$aDemon Possessions
=450  \\$wnnna$aDemonic Possessions
=450  \\$wnnna$aPossession, Demon
=450  \\$wnnna$aPossession, Demonic
=450  \\$wnnna$aPossession, Spirit
=450  \\$wnnna$aPossessions, Demon
=450  \\$wnnna$aPossessions, Demonic
=450  \\$wnnna$aPossessions, Spirit
=450  \\$wnnna$aSpirit Possessions
=550  \\$wh$aReligion and Medicine
=680  \\$iThe idea that abnormal behavior or a medical condition is evidence that a person is under the control of a supernatural power or spirit. This belief was most commonly held in religion and medicine of the medieval period and is also held in many tribal cultures today.
=688  \\$a2016
=750  \0$aSpirit possession$0(DLC)sh 85126747$5IEN-M

=LDR  01099nz  a2200289n  4500
=001  9880585858802441
=005  20171026110840.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069474
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x742.$x686.$x850.$x877.$x500
=072  \\$aD13.$x695.$x740.$x850.$x877.$x500
=072  \\$aD13.$x695.$x827.$x919.$x877.$x500
=150  \\$aSofosbuvir
=450  \\$wnnna$a2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester
=450  \\$wnnna$aGS-7977
=450  \\$wnnna$aPSI 7977
=450  \\$wnnna$aPSI-7977
=450  \\$wnnna$aPSI7977
=450  \\$wnnna$aSovaldi
=450  \\$wnnna$a7977, PSI
=450  \\$wnnna$aGS 7977
=450  \\$wnnna$aGS7977
=550  \\$wg$aUridine Monophosphate
=680  \\$iA uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.
=688  \\$a2016 (2010)
=750  \2$aSofosbuvir$0(DLC)sh2015002965$5IEN-M

=LDR  00523nz  a2200169n  4500
=001  9880585859102441
=005  20171026110132.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067570
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x784.$x629.$x529.$x663
=150  \\$aSocial Learning
=450  \\$wnnna$aLearning, Social
=550  \\$wg$aLearning
=680  \\$iThe concept of new knowledge acquisition through observation and interaction with others.
=688  \\$a2016
=750  \0$aSocial learning$0(DLC)sh 85123970$5IEN-M

=LDR  00729nz  a2200217n  4500
=001  9880585863602441
=005  20171026100123.0
=008  150702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068776
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x954.$x842
=150  \\$aSleep Aids, Pharmaceutical
=450  \\$wnnna$aSleep Inducers
=450  \\$wnnna$aSleep Promoting Agents
=450  \\$wnnna$aAgents, Sleep Promoting
=450  \\$wnnna$aPharmaceutical Sleep Aids
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aOrexin Receptor Antagonists
=680  \\$iDrugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.
=688  \\$a2016
=750  \0$aHypnotics$0(DLC)sh 85063749$5IEN-M

=LDR  00546nz  a2200193n  4500
=001  9880614193302441
=005  20171221113938.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D059472
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x360.$x340.$x11
=150  \\$aExome
=450  \\$wnnna$aExomes
=550  \\$aExons
=550  \\$wg$aGenome
=550  \\$aTranscriptome
=680  \\$iThat part of the genome that corresponds to the complete complement of EXONS of an organism or cell.
=688  \\$a2012
=750  \0$aExomes$0(DLC)sh2015001308$5IEN-M

=LDR  00824nz  a2200241n  4500
=001  9880614194202441
=005  20171221111103.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D007989
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x739.$x794.$x511
=150  \\$aLibido
=450  \\$wnnna$aDecreased Libido
=450  \\$wnnna$aIncreased Libido
=450  \\$wnnna$aLibido, Decreased
=450  \\$wnnna$aLibido, Increased
=550  \\$wh$aPsychoanalytic Theory
=550  \\$aInstinct
=550  \\$aMotivation
=550  \\$aSex
=680  \\$iThe psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). It may also connote the psychic energy associated with instincts in general that motivate behavior.
=688  \\$a68
=750  \0$aLibido$0(DLC)sh2015001702$5IEN-M

=LDR  00782nz  a2200181n  4500
=001  9880614197002441
=005  20171220160514.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D062791
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x799.$x638.$x602
=072  \\$aN6.$x850.$x810.$x370.$x365
=150  \\$aOptically Stimulated Luminescence Dosimetry
=450  \\$aOptically Stimulated Luminescent Dosimetry
=550  \\$wg$aRadiation Monitoring
=680  \\$iThe use of a radiation monitoring device composed of material which emits light after being illuminated. The amount of light emitted is proportional to the amount of IONIZING RADIATION to which the material has been previously exposed.
=688  \\$a2013
=750  \2$aOptically stimulated luminescence$0(DLC)sh2015001661$5IEN-M

=LDR  01625cz  a2200385n  4500
=001  9880614208702441
=005  20171219160202.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D034622
=040  \\$aDNLM$cDNLM
=060  \0$aQU 58.7
=072  \\$aG5.$x308.$x203.$x374.$x790
=150  \\$aRNA Interference
=450  \\$wnnna$aCo-Suppression
=450  \\$wnnna$aCosuppression
=450  \\$wnnna$aPosttranscriptional Gene Silencing
=450  \\$wnnna$aRNA Silencing
=450  \\$wnnna$aRNAi
=450  \\$aGene Silencing, Post-Transcriptional
=450  \\$aPost-Transcriptional Gene Silencing
=450  \\$wnnna$aCo Suppression
=450  \\$wnnna$aGene Silencing, Post Transcriptional
=450  \\$wnnna$aGene Silencing, Posttranscriptional
=450  \\$wnnna$aGene Silencings, Posttranscriptional
=450  \\$wnnna$aInterference, RNA
=450  \\$wnnna$aPost Transcriptional Gene Silencing
=450  \\$wnnna$aPost-Transcriptional Gene Silencings
=450  \\$wnnna$aSilencing, Post-Transcriptional Gene
=550  \\$wg$aGene Silencing
=550  \\$aAntagomirs
=550  \\$aRNA, Small Interfering
=550  \\$aRNA-Induced Silencing Complex
=680  \\$iA gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process.
=688  \\$a2003
=750  \0$aRNA interference$0(DLC)sh2015001314$5IEN-M

=LDR  00556nz  a2200169n  4500
=001  9880614209202441
=005  20171219145945.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069602
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x987
=150  \\$aWorking Poor
=450  \\$wnnna$aPoor, Working
=550  \\$wg$aPersons
=680  \\$iPeople who are in the labor force either working or looking for work for 27 weeks or more in a year, but whose income fall below a given poverty line.
=688  \\$a2016
=750  \0$aWorking poor$0(DLC)sh 00006746$5IEN-M

=LDR  00767nz  a2200253n  4500
=001  9880614209402441
=005  20171219144437.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066477
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x946.$x675
=150  \\$aWork Performance
=450  \\$wnnna$aJob Performance
=450  \\$wnnna$aPerformance at Work
=450  \\$wnnna$aJob Performances
=450  \\$wnnna$aPerformance, Job
=450  \\$wnnna$aPerformance, Work
=450  \\$wnnna$aPerformances, Job
=450  \\$wnnna$aPerformances, Work
=450  \\$wnnna$aWork Performances
=550  \\$wg$aWork
=680  \\$iMeasure of how well someone performs given tasks at their place of work.
=688  \\$a2016
=750  \0$aPerformance$0(DLC)sh 85099805$5IEN-M

=LDR  00982nz  a2200253n  4500
=001  9880614212302441
=005  20171219120302.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069578
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x539.$x221.$x750
=150  \\$aWaterborne Diseases
=450  \\$wnnna$aWater-related Diseases
=450  \\$wnnna$aDisease, Water-related
=450  \\$wnnna$aDisease, Waterborne
=450  \\$wnnna$aDiseases, Water-related
=450  \\$wnnna$aDiseases, Waterborne
=450  \\$wnnna$aWater related Diseases
=450  \\$wnnna$aWater-related Disease
=450  \\$wnnna$aWaterborne Disease
=550  \\$wg$aCommunicable Diseases
=680  \\$iIllnesses due to micro-organisms and chemicals in drinking water, those caused by organisms having part of their lifecycle in water or those with water-related vectors, and others spread by aerosols containing pathogens.
=688  \\$a2016
=750  \0$aWaterborne infection$0(DLC)sh 85145672$5IEN-M

=LDR  00891nz  a2200277n  4500
=001  9880614213502441
=005  20171219115346.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067398
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x946
=072  \\$aI1.$x880.$x735.$x950.$x500.$x951.$x500
=072  \\$aN6.$x850.$x460.$x350.$x600.$x903.$x500
=150  \\$aWar-Related Injuries
=450  \\$wnnna$aWar-Related Trauma
=450  \\$wnnna$aInjuries, War-Related
=450  \\$wnnna$aInjury, War-Related
=450  \\$wnnna$aTrauma, War-Related
=450  \\$wnnna$aWar Related Injuries
=450  \\$wnnna$aWar Related Trauma
=450  \\$wnnna$aWar-Related Injury
=550  \\$wg$aWar Exposure
=550  \\$wg$aWounds and Injuries
=680  \\$iWOUNDS and INJURIES and PSYCHOLOGICAL TRAUMA sustained during WAR.
=688  \\$a2016
=750  \0$aWar wounds$0(DLC)sh 85145233$5IEN-M

=LDR  01442nz  a2200409n  4500
=001  9880614215302441
=005  20171219112044.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069470
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x33.$x415.$x510.$x500.$x901
=072  \\$aD2.$x92.$x471.$x683.$x948
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x318.$x750
=072  \\$aD10.$x289.$x510.$x500.$x901
=150  \\$aVenlafaxine Hydrochloride
=450  \\$wnnna$a1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl
=450  \\$wnnna$aCyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
=450  \\$wnnna$aDobupal
=450  \\$wnnna$aEfexor
=450  \\$wnnna$aEffexor
=450  \\$wnnna$aSila-Venlafaxine
=450  \\$wnnna$aTrevilor
=450  \\$wnnna$aVandral
=450  \\$wnnna$aVenlafaxine
=450  \\$wnnna$aWy 45030
=450  \\$wnnna$aWy-45,030
=450  \\$wnnna$aWy-45030
=450  \\$wnnna$aHydrochloride, Venlafaxine
=450  \\$wnnna$aSila Venlafaxine
=450  \\$wnnna$aWy 45,030
=450  \\$wnnna$aWy45,030
=450  \\$wnnna$aWy45030
=550  \\$wg$aCyclohexanols
=550  \\$wg$aPhenethylamines
=680  \\$iA cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
=688  \\$a2016 (1986)
=750  \0$aVenlafaxine$0(DLC)sh 98003963$5IEN-M

=LDR  00668nz  a2200217n  4500
=001  9880614227402441
=005  20171219110112.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067075
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x300.$x850.$x450
=072  \\$aJ2.$x500.$x850.$x800
=150  \\$aVegetable Products
=450  \\$wnnna$aProduct, Vegetable
=450  \\$wnnna$aProducts, Vegetable
=450  \\$wnnna$aVegetable Product
=550  \\$wg$aVegetables
=550  \\$wh$aSoy Foods
=680  \\$iFood that is manufactured from various parts of vegetables.
=688  \\$a2016
=750  \0$iBroader mapping$aPlant products$0(DLC)sh 85102800$4BM$5IEN-M

=LDR  01778nz  a2200457n  4500
=001  9880614227702441
=005  20220926172851.0
=008  150707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069756
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x189.$x500
=150  \\$aUndocumented Immigrants
=450  \\$wnnna$aIllegal Aliens
=450  \\$wnnna$aIllegal Immigrants
=450  \\$wnnna$aUnauthorized Immigrants
=450  \\$wnnna$aUndocumented Aliens
=450  \\$wnnna$aUndocumented Workers
=450  \\$wnnna$aAlien, Illegal
=450  \\$wnnna$aAlien, Undocumented
=450  \\$wnnna$aAliens, Illegal
=450  \\$wnnna$aAliens, Undocumented
=450  \\$wnnna$aIllegal Alien
=450  \\$wnnna$aIllegal Immigrant
=450  \\$wnnna$aImmigrant, Illegal
=450  \\$wnnna$aImmigrant, Unauthorized
=450  \\$wnnna$aImmigrant, Undocumented
=450  \\$wnnna$aImmigrants, Illegal
=450  \\$wnnna$aImmigrants, Unauthorized
=450  \\$wnnna$aImmigrants, Undocumented
=450  \\$wnnna$aUnauthorized Immigrant
=450  \\$wnnna$aUndocumented Alien
=450  \\$wnnna$aUndocumented Immigrant
=450  \\$wnnna$aUndocumented Worker
=450  \\$wnnna$aWorker, Undocumented
=450  \\$wnnna$aWorkers, Undocumented
=550  \\$wg$aEmigrants and Immigrants
=680  \\$iForeign nationals residing in a country without legal immigration status, or in violation of the immigration laws of that country.
=688  \\$a2016
=750  \0$81$wb$iBroader mapping$aNoncitizens$0(DLC)sh 85003545$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aIllegal immigration$0(DLC)sh2016000739$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aNoncitizens$iand$aIllegal immigration$5IEN-M

=LDR  01905nz  a2200553n  4500
=001  9880614244302441
=005  20171213162223.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000066608
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x22.$x750
=072  \\$aF1.$x145.$x317.$x269.$x875
=072  \\$aI1.$x880.$x735.$x878
=150  \\$aUnderage Drinking
=450  \\$wnnna$aAdolescent Alcohol Consumption
=450  \\$wnnna$aAdolescent Alcohol Use
=450  \\$wnnna$aAdolescent Drinking
=450  \\$wnnna$aLegal Drinking Age
=450  \\$wnnna$aMinimum Drinking Age
=450  \\$wnnna$aMinimum Legal Drinking Age
=450  \\$wnnna$aTeen Drinking
=450  \\$wnnna$aTeenage Drinking
=450  \\$wnnna$aUnderage Alcohol Consumption
=450  \\$wnnna$aUnderage Alcohol Use
=450  \\$wnnna$aYouth Alcohol Consumption
=450  \\$wnnna$aYouth Drinking
=450  \\$wnnna$aAlcohol Consumption, Adolescent
=450  \\$wnnna$aAlcohol Consumption, Underage
=450  \\$wnnna$aAlcohol Consumption, Youth
=450  \\$wnnna$aAlcohol Use, Adolescent
=450  \\$wnnna$aAlcohol Use, Underage
=450  \\$wnnna$aDrinking Age, Legal
=450  \\$wnnna$aDrinking Age, Minimum
=450  \\$wnnna$aDrinking Ages, Legal
=450  \\$wnnna$aDrinking Ages, Minimum
=450  \\$wnnna$aDrinking, Adolescent
=450  \\$wnnna$aDrinking, Teen
=450  \\$wnnna$aDrinking, Teenage
=450  \\$wnnna$aDrinking, Underage
=450  \\$wnnna$aDrinking, Youth
=450  \\$wnnna$aLegal Drinking Ages
=450  \\$wnnna$aMinimum Drinking Ages
=550  \\$wg$aAdolescent Behavior
=550  \\$wg$aAlcohol Drinking
=550  \\$wg$aSocial Problems
=550  \\$aAlcohol Drinking in College
=680  \\$iConsumption of ALCOHOLIC BEVERAGES by persons under the legal drinking age.
=688  \\$a2016
=750  \0$aYouth$xAlcohol use$0(DLC)sh 85149311$5IEN-M

=LDR  00768nz  a2200193n  4500
=001  9880614264002441
=005  20171212100746.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068878
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x60.$x875
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x60.$x875
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x200.$x875
=150  \\$aTrastuzumab
=450  \\$wnnna$aHerceptin
=550  \\$wg$aAntibodies, Monoclonal, Humanized
=680  \\$iA humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
=688  \\$a2016 (1998)
=750  \0$aTrastuzumab$0(DLC)sh 98002670$5IEN-M

=LDR  02204cz  a2200649n  4500
=001  9880617265202441
=005  20180102161047.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005247
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x113.$x547
=072  \\$aF1.$x145.$x407
=072  \\$aG7.$x203.$x650.$x353
=150  \\$aFeeding Behavior
=450  \\$wnnna$aDiet Habits
=450  \\$wnnna$aEating Habits
=450  \\$aDietary Habits
=450  \\$aEating Behavior
=450  \\$aFeeding Patterns
=450  \\$wnno$aFood Habits
=450  \\$wnnna$aBehavior, Eating
=450  \\$wnnna$aBehavior, Feeding
=450  \\$wnnna$aBehaviors, Eating
=450  \\$wnnna$aBehaviors, Feeding
=450  \\$wnnna$aDiet Habit
=450  \\$wnnna$aDietary Habit
=450  \\$wnnna$aEating Behaviors
=450  \\$wnnna$aEating Habit
=450  \\$wnnna$aFeeding Behaviors
=450  \\$wnnna$aFeeding Pattern
=450  \\$wnnna$aFood Habit
=450  \\$wnnna$aHabit, Diet
=450  \\$wnnna$aHabit, Dietary
=450  \\$wnnna$aHabit, Eating
=450  \\$wnnna$aHabit, Food
=450  \\$wnnna$aHabits, Diet
=450  \\$wnnna$aHabits, Dietary
=450  \\$wnnna$aHabits, Eating
=450  \\$wnnna$aHabits, Food
=450  \\$wnnna$aPattern, Feeding
=450  \\$wnnna$aPatterns, Feeding
=550  \\$wg$aBehavior
=550  \\$wg$aBehavior, Animal
=550  \\$wg$aNutritional Physiological Phenomena
=550  \\$wh$aBottle Feeding
=550  \\$wh$aBreast Feeding
=550  \\$wh$aCannibalism
=550  \\$wh$aCarnivory
=550  \\$wh$aCoprophagia
=550  \\$wh$aFasting
=550  \\$wh$aFood Preferences
=550  \\$wh$aHerbivory
=550  \\$aNutrition Disorders
=667  \\$ahuman & animal; = manner of eating or feeding: differentiate from EATING, the act of eating or feeding; permitted for feeding behavior of insects, as mosquitoes on skin, ticks sucking blood, maggots on flesh, etc., but NIM with feeding organism IM
=680  \\$iBehavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.
=688  \\$a1969
=750  \0$aFood habits$0(DLC)sh 85050275$5IEN-M

=LDR  01422cz  a2200421n  4500
=001  9880617274102441
=005  20200616130908.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003256
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x421.$x143.$x262
=072  \\$aN3.$x540.$x245.$x360
=150  \\$aCommunity Participation
=450  \\$wnnna$aCommunity Involvement
=450  \\$wnnna$aPublic Participation
=450  \\$aCommunity Action
=450  \\$aConsumer Involvement
=450  \\$aConsumer Participation
=450  \\$wnnna$aAction, Community
=450  \\$wnnna$aActions, Community
=450  \\$wnnna$aCommunity Actions
=450  \\$wnnna$aCommunity Involvements
=450  \\$wnnna$aConsumer Involvements
=450  \\$wnnna$aInvolvement, Community
=450  \\$wnnna$aInvolvement, Consumer
=450  \\$wnnna$aInvolvements, Community
=450  \\$wnnna$aParticipation, Community
=450  \\$wnnna$aParticipation, Consumer
=450  \\$wnnna$aParticipation, Public
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aConsumer Organizations
=550  \\$wh$aPatient Participation
=550  \\$aDelivery of Health Care
=550  \\$aPatient Care Planning
=550  \\$aPolitical Activism
=680  \\$iInvolvement of members of the community in the affairs of that community.
=688  \\$a74
=750  \0$iRelated mapping$aPolitical participation$0(DLC)sh 85104370$4RM$5IEN-M

=LDR  01594nz  a2200421n  4500
=001  9880625822502441
=005  20200403105943.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072317
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x309.$x500.$x450
=072  \\$aD3.$x633.$x300.$x786
=150  \\$aPolychlorinated Dibenzodioxins
=450  \\$wnnna$a2,3,7,8-Tetrachlorodibenzo-p-dioxin
=450  \\$wnnna$aChlorinated Dibenzo-p-dioxins
=450  \\$wnnna$aDibenzo(b,e)(1,4)dioxin, 2,3,7,8-tetrachloro-
=450  \\$wnnna$aPCDD
=450  \\$wnnna$aPolychlorinated Dibenzo-p-dioxins
=450  \\$wnnna$aPolychlorinated Dibenzodioxin
=450  \\$wnnna$aPolychlorodibenzo-4-dioxin
=450  \\$wnnna$aPolychlorodibenzo-p-dioxin
=450  \\$wnnna$aTetrachlorodibenzo-p-dioxin
=450  \\$aTCDD
=450  \\$wnno$aTetrachlorodibenzodioxin
=450  \\$wnnna$aChlorinated Dibenzo p dioxins
=450  \\$wnnna$aDibenzo-p-dioxins, Chlorinated
=450  \\$wnnna$aDibenzo-p-dioxins, Polychlorinated
=450  \\$wnnna$aDibenzodioxin, Polychlorinated
=450  \\$wnnna$aDibenzodioxins, Polychlorinated
=450  \\$wnnna$aPolychlorinated Dibenzo p dioxins
=450  \\$wnnna$aPolychlorodibenzo 4 dioxin
=450  \\$wnnna$aPolychlorodibenzo p dioxin
=450  \\$wnnna$aTetrachlorodibenzo p dioxin
=550  \\$wg$aDioxins
=550  \\$wh$aAgent Orange
=680  \\$iDibenzodioxin derivatives that contain multiple chloride atoms bound to the benzene ring structures.
=688  \\$a2017(1976)
=750  \0$aPolychlorinated dibenzodioxins$0(DLC)sh 90001396$5IEN-M

=LDR  00734cz  a2200217n  4500
=001  9880625824802441
=005  20180119092410.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D011562
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x132.$x436.$x613
=072  \\$aD3.$x633.$x100.$x473.$x402.$x613
=072  \\$aD3.$x633.$x100.$x473.$x914.$x700
=150  \\$aPsilocybin
=450  \\$wnnna$aPsilocibin
=450  \\$wnno$aPsilocybine
=550  \\$wg$aIndole Alkaloids
=550  \\$wg$aTryptamines
=680  \\$iThe major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin. (From Merck Index, 11th ed)
=688  \\$a66(63)
=750  \0$aPsilocybin$0(DLC)sh 85108320$5IEN-M

=LDR  01656nz  a2200469n  4500
=001  9881821065602441
=005  20220302162838.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000072957
=035  \\$a(DNLM)D000072957
=035  \\$a(NLM)987391741300041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x508.$x150.$x600.$x500.$x500
=150  \\$aAlaskan Natives
=450  \\$wnnna$aAlaska Natives
=450  \\$wnnna$aAlaska's Indigenous People
=450  \\$wnnna$aIndigenous People of Alaska
=450  \\$aIndigenous Alaskans
=450  \\$aNative Alaskans
=450  \\$wnnna$aAlaska Indigenous People
=450  \\$wnnna$aAlaska Indigenous Peoples
=450  \\$wnnna$aAlaska Native
=450  \\$wnnna$aAlaska's Indigenous Peoples
=450  \\$wnnna$aAlaskan Native
=450  \\$wnnna$aAlaskan, Indigenous
=450  \\$wnnna$aAlaskan, Native
=450  \\$wnnna$aAlaskans, Indigenous
=450  \\$wnnna$aAlaskans, Native
=450  \\$wnnna$aAlaskas Indigenous People
=450  \\$wnnna$aIndigenous Alaskan
=450  \\$wnnna$aIndigenous People, Alaska's
=450  \\$wnnna$aIndigenous Peoples, Alaska's
=450  \\$wnnna$aNative Alaskan
=450  \\$wnnna$aNative, Alaskan
=450  \\$wnnna$aNatives, Alaska
=450  \\$wnnna$aNatives, Alaskan
=450  \\$wnnna$aPeople, Alaska's Indigenous
=450  \\$wnnna$aPeoples, Alaska's Indigenous
=667  \\$aspecify ethnic group if pertinent; do not confuse with INUITS
=680  \\$iPersons having origins in any indigenous people of ALASKA and their descendants.
=688  \\$a2017
=750  \0$aAlaska Natives$0(DLC)sh2009007114$5IEN-M

=LDR  01103cz  a2200289n  4500
=001  9880630772902441
=005  20180205104557.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D053687
=040  \\$aDNLM$cDNLM
=060  \0$aQU 325
=072  \\$aA11.$x872.$x40
=150  \\$aAdult Stem Cells
=450  \\$wnnna$aAdult Somatic Stem Cells
=450  \\$wnnna$aSomatic Adult Stem Cells
=450  \\$wnnna$aSomatic Stem Cells
=450  \\$wnnna$aAdult Stem Cell
=450  \\$wnnna$aSomatic Stem Cell
=450  \\$wnnna$aStem Cell, Somatic
=450  \\$wnnna$aStem Cells, Adult
=450  \\$wnnna$aStem Cells, Somatic
=550  \\$wg$aStem Cells
=550  \\$wh$aAdult Germline Stem Cells
=550  \\$wh$aInduced Pluripotent Stem Cells
=680  \\$iTissue-specific stem cells (also known as Somatic Stem Cells) that appear during fetal development and remain in the body throughout life. The key functions of adult stem cells are to maintain and repair the specific tissues where they reside (e.g. skin or blood).
=688  \\$a2007
=750  \0$aAdult stem cells$0(DLC)sh2016002116$5IEN-M

=LDR  00611nz  a2200193n  4500
=001  9880630773102441
=005  20180205103739.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072956
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x872.$x40.$x250
=150  \\$aAdult Germline Stem Cells
=450  \\$wnnna$aGermline Adult Stem Cells
=450  \\$wnnna$aSpermatogonial Progenitor Cells
=450  \\$wnnna$aProgenitor Cells, Spermatogonial
=450  \\$wnnna$aSpermatogonial Progenitor Cell
=550  \\$wg$aAdult Stem Cells
=680  \\$iProgenitor stem cells found in the testicles.
=688  \\$a2017(1994)

=LDR  01539nz  a2200445n  4500
=001  9880634564502441
=005  20180212140316.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070377
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x88
=150  \\$aAnti-Vaccination Movement
=450  \\$wnnna$aAnti-Vaccination Groups
=450  \\$wnnna$aAnti-Vaccine Groups
=450  \\$wnnna$aAnti-Vaccine Movement
=450  \\$wnnna$aAntivaccination Movement
=450  \\$wnnna$aAnti Vaccination Groups
=450  \\$wnnna$aAnti Vaccination Movement
=450  \\$wnnna$aAnti Vaccine Groups
=450  \\$wnnna$aAnti Vaccine Movement
=450  \\$wnnna$aAnti-Vaccination Group
=450  \\$wnnna$aAnti-Vaccination Movements
=450  \\$wnnna$aAnti-Vaccine Group
=450  \\$wnnna$aAnti-Vaccine Movements
=450  \\$wnnna$aAntivaccination Movements
=450  \\$wnnna$aGroup, Anti-Vaccination
=450  \\$wnnna$aGroup, Anti-Vaccine
=450  \\$wnnna$aGroups, Anti-Vaccination
=450  \\$wnnna$aGroups, Anti-Vaccine
=450  \\$wnnna$aMovement, Anti-Vaccination
=450  \\$wnnna$aMovement, Anti-Vaccine
=450  \\$wnnna$aMovement, Antivaccination
=450  \\$wnnna$aMovements, Anti-Vaccination
=450  \\$wnnna$aMovements, Anti-Vaccine
=450  \\$wnnna$aMovements, Antivaccination
=550  \\$wg$aHuman Activities
=550  \\$aVaccination Refusal
=680  \\$iGroup activities directed against VACCINATION.
=688  \\$a2017
=750  \0$aAnti-vaccination movement$0(DLC)sh2016002539$5IEN-M

=LDR  01177nz  a2200325n  4500
=001  9880634565102441
=005  20180212135547.0
=008  160629\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070598
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x558.$x554.$x213
=150  \\$aAnterior Cruciate Ligament Injuries
=450  \\$wnnna$aACL Injuries
=450  \\$wnnna$aACL Tears
=450  \\$wnnna$aAnterior Cruciate Ligament Injury
=450  \\$wnnna$aAnterior Cruciate Ligament Tear
=450  \\$wnnna$aAnterior Cruciate Ligament Tears
=450  \\$wnnna$aACL Injury
=450  \\$wnnna$aACL Tear
=450  \\$wnnna$aInjuries, ACL
=450  \\$wnnna$aInjury, ACL
=450  \\$wnnna$aTear, ACL
=450  \\$wnnna$aTears, ACL
=450  \\$aAnterior Cruciate Ligament$xinjuries
=550  \\$wh$aKnee Injuries
=680  \\$iSprain or tear injuries to the ANTERIOR CRUCIATE LIGAMENT of the knee.
=688  \\$a2017
=750  \0$81$wb$aAnterior cruciate ligament$0(DLC)sh 86004623$5IEN-M
=780  \0$81$wb$aWounds and injuries$0(DLC)sh 99004991$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aAnterior cruciate ligament--Wounds and injuries

=LDR  00982nz  a2200241n  4500
=001  9880634570602441
=005  20180212111155.0
=008  160629\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072676
=040  \\$aDNLM$cDNLM
=072  \\$aC7.$x160
=150  \\$aAnkyloglossia
=450  \\$wnnna$aPartial Ankyloglossia
=450  \\$wnnna$aTongue Tie
=450  \\$wnnna$aAnkyloglossia, Partial
=450  \\$wnnna$aAnkyloglossias
=450  \\$wnnna$aAnkyloglossias, Partial
=450  \\$wnnna$aPartial Ankyloglossias
=450  \\$wnnna$aTongue Ties
=550  \\$wg$aStomatognathic Diseases
=680  \\$iA severe congenital restriction of TONGUE movement, resulting from fusion or adherence of the tongue to the floor of the mouth. In partial ankyloglossia (tongue-tie) the LINGUAL FRENUM is abnormally short, or is attached too close to the tip of the tongue. OMIM: 106280
=688  \\$a2017; use under Mouth Abnormalities 2013-2016
=750  \0$aAnkyloglossia$0(DLC)sh 85005325$5IEN-M

=LDR  00807nz  a2200265n  4500
=001  9880634571402441
=005  20180212105604.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072080
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x140.$x40
=072  \\$aM1.$x526.$x485.$x810.$x40
=072  \\$aN2.$x360.$x140.$x40
=072  \\$aN2.$x360.$x810.$x40
=150  \\$aAnesthesiologists
=450  \\$wnnna$aPhysician Anesthetists
=450  \\$wnnna$aAnesthesiologist
=450  \\$wnnna$aAnesthetist, Physician
=450  \\$wnnna$aAnesthetists, Physician
=450  \\$wnnna$aPhysician Anesthetist
=550  \\$wg$aAnesthetists
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in ANESTHESIOLOGY.
=688  \\$a2017
=750  \0$aAnesthesiologists$0(DLC)sh 85004969$5IEN-M

=LDR  00929nz  a2200289n  4500
=001  9880634573302441
=005  20180212104717.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070378
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100.$x50
=150  \\$aAmaryllidaceae
=450  \\$wnnna$aCyrtanthus
=450  \\$wnnna$aZephyrlily
=450  \\$aClivia
=450  \\$aHippeastrum
=450  \\$aZephyranthes
=450  \\$wnnna$aZephyrlilies
=550  \\$wg$aAsparagales
=550  \\$wh$aAllium
=550  \\$wh$aCrinum
=550  \\$wh$aGalanthus
=550  \\$wh$aLycoris
=550  \\$wh$aNarcissus
=680  \\$iA family of herbaceous plants with bulbs or rhizomes in the order Asparagales.
=688  \\$a2017; for CLIVIA, HIPPEASTRUM, and ZEPHYRANTHES use LILIACEAE 2003-2016;  for CYRTANTHUS use LILIACEAE 2004-2016
=750  \0$aAmaryllidaceae$0(DLC)sh 85004113$5IEN-M

=LDR  00537nz  a2200181n  4500
=001  9880634573902441
=005  20180212091215.0
=008  160706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072223
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x20
=072  \\$aN2.$x360.$x810.$x20
=150  \\$aAllergists
=450  \\$wnnna$aAllergist
=550  \\$wg$aPhysicians
=680  \\$iPhysicians specializing in treating individuals with hypersensitivity to ALLERGENS.
=688  \\$a2017
=750  \0$aAllergists$0(DLC)sh 85003661$5IEN-M

=LDR  00606nz  a2200181n  4500
=001  9880635499402441
=005  20180223104733.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072018
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x170
=072  \\$aN2.$x360.$x170
=150  \\$aAudiologists
=450  \\$wnnna$aAudiologist
=550  \\$wg$aHealth Personnel
=680  \\$iProfessionals skilled at diagnostic testing of hearing, HEARING IMPAIRMENT, and CORRECTION OF HEARING IMPAIRMENT by non-medical or non-surgical means.
=688  \\$a2017
=750  \0$aAudiologists$0(DLC)sh 85009468$5IEN-M

=LDR  00759nz  a2200241n  4500
=001  9880635517202441
=005  20190628102623.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070381
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x618.$x100
=150  \\$aAsparagales
=450  \\$aGaltonia
=550  \\$wg$aLilianae
=550  \\$wh$aAmaryllidaceae
=550  \\$wh$aAsparagaceae
=550  \\$wh$aHypoxidaceae
=550  \\$wh$aIridaceae
=550  \\$wh$aOrchidaceae
=550  \\$wh$aXanthorrhoeaceae
=680  \\$iAn order of monocotyledons (superorder Lilianae) in the class Magnoliopsida (Angiosperms).
=688  \\$a2017; for GALTONIA use LILIACEAE 2003-2016
=750  \0$aAsparagales$0(DLC)sh2003009819$5IEN-M

=LDR  00691nz  a2200181n  4500
=001  9880635528202441
=005  20180221135156.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072698
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x696.$x50
=072  \\$aI1.$x880.$x735.$x820.$x500.$x125
=150  \\$aApartheid
=550  \\$wh$aPolitical Systems
=550  \\$wg$aRace Relations
=680  \\$iA former political system in SOUTH AFRICA which enforced segregation in all forms, including physical, political, legal and economic discrimination, against all non-white, non-European racial groups.
=688  \\$a2017; use Race RELATIONS 1988-2016
=750  \0$aApartheid$0(DLC)sh 85005905$5IEN-M

=LDR  00710nz  a2200205n  4500
=001  9880637670002441
=005  20180306104618.0
=008  160629\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071941
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x225.$x313
=072  \\$aE2.$x319.$x347.$x500
=150  \\$aBarium Enema
=450  \\$wnnna$aBarium Enemas
=450  \\$wnnna$aEnema, Barium
=550  \\$wg$aEnema
=550  \\$wg$aFluoroscopy
=680  \\$iX-RAY examination of LOWER GASTROINTESTINAL TRACT. Imaging is done while a BARIUM COMPOUND (e.g., BARIUM SULFATE) fills the large intestine via the rectum as a CONTRAST MATERIAL.
=688  \\$a2017
=750  \0$aBarium enema$0(DLC)sh 85011857$5IEN-M

=LDR  01016nz  a2200301n  4500
=001  9880638669202441
=005  20180306143732.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072296
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x108
=150  \\$aBathroom Equipment
=450  \\$wnnna$aBedpans
=450  \\$wnnna$aCommodes
=450  \\$wnnna$aUrinals
=450  \\$wnnna$aBathroom Equipments
=450  \\$wnnna$aBedpan
=450  \\$wnnna$aCommode
=450  \\$wnnna$aEquipment, Bathroom
=450  \\$wnnna$aEquipments, Bathroom
=450  \\$wnnna$aUrinal
=550  \\$wg$aEquipment and Supplies
=550  \\$aToilet Facilities
=680  \\$iReceptacles used for collection of human excrement.
=688  \\$a2017
=750  \0$81$wb$iBroader mapping$aBathrooms$0(DLC)sh 85012333$4BM$5IEN-M
=780  \0$81$wb$aBroader mapping$aEquipment and supplies$0(DLC)sh00005850$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading:$aBathrooms$xEquipment and supplies

=LDR  00736nz  a2200169n  4500
=001  9880640760002441
=005  20180309104046.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070060
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x180.$x500
=072  \\$aB3.$x660.$x125.$x50.$x500
=150  \\$aBdellovibrio bacteriovorus
=550  \\$wg$aBdellovibrio
=680  \\$iA non-pathogenic, obligate aerobic, Gram-negative species of Bdellovibrio that occurs in water and soil, as well as the intestines of birds and mammals. It can infect and lyse pathogenic GRAM-NEGATIVE BACTERIA and can function as a PROBIOTIC and ANTI-BACTERIAL AGENT.
=688  \\$a2017
=750  \0$aBdellovibrio bacteriovorus$0(DLC)sh 85012595$5IEN-M

=LDR  00655cz  a2200217n  4500
=001  9880642255502441
=005  20180315192246.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D003288
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x974.$x250
=150  \\$aContusions
=450  \\$aBruise
=450  \\$wnnna$aBruises
=450  \\$wnnna$aContusion
=550  \\$wg$aWounds, Nonpenetrating
=550  \\$wh$aBrain Contusion
=550  \\$wh$aMyocardial Contusions
=667  \\$adifferentiate from ECCHYMOSIS: use term in the text
=680  \\$iInjuries resulting in hemorrhage, usually manifested in the skin.
=750  \0$aBruises$0(DLC)sh 98002870$5IEN-M

=LDR  01247nz  a2200373n  4500
=001  9880642255702441
=005  20160901000000.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070624
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x199.$x444.$x375
=072  \\$aC10.$x900.$x300.$x87.$x235.$x375
=072  \\$aC26.$x915.$x300.$x200.$x194.$x375
=072  \\$aC26.$x974.$x250.$x500
=150  \\$aBrain Contusion
=450  \\$wnnna$aCerebellar Contusion
=450  \\$wnnna$aCerebral Contusion
=450  \\$wnnna$aContusio Cerebri
=450  \\$wnnna$aCortical Contusion
=450  \\$wnnna$aBrain Contusions
=450  \\$wnnna$aCerebellar Contusions
=450  \\$wnnna$aCerebral Contusions
=450  \\$wnnna$aContusion, Brain
=450  \\$wnnna$aContusion, Cerebellar
=450  \\$wnnna$aContusion, Cerebral
=450  \\$wnnna$aContusion, Cortical
=450  \\$wnnna$aContusions, Brain
=450  \\$wnnna$aContusions, Cerebellar
=450  \\$wnnna$aContusions, Cerebral
=450  \\$wnnna$aContusions, Cortical
=450  \\$wnnna$aCortical Contusions
=550  \\$aBrain Hemorrhage, Traumatic
=680  \\$iA bruise of the brain from an impact of the skull.
=688  \\$a2017; use BRAIN INJURIES 1998-2016

=LDR  00874nz  a2200289n  4500
=001  9880642256002441
=005  20180315170751.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071298
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x260.$x127
=072  \\$aI1.$x76.$x368.$x792
=072  \\$aI1.$x198.$x780.$x937.$x883
=150  \\$aBody Remains
=450  \\$wnnna$aAnimal Remains
=450  \\$wnnna$aHuman Remains
=450  \\$wnnna$aSkeletal Remains
=450  \\$wnnna$aRemains, Animal
=450  \\$wnnna$aRemains, Body
=450  \\$wnnna$aRemains, Human
=450  \\$wnnna$aRemains, Skeletal
=550  \\$wg$aAnthropology, Physical
=550  \\$wg$aDeath
=550  \\$wg$aForensic Medicine
=680  \\$iThe physical entity of a deceased human or animal.
=688  \\$a2017
=750  \0$iBroader mapping$aAnthropometry$0(DLC)sh 85005588$4BM$5IEN-M

=LDR  00663nz  a2200169n  4500
=001  9880642373402441
=005  20180314100147.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069985
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x100.$x313
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x100.$x313
=150  \\$aBifidobacterium bifidum
=550  \\$wg$aBifidobacterium
=680  \\$iA species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT, especially in infants, and in FERMENTED DAIRY PRODUCTS. It produces BACTERIOCINS and is used as a PROBIOTIC.
=688  \\$a2017
=750  \0$aBifidobacterium bifidum$0(DLC)sh 88023218$5IEN-M

=LDR  00906nz  a2200253n  4500
=001  9880643159102441
=005  20180319104752.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070696
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x700.$x250
=072  \\$aG7.$x203.$x300.$x350.$x300.$x222
=072  \\$aG7.$x203.$x300.$x350.$x525.$x250
=072  \\$aJ2.$x200.$x700.$x250
=072  \\$aJ2.$x500.$x350.$x300.$x222
=072  \\$aJ2.$x500.$x350.$x525.$x250
=150  \\$aButtermilk
=450  \\$wnnna$aButter Milk
=450  \\$wnnna$aMilk, Butter
=550  \\$wg$aCultured Milk Products
=550  \\$wg$aMilk
=680  \\$iA beverage made from cow's milk fermented by LACTIC ACID-producing bacteria, especially LACTOCOCCUS LACTIS and LACTOBACILLUS BULGARICUS.
=688  \\$a2017; use MILK 1998-2003 and CULTURED MILK PRODUCTS 2004-2016
=750  \0$aButtermilk$0(DLC)sh 85018388$5IEN-M

=LDR  00596nz  a2200181n  4500
=001  9880643171502441
=005  20180316121604.0
=008  160629\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071378
=040  \\$aDNLM$cDNLM
=072  \\$aC5.$x330.$x488.$x50
=150  \\$aBunion
=450  \\$wnnna$aBunions
=550  \\$wg$aFoot Deformities, Acquired
=550  \\$wh$aBunion, Tailor's
=680  \\$iAbnormal swelling of the inner aspect of the first metatarsal head affecting the first METATARSOPHALANGEAL JOINT.
=688  \\$a2017; use HALLUX VALGUS 1967-2016
=750  \0$aBunion$0(DLC)sh 85018006$5IEN-M

=LDR  00582nz  a2200205n  4500
=001  9880643590302441
=005  20180404103545.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070621
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x830.$x500
=072  \\$aE1.$x370.$x390.$x830.$x500
=150  \\$aCystography
=450  \\$wnnna$aCystogram
=450  \\$wnnna$aCystograms
=450  \\$wnnna$aCystographies
=550  \\$wg$aUrography
=680  \\$iRadiography of the URINARY BLADDER.
=688  \\$a2017
=750  \0$aBladder$xRadiography$0(DLC)sh 85014734$5IEN-M

=LDR  00620nz  a2200169n  4500
=001  9880643611302441
=005  20180402114131.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072117
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x225
=150  \\$aCounselors
=450  \\$wnnna$aCounselor
=550  \\$wg$aOccupational Groups
=680  \\$iProfessionals trained in providing information, guidance, and recommendations to individual clients or families to support their decision making and development of coping skills.
=688  \\$a2017; use COUNSELING 1978-2016
=750  \0$aCounselors$0(DLC)sh 85033428$5IEN-M

=LDR  00713nz  a2200217n  4500
=001  9880643619802441
=005  20180330111322.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071538
=040  \\$aDNLM$cDNLM
=072  \\$aA10.$x165.$x265.$x521
=150  \\$aCortical Bone
=450  \\$wnnna$aCompact Bone
=450  \\$wnnna$aCompact Bone Tissue
=450  \\$wnnna$aCompact Bones
=450  \\$wnnna$aSubstantia Compacta
=550  \\$wg$aBone and Bones
=550  \\$wh$aHaversian System
=680  \\$iA type of osseous tissue which makes up the outer layer of bone. It is dense, rigid, strong, and forms concentric lamellar OSTEONS.
=688  \\$a2017
=750  \0$aCompact bone$0(DLC)sh 88007604$5IEN-M

=LDR  01091nz  a2200265n  4500
=001  9880643620902441
=005  20180330102415.0
=008  930806\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D017630
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x585.$x250
=150  \\$aConnexins
=450  \\$wnnna$aGap Junction Channel Proteins
=450  \\$wnnna$aGap Junction Protein
=450  \\$aGap Junction Proteins
=450  \\$wnnna$aJunction Protein, Gap
=450  \\$wnnna$aJunction Proteins, Gap
=550  \\$wg$aMembrane Transport Proteins
=550  \\$wh$aConnexin 43
=550  \\$wh$aConnexin 26
=550  \\$aGap Junctions
=550  \\$aErythrokeratodermia Variabilis
=680  \\$iA group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions.
=688  \\$a94; GAP JUNCTION PROTEIN was (NM) 1982-93
=750  \0$aConnexins$0(DLC)sh 96007297$5IEN-M

=LDR  00694nz  a2200229n  4500
=001  9880643629602441
=005  20180328105015.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000069956
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x300.$x195
=072  \\$aJ2.$x500.$x195
=150  \\$aChocolate
=450  \\$wnnna$aCocoa Powder
=450  \\$wnnna$aChocolates
=450  \\$wnnna$aCocoa Powders
=450  \\$wnnna$aPowder, Cocoa
=450  \\$wnnna$aPowders, Cocoa
=550  \\$wg$aFood
=680  \\$iFood product prepared from fermenting, roasting, and grinding the seeds of the COCOA plant.
=688  \\$a2017; use CACAO 1963-2016
=750  \0$aChocolate$0(DLC) sh 85024603$5IEN-M

=LDR  00611nz  a2200181n  4500
=001  9880643630202441
=005  20180328092522.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071697
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x885.$x281
=150  \\$aCellulite
=450  \\$wnnna$aCellulites
=550  \\$wh$aSkin Manifestations
=550  \\$aCellulitis
=680  \\$iSkin lumpiness or skin surface dimpling often seen on the thighs, buttocks and abdomen. It is due to protrusion of SUBCUTANEOUS FAT into the DERMIS layer of skin.
=688  \\$a2017
=750  \0$aCellulite$0(DLC)sh 91004387$5IEN-M

=LDR  00855nz  a2200241n  4500
=001  9880643639302441
=005  20180326143503.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072599
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x685.$x500
=072  \\$aI3.$x450.$x642.$x845.$x54.$x300
=072  \\$aI3.$x450.$x642.$x845.$x54.$x800.$x500
=072  \\$aN1.$x400.$x150
=072  \\$aN1.$x400.$x545.$x500
=150  \\$aCardiorespiratory Fitness
=450  \\$wnnna$aFitness, Cardiorespiratory
=550  \\$wg$aAthletic Performance
=550  \\$wg$aHealth
=550  \\$wg$aPhysical Fitness
=680  \\$iA measure of the functional capabilities of the heart, lungs and muscles, relative to the demands of specific exercise routines such as running or cycling.
=688  \\$a2017
=750  \0$aCardiopulmonary fitness$0(DLC)sh2012003905$5IEN

=LDR  00588nz  a2200181n  4500
=001  9880643639702441
=005  20180326134841.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072096
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x128
=072  \\$aN2.$x360.$x810.$x128
=150  \\$aCardiologists
=450  \\$wnnna$aCardiologist
=550  \\$wg$aPhysicians
=680  \\$iQualified medical professionals who specialize in preventing and treating disorders of the heart and CARDIOVASCULAR SYSTEM.
=688  \\$a2017
=750  \0$aCardiologists$0(DLC)sh 85020211$5IEN-M

=LDR  01231nz  a2200301n  4500
=001  9880643643802441
=005  20180326131703.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072038
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x760.$x169.$x63.$x500.$x185
=072  \\$aE2.$x831.$x185
=072  \\$aH2.$x403.$x680.$x600.$x250
=072  \\$aN2.$x421.$x784.$x244
=150  \\$aCardiac Rehabilitation
=450  \\$wnnna$aCardiovascular Rehabilitation
=450  \\$wnnna$aCardiac Rehabilitations
=450  \\$wnnna$aCardiovascular Rehabilitations
=450  \\$wnnna$aRehabilitation, Cardiac
=450  \\$wnnna$aRehabilitation, Cardiovascular
=450  \\$wnnna$aRehabilitations, Cardiac
=450  \\$wnnna$aRehabilitations, Cardiovascular
=450  \\$aCardiovascular Diseases$xrehabilitation
=550  \\$wg$aRehabilitation
=550  \\$aRecovery of Function
=680  \\$iRestoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.
=688  \\$a2017
=750  \0$aHeart$xDiseases$xPatients$xRehabilitation$0(DLC)sh 85020190$5IEN-M

=LDR  00637nz  a2200217n  4500
=001  9880643648602441
=005  20180323113941.0
=008  160629\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072601
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x132.$x125
=150  \\$aCannula
=450  \\$wnnna$aCannulae
=450  \\$wnnna$aNasal Cannula
=450  \\$wnnna$aNasal Cannulae
=450  \\$wnnna$aCannula, Nasal
=450  \\$wnnna$aCannulae, Nasal
=550  \\$wg$aCatheters
=680  \\$iShort, hollow cylinders or tubes for insertion into a canal, vessel, or body cavity.
=688  \\$a2017(1978)
=750  \0$aCannula$0(DLC)sh 85019632$5IEN-M

=LDR  02369nz  a2200673n  4500
=001  9880643649202441
=005  20180323105708.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072716
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x597.$x617.$x185
=072  \\$aC23.$x888.$x592.$x612.$x212
=150  \\$aCancer Pain
=450  \\$wnnna$aCancer-Associated Pain
=450  \\$wnnna$aCancer-Related Pain
=450  \\$wnnna$aNeoplasm-Associated Pain
=450  \\$wnnna$aNeoplasm-Related Pain
=450  \\$wnnna$aOncological Pain
=450  \\$wnnna$aOncology Pain
=450  \\$wnnna$aTumor-Associated Pain
=450  \\$wnnna$aTumor-Related Pain
=450  \\$wnnna$aCancer Associated Pain
=450  \\$wnnna$aCancer Pains
=450  \\$wnnna$aCancer Related Pain
=450  \\$wnnna$aCancer-Associated Pains
=450  \\$wnnna$aCancer-Related Pains
=450  \\$wnnna$aNeoplasm Associated Pain
=450  \\$wnnna$aNeoplasm Related Pain
=450  \\$wnnna$aNeoplasm-Associated Pains
=450  \\$wnnna$aNeoplasm-Related Pains
=450  \\$wnnna$aOncological Pains
=450  \\$wnnna$aOncology Pains
=450  \\$wnnna$aPain, Cancer
=450  \\$wnnna$aPain, Cancer-Associated
=450  \\$wnnna$aPain, Cancer-Related
=450  \\$wnnna$aPain, Neoplasm-Associated
=450  \\$wnnna$aPain, Neoplasm-Related
=450  \\$wnnna$aPain, Oncological
=450  \\$wnnna$aPain, Oncology
=450  \\$wnnna$aPain, Tumor-Associated
=450  \\$wnnna$aPain, Tumor-Related
=450  \\$wnnna$aPains, Cancer
=450  \\$wnnna$aPains, Cancer-Associated
=450  \\$wnnna$aPains, Cancer-Related
=450  \\$wnnna$aPains, Neoplasm-Associated
=450  \\$wnnna$aPains, Neoplasm-Related
=450  \\$wnnna$aPains, Oncological
=450  \\$wnnna$aPains, Oncology
=450  \\$wnnna$aPains, Tumor-Associated
=450  \\$wnnna$aPains, Tumor-Related
=450  \\$wnnna$aTumor Associated Pain
=450  \\$wnnna$aTumor Related Pain
=450  \\$wnnna$aTumor-Associated Pains
=450  \\$wnnna$aTumor-Related Pains
=550  \\$wg$aPain
=667  \\$anot for treatment-related pain
=680  \\$iPain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.
=688  \\$a2017
=750  \0$aCancer pain$0(DLC)sh 87007052$5IEN-M

=LDR  00744nz  a2200205n  4500
=001  9880643672302441
=005  20180321102502.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070456
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x181
=150  \\$aCall Centers
=450  \\$wnnna$aCall Center
=450  \\$wnnna$aCenter, Call
=450  \\$wnnna$aCenters, Call
=550  \\$wg$aCommunications Media
=550  \\$wh$aHotlines
=680  \\$iA facility set up for the purpose of handling large volumes of telephone calls. Call Centers typically utilize some form of computer automation for receiving, dispatching, screening, logging and forwarding telephone calls.
=688  \\$a2017
=750  \0$aCall centers$0(DLC) sh96005575$5IEN-M

=LDR  00569nz  a2200181n  4500
=001  9880643672502441
=005  20180321095603.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072437
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x60
=150  \\$aCalendars as Topic
=450  \\$wnnna$aCalendars as Topics
=550  \\$wg$aInformation Science
=667  \\$ado not confuse with the Publication Type CALENDARS
=680  \\$iWorks about documents or charts that show days, weeks, and months of a year.
=688  \\$a2017
=750  \0$aCalendars$0(DLC)sh 85018851$5IEN-M

=LDR  00610nz  a2200205n  4500
=001  9880646571902441
=005  20180406114534.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072699
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x820
=150  \\$aSocial Segregation
=450  \\$wnnna$aRacial Segregation
=450  \\$wnnna$aRacial Segregations
=450  \\$wnnna$aSegregation, Racial
=450  \\$wnnna$aSegregation, Social
=550  \\$wg$aSocial Problems
=550  \\$wh$aRace Relations
=680  \\$iBarriers based on group membership.
=750  \0$aSegregation$0(DLC)sh 85119585$5IEN-M

=LDR  00578nz  a2200157n  4500
=001  9880646572002441
=005  20180406112134.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072697
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x820.$x500.$x250
=150  \\$aDesegregation
=550  \\$wg$aRace Relations
=680  \\$iEnding segregation (separation) of different groups of people, usually based on race, in schools, housing, organizations, etc.
=688  \\$a2017; use Race RELATIONS 1988-2016
=750  \0$iRelated mapping$aSegregation$0(DLC)sh 85119585$4RM$5IEN-M

=LDR  00472nz  a2200169n  4500
=001  9880646572202441
=005  20180406091110.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072085
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x215
=072  \\$aN2.$x360.$x810.$x215
=150  \\$aDermatologists
=450  \\$wnnna$aDermatologist
=550  \\$wh$aPhysicians
=680  \\$iPhysicians who specialize in treating disorders of the skin.
=688  \\$a2017

=LDR  00693nz  a2200229n  4500
=001  9880652171402441
=005  20180409110948.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070601
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x642.$x249.$x220
=072  \\$aG7.$x203.$x650.$x240.$x120
=150  \\$aDiet, Carbohydrate Loading
=450  \\$wnnna$aCarbohydrate Loading
=450  \\$wnnna$aCarbohydrate Loading Diet
=450  \\$wnnna$aCarbohydrate Loading Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=550  \\$aDietary Carbohydrates
=680  \\$iA diet rich in DIETARY CARBOHYDRATES.
=688  \\$a2017
=750  \0$aHigh-carbohydrate diet$0(DLC)sh 85060664$5IEN-M

=LDR  00749nz  a2200217n  4500
=001  9880652172102441
=005  20180409104105.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072338
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x309.$x250
=072  \\$aD3.$x633.$x300.$x258.$x500
=150  \\$aDibenzofurans, Polychlorinated
=450  \\$wnnna$aChlorinated Dibenzofurans
=450  \\$wnnna$aPolychlorinated Dibenzofurans
=450  \\$wnnna$aDibenzofurans, Chlorinated
=550  \\$wg$aDibenzofurans
=550  \\$wg$aDioxins and Dioxin-like Compounds
=680  \\$iDibenzofurans that contain chloride atoms bound to the aromatic rings of the structure.
=688  \\$a2017
=750  \0$aPolychlorinated dibenzofurans$0(DLC)sh 86003080$5IEN-M

=LDR  00548nz  a2200181n  4500
=001  9880652172402441
=005  20180409103326.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072318
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x300.$x258
=150  \\$aDibenzofurans
=450  \\$wnnna$aFurans, Dibenzo
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wh$aDibenzofurans, Polychlorinated
=550  \0$aDibenzofurans$0(DLC)sh 85037649$5IEN-M
=680  \\$iCompounds that include the structure of dibenzofuran.
=688  \\$a2017

=LDR  00591nz  a2200181n  4500
=001  9880652836002441
=005  20180416101212.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071278
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x330
=150  \\$aDomestication
=450  \\$wnnna$aAnimal Taming
=450  \\$wnnna$aTaming, Animal
=550  \\$aAgriculture
=680  \\$iA systematic process of adapting wild species of animals and plants into new environments often in close association or proximity to humans.
=688  \\$a2017
=750  \0$aDomestication$0(DLC)sh 85038949$5IEN-M

=LDR  00464nz  a2200169n  4500
=001  9880652836402441
=005  20180416095024.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072441
=040  \\$aDNLM$cDNLM
=072  \\$aD13.$x444.$x308.$x65
=150  \\$aDNA, Ancient
=450  \\$wnnna$aAncient DNA
=550  \\$wg$aDNA
=680  \\$iDNA isolated from fossils or other ancient specimens.
=688  \\$a2017
=750  \0$aDNA, Fossil$0(DLC)sh 92005763$5IEN-M

=LDR  00751nz  a2200229n  4500
=001  9880652837502441
=005  20180416085344.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071826
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x125.$x474
=150  \\$aDistracted Driving
=450  \\$wnnna$aDriving While Distracted
=450  \\$wnnna$aInattentive Driving
=450  \\$wnnna$aDistracted, Driving While
=450  \\$wnnna$aDriving, Distracted
=450  \\$wnnna$aDriving, Inattentive
=450  \\$wnnna$aWhile Distracted, Driving
=550  \\$wg$aAutomobile Driving
=680  \\$iBehavior which detracts from the focus necessary to operate an automobile safely.
=688  \\$a2017
=750  \2$aDistracted driving$0(DLC)sh2003006444$5IEN-M

=LDR  00665nz  a2200193n  4500
=001  9880654057802441
=005  20181214151059.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071195
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x702
=150  \\$aEducational Personnel
=450  \\$wnnna$aPersonnel, Educational
=550  \\$wg$aOccupational Groups
=550  \\$wh$aFaculty
=550  \\$wh$aSchool Teachers
=680  \\$iProfessionals responsible for teaching in an institution or place of learning such as a school, college, vocational institute, or university.
=688  \\$a2017; use TEACHING 1979-2016
=750  \0$aTeachers$0(DLC)sh 85132964$5IEN-M

=LDR  00599nz  a2200193n  4500
=001  9880673269702441
=005  20180621160726.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072218
=035  \\$a(NLM)987391455000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x330.$x397
=072  \\$aN2.$x360.$x330.$x397
=150  \\$aEndodontists
=450  \\$wnnna$aEndodontist
=550  \\$wg$aDentists
=680  \\$iDentists specializing in the treatment of injuries and diseases of the DENTAL PULP.
=688  \\$a2017; use Dentists 2016
=750  \0$aEndodontists$0(DLC)sh 85043077$5IEN-M

=LDR  00575nz  a2200193n  4500
=001  9880673269902441
=005  20180621153838.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072097
=035  \\$a(NLM)987391495900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x303
=072  \\$aN2.$x360.$x810.$x303
=150  \\$aEndocrinologists
=450  \\$wnnna$aEndocrinologist
=550  \\$wh$aPhysicians
=680  \\$iPhysicians who specialize in treating ENDOCRINE SYSTEM DISEASES.
=688  \\$a2017
=750  \0$aEndocrinologists$5IEN-M$0(DLC)sh 85043067

=LDR  00749nz  a2200217n  4500
=001  9880673270402441
=005  20180621151502.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071441
=035  \\$a(NLM)987391150300041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x754.$x293
=150  \\$aEmotion-Focused Therapy
=450  \\$wnnna$aEmotion Focused Therapy
=450  \\$wnnna$aEmotion-Focused Therapies
=450  \\$wnnna$aTherapies, Emotion-Focused
=450  \\$wnnna$aTherapy, Emotion-Focused
=550  \\$wg$aPsychotherapy
=680  \\$iIntervention that relies on free expression of emotions with coaching to enhance awareness of emotional experiences.
=688  \\$a2017
=750  \0$aEmotion-focused therapy$0(DLC) sh2006008652$5IEN-M

=LDR  00774nz  a2200193n  4500
=001  9880673550002441
=005  20180626160356.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072158
=035  \\$a(NLM)987391602500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x353
=072  \\$aN2.$x360.$x345
=150  \\$aEpidemiologists
=450  \\$wnnna$aEpidemiologist
=550  \\$wg$aHealth Personnel
=680  \\$iQualified medical professionals who study the causes, incidence, and characteristic behavior of disease outbreaks or other health-related conditions and determine the interrelationships of hosts, agents, and environment related to the distribution and control of diseases.
=688  \\$a2017
=750  \0$aEpidemiologists$0(DLC)sh 85044371$5IEN-M

=LDR  00500nz  a2200169n  4500
=001  9880674673202441
=005  20180702120453.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071825
=035  \\$a(NLM)987391256600041
=040  \\$aDNLM$cDNLM
=072  \\$aB5.$x256
=150  \\$aExtremophiles
=550  \\$wg$aOrganism Forms
=680  \\$iOrganisms specifically adapted to live in EXTREME ENVIRONMENTS.
=688  \\$a2017
=750  \0$aExtreme environments$xMicrobiology$0(DLC)sh 93000526$5IEN-M

=LDR  00829nz  a2200217n  4500
=001  9880674673502441
=005  20180702115300.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071251
=035  \\$a(NLM)987391104400041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x260
=150  \\$aExtreme Environments
=450  \\$wnnna$aEnvironment, Extreme
=450  \\$wnnna$aEnvironments, Extreme
=450  \\$wnnna$aExtreme Environment
=550  \\$wg$aEnvironment
=550  \\$aExtremophiles
=680  \\$iAn ENVIRONMENT which falls outside the range of tolerance for the survival of organisms that are not specifically adapted to survive or thrive in it. Examples of such environments are among the hottest and coldest places on earth.
=688  \\$a2017
=750  \0$aExtreme environments$0(DLC)sh 89006065$5IEN-M

=LDR  00522nz  a2200181n  4500
=001  9880674673902441
=005  20180702113449.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000070337
=035  \\$a(NLM)987390728300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x261.$x506
=150  \\$aExpropriation
=450  \\$wnnna$aExpropriations
=550  \\$wg$aEconomics
=680  \\$iTaking of goods, property, or right of use by GOVERNMENT or others.
=688  \\$a2017
=750  \0$aEminent domain$0(DLC)sh 85042794$5IEN-M

=LDR  00734nz  a2200205n  4500
=001  9880675673702441
=005  20180703112140.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071216
=035  \\$a(NLM)987391217900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x702.$x250.$x736
=150  \\$aFaculty, Pharmacy
=450  \\$wnnna$aPharmacy Faculty
=550  \\$wg$aFaculty
=680  \\$iTeaching and administrative staff having academic rank in a pharmacy school or department.
=688  \\$a2017; was heading 1968-1985, use FACULTY 1986-2016
=750  \0$81$wb$aPharmacy Colleges
=780  \0$81$wb$aFaculty
=788  \0$iSearch also under the following Library of Congress Subject Heading:$aPharmacy Colleges--Faculty

=LDR  01167nz  a2200253n  4500
=001  9880678370102441
=005  20180709152745.0
=008  160705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071562
=035  \\$a(NLM)987391397800041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x404.$x38
=150  \\$aFractures, Avulsion
=450  \\$wnnna$aSprain Fracture
=450  \\$wnnna$aAvulsion Fracture
=450  \\$wnnna$aAvulsion Fractures
=450  \\$wnnna$aFracture, Avulsion
=450  \\$wnnna$aFracture, Sprain
=450  \\$wnnna$aFractures, Sprain
=450  \\$wnnna$aSprain Fractures
=550  \\$wh$aFractures, Bone
=680  \\$iTearing away of the CORTICAL BONE fragment at the location of a strong ligament or tendon attachment. The bone fragment detachment site often occurs near a soft site (e.g., GROWTH PLATE) at the base where LIGAMENTS; TENDONS; or JOINT CAPSULES attach. In younger patients it is most often caused by a sudden forceful pull on a tendon in the opposite direction of the bone movement. In the elderly it is associated with osteoporotic INSUFFICIENCY FRACTURES.
=688  \\$a2017
=750  \0$aAvulsion fractures$0(DLC)sh 89002127$5IEN-M

=LDR  00913nz  a2200205n  4500
=001  9880678372102441
=005  20180709115939.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071235
=035  \\$a(NLM)987391198700041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x698.$x735.$x700.$x813
=072  \\$aD12.$x776.$x395.$x650.$x875.$x625
=072  \\$aD12.$x776.$x860.$x300.$x806.$x813
=150  \\$aFibromodulin
=450  \\$wnnna$aFMOD Protein
=550  \\$wg$aSmall Leucine-Rich Proteoglycans
=680  \\$iA small leucine-rich proteoglycan that contains 4 KERATAN SULFATE chains within the leucine repeat region. It interacts with COLLAGEN TYPE I and COLLAGEN TYPE II fibrils and may function to control the rate of EXTRACELLULAR MATRIX assembly. It also sequesters TRANSFORMING GROWTH FACTOR BETA in the extracellular matrix.
=688  \\$a2017 (1989)
=750  \0$aFibromodulin$0(DLC)sh2016002130$5IEN-M

=LDR  00920nz  a2200229n  4500
=001  9880678373702441
=005  20180709103926.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000071938
=035  \\$a(NLM)987391527200041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x321
=150  \\$aFasciotomy
=450  \\$wnnna$aFasciectomy
=450  \\$aFascia$xsurgery
=550  \\$wg$aSurgical Procedures, Operative
=550  \\$aFascia
=680  \\$iSurgical incision on the FASCIA. It is used to decompress compartment pressure (e.g. in COMPARTMENT SYNDROMES; circumferential burns and extremity injuries) or to release contractures (e.g. in DUPUYTREN'S CONTRACTURE).
=688  \\$a2017
=750  \0$81$wb$aFasciae (Anatomy)$0(DLC)sh 85047352$5IEN-M
=750  \0$81$wb$aSurgery$0(DLC)sh 99005416$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Heading$aFasciae (Anatomy)--Surgery$5IEN-M

=LDR  00600nz  a2200205n  4500
=001  9880678374202441
=005  20180709101154.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000072480
=035  \\$a(NLM)987391818000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x540.$x150
=150  \\$aFarms
=450  \\$wnnna$aVineyards
=450  \\$wnnna$aFarm
=450  \\$wnnna$aVineyard
=550  \\$wg$aManufacturing and Industrial Facilities
=680  \\$iAreas of land set aside to grow crops or raise LIVESTOCK.
=688  \\$a2017; use AGRICULTURE 2016
=750  \0$aFarms$0(DLC)sh 85047299$5IEN-M

=LDR  01678cz  a2200349n  4500
=001  9880364135102441
=005  20141212211302.0
=008  890719\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015914
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x452.$x150
=150  \\$aEstrogen Replacement Therapy
=450  \\$wnnna$aEstrogen Progestin Combination Therapy
=450  \\$wnnna$aEstrogen Progestin Replacement Therapy
=450  \\$wnnna$aEstrogen Replacement
=450  \\$wnnna$aEstrogen Replacement Therapies
=450  \\$wnnna$aEstrogen Replacements
=450  \\$aHormone Replacement Therapy, Post-Menopausal
=450  \\$wnnna$aHormone Replacement Therapy, Post Menopausal
=450  \\$aPostmenopausal Hormone Replacement Therapy
=450  \\$wnnna$aReplacement, Estrogen
=450  \\$wnnna$aReplacement Therapies, Estrogen
=450  \\$aReplacement Therapy, Estrogen
=450  \\$wnnna$aReplacements, Estrogen
=450  \\$wnnna$aTherapies, Estrogen Replacement
=450  \\$wnnna$aTherapy, Estrogen Replacement
=550  \\$wg$aHormone Replacement Therapy
=550  \\$aMenopause
=667  \\$acoord IM with specific estrogen (IM or NIM) and also specific progestational agent (IM or NIM) if pertinent; check tag FEMALE; DF: ESTROGEN REPLACE
=680  \\$iThe use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
=688  \\$a90
=750  \0$aEstrogen$xTherapeutic use$5IEN$0(DLC)sh 85045015

=LDR  00845cz  a2200217n  4500
=001  9880364135202441
=005  20141212211301.0
=008  891003\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015913
=035  \\$aCBD0882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x155
=150  \\$aChelation Therapy
=450  \\$wnnna$aChelation Therapies
=450  \\$wnnna$aTherapies, Chelation
=450  \\$wnnna$aTherapy, Chelation
=550  \\$wg$aDrug Therapy
=667  \\$acoord IM with specific chelating agent /ther use (IM) + metal being chelated with no qualif
=680  \\$iTherapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.
=688  \\$a90
=750  \0$aChelation therapy$5IEN$0(DLC)sh 85022868

=LDR  01239cz  a2200349n  4500
=001  9880364135302441
=005  20141212211301.0
=008  890906\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015912
=035  \\$aCBD0881HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x913
=150  \\$aThrombolytic Therapy
=450  \\$wnnna$aFibrinolytic Therapies
=450  \\$aFibrinolytic Therapy
=450  \\$wnnna$aTherapeutic Thrombolyses
=450  \\$wnnna$aTherapeutic Thrombolysis
=450  \\$wnnna$aTherapies, Fibrinolytic
=450  \\$wnnna$aTherapies, Thrombolytic
=450  \\$wnnna$aTherapy, Fibrinolytic
=450  \\$wnnna$aTherapy, Thrombolytic
=450  \\$wnnna$aThrombolyses, Therapeutic
=450  \\$aThrombolysis, Therapeutic
=450  \\$wnnna$aThrombolytic Therapies
=550  \\$wg$aDrug Therapy
=550  \\$wh$aHirudin Therapy
=550  \\$aMechanical Thrombolysis
=550  \\$aThrombectomy
=667  \\$acoordinate IM with specific thrombolytic agents /ther use (IM) if specified + disease /drug ther (IM)
=680  \\$iUse of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
=688  \\$a90
=750  \0$aThrombolytic therapy$5IEN$0(DLC)sh 91000682

=LDR  00807cz  a2200217n  4500
=001  9880364135402441
=005  20141212211300.0
=008  890516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015911
=035  \\$aCBD0880HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x805
=150  \\$aSclerotherapy
=450  \\$wnnna$aSclerotherapies
=550  \\$wg$aDrug Therapy
=550  \\$aSclerosing Solutions
=550  \\$aVaricose Veins
=667  \\$acoord IM with dis /ther (IM), not /drug ther
=680  \\$iTreatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels.
=688  \\$a90
=750  \0$aSclerotherapy$5IEN$0(DLC)sh 85066447

=LDR  01090cz  a2200241n  4500
=001  9880364135502441
=005  20141212211300.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015908
=035  \\$aCBD0879M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x50.$x215
=150  \\$aCounterpulsation
=450  \\$wnnna$aCounterpulsation, Diastolic
=450  \\$aCounterpulsation, External
=450  \\$aDiastolic Counterpulsation
=450  \\$wnnna$aExternal Counterpulsation
=550  \\$wg$aAssisted Circulation
=550  \\$wh$aIntra-Aortic Balloon Pumping
=667  \\$aa type of assisted circulation; do not use /util except by MeSH definition
=680  \\$iA technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.
=688  \\$a90
=750  \0$aEnhanced external counterpulsation$0(DLC) sh2005003559$5IEN-M

=LDR  01689cz  a2200481n  4500
=001  9880364135602441
=005  20141212192649.0
=008  891004\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015907
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x378.$x330
=072  \\$aE1.$x370.$x388.$x250.$x360
=072  \\$aE4.$x502.$x250.$x360
=072  \\$aE4.$x520.$x360
=072  \\$aE4.$x950.$x300.$x539
=150  \\$aHysteroscopy
=450  \\$wnnna$aEndoscopies, Uterine
=450  \\$aEndoscopy, Uterine
=450  \\$wnnna$aHysteroscopic Surgeries
=450  \\$wnnna$aHysteroscopic Surgery
=450  \\$wnnna$aHysteroscopic Surgical Procedure
=450  \\$aHysteroscopic Surgical Procedures
=450  \\$wnnna$aHysteroscopies
=450  \\$wnnna$aProcedure, Hysteroscopic Surgical
=450  \\$wnnna$aProcedures, Hysteroscopic Surgical
=450  \\$wnnna$aSurgeries, Hysteroscopic
=450  \\$wnnna$aSurgery, Hysteroscopic
=450  \\$wnnna$aSurgical Procedure, Hysteroscopic
=450  \\$aSurgical Procedures, Hysteroscopic
=450  \\$wnnna$aUterine Endoscopies
=450  \\$aUterine Endoscopy
=450  \\$wnnna$aUteroscopies
=450  \\$wnnna$aUteroscopy
=550  \\$wg$aDiagnostic Techniques, Obstetrical and Gynecological
=550  \\$wg$aEndoscopy
=550  \\$wg$aGynecologic Surgical Procedures
=550  \\$wg$aObstetric Surgical Procedures
=550  \\$aHysteroscopes
=550  \\$aUterus
=667  \\$a/ instrum permitted but consider also HYSTEROSCOPES
=680  \\$iEndoscopic examination, therapy or surgery of the interior of the uterus.
=688  \\$a90; was see ENDOSCOPY 1979-89
=750  \0$aHysteroscopy$5IEN$0(DLC)sh 85063859

=LDR  01140cz  a2200313n  4500
=001  9880364135702441
=005  20141212192648.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015903
=035  \\$aCBD0874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600.$x630.$x500
=072  \\$aE5.$x490.$x815
=150  \\$aMoire Topography
=450  \\$wnnna$aMoire Pattern
=450  \\$wnnna$aMoire Patterns
=450  \\$wnnna$aMoire Photograph
=450  \\$wnnna$aMoire Photographs
=450  \\$wnnna$aPattern, Moire
=450  \\$wnnna$aPatterns, Moire
=450  \\$wnnna$aPhotograph, Moire
=450  \\$wnnna$aPhotographs, Moire
=450  \\$aTopography, Moire
=550  \\$wg$aInterferometry
=550  \\$wg$aPhotogrammetry
=667  \\$ain titles & translations spell moiré; DF: MOIRE TOPOGR
=680  \\$iA method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources.
=688  \\$a90
=750  \0$aMoir�e topography$5IEN$0(DLC)sh 90003252

=LDR  01286cz  a2200385n  4500
=001  9880364135802441
=005  20141212211259.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015902
=035  \\$aCBD0873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x420
=150  \\$aGamma Cameras
=450  \\$wnnna$aCamera, Gamma
=450  \\$wnnna$aCamera, Nuclear
=450  \\$wnnna$aCamera, Scintillation
=450  \\$wnnna$aCameras, Gamma
=450  \\$wnnna$aCameras, Nuclear
=450  \\$wnnna$aCameras, Scintillation
=450  \\$wnnna$aGamma Camera
=450  \\$wnnna$aNuclear Camera
=450  \\$wnnna$aNuclear Cameras
=450  \\$wnnna$aScinti-Camera
=450  \\$wnnna$aScinti-Cameras
=450  \\$wnnna$aScinti Cameras
=450  \\$wnnna$aScintillation Camera
=450  \\$aScintillation Cameras
=550  \\$wg$aEquipment and Supplies
=550  \\$aRadionuclide Imaging
=550  \\$aScintillation Counting
=550  \\$aTomography, Emission-Computed
=667  \\$ado not use /util except by MeSH definition
=680  \\$iElectronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers.
=688  \\$a90
=750  \0$aScintillation cameras$5IEN$0(DLC)sh 85118710

=LDR  01506cz  a2200277n  4500
=001  9880364135902441
=005  20141212211258.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015901
=035  \\$aCBD0872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600.$x350.$x700.$x60
=072  \\$aE1.$x370.$x350.$x700.$x60.$x60
=072  \\$aE1.$x370.$x350.$x700.$x700.$x60
=072  \\$aE1.$x370.$x350.$x760.$x60
=072  \\$aE1.$x370.$x370.$x50.$x60
=150  \\$aAngiography, Digital Subtraction
=450  \\$aDigital Subtraction Angiography
=450  \\$aSubtraction Angiography, Digital
=550  \\$wg$aAngiography
=550  \\$wg$aRadiographic Image Enhancement
=550  \\$wg$aSubtraction Technique
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: DS ANGIOGR
=680  \\$iA method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues.
=688  \\$a90
=750  \0$aDigital subtraction angiography$5IEN$0(DLC)sh 88004988

=LDR  02924cz  a2200469n  4500
=001  9880364136002441
=005  20181220102314.0
=008  890516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015899
=035  \\$aCBD0870M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x350.$x800.$x800
=072  \\$aE1.$x370.$x350.$x600.$x350.$x800.$x800
=072  \\$aE1.$x370.$x350.$x710.$x800.$x800
=072  \\$aE1.$x370.$x350.$x825.$x800.$x800
=072  \\$aE1.$x370.$x384.$x730.$x800.$x800
=150  \\$aTomography, Emission-Computed, Single-Photon
=450  \\$aCAT Scan, Single-Photon Emission
=450  \\$wnnna$aCAT Scan, Single Photon Emission
=450  \\$aCT Scan, Single-Photon Emission
=450  \\$wnnna$aCT Scan, Single Photon Emission
=450  \\$wnnna$aEmission-Computed Tomography, Single-Photon
=450  \\$aRadionuclide Tomography, Single-Photon Emission-Computed
=450  \\$wnnna$aRadionuclide Tomography, Single Photon Emission Computed
=450  \\$aSingle-Photon Emission-Computed Tomography
=450  \\$wnnna$aSingle Photon Emission Computed Tomography
=450  \\$wnnna$aSingle-Photon Emission Computer-Assisted Tomography
=450  \\$wnnna$aSingle Photon Emission Computer Assisted Tomography
=450  \\$wnnna$aSingle-Photon Emission Computerized Tomography
=450  \\$wnnna$aSingle Photon Emission Computerized Tomography
=450  \\$wnnna$aSingle-Photon Emission CT Scan
=450  \\$wnnna$aSingle Photon Emission CT Scan
=450  \\$aSPECT
=450  \\$aTomography, Single-Photon, Emission-Computed
=450  \\$wnnna$aTomography, Single-Photon Emission-Computed
=550  \\$wg$aTomography, Emission-Computed
=550  \\$wh$aCardiac-Gated Single-Photon Emission Computer-Assisted Tomography
=550  \\$wh$aSingle Photon Emission Computed Tomography Computed Tomography
=667  \\$aDF: CT SINGLE PHOTON EMISS
=680  \\$iA method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
=688  \\$a90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY & SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989
=750  \0$aSingle-photon emission computed tomography$0(DLC)sh2006001159$5IEN-M

=LDR  01104cz  a2200217n  4500
=001  9880364136102441
=005  20200529150534.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015897
=035  \\$aCBD0868HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x350.$x225
=072  \\$aN6.$x850.$x490.$x687
=150  \\$aComorbidity
=450  \\$wnnna$aComorbidities
=550  \\$wg$aEpidemiologic Factors
=550  \\$wh$aMultimorbidity
=667  \\$a"presence of co-existing or additional diseases" in epidemiol studies: do not confuse with /compl; IM GEN only; coord NIM with both diseases /epidemiol (IM), not /compl; specify geog if pertinent
=680  \\$iThe presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
=688  \\$a90
=750  \0$aComorbidity$5IEN-M$0(DLC)sh 98006573

=LDR  00634cz  a2200193n  4500
=001  9880364136202441
=005  20141212211255.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015894
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x350
=150  \\$aGenome, Human
=450  \\$wnnna$aGenomes, Human
=450  \\$aHuman Genome
=450  \\$wnnna$aHuman Genomes
=550  \\$wg$aGenome
=680  \\$iThe complete genetic complement contained in the DNA of a set of CHROMOSOMES in a HUMAN. The length of the human genome is about 3 billion base pairs.
=688  \\$a90
=750  \0$aHuman genome$5IEN-M$0(DLC)sh 94002900

=LDR  01486cz  a2200445n  4500
=001  9880364136302441
=005  20141212211255.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015891
=035  \\$aCBD0865M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x215
=150  \\$aCystatins
=450  \\$wnnna$aCystatin-Related Proteins
=450  \\$wnnna$aCystatin Related Proteins
=450  \\$aCystatin Superfamily
=450  \\$wnnna$aCystatins, Type 1
=450  \\$wnnna$aCystatins, Type 2
=450  \\$wnnna$aCystatins, Type 3
=450  \\$wnnna$aCystatins, Type I
=450  \\$wnnna$aCystatins, Type II
=450  \\$wnnna$aCystatins, Type III
=450  \\$wnnna$aStefins
=450  \\$wnnna$aType 1 Cystatins
=450  \\$wnnna$aType 2 Cystatins
=450  \\$wnnna$aType 3 Cystatins
=450  \\$wnnna$aType I Cystatins
=450  \\$wnnna$aType II Cystatins
=450  \\$wnnna$aType III Cystatins
=550  \\$wg$aProteins
=550  \\$wh$aCystatin A
=550  \\$wh$aCystatin B
=550  \\$wh$aCystatin C
=550  \\$wh$aCystatin M
=550  \\$wh$aFetuins
=550  \\$wh$aSalivary Cystatins
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA homologous group of endogenous CYSTEINE PROTEINASE INHIBITORS. The cystatins inhibit most CYSTEINE ENDOPEPTIDASES such as PAPAIN, and other peptidases which have a sulfhydryl group at the active site.
=688  \\$a90
=750  \0$aCystatins$0(DLC)sh2007008381$5IEN-M

=LDR  01064cz  a2200313n  4500
=001  9880364136402441
=005  20141212211252.0
=008  890516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015871
=035  \\$aCBD0853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x768.$x500
=150  \\$aScientific Misconduct
=450  \\$wnnna$aData, Fraudulent
=450  \\$aEthics in Publishing
=450  \\$aFraud, Scientific
=450  \\$wnnna$aFrauds, Scientific
=450  \\$aFraudulent Data
=450  \\$wnnna$aMisconduct, Research
=450  \\$wnnna$aMisconduct, Scientific
=450  \\$wnnna$aPublishing, Ethics in
=450  \\$aResearch Misconduct
=450  \\$wnnna$aScientific Fraud
=450  \\$wnnna$aScientific Frauds
=550  \\$wg$aProfessional Misconduct
=667  \\$aPROFESSIONAL MISCONDUCT is also available
=680  \\$iIntentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.
=688  \\$a90
=750  \0$aFraud in science$5IEN$0(DLC)sh 85051625

=LDR  00844cz  a2200241n  4500
=001  9880364136502441
=005  20180103094408.0
=008  891016\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015870
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x355.$x310
=150  \\$aGene Expression
=450  \\$wnnna$aExpression, Gene
=450  \\$wnnna$aExpressions, Gene
=450  \\$wnnna$aGene Expressions
=450  \\$wnnoa$aPolarity of Translation$5IEN-M
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aProtein Biosynthesis
=550  \\$wh$aTranscription, Genetic
=550  \\$aGene Expression Profiling
=680  \\$iThe phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
=688  \\$a90; MYELOID ANTIGEN EXPRESSION was heading 1994
=750  \0$aGene expression$5IEN$0(DLC)sh 85053734

=LDR  00842cz  a2200229n  4500
=001  9880364136602441
=005  20141212211251.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015868
=035  \\$aCBD0851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x160.$x478.$x700
=072  \\$aC11.$x941.$x879.$x780.$x900.$x300.$x659
=072  \\$aC11.$x941.$x879.$x900.$x500
=150  \\$aPars Planitis
=450  \\$wnnna$aPlanitis, Pars
=550  \\$wg$aChoroiditis
=550  \\$wg$aUveitis, Intermediate
=667  \\$aa type of uveitis
=680  \\$iForm of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.
=688  \\$a90
=750  \0$aPars planitis$5IEN$0(DLC)sh 85098305

=LDR  00939cz  a2200205n  4500
=001  9880364136702441
=005  20141212211250.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015866
=035  \\$aCBD0849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x879.$x780.$x900
=150  \\$aUveitis, Posterior
=450  \\$wnnna$aPosterior Uveitis
=550  \\$wg$aPanuveitis
=550  \\$wh$aChoroiditis
=667  \\$ainflammation of the choroid, retina & vitreous body; of choroid alone = CHOROIDITIS; of choroid + retina = CHORIORETINITIS; of vitreous body alone = VITREOUS BODY (IM) + EYE DISEASES (NIM)
=680  \\$iInflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.
=688  \\$a90
=750  \0$aPosterior uveitis$5IEN-M$0(DLC)sh 94006540

=LDR  01162cz  a2200373n  4500
=001  9880364136802441
=005  20141212211250.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015865
=035  \\$aCBD0848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x600
=150  \\$aRacquet Sports
=450  \\$aBadminton
=450  \\$wnnna$aBall, Racket
=450  \\$aLacrosse
=450  \\$wnnna$aRacket Ball
=450  \\$aRacket Games$5IEN
=450  \\$wnnna$aRacket Sport
=450  \\$wnnna$aRacket Sports
=450  \\$wnnna$aRacketball
=450  \\$wnnna$aRacquet Sport
=450  \\$aRacquetball
=450  \\$wnnna$aSport, Racket
=450  \\$wnnna$aSport, Racquet
=450  \\$wnnna$aSports, Racket
=450  \\$wnnna$aSports, Racquet
=450  \\$wnnna$aSquash (Sport)
=550  \\$wg$aSports
=550  \\$wh$aTennis
=667  \\$a/inj: coord IM with specific injury (IM); Manual 30.15.1; do not confuse X ref SQUASH (SPORT) with SQUASH PLANT see CUCURBITA
=680  \\$iGames in which players use a racquet to hit a ball or similar type object.
=688  \\$a90
=750  \0$aRacket games$5IEN$0(DLC)sh 85110277

=LDR  01073cz  a2200265n  4500
=001  9880364136902441
=005  20141212211249.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015863
=035  \\$aCBD0846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x941.$x375.$x360
=072  \\$aC11.$x941.$x879.$x780.$x880.$x400
=150  \\$aIridocyclitis
=450  \\$wnnna$aCyclitides, Heterochromic
=450  \\$aCyclitis, Heterochromic
=450  \\$wnnna$aHeterochromic Cyclitides
=450  \\$aHeterochromic Cyclitis
=450  \\$wnnna$aIridocyclitides
=550  \\$wg$aIris Diseases
=550  \\$wg$aUveitis, Anterior
=667  \\$aa type of anterior uveitis
=680  \\$iAcute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.
=688  \\$a90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85
=750  \0$aIridocyclitis$5IEN$0(DLC)sh 85068073

=LDR  00513cz  a2200169n  4500
=001  9880364137002441
=005  20141212211249.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015858
=035  \\$aCBD0843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744.$x126
=150  \\$aAnisometropia
=550  \\$wg$aRefractive Errors
=680  \\$iA condition of an inequality of refractive power of the two eyes.
=688  \\$a90; was see REFRACTIVE ERRORS 1984-89
=750  \0$aAnisometropia$5IEN$0(DLC)sh 85005302

=LDR  01640cz  a2200397n  4500
=001  9880364137102441
=005  20141212211248.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015853
=035  \\$aCBD0841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x325
=150  \\$aCysteine Proteinase Inhibitors
=450  \\$wnnna$aAcid Cysteine Proteinase Inhibitors
=450  \\$wnnna$aalpha-Cysteine Protease Inhibitors
=450  \\$wnnna$aalpha Cysteine Protease Inhibitors
=450  \\$wnnna$aAntagonists, Cysteine Proteinase
=450  \\$aCysteine Endopeptidases$xantagonists & inhibitors
=450  \\$aCysteine Protease Inhibitors
=450  \\$aCysteine Proteases$xantagonists & inhibitors
=450  \\$aCysteine Proteinase Antagonists
=450  \\$aCysteine Proteinase Inhibitors, Endogenous
=450  \\$aCysteine Proteinase Inhibitors, Exogenous
=450  \\$wnnna$aInhibitors, alpha-Cysteine Protease
=450  \\$wnnna$aInhibitors, Cysteine Protease
=450  \\$wnnna$aInhibitors, Cysteine Proteinase
=450  \\$wnnna$aProtease Inhibitors, alpha-Cysteine
=450  \\$wnnna$aProtease Inhibitors, Cysteine
=450  \\$wnnna$aProteinase Antagonists, Cysteine
=450  \\$wnnna$aProteinase Inhibitors, Cysteine
=550  \\$wg$aProtease Inhibitors
=550  \\$wh$aCaspase Inhibitors
=667  \\$a/biosyn /physiol permitted only with endogenous proteinase inhib; DF: CYSTEINE PROTEINASE INHIB
=680  \\$iExogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.
=688  \\$a90
=750  \0$aCysteine proteinases$xInhibitors$5IEN$0(DLC)sh2007008470

=LDR  02036cz  a2200529n  4500
=001  9880364137202441
=005  20141212211247.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015850
=035  \\$aCBD0838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x506
=072  \\$aD12.$x776.$x467.$x374.$x465.$x506
=072  \\$aD23.$x529.$x374.$x465.$x506
=150  \\$aInterleukin-6
=450  \\$wnnna$aB-Cell Differentiation Factor
=450  \\$wnnna$aB Cell Differentiation Factor
=450  \\$wnnna$aB-Cell Differentiation Factor-2
=450  \\$wnnna$aB Cell Differentiation Factor 2
=450  \\$wnnna$aB Cell Stimulatory Factor-2
=450  \\$wnnna$aB-Cell Stimulatory Factor 2
=450  \\$wnnna$aB-Cell Stimulatory Factor-2
=450  \\$wnnna$aB Cell Stimulatory Factor 2
=450  \\$wnnna$aBSF-2
=450  \\$wnnna$aDifferentiation Factor-2, B-Cell
=450  \\$wnnna$aDifferentiation Factor 2, B Cell
=450  \\$wnnna$aDifferentiation Factor, B-Cell
=450  \\$wnnna$aDifferentiation Factor, B Cell
=450  \\$wnnna$aDifferentiation-Inducing Protein, Myeloid
=450  \\$wnnna$aGrowth Factor, Hybridoma
=450  \\$wnnna$aGrowth Factor, Plasmacytoma
=450  \\$aHepatocyte-Stimulating Factor
=450  \\$wnnna$aHepatocyte Stimulating Factor
=450  \\$aHybridoma Growth Factor
=450  \\$wnnna$aIFN-beta 2
=450  \\$aIL-6
=450  \\$wnnna$aIL6
=450  \\$wnnna$aInterleukin 6
=450  \\$aMGI-2
=450  \\$aMyeloid Differentiation-Inducing Protein
=450  \\$wnnna$aMyeloid Differentiation Inducing Protein
=450  \\$aPlasmacytoma Growth Factor
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 6 or IL6
=680  \\$iA cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS.
=688  \\$a90
=750  \0$aInterleukin-6$5IEN$0(DLC)sh 92001229

=LDR  01415cz  a2200361n  4500
=001  9880364137302441
=005  20141212211246.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015849
=035  \\$aCBD0837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x822.$x750.$x695
=072  \\$aD12.$x644.$x861.$x695
=072  \\$aD12.$x776.$x645.$x750.$x695
=072  \\$aD12.$x776.$x872.$x695
=072  \\$aD23.$x119.$x832
=150  \\$aPlasminogen Inactivators
=450  \\$wnnna$aEndothelial Plasminogen Activator Inhibitors
=450  \\$wnnna$aInactivators, Plasminogen
=450  \\$wnnna$aInhibitors, Plasminogen Activator
=450  \\$wnnna$aPlacental Plasminogen Activator Inhibitors
=450  \\$aPlasminogen Activator Inhibitors
=450  \\$wnnna$aPlasminogen Activator Inhibitors, Endothelial
=450  \\$wnnna$aPlasminogen Activator Inhibitors, Placental
=550  \\$wg$aBlood Coagulation Factors
=550  \\$wg$aSerpins
=550  \\$wh$aPlasminogen Activator Inhibitor 1
=550  \\$wh$aPlasminogen Activator Inhibitor 2
=550  \\$wh$aProtein C Inhibitor
=550  \\$wh$aSerpin E2
=680  \\$iImportant modulators of the activity of plasminogen activators. The inhibitors belong to the serpin family of proteins and inhibit both the tissue-type and urokinase-type plasminogen activators.
=688  \\$a90
=750  \0$aPlasminogen activators$xInhibitors$5IEN-M

=LDR  01206cz  a2200349n  4500
=001  9880364137402441
=005  20141212211245.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015848
=035  \\$aCBD0836HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x505
=072  \\$aD12.$x776.$x467.$x374.$x465.$x505
=072  \\$aD23.$x529.$x374.$x465.$x505
=150  \\$aInterleukin-5
=450  \\$aB-Cell Growth Factor-II
=450  \\$wnnna$aB Cell Growth Factor II
=450  \\$wnnna$aBCGF-II
=450  \\$wnnna$aDifferentiation Factor, Eosinophil
=450  \\$aEosinophil Differentiation Factor
=450  \\$aIL-5
=450  \\$wnnna$aIL5
=450  \\$wnnna$aInterleukin 5
=450  \\$wnnna$aReplacing Factor, T-Cell
=450  \\$wnnna$aT-Cell-Replacing Factor
=450  \\$aT-Cell Replacing Factor
=450  \\$wnnna$aT Cell Replacing Factor
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 5 or IL5
=680  \\$iA cytokine that promotes differentiation and activation of EOSINOPHILS. It also triggers activated B-LYMPHOCYTES to differentiate into IMMUNOGLOBULIN-secreting cells.
=688  \\$a90
=750  \0$aInterleukin-5$0(DLC) sh 95001692$5IEN-M

=LDR  01736cz  a2200457n  4500
=001  9880364137502441
=005  20141212211245.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015847
=035  \\$aCBD0835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x465.$x504
=072  \\$aD12.$x776.$x467.$x374.$x465.$x504
=072  \\$aD23.$x529.$x374.$x465.$x504
=150  \\$aInterleukin-4
=450  \\$wnnna$aB-Cell Growth Factor-1
=450  \\$wnnna$aB Cell Growth Factor 1
=450  \\$aB-Cell Growth Factor-I
=450  \\$wnnna$aB Cell Growth Factor I
=450  \\$wnnna$aB-Cell Proliferating Factor
=450  \\$wnnna$aB Cell Proliferating Factor
=450  \\$wnnna$aB-Cell Stimulating Factor-1
=450  \\$wnnna$aB Cell Stimulating Factor 1
=450  \\$wnnna$aB Cell Stimulatory Factor-1
=450  \\$wnnna$aB-Cell Stimulatory Factor 1
=450  \\$aB-Cell Stimulatory Factor-1
=450  \\$wnnna$aB Cell Stimulatory Factor 1
=450  \\$wnnna$aBCGF-1
=450  \\$aBinetrakin
=450  \\$wnnna$aBSF-1
=450  \\$aIL-4
=450  \\$wnnna$aIL4
=450  \\$wnnna$aInterleukin 4
=450  \\$aMast Cell Growth Factor-2
=450  \\$wnnna$aMast Cell Growth Factor 2
=450  \\$wnnna$aMCGF-2
=550  \\$wg$aInterleukins
=667  \\$aDF: IL 4 or IL4
=680  \\$iA soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells.
=688  \\$a90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96
=750  \0$aInterleukin-4$5IEN$0(DLC)sh 91004837

=LDR  00799cz  a2200229n  4500
=001  9880364137602441
=005  20141212211245.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015846
=035  \\$aCBD0834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x500
=072  \\$aD12.$x776.$x467.$x374.$x500
=072  \\$aD23.$x529.$x374.$x500
=150  \\$aMonokines
=550  \\$wg$aCytokines
=550  \\$wh$aInterleukin-1
=550  \\$wh$aTumor Necrosis Factor-alpha
=667  \\$a/biosyn /drug eff /physiol /ultrastruct permitted
=680  \\$iSoluble mediators of the immune response that are neither antibodies nor complement. They are produced largely, but not exclusively, by monocytes and macrophages.
=688  \\$a90
=750  \0$aMonokines$5IEN$0(DLC)sh 87001114

=LDR  01925cz  a2200421n  4500
=001  9880364137702441
=005  20141212211243.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015843
=035  \\$aCBD0831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x822.$x750
=072  \\$aD12.$x644.$x861
=072  \\$aD12.$x776.$x645.$x750
=072  \\$aD12.$x776.$x872
=150  \\$aSerpins
=450  \\$aSerpin Superfamily
=450  \\$wnnna$aSuperfamily, Serpin
=550  \\$wg$aPeptides
=550  \\$wg$aProteinase Inhibitory Proteins, Secretory
=550  \\$wg$aProteins
=550  \\$wh$aalpha 1-Antichymotrypsin
=550  \\$wh$aalpha 1-Antitrypsin
=550  \\$wh$aalpha-2-Antiplasmin
=550  \\$wh$aAngiotensinogen
=550  \\$wh$aAntithrombin Proteins
=550  \\$wh$aComplement C1 Inactivator Proteins
=550  \\$wh$aHSP47 Heat-Shock Proteins
=550  \\$wh$aOvalbumin
=550  \\$wh$aPlasminogen Inactivators
=550  \\$wh$aThyroxine-Binding Globulin
=550  \\$wh$aTranscortin
=550  \\$aBlood Proteins
=550  \\$aSerine Proteinase Inhibitors
=667  \\$a"a family of SERine Proteinase INhibitors", thus the source of the name
=680  \\$iA family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.
=688  \\$a90
=750  \0$aSerpins$5IEN$0(DLC)sh 90002324

=LDR  01144cz  a2200313n  4500
=001  9880364137802441
=005  20141212211243.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015842
=035  \\$aCBD0830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x800
=150  \\$aSerine Proteinase Inhibitors
=450  \\$aSerine Endopeptidase Inhibitors
=450  \\$aSerine Endopeptidases$xantagonists & inhibitors
=450  \\$aSerine Protease Inhibitors
=450  \\$wnnna$aSerine Protease Inhibitors, Endogenous
=450  \\$wnnna$aSerine Protease Inhibitors, Exogenous
=450  \\$aSerine Proteases$xantagonists & inhibitors
=450  \\$aSerine Proteinase Antagonists
=450  \\$aSerine Proteinase Inhibitors, Endogenous
=450  \\$aSerine Proteinase Inhibitors, Exogenous
=550  \\$wg$aProtease Inhibitors
=550  \\$wh$aAntithrombins
=550  \\$wh$aTrypsin Inhibitors
=667  \\$aDF: SERINE PROTEINASE INHIB
=680  \\$iExogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES.
=688  \\$a90
=750  \0$aSerine Proteinases$xInhibitors$5IEN$0(DLC)sh 90002322

=LDR  00823cz  a2200229n  4500
=001  9880364137902441
=005  20180314111710.0
=008  890516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015837
=035  \\$aCBD0826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x568.$x900
=150  \\$aVestibular Diseases
=450  \\$wnnna$aDisease, Vestibular
=450  \\$wnnna$aDiseases, Vestibular
=450  \\$wnnna$aVestibular Disease
=550  \\$wg$aLabyrinth Diseases
=550  \\$wh$aBilateral Vestibulopathy
=550  \\$wh$aVertigo
=680  \\$iPathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
=688  \\$a90
=750  \0$aVestibular apparatus$xDiseases$5IEN$0(DLC)sh 85142953

=LDR  04238cz  a2200949n  4500
=001  9880364138002441
=005  20141212211240.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015835
=035  \\$aCBD0825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x758
=072  \\$aC10.$x292.$x562
=072  \\$aC11.$x590
=150  \\$aOcular Motility Disorders
=450  \\$aBrown Tendon Sheath Syndrome
=450  \\$wnnna$aBrown's Tendon Sheath Syndrome
=450  \\$wnnna$aConjugate Gaze Spasm
=450  \\$wnnna$aConjugate Gaze Spasms
=450  \\$wnnna$aConvergence Excess
=450  \\$wnnna$aConvergence Excesses
=450  \\$wnnna$aConvergence Insufficiencies
=450  \\$aConvergence Insufficiency
=450  \\$wnnna$aCyclophoria
=450  \\$wnnna$aCyclophorias
=450  \\$wnnna$aDeficiencies, Smooth Pursuit
=450  \\$wnnna$aDeficiency, Smooth Pursuit
=450  \\$wnnna$aDeviation, Skew
=450  \\$wnnna$aDeviations, Skew
=450  \\$wnnna$aDyskinesia, Paroxysmal Ocular
=450  \\$wnnna$aDyskinesias, Paroxysmal Ocular
=450  \\$wnnna$aExcess, Convergence
=450  \\$wnnna$aEye Motility Disorder
=450  \\$wnnna$aEye Motility Disorders
=450  \\$wnnna$aEye Movement Disorder
=450  \\$aEye Movement Disorders
=450  \\$wnnna$aGaze Spasms, Conjugate
=450  \\$wnnna$aInsufficiencies, Convergence
=450  \\$wnnna$aInsufficiency, Convergence
=450  \\$aInternuclear Ophthalmoplegia
=450  \\$wnnna$aInternuclear Ophthalmoplegias
=450  \\$wnnna$aOcular Dyskinesia, Paroxysmal
=450  \\$wnnna$aOcular Dyskinesias, Paroxysmal
=450  \\$wnnna$aOcular Motility Disorder
=450  \\$aOcular Torticollis
=450  \\$wnnna$aOphthalmoplegia, Internuclear
=450  \\$wnnna$aOphthalmoplegias, Internuclear
=450  \\$aOpsoclonus
=450  \\$aParinaud Syndrome
=450  \\$wnnna$aParinaud's Syndrome
=450  \\$wnnna$aParinauds Syndrome
=450  \\$wnnna$aParoxysmal Ocular Dyskinesia
=450  \\$wnnna$aParoxysmal Ocular Dyskinesias
=450  \\$wnnna$aPseudoophthalmoplegia
=450  \\$wnnna$aPseudoophthalmoplegias
=450  \\$wnnna$aPursuit Deficiencies, Smooth
=450  \\$wnnna$aPursuit Deficiency, Smooth
=450  \\$aSkew Deviation
=450  \\$wnnna$aSkew Deviations
=450  \\$wnnna$aSmooth Pursuit Deficiencies
=450  \\$aSmooth Pursuit Deficiency
=450  \\$wnnna$aSpasm of Conjugate Gaze
=450  \\$wnnna$aSyndrome, Brown's Tendon Sheath
=450  \\$wnnna$aSyndrome, Parinaud
=450  \\$wnnna$aSyndrome, Parinaud's
=450  \\$wnnna$aTendon Sheath Syndrome of Brown
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wg$aCranial Nerve Diseases
=550  \\$wg$aEye Diseases
=550  \\$wh$aDuane Retraction Syndrome
=550  \\$wh$aMiller Fisher Syndrome
=550  \\$wh$aNystagmus, Pathologic
=550  \\$wh$aOculomotor Nerve Diseases
=550  \\$wh$aOphthalmoplegia
=550  \\$wh$aOphthalmoplegia, Chronic Progressive External
=550  \\$wh$aOpsoclonus-Myoclonus Syndrome
=550  \\$wh$aStrabismus
=550  \\$wh$aTolosa-Hunt Syndrome
=667  \\$aGEN: prefer specifics
=680  \\$iDisorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240)
=688  \\$a1990
=750  \0$aEye$xMovement disorders$5IEN$0(DLC)sh 85046665

=LDR  00693cz  a2200205n  4500
=001  9880364138102441
=005  20141212211239.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015834
=035  \\$aCBD0824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x568.$x120
=150  \\$aCochlear Diseases
=450  \\$wnnna$aCochlear Disease
=450  \\$wnnna$aDisease, Cochlear
=450  \\$wnnna$aDiseases, Cochlear
=550  \\$wg$aLabyrinth Diseases
=680  \\$iPathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).
=688  \\$a90
=750  \0$aCochlea$xDiseases$5IEN

=LDR  01621cz  a2200349n  4500
=001  9880364138202441
=005  20141212211238.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015831
=035  \\$aCBD0823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x450.$x565.$x575.$x610
=072  \\$aC5.$x116.$x99.$x708.$x670
=150  \\$aOsteochondroma
=450  \\$wnnna$aCartilaginous Exostoses
=450  \\$wnnna$aCartilaginous Exostosis
=450  \\$aChondrosteoma
=450  \\$wnnna$aChondrosteomas
=450  \\$wnnna$aExostoses, Cartilaginous
=450  \\$wnnna$aExostoses, Osteocartilaginous
=450  \\$aExostosis, Cartilaginous
=450  \\$aExostosis, Osteocartilaginous
=450  \\$wnnna$aOsteocartilaginous Exostoses
=450  \\$wnnna$aOsteocartilaginous Exostosis
=450  \\$wnnna$aOsteochondromas
=550  \\$wg$aNeoplasms, Bone Tissue
=550  \\$wg$aOsteochondrodysplasias
=550  \\$wh$aOsteochondromatosis
=667  \\$asolitary; note OSTEOCHONDROMAS, MULTIPLE see EXOSTOSES, MULTIPLE HEREDITARY; /blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS (IM) or specific precoord bone/neopl term (IM) or specific bone (IM) + BONE NEOPLASMS (IM)
=680  \\$iA cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors.
=688  \\$a90
=750  \0$aOsteochondroma$5IEN$0(DLC)sh 85095962

=LDR  00995cz  a2200289n  4500
=001  9880364138302441
=005  20141212211235.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015823
=035  \\$aCBD0816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x300.$x125
=072  \\$aC3.$x752.$x49.$x203
=072  \\$aC11.$x204.$x564.$x112
=072  \\$aC11.$x294.$x725.$x125
=150  \\$aAcanthamoeba Keratitis
=450  \\$wnnna$aAcanthamoeba Keratitides
=450  \\$wnnna$aKeratitides, Acanthamoeba
=450  \\$aKeratitis, Acanthamoeba
=550  \\$wg$aAmebiasis
=550  \\$wg$aEye Infections, Parasitic
=550  \\$wg$aKeratitis
=667  \\$anote category: a corneal dis: do not confuse with KERATOACANTHOMA, a skin dis
=680  \\$iInfection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness.
=688  \\$a90
=750  \0$81$wb$aKeratitis$5IEN$0(DLC)sh 85072035
=750  \0$81$wb$aAcanthamoeba$5IEN-HS$0(DLC)sh 88021265

=LDR  02088cz  a2200529n  4500
=001  9880364138402441
=005  20141212211234.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015820
=035  \\$aCBD0813M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x200.$x200
=072  \\$aD12.$x776.$x543.$x550.$x200.$x200
=072  \\$aD23.$x50.$x301.$x350.$x200
=150  \\$aCadherins
=450  \\$wnnna$aCadherin-1
=450  \\$wnnna$aCadherin 1
=450  \\$wnnna$aCadherin-2
=450  \\$wnnna$aCadherin 2
=450  \\$wnnna$aCadherin-3
=450  \\$wnnna$aCadherin 3
=450  \\$wnnna$aCadherins, Neural
=450  \\$wnnna$aCadherins, Placental
=450  \\$wnnna$aE-Cadherin
=450  \\$wnnna$aE Cadherin
=450  \\$aE-Cadherins
=450  \\$wnnna$aE Cadherins
=450  \\$wnnna$aEpithelial-Cadherins
=450  \\$wnnna$aEpithelial Cadherins
=450  \\$wnnna$aLiver Cell Adhesion Molecule
=450  \\$aLiver Cell Adhesion Molecules
=450  \\$wnnna$aN-Cadherin
=450  \\$wnnna$aN Cadherin
=450  \\$aN-Cadherins
=450  \\$wnnna$aN Cadherins
=450  \\$wnnna$aNeural Cadherins
=450  \\$wnnna$aP-Cadherin
=450  \\$wnnna$aP Cadherin
=450  \\$aP-Cadherins
=450  \\$wnnna$aP Cadherins
=450  \\$wnnna$aPlacental Cadherins
=450  \\$aUvomorulin
=550  \\$wg$aCell Adhesion Molecules
=550  \\$wh$aDesmosomal Cadherins
=680  \\$iCalcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body.
=688  \\$a90; N CADHERIN was NM 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95
=750  \0$aCadherins$0(DLC)sh2004014907$5IEN-M

=LDR  00870cz  a2200253n  4500
=001  9880364138502441
=005  20141212211233.0
=008  890620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015819
=035  \\$aCBD0812HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x793
=072  \\$aF3.$x900.$x793
=150  \\$aSubstance Abuse, Intravenous
=450  \\$aDrug Abuse, Intravenous
=450  \\$aDrug Abuse, Parenteral
=450  \\$aIntravenous Drug Abuse
=450  \\$wnnna$aIntravenous Substance Abuse
=450  \\$wnnna$aParenteral Drug Abuse
=550  \\$wg$aSubstance-Related Disorders
=667  \\$aIM + specific drug or substance IM (without qualif); for "abuse, overuse or misuse"; DF: IVDA
=680  \\$iAbuse, overuse, or misuse of a substance by its injection into a vein.
=688  \\$a90
=750  \0$aIntravenous drug abuse$5IEN$0(DLC)sh 90001084

=LDR  01244cz  a2200361n  4500
=001  9880364138602441
=005  20141212211232.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015817
=035  \\$aCBD0810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x375
=072  \\$aC11.$x294
=150  \\$aEye Infections
=450  \\$wnnna$aEye Infection
=450  \\$wnnna$aInfection, Eye
=450  \\$wnnna$aInfection, Ocular
=450  \\$wnnna$aInfections, Eye
=450  \\$wnnna$aInfections, Ocular
=450  \\$wnnna$aOcular Infection
=450  \\$aOcular Infections
=550  \\$wg$aEye Diseases
=550  \\$wg$aInfection
=550  \\$wh$aCorneal Ulcer
=550  \\$wh$aEndophthalmitis
=550  \\$wh$aEye Infections, Bacterial
=550  \\$wh$aEye Infections, Fungal
=550  \\$wh$aEye Infections, Parasitic
=550  \\$wh$aEye Infections, Viral
=667  \\$acoord IM with specific infect dis (IM); DF: EYE INFECT
=680  \\$iInfection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.
=688  \\$a90
=750  \0$aEye$xInfections$5IEN$0(DLC)sh 90004931

=LDR  02288cz  a2200577n  4500
=001  9880364138702441
=005  20200605143732.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015815
=035  \\$aCBD0808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x200
=072  \\$aD12.$x776.$x543.$x550.$x200
=072  \\$aD23.$x50.$x301.$x350
=150  \\$aCell Adhesion Molecules
=450  \\$wnnna$aAdhesion Molecules, Cell
=450  \\$wnnna$aAdhesion Molecules, Intercellular
=450  \\$wnnna$aAdhesion Molecules, Leukocyte
=450  \\$aIntercellular Adhesion Molecules
=450  \\$aLeukocyte Adhesion Molecules
=450  \\$wnnna$aMolecules, Cell Adhesion
=450  \\$wnnna$aMolecules, Intercellular Adhesion
=450  \\$wnnna$aMolecules, Leukocyte Adhesion
=450  \\$wnnna$aSaccharide Mediated Cell Adhesion Molecules
=450  \\$aSaccharide-Mediated Cell Adhesion Molecules
=550  \\$wg$aAntigens, Surface
=550  \\$wg$aMembrane Glycoproteins
=550  \\$wh$aAntigens, CD99
=550  \\$wh$aAntigens, CD146
=550  \\$wh$aAntigens, CD164
=550  \\$wh$aAntigens, CD24
=550  \\$wh$aAntigens, CD31
=550  \\$wh$aCadherin Related Proteins
=550  \\$wh$aCadherins
=550  \\$wh$aCarcinoembryonic Antigen
=550  \\$wh$aCD4 Immunoadhesins
=550  \\$wh$aCell Adhesion Molecules, Neuronal
=550  \\$wh$aEpithelial Cell Adhesion Molecule
=550  \\$wh$aIntegrin alphaXbeta2
=550  \\$wh$aIntercellular Adhesion Molecule-1
=550  \\$wh$aIntercellular Adhesion Molecule-3
=550  \\$wh$aJunctional Adhesion Molecules
=550  \\$wh$aReceptors, Lymphocyte Homing
=550  \\$wh$aSelectins
=550  \\$wh$aSialic Acid Binding Ig-like Lectin 2
=550  \\$wh$aVascular Cell Adhesion Molecule-1
=550  \\$aIntegrins
=667  \\$aGEN or unspecified; prefer specifics; DF: I CAMS
=680  \\$iSurface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis.
=688  \\$a90
=750  \0$aCell adhesion molecules$5IEN$0(DLC)sh 89002311

=LDR  00738cz  a2200229n  4500
=001  9880364138802441
=005  20141212211230.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015814
=035  \\$aCBD0807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x540
=150  \\$aOcular Hypotension
=450  \\$wnnna$aHypotension, Ocular
=450  \\$wnnna$aHypotony, Ocular
=450  \\$aOcular Hypotony
=550  \\$wg$aEye Diseases
=550  \\$aIntraocular Pressure
=667  \\$a"abnormally low intraocular pressure": do not confuse with OCULAR HYPERTENSION
=680  \\$iAbnormally low intraocular pressure often related to chronic inflammation (uveitis).
=688  \\$a90
=750  \0$aOcular hypotony$5IEN$0(DLC)sh 85094051

=LDR  02462cz  a2200673n  4500
=001  9880364138902441
=005  20141212211230.0
=008  890516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015813
=035  \\$aCBD0806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x885
=072  \\$aN6.$x850.$x780.$x500.$x765
=150  \\$aSubstance Abuse Detection
=450  \\$wnnna$aDetection, Drug Abuse
=450  \\$wnnna$aDetection, Illicit Drug
=450  \\$wnnna$aDetection, Street Drug
=450  \\$wnnna$aDetection, Substance Abuse
=450  \\$wnnna$aDetections, Drug Abuse
=450  \\$wnnna$aDetections, Illicit Drug
=450  \\$wnnna$aDetections, Street Drug
=450  \\$wnnna$aDetections, Substance Abuse
=450  \\$wnnna$aDrug Abuse Detection
=450  \\$wnnna$aDrug Abuse Detections
=450  \\$wnnna$aDrug Abuse Screening
=450  \\$wnnna$aDrug Abuse Screenings
=450  \\$aDrug Abuse Testing
=450  \\$wnnna$aDrug Abuse Testings
=450  \\$wnnna$aDrug Testing, Illicit
=450  \\$wnnna$aDrug Testings, Illicit
=450  \\$wnnna$aIllicit Drug Detection
=450  \\$wnnna$aIllicit Drug Detections
=450  \\$aIllicit Drug Testing
=450  \\$wnnna$aIllicit Drug Testings
=450  \\$wnnna$aScreening, Drug Abuse
=450  \\$wnnna$aScreenings, Drug Abuse
=450  \\$wnnna$aStreet Drug Detection
=450  \\$wnnna$aStreet Drug Detections
=450  \\$aStreet Drug Testing
=450  \\$wnnna$aStreet Drug Testings
=450  \\$wnnna$aSubstance Abuse Detections
=450  \\$aSubstance Abuse Testing
=450  \\$wnnna$aSubstance Abuse Testings
=450  \\$wnnna$aTesting, Drug Abuse
=450  \\$wnnna$aTesting, Illicit Drug
=450  \\$wnnna$aTesting, Street Drug
=450  \\$wnnna$aTesting, Substance Abuse
=450  \\$wnnna$aTestings, Drug Abuse
=450  \\$wnnna$aTestings, Illicit Drug
=450  \\$wnnna$aTestings, Street Drug
=450  \\$wnnna$aTestings, Substance Abuse
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aMass Screening
=550  \\$aEnzyme Multiplied Immunoassay Technique
=550  \\$aMandatory Testing
=667  \\$acoord IM with precoord substance abuse term (IM) or substance abused (IM)
=680  \\$iDetection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
=688  \\$a90
=750  \0$aDrug testing$5IEN$0(DLC)sh 87002832

=LDR  01812cz  a2200481n  4500
=001  9880364139002441
=005  20141212211229.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015812
=035  \\$aCBD0805HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x525.$x381.$x56
=150  \\$aGlaucoma, Angle-Closure
=450  \\$wnnna$aAngle Closure Glaucoma
=450  \\$wnnna$aAngle-Closure Glaucoma
=450  \\$wnnna$aAngle Closure Glaucomas
=450  \\$wnnna$aAngle-Closure Glaucomas
=450  \\$wnnna$aClosed-Angle Glaucoma
=450  \\$wnnna$aClosed-Angle Glaucomas
=450  \\$wnnna$aGlaucoma, Angle Closure
=450  \\$aGlaucoma, Closed-Angle
=450  \\$wnnna$aGlaucoma, Closed Angle
=450  \\$wnnna$aGlaucoma, Narrow-Angle
=450  \\$wnnna$aGlaucoma, Narrow Angle
=450  \\$wnnna$aGlaucoma, Uncompensated
=450  \\$wnnna$aGlaucoma, Uncompensative
=450  \\$wnnna$aGlaucomas, Angle Closure
=450  \\$wnnna$aGlaucomas, Angle-Closure
=450  \\$wnnna$aGlaucomas, Closed-Angle
=450  \\$wnnna$aGlaucomas, Narrow-Angle
=450  \\$wnnna$aGlaucomas, Uncompensated
=450  \\$wnnna$aGlaucomas, Uncompensative
=450  \\$wnnna$aNarrow-Angle Glaucoma
=450  \\$wnnna$aNarrow-Angle Glaucomas
=450  \\$wnnna$aUncompensated Glaucoma
=450  \\$wnnna$aUncompensated Glaucomas
=450  \\$wnnna$aUncompensative Glaucoma
=450  \\$wnnna$aUncompensative Glaucomas
=550  \\$wg$aGlaucoma
=667  \\$ado not confuse with GLAUCOMA, OPEN-ANGLE: note X ref
=680  \\$iA form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.
=688  \\$a90
=750  \0$aAngle-closure Glaucoma$5IEN$0(DLC)sh 90000715

=LDR  01123cz  a2200277n  4500
=001  9880364139102441
=005  20141212211229.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015811
=035  \\$aCBD0804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x364.$x978.$x400
=072  \\$aC11.$x319.$x494.$x400
=072  \\$aC11.$x941.$x375.$x375
=072  \\$aC11.$x941.$x855.$x400
=150  \\$aIris Neoplasms
=450  \\$wnnna$aIris Neoplasm
=450  \\$wnnna$aNeoplasm, Iris
=450  \\$wnnna$aNeoplasms, Iris
=550  \\$wg$aIris Diseases
=550  \\$wg$aUveal Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl (IM)
=680  \\$iTumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.
=688  \\$a90
=750  \0$aIris (Eye)$xTumors$5IEN-M
=750  \0$aIris (Eye)$xCancer$5IEN-HS

=LDR  00765cz  a2200217n  4500
=001  9880364139202441
=005  20141212211226.0
=008  890906\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015801
=035  \\$aCBD0794HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x419
=150  \\$aHelminth Proteins
=450  \\$wnnna$aProteins, Helminth
=550  \\$wg$aProteins
=550  \\$wh$aCaenorhabditis elegans Proteins
=667  \\$a/drug eff /ultrastruct permitted; /physiol permitted for function within the helminth; coord IM with specific protein (IM) + specific helminth (IM)
=680  \\$iProteins found in any species of helminth.
=688  \\$a90
=750  \0$81$wb$aHelminths$5IEN$0(DLC)sh 85060076
=750  \0$81$wb$aProteins$5IEN-HS$0(DLC)sh 85107666

=LDR  01116cz  a2200289n  4500
=001  9880364139302441
=005  20141212211224.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015796
=035  \\$aCBD0789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x395.$x550.$x489.$x500.$x270
=072  \\$aD12.$x776.$x543.$x550.$x421.$x500.$x270
=072  \\$aD23.$x50.$x301.$x500.$x100.$x500.$x270
=072  \\$aD23.$x50.$x301.$x500.$x450.$x380.$x270
=072  \\$aD23.$x50.$x705.$x552.$x100.$x500.$x270
=072  \\$aD23.$x50.$x705.$x552.$x450.$x380.$x270
=150  \\$aHLA-B27 Antigen
=450  \\$wnnna$aAntigen, HLA-B27
=450  \\$wnnna$aHLA-B27
=450  \\$wnnna$aHLA B27 Antigen
=450  \\$wnnna$aHLA Class I Histocompatibility Antigen, B-27 alpha Chain
=450  \\$wnnna$aHLA Class I Histocompatibility Antigen, B 27 alpha Chain
=550  \\$wg$aHLA-B Antigens
=680  \\$iA specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*27 allele family.
=688  \\$a90
=750  \0$aHLA-B27 antigen$0(DLC) sh 96006071$5IEN-M

=LDR  01021cz  a2200253n  4500
=001  9880364139402441
=005  20141212211221.0
=008  890714\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015786
=035  \\$aCBD0779HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x244.$x187.$x500
=072  \\$aD12.$x776.$x422.$x220.$x187.$x500
=150  \\$aCytochromes b5
=450  \\$wnnna$aApocytochrome b5
=450  \\$wnnna$aCytochrome b-5
=450  \\$wnnna$aCytochrome b 5
=450  \\$wnnna$aCytochrome b5
=450  \\$wnnna$aFerricytochrome b5
=550  \\$wg$aCytochrome b Group
=667  \\$aspell in titles & translations with lowercase b: cytochrome b5
=680  \\$iCytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASES. They are reduced by the enzyme CYTOCHROME-B(5) REDUCTASE.
=688  \\$a2004(1990); for APOCYTOCHROME B5 use CYTOCHROMES B (NM) 1980-2003
=750  \0$aCytochrome b5$5IEN-M

=LDR  01614cz  a2200469n  4500
=001  9880364139502441
=005  20141212192648.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015784
=035  \\$aCBD0777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x77
=072  \\$aD2.$x33.$x755.$x624.$x698.$x77
=072  \\$aD2.$x92.$x63.$x624.$x698.$x77
=150  \\$aBetaxolol
=450  \\$wnnna$aAlcon, Betaxolol
=450  \\$wnnna$aAlcon Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aAllphar Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aALO-1401-02
=450  \\$wnnna$aALO 1401 02
=450  \\$wnnna$aALO140102
=450  \\$wnnna$aBetaxolol Alcon
=450  \\$wnnna$aBetaxolol Hydrochloride
=450  \\$wnnna$aBetoptic
=450  \\$wnnna$aBetoptima
=450  \\$wnnna$aBoots Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aHydrochloride, Betaxolol
=450  \\$wnnna$aKerlon
=450  \\$wnnna$aKerlone
=450  \\$wnnna$aLorex Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aOxodal
=450  \\$wnnna$aSchwarz Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aSearle Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aSL-75212
=450  \\$wnnna$aSL 75212
=450  \\$wnnna$aSL75212
=450  \\$wnnna$aSynthélabo Brand of Betaxolol Hydrochloride
=450  \\$wnnna$aSynthelabo Brand of Betaxolol Hydrochloride
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
=688  \\$a90
=750  \0$aBetaxolol$5IEN$0(DLC)sh 85013454

=LDR  01570cz  a2200361n  4500
=001  9880364139702441
=005  20141212211218.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015775
=035  \\$aCBD0770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x437
=150  \\$aFractures, Stress
=450  \\$wnnna$aFatigue Fracture
=450  \\$aFatigue Fractures
=450  \\$wnnna$aFracture, Fatigue
=450  \\$wnnna$aFracture, Insufficiency
=450  \\$wnnna$aFracture, March
=450  \\$wnnna$aFracture, Stress
=450  \\$aFractures, Fatigue
=450  \\$wnnna$aFractures, Insufficiency
=450  \\$aFractures, March
=450  \\$wnnna$aInsufficiency Fracture
=450  \\$wnnna$aInsufficiency Fractures
=450  \\$wnnna$aMarch Fracture
=450  \\$wnnna$aMarch Fractures
=450  \\$wnnna$aStress Fracture
=450  \\$aStress Fractures
=550  \\$wg$aFractures, Bone
=667  \\$acoordinate IM with specific organ / inj or organ/fracture term (IM); entry term FATIGUE FRACTURES refers to bone fractures: do not use for metal fatigue as in fatigue fractures of amalgams, nails, screw plates, etc (index under STRESS, MECHANICAL)
=680  \\$iFractures due to the strain caused by repetitive exercise. They are thought to arise from a combination of MUSCLE FATIGUE and bone failure, and occur in situations where BONE REMODELING predominates over repair. The most common sites of stress fractures are the METATARSUS; FIBULA; TIBIA; and FEMORAL NECK.
=688  \\$a90
=750  \0$aStress factors (Orthopedics)$5IEN

=LDR  01020cz  a2200265n  4500
=001  9880364139802441
=005  20141212211218.0
=008  890901\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015774
=035  \\$aCBD0769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x758.$x399.$x454.$x250.$x300
=150  \\$aGanciclovir
=450  \\$wnnna$aBIOLF-62
=450  \\$wnnna$aBW-759
=450  \\$wnnna$aCytovene
=450  \\$wnnna$aGanciclovir, Monosodium Salt
=450  \\$wnnna$aGanciclovir Sodium
=450  \\$wnnna$aGancyclovir
=450  \\$wnnna$aRS-21592
=550  \\$wg$aAcyclovir
=667  \\$ado not confuse DHPG, a common abbrev for ganciclovir with DHPG for both 3,4-dihydroxyphenylglycol & 3,4-dihydroxyphenylethylene glycol
=680  \\$iAn ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.
=688  \\$a90
=750  \0$aGanciclovir$5IEN$0(DLC)sh 91002390

=LDR  01171cz  a2200349n  4500
=001  9880364139902441
=005  20141212211216.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015767
=035  \\$aCBD0765M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x810.$x410
=150  \\$aMefloquine
=450  \\$wnnna$aHoffmann-La Roche Brand of Mefloquine Hydrochloride
=450  \\$wnnna$aHoffmann La Roche Brand of Mefloquine Hydrochloride
=450  \\$wnnna$aLariam
=450  \\$wnnna$aMefloquine Hydrochloride
=450  \\$wnnna$aMephloquine
=450  \\$wnnna$aRo-21-5998-001
=450  \\$wnnna$aRo 21 5998 001
=450  \\$wnnna$aRo215998001
=450  \\$wnnna$aRoche Brand of Mefloquine Hydrochloride
=450  \\$wnnna$aWR-142,490
=450  \\$wnnna$aWR 142,490
=450  \\$wnnna$aWR-177,602
=450  \\$wnnna$aWR 177,602
=450  \\$wnnna$aWR142,490
=450  \\$wnnna$aWR177,602
=550  \\$wg$aQuinolines
=680  \\$iA phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.
=688  \\$a90
=750  \0$aMefloquine$5IEN-M$0(DLC)sh 99004654

=LDR  02579cz  a2200733n  4500
=001  9880364140002441
=005  20141212192647.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015766
=035  \\$aCBD0764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x22
=072  \\$aD3.$x438.$x103.$x70
=150  \\$aAlbendazole
=450  \\$wnnna$aAlbendazole Armstrong Brand
=450  \\$wnnna$aAlbendazole Diba Brand
=450  \\$wnnna$aAlbendazole Fustery Brand
=450  \\$wnnna$aAlbendazole Hormona Brand
=450  \\$wnnna$aAlbendazole Liferpal Brand
=450  \\$wnnna$aAlbendazole Monohydrochloride
=450  \\$wnnna$aAlbendazole Noé-Socopharm Brand
=450  \\$wnnna$aAlbendazole Pfizer Brand
=450  \\$wnnna$aAlbendazole Sanicoopa Brand
=450  \\$wnnna$aAlbendazole Valdecasas Brand
=450  \\$wnnna$aAlbendoral
=450  \\$wnnna$aAlbenza
=450  \\$wnnna$aArmstrong Brand of Albendazole
=450  \\$wnnna$aBendapar
=450  \\$wnnna$aBilutac
=450  \\$wnnna$aDiba Brand of Albendazole
=450  \\$wnnna$aDigezanol
=450  \\$wnnna$aDisthelm
=450  \\$wnnna$aDisthelm, Mediamix V
=450  \\$wnnna$aEndoplus
=450  \\$wnnna$aEskazole
=450  \\$wnnna$aFustery Brand of Albendazole
=450  \\$wnnna$aGascop
=450  \\$wnnna$aHormona Brand of Albendazole
=450  \\$wnnna$aLiferpal Brand of Albendazole
=450  \\$wnnna$aLurdex
=450  \\$wnnna$aMediamix V Disthelm
=450  \\$wnnna$aMetiazol
=450  \\$wnnna$aMonohydrochloride, Albendazole
=450  \\$wnnna$aNoé-Socopharm Brand of Albendazole
=450  \\$wnnna$aNoé Socopharm Brand of Albendazole
=450  \\$wnnna$aPfizer Brand of Albendazole
=450  \\$wnnna$aSanicoopa Brand of Albendazole
=450  \\$wnnna$aSK&F-62979
=450  \\$wnnna$aSK&F 62979
=450  \\$wnnna$aSK&F62979
=450  \\$wnnna$aSKF-62979
=450  \\$wnnna$aSKF 62979
=450  \\$wnnna$aSKF62979
=450  \\$wnnna$aSmith Kline & French Brand of Albendazole
=450  \\$wnnna$aSmithKline Beecham Brand of Albendazole
=450  \\$wnnna$aV Disthelm, Mediamix
=450  \\$wnnna$aValbazen
=450  \\$wnnna$aValdecasas Brand of Albendazole
=450  \\$wnnna$aZentel
=550  \\$wg$aBenzimidazoles
=550  \\$wg$aCarbamates
=680  \\$iA benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
=688  \\$a90
=750  \0$aAlbendazole$5IEN$0(DLC)sh 86002976

=LDR  01195cz  a2200313n  4500
=001  9880364140102441
=005  20141212211215.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015760
=035  \\$aCBD0758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x265.$x100
=150  \\$aAlfentanil
=450  \\$wnnna$aAlfenta
=450  \\$wnnna$aAlfentanil Hydrochloride
=450  \\$aAlfentanyl
=450  \\$wnnna$aEsteve Brand of Alfentanil Hydrochloride
=450  \\$wnnna$aFanaxal
=450  \\$wnnna$aICI Brand of Alfentanil Hydrochloride
=450  \\$wnnna$aJanssen Brand of Alfentanil Hydrochloride
=450  \\$wnnna$aLimifen
=450  \\$wnnna$aR-39209
=450  \\$wnnna$aR 39209
=450  \\$wnnna$aR39209
=450  \\$wnnna$aRapifen
=550  \\$wg$aFentanyl
=680  \\$iA short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.
=688  \\$a90
=750  \0$aAlfentanil$5IEN$0(DLC)sh 90001122

=LDR  01009cz  a2200301n  4500
=001  9880364140202441
=005  20161109162851.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015746
=035  \\$aCBD0749HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x646.$x100
=072  \\$aC23.$x888.$x821.$x30
=150  \\$aAbdominal Pain
=450  \\$wnnna$aAbdominal Pains
=450  \\$wnnna$aColicky Pain
=450  \\$wnnna$aPain, Abdominal
=450  \\$wnnna$aPain, Colicky
=450  \\$wnnna$aPains, Abdominal
=550  \\$wg$aPain
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$wh$aAbdomen, Acute
=550  \\$wh$aColic
=550  \\$wh$aRenal Colic
=667  \\$ado not confuse with ABDOMEN, ACUTE for abrupt abdom dis requiring emerg surg
=680  \\$iSensation of discomfort, distress, or agony in the abdominal region; generally associated with functional disorders, tissue injuries, or diseases.
=688  \\$a90
=750  \0$aAbdominal pain$5IEN$0(DLC)sh 85000111

=LDR  01472cz  a2200325n  4500
=001  9880364140302441
=005  20141212211209.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015740
=035  \\$aCBD0743HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x97
=072  \\$aD12.$x776.$x641.$x650.$x97
=150  \\$aCalcitonin Gene-Related Peptide
=450  \\$wnnna$aalpha-CGRP
=450  \\$wnnna$aalpha CGRP
=450  \\$wnnna$abeta-CGRP
=450  \\$wnnna$abeta CGRP
=450  \\$wnnna$aCalcitonin Gene Related Peptide
=450  \\$wnnna$aCalcitonin Gene-Related Peptide I
=450  \\$wnnna$aCalcitonin Gene Related Peptide I
=450  \\$wnnna$aCalcitonin Gene-Related Peptide II
=450  \\$wnnna$aCalcitonin Gene Related Peptide II
=450  \\$wnnna$aGene-Related Peptide, Calcitonin
=450  \\$wnnna$aPeptide, Calcitonin Gene-Related
=550  \\$wg$aNeuropeptides
=667  \\$aDF: CGRP
=680  \\$iCalcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
=688  \\$a90
=750  \0$aCaicotinin gene-related peptide$5IEN

=LDR  00635cz  a2200181n  4500
=001  9880364140402441
=005  20141212211208.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015737
=035  \\$aCBD0740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x203.$x580
=150  \\$aNisoldipine
=450  \\$wnnna$aBay K 5552
=550  \\$wg$aDihydropyridines
=680  \\$iA dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
=688  \\$a90
=750  \0$aNisoldipine$5IEN-M$0(DLC)sh 93004330

=LDR  01531cz  a2200421n  4500
=001  9880364140502441
=005  20141212192645.0
=008  890906\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015735
=035  \\$aCBD0738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x365.$x415.$x580
=150  \\$aMifepristone
=450  \\$wnnna$aContragest Brand of Mifepristone
=450  \\$wnnna$aDanco Brand of Mifepristone
=450  \\$wnnna$aExelgyn Brand of Mifepristone
=450  \\$wnnna$aMifégyne
=450  \\$wnnna$aMifegyne
=450  \\$wnnna$aMifeprex
=450  \\$wnnna$aMifepristone Contragest Brand
=450  \\$wnnna$aMifepristone Danco Brand
=450  \\$wnnna$aMifepristone Exelgyn Brand
=450  \\$wnnna$aR-38486
=450  \\$wnnna$aR 38486
=450  \\$wnnna$aR38486
=450  \\$wnnna$aRU-38486
=450  \\$wnnna$aRU 38486
=450  \\$wnnna$aRU-486
=450  \\$wnnna$aRU 486
=450  \\$wnnna$aRU38486
=450  \\$wnnna$aRU486
=450  \\$wnnna$aZK-98296
=450  \\$wnnna$aZK 98296
=450  \\$wnnna$aZK98296
=550  \\$wg$aEstrenes
=680  \\$iA progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
=688  \\$a90
=750  \0$aMifepristone$5IEN$0(DLC)sh 85085059

=LDR  01307cz  a2200361n  4500
=001  9880364140602441
=005  20141212211207.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x325
=150  \\$aGene Library
=450  \\$wnnna$acDNA Libraries
=450  \\$acDNA Library
=450  \\$wnnna$aDNA Libraries
=450  \\$aDNA Library
=450  \\$wnnna$aGene Libraries
=450  \\$wnnna$aLibraries, cDNA
=450  \\$wnnna$aLibraries, DNA
=450  \\$wnnna$aLibraries, Gene
=450  \\$wnnna$aLibrary, cDNA
=450  \\$wnnna$aLibrary, DNA
=450  \\$wnnna$aLibrary, Gene
=550  \\$wg$aGenetic Structures
=550  \\$wh$aGenomic Library
=550  \\$wh$aPeptide Library
=550  \\$aCombinatorial Chemistry Techniques
=550  \\$aDatabases, Nucleic Acid
=550  \\$aExpressed Sequence Tags
=667  \\$ado not confuse with GENOMIC LIBRARY
=680  \\$iA large collection of DNA fragments cloned (CLONING, MOLECULAR) from a given organism, tissue, organ, or cell type. It may contain complete genomic sequences (GENOMIC LIBRARY) or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences.
=688  \\$a90
=750  \0$aGene libraries$5IEN$0(DLC)sh 90004176

=LDR  01702cz  a2200457n  4500
=001  9880364140702441
=005  20141212211206.0
=008  890714\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015721
=035  \\$aCBD0732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x300
=072  \\$aD20.$x215.$x894.$x135.$x535.$x300
=072  \\$aD20.$x215.$x894.$x691.$x263.$x300
=072  \\$aD20.$x215.$x894.$x691.$x824.$x300
=072  \\$aD20.$x215.$x894.$x815.$x300
=150  \\$aDiphtheria-Tetanus-Pertussis Vaccine
=450  \\$wnnna$aDi-Te-Per Vaccine
=450  \\$wnnna$aDi Te Per Vaccine
=450  \\$aDiphtheria-Pertussis-Tetanus Vaccine
=450  \\$wnnna$aDiphtheria Pertussis Tetanus Vaccine
=450  \\$wnnna$aDiphtheria Tetanus Pertussis Vaccine
=450  \\$aDPT Vaccine
=450  \\$aDTP Vaccine
=450  \\$aDTwP Vaccine
=450  \\$wnnna$aVaccine, Di-Te-Per
=450  \\$wnnna$aVaccine, Diphtheria-Pertussis-Tetanus
=450  \\$wnnna$aVaccine, Diphtheria-Tetanus-Pertussis
=450  \\$wnnna$aVaccine, DPT
=450  \\$wnnna$aVaccine, DTP
=450  \\$wnnna$aVaccine, DTwP
=550  \\$wg$aBacterial Vaccines
=550  \\$wg$aDiphtheria Toxoid
=550  \\$wg$aPertussis Vaccine
=550  \\$wg$aTetanus Toxoid
=550  \\$wg$aVaccines, Combined
=550  \\$aDiphtheria Toxoid
=667  \\$aDIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS VACCINE are also available
=680  \\$iA vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
=688  \\$a1990
=750  \0$aDPT vaccine$5IEN$0(DLC)sh 85039252

=LDR  01987cz  a2200469n  4500
=001  9880364140802441
=005  20141212211205.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015718
=035  \\$aCBD0729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x270.$x305
=150  \\$aFibrin Tissue Adhesive
=450  \\$wnnna$aAdhesive, Fibrin
=450  \\$wnnna$aAdhesive, Fibrin Tissue
=450  \\$wnnna$aAdhesive, Fibrinogen
=450  \\$aAutologous Fibrin Tissue Adhesive
=450  \\$wnnna$aBeriplast
=450  \\$wnnna$aCrosseal
=450  \\$aFibrin Adhesive
=450  \\$aFibrin Glue
=450  \\$wnnna$aFibrin Klebe System Immuno
=450  \\$wnnna$aFibrin Seal
=450  \\$wnnna$aFibrin Sealant
=450  \\$wnnna$aFibrin Sealant, Human
=450  \\$aFibrin Sealant System
=450  \\$aFibrinogen Adhesive
=450  \\$wnnna$aGlue, Fibrin
=450  \\$wnnna$aHuman Fibrin Sealant
=450  \\$wnnna$aSeal, Fibrin
=450  \\$wnnna$aSealant, Fibrin
=450  \\$wnnna$aSealant, Human Fibrin
=450  \\$wnnna$aSealant System, Fibrin
=450  \\$wnnna$aTisseel
=450  \\$wnnna$aTissel
=450  \\$wnnna$aTissucol
=450  \\$wnnna$aTissue Adhesive, Fibrin
=450  \\$wnnna$aTransglutine
=550  \\$wg$aFibrin
=680  \\$iAn autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.
=688  \\$a90
=750  \0$aFibrin tissue adhesive$5IEN-M$0(DLC)sh 94004664

=LDR  00619cz  a2200205n  4500
=001  9880364140902441
=005  20141212211203.0
=008  890526\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015714
=035  \\$aCBD0725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x737.$x684
=150  \\$aPlagiarism
=550  \\$wg$aPublishing
=550  \\$aAuthorship
=550  \\$aScientific Misconduct
=667  \\$aIM; do not confuse with DUPLICATE PUBLICATION: read MeSH definition; no qualif
=680  \\$iPassing off as one's own the work of another without credit.
=688  \\$a90
=750  \0$aPlagiarism$5IEN$0(DLC)sh 85102580

=LDR  01058cz  a2200265n  4500
=001  9880364141002441
=005  20141212211203.0
=008  890622\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015709
=035  \\$aCBD0723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x377
=150  \\$aCorrespondence as Topic
=450  \\$wnnna$aCorrespondence as Topics
=450  \\$wnnna$aLetters as Topic
=450  \\$wnnna$aLetters as Topics
=550  \\$wg$aWriting
=550  \\$wh$aElectronic Mail
=550  \\$wh$aText Messaging
=667  \\$ado not confuse with the Publication Types LETTER or COLLECTED CORRESPONDENCE
=680  \\$iCommunication between persons or between institutions or organizations by an exchange of letters. Its use in indexing and cataloging will generally figure in historical and biographical material.
=688  \\$a2008(1990)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Correspondence
=688  \\$a90; CORRESPONDENCE was see WRITING 1966-89
=750  \0$aLetter writing$0(DLC) sh 85076220$5IEN-HS

=LDR  01324cz  a2200325n  4500
=001  9880364141102441
=005  20201209131140.0
=008  890619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015706
=035  \\$aCBD0721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x99.$x325
=072  \\$aL1.$x453.$x183.$x291
=150  \\$aBibliometrics
=450  \\$wnnna$aAnalyses, Bibliometric
=450  \\$wnnna$aAnalysis, Bibliometric
=450  \\$wnnna$aBibliographies, Statistical
=450  \\$aBibliography, Statistical
=450  \\$wnnna$aBibliometric Analyses
=450  \\$wnnna$aBibliometric Analysis
=450  \\$wnnna$aStatistical Bibliographies
=450  \\$wnnna$aStatistical Bibliography
=550  \\$wg$aBibliography as Topic
=550  \\$wh$aJournal Impact Factor
=550  \\$wh$aKnowledge Discovery
=550  \\$aStatistics as Topic
=667  \\$aIM; coord with subject (IM); med bibliometrics: do not coordinate with MEDICINE
=680  \\$iThe use of statistical methods in the analysis of a body of literature to reveal the historical development of subject fields and patterns of authorship, publication, and use. Formerly called statistical bibliography. (from The ALA Glossary of Library and Information Science, 1983)
=688  \\$a90
=750  \0$aBibliometrics$5IEN$0(DLC)sh 85013873

=LDR  01942cz  a2200433n  4500
=001  9880364141202441
=005  20190523152133.0
=008  890619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015704
=035  \\$aCBD0720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x810.$x500
=072  \\$aD12.$x776.$x543.$x750.$x830.$x700.$x25
=072  \\$aD23.$x50.$x301.$x264.$x894.$x100
=072  \\$aD23.$x101.$x100.$x894.$x100
=150  \\$aCD4 Antigens
=450  \\$wnno$aAntigens, CD4
=450  \\$wnnna$aAntigen, CD4
=450  \\$wnnna$aAntigens, T-Cell T4
=450  \\$wnnna$aCD4 Antigen
=450  \\$aCD4 Molecule
=450  \\$wnnna$aCD4 Receptor, Surface
=450  \\$aCD4 Receptors
=450  \\$wnnna$aCD4 Receptors, Surface
=450  \\$aReceptors, CD4
=450  \\$wnnna$aReceptors, Surface CD4
=450  \\$wnnna$aSurface CD4 Receptor
=450  \\$wnnna$aSurface CD4 Receptors
=450  \\$wnnna$aT-Cell T4 Antigens
=450  \\$aT4 Antigens, T-Cell
=450  \\$wnnna$aT4 Antigens, T Cell
=550  \\$wg$aAntigens, Differentiation, T-Lymphocyte
=550  \\$wg$aReceptors, HIV
=550  \\$wg$aReceptors, Interleukin-16
=550  \\$aCD4-Positive T-Lymphocytes
=667  \\$afor hematodermic CD4/CD56 neoplasm use LYMPHOMA, NON-HODGKIN
=680  \\$i55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.
=688  \\$a90; was CD4 ANTIGENS see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989
=750  \0$aCD4 antigen$0(DLC)sh 96009226$5IEN=M

=LDR  01242cz  a2200301n  4500
=001  9880364141302441
=005  20190521140811.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015703
=035  \\$aCBD0719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x264.$x35
=072  \\$aD23.$x101.$x100.$x110
=150  \\$aAntigens, CD
=450  \\$wnnna$aCD Antigens
=450  \\$wnnna$aCluster of Differentiation Antigens
=450  \\$wnnna$aCluster of Differentiation Markers
=450  \\$aDifferentiation Antigens, Leukocyte, Human
=450  \\$aLeukocyte Differentiation Antigens, Human
=550  \\$wg$aAntigens, Differentiation
=550  \\$wh$aAntigens, CD1
=550  \\$wh$aAntigens, CD19
=550  \\$wh$aAntigens, CD20
=550  \\$wh$aAntigens, CD34
=550  \\$wh$aAntigens, CD7
=680  \\$iDifferentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
=688  \\$a90
=750  \0$aCD antigens$0(DLC) sh 91001903$5IEN

=LDR  01615cz  a2200409n  4500
=001  9880364141402441
=005  20141212211149.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015674
=035  \\$aCBD0699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x531
=072  \\$aC22.$x520
=150  \\$aMammary Neoplasms, Animal
=450  \\$wnnna$aAnimal Mammary Carcinoma
=450  \\$wnnna$aAnimal Mammary Carcinomas
=450  \\$wnnna$aAnimal Mammary Neoplasm
=450  \\$wnnna$aAnimal Mammary Neoplasms
=450  \\$wnnna$aCarcinoma, Animal Mammary
=450  \\$wnnna$aCarcinomas, Animal Mammary
=450  \\$wnnna$aMammary Carcinoma, Animal
=450  \\$wnnna$aMammary Carcinomas, Animal
=450  \\$wnnna$aMammary Neoplasm
=450  \\$wnnna$aMammary Neoplasm, Animal
=450  \\$wnnna$aMammary Neoplasms
=450  \\$wnnna$aNeoplasm, Animal Mammary
=450  \\$wnnna$aNeoplasm, Mammary
=450  \\$wnnna$aNeoplasms, Animal Mammary
=450  \\$wnnna$aNeoplasms, Mammary
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aMammary Neoplasms, Experimental
=667  \\$aanimal only but MAMMARY NEOPLASMS, EXPERIMENTAL is also available; coord IM with histol type of neopl (IM) + precoord animal/dis term (IM) + specific animal (NIM); do not coord with NEOPLASMS, EXPERIMENTAL; check tag ANIMALS
=680  \\$iTumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).
=688  \\$a2004 (1990)
=750  \0$aMammary glands$0(DLC)sh2010009734$xCancer$5IEN-M
=750  \0$aMammary glands$xTumors$0(IEN)395582$5IEN-M

=LDR  02883cz  a2200601n  4500
=001  9880364141502441
=005  20141212211148.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015673
=035  \\$aCBD0698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x330
=072  \\$aC5.$x651.$x310
=072  \\$aC10.$x228.$x440.$x600
=072  \\$aC10.$x668.$x364
=150  \\$aFatigue Syndrome, Chronic
=450  \\$wnnna$aChronic Fatigue and Immune Dysfunction Syndrome
=450  \\$wnnna$aChronic Fatigue Disorder
=450  \\$wnnna$aChronic Fatigue Disorders
=450  \\$wnnna$aChronic Fatigue-Fibromyalgia Syndrome
=450  \\$wnnna$aChronic Fatigue Fibromyalgia Syndrome
=450  \\$wnnna$aChronic Fatigue-Fibromyalgia Syndromes
=450  \\$aChronic Fatigue Syndrome
=450  \\$wnnna$aChronic Fatigue Syndromes
=450  \\$wnnna$aDisorders, Chronic Fatigue
=450  \\$aEncephalomyelitis, Myalgic
=450  \\$wnnna$aFatigue Disorder, Chronic
=450  \\$wnnna$aFatigue Disorders, Chronic
=450  \\$wnnna$aFatigue-Fibromyalgia Syndrome, Chronic
=450  \\$wnnna$aFatigue-Fibromyalgia Syndromes, Chronic
=450  \\$wnnna$aFatigue Syndrome, Postviral
=450  \\$wnnna$aFatigue Syndromes, Chronic
=450  \\$wnnna$aFatigue Syndromes, Postviral
=450  \\$aInfectious Mononucleosis-Like Syndrome, Chronic
=450  \\$wnnna$aInfectious Mononucleosis Like Syndrome, Chronic
=450  \\$wnnna$aMyalgic Encephalomyelitis
=450  \\$aPostviral Fatigue Syndrome
=450  \\$wnnna$aPostviral Fatigue Syndromes
=450  \\$wnnna$aRoyal Free Disease
=450  \\$wnnna$aSyndrome, Chronic Fatigue-Fibromyalgia
=450  \\$wnnna$aSyndromes, Chronic Fatigue-Fibromyalgia
=450  \\$wnnna$aSyndromes, Postviral Fatigue
=550  \\$wg$aEncephalomyelitis
=550  \\$wg$aMuscular Diseases
=550  \\$wg$aNeuromuscular Diseases
=550  \\$wg$aVirus Diseases
=550  \\$aFibromyalgia
=550  \\$aHerpesvirus 4, Human
=550  \\$aNeurasthenia
=667  \\$aa clinical entity: do not confuse with "chronic fatigue" ( = FATIGUE (IM) + CHRONIC DISEASE (NIM)); DF: CFIDS
=680  \\$iA syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
=688  \\$a90
=750  \0$aChronic fatigue syndrome$0(DLC) sh 88006956$5IEN

=LDR  00966cz  a2200277n  4500
=001  9880364141602441
=005  20141212211146.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015671
=035  \\$aCBD0696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x186.$x250
=072  \\$aE2.$x190.$x44.$x244
=072  \\$aE2.$x342.$x543
=072  \\$aE2.$x779.$x468.$x399
=072  \\$aE3.$x91.$x823.$x500
=072  \\$aE3.$x155.$x519
=150  \\$aElectroacupuncture
=550  \\$wg$aAcupuncture Therapy
=550  \\$wg$aAnesthesia
=550  \\$wg$aCombined Modality Therapy
=550  \\$wg$aElectric Stimulation Therapy
=550  \\$wg$aTranscutaneous Electric Nerve Stimulation
=680  \\$iA form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; REHABILITATION; and treatment for diseases.
=688  \\$a90
=750  \0$aElectroacupuncture$5IEN$0(DLC)sh 85042095

=LDR  00722cz  a2200241n  4500
=001  9880364141702441
=005  20141212211146.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015669
=035  \\$aCBD0694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x44.$x555.$x35
=150  \\$aAcupuncture Points
=450  \\$wnnna$aAcupoint
=450  \\$aAcupoints
=450  \\$wnnna$aAcupuncture Point
=450  \\$wnnna$aPoint, Acupuncture
=450  \\$wnnna$aPoints, Acupuncture
=550  \\$wg$aMeridians
=550  \\$aTrigger Points
=680  \\$iDesignated locations along nerves or organ meridians for inserting acupuncture needles.
=688  \\$a90
=750  \0$aAcupuncture points$5IEN$0(DLC)sh 85000764

=LDR  01029cz  a2200229n  4500
=001  9880364141802441
=005  20141212211145.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015667
=035  \\$aCBD0692M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x44.$x105
=072  \\$aE3.$x91.$x48
=150  \\$aAcupuncture Analgesia
=450  \\$wnnna$aAcupuncture Anesthesia
=450  \\$aAnalgesia, Acupuncture
=450  \\$wnnna$aAnesthesia, Acupuncture
=550  \\$wg$aAcupuncture Therapy
=550  \\$wg$aAnalgesia
=680  \\$iAnalgesia produced by the insertion of ACUPUNCTURE needles at certain ACUPUNCTURE POINTS on the body. This activates small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary/hypothalamus - to produce analgesia.
=688  \\$a1990; for ACUPUNCTURE ANESTHESIA use ACUPUNCTURE ANESTHESIA 1991-2001; use ACUPUNCTURE 1990
=750  \0$aAcupuncture anesthesia$5IEN-M$0(DLC)sh 85000763

=LDR  02302cz  a2200697n  4500
=001  9880364141902441
=005  20160815103519.0
=008  890901\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015662
=035  \\$aCBD0690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x884.$x725.$x867.$x500
=072  \\$aD2.$x92.$x146.$x807.$x867.$x500
=072  \\$aD2.$x886.$x590.$x700.$x725.$x867.$x500
=072  \\$aD3.$x383.$x742.$x906.$x500
=072  \\$aD26.$x310.$x875
=150  \\$aTrimethoprim-Sulfamethoxazole Drug Combination
=450  \\$wnno$aTrimethoprim-Sulfamethoxazole Combination
=450  \\$wnnna$aAbactrim
=450  \\$wnnna$aBactifor
=450  \\$wnnna$aBactrim
=450  \\$wnnna$aBiseptol
=450  \\$wnnna$aBiseptol-480
=450  \\$wnnna$aBiseptol 480
=450  \\$wnnna$aBiseptol480
=450  \\$wnnna$aCentran
=450  \\$wnnna$aCentrin
=450  \\$wnnna$aCo-Trimoxazole
=450  \\$wnnna$aCo Trimoxazole
=450  \\$wnnna$aCotrimoxazole
=450  \\$wnnna$aDrylin
=450  \\$wnnna$aEslectin
=450  \\$wnnna$aEusaprim
=450  \\$wnnna$aInsozalin
=450  \\$wnnna$aKepinol
=450  \\$wnnna$aKepinol Forte
=450  \\$wnnna$aLescot
=450  \\$wnnna$aMetomide
=450  \\$wnnna$aOriprim
=450  \\$wnnna$aSeptra
=450  \\$wnnna$aSeptrin
=450  \\$wnnna$aSulfamethoxazole-Trimethoprim Combination
=450  \\$wnnna$aSulfamethoxazole Trimethoprim Combination
=450  \\$wnnna$aSulprim
=450  \\$wnnna$aSumetrolim
=450  \\$wnnna$aTMP SMX
=450  \\$wnnna$aTMP-SMX
=450  \\$wnnna$aTrimedin
=450  \\$wnnna$aTrimethoprim-Sulfamethoxazole
=450  \\$wnnna$aTrimethoprim Sulfamethoxazole
=450  \\$wnnna$aTrimethoprim Sulfamethoxazole Combination
=450  \\$wnnna$aTrimethoprimsulfa
=450  \\$wnnna$aTrimezole
=450  \\$wnnna$aTrimosulfa
=550  \\$wg$aDrug Combinations
=550  \\$wg$aSulfamethoxazole
=550  \\$wg$aTrimethoprim
=667  \\$aDF: TMP SMX
=680  \\$iA drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
=688  \\$a90
=750  \0$aCo-trimoxazole$5IEN$0(DLC)sh 85027289

=LDR  00962cz  a2200277n  4500
=001  9880364142002441
=005  20141212211144.0
=008  890703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015661
=035  \\$aCBD0689M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x450.$x600
=072  \\$aB3.$x660.$x250.$x550
=150  \\$aPasteurellaceae
=450  \\$aHistophilus
=550  \\$wg$aGammaproteobacteria
=550  \\$wg$aGram-Negative Facultatively Anaerobic Rods
=550  \\$wh$aActinobacillus
=550  \\$wh$aAggregatibacter
=550  \\$wh$aHaemophilus
=550  \\$wh$aMannheimia
=550  \\$wh$aPasteurella
=667  \\$ainfection = PASTEURELLACEAE INFECTIONS
=680  \\$iA family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.
=688  \\$a90
=750  \0$aPasteurellaceae$0(DLC)sh2006002252$5IEN-M

=LDR  02447cz  a2200541n  4500
=001  9880364142102441
=005  20180202114639.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015658
=035  \\$aCBD0686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x400
=072  \\$aC2.$x800.$x801.$x400
=072  \\$aC20.$x673.$x480
=150  \\$aHIV Infections
=450  \\$wnnna$aHIV Infection
=450  \\$wnnna$aHTLV-III Infection
=450  \\$aHTLV-III Infections
=450  \\$wnnna$aHTLV III Infections
=450  \\$wnnna$aHTLV-III-LAV Infection
=450  \\$aHTLV-III-LAV Infections
=450  \\$wnnna$aHTLV III LAV Infections
=450  \\$wnnna$aInfection, HIV
=450  \\$wnnna$aInfection, HTLV-III
=450  \\$wnnna$aInfection, HTLV-III-LAV
=450  \\$wnnna$aInfections, HIV
=450  \\$wnnna$aInfections, HTLV-III
=450  \\$wnnna$aInfections, HTLV-III-LAV
=450  \\$aT-Lymphotropic Virus Type III Infections, Human
=450  \\$wnnna$aT Lymphotropic Virus Type III Infections, Human
=550  \\$wg$aImmunologic Deficiency Syndromes
=550  \\$wg$aLentivirus Infections
=550  \\$wg$aSexually Transmitted Diseases, Viral
=550  \\$wh$aAcquired Immunodeficiency Syndrome
=550  \\$wh$aAcute Retroviral Syndrome
=550  \\$wh$aAIDS Arteritis, Central Nervous System
=550  \\$wh$aAIDS-Associated Nephropathy
=550  \\$wh$aAIDS Dementia Complex
=550  \\$wh$aAIDS-Related Complex
=550  \\$wh$aAIDS-Related Opportunistic Infections
=550  \\$wh$aHIV-Associated Lipodystrophy Syndrome
=550  \\$wh$aHIV Enteropathy
=550  \\$wh$aHIV Seropositivity
=550  \\$wh$aHIV Wasting Syndrome
=667  \\$acaused by a lentivirus; GEN or unspecified; coord IM with HIV-1 (IM) or HIV-2 (IM); note specific indentions under HIV INFECTIONS; DF: HIV INFECT
=680  \\$iIncludes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
=688  \\$a90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION & HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89
=750  \0$aHIV infections$5IEN$0(DLC)sh 91004036

=LDR  01725cz  a2200361n  4500
=001  9880364142202441
=005  20141212211141.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015654
=035  \\$aCBD0682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x280.$x382.$x150.$x750.$x400
=072  \\$aB4.$x909.$x204.$x382.$x150.$x750.$x400
=150  \\$aHerpesvirus 6, Human
=450  \\$wnnna$aB-Lymphotropic Virus, Human
=450  \\$wnnna$aB-Lymphotropic Viruses, Human
=450  \\$aHBLV
=450  \\$aHerpesvirus 6A, Human
=450  \\$aHerpesvirus 6B, Human
=450  \\$wnnna$aHHV-6
=450  \\$wnnna$aHHV-6A
=450  \\$wnnna$aHHV-6B
=450  \\$aHuman B-Lymphotropic Virus
=450  \\$wnnna$aHuman B Lymphotropic Virus
=450  \\$wnnna$aHuman B-Lymphotropic Viruses
=450  \\$aHuman herpesvirus 6
=450  \\$wnnna$aHuman Herpesvirus 6A
=450  \\$wnnna$aHuman Herpesvirus 6B
=550  \\$wg$aRoseolovirus
=667  \\$ainfection: coord IM with ROSEOLOVIRUS INFECTIONS (IM) but consider also EXANTHEMA SUBITUM
=680  \\$iThe type species of ROSEOLOVIRUS isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6; (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM and has been implicated in encephalitis.
=688  \\$a94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93
=750  \0$aHuman herpesvirus-6$5IEN$0(DLC)sh 92000218

=LDR  00849cz  a2200265n  4500
=001  9880364142302441
=005  20141212211140.0
=008  890515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015651
=035  \\$aCBD0679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x680
=150  \\$aMycotoxicosis
=450  \\$aFungus Poisoning
=450  \\$wnnna$aFungus Poisonings
=450  \\$wnnna$aMycotoxicoses
=450  \\$wnnna$aPoisoning, Fungus
=450  \\$wnnna$aPoisonings, Fungus
=550  \\$wg$aPoisoning
=550  \\$wh$aErgotism
=550  \\$wh$aMushroom Poisoning
=667  \\$a"caused by ingestion of mycotoxins (toxins of fungal origin)"
=680  \\$iPoisoning caused by the ingestion of mycotoxins (toxins of fungal origin).
=688  \\$a90; was see MUSHROOM POISONING 1985-89
=750  \0$aMycotoxicoses$5IEN$0(DLC)sh 85089201

=LDR  00691cz  a2200193n  4500
=001  9880364142402441
=005  20141212211137.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015642
=035  \\$aCBD0670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x740.$x675
=150  \\$aRadiology, Interventional
=450  \\$wnnna$aInterventional Radiology
=550  \\$wg$aRadiology
=667  \\$aSPEC: SPEC qualif; for diag use RADIOGRAPHY, INTERVENTIONAL; DF: RADIOL INTERVENTIONAL
=680  \\$iSubspecialty of radiology that combines organ system radiography, catheter techniques and sectional imaging.
=688  \\$a90
=750  \0$aInterventional radiology$5IEN$0(DLC)sh 85110776

=LDR  00878cz  a2200229n  4500
=001  9880364142502441
=005  20141212211135.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015636
=035  \\$aCBD0666M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x210.$x450.$x150.$x500
=072  \\$aD1.$x524.$x475
=150  \\$aMagnesium Chloride
=450  \\$wnnna$aChloride, Magnesium
=450  \\$wnnna$aMgCl2
=550  \\$wg$aChlorides
=550  \\$wg$aMagnesium Compounds
=667  \\$aused as a source of magnesium ions
=680  \\$iMagnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys.
=688  \\$a90
=750  \0$aMagnesium chloride$0(DLC)sh2009007663$5IEN-M

=LDR  00704cz  a2200193n  4500
=001  9880364142602441
=005  20141212211134.0
=008  890525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015632
=035  \\$aCBD0663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x450
=150  \\$a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
=450  \\$aMPTP
=450  \\$wnnna$aN-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
=550  \\$wg$aPyridines
=680  \\$iA dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
=688  \\$a90
=750  \0$aMethylphenyltetrahydropyridine$5IEN-M$0(DLC)sh 86002892

=LDR  01132cz  a2200253n  4500
=001  9880364142702441
=005  20141212211133.0
=008  890407\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015626
=035  \\$aCBD0662M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x680.$x800
=150  \\$aTissue Expansion
=450  \\$wnnna$aExpansion, Tissue
=450  \\$wnnna$aExpansions, Tissue
=450  \\$wnnna$aTissue Expansions
=550  \\$wg$aReconstructive Surgical Procedures
=550  \\$wh$aNerve Expansion
=550  \\$aBone Lengthening
=550  \\$aTissue Engineering
=550  \\$aTissue Expansion Devices
=680  \\$iA procedure whereby the body is stimulated to generate extra soft tissue by the application of stretching forces that stimulate new growth of tissue which, over a period of time, results in a 2-dimensional expansion of the tissue. The procedure is used in reconstructive surgery for injuries caused by trauma, burns, or ablative surgery. Various types of TISSUE EXPANSION DEVICES have been developed that exert stretching forces.
=688  \\$a90
=750  \0$aTissue expansion$0(DLC) sh 96002329$5IEN-M

=LDR  00567cz  a2200169n  4500
=001  9880364142802441
=005  20141212200340.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003395
=035  \\$aCBA8554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368.$x239
=150  \\$aCraniology
=550  \\$wg$aAnthropology, Physical
=667  \\$aspecialty; do not confuse with CRANIOMETRY see CEPHALOMETRY; DF: CRANIOL
=680  \\$iThe scientific study of variations in size, shape, and proportion of the cranium.
=750  \0$aCraniology$5IEN$0(DLC)sh 85033751

=LDR  00911cz  a2200301n  4500
=001  9880364142902441
=005  20180402113735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003376
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x176
=072  \\$aF4.$x408.$x413
=072  \\$aN2.$x421.$x143.$x303
=072  \\$aN2.$x421.$x461.$x363
=150  \\$aCounseling
=450  \\$wnnna$aCounselor
=450  \\$wnnna$aCounselors
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aMental Health Services
=550  \\$wg$aPsychology, Applied
=550  \\$wh$aDirective Counseling
=550  \\$wh$aDistance Counseling
=550  \\$wh$aPastoral Care
=550  \\$wh$aSex Counseling
=667  \\$aGEN; prefer specifics
=680  \\$iThe giving of advice and assistance to individuals with educational or personal problems.
=688  \\$a66(64)
=750  \0$aCounseling$0(DLC)sh 85033421

=LDR  00844cz  a2200205n  4500
=001  9880364143002441
=005  20141212200333.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003371
=035  \\$aCBA8552HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x248
=072  \\$aC23.$x888.$x852.$x293
=150  \\$aCough
=450  \\$wnnna$aCoughs
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=667  \\$a/drug ther: consider also ANTITUSSIVE AGENTS
=680  \\$iA sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
=750  \0$aCough$5IEN$0(DLC)sh 85033394

=LDR  00904cz  a2200253n  4500
=001  9880364143102441
=005  20141212200313.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003300
=035  \\$aCBA8551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x195
=072  \\$aD1.$x268.$x956.$x170
=072  \\$aD1.$x552.$x544.$x195
=150  \\$aCopper
=450  \\$aCopper Compounds$5IEN
=450  \\$aOrganocopper Compounds$5IEN
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aCu-63; Cu-65 = COPPER (IM) + ISOTOPES (NIM); Cu-58-62, 64, 66-68 = COPPER RADIOISOTOPES (IM)
=680  \\$iA heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.
=750  \0$aCopper compounds$5IEN-M$0(DLC)sh 85032355
=750  \0$aCopper$5IEN-HS$0(DLC)sh 85032278
=750  \0$aCopper in the body$5IEN-HS$0(DLC)sh 85032365

=LDR  00546cz  a2200193n  4500
=001  9880364143202441
=005  20141212200253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003243
=035  \\$aCBA8549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x409
=072  \\$aF2.$x830.$x233
=150  \\$aConsciousness
=450  \\$wnnna$aConsciousnesses
=550  \\$wg$aCognition
=550  \\$wg$aPsychophysiology
=680  \\$iSense of awareness of self and of the environment.
=750  \0$aConsciousness$5IEN$0(DLC)sh 85031235

=LDR  01073cz  a2200229n  4500
=001  9880364143302441
=005  20141212203535.0
=008  780515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D008947
=035  \\$aCBA8548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x540
=150  \\$aMixed Connective Tissue Disease
=450  \\$aConnective Tissue Disease, Mixed
=450  \\$wnnna$aMCTD
=450  \\$aSharp Syndrome
=450  \\$wnnna$aSyndrome, Sharp
=550  \\$wg$aConnective Tissue Diseases
=667  \\$adisease entity: read definition & do not confuse with CONNECTIVE TISSUE DISEASES; DF: MCTD
=680  \\$iA syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence.
=688  \\$a79
=750  \0$aMixed connective tissue disease$5IEN$0(DLC)sh 86008039

=LDR  00968cz  a2200301n  4500
=001  9880364143402441
=005  20141212200251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003238
=035  \\$aCBA8547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165
=150  \\$aConnective Tissue
=450  \\$wnnna$aConnective Tissues
=450  \\$wnnna$aTissue, Connective
=450  \\$wnnna$aTissues, Connective
=550  \\$wg$aTissues
=550  \\$wh$aAdipose Tissue
=550  \\$wh$aAdventitia
=550  \\$wh$aBone and Bones
=550  \\$wh$aCartilage
=550  \\$wh$aElastic Tissue
=550  \\$wh$aGranulation Tissue
=550  \\$wh$aSubcutaneous Tissue
=550  \\$wh$aWharton Jelly
=667  \\$ainflammation: consider CELLULITIS
=680  \\$iTissue that supports and binds other tissues. It consists of CONNECTIVE TISSUE CELLS embedded in a large amount of EXTRACELLULAR MATRIX.
=750  \0$aConnective tissues$5IEN$0(DLC)sh 85031183

=LDR  00614cz  a2200193n  4500
=001  9880364143502441
=005  20141212200243.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003212
=035  \\$aCBA8546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x250
=150  \\$aCondiments
=450  \\$wnnna$aCondiment
=550  \\$wg$aFood
=550  \\$wh$aSpices
=667  \\$aSPICES & other condiments are also available
=680  \\$iAromatic substances added to food before or after cooking to enhance its flavor. These are usually of vegetable origin.
=750  \0$aCondiments$5IEN-M$0(DLC)sh 85030772

=LDR  01100cz  a2200301n  4500
=001  9880364143602441
=005  20141212200224.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003156
=035  \\$aCBA8545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x408.$x307
=072  \\$aN2.$x421.$x143.$x183
=072  \\$aN2.$x421.$x461.$x232
=150  \\$aCommunity Mental Health Services
=450  \\$wnnna$aAssertive Community Treatment
=450  \\$wnnna$aCommunity Treatment, Assertive
=450  \\$wnnna$aHealth Services, Community Mental
=450  \\$aMental Health Services, Community
=450  \\$wnnna$aServices, Community Mental Health
=450  \\$wnnna$aServices, Mental Health Community
=450  \\$wnnna$aTreatment, Assertive Community
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aMental Health Services
=667  \\$aPublic Laws 88-164 & 89-105
=680  \\$iDiagnostic, therapeutic and preventive mental health services provided for individuals in the community.
=688  \\$a67
=750  \0$aCommunity mental health services$5IEN-M$0(DLC)sh 85029245

=LDR  01854cz  a2200541n  4500
=001  9880364143702441
=005  20180102090820.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003153
=035  \\$aCBA8544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143
=150  \\$aCommunity Health Services
=450  \\$wnnna$aCare, Community Health
=450  \\$aCommunity Health Care
=450  \\$wnnna$aCommunity Health Service
=450  \\$wnnna$aCommunity Healthcare
=450  \\$wnnna$aCommunity Healthcares
=450  \\$wnnna$aHealth Care, Community
=450  \\$wnnna$aHealth Service, Community
=450  \\$wnnna$aHealth Services, Community
=450  \\$wnnna$aHealthcare, Community
=450  \\$wnnna$aHealthcares, Community
=450  \\$wnnna$aService, Community Health
=450  \\$wnnna$aServices, Community Health
=550  \\$wg$aHealth Services
=550  \\$wh$aChild Health Services
=550  \\$wh$aCommunity Health Nursing
=550  \\$wh$aCommunity Mental Health Services
=550  \\$wh$aCommunity Networks
=550  \\$wh$aCommunity Participation
=550  \\$wh$aCommunity Pharmacy Services
=550  \\$wh$aCounseling
=550  \\$wh$aFamily Planning Services
=550  \\$wh$aFoster Home Care
=550  \\$wh$aHome Care Services
=550  \\$wh$aHospices
=550  \\$wh$aMaternal Health Services
=550  \\$wh$aOccupational Health Services
=550  \\$wh$aPreventive Health Services
=550  \\$wh$aSenior Centers
=550  \\$aCommunity Health Planning
=550  \\$aPublic Health Administration
=550  \\$aSocial Work
=667  \\$aIM; DF: COMMUNITY HEALTH SERV
=680  \\$iDiagnostic, therapeutic and preventive health services provided for individuals in the community.
=688  \\$a67(65)
=750  \0$aCommunity health services$5IEN$0(DLC)sh 85029232

=LDR  02161cz  a2200637n  4500
=001  9880364143802441
=005  20200625123706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003142
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x209
=072  \\$aL1.$x143
=150  \\$aCommunication
=450  \\$wnnna$aCommunication, Personal
=450  \\$wnnna$aCommunication Program
=450  \\$wnnna$aCommunication Programs
=450  \\$wnnna$aCommunications Personnel
=450  \\$aLiteracy
=450  \\$wnnna$aMisinformation
=450  \\$wnnna$aPersonal Communication
=450  \\$wnnna$aPersonnel, Communications
=450  \\$wnnna$aProgram, Communication
=450  \\$wnnna$aPrograms, Communication
=550  \\$wg$aBehavior
=550  \\$wg$aInformation Science
=550  \\$wh$aAccess to Information
=550  \\$wh$aAdvertising as Topic
=550  \\$wh$aAnswering Services
=550  \\$wh$aCell Phone Use
=550  \\$wh$aCommunication Barriers
=550  \\$wh$aComputer Literacy
=550  \\$wh$aCybernetics
=550  \\$wh$aDiffusion of Innovation
=550  \\$wh$aDisclosure
=550  \\$wh$aHealth Communication
=550  \\$wh$aHotlines
=550  \\$wh$aInformation Dissemination
=550  \\$wh$aInformation Literacy
=550  \\$wh$aInformation Seeking Behavior
=550  \\$wh$aInterdisciplinary Communication
=550  \\$wh$aLanguage
=550  \\$wh$aNarration
=550  \\$wh$aNegotiating
=550  \\$wh$aNonverbal Communication
=550  \\$wh$aPersuasive Communication
=550  \\$wh$aPropaganda
=550  \\$wh$aPublic Service Announcements as Topic
=550  \\$wh$aReminder Systems
=550  \\$wh$aScholarly Communication
=550  \\$wh$aSocial Networking
=550  \\$wh$aTeach-Back Communication
=550  \\$wh$aVerbal Behavior
=667  \\$aincludes personal & technological communication; ANIMAL COMMUNICATION is also available
=680  \\$iThe exchange or transmission of ideas, attitudes, or beliefs between individuals or groups.
=750  \0$aCommunication$5IEN-M$0(DLC)sh 85029027
=750  \0$aInterpersonal communication$0(DLC)sh 85067481$5IEN-M

=LDR  01382cz  a2200385n  4500
=001  9880364143902441
=005  20200526130214.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003140
=035  \\$aCBA8542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200
=150  \\$aCommunicable Disease Control
=450  \\$aCommunicable Diseases$xprevention & control
=450  \\$wnnna$aControl, Communicable Disease
=450  \\$wnnna$aControl, Parasite
=450  \\$wnnna$aParasite Control
=550  \\$wg$aPublic Health Practice
=550  \\$wh$aAnimal Culling
=550  \\$wh$aContact Tracing
=550  \\$wh$aDisease Notification
=550  \\$wh$aFumigation
=550  \\$wh$aHand Hygiene
=550  \\$wh$aImmunization
=550  \\$wh$aInfection Control
=550  \\$wh$aMandatory Testing
=550  \\$wh$aMass Drug Administration
=550  \\$wh$aPest Control
=550  \\$wh$aSanitation
=550  \\$wh$aUniversal Precautions
=550  \\$aDisease Eradication
=550  \\$aInfectious Disease Medicine
=667  \\$ageneral only: prefer specific disease with /prev; INFECTION CONTROL is also available: see note there
=680  \\$iPrograms of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.
=750  \0$aCommunicable diseases$xPrevention$5IEN$0(DLC)sh 85029020

=LDR  01238cz  a2200301n  4500
=001  9880364144002441
=005  20141212200206.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003106
=035  \\$aCBA8541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526.$x356
=072  \\$aA3.$x556.$x249.$x249.$x356
=150  \\$aColon
=450  \\$wnnna$aAppendices, Omental
=450  \\$aAppendix Epiploica
=450  \\$wnnna$aAppendix, Omental
=450  \\$wnnna$aOmental Appendices
=450  \\$wnnna$aOmental Appendix
=450  \\$aTaenia Coli
=550  \\$wg$aIntestine, Large
=550  \\$wh$aColon, Ascending
=550  \\$wh$aColon, Descending
=550  \\$wh$aColon, Sigmoid
=550  \\$wh$aColon, Transverse
=667  \\$aX ref TAENIA COLI: do not confuse with Taenia, a genus of tapeworm; inflammation = COLITIS; /surg: do not confuse with specialty COLORECTAL SURGERY & consider also COLECTOMY or COLOSTOMY; note X refs: coord with specific tissue type if appropriate
=680  \\$iThe segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.
=750  \0$aColon (Anatomy)$5IEN$0(DLC)sh 85028542

=LDR  01639cz  a2200313n  4500
=001  9880364144102441
=005  20141212200203.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003095
=035  \\$aCBA8540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x300.$x200
=150  \\$aCollagen Diseases
=450  \\$wnnna$aCollagen Disease
=450  \\$wnnna$aDisease, Collagen
=450  \\$wnnna$aDiseases, Collagen
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wh$aEhlers-Danlos Syndrome
=550  \\$wh$aEpidermolysis Bullosa Dystrophica
=550  \\$wh$aKeloid
=550  \\$wh$aNecrobiotic Disorders
=550  \\$wh$aNephritis, Hereditary
=550  \\$wh$aOsteogenesis Imperfecta
=550  \\$aAntibodies, Antinuclear
=550  \\$aConnective Tissue Diseases
=550  \\$aRheumatology
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iHistorically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494)
=750  \0$aCollagen diseases$5IEN$0(DLC)sh 85027970

=LDR  01128cz  a2200337n  4500
=001  9880364144202441
=005  20201124145100.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003080
=035  \\$aCBA8539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x906.$x595.$x272
=072  \\$aG16.$x500.$x275.$x63.$x725.$x710.$x300
=072  \\$aG16.$x500.$x750.$x775.$x710.$x300
=072  \\$aN6.$x230.$x300.$x100.$x725.$x154
=072  \\$aN6.$x230.$x300.$x100.$x725.$x710.$x300
=150  \\$aCold Temperature
=360  \\$iconsider also terms at$aCRYO-
=450  \\$aCold
=450  \\$wnnna$aCold Temperatures
=450  \\$wnnna$aTemperature, Cold
=450  \\$wnnna$aTemperatures, Cold
=550  \\$wg$aTemperature
=550  \\$wg$aWeather
=550  \\$wh$aExtreme Cold Weather
=550  \\$wh$aFreezing
=667  \\$acooling of organs during surg goes under HYPOTHERMIA, INDUCED
=680  \\$iAn absence of warmth or heat or a temperature notably below an accustomed norm.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Cold
=750  \0$aCold$0(DLC) sh 85027909$5IEN

=LDR  00710cz   2200205n  4500
=001  9880364144302441
=005  20220926153826.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003069
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x249
=072  \\$aJ2.$x200.$x325
=150  \\$aCoffee
=550  \\$wg$aBeverages
=550  \\$wg$aPlant Preparations
=550  \\$aCoffea
=667  \\$afor the plant use COFFEA
=680  \\$iA beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.
=750  \0$aCoffee$5IEN$0(DLC)sh 85027699
=750  \0$iNarrower mapping$aRobusta coffee$0(DLC)sh2021006939$4NM$5IEN-M

=LDR  00877cz  a2200289n  4500
=001  9880364144402441
=005  20141212200126.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002980
=035  \\$aCBA8537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x71
=072  \\$aN6.$x230.$x300.$x100.$x250
=150  \\$aClimate
=450  \\$wnnna$aClimates
=450  \\$aClimatology$5IEN
=550  \\$wg$aAtmosphere
=550  \\$wg$aEnvironment
=550  \\$wh$aCold Climate
=550  \\$wh$aDesert Climate
=550  \\$wh$aEl Nino-Southern Oscillation
=550  \\$wh$aMicroclimate
=550  \\$wh$aSeasons
=550  \\$wh$aTropical Climate
=667  \\$ageneral; note specifics
=680  \\$iThe longterm manifestations of WEATHER. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aClimatology$5IEN$0(DLC)sh 85027044

=LDR  01707cz  a2200445n  4500
=001  9880364144502441
=005  20141212200113.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002940
=035  \\$aCBA8536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x180.$x562.$x190
=150  \\$aCircadian Rhythm
=450  \\$wnnna$aCircadian Rhythms
=450  \\$aDiurnal Rhythm
=450  \\$wnnna$aDiurnal Rhythms
=450  \\$aNyctohemeral Rhythm
=450  \\$wnnna$aNyctohemeral Rhythms
=450  \\$wnnna$aRhythm, Circadian
=450  \\$wnnna$aRhythm, Diurnal
=450  \\$wnnna$aRhythm, Nyctohemeral
=450  \\$wnnna$aRhythm, Twenty-Four Hour
=450  \\$wnnna$aRhythms, Circadian
=450  \\$wnnna$aRhythms, Diurnal
=450  \\$wnnna$aRhythms, Nyctohemeral
=450  \\$wnnna$aRhythms, Twenty-Four Hour
=450  \\$aTwenty-Four Hour Rhythm
=450  \\$wnnna$aTwenty Four Hour Rhythm
=450  \\$wnnna$aTwenty-Four Hour Rhythms
=550  \\$wg$aPeriodicity
=550  \\$wh$aActivity Cycles
=550  \\$aBiological Clocks
=550  \\$aChronotherapy
=550  \\$aCircadian Clocks
=550  \\$aPeriodicity
=550  \\$aPhotoperiod
=667  \\$adrug administration based on circadian rhythm = DRUG CHRONOTHERAPY: do not coordinate with CIRCADIAN RHYTHM or DRUG ADMINISTRATION SCHEDULE; jet lag: index JET LAG SYNDROME
=680  \\$iThe regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, and feeding.
=688  \\$a66(64); DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85 (Prov 1969-74)
=750  \0$aCircadian rhythms$0(DLC) sh 85026049$5IEN

=LDR  01123cz  a2200193n  4500
=001  9880364144602441
=005  20141212200110.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002923
=035  \\$aCBA8535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x180.$x165
=150  \\$aCilia
=450  \\$wnnna$aCilium
=550  \\$wg$aCell Surface Extensions
=667  \\$aIM GEN only; NIM when specific organ is IM; A 11 qualif except /cytol; /genet permitted; do not confuse with the protozoa CILIATA see CILIOPHORA or with the Latin plural of EYELASHES
=680  \\$iPopulations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King & Stansfield, A Dictionary of Genetics, 4th ed)
=688  \\$a65(64)
=750  \0$aCilia and ciliary motion$5IEN$0(DLC)sh 85025973

=LDR  01366cz  a2200373n  4500
=001  9880364144702441
=005  20141212200059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002875
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x187
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190
=072  \\$aG5.$x360.$x162
=150  \\$aChromosomes
=450  \\$wnnna$aChromosome
=550  \\$wg$aCellular Structures
=550  \\$wg$aGenetic Structures
=550  \\$wg$aIntranuclear Space
=550  \\$wh$aChromosome Structures
=550  \\$wh$aChromosomes, Archaeal
=550  \\$wh$aChromosomes, Artificial
=550  \\$wh$aChromosomes, Bacterial
=550  \\$wh$aChromosomes, Fungal
=550  \\$wh$aChromosomes, Insect
=550  \\$wh$aChromosomes, Mammalian
=550  \\$wh$aChromosomes, Plant
=550  \\$wh$aIsochromosomes
=550  \\$wh$aKaryotype
=550  \\$wh$aPolytene Chromosomes
=550  \\$wh$aRing Chromosomes
=550  \\$wh$aSex Chromosomes
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iIn a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=750  \0$aChromosomes$5IEN$0(DLC)sh 85025391

=LDR  00879cz  a2200217n  4500
=001  9880364144802441
=005  20141212200011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002736
=035  \\$aCBA8533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x700.$x140
=150  \\$aChloroplasts
=450  \\$wnnna$aChloroplast
=450  \\$wnnna$aEtioplast
=450  \\$wnnna$aEtioplasts
=550  \\$wg$aPlastids
=550  \\$wh$aThylakoids
=680  \\$iPlant cell inclusion bodies that contain the photosynthetic pigment CHLOROPHYLL, which is associated with the membrane of THYLAKOIDS. Chloroplasts occur in cells of leaves and young stems of plants. They are also found in some forms of PHYTOPLANKTON such as HAPTOPHYTA; DINOFLAGELLATES; DIATOMS; and CRYPTOPHYTA.
=688  \\$a66(64)
=750  \0$aChloroplasts$5IEN-M$0(DLC)sh 85024586

=LDR  01111cz  a2200337n  4500
=001  9880364144902441
=005  20141212200011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002734
=035  \\$aCBA8532HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x374
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500.$x640.$x220
=072  \\$aD3.$x549.$x909.$x374
=072  \\$aD3.$x549.$x909.$x500.$x640.$x220
=072  \\$aD4.$x345.$x783.$x374
=072  \\$aD4.$x345.$x783.$x500.$x640.$x220
=072  \\$aD23.$x767.$x727.$x220
=072  \\$aD23.$x767.$x727.$x640.$x220
=150  \\$aChlorophyll
=450  \\$wnnna$a740, Chlorophyll
=450  \\$wnnna$aChlorophyll 740
=550  \\$wg$aMetalloporphyrins
=550  \\$wg$aPorphyrins
=550  \\$wg$aTetrapyrroles
=550  \\$wh$aBacteriochlorophylls
=550  \\$wh$aChlorophyllides
=550  \\$wh$aPheophytins
=550  \\$wh$aProtochlorophyllide
=680  \\$iPorphyrin derivatives containing magnesium that act to convert light energy in photosynthetic organisms.
=750  \0$aChlorophyll$5IEN$0(DLC)sh 85024579

=LDR  00690cz  a2200217n  4500
=001  9880364145002441
=005  20161109160038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002669
=035  \\$aCBA8531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x293
=150  \\$aChild Welfare
=450  \\$wnnna$aWelfare, Child
=550  \\$wg$aSocial Welfare
=550  \\$wh$aChild Advocacy
=550  \\$wh$aChild Custody
=550  \\$wh$aChild Day Care Centers
=667  \\$acheck the tag CHILD or specific
=680  \\$iOrganized efforts by communities or organizations to improve the health and well-being of the child.
=750  \0$aChild welfare$5IEN$0(DLC)sh 85023396

=LDR  01333cz  a2200253n  4500
=001  9880364145102441
=005  20141212195953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002668
=035  \\$aCBA8530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x318
=150  \\$aChild Rearing
=450  \\$wnnna$aChild Rearings
=450  \\$wnnna$aRearing, Child
=450  \\$wnnna$aRearings, Child
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aToilet Training
=550  \\$aChild Care
=550  \\$aParenting
=667  \\$acheck also tag CHILD or specific; differentiate from PARENTING which emphasizes the role & responsibility of the parent while CHILD REARING emphasizes the upbringing: read MeSH definitions but if in doubt use term of author
=680  \\$iThe training or bringing-up of children by parents or parent-substitutes. It is used also for child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. It differs from PARENTING in that in child rearing the emphasis is on the act of training or bringing up the child and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent.
=688  \\$a68(64)
=750  \0$aChild rearing$5IEN-M$0(DLC)sh 85023387

=LDR  00939nz  a2200265n  4500
=001  9881575863902441
=005  20180904000000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077588
=035  \\$a(NLM)9811675370500041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x250
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x266
=072  \\$aD3.$x383.$x129.$x799.$x363
=150  \\$aDeferasirox
=450  \\$wnnna$a4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid
=450  \\$wnnna$aExjade
=450  \\$wnnna$aICL 670
=450  \\$wnnna$aICL 670A
=450  \\$wnnna$aICL-670
=450  \\$wnnna$aICL-670A
=450  \\$wnnna$aICL670
=450  \\$wnnna$aICL670A
=680  \\$iA triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA.
=688  \\$a2019 (2000)

=LDR  00586nz  a2200157n  4500
=001  9881575865702441
=005  20180904000000.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078326
=035  \\$a(NLM)9811675308900041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x288
=150  \\$aData Visualization
=450  \\$wnnna$aVisualization, Data
=680  \\$iFacilitating understanding of the significance of data by placing it in a visual context. Patterns, trends and correlations that might go undetected in text-based data may be exposed and recognized easier.
=688  \\$a2019

=LDR  01281cz  a2200325n  4500
=001  9881575865902441
=005  20210129205431.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077224
=035  \\$a(NLM)9811683548700041
=040  \\$aDNLM$cDNLM
=060  \0$aHV 6773.15.C92
=072  \\$aF1.$x145.$x126.$x125.$x550.$x500
=072  \\$aF1.$x145.$x813.$x213.$x500.$x500
=072  \\$aI1.$x880.$x735.$x70.$x500
=150  \\$aCyberbullying
=450  \\$aCyber Bullying
=450  \\$aCyber-Victimization
=450  \\$aOn-line Bullying
=450  \\$aOnline Bullying
=450  \\$aVirtual Bullying
=450  \\$wnnna$aBullying, Cyber
=450  \\$wnnna$aBullying, On-line
=450  \\$wnnna$aBullying, Online
=450  \\$wnnna$aBullying, Virtual
=450  \\$wnnna$aCyber Victimization
=450  \\$wnnna$aOn line Bullying
=680  \\$iBullying that takes place over digital devices like cell phones and computers. It includes sending, posting, or sharing negative, harmful, false, or mean content about someone else. It can include sharing personal or private information about someone else causing embarrassment or humiliation. (from https://www.stopbullying.gov)
=688  \\$a2019; use Bullying 2018
=750  \0$aCyberbullying$0(DLC)sh2006004667$5IEN-M

=LDR  00868nz  a2200217n  4500
=001  9881586372302441
=005  20210208175313.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077330
=035  \\$a(NLM)9811675730000041
=040  \\$aDNLM$cDNLM
=072  \\$aD26.$x776.$x498.$x500.$x750
=150  \\$aSaline Solution
=450  \\$wnnna$a0.9% NaCl
=450  \\$wnnna$a0.9% Saline
=450  \\$wnnna$aNormal Saline
=450  \\$wnnna$aSaline, 0.9%
=450  \\$wnnna$aSaline, Normal
=680  \\$iA crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY.
=688  \\$a2019; use SODIUM CHLORIDE 1978-2018
=750  \0$iBroader mapping$aSolution (Chemistry)$0(DLC)sh 85124730$4BM$5IEN-M

=LDR  00517nz  a2200169n  4500
=001  9881586372402441
=005  20210208173312.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078602
=035  \\$a(NLM)9811675429800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x933
=150  \\$aSadness
=450  \\$wnnna$aUnhappiness
=680  \\$iFeeling or showing sorrow; the sense of being unhappy. It is related to DEPRESSION but is not synonymous.
=688  \\$a2019
=750  \0$aSadness$0(DLC) sh 85116428$5IEN-M

=LDR  00970nz  a2200253n  4500
=001  9881586471802441
=005  20210208113102.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077154
=035  \\$a(NLM)9811684143800041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x886.$x675.$x933.$x500
=072  \\$aD3.$x383.$x129.$x708.$x933.$x500
=150  \\$aRosiglitazone
=450  \\$wnnna$a5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
=450  \\$wnnna$aAvandia
=450  \\$wnnna$aBRL 49653
=450  \\$wnnna$aBRL-49653
=450  \\$wnnna$aBRL49653
=450  \\$wnnna$aRosiglitazone Maleate
=550  \\$aPioglitazone
=680  \\$iA thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.
=688  \\$a2019 (1994)
=750  \0$aRosiglitazone$0(DLC) sh2009002732$5IEN-M

=LDR  00746nz  a2200193n  4500
=001  9881586472002441
=005  20210208110633.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077315
=035  \\$a(NLM)9811675544400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x263.$x750
=072  \\$aF1.$x470.$x93.$x640.$x500
=072  \\$aI1.$x880.$x735.$x223.$x375
=072  \\$aI3.$x125.$x824
=150  \\$aRoad Rage
=680  \\$iExtreme anger generated from a traffic incident or accident that leads to an assault with a motor vehicle or other dangerous weapon by the operator or passenger(s) of one motor vehicle on the operator or passenger(s) of another motor vehicle.
=688  \\$a2019
=750  \0$aRoad rage$0(DLC) sh 96010119$5IEN-M

=LDR  00559nz  a2200169n  4500
=001  9881587173502441
=005  20210209124635.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076607
=035  \\$a(NLM)9811684076600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x890
=150  \\$aSaxifragales
=450  \\$wnnna$aSaxiphragales
=680  \\$iOrder of dicotyledonous flowering plants consisting of 16 families, 112 genera, and nearly 2,500 species.
=688  \\$a2019
=750  \0$aSaxifragales$0(DLC)sh2015001822$5IEN-M

=LDR  01670nz  a2200433n  4500
=001  9881587173702441
=005  20210209123643.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077323
=035  \\$a(NLM)9811675535500041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x775.$x813
=150  \\$aSalt Stress
=450  \\$wnnna$aSalinity Stress
=450  \\$wnnna$aSalinity Stress Reaction
=450  \\$wnnna$aSalinity Stress Reponse
=450  \\$wnnna$aSalt Stress Reaction
=450  \\$wnnna$aSalt Stress Response
=450  \\$wnnna$aReaction, Salinity Stress
=450  \\$wnnna$aReaction, Salt Stress
=450  \\$wnnna$aReponse, Salinity Stress
=450  \\$wnnna$aResponse, Salt Stress
=450  \\$wnnna$aSalinity Stress Reactions
=450  \\$wnnna$aSalinity Stress Reponses
=450  \\$wnnna$aSalinity Stresses
=450  \\$wnnna$aSalt Stress Reactions
=450  \\$wnnna$aSalt Stress Responses
=450  \\$wnnna$aSalt Stresses
=450  \\$wnnna$aStress Reaction, Salinity
=450  \\$wnnna$aStress Reaction, Salt
=450  \\$wnnna$aStress Reponse, Salinity
=450  \\$wnnna$aStress Response, Salt
=450  \\$wnnna$aStress, Salinity
=450  \\$wnnna$aStress, Salt
=680  \\$iThe condition that results from ion toxicity due to ion imbalances (e.g., excessive Na+ and deficiency in Mg++).
=688  \\$a2019
=750  \0$81$wb$iBroader mapping$aSalt$0(DLC)sh 85116850$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aStress (Physiology)$0(DLC)sh 85128702$4BM$5IEN-M
=788  \\$iSee also the following Library of Congress Subject Headings used together in the same record:$aSalt$iand$aStress (Physiology)$5IEN-M

=LDR  00715nz  a2200193n  4500
=001  9881589971302441
=005  20210210165828.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077773
=035  \\$a(NLM)9811675632000041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x193
=072  \\$aN2.$x421.$x784.$x411
=150  \\$aHospitals, Rehabilitation
=450  \\$wnnna$aHospital, Rehabilitation
=450  \\$wnnna$aRehabilitation Hospitals
=680  \\$iFree standing rehabilitation hospitals and rehabilitation units in acute care hospitals.  They provide an intensive inpatient rehabilitation program.
=688  \\$a2019
=750  \0$aHospitals$xRehabilitation services$0(DLC) sh 86002662$5IEN-M

=LDR  00599cz  a2200205n  4500
=001  9881589971602441
=005  20210210164847.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077406
=035  \\$a(NLM)9811675683400041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 711
=072  \\$aK1.$x400.$x456
=150  \\$aHistory of Pharmacy
=450  \\$wnnna$aPharmacy, History
=450  \\$wnnna$aPharmacy History
=450  \\$aPharmacy$xhistory
=680  \\$iStudy of the origins and development of the field of PHARMACY.
=688  \\$a2019
=750  \0$aPharmacy$xHistory$0(DLC) sh2008109180$5IEN-M

=LDR  00651nz  a2200169n  4500
=001  9881589971902441
=005  20210210162425.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076889
=035  \\$a(NLM)9811684505500041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x178.$x682.$x550
=150  \\$aGray Literature
=450  \\$wnnna$aGrey Literature
=680  \\$iWorks that include publications such as reports, theses, conference papers, translations and limited circulation government documents which are not normally available through commercial publication sources. (LCSH)
=688  \\$a2019
=750  \0$aGray literature$0(DLC) sh 89006158$5IEN-M

=LDR  00945cz  a2200277n  4500
=001  9881589972202441
=005  20210210152705.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078064
=035  \\$a(NLM)9811675145400041
=040  \\$aDNLM$cDNLM
=060  \0$aWQ 200
=072  \\$aC23.$x888.$x144.$x243.$x926.$x500
=072  \\$aG7.$x345.$x249.$x314.$x120.$x200.$x926.$x500
=072  \\$aG8.$x686.$x330
=150  \\$aGestational Weight Gain
=450  \\$wnnna$aMaternal Weight Gain
=450  \\$wnnna$aPostpartum Weight Retention
=450  \\$wnnna$aPregnancy Weight Gain
=450  \\$wnnna$aWeight Gain, Gestational
=450  \\$wnnna$aWeight Gain, Maternal
=450  \\$wnnna$aWeight Gain, Pregnancy
=450  \\$wnnna$aWeight Retention, Postpartum
=680  \\$iIncrease in body weight of the mother during the course of her PREGNANCY.
=688  \\$a2019
=750  \0$aPregnant women$xWeight gain$0(DLC) sh 86000659$5IEN-M

=LDR  00829nz  a2200229n  4500
=001  9881590469602441
=005  20210212180147.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076666
=035  \\$a(NLM)9811684524000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x908
=150  \\$aSolanales
=450  \\$wnnna$aCestrales
=450  \\$wnnna$aConvolvulales
=450  \\$wnnna$aCuscutales
=450  \\$wnnna$aHydroleales
=450  \\$wnnna$aNolanales
=450  \\$wnnna$aSphenocleales
=680  \\$iAn order of flowering plants comprising tropical and temperate species, major crop plants such as potatoes, tomatoes, bell peppers, eggplants, tobacco, and the garden petunia. Its largest family is the SOLANACEAE.
=688  \\$a2019
=750  \0$aTubiflorae$0(DLC) sh 85138462$5IEN-M

=LDR  01172nz  a2200289n  4500
=001  9881590773002441
=005  20210211145905.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077923
=035  \\$a(NLM)9811675159700041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x540.$x828.$x919
=150  \\$aSocieties, Veterinary
=450  \\$wnnna$aSociety, Veterinary
=450  \\$wnnna$aVeterinary Hospital Societies
=450  \\$wnnna$aVeterinary Societies
=450  \\$wnnna$aVeterinary Society
=450  \\$wnnna$aHospital Societies, Veterinary
=450  \\$wnnna$aHospital Society, Veterinary
=450  \\$wnnna$aSocieties, Veterinary Hospital
=450  \\$wnnna$aSociety, Veterinary Hospital
=450  \\$wnnna$aVeterinary Hospital Society
=680  \\$iOrganizations having institutional membership limited to veterinarians and veterinary institutions.
=688  \\$a2019
=750  \0$81$wb$iBroader mapping$aVeterinary medicine$0(DLC)sh 85143046$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xSocieties, etc.$0(DLC)sh2001008901$4BM$wIEN-M
=788  \0$iSee also under the Library of Congress Subject Heading$aVeterinary medicine--Societies, etc.$5IEN-M

=LDR  00466cz  a2200181n  4500
=001  9881590773202441
=005  20210211140927.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077260
=035  \\$a(NLM)9811683925900041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 146
=072  \\$aC23.$x888.$x900
=150  \\$aSleepiness
=450  \\$wnnna$aSomnolence
=680  \\$iCompelling urge to sleep.
=688  \\$a2019
=750  \0$aDrowsiness$0(DLC) sh 93003994$5IEN-M

=LDR  01061cz  a2200301n  4500
=001  9881590773402441
=005  20210211140229.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077310
=035  \\$a(NLM)9811675545900041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x830.$x855.$x796.$x835
=072  \\$aG11.$x561.$x803.$x754.$x835
=150  \\$aSleep, Slow-Wave
=450  \\$wnnna$aDeep Sleep
=450  \\$wnnna$aDelta Sleep
=450  \\$wnnna$aN3 Sleep
=450  \\$wnnna$aNREM Stage 3
=450  \\$wnnna$aSlow-Wave Sleep
=450  \\$wnnna$aSleep, Deep
=450  \\$wnnna$aSleep, Delta
=450  \\$wnnna$aSleep, N3
=450  \\$wnnna$aSleep, Slow Wave
=450  \\$wnnna$aSlow Wave Sleep
=450  \\$wnnna$aStage 3, NREM
=680  \\$iA stage of sleep characterized by synchronized wave activity as observed in the ELECTROENCEPHALOGRAM; the waves exhibit a frequency of 0.5 to 2 Hz, and a peak-to-peak amplitude greater than 75 microvolts.
=688  \\$a2019; use SLEEP 1998-2018
=750  \0$aSlow wave sleep$0(DLC) sh 88007034$5IEN-M

=LDR  00677nz  a2200229n  4500
=001  9881590773902441
=005  20210211134905.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077708
=035  \\$a(NLM)9811675500700041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x695.$x575
=150  \\$aSitting Position
=450  \\$wnnna$aSeated Position
=450  \\$wnnna$aSitting
=450  \\$wnnna$aPosition, Seated
=450  \\$wnnna$aPosition, Sitting
=450  \\$wnnna$aPositions, Seated
=450  \\$wnnna$aSeated Positions
=450  \\$wnnna$aSitting Positions
=688  \\$a2019; use Posture (2006-2018)
=750  \0$aSitting position$0(DLC) sh 85123040$5IEN-M

=LDR  01092cz  a2200265n  4500
=001  9881590870502441
=005  20210212075032.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078462
=035  \\$a(NLM)9811675291900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420
=072  \\$aF1.$x829.$x401.$x650.$x918
=072  \\$aF4.$x754.$x720.$x605
=072  \\$aF4.$x754.$x932
=150  \\$aTherapeutic Alliance
=450  \\$wnnna$aAlliance, Therapeutic
=450  \\$wnnna$aAlliances, Therapeutic
=450  \\$wnnna$aTherapeutic Alliances
=550  \\$wg$aProfessional-Patient Relations
=550  \\$wg$aPsychotherapeutic Processes
=550  \\$wg$aPsychotherapy
=680  \\$iA relational factor in counseling that includes three dimensions: goal consensus between counselor and client, collaboration on counseling-related tasks, and emotional bonding.  It is referred to as the working alliance between a therapist and a client in psychotherapy and closely correlated with positive client outcomes.
=688  \\$a2019
=750  \0$aTherapeutic alliance$0(DLC)sh 93006341$5IEN-M

=LDR  01152nz  a2200349n  4500
=001  9881590870802441
=005  20210219093321.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077291
=035  \\$a(NLM)9811675566800041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x953
=072  \\$aD4.$x615.$x638.$x953
=150  \\$aTerbinafine
=450  \\$wnnna$a(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride
=450  \\$wnnna$aDA 5505
=450  \\$wnnna$aLamisil
=450  \\$wnnna$aSF 86-327
=450  \\$wnnna$aSF-86-327
=450  \\$wnnna$aTDT-067
=450  \\$wnnna$aTerbinafine Hydrochloride
=450  \\$wnnna$aTerbinafine, (Z)-
=450  \\$wnnna$aTerbinafine, (Z)-isomer
=450  \\$wnnna$aSF 86 327
=450  \\$wnnna$aSF 86327
=450  \\$wnnna$aSF86327
=450  \\$wnnna$aTDT 067
=450  \\$wnnna$aTDT067
=550  \\$wg$aNaphthalenes
=680  \\$iA naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails.
=688  \\$a2019 (1984)
=750  \0$aTerbinafine$0(DLC) sh2001002939$5IEN-M

=LDR  00629cz  a2200205n  4500
=001  9881590872902441
=005  20210211133251.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077230
=035  \\$a(NLM)9811683547200041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x539
=072  \\$aL1.$x224.$x230.$x110.$x500.$x625
=150  \\$aInternet Access
=450  \\$aWeb Access
=450  \\$wnnna$aAccess, Internet
=450  \\$wnnna$aAccess, Web
=680  \\$iAbility to connect to access services available on the Internet.
=688  \\$a2019; INTERNET (1999-2018)
=750  \0$aInternet access$0(DLC)sh2012004026$5IEN-M

=LDR  00773nz  a2200181n  4500
=001  9881590873802441
=005  20210211132059.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076702
=035  \\$a(NLM)9811684517500041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x400.$x468
=072  \\$aN3.$x706.$x615.$x473.$x250
=150  \\$aInternational Health Regulations
=450  \\$wnnna$aInternational Health Regulation
=680  \\$iRegulations to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks. (www.who.int/features/qa/39/en)
=688  \\$a2019
=750  \0$aPublic health laws, International$0(DLC)sh 85108660$5IEN-M

=LDR  02125nz  a2200577n  4500
=001  9881590874002441
=005  20210211105443.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076662
=035  \\$a(NLM)9811684530000041
=040  \\$aDNLM$cDNLM
=072  \\$aG6.$x373
=072  \\$aG16.$x527
=150  \\$aHost Microbial Interactions
=450  \\$wnnna$aBacteria Host Interactions
=450  \\$wnnna$aBacterial-Host Interactions
=450  \\$wnnna$aBacterium-Host Interactions
=450  \\$wnnna$aHost Bacteria Interactions
=450  \\$wnnna$aHost Microbe Interactions
=450  \\$wnnna$aHost Microbiota Interactions
=450  \\$wnnna$aHost Virus Interactions
=450  \\$wnnna$aHost-Fungal Interactions
=450  \\$wnnna$aHost-Microbial Interface
=450  \\$wnnna$aMicrobe Host Interactions
=450  \\$wnnna$aMicrobial Host Interactions
=450  \\$wnnna$aMicrobiota Host Interactions
=450  \\$wnnna$aViral-Host Interactions
=450  \\$wnnna$aVirus Host Interactions
=450  \\$wnnna$aBacteria Host Interaction
=450  \\$wnnna$aBacterial Host Interactions
=450  \\$wnnna$aBacterial-Host Interaction
=450  \\$wnnna$aBacterium Host Interactions
=450  \\$wnnna$aBacterium-Host Interaction
=450  \\$wnnna$aHost Bacteria Interaction
=450  \\$wnnna$aHost Fungal Interactions
=450  \\$wnnna$aHost Microbe Interaction
=450  \\$wnnna$aHost Microbial Interaction
=450  \\$wnnna$aHost Microbial Interface
=450  \\$wnnna$aHost Microbiota Interaction
=450  \\$wnnna$aHost Virus Interaction
=450  \\$wnnna$aHost-Fungal Interaction
=450  \\$wnnna$aHost-Microbial Interfaces
=450  \\$wnnna$aMicrobe Host Interaction
=450  \\$wnnna$aMicrobial Host Interaction
=450  \\$wnnna$aMicrobiota Host Interaction
=450  \\$wnnna$aViral Host Interactions
=450  \\$wnnna$aViral-Host Interaction
=450  \\$wnnna$aVirus Host Interaction
=680  \\$iInteractions between a host and microbe or microbiota.
=688  \\$a2019
=750  \0$aHost-bacteria relationships$0(DLC) sh 87005692$5IEN-M

=LDR  01364cz  a2200421n  4500
=001  9881591261602441
=005  20210217180102.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077334
=035  \\$a(NLM)9811675561000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x725.$x971
=150  \\$aZolpidem
=450  \\$wnnna$aAmbien
=450  \\$wnnna$aAmsic
=450  \\$wnnna$aBikalm
=450  \\$wnnna$aDalparan
=450  \\$wnnna$aN,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate
=450  \\$wnnna$aSL 80.0750
=450  \\$wnnna$aSL-800750-23-N
=450  \\$wnnna$aStilnoct
=450  \\$wnnna$aStilnox
=450  \\$wnnna$aZodormdura
=450  \\$wnnna$aZoldem
=450  \\$wnnna$aZolirin
=450  \\$wnnna$aZolpi-Lich
=450  \\$wnnna$aZolpidem 1A Pharma
=450  \\$wnnna$aZolpidem AbZ
=450  \\$wnnna$aZolpidem Hemitartrate
=450  \\$wnnna$aZolpidem Tartrate
=450  \\$wnnna$aZolpimist
=450  \\$wnnna$aZolpinox
=450  \\$aImidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-
=450  \\$wnnna$aSL 800750 23 N
=450  \\$wnnna$aZolpi Lich
=680  \\$iAn imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
=688  \\$a2019 (1985)
=750  \2$aZolpidem$0(DLC) sh 87005154$5IEN-M

=LDR  00995cz  a2200313n  4500
=001  9881591261802441
=005  20210217174901.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078329
=035  \\$a(NLM)9811675306100041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x452.$x525
=150  \\$aWorkforce
=450  \\$wnnna$aHuman Resources
=450  \\$wnnna$aLabor Supply
=450  \\$wnnna$aManpower
=450  \\$wnnna$aStaffing
=450  \\$wnnna$aWomanpower
=450  \\$wnnna$aHuman Resource
=450  \\$wnnna$aLabor Supplies
=450  \\$wnnna$aManpowers
=450  \\$wnnna$aStaffings
=450  \\$wnnna$aSupply, Labor
=450  \\$wnnna$aWomanpowers
=450  \\$wnnna$aWorkforces
=667  \\$acoordinate with specific discipline, occupation, service or program if pertinent; HEALTH WORKFORCE is also available
=680  \\$iThe number of people working or available for work or service.
=688  \\$a2019(1968)
=750  \0$aLabor supply$0(DLC) sh 85073724$5IEN-M

=LDR  01058nz  a2200373n  4500
=001  9881591262002441
=005  20210217173818.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078623
=035  \\$a(NLM)9811675425000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x836.$x649
=150  \\$aWool Fiber
=450  \\$wnnna$aWool Fabric
=450  \\$wnnna$aWool Textiles
=450  \\$wnnna$aWoolen Fiber
=450  \\$wnnna$aWoolens
=450  \\$wnnna$aFabric, Wool
=450  \\$wnnna$aFabrics, Wool
=450  \\$wnnna$aFiber, Wool
=450  \\$wnnna$aFiber, Woolen
=450  \\$wnnna$aFibers, Wool
=450  \\$wnnna$aFibers, Woolen
=450  \\$wnnna$aTextile, Wool
=450  \\$wnnna$aTextiles, Wool
=450  \\$wnnna$aWool Fabrics
=450  \\$wnnna$aWool Fibers
=450  \\$wnnna$aWool Textile
=450  \\$wnnna$aWoolen Fibers
=550  \\$aWool
=667  \\$aWOOL is also available
=680  \\$iFilament, thread, or yarn produced from WOOL.
=688  \\$a2019
=750  \0$aWool fabrics$0(DLC) sh 85148058$5IEN-M

=LDR  00532cz  a2200169n  4500
=001  9881591262402441
=005  20210217171722.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078882
=035  \\$a(NLM)9811675261600041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x230.$x110.$x500.$x875
=150  \\$aWeb Archives as Topic
=667  \\$ado not confuse with the Publication Type WEB ARCHIVE
=680  \\$iWorks about collections of preserved web pages.
=688  \\$a2019
=750  \0$aWeb archives$0(DLC) sh2004001365$5IEN-M

=LDR  01089cz  a2200205n  4500
=001  9881591272002441
=005  20210215171824.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078202
=035  \\$a(NLM)9811675330300041
=040  \\$aDNLM$cDNLM
=060  \0$aW 20.5
=072  \\$aL1.$x178.$x682.$x759.$x575
=150  \\$aSystematic Reviews as Topic
=450  \\$wnnna$aReviews Systematic as Topic
=450  \\$aSystematic Review as Topic
=667  \\$ado not confuse with the Publication Type SYSTEMATIC REVIEW
=680  \\$iWorks about a review of primary literature in health and health policy that attempt to identify, appraise, and synthesize all the empirical evidence that meets specified eligibility criteria to answer a given research question. Its conduct uses explicit methods aimed at minimizing bias in order to produce more reliable findings regarding the effects of interventions for prevention, treatment, and rehabilitation that can be used to inform decision making.
=688  \\$a2019
=750  \0$aSystematic reviews (Medical research)$0(DLC) sh 97007019$5IEN-M

=LDR  00674cz  a2200229n  4500
=001  9881591272202441
=005  20210215171115.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076742
=035  \\$a(NLM)9811684515900041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 55
=072  \\$aD26.$x909
=150  \\$aSynthetic Drugs
=450  \\$wnnna$aSynthesized Drugs
=450  \\$wnnna$aSynthetic Drug
=450  \\$wnnna$aDrug, Synthetic
=450  \\$wnnna$aDrugs, Synthesized
=450  \\$wnnna$aDrugs, Synthetic
=680  \\$iLegal or illegal drugs created using SYNTHETIC CHEMISTRY TECHNIQUES.
=688  \\$a2019
=750  \0$aSynthetic drugs$0(DLC) sh 85131658$5IEN-M

=LDR  00517nz  a2200169n  4500
=001  9881591272402441
=005  20210215170118.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076603
=035  \\$a(NLM)9811684077300041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x490.$x937
=150  \\$aSyndemic
=450  \\$wnnna$aSyndemics
=680  \\$iSynergistically-interacting health conditions producing excess disease occurrence in a population.
=688  \\$a2019
=750  \0$aSyndemics$0(DLC)sh2014100257$5IEN-M

=LDR  01097nz  a2200241n  4500
=001  9881591272602441
=005  20210215165526.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076502
=035  \\$a(NLM)9811684069200041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x655.$x500.$x608.$x700
=072  \\$aN6.$x230.$x80.$x900
=150  \\$aSustainable Development
=450  \\$wnnna$aSmart Growth
=450  \\$wnnna$aSustainble Development Goals
=450  \\$wnnna$aDevelopment Goal, Sustainble
=450  \\$wnnna$aDevelopments, Sustainable
=450  \\$wnnna$aGoal, Sustainble Development
=450  \\$wnnna$aSustainble Development Goal
=680  \\$iA process of change in which the exploitation of resources, the direction of investments, the orientation of technological development; and institutional change are all in harmony and enhance both current and future potential to meet human needs and aspirations. (http://www.un-documents.net/ocf-02.htm#I)
=688  \\$a2019; 1994-2018 see Conservation of Natural Resources
=750  \0$aSustainable development$0(DLC)sh 92005743$5IEN-M

=LDR  00818cz  a2200193n  4500
=001  9881591467902441
=005  20210216164740.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078782
=035  \\$a(NLM)9811675413300041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 521
=072  \\$aH2.$x403.$x894
=150  \\$aVaccinology
=680  \\$iBranch of medicine concerned with the development of vaccines to control disease by identifying genetic and other mechanisms and pathways that determine immune responses, and thereby provide new candidate vaccine approaches.
=688  \\$a2019
=750  \0$81$wb$iRelated mapping$aVaccines$0(DLC)sh 85141718$4RM$5IEN-M
=780  \0$81$wb$xDevelopment$0(DLC)sh 99005534$4IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aVaccines--Develpment$5IEN-M

=LDR  00762nz  a2200217n  4500
=001  9881591470502441
=005  20210215120223.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077122
=035  \\$a(NLM)9811683454400041
=040  \\$aDNLM$cDNLM
=072  \\$aD4.$x345.$x103.$x444.$x500
=072  \\$aD9.$x698.$x365.$x855.$x400.$x375.$x444.$x500
=150  \\$aSugammadex
=450  \\$wnnna$a6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt
=450  \\$wnnna$aBridion
=450  \\$wnnna$aOrg 25969
=450  \\$wnnna$aSugammadex Sodium
=680  \\$iA gamma-cyclodextrin that functions as a reversal agent for the neuromuscular blocker ROCURONIUM BROMIDE.
=688  \\$a2019 (2002)
=750  \0$aSugammadex$0(DLC) sh2010013496$5IEN-M

=LDR  00594nz  a2200181n  4500
=001  9881591470702441
=005  20210215115413.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000078783
=035  \\$a(NLM)9811675410700041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x695.$x600
=150  \\$aStanding Position
=450  \\$wnnna$aPosition, Standing
=450  \\$wnnna$aStanding Positions
=680  \\$iHuman position in which the body is held in an upright orthostatic position and supported only by the feet.
=688  \\$a2019
=750  \0$aStanding position$0(DLC) sh 85127321$5IEN-M

=LDR  01028nz  a2200277n  4500
=001  9881591562602441
=005  20210219093101.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076764
=035  \\$a(NLM)9811684512400041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x460.$x685
=150  \\$aTraffic-Related Pollution
=450  \\$wnnna$aTraffic Pollution
=450  \\$wnnna$aVehicle Pollution
=450  \\$wnnna$aPollution, Traffic
=450  \\$wnnna$aPollution, Traffic-Related
=450  \\$wnnna$aPollution, Vehicle
=450  \\$wnnna$aTraffic Related Pollution
=550  \\$aVehicle Emissions
=550  \\$wg$aEnvironmental Pollution
=680  \\$iContamination of the ENVIRONMENT by VEHICLE EMISSIONS.
=688  \\$a2019
=750  \0$81$wb$aAutomobiles$xMotors$xExhaust gas$0(DLC) sh 85010310$5IEN-M
=750  \0$81$wb$aAir$xPollution$0(DLC) sh 85002574$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings:$aAutomobiles-Motors-Exhaust gases$iand Air-Pollution$5IEN-M

=LDR  00951nz  a2200265n  4500
=001  9881591568402441
=005  20210219093530.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077236
=035  \\$a(NLM)9811683548600041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x947.$x875.$x359.$x250.$x500
=072  \\$aD9.$x947.$x875.$x465.$x354.$x500
=150  \\$aTopiramate
=450  \\$wnnna$a2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
=450  \\$wnnna$aEpitomax
=450  \\$wnnna$aMcN 4853
=450  \\$wnnna$aMcN-4853
=450  \\$wnnna$aTopamax
=450  \\$wnnna$aUSL255
=450  \\$wnnna$aMcN4853
=550  \\$wg$aFructose
=680  \\$iA sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.
=688  \\$a2019 (1987)
=750  \0$aTopiramate$0(DLC) sh 97000684$5IEN-M

=LDR  00890cz  a2200241n  4500
=001  9881591644902441
=005  20210223125010.0
=008  750725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D005524
=035  \\$a(NLM)98194599670000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x423.$x850
=150  \\$aFood Technology
=450  \\$wnnna$aFood Sciences
=450  \\$aTechnology, Food
=450  \\$wnnna$aFood Science
=450  \\$wnnna$aScience, Food
=450  \\$wnnna$aSciences, Food
=550  \\$aNutritional Sciences
=667  \\$ausually in reference to the food industry and food manufacture or preparation on a large scale; covers aroma, flavor, color, texture, temperature, preparability, cookability, packaging, etc.
=680  \\$iThe application of knowledge to the food industry.
=688  \\$a76; was NON MESH before 1976
=750  \0$aFood science$0(DLC)sh2018000786$5IEN-M

=LDR  00559cz  a2200181n  4500
=001  9881591645102441
=005  20210223123856.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D032201
=035  \\$a(NLM)98197638760000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x583.$x670.$x270
=150  \\$aEuphrasia
=450  \\$aEyebright
=450  \\$wnnna$aEyebrights
=680  \\$iA plant genus of the family Orobanchaceae used in FOLK REMEDIES for the eyes.
=688  \\$a2003
=750  \0$aEyebrights$0(DLC)sh2018002858$5IEN-M

=LDR  00961cz  a2200253n  4500
=001  9881591662902441
=005  20210217133633.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077235
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x827.$x915
=072  \\$aD3.$x633.$x100.$x473.$x402.$x681.$x827.$x915
=072  \\$aD3.$x633.$x100.$x496.$x500.$x500.$x681.$x827.$x915
=150  \\$aVinorelbine
=450  \\$wnnna$a5'-Nor-anhydrovinblastine
=450  \\$wnnna$aKW 2307
=450  \\$wnnna$aKW-2307
=450  \\$wnnna$aNavelbine
=450  \\$wnnna$aVinorelbine Tartrate
=450  \\$wnnna$a5' Nor anhydrovinblastine
=450  \\$wnnna$aKW2307
=680  \\$iA vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES.
=688  \\$a2019 (1981)
=750  \0$aVinorelbine$0(DLC) sh2003000012$5IEN-M

=LDR  00965nz  a2200253n  4500
=001  9881591663702441
=005  20210217132307.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077362
=035  \\$a(NLM)9811675701600041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500.$x940
=072  \\$aD3.$x633.$x400.$x909.$x500.$x940
=072  \\$aD4.$x345.$x783.$x500.$x940
=150  \\$aVerteporfin
=450  \\$wnnna$a18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo(b)porphine-9,13-dipropanoic acid monomethyl ester
=450  \\$wnnna$aBPD Verteporfin
=450  \\$wnnna$aBPD-MA
=450  \\$wnnna$aBenzoporphyrin Derivative Monoacid Ring A
=450  \\$wnnna$aVerteporphin
=450  \\$wnnna$aVisudyne
=680  \\$iA benzoporphyrin derivative that is used in PHOTOCHEMOTHERAPY to treat wet type MACULAR DEGENERATION.
=688  \\$a2019 (1996)
=750  \0$aVerteporfin$0(DLC)sh2012001665$5IEN-M

=LDR  01682nz  a2200373n  4500
=001  9881591665002441
=005  20210216175404.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000076665
=035  \\$a(NLM)9811684525500041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x710.$x900
=072  \\$aE1.$x370.$x384.$x730.$x900
=072  \\$aE1.$x370.$x386.$x700.$x963
=150  \\$aVentilation-Perfusion Scan
=450  \\$wnnna$aLung VQ Scan
=450  \\$wnnna$aLung Ventilation Perfusion Scans
=450  \\$wnnna$aPulmonary Ventilation Perfusion Scans
=450  \\$wnnna$aV-Q Scintigraphy
=450  \\$wnnna$aVQ Lung Scan
=450  \\$wnnna$aVentilation Perfusion Lung Scan
=450  \\$wnnna$aVentilation-Perfusion Scintigraphy
=450  \\$wnnna$aLung VQ Scans
=450  \\$wnnna$aV-Q Scintigraphies
=450  \\$wnnna$aVQ Lung Scans
=450  \\$wnnna$aVentilation Perfusion Scan
=450  \\$wnnna$aVentilation Perfusion Scintigraphy
=450  \\$wnnna$aVentilation-Perfusion Scans
=450  \\$wnnna$aVentilation-Perfusion Scintigraphies
=680  \\$iA two-part radionuclide imaging that measures VENTILATION-PERFUSION RATIO of the lungs often used to investigate PULMONARY EMBOLISM. Image acquisitions may be performed using various combinations of gamma camera, PET and SPECT scanning techniques.
=688  \\$a2019
=750  \0$81$wb$aVentilation-perfusion ratio$0(DLC)sh 85142750$5IEN-M
=750  \0$81$wb$aRadioisotope scanning$0(DLC)sh 85110710$5IEN-M
=788  \\$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aVentilation-perfusion ratio$iand$aRadioisotope scanning$5IEN-M

=LDR  00898nz  a2200217n  4500
=001  9881591665202441
=005  20210216171407.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000077562
=035  \\$a(NLM)9811675389000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x633.$x100.$x759.$x758.$x399.$x454.$x250.$x300.$x500
=150  \\$aValganciclovir
=450  \\$wnnna$aGanciclovir L-valyl Ester
=450  \\$wnnna$aValcyt
=450  \\$wnnna$aValcyte
=450  \\$wnnna$aValganciclovir Hydrochloride
=450  \\$wnnna$aGanciclovir L valyl Ester
=680  \\$iA ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.
=688  \\$a2019 (1999)
=750  \0$aValganciclovir$0(DLC) sh2004001923$5IEN-M

=LDR  01917nz  a2200493n  4500
=001  9881598260002441
=005  20210303173759.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000085703
=035  \\$a(NLM)9817067898600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x859
=150  \\$aTherapy Animals
=450  \\$aComfort Animals
=450  \\$aEmotional Support Animals
=450  \\$aEmotional Support Dogs
=450  \\$aPet Therapy Animals
=450  \\$aPet Therapy Dogs
=450  \\$aTherapy Dogs
=450  \\$wnnna$aAnimal, Comfort
=450  \\$wnnna$aAnimal, Emotional Support
=450  \\$wnnna$aAnimal, Pet Therapy
=450  \\$wnnna$aAnimal, Therapy
=450  \\$wnnna$aAnimals, Comfort
=450  \\$wnnna$aAnimals, Emotional Support
=450  \\$wnnna$aAnimals, Pet Therapy
=450  \\$wnnna$aAnimals, Therapy
=450  \\$wnnna$aComfort Animal
=450  \\$wnnna$aDog, Emotional Support
=450  \\$wnnna$aDog, Pet Therapy
=450  \\$wnnna$aDog, Therapy
=450  \\$wnnna$aDogs, Emotional Support
=450  \\$wnnna$aDogs, Pet Therapy
=450  \\$wnnna$aDogs, Therapy
=450  \\$wnnna$aEmotional Support Animal
=450  \\$wnnna$aEmotional Support Dog
=450  \\$wnnna$aPet Therapy Animal
=450  \\$wnnna$aPet Therapy Dog
=450  \\$wnnna$aTherapy Animal
=450  \\$wnnna$aTherapy Dog
=450  \\$wnnna$aTherapy Dog, Pet
=680  \\$iTherapy animals visit hospitals, nursing homes, hospices, schools, and other places where people may be facing health challenges or stressors to provide an emotional or mental health benefit by their presence.  They may also be used to assist physical and occupational therapists.  Therapy animals are generally registered, trained, and screened, but are not covered by laws as are service animals.
=688  \\$a2021
=750  \0$aEmotional support animals$0(DLC)sh2019000040$5IEN-M

=LDR  00999nz  a2200265n  4500
=001  9881598260302441
=005  20210303172818.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081411
=035  \\$a(NLM)9812406321500041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x160.$x125
=072  \\$aL1.$x296.$x55
=150  \\$aAugmented Reality
=450  \\$aMixed Reality
=450  \\$wnnna$aAugmented Realities
=450  \\$wnnna$aMixed Realities
=450  \\$wnnna$aRealities, Augmented
=450  \\$wnnna$aRealities, Mixed
=450  \\$wnnna$aReality, Augmented
=450  \\$wnnna$aReality, Mixed
=680  \\$iTechnology in which images of virtual objects and/or other digital information are superimposed over the real time view of the physical objects providing a composite view with guides for carrying out a task with or on the physical objects.
=688  \\$a2020
=750  \2$aAugmented reality$0(DLC)sh2006020069$5IEN-M
=750  \2$aMixed reality$0(DLC)sh2010014466$5IEN-M

=LDR  00776cz  a2200253n  4500
=001  9881616770902441
=005  20200901000000.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080483
=035  \\$a(NLM)9812406005100041
=040  \\$aDNLM$cDNLM
=060  \0$aWN 610
=072  \\$aM1.$x860.$x325
=150  \\$aAtomic Bomb Survivors
=450  \\$aAtomic Bomb-Affected People
=450  \\$aHibakusha
=450  \\$wnnna$aAtomic Bomb Affected People
=450  \\$wnnna$aAtomic Bomb Survivor
=450  \\$wnnna$aAtomic Bomb-Affected Peoples
=450  \\$wnnna$aBomb Survivors, Atomic
=450  \\$wnnna$aSurvivor, Atomic Bomb
=450  \\$wnnna$aSurvivors, Atomic Bomb
=680  \\$iPersons who survived exposure to RADIATION due to ATOMIC BOMBS.
=688  \\$a2020

=LDR  00979cz  a2200313n  4500
=001  9881616771002441
=005  20210317175503.0
=008  150706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000067697
=035  \\$a(NLM)985399362000041
=040  \\$aDNLM$cDNLM
=060  \0$aWS 460
=072  \\$aN1.$x400.$x75
=150  \\$aAdolescent Health
=450  \\$wnnna$aAdolescent Well Being
=450  \\$wnnna$aAdolescent Well-Being
=450  \\$wnnna$aTeen Health
=450  \\$aAdolescent Wellbeing
=450  \\$wnnna$aHealth, Adolescent
=450  \\$wnnna$aHealth, Teen
=450  \\$wnnna$aWell Being, Adolescent
=450  \\$wnnna$aWell-Being, Adolescent
=450  \\$wnnna$aWellbeing, Adolescent
=550  \\$aAdolescent Medicine
=550  \\$aChild Welfare
=550  \\$aAdolescent Health Services
=680  \\$iThe concept covering the physical and mental conditions of ADOLESCENTS.
=688  \\$a2016
=750  \0$aTeenagers$xHealth and hygiene$0(DLC)sh 93001263$5IEN-M

=LDR  00779cz  a2200241n  4500
=001  9881616774202441
=005  20210317113356.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D024002
=035  \\$a(NLM)98198901690000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x260.$x356
=072  \\$aD12.$x776.$x660.$x235.$x400.$x600
=072  \\$aD12.$x776.$x664.$x235.$x400.$x600
=150  \\$aHMGB Proteins
=450  \\$wnnna$aHMG-B
=450  \\$wnnna$aHMGB
=450  \\$wnnna$aHigh Mobility Group Box Proteins
=450  \\$aHMG-Box Proteins
=450  \\$wnnna$aHMG Box Proteins
=680  \\$iA family of sequence-related proteins similar to HMGB1 PROTEIN that contains specific HMG-BOX DOMAINS.
=688  \\$a2002
=750  \0$aHMGB proteins$0(DLC)sh2019102750$5IEN-M

=LDR  02408nz  a2200589n  4500
=001  9881619066802441
=005  20210319150114.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080051
=035  \\$a(NLM)9812405734900041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x108
=150  \\$aCommunity-Based Health Insurance
=450  \\$aCommunity Health Insurance
=450  \\$aCommunity-Based Health Financing
=450  \\$aHealth Micro Insurance
=450  \\$aMicro-Health Insurance
=450  \\$aMutual Health Insurance
=450  \\$wnnna$aCommunity Based Health Financing
=450  \\$wnnna$aCommunity Based Health Insurance
=450  \\$wnnna$aCommunity Health Insurances
=450  \\$wnnna$aCommunity-Based Health Financings
=450  \\$wnnna$aCommunity-Based Health Insurances
=450  \\$wnnna$aFinancing, Community-Based Health
=450  \\$wnnna$aFinancings, Community-Based Health
=450  \\$wnnna$aHealth Financing, Community-Based
=450  \\$wnnna$aHealth Financings, Community-Based
=450  \\$wnnna$aHealth Insurance, Community
=450  \\$wnnna$aHealth Insurance, Community-Based
=450  \\$wnnna$aHealth Insurance, Mutual
=450  \\$wnnna$aHealth Insurances, Community
=450  \\$wnnna$aHealth Insurances, Community-Based
=450  \\$wnnna$aHealth Insurances, Mutual
=450  \\$wnnna$aHealth Micro Insurances
=450  \\$wnnna$aInsurance, Community Health
=450  \\$wnnna$aInsurance, Community-Based Health
=450  \\$wnnna$aInsurance, Health Micro
=450  \\$wnnna$aInsurance, Micro-Health
=450  \\$wnnna$aInsurance, Mutual Health
=450  \\$wnnna$aInsurances, Community Health
=450  \\$wnnna$aInsurances, Community-Based Health
=450  \\$wnnna$aInsurances, Health Micro
=450  \\$wnnna$aInsurances, Micro-Health
=450  \\$wnnna$aInsurances, Mutual Health
=450  \\$wnnna$aMicro Health Insurance
=450  \\$wnnna$aMicro Insurance, Health
=450  \\$wnnna$aMicro Insurances, Health
=450  \\$wnnna$aMicro-Health Insurances
=450  \\$wnnna$aMutual Health Insurances
=680  \\$iLow-cost HEALTH INSURANCE in which community, cooperative, mutual, and/or self-help resources are pooled to mitigate health risks and cover health care services in full or in part.
=688  \\$a2020
=750  \0$aMutual health organizations$0(DLC)sh2019005211$5IEN

=LDR  00972cz  a2200265n  4500
=001  9881620162402441
=005  20210323121611.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068579
=035  \\$a(NLM)985399578600041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x65.$x884.$x247
=072  \\$aD2.$x886.$x590.$x700.$x247
=072  \\$aD3.$x383.$x129.$x539.$x160
=150  \\$aCelecoxib
=450  \\$wnnna$a4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
=450  \\$wnnna$aCelebrex
=450  \\$wnnna$aSC 58635
=450  \\$wnnna$aSC-58635
=450  \\$wnnna$aSC58635
=550  \\$wg$aSulfonamides
=550  \\$wg$aPyrazoles
=680  \\$iA pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.
=688  \\$a2016 (1997)
=750  \0$aCelecoxib$0(DLC)sh 00009577$5IEN-M

=LDR  00440cz  a2200169n  4500
=001  9881620162902441
=005  20210323105852.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D002641
=035  \\$a(NLM)98198961060000041
=040  \\$aDNLM$cDNLM
=072  \\$aZ1.$x107.$x567.$x875.$x350.$x350.$x200
=072  \\$aZ1.$x433.$x305
=151  \\$aChicago (Ill.)
=550  \\$wg$aCities
=551  \\$wg$aIllinois
=680  \\$iA city in Illinois.

=LDR  00822cz  a2200229n  4500
=001  9881620163102441
=005  20210323104554.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068356
=035  \\$a(NLM)985399618700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x595
=150  \\$aSelf-Control
=450  \\$wnnna$aSelf Control
=450  \\$wnnna$aSelf Regulation
=450  \\$wnnna$aSelf-Regulation
=450  \\$wnnna$aControl, Self
=450  \\$wnnna$aRegulation, Self
=550  \\$wg$aSocial Behavior
=680  \\$iAn individual's ability to manage and monitor their emotions, behaviors, and desires in the face of external demands in order to function in society.
=688  \\$a2016; for SELF REGULATION use SOCIAL CONTROL, INFORMAL 1997-2015
=750  \0$aSelf-control$0(DLC)sh 85119718$5IEN-M

=LDR  01950cz  a2200445n  4500
=001  9881620163302441
=005  20210323103748.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000068800
=035  \\$a(NLM)985399705100041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x541.$x500.$x697.$x624
=072  \\$aD12.$x776.$x124.$x486.$x485.$x538.$x500.$x624
=072  \\$aD12.$x776.$x124.$x486.$x485.$x680.$x697.$x624
=072  \\$aD12.$x776.$x124.$x790.$x651.$x538.$x500.$x624
=072  \\$aD12.$x776.$x124.$x790.$x651.$x680.$x660.$x624
=072  \\$aD12.$x776.$x377.$x715.$x548.$x538.$x500.$x624
=072  \\$aD12.$x776.$x377.$x715.$x548.$x680.$x660.$x624
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x760.$x232
=150  \\$aEtanercept
=450  \\$wnnna$aEnbrel
=450  \\$wnnna$aErelzi
=450  \\$wnnna$aEtanercept-szzs
=450  \\$wnnna$aRecombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
=450  \\$wnnna$aTNF Receptor Type II-IgG Fusion Protein
=450  \\$wnnna$aTNFR-Fc Fusion Protein
=450  \\$wnnna$aTNR 001
=450  \\$wnnna$aTNR-001
=450  \\$wnnna$aTNT Receptor Fusion Protein
=450  \\$wnnna$aTNTR-Fc
=450  \\$wnnna$aFusion Protein, TNFR-Fc
=450  \\$wnnna$aRecombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein
=450  \\$wnnna$aTNF Receptor Type II IgG Fusion Protein
=450  \\$wnnna$aTNFR Fc Fusion Protein
=450  \\$wnnna$aTNR001
=550  \\$wg$aImmunoglobulin G
=550  \\$wg$aReceptors, Tumor Necrosis Factor
=680  \\$iA recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
=688  \\$a2016 (1997)
=750  \0$aEtanercept$0(DLC)sh2002010979$5IEN-M

=LDR  01246cz  a2200325n  4500
=001  9881620168902441
=005  20210322152125.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D012645
=035  \\$a(NLM)98196663960000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x731.$x700
=072  \\$aD2.$x886.$x30.$x676.$x900
=072  \\$aD12.$x125.$x166.$x676.$x900
=150  \\$aSelenomethionine
=450  \\$wnnna$aSelenomethionine Hydrochloride, (S)-Isomer
=450  \\$wnnna$aSelenomethionine, (+,-)-Isomer
=450  \\$wnnna$aSelenomethionine, (R)-Isomer
=450  \\$wnnna$aSelenomethionine, (S)-Isomer
=450  \\$wnnna$aSethotope
=450  \\$aButanoic acid, 2-amino-4-(methylseleno)-
=450  \\$aRadioselenomethionine
=450  \\$aSelenomethionine Se 75
=450  \\$wnnna$aSe 75, Selenomethionine
=550  \\$wg$aOrganoselenium Compounds
=550  \\$wg$aMethionine
=667  \\$afor radiolabeled selenomethionine, coordinate with SELENIUM RADIOISOTOPES or see Supplementary Concept Records for  specific radiolabeled selnomethionine terms
=680  \\$iDiagnostic aid in pancreas function determination.
=688  \\$a91(75); was see under SELENIUM 1975-90
=750  \0$aSelenomethionine$0(DLC)sh2019000297$5IEN-M

=LDR  00970cz  a2200181n  4500
=001  9880364185302441
=005  20141212215413.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x247
=150  \\$aFollistatin
=450  \\$aActivin-Binding Protein
=450  \\$wnnna$aActivin Binding Protein
=550  \\$wg$aCarrier Proteins
=680  \\$iA broadly distributed protein that binds directly to ACTIVINS. It functions as an activin antagonist, inhibits FOLLICLE STIMULATING HORMONE secretion, regulates CELL DIFFERENTIATION, and plays an important role in embryogenesis. Follistatin is a single glycosylated polypeptide chain of approximately 37-kDa and is not a member of the inhibin family (INHIBINS). Follistatin also binds and neutralizes many members of the TRANSFORMING GROWTH FACTOR BETA family.
=688  \\$a2003; use FOLLISTATIN (NM) 1988-2002
=750  \0$aFollistatin$5IEN-M$0(DLC)sh 97005109

=LDR  00816cz  a2200193n  4500
=001  9880364185402441
=005  20141212193038.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x900.$x300.$x87.$x850
=072  \\$aC26.$x260.$x118.$x825
=072  \\$aC26.$x915.$x300.$x200.$x825
=150  \\$aShaken Baby Syndrome
=550  \\$wg$aBrain Injuries
=550  \\$aChild Abuse
=680  \\$iBrain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.
=688  \\$a2003
=750  \0$aShaken baby syndrome$5IEN-M$0(DLC)sh2002006057



=LDR  01057cz  a2200217n  4500
=001  9880364185602441
=005  20141212193038.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038524
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x825.$x500.$x150
=150  \\$aDiffusion Magnetic Resonance Imaging
=450  \\$wnnna$aDiffusion MRI
=450  \\$wnnna$aDiffusion MRIs
=450  \\$wnnna$aDiffusion Weighted MRI
=450  \\$aMagnetic Resonance Imaging, Diffusion
=450  \\$wnnna$aMRI, Diffusion Weighted
=550  \\$wg$aMagnetic Resonance Imaging
=680  \\$iA diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.
=688  \\$a2003
=750  \0$aDiffusion magnetic resonance imaging$0(DLC)sh2005006810$5IEN-M

=LDR  00806cz  a2200181n  4500
=001  9880364185702441
=005  20141212215407.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038481
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x44
=150  \\$aAnterior Temporal Lobectomy
=450  \\$wnnna$aLobectomy, Anterior Temporal
=550  \\$wg$aNeurosurgical Procedures
=550  \\$aEpilepsy, Temporal Lobe
=680  \\$iA neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy (EPILEPSY, TEMPORAL LOBE).
=688  \\$a2003
=750  \0$aTemporal lobectomy$5IEN-M$0(DLC)sh 90001888

=LDR  00831cz  a2200217n  4500
=001  9880364185802441
=005  20141212193037.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x642.$x249.$x270
=072  \\$aG7.$x610.$x240.$x270
=150  \\$aDiet, Mediterranean
=450  \\$wnnna$aDiets, Mediterranean
=450  \\$aMediterranean Diet
=450  \\$wnnna$aMediterranean Diets
=550  \\$wg$aDiet
=550  \\$wg$aDiet Therapy
=680  \\$iA diet typical of the Mediterranean region characterized by a pattern high in fruits and vegetables, cereals and bread, potatoes, poultry, beans, nuts, olive oil and fish while low in red meat and dairy and moderate in alcohol consumption.
=688  \\$a2003
=750  \0$aDiet$zMediterranean Region$5IEN-M$0(DLC)sh2009123353

=LDR  01163cz  a2200277n  4500
=001  9880364185902441
=005  20180712180724.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038362
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x117.$x875
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x429.$x500
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x646.$x625
=072  \\$aD12.$x644.$x360.$x300.$x500
=072  \\$aD12.$x776.$x476.$x81.$x875
=072  \\$aD12.$x776.$x476.$x300.$x500
=150  \\$aGlycogen Synthase Kinase 3
=450  \\$wnnna$aGSK-3
=450  \\$wnnna$agsk-3 Gene Product
=550  \\$wg$aAxin Signaling Complex
=550  \\$wg$aGlycogen Synthase Kinases
=550  \\$wg$aProline-Directed Protein Kinases
=550  \\$wh$aGlycogen Synthase Kinase 3 beta
=680  \\$iA glycogen synthase kinase that was originally described as a key enzyme involved in glycogen metabolism. It regulates a diverse array of functions such as CELL DIVISION, microtubule function and APOPTOSIS.
=688  \\$a2003; use GLYCOGEN SYNTHASE KINASE 3 (NM) 1995-2002
=750  \0$aGlycogen synthase kinase-3$0(DLC)sh2006001666$5IEN-M

=LDR  01093cz  a2200253n  4500
=001  9880364186002441
=005  20141212215404.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x345
=072  \\$aG7.$x610.$x660.$x500
=072  \\$aJ1.$x576.$x423.$x850.$x730.$x750.$x500
=072  \\$aN6.$x850.$x601.$x750.$x500
=150  \\$aGlycemic Index
=450  \\$wnnna$aGlycemic Index Number
=450  \\$wnnna$aGlycemic Index Numbers
=450  \\$wnnna$aGlycemic Indices
=550  \\$wg$aMetabolic Phenomena
=550  \\$wg$aNutritive Value
=550  \\$aBlood Glucose
=680  \\$iA numerical system of measuring the rate of BLOOD GLUCOSE generation by a particular food item as compared to a reference item, such as glucose = 100. Foods with higher glycemic index numbers create greater blood sugar swings. These numbers do not correspond to calories or amounts of food intake but rather, depend on the rates of digestion and absorption of these food items.
=688  \\$a2003
=750  \0$aGlycemic index$5IEN-M$0(DLC)sh 92003938

=LDR  00956cz  a2200253n  4500
=001  9880364186102441
=005  20141212215404.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x875.$x977
=072  \\$aE5.$x200.$x875.$x977
=072  \\$aG6.$x590.$x875.$x730
=072  \\$aG6.$x920.$x875.$x730
=150  \\$aVirus Inactivation
=450  \\$wnnna$aInactivation, Viral
=450  \\$wnnna$aInactivation, Virus
=450  \\$aViral Inactivation
=550  \\$wg$aMicrobiological Techniques
=550  \\$wg$aVirus Physiological Processes
=550  \\$aAntiviral Agents
=680  \\$iInactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS.
=688  \\$a2003
=750  \0$aViruses$xInactivation$5IEN-M$0(DLC)sh 88006385

=LDR  01624cz  a2200337n  4500
=001  9880364186202441
=005  20150529161112.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038261
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x362.$x312
=072  \\$aC10.$x228.$x140.$x695.$x625.$x312
=072  \\$aC10.$x314.$x400.$x312
=072  \\$aC10.$x574.$x500.$x24
=072  \\$aC16.$x320.$x400.$x24
=072  \\$aC16.$x320.$x565.$x189.$x362.$x312
=072  \\$aC18.$x452.$x132.$x100.$x362.$x312
=072  \\$aC18.$x452.$x648.$x189.$x362.$x312
=150  \\$aAlexander Disease
=450  \\$wnnna$aAlexander's Disease
=450  \\$wnnna$aAlexanders Disease
=450  \\$wnnna$aDemyelinogenic Leukodystrophy
=450  \\$wnnna$aDysmyelinogenic Leukodystrophy
=450  \\$wnnna$aFibrinoid Degeneration of Astrocytes
=450  \\$wnnna$aLeukodystrophy with Rosenthal Fibers
=550  \\$wg$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$aGlial Fibrillary Acidic Protein
=680  \\$iRare leukoencephalopathy with infantile-onset accumulation of Rosenthal fibers in the subpial, periventricular, and subependymal zones of the brain. Rosenthal fibers are GLIAL FIBRILLARY ACIDIC PROTEIN aggregates found in ASTROCYTES. Juvenile- and adult-onset types show progressive atrophy of the lower brainstem instead. De novo mutations in the GFAP gene are associated with the disease with propensity for paternal inheritance.
=688  \\$a2003
=750  \0$aAlexander disease$0(DLC)sh2014002025$5IEN-M

=LDR  00667cz  a2200241n  4500
=001  9880364186302441
=005  20141212215357.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x787
=150  \\$aSnow Sports
=450  \\$wnnna$aSledding
=450  \\$wnnna$aSnow Sport
=450  \\$wnnna$aSnowmobiling
=450  \\$wnnna$aSport, Snow
=450  \\$wnnna$aSports, Snow
=550  \\$wg$aSports
=550  \\$wh$aSkiing
=667  \\$a/inj: coord with specific injury (IM)
=680  \\$iSports activities in the snow.
=688  \\$a2003
=750  \0$aWinter sports$5IEN-M$0(DLC)sh 85147041

=LDR  01087cz  a2200301n  4500
=001  9880364186402441
=005  20141212215356.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D038081
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x377
=072  \\$aG8.$x686.$x785.$x760.$x170.$x450
=150  \\$aOrganogenesis
=550  \\$wg$aEmbryonic and Fetal Development
=550  \\$wh$aCementogenesis
=550  \\$wh$aDentinogenesis
=550  \\$wh$aFetal Organ Maturity
=550  \\$wh$aLymphangiogenesis
=550  \\$wh$aMusculoskeletal Development
=550  \\$wh$aNeurogenesis
=550  \\$wh$aOdontogenesis
=550  \\$wh$aOrganogenesis, Plant
=550  \\$wh$aSex Determination Processes
=550  \\$wh$aSex Differentiation
=667  \\$ahuman and animal; mammalian and non-mammalian; coord with specific organ/embryol
=680  \\$iFormation of differentiated cells and complicated tissue organization to provide specialized functions.
=688  \\$a2003; use FETAL DEVELOPMENT 1995-2002
=750  \0$aMorphogenesis$5IEN-M$0(DLC)sh 85087346

=LDR  00858cz  a2200181n  4500
=001  9880364186502441
=005  20141212215354.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037961
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x462.$x500
=150  \\$aFrullania
=450  \\$wnnna$aFrullanias
=550  \\$wg$aHepatophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Jubulaceae, subclass JUNGERMANNIAE. Members contain eudesmane-type sesquiterpene lactones and cause CONTACT DERMATITIS.
=688  \\$a2003
=750  \0$aFrullania$5IEN-M$0(DLC)sh 88022274

=LDR  01199cz  a2200325n  4500
=001  9880364186602441
=005  20141212215353.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037921
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x208
=150  \\$aGift Giving
=450  \\$wnnna$aContribution, Financial
=450  \\$wnnna$aContributions, Financial
=450  \\$wnnna$aFinancial Contribution
=450  \\$aFinancial Contributions
=450  \\$wnnna$aFinancial Gift
=450  \\$wnnna$aFinancial Gifts
=450  \\$wnnna$aGift, Financial
=450  \\$wnnna$aGiftgiving
=450  \\$wnnna$aGifts
=450  \\$aGifts, Financial
=550  \\$wg$aSocial Behavior
=550  \\$aAltruism
=550  \\$aCharities
=550  \\$aFinancial Support
=550  \\$aFund Raising
=680  \\$iThe bestowing of tangible or intangible benefits, voluntarily and usually without expectation of anything in return. However, gift giving may be motivated by feelings of ALTRUISM or gratitude, by a sense of obligation, or by the hope of receiving something in return.
=688  \\$a2003; for GIFTS, FINANCIAL use FUND RAISING 1978-2002
=750  \0$aGifts$5IEN-M$0(DLC)sh 85054894

=LDR  01065cz  a2200265n  4500
=001  9880364186702441
=005  20141212193037.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x905.$x199.$x249.$x750
=072  \\$aE5.$x335
=072  \\$aN2.$x421.$x585.$x905.$x199.$x500.$x750
=150  \\$aEuthanasia, Animal
=450  \\$aAnimal Euthanasia
=450  \\$wnnna$aAnimal Mercy Killing
=450  \\$wnnna$aMercy Killing, Animal
=550  \\$wg$aEuthanasia, Active
=550  \\$wg$aInvestigative Techniques
=550  \\$aAnimal Culling
=550  \\$aAnimal Welfare
=667  \\$amethods of "sacrificing" animals go here if the topic of discussion; for euthanasia of laboratory animals, coordinate with ANIMALS, LABORATORY
=680  \\$iThe killing of animals for reasons of mercy, to control disease transmission or maintain the health of animal populations, or for experimental purposes (ANIMAL EXPERIMENTATION).
=688  \\$a2003
=750  \0$aEuthanasia of animals$5IEN-M$0(DLC)sh 92002412

=LDR  00686cz  a2200229n  4500
=001  9880364186802441
=005  20141212215353.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x975.$x807
=150  \\$aPregnant Women
=450  \\$wnnna$aPregnant Woman
=450  \\$wnnna$aWoman, Pregnant
=450  \\$aWomen, Pregnant
=550  \\$wg$aWomen
=550  \\$aMaternal-Fetal Relations
=550  \\$aPregnancy
=667  \\$aIM as psychol or social entity
=680  \\$iHuman females who are pregnant, as cultural, psychological, or sociological entities.
=688  \\$a2003
=750  \0$aPregnant women$5IEN-M$0(DLC)sh 85106300

=LDR  00823cz  a2200181n  4500
=001  9880364186902441
=005  20141212215352.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x437.$x249
=150  \\$aCasearia
=450  \\$wnnna$aCasearias
=550  \\$wg$aFlacourtiaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FLACOURTIACEAE. Members contain casearins which are clerodane type DITERPENES.
=688  \\$a2003
=750  \0$aCasearia$5IEN-M$0(DLC)sh 85020575

=LDR  01397cz  a2200385n  4500
=001  9880364187002441
=005  20141212215352.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x330.$x615
=150  \\$aHammer Toe Syndrome
=450  \\$aClaw Toe
=450  \\$wnnna$aClaw Toes
=450  \\$wnnna$aClawtoe
=450  \\$wnnna$aClawtoes
=450  \\$aHammer Toe
=450  \\$wnnna$aHammer Toes
=450  \\$wnnna$aHammertoe Syndrome
=450  \\$wnnna$aHammertoe Syndromes
=450  \\$aMallet Toe
=450  \\$wnnna$aMallet Toes
=450  \\$wnnna$aSyndrome, Hammer Toe
=450  \\$wnnna$aSyndrome, Hammertoe
=450  \\$wnnna$aSyndromes, Hammertoe
=450  \\$wnnna$aToe, Claw
=450  \\$wnnna$aToe, Hammer
=450  \\$wnnna$aToe, Mallet
=450  \\$wnnna$aToes, Claw
=450  \\$wnnna$aToes, Hammer
=450  \\$wnnna$aToes, Mallet
=550  \\$wg$aFoot Deformities
=680  \\$iA condition characterized by a series of interrelated digital symptoms and joint changes of the lesser digits and METATARSOPHALANGEAL JOINTS of the FOOT. The syndrome can include some or all of the following conditions: hammer toe, claw toe, mallet toe, overlapping fifth toe, curly toe, EXOSTOSIS; HYPEROSTOSIS; interdigital heloma, or contracted toe.
=688  \\$a2003
=750  \0$aHammertoe$5IEN-M$0(DLC)sh 85058578

=LDR  01622cz  a2200301n  4500
=001  9880364187102441
=005  20141212215351.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x520.$x200.$x650
=072  \\$aD8.$x811.$x913.$x400.$x725.$x115.$x961
=072  \\$aD12.$x776.$x476.$x900
=150  \\$aSirtuins
=450  \\$wnnna$aSilent Mating Type Information Regulator 2-like Proteins
=450  \\$wnnna$aSilent Mating Type Information Regulator 2 like Proteins
=450  \\$aSir2-like Proteins
=450  \\$wnnna$aSir2 like Proteins
=550  \\$wg$aADP Ribose Transferases
=550  \\$wg$aGroup III Histone Deacetylases
=550  \\$wg$aIntracellular Signaling Peptides and Proteins
=550  \\$wh$aSirtuin 1
=550  \\$wh$aSirtuin 2
=550  \\$wh$aSirtuin 3
=550  \\$aSilent Information Regulator Proteins, Saccharomyces cerevisiae
=680  \\$iA homologous family of regulatory enzymes that are structurally related to the protein silent mating type information regulator 2 (Sir2) found in Saccharomyces cerevisiae. Sirtuins contain a central catalytic core region which binds NAD. Several of the sirtuins utilize NAD to deacetylate proteins such as HISTONES and are categorized as GROUP III HISTONE DEACETYLASES. Several other sirtuin members utilize NAD to transfer ADP-RIBOSE to proteins and are categorized as MONO ADP-RIBOSE TRANSFERASES, while a third group of sirtuins appears to have both deacetylase and ADP ribose transferase activities.
=688  \\$a2003
=750  \0$aSirtuins$0(DLC)sh2010012830$5IEN-M

=LDR  00885cz  a2200265n  4500
=001  9880364187202441
=005  20141212215351.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x250.$x500
=072  \\$aJ1.$x637.$x512.$x850.$x500
=150  \\$aNanotubes, Carbon
=450  \\$wnnna$aBuckytube
=450  \\$aBuckytubes
=450  \\$wnnna$aCarbon Nanotube
=450  \\$aCarbon Nanotubes
=450  \\$wnnna$aNanoribbon
=450  \\$aNanoribbons
=450  \\$wnnna$aNanotube, Carbon
=550  \\$wg$aFullerenes
=550  \\$wg$aNanotubes
=680  \\$iNanometer-sized tubes composed mainly of CARBON. Such nanotubes are used as probes for high-resolution structural and chemical imaging of biomolecules with ATOMIC FORCE MICROSCOPY.
=688  \\$a2003
=750  \0$aCarbon nanotubes$0(DLC)sh2013002061$5IEN-M

=LDR  00963cz  a2200253n  4500
=001  9880364187302441
=005  20141212215351.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150.$x250
=072  \\$aJ1.$x637.$x512.$x600.$x612.$x350
=150  \\$aFullerenes
=450  \\$wnnna$aBuckminsterfullerene
=450  \\$wnnna$aBuckminsterfullerenes
=450  \\$wnnna$aBuckyball
=450  \\$aBuckyballs
=450  \\$wnnna$aFullerene
=550  \\$wg$aCarbon
=550  \\$wg$aNanospheres
=550  \\$wh$aNanotubes, Carbon
=680  \\$iA polyhedral CARBON structure composed of around 60-80 carbon atoms in pentagon and hexagon configuration. They are named after Buckminster Fuller because of structural resemblance to geodesic domes. Fullerenes can be made in high temperature such as arc discharge in an inert atmosphere.
=688  \\$a2003
=750  \0$aFullerenes$0(DLC) sh 91005662$5IEN-M

=LDR  00610cz  a2200193n  4500
=001  9880364187402441
=005  20141212215348.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x389.$x338.$x55
=072  \\$aD2.$x455.$x849.$x765.$x211
=072  \\$aD2.$x737.$x55
=150  \\$aArtemisinins
=550  \\$wg$aPeroxides
=550  \\$wg$aSesquiterpenes
=680  \\$iA group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).
=688  \\$a2003
=750  \0$aArtemisinin$0(DLC)sh2007003203$5IEN-M

=LDR  00918cz  a2200313n  4500
=001  9880364187502441
=005  20141212215344.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037462
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x361
=150  \\$aCubozoa
=450  \\$aBox Jellyfish
=450  \\$wnnna$aBox Jellyfishs
=450  \\$aCarybdea
=450  \\$wnnna$aCarybdeas
=450  \\$aChironex
=450  \\$wnnna$aChironices
=450  \\$wnnna$aCubozoas
=450  \\$aJellyfish, Box
=450  \\$wnnna$aJellyfishs, Box
=450  \\$wnnna$aSea Wasp
=450  \\$aSea Wasps
=450  \\$wnnna$aWasp, Sea
=450  \\$wnnna$aWasps, Sea
=550  \\$wg$aCnidaria
=680  \\$iThe class of box jellyfish, in the phylum CNIDARIA, characterized by their cube shape, and considered the most venomous jellyfish.
=688  \\$a2003
=750  \0$aCubomedusae$5IEN-M$0(DLC)sh 85034656

=LDR  00989cz  a2200277n  4500
=001  9880364187602441
=005  20141212215344.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x690.$x750
=150  \\$aSea Nettle, East Coast
=450  \\$wnnna$aAtlantic Sea Nettle
=450  \\$wnnna$aAtlantic Sea Nettles
=450  \\$aChrysaora quinquecirrha
=450  \\$wnnna$aChrysaora quinquecirrhas
=450  \\$wnnna$aNettle, Atlantic Sea
=450  \\$wnnna$aNettles, Atlantic Sea
=450  \\$wnnna$aquinquecirrha, Chrysaora
=450  \\$wnnna$aquinquecirrhas, Chrysaora
=450  \\$wnnna$aSea Nettle, Atlantic
=450  \\$wnnna$aSea Nettles, Atlantic
=550  \\$wg$aScyphozoa
=680  \\$iSpecies of jellyfish, in the family Pelagiidae, order Semaeostomeae, class SCYPHOZOA. Their painful sting is caused by a venom toxic to humans.
=688  \\$a2003
=750  \0$aSea nettle$5IEN-M$0(DLC)sh 87020072

=LDR  00732cz  a2200229n  4500
=001  9880364187702441
=005  20141212215344.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x237
=150  \\$aAnthozoa
=450  \\$wnnna$aAnthozoas
=450  \\$wnnna$aCoral
=450  \\$aCorals
=550  \\$wg$aCnidaria
=550  \\$wh$aRenilla
=550  \\$wh$aSea Anemones
=550  \\$aCoral Reefs
=680  \\$iA class in the phylum CNIDARIA, comprised mostly of corals and anemones. All members occur only as polyps; the medusa stage is completely absent.
=688  \\$a2003; for CORALS use CNIDARIA 1998-2002
=750  \0$aAnthozoa$5IEN-M$0(DLC)sh 85005545

=LDR  01433cz  a2200397n  4500
=001  9880364187802441
=005  20141212215343.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037402
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x485
=150  \\$aHydrozoa
=450  \\$wnnna$aHydrozoan
=450  \\$wnnna$aHydrozoans
=450  \\$wnnna$aHydrozoas
=450  \\$aLiriope tetraphylla
=450  \\$wnnna$aLiriope tetraphyllas
=450  \\$wnnna$aMan-of-War, Portuguese
=450  \\$wnnna$aMan-of-Wars, Portuguese
=450  \\$wnnna$aphysali, Physalia
=450  \\$wnnna$aPhysalia
=450  \\$wnnna$aPhysalia physali
=450  \\$aPhysalia physalis
=450  \\$wnnna$aPhysalias
=450  \\$wnnna$aphysalis, Physalia
=450  \\$aPortuguese Man-of-War
=450  \\$wnnna$aPortuguese Man of War
=450  \\$wnnna$aPortuguese Man-of-Wars
=450  \\$wnnna$atetraphylla, Liriope
=450  \\$wnnna$atetraphyllas, Liriope
=550  \\$wg$aCnidaria
=550  \\$wh$aHydra
=667  \\$ado not confuse X ref LIRIOPE TETRAPHYLLA with LIRIOPE PLANT
=680  \\$iA class in the phylum CNIDARIA which alternates between polyp and medusa forms during their life cycle. There are over 2700 species in five orders.
=688  \\$a2003; use HYDRA 1997-2000, use CNIDARIA 2001-2002; for PHYSALIA & PORTUGESE MAN-OF-WAR use CNIDARIA 1998-2002
=750  \0$aHydrozoa$5IEN-M$0(DLC)sh 85063512

=LDR  01804cz  a2200529n  4500
=001  9880364187902441
=005  20141212215343.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x308.$x690
=150  \\$aScyphozoa
=450  \\$aAurelia aurita
=450  \\$wnnna$aAurelia auritas
=450  \\$wnnna$aaurita, Aurelia
=450  \\$wnnna$aauritas, Aurelia
=450  \\$wnnna$aChrysaora fuscescen
=450  \\$aChrysaora fuscescens
=450  \\$wnnna$afuscescen, Chrysaora
=450  \\$wnnna$afuscescens, Chrysaora
=450  \\$wnnna$aJellies, Moon
=450  \\$wnnna$aJelly, Moon
=450  \\$wnno$aJellyfish$5IEN-HS
=450  \\$aJellyfish, Moon
=450  \\$aJellyfish, True
=450  \\$wnnna$aJellyfishs, Moon
=450  \\$wnnna$aJellyfishs, True
=450  \\$wnnna$aMoon Jellies
=450  \\$wnnna$aMoon Jelly
=450  \\$aMoon Jellyfish
=450  \\$wnnna$aMoon Jellyfishs
=450  \\$wnnna$aNettle, Pacific Sea
=450  \\$wnnna$aNettles, Pacific Sea
=450  \\$wnnna$aPacific Sea Nettle
=450  \\$wnnna$aPacific Sea Nettles
=450  \\$wnnna$aScyphozoas
=450  \\$wnnna$aSea Nettle, Pacific
=450  \\$aSea Nettle, West Coast
=450  \\$wnnna$aSea Nettles, Pacific
=450  \\$wnnna$aTrue Jellyfish
=450  \\$wnnna$aTrue Jellyfishs
=550  \\$wg$aCnidaria
=550  \\$wh$aSea Nettle, East Coast
=667  \\$ado not confuse the genus Aurelia with the species Paramecium aurelia
=680  \\$iThe class of true jellyfish, in the phylum CNIDARIA. They are mostly free-swimming marine organisms that go through five stages in their life cycle and exhibit two body forms: polyp and medusa.
=688  \\$a2003
=750  \0$aScyphozoa$5IEN-M$0(DLC)sh 85119191

=LDR  01500cz  a2200349n  4500
=001  9880364188002441
=005  20141212215341.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037342
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x725.$x115.$x680
=072  \\$aD23.$x946.$x123.$x946.$x690
=072  \\$aD23.$x946.$x896.$x980.$x690
=150  \\$aPertussis Toxin
=450  \\$wnnna$aHistamine-Sensitizing Factor
=450  \\$wnnna$aHistamine Sensitizing Factor
=450  \\$aIAP Pertussis Toxin
=450  \\$aIslet-Activating Protein
=450  \\$wnnna$aIslet Activating Protein
=450  \\$wnnna$aIslets-Activating Protein
=450  \\$wnnna$aIslets Activating Protein
=450  \\$wnnna$aLymphocytosis-Promoting Factor
=450  \\$wnnna$aLymphocytosis Promoting Factor
=450  \\$aPertussigen
=450  \\$wnnna$aPertussis Toxin, IAP
=450  \\$wnnna$aToxin, IAP Pertussis
=450  \\$wnnna$aToxin, Pertussis
=550  \\$wg$aADP Ribose Transferases
=550  \\$wg$aVirulence Factors, Bordetella
=680  \\$iOne of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity.
=688  \\$a2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR use VIRULENCE FACTORS, BORDETELLA 1986-2002
=750  \0$aPertussis toxin$5IEN$0(DLC)sh 85100185

=LDR  00700cz  a2200181n  4500
=001  9880364188102441
=005  20141212215341.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x146.$x432
=072  \\$aD23.$x946.$x587.$x385
=150  \\$aFumonisins
=550  \\$wg$aAlkanes
=550  \\$wg$aMycotoxins
=680  \\$iA group of MYCOTOXINS found in CORN contaminated with FUSARIUM fungus. They are chains of about 20 carbons with acidic ester, acetylamino and sometimes other substituents. They inhibit ceramide synthetase conversion of SPHINGOLIPIDS to CERAMIDES.
=688  \\$a2003
=750  \0$aFumonisins$5IEN-M$0(DLC)sh 95009543

=LDR  01156cz  a2200337n  4500
=001  9880364188202441
=005  20141212215340.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037302
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x325
=150  \\$aCtenophora
=450  \\$aBeroe
=450  \\$wnnna$aBeroes
=450  \\$aComb Jellies
=450  \\$wnnna$aComb Jelly
=450  \\$wnnna$aCtenophoras
=450  \\$wnnna$aCtenophore
=450  \\$aCtenophores
=450  \\$wnnna$aJellies, Comb
=450  \\$wnnna$aJelly, Comb
=450  \\$wnnna$aMnemiopses
=450  \\$aMnemiopsis
=450  \\$wnnna$aSea Walnut
=450  \\$aSea Walnuts
=450  \\$wnnna$aWalnut, Sea
=450  \\$wnnna$aWalnuts, Sea
=550  \\$wg$aInvertebrates
=680  \\$iPhylum of marine colenterates characterized by eight comb rows of fused cilia on the body surface. In contrast to CNIDARIA they lack stinging cells, but they are voracious predators and possess sticky cells (colloblasts) for capturing prey. Most species are transparent and many exhibit bioluminescence.
=688  \\$a2003
=750  \0$aCtenophora$5IEN-M$0(DLC)sh 85034533

=LDR  01519cz  a2200325n  4500
=001  9880364188302441
=005  20141212215340.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037282
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x360.$x381.$x374
=072  \\$aD12.$x776.$x157.$x125.$x412.$x374
=072  \\$aD12.$x776.$x476.$x387.$x374
=072  \\$aD12.$x776.$x503.$x303
=150  \\$aCalreticulin
=450  \\$wnnna$a55-kDa High-Affinity Calcium Binding Protein
=450  \\$wnnna$a55 kDa High Affinity Calcium Binding Protein
=450  \\$wnnna$aCAB-63
=450  \\$wnnna$aCalcium-Binding Protein-3
=450  \\$wnnna$aCalcium Binding Protein 3
=450  \\$wnnna$aCalregulin
=450  \\$wnnna$aCBP3 (Liver)
=450  \\$wnnna$acC1qR Protein
=450  \\$wnnna$aERp60
=450  \\$wnnna$aHACBP
=550  \\$wg$aIntracellular Calcium-Sensing Proteins
=550  \\$wg$aLectins
=680  \\$iA multifunctional protein that is found primarily within membrane-bound organelles. In the ENDOPLASMIC RETICULUM it binds to specific N-linked oligosaccharides found on newly-synthesized proteins and functions as a MOLECULAR CHAPERONE that may play a role in PROTEIN FOLDING or retention and degradation of misfolded proteins. In addition calreticulin is a major storage form for CALCIUM and functions as a calcium-signaling molecule that can regulate intracellular calcium HOMEOSTASIS.
=688  \\$a2003; use CALRETICULIN (NM) 1990-2002
=750  \0$aCalreticulin$5IEN-M$0(DLC)sh 95006839

=LDR  01152cz  a2200229n  4500
=001  9880364188402441
=005  20141212215338.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037222
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x503.$x280.$x249
=150  \\$aCollectins
=450  \\$wnnna$aCollagenous Lectins
=450  \\$wnnna$aCollectin
=450  \\$wnnna$aLectins, Collagenous
=550  \\$wg$aLectins, C-Type
=550  \\$wh$aMannose-Binding Lectin
=550  \\$wh$aPulmonary Surfactant-Associated Protein A
=550  \\$wh$aPulmonary Surfactant-Associated Protein D
=680  \\$iA class of C-type lectins that target the carbohydrate structures found on invading pathogens. Binding of collectins to microorganisms results in their agglutination and enhanced clearance. Collectins form trimers that may assemble into larger oligomers. Each collectin polypeptide chain consists of four regions: a relatively short N-terminal region, a collagen-like region, an alpha-helical coiled-coil region, and carbohydrate-binding region.
=688  \\$a2003; use COLLECTINS (NM) 1980-2002
=750  \0$aCollectins$5IEN-M$0(DLC)sh 96007090

=LDR  01438cz  a2200349n  4500
=001  9880364188502441
=005  20141212215335.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037121
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x503.$x499
=072  \\$aD12.$x776.$x765.$x678
=150  \\$aPlant Lectins
=450  \\$wnnna$aAgglutinins, Plant
=450  \\$wnnna$aHemagglutinins, Plant
=450  \\$aLectins, Plant
=450  \\$wnnna$aPhytagglutinins
=450  \\$wnnna$aPlant Agglutinins
=450  \\$wnnna$aPlant Hemagglutinins
=550  \\$wg$aLectins
=550  \\$wg$aPlant Proteins
=550  \\$wh$aAbrin
=550  \\$wh$aConcanavalin A
=550  \\$wh$aPeanut Agglutinin
=550  \\$wh$aPhytohemagglutinins
=550  \\$wh$aPokeweed Mitogens
=550  \\$wh$aRibosome Inactivating Proteins, Type 2
=550  \\$wh$aRicin
=550  \\$wh$aWheat Germ Agglutinins
=680  \\$iProtein or glycoprotein substances of plant origin that bind to sugar moieties in cell walls or membranes. Some carbohydrate-metabolizing proteins (ENZYMES) from PLANTS also bind to carbohydrates, however they are not considered lectins. Many plant lectins change the physiology of the membrane of BLOOD CELLS to cause agglutination, mitosis, or other biochemical changes. They may play a role in plant defense mechanisms.
=688  \\$a2003; use LECTINS 1979-2002
=750  \0$aPlant lectins$5IEN-M$0(DLC)sh 85102759

=LDR  01446cz  a2200337n  4500
=001  9880364188602441
=005  20180328102349.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D037102
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x503
=150  \\$aLectins
=450  \\$aAnimal Lectins
=450  \\$wnnna$aIsolectin
=450  \\$aIsolectins
=450  \\$wnnna$aLectins, Animal
=550  \\$wg$aProteins
=550  \\$wh$aCalnexin
=550  \\$wh$aCalreticulin
=550  \\$wh$aChitinase-3-Like Protein 1
=550  \\$wh$aDiscoidins
=550  \\$wh$aGalectins
=550  \\$wh$aLectins, C-Type
=550  \\$wh$aMannose-Binding Lectins
=550  \\$wh$aPlant Lectins
=550  \\$wh$aReceptors, N-Acetylglucosamine
=550  \\$wh$aSelectins
=550  \\$wh$aSialic Acid Binding Immunoglobulin-like Lectins
=680  \\$iProteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition.
=688  \\$a2003; for ISOLECTIN use LECTINS (NM) 1979-2002
=750  \0$aLectins$5IEN$0(DLC)sh 85075672

=LDR  00794cz  a2200181n  4500
=001  9880364188702441
=005  20141212215329.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036941
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x812.$x332
=150  \\$aPeperomia
=450  \\$wnnna$aPeperomias
=550  \\$wg$aPiperaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family PIPERACEAE. Members contain prenylated quinones.
=688  \\$a2003
=750  \0$aPeperomia$0(DLC) sh2003011259$5IEN-M

=LDR  00948cz  a2200205n  4500
=001  9880364188802441
=005  20141212193036.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x82
=150  \\$aAspalathus
=450  \\$wnnna$aAspalathus linearis
=450  \\$wnnna$aRooibo
=450  \\$aRooibos
=550  \\$wg$aFabaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family FABACEAE. It is the source of an herbal tea that is commonly consumed in South Africa. Members contain aspalathin and other polyphenols (PHENOLS).
=688  \\$a2003
=750  \0$aAspalathus$5IEN-M$0(DLC)sh 85008676

=LDR  01075cz  a2200253n  4500
=001  9880364188902441
=005  20141212215327.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036901
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x596
=150  \\$aPetasites
=450  \\$aButterbur
=450  \\$wnnna$aButterburs
=450  \\$aColtsfoot, Sweet
=450  \\$wnnna$aColtsfoots, Sweet
=450  \\$wnnna$aPetasite
=450  \\$wnnna$aSweet Coltsfoot
=450  \\$wnnna$aSweet Coltsfoots
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain SESQUITERPENES. The common name of sweet coltsfoot is similar to the common name for TUSSILAGO.
=688  \\$a2003
=750  \0$aPetasites$0(DLC)sh2012003764$5IEN-M

=LDR  01092cz  a2200301n  4500
=001  9880364189002441
=005  20141212215326.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036861
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x520.$x252
=150  \\$aDelivery, Obstetric
=450  \\$wnnna$aDeliveries, Obstetric
=450  \\$wnnna$aObstetric Deliveries
=450  \\$wnnna$aObstetric Delivery
=550  \\$wg$aObstetric Surgical Procedures
=550  \\$wh$aCesarean Section
=550  \\$wh$aEpisiotomy
=550  \\$wh$aExtraction, Obstetrical
=550  \\$wh$aLabor, Induced
=550  \\$wh$aVaginal Birth after Cesarean
=550  \\$wh$aVersion, Fetal
=550  \\$aLabor Presentation
=550  \\$aTrial of Labor
=667  \\$a"tokolysis": translate as "tocolysis" & index as TOCOLYSIS
=680  \\$iDelivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.
=688  \\$a2003
=750  \0$aDelivery (Obstetrics)$5IEN-M$0(DLC)sh 85036582

=LDR  01015cz  a2200265n  4500
=001  9880364189102441
=005  20141212215325.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x415.$x246
=150  \\$aCiguatera Poisoning
=450  \\$aCiguatera
=450  \\$wnnna$aCiguatera Fish Poisoning
=450  \\$wnnna$aCiguatera Fish Poisonings
=450  \\$wnnna$aCiguatera Poisonings
=450  \\$aCiguatoxins$xpoisoning
=450  \\$wnnna$aPoisoning, Ciguatera
=450  \\$wnnna$aPoisoning, Ciguatera Fish
=450  \\$wnnna$aPoisonings, Ciguatera
=450  \\$wnnna$aPoisonings, Ciguatera Fish
=550  \\$wg$aFoodborne Diseases
=680  \\$iPoisoning caused by ingestion of SEAFOOD containing microgram levels of CIGUATOXINS. The poisoning is characterized by gastrointestinal, neurological and cardiovascular disturbances.
=688  \\$a2003; see CIGUATOXINS 1978-2002
=750  \0$aPoisonous fishes$xToxicology$5IEN-M$0(DLC)sh 85103944

=LDR  00699cz  a2200253n  4500
=001  9880364189202441
=005  20141212215324.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x769.$x490
=150  \\$aParturition
=450  \\$aBirth
=450  \\$wnnna$aBirths
=450  \\$aChildbirth
=450  \\$wnnna$aChildbirths
=450  \\$wnnna$aParturitions
=550  \\$wg$aPregnancy
=550  \\$wh$aHome Childbirth
=550  \\$wh$aNatural Childbirth
=550  \\$wh$aTerm Birth
=680  \\$iThe process of giving birth to one or more offspring.
=688  \\$a2003
=750  \0$aParturition$5IEN-M$0(DLC)sh 85098407

=LDR  00711cz  a2200181n  4500
=001  9880364189302441
=005  20141212215323.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x331.$x99
=150  \\$aBlastula
=450  \\$wnnna$aBlastulae
=550  \\$wg$aEmbryo, Nonmammalian
=667  \\$anon-mammalian only; mammalian, use BLASTOCYST
=680  \\$iAn early non-mammalian embryo that follows the MORULA stage. A blastula resembles a hollow ball with the layer of cells surrounding a fluid-filled cavity (blastocele). The layer of cells is called BLASTODERM.
=688  \\$a2003; use BLASTOCYST 1980-2002
=750  \0$aBlastula$5IEN-M$0(DLC)sh 94004613

=LDR  00610cz  a2200181n  4500
=001  9880364189402441
=005  20141212215322.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x919.$x490
=150  \\$aLimonins
=450  \\$aLimonoids
=450  \\$aTetranortriterpenoids
=550  \\$wg$aTriterpenes
=680  \\$iA group of degraded TRITERPENES in which the four terminal carbons of the C17 side chain have been removed, and the remaining portion often forming C17 furans.
=688  \\$a2003
=750  \0$aLimonoids$5IEN-M$0(DLC)sh 00000249

=LDR  00816cz  a2200181n  4500
=001  9880364189502441
=005  20141212215322.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036661
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x150.$x385
=150  \\$aEchium
=450  \\$wnnna$aEchiums
=550  \\$wg$aBoraginaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BORAGINACEAE. Members contain GAMMA-LINOLENIC ACID and PYRROLIZIDINE ALKALOIDS.
=688  \\$a2003
=750  \0$aEchium$5IEN-M$0(DLC)sh 87000504

=LDR  01139cz  a2200205n  4500
=001  9880364189602441
=005  20141212215321.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036641
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x458.$x500
=072  \\$aE5.$x595.$x458.$x500
=150  \\$aMicroscopy, Fluorescence, Multiphoton
=450  \\$aFluorescence Microscopy, Multiphoton
=450  \\$wnnna$aMicroscopy, Multiphoton Fluorescence
=450  \\$aMultiphoton Fluorescence Microscopy
=550  \\$wg$aMicroscopy, Fluorescence
=680  \\$iFluorescence microscopy utilizing multiple low-energy photons to produce the excitation event of the fluorophore. Multiphoton microscopes have a simplified optical path in the emission side due to the lack of an emission pinhole, which is necessary with normal confocal microscopes. Ultimately this allows spatial isolation of the excitation event, enabling deeper imaging into optically thick tissue, while restricting photobleaching and phototoxicity to the area being imaged.
=688  \\$a2003
=750  \0$aMultiphoton excitation microscopy$5IEN-M$0(DLC)sh2002008674

=LDR  01265cz  a2200301n  4500
=001  9880364189702441
=005  20141212215321.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036625
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x843
=150  \\$aStevia
=450  \\$aEupatorium rebaudianum
=450  \\$wnnna$aEupatorium rebaudianums
=450  \\$wnnna$arebaudiana, Stevia
=450  \\$wnnna$arebaudianas, Stevia
=450  \\$wnnna$arebaudianum, Eupatorium
=450  \\$wnnna$arebaudianums, Eupatorium
=450  \\$wnnna$aStevia rebaudiana
=450  \\$wnnna$aStevia rebaudianas
=450  \\$wnnna$aStevias
=450  \\$aSweetleaf
=450  \\$wnnna$aSweetleafs
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening (SWEETENING AGENTS).
=688  \\$a2003
=750  \0$aStevia$5IEN-M$0(DLC)sh 85128078

=LDR  00908cz  a2200229n  4500
=001  9880364189902441
=005  20141212215320.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036623
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x356
=150  \\$aGrindelia
=450  \\$wnnna$aGrindelias
=450  \\$aGumplant
=450  \\$wnnna$aGumplants
=450  \\$aGumweed
=450  \\$wnnna$aGumweeds
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain triterpenoid sapogenins.
=688  \\$a2003
=750  \0$aGrindelia$5IEN-M$0(DLC)sh 85057367

=LDR  01272cz  a2200277n  4500
=001  9880364190002441
=005  20141212215319.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x203
=150  \\$aChromolaena
=450  \\$wnnna$aChromolaena odorata
=450  \\$wnnna$aChromolaena odoratas
=450  \\$wnnna$aChromolaenas
=450  \\$aEupatorium odoratum
=450  \\$wnnna$aEupatorium odoratums
=450  \\$wnnna$aodorata, Chromolaena
=450  \\$wnnna$aodoratas, Chromolaena
=450  \\$wnnna$aodoratum, Eupatorium
=450  \\$wnnna$aodoratums, Eupatorium
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. The common name of thoroughwort is also used for other plants including EUPATORIUM; CHROMOLAENA, Hebeclinium and Koanophyllon. Eupolin is the aqueous extract of the leaves.
=688  \\$a2003
=750  \0$aChromolaena$5IEN-M$0(DLC)sh 95005906

=LDR  01120cz  a2200181n  4500
=001  9880364190102441
=005  20141212215318.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036602
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x347
=150  \\$aEupatorium
=450  \\$wnnna$aEupatoriums
=550  \\$wg$aAsteraceae
=667  \\$aEUPATORIUM REBAUDIANUM see STEVIA; EUPATORIUM ODORATUM see CHROMOLAENA and EUPATORIUM ADENOPHORUM see AGERATINA are also available; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Ingestion has been associated with MILK SICKNESS. The common name of thoroughwort is also used for other plants including CHROMOLAENA; Hebeclinium, and Koanophyllon.
=688  \\$a2003
=750  \0$aEupatorium$5IEN-M$0(DLC)sh 88022788

=LDR  01114cz  a2200229n  4500
=001  9880364190202441
=005  20141212215318.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036582
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x665
=150  \\$aRudbeckia
=450  \\$aConeflower, Orange
=450  \\$wnnna$aConeflowers, Orange
=450  \\$wnnna$aOrange Coneflower
=450  \\$wnnna$aOrange Coneflowers
=450  \\$wnnna$aRudbeckias
=550  \\$wg$aAsteraceae
=667  \\$aX ref CONEFLOWER, ORANGE: CONEFLOWER, PURPLE see ECHINACEA and CONEFLOWER, PRAIRIE see RATIBIDA are also available; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Some Rudbeckia species have been reclassified to ECHINACEA; RATIBIDA; or HELIANTHUS.
=688  \\$a2003
=750  \0$aRudbeckia$5IEN-M$0(DLC)sh 85115707

=LDR  00824cz  a2200181n  4500
=001  9880364190302441
=005  20141212215317.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036562
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x425
=150  \\$aHelichrysum
=450  \\$wnnna$aHelichrysums
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain CHALCONE, helichrysetin, arenarin, and flamin.
=688  \\$a2003
=750  \0$aHelichrysum$5IEN-M$0(DLC)sh 96009383

=LDR  01279cz  a2200337n  4500
=001  9880364190402441
=005  20141212215316.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036561
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x94
=150  \\$aCajanus
=450  \\$wnnna$acajan, Cajanus
=450  \\$wnnna$acajans, Cajanus
=450  \\$wnnna$aCajanus cajan
=450  \\$wnnna$aCajanus cajans
=450  \\$aPea Plant, Pigeon
=450  \\$wnnna$aPea Plants, Pigeon
=450  \\$wnnna$aPigeon Pea Plant
=450  \\$wnnna$aPigeon Pea Plants
=450  \\$aPigeonpea Plant
=450  \\$wnnna$aPigeonpea Plants
=450  \\$wnnna$aPlant, Pigeon Pea
=450  \\$wnnna$aPlant, Pigeonpea
=450  \\$wnnna$aPlants, Pigeon Pea
=450  \\$wnnna$aPlants, Pigeonpea
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE that is used for food in NIGERIA.
=688  \\$a2003
=750  \0$aCajanus$5IEN-M$0(DLC)sh 85018719

=LDR  02546cz  a2200625n  4500
=001  9880364190502441
=005  20141212215316.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036542
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x350.$x810.$x800
=072  \\$aE1.$x370.$x350.$x600.$x350.$x700.$x810.$x800
=072  \\$aE1.$x370.$x350.$x700.$x700.$x810.$x800
=072  \\$aE1.$x370.$x350.$x700.$x810.$x810.$x800
=072  \\$aE1.$x370.$x350.$x825.$x810.$x810.$x800
=150  \\$aTomography, Spiral Computed
=450  \\$aCAT Scan, Spiral
=450  \\$wnnna$aCAT Scans, Spiral
=450  \\$wnnna$aComputed Tomography, Helical
=450  \\$wnnna$aComputed Tomography, Spiral
=450  \\$wnnna$aComputer-Assisted Tomography, Spiral
=450  \\$wnnna$aComputer Assisted Tomography, Spiral
=450  \\$wnnna$aComputerized Tomography, Spiral
=450  \\$wnnna$aCT, Helical
=450  \\$aCT Scan, Spiral
=450  \\$wnnna$aCT Scans, Spiral
=450  \\$wnnna$aCT, Spiral
=450  \\$wnnna$aCTs, Helical
=450  \\$wnnna$aCTs, Spiral
=450  \\$aHelical Computed Tomography
=450  \\$aHelical CT
=450  \\$wnnna$aHelical CTs
=450  \\$wnnna$aScan, Spiral CAT
=450  \\$wnnna$aScan, Spiral CT
=450  \\$wnnna$aScans, Spiral CAT
=450  \\$wnnna$aScans, Spiral CT
=450  \\$wnnna$aSpiral CAT Scan
=450  \\$wnnna$aSpiral CAT Scans
=450  \\$aSpiral Computed Tomography
=450  \\$wnnna$aSpiral Computer-Assisted Tomography
=450  \\$wnnna$aSpiral Computerized Tomography
=450  \\$aSpiral CT
=450  \\$wnnna$aSpiral CT Scan
=450  \\$wnnna$aSpiral CT Scans
=450  \\$wnnna$aSpiral CTs
=450  \\$aTomography, Helical Computed
=450  \\$wnnna$aTomography, Spiral Computer-Assisted
=450  \\$wnnna$aTomography, Spiral Computerized
=550  \\$wg$aTomography, X-Ray Computed
=550  \\$wh$aMultidetector Computed Tomography
=550  \\$wh$aSpiral Cone-Beam Computed Tomography
=667  \\$ado not confuse with SPIRAL CONE-BEAM COMPUTED TOMOGRAPHY
=680  \\$iComputed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.
=688  \\$a2003
=750  \0$aSpiral computed tomography$0(DLC) sh 94003037$5IEN-M

=LDR  00996cz  a2200301n  4500
=001  9880364190602441
=005  20141212215314.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x605.$x500
=150  \\$aMetered Dose Inhalers
=450  \\$wnnna$aInhaler, Metered Dose
=450  \\$aInhalers, Metered Dose
=450  \\$wnnna$aMDI (Inhalers)
=450  \\$wnnna$aMetered Dose Inhaler
=450  \\$wnnna$aSpacer Inhaler
=450  \\$wnnna$aSpacer-Inhaler
=450  \\$wnnna$aSpacer-Inhalers
=450  \\$aSpacer Inhalers
=450  \\$wnnna$aSpinhaler
=450  \\$wnnna$aSpinhalers
=550  \\$wg$aNebulizers and Vaporizers
=550  \\$wh$aInhalation Spacers
=667  \\$ado not confuse entry term SPACER INHALERS with INHALATION SPACERS
=680  \\$iA small aerosol canister used to release a calibrated amount of medication for inhalation.
=688  \\$a2003
=750  \0$aMetered-dose inhalers$5IEN-M$0(DLC)sh 98006414

=LDR  00845cz  a2200301n  4500
=001  9880364190702441
=005  20141212215313.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036441
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x595
=150  \\$aOsmeriformes
=450  \\$aAyu
=450  \\$aGalaxias maculatus
=450  \\$wnnna$aGalaxiid
=450  \\$aGalaxiidae
=450  \\$wnnna$aGalaxiids
=450  \\$aOsmeridae
=450  \\$wnnna$aPlecoglossidae
=450  \\$wnnna$aPlecoglossinae
=450  \\$wnnna$aPlecoglossus altiveli
=450  \\$wnnna$aPlecoglossus altivelis
=450  \\$wnnna$aSmelt
=450  \\$aSmelts
=550  \\$wg$aFishes
=680  \\$iAn order of fish including smelts, galaxiids, and salamanderfish.
=688  \\$a2003
=750  \0$aOsmeriformes$5IEN-M$0(DLC)sh2002000083

=LDR  00801cz  a2200229n  4500
=001  9880364190802441
=005  20141212215312.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x940.$x800
=150  \\$aToxicity Tests, Chronic
=450  \\$wnnna$aChronic Toxicity Test
=450  \\$aChronic Toxicity Tests
=450  \\$wnnna$aTest, Chronic Toxicity
=450  \\$wnnna$aTests, Chronic Toxicity
=450  \\$wnnna$aToxicity Test, Chronic
=550  \\$wg$aToxicity Tests
=667  \\$aTOXICITY TESTS, SUBCHRONIC is also available
=680  \\$iExperiments designed to determine the potential toxic effects of a long-term exposure to a chemical or chemicals.
=688  \\$a2003
=750  \0$aChronic toxicity testing$5IEN-M$0(DLC)sh 88001078

=LDR  01690cz  a2200553n  4500
=001  9880364190902441
=005  20141212215308.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036361
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699
=072  \\$aD12.$x644.$x548
=150  \\$aPeptide Hormones
=450  \\$aHormones, Peptide
=450  \\$wnnna$aHormones, Polypeptide
=450  \\$aPolypeptide Hormones
=550  \\$wg$aHormones
=550  \\$wg$aPeptides
=550  \\$wh$aActivins
=550  \\$wh$aAdipokines
=550  \\$wh$aAdrenomedullin
=550  \\$wh$aAngiotensins
=550  \\$wh$aBombesin
=550  \\$wh$aCalcitonin
=550  \\$wh$aGastric Inhibitory Polypeptide
=550  \\$wh$aGastrins
=550  \\$wh$aGhrelin
=550  \\$wh$aGonadotropins
=550  \\$wh$aHypothalamic Hormones
=550  \\$wh$aInhibins
=550  \\$wh$aMotilin
=550  \\$wh$aNatriuretic Peptides
=550  \\$wh$aPancreatic Hormones
=550  \\$wh$aParathyroid Hormone
=550  \\$wh$aParathyroid Hormone-Related Protein
=550  \\$wh$aPeptide PHI
=550  \\$wh$aPeptide YY
=550  \\$wh$aPituitary Hormones
=550  \\$wh$aPlacental Hormones
=550  \\$wh$aRelaxin
=550  \\$wh$aSecretin
=550  \\$wh$aThymosin
=550  \\$wh$aUrocortins
=550  \\$wh$aUrotensins
=550  \\$wh$aVasoactive Intestinal Peptide
=550  \\$aIntercellular Signaling Peptides and Proteins
=680  \\$iHormones synthesized from amino acids. They are distinguished from INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS in that their actions are systemic.
=688  \\$a2003
=750  \0$aPeptide hormones$5IEN-M$0(DLC)sh 85099689

=LDR  02414cz  a2200625n  4500
=001  9880364191002441
=005  20180725111804.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036341
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276
=072  \\$aD12.$x776.$x467
=072  \\$aD23.$x529
=150  \\$aIntercellular Signaling Peptides and Proteins
=450  \\$aGrowth Factors
=450  \\$aParacrine Peptide Factors
=450  \\$aParacrine Protein Factors
=450  \\$wnnna$aPeptide Factors, Paracrine
=550  \\$wg$aBiological Factors
=550  \\$wg$aPeptides
=550  \\$wg$aProteins
=550  \\$wh$aAdipokines
=550  \\$wh$aAgouti-Related Protein
=550  \\$wh$aAgouti Signaling Protein
=550  \\$wh$aAngiogenic Proteins
=550  \\$wh$aB7 Antigens
=550  \\$wh$aCCN Intercellular Signaling Proteins
=550  \\$wh$aCytokines
=550  \\$wh$aEGF Family of Proteins
=550  \\$wh$aEndothelial Growth Factors
=550  \\$wh$aEndothelins
=550  \\$wh$aEphrins
=550  \\$wh$aFibroblast Growth Factors
=550  \\$wh$aHedgehog Proteins
=550  \\$wh$aInterferons
=550  \\$wh$aKinins
=550  \\$wh$aKisspeptins
=550  \\$wh$aNerve Growth Factors
=550  \\$wh$aParathyroid Hormone-Related Protein
=550  \\$wh$aPlatelet-Derived Growth Factor
=550  \\$wh$aSemaphorins
=550  \\$wh$aSerrate-Jagged Proteins
=550  \\$wh$aSomatomedins
=550  \\$wh$aTGF-beta Superfamily Proteins
=550  \\$wh$aTolloid-Like Metalloproteinases
=550  \\$wh$aTransforming Growth Factors
=550  \\$wh$aTumor Necrosis Factors
=550  \\$wh$aWnt Proteins
=550  \\$aParacrine Communication
=550  \\$aPeptide Hormones
=667  \\$ageneral or unspecified; prefer specifics; coordinate with PARACRINE COMMUNICATION if pertinent; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS is also available
=680  \\$iRegulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.
=688  \\$a2003; for GROWTH FACTORS use GROWTH SUBSTANCES 1999-2006
=688  \\$a2003
=750  \0$aGrowth factors$0(DLC) sh 85057532$5IEN-M

=LDR  00924cz  a2200217n  4500
=001  9880364191102441
=005  20141212193035.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036301
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x241.$x850
=150  \\$aQualitative Research
=450  \\$wnnna$aResearch, Qualitative
=550  \\$wg$aEmpirical Research
=550  \\$wh$aHermeneutics
=550  \\$aAnthropology, Cultural
=550  \\$aFocus Groups
=667  \\$acoordinate with specific qualitative research method if pertinent
=680  \\$iAny type of research that employs nonnumeric information to explore individual or group characteristics, producing findings not arrived at by statistical procedures or other quantitative means. (Qualitative Inquiry: A Dictionary of Terms Thousand Oaks, CA: Sage Publications, 1997)
=688  \\$a2003
=750  \0$aQualitative research$5IEN-M$0(DLC)sh 99004969

=LDR  00899cz  a2200241n  4500
=001  9880364191202441
=005  20141212215305.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x343.$x249
=072  \\$aH1.$x770.$x644.$x145.$x350
=150  \\$aGenetic Research
=450  \\$wnnna$aResearch, Genetic
=550  \\$wg$aBiomedical Research
=550  \\$wg$aGenetics
=550  \\$wh$aGene Ontology
=550  \\$wh$aHapMap Project
=550  \\$wh$aHuman Genome Project
=667  \\$agenetic research as a field or the progress or status of genetic research; do not add routinely for specific research studies in genetics
=680  \\$iResearch into the cause, transmission, amelioration, elimination, or enhancement of inherited disorders and traits.
=688  \\$a2003
=750  \0$aGenetics$xResearch$5IEN-M$0(DLC)sh 85053880

=LDR  01056cz  a2200373n  4500
=001  9880364191302441
=005  20160801111242.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036226
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x550
=072  \\$aB1.$x650.$x819
=150  \\$aSeedlings
=450  \\$wnno$aSeedling
=450  \\$wnnna$aMalted Grain
=450  \\$wnnna$aSprouted Seeds
=450  \\$wnnna$aSprouted, Seed
=450  \\$wnnna$aSprout, Plant
=450  \\$wnnna$aSprouts, Plant
=450  \\$wnnna$aGrain, Malted
=450  \\$wnnna$aGrains, Malted
=450  \\$wnnna$aMalted Grains
=450  \\$wnnna$aPlant Sprout
=450  \\$wnnna$aPlant Sprouts
=450  \\$wnnna$aSeed, Sprouted
=450  \\$wnnna$aSeeds, Sprouted
=550  \\$wg$aPlant Structures
=550  \\$wg$aPlants
=550  \\$wh$aHypocotyl
=550  \\$aGermination
=550  \\$aPlant Shoots
=680  \\$iYoung plants produced at the completion of GERMINATION of SEEDS.
=688  \\$a2015; 1995
=750  \0$aSeedlings$5IEN-M$0(DLC)sh 85119536

=LDR  00997cz  a2200229n  4500
=001  9880364191402441
=005  20141212215302.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036142
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x575.$x483.$x444
=150  \\$aMentha piperita
=450  \\$wnnna$aMentha piperitas
=450  \\$aPeppermint
=450  \\$wnnna$aPeppermints
=450  \\$wnnna$apiperita, Mentha
=450  \\$wnnna$apiperitas, Mentha
=550  \\$wg$aMentha
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family LAMIACEAE that is the source of peppermint oil.
=688  \\$a2003; for PEPPERMINT use MENTHA PIPERITA (NM) 1973-2002
=750  \0$aPeppermint$5IEN-M$0(DLC)sh 85099669

=LDR  00805cz  a2200253n  4500
=001  9880364191502441
=005  20141212215300.0
=008  020103\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036103
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x603
=072  \\$aJ1.$x897.$x520.$x600
=150  \\$aNanotechnology
=450  \\$wnnna$aNanotechnologies
=550  \\$wg$aMiniaturization
=550  \\$wg$aNatural Science Disciplines
=550  \\$wh$aNanomedicine
=550  \\$aMicrochemistry
=550  \\$aMicrochip Analytical Procedures
=550  \\$aNanostructures
=550  \\$aNanotubes
=680  \\$iThe development and use of techniques to study physical phenomena and construct structures in the nanoscale size range or smaller.
=688  \\$a2002
=750  \0$aNanotechnology$5IEN-M$0(DLC)sh 91001490

=LDR  01009cz  a2200229n  4500
=001  9880364191602441
=005  20141212215259.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036083
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x118
=150  \\$aAtractylis
=450  \\$wnnna$aAtractyli
=450  \\$wnnna$aAtractylis gummifera
=450  \\$wnnna$aAtractylis gummiferas
=450  \\$wnnna$agummifera, Atractylis
=450  \\$wnnna$agummiferas, Atractylis
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE which inhibits ADENINE NUCLEOTIDE TRANSLOCASE.
=688  \\$a2003
=750  \0$aAtractylis$5IEN-M$0(DLC)sh 85009348

=LDR  03581cz  a2200841n  4500
=001  9880364191702441
=005  20141212215256.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D036002
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x725.$x115
=150  \\$aADP Ribose Transferases
=450  \\$wnnna$aADP Ribose Transferase
=450  \\$wnnna$aADP-ribose Transferases, Mono
=450  \\$aADP-Ribosyltransferase
=450  \\$wnnna$aADP Ribosyltransferase
=450  \\$wnnna$aADP-Ribosyltransferase, NAD
=450  \\$wnnna$aADP-Ribosyltransferase, NAD-Agmatine
=450  \\$wnnna$aADP-Ribosyltransferase, NAD-Arginine
=450  \\$wnnna$aADP-Ribosyltransferase, NAD+
=450  \\$wnnna$aADP-Ribosyltransferase, NADP-Arginine
=450  \\$wnnna$aADPribose Transferase, Mono
=450  \\$wnnna$aADPribose Transferases, Mono
=450  \\$wnnna$aADPRT
=450  \\$wnnna$aADPRTs
=450  \\$wnnna$aART Transferase
=450  \\$wnnna$aART Transferases
=450  \\$wnnna$aARTase
=450  \\$wnnna$aARTases
=450  \\$wnnna$aMono(ADP-Ribose) Transferase
=450  \\$wnnna$aMono ADP-ribose Transferases
=450  \\$aMono(ADP-Ribose) Transferases
=450  \\$wnnna$aMono ADP ribose Transferases
=450  \\$wnnna$aMono(ADP-Ribosyl)transferase
=450  \\$wnnna$aMono-ADP-Ribosyltransferase
=450  \\$wnnna$aMono ADP Ribosyltransferase
=450  \\$wnnna$aMono ADPribose Transferase
=450  \\$wnnna$aMono ADPribose Transferases
=450  \\$wnnna$aMono(ADPribosyl)transferase
=450  \\$wnnna$aMonoADPribosyltransferase
=450  \\$wnnna$aNAD(+)-L-arginine ADP-D-ribosyltransferase
=450  \\$wnnna$aNAD ADP-Ribosyltransferase
=450  \\$wnnna$aNAD ADP Ribosyltransferase
=450  \\$wnnna$aNAD-Agmatine ADP-Ribosyltransferase
=450  \\$wnnna$aNAD Agmatine ADP Ribosyltransferase
=450  \\$wnnna$aNAD-Arginine ADP-Ribosyltransferase
=450  \\$wnnna$aNAD Arginine ADP Ribosyltransferase
=450  \\$aNAD(P)(+)-Arginine ADP-Ribosyltransferase
=450  \\$aNAD+ ADP-Ribosyltransferase
=450  \\$wnnna$aNAD+ ADP Ribosyltransferase
=450  \\$wnnna$aNADP-ADPRTase
=450  \\$wnnna$aNADP ADPRTase
=450  \\$wnnna$aNADP-Arginine ADP-Ribosyltransferase
=450  \\$wnnna$aNADP Arginine ADP Ribosyltransferase
=450  \\$wnnna$aRibose Transferase, ADP
=450  \\$wnnna$aRibose Transferases, ADP
=450  \\$wnnna$aTransferase, ADP Ribose
=450  \\$wnnna$aTransferase, ART
=450  \\$wnnna$aTransferase, Mono ADPribose
=450  \\$wnnna$aTransferases, ADP Ribose
=450  \\$wnnna$aTransferases, ART
=450  \\$wnnna$aTransferases, Mono ADP-ribose
=450  \\$wnnna$aTransferases, Mono ADPribose
=550  \\$wg$aPentosyltransferases
=550  \\$wh$aCholera Toxin
=550  \\$wh$aDiphtheria Toxin
=550  \\$wh$aNAD+ Nucleosidase
=550  \\$wh$aPertussis Toxin
=550  \\$wh$aPoly(ADP-ribose) Polymerases
=550  \\$wh$aSirtuins
=680  \\$iEnzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water (i.e., hydrolysis) is catalyzed by the NADASES. The mono(ADP-ribose)transferases transfer a single ADP-ribose. POLY(ADP-RIBOSE) POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.
=688  \\$a2003; for NAD+ ADP-RIBOSYLTRANSFERASE use POLY(ADP-RIBOSE) POLYMERASES 1988-2002
=750  \0$aNAD-ADP-ribosyltransferase$5IEN-M$0(DLC)sh 00000059

=LDR  01008cz  a2200253n  4500
=001  9880364191802441
=005  20141212215255.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x87.$x412
=150  \\$aHedera
=450  \\$wnnna$aEnglish Ivy
=450  \\$wnnna$aHedera helices
=450  \\$wnnna$aHedera helix
=450  \\$wnnna$aHederas
=450  \\$wnnna$ahelices, Hedera
=450  \\$wnnna$ahelix, Hedera
=450  \\$aIvy, English
=550  \\$wg$aAraliaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ARALIACEAE. Members contain hederin (olean-12-ene) type TRITERPENES.
=688  \\$a2003
=750  \0$aIvy$5IEN-M$0(DLC)sh 85069129

=LDR  00905cz  a2200193n  4500
=001  9880364191902441
=005  20141212215255.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035962
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x977
=150  \\$aZosteraceae
=450  \\$wnnna$aZostera
=450  \\$wnnna$aZosteras
=550  \\$wg$aAlismatidae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Najadales, subclass ALISMATIDAE, class Liliopsida (monocotyledons). This is a group of perennial aquatic herbs with basal leaves.
=688  \\$a2003
=750  \0$aZosteraceae$5IEN-M$0(DLC)sh 88023200

=LDR  01234cz  a2200277n  4500
=001  9880364192102441
=005  20141212215253.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x462
=150  \\$aHepatophyta
=450  \\$wnnna$aBazzania
=450  \\$wnnna$aBazzanias
=450  \\$wnnna$aHepatophytas
=450  \\$wnnna$aJungermanniae
=450  \\$wnnna$aLiverwort
=450  \\$aLiverworts
=450  \\$wnnna$aMarchantiae
=550  \\$wg$aEmbryophyta
=550  \\$wh$aFrullania
=550  \\$wh$aMarchantia
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant division. They are simple plants that lack vascular tissue and possess rudimentary rootlike organs (rhizoids). Like MOSSES, liverworts have alternation of generations between haploid gamete-bearing forms (gametophytes) and diploid spore-bearing forms (sporophytes).
=688  \\$a2003
=750  \0$aLiverworts$5IEN-M$0(DLC)sh 85077781

=LDR  01198cz  a2200253n  4500
=001  9880364192202441
=005  20141212215252.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035924
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x543
=150  \\$aMontanoa
=450  \\$wnnna$aMontanoa tomentosa
=450  \\$wnnna$aMontanoa tomentosas
=450  \\$wnnna$aMontanoas
=450  \\$wnnna$atomentosa, Montanoa
=450  \\$wnnna$atomentosas, Montanoa
=450  \\$aZoapatle
=450  \\$wnnna$aZoapatles
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Steroidal activity has been observed in animals. Members of this genus contain sesquiterpene lactones such as tomentosin, OXEPINS such as zoapatanol, and kaurene type DITERPENES.
=688  \\$a2003; for ZOAPATLE use MONTANOA (NM) 1980-2002
=750  \0$aMontanoa$5IEN-M$0(DLC)sh 85087023

=LDR  00627cz  a2200205n  4500
=001  9880364192302441
=005  20141212215250.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035863
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x616
=072  \\$aF1.$x829.$x500.$x679
=072  \\$aK1.$x559.$x472
=150  \\$aMoral Development
=450  \\$wnnna$aDevelopment, Moral
=550  \\$wg$aMorals
=550  \\$wg$aPersonality Development
=680  \\$iThe process by which individuals internalize standards of right and wrong conduct.
=688  \\$a2003
=750  \0$aMoral development$5IEN-M$0(DLC)sh 85087199

=LDR  01537cz  a2200373n  4500
=001  9880364192502441
=005  20201217172226.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035843
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x770.$x644.$x145
=150  \\$aBiomedical Research
=450  \\$aClinical Research
=450  \\$aMedical Research
=450  \\$wnnna$aResearch, Biomedical
=450  \\$wnnna$aResearch, Clinical
=450  \\$wnnna$aResearch, Medical
=550  \\$wg$aResearch
=550  \\$wh$aDental Research
=550  \\$wh$aEmbryo Research
=550  \\$wh$aFetal Research
=550  \\$wh$aGenetic Research
=550  \\$wh$aHealth Services Research
=550  \\$wh$aHuman Experimentation
=550  \\$wh$aNursing Research
=550  \\$wh$aOutcome Assessment, Health Care
=550  \\$wh$aPharmaceutical Research
=550  \\$wh$aRehabilitation Research
=550  \\$wh$aStem Cell Research
=550  \\$wh$aTranslational Medical Research
=667  \\$abiomedical research as a field or the progress or status of biomedical research; do not add routinely for specific studies in biomedicine; do not coord with MEDICINE: Manual 29.16; for Clinical Research, CLINICAL TRIALS AS TOPIC (see note there) and HUMAN EXPERIMENTATION are also available
=680  \\$iResearch that involves the application of the natural sciences, especially biology and physiology, to medicine. (from American Heritage Dictionary, 4th ed)
=688  \\$a2003
=750  \0$aMedicine$xResearch$5IEN-M$0(DLC)sh 85083097

=LDR  00803cz  a2200181n  4500
=001  9880364192602441
=005  20141212215247.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x190
=150  \\$aDalbergia
=450  \\$wnnna$aDalbergias
=550  \\$wg$aFabaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family FABACEAE. Members of this genus can cause CONTACT DERMATITIS.
=688  \\$a2003
=750  \0$aDalbergia$5IEN-M$0(DLC)sh 85035510

=LDR  00787cz   2200265n  4500
=001  9880364192702441
=005  20240216142320.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035781
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x263.$x500.$x490
=072  \\$aI1.$x880.$x853.$x150.$x500.$x505
=072  \\$aM1.$x781
=150  \\$aSiblings
=450  \\$wnnna$aBrother
=450  \\$wnnna$aBrothers
=450  \\$wnnna$aSibling
=450  \\$wnnna$aSister
=450  \\$wnnna$aSisters
=550  \\$wg$aNuclear Family
=550  \\$wg$aPersons
=667  \\$ause only when the subject of discussion
=680  \\$iPersons or animals having at least one parent in common. (American College Dictionary, 3d ed)
=688  \\$a2003
=750  \0$aSiblings$5IEN$0(DLC)sh 85017225

=LDR  00876cz  a2200205n  4500
=001  9880364192802441
=005  20141212215247.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035742
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x512
=150  \\$aMikania
=450  \\$aGuaco
=450  \\$wnnna$aGuacos
=450  \\$wnnna$aMikanias
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain scandenolide (a sesquiterpene lactone) and germacranolides.
=688  \\$a2003
=750  \0$aMikania$5IEN-M$0(DLC)sh 85085083

=LDR  00807cz  a2200181n  4500
=001  9880364192902441
=005  20141212215246.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035741
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x984
=150  \\$aVernonia
=450  \\$wnnna$aVernonias
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain germacrane and sesquiterpene LACTONES.
=688  \\$a2003
=750  \0$aVernonia$5IEN-M$0(DLC)sh 88023182

=LDR  01067cz  a2200253n  4500
=001  9880364193002441
=005  20141212215246.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035723
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x20.$x500
=150  \\$aMesembryanthemum
=450  \\$aIce Plant
=450  \\$wnnna$aIce Plants
=450  \\$aIceplant
=450  \\$wnnna$aIceplants
=450  \\$wnnna$aMesembryanthemums
=450  \\$wnnna$aPlant, Ice
=450  \\$wnnna$aPlants, Ice
=550  \\$wg$aAizoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family AIZOACEAE. It is a native of Africa and widely planted for erosion control to stabilize soil along roadsides and beaches.
=688  \\$a2003
=750  \0$aMesembryanthemum$5IEN-M$0(DLC)sh 85083911

=LDR  01026cz  a2200253n  4500
=001  9880364193102441
=005  20190625134130.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035722
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x050
=150  \\$aAizoaceae
=450  \\$aSesuvium
=450  \\$wnnna$aSesuviums
=450  \\$aTetragonia
=450  \\$wnnna$aTetragonias
=450  \\$aTrianthema
=450  \\$wnnna$aTrianthemas
=550  \\$wg$aCaryophyllales
=550  \\$wh$aMesembryanthemum
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.
=688  \\$a2003
=750  \0$aAizoaceae$5IEN-M$0(DLC)sh 85003024

=LDR  00918cz  a2200205n  4500
=001  9880364193202441
=005  20200422104403.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035704
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x198.$x500.$x675
=150  \\$aMolluginaceae
=450  \\$aGlinus
=450  \\$aMollugo
=450  \\$wnnna$aMollugos
=550  \\$wg$aCaryophyllales
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Some members contain triterpenoid saponins.
=688  \\$a2003
=750  \0$aMolluginaceae$5IEN-M$0(DLC)sh 85086607

=LDR  01372cz  a2200361n  4500
=001  9880364193302441
=005  20141212215245.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035703
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x931
=150  \\$aTherapies, Investigational
=450  \\$wnnna$aExperimental Therapies
=450  \\$wnnna$aExperimental Therapy
=450  \\$wnnna$aInnovative Therapies
=450  \\$wnnna$aInnovative Therapy
=450  \\$aInvestigational Therapies
=450  \\$wnnna$aInvestigational Therapy
=450  \\$wnnna$aInvestigational Treatment
=450  \\$wnnna$aInvestigational Treatments
=450  \\$wnnna$aTherapies, Experimental
=450  \\$wnnna$aTherapies, Innovative
=450  \\$wnnna$aTherapy, Experimental
=450  \\$wnnna$aTherapy, Innovative
=450  \\$wnnna$aTherapy, Investigational
=450  \\$wnnna$aTreatment, Investigational
=450  \\$wnnna$aTreatments, Investigational
=550  \\$wg$aTherapeutics
=550  \\$wh$aCompassionate Use Trials
=550  \\$aClinical Trials as Topic
=680  \\$iTreatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.
=688  \\$a2003
=750  \0$aTherapeutics, Experimental$5IEN-M$0(DLC)sh 85134727

=LDR  01038cz  a2200205n  4500
=001  9880364193402441
=005  20190726132837.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035702
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x937.$x937.$x427
=150  \\$aCecropia Plant
=450  \\$wnnna$aCecropia Plants
=450  \\$wnnna$aPlant, Cecropia
=450  \\$wnnna$aPlants, Cecropia
=550  \\$wg$aUrticaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family CECROPIACEAE. Hypotensive and hypoglycemic effects have been observed in animals after ingesting members of this genus. There is no relation to cecropia moth (Hyalophora cecropia) see MOTHS.
=688  \\$a2003
=750  \0$aCecropia$5IEN-M$0(DLC)sh 88022656

=LDR  00859cz  a2200181n  4500
=001  9880364193502441
=005  20141212215243.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035684
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x400.$x344.$x333
=150  \\$aGnetum
=450  \\$wnnna$aGnetums
=550  \\$wg$aGnetophyta
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Gnetaceae, order Gnetales class Gnetopsida, division GNETOPHYTA. Members contain STILBENES and benzylisoquinoline alkaloids.
=688  \\$a2003
=750  \0$aGnetum$5IEN-M$0(DLC)sh 85055453

=LDR  00927cz  a2200181n  4500
=001  9880364193602441
=005  20141212215242.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035681
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x900.$x500.$x750.$x750.$x44
=150  \\$aAdiantum
=450  \\$wnnna$aAdiantums
=550  \\$wg$aPteridaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Pteridaceae. Members contain TRITERPENES. Some species in this genus are called maidenhair fern which is also a common name occasionally used for Lygodium (FERNS) and POLYPODIUM.
=688  \\$a2003
=750  \0$aMaidenhair ferns$5IEN-M$0(DLC)sh 86000738

=LDR  00816cz  a2200241n  4500
=001  9880364193702441
=005  20141212215241.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035642
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x963
=072  \\$aI1.$x880.$x604.$x583.$x80.$x134.$x900
=150  \\$aWhistleblowing
=450  \\$wnnna$aWhistle Blower
=450  \\$wnnna$aWhistle Blowers
=450  \\$wnnna$aWhistle Blowing
=450  \\$wnnna$aWhistleblower
=450  \\$wnnna$aWhistleblowers
=550  \\$wg$aDisclosure
=550  \\$wg$aSocial Behavior
=680  \\$iThe reporting of observed or suspected PROFESSIONAL MISCONDUCT or incompetence to appropriate authorities or to the public.
=688  \\$a2003; use DISCLOSURE 1997-2002
=750  \0$aWhistle blowing$5IEN-M$0(DLC)sh 85146449

=LDR  00600cz  a2200193n  4500
=001  9880364193802441
=005  20141212193033.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x853.$x350
=072  \\$aK1.$x922
=150  \\$aSecularism
=550  \\$wg$aHumanities
=550  \\$wg$aSociological Factors
=550  \\$aReligion
=680  \\$iIndifference to, or rejection of, RELIGION or religious considerations. (From Merriam-Webster's Collegiate Dictionary, 10th ed)
=688  \\$a2003
=750  \0$aSecularism$5IEN-M$0(DLC)sh 85119460

=LDR  00941cz  a2200265n  4500
=001  9880364193902441
=005  20141212215240.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035583
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x906
=150  \\$aRare Diseases
=450  \\$wnnna$aDisease, Orphan
=450  \\$wnnna$aDisease, Rare
=450  \\$wnnna$aDiseases, Orphan
=450  \\$wnnna$aDiseases, Rare
=450  \\$wnnna$aOrphan Disease
=450  \\$wnnna$aOrphan Diseases
=450  \\$wnnna$aRare Disease
=550  \\$wg$aDisease Attributes
=550  \\$aNeglected Diseases
=667  \\$acoord with specific disease; index only when discussed as rare disease
=680  \\$iA large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.
=688  \\$a2003
=750  \0$aRare diseases$5IEN-M$0(DLC)sh 92005613

=LDR  00721cz  a2200205n  4500
=001  9880364194002441
=005  20141212215238.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035503
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x939
=072  \\$aH1.$x158.$x273.$x866
=150  \\$aSociobiology
=550  \\$wg$aBehavioral Sciences
=550  \\$wg$aBiology
=550  \\$aBiological Evolution
=550  \\$aGenetics, Behavioral
=680  \\$iThe comparative study of social organization in animals including humans, especially with regard to its genetic basis and evolutionary history. (Merriam-Webster's Collegiate Dictionary, 10th ed)
=688  \\$a2003
=750  \0$aSociobiology$5IEN-M$0(DLC)sh 85124192

=LDR  00433cz  a2200157n  4500
=001  9880364194102441
=005  20141212215238.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035502
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401.$x825
=150  \\$aTrust
=550  \\$wg$aInterpersonal Relations
=680  \\$iConfidence in or reliance on a person or thing.
=688  \\$a2003
=750  \0$aTrust$5IEN-M$0(DLC)sh 85138261

=LDR  00702cz  a2200217n  4500
=001  9880364194202441
=005  20141212215238.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035501
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x900
=072  \\$aF2.$x463.$x785.$x373.$x820
=072  \\$aG17.$x680.$x875
=072  \\$aN5.$x715.$x360.$x750.$x625.$x850
=072  \\$aN6.$x850.$x520.$x830.$x600.$x900
=150  \\$aUncertainty
=550  \\$wg$aDecision Making
=550  \\$wg$aProbability
=680  \\$iThe condition in which reasonable knowledge regarding risks, benefits, or the future is not available.
=688  \\$a2003
=750  \0$aUncertainty$5IEN-M$0(DLC)sh 85139563

=LDR  00958cz  a2200229n  4500
=001  9880364194302441
=005  20141212215236.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035401
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x100.$x244
=150  \\$aConyza
=450  \\$aAsthmaweed
=450  \\$wnnna$aAsthmaweeds
=450  \\$wnnna$aConyzas
=450  \\$aHorseweed
=450  \\$wnnna$aHorseweeds
=550  \\$wg$aAsteraceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ASTERACEAE. Members contain alkenynes, daucosterol, friedelinol, conyzasaponins and other TRITERPENES.
=688  \\$a2003
=750  \0$aConyza$0(DLC)sh2006001125$5IEN-M

=LDR  00877cz  a2200193n  4500
=001  9880364194402441
=005  20141212215234.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035322
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x707
=150  \\$aMelastomataceae
=450  \\$aMiconia
=450  \\$wnnna$aMiconias
=550  \\$wg$aAngiosperms
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida composed of tropical plants with parallel-nerved leaves.
=688  \\$a2003
=750  \0$aMelastomataceae$5IEN-M$0(DLC)sh 85083393

=LDR  00700cz  a2200205n  4500
=001  9880364194502441
=005  20141212215233.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x400.$x625
=150  \\$aPlant Tubers
=450  \\$wnnna$aPlant Tuber
=450  \\$wnnna$aTuber, Plant
=450  \\$aTubers, Plant
=550  \\$wg$aPlant Roots
=667  \\$acoord with specific plant
=680  \\$iAn enlarged underground root or stem of some plants. It is usually rich in carbohydrates. Some, such as POTATOES, are important human FOOD. They may reproduce vegetatively from buds.
=688  \\$a2003
=750  \0$aTubers$5IEN-M$0(DLC)sh 85138451

=LDR  02408cz  a2200841n  4500
=001  9880364194602441
=005  20141212215233.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035264
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x249.$x500
=150  \\$aFlowers
=450  \\$wnnna$aAnther, Plant
=450  \\$wnnna$aAnthers, Plant
=450  \\$wnnna$aBloom, Plant
=450  \\$aBlooms, Plant
=450  \\$wnnna$aBlossom
=450  \\$aBlossoms
=450  \\$wnnna$aCalyx, Plant
=450  \\$wnnna$aCalyxs, Plant
=450  \\$wnnna$aCarpal, Plant
=450  \\$wnnna$aCarpals, Plant
=450  \\$wnnna$aCorolla, Plant
=450  \\$wnnna$aCorollas, Plant
=450  \\$wnnna$aFilament, Flower
=450  \\$wnnna$aFilaments, Flower
=450  \\$wnnna$aFlower
=450  \\$wnnna$aFlower Filament
=450  \\$wnnna$aFlower Filaments
=450  \\$wnnna$aOvaries, Plant
=450  \\$wnnna$aOvary, Plant
=450  \\$wnnna$aPetal, Plant
=450  \\$wnnna$aPetals, Plant
=450  \\$aPistil
=450  \\$wnnna$aPistils
=450  \\$wnnna$aPlant Anther
=450  \\$wnnna$aPlant Anthers
=450  \\$wnnna$aPlant Bloom
=450  \\$wnnna$aPlant Blooms
=450  \\$wnnna$aPlant Calyx
=450  \\$wnnna$aPlant Calyxs
=450  \\$wnnna$aPlant Carpal
=450  \\$wnnna$aPlant Carpals
=450  \\$wnnna$aPlant Corolla
=450  \\$wnnna$aPlant Corollas
=450  \\$wnnna$aPlant Ovaries
=450  \\$wnnna$aPlant Ovary
=450  \\$wnnna$aPlant Petal
=450  \\$wnnna$aPlant Petals
=450  \\$wnnna$aPlant Sepal
=450  \\$wnnna$aPlant Sepals
=450  \\$wnnna$aPlant Stamen
=450  \\$wnnna$aPlant Stamens
=450  \\$wnnna$aPlant Stigma
=450  \\$wnnna$aPlant Stigmas
=450  \\$aPlant Style
=450  \\$wnnna$aPlant Styles
=450  \\$wnnna$aSepal, Plant
=450  \\$wnnna$aSepals, Plant
=450  \\$wnnna$aStamen, Plant
=450  \\$wnnna$aStamens, Plant
=450  \\$wnnna$aStigma, Plant
=450  \\$wnnna$aStigmas, Plant
=450  \\$wnnna$aStyle, Plant
=450  \\$wnnna$aStyles, Plant
=550  \\$wg$aFlowering Tops
=550  \\$wh$aGerm Cells, Plant
=550  \\$wh$aInflorescence
=550  \\$aPlant Nectar
=667  \\$acoordinate with specific plant
=680  \\$iThe reproductive organs of plants.
=688  \\$a2003
=750  \0$aFlowers$5IEN-M$0(DLC)sh 85049332

=LDR  00839cz  a2200181n  4500
=001  9880364194702441
=005  20141212215231.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035201
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x822.$x71
=150  \\$aBrachiaria
=450  \\$wnnna$aBrachiarias
=550  \\$wg$aPoaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family POACEAE originating from the savanna of eastern Africa. It is widely grown for livestock forage.
=688  \\$a2003
=750  \0$aBrachiaria$5IEN-M$0(DLC)sh 88022604

=LDR  01352cz  a2200325n  4500
=001  9880364194802441
=005  20141212215228.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035163
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x148.$x750
=150  \\$aBombax
=450  \\$wnnna$aBombax ceiba
=450  \\$wnnna$aBombax ceibas
=450  \\$wnnna$aBombax malabaricum
=450  \\$wnnna$aBombax malabaricums
=450  \\$wnnna$aBombaxs
=450  \\$wnnna$aceiba, Bombax
=450  \\$wnnna$aceibas, Bombax
=450  \\$wnnna$amalabaricum, Bombax
=450  \\$wnnna$amalabaricum, Salmalia
=450  \\$wnnna$amalabaricums, Bombax
=450  \\$wnnna$amalabaricums, Salmalia
=450  \\$wnnna$aSalmalia malabaricum
=450  \\$wnnna$aSalmalia malabaricums
=550  \\$wg$aBombacaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used like kapok (CEIBA) for floatation, stuffing, and insulation.
=688  \\$a2003
=750  \0$aBombax$5IEN-M$0(DLC)sh 88022601

=LDR  00858cz  a2200205n  4500
=001  9880364194902441
=005  20141212215228.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035162
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x148.$x500
=150  \\$aAdansonia
=450  \\$wnnna$aAdansonias
=450  \\$aBaobab
=450  \\$wnnna$aBaobabs
=550  \\$wg$aBombacaceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.
=688  \\$a2003
=750  \0$aAdansonia$5IEN-M$0(DLC)sh 85000796

=LDR  01217cz  a2200349n  4500
=001  9880364195002441
=005  20200109131828.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035161
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x148
=150  \\$aBombacaceae
=450  \\$aBalsa
=450  \\$wnnna$aBalsas
=450  \\$aDurian
=450  \\$wnnna$aDurians
=450  \\$aDurio
=450  \\$wnnna$aDurios
=450  \\$aOchroma
=450  \\$wnnna$aOchromas
=450  \\$aPachira
=450  \\$wnnna$aPachiras
=450  \\$aQuararibea
=450  \\$wnnna$aQuararibeas
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAdansonia
=550  \\$wh$aBombax
=550  \\$wh$aCeiba
=667  \\$aprefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida of tropical trees.
=688  \\$a2003
=750  \0$aBombacaceae$5IEN-M$0(DLC)sh 85015462

=LDR  00843cz  a2200217n  4500
=001  9880364195102441
=005  20141212215227.0
=008  020703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D035082
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x409.$x137
=072  \\$aN3.$x540.$x348.$x500
=150  \\$aFederal Government
=450  \\$wnnna$aGovernment, Federal
=450  \\$wnnna$aNational Government
=550  \\$wg$aGovernment
=550  \\$wh$aUnited States Government Agencies
=667  \\$anot restricted to the U.S.; use when legislation or regulation at the national, as opposed to the state, provincial, or local level, is under discussion; specify country
=680  \\$iThe level of governmental organization and function at the national or country-wide level.
=688  \\$a2003
=750  \0$aFederal government$5IEN-M$0(DLC)sh 85047611

=LDR  01000cz  a2200205n  4500
=001  9880364195202441
=005  20141212215223.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x33.$x777
=150  \\$aSagittaria
=450  \\$aArrowhead
=450  \\$wnnna$aArrowheads
=450  \\$wnnna$aSagittarias
=550  \\$wg$aAlismataceae
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family ALISMATACEAE that grows in salty marshes and is used for phytoremediation of oil spills. The unisexual flowers have 3 sepals and 3 petals. Members contain trifoliones (DITERPENES).
=688  \\$a2003
=750  \0$aArrowhead (Plants)$5IEN-M$0(DLC)sh 00003725

=LDR  01410cz  a2200277n  4500
=001  9880364195302441
=005  20141212193033.0
=008  020702\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D034902
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x25.$x33.$x44
=150  \\$aAlisma
=450  \\$wnnna$aAlisma plantago-aquatica
=450  \\$wnnna$aAlisma plantago aquatica
=450  \\$wnnna$aAlismas
=450  \\$wnnna$aCommon Water Plantain
=450  \\$wnnna$aCommon Water Plantains
=450  \\$wnnna$aPlantain, Common Water
=450  \\$wnnna$aPlantains, Common Water
=450  \\$wnnna$aWater Plantain, Common
=450  \\$wnnna$aWater Plantains, Common
=550  \\$wg$aAlismataceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family ALISMATACEAE. The flowers have 3 green sepals, 3 yellow and white petals, 6 stamens, and several pistils. Members contain TRITERPENES and SESQUITERPENES. Alisma is a component of tokishakuyakusan. Some species in this genus are called water plantain which is also a common name for other ALISMATACEAE plants.
=688  \\$a2003
=750  \0$aAlisma$5IEN-M$0(DLC)sh 88022539

=LDR  02400cz  a2200565n  4500
=001  9880363174402441
=005  20141212195723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002551
=035  \\$aCAZ5710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195.$x205
=072  \\$aC10.$x228.$x140.$x211.$x280
=072  \\$aC10.$x551.$x240.$x250.$x200
=150  \\$aCerebral Ventricle Neoplasms
=450  \\$wnnna$aBrain Ventricular Neoplasm
=450  \\$wnnna$aBrain Ventricular Neoplasms
=450  \\$wnnna$aBrain Ventricular Tumor
=450  \\$wnnna$aBrain Ventricular Tumors
=450  \\$wnnna$aCerebral Ventricle Neoplasm
=450  \\$wnnna$aCerebral Ventricle Tumor
=450  \\$wnnna$aCerebral Ventricle Tumors
=450  \\$wnnna$aCerebroventricular Neoplasm
=450  \\$wnnna$aCerebroventricular Neoplasms
=450  \\$wnnna$aIntraventricular Neoplasm
=450  \\$aIntraventricular Neoplasms
=450  \\$wnnna$aNeoplasm, Brain Ventricular
=450  \\$wnnna$aNeoplasm, Cerebral Ventricle
=450  \\$wnnna$aNeoplasm, Cerebroventricular
=450  \\$wnnna$aNeoplasm, Intraventricular
=450  \\$wnnna$aNeoplasms, Brain Ventricular
=450  \\$wnnna$aNeoplasms, Cerebral Ventricle
=450  \\$wnnna$aNeoplasms, Cerebroventricular
=450  \\$wnnna$aNeoplasms, Intraventricular
=450  \\$wnnna$aNeoplasms, Ventricular, Brain
=450  \\$wnnna$aTumor, Brain Ventricular
=450  \\$wnnna$aTumor, Cerebral Ventricle
=450  \\$wnnna$aTumors, Brain Ventricular
=450  \\$wnnna$aTumors, Cerebral Ventricle
=450  \\$wnnna$aVentricle Tumor, Cerebral
=450  \\$wnnna$aVentricle Tumors, Cerebral
=450  \\$wnnna$aVentricular Neoplasm, Brain
=450  \\$aVentricular Neoplasms, Brain
=450  \\$wnnna$aVentricular Tumor, Brain
=450  \\$aVentricular Tumors, Brain
=550  \\$wg$aBrain Neoplasms
=550  \\$wh$aChoroid Plexus Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iNeoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.
=750  \0$aBrain$xVentricles$xTumors$5IEN-M$0(DLC)sh 85022114

=LDR  01245cz  a2200445n  4500
=001  9880363174502441
=005  20141212192053.0
=008  860418\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002550
=035  \\$aCAZ5709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x155
=150  \\$aCerebral Veins
=450  \\$aBasal Vein
=450  \\$wnnna$aBasal Veins
=450  \\$wnnna$aCerebral Vein
=450  \\$wnnna$aGalen Vein
=450  \\$aPial Vein
=450  \\$wnnna$aPial Veins
=450  \\$aSylvian Vein
=450  \\$wnnna$aTerminal Vein
=450  \\$wnnna$aTerminal Veins
=450  \\$aThalamostriate Vein
=450  \\$wnnna$aThalamostriate Veins
=450  \\$wnnna$aVein, Basal
=450  \\$wnnna$aVein, Cerebral
=450  \\$aVein of Galen
=450  \\$wnnna$aVein, Pial
=450  \\$wnnna$aVein, Sylvian
=450  \\$wnnna$aVein, Terminal
=450  \\$wnnna$aVein, Thalamostriate
=450  \\$wnnna$aVeins, Basal
=450  \\$wnnna$aVeins, Cerebral
=450  \\$wnnna$aVeins, Pial
=450  \\$wnnna$aVeins, Terminal
=450  \\$wnnna$aVeins, Thalamostriate
=550  \\$wg$aVeins
=680  \\$iVeins draining the cerebrum.
=688  \\$a87
=750  \0$aCerebral veins$5IEN$0(DLC)sh 85022110

=LDR  03700cz  a2200757n  4500
=001  9880363174602441
=005  20141212195723.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002549
=035  \\$aCAZ5708HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x375.$x112
=072  \\$aC10.$x228.$x140.$x400
=072  \\$aC10.$x228.$x140.$x695.$x562.$x112
=072  \\$aC10.$x314.$x350.$x112
=072  \\$aC20.$x111.$x258.$x250.$x175
=150  \\$aDiffuse Cerebral Sclerosis of Schilder
=450  \\$wnnna$aAlper Disease
=450  \\$wnnna$aAlper Syndrome
=450  \\$wnnna$aAlpers Diffuse Degeneration of Cerebral Gray Matter with Hepatic Cirrhosis
=450  \\$wnnna$aAlpers Disease
=450  \\$wnnna$aAlpers' Disease
=450  \\$wnnna$aAlper's Disease
=450  \\$wnnna$aAlpers-Huttenlocher Syndrome
=450  \\$wnnna$aAlpers Huttenlocher Syndrome
=450  \\$wnnna$aAlpers Progressive Infantile Poliodystrophy
=450  \\$wnnna$aAlpers' Syndrome
=450  \\$aAlpers Syndrome
=450  \\$wnnna$aAlper's Syndrome
=450  \\$aBalo Concentric Sclerosis
=450  \\$wnnna$aBalo's Concentric Sclerosis
=450  \\$aCerebral Sclerosis, Diffuse
=450  \\$wnnna$aConcentric Sclerosis, Balo
=450  \\$wnnna$aConcentric Sclerosis, Balo's
=450  \\$wnnna$aDiffuse Cerebral Scleroses
=450  \\$wnnna$aDiffuse Cerebral Sclerosis
=450  \\$wnnna$aDiffuse Scleroses, Myelinoclastic
=450  \\$wnnna$aDiffuse Sclerosis, Myelinoclastic
=450  \\$wnnna$aDisease, Alpers'
=450  \\$wnnna$aDisease, Schilder
=450  \\$wnnna$aDisease, Schilder's
=450  \\$aEncephalitis Periaxialis
=450  \\$wnnna$aEncephalitis Periaxialis Concentrica
=450  \\$wnnna$aEncephalitis Periaxialis Diffusa
=450  \\$wnnna$aMyelinoclastic Diffuse Scleroses
=450  \\$aMyelinoclastic Diffuse Sclerosis
=450  \\$wnnna$aNeuronal Degeneration Of Childhood With Liver Disease, Progressive
=450  \\$aPoliodystrophia Cerebri
=450  \\$wnnna$aProgressive Neuronal Degeneration of Childhood with Liver Disease
=450  \\$wnnna$aProgressive Sclerosing Poliodystrophies
=450  \\$wnnna$aProgressive Sclerosing Poliodystrophy
=450  \\$aSchilder Disease
=450  \\$wnnna$aSchilder's Disease
=450  \\$wnnna$aSchilders Disease
=450  \\$wnnna$aScleroses, Balo's Concentric
=450  \\$wnnna$aScleroses, Myelinoclastic Diffuse
=450  \\$wnnna$aSclerosis, Diffuse Cerebral
=450  \\$wnnna$aSclerosis, Myelinoclastic Diffuse
=450  \\$wnnna$aSudanophilic Cerebral Sclerosis
=450  \\$wnnna$aSyndrome, Alpers
=450  \\$wnnna$aSyndrome, Alpers-Huttenlocher
=550  \\$wg$aBrain Diseases
=550  \\$wg$aDemyelinating Autoimmune Diseases, CNS
=680  \\$iA rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers' Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. (From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13(4-5):267-73)
=688  \\$a2000(1963)
=750  \0$aCerebral sclerosis, Diffuse$5IEN$0(DLC)sh 85022109

=LDR  02372cz  a2200517n  4500
=001  9880363174702441
=005  20141212195721.0
=008  790308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002548
=035  \\$aCAZ5707HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x868.$x625
=072  \\$aE4.$x494.$x150
=150  \\$aCerebral Revascularization
=450  \\$wnnna$aArterial Bypass, EC-IC
=450  \\$wnnna$aArterial Bypass, Extracranial-Intracranial
=450  \\$wnnna$aArterial Bypasses, EC-IC
=450  \\$wnnna$aArterial Bypasses, Extracranial-Intracranial
=450  \\$aBrain Revascularization
=450  \\$wnnna$aBypass, EC-IC Arterial
=450  \\$wnnna$aBypass, Extracranial-Intracranial Arterial
=450  \\$wnnna$aBypass, STA-MCA
=450  \\$wnnna$aBypasses, EC-IC Arterial
=450  \\$wnnna$aBypasses, Extracranial-Intracranial Arterial
=450  \\$wnnna$aBypasses, STA-MCA
=450  \\$wnnna$aCerebral Microsurgical Revascularization
=450  \\$wnnna$aCerebral Microsurgical Revascularizations
=450  \\$aEC-IC Arterial Bypass
=450  \\$wnnna$aEC IC Arterial Bypass
=450  \\$wnnna$aEC-IC Arterial Bypasses
=450  \\$aExtracranial-Intracranial Arterial Bypass
=450  \\$wnnna$aExtracranial Intracranial Arterial Bypass
=450  \\$wnnna$aExtracranial-Intracranial Arterial Bypasses
=450  \\$aMicrosurgical Revascularization, Cerebral
=450  \\$wnnna$aRevascularization, Brain
=450  \\$wnnna$aRevascularization, Cerebral
=450  \\$wnnna$aRevascularization, Cerebral Microsurgical
=450  \\$aSTA-MCA Bypass
=450  \\$wnnna$aSTA MCA Bypass
=450  \\$wnnna$aSTA-MCA Bypasses
=550  \\$wg$aMicrosurgery
=550  \\$wg$aVascular Grafting
=667  \\$ado not use /util except by MeSH definition
=680  \\$iMicrosurgical revascularization to improve intracranial circulation. It usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization (e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass). It is performed by joining two arteries (direct anastomosis or use of graft) or by free autologous transplantation of highly vascularized tissue to the surface of the brain.
=688  \\$a80
=750  \0$aCerebral revascularization$5IEN$0(DLC)sh 85022108

=LDR  03456cz  a2200721n  4500
=001  9880363174802441
=005  20141212195721.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002547
=035  \\$aCAZ5706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x140.$x254
=150  \\$aCerebral Palsy
=450  \\$wnnna$aAthetoid Cerebral Palsy
=450  \\$wnnna$aAtonic Cerebral Palsy
=450  \\$wnnna$aCerebral Palsies, Athetoid
=450  \\$wnnna$aCerebral Palsies, Dyskinetic
=450  \\$wnnna$aCerebral Palsies, Dystonic-Rigid
=450  \\$wnnna$aCerebral Palsies, Monoplegic
=450  \\$wnnna$aCerebral Palsy, Athetoid
=450  \\$wnnna$aCerebral Palsy, Atonic
=450  \\$wnnna$aCerebral Palsy, Congenital
=450  \\$wnnna$aCerebral Palsy, Diplegic, Infantile
=450  \\$wnnna$aCerebral Palsy, Dyskinetic
=450  \\$wnnna$aCerebral Palsy, Dystonic-Rigid
=450  \\$wnnna$aCerebral Palsy, Dystonic Rigid
=450  \\$wnnna$aCerebral Palsy, Hypotonic
=450  \\$wnnna$aCerebral Palsy, Mixed
=450  \\$wnnna$aCerebral Palsy, Monoplegic
=450  \\$wnnna$aCerebral Palsy, Monoplegic, Infantile
=450  \\$wnnna$aCerebral Palsy, Quadriplegic, Infantile
=450  \\$wnnna$aCerebral Palsy, Rolandic Type
=450  \\$wnnna$aCerebral Palsy, Spastic
=450  \\$wnnna$aCongenital Cerebral Palsy
=450  \\$wnnna$aCP (Cerebral Palsy)
=450  \\$wnnna$aDiplegia, Spastic
=450  \\$wnnna$aDiplegias, Spastic
=450  \\$aDiplegic Infantile Cerebral Palsy
=450  \\$wnnna$aDyskinetic Cerebral Palsy
=450  \\$wnnna$aDystonic-Rigid Cerebral Palsies
=450  \\$wnnna$aDystonic-Rigid Cerebral Palsy
=450  \\$wnnna$aHypotonic Cerebral Palsies
=450  \\$wnnna$aHypotonic Cerebral Palsy
=450  \\$wnnna$aInfantile Cerebral Palsy, Diplegic
=450  \\$wnnna$aInfantile Cerebral Palsy, Monoplegic
=450  \\$wnnna$aInfantile Cerebral Palsy, Quadriplegic
=450  \\$aLittle Disease
=450  \\$wnnna$aLittle's Disease
=450  \\$wnnna$aMixed Cerebral Palsies
=450  \\$wnnna$aMixed Cerebral Palsy
=450  \\$wnnna$aMonoplegic Cerebral Palsies
=450  \\$aMonoplegic Cerebral Palsy
=450  \\$wnnna$aMonoplegic Infantile Cerebral Palsy
=450  \\$aQuadriplegic Infantile Cerebral Palsy
=450  \\$wnnna$aRolandic Type Cerebral Palsy
=450  \\$wnnna$aSpastic Cerebral Palsies
=450  \\$wnnna$aSpastic Cerebral Palsy
=450  \\$aSpastic Diplegia
=450  \\$wnnna$aSpastic Diplegias
=550  \\$wg$aBrain Damage, Chronic
=667  \\$ado not index under MUSCLE SPASTICITY unless especially discussed & then only NIM
=680  \\$iA heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
=750  \0$aCerebral palsy$5IEN$0(DLC)sh 85022104

=LDR  01317cz  a2200349n  4500
=001  9880363174902441
=005  20141212195719.0
=008  771208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002545
=035  \\$aCAZ5704HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x150
=072  \\$aC14.$x907.$x253.$x92
=150  \\$aBrain Ischemia
=450  \\$wnnna$aBrain Ischemias
=450  \\$aCerebral Ischemia
=450  \\$wnnna$aCerebral Ischemias
=450  \\$wnnna$aEncephalopathy, Ischemic
=450  \\$wnnna$aIschemia, Brain
=450  \\$wnnna$aIschemia, Cerebral
=450  \\$wnnna$aIschemias, Cerebral
=450  \\$wnnna$aIschemic Encephalopathies
=450  \\$aIschemic Encephalopathy
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wh$aBrain Infarction
=550  \\$wh$aHypoxia-Ischemia, Brain
=550  \\$wh$aIschemic Attack, Transient
=550  \\$wh$aVertebrobasilar Insufficiency
=667  \\$aISCHEMIC ATTACK, TRANSIENT is available
=680  \\$iLocalized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
=688  \\$a2000(1979)
=750  \0$aCerebral ischemia$5IEN$0(DLC)sh 85022095

=LDR  02358cz  a2200529n  4500
=001  9880363175002441
=005  20141212195718.0
=008  780522\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002544
=035  \\$aCAZ5703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x150.$x477.$x200
=072  \\$aC10.$x228.$x140.$x300.$x775.$x200.$x200
=072  \\$aC14.$x907.$x253.$x92.$x477.$x200
=072  \\$aC14.$x907.$x253.$x855.$x200.$x200
=150  \\$aCerebral Infarction
=450  \\$aAnterior Choroidal Artery Infarction
=450  \\$wnnna$aCerebral Infarction, Left Hemisphere
=450  \\$wnnna$aCerebral Infarction, Right Hemisphere
=450  \\$wnnna$aCerebral Infarctions
=450  \\$wnnna$aCerebral, Left Hemisphere, Infarction
=450  \\$wnnna$aCerebral, Right Hemisphere, Infarction
=450  \\$aInfarction, Cerebral
=450  \\$wnnna$aInfarction, Cerebral, Left Hemisphere
=450  \\$wnnna$aInfarction, Cerebral, Right Hemisphere
=450  \\$wnnna$aInfarction, Left Hemisphere, Cerebral
=450  \\$wnnna$aInfarction, Right Hemisphere, Cerebral
=450  \\$wnnna$aInfarction, Subcortical
=450  \\$wnnna$aInfarctions, Cerebral
=450  \\$wnnna$aInfarctions, Subcortical
=450  \\$wnnna$aLeft Hemisphere, Cerebral Infarction
=450  \\$wnnna$aLeft Hemisphere, Infarction, Cerebral
=450  \\$aPosterior Choroidal Artery Infarction
=450  \\$wnnna$aRight Hemisphere, Cerebral Infarction
=450  \\$wnnna$aRight Hemisphere, Infarction, Cerebral
=450  \\$aSubcortical Infarction
=450  \\$wnnna$aSubcortical Infarctions
=550  \\$wg$aBrain Infarction
=550  \\$wh$aDementia, Multi-Infarct
=550  \\$wh$aInfarction, Anterior Cerebral Artery
=550  \\$wh$aInfarction, Middle Cerebral Artery
=550  \\$wh$aInfarction, Posterior Cerebral Artery
=550  \\$aInfarction
=667  \\$aDF: CEREBRAL INFARCT
=680  \\$iThe formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
=688  \\$a1979
=750  \0$aCerebral infarction$5IEN$0(DLC)sh 85016341

=LDR  01206cz  a2200301n  4500
=001  9880363175102441
=005  20141212195717.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002542
=035  \\$aCAZ5701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x525
=072  \\$aC14.$x907.$x253.$x566
=072  \\$aC14.$x907.$x355.$x590.$x213
=072  \\$aC14.$x907.$x355.$x830.$x850.$x213
=150  \\$aIntracranial Embolism and Thrombosis
=450  \\$aBrain Embolism and Thrombosis
=450  \\$aCerebral Embolism and Thrombosis
=450  \\$wnnna$aEmbolism and Thrombosis, Brain
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wg$aThromboembolism
=550  \\$wh$aCarotid Artery Thrombosis
=550  \\$wh$aIntracranial Embolism
=550  \\$wh$aIntracranial Thrombosis
=667  \\$aused for searching: indexers and catalogers apply specifics
=680  \\$iEmbolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.
=688  \\$a2000(1963)
=750  \0$aCerebral embolism and thrombosis$5IEN$0(DLC)sh 85022092

=LDR  01666cz  a2200397n  4500
=001  9880363175202441
=005  20141212195716.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002539
=035  \\$aCAZ5699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x510.$x200
=072  \\$aC14.$x907.$x253.$x560.$x200
=150  \\$aCerebral Arterial Diseases
=450  \\$wnnna$aArterial Disease, Cerebral
=450  \\$wnnna$aArterial Diseases, Cerebral
=450  \\$wnnna$aArtery Disease, Cerebral
=450  \\$wnnna$aArtery Diseases, Cerebral
=450  \\$wnnna$aCerebral Arterial Disease
=450  \\$wnnna$aCerebral Artery Disease
=450  \\$aCerebral Artery Diseases
=450  \\$wnnna$aDisease, Cerebral Arterial
=450  \\$wnnna$aDisease, Cerebral Artery
=450  \\$wnnna$aDiseases, Cerebral Arterial
=450  \\$wnnna$aDiseases, Cerebral Artery
=550  \\$wg$aIntracranial Arterial Diseases
=550  \\$wh$aCADASIL
=550  \\$wh$aCerebral Amyloid Angiopathy
=550  \\$wh$aInfarction, Anterior Cerebral Artery
=550  \\$wh$aInfarction, Middle Cerebral Artery
=550  \\$wh$aInfarction, Posterior Cerebral Artery
=550  \\$wh$aMoyamoya Disease
=667  \\$acoordinate IM with specific cerebral artery (IM); see note at CEREBRAL ARTERIES for scope of "cerebral arteries"
=680  \\$iPathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.
=688  \\$a2000(1963)
=750  \0$aCerebral arteries$xDiseases$5IEN

=LDR  02472cz  a2200517n  4500
=001  9880363175302441
=005  20141212195715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002538
=035  \\$aCAZ5698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x520
=072  \\$aC10.$x500.$x190.$x500
=072  \\$aC14.$x240.$x850.$x750.$x295
=072  \\$aC14.$x240.$x850.$x875.$x500
=072  \\$aC14.$x907.$x150.$x295
=072  \\$aC14.$x907.$x253.$x560.$x400
=072  \\$aC16.$x131.$x240.$x850.$x750.$x295
=072  \\$aC16.$x131.$x240.$x850.$x875.$x500
=072  \\$aC16.$x131.$x666.$x190.$x500
=150  \\$aIntracranial Arteriovenous Malformations
=450  \\$wnnna$aArteriovenous Malformation, Cerebral
=450  \\$wnnna$aArteriovenous Malformation, Intracranial
=450  \\$aArteriovenous Malformations, Cerebral
=450  \\$wnnna$aArteriovenous Malformations, Intracranial
=450  \\$wnnna$aAVM (Arteriovenous Malformation) Intracranial
=450  \\$wnnna$aCerebral Arteriovenous Malformation
=450  \\$wnnna$aCerebral Arteriovenous Malformations
=450  \\$wnnna$aCongenital Intracranial Arteriovenous Malformations
=450  \\$wnnna$aIntracranial Arteriovenous Malformation
=450  \\$wnnna$aIntracranial Arteriovenous Malformation, Ruptured
=450  \\$aIntracranial Arteriovenous Malformations, Congenital
=450  \\$wnnna$aMalformation, Cerebral Arteriovenous
=450  \\$wnnna$aMalformation, Intracranial Arteriovenous
=450  \\$wnnna$aMalformations, Cerebral Arteriovenous
=450  \\$wnnna$aMalformations, Intracranial Arteriovenous
=450  \\$wnnna$aRuptured Intracranial Arteriovenous Malformation
=550  \\$wg$aArteriovenous Malformations
=550  \\$wg$aCentral Nervous System Vascular Malformations
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wg$aIntracranial Arterial Diseases
=550  \\$wh$aVein of Galen Malformations
=667  \\$acoordinate IM with ARTERIOVENOUS FISTULA (IM); DF: INTRACRANIAL AVM
=680  \\$iCongenital vascular anomalies in the brain characterized by direct communication between an artery and a vein without passing through the CAPILLARIES. The locations and size of the shunts determine the symptoms including HEADACHES; SEIZURES; STROKE; INTRACRANIAL HEMORRHAGES; mass effect; and vascular steal effect.
=688  \\$a2000(1973)
=750  \0$aCerebral arteriovenous malformations$5IEN-M$0(DLC)sh 98006254

=LDR  01816cz  a2200397n  4500
=001  9880363175402441
=005  20141212195715.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002537
=035  \\$aCAZ5697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x510.$x800
=072  \\$aC14.$x907.$x137.$x126.$x372
=072  \\$aC14.$x907.$x253.$x560.$x350
=150  \\$aIntracranial Arteriosclerosis
=450  \\$wnnna$aArterioscleroses, Cerebral
=450  \\$wnnna$aArterioscleroses, Intracranial
=450  \\$wnnna$aArteriosclerosis, Cerebral
=450  \\$wnnna$aArteriosclerosis, Intracranial
=450  \\$wnnna$aAtheroscleroses, Cerebral
=450  \\$wnnna$aAtheroscleroses, Intracranial
=450  \\$wnnna$aAtherosclerosis, Cerebral
=450  \\$wnnna$aAtherosclerosis, Intracranial
=450  \\$wnnna$aCerebral Arterioscleroses
=450  \\$aCerebral Arteriosclerosis
=450  \\$wnnna$aCerebral Atheroscleroses
=450  \\$wnnna$aCerebral Atherosclerosis
=450  \\$wnnna$aIntracranial Arterioscleroses
=450  \\$wnnna$aIntracranial Atheroscleroses
=450  \\$aIntracranial Atherosclerosis
=550  \\$wg$aArteriosclerosis
=550  \\$wg$aIntracranial Arterial Diseases
=550  \\$wh$aDementia, Vascular
=680  \\$iVascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
=688  \\$a2000(1963)
=750  \0$aCerebral arteriosclerosis$5IEN$0(DLC)sh 85022086

=LDR  01060cz  a2200277n  4500
=001  9880363175502441
=005  20141212195714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002536
=035  \\$aCAZ5696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x228
=150  \\$aCerebral Arteries
=450  \\$wnnna$aArteries, Cerebral
=450  \\$wnnna$aArtery, Cerebral
=450  \\$wnnna$aCerebral Artery
=550  \\$wg$aArteries
=550  \\$wh$aAnterior Cerebral Artery
=550  \\$wh$aCircle of Willis
=550  \\$wh$aMiddle Cerebral Artery
=550  \\$wh$aPosterior Cerebral Artery
=550  \\$wh$aTemporal Arteries
=667  \\$ageneral; prefer specifics; do not use for arteries of non-cerebral parts of the brain, as cerebellar artery (= CEREBELLUM/blood supply + ARTERIES); /abnorm: consider also INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
=680  \\$iThe arterial blood vessels supplying the CEREBRUM.
=688  \\$a/radiography was CEREBRAL ANGIOGRAPHY 1975-94
=750  \0$aCerebral arteries$5IEN$0(DLC)sh 85022084

=LDR  01961cz  a2200457n  4500
=001  9880363175602441
=005  20141212195714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002534
=035  \\$aCAZ5694HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x624
=150  \\$aHypoxia, Brain
=450  \\$aAnoxia, Brain
=450  \\$wnnna$aAnoxia, Cerebral
=450  \\$wnnna$aAnoxic Brain Damage
=450  \\$wnnna$aAnoxic Encephalopathies
=450  \\$aAnoxic Encephalopathy
=450  \\$wnnna$aBrain Anoxia
=450  \\$wnnna$aBrain Damage, Anoxic
=450  \\$wnnna$aBrain Damage, Hypoxic
=450  \\$aBrain Hypoxia
=450  \\$aCerebral Anoxia
=450  \\$wnnna$aCerebral Hypoxia
=450  \\$wnnna$aDamage, Anoxic Brain
=450  \\$wnnna$aDamage, Hypoxic Brain
=450  \\$wnnna$aEncephalopathies, Anoxic
=450  \\$wnnna$aEncephalopathies, Hypoxic
=450  \\$wnnna$aEncephalopathy, Anoxic
=450  \\$aEncephalopathy, Hypoxic
=450  \\$wnnna$aHypoxia, Cerebral
=450  \\$wnnna$aHypoxic Brain Damage
=450  \\$wnnna$aHypoxic Encephalopathies
=450  \\$aHypoxic Encephalopathy
=550  \\$wg$aBrain Diseases
=550  \\$wh$aHypoxia-Ischemia, Brain
=550  \\$aAnoxia
=667  \\$ado not confuse with BRAIN ISCHEMIA, a reduced blood supply
=680  \\$iA reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.
=688  \\$a2000(1963)
=750  \0$aCerebral anoxia$5IEN$0(DLC)sh 85022083

=LDR  01189cz  a2200301n  4500
=001  9880363175702441
=005  20141212195713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002533
=035  \\$aCAZ5693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x180
=072  \\$aE1.$x370.$x350.$x700.$x60.$x180
=072  \\$aE1.$x370.$x350.$x700.$x560.$x180
=072  \\$aE1.$x370.$x370.$x50.$x180
=072  \\$aE1.$x370.$x376.$x537.$x750.$x180
=072  \\$aE5.$x629.$x937.$x180
=150  \\$aCerebral Angiography
=450  \\$wnnna$aAngiographies, Cerebral
=450  \\$aAngiography, Cerebral
=450  \\$wnnna$aCerebral Angiographies
=550  \\$wg$aAngiography
=550  \\$wg$aNeuroradiography
=550  \\$aCerebral Arteries
=550  \\$aCerebral Veins
=667  \\$aGEN or unspecified only: not a substitute for CEREBRAL ARTERIES /radiogr or CEREBRAL VEINS /radiogr; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL ANGIOGR
=680  \\$iRadiography of the vascular system of the brain after injection of a contrast medium.
=750  \0$aBrain$xBlood-vessels$xRadiography$5IEN$0(DLC)sh 85016326

=LDR  03051cz  a2200721n  4500
=001  9880363175802441
=005  20141212195713.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002532
=035  \\$aCAZ5692HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x510.$x600
=072  \\$aC14.$x907.$x55.$x635
=072  \\$aC14.$x907.$x253.$x560.$x300
=150  \\$aIntracranial Aneurysm
=450  \\$wnnna$aAneurysm, Anterior Cerebral Artery
=450  \\$wnnna$aAneurysm, Anterior Communicating Artery
=450  \\$wnnna$aAneurysm, Basilar Artery
=450  \\$wnnna$aAneurysm, Berry
=450  \\$wnnna$aAneurysm, Brain
=450  \\$aAneurysm, Cerebral
=450  \\$wnnna$aAneurysm, Giant Intracranial
=450  \\$aAneurysm, Intracranial
=450  \\$wnnna$aAneurysm, Intracranial Mycotic
=450  \\$wnnna$aAneurysm, Middle Cerebral Artery
=450  \\$wnnna$aAneurysm, Posterior Cerebral Artery
=450  \\$wnnna$aAneurysm, Posterior Communicating Artery
=450  \\$wnnna$aAneurysms, Basilar Artery
=450  \\$wnnna$aAneurysms, Berry
=450  \\$wnnna$aAneurysms, Brain
=450  \\$wnnna$aAneurysms, Cerebral
=450  \\$wnnna$aAneurysms, Giant Intracranial
=450  \\$wnnna$aAneurysms, Intracranial
=450  \\$wnnna$aAneurysms, Intracranial Mycotic
=450  \\$wnnna$aAnterior Cerebral Artery Aneurysm
=450  \\$wnnna$aAnterior Communicating Artery Aneurysm
=450  \\$wnnna$aArtery Aneurysm, Basilar
=450  \\$wnnna$aArtery Aneurysms, Basilar
=450  \\$aBasilar Artery Aneurysm
=450  \\$wnnna$aBasilar Artery Aneurysms
=450  \\$aBerry Aneurysm
=450  \\$wnnna$aBerry Aneurysms
=450  \\$aBrain Aneurysm
=450  \\$wnnna$aBrain Aneurysms
=450  \\$aCerebral Aneurysm
=450  \\$wnnna$aCerebral Aneurysms
=450  \\$aGiant Intracranial Aneurysm
=450  \\$wnnna$aGiant Intracranial Aneurysms
=450  \\$wnnna$aIntracranial Aneurysm, Giant
=450  \\$wnnna$aIntracranial Aneurysms
=450  \\$wnnna$aIntracranial Aneurysms, Giant
=450  \\$wnnna$aIntracranial Mycotic Aneurysm
=450  \\$wnnna$aIntracranial Mycotic Aneurysms
=450  \\$wnnna$aMiddle Cerebral Artery Aneurysm
=450  \\$aMycotic Aneurysm, Intracranial
=450  \\$wnnna$aMycotic Aneurysms, Intracranial
=450  \\$wnnna$aPosterior Cerebral Artery Aneurysm
=450  \\$wnnna$aPosterior Communicating Artery Aneurysm
=550  \\$wg$aAneurysm
=550  \\$wg$aIntracranial Arterial Diseases
=680  \\$iAbnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (>2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)
=688  \\$a2000(1969)
=750  \0$aIntracranial aneurysms$5IEN$0(DLC)sh 85067613

=LDR  01265cz  a2200301n  4500
=001  9880363175902441
=005  20141212192051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002531
=035  \\$aCAZ5691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x200
=072  \\$aA8.$x186.$x211.$x865.$x428.$x200
=150  \\$aCerebellum
=450  \\$wnnna$aCerebelli, Corpus
=450  \\$wnnna$aCerebellums
=450  \\$wnnna$aCerebellus, Corpus
=450  \\$wnnna$aCorpus Cerebelli
=450  \\$wnnna$aCorpus Cerebellus
=450  \\$wnnna$aParencephalon
=450  \\$wnnna$aParencephalons
=550  \\$wg$aMetencephalon
=550  \\$wh$aCerebellar Cortex
=550  \\$wh$aCerebellar Nuclei
=550  \\$wh$aCerebellopontine Angle
=667  \\$acerebellar artery = CEREBELLUM /blood supply (IM) + ARTERIES (NIM)
=680  \\$iThe part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.
=750  \0$aCerebellum$5IEN$0(DLC)sh 85022078

=LDR  01049cz  a2200277n  4500
=001  9880363176002441
=005  20141212195712.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002530
=035  \\$aCAZ5690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x200.$x462
=072  \\$aA8.$x186.$x211.$x865.$x428.$x200.$x462
=150  \\$aCerebellopontine Angle
=450  \\$wnnna$aAngle, Cerebellopontile
=450  \\$wnnna$aAngle, Cerebellopontine
=450  \\$wnnna$aAngles, Cerebellopontile
=450  \\$wnnna$aAngles, Cerebellopontine
=450  \\$aCerebellopontile Angle
=450  \\$wnnna$aCerebellopontile Angles
=450  \\$wnnna$aCerebellopontine Angles
=550  \\$wg$aCerebellum
=667  \\$adiseases: coord IM with CEREBELLAR DISEASES (IM); neopl: coord (IM) with CEREBELLAR NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iJunction between the cerebellum and the pons.
=688  \\$a90; was CEREBELLOPONTILE ANGLE 1966-89
=750  \0$aCerebellopontile angle$5IEN$0(DLC)sh 86008094

=LDR  02894cz  a2200769n  4500
=001  9880363176102441
=005  20141212192051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002529
=035  \\$aCAZ5689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x200.$x337
=072  \\$aA8.$x186.$x211.$x865.$x428.$x200.$x337
=150  \\$aCerebellar Nuclei
=450  \\$wnnna$aAmiculum of the Dentate Nucleus
=450  \\$wnnna$aAnterior Interposed Nucleus
=450  \\$wnnna$aAnterior Interpositus Nucleus
=450  \\$wnnna$aCentral Nuclei
=450  \\$wnnna$aCentral Nucleus
=450  \\$wnnna$aCerebellar Nuclei, Deep
=450  \\$wnnna$aCerebellar Nucleus
=450  \\$wnnna$aCerebellar Nucleus, Deep
=450  \\$wnnna$aCerebellar Nucleus, Dentate
=450  \\$wnnna$aCerebellar Nucleus, Fastigial
=450  \\$wnnna$aCerebellar Nucleus, Lateral
=450  \\$wnnna$aCerebellar Nucleus, Medial
=450  \\$wnnna$aDeep Cerebellar Nuclei
=450  \\$wnnna$aDeep Cerebellar Nucleus
=450  \\$wnnna$aDentate Cerebellar Nucleus
=450  \\$aDentate Nucleus
=450  \\$wnnna$aEmboliformis, Nucleus
=450  \\$wnnna$aFastigial Cerebellar Nucleus
=450  \\$wnnna$aFastigial Nucleus
=450  \\$wnnna$aFastigii, Nucleus
=450  \\$wnnna$aGlobosus, Nucleus
=450  \\$wnnna$aInterposed Nucleus, Anterior
=450  \\$wnnna$aInterpositus Nucleus, Anterior
=450  \\$wnnna$aIntracerebellar Nuclei
=450  \\$wnnna$aIntracerebellar Nucleus
=450  \\$wnnna$aLateral Cerebellar Nucleus
=450  \\$wnnna$aMedial Cerebellar Nucleus
=450  \\$wnnna$aNuclei, Central
=450  \\$wnnna$aNuclei, Cerebellar
=450  \\$wnnna$aNuclei, Deep Cerebellar
=450  \\$wnnna$aNuclei, Intracerebellar
=450  \\$wnnna$aNucleus, Anterior Interposed
=450  \\$wnnna$aNucleus, Anterior Interpositus
=450  \\$wnnna$aNucleus, Central
=450  \\$wnnna$aNucleus, Cerebellar
=450  \\$wnnna$aNucleus, Deep Cerebellar
=450  \\$wnnna$aNucleus, Dentate
=450  \\$wnnna$aNucleus, Dentate Cerebellar
=450  \\$aNucleus Dentatus
=450  \\$aNucleus Emboliformis
=450  \\$wnnna$aNucleus, Fastigial
=450  \\$wnnna$aNucleus, Fastigial Cerebellar
=450  \\$aNucleus Fastigii
=450  \\$wnnna$aNucleus Fastigius
=450  \\$aNucleus Globosus
=450  \\$wnnna$aNucleus, Intracerebellar
=450  \\$wnnna$aNucleus, Lateral Cerebellar
=450  \\$wnnna$aNucleus, Medial Cerebellar
=550  \\$wg$aCerebellum
=667  \\$adiseases: coordinate IM with CEREBELLAR DISEASES (IM)
=680  \\$iFour clusters of neurons located deep within the WHITE MATTER of the CEREBELLUM, which are the nucleus dentatus, nucleus emboliformis, nucleus globosus, and nucleus fastigii.
=688  \\$a71
=750  \0$aCerebellar nuclei$5IEN$0(DLC)sh 85022075

=LDR  02634cz  a2200589n  4500
=001  9880363176202441
=005  20141212195711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002528
=035  \\$aCAZ5688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195.$x411.$x211
=072  \\$aC10.$x228.$x140.$x211.$x500.$x200
=072  \\$aC10.$x228.$x140.$x252.$x200
=072  \\$aC10.$x551.$x240.$x250.$x400.$x300
=150  \\$aCerebellar Neoplasms
=450  \\$wnnna$aBenign Cerebellar Neoplasm
=450  \\$aBenign Cerebellar Neoplasms
=450  \\$wnnna$aCancer, Cerebellar
=450  \\$aCerebellar Cancer
=450  \\$wnnna$aCerebellar Cancers
=450  \\$wnnna$aCerebellar Neoplasm
=450  \\$wnnna$aCerebellar Neoplasm, Benign
=450  \\$wnnna$aCerebellar Neoplasm, Malignant
=450  \\$wnnna$aCerebellar Neoplasm, Primary
=450  \\$wnnna$aCerebellar Neoplasms, Benign
=450  \\$wnnna$aCerebellar Neoplasms, Malignant
=450  \\$wnnna$aCerebellar Neoplasms, Primary
=450  \\$wnnna$aCerebellar Tumor
=450  \\$wnnna$aCerebellar Tumors
=450  \\$wnnna$aCerebellum Primary Neoplasm
=450  \\$wnnna$aCerebellum Primary Neoplasms
=450  \\$wnnna$aMalignant Cerebellar Neoplasm
=450  \\$aMalignant Cerebellar Neoplasms
=450  \\$wnnna$aNeoplasm, Benign Cerebellar
=450  \\$wnnna$aNeoplasm, Cerebellar
=450  \\$wnnna$aNeoplasm, Cerebellum Primary
=450  \\$wnnna$aNeoplasm, Malignant Cerebellar
=450  \\$wnnna$aNeoplasms, Cerebellar
=450  \\$wnnna$aNeoplasms, Cerebellar, Benign
=450  \\$wnnna$aNeoplasms, Cerebellar, Malignant
=450  \\$wnnna$aNeoplasms, Cerebellar, Primary
=450  \\$wnnna$aPrimary Cerebellar Neoplasm
=450  \\$wnnna$aPrimary Cerebellar Neoplasms
=450  \\$wnnna$aPrimary Neoplasm, Cerebellum
=450  \\$wnnna$aPrimary Neoplasms, Cerebellum
=450  \\$wnnna$aTumor, Cerebellar
=550  \\$wg$aCerebellar Diseases
=550  \\$wg$aInfratentorial Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iPrimary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)
=750  \0$aCerebellum$xTumors$5IEN-M$0(DLC)sh 85022082

=LDR  01473cz  a2200409n  4500
=001  9880363176302441
=005  20141212195710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002526
=035  \\$aCAZ5686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x252
=150  \\$aCerebellar Diseases
=450  \\$wnnna$aCerebellar Disease
=450  \\$wnnna$aCerebellar Disorder
=450  \\$wnnna$aCerebellar Disorders
=450  \\$aCerebellar Dysfunction
=450  \\$wnnna$aCerebellar Dysfunctions
=450  \\$wnnna$aCerebellar Syndrome
=450  \\$wnnna$aCerebellar Syndromes
=450  \\$wnnna$aCerebellum Disease
=450  \\$aCerebellum Diseases
=450  \\$wnnna$aDisease, Cerebellar
=450  \\$wnnna$aDisease, Cerebellum
=450  \\$wnnna$aDisorder, Cerebellar
=450  \\$wnnna$aDysfunction, Cerebellar
=450  \\$wnnna$aSyndrome, Cerebellar
=550  \\$wg$aBrain Diseases
=550  \\$wh$aCerebellar Ataxia
=550  \\$wh$aCerebellar Neoplasms
=550  \\$wh$aDandy-Walker Syndrome
=550  \\$wh$aMiller Fisher Syndrome
=550  \\$wh$aParaneoplastic Cerebellar Degeneration
=550  \\$wh$aSpinocerebellar Degenerations
=667  \\$aGEN: prefer specifics
=680  \\$iDiseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
=750  \0$aCerebellum$xDiseases$5IEN$0(DLC)sh 85022081

=LDR  00950cz  a2200265n  4500
=001  9880363176402441
=005  20141212192050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002525
=035  \\$aCAZ5685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x200.$x212
=072  \\$aA8.$x186.$x211.$x865.$x428.$x200.$x212
=150  \\$aCerebellar Cortex
=450  \\$wnnna$aCerebelli, Cortex
=450  \\$wnnna$aCerebellus, Cortex
=450  \\$wnnna$aCortex, Cerebellar
=450  \\$wnnna$aCortex Cerebelli
=450  \\$wnnna$aCortex Cerebellus
=550  \\$wg$aCerebellum
=550  \\$wh$aCerebellar Vermis
=550  \\$wh$aPurkinje Cells
=667  \\$adiseases: coordinate IM with CEREBELLAR DISEASES (IM)
=680  \\$iThe superficial GRAY MATTER of the CEREBELLUM. It consists of two main layers, the stratum moleculare and the stratum granulosum.
=750  \0$aCerebellar cortex$5IEN$0(DLC)sh 85022074

=LDR  02054cz  a2200481n  4500
=001  9880363176502441
=005  20141212195709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002524
=035  \\$aCAZ5684HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x252.$x190
=072  \\$aC10.$x597.$x350.$x90.$x500
=072  \\$aC23.$x888.$x592.$x350.$x90.$x200
=150  \\$aCerebellar Ataxia
=450  \\$wnnna$aAdiadochokineses
=450  \\$aAdiadochokinesis
=450  \\$aAtaxia, Cerebellar
=450  \\$wnnna$aAtaxias, Cerebellar
=450  \\$wnnna$aCerebellar Ataxias
=450  \\$aCerebellar Dysmetria
=450  \\$wnnna$aCerebellar Dysmetrias
=450  \\$wnnna$aCerebellar Hemiataxia
=450  \\$wnnna$aCerebellar Hemiataxias
=450  \\$wnnna$aCerebellar Incoordination
=450  \\$wnnna$aCerebellar Incoordinations
=450  \\$aDysmetria
=450  \\$wnnna$aDysmetria, Cerebellar
=450  \\$wnnna$aDysmetrias
=450  \\$wnnna$aDysmetrias, Cerebellar
=450  \\$wnnna$aHemiataxia, Cerebellar
=450  \\$wnnna$aHemiataxias, Cerebellar
=450  \\$wnnna$aHypermetria
=450  \\$wnnna$aHypermetrias
=450  \\$wnnna$aIncoordination, Cerebellar
=450  \\$wnnna$aIncoordinations, Cerebellar
=550  \\$wg$aAtaxia
=550  \\$wg$aCerebellar Diseases
=550  \\$wh$aSpinocerebellar Ataxias
=667  \\$aDENTATE CEREBELLAR ATAXIA see MYOCLONIC CEREBELLAR DYSSYNERGIA is also available; ATAXIAS, HEREDITARY see SPINOCEREBELLAR DEGENERATION is also available
=680  \\$iIncoordination of voluntary movements that occur as a manifestation of CEREBELLAR DISEASES. Characteristic features include a tendency for limb movements to overshoot or undershoot a target (dysmetria), a tremor that occurs during attempted movements (intention TREMOR), impaired force and rhythm of diadochokinesis (rapidly alternating movements), and GAIT ATAXIA. (From Adams et al., Principles of Neurology, 6th ed, p90)
=688  \\$a1968
=750  \0$aCerebellar ataxia$5IEN$0(DLC)sh 92003930

=LDR  01317cz  a2200421n  4500
=001  9880363176602441
=005  20160801105307.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002523
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x500.$x750.$x500
=072  \\$aB1.$x650.$x510.$x344.$x250
=072  \\$aG7.$x203.$x300.$x300.$x550
=072  \\$aG7.$x203.$x300.$x775.$x500
=072  \\$aJ2.$x500.$x300.$x550
=072  \\$aJ2.$x500.$x775.$x500
=150  \\$aEdible Grain
=450  \\$wnno$aCereals
=450  \\$wnnna$aCereal
=450  \\$wnnna$aCereal Grain
=450  \\$wnnna$aCereal Grains
=450  \\$wnnna$aEdible Grains
=450  \\$wnnna$aGrain, Cereal
=450  \\$wnnna$aGrain, Edible
=450  \\$wnnna$aGrains, Cereal
=450  \\$wnnna$aGrains, Edible
=550  \\$wg$aCrops, Agricultural
=550  \\$wg$aSeeds
=550  \\$wh$aWhole Grains
=550  \\$wh$aFagopyrum
=550  \\$wh$aHordeum
=550  \\$wh$aPanicum
=550  \\$wh$aTriticum
=550  \\$wh$aZea mays
=667  \\$ado not restrict to processed grain or cereals such as breakfast food
=680  \\$iSEEDS used as a major nutritional source, most often the grain from the POACEAE family.
=688  \\$a2016 (1966) GRAIN & MALT were headings 1963-84
=750  \0$aGrain$5IEN$0(DLC)sh 85056208

=LDR  01048cz  a2200193n  4500
=001  9880363176802441
=005  20201112175025.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002521
=035  \\$aCAZ5681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199.$x120.$x126
=150  \\$aCercopithecus
=550  \\$wg$aCercopithecinae
=550  \\$wh$aChlorocebus aethiops
=667  \\$aOld World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species: C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi.
=688  \\$a75
=750  \0$aCercopithecus$5IEN$0(DLC)sh 85022059

=LDR  01645cz  a2200469n  4500
=001  9880363176902441
=005  20141212195707.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002520
=035  \\$aCAZ5680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x112.$x199
=150  \\$aCercopithecidae
=450  \\$aCatarrhina
=450  \\$wnnna$aCatarrhinas
=450  \\$wnnna$aLangur
=450  \\$aLangurs
=450  \\$aMiopithecus talapoin
=450  \\$wnnna$aMiopithecus talapoins
=450  \\$wnnna$aMonkey, Old World
=450  \\$aMonkey, Talapoin
=450  \\$aMonkeys, Old World
=450  \\$wnnna$aMonkeys, Talapoin
=450  \\$wnnna$aOld World Monkey
=450  \\$wnnna$aOld World Monkeys
=450  \\$wnnna$aPresbyti
=450  \\$aPresbytis
=450  \\$wnnna$aPygathrices
=450  \\$aPygathrix
=450  \\$wnnna$atalapoin, Miopithecus
=450  \\$wnnna$aTalapoin Monkey
=450  \\$wnnna$aTalapoin Monkeys
=450  \\$wnnna$atalapoins, Miopithecus
=450  \\$wnnna$aWorld Monkey, Old
=450  \\$wnnna$aWorld Monkeys, Old
=550  \\$wg$aCatarrhini
=550  \\$wh$aCercopithecinae
=550  \\$wh$aColobinae
=667  \\$aa family of Old World monkeys: do not confuse with CERCOPITHECINAE, a subfamily; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iThe family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia.
=688  \\$a81
=750  \0$aCercopithecidae$5IEN$0(DLC)sh 85022058

=LDR  01092cz  a2200277n  4500
=001  9880363177002441
=005  20141212195707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002519
=035  \\$aCAZ5679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x208
=150  \\$aCeratopogonidae
=450  \\$wnnna$aBiting Midge
=450  \\$wnnna$aBiting Midges
=450  \\$wnnna$aCulicoide
=450  \\$aCulicoides
=450  \\$wnnna$aLeptoconop
=450  \\$aLeptoconops
=450  \\$wnnna$aMidge, Biting
=450  \\$aMidges, Biting
=550  \\$wg$aDiptera
=667  \\$ado not confuse X ref CULICOIDES with CULEX, mosquito; do not use /drug eff for insecticides: TN 111; gall midges: index under DIPTERA
=680  \\$iA family of biting midges, in the order DIPTERA. It includes the genus Culicoides which transmits filarial parasites pathogenic to man and other primates.
=688  \\$a81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80
=750  \0$aCeratopogonidae$5IEN-HS$0(DLC)sh 85022043

=LDR  01132cz  a2200289n  4500
=001  9880363177102441
=005  20141212195706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002518
=035  \\$aCAZ5678NU
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x313
=072  \\$aD9.$x400.$x410.$x420.$x525.$x200
=072  \\$aD10.$x390.$x470.$x675.$x200
=072  \\$aD10.$x570.$x877.$x360.$x612.$x200
=150  \\$aCeramides
=550  \\$wg$aAmides
=550  \\$wg$aNeutral Glycosphingolipids
=550  \\$wh$aCerebrosides
=550  \\$wh$aGlobosides
=550  \\$wh$aLactosylceramides
=550  \\$wh$aTrihexosylceramides
=550  \\$aFabry Disease
=667  \\$acarbohydrate ceramides: index under CEREBROSIDES (one carbohydrate group) or NEUTRAL GLYCOSPHINGOLIPIDS (more than one carbohydrate group)
=680  \\$iMembers of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE.
=688  \\$a72
=750  \0$aCeramides$0(DLC)sh2002008720$5IEN-M

=LDR  01055cz  a2200265n  4500
=001  9880363177202441
=005  20141212195706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002516
=035  \\$aCAZ5676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x264
=072  \\$aJ1.$x637.$x51.$x264
=072  \\$aJ1.$x637.$x153
=150  \\$aCeramics
=450  \\$wnnna$aCeramic
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aManufactured Materials
=550  \\$wh$aDental Porcelain
=550  \\$wh$aOrganically Modified Ceramics
=667  \\$anot restricted to dentistry; D25-26 qualif
=680  \\$iProducts made by baking or firing nonmetallic minerals (clay and similar materials). In making dental restorations or parts of restorations the material is fused porcelain. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Boucher's Clinical Dental Terminology, 4th ed)
=688  \\$a73(67)
=750  \0$aCeramics$5IEN-M$0(DLC)sh 85022017
=750  \0$aCeramics in medicine$5IEN-HS$0(DLC)sh 85022024

=LDR  01746cz  a2200517n  4500
=001  9880363177302441
=005  20141212192049.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002515
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x200.$x185
=072  \\$aD2.$x886.$x665.$x74.$x200.$x185
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x200.$x185
=150  \\$aCephradine
=450  \\$wnnna$aAlpharma Brand of Cephradine
=450  \\$wnnna$aAnspor
=450  \\$wnnna$aBouchara Brand of Cephradine
=450  \\$wnnna$aBristol-Myers Squibb Brand of Cefradine
=450  \\$wnnna$aCefradine
=450  \\$wnnna$aCephradine Dihydrate
=450  \\$wnnna$aCephradine, Non-Stoichiometric Hydrate
=450  \\$wnnna$aCephradine, Non Stoichiometric Hydrate
=450  \\$wnnna$aDexef
=450  \\$wnnna$aDexo Brand of Cephradine
=450  \\$wnnna$aDihydrate, Cephradine
=450  \\$wnnna$aGalen Brand of Cephradine
=450  \\$wnnna$aKelsef
=450  \\$wnnna$aMaxisporin
=450  \\$wnnna$aNicef
=450  \\$wnnna$aNon-Stoichiometric Hydrate Cephradine
=450  \\$wnnna$aReig Jofre Brand of Cephradine
=450  \\$wnnna$aSefril
=450  \\$wnnna$aSepta Brand of Cephradine
=450  \\$wnnna$aSeptacef
=450  \\$wnnna$aSQ-11436
=450  \\$wnnna$aSQ 11436
=450  \\$wnnna$aSQ11436
=450  \\$wnnna$aSquibb Brand of Cephradine
=450  \\$wnnna$aVelocef
=450  \\$wnnna$aVelosef
=450  \\$wnnna$aYamanouchi Brand of Cephradine
=450  \\$wnnna$aZeefra Gé
=550  \\$wg$aCephalexin
=680  \\$iA semi-synthetic cephalosporin antibiotic.
=688  \\$a91(75); was see under CEPHALOSPORINS 1975-90
=750  \0$aCephradine$5IEN$0(DLC)sh 85021986

=LDR  01148cz  a2200337n  4500
=001  9880363177402441
=005  20141212195705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002511
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249
=072  \\$aD2.$x886.$x665.$x74
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249
=150  \\$aCephalosporins
=450  \\$wnnna$aAcids, Cephalosporanic
=450  \\$aAntibiotics, Cephalosporin
=450  \\$wnnna$aCephalosporanic Acids
=450  \\$wnnna$aCephalosporin Antibiotics
=550  \\$wg$abeta-Lactams
=550  \\$wg$aThiazines
=550  \\$wh$aCefamandole
=550  \\$wh$aCefazolin
=550  \\$wh$aCefonicid
=550  \\$wh$aCefsulodin
=550  \\$wh$aCephacetrile
=550  \\$wh$aCephalexin
=550  \\$wh$aCephaloridine
=550  \\$wh$aCephamycins
=680  \\$iA group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
=688  \\$a66(65)
=750  \0$aCephalosporins$5IEN$0(DLC)sh 85021981

=LDR  01066cz  a2200289n  4500
=001  9880363177502441
=005  20141212195705.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002510
=035  \\$aCAZ5670HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x87.$x180.$x229
=150  \\$aCephalosporinase
=450  \\$wnnna$aAmidase, Cephalexin
=450  \\$wnnna$aAmido-beta-Lactam Hydrolase, Cephalosporin
=450  \\$wnnna$abeta-Lactamase, Cephalosporin
=450  \\$abeta-Lactamase II
=450  \\$wnnna$abeta Lactamase II
=450  \\$wnnna$aCephalexin Amidase
=450  \\$wnnna$aCephalosporin Amido-beta-Lactam Hydrolase
=450  \\$wnnna$aCephalosporin Amido beta Lactam Hydrolase
=450  \\$wnnna$aCephalosporin beta-Lactamase
=450  \\$wnnna$aCephalosporin beta Lactamase
=450  \\$wnnna$aHydrolase, Cephalosporin Amido-beta-Lactam
=550  \\$wg$abeta-Lactamases
=688  \\$a91(75); was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78
=750  \0$aBeta lactamases$5IEN$0(DLC)sh 85013446

=LDR  01036cz  a2200277n  4500
=001  9880363177602441
=005  20141212195703.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002504
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x386.$x682.$x875
=072  \\$aD2.$x241.$x511.$x316.$x495
=150  \\$aMeclofenoxate
=450  \\$wnnna$aAlpharma Brand of Meclofenoxate Hydrochloride
=450  \\$wnnna$aAtsefen
=450  \\$aCentrophenoxine
=450  \\$wnnna$aCerutil
=450  \\$wnnna$aCetrexin
=450  \\$wnnna$aHelfergin
=450  \\$wnnna$aLundbeck Brand of Meclofenoxate Hydrochloride
=450  \\$wnnna$aMeclofenoxate Hydrochloride
=550  \\$wg$aGlycolates
=550  \\$wg$aPhenoxyacetates
=680  \\$iAn ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.
=688  \\$a91(65); was CENTROPHENOXINE see under GLYCOLATES 1975-90 & see under ACETIC ACIDS 1965-74 (Prov 1965-67); MECLOFENOXATE was see CENTROPHENOXINE 1977-90
=750  \0$aMeclofenoxate$5IEN$0(DLC)sh 85021949

=LDR  00826cz  a2200229n  4500
=001  9880363177702441
=005  20141212195702.0
=008  770429\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002503
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x165
=072  \\$aG5.$x360.$x160.$x165
=150  \\$aCentromere
=450  \\$wnnna$aCentromeres
=550  \\$wg$aChromosome Structures
=550  \\$wh$aKinetochores
=550  \\$aCentromere Protein B
=550  \\$aDNA, Satellite
=550  \\$aSpindle Apparatus
=680  \\$iThe clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division.
=688  \\$a91(78); was see under CHROMOSOMES 1978-90
=750  \0$aCentromere$5IEN-M$0(DLC)sh 97000500

=LDR  00829cz  a2200205n  4500
=001  9880363177802441
=005  20141212195702.0
=008  780310\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002502
=035  \\$aCAZ5663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x585.$x160.$x130
=072  \\$aA11.$x284.$x430.$x214.$x190.$x750.$x820.$x500.$x500.$x130
=150  \\$aCentrioles
=450  \\$wnnna$aCentriole
=550  \\$wg$aCentrosome
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iSelf-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder.
=688  \\$a85(79); was see under ORGANOIDS 1979-84
=750  \0$aCentrioles$5IEN$0(DLC)sh 85021940

=LDR  00925cz  a2200241n  4500
=001  9880363177902441
=005  20141212195702.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002501
=035  \\$aCAZ5662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x181.$x724.$x336.$x336
=072  \\$aE5.$x196.$x941.$x336.$x419
=150  \\$aCentrifugation, Zonal
=450  \\$wnnna$aCentrifugations, Zonal
=450  \\$wnnna$aZonal Centrifugation
=450  \\$wnnna$aZonal Centrifugations
=450  \\$aZonal Centrifuge$5IEN
=550  \\$wg$aCentrifugation, Density Gradient
=667  \\$aa type of density gradient centrif; NIM
=680  \\$iCentrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a68(66)
=750  \0$aZonal centrifuge$5IEN$0(DLC)sh 85149952

=LDR  01212cz  a2200277n  4500
=001  9880363178002441
=005  20141212195701.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002499
=035  \\$aCAZ5660HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x181.$x724.$x336
=072  \\$aE5.$x196.$x941.$x336
=150  \\$aCentrifugation, Density Gradient
=450  \\$wnnna$aCentrifugations, Density Gradient
=450  \\$wnnna$aDensity Gradient Centrifugation
=450  \\$wnnna$aDensity Gradient Centrifugations
=450  \\$wnnna$aGradient Centrifugation, Density
=450  \\$wnnna$aGradient Centrifugations, Density
=550  \\$wg$aUltracentrifugation
=550  \\$wh$aCentrifugation, Isopycnic
=550  \\$wh$aCentrifugation, Zonal
=667  \\$aa type of ultracentrif; NIM; index sucrose density gradient centrif here but ignore SUCROSE
=680  \\$iSeparation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a68(66)
=750  \0$aCentrifugation, Density gradient$5IEN$0(DLC)sh 85021938

=LDR  00818cz  a2200229n  4500
=001  9880363178102441
=005  20141212195700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002496
=035  \\$aCAZ5658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x330.$x380.$x76.$x732.$x336
=150  \\$aCentral Venous Pressure
=450  \\$wnnna$aCentral Venous Pressures
=450  \\$wnnna$aPressure, Central Venous
=450  \\$wnnna$aPressures, Central Venous
=450  \\$aVenous Pressure, Central
=450  \\$wnnna$aVenous Pressures, Central
=550  \\$wg$aVenous Pressure
=680  \\$iThe blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity.
=688  \\$a70
=750  \0$aCentral venous pressure$5IEN$0(DLC)sh 85021926

=LDR  00953cz  a2200253n  4500
=001  9880363178202441
=005  20141212195700.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002495
=035  \\$aCAZ5657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x260
=072  \\$aN4.$x452.$x442.$x422.$x260
=150  \\$aCentral Supply, Hospital
=450  \\$wnnna$aCentral Supplies, Hospital
=450  \\$aHospital Central Supplies
=450  \\$aHospital Central Supply
=450  \\$wnnna$aSupplies, Hospital Central
=450  \\$wnnna$aSupply, Hospital Central
=550  \\$wg$aHospital Departments
=667  \\$ado not confuse with CENTRALIZED HOSPITAL SERVICES
=680  \\$iHospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment.
=688  \\$a78; was HOSPITAL CENTRAL SUPPLY 1968-77
=750  \0$aHospitals$xCentral service departments$5IEN$0(DLC)sh 85062304

=LDR  01730cz  a2200397n  4500
=001  9880363178302441
=005  20141212195659.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002494
=035  \\$aCAZ5656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x395
=072  \\$aC10.$x228.$x228
=150  \\$aCentral Nervous System Infections
=450  \\$wnnna$aCentral Nervous System Infection
=450  \\$wnnna$aInfections, Central Nervous System
=550  \\$wg$aBacterial Infections and Mycoses
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wh$aBrain Abscess
=550  \\$wh$aCentral Nervous System Bacterial Infections
=550  \\$wh$aCentral Nervous System Fungal Infections
=550  \\$wh$aCentral Nervous System Parasitic Infections
=550  \\$wh$aCentral Nervous System Viral Diseases
=550  \\$wh$aEmpyema, Subdural
=550  \\$wh$aEncephalitis
=550  \\$wh$aEncephalomyelitis
=550  \\$wh$aEpidural Abscess
=550  \\$wh$aMeningitis
=550  \\$wh$aMeningoencephalitis
=550  \\$wh$aMyelitis
=550  \\$wh$aPerimeningeal Infections
=550  \\$wh$aPrion Diseases
=667  \\$aGEN or unspecified; prefer specifics; coord IM with specific site/dis term (IM) if pertinent; DF: CNS INFECT
=680  \\$iPathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.
=688  \\$a1998; use explode 1971-1997
=750  \0$aCentral nervous system$xInfections$5IEN-M$0(DLC)sh2001008632

=LDR  01142cz  a2200325n  4500
=001  9880363178402441
=005  20180718113436.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002493
=035  \\$aCAZ5655HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228
=150  \\$aCentral Nervous System Diseases
=450  \\$wnnna$aCentral Nervous System Disorders
=450  \\$wnnna$aCNS Disease
=450  \\$wnnna$aCNS Diseases
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aBrain Diseases
=550  \\$wh$aCentral Nervous System Infections
=550  \\$wh$aEncephalomyelitis
=550  \\$wh$aHigh Pressure Neurological Syndrome
=550  \\$wh$aHyperekplexia
=550  \\$wh$aMeningitis
=550  \\$wh$aMovement Disorders
=550  \\$wh$aOcular Motility Disorders
=550  \\$wh$aPneumocephalus
=550  \\$wh$aSpinal Cord Diseases
=667  \\$aGEN: prefer specifics; DF: CNS DIS
=680  \\$iDiseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
=750  \0$aCentral nervous system$xDiseases$5IEN$0(DLC)sh 85021909

=LDR  01240cz  a2200277n  4500
=001  9880363178502441
=005  20141212195658.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002492
=035  \\$aCAZ5654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277
=072  \\$aD27.$x505.$x954.$x427.$x210
=150  \\$aCentral Nervous System Depressants
=450  \\$wnnna$aCNS Depressants
=450  \\$wnnna$aDepressants, CNS
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aAnesthetics
=550  \\$wh$aHypnotics and Sedatives
=550  \\$wh$aNarcotics
=550  \\$wh$aTranquilizing Agents
=667  \\$aGEN or unspecified; prefer specific groups or specific drugs; consider also CENTRAL NERVOUS SYSTEM /drug eff or BRAIN /drug eff; DF: CNS DEPRESS
=680  \\$iA very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).
=688  \\$a79; was NON MESH before 1979
=750  \0$aCentral nervous system depressants$5IEN$0(DLC)sh 87002381

=LDR  01142cz  a2200313n  4500
=001  9880363178602441
=005  20141212192048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002490
=035  \\$aCAZ5652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186
=150  \\$aCentral Nervous System
=450  \\$wnnna$aAxi, Cerebrospinal
=450  \\$wnnna$aAxis, Cerebrospinal
=450  \\$wnnna$aCentral Nervous Systems
=450  \\$wnnna$aCerebrospinal Axi
=450  \\$wnnna$aCerebrospinal Axis
=450  \\$wnnna$aNervous System, Central
=450  \\$wnnna$aNervous Systems, Central
=450  \\$wnnna$aSystem, Central Nervous
=450  \\$wnnna$aSystems, Central Nervous
=550  \\$wg$aNervous System
=550  \\$wh$aBrain
=550  \\$wh$aMeninges
=550  \\$wh$aSpinal Cord
=667  \\$aprefer BRAIN or SPINAL CORD; "CNS effects" or "central effects" of drugs in texts usually means BRAIN /drug eff, not CNS /drug eff
=680  \\$iThe main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.
=750  \0$aCentral nervous system$5IEN$0(DLC)sh 85021906

=LDR  01181cz  a2200289n  4500
=001  9880363178702441
=005  20141212195655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002481
=035  \\$aCAZ5645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x130
=072  \\$aC1.$x539.$x830.$x200
=072  \\$aC17.$x300.$x185
=072  \\$aC23.$x550.$x470.$x756.$x200
=150  \\$aCellulitis
=450  \\$aPhlegmon
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aSkin Diseases, Infectious
=550  \\$wg$aSuppuration
=550  \\$wh$aOrbital Cellulitis
=550  \\$aConnective Tissue
=667  \\$a"cellulite" in Amer or Eng lit is indexed under OBESITY (IM) + ADIPOSE TISSUE (IM), in French lit "cellulite" can be "cellulite" or CELLULITIS
=680  \\$iAn acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.
=688  \\$aPHLEGMON was heading 1963-78
=750  \0$aPhlegmon$5IEN-M$0(DLC)sh 85101012
=750  \0$aCellulitis$5IEN-HS$0(DLC)sh 85021701

=LDR  01063cz  a2200313n  4500
=001  9880363178802441
=005  20141212195655.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002480
=035  \\$aCAZ5644HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x420.$x200.$x200
=150  \\$aCellulase
=450  \\$wnnna$abeta-1,4-Glucan-4-Glucanohydrolase
=450  \\$wnnna$abeta 1,4 Glucan 4 Glucanohydrolase
=450  \\$wnnna$aCellulysin
=450  \\$aEndo-1,4-beta-Glucanase
=450  \\$wnnna$aEndo 1,4 beta Glucanase
=450  \\$wnnna$aEndoglucanase
=450  \\$wnnna$aEndoglucanase A
=450  \\$wnnna$aEndoglucanase C
=450  \\$wnnna$aEndoglucanase E
=450  \\$wnnna$aEndoglucanase IV
=450  \\$wnnna$aEndoglucanase Y
=550  \\$wg$aCellulases
=667  \\$aCELLULASES is also available
=680  \\$iAn endocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages in CELLULOSE, lichenin, and cereal beta-glucans.
=688  \\$a77(73)
=750  \0$aCellulase$5IEN$0(DLC)sh 87007095

=LDR  02016cz  a2200637n  4500
=001  9880363178902441
=005  20141212195653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002477
=035  \\$aCAZ5641HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11
=150  \\$aCells
=450  \\$wnnna$aCell
=550  \\$wh$aAcinar Cells
=550  \\$wh$aAntibody-Producing Cells
=550  \\$wh$aAntigen-Presenting Cells
=550  \\$wh$aBlastomeres
=550  \\$wh$aBlood Cells
=550  \\$wh$aBone Marrow Cells
=550  \\$wh$aCells, Cultured
=550  \\$wh$aCells, Immobilized
=550  \\$wh$aCellular Structures
=550  \\$wh$aChromaffin Cells
=550  \\$wh$aConnective Tissue Cells
=550  \\$wh$aEndocrine Cells
=550  \\$wh$aEpithelial Cells
=550  \\$wh$aErythroid Cells
=550  \\$wh$aEukaryotic Cells
=550  \\$wh$aGerm Cells
=550  \\$wh$aGiant Cells
=550  \\$wh$aHepatic Stellate Cells
=550  \\$wh$aMesophyll Cells
=550  \\$wh$aMuscle Cells
=550  \\$wh$aMyeloid Cells
=550  \\$wh$aMyoblasts
=550  \\$wh$aNeoplastic Cells, Circulating
=550  \\$wh$aNeuroglia
=550  \\$wh$aNeurons
=550  \\$wh$aOxyphil Cells
=550  \\$wh$aPancreatic Stellate Cells
=550  \\$wh$aPericytes
=550  \\$wh$aPhagocytes
=550  \\$wh$aPlant Cells
=550  \\$wh$aProkaryotic Cells
=550  \\$wh$aProtoplasts
=550  \\$wh$aReed-Sternberg Cells
=550  \\$wh$aSpheroplasts
=550  \\$wh$aSpores
=550  \\$wh$aStem Cells
=550  \\$wh$aThymocytes
=550  \\$aCell Biology
=667  \\$ageneral; prefer specific cell or specific anatomical term or organism with /cytol; cell stages = CELL CYCLE
=680  \\$iThe fundamental, structural, and functional units or subunits of living organisms. They are composed of CYTOPLASM containing various ORGANELLES and a CELL MEMBRANE boundary.
=688  \\$a72; was see under CYTOLOGY 1963-71
=750  \0$aCells$5IEN$0(DLC)sh 85021678

=LDR  00946cz  a2200229n  4500
=001  9880363179002441
=005  20141212195653.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002476
=035  \\$aCAZ5640HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x720.$x99.$x500.$x252
=072  \\$aJ1.$x637.$x51.$x720.$x99.$x500.$x252
=072  \\$aJ1.$x637.$x118
=150  \\$aCellophane
=450  \\$wnnna$aCellophanes
=550  \\$wg$aCellulose
=550  \\$wg$aManufactured Materials
=550  \\$aCellulose
=667  \\$aD25-26 qualif
=680  \\$iA generic name for film produced from wood pulp by the viscose process. It is a thin, transparent sheeting of regenerated cellulose, moisture-proof and sometimes dyed, and used chiefly as food wrapping or as bags for dialysis. (Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aCellophane$5IEN$0(DLC)sh 85021677

=LDR  00935cz  a2200253n  4500
=001  9880363179102441
=005  20141212195652.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002473
=035  \\$aCAZ5637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x183
=150  \\$aCell Wall
=450  \\$wnnna$aCell Walls
=450  \\$wnnna$aWall, Cell
=450  \\$wnnna$aWalls, Cell
=550  \\$wg$aCellular Structures
=550  \\$wh$aCell Wall Skeleton
=550  \\$aMembranes
=680  \\$iThe outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.
=688  \\$a67(66)
=750  \0$aBacterial cell walls$5IEN-M$0(DLC)sh 85010842
=750  \0$aFungal cell walls$5IEN-HS$0(DLC)sh 85052428
=750  \0$aPlant cell walls$5IEN-HS$0(DLC)sh 85102711

=LDR  01206cz  a2200301n  4500
=001  9880363179202441
=005  20141212195652.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002472
=035  \\$aCAZ5636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x98.$x500.$x160
=072  \\$aC23.$x550.$x727.$x98.$x500.$x160
=072  \\$aG6.$x590.$x875.$x210
=072  \\$aG6.$x920.$x875.$x210
=150  \\$aCell Transformation, Viral
=450  \\$wnnna$aCell Transformations, Viral
=450  \\$wnnna$aTransformation, Viral Cell
=450  \\$wnnna$aTransformations, Viral Cell
=450  \\$wnnna$aViral Cell Transformation
=450  \\$wnnna$aViral Cell Transformations
=550  \\$wg$aCell Transformation, Neoplastic
=550  \\$wg$aVirus Physiological Processes
=550  \\$aCell Line, Transformed
=667  \\$ado not confuse with CYTOPATHOGENIC EFFECT, VIRAL: see scope notes; DF: CELL TRANSFORM VIRAL
=680  \\$iAn inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
=688  \\$a78
=750  \0$aViral cell transformation$0(DLC) sh 89007010$5IEN

=LDR  01763cz  a2200409n  4500
=001  9880363179302441
=005  20141212195651.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002471
=035  \\$aCAZ5635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x697.$x98.$x500
=072  \\$aC23.$x550.$x727.$x98.$x500
=150  \\$aCell Transformation, Neoplastic
=450  \\$wnnna$aCell Neoplastic Transformation
=450  \\$wnnna$aCell Neoplastic Transformations
=450  \\$wnnna$aCell Transformations, Neoplastic
=450  \\$wnnna$aNeoplastic Cell Transformation
=450  \\$wnnna$aNeoplastic Cell Transformations
=450  \\$aNeoplastic Transformation, Cell
=450  \\$wnnna$aNeoplastic Transformations, Cell
=450  \\$wnnna$aTransformation, Cell Neoplastic
=450  \\$wnnna$aTransformation, Neoplastic Cell
=450  \\$wnnna$aTransformation, Tumorigenic
=450  \\$wnnna$aTransformations, Cell Neoplastic
=450  \\$wnnna$aTransformations, Neoplastic Cell
=450  \\$wnnna$aTransformations, Tumorigenic
=450  \\$wnnna$aTumorigenic Transformation
=450  \\$wnnna$aTumorigenic Transformations
=550  \\$wg$aCarcinogenesis
=550  \\$wh$aBlast Crisis
=550  \\$wh$aCell Transformation, Viral
=550  \\$aCell Line, Transformed
=667  \\$ado not confuse with CELL DIFFERENTIATION, a normal process in morphogenesis
=680  \\$iCell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
=688  \\$a70(68)
=750  \0$aCell transformation$5IEN$0(DLC)sh 85021670

=LDR  01306cz  a2200373n  4500
=001  9880363179402441
=005  20141212195650.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002469
=035  \\$aCAZ5633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x363
=072  \\$aE5.$x200.$x500.$x363
=072  \\$aE5.$x242.$x363
=150  \\$aCell Separation
=450  \\$aCell Isolation
=450  \\$wnnna$aCell Isolations
=450  \\$aCell Segregation
=450  \\$wnnna$aCell Segregations
=450  \\$wnnna$aCell Separations
=450  \\$wnnna$aIsolation, Cell
=450  \\$wnnna$aIsolations, Cell
=450  \\$wnnna$aSegregation, Cell
=450  \\$wnnna$aSegregations, Cell
=450  \\$wnnna$aSeparation, Cell
=450  \\$wnnna$aSeparations, Cell
=550  \\$wg$aCytological Techniques
=550  \\$wh$aCytapheresis
=550  \\$wh$aFlow Cytometry
=550  \\$wh$aImmunomagnetic Separation
=550  \\$wh$aLeukocyte Reduction Procedures
=667  \\$aseparation of 2 or more cells; do not confuse with CELL FRACTIONATION; NIM, no qualif; when IM, qualif permitted; not for micro-organisms; flow cell sorting & fluorescence- activated cell sorting: coord with FLOW CYTOMETRY
=688  \\$a74(72)
=750  \0$aCell separation$5IEN$0(DLC)sh 85021668

=LDR  02740cz  a2200841n  4500
=001  9880363179502441
=005  20170621103342.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002468
=035  \\$aCAZ5632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4
=150  \\$aCell Physiological Phenomena
=450  \\$wnnna$aCell Physiological Phenomenon
=450  \\$nnnna$aCell Physiological Process
=450  \\$wnno$aCell Physiological Processes
=450  \\$wnno$aCell Physiology
=450  \\$aCells$xphysiology
=450  \\$wnnna$aPhenomena, Cell Physiological
=450  \\$wnnna$aPhenomenon, Cell Physiological
=450  \\$wnnna$aPhysiological Process, Cell
=450  \\$wnnna$aPhysiological Processes, Cell
=450  \\$wnnna$aPhysiology, Cell
=450  \\$wnnna$aProcess, Cell Physiological
=450  \\$wnnna$aProcesses, Cell Physiological
=550  \\$wh$aCell Adhesion
=550  \\$wh$aCell Aging
=550  \\$wh$aCell Communication
=550  \\$wh$aCell Compartmentation
=550  \\$wh$aCell Count
=550  \\$wh$aCell Cycle
=550  \\$wh$aCell Death
=550  \\$wh$aCell Dedifferentiation
=550  \\$wh$aCell Differentiation
=550  \\$wh$aCell Fusion
=550  \\$wh$aCell Growth Processes
=550  \\$wh$aCell-in-Cell Formation
=550  \\$wh$aCell Lineage
=550  \\$wh$aCell Membrane Permeability
=550  \\$wh$aCell Movement
=550  \\$wh$aCell Polarity
=550  \\$wh$aCell Respiration
=550  \\$wh$aCell Shape
=550  \\$wh$aCell Size
=550  \\$wh$aCell Survival
=550  \\$wh$aCell Transdifferentiation
=550  \\$wh$aCellular Microenvironment
=550  \\$wh$aClonal Evolution
=550  \\$wh$aContact
=550  \\$wh$aCytoplasmic Streaming
=550  \\$wh$aDNA Packaging
=550  \\$wh$aEndocytosis
=550  \\$wh$aEndoplasmic Reticulum Stress
=550  \\$wh$aExocytosis
=550  \\$wh$aLymphocyte Cooperation
=550  \\$wh$aMembrane Fluidity
=550  \\$wh$aMembrane Fusion
=550  \\$wh$aMembrane Potentials
=550  \\$wh$aMitochondrial Swelling
=550  \\$wh$aMitochondrial Turnover
=550  \\$wh$aOrganelle Biogenesis
=550  \\$wh$aOrganelle Shape
=550  \\$wh$aOrganelle Size
=550  \\$wh$aRadiation Tolerance
=550  \\$wh$aRe-Epithelialization
=550  \\$wh$aReceptor Aggregation
=550  \\$wh$aReceptor Cross-Talk
=550  \\$wh$aSignal Transduction
=667  \\$ageneral or unspecified; prefer specifics; DF: CELL PHYSIOL
=680  \\$iCellular processes, properties, and characteristics.
=688  \\$a2009 (1998)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Cell Physiology
=750  \0$aCell physiology$0(DLC) sh 85021662$5IEN

=LDR  01149cz  a2200241n  4500
=001  9880363179602441
=005  20141212195649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002466
=035  \\$aCAZ5631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x175
=150  \\$aCell Nucleolus
=450  \\$wnnna$aCell Nucleoli
=450  \\$wnnna$aNucleoli, Cell
=450  \\$wnnna$aNucleolus, Cell
=450  \\$aPlasmosome
=450  \\$wnnna$aPlasmosomes
=550  \\$wg$aIntranuclear Space
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iWithin most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed)
=688  \\$a67(65)
=750  \0$aNucleolus$5IEN$0(DLC)sh 85093151

=LDR  01363cz  a2200409n  4500
=001  9880363179702441
=005  20170620111508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002465
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x198
=072  \\$aG7.$x568.$x500.$x180
=150  \\$aCell Movement
=450  \\$wnnna$aCell Locomotion
=450  \\$aCell Migration
=450  \\$wnnna$aCell Motility
=450  \\$wnnna$aCell Movements
=450  \\$aLocomotion, Cell
=450  \\$aMigration, Cell
=450  \\$aMotility, Cell
=450  \\$aMovement, Cell
=450  \\$wnnna$aMovements, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wg$aLocomotion
=550  \\$wh$aCell Aggregation
=550  \\$wh$aCell Migration Inhibition
=550  \\$wh$aChemotaxis
=550  \\$wh$aOvum Transport
=550  \\$wh$aSperm Motility
=550  \\$wh$aSperm Transport
=550  \\$wh$aTranscellular Cell Migration
=550  \\$wh$aTransendothelial and Transepithelial Migration
=550  \\$aCell Tracking
=667  \\$anot for microorganisms; do not confuse with CYTOKINESIS or CYTOPLASMIC STREAMING
=680  \\$iThe movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
=688  \\$a70(68)
=750  \0$aCell migration$5IEN$0(DLC)sh 85021657

=LDR  01310cz  a2200385n  4500
=001  9880363179802441
=005  20141212195648.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002462
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149
=150  \\$aCell Membrane
=450  \\$wnnna$aCell Membranes
=450  \\$wnnna$aCytoplasmic Membrane
=450  \\$wnnna$aCytoplasmic Membranes
=450  \\$wnnna$aMembrane, Cell
=450  \\$wnnna$aMembrane, Cytoplasmic
=450  \\$wnnna$aMembrane, Plasma
=450  \\$wnnna$aMembranes, Cell
=450  \\$wnnna$aMembranes, Cytoplasmic
=450  \\$wnnna$aMembranes, Plasma
=450  \\$aPlasma Membrane
=450  \\$wnnna$aPlasma Membranes
=550  \\$wg$aCellular Structures
=550  \\$wh$aCell Membrane Structures
=550  \\$wh$aErythrocyte Membrane
=550  \\$wh$aIntracellular Membranes
=550  \\$wh$aPurple Membrane
=550  \\$wh$aSarcolemma
=550  \\$wh$aSynaptic Membranes
=550  \\$aMembranes
=667  \\$acoordinate with specific cell /ultrastruct; permitted with micro-organisms
=680  \\$iThe lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
=688  \\$a65(64)
=750  \0$aCell membranes$5IEN$0(DLC)sh 85021654

=LDR  01084cz  a2200337n  4500
=001  9880363179902441
=005  20141212195647.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002460
=035  \\$aCAZ5626HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x251.$x210
=150  \\$aCell Line
=450  \\$wnnna$aCell Lines
=450  \\$wnnna$aLine, Cell
=450  \\$wnnna$aLines, Cell
=550  \\$wg$aCells, Cultured
=550  \\$wh$a3T3 Cells
=550  \\$wh$aCell Line, Transformed
=550  \\$wh$aCell Line, Tumor
=550  \\$wh$aCHO Cells
=550  \\$wh$aL Cells (Cell Line)
=550  \\$wh$aLLC-PK1 Cells
=550  \\$wh$aMadin Darby Canine Kidney Cells
=550  \\$wh$aSf9 Cells
=550  \\$wh$aVero Cells
=550  \\$aCulture Techniques
=667  \\$aalmost always NIM with no subheadings; check ANIMALS or HUMAN; do not routinely add tissue or organ; policy: Manual 21.57, 22.26.1
=680  \\$iEstablished cell cultures that have the potential to propagate indefinitely.
=688  \\$a72(69)
=750  \0$aCell lines$5IEN$0(DLC)sh 85021651

=LDR  01544cz  a2200421n  4500
=001  9880363180002441
=005  20161216103228.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002455
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x134.$x220
=072  \\$aG4.$x299.$x233.$x750.$x500
=072  \\$aG5.$x355.$x105
=072  \\$aG7.$x700.$x320.$x249.$x410.$x750.$x500
=150  \\$aCell Division
=450  \\$wnnna$aCell Division Phase
=450  \\$wnnna$aCell Divisions
=450  \\$wnnna$aDivision, Cell
=450  \\$wnnna$aDivision Phase, Cell
=450  \\$wnnna$aDivisions, Cell
=450  \\$aM Phase
=450  \\$wnnna$aM Phases
=450  \\$wnnna$aPhase, Cell Division
=450  \\$wnnna$aPhase, M
=450  \\$wnnna$aPhases, M
=550  \\$wg$aCell Cycle
=550  \\$wg$aCell Proliferation
=550  \\$wg$aGenetic Processes
=550  \\$wh$aAsymmetric Cell Division
=550  \\$wh$aCell Nucleus Division
=550  \\$wh$aCell Self Renewal
=550  \\$wh$aCytokinesis
=550  \\$wh$aTelomere Homeostasis
=550  \\$aCleavage Stage, Ovum
=667  \\$acoordinate with specific cell /cytol; permitted with microorganisms; for cell division of cytoplasm only, use CYTOKINESIS; note X ref M PHASE: MITOTIC M PHASE and MEIOTIC M PHASE are also available
=680  \\$iThe fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
=688  \\$a1963 for M PHASE use MITOSIS 1991-2004
=750  \0$aCell division$5IEN-M$0(DLC)sh 85021646

=LDR  01184cz  a2200325n  4500
=001  9880363180102441
=005  20170620102133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002454
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x152
=150  \\$aCell Differentiation
=450  \\$wnnna$aCell Differentiations
=450  \\$wnnna$aDifferentiation, Cell
=450  \\$wnnna$aDifferentiations, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aAdipogenesis
=550  \\$wh$aAsymmetric Cell Division
=550  \\$wh$aCellular Reprogramming
=550  \\$wh$aEmbryonic Induction
=550  \\$wh$aGametogenesis
=550  \\$wh$aHematopoiesis
=550  \\$wh$aNeurogenesis
=550  \\$aCell Lineage
=550  \\$aEmbryo, Mammalian
=550  \\$aGene Expression Regulation
=667  \\$anot for micro-organisms; CELL DEDIFFERENTIATION and CELL TRANSDIFFERENTIATION are also available
=680  \\$iProgressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
=688  \\$a66(64)
=750  \0$aCell differentiation$0(DLC) sh 85021645$5IEN

=LDR  01308cz  a2200337n  4500
=001  9880363180202441
=005  20170620101637.0
=008  770504\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002453
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x144
=150  \\$aCell Cycle
=450  \\$wnnna$aCell Cycles
=450  \\$wnnna$aCell Division Cycle
=450  \\$wnnna$aCell Division Cycles
=450  \\$wnnna$aCycle, Cell
=450  \\$wnnna$aCycle, Cell Division
=450  \\$wnnna$aCycles, Cell
=450  \\$wnnna$aCycles, Cell Division
=450  \\$wnnna$aDivision Cycle, Cell
=450  \\$wnnna$aDivision Cycles, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aCell Cycle Checkpoints
=550  \\$wh$aCell Division
=550  \\$wh$aInterphase
=550  \\$aCell Cycle Proteins
=550  \\$aGenes, cdc
=667  \\$acoordinate with specific cell /cytol; permitted with microorganisms
=680  \\$iThe complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.
=688  \\$a78
=750  \0$aCell cycle$5IEN$0(DLC)sh 85021643

=LDR  00835cz  a2200241n  4500
=001  9880363180302441
=005  20170619102305.0
=008  770301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002451
=035  \\$aCAZ5619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x128
=150  \\$aCell Compartmentation
=450  \\$wnnna$aCell Compartmentations
=450  \\$wnnna$aCompartmentation, Cell
=450  \\$wnnna$aCompartmentations, Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aChromosome Positioning
=550  \\$aCell Nucleus
=667  \\$apermitted with micro-organisms
=680  \\$iA partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc.
=688  \\$a78
=750  \0$aCell compartmentation$5IEN$0(DLC)sh 85021641

=LDR  01397cz  a2200385n  4500
=001  9880363180402441
=005  20170619101359.0
=008  770516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002450
=035  \\$aCAZ5618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x85
=150  \\$aCell Communication
=450  \\$wnnna$aCell Communications
=450  \\$aCell Interaction
=450  \\$wnnna$aCell Interactions
=450  \\$aCell-to-Cell Interaction
=450  \\$wnnna$aCell to Cell Interaction
=450  \\$wnnna$aCell-to-Cell Interactions
=450  \\$wnnna$aCommunication, Cell
=450  \\$wnnna$aCommunications, Cell
=450  \\$wnnna$aInteraction, Cell
=450  \\$wnnna$aInteraction, Cell-to-Cell
=450  \\$wnnna$aInteractions, Cell
=450  \\$wnnna$aInteractions, Cell-to-Cell
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aAutocrine Communication
=550  \\$wh$aBystander Effect
=550  \\$wh$aEmbryonic Induction
=550  \\$wh$aParacrine Communication
=550  \\$wh$aQuorum Sensing
=667  \\$anot for micro-organisms
=680  \\$iAny of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP.
=688  \\$a78
=750  \0$aCell interaction$5IEN$0(DLC)sh 85021649

=LDR  00706cz  a2200217n  4500
=001  9880363180502441
=005  20141212195644.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002449
=035  \\$aCAZ5617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x299.$x283.$x251
=150  \\$aCell Aggregation
=450  \\$wnnna$aAggregation, Cell
=450  \\$wnnna$aAggregations, Cell
=450  \\$wnnna$aCell Aggregations
=550  \\$wg$aCell Movement
=667  \\$aNIM; not for micro-organisms
=680  \\$iThe phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
=688  \\$a68(65)
=750  \0$aCell aggregation$5IEN$0(DLC)sh 85021640

=LDR  00739cz  a2200241n  4500
=001  9880363180602441
=005  20170619100835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002448
=035  \\$aCAZ5616HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x22
=150  \\$aCell Adhesion
=450  \\$wnnna$aAdhesion, Cell
=450  \\$wnnna$aAdhesions, Cell
=450  \\$wnnna$aCell Adhesions
=550  \\$wg$aCell Physiological Phenomena
=550  \\$aCell-Matrix Junctions
=550  \\$aFocal Adhesions
=667  \\$aNIM; permitted with micro-organisms but BACTERIAL ADHESION is available
=680  \\$iAdherence of cells to surfaces or to other cells.
=688  \\$a72(70)
=750  \0$aCell adhesion$5IEN$0(DLC)sh 85021639

=LDR  01005cz  a2200265n  4500
=001  9880363180702441
=005  20141212195643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002447
=035  \\$aCAZ5615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50.$x50.$x150
=072  \\$aA8.$x800.$x800.$x60.$x150
=150  \\$aCeliac Plexus
=450  \\$aCoeliac Plexus
=450  \\$wnnna$aCoeliacus, Plexus
=450  \\$wnnna$aPlexus, Celiac
=450  \\$wnnna$aPlexus, Coeliac
=450  \\$aPlexus Coeliacus
=450  \\$wnnna$aPlexus, Solar
=450  \\$aSolar Plexus
=550  \\$wg$aAutonomic Pathways
=667  \\$athe largest autonomic plexus; in the abdomen
=680  \\$iA complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries.
=750  \0$aSolar plexus$5IEN$0(DLC)sh 85124533

=LDR  01520cz  a2200397n  4500
=001  9880363180802441
=005  20141212195643.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002446
=035  \\$aCAZ5614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x637.$x250
=072  \\$aC18.$x452.$x603.$x250
=150  \\$aCeliac Disease
=450  \\$wnnna$aCeliac Sprue
=450  \\$wnnna$aDisease, Celiac
=450  \\$wnnna$aEnteropathies, Gluten
=450  \\$wnnna$aEnteropathies, Gluten-Sensitive
=450  \\$wnnna$aEnteropathy, Gluten
=450  \\$wnnna$aEnteropathy, Gluten-Sensitive
=450  \\$wnnna$aGluten Enteropathies
=450  \\$aGluten Enteropathy
=450  \\$wnnna$aGluten-Sensitive Enteropathies
=450  \\$wnnna$aGluten-Sensitive Enteropathy
=450  \\$wnnna$aGluten Sensitive Enteropathy
=450  \\$wnnna$aNontropical Sprue
=450  \\$wnnna$aSprue
=450  \\$aSprue, Celiac
=450  \\$aSprue, Nontropical
=550  \\$wg$aMalabsorption Syndromes
=550  \\$aEnteropathy-Associated T-Cell Lymphoma
=550  \\$aSprue, Tropical
=550  \\$aWheat Hypersensitivity
=667  \\$ado not confuse with SPRUE, TROPICAL
=680  \\$iA malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
=750  \0$aCeliac disease$5IEN$0(DLC)sh 85021632

=LDR  00652cz  a2200193n  4500
=001  9880363180902441
=005  20141212195642.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002445
=035  \\$aCAZ5613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x207
=150  \\$aCeliac Artery
=450  \\$wnnna$aArteries, Celiac
=450  \\$wnnna$aArtery, Celiac
=450  \\$wnnna$aCeliac Arteries
=550  \\$wg$aArteries
=680  \\$iThe arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries.
=750  \0$aCeliac artery$5IEN$0(DLC)sh 85021630

=LDR  00841cz  a2200217n  4500
=001  9880363181002441
=005  20141212195642.0
=008  790301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x190.$x190.$x165
=072  \\$aD2.$x886.$x665.$x74.$x190.$x190.$x165
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x190.$x190.$x165
=150  \\$aCefuroxime
=450  \\$wnnna$aCephuroxime
=450  \\$wnnna$aKetocef
=450  \\$wnnna$aZinacef
=550  \\$wg$aCefotaxime
=680  \\$iBroad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
=688  \\$a91(80); was see under CEPHALOSPORINS 1980-90
=750  \0$aCefuroxime$5IEN$0(DLC)sh 85021605

=LDR  02581cz  a2200721n  4500
=001  9880363181102441
=005  20141212195642.0
=008  850606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002443
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x190.$x190.$x155
=072  \\$aD2.$x886.$x665.$x74.$x190.$x190.$x155
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x190.$x190.$x155
=150  \\$aCeftriaxone
=450  \\$wnnna$aAnhydrous Ceftriaxone Sodium
=450  \\$wnnna$aBenaxona
=450  \\$wnnna$aBoehringer Mannheim Brand of Ceftriaxone Sodium
=450  \\$wnnna$aCefatriaxone
=450  \\$wnnna$aCefaxona
=450  \\$wnnna$aCeftrex
=450  \\$wnnna$aCeftriaxon
=450  \\$wnnna$aCeftriaxon Curamed
=450  \\$wnnna$aCeftriaxon Hexal
=450  \\$wnnna$aCeftriaxona Andreu
=450  \\$wnnna$aCeftriaxona LDP Torlan
=450  \\$wnnna$aCeftriaxone, Disodium Salt
=450  \\$wnnna$aCeftriaxone, Disodium Salt, Hemiheptahydrate
=450  \\$wnnna$aCeftriaxone Irex
=450  \\$wnnna$aCeftriaxone Sodium
=450  \\$wnnna$aCeftriaxone Sodium, Anhydrous
=450  \\$wnnna$aColumbia Brand of Ceftriaxone
=450  \\$wnnna$aCuramed Brand of Ceftriaxone Sodium
=450  \\$wnnna$aFustery Brand of Ceftriaxone Sodium
=450  \\$wnnna$aGalen Brand of Ceftriaxone Sodium
=450  \\$wnnna$aHexal Brand of Ceftriaxone Sodium
=450  \\$wnnna$aHoffman-La Roche Brand of Ceftriaxone Sodium
=450  \\$wnnna$aHoffman La Roche Brand of Ceftriaxone Sodium
=450  \\$wnnna$aInibsa Brand of Ceftriaxone Sodium
=450  \\$wnnna$aIrex Brand of Ceftriaxone
=450  \\$wnnna$aLendacin
=450  \\$wnnna$aLongacef
=450  \\$wnnna$aLongaceph
=450  \\$wnnna$aPisa Brand of Ceftriaxone Sodium
=450  \\$wnnna$aRo 13-9904
=450  \\$wnnna$aRo-13-9904
=450  \\$wnnna$aRo 13 9904
=450  \\$wnnna$aRo 139904
=450  \\$wnnna$aRo13-9904
=450  \\$wnnna$aRo13 9904
=450  \\$wnnna$aRo139904
=450  \\$wnnna$aRocefalin
=450  \\$wnnna$aRocefin
=450  \\$wnnna$aRocephin
=450  \\$wnnna$aRocephine
=450  \\$wnnna$aRoche Brand of Ceftriaxone Sodium
=450  \\$wnnna$aSodium, Ceftriaxone
=450  \\$wnnna$aSyntex Brand of Ceftriaxone Sodium
=450  \\$wnnna$aTacex
=450  \\$wnnna$aTerbac
=550  \\$wg$aCefotaxime
=680  \\$iA broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
=688  \\$a86
=750  \0$aCeftriaxone$0(DLC)sh2013002816$5IEN-M

=LDR  01616cz  a2200433n  4500
=001  9880363181202441
=005  20141212210957.0
=008  880531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015313
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x250.$x199
=072  \\$aD2.$x886.$x665.$x74.$x250.$x199
=072  \\$aD3.$x383.$x129.$x617.$x235
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x250.$x199
=150  \\$aCefotetan
=450  \\$wnnna$aApacef
=450  \\$wnnna$aApatef
=450  \\$wnnna$aAstra Brand of Cefotetan Disodium
=450  \\$wnnna$aAstraZeneca Brand of Cefotetan Disodium
=450  \\$wnnna$aCefotan
=450  \\$wnnna$aCefotetan Disodium
=450  \\$wnnna$aCefotetan Disodium Salt
=450  \\$wnnna$aCeftotan
=450  \\$wnnna$aDisodium, Cefotetan
=450  \\$wnnna$aDisodium Salt, Cefotetan
=450  \\$wnnna$aICI-156834
=450  \\$wnnna$aICI 156834
=450  \\$wnnna$aICI156834
=450  \\$wnnna$aLederle Brand of Cefotetan Disodium
=450  \\$wnnna$aSalt, Cefotetan Disodium
=450  \\$wnnna$aWyeth Brand of Cefotetan Disodium
=450  \\$wnnna$aYM-09330
=450  \\$wnnna$aYM 09330
=450  \\$wnnna$aYM09330
=550  \\$wg$aCephamycins
=550  \\$wg$aTetrazoles
=680  \\$iA semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
=688  \\$a89
=750  \0$aCefotetan$5IEN$0(DLC)sh 85021604

=LDR  01843cz  a2200589n  4500
=001  9880363181302441
=005  20141212195640.0
=008  810513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002439
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x190.$x190
=072  \\$aD2.$x886.$x665.$x74.$x190.$x190
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x190.$x190
=150  \\$aCefotaxime
=450  \\$wnnna$aAventis Brand of Cefotaxime Sodium
=450  \\$wnnna$aAventis Pharma Brand of Cefotaxime Sodium
=450  \\$wnnna$aBenaxima
=450  \\$wnnna$aBiosint
=450  \\$wnnna$aCefotaxim
=450  \\$wnnna$aCefotaxime Sodium
=450  \\$wnnna$aCefradil
=450  \\$wnnna$aCephotaxim
=450  \\$wnnna$aClaforan
=450  \\$wnnna$aFotexina
=450  \\$wnnna$aFustery Brand of Cefotaxime Sodium
=450  \\$wnnna$aGalen Brand of Cefotaxime Sodium
=450  \\$wnnna$aHoechst Brand of Cefotaxime Sodium
=450  \\$wnnna$aHR-756
=450  \\$wnnna$aHR 756
=450  \\$wnnna$aHR756
=450  \\$wnnna$aKendrick
=450  \\$wnnna$aKlaforan
=450  \\$wnnna$aLiomont Brand of Cefotaxime Sodium
=450  \\$wnnna$aMerck Brand of Cefotaxime Sodium
=450  \\$wnnna$aPisa Brand of Cefotaxime Sodium
=450  \\$wnnna$aPrimafen
=450  \\$wnnna$aRu-24756
=450  \\$wnnna$aRu 24756
=450  \\$wnnna$aRu24756
=450  \\$wnnna$aSodium, Cefotaxime
=450  \\$wnnna$aTaporin
=450  \\$wnnna$aViken Brand of Cefotaxime Sodium
=550  \\$wg$aCephacetrile
=550  \\$wh$aCefixime
=550  \\$wh$aCefmenoxime
=550  \\$wh$aCefotiam
=550  \\$wh$aCeftizoxime
=550  \\$wh$aCeftriaxone
=550  \\$wh$aCefuroxime
=680  \\$iSemisynthetic broad-spectrum cephalosporin.
=688  \\$a82
=750  \0$aCefotaxime$5IEN$0(DLC)sh 90001869

=LDR  01210cz  a2200337n  4500
=001  9880363181402441
=005  20141212192046.0
=008  830404\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002438
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x150.$x160
=072  \\$aD2.$x886.$x665.$x74.$x150.$x160
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x150.$x160
=150  \\$aCefoperazone
=450  \\$wnnna$aCéfobis
=450  \\$wnnna$aCefobid
=450  \\$wnnna$aCefoperazon
=450  \\$wnnna$aCefoperazone Sodium
=450  \\$wnnna$aCefoperazone Sodium Salt
=450  \\$wnnna$aFarmasierra Brand of Cefoperazone Sodium
=450  \\$wnnna$aPfizer Brand of Cefoperazone Sodium
=450  \\$wnnna$aSalt, Cefoperazone Sodium
=450  \\$wnnna$aSodium, Cefoperazone
=450  \\$wnnna$aSodium Salt, Cefoperazone
=450  \\$wnnna$aT-1551
=450  \\$wnnna$aT 1551
=450  \\$wnnna$aT1551
=550  \\$wg$aCefamandole
=680  \\$iSemisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.
=688  \\$a84
=750  \0$aCefoperazone$5IEN$0(DLC)sh 89005967

=LDR  00957cz  a2200301n  4500
=001  9880363181502441
=005  20141212195638.0
=008  790301\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002433
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x249.$x200.$x155
=072  \\$aD2.$x886.$x665.$x74.$x200.$x155
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x249.$x200.$x155
=150  \\$aCefaclor
=450  \\$wnnna$aAnhydrous, Cefaclor
=450  \\$wnnna$aCeclor
=450  \\$wnnna$aCefaclor Anhydrous
=450  \\$wnnna$aCefaclor Monohydrate
=450  \\$wnnna$aKeclor
=450  \\$wnnna$aLilly 99638
=450  \\$wnnna$aMonohydrate, Cefaclor
=450  \\$wnnna$aS-6472
=450  \\$wnnna$aS 6472
=450  \\$wnnna$aS6472
=550  \\$wg$aCephalexin
=680  \\$iSemisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
=688  \\$a91(80); was see under CEPHALEXIN 1980-90
=750  \0$aCefaclor$5IEN-M$0(DLC)sh 99000071

=LDR  00702cz  a2200205n  4500
=001  9880363181602441
=005  20141212195638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002432
=035  \\$aCAZ5595HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526.$x209
=072  \\$aA3.$x556.$x249.$x249.$x209
=150  \\$aCecum
=450  \\$wnnna$aCecums
=550  \\$wg$aIntestine, Large
=550  \\$wh$aAppendix
=667  \\$aInflammation = CECITIS see TYPHLITIS
=680  \\$iThe blind sac or outpouching area of the LARGE INTESTINE that is below the entrance of the SMALL INTESTINE. It has a worm-like extension, the vermiform APPENDIX.
=750  \0$aCecum$5IEN$0(DLC)sh 85021593

=LDR  01004cz  a2200325n  4500
=001  9880363181702441
=005  20141212195637.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002430
=035  \\$aCAZ5593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411.$x184
=072  \\$aC6.$x301.$x371.$x411.$x184
=072  \\$aC6.$x405.$x249.$x411.$x184
=072  \\$aC6.$x405.$x469.$x110.$x417
=072  \\$aC6.$x405.$x469.$x491.$x184
=150  \\$aCecal Neoplasms
=450  \\$wnnna$aCancer, Cecal
=450  \\$aCancer of Cecum
=450  \\$wnnna$aCancer of the Cecum
=450  \\$aCecal Cancer
=450  \\$wnnna$aCecal Neoplasm
=450  \\$wnnna$aNeoplasm, Cecal
=450  \\$wnnna$aNeoplasms, Cecal
=550  \\$wg$aCecal Diseases
=550  \\$wg$aIntestinal Neoplasms
=550  \\$wh$aAppendiceal Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the CECUM.
=750  \0$aCecum$xCancer$5IEN-M$0(DLC)sh 85021594

=LDR  01525cz  a2200349n  4500
=001  9880363181802441
=005  20141212195637.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002428
=035  \\$aCAZ5591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x120.$x120
=150  \\$aCebus
=450  \\$wnnna$aCapuchin Monkey
=450  \\$wnnna$aCapuchin Monkeys
=450  \\$aMonkey, Capuchin
=450  \\$aMonkey, Ring-Tail
=450  \\$wnnna$aMonkey, Ring Tail
=450  \\$wnnna$aMonkey, Ring-Tailed
=450  \\$wnnna$aMonkey, Ring Tailed
=450  \\$wnnna$aMonkeys, Capuchin
=450  \\$wnnna$aMonkeys, Ring-Tail
=450  \\$wnnna$aMonkeys, Ring-Tailed
=450  \\$wnnna$aRing-Tail Monkey
=450  \\$wnnna$aRing-Tail Monkeys
=450  \\$wnnna$aRing-Tailed Monkey
=450  \\$wnnna$aRing-Tailed Monkeys
=550  \\$wg$aCebinae
=667  \\$aNew World monkey; NIM when exper animal: no qualif; when IM, qualif permitted; diseases: coord IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the family CEBIDAE, subfamily CEBINAE, consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over the eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South America.
=688  \\$a91(81); was see under CEBIDAE 1981-90
=750  \0$aCapuchin monkeys$5IEN-M$0(DLC)sh 85020027

=LDR  01002cz  a2200229n  4500
=001  9880363181902441
=005  20141212195636.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150
=150  \\$aCebidae
=450  \\$aPlatyrrhina
=450  \\$wnnna$aPlatyrrhinas
=550  \\$wg$aPlatyrrhini
=550  \\$wh$aCallitrichinae
=550  \\$wh$aCebinae
=550  \\$wh$aSaimirinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA family of New World monkeys in the infraorder PLATYRRHINI, consisting of nine subfamilies: ALOUATTINAE; AOTINAE; Atelinae; Callicebinae; CALLIMICONINAE; CALLITRICHINAE; CEBINAE; Pithecinae; and SAIMIRINAE. They inhabit the forests of South and Central America, comprising the largest family of South American monkeys.
=688  \\$a81
=750  \0$aCebidae$5IEN-M$0(DLC)sh 85021581

=LDR  00535cz  a2200169n  4500
=001  9880363182002441
=005  20141212195636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002426
=035  \\$aCAZ5589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x224.$x334
=150  \\$aCavernous Sinus
=450  \\$wnnna$aSinus, Cavernous
=550  \\$wg$aCranial Sinuses
=680  \\$iAn irregularly shaped venous space in the dura mater at either side of the sphenoid bone.
=750  \0$aCavernous sinus$5IEN$0(DLC)sh 85021503

=LDR  00755cz  a2200229n  4500
=001  9880363182102441
=005  20141212195636.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002425
=035  \\$aCAZ5588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x154
=072  \\$aE4.$x14.$x170
=150  \\$aCautery
=450  \\$wnnna$aCauterization
=450  \\$wnnna$aCauterizations
=550  \\$wg$aAblation Techniques
=550  \\$wg$aTherapeutics
=550  \\$wh$aElectrocoagulation
=667  \\$acoordinate with organ or disease /surg
=680  \\$iThe application of a caustic substance, a hot instrument, an electric current, or other agent to control bleeding while removing or destroying tissue.
=750  \0$aCautery$5IEN$0(DLC)sh 85021470

=LDR  01250cz  a2200217n  4500
=001  9880363182202441
=005  20141212195635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002424
=035  \\$aCAZ5587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x185
=072  \\$aD27.$x888.$x569.$x185
=150  \\$aCaustics
=450  \\$aCorrosives
=450  \\$aEscharotics$5IEN
=550  \\$wg$aNoxae
=550  \\$wg$aSpecialty Uses of Chemicals
=667  \\$acaustic injury: index CAUSTICS /tox + BURNS, CHEMICAL + organ /inj; see also note on ESOPHAGEAL STENOSIS
=680  \\$iStrong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year.
=750  \0$aEscharotics$5IEN$0(DLC)sh 85044784

=LDR  01180cz  a2200277n  4500
=001  9880363182302441
=005  20141212195635.0
=008  870513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002423
=035  \\$aCAZ5586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x550.$x250
=072  \\$aL1.$x280.$x975.$x550.$x250
=072  \\$aN1.$x224.$x935.$x698.$x100
=072  \\$aN6.$x850.$x505.$x400.$x975.$x550.$x250
=072  \\$aN6.$x850.$x520.$x308.$x985.$x550.$x250
=150  \\$aCause of Death
=450  \\$wnnna$aCauses of Death
=450  \\$wnnna$aDeath Cause
=450  \\$wnnna$aDeath Causes
=550  \\$wg$aMortality
=550  \\$aDeath
=667  \\$anote categories; do not use for cause of death in every clinical case; restrict to cause of death as an epidemiological consideration: "mortality by cause of death", "certification of cause of death"; probably IM in such cases; coord NIM with specific disease /mortal (IM); specify geog if pertinent
=680  \\$iFactors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
=688  \\$a88
=750  \0$aDeath$xCauses$5IEN$0(DLC)sh 85036086

=LDR  01406cz  a2200325n  4500
=001  9880363182402441
=005  20141212195635.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002422
=035  \\$aCAZ5585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177.$x195.$x200
=072  \\$aC10.$x668.$x829.$x250.$x200
=072  \\$aC10.$x668.$x829.$x600.$x200
=150  \\$aCausalgia
=450  \\$wnnna$aCausalgia Syndrome
=450  \\$wnnna$aCausalgia Syndromes
=450  \\$aComplex Regional Pain Syndrome Type II
=450  \\$wnnna$aCRPS Type II
=450  \\$wnnna$aDeafferentation Pain
=450  \\$wnnna$aPain, Deafferentation
=450  \\$wnnna$aSyndrome, Causalgia
=450  \\$wnnna$aSyndromes, Causalgia
=450  \\$wnnna$aType II Complex Regional Pain Syndrome
=550  \\$wg$aComplex Regional Pain Syndromes
=550  \\$wg$aNeuralgia
=667  \\$acoord IM with specific nerve (IM)
=680  \\$iA complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)
=688  \\$a1991(1971); was see under NEURALGIA 1971-1990
=750  \0$aCausalgia$5IEN$0(DLC)sh 85021457

=LDR  00677cz  a2200205n  4500
=001  9880363182502441
=005  20141212192046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002421
=035  \\$aCAZ5584HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x249.$x487.$x550.$x184
=150  \\$aCaudate Nucleus
=450  \\$wnnna$aCaudatus
=450  \\$wnnna$aCaudatus, Nucleus
=450  \\$wnnna$aNucleus, Caudate
=450  \\$wnnna$aNucleus Caudatus
=550  \\$wg$aNeostriatum
=680  \\$iElongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.
=750  \0$aCaudate nucleus$0(DLC) sh 85021443$5IEN

=LDR  00943cz  a2200229n  4500
=001  9880363182602441
=005  20141212192046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002420
=035  \\$aCAZ5583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x725.$x150
=150  \\$aCauda Equina
=450  \\$wnnna$aEquina, Cauda
=450  \\$aFilum Terminale
=450  \\$wnnna$aTerminale, Filum
=550  \\$wg$aSpinal Nerve Roots
=550  \\$aSpinal Cord
=667  \\$adisease: coordinate IM with PERIPHERAL NERVOUS SYSTEM DISEASES (IM); neoplasms: coordinate IM with PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM); cauda equina syndrome: CAUDA EQUINA SYNDROME see POLYRADICULOPATHY is available
=680  \\$iThe lower part of the SPINAL CORD consisting of the lumbar, sacral, and coccygeal nerve roots.
=688  \\$aFILUM TERMINALE was see under CAUDA EQUINA 1963-78
=750  \0$aCauda equina$5IEN$0(DLC)sh 85021442

=LDR  01765cz  a2200445n  4500
=001  9880363182702441
=005  20141212195634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002418
=035  \\$aCAZ5581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC22.$x196
=150  \\$aCattle Diseases
=450  \\$wnnna$aBovine Disease
=450  \\$wnnna$aBovine Diseases
=450  \\$wnnna$aCattle Disease
=450  \\$wnnna$aDisease, Bovine
=450  \\$wnnna$aDisease, Cattle
=450  \\$wnnna$aDiseases, Bovine
=450  \\$wnnna$aDiseases, Cattle
=550  \\$wg$aAnimal Diseases
=550  \\$wh$aBovine Respiratory Disease Complex
=550  \\$wh$aBovine Virus Diarrhea-Mucosal Disease
=550  \\$wh$aBrucellosis, Bovine
=550  \\$wh$aEncephalopathy, Bovine Spongiform
=550  \\$wh$aEnzootic Bovine Leukosis
=550  \\$wh$aEphemeral Fever
=550  \\$wh$aFreemartinism
=550  \\$wh$aHemorrhagic Syndrome, Bovine
=550  \\$wh$aInfectious Bovine Rhinotracheitis
=550  \\$wh$aLumpy Skin Disease
=550  \\$wh$aMalignant Catarrh
=550  \\$wh$aMastitis, Bovine
=550  \\$wh$aTheileriasis
=550  \\$wh$aTrypanosomiasis, Bovine
=550  \\$wh$aTuberculosis, Bovine
=550  \\$wh$aWhite Heifer Disease
=667  \\$aIM GEN or unspecified; coord IM with specific dis /vet (IM) or specific cattle dis (IM); for abnormalities or injuries, index under CATTLE /abnorm or CATTLE /inj; includes diseases of yaks & zebus but does not include diseases of BISON or BUFFALOES; don't forget also check tags CATTLE (NIM) & ANIMALS; DF: CATTLE DIS
=680  \\$iDiseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.
=750  \0$aCattle$xDiseases$5IEN$0(DLC)sh 85021307

=LDR  01139cz  a2200253n  4500
=001  9880363182802441
=005  20141212195507.0
=008  771202\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002139
=035  \\$aCAZ5305M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x95
=072  \\$aB4.$x909.$x777.$x162
=150  \\$aCaliciviridae
=450  \\$wnno$aCalicivirus$5IEN-M
=550  \\$wg$aRNA Viruses
=550  \\$wh$aLagovirus
=550  \\$wh$aNorovirus
=550  \\$wh$aSapovirus
=550  \\$wh$aVesivirus
=667  \\$ainfection = CALICIVIRIDAE INFECTIONS
=680  \\$iA family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped (chalice) indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.
=688  \\$a82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICVIRIDAE 1993
=750  \0$aCaliciviruses$5IEN-M$0(DLC)sh 99004704

=LDR  00910cz  a2200217n  4500
=001  9880363182902441
=005  20141212195507.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002138
=035  \\$aCAZ5304HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x140
=072  \\$aE5.$x978.$x155
=150  \\$aCalibration
=450  \\$wnnna$aCalibrations
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aWeights and Measures
=667  \\$aNIM; coord with specific scale (IM) if relevant
=680  \\$iDetermination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output.
=688  \\$a91(78); was see under WEIGHTS AND MEASURES 1978-90
=750  \0$aCalibration$5IEN$0(DLC)sh 85018860

=LDR  00988cz  a2200253n  4500
=001  9880363183002441
=005  20141212195506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002137
=035  \\$aCAZ5303HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x300.$x175
=150  \\$aCalculi
=450  \\$wnnna$aBiliary or Urinary Stones
=450  \\$wnnna$aCalculus
=550  \\$wg$aPathological Conditions, Anatomical
=550  \\$wh$aDental Calculus
=550  \\$wh$aGallstones
=550  \\$wh$aSalivary Calculi
=550  \\$wh$aUrinary Calculi
=550  \\$aLithiasis
=667  \\$aGEN or unspecified: prefer specifics; coord IM with organ/diseases term (IM); chem composition of calculi: use /chem; /ultrastruct permitted; chemolysis of calculi: coord dis with /ther, not /drug ther
=680  \\$iAn abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
=750  \0$aCalculi$5IEN$0(DLC)sh 85018800

=LDR  00785cz  a2200181n  4500
=001  9880363183102441
=005  20141212195506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002136
=035  \\$aCAZ5302HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x315
=150  \\$aCalcium, Dietary
=450  \\$aDietary Calcium
=550  \\$wg$aCalcium Compounds
=667  \\$a/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther
=680  \\$iCalcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.
=750  \0$aCalcium in human nutrition$5IEN-M$0(DLC)sh 91004650

=LDR  01297cz  a2200385n  4500
=001  9880363183202441
=005  20190107100348.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002135
=035  \\$aCAZ5301HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x125
=150  \\$aCalcium-Binding Proteins
=450  \\$wnnna$aBinding Proteins, Calcium
=450  \\$wnnna$aCalcium Binding Proteins
=550  \\$wg$aCarrier Proteins
=550  \\$wh$aAnnexins
=550  \\$wh$aCalbindins
=550  \\$wh$aSerrate-Jagged Proteins
=550  \\$wh$aCalsequestrin
=550  \\$wh$aFetuins
=550  \\$wh$aIntracellular Calcium-Sensing Proteins
=550  \\$wh$aMyosin Light Chains
=550  \\$wh$aOsteocalcin
=550  \\$wh$aOsteonectin
=550  \\$wh$aS100 Proteins
=550  \\$wh$aSecretagogins
=550  \\$wh$aSerrate-Jagged Proteins
=550  \\$wh$aStromal Interaction Molecules
=550  \\$wh$aSynaptotagmins
=550  \\$wh$aTroponin C
=667  \\$aRECEPTORS, CALCIUM-SENSING is also available
=680  \\$iProteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.
=688  \\$a80
=750  \0$aCalcium-binding proteins$5IEN$0(DLC)sh 85018777

=LDR  02010cz  a2200529n  4500
=001  9880363183302441
=005  20141212195505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002133
=035  \\$aCAZ5299HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x375
=072  \\$aD1.$x578.$x215
=072  \\$aD1.$x875.$x800.$x800.$x850.$x125
=150  \\$aCalcium Sulfate
=450  \\$wnnna$aAlabaster
=450  \\$wnnna$aAnhydrous Calcium Sulfate
=450  \\$wnnna$aAnhydrous Sulfate of Lime
=450  \\$wnnna$aArtificial Dental Stone
=450  \\$wnnna$aCalcium Sulfate (1:1), Dihydrate
=450  \\$wnnna$aCalcium Sulfate (1:1), Hemihydrate
=450  \\$wnnna$aCalcium Sulfate (2:1)
=450  \\$wnnna$aCalcium Sulfate, Anhydrous
=450  \\$wnnna$aCalcium Sulfate, Dihydrate
=450  \\$wnnna$aCalcium Sulfate, Hemihydrate
=450  \\$wnnna$aCalcium Sulphate
=450  \\$aDental Gypsum
=450  \\$aDental Stone, Artificial
=450  \\$wnnna$aDihydrate Calcium Sulfate
=450  \\$wnnna$aDrierite
=450  \\$wnnna$aGypsite
=450  \\$aGypsum
=450  \\$wnnna$aGypsum, Dental
=450  \\$wnnna$aHemihydrate Calcium Sulfate
=450  \\$wnnna$aKarstenite
=450  \\$wnnna$aLime Anhydrous Sulfate
=450  \\$wnnna$aParis Plaster
=450  \\$aPlaster of Paris
=450  \\$wnnna$aStone, Artificial Dental
=450  \\$wnnna$aSulfate, Calcium
=450  \\$wnnna$aSulphate, Calcium
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aMinerals
=550  \\$wg$aSulfates
=680  \\$iA calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum.
=688  \\$a80; PLASTER OF PARIS was heading 1963-79
=750  \0$aCalcium sulfate$5IEN$0(DLC)sh 85018793

=LDR  00886cz  a2200265n  4500
=001  9880363183402441
=005  20141212195504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002130
=035  \\$aCAZ5296HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374.$x75
=072  \\$aD1.$x146.$x360
=072  \\$aD1.$x695.$x625.$x675.$x650.$x75
=150  \\$aCalcium Phosphates
=450  \\$aCalcium Phosphate$5IEN
=450  \\$wnnna$aPhosphates, Calcium
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aPhosphates
=550  \\$wh$aApatites
=550  \\$wh$aCalcium Pyrophosphate
=667  \\$aGEN or unspecified; prefer specifics; often used as calcium supplement
=680  \\$iCalcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.
=688  \\$a65(64)
=750  \0$aCalcium phosphate$5IEN$0(DLC)sh 85018790

=LDR  01057cz  a2200301n  4500
=001  9880363183502441
=005  20141212195504.0
=008  771209\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002129
=035  \\$aCAZ5295HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x337.$x593.$x750.$x500
=150  \\$aCalcium Oxalate
=450  \\$wnnna$aCalcium Oxalate (1:1)
=450  \\$wnnna$aCalcium Oxalate Dihydrate
=450  \\$wnnna$aCalcium Oxalate Dihydrate (1:1)
=450  \\$wnnna$aCalcium Oxalate Monohydrate
=450  \\$wnnna$aCalcium Oxalate Monohydrate (1:1)
=450  \\$wnnna$aCalcium Oxalate Trihydrate
=450  \\$wnnna$aDihydrate, Calcium Oxalate
=450  \\$wnnna$aMonohydrate, Calcium Oxalate
=450  \\$wnnna$aOxalate, Calcium
=450  \\$wnnna$aTrihydrate, Calcium Oxalate
=550  \\$wg$aOxalic Acid
=667  \\$aOXALATES is also available
=680  \\$iThe calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi.
=688  \\$a79
=750  \0$aCalcium oxalate$5IEN$0(DLC)sh 85018789

=LDR  00973cz  a2200277n  4500
=001  9880363183602441
=005  20141212195503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002128
=035  \\$aCAZ5294HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x174
=150  \\$aCalcium Metabolism Disorders
=450  \\$wnnna$aCalcium Metabolism Disorder
=450  \\$wnnna$aDisorder, Calcium Metabolism
=450  \\$wnnna$aDisorders, Calcium Metabolism
=550  \\$wg$aMetabolic Diseases
=550  \\$wh$aCalcinosis
=550  \\$wh$aDecalcification, Pathologic
=550  \\$wh$aHypercalcemia
=550  \\$wh$aHypocalcemia
=550  \\$wh$aPseudohypoparathyroidism
=550  \\$wh$aRickets
=667  \\$aGEN or unspecified; prefer specifics; DF: CALCIUM METAB DIS
=680  \\$iDisorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.
=750  \0$aCalcium$xMetabolism$xDisorders$5IEN$0(DLC)sh 85018773

=LDR  00691cz  a2200205n  4500
=001  9880363183702441
=005  20141212195503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002127
=035  \\$aCAZ5293HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x98
=150  \\$aCalcium Isotopes
=450  \\$wnnna$aIsotopes, Calcium
=550  \\$wg$aIsotopes
=550  \\$wh$aCalcium Radioisotopes
=550  \\$aCalcium
=667  \\$aCa-42-44, 46, 48; NIM
=680  \\$iStable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. Ca-42-44, 46, and 48 are stable calcium isotopes.
=750  \0$aCalcium$xIsotopes$5IEN-M$0(DLC)sh 85018770

=LDR  00741cz  a2200229n  4500
=001  9880363183802441
=005  20141212195503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002126
=035  \\$aCAZ5292HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x335
=072  \\$aD1.$x455.$x275
=150  \\$aCalcium Hydroxide
=450  \\$wnnna$aHydroxide, Calcium
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aHydroxides
=550  \\$aDental Cavity Lining
=550  \\$aDental Pulp Capping
=680  \\$iA white powder prepared from lime that has many medical and industrial uses. It is in many dental formulations, especially for root canal filling.
=688  \\$a67
=750  \0$aCalcium hydroxide$5IEN$0(DLC)sh 90004203

=LDR  00813cz  a2200205n  4500
=001  9880363183902441
=005  20141212195502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002124
=035  \\$aCAZ5290HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x325
=072  \\$aD1.$x303.$x350.$x300.$x150
=150  \\$aCalcium Fluoride
=450  \\$wnnna$aFluoride, Calcium
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aFluorides
=680  \\$iCalcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. (From Merck Index, 11th ed)
=688  \\$a65
=750  \0$aCalcium fluoride$5IEN-M$0(DLC)sh2001000599

=LDR  00844cz  a2200253n  4500
=001  9880363184002441
=005  20141212195501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002122
=035  \\$aCAZ5288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x300
=072  \\$aD1.$x210.$x450.$x150.$x150
=150  \\$aCalcium Chloride
=450  \\$wnnna$aCalcium Chloride, Anhydrous
=450  \\$wnnna$aCalcium Chloride Dihydrate
=450  \\$wnnna$aChloride, Calcium
=450  \\$wnnna$aChloride Dihydrate, Calcium
=450  \\$wnnna$aDihydrate, Calcium Chloride
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aChlorides
=680  \\$iA salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.
=688  \\$a65
=750  \0$aCalcium chloride$5IEN$0(DLC)sh 85018781

=LDR  02561cz  a2200517n  4500
=001  9880363184102441
=005  20200717131511.0
=008  880512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015220
=035  \\$aCAZ5287HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x157.$x530.$x400.$x150
=072  \\$aD12.$x776.$x543.$x550.$x450.$x150
=072  \\$aD12.$x776.$x543.$x585.$x400.$x150
=150  \\$aCalcium Channels
=450  \\$wnnna$aCalcium Channel
=450  \\$wnnna$aCalcium Channel Antagonist Receptor
=450  \\$wnnna$aCalcium Channel Antagonist Receptors
=450  \\$wnnna$aCalcium Channel Blocker Receptor
=450  \\$wnnna$aCalcium Channel Blocker Receptors
=450  \\$wnnna$aCalcium Channels, Voltage-Dependent
=450  \\$wnnna$aCalcium Ion Channel
=450  \\$wnnna$aCalcium Ion Channels
=450  \\$wnnna$aChannels, Voltage-Dependent Calcium
=450  \\$wnnna$aIon Channel, Calcium
=450  \\$aIon Channels, Calcium
=450  \\$wnnna$aReceptors, Calcium Channel Antagonist
=450  \\$aReceptors, Calcium Channel Blocker
=450  \\$wnnna$aVDCC
=450  \\$wnnna$aVoltage-Dependent Calcium Channels
=450  \\$wnnna$aVoltage Dependent Calcium Channels
=550  \\$wg$aIon Channels
=550  \\$wh$aCalcium Channels, L-Type
=550  \\$wh$aCalcium Channels, N-Type
=550  \\$wh$aCalcium Channels, T-Type
=550  \\$wh$aCalcium Release Activated Calcium Channels
=550  \\$wh$aInositol 1,4,5-Trisphosphate Receptors
=550  \\$wh$aRyanodine Receptor Calcium Release Channel
=550  \\$wh$aTRPC6 Cation Channel
=550  \\$wh$aTRPP Cation Channels
=550  \\$aCalcium Signaling
=550  \\$aCalcium-Transporting ATPases
=667  \\$aL-, N-, P-, Q-, R-, & T-Type CALCIUM CHANNELS are available; DF: CA CHANNELS
=680  \\$iVoltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue.
=688  \\$a89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 (was CALCIUM CHANNEL BLOCKER RECEPTOR (NM) 1983-92); CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS & RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993
=750  \0$aCalcium channels$5IEN$0(DLC)sh 87001232

=LDR  01549cz  a2200397n  4500
=001  9880363184202441
=005  20141212192037.0
=008  810512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002121
=035  \\$aCAZ5286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x562.$x249
=072  \\$aD27.$x505.$x954.$x411.$x192
=150  \\$aCalcium Channel Blockers
=450  \\$wnnna$aAntagonists, Calcium Channel
=450  \\$wnnna$aAntagonists, Exogenous Calcium
=450  \\$wnnna$aBlockers, Calcium Channel
=450  \\$aCalcium Antagonists, Exogenous
=450  \\$aCalcium Blockaders, Exogenous
=450  \\$aCalcium Channel Agonists$xantagonists & inhibitors
=450  \\$wnnna$aCalcium Channel Antagonists
=450  \\$wnnna$aCalcium Channel Blocking Drugs
=450  \\$aCalcium Channels$xantagonists & inhibitors
=450  \\$aCalcium Inhibitors, Exogenous
=450  \\$aChannel Blockers, Calcium
=450  \\$wnnna$aExogenous Calcium Antagonists
=450  \\$wnnna$aExogenous Calcium Blockaders
=450  \\$wnnna$aExogenous Calcium Inhibitors
=450  \\$aRyanodine Receptor Calcium Release Channel$xantagonists & inhibitors
=550  \\$wg$aCardiovascular Agents
=550  \\$wg$aMembrane Transport Modulators
=550  \\$aAnti-Arrhythmia Agents
=550  \\$aCalcium Channels
=680  \\$iA class of drugs that act by selective inhibition of calcium influx through cellular membranes.
=688  \\$a83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982
=750  \0$aCalcium$xAntagonists$5IEN$0(DLC)sh 85018769

=LDR  01182cz  a2200349n  4500
=001  9880363184302441
=005  20141212195500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002119
=035  \\$aCAZ5284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x146.$x275
=072  \\$aD1.$x200.$x275.$x150.$x150
=072  \\$aD1.$x578.$x200
=150  \\$aCalcium Carbonate
=450  \\$wnnna$aAragonite
=450  \\$wnnna$aCalcite
=450  \\$wnnna$aCalcium Milk
=450  \\$wnnna$aCarbonate, Calcium
=450  \\$wnnna$aChalk
=450  \\$wnnna$aLimestone
=450  \\$wnnna$aMarble
=450  \\$wnnna$aMilk of Calcium
=450  \\$wnnna$aVaterite
=550  \\$wg$aCalcium Compounds
=550  \\$wg$aCarbonates
=550  \\$wg$aMinerals
=550  \\$wh$aNacre
=667  \\$aoccurs in nature as chalk, limestone or marble; used in med as a buffer in hemodialysis
=680  \\$iCarbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
=688  \\$a65
=750  \0$aCalcium carbonate$5IEN-HS$0(DLC)sh 85018780

=LDR  00740cz  a2200193n  4500
=001  9880364560402441
=005  20141212221801.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056899
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x625
=150  \\$aOxymonadida
=450  \\$wnnna$aOxymonad
=450  \\$wnnna$aOxymonads
=550  \\$wg$aEukaryota
=667  \\$ainfection; coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iAn order of EUKARYOTES found in the gut of termites and other insects that live on LIGNIN. MITOCHONDRIA and GOLGI APPARATUS are absent from oxymonads.
=688  \\$a2010
=750  \0$aOxymonadida$0(DLC) sh 88021393$5IEN-M

=LDR  00939cz  a2200241n  4500
=001  9880364560502441
=005  20150527105521.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056897
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x175
=150  \\$aChoanoflagellata
=450  \\$wnnna$aChoanoflagellate
=450  \\$wnnna$aChoanoflagellates
=450  \\$wnnna$aChoanoflagellida
=450  \\$wnnna$aChoanoflagellidas
=450  \\$wnnna$aChoanozoa
=450  \\$wnnna$aChoanozoas
=550  \\$wg$aEukaryota
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
=680  \\$iAn order of stalked, sessile, single-celled EUKARYOTES. They are considered the transitional link between the flagellated protozoa and the SPONGES, the most primitive metazoans.
=688  \\$a2010
=750  \0$aChoanoflagellates$0(DLC)sh2014001692$5IEN-M

=LDR  00308cz  a2200109n  4500
=001  9880364560602441
=005  20130401105618.0
=008  090706\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=035  \\$a(DNLM)D056890Q000472
=040  \\$aDNLM$cDNLM
=150  \\$aEukaryota$xpathogenicity
=750  \0$aEukaryota$xpathogenicity$0(DLC)sh 85107820$5IEN-M

=LDR  00906cz  a2200265n  4500
=001  9880364560702441
=005  20141212221757.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056888
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x670
=072  \\$aN2.$x421.$x585.$x700
=150  \\$aPatient Positioning
=450  \\$wnnna$aPatient Positionings
=450  \\$wnnna$aPositioning, Patient
=450  \\$wnnna$aPositionings, Patient
=550  \\$wg$aPatient Care
=550  \\$wh$aKangaroo-Mother Care Method
=550  \\$aMoving and Lifting Patients
=550  \\$aPosture
=550  \\$aRadiotherapy, Image-Guided
=667  \\$ado not confuse with MOVING AND LIFTING PATIENTS
=680  \\$iMoving a patient into a specific position or POSTURE to facilitate examination, surgery, or for therapeutic purposes.
=688  \\$a2010
=750  \0$aPatients$xPositioning$0(DLC) sh 85122270$5IEN-M

=LDR  01017cz  a2200241n  4500
=001  9880364560802441
=005  20141212221753.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056831
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x234
=072  \\$aD2.$x256
=072  \\$aD2.$x691.$x214
=150  \\$aCoordination Complexes
=450  \\$wnnna$aComplexes, Coordination
=450  \\$wnnna$aComplexes, Metal
=450  \\$wnnna$aMetal Complexes
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganic Chemicals
=550  \\$wg$aOrganometallic Compounds
=680  \\$iNeutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged.
=688  \\$a2010
=750  \0$aMetal complexes$0(DLC) sh 88005204$5IEN-M

=LDR  01031cz  a2200217n  4500
=001  9880364560902441
=005  20141212221749.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056810
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x723.$x70
=150  \\$aAcaricides
=450  \\$wnnna$aAgent, Mite Control
=450  \\$wnnna$aControl Agent, Mite
=450  \\$wnnna$aMite Control Agent
=450  \\$wnnna$aMiticide
=550  \\$wg$aPesticides
=667  \\$aFor use to kill or control mites and ticks, use no qualifiers on the acaricide or the mite or tick; appropriate qualifiers may be used when other aspects of the acaricide are discussed, such as the effect on a physiologic process or behavioral aspect of the mite or tick.
=680  \\$iA pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators.
=688  \\$a2010
=750  \0$aAcaricides$0(DLC) sh 85000332$5IEN-M

=LDR  00964cz  a2200289n  4500
=001  9880364561002441
=005  20141212221746.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056804
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x147
=072  \\$aN6.$x230.$x132.$x644.$x124
=150  \\$aBiofuels
=450  \\$wnnna$aBiodiesel
=450  \\$wnnna$aBiodiesels
=450  \\$wnnna$aBiofuel
=450  \\$wnnna$aBiofuel Oil
=450  \\$wnnna$aBiofuel Oils
=450  \\$wnnna$aBiogas
=450  \\$wnnna$aOil, Biofuel
=450  \\$wnnna$aOils, Biofuel
=550  \\$wg$aComplex Mixtures
=550  \\$wg$aRenewable Energy
=667  \\$ado not confuse with BIOFUEL CELLS see BIOELECTRIC ENERGY SOURCES
=680  \\$iHydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).
=688  \\$a2010
=750  \0$aBiomass energy$0(DLC) sh 85014231$5IEN-M

=LDR  01326cz  a2200349n  4500
=001  9880364561102441
=005  20141212221745.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056785
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x488.$x585.$x850
=072  \\$aI1.$x76.$x201.$x450.$x654.$x558.$x750
=150  \\$aMedicine, Mongolian Traditional
=450  \\$wnnna$aFolk Medicine, Mongolian
=450  \\$wnnna$aFolk Medicines, Mongolian
=450  \\$wnnna$aMedicine, Mongolian
=450  \\$wnnna$aMedicine, Mongolian Folk
=450  \\$wnnna$aMedicines, Mongolian
=450  \\$wnnna$aMedicines, Mongolian Folk
=450  \\$wnnna$aMedicines, Mongolian Traditional
=450  \\$wnnna$aMongolian Folk Medicine
=450  \\$wnnna$aMongolian Folk Medicines
=450  \\$wnnna$aMongolian Medicine
=450  \\$wnnna$aMongolian Medicines
=450  \\$wnnna$aMongolian Traditional Medicine
=450  \\$wnnna$aMongolian Traditional Medicines
=450  \\$wnnna$aTraditional Medicine, Mongolian
=450  \\$wnnna$aTraditional Medicines, Mongolian
=550  \\$wg$aMedicine, East Asian Traditional
=680  \\$iMedical practice indigenous to the peoples of Mongolia, developed over many years according to their culture, beliefs, and traditions.
=688  \\$a2010
=750  \0$aMedicine, Mongolian

=LDR  01143cz  a2200361n  4500
=001  9880364561202441
=005  20141212221744.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056771
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x249.$x500.$x249.$x249
=150  \\$aOvule
=450  \\$wnnna$aFemale Gamete, Plant
=450  \\$wnnna$aFemale Gametes, Plant
=450  \\$wnnna$aFemale Gametophyte
=450  \\$wnnna$aFemale Gametophytes
=450  \\$wnnna$aGamete, Plant Female
=450  \\$wnnna$aGametes, Plant Female
=450  \\$wnnna$aGametophyte, Female
=450  \\$wnnna$aGametophytes, Female
=450  \\$wnnna$aMegagametophyte
=450  \\$wnnna$aMegagametophytes
=450  \\$wnnna$aMegaspore, Plant
=450  \\$wnnna$aMegaspores, Plant
=450  \\$wnnna$aOvules
=450  \\$wnnna$aPlant Female Gamete
=450  \\$wnnna$aPlant Female Gametes
=450  \\$wnnna$aPlant Megaspore
=450  \\$wnnna$aPlant Megaspores
=550  \\$wg$aGerm Cells, Plant
=680  \\$iThe element in plants that contains the female GAMETOPHYTES.
=688  \\$a2010
=750  \0$aOvules$0(DLC) sh 85096270$5IEN-M

=LDR  01134cz  a2200277n  4500
=001  9880364561302441
=005  20170609105258.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056747
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x465
=072  \\$aG12.$x535
=150  \\$aImmunomodulation
=450  \\$wnnna$aImmunomodulations
=450  \\$wnnna$aImmunomodulatory Therapies
=450  \\$wnnna$aImmunomodulatory Therapy
=450  \\$wnnna$aTherapies, Immunomodulatory
=450  \\$wnnna$aTherapy, Immunomodulatory
=550  \\$wg$aBiological Therapy
=550  \\$wg$aImmune System Phenomena
=550  \\$wh$aImmune Tolerance
=550  \\$wh$aImmunotherapy
=550  \\$wh$aNeuroimmunomodulation
=680  \\$iAlteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.
=688  \\$a2010
=750  \0$aImmune response$xRegulation$0(DLC) sh 85064538$5IEN-M

=LDR  00913cz  a2200265n  4500
=001  9880364561402441
=005  20141212221734.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056727
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x50.$x565
=072  \\$aG16.$x500.$x275.$x157.$x49.$x250
=072  \\$aJ1.$x256.$x214
=072  \\$aN6.$x230.$x80.$x200
=072  \\$aN6.$x230.$x124.$x49.$x250
=150  \\$aEndangered Species
=450  \\$wnnna$aSpecies, Endangered
=450  \\$wnnna$aSpecies, Threatened
=450  \\$aThreatened Species
=550  \\$wg$aAnimal Population Groups
=550  \\$wg$aBiodiversity
=550  \\$wg$aConservation of Natural Resources
=680  \\$iAn animal or plant species in danger of extinction. Causes can include human activity, changing climate, or change in predator/prey ratios.
=688  \\$a2010
=750  \0$aEndangered species$0(DLC) sh 85043044$5IEN-M

=LDR  00529cz  a2200169n  4500
=001  9880364561502441
=005  20141212221732.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056705
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x46
=150  \\$aApitherapy
=450  \\$wnnna$aApitherapies
=550  \\$wg$aTherapeutics
=680  \\$iThe medical use of honey bee products such as BEE VENOM; HONEY; bee pollen; PROPOLIS; and royal jelly.
=688  \\$a2010
=750  \0$aBee products$xTherapeutic use$0(DLC)sh2007006380$5IEN-M

=LDR  00879cz  a2200253n  4500
=001  9880364561602441
=005  20141212221730.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056692
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x718.$x622
=072  \\$aJ2.$x500.$x400.$x500
=072  \\$aJ2.$x500.$x456.$x249
=072  \\$aJ2.$x500.$x525.$x400.$x500
=150  \\$aPrebiotics
=450  \\$wnnna$aPrebiotic
=550  \\$wg$aDietary Fiber
=550  \\$wg$aDietary Supplements
=550  \\$wg$aFood, Fortified
=550  \\$wg$aPolysaccharides, Bacterial
=667  \\$aDo not confuse with PROBIOTICS
=680  \\$iNon-digestible food ingredients mostly of a carbohydrate base that improve human health by selectively stimulating the growth and/or activity of existing bacteria in the colon.
=688  \\$a2010
=750  \0$aPrebiotics$0(DLC)sh2007006574$5IEN-M

=LDR  01675cz  a2200373n  4500
=001  9880364561702441
=005  20141212221727.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056667
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x225.$x500
=072  \\$aL1.$x725.$x249
=072  \\$aN4.$x452.$x910.$x99
=150  \\$aBiometric Identification
=450  \\$wnnna$aAuthentication, Biometric
=450  \\$wnnna$aAuthentications, Biometric
=450  \\$wnnna$aAutomated Facial Recognition
=450  \\$wnnna$aAutomated Facial Recognitions
=450  \\$wnnna$aBiometric Authentication
=450  \\$wnnna$aBiometric Authentications
=450  \\$wnnna$aBiometric Identifications
=450  \\$wnnna$aFacial Recognition, Automated
=450  \\$wnnna$aFacial Recognitions, Automated
=450  \\$wnnna$aIdentification, Biometric
=450  \\$wnnna$aIdentifications, Biometric
=450  \\$wnnna$aRecognition, Automated Facial
=450  \\$wnnna$aRecognitions, Automated Facial
=550  \\$wg$aBiometry
=550  \\$wg$aPattern Recognition, Automated
=550  \\$wg$aSecurity Measures
=550  \\$wh$aDNA Fingerprinting
=680  \\$iA method of differentiating individuals based on the analysis of qualitative or quantitative biological traits or patterns. This process which has applications in forensics and identity theft prevention includes DNA profiles or DNA fingerprints, hand fingerprints, automated facial recognition, iris scan, hand geometry, retinal scan, vascular patterns, automated voice pattern recognition, and ultrasound of fingers.
=688  \\$a2010
=750  \0$aBiometric identification$0(DLC)sh2001010964$5IEN-M

=LDR  00889cz  a2200241n  4500
=001  9880364561802441
=005  20141212221727.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056666
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x833.$x525
=150  \\$aMastodons
=450  \\$wnnna$aAmerican Mastodon
=450  \\$wnnna$aAmerican Mastodons
=450  \\$wnnna$aMammut
=450  \\$wnnna$aMammut americanum
=450  \\$wnnna$aMastodon
=450  \\$wnnna$aMastodon, American
=450  \\$wnnna$aMastodons, American
=550  \\$wg$aProboscidea Mammal
=680  \\$iAn extinct genus of large mammals in the family Mammutidae, that fed by browsing on tall plants. Eurasian species died out three million years ago, but some specimens of the American Mastodon survived the last Ice Age.
=688  \\$a2010
=750  \0$aMastodons$0(DLC) sh 85082008$5IEN-M

=LDR  00802cz  a2200241n  4500
=001  9880364561902441
=005  20141212221727.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056665
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x833.$x500
=150  \\$aMammoths
=450  \\$wnnna$aMammoth
=450  \\$wnnna$aMammoth, Woolly
=450  \\$wnnna$aMammoths, Woolly
=450  \\$wnnna$aMammuthus
=450  \\$wnnna$aMammuthus primigenius
=450  \\$aWoolly Mammoth
=450  \\$wnnna$aWoolly Mammoths
=550  \\$wg$aProboscidea Mammal
=680  \\$iAn extinct genus of large mammals in the family Elephantidae that fed by grazing on low vegetation. Most died out at the end of the last ice age.
=688  \\$a2010
=750  \0$aMammoths$0(DLC) sh 85080280$5IEN-M

=LDR  00927cz  a2200241n  4500
=001  9880364562002441
=005  20141212221726.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056662
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x833
=150  \\$aProboscidea Mammal
=450  \\$wnnna$aMammal, Proboscidea
=450  \\$wnnna$aMammals, Proboscidea
=450  \\$wnnna$aProboscidea Mammals
=550  \\$wg$aMammals
=550  \\$wh$aElephants
=550  \\$wh$aMammoths
=550  \\$wh$aMastodons
=667  \\$ado not confuse the order Proboscidea with the Proboscidea plant genus (PEDALIACEAE).
=680  \\$iAn order of MAMMALS that feeds using their trunks. It contains one family, the Elephantidae, comprised of two living genera of ELEPHANTS plus the extinct MAMMOTHS and MASTODONS.
=688  \\$a2010; use ELEPHANTS 2003-2009
=750  \0$aProboscidea (Mammals)$0(DLC) sh 85107115$5IEN-M

=LDR  01298cz  a2200265n  4500
=001  9880364562102441
=005  20141212221723.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056650
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x944.$x951
=150  \\$aVulvodynia
=450  \\$aGeneralized Vulvodynia
=450  \\$wnnna$aGeneralized Vulvodynias
=450  \\$aVestibulodynia
=450  \\$wnnna$aVestibulodynias
=450  \\$wnnna$aVulvodynia, Generalized
=450  \\$wnnna$aVulvodynias
=450  \\$wnnna$aVulvodynias, Generalized
=550  \\$wg$aVulvar Diseases
=550  \\$aVulvar Vestibulitis
=667  \\$ado not confuse with VULVAR VESTIBULITIS
=680  \\$iComplex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.
=688  \\$a2010; for Vestibulodynia, use VULVAR VESTIBULITIS SYNDROME 2008-2009
=750  \0$aVulvodynia$0(DLC)sh2004000507$5IEN-M

=LDR  00462cz  a2200169n  4500
=001  9880364562202441
=005  20141212221721.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x207
=150  \\$aBeekeeping
=450  \\$aApiculture
=550  \\$wg$aAgriculture
=680  \\$iThe management and maintenance of colonies of honeybees.
=688  \\$a2010
=750  \0$aBee culture$0(DLC) sh 85012792$5IEN-M

=LDR  00888cz  a2200289n  4500
=001  9880364562302441
=005  20141212221720.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056626
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x249.$x500.$x624
=150  \\$aInflorescence
=450  \\$wnnna$aFlower Head
=450  \\$wnnna$aFlower Heads
=450  \\$wnnna$aHead, Flower
=450  \\$wnnna$aHeads, Flower
=450  \\$wnnna$aInflorescence Type
=450  \\$wnnna$aInflorescence Types
=450  \\$wnnna$aInflorescences
=450  \\$wnnna$aTassel
=450  \\$wnnna$aTassels
=450  \\$wnnna$aType, Inflorescence
=450  \\$wnnna$aTypes, Inflorescence
=550  \\$wg$aFlowers
=680  \\$iA cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.
=688  \\$a2010
=750  \0$aInflorescences$0(DLC) sh 85066121$5IEN-M

=LDR  00785cz  a2200169n  4500
=001  9880364562402441
=005  20141212221720.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056625
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x500.$x750.$x666
=150  \\$aEndosperm
=450  \\$wnnna$aEndosperms
=550  \\$wg$aSeeds
=680  \\$iNutritive tissue of the seeds of flowering plants that surrounds the EMBRYOS. It is produced by a parallel process of fertilization in which a second male gamete from the pollen grain fuses with two female nuclei within the embryo sac. The endosperm varies in ploidy and contains reserves of starch, oils, and proteins, making it an important source of human nutrition.
=688  \\$a2010
=750  \0$aEndosperm$0(DLC)sh2007009535$5IEN-M

=LDR  00710cz  a2200193n  4500
=001  9880364562502441
=005  20141212221719.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x784.$x500.$x400
=072  \\$aD26.$x667.$x500
=150  \\$aGrape Seed Extract
=450  \\$wnnna$aExtract, Grape Seed
=450  \\$wnnna$aSeed Extract, Grape
=550  \\$wg$aPlant Extracts
=680  \\$iExudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (BIOFLAVONOIDS and polyphenols) credited with important medicinal properties.
=688  \\$a2010 (2001)
=750  \0$aGrape seed oil$0(DLC)sh2009008246$5IEN-M

=LDR  01011cz  a2200253n  4500
=001  9880364562602441
=005  20141212221717.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056572
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x360
=150  \\$aHistone Deacetylase Inhibitors
=450  \\$wnnna$aDeacetylase Inhibitor, Histone
=450  \\$wnnna$aDeacetylase Inhibitors, Histone
=450  \\$wnnna$aHDAC Inhibitors
=450  \\$wnnna$aHistone Deacetylase Inhibitor
=450  \\$aHistone Deacetylases$xantagonists & inhibitors
=450  \\$wnnna$aInhibitor, Histone Deacetylase
=450  \\$wnnna$aInhibitors, HDAC
=450  \\$wnnna$aInhibitors, Histone Deacetylase
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains.
=688  \\$a2010
=750  \0$aHistone deacetylase inhibitors$0(IEN)9129016$5IEN-M

=LDR  02887cz  a2200685n  4500
=001  9880364562702441
=005  20180102145948.0
=008  090706\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D056486
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x552.$x195
=072  \\$aC25.$x100.$x562
=072  \\$aC25.$x723.$x260
=150  \\$aChemical and Drug Induced Liver Injury
=450  \\$wnnna$aAcute Liver Injury, Drug-Induced
=450  \\$wnnna$aAcute Liver Injury, Drug Induced
=450  \\$wnnna$aChemically-Induced Liver Toxicities
=450  \\$wnnna$aChemically Induced Liver Toxicities
=450  \\$wnnna$aChemically-Induced Liver Toxicity
=450  \\$wnnna$aChemically Induced Liver Toxicity
=450  \\$wnnna$aDisease, Drug-Induced Liver
=450  \\$wnnna$aDiseases, Drug-Induced Liver
=450  \\$wnnna$aDrug-Induced Acute Liver Injury
=450  \\$wnnna$aDrug Induced Acute Liver Injury
=450  \\$wnnna$aDrug-Induced Hepatitides
=450  \\$wnnna$aDrug-Induced Hepatitis
=450  \\$wnnna$aDrug-Induced Liver Disease
=450  \\$wnnna$aDrug Induced Liver Disease
=450  \\$wnnna$aDrug-Induced Liver Diseases
=450  \\$wnno$aDrug-Induced Liver Injury
=450  \\$wnnna$aDrug-Induced Liver Injuries
=450  \\$wnnna$aDrug Induced Liver Injury
=450  \\$wnnna$aHepatitides, Drug-Induced
=450  \\$wnnna$aHepatitides, Toxic
=450  \\$wnnna$aHepatitis, Drug-Induced
=450  \\$wnnna$aHepatitis, Drug Induced
=450  \\$wnnna$aHepatitis, Toxic
=450  \\$wnnna$aInjuries, Drug-Induced Liver
=450  \\$wnnna$aInjury, Drug-Induced Liver
=450  \\$wnnna$aLiver Disease, Drug-Induced
=450  \\$aLiver Diseases$xchemically induced
=450  \\$wnnna$aLiver Diseases, Drug-Induced
=450  \\$wnnna$aLiver Injuries, Drug-Induced
=450  \\$aLiver Injury, Drug-Induced
=450  \\$wnnna$aLiver Injury, Drug Induced
=450  \\$wnnna$aLiver Injury, Drug-Induced, Acute
=450  \\$wnnna$aLiver Toxicities, Chemically-Induced
=450  \\$wnnna$aLiver Toxicity, Chemically-Induced
=450  \\$wnnna$aToxic Hepatitides
=450  \\$wnnna$aToxic Hepatitis
=450  \\$wnnna$aToxicities, Chemically-Induced Liver
=450  \\$wnnna$aToxicity, Chemically-Induced Liver
=550  \\$wg$aDrug-Related Side Effects and Adverse Reactions
=550  \\$wg$aLiver Diseases
=550  \\$wg$aPoisoning
=550  \\$wh$aDrug-Induced Liver Injury, Chronic
=667  \\$acoordinate IM with specific drug /adv eff/pois or /tox (IM); DRUG-INDUCED LIVER INJURY, CHRONIC is also available
=680  \\$iA spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, heerbal and dietary supplements and chemicals from the environment.
=688  \\$a2017 (2010)
=750  \0$aToxic hepatitis$0(DLC) sh 85136323$5IEN-M

=LDR  02551cz  a2200577n  4500
=001  9880364562802441
=005  20141212221110.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054023
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490.$x480
=072  \\$aE7.$x710.$x520.$x480
=150  \\$aLasers, Semiconductor
=450  \\$wnnna$aArsenide Laser, Gallium
=450  \\$wnnna$aArsenide Lasers, Gallium
=450  \\$wnnna$aDiode Laser
=450  \\$wnnna$aDiode Laser, Semiconductor
=450  \\$aDiode Lasers
=450  \\$wnnna$aDiode Lasers, Semiconductor
=450  \\$wnnna$aGaAlAs Laser
=450  \\$wnnna$aGaAlAs Lasers
=450  \\$wnnna$aGaAs Laser
=450  \\$wnnna$aGaAs Lasers
=450  \\$aGallium Aluminum Arsenide Lasers
=450  \\$wnnna$aGallium Arsenide Laser
=450  \\$aGallium Arsenide Lasers
=450  \\$wnnna$aLaser, Diode
=450  \\$wnnna$aLaser, GaAlAs
=450  \\$wnnna$aLaser, GaAs
=450  \\$wnnna$aLaser, Gallium Arsenide
=450  \\$wnnna$aLaser, Quantum Cascade
=450  \\$wnnna$aLaser, Semiconductor
=450  \\$wnnna$aLaser, Semiconductor Diode
=450  \\$wnnna$aLasers, Diode
=450  \\$wnnna$aLasers, GaAlAs
=450  \\$wnnna$aLasers, GaAs
=450  \\$wnnna$aLasers, Gallium Aluminum Arsenide
=450  \\$wnnna$aLasers, Gallium Arsenide
=450  \\$wnnna$aLasers, Quantum Cascade
=450  \\$wnnna$aLasers, Semiconductor Diode
=450  \\$wnnna$aQuantum Cascade Laser
=450  \\$wnnna$aQuantum Cascade Lasers
=450  \\$wnnna$aSemiconductor Diode Laser
=450  \\$wnnna$aSemiconductor Diode Lasers
=450  \\$wnnna$aSemiconductor Laser
=450  \\$wnnna$aSemiconductor Lasers
=550  \\$wg$aLasers
=667  \\$a/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LASER THERAPY, LOW-LEVEL (IM)
=680  \\$iLasers with a semiconductor diode as the active medium. Diode lasers transform electric energy to light using the same principle as a light-emitting diode (LED), but with internal reflection capability, thus forming a resonator where a stimulated light can reflect back and forth, allowing only a certain wavelength to be emitted. The emission of a given device is determined by the active compound used (e.g., gallium arsenide crystals doped with aluminum or indium). Typical wavelengths are 810, 1,060 and 1,300 nm. (From UMDNS, 2005)
=688  \\$a2008
=750  \0$aSemiconductor lasers$0(DLC) sh 85119896$5IEN-M

=LDR  01182cz  a2200265n  4500
=001  9880364562902441
=005  20141212221109.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054022
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287
=150  \\$aCerebrum
=450  \\$wnnna$aCerebral Hemisphere
=450  \\$wnnna$aCerebral Hemisphere, Left
=450  \\$wnnna$aCerebral Hemisphere, Right
=450  \\$wnnna$aCerebral Hemispheres
=450  \\$wnnna$aLeft Cerebral Hemisphere
=450  \\$wnnna$aRight Cerebral Hemisphere
=550  \\$wg$aTelencephalon
=550  \\$wh$aBasal Ganglia
=550  \\$wh$aCerebral Cortex
=550  \\$wh$aOlfactory Cortex
=680  \\$iDerived from TELENCEPHALON, cerebrum is composed of a right and a left hemisphere. Each contains an outer cerebral cortex and a subcortical basal ganglia. The cerebrum includes all parts within the skull except the MEDULLA OBLONGATA, the PONS, and the CEREBELLUM. Cerebral functions include sensorimotor, emotional, and intellectual activities.
=688  \\$a2008; use TELENCEPHALON 2001-2007; use BRAIN 1975-2000
=750  \0$aCerebral hemispheres$0(DLC) sh 85022094$5IEN-M

=LDR  02881cz  a2200865n  4500
=001  9880364563002441
=005  20141212221109.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054020
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490.$x367
=072  \\$aE7.$x710.$x520.$x367
=150  \\$aLasers, Gas
=450  \\$wnnna$aArgon Ion Laser
=450  \\$aArgon Ion Lasers
=450  \\$wnnna$aCarbon Dioxide Laser
=450  \\$aCarbon Dioxide Lasers
=450  \\$wnnna$aCO2 Laser
=450  \\$aCO2 Lasers
=450  \\$wnnna$aCopper Vapor Laser
=450  \\$aCopper Vapor Lasers
=450  \\$wnnna$aDioxide Laser, Carbon
=450  \\$wnnna$aDioxide Lasers, Carbon
=450  \\$wnnna$aGas Laser
=450  \\$aGas Lasers
=450  \\$wnnna$aGold Vapor Laser
=450  \\$aGold Vapor Lasers
=450  \\$wnnna$aHelium Laser
=450  \\$aHelium Lasers
=450  \\$aHelium Neon Gas Lasers
=450  \\$wnnna$aHeNe Laser
=450  \\$wnnna$aHeNe Lasers
=450  \\$wnnna$aIon Laser, Argon
=450  \\$wnnna$aIon Laser, Xenon
=450  \\$wnnna$aIon Lasers, Argon
=450  \\$wnnna$aIon Lasers, Xenon
=450  \\$wnnna$aLaser, Argon Ion
=450  \\$wnnna$aLaser, Carbon Dioxide
=450  \\$wnnna$aLaser, CO2
=450  \\$wnnna$aLaser, Copper Vapor
=450  \\$wnnna$aLaser, Gas
=450  \\$wnnna$aLaser, Gold Vapor
=450  \\$wnnna$aLaser, Helium
=450  \\$wnnna$aLaser, HeNe
=450  \\$wnnna$aLaser, Metal Vapor
=450  \\$wnnna$aLaser, Nitrogen
=450  \\$wnnna$aLaser, Xenon Ion
=450  \\$wnnna$aLasers, Argon Ion
=450  \\$wnnna$aLasers, Carbon Dioxide
=450  \\$wnnna$aLasers, CO2
=450  \\$wnnna$aLasers, Copper Vapor
=450  \\$wnnna$aLasers, Gold Vapor
=450  \\$wnnna$aLasers, Helium
=450  \\$wnnna$aLasers, Helium Neon Gas
=450  \\$wnnna$aLasers, HeNe
=450  \\$wnnna$aLasers, Metal Vapor
=450  \\$wnnna$aLasers, Nitrogen
=450  \\$wnnna$aLasers, Xenon Ion
=450  \\$wnnna$aMetal Vapor Laser
=450  \\$aMetal Vapor Lasers
=450  \\$wnnna$aNitrogen Laser
=450  \\$aNitrogen Lasers
=450  \\$wnnna$aVapor Laser, Copper
=450  \\$wnnna$aVapor Laser, Gold
=450  \\$wnnna$aVapor Laser, Metal
=450  \\$wnnna$aVapor Lasers, Copper
=450  \\$wnnna$aVapor Lasers, Gold
=450  \\$wnnna$aVapor Lasers, Metal
=450  \\$wnnna$aXenon Ion Laser
=450  \\$aXenon Ion Lasers
=550  \\$wg$aLasers
=667  \\$a/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LASER THERAPY, LOW-LEVEL (IM)
=680  \\$iLasers in which a gas lasing medium is stimulated to emit light by an electric current or high-frequency oscillator.
=688  \\$a2008
=750  \0$aGas lasers$0(DLC) sh 85053309$5IEN-M

=LDR  03630cz  a2200913n  4500
=001  9880364563102441
=005  20141212221107.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D054018
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490.$x244
=072  \\$aE7.$x710.$x520.$x244
=150  \\$aLasers, Excimer
=450  \\$wnnna$aArF Excimer Laser
=450  \\$wnnna$aArF Excimer Lasers
=450  \\$wnnna$aArF Laser
=450  \\$wnnna$aArF Lasers
=450  \\$aArgon Fluoride Excimer Lasers
=450  \\$wnnna$aArgon Fluoride Laser
=450  \\$wnnna$aArgon Fluoride Lasers
=450  \\$wnnna$aChloride Laser, Krypton
=450  \\$wnnna$aChloride Laser, Xenon
=450  \\$wnnna$aChloride Lasers, Krypton
=450  \\$wnnna$aChloride Lasers, Xenon
=450  \\$wnnna$aExcimer Laser
=450  \\$wnnna$aExcimer Laser, ArF
=450  \\$wnnna$aExcimer Laser, KrCl
=450  \\$wnnna$aExcimer Laser, XeCl
=450  \\$aExcimer Lasers
=450  \\$wnnna$aExcimer Lasers, ArF
=450  \\$wnnna$aExcimer Lasers, Argon Fluoride
=450  \\$wnnna$aExcimer Lasers, KrCl
=450  \\$wnnna$aExcimer Lasers, Krypton Chloride
=450  \\$wnnna$aExcimer Lasers, XeCl
=450  \\$wnnna$aExcimer Lasers, Xenon Chloride
=450  \\$wnnna$aFluoride Laser, Argon
=450  \\$wnnna$aFluoride Lasers, Argon
=450  \\$wnnna$aKrCl Excimer Laser
=450  \\$wnnna$aKrCl Excimer Lasers
=450  \\$wnnna$aKrCl Laser
=450  \\$wnnna$aKrCl Lasers
=450  \\$aKrypton Chloride Excimer Lasers
=450  \\$wnnna$aKrypton Chloride Laser
=450  \\$wnnna$aKrypton Chloride Lasers
=450  \\$wnnna$aLaser, ArF
=450  \\$wnnna$aLaser, ArF Excimer
=450  \\$wnnna$aLaser, Argon Fluoride
=450  \\$wnnna$aLaser, Excimer
=450  \\$wnnna$aLaser, KrCl
=450  \\$wnnna$aLaser, KrCl Excimer
=450  \\$wnnna$aLaser, Krypton Chloride
=450  \\$wnnna$aLaser, XeCl
=450  \\$wnnna$aLaser, XeCl Excimer
=450  \\$wnnna$aLaser, Xenon Chloride
=450  \\$wnnna$aLasers, ArF
=450  \\$wnnna$aLasers, ArF Excimer
=450  \\$wnnna$aLasers, Argon Fluoride
=450  \\$wnnna$aLasers, Argon Fluoride Excimer
=450  \\$wnnna$aLasers, KrCl
=450  \\$wnnna$aLasers, KrCl Excimer
=450  \\$wnnna$aLasers, Krypton Chloride
=450  \\$wnnna$aLasers, Krypton Chloride Excimer
=450  \\$wnnna$aLasers, XeCl
=450  \\$wnnna$aLasers, XeCl Excimer
=450  \\$wnnna$aLasers, Xenon Chloride
=450  \\$wnnna$aLasers, Xenon Chloride Excimer
=450  \\$wnnna$aXeCl Excimer Laser
=450  \\$wnnna$aXeCl Excimer Lasers
=450  \\$wnnna$aXeCl Laser
=450  \\$wnnna$aXeCl Lasers
=450  \\$aXenon Chloride Excimer Lasers
=450  \\$wnnna$aXenon Chloride Laser
=450  \\$wnnna$aXenon Chloride Lasers
=550  \\$wg$aLasers
=550  \\$aPhotorefractive Keratectomy
=667  \\$a/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LASER THERAPY, LOW-LEVEL (IM)
=680  \\$iGas lasers with excited dimers (i.e., excimers) as the active medium. The most commonly used are rare gas monohalides (e.g., argon fluoride, xenon chloride). Their principal emission wavelengths are in the ultraviolet range and depend on the monohalide used (e.g., 193 nm for ArF, 308 nm for Xe Cl). These lasers are operated in pulsed and Q-switched modes and used in photoablative decomposition involving actual removal of tissue. (UMDNS, 2005)
=688  \\$a2008
=750  \0$aExcimer lasers$0(DLC) sh 85046237$5IEN-M

=LDR  01031cz  a2200289n  4500
=001  9880364563202441
=005  20141212221103.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053958
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x928.$x374
=150  \\$aDipterocarpaceae
=450  \\$wnnna$aDryobalanop
=450  \\$aDryobalanops
=450  \\$aHopea
=450  \\$wnnna$aHopeas
=450  \\$wnnna$aMonote
=450  \\$aMonotes
=450  \\$aShorea
=450  \\$wnnna$aShoreas
=450  \\$aVateria
=450  \\$wnnna$aVaterias
=550  \\$wg$aTheales
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant family of the order Theales.
=688  \\$a2008; use THEALES 2002-2007
=750  \0$aDipterocarpaceae$0sh 85038240$5IEN

=LDR  04985cz  a2201273n  4500
=001  9880364563302441
=005  20141212221100.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053844
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x632.$x490.$x490
=072  \\$aE7.$x710.$x520.$x490
=150  \\$aLasers, Solid-State
=450  \\$wnnna$aAlexandrite Laser
=450  \\$aAlexandrite Lasers
=450  \\$aDiode Pumped Solid State Lasers
=450  \\$wnnna$aEr-YAG Laser
=450  \\$aEr-YAG Lasers
=450  \\$wnnna$aEr YAG Lasers
=450  \\$aErbium-Doped Yttrium Aluminum Garnet Lasers
=450  \\$wnnna$aErbium Doped Yttrium Aluminum Garnet Lasers
=450  \\$wnnna$aErbium YAG Laser
=450  \\$wnnna$aErbium YAG Lasers
=450  \\$wnnna$aHo YAG Laser
=450  \\$wnnna$aHo-YAG Laser
=450  \\$aHo YAG Lasers
=450  \\$wnnna$aHo-YAG Lasers
=450  \\$aHolmium Doped Yttrium Aluminum Garnet Lasers
=450  \\$wnnna$aHolmium Laser
=450  \\$wnnna$aHolmium Lasers
=450  \\$wnnna$aHolmium-YAG Laser
=450  \\$aHolmium-YAG Lasers
=450  \\$wnnna$aHolmium YAG Lasers
=450  \\$wnnna$aKTP Laser
=450  \\$wnnna$aKTP Lasers
=450  \\$wnnna$aLaser, Alexandrite
=450  \\$wnnna$aLaser, Er-YAG
=450  \\$wnnna$aLaser, Erbium YAG
=450  \\$wnnna$aLaser, Ho YAG
=450  \\$wnnna$aLaser, Ho-YAG
=450  \\$wnnna$aLaser, Holmium
=450  \\$wnnna$aLaser, Holmium-YAG
=450  \\$wnnna$aLaser, KTP
=450  \\$wnnna$aLaser, Nd-YAG
=450  \\$wnnna$aLaser, Ruby
=450  \\$wnnna$aLaser, Solid-State
=450  \\$wnnna$aLaser, YAG
=450  \\$wnnna$aLaser, YLF
=450  \\$wnnna$aLaser, YSGG
=450  \\$wnnna$aLaser, Yttrium-Lithium-Fluoride
=450  \\$wnnna$aLaser, Yttrium-Scandium-Gallium Garnet
=450  \\$wnnna$aLasers, Alexandrite
=450  \\$wnnna$aLasers, Diode Pumped Solid State
=450  \\$wnnna$aLasers, Er-YAG
=450  \\$wnnna$aLasers, Er YAG
=450  \\$wnnna$aLasers, Erbium-Doped Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Erbium Doped Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Erbium YAG
=450  \\$wnnna$aLasers, Ho-YAG
=450  \\$wnnna$aLasers, Ho YAG
=450  \\$wnnna$aLasers, Holmium
=450  \\$wnnna$aLasers, Holmium Doped Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Holmium-YAG
=450  \\$wnnna$aLasers, KTP
=450  \\$wnnna$aLasers, Nd-YAG
=450  \\$wnnna$aLasers, Nd YAG
=450  \\$wnnna$aLasers, Neodymium-Doped Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Neodymium Doped Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Ruby
=450  \\$wnnna$aLasers, Solid State
=450  \\$wnnna$aLasers, YAG
=450  \\$wnnna$aLasers, YLF
=450  \\$wnnna$aLasers, YSGG
=450  \\$wnnna$aLasers, Yttrium Aluminum Garnet
=450  \\$wnnna$aLasers, Yttrium-Lithium-Fluoride
=450  \\$wnnna$aLasers, Yttrium Lithium Fluoride
=450  \\$wnnna$aLasers, Yttrium-Scandium-Gallium Garnet
=450  \\$wnnna$aNd-YAG Laser
=450  \\$aNd-YAG Lasers
=450  \\$wnnna$aNd YAG Lasers
=450  \\$aNeodymium-Doped Yttrium Aluminum Garnet Lasers
=450  \\$wnnna$aNeodymium Doped Yttrium Aluminum Garnet Lasers
=450  \\$wnnna$aPotassium Titanyl Phosphate Lasers
=450  \\$wnnna$aRuby Laser
=450  \\$aRuby Lasers
=450  \\$wnnna$aSolid-State Laser
=450  \\$wnnna$aSolid-State Lasers
=450  \\$wnnna$aYAG Laser
=450  \\$wnnna$aYAG Laser, Erbium
=450  \\$wnnna$aYAG Laser, Ho
=450  \\$aYAG Lasers
=450  \\$wnnna$aYAG Lasers, Erbium
=450  \\$wnnna$aYAG Lasers, Ho
=450  \\$wnnna$aYLF Laser
=450  \\$aYLF Lasers
=450  \\$wnnna$aYSGG Laser
=450  \\$aYSGG Lasers
=450  \\$wnnna$aYttrium Aluminum Garnet Lasers
=450  \\$wnnna$aYttrium-Lithium-Fluoride Laser
=450  \\$aYttrium-Lithium-Fluoride Lasers
=450  \\$wnnna$aYttrium Lithium Fluoride Lasers
=450  \\$wnnna$aYttrium-Scandium-Gallium Garnet Laser
=450  \\$aYttrium-Scandium-Gallium Garnet Lasers
=450  \\$wnnna$aYttrium Scandium Gallium Garnet Lasers
=550  \\$wg$aLasers
=667  \\$a/ther use: coordinate IM with disease /surg (IM), but for low-level laser therapy coordinate / ther use IM with disease /radiother (IM) + LASER THERAPY, LOW-LEVEL (IM)
=680  \\$iLasers which use a solid, as opposed to a liquid or gas, as the lasing medium. Common materials used are crystals, such as YAG (YTTRIUM aluminum garnet); alexandrite; and CORUNDUM, doped with a rare earth element such as a NEODYMIUM; ERBIUM; or HOLMIUM. The output is sometimes additionally modified by addition of non-linear optical materials such as potassium titanyl phosphate crystal, which for example is used with neodymium YAG lasers to convert the output light to the visible range.
=688  \\$a2008
=750  \0$aSolid-state lasers$0(DLC) sh 85124638$5IEN-M

=LDR  02424cz  a2200661n  4500
=001  9880364563402441
=005  20141212221027.0
=008  070709\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053685
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x594
=072  \\$aE4.$x14.$x520
=150  \\$aLaser Therapy
=450  \\$wnnna$aAblation, Laser
=450  \\$wnnna$aAblation, Laser Tissue
=450  \\$wnnna$aKnife, Laser
=450  \\$wnnna$aKnifes, Laser
=450  \\$wnnna$aKnive, Laser
=450  \\$wnnna$aKnives, Laser
=450  \\$wnnna$aLaser Ablation
=450  \\$aLaser Knife
=450  \\$wnnna$aLaser Knifes
=450  \\$wnnna$aLaser Knive
=450  \\$wnnna$aLaser Knives
=450  \\$wnnna$aLaser Photoablation of Tissue
=450  \\$aLaser Scalpel
=450  \\$wnnna$aLaser Scalpels
=450  \\$wnnna$aLaser Surgeries
=450  \\$wnnna$aLaser Surgery
=450  \\$wnnna$aLaser Therapies
=450  \\$wnnna$aLaser Tissue Ablation
=450  \\$wnnna$aLaser Treatment, Nonablative
=450  \\$wnnna$aLaser Treatments, Nonablative
=450  \\$wnnna$aLaser Vaporization
=450  \\$aLasers$xtherapeutic use
=450  \\$wnnna$aNonablative Laser Treatment
=450  \\$wnnna$aNonablative Laser Treatments
=450  \\$wnnna$aPulsed Laser Tissue Ablation
=450  \\$wnnna$aScalpel, Laser
=450  \\$wnnna$aScalpels, Laser
=450  \\$wnnna$aSurgeries, Laser
=450  \\$aSurgery, Laser
=450  \\$wnnna$aTherapies, Laser
=450  \\$wnnna$aTherapy, Laser
=450  \\$wnnna$aTissue Ablation, Laser
=450  \\$aVaporization, Laser
=550  \\$wg$aAblation Techniques
=550  \\$wg$aTherapeutics
=550  \\$wh$aAngioplasty, Laser
=550  \\$wh$aCorneal Surgery, Laser
=550  \\$wh$aLaser Coagulation
=550  \\$wh$aLaser Therapy, Low-Level
=550  \\$wh$aLithotripsy, Laser
=667  \\$ageneral; prefer specifics or specific laser term/ ther use; coordinate with disease and/or organ /surg; LASER THERAPY, LOW-LEVEL is also available; laser surgery of cataract = LASER SURGERY (IM) see LASER THERAPY + CATARACT EXTRACTION (IM)
=680  \\$iThe use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue.
=688  \\$a2008
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20081103: 150:##:_{dollar}a Laser Surgery
=750  \0$aLasers in surgery$0(DLC) sh 85074810$5IEN-M

=LDR  01128cz  a2200241n  4500
=001  9880364563502441
=005  20170404142945.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053918
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x498
=150  \\$aPapillomavirus Vaccines
=450  \\$wnnna$aHPV Vaccines
=450  \\$wnnna$aHuman Papilloma Virus Vaccines
=450  \\$aHuman Papillomavirus Vaccines
=450  \\$wnnna$aPapillomavirus Vaccines, Human
=450  \\$wnnna$aVaccines, Human Papillomavirus
=450  \\$wnnna$aVaccines, Papillomavirus
=550  \\$wg$aViral Vaccines
=550  \\$wh$aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
=680  \\$iVaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
=688  \\$a2007
=750  \0$aPapillomavirus vaccines$0(DLC) sh 99003243$5IEN-M

=LDR  00960cz  a2200265n  4500
=001  9880364563602441
=005  20141212221057.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053841
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x385
=072  \\$aE5.$x301.$x270
=072  \\$aG2.$x149.$x535.$x250
=072  \\$aG2.$x149.$x767.$x645.$x250
=072  \\$aG2.$x685.$x495.$x250
=072  \\$aG2.$x842.$x700.$x495.$x250
=072  \\$aG2.$x842.$x750.$x645.$x250
=150  \\$aElectroosmosis
=450  \\$wnnna$aElectroosmotic Flow
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aElectrochemical Techniques
=550  \\$wg$aOsmosis
=680  \\$iThe motion of a liquid through a membrane (or plug or capillary) consequent upon the application of an electric field across the membrane. (Oxford Dictionary of Biochemistry and Molecular Biology, 2001)
=688  \\$a2007
=750  \0$aElectro-osmosis$0(DLC) sh 85042093$5IEN-M

=LDR  01454cz  a2200301n  4500
=001  9880364563702441
=005  20141212221057.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053840
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x322
=072  \\$aC16.$x320.$x100
=150  \\$aBrugada Syndrome
=450  \\$wnnna$aBrugada ECG Pattern
=450  \\$wnnna$aBrugada Syndrome 1
=450  \\$wnnna$aBrugada Type ECG Pattern
=450  \\$wnnna$aECG Pattern, Brugada
=450  \\$wnnna$aRight Bundle Branch Block, St Segment Elevation, And Sudden Death Syndrome
=450  \\$wnnna$aSudden Unexplained Death Syndrome
=450  \\$wnnna$aSudden Unexplained Nocturnal Death Syndrome
=450  \\$wnnna$aSudden Unexplained Nocturnal Death Syndrome (SUNDS)
=550  \\$wg$aArrhythmias, Cardiac
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$aVoltage-Gated Sodium Channel beta-1 Subunit
=550  \\$aVoltage-Gated Sodium Channel beta-3 Subunit
=680  \\$iAn autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.
=688  \\$a2007
=750  \0$aBrugada syndrome$0(DLC)sh2004000521$5IEN-M

=LDR  01423cz  a2200265n  4500
=001  9880364563802441
=005  20141212221056.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053838
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x822.$x830
=072  \\$aG1.$x595.$x861.$x755
=150  \\$aScattering, Small Angle
=450  \\$wnnna$aAngle Scattering, Low
=450  \\$wnnna$aAngle Scatterings, Low
=450  \\$wnnna$aLow Angle Scattering
=450  \\$wnnna$aLow Angle Scatterings
=450  \\$wnnna$aScattering, Low Angle
=450  \\$wnnna$aScatterings, Low Angle
=450  \\$aSmall Angle Scattering
=550  \\$wg$aScattering, Radiation
=667  \\$afor SAXS coordinate with X-RAY DIFFRACTION; for SANS coordinate with NEUTRON DIFFRACTION; for SALS coordinate with LIGHT
=680  \\$iScattering of a beam of electromagnetic or acoustic RADIATION, or particles, at small angles by particles or cavities whose dimensions are many times as large as the wavelength of the radiation or the de Broglie wavelength of the scattered particles. Also know as low angle scattering. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Small angle scattering (SAS) techniques, small angle neutron (SANS), X-ray (SAXS), and light (SALS, or just LS) scattering, are used to characterize objects on a nanoscale.
=688  \\$a2007
=750  \0$aSmall-angle scattering$0(DLC) sh 87005329$5IEN-M

=LDR  00854cz  a2200193n  4500
=001  9880364563902441
=005  20141212221054.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053834
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x317
=150  \\$aExplosive Agents
=450  \\$wnnna$aAgents, Explosive
=450  \\$wnnna$aExplosives
=550  \\$wg$aSpecialty Uses of Chemicals
=550  \\$aBombs
=680  \\$iSubstances that are energetically unstable and can produce a sudden expansion of the material, called an explosion, which is accompanied by heat, pressure and noise. Other things which have been described as explosive that are not included here are explosive action of laser heating, human performance, sudden epidemiological outbreaks, or fast cell growth.
=688  \\$a2007
=750  \0$aExplosives$0(DLC) sh 85046474$5IEN-M

=LDR  01267cz   2200337n  4500
=001  9880364564002441
=005  20230901102102.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053833
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x157.$x812
=072  \\$aN6.$x230.$x124.$x625
=150  \\$aWetlands
=450  \\$wnnna$aBog
=450  \\$wnnna$aBogs
=450  \\$wnnna$aMangrove Swamp
=450  \\$wnnna$aMangrove Swamps
=450  \\$wnnna$aMarsh
=450  \\$wnnna$aMarshes
=450  \\$wnnna$aSwamp
=450  \\$wnnna$aSwamp, Mangrove
=450  \\$wnnna$aSwamps
=450  \\$wnnna$aSwamps, Mangrove
=450  \\$wnnna$aWetland
=550  \\$wg$aEcosystem
=550  \\$aAvicennia
=667  \\$anote entry term MANGROVE SWAMPS: MANGROVE, GREY see AVICENNIA and MANGROVE, AMERICAN and MANGROVE, RED see RHIZOPHORACEAE are also available
=680  \\$iEnvironments or habitats at the interface between truly terrestrial ecosystems and truly aquatic systems making them different from each yet highly dependent on both. Adaptations to low soil oxygen characterize many wetland species.
=688  \\$a2007
=750  \0$aWetlands$0(DLC) sh 85146328$5IEN-M
=750  \0$iNarrower mapping$aTidal wetlands$0(DLC)sh2022006392$4NM$5IEN-M

=LDR  00853cz  a2200229n  4500
=001  9880364564102441
=005  20141212221049.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053822
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x147.$x50
=150  \\$aAiluridae
=450  \\$aAilurus
=450  \\$wnnna$aLesser Panda
=450  \\$wnnna$aLesser Pandas
=450  \\$wnnna$aPanda, Lesser
=450  \\$aPandas, Lesser
=550  \\$wg$aCarnivora
=667  \\$anote X ref PANDAS, LESSER: PANDAS, GIANT and PANDAS, GREATER see URSIDAE is also available
=680  \\$iA family in the suborder Caniformia, Order CARNIVORA, comprised of one genus Ailurus, the lesser pandas.
=688  \\$a2007; for AILURUS use PROCYONIDAE 1998-2006; for PANDAS, LESSER use CARNIVORA 1997-2004
=750  \0$aAiluridae$0(DLC)sh2006002949$5IEN-M

=LDR  00826cz  a2200253n  4500
=001  9880364564202441
=005  20141212221049.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053821
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x190
=072  \\$aC14.$x260
=150  \\$aCardiovascular Infections
=450  \\$wnnna$aCardiovascular Infection
=450  \\$wnnna$aInfection, Cardiovascular
=450  \\$aInfections, Cardiovascular
=550  \\$wg$aCardiovascular Diseases
=550  \\$wg$aInfection
=550  \\$wh$aEndocarditis, Bacterial
=550  \\$wh$aSyphilis, Cardiovascular
=550  \\$wh$aTuberculosis, Cardiovascular
=680  \\$iPathological conditions of the CARDIOVASCULAR SYSTEM caused by infections.
=688  \\$a2007
=750  \0$aCardiovascular system$xInfections$0(IEN)7959333$5IEN-M

=LDR  00934cz  a2200253n  4500
=001  9880364564302441
=005  20141212221049.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053820
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x575
=150  \\$aPitheciidae
=450  \\$aCacajao
=450  \\$aCallicebinae
=450  \\$wnnna$aCallicebus
=450  \\$aChiropotes
=450  \\$aPithecia
=450  \\$aPitheciinae
=450  \\$wnnna$aPithecinae
=550  \\$wg$aPlatyrrhini
=550  \\$wh$aCallicebus
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA family of New World monkeys in the infraorder PLATYRRHINI consisting of two subfamilies: Callicebinae and Pitheciinae.
=688  \\$a2007; for Cacajao, Callicebinae, Chiropotes, & Pithecinae use CEBIDAE 1992-2006
=750  \0$aPitheciidae$0(DLC)sh2006001563$5IEN-M

=LDR  01546cz  a2200409n  4500
=001  9880364564402441
=005  20141212193116.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053819
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x75.$x75
=150  \\$aAtelinae
=450  \\$aAteles
=450  \\$wnnna$aBrachytele
=450  \\$wnnna$aBrachyteles
=450  \\$wnnna$aLagothrices
=450  \\$aLagothrix
=450  \\$aMonkey, Spider
=450  \\$aMonkey, Woolly
=450  \\$wnnna$aMonkey, Woolly Spider
=450  \\$wnnna$aMonkeys, Spider
=450  \\$wnnna$aMonkeys, Woolly
=450  \\$wnnna$aMonkeys, Woolly Spider
=450  \\$aSpider Monkey
=450  \\$wnnna$aSpider Monkey, Woolly
=450  \\$wnnna$aSpider Monkeys
=450  \\$wnnna$aSpider Monkeys, Woolly
=450  \\$aWoolly Monkey
=450  \\$wnnna$aWoolly Monkeys
=450  \\$wnnna$aWoolly Spider Monkey
=450  \\$wnnna$aWoolly Spider Monkeys
=550  \\$wg$aAtelidae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA subfamily in the family ATELIDAE, comprising three genera: woolly monkeys (Lagothrix), spider monkeys (Ateles), and woolly spider monkeys (Brachyteles).
=688  \\$a2007; use CEBIDAE 1992-2006; for BRACYTELES use CEBIDAE 1992-2006; for ATELES & LAGOTHRIX use CEBIDAE 1981-2006
=750  \0$aSpider monkeys$0(DLC) sh 85126622$5IEN-M
=750  \0$aWoolly monkeys$0(DLC) sh 85148082$5IEN-M

=LDR  00676cz  a2200205n  4500
=001  9880364564502441
=005  20141212221047.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053803
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x330.$x149
=072  \\$aI1.$x198.$x780.$x937.$x441
=150  \\$aForensic Genetics
=450  \\$wnnna$aForensic Genetic
=450  \\$wnnna$aGenetic, Forensic
=450  \\$wnnna$aGenetics, Forensic
=550  \\$wg$aForensic Medicine
=680  \\$iThe application of genetic analyses and MOLECULAR DIAGNOSTIC TECHNIQUES to legal matters and crime analysis.
=688  \\$a2007
=750  \0$aForensic genetics$0(DLC) sh 86005931$5IEN-M

=LDR  00924cz  a2200229n  4500
=001  9880364564602441
=005  20141212193115.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053783
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x502.$x515
=150  \\$aMagnetic Resonance Imaging, Interventional
=450  \\$aInterventional Magnetic Resonance Imaging
=450  \\$wnnna$aInterventional MRI
=450  \\$wnnna$aMagnetic Resonance Guided Interventional Procedures
=450  \\$aMR Guided Interventional Procedures
=450  \\$aMRI, Interventional
=550  \\$wg$aMinimally Invasive Surgical Procedures
=667  \\$acoordinate with specific minimally invasive procedure if pertinent
=680  \\$iMinimally invasive procedures guided with the aid of magnetic resonance imaging to visualize tissue structures.
=688  \\$a2007
=750  \0$aInterventional magnetic resonance imaging$0(DLC) sh 97004158$5IEN-M

=LDR  00584cz  a2200169n  4500
=001  9880364564702441
=005  20141212221042.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053770
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x925
=150  \\$aNanowires
=450  \\$wnnna$aNanowire
=550  \\$wg$aNanostructures
=680  \\$iNanometer-scale wires made of materials that conduct electricity. They can be coated with molecules such as antibodies that will bind to proteins and other substances.
=688  \\$a2007
=750  \0$aNanowires$0(DLC) sh 97004111$5IEN-M

=LDR  00753cz  a2200205n  4500
=001  9880364564802441
=005  20141212193115.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053769
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x260.$x575
=072  \\$aE2.$x319.$x300.$x380.$x575
=072  \\$aJ1.$x637.$x512.$x600.$x575
=150  \\$aNanocapsules
=450  \\$wnnna$aNanocapsule
=550  \\$wg$aDrug Carriers
=550  \\$wg$aNanoparticles
=680  \\$iNanometer-sized, hollow, spherically-shaped objects that can be utilized to encapsulate small amounts of pharmaceuticals, enzymes, or other catalysts (Glossary of Biotechnology and Nanobiotechnology, 4th ed).
=688  \\$a2007
=750  \0$aNanocapsules$0(DLC)sh2011002639$5IEN-M

=LDR  00777cz  a2200193n  4500
=001  9880364564902441
=005  20141212221041.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053763
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x696
=150  \\$aPresenilins
=450  \\$wnnna$aPresenilin
=550  \\$wg$aMembrane Proteins
=550  \\$wh$aPresenilin-1
=550  \\$wh$aPresenilin-2
=680  \\$iIntegral membrane proteins and essential components of the gamma-secretase complex that catalyzes the cleavage of membrane proteins such as NOTCH RECEPTORS and AMYLOID BETA-PEPTIDES precursors. Mutations of presenilins lead to presenile ALZHEIMER DISEASE with onset before age 65 years.
=688  \\$a2007
=750  \0$aPresenilins$0(DLC) sh 97009060$5IEN-M

=LDR  00623cz  a2200169n  4500
=001  9880364565002441
=005  20141212221040.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053761
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x150
=150  \\$aNanocomposites
=450  \\$wnnna$aNanocomposite
=550  \\$wg$aNanostructures
=680  \\$iNanometer-scale composite structures composed of organic molecules intimately incorporated with inorganic molecules. (Glossary of Biotechnology and Nanobiotechology Terms, 4th ed)
=688  \\$a2007
=750  \0$aNanocomposites (Materials)$0(DLC)sh2008002284$5IEN-M

=LDR  01241cz  a2200337n  4500
=001  9880364565102441
=005  20141212221039.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053758
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x512.$x600
=150  \\$aNanoparticles
=450  \\$wnnna$aMaterial, Nanocrystalline
=450  \\$wnnna$aMaterials, Nanocrystalline
=450  \\$wnnna$aNanocrystal
=450  \\$wnnna$aNanocrystalline Material
=450  \\$aNanocrystalline Materials
=450  \\$aNanocrystals
=450  \\$wnnna$aNanoparticle
=550  \\$wg$aNanostructures
=550  \\$wh$aCalcifying Nanoparticles
=550  \\$wh$aDendrimers
=550  \\$wh$aMetal Nanoparticles
=550  \\$wh$aNanocapsules
=550  \\$wh$aNanoconjugates
=550  \\$wh$aNanodiamonds
=550  \\$wh$aNanospheres
=550  \\$wh$aQuantum Dots
=680  \\$iNanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
=688  \\$a2007; use NANOSTRUCTURES 2005-2006
=750  \0$aNanoparticles$0(DLC) sh 85089689$5IEN-M

=LDR  01215cz  a2200193n  4500
=001  9880364565202441
=005  20141212221035.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053719
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x566.$x880
=150  \\$aTandem Mass Spectrometry
=450  \\$wnnna$aMass Spectrometry-Mass Spectrometry
=450  \\$wnnna$aMass Spectrometry Mass Spectrometry
=450  \\$wnnna$aMass Spectrometry, Tandem
=550  \\$wg$aMass Spectrometry
=680  \\$iA mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection.
=688  \\$a2007
=750  \0$aTandem mass spectrometry$0(DLC)sh2006020214$5IEN-M

=LDR  01560cz  a2200361n  4500
=001  9880364565302441
=005  20190426132455.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053707
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x580
=150  \\$aReceptors, Interleukin-12
=450  \\$wnnna$aIL-12 Receptor
=450  \\$wnnna$aIL 12 Receptor
=450  \\$aIL-12 Receptors
=450  \\$wnnna$aIL 12 Receptors
=450  \\$wnnna$aInterleukin-12 Receptor
=450  \\$wnnna$aInterleukin 12 Receptor
=450  \\$aInterleukin-12 Receptors
=450  \\$wnnna$aInterleukin 12 Receptors
=450  \\$wnnna$aReceptor, IL-12
=450  \\$wnnna$aReceptor, Interleukin-12
=450  \\$wnnna$aReceptor, Interleukin 12
=450  \\$wnnna$aReceptors, IL-12
=450  \\$wnnna$aReceptors, Interleukin 12
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aInterleukin-12 Receptor beta 1 Subunit
=550  \\$wh$aInterleukin-12 Receptor beta 2 Subunit
=680  \\$iCell surface receptors for INTERLEUKIN-12. They exist as dimers of beta 1 and beta 2 subunits. Signaling from interleukin-12 receptors occurs through their interaction with JANUS KINASES.
=688  \\$a2007(1994)
=750  \0$81$wb$iBroader mapping$aInterleukin-12$0(DLC) sh 96009262$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-12--Receptors$9Search also under the Library of Congress Subject Heading:

=LDR  01333cz  a2200349n  4500
=001  9880364565402441
=005  20141212221031.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053704
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250.$x250.$x250.$x140
=150  \\$aCapsule Endoscopy
=450  \\$wnnna$aCapsule Endoscopies
=450  \\$wnnna$aCapsule Endoscopies, Video
=450  \\$wnnna$aCapsule Endoscopies, Wireless
=450  \\$wnnna$aCapsule Endoscopy, Video
=450  \\$wnnna$aCapsule Endoscopy, Wireless
=450  \\$wnnna$aEndoscopies, Capsule
=450  \\$wnnna$aEndoscopies, Video Capsule
=450  \\$wnnna$aEndoscopies, Wireless Capsule
=450  \\$wnnna$aEndoscopy, Capsule
=450  \\$wnnna$aEndoscopy, Video Capsule
=450  \\$wnnna$aEndoscopy, Wireless Capsule
=450  \\$wnnna$aVideo Capsule Endoscopies
=450  \\$wnnna$aVideo Capsule Endoscopy
=450  \\$wnnna$aWireless Capsule Endoscopies
=450  \\$wnnna$aWireless Capsule Endoscopy
=550  \\$wg$aEndoscopy, Gastrointestinal
=550  \\$aCapsule Endoscopes
=680  \\$iNon-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel.
=688  \\$a2007
=750  \0$aCapsule endoscopy$0(DLC)sh2007003153$5IEN-M

=LDR  01590cz  a2200361n  4500
=001  9880364565502441
=005  20190426131542.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053701
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x550
=150  \\$aReceptors, Interleukin-10
=450  \\$wnnna$aIL-10 Receptor
=450  \\$wnnna$aIL 10 Receptor
=450  \\$wnnna$aIL-10 Receptors
=450  \\$wnnna$aInterleukin-10 Receptor
=450  \\$wnnna$aInterleukin 10 Receptor
=450  \\$aInterleukin-10 Receptors
=450  \\$wnnna$aInterleukin 10 Receptors
=450  \\$wnnna$aReceptor, IL-10
=450  \\$wnnna$aReceptor, Interleukin-10
=450  \\$wnnna$aReceptor, Interleukin 10
=450  \\$aReceptors, IL-10
=450  \\$wnnna$aReceptors, IL 10
=450  \\$wnnna$aReceptors, Interleukin 10
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aInterleukin-10 Receptor alpha Subunit
=550  \\$wh$aInterleukin-10 Receptor beta Subunit
=680  \\$iCell surface receptors for INTERLEUKIN-10. They exist as a tetramer of two alpha chains (INTERLEUKIN-10 RECEPTOR ALPHA CHAIN) and two beta chains (INTERLEUKIN-10 RECEPTOR, BETA CHAIN). Signaling from interleukin-10 receptors occurs through their interaction with JANUS KINASES.
=688  \\$a2007(1993)
=750  \0$81$wb$iBroader mapping$aInterleukin-10$0(DLC)sh 94007678$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-10--Receptors$5IEN-M

=LDR  01461cz  a2200349n  4500
=001  9880364565602441
=005  20190426152705.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053700
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x695.$x160.$x500.$x750
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x125.$x500.$x750
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x421
=150  \\$aReceptors, Interleukin-8
=450  \\$aIL-8 Receptors
=450  \\$wnnna$aIL 8 Receptors
=450  \\$wnnna$aIL8 Receptors
=450  \\$aInterleukin-8 Receptors
=450  \\$wnnna$aInterleukin 8 Receptors
=450  \\$wnnna$aReceptors, IL-8
=450  \\$wnnna$aReceptors, IL8
=450  \\$wnnna$aReceptors, Interleukin 8
=550  \\$wg$aReceptors, CXCR
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aReceptors, Interleukin-8A
=550  \\$wh$aReceptors, Interleukin-8B
=667  \\$aRECEPTORS, INTERLEUKIN-8A and RECEPTORS, INTERLEUKIN-8B are also available
=680  \\$iCell surface receptors that are specific for INTERLEUKIN-8. Two specific receptor subtypes (type A and B) have been found and bind IL-8 with high affinity.
=688  \\$a2007
=750  \0$81$wb$iBroader mapping$aInterleukin-8$0(DLC) sh 91003712$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-8--Receptors$5IEN-M

=LDR  01222cz  a2200313n  4500
=001  9880364565702441
=005  20141212221023.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053672
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x341
=072  \\$aE5.$x242.$x448.$x500
=072  \\$aE5.$x301.$x500.$x500
=150  \\$aElectrochemotherapy
=450  \\$wnnna$aElectrochemotherapies
=450  \\$wnnna$aElectropermeabilisation Therapies
=450  \\$wnnna$aElectropermeabilisation Therapy
=450  \\$wnnna$aElectroporation Therapies
=450  \\$aElectroporation Therapy
=450  \\$wnnna$aTherapies, Electropermeabilisation
=450  \\$wnnna$aTherapies, Electroporation
=450  \\$wnnna$aTherapy, Electropermeabilisation
=450  \\$wnnna$aTherapy, Electroporation
=550  \\$wg$aDrug Therapy
=550  \\$wg$aElectroporation
=667  \\$acoordinate with disease/drug ther
=680  \\$iA treatment modality that uses pulsed electrical currents to permeabilize cell membranes (ELECTROPORATION) and thereby enhance the uptake of chemotherapeutic agents, vaccines, or genes into the body's cells.
=688  \\$a2007
=750  \0$aElectroporation$xTherapeutic use$0(IEN)7965437$5IEN-M

=LDR  01548cz  a2200361n  4500
=001  9880364565802441
=005  20190426133058.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053660
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x600
=150  \\$aReceptors, Interleukin-13
=450  \\$wnnna$aIL-13 Receptor
=450  \\$wnnna$aIL 13 Receptor
=450  \\$aIL-13 Receptors
=450  \\$wnnna$aIL 13 Receptors
=450  \\$wnnna$aInterleukin-13 Receptor
=450  \\$wnnna$aInterleukin 13 Receptor
=450  \\$aInterleukin-13 Receptors
=450  \\$wnnna$aInterleukin 13 Receptors
=450  \\$wnnna$aReceptor, IL-13
=450  \\$wnnna$aReceptor, Interleukin-13
=450  \\$wnnna$aReceptor, Interleukin 13
=450  \\$wnnna$aReceptors, IL-13
=450  \\$wnnna$aReceptors, Interleukin 13
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aInterleukin-13 Receptor alpha2 Subunit
=550  \\$wh$aReceptors, Interleukin-4, Type II
=680  \\$iCell surface receptors for INTERLEUKIN-13. Included under this heading are the INTERLEUKIN-13 RECEPTOR ALPHA2 which is a monomeric receptor and the INTERLEUKIN-4 RECEPTOR TYPE II which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13.
=688  \\$a2007(1993)
=750  \0$81$wb$iBroader mapping$aInterleukin-13$0((DLC)sh2003010926$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-13--Receptors

=LDR  01326cz  a2200265n  4500
=001  9880364565902441
=005  20161216105000.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053652
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x200.$x500.$x380.$x500
=072  \\$aE5.$x393.$x85.$x500
=072  \\$aE5.$x820.$x540
=150  \\$aNuclear Transfer Techniques
=450  \\$aCell Nucleus$xtransplantation
=450  \\$wnnna$aNuclear Transfer Technique
=450  \\$wnnna$aNuclear Transplantation
=450  \\$wnnna$aSomatic Cell Nuclear Transfer Technique
=450  \\$wnnna$aTransplantation, Nuclear
=550  \\$wg$aCellular Reprogramming Techniques
=550  \\$wg$aReproductive Techniques
=550  \\$aCloning, Organism
=680  \\$iMethods of implanting a CELL NUCLEUS from a donor cell into an enucleated acceptor cell. Often the nucleus of a somatic cell is transferred into a recipient OVUM or stem cell (STEM CELLS) with the nucleus removed. This technology may provide means to generate autologous diploid pluripotent cell for therapeutic cloning, and a model for studying NUCLEAR REPROGRAMMING in embryonic stem cells. Nuclear transfer was first accomplished with frog eggs (RANA PIPIENS) and reported in 1952.
=688  \\$a2007
=750  \0$aCell nuclei$xTransplantation$0(DLC) sh 85021660$5IEN-M

=LDR  01570cz  a2200349n  4500
=001  9880364566002441
=005  20190426140815.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053649
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x420.$x380
=150  \\$aReceptors, Interleukin-5
=450  \\$aIL-5 Receptors
=450  \\$wnnna$aIL 5 Receptors
=450  \\$wnnna$aIL5 Receptor
=450  \\$wnnna$aInterleukin 5 Receptor
=450  \\$wnnna$aInterleukin-5 Receptor
=450  \\$aInterleukin-5 Receptors
=450  \\$wnnna$aInterleukin 5 Receptors
=450  \\$wnnna$aReceptor, IL5
=450  \\$wnnna$aReceptor, Interleukin 5
=450  \\$wnnna$aReceptor, Interleukin-5
=450  \\$wnnna$aReceptors, IL-5
=450  \\$wnnna$aReceptors, Interleukin 5
=550  \\$wg$aReceptors, Interleukin
=550  \\$wh$aCytokine Receptor Common beta Subunit
=550  \\$wh$aInterleukin-5 Receptor alpha Subunit
=680  \\$iCell surface receptors that are specific for INTERLEUKIN-5. They are heterodimeric proteins consisting of the INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT. Signaling from interleukin-5 receptors can occur through interaction of their cytoplasmic domains with SYNTENINS.
=688  \\$a2007(1988)
=750  \0$81$wb$iBroader mapping$aInterleukin-5$0(DLC) sh 95001692$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aInterleukin-5--Receptors$5IEN-M

=LDR  00598cz  a2200193n  4500
=001  9880364566102441
=005  20141212221009.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053630
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x300.$x100
=072  \\$aD2.$x241.$x511.$x390.$x100
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x100
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x100
=150  \\$aDepsides
=550  \\$wg$aHydroxybenzoates
=680  \\$iPhenolic benzoic acid esters.
=688  \\$a2007(1978)
=750  \0$aDepsides$0(DLC) sh 85037062$5IEN-M

=LDR  01107cz  a2200277n  4500
=001  9880364566202441
=005  20190507153227.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053628
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x610
=150  \\$aReceptors, Thrombopoietin
=450  \\$aAntigens, CD110
=450  \\$aCD110 Antigens
=450  \\$wnnna$aLigand Receptor, MPL
=450  \\$wnnna$aMPL Ligand Receptor
=450  \\$wnnna$aReceptor, MPL Ligand
=450  \\$wnnna$aReceptor, Thrombopoietin
=450  \\$wnnna$aThrombopoietin Receptor
=450  \\$wnnna$aThrombopoietin Receptors
=550  \\$wg$aReceptors, Cytokine
=680  \\$iCell surface receptors that are specific for THROMBOPOIETIN. They signal through interaction with JANUS KINASES such as JANUS KINASE 2.
=688  \\$a2007
=750  \0$81$wb$iBroader mapping$aThrombopoietin$0(DLC)sh 96010009$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aThrombopoietin--Receptors$5IEN-M

=LDR  00866cz  a2200181n  4500
=001  9880364566302441
=005  20141212221005.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053608
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x358.$x800.$x500
=072  \\$aC23.$x888.$x592.$x604.$x359.$x800.$x500
=150  \\$aStupor
=450  \\$wnnna$aNarcosis
=550  \\$wg$aUnconsciousness
=680  \\$iA state of reduced sensibility and response to stimuli which is distinguished from COMA in that the person can be aroused by vigorous and repeated stimulation. The person is still conscious and can make voluntary movements. It can be induced by CENTRAL NERVOUS SYSTEM AGENTS. The word derives from Latin stupere and is related to stunned, stupid, dazed or LETHARGY.
=688  \\$a2007; use COMA 2000-2006
=750  \0$aStupor$0(DLC) sh 85129349$5IEN-M

=LDR  01084cz  a2200253n  4500
=001  9880364566402441
=005  20141212221004.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053607
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x77
=072  \\$aD12.$x644.$x548.$x17
=150  \\$aAdrenomedullin
=450  \\$wnnna$aADM (1-52)
=450  \\$wnnna$aADM(1-52)
=450  \\$wnnna$aAdrenomedullin (1-52)
=450  \\$wnnna$aPAMP(1-20)NH2
=450  \\$wnnna$aProadrenomedullin (1-20)
=450  \\$wnnna$aProadrenomedullin N-Terminal 20 Peptide
=450  \\$wnnna$aProadrenomedullin N Terminal 20 Peptide
=550  \\$wg$aPeptide Hormones
=680  \\$iA 52-amino acid peptide with multi-functions. It was originally isolated from PHEOCHROMOCYTOMA and ADRENAL MEDULLA but is widely distributed throughout the body including lung and kidney tissues. Besides controlling fluid-electrolyte homeostasis, adrenomedullin is a potent vasodilator and can inhibit pituitary ACTH secretion.
=688  \\$a2007 (1993)
=750  \0$aAdrenomedullin$0(DLC) sh 99004439$5IEN-M

=LDR  01878cz  a2200373n  4500
=001  9880364566502441
=005  20190501110808.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053606
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x500
=072  \\$aD12.$x776.$x543.$x750.$x705.$x852.$x555.$x800
=150  \\$aReceptors, OSM-LIF
=450  \\$wnnna$aLeukemia Inhibitory Factor-Oncostatin M Shared Receptor
=450  \\$wnnna$aLeukemia Inhibitory Factor Oncostatin M Shared Receptor
=450  \\$aLeukemia Inhibitory Factor Receptor
=450  \\$wnnna$aLeukemia Inhibitory Factor Receptors
=450  \\$wnnna$aLIF Receptors
=450  \\$wnnna$aOncostatin M-Leukemia Inhibitory Factor Shared Receptor
=450  \\$wnnna$aOncostatin M Leukemia Inhibitory Factor Shared Receptor
=450  \\$wnnna$aOncostatin M Type I Receptor
=450  \\$wnnna$aOSM-LIF Receptors
=450  \\$aReceptors, Leukemia Inhibitory Factor
=450  \\$wnnna$aReceptors, LIF
=450  \\$wnnna$aReceptors, OSM LIF
=550  \\$wg$aReceptors, Cytokine
=550  \\$wg$aReceptors, Oncostatin M
=550  \\$wh$aCytokine Receptor gp130
=550  \\$wh$aLeukemia Inhibitory Factor Receptor alpha Subunit
=680  \\$iCell surface receptors formed from the dimerization of LIF RECEPTOR ALPHA SUBUNIT with CYTOKINE RECEPTOR GP130. Although originally described as receptors for LEUKEMIA INHIBITORY FACTOR these receptors also bind the closely-related protein ONCOSTATIN M and are referred to as both LIF receptors and type I oncostatin M receptors.
=688  \\$a2007(1991)
=750  \0$81$wb$iBroader mapping$aLeukemia inhibitory factor$0(DLC)sh 92001230$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReceptors$0(DLC)sh2002007652$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading:$aLeukemia--Receptors$5IEN-M

=LDR  01421cz  a2200325n  4500
=001  9880364566602441
=005  20141212221003.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053605
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x470
=072  \\$aD12.$x776.$x467.$x374.$x470
=072  \\$aD23.$x529.$x374.$x470
=150  \\$aLeukemia Inhibitory Factor
=450  \\$wnnna$aAM424
=450  \\$wnnna$aAMRAD Brand of Recombinant Human Leukemia Inhibitory Factor
=450  \\$wnnna$aCholinergic Differentiation Factor
=450  \\$wnnna$aD Factor (Leukemia Inhibitory Factor)
=450  \\$wnnna$aDifferentiation Factor, Cholinergic
=450  \\$wnnna$aDifferentiation-Stimulating Factor
=450  \\$wnnna$aDifferentiation Stimulating Factor
=450  \\$wnnna$aDifferentiation-Stimulating Factor, Myeloid
=450  \\$wnnna$aEmfilermin
=450  \\$wnnna$aInhibitory Factor, Leukemia
=450  \\$wnnna$aMyeloid Differentiation-Stimulating Factor
=450  \\$wnnna$aMyeloid Differentiation Stimulating Factor
=550  \\$wg$aCytokines
=680  \\$iAn INTERLEUKIN-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. Leukemia inhibitory factor binds to and acts through the lif receptor.
=688  \\$a2007(1980)
=750  \0$aLeukemia inhibitory factor$0(DLC) sh 92001230$5IEN-M

=LDR  00876cz  a2200205n  4500
=001  9880364566702441
=005  20141212221003.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053604
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x227
=072  \\$aI1.$x198.$x780.$x952
=150  \\$aForensic Nursing
=450  \\$wnnna$aForensic Nursings
=450  \\$aNursing, Forensic
=550  \\$wg$aForensic Sciences
=550  \\$wg$aSpecialties, Nursing
=680  \\$iThe application of NURSING knowledge to questions of law. It is a specialty of nursing practice involving victims of crime which includes not only attending to the physical and emotional distress of victims, but also the identifying, collecting, and preserving evidence for law enforcement and the criminal justice system.
=688  \\$a2007
=750  \0$aForensic nursing$0(DLC) sh 97007377$5IEN-M

=LDR  01143cz  a2200301n  4500
=001  9880364566802441
=005  20170707113039.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053595
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x872.$x700.$x250
=150  \\$aEmbryonic Stem Cells
=450  \\$wnnna$aCell, Embryonic Stem
=450  \\$wnnna$aCells, Embryonic Stem
=450  \\$wnnna$aEmbryonic Stem Cell
=450  \\$wnnna$aStem Cell, Embryonic
=450  \\$aStem Cells, Embryonic
=550  \\$wg$aPluripotent Stem Cells
=550  \\$wh$aBlastomeres
=550  \\$wh$aEmbryoid Bodies
=550  \\$wh$aEmbryonal Carcinoma Stem Cells
=550  \\$wh$aEmbryonic Germ Cells
=550  \\$wh$aHuman Embryonic Stem Cells
=550  \\$wh$aMouse Embryonic Stem Cells
=550  \\$aBlastocyst Inner Cell Mass
=680  \\$iCells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells.
=688  \\$a2007
=750  \0$aEmbryonic stem cells$0(DLC) sh 92005532$5IEN-M

=LDR  00622cz  a2200205n  4500
=001  9880364566902441
=005  20141212221002.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053593
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x703.$x795.$x424
=072  \\$aH2.$x628.$x795.$x424
=072  \\$aI1.$x198.$x780.$x968
=150  \\$aForensic Toxicology
=450  \\$wnnna$aToxicology, Forensic
=550  \\$wg$aForensic Sciences
=550  \\$wg$aToxicology
=680  \\$iThe application of TOXICOLOGY knowledge to questions of law.
=688  \\$a2007
=750  \0$aForensic toxicology$0(DLC) sh 85050562$5IEN-M

=LDR  00892cz  a2200229n  4500
=001  9880364567002441
=005  20141212221001.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053591
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x617.$x894
=072  \\$aC23.$x888.$x592.$x612.$x888
=072  \\$aC23.$x888.$x646.$x690
=150  \\$aPain, Referred
=450  \\$aFacial Pain, Referred
=450  \\$wnnna$aReferred Facial Pain
=450  \\$aReferred Pain
=550  \\$wg$aPain
=667  \\$acoordinate with specific pain term if pertinent
=680  \\$iA type of pain that is perceived in an area away from the site where the pain arises, such as facial pain caused by lesion of the VAGUS NERVE, or throat problem generating referred pain in the ear.
=688  \\$a2007; for REFERRED FACIAL PAIN use FACIAL PAIN 2000-2006
=750  \0$aReferred pain$0(DLC) sh 93002608$5IEN-M

=LDR  00814cz  a2200217n  4500
=001  9880364567102441
=005  20141212220958.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053580
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x425
=072  \\$aG11.$x427.$x560
=150  \\$aMuscle Strength
=450  \\$wnnna$aStrength, Muscle
=550  \\$wg$aMusculoskeletal Physiological Phenomena
=550  \\$wg$aPhysical Examination
=550  \\$wh$aHand Strength
=550  \\$aMuscle Contraction
=680  \\$iThe amount of force generated by MUSCLE CONTRACTION. Muscle strength can be measured during isometric, isotonic, or isokinetic contraction, either manually or using a device such as a MUSCLE STRENGTH DYNAMOMETER.
=688  \\$a2007
=750  \0$aMuscle strength$0(DLC) sh 85088685$5IEN-M

=LDR  00714cz  a2200229n  4500
=001  9880364567202441
=005  20250501094736.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053566
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x357
=150  \\$aFeminine Hygiene Products
=450  \\$wnnna$aFeminine Hygiene Product
=450  \\$wnnna$aHygiene Product, Feminine
=450  \\$wnnna$aHygiene Products, Feminine
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aMenstrual Hygiene Products
=550  \\$wh$aVaginal Creams, Foams, and Jellies
=550  \\$aVaginal Douching
=680  \\$iPersonal care items for women.
=688  \\$a2007
=750  \0$aMenstrual products$0(DLC)sh2007001895$5IEN-M

=LDR  00728cz  a2200205n  4500
=001  9880364567302441
=005  20141212193114.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053545
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280.$x697
=150  \\$aSpirulina
=450  \\$wnnna$aArthrospira
=450  \\$wnnna$aArthrospira maxima
=450  \\$wnnna$aSpirulina maxima
=550  \\$wg$aCyanobacteria
=667  \\$ado not confuse with the cephalopod suborder Spirulina
=680  \\$iA genus of filamentous CYANOBACTERIA found in most lakes and ponds. It has been used as a nutritional supplement particularly due to its high protein content.
=688  \\$a2007 (1982)
=750  \0$aSpirulina$0(DLC) sh 85126795$5IEN-M

=LDR  01205cz  a2200313n  4500
=001  9880364567402441
=005  20141212220932.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053495
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x374.$x625
=072  \\$aD12.$x776.$x395.$x700.$x837
=072  \\$aD12.$x776.$x467.$x374.$x625
=072  \\$aD12.$x776.$x860.$x300.$x762
=072  \\$aD23.$x529.$x374.$x625
=150  \\$aOsteopontin
=450  \\$wnnna$aBone Sialoprotein 1
=450  \\$wnnna$aBone Sialoprotein I
=450  \\$wnnna$aSecreted Phosphoprotein 1
=450  \\$wnnna$aSialoprotein 1
=450  \\$wnnna$aSialoprotein 1, Bone
=450  \\$wnnna$aSialoprotein I, Bone
=450  \\$wnnna$aUropontin
=550  \\$wg$aCytokines
=550  \\$wg$aExtracellular Matrix Proteins
=550  \\$wg$aSialoglycoproteins
=680  \\$iA negatively-charged extracellular matrix protein that plays a role in the regulation of BONE metabolism and a variety of other biological functions. Cell signaling by osteopontin may occur through a cell adhesion sequence that recognizes INTEGRIN ALPHA-V BETA-3.
=688  \\$a2007(1987)
=750  \0$aOsteopontin$0(DLC) sh 95002373$5IEN-M

=LDR  00850cz  a2200241n  4500
=001  9880364567502441
=005  20141212220928.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053483
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x230
=150  \\$aEye Movement Measurements
=450  \\$wnnna$aEye Movement Measurement
=450  \\$wnnna$aMeasurement, Eye Movement
=450  \\$wnnna$aMeasurements, Eye Movement
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$wh$aElectronystagmography
=550  \\$wh$aElectrooculography
=550  \\$aEye Movements
=667  \\$anystagmography may go here but consider also ELECTRONYSTAGMOGRAPHY; EYE MOVEMENTS is also available
=680  \\$iMethods and procedures for recording EYE MOVEMENTS.
=688  \\$a2007
=750  \0$aEye tracking$0(DLC)sh2014000212$5IEN-M

=LDR  01006cz  a2200313n  4500
=001  9880364567602441
=005  20170609105018.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053476
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x510
=150  \\$aExtinction, Biological
=450  \\$wnnna$aBiological Extinction
=450  \\$wnnna$aBiological Extinctions
=450  \\$aExtinction, Mass
=450  \\$aExtinction, Species
=450  \\$wnnna$aExtinctions, Biological
=450  \\$wnnna$aExtinctions, Mass
=450  \\$wnnna$aExtinctions, Species
=450  \\$aMass Extinction
=450  \\$wnnna$aMass Extinctions
=450  \\$aSpecies Extinction
=450  \\$wnnna$aSpecies Extinctions
=550  \\$wg$aBiological Phenomena
=550  \\$aEndangered Species
=667  \\$aEXTINCTION, PSYCHOLOGICAL is also available
=680  \\$iThe ceasing of existence of a species or taxonomic groups of organisms.
=688  \\$a2007
=750  \0$aExtinction (Biology)$0(DLC) sh 85046568$5IEN-M

=LDR  01197cz  a2200277n  4500
=001  9880364567702441
=005  20141212220914.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053421
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x668.$x829.$x380
=072  \\$aC14.$x907.$x440
=072  \\$aC24.$x400
=150  \\$aHand-Arm Vibration Syndrome
=450  \\$wnnna$aHand Arm Vibration Syndrome
=450  \\$wnnna$aHand-Arm Vibration Syndromes
=450  \\$wnnna$aSyndrome, Hand-Arm Vibration
=450  \\$wnnna$aSyndromes, Hand-Arm Vibration
=450  \\$wnnna$aVibration Syndrome, Hand-Arm
=450  \\$wnnna$aVibration Syndromes, Hand-Arm
=550  \\$wg$aOccupational Diseases
=550  \\$wg$aPeripheral Nervous System Diseases
=550  \\$wg$aVascular Diseases
=680  \\$iAn occupational disorder resulting from prolonged exposure to vibration, affecting the fingers, hands, and forearms. It occurs in workers who regularly use vibrating tools such as jackhammers, power chain saws, riveters, etc. Symptoms include episodic finger blanching, NUMBNESS, tingling, and loss of nerve sensitivity.
=688  \\$a2007
=750  \0$aVibration syndrome$0(DLC) sh 85143127$5IEN-M

=LDR  00995cz  a2200265n  4500
=001  9880364567802441
=005  20141212220911.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053403
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x564
=150  \\$aLateral Line System
=450  \\$wnnna$aCanal, Lateral Line
=450  \\$wnnna$aLateral Line Canal
=450  \\$wnnna$aLateral Line Organ
=450  \\$wnnna$aLateral Line Organs
=450  \\$wnnna$aLateral Line Systems
=450  \\$wnnna$aOrgan, Lateral Line
=450  \\$wnnna$aOrgans, Lateral Line
=450  \\$wnnna$aSystem, Lateral Line
=450  \\$wnnna$aSystems, Lateral Line
=550  \\$wg$aAnimal Structures
=680  \\$iAquatic vertebrate sensory system in fish and amphibians. It is composed of sense organs (canal organs and pit organs) containing neuromasts (MECHANORECEPTORS) that detect water displacement caused by moving objects.
=688  \\$a2007
=750  \0$aLateral line organs$0(DLC) sh 85074844$5IEN-M

=LDR  00673cz  a2200205n  4500
=001  9880364567902441
=005  20141212220854.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053281
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x244
=072  \\$aD2.$x455.$x326.$x397.$x662.$x500.$x500
=150  \\$aEnediynes
=450  \\$wnnna$aEnediyne Group
=550  \\$wg$aAlkenes
=550  \\$wg$aDiynes
=550  \\$wh$aZinostatin
=680  \\$iCompounds with triple bonds to each side of a double bond. Many of these are CYTOTOXINS and are researched for use as CYTOTOXIC ANTIBIOTICS.
=688  \\$a2007
=750  \0$aEnediynes$0(DLC) sh 00006818$5IEN-M

=LDR  01651cz  a2200421n  4500
=001  9880364568102441
=005  20141212220852.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053263
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x80.$x689.$x360
=150  \\$aGene Regulatory Networks
=450  \\$wnnna$aCircuit, Gene
=450  \\$wnnna$aCircuits, Gene
=450  \\$wnnna$aGene Circuit
=450  \\$aGene Circuits
=450  \\$wnnna$aGene Module
=450  \\$aGene Modules
=450  \\$wnnna$aGene Network
=450  \\$aGene Networks
=450  \\$wnnna$aGene Regulatory Network
=450  \\$wnnna$aModule, Gene
=450  \\$wnnna$aModules, Gene
=450  \\$wnnna$aNetwork, Gene
=450  \\$wnnna$aNetwork, Gene Regulatory
=450  \\$wnnna$aNetwork, Transcriptional
=450  \\$wnnna$aNetworks, Gene
=450  \\$wnnna$aNetworks, Gene Regulatory
=450  \\$wnnna$aNetworks, Transcriptional
=450  \\$wnnna$aRegulatory Network, Gene
=450  \\$wnnna$aRegulatory Networks, Gene
=450  \\$wnnna$aTranscriptional Network
=450  \\$aTranscriptional Networks
=550  \\$wg$aRegulatory Sequences, Nucleic Acid
=550  \\$aProtein Interaction Maps
=680  \\$iInteracting DNA-encoded regulatory subsystems in the GENOME that coordinate input from activator and repressor TRANSCRIPTION FACTORS during development, cell differentiation, or in response to environmental cues. The networks function to ultimately specify expression of particular sets of GENES for specific conditions, times, or locations.
=688  \\$a2007
=750  \0$aGene regulatory networks$5IEN-M$0(DLC)sh2012001089

=LDR  00845cz  a2200181n  4500
=001  9880364568202441
=005  20141212220851.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053260
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x633.$x937.$x339
=150  \\$aSoot
=450  \\$wnnna$aBlack, Carbon
=450  \\$aCarbon Black
=550  \\$wg$aSmoke
=680  \\$iA dark powdery deposit of unburned fuel residues, composed mainly of amorphous CARBON and some HYDROCARBONS, that accumulates in chimneys, automobile mufflers and other surfaces exposed to smoke. It is the product of incomplete combustion of carbon-rich organic fuels in low oxygen conditions. It is sometimes called lampblack or carbon black and is used in INK, in rubber tires, and to prepare CARBON NANOTUBES.
=688  \\$a2007
=750  \0$aSoot$0(DLC) sh 85125274$5IEN-M

=LDR  01428cz  a2200301n  4500
=001  9880364568302441
=005  20141212220845.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053218
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x73
=150  \\$aReceptors, Death Domain
=450  \\$aDeath Domain Receptors
=450  \\$wnnna$aDeath Receptors
=450  \\$wnnna$aDomain Receptors, Death
=450  \\$wnnna$aDR Family Receptors
=450  \\$wnnna$aReceptors, Death
=450  \\$wnnna$aReceptors, Death Domain Family
=450  \\$wnnna$aReceptors, DR Family
=550  \\$wg$aReceptors, Cell Surface
=550  \\$wh$aAntigens, CD95
=550  \\$wh$aEdar Receptor
=550  \\$wh$aReceptors, TNF-Related Apoptosis-Inducing Ligand
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Member 25
=550  \\$wh$aReceptors, Tumor Necrosis Factor, Type I
=680  \\$iA family of cell surface receptors that signal via a conserved domain that extends into the cell CYTOPLASM. The conserved domain is referred to as a death domain due to the fact that many of these receptors are involved in signaling APOPTOSIS. Several DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS can bind to the death domains of the activated receptors and through a complex series of interactions activate apoptotic mediators such as CASPASES.
=688  \\$a2007
=750  \0$aDeath receptors$0(DLC)sh2009010984$5IEN-M

=LDR  00812cz  a2200241n  4500
=001  9880364568402441
=005  20141212220844.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053210
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x651
=072  \\$aD26.$x655
=150  \\$aPharmaceutical Preparations, Dental
=450  \\$wnnna$aDental Drugs
=450  \\$wnnna$aDental Pharmaceutical Preparations
=450  \\$aDrugs, Dental
=450  \\$wnnna$aPreparations, Dental Pharmaceutical
=550  \\$wg$aBiomedical and Dental Materials
=550  \\$wg$aPharmaceutical Preparations
=667  \\$ageneral or unspecified only; do not add routinely as a coordinate with specific drugs
=680  \\$iDrugs intended for DENTISTRY.
=688  \\$a2007
=750  \0$aDental pharmacology$0(DLC) sh 85036914$5IEN-M

=LDR  00600cz  a2200181n  4500
=001  9880364568502441
=005  20141212220844.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053209
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x320.$x443
=150  \\$aHerbicide Resistance
=450  \\$wnnna$aResistance, Herbicide
=550  \\$wg$aDrug Resistance
=667  \\$aIM when general; NIM when with specific herbicide (IM) & specific plant (IM)
=680  \\$iDiminished or failed response of PLANTS to HERBICIDES.
=688  \\$a2007
=750  \0$aHerbicide resistance$0(DLC) sh 85060341$5IEN-M

=LDR  00728cz  a2200193n  4500
=001  9880364568602441
=005  20141212220843.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053205
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x24.$x249.$x500.$x249.$x500.$x500
=150  \\$aPollen Tube
=450  \\$wnnna$aPollen Tubes
=450  \\$wnnna$aTube, Pollen
=450  \\$wnnna$aTubes, Pollen
=550  \\$wg$aPollen
=680  \\$iA growth from a pollen grain down into the flower style which allows two sperm to pass, one to the ovum within the ovule, and the other to the central cell of the ovule to produce endosperm of SEEDS.
=688  \\$a2007; use FLOWERS 2002-2006
=750  \0$aPollen tube$0(DLC) sh 85104519$5IEN-M

=LDR  00938cz  a2200241n  4500
=001  9880364568702441
=005  20141212220842.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053204
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA18.$x400.$x875
=150  \\$aRoot Nodules, Plant
=450  \\$wnnna$aNodule, Plant Root
=450  \\$wnnna$aNodules, Plant Root
=450  \\$wnnna$aPlant Root Nodule
=450  \\$wnnna$aPlant Root Nodules
=450  \\$wnnna$aRoot Nodule, Plant
=550  \\$wg$aPlant Roots
=550  \\$aMycorrhizae
=550  \\$aPlant Root Nodulation
=680  \\$iKnobbed structures formed from and attached to plant roots, especially of LEGUMES, which result from symbiotic infection by nitrogen fixing bacteria such as RHIZOBIUM or FRANKIA. Root nodules are structures related to MYCORRHIZAE formed by symbiotic associations with fungi.
=688  \\$a2007
=750  \0$aRoot-tubercles$0(DLC) sh 85115371$5IEN-M

=LDR  00714cz  a2200265n  4500
=001  9880364568802441
=005  20141212220837.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053149
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x739
=072  \\$aD9.$x698.$x700
=072  \\$aD20.$x215.$x721.$x249
=150  \\$aPlant Gums
=450  \\$wnnna$aGums, Plant
=550  \\$wg$aBiopolymers
=550  \\$wg$aPlant Exudates
=550  \\$wg$aPolysaccharides
=550  \\$wh$aChewing Gum
=550  \\$wh$aGum Arabic
=550  \\$wh$aKaraya Gum
=550  \\$wh$aTragacanth
=680  \\$iPolysaccharide gums from PLANTS.
=688  \\$a2007
=750  \0$aGums and resins$0(DLC) sh 85057914$5IEN-M

=LDR  00620cz  a2200217n  4500
=001  9880364568902441
=005  20141212220836.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x721
=150  \\$aPlant Exudates
=450  \\$wnnna$aExudates, Plant
=550  \\$wg$aBiological Products
=550  \\$wh$aGutta-Percha
=550  \\$wh$aLatex
=550  \\$wh$aPlant Gums
=550  \\$wh$aResins, Plant
=680  \\$iSubstances released by PLANTS such as PLANT GUMS and PLANT RESINS.
=688  \\$a2007
=750  \0$aPlant exudates$0(DLC) sh 87001174$5IEN-M

=LDR  00786cz  a2200193n  4500
=001  9880364569002441
=005  20141212220830.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053099
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x936.$x231
=072  \\$aC13.$x351.$x968.$x419.$x936.$x231
=072  \\$aC23.$x550.$x145
=150  \\$aAzotemia
=550  \\$wg$aPathologic Processes
=550  \\$wg$aUremia
=680  \\$iA biochemical abnormality referring to an elevation of BLOOD UREA NITROGEN and CREATININE. Azotemia can be produced by KIDNEY DISEASES or other extrarenal disorders. When azotemia becomes associated with a constellation of clinical signs, it is termed UREMIA.
=688  \\$a2007; use UREMIA 1975-2006
=750  \0$aAzotemia$0(DLC) sh 85010664$5IEN-M

=LDR  00712cz  a2200193n  4500
=001  9880364569102441
=005  20141212220826.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053001
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x840
=150  \\$aTool Use Behavior
=450  \\$wnnna$aBehavior, Tool Use
=450  \\$wnnna$aBehaviors, Tool Use
=450  \\$wnnna$aTool Use Behaviors
=550  \\$wg$aBehavior, Animal
=680  \\$iModifying, carrying, or manipulating an item external to itself by an animal, before using it to effect a change on the environment or itself (from Beck, Animal Tool Behavior, 1980).
=688  \\$a2007
=750  \0$aTool use in animals$0(DLC) sh 85136047$5IEN-M

=LDR  00703cz  a2200169n  4500
=001  9880364569202441
=005  20141212220826.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D053000
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x59
=150  \\$aAnalytic Sample Preparation Methods
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$aHistocytological Preparation Techniques
=680  \\$iUse of various chemical separation and extraction methods, such as SOLID PHASE EXTRACTION; CHROMATOGRAPHY; and SUPERCRITICAL FLUID EXTRACTION; to prepare samples for analytical measurement of components.
=688  \\$a2007
=750  \0$aSample preparation (Chemistry)$0(DLC)sh2005006068$5IEN-M

=LDR  00682cz  a2200169n  4500
=001  9880364569302441
=005  20141212220826.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052998
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x447
=072  \\$aD12.$x644.$x641.$x447
=150  \\$aMicrocystins
=550  \\$wg$aPeptides, Cyclic
=680  \\$iCyclic heptapeptides found in MICROCYSTIS and other CYANOBACTERIA. Hepatotoxic and carcinogenic effects have been noted. They are sometimes called cyanotoxins, which should not be confused with chemicals containing a cyano group (CN) which are toxic.
=688  \\$a2007
=750  \0$aMicrocystins$0(DLC) sh 92005156$5IEN-M

=LDR  00666cz  a2200193n  4500
=001  9880364569402441
=005  20141212220825.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052981
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x541
=150  \\$aMetarhizium
=450  \\$wnnna$aanisopliae, Metarhizium
=450  \\$wnnna$aMetarhizium anisopliae
=450  \\$wnnna$aMetarhiziums
=550  \\$wg$aMitosporic Fungi
=680  \\$iA mitosporic fungal genus in the family Clavicipitaceae. It has teleomorphs in the family Nectriaceae. Metarhizium anisopliae is used in PESTICIDES.
=688  \\$a2007
=750  \0$aMetarhizium$0(DLC) sh 88022073$5IEN-M

=LDR  00568cz  a2200181n  4500
=001  9880364569502441
=005  20141212220825.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052980
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x578.$x840.$x468
=072  \\$aD3.$x549.$x909.$x468
=072  \\$aD4.$x345.$x783.$x468
=150  \\$aPhycobilins
=550  \\$wg$aTetrapyrroles
=680  \\$iOpen chain tetrapyrroles that function as light harvesting chromophores in PHYCOBILIPROTEINS.
=688  \\$a2007
=750  \0$aPhycobilins$0(DLC) sh 85101464$5IEN-M

=LDR  01125cz  a2200229n  4500
=001  9880364569602441
=005  20141212220825.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052979
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x500.$x562.$x488.$x490.$x500.$x500
=072  \\$aD8.$x811.$x600.$x710.$x490.$x500.$x500
=150  \\$aPhycobiliproteins
=450  \\$wnnna$aLight-Harvesting Bacteriochlorophyll Protein Complexes
=450  \\$wnnna$aLight Harvesting Bacteriochlorophyll Protein Complexes
=550  \\$wg$aPhycobilisomes
=550  \\$wh$aPhycocyanin
=550  \\$wh$aPhycoerythrin
=680  \\$iLight harvesting proteins found in phycobilisomes.
=688  \\$a2007; use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2006, use LIGHT-HARVESTING PROTEIN COMPLEXES (NM) 1980-2003 & PROTEINS 1978-1979; for LIGHT-HARVESTING BACTERIOCHLOROPHYLL PROTEIN COMPLEXES use LIGHT-HARVESTING PROTEIN COMPLEXES 1991-2011
=688  \\$a2007; use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2006, use LIGHT-HARVESTING PROTEIN COMPLEXES (NM) 1980-2003 & PROTEINS 1978-1979
=750  \0$aPhycobiliproteins$0(DLC) sh 86002305$5IEN-M

=LDR  01750cz  a2200433n  4500
=001  9880364569702441
=005  20141212193111.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052918
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x256.$x282
=072  \\$aN6.$x230.$x80.$x600
=072  \\$aN6.$x850.$x460.$x375
=150  \\$aEnvironmental Restoration and Remediation
=450  \\$wnnna$aCleanup, Environmental
=450  \\$wnnna$aCleanups, Environmental
=450  \\$aEnvironmental Cleanup
=450  \\$wnnna$aEnvironmental Cleanups
=450  \\$aEnvironmental Remediation
=450  \\$wnnna$aEnvironmental Remediations
=450  \\$aEnvironmental Restoration
=450  \\$aPollution Remediation
=450  \\$wnnna$aRemediation, Environmental
=450  \\$wnnna$aRemediation, Pollution
=450  \\$wnnna$aRemediation, Site
=450  \\$wnnna$aRemediations, Environmental
=450  \\$wnnna$aRemediations, Site
=450  \\$wnnna$aRestoration, Environmental
=450  \\$aSite Remediation
=450  \\$wnnna$aSite Remediations
=550  \\$wg$aConservation of Natural Resources
=550  \\$wg$aEnvironmental Pollution
=550  \\$wh$aBiodegradation, Environmental
=550  \\$aAgricultural Inoculants
=680  \\$iRestoration of an environment, ecosystem, or habitat that was physically damaged during land development or by natural disaster, or contaminated by ENVIRONMENTAL POLLUTANTS. This is accomplished by various chemical, biological, and bulk movement methods, in conjunction with ENVIRONMENTAL MONITORING.
=688  \\$a2015 (2007)
=688  \\$aHeading changed 20140902 from: 150:##:_{dollar}a Environmental Remediation
=688  \\$a2007
=750  \0$aIn situ remediation$0(DLC) sh 94005803$5IEN-M

=LDR  01133cz  a2200325n  4500
=001  9880364569802441
=005  20141212220822.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052898
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x650
=150  \\$aOptical Tweezers
=450  \\$wnnna$aLaser Tweezer
=450  \\$wnnna$aLaser Tweezers
=450  \\$wnnna$aOptical Trap
=450  \\$wnnna$aOptical Trapping
=450  \\$wnnna$aOptical Traps
=450  \\$wnnna$aOptical Tweezer
=450  \\$wnnna$aTrap, Optical
=450  \\$wnnna$aTrapping, Optical
=450  \\$wnnna$aTraps, Optical
=450  \\$wnnna$aTweezer, Laser
=450  \\$wnnna$aTweezer, Optical
=450  \\$wnnna$aTweezers, Laser
=450  \\$wnnna$aTweezers, Optical
=550  \\$wg$aInvestigative Techniques
=550  \\$aLasers
=680  \\$iA technique that uses LASERS to trap, image, and manipulate small objects (biomolecules, supramolecular assembles, DENDRIMERS) in three dimensional space. (From Glossary of Biotechnology and Nanobiotechnology Terms, 4th ed.)
=688  \\$a2007
=750  \0$aOptical tweezers$0(DLC)sh2009008496$5IEN-M

=LDR  00921cz  a2200217n  4500
=001  9880364569902441
=005  20141212220822.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052880
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x767
=072  \\$aC5.$x651.$x594.$x909
=072  \\$aC10.$x668.$x491.$x562.$x787
=150  \\$aPyomyositis
=450  \\$wnnna$aMyositis, Tropical
=450  \\$wnnna$aTropical Myositis
=550  \\$wg$aMyositis
=550  \\$wg$aSuppuration
=680  \\$iAn intramuscular suppuration of the large skeletal muscle groups. It is associated with INFECTION such as STAPHYLOCOCCUS AUREUS and PYODERMA. It was known as a tropical disease but is increasing among the immunocompromised (IMMUNOCOMPROMISED HOST). Symptoms include muscle pain, FEVER, and leucocytosis. It has been diagnosed by MRI SCANS.
=688  \\$a2007
=750  \0$aMyositis tropica$0(DLC) sh 85089277$5IEN-M

=LDR  00973cz  a2200229n  4500
=001  9880364570002441
=005  20141212220821.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052858
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x829.$x707
=072  \\$aC13.$x351.$x968.$x829.$x508
=072  \\$aC23.$x300.$x842.$x624.$x249
=150  \\$aCystocele
=450  \\$aFallen Urinary Bladder
=450  \\$wnnna$aProlapse, Urinary Bladder
=450  \\$aUrinary Bladder Prolapse
=550  \\$wg$aPelvic Organ Prolapse
=550  \\$wg$aUrinary Bladder Diseases
=680  \\$iA HERNIA-like condition in which the weakened pelvic muscles cause the URINARY BLADDER to drop from its normal position. Fallen urinary bladder is more common in females with the bladder dropping into the VAGINA and less common in males with the bladder dropping into the SCROTUM.
=688  \\$a2007; use URINARY BLADDER DISEASE 1990-2006
=750  \0$aCystocele$0(DLC) sh 85014730$5IEN-M

=LDR  00528cz  a2200181n  4500
=001  9880364570102441
=005  20141212220818.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052816
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x444.$x492.$x362
=150  \\$aForeskin
=450  \\$wnnna$aForeskins
=550  \\$wg$aPenis
=550  \\$aCircumcision, Male
=680  \\$iThe double-layered skin fold that covers the GLANS PENIS, the head of the penis.
=688  \\$a2007
=750  \0$aForeskin$0(DLC)sh2012003778$5IEN-M

=LDR  01146cz  a2200325n  4500
=001  9880364570202441
=005  20141212220818.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12
=150  \\$aMale Urogenital Diseases
=450  \\$wnnna$aGenitourinary Disease, Male
=450  \\$wnnna$aGenitourinary Diseases, Male
=450  \\$wnnna$aMale Genitourinary Disease
=450  \\$wnnna$aMale Genitourinary Diseases
=450  \\$wnnna$aMale Urogenital Disease
=450  \\$wnnna$aUrogenital Disease, Male
=450  \\$wnno$aUrogenital Diseases$5IEN-M
=450  \\$wnnna$aUrogenital Diseases, Male
=550  \\$wh$aGenital Diseases, Male
=550  \\$wh$aPelvic Floor Disorders
=550  \\$wh$aTuberculosis, Urogenital
=550  \\$wh$aUrogenital Abnormalities
=550  \\$wh$aUrogenital Neoplasms
=550  \\$wh$aUrologic Diseases
=667  \\$ageneral; prefer specifics
=680  \\$iPathological processes of the male URINARY TRACT and the reproductive system (GENITALIA, MALE).
=688  \\$a2007
=750  \0$aGenitourinary organs$xDiseases$0(DLC) sh 85053898$5IEN-M

=LDR  01235cz  a2200337n  4500
=001  9880364570302441
=005  20141212220816.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052776
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351
=150  \\$aFemale Urogenital Diseases
=450  \\$wnnna$aFemale Genitourinary Disease
=450  \\$aFemale Genitourinary Diseases
=450  \\$wnnna$aFemale Urogenital Disease
=450  \\$wnnna$aGenitourinary Disease, Female
=450  \\$wnnna$aGenitourinary Diseases, Female
=450  \\$wnnna$aUrogenital Disease, Female
=450  \\$wnno$aUrogenital Diseases$5IEN-M
=450  \\$wnnna$aUrogenital Diseases, Female
=550  \\$wg$aFemale Urogenital Diseases and Pregnancy Complications
=550  \\$wh$aGenital Diseases, Female
=550  \\$wh$aPelvic Floor Disorders
=550  \\$wh$aTuberculosis, Urogenital
=550  \\$wh$aUrogenital Abnormalities
=550  \\$wh$aUrogenital Neoplasms
=550  \\$wh$aUrologic Diseases
=667  \\$ageneral; prefer specifics
=680  \\$iPathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).
=688  \\$a2007
=750  \0$aGenitourinary organs$xDiseases$0(DLC) sh 85053898

=LDR  01044cz  a2200265n  4500
=001  9880364570402441
=005  20141212220815.0
=008  060705\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D052700
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x565.$x830
=072  \\$aB4.$x909.$x777.$x618.$x830
=150  \\$aTeschovirus
=450  \\$wnnna$aPorcine teschovirus
=450  \\$wnnna$aPorcine teschoviruses
=450  \\$aTalfan Disease Virus
=450  \\$aTeschen Disease Virus
=450  \\$wnnna$ateschovirus, Porcine
=450  \\$wnnna$aTeschoviruses
=450  \\$wnnna$ateschoviruses, Porcine
=550  \\$wg$aPicornaviridae
=667  \\$ainfection: coordinate IM with PICORNAVIRIDAE INFECTIONS (IM)
=680  \\$iA genus in the family PICORNAVIRIDAE that can cause polioencephalomyelitis in pigs. The type species Porcine teschovirus is comprised of multiple strains.
=688  \\$a2007; for TALFAN DISEASE VIRUS & TESCHEN DISEASE VIRUS use ENTEROVIRUSES, PORCINE 1974-2006
=750  \0$aTeschen disease virus$0(DLC) sh 85134132$5IEN

=LDR  00689cz  a2200193n  4500
=001  9880363338102441
=005  20141212195029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001271
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x147
=150  \\$aAtlases as Topic
=450  \\$wnnna$aAtlases as Topics
=550  \\$wg$aReference Books
=667  \\$aanatomical atlases go under ATLASES AS TOPIC (IM) + ANATOMY, ARTISTIC (IM)
=680  \\$iCollections of illustrative plates, charts, etc., usually with explanatory captions.
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Atlases
=750  \0$aAtlases$0(DLC) sh 85009231$5IEN

=LDR  00604cz  a2200205n  4500
=001  9880363338202441
=005  20141212195029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001270
=035  \\$aCAZ4425HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x151.$x500
=150  \\$aCervical Atlas
=450  \\$wnnoa$aAtlas$5IEN-M
=450  \\$aAtlas, Cervical
=550  \\$wg$aCervical Vertebrae
=680  \\$iThe first cervical vertebra.
=688  \\$a2009 (1963)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Atlas
=750  \0$aAtlas (Vertebra)$0(DLC) sh 85009226$5IEN

=LDR  02341cz  a2200481n  4500
=001  9880363338302441
=005  20141212195051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001342
=035  \\$aCAZ4497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x177
=150  \\$aAutonomic Nervous System Diseases
=450  \\$wnnna$aANS (Autonomic Nervous System) Diseases
=450  \\$wnnna$aANS Disease
=450  \\$wnnna$aANS Diseases
=450  \\$wnnna$aAutonomic Central Nervous System Diseases
=450  \\$wnnna$aAutonomic Disease
=450  \\$wnnna$aAutonomic Diseases
=450  \\$wnnna$aAutonomic Dysfunction, Segmental
=450  \\$wnnna$aAutonomic Dysfunctions, Segmental
=450  \\$wnnna$aAutonomic Nervous System Disorders
=450  \\$wnnna$aAutonomic Peripheral Nervous System Diseases
=450  \\$aCentral Autonomic Nervous System Diseases
=450  \\$aDisorders of the Autonomic Nervous System
=450  \\$aNervous System Diseases, Autonomic
=450  \\$aNervous System Diseases, Parasympathetic
=450  \\$aNervous System Diseases, Sympathetic
=450  \\$aParasympathetic Nervous System Diseases
=450  \\$aPeripheral Autonomic Nervous System Diseases
=450  \\$wnnna$aSegmental Autonomic Dysfunction
=450  \\$wnnna$aSegmental Autonomic Dysfunctions
=450  \\$aSympathetic Nervous System Diseases
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aAdie Syndrome
=550  \\$wh$aAutonomic Dysreflexia
=550  \\$wh$aComplex Regional Pain Syndromes
=550  \\$wh$aHorner Syndrome
=550  \\$wh$aPrimary Dysautonomias
=550  \\$wh$aSweating, Gustatory
=680  \\$iDiseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.
=688  \\$a1981; was AUTONOMIC SYSTEM DISEASES (NON MESH) before 1981
=750  \0$aAutonomic nervous system$xDiseases$5IEN$0(DLC)sh 85090939

=LDR  00807cz  a2200253n  4500
=001  9880363338402441
=005  20141212195029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001269
=035  \\$aCAZ4424HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x101
=150  \\$aAtlanto-Occipital Joint
=450  \\$wnnna$aAtlanto Occipital Joint
=450  \\$wnnna$aAtlanto-Occipital Joints
=450  \\$aAtloido-Occipital Joint
=450  \\$wnnna$aAtloido Occipital Joint
=450  \\$wnnna$aAtloido-Occipital Joints
=450  \\$wnnna$aJoint, Atlanto-Occipital
=450  \\$wnnna$aJoint, Atloido-Occipital
=450  \\$wnnna$aJoints, Atlanto-Occipital
=450  \\$wnnna$aJoints, Atloido-Occipital
=550  \\$wg$aJoints
=750  \0$aAtlanto-occipital joint$5IEN$0(DLC)sh 85009220

=LDR  01096cz  a2200313n  4500
=001  9880363338502441
=005  20141212195028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001265
=035  \\$aCAZ4420HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x115
=150  \\$aAthletic Injuries
=450  \\$wnnna$aAthletic Injury
=450  \\$wnnna$aInjuries, Athletic
=450  \\$wnnna$aInjuries, Sports
=450  \\$wnnna$aInjury, Athletic
=450  \\$wnnna$aInjury, Sports
=450  \\$aSports for Persons with Disabilities$xinjuries
=450  \\$aSports Injuries
=450  \\$aSports$xinjuries
=450  \\$wnnna$aSports Injury
=550  \\$wg$aWounds and Injuries
=550  \\$aSports
=550  \\$aSports Medicine
=667  \\$aGEN only: prefer specific sport /inj; when GEN, coord IM with specific inj (IM); Manual 30.15.1: relation to SPORTS MEDICINE; consider also TENNIS ELBOW but see note there
=680  \\$iInjuries incurred during participation in competitive or non-competitive sports.
=688  \\$a68
=750  \0$aSports injuries$5IEN$0(DLC)sh 85126888

=LDR  02007cz  a2200433n  4500
=001  9880363338602441
=005  20141212192014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001341
=035  \\$aCAZ4496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x50
=150  \\$aAutonomic Nervous System
=450  \\$wnnna$aAutonomic Nervous Systems
=450  \\$wnnna$aNervous System, Autonomic
=450  \\$wnnna$aNervous System, Vegetative
=450  \\$wnnna$aNervous System, Visceral
=450  \\$wnnna$aNervous Systems, Autonomic
=450  \\$wnnna$aNervous Systems, Vegetative
=450  \\$wnnna$aNervous Systems, Visceral
=450  \\$wnnna$aSystem, Autonomic Nervous
=450  \\$wnnna$aSystem, Vegetative Nervous
=450  \\$wnnna$aSystem, Visceral Nervous
=450  \\$wnnna$aSystems, Autonomic Nervous
=450  \\$wnnna$aSystems, Vegetative Nervous
=450  \\$wnnna$aSystems, Visceral Nervous
=450  \\$wnnna$aVegetative Nervous System
=450  \\$wnnna$aVegetative Nervous Systems
=450  \\$wnnna$aVisceral Nervous System
=450  \\$wnnna$aVisceral Nervous Systems
=550  \\$wg$aPeripheral Nervous System
=550  \\$wh$aAutonomic Pathways
=550  \\$wh$aEnteric Nervous System
=550  \\$wh$aGanglia, Autonomic
=550  \\$wh$aParasympathetic Nervous System
=550  \\$wh$aSympathetic Nervous System
=667  \\$adysfunction = AUTONOMIC NERVOUS SYSTEM DISEASES but consider also DYSAUTONOMIA, FAMILIAL
=680  \\$iThe ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
=750  \0$aAutonomic nervous system$5IEN$0(DLC)sh 85090938

=LDR  01577cz  a2200409n  4500
=001  9880363338702441
=005  20141212195050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001337
=035  \\$aCAZ4492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50
=150  \\$aAutonomic Agents
=450  \\$wnnna$aAgents, Autonomic
=450  \\$wnnna$aAutonomic Drugs
=450  \\$wnnna$aAutonomic Effect
=450  \\$wnnna$aAutonomic Effects
=450  \\$wnnna$aDrugs, Autonomic
=450  \\$wnnna$aEffect, Autonomic
=450  \\$wnnna$aEffects, Autonomic
=550  \\$wg$aPeripheral Nervous System Agents
=550  \\$wh$aAntiemetics
=550  \\$wh$aBronchoconstrictor Agents
=550  \\$wh$aBronchodilator Agents
=550  \\$wh$aEmetics
=550  \\$wh$aGanglionic Blockers
=550  \\$wh$aGanglionic Stimulants
=550  \\$wh$aMiotics
=550  \\$wh$aMydriatics
=550  \\$wh$aParasympatholytics
=550  \\$wh$aParasympathomimetics
=550  \\$wh$aSympatholytics
=550  \\$wh$aSympathomimetics
=667  \\$ageneral or unspecified; prefer specifics; note entry term AUTONOMIC EFFECT: use only for the autonomic effect of a chemical substance
=680  \\$iAgents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.
=688  \\$a82; was AUTONOMIC DRUGS 1963-81
=750  \0$aAutonomic drugs$5IEN$0(DLC)sh 85010456

=LDR  01479cz  a2200349n  4500
=001  9880363338802441
=005  20141212195027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001264
=035  \\$aCAZ4419HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x110
=072  \\$aC23.$x888.$x592.$x350.$x110
=150  \\$aAthetosis
=450  \\$wnnna$aAthetoid Movement
=450  \\$aAthetoid Movements
=450  \\$wnnna$aAthetoses
=450  \\$wnnna$aDisease, Hammond
=450  \\$wnnna$aDisease, Hammond's
=450  \\$wnnna$aDiseases, Hammond
=450  \\$wnnna$aDiseases, Hammond's
=450  \\$wnnna$aHammond Disease
=450  \\$wnnna$aHammond Diseases
=450  \\$wnnna$aHammond's Disease
=450  \\$wnnna$aHammonds Disease
=450  \\$wnnna$aHammond's Diseases
=450  \\$wnnna$aMovement, Athetoid
=450  \\$wnnna$aMovements, Athetoid
=550  \\$wg$aDyskinesias
=667  \\$achoreoathetosis = CHOREA (IM) + ATHETOSIS (IM)
=680  \\$iA dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. (From Adams et al., Principles of Neurology, 6th ed, p76)
=750  \0$aAthetosis$5IEN$0(DLC)sh 85009134

=LDR  00599cz  a2200169n  4500
=001  9880363338902441
=005  20141212195049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001336
=035  \\$aCAZ4491HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x500.$x100
=150  \\$aAutomobiles
=450  \\$wnnna$aAutomobile
=550  \\$wg$aMotor Vehicles
=680  \\$iA usually four-wheeled automotive vehicle designed for passenger transportation and commonly propelled by an internal-combustion engine using a volatile fuel. (Webster, 1973)
=750  \0$aAutomobiles$5IEN$0(DLC)sh 85010201

=LDR  00905cz  a2200253n  4500
=001  9880363339002441
=005  20141212195027.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001262
=035  \\$aCAZ4417HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x624.$x698.$x70
=072  \\$aD2.$x33.$x755.$x624.$x698.$x70
=072  \\$aD2.$x92.$x63.$x624.$x698.$x70
=150  \\$aAtenolol
=450  \\$wnnna$aICI-66082
=450  \\$wnnna$aICI 66082
=450  \\$wnnna$aICI66082
=450  \\$wnnna$aTenormin
=450  \\$wnnna$aTenormine
=550  \\$wg$aPhenoxypropanolamines
=680  \\$iA cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
=688  \\$a84(78); was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77
=750  \0$aAtenolol$5IEN$0(DLC)sh 85009098

=LDR  01232cz  a2200325n  4500
=001  9880363339102441
=005  20141212195049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001335
=035  \\$aCAZ4490HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x832
=150  \\$aVehicle Emissions
=450  \\$aAutomobile Exhaust
=450  \\$aDiesel Exhaust
=450  \\$wnnna$aEmission, Vehicle
=450  \\$wnnna$aEmission, Vehicular
=450  \\$wnnna$aEmissions, Vehicle
=450  \\$wnnna$aEmissions, Vehicular
=450  \\$aEngine Exhaust
=450  \\$wnnna$aExhaust, Automobile
=450  \\$wnnna$aExhaust, Diesel
=450  \\$wnnna$aExhaust, Engine
=450  \\$wnnna$aVehicle Emission
=450  \\$wnnna$aVehicular Emission
=450  \\$wnnna$aVehicular Emissions
=550  \\$wg$aComplex Mixtures
=680  \\$iGases, fumes, vapors, and odors escaping from the cylinders of a gasoline or diesel internal-combustion engine. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed & Random House Unabridged Dictionary, 2d ed)
=688  \\$a96; was AUTOMOBILE EXHAUST 1963-95; was in Cat G only 1968-74, was in Cat G & J 1963-67
=750  \0$aMotor vehicles$xMotors$xExhaust gas$5IEN-HS

=LDR  00972cz  a2200265n  4500
=001  9880363339202441
=005  20180416085133.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001334
=035  \\$aCAZ4489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x125
=150  \\$aAutomobile Driving
=450  \\$aAutomobile Drivers$5IEN
=450  \\$wnnna$aAutomobile Drivings
=450  \\$wnnna$aDriving, Automobile
=450  \\$wnnna$aDrivings, Automobile
=550  \\$wg$aHuman Activities
=550  \\$wh$aAutomobile Driver Examination
=550  \\$wh$aDistracted Driving
=550  \\$wh$aDriving Under the Influence
=680  \\$iThe effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving.
=688  \\$a67(64)
=750  \0$aAutomobile driving$5IEN-M$0(DLC)sh 85010133
=750  \0$aAutomobile drivers$5IEN-HS$0(DLC)sh 85010126

=LDR  00880cz  a2200241n  4500
=001  9880363339302441
=005  20141212195048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001333
=035  \\$aCAZ4488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x125.$x299
=150  \\$aAutomobile Driver Examination
=450  \\$wnnna$aAutomobile Driver Examinations
=450  \\$aAutomobile Drivers' Tests$5IEN
=450  \\$wnnna$aDriver Examination, Automobile
=450  \\$wnnna$aDriver Examinations, Automobile
=450  \\$wnnna$aExamination, Automobile Driver
=450  \\$wnnna$aExaminations, Automobile Driver
=550  \\$wg$aAutomobile Driving
=667  \\$aDF: AUTO DRIVER EXAM
=680  \\$iGovernment required written and driving test given to individuals prior to obtaining an operator's license.
=750  \0$aAutomobile drivers' tests$5IEN$0(DLC)sh 85010131

=LDR  00505cz  a2200157n  4500
=001  9880363339402441
=005  20201113165641.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001332
=035  \\$aCAZ4487HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x179.$x149
=150  \\$aAutomatism
=550  \\$wg$aConditioning, Psychological
=680  \\$iAutomatic, mechanical, and apparently undirected behavior which is outside of conscious control.
=750  \0$aAutomatism$5IEN$0(DLC)sh 85010119

=LDR  00890cz  a2200205n  4500
=001  9880363339502441
=005  20141212195048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001331
=035  \\$aCAZ4486HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x897.$x104
=150  \\$aAutomation
=450  \\$wnnna$aAutomations
=550  \\$wg$aTechnology
=550  \\$wh$aAutomation, Laboratory
=550  \\$wh$aRobotics
=667  \\$afor automation as a concept in technol: not for "automated" equipment or "automated" processes & techniques ( = specific technique without AUTOMATION unless especially discussed)
=680  \\$iControlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. (From Webster's Collegiate Dictionary, 1993)
=750  \0$aAutomation$5IEN$0(DLC)sh 85010116

=LDR  03364cz  a2200781n  4500
=001  9880363339602441
=005  20141212195027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001261
=035  \\$aCAZ4416HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x381.$x730
=150  \\$aPulmonary Atelectasis
=450  \\$wnnna$aAtelectases
=450  \\$wnnna$aAtelectases, Compression
=450  \\$wnnna$aAtelectases, Compression Pulmonary
=450  \\$wnnna$aAtelectases, Congestive
=450  \\$wnnna$aAtelectases, Congestive Pulmonary
=450  \\$wnnna$aAtelectases, Contraction Pulmonary
=450  \\$wnnna$aAtelectases, Postoperative Pulmonary
=450  \\$wnnna$aAtelectases, Pulmonary
=450  \\$wnnna$aAtelectases, Resorption
=450  \\$wnnna$aAtelectases, Resorption Pulmonary
=450  \\$wnnna$aAtelectasis
=450  \\$wnnna$aAtelectasis, Compression
=450  \\$wnnna$aAtelectasis, Compression Pulmonary
=450  \\$aAtelectasis, Congestive
=450  \\$wnnna$aAtelectasis, Congestive Pulmonary
=450  \\$wnnna$aAtelectasis, Contraction Pulmonary
=450  \\$wnnna$aAtelectasis, Postoperative Pulmonary
=450  \\$wnnna$aAtelectasis, Pulmonary
=450  \\$wnnna$aAtelectasis, Resorption
=450  \\$wnnna$aAtelectasis, Resorption Pulmonary
=450  \\$wnnna$aCollapse, Lung
=450  \\$wnnna$aCompression Atelectases
=450  \\$wnnna$aCompression Atelectasis
=450  \\$wnnna$aCompression Pulmonary Atelectases
=450  \\$wnnna$aCompression Pulmonary Atelectasis
=450  \\$wnnna$aCongestive Atelectases
=450  \\$wnnna$aCongestive Atelectasis
=450  \\$wnnna$aCongestive Pulmonary Atelectases
=450  \\$wnnna$aCongestive Pulmonary Atelectasis
=450  \\$wnnna$aContraction Pulmonary Atelectases
=450  \\$wnnna$aContraction Pulmonary Atelectasis
=450  \\$aLung Collapse
=450  \\$wnnna$aPostoperative Pulmonary Atelectases
=450  \\$wnnna$aPostoperative Pulmonary Atelectasis
=450  \\$wnnna$aPulmonary Atelectases
=450  \\$wnnna$aPulmonary Atelectases, Compression
=450  \\$wnnna$aPulmonary Atelectases, Congestive
=450  \\$wnnna$aPulmonary Atelectases, Contraction
=450  \\$wnnna$aPulmonary Atelectases, Postoperative
=450  \\$wnnna$aPulmonary Atelectases, Resorption
=450  \\$wnnna$aPulmonary Atelectasis, Compression
=450  \\$wnnna$aPulmonary Atelectasis, Congestive
=450  \\$wnnna$aPulmonary Atelectasis, Contraction
=450  \\$wnnna$aPulmonary Atelectasis, Postoperative
=450  \\$wnnna$aPulmonary Atelectasis, Resorption
=450  \\$wnnna$aResorption Atelectases
=450  \\$wnnna$aResorption Atelectasis
=450  \\$wnnna$aResorption Pulmonary Atelectases
=450  \\$wnnna$aResorption Pulmonary Atelectasis
=550  \\$wg$aLung Diseases
=550  \\$wh$aMiddle Lobe Syndrome
=680  \\$iAbsence of air in the entire or part of a lung, such as an incompletely inflated neonate lung or a collapsed adult lung. Pulmonary atelectasis can be caused by airway obstruction, lung compression, fibrotic contraction, or other factors.
=688  \\$a2009 (1963); for ATELECTASIS, CONGESTIVE use RESPIRATORY DISTRESS SYNDROME, ADULT 1976-2008
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Atelectasis
=750  \0$aAtelectasis$0(DLC) sh 85009092$5IEN

=LDR  01855cz  a2200385n  4500
=001  9880363339702441
=005  20141212195025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001260
=035  \\$aCAZ4415HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x252.$x190.$x530.$x60
=072  \\$aC10.$x562.$x100
=072  \\$aC10.$x597.$x350.$x90.$x500.$x530.$x60
=072  \\$aC14.$x907.$x823.$x213
=072  \\$aC16.$x320.$x80
=072  \\$aC18.$x452.$x284.$x60
=072  \\$aC20.$x673.$x290
=150  \\$aAtaxia Telangiectasia
=450  \\$wnnna$aAtaxia-Telangiectasia
=450  \\$wnnna$aAtaxia Telangiectasia Syndrome
=450  \\$aLouis-Bar Syndrome
=450  \\$wnnna$aLouis Bar Syndrome
=450  \\$wnnna$aSyndrome, Ataxia Telangiectasia
=450  \\$wnnna$aSyndrome, Louis-Bar
=450  \\$wnnna$aTelangiectasia, Cerebello-Oculocutaneous
=550  \\$wg$aDNA Repair-Deficiency Disorders
=550  \\$wg$aGenetic Diseases, Inborn
=550  \\$wg$aImmunologic Deficiency Syndromes
=550  \\$wg$aNeurocutaneous Syndromes
=550  \\$wg$aSpinocerebellar Ataxias
=550  \\$wg$aTelangiectasis
=680  \\$iAn autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23).
=688  \\$a1968
=750  \0$aAtaxia telangiectasia$5IEN$0(DLC)sh 85009081

=LDR  00644cz  a2200193n  4500
=001  9880363339902441
=005  20141212195047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001329
=035  \\$aCAZ4484HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x224.$x617.$x236
=150  \\$aAutolysis
=450  \\$wnnna$aAutolyses
=550  \\$wg$aPostmortem Changes
=667  \\$arestrict to humans and higher animals; BACTERIOLYSIS is also available
=680  \\$iThe spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes.
=688  \\$a72(68)
=750  \0$aAutolysis$5IEN$0(DLC)sh 85010078

=LDR  02115cz  a2200553n  4500
=001  9880363340002441
=005  20200717174426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001327
=035  \\$aCAZ4482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC20.$x111
=150  \\$aAutoimmune Diseases
=450  \\$wnnna$aAutoimmune Disease
=450  \\$wnnna$aDisease, Autoimmune
=450  \\$wnnna$aDiseases, Autoimmune
=550  \\$wg$aImmune System Diseases
=550  \\$wh$aAddison Disease
=550  \\$wh$aAnemia, Hemolytic, Autoimmune
=550  \\$wh$aAnti-Glomerular Basement Membrane Disease
=550  \\$wh$aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
=550  \\$wh$aAntiphospholipid Syndrome
=550  \\$wh$aArthritis, Juvenile
=550  \\$wh$aArthritis, Rheumatoid
=550  \\$wh$aAutoimmune Diseases of the Nervous System
=550  \\$wh$aAutoimmune Lymphoproliferative Syndrome
=550  \\$wh$aDermatitis Herpetiformis
=550  \\$wh$aDiabetes Mellitus, Type 1
=550  \\$wh$aGlomerulonephritis, IGA
=550  \\$wh$aGlomerulonephritis, Membranous
=550  \\$wh$aGraves Disease
=550  \\$wh$aHepatitis, Autoimmune
=550  \\$wh$aLambert-Eaton Myasthenic Syndrome
=550  \\$wh$aLatent Autoimmune Diabetes in Adults
=550  \\$wh$aLinear IgA Bullous Dermatosis
=550  \\$wh$aLupus Erythematosus, Systemic
=550  \\$wh$aOphthalmia, Sympathetic
=550  \\$wh$aPemphigoid, Bullous
=550  \\$wh$aPemphigus
=550  \\$wh$aPolyendocrinopathies, Autoimmune
=550  \\$wh$aPurpura, Thrombocytopenic, Idiopathic
=550  \\$wh$aThyroiditis, Autoimmune
=550  \\$wh$aUndifferentiated Connective Tissue Diseases
=550  \\$aAutoantibodies
=550  \\$aAutoimmunity
=550  \\$aSelf Tolerance
=667  \\$aAUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM is available
=680  \\$iDisorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
=750  \0$aAutoimmune diseases$5IEN$0(DLC)sh 85010076

=LDR  00800cz  a2200253n  4500
=001  9880363340102441
=005  20141212195046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001326
=035  \\$aCAZ4481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x217.$x100
=072  \\$aF4.$x754.$x103
=150  \\$aAutogenic Training
=450  \\$wnnna$aAutogenic Trainings
=450  \\$wnnna$aTraining, Autogenic
=450  \\$wnnna$aTrainings, Autogenic
=550  \\$wg$aHypnosis
=550  \\$wg$aPsychotherapy
=550  \\$aSuggestion
=667  \\$aa psychother technique
=680  \\$iTechnique based on muscle relaxation during self-hypnotic exercises. It is used in conjunction with psychotherapy.
=688  \\$a66(63)
=750  \0$aAutogenic training$5IEN$0(DLC)sh 85010062

=LDR  02495cz  a2200637n  4500
=001  9880363340202441
=005  20141212195025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001259
=035  \\$aCAZ4414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x90
=072  \\$aC23.$x888.$x592.$x350.$x90
=150  \\$aAtaxia
=450  \\$wnnna$aAppendicular Ataxia
=450  \\$wnnna$aAppendicular Ataxias
=450  \\$wnnna$aAtaxia, Appendicular
=450  \\$wnnna$aAtaxia, Limb
=450  \\$wnnna$aAtaxia, Motor
=450  \\$wnnna$aAtaxia, Sensory
=450  \\$wnnna$aAtaxia, Truncal
=450  \\$wnnna$aAtaxias
=450  \\$wnnna$aAtaxias, Appendicular
=450  \\$wnnna$aAtaxias, Limb
=450  \\$wnnna$aAtaxias, Motor
=450  \\$wnnna$aAtaxias, Sensory
=450  \\$wnnna$aAtaxias, Truncal
=450  \\$wnnna$aAtaxy
=450  \\$aCoordination Impairment
=450  \\$wnnna$aCoordination Impairments
=450  \\$wnnna$aCoordination Lack
=450  \\$wnnna$aDyscoordination
=450  \\$aDyssynergia
=450  \\$wnnna$aImpairment, Coordination
=450  \\$wnnna$aImpairments, Coordination
=450  \\$aIncoordination
=450  \\$wnnna$aIncoordinations
=450  \\$wnnna$aLack of Coordination
=450  \\$wnnna$aLimb Ataxia
=450  \\$wnnna$aLimb Ataxias
=450  \\$wnnna$aMotor Ataxia
=450  \\$wnnna$aMotor Ataxias
=450  \\$wnnna$aRubral Tremor
=450  \\$wnnna$aRubral Tremors
=450  \\$wnnna$aSensory Ataxia
=450  \\$wnnna$aSensory Ataxias
=450  \\$wnnna$aTremor, Rubral
=450  \\$wnnna$aTremors, Rubral
=450  \\$wnnna$aTruncal Ataxia
=450  \\$wnnna$aTruncal Ataxias
=550  \\$wg$aDyskinesias
=550  \\$wh$aCerebellar Ataxia
=550  \\$wh$aGait Ataxia
=667  \\$anote specifics; coord other ataxias with organ/diseases term; enzootic = SWAYBACK; familial: consider also SPINOCEREBELLAR DEGENERATIONS
=680  \\$iImpairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
=750  \0$aAtaxia$5IEN$0(DLC)sh 85009080

=LDR  01074cz  a2200301n  4500
=001  9880363340302441
=005  20141212195045.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001323
=035  \\$aCAZ4478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x323
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x323
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x323
=150  \\$aAutoantibodies
=550  \\$wg$aAntibodies
=550  \\$wh$aAntibodies, Antineutrophil Cytoplasmic
=550  \\$wh$aAntibodies, Antinuclear
=550  \\$wh$aAntibodies, Antiphospholipid
=550  \\$wh$aComplement C3 Nephritic Factor
=550  \\$wh$aImmunoconglutinins
=550  \\$wh$aImmunoglobulins, Thyroid-Stimulating
=550  \\$wh$aRheumatoid Factor
=550  \\$aAutoimmune Diseases
=550  \\$aAutoimmunity
=667  \\$ado not confuse with ANTIBODIES, ANTI-IDIOTYPIC
=680  \\$iAntibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
=750  \0$aAutoantibodies$5IEN$0(DLC)sh 85010046

=LDR  00909cz  a2200193n  4500
=001  9880363340402441
=005  20141212195024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001256
=035  \\$aCAZ4411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x65
=150  \\$aAstronomy
=450  \\$aAstronomers$5IEN
=550  \\$wg$aPhysics
=667  \\$athe discipline (education, history, etc) only; use ASTRONOMICAL PHENOMENA or specifics treed under it for properties and processes of matter in outer space (stars, planets, comets etc)
=680  \\$iThe science concerned with celestial bodies and the observation and interpretation of the radiation received in the vicinity of the earth from the component parts of the universe (McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed)
=750  \0$aAstronomy$5IEN-M$0(DLC)sh 85009003
=750  \0$aAstronomers$5IEN-HS$0(DLC)sh 85008992

=LDR  00493cz   2200169n  4500
=001  9880363340502441
=005  20230831161543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001255
=035  \\$aCAZ4410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x672.$x296
=150  \\$aAstrology
=550  \\$wg$aOccultism
=667  \\$aa form of occultism; DF: ASTROL
=750  \0$aAstrology$5IEN$0(DLC)sh 85008893
=750  \0$iNarrower mapping$aAstrology, Ethiopian$0(DLC)sh2022006992$4NM$5IEN-M

=LDR  01266cz  a2200313n  4500
=001  9880363340602441
=005  20161024095731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001321
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x625.$x164.$x125
=150  \\$aAutistic Disorder
=450  \\$wnnna$aAutism
=450  \\$wnnna$aAutism, Early Infantile
=450  \\$aAutism, Infantile
=450  \\$wnnna$aAutisms
=450  \\$wnnna$aDisorder, Autistic
=450  \\$wnnna$aDisorders, Autistic
=450  \\$wnnna$aEarly Infantile Autism
=450  \\$wnnna$aInfantile Autism
=450  \\$wnnna$aInfantile Autism, Early
=450  \\$wnnna$aKanner Syndrome
=450  \\$aKanner's Syndrome
=450  \\$wnnna$aKanners Syndrome
=450  \\$wnnna$aSyndrome, Kanner's
=550  \\$wg$aChild Development Disorders, Pervasive
=680  \\$iA disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
=688  \\$a1981(1966)
=750  \0$aAutism$0(DLC) sh 85010038$5IEN-M

=LDR  00586cz  a2200181n  4500
=001  9880363340702441
=005  20141212195044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001319
=035  \\$aCAZ4474HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x143.$x506.$x423.$x906.$x215
=150  \\$aAuthorship
=450  \\$wnnna$aAuthorships
=550  \\$wg$aWriting
=667  \\$ado not confuse with WRITING or PUBLISHING
=680  \\$iThe profession of writing. Also the identity of the writer as the creator of a literary production.
=750  \0$aAuthorship$5IEN$0(DLC)sh 85010030

=LDR  00669cz  a2200181n  4500
=001  9880363340802441
=005  20141212195044.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001318
=035  \\$aCAZ4473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x98
=150  \\$aAuthoritarianism
=450  \\$wnnna$aAuthoritarianisms
=550  \\$wg$aPersonality
=667  \\$ano qualif
=680  \\$iThe personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships.
=750  \0$aAuthoritarianism (Personality trait)$5IEN$0(DLC)sh 87007050

=LDR  00574cz  a2200193n  4500
=001  9880363340902441
=005  20141212195043.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001314
=035  \\$aCAZ4469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x60
=150  \\$aAuscultation
=450  \\$wnnna$aAuscultations
=550  \\$wg$aPhysical Examination
=550  \\$wh$aHeart Auscultation
=667  \\$a/instrum: STETHOSCOPES is also available
=680  \\$iAct of listening for sounds within the body.
=750  \0$aAuscultation$5IEN$0(DLC)sh 85009560

=LDR  01457cz  a2200361n  4500
=001  9880363341002441
=005  20141212195042.0
=008  860616\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001310
=035  \\$aCAZ4465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x675.$x249.$x150
=150  \\$aAuranofin
=450  \\$wnnna$aAuranofin Recordati Brand
=450  \\$wnnna$aAuranofin Robapharm Brand
=450  \\$wnnna$aAuranofin Rubio Brand
=450  \\$wnnna$aAuranofin Yamanouchi Brand
=450  \\$wnnna$aCrisinor
=450  \\$wnnna$aRecordati Brand of Auranofin
=450  \\$wnnna$aRidaura
=450  \\$wnnna$aRidauran
=450  \\$wnnna$aRobapharm Brand of Auranofin
=450  \\$wnnna$aRubio Brand of Auranofin
=450  \\$wnnna$aSK&F-39162
=450  \\$wnnna$aSK&F 39162
=450  \\$wnnna$aSK&F D 39162
=450  \\$wnnna$aSK&F39162
=450  \\$wnnna$aSmithKline Beecham Brand of Auranofin
=450  \\$wnnna$aYamanouchi Brand of Auranofin
=550  \\$wg$aAurothioglucose
=680  \\$iAn oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
=688  \\$a87
=750  \0$aAuranofin$0(DLC) sh 85009540$5IEN

=LDR  00776cz  a2200253n  4500
=001  9880363341102441
=005  20141212195042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001309
=035  \\$aCAZ4464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x71.$x173
=072  \\$aF2.$x463.$x593.$x710.$x190
=150  \\$aAuditory Threshold
=450  \\$wnnna$aAuditory Thresholds
=450  \\$aHearing Levels$5IEN
=450  \\$wnnna$aThreshold, Auditory
=450  \\$wnnna$aThresholds, Auditory
=550  \\$wg$aAuditory Perception
=550  \\$wg$aSensory Thresholds
=550  \\$wh$aAuditory Fatigue
=680  \\$iThe audibility limit of discriminating sound intensity and pitch.
=688  \\$a68
=750  \0$aHearing levels$5IEN$0(DLC)sh 85059628

=LDR  04563cz  a2201009n  4500
=001  9880363341202441
=005  20141212195023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001254
=035  \\$aCAZ4409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x600.$x380.$x80
=072  \\$aC4.$x557.$x470.$x670.$x380.$x80
=072  \\$aC4.$x557.$x580.$x625.$x600.$x380.$x80
=150  \\$aAstrocytoma
=450  \\$wnnna$aAnaplastic Astrocytoma
=450  \\$wnnna$aAnaplastic Astrocytomas
=450  \\$wnnna$aAstrocytic Glioma
=450  \\$wnnna$aAstrocytic Gliomas
=450  \\$wnnna$aAstrocytoma, Anaplastic
=450  \\$wnnna$aAstrocytoma, Cerebral
=450  \\$wnnna$aAstrocytoma, Childhood Cerebral
=450  \\$wnnna$aAstrocytoma, Fibrillary
=450  \\$wnnna$aAstrocytoma, Gemistocytic
=450  \\$wnnna$aAstrocytoma, Grade I
=450  \\$wnnna$aAstrocytoma, Grade II
=450  \\$wnnna$aAstrocytoma, Grade III
=450  \\$wnnna$aAstrocytoma, Intracranial
=450  \\$wnnna$aAstrocytoma, Juvenile Pilocytic
=450  \\$wnnna$aAstrocytoma, Pilocytic
=450  \\$wnnna$aAstrocytoma, Protoplasmic
=450  \\$aAstrocytoma, Subependymal Giant Cell
=450  \\$wnnna$aAstrocytomas
=450  \\$wnnna$aAstrocytomas, Anaplastic
=450  \\$wnnna$aAstrocytomas, Cerebral
=450  \\$wnnna$aAstrocytomas, Childhood Cerebral
=450  \\$wnnna$aAstrocytomas, Fibrillary
=450  \\$wnnna$aAstrocytomas, Gemistocytic
=450  \\$wnnna$aAstrocytomas, Grade I
=450  \\$wnnna$aAstrocytomas, Grade II
=450  \\$wnnna$aAstrocytomas, Grade III
=450  \\$wnnna$aAstrocytomas, Intracranial
=450  \\$wnnna$aAstrocytomas, Juvenile Pilocytic
=450  \\$wnnna$aAstrocytomas, Pilocytic
=450  \\$wnnna$aAstrocytomas, Protoplasmic
=450  \\$wnnna$aAstroglioma
=450  \\$wnnna$aAstrogliomas
=450  \\$wnnna$aCerebral Astrocytoma
=450  \\$wnnna$aCerebral Astrocytoma, Childhood
=450  \\$wnnna$aCerebral Astrocytomas
=450  \\$wnnna$aCerebral Astrocytomas, Childhood
=450  \\$wnnna$aChildhood Cerebral Astrocytoma
=450  \\$wnnna$aChildhood Cerebral Astrocytomas
=450  \\$wnnna$aFibrillary Astrocytoma
=450  \\$wnnna$aFibrillary Astrocytomas
=450  \\$wnnna$aGemistocytic Astrocytoma
=450  \\$wnnna$aGemistocytic Astrocytomas
=450  \\$aGlioma, Astrocytic
=450  \\$wnnna$aGliomas, Astrocytic
=450  \\$wnnna$aGrade I Astrocytoma
=450  \\$wnnna$aGrade I Astrocytomas
=450  \\$wnnna$aGrade II Astrocytoma
=450  \\$wnnna$aGrade II Astrocytomas
=450  \\$wnnna$aGrade III Astrocytoma
=450  \\$wnnna$aGrade III Astrocytomas
=450  \\$wnnna$aIntracranial Astrocytoma
=450  \\$wnnna$aIntracranial Astrocytomas
=450  \\$wnnna$aJuvenile Pilocytic Astrocytoma
=450  \\$wnnna$aJuvenile Pilocytic Astrocytomas
=450  \\$wnnna$aMixed Oligoastrocytoma
=450  \\$wnnna$aMixed Oligoastrocytomas
=450  \\$aOligoastrocytoma, Mixed
=450  \\$wnnna$aOligoastrocytomas, Mixed
=450  \\$wnnna$aPilocytic Astrocytoma
=450  \\$wnnna$aPilocytic Astrocytoma, Juvenile
=450  \\$wnnna$aPilocytic Astrocytomas
=450  \\$wnnna$aPilocytic Astrocytomas, Juvenile
=450  \\$wnnna$aProtoplasmic Astrocytoma
=450  \\$wnnna$aProtoplasmic Astrocytomas
=450  \\$wnnna$aSubependymal Giant Cell Astrocytoma
=550  \\$wg$aGlioma
=550  \\$wh$aGlioblastoma
=550  \\$wh$aOptic Nerve Glioma
=667  \\$acoord IM with precoord CNS/neopl term (IM) + site (IM); Grades I-III go here, with pathol; for ASTROCYTOMA, GRADE IV see GLIOBLASTOMA; for SUBEPENDYMAL ASTROCYTOMA see GLIOMA, SUBEPENDYMAL; for MIXED OLIGODENDROGLIOMA-ASTROCYTOMA see OLIGODENDROGLIOMA
=680  \\$iNeoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
=688  \\$a1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL use GLIOMA 1994-1999
=750  \0$aAstrocytomas$5IEN$0(DLC)sh 92001188

=LDR  01065cz  a2200217n  4500
=001  9880363341302441
=005  20141212195022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001253
=035  \\$aCAZ4408HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x637.$x200
=072  \\$aA11.$x650.$x200
=150  \\$aAstrocytes
=450  \\$wnnna$aAstrocyte
=450  \\$aAstroglia
=450  \\$wnnna$aAstroglias
=550  \\$wg$aNeuroglia
=680  \\$iA class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury.
=688  \\$a79(75); was see under NEUROGLIA 1963-78
=750  \0$aAstrocytes$5IEN$0(DLC)sh 85008884

=LDR  00823cz  a2200241n  4500
=001  9880363341402441
=005  20141212195021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001252
=035  \\$aCAZ4407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x207
=072  \\$aD27.$x505.$x954.$x444.$x100
=150  \\$aAstringents
=450  \\$wnnna$aAstringent Effect
=450  \\$wnnna$aAstringent Effects
=450  \\$wnnna$aEffect, Astringent
=450  \\$wnnna$aEffects, Astringent
=550  \\$wg$aDermatologic Agents
=550  \\$wg$aPhysiological Effects of Drugs
=680  \\$iAgents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.
=688  \\$aANTIPERSPIRANTS was see ASTRINGENTS 1985-94
=750  \0$aAstringents$5IEN-M$0(DLC)sh 85008881

=LDR  00742cz  a2200169n  4500
=001  9880363341502441
=005  20141212195021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001251
=035  \\$aCAZ4406HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x744.$x212
=150  \\$aAstigmatism
=550  \\$wg$aRefractive Errors
=667  \\$arefractive error
=680  \\$iUnequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed)
=750  \0$aAstigmatism$5IEN$0(DLC)sh 85008867

=LDR  01526cz  a2200337n  4500
=001  9880363341602441
=005  20141212195021.0
=008  780512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001250
=035  \\$aCAZ4405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x108.$x110
=072  \\$aC8.$x674.$x95.$x110
=072  \\$aC20.$x543.$x480.$x680.$x95.$x110
=150  \\$aAsthma, Exercise-Induced
=450  \\$wnnna$aAsthma, Exercise Induced
=450  \\$wnnna$aAsthmas, Exercise-Induced
=450  \\$aBronchospasm, Exercise-Induced
=450  \\$wnnna$aBronchospasm, Exercise Induced
=450  \\$wnnna$aBronchospasms, Exercise-Induced
=450  \\$aExercise-Induced Asthma
=450  \\$wnnna$aExercise Induced Asthma
=450  \\$wnnna$aExercise-Induced Asthmas
=450  \\$aExercise-Induced Bronchospasm
=450  \\$wnnna$aExercise Induced Bronchospasm
=450  \\$wnnna$aExercise-Induced Bronchospasms
=550  \\$wg$aAsthma
=550  \\$aVocal Cord Dysfunction
=680  \\$iAsthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).
=688  \\$a91(79); was see under ASTHMA 1979-90
=750  \0$aExercise-induced asthma$5IEN-M$0(DLC)sh 99000132

=LDR  02624cz  a2200613n  4500
=001  9880363341702441
=005  20141212195042.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001308
=035  \\$aCAZ4463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x807.$x186.$x94
=072  \\$aC10.$x228.$x140.$x68.$x94
=072  \\$aC10.$x597.$x606.$x762.$x200
=072  \\$aC23.$x888.$x592.$x604.$x764.$x200
=072  \\$aF1.$x700.$x750.$x200
=072  \\$aF3.$x87.$x250.$x100
=150  \\$aAuditory Perceptual Disorders
=450  \\$aAcoustic Perceptual Disorder
=450  \\$wnnna$aAcoustic Perceptual Disorders
=450  \\$wnnna$aAuditory Comprehension Disorder
=450  \\$wnnna$aAuditory Comprehension Disorders
=450  \\$wnnna$aAuditory Inattention
=450  \\$wnnna$aAuditory Inattentions
=450  \\$wnnna$aAuditory Perceptual Disorder
=450  \\$wnnna$aAuditory Processing Disorder
=450  \\$wnnna$aAuditory Processing Disorders
=450  \\$wnnna$aComprehension Disorder, Auditory
=450  \\$wnnna$aComprehension Disorders, Auditory
=450  \\$wnnna$aDisorder, Acoustic Perceptual
=450  \\$wnnna$aDisorder, Auditory Comprehension
=450  \\$wnnna$aDisorder, Auditory Processing
=450  \\$wnnna$aDisorder, Psychoacoustical
=450  \\$wnnna$aDisorders, Acoustic Perceptual
=450  \\$wnnna$aDisorders, Auditory Comprehension
=450  \\$wnnna$aDisorders, Auditory Processing
=450  \\$wnnna$aDisorders, Psychoacoustical
=450  \\$wnnna$aInattention, Auditory
=450  \\$wnnna$aInattentions, Auditory
=450  \\$wnnna$aPerceptual Disorder, Acoustic
=450  \\$wnnna$aPerceptual Disorder, Auditory
=450  \\$wnnna$aPerceptual Disorders, Acoustic
=450  \\$aPerceptual Disorders, Auditory
=450  \\$wnnna$aProcessing Disorder, Auditory
=450  \\$wnnna$aProcessing Disorders, Auditory
=450  \\$wnnna$aPsychoacoustical Disorder
=450  \\$wnnna$aPsychoacoustical Disorders
=550  \\$wg$aAuditory Diseases, Central
=550  \\$wg$aCognition Disorders
=550  \\$wg$aPerceptual Disorders
=550  \\$aAuditory Perception
=680  \\$iAcquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.
=688  \\$a91(80); was see under PERCEPTUAL DISORDERS 1980-90
=750  \0$aWord deafness$5IEN-HS$0(DLC)sh 85148096

=LDR  01474cz  a2200349n  4500
=001  9880363341802441
=005  20141212195020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001249
=035  \\$aCAZ4404HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x127.$x108
=072  \\$aC8.$x381.$x495.$x108
=072  \\$aC8.$x674.$x95
=072  \\$aC20.$x543.$x480.$x680.$x95
=150  \\$aAsthma
=450  \\$aAsthma, Bronchial
=450  \\$wnnna$aAsthmas
=450  \\$aAsthmatics$5IEN
=450  \\$aBronchial Asthma
=550  \\$wg$aBronchial Diseases
=550  \\$wg$aLung Diseases, Obstructive
=550  \\$wg$aRespiratory Hypersensitivity
=550  \\$wh$aAsthma, Aspirin-Induced
=550  \\$wh$aAsthma, Exercise-Induced
=550  \\$wh$aAsthma, Occupational
=550  \\$wh$aStatus Asthmaticus
=550  \\$aBronchial Hyperreactivity
=667  \\$anote specifics; ASTHMA, CARDIAC see DYSPNEA, PAROXYSMAL is also available; in historical literature consider indexing "phthisic" here; "phthisis" probably goes under TUBERCULOSIS, PULMONARY
=680  \\$iA form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
=750  \0$aAsthmatics$5IEN-M$0(DLC)sh 85008865
=750  \0$aAsthma$5IEN-HS$0(DLC)sh 85008860

=LDR  00812cz  a2200241n  4500
=001  9880363341902441
=005  20141212195020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001248
=035  \\$aCAZ4403HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x93
=150  \\$aAsthenopia
=450  \\$aEye Fatigue
=450  \\$aEyestrain
=450  \\$wnnna$aFatigue, Eye
=450  \\$aFatigue, Visual
=450  \\$aVisual Fatigue
=550  \\$wg$aEye Diseases
=667  \\$aocular fatigue
=680  \\$iTerm generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches.
=688  \\$aEYESTRAIN was heading 1963-67
=750  \0$aAsthenopia$5IEN$0(DLC)sh 85008857

=LDR  00620cz  a2200205n  4500
=001  9880363342002441
=005  20141212195019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001247
=035  \\$aCAZ4402HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x89
=150  \\$aAsthenia
=450  \\$wnnna$aAsthenias
=550  \\$wg$aSigns and Symptoms
=550  \\$aFatigue
=550  \\$aMuscle Weakness
=667  \\$aNEUROCIRCULATORY ASTHENIA is also available
=680  \\$iClinical sign or symptom manifested as debility, or lack or loss of strength and energy.
=750  \0$aAsthenia$5IEN$0(DLC)sh 85008856

=LDR  00751cz  a2200193n  4500
=001  9880363342102441
=005  20141212195019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001246
=035  \\$aCAZ4401HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271.$x110
=072  \\$aD1.$x268.$x380.$x75
=150  \\$aAstatine
=550  \\$wg$aElements, Radioactive
=550  \\$wg$aHalogens
=667  \\$anaturally radioactive; IM
=680  \\$iAstatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.
=750  \0$aAstatine$5IEN$0(DLC)sh 85008844

=LDR  01067cz  a2200313n  4500
=001  9880363342202441
=005  20141212195041.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001307
=035  \\$aCAZ4462HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x71
=150  \\$aAuditory Perception
=450  \\$wnnna$aAuditory Perceptions
=450  \\$wnnna$aPerception, Auditory
=450  \\$wnnna$aPerceptions, Auditory
=550  \\$wg$aPerception
=550  \\$wh$aAuditory Threshold
=550  \\$wh$aLoudness Perception
=550  \\$wh$aPerceptual Masking
=550  \\$wh$aPitch Perception
=550  \\$wh$aSound Localization
=550  \\$wh$aSpeech Perception
=550  \\$aAuditory Perceptual Disorders
=550  \\$aHearing
=667  \\$adifferentiate from HEARING: auditory perception takes place in the brain, hearing takes place in the ear
=680  \\$iThe process whereby auditory stimuli are selected, organized, and interpreted by the organism.
=688  \\$a68(67)
=750  \0$aAuditory perception$5IEN$0(DLC)sh 85009496

=LDR  00632cz  a2200217n  4500
=001  9880363342302441
=005  20141212192012.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001306
=035  \\$aCAZ4461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x612.$x220.$x110
=150  \\$aAuditory Pathways
=450  \\$wnnna$aAuditory Pathway
=450  \\$wnnna$aPathway, Auditory
=450  \\$wnnna$aPathways, Auditory
=550  \\$wg$aAfferent Pathways
=550  \\$aTrapezoid Body
=667  \\$adis: coord NIM with AUDITORY DISEASES, CENTRAL (IM)
=688  \\$a72(71)
=750  \0$aAuditory pathways$5IEN$0(DLC)sh 85009495

=LDR  01508cz  a2200397n  4500
=001  9880363342402441
=005  20141212195040.0
=008  781222\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001304
=035  \\$aCAZ4459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x807.$x186
=072  \\$aC10.$x228.$x140.$x68
=150  \\$aAuditory Diseases, Central
=450  \\$aAuditory Cortex Disorder
=450  \\$wnnna$aAuditory Cortex Disorders
=450  \\$wnnna$aAuditory Disease, Central
=450  \\$wnnna$aAuditory Dysfunction, Central
=450  \\$wnnna$aAuditory Pathway Disorders, Central
=450  \\$wnnna$aCentral Auditory Disease
=450  \\$aCentral Auditory Diseases
=450  \\$wnnna$aCentral Auditory Dysfunction
=450  \\$wnnna$aCentral Auditory Pathway Disorders
=450  \\$wnnna$aCortex Disorder, Auditory
=450  \\$wnnna$aCortex Disorders, Auditory
=450  \\$wnnna$aDysfunction, Central Auditory
=450  \\$wnnna$aDysfunctions, Central Auditory
=550  \\$wg$aBrain Diseases
=550  \\$wg$aRetrocochlear Diseases
=550  \\$wh$aAuditory Perceptual Disorders
=550  \\$wh$aHearing Loss, Central
=550  \\$aAuditory Cortex
=550  \\$aAuditory Pathways
=680  \\$iDisorders of hearing or auditory perception due to pathological processes of the AUDITORY PATHWAYS in the CENTRAL NERVOUS SYSTEM. These include CENTRAL HEARING LOSS and AUDITORY PERCEPTUAL DISORDERS.
=688  \\$a1980
=750  \0$aAuditory pathways$xDiseases$5IEN-M

=LDR  02085cz  a2200577n  4500
=001  9880363342502441
=005  20141212192011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001303
=035  \\$aCAZ4458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x814.$x249
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x863.$x297
=150  \\$aAuditory Cortex
=450  \\$wnnna$aArea, Auditory
=450  \\$wnnna$aArea, Temporal Auditory
=450  \\$wnnna$aAreas, Auditory
=450  \\$wnnna$aAreas, Temporal Auditory
=450  \\$wnnna$aAuditory Area
=450  \\$wnnna$aAuditory Area, Temporal
=450  \\$wnnna$aAuditory Areas
=450  \\$wnnna$aAuditory Areas, Temporal
=450  \\$wnnna$aAuditory Cortex, Primary
=450  \\$wnnna$aAuditory Cortices, Primary
=450  \\$wnnna$aConvolutions, Heschl's
=450  \\$wnnna$aCortex, Auditory
=450  \\$wnnna$aCortex, Primary Auditory
=450  \\$wnnna$aCortices, Primary Auditory
=450  \\$wnnna$aGyri, Heschl's
=450  \\$wnnna$aGyri, Transverse Temporal
=450  \\$wnnna$aGyrus, Transverse Temporal
=450  \\$wnnna$aHeschl Convolutions
=450  \\$wnnna$aHeschl Gyri
=450  \\$wnnna$aHeschl's Convolutions
=450  \\$wnnna$aHeschls Convolutions
=450  \\$wnnna$aHeschl's Gyri
=450  \\$wnnna$aHeschls Gyri
=450  \\$wnnna$aPrimary Auditory Cortex
=450  \\$wnnna$aPrimary Auditory Cortices
=450  \\$wnnna$aTemporal Auditory Area
=450  \\$wnnna$aTemporal Auditory Areas
=450  \\$wnnna$aTemporal Gyri, Transverse
=450  \\$wnnna$aTemporal Gyrus, Transverse
=450  \\$wnnna$aTransverse Temporal Gyri
=450  \\$wnnna$aTransverse Temporal Gyrus
=550  \\$wg$aSensorimotor Cortex
=550  \\$wg$aTemporal Lobe
=667  \\$adiseases: coordinate with AUDITORY DISEASES, CENTRAL
=680  \\$iThe region of the cerebral cortex that receives the auditory radiation from the MEDIAL GENICULATE BODY.
=688  \\$a70(68)
=750  \0$aAuditory cortex$5IEN$0(DLC)sh 90000646

=LDR  00817cz  a2200229n  4500
=001  9880363342602441
=005  20141212195040.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001302
=035  \\$aCAZ4457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x382.$x375.$x60.$x60
=150  \\$aAudiometry, Speech
=450  \\$wnnna$aAudiometries, Speech
=450  \\$wnnna$aSpeech Audiometries
=450  \\$wnnna$aSpeech Audiometry
=550  \\$wg$aAudiometry
=550  \\$wh$aSpeech Discrimination Tests
=550  \\$wh$aSpeech Reception Threshold Test
=680  \\$iMeasurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators.
=688  \\$a80
=750  \0$aAudiometry, Speech$5IEN$0(DLC)sh 85009475

=LDR  00830cz  a2200229n  4500
=001  9880363342702441
=005  20141212195019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001244
=035  \\$aCAZ4399HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x69
=072  \\$aF4.$x754.$x720.$x346
=150  \\$aAssociation
=450  \\$wnnna$aAssociations
=550  \\$wg$aLearning
=550  \\$wg$aPsychotherapeutic Processes
=550  \\$wh$aAssociation Learning
=667  \\$aa psychol or learning context; no qualif; DF: ASSOC
=680  \\$iA functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.
=688  \\$a66(65)
=750  \0$aAssociation of ideas$5IEN$0(DLC)sh 85008807

=LDR  00600cz  a2200193n  4500
=001  9880363342802441
=005  20141212195018.0
=008  790411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001242
=035  \\$aCAZ4397HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x49
=150  \\$aAssertiveness
=450  \\$wnnna$aAssertivenesses
=550  \\$wg$aPersonality
=667  \\$ano qualif; assertiveness training: coord IM with BEHAVIOR THERAPY (IM)
=680  \\$iStrongly insistent, self-assured, and demanding behavior.
=688  \\$a80
=750  \0$aAssertiveness (Psychology)$5IEN$0(DLC)sh 85008774

=LDR  01466cz  a2200385n  4500
=001  9880363342902441
=005  20141212195018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001241
=035  \\$aCAZ4396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x595.$x176
=150  \\$aAspirin
=450  \\$wnnna$a2-(Acetyloxy)benzoic Acid
=450  \\$aAcetylsalicylic Acid
=450  \\$wnnna$aAcetysal
=450  \\$wnnna$aAcid, Acetylsalicylic
=450  \\$wnnna$aAcylpyrin
=450  \\$wnnna$aAloxiprimum
=450  \\$wnnna$aColfarit
=450  \\$wnnna$aDispril
=450  \\$wnnna$aEasprin
=450  \\$wnnna$aEcotrin
=450  \\$wnnna$aEndosprin
=450  \\$wnnna$aMagnecyl
=450  \\$wnnna$aMicristin
=450  \\$wnnna$aPolopirin
=450  \\$wnnna$aPolopiryna
=450  \\$wnnna$aSolprin
=450  \\$wnnna$aSolupsan
=450  \\$wnnna$aZorprin
=550  \\$wg$aSalicylates
=680  \\$iThe prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
=688  \\$a65; was ACETYLSALICYLIC ACID 1963-64
=750  \0$aAspirin$5IEN$0(DLC)sh 85008731

=LDR  00672cz  a2200217n  4500
=001  9880363343102441
=005  20141212195017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001239
=035  \\$aCAZ4394M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG9.$x772.$x770.$x755.$x700.$x390
=150  \\$aInhalation
=450  \\$wnno$aAspiration$5IEN-HS
=450  \\$aInhaling
=450  \\$wnnna$aInspiration, Respiratory
=450  \\$wnnna$aRespiratory Inspiration
=550  \\$wg$aRespiratory Mechanics
=680  \\$iThe act of BREATHING in.
=688  \\$a2004(1966); was see under RESPIRATION 1966-1990
=750  \0$aAspiration and aspirators$5IEN-M$0(DLC)sh 85008729

=LDR  00636cz  a2200193n  4500
=001  9880363343202441
=005  20141212195017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001238
=035  \\$aCAZ4393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x614.$x92
=150  \\$aAsphyxia Neonatorum
=450  \\$aAsphyxia$xcongenital
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$aFetal Hypoxia
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; tag INFANT, NEWBORN
=680  \\$iRespiratory failure in the newborn. (Dorland, 27th ed)
=750  \0$aAsphyxia neonatorum$5IEN$0(DLC)sh 85008719

=LDR  00748cz  a2200229n  4500
=001  9880363343302441
=005  20141212195017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001237
=035  \\$aCAZ4392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x95
=072  \\$aC26.$x103
=150  \\$aAsphyxia
=450  \\$wnnna$aAsphyxias
=450  \\$aSuffocation
=450  \\$wnnna$aSuffocations
=550  \\$wg$aDeath
=550  \\$wg$aWounds and Injuries
=667  \\$ain newborn inf = ASPHYXIA NEONATORUM + tag INFANT, NEWBORN; choking: use AIRWAY OBSTRUCTION
=680  \\$iA pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
=750  \0$aAsphyxia$5IEN$0(DLC)sh 85008718

=LDR  00695cz  a2200217n  4500
=001  9880363343402441
=005  20141212195016.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001234
=035  \\$aCAZ4389HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x81.$x450
=150  \\$aAspergillus niger
=450  \\$wnnna$aAspergillus nigers
=450  \\$wnnna$aniger, Aspergillus
=450  \\$wnnna$anigers, Aspergillus
=550  \\$wg$aAspergillus
=667  \\$ainfection: coord IM with ASPERGILLOSIS (IM)
=680  \\$iAn imperfect fungus causing smut or black mold of several fruits, vegetables, etc.
=688  \\$a78(75)
=750  \0$aAspergillus niger$5IEN$0(DLC)sh 88022019

=LDR  00741cz  a2200217n  4500
=001  9880363343502441
=005  20141212195016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001233
=035  \\$aCAZ4388HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x81.$x420
=150  \\$aAspergillus nidulans
=450  \\$wnnna$aAspergillus nidulan
=450  \\$wnnna$anidulan, Aspergillus
=450  \\$wnnna$anidulans, Aspergillus
=550  \\$wg$aAspergillus
=667  \\$ainfection: coord IM with ASPERGILLOSIS (IM)
=680  \\$iA species of imperfect fungi from which the antibiotic nidulin is obtained. Its teleomorph is Emericella nidulans.
=688  \\$a74(72)
=750  \0$aAspergillus nidulans$5IEN-HS$0(DLC)sh 94006296

=LDR  00686cz  a2200193n  4500
=001  9880363343602441
=005  20141212195016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001232
=035  \\$aCAZ4387M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x81.$x295
=150  \\$aAspergillus fumigatus
=450  \\$wnnna$afumigatus, Aspergillus
=550  \\$wg$aAspergillus
=667  \\$ainfection: coord IM with ASPERGILLOSIS (IM)
=680  \\$iA species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.
=688  \\$a74(72)
=750  \0$aAspergillus fumigatus$5IEN-M$0(DLC)sh 99002466

=LDR  00718cz  a2200193n  4500
=001  9880363343702441
=005  20141212195016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001231
=035  \\$aCAZ4386M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x81.$x170
=150  \\$aAspergillus flavus
=450  \\$wnnna$aflavus, Aspergillus
=550  \\$wg$aAspergillus
=667  \\$ainfection: coord IM with ASPERGILLOSIS (IM)
=680  \\$iA species of imperfect fungi which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic flavicin.
=688  \\$a74(72)
=750  \0$aAspergillus flavus$0(DLC) sh2003010286$5IEN-M

=LDR  00833cz  a2200241n  4500
=001  9880363343802441
=005  20141212195015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001230
=035  \\$aCAZ4385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x81
=150  \\$aAspergillus
=550  \\$wg$aMitosporic Fungi
=550  \\$wh$aAspergillus flavus
=550  \\$wh$aAspergillus fumigatus
=550  \\$wh$aAspergillus nidulans
=550  \\$wh$aAspergillus niger
=550  \\$wh$aAspergillus ochraceus
=550  \\$wh$aAspergillus oryzae
=667  \\$aGEN or unspecified; prefer specific genera; infection = ASPERGILLOSIS
=680  \\$iA genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family Trichocomaceae.
=750  \0$aAspergillus$5IEN$0(DLC)sh 86002965

=LDR  03126cz  a2200745n  4500
=001  9880363343902441
=005  20141212194845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000961
=035  \\$aCAZ4116HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA12.$x207.$x152.$x846.$x500.$x203
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573.$x203
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x573.$x203
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x573.$x203
=072  \\$aD20.$x215.$x401.$x203
=150  \\$aAntilymphocyte Serum
=450  \\$wnnna$aAnti-Thymocyte Globulin
=450  \\$wnnna$aAnti Thymocyte Globulin
=450  \\$wnnna$aAnti-Thymocyte Globulins
=450  \\$wnnna$aAntibodies, Antilymphocyte
=450  \\$wnnna$aAntibodies, Lymphocytotoxic
=450  \\$wnnna$aAntibody, Antilymphocyte
=450  \\$wnnna$aAntibody, Lymphocytotoxic
=450  \\$wnnna$aAntilymphoblast Globulin
=450  \\$aAntilymphoblast Globulins
=450  \\$aAntilymphocyte Antibodies
=450  \\$wnnna$aAntilymphocyte Antibody
=450  \\$aAntilymphocyte Globulin
=450  \\$wnnna$aAntilymphocyte Globulins
=450  \\$wnnna$aAntilymphocyte Immunoglobulin
=450  \\$wnnna$aAntilymphocyte Immunoglobulins
=450  \\$wnnna$aAntilymphocyte Serums
=450  \\$aAntilymphocytic Serum$5IEN
=450  \\$wnnna$aAntithymocyte Globulin
=450  \\$wnnna$aAntithymocyte Globulins
=450  \\$wnnna$aAntithymoglobulin
=450  \\$wnnna$aAntithymoglobulins
=450  \\$aATGAM
=450  \\$wnnna$aGlobulin, Anti-Thymocyte
=450  \\$wnnna$aGlobulin, Antilymphoblast
=450  \\$wnnna$aGlobulin, Antilymphocyte
=450  \\$wnnna$aGlobulin, Antithymocyte
=450  \\$wnnna$aGlobulins, Anti-Thymocyte
=450  \\$wnnna$aGlobulins, Antilymphoblast
=450  \\$wnnna$aGlobulins, Antilymphocyte
=450  \\$wnnna$aGlobulins, Antithymocyte
=450  \\$wnnna$aImmunoglobulin, Antilymphocyte
=450  \\$wnnna$aImmunoglobulins, Antilymphocyte
=450  \\$wnnna$aLymphocyte Immune Globulin, Anti-Thymocyte Globulin
=450  \\$wnnna$aLymphocyte Immune Globulin, Anti Thymocyte Globulin
=450  \\$wnnna$aLymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine)
=450  \\$aLymphocytotoxic Antibodies
=450  \\$wnnna$aLymphocytotoxic Antibody
=450  \\$wnnna$aPressimmune
=450  \\$wnnna$aSerum, Antilymphocyte
=450  \\$wnnna$aSerums, Antilymphocyte
=550  \\$wg$aImmune Sera
=550  \\$aImmunosuppression
=550  \\$aImmunosuppressive Agents
=550  \\$aLymphocytes
=667  \\$aantithymocyte & anti-theta serum: index ANTILYMPHOCYTE SERUM + T LYMPHOCYTES /immunol; "lymphocytotoxin": index CYTOTOXINS + LYMPHOCYTES but note entry term LYMPHOCYTOTOXIC ANTIBODIES for antibodies to lymphocytes
=680  \\$iSerum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
=688  \\$a70(68); LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978
=750  \0$aAntilymphocytic serum$5IEN$0(DLC)sh 85005694

=LDR  01293cz  a2200385n  4500
=001  9880363344002441
=005  20141212194844.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000960
=035  \\$aCAZ4115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186.$x71
=072  \\$aD27.$x505.$x954.$x557.$x500
=150  \\$aHypolipidemic Agents
=450  \\$wnnna$aAgents, Antilipemic
=450  \\$wnnna$aAgents, Hypolipidemic
=450  \\$wnnna$aAntihyperlipemics
=450  \\$wnnna$aAntihyperlipidemics
=450  \\$aAntilipemic Agents
=450  \\$wnnna$aAntilipemic Drugs
=450  \\$wnnna$aAntilipemics
=450  \\$wnnna$aDrugs, Antilipemic
=450  \\$wnnna$aDrugs, Hypolipidemic
=450  \\$wnnna$aHypolipidemic Drugs
=550  \\$wg$aAntimetabolites
=550  \\$wg$aLipid Regulating Agents
=550  \\$wh$aAnticholesteremic Agents
=550  \\$wh$aFatty Acid Synthesis Inhibitors
=550  \\$wh$aLipotropic Agents
=550  \\$aLipids
=680  \\$iSubstances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.
=688  \\$a2010(1966)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Antilipemic Agents
=688  \\$a72(66)
=750  \0$aAntilipemic agents$0(DLC) sh 85005684$5IEN

=LDR  01445cz  a2200337n  4500
=001  9880363344102441
=005  20141212194843.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000959
=035  \\$aCAZ4114HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411.$x162
=150  \\$aAntihypertensive Agents
=450  \\$wnnna$aAgents, Anti-Hypertensive
=450  \\$wnnna$aAgents, Antihypertensive
=450  \\$wnnna$aAnti-Hypertensive Agents
=450  \\$wnnna$aAnti Hypertensive Agents
=450  \\$wnnna$aAnti-Hypertensive Drugs
=450  \\$wnnna$aAnti Hypertensive Drugs
=450  \\$wnnna$aAnti-Hypertensives
=450  \\$wnnna$aAnti Hypertensives
=450  \\$wnnna$aAntihypertensive Drugs
=450  \\$wnnna$aAntihypertensives
=450  \\$wnnna$aDrugs, Anti-Hypertensive
=450  \\$wnnna$aDrugs, Antihypertensive
=550  \\$wg$aCardiovascular Agents
=550  \\$aCalcium Channel Blockers
=550  \\$aHypertension
=667  \\$anot for ocular hypertension
=680  \\$iDrugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
=750  \0$aHypotensive agents$5IEN$0(DLC)sh 85063821

=LDR  00855cz  a2200277n  4500
=001  9880363344202441
=005  20141212194842.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000956
=035  \\$aCAZ4111HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x327
=150  \\$aAntigens, Viral
=450  \\$aViral Antigens
=550  \\$wg$aAntigens
=550  \\$wh$aAdenovirus Early Proteins
=550  \\$wh$aAntigens, Viral, Tumor
=550  \\$wh$aDeltaretrovirus Antigens
=550  \\$wh$aEpstein-Barr Virus Nuclear Antigens
=550  \\$wh$aHemagglutinins, Viral
=550  \\$wh$aHepatitis Antigens
=550  \\$wh$aHIV Antigens
=667  \\$acoord IM with specific virus /immunol (IM)
=680  \\$iSubstances elaborated by viruses that have antigenic activity.
=688  \\$a73
=750  \0$aViral antigens$5IEN$0(DLC)sh 85143726

=LDR  01771cz  a2200481n  4500
=001  9880363344302441
=005  20141212194841.0
=008  780501\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000954
=035  \\$aCAZ4108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301
=150  \\$aAntigens, Surface
=450  \\$wnnna$aAntigen, Cell Surface
=450  \\$wnnna$aAntigen, Surface
=450  \\$wnnna$aAntigens, Cell Surface
=450  \\$wnnna$aCell Surface Antigen
=450  \\$aCell Surface Antigens
=450  \\$wnnna$aImmunologic Surface Markers
=450  \\$wnnna$aImmunological Surface Markers
=450  \\$wnnna$aMarkers, Immunologic Surface
=450  \\$wnnna$aMarkers, Immunological Surface
=450  \\$wnnna$aSurface Antigen
=450  \\$wnnna$aSurface Antigen, Cell
=450  \\$aSurface Antigens
=450  \\$wnnna$aSurface Antigens, Cell
=450  \\$wnnna$aSurface Markers, Immunologic
=450  \\$aSurface Markers, Immunological
=550  \\$wg$aAntigens
=550  \\$wh$aAntigens, Differentiation
=550  \\$wh$aArrestin
=550  \\$wh$aB7 Antigens
=550  \\$wh$aBlood Group Antigens
=550  \\$wh$aCell Adhesion Molecules
=550  \\$wh$aHistocompatibility Antigens
=550  \\$wh$aLeukocyte L1 Antigen Complex
=550  \\$wh$aLymphocyte Antigen 96
=550  \\$wh$aMinor Lymphocyte Stimulatory Antigens
=550  \\$wh$aVariant Surface Glycoproteins, Trypanosoma
=667  \\$acoord NIM with specific antigen/organism heading (IM)
=680  \\$iAntigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.
=688  \\$a79
=750  \0$aCell surface antigens$5IEN$0(DLC)sh 87006699

=LDR  01443cz  a2200409n  4500
=001  9880363344402441
=005  20200611123234.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000951
=035  \\$aCAZ4105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x285
=150  \\$aAntigens, Neoplasm
=450  \\$wnnna$aAntigens, Tumor
=450  \\$aNeoplasm Antigens
=450  \\$aTumor Antigens
=550  \\$wg$aAntigens
=550  \\$wh$aAntigens, CD147
=550  \\$wh$aAntigens, CD24
=550  \\$wh$aAntigens, CD30
=550  \\$wh$aAntigens, Tumor-Associated, Carbohydrate
=550  \\$wh$aAntigens, Viral, Tumor
=550  \\$wh$aCarbonic Anhydrase IX
=550  \\$wh$aCarcinoembryonic Antigen
=550  \\$wh$aEpithelial Cell Adhesion Molecule
=550  \\$wh$aFolate Receptor 1
=550  \\$wh$aMelanoma-Specific Antigens
=550  \\$wh$aNeprilysin
=550  \\$wh$aPancreatitis-Associated Proteins
=550  \\$wh$aProstate-Specific Antigen
=550  \\$wh$aTissue Polypeptide Antigen
=550  \\$aNeoplasm Proteins
=550  \\$aNeoplasms
=667  \\$acoord IM with required neopl coords with /immunol (IM); Manual 24.4.4.1+
=680  \\$iProteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
=688  \\$a73
=750  \0$aTumor antigens$5IEN$0(DLC)sh 85138549

=LDR  00695cz  a2200241n  4500
=001  9880363344502441
=005  20141212194838.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000946
=035  \\$aCAZ4101HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x202
=150  \\$aAntigens, Fungal
=450  \\$aFungal Antigens
=550  \\$wg$aAntigens
=550  \\$wh$aCoccidioidin
=550  \\$wh$aFungal Polysaccharides
=550  \\$wh$aHistoplasmin
=550  \\$wh$aTrichophytin
=667  \\$acoord IM with specific fungus /immunol (IM)
=680  \\$iSubstances of fungal origin that have antigenic activity.
=688  \\$a73
=750  \0$aFungal antigens$5IEN$0(DLC)sh 85052427

=LDR  00820cz  a2200253n  4500
=001  9880363344602441
=005  20141212194835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000942
=035  \\$aCAZ4096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x161
=150  \\$aAntigens, Bacterial
=450  \\$aBacterial Antigens
=550  \\$wg$aAntigens
=550  \\$wh$aAdhesins, Bacterial
=550  \\$wh$aLepromin
=550  \\$wh$aPolysaccharides, Bacterial
=550  \\$wh$aStaphylococcal Protein A
=550  \\$wh$aTuberculin
=667  \\$acoord IM with specific bacterium /immunol (IM); DF: ANTIGENS BACT
=680  \\$iSubstances elaborated by bacteria that have antigenic activity.
=688  \\$a73; was BACTERIAL ANTIGENS 1971-72 (Prov)
=750  \0$aBacterial antigens$5IEN$0(DLC)sh 85010839

=LDR  01281cz  a2200421n  4500
=001  9880363344702441
=005  20141212194835.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000941
=035  \\$aCAZ4095HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50
=150  \\$aAntigens
=450  \\$wnnna$aAntigen
=550  \\$wg$aBiological Factors
=550  \\$wh$aAllergens
=550  \\$wh$aAntigen-Antibody Complex
=550  \\$wh$aAntigens, Archaeal
=550  \\$wh$aAntigens, Bacterial
=550  \\$wh$aAntigens, Dermatophagoides
=550  \\$wh$aAntigens, Fungal
=550  \\$wh$aAntigens, Helminth
=550  \\$wh$aAntigens, Heterophile
=550  \\$wh$aAntigens, Neoplasm
=550  \\$wh$aAntigens, Nuclear
=550  \\$wh$aAntigens, Plant
=550  \\$wh$aAntigens, Protozoan
=550  \\$wh$aAntigens, Surface
=550  \\$wh$aAntigens, T-Independent
=550  \\$wh$aAntigens, Viral
=550  \\$wh$aAutoantigens
=550  \\$wh$aEpitopes
=550  \\$wh$aIsoantigens
=550  \\$wh$aSuperantigens
=550  \\$wh$aVaccines, Synthetic
=667  \\$aGEN or unspecified: prefer specifics
=680  \\$iSubstances that are recognized by the immune system and induce an immune reaction.
=750  \0$aAntigens$5IEN$0(DLC)sh 85005675

=LDR  01056cz  a2200301n  4500
=001  9880363344802441
=005  20141212194834.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000939
=035  \\$aCAZ4093HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x550
=150  \\$aEpitopes
=450  \\$aAntigenic Determinants
=450  \\$aAntigenic Specificity
=450  \\$wnnna$aDeterminants, Antigenic
=450  \\$wnnna$aSpecificity, Antigenic
=550  \\$wg$aAntigens
=550  \\$wh$aAntigens, Tumor-Associated, Carbohydrate
=550  \\$wh$aEpitopes, B-Lymphocyte
=550  \\$wh$aEpitopes, T-Lymphocyte
=550  \\$wh$aHaptens
=550  \\$wh$aImmunodominant Epitopes
=550  \\$wh$aImmunoglobulin Idiotypes
=667  \\$aX ref ANTIGENIC DETERMINANTS: do not confuse with genetic determinants ( = GENES or specific)
=680  \\$iSites on an antigen that interact with specific antibodies.
=688  \\$a96; was ANTIGENIC DETERMINANTS 1970-95 (as Prov 1970-71)
=750  \0$aAntigenic determinants$5IEN$0(DLC)sh 88005889

=LDR  01513cz  a2200337n  4500
=001  9880363344902441
=005  20141212194833.0
=008  840530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000938
=035  \\$aCAZ4092HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x66
=072  \\$aA15.$x382.$x66
=150  \\$aAntigen-Presenting Cells
=450  \\$wnnna$aAccessory Cell, Immunologic
=450  \\$aAccessory Cells, Immunologic
=450  \\$wnnna$aAntigen-Presenting Cell
=450  \\$wnnna$aAntigen Presenting Cells
=450  \\$wnnna$aCell, Antigen-Presenting
=450  \\$wnnna$aCell, Immunologic Accessory
=450  \\$wnnna$aCells, Antigen-Presenting
=450  \\$wnnna$aCells, Immunologic Accessory
=450  \\$wnnna$aImmunologic Accessory Cell
=450  \\$aImmunologic Accessory Cells
=550  \\$wg$aCells
=550  \\$wg$aImmune System
=550  \\$wh$aDendritic Cells
=550  \\$wh$aDendritic Cells, Follicular
=680  \\$iA heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors.
=688  \\$a85
=750  \0$aAntigen presenting cells$5IEN$0(DLC)sh 87006338

=LDR  01091cz  a2200337n  4500
=001  9880363345002441
=005  20141212194833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000937
=035  \\$aCAZ4091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x143
=150  \\$aAntigen-Antibody Reactions
=450  \\$wnnna$aAntigen-Antibody Reaction
=450  \\$wnnna$aAntigen Antibody Reactions
=450  \\$wnnna$aReaction, Antigen-Antibody
=450  \\$wnnna$aReactions, Antigen-Antibody
=550  \\$wg$aImmune System Processes
=550  \\$wh$aAgglutination
=550  \\$wh$aAntibody Affinity
=550  \\$wh$aAntigenic Modulation
=550  \\$wh$aBinding Sites, Antibody
=550  \\$wh$aCross Reactions
=550  \\$wh$aHemolysis
=550  \\$wh$aImmunologic Capping
=550  \\$wh$aPassive Cutaneous Anaphylaxis
=550  \\$wh$aRh Isoimmunization
=550  \\$aAntibodies
=550  \\$aAntigens
=680  \\$iThe processes triggered by interactions of ANTIBODIES with their ANTIGENS.
=750  \0$aAntigen-antibody reactions$5IEN$0(DLC)sh 85005674

=LDR  01222cz  a2200337n  4500
=001  9880363345102441
=005  20141212194833.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000936
=035  \\$aCAZ4090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x257
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x257
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x257
=072  \\$aD23.$x50.$x101
=150  \\$aAntigen-Antibody Complex
=450  \\$wnnna$aAntigen Antibody Complex
=450  \\$wnnna$aAntigen-Antibody Complexes
=450  \\$wnnna$aAntigen Antibody Complexes
=450  \\$wnnna$aComplex, Antigen-Antibody
=450  \\$wnnna$aComplex, Immune
=450  \\$wnnna$aComplexes, Antigen-Antibody
=450  \\$wnnna$aComplexes, Immune
=450  \\$aImmune Complex
=450  \\$wnnna$aImmune Complexes
=550  \\$wg$aAntibodies
=550  \\$wg$aAntigens
=550  \\$aImmunoprecipitation
=680  \\$iThe complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.
=688  \\$a72(70)
=750  \0$aImmune complexes$5IEN$0(DLC)sh 85064535

=LDR  01176cz  a2200277n  4500
=001  9880363345202441
=005  20141212194832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000935
=035  \\$aCAZ4089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x136
=150  \\$aAntifungal Agents
=450  \\$wnnna$aAgents, Antifungal
=450  \\$wnnna$aAntibiotics, Antifungal
=450  \\$wnnna$aAntifungal Antibiotics
=450  \\$aFungicides, Therapeutic
=450  \\$wnnna$aTherapeutic Fungicides
=550  \\$wg$aAnti-Infective Agents
=550  \\$aFungi
=550  \\$aMycoses
=667  \\$aused in therapy: differentiate from FUNGICIDES, INDUSTRIAL; for resistance to antifungal agents, DRUG RESISTANCE, FUNGAL and DRUG RESISTANCE, MULTIPLE, FUNGAL are available
=680  \\$iSubstances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
=688  \\$a1967
=688  \\$a67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66
=750  \0$aAntifungal agents$0(DLC) sh 85005673$5IEN

=LDR  00973cz  a2200289n  4500
=001  9880363345302441
=005  20141212194832.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000934
=035  \\$aCAZ4088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x178
=072  \\$aD27.$x720.$x877.$x48
=150  \\$aAntifoaming Agents
=450  \\$wnnna$aAgents, Antifoaming
=450  \\$wnnna$aAgents, Defoaming
=450  \\$aAntiflatulents
=450  \\$aDefoaming Agents
=450  \\$aFoam Retardants
=450  \\$wnnna$aRetardants, Foam
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wg$aSurface-Active Agents
=550  \\$aFlatulence
=667  \\$aD25-26 qualif; consider also FLATULENCE /drug ther
=680  \\$iAgents used to prevent the formation of foam or to treat flatulence or bloat.
=688  \\$a91(77); was see under SURFACE-ACTIVE AGENTS 1977-90
=750  \0$aAntifoaming agents$5IEN$0(DLC)sh 85005672

=LDR  01112cz  a2200301n  4500
=001  9880363345402441
=005  20141212194832.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000933
=035  \\$aCAZ4087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x421.$x500
=072  \\$aD27.$x505.$x954.$x502.$x270.$x463.$x91
=150  \\$aAntifibrinolytic Agents
=450  \\$wnnna$aAgents, Antifibrinolytic
=450  \\$aAntifibrinolysins
=450  \\$wnnna$aAntifibrinolytics
=450  \\$aAntiplasmins
=450  \\$aFibrinolytic Agents$xantagonists & inhibitors
=450  \\$wnnna$aInhibitor, Plasmin
=450  \\$wnnna$aInhibitors, Plasmin
=450  \\$wnnna$aPlasmin Inhibitor
=450  \\$wnnna$aPlasmin Inhibitors
=550  \\$wg$aFibrin Modulating Agents
=550  \\$wg$aHemostatics
=680  \\$iAgents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
=688  \\$a66
=750  \0$aAntifibrinolytic agents$5IEN$0(DLC)sh 85005671

=LDR  01428cz  a2200433n  4500
=001  9880363345502441
=005  20141212194831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000932
=035  \\$aCAZ4086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x50.$x30
=072  \\$aD27.$x505.$x954.$x427.$x95
=072  \\$aD27.$x505.$x954.$x483.$x200
=150  \\$aAntiemetics
=450  \\$wnnna$aAgents, Antiemetic
=450  \\$wnnna$aAnti-Emetic Effect
=450  \\$wnnna$aAnti Emetic Effect
=450  \\$wnnna$aAnti-Emetic Effects
=450  \\$wnnna$aAnti Emetic Effects
=450  \\$wnnna$aAnti-emetics
=450  \\$wnnna$aAnti emetics
=450  \\$wnnna$aAntiemetic Agents
=450  \\$wnnna$aAntiemetic Drugs
=450  \\$wnnna$aAntiemetic Effect
=450  \\$wnnna$aAntiemetic Effects
=450  \\$wnnna$aDrugs, Antiemetic
=450  \\$wnnna$aEffect, Anti-Emetic
=450  \\$wnnna$aEffect, Antiemetic
=450  \\$wnnna$aEffects, Anti-Emetic
=450  \\$wnnna$aEffects, Antiemetic
=550  \\$wg$aAutonomic Agents
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aGastrointestinal Agents
=550  \\$aNausea
=550  \\$aVomiting
=667  \\$anote entry term ANTIEMETIC EFFECT: use only for the antiemetic effect of a chemical substance
=680  \\$iDrugs used to prevent NAUSEA or VOMITING.
=750  \0$aAntiemetics$5IEN$0(DLC)sh 85005667

=LDR  00718cz  a2200253n  4500
=001  9880363345602441
=005  20141212194831.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000931
=035  \\$aCAZ4085HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x706.$x37
=072  \\$aD27.$x720.$x799.$x37
=150  \\$aAntidotes
=450  \\$aPoisons$xantagonists & inhibitors
=450  \\$wnnna$aTheriacs
=550  \\$wg$aProtective Agents
=550  \\$aAntivenins
=550  \\$aChelating Agents
=550  \\$aPoisoning
=550  \\$aToxins, Biological
=680  \\$iAgents counteracting or neutralizing the action of POISONS.
=688  \\$a66(64)
=750  \0$aAntidotes$5IEN$0(DLC)sh 85005663

=LDR  01108cz  a2200301n  4500
=001  9880363345702441
=005  20141212194830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000930
=035  \\$aCAZ4084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x483.$x161
=150  \\$aAntidiarrheals
=450  \\$wnnna$aAgents, Antidiarrheal
=450  \\$wnnna$aAgents, Antiperistaltic
=450  \\$wnnna$aAntidiarrheal Agents
=450  \\$wnnna$aAntidiarrheal Drugs
=450  \\$wnnna$aAntiperistaltic Agents
=450  \\$wnnna$aAntiperistaltic Drugs
=450  \\$aAntiperistaltics
=450  \\$wnnna$aDrugs, Antidiarrheal
=450  \\$wnnna$aDrugs, Antiperistaltic
=550  \\$wg$aGastrointestinal Agents
=550  \\$aDiarrhea
=667  \\$aconsider also DIARRHEA /drug ther
=680  \\$iMiscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.
=688  \\$a75; was see under GASTROINTESTINAL AGENTS 1969-74
=750  \0$aAntidiarrheals$5IEN$0(DLC)sh 85005662

=LDR  01635cz  a2200301n  4500
=001  9880363345802441
=005  20141212194830.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000928
=035  \\$aCAZ4082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x700.$x122
=150  \\$aAntidepressive Agents
=450  \\$wnnna$aAgents, Antidepressive
=450  \\$wnnna$aAntidepressant Drugs
=450  \\$aAntidepressants
=450  \\$wnnna$aDrugs, Antidepressant
=450  \\$aThymoanaleptics
=450  \\$aThymoleptics
=550  \\$wg$aPsychotropic Drugs
=550  \\$wh$aAntidepressive Agents, Second-Generation
=550  \\$wh$aAntidepressive Agents, Tricyclic
=550  \\$aDepression
=550  \\$aMonoamine Oxidase Inhibitors
=667  \\$aGEN or unspecified; prefer specific groups or specific antidepressive agents; consider also DEPRESSION /drug ther
=680  \\$iMood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.
=688  \\$a66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78
=750  \0$aAntidepressants$5IEN$0(DLC)sh 85005661

=LDR  01088cz  a2200325n  4500
=001  9880363345902441
=005  20141212194829.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000927
=035  \\$aCAZ4081HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x80
=150  \\$aAnticonvulsants
=450  \\$wnnna$aAgents, Anticonvulsive
=450  \\$wnnna$aAgents, Antiepileptic
=450  \\$wnnna$aAnticonvulsant Drugs
=450  \\$wnnna$aAnticonvulsive Agents
=450  \\$wnnna$aAnticonvulsive Drugs
=450  \\$aAntiepileptic Agents
=450  \\$wnnna$aAntiepileptic Drugs
=450  \\$wnnna$aAntiepileptics
=450  \\$wnnna$aDrugs, Anticonvulsant
=450  \\$wnnna$aDrugs, Anticonvulsive
=450  \\$wnnna$aDrugs, Antiepileptic
=550  \\$wg$aCentral Nervous System Agents
=550  \\$aBarbiturates
=550  \\$aSeizures
=667  \\$aGEN or unspecified; prefer specifics; consider also CONVULSIONS /drug ther
=680  \\$iDrugs used to prevent SEIZURES or reduce their severity.
=750  \0$aAnticonvulsants$5IEN$0(DLC)sh 85005657

=LDR  00843cz  a2200265n  4500
=001  9880363346002441
=005  20141212191956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000925
=035  \\$aCAZ4079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x119
=150  \\$aAnticoagulants
=450  \\$wnnna$aAgents, Anticoagulant
=450  \\$wnnna$aAnticoagulant Agents
=450  \\$wnnna$aAnticoagulant Drugs
=450  \\$wnnna$aDrugs, Anticoagulant
=450  \\$wnnna$aIndirect Thrombin Inhibitors
=450  \\$wnnna$aInhibitors, Indirect Thrombin
=450  \\$wnnna$aThrombin Inhibitors, Indirect
=550  \\$wg$aHematologic Agents
=550  \\$wh$aAntithrombins
=550  \\$aBlood Coagulation
=680  \\$iAgents that prevent clotting.
=750  \0$aAnticoagulants (Medicine)$5IEN$0(DLC)sh 85005656

=LDR  01036cz  a2200301n  4500
=001  9880363346102441
=005  20141212191955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000924
=035  \\$aCAZ4078HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186.$x71.$x202
=072  \\$aD27.$x505.$x954.$x557.$x500.$x202
=150  \\$aAnticholesteremic Agents
=450  \\$wnnna$aAgents, Anticholesteremic
=450  \\$wnnna$aAgents, Hypocholesteremic
=450  \\$wnnna$aAnticholesteremic Drugs
=450  \\$wnnna$aAnticholesteremics
=450  \\$aCholesterol$xantagonists & inhibitors
=450  \\$aCholesterol Inhibitors
=450  \\$wnnna$aDrugs, Anticholesteremic
=450  \\$aHypocholesteremic Agents
=450  \\$wnnna$aInhibitors, Cholesterol
=550  \\$wg$aHypolipidemic Agents
=550  \\$wh$aHydroxymethylglutaryl-CoA Reductase Inhibitors
=680  \\$iSubstances used to lower plasma CHOLESTEROL levels.
=688  \\$a66(64)
=750  \0$aAnticholesteremic agents$5IEN$0(DLC)sh 85005653

=LDR  02689cz  a2200673n  4500
=001  9880363346202441
=005  20141212194829.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000922
=035  \\$aCAZ4076HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x580.$x450
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x580.$x450
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x580.$x450
=072  \\$aD27.$x888.$x569.$x271
=150  \\$aImmunotoxins
=450  \\$wnnna$aAffinotoxins
=450  \\$aAntibody-Toxin Conjugates
=450  \\$wnnna$aAntibody Toxin Conjugates
=450  \\$wnnna$aAntibody-Toxin Conjugates, Monoclonal
=450  \\$aAntibody-Toxin Hybrids
=450  \\$wnnna$aAntibody Toxin Hybrids
=450  \\$wnnna$aCarrier, Toxin
=450  \\$wnnna$aCarriers, Toxin
=450  \\$wnnna$aChimeric Toxin
=450  \\$aChimeric Toxins
=450  \\$wnnna$aConjugate, Toxin
=450  \\$wnnna$aConjugates, Antibody-Toxin
=450  \\$wnnna$aConjugates, Cytotoxin-Antibody
=450  \\$wnnna$aConjugates, Monoclonal Antibody-Toxin
=450  \\$wnnna$aConjugates, Toxin
=450  \\$wnnna$aConjugates, Toxin-Antibody
=450  \\$aCytotoxin-Antibody Conjugates
=450  \\$wnnna$aCytotoxin Antibody Conjugates
=450  \\$wnnna$aHybrids, Antibody-Toxin
=450  \\$wnnna$aHybrids, Toxin-Antibody
=450  \\$wnnna$aImmunotoxin
=450  \\$wnnna$aMonoclonal Antibody-Toxin Conjugates
=450  \\$wnnna$aMonoclonal Antibody Toxin Conjugates
=450  \\$aTargeted Toxins
=450  \\$aToxin-Antibody Conjugates
=450  \\$wnnna$aToxin Antibody Conjugates
=450  \\$aToxin-Antibody Hybrids
=450  \\$wnnna$aToxin Antibody Hybrids
=450  \\$wnnna$aToxin Carrier
=450  \\$aToxin Carriers
=450  \\$wnnna$aToxin, Chimeric
=450  \\$wnnna$aToxin Conjugate
=450  \\$aToxin Conjugates
=450  \\$aToxins, Chimeric
=450  \\$aToxins, Targeted
=550  \\$wg$aImmunoconjugates
=550  \\$wg$aNoxae
=550  \\$aAntibodies, Bispecific
=550  \\$aRecombinant Fusion Proteins
=667  \\$acoordinate IM with specific toxin (IM) + specific immune substance (NIM)
=680  \\$iSemisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.
=688  \\$a90; was ANTIBODY-TOXIN CONJUGATES 1987-89
=750  \0$aAntibody-toxin conjugates$5IEN$0(DLC)sh 87005963

=LDR  01831cz  a2200361n  4500
=001  9880363346302441
=005  20141212194827.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000920
=035  \\$aCAZ4074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG12.$x425.$x270.$x70
=150  \\$aAntibody-Dependent Cell Cytotoxicity
=450  \\$aADCC
=450  \\$wnnna$aAntibody-Dependent Cell Cytotoxicities
=450  \\$wnnna$aAntibody Dependent Cell Cytotoxicity
=450  \\$wnnna$aAntibody-Dependent Cell Cytoxicities
=450  \\$wnnna$aAntibody-Dependent Cell Cytoxicity
=450  \\$wnnna$aCell Cytotoxicities, Antibody-Dependent
=450  \\$wnnna$aCell Cytotoxicity, Antibody-Dependent
=450  \\$wnnna$aCell Cytoxicities, Antibody-Dependent
=450  \\$wnnna$aCell Cytoxicity, Antibody-Dependent
=450  \\$wnnna$aCell Cytoxicity, Antibody Dependent
=450  \\$wnnna$aCytotoxicities, Antibody-Dependent Cell
=450  \\$aCytotoxicity, Antibody-Dependent Cell
=450  \\$wnnna$aCytotoxicity, Antibody Dependent Cell
=450  \\$wnnna$aCytoxicities, Antibody-Dependent Cell
=450  \\$wnnna$aCytoxicity, Antibody-Dependent Cell
=550  \\$wg$aCytotoxicity, Immunologic
=667  \\$aDF: note short X ref
=680  \\$iThe phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent.
=688  \\$a78
=750  \0$aAntibody-dependent cell cytotoxicity$5IEN$0(DLC)sh 85005651

=LDR  01647cz  a2200301n  4500
=001  9880363346402441
=005  20141212194826.0
=008  790223\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000916
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x365.$x36
=072  \\$aG12.$x51
=072  \\$aG12.$x500.$x199
=150  \\$aAntibody Diversity
=450  \\$wnnna$aAntibody Diversities
=450  \\$wnnna$aDiversities, Antibody
=450  \\$wnnna$aDiversity, Antibody
=450  \\$wnnna$aGerm Line Theories
=450  \\$aGerm Line Theory
=450  \\$wnnna$aTheories, Germ Line
=450  \\$wnnna$aTheory, Germ Line
=550  \\$wg$aGenetic Variation
=550  \\$wg$aImmune System Phenomena
=550  \\$wg$aImmunogenetic Phenomena
=550  \\$aGene Rearrangement
=680  \\$iThe phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.
=688  \\$a80
=750  \0$aAntibody diversity$5IEN$0(DLC)sh 85005652

=LDR  00842cz  a2200241n  4500
=001  9880363346502441
=005  20141212194825.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000914
=035  \\$aCAZ4068HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x254
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x254
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x254
=150  \\$aAntibodies, Viral
=450  \\$aViral Antibodies
=550  \\$wg$aAntibodies
=550  \\$wh$aDeltaretrovirus Antibodies
=550  \\$wh$aHepatitis Antibodies
=667  \\$acoordinate IM with specific virus /immunol (IM); do not coordinate with ANTIBODY FORMATION for /biosyn
=680  \\$iImmunoglobulins produced in response to VIRAL ANTIGENS.
=688  \\$a73
=750  \0$aViral antibodies$5IEN$0(DLC)sh 89004437

=LDR  00999cz  a2200277n  4500
=001  9880363346602441
=005  20170404154658.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000911
=035  \\$aCAZ4065HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224
=150  \\$aAntibodies, Monoclonal
=450  \\$aMonoclonal Antibodies
=550  \\$wg$aAntibodies
=550  \\$wh$aAntibodies, Monoclonal, Humanized
=550  \\$wh$aAntibodies, Monoclonal, Murine-Derived
=550  \\$wh$aInfliximab
=550  \\$wh$aSingle-Chain Antibodies
=550  \\$aHybridomas
=667  \\$ado not coordinate with ANTIBODY FORMATION for biosyn; ANTIBODY-TOXIN CONJUGATES is available as a toxin carrier: see note there
=680  \\$iAntibodies produced by a single clone of cells.
=688  \\$a82
=750  \0$aMonoclonal antibodies$5IEN$0(DLC)sh 85005650

=LDR  00780cz  a2200229n  4500
=001  9880363346702441
=005  20141212194821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000903
=035  \\$aCAZ4056HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x248.$x106
=150  \\$aAntibiotics, Antineoplastic
=450  \\$wnno$aAntibiotics, Anthracycline$5IEN-M
=450  \\$wnnna$aAntibiotics, Cytotoxic
=450  \\$aAntineoplastic Antibiotics
=450  \\$aCytotoxic Antibiotics
=550  \\$wg$aAntineoplastic Agents
=667  \\$aGEN: prefer specifics
=680  \\$iChemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
=688  \\$a67
=750  \0$aAntineoplastic antibiotics$5IEN$0(DLC)sh 88001840

=LDR  01612cz  a2200421n  4500
=001  9880363346802441
=005  20141212194821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000900
=035  \\$aCAZ4052HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x85
=150  \\$aAnti-Bacterial Agents
=450  \\$wnnna$aAgents, Anti-Bacterial
=450  \\$wnnna$aAgents, Anti-Mycobacterial
=450  \\$wnnna$aAgents, Antibacterial
=450  \\$wnnna$aAgents, Antimycobacterial
=450  \\$wnnna$aAgents, Bacteriocidal
=450  \\$wnnna$aAnti Bacterial Agents
=450  \\$wnnna$aAnti-Mycobacterial Agents
=450  \\$wnnna$aAnti Mycobacterial Agents
=450  \\$wnnna$aAntibacterial Agents
=450  \\$aAntibiotics
=450  \\$wnnoa$aAntibiotics, Lactam$5IEN-M
=450  \\$wnnoa$aAntibiotics, Macrolide$5IEN-M
=450  \\$wnnna$aAntimycobacterial Agents
=450  \\$wnnna$aBacteriocidal Agents
=450  \\$wnnna$aBacteriocides
=550  \\$wg$aAnti-Infective Agents
=550  \\$wh$aAntibiotics, Antitubercular
=550  \\$wh$aAntitreponemal Agents
=550  \\$wh$aAntitubercular Agents
=550  \\$wh$abeta-Lactamase Inhibitors
=550  \\$wh$aLeprostatic Agents
=667  \\$aGEN or unspecified; resistance to antibiotics = DRUG RESISTANCE, BACTERIAL or specifics; preop use of antibiotics for prev of infect: index under ANTIBIOTIC PROPHYLAXIS (IM) + specific antibiotic /ther use (IM)
=680  \\$iSubstances that reduce the growth or reproduction of BACTERIA.
=688  \\$a2004(1963)
=750  \0$aAntibiotics$0(DLC) sh 85005638$5IEN

=LDR  01042cz  a2200301n  4500
=001  9880363346902441
=005  20170607112312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000898
=035  \\$aCAZ4050HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG6.$x550.$x50
=072  \\$aG16.$x62
=150  \\$aAntibiosis
=450  \\$wnnna$aAntagonism, Microbial
=450  \\$wnnna$aAntagonisms, Microbial
=450  \\$wnnna$aAntibioses
=450  \\$aBacterial Interference
=450  \\$wnnna$aBacterial Interferences
=450  \\$wnnna$aInterference, Bacterial
=450  \\$wnnna$aInterferences, Bacterial
=450  \\$aMicrobial Antagonism
=450  \\$wnnna$aMicrobial Antagonisms
=550  \\$wg$aBiological Phenomena
=550  \\$wg$aMicrobial Interactions
=680  \\$iA natural association between organisms that is detrimental to at least one of them. This often refers to the production of chemicals by one microorganism that is harmful to another.
=688  \\$a72(65)
=750  \0$aAntibiosis$5IEN$0(DLC)sh 85005636

=LDR  01151cz  a2200301n  4500
=001  9880363347002441
=005  20141212194820.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000897
=035  \\$aCAZ4049HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x483.$x203
=150  \\$aAnti-Ulcer Agents
=450  \\$wnnna$aAgents, Anti-Ulcer
=450  \\$wnnna$aAnti Ulcer Agents
=450  \\$wnnna$aAnti-Ulcer Drugs
=450  \\$wnnna$aAnti Ulcer Drugs
=450  \\$wnnna$aDrugs, Anti-Ulcer
=550  \\$wg$aGastrointestinal Agents
=550  \\$aAntacids
=550  \\$aEpidermal Growth Factor
=550  \\$aHistamine H2 Antagonists
=550  \\$aParasympatholytics
=550  \\$aPeptic Ulcer
=667  \\$arestrict to gastrointestinal ulcers
=680  \\$iVarious agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
=688  \\$a77
=750  \0$aAntiulcer drugs$5IEN$0(DLC)sh 88005043

=LDR  02847cz  a2200577n  4500
=001  9880363347102441
=005  20141212194819.0
=008  860623\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000894
=035  \\$aCAZ4046HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x663.$x850.$x14.$x40.$x500
=072  \\$aD27.$x505.$x954.$x158.$x30
=072  \\$aD27.$x505.$x954.$x329.$x30
=150  \\$aAnti-Inflammatory Agents, Non-Steroidal
=450  \\$wnnna$aAgents, Aspirin-Like
=450  \\$wnnna$aAgents, Non-Steroidal Anti-Inflammatory
=450  \\$wnnna$aAgents, Non-Steroidal Anti-Rheumatic
=450  \\$wnnna$aAgents, Non-Steroidal Antirheumatic
=450  \\$wnnna$aAgents, Nonsteroidal Anti-Inflammatory
=450  \\$wnnna$aAgents, Nonsteroidal Antiinflammatory
=450  \\$aAnalgesics, Anti-Inflammatory
=450  \\$wnnna$aAnalgesics, Anti Inflammatory
=450  \\$wnnna$aAnti Inflammatory Agents, Non Steroidal
=450  \\$wnnna$aAnti Inflammatory Agents, Nonsteroidal
=450  \\$wnnna$aAnti-Inflammatory Agents, Nonsteroidal
=450  \\$wnnna$aAnti-Inflammatory Analgesics
=450  \\$aAnti-Rheumatic Agents, Non-Steroidal
=450  \\$wnnna$aAnti Rheumatic Agents, Non Steroidal
=450  \\$wnnna$aAntiinflammatory Agents, Non Steroidal
=450  \\$wnnna$aAntiinflammatory Agents, Nonsteroidal
=450  \\$wnnna$aAntirheumatic Agents, Non-Steroidal
=450  \\$wnnna$aAntirheumatic Agents, Non Steroidal
=450  \\$aAspirin-Like Agents
=450  \\$wnnna$aAspirin Like Agents
=450  \\$aNon-Steroidal Anti-Inflammatory Agents
=450  \\$wnnna$aNon Steroidal Anti Inflammatory Agents
=450  \\$wnnna$aNon-Steroidal Anti-Rheumatic Agents
=450  \\$wnnna$aNon-Steroidal Antirheumatic Agents
=450  \\$wnnna$aNonsteroidal Anti-Inflammatory Agents
=450  \\$wnnna$aNonsteroidal Anti Inflammatory Agents
=450  \\$wnnna$aNonsteroidal Antiinflammatory Agents
=450  \\$wnnna$aNSAIDs
=550  \\$wg$aAnalgesics, Non-Narcotic
=550  \\$wg$aAnti-Inflammatory Agents
=550  \\$wg$aAntirheumatic Agents
=550  \\$wh$aCyclooxygenase Inhibitors
=550  \\$aFever
=680  \\$iAnti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
=688  \\$a87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89
=750  \0$aNonsteroidal anti-inflammatory agents$0(DLC) sh 85092365$5IEN

=LDR  01384cz  a2200385n  4500
=001  9880363347202441
=005  20141212194818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000893
=035  \\$aCAZ4045HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x158
=150  \\$aAnti-Inflammatory Agents
=450  \\$wnnna$aAgents, Anti-Inflammatory
=450  \\$wnnna$aAgents, Anti Inflammatory
=450  \\$wnnna$aAgents, Antiinflammatory
=450  \\$wnnna$aAnti-Inflammatories
=450  \\$wnnna$aAnti Inflammatories
=450  \\$wnnna$aAnti Inflammatory Agents
=450  \\$wnnoa$aAnti-Inflammatory Agents, Steroidal$5IEN-M
=450  \\$wnnoa$aAnti-Inflammatory Agents, Topical$5IEN-M
=450  \\$wnnna$aAntiinflammatories
=450  \\$wnnna$aAntiinflammatory Agents
=450  \\$wnnoa$aGlucocorticoids, Topical$5IEN-M
=450  \\$wnno$aHydrocortisone, Topical$5IEN-M
=450  \\$wnno$aPrednisolone, Topical$5IEN-HS
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnti-Inflammatory Agents, Non-Steroidal
=550  \\$wh$aDemulcents
=550  \\$aFever
=550  \\$aInflammation
=667  \\$ado not confuse with INFLAMMATION MEDIATORS; DF: ANTI INFLAMM AGENTS or ANTIINFLAMM AGENTS
=680  \\$iSubstances that reduce or suppress INFLAMMATION.
=688  \\$a66(64)
=750  \0$aAnti-inflammatory agents$5IEN$0(DLC)sh 85005615

=LDR  01682cz  a2200409n  4500
=001  9880363347302441
=005  20141212194818.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000891
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x187
=150  \\$aAnti-Infective Agents, Local
=450  \\$wnnna$aAgents, Local Anti-Infective
=450  \\$wnnna$aAgents, Local Antiinfective
=450  \\$wnnna$aAgents, Topical Anti-Infective
=450  \\$wnnna$aAgents, Topical Antiinfective
=450  \\$wnnna$aAnti Infective Agents, Local
=450  \\$aAnti-Infective Agents, Topical
=450  \\$wnnna$aAnti Infective Agents, Topical
=450  \\$wnnna$aAntiinfective Agents, Local
=450  \\$wnnna$aAntiinfective Agents, Topical
=450  \\$aAntiseptics
=450  \\$wnnna$aLocal Anti-Infective Agents
=450  \\$wnnna$aLocal Anti Infective Agents
=450  \\$wnnna$aLocal Antiinfective Agents
=450  \\$aMicrobicides, Local
=450  \\$aMicrobicides, Topical
=450  \\$wnnna$aTopical Anti-Infective Agents
=450  \\$wnnna$aTopical Anti Infective Agents
=450  \\$wnnna$aTopical Antiinfective Agents
=550  \\$wg$aAnti-Infective Agents
=550  \\$wh$aHand Sanitizers
=550  \\$aDermatologic Agents
=550  \\$aIodophors
=680  \\$iSubstances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.
=688  \\$a67; ANTISEPTICS & ANTISEPTICS, HALOGEN & ANTISEPTICS, MERCURIAL & ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66
=750  \0$aAntiseptics$5IEN$0(DLC)sh 85005768

=LDR  01354cz  a2200385n  4500
=001  9880363347402441
=005  20141212194817.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000890
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122
=150  \\$aAnti-Infective Agents
=450  \\$wnnna$aAgents, Anti-Infective
=450  \\$wnnna$aAgents, Anti-Microbial
=450  \\$wnnna$aAgents, Antiinfective
=450  \\$wnnna$aAgents, Antimicrobial
=450  \\$wnnna$aAnti Infective Agents
=450  \\$wnnna$aAnti-Microbial Agents
=450  \\$wnnna$aAnti Microbial Agents
=450  \\$wnnna$aAntiinfective Agents
=450  \\$wnnna$aAntimicrobial Agents
=450  \\$aMicrobicides
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAnti-Bacterial Agents
=550  \\$wh$aAnti-Infective Agents, Local
=550  \\$wh$aAnti-Infective Agents, Urinary
=550  \\$wh$aAntifungal Agents
=550  \\$wh$aAntiparasitic Agents
=550  \\$wh$aAntiviral Agents
=550  \\$wh$aDisinfectants
=550  \\$aInfection
=550  \\$aParasites
=667  \\$ageneral or unspecified; prefer specific groups
=680  \\$iSubstances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
=750  \0$aAnti-infective agents$5IEN$0(DLC)sh 85005613

=LDR  02043cz  a2200469n  4500
=001  9880363347502441
=005  20141212194816.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000889
=035  \\$aCAZ4040HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x411.$x97
=150  \\$aAnti-Arrhythmia Agents
=450  \\$wnnna$aAgents, Anti-Arrhythmia
=450  \\$wnnna$aAgents, Antiarrhythmia
=450  \\$wnnna$aAgents, Antifibrillatory
=450  \\$wnnna$aAnti Arrhythmia Agents
=450  \\$wnnna$aAnti-Arrhythmia Drugs
=450  \\$wnnna$aAnti Arrhythmia Drugs
=450  \\$wnnna$aAnti-Arrhythmics
=450  \\$wnnna$aAnti Arrhythmics
=450  \\$wnnna$aAntiarrhythmia Agents
=450  \\$wnnna$aAntiarrhythmia Drugs
=450  \\$wnnna$aAntiarrhythmic Drugs
=450  \\$aAntifibrillatory Agents
=450  \\$aCardiac Depressants
=450  \\$wnnna$aDepressants, Cardiac
=450  \\$wnnna$aDepressants, Myocardial
=450  \\$wnnna$aDrugs, Anti-Arrhythmia
=450  \\$wnnna$aDrugs, Antiarrhythmia
=450  \\$wnnna$aDrugs, Antiarrhythmic
=450  \\$aMyocardial Depressants
=550  \\$wg$aCardiovascular Agents
=550  \\$aArrhythmias, Cardiac
=550  \\$aCalcium Channel Blockers
=550  \\$aHeart
=550  \\$aPotassium Channel Blockers
=550  \\$aSodium Channel Blockers
=667  \\$aconsider also ARRHYTHMIAS, CARDIAC /drug ther
=680  \\$iAgents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
=688  \\$a76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75
=750  \0$aMyocardial depressants$5IEN$0(DLC)sh 85089244

=LDR  01941cz  a2200457n  4500
=001  9880363347602441
=005  20170827150038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000888
=035  \\$aCAZ4039HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x71
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x71
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x71
=150  \\$aAntibodies, Anti-Idiotypic
=450  \\$wnnna$aAnti Antibodies
=450  \\$aAnti-Antibodies
=450  \\$wnnna$aAnti-gamma Globulin Antibodies
=450  \\$wnnna$aAnti gamma Globulin Antibodies
=450  \\$aAnti-Idiotype Antibodies
=450  \\$wnnna$aAnti Idiotype Antibodies
=450  \\$wnnna$aAnti-Idiotypic Antibodies
=450  \\$wnnna$aAntibodies, Anti
=450  \\$wnnna$aAntibodies, Anti-gamma Globulin
=450  \\$wnnna$aAntibodies, Anti-Idiotype
=450  \\$wnnna$aAntibodies, Anti Idiotypic
=450  \\$wnnna$aAntibodies, Antigamma Globulin
=450  \\$aAntibodies, Internal Image
=450  \\$aAntigamma Globulin Antibodies
=450  \\$aAntiglobulins
=450  \\$wnnna$aGlobulin Antibodies, Anti-gamma
=450  \\$wnnna$aGlobulin Antibodies, Antigamma
=450  \\$wnnna$aImage Antibodies, Internal
=450  \\$wnnna$aInternal Image Antibodies
=550  \\$wg$aAntibodies
=550  \\$wh$aOmalizumab
=550  \\$aEpitopes
=667  \\$ause only for anti-immunoglobulin antibodies such as anti-IGA antibodies, anti-IGG antibodies, etc.: coordinate IM with IMMUNOGLOBULIN A (IM), IMMUNOGLOBULIN G (IM), etc.; caution: anti-liver antibodies for example = ANTIBODIES + LIVER /immunol, not ANTI-ANTIBODIES
=680  \\$iAntibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
=688  \\$a90; was ANTI-ANTIBODIES 1966-89 (Prov 1966)
=750  \0$aAnti-idiotypic antibodies$5IEN$0(DLC)sh 90000322

=LDR  00690cz  a2200193n  4500
=001  9880363347702441
=005  20141212194815.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000887
=035  \\$aCAZ4038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x88
=072  \\$aK1.$x844.$x58
=150  \\$aAnthroposophy
=550  \\$wg$aComplementary Therapies
=550  \\$wg$aReligion
=680  \\$iKnowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher (1861-1925). (Webster, 3d ed)
=688  \\$a67,63-65
=750  \0$aAnthroposophy$5IEN$0(DLC)sh 85005595

=LDR  01109cz  a2200337n  4500
=001  9880363347802441
=005  20180725114335.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000886
=035  \\$aCAZ4037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x24
=072  \\$aE5.$x41
=072  \\$aN6.$x850.$x505.$x200.$x100
=150  \\$aAnthropometry
=550  \\$wg$aBiometry
=550  \\$wg$aInvestigative Techniques
=550  \\$wg$aPhysical Examination
=550  \\$wh$aBody Mass Index
=550  \\$wh$aBody Weights and Measures
=550  \\$wh$aCephalometry
=550  \\$wh$aCrown-Rump Length
=550  \\$wh$aKinanthropometry
=550  \\$wh$aOdontometry
=550  \\$wh$aPelvimetry
=550  \\$aAnthropology, Physical
=550  \\$aBody Composition
=550  \\$aBody Weights and Measures
=667  \\$aprimate only; consider also specific terms under BODY WEIGHTS AND MEASURES
=680  \\$iThe technique that deals with the measurement of the size, weight, and proportions of the human or other primate body.
=750  \0$aAnthropometry$5IEN$0(DLC)sh 85005588

=LDR  00850cz  a2200241n  4500
=001  9880363347902441
=005  20180315165621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000885
=035  \\$aCAZ4036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x368
=150  \\$aAnthropology, Physical
=450  \\$wnnna$aPhysical Anthropology
=550  \\$wg$aAnthropology
=550  \\$wh$aBody Remains
=550  \\$wh$aCraniology
=550  \\$wh$aForensic Anthropology
=550  \\$wh$aPaleontology
=667  \\$aIM as SPEC: SPEC qualif; NIM as coord, no qualif; DF: ANTHROPOL PHYSICAL
=680  \\$iThe comparative science dealing with the physical characteristics of humans as related to their origin, evolution, and development in the total environment.
=688  \\$a68
=750  \0$aPhysical anthropology$5IEN-HS$0(DLC)sh 85101512

=LDR  00863cz  a2200241n  4500
=001  9880363348002441
=005  20141212194814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000883
=035  \\$aCAZ4034HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x879.$x201
=072  \\$aI1.$x76
=150  \\$aAnthropology
=450  \\$aAnthropologists$5IEN
=550  \\$wg$aSocial Sciences
=550  \\$wh$aAnthropology, Cultural
=550  \\$wh$aAnthropology, Medical
=550  \\$wh$aAnthropology, Physical
=667  \\$aIM as SPEC: SPEC qualif; HOMINIDAE is available as taxonomic Man; NIM as coord with no qualif; med anthropology: do not coord with MEDICINE; DF: ANTHROPOL
=680  \\$iThe science devoted to the comparative study of man.
=750  \0$aAnthropology$5IEN-M$0(DLC)sh 85005581
=750  \0$aAnthropologists$5IEN-HS$0(DLC)sh 85005579

=LDR  01183cz  a2200265n  4500
=001  9880363348102441
=005  20141212194814.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000882
=035  \\$aCAZ4033HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400
=150  \\$aHaplorhini
=450  \\$aAnthropoidea
=450  \\$wnnna$aAnthropoids
=450  \\$wnnna$aMonkey
=450  \\$aMonkeys
=550  \\$wg$aPrimates
=550  \\$wh$aCatarrhini
=550  \\$wh$aPlatyrrhini
=550  \\$wh$aTarsii
=667  \\$anote X refs; many Old World & New World monkey families & genera are available: diseases of monkey families & genera: coordinate IM with MONKEY DISEASES (IM); Manual 22.28+
=680  \\$iA suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes).
=688  \\$a92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80
=750  \0$aMonkeys$0(DLC) sh 85086864$5IEN-M

=LDR  01498cz  a2200361n  4500
=001  9880364530202441
=005  20150325102713.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065786
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x785.$x373.$x346.$x700
=150  \\$aDelay Discounting
=450  \\$wnnna$aDecision Making, Intertemporal
=450  \\$wnnna$aDecision-Making, Intertemporal
=450  \\$wnnna$aDeferred Gratification
=450  \\$wnnna$aDelayed Gratification
=450  \\$wnnna$aDiscounting, Delay
=450  \\$wnnna$aDiscounting, Temporal
=450  \\$wnnna$aGratification, Deferred
=450  \\$wnnna$aGratification, Delayed
=450  \\$wnnna$aIntertemporal Decision Making
=450  \\$wnnna$aIntertemporal Decision-Making
=450  \\$wnnna$aIntertemporal Preference
=450  \\$wnnna$aIntertemporal Preferences
=450  \\$wnnna$aPreference, Intertemporal
=450  \\$wnnna$aPreferences, Intertemporal
=450  \\$wnnna$aTemporal Discounting
=550  \\$wg$aChoice Behavior
=550  \\$aImpulsive Behavior
=550  \\$aReward
=680  \\$iThe tendency to devalue an outcome as a function of its temporal delay or probability of achievement. It can be evaluated in a psychological paradigm that involves the choice between receiving a smaller immediate reward or a larger delayed reward, and may be used to provide a measure of impulsive behavior.
=688  \\$a2015
=750  \0$aDelay discounting (Psychology)$0(DLC)sh2013002387$5IEN-M

=LDR  00758cz  a2200241n  4500
=001  9880364530302441
=005  20150415174600.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065768
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x583
=072  \\$aC16.$x320.$x495
=150  \\$aLennox Gastaut Syndrome
=450  \\$wnnna$aGastaut Syndrome, Lennox
=450  \\$wnnna$aGastaut Syndromes, Lennox
=450  \\$wnnna$aLennox Gastaut Syndromes
=450  \\$wnnna$aSyndrome, Lennox Gastaut
=450  \\$wnnna$aSyndromes, Lennox Gastaut
=550  \\$wg$aEpilepsy
=550  \\$wg$aGenetic Diseases, Inborn
=680  \\$iA childhood-onset epilepsy syndrome.
=688  \\$a2015
=750  \0$aLennox-Gastaut syndrome$0(DLC)sh 88003575$5IEN-M

=LDR  00898cz  a2200229n  4500
=001  9880364530402441
=005  20150227092825.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065767
=040  \\$aDNLM$cDNLM
=072  \\$aG3.$x495.$x244.$x224
=072  \\$aG3.$x787.$x225.$x224
=072  \\$aG7.$x690.$x725.$x225.$x224
=150  \\$aActivation, Metabolic
=450  \\$wnnna$aActivation, Drug
=450  \\$wnnna$aDrug Activation
=450  \\$aMetabolic Activation
=550  \\$wg$aBiotransformation
=667  \\$arestrict to chemical changes of exogenous substances; IM general only; coordinate NIM with specific drug /pharmacokin (IM) or /metab (IM)
=680  \\$iThe conversion of an exogenous substance by a biological system resulting in the production on an active metabolite.
=688  \\$a2015; use Biotransformation 1980-2014
=750  \0$aDrug activation$0(DLC)sh 90005538$5IEN-M

=LDR  01674cz  a2200481n  4500
=001  9880364530502441
=005  20150429144712.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065749
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x615
=150  \\$aPhoeniceae
=450  \\$wnnna$adactylifera, Phoenix
=450  \\$wnnna$aDate Fruit
=450  \\$wnnna$aDate Fruits
=450  \\$wnnna$aDate Palm
=450  \\$wnnna$aDate, Palm
=450  \\$wnnna$aDate Palm Fruit
=450  \\$wnnna$aDate Palm Fruits
=450  \\$wnnna$aDate Palm Tree
=450  \\$wnnna$aDate Palm Trees
=450  \\$wnnna$aDate Palms
=450  \\$aDates, Palm
=450  \\$wnnna$aFruit, Date
=450  \\$wnnna$aFruit, Date Palm
=450  \\$wnnna$aFruits, Date
=450  \\$wnnna$aFruits, Date Palm
=450  \\$wnnna$aPalm Date
=450  \\$wnnna$aPalm, Date
=450  \\$wnnna$aPalm Dates
=450  \\$wnnna$aPalm Fruit, Date
=450  \\$wnnna$aPalm Fruits, Date
=450  \\$wnnna$aPalm Tree, Date
=450  \\$wnnna$aPalm Trees, Date
=450  \\$wnnna$aPalms, Date
=450  \\$aPhoenix dactylifera
=450  \\$wnnna$aTree, Date Palm
=450  \\$wnnna$aTrees, Date Palm
=550  \\$wg$aArecaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iTribe of palms in the subfamily Coryphoideae, family Arecaceae.
=688  \\$a2015
=750  \0$aDate palm$0(DLC)sh 85035878$5IEN-M

=LDR  01833cz  a2200505n  4500
=001  9880364530602441
=005  20150402132931.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065748
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x93.$x480
=150  \\$aEuterpe
=450  \\$wnnna$aAçai Berries
=450  \\$wnnna$aAçai Berry
=450  \\$aAcai Berries
=450  \\$wnnna$aAcai Berry
=450  \\$wnnna$aAssai Palm
=450  \\$wnnna$aAssai Palm Berries
=450  \\$wnnna$aAssai Palm Berry
=450  \\$wnnna$aAssai Palms
=450  \\$wnnna$aBerries, Açai
=450  \\$wnnna$aBerries, Acai
=450  \\$wnnna$aBerries, Assai Palm
=450  \\$wnnna$aBerry, Açai
=450  \\$wnnna$aBerry, Acai
=450  \\$wnnna$aBerry, Assai Palm
=450  \\$wnnna$aEuterpe edulis
=450  \\$wnnna$aEuterpe oleracea
=450  \\$wnnna$aEuterpe oleracea Mart.
=450  \\$wnnna$aEuterpe oleracea Mart.s
=450  \\$wnnna$aEuterpe precatoria
=450  \\$wnnna$aEuterpes
=450  \\$wnnna$aMart., Euterpe oleracea
=450  \\$wnnna$aMart.s, Euterpe oleracea
=450  \\$wnnna$aoleracea Mart., Euterpe
=450  \\$wnnna$aoleracea Mart.s, Euterpe
=450  \\$wnnna$aPalm, Assai
=450  \\$wnnna$aPalm Berries, Assai
=450  \\$wnnna$aPalm Berry, Assai
=450  \\$wnnna$aPalms, Assai
=550  \\$wg$aArecaceae
=667  \\$acoordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations /ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA genus in the family Arecaceae. They are a source of ACAI BERRIES.
=688  \\$a2015; use ARECACEAE 2004-2014
=750  \0$aEuterpe$0(DLC)sh 88022790

=LDR  01537cz  a2200421n  4500
=001  9880364530702441
=005  20150310131608.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065711
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x730.$x885.$x287.$x500.$x270.$x700.$x500
=150  \\$aBroca Area
=450  \\$wnnna$aArea, Broca
=450  \\$wnnna$aArea, Broca's
=450  \\$wnnna$aArea, Broca's Speech
=450  \\$wnnna$aBroca Region
=450  \\$wnnna$aBroca Speech Area
=450  \\$wnnna$aBroca's Area
=450  \\$wnnna$aBrocas Area
=450  \\$wnnna$aBroca's Region
=450  \\$wnnna$aBrocas Region
=450  \\$wnnna$aBroca's Speech Area
=450  \\$wnnna$aBrocas Speech Area
=450  \\$wnnna$aOperculari, Pars
=450  \\$wnnna$aOpercularis, Pars
=450  \\$wnnna$aPars Operculari
=450  \\$wnnna$aPars Opercularis
=450  \\$wnnna$aPars Triangulari
=450  \\$wnnna$aPars Triangularis
=450  \\$wnnna$aRegion, Broca's
=450  \\$wnnna$aSpeech Area, Broca's
=450  \\$wnnna$aTriangulari, Pars
=450  \\$wnnna$aTriangularis, Pars
=550  \\$wg$aPrefrontal Cortex
=550  \\$aWernicke Area
=680  \\$iFunctional neuroanatomical region of the inferior frontal gyrus consisting of pars opercularis and pars triangularis. It is important in SPEECH and LANGUAGE production. Injuries to Broca area are associated with BROCA APHASIA and APRAXIA.
=688  \\$a2015 (1982); use FRONTAL LOBE 1982-2014
=750  \0$aBroca's area$0(DLC)sh2011000065$5IEN-M

=LDR  01063cz  a2200265n  4500
=001  9880364530802441
=005  20150311134124.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065632
=040  \\$aDNLM$cDNLM
=072  \\$aC2.$x782.$x930.$x100.$x184
=150  \\$aChikungunya Fever
=450  \\$wnnna$aChikungunya Fevers
=450  \\$wnnna$aChikungunya Virus Infection
=450  \\$wnnna$aChikungunya Virus Infections
=450  \\$wnnna$aFever, Chikungunya
=450  \\$wnnna$aFevers, Chikungunya
=450  \\$wnnna$aInfection, Chikungunya Virus
=450  \\$wnnna$aInfections, Chikungunya Virus
=450  \\$wnnna$aVirus Infection, Chikungunya
=450  \\$wnnna$aVirus Infections, Chikungunya
=550  \\$wg$aAlphavirus Infections
=680  \\$iAn acute infection caused by a mosquito-borne alphavirus CHIKUNGUNYA VIRUS characterized by RASH; FEVER; JOINT PAINS; CONJUNCTIVITIS; MENINGOENCEPHALITIS; LYMPHOPENIA; and THROMBOCYTOPENIA.
=688  \\$a2015; use under CHIKUNGUNYA FEVER 2010-2014
=750  \0$aChikungunya$0(DLC)sh2007000089$5IEN-M

=LDR  02232cz  a2200529n  4500
=001  9880364530902441
=005  20150323160905.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065607
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x389.$x500
=072  \\$aD27.$x505.$x519.$x389.$x335
=150  \\$aCytochrome P-450 Enzyme Inhibitors
=450  \\$wnnna$aCytochrome P-450-Dependent Monooxygenase Inhibitors
=450  \\$wnnna$aCytochrome P 450 Dependent Monooxygenase Inhibitors
=450  \\$wnnna$aCytochrome P 450 Enzyme Inhibitors
=450  \\$aCytochrome P-450 Enzyme System$xantagonists & inhibitors
=450  \\$wnnna$aCytochrome P-450 Inhibitors
=450  \\$wnnna$aCytochrome P 450 Inhibitors
=450  \\$wnnna$aCytochrome P-450 Monooxygenase Inhibitors
=450  \\$wnnna$aCytochrome P 450 Monooxygenase Inhibitors
=450  \\$wnnna$aCytochrome P-450 Oxygenase Inhibitors
=450  \\$wnnna$aCytochrome P 450 Oxygenase Inhibitors
=450  \\$wnnna$aEnzyme Inhibitors, P-450
=450  \\$wnnna$aEnzyme Inhibitors, P450
=450  \\$wnnna$aInhibitors, Cytochrome P-450
=450  \\$wnnna$aInhibitors, P-450 Enzyme
=450  \\$wnnna$aInhibitors, P450 Enzyme
=450  \\$wnnna$aP-450 Enzyme Inhibitors
=450  \\$wnnna$aP 450 Enzyme Inhibitors
=450  \\$wnnna$aP-450 Inhibitors, Cytochrome
=450  \\$wnnna$aP450 Enzyme Inhibitors
=550  \\$wg$aEnzyme Inhibitors
=550  \\$wg$aMetabolic Side Effects of Drugs and Substances
=550  \\$wh$a14-alpha Demethylase Inhibitors
=550  \\$wh$aCytochrome P-450 CYP1A2 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2B6 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2C19 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2C8 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2C9 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2D6 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP2E1 Inhibitors
=550  \\$wh$aCytochrome P-450 CYP3A Inhibitors
=667  \\$ageneral or unspecified; note specifics treed here
=680  \\$iDrugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES.
=688  \\$a2015
=750  \0$aCytochrome P-450$xInhibitors$0(IEN)10660434

=LDR  01181cz  a2200265n  4500
=001  9880364531002441
=005  20150417110324.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065606
=040  \\$aDNLM$cDNLM
=072  \\$aC25.$x100.$x812
=072  \\$aD27.$x505.$x389
=150  \\$aMetabolic Side Effects of Drugs and Substances
=450  \\$wnnna$aDrug Effects on Metabolism
=450  \\$wnnna$aMetabolic Side Effects of Drugs
=450  \\$wnnna$aMetabolic Side Effects of Substances
=450  \\$wnnna$aSubstance Effects on Metabolism
=550  \\$wg$aDrug-Related Side Effects and Adverse Reactions
=550  \\$wg$aPharmacologic Actions
=550  \\$wh$aCytochrome P-450 Enzyme Inducers
=550  \\$wh$aCytochrome P-450 Enzyme Inhibitors
=667  \\$aused for searching: indexers and catalogers apply specifics
=680  \\$iSpecific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTIONS.
=688  \\$a2015
=750  \0$aMetabolism$xEffect of drugs on$0(DLC)sh 85084015$5IEN-M

=LDR  01166cz  a2200337n  4500
=001  9880364531102441
=005  20150227084606.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065567
=040  \\$aDNLM$cDNLM
=072  \\$aG3.$x495.$x23.$x500
=072  \\$aG3.$x787.$x24.$x500
=072  \\$aG7.$x690.$x725.$x15.$x500
=150  \\$aAbsorption, Physiological
=450  \\$wnnna$aAbsorption, Systemic
=450  \\$wnnna$aPhysiological Absorption
=450  \\$wnnna$aSystemic Absorption
=550  \\$wg$aAbsorption
=550  \\$wh$aGastrointestinal Absorption
=550  \\$wh$aIntramuscular Absorption
=550  \\$wh$aOcular Absorption
=550  \\$wh$aPeritoneal Absorption
=550  \\$wh$aRenal Reabsorption
=550  \\$wh$aRespiratory Tract Absorption
=550  \\$wh$aSkin Absorption
=550  \\$wh$aSubcutaneous Absorption
=550  \\$wh$aVaginal Absorption
=550  \\$aAbsorption, Physicochemical
=680  \\$iUptake of substances by the body, tissues, or cells. The uptake may occur by various forms of BIOLOGICAL TRANSPORT or by simple DIFFUSION.
=688  \\$a2015
=750  \0$aAbsorption (Physiology)$5IEN$0(DLC)sh 85000246

=LDR  00728cz  a2200253n  4500
=001  9880364531202441
=005  20170628113411.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065546
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x211
=072  \\$aG3.$x787.$x321
=072  \\$aG7.$x690.$x725.$x321
=150  \\$aDrug Liberation
=450  \\$wnnna$aDissolution, Drug
=450  \\$wnnna$aDrug Dissolution
=450  \\$wnnna$aDrug Release
=450  \\$wnnna$aLiberation, Drug
=450  \\$wnnna$aRelease, Drug
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPharmacokinetics
=680  \\$iRelease of drugs from DOSAGE FORMS into solution.
=688  \\$a2015
=750  \0$aDrugs$xSolubility$0(DLC)sh 91003550$5IEN-M

=LDR  01100cz  a2200277n  4500
=001  9880364531302441
=005  20150320162013.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065469
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x373
=150  \\$aCuniculidae
=450  \\$wnnna$aAgouti paca
=450  \\$wnnna$aAgoutidae
=450  \\$wnnna$aCuniculus
=450  \\$wnnna$aCuniculus paca
=450  \\$wnnna$aLowland Paca
=450  \\$wnnna$aLowland Pacas
=450  \\$wnnna$aPaca, Lowland
=450  \\$wnnna$aPacas
=450  \\$wnnna$aPacas, Lowland
=550  \\$wg$aRodentia
=667  \\$ado not confuse entry term AGOUTIDAE with AGOUTIS see DASYPROCTIDAE
=680  \\$iA family of large (20 to 30 inches long) plant eating rodents found in Central and South America. They are nearly tailless and have chunky bodies, dark brown fur with spotted lines along their sides and back, with stout legs and hind limbs that are longer than the forelimbs, and a large, square head with short ears.
=688  \\$a2015
=750  \0$aAgoutidae$0(DLC)sh 85096416$5IEN-M

=LDR  01222cz  a2200337n  4500
=001  9880364531402441
=005  20150325095001.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065468
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x865.$x419
=150  \\$aDasyproctidae
=450  \\$wnnna$aAcouchi
=450  \\$wnnna$aAcouchis
=450  \\$wnnna$aAgouti, Brazilian
=450  \\$wnnna$aAgoutis
=450  \\$wnnna$aAgoutis, Brazilian
=450  \\$wnnna$aBrazilian Agouti
=450  \\$wnnna$aBrazilian Agoutis
=450  \\$wnnna$aDasyprocta
=450  \\$wnnna$aDasyprocta leporina
=450  \\$wnnna$aGreen Acouchi
=450  \\$wnnna$aMyoprocta
=450  \\$wnnna$aMyoprocta acouchy
=450  \\$wnnna$aMyoprocta pratti
=450  \\$wnnna$aRed Acouchi
=550  \\$wg$aRodentia
=667  \\$ado not confuse entry term Agoutis with AGOUTIDAE see CUNICULIDAE
=680  \\$iA family of Central and South American plant-eating rodents comprising the agoutis (Dasyprocta) and acouchis (Myoprocta). They look similar to guinea pigs (CAVIA) but are larger and have longer legs. Their fur is reddish or dark brown.
=688  \\$a2015
=750  \0$aDasyproctidae$0(DLC)sh 85035845$5IEN-M

=LDR  01138cz  a2200229n  4500
=001  9880364531502441
=005  20150430133943.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065446
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x568.$x968.$x500
=072  \\$aF3.$x600.$x300.$x550
=150  \\$aPremenstrual Dysphoric Disorder
=450  \\$wnnna$aDisorder, Premenstrual Dysphoric
=450  \\$wnnna$aDysphoric Disorder, Premenstrual
=450  \\$wnnna$aPremenstrual Dysphoric Syndrome
=450  \\$wnnna$aSyndrome, Premenstrual Dysphoric
=550  \\$wg$aDepressive Disorder
=550  \\$wg$aPremenstrual Syndrome
=680  \\$iA condition in which a woman suffers from severe depression, irritability, and tension before MENSTRUATION. Premenstrual dysphoric disorder (PMDD) may involve a wide range of physical or emotional symptoms, which are more severe and debilitating than those seen with premenstrual syndrome (PMS), and which include at least one mood-related symptom. Symptoms usually stop when, or shortly after, menstruation begins.
=688  \\$a2015
=750  \0$aPremenstrual syndrome$0(DLC)sh 85106325$5IEN-M

=LDR  00947cz  a2200241n  4500
=001  9880364531602441
=005  20150311135013.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065327
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x590.$x530.$x698.$x277.$x61
=072  \\$aI3.$x350.$x61
=150  \\$aCircuit-Based Exercise
=450  \\$wnnna$aCircuit Based Exercise
=450  \\$wnnna$aCircuit-Based Exercises
=450  \\$wnnna$aCircuit Training
=450  \\$wnnna$aExercise, Circuit-Based
=450  \\$wnnna$aExercises, Circuit-Based
=450  \\$wnnna$aTraining, Circuit
=550  \\$wg$aExercise
=680  \\$iAlternating sets of exercise that work out different muscle groups and that also alternate between aerobic and anaerobic exercises, which, when combined together, offer an overall program to improve strength, stamina, balance, or functioning.
=688  \\$a2015
=750  \0$aCircuit training$0(DLC)sh 85026066$5IEN-M

=LDR  01351cz  a2200445n  4500
=001  9880364531702441
=005  20150320153130.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065306
=040  \\$aDNLM$cDNLM
=072  \\$aC11.$x204.$x284
=072  \\$aC11.$x297.$x374
=072  \\$aC26.$x260.$x275.$x250.$x124
=150  \\$aCorneal Injuries
=450  \\$wnnna$aCornea Injuries
=450  \\$aCornea$xinjuries
=450  \\$wnnna$aCornea Injury
=450  \\$wnnna$aCorneal Damage
=450  \\$wnnna$aCorneal Damages
=450  \\$wnnna$aCorneal Injury
=450  \\$wnnna$aCorneal Scar
=450  \\$wnnna$aCorneal Scars
=450  \\$wnnna$aCorneal Trauma
=450  \\$wnnna$aCorneal Traumas
=450  \\$wnnna$aDamage, Corneal
=450  \\$wnnna$aDamages, Corneal
=450  \\$wnnna$aInjuries, Cornea
=450  \\$wnnna$aInjuries, Corneal
=450  \\$wnnna$aInjury, Cornea
=450  \\$wnnna$aInjury, Corneal
=450  \\$wnnna$aScar, Corneal
=450  \\$wnnna$aScars, Corneal
=450  \\$wnnna$aTrauma, Corneal
=450  \\$wnnna$aTraumas, Corneal
=550  \\$wg$aCorneal Diseases
=550  \\$wg$aEye Injuries
=550  \\$wh$aCorneal Perforation
=680  \\$iDamage or trauma inflicted to the CORNEA by external means.
=688  \\$a2015
=750  \0$aCornea$xWounds and injuries$0(IEN)10660414$5IEN-M

=LDR  00937cz  a2200253n  4500
=001  9880364531802441
=005  20150501095215.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065287
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x950.$x875.$x500
=072  \\$aE4.$x749.$x500
=072  \\$aL1.$x700.$x508.$x100.$x710.$x800.$x500
=150  \\$aRobotic Surgical Procedures
=450  \\$wnnna$aProcedure, Robotic Surgical
=450  \\$wnnna$aProcedures, Robotic Surgical
=450  \\$wnnna$aRobotic Surgical Procedure
=450  \\$wnnna$aSurgical Procedure, Robotic
=450  \\$aSurgical Procedures, Robotic
=550  \\$wg$aSurgery, Computer-Assisted
=550  \\$aRobotics
=680  \\$iSurgical procedures performed using a computer that remotely controls surgical instruments attached to mechanical arms designed to perform the tasks of the surgeon.
=688  \\$a2015
=750  \0$aSurgical robots$0(DLC)sh2006006123$5IEN-M

=LDR  00724cz  a2200229n  4500
=001  9880364531902441
=005  20150406102449.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065260
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x78.$x840.$x490
=072  \\$aD20.$x215.$x721.$x500.$x354
=150  \\$aFrankincense
=450  \\$wnnna$aFrankincense Resin
=450  \\$aOlibanum
=450  \\$wnnna$aOlibanum Resin
=450  \\$wnnna$aResin, Frankincense
=450  \\$wnnna$aResin, Olibanum
=550  \\$wg$aResins, Plant
=680  \\$iResin exudate from certain trees of the genus BOSWELLIA in the BURSERACEAE family.
=688  \\$a2015; use BOSWELLIA 2002-2014
=750  \0$aFrankincense$5IEN-M$0(DLC)sh 96011403

=LDR  01312cz  a2200313n  4500
=001  9880364532002441
=005  20150320161655.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065246
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x374.$x52
=072  \\$aN5.$x300.$x206
=150  \\$aCulturally Competent Care
=450  \\$wnnna$aCare, Cross-Cultural
=450  \\$wnnna$aCare, Cultural
=450  \\$wnnna$aCare, Culturally Competent
=450  \\$wnnna$aCare, Culturally Congruent
=450  \\$wnnna$aCross-Cultural Care
=450  \\$wnnna$aCross Cultural Care
=450  \\$wnnna$aCultural Care
=450  \\$wnnna$aCulturally Competent Health Care
=450  \\$wnnna$aCulturally Congruent Care
=550  \\$wg$aDelivery of Health Care
=550  \\$aClinical Competence
=550  \\$aCultural Competency
=550  \\$aTranscultural Nursing
=680  \\$iHealth care services that are respectful of and responsive to the health beliefs, practices and cultural and linguistic needs of diverse patients. The provider and the patient each bring their individual learned patterns of language and culture to the health care experience which must be transcended to achieve equal access and quality health care.
=688  \\$a2015
=750  \0$aTranscultural medical care$0(DLC)sh 88004309$5IEN-M

=LDR  00947cz  a2200193n  4500
=001  9880364532102441
=005  20200611113234.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065133
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x750.$x500
=150  \\$aEphemeroptera
=450  \\$wnnna$aMayflies
=450  \\$wnnna$aMayfly
=550  \\$wg$aPalaeoptera
=667  \\$afor killing Ephemeroptera with insecticides, see note at INSECTICIDES
=680  \\$iAn Order of aquatic INSECTS comprising about 2,500 species worldwide. It is the only insect group with two flying stages, each with relatively large forewings. The immature stage called "naiad" or "nymph" lasts one year in fresh water, and the adult stage is shortlived, lasting from a few minutes to a few days, depending on the species. The Ephemeroptera includes mayflies (also called shadflies)
=688  \\$a2015
=750  \0$aMayflies$0(DLC)sh 85082422$5IEN-M

=LDR  01555cz  a2200325n  4500
=001  9880364532202441
=005  20150305094334.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065105
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x124
=072  \\$aD27.$x505.$x954.$x427.$x90.$x50.$x249
=150  \\$aAromatic Amino Acid Decarboxylase Inhibitors
=450  \\$wnnna$aAromatic-L-Amino-Acid Decarboxylase Inihbitors
=450  \\$wnnna$aAromatic L Amino Acid Decarboxylase Inihbitors
=450  \\$aAromatic-L-Amino-Acid Decarboxylases$xantagonists & inhibitors
=450  \\$wnnna$aDecarboxylase Inhibitors, Dihydroxyphenylalanine
=450  \\$wnnna$aDecarboxylase Inhibitors, DOPA
=450  \\$wnnna$aDecarboxylase Inihbitors, Aromatic-L-Amino-Acid
=450  \\$wnnna$aDihydroxyphenylalanine Decarboxylase Inhibitors
=450  \\$aDopa Decarboxylase$xantagonists & inhibitors
=450  \\$wnnna$aDOPA Decarboxylase Inhibitors
=450  \\$wnnna$aInhibitors, Dihydroxyphenylalanine Decarboxylase
=450  \\$wnnna$aInhibitors, DOPA Decarboxylase
=450  \\$wnnna$aInihbitors, Aromatic-L-Amino-Acid Decarboxylase
=550  \\$wg$aAntiparkinson Agents
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES. Pharmaceutical agents in this category are used in conjunction with LEVODOPA in order to slow its metabolism.
=688  \\$a2015
=750  \0$aAromatic amino acid decarboxylases$xInhibitors$0(DLC)sh 85007396$5IEN-M

=LDR  01031cz  a2200265n  4500
=001  9880364532302441
=005  20150415174934.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065102
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x450
=072  \\$aN2.$x360.$x67.$x450
=150  \\$aLicensed Practical Nurses
=450  \\$wnnna$aLicensed Practical Nurse
=450  \\$wnnna$aLicensed Vocational Nurse
=450  \\$wnnna$aLicensed Vocational Nurses
=450  \\$wnnna$aNurse, Licensed Practical
=450  \\$wnnna$aNurse, Licensed Vocational
=450  \\$wnnna$aNurses, Licensed Practical
=450  \\$wnnna$aNurses, Licensed Vocational
=550  \\$wg$aAllied Health Personnel
=550  \\$aNursing, Practical
=680  \\$iHealth personnel who do not hold professional degrees or credentials, but have completed training and are licensed to provide routine patient care under the direction of registered nurses and physicians.
=688  \\$a2015
=750  \0$aPractical nurses$0(DLC)sh 85106045$5IEN-M

=LDR  00688cz  a2200181n  4500
=001  9880364532402441
=005  20150518165944.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065099
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x452.$x758.$x377.$x968
=150  \\$aTravel Nursing
=450  \\$wnnna$aNursing, Travel
=550  \\$wg$aNursing
=667  \\$ado not confuse with TRAVEL MEDICINE - a field focusing on disease prevention and safety of patients during international travel
=680  \\$iA type of nursing practice involving licensed professional nurses who travel to work in temporary nursing positions.
=688  \\$a2015
=750  \0$aTravel nursing$0(DLC)sh2005006718$5IEN-M

=LDR  01111cz  a2200301n  4500
=001  9880364532502441
=005  20150305105102.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065093
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x400
=072  \\$aD27.$x505.$x954.$x122.$x85.$x516
=150  \\$abeta-Lactamase Inhibitors
=450  \\$wnnna$aAntagonists, beta Lactamase
=450  \\$wnnna$abeta Lactamase Antagonists
=450  \\$abeta Lactamase Inhibitors
=450  \\$abeta-Lactamases$xantagonists & inhibitors
=450  \\$aCephalosporinase$xantagonists & inhibitors
=450  \\$wnnna$aInhibitors, beta Lactamase
=450  \\$wnnna$aInhibitors, beta-Lactamase
=450  \\$wnnna$aLactamase Antagonists, beta
=450  \\$wnnna$aLactamase Inhibitors, beta
=450  \\$aPenicillinase$xantagonists & inhibitors
=550  \\$wg$aAnti-Bacterial Agents
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iEndogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
=688  \\$a2015
=750  \0$aBeta lactamases$xInhibitors$0(DLC)sh 93005758$5IEN-M

=LDR  01460cz  a2200361n  4500
=001  9880364532602441
=005  20150406104754.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D065089
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x320
=072  \\$aD27.$x505.$x696.$x422.$x249
=150  \\$aGlycoside Hydrolase Inhibitors
=450  \\$wnnna$aalpha-Amylase Inhibitors, Intestinal
=450  \\$wnnna$aalpha-Amylase Inhibitors, Pancreatic
=450  \\$wnnna$aalpha Amylase Inhibitors, Pancreatic
=450  \\$aalpha-Glucosidase Inhibitors
=450  \\$wnnna$aalpha Glucosidase Inhibitors
=450  \\$aalpha-Glucosidases$xantagonists & inhibitors
=450  \\$wnnna$aHydrolase Inhibitors, Glycoside
=450  \\$wnnna$aInhibitors, alpha-Glucosidase
=450  \\$wnnna$aInhibitors, Glycoside Hydrolase
=450  \\$wnnna$aInhibitors, Intestinal alpha-Amylase
=450  \\$wnnna$aInhibitors, Pancreatic alpha-Amylase
=450  \\$wnnna$aIntestinal alpha-Amylase Inhibitors
=450  \\$wnnna$aIntestinal alpha Amylase Inhibitors
=450  \\$wnnna$aPancreatic alpha-Amylase Inhibitors
=450  \\$wnnna$aPancreatic alpha Amylase Inhibitors
=550  \\$wg$aEnzyme Inhibitors
=550  \\$wg$aHypoglycemic Agents
=680  \\$iCompounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and APHA-GLUCOSIDASES.
=688  \\$a2015
=750  \0$aGlycosidases$xInhibitors$0(DLC)sh 89003349

=LDR  00608cz  a2200193n  4500
=001  9880364532702441
=005  20141212222825.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D065026
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x572
=150  \\$aHope
=450  \\$wnnna$aHopefulness
=450  \\$wnnna$aHopes
=550  \\$wg$aEmotions
=667  \\$ause only in the context of a mental process (for example, hope as a motivation for recovery, but not hope for increased research funding)
=680  \\$iBelief in a positive outcome.
=688  \\$a2014
=750  \0$aHope$0(DLC)sh 85061922$5IEN-M

=LDR  01052cz  a2200313n  4500
=001  9880364532802441
=005  20141212193224.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D065006
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x500.$x384.$x100.$x422
=072  \\$aE1.$x370.$x225.$x998.$x54.$x422
=072  \\$aE4.$x74.$x422
=072  \\$aE5.$x200.$x500.$x384.$x100.$x422
=072  \\$aE5.$x200.$x998.$x54.$x422
=072  \\$aE5.$x242.$x384.$x100.$x422
=150  \\$aPapanicolaou Test
=450  \\$wnnna$aPap Smear
=450  \\$wnnna$aPap Test
=450  \\$aPapanicolaou Smear
=450  \\$wnnna$aSmear, Pap
=450  \\$wnnna$aSmear, Papanicolaou
=450  \\$wnnna$aTest, Pap
=450  \\$wnnna$aTest, Papanicolaou
=550  \\$wg$aBiopsy
=667  \\$acoordinate with VAGINAL SMEARS if pertinent
=680  \\$iCytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
=688  \\$a2014; use VAGINAL SMEARS 1991-2013
=750  \0$aPap test$0(DLC)sh 85097526$5IEN-M

=LDR  00880cz  a2200253n  4500
=001  9880364532902441
=005  20141212222824.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064987
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x95.$x147
=150  \\$aCell- and Tissue-Based Therapy
=450  \\$wnnna$aCell and Tissue Based Therapy
=450  \\$aCell Therapy
=450  \\$wnnna$aTherapy, Cell
=450  \\$wnnna$aTherapy, Tissue
=450  \\$aTissue Therapy
=550  \\$wg$aBiological Therapy
=550  \\$wh$aCell Transplantation
=550  \\$wh$aTissue Transplantation
=550  \\$aTissue Therapy, Historical
=680  \\$iTherapies that involve the TRANSPLANTATION of CELLS or TISSUES developed for the purpose of restoring the function of diseased or dysfunctional cells or tissues.
=688  \\$a2014
=750  \0$aCellular therapy$5IEN$0(DLC)sh 85021700

=LDR  00837cz  a2200205n  4500
=001  9880364533002441
=005  20141212222824.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064926
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x520.$x596
=150  \\$aNeurophysiological Monitoring
=450  \\$wnnna$aMonitoring, Neurophysiologic
=450  \\$wnnna$aMonitoring, Neurophysiological
=450  \\$wnnna$aNeurophysiologic Monitoring
=550  \\$wg$aMonitoring, Physiologic
=550  \\$wh$aIntraoperative Neurophysiological Monitoring
=680  \\$iThe systematic checking of the condition and function of a patient's CENTRAL NERVOUS SYSTEM during disease periods or following injuries, using various NEUROLOGICAL DIAGNOSTIC TECHNIQUES.
=688  \\$a2014
=750  \0$aNeurophysiologic monitoring$0(DLC)sh 95002453$5IEN-M

=LDR  00618cz  a2200193n  4500
=001  9880364533102441
=005  20141212222823.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x186.$x500
=072  \\$aE2.$x779.$x474.$x124.$x500
=150  \\$aQigong
=450  \\$aCh'i Kung
=450  \\$aQi Gong
=550  \\$wg$aBreathing Exercises
=680  \\$iAn ancient Chinese system of postures, exercises, breathing techniques, and meditations designed to improve and enhance the body's QI.
=688  \\$a2014
=750  \0$aQi gong$0(DLC)sh 85023204$5IEN-M

=LDR  00622cz  a2200193n  4500
=001  9880364533202441
=005  20141212222823.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064891
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x159
=150  \\$aDisaster Victims
=450  \\$wnnna$aDisaster Victim
=450  \\$wnnna$aVictim, Disaster
=450  \\$wnnna$aVictims, Disaster
=550  \\$wg$aPersons
=680  \\$iPersons adversely effected by DISASTERS, occurrences that result in property damage, deaths, and/or injuries to a community.
=688  \\$a2014
=750  \0$aDisaster victims$0(DLC) sh 86002460$5IEN-M

=LDR  00878cz  a2200193n  4500
=001  9880364533302441
=005  20141212222822.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064889
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x775
=150  \\$aPsychotherapy, Psychodynamic
=450  \\$wnnna$aPsychodynamic Psychotherapies
=450  \\$wnnna$aPsychodynamic Psychotherapy
=450  \\$wnnna$aPsychotherapies, Psychodynamic
=550  \\$wg$aPsychotherapy
=680  \\$iForms of PSYCHOTHERAPY falling within or deriving from the psychoanalytic tradition, that view individuals as reacting to unconscious forces (e.g., motivation, drive), that focus on processes of change and development, and that place a premium on self understanding and making meaning of what is unconscious.
=688  \\$a2014
=750  \0$aPsychodynamic psychotherapy$0(DLC)sh 90000087$5IEN-M

=LDR  00697cz  a2200217n  4500
=001  9880364533402441
=005  20141212222822.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064878
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x940
=072  \\$aL1.$x470.$x937
=150  \\$aWeb Browser
=450  \\$wnnna$aBrowser, Web
=450  \\$wnnna$aBrowsers, Web
=450  \\$wnnna$aWeb Browsers
=550  \\$wg$aInformation Storage and Retrieval
=550  \\$wg$aSoftware
=680  \\$iSoftware application for retrieving, presenting and traversing information resources on the World Wide Web.
=688  \\$a2014
=750  \0$aBrowsers (Computer programs)$0(DLC)sh 98001500$5IEN-M

=LDR  01113cz  a2200229n  4500
=001  9880364533502441
=005  20141212222821.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064877
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x191.$x152
=072  \\$aI1.$x880.$x735.$x384.$x599
=150  \\$aOrgan Trafficking
=450  \\$wnnna$aOrgan Traffickings
=450  \\$wnnna$aTrafficking, Organ
=450  \\$wnnna$aTraffickings, Organ
=550  \\$wg$aCrime
=550  \\$wg$aHuman Rights Abuses
=550  \\$aHuman Trafficking
=680  \\$iCriminal activity that occurs in three broad categories. Firstly, cases where traffickers force or deceive the victims into giving up an organ. Secondly, there are cases where victims formally or informally agree to sell an organ and are cheated because they are not paid for the organ or are paid less than the promised price. Thirdly, vulnerable persons are treated for an ailment, which may or may not exist and thereupon organs are removed without the victim's knowledge.
=688  \\$a2014
=750  \0$aOrgan trafficking$0(DLC)sh 98001276$5IEN-M

=LDR  00653cz  a2200205n  4500
=001  9880364533602441
=005  20141212222819.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064870
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x883.$x209
=150  \\$aAir Travel
=450  \\$wnnna$aAir Travels
=450  \\$wnnna$aTravel, Air
=550  \\$wg$aTravel
=550  \\$aAerospace Medicine
=550  \\$aJet Lag Syndrome
=680  \\$iAspects of health and disease related to air travel. It includes the physiologic and psychologic beneficial or adverse effects.
=688  \\$a2014; use TRAVEL 2013
=750  \0$aAir travel$0(DLC)sh 85002716$5IEN-M

=LDR  00748cz  a2200157n  4500
=001  9880364533702441
=005  20201008104154.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064869
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137.$x428.$x249
=150  \\$aAcceptance and Commitment Therapy
=550  \\$wg$aCognitive Behavioral Therapy
=680  \\$iContextually focused form of cognitive behavioral psychotherapy that uses MINDFULNESS and behavioral activation to increase patients' psychological flexibility in areas such as ability to engage in values-based, positive behaviors while experiencing difficult thoughts, emotions, or sensations.
=688  \\$a2014
=750  \0$aAcceptance and commitment therapy$0(DLC)sh2006000684$5IEN-M

=LDR  00982cz  a2200289n  4500
=001  9880364533802441
=005  20160429133854.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064868
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x900.$x575
=150  \\$aEthnic Violence
=450  \\$wnno$aEthnic Conflict
=450  \\$wnnna$aConflict, Ethnic
=450  \\$wnnna$aConflicts, Ethnic
=450  \\$wnnna$aEthnic Conflicts
=450  \\$wnnna$aEthnic Violences
=450  \\$wnnna$aEthnic War
=450  \\$wnnna$aEthnic Wars
=450  \\$wnnna$aViolence, Ethnic
=450  \\$wnnna$aWar, Ethnic
=450  \\$wnnna$aWars, Ethnic
=550  \\$wg$aViolence
=550  \\$wh$aEthnic Cleansing
=680  \\$iViolence or other hostile behavior arising when an ethnic group either feels itself under threat, or where it seeks to assert its superiority or dominance over other groups.
=688  \\$a2014 (2016)
=750  \0$aEthnic conflict$0(DLC)sh 00006554$5IEN-M

=LDR  00761cz  a2200181n  4500
=001  9880364533902441
=005  20201008104421.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064866
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x551
=072  \\$aF4.$x754.$x137.$x428.$x500
=150  \\$aMindfulness
=550  \\$wg$aCognitive Behavioral Therapy
=550  \\$wg$aMental Processes
=680  \\$iA psychological state of awareness, the practices that promote this awareness, a mode of processing information and a character trait. As a therapy mindfulness is defined as a moment-to-moment awareness of one's experience without judgment and as a state and not a trait.
=688  \\$a2014
=750  \0$aMindfulness (Psychology)$0(DLC)sh2015000815$5IEN-M

=LDR  01123cz  a2200289n  4500
=001  9880364534002441
=005  20141212222818.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064846
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x834
=150  \\$aSports for Persons with Disabilities
=450  \\$wnnna$aAdaptive Sport
=450  \\$wnnna$aAdaptive Sports
=450  \\$wnnna$aPara-athletic
=450  \\$wnnna$aPara-athletics
=450  \\$wnnna$aPara athletics
=450  \\$wnnna$aParathletic
=450  \\$wnnna$aParathletics
=450  \\$wnnna$aSport, Adaptive
=450  \\$wnnna$aSports, Adaptive
=450  \\$aSports for the Disabled
=550  \\$wg$aSports
=550  \\$aRehabilitation
=680  \\$iActivities or games played by PERSONS WITH DISABILITIES, usually requiring physical effort or skill. The activities or games may be specifically created or based on existing sports, with or without modifications, to meet the needs of persons with physical or intellectual disabilities.
=688  \\$a2014
=750  \0$aSports for people with disabilities$0(DLC)sh 85126930$5IEN-M

=LDR  00737cz  a2200205n  4500
=001  9880364534102441
=005  20141212222818.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064830
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x833
=150  \\$aTemperance Movement
=450  \\$wnnna$aMovement, Temperance
=450  \\$wnnna$aMovements, Temperance
=450  \\$wnnna$aTemperance Movements
=450  \\$wnnna$aWomen's Christian Temperance Union
=550  \\$wg$aHuman Activities
=680  \\$iSocial effort most active in the 19th and early 20th centuries dedicated to promoting moderation or complete abstinence in the use of ALCOHOLIC BEVERAGES.
=688  \\$a2014
=750  \0$aTemperance$xSocieties, etc.$0(DLC)sh 85133705

=LDR  01336cz  a2200277n  4500
=001  9880364534202441
=005  20141212222817.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x416.$x617
=072  \\$aD8.$x811.$x682.$x690.$x708.$x694
=150  \\$aProlyl Hydroxylases
=450  \\$wnnna$aHydroxylases, Prolyl
=450  \\$wnnna$aPeptidyl Prolyl Hydroxylase
=450  \\$aProline,2-Oxoglutarate 4-Dioxygenase
=450  \\$aProline Hydroxylase
=450  \\$wnnna$aProlyl 4-Hydroxylase
=450  \\$wnnna$aProlyl Hydroxylase
=550  \\$wg$aDioxygenases
=550  \\$wg$aMixed Function Oxygenases
=550  \\$wh$aHypoxia-Inducible Factor-Proline Dioxygenases
=550  \\$wh$aProcollagen-Proline Dioxygenase
=680  \\$iEnzymes that specifically hydroxylate PROLINE residues on proteins.
=688  \\$a2014; for PROLYL 4-HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1983-2013; for PEPTIDYL PROLYL HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1985-2013; for PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1977-2013; for PROLINE HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1993-2013; for PROLYL HYDROXYLASE use PROCOLLAGEN-PROLINE DIOXYGENASE 1982-2013
=750  \0$aProline hydroxylase$5IEN$0(DLC)sh 89003307

=LDR  00859cz  a2200253n  4500
=001  9880364534302441
=005  20141212222817.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064827
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x850.$x710.$x625
=072  \\$aE7.$x862.$x710.$x625
=150  \\$aMyocutaneous Flap
=450  \\$wnnna$aFlap, Musculocutaneous
=450  \\$wnnna$aFlap, Myocutaneous
=450  \\$wnnna$aFlaps, Musculocutaneous
=450  \\$wnnna$aFlaps, Myocutaneous
=450  \\$wnnna$aMusculocutaneous Flap
=450  \\$wnnna$aMusculocutaneous Flaps
=450  \\$wnnna$aMyocutaneous Flaps
=550  \\$wg$aSurgical Flaps
=680  \\$iA mass of tissue, including skin and muscle, that has been cut away from surrounding areas for transplantation.
=688  \\$a2014
=750  \0$aMusculocutaneous flaps$0(DLC)sh 89000960$5IEN-M

=LDR  00822cz  a2200229n  4500
=001  9880364534402441
=005  20141212222815.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064801
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x737
=150  \\$aPhospholipase A2 Inhibitors
=450  \\$wnnna$aA2 Antagonists, Phospholipase
=450  \\$wnnna$aA2 Inhibitors, Phospholipase
=450  \\$wnnna$aAntagonists, Phospholipase A2
=450  \\$wnnna$aInhibitors, Phospholipase A2
=450  \\$wnnna$aPhospholipase A2 Antagonists
=450  \\$aPhospholipases A2$xantagonists & inhibitors
=550  \\$wg$aEnzyme Inhibitors
=680  \\$iCompounds that inhibit or block the activity of a PHOSPHOLIPASE A2 enzyme.
=688  \\$a2014
=750  \0$aPhospholipase A2$xInhibitors$0(DLC)sh 90001216$5IEN-

=LDR  01013cz  a2200265n  4500
=001  9880364534502441
=005  20141212222813.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064796
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x830.$x750
=072  \\$aH2.$x956.$x929
=150  \\$aVeterinary Sports Medicine
=450  \\$wnnna$aMedicine, Sports Veterinary
=450  \\$wnnna$aMedicine, Veterinary Sports
=450  \\$wnnna$aSports Medicine, Veterinary
=450  \\$wnnna$aSports Medicines, Veterinary
=450  \\$wnnna$aSports Veterinary Medicine
=450  \\$wnnna$aVeterinary Medicine, Sports
=550  \\$wg$aSports Medicine
=550  \\$wg$aVeterinary Medicine
=550  \\$aPhysical Conditioning, Animal
=680  \\$iThe field of veterinary medicine concerned with PHYSICAL FITNESS of animals in sports (horse racing, dog racing, etc.) and the diagnosis and treatment of sports injuries in animals.
=688  \\$a2014
=750  \0$aEquine sports medicine$0(DLC)sh 87005624$5IEN-M

=LDR  00611cz  a2200217n  4500
=001  9880364534602441
=005  20141212222812.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064793
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x863
=150  \\$aTeratogenesis
=550  \\$wg$aPathologic Processes
=550  \\$aAbnormalities, Drug-Induced
=550  \\$aAbnormalities, Radiation-Induced
=550  \\$aMutagenesis
=550  \\$aTeratogens
=550  \\$aTeratology
=680  \\$iThe formation of CONGENITAL ABNORMALITIES.
=688  \\$a2014
=750  \0$aTeratogenesis$0(DLC)sh 85133983$5IEN-M

=LDR  00768cz  a2200229n  4500
=001  9880364534702441
=005  20141212222810.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064786
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN5.$x715.$x350.$x350.$x625.$x500
=072  \\$aN6.$x850.$x490.$x734.$x875.$x500
=150  \\$aNocebo Effect
=450  \\$wnnna$aEffect, Nocebo
=450  \\$wnnna$aEffects, Nocebo
=450  \\$wnnna$aNocebo
=450  \\$wnnna$aNocebo Effects
=550  \\$wg$aPlacebo Effect
=667  \\$anot restricted to drugs; IM general only
=680  \\$iAn adverse effect occurring with a medical treatment that is not attributable to the actions of the treatment.
=688  \\$a2014
=750  \0$aNocebos (Medicine)$0(DLC)sh2008008734$5IEN-M

=LDR  00876cz  a2200229n  4500
=001  9880364534802441
=005  20141212222809.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064751
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x625.$x62
=150  \\$aAmmonium Compounds
=450  \\$wnnna$aAmmonium
=550  \\$wg$aNitrogen Compounds
=550  \\$wh$aAmmonium Chloride
=550  \\$wh$aAmmonium Hydroxide
=550  \\$wh$aAmmonium Sulfate
=550  \\$wh$aHydroxylamine
=550  \\$wh$aQuaternary Ammonium Compounds
=680  \\$iInorganic compounds that include a positively charged tetrahedral nitrogen (ammonium ion) as part of their structure. This class of compounds includes a broad variety of simple ammonium salts and derivatives.
=688  \\$a2014; use QUATERNARY AMMONIUM COMPOUNDS 2006-2013
=750  \0$aAmmonium compounds$0(DLC) sh 85004547$5IEN

=LDR  00904cz  a2200277n  4500
=001  9880364534902441
=005  20141212222803.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064700
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x407.$x717
=072  \\$aM1.$x526.$x485.$x650.$x662
=072  \\$aN2.$x360.$x650.$x662
=150  \\$aNurses, International
=450  \\$wnnna$aForeign Nurse
=450  \\$wnnna$aForeign Nurses
=450  \\$wnnna$aInternational Nurse
=450  \\$wnnna$aInternational Nurses
=450  \\$wnnna$aNurse, Foreign
=450  \\$wnnna$aNurse, International
=450  \\$wnnna$aNurses, Foreign
=550  \\$wg$aForeign Professional Personnel
=550  \\$wg$aNurses
=680  \\$iNurses who provide nursing care in countries other than the ones in which they received their training.
=688  \\$a2014
=750  \0$aNurses, Foreign$0(DLC)sh 85093358$5IEN-M

=LDR  01106cz  a2200241n  4500
=001  9880364535002441
=005  20141212222802.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064698
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x150.$x750
=072  \\$aN2.$x421.$x143.$x150.$x750
=150  \\$aParish Nursing
=450  \\$wnnna$aChurch Nursing
=450  \\$wnnna$aFaith Community Nursing
=450  \\$wnnna$aNursing, Church
=450  \\$wnnna$aNursing, Faith Community
=450  \\$wnnna$aNursing, Parish
=550  \\$wg$aCommunity Health Nursing
=550  \\$aReligion and Medicine
=680  \\$iA nursing specialty involving programs designed to bring wholeness and healing to a particular faith community through addressing the health needs of body, mind, and spirit. They are coordinated by registered NURSES and may involve HEALTH EDUCATION and counseling, facilitation, referral, PATIENT ADVOCACY, and health care plan interpretation, as influenced and defined by the unique needs of the congregation.
=688  \\$a2014
=750  \0$aParish nursing$0(DLC)sh 98004190$5IEN

=LDR  00897cz  a2200229n  4500
=001  9880364535102441
=005  20141212222801.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064694
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x478.$x676.$x806
=072  \\$aN2.$x421.$x816.$x500
=150  \\$aRural Nursing
=450  \\$wnnna$aNursing, Remote Rural
=450  \\$wnnna$aNursing, Rural
=450  \\$wnnna$aRemote Rural Nursing
=450  \\$wnnna$aRural Nursing, Remote
=550  \\$wg$aRural Health Services
=550  \\$wg$aSpecialties, Nursing
=680  \\$iA branch of nursing requiring generalist training with specialty knowledge in crisis assessment and management in all subdisciplines of nursing. Rural nursing practices often include geographical and social distance concepts in delivery of health care.
=688  \\$a2014
=750  \0$aRural nursing$0(DLC)sh 98002712$5IEN-M

=LDR  01370cz  a2200373n  4500
=001  9880364535202441
=005  20141212222801.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064691
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x650.$x655
=072  \\$aN2.$x360.$x650.$x655
=150  \\$aNurses, Community Health
=450  \\$wnnna$aCommunity Health Nurse
=450  \\$wnnna$aCommunity Health Nurses
=450  \\$wnnna$aHealth Visitor
=450  \\$aHealth Visitors
=450  \\$wnnna$aHome Health Nurse
=450  \\$wnnna$aHome Health Nurses
=450  \\$wnnna$aHome Nurse
=450  \\$wnnna$aHome Nurses
=450  \\$wnnna$aNurse, Community Health
=450  \\$wnnna$aNurse, Home
=450  \\$wnnna$aNurse, Home Health
=450  \\$wnnna$aNurse, Visiting
=450  \\$wnnna$aNurses, Home
=450  \\$wnnna$aNurses, Home Health
=450  \\$wnnna$aNurses, Visiting
=450  \\$wnnna$aVisiting Nurse
=450  \\$aVisiting Nurses
=550  \\$wg$aNurses
=680  \\$iNurses whose work combines elements of both primary care nursing and public health practice and takes place primarily outside the therapeutic institution. Primary nursing care is directed to individuals, families, or groups in their natural settings within communities.
=688  \\$a2014
=750  \0$aCommunity health nurses$0(DLC)sh 97001113$5IEN-M

=LDR  00877cz  a2200205n  4500
=001  9880364535302441
=005  20141212222800.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064689
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x650.$x835
=072  \\$aN2.$x360.$x650.$x835
=150  \\$aNurses, Public Health
=450  \\$wnnna$aNurse, Public Health
=450  \\$wnnna$aPublic Health Nurse
=450  \\$aPublic Health Nurses
=550  \\$wg$aNurses
=680  \\$iNurses whose goal is to improve health and quality of life in a population or community through the prevention and treatment of disease and other physical and mental health conditions, the surveillance of cases and health indicators, and the promotion of healthy behaviors through public education and awareness.
=688  \\$a2014
=750  \0$aPublic health nurses$5IEN-M$0(DLC)sh 85108661

=LDR  00651cz  a2200229n  4500
=001  9880364535402441
=005  20141212222759.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064686
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x676
=072  \\$aN2.$x360.$x67.$x676
=150  \\$aNutritionists
=450  \\$wnnna$aDietician
=450  \\$aDieticians
=450  \\$wnnna$aDietitian
=450  \\$wnnna$aDietitians
=450  \\$wnnna$aNutritionist
=550  \\$wg$aAllied Health Personnel
=680  \\$iPersons specially trained in NUTRITION SCIENCES.
=688  \\$a2014
=750  \0$aNutritionists$0(DLC) sh 85093480$5IEN-M

=LDR  00726cz  a2200217n  4500
=001  9880364535602441
=005  20141212222756.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064593
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x941.$x875
=150  \\$aHeterografts
=450  \\$wnnna$aHeterograft
=450  \\$wnnna$aXenograft
=450  \\$wnnna$aXenografts
=550  \\$wg$aTransplants
=550  \\$aTransplantation, Heterologous
=667  \\$ause for the heterograft itself; use HETEROGRAFTING see TRANSPLANTATION, HETEROLOGOUS for the surgical procedure
=680  \\$iTissues, cells or organs transplanted between animals of different species.
=688  \\$a2014
=750  \0$aXenografts$5IEN$0(DLC)sh 85148789

=LDR  00932cz  a2200265n  4500
=001  9880364535702441
=005  20141212222755.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064592
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x941.$x750
=150  \\$aAutografts
=450  \\$wnnna$aAutograft
=450  \\$wnnna$aAutologous Transplant
=450  \\$wnnna$aAutologous Transplants
=450  \\$wnnna$aAutotransplant
=450  \\$wnnna$aAutotransplants
=450  \\$wnnna$aTransplant, Autologous
=450  \\$wnnna$aTransplants, Autologous
=550  \\$wg$aTransplants
=550  \\$aTransplantation, Autologous
=667  \\$ause for the autograft itself; use AUTOGRAFTING see TRANSPLANTATION, AUTOLOGOUS for the surgical procedure
=680  \\$iTransplant comprised of an individual's own tissue, transferred from one part of the body to another.
=688  \\$a2014
=750  \0$aAutografts$0(DLC)sh 85010065$5IEN-M

=LDR  00798cz  a2200253n  4500
=001  9880364535802441
=005  20141212222755.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064591
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x941.$x500
=150  \\$aAllografts
=450  \\$wnnna$aAllograft
=450  \\$wnnna$aHomograft
=450  \\$wnnna$aHomografts
=450  \\$wnnna$aHomologous Transplant
=450  \\$wnnna$aHomologous Transplants
=450  \\$wnnna$aTransplant, Homologous
=450  \\$wnnna$aTransplants, Homologous
=550  \\$wg$aTransplants
=550  \\$aTransplantation, Homologous
=680  \\$iTissues, cells, or organs transplanted between genetically different individuals of the same species.
=688  \\$a2014
=750  \0$aHomografts$5IEN$0(DLC)sh 85061768

=LDR  01332cz  a2200313n  4500
=001  9880364535902441
=005  20170608153625.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064587
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x635
=072  \\$aG3.$x615
=072  \\$aG7.$x410.$x810
=150  \\$aOsmoregulation
=450  \\$wnnna$aOsmotic Stress Regulating Pathway
=450  \\$wnnna$aOsmotic Stress Response
=450  \\$wnnna$aOsmotic Stress Responses
=450  \\$wnnna$aResponse, Osmotic Stress
=450  \\$wnnna$aResponses, Osmotic Stress
=450  \\$wnnna$aStress Response, Osmotic
=450  \\$wnnna$aStress Responses, Osmotic
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aWater-Electrolyte Balance
=550  \\$aOsmotic Pressure
=680  \\$iThe response of cells in sensing a difference in OSMOTIC PRESSURE between the inside and outside of the cell. This response includes signaling from osmotic sensors to activate transcription factors, which in turn regulate the expression of osmocompensatory genes, all functioning to maintain CELL VOLUME and the water concentration inside the cells.
=688  \\$a2014; use WATER-ELECTROLYTE BALANCE 1975-2013
=750  \0$aOsmoregulation$0(DLC)sh 85095932$5IEN-M

=LDR  01614cz  a2200445n  4500
=001  9880364536002441
=005  20141212222753.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064586
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x810.$x449
=150  \\$aSelenic Acid
=450  \\$wnnna$aAcid, Selenic
=450  \\$wnnna$aAmmonium Selenate
=450  \\$wnnna$aCalcium Selenate
=450  \\$wnnna$aDisodium Selenate
=450  \\$wnnna$aMagnesium Selenate
=450  \\$wnnna$aMonosodium Selenate
=450  \\$wnnna$aPotassium Selenate
=450  \\$wnnna$aSelenate
=450  \\$wnnna$aSelenate, Ammonium
=450  \\$wnnna$aSelenate, Calcium
=450  \\$wnnna$aSelenate, Disodium
=450  \\$wnnna$aSelenate, Magnesium
=450  \\$wnnna$aSelenate, Monosodium
=450  \\$wnnna$aSelenate, Potassium
=450  \\$wnnna$aSelenate, Sodium
=450  \\$wnnna$aSelenic Acid, Ammonium Salt
=450  \\$wnnna$aSelenic Acid, Calcium Salt
=450  \\$wnnna$aSelenic Acid, Diammonium Salt
=450  \\$wnnna$aSelenic Acid, Disodium Salt, 75Se-Labeled
=450  \\$wnnna$aSelenic Acid, Disodium Salt, Decahydrate
=450  \\$wnnna$aSelenic Acid, Magnesium Salt
=450  \\$wnnna$aSelenic Acid, Monosodium Salt
=450  \\$wnnna$aSelenic Acid, Potassium Salt
=450  \\$wnnna$aSodium Selenate
=550  \\$wg$aSelenium Compounds
=680  \\$iA strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.
=688  \\$a2014
=750  \0$aSelenic acid$0(DLC)sh 85119685$5IEN-M

=LDR  01000cz  a2200253n  4500
=001  9880364536102441
=005  20141212222748.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064527
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x625.$x124
=072  \\$aG15.$x744.$x111
=150  \\$aEtiolation
=450  \\$wnnna$aDe-etiolation
=450  \\$wnnna$aDe etiolation
=450  \\$wnnna$aDe-etiolations
=450  \\$wnnna$aDeetiolation
=450  \\$wnnna$aDeetiolations
=450  \\$wnnna$aEtiolations
=550  \\$wg$aPlant Development
=550  \\$wg$aPlant Physiological Processes
=680  \\$iPhysical changes in the growth patterns of a plant brought on by sustained absence of light. These changes are characterized by lengthened internodes which produce long weak stems, fewer leaves, and pale yellow color (chlorosis). The physiological basis for etiolation is induction of the phytohormone, AUXIN.
=688  \\$a2014
=750  \0$aEtiolation$0(DLC)sh 85045445$5IEN-M

=LDR  00647cz  a2200205n  4500
=001  9880364536202441
=005  20141212222745.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064450
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x912
=072  \\$aI1.$x880.$x735.$x900.$x912
=150  \\$aWorkplace Violence
=450  \\$wnnna$aViolence, Workplace
=450  \\$wnnna$aViolences, Workplace
=450  \\$wnnna$aWorkplace Violences
=550  \\$wg$aViolence
=680  \\$iThreatened or actual attempt to harm others at place of employment.
=688  \\$a2014
=750  \0$aViolence in the workplace$0(DLC)sh 93009549$5IEN-M

=LDR  00770cz  a2200205n  4500
=001  9880364536302441
=005  20141212222740.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x364.$x609.$x750
=072  \\$aD27.$x720.$x888.$x750
=072  \\$aJ2.$x500.$x512.$x400.$x700.$x750
=150  \\$aNutritive Sweeteners
=450  \\$wnnna$aArtificial Sweeteners, Nutritive
=450  \\$wnnna$aSweeteners, Nutritive
=550  \\$wg$aSweetening Agents
=680  \\$iAny agent that adds not only sweet taste but some energy value to food. They include natural sugars such as SUCROSE; FRUCTOSE; and GALACTOSE; and certain SUGAR ALCOHOLS.
=688  \\$a2014
=750  \0$aNatural sweeteners$0(DLC)sh 85090265$5IEN-M

=LDR  00772cz  a2200229n  4500
=001  9880364536402441
=005  20141212222740.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064425
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x642
=150  \\$aHerbals as Topic
=450  \\$wnnna$aas Topic, Herbals
=450  \\$wnnna$aas Topics, Herbals
=450  \\$wnnna$aHerbals as Topics
=450  \\$wnnna$aTopic, Herbals as
=450  \\$wnnna$aTopics, Herbals as
=550  \\$wg$aReference Books
=667  \\$ado not confuse with the Publication Type HERBALS
=680  \\$iWorks about books, articles or other publications on herbs or plants describing their medicinal value.
=688  \\$a2014
=750  \0$aHerbals$0(DLC)sh 85060336$5IEN-M

=LDR  00653cz  a2200229n  4500
=001  9880364536502441
=005  20141212193222.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064424
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x958
=150  \\$aTobacco Use
=450  \\$wnnna$aChewing, Tobacco
=450  \\$wnnna$aConsumption, Tobacco
=450  \\$wnnna$aTobacco Chewing
=450  \\$aTobacco Consumption
=450  \\$wnnna$aTobacco Uses
=550  \\$wg$aBehavior
=550  \\$wh$aSmoking
=680  \\$iUse of TOBACCO (Nicotiana tabacum L) and TOBACCO PRODUCTS.
=688  \\$a2014
=750  \0$aTobacco use$0(DLC)sh 85135732$5IEN-M

=LDR  01223cz  a2200373n  4500
=001  9880364536602441
=005  20141212222739.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064423
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x247
=072  \\$aI1.$x880.$x735.$x191.$x101
=150  \\$aDrug Trafficking
=450  \\$wnnna$aDealing, Drug
=450  \\$wnnna$aDealings, Drug
=450  \\$wnnna$aDrug Dealing
=450  \\$wnnna$aDrug Dealings
=450  \\$wnnna$aDrug Smuggling
=450  \\$wnnna$aDrug Smugglings
=450  \\$wnnna$aDrug Trade, Illicit
=450  \\$wnnna$aDrug Trades, Illicit
=450  \\$wnnna$aDrug Traffickings
=450  \\$wnnna$aIllicit Drug Trade
=450  \\$wnnna$aIllicit Drug Trades
=450  \\$wnnna$aSmuggling, Drug
=450  \\$wnnna$aSmugglings, Drug
=450  \\$wnnna$aTrade, Illicit Drug
=450  \\$wnnna$aTrades, Illicit Drug
=450  \\$wnnna$aTrafficking, Drug
=450  \\$wnnna$aTraffickings, Drug
=550  \\$wg$aCrime
=680  \\$iThe illegal acquisition, sale, production, transport, movement, and distribution of controlled substances such as narcotics.
=688  \\$a2014
=750  \0$aDrug traffic$0(DLC)sh 88000332$5IEN-M

=LDR  02733cz  a2200661n  4500
=001  9880364536702441
=005  20200517173836.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064420
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x100
=150  \\$aDrug-Related Side Effects and Adverse Reactions
=450  \\$wnnna$aAdverse Drug Event
=450  \\$wnnna$aAdverse Drug Events
=450  \\$wnnna$aAdverse Drug Reaction
=450  \\$wnnna$aAdverse Drug Reactions
=450  \\$wnnna$aDrug Event, Adverse
=450  \\$wnnna$aDrug Events, Adverse
=450  \\$wnnna$aDrug Reaction, Adverse
=450  \\$wnnna$aDrug Reactions, Adverse
=450  \\$wnnna$aDrug Related Side Effects and Adverse Reactions
=450  \\$wnnna$aDrug Side Effect
=450  \\$wnnna$aDrug Side Effects
=450  \\$aDrug Therapy$xadverse effects
=450  \\$wnnna$aDrug Toxicities
=450  \\$wnnna$aDrug Toxicity
=450  \\$wnnna$aDrugs Side Effect
=450  \\$wnnna$aDrugs Side Effects
=450  \\$wnnna$aEffect, Drug Side
=450  \\$wnnna$aEffects, Drug Side
=450  \\$wnnna$aEvent, Adverse Drug
=450  \\$wnnna$aEvents, Adverse Drug
=450  \\$aPharmaceutical Preparations$xadverse effects
=450  \\$aPharmaceutical Preparations$xtoxicity
=450  \\$wnnna$aReaction, Adverse Drug
=450  \\$wnnna$aReactions, Adverse Drug
=450  \\$wnnna$aSide Effect, Drug
=450  \\$wnnna$aSide Effects, Drug
=450  \\$wnnna$aSide Effects of Drugs
=450  \\$wnnna$aToxicities, Drug
=450  \\$wnnna$aToxicity, Drug
=550  \\$wg$aChemically-Induced Disorders
=550  \\$wh$aAkathisia, Drug-Induced
=550  \\$wh$aAnticholinergic Syndrome
=550  \\$wh$aCardiotoxicity
=550  \\$wh$aDrug Hypersensitivity
=550  \\$wh$aDrug-Induced Liver Injury
=550  \\$wh$aDyskinesia, Drug-Induced
=550  \\$wh$aInjection Site Reaction
=550  \\$wh$aMetabolic Side Effects of Drugs and Substances
=550  \\$wh$aPropofol Infusion Syndrome
=550  \\$wh$aSerotonin Syndrome
=550  \\$aClinical Trials, Phase IV as Topic
=550  \\$aDrug Interactions
=667  \\$ageneral or unspecified only; prefer specific drug-related disorder + specific drug with / adv eff / pois or / tox; for disorders relating to the abuse of drugs use SUBSTANCE-RELATED DISORDERS or specifics
=680  \\$iDisorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
=688  \\$a2014; DRUG-TOXICITY was heading 1998-2013
=750  \0$aDrugs$xSide effects$0(DLC)sh 85039746$5IEN-M

=LDR  01044cz  a2200217n  4500
=001  9880364536802441
=005  20141212222738.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064416
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x377
=150  \\$aHospital Medicine
=450  \\$wnnna$aMedicine, Hospital
=550  \\$wg$aMedicine
=550  \\$aHospitalists
=667  \\$ause for the specialty only
=680  \\$iThe branch of medicine concerned with the delivery of comprehensive medical care to hospitalized patients. Practitioners include physicians and non-physician providers who engage in clinical care, teaching, research, or leadership in the field of general hospital medicine.(from http://www.hospitalmedicine.org/AM/Template.cfm?Section=Hospitalist_Definition)
=688  \\$a2014
=750  \0$81$wb$aHospital care$0(DLC)sh 85062238$5IEN-M
=750  \0$81$wb$aMedicine$0(DLC)sh 85083064$5IEN-M
=788  \0$iSearch also under the following headings used together in the same record:$aHospital care$iand$aMedicine$5IEN

=LDR  01410cz  a2200265n  4500
=001  9880364536902441
=005  20141212222736.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x748.$x470
=072  \\$aI1.$x880.$x735.$x384.$x399
=150  \\$aHuman Trafficking
=450  \\$wnnna$aHuman Traffickings
=450  \\$wnnna$aSex Trafficking
=450  \\$wnnna$aSex Traffickings
=450  \\$wnnna$aTrafficking, Human
=450  \\$wnnna$aTrafficking, Sex
=450  \\$wnnna$aTraffickings, Human
=550  \\$wg$aHuman Rights Abuses
=550  \\$wg$aSex Offenses
=550  \\$aOrgan Trafficking
=680  \\$iRecruitment, transportation, transfer, harboring or receipt of persons, by means of the threat or use of force or other forms of coercion, of abduction, of fraud, of deception, of the abuse of power or of a position of vulnerability or of the giving or receiving of payments or benefits to achieve the consent of a person having control over another person, for the purpose of exploitation. (UN. Protocol to prevent, suppress and punish trafficking in persons, especially women and children, supplementing the United Nations convention against transnational organized crime. General Assembly resolution 55/25. United Nations General Assembly, 2000)
=688  \\$a2014
=750  \0$aHuman trafficking$0(DLC)sh2006002629$5IEN-M

=LDR  00903cz  a2200229n  4500
=001  9880364537002441
=005  20141212222735.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x143.$x913
=072  \\$aN2.$x860
=150  \\$aSenior Centers
=450  \\$wnnna$aCenter, Senior
=450  \\$wnnna$aCenters for the Aged
=450  \\$wnnna$aCenters, Senior
=450  \\$wnnna$aSenior Center
=550  \\$wg$aCommunity Health Services
=550  \\$wg$aHealth Care Facilities, Manpower, and Services
=680  \\$iCommunity centers for older adults and providers of resources for the community. In addition to providing services and activities for older adults that reflect the community's diversity, they link participants with resources offered by other agencies.
=688  \\$a2014
=750  \0$aSenior centers$0(DLC)sh2004003367$5IEN-M

=LDR  02755cz  a2200721n  4500
=001  9880364537102441
=005  20141212222735.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064386
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x404.$x14
=150  \\$aAnkle Fractures
=450  \\$wnnna$aAnkle Fracture
=450  \\$wnnna$aAnkle Fracture, Bimalleolar
=450  \\$wnnna$aAnkle Fracture, Trimalleolar
=450  \\$wnnna$aAnkle Fractures, Bimalleolar
=450  \\$wnnna$aAnkle Fractures, Trimalleolar
=450  \\$wnnna$aBimalleolar Ankle Fracture
=450  \\$wnnna$aBimalleolar Ankle Fractures
=450  \\$wnnna$aBimalleolar Equivalent Ankle Fractures
=450  \\$wnnna$aBimalleolar Equivalent Fracture
=450  \\$wnnna$aBimalleolar Equivalent Fractures
=450  \\$wnnna$aBimalleolar Fracture
=450  \\$wnnna$aBimalleolar Fractures
=450  \\$wnnna$aEquivalent Fracture, Bimalleolar
=450  \\$wnnna$aEquivalent Fractures, Bimalleolar
=450  \\$wnnna$aFracture, Ankle
=450  \\$wnnna$aFracture, Bimalleolar
=450  \\$wnnna$aFracture, Bimalleolar Ankle
=450  \\$wnnna$aFracture, Bimalleolar Equivalent
=450  \\$wnnna$aFracture, Lateral Malleolus
=450  \\$wnnna$aFracture, Medial Malleolus
=450  \\$wnnna$aFracture, Posterior Malleolus
=450  \\$wnnna$aFracture, Trimalleolar
=450  \\$wnnna$aFracture, Trimalleolar Ankle
=450  \\$wnnna$aFractures, Ankle
=450  \\$wnnna$aFractures, Bimalleolar
=450  \\$wnnna$aFractures, Bimalleolar Ankle
=450  \\$wnnna$aFractures, Bimalleolar Equivalent
=450  \\$wnnna$aFractures, Lateral Malleolus
=450  \\$wnnna$aFractures, Medial Malleolus
=450  \\$wnnna$aFractures, Posterior Malleolus
=450  \\$wnnna$aFractures, Trimalleolar
=450  \\$wnnna$aFractures, Trimalleolar Ankle
=450  \\$wnnna$aLateral Malleolus Fracture
=450  \\$wnnna$aLateral Malleolus Fractures
=450  \\$wnnna$aMalleolus Fracture, Lateral
=450  \\$wnnna$aMalleolus Fracture, Medial
=450  \\$wnnna$aMalleolus Fracture, Posterior
=450  \\$wnnna$aMalleolus Fractures, Lateral
=450  \\$wnnna$aMalleolus Fractures, Medial
=450  \\$wnnna$aMalleolus Fractures, Posterior
=450  \\$wnnna$aMedial Malleolus Fracture
=450  \\$wnnna$aMedial Malleolus Fractures
=450  \\$wnnna$aPosterior Malleolus Fracture
=450  \\$wnnna$aPosterior Malleolus Fractures
=450  \\$wnnna$aTrimalleolar Ankle Fracture
=450  \\$wnnna$aTrimalleolar Ankle Fractures
=450  \\$wnnna$aTrimalleolar Fracture
=450  \\$wnnna$aTrimalleolar Fractures
=550  \\$wg$aFractures, Bone
=688  \\$a2014
=750  \0$aAnkle$xFractures$0(DLC)sh 85005317$5IEN-M

=LDR  01160cz  a2200313n  4500
=001  9880364537202441
=005  20141212222734.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064371
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x900.$x449.$x500
=072  \\$aN6.$x850.$x860.$x510.$x900.$x700.$x500
=150  \\$aHazardous Waste Sites
=450  \\$wnnna$aDump, Toxic Waste
=450  \\$wnnna$aDumps, Toxic Waste
=450  \\$wnnna$aHazardous Waste Site
=450  \\$wnnna$aSite, Hazardous Waste
=450  \\$wnnna$aSites, Hazardous Waste
=450  \\$wnnna$aToxic Waste Dump
=450  \\$wnnna$aToxic Waste Dumps
=450  \\$wnnna$aWaste Dump, Toxic
=450  \\$wnnna$aWaste Dumps, Toxic
=450  \\$wnnna$aWaste Site, Hazardous
=450  \\$wnnna$aWaste Sites, Hazardous
=550  \\$wg$aWaste Disposal Facilities
=667  \\$aspecify geographic location if pertinent
=680  \\$iSites where HAZARDOUS SUBSTANCES are deposited. Some have facilities for safely storing, processing, and recycling these waste products.
=688  \\$a2014
=750  \0$aHazardous waste sites$0(DLC)sh 85059447$5IEN-M

=LDR  00529cz  a2200181n  4500
=001  9880364537302441
=005  20141212222733.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064367
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x625
=072  \\$aE5.$x638
=150  \\$aOlfactometry
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aInvestigative Techniques
=680  \\$iProcedures for measuring a response to odorants.
=688  \\$a2014
=750  \0$aOlfactometry$0(DLC)sh 85094596$5IEN-M

=LDR  00885cz  a2200277n  4500
=001  9880364537402441
=005  20141212222732.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064349
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG5.$x360.$x340.$x358
=150  \\$aGenome, Microbial
=450  \\$wnnna$aGenomes, Microbial
=450  \\$wnnna$aMicrobial Genome
=450  \\$wnnna$aMicrobial Genomes
=550  \\$wg$aGenome
=550  \\$wh$aGenes, Microbial
=550  \\$wh$aGenome, Archaeal
=550  \\$wh$aGenome, Bacterial
=550  \\$wh$aGenome, Fungal
=550  \\$wh$aGenome, Viral
=550  \\$aGenetics, Microbial
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iThe genetic complement of a microorganism as represented in its DNA or in some microorganisms its RNA.
=688  \\$a2014
=750  \0$aMicrobial genomes$0(DLC)sh2003008341$5IEN-M

=LDR  01104cz  a2200241n  4500
=001  9880364537502441
=005  20141212222732.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064347
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x666.$x450
=072  \\$aE5.$x595.$x666.$x450
=150  \\$aMicroscopy, Electrochemical, Scanning
=450  \\$wnnna$aElectrochemical Microscopy, Scanning
=450  \\$wnnna$aElectrochemical Scanning Microscopy
=450  \\$wnnna$aMicroscopy, Electrochemical Scanning
=450  \\$wnnna$aMicroscopy, Scanning Electrochemical
=450  \\$wnnna$aScanning Electrochemical Microscopy
=450  \\$wnnna$aScanning Microscopy, Electrochemical
=550  \\$wg$aMicroscopy, Scanning Probe
=680  \\$iA scanning probe microscopy technique that uses an ultramicroelectrode as the scanning probe that simultaneously records changes in electrochemical potential as it scans thereby creating topographical images with localized electrochemical information.
=688  \\$a2014
=750  \0$aScanning electrochemical microscopy$0(DLC)sh2001001843$5IEN-M

=LDR  01138cz  a2200277n  4500
=001  9880364537602441
=005  20141212222728.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064306
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x364.$x609.$x500
=072  \\$aD27.$x720.$x888.$x500
=072  \\$aJ2.$x500.$x512.$x400.$x700.$x500
=150  \\$aNon-Nutritive Sweeteners
=450  \\$wnnna$aArtificial Sweeteners, Non-Nutritive
=450  \\$wnnna$aArtificial Sweeteners, Non Nutritive
=450  \\$wnnna$aHigh-Intensity Sweeteners
=450  \\$wnnna$aHigh Intensity Sweeteners
=450  \\$wnnna$aNon-Nutritive Artificial Sweeteners
=450  \\$wnnna$aNon Nutritive Sweeteners
=450  \\$wnnna$aSweeteners, High-Intensity
=450  \\$wnnna$aSweeteners, Non-Nutritive
=550  \\$wg$aSweetening Agents
=680  \\$iChemical additives, such as aspartame, saccharin, and sucralose, that give a sweet taste to foods without contributing significant calories or promoting tooth decay. They are generally much sweeter than sucrose.
=688  \\$a2014
=750  \0$aNonnutritive sweeteners$0(DLC)sh 85092345$5IEN-M

=LDR  01171cz  a2200337n  4500
=001  9880364537702441
=005  20141212222722.0
=008  130708\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D064229
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x65.$x480.$x500
=072  \\$aL1.$x453.$x245.$x945.$x79
=072  \\$aL1.$x700.$x508.$x300.$x550.$x500
=150  \\$aBiological Ontologies
=450  \\$wnnna$aBiologic Ontologies
=450  \\$wnnna$aBiologic Ontology
=450  \\$wnnna$aBiological Ontology
=450  \\$wnnna$aBiomedical Ontologies
=450  \\$wnnna$aBiomedical Ontology
=450  \\$wnnna$aOntologies, Biologic
=450  \\$wnnna$aOntologies, Biological
=450  \\$wnnna$aOntologies, Biomedical
=450  \\$wnnna$aOntology, Biologic
=450  \\$wnnna$aOntology, Biological
=450  \\$wnnna$aOntology, Biomedical
=550  \\$wg$aKnowledge Bases
=550  \\$wg$aVocabulary, Controlled
=550  \\$wh$aGene Ontology
=680  \\$iStructured vocabularies describing concepts from the fields of biology and relationships between concepts.
=688  \\$a2014
=750  \0$aOntologies (Information retrieval)$0(DLC)sh2005006014$5IEN-M

=LDR  01369cz  a2200373n  4500
=001  9880364537802441
=005  20141212222615.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063188
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180.$x708.$x210
=150  \\$aRana clamitans
=450  \\$wnnna$aAquarana clamitans
=450  \\$wnnna$aBronze Frog
=450  \\$wnnna$aBronze Frogs
=450  \\$wnnna$aFrog, Bronze
=450  \\$aFrog, Green
=450  \\$wnnna$aFrog, Northern Green
=450  \\$wnnna$aFrogs, Bronze
=450  \\$wnnna$aFrogs, Northern Green
=450  \\$aGreen Frog
=450  \\$wnnna$aGreen Frog, Northern
=450  \\$wnnna$aGreen Frogs, Northern
=450  \\$wnnna$aLithobates clamitans
=450  \\$wnnna$aLithobates clamitans melanota
=450  \\$wnnna$aNorthern Green Frog
=450  \\$wnnna$aNorthern Green Frogs
=450  \\$wnnna$aRana clamitans clamitans
=450  \\$wnnna$aRana clamitans melanota
=550  \\$wg$aRanidae
=667  \\$aNIM with no qualifiers when experimental animal
=680  \\$iA species of the family Ranidae which occurs primarily in the eastern half of the United States and Canada. Two subspecies exist, commonly referred to as green frog (R. c. melanota) and bronze frog (R. c. clamitans).
=688  \\$a2013
=750  \0$aGreen frog$0(DLC)sh 85057213$5IEN-M

=LDR  00727cz  a2200217n  4500
=001  9880364537902441
=005  20141212222612.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063172
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x645.$x562.$x249
=150  \\$aGenioplasty
=450  \\$wnnna$aChin Repositioning
=450  \\$wnnna$aChin Repositionings
=450  \\$wnnna$aGenioplasties
=450  \\$wnnna$aRepositioning, Chin
=450  \\$wnnna$aRepositionings, Chin
=550  \\$wg$aOrthognathic Surgical Procedures
=680  \\$iA surgical procedure done largely for cosmetic reasons to correct receding chins, chin misalignment, or chin excess.
=688  \\$a2013
=750  \0$aGenioplasty$0(DLC)sh 92004212$5IEN-M

=LDR  00831cz  a2200253n  4500
=001  9880364538002441
=005  20141212222610.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063148
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG15.$x744.$x735
=150  \\$aPlant Dispersal
=450  \\$wnnna$aDispersal, Plant
=450  \\$wnnna$aDispersals, Plant
=450  \\$wnnna$aDistribution, Plant
=450  \\$wnnna$aDistributions, Plant
=450  \\$wnnna$aPlant Dispersals
=450  \\$wnnna$aPlant Distribution
=450  \\$wnnna$aPlant Distributions
=550  \\$wg$aPlant Physiological Processes
=550  \\$wh$aSeed Dispersal
=680  \\$iThe physical distribution of plants in various forms and stages of development through time and space.
=688  \\$a2013
=750  \0$aPlants$xDispersal$0(DLC)sh 88002649$5IEN-M

=LDR  00904cz  a2200277n  4500
=001  9880364538102441
=005  20141212222609.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063147
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x69
=072  \\$aG16.$x49
=150  \\$aAnimal Distribution
=450  \\$aAnimal Dispersal
=450  \\$wnnna$aAnimal Dispersals
=450  \\$wnnna$aAnimal Distributions
=450  \\$wnnna$aDispersal, Animal
=450  \\$wnnna$aDispersals, Animal
=450  \\$wnnna$aDistribution, Animal
=450  \\$wnnna$aDistributions, Animal
=550  \\$wg$aBehavior, Animal
=550  \\$wg$aBiological Phenomena
=550  \\$wh$aAnimal Migration
=680  \\$iA process by which animals in various forms and stages of development are physically distributed through time and space.
=688  \\$a2013
=750  \0$aZoogeography$0(DLC)sh 85149975$5IEN-M

=LDR  00825cz  a2200277n  4500
=001  9880364538202441
=005  20141212222608.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063129
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x260.$x730
=072  \\$aI1.$x880.$x735.$x607
=150  \\$aParental Death
=450  \\$wnnna$aDeath, Parental
=450  \\$wnnna$aDeath, Paternal
=450  \\$wnnna$aDeaths, Parental
=450  \\$wnnna$aDeaths, Paternal
=450  \\$wnnna$aParental Deaths
=450  \\$wnnna$aPaternal Death
=450  \\$wnnna$aPaternal Deaths
=550  \\$wg$aDeath
=550  \\$wg$aSocial Problems
=550  \\$wh$aMaternal Death
=680  \\$iThe death of the father or mother or another person in this role.
=688  \\$a2013
=750  \0$aParents$xDeath$0(DLC)sh 86000669$5IEN-M

=LDR  00833cz  a2200241n  4500
=001  9880364538302441
=005  20141212222607.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063126
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x148.$x108
=150  \\$aBalloon Valvuloplasty
=450  \\$wnnna$aBalloon Valvotomies
=450  \\$aBalloon Valvotomy
=450  \\$wnnna$aBalloon Valvuloplasties
=450  \\$wnnna$aValvotomies, Balloon
=450  \\$wnnna$aValvotomy, Balloon
=450  \\$wnnna$aValvuloplasties, Balloon
=450  \\$wnnna$aValvuloplasty, Balloon
=550  \\$wg$aCatheterization
=680  \\$iWidening of a stenosed HEART VALVE by the insertion of a balloon CATHETER into the valve and inflation of the balloon.
=688  \\$a2013
=750  \0$aPercutaneous balloon valvuloplasty$0(DLC)sh 90005278$5IEN-M

=LDR  01811cz  a2200481n  4500
=001  9880364538402441
=005  20200908125210.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063106
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x777.$x500
=150  \\$aTransgender Persons
=450  \\$wnno$aTransgendered Persons
=450  \\$wnnna$aGender-Variant Person
=450  \\$wnnna$aGender-Variant Persons
=450  \\$wnnna$aGender Variant Person
=450  \\$wnnna$aGender Variant Persons
=450  \\$wnnna$aGenderqueer Person
=450  \\$wnnna$aGenderqueer Persons
=450  \\$wnnna$aPerson, Transgender
=450  \\$wnnna$aPerson, Transgendered
=450  \\$wnnna$aPerson, Transsexual
=450  \\$wnnna$aPersons, Transgender
=450  \\$wnnna$aPersons, Transgendered
=450  \\$wnnna$aPersons, Transsexual
=450  \\$wnnna$aTransgender Person
=450  \\$wnnna$aTransgender Persons
=450  \\$wnnna$aTransgendered Person
=450  \\$wnnna$aTransgender
=450  \\$wnnna$aTransgenders
=450  \\$wnnna$aTranssexual
=450  \\$wnnna$aTranssexuals
=450  \\$wnnna$aTranssexual Person
=450  \\$wnnna$aTranssexual Persons
=550  \\$wg$aSexual and Gender Minorities
=550  \\$aDisorders of Sex Development
=550  \\$aGender Identity
=550  \\$aHealth Services for Transgendered Persons
=550  \\$aTranssexualism
=667  \\$aindex both MALE and FEMALE check tags
=680  \\$iPersons having a sense of persistent identification with, and expression of, gender-coded behaviors not typically associated with one's anatomical sex at birth, and with or without a desire to undergo SEX REASSIGNMENT PROCEDURES.
=688  \\$a2016 (2013); use TRANSSEXUALISM (2001-2012)
=750  \0$aTransgender people$0(DLC)sh2007003708$5IEN-M

=LDR  01609cz  a2200481n  4500
=001  9880364538502441
=005  20141212222606.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063105
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x787.$x839.$x500
=072  \\$aN3.$x219.$x521.$x346.$x506.$x281
=150  \\$aFood Assistance
=450  \\$wnnna$aAid Program, Food
=450  \\$wnnna$aAid Programs, Food
=450  \\$wnnna$aAssistance, Food
=450  \\$wnnna$aAssistance Program, Food
=450  \\$wnnna$aAssistance Programs, Food
=450  \\$wnnna$aFood Aid Program
=450  \\$wnnna$aFood Aid Programs
=450  \\$wnnna$aFood Assistance Program
=450  \\$wnnna$aFood Assistance Programs
=450  \\$wnnna$aFood Stamp
=450  \\$wnnna$aFood Stamp Program
=450  \\$wnnna$aFood Stamp Programs
=450  \\$wnnna$aFood Stamps
=450  \\$wnnna$aProgram, Food Aid
=450  \\$wnnna$aProgram, Food Assistance
=450  \\$wnnna$aProgram, Food Stamp
=450  \\$wnnna$aPrograms, Food Aid
=450  \\$wnnna$aPrograms, Food Assistance
=450  \\$wnnna$aPrograms, Food Stamp
=450  \\$wnnna$aStamp, Food
=450  \\$wnnna$aStamp Program, Food
=450  \\$wnnna$aStamp Programs, Food
=450  \\$wnnna$aStamps, Food
=450  \\$wnnna$aSupplemental Nutrition Assistance Program
=550  \\$wg$aPublic Assistance
=550  \\$wg$aRelief Work
=667  \\$ado not confuse with FOOD SERVICES
=680  \\$iFood or financial assistance for food given to those in need.
=688  \\$a2013
=750  \0$aFood relief$0(DLC)sh 85050314$5IEN-M

=LDR  01076cz  a2200313n  4500
=001  9880364538602441
=005  20171102160750.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063065
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x705.$x429
=150  \\$aOrganophosphonates
=450  \\$wnnna$aAcid Esters, Phosphonic
=450  \\$wnnna$aEsters, Phosphonic Acid
=450  \\$wnnna$aPhosphonates
=450  \\$wnnna$aPhosphonic Acid Esters
=550  \\$wg$aOrganophosphorus Compounds
=550  \\$wh$aAminoethylphosphonic Acid
=550  \\$wh$aArmin
=550  \\$wh$aDiphosphonates
=550  \\$wh$aFosfomycin
=550  \\$wh$aOrganofluorophosphonates
=550  \\$wh$aOrganothiophosphonates
=550  \\$wh$aPhosphonoacetic Acid
=550  \\$wh$aTenofovir
=550  \\$wh$aTrichlorfon
=680  \\$iCarbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
=688  \\$a2013
=750  \0$aPhosphonates$0(DLC)sh 85101109$5IEN-M

=LDR  00803cz  a2200241n  4500
=001  9880364538702441
=005  20200805175642.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D063045
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x280.$x179
=150  \\$aCrowdsourcing
=450  \\$wnnna$aCrowd Sourcing
=450  \\$wnnna$aCrowd Sourcings
=450  \\$wnnna$aCrowdsource
=450  \\$wnnna$aCrowdsources
=450  \\$wnnna$aCrowdsourcings
=450  \\$wnnna$aSourcing, Crowd
=450  \\$wnnna$aSourcings, Crowd
=550  \\$wg$aData Collection
=680  \\$iSocial media model for enabling public involvement and recruitment in participation. Use of social media to collect feedback and recruit volunteer subjects.
=688  \\$a2013
=750  \0$aCrowdsourcing$0(DLC)sh2017004056$5IEN-M

=LDR  00824cz  a2200181n  4500
=001  9880364538802441
=005  20160511165916.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062985
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x325
=150  \\$aHealth Services for Transgender Persons
=450  \\$wnno$aHealth Services for Transgendered Persons
=550  \\$wg$aHealth Services
=550  \\$aTransgender Persons
=680  \\$iAccess to specialized care for transgender populations. Health systems organized to take account of the special healthcare needs of marginalized groups who may face barriers in accessing health services. (http://www.who.int/reproductivehealth/topics/linkages/guidance_package.pdf)
=688  \\$a2016 (2013)
=750  \0$aTransgender people$xMedical care$0(IEN)9880447839302441$5IEN-M

=LDR  00981cz  a2200277n  4500
=001  9880364538902441
=005  20141212222602.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062966
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x240.$x547
=072  \\$aN6.$x230.$x300.$x100.$x700.$x500
=150  \\$aOzone Depletion
=450  \\$wnnna$aDepletion, Ozone
=450  \\$wnnna$aDepletion, Ozone Layer
=450  \\$wnnna$aHole, Ozone
=450  \\$wnnna$aHoles, Ozone
=450  \\$wnnna$aLayer Depletion, Ozone
=450  \\$wnnna$aOzone Hole
=450  \\$wnnna$aOzone Holes
=450  \\$wnnna$aOzone Layer Depletion
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aStratospheric Ozone
=680  \\$iA shift in the balance between production and destruction of STRATOSPHERIC OZONE that results in a decline of the amount of OZONE in the lower stratosphere.
=688  \\$a2013
=750  \0$aOzone layer depletion$0(DLC)sh 88004697$5IEN-M

=LDR  00941cz  a2200229n  4500
=001  9880364539002441
=005  20141212222601.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062952
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x362.$x670.$x600.$x500
=072  \\$aG16.$x500.$x275.$x63.$x700
=072  \\$aN6.$x230.$x300.$x100.$x700
=150  \\$aStratospheric Ozone
=450  \\$aOzone Layer
=450  \\$wnnna$aOzone, Stratospheric
=550  \\$wg$aAtmosphere
=550  \\$wg$aOzone
=550  \\$wh$aOzone Depletion
=680  \\$iOzone in the Earth's stratosphere. It is produced continuously by the action of solar ULTRAVIOLET RAYS on oxygen in the stratosphere. The stratospheric ozone (especially at the ozone layer) blocks much of the solar UV radiation of wavelengths of 320 nanometers or less from being transmitted to lower ATMOSPHERE of the Earth.
=688  \\$a2013
=750  \0$aOzone layer$0(DLC)sh 88004695$5IEN-M

=LDR  00844cz  a2200253n  4500
=001  9880364539102441
=005  20141212222557.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062845
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x18.$x214
=072  \\$aD2.$x455.$x526.$x439.$x196
=150  \\$aChloroacetates
=450  \\$wnnna$aAcids, Chloroacetic
=450  \\$wnnna$aChloroacetic Acids
=450  \\$aDichloroacetic Acid$xanalogs & derivatives
=450  \\$aTrichloroacetic Acid$xanalogs & derivatives
=550  \\$wg$aAcetates
=550  \\$wg$aHydrocarbons, Chlorinated
=550  \\$wh$aDichloroacetic Acid
=550  \\$wh$aTrichloroacetic Acid
=680  \\$iACETIC ACID or acetic acid esters substituted with one or more CHLORINE atoms.
=688  \\$a2013
=750  \0$aChloroacetic acids$0(DLC)sh 85024554$5IEN-M

=LDR  00803cz  a2200253n  4500
=001  9880364539302441
=005  20141212222554.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062787
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x383
=072  \\$aE2.$x319.$x754.$x500
=150  \\$aDrug Overdose
=450  \\$wnnna$aDrug Overdoses
=450  \\$wnnna$aOverdose, Drug
=450  \\$wnnna$aOverdoses, Drug
=550  \\$wg$aPrescription Drug Misuse
=550  \\$wg$aSubstance-Related Disorders
=550  \\$aInappropriate Prescribing
=550  \\$aMedication Errors
=550  \\$aSubstance-Related Disorders
=680  \\$iAccidental or deliberate use of a medication or street drug in excess of normal dosage.
=688  \\$a2013
=750  \0$aDrugs$xOverdose$0(DLC)sh 85039740$5IEN-M

=LDR  00900cz  a2200217n  4500
=001  9880364539402441
=005  20141212222546.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062611
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x944.$x730
=072  \\$aN6.$x850.$x460.$x710.$x730
=150  \\$aSolid Waste
=450  \\$wnnna$aSolid Wastes
=450  \\$wnnna$aWaste, Solid
=450  \\$wnnna$aWastes, Solid
=550  \\$wg$aWaste Products
=550  \\$aRefuse Disposal
=680  \\$iGarbage, refuse, or sludge, or other discarded materials from a wastewater treatment plant, water supply treatment plant, and air pollution control facility that include solid, semi-solid, or contained material. It does not include materials dissolved in domestic sewage, irrigation return flows, or industrial discharges.
=688  \\$a2013
=750  \0$aRefuse and refuse disposal$5IEN$0(DLC)sh 85112316

=LDR  00641cz  a2200169n  4500
=001  9880364539502441
=005  20141212222544.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062605
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x408.$x782.$x512
=150  \\$aQuillaja Saponins
=450  \\$wnnna$aSaponins, Quillaja
=550  \\$wg$aSaponins
=680  \\$iNatural detergents made up of a heterogeneous mixture of molecules having a triterpenoid core structure. They vary in aglycone (sapogenin) and sugar moieties, including glucose.
=688  \\$a2013; use Quillaja 2003-2012
=750  \0$aTriterpenoid saponins$0(DLC)sh 89000755$5IEN-M

=LDR  00856cz  a2200205n  4500
=001  9880364539602441
=005  20141212222537.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x570
=150  \\$aNarrative Therapy
=450  \\$wnnna$aNarrative Therapies
=450  \\$wnnna$aTherapies, Narrative
=450  \\$wnnna$aTherapy, Narrative
=550  \\$wg$aPsychotherapy
=550  \\$aNarration
=680  \\$iA form of PSYCHOTHERAPY that centers on the individuals as the experts in their own lives and views problems as separate from people. It is assumed that people have many skills, competencies, beliefs, values, commitments, and abilities that will assist them to reduce the influence of problems in their lives.
=688  \\$a2013
=750  \0$aNarrative therapy$0(DLC)sh2001008823$5IEN-M

=LDR  00755cz  a2200217n  4500
=001  9880364539702441
=005  20141212193208.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062487
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x813.$x817
=072  \\$aI1.$x880.$x853.$x872
=150  \\$aSocial Marginalization
=450  \\$wnnna$aMarginalization, Social
=450  \\$wnnna$aMarginalizations, Social
=450  \\$wnnna$aSocial Marginalizations
=550  \\$wg$aSocial Behavior
=550  \\$wg$aSociological Factors
=680  \\$iIndividuals or groups, excluded from participation in the economic, social, and political activities of membership in a community.
=688  \\$a2013
=750  \0$aMarginality, Social$0(DLC)sh 85081057$5IEN-M

=LDR  01011cz  a2200205n  4500
=001  9880364539802441
=005  20141212222536.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062486
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x700.$x324
=072  \\$aN5.$x715.$x360.$x300.$x375.$x625.$x324
=072  \\$aN6.$x850.$x520.$x308.$x250.$x700.$x324
=072  \\$aN6.$x850.$x780.$x675.$x487
=150  \\$aPublic Health Surveillance
=450  \\$wnnna$aSurveillance, Public Health
=550  \\$wg$aPopulation Surveillance
=680  \\$iThe ongoing, systematic collection, analysis, and interpretation of health-related data with the purpose of preventing or controlling disease or injury, or of identifying unusual events of public health importance, followed by the dissemination and use of information for public health action. (From Am J Prev Med 2011;41(6):636)
=688  \\$a2013, use Population Surveillance 1990-2012
=750  \0$aPublic health surveillance$0(DLC)sh 91006354$5IEN-M

=LDR  00783cz  a2200289n  4500
=001  9880364539902441
=005  20141212222534.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062410
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x432.$x500.$x775
=072  \\$aF1.$x145.$x466.$x349.$x500.$x775
=072  \\$aJ2.$x500.$x590.$x780
=150  \\$aSnacks
=450  \\$wnnna$aFood, Snack
=450  \\$wnnna$aFoods, Snack
=450  \\$wnnna$aSnack
=450  \\$wnnna$aSnack Food
=450  \\$wnnna$aSnack Foods
=450  \\$aSnacking
=450  \\$wnnna$aSnackings
=450  \\$aSnacktime
=450  \\$wnnna$aSnacktimes
=550  \\$wg$aMeals
=680  \\$iFoods eaten between MEALTIMES.
=688  \\$a2013
=750  \0$aSnack foods$0(DLC)sh 85123717$5IEN-M

=LDR  00690cz  a2200253n  4500
=001  9880364540002441
=005  20141212222534.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062409
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x432.$x500.$x550
=072  \\$aF1.$x145.$x466.$x349.$x500.$x550
=072  \\$aJ2.$x500.$x590.$x560
=150  \\$aLunch
=450  \\$wnnna$aLunch Time
=450  \\$wnnna$aLunch Times
=450  \\$aLunchtime
=450  \\$wnnna$aLunchtimes
=450  \\$wnnna$aTime, Lunch
=450  \\$wnnna$aTimes, Lunch
=550  \\$wg$aMeals
=680  \\$iThe meal taken at midday.
=688  \\$a2013
=750  \0$aLuncheons$0(DLC)sh 85078869$5IEN-M

=LDR  00830cz  a2200289n  4500
=001  9880364540102441
=005  20141212222534.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062408
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x432.$x500.$x100
=072  \\$aF1.$x145.$x466.$x349.$x500.$x100
=072  \\$aJ2.$x500.$x590.$x120
=150  \\$aBreakfast
=450  \\$wnnna$aBreakfast Time
=450  \\$wnnna$aBreakfast Times
=450  \\$wnnna$aBreakfasts
=450  \\$wnnna$aMeal, Morning
=450  \\$wnnna$aMeals, Morning
=450  \\$wnnna$aMorning Meal
=450  \\$wnnna$aMorning Meals
=450  \\$wnnna$aTime, Breakfast
=450  \\$wnnna$aTimes, Breakfast
=550  \\$wg$aMeals
=680  \\$iThe first meal of the day.
=688  \\$a2013
=750  \0$aBreakfasts$0(DLC)sh 85016672$5IEN-M

=LDR  01185cz  a2200433n  4500
=001  9880364540202441
=005  20141212222533.0
=008  120703\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D062407
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x432.$x500
=072  \\$aF1.$x145.$x466.$x349.$x500
=072  \\$aJ2.$x500.$x590
=150  \\$aMeals
=450  \\$aDinner
=450  \\$aDinner Time
=450  \\$wnnna$aDinner Times
=450  \\$wnnna$aDinners
=450  \\$wnnna$aDinnertime
=450  \\$wnnna$aDinnertimes
=450  \\$wnnna$aMeal
=450  \\$wnnna$aMeal Time
=450  \\$wnnna$aMeal Times
=450  \\$wnnna$aMealtime
=450  \\$aMealtimes
=450  \\$wnnna$aSupper
=450  \\$wnnna$aSuppers
=450  \\$wnnna$aTime, Dinner
=450  \\$wnnna$aTime, Meal
=450  \\$wnnna$aTimes, Dinner
=450  \\$wnnna$aTimes, Meal
=550  \\$wg$aFood
=550  \\$wg$aFood Habits
=550  \\$wh$aBreakfast
=550  \\$wh$aLunch
=550  \\$wh$aSnacks
=680  \\$iA portion of the food eaten for the day, usually at regular occasions during the day.
=688  \\$a2013
=750  \0$aDinners and dining$0(DLC)sh 85038076$5IEN-M

=LDR  02335cz  a2200541n  4500
=001  9880364165302441
=005  20141212210515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014463
=035  \\$aCBA7801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x850
=150  \\$aUltrasonography
=450  \\$wnnna$aComputer Echotomography
=450  \\$wnnna$aDiagnoses, Ultrasonic
=450  \\$wnnna$aDiagnosis, Ultrasonic
=450  \\$aEchography
=450  \\$aEchotomography
=450  \\$aEchotomography, Computer
=450  \\$wnnna$aImaging, Ultrasonic
=450  \\$wnnna$aImaging, Ultrasound
=450  \\$wnnna$aImagings, Ultrasound
=450  \\$wnnna$aMedical Sonography
=450  \\$aSonography, Medical
=450  \\$aTomography, Ultrasonic
=450  \\$wnnna$aUltrasonic Diagnoses
=450  \\$aUltrasonic Diagnosis
=450  \\$aUltrasonic Imaging
=450  \\$wnnna$aUltrasonic Tomography
=450  \\$aUltrasonics$xdiagnostic use
=450  \\$wnnna$aUltrasound Imaging
=450  \\$wnnna$aUltrasound Imagings
=550  \\$wg$aDiagnostic Imaging
=550  \\$wh$aCarotid Intima-Media Thickness
=550  \\$wh$aEchocardiography
=550  \\$wh$aEchoencephalography
=550  \\$wh$aElasticity Imaging Techniques
=550  \\$wh$aEndosonography
=550  \\$wh$aMicroscopy, Acoustic
=550  \\$wh$aUltrasonography, Doppler
=550  \\$wh$aUltrasonography, Interventional
=550  \\$wh$aUltrasonography, Mammary
=550  \\$wh$aUltrasonography, Prenatal
=550  \\$aAnatomy, Cross-Sectional
=667  \\$ageneral only; prefer /ultrasonogr with organs & diseases: Manual 19.7+, 19.8.77; entry term ECHOTOMOGRAPHY is seen in foreign liturature: if so, use "ultrasonography" or "ultrasonic diagnosis" or "ultrasonic imaging" in translations & not "echotomography"; note many specific ultrasonographic technipues are available; DF: ULTRASONOGR
=680  \\$iThe visualization of deep structures of the body by recording the reflections or echoes of ultrasonic pulses directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz.
=688  \\$a91; was ULTRASONIC DIAGNOSIS 1985-90; was DIAGNOSIS, ULTRASONIC (NON MESH) 1974-84
=750  \0$aUltrasonic imaging$0(DLC) sh 85139483$5IEN

=LDR  01200cz  a2200253n  4500
=001  9880364165402441
=005  20141212210514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014462
=035  \\$aCBA7800HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x292.$x975
=072  \\$aE5.$x196.$x454.$x807
=072  \\$aG1.$x595.$x280.$x807
=072  \\$aG2.$x149.$x767.$x600.$x807
=072  \\$aG2.$x842.$x750.$x600.$x807
=150  \\$aUltrafiltration
=550  \\$wg$aExtracorporeal Circulation
=550  \\$wg$aFiltration
=550  \\$wh$aHemofiltration
=667  \\$aNIM; ultrafilt of blood is indexed under HEMOFILTRATION or HEMODIAFILTRATION if combined with hemodialysis
=680  \\$iThe separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS).
=688  \\$a73
=750  \0$aUltrafiltration$5IEN$0(DLC)sh 85139469

=LDR  00837cz  a2200229n  4500
=001  9880364165502441
=005  20141212210514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014461
=035  \\$aCBA7799HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x181.$x724
=072  \\$aE5.$x196.$x941
=150  \\$aUltracentrifugation
=550  \\$wg$aCentrifugation
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wh$aCentrifugation, Density Gradient
=550  \\$aCentrifugation
=667  \\$aan anal chem technique; GEN or unspecified; prefer specifics; NIM
=680  \\$iCentrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a65
=750  \0$aUltracentrifugation$5IEN$0(DLC)sh 89000198

=LDR  01056cz  a2200229n  4500
=001  9880364165602441
=005  20141212210514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014460
=035  \\$aCBA7798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x939
=150  \\$aUltimobranchial Body
=450  \\$wnnna$aBodies, Ultimobranchial
=450  \\$wnnna$aBody, Ultimobranchial
=450  \\$wnnna$aUltimobranchial Bodies
=550  \\$wg$aAnimal Structures
=550  \\$aThyroid Gland
=667  \\$aembryonic structure in animals; /embryol permitted but consider other qualif
=680  \\$iA diverticulum from the fourth pharyngeal pouch of an embryo, regarded by some as a rudimentary fifth pharyngeal pouch and by others as a lateral thyroid primordium. The ultimobranchial bodies of lower vertebrates contain large amounts of calcitonin. In mammals the bodies fuse with the thyroid gland and are thought to develop into the parafollicular cells. (Stedman, 25th ed)
=688  \\$a73
=750  \0$aUltimobranchial body$5IEN$0(DLC)sh 85139463

=LDR  00938cz  a2200205n  4500
=001  9880364165702441
=005  20141212210513.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014459
=035  \\$aCBA7797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x50.$x850
=150  \\$aUlnar Nerve
=450  \\$wnnna$aNerve, Ulnar
=450  \\$wnnna$aNerves, Ulnar
=450  \\$wnnna$aUlnar Nerves
=550  \\$wg$aBrachial Plexus
=667  \\$adis = ULNAR NEUROPATHY; neopl = ULNAR NEUROPATHY (IM) + PERIPHERAL NERVOUS SYSTEM NEOPLASMS (IM) + histol type of neopl (IM)
=680  \\$iA major nerve of the upper extremity. In humans, the fibers of the ulnar nerve originate in the lower cervical and upper thoracic spinal cord (usually C7 to T1), travel via the medial cord of the brachial plexus, and supply sensory and motor innervation to parts of the hand and forearm.
=750  \0$aUlnar nerve$5IEN$0(DLC)sh 85139450

=LDR  00473cz  a2200181n  4500
=001  9880364165802441
=005  20141212210513.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014457
=035  \\$aCBA7795HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x87.$x90.$x850
=150  \\$aUlna
=450  \\$wnnna$aUlnas
=550  \\$wg$aArm Bones
=550  \\$wh$aOlecranon Process
=667  \\$afracture = ULNA FRACTURES
=750  \0$aUlna$5IEN$0(DLC)sh 85139449

=LDR  00757cz  a2200169n  4500
=001  9880364165902441
=005  20141212210513.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014456
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x891
=150  \\$aUlcer
=450  \\$wnnna$aUlcers
=550  \\$wg$aPathologic Processes
=667  \\$acoord IM with organ/dis precoord (IM) but note specific precoord ulcer terms; RODENT ULCER see CARCINOMA, BASAL CELL is available; stress ulcer: index under PEPTIC ULCER or specific (IM) + STRESS, PHYSIOLOGICAL or STRESS, PSYCHOLOGICAL (IM)
=680  \\$iA lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.
=750  \0$aUlcers$5IEN$0(DLC)sh 85139428

=LDR  03094cz  a2200613n  4500
=001  9880364166002441
=005  20200515143136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014453
=035  \\$aCBA7791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x480
=150  \\$aGlucuronosyltransferase
=450  \\$wnnna$a17 beta-Hydroxysteroid UDP-Glucuronosyltransferase
=450  \\$wnnna$a17 beta Hydroxysteroid UDP Glucuronosyltransferase
=450  \\$wnnna$a4-Nitrophenol-UDP-Glucuronosyltransferase
=450  \\$wnnna$a4 Nitrophenol UDP Glucuronosyltransferase
=450  \\$wnnna$a7-Hydroxycoumarin UDP Glucuronyltransferase
=450  \\$wnnna$a7 Hydroxycoumarin UDP Glucuronyltransferase
=450  \\$wnnna$aAndrosterone UDP-Glucuronosyltransferase
=450  \\$wnnna$aAndrosterone UDP Glucuronosyltransferase
=450  \\$wnnna$aBilirubin UDP-Glucuronyltransferase
=450  \\$wnnna$aBilirubin UDP Glucuronyltransferase
=450  \\$wnnna$aEstrogen UDP-Glucuronosyltransferase
=450  \\$wnnna$aEstrogen UDP Glucuronosyltransferase
=450  \\$wnnna$aEstrone Glucuronyltransferase
=450  \\$wnnna$aGlucuronic Transferase
=450  \\$wnnna$aGlucuronosyltransferase, UDP
=450  \\$wnnna$aGlucuronyl Transferase, UDP
=450  \\$aGlucuronyltransferase
=450  \\$wnnna$aGlucuronyltransferase, 7-Hydroxycoumarin UDP
=450  \\$wnnna$aGlucuronyltransferase, Estrone
=450  \\$wnnna$aGlucuronyltransferase, Morphine
=450  \\$wnnna$aMorphine Glucuronyltransferase
=450  \\$wnnna$ap-Nitrophenyl UDP-Glucuronosyltransferase
=450  \\$wnnna$ap Nitrophenyl UDP Glucuronosyltransferase
=450  \\$wnnna$aTransferase, Glucuronic
=450  \\$wnnna$aTransferase, UDP Glucuronyl
=450  \\$wnnna$aUDP-Glucuronic Acid 3-O-beta-D-Galactosyl-D-Galactose Glucuronosyltransferase
=450  \\$wnnna$aUDP Glucuronic Acid 3 O beta D Galactosyl D Galactose Glucuronosyltransferase
=450  \\$aUDP Glucuronosyltransferase
=450  \\$wnnna$aUDP-Glucuronosyltransferase, 17 beta-Hydroxysteroid
=450  \\$wnnna$aUDP-Glucuronosyltransferase, Androsterone
=450  \\$wnnna$aUDP-Glucuronosyltransferase, Estrogen
=450  \\$wnnna$aUDP-Glucuronosyltransferase, p-Nitrophenyl
=450  \\$wnnna$aUDP Glucuronyl Transferase
=450  \\$wnnna$aUDP Glucuronyltransferase, 7-Hydroxycoumarin
=450  \\$wnnna$aUDP-Glucuronyltransferase, Bilirubin
=550  \\$wg$aHexosyltransferases
=550  \\$wh$aHyaluronan Synthases
=667  \\$a/defic: consider also CRIGLER-NAJJAR SYNDROME & coord with BILIRUBIN /metab (NIM)
=680  \\$iA family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.
=688  \\$a92; was UDP GLUCURONOSYLTRANSFERASE 1973-91 (see under HEXOSYLTRANSFERASES 1975-76, Prov 1973-74)
=750  \0$aGlucuronosyltransferase$0(DLC) sh 94006120$5IEN-M

=LDR  00678cz  a2200193n  4500
=001  9880364166102441
=005  20141212210511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014451
=035  \\$aCBA7789HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x806.$x250.$x900
=072  \\$aD8.$x211.$x935
=150  \\$aUbiquinone
=450  \\$aCoenzyme Q
=550  \\$wg$aBenzoquinones
=550  \\$wg$aCoenzymes
=680  \\$iA lipid-soluble benzoquinone which is involved in ELECTRON TRANSPORT in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.
=750  \0$aUbiquinones$5IEN$0(DLC)sh 85139235

=LDR  01085cz  a2200337n  4500
=001  9880364166202441
=005  20210217132538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014443
=035  \\$aCBA7780HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x875
=150  \\$aTyrosine
=450  \\$wnnna$aL-Tyrosine
=450  \\$wnnna$aL Tyrosine
=450  \\$wnnna$apara-Tyrosine
=450  \\$wnnna$apara Tyrosine
=450  \\$wnnna$aTyrosine, L-isomer
=450  \\$wnnna$aTyrosine, L isomer
=550  \\$wg$aAmino Acids, Aromatic
=550  \\$wh$aBetalains
=550  \\$wh$aDihydroxyphenylalanine
=550  \\$wh$aDiiodotyrosine
=550  \\$wh$aMelanins
=550  \\$wh$aMethyltyrosines
=550  \\$wh$aMonoiodotyrosine
=550  \\$wh$aPhosphotyrosine
=550  \\$wh$aTirofiban
=667  \\$a/blood: consider also TYROSINEMIAS
=680  \\$iA non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.
=750  \0$aTyrosine$5IEN$0(DLC)sh 85139195

=LDR  01408cz  a2200289n  4500
=001  9880364166302441
=005  20141212210508.0
=008  760419\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014442
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x708.$x125.$x500
=150  \\$aMonophenol Monooxygenase
=450  \\$wnnna$aCresolase
=450  \\$aDopa Oxidase
=450  \\$wnnna$aMonooxygenase, Monophenol
=450  \\$wnnna$aOxidase, Dopa
=450  \\$wnnna$aOxidase, Phenol
=450  \\$wnnna$aPhenol Oxidase
=450  \\$aPhenoloxidase
=450  \\$wnnna$aPhenoloxidase A
=450  \\$wnnna$aPhenoloxidase B
=450  \\$aTyrosinase
=550  \\$wg$aCatechol Oxidase
=667  \\$a/defic: consider also ALBINISM
=680  \\$iAn enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.
=688  \\$a92; was TYROSINASE 1977-91 (see under DIPHENOL OXIDASES 1977-90); TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 & see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1973-91 (see under DIPHENOL OXIDASES 1968-90 (Prov 1973-74)), was see under TYROSINE DECARBOXYLASE 1963-67
=750  \0$aPhenol oxidase$5IEN-M$0(DLC)sh 87008051

=LDR  00974cz  a2200229n  4500
=001  9880364166402441
=005  20141212210507.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014440
=035  \\$aCBA7777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x345.$x566.$x850.$x920
=072  \\$aD12.$x644.$x641.$x850.$x920
=072  \\$aD12.$x644.$x905.$x920
=150  \\$aTyrocidine
=450  \\$wnnna$aBrevicidin
=450  \\$wnnna$aRapicidin
=450  \\$wnnna$aTyrocidines
=550  \\$wg$aTyrothricin
=680  \\$iAn antibiotic mixture produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent (40-60 per cent) of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, that is very toxic parenterally.
=688  \\$a94; was TYROCIDINES 1975-93 (see under TYROTHRICIN 1975-90)
=750  \0$aTyrocidines$5IEN$0(DLC)sh 85139184

=LDR  00965cz  a2200229n  4500
=001  9880364166502441
=005  20141212210507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014439
=035  \\$aCBA7776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x811
=150  \\$aTyramine
=450  \\$wnnna$a4-(2-Aminoethyl)phenol
=450  \\$wnnna$ap-Tyramine
=450  \\$wnnna$apara-Tyramine
=550  \\$wg$aBiogenic Monoamines
=550  \\$wh$aOctopamine
=550  \\$wh$aSynephrine
=667  \\$aa biogenic amine
=680  \\$iAn indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems.
=750  \0$aTyramine$5IEN$0(DLC)sh 87007397

=LDR  01780cz  a2200409n  4500
=001  9880364166602441
=005  20141212210507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014438
=035  \\$aCBA7775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x790.$x805
=150  \\$aTyphus, Epidemic Louse-Borne
=450  \\$wnnna$aBrill Disease
=450  \\$aBrill-Zinsser Disease
=450  \\$wnnna$aBrill Zinsser Disease
=450  \\$aBrill's Disease
=450  \\$wnnna$aBrills Disease
=450  \\$wnnna$aDisease, Brill
=450  \\$wnnna$aDisease, Brill-Zinsser
=450  \\$wnnna$aDisease, Brill's
=450  \\$wnnna$aEpidemic Louse-Borne Typhus
=450  \\$wnnna$aEpidemic Typhus
=450  \\$wnnna$aFever, Jail
=450  \\$wnnna$aFevers, Jail
=450  \\$wnnna$aJail Fever
=450  \\$wnnna$aJail Fevers
=450  \\$wnnna$aLouse-Borne Typhus, Epidemic
=450  \\$aTyphus
=450  \\$wnnna$aTyphus, Epidemic
=450  \\$wnnna$aTyphus, Epidemic Louse Borne
=450  \\$aTyphus Fever$5IEN
=550  \\$wg$aRickettsia Infections
=667  \\$acaused by Rickettsia prowazekii
=680  \\$iThe classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances.
=688  \\$a77; was TYPHUS 1963-76; BRILL'S DISEASE was heading 1975-96 (see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76), was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL'S DISEASE 1992-96
=750  \0$aTyphus fever$5IEN$0(DLC)sh 85139169

=LDR  00979cz  a2200253n  4500
=001  9880364166702441
=005  20141212210506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014437
=035  \\$aCBA7774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x790.$x800
=150  \\$aTyphus, Endemic Flea-Borne
=450  \\$wnnna$aEndemic Flea-Borne Typhus
=450  \\$wnnna$aEndemic Typhus
=450  \\$wnnna$aFlea-Borne Typhus, Endemic
=450  \\$aMurine Typhus
=450  \\$wnnna$aTyphus, Endemic
=450  \\$wnnna$aTyphus, Endemic Flea Borne
=450  \\$aTyphus, Murine
=550  \\$wg$aRickettsia Infections
=680  \\$iAn infectious disease clinically similar to epidemic louse-borne typhus (TYPHUS, EPIDEMIC LOUSE-BORNE), but caused by RICKETTSIA TYPHI, which is transmitted from rat to man by the rat flea, XENOPSYLLA CHEOPIS.
=688  \\$a77; was TYPHUS, MURINE 1963-76
=750  \0$aTyphus, Endemic flea-borne$5IEN$0(DLC)sh 85139168

=LDR  01030cz  a2200277n  4500
=001  9880364166802441
=005  20141212210506.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014436
=035  \\$aCBA7773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x215.$x894.$x135.$x685.$x910
=150  \\$aTyphoid-Paratyphoid Vaccines
=450  \\$aParatyphoid Vaccine
=450  \\$wnnna$aParatyphoid Vaccines
=450  \\$wnnna$aTyphoid Paratyphoid Vaccines
=450  \\$aTyphoid Vaccine
=450  \\$wnnna$aTyphoid Vaccines
=450  \\$wnnna$aVaccine, Paratyphoid
=450  \\$wnnna$aVaccine, Typhoid
=450  \\$wnnna$aVaccines, Paratyphoid
=450  \\$wnnna$aVaccines, Typhoid
=450  \\$wnnna$aVaccines, Typhoid-Paratyphoid
=550  \\$wg$aSalmonella Vaccines
=680  \\$iVaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.
=750  \0$aTyphoid vaccine$5IEN$0(DLC)sh 85139161

=LDR  00902cz  a2200289n  4500
=001  9880364166902441
=005  20141212210505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014435
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x821.$x873
=150  \\$aTyphoid Fever
=450  \\$wnnna$aAbdominal Typhus
=450  \\$aEnteric Fever
=450  \\$wnnna$aEnteric Fevers
=450  \\$wnnna$aFever, Enteric
=450  \\$wnnna$aFever, Typhoid
=450  \\$wnnna$aFevers, Enteric
=450  \\$wnnna$aFevers, Typhoid
=450  \\$wnnna$aTyphoid
=450  \\$wnnna$aTyphoid Fevers
=450  \\$wnnna$aTyphoids
=450  \\$aTyphus, Abdominal
=550  \\$wg$aSalmonella Infections
=680  \\$iAn acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
=688  \\$a2001(1963)
=750  \0$aTyphoid fever$5IEN$0(DLC)sh 85139156

=LDR  01105cz  a2200313n  4500
=001  9880364167002441
=005  20141212210505.0
=008  840406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014434
=035  \\$aCBA7771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x880
=150  \\$aType A Personality
=450  \\$wnnna$aCoronary-Prone Personalities
=450  \\$aCoronary-Prone Personality
=450  \\$wnnna$aCoronary Prone Personality
=450  \\$wnnna$aPersonalities, Coronary-Prone
=450  \\$wnnna$aPersonalities, Type A
=450  \\$wnnna$aPersonality, Coronary-Prone
=450  \\$aPersonality Type A
=450  \\$wnnna$aPersonality, Type A
=450  \\$aType A Behavior$5IEN
=450  \\$wnnna$aType A Personalities
=450  \\$wnnna$aType A, Personality
=550  \\$wg$aPersonality Development
=667  \\$ano qualif
=680  \\$iEstablished behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression.
=688  \\$a85
=750  \0$aType A behavior$5IEN$0(DLC)sh 85139093

=LDR  01002cz  a2200229n  4500
=001  9880364167102441
=005  20141212210505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014433
=035  \\$aCBA7770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x580.$x450.$x873
=150  \\$aTympanoplasty
=450  \\$wnnna$aTympanoplasties
=550  \\$wg$aOtologic Surgical Procedures
=550  \\$aEar, Middle
=550  \\$aMyringoplasty
=550  \\$aTympanic Membrane
=667  \\$asurg reconstruction of hearing mechanism of middle ear; repair of tympanic membrane perforation = MYRINGOPLASTY; do not use /util except by MeSH definition
=680  \\$iSurgical reconstruction of the hearing mechanism of the middle ear, with restoration of the drum membrane to protect the round window from sound pressure, and establishment of ossicular continuity between the tympanic membrane and the oval window. (Dorland, 28th ed.)
=688  \\$a66(64)
=750  \0$aTympanoplasty$5IEN$0(DLC)sh 85139085

=LDR  00944cz  a2200229n  4500
=001  9880364167202441
=005  20141212210504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014432
=035  \\$aCBA7769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x272.$x702
=150  \\$aTympanic Membrane
=450  \\$wnnna$aEardrum
=450  \\$wnnna$aEardrums
=450  \\$wnnna$aMembrane, Tympanic
=450  \\$wnnna$aMembranes, Tympanic
=450  \\$wnnna$aTympanic Membranes
=550  \\$wg$aEar, External
=667  \\$ado not confuse with TYMPANUM; /surg: consider MYRINGOPLASTY & TYMPANOPLASTY
=680  \\$iAn oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity (EAR, MIDDLE). It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.
=750  \0$aTympanic membrane$5IEN$0(DLC)sh 85139082

=LDR  00762cz  a2200253n  4500
=001  9880364167302441
=005  20141212210503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014428
=035  \\$aCBA7765HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x85.$x806
=150  \\$aTwins, Conjoined
=450  \\$wnnna$aConjoined Twin
=450  \\$wnnna$aConjoined Twins
=450  \\$wnnna$aSiamese Twin
=450  \\$aSiamese Twins
=450  \\$wnnna$aTwin, Conjoined
=450  \\$wnnna$aTwin, Siamese
=450  \\$aTwins, Siamese
=550  \\$wg$aAbnormalities, Severe Teratoid
=667  \\$anote category; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=688  \\$a66
=750  \0$aConjoined twins$5IEN-M$0(DLC)sh 85122193

=LDR  00824cz  a2200205n  4500
=001  9880364167402441
=005  20141212210503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014427
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x438.$x873
=150  \\$aTwins
=450  \\$wnnna$aTwin
=550  \\$wg$aMultiple Birth Offspring
=550  \\$wh$aTwins, Dizygotic
=550  \\$wh$aTwins, Monozygotic
=550  \\$aDiseases in Twins
=667  \\$ahuman only: for animals use LITTER SIZE; PREGNANCY, TWIN is also available
=680  \\$iTwo individuals derived from two FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother. Twins are either monozygotic (TWINS, MONOZYGOTIC) or dizygotic (TWINS, DIZYGOTIC).
=750  \0$aTwins$5IEN$0(DLC)sh 85139043

=LDR  00527cz  a2200181n  4500
=001  9880364167502441
=005  20141212210503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014426
=035  \\$aCBA7763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x848
=150  \\$aTurtles
=450  \\$wnnna$aTurtle
=550  \\$wg$aReptiles
=667  \\$asea turtles, fresh water turtles (terrapin), land turtles (tortoise); IM; qualif permitted
=688  \\$a68
=750  \0$aTurtles$5IEN$0(DLC)sh 85138961

=LDR  00844cz  a2200193n  4500
=001  9880364167602441
=005  20141212210503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014425
=035  \\$aCBA7762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x627.$x675.$x800
=072  \\$aD20.$x215.$x721.$x500.$x881
=150  \\$aTurpentine
=550  \\$wg$aOils, Volatile
=550  \\$wg$aResins, Plant
=667  \\$aD25-26 qualif
=680  \\$iThe concrete oleoresin obtained from Pinus palustris Mill. (Pinaceae) and other species of Pinus. It contains a volatile oil, to which its properties are due, and to which form it is generally used. (Dorland, 28th ed) Turpentine is used as a solvent and an experimental irritant in biomedical research. Turpentine toxicity is of medical interest.
=750  \0$aTurpentine$5IEN$0(DLC)sh 85138945

=LDR  02420cz  a2200517n  4500
=001  9880364167702441
=005  20141212210502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014424
=035  \\$aCBA7761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x316.$x309.$x872
=072  \\$aC12.$x706.$x316.$x795.$x750
=072  \\$aC13.$x351.$x875.$x253.$x309.$x872
=072  \\$aC13.$x351.$x875.$x253.$x795.$x750
=072  \\$aC14.$x240.$x400.$x980
=072  \\$aC14.$x280.$x400.$x980
=072  \\$aC16.$x131.$x240.$x400.$x970
=072  \\$aC16.$x131.$x260.$x830.$x835.$x750
=072  \\$aC16.$x131.$x939.$x316.$x309.$x872
=072  \\$aC16.$x131.$x939.$x316.$x795.$x750
=072  \\$aC16.$x320.$x180.$x830.$x835.$x750
=072  \\$aC19.$x391.$x119.$x309.$x872
=072  \\$aC19.$x391.$x119.$x795.$x750
=150  \\$aTurner Syndrome
=450  \\$aBonnevie-Ullrich Syndrome
=450  \\$wnnna$aBonnevie Ullrich Syndrome
=450  \\$aGonadal Dysgenesis, 45,X
=450  \\$aGonadal Dysgenesis, XO
=450  \\$wnnna$aMonosomy X
=450  \\$wnnna$aStatus Bonnevie-Ullrich
=450  \\$wnnna$aStatus Bonnevie Ullrich
=450  \\$wnnna$aSyndrome, Ullrich-Turner
=450  \\$wnnna$aTurner's Syndrome
=450  \\$wnnna$aTurners Syndrome
=450  \\$wnnna$aUllrich-Turner Syndrome
=450  \\$wnnna$aUllrich Turner Syndrome
=450  \\$wnnna$aXO Gonadal Dysgenesis
=550  \\$wg$aGonadal Dysgenesis
=550  \\$wg$aHeart Defects, Congenital
=550  \\$wg$aSex Chromosome Disorders of Sex Development
=550  \\$aNoonan Syndrome
=667  \\$ain females; TURNER SYNDROME, MALE see NOONAN SYNDROME is also available
=680  \\$iA syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant.
=688  \\$a2002(1963); for BONNEVIE-ULLRICH SYNDROME use SEX CHROMOSOME ABNORMALITIES 1963-2001
=750  \0$aTurner's syndrome$5IEN$0(DLC)sh 85138930

=LDR  00787cz  a2200229n  4500
=001  9880364167802441
=005  20141212210501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014422
=035  \\$aCBA7759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x350.$x800
=072  \\$aB1.$x50.$x150.$x900.$x248.$x617.$x800
=150  \\$aTurkeys
=450  \\$wnnna$aMeleagrididae
=450  \\$aMeleagridinae
=550  \\$wg$aGalliformes
=550  \\$wg$aPoultry
=667  \\$adiseases: coord IM with POULTRY DISEASES (IM)
=680  \\$iLarge woodland game BIRDS in the subfamily Meleagridinae, family Phasianidae, order GALLIFORMES. Formerly they were considered a distinct family, Melegrididae.
=688  \\$a1968
=750  \0$aTurkeys$5IEN$0(DLC)sh 85138859

=LDR  01016cz  a2200265n  4500
=001  9880364167902441
=005  20141212210501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014420
=035  \\$aCBA7757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x948
=072  \\$aA4.$x531.$x898
=150  \\$aTurbinates
=450  \\$wnnna$aConchae Nasale
=450  \\$wnnna$aConchae Nasales
=450  \\$aNasal Concha
=450  \\$wnnna$aNasal Conchas
=450  \\$wnnna$aTurbinate
=450  \\$aTurbinate Bones$5IEN
=550  \\$wg$aFacial Bones
=550  \\$wg$aNose
=667  \\$afractures: coordinate TURBINATES /inj (IM) + SKULL FRACTURES (IM)
=680  \\$iThe scroll-like bony plates with curved margins on the lateral wall of the NASAL CAVITY. Turbinates, also called nasal concha, increase the surface area of nasal cavity thus providing a mechanism for rapid warming and humidification of air as it passes to the lung.
=750  \0$aTurbinate bones$5IEN$0(DLC)sh 85138715

=LDR  00612cz  a2200205n  4500
=001  9880364168002441
=005  20141212210500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014419
=035  \\$aCBA7756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x847
=150  \\$aTurbellaria
=450  \\$wnnna$aTurbellarias
=550  \\$wg$aPlatyhelminths
=550  \\$wh$aPlanarians
=667  \\$aa class of platyhelminths not usually parasitic
=680  \\$iA class of free-living freshwater flatworms of North America.
=688  \\$a65
=750  \0$aTurbellaria$5IEN$0(DLC)sh 85138711

=LDR  01345cz  a2200289n  4500
=001  9880364168102441
=005  20141212210500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014418
=035  \\$aCBA7755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x875.$x770
=150  \\$aTupaiidae
=450  \\$aPtilocercus
=450  \\$wnnna$aShrew, Tree
=450  \\$aShrews, Tree
=450  \\$wnnna$aTree Shrew
=450  \\$aTree Shrews
=450  \\$wnnna$aTreeshrew
=450  \\$wnnna$aTreeshrews
=450  \\$aTupaiinae
=550  \\$wg$aScandentia
=550  \\$wh$aTupaia
=667  \\$afamily of tree shrews; do not confuse X ref TREE SHREWS with SHREWS (insectivore); IM; qualif permitted
=680  \\$iThe only family of the order SCANDENTIA, variously included in the order Insectivora or in the order Primates, and often in the order Microscelidea, consisting of five genera. They are TUPAIA, Ananthana (Indian tree shrew), Dendrogale (small smooth-tailed tree shrew), Urogale (Mindanao tree shrew), and Ptilocercus (pen-tailed tree shrew). The tree shrews inhabit the forest areas of eastern Asia from India and southwestern China to Borneo and the Philippines.
=688  \\$a81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74
=750  \0$aTupaiidae$5IEN$0(DLC)sh 85138686

=LDR  00735cz  a2200181n  4500
=001  9880364168202441
=005  20141212210459.0
=008  800509\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014417
=035  \\$aCBA7754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x875.$x770.$x770
=150  \\$aTupaia
=550  \\$wg$aTupaiidae
=667  \\$atree shrew; IM; qualif permitted
=680  \\$iA genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia.
=688  \\$a91(81); was see under TUPAIIDAE 1981-90
=750  \0$aTupaia$5IEN$0(DLC)sh 85138683

=LDR  00855cz  a2200193n  4500
=001  9880364168302441
=005  20141212210459.0
=008  780208\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014415
=035  \\$aCBA7752HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x725
=072  \\$aD13.$x570.$x685.$x725
=150  \\$aTunicamycin
=550  \\$wg$aPyrimidine Nucleosides
=667  \\$aan antibiotic; do not use /biosyn unless by living matter
=680  \\$iAn N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.
=688  \\$a87(79); was see under GLUCOSAMINE 1979-86
=750  \0$aTunicamycin$5IEN$0(DLC)sh 85138639

=LDR  01008cz  a2200217n  4500
=001  9880364168402441
=005  20141212210459.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014414
=035  \\$aCBA7751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x556.$x887
=072  \\$aD1.$x268.$x956.$x882
=072  \\$aD1.$x552.$x544.$x887
=150  \\$aTungsten
=450  \\$aWolfram
=550  \\$wg$aMetals, Heavy
=550  \\$wg$aTransition Elements
=667  \\$aW-184; W-180, 182, 183, 186 = TUNGSTEN (IM) + ISOTOPES (NIM); W-176-179, 181, 185, 187-189 = TUNGSTEN (IM) + RADIOISOTOPES (IM)
=680  \\$iTungsten. A metallic element with the atomic symbol W, atomic number 74, and atomic weight 183.85. It is used in many manufacturing applications, including increasing the hardness, toughness, and tensile strength of steel; manufacture of filaments for incandescent light bulbs; and in contact points for automotive and electrical apparatus.
=750  \0$aTungsten$5IEN-M$0(DLC)sh 85138607

=LDR  00627cz  a2200193n  4500
=001  9880364168502441
=005  20141212210458.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014413
=035  \\$aCBA7750HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x602.$x825
=150  \\$aTuna
=450  \\$wnnna$aTunas
=550  \\$wg$aPerciformes
=667  \\$acanned tuna = TUNA (IM) + FOOD PRESERVATION (IM)
=680  \\$iCommon name for various species of large, vigorous ocean fishes in the family Scombridae.
=688  \\$a91(75); was see under FISHES 1975-90
=750  \0$aTuna$5IEN$0(DLC)sh 85138573

=LDR  03482cz  a2200877n  4500
=001  9880364168602441
=005  20200611123411.0
=008  870327\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014408
=035  \\$aCBA7745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x101.$x140
=150  \\$aBiomarkers, Tumor
=450  \\$wnno$aTumor Markers, Biological
=450  \\$wnnna$aBiochemical Tumor Marker
=450  \\$wnnna$aBiochemical Tumor Markers
=450  \\$wnnna$aBiologic Tumor Marker
=450  \\$wnnna$aBiologic Tumor Markers
=450  \\$wnnna$aBiological Tumor Marker
=450  \\$wnnna$aBiological Tumor Markers
=450  \\$wnnna$aBiomarkers, Cancer
=450  \\$wnnna$aCancer Biomarkers
=450  \\$aCarcinogen Markers
=450  \\$wnnna$aMarker, Biochemical Tumor
=450  \\$wnnna$aMarker, Biologic Tumor
=450  \\$wnnna$aMarker, Biological Tumor
=450  \\$wnnna$aMarker, Neoplasm Metabolite
=450  \\$wnnna$aMarker, Tumor Metabolite
=450  \\$wnnna$aMarkers, Biochemical Tumor
=450  \\$wnnna$aMarkers, Biologic Tumor
=450  \\$wnnna$aMarkers, Biological Tumor
=450  \\$wnnna$aMarkers, Carcinogen
=450  \\$wnnna$aMarkers, Neoplasm Metabolite
=450  \\$aMarkers, Tumor
=450  \\$wnnna$aMarkers, Tumor Metabolite
=450  \\$wnnna$aMetabolite Marker, Neoplasm
=450  \\$wnnna$aMetabolite Marker, Tumor
=450  \\$aMetabolite Markers, Neoplasm
=450  \\$wnnna$aMetabolite Markers, Tumor
=450  \\$wnnna$aNeoplasm Metabolite Marker
=450  \\$wnnna$aNeoplasm Metabolite Markers
=450  \\$wnnna$aTumor Bionarkers
=450  \\$wnnna$aTumor Marker, Biochemical
=450  \\$wnnna$aTumor Marker, Biologic
=450  \\$wnnna$aTumor Marker, Biological
=450  \\$wnnna$aTumor Markers
=450  \\$aTumor Markers, Biochemical
=450  \\$wnnna$aTumor Markers, Biologic
=450  \\$wnnna$aTumor Metabolite Marker
=450  \\$wnnna$aTumor Metabolite Markers
=550  \\$wg$aBiomarkers
=550  \\$wh$aalpha-Fetoproteins
=550  \\$wh$aAntigens, CD30
=550  \\$wh$aAntigens, Tumor-Associated, Carbohydrate
=550  \\$wh$aCarcinoembryonic Antigen
=550  \\$wh$aChorionic Gonadotropin, beta Subunit, Human
=550  \\$wh$aHormones, Ectopic
=550  \\$wh$aKi-67 Antigen
=550  \\$wh$aMammaglobin A
=550  \\$wh$aNephroblastoma Overexpressed Protein
=550  \\$wh$aNeprilysin
=550  \\$wh$aNormetanephrine
=550  \\$wh$aPancreatitis-Associated Proteins
=550  \\$wh$aProliferating Cell Nuclear Antigen
=550  \\$wh$aProstate-Specific Antigen
=550  \\$wh$aReceptor, ErbB-2
=550  \\$wh$aReceptor, ErbB-3
=550  \\$wh$aReceptor, ErbB-4
=550  \\$wh$aSynaptophysin
=550  \\$wh$aTissue Kallikreins
=550  \\$wh$aTissue Polypeptide Antigen
=550  \\$aNeoplasm Proteins
=667  \\$aIM; coord with specific substance (IM) if pertinent; DF: TUMOR MARKERS; Manual 24.4.4.5
=680  \\$iMolecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES, POLYAMINES, and specific CELL MEMBRANE PROTEINS and LIPIDS
=688  \\$a2016(1988)
=750  \0$aTumor markers$5IEN$0(DLC)sh 85138551

=LDR  00991cz  a2200253n  4500
=001  9880364168702441
=005  20141212210454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014406
=035  \\$aCBA7742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x825.$x900
=072  \\$aC1.$x252.$x400.$x939
=150  \\$aTularemia
=450  \\$aFrancisella tularensis Infection
=450  \\$wnnna$aFrancisella tularensis Infections
=450  \\$wnnna$aInfection, Francisella tularensis
=450  \\$wnnna$aInfections, Francisella tularensis
=450  \\$wnnna$aTularemias
=550  \\$wg$aGram-Negative Bacterial Infections
=550  \\$wg$aTick-Borne Diseases
=667  \\$acaused by Francisella tularensis (formerly Pasteurella tularensis)
=680  \\$iA plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness.
=750  \0$aTularemia$5IEN$0(DLC)sh 85138512

=LDR  01539cz  a2200313n  4500
=001  9880364168802441
=005  20141212210454.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014405
=035  \\$aCBA7741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x456.$x840
=072  \\$aD12.$x644.$x541.$x500.$x650.$x750
=072  \\$aD12.$x776.$x124.$x486.$x485.$x397.$x500
=072  \\$aD12.$x776.$x124.$x486.$x485.$x680.$x650.$x750
=072  \\$aD12.$x776.$x124.$x790.$x651.$x397.$x500
=072  \\$aD12.$x776.$x124.$x790.$x651.$x680.$x650.$x750
=072  \\$aD12.$x776.$x377.$x715.$x548.$x397.$x500
=072  \\$aD12.$x776.$x377.$x715.$x548.$x680.$x650.$x750
=150  \\$aTuftsin
=450  \\$wnnna$aL-Thr-L-Lys-L-Pro-L-Arg
=450  \\$wnnna$aL-Threonyl-L-Lysyl-L-Prolyl-L-Arginine
=450  \\$wnnna$aTaftsin
=550  \\$wg$agamma-Globulins
=550  \\$wg$aImmunoglobulin Fab Fragments
=550  \\$wg$aOligopeptides
=680  \\$iN(2)-((1-(N(2)-L-Threonyl)-L-lysyl)-L-prolyl)-L-arginine. A tetrapeptide produced in the spleen by enzymatic cleavage of a leukophilic gamma-globulin. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the gamma-globulin molecule.
=688  \\$a84(75); was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ (with LEUCOKININ a see ref to it) was see under GAMMA GLOBULINS 1975-83; LEUKOKININ & LEUCOKININ were see TUFTSIN 1984-93
=750  \0$aTuftsin$5IEN$0(DLC)sh 85138488

=LDR  00893cz  a2200277n  4500
=001  9880364168902441
=005  20141212210453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014403
=035  \\$aCBA7739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x922
=072  \\$aD2.$x675.$x276.$x922
=072  \\$aD3.$x132.$x98.$x916
=072  \\$aD3.$x438.$x531.$x85.$x944
=072  \\$aD3.$x438.$x531.$x820.$x875
=150  \\$aTubocurarine
=450  \\$wnnna$ad-Tubocurare
=450  \\$wnnna$ad-Tubocurarine
=450  \\$wnnna$aTubocurare
=450  \\$wnnna$aTubocurarine Chloride
=550  \\$wg$aBenzylisoquinolines
=550  \\$wg$aQuaternary Ammonium Compounds
=550  \\$wg$aTetrahydroisoquinolines
=680  \\$iA neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.
=750  \0$aTubocurarine$5IEN$0(DLC)sh 85138466

=LDR  02694cz  a2200649n  4500
=001  9880364169002441
=005  20141212192615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014402
=035  \\$aCBA7738HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x445.$x810
=072  \\$aC4.$x651.$x800
=072  \\$aC4.$x700.$x632
=072  \\$aC10.$x500.$x507.$x400.$x750
=072  \\$aC10.$x562.$x850
=072  \\$aC10.$x574.$x500.$x865
=072  \\$aC16.$x131.$x666.$x507.$x400.$x750
=072  \\$aC16.$x320.$x400.$x880
=072  \\$aC16.$x320.$x700.$x636
=150  \\$aTuberous Sclerosis
=450  \\$wnnna$aAdenoma Sebaceum
=450  \\$aBourneville Disease
=450  \\$wnnna$aBourneville Phacomatosis
=450  \\$wnnna$aBourneville Phakomatosis
=450  \\$wnnna$aBourneville-Pringle Disease
=450  \\$wnnna$aBourneville Pringle Disease
=450  \\$wnnna$aBourneville-Pringle's Disease
=450  \\$wnnna$aBourneville Pringle's Disease
=450  \\$wnnna$aBourneville-Pringles Disease
=450  \\$wnnna$aBourneville Syndrome
=450  \\$wnnna$aBourneville's Disease
=450  \\$wnnna$aBourneville's Syndrome
=450  \\$wnnna$aCerebral Scleroses
=450  \\$wnnna$aCerebral Sclerosis
=450  \\$wnnna$aDisease, Bourneville-Pringle
=450  \\$wnnna$aDisease, Bourneville-Pringle's
=450  \\$aEpiloia
=450  \\$wnnna$aPhacomatosis, Bourneville
=450  \\$aPhakomatosis, Bourneville
=450  \\$wnnna$aSclerosis, Cerebral
=450  \\$wnnna$aSclerosis Tuberosa
=450  \\$wnnna$aSclerosis, Tuberose
=450  \\$wnnna$aSclerosis, Tuberous
=450  \\$wnnna$aSyndrome, Bourneville
=450  \\$wnnna$aSyndrome, Bourneville's
=450  \\$wnnna$aTuberose Sclerosis
=450  \\$wnnna$aTuberous Sclerosis Complex
=550  \\$wg$aHamartoma
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$wg$aMalformations of Cortical Development, Group I
=550  \\$wg$aNeoplasms, Multiple Primary
=550  \\$wg$aNeoplastic Syndromes, Hereditary
=550  \\$wg$aNeurocutaneous Syndromes
=550  \\$aFibroma
=680  \\$iAutosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
=750  \0$aTuberous sclerosis$0(DLC) sh 85138450$5IEN

=LDR  01090cz  a2200289n  4500
=001  9880364169102441
=005  20141212210453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014401
=035  \\$aCBA7737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x944
=072  \\$aC12.$x672
=072  \\$aC13.$x351.$x750
=150  \\$aTuberculosis, Urogenital
=450  \\$wnnna$aTuberculoses, Urogenital
=450  \\$wnnna$aUrogenital Tuberculoses
=450  \\$wnnna$aUrogenital Tuberculosis
=550  \\$wg$aFemale Urogenital Diseases
=550  \\$wg$aMale Urogenital Diseases
=550  \\$wg$aTuberculosis
=550  \\$wh$aTuberculosis, Female Genital
=550  \\$wh$aTuberculosis, Male Genital
=550  \\$wh$aTuberculosis, Renal
=667  \\$ageneral; prefer TUBERCULOSIS, FEMALE GENITAL; TUBERCULOSIS, MALE GENITAL; or TUBERCULOSIS, RENAL
=680  \\$iA general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female.
=750  \0$aGenitourinary organs$xTuberculosis$5IEN$0(DLC)sh 85053906

=LDR  01172cz  a2200325n  4500
=001  9880364169202441
=005  20141212210452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014399
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x831.$x722
=072  \\$aC1.$x539.$x160.$x886.$x722
=072  \\$aC5.$x116.$x165.$x886.$x722
=072  \\$aC5.$x116.$x900.$x853.$x850
=150  \\$aTuberculosis, Spinal
=450  \\$wnnna$aDisease, Pott
=450  \\$wnnna$aDisease, Pott's
=450  \\$aPott Disease
=450  \\$aPott's Disease
=450  \\$wnnna$aPotts Disease
=450  \\$wnnna$aPott's Paraplegia
=450  \\$wnnna$aSpinal Tuberculoses
=450  \\$wnnna$aSpinal Tuberculosis
=450  \\$wnnna$aTuberculoses, Spinal
=550  \\$wg$aSpondylitis
=550  \\$wg$aTuberculosis, Osteoarticular
=550  \\$aPott Puffy Tumor
=667  \\$acoordinate IM with specific vertebra (IM); do not confuse entry term POTT DISEASE with POTT-PUFFY TUMOR
=680  \\$iOsteitis or caries of the vertebrae, usually occurring as a complication of tuberculosis of the lungs.
=750  \0$aSpine$xTuberculosis$5IEN$0(DLC)sh 85126704

=LDR  00808cz  a2200253n  4500
=001  9880364169302441
=005  20141212210452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014398
=035  \\$aCBA7734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x944.$x847
=072  \\$aC12.$x672.$x847
=072  \\$aC12.$x777.$x419.$x912
=072  \\$aC13.$x351.$x750.$x970
=072  \\$aC13.$x351.$x968.$x419.$x912
=150  \\$aTuberculosis, Renal
=450  \\$wnnna$aRenal Tuberculoses
=450  \\$wnnna$aRenal Tuberculosis
=450  \\$wnnna$aTuberculoses, Renal
=550  \\$wg$aKidney Diseases
=550  \\$wg$aTuberculosis, Urogenital
=680  \\$iInfection of the KIDNEY with species of MYCOBACTERIUM.
=750  \0$aKidneys$xTuberculosis$5IEN$0(DLC)sh 85072274

=LDR  01003cz  a2200301n  4500
=001  9880364169402441
=005  20141212210451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014396
=035  \\$aCBA7732HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x877
=072  \\$aC8.$x528.$x928
=072  \\$aC8.$x730.$x912
=150  \\$aTuberculosis, Pleural
=450  \\$wnnna$aPleural Tuberculoses
=450  \\$wnnna$aPleural Tuberculosis
=450  \\$wnnna$aPleurisies, Tuberculous
=450  \\$aPleurisy, Tuberculous
=450  \\$wnnna$aTuberculoses, Pleural
=450  \\$wnnna$aTuberculous Pleurisies
=450  \\$wnnna$aTuberculous Pleurisy
=550  \\$wg$aPleural Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wg$aTuberculosis
=550  \\$wh$aEmpyema, Tuberculous
=680  \\$iTuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs.
=750  \0$aPleura$xTuberculosis$5IEN$0(DLC)sh 85103498

=LDR  01245cz  a2200349n  4500
=001  9880364169502441
=005  20141212210450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014394
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x831
=072  \\$aC1.$x539.$x160.$x886
=072  \\$aC5.$x116.$x165.$x886
=150  \\$aTuberculosis, Osteoarticular
=450  \\$wnnna$aBone Tuberculoses
=450  \\$aBone Tuberculosis
=450  \\$wnnna$aJoint Tuberculoses
=450  \\$aJoint Tuberculosis
=450  \\$wnnna$aOsteoarticular Tuberculoses
=450  \\$wnnna$aOsteoarticular Tuberculosis
=450  \\$wnnna$aTuberculoses, Bone
=450  \\$wnnna$aTuberculoses, Joint
=450  \\$wnnna$aTuberculoses, Osteoarticular
=450  \\$wnnna$aTuberculosis, Bone
=450  \\$wnnna$aTuberculosis, Joint
=550  \\$wg$aBone Diseases, Infectious
=550  \\$wg$aTuberculosis
=550  \\$wh$aTuberculosis, Spinal
=667  \\$aIM; may be osteo- or artic; coord IM with specific bone or joint (IM) or bone or joint dis (IM)
=680  \\$iTuberculosis of the bones or joints.
=750  \0$aBones$xTuberculosis$5IEN-M$0(DLC)sh 85015552
=750  \0$aJoints$xTuberculosis$5IEN-HS$0(DLC)sh 85070667

=LDR  00905cz  a2200241n  4500
=001  9880364169602441
=005  20141212210450.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014393
=035  \\$aCBA7729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x809
=072  \\$aC7.$x465.$x943
=150  \\$aTuberculosis, Oral
=450  \\$wnnna$aOral Tuberculoses
=450  \\$wnnna$aOral Tuberculosis
=450  \\$wnnna$aTuberculoses, Oral
=550  \\$wg$aMouth Diseases
=550  \\$wg$aTuberculosis
=667  \\$a"tuberc of the mouth, tongue & salivary glands"; IM; coord IM with specific mouth, tongue or salivary gland heading (IM) or mouth, tongue or salivary dis heading (IM)
=680  \\$iTuberculosis of the mouth, tongue, and salivary glands.
=688  \\$a91(72); was see under TUBERCULOSIS 1972-90
=750  \0$aMouth$xTuberculosis$5IEN$0(DLC)sh 85088003

=LDR  02514cz  a2200493n  4500
=001  9880364169702441
=005  20141212210449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014390
=035  \\$aCBA7726HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x500.$x800
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x570.$x600
=072  \\$aC10.$x228.$x228.$x180.$x500.$x937
=072  \\$aC10.$x228.$x228.$x180.$x850.$x800
=072  \\$aC10.$x228.$x228.$x507.$x280.$x915
=150  \\$aTuberculosis, Meningeal
=450  \\$wnnna$aHypertrophic Pachymeningitides, Tuberculous
=450  \\$wnnna$aHypertrophic Pachymeningitis, Tuberculous
=450  \\$wnnna$aMeningeal Tuberculoses
=450  \\$wnnna$aMeningeal Tuberculosis
=450  \\$wnnna$aMeningitides, Tubercular
=450  \\$wnnna$aMeningitides, Tuberculosis
=450  \\$wnnna$aMeningitides, Tuberculous
=450  \\$wnnna$aMeningitis, Tubercular
=450  \\$wnnna$aMeningitis, Tuberculosis
=450  \\$aMeningitis, Tuberculous
=450  \\$wnnna$aPachymeningitides, Tuberculous Hypertrophic
=450  \\$wnnna$aPachymeningitis, Tuberculous Hypertrophic
=450  \\$wnnna$aTB Meningitides
=450  \\$wnnna$aTB Meningitis
=450  \\$wnnna$aTubercular Meningitides
=450  \\$wnnna$aTubercular Meningitis
=450  \\$wnnna$aTuberculoses, Meningeal
=450  \\$wnnna$aTuberculosis Meningitides
=450  \\$wnnna$aTuberculosis Meningitis
=450  \\$wnnna$aTuberculous Hypertrophic Pachymeningitides
=450  \\$wnnna$aTuberculous Hypertrophic Pachymeningitis
=450  \\$wnnna$aTuberculous Meningitides
=450  \\$wnnna$aTuberculous Meningitis
=550  \\$wg$aMeningitis, Bacterial
=550  \\$wg$aTuberculosis, Central Nervous System
=680  \\$iA form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9)
=750  \0$aMeninges$xTuberculosis$5IEN$0(DLC)sh 85083560

=LDR  00952cz  a2200265n  4500
=001  9880364169802441
=005  20141212210448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014389
=035  \\$aCBA7725HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x944.$x721
=072  \\$aC12.$x294.$x909
=072  \\$aC12.$x672.$x721
=150  \\$aTuberculosis, Male Genital
=450  \\$wnnna$aGenital Tuberculoses, Male
=450  \\$wnnna$aGenital Tuberculosis, Male
=450  \\$wnnna$aMale Genital Tuberculoses
=450  \\$aMale Genital Tuberculosis
=450  \\$wnnna$aTuberculoses, Male Genital
=550  \\$wg$aGenital Diseases, Male
=550  \\$wg$aTuberculosis, Urogenital
=667  \\$acoordinate IM with specific organ or organ /dis (IM)
=680  \\$iMYCOBACTERIUM infections of the male reproductive tract (GENITALIA, MALE).
=750  \0$aGenerative organs, Male$xTuberculosis$5IEN$0(DLC)sh 85053845

=LDR  01429cz  a2200385n  4500
=001  9880364169902441
=005  20141212210448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014388
=035  \\$aCBA7724HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x719
=072  \\$aC15.$x604.$x315.$x809
=072  \\$aC15.$x604.$x921
=150  \\$aTuberculosis, Lymph Node
=450  \\$wnnna$aCervical Lymphadenitis, Mycobacterial
=450  \\$aCervical Tuberculous Lymphadenitis
=450  \\$wnnna$aLymph Node Tuberculoses
=450  \\$wnnna$aLymph Node Tuberculosis
=450  \\$wnnna$aLymphadenitis, Cervical Tuberculous
=450  \\$wnnna$aLymphadenitis, Mycobacterial Cervical
=450  \\$aLymphadenitis, Tuberculous
=450  \\$aMycobacterial Cervical Lymphadenitis
=450  \\$aScrofula
=450  \\$wnnna$aScrofulas
=450  \\$wnnna$aTuberculoses, Lymph Node
=450  \\$wnnna$aTuberculous Lymphadenitis
=450  \\$wnnna$aTuberculous Lymphadenitis, Cervical
=550  \\$wg$aLymphadenitis
=550  \\$wg$aLymphatic Diseases
=550  \\$wg$aTuberculosis
=550  \\$wh$aKing's Evil
=667  \\$aX ref SCROFULA in hist articles = KING'S EVIL: see MeSH definition there
=680  \\$iInfection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.
=750  \0$aLymphatics$xTuberculosis$5IEN$0(DLC)sh 85079139

=LDR  00972cz  a2200289n  4500
=001  9880364170002441
=005  20141212210448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014387
=035  \\$aCBA7723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x696
=072  \\$aC8.$x360.$x860
=072  \\$aC8.$x730.$x860
=072  \\$aC9.$x400.$x860
=150  \\$aTuberculosis, Laryngeal
=450  \\$wnnna$aLaryngeal Tuberculoses
=450  \\$wnnna$aLaryngeal Tuberculosis
=450  \\$wnnna$aLarynx Tuberculoses
=450  \\$wnnna$aLarynx Tuberculosis
=450  \\$wnnna$aTuberculoses, Laryngeal
=450  \\$wnnna$aTuberculosis of Larynx
=550  \\$wg$aLaryngeal Diseases
=550  \\$wg$aRespiratory Tract Infections
=550  \\$wg$aTuberculosis
=680  \\$iTuberculosis involving the larynx, producing ulceration of the VOCAL CORDS and the LARYNGEAL MUCOSA.
=750  \0$aThroat$xTuberculosis$5IEN$0(DLC)sh 85135064

=LDR  00890cz  a2200205n  4500
=001  9880364170102441
=005  20141212210447.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014385
=035  \\$aCBA7721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x628
=072  \\$aC6.$x405.$x874
=150  \\$aTuberculosis, Gastrointestinal
=450  \\$wnnna$aGastrointestinal Tuberculosis
=550  \\$wg$aGastrointestinal Diseases
=550  \\$wg$aTuberculosis
=667  \\$acoord IM with specific organ or organ /dis (IM)
=680  \\$iTUBERCULOSIS that involves any region of the GASTROINTESTINAL TRACT, mostly in the distal ILEUM and the CECUM. In most cases, MYCOBACTERIUM TUBERCULOSIS is the pathogen. Clinical features include ABDOMINAL PAIN; FEVER; and palpable mass in the ileocecal area.
=750  \0$aIntestines$xTuberculosis$5IEN$0(DLC)sh 85067601

=LDR  01177cz  a2200361n  4500
=001  9880364170202441
=005  20141212210446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014382
=035  \\$aCBA7718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x583
=072  \\$aC1.$x252.$x825.$x820
=072  \\$aC1.$x539.$x800.$x720.$x820
=072  \\$aC17.$x800.$x838.$x765.$x820
=150  \\$aTuberculosis, Cutaneous
=450  \\$wnnna$aCutaneous Tuberculoses
=450  \\$wnnna$aCutaneous Tuberculosis
=450  \\$aScrofuloderma
=450  \\$wnnna$aScrofulodermas
=450  \\$wnnna$aSkin Tuberculoses
=450  \\$aSkin Tuberculosis
=450  \\$aTuberculid
=450  \\$wnnna$aTuberculids
=450  \\$wnnna$aTuberculoses, Cutaneous
=450  \\$wnnna$aTuberculoses, Skin
=450  \\$wnnna$aTuberculosis, Skin
=550  \\$wg$aSkin Diseases, Bacterial
=550  \\$wg$aTuberculosis
=550  \\$wh$aErythema Induratum
=550  \\$wh$aLupus Vulgaris
=680  \\$iTuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.
=750  \0$aSkin$xTuberculosis$5IEN$0(DLC)sh 85123186

=LDR  01051cz  a2200253n  4500
=001  9880364170302441
=005  20141212210446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014381
=035  \\$aCBA7717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x561
=072  \\$aC1.$x539.$x190.$x750
=072  \\$aC14.$x260.$x750
=150  \\$aTuberculosis, Cardiovascular
=450  \\$wnnna$aCardiovascular Tuberculoses
=450  \\$aCardiovascular Tuberculosis
=450  \\$wnnna$aTuberculoses, Cardiovascular
=550  \\$wg$aCardiovascular Infections
=550  \\$wg$aTuberculosis
=550  \\$wh$aPericarditis, Tuberculous
=667  \\$acoordinate IM with specific cardiovascular term (IM) or specific cardiovascular disease (IM)
=680  \\$iPathological conditions of the CARDIOVASCULAR SYSTEM caused by infection of MYCOBACTERIUM TUBERCULOSIS. Tuberculosis involvement may include the HEART; the BLOOD VESSELS; or the PERICARDIUM.
=750  \0$aCardiovascular system$xTuberculosis$5IEN$0(DLC)sh 85020240

=LDR  00818cz  a2200229n  4500
=001  9880364170402441
=005  20141212210446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014380
=035  \\$aCBA7716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846.$x538
=072  \\$aC22.$x196.$x927
=150  \\$aTuberculosis, Bovine
=450  \\$wnnna$aBovine Tuberculoses
=450  \\$wnnna$aBovine Tuberculosis
=450  \\$wnnna$aTuberculoses, Bovine
=550  \\$wg$aCattle Diseases
=550  \\$wg$aTuberculosis
=667  \\$acaused by Mycobacterium bovis; don't forget also CATTLE (NIM) & check tag ANIMALS
=680  \\$iAn infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals.
=750  \0$aTuberculosis in cattle$5IEN$0(DLC)sh 85138439

=LDR  02183cz  a2200553n  4500
=001  9880364170502441
=005  20141212210445.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014376
=035  \\$aCBA7712HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x40.$x552.$x846
=150  \\$aTuberculosis
=450  \\$wnnna$aDisease, Koch's
=450  \\$wnnna$aDisease, Kochs
=450  \\$wnnna$aKoch Disease
=450  \\$wnnna$aKoch's Disease
=450  \\$wnnna$aKochs Disease
=450  \\$wnnna$aTuberculoses
=550  \\$wg$aMycobacterium Infections
=550  \\$wh$aLatent Tuberculosis
=550  \\$wh$aPeritonitis, Tuberculous
=550  \\$wh$aTuberculoma
=550  \\$wh$aTuberculosis, Avian
=550  \\$wh$aTuberculosis, Bovine
=550  \\$wh$aTuberculosis, Cardiovascular
=550  \\$wh$aTuberculosis, Central Nervous System
=550  \\$wh$aTuberculosis, Cutaneous
=550  \\$wh$aTuberculosis, Endocrine
=550  \\$wh$aTuberculosis, Gastrointestinal
=550  \\$wh$aTuberculosis, Hepatic
=550  \\$wh$aTuberculosis, Laryngeal
=550  \\$wh$aTuberculosis, Lymph Node
=550  \\$wh$aTuberculosis, Miliary
=550  \\$wh$aTuberculosis, Multidrug-Resistant
=550  \\$wh$aTuberculosis, Ocular
=550  \\$wh$aTuberculosis, Oral
=550  \\$wh$aTuberculosis, Osteoarticular
=550  \\$wh$aTuberculosis, Pleural
=550  \\$wh$aTuberculosis, Pulmonary
=550  \\$wh$aTuberculosis, Splenic
=550  \\$wh$aTuberculosis, Urogenital
=550  \\$aAntitubercular Agents
=550  \\$aInterferon-gamma Release Tests
=550  \\$aTuberculin Test
=667  \\$acaused by various species of Mycobacterium; GEN: prefer specifics; if unspecified as just "tuberculosis", TUBERCULOSIS, PULMONARY is probably the correct heading but check text carefully; tuberculid: index under TUBERCULOSIS, CUTANEOUS; /drug ther: consider also ANTITUBERCULAR AGENTS; indexing policy: Manual 23.13.2
=680  \\$iAny of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.
=688  \\$aTUBERCULOSIS IMMUNITY was heading 1963-66
=750  \0$aTuberculosis$5IEN$0(DLC)sh 85138408

=LDR  00968cz  a2200253n  4500
=001  9880364170602441
=005  20141212210444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014374
=035  \\$aCBA7710HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x225.$x812.$x871.$x800
=072  \\$aE5.$x200.$x812.$x871.$x800
=072  \\$aE5.$x478.$x594.$x890.$x800
=150  \\$aTuberculin Test
=450  \\$wnnna$aTest, Tuberculin
=450  \\$wnnna$aTests, Tuberculin
=450  \\$wnnna$aTuberculin Tests
=550  \\$wg$aSkin Tests
=550  \\$aInterferon-gamma Release Tests
=550  \\$aTuberculosis
=680  \\$iOne of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection.
=688  \\$a66; was TUBERCULIN REACTION 1963-65
=750  \0$aTuberculin test$5IEN$0(DLC)sh 85138407

=LDR  01007cz  a2200301n  4500
=001  9880364170702441
=005  20141212210444.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014373
=035  \\$aCBA7709HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x161.$x845
=150  \\$aTuberculin
=450  \\$wnnna$aPPD
=450  \\$wnnna$aPPD-B
=450  \\$wnnna$aPPD B
=450  \\$wnnna$aPPD-CG
=450  \\$wnnna$aPPD CG
=450  \\$wnnna$aPPD-F
=450  \\$wnnna$aPPD F
=450  \\$wnnna$aPPD-L
=450  \\$wnnna$aPPD L
=450  \\$wnnna$aPPD-S
=450  \\$wnnna$aPurified Protein Derivative of Tuberculin
=550  \\$wg$aAntigens, Bacterial
=667  \\$a/diag use = probably TUBERCULIN TEST
=680  \\$iA protein extracted from boiled culture of tubercle bacilli (MYCOBACTERIUM TUBERCULOSIS). It is used in the tuberculin skin test (TUBERCULIN TEST) for the diagnosis of tuberculosis infection in asymptomatic persons.
=750  \0$aTuberculin$5IEN$0(DLC)sh 85138406

=LDR  00854cz  a2200229n  4500
=001  9880364170802441
=005  20141212210443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014370
=035  \\$aCBA7706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x289.$x400.$x700
=150  \\$aTsetse Flies
=450  \\$wnnna$aFlies, Tsetse
=450  \\$wnnna$aFly, Tsetse
=450  \\$aGlossina
=450  \\$wnnna$aGlossinas
=450  \\$wnnna$aTsetse Fly
=550  \\$wg$aGlossinidae
=667  \\$avectors of various species of Trypanosoma; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iBloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes.
=750  \0$aTsetse-flies$5IEN$0(DLC)sh 85138319

=LDR  01000cz  a2200229n  4500
=001  9880364170902441
=005  20141212210433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014337
=035  \\$aCBA7673HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x817.$x750.$x825
=150  \\$aTrout
=450  \\$wnnna$aChar
=450  \\$aChars
=450  \\$aSalvelinus
=550  \\$wg$aSalmonidae
=550  \\$wh$aOncorhynchus
=667  \\$agenera Oncorhynchus and Salmo may be either salmon or trout; check text
=680  \\$iVarious fish of the family SALMONIDAE, usually smaller than salmon. They are mostly restricted to cool clear freshwater. Some are anadromous. They are highly regarded for their handsome colors, rich well-flavored flesh, and gameness as an angling fish. The genera Salvelinus, Salmo, and ONCORHYNCHUS have been introduced virtually throughout the world.
=688  \\$a1991(1975); use SALMONIDAE 1968-1974
=750  \0$aTrout$5IEN$0(DLC)sh 85138085

=LDR  01045cz  a2200277n  4500
=001  9880364171002441
=005  20141212210442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014366
=035  \\$aCBA7702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x690.$x416.$x722
=150  \\$aTryptophan Oxygenase
=450  \\$wnnna$a2,3-Dioxygenase, Tryptophan
=450  \\$wnnna$aDioxygenase, TDO
=450  \\$wnnna$aOxygenase, Tryptophan
=450  \\$wnnna$aPyrrolase, Tryptophan
=450  \\$wnnna$aTDO Dioxygenase
=450  \\$wnnna$aTryptophan 2,3-Dioxygenase
=450  \\$wnnna$aTryptophan 2,3 Dioxygenase
=450  \\$aTryptophan Pyrrolase
=550  \\$wg$aDioxygenases
=550  \\$aTryptophan Hydroxylase
=680  \\$iA dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.
=688  \\$a68(65)
=750  \0$aTryptophan oxygenase$0(DLC) sh 89006937$5IEN

=LDR  01223cz  a2200361n  4500
=001  9880364171102441
=005  20141212210432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014335
=035  \\$aCBA7671M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x730.$x800
=072  \\$aD12.$x776.$x210.$x500.$x895
=072  \\$aD12.$x776.$x220.$x525.$x800
=150  \\$aTropomyosin
=450  \\$wnnna$aalpha-Tropomyosin
=450  \\$wnnna$aalpha Tropomyosin
=450  \\$wnnna$abeta-Tropomyosin
=450  \\$wnnna$abeta Tropomyosin
=450  \\$wnnna$agamma-Tropomyosin
=450  \\$wnnna$agamma Tropomyosin
=450  \\$wnnna$aMg, Tropomyosin
=450  \\$wnnna$aMiniparamyosin
=450  \\$aParamyosin
=450  \\$wnnna$aParatropomyosin
=450  \\$wnnna$aTropomyosin Mg
=550  \\$wg$aMicrofilament Proteins
=550  \\$wg$aMuscle Proteins
=550  \\$aCardiomyopathy, Hypertrophic, Familial
=667  \\$aa muscle protein; /biosyn /physiol permitted
=680  \\$iA protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by TROPONIN.
=688  \\$a74(71)
=750  \0$aTropomyosins$5IEN-M$0(DLC)sh 99000479

=LDR  00670cz  a2200181n  4500
=001  9880364171202441
=005  20141212210430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014330
=035  \\$aCBA7666HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x879
=150  \\$aTropical Medicine
=450  \\$wnnna$aMedicine, Tropical
=550  \\$wg$aMedicine
=667  \\$ause for the specialty only; "tropical diseases" when very general but avoid: prefer specific diseases
=680  \\$iThe branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions.
=750  \0$aTropical medicine$5IEN$0(DLC)sh 85138061

=LDR  01944cz  a2200517n  4500
=001  9880364171302441
=005  20141212210441.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014364
=035  \\$aCBA7700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x50.$x850
=072  \\$aD12.$x125.$x142.$x875
=150  \\$aTryptophan
=450  \\$wnnna$aArdeydorm
=450  \\$wnnna$aArdeypharm Brand of Tryptophan
=450  \\$wnnna$aArdeytropin
=450  \\$wnnna$aesparma Brand of Tryptophan
=450  \\$wnnna$aICN Brand of Tryptophan
=450  \\$wnnna$aKalma Brand of Tryptophan
=450  \\$wnnna$aL-Tryptophan
=450  \\$wnnna$aL Tryptophan
=450  \\$wnnna$aL-Tryptophan-ratiopharm
=450  \\$wnnna$aL Tryptophan ratiopharm
=450  \\$wnnna$aLevotryptophan
=450  \\$wnnna$aLyphan
=450  \\$wnnna$aMerck Brand of Tryptophan
=450  \\$wnnna$aNaturruhe
=450  \\$wnnna$aNiddapharm Brand of Tryptophan
=450  \\$wnnna$aOptimax
=450  \\$wnnna$aPharmascience Brand of Tryptophan
=450  \\$wnnna$aPMS-Tryptophan
=450  \\$wnnna$aPMS Tryptophan
=450  \\$wnnna$aratio-Tryptophan
=450  \\$wnnna$aratio Tryptophan
=450  \\$wnnna$aRatiopharm Brand of Tryptophan
=450  \\$wnnna$aTrofan
=450  \\$wnnna$aTryptacin
=450  \\$wnnna$aTryptan
=450  \\$wnnna$aTryptophan Metabolism Alterations
=450  \\$wnnna$aUpsher-Smith Brand of Tryptophan
=550  \\$wg$aAmino Acids, Aromatic
=550  \\$wg$aAmino Acids, Essential
=550  \\$wh$a5-Hydroxytryptophan
=680  \\$iAn essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals.
=750  \0$aTryptophan$0(DLC) sh 86000850$5IEN

=LDR  00806cz  a2200289n  4500
=001  9880364171402441
=005  20180119092250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014363
=035  \\$aCBA7699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x211.$x215.$x801
=072  \\$aD3.$x438.$x473.$x914
=150  \\$aTryptamines
=450  \\$aIndolylethylamines
=450  \\$wnnna$aTriptans
=550  \\$wg$aBiogenic Monoamines
=550  \\$wg$aIndoles
=550  \\$wh$aDihydroxytryptamines
=550  \\$wh$aMelatonin
=550  \\$wh$aN,N-Dimethyltryptamine
=550  \\$wh$aPsilocybin
=550  \\$wh$aSerotonin
=550  \\$wh$aSumatriptan
=680  \\$iDecarboxylated monoamine derivatives of TRYPTOPHAN.
=688  \\$a66(64)
=750  \0$aTryptamine$5IEN$0(DLC)sh 85138304

=LDR  02331cz  a2200517n  4500
=001  9880364171502441
=005  20141212210430.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014328
=035  \\$aCBA7664HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x955
=072  \\$aC4.$x850.$x908
=072  \\$aC13.$x703.$x720.$x949
=150  \\$aTrophoblastic Neoplasms
=450  \\$wnnna$aCancer, Trophoblast
=450  \\$wnnna$aCancer, Trophoblastic
=450  \\$wnnna$aCancers, Trophoblast
=450  \\$wnnna$aCancers, Trophoblastic
=450  \\$wnnna$aNeoplasm, Trophoblast
=450  \\$wnnna$aNeoplasm, Trophoblastic
=450  \\$wnnna$aNeoplasms, Trophoblast
=450  \\$wnnna$aNeoplasms, Trophoblastic
=450  \\$wnnna$aTrophoblast Cancer
=450  \\$wnnna$aTrophoblast Cancers
=450  \\$wnnna$aTrophoblast Neoplasm
=450  \\$wnnna$aTrophoblast Neoplasms
=450  \\$wnnna$aTrophoblast Tumor
=450  \\$wnnna$aTrophoblast Tumors
=450  \\$aTrophoblastic Cancer
=450  \\$wnnna$aTrophoblastic Cancers
=450  \\$wnnna$aTrophoblastic Neoplasm
=450  \\$aTrophoblastic Tumor
=450  \\$wnnna$aTrophoblastic Tumors
=450  \\$wnnna$aTumor, Trophoblast
=450  \\$wnnna$aTumor, Trophoblastic
=450  \\$wnnna$aTumors, Trophoblast
=450  \\$wnnna$aTumors, Trophoblastic
=550  \\$wg$aNeoplasms, Germ Cell and Embryonal
=550  \\$wg$aPregnancy Complications, Neoplastic
=550  \\$wh$aChoriocarcinoma
=550  \\$wh$aGestational Trophoblastic Disease
=667  \\$a= "trophoblastic disease"; coord IM with UTERINE NEOPLASMS (IM); check the tags FEMALE & PREGNANCY if needed
=680  \\$iTrophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691)
=688  \\$a94; was TROPHOBLASTIC TUMOR 1963-93
=750  \0$aTrophoblastic tumors$5IEN$0(DLC)sh 85138049

=LDR  00764cz  a2200205n  4500
=001  9880364171602441
=005  20141212210440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014362
=035  \\$aCBA7698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x622.$x885
=150  \\$aTrypsinogen
=450  \\$wnnna$a1, Trypsinogen
=450  \\$wnnna$aTrypsinogen 1
=550  \\$wg$aEnzyme Precursors
=550  \\$aPancreatic Juice
=667  \\$aan enzyme precursor; /defic: consider also MALABSORPTION SYNDROMES (IM) + AMINO ACID METABOLISM, INBORN ERRORS (IM)
=680  \\$iThe inactive proenzyme of trypsin secreted by the pancreas, activated in the duodenum via cleavage by enteropeptidase. (Stedman, 25th ed)
=750  \0$aTrypsinogen$5IEN$0(DLC)sh 85138303

=LDR  01036cz  a2200277n  4500
=001  9880364171702441
=005  20141212210429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014327
=035  \\$aCBA7663HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x382.$x992
=072  \\$aA16.$x254.$x500.$x766
=072  \\$aA16.$x710.$x802
=150  \\$aTrophoblasts
=450  \\$wnnna$aCytotrophoblast
=450  \\$aCytotrophoblasts
=450  \\$wnnna$aSyncytiotrophoblast
=450  \\$aSyncytiotrophoblasts
=450  \\$wnnna$aTrophoblast
=550  \\$wg$aBlastocyst
=550  \\$wg$aEndocrine Cells
=550  \\$wg$aPlacenta
=680  \\$iCells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface (PLACENTA).
=688  \\$a68(64)
=750  \0$aTrophoblast$5IEN$0(DLC)sh 85138048

=LDR  00788cz  a2200205n  4500
=001  9880364171802441
=005  20141212210440.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014361
=035  \\$aCBA7697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x800.$x900
=150  \\$aTrypsin Inhibitors
=450  \\$wnnna$aInhibitors, Trypsin
=450  \\$aTrypsin$xantagonists & inhibitors
=550  \\$wg$aSerine Proteinase Inhibitors
=667  \\$aGEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; ALPHA 1-ANTITRYPSIN is available; DF: TRYPSIN INHIB
=680  \\$iSerine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds.
=688  \\$a65
=750  \0$aTrypsin inhibitors$5IEN$0(DLC)sh 85138302

=LDR  00973cz  a2200313n  4500
=001  9880364171902441
=005  20141212210429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014326
=035  \\$aCBA7662HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x145.$x74.$x722
=072  \\$aD3.$x132.$x889
=072  \\$aD3.$x605.$x869
=072  \\$aD4.$x75.$x80.$x875.$x99.$x722
=150  \\$aTropanes
=450  \\$wnnna$aAzabicyclo(3.2.1)Octanes
=550  \\$wg$aAlkaloids
=550  \\$wg$aAzabicyclo Compounds
=550  \\$wg$aHeterocyclic Compounds, Bridged-Ring
=550  \\$wh$aAtropine Derivatives
=550  \\$wh$aBelladonna Alkaloids
=550  \\$wh$aBenztropine
=550  \\$wh$aCocaine
=550  \\$wh$aNortropanes
=550  \\$wh$aScopolamine Derivatives
=680  \\$iN-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in PLANTS.
=688  \\$a69; was see under NORTROPANES 1963-68
=750  \0$aTropanes$5IEN$0(DLC)sh 91005153

=LDR  00870cz  a2200229n  4500
=001  9880364172002441
=005  20141212210439.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014357
=035  \\$aCBA7693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x895
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x895
=150  \\$aTrypsin
=450  \\$wnnna$abeta-Trypsin
=450  \\$wnnna$abeta Trypsin
=450  \\$wnnna$aTripcellim
=450  \\$wnnna$aTrypure
=550  \\$wg$aSerine Endopeptidases
=550  \\$aPancreatic Juice
=680  \\$iA serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.
=750  \0$aTrypsin$5IEN$0(DLC)sh 85138301

=LDR  01448cz  a2200277n  4500
=001  9880364172102441
=005  20141212210438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014355
=035  \\$aCBA7691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x900.$x200
=150  \\$aChagas Disease
=450  \\$wnnna$aAmerican Trypanosomiasis
=450  \\$wnnna$aChagas' Disease
=450  \\$wnnna$aDisease, Chagas
=450  \\$wnnna$aDisease, Chagas'
=450  \\$wnnna$aSouth American Trypanosomiasis
=450  \\$wnnna$aTrypanosomiasis, American
=450  \\$aTrypanosomiasis, South American
=550  \\$wg$aTrypanosomiasis
=550  \\$wh$aChagas Cardiomyopathy
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; CHAGAS CARDIOMYOPATHY is also available.
=680  \\$iInfection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
=688  \\$a92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91
=750  \0$aChagas disease$5IEN-M$0(DLC)sh 85022320

=LDR  01509cz  a2200433n  4500
=001  9880364172202441
=005  20141212210428.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x419.$x875
=150  \\$aTrombiculidae
=450  \\$wnnna$aBug, Red
=450  \\$wnnna$aBugs, Red
=450  \\$wnnna$aChigger
=450  \\$aChiggers
=450  \\$wnnna$aEutrombicula
=450  \\$wnnna$aEutrombiculas
=450  \\$wnnna$aHarvest Mite
=450  \\$aHarvest Mites
=450  \\$aLeptotrombidium
=450  \\$wnnna$aLeptotrombidiums
=450  \\$wnnna$aMite, Harvest
=450  \\$wnnna$aMite, Trombiculid
=450  \\$wnnna$aMites, Harvest
=450  \\$wnnna$aMites, Trombiculid
=450  \\$aNeotrombicula
=450  \\$wnnna$aNeotrombiculas
=450  \\$wnnna$aRed Bug
=450  \\$aRed Bugs
=450  \\$aTrombicula
=450  \\$wnnna$aTrombiculas
=450  \\$wnnna$aTrombiculid Mite
=450  \\$aTrombiculid Mites
=550  \\$wg$aMites
=667  \\$ainfection = TROMBICULIASIS
=680  \\$iFamily of MITES in the superfamily Trombiculoidea, suborder Prostigmata, which attack humans and other vertebrates, causing DERMATITIS and severe allergic reactions. Chiggers, red bugs, and harvest mites commonly refer to the larval stage of Trombiculid mites, the only parasitic stage of the mite's life cycle.
=688  \\$a91(75); was see under MITES 1975-90
=750  \2$aTrombiculidae$5IEN-M

=LDR  00995cz  a2200289n  4500
=001  9880364172302441
=005  20141212210438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014354
=035  \\$aCBA7690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x701.$x688.$x896
=072  \\$aC3.$x752.$x300.$x900.$x802
=072  \\$aC3.$x752.$x625.$x896
=072  \\$aC22.$x196.$x888
=072  \\$aC22.$x674.$x710.$x896
=150  \\$aTrypanosomiasis, Bovine
=450  \\$wnnna$aBovine Trypanosomiases
=450  \\$wnnna$aBovine Trypanosomiasis
=450  \\$wnnna$aTrypanosomiases, Bovine
=550  \\$wg$aCattle Diseases
=550  \\$wg$aProtozoan Infections, Animal
=550  \\$wg$aTrypanosomiasis
=667  \\$adon't forget also CATTLE (NIM) & check tag ANIMALS; coord IM with specific type of trypanosomiasis /vet (NIM)
=680  \\$iInfection in cattle caused by various species of trypanosomes.
=688  \\$a68
=750  \0$aTrypanosomiasis in cattle$5IEN$0(DLC)sh 85138296

=LDR  00753cz  a2200181n  4500
=001  9880364172402441
=005  20141212210427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014319
=035  \\$aCBA7655HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x608.$x700.$x670
=150  \\$aTriturus
=550  \\$wg$aSalamandridae
=667  \\$aaquatic newt; NIM when exper animal: no qualif; IM; qualif permitted
=680  \\$iA genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus (crested newt).
=688  \\$a72
=750  \0$aTriturus$5IEN$0(DLC)sh 85137940

=LDR  00721cz  a2200205n  4500
=001  9880364172502441
=005  20141212210426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014318
=035  \\$aCBA7654HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x630.$x800.$x849
=150  \\$aTritrichomonas
=450  \\$wnnna$aTritrichomona
=550  \\$wg$aTrichomonadida
=550  \\$wh$aTritrichomonas foetus
=667  \\$ainfection: coordinate IM with PROTOZOAN INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of flagellate EUKARYOTES possessing three long anterior flagella.
=688  \\$a72
=750  \0$aTritrichomonas$5IEN$0(DLC)sh 88021476

=LDR  00469cz  a2200181n  4500
=001  9880364172602441
=005  20141212210426.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014316
=035  \\$aCBA7652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x435.$x719
=072  \\$aD1.$x496.$x749.$x925
=150  \\$aTritium
=550  \\$wg$aHydrogen
=550  \\$wg$aRadioisotopes
=667  \\$a= H3; naturally radioactive
=750  \0$aTritium$5IEN$0(DLC)sh 85137936

=LDR  01802cz  a2200301n  4500
=001  9880364172702441
=005  20141212210438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014353
=035  \\$aCBA7689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x900.$x719
=150  \\$aTrypanosomiasis, African
=450  \\$aAfrican Sleeping Sickness
=450  \\$wnnna$aAfrican Sleeping Sicknesses
=450  \\$wnnna$aAfrican Trypanosomiases
=450  \\$wnnna$aAfrican Trypanosomiasis
=450  \\$aNagana
=450  \\$wnnna$aSickness, African Sleeping
=450  \\$wnnna$aSicknesses, African Sleeping
=450  \\$wnnna$aSleeping Sickness, African
=450  \\$wnnna$aSleeping Sicknesses, African
=450  \\$wnnna$aTrypanosomiases, African
=550  \\$wg$aTrypanosomiasis
=667  \\$afor trypanosomiasis in tropical Africa caused by any species of Trypanosoma; coordinate with NEGLECTED DISEASES if pertinent; coordinate IM with TRYPANOSOMA BRUCEI GAMBIENSE (IM) for Gambian trypanosomiasis; entry term NAGANA: coordinate TRYPANOSOMIASIS, AFRICAN /vet (IM) with specific Trypanosoma species (IM) + animal disease term (IM) + specific animal (IM or NIM) + check tag ANIMALS; specify geographic term pertinent
=680  \\$iA disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces "African sleeping sickness." Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
=688  \\$aNAGANA was heading 1991-94; was see under TRYPANOSOMIASIS, AFRICAN 1973-90; was see under TRYPANOSOMIASIS, BOVINE 1968-mid 72
=750  \0$aAfrican trypanosomiasis$5IEN$0(DLC)sh 85001750

=LDR  01105cz  a2200325n  4500
=001  9880364172802441
=005  20141212210425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014314
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x50.$x750
=072  \\$aC23.$x550.$x210.$x182.$x500
=072  \\$aG5.$x365.$x590.$x175.$x50.$x750
=072  \\$aG5.$x365.$x590.$x175.$x183.$x500
=072  \\$aG5.$x700.$x131.$x750
=150  \\$aTrisomy
=450  \\$wnnna$aChromosomal Triplication
=450  \\$wnnna$aChromosomal Triplications
=450  \\$wnnna$aPartial Trisomies
=450  \\$aPartial Trisomy
=450  \\$wnnna$aTrisomies
=450  \\$wnnna$aTrisomies, Partial
=450  \\$wnnna$aTrisomy, Partial
=550  \\$wg$aAneuploidy
=550  \\$wg$aChromosome Duplication
=550  \\$aTriploidy
=667  \\$acoordinate IM with specific chromosome number (IM); TRISOMY 21 see DOWN SYNDROME is also available
=680  \\$iThe possession of a third chromosome of any one type in an otherwise diploid cell.
=688  \\$a64(63)
=750  \0$aTrisomy$5IEN$0(DLC)sh 85137919

=LDR  00748cz  a2200229n  4500
=001  9880364172902441
=005  20141212210437.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014352
=035  \\$aCBA7688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x752.$x300.$x900
=150  \\$aTrypanosomiasis
=450  \\$wnnna$aTrypanosomiases
=550  \\$wg$aEuglenozoa Infections
=550  \\$wh$aChagas Disease
=550  \\$wh$aDourine
=550  \\$wh$aTrypanosomiasis, African
=550  \\$wh$aTrypanosomiasis, Bovine
=667  \\$ageneral or unspecified; prefer specifics; coordinate with NEGLECTED DISEASES if pertinent
=680  \\$iInfection with protozoa of the genus TRYPANOSOMA.
=750  \0$aTrypanosomiasis$5IEN$0(DLC)sh 85138293

=LDR  01165cz  a2200325n  4500
=001  9880364173002441
=005  20141212210425.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014313
=035  \\$aCBA7649HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x613.$x750.$x700
=072  \\$aC23.$x888.$x592.$x608.$x750.$x700
=150  \\$aTrismus
=450  \\$wnnna$aLock Jaw
=450  \\$aLockjaw
=450  \\$aMasseter Muscle Spasm
=450  \\$wnnna$aMasseter Muscle Spasms
=450  \\$wnnna$aMasseter Spasm
=450  \\$wnnna$aMasseter Spasms
=450  \\$wnnna$aMuscle Spasm, Masseter
=450  \\$wnnna$aMuscle Spasms, Masseter
=450  \\$wnnna$aSpasm, Masseter
=450  \\$wnnna$aSpasm, Masseter Muscle
=450  \\$wnnna$aSpasms, Masseter
=450  \\$wnnna$aSpasms, Masseter Muscle
=550  \\$wg$aSpasm
=550  \\$aTetanus
=680  \\$iSpasmodic contraction of the masseter muscle resulting in forceful jaw closure. This may be seen with a variety of diseases, including TETANUS, as a complication of radiation therapy, trauma, or in association with neoplastic conditions.
=750  \0$aTrismus$5IEN$0(DLC)sh 85137918

=LDR  00675cz  a2200181n  4500
=001  9880364173102441
=005  20141212210424.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014310
=035  \\$aCBA7646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x438.$x768
=150  \\$aTriplets
=450  \\$wnnna$aTriplet
=550  \\$wg$aMultiple Birth Offspring
=667  \\$ahuman only: for animals use LITTER SIZE; PREGNANCY, TRIPLET is also available
=680  \\$iThree individuals derived from three FETUSES that were fertilized at or about the same time, developed in the UTERUS simultaneously, and born to the same mother.
=750  \0$aTriplets$5IEN$0(DLC)sh 85137901

=LDR  01151cz  a2200277n  4500
=001  9880364173202441
=005  20141212210423.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014305
=035  \\$aCBA7641M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x475.$x200.$x775
=150  \\$aTriose-Phosphate Isomerase
=450  \\$wnnna$aIsomerase, Phosphotriose
=450  \\$wnnna$aIsomerase, Triose-Phosphate
=450  \\$wnnna$aIsomerase, Triosephosphate
=450  \\$wnnna$aMutase, Triosephosphate
=450  \\$aPhosphotriose Isomerase
=450  \\$wnnna$aTriose Phosphate Isomerase
=450  \\$aTriosephosphate Isomerase
=450  \\$aTriosephosphate Mutase
=550  \\$wg$aAldose-Ketose Isomerases
=667  \\$a/defic: consider also ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC
=680  \\$iAn enzyme that catalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease (ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC). EC 5.3.1.1.
=688  \\$a98(75)
=750  \0$aTriose-phosphate isomerase$0(DLC)sh2005006804$5IEN-M

=LDR  01495cz  a2200313n  4500
=001  9880364173302441
=005  20141212210437.0
=008  850311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014351
=035  \\$aCBA7687HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868
=150  \\$aTrypanosomatina
=450  \\$aBlastocrithidia
=450  \\$wnnna$aBlastocrithidias
=450  \\$wnnna$aHerpetomona
=450  \\$aHerpetomonas
=450  \\$wnnna$aLeptomona
=450  \\$aLeptomonas
=450  \\$aTrypanosomatidae
=450  \\$wnnna$aTrypanosomatinas
=550  \\$wg$aKinetoplastida
=550  \\$wh$aCrithidia
=550  \\$wh$aLeishmania
=550  \\$wh$aTrypanosoma
=667  \\$ainfection: coordinate IM with EUGLENOZOA INFECTIONS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA suborder of monoflagellate parasitic protozoa that lives in the blood and tissues of man and animals. Representative genera include: Blastocrithidia, Leptomonas, CRITHIDIA, Herpetomonas, LEISHMANIA, Phytomonas, and TRYPANOSOMA. Species of this suborder may exist in two or more morphologic stages formerly named after genera exemplifying these forms - amastigote (LEISHMANIA), choanomastigote (CRITHIDIA), promastigote (Leptomonas), opisthomastigote (Herpetomonas), epimastigote (Blastocrithidia), and trypomastigote (TRYPANOSOMA).
=688  \\$a92; was TRYPANOSOMATIDAE 1986-91
=750  \0$aTrypanosomatidae$5IEN-M$0(DLC)sh 85138298

=LDR  01435cz  a2200289n  4500
=001  9880364173402441
=005  20141212210435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014346
=035  \\$aCBA7682HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868.$x887.$x80
=150  \\$aTrypanosoma brucei brucei
=450  \\$wnnna$abrucei brucei, Trypanosoma
=450  \\$wnnna$abrucei bruceus, Trypanosoma
=450  \\$wnnna$abrucei, Trypanosoma
=450  \\$wnnna$abrucei, Trypanosoma brucei
=450  \\$wnnna$abruceus, Trypanosoma
=450  \\$wnnna$abruceus, Trypanosoma brucei
=450  \\$aTrypanosoma brucei
=450  \\$wnnna$aTrypanosoma brucei bruceus
=450  \\$wnnna$aTrypanosoma bruceus
=550  \\$wg$aTrypanosoma
=667  \\$acauses nagana & also TRYPANOSOMIASIS, BOVINE in African cattle or TRYPANOSOMIASIS, AFRICAN /vet in African game animals; infection: coord IM with TRYPANOSOMIASIS, AFRICAN (IM) but see note there for X ref NAGANA see TRYPANOSOMIASIS, AFRICAN; for antigens, coord with ANTIGENS, PROTOZOAN, for antibodies, coord with ANTIBODIES, PROTOZOAN
=680  \\$iA hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina).
=688  \\$a84; was TRYPANOSOMA BRUCEI 1972-83
=750  \0$aTrypanosoma brucei$5IEN$0(DLC)sh 85138292

=LDR  01231cz  a2200301n  4500
=001  9880364173502441
=005  20141212210435.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014345
=035  \\$aCBA7681HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x268.$x475.$x868.$x887
=150  \\$aTrypanosoma
=450  \\$wnnna$aNannomona
=450  \\$aNannomonas
=450  \\$wnnna$aTrypanosomas
=550  \\$wg$aTrypanosomatina
=550  \\$wh$aTrypanosoma brucei brucei
=550  \\$wh$aTrypanosoma brucei gambiense
=550  \\$wh$aTrypanosoma brucei rhodesiense
=550  \\$wh$aTrypanosoma congolense
=550  \\$wh$aTrypanosoma cruzi
=550  \\$wh$aTrypanosoma lewisi
=550  \\$wh$aTrypanosoma rangeli
=550  \\$wh$aTrypanosoma vivax
=667  \\$ageneral; prefer specifics; infection = TRYPANOSOMIASIS but prefer specific types of trypanosomiasis; agents to treat trypanosomiasis = TRYPANOCIDAL AGENTS; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle.
=750  \0$aTrypanosoma$5IEN$0(DLC)sh 85138291

=LDR  00549cz  a2200169n  4500
=001  9880364173602441
=005  20141212210422.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014303
=035  \\$aCBA7639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x832.$x868
=150  \\$aTrinitrotoluene
=450  \\$aTNT
=550  \\$wg$aToluene
=680  \\$iA 2,4,6-trinitrotoluene, which is an explosive chemical that can cause skin irritation and other toxic consequences.
=750  \0$aTNT (Chemical)$5IEN-M$0(DLC)sh2001000298

=LDR  01030cz  a2200301n  4500
=001  9880364173702441
=005  20141212210434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014344
=035  \\$aCBA7680HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250.$x100.$x875
=150  \\$aTrypanocidal Agents
=450  \\$wnnna$aAgents, Trypanocidal
=450  \\$wnnna$aAgents, Trypanosomicidal
=450  \\$wnnna$aDrugs, Trypanocidal
=450  \\$wnnna$aTrypanocidal Drugs
=450  \\$wnnna$aTrypanocides
=450  \\$wnnna$aTrypanosomicidal Agents
=450  \\$wnnna$aTrypanosomicides
=450  \\$aTryparsamide$5IEN-M
=550  \\$wg$aAntiprotozoal Agents
=550  \\$aTrypanosoma
=550  \\$aTrypanosomiasis
=667  \\$aconsider also TRYPANOSOMA /drug eff & TRYPANOSOMIASIS /drug ther or pertinent specifics
=680  \\$iAgents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.
=688  \\$a74(72)
=750  \0$aTryparsamide$5IEN$0(DLC)sh 85138299

=LDR  00926cz  a2200289n  4500
=001  9880364173802441
=005  20141212210434.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014343
=035  \\$aCBA7679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x172.$x975
=072  \\$aD2.$x455.$x426.$x559.$x847.$x638.$x555.$x875
=072  \\$aD2.$x886.$x645.$x600.$x80.$x50.$x650.$x875
=072  \\$aD4.$x615.$x638.$x555.$x875
=150  \\$aTrypan Blue
=450  \\$wnnna$aBlue, Diamine
=450  \\$wnnna$aBlue, Niagara
=450  \\$wnnna$aBlue, Trypan
=450  \\$wnnna$aD.O.R.C. International Brand of Trypan Blue
=450  \\$wnnna$aDiamine Blue
=450  \\$wnnna$aNiagara Blue
=450  \\$wnnna$aVisionBlue
=550  \\$wg$aAzo Compounds
=550  \\$wg$aNaphthalenesulfonates
=680  \\$iA diazo-naphthalene sulfonate that is widely used as a stain.
=750  \0$aTrypan blue$5IEN$0(DLC)sh 85138290

=LDR  00729cz  a2200205n  4500
=001  9880364173902441
=005  20141212210434.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014341
=035  \\$aCBA7677HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x70.$x940
=072  \\$aN4.$x452.$x394.$x600
=150  \\$aTrustees
=450  \\$wnnna$aTrustee
=550  \\$wg$aAdministrative Personnel
=550  \\$wg$aGoverning Board
=680  \\$iBoard members of an institution or organization who are entrusted with the administering of funds and the directing of policy.
=688  \\$a91(80); was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79
=750  \0$aTrusts and trustees$5IEN$0(DLC)sh 85138271

=LDR  00486cz  a2200157n  4500
=001  9880364174002441
=005  20141212210433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014340
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x925
=150  \\$aTrusses
=550  \\$wg$aSurgical Equipment
=550  \\$aHernia
=680  \\$iA surgical device designed for retaining a hernia in a reduced state within the abdominal cavity.
=750  \0$aTrusses (Surgery)$5IEN$0(DLC)sh 85138260

=LDR  00966cz  a2200205n  4500
=001  9880364174102441
=005  20141212210433.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014339
=035  \\$aCBA7675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x560.$x98.$x500
=072  \\$aC14.$x280.$x400.$x560.$x98.$x500
=072  \\$aC16.$x131.$x240.$x400.$x560.$x98.$x500
=150  \\$aTruncus Arteriosus, Persistent
=450  \\$wnnna$aPersistent Truncus Arteriosus
=550  \\$wg$aAortopulmonary Septal Defect
=680  \\$iA congenital anomaly caused by the failed development of TRUNCUS ARTERIOSUS into separate AORTA and PULMONARY ARTERY. It is characterized by a single arterial trunk that forms the outlet for both HEART VENTRICLES and gives rise to the systemic, pulmonary, and coronary arteries. It is always accompanied by a ventricular septal defect.
=688  \\$a77
=750  \0$aTruncus arteriosus, Persistent$5IEN$0(DLC)sh 85138254

=LDR  00742cz  a2200205n  4500
=001  9880364174202441
=005  20141212210433.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014338
=035  \\$aCBA7674HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x278.$x930
=072  \\$aA16.$x378.$x303.$x930
=150  \\$aTruncus Arteriosus
=450  \\$wnnna$aArteriosus, Truncus
=550  \\$wg$aFetal Heart
=667  \\$anormal; abnormal is probably TRUNCUS ARTERIOSUS, PERSISTENT; pseudotruncus arteriosus = TETRALOGY OF FALLOT
=680  \\$iThe arterial trunk arising from the fetal heart. During development, it divides into AORTA and the PULMONARY ARTERY.
=688  \\$a77
=750  \0$aTruncus arteriosus$5IEN$0(DLC)sh 85138253

=LDR  03297cz  a2200841n  4500
=001  9880364174302441
=005  20141212210421.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014299
=035  \\$aCBA7635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x240.$x918
=150  \\$aTrimipramine
=450  \\$wnnna$a10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine
=450  \\$wnnna$aApo-Trimip
=450  \\$wnnna$aApo Trimip
=450  \\$wnnna$aApotex Brand of Trimipramine Maleate
=450  \\$wnnna$aApoTrimip
=450  \\$wnnna$aAventis Brand of Trimipramine
=450  \\$wnnna$aAventis Brand of Trimipramine Maleate
=450  \\$wnnna$aAWD.pharma Brand of Trimipramine Maleate
=450  \\$wnnna$aAzupharma Brand of Trimipramine Maleate
=450  \\$wnnna$abetapharm Brand of Trimipramine Maleate
=450  \\$wnnna$aEldoral
=450  \\$wnnna$aHerphonal
=450  \\$wnnna$aHexal Brand of Trimipramine
=450  \\$wnnna$aMerck dura Brand of Trimipramine Maleate
=450  \\$wnnna$aneurazpharm Brand of Trimipramine Maleate
=450  \\$wnnna$aNeuro Hexal Brand of Trimipramine Maleate
=450  \\$wnnna$aNovo-Tripramine
=450  \\$wnnna$aNovo Tripramine
=450  \\$wnnna$aNovopharm Brand of Trimipramine Maleate
=450  \\$wnnna$aNovoTripramine
=450  \\$wnnna$aNu-Pharm Brand of Trimipramine Maleate
=450  \\$wnnna$aNu Pharm Brand of Trimipramine Maleate
=450  \\$wnnna$aNu-Trimipramine
=450  \\$wnnna$aNu Trimipramine
=450  \\$wnnna$aNuTrimipramine
=450  \\$wnnna$aOdyssey Brand of Trimipramine Maleate
=450  \\$wnnna$aRhodiapharm Brand of Trimipramine Maleate
=450  \\$wnnna$aRhone-Poulenc Rorer Brand of Trimipramine Maleate
=450  \\$wnnna$aRhone Poulenc Rorer Brand of Trimipramine Maleate
=450  \\$wnnna$aRhotrimine
=450  \\$wnnna$aStadapharm Brand of Trimipramine Maleate
=450  \\$wnnna$aStangyl
=450  \\$wnnna$aSurmontil
=450  \\$wnnna$aSurmontil Maleate
=450  \\$wnnna$aTemmler Brand of Trimipramine Maleate
=450  \\$aTrimeprimine
=450  \\$wnnna$aTrimidura
=450  \\$wnnna$aTrimineurin
=450  \\$wnnna$aTrimineurin Maleate
=450  \\$wnnna$aTrimipramin AZU
=450  \\$wnnna$aTrimipramin beta
=450  \\$wnnna$aTrimipramin-neurazpharm
=450  \\$wnnna$aTrimipramin neurazpharm
=450  \\$wnnna$aTrimipramin Stada
=450  \\$wnnna$aTrimipramine, (+-)-Isomer
=450  \\$wnnna$aTrimipramine Aventis Brand
=450  \\$wnnna$aTrimipramine Hexal Brand
=450  \\$wnnna$aTrimipramine, (-)-Isomer
=450  \\$wnnna$aTrimipramine Maleate
=450  \\$wnnna$aTrimipramine Maleate (1:1)
=450  \\$wnnna$aTrimipramine Maleate (1:1), (+)-Isomer
=450  \\$wnnna$aTrimipramine Maleate (1:1), (+-)-Isomer
=450  \\$wnnna$aTrimipramine Maleate (1:1), (-)-Isomer
=450  \\$wnnna$aTrimipramine Mesylate
=450  \\$wnnna$aTrimipramine Monohydrochloride
=450  \\$wnnna$aTrimipraminneurazpharm
=550  \\$wg$aDibenzazepines
=680  \\$iTricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.
=688  \\$a91(75); was see under DIBENZAZEPINES 1975-90
=750  \0$aTrimipramine$5IEN$0(DLC)sh 85137543

=LDR  00709cz  a2200217n  4500
=001  9880364174402441
=005  20160826164123.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047849
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x469
=072  \\$aK1.$x400.$x504.$x937.$x500
=150  \\$aCrimean War
=450  \\$wnnna$aCrimean War, 1853-1856
=450  \\$wnnna$aCrimean War, 1853 1856
=450  \\$wnnna$aWar, Crimean
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 19th Century
=680  \\$iConflict between RUSSIA (Pre-1917); the OTTOMAN EMPIRE; ENGLAND; FRANCE; and Sardinia.
=688  \\$a2005
=750  \0$aCrimean War, 1853-1856$0(DLC) sh 85034020$5IEN-M

=LDR  00748cz  a2200217n  4500
=001  9880364174502441
=005  20160826171552.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047848
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x844
=072  \\$aK1.$x400.$x504.$x968.$x650
=150  \\$aRussian-Japanese War
=450  \\$wnnna$aRussian Japanese War
=450  \\$wnnna$aRusso-Japanese War, 1904-1905
=450  \\$wnnna$aRusso Japanese War, 1904 1905
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iConflict from 1904 through 1905 between Russia and Japan regarding Manchuria and Korea.
=688  \\$a2005
=750  \0$aRusso-Japanese War, 1904-1905$0(DLC) sh 85116039$5IEN-M

=LDR  00868cz  a2200253n  4500
=001  9880364174602441
=005  20160826172123.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047832
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x875
=072  \\$aK1.$x400.$x504.$x937.$x750
=150  \\$aSpanish-American War, 1898
=450  \\$wnnna$aAmerican War, Spanish
=450  \\$wnnna$aAmerican Wars, Spanish
=450  \\$wnnna$aSpanish American War
=450  \\$wnnna$aSpanish American Wars
=450  \\$wnnna$aWar, Spanish American
=450  \\$wnnna$aWars, Spanish American
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 19th Century
=680  \\$iConflict between Spain and the United States, arising out of Spanish policies in Cuba.
=688  \\$a2005
=750  \0$aSpanish-American War, 1898$0(DLC) sh 85140286$5IEN-M

=LDR  00981cz  a2200277n  4500
=001  9880364174702441
=005  20160826165306.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047830
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x657
=072  \\$aK1.$x400.$x504.$x968.$x400
=150  \\$aGulf War
=450  \\$wnnna$aDesert Shield, Operation
=450  \\$wnnna$aDesert Storm, Operation
=450  \\$wnnna$aOperation Desert Shield
=450  \\$aOperation Desert Storm
=450  \\$wnnna$aPersian Gulf War, 1991
=450  \\$wnnna$aShield, Operation Desert
=450  \\$wnnna$aStorm, Operation Desert
=450  \\$wnnna$aWar, Gulf
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iUnited Nations' action to intervene in conflict between the nation of Kuwait and occupying Iraqi forces, occurring from 1990 through 1991.
=688  \\$a2005
=750  \0$aPersian Gulf War, 1991$0(DLC) sh 91001459$5IEN-M

=LDR  01436cz  a2200385n  4500
=001  9880364174802441
=005  20160826172402.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047829
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x937
=072  \\$aK1.$x400.$x504.$x968.$x850
=150  \\$aVietnam Conflict
=450  \\$wnnna$a1961-1975 Vietnamese Conflict
=450  \\$wnnna$a1961-1975 Vietnamese Conflicts
=450  \\$wnnna$aConflict, 1961-1975 Vietnamese
=450  \\$wnnna$aConflict, Viet Nam
=450  \\$wnnna$aConflict, Vietnam
=450  \\$wnnna$aConflicts, 1961-1975 Vietnamese
=450  \\$wnnna$aIndochina War
=450  \\$wnnna$aIndochina Wars
=450  \\$aViet Nam Conflict
=450  \\$wnnna$aViet Nam War
=450  \\$wnnna$aVietnamese Conflict, 1961-1975
=450  \\$wnnna$aVietnamese Conflict, 1961 1975
=450  \\$wnnna$aVietnamese Conflicts, 1961-1975
=450  \\$wnnna$aWar, Indochina
=450  \\$wnnna$aWar, Viet Nam
=450  \\$wnnna$aWars, Indochina
=450  \\$wnnna$aWars, Viet Nam
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iA conflict occurring from 1954 through 1975 within the Republic of Vietnam. It involved neighboring nations and the United States and other members of the Southeast Asia Treaty Organization.
=688  \\$a2005
=750  \0$aVietnam War, 1961-1975$0(DLC) sh 85143277$5IEN-M

=LDR  01447cz  a2200445n  4500
=001  9880364174902441
=005  20160826172626.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047828
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x968
=072  \\$aK1.$x400.$x504.$x968.$x900
=150  \\$aWorld War I
=450  \\$wnnna$a1914-1918 World War
=450  \\$wnnna$a1st World War
=450  \\$wnnna$a1st World Wars
=450  \\$wnnoa$aEuropean War, 1914-1918$5IEN-M
=450  \\$wnnna$aFirst World War
=450  \\$wnnna$aFirst World Wars
=450  \\$wnnna$aGreat War
=450  \\$wnnna$aGreat Wars
=450  \\$wnnna$aWar, 1st World
=450  \\$wnnna$aWar, First World
=450  \\$wnnna$aWar, Great
=450  \\$wnnna$aWars, 1914-1918 World
=450  \\$wnnna$aWars, 1st World
=450  \\$wnnna$aWars, First World
=450  \\$wnnna$aWars, Great
=450  \\$wnnna$aWorld War, 1914-1918
=450  \\$wnnna$aWorld War, 1914 1918
=450  \\$wnnna$aWorld War, 1st
=450  \\$wnnna$aWorld War, First
=450  \\$wnnna$aWorld Wars, 1914-1918
=450  \\$wnnna$aWorld Wars, 1st
=450  \\$wnnna$aWorld Wars, First
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iGlobal conflict primarily fought on European continent, that occurred between 1914 and 1918.
=688  \\$a2005
=750  \0$aWorld War, 1914-1918$0(DLC) sh 85148236$5IEN-M

=LDR  01214cz  a2200253n  4500
=001  9880364175002441
=005  20141212220045.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047808
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x706.$x316.$x129
=072  \\$aC13.$x351.$x875.$x253.$x129
=072  \\$aC16.$x131.$x939.$x316.$x129
=072  \\$aC19.$x391.$x119.$x129
=150  \\$aAdrenogenital Syndrome
=450  \\$wnnna$aAdrenogenital Syndromes
=450  \\$wnnna$aSyndrome, Adrenogenital
=450  \\$wnnna$aSyndromes, Adrenogenital
=550  \\$wg$aDisorders of Sex Development
=550  \\$wh$aAdrenal Hyperplasia, Congenital
=550  \\$wh$aHyperandrogenism
=680  \\$iAbnormal SEX DIFFERENTIATION or congenital DISORDERS OF SEX DEVELOPMENT caused by abnormal levels of steroid hormones expressed by the GONADS or the ADRENAL GLANDS, such as in CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.
=688  \\$a2005; use ADRENAL HYPERPLASIA, CONGENITAL 1980-2004
=750  \0$aAdrenogenital syndrome$0(DLC) sh 85001014$5IEN

=LDR  01277cz  a2200385n  4500
=001  9880364175102441
=005  20160826172824.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047789
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x984
=072  \\$aK1.$x400.$x504.$x968.$x901
=150  \\$aWorld War II
=450  \\$wnnna$a1939-1945 World War
=450  \\$wnnna$a2nd World War
=450  \\$wnnna$a2nd World Wars
=450  \\$wnnna$aSecond World War
=450  \\$wnnna$aSecond World Wars
=450  \\$wnnna$aWar, 1939-1945 World
=450  \\$wnnna$aWar, 2nd World
=450  \\$wnnna$aWar II, World
=450  \\$wnnna$aWar, Second World
=450  \\$wnnna$aWars, 2nd World
=450  \\$wnnna$aWars, Second World
=450  \\$aWorld War, 1939-1945
=450  \\$wnnna$aWorld War, 1939 1945
=450  \\$wnnna$aWorld War, 2nd
=450  \\$wnnna$aWorld War, Second
=450  \\$wnnna$aWorld Wars, 2nd
=450  \\$wnnna$aWorld Wars, Second
=550  \\$wg$aArmed Conflicts
=550  \\$wg$aHistory, 20th Century
=680  \\$iGlobal conflict involving countries of Europe, Africa, Asia, and North America that occurred between 1939 and 1945.
=688  \\$a2005
=750  \0$aWorld War, 1939-1945$0(DLC) sh 85148273$5IEN-M

=LDR  00671cz  a2200193n  4500
=001  9880364175202441
=005  20141212220042.0
=008  040707\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D047709
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x91.$x426.$x400
=150  \\$aHirudo medicinalis
=450  \\$wnnna$aHirudo medicinali
=450  \\$wnnna$amedicinali, Hirudo
=450  \\$wnnna$amedicinalis, Hirudo
=550  \\$wg$aLeeches
=680  \\$iA species of European freshwater LEECHES used for BLOODLETTING in ancient times and also for LEECHING in modern times.
=688  \\$a2005; use LEECHES 2002-2004
=750  \0$aHirudo medicinalis$0(DLC) sh 88021573$5IEN-M

=LDR  01492cz  a2200289n  4500
=001  9880363214902441
=005  20141212194933.0
=008  800402\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001105
=035  \\$aCAZ4259HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB2
=150  \\$aArchaea
=450  \\$aArchaebacteria
=450  \\$aArchaeobacteria
=450  \\$wnnna$aArchaeon
=450  \\$wnnna$aArchebacteria
=550  \\$wh$aBlood-Borne Pathogens
=550  \\$wh$aCrenarchaeota
=550  \\$wh$aEuryarchaeota
=550  \\$wh$aKorarchaeota
=550  \\$wh$aNanoarchaeota
=550  \\$aMicrobiology
=667  \\$ain taxonomy, one of the 3 domains of life along with BACTERIA & Eucarya
=680  \\$iOne of the three domains of life (the others being BACTERIA and Eukarya), formerly called Archaebacteria under the taxon Bacteria, but now considered separate and distinct. They are characterized by: (1) the presence of characteristic tRNAs and ribosomal RNAs; (2) the absence of peptidoglycan cell walls; (3) the presence of ether-linked lipids built from branched-chain subunits; and (4) their occurrence in unusual habitats. While archaea resemble bacteria in morphology and genomic organization, they resemble eukarya in their method of genomic replication. The domain contains at least four kingdoms: CRENARCHAEOTA; EURYARCHAEOTA; NANOARCHAEOTA; and KORARCHAEOTA.
=688  \\$a98(81); ARCHAEA was see ARCHAEOBACTERIA 1995-97
=750  \0$aArchaebacteria$5IEN-M$0(DLC)sh 86006229

=LDR  01144cz  a2200253n  4500
=001  9880363215002441
=005  20141212194933.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001103
=035  \\$aCAZ4257HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x80
=150  \\$aArboviruses
=450  \\$wnnna$aArbovirus
=450  \\$wnnna$aArthropod-Borne Virus
=450  \\$aArthropod-Borne Viruses
=450  \\$wnnna$aArthropod Borne Viruses
=450  \\$wnnna$aVirus, Arthropod-Borne
=450  \\$wnnna$aViruses, Arthropod-Borne
=550  \\$wg$aViruses
=667  \\$aGEN; from ARthropod-BOrne; infection = ARBOVIRUS INFECTIONS
=680  \\$iArthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed)
=688  \\$a75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80
=750  \0$aArboviruses$5IEN$0(DLC)sh 85008131

=LDR  01129cz  a2200337n  4500
=001  9880363215102441
=005  20190225162443.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001102
=035  \\$aCAZ4256HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81
=150  \\$aArbovirus Infections
=450  \\$wnnna$aArbovirus Infection
=450  \\$wnnna$aInfection, Arbovirus
=450  \\$wnnna$aInfections, Arbovirus
=550  \\$wg$aVirus Diseases
=550  \\$wh$aAfrican Horse Sickness
=550  \\$wh$aBluetongue
=550  \\$wh$aDengue
=550  \\$wh$aEncephalitis, Arbovirus
=550  \\$wh$aEncephalomyelitis, Equine
=550  \\$wh$aPhlebotomus Fever
=550  \\$wh$aRift Valley Fever
=550  \\$wh$aTick-Borne Diseases
=550  \\$wh$aYellow Fever
=550  \\$wh$aZika Virus Infection
=667  \\$aGEN; consider also 2 major groups, BUNYAVIRUS INFECTIONS & TOGAVIRUS INFECTIONS or specifics
=680  \\$iInfections caused by arthropod-borne viruses, general or unspecified.
=688  \\$a65; was ARBORVIRUS INFECTIONS 1963-64
=750  \0$aArbovirus infections$5IEN$0(DLC)sh 85006472

=LDR  01234cz  a2200229n  4500
=001  9880363215202441
=005  20141212194932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001100
=035  \\$aCAZ4254HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x228.$x507.$x97
=150  \\$aArachnoiditis
=450  \\$wnnna$aArachnoid Membrane Inflammation
=450  \\$wnnna$aArachnoid Membrane Inflammations
=450  \\$wnnna$aArachnoiditides
=450  \\$wnnna$aInflammation, Arachnoid Membrane
=450  \\$wnnna$aInflammations, Arachnoid Membrane
=550  \\$wg$aMeningitis
=680  \\$iAcute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. (From Joynt, Clinical Neurology, 1997, Ch48, p25)
=688  \\$a1967
=750  \0$aArachnoiditis$5IEN$0(DLC)sh 85006372

=LDR  00821cz  a2200265n  4500
=001  9880363215302441
=005  20141212194931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001098
=035  \\$aCAZ4252HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x723.$x127.$x723
=072  \\$aC26.$x176.$x790
=150  \\$aSpider Bites
=450  \\$aArachnidism
=450  \\$wnnna$aArachnidism, Necrotic
=450  \\$wnnna$aBite, Spider
=450  \\$wnnna$aBites, Spider
=450  \\$wnnna$aNecrotic Arachnidism
=450  \\$wnnna$aSpider Bite
=550  \\$wg$aBites and Stings
=550  \\$aSpider Venoms
=680  \\$iThe effects, both local and systemic, caused by the bites of SPIDERS.
=688  \\$aHeading changed 20130903 from: 150:##:_{dollar}a Arachnidism
=750  \0$aSpider bites$5IEN-M$0(DLC)sh2002000892

=LDR  00639cz  a2200229n  4500
=001  9880363215402441
=005  20141212194931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001097
=035  \\$aCAZ4251HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166
=150  \\$aArachnida
=450  \\$wnnna$aArachnid
=450  \\$wnnna$aArachnidas
=450  \\$wnnna$aArachnids
=550  \\$wg$aArthropods
=550  \\$wh$aAcari
=550  \\$wh$aScorpions
=550  \\$wh$aSpiders
=680  \\$iA class of Arthropoda that includes SPIDERS; TICKS; MITES; and SCORPIONS.
=750  \0$aArachnida$5IEN$0(DLC)sh 85006366

=LDR  01173cz  a2200313n  4500
=001  9880363215502441
=005  20141212194926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001082
=035  \\$aCAZ4236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x371.$x60.$x67.$x70
=072  \\$aA12.$x207.$x270.$x40
=150  \\$aAqueous Humor
=450  \\$aAqueous Flare
=450  \\$wnnna$aAqueous Flares
=450  \\$wnnna$aAqueous Humors
=450  \\$wnnna$aFlare, Aqueous
=450  \\$wnnna$aFluid, Intraocular
=450  \\$wnnna$aFluids, Intraocular
=450  \\$wnnna$aHumor, Aqueous
=450  \\$wnnna$aHumors, Aqueous
=450  \\$aIntraocular Fluid
=450  \\$wnnna$aIntraocular Fluids
=550  \\$wg$aAnterior Chamber
=550  \\$wg$aExtracellular Fluid
=667  \\$ain the eye
=680  \\$iThe clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319)
=750  \0$aAqueous humor$5IEN$0(DLC)sh 85006263

=LDR  00873cz  a2200229n  4500
=001  9880363215602441
=005  20141212194925.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001079
=035  \\$aCAZ4233HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x625.$x650.$x135
=072  \\$aC4.$x557.$x470.$x35.$x250
=072  \\$aC4.$x557.$x580.$x625.$x650.$x135
=150  \\$aApudoma
=450  \\$wnnna$aApudomas
=550  \\$wg$aAdenoma
=550  \\$wg$aNeuroendocrine Tumors
=667  \\$afor derivation of word see note on APUD; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ /neopl term (IM)
=680  \\$iA general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.
=688  \\$a78
=750  \0$aChromaffin cells$xTumors$5IEN$0(DLC)sh 85025331

=LDR  00690cz  a2200217n  4500
=001  9880363215702441
=005  20141212194925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001077
=035  \\$aCAZ4231HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x711.$x141
=150  \\$aAptitude Tests
=450  \\$wnnna$aAptitude Test
=450  \\$wnnna$aTest, Aptitude
=450  \\$wnnna$aTests, Aptitude
=550  \\$wg$aPsychological Tests
=550  \\$wh$aIntelligence Tests
=550  \\$aEducational Measurement
=680  \\$iPrimarily non-verbal tests designed to predict an individual's future learning ability or performance.
=750  \0$aAbility$xTesting$5IEN$0(DLC)sh 85000157

=LDR  00659cz  a2200229n  4500
=001  9880363215802441
=005  20141212194925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001076
=035  \\$aCAZ4230HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x131
=150  \\$aAptitude
=450  \\$wnnna$aAbilities
=450  \\$aAbility
=450  \\$wnnna$aAptitudes
=450  \\$aTalent
=450  \\$wnnna$aTalents
=550  \\$wg$aPsychology, Educational
=680  \\$iThe ability to acquire general or special types of knowledge or skill.
=688  \\$aTALENT was see under APTITUDE 1963-78
=750  \0$aAbility$5IEN$0(DLC)sh 85000155

=LDR  04494cz  a2201117n  4500
=001  9880363215902441
=005  20141212194924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001072
=035  \\$aCAZ4226HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x881.$x350
=072  \\$aC23.$x888.$x592.$x604.$x80
=072  \\$aC23.$x888.$x592.$x604.$x882.$x350
=072  \\$aF1.$x700.$x80
=072  \\$aF1.$x700.$x875.$x350
=150  \\$aApraxias
=450  \\$wnnna$a1, Speech-Language Disorder
=450  \\$wnnna$a1s, Speech-Language Disorder
=450  \\$wnnna$aApraxia
=450  \\$wnnna$aApraxia, Articulatory
=450  \\$wnnna$aApraxia, Developmental Verbal
=450  \\$wnnna$aApraxia, Dressing
=450  \\$wnnna$aApraxia, Facial-Oral
=450  \\$wnnna$aApraxia, Facial Oral
=450  \\$wnnna$aApraxia, Gestural
=450  \\$wnnna$aApraxia, Ideational
=450  \\$wnnna$aApraxia, Motor
=450  \\$wnnna$aApraxia of Phonation
=450  \\$wnnna$aApraxia, Oral
=450  \\$wnnna$aApraxia, Verbal
=450  \\$wnnna$aApraxias, Articulatory
=450  \\$wnnna$aApraxias, Developmental Verbal
=450  \\$wnnna$aApraxias, Dressing
=450  \\$wnnna$aApraxias, Facial-Oral
=450  \\$wnnna$aApraxias, Gestural
=450  \\$wnnna$aApraxias, Ideational
=450  \\$wnnna$aApraxias, Motor
=450  \\$wnnna$aApraxias, Oral
=450  \\$wnnna$aApraxias, Verbal
=450  \\$wnnna$aArticulatory Apraxia
=450  \\$wnnna$aArticulatory Apraxias
=450  \\$wnnna$aArticulatory Dyspraxia
=450  \\$wnnna$aArticulatory Dyspraxias
=450  \\$wnnna$aDevelopmental Verbal Apraxia
=450  \\$wnnna$aDevelopmental Verbal Apraxias
=450  \\$wnnna$aDevelopmental Verbal Dyspraxia
=450  \\$wnnna$aDevelopmental Verbal Dyspraxias
=450  \\$wnnna$aDisorder 1, Speech-Language
=450  \\$wnnna$aDisorder 1s, Speech-Language
=450  \\$aDressing Apraxia
=450  \\$wnnna$aDressing Apraxias
=450  \\$aDyspraxia
=450  \\$wnnna$aDyspraxia, Articulatory
=450  \\$wnnna$aDyspraxia, Developmental Verbal
=450  \\$wnnna$aDyspraxia, Oral
=450  \\$wnnna$aDyspraxia, Verbal
=450  \\$wnnna$aDyspraxias
=450  \\$wnnna$aDyspraxias, Articulatory
=450  \\$wnnna$aDyspraxias, Developmental Verbal
=450  \\$wnnna$aDyspraxias, Oral
=450  \\$wnnna$aDyspraxias, Verbal
=450  \\$wnnna$aFacial-Oral Apraxia
=450  \\$wnnna$aFacial-Oral Apraxias
=450  \\$wnnna$aGestural Apraxia
=450  \\$wnnna$aGestural Apraxias
=450  \\$aIdeational Apraxia
=450  \\$wnnna$aIdeational Apraxias
=450  \\$wnnna$aMotor Apraxia
=450  \\$wnnna$aMotor Apraxias
=450  \\$wnnna$aOral Apraxia
=450  \\$wnnna$aOral Apraxias
=450  \\$wnnna$aOral Dyspraxia
=450  \\$wnnna$aOral Dyspraxias
=450  \\$wnnna$aPhonation Apraxia
=450  \\$wnnna$aPhonation Apraxias
=450  \\$wnnna$aSpeech And Language Disorder With Orofacial Dyspraxia
=450  \\$wnnna$aSpeech-Language Disorder 1
=450  \\$wnnna$aSpeech Language Disorder 1
=450  \\$wnnna$aSpeech-Language Disorder 1s
=450  \\$wnnna$aVerbal Apraxia
=450  \\$wnnna$aVerbal Apraxia, Developmental
=450  \\$wnnna$aVerbal Apraxias
=450  \\$wnnna$aVerbal Apraxias, Developmental
=450  \\$wnnna$aVerbal Dyspraxia
=450  \\$wnnna$aVerbal Dyspraxia, Developmental
=450  \\$wnnna$aVerbal Dyspraxias
=450  \\$wnnna$aVerbal Dyspraxias, Developmental
=550  \\$wg$aNeurobehavioral Manifestations
=550  \\$wg$aPsychomotor Disorders
=550  \\$wh$aAlien Hand Syndrome
=550  \\$wh$aApraxia, Ideomotor
=550  \\$wh$aGait Apraxia
=680  \\$iA group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor (see APRAXIA, IDEOMOTOR) and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. (From Adams et al., Principles of Neurology, 6th ed, pp56-7)
=688  \\$a2000(1966)
=750  \0$aApraxia$0(DLC) sh 85006193$5IEN-M

=LDR  01203cz  a2200349n  4500
=001  9880363216002441
=005  20141212194922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001071
=035  \\$aCAZ4225HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x95
=150  \\$aAppointments and Schedules
=450  \\$wnnna$aAppointment
=450  \\$wnnna$aAppointment, Patient
=450  \\$wnnna$aAppointments
=450  \\$wnnna$aAppointments, Patient
=450  \\$wnnna$aPatient Appointment
=450  \\$aPatient Appointments
=450  \\$wnnna$aPatient Schedule
=450  \\$aPatient Schedules
=450  \\$wnnna$aSchedule
=450  \\$wnnna$aSchedule, Patient
=450  \\$wnnna$aSchedules
=450  \\$wnnna$aSchedules and Appointments
=450  \\$aSchedules, Patient
=550  \\$wg$aOrganization and Administration
=550  \\$wh$aWaiting Lists
=667  \\$ano qualif; DF: APPOINTMENTS
=680  \\$iThe different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc.
=688  \\$a68
=750  \0$aMedical appointments and schedules$5IEN$0(DLC)sh 85082860

=LDR  01258cz  a2200397n  4500
=001  9880363216102441
=005  20141212194921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001067
=035  \\$aCAZ4222HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x140.$x155
=150  \\$aAppetite Depressants
=450  \\$wnnna$aAgents, Anorectic
=450  \\$wnnna$aAnorectic Agents
=450  \\$aAnorectics
=450  \\$wnnna$aAnorexic Drugs
=450  \\$wnnna$aAnorexigenic Drugs
=450  \\$wnnna$aAppetite-Depressing Drugs
=450  \\$wnnna$aAppetite Depressing Drugs
=450  \\$wnnna$aAppetite-Suppressant Drugs
=450  \\$wnnna$aAppetite Suppressant Drugs
=450  \\$aAppetite Suppressants
=450  \\$wnnna$aDepressants, Appetite
=450  \\$wnnna$aDrugs, Anorexic
=450  \\$wnnna$aDrugs, Anorexigenic
=450  \\$wnnna$aDrugs, Appetite-Depressing
=450  \\$wnnna$aDrugs, Appetite-Suppressant
=450  \\$wnnna$aSuppressants, Appetite
=550  \\$wg$aAnti-Obesity Agents
=550  \\$aAmphetamines
=550  \\$aAppetite
=550  \\$aObesity
=550  \\$aSincalide
=680  \\$iAgents that are used to suppress appetite.
=750  \0$aAppetite depressants$5IEN$0(DLC)sh 85006101

=LDR  00856cz  a2200277n  4500
=001  9880363216202441
=005  20141212191958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001066
=035  \\$aCAZ4221HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x830.$x71
=072  \\$aG7.$x610.$x390.$x70
=072  \\$aG10.$x261.$x390.$x70
=150  \\$aAppetite
=450  \\$wnnna$aAlteration, Appetite
=450  \\$wnnna$aAlterations, Appetite
=450  \\$wnnna$aAppetite Alteration
=450  \\$wnnna$aAppetite Alterations
=450  \\$wnnna$aAppetites
=550  \\$wg$aHunger
=550  \\$wg$aPsychophysiology
=550  \\$wh$aAppetite Regulation
=550  \\$aCraving
=680  \\$iNatural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS.
=750  \0$aAppetite$5IEN$0(DLC)sh 85006099

=LDR  00764cz  a2200205n  4500
=001  9880363216302441
=005  20141212194920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001065
=035  \\$aCAZ4220HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526.$x209.$x290
=072  \\$aA3.$x556.$x249.$x249.$x209.$x290
=150  \\$aAppendix
=450  \\$wnnna$aAppendix, Vermiform
=450  \\$wnnna$aVermiform Appendix
=550  \\$wg$aCecum
=667  \\$a/surg: probably APPENDECTOMY; diseases: coord IM with CECAL DISEASES (IM); inflammation = APPENDICITIS; "ruptured" or "perforated" appendix: see note under APPENDICITIS
=680  \\$iA worm-like blind tube extension from the CECUM.
=750  \0$aAppendix (Anatomy)$5IEN$0(DLC)sh 85006091

=LDR  00840cz  a2200253n  4500
=001  9880363216402441
=005  20141212194920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001064
=035  \\$aCAZ4219HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x463.$x99
=072  \\$aC6.$x405.$x205.$x99
=072  \\$aC6.$x405.$x469.$x110.$x207
=150  \\$aAppendicitis
=450  \\$wnnna$aAppendicitis, Perforated
=450  \\$wnnna$aAppendicitis, Ruptured
=450  \\$wnnna$aPerforated Appendicitis
=450  \\$wnnna$aRuptured Appendicitis
=550  \\$wg$aCecal Diseases
=550  \\$wg$aGastroenteritis
=550  \\$wg$aIntraabdominal Infections
=680  \\$iAcute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.
=750  \0$aAppendicitis$5IEN$0(DLC)sh 85006090

=LDR  00592cz  a2200193n  4500
=001  9880363216502441
=005  20141212194919.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001062
=035  \\$aCAZ4217HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x78
=150  \\$aAppendectomy
=450  \\$wnnna$aAppendectomies
=550  \\$wg$aDigestive System Surgical Procedures
=550  \\$aAppendix
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical removal of the vermiform appendix. (Dorland, 28th ed)
=750  \0$aAppendectomy$5IEN$0(DLC)sh 85006088

=LDR  01967cz  a2200457n  4500
=001  9880363216602441
=005  20141212194918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001058
=035  \\$aCAZ4213HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x98.$x38.$x290
=072  \\$aD3.$x438.$x531.$x85.$x30.$x290
=072  \\$aD3.$x549.$x95.$x290
=150  \\$aApomorphine
=450  \\$wnnna$aAguettant Brand of Apomorphine Hydrochloride
=450  \\$wnnna$aAnhydrous Apomorphine Hydrochloride
=450  \\$wnnna$aAnhydrous, Apomorphine Hydrochloride
=450  \\$wnnna$aApokinon
=450  \\$wnnna$aApomorphin-Teclapharm
=450  \\$wnnna$aApomorphin Teclapharm
=450  \\$wnnna$aApomorphine Chloride
=450  \\$wnnna$aApomorphine Hydrochloride
=450  \\$wnnna$aApomorphine Hydrochloride Anhydrous
=450  \\$wnnna$aApomorphine Hydrochloride, Anhydrous
=450  \\$wnnna$aApomorphine Hydrochloride, Hemihydrate
=450  \\$wnnna$aApomorphinTeclapharm
=450  \\$wnnna$aBritaject
=450  \\$wnnna$aBritannia Brand of Apomorphine Hydrochloride
=450  \\$wnnna$aChloride, Apomorphine
=450  \\$wnnna$aHemihydrate Apomorphine Hydrochloride
=450  \\$wnnna$aHydrochloride Anhydrous, Apomorphine
=450  \\$wnnna$aHydrochloride, Anhydrous Apomorphine
=450  \\$wnnna$aHydrochloride, Apomorphine
=450  \\$wnnna$aHydrochloride, Hemihydrate Apomorphine
=450  \\$wnnna$aTeclapharm Brand of Apomorphine Hydrochloride
=550  \\$wg$aAporphines
=667  \\$aapomorphine derivatives = APOMORPHINE/analogs
=680  \\$iA derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.
=688  \\$aAPOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77
=750  \0$aApomorphine$5IEN$0(DLC)sh 85006044

=LDR  01760cz  a2200361n  4500
=001  9880363216702441
=005  20141212194917.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001057
=035  \\$aCAZ4212HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x91.$x500
=072  \\$aD12.$x776.$x70.$x400.$x500
=072  \\$aD12.$x776.$x521.$x120.$x500
=150  \\$aApolipoproteins E
=450  \\$wnnna$aApo E
=450  \\$aApo-E
=450  \\$wnnna$aApo E Isoproteins
=450  \\$wnnna$aApoE
=450  \\$wnnna$aApolipoprotein E Isoproteins
=450  \\$wnnna$aApoprotein (E)
=450  \\$wnnna$aApoproteins E
=450  \\$wnnna$aIsoproteins, Apo E
=450  \\$wnnna$aIsoproteins, Apolipoprotein E
=550  \\$wg$aApolipoproteins
=550  \\$wh$aApolipoprotein E2
=550  \\$wh$aApolipoprotein E3
=550  \\$wh$aApolipoprotein E4
=550  \\$aLow Density Lipoprotein Receptor-Related Protein-1
=680  \\$iA class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III.
=688  \\$a1985; for APOLIPOPROTEIN E ISOPROTEINS use APOLIPOPROTEINS E 1985-2006 & use APOLIPOPROTEINS 1983-1984
=688  \\$a85; APOLIPOPROTEIN E was see APOLIPOPROTEINS E 1985-93
=750  \0$aApolipoprotein E$5IEN-M$0(DLC)sh 93009095

=LDR  01334cz  a2200277n  4500
=001  9880363216802441
=005  20141212194917.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001055
=035  \\$aCAZ4210M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x91.$x300
=072  \\$aD12.$x776.$x70.$x400.$x300
=072  \\$aD12.$x776.$x521.$x120.$x300
=150  \\$aApolipoproteins B
=450  \\$wnnna$aApo B
=450  \\$aApo-B
=450  \\$wnnna$aApoB
=450  \\$wnnna$aApoprotein (B)
=450  \\$wnnna$aApoproteins B
=550  \\$wg$aApolipoproteins
=550  \\$wh$aApolipoprotein B-100
=550  \\$wh$aApolipoprotein B-48
=680  \\$iMajor structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA.
=688  \\$a85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93
=750  \0$aApolipoprotein B$0(DLC) sh2004004536$5IEN-M

=LDR  01111cz  a2200301n  4500
=001  9880363216902441
=005  20141212194916.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001053
=035  \\$aCAZ4208HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x532.$x91
=072  \\$aD12.$x776.$x70.$x400
=072  \\$aD12.$x776.$x521.$x120
=150  \\$aApolipoproteins
=450  \\$wnnna$aApolipoprotein
=550  \\$wg$aApoproteins
=550  \\$wg$aLipoproteins
=550  \\$wh$aApolipoproteins A
=550  \\$wh$aApolipoproteins B
=550  \\$wh$aApolipoproteins C
=550  \\$wh$aApolipoproteins D
=550  \\$wh$aApolipoproteins E
=550  \\$aLipoproteins
=667  \\$ageneral; prefer specifics
=680  \\$iProtein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.
=688  \\$a77
=750  \0$aApolipoproteins$0(DLC) sh 86003932$5IEN

=LDR  00770cz  a2200217n  4500
=001  9880363217002441
=005  20141212194915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001050
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x336.$x899.$x206
=072  \\$aA17.$x815.$x830.$x206
=150  \\$aApocrine Glands
=450  \\$wnnna$aApocrine Gland
=450  \\$wnnna$aGland, Apocrine
=450  \\$wnnna$aGlands, Apocrine
=550  \\$wg$aSweat Glands
=667  \\$a/secret: consider also SWEAT or SWEATING
=680  \\$iLarge, branched, specialized sweat glands that empty into the upper portion of a HAIR FOLLICLE instead of directly onto the SKIN.
=688  \\$a91(75); was see under SWEAT GLANDS 1975-90
=750  \0$aApocrine glands$5IEN$0(DLC)sh 85006004

=LDR  00768cz  a2200229n  4500
=001  9880363217102441
=005  20141212194914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001049
=035  \\$aCAZ4204HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x85
=072  \\$aC23.$x888.$x852.$x130
=150  \\$aApnea
=450  \\$wnnna$aApneas
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wh$aSleep Apnea Syndromes
=550  \\$aRespiration
=667  \\$ado not confuse APNEA with other resp disord: use only when text uses APNEA; apnea neonatorum = APNEA + check tags INFANT, NEWBORN + HUMAN
=680  \\$iA transient absence of spontaneous respiration.
=750  \0$aApnea$5IEN$0(DLC)sh 85005999

=LDR  00782cz  a2200193n  4500
=001  9880363217202441
=005  20141212194914.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001048
=035  \\$aCAZ4203HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x400.$x60
=150  \\$aAplysia
=450  \\$wnnna$aAplysias
=550  \\$wg$aGastropoda
=667  \\$amollusk; /microbiol /parasitol /virol permitted
=680  \\$iAn opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya (seaweed) species.
=688  \\$a78
=750  \0$aAplysia$5IEN$0(DLC)sh 88020907

=LDR  00773cz  a2200241n  4500
=001  9880363217302441
=005  20141212194914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001047
=035  \\$aCAZ4202HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x100
=072  \\$aE6.$x397.$x102
=072  \\$aE6.$x645.$x100
=150  \\$aApicoectomy
=450  \\$wnnna$aApicoectomies
=550  \\$wg$aEndodontics
=550  \\$wg$aOral Surgical Procedures
=550  \\$aTooth Apex
=667  \\$ado not use /util except by MeSH definition
=680  \\$iExcision of the apical portion of a tooth through an opening made in the overlying labial, buccal, or palatal alveolar bone. (Dorland, 28th ed)
=688  \\$a65
=750  \0$aApicoectomy$5IEN$0(DLC)sh 85005980

=LDR  00758cz  a2200217n  4500
=001  9880363217402441
=005  20141212194914.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001046
=035  \\$aCAZ4201HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x282.$x45
=072  \\$aD27.$x505.$x954.$x427.$x220.$x45
=150  \\$aAphrodisiacs
=450  \\$wnnna$aAphrodisiac Effect
=450  \\$wnnna$aAphrodisiac Effects
=450  \\$wnnna$aEffect, Aphrodisiac
=450  \\$wnnna$aEffects, Aphrodisiac
=550  \\$wg$aCentral Nervous System Stimulants
=680  \\$iChemical agents or odors that stimulate sexual desires. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aAphrodisiacs$5IEN$0(DLC)sh 85005968

=LDR  01003cz  a2200253n  4500
=001  9880363217502441
=005  20141212194913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001045
=035  \\$aCAZ4200HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x517.$x116
=150  \\$aAphorisms and Proverbs as Topic
=450  \\$wnnna$aFables as Topic
=450  \\$wnnna$aFables as Topics
=450  \\$wnnna$aProverbs and Aphorisms as Topic
=450  \\$wnnna$aProverbs as Topic
=450  \\$wnnna$aProverbs as Topics
=550  \\$wg$aLiterature
=667  \\$aincludes fables & maxims; do not confuse with Publication Type APHORISMS AND PROVERBS
=680  \\$iShort popular sayings effectively expressing or astutely professing general truths or useful thoughts. (From Random House Unabridged Dictionary, 2d ed, p97, p1556)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Aphorisms and Proverbs
=750  \0$aAphorisms and apothegms$0(DLC) sh 85005966$5IEN-HS

=LDR  01098cz  a2200337n  4500
=001  9880363217602441
=005  20141212194913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001042
=035  \\$aCAZ4197HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x412.$x165
=150  \\$aAphids
=450  \\$wnnna$aAphid
=450  \\$aAphididae
=450  \\$aLice, Plant
=450  \\$wnnna$aLices, Plant
=450  \\$wnnna$aLouse, Plant
=450  \\$wnnna$aLouses, Plant
=450  \\$aMyzus
=450  \\$aPlant Lice
=450  \\$wnnna$aPlant Lices
=450  \\$wnnna$aPlant Louse
=450  \\$wnnna$aPlant Louses
=450  \\$wnnna$aSchizaphi
=450  \\$aSchizaphis
=550  \\$wg$aHemiptera
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iA family (Aphididae) of small insects, in the suborder Sternorrhyncha, that suck the juices of plants. Important genera include Schizaphis and Myzus. The latter is known to carry more than 100 virus diseases between plants.
=688  \\$a72
=750  \0$aAphids$0(DLC) sh 85005957$5IEN

=LDR  02845cz  a2200745n  4500
=001  9880363217702441
=005  20141212191958.0
=008  781214\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001039
=035  \\$aCAZ4194HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x100.$x100
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x100.$x100
=150  \\$aAphasia, Broca
=450  \\$wnnna$aAgrammatic Broca Aphasia
=450  \\$wnnna$aAgrammatic Broca Aphasias
=450  \\$wnnna$aAgrammatic Broca's Aphasia
=450  \\$wnnna$aAgrammatic Brocas Aphasia
=450  \\$wnnna$aAgrammatic Broca's Aphasias
=450  \\$aAgrammatism
=450  \\$wnnna$aAnterior Aphasia
=450  \\$wnnna$aAnterior Aphasias
=450  \\$wnnna$aAphasia, Agrammatic Broca
=450  \\$wnnna$aAphasia, Agrammatic Broca's
=450  \\$wnnna$aAphasia, Anterior
=450  \\$wnnna$aAphasia, Ataxic
=450  \\$wnnna$aAphasia, Expressive
=450  \\$wnnna$aAphasia, Frontocortical
=450  \\$aAphasia, Motor
=450  \\$aAphasia, Nonfluent
=450  \\$wnnna$aAphasia Syndrome, Verbal
=450  \\$wnnna$aAphasia Syndromes, Verbal
=450  \\$wnnna$aAphasias, Agrammatic Broca
=450  \\$wnnna$aAphasias, Agrammatic Broca's
=450  \\$wnnna$aAphasias, Anterior
=450  \\$wnnna$aAphasias, Ataxic
=450  \\$wnnna$aAphasias, Broca
=450  \\$wnnna$aAphasias, Frontocortical
=450  \\$wnnna$aAtaxic Aphasia
=450  \\$wnnna$aAtaxic Aphasias
=450  \\$aBroca Aphasia
=450  \\$wnnna$aBroca Aphasia, Agrammatic
=450  \\$wnnna$aBroca Aphasias
=450  \\$wnnna$aBroca Aphasias, Agrammatic
=450  \\$wnnna$aBroca Dysphasia
=450  \\$wnnna$aBroca's Aphasia, Agrammatic
=450  \\$wnnna$aBroca's Aphasias, Agrammatic
=450  \\$wnnna$aBroca's Dysphasia
=450  \\$aDysphasia, Broca
=450  \\$wnnna$aDysphasia, Broca's
=450  \\$wnnna$aDysphasia, Brocas
=450  \\$wnnna$aExpressive Aphasia
=450  \\$wnnna$aFrontocortical Aphasia
=450  \\$wnnna$aFrontocortical Aphasias
=450  \\$wnnna$aMotor Aphasia
=450  \\$wnnna$aNonfluent Aphasia
=450  \\$wnnna$aSyndrome, Verbal Aphasia
=450  \\$wnnna$aSyndromes, Verbal Aphasia
=450  \\$wnnna$aVerbal Aphasia Syndrome
=450  \\$wnnna$aVerbal Aphasia Syndromes
=550  \\$wg$aAphasia
=667  \\$ado not confuse with APHASIA, WERNICKE
=680  \\$iAn aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).
=688  \\$a1991(1980)
=750  \0$aAgrammatism$5IEN$0(DLC)sh 85002252

=LDR  04511cz  a2201237n  4500
=001  9880363217802441
=005  20141212194911.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001037
=035  \\$aCAZ4192HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x800.$x100
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x800.$x100
=150  \\$aAphasia
=450  \\$wnnna$aAcquired Aphasia
=450  \\$wnnna$aAgeusic Aphasia
=450  \\$wnnna$aAgeusic Aphasias
=450  \\$wnnna$aAlogia
=450  \\$wnnna$aAlogias
=450  \\$wnnna$aAnepia
=450  \\$wnnna$aAnepias
=450  \\$aAphasia, Acquired
=450  \\$wnnna$aAphasia, Ageusic
=450  \\$wnnna$aAphasia, Auditory Discriminatory
=450  \\$wnnna$aAphasia, Commisural
=450  \\$wnnna$aAphasia, Functional
=450  \\$wnnna$aAphasia, Global
=450  \\$wnnna$aAphasia, Graphomotor
=450  \\$wnnna$aAphasia, Intellectual
=450  \\$wnnna$aAphasia, Mixed
=450  \\$wnnna$aAphasia, Post-Ictal
=450  \\$wnnna$aAphasia, Post Ictal
=450  \\$wnnna$aAphasia, Post-Traumatic
=450  \\$wnnna$aAphasia, Post Traumatic
=450  \\$wnnna$aAphasia, Progressive
=450  \\$wnnna$aAphasia, Semantic
=450  \\$wnnna$aAphasia, Syntactical
=450  \\$wnnna$aAphasias, Ageusic
=450  \\$wnnna$aAphasias, Auditory Discriminatory
=450  \\$wnnna$aAphasias, Commisural
=450  \\$wnnna$aAphasias, Functional
=450  \\$wnnna$aAphasias, Global
=450  \\$wnnna$aAphasias, Graphomotor
=450  \\$wnnna$aAphasias, Intellectual
=450  \\$wnnna$aAphasias, Mixed
=450  \\$wnnna$aAphasias, Post-Ictal
=450  \\$wnnna$aAphasias, Post-Traumatic
=450  \\$wnnna$aAphasias, Progressive
=450  \\$wnnna$aAphasias, Semantic
=450  \\$wnnna$aAphasias, Syntactical
=450  \\$wnnna$aAuditory Discriminatory Aphasia
=450  \\$wnnna$aAuditory Discriminatory Aphasias
=450  \\$wnnna$aCommisural Aphasia
=450  \\$wnnna$aCommisural Aphasias
=450  \\$wnnna$aDejerine-Lichtheim Phenomenon
=450  \\$wnnna$aDejerine Lichtheim Phenomenon
=450  \\$wnnna$aDiscriminatory Aphasia, Auditory
=450  \\$wnnna$aDiscriminatory Aphasias, Auditory
=450  \\$aDysphasia
=450  \\$wnnna$aDysphasia, Global
=450  \\$wnnna$aDysphasias, Global
=450  \\$wnnna$aFunctional Aphasia
=450  \\$wnnna$aFunctional Aphasias
=450  \\$wnnna$aGlobal Aphasia
=450  \\$wnnna$aGlobal Aphasias
=450  \\$wnnna$aGlobal Dysphasia
=450  \\$wnnna$aGlobal Dysphasias
=450  \\$wnnna$aGraphomotor Aphasia
=450  \\$wnnna$aGraphomotor Aphasias
=450  \\$wnnna$aIntellectual Aphasia
=450  \\$wnnna$aIntellectual Aphasias
=450  \\$wnnna$aLichtheim Sign
=450  \\$wnnna$aLichtheim's Sign
=450  \\$wnnna$aLichtheims Sign
=450  \\$wnnna$aLogagnosia
=450  \\$wnnna$aLogagnosias
=450  \\$wnnna$aLogamnesia
=450  \\$wnnna$aLogamnesias
=450  \\$wnnna$aLogasthenia
=450  \\$wnnna$aLogasthenias
=450  \\$wnnna$aMixed Aphasia
=450  \\$wnnna$aMixed Aphasias
=450  \\$wnnna$aPhenomenon, Dejerine-Lichtheim
=450  \\$wnnna$aPost-Ictal Aphasia
=450  \\$wnnna$aPost-Ictal Aphasias
=450  \\$wnnna$aPost-Traumatic Aphasia
=450  \\$wnnna$aPost-Traumatic Aphasias
=450  \\$wnnna$aProgressive Aphasia
=450  \\$wnnna$aProgressive Aphasias
=450  \\$wnnna$aSemantic Aphasia
=450  \\$wnnna$aSemantic Aphasias
=450  \\$wnnna$aSign, Lichtheim's
=450  \\$wnnna$aSyntactical Aphasia
=450  \\$wnnna$aSyntactical Aphasias
=550  \\$wg$aSpeech Disorders
=550  \\$wh$aAphasia, Broca
=550  \\$wh$aAphasia, Conduction
=550  \\$wh$aAphasia, Primary Progressive
=550  \\$wh$aAphasia, Wernicke
=550  \\$aDominance, Cerebral
=550  \\$aLandau-Kleffner Syndrome
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iA cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
=688  \\$a1963
=750  \0$aAphasia$5IEN-M$0(DLC)sh 85005950
=750  \0$aAphasic persons$5IEN-HS$0(DLC)sh 85005953

=LDR  00970cz  a2200217n  4500
=001  9880363217902441
=005  20141212194909.0
=008  770411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001035
=035  \\$aCAZ4190HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x510.$x103
=150  \\$aAphakia
=450  \\$wnnna$aAphakias
=550  \\$wg$aLens Diseases
=550  \\$wh$aAphakia, Postcataract
=550  \\$aLens, Crystalline
=667  \\$aabsence of lens from any cause (congen, inj, dis); /congen permitted; after cataract extract = APHAKIA, POSTCATARACT; "aphakic eye" is probably APHAKIA, POSTCATARACT but PSEUDOPHAKIA is available for the postcataract eye fitted with an intraocular lens
=680  \\$iAbsence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.
=688  \\$a78
=750  \0$aAphakia$5IEN$0(DLC)sh 85005947

=LDR  01037cz  a2200193n  4500
=001  9880363218002441
=005  20141212194909.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001034
=035  \\$aCAZ4189HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x600.$x50
=150  \\$aApgar Score
=450  \\$wnnna$aScore, Apgar
=550  \\$wg$aPhysical Examination
=667  \\$acheck the tags HUMANS & INFANT, NEWBORN
=680  \\$iA method, developed by Dr. Virginia Apgar, to evaluate a newborn's adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.
=688  \\$a73(71)
=750  \0$aApgar score$5IEN$0(DLC)sh 85005946

=LDR  01192cz  a2200313n  4500
=001  9880363218102441
=005  20141212194909.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001032
=035  \\$aCAZ4187HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x931.$x190
=150  \\$aApazone
=450  \\$wnnna$a5-(Dimethylamino)-9-methyl-2-propyl-1H-pyrazolo(1,2-a)(1,2,4)benzotriazine-1,3(2H)-dione
=450  \\$wnnna$aApazone Dihydrate
=450  \\$wnnna$aASTA Medica Brand of Azapropazone
=450  \\$aAzapropazone
=450  \\$wnnna$aDagra Brand of Azapropazone Dihydrate
=450  \\$wnnna$aDihydrate, Apazone
=450  \\$wnnna$aDu Pont Brand of Azapropazone Dihydrate
=450  \\$wnnna$aProlixan
=450  \\$wnnna$aRheumox
=450  \\$wnnna$aRobins Brand of Azapropazone Dihydrate
=450  \\$wnnna$aTolyprin
=450  \\$wnnna$aWyeth Brand of Azapropazone Dihydrate
=550  \\$wg$aTriazines
=680  \\$iAn anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.
=688  \\$a91(75); was see under TRIAZINES 1975-90
=750  \0$aAzapropazone$5IEN$0(DLC)sh 85010628

=LDR  00932cz  a2200241n  4500
=001  9880363218202441
=005  20141212194908.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001031
=035  \\$aCAZ4186HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x29.$x260.$x700.$x675.$x374.$x75.$x25
=072  \\$aD1.$x146.$x360.$x50
=072  \\$aD1.$x578.$x122
=072  \\$aD1.$x695.$x625.$x675.$x650.$x75.$x25
=150  \\$aApatites
=550  \\$wg$aCalcium Phosphates
=550  \\$wg$aMinerals
=550  \\$wh$aHydroxyapatites
=667  \\$aa group of phosphate minerals
=680  \\$iA group of phosphate minerals that includes ten mineral species and has the general formula X5(YO4)3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a66(64)
=750  \0$aApatite$5IEN$0(DLC)sh 85005932

=LDR  00848cz  a2200229n  4500
=001  9880363218302441
=005  20141212194907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001027
=035  \\$aCAZ4182HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x700.$x60.$x70
=072  \\$aE1.$x370.$x370.$x50.$x70
=150  \\$aAortography
=450  \\$aAorta$xradiography
=450  \\$wnnna$aAortographies
=550  \\$wg$aAngiography
=550  \\$aAorta
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: AORTOGR
=680  \\$iRadiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.
=688  \\$a66; was see under ANGIOGRAPHY 1963-65
=750  \0$aAorta$xRadiography$5IEN$0(DLC)sh 85005861

=LDR  01681cz  a2200421n  4500
=001  9880363218402441
=005  20141212194907.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001026
=035  \\$aCAZ4181HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x376.$x719.$x332
=072  \\$aE4.$x100.$x814.$x868.$x750
=072  \\$aE4.$x928.$x220.$x520.$x220
=150  \\$aCoronary Artery Bypass
=450  \\$aAortocoronary Bypass
=450  \\$wnnna$aAortocoronary Bypasses
=450  \\$wnnna$aArtery Bypass, Coronary
=450  \\$wnnna$aArtery Bypasses, Coronary
=450  \\$wnnna$aBypass, Aortocoronary
=450  \\$aBypass, Coronary Artery
=450  \\$wnnna$aBypass Surgery, Coronary Artery
=450  \\$wnnna$aBypasses, Aortocoronary
=450  \\$wnnna$aBypasses, Coronary Artery
=450  \\$wnnna$aCoronary Artery Bypass Grafting
=450  \\$wnnna$aCoronary Artery Bypass Surgery
=450  \\$wnnna$aCoronary Artery Bypasses
=550  \\$wg$aMyocardial Revascularization
=550  \\$wg$aVascular Grafting
=550  \\$wh$aCoronary Artery Bypass, Off-Pump
=550  \\$wh$aInternal Mammary-Coronary Artery Anastomosis
=550  \\$aAorta
=550  \\$aCoronary Disease
=550  \\$aCoronary Vessels
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
=688  \\$a90; was AORTOCORONARY BYPASS 1973-89 (Prov 1972)
=750  \0$aCoronary artery bypass$5IEN$0(DLC)sh 85005874

=LDR  00546cz  a2200205n  4500
=001  9880363218502441
=005  20141212194906.0
=008  790424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001025
=035  \\$aCAZ4180HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x109.$x320
=072  \\$aC14.$x907.$x940.$x80
=150  \\$aAortitis
=450  \\$wnnna$aAortitides
=550  \\$wg$aAortic Diseases
=550  \\$wg$aVasculitis
=680  \\$iInflammation of the wall of the AORTA.
=688  \\$a80
=750  \0$aAortitis$0(DLC) sh 85005873$5IEN

=LDR  01303cz  a2200325n  4500
=001  9880363218602441
=005  20141212194906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001024
=035  \\$aCAZ4179HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x150
=072  \\$aC14.$x280.$x955.$x249
=150  \\$aAortic Valve Stenosis
=450  \\$aAortic Stenosis
=450  \\$wnnna$aAortic Valve Stenoses
=450  \\$wnnna$aStenoses, Aortic
=450  \\$wnnna$aStenoses, Aortic Valve
=450  \\$wnnna$aStenosis, Aortic
=450  \\$wnnna$aStenosis, Aortic Valve
=450  \\$wnnna$aValve Stenoses, Aortic
=450  \\$wnnna$aValve Stenosis, Aortic
=550  \\$wg$aHeart Valve Diseases
=550  \\$wg$aVentricular Outflow Obstruction
=550  \\$wh$aAortic Stenosis, Subvalvular
=550  \\$wh$aAortic Stenosis, Supravalvular
=667  \\$aaortic valve atresia = AORTIC VALVE /abnorm
=680  \\$iA pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
=688  \\$a67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66
=750  \0$aAortic valve$xStenosis$0(DLC) sh 85005871$5IEN

=LDR  01088cz  a2200265n  4500
=001  9880363218702441
=005  20141212194905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001022
=035  \\$aCAZ4177HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x484.$x95
=150  \\$aAortic Valve Insufficiency
=450  \\$aAortic Incompetence
=450  \\$aAortic Regurgitation
=450  \\$aAortic Valve Incompetence
=450  \\$wnnna$aIncompetence, Aortic
=450  \\$wnnna$aIncompetence, Aortic Valve
=450  \\$wnnna$aInsufficiency, Aortic Valve
=450  \\$wnnna$aRegurgitation, Aortic
=450  \\$wnnna$aRegurgitation, Aortic Valve
=550  \\$wg$aHeart Valve Diseases
=680  \\$iPathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
=688  \\$a67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92
=750  \0$aAortic valve insufficiency$5IEN$0(DLC)sh 85005870

=LDR  00801cz  a2200217n  4500
=001  9880363218802441
=005  20141212194905.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001021
=035  \\$aCAZ4176HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x510.$x110
=150  \\$aAortic Valve
=450  \\$wnnna$aAortic Valves
=450  \\$wnnna$aValve, Aortic
=450  \\$wnnna$aValves, Aortic
=550  \\$wg$aHeart Valves
=667  \\$adis: coord IM with HEART VALVE DISEASES (IM) but note specific aortic valve dis; atresia: index AORTIC VALVE /abnorm
=680  \\$iThe valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.
=688  \\$aAORTIC VALVE DISEASES was heading 1963-66
=750  \0$aAortic valve$5IEN$0(DLC)sh 85005867

=LDR  00848cz  a2200253n  4500
=001  9880363218902441
=005  20141212194904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001018
=035  \\$aCAZ4173HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x109
=150  \\$aAortic Diseases
=450  \\$wnnna$aAortic Disease
=450  \\$wnnna$aDisease, Aortic
=450  \\$wnnna$aDiseases, Aortic
=550  \\$wg$aVascular Diseases
=550  \\$wh$aAortic Aneurysm
=550  \\$wh$aAortic Arch Syndromes
=550  \\$wh$aAortitis
=550  \\$wh$aLeriche Syndrome
=667  \\$ainflammatory disease = AORTITIS but note AORTITIS, SYPHILITIC; GIANT CELL AORTITIS; and AORTITIS SYNDROME are also available
=680  \\$iPathological processes involving any part of the AORTA.
=750  \0$aAorta$xDiseases$5IEN$0(DLC)sh 85005858

=LDR  01234cz  a2200301n  4500
=001  9880363219002441
=005  20141212194904.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001017
=035  \\$aCAZ4172HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x90
=072  \\$aC14.$x280.$x400.$x90
=072  \\$aC16.$x131.$x240.$x400.$x90
=150  \\$aAortic Coarctation
=450  \\$wnnna$aAorta Coarctation
=450  \\$wnnna$aAorta Coarctations
=450  \\$wnnna$aAorta Dominant Coarctation
=450  \\$wnnna$aAorta Dominant Coarctations
=450  \\$wnnna$aAortic Coarctations
=450  \\$wnnna$aCoarctation, Aortic
=450  \\$wnnna$aCoarctation of Aorta
=450  \\$wnnna$aCoarctation of Aorta Dominant
=450  \\$wnnna$aCoarctation of the Aorta
=450  \\$wnnna$aCoarctations, Aortic
=550  \\$wg$aHeart Defects, Congenital
=680  \\$iA birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.
=750  \0$aAortic coarctation$5IEN$0(DLC)sh 85005865

=LDR  00996cz  a2200277n  4500
=001  9880363219102441
=005  20141212194903.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001014
=035  \\$aCAZ4169HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x55.$x239
=072  \\$aC14.$x907.$x109.$x139
=150  \\$aAortic Aneurysm
=450  \\$wnnna$aAneurysm, Aortic
=450  \\$wnnna$aAneurysms, Aortic
=450  \\$wnnna$aAortic Aneurysms
=550  \\$wg$aAneurysm
=550  \\$wg$aAortic Diseases
=550  \\$wh$aAortic Aneurysm, Abdominal
=550  \\$wh$aAortic Aneurysm, Thoracic
=550  \\$wh$aAortic Rupture
=550  \\$wh$aLoeys-Dietz Syndrome
=667  \\$ageneral or unspecified; prefer specifics; ruptured aortic aneurysm = AORTIC RUPTURE; for dissecting aneurysm of aorta, coordinate IM with ANEURYSM, DISSECTING (IM)
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of AORTA.
=750  \0$aAortic aneurysms$5IEN$0(DLC)sh 85005864

=LDR  00661cz  a2200205n  4500
=001  9880363219202441
=005  20141212194902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001012
=035  \\$aCAZ4167HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x56.$x205
=150  \\$aAorta, Abdominal
=450  \\$wnnna$aAbdominal Aorta
=450  \\$wnnna$aAbdominal Aortas
=450  \\$wnnna$aAortas, Abdominal
=550  \\$wg$aAorta
=667  \\$acoord NIM with aortic dis terms (IM)
=680  \\$iThe aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries.
=750  \0$aAbdominal aorta$5IEN$0(DLC)sh 85000106

=LDR  00849cz  a2200265n  4500
=001  9880363219302441
=005  20141212194902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001011
=035  \\$aCAZ4166HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x56
=150  \\$aAorta
=450  \\$aAorta, Ascending
=450  \\$wnnna$aAortas
=450  \\$wnnna$aAortas, Ascending
=450  \\$wnnna$aAscending Aorta
=450  \\$wnnna$aAscending Aortas
=550  \\$wg$aArteries
=550  \\$wh$aAorta, Abdominal
=550  \\$wh$aAorta, Thoracic
=550  \\$wh$aSinus of Valsalva
=667  \\$a/surg: consider also CORONARY ARTERY BYPASS; inflammation = AORTITIS but note also AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR
=680  \\$iThe main trunk of the systemic arteries.
=750  \0$aAorta$5IEN$0(DLC)sh 85005856

=LDR  00838cz  a2200229n  4500
=001  9880363219402441
=005  20170717161654.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001010
=035  \\$aCAZ4165HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x300
=072  \\$aF3.$x625.$x47
=150  \\$aAnxiety, Separation
=450  \\$wnnna$aAnxiety Disorder, Separation
=450  \\$wnnna$aSeparation Anxiety
=450  \\$aSeparation Anxiety Disorder
=550  \\$wg$aAnxiety Disorders
=550  \\$wg$aNeurodevelopmental Disorders
=680  \\$iAnxiety experienced by an individual upon separation from a person or object of particular significance to him.
=688  \\$a68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74
=750  \0$aSeparation anxiety$5IEN-HS$0(DLC)sh 93001187

=LDR  00714cz  a2200241n  4500
=001  9880363219502441
=005  20141212194902.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001009
=035  \\$aCAZ4164HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470.$x132.$x150
=150  \\$aAnxiety, Castration
=450  \\$wnnna$aCastration Anxiety
=450  \\$aCastration Complex
=450  \\$wnnna$aCastration Complices
=450  \\$wnnna$aComplex, Castration
=450  \\$wnnna$aComplices, Castration
=550  \\$wg$aAnxiety
=550  \\$wh$aKoro
=680  \\$iAnxiety due to fantasized injuries to or loss of the genitals.
=688  \\$a70(65)
=750  \0$aCastration anxiety$5IEN$0(DLC)sh 85020753

=LDR  01235cz  a2200397n  4500
=001  9880363219602441
=005  20171212103618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001008
=035  \\$aCAZ4163HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80
=150  \\$aAnxiety Disorders
=450  \\$wnnna$aAnxiety Disorder
=450  \\$aAnxiety Neuroses
=450  \\$wnnna$aAnxiety State, Neurotic
=450  \\$aAnxiety States, Neurotic
=450  \\$wnnna$aDisorder, Anxiety
=450  \\$wnnna$aDisorders, Anxiety
=450  \\$aNeuroses, Anxiety
=450  \\$wnnna$aNeurotic Anxiety State
=450  \\$wnnna$aNeurotic Anxiety States
=450  \\$wnnna$aState, Neurotic Anxiety
=450  \\$wnnna$aStates, Neurotic Anxiety
=550  \\$wg$aMental Disorders
=550  \\$wh$aAgoraphobia
=550  \\$wh$aNeurocirculatory Asthenia
=550  \\$wh$aObsessive-Compulsive Disorder
=550  \\$wh$aPanic Disorder
=550  \\$wh$aPhobic Disorders
=550  \\$aAnti-Anxiety Agents
=550  \\$aAnxiety
=667  \\$adifferentiate from ANXIETY
=680  \\$iPersistent and disabling ANXIETY.
=688  \\$a81; was NEUROSES, ANXIETY 1963-80
=750  \0$aAnxiety disorders$0(DLC)sh2005006293$5IEN-M

=LDR  01439cz  a2200433n  4500
=001  9880363219802441
=005  20141212194900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001005
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x274.$x476.$x411.$x307.$x790.$x40
=072  \\$aC6.$x301.$x371.$x411.$x307.$x790.$x40
=072  \\$aC6.$x405.$x249.$x411.$x307.$x790.$x40
=072  \\$aC6.$x405.$x469.$x491.$x307.$x790.$x40
=072  \\$aC6.$x405.$x469.$x860.$x101.$x163
=072  \\$aC6.$x405.$x469.$x860.$x180.$x500.$x40
=150  \\$aAnus Neoplasms
=450  \\$aAnal Cancer
=450  \\$wnnna$aAnal Cancers
=450  \\$wnnna$aAnal Neoplasm
=450  \\$wnnna$aAnal Neoplasms
=450  \\$wnnna$aAnus Cancer
=450  \\$wnnna$aAnus Cancers
=450  \\$wnnna$aAnus Neoplasm
=450  \\$wnnna$aCancer, Anal
=450  \\$aCancer of Anus
=450  \\$wnnna$aCancer of the Anus
=450  \\$wnnna$aCancers, Anal
=450  \\$wnnna$aNeoplasm, Anal
=450  \\$wnnna$aNeoplasm, Anus
=450  \\$wnnna$aNeoplasms, Anal
=450  \\$wnnna$aNeoplasms, Anus
=550  \\$wg$aAnus Diseases
=550  \\$wg$aRectal Neoplasms
=550  \\$wh$aAnal Gland Neoplasms
=667  \\$ado not confuse with ANAL GLAND NEOPLASMS (in animals only); coord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the ANAL CANAL.
=688  \\$a1999
=750  \0$aAnus$xCancer$5IEN$0(DLC)sh 85005827

=LDR  01200cz  a2200349n  4500
=001  9880363219902441
=005  20141212194900.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001003
=035  \\$aCAZ4158HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x526.$x70
=072  \\$aA3.$x556.$x249.$x249.$x70
=150  \\$aAnal Canal
=360  \\$iconsider also terms at$aPROCT-
=450  \\$wnnna$aAnal Gland
=450  \\$aAnal Gland, Human
=450  \\$wnnna$aAnal Glands, Human
=450  \\$aAnal Sphincter
=450  \\$wnnna$aAnal Sphincters
=450  \\$aAnus
=450  \\$wnnna$aGland, Human Anal
=450  \\$wnnna$aGlands, Human Anal
=450  \\$wnnna$aHuman Anal Gland
=450  \\$wnnna$aHuman Anal Glands
=450  \\$wnnna$aSphincter, Anal
=450  \\$wnnna$aSphincters, Anal
=550  \\$wg$aIntestine, Large
=667  \\$ainflammation = PROCTITIS; do not confuse X ref ANAL GLAND with ANAL GLAND, ANIMAL see ANAL SACS
=680  \\$iThe terminal segment of the LARGE INTESTINE, beginning from the ampulla of the RECTUM and ending at the anus.
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Anus
=750  \0$aAnus$0(DLC) sh 85005826$5IEN

=LDR  00881cz  a2200241n  4500
=001  9880363220002441
=005  20141212194859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001002
=035  \\$aCAZ4157HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x419.$x78
=072  \\$aC12.$x777.$x934.$x141
=072  \\$aC13.$x351.$x968.$x419.$x78
=072  \\$aC13.$x351.$x968.$x934.$x70
=150  \\$aAnuria
=450  \\$wnnna$aAnurias
=550  \\$wg$aKidney Diseases
=550  \\$wg$aUrination Disorders
=550  \\$aUrine
=667  \\$ado not confuse with OLIGURIA, diminished amount
=680  \\$iAbsence of urine formation. It is usually associated with complete bilateral ureteral (URETER) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.
=750  \0$aAnuria$5IEN$0(DLC)sh 85005820

=LDR  00995cz  a2200181n  4500
=001  9880363220202441
=005  20141212194859.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001000
=035  \\$aCAZ4155HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x479.$x205
=150  \\$aAnts
=450  \\$wnnna$aAnt
=550  \\$wg$aHymenoptera
=667  \\$a/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111
=680  \\$iInsects of the family Formicidae, very common and widespread, probably the most successful of all the insect groups. All ants are social insects, and most colonies contain three castes, queens, males, and workers. Their habits are often very elaborate and a great many studies have been made of ant behavior. Ants produce a number of secretions that function in offense, defense, and communication. (From Borror, et al., An Introduction to the Study of Insects, 4th ed, p676)
=750  \0$aAnts$5IEN$0(DLC)sh 85005804

=LDR  00821cz  a2200193n  4500
=001  9880363220302441
=005  20141212194858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000999
=035  \\$aCAZ4154HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x507.$x288
=150  \\$aAntlers
=450  \\$wnnna$aAntler
=550  \\$wg$aHorns
=667  \\$aa type of horn, on males of the deer family
=680  \\$iThe horn of an animal of the deer family, typically present only in the male. It differs from the HORNS of other animals in being a solid, generally branched bony outgrowth that is shed and renewed annually. The word antler comes from the Latin anteocularis, ante (before) + oculus (eye). (From Webster, 3d ed)
=688  \\$a91(75); was see under HORNS 1975-90
=750  \0$aAntlers$5IEN$0(DLC)sh 85005791

=LDR  01258cz  a2200289n  4500
=001  9880363220402441
=005  20141212194858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000998
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x388
=150  \\$aAntiviral Agents
=450  \\$wnnna$aAgents, Antiviral
=450  \\$wnnna$aAntiviral Drugs
=450  \\$aAntivirals
=450  \\$wnnna$aDrugs, Antiviral
=450  \\$wnnoa$aVirus Inhibitors$5IEN-M
=550  \\$wg$aAnti-Infective Agents
=550  \\$wh$aAnti-Retroviral Agents
=550  \\$wh$aViral Fusion Protein Inhibitors
=550  \\$aInterferon Inducers
=550  \\$aVirus Diseases
=550  \\$aVirus Inactivation
=550  \\$aViruses
=667  \\$afor resistance to antiviral agents, DRUG RESISTANCE, VIRAL and DRUG RESISTANCE, MULTIPLE, VIRAL are available
=680  \\$iAgents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
=750  \0$aAntiviral agents$0(DLC) sh 85005787$5IEN

=LDR  01118cz  a2200349n  4500
=001  9880363220502441
=005  20141212194858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000997
=035  \\$aCAZ4152HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x301.$x138
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573.$x601.$x138
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x301.$x138
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x301.$x138
=072  \\$aD20.$x215.$x121.$x163
=150  \\$aAntivenins
=450  \\$wnnna$aAnti-Venins
=450  \\$wnnna$aAnti Venins
=450  \\$wnnna$aAnti-Venoms
=450  \\$wnnna$aAnti Venoms
=450  \\$wnnna$aAntivenoms
=450  \\$aVenoms$xantagonists & inhibitors
=550  \\$wg$aAntitoxins
=550  \\$aAntidotes
=550  \\$aSnake Bites
=550  \\$aSnake Venoms
=550  \\$aVenoms
=667  \\$acoordinate IM with specific venom
=680  \\$iAntisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS.
=688  \\$a65(63)
=750  \0$aAntivenins$5IEN$0(DLC)sh 85005786

=LDR  00949cz  a2200277n  4500
=001  9880363220602441
=005  20141212194857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000996
=035  \\$aCAZ4151HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x153
=072  \\$aD27.$x505.$x954.$x796.$x90
=150  \\$aAntitussive Agents
=450  \\$wnnna$aAgents, Antitussive
=450  \\$wnnna$aAntitussive Drugs
=450  \\$wnnna$aAntitussives
=450  \\$wnnna$aCough Suppressants
=450  \\$wnnna$aDrugs, Antitussive
=450  \\$wnnna$aSuppressants, Cough
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aRespiratory System Agents
=550  \\$aCough
=550  \\$aExpectorants
=680  \\$iAgents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.
=750  \0$aAntitussive agents$5IEN$0(DLC)sh 85005785

=LDR  01245cz  a2200265n  4500
=001  9880363220702441
=005  20141212194857.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000995
=035  \\$aCAZ4150HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x85.$x255
=150  \\$aAntitubercular Agents
=450  \\$wnnna$aAgents, Antitubercular
=450  \\$wnnna$aAgents, Tuberculostatic
=450  \\$wnnna$aAntitubercular Drugs
=450  \\$wnnna$aDrugs, Antitubercular
=450  \\$aTuberculostatic Agents
=550  \\$wg$aAnti-Bacterial Agents
=550  \\$wh$aAntibiotics, Antitubercular
=550  \\$aMycobacterium tuberculosis
=550  \\$aTuberculosis
=667  \\$aconsider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther
=680  \\$iDrugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
=750  \0$aAntitubercular agents$5IEN$0(DLC)sh 85005784

=LDR  01108cz  a2200313n  4500
=001  9880363220802441
=005  20141212194856.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000992
=035  \\$aCAZ4147HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x301
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x573.$x601
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x301
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x301
=072  \\$aD20.$x215.$x121
=150  \\$aAntitoxins
=550  \\$wg$aAntibodies
=550  \\$wg$aBiological Products
=550  \\$wg$aImmune Sera
=550  \\$wh$aAntivenins
=550  \\$wh$aBotulinum Antitoxin
=550  \\$wh$aDiphtheria Antitoxin
=550  \\$wh$aTetanus Antitoxin
=550  \\$aToxins, Biological
=667  \\$acoordinate IM with specific toxin (IM or NIM)
=680  \\$iAntisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.
=688  \\$a66; TOXINS AND ANTITOXINS was heading 1963-65
=750  \0$aAntitoxins$5IEN$0(DLC)sh 85005780

=LDR  01133cz  a2200277n  4500
=001  9880363220902441
=005  20141212194855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000991
=035  \\$aCAZ4146HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x745.$x800.$x449
=072  \\$aD27.$x505.$x954.$x502.$x119.$x500
=150  \\$aAntithrombins
=450  \\$wnnna$aAntithrombins, Direct
=450  \\$aDirect Antithrombins
=450  \\$wnnna$aDirect Thrombin Inhibitors
=450  \\$wnnna$aThrombin Inhibitors, Direct
=550  \\$wg$aAnticoagulants
=550  \\$wg$aSerine Proteinase Inhibitors
=550  \\$wh$aFactor Xa Inhibitors
=667  \\$aANTITHROMBIN PROTEINS is also available
=680  \\$iEndogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins.
=688  \\$a2011(1964)
=688  \\$a76; was ANTITHROMBIN 1964-75 (Prov 1964-66)
=750  \0$aAntithrombins$5IEN$0(DLC)sh 89001670

=LDR  01882cz  a2200493n  4500
=001  9880363221002441
=005  20141212194855.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000990
=035  \\$aCAZ4145HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x822.$x750.$x60.$x500
=072  \\$aD12.$x644.$x861.$x60.$x500
=072  \\$aD12.$x776.$x124.$x790.$x106.$x125
=072  \\$aD12.$x776.$x377.$x715.$x85.$x125
=072  \\$aD12.$x776.$x645.$x750.$x60.$x500
=072  \\$aD12.$x776.$x872.$x60.$x500
=072  \\$aD23.$x113.$x25
=150  \\$aAntithrombin III
=450  \\$wnnna$aAntithrombin Bayer Brand
=450  \\$wnnna$aAntithrombin Grifols Brand
=450  \\$wnnna$aAntithrombin III-Alpha
=450  \\$wnnna$aAntithrombin III Alpha
=450  \\$wnnna$aAntithrombin IIIAlpha
=450  \\$wnnna$aAntithrombin Pharmacia Brand
=450  \\$wnnna$aAtenativ
=450  \\$wnnna$aAventis Behring Brand of Antithrombin III
=450  \\$wnnna$aBayer Brand of Antithrombin
=450  \\$wnnna$aCofactor I, Heparin
=450  \\$wnnna$aGrifols Brand of Antithrombin
=450  \\$wnnna$aHeparin Co-Factor I
=450  \\$wnnna$aHeparin Co Factor I
=450  \\$aHeparin Cofactor I
=450  \\$wnnna$aKybernin
=450  \\$wnnna$aPharmacia Brand of Antithrombin
=450  \\$wnnna$aSerpin C1
=450  \\$wnnna$aThrombate III
=550  \\$wg$aAlpha-Globulins
=550  \\$wg$aAntithrombin Proteins
=550  \\$wg$aBlood Coagulation Factor Inhibitors
=680  \\$iA plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
=688  \\$a1979
=688  \\$a79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78, was HEPARIN CO-FACTOR 1963-74 (Prov)
=750  \0$aAntithrombin III$5IEN$0(DLC)sh 89001669

=LDR  01415cz  a2200385n  4500
=001  9880363221102441
=005  20141212194854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000988
=035  \\$aCAZ4143HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x138
=072  \\$aD27.$x505.$x696.$x875.$x360.$x443.$x68
=072  \\$aD27.$x505.$x954.$x705.$x360.$x443.$x68
=072  \\$aD27.$x888.$x569.$x71
=150  \\$aAntispermatogenic Agents
=450  \\$wnnna$aAgents, Antispermatogenic
=450  \\$wnnna$aAntispermatogenic Effect
=450  \\$wnnna$aAntispermatogenic Effects
=450  \\$wnnna$aBlocking Agents, Sperm Maturation
=450  \\$wnnna$aEffect, Antispermatogenic
=450  \\$wnnna$aEffects, Antispermatogenic
=450  \\$aSperm Maturation Blocking Agents
=550  \\$wg$aContraceptive Agents, Male
=550  \\$wg$aNoxae
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$wh$aSperm Immobilizing Agents
=550  \\$wh$aSpermatocidal Agents
=550  \\$wh$aSpermatogenesis-Blocking Agents
=550  \\$aSperm Maturation
=550  \\$aSpermatogenesis
=550  \\$aSpermatozoa
=680  \\$iAgents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.
=688  \\$a75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91
=750  \0$aAntispermatogenic agents$5IEN-M$0(DLC)sh 94000089

=LDR  02006cz  a2200445n  4500
=001  9880363221202441
=005  20141212194854.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000987
=035  \\$aCAZ4142HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x675.$x50
=150  \\$aAntisocial Personality Disorder
=450  \\$wnnna$aAntisocial Personalities
=450  \\$wnnna$aAntisocial Personality
=450  \\$wnnna$aAntisocial Personality Disorders
=450  \\$wnnna$aBehavior, Dyssocial
=450  \\$wnnna$aBehaviors, Dyssocial
=450  \\$wnnna$aDisorder, Antisocial Personality
=450  \\$wnnna$aDisorders, Antisocial Personality
=450  \\$aDyssocial Behavior
=450  \\$wnnna$aDyssocial Behaviors
=450  \\$wnnna$aPersonalities, Antisocial
=450  \\$wnnna$aPersonalities, Psychopathic
=450  \\$wnnna$aPersonalities, Sociopathic
=450  \\$wnnna$aPersonality, Antisocial
=450  \\$aPersonality Disorder, Antisocial
=450  \\$wnnna$aPersonality Disorders, Antisocial
=450  \\$wnnna$aPersonality, Psychopathic
=450  \\$wnnna$aPersonality, Sociopathic
=450  \\$wnnna$aPsychopathic Personalities
=450  \\$aPsychopathic Personality
=450  \\$wnnna$aSociopathic Personalities
=450  \\$aSociopathic Personality
=550  \\$wg$aPersonality Disorders
=550  \\$aConduct Disorder
=550  \\$aSocial Behavior Disorders
=680  \\$iA personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994)
=688  \\$a81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75
=750  \0$aAntisocial personality disorders$5IEN$0(DLC)sh 85005772

=LDR  00773cz  a2200229n  4500
=001  9880363221302441
=005  20141212194853.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000986
=035  \\$aCAZ4141HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x502.$x135
=150  \\$aAntisickling Agents
=450  \\$wnnna$aAgents, Antisickling
=450  \\$wnnna$aAgents, Desickling
=450  \\$aDesickling Agents
=550  \\$wg$aHematologic Agents
=550  \\$aAnemia, Sickle Cell
=667  \\$aconsider also ANEMIA, SICKLE CELL /drug ther
=680  \\$iAgents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.
=688  \\$a77
=750  \0$aAntisickling agents$5IEN$0(DLC)sh 85005771

=LDR  00611cz  a2200181n  4500
=001  9880363221402441
=005  20141212194853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000985
=035  \\$aCAZ4140HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x450.$x150
=150  \\$aAntisepsis
=550  \\$wg$aInfection Control
=550  \\$wh$aAsepsis
=667  \\$adifferentiate from ASEPSIS: ANTISEPSIS is the destruction of pathogens, ASEPSIS is the prev of their invasion
=680  \\$iThe destruction of germs causing disease.
=750  \0$aAsepsis and antisepsis$5IEN$0(DLC)sh 85008579

=LDR  00738cz  a2200193n  4500
=001  9880363221502441
=005  20141212194853.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000983
=035  \\$aCAZ4138HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x539.$x850.$x88
=150  \\$aAntipyrine
=450  \\$wnnna$aAnodynin
=450  \\$aPhenazone
=450  \\$wnnna$aPyramidone
=550  \\$wg$aPyrazolones
=680  \\$iAn analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
=750  \0$aAntipyrine$5IEN$0(DLC)sh 85005740

=LDR  00947cz  a2200301n  4500
=001  9880363221602441
=005  20141212194852.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000981
=035  \\$aCAZ4136HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250.$x100
=150  \\$aAntiprotozoal Agents
=450  \\$wnnna$aAgents, Antiprotozoal
=450  \\$wnnna$aSchizonticides
=550  \\$wg$aAntiparasitic Agents
=550  \\$wh$aAmebicides
=550  \\$wh$aAntimalarials
=550  \\$wh$aAntitrichomonal Agents
=550  \\$wh$aCoccidiostats
=550  \\$wh$aTrypanocidal Agents
=550  \\$aAnti-Infective Agents
=550  \\$aParasites
=550  \\$aProtozoan Infections
=667  \\$aGEN or unspecified; prefer specific groups or specific antiprotozoal agent
=680  \\$iSubstances that are destructive to protozoans.
=688  \\$a67
=750  \0$aAntiprotozoal agents$0(DLC)sh2006008925$5IEN-M

=LDR  01269cz  a2200289n  4500
=001  9880363221702441
=005  20141212194851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000978
=035  \\$aCAZ4133HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x90.$x50
=150  \\$aAntiparkinson Agents
=450  \\$wnnna$aAgents, Antiparkinson
=450  \\$wnnna$aAgents, Antiparkinsonian
=450  \\$wnnna$aAntiparkinson Drugs
=450  \\$wnnna$aAntiparkinsonian Agents
=450  \\$wnnna$aAntiparkinsonians
=450  \\$wnnna$aDrugs, Antiparkinson
=550  \\$wg$aAnti-Dyskinesia Agents
=550  \\$wh$aAromatic Amino Acid Decarboxylase Inhibitors
=550  \\$wh$aCatechol O-Methyltransferase Inhibitors
=550  \\$aParasympatholytics
=667  \\$aGEN or unspecified; prefer specifics; consider also PARKINSON DISEASE /drug ther
=680  \\$iAgents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
=688  \\$a76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72
=750  \0$aAntiparkinsonian agents$5IEN$0(DLC)sh 85005730

=LDR  00823cz  a2200253n  4500
=001  9880363221802441
=005  20141212194851.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000977
=035  \\$aCAZ4132HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250
=150  \\$aAntiparasitic Agents
=450  \\$wnnna$aAgents, Antiparasitic
=450  \\$wnnna$aAntiparasitic Drugs
=450  \\$wnnna$aAntiparasitics
=450  \\$wnnna$aDrugs, Antiparasitic
=450  \\$aParasiticides
=550  \\$wg$aAnti-Infective Agents
=550  \\$wh$aAnthelmintics
=550  \\$wh$aAntiprotozoal Agents
=680  \\$iDrugs used to treat or prevent parasitic infections.
=688  \\$a96; was NON MESH 1967-95; PARASITICIDES was heading 1963-66
=750  \0$aAntiparasitic agents$5IEN-M$0(DLC)sh 85005729

=LDR  01465cz  a2200385n  4500
=001  9880363221902441
=005  20141212194850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000975
=035  \\$aCAZ4130HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x217
=072  \\$aD27.$x505.$x696.$x706.$x125
=072  \\$aD27.$x720.$x799.$x47
=150  \\$aAntioxidants
=450  \\$wnnna$aAnti-Oxidant Effect
=450  \\$wnnna$aAnti Oxidant Effect
=450  \\$wnnna$aAnti-Oxidant Effects
=450  \\$wnnna$aAnti Oxidant Effects
=450  \\$wnnna$aAntioxidant Effect
=450  \\$wnnna$aAntioxidant Effects
=450  \\$wnnna$aEffect, Anti-Oxidant
=450  \\$wnnna$aEffect, Antioxidant
=450  \\$wnnna$aEffects, Anti-Oxidant
=450  \\$wnnna$aEffects, Antioxidant
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wg$aProtective Agents
=550  \\$wh$aFree Radical Scavengers
=550  \\$aFood Preservatives
=550  \\$aOxidants
=550  \\$aOxidation-Reduction
=550  \\$aPreservatives, Pharmaceutical
=667  \\$anote entry term ANTIOXIDANT EFFECT: use only for the antioxidant effect of a chemical substance
=680  \\$iNaturally occurring or synthetic substances that inhibit or retard the oxidation of a substance to which it is added. They counteract the harmful and damaging effects of oxidation in animal tissues.
=750  \0$aAntioxidants$5IEN$0(DLC)sh 85005727

=LDR  01695cz  a2200373n  4500
=001  9880363222002441
=005  20141212194850.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000974
=035  \\$aCAZ4129HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x323.$x204
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x323.$x204
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x323.$x204
=150  \\$aAntibodies, Antinuclear
=450  \\$aAnti-DNA Antibodies
=450  \\$wnnna$aAnti DNA Antibodies
=450  \\$aAntibodies, Anti-DNA
=450  \\$wnnna$aAntibodies, Anti DNA
=450  \\$wnnna$aAntibodies, Fluorescent Antinuclear
=450  \\$wnnna$aAntibody, Antinuclear
=450  \\$aAntinuclear Antibodies
=450  \\$wnnna$aAntinuclear Antibodies, Fluorescent
=450  \\$wnnna$aAntinuclear Antibody
=450  \\$wnnna$aAntinuclear Factor
=450  \\$aAntinuclear Factors
=450  \\$wnnna$aFactor, Antinuclear
=450  \\$wnnna$aFactors, Antinuclear
=450  \\$aFluorescent Antinuclear Antibodies
=550  \\$wg$aAutoantibodies
=667  \\$acoordinate with specific nuclear antigen; do not coordinate with ANTIBODY FORMATION for /biosyn
=680  \\$iAutoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.
=688  \\$a90; was ANTINUCLEAR FACTORS 1966-89 (Prov 1966-69)
=750  \0$aAntinuclear factors$5IEN$0(DLC)sh 85005720

=LDR  02328cz  a2200577n  4500
=001  9880363222102441
=005  20190514164714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000970
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x248
=150  \\$aAntineoplastic Agents
=450  \\$wnnna$aAgents, Anticancer
=450  \\$wnnna$aAgents, Antineoplastic
=450  \\$wnnna$aAgents, Antitumor
=450  \\$wnnna$aAgents, Cancer Chemotherapy
=450  \\$wnnna$aAgents, Chemotherapeutic Anticancer
=450  \\$wnnna$aAnticancer Agents
=450  \\$wnnna$aAntineoplastic Drugs
=450  \\$wnnna$aAntineoplastics
=450  \\$wnnna$aAntitumor Agents
=450  \\$wnnna$aAntitumor Drugs
=450  \\$wnnna$aCancer Chemotherapy Agents
=450  \\$wnnna$aCancer Chemotherapy Drugs
=450  \\$wnnna$aChemotherapeutic Anticancer Agents
=450  \\$wnnna$aChemotherapeutic Anticancer Drug
=450  \\$wnnna$aChemotherapy Agents, Cancer
=450  \\$wnnna$aChemotherapy Drugs, Cancer
=450  \\$wnnna$aDrug, Chemotherapeutic Anticancer
=450  \\$wnnna$aDrugs, Antineoplastic
=450  \\$wnnna$aDrugs, Antitumor
=450  \\$wnnna$aDrugs, Cancer Chemotherapy
=550  \\$wg$aTherapeutic Uses
=550  \\$wh$aAngiogenesis Inhibitors
=550  \\$wh$aAntibiotics, Antineoplastic
=550  \\$wh$aAnticarcinogenic Agents
=550  \\$wh$aAntimetabolites, Antineoplastic
=550  \\$wh$aAntimitotic Agents
=550  \\$wh$aAntineoplastic Agents, Alkylating
=550  \\$wh$aAntineoplastic Agents, Hormonal
=550  \\$wh$aAntineoplastic Agents, Phytogenic
=550  \\$wh$aMyeloablative Agonists
=550  \\$wh$aPoly(ADP-ribose) Polymerase Inhibitors
=550  \\$wh$aTopoisomerase Inhibitors
=550  \\$aAnticarcinogenic Agents
=550  \\$aCytotoxins
=550  \\$aInterferon Inducers
=550  \\$aNeoplasms
=667  \\$a/admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+
=680  \\$iSubstances that inhibit or prevent the proliferation of NEOPLASMS.
=750  \0$aAntineoplastic agents$0(DLC) sh 85005714$5IEN-M

=LDR  01010cz  a2200277n  4500
=001  9880363222202441
=005  20141212194847.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000969
=035  \\$aCAZ4124HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250.$x75.$x80
=150  \\$aAntinematodal Agents
=450  \\$wnnna$aAgents, Antinematodal
=450  \\$wnnna$aAntinematodal Drugs
=450  \\$wnnna$aAntinematodals
=450  \\$wnnna$aDrugs, Antinematodal
=450  \\$aNematocides
=550  \\$wg$aAnthelmintics
=550  \\$wh$aFilaricides
=550  \\$aNematoda
=550  \\$aNematode Infections
=667  \\$aconsider also NEMATODA /drug eff & NEMATODE INFECTIONS /drug ther or pertinent specifics
=680  \\$iSubstances used in the treatment or control of nematode infestations. They are used also in veterinary practice.
=688  \\$a76(75); was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75
=750  \0$aNematocides$5IEN$0(DLC)sh 85090700

=LDR  00974cz  a2200265n  4500
=001  9880363222302441
=005  20141212194846.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000966
=035  \\$aCAZ4121HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x691.$x75
=150  \\$aAntimony Potassium Tartrate
=450  \\$wnnna$aAntimony, Tartrated
=450  \\$wnnna$aAntimonyltartrate, Potassium
=450  \\$wnnna$aEmetic, Tartar
=450  \\$aPotassium Antimonyltartrate
=450  \\$wnnna$aPotassium Tartrate, Antimony
=450  \\$aTartar Emetic
=450  \\$wnnna$aTartrate, Antimony Potassium
=450  \\$wnnna$aTartrated Antimony
=550  \\$wg$aOrganometallic Compounds
=680  \\$iA schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
=688  \\$a91(76); was see under ANTIMONY 1976-90
=750  \0$aTartar emetic$5IEN$0(DLC)sh 85132705

=LDR  00989cz  a2200241n  4500
=001  9880363222402441
=005  20141212194846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000965
=035  \\$aCAZ4120HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x513.$x124
=072  \\$aD1.$x268.$x556.$x50
=072  \\$aD1.$x552.$x544.$x50
=150  \\$aAntimony
=450  \\$aAntimony Compounds$5IEN
=450  \\$aOrganoantimony Compounds$5IEN
=550  \\$wg$aMetalloids
=550  \\$wg$aMetals, Heavy
=667  \\$aSb-121; Sb-123 = ANTIMONY (IM) + ISOTOPES (NIM); Sb-112-120, 122, 124-133 = ANTIMONY (IM) + RADIOISOTOPES (IM)
=680  \\$iA metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.
=750  \0$aAntimony$5IEN-HS$0(DLC)sh 85005702
=750  \0$aAntimony compounds$5IEN-HS$0(DLC)sh 85005707

=LDR  00804cz  a2200241n  4500
=001  9880363222502441
=005  20141212194846.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000964
=035  \\$aCAZ4119HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186.$x144
=072  \\$aD27.$x505.$x954.$x248.$x144
=072  \\$aD27.$x888.$x569.$x42.$x30
=150  \\$aAntimetabolites, Antineoplastic
=450  \\$aAntineoplastic Antimetabolites
=550  \\$wg$aAntimetabolites
=550  \\$wg$aAntineoplastic Agents
=667  \\$aTN 4: relation to ANTINEOPLASTIC AGENTS
=680  \\$iAntimetabolites that are useful in cancer chemotherapy.
=688  \\$a75
=750  \0$81$wb$aAntimetabolites$5IEN$0(DLC)sh 85005699
=750  \0$81$wb$aAntineoplastic agents$5IEN-HS$0(DLC)sh 85005714

=LDR  00766cz  a2200205n  4500
=001  9880363222602441
=005  20141212194845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000963
=035  \\$aCAZ4118HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x186
=072  \\$aD27.$x888.$x569.$x42
=150  \\$aAntimetabolites
=550  \\$wg$aMolecular Mechanisms of Pharmacological Action
=550  \\$wg$aNoxae
=550  \\$wh$aAntimetabolites, Antineoplastic
=550  \\$wh$aHypolipidemic Agents
=680  \\$iDrugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033)
=750  \0$aAntimetabolites$5IEN$0(DLC)sh 85005699

=LDR  00968cz  a2200265n  4500
=001  9880363222702441
=005  20141212194845.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000962
=035  \\$aCAZ4117HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x122.$x250.$x100.$x85
=150  \\$aAntimalarials
=450  \\$wnnna$aAgents, Antimalarial
=450  \\$wnnna$aAnti-Malarials
=450  \\$wnnna$aAnti Malarials
=450  \\$wnnna$aAntimalarial Agents
=450  \\$wnnna$aAntimalarial Drugs
=450  \\$wnnna$aDrugs, Antimalarial
=550  \\$wg$aAntiprotozoal Agents
=550  \\$aAntirheumatic Agents
=550  \\$aMalaria
=550  \\$aPlasmodium
=680  \\$iAgents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
=750  \0$aAntimalarials$5IEN$0(DLC)sh 85005696

=LDR  01300cz  a2200325n  4500
=001  9880363222802441
=005  20141212194742.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000782
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x210.$x50
=072  \\$aG5.$x365.$x590.$x175.$x50
=072  \\$aG5.$x700.$x131
=150  \\$aAneuploidy
=450  \\$wnnna$aAneuploid
=450  \\$wnnna$aAneuploid Cell
=450  \\$wnnna$aAneuploid Cells
=450  \\$wnnna$aAneuploidies
=450  \\$wnnna$aAneuploids
=450  \\$wnnna$aCell, Aneuploid
=450  \\$wnnna$aCells, Aneuploid
=550  \\$wg$aChromosome Aberrations
=550  \\$wg$aPloidies
=550  \\$wh$aMonosomy
=550  \\$wh$aTetrasomy
=550  \\$wh$aTrisomy
=550  \\$aAneugens
=680  \\$iThe chromosomal constitution of cells which deviate from the normal by the addition or subtraction of CHROMOSOMES, chromosome pairs, or chromosome fragments. In a normally diploid cell (DIPLOIDY) the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is MONOSOMY (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is TRISOMY (symbol: 2N+1).
=688  \\$a68
=750  \0$aAneuploidy$5IEN$0(DLC)sh 85004984

=LDR  00646cz  a2200181n  4500
=001  9880363222902441
=005  20141212194741.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000780
=035  \\$aCAZ3931HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x195.$x249
=150  \\$aAnestrus
=550  \\$wg$aEstrous Cycle
=667  \\$anon-primate mammals only
=680  \\$iA state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.
=688  \\$a91(75); was see under ESTRUS 1975-90
=750  \0$aAnestrus$5IEN$0(DLC)sh 85004981

=LDR  01420cz  a2200325n  4500
=001  9880363223002441
=005  20141212194740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000777
=035  \\$aCAZ3928HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x277.$x100
=072  \\$aD27.$x505.$x954.$x427.$x210.$x100
=150  \\$aAnesthetics
=450  \\$wnnna$aAgents, Anesthetic
=450  \\$wnnna$aAnesthetic Agents
=450  \\$wnnna$aAnesthetic Drugs
=450  \\$wnnna$aAnesthetic Effect
=450  \\$wnnna$aAnesthetic Effects
=450  \\$wnnna$aDrugs, Anesthetic
=450  \\$wnnna$aEffect, Anesthetic
=450  \\$wnnna$aEffects, Anesthetic
=550  \\$wg$aCentral Nervous System Depressants
=550  \\$wh$aAnesthetics, Combined
=550  \\$wh$aAnesthetics, General
=550  \\$wh$aAnesthetics, Local
=550  \\$aAnalgesics
=667  \\$ageneral or unspecified; prefer specific groups; use no qualifiers for anesthetics when used to produce anesthesia; coordinate with type of anesthesia: Manual 26.21+; policy: Manual 25.20+
=680  \\$iAgents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.
=750  \0$aAnesthetics$5IEN$0(DLC)sh 85004977

=LDR  00505cz  a2200169n  4500
=001  9880363223102441
=005  20180212105247.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000776
=035  \\$aCAZ3927HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x66
=150  \\$aAnesthesiology
=550  \\$wg$aMedicine
=667  \\$aSPEC: SPEC qualif; DF: ANESTHESIOL
=680  \\$iA specialty concerned with the study of anesthetics and anesthesia.
=750  \0$aAnesthesiology$5IEN-M$0(DLC)sh 85004972

=LDR  00629cz  a2200205n  4500
=001  9880363223202441
=005  20141212194740.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000775
=035  \\$aCAZ3926HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x86.$x331
=150  \\$aAnesthesia, Spinal
=450  \\$wnnna$aAnesthesias, Spinal
=450  \\$wnnna$aSpinal Anesthesia
=450  \\$wnnna$aSpinal Anesthesias
=550  \\$wg$aAnesthesia, Conduction
=550  \\$aInjections, Spinal
=667  \\$a/educ: coord IM (no qualif with ANESTHESIOLOGY /educ (NIM))
=750  \0$aSpinal anesthesia$5IEN$0(DLC)sh 85126663

=LDR  00602cz  a2200193n  4500
=001  9880363223302441
=005  20141212194739.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000771
=035  \\$aCAZ3922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x308
=150  \\$aAnesthesia, Intravenous
=450  \\$wnnna$aAnesthesias, Intravenous
=450  \\$wnnna$aIntravenous Anesthesia
=450  \\$wnnna$aIntravenous Anesthesias
=550  \\$wg$aAnesthesia
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=750  \0$aIntravenous anesthesia$5IEN$0(DLC)sh 85067630

=LDR  00864cz  a2200253n  4500
=001  9880363223402441
=005  20160406175522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000770
=035  \\$aCAZ3921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x253
=150  \\$aAnesthesia, Endotracheal
=450  \\$wnnna$aAnesthesias, Endotracheal
=450  \\$wnno$aAnesthesia, Intratracheal
=450  \\$wnnna$aAnesthesias, Intratracheal
=450  \\$aEndotracheal Anesthesia
=450  \\$wnnna$aEndotracheal Anesthesias
=450  \\$wnnna$aIntratracheal Anesthesia
=450  \\$wnnna$aIntratracheal Anesthesias
=550  \\$wg$aAnesthesia
=550  \\$aTrachea
=680  \\$iProcedure in which an anesthetic such as a gas or mixture of gases is inhaled through a tube in the lungs.
=750  \0$aIntratracheal anesthesia$5IEN$0(DLC)sh 85067625

=LDR  00852cz  a2200229n  4500
=001  9880363223502441
=005  20141212194738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000769
=035  \\$aCAZ3920HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x197.$x197
=150  \\$aAnesthesia, Inhalation
=450  \\$wnnna$aAnesthesia, Insufflation
=450  \\$wnnna$aInhalation Anesthesia
=450  \\$aInsufflation Anesthesia
=550  \\$wg$aAnesthesia, General
=550  \\$wh$aAnesthesia, Closed-Circuit
=550  \\$aAdministration, Inhalation
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=680  \\$iAnesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.
=750  \0$aInhalation anesthesia$5IEN$0(DLC)sh 85066369

=LDR  00693cz  a2200229n  4500
=001  9880363223602441
=005  20141212194738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000768
=035  \\$aCAZ3919HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x197
=150  \\$aAnesthesia, General
=450  \\$wnnna$aAnesthesias, General
=450  \\$wnnna$aGeneral Anesthesia
=450  \\$wnnna$aGeneral Anesthesias
=550  \\$wg$aAnesthesia
=550  \\$wh$aAnesthesia, Inhalation
=550  \\$wh$aAnesthesia, Rectal
=550  \\$wh$aBalanced Anesthesia
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=750  \0$aAnesthesia$5IEN$0(DLC)sh 85004952

=LDR  00809cz  a2200265n  4500
=001  9880363223702441
=005  20141212194738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000767
=035  \\$aCAZ3918HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x86.$x131
=150  \\$aAnesthesia, Epidural
=450  \\$aAnesthesia, Extradural
=450  \\$aAnesthesia, Peridural
=450  \\$aEpidural Anesthesia
=450  \\$wnnna$aExtradural Anesthesia
=450  \\$wnnna$aPeridural Anesthesia
=550  \\$wg$aAnesthesia, Conduction
=550  \\$wh$aAnesthesia, Caudal
=550  \\$aInjections, Epidural
=550  \\$aInjections, Spinal
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=688  \\$a72(71)
=750  \0$aPeridural anesthesia$5IEN$0(DLC)sh 85099864

=LDR  00670cz  a2200217n  4500
=001  9880363223802441
=005  20141212194738.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000766
=035  \\$aCAZ3917HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x141
=072  \\$aE6.$x45
=150  \\$aAnesthesia, Dental
=450  \\$aDental Anesthesia
=550  \\$wg$aAnesthesia
=550  \\$wg$aDentistry
=550  \\$wh$aHypnosis, Dental
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=688  \\$aANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92
=750  \0$aAnesthesia in dentistry$5IEN$0(DLC)sh 85004960

=LDR  00730cz  a2200241n  4500
=001  9880363223902441
=005  20141212194737.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000765
=035  \\$aCAZ3916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155.$x86
=150  \\$aAnesthesia, Conduction
=450  \\$aAnesthesia, Regional
=450  \\$wnnna$aConduction Anesthesia
=450  \\$wnnna$aRegional Anesthesia
=550  \\$wg$aAnesthesia
=550  \\$wh$aAnesthesia, Epidural
=550  \\$wh$aAnesthesia, Local
=550  \\$wh$aAnesthesia, Spinal
=550  \\$wh$aNerve Block
=667  \\$a/educ: coord IM (no qualif) with ANESTHESIOLOGY /educ (NIM)
=750  \0$aConduction anesthesia$5IEN$0(DLC)sh 85030806

=LDR  01694cz  a2200397n  4500
=001  9880363224002441
=005  20141212194736.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000761
=035  \\$aCAZ3912HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x70
=072  \\$aN4.$x452.$x442.$x422.$x70
=150  \\$aAnesthesia Department, Hospital
=450  \\$wnnna$aAnesthesia Department
=450  \\$wnnna$aAnesthesia Departments
=450  \\$wnnna$aAnesthesia Departments, Hospital
=450  \\$wnnna$aAnesthesia-Resuscitation Department, Hospital
=450  \\$wnnna$aAnesthesia Resuscitation Department, Hospital
=450  \\$wnnna$aAnesthesia-Resuscitation Departments, Hospital
=450  \\$wnnna$aDepartment, Anesthesia
=450  \\$wnnna$aDepartment, Hospital Anesthesia
=450  \\$wnnna$aDepartment, Hospital Anesthesia-Resuscitation
=450  \\$wnnna$aDepartments, Anesthesia
=450  \\$wnnna$aDepartments, Hospital Anesthesia
=450  \\$wnnna$aDepartments, Hospital Anesthesia-Resuscitation
=450  \\$aHospital Anesthesia Department
=450  \\$wnnna$aHospital Anesthesia Departments
=450  \\$aHospital Anesthesia-Resuscitation Department
=450  \\$wnnna$aHospital Anesthesia Resuscitation Department
=450  \\$wnnna$aHospital Anesthesia-Resuscitation Departments
=550  \\$wg$aHospital Departments
=667  \\$aDF: ANESTH DEP
=680  \\$iHospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics.
=688  \\$a91(Aug 77); was see under HOSPITAL DEPARTMENTS 1977-90
=750  \0$aHospitals$xAnesthesia services$5IEN$0(DLC)sh 85062300

=LDR  00842cz  a2200229n  4500
=001  9880363224102441
=005  20141212194735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000759
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x954.$x427.$x10
=150  \\$aAdjuvants, Anesthesia
=450  \\$wnnna$aAdjuvants, Anesthetic
=450  \\$aAnesthesia Adjuvants
=450  \\$wnnna$aAnesthetic Adjuvants
=550  \\$wg$aCentral Nervous System Agents
=550  \\$aAnesthetics
=550  \\$aBalanced Anesthesia
=667  \\$aIM; coord with specific adjuvant (IM) & specific type of anesthesia (IM)
=680  \\$iAgents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.
=688  \\$a99(63)
=750  \0$aAnesthesia adjuvants$5IEN-M$0(DLC)sh 85004958

=LDR  01039cz  a2200289n  4500
=001  9880363224202441
=005  20200407173200.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000758
=035  \\$aCAZ3909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x155
=150  \\$aAnesthesia
=550  \\$wg$aAnesthesia and Analgesia
=550  \\$wh$aAnesthesia, Cardiac Procedures
=550  \\$wh$aAnesthesia, Conduction
=550  \\$wh$aAnesthesia, Dental
=550  \\$wh$aAnesthesia, General
=550  \\$wh$aAnesthesia, Endotracheal
=550  \\$wh$aAnesthesia, Intravenous
=550  \\$wh$aAnesthesia, Obstetrical
=550  \\$wh$aCryoanesthesia
=550  \\$wh$aElectroacupuncture
=550  \\$wh$aHypnosis, Anesthetic
=667  \\$aManual 26.21+
=680  \\$iA state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
=750  \0$aAnesthesia$5IEN$0(DLC)sh 85004952

=LDR  01829cz  a2200409n  4500
=001  9880363224302441
=005  20141212194735.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000757
=035  \\$aCAZ3908HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x196
=072  \\$aC16.$x131.$x85.$x197
=072  \\$aC16.$x131.$x666.$x680.$x196
=150  \\$aAnencephaly
=450  \\$wnnna$aAbsence of Brain, Congenital
=450  \\$wnnna$aAnencephalia
=450  \\$wnnna$aAnencephalias
=450  \\$wnnna$aAnencephalies, Partial
=450  \\$wnnna$aAnencephalus
=450  \\$wnnna$aAnencephaly, Hemicranial
=450  \\$wnnna$aAnencephaly, Incomplete
=450  \\$wnnna$aAnencephaly, Partial
=450  \\$wnnna$aAprosencephalies
=450  \\$aAprosencephaly
=450  \\$wnnna$aBrain Congenital Absence
=450  \\$wnnna$aCongenital Absence of Brain
=450  \\$wnnna$aHemicranial Anencephaly
=450  \\$wnnna$aIncomplete Anencephaly
=450  \\$wnnna$aPartial Anencephalies
=450  \\$wnnna$aPartial Anencephaly
=550  \\$wg$aAbnormalities, Severe Teratoid
=550  \\$wg$aNeural Tube Defects
=550  \\$aalpha-Fetoproteins
=680  \\$iA malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive (brain stem) reflexes and usually do not survive for more than two weeks. (From Menkes, Textbook of Child Neurology, 5th ed, p247)
=688  \\$a79; was ANENCEPHALUS 1964-78 (Prov 1964-65)
=750  \0$aAnencephaly$5IEN$0(DLC)sh 85004949

=LDR  01820cz  a2200445n  4500
=001  9880363224402441
=005  20141212194734.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000755
=035  \\$aCAZ3906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x150.$x150
=072  \\$aC15.$x378.$x420.$x155
=072  \\$aC16.$x320.$x70.$x150
=072  \\$aC16.$x320.$x365.$x155
=150  \\$aAnemia, Sickle Cell
=450  \\$wnnna$aAnemias, Sickle Cell
=450  \\$wnnna$aCell Disease, Sickle
=450  \\$wnnna$aCell Diseases, Sickle
=450  \\$wnnna$aCell Disorder, Sickle
=450  \\$wnnna$aCell Disorders, Sickle
=450  \\$wnnna$aDisease, Hemoglobin S
=450  \\$wnnna$aHbS Disease
=450  \\$aHemoglobin S Disease
=450  \\$wnnna$aHemoglobin S Diseases
=450  \\$wnnna$aSickle Cell Anemia
=450  \\$wnnna$aSickle Cell Anemias
=450  \\$wnnna$aSickle Cell Disease
=450  \\$wnnna$aSickle Cell Diseases
=450  \\$wnnna$aSickle Cell Disorder
=450  \\$wnnna$aSickle Cell Disorders
=450  \\$wnnna$aSickling Disorder Due to Hemoglobin S
=550  \\$wg$aAnemia, Hemolytic, Congenital
=550  \\$wg$aHemoglobinopathies
=550  \\$wh$aAcute Chest Syndrome
=550  \\$wh$aHemoglobin SC Disease
=550  \\$wh$aSickle Cell Trait
=667  \\$aPL 92-294: Natl Sickle Cell Anemia Control Act; sickle cell dis goes here unless specifically HEMOGLOBIN SC DISEASE or HEMOGLOBIN C DISEASE or SICKLE CELL TRAIT or THALASSEMIA; /drug ther: consider also ANTISICKLING AGENTS
=680  \\$iA disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
=750  \0$aSickle cell anemia$0(DLC) sh 85122294$5IEN

=LDR  01160cz  a2200277n  4500
=001  9880363224502441
=005  20141212194733.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000752
=035  \\$aCAZ3903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x252.$x196.$x500
=072  \\$aC18.$x654.$x521.$x500.$x133.$x699.$x923.$x280
=150  \\$aAnemia, Pernicious
=450  \\$wnnna$aAddison Anemia
=450  \\$aAddison's Anemia
=450  \\$wnnna$aAddisons Anemia
=450  \\$wnnna$aAnemia, Addison
=450  \\$aAnemia, Addison's
=450  \\$wnnna$aAnemia, Addisons
=450  \\$wnnna$aPernicious Anemia
=550  \\$wg$aAnemia, Megaloblastic
=550  \\$wg$aVitamin B 12 Deficiency
=667  \\$aa type of megaloblastic anemia
=680  \\$iA megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)
=750  \0$aPernicious anemia$5IEN$0(DLC)sh 85100005

=LDR  00816cz  a2200229n  4500
=001  9880363224602441
=005  20141212194732.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000749
=035  \\$aCAZ3900HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x252.$x196
=150  \\$aAnemia, Megaloblastic
=450  \\$wnnna$aAnemias, Megaloblastic
=450  \\$wnnna$aMegaloblastic Anemia
=450  \\$wnnna$aMegaloblastic Anemias
=550  \\$wg$aAnemia, Macrocytic
=550  \\$wh$aAnemia, Pernicious
=550  \\$aMegaloblasts
=680  \\$iA disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.
=688  \\$a91(75); was see under ANEMIA, MACROCYTIC 1975-90
=750  \0$aMegaloblastic anemia$5IEN$0(DLC)sh 85083284

=LDR  01291cz  a2200241n  4500
=001  9880363224702441
=005  20141212194731.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000747
=035  \\$aCAZ3898HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x196
=150  \\$aAnemia, Hypochromic
=450  \\$wnnna$aAnemias, Hypochromic
=450  \\$wnnna$aChloroses
=450  \\$aChlorosis
=450  \\$wnnna$aHypochromic Anemia
=450  \\$wnnna$aHypochromic Anemias
=550  \\$wg$aAnemia
=550  \\$wh$aAnemia, Iron-Deficiency
=667  \\$anote X ref; ANEMIA, IRON-DEFICIENCY is also available
=680  \\$iAnemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)
=750  \0$aHypochromic anemia$5IEN-HS$0(DLC)sh 85063766

=LDR  01810cz  a2200457n  4500
=001  9880363224802441
=005  20141212194730.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000744
=035  \\$aCAZ3895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x378.$x71.$x141.$x125
=072  \\$aC20.$x111.$x175
=150  \\$aAnemia, Hemolytic, Autoimmune
=450  \\$wnnna$aAcquired Autoimmune Hemolytic Anemia
=450  \\$wnnna$aAgglutinin Disease, Cold
=450  \\$wnnna$aAgglutinin Diseases, Cold
=450  \\$wnnna$aAnemia, Autoimmune Hemolytic
=450  \\$wnnna$aAnemia, Hemolytic, Cold Antibody
=450  \\$aAnemia, Hemolytic, Idiopathic Acquired
=450  \\$wnnna$aAnemias, Autoimmune Hemolytic
=450  \\$aAutoimmune Hemolytic Anemia
=450  \\$wnnna$aAutoimmune Hemolytic Anemias
=450  \\$aCold Agglutinin Disease
=450  \\$wnnna$aCold Agglutinin Diseases
=450  \\$wnnna$aCold Antibody Disease
=450  \\$wnnna$aCold Antibody Diseases
=450  \\$wnnna$aCold Antibody Hemolytic Anemia
=450  \\$wnnna$aDisease, Cold Agglutinin
=450  \\$wnnna$aDisease, Cold Antibody
=450  \\$wnnna$aDiseases, Cold Agglutinin
=450  \\$wnnna$aDiseases, Cold Antibody
=450  \\$aHemolytic Anemia, Autoimmune
=450  \\$wnnna$aHemolytic Anemias, Autoimmune
=450  \\$wnnna$aIdiopathic Autoimmune Hemolytic Anemia
=550  \\$wg$aAnemia, Hemolytic
=550  \\$wg$aAutoimmune Diseases
=680  \\$iAcquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
=688  \\$a1968; use ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-1967
=688  \\$a68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67
=750  \0$aHemolytic anemia, Autoimmune$5IEN$0(DLC)sh 85060211

=LDR  00966cz  a2200229n  4500
=001  9880363640802441
=005  20141212202716.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007667
=035  \\$aCBA0871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x538
=072  \\$aD23.$x50.$x705.$x230.$x538
=150  \\$aKidd Blood-Group System
=450  \\$wnnna$aBlood-Group System, Kidd
=450  \\$wnnna$aKidd Blood Group System
=450  \\$wnnna$aSystem, Kidd Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iA group of antigens consisting principally of Jk(a) and Jk(b), determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes.
=688  \\$a91(76); was see under BLOOD GROUPS 1976-90
=750  \0$aBlood groups$xKidd system$5IEN$0(DLC)sh 88003253

=LDR  01020cz  a2200289n  4500
=001  9880363640902441
=005  20141212202715.0
=008  810513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007665
=035  \\$aCBA0869HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x778.$x370
=072  \\$aD3.$x383.$x621.$x370
=072  \\$aD3.$x383.$x903.$x370
=150  \\$aKetotifen
=450  \\$wnnna$a4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one
=450  \\$wnnna$aFumarate, Ketotifen
=450  \\$wnnna$aKetotifen Fumarate
=450  \\$wnnna$aKetotifene
=450  \\$wnnna$aKetotiphen
=450  \\$wnnna$aKetotiphene
=450  \\$wnnna$aZaditen
=550  \\$wg$aPiperidines
=550  \\$wg$aThiophenes
=680  \\$iA cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
=688  \\$a82
=750  \0$aKetotifen$5IEN$0(DLC)sh 85072098

=LDR  00940cz  a2200325n  4500
=001  9880363641002441
=005  20141212202714.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007659
=035  \\$aCBA0863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x522
=150  \\$aKetones
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetone
=550  \\$wh$aAcetophenones
=550  \\$wh$aBenzophenones
=550  \\$wh$aButanones
=550  \\$wh$aButyrophenones
=550  \\$wh$aCamphor
=550  \\$wh$aCyclohexanones
=550  \\$wh$aHexanones
=550  \\$wh$aKetone Bodies
=550  \\$wh$aMannich Bases
=550  \\$wh$aMethadone
=550  \\$wh$aPentanones
=550  \\$wh$aPhosgene
=550  \\$wh$aPropiophenones
=667  \\$aKETO ACIDS & KETOSES are also available; ketonemia & ketonuria go under KETONE BODIES; ketogenesis is probably KETONE BODIES /biosyn
=750  \0$aKetones$5IEN$0(DLC)sh 85072095

=LDR  00769cz  a2200253n  4500
=001  9880363641102441
=005  20141212202712.0
=008  830311\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007654
=035  \\$aCBA0858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x606.$x560
=150  \\$aKetoconazole
=450  \\$wnnna$aJanssen Brand of Ketoconazole
=450  \\$wnnna$aKetoconazole Janssen Brand
=450  \\$wnnna$aNizoral
=450  \\$wnnna$aR-41400
=450  \\$wnnna$aR 41400
=450  \\$wnnna$aR41,400
=450  \\$wnnna$aR41400
=550  \\$wg$aPiperazines
=680  \\$iBroad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.
=688  \\$a84
=750  \0$aKetoconazole$5IEN$0(DLC)sh 89006385

=LDR  00639cz  a2200241n  4500
=001  9880363641202441
=005  20141212202711.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007651
=035  \\$aCBA0855HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x755
=150  \\$aKeto Acids
=450  \\$wnnna$aAcids, Keto
=450  \\$aKetonic Acids$5IEN
=550  \\$wg$aCarboxylic Acids
=550  \\$wh$aAcetoacetates
=550  \\$wh$aHippurates
=550  \\$wh$aKetoglutaric Acids
=550  \\$wh$aLevulinic Acids
=550  \\$wh$aOxaloacetates
=550  \\$wh$aPyruvates
=750  \0$aKetonic acids$5IEN$0(DLC)sh 85072096

=LDR  01038cz  a2200277n  4500
=001  9880363641302441
=005  20141212202711.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007650
=035  \\$aCBA0854M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x621.$x365
=072  \\$aD3.$x438.$x786.$x830.$x333
=150  \\$aKetanserin
=450  \\$wnnna$a3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
=450  \\$wnnna$aR-41,468
=450  \\$wnnna$aR 41,468
=450  \\$wnnna$aR-41468
=450  \\$wnnna$aR 41468
=450  \\$wnnna$aR41,468
=450  \\$wnnna$aR41468
=550  \\$wg$aPiperidines
=550  \\$wg$aQuinazolinones
=680  \\$iA selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
=688  \\$a87
=750  \0$aKetanserin$0(DLC) sh 90000693$5IEN-M

=LDR  01052cz  a2200301n  4500
=001  9880363641402441
=005  20141212202710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007649
=035  \\$aCBA0853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x652
=150  \\$aKetamine
=450  \\$wnnna$a2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
=450  \\$wnnna$aCalipsol
=450  \\$wnnna$aCalypsol
=450  \\$wnnna$aCI-581
=450  \\$wnnna$aCI 581
=450  \\$wnnna$aCI581
=450  \\$wnnna$aKalipsol
=450  \\$wnnna$aKetalar
=450  \\$wnnna$aKetamine Hydrochloride
=450  \\$wnnna$aKetanest
=450  \\$wnnna$aKetaset
=550  \\$wg$aCyclohexanes
=680  \\$iA cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
=688  \\$a73; was CI-581 1969-72 (Prov)
=750  \0$aKetamine$5IEN$0(DLC)sh 92004206

=LDR  00736cz  a2200193n  4500
=001  9880363641502441
=005  20141212202710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007648
=035  \\$aCBA0852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x345.$x630.$x600
=072  \\$aN6.$x230.$x132.$x258.$x630.$x600
=150  \\$aKerosene
=450  \\$aKerosine
=550  \\$wg$aPetroleum
=680  \\$iA refined petroleum fraction used as a fuel as well as a solvent.
=688  \\$a98; was KEROSINE 1982-97 (see under PETROLEUM 1982-90); was KEROSENE see under PETROLEUM 1963-81 (Prov 1963-74); was Cat J heading only 1975-81, Cat D & H heading 1968-74, Cat D heading only 1963-67
=750  \0$aKerosene$5IEN$0(DLC)sh 85072068

=LDR  01677cz  a2200337n  4500
=001  9880363641602441
=005  20141212192255.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007647
=035  \\$aCBA0851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x480
=072  \\$aC15.$x378.$x295.$x502
=072  \\$aC16.$x614.$x304.$x502
=072  \\$aC18.$x452.$x132.$x480
=072  \\$aC20.$x306.$x502
=072  \\$aC23.$x550.$x429.$x750
=150  \\$aKernicterus
=450  \\$wnnna$aBilirubin Encephalopathies
=450  \\$aBilirubin Encephalopathy
=450  \\$wnnna$aEncephalopathies, Bilirubin
=450  \\$wnnna$aEncephalopathies, Hyperbilirubinemic
=450  \\$wnnna$aEncephalopathy, Bilirubin
=450  \\$wnnna$aEncephalopathy, Hyperbilirubinemic
=450  \\$wnnna$aHyperbilirubinemic Encephalopathies
=450  \\$aHyperbilirubinemic Encephalopathy
=550  \\$wg$aBrain Diseases, Metabolic
=550  \\$wg$aErythroblastosis, Fetal
=550  \\$wg$aHyperbilirubinemia
=680  \\$iA term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)
=750  \0$aKernicterus$5IEN$0(DLC)sh 85072064

=LDR  00711cz  a2200217n  4500
=001  9880363641702441
=005  20141212202710.0
=008  860620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007646
=035  \\$aCBA0850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x825.$x550
=150  \\$aKeratotomy, Radial
=450  \\$wnnna$aKeratotomies, Radial
=450  \\$wnnna$aRadial Keratotomies
=450  \\$aRadial Keratotomy
=550  \\$wg$aRefractive Surgical Procedures
=550  \\$aCornea
=680  \\$iA procedure to surgically correct REFRACTIVE ERRORS by cutting radial slits into the CORNEA to change its refractive properties.
=688  \\$a87
=750  \0$aKeratotomy, Radial$5IEN$0(DLC)sh 85072042

=LDR  02049cz  a2200457n  4500
=001  9880363641802441
=005  20141212202709.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007644
=035  \\$aCBA0848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x850.$x190
=072  \\$aC17.$x800.$x428.$x275
=072  \\$aC17.$x800.$x827.$x190
=150  \\$aDarier Disease
=450  \\$wnnna$aAcantholytic Dyskeratotic Epidermal Nevi
=450  \\$wnnna$aAcantholytic Dyskeratotic Epidermal Nevus
=450  \\$wnnna$aAcrokeratosis Verruciformis
=450  \\$aAcrokeratosis Verruciformis of Hopf
=450  \\$aDarier-White Disease
=450  \\$wnnna$aDarier White Disease
=450  \\$wnnna$aDarier-White Diseases
=450  \\$wnnna$aDarier's Disease
=450  \\$wnnna$aDariers Disease
=450  \\$wnnna$aDisease, Darier
=450  \\$wnnna$aDisease, Darier-White
=450  \\$wnnna$aDisease, Darier's
=450  \\$wnnna$aDisease, Hopf
=450  \\$wnnna$aDiseases, Darier-White
=450  \\$wnnna$aDiseases, Hopf
=450  \\$wnnna$aHopf Acrokeratosis Verruciformis
=450  \\$wnnna$aHopf Disease
=450  \\$wnnna$aHopf Diseases
=450  \\$aKeratosis Follicularis
=450  \\$wnnna$aVerruciformis, Acrokeratosis
=550  \\$wg$aKeratosis
=550  \\$wg$aSkin Diseases, Genetic
=680  \\$iAn autosomal dominantly inherited skin disorder characterized by warty malodorous papules that coalesce into plaques. It is caused by mutations in the ATP2A2 gene encoding SERCA2 protein, one of the SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. The condition is similar, clinically and histologically, to BENIGN FAMILIAL PEMPHIGUS, another autosomal dominant skin disorder. Both diseases have defective calcium pumps (CALCIUM-TRANSPORTING ATPASES) and unstable desmosomal adhesion junctions (DESMOSOMES) between KERATINOCYTES.
=688  \\$a2009 (1966)
=688  \\$aHeading changed 20081103 from: 150:##:_{dollar}a Keratosis Follicularis
=750  \0$aKeratosis follicularis$0(DLC) sh 85072041$5IEN

=LDR  01564cz  a2200433n  4500
=001  9880363641902441
=005  20141212202708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007642
=035  \\$aCBA0846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x428
=150  \\$aKeratosis
=450  \\$wnnna$aBlennorrhagica, Keratosis
=450  \\$wnnna$aBlennorrhagicas, Keratosis
=450  \\$wnnna$aBlennorrhagicum, Keratoderma
=450  \\$wnnna$aBlennorrhagicums, Keratoderma
=450  \\$aKeratoderma Blennorrhagicum
=450  \\$wnnna$aKeratoderma Blennorrhagicums
=450  \\$aKeratoma
=450  \\$wnnna$aKeratomas
=450  \\$wnnna$aKeratoses
=450  \\$aKeratosis Blennorrhagica
=450  \\$wnnna$aKeratosis Blennorrhagicas
=550  \\$wg$aSkin Diseases
=550  \\$wh$aCallosities
=550  \\$wh$aCholesteatoma
=550  \\$wh$aDarier Disease
=550  \\$wh$aErythrokeratodermia Variabilis
=550  \\$wh$aIchthyosis
=550  \\$wh$aKeratoderma, Palmoplantar
=550  \\$wh$aKeratosis, Actinic
=550  \\$wh$aKeratosis, Seborrheic
=550  \\$wh$aParakeratosis
=550  \\$wh$aPorokeratosis
=667  \\$aa horny skin dis
=680  \\$iAny horny growth such as a wart or callus.
=688  \\$aKERATODERMA BLENNORRHAGICUM was heading 1975-96 (was KERATOSIS BLENNORRHAGICA 1963-92 (see under KERATOSIS 1979-90, see under GONORRHEA 1975-78)), was see under GONORRHEA 1963-74; KERATOSIS BLENNORRHAGICA was see KERATODERMA BLENNORRHAGICUM 1993-96
=750  \0$aKeratosis$0(DLC) sh 85072040$5IEN

=LDR  00750cz  a2200169n  4500
=001  9880363642002441
=005  20141212202708.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007640
=035  \\$aCBA0844M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x204.$x627
=150  \\$aKeratoconus
=550  \\$wg$aCorneal Diseases
=667  \\$acone-shaped protrusion of cornea
=680  \\$iA noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. (From Dorland, 27th ed)
=750  \0$aKeratoconus$5IEN-M$0(DLC)sh 98007487

=LDR  00992cz  a2200241n  4500
=001  9880363642102441
=005  20141212202707.0
=008  850605\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007638
=035  \\$aCBA0842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187.$x183.$x394.$x550
=072  \\$aC11.$x204.$x564.$x585.$x630
=072  \\$aC11.$x496.$x260.$x394
=150  \\$aKeratoconjunctivitis Sicca
=450  \\$wnnna$aSicca, Keratoconjunctivitis
=550  \\$wg$aDry Eye Syndromes
=550  \\$wg$aKeratoconjunctivitis
=550  \\$aSjogren's Syndrome
=667  \\$aif with xerostomia or xerostomia & connective tissue dis, index as SJOGREN'S SYNDROME
=680  \\$iDrying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.
=688  \\$a91(86); was see under KERATOCONJUNCTIVITIS 1986-90
=750  \0$aKeratoconjunctivitis sicca$5IEN$0(DLC)sh 85072038

=LDR  00725cz  a2200229n  4500
=001  9880363642202441
=005  20141212202707.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007637
=035  \\$aCBA0841HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x187.$x183.$x394
=072  \\$aC11.$x204.$x564.$x585
=150  \\$aKeratoconjunctivitis
=450  \\$wnnna$aKeratoconjunctivitides
=550  \\$wg$aConjunctivitis
=550  \\$wg$aKeratitis
=550  \\$wh$aKeratoconjunctivitis, Infectious
=550  \\$wh$aKeratoconjunctivitis Sicca
=667  \\$ainflamm of cornea & conjunctiva
=680  \\$iSimultaneous inflammation of the cornea and conjunctiva.
=750  \0$aKeratoconjunctivitis$5IEN$0(DLC)sh 85072037

=LDR  00990cz  a2200181n  4500
=001  9880363642302441
=005  20141212202706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007636
=035  \\$aCBA0840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x417
=150  \\$aKeratoacanthoma
=450  \\$wnnna$aKeratoacanthomas
=550  \\$wg$aSkin Diseases
=667  \\$anote category: non-neoplastic; coord IM with precoord organ/dis term (IM); do not confuse with ACANTHAMOEBA KERATITIS
=680  \\$iA benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.
=750  \0$aKeratoacanthoma$5IEN$0(DLC)sh 85072036

=LDR  00672cz  a2200229n  4500
=001  9880363642402441
=005  20141212202706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007634
=035  \\$aCBA0838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x204.$x564
=150  \\$aKeratitis
=450  \\$wnnna$aKeratitides
=550  \\$wg$aCorneal Diseases
=550  \\$wh$aAcanthamoeba Keratitis
=550  \\$wh$aCorneal Ulcer
=550  \\$wh$aKeratitis, Herpetic
=550  \\$wh$aKeratoconjunctivitis
=667  \\$ainflamm of cornea; GEN or unspecified; prefer specifics
=680  \\$iInflammation of the cornea.
=750  \0$aKeratitis$5IEN$0(DLC)sh 85072035

=LDR  01720cz  a2200373n  4500
=001  9880363642502441
=005  20141212202706.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007633
=035  \\$aCBA0837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x593.$x450
=072  \\$aD12.$x776.$x220.$x475.$x450
=072  \\$aD12.$x776.$x860.$x607
=150  \\$aKeratins
=450  \\$wnnna$aalpha-Keratin
=450  \\$wnnna$aalpha Keratin
=450  \\$aCytokeratin
=450  \\$wnnna$aGlycosylated Keratin
=450  \\$wnnna$aKeratin
=450  \\$wnnna$aKeratin-Associated Proteins
=450  \\$wnnna$aKeratin Associated Proteins
=450  \\$wnnna$aKeratin, Glycosylated
=550  \\$wg$aIntermediate Filament Proteins
=550  \\$wg$aScleroproteins
=550  \\$wh$abeta-Keratins
=550  \\$wh$aKeratins, Hair-Specific
=550  \\$wh$aKeratins, Type I
=550  \\$wh$aKeratins, Type II
=550  \\$aTissue Polypeptide Antigen
=680  \\$iA class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
=688  \\$a2007(1966)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Keratin
=750  \0$aKeratin$0(DLC) sh 85072032$5IEN

=LDR  00832cz  a2200193n  4500
=001  9880363642602441
=005  20141212202705.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007631
=035  \\$aCBA0835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x190
=150  \\$aChlordecone
=450  \\$wnnna$aKepone
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iA highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals.
=688  \\$a96; was KEPONE 1977-95 (see under INSECTICIDES, ORGANOCHLORINE 1977-90); CHLORDECONE was see KEPONE 1977-95
=750  \0$aChlordecone$5IEN$0(DLC)sh 85024528

=LDR  01021cz  a2200229n  4500
=001  9880363642702441
=005  20141212202704.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007626
=035  \\$aCBA0830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD23.$x50.$x301.$x290.$x533
=072  \\$aD23.$x50.$x705.$x230.$x533
=150  \\$aKell Blood-Group System
=450  \\$wnnna$aBlood-Group System, Kell
=450  \\$wnnna$aKell Blood Group System
=450  \\$wnnna$aSystem, Kell Blood-Group
=550  \\$wg$aBlood Group Antigens
=667  \\$aIM; coord with disease /blood (IM), not /immunol nor /genet; TN 230
=680  \\$iMultiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome.
=688  \\$a91(76); was see under BLOOD GROUPS 1976-90
=750  \0$aBlood groups$xKell system$5IEN$0(DLC)sh 90002512

=LDR  00876cz  a2200229n  4500
=001  9880363642802441
=005  20141212202535.0
=008  860530\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007353
=035  \\$aCBA0549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x508
=150  \\$aInsurance, Long-Term Care
=450  \\$wnnna$aInsurance, Long Term Care
=450  \\$aLong-Term Care Insurance
=450  \\$wnnna$aLong Term Care Insurance
=550  \\$wg$aInsurance, Health
=550  \\$aLong-Term Care
=667  \\$aspecify geog if possible
=680  \\$iHealth insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.
=688  \\$a92; was INSURANCE, LONG TERM CARE 1987-91
=750  \0$aLong-term care insurance$5IEN-M$0(DLC)sh 88001074

=LDR  00661cz  a2200205n  4500
=001  9880363642902441
=005  20141212202534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007352
=035  \\$aCBA0548HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x543
=150  \\$aInsurance, Life
=450  \\$wnnna$aInsurances, Life
=450  \\$wnnna$aLife Insurance
=450  \\$wnnna$aLife Insurances
=550  \\$wg$aInsurance
=667  \\$aspecify geog if possible
=680  \\$iInsurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured.
=750  \0$aLife insurance$5IEN$0(DLC)sh 85066960

=LDR  00753cz  a2200229n  4500
=001  9880363643002441
=005  20141212192251.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007351
=035  \\$aCBA0547HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x443
=150  \\$aInsurance, Liability
=450  \\$wnnna$aInsurance, No-Fault
=450  \\$wnnna$aLiability Insurance
=450  \\$aNo-Fault Insurance
=450  \\$wnnna$aNo Fault Insurance
=550  \\$wg$aInsurance
=550  \\$aMalpractice
=667  \\$aadd geographic term if pertinent
=680  \\$iInsurance against loss resulting from liability for injury or damage to the persons or property of others.
=750  \0$aLiability insurance$5IEN$0(DLC)sh 85066956

=LDR  00788cz  a2200217n  4500
=001  9880363643102441
=005  20141212202534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007350
=035  \\$aCBA0546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x492
=150  \\$aInsurance, Hospitalization
=450  \\$aGroup Hospitalization
=450  \\$wnnna$aHospitalization, Group
=450  \\$aHospitalization Insurance
=550  \\$wg$aInsurance, Health
=667  \\$aspecify geog if possible
=680  \\$iHealth insurance providing benefits to cover or partly cover hospital expenses.
=688  \\$aGROUP HOSPITALIZATION was heading 1975-91 (see under INSURANCE, HOSPITALIZATION 1975-90)
=750  \0$aHospitalization insurance$5IEN-M$0(DLC)sh 85066945

=LDR  02130cz  a2200565n  4500
=001  9880363643202441
=005  20190131132802.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007348
=035  \\$aCBA0544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343
=150  \\$aInsurance, Health
=450  \\$aGroup Health Insurance
=450  \\$aHealth Insurance
=450  \\$wnnna$aHealth Insurance, Group
=450  \\$aHealth Insurance, Voluntary
=450  \\$wnnna$aInsurance, Group Health
=450  \\$wnnna$aInsurance, Voluntary Health
=450  \\$wnnna$aVoluntary Health Insurance
=550  \\$wg$aInsurance
=550  \\$wh$aFor-Profit Insurance Plans
=550  \\$wh$aHealth Benefit Plans, Employee
=550  \\$wh$aHealth Insurance Portability and Accountability Act
=550  \\$wh$aInsurance, Accident
=550  \\$wh$aInsurance, Dental
=550  \\$wh$aInsurance, Health, Reimbursement
=550  \\$wh$aInsurance, Hospitalization
=550  \\$wh$aInsurance, Long-Term Care
=550  \\$wh$aInsurance, Major Medical
=550  \\$wh$aInsurance, Medigap
=550  \\$wh$aInsurance, Nursing Services
=550  \\$wh$aInsurance, Pharmaceutical Services
=550  \\$wh$aInsurance, Physician Services
=550  \\$wh$aInsurance, Psychiatric
=550  \\$wh$aInsurance, Surgical
=550  \\$wh$aManaged Care Programs
=550  \\$wh$aManaged Competition
=550  \\$wh$aMedical Savings Accounts
=550  \\$wh$aMedicare
=550  \\$wh$aNational Health Insurance, United States
=550  \\$wh$aNot-For-Profit Insurance Plans
=550  \\$wh$aPatient Protection and Affordable Care Act
=550  \\$wh$aPrepaid Health Plans
=550  \\$wh$aSingle-Payer System
=550  \\$wh$aValue-Based Purchasing
=550  \\$wh$aValue-Based Health Insurance
=667  \\$aspecify geographic term if possible; CHAMPUS: index under HEALTH BENEFIT PLANS, EMPLOYEE
=680  \\$iInsurance providing coverage of medical, surgical, or hospital care in general or for which there is no specific heading.
=750  \0$aHealth insurance$0(DLC) sh 85066932$5IEN

=LDR  00974cz  a2200277n  4500
=001  9880363643302441
=005  20141212202533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007347
=035  \\$aCBA0543HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x450
=150  \\$aInsurance, Dental
=450  \\$wnnna$aCare, Prepaid Dental
=450  \\$wnnna$aDental Care Plan
=450  \\$aDental Care Plans
=450  \\$wnnna$aDental Care, Prepaid
=450  \\$wnnna$aDental Insurance
=450  \\$wnnna$aPlan, Dental Care
=450  \\$wnnna$aPlans, Dental Care
=450  \\$aPrepaid Dental Care
=550  \\$wg$aInsurance, Health
=667  \\$aspecify geog if possible; DF: INSURANCE DENT
=680  \\$iInsurance providing coverage for dental care.
=688  \\$aDENTAL CARE PLANS was see under INSURANCE, DENTAL 1963-78; PREPAID DENTAL CARE was see under INSURANCE, DENTAL 1969-78
=750  \0$aDental insurance$5IEN$0(DLC)sh 85066878

=LDR  00682cz  a2200205n  4500
=001  9880363643402441
=005  20141212202532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007346
=035  \\$aCBA0542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x343.$x409
=150  \\$aInsurance, Accident
=450  \\$aAccident Insurance
=450  \\$wnnna$aAccident Insurances
=450  \\$wnnna$aInsurances, Accident
=550  \\$wg$aInsurance, Health
=667  \\$aspecify geog if possible
=680  \\$iInsurance providing coverage for physical injury suffered as a result of unavoidable circumstances.
=750  \0$aAccident insurance$5IEN$0(DLC)sh 85066827

=LDR  01726cz  a2200421n  4500
=001  9880363643502441
=005  20141212202532.0
=008  850424\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007345
=035  \\$aCBA0539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x215
=150  \\$aInsurance Claim Review
=450  \\$wnnna$aAnalyses, Claims
=450  \\$wnnna$aAnalysis, Claims
=450  \\$wnnna$aAudit, Insurance
=450  \\$wnnna$aAudits, Insurance
=450  \\$wnnna$aClaim Review, Insurance
=450  \\$wnnna$aClaim Reviews, Insurance
=450  \\$wnnna$aClaims Analyses
=450  \\$wnnna$aClaims Analysis
=450  \\$wnnna$aClaims Processing, Insurance
=450  \\$aClaims Review
=450  \\$wnnna$aClaims Reviews
=450  \\$aInsurance Audit
=450  \\$wnnna$aInsurance Audits
=450  \\$wnnna$aInsurance Claim Reviews
=450  \\$aInsurance Claims Processing
=450  \\$wnnna$aProcessing, Insurance Claims
=450  \\$wnnna$aReview, Claims
=450  \\$wnnna$aReview, Insurance Claim
=450  \\$wnnna$aReviews, Claims
=450  \\$wnnna$aReviews, Insurance Claim
=550  \\$wg$aInsurance
=550  \\$aUtilization Review
=680  \\$iReview of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.
=688  \\$a91(86); was see under INSURANCE, HEALTH 1986-90
=750  \0$aInsurance claims$5IEN-M$0(DLC)sh 94003203

=LDR  00633cz  a2200193n  4500
=001  9880363643602441
=005  20141212202531.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007344
=035  \\$aCBA0538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x210
=150  \\$aInsurance Claim Reporting
=450  \\$wnnna$aClaim Reporting, Insurance
=450  \\$wnnna$aReporting, Insurance Claim
=550  \\$wg$aInsurance
=680  \\$iThe design, completion, and filing of forms with the insurer.
=688  \\$a91(Aug 77); was see under INSURANCE 1977-90
=750  \0$aInsurance claims$5IEN-M$0(DLC)sh 94003203

=LDR  01195cz  a2200313n  4500
=001  9880363643702441
=005  20141212192251.0
=008  770511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007342
=035  \\$aCBA0536HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x576.$x130
=150  \\$aInsurance Benefits
=450  \\$wnnna$aBeneficiaries, Insurance
=450  \\$wnnna$aBeneficiary, Insurance
=450  \\$wnnna$aBenefit, Health
=450  \\$wnnna$aBenefit, Insurance
=450  \\$wnnna$aBenefits, Health
=450  \\$wnnna$aBenefits, Insurance
=450  \\$wnnna$aHealth Benefit
=450  \\$aHealth Benefits
=450  \\$wnnna$aInsurance Beneficiaries
=450  \\$wnnna$aInsurance Beneficiary
=450  \\$wnnna$aInsurance Benefit
=550  \\$wg$aInsurance
=667  \\$acoordinate IM with specific type of insurance (IM) + geographic term if pertinent
=680  \\$iPayments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed.
=688  \\$a78
=750  \2$aEmployer-sponsored health insurance$5IEN-M

=LDR  01391cz  a2200397n  4500
=001  9880363643902441
=005  20141212202531.0
=008  810520\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007340
=035  \\$aCBA0534M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x470.$x35.$x100.$x852
=072  \\$aC4.$x588.$x274.$x761.$x249.$x500
=072  \\$aC4.$x588.$x322.$x475.$x249.$x500
=072  \\$aC6.$x301.$x761.$x249.$x500
=072  \\$aC6.$x689.$x667.$x249.$x500
=072  \\$aC19.$x344.$x421.$x249.$x500
=150  \\$aInsulinoma
=450  \\$aAdenoma, beta-Cell
=450  \\$wnnna$aAdenoma, beta Cell
=450  \\$wnnna$aAdenomas, beta-Cell
=450  \\$wnnna$abeta-Cell Adenoma
=450  \\$wnnna$abeta-Cell Adenomas
=450  \\$abeta-Cell Tumor
=450  \\$wnnna$abeta Cell Tumor
=450  \\$wnnna$abeta-Cell Tumors
=450  \\$wnnna$aInsulinomas
=450  \\$aInsuloma
=450  \\$wnnna$aInsulomas
=450  \\$wnnna$aTumor, beta-Cell
=450  \\$wnnna$aTumors, beta-Cell
=550  \\$wg$aAdenoma, Islet Cell
=667  \\$acoord IM with PANCREATIC NEOPLASMS (IM)
=680  \\$iA benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
=688  \\$a91(82); was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81
=750  \0$aIslands of Langerhans$xTumors$0(DLC) sh 85068606$5IEN

=LDR  00955cz  a2200265n  4500
=001  9880363644002441
=005  20141212202529.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007333
=035  \\$aCBA0527HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x394.$x968.$x500
=072  \\$aG7.$x690.$x320.$x617
=150  \\$aInsulin Resistance
=450  \\$wnnna$aInsulin Sensitivity
=450  \\$wnnna$aResistance, Insulin
=450  \\$wnnna$aSensitivity, Insulin
=550  \\$wg$aDrug Resistance
=550  \\$wg$aHyperinsulinism
=550  \\$wh$aMetabolic Syndrome X
=550  \\$aDonohue Syndrome
=667  \\$aINSULIN RESISTANCE SYNDROME X see METABOLIC SYNDROME X is available
=680  \\$iDiminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
=688  \\$a67(64)
=750  \0$aInsulin resistance$5IEN$0(DLC)sh 85066799

=LDR  02107cz  a2200445n  4500
=001  9880363644102441
=005  20141212202529.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007332
=035  \\$aCBA0526HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x300.$x508
=072  \\$aE7.$x505.$x508
=072  \\$aE7.$x858.$x82.$x505.$x508
=150  \\$aInsulin Infusion Systems
=450  \\$wnnna$aArtificial beta Cell
=450  \\$wnnna$aArtificial beta Cells
=450  \\$wnnna$aArtificial Endocrine Pancreas
=450  \\$abeta Cell, Artificial
=450  \\$wnnna$abeta Cells, Artificial
=450  \\$wnnna$aCell, Artificial beta
=450  \\$wnnna$aCells, Artificial beta
=450  \\$wnnna$aEndocrine Pancreas, Artificial
=450  \\$wnnna$aImplantable Programmable Insulin Pump
=450  \\$wnnna$aInfusion System, Insulin
=450  \\$wnnna$aInfusion Systems, Insulin
=450  \\$wnnna$aInsulin Infusion System
=450  \\$wnnna$aInsulin Pump, Programmable Implantable
=450  \\$aInsulin Pumps$5IEN
=450  \\$aPancreas, Artificial Endocrine
=450  \\$aProgrammable Implantable Insulin Pump
=450  \\$wnnna$aPump, Programmable Implantable Insulin
=450  \\$wnnna$aSystem, Insulin Infusion
=450  \\$wnnna$aSystems, Insulin Infusion
=550  \\$wg$aDrug Delivery Systems
=550  \\$wg$aInfusion Pumps
=667  \\$adoes not include conventional insulin injections ( = INSULIN /admin + specific injection term); for implantable insulin infusion devices coordinate IM with INFUSION PUMPS, IMPLANTABLE (NIM); insulin patches: index INSULIN /admin (IM) + ADMINISTRATION, CUTANEOUS (NIM)
=680  \\$iPortable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
=688  \\$a82
=750  \0$aInsulin pumps$5IEN$0(DLC)sh 89000020

=LDR  00849cz  a2200241n  4500
=001  9880363644202441
=005  20141212202528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007331
=035  \\$aCBA0525M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x358.$x800.$x200.$x600
=072  \\$aC18.$x452.$x394.$x984.$x492
=150  \\$aInsulin Coma
=450  \\$wnnna$aComa, Insulin
=450  \\$wnnna$aInsulin Shock
=450  \\$wnnna$aShock, Insulin
=550  \\$wg$aComa
=550  \\$wg$aHypoglycemia
=550  \\$aConvulsive Therapy
=680  \\$iSevere HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.
=688  \\$a91(64); was see under HYPOGLYCEMIA 1964-90
=750  \0$aInsulin shock$5IEN$0(DLC)sh 85066800

=LDR  00606cz  a2200193n  4500
=001  9880363644302441
=005  20141212202528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007330
=035  \\$aCBA0524HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x656
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x656
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x656
=150  \\$aInsulin Antibodies
=450  \\$wnnna$aAntibodies, Insulin
=550  \\$wg$aAntibodies
=680  \\$iAntibodies specific to INSULIN.
=750  \0$aInsulin antibodies$5IEN$0(DLC)sh 85066798

=LDR  01781cz  a2200337n  4500
=001  9880363644402441
=005  20141212202527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007328
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x587.$x200.$x500.$x625
=072  \\$aD12.$x644.$x548.$x586.$x200.$x500.$x625
=150  \\$aInsulin
=450  \\$wnnna$aChain, Insulin B
=450  \\$wnnna$aIletin
=450  \\$wnnna$aInsulin A Chain
=450  \\$wnnna$aInsulin B Chain
=450  \\$wnnna$aInsulin, Regular
=450  \\$wnnna$aInsulin, Sodium
=450  \\$wnnna$aInsulin, Soluble
=450  \\$wnnna$aNovolin
=450  \\$wnnna$aRegular Insulin
=450  \\$wnnna$aSodium Insulin
=450  \\$wnnna$aSoluble Insulin
=550  \\$wg$aProinsulin
=550  \\$wh$aInsulin, Regular, Human
=550  \\$wh$aInsulin, Regular, Pork
=550  \\$aHyperinsulinism
=667  \\$a/blood: consider also HYPERINSULINEMIA (excessively high blood insulin levels) but do not confuse with HYPERINSULINISM (excessive secretion of insulin by pancreas); /immunology: consider also INSULIN ANTIBODIES; precursor = PROINSULIN; INSULIN INFUSION SYSTEMS is available
=680  \\$iA 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).
=750  \0$aInsulin$5IEN$0(DLC)sh 85066794

=LDR  01143cz  a2200289n  4500
=001  9880363644502441
=005  20141212202526.0
=008  780516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007326
=035  \\$aCBA0520HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x415
=072  \\$aN2.$x421.$x585.$x415
=150  \\$aInstitutionalization
=450  \\$aInstitutional Care$5IEN
=450  \\$wnnna$aInstitutionalizations
=450  \\$wnnna$aInstitutionalized Person
=450  \\$wnnna$aInstitutionalized Persons
=450  \\$wnnna$aPerson, Institutionalized
=450  \\$wnnna$aPersons, Institutionalized
=550  \\$wg$aPatient Care
=550  \\$wh$aDeinstitutionalization
=550  \\$aHospitalization
=667  \\$acoord IM with type of institution (IM) if pertinent; institutionalization of mentally ill: consider also COMMITMENT OF MENTALLY ILL
=680  \\$iThe caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution.
=688  \\$a79
=750  \0$aInstitutional care$5IEN$0(DLC)sh 85066744

=LDR  01057cz  a2200301n  4500
=001  9880363644602441
=005  20141212202525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007323
=035  \\$aCBA0517HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x658.$x642
=150  \\$aInstinct
=450  \\$wnnna$aBehavior, Innate
=450  \\$wnnna$aBehaviors, Innate
=450  \\$aFixed Action Pattern
=450  \\$wnnna$aFixed Action Patterns
=450  \\$aInnate Behavior
=450  \\$wnnna$aInnate Behaviors
=450  \\$wnnna$aInstincts
=450  \\$wnnna$aPattern, Fixed Action
=450  \\$wnnna$aPatterns, Fixed Action
=550  \\$wg$aMotivation
=550  \\$aDrive
=667  \\$ahuman & animal; no qualif
=680  \\$iStereotyped patterns of response, characteristic of a given species, that have been phylogenetically adapted to a specific type of situation.
=688  \\$aFIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78; INNATE BEHAVIOR was see under INSTINCT 1968-78
=750  \0$aInstinct$5IEN$0(DLC)sh 85066739

=LDR  02107cz  a2200541n  4500
=001  9880363644702441
=005  20141212202523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007319
=035  \\$aCBA0513HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x886.$x425.$x800.$x800
=072  \\$aF3.$x870.$x400.$x800.$x800
=150  \\$aSleep Initiation and Maintenance Disorders
=450  \\$wnnna$aAwakening, Early
=450  \\$wnnna$aChronic Insomnia
=450  \\$wnnna$aDIMS (Disorders of Initiating and Maintaining Sleep)
=450  \\$aDisorders of Initiating and Maintaining Sleep
=450  \\$wnnna$aDysfunction, Sleep Initiation
=450  \\$wnnna$aDysfunctions, Sleep Initiation
=450  \\$wnnna$aEarly Awakening
=450  \\$aInsomnia
=450  \\$wnnna$aInsomnia, Chronic
=450  \\$wnnna$aInsomnia Disorder
=450  \\$wnnna$aInsomnia Disorders
=450  \\$wnnna$aInsomnia, Nonorganic
=450  \\$wnnna$aInsomnia, Primary
=450  \\$wnnna$aInsomnia, Psychophysiological
=450  \\$wnnna$aInsomnia, Rebound
=450  \\$wnnna$aInsomnia, Secondary
=450  \\$wnnna$aInsomnia, Transient
=450  \\$wnnna$aInsomnias
=450  \\$wnnna$aNonorganic Insomnia
=450  \\$wnnna$aPrimary Insomnia
=450  \\$wnnna$aPsychophysiological Insomnia
=450  \\$wnnna$aRebound Insomnia
=450  \\$wnnna$aSecondary Insomnia
=450  \\$wnnna$aSleep Initiation Dysfunction
=450  \\$wnnna$aSleep Initiation Dysfunctions
=450  \\$aSleeplessness
=450  \\$wnnna$aTransient Insomnia
=550  \\$wg$aSleep Disorders, Intrinsic
=550  \\$wh$aInsomnia, Fatal Familial
=550  \\$aWakefulness
=667  \\$ado not confuse with SLEEP DEPRIVATION, being deprived of sleep or prevented from sleeping; usually chronic so do not coord with CHRONIC DISEASE
=680  \\$iDisorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
=688  \\$a2000(1966)
=750  \0$aInsomnia$5IEN$0(DLC)sh 85066717

=LDR  01316cz  a2200325n  4500
=001  9880363644802441
=005  20141212202523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007318
=035  \\$aCBA0512HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x574
=150  \\$aInservice Training
=450  \\$wnnna$aEmployee Orientation Program
=450  \\$aEmployee Orientation Programs
=450  \\$wnnna$aOn-the-Job Training
=450  \\$wnnna$aOn the Job Training
=450  \\$wnnna$aOrientation Program, Employee
=450  \\$aOrientation Programs, Employee
=450  \\$wnnna$aProgram, Employee Orientation
=450  \\$wnnna$aPrograms, Employee Orientation
=450  \\$wnnna$aTraining, Inservice
=450  \\$wnnna$aTraining, On-the-Job
=550  \\$wg$aEducation
=550  \\$wh$aStaff Development
=667  \\$aDF: INSERV TRAINING
=680  \\$iOn the job training programs for personnel carried out within an institution or agency. It includes orientation programs.
=688  \\$a70(67)
=780  \0$wb$xIn-service training$5IEN
=788  \0$isubdivision$aIn-service training$iunder occupational groups and types of employees for works on their continuing professional education during service to increase their effectiveness on the job, e.g.$aTeachers--In-service training$5IEN-M

=LDR  01103cz  a2200313n  4500
=001  9880363644902441
=005  20141212202522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007315
=035  \\$aCBA0509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x540
=072  \\$aE2.$x875.$x800.$x937
=072  \\$aE5.$x820.$x800.$x937
=072  \\$aG8.$x686.$x785.$x760.$x363.$x492
=150  \\$aInsemination, Artificial
=450  \\$aArtificial Insemination
=450  \\$wnnna$aArtificial Inseminations
=450  \\$wnnna$aEutelegeneses
=450  \\$wnnna$aEutelegenesis
=450  \\$wnnna$aInseminations, Artificial
=550  \\$wg$aInsemination
=550  \\$wg$aReproductive Techniques
=550  \\$wg$aReproductive Techniques, Assisted
=550  \\$wh$aInsemination, Artificial, Heterologous
=550  \\$wh$aInsemination, Artificial, Homologous
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iArtificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.
=750  \0$aArtificial insemination, Human$5IEN-M$0(DLC)sh 85008176

=LDR  00593nz  a2200193n  4500
=001  9882116471702441
=005  20230127145135.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007312
=035  \\$a(DNLM)D007312
=035  \\$a(NLM)98194957270000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x961
=150  \\$aEulipotyphla
=450  \\$aInsectivora
=450  \\$aSoricomorpha
=680  \\$iAn order of insect eating MAMMALS including MOLES; SHREWS; HEDGEHOGS.
=688  \\$a2022(2010)
=750  \0$aEulipotyphla$0(DLC)sh2007010200$5IEN-M

=LDR  01289cz  a2200265n  4500
=001  9880363645202441
=005  20141212202520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007306
=035  \\$aCBA0500HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700.$x491
=072  \\$aD27.$x720.$x723.$x491
=072  \\$aD27.$x888.$x723.$x491
=150  \\$aInsecticides
=450  \\$wnnoa$aInsecticides, Botanical$5IEN-M
=450  \\$wnnoa$aInsecticides, Carbamate$5IEN-M
=450  \\$wnnoa$aInsecticides, Organochlorine$5IEN-M
=450  \\$wnnoa$aInsecticides, Organophosphate$5IEN-M
=450  \\$wnnoa$aInsecticides, Organothiophosphate$5IEN-M
=550  \\$wg$aPesticides
=550  \\$aCholinesterase Inhibitors
=667  \\$afor use to kill or control insects, use no qualifiers on the insecticide or the insect; appropriate qualifiers may be used when other aspects of the insecticide are discussed such as the effect on a physiologic process or behavioral aspect of the insect.
=680  \\$iPesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics.
=750  \0$aInsecticides$5IEN$0(DLC)sh 85066663

=LDR  00834cz  a2200241n  4500
=001  9880363645302441
=005  20141212202520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007305
=035  \\$aCBA0499HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x690.$x320.$x491
=150  \\$aInsecticide Resistance
=450  \\$wnnna$aInsecticide Resistances
=450  \\$wnnna$aResistance, Insecticide
=450  \\$wnnna$aResistances, Insecticide
=550  \\$wg$aDrug Resistance
=550  \\$aInsect Control
=550  \\$aMosquito Control
=667  \\$aIM when general; NIM when with specific insecticide (IM) & specific insect (IM)
=680  \\$iThe development by insects of resistance to insecticides.
=688  \\$a67; was INSECTICIDES RESISTANCE 1964-66 (Prov)
=750  \0$aInsecticide resistance$5IEN$0(DLC)sh 85066662

=LDR  01033cz  a2200325n  4500
=001  9880363645402441
=005  20141212202520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007304
=035  \\$aCBA0498HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x525
=150  \\$aInsect Viruses
=450  \\$wnnna$aInsect Virus
=450  \\$aPolyhedrosis Viruses$5IEN
=450  \\$wnnna$aVirus, Insect
=450  \\$wnnna$aViruses, Insect
=550  \\$wg$aViruses
=550  \\$wh$aAscoviridae
=550  \\$wh$aBaculoviridae
=550  \\$wh$aDensovirinae
=550  \\$wh$aDicistroviridae
=550  \\$wh$aEntomopoxvirinae
=550  \\$wh$aIridovirus
=550  \\$wh$aNodaviridae
=550  \\$wh$aPolydnaviridae
=667  \\$aIM; coord with specific insect /virol (IM)
=680  \\$iViruses infecting insects, the largest family being BACULOVIRIDAE.
=688  \\$a63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1973-77 (Prov 1973-74)
=750  \0$aInsects$xViruses$5IEN$0(DLC)sh 85066661

=LDR  00891cz  a2200217n  4500
=001  9880363645502441
=005  20180822112821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007303
=035  \\$aCBA0497HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x310.$x350.$x100.$x500
=150  \\$aInsect Vectors
=450  \\$wnnna$aInsect Vector
=450  \\$wnnna$aVector, Insect
=450  \\$wnnna$aVectors, Insect
=550  \\$wg$aArthropod Vectors
=550  \\$wh$aMosquito Vectors
=667  \\$acoord IM with specific insect (IM); specify both infecting organism & vector if pertinent; in the trypanosome-tsetse fly-cow relationship, the fly (not the cow) is the insect vector
=680  \\$iInsects that transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.
=750  \0$aInsects as carriers of disease$5IEN$0(DLC)sh 85066702

=LDR  00731cz  a2200229n  4500
=001  9880363645602441
=005  20141212202519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007302
=035  \\$aCBA0496HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x706.$x434
=072  \\$aD27.$x720.$x31.$x700.$x441
=072  \\$aD27.$x720.$x723.$x441
=072  \\$aD27.$x888.$x723.$x441
=150  \\$aInsect Repellents
=450  \\$wnnna$aRepellents, Insect
=550  \\$wg$aPesticides
=550  \\$wg$aProtective Agents
=667  \\$aspecify insect if pertinent
=680  \\$iSubstances causing insects to turn away from them or reject them as food.
=750  \0$aInsect baits and repellents$5IEN$0(DLC)sh 85066640

=LDR  00765cz  a2200217n  4500
=001  9880363645702441
=005  20141212202519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007301
=035  \\$aCBA0495HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x445.$x573
=150  \\$aInsect Hormones
=450  \\$wnnna$aHormones, Insect
=550  \\$wg$aInvertebrate Hormones
=550  \\$wh$aEcdysteroids
=550  \\$wh$aJuvenile Hormones
=667  \\$acoord IM with specific insect (IM)
=680  \\$iHormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones.
=688  \\$a77(75); was see under INVERTEBRATE HORMONES 1967-76
=750  \0$aInsect hormones$5IEN$0(DLC)sh 85066644

=LDR  00815cz  a2200193n  4500
=001  9880363645802441
=005  20141212202518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007300
=035  \\$aCBA0494HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x650.$x425
=150  \\$aInsect Control
=450  \\$wnnna$aControl, Insect
=550  \\$wg$aPest Control
=550  \\$wh$aMosquito Control
=667  \\$afor sterilization of insects, coord specific insect (IM) + PEST CONTROL, BIOLOGICAL (IM) but not also STERILIZATION, REPRODUCTIVE (see note there) & not also INSECT CONTROL
=680  \\$iThe reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.
=750  \0$aInsect pests$xControl$5IEN$0(DLC)sh 85066647

=LDR  01375cz  a2200301n  4500
=001  9880363645902441
=005  20141212202518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007298
=035  \\$aCBA0492HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x96.$x544.$x335.$x528
=072  \\$aI1.$x198.$x780.$x937.$x469.$x528
=072  \\$aI1.$x880.$x604.$x583.$x310.$x528
=072  \\$aN3.$x706.$x535.$x351.$x528
=150  \\$aInsanity Defense
=450  \\$aCriminal Insanity
=450  \\$wnnna$aDefense, Insanity
=450  \\$wnnna$aInsanity, Criminal
=450  \\$aMcNaughton Rule
=450  \\$aM'Naghten Rule
=450  \\$wnnna$aRule, McNaughton
=450  \\$wnnna$aRule, M'Naghten
=550  \\$wg$aForensic Psychiatry
=550  \\$aMental Competency
=680  \\$iA legal concept that an accused is not criminally responsible if, at the time of committing the act, the person was laboring under such a defect of reason from disease of the mind as not to know the nature and quality of the act done or if the act was known, to not have known that what was done was wrong. (From Black's Law Dictionary, 6th ed)
=688  \\$a91(85); was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968
=750  \0$aInsanity defense$0(DLC)sh2007003620$5IEN

=LDR  00850cz  a2200241n  4500
=001  9880363646002441
=005  20141212202517.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007295
=035  \\$aCBA0489HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x519.$x400
=072  \\$aD9.$x853.$x519.$x400
=072  \\$aD9.$x894.$x480
=150  \\$aInositol Phosphates
=450  \\$wnnna$aPhosphates, Inositol
=550  \\$wg$aInositol
=550  \\$wg$aSugar Phosphates
=550  \\$wh$aInositol 1,4,5-Trisphosphate
=550  \\$wh$aPhytic Acid
=680  \\$iPhosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID.
=688  \\$a90(78); was see under SUGAR PHOSPHATES 1978-89
=750  \0$aInositol phosphates$0(DLC) sh 89001804$5IEN

=LDR  00897cz  a2200229n  4500
=001  9880363646102441
=005  20141212202517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007294
=035  \\$aCBA0488HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x800.$x519
=072  \\$aD9.$x853.$x519
=150  \\$aInositol
=450  \\$wnnna$aChiro-Inositol
=450  \\$wnnna$aChiro Inositol
=450  \\$wnnna$aMesoinositol
=450  \\$aMyoinositol
=550  \\$wg$aSugar Alcohols
=550  \\$wh$aInositol Phosphates
=680  \\$iAn isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
=750  \0$aInositol$0(DLC) sh 85066543$5IEN

=LDR  00970cz  a2200241n  4500
=001  9880363646202441
=005  20190315153429.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007288
=035  \\$aCBA0482HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x633.$x100.$x759.$x590.$x616
=072  \\$aD13.$x570.$x583.$x616
=072  \\$aD13.$x570.$x800.$x573
=150  \\$aInosine
=550  \\$wg$aPurine Nucleosides
=550  \\$wg$aRibonucleosides
=550  \\$wh$aDidanosine
=550  \\$wh$aInosine Pranobex
=550  \\$wh$aThioinosine
=680  \\$iA purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
=688  \\$a73(71); was see under NUCLEOSIDES 1963-71
=750  \0$aInosine$5IEN$0(DLC)sh 90000261

=LDR  02499cz  a2200781n  4500
=001  9880363646302441
=005  20141212202515.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007287
=035  \\$aCBA0481HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1
=150  \\$aInorganic Chemicals
=450  \\$wnnna$aChemicals, Inorganic
=550  \\$wh$aAcids
=550  \\$wh$aAlkalies
=550  \\$wh$aAluminum Compounds
=550  \\$wh$aArsenicals
=550  \\$wh$aBarium Compounds
=550  \\$wh$aBoron Compounds
=550  \\$wh$aBromine Compounds
=550  \\$wh$aCadmium Compounds
=550  \\$wh$aCalcium Compounds
=550  \\$wh$aCarbon Compounds, Inorganic
=550  \\$wh$aChlorine Compounds
=550  \\$wh$aChromium Compounds
=550  \\$wh$aCoordination Complexes
=550  \\$wh$aElectrolytes
=550  \\$wh$aElements
=550  \\$wh$aFluorine Compounds
=550  \\$wh$aFree Radicals
=550  \\$wh$aGases
=550  \\$wh$aGold Compounds
=550  \\$wh$aHydrogen
=550  \\$wh$aHydroxides
=550  \\$wh$aIodine Compounds
=550  \\$wh$aIron Compounds
=550  \\$wh$aIsotopes
=550  \\$wh$aLithium Compounds
=550  \\$wh$aMagnesium Compounds
=550  \\$wh$aManganese Compounds
=550  \\$wh$aMercury Compounds
=550  \\$wh$aMetals
=550  \\$wh$aMinerals
=550  \\$wh$aNitrogen Compounds
=550  \\$wh$aOsmium Compounds
=550  \\$wh$aOxygen Compounds
=550  \\$wh$aPhosphorus Compounds
=550  \\$wh$aPlatinum Compounds
=550  \\$wh$aPotassium Compounds
=550  \\$wh$aRuthenium Compounds
=550  \\$wh$aSalts
=550  \\$wh$aSelenium Compounds
=550  \\$wh$aSilicon Compounds
=550  \\$wh$aSilver Compounds
=550  \\$wh$aSodium Compounds
=550  \\$wh$aSulfur Compounds
=550  \\$wh$aTechnetium Compounds
=550  \\$wh$aThorium Compounds
=550  \\$wh$aTin Compounds
=550  \\$wh$aTungsten Compounds
=550  \\$wh$aUranium Compounds
=550  \\$wh$aVanadium Compounds
=550  \\$wh$aZinc Compounds
=667  \\$aGEN or unspecified; prefer specific groups or specific chemicals
=680  \\$iA broad class of substances encompassing all those that do not include carbon and its derivatives as their principal elements. However, carbides, carbonates, cyanides, cyanates, and carbon disulfide are included in this class.
=688  \\$a98; use explode 1975-97
=750  \0$aInorganic compounds$5IEN-M$0(DLC)sh 86005967

=LDR  01431cz  a2200373n  4500
=001  9880363646402441
=005  20141212202514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007284
=035  \\$aCBA0478HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323.$x428.$x275
=072  \\$aE6.$x780.$x345.$x737.$x500
=072  \\$aE6.$x780.$x345.$x817
=072  \\$aE7.$x695.$x190.$x190.$x350
=150  \\$aInlays
=450  \\$wnnna$aDental Inlay
=450  \\$aDental Inlays
=450  \\$wnnna$aDental Onlay
=450  \\$aDental Onlays
=450  \\$wnnna$aInlay
=450  \\$wnnna$aInlay, Dental
=450  \\$wnnna$aInlays, Dental
=450  \\$wnnna$aOnlay
=450  \\$wnnna$aOnlay, Dental
=450  \\$aOnlays
=450  \\$wnnna$aOnlays, Dental
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aDental Restoration, Permanent
=550  \\$aDental Materials
=667  \\$acoord IM with specific tooth (IM) if pertinent + specific material (IM)
=680  \\$iRestorations of metal, porcelain, or plastic made to fit a cavity preparation, then cemented into the tooth. Onlays are restorations which fit into cavity preparations and overlay the occlusal surface of a tooth or teeth. Onlays are retained by frictional or mechanical factors.
=688  \\$a63; DENTAL ONLAYS & ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90
=750  \0$aInlays (Dentistry)$5IEN$0(DLC)sh 85066491

=LDR  00414cz  a2200169n  4500
=001  9880363646502441
=005  20141212192250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007281
=035  \\$aCBA0475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x637.$x500
=150  \\$aInk
=450  \\$wnnna$aInks
=550  \\$wg$aManufactured Materials
=667  \\$ano qualif
=750  \0$aInk$5IEN$0(DLC)sh 85066453

=LDR  00965cz  a2200265n  4500
=001  9880363646602441
=005  20141212192250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007279
=035  \\$aCBA0473HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x620
=150  \\$aInjections, Subcutaneous
=450  \\$wnnna$aInjection, Subcutaneous
=450  \\$aInjections, Hypodermic$5IEN
=450  \\$wnnna$aSubcutaneous Injection
=450  \\$wnnna$aSubcutaneous Injections
=550  \\$wg$aInjections
=550  \\$wh$aInjections, Intradermal
=550  \\$wh$aInjections, Jet
=550  \\$wh$aMesotherapy
=550  \\$aSubcutaneous Absorption
=667  \\$aNIM; do not use /util except by MeSH definition; DF: INJECT SUBCUTANEOUS
=680  \\$iForceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.
=750  \0$aInjections, Hypodermic$5IEN$0(DLC)sh 85066437

=LDR  01011cz  a2200313n  4500
=001  9880363646702441
=005  20141212202512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007278
=035  \\$aCBA0472HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x580
=150  \\$aInjections, Spinal
=450  \\$wnnna$aInjection, Intraspinal
=450  \\$wnnna$aInjection, Intrathecal
=450  \\$wnnna$aInjection, Spinal
=450  \\$aInjections, Intraspinal
=450  \\$aInjections, Intrathecal
=450  \\$wnnna$aIntraspinal Injection
=450  \\$aIntraspinal Injections
=450  \\$wnnna$aIntrathecal Injection
=450  \\$aIntrathecal Injections
=450  \\$wnnna$aSpinal Injection
=450  \\$wnnna$aSpinal Injections
=550  \\$wg$aInjections
=550  \\$wh$aInjections, Epidural
=667  \\$ado not confuse with INFUSIONS, SPINAL
=688  \\$a87; was INJECTIONS, INTRATHECAL 1963-86 (Prov 1963-65)
=750  \0$aInjections, Spinal$5IEN$0(DLC)sh 85066448

=LDR  00911cz  a2200241n  4500
=001  9880363646802441
=005  20141212202512.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007275
=035  \\$aCBA0469HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x82.$x750
=072  \\$aE2.$x319.$x267.$x530.$x540
=150  \\$aInjections, Intravenous
=450  \\$wnnna$aInjection, Intravenous
=450  \\$wnnna$aIntravenous Injection
=450  \\$wnnna$aIntravenous Injections
=550  \\$wg$aAdministration, Intravenous
=550  \\$wg$aInjections
=550  \\$aPhlebotomy
=667  \\$aNIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRAVENOUS ( = "long-term (minutes to hours) admin"); DF: INJECT INTRAVENOUS
=680  \\$iInjections made into a vein for therapeutic or experimental purposes.
=750  \0$aInjections, Intravenous$5IEN$0(DLC)sh 85066445

=LDR  00875cz  a2200229n  4500
=001  9880363646902441
=005  20141212192249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007274
=035  \\$aCBA0468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x490
=150  \\$aInjections, Intraperitoneal
=450  \\$wnnna$aInjection, Intraperitoneal
=450  \\$wnnna$aIntraperitoneal Injection
=450  \\$wnnna$aIntraperitoneal Injections
=550  \\$wg$aInjections
=550  \\$aPeritoneal Absorption
=667  \\$aNIM; do not use /util except by MeSH definition; DF: INJECT INTRAPERITONEAL
=680  \\$iForceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
=688  \\$a66(64)
=750  \0$aInjections, Intraperitoneal$5IEN$0(DLC)sh 85066444

=LDR  00849cz  a2200217n  4500
=001  9880363647002441
=005  20141212192249.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007273
=035  \\$aCBA0467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x460
=150  \\$aInjections, Intramuscular
=450  \\$wnnna$aInjection, Intramuscular
=450  \\$wnnna$aIntramuscular Injection
=450  \\$wnnna$aIntramuscular Injections
=550  \\$wg$aInjections
=550  \\$aIntramuscular Absorption
=667  \\$aNIM; do not use /util except by MeSH definition; DF: INJECT INTRAMUSCULAR
=680  \\$iForceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
=750  \0$aInjections, Intramuscular$5IEN$0(DLC)sh 85066442

=LDR  00902cz  a2200217n  4500
=001  9880363647102441
=005  20141212202511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007271
=035  \\$aCBA0465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x620.$x410
=150  \\$aInjections, Intradermal
=450  \\$wnnna$aInjection, Intradermal
=450  \\$wnnna$aIntradermal Injection
=450  \\$wnnna$aIntradermal Injections
=550  \\$wg$aInjections, Subcutaneous
=667  \\$aNIM; do not use /util except by MeSH definition; DF: INJECT INTRADERMAL
=680  \\$iThe forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer.
=688  \\$a91(87)66(64); was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86; was Prov 1964-65
=750  \0$aInjections, Intradermal$5IEN$0(DLC)sh 85066440

=LDR  00973cz  a2200289n  4500
=001  9880363647202441
=005  20141212202511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007270
=035  \\$aCBA0464HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x380
=150  \\$aInjections, Intra-Articular
=450  \\$wnnna$aInjection, Intra-Articular
=450  \\$wnnna$aInjection, Intraarticular
=450  \\$wnnna$aInjections, Intra Articular
=450  \\$wnnna$aInjections, Intraarticular
=450  \\$wnnna$aIntra-Articular Injection
=450  \\$wnnna$aIntra-Articular Injections
=450  \\$wnnna$aIntra Articular Injections
=450  \\$wnnna$aIntraarticular Injection
=450  \\$wnnna$aIntraarticular Injections
=550  \\$wg$aInjections
=550  \\$wh$aViscosupplementation
=667  \\$aNIM; do not use /util except by MeSH definition
=688  \\$a66(64)
=750  \0$aInjections, Intra-articular$5IEN$0(DLC)sh 85066439

=LDR  00973cz  a2200265n  4500
=001  9880363647302441
=005  20141212202510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007269
=035  \\$aCBA0463HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530.$x370
=150  \\$aInjections, Intra-Arterial
=450  \\$wnnna$aInjection, Intra-Arterial
=450  \\$wnnna$aInjection, Intraarterial
=450  \\$wnnna$aInjections, Intra Arterial
=450  \\$wnnna$aInjections, Intraarterial
=450  \\$wnnna$aIntra-Arterial Injection
=450  \\$wnnna$aIntra-Arterial Injections
=450  \\$wnnna$aIntra Arterial Injections
=450  \\$wnnna$aIntraarterial Injection
=450  \\$wnnna$aIntraarterial Injections
=550  \\$wg$aInjections
=667  \\$aNIM; do not use /util except by MeSH definition; do not confuse with INFUSIONS, INTRA-ARTERIAL; DF: INJECT INTRA ARTERIAL
=750  \0$aInjections, Intra-arterial$5IEN$0(DLC)sh 85066438

=LDR  01276cz  a2200349n  4500
=001  9880363647402441
=005  20170405153638.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007267
=035  \\$aCBA0461HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x530
=150  \\$aInjections
=450  \\$wnnna$aInjectable
=450  \\$wnnna$aInjectables
=450  \\$wnnna$aInjection
=550  \\$wg$aDrug Administration Routes
=550  \\$wh$aInjections, Intra-Arterial
=550  \\$wh$aInjections, Intra-Articular
=550  \\$wh$aInjections, Intralesional
=550  \\$wh$aInjections, Intralymphatic
=550  \\$wh$aInjections, Intramuscular
=550  \\$wh$aInjections, Intraocular
=550  \\$wh$aInjections, Intraperitoneal
=550  \\$wh$aInjection, Intratympanic
=550  \\$wh$aInjections, Intravenous
=550  \\$wh$aInjections, Intraventricular
=550  \\$wh$aInjections, Spinal
=550  \\$wh$aInjections, Subcutaneous
=550  \\$wh$aMicroinjections
=667  \\$aGEN or unspecified; prefer specifics; NIM; do not use /util except by MeSH definition; periodontal ligament injection (PDLI) = PERIODONTAL LIGAMENT (IM) + ANESTHESIA, DENTAL (IM); Manual 26.25; DF: INJECT
=750  \0$aInjections$5IEN$0(DLC)sh 85066433

=LDR  01723cz  a2200409n  4500
=001  9880363647602441
=005  20141212202509.0
=008  820511\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007265
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x334.$x968
=072  \\$aD6.$x472.$x699.$x337
=072  \\$aD12.$x644.$x548.$x387
=072  \\$aD12.$x776.$x395.$x439
=150  \\$aInhibins
=450  \\$wnnna$aFemale Inhibin
=450  \\$wnnna$aFemale Inhibins
=450  \\$wnnna$aInhibin
=450  \\$wnnna$aInhibin-F
=450  \\$wnnna$aInhibin F
=450  \\$wnnna$aInhibin, Female
=450  \\$wnnna$aInhibin, Ovarian
=450  \\$wnnna$aInhibin, Testicular
=450  \\$wnnna$aInhibins, Female
=450  \\$wnnna$aInhibins, Testicular
=450  \\$wnnna$aOvarian Inhibin
=450  \\$wnnna$aTesticular Inhibin
=450  \\$wnnna$aTesticular Inhibins
=550  \\$wg$aGlycoproteins
=550  \\$wg$aGonadal Hormones
=550  \\$wg$aPeptide Hormones
=550  \\$wh$aInhibin-beta Subunits
=550  \\$aReceptors, LHRH
=667  \\$a/biosyn /physiol permitted
=680  \\$iGlycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively
=688  \\$a2002; (1983)
=750  \0$aInhibin$5IEN$0(DLC)sh 85066402

=LDR  01872cz  a2200445n  4500
=001  9880363647702441
=005  20141212202508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007263
=035  \\$aCBA0457HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x319.$x267.$x510
=150  \\$aInfusions, Parenteral
=450  \\$wnnna$aInfusion, Intra-Abdominal
=450  \\$wnnna$aInfusion, Intraperitoneal
=450  \\$wnnna$aInfusion, Parenteral
=450  \\$wnnna$aInfusion, Peritoneal
=450  \\$wnnna$aInfusions, Intra-Abdominal
=450  \\$wnnna$aInfusions, Intraperitoneal
=450  \\$wnnna$aInfusions, Peritoneal
=450  \\$wnnna$aIntra-Abdominal Infusion
=450  \\$aIntra-Abdominal Infusions
=450  \\$wnnna$aIntra Abdominal Infusions
=450  \\$wnnna$aIntraperitoneal Infusion
=450  \\$aIntraperitoneal Infusions
=450  \\$wnnna$aParenteral Infusion
=450  \\$aParenteral Infusions
=450  \\$wnnna$aPeritoneal Infusion
=450  \\$aPeritoneal Infusions
=550  \\$wg$aDrug Administration Routes
=550  \\$wh$aInfusions, Intra-Arterial
=550  \\$wh$aInfusions, Intralesional
=550  \\$wh$aInfusions, Intraosseous
=550  \\$wh$aInfusions, Intravenous
=550  \\$wh$aInfusions, Intraventricular
=550  \\$wh$aInfusions, Spinal
=550  \\$wh$aInfusions, Subcutaneous
=667  \\$arestrict to method of admin of drugs & chemicals; not for replacement of fluids ( = FLUID THERAPY) nor for nourishment ( = PARENTERAL FEEDING); GEN or unspecified; prefer specifics; do not use /util except by MeSH definition
=680  \\$iThe administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.
=750  \0$aParenteral therapy$5IEN$0(DLC)sh 85098004

=LDR  00652cz  a2200229n  4500
=001  9880363647802441
=005  20141212202404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007100
=035  \\$aCBA0289HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x510
=150  \\$aImitative Behavior
=450  \\$wnnna$aBehavior, Imitative
=450  \\$wnnna$aBehaviors, Imitative
=450  \\$aImitation$5IEN
=450  \\$wnnna$aImitative Behaviors
=550  \\$wg$aBehavior
=667  \\$ahuman & animal
=680  \\$iThe mimicking of the behavior of one individual by another.
=688  \\$a68
=750  \0$aImitation$5IEN$0(DLC)sh 85064501

=LDR  00962cz  a2200265n  4500
=001  9880363647902441
=005  20141212202404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007099
=035  \\$aCBA0288HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x240.$x485
=150  \\$aImipramine
=450  \\$aImidobenzyle
=450  \\$wnnna$aImipramine Hydrochloride
=450  \\$wnnna$aImipramine Monohydrochloride
=450  \\$aImizin
=450  \\$wnnna$aJanimine
=450  \\$wnnna$aMelipramine
=450  \\$wnnna$aNorchlorimipramine
=450  \\$wnnna$aPryleugan
=450  \\$wnnna$aTofranil
=550  \\$wg$aDibenzazepines
=680  \\$iThe prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
=750  \0$aImipramine$5IEN$0(DLC)sh 85064499

=LDR  01037cz  a2200337n  4500
=001  9880363648002441
=005  20141212202404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007098
=035  \\$aCBA0286HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x583
=072  \\$aD2.$x491.$x485
=072  \\$aD12.$x125.$x72.$x401
=150  \\$aImino Acids
=450  \\$wnnna$aAcids, Imino
=450  \\$wnnna$aAcids, Secondary Amino
=450  \\$aAmino Acids, Secondary
=450  \\$wnnna$aSecondary Amino Acids
=550  \\$wg$aAcids, Acyclic
=550  \\$wg$aAmino Acids, Cyclic
=550  \\$wg$aImines
=550  \\$wh$aAzetidinecarboxylic Acid
=550  \\$wh$aProline
=550  \\$wh$aPyrrolidonecarboxylic Acid
=550  \\$wh$aTechnetium Tc 99m Diethyl-iminodiacetic Acid
=550  \\$wh$aTechnetium Tc 99m Disofenin
=550  \\$wh$aTechnetium Tc 99m Lidofenin
=667  \\$ado not confuse with AMINO ACIDS; DF: AA SECOND for X ref
=688  \\$a74
=750  \0$aImino acids$5IEN$0(DLC)sh 85064496

=LDR  00574cz  a2200217n  4500
=001  9880363648102441
=005  20141212202403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007097
=035  \\$aCBA0285HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x491
=150  \\$aImines
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aCarbodiimides
=550  \\$wh$aImino Acids
=550  \\$wh$aImino Sugars
=550  \\$wh$aPolyethyleneimine
=550  \\$wh$aSchiff Bases
=667  \\$ado not confuse with IMIDES or AMINES
=750  \0$aImines$5IEN$0(DLC)sh 85064495

=LDR  00719cz  a2200217n  4500
=001  9880363648202441
=005  20141212202403.0
=008  790221\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007096
=035  \\$aCBA0284HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x478.$x400
=150  \\$aImidoesters
=450  \\$aImidates
=550  \\$wg$aImides
=550  \\$wh$aDimethyl Adipimidate
=550  \\$wh$aDimethyl Suberimidate
=667  \\$areagents; D25-26 qualif
=680  \\$iEsters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents.
=688  \\$a80
=750  \0$aImidoesters$5IEN$0(DLC)sh 85064494

=LDR  00604cz  a2200229n  4500
=001  9880363648302441
=005  20141212202403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007094
=035  \\$aCBA0282HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x478
=150  \\$aImides
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aImidoesters
=550  \\$wh$aMaleimides
=550  \\$wh$aNaphthalimides
=550  \\$wh$aPantothenic Acid
=550  \\$wh$aPhthalimides
=550  \\$wh$aSuccinimides
=667  \\$ado not confuse with IMINES or AMIDES
=750  \0$aImides$5IEN$0(DLC)sh 85064493

=LDR  01960cz  a2200637n  4500
=001  9880363648402441
=005  20171215154122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007093
=035  \\$aCBA0281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308
=150  \\$aImidazoles
=550  \\$wg$aAzoles
=550  \\$wh$a4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
=550  \\$wh$aAminoimidazole Carboxamide
=550  \\$wh$aAntazoline
=550  \\$wh$aBiotin
=550  \\$wh$aBis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide
=550  \\$wh$aCarbimazole
=550  \\$wh$aCimetidine
=550  \\$wh$aClotrimazole
=550  \\$wh$aCreatinine
=550  \\$wh$aDacarbazine
=550  \\$wh$aDexmedetomidine
=550  \\$wh$aEconazole
=550  \\$wh$aEnoximone
=550  \\$wh$aEtimizol
=550  \\$wh$aEtomidate
=550  \\$wh$aFadrozole
=550  \\$wh$aFluspirilene
=550  \\$wh$aHistamine
=550  \\$wh$aHistidinol
=550  \\$wh$aIdazoxan
=550  \\$wh$aImidazolidines
=550  \\$wh$aImidazolines
=550  \\$wh$aImpromidine
=550  \\$wh$aLevamisole
=550  \\$wh$aLosartan
=550  \\$wh$aMedetomidine
=550  \\$wh$aMethimazole
=550  \\$wh$aMiconazole
=550  \\$wh$aNaphazoline
=550  \\$wh$aNiridazole
=550  \\$wh$aNitroimidazoles
=550  \\$wh$aOlmesartan Medoxomil
=550  \\$wh$aOndansetron
=550  \\$wh$aOxymetazoline
=550  \\$wh$aPhentolamine
=550  \\$wh$aTetramisole
=550  \\$wh$aTrimethaphan
=550  \\$wh$aUrocanic Acid
=550  \\$wh$aVardenafil Dihydrochloride
=550  \\$aBenzimidazoles
=680  \\$iCompounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
=750  \0$aImidazoles$5IEN$0(DLC)sh 85064491

=LDR  00738cz  a2200205n  4500
=001  9880363648502441
=005  20141212202402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007092
=035  \\$aCBA0280HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x188.$x634
=150  \\$aImagination
=450  \\$wnnna$aImaginations
=550  \\$wg$aCognition
=550  \\$wh$aDreams
=550  \\$wh$aFantasy
=667  \\$anote see related IMAGERY (PSYCHOTHERAPY): use of images & imagery as a psychother technique so do not confuse with images produced by the imagination ( = IMAGINATION)
=680  \\$iA new pattern of perceptual or ideational material derived from past experience.
=750  \0$aImagination$5IEN$0(DLC)sh 85064466

=LDR  01644cz  a2200421n  4500
=001  9880363648602441
=005  20141212202401.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007091
=035  \\$aCBA0279HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x308
=150  \\$aImage Processing, Computer-Assisted
=450  \\$wnnna$aAnalysis, Computer-Assisted Image
=450  \\$wnnna$aComputer-Assisted Image Analyses
=450  \\$wnnna$aComputer-Assisted Image Analysis
=450  \\$wnnna$aComputer Assisted Image Analysis
=450  \\$aComputer-Assisted Image Processing
=450  \\$wnnna$aComputer Assisted Image Processing
=450  \\$wnnna$aImage Analyses, Computer-Assisted
=450  \\$aImage Analysis, Computer-Assisted
=450  \\$wnnna$aImage Analysis, Computer Assisted
=450  \\$wnnna$aImage Processing, Computer Assisted
=450  \\$aImage Reconstruction
=450  \\$wnnna$aImage Reconstructions
=450  \\$wnnna$aReconstruction, Image
=450  \\$wnnna$aReconstructions, Image
=550  \\$wg$aComputing Methodologies
=550  \\$wh$aData Compression
=550  \\$wh$aImage Enhancement
=550  \\$wh$aImaging, Three-Dimensional
=550  \\$aData Compression
=550  \\$aDiagnostic Imaging
=550  \\$aMultimodal Imaging
=667  \\$aimage analysis for diagnostic purposes is IMAGE INTERPRETATION, COMPUTER-ASSISTED
=680  \\$iA technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.
=688  \\$a87
=750  \0$aImage processing$5IEN$0(DLC)sh 85064446

=LDR  01457cz  a2200349n  4500
=001  9880363648702441
=005  20141212202400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007089
=035  \\$aCBA0277HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x600.$x350
=072  \\$aL1.$x224.$x308.$x380
=150  \\$aImage Enhancement
=450  \\$wnnna$aEnhancement, Image
=450  \\$wnnna$aEnhancement, Image Quality
=450  \\$wnnna$aEnhancements, Image
=450  \\$wnnna$aEnhancements, Image Quality
=450  \\$wnnna$aImage Enhancements
=450  \\$wnnna$aImage Quality Enhancement
=450  \\$wnnna$aImage Quality Enhancements
=450  \\$wnnna$aQuality Enhancement, Image
=450  \\$wnnna$aQuality Enhancements, Image
=550  \\$wg$aImage Processing, Computer-Assisted
=550  \\$wg$aPhotography
=550  \\$wh$aRadiographic Image Enhancement
=550  \\$wh$aRadiography, Dual-Energy Scanned Projection
=550  \\$wh$aTomography, Emission-Computed
=667  \\$aRADIOGRAPHIC IMAGE ENHANCEMENT is also available
=680  \\$iImprovement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural MICROSCOPY, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level.
=688  \\$a73(72)
=750  \0$aImage processing$5IEN$0(DLC)sh 85064446

=LDR  01764cz  a2200541n  4500
=001  9880363648802441
=005  20141212202400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007088
=035  \\$aCBA0276HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x762.$x400
=072  \\$aC23.$x888.$x592.$x604.$x764.$x400
=072  \\$aF1.$x700.$x750.$x400
=072  \\$aF2.$x463.$x593.$x446
=150  \\$aIllusions
=450  \\$wnnna$aAuditory Illusion
=450  \\$wnnna$aAuditory Illusions
=450  \\$aAutokinetic Effect
=450  \\$wnnna$aAutokinetic Effects
=450  \\$wnnna$aAutokinetic Illusion
=450  \\$wnnna$aAutokinetic Illusions
=450  \\$wnnna$aEffect, Autokinetic
=450  \\$wnnna$aEffects, Autokinetic
=450  \\$wnnna$aIllusion
=450  \\$wnnna$aIllusion, Auditory
=450  \\$wnnna$aIllusion, Autokinetic
=450  \\$wnnna$aIllusion, Kinesthetic
=450  \\$wnnna$aIllusion, Tactile
=450  \\$wnnna$aIllusion, Visual
=450  \\$wnnna$aIllusions, Auditory
=450  \\$wnnna$aIllusions, Autokinetic
=450  \\$wnnna$aIllusions, Kinesthetic
=450  \\$wnnna$aIllusions, Tactile
=450  \\$wnnna$aIllusions, Visual
=450  \\$wnnna$aKinesthetic Illusion
=450  \\$wnnna$aKinesthetic Illusions
=450  \\$wnnna$aTactile Illusion
=450  \\$wnnna$aTactile Illusions
=450  \\$wnnna$aVisual Illusion
=450  \\$wnnna$aVisual Illusions
=550  \\$wg$aPerception
=550  \\$wg$aPerceptual Disorders
=550  \\$wh$aOptical Illusions
=667  \\$ado not confuse with DELUSIONS
=680  \\$iThe misinterpretation of a real external, sensory experience.
=688  \\$a1963
=750  \0$aHallucinations and illusions$5IEN$0(DLC)sh 85058489

=LDR  01178cz  a2200349n  4500
=001  9880363648902441
=005  20141212192245.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007086
=035  \\$aCBA0274HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x735.$x424
=072  \\$aI1.$x880.$x853.$x150.$x465
=150  \\$aIllegitimacy
=450  \\$wnnna$aFather, Unmarried
=450  \\$wnnna$aFathers, Unmarried
=450  \\$wnnna$aLegitimacy
=450  \\$wnnna$aMother, Unmarried
=450  \\$wnnna$aMothers, Unmarried
=450  \\$wnnna$aPregnancies, Premarital
=450  \\$wnnna$aPregnancy, Premarital
=450  \\$wnnna$aPremarital Pregnancies
=450  \\$wnnna$aPremarital Pregnancy
=450  \\$wnnna$aUnmarried Father
=450  \\$wnnna$aUnmarried Fathers
=450  \\$wnnna$aUnmarried Mother
=450  \\$wnnna$aUnmarried Mothers
=550  \\$wg$aFamily
=550  \\$wg$aSocial Problems
=667  \\$athe child or the unwed parents; if with ref to parents, coord IM with PARENTS (IM)
=680  \\$iThe state of birth outside of wedlock. It may refer to the offspring or the parents.
=750  \0$aIllegitimacy$5IEN$0(DLC)sh 85064281

=LDR  00489cz  a2200169n  4500
=001  9880363649002441
=005  20141212202359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007085
=035  \\$aCBA0273HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x43.$x825.$x434
=150  \\$aIlium
=450  \\$wnnna$aIliums
=550  \\$wg$aPelvic Bones
=667  \\$apart of the hip; do not confuse with ILEUM, part of the small intestine
=750  \0$aIlium$5IEN$0(DLC)sh 85064269

=LDR  00682cz  a2200193n  4500
=001  9880363649102441
=005  20141212202359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007084
=035  \\$aCBA0272HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x908.$x427
=150  \\$aIliac Vein
=450  \\$wnnna$aIliac Veins
=450  \\$wnnna$aVein, Iliac
=450  \\$wnnna$aVeins, Iliac
=550  \\$wg$aVeins
=680  \\$iA vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava.
=750  \0$aIliac vein$5IEN$0(DLC)sh 85064264

=LDR  00623cz  a2200193n  4500
=001  9880363649202441
=005  20141212202359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007083
=035  \\$aCBA0271HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x444
=150  \\$aIliac Artery
=450  \\$wnnna$aArteries, Iliac
=450  \\$wnnna$aArtery, Iliac
=450  \\$wnnna$aIliac Arteries
=550  \\$wg$aArteries
=680  \\$iEither of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs.
=750  \0$aIliac artery$5IEN$0(DLC)sh 85064262

=LDR  01186cz  a2200217n  4500
=001  9880363649302441
=005  20141212202358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007082
=035  \\$aCBA0270HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA3.$x556.$x124.$x684.$x249
=072  \\$aA3.$x556.$x249.$x124
=150  \\$aIleum
=550  \\$wg$aIntestine, Small
=550  \\$wg$aLower Gastrointestinal Tract
=550  \\$wh$aIleocecal Valve
=550  \\$wh$aMeckel Diverticulum
=667  \\$ado not confuse with ILEUS or ILIUM; /surg: consider ILEOSTOMY; inflammation = ILEITIS; ileocecal intussusception or invagination: index under ILEOCECAL VALVE (IM) + INTUSSUSCEPTION (IM) + ILEAL DISEASES (NIM); ileocolic intussusception: index under ILEAL DISEASES (IM) + INTUSSUSCEPTION (IM) but not also COLONIC DISEASES; ileum as smooth muscle is probably MUSCLE, SMOOTH (IM) + ILEUM (NIM); jejuno-ileal bypass or shunt or jejuno-ileostomy in obesity: index under JEJUNOILEAL BYPASS (note XR ref)
=680  \\$iThe distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
=750  \0$aIleum$5IEN$0(DLC)sh 85064258

=LDR  01527cz  a2200409n  4500
=001  9880363649402441
=005  20141212202358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007081
=035  \\$aCBA0269HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x210.$x338.$x508
=072  \\$aE4.$x579.$x338.$x508
=150  \\$aIleostomy
=450  \\$wnnna$aContinent Ileostomies
=450  \\$wnnna$aContinent Ileostomy
=450  \\$wnnna$aIleostomies
=450  \\$wnnna$aIleostomies, Continent
=450  \\$wnnna$aIleostomies, Incontinent
=450  \\$wnnna$aIleostomies, Loop
=450  \\$wnnna$aIleostomies, Tube
=450  \\$wnnna$aIleostomy, Continent
=450  \\$wnnna$aIleostomy, Incontinent
=450  \\$wnnna$aIleostomy, Loop
=450  \\$wnnna$aIleostomy, Tube
=450  \\$wnnna$aIncontinent Ileostomies
=450  \\$wnnna$aIncontinent Ileostomy
=450  \\$wnnna$aLoop Ileostomies
=450  \\$aLoop Ileostomy
=450  \\$wnnna$aTube Ileostomies
=450  \\$aTube Ileostomy
=550  \\$wg$aEnterostomy
=550  \\$aIleum
=550  \\$aSurgical Stomas
=667  \\$arestrict to ileal stoma on abdominal wall: do not confuse with JEJUNOILEAL BYPASS
=680  \\$iSurgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop (continent) or tube (incontinent) procedures are most often employed.
=750  \0$aIleostomy$5IEN$0(DLC)sh 85064255

=LDR  00628cz  a2200217n  4500
=001  9880363649502441
=005  20141212202357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007079
=035  \\$aCBA0267HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x462.$x624
=072  \\$aC6.$x405.$x469.$x326.$x875
=072  \\$aC6.$x405.$x469.$x420.$x520
=150  \\$aIleitis
=550  \\$wg$aEnteritis
=550  \\$wg$aIleal Diseases
=550  \\$wh$aPouchitis
=550  \\$aEnteritis
=680  \\$iInflammation of any segment of the ILEUM and the ILEOCECAL VALVE.
=750  \0$aIleitis$0(DLC)sh2006001585$5IEN-M

=LDR  00703cz  a2200241n  4500
=001  9880363649602441
=005  20141212202357.0
=008  790427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007077
=035  \\$aCBA0265HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x469.$x420
=150  \\$aIleal Diseases
=450  \\$wnnna$aDisease, Ileal
=450  \\$wnnna$aDiseases, Ileal
=450  \\$wnnna$aIleal Disease
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aIleal Neoplasms
=550  \\$wh$aIleitis
=667  \\$ainflamm dis = ILEITIS
=680  \\$iPathological development in the ILEUM including the ILEOCECAL VALVE.
=688  \\$a80
=750  \0$aIleum$xDiseases$0(DLC) sh 85064259$5IEN

=LDR  00565cz  a2200193n  4500
=001  9880363649702441
=005  20141212202357.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007076
=035  \\$aCBA0264HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x833.$x393.$x500
=150  \\$aIguanas
=450  \\$wnnna$aIguana
=550  \\$wg$aLizards
=667  \\$aIM; qualif permitted
=680  \\$iLarge herbivorous tropical American lizards.
=688  \\$a91(75); was see under LIZARDS 1975-90
=750  \0$aIguana (Genus)$5IEN$0(DLC)sh 85064217

=LDR  01219cz  a2200289n  4500
=001  9880363649802441
=005  20141212202356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007075
=035  \\$aCBA0263HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x574
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x574
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x574
=150  \\$aImmunoglobulin M
=450  \\$wnnna$a19S Gamma Globulin
=450  \\$aGamma Globulin, 19S
=450  \\$aIgM
=450  \\$wnnna$aIgM1
=450  \\$wnnna$aIgM2
=550  \\$wg$aImmunoglobulin Isotypes
=550  \\$wh$aImmunoglobulin mu-Chains
=550  \\$aImmunoglobulin J-Chains
=667  \\$a/defic = IMMUNOGLOBULIN M / defic + DYSGAMMAGLOBULINEMIA (IM); gammopathy: coordinate IMMUNOGLOBULIN M (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text;
=680  \\$iA class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.
=688  \\$a2002(1973)
=750  \0$aImmunoglobulin M$5IEN$0(DLC)sh 85064567

=LDR  01561cz  a2200445n  4500
=001  9880363649902441
=005  20170208151046.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007074
=035  \\$aCBA0262HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x393
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x393
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x393
=150  \\$aImmunoglobulin G
=450  \\$wnnna$a7S Gamma Globulin
=450  \\$wnnna$aAllerglobuline
=450  \\$aGamma Globulin, 7S
=450  \\$wnnna$aGT, Immunoglobulin
=450  \\$aIgG
=450  \\$wnnna$aIgG(T)
=450  \\$wnnna$aIgG1
=450  \\$wnnna$aIgG2
=450  \\$wnnna$aIgG2A
=450  \\$wnnna$aIgG2B
=450  \\$wnnna$aIgG3
=450  \\$wnnna$aIgG4
=450  \\$wnnna$aImmunoglobulin GT
=450  \\$wnnna$aPolyglobin
=550  \\$wg$aImmunoglobulin Isotypes
=550  \\$wh$aEtanercept
=550  \\$wh$aImmunoglobulin gamma-Chains
=550  \\$wh$aImmunoglobulins, Intravenous
=550  \\$wh$aLong-Acting Thyroid Stimulator
=550  \\$wh$aMuromonab-CD3
=550  \\$wh$aRho(D) Immune Globulin
=667  \\$agammopathy: coordinate IMMUNOGLOBULIN G (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA, follow text
=680  \\$iThe major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
=688  \\$a2002(1971)
=750  \0$aImmunoglobulin G$5IEN$0(DLC)sh 85064565

=LDR  01049cz  a2200241n  4500
=001  9880363650002441
=005  20141212202355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007073
=035  \\$aCBA0261HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x312
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x312
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x312
=150  \\$aImmunoglobulin E
=450  \\$wnnna$aE, Immunoglobulin
=450  \\$aIgE
=550  \\$wg$aImmunoglobulin Isotypes
=550  \\$wh$aImmunoglobulin epsilon-Chains
=667  \\$a/defic = IMMUNOGLOBULIN E / defic + DYSGAMMAGLOBULINEMIA (IM); gammopathy: coordinate IMMUNOGLOBULIN E (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text;
=680  \\$iAn immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
=688  \\$a2002(1971)
=750  \0$aImmunoglobulin E$5IEN$0(DLC)sh 85064564

=LDR  01057cz  a2200253n  4500
=001  9880363650102441
=005  20141212202355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007072
=035  \\$aCBA0260HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x251
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x251
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x251
=150  \\$aImmunoglobulin D
=450  \\$aIgD
=450  \\$wnnna$aIgD1
=450  \\$wnnna$aIgD2
=550  \\$wg$aImmunoglobulin Isotypes
=550  \\$wh$aImmunoglobulin delta-Chains
=667  \\$a/defic = IMMUNOGLOBULIN D / defic + DYSGAMMAGLOBULINEMIA (IM); gammopathy: coordinate IMMUNOGLOBULIN D (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text;
=680  \\$iAn immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES.
=688  \\$a2002(1971)
=750  \0$aImmunoglobulin D$5IEN$0(DLC)sh 85064563

=LDR  01252cz  a2200265n  4500
=001  9880363650202441
=005  20141212202354.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007070
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x619.$x26
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x619.$x26
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x619.$x26
=150  \\$aImmunoglobulin A
=450  \\$aIgA
=450  \\$wnnna$aIgA1
=450  \\$wnnna$aIgA2
=550  \\$wg$aImmunoglobulin Isotypes
=550  \\$wh$aImmunoglobulin A, Secretory
=550  \\$wh$aImmunoglobulin alpha-Chains
=550  \\$aImmunoglobulin J-Chains
=667  \\$agammopathy: coordinate IMMUNOGLOBULIN A (IM) with PARAPROTEINEMIAS (IM) but consider also HYPERGAMMAGLOBULINEMIA (IM), follow text; salivary immunoglobulin A: index IGA, SECRETORY + SALIVA/ immunol; immunoglobulin A in tears: index IGA, SECRETORY + TEARS/ immunol
=680  \\$iRepresents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
=688  \\$a2002(1971)
=750  \0$aImmunoglobulin A$5IEN$0(DLC)sh 85064561

=LDR  00665cz  a2200217n  4500
=001  9880363650402441
=005  20141212202351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007060
=035  \\$aCBA0247HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x347
=072  \\$aF2.$x739.$x794.$x371
=150  \\$aId
=450  \\$wnnna$aIds
=550  \\$wg$aPersonality Development
=550  \\$wg$aPsychoanalytic Theory
=667  \\$ano qualif
=680  \\$iThe part of the personality structure which harbors the unconscious instinctive desires and strivings of the individual.
=688  \\$a68
=750  \0$aId (Psychology)$5IEN$0(DLC)sh 85064104

=LDR  01049cz  a2200313n  4500
=001  9880363650502441
=005  20141212202351.0
=008  860415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007059
=035  \\$aCBA0246HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x80.$x148
=150  \\$aIctaluridae
=450  \\$aAmeiurus
=450  \\$wnnna$aBullhead Catfishes
=450  \\$aCatfish, Channel
=450  \\$wnnna$aCatfishes, Bullhead
=450  \\$wnnna$aCatfishes, Channel
=450  \\$aChannel Catfish
=450  \\$wnnna$aChannel Catfishes
=450  \\$aIctalurus
=450  \\$wnnna$aIctalurus punctatus
=450  \\$wnnna$aNoturus
=450  \\$wnnna$aPylodictis
=450  \\$wnnna$aPylodictus
=550  \\$wg$aCatfishes
=680  \\$iA family of North American freshwater CATFISHES. It consists of four genera (Ameiurus, Ictalurus, Noturus, Pylodictis,) comprising several species, two of which are eyeless.
=688  \\$a91(87); was see under CATFISH 1987-90
=750  \0$aIctaluridae$0(DLC) sh 85064099$5IEN

=LDR  01362cz  a2200337n  4500
=001  9880363650602441
=005  20141212202350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007057
=035  \\$aCBA0244HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x831.$x512
=072  \\$aC16.$x614.$x492
=072  \\$aC17.$x800.$x428.$x333
=072  \\$aC17.$x800.$x804.$x512
=150  \\$aIchthyosis
=450  \\$wnnna$aIchthyoses
=450  \\$aXeroderma
=450  \\$wnnna$aXerodermas
=550  \\$wg$aInfant, Newborn, Diseases
=550  \\$wg$aKeratosis
=550  \\$wg$aSkin Abnormalities
=550  \\$wh$aIchthyosiform Erythroderma, Congenital
=550  \\$wh$aIchthyosis Bullosa of Siemens
=550  \\$wh$aIchthyosis Vulgaris
=550  \\$wh$aIchthyosis, X-Linked
=550  \\$wh$aSjogren-Larsson Syndrome
=667  \\$aGEN or unspecified; prefer specifics; unspecified dryness of skin is indexed under SKIN DISEASES, not here
=680  \\$iAny of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.
=688  \\$aERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78
=750  \0$aIchthyosis$0(DLC) sh 89003841$5IEN

=LDR  00709cz  a2200265n  4500
=001  9880363650702441
=005  20141212202350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007053
=035  \\$aCBA0240HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x455.$x900.$x400
=072  \\$aD1.$x650.$x550.$x925.$x400
=072  \\$aG16.$x500.$x275.$x410
=072  \\$aG16.$x500.$x750.$x775.$x342
=072  \\$aN6.$x230.$x291
=150  \\$aIce
=550  \\$wg$aEnvironment
=550  \\$wg$aWater
=550  \\$wg$aWeather
=550  \\$wh$aIce Cover
=550  \\$aFreezing
=550  \\$aWater
=680  \\$iThe solid substance formed by the FREEZING of water.
=750  \0$aIce$5IEN$0(DLC)sh 85063965

=LDR  02021cz  a2200601n  4500
=001  9880363650802441
=005  20141212202350.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007052
=035  \\$aCBA0239HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x223.$x701.$x430
=150  \\$aIbuprofen
=450  \\$wnnna$aalpha-Methyl-4-(2-methylpropyl)benzeneacetic Acid
=450  \\$wnnna$aAluminum Salt Ibuprofen
=450  \\$wnnna$aBrufen
=450  \\$wnnna$aCalcium Salt Ibuprofen
=450  \\$wnnna$aI.V. Solution, Ibuprofen
=450  \\$wnnna$aIbumetin
=450  \\$wnnna$aIbuprofen, (+-)-Isomer
=450  \\$wnnna$aIbuprofen, Aluminum Salt
=450  \\$wnnna$aIbuprofen, Calcium Salt
=450  \\$wnnna$aIbuprofen, Copper (2+) Salt
=450  \\$wnnna$aIbuprofen I.V. Solution
=450  \\$wnnna$aIbuprofen, Magnesium Salt
=450  \\$wnnna$aIbuprofen, Potassium Salt
=450  \\$wnnna$aIbuprofen, (R)-Isomer
=450  \\$wnnna$aIbuprofen, (S)-Isomer
=450  \\$wnnna$aIbuprofen, Sodium Salt
=450  \\$wnnna$aIbuprofen-Zinc
=450  \\$wnnna$aIbuprofen Zinc
=450  \\$wnnna$aIbuprofen, Zinc Salt
=450  \\$wnnna$aIP-82
=450  \\$wnnna$aIP 82
=450  \\$wnnna$aIP82
=450  \\$wnnna$aMagnesium Salt Ibuprofen
=450  \\$wnnna$aMotrin
=450  \\$wnnna$aNuprin
=450  \\$wnnna$aPotassium Salt Ibuprofen
=450  \\$wnnna$aRufen
=450  \\$wnnna$aSalprofen
=450  \\$wnnna$aSalt Ibuprofen, Magnesium
=450  \\$wnnna$aSalt Ibuprofen, Sodium
=450  \\$wnnna$aSalt Ibuprofen, Zinc
=450  \\$wnnna$aSodium Salt Ibuprofen
=450  \\$wnnna$aTrauma-Dolgit Gel
=450  \\$wnnna$aTrauma Dolgit Gel
=450  \\$wnnna$aTraumaDolgit Gel
=450  \\$wnnna$aZinc Salt Ibuprofen
=550  \\$wg$aPhenylpropionates
=680  \\$iA nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.
=688  \\$a78(75)
=750  \0$aIbuprofen$5IEN-M$0(DLC)sh 97005926

=LDR  01040cz  a2200277n  4500
=001  9880363650902441
=005  20141212202349.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007050
=035  \\$aCBA0237HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x436.$x681.$x444
=072  \\$aD3.$x438.$x473.$x390
=072  \\$aD3.$x438.$x473.$x402.$x681.$x444
=150  \\$aIbogaine
=450  \\$a12-Methoxyibogamine
=450  \\$wnnna$a12 Methoxyibogamine
=450  \\$wnnna$aEndabuse
=450  \\$wnnna$aNIH-10567
=450  \\$wnnna$aNIH 10567
=450  \\$wnnna$aNIH10567
=550  \\$wg$aIndoles
=550  \\$wg$aSecologanin Tryptamine Alkaloids
=680  \\$iOne of several indole alkaloids extracted from Tabernanthe iboga, Baill. It has a complex pharmacological profile, and interacts with multiple systems of neurotransmission. Ibogaine has psychoactive properties and appears to modulate tolerance to opiates.
=688  \\$a91(76); was see under ALKALOIDS 1976-90
=750  \0$aIbogaine$5IEN-M$0(DLC)sh 96009537

=LDR  00955cz  a2200217n  4500
=001  9880363651002441
=005  20141212202348.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007049
=035  \\$aCBA0236HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x875
=150  \\$aIatrogenic Disease
=450  \\$wnnna$aDisease, Iatrogenic
=450  \\$wnnna$aDiseases, Iatrogenic
=450  \\$wnnna$aIatrogenic Diseases
=550  \\$wg$aDisease Attributes
=550  \\$aMedical Errors
=667  \\$aIM for general or as coord with specific iatrogenic dis; article must discuss dis as iatrogenic: do not routinely index adv eff of drugs or procedures as iatrogenic
=680  \\$iAny adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by the patient during the course of treatment.
=750  \0$aIatrogenic diseases$5IEN$0(DLC)sh 85063896

=LDR  01105cz  a2200313n  4500
=001  9880363235002441
=005  20170609102250.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000222
=035  \\$aCAZ3369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x25
=072  \\$aG16.$x12.$x500
=150  \\$aAdaptation, Physiological
=450  \\$wnnna$aAdaptation, Physiologic
=450  \\$wnnna$aAdaptations, Physiologic
=450  \\$wnnna$aAdaptations, Physiological
=450  \\$wnnna$aPhysiologic Adaptation
=450  \\$wnnna$aPhysiologic Adaptations
=450  \\$wnnna$aPhysiological Adaptation
=450  \\$wnnna$aPhysiological Adaptations
=550  \\$wg$aAdaptation, Biological
=550  \\$wg$aPhysiological Phenomena
=550  \\$wh$aAcclimatization
=550  \\$wh$aAllostasis
=550  \\$wh$aBody Temperature Regulation
=667  \\$aPSYCHOLOGICAL ADAPTATION is also available; DF: ADAPTATION PHYSIOL
=680  \\$iThe non-genetic biological changes of an organism in response to challenges in its ENVIRONMENT.
=750  \0$aAdaptation (Physiology)$5IEN$0(DLC)sh 85000801

=LDR  00783cz  a2200217n  4500
=001  9880363235102441
=005  20170628104640.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000327
=035  \\$aCAZ3475HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x30
=072  \\$aG2.$x20
=150  \\$aAdsorption
=450  \\$wnnna$aAdsorptions
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aPhysical Phenomena
=667  \\$aalmost never IM
=680  \\$iThe adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily.
=750  \0$aAdsorption (Biology)$5IEN-M$0(DLC)sh 85001023
=750  \0$aAdsorption$5IEN-HS$0(DLC)sh 85001022

=LDR  01131cz  a2200265n  4500
=001  9880363235202441
=005  20141212194433.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000221
=035  \\$aCAZ3368HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG14.$x640.$x154
=150  \\$aAdaptation, Ocular
=450  \\$wnnna$aAdaptation, Light
=450  \\$wnnna$aAdaptations, Light
=450  \\$wnnna$aAdaptations, Ocular
=450  \\$aLight Adaptation
=450  \\$wnnna$aLight Adaptations
=450  \\$wnnna$aOcular Adaptation
=450  \\$wnnna$aOcular Adaptations
=550  \\$wg$aOcular Physiological Processes
=550  \\$wh$aDark Adaptation
=667  \\$aadjustment of eye to variations in intensity of light; do not confuse with ACCOMMODATION, OCULAR, adjustment of lens to distance
=680  \\$iThe adjustment of the eye to variations in the intensity of light. Light adaptation is the adjustment of the eye when the light threshold is increased; DARK ADAPTATION when the light is greatly reduced. (From Cline et al., Dictionary of Visual Science, 4th ed)
=750  \0$aEye$xAdaptation$5IEN$0(DLC)sh 85046645

=LDR  02627cz  a2200541n  4500
=001  9880363235302441
=005  20141212194511.0
=008  820427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000326
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x163.$x100.$x362.$x250
=072  \\$aC10.$x228.$x140.$x163.$x100.$x680.$x100
=072  \\$aC10.$x228.$x140.$x695.$x625.$x250
=072  \\$aC10.$x314.$x400.$x250
=072  \\$aC10.$x597.$x606.$x643.$x455.$x124
=072  \\$aC16.$x320.$x322.$x500.$x124
=072  \\$aC16.$x320.$x400.$x525.$x124
=072  \\$aC16.$x320.$x565.$x189.$x362.$x250
=072  \\$aC16.$x320.$x565.$x189.$x680.$x100
=072  \\$aC16.$x320.$x565.$x663.$x112
=072  \\$aC18.$x452.$x132.$x100.$x362.$x250
=072  \\$aC18.$x452.$x132.$x100.$x680.$x100
=072  \\$aC18.$x452.$x648.$x189.$x362.$x250
=072  \\$aC18.$x452.$x648.$x189.$x680.$x100
=072  \\$aC18.$x452.$x648.$x663.$x112
=072  \\$aC19.$x53.$x500.$x270
=150  \\$aAdrenoleukodystrophy
=450  \\$wnnna$aAdrenoleukodystrophy, X-Linked
=450  \\$aAdrenomyeloneuropathy
=450  \\$wnnna$aALD (Adrenoleukodystrophy)
=450  \\$aSchilder-Addison Complex
=450  \\$wnnna$aSchilder Addison Complex
=450  \\$wnnna$aX-ALD
=450  \\$wnnna$aX ALD
=450  \\$wnnna$aX-ALD (X-Linked Adrenoleukodystrophy)
=450  \\$wnnna$aX ALD (X Linked Adrenoleukodystrophy)
=450  \\$aX-Linked Adrenoleukodystrophy
=450  \\$wnnna$aX Linked Adrenoleukodystrophy
=550  \\$wg$aAdrenal Insufficiency
=550  \\$wg$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wg$aMental Retardation, X-Linked
=550  \\$wg$aPeroxisomal Disorders
=550  \\$aATP-Binding Cassette Transporters
=667  \\$ado not confuse with ADRENOLEUKODYSTROPHY, NEONATAL see PEROXISOMAL DISORDERS
=680  \\$iAn X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).
=688  \\$a1991(1983)
=750  \0$aAdrenomyeloneuropathy$5IEN$0(DLC)sh 91005115
=750  \0$aAdrenoleukodystrophy$5IEN-HS$0(DLC)sh 90001240

=LDR  00866cz  a2200205n  4500
=001  9880363235402441
=005  20170609111047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000220
=035  \\$aCAZ3367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x24
=150  \\$aAdaptation, Biological
=450  \\$wnnna$aAdaptation, Biologic
=450  \\$wnnna$aBiologic Adaptation
=450  \\$wnnna$aBiological Adaptation
=550  \\$wg$aBiological Phenomena
=667  \\$amuch of biol adapt will be ADAPTATION, PHYSIOLOGICAL as more specific; mimicry except for MOLECULAR MIMICRY goes here; DF: ADAPTATION BIOL
=680  \\$iChanges in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological (ADAPTATION, PHYSIOLOGICAL), phenotypic and genetic changes.
=750  \0$aAdaptation (Biology)$5IEN$0(DLC)sh 85000800

=LDR  02167cz  a2200469n  4500
=001  9880363235502441
=005  20141212194510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000324
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x327.$x935.$x59
=072  \\$aD6.$x472.$x699.$x327.$x935.$x531.$x500
=072  \\$aD6.$x472.$x699.$x631.$x525.$x600.$x59
=072  \\$aD6.$x472.$x699.$x631.$x525.$x600.$x531.$x500
=072  \\$aD12.$x644.$x400.$x400.$x935.$x59
=072  \\$aD12.$x644.$x400.$x400.$x935.$x531.$x500
=072  \\$aD12.$x644.$x548.$x365.$x935.$x59
=072  \\$aD12.$x644.$x548.$x365.$x935.$x531.$x500
=072  \\$aD12.$x644.$x548.$x691.$x525.$x690.$x59
=072  \\$aD12.$x644.$x548.$x691.$x525.$x690.$x531.$x500
=072  \\$aD12.$x776.$x641.$x650.$x405.$x935.$x59
=072  \\$aD12.$x776.$x641.$x650.$x405.$x935.$x531.$x500
=150  \\$aAdrenocorticotropic Hormone
=450  \\$wnnna$a1-39 ACTH
=450  \\$aACTH
=450  \\$wnnna$aACTH (1-39)
=450  \\$wnnna$aAdrenocorticotrophic Hormone
=450  \\$aAdrenocorticotropin
=450  \\$wnnna$aCorticotrophin
=450  \\$wnnna$aCorticotrophin (1-39)
=450  \\$aCorticotropin
=450  \\$wnnna$aCorticotropin (1-39)
=450  \\$wnnna$aHormone, Adrenocorticotrophic
=450  \\$wnnna$aHormone, Adrenocorticotropic
=550  \\$wg$aMelanocortins
=550  \\$wg$aPro-Opiomelanocortin
=550  \\$wh$aCosyntropin
=680  \\$iAn anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).
=688  \\$a2007, 1987-1993 (1963)
=688  \\$aHeading changed 20061114 from: 150:##:_{dollar}a Corticotropin
=688  \\$a94,63-86; was ADRENOCORTICOTROPIC HORMONE 1987-93; /adv eff-pois-tox was CORTICOTROPIN TOXICOLOGY 1963-65; /ther use was CORTICOTROPIN, THERAPEUTIC 1965
=750  \0$aACTH$0(DLC) sh 85000684$5IEN

=LDR  01295cz  a2200313n  4500
=001  9880363235602441
=005  20141212194432.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000219
=035  \\$aCAZ3366HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x558.$x137
=072  \\$aC23.$x550.$x73.$x425.$x25
=150  \\$aAdams-Stokes Syndrome
=450  \\$wnnna$aAdam-Stokes Attacks
=450  \\$wnnna$aAdam Stokes Attacks
=450  \\$wnnna$aAdams Stokes Syndrome
=450  \\$wnnna$aAttacks, Adam-Stokes
=450  \\$wnnna$aAttacks, Stokes-Adams
=450  \\$aStokes-Adams Attacks
=450  \\$wnnna$aStokes Adams Attacks
=450  \\$wnnna$aStokes-Adams Syndrome
=450  \\$wnnna$aStokes Adams Syndrome
=450  \\$wnnna$aSyndrome, Adams-Stokes
=450  \\$wnnna$aSyndrome, Stokes-Adams
=550  \\$wg$aHeart Block
=680  \\$iA condition of fainting spells caused by heart block, often an atrioventricular block, that leads to BRADYCARDIA and drop in CARDIAC OUTPUT. When the cardiac output becomes too low, the patient faints (SYNCOPE). In some cases, the syncope attacks are transient and in others cases repetitive and persistent.
=688  \\$a65(63); was see under HEART BLOCK 1963-64
=750  \0$aAdams-Stokes syndrome$5IEN$0(DLC)sh 85000793

=LDR  00771cz  a2200253n  4500
=001  9880363235702441
=005  20141212194431.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000218
=035  \\$aCAZ3365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x100.$x50
=072  \\$aD2.$x455.$x426.$x392.$x368.$x75
=150  \\$aAdamantane
=450  \\$wnnna$aDiamantane
=550  \\$wg$aBridged Compounds
=550  \\$wg$aCycloparaffins
=550  \\$wh$aAmantadine
=550  \\$wh$aMethenamine
=550  \\$wh$aRimantadine
=667  \\$aa cycloparaffin
=680  \\$iA tricyclo bridged hydrocarbon.
=688  \\$a80(75); was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95
=750  \0$aAdamantane$5IEN$0(DLC)sh 85000784

=LDR  01025cz  a2200325n  4500
=001  9880363235802441
=005  20141212191933.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000320
=035  \\$aCAZ3468HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x100.$x500
=072  \\$aA8.$x675.$x542.$x75
=072  \\$aA11.$x671.$x501.$x75
=150  \\$aAdrenergic Fibers
=450  \\$wnnna$aAdrenergic Fiber
=450  \\$wnnna$aFiber, Adrenergic
=450  \\$wnnna$aFiber, Sympathetic
=450  \\$wnnna$aFibers, Adrenergic
=450  \\$wnnna$aFibers, Sympathetic
=450  \\$wnnna$aSympathetic Fiber
=450  \\$aSympathetic Fibers
=550  \\$wg$aAdrenergic Neurons
=550  \\$wg$aNerve Fibers
=550  \\$wh$aSympathetic Fibers, Postganglionic
=550  \\$aAdrenergic Neurons
=667  \\$aADRENERGIC NEURONS is also available
=680  \\$iNerve fibers liberating catecholamines at a synapse after an impulse.
=688  \\$a77
=750  \0$aAdrenergic mechanisms$5IEN$0(DLC)sh 85001010

=LDR  01704cz  a2200433n  4500
=001  9880363235902441
=005  20141212194431.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000217
=035  \\$aCAZ3364HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x913.$x50
=150  \\$aAcyltransferases
=550  \\$wg$aTransferases
=550  \\$wh$a1-Acylglycerol-3-Phosphate O-Acyltransferase
=550  \\$wh$a1-Acylglycerophosphocholine O-Acyltransferase
=550  \\$wh$a2-Isopropylmalate Synthase
=550  \\$wh$a3-Oxoacyl-(Acyl-Carrier-Protein) Synthase
=550  \\$wh$a5-Aminolevulinate Synthetase
=550  \\$wh$aAcetyl-CoA C-Acyltransferase
=550  \\$wh$aAcetyltransferases
=550  \\$wh$aAcyl-Carrier Protein S-Malonyltransferase
=550  \\$wh$aAminoacyltransferases
=550  \\$wh$aATP Citrate (pro-S)-Lyase
=550  \\$wh$aCarnitine Acyltransferases
=550  \\$wh$aCitrate (si)-Synthase
=550  \\$wh$aDiacylglycerol O-Acyltransferase
=550  \\$wh$aGlycerol-3-Phosphate O-Acyltransferase
=550  \\$wh$aHomoserine O-Succinyltransferase
=550  \\$wh$aHydroxymethylglutaryl-CoA Synthase
=550  \\$wh$aMalate Synthase
=550  \\$wh$aPhosphatidylcholine-Sterol O-Acyltransferase
=550  \\$wh$aRetinol O-Fatty-Acyltransferase
=550  \\$wh$aSerine C-Palmitoyltransferase
=550  \\$wh$aSphingosine N-Acyltransferase
=550  \\$wh$aSterol O-Acyltransferase
=680  \\$iEnzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. (From Enzyme Nomenclature 1992) EC 2.3.
=688  \\$a64
=750  \0$aAcyltransferases$0(DLC) sh 87001830$5IEN

=LDR  00858cz  a2200253n  4500
=001  9880363236002441
=005  20170608115403.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000215
=035  \\$aCAZ3362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x12
=072  \\$aG2.$x607.$x63
=072  \\$aG3.$x40
=150  \\$aAcylation
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$wh$aAcetylation
=550  \\$wh$aAminoacylation
=667  \\$aalmost never IM; enzymatic acylation: coord NIM with ACYLTRANSFERASES (IM) + substrate (NIM) or specific acyltransferase (IM); ACETYLATION & ACETYLTRANSFERASES are also available
=680  \\$iThe addition of an organic acid radical into a molecule.
=688  \\$a74(71)
=750  \0$aAcylation$5IEN$0(DLC)sh 85000770

=LDR  02384cz  a2200517n  4500
=001  9880363236102441
=005  20141212194508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000319
=035  \\$aCAZ3467HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x50.$x200.$x200
=072  \\$aD27.$x505.$x696.$x577.$x50.$x200.$x200
=150  \\$aAdrenergic beta-Antagonists
=450  \\$wnnna$aAdrenergic beta Antagonists
=450  \\$wnnna$aAdrenergic beta-Blockers
=450  \\$aAdrenergic beta-Receptor Blockaders
=450  \\$wnnna$aAdrenergic beta Receptor Blockaders
=450  \\$wnnna$aAgents, beta-Adrenergic Blocking
=450  \\$wnnna$abeta-Adrenergic Blockers
=450  \\$wnnna$abeta Adrenergic Blockers
=450  \\$abeta-Adrenergic Blocking Agents
=450  \\$wnnna$abeta Adrenergic Blocking Agents
=450  \\$abeta-Adrenergic Receptor Blockaders
=450  \\$wnnna$abeta Adrenergic Receptor Blockaders
=450  \\$wnnna$abeta-Antagonists, Adrenergic
=450  \\$abeta-Blockers, Adrenergic
=450  \\$wnnna$abeta Blockers, Adrenergic
=450  \\$wnnna$abeta-Receptor Blockaders, Adrenergic
=450  \\$wnnna$aBlockaders, Adrenergic beta-Receptor
=450  \\$wnnna$aBlockaders, beta-Adrenergic Receptor
=450  \\$wnnna$aBlockers, beta-Adrenergic
=450  \\$wnnna$aBlocking Agents, beta-Adrenergic
=450  \\$wnnna$aReceptor Blockaders, beta-Adrenergic
=450  \\$aReceptors, Adrenergic, beta$xantagonists & inhibitors
=550  \\$wg$aAdrenergic Antagonists
=550  \\$wh$aAdrenergic beta-1 Receptor Antagonists
=550  \\$wh$aAdrenergic beta-2 Receptor Antagonists
=550  \\$wh$aAdrenergic beta-3 Receptor Antagonists
=550  \\$aAnti-Anxiety Agents
=550  \\$aAnti-Arrhythmia Agents
=550  \\$aAntihypertensive Agents
=667  \\$aGEN or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-AGONISTS; DF: ADREN BETA ANTAG
=680  \\$iDrugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
=688  \\$a95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
=750  \0$aAdrenergic beta blockers$5IEN$0(DLC)sh 85001009

=LDR  02553cz  a2200601n  4500
=001  9880363236202441
=005  20141212194508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000318
=035  \\$aCAZ3466HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x50.$x100.$x200
=072  \\$aD27.$x505.$x696.$x577.$x50.$x100.$x200
=150  \\$aAdrenergic beta-Agonists
=450  \\$wnnna$aAdrenergic beta-Agonist
=450  \\$wnnna$aAdrenergic beta Agonist
=450  \\$wnnna$aAdrenergic beta Agonists
=450  \\$wnnna$aAdrenergic beta-Receptor Agonist
=450  \\$wnnna$aAdrenergic beta Receptor Agonist
=450  \\$aAdrenergic beta-Receptor Agonists
=450  \\$wnnna$aAdrenergic beta Receptor Agonists
=450  \\$wnnna$aAgonist, Adrenergic beta-Receptor
=450  \\$wnnna$aAgonist, beta-Adrenergic
=450  \\$wnnna$aAgonist, beta-Adrenergic Receptor
=450  \\$wnnna$aAgonists, Adrenergic beta-Receptor
=450  \\$wnnna$aAgonists, beta-Adrenergic
=450  \\$wnnna$aAgonists, beta-Adrenergic Receptor
=450  \\$wnnna$abeta-Adrenergic Agonist
=450  \\$wnnna$abeta Adrenergic Agonist
=450  \\$abeta-Adrenergic Agonists
=450  \\$wnnna$abeta Adrenergic Agonists
=450  \\$wnnna$abeta-Adrenergic Receptor Agonist
=450  \\$wnnna$abeta Adrenergic Receptor Agonist
=450  \\$abeta-Adrenergic Receptor Agonists
=450  \\$wnnna$abeta Adrenergic Receptor Agonists
=450  \\$wnnna$abeta-Agonist, Adrenergic
=450  \\$wnnna$abeta-Agonists, Adrenergic
=450  \\$wnnna$abeta-Receptor Agonist, Adrenergic
=450  \\$wnnna$abeta-Receptor Agonists, Adrenergic
=450  \\$wnnna$aBetamimetics
=450  \\$wnnna$aReceptor Agonist, beta-Adrenergic
=450  \\$wnnna$aReceptor Agonists, beta-Adrenergic
=450  \\$wnnna$aReceptor Agonists, beta Adrenergic
=450  \\$aReceptors, Adrenergic, beta$xagonists
=450  \\$wnnna$aReceptors Agonists, Adrenergic beta
=550  \\$wg$aAdrenergic Agonists
=550  \\$wh$aAdrenergic beta-1 Receptor Agonists
=550  \\$wh$aAdrenergic beta-2 Receptor Agonists
=550  \\$wh$aAdrenergic beta-3 Receptor Agonists
=667  \\$ageneral or unspecified; prefer specifics; do not confuse with ADRENERGIC BETA-ANTAGONISTS; DF: ADREN BETA AGON or ADREN BETA AG
=680  \\$iDrugs that selectively bind to and activate beta-adrenergic receptors.
=688  \\$a95; was ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 (Prov 1969-72)
=750  \0$aAdrenergic beta agonists$5IEN$0(DLC)sh 87007000

=LDR  02339cz  a2200493n  4500
=001  9880363236302441
=005  20141212194507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000317
=035  \\$aCAZ3465HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x519.$x625.$x50.$x200.$x100
=072  \\$aD27.$x505.$x696.$x577.$x50.$x200.$x100
=150  \\$aAdrenergic alpha-Antagonists
=450  \\$wnnna$aAdrenergic alpha Antagonists
=450  \\$wnnna$aAdrenergic alpha-Blockers
=450  \\$wnnna$aAdrenergic alpha Blockers
=450  \\$aAdrenergic alpha-Receptor Blockaders
=450  \\$wnnna$aAdrenergic alpha Receptor Blockaders
=450  \\$wnnna$aAgents, alpha-Adrenergic Blocking
=450  \\$wnnna$aalpha-Adrenergic Blockers
=450  \\$wnnna$aalpha Adrenergic Blockers
=450  \\$aalpha-Adrenergic Blocking Agents
=450  \\$wnnna$aalpha Adrenergic Blocking Agents
=450  \\$aalpha-Adrenergic Receptor Blockaders
=450  \\$wnnna$aalpha Adrenergic Receptor Blockaders
=450  \\$wnnna$aalpha-Antagonists, Adrenergic
=450  \\$aalpha-Blockers, Adrenergic
=450  \\$wnnna$aalpha Blockers, Adrenergic
=450  \\$wnnna$aalpha-Receptor Blockaders, Adrenergic
=450  \\$wnnna$aBlockaders, Adrenergic alpha-Receptor
=450  \\$wnnna$aBlockaders, alpha-Adrenergic Receptor
=450  \\$wnnna$aBlockers, alpha-Adrenergic
=450  \\$wnnna$aBlocking Agents, alpha-Adrenergic
=450  \\$wnnna$aReceptor Blockaders, alpha-Adrenergic
=450  \\$aReceptors, Adrenergic, alpha$xantagonists & inhibitors
=550  \\$wg$aAdrenergic Antagonists
=550  \\$wh$aAdrenergic alpha-1 Receptor Antagonists
=550  \\$wh$aAdrenergic alpha-2 Receptor Antagonists
=550  \\$aAntihypertensive Agents
=667  \\$aGEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS; DF: ADREN ALPHA ANTAG
=680  \\$iDrugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
=688  \\$a95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 (Prov 1969-72)
=750  \0$aAdrenergic alpha blockers$5IEN$0(DLC)sh 85001008

=LDR  01117cz  a2200229n  4500
=001  9880363236402441
=005  20141212194504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000311
=035  \\$aCAZ3459HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x71
=150  \\$aAdrenal Glands
=450  \\$wnnna$aAdrenal Gland
=450  \\$wnnna$aGland, Adrenal
=450  \\$wnnna$aGlands, Adrenal
=550  \\$wg$aEndocrine Glands
=550  \\$wh$aAdrenal Cortex
=550  \\$wh$aAdrenal Medulla
=667  \\$a/surg = probably ADRENALECTOMY; hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; hyperplasia = ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM); congenital adrenal hyperplasia (CAH) = ADRENAL HYPERPLASIA, CONGENITAL
=680  \\$iA pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS.
=750  \0$aAdrenal glands$5IEN$0(DLC)sh 85000998

=LDR  01406cz  a2200421n  4500
=001  9880363236502441
=005  20141212194503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000310
=035  \\$aCAZ3458HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x78
=072  \\$aC19.$x53.$x347
=072  \\$aC19.$x344.$x78
=150  \\$aAdrenal Gland Neoplasms
=450  \\$aAdrenal Cancer
=450  \\$wnnna$aAdrenal Cancers
=450  \\$wnnna$aAdrenal Gland Cancer
=450  \\$wnnna$aAdrenal Gland Cancers
=450  \\$wnnna$aAdrenal Gland Neoplasm
=450  \\$wnnna$aAdrenal Neoplasm
=450  \\$wnnna$aAdrenal Neoplasms
=450  \\$wnnna$aCancer, Adrenal
=450  \\$wnnna$aCancer, Adrenal Gland
=450  \\$wnnna$aCancer of the Adrenal Gland
=450  \\$wnnna$aCancers, Adrenal
=450  \\$wnnna$aCancers, Adrenal Gland
=450  \\$wnnna$aNeoplasm, Adrenal
=450  \\$wnnna$aNeoplasm, Adrenal Gland
=450  \\$wnnna$aNeoplasms, Adrenal
=450  \\$wnnna$aNeoplasms, Adrenal Gland
=550  \\$wg$aAdrenal Gland Diseases
=550  \\$wg$aEndocrine Gland Neoplasms
=550  \\$wh$aAdrenal Cortex Neoplasms
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancer of the ADRENAL GLANDS.
=750  \0$aAdrenal glands$xCancer$5IEN-M$0(DLC)sh2010008245
=750  \0$aAdrenal glands$xTumors$5IEN-HS$0(DLC)sh 85001004

=LDR  01308cz  a2200301n  4500
=001  9880363236602441
=005  20141212194503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000308
=035  \\$aCAZ3456HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53.$x800
=150  \\$aAdrenocortical Hyperfunction
=450  \\$wnnna$aAdrenal Gland Hyperfunction
=450  \\$wnnna$aHyperadrenalism
=450  \\$aHyperadrenocorticism
=450  \\$aHypercorticism
=450  \\$wnnna$aHyperfunction, Adrenal Gland
=450  \\$wnnna$aHyperfunction, Adrenocortical
=550  \\$wg$aAdrenal Gland Diseases
=550  \\$wh$aCushing Syndrome
=550  \\$wh$aHyperaldosteronism
=550  \\$aAdrenal Cortex Hormones
=667  \\$ado not confuse with ADRENAL GLAND HYPOFUNCTION; non-congenital adrenal hyperplasia: index under ADRENAL GLANDS /pathol (IM) + HYPERPLASIA (NIM)
=680  \\$iExcess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.
=688  \\$a2005 (1968)
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Adrenal Gland Hyperfunction
=750  \0$aHyperadrenocorticism$0(DLC) sh 85063664$5IEN-M

=LDR  01081cz  a2200289n  4500
=001  9880363236702441
=005  20141212194502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000307
=035  \\$aCAZ3455HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53
=150  \\$aAdrenal Gland Diseases
=450  \\$wnnna$aAdrenal Gland Disease
=450  \\$wnnna$aDisease, Adrenal Gland
=450  \\$wnnna$aDiseases, Adrenal Gland
=450  \\$wnnna$aGland Disease, Adrenal
=450  \\$wnnna$aGland Diseases, Adrenal
=550  \\$wg$aEndocrine System Diseases
=550  \\$wh$aAdrenal Cortex Diseases
=550  \\$wh$aAdrenal Gland Neoplasms
=550  \\$wh$aAdrenal Hyperplasia, Congenital
=550  \\$wh$aAdrenal Insufficiency
=550  \\$wh$aAdrenocortical Hyperfunction
=667  \\$ageneral; prefer specifics; coordinate IM with ADRENAL MEDULLA (IM) for diseases of adrenal medulla; for adrenal hyperplasia see note at ADRENAL GLANDS
=680  \\$iPathological processes of the ADRENAL GLANDS.
=750  \0$aAdrenal glands$xDiseases$5IEN-M$0(DLC)sh 85001000

=LDR  00580cz  a2200193n  4500
=001  9880363236802441
=005  20141212194559.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000471
=035  \\$aCAZ3620HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x452.$x76.$x354
=150  \\$aAlkalosis
=450  \\$wnnna$aAlkaloses
=550  \\$wg$aAcid-Base Imbalance
=550  \\$wh$aAlkalosis, Respiratory
=550  \\$aAcid-Base Equilibrium
=680  \\$iA pathological condition that removes acid or adds base to the body fluids.
=750  \0$aAlkalosis$5IEN$0(DLC)sh 85003603

=LDR  01429cz  a2200409n  4500
=001  9880363236902441
=005  20141212194502.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000306
=035  \\$aCAZ3454HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322.$x78.$x265
=072  \\$aC19.$x53.$x98.$x265
=072  \\$aC19.$x53.$x347.$x500
=072  \\$aC19.$x344.$x78.$x265
=150  \\$aAdrenal Cortex Neoplasms
=450  \\$wnnna$aAdrenal Cortex Cancer
=450  \\$wnnna$aAdrenal Cortex Cancers
=450  \\$wnnna$aAdrenal Cortex Neoplasm
=450  \\$aAdrenocortical Cancer
=450  \\$wnnna$aAdrenocortical Cancers
=450  \\$wnnna$aCancer, Adrenal Cortex
=450  \\$wnnna$aCancer, Adrenocortical
=450  \\$aCancer of Adrenal Cortex
=450  \\$wnnna$aCancer of the Adrenal Cortex
=450  \\$wnnna$aCancers, Adrenal Cortex
=450  \\$wnnna$aCancers, Adrenocortical
=450  \\$wnnna$aNeoplasm, Adrenal Cortex
=450  \\$wnnna$aNeoplasms, Adrenal Cortex
=550  \\$wg$aAdrenal Cortex Diseases
=550  \\$wg$aAdrenal Gland Neoplasms
=550  \\$wh$aAdrenocortical Adenoma
=550  \\$wh$aAdrenocortical Carcinoma
=667  \\$acoord IM with histol type of neopl (IM)
=680  \\$iTumors or cancers of the ADRENAL CORTEX.
=688  \\$a79(75)63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78
=750  \0$aAdrenal cortex$xTumors$5IEN-M$0(DLC)sh 85000997

=LDR  06957cz  a2201921n  4500
=001  9880363237002441
=005  20141212191924.0
=008  820505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x759.$x758.$x399.$x454.$x250
=150  \\$aAcyclovir
=450  \\$wnnna$a9-((2-Hydroxyethoxy)methyl)guanine
=450  \\$wnnna$aAbello Brand of Aciclovir
=450  \\$wnnna$aAci-Sanorania
=450  \\$wnnna$aAci Sanorania
=450  \\$wnnna$aAcic
=450  \\$wnnna$aAciclobeta
=450  \\$wnnna$aAciclostad
=450  \\$wnnna$aAciclovir
=450  \\$wnnna$aAciclovir Abello Brand
=450  \\$wnnna$aAciclovir Alcon Brand
=450  \\$wnnna$aAciclovir Alonga
=450  \\$wnnna$aAciclovir Alphapharm Brand
=450  \\$wnnna$aAciclovir Amrad Brand
=450  \\$wnnna$aAciclovir Azupharma Brand
=450  \\$wnnna$aAciclovir Betapharm Brand
=450  \\$wnnna$aAciclovir Britisfarma Brand
=450  \\$wnnna$aAciclovir Clonmel Brand
=450  \\$wnnna$aAciclovir ct-Arzneimittel Brand
=450  \\$wnnna$aAciclovir Dermapharm Brand
=450  \\$wnnna$aAciclovir Fabrigen Brand
=450  \\$wnnna$aAciclovir Fustery Brand
=450  \\$wnnna$aAciclovir Grünenthal Brand
=450  \\$wnnna$aAciclovir Grin Brand
=450  \\$wnnna$aAciclovir Hexal Brand
=450  \\$wnnna$aAciclovir Isis Brand
=450  \\$wnnna$aAciclovir Kendrick Brand
=450  \\$wnnna$aAciclovir Lichtenstein Brand
=450  \\$wnnna$aAciclovir Liomont Brand
=450  \\$wnnna$aAciclovir Mann Brand
=450  \\$wnnna$aAciclovir Menarini Brand
=450  \\$wnnna$aAciclovir Niddapharm Brand
=450  \\$wnnna$aAciclovir Novag Brand
=450  \\$wnnna$aAciclovir Novartis Brand
=450  \\$wnnna$aAciclovir Pensa Brand
=450  \\$wnnna$aAciclovir Pisa Brand
=450  \\$wnnna$aAciclovir Rentschler Brand
=450  \\$wnnna$aAciclovir-Sanorania
=450  \\$wnnna$aAciclovir Sanorania
=450  \\$wnnna$aAciclovir Sanorania Brand
=450  \\$wnnna$aAciclovir Stada Brand
=450  \\$wnnna$aAciclovir TAD Brand
=450  \\$wnnna$aAciclovir Ursapharm Brand
=450  \\$wnnna$aaciclovir von ct
=450  \\$wnnna$aAciclovir Warner-Lambert Brand
=450  \\$wnnna$aAciclovir Wellcome Brand
=450  \\$wnnna$aAciclovir Wolff Brand
=450  \\$wnnna$aAciclovir Yamanouchi Brand
=450  \\$wnnna$aAciclovir Zyma Brand
=450  \\$wnnna$aAcifur
=450  \\$wnnna$aAcipen Solutab
=450  \\$wnnna$aAcivir
=450  \\$wnnna$aActivir
=450  \\$wnnna$aAcyclo-V
=450  \\$wnnna$aAcyclo V
=450  \\$aAcycloguanosine
=450  \\$wnnna$aAcyclovir Sodium
=450  \\$wnnna$aAlcon Brand of Aciclovir
=450  \\$wnnna$aAlonga Brand of Aciclovir
=450  \\$wnnna$aAlonga Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aAlphapharm Brand of Aciclovir
=450  \\$wnnna$aAmrad Brand of Aciclovir
=450  \\$wnnna$aAntiherpes Creme
=450  \\$wnnna$aAvirax
=450  \\$wnnna$aAzupharma Brand of Aciclovir
=450  \\$wnnna$aBetapharm Brand of Aciclovir
=450  \\$wnnna$aBritisfarma Brand of Aciclovir
=450  \\$wnnna$aBritisfarma Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aBull Brand of Aciclovir
=450  \\$wnnna$aCicloferon
=450  \\$wnnna$aClonmel Brand of Aciclovir
=450  \\$wnnna$aClonorax
=450  \\$wnnna$act-Arzneimittel Brand of Aciclovir
=450  \\$wnnna$act Arzneimittel Brand of Aciclovir
=450  \\$wnnna$acurasan Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aCusiviral
=450  \\$wnnna$aDermapharm Brand of Aciclovir
=450  \\$wnnna$aFabrigen Brand of Aciclovir
=450  \\$wnnna$aFustery Brand of Aciclovir
=450  \\$wnnna$aGenvir
=450  \\$wnnna$aGlaxo Wellcome Brand of Aciclovir
=450  \\$wnnna$aGlaxo Wellcome Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aGrünenthal Brand of Aciclovir
=450  \\$wnnna$aGrünenthal Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aGrin Brand of Aciclovir
=450  \\$wnnna$aHerpetad
=450  \\$wnnna$aHerpofug
=450  \\$wnnna$aHerpotern
=450  \\$wnnna$aHerpoviric
=450  \\$wnnna$aHexal Brand of Aciclovir
=450  \\$wnnna$aHexal Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aIsavir
=450  \\$wnnna$aIsis Brand of Aciclovir
=450  \\$wnnna$aKendrick Brand of Aciclovir
=450  \\$wnnna$aLaciken
=450  \\$wnnna$aLichtenstein Brand of Aciclovir
=450  \\$wnnna$aLiomont Brand of Aciclovir
=450  \\$wnnna$aMann Brand of Aciclovir
=450  \\$wnnna$aMapox
=450  \\$wnnna$aMaynar
=450  \\$wnnna$aMenarini Brand of Aciclovir
=450  \\$wnnna$aMenarini Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aMilavir
=450  \\$wnnna$aNiddapharm Brand of Aciclovir
=450  \\$wnnna$aNovag Brand of Aciclovir
=450  \\$wnnna$aNovartis Brand of Aciclovir
=450  \\$wnnna$aOpthavir
=450  \\$wnnna$aParke Davis Brand of Aciclovir
=450  \\$wnnna$aPensa Brand of Aciclovir
=450  \\$wnnna$aPensa Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aPharma Investi Brand of Aciclovir
=450  \\$wnnna$aPisa Brand of Aciclovir
=450  \\$wnnna$aRentschler Brand of Aciclovir
=450  \\$wnnna$aRentschler Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aSanorania Brand of Aciclovir
=450  \\$wnnna$aSanorania Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aSodium, Acyclovir
=450  \\$wnnna$aSolutab, Acipen
=450  \\$wnnna$aStada Brand of Aciclovir
=450  \\$wnnna$aSupraviran
=450  \\$wnnna$aTAD Brand of Aciclovir
=450  \\$wnnna$aUrsapharm Brand of Aciclovir
=450  \\$wnnna$aViclovir
=450  \\$wnnna$aVipral
=450  \\$wnnna$aVirax-Puren
=450  \\$wnnna$aVirax Puren
=450  \\$wnnna$aViraxPuren
=450  \\$wnnna$aVirherpes
=450  \\$wnnna$aVirmen
=450  \\$wnnna$aVirolex
=450  \\$wnnna$aVirupos
=450  \\$wnnna$aVirzin
=450  \\$wnnna$aWarner-Lambert Brand of Aciclovir
=450  \\$wnnna$aWarner Lambert Brand of Aciclovir
=450  \\$wnnna$aWarner Wellcome Brand of Aciclovir
=450  \\$wnnna$aWellcome-248U
=450  \\$wnnna$aWellcome 248U
=450  \\$wnnna$aWellcome Brand of Aciclovir
=450  \\$wnnna$aWellcome Brand of Aciclovir Sodium Salt
=450  \\$wnnna$aWellcome248U
=450  \\$wnnna$aWolff Brand of Aciclovir
=450  \\$wnnna$aYamanouchi Brand of Aciclovir
=450  \\$wnnna$aZoliparin
=450  \\$wnnna$aZovirax
=450  \\$wnnna$aZovirax for Injection
=450  \\$wnnna$aZyclir
=450  \\$wnnna$aZyma Brand of Aciclovir
=550  \\$wg$aGuanine
=550  \\$wh$aGanciclovir
=680  \\$iA GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.
=688  \\$a83
=750  \0$aAcyclovir$5IEN$0(DLC)sh 88002652

=LDR  00787cz  a2200253n  4500
=001  9880363237102441
=005  20141212194501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000305
=035  \\$aCAZ3453HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x40
=150  \\$aAdrenal Cortex Hormones
=450  \\$aAdrenocortical Hormones$5IEN
=450  \\$aCorticoids
=450  \\$aCorticosteroids
=450  \\$wnnna$aHormones, Adrenal Cortex
=550  \\$wg$aHormones
=550  \\$wh$a17-Ketosteroids
=550  \\$wh$aGlucocorticoids
=550  \\$wh$aHydroxycorticosteroids
=550  \\$aAdrenal Insufficiency
=667  \\$aGEN only; avoid: prefer specifics; /defic: consider also ADRENAL GLAND HYPOFUNCTION
=750  \0$aAdrenocortical hormones$5IEN$0(DLC)sh 85001012

=LDR  01846cz  a2200565n  4500
=001  9880363237202441
=005  20141212194558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000470
=035  \\$aCAZ3619HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132
=150  \\$aAlkaloids
=450  \\$wnnna$aAlkaloids, Plant
=450  \\$aPlant Alkaloids
=550  \\$wg$aHeterocyclic Compounds
=550  \\$wh$a1-Deoxynojirimycin
=550  \\$wh$aAconitine
=550  \\$wh$aAcridones
=550  \\$wh$aAmaryllidaceae Alkaloids
=550  \\$wh$aAnabasine
=550  \\$wh$aArecoline
=550  \\$wh$aBenzophenanthridines
=550  \\$wh$aBenzylisoquinolines
=550  \\$wh$aBetalains
=550  \\$wh$aCamptothecin
=550  \\$wh$aCinchona Alkaloids
=550  \\$wh$aColchicine
=550  \\$wh$aDihydro-beta-Erythroidine
=550  \\$wh$aEmetine
=550  \\$wh$aErgot Alkaloids
=550  \\$wh$aHarringtonines
=550  \\$wh$aIndole Alkaloids
=550  \\$wh$aLobeline
=550  \\$wh$aMescaline
=550  \\$wh$aMuscarine
=550  \\$wh$aOpiate Alkaloids
=550  \\$wh$aPilocarpine
=550  \\$wh$aPyrrolizidine Alkaloids
=550  \\$wh$aRyanodine
=550  \\$wh$aSalsoline Alkaloids
=550  \\$wh$aSolanaceous Alkaloids
=550  \\$wh$aSparteine
=550  \\$wh$aSwainsonine
=550  \\$wh$aTropanes
=550  \\$wh$aVeratrum Alkaloids
=550  \\$wh$aXanthines
=667  \\$ageneral or unspecified; prefer specific groups or specific alkaloid; note entry term Plant Alkaloids: coordinate with specific plant if pertinent
=680  \\$iOrganic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAlkaloids$0(DLC) sh 85003598$5IEN

=LDR  00682cz  a2200181n  4500
=001  9880363237302441
=005  20141212194558.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000469
=035  \\$aCAZ3618HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x650.$x35
=150  \\$aAlkaline Phosphatase
=550  \\$wg$aPhosphoric Monoester Hydrolases
=667  \\$a/defic: consider also HYPOPHOSPHATASIA
=680  \\$iAn enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
=688  \\$a/blood was BLOOD ALKALINE PHOSPHATASE 1963-67
=750  \0$aAlkaline phosphatase$5IEN$0(DLC)sh 85003597

=LDR  00812cz  a2200241n  4500
=001  9880363237402441
=005  20141212194501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000303
=035  \\$aCAZ3451HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19.$x53.$x98
=150  \\$aAdrenal Cortex Diseases
=450  \\$wnnna$aAdrenal Cortex Disease
=450  \\$wnnna$aCortex Disease, Adrenal
=450  \\$wnnna$aCortex Diseases, Adrenal
=450  \\$wnnna$aDisease, Adrenal Cortex
=450  \\$wnnna$aDiseases, Adrenal Cortex
=550  \\$wg$aAdrenal Gland Diseases
=550  \\$wh$aAdrenal Cortex Neoplasms
=680  \\$iPathological processes of the ADRENAL CORTEX.
=688  \\$a79(75)63-67; was see under ADRENAL GLAND DISEASES 1975-78
=750  \0$aAdrenal cortex$xdiseases$5IEN$0(DLC)sh 85000995

=LDR  00810cz  a2200229n  4500
=001  9880363237502441
=005  20141212194557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000468
=035  \\$aCAZ3617HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x45
=150  \\$aAlkalies
=450  \\$aAlkali
=450  \\$wnnna$aAlkalis
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aCarbonates
=550  \\$wh$aHydroxides
=550  \\$wh$aLewis Bases
=667  \\$asingular form is "alkali"; /adv eff: consider also MILK-ALKALI SYNDROME see HYPERCALCEMIA
=680  \\$iUsually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. (Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAlkalies$5IEN$0(DLC)sh 85003591

=LDR  01041cz  a2200229n  4500
=001  9880363237602441
=005  20141212194501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000302
=035  \\$aCAZ3450HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407.$x71.$x140
=150  \\$aAdrenal Cortex
=450  \\$wnnna$aCortex, Adrenal
=550  \\$wg$aAdrenal Glands
=550  \\$wh$aZona Fasciculata
=550  \\$wh$aZona Glomerulosa
=550  \\$wh$aZona Reticularis
=667  \\$aPITUITARY-ADRENAL SYSTEM is available
=680  \\$iThe outer layer of the adrenal gland. It is derived from MESODERM and comprised of three zones (outer ZONA GLOMERULOSA, middle ZONA FASCICULATA, and inner ZONA RETICULARIS) with each producing various steroids preferentially, such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and ANDROSTENEDIONE. Adrenal cortex function is regulated by pituitary ADRENOCORTICOTROPIN.
=688  \\$a78(75)63-67; was see under ADRENAL GLANDS 1968-77
=750  \0$aAdrenal cortex$5IEN$0(DLC)sh 85000993

=LDR  00611cz  a2200217n  4500
=001  9880363237702441
=005  20141212194557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000466
=035  \\$aCAZ3615HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x146
=150  \\$aAlkadienes
=450  \\$aDiolefins
=450  \\$aPentadienes
=550  \\$wg$aPolyenes
=550  \\$wh$aButadienes
=550  \\$wh$aChloroprene
=680  \\$iAcyclic branched or unbranched hydrocarbons having two carbon-carbon double bonds.
=688  \\$a74
=750  \0$aDiolefins$5IEN$0(DLC)sh 85038112

=LDR  00753cz   2200229n  4500
=001  9880363237802441
=005  20230831160330.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000465
=035  \\$aCAZ3614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG17.$x35
=072  \\$aL1.$x224.$x50
=150  \\$aAlgorithms
=450  \\$wnnna$aAlgorithm
=550  \\$wg$aComputing Methodologies
=550  \\$wg$aMathematical Concepts
=550  \\$wh$aArtificial Intelligence
=680  \\$iA procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.
=688  \\$a87
=750  \0$aAlgorithms$5IEN$0(DLC)sh 85003487
=750  \0$iNarrower mapping$aGreedy algorithms$0(DLC)sh2022007582$4NM$5IEN-M

=LDR  00555cz  a2200169n  4500
=001  9880363237902441
=005  20141212194557.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000464
=035  \\$aCAZ3613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x68
=150  \\$aAlginates
=550  \\$wg$aPolysaccharides
=667  \\$aD25-26 qualif
=680  \\$iSalts of alginic acid that are extracted from marine kelp and used to make dental impressions and as absorbent material for surgical dressings.
=750  \0$aAlginates$5IEN$0(DLC)sh 89005062

=LDR  01429cz  a2200313n  4500
=001  9880363238002441
=005  20141212194556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000461
=035  \\$aCAZ3610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x700
=150  \\$aRhodophyta
=450  \\$aAlgae, Red
=450  \\$aRed Algae
=550  \\$wg$aPlants
=550  \\$wh$aChondrus
=550  \\$wh$aGracilaria
=550  \\$wh$aLaurencia
=550  \\$wh$aPlocamium
=550  \\$wh$aPorphyra
=550  \\$wh$aPorphyridium
=550  \\$aSeaweed
=667  \\$ageneral or unspecified; prefer specifics; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iPlants of the division Rhodophyta, commonly known as red algae, in which the red pigment (PHYCOERYTHRIN) predominates. However, if this pigment is destroyed, the algae can appear purple, brown, green, or yellow. Two important substances found in the cell walls of red algae are AGAR and CARRAGEENAN. Some rhodophyta are notable SEAWEED (macroalgae).
=688  \\$a2011 (1971)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Algae, Red
=688  \\$a74(71)
=750  \0$aRed algae$0(DLC) sh 85113776$5IEN

=LDR  01202cz  a2200301n  4500
=001  9880363238102441
=005  20141212194429.0
=008  860325\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000210
=035  \\$aCAZ3357HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x470.$x99
=150  \\$aAcute-Phase Reaction
=450  \\$wnnna$aAcute Phase Reaction
=450  \\$wnnna$aAcute-Phase Response
=450  \\$aAcute-Phase State
=450  \\$wnnna$aAcute Phase State
=450  \\$aReaction, Acute-Phase
=450  \\$wnnna$aReaction, Acute Phase
=450  \\$aResponse, Acute-Phase
=450  \\$wnnna$aResponse, Acute Phase
=450  \\$wnnna$aState, Acute-Phase
=550  \\$wg$aInflammation
=550  \\$aInflammation
=667  \\$anote category: in presence of a dis, use /etiol, not /compl
=680  \\$iAn early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
=688  \\$a92; was ACUTE PHASE REACTION 1987-91 (see under INFLAMMATION 1987-90)
=750  \0$aAcute phase reaction$0(DLC) sh 89004557$5IEN

=LDR  01435cz  a2200325n  4500
=001  9880363238202441
=005  20141212194556.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000460
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x150
=150  \\$aChlorophyta
=450  \\$aAlgae, Green
=450  \\$wnnna$aGreen Algae
=550  \\$wg$aViridiplantae
=550  \\$wh$aAcetabularia
=550  \\$wh$aCaulerpa
=550  \\$wh$aChlorella
=550  \\$wh$aPrototheca
=550  \\$wh$aScenedesmus
=550  \\$wh$aUlva
=550  \\$wh$aVolvocida
=550  \\$wh$aVolvox
=550  \\$aPhytoplankton
=550  \\$aSeaweed
=667  \\$ageneral or unspecified; prefer specifics; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA phylum of photosynthetic EUKARYOTA bearing double membrane-bound plastids containing chlorophyll a and b. They comprise the classical green algae, and represent over 7000 species that live in a variety of primarily aquatic habitats. Only about ten percent are marine species, most live in freshwater.
=688  \\$a70
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Algae, Green
=750  \0$aGreen algae$0(DLC) sh 85024578$5IEN

=LDR  01245cz  a2200337n  4500
=001  9880363238302441
=005  20141212194555.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000459
=035  \\$aCAZ3608HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x750.$x600
=150  \\$aPhaeophyta
=450  \\$aAlgae, Brown
=450  \\$wnnna$aBrown Algae
=450  \\$aPhaeophyceae
=550  \\$wg$aStramenopiles
=550  \\$wh$aAscophyllum
=550  \\$wh$aFucus
=550  \\$wh$aKelp
=550  \\$wh$aLaminaria
=550  \\$wh$aMacrocystis
=550  \\$wh$aSargassum
=550  \\$wh$aUndaria
=550  \\$aSeaweed
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA division of predominantly marine EUKARYOTA, commonly known as brown algae, having CHROMATOPHORES containing carotenoid PIGMENTS, BIOLOGICAL. ALGINATES and phlorotannins occur widely in all major orders. They are considered the most highly evolved algae because of their well-developed multicellular organization and structural complexity.
=688  \\$a2011 (1971)
=688  \\$aHeading changed 20100901 from: 150:##:_{dollar}a Algae, Brown
=688  \\$a91(71); was see under ALGAE 1971-90
=750  \0$aBrown algae$0(DLC) sh 85100540$5IEN

=LDR  01985cz  a2200529n  4500
=001  9880363238402441
=005  20180815121231.0
=008  860414\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000209
=035  \\$aCAZ3356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x124.$x50
=150  \\$aAcute-Phase Proteins
=450  \\$wnnna$aAcute-Phase Glycoproteins
=450  \\$wnnna$aAcute Phase Glycoproteins
=450  \\$wnnna$aAcute-Phase Protein
=450  \\$wnnna$aAcute Phase Protein
=450  \\$wnnna$aAcute Phase Proteins
=450  \\$aAcute-Phase Reactants
=450  \\$wnnna$aAcute Phase Reactants
=450  \\$wnnna$aGlycoproteins, Acute-Phase
=450  \\$wnnna$aProtein, Acute-Phase
=450  \\$aProteins, Acute-Phase
=450  \\$wnnna$aProteins, Acute Phase
=450  \\$aReactants, Acute-Phase
=450  \\$wnnna$aReactants, Acute Phase
=550  \\$wh$aLipocalin-2
=550  \\$wg$aBlood Proteins
=550  \\$wh$aalpha 1-Antichymotrypsin
=550  \\$wh$aalpha 1-Antitrypsin
=550  \\$wh$aalpha-Macroglobulins
=550  \\$wh$aC-Reactive Protein
=550  \\$wh$aCeruloplasmin
=550  \\$wh$aComplement C3
=550  \\$wh$aFibrinogen
=550  \\$wh$aHaptoglobins
=550  \\$wh$aHemopexin
=550  \\$wh$aOrosomucoid
=550  \\$wh$aSerum Albumin
=550  \\$wh$aSerum Amyloid A Protein
=550  \\$wh$aSerum Amyloid P-Component
=550  \\$wh$aTransferrin
=550  \\$wh$aTrypsin Inhibitor, Kazal Pancreatic
=667  \\$ablood proteins; /biosyn /drug eff /physiol permitted
=680  \\$iProteins that are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers.
=688  \\$a87
=750  \0$aAcute phase proteins$0(DLC) sh 89004558$5IEN

=LDR  00685cz  a2200217n  4500
=001  9880363238502441
=005  20141212194428.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000208
=035  \\$aCAZ3355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x125
=150  \\$aAcute Disease
=450  \\$wnnna$aAcute Diseases
=450  \\$wnnna$aDisease, Acute
=450  \\$wnnna$aDiseases, Acute
=550  \\$wg$aDisease Attributes
=667  \\$aIM GEN only; usually NIM with specific dis IM; no qualif when NIM; Manual 23.16+
=680  \\$iDisease having a short and relatively severe course.
=688  \\$a68
=750  \0$aAcute diseases$0(DLC)sh2012004404$5IEN-M

=LDR  02182cz  a2200505n  4500
=001  9880363238602441
=005  20190130130136.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000458
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x280
=072  \\$aB3.$x440.$x475.$x100
=150  \\$aCyanobacteria
=450  \\$wnnna$aAlgae, Blue Green
=450  \\$aAlgae, Blue-Green
=450  \\$wnnna$aBacteria, Blue Green
=450  \\$wnnna$aBacteria, Blue-Green
=450  \\$wnnna$aBlue Green Algae
=450  \\$wnnna$aBlue-Green Algae
=450  \\$wnnna$aBlue Green Bacteria
=450  \\$aBlue-Green Bacteria
=450  \\$aCyanophyceae
=550  \\$wg$aBacteria
=550  \\$wg$aGram-Negative Oxygenic Photosynthetic Bacteria
=550  \\$wh$aAnabaena
=550  \\$wh$aAphanizomenon
=550  \\$wh$aCyanothece
=550  \\$wh$aCylindrospermopsis
=550  \\$wh$aMicrocystis
=550  \\$wh$aNodularia
=550  \\$wh$aNostoc
=550  \\$wh$aOscillatoria
=550  \\$wh$aPlectonema
=550  \\$wh$aProchlorophytes
=550  \\$wh$aSpirulina
=550  \\$wh$aSynechococcus
=550  \\$wh$aSynechocystis
=550  \\$wh$aTrichodesmium
=550  \\$aPhytoplankton
=667  \\$ageneral or unspecified; prefer specifics; do not confuse X ref CYANOPHYCEAE with CYANOPHORA
=680  \\$iA phylum of oxygenic photosynthetic bacteria comprised of unicellular to multicellular bacteria possessing CHLOROPHYLL a and carrying out oxygenic PHOTOSYNTHESIS. Cyanobacteria are the only known organisms capable of fixing both CARBON DIOXIDE (in the presence of light) and NITROGEN. Cell morphology can include nitrogen-fixing heterocysts and/or resting cells called akinetes. Formerly called blue-green algae, cyanobacteria were traditionally treated as ALGAE.
=688  \\$a92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Synechococcus
=688  \\$aFormer heading, from 4XX field with {dollar}w deleted 20051206: 150:##:_{dollar}a Synechocystis
=750  \0$aCyanobacteria$5IEN$0(DLC)sh 85015067

=LDR  01042cz  a2200253n  4500
=001  9880363238702441
=005  20141212194428.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000206
=035  \\$aCAZ3353HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x740.$x100
=072  \\$aN5.$x715.$x360.$x750.$x100
=072  \\$aN6.$x850.$x520.$x830.$x100
=150  \\$aActuarial Analysis
=450  \\$wnnna$aActuarial Analyses
=450  \\$wnnna$aAnalyses, Actuarial
=450  \\$wnnna$aAnalysis, Actuarial
=550  \\$wg$aStatistics as Topic
=550  \\$wh$aLife Tables
=667  \\$aIM; few qualif apply
=680  \\$iThe application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.
=688  \\$a79
=750  \0$aInsurance$xMathematics$5IEN$0(DLC)sh 85066815

=LDR  00633cz  a2200181n  4500
=001  9880363238802441
=005  20141212194427.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000205
=035  \\$aCAZ3352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x210.$x500.$x154
=150  \\$aActomyosin
=550  \\$wg$aMuscle Proteins
=667  \\$aa muscle protein; /biosyn /physiol permitted
=680  \\$iA protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle.
=688  \\$a73(71); was see under MUSCLE PROTEINS 1963-72
=750  \0$aActomyosin$5IEN$0(DLC)sh 85000743

=LDR  00890cz  a2200217n  4500
=001  9880363238902441
=005  20141212194554.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000455
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x401.$x590.$x500
=072  \\$aJ2.$x500.$x300.$x100.$x555
=150  \\$aMedicago sativa
=450  \\$aAlfalfa
=450  \\$aLucerne
=550  \\$wg$aAnimal Feed
=550  \\$wg$aMedicago
=667  \\$acoord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant species of the family FABACEAE widely cultivated for animal feed.
=688  \\$a2002(1963)
=750  \0$aAlfalfa$5IEN$0(DLC)sh 85003383

=LDR  01327cz  a2200301n  4500
=001  9880363239002441
=005  20141212194553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000453
=035  \\$aCAZ3602HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x700.$x91
=072  \\$aC2.$x839.$x91
=072  \\$aC20.$x673.$x774.$x257.$x270
=072  \\$aC22.$x62
=150  \\$aAleutian Mink Disease
=450  \\$wnnna$aAleutian Disease of Mink
=450  \\$wnnna$aDisease, Aleutian Mink
=450  \\$wnnna$aMink Disease, Aleutian
=550  \\$wg$aAnimal Diseases
=550  \\$wg$aChediak-Higashi Syndrome
=550  \\$wg$aParvoviridae Infections
=550  \\$wg$aSlow Virus Diseases
=550  \\$aChediak-Higashi Syndrome
=667  \\$acaused by a parvovirus; don't forget also MINK (NIM) & check tag ANIMALS
=680  \\$iA slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible.
=688  \\$a71
=750  \0$aMink Aleutian disease$5IEN-M$0(DLC)sh 85085746

=LDR  00649cz  a2200193n  4500
=001  9880363239102441
=005  20141212194553.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000452
=035  \\$aCAZ3601HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x42
=150  \\$aAldrin
=450  \\$wnnna$aIsodrin
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iA highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed)
=688  \\$a73(71)
=750  \0$aAldrin$5IEN$0(DLC)sh 91004744

=LDR  01443cz  a2200361n  4500
=001  9880363239202441
=005  20141212194553.0
=008  770517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000451
=035  \\$aCAZ3600HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x347.$x700
=072  \\$aD27.$x505.$x696.$x399.$x450.$x600
=072  \\$aD27.$x505.$x696.$x560.$x500.$x726.$x249
=150  \\$aMineralocorticoid Receptor Antagonists
=450  \\$aAldosterone Antagonists
=450  \\$aAldosterone$xantagonists & inhibitors
=450  \\$wnnna$aAldosterone Receptor Antagonists
=450  \\$wnnna$aAntagonists, Aldosterone
=450  \\$wnnna$aAntagonists, Aldosterone Receptor
=450  \\$wnnna$aAntagonists, Mineralocorticoid
=450  \\$wnnna$aAntagonists, Mineralocorticoid Receptor
=450  \\$wnnna$aMineralocorticoid Antagonists
=450  \\$wnnna$aReceptor Antagonists, Aldosterone
=450  \\$wnnna$aReceptor Antagonists, Mineralocorticoid
=450  \\$aReceptors, Mineralocorticoid$xantagonists & inhibitors
=550  \\$wg$aDiuretics, Potassium Sparing
=550  \\$wg$aHormone Antagonists
=680  \\$iDrugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.
=688  \\$a2013(1963)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Aldosterone Antagonists
=688  \\$a78,63-67
=750  \0$aAldosterone antagonists$5IEN$0(DLC)sh 85003338

=LDR  00965cz  a2200217n  4500
=001  9880363239302441
=005  20141212194552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000450
=035  \\$aCAZ3599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x745.$x654.$x62
=072  \\$aD6.$x472.$x40.$x585.$x353.$x118
=150  \\$aAldosterone
=450  \\$wnnna$aAldosterone, (+-)-Isomer
=450  \\$wnnna$aAldosterone, (11 beta,17 alpha)-Isomer
=550  \\$wg$a11-Hydroxycorticosteroids
=550  \\$wg$aPregnenediones
=667  \\$a/defic: consider also HYPOALDOSTERONISM; consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM & do not index under ALDOSTERONE unless particularly discussed
=680  \\$iA hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.
=750  \0$aAldosterone$5IEN$0(DLC)sh 85003337

=LDR  01285cz  a2200325n  4500
=001  9880363239402441
=005  20141212194552.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000449
=035  \\$aCAZ3598HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x150.$x700.$x75
=072  \\$aD8.$x811.$x682.$x47.$x820.$x275
=150  \\$aAldehyde Reductase
=450  \\$aAldose Reductase
=450  \\$wnnna$aAldose Reductase Ia
=450  \\$wnnna$aAldose Reductase Ib
=450  \\$wnnna$aErythrose Reductase
=450  \\$wnnna$aReductase, Aldehyde
=450  \\$wnnna$aReductase, Aldose
=450  \\$wnnna$aReductase, Erythrose
=450  \\$wnnna$aReductase Ia, Aldose
=450  \\$wnnna$aReductase Ib, Aldose
=450  \\$wnnna$aReductase, Xylose
=450  \\$wnnna$aXylose Reductase
=550  \\$wg$aNAD (+) and NADP (+) Dependent Alcohol Oxidoreductases
=550  \\$wg$aSugar Alcohol Dehydrogenases
=680  \\$iAn enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21.
=688  \\$a92; was ALDOSE REDUCTASE 1976-91 (see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77)
=750  \0$aAldose reductase$5IEN$0(DLC)sh 86005604

=LDR  00840cz  a2200289n  4500
=001  9880363239502441
=005  20141212194552.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000448
=035  \\$aCAZ3597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x46
=150  \\$aAldicarb
=450  \\$wnnna$aENT-27,093
=450  \\$wnnna$aENT 27,093
=450  \\$wnnna$aENT27,093
=450  \\$wnnna$aTemik
=450  \\$wnnna$aUC-21,149
=450  \\$wnnna$aUC 21,149
=450  \\$wnnna$aUC-21149
=450  \\$wnnna$aUC 21149
=450  \\$wnnna$aUC21,149
=450  \\$wnnna$aUC21149
=550  \\$wg$aCarbamates
=680  \\$iCarbamate derivative used as an insecticide, acaricide, and nematocide.
=688  \\$a91(72); was see under INSECTICIDES, CARBAMATE 1972-90
=750  \0$aAldicarb$5IEN$0(DLC)sh 91005885

=LDR  00829cz  a2200301n  4500
=001  9880363239602441
=005  20141212194551.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000447
=035  \\$aCAZ3596HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x47
=150  \\$aAldehydes
=450  \\$aHydroxypentenal$5IEN-M
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAcetaldehyde
=550  \\$wh$aAcrolein
=550  \\$wh$aBenzaldehydes
=550  \\$wh$aFormaldehyde
=550  \\$wh$aFuraldehyde
=550  \\$wh$aGlutaral
=550  \\$wh$aGlyceraldehyde
=550  \\$wh$aGlyoxal
=550  \\$wh$aMalondialdehyde
=550  \\$wh$ao-Phthalaldehyde
=550  \\$wh$aRetinaldehyde
=680  \\$iOrganic compounds containing a carbonyl group in the form -CHO.
=750  \0$aAldehydes$5IEN$0(DLC)sh 85003324

=LDR  01148cz  a2200301n  4500
=001  9880363239702441
=005  20180205113408.0
=008  840411\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000444
=035  \\$aCAZ3593HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x657.$x163.$x249
=150  \\$aAldehyde Dehydrogenase
=450  \\$wnnna$aAldehyde Dehydrogenase E1
=450  \\$wnnna$aAldehyde Dehydrogenase E2
=450  \\$wnnna$aAldehyde Dehydrogenase (NAD(+))
=450  \\$wnnna$aAldehyde-NAD Oxidoreductase
=450  \\$wnnna$aAldehyde NAD Oxidoreductase
=450  \\$aD-Glucuronolactone Dehydrogenase
=450  \\$wnnna$aD Glucuronolactone Dehydrogenase
=450  \\$wnnna$aDehydrogenase, Aldehyde
=450  \\$wnnna$aDehydrogenase, D-Glucuronolactone
=550  \\$wg$aAldehyde Oxidoreductases
=550  \\$wh$aAldehyde Dehydrogenase, Mitochondrial
=550  \\$wh$aomega-Crystallins
=680  \\$iAn enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70.
=688  \\$a85
=750  \0$aAldehyde dehydrogenase$0(DLC) sh 85003323$5IEN

=LDR  00849cz  a2200289n  4500
=001  9880363239802441
=005  20141212194549.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000440
=035  \\$aCAZ3589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x415.$x110
=072  \\$aD10.$x289.$x110
=150  \\$aButanols
=450  \\$a1-Butanol$xanalogs & derivatives
=450  \\$aAlcohols, Butyl
=450  \\$wnnna$aButyl Alcohols
=450  \\$wnnna$aButylhydroxides
=450  \\$wnnna$aHydroxybutanes
=550  \\$wg$aFatty Alcohols
=550  \\$wh$a1-Butanol
=550  \\$wh$aChlorobutanol
=550  \\$wh$atert-Butyl Alcohol
=667  \\$a1-BUTANOL and TERT-BUTYL ALCOHOL also available
=680  \\$iIsomeric forms and derivatives of butanol (C4H9OH).
=688  \\$a98(72)
=750  \0$aButanol$5IEN-M$0(DLC)sh 85018354

=LDR  01167cz  a2200301n  4500
=001  9880363239902441
=005  20141212194548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000438
=035  \\$aCAZ3587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33
=150  \\$aAlcohols
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aAmino Alcohols
=550  \\$wh$aBenzyl Alcohols
=550  \\$wh$aChlorohydrins
=550  \\$wh$aEthanol
=550  \\$wh$aFatty Alcohols
=550  \\$wh$aGlycols
=550  \\$wh$aHexanols
=550  \\$wh$aMethanol
=550  \\$wh$aPolyvinyl Alcohol
=550  \\$wh$aPropanols
=550  \\$wh$aSugar Alcohols
=667  \\$ado not use for "alcohol" ( = ETHANOL); diols = GLYCOLS; hypophysectomy by alcohol (ethanol) injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed
=680  \\$iAlkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)
=750  \0$aAlcohols$0(DLC) sh 85003314$5IEN

=LDR  02118cz  a2200337n  4500
=001  9880363240002441
=005  20141212194548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000437
=035  \\$aCAZ3586HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x100.$x250
=072  \\$aF3.$x900.$x100.$x350
=150  \\$aAlcoholism
=450  \\$wnnna$aAbuse, Alcohol
=450  \\$wnnna$aAddiction, Alcohol
=450  \\$aAlcohol Abuse
=450  \\$wnnna$aAlcohol Addiction
=450  \\$wnnna$aAlcohol Dependence
=450  \\$aAlcoholic Intoxication, Chronic
=450  \\$aAlcoholics$5IEN
=450  \\$wnnna$aChronic Alcoholic Intoxication
=450  \\$wnnna$aDependence, Alcohol
=450  \\$wnnna$aIntoxication, Chronic Alcoholic
=550  \\$wg$aAlcohol-Related Disorders
=550  \\$aAlcohol Drinking
=550  \\$aFetal Alcohol Spectrum Disorders
=550  \\$aSocial Problems
=667  \\$ahuman & animal; note entry term ALCOHOLIC INTOXICATION, CHRONIC: do not coordinate with CHRONIC DISEASE; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION and ALCOHOLICS; acute alcoholic intoxication = ETHANOL /pois; consider also ALCOHOL-INDUCED DISORDERS and specifics; index other complications of alcoholism under ALCOHOLISM /compl (IM) + disease /etiol not /chem ind (IM); abstinence from alcohol in alcoholism: coordinate with TEMPERANCE (NIM)
=680  \\$iA primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
=750  \0$aAlcoholism$0(DLC) sh 85003292$5IEN-M

=LDR  00758cz  a2200253n  4500
=001  9880363240102441
=005  20141212194547.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000434
=035  \\$aCAZ3583HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x200.$x100
=150  \\$aAlcoholic Beverages
=450  \\$wnnna$aAlcoholic Beverage
=450  \\$wnnna$aBeverage, Alcoholic
=450  \\$wnnna$aBeverages, Alcoholic
=550  \\$wg$aBeverages
=550  \\$wh$aAbsinthe
=550  \\$wh$aBeer
=550  \\$wh$aWine
=550  \\$aEthanol
=667  \\$aGEN; BEER & WINE are available; chronic consumption of alcoholic bev = ALCOHOLISM
=680  \\$iDrinkable liquids containing ETHANOL.
=750  \0$aAlcoholic beverages$5IEN$0(DLC)sh 85003283

=LDR  00871cz  a2200265n  4500
=001  9880363240202441
=005  20141212194546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000432
=035  \\$aCAZ3581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x623
=150  \\$aMethanol
=450  \\$aAlcohol, Methyl
=450  \\$wnnna$aAlcohol, Wood
=450  \\$wnnna$aCarbinol
=450  \\$wnnna$aMethoxide, Sodium
=450  \\$wnnna$aMethyl Alcohol
=450  \\$wnnna$aSodium Methoxide
=450  \\$wnnna$aWood Alcohol
=550  \\$wg$aAlcohols
=667  \\$afor wood alcohol
=680  \\$iA colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.
=688  \\$a98;
=750  \0$aMethanol$5IEN$0(DLC)sh 85084383

=LDR  01683cz  a2200337n  4500
=001  9880363240302441
=005  20161215095624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000431
=035  \\$aCAZ3580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x375
=150  \\$aEthanol
=450  \\$wnnna$aAbsolute Alcohol
=450  \\$wnnna$aAlcohol, Absolute
=450  \\$aAlcohol, Ethyl
=450  \\$wnnna$aAlcohol, Grain
=450  \\$wnnna$aEthyl Alcohol
=450  \\$wnnna$aGrain Alcohol
=550  \\$wg$aAlcohols
=550  \\$wh$aBlood Alcohol Content
=550  \\$wh$aEthamoxytriphetol
=550  \\$wh$aEthanolamines
=550  \\$wh$aEthylene Chlorohydrin
=550  \\$wh$aMercaptoethanol
=550  \\$wh$aPhenylethyl Alcohol
=550  \\$wh$aTrifluoroethanol
=667  \\$afor "alcohol" unspecified; / antag: consider also ALCOHOL DETERRENTS; ethanol production by organisms = / metab; use/ pois for acute alcohol poisoning & acute alcoholic intoxication; available also are BINGE DRINKING, DRUNKENNESS see ALCOHOLIC INTOXICATION, ALCOHOLISM and ALCOHOLIC BEVERAGES; hypophysectomy by alcohol injection = HYPOPHYSECTOMY, CHEMICAL & do not index under ETHANOL unless particularly discussed; "abstinence from alcohol" = TEMPERANCE
=680  \\$iA clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.
=688  \\$a98(63)
=750  \0$aEthanol$0(DLC)sh2009007801$5IEN-M

=LDR  02050cz  a2200373n  4500
=001  9880363240402441
=005  20141212194546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000430
=035  \\$aCAZ3579HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x720.$x112.$x200
=072  \\$aC25.$x723.$x705.$x150.$x200
=072  \\$aC25.$x775.$x100.$x87.$x193.$x200
=072  \\$aC25.$x775.$x835.$x250
=072  \\$aF3.$x900.$x100.$x100
=072  \\$aF3.$x900.$x825.$x500
=150  \\$aAlcohol Withdrawal Delirium
=450  \\$wnnna$aAlcohol Withdrawal Associated Autonomic Hyperactivity
=450  \\$aAlcohol Withdrawal Hallucinosis
=450  \\$wnnna$aAlcohol Withdrawal-Induced Delirium Tremens
=450  \\$wnnna$aAlcohol Withdrawal Induced Delirium Tremens
=450  \\$aAutonomic Hyperactivity, Alcohol Withdrawal Associated
=450  \\$wnnna$aDelirium, Alcohol Withdrawal
=450  \\$aDelirium Tremens
=450  \\$wnnna$aDelirium Tremens, Alcohol Withdrawal Induced
=450  \\$wnnna$aHallucinosis, Alcohol Withdrawal
=550  \\$wg$aAlcohol-Induced Disorders, Nervous System
=550  \\$wg$aAlcohol-Related Disorders
=550  \\$wg$aSubstance Withdrawal Syndrome
=667  \\$anote X ref; do not confuse with "alcohol withdrawal syndrome" ( = SUBSTANCE WITHDRAWAL SYNDROME (IM) + ETHANOL /adv eff (IM)); ALCOHOL WITHDRAWAL SEIZURES is available
=680  \\$iAn acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175)
=688  \\$a91(81); was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80
=750  \0$aDelirium tremens$5IEN$0(DLC)sh 85036580

=LDR  01093cz  a2200253n  4500
=001  9880363240502441
=005  20171213161728.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000428
=035  \\$aCAZ3577HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x317.$x269
=150  \\$aAlcohol Drinking
=450  \\$aAlcohol Consumption
=450  \\$wnnna$aConsumption, Alcohol
=450  \\$aDrinking, Alcohol
=550  \\$wg$aDrinking Behavior
=550  \\$wh$aBinge Drinking
=550  \\$wh$aUnderage Drinking
=550  \\$aDrinking
=667  \\$aavailable also are BINGE DRINKING and DRUNKENNESS see ALCOHOLIC INTOXICATION; acute alcohol intoxication = ETHANOL / pois; chronic alcohol consumption = ALCOHOLISM; TEMPERANCE is available for "abstinence from alcohol" but do not confuse with alcohol withdrawal (see note under ALCOHOL WITHDRAWAL DELIRIUM & SUBSTANCE WITHDRAWAL SYNDROME)
=680  \\$iBehaviors associated with the ingesting of alcoholic beverages, including social drinking.
=688  \\$a69
=750  \0$aDrinking of alcoholic beverages$5IEN$0(DLC)sh 85039589

=LDR  01293cz  a2200301n  4500
=001  9880363240602441
=005  20141212194544.0
=008  860409\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000426
=035  \\$aCAZ3575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x682.$x47.$x820.$x250
=150  \\$aAlcohol Dehydrogenase
=450  \\$wnnna$aAlcohol Dehydrogenase I
=450  \\$wnnna$aAlcohol Dehydrogenase II
=450  \\$wnnna$aAlcohol Dehydrogenase (NAD+)
=450  \\$wnnna$aAlcohol Dehydrogenase, Yeast
=450  \\$wnnna$aAlcohol-NAD+ Oxidoreductase
=450  \\$wnnna$aAlcohol NAD+ Oxidoreductase
=450  \\$wnnna$aDehydrogenase, Alcohol
=450  \\$wnnna$aDehydrogenase, Yeast Alcohol
=450  \\$wnnna$aOxidoreductase, Alcohol-NAD+
=450  \\$wnnna$aYeast Alcohol Dehydrogenase
=550  \\$wg$aNAD (+) and NADP (+) Dependent Alcohol Oxidoreductases
=667  \\$aa specific enzyme; do not confuse with ALCOHOL OXIDOREDUCTASES
=680  \\$iA zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.
=688  \\$a87
=750  \0$aAlcohol dehydrogenase$5IEN$0(DLC)sh 85003276

=LDR  00524cz  a2200205n  4500
=001  9880363240702441
=005  20141212194542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000422
=035  \\$aCAZ3571HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x75
=150  \\$aAlchemy
=450  \\$wnnna$aAlchemies
=450  \\$aAlchemists$5IEN
=550  \\$wg$aHistory
=550  \\$aChemistry
=667  \\$ano qualif
=750  \0$aAlchemists$5IEN-M$0(DLC)sh 85003263
=750  \0$aAlchemy$5IEN-HS$0(DLC)sh 85003265

=LDR  00869cz  a2200205n  4500
=001  9880363240802441
=005  20141212194542.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000421
=035  \\$aCAZ3570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x117.$x50
=072  \\$aB3.$x660.$x75.$x27.$x50
=150  \\$aAlcaligenes
=550  \\$wg$aAlcaligenaceae
=550  \\$wh$aAlcaligenes faecalis
=667  \\$aALCALIGENES EUTROPHA see CUPRIAVIDUS NECATOR is available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS (IM)
=680  \\$iA genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans.
=688  \\$a1976 (1963)
=750  \0$aAlcaligenes$5IEN$0(DLC)sh 88023212

=LDR  01180cz  a2200313n  4500
=001  9880363240902441
=005  20170322101312.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000420
=035  \\$aCAZ3569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x57
=072  \\$aD2.$x92.$x63.$x291.$x57
=072  \\$aD2.$x92.$x471.$x683.$x61
=150  \\$aAlbuterol
=450  \\$wnnna$a2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
=450  \\$wnnna$aAlbuterol Sulfate
=450  \\$wnnna$aProventil
=450  \\$aSalbutamol
=450  \\$wnnna$aSultanol
=450  \\$wnnna$aVentolin
=550  \\$wg$aEthanolamines
=550  \\$wg$aPhenethylamines
=550  \\$wh$aAlbuterol, Ipratropium Drug Combination
=550  \\$wh$aLevalbuterol
=550  \\$wh$aSalmeterol Xinafoate
=680  \\$iA short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
=688  \\$a74
=750  \0$aAlbuterol$5IEN$0(DLC)sh 85003253

=LDR  00660cz  a2200217n  4500
=001  9880363241002441
=005  20141212194541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000419
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC12.$x777.$x934.$x734.$x269
=072  \\$aC13.$x351.$x968.$x934.$x734.$x269
=072  \\$aC23.$x888.$x942.$x750.$x269
=150  \\$aAlbuminuria
=450  \\$aAlbumins$xurine
=450  \\$wnnna$aAlbuminurias
=450  \\$aSerum Albumin$xurine
=550  \\$wg$aProteinuria
=550  \\$aUrine
=680  \\$iThe presence of albumin in the urine, an indicator of KIDNEY DISEASES.
=750  \0$aAlbuminuria$5IEN$0(DLC)sh 85003247

=LDR  00764cz  a2200253n  4500
=001  9880363241102441
=005  20141212194541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000418
=035  \\$aCAZ3567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x34
=150  \\$aAlbumins
=550  \\$wg$aProteins
=550  \\$wh$aC-Reactive Protein
=550  \\$wh$aConalbumin
=550  \\$wh$aLactalbumin
=550  \\$wh$aOvalbumin
=550  \\$wh$aParvalbumins
=550  \\$wh$aRicin
=550  \\$wh$aSerum Albumin
=550  \\$wh$aTechnetium Tc 99m Aggregated Albumin
=680  \\$iWater-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.
=750  \0$aAlbumins$5IEN$0(DLC)sh 85003246

=LDR  01268cz   2200337n  4500
=001  9880363241202441
=005  20240216170548.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000417
=035  \\$aCAZ3566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x270.$x40
=072  \\$aC16.$x320.$x290.$x40
=072  \\$aC16.$x320.$x565.$x100.$x102
=072  \\$aC16.$x320.$x850.$x80
=072  \\$aC17.$x800.$x621.$x440.$x102
=072  \\$aC17.$x800.$x827.$x80
=072  \\$aC18.$x452.$x648.$x100.$x102
=150  \\$aAlbinism
=450  \\$aAlbinos$5IEN
=550  \\$wg$aAmino Acid Metabolism, Inborn Errors
=550  \\$wg$aEye Diseases, Hereditary
=550  \\$wg$aHypopigmentation
=550  \\$wg$aSkin Diseases, Genetic
=550  \\$wh$aAlbinism, Ocular
=550  \\$wh$aAlbinism, Oculocutaneous
=550  \\$wh$aPiebaldism
=550  \\$aMonophenol Monooxygenase
=667  \\$ahypopigmentation of skin, hair, eye; GEN or unspecified; prefer specifics; do not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iGeneral term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.
=750  \0$aPeople with albinism$5IEN$0(DLC)sh2022007318

=LDR  01152cz  a2200313n  4500
=001  9880363241302441
=005  20141212191936.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000409
=035  \\$aCAZ3558HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x42
=150  \\$aAlanine
=450  \\$wnnna$aAbufène
=450  \\$wnnna$aAlanine Doms-Adrian Brand
=450  \\$wnnna$aAlanine, L-Isomer
=450  \\$wnnna$aAlanine, L Isomer
=450  \\$wnnna$aDoms-Adrian Brand of Alanine
=450  \\$wnnna$aDoms Adrian Brand of Alanine
=450  \\$wnnna$aL-Alanine
=450  \\$wnnna$aL Alanine
=450  \\$wnnna$aL-Isomer Alanine
=550  \\$wg$aAmino Acids
=550  \\$wh$abeta-Alanine
=550  \\$wh$aLysinoalanine
=550  \\$wh$aMimosine
=667  \\$aBETA-ALANINE is also available
=680  \\$iA non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
=750  \0$aAlanine$5IEN$0(DLC)sh 85003136

=LDR  01221cz  a2200277n  4500
=001  9880363241402441
=005  20141212194537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000405
=035  \\$aCAZ3554HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x42
=150  \\$aAkinetic Mutism
=450  \\$wnnna$aAkinetic Autism
=450  \\$wnnna$aAkinetic Mutisms
=450  \\$wnnna$aAutism, Akinetic
=450  \\$wnnna$aComa Vigil
=450  \\$wnnna$aComa Vigilans
=450  \\$aMutism, Akinetic
=450  \\$wnnna$aVigil, Coma
=450  \\$wnnna$aVigils, Coma
=550  \\$wg$aBrain Diseases
=550  \\$aPersistent Vegetative State
=680  \\$iA syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67)
=688  \\$a1971
=750  \0$aMutism, Akinetic$5IEN$0(DLC)sh 85089142

=LDR  00877cz  a2200253n  4500
=001  9880363241502441
=005  20141212194536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000402
=035  \\$aCAZ3551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x846.$x185
=150  \\$aAirway Obstruction
=450  \\$wnnna$aAirway Obstructions
=450  \\$aChoking
=450  \\$wnnna$aObstruction, Airway
=450  \\$wnnna$aObstructions, Airway
=550  \\$wg$aRespiratory Insufficiency
=550  \\$wh$aNasal Obstruction
=550  \\$aLung Diseases, Obstructive
=667  \\$aacute; chronic airway obstruction = PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; NASAL OBSTRUCTION is also available
=680  \\$iAny hindrance to the passage of air into and out of the lungs.
=688  \\$a72(71)
=750  \0$aRespiratory organs$xObstructions$5IEN-M$0(DLC)sh 85113206

=LDR  01009cz   2200301n  4500
=001  9880363241602441
=005  20220922161025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000401
=035  \\$aCAZ3550HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x937.$x285.$x100
=150  \\$aAircraft
=450  \\$wnnna$aAirplane
=450  \\$wnnna$aAirplanes
=450  \\$wnnna$aEjection Seat
=450  \\$aEjection Seats
=450  \\$wnnna$aHelicopter
=450  \\$aHelicopters
=450  \\$wnnna$aSeat, Ejection
=450  \\$wnnna$aSeats, Ejection
=550  \\$wg$aAviation
=550  \\$wh$aAir Ambulances
=550  \\$aAviation
=680  \\$iA weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. (Webster, 1973)
=688  \\$aEJECTION SEATS was heading 1963-82
=750  \0$aAirplanes$5IEN$0(DLC)sh 85002782
=750  \0$iNarrower mapping$aXi'an airplanes$0(DLC)sh2021005549$4NM$5IEN-M

=LDR  01116cz  a2200313n  4500
=001  9880363241702441
=005  20141212194535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000400
=035  \\$aCAZ3549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA13.$x48
=150  \\$aAir Sacs
=450  \\$aAir Bladder
=450  \\$wnnna$aAir Bladders
=450  \\$wnnna$aAir Sac
=450  \\$wnnna$aBladder, Air
=450  \\$wnnna$aBladders, Air
=450  \\$wnnna$aSac, Air
=450  \\$wnnna$aSacs, Air
=450  \\$aSwimbladder
=450  \\$wnnna$aSwimbladders
=550  \\$wg$aAnimal Structures
=550  \\$aLung
=667  \\$ain birds, fish, insects & mammals; sacculitis in veterinary animals: coord IM with RESPIRATORY TRACT DISEASES/vet (IM) or RESPIRATORY TRACT INFECTIONS/vet (IM)
=680  \\$iThin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals.
=688  \\$a68; AIR BLADDER was heading 1968-80
=750  \0$aAir sacs (Bird anatomy)$5IEN-M$0(DLC)sh 85002697
=750  \0$aAir-bladder (in fishes)$5IEN-HS$0(DLC)sh 85002603

=LDR  00975cz  a2200241n  4500
=001  9880363241802441
=005  20141212194535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000397
=035  \\$aCAZ3546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x460.$x100
=150  \\$aAir Pollution
=450  \\$wnnna$aAir Pollutions
=450  \\$wnnna$aPollution, Air
=450  \\$wnnna$aPollutions, Air
=550  \\$wg$aEnvironmental Pollution
=550  \\$wh$aAir Pollution, Indoor
=550  \\$wh$aAir Pollution, Radioactive
=550  \\$wh$aTobacco Smoke Pollution
=667  \\$aincludes pollen in the air (coordinate with POLLEN)
=680  \\$iThe presence of contaminants or pollutant substances in the air (AIR POLLUTANTS) that interfere with human health or welfare, or produce other harmful environmental effects. The substances may include GASES; PARTICULATE MATTER; or volatile ORGANIC CHEMICALS.
=750  \0$aAir$xPollution$0(DLC) sh 85002574$5IEN

=LDR  01178cz  a2200313n  4500
=001  9880363241902441
=005  20200514110019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000393
=035  \\$aCAZ3542HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x888.$x284.$x101
=150  \\$aAir Pollutants
=450  \\$wnnna$aAir Environmental Pollutants
=450  \\$wnnna$aAir Pollutants, Environmental
=450  \\$wnnna$aEnvironmental Air Pollutants
=450  \\$wnnna$aEnvironmental Pollutants, Air
=450  \\$wnnna$aPollutants, Air
=450  \\$wnnna$aPollutants, Air Environmental
=450  \\$wnnna$aPollutants, Environmental Air
=550  \\$wg$aEnvironmental Pollutants
=550  \\$wh$aAir Pollutants, Occupational
=550  \\$wh$aAir Pollutants, Radioactive
=550  \\$wh$aGreenhouse Gases
=667  \\$aspecify pollutant if pertinent
=680  \\$iAny substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or material. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS.
=688  \\$a1975
=688  \\$a75
=750  \0$aAir$xPollution$0(DLC) sh 85002574$5IEN

=LDR  00766cz  a2200217n  4500
=001  9880363242002441
=005  20141212194533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000391
=035  \\$aCAZ3540HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x540.$x274.$x110
=072  \\$aN6.$x850.$x425.$x110
=150  \\$aAir Microbiology
=450  \\$aAir$xmicrobiology
=450  \\$aAir$xvirology
=450  \\$wnnna$aMicrobiology, Air
=550  \\$wg$aEnvironmental Microbiology
=667  \\$aIM; coord IM with specific bact, virus or fungus (IM); DF: AIR MICROBIOL
=680  \\$iThe presence of bacteria, viruses, and fungi in the air. This term is not restricted to pathogenic organisms.
=750  \0$aAir$xMicrobiology$5IEN$0(DLC)sh 85002572

=LDR  00844cz  a2200265n  4500
=001  9880363242102441
=005  20170627113331.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000390
=035  \\$aCAZ3539HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x35
=072  \\$aG16.$x500.$x50
=072  \\$aN6.$x230.$x300.$x100.$x150.$x100
=150  \\$aAir Ionization
=450  \\$wnnna$aAir Ionizations
=450  \\$wnnna$aIonization, Air
=450  \\$wnnna$aIonizations, Air
=550  \\$wg$aAir
=550  \\$wg$aChemical Phenomena
=550  \\$wg$aEcological and Environmental Processes
=550  \\$wg$aPhysicochemical Processes
=680  \\$iThe dissociation of molecules in the air into positive and negative ions under the influence of an electric field.
=688  \\$a70(65)
=750  \0$aIonized air$5IEN$0(DLC)sh 85002592

=LDR  01186cz  a2200289n  4500
=001  9880363242202441
=005  20141212194533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000389
=035  \\$aCAZ3538HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x230.$x150.$x50
=150  \\$aAir Conditioning
=450  \\$wnnna$aAir Conditionings
=450  \\$aAir Revitalization
=450  \\$wnnna$aAir Revitalizations
=450  \\$aClimate Control
=450  \\$wnnna$aClimate Controls
=450  \\$wnnna$aConditioning, Air
=450  \\$wnnna$aConditionings, Air
=450  \\$wnnna$aControl, Climate
=450  \\$wnnna$aControls, Climate
=450  \\$wnnna$aRevitalization, Air
=450  \\$wnnna$aRevitalizations, Air
=550  \\$wg$aEnvironment, Controlled
=680  \\$iThe maintenance of certain aspects of the environment within a defined space to facilitate the function of that space; aspects controlled include air temperature and motion, radiant heat level, moisture, and concentration of pollutants such as dust, microorganisms, and gases. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aAir conditioning$5IEN$0(DLC)sh 85002610

=LDR  00715cz  a2200217n  4500
=001  9880363242302441
=005  20141212194532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000388
=035  \\$aCAZ3537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x63.$x150
=072  \\$aN6.$x230.$x300.$x100.$x150
=150  \\$aAir
=550  \\$wg$aAtmosphere
=550  \\$wh$aAir Ionization
=550  \\$wh$aAir Movements
=550  \\$wh$aCompressed Air
=667  \\$ado not confuse with ATMOSPHERE or OXYGEN
=680  \\$iThe mixture of gases present in the earth's atmosphere consisting of oxygen, nitrogen, carbon dioxide, and small amounts of other gases.
=750  \0$aAir$5IEN$0(DLC)sh 85002570

=LDR  01498cz  a2200313n  4500
=001  9880363242402441
=005  20141212194532.0
=008  860618\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000386
=035  \\$aCAZ3535HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x815.$x616.$x400.$x80
=072  \\$aC2.$x800.$x801.$x400.$x80
=072  \\$aC2.$x839.$x80
=072  \\$aC20.$x673.$x480.$x80
=150  \\$aAIDS-Related Complex
=450  \\$wnnna$aAIDS Related Complex
=450  \\$aARC
=450  \\$wnnna$aComplex, AIDS-Related
=450  \\$aLymphadenopathy Syndrome
=450  \\$wnnna$aLymphadenopathy Syndromes
=450  \\$wnnna$aSyndrome, Lymphadenopathy
=450  \\$wnnna$aSyndromes, Lymphadenopathy
=550  \\$wg$aHIV Infections
=550  \\$wg$aSlow Virus Diseases
=667  \\$acoord IM with HIV-1 or HIV-2 (IM) if pertinent; DF: note short X ref
=680  \\$iA prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS.
=688  \\$a87
=750  \0$aAIDS-related complex$5IEN$0(DLC)sh 86002565

=LDR  00950cz  a2200229n  4500
=001  9880363242502441
=005  20141212194531.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000385
=035  \\$aCAZ3533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x521.$x346.$x506.$x849.$x95
=150  \\$aAid to Families with Dependent Children
=450  \\$wnnna$aAllowance, Family
=450  \\$wnnna$aAllowances, Family
=450  \\$wnnna$aFamily Allowance
=450  \\$wnnna$aFamily Allowances
=550  \\$wg$aSocial Security
=667  \\$atreed under SOCIAL SECURITY; specify geog; DF: AFDC
=680  \\$iFinancial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S.
=688  \\$a78(75); was see under PUBLIC ASSISTANCE 1968-77
=750  \0$aAid to families with dependent children programs$5IEN$0(DLC)sh 89003862

=LDR  01318cz  a2200433n  4500
=001  9880363242602441
=005  20180416100607.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000383
=035  \\$aCAZ3531HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40
=150  \\$aAgriculture
=450  \\$wnnna$aAgricultural Development
=450  \\$wnnna$aDevelopment, Agricultural
=450  \\$wnnna$aLand Supplies
=450  \\$wnnna$aLand Supply
=450  \\$wnnna$aSupplies, Land
=450  \\$wnnna$aSupply, Land
=550  \\$wg$aTechnology, Industry, and Agriculture
=550  \\$wh$aAgricultural Irrigation
=550  \\$wh$aAnimal Husbandry
=550  \\$wh$aAquaculture
=550  \\$wh$aBeekeeping
=550  \\$wh$aBiological Control Agents
=550  \\$wh$aCrop Production
=550  \\$wh$aCrop Protection
=550  \\$wh$aDairying
=550  \\$wh$aDomestication
=550  \\$wh$aGardening
=550  \\$wh$aGardens
=550  \\$wh$aHydroponics
=550  \\$wh$aOrganic Agriculture
=550  \\$wh$aWeed Control
=550  \\$aAgricultural Inoculants
=667  \\$aSPEC: SPEC qualif
=680  \\$iThe science of soil cultivation, crop production, and livestock raising.
=750  \0$aAgriculturists$5IEN-M$0(DLC)sh 85002496
=750  \0$aAgriculture$5IEN-HS$0(DLC)sh 85002415

=LDR  02013cz  a2200433n  4500
=001  9880363242702441
=005  20141212194530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D000382
=035  \\$aCAZ3530HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC24.$x80
=150  \\$aAgricultural Workers' Diseases
=450  \\$wnnna$aAgricultural Worker Disease
=450  \\$wnnna$aAgricultural Worker Diseases
=450  \\$wnnna$aAgricultural Worker's Disease
=450  \\$wnnna$aAgricultural Workers Disease
=450  \\$wnnna$aAgricultural Workers' Disease
=450  \\$wnnna$aAgricultural Worker's Diseases
=450  \\$wnnna$aAgricultural Workers Diseases
=450  \\$wnnna$aDisease, Agricultural Worker
=450  \\$wnnna$aDisease, Agricultural Worker's
=450  \\$wnnna$aDisease, Agricultural Workers'
=450  \\$wnnna$aDiseases, Agricultural Worker
=450  \\$wnnna$aDiseases, Agricultural Worker's
=450  \\$wnnna$aDiseases, Agricultural Workers'
=450  \\$wnnna$aWorker Disease, Agricultural
=450  \\$wnnna$aWorker Diseases, Agricultural
=450  \\$wnnna$aWorker's Disease, Agricultural
=450  \\$wnnna$aWorkers' Disease, Agricultural
=450  \\$wnnna$aWorker's Diseases, Agricultural
=450  \\$wnnna$aWorkers' Diseases, Agricultural
=550  \\$wg$aOccupational Diseases
=550  \\$wh$aFarmer's Lung
=550  \\$wh$aSilo Filler's Disease
=550  \\$aRural Health
=667  \\$acoord IM with specific dis (IM); specify geog if pertinent
=680  \\$iDiseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.
=750  \0$aAgricultural laborers$xDiseases$5IEN$0(DLC)sh 85002339

=LDR  01501cz  a2200337n  4500
=001  9880363274402441
=005  20141212200628.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003915
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x577.$x249.$x200
=072  \\$aD3.$x549.$x686.$x212
=072  \\$aD3.$x605.$x497.$x212
=072  \\$aD4.$x615.$x723.$x795.$x200
=150  \\$aDextromethorphan
=450  \\$ad-Methorphan
=450  \\$wnnna$aDelsym
=450  \\$wnnna$aDextromethorphan, (+-)-Isomer
=450  \\$wnnna$aDextromethorphan Hydrobromide
=450  \\$wnnna$aDextromethorphan Hydrobromide, (+-)-Isomer
=450  \\$wnnna$aDextromethorphan Hydrobromide, Monohydrate
=450  \\$wnnna$aDextromethorphan Hydrochloride
=450  \\$wnnna$aHydrobromide, Dextromethorphan
=450  \\$wnnna$aHydrochloride, Dextromethorphan
=450  \\$wnnna$al-Methorphan
=450  \\$wnnna$aLevomethorphan
=450  \\$wnnna$aRacemethorphan
=550  \\$wg$aMorphinans
=680  \\$iMethyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
=688  \\$a91(72); was see under LEVORPHANOL 1972-90
=750  \0$aDextromethorphan$0(DLC)sh2007010731$5IEN-M

=LDR  00492cz  a2200169n  4500
=001  9880363274502441
=005  20141212200626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003912
=035  \\$aCAZ7038HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9.$x698.$x365.$x855.$x400
=150  \\$aDextrins
=550  \\$wg$aStarch
=550  \\$wh$aCyclodextrins
=688  \\$a91(75); was see under STARCH 1979-90; was see under POLYSACCHARIDES 1963-78
=750  \0$aDextrins$5IEN$0(DLC)sh 85037426

=LDR  01864cz  a2200589n  4500
=001  9880363274602441
=005  20141212200626.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003911
=035  \\$aCAZ7037HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x272
=072  \\$aD9.$x698.$x365.$x272
=150  \\$aDextrans
=450  \\$wnnna$aDextran
=450  \\$wnnna$aDextran 40
=450  \\$wnnna$aDextran 40000
=450  \\$wnnna$aDextran 70
=450  \\$wnnna$aDextran 75
=450  \\$wnnna$aDextran 80
=450  \\$wnnna$aDextran B-1355
=450  \\$wnnna$aDextran B 1355
=450  \\$wnnna$aDextran B-1355-S
=450  \\$wnnna$aDextran B 1355 S
=450  \\$wnnna$aDextran B1355
=450  \\$wnnna$aDextran B512
=450  \\$wnnna$aDextran Derivatives
=450  \\$wnnna$aDextran M 70
=450  \\$wnnna$aDextran T-40
=450  \\$wnnna$aDextran T 40
=450  \\$wnnna$aDextran T-500
=450  \\$wnnna$aDextran T 500
=450  \\$wnnna$aDextran T 70
=450  \\$wnnna$aHemodex
=450  \\$wnnna$aHyskon
=450  \\$wnnna$aInfukoll
=450  \\$wnnna$aMacrodex
=450  \\$wnnna$aPolyglucin
=450  \\$wnnna$aPromit
=450  \\$wnnna$aRheodextran
=450  \\$wnnna$aRheoisodex
=450  \\$wnnna$aRheomacrodex
=450  \\$wnnna$aRheopolyglucin
=450  \\$wnnna$aRondex
=450  \\$wnnna$aSaviosol
=550  \\$wg$aGlucans
=550  \\$wh$aDEAE-Dextran
=550  \\$wh$aDextran Sulfate
=550  \\$wh$aIron-Dextran Complex
=680  \\$iA group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
=688  \\$a79; was DEXTRAN 1963-78
=750  \0$aDextran$5IEN$0(DLC)sh 85037424

=LDR  00599cz  a2200217n  4500
=001  9880363274702441
=005  20141212200625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003910
=035  \\$aCAZ7036HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x283
=150  \\$aDextranase
=450  \\$wnnna$a447-G, Glucanase
=450  \\$wnnna$aEndo-Dextranase
=450  \\$wnnna$aEndo Dextranase
=450  \\$wnnna$aGlucanase 447-G
=450  \\$wnnna$aGlucanase 447 G
=550  \\$wg$aGlycoside Hydrolases
=688  \\$a73(71)
=750  \0$aDextranase$5IEN$0(DLC)sh 85037425

=LDR  02686cz  a2200673n  4500
=001  9880363274802441
=005  20141212200624.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003906
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x615.$x500.$x300
=150  \\$aDeveloping Countries
=450  \\$wnnna$aCountries, Developing
=450  \\$wnnna$aCountries, Least Developed
=450  \\$wnnna$aCountries, Less-Developed
=450  \\$wnnna$aCountries, Third-World
=450  \\$wnnna$aCountries, Under-Developed
=450  \\$wnnna$aCountry, Developing
=450  \\$wnnna$aCountry, Least Developed
=450  \\$wnnna$aCountry, Less-Developed
=450  \\$wnnna$aCountry, Third-World
=450  \\$wnnna$aCountry, Under-Developed
=450  \\$wnnna$aDeveloped Countries, Least
=450  \\$wnnna$aDeveloped Country, Least
=450  \\$wnnna$aDeveloping Country
=450  \\$wnnna$aDeveloping Nation
=450  \\$wnnna$aDeveloping Nations
=450  \\$wnnna$aLeast Developed Countries
=450  \\$wnnna$aLeast Developed Country
=450  \\$aLess-Developed Countries
=450  \\$wnnna$aLess Developed Countries
=450  \\$wnnna$aLess-Developed Country
=450  \\$wnnna$aLess-Developed Nation
=450  \\$wnnna$aLess-Developed Nations
=450  \\$wnnna$aLess Developed Nations
=450  \\$wnnna$aNation, Less-Developed
=450  \\$wnnna$aNation, Third-World
=450  \\$wnnna$aNation, Under-Developed
=450  \\$wnnna$aNations, Developing
=450  \\$wnnna$aNations, Less-Developed
=450  \\$wnnna$aNations, Third-World
=450  \\$wnnna$aNations, Under-Developed
=450  \\$aThird-World Countries
=450  \\$wnnna$aThird World Countries
=450  \\$wnnna$aThird-World Country
=450  \\$wnnna$aThird-World Nation
=450  \\$wnnna$aThird-World Nations
=450  \\$wnnna$aThird World Nations
=450  \\$aUnder-Developed Countries
=450  \\$wnnna$aUnder Developed Countries
=450  \\$wnnna$aUnder-Developed Country
=450  \\$wnnna$aUnder-Developed Nation
=450  \\$wnnna$aUnder-Developed Nations
=450  \\$wnnna$aUnder Developed Nations
=550  \\$wg$aInternational Cooperation
=667  \\$ado not confuse with DEVELOPED COUNTRIES; IM; specify country or countries if relevant
=680  \\$iCountries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.
=688  \\$a71
=750  \0$aDeveloping countries$5IEN-M$0(DLC)sh 85037341

=LDR  02460cz  a2200841n  4500
=001  9880363274902441
=005  20141212200623.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003904
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381
=150  \\$aMitosporic Fungi
=450  \\$wnnna$aDeuteromycete
=450  \\$aDeuteromycetes
=450  \\$aDeuteromycota
=450  \\$wnnna$aDeuteromycotas
=450  \\$aFungi imperfecti
=450  \\$wnnna$aFungi imperfectus
=450  \\$aFungi, Mitosporic
=450  \\$wnnna$aFungus, Mitosporic
=450  \\$wnnna$aHyphomycete
=450  \\$aHyphomycetes
=450  \\$wnnna$aimperfecti, Fungi
=450  \\$wnnna$aimperfectus, Fungi
=450  \\$wnnna$aMitosporic Fungus
=550  \\$wg$aFungi
=550  \\$wh$aAcremonium
=550  \\$wh$aAlternaria
=550  \\$wh$aAspergillus
=550  \\$wh$aBeauveria
=550  \\$wh$aBlastomyces
=550  \\$wh$aBotrytis
=550  \\$wh$aBrettanomyces
=550  \\$wh$aCandida
=550  \\$wh$aChrysosporium
=550  \\$wh$aCladosporium
=550  \\$wh$aCoccidioides
=550  \\$wh$aColletotrichum
=550  \\$wh$aCryptococcus
=550  \\$wh$aDuddingtonia
=550  \\$wh$aEpidermophyton
=550  \\$wh$aExophiala
=550  \\$wh$aFusarium
=550  \\$wh$aGeotrichum
=550  \\$wh$aGliocladium
=550  \\$wh$aHelminthosporium
=550  \\$wh$aHistoplasma
=550  \\$wh$aKloeckera
=550  \\$wh$aLacazia
=550  \\$wh$aMadurella
=550  \\$wh$aMalassezia
=550  \\$wh$aMetarhizium
=550  \\$wh$aMicrosporum
=550  \\$wh$aNeotyphodium
=550  \\$wh$aPaecilomyces
=550  \\$wh$aParacoccidioides
=550  \\$wh$aPenicillium
=550  \\$wh$aPhialophora
=550  \\$wh$aPyricularia grisea
=550  \\$wh$aRhizoctonia
=550  \\$wh$aRhodotorula
=550  \\$wh$aScedosporium
=550  \\$wh$aScopulariopsis
=550  \\$wh$aSporothrix
=550  \\$wh$aStachybotrys
=550  \\$wh$aTrichoderma
=550  \\$wh$aTrichophyton
=550  \\$wh$aTrichosporon
=550  \\$wh$aVerticillium
=667  \\$aGEN or unspecified; prefer specifics; infection = MYCOSES or specific mycosis (IM)
=680  \\$iA large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.
=688  \\$a99(73)
=750  \0$aFungi imperfecti$5IEN-M$0(DLC)sh 85052470

=LDR  00765cz  a2200241n  4500
=001  9880363275002441
=005  20141212200622.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003903
=035  \\$aCAZ7029HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x435.$x256
=072  \\$aD1.$x496.$x289
=150  \\$aDeuterium
=450  \\$aDeuterium Ions$5IEN
=450  \\$aDeuterons
=550  \\$wg$aHydrogen
=550  \\$wg$aIsotopes
=550  \\$wh$aDeuterium Oxide
=667  \\$aheavy hydrogen; HEAVY WATER see DEUTERIUM OXIDE is also available
=680  \\$iDeuterium. The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.
=750  \0$aDeuterium ions$5IEN-M$0(DLC)sh 85037317
=750  \0$aDeuterium$5IEN-HS$0(DLC)sh 85037316

=LDR  01067cz  a2200265n  4500
=001  9880363275102441
=005  20141212200621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003901
=035  \\$aCAZ7027HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x350
=072  \\$aB3.$x660.$x125.$x125
=072  \\$aB3.$x900.$x350
=150  \\$aDesulfovibrio
=550  \\$wg$aDeltaproteobacteria
=550  \\$wg$aGram-Negative Anaerobic Straight, Curved, and Helical Rods
=550  \\$wg$aSulfur-Reducing Bacteria
=550  \\$wh$aDesulfovibrio africanus
=550  \\$wh$aDesulfovibrio desulfuricans
=550  \\$wh$aDesulfovibrio gigas
=550  \\$wh$aDesulfovibrio vulgaris
=667  \\$ainfection: coord IM with DESULFOVIBRIONACEAE INFECTIONS (IM)
=680  \\$iA genus of gram-negative, anaerobic, rod-shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide. Organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces.
=750  \0$aDesulfovibrio$0(DLC) sh 94005996$5IEN-M

=LDR  01068cz  a2200193n  4500
=001  9880363275202441
=005  20141212200620.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003896
=035  \\$aCAZ7022HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x149.$x165.$x420.$x297
=150  \\$aDesmosomes
=450  \\$wnnna$aDesmosome
=550  \\$wg$aIntercellular Junctions
=667  \\$aA 11 qualif except /cytol; /genet permitted
=680  \\$iA type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
=688  \\$a72
=750  \0$aDesmosomes$0(DLC) sh 94007403$5IEN-M

=LDR  02703cz  a2200637n  4500
=001  9880363275302441
=005  20141212200619.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003894
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD6.$x472.$x699.$x631.$x692.$x781.$x100.$x250
=072  \\$aD12.$x644.$x400.$x900.$x100.$x250
=072  \\$aD12.$x644.$x456.$x925.$x100.$x250
=072  \\$aD12.$x644.$x548.$x691.$x692.$x781.$x100.$x250
=072  \\$aD12.$x776.$x641.$x650.$x937.$x100.$x250
=150  \\$aDeamino Arginine Vasopressin
=450  \\$wnnna$a1-Deamino-8-D-arginine Vasopressin
=450  \\$wnnna$a1-Desamino-8-arginine Vasopressin
=450  \\$wnnna$aAcetate, Desmopressin
=450  \\$wnnna$aAdiuretin
=450  \\$wnnna$aAdiuretin SD
=450  \\$wnnna$aApo-Desmopressin
=450  \\$wnnna$aApotex Brand of Deamino Arginine Vasopressin
=450  \\$wnnna$aArginine Vasopressin, Deamino
=450  \\$wnnna$aDDAVP
=450  \\$wnnna$aDesmogalen
=450  \\$aDesmopressin
=450  \\$wnnna$aDesmopressin Acetate
=450  \\$wnnna$aDesmopressin Monoacetate
=450  \\$wnnna$aDesmopressin Monoacetate, Trihydrate
=450  \\$wnnna$aDesmopressine Ferring
=450  \\$wnnna$aDesmospray
=450  \\$wnnna$aDesmotabs
=450  \\$wnnna$aFerring Brand 1 of Desmopressin Acetate
=450  \\$wnnna$aFerring Brand 2 of Desmopressin Acetate
=450  \\$wnnna$aFerring, Desmopressine
=450  \\$wnnna$aGalen Brand of Desmopressin Acetate
=450  \\$wnnna$aHoyer Brand of Desmopressin Acetate
=450  \\$wnnna$aIQFA Brand of Desmopressin Acetate
=450  \\$wnnna$aMinirin
=450  \\$wnnna$aMinurin
=450  \\$wnnna$aMonoacetate, Desmopressin
=450  \\$wnnna$aMonoacetate, Trihydrate Desmopressin
=450  \\$wnnna$aNocutil
=450  \\$wnnna$aNorgine Brand of Desmopressin Acetate
=450  \\$wnnna$aOctim
=450  \\$wnnna$aOctostim
=450  \\$wnnna$aTrihydrate Desmopressin Monoacetate
=450  \\$wnnna$aVasopressin, 1-Deamino-8-D-arginine
=450  \\$wnnna$aVasopressin, 1-Desamino-8-arginine
=450  \\$aVasopressin, Deamino Arginine
=550  \\$wg$aArginine Vasopressin
=680  \\$iA synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.
=688  \\$a86(79); was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Desmopressin
=750  \0$aDesmopressin$0(DLC) sh 93001848$5IEN-M

=LDR  01097cz  a2200253n  4500
=001  9880363275402441
=005  20201209104704.0
=008  880423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015198
=035  \\$aCAZ7016HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x200
=150  \\$aDesigner Drugs
=450  \\$aCustomized Drugs
=450  \\$wnnna$aDrugs, Customized
=450  \\$wnnna$aDrugs, Designer
=550  \\$wg$aPharmaceutical Preparations
=550  \\$aDrug Design
=550  \\$aIllicit Drugs
=550  \\$aSubstance-Related Disorders
=667  \\$aD25-26 qualif; coord IM with specific drug or chemical (IM); do not confuse with DRUG DESIGN
=680  \\$iDrugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
=688  \\$a89
=750  \0$aDesigner drugs$5IEN$0(DLC)sh 86006022

=LDR  00885cz  a2200229n  4500
=001  9880363275502441
=005  20141212200618.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003889
=035  \\$aCAZ7014HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG16.$x500.$x275.$x71.$x325
=072  \\$aN6.$x230.$x300.$x100.$x250.$x325
=150  \\$aDesert Climate
=450  \\$wnnna$aClimate, Desert
=450  \\$wnnna$aClimates, Desert
=450  \\$wnnna$aDesert Climates
=550  \\$wg$aClimate
=550  \\$aHot Temperature
=667  \\$aspecify geog if pertinent
=680  \\$iA type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=750  \0$aArid regions$5IEN$0(DLC)sh 85007141

=LDR  01136cz  a2200277n  4500
=001  9880363275602441
=005  20141212200617.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003887
=035  \\$aCAZ7012HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x754.$x137.$x506
=150  \\$aDesensitization, Psychologic
=450  \\$wnnna$aDesensitization, Psychological
=450  \\$wnnna$aDesensitization (Psychology)
=450  \\$wnnna$aDesensitizations (Psychology)
=450  \\$wnnna$aPsychologic Desensitization
=450  \\$wnnna$aPsychological Desensitization
=550  \\$wg$aBehavior Therapy
=550  \\$wh$aEye Movement Desensitization Reprocessing
=550  \\$wh$aImplosive Therapy
=550  \\$wh$aVirtual Reality Exposure Therapy
=667  \\$aa behavior ther technique; DF: DESENSITIZATION PSYCHOL
=680  \\$iA behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.
=688  \\$a95; was DESENSITIZATION (PSYCHOLOGY) 1975-94 (see under BEHAVIOR THERAPY 1975-90)
=750  \0$aDesensitization (Psychotherapy)$5IEN-M$0(DLC)sh 85037132

=LDR  01281cz  a2200361n  4500
=001  9880363275702441
=005  20141212200616.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003883
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x650.$x80
=150  \\$aArthrodermataceae
=450  \\$aArthroderma
=450  \\$wnnna$aArthrodermas
=450  \\$wnnna$aCtenomyce
=450  \\$aCtenomyces
=450  \\$wnnna$aCutaneous Fungi
=450  \\$wnnna$aCutaneous Fungus
=450  \\$wnnna$aDermatomyce
=450  \\$wnnna$aDermatomyces
=450  \\$wnnna$aDermatophyte
=450  \\$aDermatophytes
=450  \\$wnnna$aFungi, Cutaneous
=450  \\$wnnna$aFungus, Cutaneous
=450  \\$wnnna$aKeratinomyce
=450  \\$aKeratinomyces
=450  \\$wnnna$aNannizzia
=450  \\$wnnna$aNannizzias
=550  \\$wg$aOnygenales
=667  \\$ainfection = DERMATOMYCOSES
=680  \\$iA family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. Genera in the family include Arthroderma, Keratinomyces, and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.
=688  \\$a99; for ARTHRODERMA use ASCOMYCOTA 1975-98; for NANNIZZIA use MICROSPORUM 1975-98
=750  \0$aDermatophytes$5IEN$0(DLC)sh 85037103

=LDR  02235cz  a2200433n  4500
=001  9880363275802441
=005  20141212200615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003882
=035  \\$aCAZ7007HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x651.$x594.$x297
=072  \\$aC5.$x651.$x594.$x819.$x500
=072  \\$aC10.$x668.$x491.$x562.$x150
=072  \\$aC10.$x668.$x491.$x562.$x575.$x500
=072  \\$aC17.$x300.$x250
=072  \\$aC17.$x800.$x185
=150  \\$aDermatomyositis
=450  \\$wnnna$aAdult Type Dermatomyositides
=450  \\$wnnna$aAdult Type Dermatomyositis
=450  \\$wnnna$aChildhood Type Dermatomyositides
=450  \\$wnnna$aChildhood Type Dermatomyositis
=450  \\$wnnna$aDermatomyositides
=450  \\$wnnna$aDermatomyositides, Adult Type
=450  \\$wnnna$aDermatomyositides, Childhood Type
=450  \\$wnnna$aDermatomyositis, Adult Type
=450  \\$wnnna$aDermatomyositis, Childhood Type
=450  \\$wnnna$aDermatopolymyositides
=450  \\$wnnna$aDermatopolymyositis
=450  \\$wnnna$aPolymyositis-Dermatomyositides
=450  \\$aPolymyositis-Dermatomyositis
=450  \\$wnnna$aPolymyositis Dermatomyositis
=550  \\$wg$aConnective Tissue Diseases
=550  \\$wg$aMyositis
=550  \\$wg$aPolymyositis
=550  \\$wg$aSkin Diseases
=667  \\$acoord IM with PARANEOPLASTIC SYNDROMES (IM) if pertinent
=680  \\$iA subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
=750  \0$aDermatomyositis$5IEN$0(DLC)sh 85037096

=LDR  01355cz  a2200421n  4500
=001  9880363275902441
=005  20141212200615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003881
=035  \\$aCAZ7006HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x800.$x200
=072  \\$aC1.$x703.$x295
=072  \\$aC17.$x800.$x838.$x208
=150  \\$aDermatomycoses
=450  \\$wnnna$aDermatomycosis
=450  \\$wnnna$aFungal Skin Disease
=450  \\$wnnna$aFungal Skin Diseases
=450  \\$wnnna$aSkin Disease, Fungal
=450  \\$aSkin Diseases, Fungal
=550  \\$wg$aMycoses
=550  \\$wg$aSkin Diseases, Infectious
=550  \\$wh$aBlastomycosis
=550  \\$wh$aCandidiasis, Chronic Mucocutaneous
=550  \\$wh$aCandidiasis, Cutaneous
=550  \\$wh$aChromoblastomycosis
=550  \\$wh$aHyalohyphomycosis
=550  \\$wh$aLobomycosis
=550  \\$wh$aMycetoma
=550  \\$wh$aParacoccidioidomycosis
=550  \\$wh$aPhaeohyphomycosis
=550  \\$wh$aSporotrichosis
=550  \\$wh$aTinea
=550  \\$wh$aTinea Versicolor
=667  \\$afungus dis of skin; coord IM with specific fungus or fungal dis (IM)
=680  \\$iSuperficial infections of the skin or its appendages by any of various fungi.
=688  \\$a77; was DERMATOMYCOSIS 1963-76
=750  \0$aDermatomycoses$5IEN$0(DLC)sh 85037095

=LDR  01051cz  a2200301n  4500
=001  9880363276002441
=005  20141212200613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003878
=035  \\$aCAZ7005HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x256
=072  \\$aI1.$x198.$x780.$x937.$x343
=150  \\$aDermatoglyphics
=450  \\$wnnna$aDermatoglyphic
=450  \\$wnnna$aFingerprint
=450  \\$aFingerprints
=450  \\$wnnna$aPlantar Print
=450  \\$aPlantar Prints
=450  \\$wnnna$aPrint, Plantar
=450  \\$wnnna$aPrints, Plantar
=550  \\$wg$aForensic Medicine
=550  \\$wg$aInvestigative Techniques
=550  \\$aBiometric Identification
=680  \\$iThe study of the patterns of ridges of the skin of the fingers, palms, toes, and soles.
=688  \\$a66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78
=750  \0$aDermatoglyphics$5IEN-M$0(DLC)sh 85037084
=750  \0$aFingerprints$5IEN-HS$0(DLC)sh 85048337

=LDR  01505cz  a2200397n  4500
=001  9880363276102441
=005  20141212200613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003877
=035  \\$aCAZ7004HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x255
=072  \\$aC17.$x800.$x815.$x255
=150  \\$aDermatitis, Contact
=450  \\$wnnna$aContact Dermatitides
=450  \\$aContact Dermatitis
=450  \\$wnnna$aContact Eczema
=450  \\$wnnna$aContact Hypersensitivities
=450  \\$wnnna$aContact Hypersensitivity
=450  \\$wnnna$aContact Sensitivities
=450  \\$wnnna$aContact Sensitivity
=450  \\$wnnna$aDermatitides, Contact
=450  \\$aDermatitis Venenata
=450  \\$aEczema, Contact
=450  \\$wnnna$aHypersensitivities, Contact
=450  \\$aHypersensitivity, Contact
=450  \\$wnnna$aSensitivities, Contact
=450  \\$aSensitivity, Contact
=550  \\$wg$aDermatitis
=550  \\$wg$aSkin Diseases, Eczematous
=550  \\$wh$aDermatitis, Allergic Contact
=550  \\$wh$aDermatitis, Irritant
=550  \\$wh$aDermatitis, Occupational
=667  \\$aunspecified as allergic or non-allergic but DERMATITIS, ALLERGIC CONTACT is available
=680  \\$iA type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.
=750  \0$aContact dermatitis$5IEN$0(DLC)sh 85031501

=LDR  01795cz  a2200433n  4500
=001  9880363276202441
=005  20141212200613.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003876
=035  \\$aCAZ7003HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x850.$x210
=072  \\$aC17.$x800.$x174.$x193
=072  \\$aC17.$x800.$x815.$x193
=072  \\$aC17.$x800.$x827.$x210
=072  \\$aC20.$x543.$x480.$x343
=150  \\$aDermatitis, Atopic
=450  \\$wnnna$aAtopic Dermatitides
=450  \\$wnnna$aAtopic Dermatitis
=450  \\$wnnna$aAtopic Eczema
=450  \\$wnnna$aAtopic Neurodermatitides
=450  \\$wnnna$aAtopic Neurodermatitis
=450  \\$wnnna$aDermatitides, Atopic
=450  \\$wnnna$aDisseminated Neurodermatitides
=450  \\$wnnna$aDisseminated Neurodermatitis
=450  \\$aEczema, Atopic
=450  \\$aEczema, Infantile
=450  \\$wnnna$aInfantile Eczema
=450  \\$wnnna$aNeurodermatitides, Atopic
=450  \\$wnnna$aNeurodermatitides, Disseminated
=450  \\$aNeurodermatitis, Atopic
=450  \\$aNeurodermatitis, Disseminated
=550  \\$wg$aDermatitis
=550  \\$wg$aHypersensitivity, Immediate
=550  \\$wg$aSkin Diseases, Eczematous
=550  \\$wg$aSkin Diseases, Genetic
=667  \\$aa type of immediate hypersensitivity
=680  \\$iA chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
=750  \0$aAtopic dermatitis$5IEN$0(DLC)sh 85009343

=LDR  02328cz  a2200589n  4500
=001  9880363276302441
=005  20141212200612.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003875
=035  \\$aCAZ7002HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x600
=072  \\$aC20.$x543.$x206.$x380
=072  \\$aC25.$x100.$x468.$x380
=150  \\$aDrug Eruptions
=450  \\$aDermatitis, Adverse Drug Reaction
=450  \\$aDermatitis Medicamentosa
=450  \\$wnnna$aDrug Eruption
=450  \\$wnnna$aDrug Eruption, Maculopapular
=450  \\$wnnna$aDrug Eruptions, Maculopapular
=450  \\$wnnna$aDrug Reaction, Morbilliform
=450  \\$wnnna$aDrug Reactions, Morbilliform
=450  \\$wnnna$aEruption, Drug
=450  \\$wnnna$aEruption, Maculopapular Drug
=450  \\$wnnna$aEruptions, Drug
=450  \\$wnnna$aEruptions, Maculopapular Drug
=450  \\$wnnna$aExanthem, Maculopapular
=450  \\$wnnna$aExanthem, Morbilliform
=450  \\$wnnna$aExanthems, Maculopapular
=450  \\$wnnna$aExanthems, Morbilliform
=450  \\$wnnna$aMaculopapular Drug Eruption
=450  \\$wnnna$aMaculopapular Drug Eruptions
=450  \\$wnnna$aMaculopapular Exanthem
=450  \\$wnnna$aMaculopapular Exanthems
=450  \\$wnnna$aMorbilliform Drug Reaction
=450  \\$wnnna$aMorbilliform Drug Reactions
=450  \\$wnnna$aMorbilliform Exanthem
=450  \\$wnnna$aMorbilliform Exanthems
=450  \\$wnnna$aReaction, Morbilliform Drug
=450  \\$wnnna$aReactions, Morbilliform Drug
=550  \\$wg$aDermatitis
=550  \\$wg$aDrug Hypersensitivity
=550  \\$wh$aAcute Generalized Exanthematous Pustulosis
=550  \\$wh$aDrug Hypersensitivity Syndrome
=550  \\$wh$aErythema Nodosum
=550  \\$wh$aHand-Foot Syndrome
=550  \\$wh$aNicolau Syndrome
=550  \\$wh$aSerum Sickness
=550  \\$wh$aStevens-Johnson Syndrome
=680  \\$iAdverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.
=688  \\$a93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74
=750  \0$aDrug-exanthems$5IEN$0(DLC)sh 85039698

=LDR  01220cz  a2200277n  4500
=001  9880363276402441
=005  20141212200611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003874
=035  \\$aCAZ7001HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x360
=072  \\$aC17.$x800.$x865.$x360
=072  \\$aC20.$x111.$x318
=150  \\$aDermatitis Herpetiformis
=450  \\$wnnna$aDisease, Duhring
=450  \\$wnnna$aDisease, Duhring's
=450  \\$wnnna$aDuhring Disease
=450  \\$aDuhring's Disease
=450  \\$wnnna$aDuhrings Disease
=550  \\$wg$aAutoimmune Diseases
=550  \\$wg$aDermatitis
=550  \\$wg$aSkin Diseases, Vesiculobullous
=667  \\$aa bullous skin dis: nothing to do with herpes
=680  \\$iRare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.
=750  \0$aDermatitis herpetiformis$5IEN$0(DLC)sh 85037083

=LDR  01037cz  a2200337n  4500
=001  9880363276502441
=005  20141212200611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003872
=035  \\$aCAZ6999HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174
=150  \\$aDermatitis
=450  \\$wnnna$aDermatitides
=550  \\$wg$aSkin Diseases
=550  \\$wh$aAcrodermatitis
=550  \\$wh$aDandruff
=550  \\$wh$aDermatitis, Atopic
=550  \\$wh$aDermatitis, Contact
=550  \\$wh$aDermatitis, Exfoliative
=550  \\$wh$aDermatitis Herpetiformis
=550  \\$wh$aDermatitis, Perioral
=550  \\$wh$aDermatitis, Seborrheic
=550  \\$wh$aDrug Eruptions
=550  \\$wh$aEczema
=550  \\$wh$aIntertrigo
=550  \\$wh$aNeurodermatitis
=550  \\$wh$aRadiodermatitis
=667  \\$aany skin inflamm; /chem ind = DERMATITIS MEDICAMENTOSA see DRUG ERUPTIONS or DERMATITIS, CONTACT
=680  \\$iAny inflammation of the skin.
=750  \0$aSkin$xInflammation$5IEN$0(DLC)sh 85123181

=LDR  01065cz  a2200277n  4500
=001  9880363549502441
=005  20170117102000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004569
=035  \\$aCAZ7706HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x300
=072  \\$aE1.$x370.$x405.$x245
=150  \\$aElectroencephalography
=450  \\$aEEG
=450  \\$wnnna$aElectroencephalogram
=450  \\$wnnna$aElectroencephalograms
=550  \\$wg$aDiagnostic Techniques, Neurological
=550  \\$wg$aElectrodiagnosis
=550  \\$wh$aBrain Waves
=550  \\$wh$aElectrocorticography
=550  \\$wh$aElectroencephalography Phase Synchronization
=550  \\$aCerebral Cortex
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: note short X ref
=680  \\$iRecording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.
=750  \0$aElectroencephalography$5IEN$0(DLC)sh 85042138

=LDR  01186cz  a2200325n  4500
=001  9880363549602441
=005  20141212201011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004568
=035  \\$aCAZ7705HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x405
=150  \\$aElectrodiagnosis
=450  \\$aElectricity$xdiagnostic use
=450  \\$wnnna$aElectrodiagnoses
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$wh$aElectrocardiography
=550  \\$wh$aElectroencephalography
=550  \\$wh$aElectrokymography
=550  \\$wh$aElectromyography
=550  \\$wh$aElectronystagmography
=550  \\$wh$aElectrooculography
=550  \\$wh$aElectrophysiologic Techniques, Cardiac
=550  \\$wh$aElectroretinography
=550  \\$wh$aMagnetocardiography
=550  \\$wh$aMagnetoencephalography
=550  \\$wh$aPlethysmography, Impedance
=667  \\$aIM; do not use /util except by MeSH definition
=680  \\$iDiagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue.
=750  \0$aElectrodiagnosis$5IEN$0(DLC)sh 85042132

=LDR  00931cz  a2200301n  4500
=001  9880363549702441
=005  20141212201010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004566
=035  \\$aCAZ7703HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x250
=150  \\$aElectrodes
=450  \\$aAnode
=450  \\$wnnna$aAnodes
=450  \\$aCathode
=450  \\$wnnna$aCathodes
=450  \\$wnnna$aElectrode
=550  \\$wg$aElectrical Equipment and Supplies
=550  \\$wh$aDefibrillators
=550  \\$wh$aElectrodes, Implanted
=550  \\$wh$aIon-Selective Electrodes
=550  \\$wh$aMicroelectrodes
=550  \\$wh$aPacemaker, Artificial
=667  \\$aNIM
=680  \\$iElectric conductors through which electric currents enter or leave a medium, whether it be an electrolytic solution, solid, molten mass, gas, or vacuum.
=688  \\$a72(68)
=750  \0$aElectrodes$5IEN$0(DLC)sh 85042110

=LDR  01752cz  a2200445n  4500
=001  9880363549802441
=005  20141212201010.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004565
=035  \\$aCAZ7702HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x570.$x200.$x583
=072  \\$aF4.$x669.$x224.$x300
=150  \\$aElectroconvulsive Therapy
=450  \\$wnnna$aConvulsive Therapies, Electric
=450  \\$aConvulsive Therapy, Electric
=450  \\$aECT (Psychotherapy)
=450  \\$wnnna$aElectric Convulsive Therapies
=450  \\$wnnna$aElectric Convulsive Therapy
=450  \\$wnnna$aElectric Shock Therapies
=450  \\$wnnna$aElectric Shock Therapy
=450  \\$wnnna$aElectroconvulsive Therapies
=450  \\$wnnna$aElectroshock Therapies
=450  \\$aElectroshock Therapy
=450  \\$wnnna$aShock Therapies, Electric
=450  \\$aShock Therapy, Electric
=450  \\$wnnna$aTherapies, Electric Convulsive
=450  \\$wnnna$aTherapies, Electric Shock
=450  \\$wnnna$aTherapies, Electroconvulsive
=450  \\$wnnna$aTherapies, Electroshock
=450  \\$wnnna$aTherapy, Electric Convulsive
=450  \\$wnnna$aTherapy, Electric Shock
=450  \\$wnnna$aTherapy, Electroconvulsive
=450  \\$wnnna$aTherapy, Electroshock
=550  \\$wg$aConvulsive Therapy
=550  \\$wg$aElectroshock
=667  \\$aa psychotherapy technique: do not confuse with ELECTROCONVULSIVE SHOCK, an experimental tool
=680  \\$iElectrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA.
=688  \\$a81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67
=750  \0$aElectroconvulsive therapy$5IEN$0(DLC)sh 85041999

=LDR  01176cz  a2200301n  4500
=001  9880363549902441
=005  20141212201009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004564
=035  \\$aCAZ7701HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x154.$x402
=072  \\$aE4.$x14.$x170.$x402
=150  \\$aElectrocoagulation
=450  \\$aDiathermy, Surgical
=450  \\$aElectrocautery
=450  \\$aEndocavitary Fulguration
=450  \\$wnnna$aFulguration, Endocavitary
=450  \\$aGalvanocautery
=450  \\$aSurgical Diathermy
=450  \\$aThermocoagulation
=550  \\$wg$aCautery
=550  \\$wh$aArgon Plasma Coagulation
=550  \\$wh$aCatheter Ablation
=550  \\$aCautery
=667  \\$acoordinate with organ or disease /surg; DF: ELECTROCOAG
=680  \\$iProcedures using an electrically heated wire or scalpel to treat hemorrhage (e.g., bleeding ulcers) and to ablate tumors, mucosal lesions, and refractory arrhythmias. It is different from ELECTROSURGERY which is used more for cutting tissue than destroying and in which the patient is part of the electric circuit.
=750  \0$aElectrocoagulation$5IEN$0(DLC)sh 85042107

=LDR  00644cz  a2200193n  4500
=001  9880363550002441
=005  20141212201009.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004563
=035  \\$aCAZ7700HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x181.$x529.$x307
=150  \\$aElectrochemistry
=450  \\$wnnna$aElectrochemistries
=550  \\$wg$aChemistry, Physical
=667  \\$aNIM with no qualif; when IM, SPEC qualif
=680  \\$iThe study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes.
=688  \\$a66
=750  \0$aElectrochemistry$0(DLC) sh 85042105$5IEN

=LDR  01165cz  a2200301n  4500
=001  9880363550102441
=005  20141212201008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004562
=035  \\$aCAZ7699HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x370.$x380.$x240
=072  \\$aE1.$x370.$x405.$x240
=150  \\$aElectrocardiography
=450  \\$aECG
=450  \\$aEKG
=450  \\$wnnna$aElectrocardiogram
=450  \\$wnnna$aElectrocardiograms
=450  \\$wnnna$aElectrocardiograph
=450  \\$wnnna$aElectrocardiographs
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aHeart Function Tests
=550  \\$wh$aBody Surface Potential Mapping
=550  \\$wh$aElectrocardiography, Ambulatory
=550  \\$wh$aVectorcardiography
=550  \\$aHeart
=680  \\$iRecording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.
=750  \0$aElectrocardiography$0(DLC) sh 85042098$5IEN-M

=LDR  01978cz  a2200469n  4500
=001  9880363550202441
=005  20141212192150.0
=008  830613\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004561
=035  \\$aCAZ7698HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x342.$x800
=072  \\$aE2.$x779.$x468.$x800
=072  \\$aE3.$x91.$x823
=150  \\$aTranscutaneous Electric Nerve Stimulation
=450  \\$aAnalgesic Cutaneous Electrostimulation
=450  \\$wnnna$aCutaneous Electrostimulation, Analgesic
=450  \\$aElectric Stimulation, Transcutaneous
=450  \\$wnnna$aElectrical Stimulation, Transcutaneous
=450  \\$aElectroanalgesia
=450  \\$wnnna$aElectrostimulation, Analgesic Cutaneous
=450  \\$wnnna$aElectrostimulation, Transdermal
=450  \\$wnnna$aNerve Stimulation, Transcutaneous
=450  \\$aPercutaneous Electric Nerve Stimulation
=450  \\$wnnna$aPercutaneous Electrical Nerve Stimulation
=450  \\$wnnna$aStimulation, Transcutaneous Electric
=450  \\$wnnna$aStimulation, Transcutaneous Electrical
=450  \\$wnnna$aStimulation, Transcutaneous Nerve
=450  \\$aTENS
=450  \\$wnnna$aTranscutaneous Electric Stimulation
=450  \\$wnnna$aTranscutaneous Electrical Nerve Stimulation
=450  \\$wnnna$aTranscutaneous Electrical Stimulation
=450  \\$wnnna$aTranscutaneous Nerve Stimulation
=450  \\$aTransdermal Electrostimulation
=550  \\$wg$aAnalgesia
=550  \\$wg$aElectric Stimulation Therapy
=550  \\$wh$aElectroacupuncture
=550  \\$aTranscranial Direct Current Stimulation
=667  \\$ado not confuse with ELECTRONARCOSIS
=680  \\$iThe use of specifically placed small electrodes to deliver electrical impulses across the SKIN to relieve PAIN. It is used less frequently to produce ANESTHESIA.
=688  \\$a90; was ELECTROANALGESIA see under ELECTROTHERAPY 1984-89
=750  \0$aTranscutaneous electrical nerve stimulation$5IEN$0(DLC)sh 85136890

=LDR  00835cz  a2200217n  4500
=001  9880363550302441
=005  20141212201008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004560
=035  \\$aCAZ7697HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x249
=150  \\$aElectricity
=550  \\$wg$aElectromagnetic Phenomena
=550  \\$wh$aElectric Capacitance
=550  \\$wh$aElectric Conductivity
=550  \\$wh$aStatic Electricity
=667  \\$a/adv eff: consider also ELECTRIC INJURIES; shock: experimental shock by electricity = ELECTROSHOCK; do not confuse with ELECTRIC INJURIES or ELECTROCONVULSIVE THERAPY
=680  \\$iThe physical effects involving the presence of electric charges at rest and in motion.
=688  \\$awas in Cat H only 1963-81
=750  \0$aElectricity$5IEN-M$0(DLC)sh 85042065

=LDR  00644cz  a2200205n  4500
=001  9880363550402441
=005  20141212201008.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004559
=035  \\$aCAZ7696HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x305.$x245
=150  \\$aElectric Wiring
=450  \\$wnnna$aElectrical Wiring
=450  \\$wnnna$aWiring, Electric
=450  \\$wnnna$aWiring, Electrical
=550  \\$wg$aElectrical Equipment and Supplies
=680  \\$iAn arrangement of wires distributing electricity.
=688  \\$a91(Aug 77); was see under ELECTRICITY 1977-90
=750  \0$aElectric wiring$5IEN$0(DLC)sh 85042056

=LDR  00959cz  a2200289n  4500
=001  9880363550502441
=005  20141212201008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004558
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x723.$x402
=150  \\$aElectric Stimulation
=450  \\$wnnna$aElectric Stimulations
=450  \\$wnnna$aElectrical Stimulation
=450  \\$wnnna$aElectrical Stimulations
=450  \\$aStimulation, Electric
=450  \\$wnnna$aStimulation, Electrical
=450  \\$wnnna$aStimulations, Electric
=450  \\$wnnna$aStimulations, Electrical
=550  \\$wg$aPhysical Stimulation
=550  \\$wh$aChronaxy
=550  \\$wh$aElectroshock
=550  \\$aDeep Brain Stimulation
=667  \\$aNIM; used therapeutically = ELECTRIC STIMULATION THERAPY
=680  \\$iUse of electric potential or currents to elicit biological responses.
=688  \\$a65(64)
=750  \0$aElectric stimulation$5IEN$0(DLC)sh 85042004

=LDR  01201cz  a2200301n  4500
=001  9880363550602441
=005  20141212201007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004556
=035  \\$aCAZ7693HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x324
=150  \\$aElectric Injuries
=450  \\$wnnna$aAccidental Electrocution
=450  \\$wnnna$aAccidental Electrocutions
=450  \\$wnnna$aElectric Injury
=450  \\$aElectrocution, Accidental
=450  \\$wnnna$aElectrocutions, Accidental
=450  \\$wnnna$aInjuries, Electric
=450  \\$wnnna$aInjury, Electric
=550  \\$wg$aWounds and Injuries
=550  \\$wh$aBurns, Electric
=550  \\$wh$aConducted Energy Weapon Injuries
=550  \\$wh$aLightning Injuries
=667  \\$aconsider also BURNS, ELECTRIC; accidental shock by electricity is ELECTRIC INJURIES, not ELECTROSHOCK (for exper shock by electricity usually in psychol lit)
=680  \\$iInjuries caused by electric currents. The concept excludes electric burns (BURNS, ELECTRIC), but includes accidental electrocution and electric shock.
=688  \\$a73; was ELECTRIC INJURY 1963-72
=750  \0$aElectrical injuries$5IEN$0(DLC)sh 85042073

=LDR  01502cz  a2200421n  4500
=001  9880363550702441
=005  20141212201006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004554
=035  \\$aCAZ7691HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x342.$x287
=150  \\$aElectric Countershock
=450  \\$aCardiac Electroversion
=450  \\$wnnna$aCardiac Electroversions
=450  \\$aCardioversion
=450  \\$wnnna$aCardioversions
=450  \\$wnnna$aCountershock, Electric
=450  \\$wnnna$aCountershocks, Electric
=450  \\$aDefibrillation, Electric
=450  \\$wnnna$aDefibrillations, Electric
=450  \\$wnnna$aElectric Countershocks
=450  \\$wnnna$aElectric Defibrillation
=450  \\$wnnna$aElectric Defibrillations
=450  \\$aElectroversion, Cardiac
=450  \\$wnnna$aElectroversion Therapies
=450  \\$wnnna$aElectroversion Therapy
=450  \\$wnnna$aElectroversions, Cardiac
=450  \\$wnnna$aTherapies, Electroversion
=450  \\$wnnna$aTherapy, Electroversion
=550  \\$wg$aElectric Stimulation Therapy
=550  \\$aArrhythmias, Cardiac
=550  \\$aDefibrillators
=550  \\$aElectric Stimulation
=667  \\$a/instrum: consider also DEFIBRILLATORS or DEFIBRILLATORS, IMPLANTABLE
=680  \\$iAn electrical current applied to the HEART to terminate a disturbance of its rhythm, ARRHYTHMIAS, CARDIAC. (Stedman, 25th ed)
=688  \\$a65(63)
=750  \0$aElectric countershock$5IEN$0(DLC)sh 85041634

=LDR  00671cz  a2200217n  4500
=001  9880363550802441
=005  20141212201006.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004553
=035  \\$aCAZ7690HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x358.$x500.$x249.$x277
=150  \\$aElectric Conductivity
=450  \\$wnnna$aConductivity, Electric
=450  \\$wnnna$aConductivity, Electrical
=450  \\$wnnna$aElectrical Conductivity
=550  \\$wg$aElectricity
=550  \\$wh$aElectric Impedance
=680  \\$iThe ability of a substrate to allow the passage of ELECTRONS.
=688  \\$a68
=750  \0$aElectric conductivity$5IEN$0(DLC)sh 85041621

=LDR  00805cz  a2200253n  4500
=001  9880363550902441
=005  20141212201005.0
=008  830606\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004552
=035  \\$aCAZ7689HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x350.$x390
=072  \\$aI1.$x880.$x735.$x900.$x350.$x390
=150  \\$aElder Abuse
=450  \\$wnnna$aAbuse, Aged
=450  \\$wnnna$aAbuse, Elder
=450  \\$aAged Abuse
=450  \\$aElder Neglect
=450  \\$wnnna$aNeglect, Elder
=550  \\$wg$aDomestic Violence
=667  \\$acheck also tag AGED
=680  \\$iEmotional, nutritional, or physical maltreatment of the older person generally by family members or by institutional personnel.
=688  \\$a84
=750  \0$aAged$xAbuse of$0(DLC) sh 85002088$5IEN

=LDR  00726cz  a2200229n  4500
=001  9880363551002441
=005  20141212201005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004551
=035  \\$aCAZ7688HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x583.$x290
=150  \\$aElbow Joint
=450  \\$wnnna$aElbow Joints
=450  \\$wnnna$aJoint, Elbow
=450  \\$wnnna$aJoints, Elbow
=550  \\$wg$aJoints
=550  \\$aOlecranon Process
=667  \\$aprimates only; differentiate from ELBOW; Manual 21.58: use FORELIMB (probably IM) + JOINTS (NIM) for non-primate vertebrates
=680  \\$iA hinge joint connecting the FOREARM to the ARM.
=688  \\$a65
=750  \0$aElbow$5IEN$0(DLC)sh 85041533

=LDR  00487cz  a2200157n  4500
=001  9880363551102441
=005  20141212201005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004550
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x378.$x800.$x420
=150  \\$aElbow
=450  \\$wnnna$aElbows
=550  \\$wg$aUpper Extremity
=667  \\$aprimates only; differentiation from ELBOW JOINT; Manual 21.58: use FORELIMB for non-primate vertebrates
=750  \0$aElbow$5IEN$0(DLC)sh 85041533

=LDR  00759cz  a2200277n  4500
=001  9880363551202441
=005  20141212201005.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004549
=035  \\$aCAZ7686HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD5.$x750.$x78.$x421
=072  \\$aD12.$x776.$x860.$x300.$x350
=150  \\$aElastin
=450  \\$wnnna$aalpha-Elastin
=450  \\$wnnna$aalpha Elastin
=450  \\$wnnna$akappa-Elastin
=450  \\$wnnna$akappa Elastin
=550  \\$wg$aBiopolymers
=550  \\$wg$aExtracellular Matrix Proteins
=550  \\$wh$aTropoelastin
=550  \\$aElastomers
=550  \\$aWilliams Syndrome
=667  \\$a/biosyn /physiol permitted
=688  \\$a66(63)
=750  \0$aElastin$5IEN$0(DLC)sh 85041518

=LDR  00637cz  a2200229n  4500
=001  9880363551302441
=005  20141212201004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004548
=035  \\$aCAZ7685HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x374.$x590
=150  \\$aElasticity
=550  \\$wg$aMechanical Phenomena
=550  \\$wh$aCompliance
=550  \\$wh$aElastic Modulus
=550  \\$aElastic Modulus
=550  \\$aElastomers
=667  \\$aof inanimate or living structures
=680  \\$iResistance and recovery from distortion of shape.
=688  \\$a67(64)
=750  \0$aElasticity$0(DLC) sh 85041516$5IEN

=LDR  00795cz  a2200241n  4500
=001  9880363551402441
=005  20141212201004.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004547
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x400
=150  \\$aElastic Tissue
=450  \\$wnnna$aElastic Fiber
=450  \\$aElastic Fibers
=450  \\$wnnna$aElastic Tissues
=450  \\$wnnna$aFiber, Elastic
=450  \\$wnnna$aFibers, Elastic
=450  \\$wnnna$aTissue, Elastic
=450  \\$wnnna$aTissues, Elastic
=550  \\$wg$aConnective Tissue
=667  \\$aELASTIC CARTILAGE is also available
=680  \\$iConnective tissue comprised chiefly of elastic fibers. Elastic fibers have two components: ELASTIN and MICROFIBRILS.
=750  \0$aElastic tissue$5IEN$0(DLC)sh 85041513

=LDR  00596cz  a2200181n  4500
=001  9880363551502441
=005  20141212201003.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004542
=035  \\$aCAZ7679HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG8.$x686.$x785.$x760.$x84
=150  \\$aEjaculation
=450  \\$wnnna$aEjaculations
=550  \\$wg$aReproduction
=550  \\$aPremature Ejaculation
=680  \\$iThe emission of SEMEN to the exterior, resulting from the contraction of muscles surrounding the male internal urogenital ducts.
=750  \0$aEjaculation$5IEN$0(DLC)sh 88007627

=LDR  00771cz  a2200193n  4500
=001  9880363551602441
=005  20141212201002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004539
=035  \\$aCAZ7676HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x43.$x75.$x189.$x250.$x250.$x250
=150  \\$aEimeria
=450  \\$wnnna$aEimerias
=550  \\$wg$aEimeriidae
=550  \\$wh$aEimeria tenella
=667  \\$ainfection: coordinate IM with COCCIDIOSIS (IM); coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc) if pertinent
=680  \\$iA genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals.
=750  \0$aEimeria$5IEN$0(DLC)sh 88021321

=LDR  00906cz  a2200265n  4500
=001  9880363551702441
=005  20141212201002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004538
=035  \\$aCAZ7675HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x593.$x292
=150  \\$aEidetic Imagery
=450  \\$wnnna$aEidetic Imageries
=450  \\$wnnna$aImageries, Eidetic
=450  \\$wnnna$aImagery, Eidetic
=450  \\$wnnna$aMemories, Photographic
=450  \\$aMemory, Photographic
=450  \\$wnnna$aPhotographic Memories
=450  \\$wnnna$aPhotographic Memory
=550  \\$wg$aPerception
=667  \\$aa form of perception
=680  \\$iA visual image which is recalled in accurate detail. It is a sort of projection of an image on a mental screen.
=688  \\$aPHOTOGRAPHIC MEMORY was see under EIDETIC IMAGERY 1969-78
=750  \0$aEidetic imagery$5IEN$0(DLC)sh 85041379

=LDR  00566cz  a2200205n  4500
=001  9880363551802441
=005  20141212201002.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004537
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD10.$x251.$x220
=150  \\$aEicosanoic Acids
=450  \\$wnnna$aAcids, Arachidic
=450  \\$wnnna$aAcids, Eicosanoic
=450  \\$aArachidic Acids
=550  \\$wg$aFatty Acids
=667  \\$afatty acids
=680  \\$i20-carbon saturated monocarboxylic acids.
=688  \\$a75
=750  \0$aEicosanoic acid$5IEN$0(DLC)sh 85006363

=LDR  00944cz  a2200241n  4500
=001  9880363551902441
=005  20141212201002.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004536
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x40.$x287
=072  \\$aB3.$x660.$x50.$x20.$x287
=150  \\$aEhrlichia
=450  \\$aCowdria
=450  \\$aEhrlichia ewingii
=550  \\$wg$aAnaplasmataceae
=550  \\$wh$aEhrlichia canis
=550  \\$wh$aEhrlichia chaffeensis
=550  \\$wh$aEhrlichia ruminantium
=667  \\$ainfection = EHRLICHIOSIS
=680  \\$iSmall, often pleomorphic, coccoid to ellipsoidal organisms occurring intracytoplasmically in circulating LYMPHOCYTES. They are the etiologic agents of tick-borne diseases of humans; DOGS; CATTLE; SHEEP; GOATS; and HORSES.
=688  \\$a91(73)63-65; was see under RICKETTSIACEAE 1973-90 (Prov 1973-75); was heading 1963-65
=750  \0$aEhrlichia$5IEN-M$0(DLC)sh 90000734

=LDR  02377cz  a2200565n  4500
=001  9880363552002441
=005  20141212201001.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004535
=035  \\$aCAZ7672HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x454.$x240
=072  \\$aC15.$x378.$x463.$x515.$x240
=072  \\$aC16.$x131.$x831.$x428
=072  \\$aC16.$x320.$x850.$x260
=072  \\$aC17.$x300.$x200.$x310
=072  \\$aC17.$x800.$x804.$x428
=072  \\$aC17.$x800.$x827.$x260
=150  \\$aEhlers-Danlos Syndrome
=450  \\$aCutis Elastica
=450  \\$wnnna$aDanlos Disease, Ehlers
=450  \\$wnnna$aDisease, Ehlers Danlos
=450  \\$wnnna$aDisease, Ehlers-Danlos
=450  \\$wnnna$aEDS IV
=450  \\$wnnna$aEhlers Danlos Disease
=450  \\$wnnna$aEhlers-Danlos Disease
=450  \\$wnnna$aEhlers Danlos Syndrome
=450  \\$wnnna$aEhlers Danlos Syndrome, Arterial Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Arterial Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Ecchymotic Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Ecchymotic Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Sack-Barabas Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Sack-Barabas Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Sack Barabas Type
=450  \\$wnnna$aEhlers Danlos Syndrome Type 4, Autosomal Dominant
=450  \\$wnnna$aEhlers-Danlos Syndrome, Type IV
=450  \\$wnnna$aEhlers Danlos Syndrome, Type IV
=450  \\$wnnna$aEhlers-Danlos Syndrome, Type IV, Autosomal Dominant
=450  \\$wnnna$aEhlers-Danlos Syndrome, Vascular Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Vascular Type
=450  \\$wnnna$aSyndrome, Ehlers-Danlos
=550  \\$wg$aCollagen Diseases
=550  \\$wg$aHemostatic Disorders
=550  \\$wg$aSkin Abnormalities
=550  \\$wg$aSkin Diseases, Genetic
=550  \\$aCutis Laxa
=550  \\$aLoeys-Dietz Syndrome
=550  \\$aReticulin
=680  \\$iA heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
=750  \0$aEhlers-Danlos syndrome$5IEN$0(DLC)sh 85041368

=LDR  00947cz  a2200241n  4500
=001  9880363552102441
=005  20141212201000.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004532
=035  \\$aCAZ7669HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x747.$x189
=072  \\$aF2.$x739.$x794.$x206
=150  \\$aEgo
=450  \\$wnnna$aEgos
=450  \\$aSelf
=550  \\$wg$aPersonality Development
=550  \\$wg$aPsychoanalytic Theory
=550  \\$wh$aReality Testing
=667  \\$ano qualif; egocentrism: index DEFENSE MECHANISMS
=680  \\$iThe conscious portion of the personality structure which serves to mediate between the demands of the primitive instinctual drives, (the id), of internalized parental and social prohibitions or the conscience, (the superego), and of reality.
=688  \\$a68; SELF was heading 1965-68, was see under PERSONALITY 1963-64
=750  \0$aEgo (Psychology)$5IEN-M$0(DLC)sh 85041254

=LDR  00843cz  a2200217n  4500
=001  9880363552202441
=005  20141212200959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004531
=035  \\$aCAZ7668HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x470
=150  \\$aEggs
=550  \\$wg$aFood
=550  \\$wh$aEgg Proteins, Dietary
=550  \\$wh$aEgg White
=550  \\$wh$aEgg Yolk
=550  \\$aPoultry Products
=667  \\$adifferentiate from OVUM; eggs as food (chicken, duck, quail, etc. eggs); fish roe & reptile eggs as food go here but if physiol or anat, use OVUM; /adv eff consider also EGG HYPERSENSITIVITY
=680  \\$iAnimal reproductive bodies, or the contents thereof, used as food. The concept is differentiated from OVUM, the anatomic or physiologic entity.
=750  \0$aEggs$5IEN$0(DLC)sh 85041229

=LDR  00781cz  a2200241n  4500
=001  9880363552302441
=005  20141212200959.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004530
=035  \\$aCAZ7667M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x690.$x325
=072  \\$aJ2.$x500.$x470.$x800
=150  \\$aEgg Yolk
=450  \\$wnnna$aEgg Yolks
=450  \\$wnnna$aYolk, Egg
=450  \\$wnnna$aYolks, Egg
=550  \\$wg$aEggs
=550  \\$wg$aOvum
=667  \\$afor both ovum nutrient & dietary portion of eggs
=680  \\$iCytoplasm stored in an egg that contains nutritional reserves for the developing embryo. It is rich in polysaccharides, lipids, and proteins.
=688  \\$awas in Cat J only 1963-76
=750  \0$aEgg yolk$0(DLC) sh2005020321$5IEN-M

=LDR  00944cz  a2200241n  4500
=001  9880363552402441
=005  20141212200958.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004525
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x612.$x380
=150  \\$aEfferent Pathways
=450  \\$wnnna$aEfferent Pathway
=450  \\$aMotor Pathways
=450  \\$wnnna$aPathway, Efferent
=450  \\$wnnna$aPathways, Efferent
=550  \\$wg$aNeural Pathways
=550  \\$wh$aExtrapyramidal Tracts
=550  \\$wh$aPyramidal Tracts
=667  \\$acoord NIM with origin (IM) + termination (IM)
=680  \\$iNerve structures through which impulses are conducted from a nerve center toward a peripheral site. Such impulses are conducted via efferent neurons (NEURONS, EFFERENT), such as MOTOR NEURONS, autonomic neurons, and hypophyseal neurons.
=688  \\$a76; was NON MESH before 1976
=750  \0$aEfferent pathways$5IEN$0(DLC)sh 85041194

=LDR  01007cz  a2200313n  4500
=001  9880363552602441
=005  20200401180052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004522
=035  \\$aCAZ7658HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x196
=150  \\$aEducational Status
=450  \\$aAcademic Achievement$5IEN
=450  \\$wnnna$aAchievement, Educational
=450  \\$wnnna$aAchievements, Educational
=450  \\$aEducational Achievement
=450  \\$wnnna$aEducational Achievements
=450  \\$wnnna$aEducational Status, Maternal
=450  \\$wnnna$aMaternal Educational Status
=450  \\$wnnna$aStatus, Educational
=450  \\$wnnna$aStatus, Maternal Educational
=550  \\$wg$aSocioeconomic Factors
=550  \\$wh$aAcademic Failure
=550  \\$wh$aLiteracy
=667  \\$aNIM; no qualif
=680  \\$iEducational attainment or level of education of individuals.
=688  \\$a68
=750  \0$aEducational attainment$0(DLC) sh2004014924$5IEN-M

=LDR  01443cz  a2200385n  4500
=001  9880363552702441
=005  20141212200957.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004521
=035  \\$aCAZ7657HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x399
=150  \\$aEducational Measurement
=450  \\$aAssessment, Educational
=450  \\$wnnna$aAssessments, Educational
=450  \\$wnnna$aEducational Assessment
=450  \\$wnnna$aEducational Assessments
=450  \\$wnnna$aEducational Measurements
=450  \\$aEducational Tests and Measurements$5IEN
=450  \\$wnnna$aExamination, Graduate Records
=450  \\$wnnna$aExaminations, Graduate Records
=450  \\$aGraduate Records Examination
=450  \\$wnnna$aGraduate Records Examinations
=450  \\$wnnna$aMeasurement, Educational
=450  \\$wnnna$aMeasurements, Educational
=550  \\$wg$aEducation
=550  \\$wh$aCollege Admission Test
=550  \\$wh$aProfessional Competence
=550  \\$wh$aSchool Admission Criteria
=550  \\$wh$aSelf-Evaluation Programs
=550  \\$wh$aTest Taking Skills
=667  \\$aDF: EDUC MEASUREMENT
=680  \\$iThe assessing of academic or educational achievement. It includes all aspects of testing and test construction.
=688  \\$a66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82
=750  \0$aEducational tests and measurements$5IEN$0(DLC)sh 85041154

=LDR  00760cz  a2200241n  4500
=001  9880363552802441
=005  20141212200956.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004520
=035  \\$aCAZ7656HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x588
=150  \\$aEducation, Veterinary
=450  \\$wnnna$aEducations, Veterinary
=450  \\$aVeterinarians$xeducation
=450  \\$aVeterinary Education
=450  \\$wnnna$aVeterinary Educations
=450  \\$aVeterinary Medicine$xeducation
=550  \\$wg$aEducation, Professional
=667  \\$aDF: EDUC VET
=680  \\$iUse for general articles concerning veterinary medical education.
=688  \\$a74
=750  \0$aVeterinary medicine$xStudy and teaching$5IEN$0(DLC)sh 85143051

=LDR  00982cz  a2200277n  4500
=001  9880363552902441
=005  20201209133625.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004519
=035  \\$aCAZ7655HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x233.$x213
=150  \\$aEducation, Special
=450  \\$wnnna$aEducations, Special
=450  \\$wnnna$aSpecial Education
=450  \\$wnnna$aSpecial Educations
=550  \\$wg$aEducation, Nonprofessional
=550  \\$wh$aEducation of Hearing Disabled
=550  \\$wh$aEducation of Intellectually Disabled
=550  \\$wh$aEducation of Visually Disabled
=550  \\$wh$aMainstreaming, Education
=550  \\$aDisabled Persons
=667  \\$aIM
=680  \\$iEducation of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction.
=688  \\$a68(66)
=750  \0$aSpecial education$5IEN$0(DLC)sh 85046212

=LDR  01114cz  a2200337n  4500
=001  9880363553002441
=005  20190124114442.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004517
=035  \\$aCAZ7653HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358
=150  \\$aEducation, Professional
=450  \\$wnnna$aProfessional Education
=550  \\$wg$aEducation
=550  \\$wh$aClinical Clerkship
=550  \\$wh$aEducation, Continuing
=550  \\$wh$aEducation, Dental
=550  \\$wh$aEducation, Graduate
=550  \\$wh$aEducation, Medical
=550  \\$wh$aEducation, Nursing
=550  \\$wh$aEducation, Pharmacy
=550  \\$wh$aEducation, Public Health Professional
=550  \\$wh$aEducation, Veterinary
=550  \\$wh$aInternship, Nonmedical
=550  \\$wh$aMentoring
=550  \\$wh$aTeacher Training
=667  \\$aGEN or unspecified; prefer specifics; DF: EDUC PROFESSIONAL
=680  \\$iFormal education and training in preparation for the practice of a profession.
=688  \\$a98; use explode 1975-97
=750  \0$aProfessional education$5IEN-M$0(DLC)sh 85107250

=LDR  00609cz  a2200205n  4500
=001  9880363553102441
=005  20141212200955.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004516
=035  \\$aCAZ7652HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x316
=150  \\$aEducation, Premedical
=450  \\$aPremedical Education
=450  \\$aStudents, Premedical$xeducation
=550  \\$wg$aEducation
=667  \\$aDF: EDUC PREMED
=680  \\$iPreparatory education meeting the requirements for admission to medical school.
=688  \\$a66
=750  \0$aPremedical education$5IEN$0(DLC)sh 85106323

=LDR  01089cz  a2200313n  4500
=001  9880363553202441
=005  20141212200954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004512
=035  \\$aCAZ7648HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x525
=150  \\$aEducation, Pharmacy
=450  \\$wnnna$aEducation, Pharmaceutic
=450  \\$wnnna$aEducation, Pharmaceutical
=450  \\$wnnna$aPharmaceutic Education
=450  \\$wnnna$aPharmaceutical Education
=450  \\$aPharmacists$xeducation
=450  \\$aPharmacy Education
=450  \\$aPharmacy$xeducation
=450  \\$aStudents, Pharmacy$xeducation
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Pharmacy, Continuing
=550  \\$wh$aEducation, Pharmacy, Graduate
=550  \\$wh$aPharmacy Residencies
=550  \\$aPharmacy
=667  \\$aDF: EDUC PHARM
=680  \\$iFormal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.
=750  \0$aPharmacy$xStudy and teaching$5IEN$0(DLC)sh 85100610

=LDR  01257cz  a2200289n  4500
=001  9880363553302441
=005  20141212200954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004511
=035  \\$aCAZ7647HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x337.$x450
=072  \\$aI2.$x358.$x462.$x565
=150  \\$aEducation, Nursing, Graduate
=450  \\$wnnna$aEducation, Graduate Nursing
=450  \\$aEducation, Nursing, Postgraduate
=450  \\$wnnna$aEducation, Postgraduate Nursing
=450  \\$wnnna$aGraduate Nursing Education
=450  \\$aNursing Education, Graduate
=450  \\$aNursing Education, Postgraduate
=450  \\$aPostgraduate Nursing Education
=550  \\$wg$aEducation, Graduate
=550  \\$wg$aEducation, Nursing
=667  \\$adifferentiate from EDUCATION, NURSING, CONTINUING: see note on EDUCATION, CONTINUING; leads to MS or PhD; DF: EDUC NURS GRAD
=680  \\$iThose educational activities engaged in by holders of a bachelor's degree in nursing, which are primarily designed to prepare them for entrance into a specific field of nursing, and may lead to board certification or a more advanced degree.
=688  \\$a66
=750  \0$aNursing$xStudy and teaching (Graduate)$5IEN$0(DLC)sh 97000137

=LDR  01065cz  a2200265n  4500
=001  9880363553402441
=005  20141212200953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004510
=035  \\$aCAZ7646HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x462.$x482
=150  \\$aEducation, Nursing, Diploma Programs
=450  \\$wnnna$aDiploma Program, Nursing
=450  \\$wnnna$aDiploma Programs, Nursing
=450  \\$wnnna$aNursing Diploma Program
=450  \\$wnnna$aNursing Diploma Programs
=450  \\$aNursing Education, Diploma Programs
=450  \\$wnnna$aProgram, Nursing Diploma
=450  \\$wnnna$aPrograms, Nursing Diploma
=550  \\$wg$aEducation, Nursing
=667  \\$a2-3-yr program in hosp school of nurs; DF: EDUC NURS DIPLOMA PROGRAMS
=680  \\$iPrograms usually offered in hospital schools of nursing leading to a registered nurse diploma (RN). Graduates are eligible for state examination for licensure as RN (Registered Nurse).
=688  \\$a67
=750  \0$aNursing$xStudy and teaching (Higher)$5IEN$0(IEN)367451

=LDR  01569cz  a2200385n  4500
=001  9880363553502441
=005  20141212200953.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004509
=035  \\$aCAZ7645HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x212.$x450
=072  \\$aI2.$x358.$x462.$x399
=150  \\$aEducation, Nursing, Continuing
=450  \\$wnnna$aContinuing Nursing Education
=450  \\$wnnna$aEducation, Continuing Nursing
=450  \\$aEducation, Nursing, Post-Basic
=450  \\$aEducation, Nursing, Post-Registration
=450  \\$wnnna$aEducation, Post-Basic Nursing
=450  \\$wnnna$aEducation, Post-Registration Nursing
=450  \\$aNursing Education, Continuing
=450  \\$aNursing Education, Post-Basic
=450  \\$wnnna$aNursing Education, Post Basic
=450  \\$aNursing Education, Post-Registration
=450  \\$wnnna$aNursing Education, Post Registration
=450  \\$aPost-Basic Nursing Education
=450  \\$wnnna$aPost Basic Nursing Education
=450  \\$aPost-Registration Nursing Education
=450  \\$wnnna$aPost Registration Nursing Education
=550  \\$wg$aEducation, Continuing
=550  \\$wg$aEducation, Nursing
=667  \\$adifferentiate from EDUCATION, NURSING, GRADUATE: see note on EDUCATION, CONTINUING; special courses, workshops, etc.; DF: EDUC NURS CONTINUING
=680  \\$iEducational programs designed to inform nurses of recent advances in their fields.
=688  \\$a66
=750  \0$aNursing$xStudy and teaching (Continuing education)$5IEN$0(DLC)sh 85093384

=LDR  01167cz  a2200265n  4500
=001  9880363553602441
=005  20141212200952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004508
=035  \\$aCAZ7644HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x462.$x316
=150  \\$aEducation, Nursing, Baccalaureate
=450  \\$wnnna$aBaccalaureate Nursing Education
=450  \\$wnnna$aBaccalaureate Nursing Educations
=450  \\$wnnna$aEducation, Baccalaureate Nursing
=450  \\$wnnna$aEducations, Baccalaureate Nursing
=450  \\$aExternal Degree Programs, Nursing
=450  \\$aNursing Education, Baccalaureate
=450  \\$wnnna$aNursing Educations, Baccalaureate
=550  \\$wg$aEducation, Nursing
=667  \\$a4-yr program leading to BS; DF: EDUC NURS BACCALAUREATE
=680  \\$iA four-year program in nursing education in a college or university leading to a B.S.N. (Bachelor of Science in Nursing). Graduates are eligible for state examination for licensure as RN (Registered Nurse).
=688  \\$a71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70
=750  \0$aNursing$xStudy and teaching (Higher)$5IEN$0(IEN)367451

=LDR  01120cz  a2200253n  4500
=001  9880363553702441
=005  20141212200952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004507
=035  \\$aCAZ7643HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x462.$x233
=150  \\$aEducation, Nursing, Associate
=450  \\$wnnna$aAssociate Nursing Education
=450  \\$wnnna$aAssociate Nursing Educations
=450  \\$wnnna$aEducation, Associate Nursing
=450  \\$wnnna$aEducations, Associate Nursing
=450  \\$aNursing Education, Associate
=450  \\$wnnna$aNursing Educations, Associate
=550  \\$wg$aEducation, Nursing
=667  \\$a2-yr community or junior college program; DF: EDUC NURS ASSOCIATE
=680  \\$iA two-year program in nursing education in a community or junior college leading to an A.D. (Associate Degree). Graduates of this program are eligible for state examination for licensure as RN (Registered Nurse).
=688  \\$a71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70
=750  \0$aNursing$xStudy and teaching (Associate degree)$5IEN$0(DLC)sh 85093383

=LDR  01121cz  a2200337n  4500
=001  9880363553802441
=005  20141212200952.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004506
=035  \\$aCAZ7642HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x462
=150  \\$aEducation, Nursing
=450  \\$wnnna$aEducations, Nursing
=450  \\$aNurses$xeducation
=450  \\$aNursing Care$xeducation
=450  \\$aNursing Education
=450  \\$aNursing$xeducation
=450  \\$wnnna$aNursing Educations
=450  \\$aStudents, Nursing$xeducation
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Nursing, Associate
=550  \\$wh$aEducation, Nursing, Baccalaureate
=550  \\$wh$aEducation, Nursing, Continuing
=550  \\$wh$aEducation, Nursing, Diploma Programs
=550  \\$wh$aEducation, Nursing, Graduate
=550  \\$wh$aNursing Education Research
=550  \\$aNursing
=667  \\$aGEN: prefer specific; DF: EDUC NURS
=680  \\$iUse for general articles concerning nursing education.
=750  \0$aNursing$xStudy and teaching$5IEN$0(DLC)sh 85093380

=LDR  01191cz  a2200241n  4500
=001  9880363553902441
=005  20141212200951.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004503
=035  \\$aCAZ7639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x337.$x350
=072  \\$aI2.$x358.$x399.$x350
=150  \\$aEducation, Medical, Graduate
=450  \\$wnnna$aEducation, Graduate Medical
=450  \\$wnnna$aGraduate Medical Education
=450  \\$aMedical Education, Graduate
=550  \\$wg$aEducation, Graduate
=550  \\$wg$aEducation, Medical
=667  \\$adifferentiate from EDUCATION, MEDICAL, CONTINUING: see note on EDUCATION, CONTINUING; Manual 34.22; DF: EDUC MED GRAD
=680  \\$iEducational programs for medical graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree.
=688  \\$a66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65
=750  \0$aMedicine$xStudy and teaching (Graduate)$5IEN$0(DLC)sh 97000133

=LDR  01049cz  a2200241n  4500
=001  9880363554002441
=005  20141212200950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004502
=035  \\$aCAZ7638HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x212.$x350
=072  \\$aI2.$x358.$x399.$x250
=150  \\$aEducation, Medical, Continuing
=450  \\$wnnna$aContinuing Medical Education
=450  \\$wnnna$aEducation, Continuing Medical
=450  \\$aMedical Education, Continuing
=550  \\$wg$aEducation, Continuing
=550  \\$wg$aEducation, Medical
=667  \\$adifferentiate from EDUCATION, MEDICAL, GRADUATE: see note on EDUCATION, CONTINUING; DF: EDUC MED CONTINUING
=680  \\$iEducational programs designed to inform physicians of recent advances in their field.
=688  \\$a66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING & EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65
=750  \0$aMedicine$xStudy and teaching (Continuing education)$5IEN$0(DLC)sh 97000135

=LDR  00942cz  a2200289n  4500
=001  9880363554102441
=005  20141212200950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004501
=035  \\$aCAZ7637HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x399
=150  \\$aEducation, Medical
=450  \\$aMedical Education
=450  \\$aMedicine$xeducation
=450  \\$aPhysicians$xeducation
=450  \\$aPhysicians, Women$xeducation
=450  \\$aStudents, Medical$xeducation
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Medical, Continuing
=550  \\$wh$aEducation, Medical, Graduate
=550  \\$wh$aEducation, Medical, Undergraduate
=550  \\$wh$aInternship and Residency
=550  \\$aMedicine
=667  \\$aManual 19.8.28, 30.7.4, 34.16; DF: EDUC MED
=680  \\$iUse for general articles concerning medical education.
=750  \0$aMedical education$5IEN-M$0(DLC)sh 85082916

=LDR  01055cz  a2200265n  4500
=001  9880363554202441
=005  20141212200950.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004500
=035  \\$aCAZ7636HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x337
=150  \\$aEducation, Graduate
=450  \\$wnnna$aEducations, Graduate
=450  \\$wnnna$aGraduate Education
=450  \\$wnnna$aGraduate Educations
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Dental, Graduate
=550  \\$wh$aEducation, Medical, Graduate
=550  \\$wh$aEducation, Nursing, Graduate
=550  \\$wh$aEducation, Pharmacy, Graduate
=667  \\$adifferentiate from EDUCATION, CONTINUING: see note on EDUCATION, CONTINUING; DF: EDUC GRAD
=680  \\$iStudies beyond the bachelor's degree at an institution having graduate programs for the purpose of preparing for entrance into a specific field, and obtaining a higher degree.
=688  \\$a70(67)
=750  \0$aUniversities and colleges$xGraduate work$5IEN$0(DLC)sh 85141124

=LDR  01110cz  a2200229n  4500
=001  9880363554302441
=005  20141212200949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004499
=035  \\$aCAZ7635HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x274.$x482
=072  \\$aI2.$x358.$x337.$x249
=150  \\$aEducation, Dental, Graduate
=450  \\$aDental Education, Graduate
=450  \\$wnnna$aGraduate Dental Education
=550  \\$wg$aEducation, Dental
=550  \\$wg$aEducation, Graduate
=667  \\$adifferentiate from EDUCATION, DENTAL, CONTINUING: see note on EDUCATION, CONTINUING; DF: EDUC DENT GRAD
=680  \\$iEducational programs for dental graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree.
=688  \\$a66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965
=750  \0$aDentistry$xStudy and teaching (Graduate)$5IEN$0(IEN)367449

=LDR  01188cz  a2200277n  4500
=001  9880363554402441
=005  20141212200949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004498
=035  \\$aCAZ7634HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x212.$x249
=072  \\$aI2.$x358.$x274.$x316
=150  \\$aEducation, Dental, Continuing
=450  \\$wnnna$aContinuing Dental Education
=450  \\$wnnna$aContinuing Dental Educations
=450  \\$aDental Education, Continuing
=450  \\$wnnna$aDental Educations, Continuing
=450  \\$wnnna$aEducation, Continuing Dental
=450  \\$wnnna$aEducations, Continuing Dental
=550  \\$wg$aEducation, Continuing
=550  \\$wg$aEducation, Dental
=667  \\$adifferentiate from EDUCATION, DENTAL, GRADUATE: see note on EDUCATION, CONTINUING; DF: EDUC DENT CONTINUING
=680  \\$iEducational programs designed to inform dentists of recent advances in their fields.
=688  \\$a66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING & EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965
=750  \0$aDentistry$xStudy and teaching (Continuing education)$5IEN$0(IEN)367448

=LDR  00820cz  a2200265n  4500
=001  9880363554502441
=005  20141212200949.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004497
=035  \\$aCAZ7633HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x274
=150  \\$aEducation, Dental
=450  \\$aDental Education
=450  \\$aDentistry$xeducation
=450  \\$aDentists$xeducation
=450  \\$aDentists, Women$xeducation
=450  \\$aStudents, Dental$xeducation
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Dental, Continuing
=550  \\$wh$aEducation, Dental, Graduate
=550  \\$aDentistry
=667  \\$aDF: EDUC DENT
=680  \\$iUse for articles concerning dental education in general.
=750  \0$aDentistry$xStudy and teaching$5IEN$0(DLC)sh 85036962

=LDR  01232cz   2200265n  4500
=001  9880363554602441
=005  20230831155615.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004496
=035  \\$aCAZ7632HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2.$x358.$x212
=150  \\$aEducation, Continuing
=450  \\$wnnna$aContinuing Education
=550  \\$wg$aEducation, Professional
=550  \\$wh$aEducation, Dental, Continuing
=550  \\$wh$aEducation, Medical, Continuing
=550  \\$wh$aEducation, Nursing, Continuing
=550  \\$wh$aEducation, Pharmacy, Continuing
=550  \\$wh$aEducation, Professional, Retraining
=667  \\$aformal or informal courses to advance or update knowledge: differentiate from EDUCATION, GRADUATE: formal prep for specialty training or advanced study leading to official certification or degree; includes refresher courses; DF: EDUC CONTINUING
=680  \\$iEducational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing.
=688  \\$a66
=750  \0$aContinuing education$5IEN$0(DLC)sh 85031562
=750  \0$iNarrower mapping$aMicrocredentials$0(DLC)sh2022005942$4NM$5IEN-M

=LDR  01398cz   2200349n  4500
=001  9880363554702441
=005  20220303085026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004495
=035  \\$aCAZ7631HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x629.$x375
=072  \\$aI2.$x233.$x213.$x400
=150  \\$aEducation of Intellectually Disabled
=450  \\$wnnna$aDisabled Education, Intellectually
=450  \\$wnnna$aDisabled Educations, Intellectually
=450  \\$wnnna$aEducation, Mentally Retarded
=450  \\$aEducation of Mentally Defective
=450  \\$aEducation of Mentally Retarded
=450  \\$aIntellectual Disability$xeducation
=450  \\$wnnna$aIntellectually Disabled Education
=450  \\$wnnna$aIntellectually Disabled Educations
=450  \\$wnnna$aMentally Defective Education
=450  \\$aPersons with Mental Disabilities$xeducation
=450  \\$wnnna$aMentally Retarded Education
=550  \\$wg$aEducation, Special
=550  \\$wg$aPsychology, Educational
=550  \\$aIntellectual Disability
=680  \\$iThe teaching or training of those individuals with subnormal intellectual functioning.
=688  \\$a67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Education of Mentally Retarded
=750  \0$aPeople with mental disabilities$xEducation$0(DLC) sh 85083670$5IEN

=LDR  01630cz  a2200505n  4500
=001  9880363554802441
=005  20181214143158.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004493
=035  \\$aCAZ7629HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI2
=150  \\$aEducation
=450  \\$wnnna$aActivities, Educational
=450  \\$wnnna$aActivity, Educational
=450  \\$wnnna$aEducational Activities
=450  \\$wnnna$aEducational Activity
=450  \\$wnnna$aLiteracy Program
=450  \\$aLiteracy Programs
=450  \\$wnnna$aProgram, Literacy
=450  \\$wnnna$aProgram, Training
=450  \\$wnnna$aPrograms, Literacy
=450  \\$wnnna$aPrograms, Training
=450  \\$aStudents$xeducation
=450  \\$wnnna$aTraining Program
=450  \\$aTraining Programs
=450  \\$wnnna$aWorkshop
=450  \\$wnnna$aWorkshops
=550  \\$wh$aCurriculum
=550  \\$wh$aEducation, Distance
=550  \\$wh$aEducation, Nonprofessional
=550  \\$wh$aEducation, Predental
=550  \\$wh$aEducation, Premedical
=550  \\$wh$aEducation, Professional
=550  \\$wh$aEducational Measurement
=550  \\$wh$aInservice Training
=550  \\$wh$aInterdisciplinary Placement
=550  \\$wh$aInternational Educational Exchange
=550  \\$wh$aMentoring
=550  \\$wh$aNeeds Assessment
=550  \\$wh$aSchools
=550  \\$wh$aTeaching
=667  \\$ageneral only; prefer /educ: Manual 19.7+, 19.8.28; policy: Manual 30.7+
=680  \\$iAcquisition of knowledge as a result of instruction in a formal course of study.
=750  \0$aEducation$5IEN$0(DLC)sh 85040989

=LDR  03343cz  a2200913n  4500
=001  9880363554902441
=005  20141212192149.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004492
=035  \\$aCAZ7628HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x782.$x258.$x368.$x250
=072  \\$aD2.$x241.$x81.$x18.$x253
=150  \\$aEdetic Acid
=450  \\$wnnna$aAcid, Edetic
=450  \\$wnnna$aAcid, Ethylenediaminetetraacetic
=450  \\$wnnna$aAcid, Ethylenedinitrilotetraacetic
=450  \\$wnnna$aCalcitetracemate, Disodium
=450  \\$wnnna$aCalcium Disodium Edetate
=450  \\$wnnna$aCalcium Disodium Versenate
=450  \\$wnnna$aCalcium Tetacine
=450  \\$wnnna$aChelaton 3
=450  \\$wnnna$aChromium EDTA
=450  \\$wnnna$aCopper EDTA
=450  \\$wnnna$aCoprin
=450  \\$wnnna$aDicobalt EDTA
=450  \\$wnnna$aDinitrilotetraacetate, Disodium Ethylene
=450  \\$wnnna$aDinitrilotetraacetate, Ethylene
=450  \\$wnnna$aDisodium Calcitetracemate
=450  \\$wnnna$aDisodium EDTA
=450  \\$wnnna$aDisodium Ethylene Dinitrilotetraacetate
=450  \\$wnnna$aDisodium Versenate, Calcium
=450  \\$wnnna$aDistannous EDTA
=450  \\$aEdathamil
=450  \\$wnnna$aEdetate, Calcium Disodium
=450  \\$wnnna$aEdetate Disodium Calcium
=450  \\$aEdetates
=450  \\$wnnna$aEdetic Acid, Calcium Salt
=450  \\$wnnna$aEdetic Acid, Calcium, Sodium Salt
=450  \\$wnnna$aEdetic Acid, Chromium Salt
=450  \\$wnnna$aEdetic Acid, Dipotassium Salt
=450  \\$wnnna$aEdetic Acid, Disodium, Magnesium Salt
=450  \\$wnnna$aEdetic Acid, Disodium, Monopotassium Salt
=450  \\$wnnna$aEdetic Acid, Disodium Salt
=450  \\$wnnna$aEdetic Acid, Disodium Salt, Dihydrate
=450  \\$wnnna$aEdetic Acid, Magnesium Salt
=450  \\$wnnna$aEdetic Acid, Monopotassium Salt
=450  \\$wnnna$aEdetic Acid, Monosodium Salt
=450  \\$wnnna$aEdetic Acid, Potassium Salt
=450  \\$wnnna$aEdetic Acid, Sodium Salt
=450  \\$aEDTA
=450  \\$wnnna$aEDTA, Chromium
=450  \\$wnnna$aEDTA, Copper
=450  \\$wnnna$aEDTA, Dicobalt
=450  \\$wnnna$aEDTA, Disodium
=450  \\$wnnna$aEDTA, Distannous
=450  \\$wnnna$aEDTA, Gallium
=450  \\$wnnna$aEDTA, Magnesium Disodium
=450  \\$wnnna$aEDTA, Potassium
=450  \\$wnnna$aEDTA, Stannous
=450  \\$wnnna$aEthylene Dinitrilotetraacetate
=450  \\$wnnna$aEthylene Dinitrilotetraacetate, Disodium
=450  \\$aEthylenediaminetetraacetic Acid
=450  \\$wnnna$aEthylenedinitrilotetraacetic Acid
=450  \\$wnnna$aGallium EDTA
=450  \\$wnnna$aMagnesium Disodium EDTA
=450  \\$wnnna$aN,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)
=450  \\$wnnna$aPotassium EDTA
=450  \\$wnnna$aStannous EDTA
=450  \\$wnnna$aTetacine, Calcium
=450  \\$aTetracemate
=450  \\$wnnna$aVersenate
=450  \\$wnnna$aVersenate, Calcium Disodium
=450  \\$wnnna$aVersene
=550  \\$wg$aAcetates
=550  \\$wg$aEthylenediamines
=680  \\$iA chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive.
=688  \\$a92(63)
=750  \0$aEthylenediaminetetraacetic acid$5IEN-M$0(DLC)sh 85045443

=LDR  00930cz  a2200229n  4500
=001  9880363555102441
=005  20141212200945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004487
=035  \\$aCAZ7623HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x277
=150  \\$aEdema
=450  \\$wnnna$aAnasarca
=450  \\$aDropsy
=450  \\$aHydrops
=550  \\$wg$aSigns and Symptoms
=550  \\$wh$aEdema, Cardiac
=550  \\$wh$aHydrops Fetalis
=667  \\$ageneral: prefer specifics; coordinate IM with organ/diseases term (IM); egg-white edema: coordinate IM with OVALBUMIN (NIM if indexed at all); EPH (Edema, Proteinuria, Hypertension) = GESTOSIS, EPH & do not index under EDEMA unless it is particularly discussed
=680  \\$iAbnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
=750  \0$aEdema$5IEN$0(DLC)sh 85040948

=LDR  00980cz  a2200265n  4500
=001  9880363555202441
=005  20141212200945.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004485
=035  \\$aCAZ7621HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x174.$x620
=072  \\$aC17.$x800.$x815.$x620
=150  \\$aEczema
=450  \\$wnnna$aDermatitides, Eczematous
=450  \\$aDermatitis, Eczematous
=450  \\$wnnna$aEczemas
=450  \\$wnnna$aEczematous Dermatitides
=450  \\$wnnna$aEczematous Dermatitis
=550  \\$wg$aDermatitis
=550  \\$wg$aSkin Diseases, Eczematous
=550  \\$wh$aEczema, Dyshidrotic
=667  \\$aan indistinct concept: check text for more specific skin dis; if more specific term is not in text, do not make a diagnosis: index here
=680  \\$iA pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).
=750  \0$aEczema$5IEN$0(DLC)sh 85040936

=LDR  01079cz  a2200277n  4500
=001  9880363555302441
=005  20141212200943.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004478
=035  \\$aCAZ7614HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x858.$x211
=150  \\$aEctoparasitic Infestations
=450  \\$wnnna$aEctoparasitic Infestation
=450  \\$wnnna$aInfestation, Ectoparasitic
=450  \\$wnnna$aInfestations, Ectoparasitic
=550  \\$wg$aSkin Diseases, Parasitic
=550  \\$wh$aFlea Infestations
=550  \\$wh$aLice Infestations
=550  \\$wh$aMite Infestations
=550  \\$wh$aMyiasis
=550  \\$wh$aTick Infestations
=667  \\$ageneral only: prefer specifics; coordinate IM with ectoparasite (IM); refers to ectoparasite on or within the skin so do not coordinate with SKIN DISEASES, PARASITIC
=680  \\$iInfestations by PARASITES which live on, or burrow into, the surface of their host's EPIDERMIS. Most ectoparasites are ARTHROPODS.
=688  \\$a68
=750  \0$aEctoparasitic infestations$5IEN$0(DLC)sh 85040891

=LDR  00603cz  a2200193n  4500
=001  9880363555402441
=005  20141212200943.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004477
=035  \\$aCAZ7613HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500.$x325.$x89
=150  \\$aEctogenesis
=450  \\$wnnna$aEctogeneses
=550  \\$wg$aEmbryonic and Fetal Development
=550  \\$aFertilization in Vitro
=680  \\$iEmbryonic and fetal development that takes place in an artificial environment in vitro.
=688  \\$a75
=750  \0$aEctogenesis$0(DLC) sh2004000282$5IEN-M

=LDR  04337cz  a2200937n  4500
=001  9880363555502441
=005  20141212200942.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004476
=035  \\$aCAZ7612HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x131.$x77.$x350
=072  \\$aC16.$x131.$x831.$x350
=072  \\$aC16.$x320.$x850.$x250
=072  \\$aC17.$x800.$x804.$x350
=072  \\$aC17.$x800.$x827.$x250
=150  \\$aEctodermal Dysplasia
=450  \\$aAnhidrotic Ectodermal Dysplasia
=450  \\$wnnna$aAnhidrotic, Ectodermal Dysplasia
=450  \\$wnnna$aAnhidrotic Ectodermal Dysplasias
=450  \\$wnnna$aAnhidrotics, Ectodermal Dysplasia
=450  \\$wnnna$aAnhydrotic Ectodermal Dysplasia
=450  \\$wnnna$aAnhydrotic Ectodermal Dysplasias
=450  \\$aAplasia Cutis Congenita
=450  \\$wnnna$aAplasia Cutis Congenita, Nonsyndromic
=450  \\$wnnna$aAutosomal Dominant Hidrotic Ectodermal Dysplasia
=450  \\$wnnna$aClouston Hidrotic Ectodermal Dysplasia
=450  \\$wnnna$aClouston Syndrome
=450  \\$wnnna$aClouston's Hidrotic Ectodermal Dysplasia
=450  \\$aClouston's Syndrome
=450  \\$wnnna$aCloustons Syndrome
=450  \\$wnnna$aCongenital Ectodermal Defect
=450  \\$wnnna$aCongenital Ectodermal Defects
=450  \\$wnnna$aDefect, Congenital Ectodermal
=450  \\$wnnna$aDefects, Congenital Ectodermal
=450  \\$wnnna$aDysplasia Anhidrotic, Ectodermal
=450  \\$wnnna$aDysplasia, Anhidrotic Ectodermal
=450  \\$wnnna$aDysplasia Anhidrotics, Ectodermal
=450  \\$wnnna$aDysplasia, Anhydrotic Ectodermal
=450  \\$wnnna$aDysplasia, Ectodermal
=450  \\$wnnna$aDysplasia, Hidrotic Ectodermal
=450  \\$wnnna$aDysplasia, Hydrotic Ectodermal
=450  \\$wnnna$aDysplasias, Anhidrotic Ectodermal
=450  \\$wnnna$aDysplasias, Anhydrotic Ectodermal
=450  \\$wnnna$aDysplasias, Ectodermal
=450  \\$wnnna$aDysplasias, Hidrotic Ectodermal
=450  \\$wnnna$aDysplasias, Hydrotic Ectodermal
=450  \\$aEctodermal Defect, Congenital
=450  \\$wnnna$aEctodermal Defects, Congenital
=450  \\$wnnna$aEctodermal Dysplasia 2, Hidrotic
=450  \\$wnnna$aEctodermal Dysplasia Anhidrotic
=450  \\$wnnna$aEctodermal Dysplasia, Anhidrotic
=450  \\$wnnna$aEctodermal Dysplasia, Anhydrotic
=450  \\$wnnna$aEctodermal Dysplasia, Hidrotic
=450  \\$wnnna$aEctodermal Dysplasia, Hidrotic, Autosomal Dominant
=450  \\$wnnna$aEctodermal Dysplasia, Hydrotic
=450  \\$wnnna$aEctodermal Dysplasias
=450  \\$wnnna$aEctodermal Dysplasias, Anhidrotic
=450  \\$wnnna$aEctodermal Dysplasias, Anhydrotic
=450  \\$wnnna$aEctodermal Dysplasias, Hydrotic
=450  \\$aHidrotic Ectodermal Dysplasia
=450  \\$wnnna$aHidrotic Ectodermal Dysplasia, Autosomal Dominant
=450  \\$wnnna$aHidrotic Ectodermal Dysplasias
=450  \\$wnnna$aHydrotic Ectodermal Dysplasia
=450  \\$wnnna$aHydrotic Ectodermal Dysplasias
=450  \\$wnnna$aSyndrome, Clouston
=450  \\$wnnna$aSyndrome, Clouston's
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aSkin Abnormalities
=550  \\$wg$aSkin Diseases, Genetic
=550  \\$wh$aEctodermal Dysplasia 1, Anhidrotic
=550  \\$wh$aEctodermal Dysplasia 3, Anhidrotic
=550  \\$wh$aEctodermal Dysplasia, Hypohidrotic, Autosomal Recessive
=550  \\$wh$aEllis-Van Creveld Syndrome
=550  \\$wh$aFocal Dermal Hypoplasia
=550  \\$wh$aNeurocutaneous Syndromes
=550  \\$wh$aPachyonychia Congenita
=680  \\$iA group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.
=688  \\$a1965
=688  \\$a65; CHRIST-SIEMENS SYNDROME was see ECTODERMAL DYSPLASIA 1987-92; CHRIST-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1968-86; CHRIS-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1965-67; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86
=750  \0$aEctodermal dysplasia$0(DLC) sh 85040890$5IEN

=LDR  01223cz  a2200301n  4500
=001  9880363555602441
=005  20141212200941.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004474
=035  \\$aCAZ7610HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x256.$x743.$x193
=072  \\$aC22.$x836.$x259
=150  \\$aEcthyma, Contagious
=450  \\$wnnna$aContagious Ecthyma
=450  \\$wnnna$aContagious Pustular Dermatitides
=450  \\$aContagious Pustular Dermatitis
=450  \\$wnnna$aDermatitides, Contagious Pustular
=450  \\$aDermatitis, Contagious Pustular
=450  \\$aOrf
=450  \\$wnnna$aPustular Dermatitides, Contagious
=450  \\$wnnna$aPustular Dermatitis, Contagious
=550  \\$wg$aPoxviridae Infections
=550  \\$wg$aSheep Diseases
=667  \\$acaused by a poxvirus; usually animal; check tag ANIMALS; don't forget also SHEEP (NIM) but do not index under SHEEP DISEASES
=680  \\$iAn infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man.
=688  \\$a70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69
=750  \0$aContagious ecthyma$5IEN$0(DLC)sh 85031511

=LDR  00783cz  a2200253n  4500
=001  9880363555702441
=005  20141212200940.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004471
=035  \\$aCAZ7607HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x338
=150  \\$aEconomics, Nursing
=450  \\$wnnna$aEconomic, Nursing
=450  \\$aNursing Care$xeconomics
=450  \\$wnnna$aNursing Economic
=450  \\$aNursing Economics
=450  \\$aNursing$xeconomics
=550  \\$wg$aEconomics
=550  \\$aNursing
=667  \\$aGEN or unspecified only: prefer /econ with specific nurs subject: Manual 19.8.27; DF: ECON NURS
=680  \\$iEconomic aspects of the nursing profession.
=688  \\$a66
=750  \0$aNursing$xEconomic aspects$5IEN$0(IEN)367444

=LDR  00834cz  a2200217n  4500
=001  9880363555802441
=005  20141212200939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004470
=035  \\$aCAZ7606HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x300
=150  \\$aEconomics, Medical
=450  \\$aMedical Economics
=450  \\$aMedicine$xeconomics
=550  \\$wg$aEconomics
=550  \\$wh$aFees, Medical
=550  \\$aMedicine
=667  \\$aGEN or unspecified only: prefer /econ with specific subject: Manual 19.8.27; DF: ECON MED
=680  \\$iEconomic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government.
=750  \0$aMedical economics$5IEN$0(DLC)sh 85082915

=LDR  00832cz  a2200253n  4500
=001  9880363555902441
=005  20141212200939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004469
=035  \\$aCAZ7605HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x262
=150  \\$aEconomics, Hospital
=450  \\$wnnna$aEconomic, Hospital
=450  \\$wnnna$aHospital Economic
=450  \\$aHospital Economics
=450  \\$aHospitals$xeconomics
=550  \\$wg$aEconomics
=550  \\$wh$aHospital Charges
=550  \\$wh$aHospital Costs
=550  \\$aHospitals
=667  \\$aGEN or unspecified only: prefer /econ with specific hosp subject: Manual 19.8.27; DF: ECON HOSP
=680  \\$iEconomic aspects related to the management and operation of a hospital.
=750  \0$aHospitals$xEconomic aspects$5IEN$0(IEN)367443

=LDR  00690cz  a2200217n  4500
=001  9880363556002441
=005  20141212200939.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004468
=035  \\$aCAZ7604HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x224
=150  \\$aEconomics, Dental
=450  \\$aDental Economics
=450  \\$aDentistry$xeconomics
=550  \\$wg$aEconomics
=550  \\$wh$aFees, Dental
=550  \\$aDentistry
=667  \\$aGEN or unspecified only: prefer /econ with specific dent subject: Manual 19.8.27; DF: ECON DENT
=680  \\$iEconomic aspects of the dental profession and dental care.
=750  \0$aDental economics$5IEN$0(DLC)sh 85036887

=LDR  01507cz  a2200361n  4500
=001  9880363556202441
=005  20141212200937.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004463
=035  \\$aCAZ7599HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x248
=072  \\$aH1.$x277.$x249
=150  \\$aEcology
=450  \\$aBionomics
=450  \\$wnnna$aEcologies
=450  \\$aEcologists$5IEN
=450  \\$wnnna$aEnvironmental Science
=450  \\$wnnna$aEnvironmental Sciences
=450  \\$wnnna$aScience, Environmental
=450  \\$wnnna$aSciences, Environmental
=550  \\$wg$aBiology
=550  \\$wg$aEarth Sciences
=550  \\$wh$aEcotoxicology
=550  \\$wh$aHydrobiology
=550  \\$wh$aHydrology
=550  \\$aConservation of Natural Resources
=550  \\$aEcosystem
=550  \\$aEnvironmental Health
=667  \\$athe discipline (education, history, etc) only; use ECOLOGICAL AND ENVIRONMENTAL PHENOMENA or specifics treed under it for characteristics and processes of ecological and environmental systems; DF: ECOL
=680  \\$iThe branch of science concerned with the interrelationship of organisms and their ENVIRONMENT, especially as manifested by natural cycles and rhythms, community development and structure, interactions between different kinds of organisms, geographic distributions, and population alterations. (Webster's, 3d ed)
=750  \0$aEcology$0(DLC) sh 85040752$5IEN-M
=750  \0$aEcologists$0(DLC) (DNLM)D004463$5IEN-HS

=LDR  00570cz  a2200181n  4500
=001  9880363556302441
=005  20141212200936.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004461
=035  \\$aCAZ7597HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x395.$x124
=150  \\$aEclampsia
=450  \\$wnnna$aEclampsias
=550  \\$wg$aHypertension, Pregnancy-Induced
=550  \\$aSeizures
=680  \\$iOnset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
=750  \0$aEclampsia$5IEN$0(DLC)sh 91004075

=LDR  00745cz  a2200205n  4500
=001  9880363556402441
=005  20141212200935.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004455
=035  \\$aCAZ7591HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x55.$x400
=150  \\$aEcholocation
=450  \\$wnnna$aEcholocations
=550  \\$wg$aAnimal Communication
=550  \\$aSound Localization
=667  \\$aanimal only; for human consider SOUND LOCALIZATION
=680  \\$iAn auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter (animal).
=688  \\$a91(72); was see under ORIENTATION 1972-90
=750  \0$aEcholocation (Physiology)$5IEN$0(DLC)sh 85040723

=LDR  01046cz  a2200289n  4500
=001  9880363556502441
=005  20141212200934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004453
=035  \\$aCAZ7589HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x937.$x260
=072  \\$aE1.$x370.$x350.$x700.$x560.$x260
=072  \\$aE1.$x370.$x350.$x850.$x260
=072  \\$aE1.$x370.$x376.$x537.$x750.$x260
=072  \\$aE5.$x629.$x937.$x260
=150  \\$aEchoencephalography
=450  \\$aBrain$xultrasonography
=450  \\$wnnna$aEchoencephalographies
=450  \\$aUltrasonic Encephalography$5IEN
=550  \\$wg$aNeuroradiography
=550  \\$wg$aUltrasonography
=550  \\$wh$aUltrasonography, Doppler, Transcranial
=667  \\$a/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOENCEPHALOGR
=680  \\$iUse of reflected ultrasound in the diagnosis of intracranial pathologic processes.
=688  \\$a67(64)
=750  \0$aUltrasonic encephalography$5IEN$0(DLC)sh 85139480

=LDR  02292cz  a2200481n  4500
=001  9880363556602441
=005  20141212210856.0
=008  880321\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015150
=035  \\$aCAZ7588HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x750.$x220
=072  \\$aE1.$x370.$x350.$x850.$x220.$x220
=072  \\$aE1.$x370.$x350.$x850.$x850.$x220
=072  \\$aE1.$x370.$x370.$x380.$x220.$x220
=150  \\$aEchocardiography, Doppler
=450  \\$wnnna$a2-D Doppler Echocardiography
=450  \\$wnnna$a2 D Doppler Echocardiography
=450  \\$wnnna$a2D Doppler Echocardiography
=450  \\$wnnna$aContinuous Doppler Echocardiography
=450  \\$aDoppler Echocardiography
=450  \\$wnnna$aDoppler Echocardiography, 2-D
=450  \\$wnnna$aDoppler Echocardiography, 2 D
=450  \\$wnnna$aDoppler Echocardiography, 2D
=450  \\$wnnna$aDoppler Echocardiography, Continuous
=450  \\$wnnna$aDoppler Echocardiography, Two-Dimensional
=450  \\$wnnna$aDoppler Echocardiography, Two Dimensional
=450  \\$wnnna$aEchocardiography, 2-D Doppler
=450  \\$wnnna$aEchocardiography, 2 D Doppler
=450  \\$wnnna$aEchocardiography, 2D Doppler
=450  \\$aEchocardiography, Continuous Doppler
=450  \\$aEchocardiography, Two-Dimensional Doppler
=450  \\$wnnna$aEchocardiography, Two Dimensional Doppler
=450  \\$wnnna$aTwo-Dimensional Doppler Echocardiography
=450  \\$wnnna$aTwo Dimensional Doppler Echocardiography
=550  \\$wg$aEchocardiography
=550  \\$wg$aUltrasonography, Doppler
=550  \\$wh$aEchocardiography, Doppler, Color
=550  \\$wh$aEchocardiography, Doppler, Pulsed
=667  \\$aGEN or unspecified; prefer specifics; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER
=680  \\$iMeasurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells.
=688  \\$a89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88
=750  \0$aDoppler Echocardiography$5IEN$0(DLC)sh 87004122

=LDR  02261cz  a2200565n  4500
=001  9880363556702441
=005  20141212200934.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004452
=035  \\$aCAZ7587HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x130.$x750
=072  \\$aE1.$x370.$x350.$x850.$x220
=072  \\$aE1.$x370.$x370.$x380.$x220
=150  \\$aEchocardiography
=450  \\$wnnna$a2-D Echocardiography
=450  \\$wnnna$a2 D Echocardiography
=450  \\$wnnna$a2D Echocardiography
=450  \\$wnnna$aContrast Echocardiography
=450  \\$wnnna$aCross-Sectional Echocardiography
=450  \\$wnnna$aCross Sectional Echocardiography
=450  \\$wnnna$aEchocardiography, 2-D
=450  \\$wnnna$aEchocardiography, 2 D
=450  \\$wnnna$aEchocardiography, 2D
=450  \\$aEchocardiography, Contrast
=450  \\$aEchocardiography, Cross-Sectional
=450  \\$wnnna$aEchocardiography, Cross Sectional
=450  \\$aEchocardiography, M-Mode
=450  \\$wnnna$aEchocardiography, M Mode
=450  \\$aEchocardiography, Transthoracic
=450  \\$aEchocardiography, Two-Dimensional
=450  \\$wnnna$aEchocardiography, Two Dimensional
=450  \\$aHeart$xultrasonography
=450  \\$wnnna$aM-Mode Echocardiography
=450  \\$wnnna$aM Mode Echocardiography
=450  \\$aMyocardium$xultrasonography
=450  \\$aTransthoracic Echocardiography
=450  \\$wnnna$aTwo-Dimensional Echocardiography
=450  \\$wnnna$aTwo Dimensional Echocardiography
=550  \\$wg$aCardiac Imaging Techniques
=550  \\$wg$aHeart Function Tests
=550  \\$wg$aUltrasonography
=550  \\$wh$aEchocardiography, Doppler
=550  \\$wh$aEchocardiography, Stress
=550  \\$wh$aEchocardiography, Three-Dimensional
=550  \\$wh$aEchocardiography, Transesophageal
=667  \\$aGEN only; prefer /ultrasonogr with specific heart dis; note X ref ECHOCARDIOGRAPHY, TRANSTHORACIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL is also available; DF: ECHOCARDIOGR
=680  \\$iUltrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
=688  \\$a73(67)
=750  \0$aEchocardiography$5IEN$0(DLC)sh 85139476

=LDR  00935cz  a2200193n  4500
=001  9880363556802441
=005  20141212200933.0
=008  810515\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004450
=035  \\$aCAZ7585HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x715.$x360
=150  \\$aEchinostomatidae
=550  \\$wg$aTrematoda
=550  \\$wh$aEchinostoma
=667  \\$aa family of trematodes; infection: coord IM with TREMATODE INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA family of flukes (TREMATODA) characterized by a collar of spines at their anterior end. The body is elongated and is covered with spines, and the two suckers are usually close together. (Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p183)
=688  \\$a98; use explode 1982-97
=750  \0$aEchinostomatidae$5IEN-M$0(DLC)sh 85040709

=LDR  01257cz  a2200217n  4500
=001  9880363556902441
=005  20141212200932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004447
=035  \\$aCAZ7582HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x408
=150  \\$aEchinodermata
=450  \\$wnnna$aEchinodermatas
=550  \\$wg$aInvertebrates
=550  \\$wh$aSea Cucumbers
=550  \\$wh$aSea Urchins
=550  \\$wh$aStarfish
=667  \\$aincludes SEA URCHINS; STARFISH; sea lilies, SEA CUCUMBERS & brittle stars; /microbiol /parasitol /virol permitted
=680  \\$iA phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea (the STARFISH or sea stars) and the Ophiuroidea (the brittle stars, also called basket stars and serpent stars). There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. (From Barnes, Invertebrate Zoology, 5th ed, pp773-826)
=750  \0$aEchinodermata$5IEN$0(DLC)sh 85040701

=LDR  00837cz  a2200193n  4500
=001  9880363557002441
=005  20141212200932.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004446
=035  \\$aCAZ7581HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x736.$x215.$x327
=150  \\$aEchinococcus
=550  \\$wg$aCestoda
=550  \\$wh$aEchinococcus granulosus
=550  \\$wh$aEchinococcus multilocularis
=667  \\$ainfection = ECHINOCOCCOSIS or its specifics; coordinate with specific helminth terms (for example, ANTIGENS, HELMINTH) if pertinent
=680  \\$iA genus of very small TAPEWORMS, in the family Taeniidae. The adult form is found in various CARNIVORA but not humans. The larval form is seen in humans under certain epidemiologic circumstances.
=750  \0$aEchinococcus$5IEN$0(DLC)sh 85040694

=LDR  01310cz  a2200373n  4500
=001  9880363557102441
=005  20141212200931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004445
=035  \\$aCAZ7580HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x396.$x480
=072  \\$aC3.$x582.$x314
=072  \\$aC8.$x381.$x517.$x314
=072  \\$aC8.$x730.$x450.$x314
=150  \\$aEchinococcosis, Pulmonary
=450  \\$wnnna$aCyst, Pulmonary Hydatid
=450  \\$wnnna$aCysts, Pulmonary Hydatid
=450  \\$wnnna$aEchinococcoses, Pulmonary
=450  \\$aHydatid Cyst, Pulmonary
=450  \\$wnnna$aHydatid Cysts, Pulmonary
=450  \\$wnnna$aHydatidoses, Pulmonary
=450  \\$aHydatidosis, Pulmonary
=450  \\$wnnna$aPulmonary Echinococcoses
=450  \\$wnnna$aPulmonary Echinococcosis
=450  \\$wnnna$aPulmonary Hydatid Cyst
=450  \\$wnnna$aPulmonary Hydatid Cysts
=450  \\$wnnna$aPulmonary Hydatidoses
=450  \\$wnnna$aPulmonary Hydatidosis
=550  \\$wg$aEchinococcosis
=550  \\$wg$aLung Diseases, Parasitic
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iHelminth infection of the lung caused by Echinococcus granulosus or Echinococcus multilocularis.
=750  \0$aLungs$xHydatids$5IEN$0(DLC)sh 85078913

=LDR  01904cz  a2200457n  4500
=001  9880363557202441
=005  20141212200931.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004444
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x396.$x314
=072  \\$aC3.$x518.$x314
=072  \\$aC6.$x552.$x664.$x272
=150  \\$aEchinococcosis, Hepatic
=450  \\$aAlveolar Echinococcis, Hepatic
=450  \\$wnnna$aAlveolar Echinococcoses, Hepatic
=450  \\$wnnna$aAlveolar Echinococcosis, Hepatic
=450  \\$wnnna$aCyst, Hepatic Hydatid
=450  \\$wnnna$aCysts, Hepatic Hydatid
=450  \\$wnnna$aEchinococcis, Hepatic Alveolar
=450  \\$wnnna$aEchinococcoses, Hepatic
=450  \\$wnnna$aEchinococcoses, Hepatic Alveolar
=450  \\$aEchinococcosis, Hepatic Alveolar
=450  \\$wnnna$aHepatic Alveolar Echinococcis
=450  \\$wnnna$aHepatic Alveolar Echinococcoses
=450  \\$wnnna$aHepatic Alveolar Echinococcosis
=450  \\$wnnna$aHepatic Echinococcoses
=450  \\$wnnna$aHepatic Echinococcosis
=450  \\$wnnna$aHepatic Hydatid Cyst
=450  \\$wnnna$aHepatic Hydatid Cysts
=450  \\$wnnna$aHepatic Hydatidoses
=450  \\$wnnna$aHepatic Hydatidosis
=450  \\$aHydatid Cyst, Hepatic
=450  \\$wnnna$aHydatid Cysts, Hepatic
=450  \\$wnnna$aHydatidoses, Hepatic
=450  \\$aHydatidosis, Hepatic
=550  \\$wg$aEchinococcosis
=550  \\$wg$aLiver Diseases, Parasitic
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent
=680  \\$iLiver disease caused by infections with parasitic tapeworms of the genus ECHINOCOCCUS, such as Echinococcus granulosus or Echinococcus multilocularis. Ingested Echinococcus ova burrow into the intestinal mucosa. The larval migration to the liver via the PORTAL VEIN leads to watery vesicles (HYDATID CYST).
=750  \0$aLiver$xHydatids$5IEN$0(DLC)sh 85077761

=LDR  01100cz  a2200277n  4500
=001  9880363557302441
=005  20141212200930.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004443
=035  \\$aCAZ7578HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC3.$x335.$x190.$x396
=150  \\$aEchinococcosis
=450  \\$wnnna$aCyst, Hydatid
=450  \\$aCysts, Hydatid
=450  \\$wnnna$aEchinococcoses
=450  \\$aHydatid Cyst
=450  \\$wnnna$aHydatid Cysts
=450  \\$wnnna$aHydatidoses
=450  \\$aHydatidosis
=550  \\$wg$aCestode Infections
=550  \\$wh$aEchinococcosis, Hepatic
=550  \\$wh$aEchinococcosis, Pulmonary
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; ECHINOCOCCOSIS, HEPATIC and ECHINOCOCCOSIS, PULMONARY are also available; Taenia echinococcus infection = ECHINOCOCCOSIS + ECHINOCOCCUS GRANULOUS
=680  \\$iAn infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.
=750  \0$aEchinococcosis$5IEN$0(DLC)sh 85040693

=LDR  00662cz  a2200217n  4500
=001  9880363557402441
=005  20141212200929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004440
=035  \\$aCAZ7575HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x222.$x265.$x165.$x500
=072  \\$aD6.$x472.$x445.$x573.$x271.$x500
=150  \\$aEcdysone
=450  \\$aMolting Hormone
=550  \\$wg$aEcdysteroids
=550  \\$aMolting
=667  \\$ado not confuse with ECDYSTERONE
=680  \\$iA steroid hormone that regulates the processes of MOLTING or ecdysis in insects.
=688  \\$a1967(1964)
=750  \0$aEcdysone$5IEN$0(DLC)sh 85040686

=LDR  01419cz  a2200349n  4500
=001  9880363557502441
=005  20141212200929.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004437
=035  \\$aCAZ7572HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x395
=072  \\$aC14.$x280.$x400.$x395
=072  \\$aC16.$x131.$x240.$x400.$x395
=150  \\$aEbstein Anomaly
=450  \\$wnnna$aAnomaly, Ebstein
=450  \\$wnnna$aAnomaly, Ebstein's
=450  \\$wnnna$aEbstein Malformation
=450  \\$wnnna$aEbstein's Anomaly
=450  \\$wnnna$aEbsteins Anomaly
=450  \\$wnnna$aEbstein's Anomaly, Familial
=450  \\$wnnna$aEbstein's Malformation
=450  \\$wnnna$aEbsteins Malformation
=450  \\$wnnna$aFamilial Ebstein Anomaly
=450  \\$wnnna$aFamilial Ebstein's Anomaly
=450  \\$wnnna$aFamilial Ebsteins Anomaly
=450  \\$wnnna$aMalformation, Ebstein's
=550  \\$wg$aHeart Defects, Congenital
=680  \\$iA congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Ebstein's Anomaly
=750  \0$aEbstein's anomaly$0(DLC) sh 85040660$5IEN

=LDR  01168cz  a2200325n  4500
=001  9880363557602441
=005  20200608110913.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001068
=035  \\$aCAZ7570HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x400
=150  \\$aFeeding and Eating Disorders
=450  \\$wnno$aEating Disorders$5IEN-M
=450  \\$wnnna$aAppetite Disorder
=450  \\$aAppetite Disorders
=450  \\$wnnna$aEating and Feeding Disorders
=550  \\$wg$aMental Disorders
=550  \\$wh$aAnorexia Nervosa
=550  \\$wh$aBinge-Eating Disorder
=550  \\$wh$aBulimia Nervosa
=550  \\$wh$aFeeding and Eating Disorders of Childhood
=550  \\$wh$aFemale Athlete Triad Syndrome
=550  \\$wh$aNight Eating Syndrome
=550  \\$wh$aPica
=667  \\$ain children, use FEEDING AND EATING DISORDERS OF CHILDHOOD if related to mental disorder
=680  \\$iA group of disorders characterized by physiological and psychological disturbances in appetite or food intake.
=688  \\$a2016 (1983)
=750  \0$aEating disorders$5IEN-M$0(DLC)sh 86004209
=750  \0$aAppetite disorders$5IEN-HS$0(DLC)sh 85006102

=LDR  00849cz  a2200277n  4500
=001  9880363557702441
=005  20141212200928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004435
=035  \\$aCAZ7569HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x610.$x593.$x260
=072  \\$aG7.$x700.$x620.$x260
=072  \\$aG10.$x261.$x326.$x240
=150  \\$aEating
=450  \\$aFood Intake
=450  \\$wnnna$aIngestion
=450  \\$wnnna$aIntake, Food
=550  \\$wg$aDigestive System Processes
=550  \\$wg$aNutrition Processes
=550  \\$wh$aDrinking
=550  \\$wh$aMastication
=667  \\$athe act of eating: do not confuse with FOOD (the substance eaten) or EATING BEHAVIOR (the manner of eating)
=680  \\$iThe consumption of edible substances.
=688  \\$a73(66)
=750  \0$aIngestion$5IEN$0(DLC)sh 85066349

=LDR  00559cz  a2200229n  4500
=001  9880363557802441
=005  20141212200928.0
=008  820426\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004433
=035  \\$aCAZ7567HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218.$x350
=072  \\$aC23.$x888.$x646.$x386
=150  \\$aEarache
=450  \\$wnnna$aEaraches
=450  \\$aOtalgia
=450  \\$wnnna$aOtalgias
=550  \\$wg$aEar Diseases
=550  \\$wg$aPain
=680  \\$iPain in the ear.
=688  \\$a83
=750  \0$aEarache$5IEN$0(DLC)sh 87007264

=LDR  01324cz  a2200337n  4500
=001  9880363557902441
=005  20141212200928.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004432
=035  \\$aCAZ7566HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x397
=150  \\$aEar, Middle
=450  \\$wnnna$aCavities, Tympanic
=450  \\$wnnna$aCavity, Tympanic
=450  \\$wnnna$aEars, Middle
=450  \\$wnnna$aMiddle Ear
=450  \\$wnnna$aMiddle Ears
=450  \\$wnnna$aTympanic Cavities
=450  \\$aTympanic Cavity
=450  \\$aTympanum
=450  \\$wnnna$aTympanums
=550  \\$wg$aEar
=550  \\$wh$aEar Ossicles
=550  \\$wh$aEustachian Tube
=550  \\$wh$aGlomus Tympanicum
=550  \\$wh$aStapedius
=550  \\$wh$aTensor Tympani
=667  \\$a/surg: consider TYMPANOPLASTY; inflammation = OTITIS MEDIA; injuries caused by pressure = EAR, MIDDLE /inj (IM) + BAROTRAUMA (IM); middle ear effusions = OTITIS MEDIA WITH EFFUSION
=680  \\$iThe space and structures directly internal to the TYMPANIC MEMBRANE and external to the inner ear (LABYRINTH). Its major components include the AUDITORY OSSICLES and the EUSTACHIAN TUBE that connects the cavity of middle ear (tympanic cavity) to the upper part of the throat.
=750  \0$aMiddle ear$5IEN$0(DLC)sh 85085017

=LDR  01299cz  a2200313n  4500
=001  9880363558002441
=005  20141212200927.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004431
=035  \\$aCAZ7565HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x272
=150  \\$aEar, External
=450  \\$wnnna$aEar, Outer
=450  \\$wnnna$aEars, External
=450  \\$wnnna$aEars, Outer
=450  \\$wnnna$aExternal Ear
=450  \\$wnnna$aExternal Ears
=450  \\$wnnna$aOuter Ear
=450  \\$wnnna$aOuter Ears
=550  \\$wg$aEar
=550  \\$wh$aEar Auricle
=550  \\$wh$aEar Canal
=550  \\$wh$aEar Cartilage
=550  \\$wh$aTympanic Membrane
=667  \\$a/abnorm permitted for congenital deformities but acquired deformities = EAR DEFORMITIES, ACQUIRED; inflammation = OTITIS EXTERNA; ear acupuncture or auriculoacupuncture or otoacupuncture (acupuncture therapy with ear as pressure point) goes here (IM) + ACUPUNCTURE THERAPY (IM)
=680  \\$iThe outer part of the hearing system of the body. It includes the shell-like EAR AURICLE which collects sound, and the EXTERNAL EAR CANAL, the TYMPANIC MEMBRANE, and the EXTERNAL EAR CARTILAGES.
=688  \\$aEAR, EXTERNAL, DEFORMITY was heading 1966-70
=750  \0$aEar, External$0(DLC) sh 85040396$5IEN

=LDR  01278cz  a2200373n  4500
=001  9880363558102441
=005  20141212200927.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004430
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x700.$x250
=072  \\$aJ1.$x637.$x215.$x600.$x199
=072  \\$aJ1.$x637.$x708.$x250
=150  \\$aEar Protective Devices
=450  \\$wnnna$aDevice, Ear Protective
=450  \\$wnnna$aDevice, Hearing Protective
=450  \\$wnnna$aDevices, Ear Protective
=450  \\$wnnna$aDevices, Hearing Protective
=450  \\$wnnna$aEar Protective Device
=450  \\$wnnna$aEarmuff
=450  \\$wnnna$aEarmuffs
=450  \\$wnnna$aEarplug
=450  \\$aEarplugs
=450  \\$wnnna$aHearing Protective Device
=450  \\$aHearing Protective Devices
=450  \\$wnnna$aProtective Device, Ear
=450  \\$wnnna$aProtective Device, Hearing
=450  \\$wnnna$aProtective Devices, Ear
=450  \\$wnnna$aProtective Devices, Hearing
=550  \\$wg$aProtective Clothing
=550  \\$wg$aProtective Devices
=680  \\$iPersonal devices for protection of the ears from loud or high intensity noise, water, or cold. These include earmuffs and earplugs.
=688  \\$a91(75)
=750  \0$aEar$xProtection$5IEN$0(IEN)367440

=LDR  01009cz  a2200277n  4500
=001  9880363558202441
=005  20141212200926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004429
=035  \\$aCAZ7563HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x397.$x247
=150  \\$aEar Ossicles
=450  \\$wnnna$aAuditory Ossicle
=450  \\$aAuditory Ossicles
=450  \\$wnnna$aEar Ossicle
=450  \\$wnnna$aOssicle, Auditory
=450  \\$wnnna$aOssicle, Ear
=450  \\$wnnna$aOssicles, Auditory
=450  \\$wnnna$aOssicles, Ear
=550  \\$wg$aEar, Middle
=550  \\$wh$aIncus
=550  \\$wh$aMalleus
=550  \\$wh$aStapes
=680  \\$iA mobile chain of three small bones (INCUS; MALLEUS; STAPES) in the TYMPANIC CAVITY between the TYMPANIC MEMBRANE and the oval window on the wall of INNER EAR. Sound waves are converted to vibration by the tympanic membrane then transmitted via these ear ossicles to the inner ear.
=750  \0$aEar ossicles$5IEN$0(DLC)sh 85040398

=LDR  01458cz  a2200433n  4500
=001  9880363558302441
=005  20141212200926.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004428
=035  \\$aCAZ7562HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x443.$x665.$x312
=072  \\$aC9.$x218.$x334
=072  \\$aC9.$x647.$x312
=150  \\$aEar Neoplasms
=450  \\$aAuricular Cancer
=450  \\$wnnna$aAuricular Cancers
=450  \\$aAuricular Neoplasms
=450  \\$wnnna$aCancer, Auricular
=450  \\$aCancer of Ear
=450  \\$wnnna$aCancer of Ear Auricle
=450  \\$wnnna$aCancer of the Ear
=450  \\$wnnna$aCancers, Auricular
=450  \\$wnnna$aEar Auricle Cancer
=450  \\$wnnna$aEar Auricle Cancers
=450  \\$wnnna$aEar Auricle Neoplasm
=450  \\$wnnna$aEar Auricle Neoplasms
=450  \\$aEar Cancer
=450  \\$wnnna$aEar Neoplasm
=450  \\$wnnna$aNeoplasm, Ear
=450  \\$wnnna$aNeoplasms, Auricular
=450  \\$wnnna$aNeoplasms, Ear
=450  \\$wnnna$aNeoplasms of Ear Auricle
=550  \\$wg$aEar Diseases
=550  \\$wg$aOtorhinolaryngologic Neoplasms
=667  \\$acoordinate IM with specific ear term (IM) + histological type of neoplasm (IM)
=680  \\$iTumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).
=688  \\$a66
=750  \0$aEar$xTumors$5IEN-M$0(DLC)sh 85040394

=LDR  01687cz  a2200517n  4500
=001  9880363558402441
=005  20141212200925.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004427
=035  \\$aCAZ7561HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC9.$x218
=150  \\$aEar Diseases
=450  \\$wnnna$aDisease, Ear
=450  \\$wnnna$aDisease, Otologic
=450  \\$wnnna$aDisease, Otological
=450  \\$wnnna$aDiseases, Ear
=450  \\$wnnna$aDiseases, Otologic
=450  \\$wnnna$aDiseases, Otological
=450  \\$wnnna$aEar Disease
=450  \\$wnnna$aOtologic Disease
=450  \\$aOtologic Diseases
=450  \\$wnnna$aOtological Disease
=450  \\$wnnna$aOtological Diseases
=550  \\$wg$aOtorhinolaryngologic Diseases
=550  \\$wh$aCholesteatoma, Middle Ear
=550  \\$wh$aCongenital Microtia
=550  \\$wh$aEar Deformities, Acquired
=550  \\$wh$aEar Neoplasms
=550  \\$wh$aEarache
=550  \\$wh$aHearing Disorders
=550  \\$wh$aHerpes Zoster Oticus
=550  \\$wh$aLabyrinth Diseases
=550  \\$wh$aMyringosclerosis
=550  \\$wh$aOtitis
=550  \\$wh$aOtomycosis
=550  \\$wh$aOtosclerosis
=550  \\$wh$aRetrocochlear Diseases
=550  \\$wh$aSusac Syndrome
=550  \\$wh$aTympanic Membrane Perforation
=550  \\$aOtorhinolaryngologic Diseases
=667  \\$ageneral only; /diag: consider also DIAGNOSTIC TECHNIQUES, OTOLOGICAL; inflammatory disease = OTITIS and its specifics
=680  \\$iPathological processes of the ear, the hearing, and the equilibrium system of the body.
=688  \\$a66
=750  \2$aEar$xDiseases$5IEN-M
=750  \2$aEar$xInfections$5IEN-M

=LDR  01309cz  a2200385n  4500
=001  9880363558502441
=005  20141212200924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004424
=035  \\$aCAZ7558M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA9.$x246.$x272.$x396
=150  \\$aEar Canal
=450  \\$wnnna$aAcoustic Canal, External
=450  \\$wnnna$aAcoustic Canals, External
=450  \\$wnnna$aAcoustic Meatus, External
=450  \\$aAuditory Canal, External
=450  \\$wnnna$aAuditory Canals, External
=450  \\$wnnna$aCanal, Ear
=450  \\$wnnna$aCanal, External Ear
=450  \\$wnnna$aCanals, Ear
=450  \\$wnnna$aCanals, External Ear
=450  \\$wnnna$aEar Canal, External
=450  \\$wnnna$aEar Canals
=450  \\$wnnna$aEar Canals, External
=450  \\$wnnna$aExternal Acoustic Canal
=450  \\$wnnna$aExternal Acoustic Canals
=450  \\$wnnna$aExternal Acoustic Meatus
=450  \\$wnnna$aExternal Auditory Canal
=450  \\$wnnna$aExternal Auditory Canals
=450  \\$wnnna$aExternal Ear Canal
=450  \\$wnnna$aExternal Ear Canals
=550  \\$wg$aEar, External
=680  \\$iThe narrow passage way that conducts the sound collected by the EAR AURICLE to the TYMPANIC MEMBRANE.
=750  \0$aEar canal$0(DLC) sh 95000315$5IEN-M

=LDR  01611cz  a2200313n  4500
=001  9880363558602441
=005  20141212200924.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004423
=035  \\$aCAZ7557HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x456.$x313
=072  \\$aA9.$x246
=150  \\$aEar
=360  \\$iconsider also terms at$aOTI-$aOTO-
=450  \\$wnnna$aApparatus, Vestibulocochlear
=450  \\$wnnna$aEars
=450  \\$wnnna$aSystem, Vestibulocochlear
=450  \\$wnnna$aVestibulocochlear Apparatus
=450  \\$aVestibulocochlear System
=550  \\$wg$aHead
=550  \\$wg$aSense Organs
=550  \\$wh$aEar, External
=550  \\$wh$aEar, Inner
=550  \\$wh$aEar, Middle
=667  \\$ageneral only or unspecified; prefer EAR, EXTERNAL or EAR, MIDDLE or EAR, INNER; /abnorm permitted but note EAR DEFORMITIES, ACQUIRED; /surg: consider also OTOLOGIC SURGICAL PROCEDURES; ear acupuncture or otopuncture or auriculoacupuncture (acupunct ther with ear as pressure point): index under ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)
=680  \\$iThe hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE.
=688  \\$aEAR, EXTERNAL, DEFORMITY was heading 1966-70
=750  \0$aEar$5IEN$0(DLC)sh 85040383

=LDR  01983cz  a2200433n  4500
=001  9880363558702441
=005  20141212200923.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004422
=035  \\$aCAZ7556HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x79.$x357
=072  \\$aC10.$x228.$x662.$x300.$x200
=072  \\$aC10.$x574.$x500.$x393
=072  \\$aC16.$x320.$x400.$x330
=150  \\$aDystonia Musculorum Deformans
=450  \\$aChildhood Torsion Disease
=450  \\$wnnna$aDystonia Deformans Musculorum
=450  \\$wnnna$aDystonia Deformans Progressiva
=450  \\$wnnna$aDystonia, Idiopathic Torsion
=450  \\$wnnna$aDystonias, Idiopathic Torsion
=450  \\$wnnna$aDystonias, Torsion
=450  \\$aIdiopathic Torsion Dystonia
=450  \\$wnnna$aIdiopathic Torsion Dystonias
=450  \\$aOppenheim-Ziehen Disease
=450  \\$wnnna$aOppenheim Ziehen Disease
=450  \\$aProgressive Torsion Spasm
=450  \\$wnnna$aSpasm, Progressive Torsion
=450  \\$wnnna$aTorsion Disease, Childhood
=450  \\$wnnna$aTorsion Disease of Childhood
=450  \\$aTorsion Dystonia
=450  \\$wnnna$aTorsion Dystonia, Idiopathic
=450  \\$wnnna$aTorsion Spasm, Progressive
=550  \\$wg$aBasal Ganglia Diseases
=550  \\$wg$aDystonic Disorders
=550  \\$wg$aHeredodegenerative Disorders, Nervous System
=550  \\$aDystonia
=680  \\$iA condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. (Adams et al., Principles of Neurology, 6th ed, p1078)
=750  \0$aDystonia musculorum deformans$5IEN$0(DLC)sh 85040349

=LDR  01428cz  a2200349n  4500
=001  9880363558802441
=005  20141212200923.0
=008  780517\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004421
=035  \\$aCAZ7555HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x350.$x300
=072  \\$aC23.$x888.$x592.$x350.$x300
=150  \\$aDystonia
=450  \\$wnnna$aDiurnal Dystonia
=450  \\$wnnna$aDystonia, Diurnal
=450  \\$wnnna$aDystonia, Limb
=450  \\$wnnna$aDystonia, Muscle
=450  \\$wnnna$aDystonia, Paroxysmal
=450  \\$wnnna$aLimb Dystonia
=450  \\$aMuscle Dystonia
=450  \\$wnnna$aParoxysmal Dystonia
=550  \\$wg$aDyskinesias
=550  \\$wh$aTorticollis
=550  \\$aDystonia Musculorum Deformans
=550  \\$aDystonic Disorders
=550  \\$aMuscle Tonus
=550  \\$aTorsion Abnormality
=667  \\$ado not confuse with MUSCLE HYPERTONIA or MUSCLE HYPOTONIA; DYSTONIC DISORDERS is available
=680  \\$iAn attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
=688  \\$a1982
=750  \0$aDystonia$5IEN$0(DLC)sh 85040348

=LDR  01750cz  a2200433n  4500
=001  9880363558902441
=005  20200722143241.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004265
=035  \\$aCAZ7396HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x40.$x25.$x159
=072  \\$aD8.$x811.$x399.$x340
=150  \\$aDNA Helicases
=450  \\$wnnna$aATP-Dependent DNA Helicases
=450  \\$wnnna$aATP Dependent DNA Helicases
=450  \\$wnnna$aDNA Helicase A
=450  \\$wnnna$aDNA Helicase E
=450  \\$wnnna$aDNA Helicase II
=450  \\$wnnna$aDNA Helicase III
=450  \\$wnnna$aDNA Helicases, ATP-Dependent
=450  \\$aDNA Unwinding Proteins
=450  \\$wnnna$aHelicases, ATP-Dependent DNA
=450  \\$wnnna$aHelicases, DNA
=450  \\$wnnna$aUnwinding Proteins, DNA
=550  \\$wg$aAdenosine Triphosphatases
=550  \\$wg$aIsomerases
=550  \\$wh$aDnaB Helicases
=550  \\$wh$aKu Autoantigen
=550  \\$wh$aMinichromosome Maintenance Proteins
=550  \\$wh$aRecQ Helicases
=550  \\$wh$aX-Linked Nuclear Protein
=550  \\$wh$aXeroderma Pigmentosum Group D Protein
=550  \\$aDNA Replication
=667  \\$ado not confuse entry term DNA UNWINDING PROTEINS with DNA UNTWISTING PROTEINS
=680  \\$iProteins that catalyze the unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. In addition DNA helicases are DNA-dependent ATPases that harness the free energy of ATP hydrolysis to translocate DNA strands.
=688  \\$a1994
=688  \\$a94; was DNA UNWINDING PROTEINS 1978-93
=750  \0$aDNA helicases$0(DLC) sh 00000062$5IEN-M

=LDR  01916cz  a2200373n  4500
=001  9880363559002441
=005  20141212200820.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004264
=035  \\$aCAZ7395HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x399.$x403.$x483
=150  \\$aDNA Topoisomerases, Type I
=450  \\$aDNA Nicking-Closing Protein
=450  \\$wnnna$aDNA Nicking-Closing Proteins
=450  \\$aDNA Relaxing Enzyme
=450  \\$wnnna$aDNA Relaxing Enzymes
=450  \\$aDNA Relaxing Protein
=450  \\$aDNA Topoisomerase
=450  \\$aDNA Topoisomerase I
=450  \\$wnnna$aDNA Type 1 Topoisomerase
=450  \\$aDNA Untwisting Enzyme
=450  \\$wnnna$aDNA Untwisting Enzymes
=450  \\$aDNA Untwisting Protein
=450  \\$wnnna$aDNA Untwisting Proteins
=450  \\$wnnna$aTopoisomerase I
=450  \\$wnnna$aType I DNA Topoisomerase
=550  \\$wg$aDNA Topoisomerases
=550  \\$aDNA Replication
=667  \\$ado not confuse entry term DNA UNTWISTING PROTEIN with DNA UNWINDING PROTEINS see DNA HELICASES; coordinate with BACTERIAL PROTEINS or ARCHAEAL PROTEINS if pertinent
=680  \\$iDNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.
=688  \\$a2002
=688  \\$a2002; use DNA TOPOISOMERASE 1994-2001, use DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN use DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME use DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME use DNA UNTWISTING ENZYMES 1978-1993; for OMEGA PROTEIN use OMEGA PROTEINS 1978-1993
=750  \0$aDNA topoisomerase I$0(DLC) sh 88003831$5IEN

=LDR  01273cz  a2200349n  4500
=001  9880363559102441
=005  20141212200819.0
=008  770513\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004263
=035  \\$aCAZ7394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x909.$x204.$x210
=072  \\$aB4.$x909.$x574.$x204
=150  \\$aDNA Tumor Viruses
=450  \\$wnnna$aDNA Tumor Virus
=450  \\$aOncogenic DNA Viruses$5IEN
=450  \\$wnnna$aTumor Virus, DNA
=450  \\$wnnna$aTumor Viruses, DNA
=450  \\$wnnna$aVirus, DNA Tumor
=450  \\$wnnna$aViruses, DNA Tumor
=550  \\$wg$aDNA Viruses
=550  \\$wg$aOncogenic Viruses
=550  \\$wh$aGammaherpesvirinae
=550  \\$wh$aHerpesvirus 1, Ranid
=550  \\$wh$aLeporipoxvirus
=550  \\$wh$aPapillomaviridae
=550  \\$wh$aPolyomaviridae
=550  \\$wh$aYatapoxvirus
=667  \\$aGEN only: prefer specifics; infection: coord IM with TUMOR VIRUS INFECTIONS (IM)
=680  \\$iDNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae.
=688  \\$a78
=750  \0$aOncogenic DNA viruses$5IEN$0(DLC)sh 88007761

=LDR  02087cz  a2200349n  4500
=001  9880363559202441
=005  20141212200819.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004262
=035  \\$aCAZ7392HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x150.$x280
=072  \\$aD8.$x811.$x277.$x352.$x335.$x350.$x300
=072  \\$aD8.$x811.$x277.$x352.$x355.$x325.$x300
=150  \\$aDNA Restriction Enzymes
=450  \\$wnnna$aDNA Restriction Enzyme
=450  \\$wnnna$aEndonuclease, Restriction
=450  \\$wnnna$aEndonucleases, Restriction
=450  \\$wnnna$aEnzymes, DNA Restriction
=450  \\$wnnna$aRestriction Endonuclease
=450  \\$aRestriction Endonucleases
=450  \\$wnnna$aRestriction Enzyme, DNA
=450  \\$wnnna$aRestriction Enzymes, DNA
=550  \\$wg$aDNA Restriction-Modification Enzymes
=550  \\$wg$aEndodeoxyribonucleases
=550  \\$wh$aDeoxyribonucleases, Type I Site-Specific
=550  \\$wh$aDeoxyribonucleases, Type II Site-Specific
=550  \\$wh$aDeoxyribonucleases, Type III Site-Specific
=667  \\$aDNA restriction enzyme used as a DNA marker: coord probably NIM with GENETIC MARKER (IM)
=680  \\$iEnzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1.
=688  \\$a79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77
=750  \0$aRestriction enzymes, DNA$5IEN$0(DLC)sh 85113284

=LDR  01182cz  a2200361n  4500
=001  9880363559302441
=005  20170609092011.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004261
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x225
=072  \\$aG5.$x226
=150  \\$aDNA Replication
=450  \\$aAutonomous Replication
=450  \\$wnnna$aAutonomous Replications
=450  \\$wnnna$aDNA Replications
=450  \\$wnnna$aReplication, Autonomous
=450  \\$wnnna$aReplication, DNA
=450  \\$wnnna$aReplications, Autonomous
=450  \\$wnnna$aReplications, DNA
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aDNA Replication Timing
=550  \\$wh$aEndoreduplication
=550  \\$wh$aS Phase
=550  \\$wh$aTelomere Shortening
=550  \\$aDNA-Binding Proteins
=550  \\$aS Phase
=550  \\$aVirus Replication
=667  \\$acoord IM with specific DNA (IM); coord IM with VIRUS REPLICATION (IM) for DNA replic in viruses; consider also DNA /biosyn
=680  \\$iThe process by which a DNA molecule is duplicated.
=688  \\$a68
=750  \0$aDNA replication$0(DLC) sh 90005926$5IEN

=LDR  02012cz  a2200409n  4500
=001  9880363559402441
=005  20201223123710.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004260
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x222
=072  \\$aG5.$x219
=150  \\$aDNA Repair
=450  \\$wnnna$aBase Excision Repair
=450  \\$wnnna$aBase Excision Repairs
=450  \\$wnnna$aExcision Repair
=450  \\$wnnna$aExcision Repair, Base
=450  \\$wnnna$aExcision Repair, Nucleotide
=450  \\$wnnna$aExcision Repairs
=450  \\$aNucleotide Excision Repair
=450  \\$wnnna$aNucleotide Excision Repairs
=450  \\$wnnna$aRepair, Base Excision
=450  \\$wnnna$aRepair, Excision
=450  \\$wnnna$aRepairs, Base Excision
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aGenetic Phenomena
=550  \\$wh$aDNA End-Joining Repair
=550  \\$wh$aDNA Mismatch Repair
=550  \\$wh$aRecombinational DNA Repair
=550  \\$wh$aSOS Response, Genetics
=550  \\$aDNA-Formamidopyrimidine Glycosylase
=550  \\$aDNA Repair Enzymes
=550  \\$aTargeted Gene Repair
=667  \\$acoord IM with specific DNA (IM)
=680  \\$iThe reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule which contained damaged regions. The major repair mechanisms are excision repair, in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand; photoreactivation repair, in which the lethal and mutagenic effects of ultraviolet light are eliminated; and post-replication repair, in which the primary lesions are not repaired, but the gaps in one daughter duplex are filled in by incorporation of portions of the other (undamaged) daughter duplex. Excision repair and post-replication repair are sometimes referred to as "dark repair" because they do not require light.
=688  \\$a74(71)
=750  \0$aDNA repair$0(DLC) sh 85037009$5IEN

=LDR  02205cz  a2200445n  4500
=001  9880363559502441
=005  20141212211008.0
=008  880601\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015342
=035  \\$aCAZ7387HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD13.$x444.$x600.$x223
=072  \\$aD27.$x505.$x259.$x750.$x600.$x223
=072  \\$aD27.$x720.$x470.$x530.$x600.$x223
=150  \\$aDNA Probes
=450  \\$aChromosomal Probes
=450  \\$wnnna$aChromosomal Probes, Whole
=450  \\$wnnna$aConserved Gene Probes
=450  \\$wnnna$aDNA Gene Probes
=450  \\$wnnna$aDNA Hybridization Probes
=450  \\$wnnna$aGene Probes, Conserved
=450  \\$aGene Probes, DNA
=450  \\$wnnna$aHybridization Probes, DNA
=450  \\$wnnna$aProbes, Chromosomal
=450  \\$wnnna$aProbes, Conserved Gene
=450  \\$wnnna$aProbes, DNA
=450  \\$wnnna$aProbes, DNA Gene
=450  \\$wnnna$aProbes, DNA Hybridization
=450  \\$wnnna$aProbes, Whole Chromosomal
=450  \\$wnnna$aWhole Chromosomal Probes
=450  \\$wnnna$aWhole Genomic DNA Probes
=550  \\$wg$aNucleic Acid Probes
=550  \\$wh$aDNA, Complementary
=550  \\$wh$aDNA Primers
=550  \\$wh$aDNA Probes, HLA
=550  \\$wh$aDNA Probes, HPV
=667  \\$aGEN or unspecified; prefer specifics; /drug eff /ultrastruct permitted; CDNA PROBES see DNA, COMPLEMENTARY is also available
=680  \\$iSpecies- or subspecies-specific DNA (including COMPLEMENTARY DNA; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections.
=688  \\$a89
=750  \0$aDNA probes$5IEN$0(DLC)sh 86007800

=LDR  02066cz  a2200517n  4500
=001  9880363408902441
=005  20141212192151.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004724
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x388.$x250
=072  \\$aE4.$x502.$x250
=150  \\$aEndoscopy
=450  \\$wnnna$aEndoscopic Surgical Procedure
=450  \\$aEndoscopic Surgical Procedures
=450  \\$wnnna$aEndoscopy, Surgical
=450  \\$wnnna$aProcedure, Endoscopic Surgical
=450  \\$wnnna$aProcedures, Endoscopic Surgical
=450  \\$wnnna$aSurgical Endoscopy
=450  \\$wnnna$aSurgical Procedure, Endoscopic
=450  \\$aSurgical Procedures, Endoscopic
=550  \\$wg$aDiagnostic Techniques, Surgical
=550  \\$wg$aMinimally Invasive Surgical Procedures
=550  \\$wh$aAngioscopy
=550  \\$wh$aArthroscopy
=550  \\$wh$aBronchoscopy
=550  \\$wh$aColposcopy
=550  \\$wh$aConversion to Open Surgery
=550  \\$wh$aCuldoscopy
=550  \\$wh$aCystoscopy
=550  \\$wh$aEndoscopy, Digestive System
=550  \\$wh$aFetoscopy
=550  \\$wh$aHysteroscopy
=550  \\$wh$aLaparoscopy
=550  \\$wh$aLaryngoscopy
=550  \\$wh$aMediastinoscopy
=550  \\$wh$aNatural Orifice Endoscopic Surgery
=550  \\$wh$aNeuroendoscopy
=550  \\$wh$aThoracoscopy
=550  \\$wh$aUreteroscopy
=550  \\$wh$aVideo-Assisted Surgery
=550  \\$aEndoscopes
=667  \\$ageneral or unspecified; prefer specifics; / instrum permitted but consider also ENDOSCOPES
=680  \\$iProcedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
=688  \\$a1963
=750  \0$aEndoscopy$5IEN-M$0(DLC)sh 85043097

=LDR  01050cz  a2200241n  4500
=001  9880363409002441
=005  20141212201109.0
=008  770516\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004723
=035  \\$aCAZ7861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x575.$x241
=072  \\$aD12.$x644.$x468.$x241
=072  \\$aD12.$x776.$x641.$x650.$x575.$x241
=150  \\$aEndorphins
=450  \\$wnnna$aEndorphin
=550  \\$wg$aOpioid Peptides
=550  \\$wh$aalpha-Endorphin
=550  \\$wh$abeta-Endorphin
=550  \\$wh$agamma-Endorphin
=680  \\$iOne of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group.
=688  \\$a78(Aug 77); was see under PEPTIDES Aug-Dec 1977
=750  \0$aEndorphins$5IEN$0(DLC)sh 85043094

=LDR  01207cz  a2200229n  4500
=001  9880363409102441
=005  20141212201109.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004721
=035  \\$aCAZ7859HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x248
=150  \\$aEndoplasmic Reticulum
=450  \\$aErgastoplasm
=450  \\$wnnna$aReticulum, Endoplasmic
=550  \\$wg$aOrganelles
=550  \\$wh$aEndoplasmic Reticulum, Rough
=550  \\$wh$aEndoplasmic Reticulum, Smooth
=667  \\$aGEN or unspecified; prefer specifics; A 11 qualif except /cytol; /genet permitted
=680  \\$iA system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed)
=688  \\$a65
=750  \0$aEndoplasmic reticulum$5IEN$0(DLC)sh 85043091

=LDR  00707cz  a2200205n  4500
=001  9880363409202441
=005  20141212201108.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004720
=035  \\$aCAZ7858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x352.$x355
=150  \\$aEndonucleases
=550  \\$wg$aEsterases
=550  \\$wh$aEndodeoxyribonucleases
=550  \\$wh$aEndoribonucleases
=550  \\$aGene Products, pol
=680  \\$iEnzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-.
=688  \\$a73
=750  \0$aEndonucleases$5IEN-M$0(DLC)sh 96010367

=LDR  01458cz   2200481n  4500
=001  9880363409302441
=005  20220302164516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004718
=035  \\$aCAZ7856HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x107.$x795
=150  \\$aSaccharomycetales
=450  \\$aBudding Yeast
=450  \\$wnnna$aBudding Yeasts
=450  \\$wnnna$aEndomycetale
=450  \\$aEndomycetales
=450  \\$wnnna$aEndomycopses
=450  \\$aEndomycopsis
=450  \\$wnnna$aSaccharomycetale
=450  \\$aYeast, Budding
=450  \\$wnnna$aYeasts, Budding
=550  \\$wg$aAscomycota
=550  \\$wh$aDebaryomyces
=550  \\$wh$aDekkera
=550  \\$wh$aDipodascus
=550  \\$wh$aEndomyces
=550  \\$wh$aEremothecium
=550  \\$wh$aHanseniaspora
=550  \\$wh$aKluyveromyces
=550  \\$wh$aLipomyces
=550  \\$wh$aMetschnikowia
=550  \\$wh$aPichia
=550  \\$wh$aSaccharomyces
=550  \\$wh$aSaccharomycopsis
=550  \\$wh$aTorulaspora
=550  \\$wh$aWilliopsis
=550  \\$wh$aYarrowia
=550  \\$wh$aZygosaccharomyces
=680  \\$iAn order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats.
=688  \\$a1999 (1963)
=688  \\$a99(63); for EREMOTHECIUM use ASCOMYCOTA 1963-74
=750  \0$aEndomycetales$5IEN$0(DLC)sh 85043089

=LDR  00737cz  a2200181n  4500
=001  9880363409402441
=005  20141212201107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004717
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x679.$x490
=150  \\$aEndometrium
=450  \\$wnnna$aEndometria
=550  \\$wg$aUterus
=550  \\$wh$aDecidua
=667  \\$ainflammation = ENDOMETRITIS
=680  \\$iThe mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
=750  \0$aEndometrium$5IEN$0(DLC)sh 85043080

=LDR  00835cz  a2200193n  4500
=001  9880363409502441
=005  20141212201107.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004715
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x351.$x500.$x163
=150  \\$aEndometriosis
=450  \\$aEndometrioma
=450  \\$wnnna$aEndometriomas
=450  \\$wnnna$aEndometrioses
=550  \\$wg$aGenital Diseases, Female
=667  \\$anon-neoplastic & nothing to do with "endometrial carcinoma" ( = ENDOMETRIAL NEOPLASMS); coord IM with specific precoord organ/dis term (IM)
=680  \\$iA condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
=750  \0$aEndometriosis$5IEN$0(DLC)sh 85043079

=LDR  00975cz  a2200277n  4500
=001  9880363409602441
=005  20180621155029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004708
=035  \\$aCAZ7846HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x397
=072  \\$aH2.$x163.$x876.$x213
=150  \\$aEndodontics
=550  \\$wg$aDentistry
=550  \\$wg$aSpecialties, Dental
=550  \\$wh$aApicoectomy
=550  \\$wh$aDental Implantation, Endosseous, Endodontic
=550  \\$wh$aDental Pulp Capping
=550  \\$wh$aPulpectomy
=550  \\$wh$aPulpotomy
=550  \\$wh$aRoot Canal Therapy
=550  \\$wh$aTooth Replantation
=667  \\$aSPEC: SPEC qualif; ENDODONTICS = the specialty, ROOT CANAL THERAPY = the patient
=680  \\$iA dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity (pulp chamber and pulp canal).
=750  \0$aEndodontics$5IEN-M$0(DLC)sh 85043075

=LDR  00782cz  a2200241n  4500
=001  9880363409702441
=005  20170620113438.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004705
=035  \\$aCAZ7843HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG4.$x417
=150  \\$aEndocytosis
=450  \\$wnnna$aEndocytoses
=550  \\$wg$aCell Physiological Phenomena
=550  \\$wh$aPhagocytosis
=550  \\$wh$aPinocytosis
=550  \\$wh$aTranscytosis
=550  \\$aEndosomes
=550  \\$aVirus Internalization
=680  \\$iCellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis.
=688  \\$a76(73); was see under PHAGOCYTOSIS 1975
=750  \0$aEndocytosis$5IEN$0(DLC)sh 85043074

=LDR  00838cz  a2200241n  4500
=001  9880363409802441
=005  20180621153704.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004704
=035  \\$aCAZ7842HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x782.$x323
=072  \\$aH2.$x403.$x429.$x323
=150  \\$aEndocrinology
=450  \\$wnnna$aEndocrinology and Metabolism Specialty
=450  \\$wnnna$aMetabolism and Endocrinology Specialty
=550  \\$wg$aInternal Medicine
=550  \\$wg$aPhysiology
=550  \\$wh$aNeuroendocrinology
=550  \\$aEndocrine System Diseases
=667  \\$aSPEC: SPEC qualif; DF: ENDOCRINOL
=680  \\$iA subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the ENDOCRINE SYSTEM.
=750  \0$aEndocrinology$5IEN-HS$0(DLC)sh 85043068

=LDR  01084cz  a2200289n  4500
=001  9880363409902441
=005  20141212201103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004702
=035  \\$aCAZ7840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA6.$x407
=150  \\$aEndocrine Glands
=450  \\$wnnna$aEndocrine Gland
=450  \\$wnnna$aGland, Endocrine
=550  \\$wg$aEndocrine System
=550  \\$wh$aAdrenal Glands
=550  \\$wh$aGonads
=550  \\$wh$aIslets of Langerhans
=550  \\$wh$aParathyroid Glands
=550  \\$wh$aPineal Gland
=550  \\$wh$aPituitary-Adrenal System
=550  \\$wh$aPituitary Gland
=550  \\$wh$aThyroid Gland
=667  \\$ageneral; prefer specifics, / surg: consider also ENDOCRINE SURGICAL PROCEDURES; endocrine deficiency: probably specific ENDOCRINE SYSTEM DISEASE: Manual 23.25.3
=680  \\$iDuctless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body.
=750  \0$aEndocrine glands$5IEN$0(DLC)sh 85043060

=LDR  01768cz  a2200493n  4500
=001  9880363410002441
=005  20141212201103.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004701
=035  \\$aCAZ7839HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x322
=072  \\$aC19.$x344
=150  \\$aEndocrine Gland Neoplasms
=450  \\$wnnna$aCancer, Endocrine
=450  \\$wnnna$aCancer, Endocrine Gland
=450  \\$aCancer of Endocrine Gland
=450  \\$wnnna$aCancer of the Endocrine Gland
=450  \\$wnnna$aCancers, Endocrine
=450  \\$wnnna$aCarcinoma, Endocrine Gland
=450  \\$wnnna$aCarcinoma of Endocrine Gland
=450  \\$aEndocrine Cancer
=450  \\$wnnna$aEndocrine Cancers
=450  \\$aEndocrine Gland Cancer
=450  \\$wnnna$aEndocrine Gland Carcinoma
=450  \\$wnnna$aEndocrine Gland Neoplasm
=450  \\$wnnna$aNeoplasm, Endocrine Gland
=450  \\$wnnna$aNeoplasms, Endocrine Gland
=550  \\$wg$aEndocrine System Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aAdrenal Gland Neoplasms
=550  \\$wh$aMultiple Endocrine Neoplasia
=550  \\$wh$aOvarian Neoplasms
=550  \\$wh$aPancreatic Neoplasms
=550  \\$wh$aParaneoplastic Endocrine Syndromes
=550  \\$wh$aParathyroid Neoplasms
=550  \\$wh$aPituitary Neoplasms
=550  \\$wh$aTesticular Neoplasms
=550  \\$wh$aThyroid Neoplasms
=667  \\$ageneral; prefer specifics; coordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the ENDOCRINE GLANDS.
=688  \\$a92; was ENDOCRINE GLAND NEOPLASMS (NON MESH) 1971-91
=750  \0$aEndocrine glands$xTumors$5IEN-M$0(DLC)sh 87001844
=750  \0$aEndocrine glands$xCancer$5IEN-HS$0(DLC)sh2010009099

=LDR  01554cz  a2200433n  4500
=001  9880363410102441
=005  20141212201102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004700
=035  \\$aCAZ7838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC19
=150  \\$aEndocrine System Diseases
=450  \\$wnnna$aDisease, Endocrine
=450  \\$wnnna$aDisease, Endocrine System
=450  \\$wnnna$aDiseases, Endocrine
=450  \\$wnnna$aDiseases, Endocrine System
=450  \\$wnnna$aDiseases of Endocrine System
=450  \\$wnnna$aEndocrine Disease
=450  \\$aEndocrine Diseases
=450  \\$wnnna$aEndocrine System Disease
=450  \\$wnnna$aSystem Disease, Endocrine
=450  \\$wnnna$aSystem Diseases, Endocrine
=550  \\$wh$aAdrenal Gland Diseases
=550  \\$wh$aBone Diseases, Endocrine
=550  \\$wh$aDiabetes Mellitus
=550  \\$wh$aDwarfism
=550  \\$wh$aEndocrine Gland Neoplasms
=550  \\$wh$aGonadal Disorders
=550  \\$wh$aParathyroid Diseases
=550  \\$wh$aPituitary Diseases
=550  \\$wh$aPolyendocrinopathies, Autoimmune
=550  \\$wh$aThyroid Diseases
=550  \\$wh$aTuberculosis, Endocrine
=550  \\$aEndocrinology
=667  \\$ageneral; prefer specific disease: Manual 23.25.3; /diag: consider also DIAGNOSTIC TECHNIQUES, ENDOCRINE
=680  \\$iPathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.
=688  \\$a2005 (1965)
=750  \0$aEndocrine glands$xDiseases$0(DLC) sh 85043061$5IEN

=LDR  00539cz  a2200181n  4500
=001  9880363410202441
=005  20141212201102.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004699
=035  \\$aCAZ7837HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x541.$x207
=150  \\$aEndocardium
=450  \\$wnnna$aEndocardiums
=550  \\$wg$aHeart
=667  \\$ainflammation = ENDOCARDITIS & its specifics
=680  \\$iThe innermost layer of the heart, comprised of endothelial cells.
=750  \0$aEndocardium$5IEN-M$0(DLC)sh 93009192

=LDR  01157cz  a2200277n  4500
=001  9880363410302441
=005  20141212201101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004697
=035  \\$aCAZ7835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x300
=072  \\$aC1.$x539.$x190.$x249
=072  \\$aC14.$x260.$x249
=072  \\$aC14.$x280.$x282.$x407
=150  \\$aEndocarditis, Bacterial
=450  \\$wnnna$aBacterial Endocarditides
=450  \\$wnnna$aBacterial Endocarditis
=450  \\$wnnna$aEndocarditides, Bacterial
=550  \\$wg$aBacterial Infections
=550  \\$wg$aCardiovascular Infections
=550  \\$wg$aEndocarditis
=550  \\$wh$aEndocarditis, Subacute Bacterial
=667  \\$acoordinate with specific bacterium /infections heading (IM) if pertinent; DF: ENDOCARDITIS BACT
=680  \\$iInflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.
=750  \0$aInfective endocarditis$5IEN$0(DLC)sh 85043055

=LDR  01102cz  a2200253n  4500
=001  9880363410402441
=005  20141212201101.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004696
=035  \\$aCAZ7834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x282
=150  \\$aEndocarditis
=450  \\$wnnna$aEndocarditides
=450  \\$wnnna$aEndocarditides, Infective
=450  \\$wnnna$aEndocarditis, Infective
=450  \\$wnnna$aInfective Endocarditides
=450  \\$wnnna$aInfective Endocarditis
=550  \\$wg$aHeart Diseases
=550  \\$wh$aEndocarditis, Bacterial
=550  \\$wh$aEndocarditis, Non-Infective
=667  \\$arheumatic endocarditis: index under RHEUMATIC HEART DISEASE (IM) + ENDOCARDITIS (IM)
=680  \\$iInflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.
=750  \0$aEndocarditis$5IEN$0(DLC)sh 85043054

=LDR  01294cz  a2200277n  4500
=001  9880363410502441
=005  20141212201100.0
=008  820423\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004694
=035  \\$aCAZ7832HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x240.$x400.$x560.$x350
=072  \\$aC14.$x280.$x400.$x560.$x350
=072  \\$aC16.$x131.$x240.$x400.$x560.$x350
=150  \\$aEndocardial Cushion Defects
=450  \\$wnnna$aCushion Defect, Endocardial
=450  \\$wnnna$aCushion Defects, Endocardial
=450  \\$wnnna$aDefect, Endocardial Cushion
=450  \\$wnnna$aDefects, Endocardial Cushion
=450  \\$wnnna$aEndocardial Cushion Defect
=450  \\$aEndocardial Cushions$xabnormalities
=450  \\$aPersistent Common Atrioventricular Canal
=550  \\$wg$aHeart Septal Defects
=680  \\$iA spectrum of septal defects involving the ATRIAL SEPTUM; VENTRICULAR SEPTUM; and the atrioventricular valves (TRICUSPID VALVE; BICUSPID VALVE). These defects are due to incomplete growth and fusion of the ENDOCARDIAL CUSHIONS which are important in the formation of two atrioventricular canals, site of future atrioventricular valves.
=688  \\$a91(83); was see under HEART SEPTAL DEFECTS 1983-90
=750  \0$aEndocardial cushion defects$0(DLC) sh 85043052$5IEN

=LDR  00544cz  a2200181n  4500
=001  9880363410602441
=005  20141212201059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004692
=035  \\$aCAZ7830HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x184.$x281
=072  \\$aC14.$x907.$x940.$x90.$x340
=150  \\$aEndarteritis
=450  \\$wnnna$aEndarteritides
=550  \\$wg$aArteritis
=680  \\$iInflammation of the inner endothelial lining (TUNICA INTIMA) of an artery.
=750  \0$aEndarteritis$5IEN$0(DLC)sh 85043046

=LDR  00964cz  a2200265n  4500
=001  9880363410702441
=005  20141212201059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004691
=035  \\$aCAZ7829HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x100.$x814.$x456
=150  \\$aEndarterectomy
=450  \\$wnnna$aEndarterectomies
=450  \\$wnnna$aThromboendarterectomies
=450  \\$aThromboendarterectomy
=550  \\$wg$aVascular Surgical Procedures
=550  \\$wh$aEndarterectomy, Carotid
=550  \\$aAngioplasty
=550  \\$aArteries
=550  \\$aAtherectomy
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY.
=688  \\$a67(65)
=750  \0$aEndarterectomy$5IEN$0(DLC)sh 87001039

=LDR  00888cz  a2200205n  4500
=001  9880363410802441
=005  20141212201059.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004690
=035  \\$aCAZ7828HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x682.$x192.$x836.$x456
=150  \\$aEncyclopedias as Topic
=450  \\$wnnna$aEncyclopedias as Topics
=550  \\$wg$aReference Books
=667  \\$ado not confuse with Publication Type ENCYCLOPEDIAS
=680  \\$iWorks containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
=688  \\$a2008(1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Encyclopedias
=750  \0$aEncyclopedias and dictionaries$0(DLC) sh 85042997$5IEN

=LDR  00769cz  a2200241n  4500
=001  9880363410902441
=005  20141212192150.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004688
=035  \\$aCAZ7826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x266
=072  \\$aF1.$x145.$x126.$x837
=072  \\$aF3.$x550.$x375.$x300
=150  \\$aEncopresis
=550  \\$wg$aBehavioral Symptoms
=550  \\$wg$aElimination Disorders
=550  \\$wg$aSigns and Symptoms, Digestive
=550  \\$aFecal Incontinence
=667  \\$aof psychol origin: differentiate from FECAL INCONTINENCE, of organic origin
=680  \\$iIncontinence of feces not due to organic defect or illness.
=688  \\$a69(63)
=750  \0$aEncopresis$5IEN$0(DLC)sh 85042990

=LDR  01967cz  a2200361n  4500
=001  9880363411002441
=005  20141212201057.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004685
=035  \\$aCAZ7823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x355.$x355
=072  \\$aC2.$x182.$x500.$x300.$x450.$x250
=072  \\$aC2.$x290.$x450.$x225
=072  \\$aC2.$x782.$x930.$x100.$x370.$x325
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x450.$x600
=072  \\$aC10.$x228.$x228.$x245.$x340.$x450.$x225
=072  \\$aC10.$x228.$x228.$x291.$x323.$x325
=072  \\$aC10.$x228.$x440.$x406.$x225
=150  \\$aEncephalomyelitis, Venezuelan Equine
=450  \\$aEncephalitis, Venezuelan Equine
=450  \\$wnnna$aEncephalomyelitides, Venezuelan Equine
=450  \\$wnnna$aEquine Encephalitis, Venezuelan
=450  \\$wnnna$aEquine Encephalomyelitides, Venezuelan
=450  \\$wnnna$aEquine Encephalomyelitis, Venezuelan
=450  \\$wnnna$aVenezuelan Equine Encephalitis
=450  \\$wnnna$aVenezuelan Equine Encephalomyelitides
=450  \\$wnnna$aVenezuelan Equine Encephalomyelitis
=550  \\$wg$aEncephalomyelitis, Equine
=667  \\$ahuman & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet; DF: ENCEPH VENEZ EQUINE
=680  \\$iA form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism (ENCEPHALITIS VIRUS, VENEZUELAN EQUINE) is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. (From Joynt, Clinical Neurology, 1996, Ch26, pp9-10)
=688  \\$a1991(1976); was see under ENCEPHALOMYELITIS, EQUINE 1976-1990
=750  \0$aVenezuelan equine encephalomyelitis$5IEN$0(DLC)sh 85142697

=LDR  01821cz  a2200397n  4500
=001  9880363411102441
=005  20141212201056.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004683
=035  \\$aCAZ7821HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x355
=072  \\$aC2.$x182.$x500.$x300.$x450
=072  \\$aC2.$x290.$x450
=072  \\$aC2.$x782.$x930.$x100.$x370
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x450
=072  \\$aC10.$x228.$x228.$x245.$x340.$x450
=072  \\$aC10.$x228.$x228.$x291.$x323
=072  \\$aC10.$x228.$x440.$x406
=150  \\$aEncephalomyelitis, Equine
=450  \\$aEncephalitis, Equine
=450  \\$wnnna$aEquine Encephalitis
=450  \\$wnnna$aEquine Encephalomyelitis
=450  \\$wnnna$aEquine Encephalomyelitis Viral Infections
=450  \\$aEquine Encephalomyelitis Virus Infections
=450  \\$wnnna$aInfections, Equine Encephalomyelitis Virus
=550  \\$wg$aAlphavirus Infections
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aEncephalitis, Viral
=550  \\$wg$aEncephalomyelitis
=550  \\$wh$aEncephalomyelitis, Eastern Equine
=550  \\$wh$aEncephalomyelitis, Venezuelan Equine
=550  \\$wh$aEncephalomyelitis, Western Equine
=667  \\$ahuman & animal; if in horses, coord with HORSE DISEASES (IM) + HORSES (NIM) & use /vet; DF: ENCEPH EQUINE
=680  \\$iA group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. (From Joynt, Clinical Neurology, 1996, Ch26, pp8-10)
=750  \0$aEquine encephalomyelitis$5IEN$0(DLC)sh 85044542

=LDR  01049cz  a2200301n  4500
=001  9880363411202441
=005  20141212201055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004682
=035  \\$aCAZ7820HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x687.$x359.$x456
=072  \\$aC22.$x905.$x323
=150  \\$aEncephalomyelitis, Enzootic Porcine
=450  \\$wnnna$aDisease, Talfan
=450  \\$wnnna$aDisease, Teschen
=450  \\$wnnna$aEnzootic Porcine Encephalomyelitis
=450  \\$aPoliomyelitis, Porcine
=450  \\$wnnna$aPorcine Encephalomyelitis, Enzootic
=450  \\$wnnna$aPorcine Poliomyelitis
=450  \\$aTalfan Disease
=450  \\$aTeschen Disease
=550  \\$wg$aEnterovirus Infections
=550  \\$wg$aSwine Diseases
=667  \\$acaused by an enterovirus; don't forget also SWINE (NIM) & check tag ANIMALS; DF: note short X ref
=680  \\$iA picornavirus infection producing symptoms similar to poliomyelitis in pigs.
=688  \\$a70
=750  \0$aTeschen disease$0(DLC) sh 85134131$5IEN

=LDR  02308cz  a2200385n  4500
=001  9880363411302441
=005  20141212201055.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004681
=035  \\$aCAZ7819HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x703.$x300
=072  \\$aC10.$x228.$x140.$x695.$x562.$x250
=072  \\$aC10.$x314.$x350.$x250
=072  \\$aC20.$x111.$x258.$x625.$x300
=072  \\$aE5.$x598.$x500.$x500.$x500
=150  \\$aEncephalomyelitis, Autoimmune, Experimental
=450  \\$wnnna$aAllergic Encephalomyelitis
=450  \\$wnnna$aAllergic Encephalomyelitis, Experimental
=450  \\$aAutoimmune Encephalomyelitis, Experimental
=450  \\$wnnna$aAutoimmune Experimental Encephalomyelitis
=450  \\$aEncephalomyelitis, Allergic
=450  \\$wnnna$aEncephalomyelitis, Autoimmune Experimental
=450  \\$wnnna$aEncephalomyelitis, Experimental Allergic
=450  \\$aEncephalomyelitis, Experimental Autoimmune
=450  \\$wnnna$aExperimental Allergic Encephalomyelitides
=450  \\$wnnna$aExperimental Allergic Encephalomyelitis
=450  \\$wnnna$aExperimental Autoimmune Encephalomyelitis
=450  \\$wnnna$aExperimental Encephalomyelitis, Autoimmune
=550  \\$wg$aDemyelinating Autoimmune Diseases, CNS
=550  \\$wg$aNervous System Autoimmune Disease, Experimental
=667  \\$acoordinate with specific demyelinating disease if pertinent; DF: ENCEPH ALLERGIC
=680  \\$iAn experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5)
=688  \\$a2005 (1964)
=750  \0$aAllergic encephalomyelitis$0(DLC) sh 85003660$5IEN

=LDR  01358cz  a2200313n  4500
=001  9880363411402441
=005  20141212201054.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004679
=035  \\$aCAZ7817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x430.$x500
=072  \\$aC10.$x228.$x228.$x291
=072  \\$aC10.$x228.$x440
=150  \\$aEncephalomyelitis
=450  \\$wnnna$aEncephalomyelitis, Inflammatory
=450  \\$wnnna$aInflammatory Encephalomyelitis
=450  \\$wnnna$aMyeloencephalitides
=450  \\$aMyeloencephalitis
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wg$aEncephalitis
=550  \\$wh$aEncephalomyelitis, Equine
=550  \\$wh$aFatigue Syndrome, Chronic
=550  \\$wh$aLeukoencephalitis, Acute Hemorrhagic
=550  \\$aEncephalitis
=667  \\$aGEN or unspecified; prefer specifics; coord IM with specific organism/infection term (IM) or other cause (IM)
=680  \\$iA general term indicating inflammation of the BRAIN and SPINAL CORD, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. There is significant overlap regarding the usage of this term and ENCEPHALITIS in the literature.
=750  \0$aEncephalomyelitis$5IEN$0(DLC)sh 85042980

=LDR  03347cz  a2200865n  4500
=001  9880363411502441
=005  20141212201053.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004677
=035  \\$aCAZ7815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x500.$x680.$x488
=072  \\$aC16.$x131.$x666.$x680.$x488
=072  \\$aC23.$x300.$x707.$x186
=150  \\$aEncephalocele
=450  \\$wnnna$aAcquired Encephalocele
=450  \\$wnnna$aAcquired Encephaloceles
=450  \\$wnnna$aBifid Cranium
=450  \\$wnnna$aBifid Craniums
=450  \\$wnnna$aBifidum, Cranium
=450  \\$wnnna$aBifidums, Cranium
=450  \\$wnnna$aCephalocele
=450  \\$wnnna$aCephaloceles
=450  \\$wnnna$aCerebellar Hernia
=450  \\$wnnna$aCerebellar Hernias
=450  \\$wnnna$aCerebellar Herniation
=450  \\$wnnna$aCerebellar Herniations
=450  \\$wnnna$aCerebral Hernia
=450  \\$wnnna$aCerebral Hernias
=450  \\$wnnna$aCranial Meningoencephalocele
=450  \\$wnnna$aCranial Meningoencephaloceles
=450  \\$wnnna$aCraniocele
=450  \\$wnnna$aCranioceles
=450  \\$wnnna$aCranium, Bifid
=450  \\$wnnna$aCranium Bifidum
=450  \\$wnnna$aCranium Bifidums
=450  \\$wnnna$aCraniums, Bifid
=450  \\$wnnna$aEncephalocele, Acquired
=450  \\$wnnna$aEncephalocele, Frontal
=450  \\$wnnna$aEncephalocele, Occipital
=450  \\$wnnna$aEncephalocele, Sincipital
=450  \\$wnnna$aEncephaloceles
=450  \\$wnnna$aEncephaloceles, Acquired
=450  \\$wnnna$aEncephaloceles, Frontal
=450  \\$wnnna$aEncephaloceles, Occipital
=450  \\$wnnna$aEncephaloceles, Sincipital
=450  \\$aFrontal Encephalocele
=450  \\$wnnna$aFrontal Encephaloceles
=450  \\$wnnna$aHernia, Cerebellar
=450  \\$aHernia, Cerebral
=450  \\$wnnna$aHernia, Tonsillar
=450  \\$wnnna$aHernias, Cerebellar
=450  \\$wnnna$aHernias, Cerebral
=450  \\$wnnna$aHernias, Tonsillar
=450  \\$wnnna$aHerniation, Cerebellar
=450  \\$wnnna$aHerniation, Tonsillar
=450  \\$wnnna$aHerniations, Cerebellar
=450  \\$wnnna$aHerniations, Tonsillar
=450  \\$wnnna$aMeningoencephalocele, Cranial
=450  \\$wnnna$aMeningoencephaloceles, Cranial
=450  \\$wnnna$aNotoencephalocele
=450  \\$wnnna$aNotoencephaloceles
=450  \\$aOccipital Encephalocele
=450  \\$wnnna$aOccipital Encephaloceles
=450  \\$wnnna$aSincipital Encephalocele
=450  \\$wnnna$aSincipital Encephaloceles
=450  \\$wnnna$aTonsillar Hernia
=450  \\$wnnna$aTonsillar Hernias
=450  \\$wnnna$aTonsillar Herniation
=450  \\$wnnna$aTonsillar Herniations
=550  \\$wg$aHernia
=550  \\$wg$aNeural Tube Defects
=667  \\$ameningoencephalocele: coordinate IM with MENINGOCELE (IM)
=680  \\$iBrain tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur.
=750  \0$aEncephalocele$5IEN$0(DLC)sh 85042979

=LDR  01946cz  a2200457n  4500
=001  9880363411602441
=005  20141212201052.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004676
=035  \\$aCAZ7814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x776.$x543.$x620.$x540
=072  \\$aD12.$x776.$x641.$x580.$x510
=150  \\$aMyelin Basic Protein
=450  \\$wnnna$aGolli-MBP1 Protein
=450  \\$wnnna$aGolli MBP1 Protein
=450  \\$wnnna$aGolli-MBP2 Protein
=450  \\$wnnna$aGolli MBP2 Protein
=450  \\$wnnna$aHOG5 Protein
=450  \\$wnnna$aHOG7 Protein
=450  \\$wnnna$aMBP1 Protein
=450  \\$wnnna$aMBP2 Protein
=450  \\$wnnna$aMBP3 Protein
=450  \\$wnnna$aMBP4 Protein
=450  \\$wnnna$aMyelin Basic Protein, 17.2 kDa Isoform
=450  \\$wnnna$aMyelin Basic Protein, 18.5 kDa Isoform
=450  \\$wnnna$aMyelin Basic Protein, 20.2 kDa Isoform
=450  \\$wnnna$aMyelin Basic Protein, 21.5 kDa Isoform
=450  \\$wnnna$aMyelin Basic Protein, Isoform 1
=450  \\$wnnna$aMyelin Basic Protein, Isoform 2
=450  \\$wnnna$aMyelin Basic Protein, Isoform 3
=450  \\$wnnna$aMyelin Basic Protein, Isoform 4
=450  \\$wnnna$aMyelin Basic Protein, Isoform 5
=450  \\$wnnna$aMyelin Basic Protein, Isoform 6
=450  \\$wnnna$aMyelin Basic Protein, Isoform 7
=550  \\$wg$aMyelin Proteins
=680  \\$iAn abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes.
=688  \\$a2013(1996)
=688  \\$aHeading changed 20120905 from: 150:##:_{dollar}a Myelin Basic Proteins
=688  \\$a96; was ENCEPHALITOGENIC BASIC PROTEINS 1973-95 (Prov 1974); MYELIN BASIC PROTEINS was see ENCEPHALITOGENIC BASIC PROTEINS 1979-95
=750  \0$aMyelin basic protein$5IEN$0(DLC)sh 89006590

=LDR  03081cz  a2200649n  4500
=001  9880363411702441
=005  20141212201051.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004675
=035  \\$aCAZ7813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x343.$x360
=072  \\$aC2.$x81.$x885.$x400
=072  \\$aC2.$x182.$x500.$x300.$x300.$x350
=072  \\$aC2.$x290.$x310.$x530
=072  \\$aC2.$x782.$x310.$x360
=072  \\$aC2.$x782.$x350.$x250.$x500
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x300.$x775
=072  \\$aC10.$x228.$x228.$x245.$x340.$x310.$x500
=150  \\$aEncephalitis, Tick-Borne
=450  \\$wnnna$aCentral European Encephalitis
=450  \\$wnnna$aEncephalitides, European Tick-Borne
=450  \\$wnnna$aEncephalitides, Louping Ill
=450  \\$wnnna$aEncephalitides, Powassan
=450  \\$wnnna$aEncephalitides, Tick-Borne
=450  \\$wnnna$aEncephalitis, Central European
=450  \\$wnnna$aEncephalitis, European Tick-Borne
=450  \\$wnnna$aEncephalitis, European Tick Borne
=450  \\$wnnna$aEncephalitis, Far Eastern Russian
=450  \\$wnnna$aEncephalitis, Louping Ill
=450  \\$wnnna$aEncephalitis, Powassan
=450  \\$wnnna$aEncephalitis, Russian Spring-Summer
=450  \\$wnnna$aEncephalitis, Russian Spring Summer
=450  \\$wnnna$aEncephalitis, Tick Borne
=450  \\$wnnna$aEuropean Tick-Borne Encephalitides
=450  \\$wnnna$aEuropean Tick-Borne Encephalitis
=450  \\$wnnna$aEuropean Tick Borne Encephalitis
=450  \\$aFar Eastern Russian Encephalitis
=450  \\$wnnna$aLouping Ill Encephalitides
=450  \\$wnnna$aLouping Ill Encephalitis
=450  \\$wnnna$aPowassan Encephalitides
=450  \\$aPowassan Encephalitis
=450  \\$wnnna$aRussian Spring-Summer Encephalitis
=450  \\$wnnna$aRussian Spring Summer Encephalitis
=450  \\$wnnna$aSpring-Summer Encephalitis, Russian
=450  \\$wnnna$aTick-Borne Encephalitides
=450  \\$wnnna$aTick-Borne Encephalitides, European
=450  \\$wnnna$aTick-Borne Encephalitis
=450  \\$wnnna$aTick Borne Encephalitis
=450  \\$wnnna$aTick-Borne Encephalitis, European
=550  \\$wg$aEncephalitis, Arbovirus
=550  \\$wg$aFlavivirus Infections
=550  \\$wg$aTick-Borne Diseases
=667  \\$acoord IM with specific virus (IM) if pertinent; DF: ENCEPH TICK BORNE
=680  \\$iEncephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. (From Joynt, Clinical Neurology, 1996, Ch26, pp14-5)
=688  \\$a1968(1966)
=750  \0$aTick-borne encephalitis$5IEN$0(DLC)sh 85042978

=LDR  01986cz  a2200385n  4500
=001  9880363411802441
=005  20141212201050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004674
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x343.$x350
=072  \\$aC2.$x182.$x500.$x300.$x300.$x300
=072  \\$aC2.$x290.$x310.$x406
=072  \\$aC2.$x782.$x310.$x350
=072  \\$aC2.$x782.$x350.$x250.$x450
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x300.$x550
=072  \\$aC10.$x228.$x228.$x245.$x340.$x310.$x406
=150  \\$aEncephalitis, St. Louis
=450  \\$wnnna$aEncephalitis, Saint Louis
=450  \\$wnnna$aEncephalitis, Viral, St. Louis
=450  \\$aLethargic Encephalitis, Type C
=450  \\$wnnna$aLouis Meningoencephalitides, St.
=450  \\$wnnna$aMeningoencephalitides, St. Louis
=450  \\$aMeningoencephalitis, St. Louis
=450  \\$aSaint Louis Encephalitis
=450  \\$wnnna$aSt. Louis Encephalitis
=450  \\$wnnna$aSt. Louis Meningoencephalitides
=450  \\$wnnna$aSt. Louis Meningoencephalitis
=450  \\$aSt. Louis Viral Encephalitis
=450  \\$wnnna$aType C Lethargic Encephalitis
=550  \\$wg$aEncephalitis, Arbovirus
=550  \\$wg$aFlavivirus Infections
=667  \\$aDF: ENCEPH ST LOUIS
=680  \\$iA viral encephalitis caused by the St. Louis encephalitis virus (ENCEPHALITIS VIRUS, ST. LOUIS), a FLAVIVIRUS. It is transmitted to humans and other vertebrates primarily by mosquitoes of the genus CULEX. The primary animal vectors are wild birds and the disorder is endemic to the midwestern and southeastern United States. Infections may be limited to an influenza-like illness or present as an ASEPTIC MENINGITIS or ENCEPHALITIS. Clinical manifestations of the encephalitic presentation may include SEIZURES, lethargy, MYOCLONUS, focal neurologic signs, COMA, and DEATH. (From Adams et al., Principles of Neurology, 6th ed, p750)
=750  \0$aSaint Louis encephalitis$5IEN$0(DLC)sh 85127171

=LDR  02740cz  a2200517n  4500
=001  9880363411902441
=005  20141212201050.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004673
=035  \\$aCAZ7811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x114.$x375.$x225
=072  \\$aC10.$x228.$x140.$x695.$x562.$x225
=072  \\$aC10.$x314.$x350.$x225
=072  \\$aC20.$x111.$x258.$x250.$x350
=150  \\$aEncephalomyelitis, Acute Disseminated
=450  \\$wnnna$aAcute Disseminated Encephalomyelitides
=450  \\$wnnna$aAcute Disseminated Encephalomyelitis
=450  \\$wnnna$aDisseminated Encephalomyelitides, Acute
=450  \\$wnnna$aDisseminated Encephalomyelitis, Acute
=450  \\$wnnna$aEncephalitides, Post-Vaccinal
=450  \\$aEncephalitis, Post-Vaccinal
=450  \\$wnnna$aEncephalitis, Post Vaccinal
=450  \\$wnnna$aEncephalitis, Postvaccinal
=450  \\$wnnna$aEncephalitis, Vaccination
=450  \\$wnnna$aEncephalomyelitides, Acute Disseminated
=450  \\$wnnna$aEncephalomyelitides, Post-Vaccinal
=450  \\$wnnna$aEncephalomyelitis, Post-Vaccinal
=450  \\$wnnna$aEncephalomyelitis, Postexanthem
=450  \\$wnnna$aEncephalomyelitis, Postinfectious
=450  \\$wnnna$aPost-Vaccinal Encephalitides
=450  \\$wnnna$aPost-Vaccinal Encephalitis
=450  \\$wnnna$aPost Vaccinal Encephalitis
=450  \\$wnnna$aPost-Vaccinal Encephalomyelitides
=450  \\$aPost-Vaccinal Encephalomyelitis
=450  \\$wnnna$aPost Vaccinal Encephalomyelitis
=450  \\$wnnna$aPostexanthem Encephalomyelitis
=450  \\$aPostinfectious Encephalomyelitis
=450  \\$wnnna$aPostvaccinal Encephalitis
=450  \\$aVaccination Encephalitis
=550  \\$wg$aDemyelinating Autoimmune Diseases, CNS
=550  \\$aHypersensitivity, Delayed
=667  \\$awhen post-vaccinal (note X ref) coord IM with vaccine source if pertinent (IM or NIM); for post-vaccinal or postinfectious inflammation of the spinal cord only, use MYELITIS, TRANSVERSE; DF: ENCEPH ACUTE DISSEM
=680  \\$iAn acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. (Adams et al., Principles of Neurology, 6th ed, p921)
=688  \\$a1995; was ENCEPHALITIS, POST-VACCINAL 1963-94
=750  \0$aPostvaccinal Encephalitis$5IEN$0(DLC)sh 85042977

=LDR  01772cz  a2200325n  4500
=001  9880363412002441
=005  20141212201049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004672
=035  \\$aCAZ7810HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x343.$x345
=072  \\$aC2.$x182.$x500.$x300.$x300.$x250
=072  \\$aC2.$x290.$x310.$x280
=072  \\$aC2.$x782.$x310.$x345
=072  \\$aC2.$x782.$x350.$x250.$x300
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x300.$x400
=072  \\$aC10.$x228.$x228.$x245.$x340.$x310.$x280
=150  \\$aEncephalitis, Japanese
=450  \\$aEncephalitis, Japanese B
=450  \\$wnnna$aJapanese B Encephalitis
=450  \\$wnnna$aJapanese B Viral Encephalitis
=450  \\$aJapanese Encephalitis
=450  \\$wnnna$aViral Encephalitis, Japanese B
=550  \\$wg$aEncephalitis, Arbovirus
=550  \\$wg$aFlavivirus Infections
=667  \\$afor encephalitis caused by Japanese B encephalitis virus only not ENCEPHALITIS VIRUSES, JAPANESE: see annotation there; DF: ENCEPH JAPANESE
=680  \\$iA mosquito-borne encephalitis caused by the Japanese B encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE) occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits (including a POLIOMYELITIS-like presentation); SEIZURES; COMA; and death. (From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351(9109):1094-7)
=688  \\$a94; was ENCEPHALITIS, JAPANESE B 1963-93
=750  \0$aJapanese B encephalitis$5IEN$0(DLC)sh 85069621

=LDR  03081cz  a2200649n  4500
=001  9880363412102441
=005  20141212201048.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004671
=035  \\$aCAZ7809HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x343
=072  \\$aC2.$x182.$x500.$x300.$x300
=072  \\$aC2.$x290.$x310
=072  \\$aC2.$x782.$x310
=072  \\$aC10.$x228.$x228.$x210.$x150.$x300.$x300
=072  \\$aC10.$x228.$x228.$x245.$x340.$x310
=150  \\$aEncephalitis, Arbovirus
=450  \\$wnnna$aArbovirus Encephalitides
=450  \\$wnnna$aArbovirus Encephalitis
=450  \\$wnnna$aArthropod-Borne Encephalitides
=450  \\$aArthropod-Borne Encephalitis
=450  \\$wnnna$aArthropod Borne Encephalitis
=450  \\$wnnna$aArthropod-Borne Viral Encephalitides
=450  \\$wnnna$aArthropod-Borne Viral Encephalitis
=450  \\$wnnna$aArthropod Borne Viral Encephalitis
=450  \\$wnnna$aEncephalitides, Arbovirus
=450  \\$wnnna$aEncephalitides, Arthropod-Borne
=450  \\$wnnna$aEncephalitides, Arthropod-Borne Viral
=450  \\$wnnna$aEncephalitides, Epidemic
=450  \\$wnnna$aEncephalitides, Mosquito-Borne
=450  \\$wnnna$aEncephalitis, Arthropod-Borne
=450  \\$wnnna$aEncephalitis, Arthropod Borne
=450  \\$wnnna$aEncephalitis, Arthropod-Borne Viral
=450  \\$aEncephalitis, Epidemic
=450  \\$wnnna$aEncephalitis, Mosquito-Borne
=450  \\$wnnna$aEncephalitis, Mosquito Borne
=450  \\$wnnna$aEpidemic Encephalitides
=450  \\$wnnna$aEpidemic Encephalitis
=450  \\$wnnna$aMosquito-Borne Encephalitides
=450  \\$aMosquito-Borne Encephalitis
=450  \\$wnnna$aMosquito Borne Encephalitis
=450  \\$wnnna$aViral Encephalitides, Arthropod-Borne
=450  \\$wnnna$aViral Encephalitis, Arthropod-Borne
=450  \\$wnnna$aViral Encephalitis, Arthropod Borne
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aEncephalitis, Viral
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aEncephalitis, California
=550  \\$wh$aEncephalitis, Japanese
=550  \\$wh$aEncephalitis, St. Louis
=550  \\$wh$aEncephalitis, Tick-Borne
=550  \\$wh$aWest Nile Fever
=667  \\$acaused by ENCEPHALITIS VIRUSES: despite X REF not an "epidemic of encephalitis"; GEN or unspecified; prefer specifics; DF: ENCEPH ARBOVIRUS
=680  \\$iInfections of the brain caused by arthropod-borne viruses (i.e., arboviruses) primarily from the families TOGAVIRIDAE; FLAVIVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; and RHABDOVIRIDAE. Life cycles of these viruses are characterized by ZOONOSES, with birds and lower mammals serving as intermediate hosts. The virus is transmitted to humans by the bite of mosquitoes (CULICIDAE) or TICKS. Clinical manifestations include fever, headache, alterations of mentation, focal neurologic deficits, and COMA. (From Clin Microbiol Rev 1994 Jan;7(1):89-116; Walton, Brain's Diseases of the Nervous System, 10th ed, p321)
=688  \\$a2000
=750  \0$aEpidemic encephalitis$5IEN$0(DLC)sh 85042976

=LDR  02196cz  a2200553n  4500
=001  9880363412202441
=005  20141212201047.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004669
=035  \\$aCAZ7807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250.$x350.$x350
=072  \\$aB4.$x909.$x777.$x270.$x511
=072  \\$aB4.$x909.$x777.$x310.$x350.$x350
=150  \\$aEncephalitis Viruses, Tick-Borne
=450  \\$wnnna$aAl-Khurma Hemorrhagic Fever Virus
=450  \\$wnnna$aAl Khurma Hemorrhagic Fever Virus
=450  \\$wnnna$aAl-Khurma virus
=450  \\$wnnna$aAl Khurma virus
=450  \\$wnnna$aAl-Khurma virus (ALKV)
=450  \\$wnnna$aAl Khurma virus (ALKV)
=450  \\$wnnna$aAlkhurma Hemorrhagic Fever Virus
=450  \\$wnnna$aAlkhurma virus
=450  \\$wnnna$aAlkhurma virus (ALKV)
=450  \\$wnnna$aEncephalitis Virus, Tick-Borne
=450  \\$wnnna$aEncephalitis Virus, Tick Borne
=450  \\$wnnna$aEncephalitis Viruses, Tick Borne
=450  \\$aHemorrhagic Fever Virus, Omsk
=450  \\$aKyasanur Forest disease virus
=450  \\$aLangat virus
=450  \\$aLouping ill virus
=450  \\$wnnna$aLouping ill viruses
=450  \\$aOmsk hemorrhagic fever virus
=450  \\$aPowassan virus
=450  \\$aTick-Borne encephalitis virus
=450  \\$wnnna$aTick Borne encephalitis virus
=450  \\$wnnna$aTick-Borne Encephalitis Viruses
=450  \\$wnnna$aTick Borne Encephalitis Viruses
=450  \\$wnnna$avirus, Al-Khurma
=450  \\$wnnna$avirus, Al-Khurma (ALKV)
=450  \\$wnnna$avirus, Alkhurma
=450  \\$wnnna$avirus, Alkhurma (ALKV)
=450  \\$wnnna$aViruses, Tick-Borne Encephalitis
=550  \\$wg$aEncephalitis Viruses
=550  \\$wg$aFlavivirus
=667  \\$ainfection = ENCEPHALITIS, TICK-BORNE
=680  \\$iA subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep.
=688  \\$a1966 (1965)
=750  \0$aTick-borne encephalitis viruses$5IEN$0(DLC)sh 85135248

=LDR  01237cz  a2200325n  4500
=001  9880363412302441
=005  20161114164105.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004660
=035  \\$aCAZ7798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x430
=150  \\$aEncephalitis
=450  \\$wnnna$aBrain Inflammation
=450  \\$wnnna$aBrain Inflammations
=450  \\$wnnna$aEncephalitis, Rasmussen
=450  \\$aInflammation, Brain
=450  \\$wnnna$aRasmussen Encephalitis
=450  \\$aRasmussen Syndrome
=450  \\$wnnna$aRasmussen's Syndrome
=550  \\$wg$aBrain Diseases
=550  \\$wh$aAnti-N-Methyl-D-Aspartate Receptor Encephalitis
=550  \\$wh$aCerebral Ventriculitis
=550  \\$wh$aInfectious Encephalitis
=550  \\$wh$aLimbic Encephalitis
=550  \\$wh$aMeningoencephalitis
=550  \\$aEncephalomyelitis
=667  \\$ageneral, note specifics particularly INFECTIOUS ENCEPHALITIS and ENCEPHALITIS, VIRAL
=680  \\$iInflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
=750  \0$aEncephalitis$5IEN$0(DLC)sh 85042975

=LDR  00957cz  a2200205n  4500
=001  9880363412402441
=005  20141212201042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004655
=035  \\$aCAZ7793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD20.$x280.$x260
=072  \\$aD26.$x255.$x165.$x260
=150  \\$aEmulsions
=550  \\$wg$aColloids
=550  \\$wh$aFat Emulsions, Intravenous
=550  \\$aMicelles
=667  \\$aIM for general only, qualif permitted; NIM (no qualif) with specific drug IM (with qualif); FAT EMULSIONS, INTRAVENOUS is also available
=680  \\$iColloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.
=750  \0$aEmulsions$5IEN$0(DLC)sh 85042950

=LDR  00780cz  a2200217n  4500
=001  9880363412502441
=005  20141212201042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004653
=035  \\$aCAZ7791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x539.$x830.$x305
=072  \\$aC23.$x550.$x470.$x756.$x305
=150  \\$aEmpyema
=550  \\$wg$aSuppuration
=550  \\$wh$aEmpyema, Pleural
=550  \\$wh$aEmpyema, Subdural
=550  \\$aAbscess
=667  \\$aGEN or unspecified; prefer specifics but empyema unspecified by author may be EMPYEMA, PLEURAL: check text; coord IM with precoord organ/dis term (IM); empyema in tuberc = EMPYEMA, TUBERCULOUS
=680  \\$iPresence of pus in a hollow organ or body cavity.
=750  \0$aEmpyema$5IEN$0(DLC)sh 85042941

=LDR  01246cz  a2200325n  4500
=001  9880363412702441
=005  20141212201040.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004650
=035  \\$aCAZ7788HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x370
=150  \\$aEmployee Performance Appraisal
=450  \\$wnnna$aAppraisal, Employee Performance
=450  \\$wnnna$aAppraisals, Employee Performance
=450  \\$wnnna$aEmployee Performance Appraisals
=450  \\$wnnna$aEvaluation, Nurses Performance
=450  \\$wnnna$aEvaluations, Nurses Performance
=450  \\$wnnna$aFamily Planning Personnel Evaluation
=450  \\$aNurses Performance Evaluation
=450  \\$wnnna$aNurses Performance Evaluations
=450  \\$aPerformance Appraisal, Employee
=450  \\$wnnna$aPerformance Appraisals, Employee
=450  \\$wnnna$aPerformance Evaluation, Nurses
=450  \\$wnnna$aPerformance Evaluations, Nurses
=550  \\$wg$aPersonnel Management
=667  \\$amed or non-med personnel
=680  \\$iThe assessment of the functioning of an employee in relation to work.
=688  \\$a91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90
=750  \0$aPerformance standards$5IEN$0(DLC)sh 85099815

=LDR  00896cz  a2200241n  4500
=001  9880363412802441
=005  20141212201040.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004649
=035  \\$aCAZ7787HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x368
=150  \\$aEmployee Incentive Plans
=450  \\$wnnna$aEmployee Incentive Plan
=450  \\$wnnna$aIncentive Plan, Employee
=450  \\$aIncentive Plans, Employee
=450  \\$wnnna$aPlan, Employee Incentive
=450  \\$wnnna$aPlans, Employee Incentive
=550  \\$wg$aPersonnel Management
=667  \\$amed or non-med personnel
=680  \\$iPrograms designed by management to motivate employees to work more efficiently with increased productivity, and greater employee satisfaction.
=688  \\$a91(79); was see under PERSONNEL MANAGEMENT 1979-90
=750  \0$aIncentive awards$5IEN$0(DLC)sh 91006355

=LDR  00920cz  a2200253n  4500
=001  9880363412902441
=005  20141212201040.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004648
=035  \\$aCAZ7786HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x362
=150  \\$aEmployee Grievances
=450  \\$wnnna$aEmployee Grievance
=450  \\$aGrievance Arbitration$5IEN
=450  \\$wnnna$aGrievance, Employee
=450  \\$aGrievance Procedures$5IEN
=450  \\$aGrievances, Employee
=550  \\$wg$aPersonnel Management
=667  \\$amed or non-med personnel
=680  \\$iFormal procedures whereby the employee expresses any dissatisfaction or feeling of injustice regarding the work situation.
=688  \\$a91(Aug 77); was see under PERSONNEL MANAGEMENT 1977-90
=750  \0$aGrievance procedures$5IEN-M$0(DLC)sh 85057340
=750  \0$aGrievance arbitration$5IEN-HS$0(DLC)sh 85057339

=LDR  01007cz  a2200277n  4500
=001  9880363413002441
=005  20141212201039.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004647
=035  \\$aCAZ7785HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x677.$x358
=150  \\$aEmployee Discipline
=450  \\$wnnna$aDiscipline, Employee
=450  \\$wnnna$aDiscipline, Personnel
=450  \\$wnnna$aDisciplines, Employee
=450  \\$wnnna$aDisciplines, Personnel
=450  \\$wnnna$aEmployee Disciplines
=450  \\$aLabor Discipline$5IEN
=450  \\$aPersonnel Discipline
=450  \\$wnnna$aPersonnel Disciplines
=550  \\$wg$aPersonnel Management
=667  \\$amed or non-med personnel
=680  \\$iRegulations or conditions imposed on employees by management in order to correct or prevent behaviors which are counterproductive to the organization.
=688  \\$a91(82); was see under PERSONNEL MANAGEMENT 1982-90
=750  \0$aLabor discipline$5IEN$0(DLC)sh 85073682

=LDR  00859cz  a2200217n  4500
=001  9880363413102441
=005  20141212201039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004645
=035  \\$aCAZ7783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x752.$x355
=072  \\$aF1.$x752.$x543.$x500.$x500
=150  \\$aEmpathy
=450  \\$aCaring
=450  \\$wnnna$aCompassion
=550  \\$wg$aEmotional Intelligence
=550  \\$wg$aPersonality
=680  \\$iAn individual's objective and insightful awareness of the feelings and behavior of another person. It should be distinguished from sympathy, which is usually nonobjective and noncritical. It includes caring, which is the demonstration of an awareness of and a concern for the good of others. (From Bioethics Thesaurus, 1992)
=688  \\$a71
=750  \0$aEmpathy$5IEN$0(DLC)sh 85042827

=LDR  01358cz   2200505n  4500
=001  9880363413202441
=005  20220922153026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004644
=035  \\$aCAZ7782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x470
=150  \\$aEmotions
=450  \\$wnnna$aEmotion
=450  \\$wnnna$aFeeling
=450  \\$aFeelings
=450  \\$wnnna$aRegret
=450  \\$wnnna$aRegrets
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aAffect
=550  \\$wh$aAnger
=550  \\$wh$aAnxiety
=550  \\$wh$aApathy
=550  \\$wh$aBereavement
=550  \\$wh$aBoredom
=550  \\$wh$aCourage
=550  \\$wh$aEuphoria
=550  \\$wh$aExpressed Emotion
=550  \\$wh$aFear
=550  \\$wh$aForgiveness
=550  \\$wh$aFrustration
=550  \\$wh$aGuilt
=550  \\$wh$aHappiness
=550  \\$wh$aHate
=550  \\$wh$aHope
=550  \\$wh$aHostility
=550  \\$wh$aJealousy
=550  \\$wh$aLaughter
=550  \\$wh$aLoneliness
=550  \\$wh$aLove
=550  \\$wh$aPleasure
=667  \\$ahuman & animal
=680  \\$iThose affective states which can be experienced and have arousing and motivational properties.
=750  \0$aEmotions$5IEN$0(DLC)sh 85042818
=750  \0$iNarrower mapping$aDiscomfort (Psychology)$0(DLC)sh2021005512$4NM$5IEN-M

=LDR  02537cz  a2200721n  4500
=001  9880363413302441
=005  20141212201038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004641
=035  \\$aCAZ7779HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240.$x600.$x525.$x500
=072  \\$aN1.$x224.$x625.$x525.$x500
=072  \\$aN6.$x850.$x505.$x400.$x700.$x525.$x500
=150  \\$aEmigration and Immigration
=450  \\$wnnna$aBorder Crossing
=450  \\$wnnna$aBorder Crossings
=450  \\$wnnna$aChain Migration
=450  \\$wnnna$aChain Migrations
=450  \\$wnnna$aCrossing, Border
=450  \\$wnnna$aCrossings, Border
=450  \\$wnnna$aEmigration
=450  \\$wnnna$aEmigrations
=450  \\$aImmigration
=450  \\$wnnna$aImmigration and Emigration
=450  \\$wnnna$aImmigrations
=450  \\$wnnna$aIn-Migration
=450  \\$wnnna$aIn Migration
=450  \\$wnnna$aIn-Migrations
=450  \\$wnnna$aInternational Migration
=450  \\$wnnna$aInternational Migrations
=450  \\$aLabor Migration
=450  \\$wnnna$aLabor Migrations
=450  \\$wnnna$aMigration, Chain
=450  \\$wnnna$aMigration, International
=450  \\$wnnna$aMigration, Labor
=450  \\$wnnna$aMigration, Return
=450  \\$wnnna$aMigration, Temporary
=450  \\$wnnna$aMigration, Turnaround
=450  \\$wnnna$aMigrations, Chain
=450  \\$wnnna$aMigrations, International
=450  \\$wnnna$aMigrations, Labor
=450  \\$wnnna$aMigrations, Return
=450  \\$wnnna$aMigrations, Temporary
=450  \\$wnnna$aMigrations, Turnaround
=450  \\$wnnna$aOut-Migration
=450  \\$wnnna$aOut Migration
=450  \\$wnnna$aOut-Migrations
=450  \\$wnnna$aResettlement and Settlement
=450  \\$wnnna$aReturn Migration
=450  \\$wnnna$aReturn Migrations
=450  \\$wnnna$aSettlement and Resettlement
=450  \\$wnnna$aTemporary Migration
=450  \\$wnnna$aTemporary Migrations
=450  \\$wnnna$aTurnaround Migration
=450  \\$wnnna$aTurnaround Migrations
=550  \\$wg$aHuman Migration
=550  \\$aEmigrants and Immigrants
=667  \\$ahumans only; EMIGRANTS AND IMMIGRANTS is also available
=680  \\$iThe process of leaving one's country to establish residence in a foreign country.
=688  \\$a1963; for LABOR MIGRATION use TRANSIENTS AND MIGRANTS 1990-2007
=688  \\$a1963; for LABOR MIGRATION use EMIGRATION AND IMMIGRATION 1990-2007
=750  \0$aEmigration and immigration$0(DLC) sh 85042782$5IEN

=LDR  01064cz  a2200265n  4500
=001  9880363413402441
=005  20141212201037.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004640
=035  \\$aCAZ7778HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x316
=072  \\$aD3.$x438.$x531.$x321
=150  \\$aEmetine
=450  \\$wnnna$aDihydrochloride, Emetine
=450  \\$wnnna$aEmetine Dihydrochloride
=450  \\$wnnna$aEmetine Hydrochloride
=450  \\$wnnna$aHydrochloride, Emetine
=450  \\$aIpecine
=450  \\$aMethylcephaeline
=550  \\$wg$aAlkaloids
=550  \\$wg$aIsoquinolines
=550  \\$aIpecac
=680  \\$iThe principal alkaloid of ipecac, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. Emetine inhibits protein synthesis in EUKARYOTIC CELLS but not PROKARYOTIC CELLS.
=750  \0$aEmetine$5IEN$0(DLC)sh 85042776

=LDR  01353cz  a2200361n  4500
=001  9880363413502441
=005  20141212201036.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004639
=035  \\$aCAZ7777HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x505.$x696.$x329
=072  \\$aD27.$x505.$x696.$x663.$x50.$x225
=072  \\$aD27.$x505.$x954.$x427.$x270
=072  \\$aD27.$x505.$x954.$x483.$x560
=150  \\$aEmetics
=450  \\$wnnna$aAgents, Emetic
=450  \\$wnnna$aDrugs, Emetic
=450  \\$wnnna$aEffect, Emetic
=450  \\$wnnna$aEffects, Emetic
=450  \\$wnnna$aEmetic Agents
=450  \\$wnnna$aEmetic Drugs
=450  \\$wnnna$aEmetic Effect
=450  \\$wnnna$aEmetic Effects
=550  \\$wg$aAutonomic Agents
=550  \\$wg$aCentral Nervous System Agents
=550  \\$wg$aGastrointestinal Agents
=550  \\$wg$aPhysiological Effects of Drugs
=550  \\$aNausea
=550  \\$aVomiting
=667  \\$anote entry term EMETIC EFFECT: use only for the emetic effect of a chemical substance
=680  \\$iAgents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.
=750  \0$aEmetics$5IEN$0(DLC)sh 85042775

=LDR  01324cz  a2200337n  4500
=001  9880363413602441
=005  20141212201035.0
=008  771207\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004637
=035  \\$aCAZ7775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF4.$x408.$x525
=072  \\$aN2.$x421.$x297.$x200
=150  \\$aEmergency Services, Psychiatric
=450  \\$wnnna$aEmergency Psychiatric Service
=450  \\$wnnna$aEmergency Psychiatric Services
=450  \\$wnnna$aEmergency Service, Psychiatric
=450  \\$wnnna$aPsychiatric Emergency Service
=450  \\$wnnna$aPsychiatric Emergency Services
=450  \\$wnnna$aPsychiatric Service, Emergency
=450  \\$wnnna$aPsychiatric Services, Emergency
=450  \\$wnnna$aService, Emergency Psychiatric
=450  \\$wnnna$aService, Psychiatric Emergency
=450  \\$wnnna$aServices, Emergency Psychiatric
=450  \\$wnnna$aServices, Psychiatric Emergency
=550  \\$wg$aEmergency Medical Services
=550  \\$wg$aMental Health Services
=667  \\$aIM; DF: EMERGENCY SERV PSYCHIATRIC
=680  \\$iOrganized services to provide immediate psychiatric care to patients with acute psychological disturbances.
=688  \\$a90(76); was see under EMERGENCY MEDICAL SERVICES 1976-89
=750  \0$aPsychiatric emergencies$5IEN$0(DLC)sh 85108347

=LDR  02616cz  a2200697n  4500
=001  9880363413702441
=005  20141212201035.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004636
=035  \\$aCAZ7774HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x354.$x422.$x336
=072  \\$aN2.$x421.$x297.$x195
=072  \\$aN4.$x452.$x442.$x422.$x336
=150  \\$aEmergency Service, Hospital
=450  \\$wnnna$aAccident and Emergency Department
=450  \\$wnnna$aDepartment, Emergency
=450  \\$wnnna$aDepartments, Emergency
=450  \\$wnnna$aEmergencies, Hospital Service
=450  \\$wnnna$aEmergency Department
=450  \\$wnnna$aEmergency Departments
=450  \\$wnnna$aEmergency Hospital Service
=450  \\$wnnna$aEmergency, Hospital Service
=450  \\$wnnna$aEmergency Hospital Services
=450  \\$aEmergency Outpatient Unit
=450  \\$wnnna$aEmergency Outpatient Units
=450  \\$wnnna$aEmergency Room
=450  \\$wnnna$aEmergency Rooms
=450  \\$wnnna$aEmergency Services, Hospital
=450  \\$wnnna$aEmergency Unit
=450  \\$wnnna$aEmergency Units
=450  \\$wnnna$aEmergency Ward
=450  \\$wnnna$aEmergency Wards
=450  \\$aHospital Emergency Service
=450  \\$wnnna$aHospital Emergency Services
=450  \\$wnnna$aHospital Service Emergencies
=450  \\$wnnna$aHospital Service Emergency
=450  \\$wnnna$aHospital Service, Emergency
=450  \\$wnnna$aHospital Services, Emergency
=450  \\$wnnna$aOutpatient Unit, Emergency
=450  \\$wnnna$aOutpatient Units, Emergency
=450  \\$wnnna$aRoom, Emergency
=450  \\$wnnna$aRooms, Emergency
=450  \\$wnnna$aService Emergencies, Hospital
=450  \\$wnnna$aService Emergency, Hospital
=450  \\$wnnna$aService, Emergency Hospital
=450  \\$wnnna$aService, Hospital Emergency
=450  \\$wnnna$aServices, Emergency Hospital
=450  \\$wnnna$aServices, Hospital Emergency
=450  \\$wnnna$aUnit, Emergency
=450  \\$wnnna$aUnit, Emergency Outpatient
=450  \\$wnnna$aUnits, Emergency
=450  \\$wnnna$aUnits, Emergency Outpatient
=450  \\$wnnna$aWard, Emergency
=450  \\$wnnna$aWards, Emergency
=550  \\$wg$aEmergency Medical Services
=550  \\$wg$aHospital Departments
=550  \\$wh$aTrauma Centers
=680  \\$iHospital department responsible for the administration and provision of immediate medical or surgical care to the emergency patient.
=688  \\$a78; was HOSPITAL EMERGENCY SERVICE 1963-77
=750  \0$aHospitals$xEmergency services$5IEN$0(DLC)sh 85062319

=LDR  00889cz  a2200205n  4500
=001  9880363413802441
=005  20181008100844.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004635
=035  \\$aCAZ7773HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH2.$x403.$x250
=150  \\$aEmergency Medicine
=450  \\$wnnna$aMedicine, Emergency
=550  \\$wg$aMedicine
=550  \\$wh$aPediatric Emergency Medicine
=667  \\$aspecialty; differentiate from EMERGENCIES, the patient; DF: EMERGENCY MED
=680  \\$iThe branch of medicine concerned with the evaluation and initial treatment of urgent and emergent medical problems, such as those caused by accidents, trauma, sudden illness, poisoning, or disasters. Emergency medical care can be provided at the hospital or at sites outside the medical facility.
=688  \\$a77
=750  \0$aEmergency medicine$5IEN$0(DLC)sh 85042755

=LDR  01554cz  a2200373n  4500
=001  9880363413902441
=005  20141212201034.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004634
=035  \\$aCAZ7772HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x373.$x250
=072  \\$aM1.$x526.$x485.$x67.$x150
=072  \\$aN2.$x360.$x67.$x150
=150  \\$aEmergency Medical Technicians
=450  \\$wnnna$aEmergency Medical Technician
=450  \\$wnnna$aEmergency Medicine Technician
=450  \\$wnnna$aEmergency Medicine Technicians
=450  \\$wnnna$aEmergency Paramedic
=450  \\$wnnna$aEmergency Paramedics
=450  \\$wnnna$aMedical Technician, Emergency
=450  \\$wnnna$aMedical Technicians, Emergency
=450  \\$wnnna$aParamedic, Emergency
=450  \\$aParamedics, Emergency
=450  \\$wnnna$aTechnician, Emergency Medical
=450  \\$wnnna$aTechnician, Emergency Medicine
=450  \\$wnnna$aTechnicians, Emergency Medical
=450  \\$wnnna$aTechnicians, Emergency Medicine
=550  \\$wg$aAllied Health Personnel
=550  \\$wg$aEmergency Responders
=667  \\$aDF: EMERGENCY MED TECHNICIANS
=680  \\$iParamedical personnel trained to provide basic emergency care and life support under the supervision of physicians and/or nurses. These services may be carried out at the site of the emergency, in the ambulance, or in a health care institution.
=688  \\$a91(79); was see under ALLIED HEALTH PERSONNEL 1979-90
=750  \0$aEmergency medical technicians$5IEN$0(DLC)sh 85042754

=LDR  02013cz  a2200541n  4500
=001  9880363414002441
=005  20200928141749.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004632
=035  \\$aCAZ7770HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x297
=150  \\$aEmergency Medical Services
=450  \\$aEmergency Care
=450  \\$wnnna$aEmergency Care, Prehospital
=450  \\$wnnna$aEmergency Health Service
=450  \\$aEmergency Health Services
=450  \\$wnnna$aEmergency Medical Service
=450  \\$wnnna$aEmergency Service, Medical
=450  \\$wnnna$aEmergency Services, Medical
=450  \\$wnnna$aEmergicenter
=450  \\$aEmergicenters
=450  \\$wnnna$aHealth Service, Emergency
=450  \\$wnnna$aHealth Services, Emergency
=450  \\$wnnna$aMedical Emergency Service
=450  \\$wnnna$aMedical Emergency Services
=450  \\$wnnna$aMedical Service, Emergency
=450  \\$wnnna$aMedical Services, Emergency
=450  \\$aPrehospital Emergency Care
=450  \\$wnnna$aService, Emergency Health
=450  \\$wnnna$aService, Emergency Medical
=450  \\$wnnna$aService, Medical Emergency
=450  \\$wnnna$aServices, Emergency Health
=450  \\$wnnna$aServices, Emergency Medical
=450  \\$wnnna$aServices, Medical Emergency
=550  \\$wg$aHealth Services
=550  \\$wh$aAdvanced Trauma Life Support Care
=550  \\$wh$aEmergency Medical Dispatch
=550  \\$wh$aEmergency Medical Service Communication Systems
=550  \\$wh$aEmergency Service, Hospital
=550  \\$wh$aEmergency Services, Psychiatric
=550  \\$wh$aPoison Control Centers
=550  \\$wh$aTransportation of Patients
=550  \\$wh$aTriage
=667  \\$aPublic Law 93-154; DF: EMERGENCY MED SERV
=680  \\$iServices specifically designed, staffed, and equipped for the emergency care of patients.
=688  \\$a80; was EMERGENCY HEALTH SERVICES 1968-79
=750  \0$aEmergency medical services$5IEN$0(DLC)sh 85042747

=LDR  01224cz  a2200265n  4500
=001  9880363414102441
=005  20141212201032.0
=008  790531\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004631
=035  \\$aCAZ7769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x297.$x58
=150  \\$aEmergency Medical Service Communication Systems
=450  \\$wnnna$aCommunication System, EMS
=450  \\$wnnna$aCommunication Systems, Emergency Medical Service
=450  \\$wnnna$aCommunication Systems, EMS
=450  \\$wnnna$aEMS Communication System
=450  \\$aEMS Communication Systems
=450  \\$wnnna$aSystem, EMS Communication
=450  \\$wnnna$aSystems, EMS Communication
=550  \\$wg$aEmergency Medical Services
=667  \\$acommun between hosp & ambulance, 911 systems, emerg calling systems, etc.: do not confuse with EMERGENCY CARE INFORMATION SYSTEMS see INFORMATION SYSTEMS; DF: EMSCS
=680  \\$iThe use of communication systems, such as telecommunication, to transmit emergency information to appropriate providers of health services.
=688  \\$a91(80); was see under EMERGENCY MEDICAL SERVICES 1980-90
=750  \0$aEmergency medical services$xCommunication systems$5IEN$0(DLC)sh 85042748

=LDR  00928cz  a2200241n  4500
=001  9880363414202441
=005  20141212201032.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004630
=035  \\$aCAZ7768HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x291.$x781
=072  \\$aN6.$x230.$x100.$x83
=072  \\$aN6.$x850.$x376
=150  \\$aEmergencies
=450  \\$wnnna$aEmergency
=550  \\$wg$aDisasters
=550  \\$wg$aDisease Attributes
=550  \\$wg$aPublic Health
=550  \\$aEmergency Treatment
=667  \\$aEMERGENCY MEDICINE is the corresponding specialty; emergencies in specific diseases: coordinate NIM with specific disease (IM); "drug emergencies": coordinate NIM with specific drug or chemical with probably /pois (IM)
=680  \\$iSituations or conditions requiring immediate intervention to avoid serious adverse results.
=750  \0$aMedical emergencies$5IEN$0(DLC)sh 85082927

=LDR  00784cz  a2200217n  4500
=001  9880363414302441
=005  20141212201031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004626
=035  \\$aCAZ7764HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x100.$x529
=072  \\$aH1.$x158.$x273.$x200.$x350
=150  \\$aEmbryology
=450  \\$wnnna$aEmbryologies
=550  \\$wg$aAnatomy
=550  \\$wg$aDevelopmental Biology
=550  \\$wh$aTeratology
=667  \\$athe discipline (education, history, etc) only; the qualifier/ embryol is available for use with specific anatomical terms, organisms, or diseases
=680  \\$iThe study of the development of an organism during the embryonic and fetal stages of life.
=750  \0$aEmbryology$5IEN$0(DLC)sh 85042722

=LDR  01426cz  a2200325n  4500
=001  9880363414402441
=005  20141212201029.0
=008  790525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004624
=035  \\$aCAZ7762HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x875.$x800.$x500
=072  \\$aE5.$x820.$x800.$x500
=150  \\$aEmbryo Transfer
=450  \\$aBlastocyst Transfer
=450  \\$aBlastocyst$xtransplantation
=450  \\$aEmbryo, Mammalian$xtransplantation
=450  \\$wnnna$aEmbryo Transfers
=450  \\$aEmbryo Transplantation$5IEN
=450  \\$wnnna$aTransfer, Embryo
=450  \\$wnnna$aTransfers, Embryo
=450  \\$wnnna$aTubal Embryo Stage Transfer
=450  \\$aTubal Embryo Transfer
=550  \\$wg$aReproductive Techniques, Assisted
=550  \\$wh$aSingle Embryo Transfer
=550  \\$aFertilization in Vitro
=667  \\$amammalian only; transfer of non-mammalian embryo = EMBRYO, NONMAMMALIAN /transpl or CHICK EMBRYO /transpl
=680  \\$iThe transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO.
=688  \\$a1980
=750  \0$aEmbryo transplantation$5IEN$0(DLC)sh 85042720

=LDR  02193cz  a2200433n  4500
=001  9880363414502441
=005  20141212201029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004622
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA16.$x254
=150  \\$aEmbryo, Mammalian
=450  \\$wnnna$aEmbryo Structure, Mammalian
=450  \\$wnnna$aEmbryo Structures, Mammalian
=450  \\$wnnna$aEmbryonic Structure, Mammalian
=450  \\$aEmbryonic Structures, Mammalian
=450  \\$wnnna$aEmbryos, Mammalian
=450  \\$wnnna$aMammalian Embryo
=450  \\$wnnna$aMammalian Embryo Structure
=450  \\$wnnna$aMammalian Embryo Structures
=450  \\$wnnna$aMammalian Embryonic Structure
=450  \\$wnnna$aMammalian Embryonic Structures
=450  \\$wnnna$aMammalian Embryos
=450  \\$wnnna$aStructure, Mammalian Embryo
=450  \\$wnnna$aStructure, Mammalian Embryonic
=450  \\$wnnna$aStructures, Mammalian Embryo
=450  \\$wnnna$aStructures, Mammalian Embryonic
=550  \\$wg$aEmbryonic Structures
=550  \\$wh$aBlastocyst
=550  \\$wh$aExtraembryonic Membranes
=550  \\$aEmbryo Research
=667  \\$ahuman: 0-2 months; use for mammalian embryo as an entity or as tissue; use the qualifier / embryol with an organ for embryologic aspects of that organ; embryonic tissue or cells in tissue & cell cultures: coordinate EMBRYO, MAMMALIAN + tissues or cell without qualifiers (not with / embryol) + culture term, all probably NIM; EMBRYO, NONMAMMALIAN is also available
=680  \\$iThe entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.
=688  \\$a2008 (1963)
=688  \\$aHeading changed 20071115 from: 150:##:_{dollar}a Embryo
=688  \\$aPRENATAL INFLUENCES was heading 1963-72
=750  \0$aHuman embryo$5IEN-M$0(DLC)sh 85062864
=750  \0$aEmbryos$5IEN-M$0(DLC)sh2003004641
=788  \0$iSubdivision$aEmbryos$iunder individual animals and groups of animals and individual plants and groups of plants.$5IEN-M

=LDR  01354cz  a2200301n  4500
=001  9880363414602441
=005  20141212201028.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004621
=035  \\$aCAZ7759HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x520.$x360
=072  \\$aE2.$x926.$x500
=150  \\$aEmbolization, Therapeutic
=450  \\$wnnna$aEmbolizations, Therapeutic
=450  \\$wnnna$aEmbolotherapies
=450  \\$aEmbolotherapy
=450  \\$wnnna$aTherapeutic Embolization
=450  \\$wnnna$aTherapeutic Embolizations
=550  \\$wg$aHemostatic Techniques
=550  \\$wg$aTherapeutic Occlusion
=550  \\$wh$aBalloon Occlusion
=550  \\$wh$aChemoembolization, Therapeutic
=550  \\$wh$aUterine Artery Embolization
=667  \\$acoord IM with disease /ther (IM), not /surg
=680  \\$iA method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.
=688  \\$a76
=750  \0$aTherapeutic embolization$5IEN-M$0(DLC)sh 96011409

=LDR  00757cz  a2200217n  4500
=001  9880363414702441
=005  20141212201028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004620
=035  \\$aCAZ7758HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x350.$x454
=150  \\$aEmbolism, Fat
=450  \\$wnnna$aEmbolisms, Fat
=450  \\$wnnna$aFat Embolism
=450  \\$wnnna$aFat Embolisms
=550  \\$wg$aEmbolism
=550  \\$wh$aEmbolism, Cholesterol
=667  \\$ado not confuse with EMBOLISM, CHOLESTEROL
=680  \\$iBlocking of a blood vessel by fat deposits in the circulation. It is often seen after fractures of large bones or after administration of CORTICOSTEROIDS.
=750  \0$aFat embolism$5IEN$0(DLC)sh 85047431

=LDR  00980cz  a2200241n  4500
=001  9880363414802441
=005  20141212201028.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004619
=035  \\$aCAZ7757HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x634.$x404
=072  \\$aC14.$x583.$x404
=072  \\$aC14.$x907.$x355.$x350.$x354
=150  \\$aEmbolism, Amniotic Fluid
=450  \\$wnnna$aAmniotic Fluid Embolism
=450  \\$wnnna$aAmniotic Fluid Embolisms
=450  \\$wnnna$aEmbolisms, Amniotic Fluid
=550  \\$wg$aEmbolism
=550  \\$wg$aPregnancy Complications, Cardiovascular
=550  \\$aAmniotic Fluid
=680  \\$iBlocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.
=750  \0$aAmniotic fluid embolism$5IEN$0(DLC)sh 85004564

=LDR  00794cz  a2200241n  4500
=001  9880363414902441
=005  20141212201027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004618
=035  \\$aCAZ7756M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x350.$x254
=150  \\$aEmbolism, Air
=450  \\$aAir Embolism
=450  \\$wnnna$aAir Embolisms
=450  \\$aEmbolism, Gas
=450  \\$wnnna$aEmbolisms, Air
=450  \\$wnnna$aEmbolisms, Gas
=450  \\$wnnna$aGas Embolism
=450  \\$wnnna$aGas Embolisms
=550  \\$wg$aEmbolism
=680  \\$iBlocking of a blood vessel by air bubbles that enter the circulatory system, usually after TRAUMA; surgical procedures, or changes in atmospheric pressure.
=750  \0$aGas embolism$0(DLC)sh2006007525$5IEN-M

=LDR  00798cz  a2200241n  4500
=001  9880363415002441
=005  20141212201027.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004617
=035  \\$aCAZ7755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x907.$x355.$x350
=150  \\$aEmbolism
=450  \\$wnnna$aEmbolisms
=450  \\$aEmbolus
=550  \\$wg$aEmbolism and Thrombosis
=550  \\$wh$aEmbolism, Air
=550  \\$wh$aEmbolism, Amniotic Fluid
=550  \\$wh$aEmbolism, Fat
=550  \\$wh$aPulmonary Embolism
=667  \\$ageneral; prefer specifics; coordinate with specific blood vessel
=680  \\$iBlocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
=750  \0$aEmbolism$5IEN$0(DLC)sh 85042696

=LDR  00927cz  a2200289n  4500
=001  9880363415102441
=005  20141212201027.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004616
=035  \\$aCAZ7754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x400.$x255
=150  \\$aEmblems and Insignia
=450  \\$aCaduceus
=450  \\$wnnna$aEmblem
=450  \\$wnnna$aEmblems
=450  \\$wnnna$aInsigne
=450  \\$aInsignia
=450  \\$wnnna$aInsignia and Emblems
=450  \\$wnnna$aInsignias
=550  \\$wg$aHistory
=550  \\$aGenealogy and Heraldry
=667  \\$aDF: EMBLEMS
=680  \\$iFigures or symbols identifying or representing organizations or societies.
=688  \\$a78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77, was Prov 1966-74; INSIGNIA AND DECORATIONS was heading 1963-65
=750  \0$aEmblems$5IEN-M$0(DLC)sh 85042693
=750  \0$aInsignia$5IEN-HS$0(DLC)sh 85066714

=LDR  00490cz  a2200169n  4500
=001  9880363415202441
=005  20141212201026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004615
=035  \\$aCAZ7753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x76.$x201.$x450.$x550.$x250
=150  \\$aEmbalming
=450  \\$wnnna$aEmbalmings
=550  \\$wg$aFuneral Rites
=680  \\$iProcess of preserving a dead body to protect it from decay.
=750  \0$aEmbalming$5IEN$0(DLC)sh 85042662

=LDR  01485cz  a2200385n  4500
=001  9880363415302441
=005  20141212201026.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004613
=035  \\$aCAZ7751HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC5.$x116.$x99.$x708.$x327
=072  \\$aC16.$x131.$x77.$x350.$x398
=072  \\$aC16.$x131.$x831.$x350.$x398
=072  \\$aC16.$x320.$x850.$x250.$x398
=072  \\$aC17.$x800.$x804.$x350.$x398
=072  \\$aC17.$x800.$x827.$x250.$x398
=150  \\$aEllis-Van Creveld Syndrome
=450  \\$aChondroectodermal Dysplasia
=450  \\$wnnna$aChondroectodermal Dysplasias
=450  \\$wnnna$aCreveld Dysplasia, Ellis-Van
=450  \\$wnnna$aDysplasia, Chondroectodermal
=450  \\$wnnna$aDysplasia, Ellis-Van Creveld
=450  \\$wnnna$aDysplasias, Chondroectodermal
=450  \\$wnnna$aEllis-Van Creveld Dysplasia
=450  \\$wnnna$aEllis Van Creveld Dysplasia
=450  \\$wnnna$aEllis Van Creveld Syndrome
=450  \\$wnnna$aSyndrome, Ellis-Van Creveld
=550  \\$wg$aEctodermal Dysplasia
=550  \\$wg$aOsteochondrodysplasias
=550  \\$aCartilage Diseases
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES
=680  \\$iDwarfism occurring in association with defective development of skin, hair, and teeth, polydactyly, and defect of the cardiac septum. (Dorland, 27th ed)
=688  \\$a65(63)
=750  \0$aEllis-van Creveld syndrome$0(DLC) sh 85042610$5IEN

=LDR  01096cz  a2200289n  4500
=001  9880363415402441
=005  20141212201025.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004609
=035  \\$aCAZ7747HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x367
=150  \\$aEliminative Behavior, Animal
=450  \\$wnnna$aAnimal Eliminative Behavior
=450  \\$wnnna$aAnimal Eliminative Behaviors
=450  \\$wnnna$aBehavior, Animal Eliminative
=450  \\$wnnna$aBehavior, Eliminative
=450  \\$wnnna$aBehaviors, Animal Eliminative
=450  \\$wnnna$aBehaviors, Eliminative
=450  \\$wnnna$aEliminative Behavior
=450  \\$wnnna$aEliminative Behaviors
=450  \\$wnnna$aEliminative Behaviors, Animal
=550  \\$wg$aBehavior, Animal
=667  \\$aelimination of urine or feces
=680  \\$iBehavior associated with the elimination of feces and urine from the body.
=688  \\$a91(79); was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78
=750  \0$aEliminative behavior$5IEN$0(DLC)sh 85042575

=LDR  00861cz  a2200253n  4500
=001  9880363415502441
=005  20141212201024.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004607
=035  \\$aCAZ7745HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x86.$x339.$x115
=150  \\$aElevators and Escalators
=450  \\$wnnna$aElevator
=450  \\$wnnna$aElevators
=450  \\$wnnna$aEscalator
=450  \\$aEscalators
=450  \\$wnnna$aEscalators and Elevators
=550  \\$wg$aFacility Design and Construction
=667  \\$afor people or equipment; DF: ELEVATORS
=680  \\$iMechanical ascending and descending devices which convey objects and/or people.
=688  \\$a91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
=750  \0$aEscalators$5IEN-M$0(DLC)sh 85044776
=750  \0$aElevators$5IEN-HS$0(DLC)sh 85042556

=LDR  00966cz  a2200277n  4500
=001  9880363415602441
=005  20141212201024.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004606
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x833.$x249
=150  \\$aElephants
=450  \\$wnnna$aAfrican Elephant
=450  \\$wnnna$aAfrican Elephants
=450  \\$wnnna$aAsiatic Elephant
=450  \\$wnnna$aAsiatic Elephants
=450  \\$wnnna$aElephant
=450  \\$wnnna$aElephant, African
=450  \\$wnnna$aElephant, Asiatic
=450  \\$wnnna$aElephants, African
=450  \\$wnnna$aElephants, Asiatic
=450  \\$wnnna$aElephas maximus
=450  \\$wnnna$aLoxodonta
=550  \\$wg$aProboscidea Mammal
=680  \\$iLarge mammals in the family Elephantidae, with columnar limbs, bulky bodies, and elongated snouts. They are the only surviving members of the PROBOSCIDEA MAMMALS.
=750  \0$aElephants$5IEN$0(DLC)sh 85042531

=LDR  02356cz  a2200613n  4500
=001  9880363415702441
=005  20141212201023.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004604
=035  \\$aCAZ7742HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC15.$x604.$x496.$x320
=150  \\$aElephantiasis
=450  \\$wnnna$aBigfoot Disease
=450  \\$wnnna$aBigfoot Diseases
=450  \\$wnnna$aDisease, Bigfoot
=450  \\$wnnna$aDisease, Microcrystal
=450  \\$wnnna$aDiseases, Bigfoot
=450  \\$wnnna$aDiseases, Microcrystal
=450  \\$wnnna$aElephantiases
=450  \\$wnnna$aElephantiases, Endemic
=450  \\$wnnna$aElephantiases, Endemic Non-Filarial
=450  \\$wnnna$aElephantiasis, Endemic
=450  \\$wnnna$aElephantiasis, Endemic Non-Filarial
=450  \\$wnnna$aElephantiasis Nostras Verrucosa
=450  \\$wnnna$aElephantiasis Nostras Verrucosas
=450  \\$wnnna$aEndemic Elephantiases
=450  \\$wnnna$aEndemic Elephantiasis
=450  \\$wnnna$aEndemic Non-Filarial Elephantiases
=450  \\$wnnna$aEndemic Non-Filarial Elephantiasis
=450  \\$wnnna$aEndemic Non Filarial Elephantiasis
=450  \\$wnnna$afoot, Mossy
=450  \\$wnnna$afoots, Mossy
=450  \\$wnnna$aLymphostatic Verrucoses
=450  \\$wnnna$aLymphostatic Verrucosis
=450  \\$wnnna$aMicrocrystal Disease
=450  \\$wnnna$aMicrocrystal Diseases
=450  \\$wnnna$aMossy foot
=450  \\$wnnna$aMossy foots
=450  \\$wnnna$aNon-Filarial Elephantiases, Endemic
=450  \\$wnnna$aNon-Filarial Elephantiasis, Endemic
=450  \\$wnnna$aNostras Verrucosa, Elephantiasis
=450  \\$wnnna$aNostras Verrucosas, Elephantiasis
=450  \\$wnnna$aPodoconioses
=450  \\$wnnna$aPodoconiosis
=450  \\$wnnna$aVerrucosa, Elephantiasis Nostras
=450  \\$wnnna$aVerrucosas, Elephantiasis Nostras
=450  \\$wnnna$aVerrucoses, Lymphostatic
=450  \\$wnnna$aVerrucosis, Lymphostatic
=550  \\$wg$aLymphedema
=667  \\$aELEPHANTIASIS, FILARIAL is also available
=680  \\$iHypertrophy and thickening of tissues from causes other than filarial infection, the latter being described as ELEPHANTIASIS, FILARIAL.
=688  \\$a91(75); was see under LYMPHEDEMA 1975-90; was see FILARIASIS & LYMPHEDEMA 1963-74
=750  \0$aElephantiasis$5IEN$0(DLC)sh 85042529

=LDR  01086cz  a2200337n  4500
=001  9880363415802441
=005  20200716171809.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004603
=035  \\$aCAZ7741HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x271
=074  \\$aD1.$x496.$x749.$x305
=150  \\$aElements, Radioactive
=450  \\$aRadioactive Elements
=550  \\$wg$aElements
=550  \\$wg$aRadioisotopes
=550  \\$wh$aActinoid Series Elements
=550  \\$wh$aAstatine
=550  \\$wh$aFrancium
=550  \\$wh$aPolonium
=550  \\$wh$aPromethium
=550  \\$wh$aRadium
=550  \\$wh$aRadon
=550  \\$wh$aTechnetium
=550  \\$wh$aTransactinide Series Elements
=550  \\$aRadioisotopes
=667  \\$aGEN; prefer specifics; these are naturally radioactive
=680  \\$iElements which exhibit atomic emission due to natural or artificial nuclear transformation. These elements spontaneously undergo radioactive decay.
=688  \\$a98; use explode 1967-97
=750  \0$aRadioactive substances$5IEN-M$0(DLC)sh 85110610

=LDR  01442cz  a2200409n  4500
=001  9880363415902441
=005  20141212201022.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004602
=035  \\$aCAZ7740HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268
=150  \\$aElements
=450  \\$aChemical Elements$5IEN-M
=550  \\$wg$aInorganic Chemicals
=550  \\$wh$aActinoid Series Elements
=550  \\$wh$aArsenic
=550  \\$wh$aBoron
=550  \\$wh$aCarbon
=550  \\$wh$aChalcogens
=550  \\$wh$aElements, Radioactive
=550  \\$wh$aHalogens
=550  \\$wh$aHydrogen
=550  \\$wh$aLanthanoid Series Elements
=550  \\$wh$aMetalloids
=550  \\$wh$aMetals, Alkali
=550  \\$wh$aMetals, Alkaline Earth
=550  \\$wh$aMetals, Heavy
=550  \\$wh$aMetals, Light
=550  \\$wh$aMetals, Rare Earth
=550  \\$wh$aNitrogen
=550  \\$wh$aNoble Gases
=550  \\$wh$aPhosphorus
=550  \\$wh$aTransition Elements
=667  \\$aGEN only; prefer specifics; ISOTOPES (little used) & RADIOISOTOPES & many specifics are also available; m for metastable = RADIOISOTOPES or specific pre-coord radioisotope
=680  \\$iSubstances that comprise all matter. Each element is made up of atoms that are identical in number of electrons and protons and in nuclear charge, but may differ in mass or number of neutrons.
=750  \0$aChemical elements$5IEN$0(DLC)sh 85022897

=LDR  01354cz  a2200373n  4500
=001  9880363416002441
=005  20180914112621.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004601
=035  \\$aCAZ7739HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249
=150  \\$aElementary Particles
=450  \\$wnnna$aBaryon
=450  \\$aBaryons
=450  \\$wnnna$aElementary Particle
=450  \\$wnnna$aFundamental Particle
=450  \\$aFundamental Particles
=450  \\$wnnna$aParticle, Elementary
=450  \\$wnnna$aParticle, Fundamental
=450  \\$wnnna$aParticles, Elementary
=450  \\$wnnna$aParticles, Fundamental
=550  \\$wg$aPhysical Phenomena
=550  \\$wh$aElectrons
=550  \\$wh$aHeavy Ions
=550  \\$wh$aMesons
=550  \\$wh$aNucleons
=550  \\$wh$aPhonons
=550  \\$wh$aPhotons
=550  \\$wh$aProtons
=667  \\$aIM; includes nucleons, quarks, gluons, neutrinos, strange particles, antiparticles
=680  \\$iIndividual components of atoms, usually subatomic; subnuclear particles are usually detected only when the atomic nucleus decays and then only transiently, as most of them are unstable, often yielding pure energy without substance, i.e., radiation.
=688  \\$a75(71); BARYONS was heading 1975-84
=750  \0$aParticles (Nuclear Physics)$5IEN$0(DLC)sh 85098374

=LDR  02161cz  a2200517n  4500
=001  9880363416102441
=005  20141212201021.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004599
=035  \\$aCAZ7737HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x342
=072  \\$aE2.$x779.$x468
=150  \\$aElectric Stimulation Therapy
=450  \\$wnnna$aElectric Stimulation, Therapeutic
=450  \\$wnnna$aElectrical Stimulation, Therapeutic
=450  \\$wnnna$aElectrical Stimulation Therapy
=450  \\$aElectricity$xtherapeutic use
=450  \\$aElectrotherapeutics$5IEN
=450  \\$aElectrotherapy
=450  \\$wnnna$aElectrotherapy, Interferential Current
=450  \\$wnnna$aInterferential Current Electrotherapy
=450  \\$wnnna$aStimulation, Therapeutic Electric
=450  \\$wnnna$aStimulation, Therapeutic Electrical
=450  \\$wnnna$aStimulation Therapy, Electric
=450  \\$wnnna$aStimulation Therapy, Electrical
=450  \\$wnnna$aTherapeutic Electric Stimulation
=450  \\$wnnna$aTherapeutic Electrical Stimulation
=450  \\$wnnna$aTherapy, Electric Stimulation
=450  \\$wnnna$aTherapy, Electrical Stimulation
=550  \\$wg$aPhysical Therapy Modalities
=550  \\$wg$aTherapeutics
=550  \\$wh$aCardiac Pacing, Artificial
=550  \\$wh$aDeep Brain Stimulation
=550  \\$wh$aElectric Countershock
=550  \\$wh$aElectroacupuncture
=550  \\$wh$aPulsed Radiofrequency Treatment
=550  \\$wh$aSpinal Cord Stimulation
=550  \\$wh$aTranscranial Direct Current Stimulation
=550  \\$wh$aTranscutaneous Electric Nerve Stimulation
=550  \\$wh$aVagus Nerve Stimulation
=550  \\$aMagnetic Field Therapy
=667  \\$ado not use /util except by MeSH definition
=680  \\$iApplication of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.
=688  \\$a90; was ELECTROTHERAPY 1966-89
=750  \0$aElectrotherapeutics$5IEN$0(DLC)sh 85042465

=LDR  00636cz  a2200193n  4500
=001  9880363416202441
=005  20141212201020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004598
=035  \\$aCAZ7736HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x262
=150  \\$aElectrosurgery
=450  \\$wnnna$aElectrosurgeries
=550  \\$wg$aSurgical Procedures, Operative
=667  \\$ado not use /util except by MeSH definition
=680  \\$iDivision of tissues by a high-frequency current applied locally with a metal instrument or needle. (Stedman, 25th ed)
=688  \\$a65
=750  \0$aElectrosurgery$5IEN$0(DLC)sh 85042464

=LDR  01291cz  a2200301n  4500
=001  9880363416302441
=005  20141212201020.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004597
=035  \\$aCAZ7735HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x723.$x402.$x403
=072  \\$aF4.$x669.$x224
=150  \\$aElectroshock
=450  \\$aElectroconvulsive Shock
=450  \\$wnnna$aElectroconvulsive Shocks
=450  \\$wnnna$aElectroshocks
=450  \\$wnnna$aShock, Electroconvulsive
=450  \\$wnnna$aShocks, Electroconvulsive
=550  \\$wg$aElectric Stimulation
=550  \\$wg$aPsychological Techniques
=550  \\$wh$aElectroconvulsive Therapy
=550  \\$wh$aTranscranial Direct Current Stimulation
=550  \\$aElectric Stimulation
=667  \\$aexper shock by electricity, usually in psychol exper: do not confuse with ELECTRIC INJURIES or ELECTROCONVULSIVE THERAPY; X ref ELECTROCONVULSIVE SHOCK: do not coord with CONVULSIONS; electrocountershock = ELECTRIC COUNTERSHOCK
=680  \\$iInduction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states.
=688  \\$a68(64); ELECTROCONVULSIVE SHOCK was heading 1966-67
=750  \0$aElectric shock$5IEN$0(DLC)sh 85041998

=LDR  00762cz  a2200217n  4500
=001  9880363416402441
=005  20141212201019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004596
=035  \\$aCAZ7734HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x225
=072  \\$aE1.$x370.$x405.$x270
=150  \\$aElectroretinography
=450  \\$wnnna$aElectroretinographies
=550  \\$wg$aDiagnostic Techniques, Ophthalmological
=550  \\$wg$aElectrodiagnosis
=550  \\$aRetina
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTRORETINOGR
=680  \\$iRecording of electric potentials in the retina after stimulation by light.
=750  \0$aElectroretinography$5IEN$0(DLC)sh 85042449

=LDR  00602cz  a2200205n  4500
=001  9880363416502441
=005  20141212201019.0
=008  840529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004595
=035  \\$aCAZ7733HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x301.$x250.$x348
=150  \\$aElectroplating
=450  \\$aElectrodeposition
=450  \\$aMetal Plating
=450  \\$wnnna$aPlating, Metal
=550  \\$wg$aElectrolysis
=680  \\$iCoating with a metal or alloy by electrolysis.
=688  \\$a91(85); was see under ELECTROLYSIS 1985-90
=750  \0$aElectroplating$5IEN$0(DLC)sh 85042445

=LDR  00848cz  a2200217n  4500
=001  9880363416602441
=005  20141212201019.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004593
=035  \\$aCAZ7731HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x378.$x430.$x250
=150  \\$aElectrophorus
=450  \\$aEel, Electric
=450  \\$aElectric Eel
=450  \\$wnnna$aElectrophorus electricus
=550  \\$wg$aGymnotiformes
=667  \\$ado not confuse X ref EEL, ELECTRIC with ELECTRIC FISH
=680  \\$iA genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel.
=688  \\$a1974
=750  \0$aElectrophorus (Fish)$5IEN-M$0(DLC)sh2002009902

=LDR  01102cz  a2200313n  4500
=001  9880363416702441
=005  20141212201018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004591
=035  \\$aCAZ7729HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x402
=072  \\$aE5.$x301.$x300.$x319
=150  \\$aElectrophoresis, Polyacrylamide Gel
=450  \\$wnnna$aGel Electrophoresis, Polyacrylamide
=450  \\$aPolyacrylamide Gel Electrophoresis
=450  \\$aSDS-PAGE
=450  \\$wnnna$aSDS PAGE
=450  \\$aSodium Dodecyl Sulfate-PAGE
=450  \\$wnnna$aSodium Dodecyl Sulfate PAGE
=450  \\$wnnna$aSodium Dodecyl Sulfate-PAGEs
=550  \\$wg$aElectrophoresis
=550  \\$wh$aDenaturing Gradient Gel Electrophoresis
=550  \\$wh$aElectrophoresis, Disc
=550  \\$wh$aElectrophoresis, Gel, Two-Dimensional
=550  \\$wh$aNative Polyacrylamide Gel Electrophoresis
=680  \\$iElectrophoresis in which a polyacrylamide gel is used as the diffusion medium.
=688  \\$a73
=750  \0$aPolyacrylamide gel electrophoresis$5IEN$0(DLC)sh 85042439

=LDR  00933cz  a2200229n  4500
=001  9880363416802441
=005  20141212201018.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004590
=035  \\$aCAZ7728HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401.$x319
=072  \\$aE5.$x301.$x300.$x236
=150  \\$aElectrophoresis, Paper
=450  \\$wnnna$aPaper Electrophoresis
=550  \\$wg$aElectrophoresis
=550  \\$wh$aNucleotide Mapping
=550  \\$wh$aPeptide Mapping
=667  \\$aNIM
=680  \\$iElectrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used.
=688  \\$a91(87)73(71); was see under ELECTROPHORESIS 1987-90; was heading 1971-86 (Prov 1971-73)
=750  \0$aPaper electrophoresis$5IEN$0(DLC)sh 85097617

=LDR  01561cz  a2200421n  4500
=001  9880363416902441
=005  20141212201017.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004586
=035  \\$aCAZ7723HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x401
=072  \\$aE5.$x301.$x300
=150  \\$aElectrophoresis
=450  \\$wnnna$aElectrophoreses
=550  \\$wg$aChemistry Techniques, Analytical
=550  \\$wg$aElectrochemical Techniques
=550  \\$wh$aBlood Protein Electrophoresis
=550  \\$wh$aBlotting, Northern
=550  \\$wh$aBlotting, Southern
=550  \\$wh$aBlotting, Southwestern
=550  \\$wh$aBlotting, Western
=550  \\$wh$aElectrophoresis, Agar Gel
=550  \\$wh$aElectrophoresis, Capillary
=550  \\$wh$aElectrophoresis, Cellulose Acetate
=550  \\$wh$aElectrophoresis, Gel, Pulsed-Field
=550  \\$wh$aElectrophoresis, Gel, Two-Dimensional
=550  \\$wh$aElectrophoresis, Paper
=550  \\$wh$aElectrophoresis, Polyacrylamide Gel
=550  \\$wh$aElectrophoresis, Starch Gel
=550  \\$wh$aElectrophoretic Mobility Shift Assay
=550  \\$wh$aImmunoelectrophoresis
=550  \\$wh$aIontophoresis
=550  \\$wh$aIsoelectric Focusing
=550  \\$wh$aIsotachophoresis
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iAn electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.
=750  \0$aElectrophoresis$0(DLC) sh 85042438$5IEN

=LDR  00959cz  a2200241n  4500
=001  9880363417002441
=005  20141212201016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004585
=035  \\$aCAZ7722HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x230.$x285
=072  \\$aE1.$x370.$x405.$x265
=150  \\$aElectrooculography
=450  \\$wnnna$aElectrooculogram
=450  \\$wnnna$aElectrooculograms
=450  \\$aEOG
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aEye Movement Measurements
=550  \\$aEye Movements
=680  \\$iRecording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium.
=688  \\$a67(64)
=750  \0$aElectrooculography$5IEN$0(DLC)sh 85042431

=LDR  01053cz  a2200265n  4500
=001  9880363417102441
=005  20141212201016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004584
=035  \\$aCAZ7721HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x380.$x230.$x280
=072  \\$aE1.$x370.$x382.$x900.$x280
=072  \\$aE1.$x370.$x405.$x260
=150  \\$aElectronystagmography
=450  \\$wnnna$aElectronystagmographies
=550  \\$wg$aElectrodiagnosis
=550  \\$wg$aEye Movement Measurements
=550  \\$wg$aVestibular Function Tests
=550  \\$aNystagmus, Pathologic
=550  \\$aNystagmus, Physiologic
=667  \\$aNIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ELECTRONYSTAGMOGR
=680  \\$iRecording of nystagmus based on changes in the electrical field surrounding the eye produced by the difference in potential between the cornea and the retina.
=688  \\$a79(75); was see under ELECTROOCULOGRAPHY 1973-78
=750  \0$aElectronystagmography$5IEN$0(DLC)sh 85042430

=LDR  01189cz  a2200313n  4500
=001  9880363417202441
=005  20141212201016.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004583
=035  \\$aCAZ7720HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG1.$x249.$x335
=072  \\$aG1.$x358.$x500.$x750
=150  \\$aElectrons
=450  \\$wnnna$aElectron
=450  \\$wnnna$aElectron, Fast
=450  \\$wnnna$aElectrons, Fast
=450  \\$wnnna$aFast Electron
=450  \\$aFast Electrons
=450  \\$wnnna$aNegatron
=450  \\$aNegatrons
=450  \\$wnnna$aPositron
=450  \\$aPositrons
=550  \\$wg$aElectromagnetic Phenomena
=550  \\$wg$aElementary Particles
=667  \\$aelementary particles; IM
=680  \\$iStable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS.
=750  \0$aElectron beams$5IEN-M$0(DLC)sh 85042200
=750  \0$aElectrons$5IEN-HS$0(DLC)sh 85042423

=LDR  00826cz  a2200205n  4500
=001  9880363417302441
=005  20141212201015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004582
=035  \\$aCAZ7719HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x293.$x319
=150  \\$aElectronics, Medical
=450  \\$wnnna$aMedical Electronics
=550  \\$wg$aElectronics
=550  \\$aBiomedical Engineering
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe research and development of ELECTRICAL EQUIPMENT AND SUPPLIES for such medical applications as diagnosis, therapy, research, anesthesia control, cardiac control, and surgery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=688  \\$a68
=750  \0$aMedical electronics$5IEN$0(DLC)sh 85082924

=LDR  00835cz  a2200229n  4500
=001  9880363417402441
=005  20141212201015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004581
=035  \\$aCAZ7718HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x671.$x293
=150  \\$aElectronics
=450  \\$wnnna$aElectronic
=550  \\$wg$aPhysics
=550  \\$wh$aBionics
=550  \\$wh$aElectronics, Medical
=550  \\$wh$aRobotics
=550  \\$aElectrical Equipment and Supplies
=680  \\$iThe study, control, and application of the conduction of ELECTRICITY through gases or vacuum, or through semiconducting or conducting materials. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
=750  \0$aElectronics$5IEN-M$0(DLC)sh 85042383
=750  \0$aElectrical engineering$5IEN-HS$0(DLC)sh 85041666

=LDR  00939cz  a2200265n  4500
=001  9880363417502441
=005  20141212201015.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004580
=035  \\$aCAZ7717HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE3.$x340
=150  \\$aElectronarcosis
=450  \\$aAnesthesia, Electric
=450  \\$wnnna$aAnesthesias, Electric
=450  \\$aElectric Anesthesia
=450  \\$wnnna$aElectric Anesthesias
=450  \\$aElectroanesthesia
=450  \\$wnnna$aElectroanesthesias
=450  \\$wnnna$aElectronarcoses
=450  \\$aElectrosleep
=550  \\$wg$aAnesthesia and Analgesia
=667  \\$ado not use /util except by MeSH definition; current applied through the brain: do not confuse with ELECTROANALGESIA ("applied through the skin")
=680  \\$iProfound stupor produced by passing an electric current through the brain.
=750  \0$aElectric anesthesia$5IEN$0(DLC)sh 85041573

=LDR  01159cz  a2200301n  4500
=001  9880363417602441
=005  20170608140634.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004579
=035  \\$aCAZ7716HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x248
=072  \\$aG3.$x295.$x531.$x403
=072  \\$aG3.$x493.$x350
=150  \\$aElectron Transport
=450  \\$wnnna$aChain, Respiratory
=450  \\$wnnna$aChains, Respiratory
=450  \\$aRespiratory Chain
=450  \\$wnnna$aRespiratory Chains
=450  \\$wnnna$aTransport, Electron
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolic Networks and Pathways
=550  \\$wg$aOxidation-Reduction
=550  \\$aElectron-Transferring Flavoproteins
=667  \\$ausually NIM; not for "proton transport" ( = PROTON PUMPS (IM) or PROTONS (IM) + BIOLOGICAL TRANSPORT (NIM))
=680  \\$iThe process by which ELECTRONS are transported from a reduced substrate to molecular OXYGEN. (From Bennington, Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984, p270)
=688  \\$a66(64)
=750  \0$aElectron transport$0sh 85042238$5IEN-M

=LDR  01657cz  a2200301n  4500
=001  9880363417702441
=005  20141212201014.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004578
=035  \\$aCAZ7715HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x867.$x519.$x274
=150  \\$aElectron Spin Resonance Spectroscopy
=450  \\$aElectron Nuclear Double Resonance
=450  \\$aElectron Paramagnetic Resonance
=450  \\$wnnna$aElectron Spin Resonance
=450  \\$aENDOR
=450  \\$aParamagnetic Resonance
=450  \\$wnnna$aParamagnetic Resonance, Electron
=450  \\$wnnna$aResonance, Electron Paramagnetic
=450  \\$wnnna$aResonance, Electron Spin
=450  \\$wnnna$aResonance, Paramagnetic
=550  \\$wg$aMagnetic Resonance Spectroscopy
=550  \\$aSpin Labels
=667  \\$ausually NIM
=680  \\$iA technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING.
=688  \\$a94; was ELECTRON SPIN RESONANCE 1966-93 (Prov 1964-66)
=750  \0$aElectron paramagnetic resonance spectroscopy$5IEN$0(DLC)sh 85042229

=LDR  00855cz  a2200193n  4500
=001  9880363417902441
=005  20141212200922.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004419
=035  \\$aCAZ7553HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x477.$x374
=072  \\$aD1.$x268.$x558.$x362.$x374
=072  \\$aD1.$x552.$x550.$x399.$x374
=150  \\$aDysprosium
=550  \\$wg$aLanthanoid Series Elements
=667  \\$aa rare earth metal; Dy-164; Dy-156, 158, 160-163 = DYSPROSIUM (IM) + ISOTOPES (NIM); Dy-149-155, 157, 159, 165-167 = DYSPROSIUM (IM) + RADIOISOTOPES (IM)
=680  \\$iDysprosium. An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts.
=750  \0$aDysprosium$5IEN$0(DLC)sh 85040345

=LDR  00874cz  a2200289n  4500
=001  9880363418002441
=005  20141212192148.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004417
=035  \\$aCAZ7551HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC8.$x618.$x326
=072  \\$aC23.$x888.$x852.$x371
=150  \\$aDyspnea
=450  \\$wnnna$aBreath Shortness
=450  \\$wnnna$aBreath Shortnesses
=450  \\$wnnna$aBreathlessness
=450  \\$wnnna$aBreathlessnesses
=450  \\$wnnna$aDyspneas
=450  \\$wnnna$aShortness of Breath
=550  \\$wg$aRespiration Disorders
=550  \\$wg$aSigns and Symptoms, Respiratory
=550  \\$wh$aDyspnea, Paroxysmal
=550  \\$aRespiration
=667  \\$ado not confuse with APNEA or other respiration disorders
=680  \\$iDifficult or labored breathing.
=750  \0$aDyspnea$5IEN$0(DLC)sh 85040344

=LDR  00546cz  a2200193n  4500
=001  9880363418102441
=005  20141212200921.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004415
=035  \\$aCAZ7549HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x888.$x821.$x236
=150  \\$aDyspepsia
=450  \\$wnnna$aDyspepsias
=450  \\$aIndigestion
=450  \\$wnnna$aIndigestions
=550  \\$wg$aSigns and Symptoms, Digestive
=680  \\$iImpaired digestion, especially after eating.
=750  \0$aIndigestion$5IEN$0(DLC)sh 85040341

=LDR  00854cz  a2200289n  4500
=001  9880363418202441
=005  20141212200920.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004412
=035  \\$aCAZ7546HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC23.$x550.$x568.$x750
=072  \\$aC23.$x888.$x646.$x587.$x500
=150  \\$aDysmenorrhea
=450  \\$wnnna$aDysmenorrheas
=450  \\$wnnna$aMenstrual Pain
=450  \\$wnnna$aMenstrual Pains
=450  \\$aMenstruation, Painful
=450  \\$wnnna$aMenstruations, Painful
=450  \\$aPain, Menstrual
=450  \\$wnnna$aPainful Menstruation
=450  \\$wnnna$aPainful Menstruations
=450  \\$wnnna$aPains, Menstrual
=550  \\$wg$aMenstruation Disturbances
=550  \\$wg$aPelvic Pain
=680  \\$iPainful menstruation.
=750  \0$aDysmenorrhea$5IEN$0(DLC)sh 85040339

=LDR  02140cz  a2200529n  4500
=001  9880363418302441
=005  20160405154958.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004411
=035  \\$aCAZ7545HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x300.$x200
=072  \\$aC10.$x597.$x606.$x150.$x550.$x200.$x500
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x300.$x200
=072  \\$aC23.$x888.$x592.$x604.$x150.$x550.$x200.$x500
=072  \\$aF3.$x87.$x700
=072  \\$aF3.$x550.$x350.$x500.$x200.$x500
=072  \\$aF3.$x550.$x450.$x400.$x500
=150  \\$aDyslexia, Acquired
=450  \\$wnnna$aAcquired Alexia
=450  \\$wnnna$aAcquired Dyslexia
=450  \\$wnnna$aAcquired Global Dyslexia
=450  \\$wnnna$aAcquired Reading Disabilities
=450  \\$wnnna$aAcquired Reading Disability
=450  \\$wnnna$aAcquired Spelling Dyslexia
=450  \\$wnnna$aAcquired Word Blindness
=450  \\$wnnna$aAcquired Word Blindnesses
=450  \\$aAlexia, Acquired
=450  \\$wnnna$aBlindness, Acquired Word
=450  \\$wnnna$aBlindnesses, Acquired Word
=450  \\$wnnna$aDisabilities, Acquired Reading
=450  \\$wnnna$aDisability, Acquired Reading
=450  \\$wnnna$aDyslexia, Acquired Global
=450  \\$wnnna$aDyslexia, Acquired Spelling
=450  \\$wnnna$aGlobal Dyslexia, Acquired
=450  \\$wnnna$aReading Disabilities, Acquired
=450  \\$aReading Disability, Acquired
=450  \\$wnnna$aSpelling Dyslexia, Acquired
=450  \\$aWord Blindness, Acquired
=450  \\$wnnna$aWord Blindnesses, Acquired
=550  \\$wg$aDyslexia
=550  \\$wg$aNeurocognitive Disorders
=550  \\$wh$aAlexia, Pure
=550  \\$aReading
=680  \\$iA receptive visual aphasia characterized by the loss of a previously possessed ability to comprehend the meaning or significance of handwritten words, despite intact vision. This condition may be associated with posterior cerebral artery infarction (INFARCTION, POSTERIOR CEREBRAL ARTERY) and other BRAIN DISEASES.
=688  \\$a1977(1963)
=750  \0$aAlexia$5IEN-HS$0(DLC)sh 85003380

=LDR  02819cz  a2200625n  4500
=001  9880363418402441
=005  20201208125007.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004410
=035  \\$aCAZ7544HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x300
=072  \\$aC10.$x597.$x606.$x150.$x550.$x200
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x300
=072  \\$aC23.$x888.$x592.$x604.$x150.$x550.$x200
=072  \\$aF3.$x550.$x350.$x500.$x200
=072  \\$aF3.$x550.$x450.$x400
=150  \\$aDyslexia
=450  \\$aAlexia
=450  \\$wnnna$aAlexias
=450  \\$wnnna$aBlindness, Word
=450  \\$wnnna$aBlindnesses, Word
=450  \\$wnnna$aDevelopmental Dyslexia
=450  \\$wnnna$aDevelopmental Dyslexias
=450  \\$wnnna$aDevelopmental Reading Disabilities
=450  \\$wnnna$aDevelopmental Reading Disability
=450  \\$wnnna$aDevelopmental Reading Disorder
=450  \\$wnnna$aDevelopmental Reading Disorders
=450  \\$wnnna$aDisabilities, Developmental Reading
=450  \\$wnnna$aDisability, Developmental Reading
=450  \\$wnnna$aDisorder, Developmental Reading
=450  \\$wnnna$aDisorder, Reading
=450  \\$wnnna$aDisorders, Developmental Reading
=450  \\$wnnna$aDisorders, Reading
=450  \\$aDyslexia, Developmental
=450  \\$wnnna$aDyslexias
=450  \\$wnnna$aDyslexias, Developmental
=450  \\$wnnna$aReading Disabilities, Developmental
=450  \\$aReading Disability, Developmental
=450  \\$aReading Disorder
=450  \\$aReading Disorder, Developmental
=450  \\$wnnna$aReading Disorders
=450  \\$wnnna$aReading Disorders, Developmental
=450  \\$wnnna$aWord Blindness
=450  \\$wnnna$aWord Blindnesses
=550  \\$wg$aLanguage Disorders
=550  \\$wg$aLearning Disabilities
=550  \\$wh$aDyslexia, Acquired
=550  \\$aLearning Disorders
=667  \\$adyslexia caused by a brain lesion is DYSLEXIA, ACQUIRED; note x-ref: ALEXIA, PURE is also available
=680  \\$iA cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual's chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. (From DSM-IV)
=688  \\$a1966(1963); for ALEXIA use DYSLEXIA, ACQUIRED 1977-1999
=750  \0$aDyslexia$5IEN-M$0(DLC)sh 85040336
=750  \0$aDyslexics$5IEN-HS$0(DLC)sh 90002277
=750  \0$aReading disability$5IEN-HS$0(DLC)sh 85111688

=LDR  01293cz  a2200217n  4500
=001  9880363418602441
=005  20141212200918.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004407
=035  \\$aCAZ7541HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x557.$x465.$x330.$x300
=150  \\$aDysgerminoma
=450  \\$aDisgerminoma
=450  \\$wnnna$aDisgerminomas
=450  \\$wnnna$aDysgerminomas
=550  \\$wg$aGerminoma
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS (IM)
=680  \\$iA malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646)
=688  \\$a79; was DISGERMINOMA 1963-78
=750  \0$aDisgerminoma$5IEN$0(DLC)sh 85038423

=LDR  02634cz  a2200613n  4500
=001  9880363418702441
=005  20141212200917.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004405
=035  \\$aCAZ7539M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x310.$x229
=072  \\$aC6.$x405.$x205.$x331.$x479
=072  \\$aC6.$x405.$x469.$x300.$x479
=150  \\$aDysentery, Bacillary
=450  \\$wnnna$aBacillary Dysentery
=450  \\$wnnna$aboydii Dysenteries, Shigella
=450  \\$wnnna$aboydii Dysentery, Shigella
=450  \\$wnnna$adysenteriae Dysenteries, Shigella
=450  \\$wnnna$adysenteriae Dysentery, Shigella
=450  \\$wnnna$aDysenteries, Shigella
=450  \\$wnnna$aDysenteries, Shigella boydii
=450  \\$wnnna$aDysenteries, Shigella dysenteriae
=450  \\$wnnna$aDysenteries, Shigella flexneri
=450  \\$wnnna$aDysenteries, Shigella sonnei
=450  \\$wnnna$aDysentery, Shiga bacillus
=450  \\$wnnna$aDysentery, Shigella
=450  \\$wnnna$aDysentery, Shigella boydii
=450  \\$wnnna$aDysentery, Shigella dysenteriae
=450  \\$wnnna$aDysentery, Shigella dysenteriae type 1
=450  \\$wnnna$aDysentery, Shigella flexneri
=450  \\$wnnna$aDysentery, Shigella sonnei
=450  \\$wnnna$aflexneri Dysenteries, Shigella
=450  \\$wnnna$aflexneri Dysentery, Shigella
=450  \\$wnnna$aShiga bacillus Dysentery
=450  \\$wnnna$aShigella boydii Dysenteries
=450  \\$wnnna$aShigella boydii Dysentery
=450  \\$wnnna$aShigella dysenteriae Dysenteries
=450  \\$wnnna$aShigella dysenteriae Dysentery
=450  \\$wnnna$aShigella Dysenteries
=450  \\$wnnna$aShigella Dysentery
=450  \\$wnnna$aShigella flexneri Dysenteries
=450  \\$wnnna$aShigella flexneri Dysentery
=450  \\$wnnna$aShigella sonnei Dysenteries
=450  \\$wnnna$aShigella sonnei Dysentery
=450  \\$aShigellosis
=450  \\$wnnna$asonnei Dysenteries, Shigella
=450  \\$wnnna$asonnei Dysentery, Shigella
=550  \\$wg$aDysentery
=550  \\$wg$aEnterobacteriaceae Infections
=550  \\$aShigella
=667  \\$acoord IM with specific organism (IM) if pertinent
=680  \\$iDYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest).
=750  \0$aShigellosis$5IEN-M$0(DLC)sh 85121416

=LDR  01095cz  a2200253n  4500
=001  9880363418802441
=005  20141212200915.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004403
=035  \\$aCAZ7537HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x205.$x331
=072  \\$aC6.$x405.$x469.$x300
=150  \\$aDysentery
=450  \\$wnnna$aDiarrheal Disease, Infectious
=450  \\$wnnna$aInfectious Diarrheal Disease
=450  \\$wnnna$aInfectious Diarrheal Diseases
=550  \\$wg$aGastroenteritis
=550  \\$wg$aIntestinal Diseases
=550  \\$wh$aDysentery, Amebic
=550  \\$wh$aDysentery, Bacillary
=550  \\$aShiga Toxins
=680  \\$iAcute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.
=750  \0$aDysentery$5IEN$0(DLC)sh 85040334

=LDR  00922cz  a2200241n  4500
=001  9880363418902441
=005  20141212200913.0
=008  840525\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D004399
=035  \\$aCAZ7533HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x400.$x575.$x180
=072  \\$aD12.$x644.$x468.$x180
=072  \\$aD12.$x776.$x641.$x650.$x575.$x180
=150  \\$aDynorphins
=450  \\$wnnna$aDynorphin
=450  \\$wnnna$aDynorphin (1-17)
=450  \\$wnnna$aDynorphin A
=450  \\$wnnna$aDynorphin A (1-17)
=550  \\$wg$aOpioid Peptides
=680  \\$iA class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters.
=688  \\$a95; was DYNORPHIN 1985-94
=750  \0$aDynorphins$5IEN-M$0(DLC)sh 97004809

=LDR  01863cz  a2200493n  4500
=001  9880363429002441
=005  20141212200546.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003793
=035  \\$aCAZ6922HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x323.$x428
=072  \\$aE6.$x780.$x345.$x737
=072  \\$aE7.$x695.$x190.$x190
=150  \\$aDental Restoration, Permanent
=450  \\$wnnna$aDental Filling, Permanent
=450  \\$aDental Fillings, Permanent
=450  \\$wnnna$aDental Permanent Filling
=450  \\$wnnna$aDental Permanent Fillings
=450  \\$wnnna$aDental Restorations, Permanent
=450  \\$wnnna$aFilling, Dental Permanent
=450  \\$wnnna$aFilling, Permanent Dental
=450  \\$wnnna$aFillings, Dental Permanent
=450  \\$wnnna$aFillings, Permanent Dental
=450  \\$wnnna$aPermanent Dental Filling
=450  \\$wnnna$aPermanent Dental Fillings
=450  \\$wnnna$aPermanent Dental Restoration
=450  \\$wnnna$aPermanent Dental Restorations
=450  \\$wnnna$aPermanent Filling, Dental
=450  \\$wnnna$aPermanent Fillings, Dental
=450  \\$wnnna$aRestoration, Permanent Dental
=450  \\$wnnna$aRestorations, Permanent Dental
=550  \\$wg$aDental Prosthesis
=550  \\$wg$aDentistry, Operative
=550  \\$wh$aCrowns
=550  \\$wh$aDental Restoration Repair
=550  \\$wh$aDental Restoration Wear
=550  \\$wh$aDental Veneers
=550  \\$wh$aInlays
=550  \\$aDental Prosthesis
=667  \\$adent restoration unspecified probably goes here; DF: DENT RESTORATION PERMANENT
=680  \\$iA restoration designed to remain in service for not less than 20 to 30 years, usually made of gold casting, cohesive gold, or amalgam. (Jablonski, Dictionary of Dentistry, 1992)
=688  \\$a65
=750  \0$aFillings (Dentistry)$5IEN$0(DLC)sh 85048221

=LDR  00841cz  a2200265n  4500
=001  9880363429102441
=005  20141212200545.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003792
=035  \\$aCAZ6921HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x375
=072  \\$aL1.$x280.$x900.$x375
=072  \\$aN4.$x452.$x859.$x341
=072  \\$aN5.$x715.$x360.$x300.$x715.$x330
=072  \\$aN6.$x850.$x520.$x308.$x940.$x375
=150  \\$aDental Records
=450  \\$wnnna$aDental Record
=450  \\$wnnna$aRecord, Dental
=450  \\$wnnna$aRecords, Dental
=550  \\$wg$aRecords as Topic
=667  \\$aDF: DENT RECORDS
=680  \\$iData collected during dental examination for the purpose of study, diagnosis, or treatment planning.
=688  \\$a67
=750  \0$aDental records$5IEN$0(DLC)sh 85036927

=LDR  01320cz  a2200385n  4500
=001  9880363429202441
=005  20141212200543.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003786
=035  \\$aCAZ6916HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x900.$x265
=150  \\$aDental Pulp Cavity
=450  \\$wnnna$aCanal, Pulp
=450  \\$wnnna$aCanal, Root
=450  \\$wnnna$aCanals, Pulp
=450  \\$wnnna$aCanals, Root
=450  \\$wnnna$aCavities, Dental Pulp
=450  \\$wnnna$aCavity, Dental Pulp
=450  \\$wnnna$aChamber, Pulp
=450  \\$wnnna$aChambers, Pulp
=450  \\$wnnna$aDental Pulp Cavities
=450  \\$aPulp Canal
=450  \\$wnnna$aPulp Canals
=450  \\$wnnna$aPulp Cavities, Dental
=450  \\$wnnna$aPulp Cavity, Dental
=450  \\$aPulp Chamber
=450  \\$wnnna$aPulp Chambers
=450  \\$aRoot Canal
=450  \\$wnnna$aRoot Canals
=550  \\$wg$aTooth Components
=667  \\$anote category & X refs; DF: DENT PULP CAVITY
=680  \\$iThe space in a tooth bounded by the dentin and containing the dental pulp. The portion of the cavity within the crown of the tooth is the pulp chamber; the portion within the root is the pulp canal or root canal.
=688  \\$a65
=750  \0$aDental pulp cavity$5IEN$0(DLC)sh 85036926

=LDR  01202cz  a2200325n  4500
=001  9880363429302441
=005  20141212200541.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003778
=035  \\$aCAZ6910HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x345.$x760
=072  \\$aE7.$x695.$x190.$x200
=150  \\$aDentures
=450  \\$wnnna$aDenture
=550  \\$wg$aDental Prosthesis
=550  \\$wh$aDenture Bases
=550  \\$wh$aDenture, Complete
=550  \\$wh$aDenture Design
=550  \\$wh$aDenture Liners
=550  \\$wh$aDenture, Overlay
=550  \\$wh$aDenture, Partial
=550  \\$wh$aDenture Rebasing
=550  \\$wh$aDenture Repair
=550  \\$wh$aDenture Retention
=550  \\$aDental Prosthesis
=667  \\$ageneral or unspecified; prefer specifics; labeling for ownership or identification = DENTURE IDENTIFICATION MARKING
=680  \\$iAn appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS; DENTAL ABUTMENTS; nor TOOTH, ARTIFICIAL.
=688  \\$a91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90
=750  \0$aDentures$5IEN$0(DLC)sh 85036984

=LDR  01324cz  a2200313n  4500
=001  9880363429402441
=005  20141212200540.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003776
=035  \\$aCAZ6909HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x264.$x377
=072  \\$aD25.$x339.$x376
=072  \\$aJ1.$x637.$x51.$x264.$x377
=072  \\$aJ1.$x637.$x51.$x339.$x376
=150  \\$aDental Porcelain
=450  \\$wnnna$aDental Porcelains
=450  \\$aPorcelain
=450  \\$wnnna$aPorcelain, Dental
=450  \\$wnnna$aPorcelains
=450  \\$wnnna$aPorcelains, Dental
=550  \\$wg$aCeramics
=550  \\$wg$aDental Materials
=550  \\$aCrowns
=550  \\$aTooth, Artificial
=667  \\$aD25-26 qualif; DF: DENT PORCELAIN
=680  \\$iA type of porcelain used in dental restorations, either jacket crowns or inlays, artificial teeth, or metal-ceramic crowns. It is essentially a mixture of particles of feldspar and quartz, the feldspar melting first and providing a glass matrix for the quartz. Dental porcelain is produced by mixing ceramic powder (a mixture of quartz, kaolin, pigments, opacifiers, a suitable flux, and other substances) with distilled water. (From Jablonski's Dictionary of Dentistry, 1992)
=688  \\$a65
=750  \0$aDental ceramics$5IEN$0(DLC)sh 85036881

=LDR  00725cz  a2200193n  4500
=001  9880363429502441
=005  20141212200539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003773
=035  \\$aCAZ6906HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x208.$x377
=150  \\$aDental Plaque
=450  \\$wnnna$aPlaque, Dental
=550  \\$wg$aDental Deposits
=667  \\$anote categories; from Cat A /chem /ultrastruct permitted; DF: DENT PLAQUE
=680  \\$iA film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.
=688  \\$a65(64); was in Cat C only 1964-74
=750  \0$aDental plaque$5IEN$0(DLC)sh 85036916

=LDR  00716cz  a2200265n  4500
=001  9880363429602441
=005  20141212200539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003772
=035  \\$aCAZ6905HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x292
=150  \\$aDental Pins
=450  \\$wnnna$aDental Peg
=450  \\$aDental Pegs
=450  \\$wnnna$aDental Pin
=450  \\$wnnna$aPeg, Dental
=450  \\$wnnna$aPegs, Dental
=450  \\$wnnna$aPin, Dental
=450  \\$wnnna$aPins, Dental
=550  \\$wg$aDentistry
=667  \\$aDF: DENT PINS
=680  \\$iSmall cylindrical pieces of metal used to enhance retention.
=688  \\$a70
=750  \0$aDental pins$5IEN$0(DLC)sh 85036915

=LDR  00724cz  a2200217n  4500
=001  9880363429702441
=005  20141212200538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003770
=035  \\$aCAZ6903HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x192.$x377
=150  \\$aDental Offices
=450  \\$wnnna$aDental Office
=450  \\$wnnna$aOffice, Dental
=450  \\$wnnna$aOffices, Dental
=550  \\$wg$aDental Facilities
=667  \\$aDF: DENT OFFICES
=680  \\$iThe room or rooms in which the dentist and dental staff provide care. Offices include all rooms in the dentist's office suite.
=688  \\$a72; was DENTAL OFFICE 1970-71 (Prov)
=750  \0$aDental offices$5IEN$0(DLC)sh 85036908

=LDR  01009cz  a2200265n  4500
=001  9880363429802441
=005  20141212200536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003762
=035  \\$aCAZ6897HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186.$x501
=072  \\$aE7.$x222.$x501
=150  \\$aDental Instruments
=450  \\$wnnna$aDental Instrument
=450  \\$aDentistry$xinstrumentation
=450  \\$wnnna$aInstrument, Dental
=450  \\$wnnna$aInstruments, Dental
=550  \\$wg$aDental Equipment
=550  \\$wh$aMatrix Bands
=550  \\$aDentistry
=667  \\$adifferentiate from DENTAL EQUIPMENT on the basis of size (instrum are entirely holdable in the hand); reamers & broaches: index under ROOT CANAL PREPARATION /instrum; DF: DENT INSTRUM
=680  \\$iHand-held tools or implements especially used by dental professionals for the performance of clinical tasks.
=688  \\$a65
=750  \0$aDental instruments and apparatus industry$5IEN-M$0(DLC)sh 85036900

=LDR  01585cz  a2200313n  4500
=001  9880363429902441
=005  20141212200535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003761
=035  \\$aCAZ6896HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x912.$x130
=150  \\$aDental Impression Technique
=450  \\$wnnna$aDental Impression Technic
=450  \\$wnnna$aDental Impression Technics
=450  \\$wnnna$aDental Impression Techniques
=450  \\$wnnna$aImpression Technic, Dental
=450  \\$wnnna$aImpression Technics, Dental
=450  \\$wnnna$aImpression Technique, Dental
=450  \\$wnnna$aImpression Techniques, Dental
=450  \\$wnnna$aTechnic, Dental Impression
=450  \\$wnnna$aTechnics, Dental Impression
=450  \\$wnnna$aTechnique, Dental Impression
=450  \\$wnnna$aTechniques, Dental Impression
=550  \\$wg$aTechnology, Dental
=667  \\$aDF: DENT IMPRESSION TECHNIQUE
=680  \\$iProcedure of producing an imprint or negative likeness of the teeth and/or edentulous areas. Impressions are made in plastic material which becomes hardened or set while in contact with the tissue. They are later filled with plaster of Paris or artificial stone to produce a facsimile of the oral structures present. Impressions may be made of a full complement of teeth, of areas where some teeth have been removed, or in a mouth from which all teeth have been extracted. (Illustrated Dictionary of Dentistry, 1982)
=688  \\$a91; was DENTAL IMPRESSION TECHNIC 1965-90
=750  \0$aDental impressions$5IEN$0(DLC)sh 85036897

=LDR  01185cz  a2200289n  4500
=001  9880363430002441
=005  20141212200535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003760
=035  \\$aCAZ6895HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339.$x334
=072  \\$aJ1.$x637.$x51.$x339.$x334
=150  \\$aDental Impression Materials
=450  \\$wnnna$aDental Impression Material
=450  \\$wnnna$aImpression Material, Dental
=450  \\$wnnna$aImpression Materials, Dental
=450  \\$wnnna$aMaterial, Dental Impression
=450  \\$wnnna$aMaterials, Dental Impression
=550  \\$wg$aDental Materials
=550  \\$wh$aInlay Casting Wax
=550  \\$aAlginates
=667  \\$aIM; coord with specific material if pertinent (IM); DF: DENT IMPRESSION MATERIALS
=680  \\$iSubstances used to create an impression, or negative reproduction, of the teeth and dental arches. These materials include dental plasters and cements, metallic oxide pastes, silicone base materials, or elastomeric materials.
=688  \\$a65
=750  \0$aPlaster casts, Dental$5IEN-M$0(DLC)sh 85103108
=750  \0$aDental impression materials$5IEN-HS$0(DLC)sh 85036896

=LDR  01478cz  a2200349n  4500
=001  9880363430102441
=005  20141212200534.0
=008  760427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003758
=035  \\$aCAZ6893HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x550.$x280.$x280
=072  \\$aE6.$x231.$x310
=072  \\$aE6.$x645.$x550.$x280.$x280
=072  \\$aE6.$x780.$x314.$x310
=150  \\$aDental Implantation, Endosseous
=450  \\$aDental Implantation, Osseointegrated
=450  \\$wnnna$aEndosseous Dental Implantation
=450  \\$aEndosseous Implantation
=450  \\$wnnna$aImplantation, Endosseous
=450  \\$wnnna$aImplantation, Endosseous Dental
=450  \\$wnnna$aImplantation, Osseointegrated Dental
=450  \\$aOsseointegrated Dental Implantation
=550  \\$wg$aDental Implantation
=550  \\$wh$aBlade Implantation
=550  \\$wh$aDental Implantation, Endosseous, Endodontic
=550  \\$wh$aImmediate Dental Implant Loading
=550  \\$aOsseointegration
=667  \\$ainsertion of implant into the bone tissue of the jaw; DENTAL IMPLANTATION, ENDOSSEOUS, ENDODONTIC is also available; do not use /util except by MeSH definition; DF: DENT IMPLANT ENDOSS
=680  \\$iInsertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment.
=688  \\$a77
=750  \0$aEndosseous dental implants$5IEN$0(DLC)sh 85064643

=LDR  01863cz  a2200397n  4500
=001  9880363430202441
=005  20141212200534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003757
=035  \\$aCAZ6892HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x545.$x550.$x280
=072  \\$aE4.$x650.$x230
=072  \\$aE6.$x231
=072  \\$aE6.$x645.$x550.$x280
=072  \\$aE6.$x780.$x314
=150  \\$aDental Implantation
=450  \\$aDental Prosthesis Implantation
=450  \\$wnnna$aDental Prosthesis Implantations
=450  \\$wnnna$aImplantation, Dental
=450  \\$wnnna$aImplantation, Dental Prosthesis
=450  \\$wnnna$aImplantations, Dental Prosthesis
=450  \\$wnnna$aProsthesis Implantation, Dental
=450  \\$wnnna$aProsthesis Implantations, Dental
=550  \\$wg$aDentistry
=550  \\$wg$aOral Surgical Procedures, Preprosthetic
=550  \\$wg$aProsthesis Implantation
=550  \\$wg$aProsthodontics
=550  \\$wh$aDental Implantation, Endosseous
=550  \\$wh$aDental Implantation, Subperiosteal
=550  \\$aDental Implants
=667  \\$aGEN or unspecified; prefer specifics; implantation of a foreign material into jaw tissue (e.g., gingival or subperiosteal), the procedure: do not confuse with DENTAL IMPLANTS, the implant itself; differentiate from TOOTH REPLANTATION (reinsertion of a tooth lost by trauma or deliberate extraction); do not use /util except by MeSH definition; DF: DENT IMPLANTATION
=680  \\$iThe grafting or inserting of a prosthetic device of alloplastic material into the oral tissue beneath the mucosal or periosteal layer or within the bone. Its purpose is to provide support and retention to a partial or complete denture.
=688  \\$a65
=750  \0$aDental implants industry$5IEN-M$0(DLC)sh 89001427
=750  \0$aDental implants$5IEN-HS$0(DLC)sh 85064641

=LDR  00982cz  a2200241n  4500
=001  9880363430302441
=005  20141212200533.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003756
=035  \\$aCAZ6891HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x105.$x376
=072  \\$aN2.$x360.$x67.$x105.$x376
=150  \\$aDental Hygienists
=450  \\$wnnna$aDental Hygienist
=450  \\$wnnna$aHygienist, Dental
=450  \\$wnnna$aHygienists, Dental
=550  \\$wg$aDental Auxiliaries
=667  \\$atrained in accredited schools & licensed to practice DENTAL PROPHYLAXIS (see note there) under a licensed dentist; DF: DENT HYGIENISTS
=680  \\$iPersons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist.
=688  \\$a65
=750  \0$aDental hygienists$5IEN$0(DLC)sh 85036895
=750  \0$aDental hygiene$5IEN$0(DLC)sh 85036893

=LDR  01334cz  a2200397n  4500
=001  9880363430402441
=005  20141212200532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003753
=035  \\$aCAZ6888HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x250.$x300
=072  \\$aE6.$x208
=072  \\$aN5.$x715.$x360.$x300.$x375.$x300
=072  \\$aN6.$x850.$x520.$x308.$x250.$x300
=072  \\$aN6.$x890.$x160
=150  \\$aDental Health Surveys
=450  \\$wnnna$aDental Health Survey
=450  \\$aDental Surveys$5IEN
=450  \\$wnnna$aHealth Survey, Dental
=450  \\$wnnna$aHealth Surveys, Dental
=450  \\$wnnna$aSurvey, Dental Health
=450  \\$wnnna$aSurveys, Dental Health
=550  \\$wg$aDentistry
=550  \\$wg$aHealth Surveys
=550  \\$wg$aPublic Health Dentistry
=550  \\$wh$aDental Plaque Index
=550  \\$wh$aDMF Index
=550  \\$wh$aIndex of Orthodontic Treatment Need
=550  \\$wh$aOral Hygiene Index
=550  \\$wh$aPeriodontal Index
=550  \\$aOral Health
=667  \\$aspecify geographic term if pertinent
=680  \\$iA systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area.
=688  \\$a72
=750  \0$aDental surveys$0(DLC) sh 85036936$5IEN

=LDR  00820cz  a2200265n  4500
=001  9880363430502441
=005  20141212200531.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003752
=035  \\$aCAZ6887HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x421.$x240
=150  \\$aDental Health Services
=450  \\$wnnna$aDental Health Service
=450  \\$wnnna$aHealth Service, Dental
=450  \\$wnnna$aHealth Services, Dental
=450  \\$wnnna$aService, Dental Health
=450  \\$wnnna$aServices, Dental Health
=550  \\$wg$aHealth Services
=550  \\$wh$aDental Care
=550  \\$wh$aDental Service, Hospital
=667  \\$aDF: DENT HEALTH SERV
=680  \\$iServices designed to promote, maintain, or restore dental health.
=688  \\$a78
=750  \0$aDental care$5IEN$0(DLC)sh 85036869

=LDR  01271cz  a2200337n  4500
=001  9880363430602441
=005  20141212200530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003748
=035  \\$aCAZ6883HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186
=072  \\$aE7.$x222
=150  \\$aDental Equipment
=450  \\$wnnna$aDental Equipments
=450  \\$aDental Instruments and Apparatus$5IEN
=450  \\$wnnna$aEquipment, Dental
=450  \\$wnnna$aEquipments, Dental
=550  \\$wg$aDentistry
=550  \\$wg$aEquipment and Supplies
=550  \\$wh$aCuring Lights, Dental
=550  \\$wh$aDental Articulators
=550  \\$wh$aDental Devices, Home Care
=550  \\$wh$aDental High-Speed Equipment
=550  \\$wh$aDental Instruments
=550  \\$wh$aRubber Dams
=550  \\$aDentistry
=667  \\$afor the dent professional, not the patient; differentiate from DENTAL INSTRUMENTS on basis of size (instrum are holdable in the hand); DF: DENT EQUIPMENT
=680  \\$iThe nonexpendable items used by the dentist or dental staff in the performance of professional duties. (From Boucher's Clinical Dental Terminology, 4th ed, p106)
=688  \\$a65
=750  \0$aDental instruments and apparatus industry$5IEN-M$0(DLC)sh 85036900

=LDR  00600cz  a2200193n  4500
=001  9880363430702441
=005  20141212200530.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003747
=035  \\$aCAZ6882HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x549.$x181
=150  \\$aDental Enamel Solubility
=450  \\$wnnna$aEnamel Solubility, Dental
=450  \\$wnnna$aSolubility, Dental Enamel
=550  \\$wg$aDental Physiological Phenomena
=680  \\$iThe susceptibility of the DENTAL ENAMEL to dissolution.
=688  \\$a65
=750  \0$aDental enamel$xSolubility$5IEN$0(DLC)sh 85042960

=LDR  01325cz  a2200301n  4500
=001  9880363430802441
=005  20141212200528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003743
=035  \\$aCAZ6878HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x900.$x255
=150  \\$aDental Enamel
=450  \\$wnnna$aCuticle, Enamel
=450  \\$wnnna$aCuticles, Enamel
=450  \\$wnnna$aDental Enamels
=450  \\$aEnamel
=450  \\$aEnamel Cuticle
=450  \\$wnnna$aEnamel Cuticles
=450  \\$wnnna$aEnamel, Dental
=450  \\$wnnna$aEnamels
=450  \\$wnnna$aEnamels, Dental
=550  \\$wg$aTooth Components
=550  \\$wh$aDental Pellicle
=667  \\$a/embryol: consider also AMELOGENESIS; DF: DENT ENAMEL
=680  \\$iA hard thin translucent layer of calcified substance which envelops and protects the dentin of the crown of the tooth. It is the hardest substance in the body and is almost entirely composed of calcium salts. Under the microscope, it is composed of thin rods (enamel prisms) held together by cementing substance, and surrounded by an enamel sheath. (From Jablonski, Dictionary of Dentistry, 1992, p286)
=688  \\$aENAMEL CUTICLE was heading 1965-96; NASMYTH'S MEMBRANE was see ENAMEL CUTICLE 1975-96
=750  \0$aDental enamel$5IEN$0(DLC)sh 85042959

=LDR  00888cz  a2200265n  4500
=001  9880363430902441
=005  20141212200528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003742
=035  \\$aCAZ6877HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186.$x250
=072  \\$aE6.$x761.$x726.$x292
=072  \\$aE7.$x222.$x250
=150  \\$aDental Devices, Home Care
=450  \\$aDental Floss
=450  \\$wnnna$aFloss, Dental
=450  \\$wnnna$aHome Care Dental Devices
=550  \\$wg$aDental Equipment
=550  \\$wg$aOral Hygiene
=550  \\$aOral Hygiene
=667  \\$aDF: DENT DEVICES HOME CARE
=680  \\$iDevices used in the home by persons to maintain dental and periodontal health. The devices include toothbrushes, dental flosses, water irrigators, gingival stimulators, etc.
=688  \\$a72
=750  \0$aOral hygiene products$5IEN$0(DLC)sh 87004523

=LDR  00987cz  a2200277n  4500
=001  9880363431002441
=005  20141212200528.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003741
=035  \\$aCAZ6876HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x208
=150  \\$aDental Deposits
=450  \\$wnnna$aDental Deposit
=450  \\$wnnna$aDeposit, Dental
=450  \\$wnnna$aDeposits, Dental
=450  \\$aMateria Alba
=550  \\$wg$aTooth Diseases
=550  \\$wh$aDental Calculus
=550  \\$wh$aDental Plaque
=550  \\$wh$aSmear Layer
=550  \\$aBiofilms
=667  \\$aDF: DENT DEPOSITS
=680  \\$iAccumulations of microflora that lead to pathological plaque and calculus which cause PERIODONTAL DISEASES. It can be considered a type of BIOFILMS. It is subtly distinguished from the protective DENTAL PELLICLE.
=688  \\$a65; was in Cat C only 1965-74; MATERIA ALBA was heading 1965-86
=750  \0$aDental deposits$5IEN$0(DLC)sh 85036884

=LDR  00676cz  a2200241n  4500
=001  9880363431102441
=005  20141212200527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003740
=035  \\$aCAZ6875HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x192.$x250
=150  \\$aDental Clinics
=450  \\$wnnna$aClinic, Dental
=450  \\$aClinics, Dental
=450  \\$wnnna$aDental Clinic
=550  \\$wg$aDental Facilities
=550  \\$aOral Health
=550  \\$aPreventive Dentistry
=667  \\$aDF: DENT CLINICS
=680  \\$iFacilities where dental care is provided to patients.
=688  \\$a65
=750  \0$aDental clinics$5IEN$0(DLC)sh 85036883

=LDR  01005cz  a2200253n  4500
=001  9880363431202441
=005  20141212200527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003739
=035  \\$aCAZ6874HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA14.$x549.$x167.$x646.$x267
=072  \\$aA14.$x549.$x167.$x900.$x250
=150  \\$aDental Cementum
=450  \\$wnnna$aCementoblast
=450  \\$aCementoblasts
=450  \\$aCementum
=450  \\$wnnna$aCementum, Dental
=550  \\$wg$aPeriodontium
=550  \\$wg$aTooth Components
=550  \\$aCementogenesis
=667  \\$ado not confuse with DENTAL CEMENTS (Cat D); DF: DENT CEMENTUM
=680  \\$iThe bonelike rigid connective tissue covering the root of a tooth from the cementoenamel junction to the apex and lining the apex of the root canal, also assisting in tooth support by serving as attachment structures for the periodontal ligament. (Jablonski, Dictionary of Dentistry, 1992)
=750  \0$aCementum$5IEN$0(DLC)sh 85021755

=LDR  01792cz  a2200469n  4500
=001  9880363431302441
=005  20141212200527.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003738
=035  \\$aCAZ6873HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339.$x291
=072  \\$aJ1.$x637.$x51.$x339.$x291
=150  \\$aDental Cements
=450  \\$wnnna$aAdhesive, Dental
=450  \\$wnnna$aAdhesive, Orthodontic
=450  \\$wnnna$aAdhesives, Dental
=450  \\$wnnna$aAdhesives, Orthodontic
=450  \\$wnnna$aCement, Dental
=450  \\$wnnna$aCements, Dental
=450  \\$wnnna$aDental Adhesive
=450  \\$aDental Adhesives
=450  \\$wnnna$aDental Cement
=450  \\$wnnna$aLuting Agent
=450  \\$aLuting Agents
=450  \\$wnnna$aOrthodontic Adhesive
=450  \\$aOrthodontic Adhesives
=550  \\$wg$aDental Materials
=550  \\$wh$aCompomers
=550  \\$wh$aDentin-Bonding Agents
=550  \\$wh$aGlass Ionomer Cements
=550  \\$wh$aOrganically Modified Ceramics
=550  \\$wh$aPolycarboxylate Cement
=550  \\$wh$aResin Cements
=550  \\$wh$aSilicate Cement
=550  \\$wh$aZinc Oxide-Eugenol Cement
=550  \\$wh$aZinc Phosphate Cement
=550  \\$aCementation
=667  \\$acoordinate IM with specific material if pertinent (IM); do not confuse with DENTAL CEMENTUM , an anatomical term or with denture adhesives ( = DENTURE RETENTION + ADHESIVES); DF: DENT CEMENTS
=680  \\$iSubstances used to bond COMPOSITE RESINS to DENTAL ENAMEL and DENTIN. These bonding or luting agents are used in restorative dentistry, ROOT CANAL THERAPY; PROSTHODONTICS; and ORTHODONTICS.
=688  \\$a72(71); was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64
=750  \0$aDental cements$5IEN$0(DLC)sh 85036879

=LDR  01258cz  a2200241n  4500
=001  9880363431402441
=005  20141212200526.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003737
=035  \\$aCAZ6872HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x931.$x325
=150  \\$aDental Cavity Preparation
=450  \\$wnnna$aCavity Preparation, Dental
=450  \\$wnnna$aCavity Preparations, Dental
=450  \\$wnnna$aDental Cavity Preparations
=450  \\$wnnna$aPreparation, Dental Cavity
=450  \\$wnnna$aPreparations, Dental Cavity
=550  \\$wg$aTooth Preparation
=550  \\$aTooth Preparation, Prosthodontic
=667  \\$arestrict to fillings & inlays; for other prep procedures TOOTH PREPARATION, PROSTHODONTIC & ROOT CANAL PREPARATION are available; DF: DENT CAVITY PREPARATION
=680  \\$iAn operation in which carious material is removed from teeth and biomechanically correct forms are established in the teeth to receive and retain restorations. A constant requirement is provision for prevention of failure of the restoration through recurrence of decay or inadequate resistance to applied stresses. (Boucher's Clinical Dental Terminology, 4th ed, p239-40)
=750  \0$aDental cavity preparation$5IEN$0(DLC)sh 85036878

=LDR  01235cz  a2200349n  4500
=001  9880363431502441
=005  20141212200525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003735
=035  \\$aCAZ6871HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x780.$x250
=072  \\$aE6.$x912.$x115
=150  \\$aDental Casting Technique
=450  \\$wnnna$aCasting Technic, Dental
=450  \\$wnnna$aCasting Technics, Dental
=450  \\$wnnna$aCasting Technique, Dental
=450  \\$wnnna$aCasting Techniques, Dental
=450  \\$wnnna$aDental Casting Technic
=450  \\$wnnna$aDental Casting Technics
=450  \\$wnnna$aDental Casting Techniques
=450  \\$wnnna$aTechnic, Dental Casting
=450  \\$wnnna$aTechnics, Dental Casting
=450  \\$wnnna$aTechnique, Dental Casting
=450  \\$wnnna$aTechniques, Dental Casting
=550  \\$wg$aProsthodontics
=550  \\$wg$aTechnology, Dental
=667  \\$aDF: DENT CASTING TECHNIQUE
=680  \\$iThe process of producing a form or impression made of metal or plaster using a mold.
=688  \\$a91; was DENTAL CASTING TECHNIC 1965-90
=750  \0$aWaxing (Dentistry)$5IEN-M$0(DLC)sh 85145804
=750  \0$aDental casting$5IEN-HS$0(DLC)sh 85036877

=LDR  01065cz  a2200265n  4500
=001  9880363431602441
=005  20141212200524.0
=008  790425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003730
=035  \\$aCAZ6867HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x170.$x310
=072  \\$aN2.$x421.$x240.$x190.$x230
=150  \\$aDental Care for Disabled
=450  \\$aDental Care for Handicapped
=450  \\$aDentistry for Disabled
=450  \\$aDentistry for Handicapped
=450  \\$wnnna$aDisabled, Dentistry for
=450  \\$wnnna$aHandicapped, Dentistry for
=550  \\$wg$aDental Care
=550  \\$aDisabled Persons
=667  \\$a= professional care by a professional; disability can refer to emotional, mental or physical dis; DF: DENT CARE DISABLED
=680  \\$iDental care for the emotionally, mentally, or physically disabled patient. It does not include dental care for the chronically ill ( = DENTAL CARE FOR CHRONICALLY ILL).
=688  \\$a93; was DENTAL CARE FOR HANDICAPPED 1980-92
=750  \0$aHandicapped$xDental care$5IEN$0(IEN)367242

=LDR  00756cz  a2200229n  4500
=001  9880363431702441
=005  20141212200523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003728
=035  \\$aCAZ6866HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC7.$x793.$x208.$x250
=072  \\$aC23.$x300.$x175.$x350
=150  \\$aDental Calculus
=450  \\$wnnna$aCalculus, Dental
=450  \\$aTartar
=550  \\$wg$aCalculi
=550  \\$wg$aDental Deposits
=667  \\$anote categories; from Cat A /chem /ultrastruct permitted; DF: DENT CALCULUS
=680  \\$iAbnormal concretion or calcified deposit that forms around the teeth or dental prostheses.
=688  \\$a64; was in Cat C only 1964-74
=750  \0$aDental calculus$5IEN$0(DLC)sh 85036868

=LDR  01066cz  a2200325n  4500
=001  9880363431802441
=005  20141212200523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003727
=035  \\$aCAZ6865HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x105
=072  \\$aN2.$x360.$x67.$x105
=150  \\$aDental Auxiliaries
=450  \\$wnnna$aAuxiliaries, Dental
=450  \\$wnnna$aAuxiliary, Dental
=450  \\$wnnna$aDental Auxiliary
=450  \\$wnnna$aDental Receptionist
=450  \\$aDental Receptionists
=450  \\$wnnna$aReceptionist, Dental
=450  \\$wnnna$aReceptionists, Dental
=550  \\$wg$aAllied Health Personnel
=550  \\$wh$aDental Assistants
=550  \\$wh$aDental Hygienists
=550  \\$wh$aDental Technicians
=550  \\$wh$aDenturists
=667  \\$aDF: DENT AUXILIARIES
=680  \\$iPersonnel whose work is prescribed and supervised by the dentist.
=688  \\$a78; was ALLIED DENTAL PERSONNEL (NON MESH) before 1978
=750  \0$aDental auxiliary personnel$5IEN$0(DLC)sh 85036863

=LDR  00877cz  a2200265n  4500
=001  9880363431902441
=005  20141212200522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003726
=035  \\$aCAZ6864HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x526.$x485.$x67.$x105.$x250
=072  \\$aN2.$x360.$x67.$x105.$x250
=150  \\$aDental Assistants
=450  \\$wnnna$aAssistant, Dental
=450  \\$wnnna$aAssistants, Dental
=450  \\$wnnna$aDental Assistant
=450  \\$wnnna$aDental Nurse
=450  \\$aDental Nurses
=450  \\$wnnna$aNurse, Dental
=450  \\$aNurses, Dental
=550  \\$wg$aDental Auxiliaries
=667  \\$aassist a dentist or hygienist; DENTAL AUXILIARIES is also available; DF: DENT ASSISTANTS
=680  \\$iIndividuals who assist the dentist or the dental hygienist.
=750  \0$aDental assistants$5IEN$0(DLC)sh 85036862

=LDR  01059cz  a2200253n  4500
=001  9880363432002441
=005  20141212200522.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003725
=035  \\$aCAZ6863HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE6.$x186.$x210
=072  \\$aE7.$x222.$x210
=150  \\$aDental Articulators
=450  \\$wnnna$aArticulator
=450  \\$wnnna$aArticulator, Dental
=450  \\$aArticulators
=450  \\$wnnna$aArticulators, Dental
=450  \\$wnnna$aDental Articulator
=550  \\$wg$aDental Equipment
=667  \\$aDF: DENT ARTICULATORS
=680  \\$iMechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements.
=688  \\$a91(77); was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74
=750  \0$aDental articulators$5IEN$0(DLC)sh 85036860

=LDR  00827cz  a2200253n  4500
=001  9880363432102441
=005  20141212200522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003724
=035  \\$aCAZ6862HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x320
=072  \\$aA14.$x521.$x320
=150  \\$aDental Arch
=450  \\$wnnna$aArch, Dental
=450  \\$wnnna$aArches, Dental
=450  \\$wnnna$aDental Arches
=550  \\$wg$aJaw
=550  \\$aAlveolar Process
=550  \\$aJaw
=667  \\$aDF: DENT ARCH
=680  \\$iThe curve formed by the row of TEETH in their normal position in the JAW. The inferior dental arch is formed by the mandibular teeth, and the superior dental arch by the maxillary teeth.
=688  \\$a66
=750  \0$aDental arch$5IEN$0(DLC)sh 85036859

=LDR  00730cz  a2200229n  4500
=001  9880363432202441
=005  20141212200522.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003723
=035  \\$aCAZ6861HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339.$x208.$x291
=072  \\$aJ1.$x637.$x51.$x339.$x208.$x291
=150  \\$aDental Amalgam
=450  \\$wnnna$aAmalgam, Dental
=450  \\$wnnna$aAmalgams, Dental
=450  \\$wnnna$aDental Amalgams
=550  \\$wg$aDental Alloys
=667  \\$aD25-26 qualif; DF: DENT AMALGAM
=680  \\$iAn alloy used in restorative dentistry that contains mercury, silver, tin, copper, and possibly zinc.
=688  \\$a65
=750  \0$aDental amalgams$5IEN$0(DLC)sh 85036857

=LDR  00950cz  a2200289n  4500
=001  9880363432302441
=005  20141212200521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003722
=035  \\$aCAZ6860HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD25.$x339.$x208
=072  \\$aJ1.$x637.$x51.$x339.$x208
=150  \\$aDental Alloys
=450  \\$wnnna$aAlloy, Dental
=450  \\$wnnna$aAlloys, Dental
=450  \\$wnnna$aDental Alloy
=450  \\$aDental Metallurgy$5IEN
=550  \\$wg$aDental Materials
=550  \\$wh$aChromium Alloys
=550  \\$wh$aDental Amalgam
=550  \\$wh$aGold Alloys
=550  \\$wh$aMetal Ceramic Alloys
=667  \\$aD25-26 qualif; DF: DENT ALLOYS
=680  \\$iA mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions for use in restorative or prosthetic dentistry.
=688  \\$a73
=750  \0$aDental metallurgy$5IEN-M$0(DLC)sh 85036907

=LDR  00712cz  a2200205n  4500
=001  9880363432402441
=005  20141212200521.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003720
=035  \\$aCAZ6858HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x196.$x712.$x224
=150  \\$aDensitometry
=450  \\$wnnna$aDensitometries
=550  \\$wg$aPhotometry
=550  \\$wh$aAbsorptiometry, Photon
=667  \\$aTOMODENSITOMETRY see TOMOGRAPHY, X-RAY COMPUTED is also available
=680  \\$iThe measurement of the density of a material by measuring the amount of light or radiation passing through (or absorbed by) the material.
=688  \\$a67(64)
=750  \0$aDensitometry$0(DLC) sh 85036847$5IEN

=LDR  01148cz  a2200301n  4500
=001  9880363432602441
=005  20141212200520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003716
=035  \\$aCAZ6854HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250.$x350.$x270
=072  \\$aB4.$x909.$x777.$x310.$x350.$x270
=150  \\$aDengue Virus
=450  \\$aBreakbone Fever Virus
=450  \\$wnnna$aBreakbone Fever Viruses
=450  \\$wnnna$aDengue Viruses
=450  \\$wnnna$aFever Virus, Breakbone
=450  \\$wnnna$aFever Viruses, Breakbone
=450  \\$wnnna$aVirus, Breakbone Fever
=450  \\$wnnna$aVirus, Dengue
=450  \\$wnnna$aViruses, Breakbone Fever
=450  \\$wnnna$aViruses, Dengue
=550  \\$wg$aFlavivirus
=667  \\$aa species of Flavivirus; infection = DENGUE or SEVERE DENGUE
=680  \\$iA species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.
=688  \\$a66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64
=750  \0$aDengue viruses$5IEN$0(DLC)sh 85036729

=LDR  01415cz  a2200385n  4500
=001  9880363432702441
=005  20141212192131.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003715
=035  \\$aCAZ6853HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x81.$x270
=072  \\$aC2.$x782.$x350.$x250.$x214
=072  \\$aC2.$x782.$x417.$x214
=150  \\$aDengue
=450  \\$wnnna$aBreak-Bone Fever
=450  \\$wnnna$aBreak Bone Fever
=450  \\$wnnna$aBreakbone Fever
=450  \\$wnnna$aClassical Dengue
=450  \\$wnnna$aClassical Dengue Fever
=450  \\$wnnna$aClassical Dengue Fevers
=450  \\$wnnna$aClassical Dengues
=450  \\$wnnna$aDengue, Classical
=450  \\$aDengue Fever
=450  \\$wnnna$aDengue Fever, Classical
=450  \\$wnnna$aFever, Break-Bone
=450  \\$wnnna$aFever, Breakbone
=450  \\$wnnna$aFever, Dengue
=550  \\$wg$aArbovirus Infections
=550  \\$wg$aFlavivirus Infections
=550  \\$wg$aHemorrhagic Fevers, Viral
=550  \\$wh$aSevere Dengue
=667  \\$acoordinate with NEGLECTED DISEASES if pertinent; SEVERE DENGUE is also available
=680  \\$iAn acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
=750  \0$aDengue$5IEN$0(DLC)sh 85036728

=LDR  01087cz  a2200301n  4500
=001  9880363432802441
=005  20141212200520.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003714
=035  \\$aCAZ6852HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x525.$x210
=150  \\$aDenervation
=450  \\$wnnna$aDenervations
=550  \\$wg$aNeurosurgical Procedures
=550  \\$wh$aAutonomic Denervation
=550  \\$wh$aAxotomy
=550  \\$wh$aCordotomy
=550  \\$wh$aGanglionectomy
=550  \\$wh$aMuscle Denervation
=550  \\$wh$aNerve Block
=550  \\$wh$aNerve Crush
=550  \\$wh$aRhizotomy
=550  \\$wh$aVagotomy
=667  \\$aGEN or unspecified; prefer specifics; coord with specific nerve /surg or /physiol or specific organ /innerv but MUSCLE DENERVATION is also available for coord with specific muscle; NIM when a study technique; do not use /util except by MeSH definition
=680  \\$iThe resection or removal of the nerve to an organ or part. (Dorland, 28th ed)
=688  \\$a65(64)
=750  \0$aDenervation$5IEN$0(DLC)sh 85036726

=LDR  02625cz  a2200601n  4500
=001  9880363432902441
=005  20141212200520.0
=008  860619\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003713
=035  \\$aCAZ6851HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA11.$x66.$x270
=072  \\$aA11.$x436.$x270
=072  \\$aA15.$x382.$x66.$x270
=072  \\$aA15.$x382.$x812.$x260
=150  \\$aDendritic Cells
=450  \\$wnnna$aCell, Dendritic
=450  \\$wnnna$aCell, Interdigitating
=450  \\$wnnna$aCell, Interdigitating Dendritic
=450  \\$wnnna$aCell, Interstitial Dendritic
=450  \\$wnnna$aCell, Plasmacytoid Dendritic
=450  \\$wnnna$aCell, Veiled
=450  \\$wnnna$aCells, Dendritic
=450  \\$wnnna$aCells, Interdigitating
=450  \\$wnnna$aCells, Interdigitating Dendritic
=450  \\$wnnna$aCells, Interstitial Dendritic
=450  \\$wnnna$aCells, Plasmacytoid Dendritic
=450  \\$wnnna$aCells, Veiled
=450  \\$wnnna$aDendritic Cell
=450  \\$wnnna$aDendritic Cell, Interdigitating
=450  \\$wnnna$aDendritic Cell, Interstitial
=450  \\$wnnna$aDendritic Cell, Plasmacytoid
=450  \\$aDendritic Cells, Interdigitating
=450  \\$wnnna$aDendritic Cells, Interstitial
=450  \\$wnnna$aDendritic Cells, Plasmacytoid
=450  \\$wnnna$aInterdigitating Cell
=450  \\$aInterdigitating Cells
=450  \\$wnnna$aInterdigitating Dendritic Cell
=450  \\$wnnna$aInterdigitating Dendritic Cells
=450  \\$wnnna$aInterstitial Dendritic Cell
=450  \\$wnnna$aInterstitial Dendritic Cells
=450  \\$wnnna$aPlasmacytoid Dendritic Cell
=450  \\$aPlasmacytoid Dendritic Cells
=450  \\$wnnna$aVeiled Cell
=450  \\$aVeiled Cells
=550  \\$wg$aAntigen-Presenting Cells
=550  \\$wg$aEpithelial Cells
=550  \\$wg$aMononuclear Phagocyte System
=550  \\$wh$aLangerhans Cells
=667  \\$ado not confuse with DENDRITES; DENDRITIC CELLS, FOLLICULAR is also available
=680  \\$iSpecialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).
=688  \\$a87
=750  \0$aDendritic cells$0sh 91001535$5IEN

=LDR  00792cz  a2200265n  4500
=001  9880363433002441
=005  20141212192130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003712
=035  \\$aCAZ6850HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x675.$x256
=072  \\$aA11.$x284.$x180.$x225
=072  \\$aA11.$x671.$x240
=150  \\$aDendrites
=450  \\$wnnna$aDendrite
=550  \\$wg$aCell Surface Extensions
=550  \\$wg$aNeurons
=550  \\$wh$aDendritic Spines
=550  \\$wh$aGrowth Cones
=550  \\$wh$aNeurites
=667  \\$ado not confuse with DENDRITIC CELLS
=680  \\$iExtensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.
=688  \\$a65(64)
=750  \0$aDendrites$5IEN$0(DLC)sh 85036698

=LDR  01325cz  a2200349n  4500
=001  9880363433102441
=005  20141212200519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003711
=035  \\$aCAZ6849HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x314
=150  \\$aDemyelinating Diseases
=450  \\$wnnna$aClinically Isolated CNS Demyelinating Syndrome
=450  \\$wnnna$aClinically Isolated Syndrome, CNS Demyelinating
=450  \\$wnnna$aDemyelinating Disease
=450  \\$wnnna$aDemyelinating Disorder
=450  \\$wnnna$aDemyelinating Disorders
=450  \\$wnnna$aDemyelination
=450  \\$wnnna$aDemyelinations
=550  \\$wg$aNervous System Diseases
=550  \\$wh$aDemyelinating Autoimmune Diseases, CNS
=550  \\$wh$aHereditary Central Nervous System Demyelinating Diseases
=550  \\$wh$aLeukoencephalopathy, Progressive Multifocal
=550  \\$wh$aMarchiafava-Bignami Disease
=550  \\$wh$aMyelinolysis, Central Pontine
=550  \\$wh$aOphthalmoplegic Migraine
=550  \\$wh$aPolyradiculoneuropathy
=550  \\$wh$aSubacute Combined Degeneration
=680  \\$iDiseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
=688  \\$a79; was DEMYELINATION 1963-78
=750  \0$aDemyelination$5IEN$0(DLC)sh 85036687

=LDR  04185cz  a2201153n  4500
=001  9880363433202441
=005  20141212200518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003710
=035  \\$aCAZ6848HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x240
=072  \\$aN1.$x224
=072  \\$aN6.$x850.$x505.$x400
=150  \\$aDemography
=450  \\$wnnna$aAccounting, Demographic
=450  \\$wnnna$aAnalyses, Demographic
=450  \\$wnnna$aAnalyses, Multiregional
=450  \\$wnnna$aAnalyses, Period
=450  \\$wnnna$aAnalysis, Demographic
=450  \\$wnnna$aAnalysis, Multiregional
=450  \\$wnnna$aAnalysis, Period
=450  \\$wnnna$aBrass Technic
=450  \\$wnnna$aBrass Technique
=450  \\$wnnna$aDemographer
=450  \\$wnnna$aDemographers
=450  \\$wnnna$aDemographic Accounting
=450  \\$wnnna$aDemographic Analyses
=450  \\$wnnna$aDemographic Analysis
=450  \\$wnnna$aDemographic and Health Surveys
=450  \\$wnnna$aDemographic Factor
=450  \\$wnnna$aDemographic Factors
=450  \\$wnnna$aDemographic Impact
=450  \\$wnnna$aDemographic Impacts
=450  \\$wnnna$aDemographic Survey
=450  \\$wnnna$aDemographic Surveys
=450  \\$wnnna$aDemographics
=450  \\$wnnna$aDemographies, Historical
=450  \\$wnnna$aDemographies, Prehistoric
=450  \\$wnnna$aDemography, Historical
=450  \\$wnnna$aDemography, Prehistoric
=450  \\$wnnna$aDistribution, Population
=450  \\$wnnna$aDistribution, Population Spatial
=450  \\$wnnna$aDistributions, Population
=450  \\$wnnna$aDistributions, Population Spatial
=450  \\$wnnna$aFactor, Demographic
=450  \\$wnnna$aFactors, Demographic
=450  \\$wnnna$aFamily Reconstitution
=450  \\$wnnna$aFamily Reconstitutions
=450  \\$wnnna$aHistorical Demographies
=450  \\$wnnna$aHistorical Demography
=450  \\$wnnna$aImpact, Demographic
=450  \\$wnnna$aImpacts, Demographic
=450  \\$wnnna$aMethod, Reverse Survival
=450  \\$wnnna$aMethod, Stable Population
=450  \\$wnnna$aMethods, Reverse Survival
=450  \\$wnnna$aMethods, Stable Population
=450  \\$wnnna$aMultiregional Analyses
=450  \\$wnnna$aMultiregional Analysis
=450  \\$wnnna$aPeriod Analyses
=450  \\$wnnna$aPeriod Analysis
=450  \\$aPopulation Distribution
=450  \\$wnnna$aPopulation Distributions
=450  \\$wnnna$aPopulation Methods, Stable
=450  \\$wnnna$aPopulation Spatial Distribution
=450  \\$wnnna$aPopulation Spatial Distributions
=450  \\$wnnna$aPrehistoric Demographies
=450  \\$wnnna$aPrehistoric Demography
=450  \\$wnnna$aReconstitution, Family
=450  \\$wnnna$aReconstitutions, Family
=450  \\$wnnna$aReverse Survival Method
=450  \\$wnnna$aReverse Survival Methods
=450  \\$wnnna$aSpatial Distribution, Population
=450  \\$wnnna$aSpatial Distributions, Population
=450  \\$wnnna$aStable Population Method
=450  \\$wnnna$aStable Population Methods
=450  \\$wnnna$aSurvey, Demographic
=450  \\$wnnna$aSurveys, Demographic
=450  \\$wnnna$aTechnic, Brass
=450  \\$wnnna$aTechnique, Brass
=550  \\$wg$aEpidemiologic Measurements
=550  \\$wg$aPopulation Characteristics
=550  \\$wg$aSocial Sciences
=550  \\$wh$aAge Distribution
=550  \\$wh$aCensuses
=550  \\$wh$aEthnic Groups
=550  \\$wh$aFamily Characteristics
=550  \\$wh$aHealth Status
=550  \\$wh$aPopulation Density
=550  \\$wh$aPopulation Dynamics
=550  \\$wh$aPopulation Groups
=550  \\$wh$aResidence Characteristics
=550  \\$wh$aSex Distribution
=550  \\$wh$aVital Statistics
=667  \\$athe statistical study of population characteristics; do not confuse with the POPULATION itself
=680  \\$iStatistical interpretation and description of a population with reference to distribution, composition, or structure.
=750  \0$aDemographers$5IEN-M$0(DLC)sh 85036653
=750  \0$aDemographic surveys$5IEN-HS$0(DLC)sh 85036657
=750  \0$aDemography$5IEN-HS$0(DLC)sh 85036659

=LDR  00570cz  a2200181n  4500
=001  9880363433302441
=005  20141212200517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003709
=035  \\$aCAZ6847HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x696.$x374
=150  \\$aDemocracy
=450  \\$wnnna$aDemocracies
=550  \\$wg$aPolitical Systems
=667  \\$ano qualif
=680  \\$iA system of government in which there is free and equal participation by the people in the political decision-making process.
=750  \0$aDemocracy$5IEN$0(DLC)sh 85036647

=LDR  01541cz  a2200361n  4500
=001  9880363433402441
=005  20141212192130.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003707
=035  \\$aCAZ6845HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x900.$x185
=072  \\$aD4.$x615.$x562.$x900.$x185
=150  \\$aDemeclocycline
=450  \\$wnnna$aAHP Brand of Demeclocycline Hydrochloride
=450  \\$wnnna$aDeclomycin
=450  \\$wnnna$aDemeclocycline, 4-epimer
=450  \\$wnnna$aDemeclocycline, Calcium (1:1) Salt
=450  \\$wnnna$aDemeclocycline, Calcium (1:2) Salt
=450  \\$wnnna$aDemeclocycline Hydrochloride
=450  \\$wnnna$aDemeclocycline Monohydrochloride
=450  \\$aDemethylchlortetracycline
=450  \\$wnnna$aGenopharm Brand of Demeclocycline Hydrochloride
=450  \\$wnnna$aHydrochloride, Demeclocycline
=450  \\$wnnna$aLédermycine
=450  \\$wnnna$aLederle Brand of Demeclocycline Hydrochloride
=450  \\$wnnna$aLedermycin
=450  \\$wnnna$aMonohydrochloride, Demeclocycline
=450  \\$wnnna$aWyeth Brand of Demeclocycline Hydrochloride
=550  \\$wg$aTetracyclines
=680  \\$iA TETRACYCLINE analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than TETRACYCLINE, it maintains effective blood levels for longer periods of time.
=688  \\$a92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91
=750  \0$aDemeclocycline$5IEN-M$0(DLC)sh 85036637

=LDR  03264cz  a2200757n  4500
=001  9880363433502441
=005  20141212210853.0
=008  880318\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D015140
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x400
=072  \\$aC10.$x228.$x140.$x300.$x510.$x800.$x500
=072  \\$aC10.$x228.$x140.$x380.$x230
=072  \\$aC10.$x228.$x140.$x695.$x500
=072  \\$aC14.$x907.$x137.$x126.$x372.$x500
=072  \\$aC14.$x907.$x253.$x560.$x350.$x500
=072  \\$aF3.$x87.$x400.$x350
=150  \\$aDementia, Vascular
=450  \\$wnnna$aAcute Onset Vascular Dementia
=450  \\$aArteriosclerotic Dementia
=450  \\$wnnna$aArteriosclerotic Dementias
=450  \\$wnnna$aArteriosclerotic Encephalopathies, Subcortical
=450  \\$wnnna$aArteriosclerotic Encephalopathy, Subcortical
=450  \\$aBinswanger Disease
=450  \\$wnnna$aBinswanger Encephalopathy
=450  \\$wnnna$aBinswanger's Disease
=450  \\$wnnna$aBinswangers Disease
=450  \\$wnnna$aBinswanger's Encephalopathy
=450  \\$wnnna$aChronic Progressive Subcortical Encephalopathy
=450  \\$wnnna$aDementia, Arteriosclerotic
=450  \\$wnnna$aDementia, Subcortical Vascular
=450  \\$wnnna$aDementias, Arteriosclerotic
=450  \\$wnnna$aDementias, Subcortical Vascular
=450  \\$wnnna$aDementias, Vascular
=450  \\$wnnna$aDisease, Binswanger
=450  \\$wnnna$aDisease, Binswanger's
=450  \\$wnnna$aEncephalopathies, Subcortical Arteriosclerotic
=450  \\$aEncephalopathy, Binswanger
=450  \\$wnnna$aEncephalopathy, Binswanger's
=450  \\$wnnna$aEncephalopathy, Binswangers
=450  \\$wnnna$aEncephalopathy, Chronic Progressive Subcortical
=450  \\$wnnna$aEncephalopathy, Subcortical Arteriosclerotic
=450  \\$wnnna$aEncephalopathy, Subcortical, Chronic Progressive
=450  \\$wnnna$aLeukoencephalopathies, Subcortical
=450  \\$aLeukoencephalopathy, Subcortical
=450  \\$wnnna$aSubcortical Arteriosclerotic Encephalopathies
=450  \\$aSubcortical Arteriosclerotic Encephalopathy
=450  \\$wnnna$aSubcortical Encephalopathy, Chronic Progressive
=450  \\$wnnna$aSubcortical Leukoencephalopathies
=450  \\$wnnna$aSubcortical Leukoencephalopathy
=450  \\$wnnna$aSubcortical Vascular Dementia
=450  \\$wnnna$aSubcortical Vascular Dementias
=450  \\$aVascular Dementia
=450  \\$wnnna$aVascular Dementia, Acute Onset
=450  \\$wnnna$aVascular Dementia, Subcortical
=450  \\$wnnna$aVascular Dementias
=450  \\$wnnna$aVascular Dementias, Subcortical
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wg$aDementia
=550  \\$wg$aIntracranial Arteriosclerosis
=550  \\$wg$aLeukoencephalopathies
=550  \\$wh$aCADASIL
=550  \\$wh$aDementia, Multi-Infarct
=680  \\$iAn imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
=688  \\$a1989
=750  \0$aVascular dementia$0(DLC) sh2004001931$5IEN-M

=LDR  01877cz  a2200469n  4500
=001  9880363433602441
=005  20160405154804.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003704
=035  \\$aCAZ6840HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x380
=072  \\$aF3.$x87.$x400
=150  \\$aDementia
=450  \\$wnnna$aAmentia
=450  \\$wnnna$aAmentias
=450  \\$wnnna$aDementia, Familial
=450  \\$wnnna$aDementias
=450  \\$wnnna$aDementias, Familial
=450  \\$wnnna$aDementias, Senile Paranoid
=450  \\$wnnna$aFamilial Dementia
=450  \\$wnnna$aFamilial Dementias
=450  \\$wnnna$aParanoid Dementia, Senile
=450  \\$wnnna$aParanoid Dementias, Senile
=450  \\$aSenile Paranoid Dementia
=450  \\$wnnna$aSenile Paranoid Dementias
=550  \\$wg$aBrain Diseases
=550  \\$wg$aNeurocognitive Disorders
=550  \\$wh$aAIDS Dementia Complex
=550  \\$wh$aAlzheimer Disease
=550  \\$wh$aAphasia, Primary Progressive
=550  \\$wh$aCreutzfeldt-Jakob Syndrome
=550  \\$wh$aDementia, Vascular
=550  \\$wh$aDiffuse Neurofibrillary Tangles with Calcification
=550  \\$wh$aFrontotemporal Lobar Degeneration
=550  \\$wh$aHuntington Disease
=550  \\$wh$aKluver-Bucy Syndrome
=550  \\$wh$aLewy Body Disease
=550  \\$aTauopathies
=680  \\$iAn acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
=688  \\$a1981(1963)
=750  \0$aDementia$5IEN$0(DLC)sh 85036638

=LDR  00656cz  a2200181n  4500
=001  9880363433702441
=005  20141212192129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003702
=035  \\$aCAZ6838HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x126.$x200
=150  \\$aDelusions
=450  \\$wnnna$aDelusion
=550  \\$wg$aBehavioral Symptoms
=667  \\$athis is the French "délire"; do not confuse with ILLUSIONS
=680  \\$iA false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.
=750  \0$aDelusions$5IEN$0(DLC)sh 87005620

=LDR  00923cz  a2200241n  4500
=001  9880363433802441
=005  20150406103335.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003700
=035  \\$aCAZ6836M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x376.$x300.$x150.$x875
=072  \\$aE1.$x370.$x405.$x245.$x287.$x875
=072  \\$aG7.$x265.$x87.$x875
=072  \\$aG11.$x561.$x127.$x875
=150  \\$aDelta Rhythm
=450  \\$wnnna$aDelta Rhythms
=450  \\$wnnna$aRhythm, Delta
=450  \\$wnnna$aRhythms, Delta
=550  \\$wg$aBrain Waves
=680  \\$iBrain waves seen on EEG characterized by a high amplitude and a frequency of 4 Hz and below. They are considered the "deep sleep waves" observed during sleep in dreamless states, infancy, and in some brain disorders.
=688  \\$a91(75); was see under ELECTROENCEPHALOGRAPHY 1975-90
=750  \0$aDelta rhythm$0(DLC)sh2005008619$5IEN-M

=LDR  01961cz  a2200433n  4500
=001  9880363433902441
=005  20141212200514.0
=008  850507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003699
=035  \\$aCAZ6835HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x440.$x450
=072  \\$aC2.$x782.$x450
=072  \\$aC6.$x552.$x380.$x705.$x450
=150  \\$aHepatitis D
=450  \\$aAmazon Black Fever
=450  \\$aBlack Fever, Amazon
=450  \\$aDelta Hepatitis
=450  \\$aDelta Infection
=450  \\$aDelta Superinfection
=450  \\$wnnna$aDelta Superinfections
=450  \\$wnnna$aDisease, Labrea
=450  \\$wnnna$aDiseases, Labrea
=450  \\$wnnna$aFever, Amazon Black
=450  \\$wnnna$aHepatitides, Delta
=450  \\$aHepatitis, Delta
=450  \\$wnnna$aInfection, Delta
=450  \\$wnnna$aInfections, Delta
=450  \\$aLabrea Disease
=450  \\$wnnna$aLabrea Diseases
=450  \\$wnnna$aSuperinfection, Delta
=450  \\$wnnna$aSuperinfections, Delta
=550  \\$wg$aHepatitis, Viral, Human
=550  \\$wg$aRNA Virus Infections
=550  \\$wh$aHepatitis D, Chronic
=667  \\$aHEPATITIS D, CHRONIC is also available; do not confuse entry term AMAZON BLACK FEVER with BLACKWATER FEVER or BLACK FEVER see LEISHMANIASIS, VISCERAL
=680  \\$iINFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
=688  \\$a98(86)
=750  \0$aDelta infection$5IEN$0(DLC)sh 86008209

=LDR  01298cz  a2200361n  4500
=001  9880363434002441
=005  20141212200514.0
=008  850507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003698
=035  \\$aCAZ6834HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x265.$x270
=072  \\$aB4.$x450.$x411
=072  \\$aB4.$x909.$x777.$x411
=150  \\$aHepatitis Delta Virus
=450  \\$aDelta Agent
=450  \\$wnnna$aDelta Agents
=450  \\$aDelta Virus
=450  \\$wnnna$aDelta Virus, Hepatitis
=450  \\$wnnna$aDelta Viruses
=450  \\$wnnna$aDelta Viruses, Hepatitis
=450  \\$aDeltavirus
=450  \\$wnnna$aDeltaviruses
=450  \\$aHepatitis D Virus
=450  \\$wnnna$aHepatitis D Viruses
=450  \\$wnnna$aHepatitis Delta Viruses
=550  \\$wg$aDefective Viruses
=550  \\$wg$aHepatitis Viruses
=550  \\$wg$aRNA Viruses
=667  \\$ainfection = HEPATITIS D or HEPATITIS D, CHRONIC
=680  \\$iA defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.
=688  \\$a98(86)
=750  \0$aDelta-associated agent$5IEN$0(DLC)sh 86008210

=LDR  03842cz  a2201081n  4500
=001  9880363434102441
=005  20181126155821.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003695
=035  \\$aCAZ6831HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x590.$x374
=072  \\$aN5.$x300
=150  \\$aDelivery of Health Care
=450  \\$wnnna$aActivities, Distributional
=450  \\$wnnna$aActivity, Distributional
=450  \\$wnnna$aCare, Health
=450  \\$wnnna$aCommunity-Based Distribution
=450  \\$wnnna$aCommunity Based Distribution
=450  \\$wnnna$aCommunity-Based Distributions
=450  \\$wnnna$aContraceptive Distribution
=450  \\$wnnna$aContraceptive Distributions
=450  \\$wnnna$aDeliveries, Healthcare
=450  \\$wnnna$aDelivery, Dental Care
=450  \\$wnnna$aDelivery, Health Care
=450  \\$wnnna$aDelivery, Healthcare
=450  \\$aDelivery of Dental Care
=450  \\$wnnna$aDelivery of Healthcare
=450  \\$wnnna$aDental Care Delivery
=450  \\$wnnna$aDistribution, Community-Based
=450  \\$wnnna$aDistribution, Contraceptive
=450  \\$wnnna$aDistribution, Non-Clinical
=450  \\$wnnna$aDistribution, Non Clinical
=450  \\$wnnna$aDistribution, Nonclinical
=450  \\$wnnna$aDistributional Activities
=450  \\$wnnna$aDistributional Activity
=450  \\$wnnna$aDistributions, Community-Based
=450  \\$wnnna$aDistributions, Contraceptive
=450  \\$wnnna$aDistributions, Non-Clinical
=450  \\$wnnna$aDistributions, Nonclinical
=450  \\$aHealth Care
=450  \\$aHealth Care Delivery
=450  \\$wnnna$aHealth Care System
=450  \\$aHealth Care Systems
=450  \\$wnnna$aHealthcare
=450  \\$wnnna$aHealthcare Deliveries
=450  \\$wnnna$aHealthcare Delivery
=450  \\$wnnna$aHealthcare System
=450  \\$wnnna$aHealthcare Systems
=450  \\$wnnna$aNon-Clinical Distribution
=450  \\$wnnna$aNon Clinical Distribution
=450  \\$wnnna$aNon-Clinical Distributions
=450  \\$wnnna$aNonclinical Distribution
=450  \\$wnnna$aNonclinical Distributions
=450  \\$wnnna$aSystem, Health Care
=450  \\$wnnna$aSystem, Healthcare
=450  \\$wnnna$aSystems, Health Care
=450  \\$wnnna$aSystems, Healthcare
=550  \\$wg$aHealth Care Quality, Access, and Evaluation
=550  \\$wg$aPatient Care Management
=550  \\$wh$aAfter-Hours Care
=550  \\$wh$aAttitude of Health Personnel
=550  \\$wh$aAttitude to Death
=550  \\$wh$aAttitude to Health
=550  \\$wh$aCulturally Competent Care
=550  \\$wh$aDelegation, Professional
=550  \\$wh$aDelivery of Health Care, Integrated
=550  \\$wh$aHealth Care Costs
=550  \\$wh$aHealth Care Reform
=550  \\$wh$aHealth Expenditures
=550  \\$wh$aHealth Priorities
=550  \\$wh$aHealth Resources
=550  \\$wh$aHealth Services Accessibility
=550  \\$wh$aHealth Services Needs and Demand
=550  \\$wh$aHealthcare Disparities
=550  \\$wh$aManaged Care Programs
=550  \\$wh$aMedical Tourism
=550  \\$wh$aNeeds Assessment
=550  \\$wh$aPractice Patterns, Dentists'
=550  \\$wh$aPractice Patterns, Nurses'
=550  \\$wh$aPractice Patterns, Physicians'
=550  \\$wh$aProduct Line Management
=550  \\$wh$aProfessional-Patient
=550  \\$wh$aProfessional Practice Gaps
=550  \\$wh$aSafety-net Providers
=550  \\$wh$aSecondary Care
=550  \\$wh$aTelemedicine
=550  \\$wh$aTertiary Healthcare
=550  \\$wh$aUncompensated Care
=667  \\$aPublic Law 91-515
=680  \\$iThe concept concerned with all aspects of providing and distributing health services to a patient population.
=688  \\$a71
=750  \0$aMedical care$5IEN$0(DLC)sh 85082871

=LDR  01259cz  a2200313n  4500
=001  9880363434202441
=005  20180618134906.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003693
=035  \\$aCAZ6829HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x337.$x500
=072  \\$aC23.$x888.$x592.$x604.$x339.$x500
=072  \\$aF1.$x700.$x250.$x500
=072  \\$aF3.$x615.$x350
=150  \\$aDelirium
=450  \\$wnnna$aDelirium of Mixed Origin
=450  \\$wnnna$aDelirium, Subacute
=450  \\$wnnna$aDeliriums, Subacute
=450  \\$wnnna$aMixed Origin Delirium
=450  \\$wnnna$aMixed Origin Deliriums
=450  \\$wnnna$aSubacute Delirium
=450  \\$wnnna$aSubacute Deliriums
=550  \\$wg$aConfusion
=550  \\$wg$aNeurocognitive Disorders
=550  \\$wh$aEmergence Delirium
=667  \\$athis is not the French "délire" ( = DELUSIONS)
=680  \\$iA disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
=750  \0$aDelirium$5IEN$0(DLC)sh 85036579

=LDR  01487cz  a2200397n  4500
=001  9880363434302441
=005  20141212192129.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003692
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x210
=072  \\$aE2.$x319.$x300.$x253
=150  \\$aDelayed-Action Preparations
=450  \\$wnnna$aControlled-Release Preparation
=450  \\$wnnna$aControlled-Release Preparations
=450  \\$wnnna$aControlled Release Preparations
=450  \\$wnnna$aDelayed-Action Preparation
=450  \\$wnnna$aDelayed Action Preparations
=450  \\$wnnna$aDepot Preparation
=450  \\$aDepot Preparations
=450  \\$wnnna$aPreparation, Controlled-Release
=450  \\$wnnna$aPreparations, Controlled-Release
=450  \\$wnnna$aProlonged-Action Preparation
=450  \\$aProlonged-Action Preparations
=450  \\$wnnna$aSustained-Release Preparation
=450  \\$aSustained-Release Preparations
=450  \\$wnnna$aTimed-Release Preparation
=450  \\$aTimed-Release Preparations
=450  \\$wnnna$aTimed Release Preparations
=550  \\$wg$aDosage Forms
=550  \\$wg$aDrug Delivery Systems
=550  \\$wh$aDrug Implants
=550  \\$wh$aTablets, Enteric-Coated
=667  \\$aIM general only; coord with specific drug
=680  \\$iDosage forms of a drug that act over a period of time by controlled-release processes or technology.
=750  \0$aControlled release preparations$5IEN$0(DLC)sh 85031661

=LDR  00609cz  a2200193n  4500
=001  9880363434402441
=005  20141212200511.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003690
=035  \\$aCAZ6826HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x425.$x540.$x203
=150  \\$aDeja Vu
=450  \\$wnnna$aVu, Deja
=550  \\$wg$aMemory
=667  \\$ain translations use accents: déj�[MARC+A0] vu
=680  \\$iA subjective feeling that an experience which is occurring for the first time has been experienced before.
=688  \\$a68
=750  \0$aD�ej�a vu$5IEN$0(DLC)sh 88007478

=LDR  01542cz  a2200373n  4500
=001  9880363434502441
=005  20141212192128.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003689
=035  \\$aCAZ6825HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132.$x810.$x428.$x600.$x800.$x800
=072  \\$aA8.$x186.$x211.$x865.$x428.$x600.$x800.$x800
=150  \\$aVestibular Nucleus, Lateral
=450  \\$aDeiter Nucleus
=450  \\$wnnna$aDeiter's Nucleus
=450  \\$wnnna$aDeiters Nucleus
=450  \\$aLateral Vestibular Nucleus
=450  \\$wnnna$aNucleus, Deiter
=450  \\$wnnna$aNucleus, Deiter's
=450  \\$wnnna$aNucleus, Lateral Vestibular
=450  \\$wnnna$aNucleus of Deiters
=450  \\$wnnna$aNucleus Vestibularis Laterali
=450  \\$wnnna$aNucleus Vestibularis Lateralis
=450  \\$wnnna$aNucleus Vestibularis Magnocellulari
=450  \\$wnnna$aNucleus Vestibularis Magnocellularis
=450  \\$wnnna$aVestibularis Laterali, Nucleus
=450  \\$wnnna$aVestibularis Lateralis, Nucleus
=450  \\$wnnna$aVestibularis Magnocellulari, Nucleus
=450  \\$wnnna$aVestibularis Magnocellularis, Nucleus
=550  \\$wg$aVestibular Nuclei
=680  \\$iVestibular nucleus lying immediately superior to the inferior vestibular nucleus and composed of large multipolar nerve cells. Its upper end becomes continuous with the superior vestibular nucleus.
=688  \\$a2000(1975); use VESTIBULAR NUCLEI 1967-1974
=750  \0$aLateral vestibular nucleus$5IEN$0(DLC)sh 85074845

=LDR  01032cz  a2200253n  4500
=001  9880363434602441
=005  20141212200511.0
=008  780508\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003688
=035  \\$aCAZ6824HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x415.$x280
=072  \\$aN2.$x421.$x585.$x415.$x280
=150  \\$aDeinstitutionalization
=450  \\$wnnna$aDeinstitutionalized Person
=450  \\$wnnna$aDeinstitutionalized Persons
=450  \\$wnnna$aPerson, Deinstitutionalized
=450  \\$wnnna$aPersons, Deinstitutionalized
=550  \\$wg$aInstitutionalization
=550  \\$aInstitutionalization
=667  \\$a"caring for individuals in the community, rather than in an institutional environment"
=680  \\$iThe practice of caring for individuals in the community, rather than in an institutional environment with resultant effects on the individual, the individual's family, the community, and the health care system.
=688  \\$a79
=750  \0$aDeinstitutionalization$5IEN$0(DLC)sh 87004505

=LDR  01450cz  a2200361n  4500
=001  9880363434702441
=005  20141212200510.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003687
=035  \\$aCAZ6823HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x54.$x79.$x429.$x625
=072  \\$aD4.$x808.$x578.$x502.$x400
=072  \\$aD6.$x472.$x40.$x502.$x400
=072  \\$aD6.$x472.$x334.$x851.$x968.$x952
=150  \\$aDehydroepiandrosterone
=450  \\$wnnna$a5-Androsten-3-beta-hydroxy-17-one
=450  \\$wnnna$a5 Androsten 3 beta hydroxy 17 one
=450  \\$wnnna$a5-Androsten-3-ol-17-one
=450  \\$wnnna$a5 Androsten 3 ol 17 one
=450  \\$wnnna$aAndrostenolone
=450  \\$aDehydroisoandrosterone
=450  \\$wnnna$aDHEA
=450  \\$aPrasterone
=450  \\$wnnna$aPrasterone, 3 alpha-Isomer
=450  \\$wnnna$aPrasterone, 3 alpha Isomer
=550  \\$wg$a17-Ketosteroids
=550  \\$wg$aAndrostenols
=550  \\$wg$aTestosterone Congeners
=550  \\$wh$aDehydroepiandrosterone Sulfate
=680  \\$iA major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
=688  \\$a2004, 1963-1992
=750  \0$aDehydroepiandrosterone$5IEN-M$0(DLC)sh 90004019

=LDR  01113cz  a2200241n  4500
=001  9880363434802441
=005  20141212200510.0
=008  770415\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003684
=035  \\$aCAZ6820M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x247.$x222.$x222.$x347.$x200
=072  \\$aD4.$x808.$x247.$x808.$x197.$x250
=072  \\$aD10.$x570.$x938.$x208.$x320
=150  \\$aDehydrocholesterols
=450  \\$wnnna$a(Z)-3 beta-Hydroxycholesta-5,27(20)-diene
=550  \\$wg$aCholestadienols
=550  \\$wg$aCholesterol
=550  \\$wh$aDesmosterol
=667  \\$ado not confuse with DIHYDROCHOLESTEROL see CHOLESTANOL; 24-DEHYDROCHOLESTEROL is see DESMOSTEROL
=680  \\$iCholesterol derivatives having an additional double bond in any position. 24-Dehydrocholesterol is DESMOSTEROL. The other most prevalent dehydrocholesterol is the 7-isomer. This compound is a precursor of cholesterol and of vitamin D3.
=688  \\$a91(78); was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66
=750  \0$aDehydrocholesterol$0(DLC) sh2004001240$5IEN-M

=LDR  01206cz  a2200301n  4500
=001  9880363434902441
=005  20141212200508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003680
=035  \\$aCAZ6817HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC6.$x405.$x117.$x119
=072  \\$aC9.$x775.$x174
=150  \\$aDeglutition Disorders
=450  \\$wnnna$aDeglutition Disorder
=450  \\$wnnna$aDisorders, Deglutition
=450  \\$aDysphagia
=450  \\$wnnna$aDysphagia, Esophageal
=450  \\$wnnna$aDysphagia, Oropharyngeal
=450  \\$wnnna$aEsophageal Dysphagia
=450  \\$wnnna$aOropharyngeal Dysphagia
=450  \\$wnnna$aSwallowing Disorder
=450  \\$aSwallowing Disorders
=550  \\$wg$aEsophageal Diseases
=550  \\$wg$aPharyngeal Diseases
=550  \\$wh$aEsophageal Motility Disorders
=680  \\$iDifficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
=750  \0$aDeglutition disorders$5IEN$0(DLC)sh 85036477

=LDR  00599cz  a2200193n  4500
=001  9880363435002441
=005  20141212200508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003679
=035  \\$aCAZ6816HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG10.$x261.$x326.$x215
=150  \\$aDeglutition
=450  \\$wnnna$aDeglutitions
=450  \\$aSwallowing
=450  \\$wnnna$aSwallowings
=550  \\$wg$aDigestive System Processes
=680  \\$iThe act of taking solids and liquids into the GASTROINTESTINAL TRACT through the mouth and throat.
=750  \0$aDeglutition$5IEN$0(DLC)sh 85036476

=LDR  00846cz  a2200205n  4500
=001  9880363435102441
=005  20141212200508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003678
=035  \\$aCAZ6815HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD27.$x720.$x31.$x700.$x366.$x181
=072  \\$aD27.$x720.$x723.$x366.$x181
=072  \\$aD27.$x888.$x723.$x366.$x181
=150  \\$aDefoliants, Chemical
=450  \\$wnnna$aChemical Defoliants
=550  \\$wg$aHerbicides
=680  \\$iHerbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley's Condensed Chemical Dictionary, 11th ed)
=688  \\$a91(75); was see under HERBICIDES 1975-90
=750  \0$aDefoliants$5IEN$0(DLC)sh 85036461

=LDR  01300cz  a2200265n  4500
=001  9880363435202441
=005  20141212200508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003677
=035  \\$aCAZ6814HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC18.$x654.$x521.$x500
=150  \\$aDeficiency Diseases
=450  \\$wnnna$aDeficiency Disease
=450  \\$wnnna$aDisease, Deficiency
=450  \\$wnnna$aDiseases, Deficiency
=550  \\$wg$aMalnutrition
=550  \\$wh$aAvitaminosis
=550  \\$wh$aMagnesium Deficiency
=550  \\$wh$aPotassium Deficiency
=550  \\$wh$aProtein Deficiency
=550  \\$wh$aSwayback
=667  \\$aGEN only: prefer /defic with specific Cat D terms: Manual 19.7+, 19.8.21; also Manual 23.25+; do not confuse with NUTRITION DISORDERS: DEFICIENCY DISEASES results from deficient intake; TN 194: as NIM & differentiation from METABOLIC DISEASES or METABOLISM, INBORN ERRORS; DF: DEFIC DIS
=680  \\$iA condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed)
=750  \0$aDeficiency diseases$5IEN$0(DLC)sh 85036451

=LDR  01356cz  a2200397n  4500
=001  9880363435302441
=005  20141212200507.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003676
=035  \\$aCAZ6813HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x570.$x394.$x265
=072  \\$aD2.$x241.$x511.$x372.$x265
=150  \\$aDeferoxamine
=450  \\$wnnna$aB, Deferoxamine
=450  \\$wnnna$aB, Desferrioxamine
=450  \\$wnnna$aDeferoxamine B
=450  \\$wnnna$aDeferoxamine Mesilate
=450  \\$wnnna$aDeferoxamine Mesylate
=450  \\$wnnna$aDeferoxamine Methanesulfonate
=450  \\$wnnna$aDeferoximine
=450  \\$wnnna$aDeferrioxamine B
=450  \\$wnnna$aDesferal
=450  \\$wnnna$aDesferioximine
=450  \\$aDesferrioxamine
=450  \\$wnnna$aDesferrioxamine B
=450  \\$wnnna$aDesferrioxamine B Mesylate
=450  \\$wnnna$aDesferroxamine
=450  \\$wnnna$aMesilate, Deferoxamine
=450  \\$wnnna$aMesylate, Deferoxamine
=450  \\$wnnna$aMesylate, Desferrioxamine B
=450  \\$wnnna$aMethanesulfonate, Deferoxamine
=550  \\$wg$aHydroxamic Acids
=680  \\$iNatural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
=688  \\$a65
=750  \0$aDeferoxamine$5IEN$0(DLC)sh 88008027

=LDR  01236cz  a2200337n  4500
=001  9880363435402441
=005  20201118175042.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003674
=035  \\$aCAZ6811HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x393
=150  \\$aDefense Mechanisms
=450  \\$wnnna$aMechanisms, Defense
=550  \\$wg$aBehavior and Behavior Mechanisms
=550  \\$wh$aActing Out
=550  \\$wh$aDenial, Psychological
=550  \\$wh$aDisplacement, Psychological
=550  \\$wh$aFantasy
=550  \\$wh$aHelplessness, Learned
=550  \\$wh$aIdentification, Psychological
=550  \\$wh$aPerceptual Defense
=550  \\$wh$aProcrastination
=550  \\$wh$aProjection
=550  \\$wh$aRationalization
=550  \\$wh$aRegression, Psychology
=550  \\$wh$aRepression, Psychology
=550  \\$wh$aSublimation, Psychological
=667  \\$ano qualif
=680  \\$iUnconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal.
=750  \0$aDefense mechanisms (Psychology)$5IEN$0(DLC)sh 85036436

=LDR  01183cz  a2200349n  4500
=001  9880363435502441
=005  20141212200505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003671
=035  \\$aCAZ6809M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x277.$x194
=072  \\$aD2.$x241.$x223.$x100.$x100.$x230
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x85.$x230
=150  \\$aDEET
=450  \\$wnnna$aDEET, 2,5-di-Me-Analog
=450  \\$wnnna$aDET
=450  \\$wnnna$aDETA
=450  \\$wnnna$aN,N-Diethyl-2,5-dimethylbenzamide
=450  \\$wnnna$aN,N-Diethyl-3-methylbenzamide
=450  \\$wnnna$aN,N Diethyl 3 methylbenzamide
=450  \\$wnnna$aN,N-Diethyl-m-toluamide
=450  \\$wnnna$aN,N Diethyl m toluamide
=450  \\$wnnna$aN,N-Diethyltoluamide
=450  \\$wnnna$aN,N Diethyltoluamide
=450  \\$wnnna$aR-209
=450  \\$wnnna$aR 209
=450  \\$wnnna$aR209
=550  \\$wg$aBenzamides
=680  \\$iA compound used as a topical insect repellent that may cause irritation to eyes and mucous membranes, but not to the skin.
=688  \\$a91(72); was see under BENZAMIDES 1972-90
=750  \0$aDeet$0(DLC)sh2007003019$5IEN-M

=LDR  01218cz  a2200217n  4500
=001  9880363435602441
=005  20141212200505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003670
=035  \\$aCAZ6808HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x373
=150  \\$aDeer
=450  \\$wnnna$aDeers
=550  \\$wg$aRuminants
=550  \\$wh$aMuntjacs
=550  \\$wh$aReindeer
=667  \\$aincludes elk, wapiti, moose, caribou, REINDEER & MUNTJACS; IM; qualif permitted
=680  \\$iThe family Cervidae of 17 genera and 45 species occurring nearly throughout North America, South America, and Eurasia, on most associated continental islands, and in northern Africa. Wild populations of deer have been established through introduction by people in Cuba, New Guinea, Australia, New Zealand, and other places where the family does not naturally occur. They are slim, long-legged and best characterized by the presence of antlers. Their habitat is forests, swamps, brush country, deserts, and arctic tundra. They are usually good swimmers; some migrate seasonally. (Walker's Mammals of the World, 5th ed, p1362)
=688  \\$a68
=750  \0$aDeer$5IEN$0(DLC)sh 85036388

=LDR  00992cz  a2200229n  4500
=001  9880363435702441
=005  20141212200505.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003669
=035  \\$aCAZ6807HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x170.$x300
=072  \\$aN3.$x219.$x521.$x576.$x90.$x300
=150  \\$aDeductibles and Coinsurance
=450  \\$aCoinsurance
=450  \\$wnnna$aCoinsurance and Deductibles
=450  \\$wnnna$aDeductibles
=550  \\$wg$aCost Sharing
=667  \\$aDF: DEDUCTIBLES
=680  \\$iCost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable.
=688  \\$a68
=750  \0$aCoinsurance$5IEN$0(DLC)sh 85027878

=LDR  01472cz  a2200397n  4500
=001  9880363435802441
=005  20141212200504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003668
=035  \\$aCAZ6806HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x893.$x665
=150  \\$aPressure Ulcer
=450  \\$wnnna$aBed Sore
=450  \\$wnnna$aBed Sores
=450  \\$aBedsore
=450  \\$wnnna$aBedsores
=450  \\$aDecubitus Ulcer
=450  \\$wnnna$aDecubitus Ulcers
=450  \\$aPressure Sore
=450  \\$wnnna$aPressure Sores
=450  \\$wnnna$aPressure Ulcers
=450  \\$wnnna$aSore, Bed
=450  \\$wnnna$aSore, Pressure
=450  \\$wnnna$aSores, Bed
=450  \\$wnnna$aSores, Pressure
=450  \\$wnnna$aUlcer, Decubitus
=450  \\$wnnna$aUlcer, Pressure
=450  \\$wnnna$aUlcers, Decubitus
=450  \\$wnnna$aUlcers, Pressure
=550  \\$wg$aSkin Ulcer
=667  \\$apressure injury resulting from prolonged pressure on the skin and tissues is indexed here
=680  \\$iAn ulceration caused by prolonged pressure on the SKIN and TISSUES when one stays in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic (ISCHEMIA) under sustained and constant pressure.
=688  \\$a2006 (1963)
=688  \\$aHeading changed 20051206 from: 150:##:_{dollar}a Decubitus Ulcer
=750  \0$aBedsores$0(DLC) sh 85012764$5IEN

=LDR  00749cz  a2200193n  4500
=001  9880363435902441
=005  20141212200504.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003666
=035  \\$aCAZ6804HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN6.$x850.$x780.$x325
=150  \\$aDecontamination
=550  \\$wg$aPublic Health Practice
=550  \\$aChemical Warfare
=680  \\$iThe removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.
=750  \0$aBiological decontamination$5IEN$0(DLC)sh2002007698
=750  \0$aDecontamination (from gases, chemicals, etc.)$5IEN$0(DLC)sh 85036227
=750  \0$aRadioactive decontamination$5IEN$0(DLC)sh 85110598

=LDR  01168cz  a2200301n  4500
=001  9880363436002441
=005  20141212200503.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003665
=035  \\$aCAZ6803HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC26.$x120.$x248
=150  \\$aDecompression Sickness
=450  \\$aBends
=450  \\$aCaisson Disease
=450  \\$wnnna$aCaisson Diseases
=450  \\$wnnna$aDisease, Caisson
=450  \\$wnnna$aDiseases, Caisson
=450  \\$wnnna$aSickness, Decompression
=550  \\$wg$aBarotrauma
=550  \\$aAerospace Medicine
=550  \\$aAtmospheric Pressure
=550  \\$aBarotrauma
=550  \\$aDiving
=550  \\$aEmbolism, Air
=550  \\$aHigh Pressure Neurological Syndrome
=680  \\$iA condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.
=750  \0$aDecompression sickness$5IEN$0(DLC)sh 85036225

=LDR  00666cz  a2200217n  4500
=001  9880363436102441
=005  20141212200503.0
=008  870406\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003663
=035  \\$aCAZ6801HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG17.$x162.$x500
=150  \\$aDecision Trees
=450  \\$wnnna$aDecision Tree
=450  \\$wnnna$aTree, Decision
=450  \\$wnnna$aTrees, Decision
=550  \\$wg$aDecision Theory
=667  \\$ano qualif
=680  \\$iA graphic device used in decision analysis, series of decision options are represented as branches (hierarchical).
=688  \\$a88
=750  \0$aDecision trees$5IEN-M$0(DLC)sh 94004363

=LDR  00788cz  a2200193n  4500
=001  9880363436202441
=005  20141212200501.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003660
=035  \\$aCAZ6798HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x300.$x680.$x135
=072  \\$aN4.$x452.$x515.$x135
=150  \\$aDecision Support Systems, Management
=550  \\$wg$aManagement Information Systems
=667  \\$aIM
=680  \\$iComputer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.
=688  \\$a91(87); was see under MANAGEMENT INFORMATION SYSTEMS 1987-90
=750  \0$aDecision support systems$5IEN-M$0(DLC)sh 86006549

=LDR  00608cz  a2200193n  4500
=001  9880363436302441
=005  20141212200501.0
=008  850523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003659
=035  \\$aCAZ6797HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN4.$x452.$x190
=150  \\$aDecision Making, Organizational
=450  \\$aOrganizational Decision Making
=550  \\$wg$aOrganization and Administration
=667  \\$ano qualif
=680  \\$iThe process by which decisions are made in an institution or other organization.
=688  \\$a86
=750  \0$aGroup decision making$5IEN-HS$0(DLC)sh 85036201

=LDR  01099cz  a2200265n  4500
=001  9880363436402441
=005  20141212200501.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003658
=035  \\$aCAZ6796HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x700.$x508.$x100
=150  \\$aDecision Making, Computer-Assisted
=450  \\$aComputer-Assisted Decision Making
=450  \\$wnnna$aComputer Assisted Decision Making
=450  \\$wnnna$aDecision Making, Computer Assisted
=450  \\$aMedical Decision Making, Computer-Assisted
=450  \\$wnnna$aMedical Decision Making, Computer Assisted
=550  \\$wg$aMedical Informatics Applications
=550  \\$wh$aDiagnosis, Computer-Assisted
=550  \\$wh$aTherapy, Computer-Assisted
=667  \\$ano qualif
=680  \\$iUse of an interactive computer system designed to assist the physician or other health professional in choosing between certain relationships or variables for the purpose of making a diagnostic or therapeutic decision.
=688  \\$a87
=750  \0$aDecision making$xData processing$5IEN$0(DLC)sh2008102118

=LDR  01166cz  a2200301n  4500
=001  9880363436502441
=005  20141212200501.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003657
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x463.$x785.$x373
=150  \\$aDecision Making
=450  \\$wnnna$aDecision Making, Shared
=450  \\$wnnna$aDecision Makings, Shared
=450  \\$wnnna$aMaking, Shared Decision
=450  \\$wnnna$aMakings, Shared Decision
=450  \\$wnnna$aShared Decision Making
=450  \\$wnnna$aShared Decision Makings
=550  \\$wg$aThinking
=550  \\$wh$aChoice Behavior
=550  \\$wh$aConsensus
=550  \\$wh$aDissent and Disputes
=550  \\$wh$aNegotiating
=550  \\$wh$aUncertainty
=550  \\$aProblem Solving
=667  \\$anot for a physician making a diagnostic decision: this is /diag or if general, DIAGNOSIS; or DIAGNOSIS, DIFFERENTIAL
=680  \\$iThe process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea.
=750  \0$aDecision making$0(DLC) sh 85036199$5IEN

=LDR  00887cz  a2200205n  4500
=001  9880363436602441
=005  20141212200500.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003656
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA5.$x360.$x319.$x679.$x490.$x373
=072  \\$aA16.$x710.$x289
=150  \\$aDecidua
=450  \\$wnnna$aDeciduas
=450  \\$wnnna$aDeciduum
=550  \\$wg$aEndometrium
=550  \\$wg$aPlacenta
=550  \\$wh$aDeciduoma
=680  \\$iThe hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis.
=750  \0$aDecidua$5IEN$0(DLC)sh 86005483

=LDR  01956cz  a2200361n  4500
=001  9880363436702441
=005  20141212192127.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003655
=035  \\$aCAZ6793HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x305
=072  \\$aC23.$x888.$x592.$x298
=150  \\$aDecerebrate State
=450  \\$aDecerebrate Posturing
=450  \\$wnnna$aDecerebrate Posturings
=450  \\$wnnna$aDecerebrate Rigidity
=450  \\$wnnna$aDecerebrate States
=450  \\$wnnna$aDecorticate Rigidities
=450  \\$aDecorticate Rigidity
=450  \\$aDecorticate State
=450  \\$wnnna$aDecorticate States
=450  \\$wnnna$aPosturing, Decerebrate
=450  \\$wnnna$aPosturings, Decerebrate
=450  \\$wnnna$aRigidities, Decorticate
=450  \\$aRigidity, Decerebrate
=450  \\$aRigidity, Decorticate
=450  \\$wnnna$aState, Decerebrate
=450  \\$wnnna$aStates, Decerebrate
=550  \\$wg$aNeurologic Manifestations
=667  \\$a"brain-isolated", "encéphale isolé", "pithed", "spinal" as in "spinal cat", "cerveau isolé" go here
=680  \\$iA condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. (From Adams et al., Principles of Neurology, 6th ed, p358)
=750  \0$aDecerebrate rigidity$5IEN$0(DLC)sh 85036189

=LDR  00879cz  a2200241n  4500
=001  9880363436802441
=005  20170608134209.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003653
=035  \\$aCAZ6791HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x195
=072  \\$aG2.$x607.$x188
=072  \\$aG3.$x225
=150  \\$aDecarboxylation
=450  \\$wnnna$aDecarboxylations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=667  \\$aalmost never IM; enzymatic decarboxylation: coord NIM with CARBOXY-LYASES (IM) + substrate (NIM) or specific carboxy-lyase (IM)
=680  \\$iThe removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound.
=688  \\$a91(71); was see under CHEMISTRY, ORGANIC 1971-90
=750  \0$aDecarboxylation$5IEN$0(DLC)sh 85036167

=LDR  00675cz  a2200181n  4500
=001  9880363436902441
=005  20141212200458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003646
=035  \\$aCAZ6784HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x176
=150  \\$aDebridement
=450  \\$wnnna$aDebridements
=550  \\$wg$aSurgical Procedures, Operative
=667  \\$ado not use /util except by MeSH definition
=680  \\$iThe removal of foreign material and devitalized or contaminated tissue from or adjacent to a traumatic or infected lesion until surrounding healthy tissue is exposed. (Dorland, 27th ed)
=750  \0$aDebridement$5IEN$0(DLC)sh 85036129

=LDR  01024cz  a2200301n  4500
=001  9880363437002441
=005  20141212200458.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003644
=035  \\$aCAZ6783HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x318.$x308.$x940.$x350
=072  \\$aL1.$x280.$x900.$x350
=072  \\$aN4.$x452.$x859.$x264
=072  \\$aN5.$x715.$x360.$x300.$x715.$x315
=072  \\$aN6.$x850.$x520.$x308.$x940.$x350
=150  \\$aDeath Certificates
=450  \\$wnnna$aCertificate, Death
=450  \\$wnnna$aCertificates, Death
=450  \\$wnnna$aDeath Certificate
=450  \\$wnnna$aDeath Record
=450  \\$wnnna$aDeath Records
=450  \\$wnnna$aRecord, Death
=450  \\$wnnna$aRecords, Death
=550  \\$wg$aRecords as Topic
=667  \\$aIM
=680  \\$iOfficial records of individual deaths including the cause of death certified by a physician, and any other required identifying information.
=750  \0$aDeath$xProof and certification$5IEN$0(DLC)sh 85036092

=LDR  01128cz  a2200325n  4500
=001  9880363437102441
=005  20141212200457.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003642
=035  \\$aCAZ6782HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x33.$x100.$x291.$x274
=072  \\$aD2.$x92.$x63.$x291.$x274
=150  \\$aDeanol
=450  \\$wnnna$aAstyl
=450  \\$wnnna$aBisorcate, Deanol
=450  \\$wnnna$aDeanol Bisorcate
=450  \\$wnnna$aDemanol
=450  \\$wnnna$aDemanyl
=450  \\$aDimethylaminoethanol
=450  \\$wnnna$aDimethylethanolamine
=450  \\$wnnna$aLaphal Brand of Deanol Bisorcate
=450  \\$wnnna$aN,N-Dimethyl-2-hydroxyethylamine
=450  \\$wnnna$aN,N Dimethyl 2 hydroxyethylamine
=450  \\$wnnna$aN,N-Dimethylethanolamine
=450  \\$wnnna$aTonibral
=550  \\$wg$aEthanolamines
=680  \\$iAn antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.
=688  \\$a91(63); was see under ETHANOLAMINES 1963-90
=750  \0$aDimethylaminoethanol$5IEN-M$0(DLC)sh 97004252

=LDR  00781cz  a2200253n  4500
=001  9880363437202441
=005  20170608133954.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003641
=035  \\$aCAZ6781HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x192
=072  \\$aG2.$x607.$x157
=072  \\$aG3.$x222
=150  \\$aDeamination
=450  \\$wnnna$aDeaminations
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$wg$aOrganic Chemistry Phenomena
=550  \\$aAmination
=667  \\$aalmost never IM; enzymatic deamination: coord NIM with specific enzyme (IM) + substrate (NIM)
=680  \\$iThe removal of an amino group (NH2) from a chemical compound.
=688  \\$a74(71)
=750  \0$aDeamination$5IEN$0(DLC)sh 85036076

=LDR  01933cz  a2200433n  4500
=001  9880363437302441
=005  20141212200455.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003635
=035  \\$aCAZ6776HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x597.$x606.$x643.$x210
=072  \\$aC16.$x131.$x77.$x272
=072  \\$aC16.$x131.$x260.$x210
=072  \\$aC16.$x320.$x180.$x210
=150  \\$aDe Lange Syndrome
=450  \\$wnnna$aAmstelodamensis, Typus Degenerativus
=450  \\$aBrachmann-De Lange Syndrome
=450  \\$wnnna$aBrachmann De Lange Syndrome
=450  \\$wnnna$aCdLS, X-Linked
=450  \\$wnnna$aCdLS2
=450  \\$aCornelia De Lange Syndrome
=450  \\$wnnna$aCornelia de Lange Syndrome 1
=450  \\$wnnna$aCornelia de Lange Syndrome 2
=450  \\$wnnna$aCornelia de Lange Syndrome 3
=450  \\$wnnna$aCornelia de Lange Syndrome, X-Linked
=450  \\$wnnna$aCornelia de Lange Syndrome, X Linked
=450  \\$wnnna$aDe Lange's Syndrome
=450  \\$wnnna$aSyndrome, Brachmann-De Lange
=450  \\$wnnna$aSyndrome, De Lange
=450  \\$wnnna$aSyndrome, De Lange's
=450  \\$wnnna$aTypus Degenerativus Amstelodamensis
=550  \\$wg$aAbnormalities, Multiple
=550  \\$wg$aChromosome Disorders
=550  \\$wg$aIntellectual Disability
=550  \\$aIntellectual Disability
=680  \\$iA syndrome characterized by growth retardation, severe MENTAL RETARDATION, short stature, a low-pitched growling cry, brachycephaly, low-set ears, webbed neck, carp mouth, depressed nasal bridge, bushy eyebrows meeting at the midline, hirsutism, and malformations of the hands. The condition may occur sporadically or be associated with an autosomal dominant pattern of inheritance or duplication of the long arm of chromosome 3. (Menkes, Textbook of Child Neurology, 5th ed, p231)
=688  \\$a2000(1964)
=750  \0$aDe Lange's syndrome$5IEN$0(DLC)sh 85036011

=LDR  01231cz  a2200301n  4500
=001  9880363437402441
=005  20141212200454.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003634
=035  \\$aCAZ6775HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x526.$x439.$x255
=150  \\$aDDT
=450  \\$wnnna$a1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane
=450  \\$wnnna$a4,4'-DDT
=450  \\$wnnna$a4,4' DDT
=450  \\$wnnna$a4,4'-Dichlorodiphenyltrichloroethane
=450  \\$wnnna$a4,4' Dichlorodiphenyltrichloroethane
=450  \\$wnnna$aBenzochloryl
=450  \\$wnnna$aChlorophenothane
=450  \\$wnnna$ap',p'-DDT
=450  \\$wnnna$aTbisC-ethane
=450  \\$wnnna$aTbisC ethane
=550  \\$wg$aHydrocarbons, Chlorinated
=667  \\$aTN 111 for eff on insects
=680  \\$iA polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens (NTP-85-002, 1985). (From Merck Index, 11th ed)
=688  \\$a1966
=750  \0$aDDT (Insecticide)$5IEN$0(DLC)sh 85035995

=LDR  00916cz  a2200253n  4500
=001  9880363437502441
=005  20160428101451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003631
=035  \\$aCAZ6772HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x760.$x246
=072  \\$aN2.$x421.$x585.$x246
=150  \\$aDay Care, Medical
=450  \\$wnno$aDay Care
=450  \\$wnnna$aCare, Day
=450  \\$aHospitalization, Partial
=450  \\$wnnna$aPartial Hospitalization
=550  \\$wg$aPatient Care
=667  \\$acare to patients hospitalized only during day-time hours; for children in day-care schools use CHILD DAY CARE CENTERS or SCHOOLS, NURSERY
=680  \\$iInstitutional health care of patients during the day. The patients return home at night.
=688  \\$a2016 (1968)
=750  \0$aPartial hospitalization$5IEN-M$0(DLC)sh 85098350
=750  \0$aDay hospitals$5IEN-HS$0(DLC)sh 85062312

=LDR  01294cz  a2200397n  4500
=001  9880363437602441
=005  20141212200453.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003630
=035  \\$aCAZ6771HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x847.$x562.$x50.$x200
=072  \\$aD4.$x615.$x562.$x50.$x200
=072  \\$aD9.$x408.$x51.$x59.$x200
=150  \\$aDaunorubicin
=450  \\$wnnna$aCerubidine
=450  \\$wnnna$aDauno-Rubidomycine
=450  \\$wnnna$aDauno Rubidomycine
=450  \\$wnnna$aDaunoblastin
=450  \\$wnnna$aDaunoblastine
=450  \\$aDaunomycin
=450  \\$wnnna$aDaunorubicin Hydrochloride
=450  \\$wnnna$aHydrochloride, Daunorubicin
=450  \\$wnnna$aNSC-82151
=450  \\$wnnna$aNSC 82151
=450  \\$wnnna$aNSC82151
=450  \\$aRubidomycin
=450  \\$aRubomycin
=550  \\$wg$aAnthracyclines
=550  \\$wh$aCarubicin
=550  \\$wh$aDoxorubicin
=550  \\$wh$aIdarubicin
=550  \\$wh$aNogalamycin
=680  \\$iA very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.
=688  \\$a80; was DAUNOMYCIN 1964-79 (Prov 1964-65)
=750  \0$aDaunomycin$5IEN$0(DLC)sh 85035905

=LDR  00752cz  a2200229n  4500
=001  9880363437702441
=005  20141212200452.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003629
=035  \\$aCAZ6770M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x178.$x847.$x698.$x500
=072  \\$aL1.$x224.$x230.$x260.$x115.$x750
=150  \\$aModems
=450  \\$wnnna$aDataphone
=450  \\$aDataphones
=450  \\$wnnna$aModem
=550  \\$wg$aComputer Peripherals
=550  \\$wg$aTelephone
=680  \\$iEquipment that sends digital information over telephone lines. The term Modem is a short form of the phrase modulator-demodulator.
=688  \\$a2000(1967); use TELECOMMUNICATIONS 1998-1999
=750  \0$aModems$5IEN-M$0(DLC)sh 85086435

=LDR  01120cz  a2200313n  4500
=001  9880363437802441
=005  20141212200452.0
=008  860617\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003628
=035  \\$aCAZ6769HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aL1.$x224.$x900.$x280
=072  \\$aL1.$x700.$x508.$x300.$x680.$x110
=072  \\$aN4.$x452.$x515.$x110
=150  \\$aDatabase Management Systems
=450  \\$wnnna$aData Base Management Systems
=450  \\$wnnna$aDatabase Management System
=450  \\$wnnna$aManagement System, Data Base
=450  \\$wnnna$aManagement Systems, Data Base
=450  \\$wnnna$aSystem, Data Base Management
=450  \\$wnnna$aSystem, Database Management
=450  \\$wnnna$aSystems, Data Base Management
=450  \\$wnnna$aSystems, Database Management
=550  \\$wg$aManagement Information Systems
=550  \\$wg$aSoftware
=667  \\$aIM: DF: DBMS
=680  \\$iSoftware designed to store, manipulate, manage, and control data for specific uses.
=688  \\$a91(87); was see under SOFTWARE 1987-90
=750  \0$aDatabase management$5IEN$0(DLC)sh 85035848

=LDR  00987cz  a2200289n  4500
=001  9880363437902441
=005  20141212200451.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003626
=035  \\$aCAZ6767HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF2.$x784.$x412.$x221
=072  \\$aL1.$x296
=150  \\$aData Display
=450  \\$wnnna$aData Displays
=450  \\$wnnna$aDisplay, Data
=450  \\$wnnna$aDisplay, Information
=450  \\$wnnna$aDisplays, Data
=450  \\$wnnna$aDisplays, Information
=450  \\$aInformation Display
=450  \\$wnnna$aInformation Displays
=550  \\$wg$aHuman Engineering
=550  \\$wg$aInformation Science
=550  \\$wh$aComputer Graphics
=680  \\$iThe visual display of data in a man-machine system. An example is when data is called from the computer and transmitted to a CATHODE RAY TUBE DISPLAY or LIQUID CRYSTAL display.
=688  \\$a66(64)
=750  \0$aInformation display systems$5IEN$0(DLC)sh 85066140

=LDR  01391cz  a2200349n  4500
=001  9880363438002441
=005  20141212200449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003622
=035  \\$aCAZ6763HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x886.$x590.$x263
=150  \\$aDapsone
=450  \\$wnnna$a4,4'-Diaminophenyl Sulfone
=450  \\$wnnna$a4,4' Diaminophenyl Sulfone
=450  \\$wnnna$aAvlosulfone
=450  \\$wnnna$aDADPS
=450  \\$wnnna$aDapsoderm-X
=450  \\$wnnna$aDapson-Fatol
=450  \\$aDiaminodiphenylsulfone
=450  \\$wnnna$aDiaphenylsulfone
=450  \\$wnnna$aDisulone
=450  \\$wnnna$aFatol Brand of Dapsone
=450  \\$wnnna$aMex-America Brand of Dapsone
=450  \\$wnnna$aOrsade Brand of Dapsone
=450  \\$wnnna$aSulfona
=450  \\$wnnna$aSulfone, 4,4'-Diaminophenyl
=450  \\$aSulfonyldianiline
=550  \\$wg$aSulfones
=550  \\$wh$aAcedapsone
=680  \\$iA sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
=750  \0$aDapsone$5IEN-M$0(DLC)sh 95004946

=LDR  00565cz  a2200169n  4500
=001  9880363438102441
=005  20141212200449.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003621
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x365.$x150.$x200
=150  \\$aDaphnia
=450  \\$wnnna$aDaphnias
=550  \\$wg$aCladocera
=680  \\$iA diverse genus of minute freshwater CRUSTACEA, of the suborder CLADOCERA. They are a major food source for both young and adult freshwater fish.
=688  \\$a72
=750  \0$aDaphnia$5IEN$0(DLC)sh 85035776

=LDR  00867cz  a2200205n  4500
=001  9880363438202441
=005  20141212200448.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003620
=035  \\$aCAZ6761HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x129.$x308.$x432.$x555.$x287
=150  \\$aDantrolene
=450  \\$wnnna$aDantrium
=450  \\$wnnna$aDantrolene Sodium
=450  \\$wnnna$aSodium, Dantrolene
=550  \\$wg$aHydantoins
=680  \\$iSkeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
=688  \\$a80(75); was see under HYDANTOINS 1975-79
=750  \0$aDantrolene$5IEN$0(DLC)sh 85035765

=LDR  00909cz  a2200301n  4500
=001  9880363438402441
=005  20141212200447.0
=008  790529\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003614
=035  \\$aCAZ6755HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x888.$x374
=072  \\$aE2.$x779.$x474.$x186
=072  \\$aE2.$x831.$x230
=072  \\$aF4.$x754.$x278
=150  \\$aDance Therapy
=450  \\$wnnna$aDance Therapies
=450  \\$wnnna$aTherapies, Dance
=450  \\$wnnna$aTherapy, Dance
=550  \\$wg$aExercise Movement Techniques
=550  \\$wg$aPsychotherapy
=550  \\$wg$aRehabilitation
=550  \\$wg$aSensory Art Therapies
=667  \\$aa psychother technique; DF: DANCE THER
=680  \\$iThe use of dancing for therapeutic purposes.
=688  \\$a80
=750  \0$aDance therapy$0(DLC) sh 85035654$5IEN
=750  \0$aDance therapists$0(DLC)sh2007010830$5IEN-M

=LDR  01447cz  a2200385n  4500
=001  9880363438502441
=005  20141212200446.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003613
=035  \\$aCAZ6754HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD4.$x808.$x745.$x432.$x235
=150  \\$aDanazol
=450  \\$wnnna$aAlphapharm Brand of Danazol
=450  \\$wnnna$aAntigen Brand of Danazol
=450  \\$wnnna$aAzol
=450  \\$wnnna$aCyclomen
=450  \\$wnnna$aDanatrol
=450  \\$wnnna$aDanazant
=450  \\$wnnna$aDanazol-ratiopharm
=450  \\$wnnna$aDanocrine
=450  \\$wnnna$aDanol
=450  \\$wnnna$aDanoval
=450  \\$wnnna$aKendrick Brand of Danazol
=450  \\$wnnna$aLadogal
=450  \\$wnnna$aNorciden
=450  \\$wnnna$aPanacrine
=450  \\$wnnna$aratiopharm Brand of Danazol
=450  \\$wnnna$aSanofi Brand of Danazol
=450  \\$wnnna$aSanofi Synthelabo Brand of Danazol
=450  \\$wnnna$aSanofi Winthrop Brand of Danazol
=550  \\$wg$aPregnadienes
=680  \\$iA synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
=688  \\$a91(75); was see under PREGNADIENES 1975-90
=750  \0$aDanazol$5IEN$0(DLC)sh 85035628

=LDR  00425cz  a2200169n  4500
=001  9880363438602441
=005  20141212200446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003612
=035  \\$aCAZ6753HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ1.$x40.$x246
=150  \\$aDairying
=450  \\$wnnna$aDairyings
=550  \\$wg$aAgriculture
=667  \\$aSPEC: SPEC qualif
=750  \0$aDairying$5IEN$0(DLC)sh 85035466

=LDR  00843cz  a2200265n  4500
=001  9880363438702441
=005  20141212200446.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003611
=035  \\$aCAZ6752HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x350
=150  \\$aDairy Products
=450  \\$wnnna$aDairy Product
=450  \\$wnnna$aProduct, Dairy
=450  \\$wnnna$aProducts, Dairy
=550  \\$wg$aFood
=550  \\$wh$aButter
=550  \\$wh$aCheese
=550  \\$wh$aIce Cream
=550  \\$wh$aMargarine
=550  \\$wh$aMilk
=667  \\$aGEN or unspecified; prefer specifics
=680  \\$iRaw and processed or manufactured milk and milk-derived products. These are usually from cows (bovine) but are also from goats, sheep, reindeer, and water buffalo.
=750  \0$aDairy products$5IEN$0(DLC)sh 85035453

=LDR  01506cz  a2200361n  4500
=001  9880363438802441
=005  20200813175619.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003609
=035  \\$aCAZ6750HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x200
=072  \\$aD4.$x345.$x566.$x252
=072  \\$aD12.$x644.$x641.$x252
=150  \\$aDactinomycin
=450  \\$wnnna$aAc-De
=450  \\$aActinomycin
=450  \\$aActinomycin D
=450  \\$wnnna$aCosmegen
=450  \\$wnnna$aCosmegen Lyovac
=450  \\$wnnna$aLemery Brand of Dactinomycin
=450  \\$wnnna$aLyovac-Cosmegen
=450  \\$wnnna$aLyovac, Cosmegen
=450  \\$aMeractinomycin
=450  \\$wnnna$aMerck Brand of Dactinomycin
=450  \\$wnnna$aMerck Frosst Brand of Dactinomycin
=450  \\$wnnna$aMerck Sharp & Dohme Brand of Dactinomycin
=450  \\$wnnna$aMSD Brand of Dactinomycin
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wg$aPeptides, Cyclic
=680  \\$iA compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)
=688  \\$a66; ACTINOMYCIN was heading 1963-95
=750  \0$aDactinomycin$0(DLC)sh2017005264$5IEN-M

=LDR  00816cz  a2200253n  4500
=001  9880363438902441
=005  20141212200445.0
=008  870318\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003608
=035  \\$aCAZ6749HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE4.$x540.$x255
=072  \\$aE4.$x579.$x255
=150  \\$aDacryocystorhinostomy
=450  \\$wnnna$aDacryocystorhinostomies
=450  \\$wnnna$aDacryocystostomies
=450  \\$aDacryocystostomy
=550  \\$wg$aOphthalmologic Surgical Procedures
=550  \\$wg$aOstomy
=550  \\$aLacrimal Apparatus
=667  \\$ado not use /util except by MeSH definition
=680  \\$iSurgical fistulization of the lacrimal sac for external drainage of an obstructed nasolacrimal duct.
=688  \\$a88
=750  \0$aDacryocystorhinostomy$5IEN$0(DLC)sh 85035364

=LDR  00640cz  a2200217n  4500
=001  9880363439002441
=005  20161216100122.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003607
=035  \\$aCAZ6748HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC11.$x496.$x221
=150  \\$aDacryocystitis
=450  \\$wnnna$aDacryoadenitides
=450  \\$aDacryoadenitis
=450  \\$wnnna$aDacryocystitides
=550  \\$wg$aLacrimal Apparatus Diseases
=550  \\$wh$aCanaliculitis
=667  \\$ainflamm of lacrimal sac
=680  \\$iInflammation of the lacrimal sac. (Dorland, 27th ed)
=750  \0$aDacryocystitis$5IEN$0(DLC)sh 85035363

=LDR  00976cz  a2200229n  4500
=001  9880363307902441
=005  20141212195539.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002248
=035  \\$aCAZ5414HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200.$x250
=072  \\$aD1.$x362.$x200
=072  \\$aD1.$x650.$x550.$x250
=150  \\$aCarbon Monoxide
=450  \\$wnnna$aMonoxide, Carbon
=550  \\$wg$aCarbon Compounds, Inorganic
=550  \\$wg$aGases
=550  \\$wg$aOxides
=667  \\$aa poisonous gas; /tox permitted but consider also CARBON MONOXIDE POISONING
=680  \\$iCarbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
=750  \0$aCarbon monoxide$5IEN$0(DLC)sh 85020121

=LDR  00654cz  a2200205n  4500
=001  9880363308002441
=005  20141212195538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002247
=035  \\$aCAZ5413HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x496.$x123
=150  \\$aCarbon Isotopes
=450  \\$wnnna$aIsotopes, Carbon
=550  \\$wg$aIsotopes
=550  \\$wh$aCarbon Radioisotopes
=550  \\$aCarbon
=667  \\$aC-13; NIM
=680  \\$iStable carbon atoms that have the same atomic number as the element carbon, but differ in atomic weight. C-13 is a stable carbon isotope.
=750  \0$aCarbon$xIsotopes$5IEN$0(DLC)sh 85020091

=LDR  00794cz  a2200205n  4500
=001  9880363308102441
=005  20141212195538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002246
=035  \\$aCAZ5412HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200.$x210
=072  \\$aD1.$x875.$x350.$x850.$x74
=150  \\$aCarbon Disulfide
=450  \\$aCarbon Disulphide$5IEN
=450  \\$wnnna$aDisulfide, Carbon
=550  \\$wg$aCarbon Compounds, Inorganic
=550  \\$wg$aSulfides
=680  \\$iA colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.
=750  \0$aCarbon disulfide$5IEN$0(DLC)sh 85020116

=LDR  01503cz  a2200361n  4500
=001  9880363308202441
=005  20141212195610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002341
=035  \\$aCAZ5509HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x200.$x355
=072  \\$aC14.$x907.$x253.$x123.$x355
=072  \\$aC14.$x907.$x253.$x566.$x206
=072  \\$aC14.$x907.$x355.$x590.$x213.$x206
=072  \\$aC14.$x907.$x355.$x830.$x850.$x213.$x206
=150  \\$aCarotid Artery Thrombosis
=450  \\$wnnna$aCarotid Artery Thromboses
=450  \\$wnnna$aCarotid Thrombosis
=450  \\$wnnna$aCommon Carotid Artery Thrombosis
=450  \\$wnnna$aExternal Carotid Artery Thrombosis
=450  \\$wnnna$aInternal Carotid Artery Thrombosis
=450  \\$wnnna$aThrombosis, Carotid
=450  \\$aThrombosis, Carotid Artery
=450  \\$wnnna$aThrombosis, Common Carotid Artery
=450  \\$wnnna$aThrombosis, External Carotid Artery
=450  \\$wnnna$aThrombosis, Internal Carotid Artery
=550  \\$wg$aCarotid Artery Diseases
=550  \\$wg$aIntracranial Embolism and Thrombosis
=667  \\$acoordinate IM with specific carotid artery (IM) if pertinent
=680  \\$iBlood clot formation in any part of the CAROTID ARTERIES. This may produce CAROTID STENOSIS or occlusion of the vessel, leading to TRANSIENT ISCHEMIC ATTACK; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.
=688  \\$a1964
=750  \0$aCarotid artery thrombosis$5IEN$0(DLC)sh 85020414

=LDR  01122cz  a2200277n  4500
=001  9880363308302441
=005  20141212195538.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002245
=035  \\$aCAZ5411HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x200.$x200
=072  \\$aD1.$x362.$x150
=072  \\$aD1.$x650.$x550.$x200
=150  \\$aCarbon Dioxide
=450  \\$wnnna$aAnhydride, Carbonic
=450  \\$aCarbonic Anhydride
=450  \\$wnnna$aDioxide, Carbon
=550  \\$wg$aCarbon Compounds, Inorganic
=550  \\$wg$aGases
=550  \\$wg$aOxides
=550  \\$wh$aDry Ice
=667  \\$ain respiration, /physiol permitted; /metab permitted for cell & tissue resp & non-lung tissue but do not use /metab for gas exchange in lung ( = PULMONARY GAS EXCHANGE) or blood CO2 transport ( = /blood but consider also HYPERCAPNIA & HYPOCAPNIA)
=680  \\$iA colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.
=750  \0$aCarbon dioxide in the body$5IEN-M$0(DLC)sh 85020111
=750  \0$aCarbon dioxide$5IEN-HS$0(DLC)sh 85020108

=LDR  00813cz  a2200241n  4500
=001  9880363308402441
=005  20141212195537.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002244
=035  \\$aCAZ5410HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x150
=150  \\$aCarbon
=450  \\$wnnna$aCarbon, Vitreous
=450  \\$wnnna$aVitreous Carbon
=550  \\$wg$aElements
=550  \\$wh$aCharcoal
=550  \\$wh$aDiamond
=550  \\$wh$aFullerenes
=550  \\$wh$aGraphite
=667  \\$aC-12
=680  \\$iA nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel.
=750  \0$aCarbon$5IEN-HS$0(DLC)sh 85020090

=LDR  01001cz  a2200289n  4500
=001  9880363308502441
=005  20171102152502.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002243
=035  \\$aCAZ5409HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x383.$x725.$x150
=072  \\$aD3.$x438.$x473.$x155
=072  \\$aD3.$x494.$x154
=150  \\$aCarbolines
=450  \\$wnnna$aBeta-Carbolines
=450  \\$wnnna$aBeta Carbolines
=450  \\$wnnna$aPyrido(4,3-b)Indoles
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wg$aIndoles
=550  \\$wg$aPyridines
=550  \\$wh$aHarmaline
=550  \\$wh$aHarmine
=550  \\$aTadalafil
=680  \\$iA group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.
=688  \\$a86(75); was see under INDOLES 1975-85
=750  \0$aCarbolines$5IEN$0(DLC)sh 85020089

=LDR  02346cz  a2200553n  4500
=001  9880363308602441
=005  20141212195610.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002340
=035  \\$aCAZ5508HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x200
=072  \\$aC14.$x907.$x253.$x123
=150  \\$aCarotid Artery Diseases
=450  \\$wnnna$aArterial Disease, Carotid
=450  \\$wnnna$aArterial Diseases, Carotid
=450  \\$wnnna$aArterial Diseases, Common Carotid
=450  \\$wnnna$aArterial Diseases, External Carotid
=450  \\$wnnna$aArterial Diseases, Internal Carotid
=450  \\$wnnna$aArtery Disease, Carotid
=450  \\$wnnna$aArtery Diseases, Carotid
=450  \\$wnnna$aArtery Disorder, Carotid
=450  \\$wnnna$aArtery Disorders, Carotid
=450  \\$wnnna$aAtherosclerotic Disease, Carotid
=450  \\$wnnna$aAtherosclerotic Diseases, Carotid
=450  \\$wnnna$aCarotid Arterial Disease
=450  \\$wnnna$aCarotid Arterial Diseases
=450  \\$wnnna$aCarotid Artery Disease
=450  \\$wnnna$aCarotid Artery Disorder
=450  \\$wnnna$aCarotid Artery Disorders
=450  \\$wnnna$aCarotid Atheroscleroses
=450  \\$aCarotid Atherosclerosis
=450  \\$wnnna$aCarotid Atherosclerotic Disease
=450  \\$wnnna$aCarotid Atherosclerotic Diseases
=450  \\$wnnna$aCommon Carotid Artery Diseases
=450  \\$wnnna$aDisorders, Carotid Artery
=450  \\$wnnna$aExternal Carotid Artery Diseases
=450  \\$wnnna$aInternal Carotid Artery Diseases
=550  \\$wg$aCerebrovascular Disorders
=550  \\$wh$aCarotid Artery Injuries
=550  \\$wh$aCarotid Artery, Internal, Dissection
=550  \\$wh$aCarotid Artery Thrombosis
=550  \\$wh$aCarotid-Cavernous Sinus Fistula
=550  \\$wh$aCarotid Stenosis
=550  \\$wh$aMoyamoya Disease
=550  \\$aPlaque, Atherosclerotic
=667  \\$ageneral or unspecified; coordinate IM with CAROTID ARTERY, COMMON; CAROTID ARTERY, INTERNAL or CAROTID ARTERY, EXTERNAL (IM) if pertinent
=680  \\$iPathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
=750  \0$aCarotid artery$xDiseases$5IEN$0(DLC)sh 85020410

=LDR  00838cz  a2200229n  4500
=001  9880363308702441
=005  20141212195609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002339
=035  \\$aCAZ5507HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x114.$x186
=150  \\$aCarotid Arteries
=450  \\$wnnna$aArteries, Carotid
=450  \\$wnnna$aArtery, Carotid
=450  \\$wnnna$aCarotid Artery
=550  \\$wg$aArteries
=550  \\$wh$aCarotid Artery, Common
=550  \\$wh$aCarotid Sinus
=667  \\$ainj = CAROTID ARTERY INJURIES or specifics
=680  \\$iEither of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.
=750  \0$aCarotid artery$5IEN$0(DLC)sh 85020409

=LDR  01088cz  a2200337n  4500
=001  9880363308802441
=005  20141212195609.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002338
=035  \\$aCAZ5506HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249
=072  \\$aD2.$x455.$x849.$x131
=072  \\$aD23.$x767.$x261
=150  \\$aCarotenoids
=450  \\$wnnna$aCarotene
=450  \\$aCarotenes
=550  \\$wg$aCyclohexenes
=550  \\$wg$aPigments, Biological
=550  \\$wg$aPolyenes
=550  \\$wg$aTerpenes
=550  \\$wh$aAbscisic Acid
=550  \\$wh$abeta Carotene
=550  \\$wh$aNorisoprenoids
=550  \\$wh$aRetinoids
=550  \\$wh$aXanthophylls
=550  \\$wh$azeta Carotene
=680  \\$iThe general name for a group of fat-soluble pigments found in green, yellow, and leafy vegetables, and yellow fruits. They are aliphatic hydrocarbons consisting of a polyisoprene backbone.
=688  \\$a1966
=750  \0$aCarotenoids$5IEN$0(DLC)sh 85020408

=LDR  01154cz  a2200313n  4500
=001  9880363308902441
=005  20200710110750.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002241
=035  \\$aCAZ5407HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD9
=150  \\$aCarbohydrates
=550  \\$wh$aAmino Sugars
=550  \\$wh$aDeoxy Sugars
=550  \\$wh$aDietary Carbohydrates
=550  \\$wh$aGlycoconjugates
=550  \\$wh$aGlycosides
=550  \\$wh$aMonosaccharides
=550  \\$wh$aPolysaccharides
=550  \\$wh$aSugar Acids
=550  \\$wh$aSugar Alcohols
=550  \\$wh$aSugar Phosphates
=550  \\$wg$aSugars
=550  \\$aGlycomics
=667  \\$ageneral only; prefer specifics; glucides go here but could also be GLYCOSIDES; carbohydrates in the diet = DIETARY CARBOHYDRATES
=680  \\$iThe largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrates are composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n.
=688  \\$a/metabolism was CARBOHYDRATE METABOLISM 1963-65
=750  \0$aCarbohydrates$5IEN-M$0(DLC)sh 85020080

=LDR  01397cz  a2200349n  4500
=001  9880363309002441
=005  20141212195536.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002239
=035  \\$aCAZ5405HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC16.$x320.$x565.$x202
=072  \\$aC18.$x452.$x648.$x202
=150  \\$aCarbohydrate Metabolism, Inborn Errors
=450  \\$wnnna$aCarbohydrate Metabolism, Inborn Error
=550  \\$wg$aMetabolism, Inborn Errors
=550  \\$wh$aCongenital Disorders of Glycosylation
=550  \\$wh$aFructose Metabolism, Inborn Errors
=550  \\$wh$aFucosidosis
=550  \\$wh$aGalactosemias
=550  \\$wh$aGlucosephosphate Dehydrogenase Deficiency
=550  \\$wh$aGlycogen Storage Disease
=550  \\$wh$aHyperoxaluria, Primary
=550  \\$wh$aLactose Intolerance
=550  \\$wh$aMannosidase Deficiency Diseases
=550  \\$wh$aMucolipidoses
=550  \\$wh$aMucopolysaccharidoses
=550  \\$wh$aMultiple Carboxylase Deficiency
=550  \\$wh$aPyruvate Metabolism, Inborn Errors
=667  \\$ado not use /congen & do not coord with INFANT, NEWBORN, DISEASES; coord IM with specific carbohydrate /metab (IM); FRUCTOSE METABOLISM, INBORN ERRORS & PYRUVATE METABOLISM, INBORN ERRORS are also available; DF: CARB METAB INBORN ERR
=688  \\$a65
=750  \0$aCarbohydrates$xMetabolism$xDisorders$xGenetic aspects$5IEN-M

=LDR  00836cz  a2200253n  4500
=001  9880363309102441
=005  20141212195535.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002235
=035  \\$aCAZ5401M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251.$x583.$x166
=150  \\$aCarbofuran
=450  \\$wnnna$a70143, Bayer
=450  \\$wnnna$aBayer 70143
=450  \\$wnnna$aFuradan
=450  \\$wnnna$aNIA-10242
=450  \\$wnnna$aNIA 10242
=450  \\$wnnna$aNIA10242
=550  \\$wg$aPhenylcarbamates
=667  \\$aTN 111 for eff on insects
=680  \\$iA cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. (From Merck Index, 11th ed)
=688  \\$a91(72); was see under INSECTICIDES, CARBAMATE 1972-90
=750  \0$aCarbofuran$0(DLC)sh2004011631$5IEN-M

=LDR  00655cz  a2200217n  4500
=001  9880363309202441
=005  20141212195534.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002234
=035  \\$aCAZ5400M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x491.$x203
=150  \\$aCarbodiimides
=550  \\$wg$aImines
=550  \\$wh$aCME-Carbodiimide
=550  \\$wh$aCyanamide
=550  \\$wh$aDicyclohexylcarbodiimide
=550  \\$wh$aEthyldimethylaminopropyl Carbodiimide
=667  \\$ado not confuse CARBODIIMIDES (a group term) with "carbodiimide" (a specific chemical)
=688  \\$a73
=750  \0$aCarbodiimides$0(DLC)sh2007002209$5IEN-M

=LDR  01325cz  a2200373n  4500
=001  9880363309302441
=005  20141212195532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002228
=035  \\$aCAZ5394HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x99.$x750.$x750.$x170
=072  \\$aD2.$x886.$x108.$x750.$x750.$x170
=072  \\$aD3.$x438.$x260.$x825.$x750.$x170
=072  \\$aD3.$x605.$x84.$x737.$x750.$x170
=072  \\$aD4.$x75.$x80.$x875.$x99.$x221.$x750.$x750.$x170
=150  \\$aCarbenicillin
=450  \\$wnnna$aAnabactyl
=450  \\$wnnna$aCarbapen
=450  \\$wnnna$aCarbecin
=450  \\$wnnna$aCarbenicillin Disodium
=450  \\$aCarboxybenzyl Penicillin
=450  \\$wnnna$aCSL Brand of Carbenicillin Disodium Salt
=450  \\$wnnna$aDisodium, Carbenicillin
=450  \\$wnnna$aGeopen
=450  \\$wnnna$aMicrocillin
=450  \\$wnnna$aPenicillin, Carboxybenzyl
=450  \\$wnnna$aPyopen
=450  \\$wnnna$aSanfer Brand of Carbenicillin Disodium Salt
=550  \\$wg$aPenicillin G
=550  \\$wh$aCarfecillin
=680  \\$iBroad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.
=688  \\$a73(71)
=750  \0$aCarbenicillin$5IEN$0(DLC)sh 85020073

=LDR  00785cz  a2200241n  4500
=001  9880363309402441
=005  20141212195532.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002227
=035  \\$aCAZ5393HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x438.$x473.$x144
=072  \\$aD3.$x494.$x148
=150  \\$aCarbazoles
=450  \\$aCarbazole$5IEN
=550  \\$wg$aHeterocyclic Compounds, 3-Ring
=550  \\$wg$aIndoles
=550  \\$wh$aEllipticines
=550  \\$wh$aOndansetron
=550  \\$wh$aStaurosporine
=680  \\$iBenzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
=688  \\$a69; was see under AZOLES 1963-68
=750  \0$aCarbazole$5IEN$0(DLC)sh 85020072

=LDR  01236cz  a2200325n  4500
=001  9880363309502441
=005  20141212192040.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002220
=035  \\$aCAZ5386HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x494.$x240.$x127
=150  \\$aCarbamazepine
=450  \\$wnnna$aAmizepine
=450  \\$wnnna$aCarbamazepine Acetate
=450  \\$wnnna$aCarbamazepine Anhydrous
=450  \\$wnnna$aCarbamazepine Dihydrate
=450  \\$wnnna$aCarbamazepine Hydrochloride
=450  \\$wnnna$aCarbamazepine L-Tartrate (4:1)
=450  \\$wnnna$aCarbamazepine Phosphate
=450  \\$wnnna$aCarbamazepine Sulfate (2:1)
=450  \\$wnnna$aCarbazepin
=450  \\$wnnna$aEpitol
=450  \\$wnnna$aFinlepsin
=450  \\$wnnna$aNeurotol
=450  \\$wnnna$aTegretol
=550  \\$wg$aDibenzazepines
=680  \\$iAn anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
=688  \\$a72(68)
=750  \0$aCarbamazepine$5IEN$0(DLC)sh 85020070

=LDR  01624cz  a2200445n  4500
=001  9880363309602441
=005  20170103104948.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002219
=035  \\$aCAZ5385HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x241.$x81.$x251
=150  \\$aCarbamates
=450  \\$wnnna$aAcids, Aminoformic
=450  \\$wnnna$aAcids, Carbamic
=450  \\$wnnna$aAminoformic Acids
=450  \\$wnnna$aCarbamic Acids
=550  \\$wg$aAcids, Acyclic
=550  \\$wh$aAlbendazole
=550  \\$wh$aAldicarb
=550  \\$wh$aBenomyl
=550  \\$wh$aCarbadox
=550  \\$wh$aCarbamyl Phosphate
=550  \\$wh$aCarbaryl
=550  \\$wh$aCarisoprodol
=550  \\$wh$aCobicistat
=550  \\$wh$aDarunavir
=550  \\$wh$aDiethylcarbamazine
=550  \\$wh$aFenbendazole
=550  \\$wh$aMebendazole
=550  \\$wh$aMeprobamate
=550  \\$wh$aMethocarbamol
=550  \\$wh$aMethomyl
=550  \\$wh$aPhenylcarbamates
=550  \\$wh$aThiocarbamates
=550  \\$wh$aThiophanate
=550  \\$wh$aUrethane
=680  \\$iDerivatives of carbamic acid, H2NC(=O)OH. Included under this heading are N-substituted and O-substituted carbamic acids. In general carbamate esters are referred to as urethanes, and polymers that include repeating units of carbamate are referred to as POLYURETHANES. Note however that polyurethanes are derived from the polymerization of ISOCYANATES and the singular term URETHANE refers to the ethyl ester of carbamic acid.
=688  \\$aTYBAMATE was heading 1965-84 (Prov 1965-72)
=750  \0$aCarbamates$5IEN$0(DLC)sh 85020069

=LDR  01292cz  a2200349n  4500
=001  9880363309702441
=005  20141212195529.0
=008  790523\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002216
=035  \\$aCAZ5382HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x125.$x72.$x401.$x623.$x270
=150  \\$aCaptopril
=450  \\$wnnna$aCapoten
=450  \\$wnnna$aLopirin
=450  \\$wnnna$a(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline
=450  \\$wnnna$aSQ-14,225
=450  \\$wnnna$aSQ 14,225
=450  \\$wnnna$aSQ-14,534
=450  \\$wnnna$aSQ 14,534
=450  \\$wnnna$aSQ-14225
=450  \\$wnnna$aSQ 14225
=450  \\$wnnna$aSQ-14534
=450  \\$wnnna$aSQ 14534
=450  \\$wnnna$aSQ14,225
=450  \\$wnnna$aSQ14,534
=450  \\$wnnna$aSQ14225
=450  \\$wnnna$aSQ14534
=550  \\$wg$aProline
=680  \\$iA potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
=688  \\$a86(80); was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93
=750  \0$aCaptopril$5IEN$0(DLC)sh 85020024

=LDR  00776cz  a2200181n  4500
=001  9880363309802441
=005  20141212192039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002214
=035  \\$aCAZ5380HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD26.$x255.$x150
=150  \\$aCapsules
=450  \\$aMicrocapsules
=550  \\$wg$aDosage Forms
=667  \\$aIM for general only; NIM (no qualif) with specific drug IM (with qualif); /adv eff permitted but be careful: it may be the adv eff of the drug in capsule form, not the capsule; note X ref MICROCAPSULES: do not confuse with MICROENCAPSULATION see DRUG COMPOUNDING
=680  \\$iHard or soft soluble containers used for the oral administration of medicine.
=750  \0$aCapsules (Pharmacy)$5IEN$0(DLC)sh 85020019

=LDR  02635cz  a2200721n  4500
=001  9880363309902441
=005  20141212192039.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002212
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x905.$x145
=072  \\$aJ2.$x500.$x850.$x175
=150  \\$aCapsicum
=450  \\$aBell Pepper
=450  \\$wnnna$aBell Peppers
=450  \\$wnnna$aCapsicum annuum
=450  \\$wnnna$aCayenne
=450  \\$aCayenne Pepper
=450  \\$wnnna$aCayenne Peppers
=450  \\$wnnna$aChile Pepper
=450  \\$wnnna$aChile Peppers
=450  \\$aChili Pepper
=450  \\$wnnna$aChili Peppers
=450  \\$aChilli Pepper
=450  \\$wnnna$aChilli Peppers
=450  \\$aGreen Pepper
=450  \\$wnnna$aGreen Peppers
=450  \\$wnnna$aHot Pepper
=450  \\$wnnna$aHot Peppers
=450  \\$aJalapeno Pepper
=450  \\$wnnna$aJalapeno Peppers
=450  \\$aPaprika
=450  \\$wnnna$aPepper, Bell
=450  \\$wnnna$aPepper, Cayenne
=450  \\$wnnna$aPepper, Chile
=450  \\$wnnna$aPepper, Chili
=450  \\$wnnna$aPepper, Chilli
=450  \\$wnnna$aPepper, Green
=450  \\$wnnna$aPepper, Hot
=450  \\$wnnna$aPepper, Jalapeno
=450  \\$wnnna$aPepper, Red
=450  \\$wnnna$aPepper, Sweet
=450  \\$wnnna$aPeppers, Bell
=450  \\$wnnna$aPeppers, Cayenne
=450  \\$wnnna$aPeppers, Chile
=450  \\$wnnna$aPeppers, Chili
=450  \\$wnnna$aPeppers, Chilli
=450  \\$wnnna$aPeppers, Green
=450  \\$wnnna$aPeppers, Hot
=450  \\$wnnna$aPeppers, Jalapeno
=450  \\$wnnna$aPeppers, Red
=450  \\$wnnna$aPeppers, Sweet
=450  \\$aPimiento
=450  \\$aRed Pepper
=450  \\$wnnna$aRed Peppers
=450  \\$wnnna$aSweet Pepper
=450  \\$wnnna$aSweet Peppers
=550  \\$wg$aSolanaceae
=550  \\$wg$aVegetables
=667  \\$aBLACK PEPPER is available as a spice; black pepper plant = PIPER NIGRUM; coordinate with specific PLANT STRUCTURES term if pertinent; for use in therapy coordinate IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent
=680  \\$iA plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates VANILLOID RECEPTORS. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.
=688  \\$a91(86)63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85
=750  \0$aPeppers$5IEN$0(DLC)sh 85099673

=LDR  01853cz  a2200565n  4500
=001  9880363310002441
=005  20141212195528.0
=008  741127\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002211
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x160.$x500
=072  \\$aD2.$x455.$x326.$x271.$x60.$x222
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x166.$x99
=072  \\$aD3.$x132.$x760.$x200
=072  \\$aD10.$x251.$x355.$x325.$x190
=150  \\$aCapsaicin
=450  \\$wnnna$a8-Methyl-N-Vanillyl-6-Nonenamide
=450  \\$wnnna$a8 Methyl N Vanillyl 6 Nonenamide
=450  \\$wnnna$aAlacan Brand of Capsaicin
=450  \\$wnnna$aAntiphlogistine Rub A-535 Capsaicin
=450  \\$wnnna$aAxsain
=450  \\$wnnna$aCapsaicine
=450  \\$wnnna$aCapsicum Farmaya
=450  \\$wnnna$aCapsidol
=450  \\$wnnna$aCapsin
=450  \\$wnnna$aCapzasin
=450  \\$wnnna$aCarter Horner Brand of Capsaicin
=450  \\$wnnna$aCentrum Brand of Capsaicin
=450  \\$wnnna$aElan Brand of Capsaicin
=450  \\$wnnna$aFlemming Brand of Capsaicin
=450  \\$wnnna$aGelcen
=450  \\$wnnna$aKatrum
=450  \\$wnnna$aLink Brand of Capsaicin
=450  \\$wnnna$aMedicis Brand of Capsaicin
=450  \\$wnnna$aNGX-4010
=450  \\$wnnna$aNGX 4010
=450  \\$wnnna$aNGX4010
=450  \\$wnnna$aSmaller Brand of Capsaicin
=450  \\$wnnna$aThompson Brand of Capsaicin
=450  \\$wnnna$aVinas Brand of Capsaicin
=450  \\$wnnna$aZacin
=450  \\$wnnna$aZostrix
=550  \\$wg$aCatechols
=550  \\$wg$aFatty Acids, Monounsaturated
=550  \\$wg$aPolyunsaturated Alkamides
=550  \\$wg$aSolanaceous Alkaloids
=680  \\$iAn alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.
=688  \\$a1984(1975)
=688  \\$a84(75)
=750  \0$aCapsaicin$0(DLC) sh 85020016$5IEN

=LDR  00834cz  a2200253n  4500
=001  9880363310102441
=005  20141212195527.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002209
=035  \\$aCAZ5375HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x65.$x589.$x200
=072  \\$aD3.$x383.$x66.$x150
=072  \\$aD3.$x383.$x411.$x200
=150  \\$aCaprolactam
=450  \\$aAminocaproic Lactam
=450  \\$wnnna$aHexahydro-2H-Azepin-2-One
=450  \\$wnnna$aHexahydro 2H Azepin 2 One
=450  \\$wnnna$aLactam, Aminocaproic
=550  \\$wg$aAzepines
=550  \\$wg$aLactams
=680  \\$iCyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.
=688  \\$a91(75); was see under AZEPINES 1975-90
=750  \0$aCaprolactam$5IEN$0(DLC)sh 88007210

=LDR  00913cz  a2200217n  4500
=001  9880363310202441
=005  20141212195526.0
=008  770505\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002204
=035  \\$aCAZ5370HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x442.$x90
=150  \\$aCapitation Fee
=450  \\$wnnna$aCapitation Fees
=450  \\$aFee, Capitation
=450  \\$wnnna$aFees, Capitation
=550  \\$wg$aFees and Charges
=667  \\$a"capitation" refers to "a fixed per capita amt without regard to no. or nature of serv provided"
=680  \\$iA method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.
=688  \\$a91(Aug 77); was see under FEES AND CHARGES 1977-90
=750  \0$aCapitation fees (Medical care)$5IEN-M$0(DLC)sh 96010387

=LDR  01588cz  a2200457n  4500
=001  9880363310302441
=005  20141212195525.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002203
=035  \\$aCAZ5369HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI1.$x880.$x604.$x160
=150  \\$aCapital Punishment
=450  \\$wnnna$aCapital Punishments
=450  \\$wnnna$aChamber Execution, Gas
=450  \\$wnnna$aDeath Penalties
=450  \\$aDeath Penalty
=450  \\$aElectrocution, Judicial
=450  \\$wnnna$aElectrocutions, Judicial
=450  \\$wnnna$aExecution, Gas Chamber
=450  \\$wnnna$aExecutions, Gas Chamber
=450  \\$wnnna$aGas Chamber Execution
=450  \\$wnnna$aGas Chamber Executions
=450  \\$wnnna$aHanging, Judicial
=450  \\$wnnna$aHangings, Judicial
=450  \\$wnnna$aInjection, Lethal
=450  \\$wnnna$aInjections, Lethal
=450  \\$wnnna$aJudicial Electrocution
=450  \\$wnnna$aJudicial Electrocutions
=450  \\$wnnna$aJudicial Hanging
=450  \\$wnnna$aJudicial Hangings
=450  \\$wnnna$aLethal Injection
=450  \\$wnnna$aLethal Injections
=450  \\$wnnna$aPenalties, Death
=450  \\$wnnna$aPenalty, Death
=450  \\$wnnna$aPunishment, Capital
=450  \\$wnnna$aPunishments, Capital
=550  \\$wg$aSocial Control, Formal
=667  \\$aentry term ELECTROCUTION, JUDICIAL: do not index also under the electricity aspect unless particularly discussed
=680  \\$iThe use of the death penalty for certain crimes.
=750  \0$aCapital punishment$5IEN-HS$0(DLC)sh 85019949

=LDR  00770cz  a2200217n  4500
=001  9880363310402441
=005  20141212195525.0
=008  770512\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002201
=035  \\$aCAZ5367HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN3.$x219.$x151.$x450.$x200
=150  \\$aCapital Expenditures
=450  \\$wnnna$aCapital Expenditure
=450  \\$wnnna$aExpenditure, Capital
=450  \\$wnnna$aExpenditures, Capital
=550  \\$wg$aHealth Expenditures
=667  \\$anot restricted to health care; NIM
=680  \\$iThose funds disbursed for facilities and equipment, particularly those related to the delivery of health care.
=688  \\$a91(Aug 77); was see under ECONOMICS 1977-90
=750  \0$aCapital investments$5IEN$0(DLC)sh 85019939

=LDR  02009cz  a2200409n  4500
=001  9880363310502441
=005  20141212195524.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002199
=035  \\$aCAZ5365HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG3.$x495.$x166.$x330
=072  \\$aG9.$x330.$x165
=150  \\$aCapillary Permeability
=450  \\$wnnna$aCapillary Permeabilities
=450  \\$wnnna$aMicrovascular Permeabilities
=450  \\$aMicrovascular Permeability
=450  \\$wnnna$aPermeabilities, Capillary
=450  \\$wnnna$aPermeabilities, Microvascular
=450  \\$wnnna$aPermeabilities, Vascular
=450  \\$aPermeability, Capillary
=450  \\$aPermeability, Microvascular
=450  \\$wnnna$aPermeability, Vascular
=450  \\$wnnna$aVascular Permeabilities
=450  \\$aVascular Permeability
=550  \\$wg$aBiological Transport
=550  \\$wg$aCardiovascular Physiological Phenomena
=550  \\$aBlood-Air Barrier
=550  \\$aBlood-Aqueous Barrier
=550  \\$aBlood-Brain Barrier
=550  \\$aBlood-Nerve Barrier
=550  \\$aBlood-Retinal Barrier
=550  \\$aBlood-Testis Barrier
=550  \\$aTransendothelial and Transepithelial Migration
=667  \\$acoord IM with endogenous substance /metab (IM) or exogenous substance /pharmacokin (IM)
=680  \\$iThe property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.
=750  \0$aCapillaries$xPermeability$5IEN$0(DLC)sh 85019926

=LDR  00940cz  a2200241n  4500
=001  9880363310602441
=005  20141212195523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002197
=035  \\$aCAZ5363HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x842.$x850.$x327
=150  \\$aCapillary Action
=450  \\$wnnna$aAction, Capillary
=450  \\$wnnna$aCapillarities
=450  \\$aCapillarity
=450  \\$wnnna$aWicking
=550  \\$wg$aSurface Properties
=550  \\$aCapillaries
=680  \\$iA phenomenon in which the surface of a liquid where it contacts a solid is elevated or depressed, because of the relative attraction of the molecules of the liquid for each other and for those of the solid. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a2012 (1966)
=688  \\$aHeading changed 20110909 from: 150:##:_{dollar}a Capillarity
=750  \0$aCapillarity$0(DLC) sh 85019928$5IEN

=LDR  00607cz  a2200193n  4500
=001  9880363310702441
=005  20141212195523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002196
=035  \\$aCAZ5362HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA7.$x231.$x461.$x165
=150  \\$aCapillaries
=450  \\$wnnna$aCapillary
=550  \\$wg$aMicrovessels
=550  \\$aCapillary Action
=667  \\$acoordinate with specific organ / blood supply; not for lymphatic capillaries
=680  \\$iThe minute vessels that connect the arterioles and venules.
=750  \0$aCapillaries$5IEN$0(DLC)sh 85019924

=LDR  01396cz  a2200289n  4500
=001  9880363310802441
=005  20141212195523.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002195
=035  \\$aCAZ5361HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x500.$x294.$x100.$x275.$x780.$x180
=150  \\$aCapillaria
=450  \\$aCapillaria hepatica
=450  \\$wnnna$aCapillaria hepaticas
=450  \\$wnnna$aCapillarias
=450  \\$wnnna$ahepatica, Capillaria
=450  \\$wnnna$ahepatica, Hepaticola
=450  \\$wnnna$ahepaticas, Capillaria
=450  \\$wnnna$ahepaticas, Hepaticola
=450  \\$aHepaticola hepatica
=450  \\$wnnna$aHepaticola hepaticas
=550  \\$wg$aTrichuroidea
=667  \\$aa genus of nematodes in liver & intestines of birds & mammals including man; infection: coord IM with ENOPLIDA INFECTIONS (IM); for antigens, coord with ANTIGENS, HELMINTH, for antibodies, coord with ANTIBODIES, HELMINTH
=680  \\$iA genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man.
=688  \\$a91(75); was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66
=750  \0$aCapillaria$5IEN$0(DLC)sh 88021609

=LDR  00797cz  a2200193n  4500
=001  9880363310902441
=005  20141212195522.0
=008  810226\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002194
=035  \\$aCAZ5360M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x700.$x300
=150  \\$aCapgras Syndrome
=450  \\$wnnna$aSyndrome, Capgras
=550  \\$wg$aSchizophrenia and Disorders with Psychotic Features
=667  \\$aa psychosis wherein patient thinks familiar persons are doubles of themselves or imposters
=680  \\$iA psychotic disorder characterized by the patient's belief that acquaintances or closely related persons have been replaced by doubles or imposters.
=688  \\$a91(82); was see under PSYCHOTIC DISORDERS 1982-90
=750  \0$aCapgras syndrome$0(DLC)sh2005005156$5IEN-M

=LDR  00533cz  a2200193n  4500
=001  9880363311002441
=005  20141212195521.0
=008  760413\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002190
=035  \\$aCAZ5356HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x113.$x547.$x200
=150  \\$aCannibalism
=450  \\$wnnna$aCannibalisms
=550  \\$wg$aFeeding Behavior
=667  \\$aanimal and human
=680  \\$iEating other individuals of one's own species.
=688  \\$a77
=750  \0$aCannibalism$5IEN$0(DLC)sh 85019617

=LDR  01224cz  a2200373n  4500
=001  9880363311102441
=005  20141212195521.0
=008  800521\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002189
=035  \\$aCAZ5355HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC25.$x775.$x635
=072  \\$aF3.$x900.$x635
=150  \\$aMarijuana Abuse
=450  \\$wnnna$aAbuse, Cannabis
=450  \\$wnnna$aAbuse, Hashish
=450  \\$wnnna$aAbuse, Marihuana
=450  \\$wnnna$aAbuse, Marijuana
=450  \\$aCannabis Abuse
=450  \\$aCannabis Dependence
=450  \\$aCannabis-Related Disorder
=450  \\$wnnna$aCannabis Related Disorder
=450  \\$wnnna$aDependence, Cannabis
=450  \\$wnnna$aDependence, Marijuana
=450  \\$wnnna$aDisorder, Cannabis-Related
=450  \\$aHashish Abuse
=450  \\$wnnna$aMarihuana Abuse
=450  \\$aMarijuana Dependence
=550  \\$wg$aSubstance-Related Disorders
=550  \\$aCannabis
=667  \\$asee note on CANNABIS
=680  \\$iThe excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning.
=688  \\$a90; was CANNABIS ABUSE 1981-89
=750  \0$aMarijuana abuse$5IEN-M$0(DLC)sh 99013770

=LDR  01575cz  a2200493n  4500
=001  9880363311202441
=005  20141212192038.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002188
=035  \\$aCAZ5354HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x175.$x500
=150  \\$aCannabis
=450  \\$aBhang
=450  \\$wnnna$aBhangs
=450  \\$wnnna$aCannabi
=450  \\$wnnna$aCannabis indica
=450  \\$wnnna$aCannabis indicas
=450  \\$wnnna$aCannabis sativa
=450  \\$wnnna$aCannabis sativas
=450  \\$aGanja
=450  \\$wnnna$aGanjas
=450  \\$aHashish
=450  \\$wnnna$aHashishs
=450  \\$aHemp
=450  \\$wnnna$aHemp Plant
=450  \\$wnnna$aHemp Plants
=450  \\$wnnna$aHemps
=450  \\$wnnna$aindica, Cannabis
=450  \\$wnnna$aindicas, Cannabis
=450  \\$wnnna$aMarihuana
=450  \\$wnnna$aMarihuanas
=450  \\$aMarijuana
=450  \\$wnnna$aMarijuanas
=450  \\$wnnna$aPlant, Hemp
=450  \\$wnnna$aPlants, Hemp
=450  \\$wnnna$asativa, Cannabis
=450  \\$wnnna$asativas, Cannabis
=550  \\$wg$aCannabaceae
=550  \\$aMedical Marijuana
=667  \\$ause in therapy = MEDICAL MARIJUANA
=680  \\$iThe plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.
=688  \\$awas in Cat B & D 1963-76
=750  \0$aCannabis$5IEN$0(DLC)sh 85019610

=LDR  00807cz  a2200241n  4500
=001  9880363311302441
=005  20141212195520.0
=008  760519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002186
=035  \\$aCAZ5352HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x90
=150  \\$aCannabinoids
=550  \\$wg$aTerpenes
=550  \\$wh$aCannabidiol
=550  \\$wh$aCannabinol
=550  \\$wh$aDronabinol
=550  \\$aCannabinoid Receptor Agonists
=550  \\$aCannabis
=550  \\$aReceptors, Cannabinoid
=680  \\$iCompounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.
=688  \\$a77
=750  \0$aCannabinoids$5IEN$0(DLC)sh 85019609

=LDR  00738cz  a2200229n  4500
=001  9880363311402441
=005  20141212195520.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002183
=035  \\$aCAZ5349HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x250
=150  \\$aCanes
=450  \\$wnnna$aCane
=450  \\$wnnna$aStick, Walking
=450  \\$wnnna$aSticks, Walking
=450  \\$wnnna$aWalking Stick
=450  \\$aWalking Sticks
=550  \\$wg$aOrthopedic Equipment
=680  \\$iSticks used as walking aids. The canes may have three or four prongs at the end of the shaft.
=688  \\$a91(75); was see under ORTHOPEDIC EQUIPMENT 1975-90
=750  \0$aStaffs (Sticks, canes, etc.)$5IEN$0(DLC)sh 85127230

=LDR  00882cz  a2200205n  4500
=001  9880363311502441
=005  20141212195519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002182
=035  \\$aCAZ5348HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x140
=150  \\$aCandy
=450  \\$wnnna$aCandies
=450  \\$aConfection
=450  \\$wnnna$aConfections
=550  \\$wg$aFood
=550  \\$wh$aChewing Gum
=680  \\$iSweet food products combining cane or beet sugars with other carbohydrates and chocolate, milk, eggs, and various flavorings. In the United States, candy refers to both sugar- and cocoa-based confections and is differentiated from sweetened baked goods; elsewhere the terms sugar confectionary, chocolate confectionary, and flour confectionary (meaning goods such as cakes and pastries) are used.
=750  \0$aCandy$5IEN$0(DLC)sh 85019581

=LDR  01080cz  a2200313n  4500
=001  9880363311602441
=005  20141212195519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002181
=035  \\$aCAZ5347HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x160.$x190
=072  \\$aC13.$x351.$x500.$x894.$x906.$x820.$x500
=072  \\$aC13.$x351.$x500.$x944.$x902.$x737.$x500
=150  \\$aCandidiasis, Vulvovaginal
=450  \\$wnnna$aMonilial Vaginitides
=450  \\$wnnna$aMonilial Vaginitis
=450  \\$aMoniliasis, Vulvovaginal
=450  \\$wnnna$aVaginitides, Monilial
=450  \\$aVaginitis, Monilial
=450  \\$wnnna$aVulvovaginal Candidiases
=450  \\$wnnna$aVulvovaginal Candidiasis
=450  \\$wnnna$aVulvovaginal Moniliases
=450  \\$wnnna$aVulvovaginal Moniliasis
=550  \\$wg$aCandidiasis
=550  \\$wg$aVulvovaginitis
=680  \\$iInfection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
=688  \\$a81; was MONILIASIS, VULVOVAGINAL 1963-80
=750  \0$aCandidiasis, Vulvovaginal$5IEN$0(DLC)sh 85019566

=LDR  01001cz  a2200301n  4500
=001  9880363311702441
=005  20141212195519.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002180
=035  \\$aCAZ5346HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x160.$x180
=072  \\$aC7.$x465.$x130
=150  \\$aCandidiasis, Oral
=450  \\$wnnna$aCandidiases, Oral
=450  \\$wnnna$aMoniliases, Oral
=450  \\$aMoniliasis, Oral
=450  \\$wnnna$aOral Candidiases
=450  \\$wnnna$aOral Candidiasis
=450  \\$wnnna$aOral Moniliases
=450  \\$wnnna$aOral Moniliasis
=450  \\$aThrush
=550  \\$wg$aCandidiasis
=550  \\$wg$aMouth Diseases
=667  \\$afungus dis of mouth; do not bother to coord with CANDIDA or CANDIDA ALBICANS
=680  \\$iInfection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
=688  \\$a81; was MONILIASIS, ORAL 1963-80
=750  \0$aThrush (Mouth disease)$5IEN$0(DLC)sh 85135089

=LDR  00985cz  a2200277n  4500
=001  9880363311802441
=005  20141212195518.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002177
=035  \\$aCAZ5343HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x703.$x160
=150  \\$aCandidiasis
=450  \\$wnnna$aCandidiases
=450  \\$wnnna$aMoniliases
=450  \\$aMoniliasis
=550  \\$wg$aMycoses
=550  \\$wh$aCandidiasis, Chronic Mucocutaneous
=550  \\$wh$aCandidiasis, Cutaneous
=550  \\$wh$aCandidiasis, Invasive
=550  \\$wh$aCandidiasis, Oral
=550  \\$wh$aCandidiasis, Vulvovaginal
=667  \\$aCANDIDIASIS, INVASIVE and CANDIDEMIA are also available
=680  \\$iInfection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
=688  \\$a81; was MONILIASIS 1963-80
=750  \0$aCandidiasis$5IEN$0(DLC)sh 85019565

=LDR  00813cz  a2200229n  4500
=001  9880363311902441
=005  20141212195517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002176
=035  \\$aCAZ5342HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x147.$x326
=072  \\$aB1.$x300.$x930.$x176.$x326
=150  \\$aCandida albicans
=450  \\$wnnna$aalbican, Candida
=450  \\$wnnna$aalbicans, Candida
=450  \\$wnnna$aCandida albican
=550  \\$wg$aCandida
=667  \\$ainfection = CANDIDIASIS or its indentions & do not coord with CANDIDA ALBICANS unless particularly discussed
=680  \\$iA unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).
=688  \\$a73(72)
=750  \0$aCandida albicans$5IEN$0(DLC)sh 85019564

=LDR  01528cz  a2200361n  4500
=001  9880363312002441
=005  20141212195517.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002175
=035  \\$aCAZ5341HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x300.$x381.$x147
=072  \\$aB1.$x300.$x930.$x176
=150  \\$aCandida
=450  \\$wnnna$aCandida utili
=450  \\$aCandida utilis
=450  \\$wnnna$aCandidas
=450  \\$aMonilia
=450  \\$wnnna$aMonilias
=450  \\$wnnna$aTorulopsis utili
=450  \\$aTorulopsis utilis
=450  \\$wnnna$autili, Candida
=450  \\$wnnna$autili, Torulopsis
=450  \\$wnnna$autilis, Candida
=450  \\$wnnna$autilis, Torulopsis
=550  \\$wg$aMitosporic Fungi
=550  \\$wg$aYeasts
=550  \\$wh$aCandida albicans
=550  \\$wh$aCandida glabrata
=550  \\$wh$aCandida tropicalis
=667  \\$ainfection = CANDIDIASIS or its indentions; for specific mycoses in scope note: coord CANDIDIASIS (IM) or its indentions (IM) with specific mycosis (IM)
=680  \\$iA genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis (CANDIDIASIS, VULVOVAGINAL), and thrush (see CANDIDIASIS, ORAL). (From Dorland, 28th ed)
=750  \0$aCandida$5IEN$0(DLC)sh 85019563

=LDR  00827cz  a2200253n  4500
=001  9880363312102441
=005  20141212195516.0
=008  770519\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002173
=035  \\$aCAZ5339HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN2.$x278.$x421.$x556.$x70
=150  \\$aCancer Care Facilities
=450  \\$wnnna$aCancer Care Facility
=450  \\$wnnna$aCancer Hospital
=450  \\$wnnna$aCancer Hospitals
=450  \\$wnnna$aFacilities, Cancer Care
=450  \\$wnnna$aFacility, Cancer Care
=450  \\$wnnna$aHospital, Cancer
=450  \\$aHospitals, Cancer
=550  \\$wg$aHospitals, Special
=680  \\$iInstitutions specializing in the care of cancer patients.
=688  \\$a91(Aug 77); was see under HOSPITALS, SPECIAL 1977-90
=750  \0$aCancer$xHospitals$5IEN$0(DLC)sh 85019511

=LDR  00534cz  a2200193n  4500
=001  9880363312202441
=005  20141212195516.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002171
=035  \\$aCAZ5337HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x250.$x150
=150  \\$aCanaries
=450  \\$wnnna$aCanary
=450  \\$aSerinus
=550  \\$wg$aFinches
=680  \\$iAny of several Old World finches of the genus Serinus.
=688  \\$a68
=750  \0$aCanaries$5IEN$0(DLC)sh 85019477

=LDR  00689cz  a2200217n  4500
=001  9880363312302441
=005  20141212195515.0
=008  760416\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002169
=035  \\$aCAZ5335HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x177
=150  \\$aCampylobacter Infections
=450  \\$wnnna$aCampylobacter Infection
=450  \\$wnnna$aInfection, Campylobacter
=450  \\$wnnna$aInfections, Campylobacter
=550  \\$wg$aGram-Negative Bacterial Infections
=667  \\$agram-neg bact infect
=680  \\$iInfections with bacteria of the genus CAMPYLOBACTER.
=688  \\$a77
=750  \0$aCampylobacter infections$5IEN-M$0(DLC)sh 85019266

=LDR  00802cz  a2200205n  4500
=001  9880363312402441
=005  20141212195515.0
=008  750801\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002168
=035  \\$aCAZ5334HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x180.$x325
=072  \\$aB3.$x660.$x150.$x100.$x220
=150  \\$aCampylobacter fetus
=450  \\$aVibrio fetus
=550  \\$wg$aCampylobacter
=667  \\$acauses abortion in cattle & sheep; infection: coord IM with CAMPYLOBACTER INFECTIONS (IM)
=680  \\$iA species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion.
=688  \\$a84(76); was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1972-75 (Prov 1972-73)
=750  \0$aCampylobacter fetus$5IEN$0(DLC)sh 88023224

=LDR  01079cz  a2200301n  4500
=001  9880363312502441
=005  20141212195515.0
=008  750725\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002167
=035  \\$aCAZ5333HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x180
=072  \\$aB3.$x660.$x150.$x100
=150  \\$aCampylobacter
=550  \\$wg$aEpsilonproteobacteria
=550  \\$wg$aGram-Negative Bacteria
=550  \\$wh$aCampylobacter coli
=550  \\$wh$aCampylobacter fetus
=550  \\$wh$aCampylobacter hyointestinalis
=550  \\$wh$aCampylobacter jejuni
=550  \\$wh$aCampylobacter lari
=550  \\$wh$aCampylobacter rectus
=550  \\$wh$aCampylobacter sputorum
=550  \\$wh$aCampylobacter upsaliensis
=667  \\$ainfection = CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER PYLORI see HELICOBACTER PYLORI is also available
=680  \\$iA genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.
=688  \\$a76
=750  \0$aCampylobacter$5IEN$0(DLC)sh 85019265

=LDR  00718cz  a2200193n  4500
=001  9880363312602441
=005  20141212195514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002166
=035  \\$aCAZ5332HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD3.$x132.$x151
=150  \\$aCamptothecin
=450  \\$wnnna$aCamptothecine
=550  \\$wg$aAlkaloids
=550  \\$wh$aTopotecan
=680  \\$iAn alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.
=688  \\$a73
=750  \0$aCamptothecin$5IEN-M$0(DLC)sh 94006761

=LDR  00473cz  a2200169n  4500
=001  9880363312702441
=005  20141212195514.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002165
=035  \\$aCAZ5331HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x159
=150  \\$aCamping
=550  \\$wg$aRecreation
=680  \\$iLiving outdoors as a recreational activity.
=750  \0$aCamps$5IEN-M$0(DLC)sh 85019246
=750  \0$aCamping$5IEN-HS$0(DLC)sh 85019231

=LDR  00745cz  a2200217n  4500
=001  9880363312802441
=005  20201112120349.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002164
=035  \\$aCAZ5330HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x455.$x849.$x575.$x781.$x234.$x326
=072  \\$aD2.$x522.$x376
=150  \\$aCamphor
=450  \\$wnnna$aCamphor, (+-)-Isomer
=450  \\$wnnna$aCamphor, (1R)-Isomer
=450  \\$wnnna$aCamphor, (1S)-Isomer
=550  \\$wg$aCamphanes
=550  \\$wg$aKetones
=680  \\$iA bicyclic monoterpene ketone found widely in plants, especially CINNAMOMUM CAMPHORA. It is used topically as a skin antipruritic and as an anti-infective agent.
=750  \0$aCamphor$5IEN$0(DLC)sh 85019223

=LDR  00934cz  a2200301n  4500
=001  9880363312902441
=005  20170616110836.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002162
=035  \\$aCAZ5328HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x190.$x180
=150  \\$aCamelus
=450  \\$wnnna$aBactrian Camel
=450  \\$wnnna$aBactrian Camels
=450  \\$wnnna$aCamel
=450  \\$wnnna$aCamel, Bactrian
=450  \\$wnno$aCamels
=450  \\$wnnna$aCamels, Bactrian
=450  \\$wnnna$aCamelus, bactrianus
=450  \\$wnnna$aCamelus, Dromedarius
=450  \\$wnnna$aDromedaries
=450  \\$aDromedary
=550  \\$wg$aCamelidae
=667  \\$aIM; qualif permitted
=680  \\$iTwo-toed, hoofed mammals with four legs, a big-lipped snout, and a humped back belonging to the family Camelidae.
=688  \\$a2017 (1968)
=750  \0$aCamels$5IEN-HS$0(DLC)sh 85019119

=LDR  00965cz  a2200313n  4500
=001  9880363313002441
=005  20141212195513.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002161
=035  \\$aCAZ5327HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x77.$x380.$x175
=150  \\$aCamelids, New World
=450  \\$wnnna$aAlpaca
=450  \\$aAlpacas
=450  \\$wnnna$aCamelid, New World
=450  \\$wnnna$aGuanaco
=450  \\$aGuanacos
=450  \\$wnnna$aLlama
=450  \\$aLlamas
=450  \\$wnnna$aNew World Camelid
=450  \\$wnnna$aNew World Camelids
=550  \\$wg$aRuminants
=667  \\$anote X refs; IM; qualif permitted
=680  \\$iRuminant mammals of South America. They are related to camels.
=688  \\$a91(75); was see under ARTIODACTYLA 1975-90
=750  \0$aGuanaco$5IEN-M$0(DLC)sh 85057584
=750  \0$aLlamas$5IEN-HS$0(DLC)sh 85077837
=750  \0$aAlpaca$5IEN-HS$0(DLC)sh 85003800

=LDR  02360cz  a2200517n  4500
=001  9880363313102441
=005  20141212195512.0
=008  850425\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002154
=035  \\$aCAZ5320HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x262.$x500.$x120
=072  \\$aD8.$x811.$x277.$x656.$x300.$x200.$x120
=150  \\$aCalpain
=450  \\$wnnna$aCa2+-Activated Protease
=450  \\$wnnna$aCa2+ Activated Protease
=450  \\$aCalcium-Activated Neutral Protease
=450  \\$wnnna$aCalcium Activated Neutral Protease
=450  \\$wnnna$aCalcium-Activated Neutral Proteinase
=450  \\$wnnna$aCalcium Activated Neutral Proteinase
=450  \\$wnnna$aCalcium-Activated Protease
=450  \\$wnnna$aCalcium Activated Protease
=450  \\$wnnna$aCalcium-Dependent Neutral Protease
=450  \\$wnnna$aCalcium Dependent Neutral Protease
=450  \\$aCalcium-Dependent Neutral Proteinase
=450  \\$wnnna$aCalcium Dependent Neutral Proteinase
=450  \\$wnnna$aCalpain I
=450  \\$wnnna$aCalpain II
=450  \\$wnnna$aDesminase
=450  \\$wnnna$aI, Calpain
=450  \\$wnnna$aII, Calpain
=450  \\$wnnna$aNeutral Protease, Calcium-Activated
=450  \\$wnnna$aNeutral Protease, Calcium-Dependent
=450  \\$wnnna$aNeutral Proteinase, Calcium-Activated
=450  \\$wnnna$aNeutral Proteinase, Calcium-Dependent
=450  \\$wnnna$aProtease, Ca2+-Activated
=450  \\$wnnna$aProtease, Calcium-Activated
=450  \\$wnnna$aProtease, Calcium-Activated Neutral
=450  \\$wnnna$aProtease, Calcium-Dependent Neutral
=450  \\$wnnna$aProteinase, Calcium-Activated Neutral
=450  \\$wnnna$aProteinase, Calcium-Dependent Neutral
=550  \\$wg$aCysteine Endopeptidases
=667  \\$a/biosyn /physiol permitted
=680  \\$iCysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4.
=688  \\$a86
=750  \0$aCalpain$5IEN-M$0(DLC)sh 90000818

=LDR  00964cz  a2200265n  4500
=001  9880363313202441
=005  20141212195511.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002153
=035  \\$aCAZ5319HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x145.$x250
=150  \\$aCalorimetry, Indirect
=450  \\$wnnna$aCalorimetries, Indirect
=450  \\$wnnna$aCalorimetries, Respiration
=450  \\$aCalorimetry, Respiration
=450  \\$wnnna$aIndirect Calorimetries
=450  \\$wnnna$aIndirect Calorimetry
=450  \\$wnnna$aRespiration Calorimetries
=450  \\$wnnna$aRespiration Calorimetry
=550  \\$wg$aCalorimetry
=667  \\$aan anal chem technique; NIM
=680  \\$iCalculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.
=688  \\$a91(75); was see under CALORIMETRY 1975-90
=750  \0$aIndirect calorimetry$5IEN$0(DLC)sh 88004418

=LDR  02438cz  a2200505n  4500
=001  9880363313402441
=005  20141212195510.0
=008  780308\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002147
=035  \\$aCAZ5313HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x360.$x381.$x249
=072  \\$aD12.$x776.$x157.$x125.$x412.$x249
=072  \\$aD12.$x776.$x476.$x387.$x249
=150  \\$aCalmodulin
=450  \\$wnnna$aActivating Factor, Phosphodiesterase
=450  \\$wnnna$aActivator, Cyclic AMP-Phosphodiesterase
=450  \\$wnnna$aActivator, Phosphodiesterase Protein
=450  \\$wnnna$aActivator Protein, Bovine
=450  \\$wnnna$aActivator Protein, Calcium-Dependent
=450  \\$wnnna$aActivator Protein, Phosphodiesterase
=450  \\$wnnna$aAMP-Phosphodiesterase Activator, Cyclic
=450  \\$wnnna$aBovine Activator Protein
=450  \\$aCalcium-Dependent Activator Protein
=450  \\$wnnna$aCalcium Dependent Activator Protein
=450  \\$aCalcium-Dependent Regulator
=450  \\$wnnna$aCalcium Dependent Regulator
=450  \\$wnnna$aCyclic AMP-Phosphodiesterase Activator
=450  \\$wnnna$aCyclic AMP Phosphodiesterase Activator
=450  \\$wnnna$aFactor, Phosphodiesterase Activating
=450  \\$wnnna$aPhosphodiesterase Activating Factor
=450  \\$wnnna$aPhosphodiesterase Activator Protein
=450  \\$wnnna$aPhosphodiesterase Protein Activator
=450  \\$wnnna$aProtein Activator, Phosphodiesterase
=450  \\$wnnna$aProtein, Bovine Activator
=450  \\$wnnna$aProtein, Calcium-Dependent Activator
=450  \\$wnnna$aProtein, Phosphodiesterase Activator
=450  \\$wnnna$aRegulator, Calcium-Dependent
=450  \\$wnnna$aRegulator, Calcium Dependent
=550  \\$wg$aIntracellular Calcium-Sensing Proteins
=550  \\$aCalcium Signaling
=667  \\$aa calcium-binding protein; /biosyn /physiol permitted
=680  \\$iA heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.
=688  \\$a84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979
=750  \0$aCalmodulin$0(DLC) sh 85019015$5IEN

=LDR  00758cz  a2200241n  4500
=001  9880363313502441
=005  20141212195509.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002146
=035  \\$aCAZ5312HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA10.$x165.$x265.$x200
=150  \\$aBony Callus
=450  \\$aCallus
=450  \\$wnnna$aCallus, Bony
=550  \\$wg$aBone and Bones
=550  \\$aBone Regeneration
=550  \\$aFracture Healing
=550  \\$aOsteogenesis
=667  \\$apost-fract bone formation; do not confuse with "callous" ( = CALLOSITIES)
=680  \\$iThe bony deposit formed between and around the broken ends of BONE FRACTURES during normal healing.
=688  \\$a2000(1973)
=750  \0$aCallus$5IEN$0(DLC)sh 85019013

=LDR  01346cz  a2200373n  4500
=001  9880363313602441
=005  20141212195509.0
=008  800507\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002144
=035  \\$aCAZ5310HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x801.$x400.$x600.$x150.$x150.$x114
=150  \\$aCallithrix
=450  \\$aCallithrix jacchus
=450  \\$aCebuella
=450  \\$wnnna$aCebuellas
=450  \\$wnnna$aCommon Marmoset
=450  \\$wnnna$aCommon Marmosets
=450  \\$aHapale
=450  \\$wnnna$aMarmoset
=450  \\$aMarmoset, Common
=450  \\$aMarmoset, Short-Tusked
=450  \\$wnnna$aMarmoset, Short Tusked
=450  \\$aMarmosets
=450  \\$wnnna$aMarmosets, Common
=450  \\$wnnna$aMarmosets, Short-Tusked
=450  \\$wnnna$aShort-Tusked Marmoset
=450  \\$wnnna$aShort-Tusked Marmosets
=550  \\$wg$aCallitrichinae
=667  \\$aindex NIM with no qualifiers when an experimental animal; diseases: coordinate IM with MONKEY DISEASES (IM)
=680  \\$iA genus of the subfamily CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing seventeen species.
=688  \\$a1992 (1981); for CEBUELLA use CALLITRICHIDAE 1981-2005
=688  \\$a92(81); was see under CALLITHRICIDAE 1981-91
=750  \0$aCallithrix$5IEN-M$0(DLC)sh 85019004

=LDR  00841cz  a2200229n  4500
=001  9880363313702441
=005  20141212195508.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002142
=035  \\$aCAZ5308HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x268.$x33.$x150
=072  \\$aD1.$x268.$x271.$x100.$x150
=072  \\$aD1.$x268.$x556.$x156
=072  \\$aD1.$x552.$x20.$x200
=072  \\$aD1.$x552.$x544.$x156
=150  \\$aCalifornium
=550  \\$wg$aActinoid Series Elements
=550  \\$wg$aMetals, Heavy
=667  \\$aman-made radioactive element; IM
=680  \\$iCalifornium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.
=750  \0$aCalifornium$5IEN$0(DLC)sh 89004338

=LDR  01262cz  a2200313n  4500
=001  9880363313802441
=005  20141212195508.0
=008  741111\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D002141
=035  \\$aCAZ5307HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x87.$x640.$x300
=072  \\$aB4.$x909.$x777.$x147.$x640.$x300
=072  \\$aB4.$x909.$x777.$x270.$x100
=150  \\$aEncephalitis Virus, California
=450  \\$aCalifornia encephalitis virus
=450  \\$wnnna$aCalifornia Encephalitis Viruses
=450  \\$wnnna$aCalifornia Group Viruses
=450  \\$wnnna$aCalifornia Virus
=450  \\$wnnna$aEncephalitis Viruses, California
=450  \\$aJamestown Canyon virus
=450  \\$aTahyna virus
=550  \\$wg$aEncephalitis Viruses
=550  \\$wg$aOrthobunyavirus
=550  \\$wh$aLa Crosse virus
=667  \\$ainfection = ENCEPHALITIS, CALIFORNIA
=680  \\$iA species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. Serotypes are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several serotypes infect humans.
=688  \\$a2002 (1977)
=750  \0$aCalifornia group viruses$5IEN$0(DLC)sh 85018907

=LDR  00653cz  a2200181n  4500
=001  9880363313902441
=005  20141212195412.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001951
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x510.$x24.$x49.$x100
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x550
=150  \\$aBrevibacterium
=550  \\$wg$aActinobacteria
=550  \\$wg$aActinomycetales
=667  \\$ain soil, water, dairy prod & decaying matter
=680  \\$iA gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.
=750  \0$aBrevibacterium$5IEN$0(DLC)sh 85016763

=LDR  00967cz  a2200253n  4500
=001  9880363314002441
=005  20141212195411.0
=008  750723\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001950
=035  \\$aCAZ5115HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD2.$x92.$x877.$x96.$x333.$x150
=072  \\$aD2.$x675.$x276.$x175.$x150
=150  \\$aBretylium Tosylate
=450  \\$wnnna$aBretylate
=450  \\$wnnna$aBretylium Tosilate
=450  \\$wnnna$aBretylol
=450  \\$wnnna$aDu Pont Brand of Bretylium Tosilate
=450  \\$wnnna$aGlaxoSmithKline Brand of Bretylium Tosilate
=450  \\$wnnna$aOrnid
=550  \\$wg$aBretylium Compounds
=680  \\$iAn agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.
=688  \\$a91(76); was see under BRETYLIUM COMPOUNDS 1976-90
=750  \0$aBretylium tosylate$5IEN$0(DLC)sh 85016760

=LDR  00779cz  a2200253n  4500
=001  9880363314102441
=005  20171012161008.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001947
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE5.$x820.$x150
=072  \\$aG5.$x90
=150  \\$aBreeding
=450  \\$wnnna$aBreedings
=550  \\$wg$aGenetic Processes
=550  \\$wg$aReproductive Techniques
=550  \\$wh$aEstrus Detection
=550  \\$wh$aEstrus Synchronization
=550  \\$wh$aHybridization, Genetic
=550  \\$wh$aInbreeding
=550  \\$wh$aSelective Breeding
=667  \\$aanimals & plants only
=680  \\$iThe production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants.
=750  \0$aBreeding$5IEN-M$0(DLC)sh 85016717

=LDR  01664cz  a2200397n  4500
=001  9880363314202441
=005  20141212195410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001946
=035  \\$aCAZ5111HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC13.$x703.$x420.$x183
=072  \\$aG8.$x686.$x520.$x150
=072  \\$aG8.$x686.$x785.$x760.$x769.$x326.$x520.$x150
=150  \\$aBreech Presentation
=450  \\$wnnna$aBreech, Complete
=450  \\$aBreech Delivery$5IEN
=450  \\$wnnna$aBreech Fetal Presentation
=450  \\$wnnna$aBreech, Incomplete
=450  \\$wnnna$aBreech Labor Presentation
=450  \\$wnnna$aBreech Presentation, Frank
=450  \\$wnnna$aComplete Breech
=450  \\$aFetal Presentation, Breech
=450  \\$wnnna$aFrank Breech Presentation
=450  \\$wnnna$aIncomplete Breech
=450  \\$aLabor Presentation, Breech
=450  \\$aPresentation, Breech
=450  \\$wnnna$aPresentation, Breech Fetal
=450  \\$wnnna$aPresentation, Breech Labor
=450  \\$wnnna$aPresentation, Frank Breech
=550  \\$wg$aLabor Presentation
=550  \\$wg$aObstetric Labor Complications
=667  \\$acheck the tags FEMALE & PREGNANCY
=680  \\$iA malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.
=688  \\$a85(75); was see under LABOR PRESENTATION 1963-84
=750  \0$aBreech delivery$5IEN$0(DLC)sh 85016712

=LDR  00866cz  a2200253n  4500
=001  9880363314302441
=005  20141212195410.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001945
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x525.$x186
=072  \\$aE2.$x779.$x474.$x124
=150  \\$aBreathing Exercises
=450  \\$wnnna$aExercise, Breathing
=450  \\$wnnna$aMuscle Training, Respiratory
=450  \\$aRespiratory Muscle Training
=450  \\$wnnna$aTraining, Respiratory Muscle
=550  \\$wg$aExercise Movement Techniques
=550  \\$wg$aMind-Body Therapies
=550  \\$wh$aQigong
=550  \\$aRespiration
=550  \\$aRespiratory Therapy
=680  \\$iTherapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration.
=750  \0$aBreathing exercises$5IEN$0(DLC)sh 85016700

=LDR  00770cz  a2200277n  4500
=001  9880363314402441
=005  20141212195409.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001944
=035  \\$aCAZ5109HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x100
=150  \\$aBreath Tests
=450  \\$wnnna$aBreath Test
=450  \\$wnnna$aBreathalyzer Test
=450  \\$aBreathalyzer Tests
=450  \\$wnnna$aTest, Breath
=450  \\$wnnna$aTest, Breathalyzer
=450  \\$wnnna$aTests, Breath
=450  \\$wnnna$aTests, Breathalyzer
=550  \\$wg$aDiagnostic Techniques and Procedures
=550  \\$aRespiration
=667  \\$aNIM
=680  \\$iAny tests done on exhaled air.
=688  \\$a74
=750  \0$aBreath tests$5IEN$0(DLC)sh 87000075

=LDR  02302cz  a2200625n  4500
=001  9880363314502441
=005  20180316105253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001943
=035  \\$aCAZ5108HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x180
=072  \\$aC17.$x800.$x90.$x500
=150  \\$aBreast Neoplasms
=450  \\$aBreast Cancer
=450  \\$wnnna$aBreast Carcinoma
=450  \\$wnnna$aBreast Neoplasm
=450  \\$wnnna$aBreast Tumor
=450  \\$aBreast Tumors
=450  \\$wnnna$aCancer, Breast
=450  \\$aCancer of Breast
=450  \\$wnnna$aCancer of the Breast
=450  \\$wnnna$aCarcinoma, Human Mammary
=450  \\$wnnna$aCarcinomas, Human Mammary
=450  \\$wnnna$aHuman Mammary Carcinoma
=450  \\$wnnna$aHuman Mammary Carcinomas
=450  \\$wnnna$aHuman Mammary Neoplasm
=450  \\$wnnna$aHuman Mammary Neoplasms
=450  \\$wnnna$aMalignant Neoplasm of Breast
=450  \\$wnnna$aMalignant Tumor of Breast
=450  \\$wnnna$aMammary Cancer
=450  \\$wnnna$aMammary Carcinoma, Human
=450  \\$wnnna$aMammary Carcinomas, Human
=450  \\$wnnna$aMammary Neoplasm, Human
=450  \\$wnnna$aMammary Neoplasms, Human
=450  \\$wnnna$aNeoplasm, Breast
=450  \\$wnnna$aNeoplasm, Human Mammary
=450  \\$wnnna$aNeoplasms, Breast
=450  \\$wnnna$aNeoplasms, Human Mammary
=450  \\$wnnna$aTumor, Breast
=450  \\$wnnna$aTumors, Breast
=550  \\$wg$aBreast Diseases
=550  \\$wg$aNeoplasms by Site
=550  \\$wh$aBreast Carcinoma In Situ
=550  \\$wh$aBreast Neoplasms, Male
=550  \\$wh$aCarcinoma, Ductal, Breast
=550  \\$wh$aCarcinoma, Lobular
=550  \\$wh$aHereditary Breast and Ovarian Cancer Syndrome
=550  \\$wh$aInflammatory Breast Neoplasms
=550  \\$wh$aTriple Negative Breast Neoplasms
=550  \\$wh$aUnilateral Breast Neoplasms
=667  \\$ahuman only; BREAST NEOPLASMS, MALE is also available; for animal use MAMMARY NEOPLASMS, ANIMAL or MAMMARY NEOPLASMS, EXPERIMENTAL: Manual 24.5+, 24.6+; coordinate IM with histological type of neoplasm (IM)
=680  \\$iTumors or cancer of the human BREAST.
=750  \0$aBreast$xTumors$5IEN-M$0(DLC)sh 85016690
=750  \0$aBreast$xCancer$5IEN-HS$0(DLC)sh 85016679

=LDR  01089cz  a2200337n  4500
=001  9880363314602441
=005  20141212195408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001942
=035  \\$aCAZ5107HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x145.$x407.$x199
=072  \\$aG7.$x610.$x220.$x500.$x500
=072  \\$aG7.$x610.$x593.$x185
=072  \\$aG7.$x700.$x620.$x185
=150  \\$aBreast Feeding
=450  \\$wnnna$aBreast Feeding, Exclusive
=450  \\$wnnna$aBreastfeeding
=450  \\$wnnna$aBreastfeeding, Exclusive
=450  \\$wnnna$aExclusive Breast Feeding
=450  \\$wnnna$aExclusive Breastfeeding
=450  \\$wnnna$aFeeding, Breast
=550  \\$wg$aFeeding Behavior
=550  \\$wg$aInfant Nutritional Physiological Phenomena
=550  \\$wg$aNutrition Processes
=550  \\$wh$aBreast Milk Expression
=550  \\$aLactation
=550  \\$aMilk, Human
=667  \\$ahuman only; /adv eff: refers to effect on infant or mother
=680  \\$iThe nursing of an infant at the breast.
=750  \0$aBreastfeeding$5IEN$0(DLC)sh 85016691

=LDR  01168cz  a2200349n  4500
=001  9880363314702441
=005  20141212195408.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001941
=035  \\$aCAZ5106HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC17.$x800.$x90
=150  \\$aBreast Diseases
=450  \\$wnnna$aBreast Disease
=450  \\$wnnna$aBreast Disease, Endocrine
=450  \\$wnnna$aBreast Diseases, Endocrine
=450  \\$wnnna$aDisease, Breast
=450  \\$wnnna$aDisease, Endocrine Breast
=450  \\$wnnna$aDiseases, Breast
=450  \\$wnnna$aDiseases, Endocrine Breast
=450  \\$wnnna$aEndocrine Breast Disease
=450  \\$wnnna$aEndocrine Breast Diseases
=550  \\$wg$aSkin Diseases
=550  \\$wh$aBreast Cyst
=550  \\$wh$aBreast Neoplasms
=550  \\$wh$aFibrocystic Breast Disease
=550  \\$wh$aGynecomastia
=550  \\$wh$aLactation Disorders
=550  \\$wh$aMastitis
=667  \\$ainflamm dis = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE
=680  \\$iPathological processes of the BREAST.
=750  \0$aBreast$xDiseases$5IEN$0(DLC)sh 85016683

=LDR  00972cz  a2200217n  4500
=001  9880363314802441
=005  20141212195407.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001940
=035  \\$aCAZ5105HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA1.$x236
=150  \\$aBreast
=360  \\$iconsider also terms at$aMAMMA-$aMAST-
=450  \\$wnnna$aBreasts
=550  \\$wg$aBody Regions
=550  \\$wh$aMammary Glands, Human
=550  \\$wh$aNipples
=667  \\$ahuman only; animal is MAMMARY GLANDS, ANIMAL; /surg: consider also MASTECTOMY & MAMMAPLASTY; inflammation = MASTITIS; tuberc of breast = MASTITIS (IM) + TUBERCULOSIS (IM), not TUBERCULOSIS, ENDOCRINE; self-examination = BREAST SELF-EXAMINATION
=680  \\$iIn humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.
=750  \0$aBreast$5IEN-HS$0(DLC)sh 85016677

=LDR  00683cz   2200181n  4500
=001  9880363314902441
=005  20230831162253.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001939
=035  \\$aCAZ5104HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aJ2.$x500.$x100
=150  \\$aBread
=450  \\$wnnna$aBreads
=550  \\$wg$aFood
=680  \\$iBaked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.
=750  \0$aBread$5IEN$0(DLC)sh 85016646
=750  \0$iNarrower mapping$aBannocks (Bread)$0(DLC)sh2022007089$4NM$5IEN-M

=LDR  01418cz  a2200325n  4500
=001  9880363315002441
=005  20141212195407.0
=008  770427\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001937
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x100.$x157.$x200
=072  \\$aJ2.$x500.$x850.$x150
=150  \\$aBrassica
=450  \\$aBroccoli
=450  \\$aBrussel Sprout
=450  \\$aCabbage
=450  \\$wnnna$aCabbages
=450  \\$aCauliflower
=450  \\$aCollard Green
=450  \\$wnnna$aCollard Greens
=450  \\$aKale
=550  \\$wg$aBrassicaceae
=550  \\$wg$aVegetables
=550  \\$wh$aBrassica napus
=550  \\$wh$aBrassica rapa
=550  \\$wh$aMustard Plant
=667  \\$aGEN or unspecified; prefer specifics; note common names as X refs; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATIONS or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA plant genus of the family Cruciferae. It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; (B. alba, B. junica, and B. nigra), turnips (BRASSICA NAPUS) and rapeseed (BRASSICA RAPA).
=688  \\$a78
=750  \0$aBrassica$5IEN$0(DLC)sh 86001831

=LDR  00925cz  a2200289n  4500
=001  9880363315102441
=005  20141212192031.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001933
=035  \\$aCAZ5098HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211.$x132
=150  \\$aBrain Stem
=450  \\$wnnna$aBrain Stems
=450  \\$wnnna$aBrainstem
=450  \\$wnnna$aBrainstems
=450  \\$wnnna$aCerebri, Truncus
=450  \\$wnnna$aCerebrus, Truncus
=450  \\$wnnna$aTruncus Cerebri
=450  \\$wnnna$aTruncus Cerebrus
=550  \\$wg$aBrain
=550  \\$wh$aMesencephalon
=550  \\$wh$aReticular Formation
=550  \\$wh$aRhombencephalon
=550  \\$wh$aTrigeminal Nuclei
=680  \\$iThe part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.
=750  \0$aBrain stem$5IEN$0(DLC)sh 85016367

=LDR  03793cz  a2200925n  4500
=001  9880363315202441
=005  20141212195405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001932
=035  \\$aCAZ5097HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC4.$x588.$x614.$x250.$x195
=072  \\$aC10.$x228.$x140.$x211
=072  \\$aC10.$x551.$x240.$x250
=150  \\$aBrain Neoplasms
=450  \\$wnnna$aBenign Brain Neoplasm
=450  \\$wnnna$aBenign Brain Neoplasms
=450  \\$wnnna$aBenign Neoplasm, Brain
=450  \\$wnnna$aBenign Neoplasms, Brain
=450  \\$wnnna$aBrain Benign Neoplasm
=450  \\$wnnna$aBrain Benign Neoplasms
=450  \\$aBrain Cancer
=450  \\$wnnna$aBrain Cancers
=450  \\$wnnna$aBrain Malignant Neoplasm
=450  \\$wnnna$aBrain Malignant Neoplasms
=450  \\$wnnna$aBrain Neoplasm
=450  \\$wnnna$aBrain Neoplasm, Benign
=450  \\$wnnna$aBrain Neoplasm, Malignant
=450  \\$wnnna$aBrain Neoplasm, Primary
=450  \\$wnnna$aBrain Neoplasms, Benign
=450  \\$wnnna$aBrain Neoplasms, Malignant
=450  \\$wnnna$aBrain Neoplasms, Malignant, Primary
=450  \\$wnnna$aBrain Neoplasms, Primary
=450  \\$wnnna$aBrain Neoplasms, Primary Malignant
=450  \\$wnnna$aBrain Tumor
=450  \\$wnnna$aBrain Tumor, Primary
=450  \\$wnnna$aBrain Tumor, Recurrent
=450  \\$aBrain Tumors
=450  \\$wnnna$aBrain Tumors, Primary
=450  \\$wnnna$aBrain Tumors, Recurrent
=450  \\$wnnna$aCancer, Brain
=450  \\$aCancer of Brain
=450  \\$wnnna$aCancer of the Brain
=450  \\$wnnna$aCancers, Brain
=450  \\$wnnna$aIntracranial Neoplasm
=450  \\$wnnna$aIntracranial Neoplasms
=450  \\$wnnna$aMalignant Brain Neoplasm
=450  \\$wnnna$aMalignant Brain Neoplasms
=450  \\$wnnna$aMalignant Neoplasm, Brain
=450  \\$wnnna$aMalignant Neoplasms, Brain
=450  \\$wnnna$aMalignant Primary Brain Neoplasms
=450  \\$aMalignant Primary Brain Tumors
=450  \\$wnnna$aNeoplasm, Brain
=450  \\$wnnna$aNeoplasm, Intracranial
=450  \\$wnnna$aNeoplasms, Brain
=450  \\$wnnna$aNeoplasms, Brain, Benign
=450  \\$wnnna$aNeoplasms, Brain, Malignant
=450  \\$wnnna$aNeoplasms, Brain, Primary
=450  \\$aNeoplasms, Intracranial
=450  \\$wnnna$aPrimary Brain Neoplasm
=450  \\$wnnna$aPrimary Brain Neoplasms
=450  \\$wnnna$aPrimary Brain Tumor
=450  \\$wnnna$aPrimary Brain Tumors
=450  \\$wnnna$aPrimary Malignant Brain Neoplasms
=450  \\$wnnna$aPrimary Malignant Brain Tumors
=450  \\$wnnna$aRecurrent Brain Tumor
=450  \\$wnnna$aRecurrent Brain Tumors
=450  \\$wnnna$aTumor, Brain
=450  \\$wnnna$aTumors, Brain
=550  \\$wg$aBrain Diseases
=550  \\$wg$aCentral Nervous System Neoplasms
=550  \\$wh$aCerebral Ventricle Neoplasms
=550  \\$wh$aInfratentorial Neoplasms
=550  \\$wh$aNeurocytoma
=550  \\$wh$aPinealoma
=550  \\$wh$aSupratentorial Neoplasms
=667  \\$a/blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain (IM) + histol type of neopl (IM)
=680  \\$iNeoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
=750  \0$aBrain$xCancer$5IEN-M$0(DLC)sh 85016329
=750  \0$aBrain$xTumors$5IEN-HS$0(DLC)sh 85016351

=LDR  01102cz  a2200313n  4500
=001  9880363315302441
=005  20141212195404.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001931
=035  \\$aCAZ5096HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x875.$x500
=072  \\$aE1.$x370.$x376.$x537.$x625.$x500
=072  \\$aE5.$x629.$x875.$x500
=150  \\$aBrain Mapping
=450  \\$aBrain Electrical Activity Mapping
=450  \\$wnnna$aBrain Mapping, Topographic
=450  \\$aFunctional Cerebral Localization
=450  \\$wnnna$aFunctional Cerebral Localizations
=450  \\$wnnna$aMapping, Brain
=450  \\$wnnna$aMapping, Topographic Brain
=450  \\$aTopographic Brain Mapping
=550  \\$wg$aFunctional Neuroimaging
=550  \\$wh$aConnectome
=550  \\$aStereotaxic Techniques
=667  \\$acoordinate with specific part of brain/ physiol
=680  \\$iImaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
=688  \\$a68(64)
=750  \0$aBrain mapping$5IEN$0(DLC)sh 88004413

=LDR  02305cz  a2200529n  4500
=001  9880363315402441
=005  20180315183858.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001930
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x199
=072  \\$aC10.$x900.$x300.$x87
=072  \\$aC26.$x915.$x300.$x200
=150  \\$aBrain Injuries
=450  \\$wnnna$aAcute Brain Injuries
=450  \\$wnnna$aAcute Brain Injury
=450  \\$aBrain$xinjuries
=450  \\$wnnna$aBrain Injuries, Acute
=450  \\$wnnna$aBrain Injuries, Focal
=450  \\$wnnna$aBrain Injury
=450  \\$wnnna$aBrain Injury, Acute
=450  \\$wnnna$aBrain Injury, Focal
=450  \\$wnnna$aBrain Laceration
=450  \\$aBrain Lacerations
=450  \\$wnnna$aFocal Brain Injuries
=450  \\$wnnna$aFocal Brain Injury
=450  \\$wnnna$aInjuries, Acute Brain
=450  \\$wnnna$aInjuries, Brain
=450  \\$wnnna$aInjuries, Focal Brain
=450  \\$wnnna$aInjury, Acute Brain
=450  \\$wnnna$aInjury, Brain
=450  \\$wnnna$aInjury, Focal Brain
=450  \\$wnnna$aLaceration, Brain
=450  \\$wnnna$aLacerations, Brain
=550  \\$wg$aBrain Diseases
=550  \\$wg$aCraniocerebral Trauma
=550  \\$wh$aBrain Hemorrhage, Traumatic
=550  \\$wh$aBrain Injuries, Diffuse
=550  \\$wh$aBrain Injuries, Traumatic
=550  \\$wh$aBrain Injury, Chronic
=550  \\$wh$aEpilepsy, Post-Traumatic
=550  \\$wh$aPneumocephalus
=550  \\$wh$aShaken Baby Syndrome
=667  \\$ageneral or unspecified; consider also /inj with specific parts of the brain; entry term BRAIN CONTUSION: do not coordinate with CONTUSIONS; do not confuse with CRANIOCEREBRAL TRAUMA
=680  \\$iAcute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
=688  \\$a1981(1963); for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999
=750  \0$aBrain$xWounds and injuries$5IEN-HS$0(DLC)sh 85016354

=LDR  01922cz  a2200445n  4500
=001  9880363315502441
=005  20141212195402.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001929
=035  \\$aCAZ5094HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x187
=150  \\$aBrain Edema
=450  \\$wnnna$aBrain Edema, Cytotoxic
=450  \\$wnnna$aBrain Edema, Vasogenic
=450  \\$aBrain Swelling
=450  \\$wnnna$aBrain Swellings
=450  \\$aCerebral Edema
=450  \\$wnnna$aCerebral Edema, Cytotoxic
=450  \\$wnnna$aCerebral Edema, Vasogenic
=450  \\$wnnna$aCerebral Edemas, Vasogenic
=450  \\$aCytotoxic Brain Edema
=450  \\$wnnna$aCytotoxic Cerebral Edema
=450  \\$wnnna$aEdema, Brain
=450  \\$wnnna$aEdema, Cerebral
=450  \\$wnnna$aEdema, Cytotoxic Brain
=450  \\$wnnna$aEdema, Cytotoxic Cerebral
=450  \\$wnnna$aEdema, Intracranial
=450  \\$wnnna$aEdema, Vasogenic Brain
=450  \\$wnnna$aEdema, Vasogenic Cerebral
=450  \\$aIntracranial Edema
=450  \\$wnnna$aSwelling, Brain
=450  \\$wnnna$aVasogenic Brain Edema
=450  \\$aVasogenic Cerebral Edema
=550  \\$wg$aBrain Diseases
=550  \\$aEdema
=550  \\$aIntracranial Hypertension
=680  \\$iIncreased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)
=688  \\$a1965(1964)
=750  \0$aCerebral edema$5IEN$0(DLC)sh 85022091

=LDR  02495cz  a2200673n  4500
=001  9880363315602441
=005  20180202114216.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001927
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140
=150  \\$aBrain Diseases
=450  \\$wnnna$aBrain Disease
=450  \\$wnnna$aBrain Disorder
=450  \\$wnnna$aBrain Disorders
=450  \\$wnnna$aCentral Nervous System Disorders, Intracranial
=450  \\$wnnna$aCentral Nervous System Intracranial Disorders
=450  \\$wnnna$aCNS Disorder, Intracranial
=450  \\$wnnna$aCNS Disorders, Intracranial
=450  \\$wnnna$aEncephalon Disease
=450  \\$wnnna$aEncephalon Diseases
=450  \\$aIntracranial Central Nervous System Disorders
=450  \\$wnnna$aIntracranial CNS Disorder
=450  \\$wnnna$aIntracranial CNS Disorders
=550  \\$wg$aCentral Nervous System Diseases
=550  \\$wh$aAcute Febrile Encephalopathy
=550  \\$wh$aAkinetic Mutism
=550  \\$wh$aAmblyopia
=550  \\$wh$aAmnesia, Transient Global
=550  \\$wh$aAuditory Diseases, Central
=550  \\$wh$aBasal Ganglia Diseases
=550  \\$wh$aBrain Abscess
=550  \\$wh$aBrain Damage, Chronic
=550  \\$wh$aBrain Death
=550  \\$wh$aBrain Diseases, Metabolic
=550  \\$wh$aBrain Edema
=550  \\$wh$aBrain Injuries
=550  \\$wh$aBrain Neoplasms
=550  \\$wh$aCerebellar Diseases
=550  \\$wh$aCerebrovascular Disorders
=550  \\$wh$aDementia
=550  \\$wh$aDiffuse Cerebral Sclerosis of Schilder
=550  \\$wh$aEncephalitis
=550  \\$wh$aEncephalomalacia
=550  \\$wh$aEpilepsy
=550  \\$wh$aHeadache Disorders
=550  \\$wh$aHydrocephalus
=550  \\$wh$aHypothalamic Diseases
=550  \\$wh$aHypoxia, Brain
=550  \\$wh$aIntracranial Hypertension
=550  \\$wh$aIntracranial Hypotension
=550  \\$wh$aKluver-Bucy Syndrome
=550  \\$wh$aLeukoencephalopathies
=550  \\$wh$aNeuroaxonal Dystrophies
=550  \\$wh$aSepsis-Associated Encephalopathy
=550  \\$wh$aSubdural Effusion
=550  \\$wh$aThalamic Diseases
=680  \\$iPathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
=750  \0$aBrain$xDiseases$5IEN$0(DLC)sh 85016332

=LDR  01240cz  a2200301n  4500
=001  9880363315702441
=005  20141212195400.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001926
=035  \\$aCAZ5091HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x151
=072  \\$aC10.$x597.$x606.$x358.$x800.$x200.$x100
=072  \\$aC23.$x550.$x260.$x159
=150  \\$aBrain Death
=450  \\$aBrain Dead
=450  \\$wnnna$aBrain Deads
=450  \\$aComa Depasse
=450  \\$wnnna$aComa, Irreversible
=450  \\$wnnna$aDeath, Brain
=450  \\$wnnna$aIrreversible Coma
=550  \\$wg$aBrain Diseases
=550  \\$wg$aComa
=550  \\$wg$aDeath
=550  \\$aDeath
=680  \\$iA state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state (e.g., sedative overdose, hypothermia, etc.) are excluded prior to making the determination of brain death. (From Adams et al., Principles of Neurology, 6th ed, pp348-9)
=688  \\$a1972(1969)
=750  \0$aBrain death$5IEN$0(DLC)sh 85016363

=LDR  01087cz  a2200241n  4500
=001  9880363315802441
=005  20141212195359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001925
=035  \\$aCAZ5090HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x140
=150  \\$aBrain Damage, Chronic
=450  \\$wnnna$aChronic Brain Damage
=450  \\$wnnna$aChronic Encephalopathy
=450  \\$aEncephalopathy, Chronic
=550  \\$wg$aBrain Diseases
=550  \\$wh$aBrain Injury, Chronic
=550  \\$wh$aCerebral Palsy
=550  \\$wh$aPersistent Vegetative State
=667  \\$acoord with specific condition causing damage if pertinent
=680  \\$iA condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
=750  \0$aBrain damage$5IEN$0(DLC)sh 85016357

=LDR  01951cz  a2200469n  4500
=001  9880363315902441
=005  20141212195359.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001924
=035  \\$aCAZ5089HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC10.$x228.$x140.$x199.$x250
=072  \\$aC10.$x900.$x300.$x87.$x125
=072  \\$aC10.$x900.$x300.$x350.$x300
=072  \\$aC26.$x260.$x118.$x150
=072  \\$aC26.$x915.$x300.$x200.$x150
=072  \\$aC26.$x974.$x150
=072  \\$aC26.$x974.$x382.$x200
=150  \\$aBrain Concussion
=450  \\$wnnna$aBrain Concussions
=450  \\$aCerebral Concussion
=450  \\$wnnna$aCerebral Concussions
=450  \\$wnnna$aCommotio Cerebri
=450  \\$wnnna$aConcussion, Brain
=450  \\$wnnna$aConcussion, Cerebral
=450  \\$wnnna$aConcussion, Intermediate
=450  \\$wnnna$aConcussion, Mild
=450  \\$wnnna$aConcussion, Severe
=450  \\$wnnna$aIntermediate Concussion
=450  \\$wnnna$aIntermediate Concussions
=450  \\$wnnna$aMild Concussion
=450  \\$wnnna$aMild Concussions
=450  \\$wnnna$aSevere Concussion
=450  \\$wnnna$aSevere Concussions
=550  \\$wg$aBrain Injuries
=550  \\$wg$aHead Injuries, Closed
=550  \\$wg$aWounds, Nonpenetrating
=550  \\$wh$aContrecoup Injury
=550  \\$wh$aPost-Concussion Syndrome
=680  \\$iA nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)
=688  \\$a65(63)
=750  \0$aBrain$xConcussion$5IEN$0(DLC)sh 85016330

=LDR  01124cz  a2200265n  4500
=001  9880363316002441
=005  20170608132144.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001923
=035  \\$aCAZ5088HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG2.$x111.$x150
=072  \\$aG3.$x185
=150  \\$aBrain Chemistry
=450  \\$wnnna$aBrain Chemistries
=450  \\$aBrain$xchemistry
=450  \\$wnnna$aChemistries, Brain
=450  \\$wnnna$aChemistry, Brain
=550  \\$wg$aBiochemical Phenomena
=550  \\$wg$aMetabolism
=550  \\$aChemistry
=667  \\$adifferentiate from BRAIN /metab; consider also /chem with specific parts of the brain but probably as NIM with BRAIN CHEMISTRY (IM) if site is merely locational & illustrative
=680  \\$iChanges in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states.
=688  \\$a65
=750  \0$aBrain chemistry$5IEN$0(DLC)sh 85016356

=LDR  02629cz  a2200589n  4500
=001  9880363316102441
=005  20141212195358.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001922
=035  \\$aCAZ5087HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x200.$x100
=072  \\$aC1.$x323
=072  \\$aC1.$x539.$x830.$x25.$x160
=072  \\$aC10.$x228.$x140.$x116
=072  \\$aC10.$x228.$x228.$x90
=072  \\$aC10.$x228.$x228.$x180.$x100
=150  \\$aBrain Abscess
=450  \\$wnnna$aAbscess, Brain
=450  \\$wnnna$aAbscess, Cerebral
=450  \\$wnnna$aAbscess, Child Brain
=450  \\$wnnna$aAbscess, Multiple Brain
=450  \\$wnnna$aAbscess, Pyogenic Brain
=450  \\$wnnna$aAbscesses, Cerebral
=450  \\$wnnna$aAbscesses, Multiple Brain
=450  \\$wnnna$aBrain Abscess, Child
=450  \\$wnnna$aBrain Abscess, Multiple
=450  \\$wnnna$aBrain Abscess, Pyogenic
=450  \\$wnnna$aBrain Abscess, Sterile
=450  \\$wnnna$aBrain Abscesses
=450  \\$wnnna$aBrain Abscesses, Multiple
=450  \\$wnnna$aBrain Abscesses, Pyogenic
=450  \\$wnnna$aBrain Abscesses, Sterile
=450  \\$wnnna$aCerebral Abscess
=450  \\$wnnna$aCerebral Abscesses
=450  \\$wnnna$aChild Brain Abscess
=450  \\$wnnna$aMultiple Brain Abscess
=450  \\$wnnna$aMultiple Brain Abscesses
=450  \\$wnnna$aPyogenic Brain Abscess
=450  \\$wnnna$aPyogenic Brain Abscesses
=450  \\$wnnna$aSterile Brain Abscess
=450  \\$wnnna$aSterile Brain Abscesses
=550  \\$wg$aAbscess
=550  \\$wg$aBacterial Infections and Mycoses
=550  \\$wg$aBrain Diseases
=550  \\$wg$aCentral Nervous System Bacterial Infections
=550  \\$wg$aCentral Nervous System Infections
=550  \\$wh$aToxoplasmosis, Cerebral
=550  \\$aEmpyema, Subdural
=667  \\$acoord IM with specific infection (IM) + specific CNS infect term (IM) + site/dis term (IM) if pertinent
=680  \\$iA circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)
=750  \0$aBrain$xAbscess$5IEN$0(DLC)sh 85016321

=LDR  01779cz  a2200337n  4500
=001  9880363316202441
=005  20141212192029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001921
=035  \\$aCAZ5086HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x186.$x211
=150  \\$aBrain
=360  \\$iconsider also terms at$aCEREBR-$aENCEPHAL-
=450  \\$wnnna$aBrains
=450  \\$wnnna$aEncephalon
=450  \\$wnnna$aEncephalons
=550  \\$wg$aCentral Nervous System
=550  \\$wh$aBlood-Brain Barrier
=550  \\$wh$aBrain Stem
=550  \\$wh$aCerebral Ventricles
=550  \\$wh$aGray Matter
=550  \\$wh$aLimbic System
=550  \\$wh$aMesencephalon
=550  \\$wh$aProsencephalon
=550  \\$wh$aRhombencephalon
=550  \\$wh$aWhite Matter
=667  \\$ageneral; /blood supply: consider also CEREBROVASCULAR CIRCULATION; CEREBRAL ARTERIES; CEREBRAL VEINS; CRANIAL SINUSES; /cytol: do not routinely convert to NEURONS; /surg: consider specific neurosurgical procedures in Category E4; inflammation = ENCEPHALITIS & its specifics; infarct = CEREBRAL INFARCTION; malacia = ENCEPHALOMALACIA; brain-isolated, encéphale isolé, cerveau isolé: index DECEREBRATE STATE
=680  \\$iThe part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
=688  \\$a/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65
=750  \0$aBrain$0(DLC) sh 85016319$5IEN-M

=LDR  02034cz  a2200469n  4500
=001  9880363316302441
=005  20141212195357.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001920
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD12.$x644.$x276.$x812.$x169
=072  \\$aD12.$x644.$x400.$x90
=072  \\$aD12.$x644.$x456.$x193
=072  \\$aD12.$x776.$x467.$x812.$x169
=072  \\$aD12.$x776.$x641.$x650.$x90
=072  \\$aD23.$x469.$x50.$x375.$x110
=072  \\$aD23.$x529.$x812.$x169
=150  \\$aBradykinin
=450  \\$wnnna$aArg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
=450  \\$wnnna$aArg Pro Pro Gly Phe Ser Pro Phe Arg
=450  \\$wnnna$aBradykinin, (1-D-Arg)-Isomer
=450  \\$wnnna$aBradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (2-D-Pro-7-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (2-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (3-D-Pro-7-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (3-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (5-D-Phe-8-D-Phe)-Isomer
=450  \\$wnnna$aBradykinin, (5-D-Phe)-Isomer
=450  \\$wnnna$aBradykinin, (6-D-Ser)-Isomer
=450  \\$wnnna$aBradykinin, (7-D-Pro)-Isomer
=450  \\$wnnna$aBradykinin, (8-D-Phe)-Isomer
=450  \\$wnnna$aBradykinin, (9-D-Arg)-Isomer
=450  \\$wnnna$aBradykinin Acetate, (9-D-Arg)-Isomer
=450  \\$wnnna$aBradykinin Diacetate
=450  \\$wnnna$aBradykinin Hydrochloride
=450  \\$wnnna$aBradykinin Triacetate
=550  \\$wg$aKinins
=550  \\$wg$aNeuropeptides
=550  \\$wg$aOligopeptides
=550  \\$wh$aKallidin
=680  \\$iA nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.
=750  \0$aBradykinin$0(DLC) sh 85016289$5IEN

=LDR  00758cz  a2200205n  4500
=001  9880363316402441
=005  20141212195356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001919
=035  \\$aCAZ5084HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC14.$x280.$x67.$x319
=072  \\$aC23.$x550.$x73.$x300
=150  \\$aBradycardia
=450  \\$aBradyarrhythmia
=450  \\$wnnna$aBradyarrhythmias
=450  \\$wnnna$aBradycardias
=550  \\$wg$aArrhythmias, Cardiac
=680  \\$iCardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
=750  \0$aBradycardia$5IEN$0(DLC)sh 85016288

=LDR  01305cz  a2200349n  4500
=001  9880363316502441
=005  20141212195356.0
=008  790307\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001918
=035  \\$aCAZ5083HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x815.$x150
=150  \\$aBrachytherapy
=450  \\$wnnna$aBrachytherapy, Radioisotope
=450  \\$aCurietherapy
=450  \\$aImplant Radiotherapy
=450  \\$wnnna$aInterstitial Radiotherapy
=450  \\$wnnna$aIntracavity Radiotherapy
=450  \\$aPlaque Therapy, Radioisotope
=450  \\$aRadioisotope Brachytherapy
=450  \\$wnnna$aRadioisotope Plaque Therapy
=450  \\$wnnna$aRadiotherapy, Implant
=450  \\$aRadiotherapy, Interstitial
=450  \\$aRadiotherapy, Intracavity
=450  \\$aRadiotherapy, Surface
=450  \\$wnnna$aSurface Radiotherapy
=450  \\$wnnna$aTherapy, Radioisotope Plaque
=550  \\$wg$aRadiotherapy
=667  \\$aa type of radiother
=680  \\$iA collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
=688  \\$a80
=750  \0$aRadioisotope brachytherapy$5IEN$0(DLC)sh 85110709

=LDR  01031cz  a2200241n  4500
=001  9880363316602441
=005  20141212192029.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001917
=035  \\$aCAZ5082HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aA8.$x800.$x800.$x720.$x50
=150  \\$aBrachial Plexus
=450  \\$wnnna$aPlexus, Brachial
=550  \\$wg$aSpinal Nerves
=550  \\$wh$aMedian Nerve
=550  \\$wh$aMusculocutaneous Nerve
=550  \\$wh$aRadial Nerve
=550  \\$wh$aUlnar Nerve
=550  \\$aBrachial Plexus Block
=667  \\$adis = BRACHIAL PLEXUS NEUROPATHIES; inflammation = BRACHIAL PLEXUS NEURITIS
=680  \\$iThe large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon.
=750  \0$aBrachial plexus$5IEN$0(DLC)sh 85016236

=LDR  00540cz  a2200169n  4500
=001  9880363316702441
=005  20141212195356.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001915
=035  \\$aCAZ5080HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE7.$x858.$x442.$x743.$x319
=150  \\$aBraces
=450  \\$wnnna$aBrace
=550  \\$wg$aOrthotic Devices
=680  \\$iOrthopedic appliances used to support, align, or hold parts of the body in correct position. (Dorland, 28th ed)
=750  \0$aOrthopedic braces$5IEN$0(DLC)sh 85095803

=LDR  00579cz  a2200181n  4500
=001  9880363316802441
=005  20141212195355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001914
=035  \\$aCAZ5079HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x210
=150  \\$aBoxing
=450  \\$wnnna$aBoxings
=550  \\$wg$aSports
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.15.1
=680  \\$iA two-person sport in which the fists are skillfully used to attack and defend.
=750  \0$aBoxing$5IEN$0(DLC)sh 85016186

=LDR  01061cz  a2200229n  4500
=001  9880363316902441
=005  20141212195355.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001912
=035  \\$aCAZ5077HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC2.$x782.$x350.$x675.$x106
=072  \\$aC22.$x196.$x106
=150  \\$aBovine Virus Diarrhea-Mucosal Disease
=450  \\$wnnna$aBovine Virus Diarrhea Mucosal Disease
=450  \\$aMucosal Disease, Bovine Viral Diarrhea
=550  \\$wg$aCattle Diseases
=550  \\$wg$aPestivirus Infections
=667  \\$aDF: BVD DIS
=680  \\$iAcute disease of cattle caused by the bovine viral diarrhea viruses (DIARRHEA VIRUSES, BOVINE VIRAL). Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.
=688  \\$a91(72); was see under CATTLE DISEASES 1972-90
=750  \0$aBovine viral diarrhea$5IEN-M$0(DLC)sh 88001704

=LDR  01198cz  a2200277n  4500
=001  9880363317002441
=005  20141212195354.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001909
=035  \\$aCAZ5074HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x650.$x200.$x600
=072  \\$aB4.$x909.$x574.$x807.$x200.$x600
=072  \\$aB4.$x909.$x777.$x731.$x200.$x600
=150  \\$aLeukemia Virus, Bovine
=450  \\$aBLV
=450  \\$aBovine Leukemia Virus
=450  \\$aCattle Leukemia Virus
=450  \\$wnnna$aLeukemia Virus, Cattle
=450  \\$wnnna$aVirus, Bovine Leukemia
=450  \\$wnnna$aVirus, Cattle Leukemia
=550  \\$wg$aDeltaretrovirus
=667  \\$aa species of the genus DELTARETROVIRUS; infection = ENZOOTIC BOVINE LEUKOSIS
=680  \\$iThe type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis.
=688  \\$a94; was BOVINE LEUKEMIA VIRUS 1977-93 (see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977); was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76
=750  \0$aBovine leukemia virus$5IEN$0(DLC)sh 86006603

=LDR  01590cz  a2200349n  4500
=001  9880363317102441
=005  20141212195354.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001908
=035  \\$aCAZ5073M@
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB4.$x820.$x250.$x700.$x150
=072  \\$aB4.$x909.$x777.$x310.$x700.$x150
=150  \\$aDiarrhea Viruses, Bovine Viral
=450  \\$wnnna$aBovine Diarrhea Virus
=450  \\$wnnna$aBovine Diarrhea Viruses
=450  \\$wnnna$aBovine Pestivirus
=450  \\$wnnna$aBovine Pestiviruses
=450  \\$aBovine Viral Diarrhea Viruses
=450  \\$wnnna$aDiarrhea Virus, Bovine
=450  \\$aDiarrhea Virus, Bovine Viral
=450  \\$wnnna$aDiarrhea Viruses, Bovine
=450  \\$wnnna$aPestiviruses, Bovine
=450  \\$wnnna$aVirus, Bovine Diarrhea
=450  \\$wnnna$aViruses, Bovine Diarrhea
=550  \\$wg$aPestivirus
=550  \\$wh$aDiarrhea Virus 1, Bovine Viral
=550  \\$wh$aDiarrhea Virus 2, Bovine Viral
=667  \\$ahistorical only: prefer specifics; infection = BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE or HEMORRHAGIC SYNDROME, BOVINE
=680  \\$iA group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species (genotypes), BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both (then unrecognized) genotypes.
=688  \\$a2002 (1975)
=750  \0$aBovine viral diarrhea virus$0(DLC)sh2004014655$5IEN-M

=LDR  01108cz  a2200277n  4500
=001  9880363317202441
=005  20141212195353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001907
=035  \\$aCAZ5072HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x400.$x780.$x790.$x125
=072  \\$aC1.$x252.$x400.$x825.$x125
=150  \\$aBoutonneuse Fever
=450  \\$wnnna$aBoutonneuse Fevers
=450  \\$wnnna$aFever, Boutonneuse
=450  \\$wnnna$aFever, Mediterranean Spotted
=450  \\$wnnna$aFevers, Boutonneuse
=450  \\$aMediterranean Spotted Fever
=450  \\$wnnna$aSpotted Fever, Mediterranean
=550  \\$wg$aRickettsia Infections
=550  \\$wg$aTick-Borne Diseases
=667  \\$acaused by RICKETTSIA CONORII
=680  \\$iA febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.
=688  \\$a87(75); was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64
=750  \0$aBoutonneuse fever$5IEN$0(DLC)sh 85016131

=LDR  01975cz  a2200469n  4500
=001  9880363317302441
=005  20141212195353.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001906
=035  \\$aCAZ5071HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aC1.$x252.$x410.$x222.$x151
=072  \\$aC10.$x668.$x758.$x200
=072  \\$aC10.$x720.$x150
=072  \\$aC25.$x723.$x415.$x151
=150  \\$aBotulism
=450  \\$wnnna$aBotulism, Foodborne
=450  \\$wnnna$aBotulism, Infant
=450  \\$aBotulism, Infantile
=450  \\$wnnna$aBotulism, Toxico-Infectious
=450  \\$wnnna$aBotulism, Toxico Infectious
=450  \\$wnnna$aBotulism, Wound
=450  \\$wnnna$aBotulisms, Foodborne
=450  \\$wnnna$aBotulisms, Infant
=450  \\$wnnna$aBotulisms, Wound
=450  \\$wnnna$aFoodborne Botulism
=450  \\$wnnna$aFoodborne Botulisms
=450  \\$wnnna$aInfant Botulism
=450  \\$wnnna$aInfant Botulisms
=450  \\$wnnna$aInfantile Botulism
=450  \\$wnnna$aToxico-Infectious Botulism
=450  \\$wnnna$aToxico Infectious Botulism
=450  \\$wnnna$aWound Botulism
=450  \\$wnnna$aWound Botulisms
=550  \\$wg$aClostridium Infections
=550  \\$wg$aFoodborne Diseases
=550  \\$wg$aNeuromuscular Junction Diseases
=550  \\$wg$aNeurotoxicity Syndromes
=550  \\$aBotulinum Toxins
=667  \\$acoordinate IM with specific Clostridium botulinum type (IM) if pertinent
=680  \\$iA disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)
=750  \0$aBotulism$5IEN$0(DLC)sh 85016076

=LDR  01753cz  a2200361n  4500
=001  9880363317402441
=005  20141212195352.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001905
=035  \\$aCAZ5070HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x480.$x153
=072  \\$aD8.$x811.$x277.$x656.$x675.$x374.$x153
=072  \\$aD12.$x776.$x97.$x156
=072  \\$aD23.$x946.$x123.$x179
=150  \\$aBotulinum Toxins
=450  \\$aBotulin
=450  \\$wnnna$aBotulinum Toxin
=450  \\$aClostridium botulinum Toxins
=450  \\$wnnna$aToxin, Botulinum
=450  \\$wnnna$aToxins, Botulinum
=450  \\$wnnna$aToxins, Clostridium botulinum
=550  \\$wg$aBacterial Proteins
=550  \\$wg$aBacterial Toxins
=550  \\$wg$aMetalloendopeptidases
=550  \\$wh$aBotulinum Toxins, Type A
=550  \\$aBotulism
=550  \\$aCholinergic Agents
=550  \\$aClostridium botulinum
=667  \\$a/antag permitted but consider also BOTULINUM ANTITOXIN
=680  \\$iToxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
=688  \\$a78; was BOTULINUM TOXIN 1969-77 (Prov 1969-71)
=750  \0$aBotulinum toxin$5IEN$0(DLC)sh 85016075

=LDR  00774cz  a2200265n  4500
=001  9880363317502441
=005  20141212195351.0
=008  741119\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001903
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x421.$x150
=072  \\$aF1.$x145.$x407.$x99
=150  \\$aBottle Feeding
=450  \\$wnnna$aBottle Feedings
=450  \\$wnnna$aBottlefeeding
=450  \\$wnnna$aBottlefeedings
=450  \\$wnnna$aFeeding, Bottle
=450  \\$wnnna$aFeedings, Bottle
=550  \\$wg$aFeeding Behavior
=550  \\$wg$aFeeding Methods
=550  \\$aBreast Feeding
=667  \\$ahuman & animal
=680  \\$iUse of nursing bottles for feeding. Applies to humans and animals.
=688  \\$a75
=750  \0$aBottle feeding$5IEN$0(DLC)sh 85016055

=LDR  00770cz  a2200241n  4500
=001  9880363317602441
=005  20141212195351.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001901
=035  \\$aCAZ5066HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aH1.$x158.$x273.$x118
=150  \\$aBotany
=450  \\$aBotanical Chemistry$5IEN
=450  \\$wnnna$aBotanies
=450  \\$aBotanists$5IEN
=550  \\$wg$aBiology
=550  \\$wh$aEthnobotany
=550  \\$wh$aPharmacognosy
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe study of the origin, structure, development, growth, function, genetics, and reproduction of plants.
=750  \0$aBotanists$5IEN-M$0(DLC)sh 85015975
=750  \0$aBotany$5IEN-HS$0(DLC)sh 85015976

=LDR  00794cz  a2200193n  4500
=001  9880363317702441
=005  20141212195350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001898
=035  \\$aCAZ5063HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x711.$x193
=072  \\$aB3.$x851.$x595.$x193
=150  \\$aBorrelia
=550  \\$wg$aSpirochaetaceae
=550  \\$wh$aBorrelia burgdorferi Group
=667  \\$aB. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index under BORRELIA INFECTIONS
=680  \\$iA genus of gram-negative, anaerobic, helical bacteria, various species of which produce RELAPSING FEVER in humans and other animals.
=750  \0$aBorrelia$5IEN$0(DLC)sh 87003149

=LDR  00910cz  a2200301n  4500
=001  9880363317802441
=005  20141212195350.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D001896
=035  \\$aCAZ5061HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aD1.$x132
=072  \\$aD2.$x203
=150  \\$aBoron Compounds
=450  \\$wnnna$aBorides
=450  \\$wnnna$aCompounds, Boron
=450  \\$aOrganoboron Compounds$5IEN
=450  \\$aOrganoboron Polymers$5IEN
=550  \\$wg$aInorganic Chemicals
=550  \\$wg$aOrganic Chemicals
=550  \\$wh$aBoranes
=550  \\$wh$aBoric Acids
=550  \\$wh$aBorinic Acids
=550  \\$wh$aBoronic Acids
=667  \\$aGEN or unspecified; prefer specifics; DF: BORON CPDS
=680  \\$iInorganic or organic compounds that contain boron as an integral part of the molecule.
=688  \\$a68
=750  \0$aBoron compounds$5IEN-HS$0(DLC)sh 89002772

=LDR  01353cz  a2200313n  4500
=001  9881627040102441
=005  20210419182627.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080583
=035  \\$a(NLM)9812405973200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x600.$x75.$x75.$x500
=150  \\$aAteles geoffroyi
=450  \\$aAteles geoffroyi frontatus
=450  \\$aAteles geoffroyi ornatus
=450  \\$aAteles geoffroyi panamensis
=450  \\$aAteles geoffroyi rufiventris
=450  \\$aAteles geoffroyi vellerosus
=450  \\$aAteles geoffroyi yucatanesis
=450  \\$aCentral American Spider Monkey
=450  \\$aGeoffroy's Spider Monkey
=450  \\$wnnna$aGeoffroy Spider Monkey
=450  \\$wnnna$aGeoffroys Spider Monkey
=450  \\$wnnna$aMonkey, Geoffroy's Spider
=450  \\$wnnna$aSpider Monkey, Geoffroy's
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species in the genus ATELES, subfamily ATELINAE, comprising several Mesoamerican spider monkeys including Geoffroy's spider monkey (Ateles geoffroyi geoffroyi). Sometimes referred to as Central American spider monkey, it inhabits rainforest from Mexico to Colombia.
=688  \\$a2020
=750  \0$aCentral American spider monkey$0(DLC) sh 85021897$5IEN-M

=LDR  00595nz  a2200157n  4500
=001  9881627042502441
=005  20210419140618.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080056
=035  \\$a(NLM)9812405931100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x625.$x500
=150  \\$aAraucariaceae
=680  \\$iA family of dioecious or monoecious evergreen trees belonging to the order Pinales, subclass Pinidaes, with spirally arranged, narrow or broad leaves often with parallel veins.
=688  \\$a2020
=750  0\$aAraucariaceae$0(DLC) sh 85006441$IEN-M

=LDR  00745nz  a2200157n  4500
=001  9881627042802441
=005  20210419135910.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080059
=035  \\$a(NLM)9812405926900041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x625.$x500.$x500.$x250
=150  \\$aAraucaria araucana
=680  \\$iAn evergreen tree commonly known as the monkey-puzzle tree. It grows to 1-1.5 m in diameter and 30-40 m in height, and is native to central and southern Chile, and western Argentina. Araucaria araucana is the hardiest among the conifers, and due to its longevity, is often described as a living fossil.
=688  \\$a2020
=750  \0$aMonkey puzzle tree$0(DLC) sh2008001881$5IEN-M

=LDR  00690cz  a2200205n  4500
=001  9881627043002441
=005  20210419134702.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080057
=035  \\$a(NLM)9812405929000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x625.$x500.$x500
=150  \\$aAraucaria
=450  \\$aAraucaria angustifolia
=450  \\$aBrazilian Pine
=450  \\$wnnna$aBrazilian Pines
=450  \\$wnnna$aPine, Brazilian
=680  \\$iA genus of evergreen conifer of the family Araucariaceae, order Pinales, that includes the monkey puzzle (Araucaria araucana).
=688  \\$a2020
=750  \0$aAraucaria$0(DLC) sh 85006439$5IEN-M

=LDR  01455nz  a2200349n  4500
=001  9881635663202441
=005  20210423154007.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081229
=035  \\$a(NLM)9812406149100041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x200
=072  \\$aJ2.$x200.$x200
=150  \\$aArtificially Sweetened Beverages
=450  \\$aDiet Beverages
=450  \\$aDiet Drinks
=450  \\$wnnna$aArtificially Sweetened Beverage
=450  \\$wnnna$aBeverage, Artificially Sweetened
=450  \\$wnnna$aBeverage, Diet
=450  \\$wnnna$aBeverages, Artificially Sweetened
=450  \\$wnnna$aBeverages, Diet
=450  \\$wnnna$aDiet Beverage
=450  \\$wnnna$aDiet Drink
=450  \\$wnnna$aDrink, Diet
=450  \\$wnnna$aDrinks, Diet
=450  \\$wnnna$aSweetened Beverage, Artificially
=450  \\$wnnna$aSweetened Beverages, Artificially
=680  \\$iBeverages sweetened with SWEETENING AGENTS that are synthetic or artificial as opposed to naturally-occurring. Examples of sweetening agents include ASPARTAME, sucralose, and saccharin.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aNonnutritive sweeteners$0(DLC)sh 85092345$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aBeverages$0(DLC)sh 85013504$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aNonnutritive sweeteners  $i and$aBeverages $5 IEN-M

=LDR  01289nz  a2200313n  4500
=001  9881635663402441
=005  20210423150353.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080910
=035  \\$a(NLM)9812406077400041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x900.$x910.$x500
=150  \\$aAmbient Intelligence
=450  \\$aAmbient Assisted Living
=450  \\$aAmbient-Assisted Living
=450  \\$wnnna$aAmbient Assisted Livings
=450  \\$wnnna$aAmbient Intelligences
=450  \\$wnnna$aAmbient-Assisted Livings
=450  \\$wnnna$aAssisted Living, Ambient
=450  \\$wnnna$aAssisted Livings, Ambient
=450  \\$wnnna$aIntelligence, Ambient
=450  \\$wnnna$aIntelligences, Ambient
=450  \\$wnnna$aLiving, Ambient Assisted
=450  \\$wnnna$aLiving, Ambient-Assisted
=450  \\$wnnna$aLivings, Ambient Assisted
=450  \\$wnnna$aLivings, Ambient-Assisted
=680  \\$iAn emerging paradigm in which people are empowered through intelligent (digital) tools embedded in the surrounding environment. These tools proactively support human existence by being sensitive, adaptive, and responsive to the needs, habits, gestures, and emotions of individuals.
=688  \\$a2020
=750  \0$aAmbient Intelligence$0(DLC)sh2005020400$5IEN-M

=LDR  01278cz  a2200277n  4500
=001  9881635666802441
=005  20210423104838.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080532
=035  \\$a(NLM)9812405986700041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x600.$x75.$x50.$x75.$x500
=150  \\$aAlouatta caraya
=450  \\$aBlack Howler Monkey, Paraguayan
=450  \\$aBlack-and-Gold Howler Monkeys
=450  \\$aMono Aullador
=450  \\$aParaguayan Black Howler Monkey
=450  \\$wnnna$aBlack and Gold Howler Monkeys
=450  \\$wnnna$aBlack-and-Gold Howler Monkey
=450  \\$wnnna$aHowler Monkey, Black-and-Gold
=450  \\$wnnna$aMonkey, Black-and-Gold Howler
=450  \\$wnnna$aMono Aulladors
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species of the genus ALOUATTA, family ATELIDAE, inhabiting the forests of South America. Although sometimes known as black howler only adult males have black hair and adult females and juveniles are gold in color. Closely related A. pigra in Central America and A. nigerrima in the Amazon are also called black howlers.
=688  \\$a2020
=750  \0$aBlack howler monkey$0(DLC) sh 85014575$5IEN-M

=LDR  01605cz  a2200373n  4500
=001  9881635667502441
=005  20210422211316.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080549
=035  \\$a(NLM)9812405978800041
=040  \\$aDNLM$cDNLM
=072  \\$aG4.$x11.$x500
=072  \\$aG4.$x146.$x954.$x53
=150  \\$aAutophagic Cell Death
=450  \\$wnnna$aAutophagic Programmed Cell Death
=450  \\$wnnna$aProgrammed Cell Death, Type II
=450  \\$aAutophagy-Dependent Cell Death
=450  \\$wnnna$aAutophagic Cell Deaths
=450  \\$wnnna$aAutophagy Dependent Cell Death
=450  \\$wnnna$aAutophagy-Dependent Cell Deaths
=450  \\$wnnna$aCell Death, Autophagic
=450  \\$wnnna$aCell Death, Autophagy-Dependent
=450  \\$wnnna$aCell Deaths, Autophagic
=450  \\$wnnna$aCell Deaths, Autophagy-Dependent
=450  \\$wnnna$aDeath, Autophagic Cell
=450  \\$wnnna$aDeath, Autophagy-Dependent Cell
=450  \\$wnnna$aDeaths, Autophagic Cell
=450  \\$wnnna$aDeaths, Autophagy-Dependent Cell
=667  \\$ado not confuse with AUTOPHAGY
=680  \\$iA major activation of the autophagic pathway, characterized by massive accumulation of AUTOPHAGOSOMES and CELL DEATH.
=688  \\$a2020; use Autophagy 2006-2019
=750  \0$81 $w b$iBroader mapping$aAutophagic vacuoles$0(DLC)sh 85021644$4BM$5IEN-M
=750  \0$81 $w b$iBroader mapping$aCell death$0(DLC)sh 85010460$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record: {dollar}a Autophagic vacuoles $i and $a Cell death $5 IEN-M

=LDR  00838cz  a2200265n  4500
=001  9881635668702441
=005  20210422153703.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080483
=035  \\$a(NLM)9812406005100041
=040  \\$aDNLM$cDNLM
=060  \0$aWN 610
=072  \\$aM1.$x860.$x325
=150  \\$aAtomic Bomb Survivors
=450  \\$aAtomic Bomb-Affected People
=450  \\$aHibakusha
=450  \\$wnnna$aAtomic Bomb Affected People
=450  \\$wnnna$aAtomic Bomb Survivor
=450  \\$wnnna$aAtomic Bomb-Affected Peoples
=450  \\$wnnna$aBomb Survivors, Atomic
=450  \\$wnnna$aSurvivor, Atomic Bomb
=450  \\$wnnna$aSurvivors, Atomic Bomb
=680  \\$iPersons who survived exposure to RADIATION due to ATOMIC BOMBS.
=688  \\$a2020
=750  \0$aAtomic bomb victims$0(DLC) sh 85009314$5IEN-M

=LDR  00954cz  a2200301n  4500
=001  9881627442502441
=005  20210420114727.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080702
=035  \\$a(NLM)9812405962300041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 447
=072  \\$aB1.$x50.$x500.$x131.$x617.$x276
=072  \\$aG7.$x203.$x300.$x463
=072  \\$aJ2.$x500.$x463
=150  \\$aEdible Insects
=450  \\$aInsects As Food
=450  \\$wnnna$aAs Food, Insects
=450  \\$wnnna$aAs Foods, Insects
=450  \\$wnnna$aEdible Insect
=450  \\$wnnna$aFood, Insects As
=450  \\$wnnna$aFoods, Insects As
=450  \\$wnnna$aInsect, Edible
=450  \\$wnnna$aInsects As Foods
=450  \\$wnnna$aInsects, Edible
=680  \\$iOrganisms of the INSECTA class that are used as food or are suitable as a nutritional source, especially by humans.
=688  \\$a2020
=750  \0$aEdible insects$0(DLC)sh 85066704$5IEN-M

=LDR  01057nz  a2200313n  4500
=001  9881627442702441
=005  20210420113732.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080122
=035  \\$a(NLM)9812405902400041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x423.$x850.$x600.$x200
=072  \\$aJ1.$x576.$x761.$x350
=150  \\$aEdible Films
=450  \\$aEdible Coating
=450  \\$aEdible Food Packaging Materials
=450  \\$aEdible Packaging
=450  \\$wnnna$aCoating, Edible
=450  \\$wnnna$aCoatings, Edible
=450  \\$wnnna$aEdible Coatings
=450  \\$wnnna$aEdible Film
=450  \\$wnnna$aEdible Packagings
=450  \\$wnnna$aFilm, Edible
=450  \\$wnnna$aFilms, Edible
=450  \\$wnnna$aPackaging, Edible
=450  \\$wnnna$aPackagings, Edible
=680  \\$iPackaging materials that can be directly consumed. They provide barrier and protection, while enhancing quality and safety of food products. (Bourtoom, 2008).
=688  \\$a2020
=750  \0$aEdible coatings$0(DLC) sh 85040962$5IEN-M

=LDR  01021nz  a2200205n  4500
=001  9881635661702441
=005  20210426125506.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080165
=035  \\$a(NLM)9812405899800041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x63.$x725.$x232
=072  \\$aG16.$x500.$x750.$x775.$x291
=072  \\$aN6.$x230.$x300.$x100.$x725.$x193
=150  \\$aExtreme Weather
=450  \\$wnnna$aWeather, Extreme
=680  \\$iEvents that have extreme values of important meteorological variables. Extreme is generally defined as either taking maximum values or exceedance above pre-existing high thresholds. Such events are generally rare; for example, extreme wind speeds exceeding the 100-year return value, which have a probability of only 0.01 of occurring in any particular year. (Stephenson, 2008)
=688  \\$a2020
=750  \0$iRelated mapping$aClimatic extremes$0(DLC) sh 85027039$4RM$5IEN-M
=750  \0$iRelated mapping$aSevere storms$0(DLC) sh 85120445$4RM$5IEN-M

=LDR  00697cz  a2200205n  4500
=001  9881635664702441
=005  20210423130241.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079265
=035  \\$a(NLM)9812405642900041
=040  \\$aDNLM$cDNLM
=060  \0$aGE 105
=072  \\$aH1.$x345
=150  \\$aEnvironmental Science
=450  \\$wnnna$aEnvironmental Sciences
=450  \\$wnnna$aScience, Environmental
=450  \\$wnnna$aSciences, Environmental
=680  \\$iScientific discipline that studies external factors, both biotic (living) and abiotic (nonliving), to which an organism is exposed.
=688  \\$a2020(2004)
=750  \0$aEnvironmental sciences$0(DLC) sh 92004048$5IEN-M

=LDR  00935nz  a2200193n  4500
=001  9881635965002441
=005  20210422151158.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079264
=035  \\$a(NLM)9812405644700041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x460.$x350.$x80.$x625
=150  \\$aEnvironmental Indicators
=450  \\$wnnna$aEnvironmental Indicator
=450  \\$wnnna$aIndicator, Environmental
=450  \\$wnnna$aIndicators, Environmental
=680  \\$iData related to climate change, ozone layer depletion, eutrophication, acidification, toxic contamination, urban environmental quality, biodiversity, cultural landscapes, waste, water resources, forest resources, fish resources, and soil degradation including desertification and erosion. (from https://www.oecd.org/env/indicators-modelling-outlooks/37551205.pdfc).
=688  \\$a2020
=750  \0$aEnvironmental indicators$0(DLC) sh 91004694$5IEN-M

=LDR  00609nz  a2200169n  4500
=001  9881635965602441
=005  20210422144437.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079102
=035  \\$a(NLM)9812405654800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x195
=072  \\$aF1.$x658.$x780.$x500
=150  \\$aEmpowerment
=680  \\$iProcess of increasing the capacity of individuals or groups to make choices and to transform those choices into desired actions as deigned by the individuals or groups.
=688  \\$a2020
=750  \0$aPower (Social sciences)$0(DLC) sh 85105976$5IEN-M

=LDR  01610nz  a2200349n  4500
=001  9881635966102441
=005  20210422143131.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080103
=035  \\$a(NLM)9812405904700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x595.$x500
=072  \\$aF1.$x470.$x311
=150  \\$aEmotional Regulation
=450  \\$aEmotion Regulation
=450  \\$aEmotion Self-Regulation
=450  \\$aEmotional Self-Regulation
=450  \\$wnnna$aEmotion Self Regulation
=450  \\$wnnna$aEmotion Self-Regulations
=450  \\$wnnna$aEmotional Regulations
=450  \\$wnnna$aEmotional Self Regulation
=450  \\$wnnna$aEmotional Self-Regulations
=450  \\$wnnna$aRegulation, Emotion
=450  \\$wnnna$aRegulation, Emotional
=450  \\$wnnna$aRegulations, Emotional
=450  \\$wnnna$aSelf-Regulation, Emotion
=450  \\$wnnna$aSelf-Regulation, Emotional
=450  \\$wnnna$aSelf-Regulations, Emotion
=450  \\$wnnna$aSelf-Regulations, Emotional
=680  \\$iThe manifestation of an emotional response by which individuals influence the intensity, duration, valence, or manifestation of their response. Emotion regulation either precedes (avoidance, interpretation) or follows an emotion (suppression, reappraisal). Emotion regulation is distinct from coping (focuses primarily on decreasing a negative emotional experience), and can include increasing or decreasing both positive and negative emotions consciously or unconsciously.
=688  \\$a2020
=750  \0$iRelated mapping$aSCERTS model$0(DLC) sh2010007046$4RM$5IEN-M

=LDR  00608nz  a2200169n  4500
=001  9881635851902441
=005  20210428124112.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081230
=035  \\$a(NLM)9812406157200041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x158.$x273.$x943.$x409.$x500
=072  \\$aI1.$x198.$x780.$x906
=150  \\$aForensic Entomology
=680  \\$iThe use of insects and related arthropods that inhabit decomposing corpses or remains in the conduct of medico-legal or medico-criminal investigations.
=688  \\$a2020
=750  \0$aForensic entomology$0(DLC) sh 86003985$5IEN-M

=LDR  00693nz  a2200229n  4500
=001  9881635852102441
=005  20210428122803.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080104
=035  \\$a(NLM)9812405904200041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x204
=150  \\$aFertility Clinics
=450  \\$aInfertility Clinics
=450  \\$wnnna$aClinic, Infertility
=450  \\$wnnna$aClinics, Fertility
=450  \\$wnnna$aClinics, Infertility
=450  \\$wnnna$aFertility Clinic
=450  \\$wnnna$aInfertility Clinic
=680  \\$iHealth clinics offering fertility treatment services.
=688  \\$a2020
=750  \0$aFertility clinics$0(DLC) sh 92004774$5IEN-M

=LDR  00734nz  a2200157n  4500
=001  9881635852402441
=005  20210428121150.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079685
=035  \\$a(NLM)9812405796900041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x423.$x750.$x500
=150  \\$aFamine
=680  \\$iThe conditions when at least 20 per cent of households in an area face extreme food shortages with a limited ability to cope; acute malnutrition rates exceed 30 per cent; and the death rate exceeds two persons per day per 10,000 persons. (From news.un.org/en/story/2011/07/382342-when-food-security-crisis-becomes-famine)
=688  \\$a2020; 1986-2019 use STARVATION
=750  \0$aFamines$0(DLC) sh 85047075$5IEN

=LDR  00741cz  a2200193n  4500
=001  9881645471802441
=005  20210510144822.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080486
=035  \\$a(NLM)9812406003800041
=040  \\$aDNLM$cDNLM
=060  \0$aQD 39.3.E46
=072  \\$aH1.$x181.$x590
=150  \\$aComputational Chemistry
=450  \\$wnnna$aChemistry, Computational
=550  \\$wg$aComputational Chemistry
=680  \\$iA branch of chemistry that utilizes computers as well as principles of chemistry and mathematics to generate data and solve problems related to the properties, structures, and reactions of molecules and materials.
=688  \\$a2020
=750  \0$aComputational chemistry$0(DLC)sh2020006312$5IEN-M

=LDR  00921nz  a2200205n  4500
=001  9881645472002441
=005  20210510143351.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079482
=035  \\$a(NLM)9812405825900041
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x200.$x885.$x287.$x249.$x320
=150  \\$aClaustrum
=450  \\$wnnna$aClaustra
=450  \\$wnnna$aEndopiriform Claustrum
=450  \\$wnnna$aInsular Claustrum
=550  \\$wg$aBasal Ganglia
=680  \\$iA gray matter lamina located underneath the inner NEOCORTEX lateral to the PUTAMEN and medial to the INSULAR CORTEX. It is considered to be a part of the basal ganglia. Extensive claustral projections exist to most cortices and subcortical structures including the AMYGDALA, the CAUDATE NUCLEUS, the HIPPOCAMPUS and the THALAMUS.
=688  \\$a2020; use BASAL GANGLIA (1978-2019)
=750  \0$aClaustrum$0(DLC) sh 89003312$5IEN-M

=LDR  00721nz  a2200217n  4500
=001  9881645472402441
=005  20210510140210.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080911
=035  \\$a(NLM)9812406076800041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x181.$x169
=072  \\$aL1.$x313.$x62
=150  \\$aCheminformatics
=450  \\$aChemoinformatics
=450  \\$wnnna$aCheminformatic
=550  \\$wg$aChemistry
=550  \\$wg$aInformatics
=680  \\$iThe use of computational and data retrieval techniques in understanding problems of chemistry. Cheminformatics strategies are useful in high throughput drug discovery.
=688  \\$a2020
=750  \0$aCheminformatics$0(DLC)sh2003001403$5IEN-M

=LDR  00918cz  a2200217n  4500
=001  9881645472702441
=005  20210510133522.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080602
=035  \\$a(NLM)9812405971300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x600.$x575.$x500
=150  \\$aCallicebus
=450  \\$aTiti Monkeys
=450  \\$wnnna$aMonkey, Titi
=450  \\$wnnna$aTiti Monkey
=550  \\$wg$aPitheciidae
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA genus of the subfamily CALLICEBINAE, family PITHECIIDAE, generally comprising of five species: C. barbarabrownae; C. coimbrai; C. melanochir; C. nigrifrons; C. personatus. Titi monkeys inhibit lower levels of the forest in South America.
=688  \\$a2020; use PITHECIIDAE 2007-2019
=750  \0$aTitis (Mammals)$0(DLC)sh 97006592$5IEN-M

=LDR  00814cz  a2200253n  4500
=001  9881647172102441
=005  20210511155900.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081007
=035  \\$a(NLM)9812406051600041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x559.$x389.$x310
=072  \\$aD2.$x455.$x849.$x575.$x219
=150  \\$aCymenes
=450  \\$aBenzenoid Menthane
=450  \\$aBenzenoid Menthanes
=450  \\$aCymene
=450  \\$wnnna$aMenthane, Benzenoid
=450  \\$wnnna$aMenthanes, Benzenoid
=550  \\$wg$aBenzene Derivatives
=550  \\$wg$aMonoterpenes
=680  \\$iA subclass of monoterpenes that contain a single benzene ring structure with an isopropyl group and one or more methyl groups.
=688  \\$a2020
=750  \0$aCymene$0(DLC) sh 85035147$5IEN-M

=LDR  01010cz  a2200241n  4500
=001  9881647172202441
=005  20210511154559.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079742
=035  \\$a(NLM)9812405785000041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 371
=072  \\$aE2.$x190.$x233
=150  \\$aCupping Therapy
=450  \\$aCupping Treatment
=450  \\$wnnna$aCupping Therapies
=450  \\$wnnna$aCupping Treatments
=450  \\$wnnna$aTherapy, Cupping
=450  \\$wnnna$aTreatment, Cupping
=550  \\$wg$aComplementary Therapies
=680  \\$iA traditional practice, most notably in traditional medicine, which involves placing cups on the skin to create suction believed to help increase blood flow and promote healing associated with chronic neck and low back pain in the short term (From National Center for Complementary and Integrative Health, https://nccih.nih.gov/news/cupping (Accessed 11/5/2018)).
=688  \\$a2020
=750  \0$aCupping$0(DLC) sh 85034832$5IEN-M

=LDR  00617nz  a2200205n  4500
=001  9881647172502441
=005  20210511153415.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080304
=035  \\$a(NLM)9812405883400041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x255
=150  \\$aCricket Sport
=450  \\$wnnna$aCricket Sports
=450  \\$wnnna$aSport, Cricket
=450  \\$wnnna$aSports, Cricket
=550  \\$wg$aSports
=680  \\$iA competitive sport played with a bat and ball between two teams of eleven players.
=688  \\$a2020
=750  \0$aCricket$0(DLC) sh 85033969$5IEN-M

=LDR  01538cz  a2200409n  4500
=001  9881640973402441
=005  20210504150051.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080623
=035  \\$a(NLM)9812405969400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x700.$x277
=150  \\$aGalagidae
=450  \\$aEuoticus
=450  \\$aGalagoides
=450  \\$aGreater Galagos
=450  \\$aLesser Galagos
=450  \\$aNeedle-Clawed Galagos
=450  \\$aOtolemur
=450  \\$aParagalago
=450  \\$aSciurocheirus
=450  \\$aSquirrel Galagos
=450  \\$wnnna$aGalago, Greater
=450  \\$wnnna$aGalago, Lesser
=450  \\$wnnna$aGalago, Needle-Clawed
=450  \\$wnnna$aGalago, Squirrel
=450  \\$wnnna$aGalagoide
=450  \\$wnnna$aGreater Galago
=450  \\$wnnna$aLesser Galago
=450  \\$wnnna$aNeedle Clawed Galagos
=450  \\$wnnna$aNeedle-Clawed Galago
=450  \\$wnnna$aOtolemurs
=450  \\$wnnna$aParagalagos
=450  \\$wnnna$aSquirrel Galago
=680  \\$iA family of Primates of the suborder Strepsirhini containing six genera. The family is widely distributed in Africa near Subsaharan region. The six genera are: Euoticus (needle-clawed galagos), GALAGO (bush babies), Galagoides (dwarf galagos), Otolemur (greater galagos), Paragalago and Sciurocheirus (squirrel galagos). All are primarily arboreal and nocturnal.
=688  \\$a2020;for EUOTICUS use under GALAGOS 1981-2019
=750  \2$aGalagos$0(DLC) sh 90005631$5IEN

=LDR  01313cz  a2200349n  4500
=001  9881642472702441
=005  20210506150631.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081011
=035  \\$a(NLM)9812406046500041
=040  \\$aDNLM$cDNLM
=060  \0$aWI 720
=072  \\$aC6.$x552.$x289
=072  \\$aC23.$x550.$x513.$x355.$x500
=072  \\$aC23.$x550.$x717.$x489.$x500
=150  \\$aHepatic Infarction
=450  \\$aHepatic Infarct
=450  \\$aLiver Infarct
=450  \\$aLiver Infarction
=450  \\$wnnna$aHepatic Infarctions
=450  \\$wnnna$aHepatic Infarcts
=450  \\$wnnna$aInfarct, Hepatic
=450  \\$wnnna$aInfarct, Liver
=450  \\$wnnna$aInfarction, Hepatic
=450  \\$wnnna$aInfarction, Liver
=450  \\$wnnna$aLiver Infarctions
=450  \\$wnnna$aLiver Infarcts
=680  \\$iFormation of infarct resulting from obstruction of HEPATIC ARTERY and/or PORTAL VEIN most often after LIVER TRANSPLANTATION or hepatobiliary surgery.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aLiver$0(DLC)sh 85077748$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aInfarction$0(DLC)sh 85066075$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aLiver$iand$aInfarction$5IEN-M

=LDR  00691cz  a2200229n  4500
=001  9881642473002441
=005  20210506142525.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081205
=035  \\$a(NLM)9812406178600041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x385
=072  \\$aE5.$x200.$x124.$x385
=150  \\$aHair Analysis
=450  \\$aHair Mineral Analysis
=450  \\$wnnna$aAnalysis, Hair
=450  \\$wnnna$aAnalysis, Hair Mineral
=450  \\$wnnna$aMineral Analysis, Hair
=550  \\$aHair
=680  \\$iExamination of hair by chemical, physical, or microscopic means.
=688  \\$a2020
=750  \0$aHair$xAnalysis$0(DLC) sh2009126167$5IEN-M

=LDR  00914nz  a2200205n  4500
=001  9881642667202441
=005  20210507150333.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081208
=035  \\$a(NLM)9812406177000041
=040  \\$aDNLM$cDNLM
=072  \\$aC16.$x320.$x798.$x500
=072  \\$aC20.$x673.$x795.$x500
=150  \\$aHereditary Complement Deficiency Diseases
=450  \\$aComplement Deficiencies
=450  \\$aInherited Complement Deficiency Diseases
=450  \\$wnnna$aComplement Deficiency
=680  \\$iGenetic disorders due to mutations in genes involved in COMPLEMENT SYSTEM PROTEINS. They are often classified into distinct pathway of complement activation where causative mutations are found (e.g., classical pathway, lectin pathway, alternative pathway, and terminal complement pathway).
=688  \\$a2020
=750  \0$aComplement deficiency (Immunology)$0(DLC) sh 85029355$5IEN-M

=LDR  00690nz  a2200193n  4500
=001  9881646872602441
=005  20210511135812.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080802
=035  \\$a(NLM)9812405953600041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x581
=072  \\$aJ1.$x40.$x498
=150  \\$aHorticulture
=450  \\$aArboriculture
=450  \\$aFloriculture
=680  \\$iBranch of agriculture which involves the cultivation of vegetables, flowers, or ornamental plants for food, industrial, medicinal, or aesthetic purposes. It does not include CROP PRODUCTION on a large scale.
=688  \\$a2020
=750  \0$aHorticulture$0(DLC) sh 85062204$5IEN-M

=LDR  00526nz  a2200157n  4500
=001  9881647052902441
=005  20210513151751.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080487
=035  \\$a(NLM)9812406002500041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x230.$x110.$x500.$x657
=150  \\$aInternet of Things
=680  \\$iNetworking capability which facilitates information flow to and from objects and devices using the INTERNET.
=688  \\$a2020
=750  \0$aInternet of things$0(DLC)sh2013000266$5IEN-M

=LDR  00742cz  a2200181n  4500
=001  9881647267302441
=005  20210513175112.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079062
=035  \\$a(NLM)9812405656100041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.I4
=072  \\$aF4.$x754.$x506
=150  \\$aInterpersonal Psychotherapy
=450  \\$wnnna$aPsychotherapy, Interpersonal
=680  \\$iInterpersonal modification of psychodynamic psychotherapy. Therapy is present-focused and seeks to resolve problems in interpersonal relations. Aspects of attachment theory are used to analyze how past relationships affect current relationships.
=688  \\$a2020
=750  \0$aInterpersonal psychotherapy$0(DLC) sh 98000176$5IEN-M

=LDR  01148nz  a2200313n  4500
=001  9881647268002441
=005  20210513140234.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081034
=035  \\$a(NLM)9812406205900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x754.$x254
=150  \\$aIndigenous Peoples
=450  \\$aFirst Nation Peoples
=450  \\$aNative Peoples
=450  \\$wnnna$aFirst Nation People
=450  \\$wnnna$aIndigenous People
=450  \\$wnnna$aNation People, First
=450  \\$wnnna$aNation Peoples, First
=450  \\$wnnna$aNative People
=450  \\$wnnna$aPeople, First Nation
=450  \\$wnnna$aPeople, Indigenous
=450  \\$wnnna$aPeople, Native
=450  \\$wnnna$aPeoples, First Nation
=450  \\$wnnna$aPeoples, Indigenous
=450  \\$wnnna$aPeoples, Native
=680  \\$iDescendants who self-identify as members of a group who inhabited a country or region at the time when people of different cultures or ethnic origins arrived. They often maintain their distinct language, culture, and beliefs.
=688  \\$a2020
=750  \0$aIndigenous peoples$0(DLC)sh 85090174$5IEN-M

=001  9881650768002441
=005  20210520135735.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080527
=035  \\$a(NLM)9812405990500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x112.$x199.$x120.$x510.$x535
=150  \\$aMacaca fuscata
=450  \\$aJapanese Macaque
=450  \\$aJapanese Monkey
=450  \\$aM. fuscata
=450  \\$aMacaca fuscata fuscata
=450  \\$aMacaca fuscata yakui
=450  \\$aMonkey, Japanese
=450  \\$aSnow Monkey
=450  \\$wnnna$aJapanese Macaques
=450  \\$wnnna$aJapanese Monkeys
=450  \\$wnnna$aMacaque, Japanese
=450  \\$wnnna$aMonkey, Snow
=450  \\$wnnna$aSnow Monkeys
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species of the genus MACACA characterized by red naked face. M. fuscata is primarily ground-dwelling in forest and mountains often near hot springs in Japan.
=688  \\$a2020(1980)
=750  \0$aJapanese macaque$0Japanese macaque$5IEN-M

=LDR  01466nz  a2200397n  4500
=001  9881650768502441
=005  20210520131045.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080531
=035  \\$a(NLM)9812405988000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x112.$x199.$x120.$x510.$x260
=150  \\$aMacaca arctoides
=450  \\$aBear Macaque
=450  \\$aBrown Stump-tailed Macaque
=450  \\$aM. arctoides
=450  \\$aM. brunneus
=450  \\$aM. speciosus
=450  \\$aM. ursinus
=450  \\$aMacacus brunneus
=450  \\$aMacacus speciosus
=450  \\$aMacacus ursinus
=450  \\$aStump-Tailed Macaque
=450  \\$wnnna$aBear Macaques
=450  \\$wnnna$aBrown Stump tailed Macaque
=450  \\$wnnna$aBrown Stump-tailed Macaques
=450  \\$wnnna$aMacaque, Bear
=450  \\$wnnna$aMacaque, Brown Stump-tailed
=450  \\$wnnna$aMacaque, Stump-Tailed
=450  \\$wnnna$aStump Tailed Macaque
=450  \\$wnnna$aStump-Tailed Macaques
=450  \\$wnnna$aStump-tailed Macaque, Brown
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species of the genus MACACA inhabiting India, China, and other parts of southern Asia. The species is characterized by its thick brown fur covering most of its body except the face and short tail.
=688  \\$a2020
=750  \0$aStump-tailed macaque$(DLC)sh 85129339$5IEN-M

=LDR  00773cz  a2200253n  4500
=001  9881651769002441
=005  20210524124156.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080925
=035  \\$a(NLM)9812406080100041
=040  \\$aDNLM$cDNLM
=060  \0$aWN 180
=072  \\$aE1.$x370.$x350.$x536
=150  \\$aMicrowave Imaging
=450  \\$aMicrowave Tomography
=450  \\$wnnna$aImaging, Microwave
=450  \\$wnnna$aImagings, Microwave
=450  \\$wnnna$aMicrowave Imagings
=450  \\$wnnna$aMicrowave Tomographies
=450  \\$wnnna$aTomographies, Microwave
=450  \\$wnnna$aTomography, Microwave
=680  \\$iUse of MICROWAVES as a diagnostic tool.
=688  \\$a2020
=750  \0$aMicrowave imaging in medicine$0(DLC)sh 86000411$5IEN-M

=LDR  01065cz  a2200289n  4500
=001  9881652044402441
=005  20210528124742.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081322
=035  \\$a(NLM)9812406139600041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 360
=072  \\$aN2.$x421.$x497
=072  \\$aN4.$x452.$x523
=150  \\$aMilitary Health Services
=450  \\$wnnna$aMilitary Health System
=450  \\$wnnna$aHealth Service, Military
=450  \\$wnnna$aHealth System, Military
=450  \\$wnnna$aMilitary Health Service
=450  \\$wnnna$aMilitary Health Systems
=450  \\$wnnna$aService, Military Health
=450  \\$wnnna$aSystem, Military Health
=680  \\$iServices organized for the diagnosis and treatment of disease and the maintenance of health primarily of MILITARY PERSONNEL.
=688  \\$a2020
=750  \0$81$wb$aSoldiers$0(DLC)sh 85124554$5IEN-M
=780  \0$81$wb$xMedical care$0(DLC)sh 00005607$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Heading$aSoldiers--Medical care$5IEN

=LDR  00764cz  a2200229n  4500
=001  9881652058302441
=005  20210525145434.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079644
=035  \\$a(NLM)9812405800900041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 360
=072  \\$aN1.$x400.$x506
=150  \\$aMilitary Health
=450  \\$aHealth of Military Personnel
=450  \\$wnnna$aHealth, Military
=450  \\$wnnna$aMilitary Personnel Health
=550  \\$aMilitary Personnel
=550  \\$aMilitary Family
=680  \\$iThe physical and mental conditions of MILITARY PERSONNEL, active duty and retired U.S. Military personnel and their dependents.
=688  \\$a2020
=750  \0$iRelated mapping$aMilitary hygiene$0(DLC)sh 85085220$4RM$5IEN-M

=LDR  01078cz  a2200265n  4500
=001  9881655862002441
=005  20210610180024.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079262
=035  \\$a(NLM)9812405648200041
=040  \\$aDNLM$cDNLM
=072  \\$aC13.$x703.$x417
=072  \\$aC18.$x654.$x726.$x500.$x633
=072  \\$aC23.$x888.$x144.$x699.$x500.$x125
=072  \\$aE1.$x370.$x600.$x115.$x100.$x160.$x120.$x699.$x500.$x312
=072  \\$aG7.$x100.$x100.$x160.$x120.$x699.$x500.$x312
=150  \\$aObesity, Maternal
=450  \\$wnnna$aMaternal Obesity
=450  \\$wnnna$aObesity in Pregnancy
=550  \\$aGestational Weight Gain
=680  \\$iBODY MASS INDEX in PREGNANT WOMEN that is excessively above the recommended cut-off.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aObesity$0(DLC)sh 85093646$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPregnancy$0(DLC)sh 85106276$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aObesity$iand$aPregnancy$5IEN-M

=LDR  01041cz  a2200289n  4500
=001  9881656065202441
=005  20210608173051.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080385
=035  \\$a(NLM)9812406026000041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x219
=072  \\$aD20.$x280.$x320.$x609
=072  \\$aD25.$x720.$x532
=072  \\$aJ1.$x637.$x51.$x720.$x584
=072  \\$aJ1.$x637.$x512.$x150.$x500
=072  \\$aJ1.$x637.$x512.$x600.$x596
=150  \\$aNanogels
=450  \\$aNanocomposite Gel
=450  \\$aNanocomposite Gels
=450  \\$aNanocomposite Hydrogel
=450  \\$aNanocomposite Hydrogels
=450  \\$wnnna$aGel, Nanocomposite
=450  \\$wnnna$aHydrogel, Nanocomposite
=680  \\$iThree-dimensional biocompatible materials formed by cross-linking a hydrophilic polymeric component (e.g., HYDROGELS). They are typically spherical particles in a size range of 20-250 nm when used for drug delivery applications.
=688  \\$a2020
=750  \0$aNanogels$0(DLC)sh2011003963$5IEN-M

=LDR  01097cz  a2200337n  4500
=001  9881656161302441
=005  20210609173629.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079524
=035  \\$a(NLM)9812405824100041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 282
=072  \\$aC25.$x775.$x643
=072  \\$aF3.$x900.$x647
=150  \\$aNarcotic-Related Disorders
=450  \\$aNarcotic Abuse
=450  \\$aNarcotic Addiction
=450  \\$aNarcotic Dependence
=450  \\$wnnna$aAbuse, Narcotic
=450  \\$wnnna$aAbuses, Narcotic
=450  \\$wnnna$aAddiction, Narcotic
=450  \\$wnnna$aDependence, Narcotic
=450  \\$wnnna$aDisorder, Narcotic-Related
=450  \\$wnnna$aNarcotic Abuses
=450  \\$wnnna$aNarcotic Addictions
=450  \\$wnnna$aNarcotic Related Disorders
=450  \\$wnnna$aNarcotic-Related Disorder
=550  \\$aNarcotics
=680  \\$iDisorders related to or resulting from abuse or misuse of NARCOTICS.
=688  \\$a2020; NARCOTIC ABUSE use OPIOID-RELATED DISORDER 1997-2019
=750  \0$aDrug addiction$0(DLC) sh 85089810$5IEN-M

=LDR  01259cz  a2200325n  4500
=001  9881663059202441
=005  20210614110201.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080052
=035  \\$a(NLM)9812405933900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 284
=072  \\$aN6.$x850.$x290.$x200.$x300
=150  \\$aOpioid Epidemic
=450  \\$aEpidemic, Opioid
=450  \\$aOpiate Epidemic
=450  \\$aOpioid Crisis
=450  \\$wnnna$aCrises, Opioid
=450  \\$wnnna$aCrisis, Opioid
=450  \\$wnnna$aEpidemic, Opiate
=450  \\$wnnna$aEpidemics, Opiate
=450  \\$wnnna$aEpidemics, Opioid
=450  \\$wnnna$aOpiate Epidemics
=450  \\$wnnna$aOpioid Crises
=450  \\$wnnna$aOpioid Epidemics
=680  \\$iWidespread use of OPIOIDS by disproportionately large numbers of individuals within a population, community, or region occurring within a relatively narrow window of time.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aOpioid abuse$0(DLC)sh 85095084$4RM$5IEN-M
=750  \0$81$wb$iBroader mapping$aEpidemics$0(DLC)sh 85044370$4RM$5IEN-M
=788  \0$iSearch also under the following Library of Congress subject headings used together in the same record:$aOpioid abuse$iand$aEpidemics$5IEN-M

=LDR  01930cz  a2200565n  4500
=001  9881663059302441
=005  20210614104752.0
=008  790529\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009293
=035  \\$a(NLM)98195534010000041
=040  \\$aDNLM$cDNLM
=072  \\$aC25.$x775.$x643.$x500
=072  \\$aF3.$x900.$x647.$x500
=150  \\$aOpioid-Related Disorders
=450  \\$wnnna$aAddiction, Opioid
=450  \\$wnnna$aDependence, Opioid
=450  \\$wnnna$aOpiate Abuse
=450  \\$wnnna$aOpioid Abuse
=450  \\$wnnna$aOpioid Addiction
=450  \\$wnnna$aOpioid Dependence
=450  \\$aOpiate Addiction
=450  \\$aOpiate Dependence
=450  \\$aOpioid Misuse
=450  \\$aOpioid Use Disorder
=450  \\$aPrescription Opioid Abuse
=450  \\$aPrescription Opioid Misuse
=450  \\$wnnna$aAbuse, Opiate
=450  \\$wnnna$aAbuse, Opioid
=450  \\$wnnna$aAbuse, Prescription Opioid
=450  \\$wnnna$aAddiction, Opiate
=450  \\$wnnna$aDependence, Opiate
=450  \\$wnnna$aDisorder, Opioid Use
=450  \\$wnnna$aMisuse, Opioid
=450  \\$wnnna$aMisuse, Prescription Opioid
=450  \\$wnnna$aOpiate Abuses
=450  \\$wnnna$aOpioid Abuse, Prescription
=450  \\$wnnna$aOpioid Abuses
=450  \\$wnnna$aOpioid Addictions
=450  \\$wnnna$aOpioid Dependences
=450  \\$wnnna$aOpioid Misuses
=450  \\$wnnna$aOpioid Related Disorders
=450  \\$wnnna$aOpioid Use Disorders
=450  \\$wnnna$aOpioid-Related Disorder
=450  \\$wnnna$aPrescription Opioid Abuses
=450  \\$wnnna$aPrescription Opioid Misuses
=550  \\$aAnalgesics, Opioid
=667  \\$acoordinate with specific opioid but note MORPHINE DEPENDENCE,  HEROIN DEPENDENCE and OPIUM DEPENDENCE are available
=680  \\$iDisorders related to or resulting from abuse or misuse of OPIOIDS.
=688  \\$a98(80)
=750  \0$aOpioid abuse$0(DLC)sh 85095084$5IEN-M

=LDR  00472nz  a2200157n  4500
=001  9881663555102441
=005  20210614134855.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081503
=035  \\$a(NLM)9812406308200041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x691.$x713
=150  \\$aOrganoiron Compounds
=680  \\$iOrganic compounds that contain iron in carbon-to-iron chemical bond.
=688  \\$a2020
=750  \2$aOrganoiron compounds$0(DLC) sh 85095555$5IEN-M

=LDR  00786nz   2200205n  4500
=001  9881647872702441
=005  20210514121920.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080030
=035  \\$a(NLM)9812405755200041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x780.$x937.$x544
=072  \\$aN6.$x850.$x698
=150  \\$aLegal Epidemiology
=450  \\$aPolicy Surveillance
=450  \\$wnnna$aEpidemiology, Legal
=450  \\$wnnna$aSurveillance, Policy
=680  \\$iScientific study of law as a factor in the cause, distribution, and prevention of disease and injury.  (From https://read.dukeupress.edu/jhppl/article/41/6/1151/40084/Policy-Surveillance-A-Vital-Public-Health-Practice).
=688  \\$a2020
=750  \0$aForensic epidemiology$0(DLC) sh 98001657$5IEN-M

=LDR  02012cz  a2200469n  4500
=001  9881689670602441
=005  20210713161821.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079424
=035  \\$a(NLM)9812405832600041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x954.$x158.$x757
=150  \\$aTumor Necrosis Factor Inhibitors
=450  \\$wnnna$aTNF Antagonists
=450  \\$wnnna$aTNF Blockers
=450  \\$wnnna$aTNF Inhibitors
=450  \\$wnnna$aTumor Necrosis Factor Antagonists
=450  \\$wnnna$aTumor Necrosis Factor Blockers
=450  \\$wnnna$aTumor Necrosis Factor-a (TNF-a) Antagonists
=450  \\$wnnna$aTumor Necrosis Factor-a (TNF-a) Blockers
=450  \\$wnnna$aTumor Necrosis Factor-a (TNF-a) Inhibitors
=450  \\$aTNF Antagonist
=450  \\$aTNF Blocker
=450  \\$aTNF Inhibitor
=450  \\$aTumor Necrosis Factor Antagonist
=450  \\$aTumor Necrosis Factor Blocker
=450  \\$aTumor Necrosis Factor Inhibitor
=450  \\$aTumor Necrosis Factor-a (TNF-a) Antagonist
=450  \\$aTumor Necrosis Factor-a (TNF-a) Blocker
=450  \\$aTumor Necrosis Factor-a (TNF-a) Inhibitor
=450  \\$wnnna$aAntagonist, TNF
=450  \\$wnnna$aAntagonists, TNF
=450  \\$wnnna$aBlocker, TNF
=450  \\$wnnna$aBlockers, TNF
=450  \\$wnnna$aInhibitor, TNF
=450  \\$wnnna$aInhibitors, TNF
=450  \\$aTumor Necrosis Factors$xantagonists & inhibitors
=680  \\$iCompounds or agents that bind to and inhibit the synthesis or activity of TUMOR NECROSIS FACTOR-alpha. Such agents are used to treat inflammatory bowel diseases and other inflammatory diseases.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aTumor necrosis factor$0(DLC) sh 87004016$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aAnti-inflammatory agents$0(DLC) sh 85005615$4BM$5IEN-M
=788  \2$iSearch also under the Library of Congress headings used together in the same record:$aTumor necrosis factor$iand$aAnti-inflammatory agents$5IEN-M

=LDR  01077nz  a2200301n  4500
=001  9881689670702441
=005  20210713155500.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081028
=035  \\$a(NLM)9812406225800041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x292.$x200.$x750.$x500
=072  \\$aC10.$x292.$x700.$x475.$x500
=072  \\$aC10.$x900.$x300.$x218.$x550.$x500
=072  \\$aC11.$x640.$x530.$x500
=072  \\$aC23.$x550.$x877
=072  \\$aC25.$x100.$x937
=072  \\$aC26.$x733.$x902
=072  \\$aG1.$x750.$x748.$x500.$x902
=150  \\$aToxic Optic Neuropathy
=450  \\$aOcular Toxicity
=450  \\$wnnna$aNeuropathy, Toxic Optic
=450  \\$wnnna$aOptic Neuropathy, Toxic
=450  \\$wnnna$aToxic Optic Neuropathies
=450  \\$wnnna$aToxicity, Ocular
=680  \\$iDamage to the eye or its function (e.g., VISUAL IMPAIRMENT) due to OPTIC NERVE damage secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
=688  \\$a2020
=750  \0$aOcular toxicology$0(DLC) sh 89005481$5IEN-M

=LDR  01011nz  a2200253n  4500
=001  9881689868602441
=005  20210714154435.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080868
=035  \\$a(NLM)9812406130500041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x780.$x200.$x800.$x800.$x900.$x900.$x500
=072  \\$aN6.$x850.$x860.$x510.$x900.$x900.$x500
=150  \\$aWater Decolorization
=450  \\$aWaste Water Decolorization
=450  \\$aWastewater Decolorization
=450  \\$wnnna$aDecolorization, Waste Water
=450  \\$wnnna$aDecolorization, Wastewater
=450  \\$wnnna$aDecolorization, Water
=450  \\$wnnna$aWater Decolorization, Waste
=550  \\$aColoring Agents
=680  \\$iThe removal of DYES; STAINS; or other COLORING AGENTS, natural or synthetic, from water sources by various processes such as ADSORPTION; BIOREMEDIATION; enzymatic digestion; and ELECTROLYSIS.
=688  \\$a2020
=750  \0$aSewage$xPurification$xColor removal$0(DLC) sh 85120470$5IEN-M

=LDR  00748cz  a2200229n  4500
=001  9881689868802441
=005  20210714152837.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081324
=035  \\$a(NLM)9812406138600041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 360
=072  \\$aN2.$x421.$x917
=072  \\$aN4.$x452.$x524
=150  \\$aVeterans Health Services
=450  \\$wnnna$aVeterans Health Service
=450  \\$wnnna$aHealth Service, Veterans
=450  \\$wnnna$aHealth Services, Veterans
=550  \\$aVeterans Health
=680  \\$iServices organized for the diagnosis and treatment of diseases and maintenance of health primarily of VETERANS.
=688  \\$a2020
=750  \0$aVeterans$xMedical care$0(DLC) sh 85142984$5IEN-M

=LDR  01209cz  a2200313n  4500
=001  9881689868902441
=005  20210714151225.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079426
=035  \\$a(NLM)9812405829600041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 100
=072  \\$aC1.$x920
=150  \\$aVector Borne Diseases
=450  \\$wnnna$aVector-Borne Diseases
=450  \\$wnnna$aVectorborne Diseases
=450  \\$aMosquito Borne Diseases
=450  \\$aMosquito-Borne Diseases
=450  \\$wnnna$aMosquito Borne Disease
=450  \\$wnnna$aMosquito-Borne Disease
=450  \\$wnnna$aVector Borne Disease
=450  \\$wnnna$aVector-Borne Disease
=450  \\$wnnna$aVectorborne Disease
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iInfectious diseases transmitted by DISEASE VECTORS.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aAnimals as carriers of disease$0(DLC)sh 85005281$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aCommunicable diseases$0(DLC)sh 85029015$4BM$5IEN-M
=788  \2$iSearch also under the Library of Congress headings used together in the same record:$aAnimals as carriers of disease$iand$aCommunicable diseases$5IEN-M

=LDR  01070nz  a2200229n  4500
=001  9881689869002441
=005  20210714144501.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079282
=035  \\$a(NLM)9812405640000041
=040  \\$aDNLM$cDNLM
=072  \\$aD26.$x650.$x800
=072  \\$aD27.$x720.$x744.$x770.$x419.$x500
=150  \\$aVaccine Excipients
=450  \\$wnnna$aExcipient, Vaccine
=450  \\$wnnna$aExcipients, Vaccine
=450  \\$wnnna$aVaccine Excipient
=680  \\$iMedia added to a vaccine for a specific purpose. These include: preservatives to prevent contamination, adjuvants to stimulate a stronger immune response, and stabilizers. (From https://www.cdc.gov/vaccines pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf)
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aExcipients$0(DLC)sh 89002897$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aVaccines$0(DLC)sh 85141718$4BM$5IEN-M
=788  \2$iSearch also under the Library of Congress headings used together in the same record:$aVaccines$iand$aExcipients$5IEN-M

=LDR  00907nz  a2200265n  4500
=001  9881689869202441
=005  20210714142846.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080562
=035  \\$a(NLM)9812405974900041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x709.$x359.$x500
=072  \\$aJ1.$x86.$x669
=072  \\$aJ1.$x293.$x910
=150  \\$aUniversal Design
=450  \\$aDesign for All
=450  \\$aHuman Centered Design
=450  \\$wnnna$aDesign, Human Centered
=450  \\$wnnna$aDesign, Universal
=450  \\$wnnna$aDesigns, Human Centered
=450  \\$wnnna$aHuman Centered Designs
=450  \\$wnnna$aUniversal Designs
=680  \\$iThe design of products and environments to be usable by all people, to the greatest extent possible, without the need for adaption or specialized design.
=688  \\$a2020
=750  \0$aUniversal design$0(DLC) sh 99003538$5IEN-M

=001  9881668299702441
=005  20210623122912.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080305
=035  \\$a(NLM)9812405882100041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x300.$x600.$x813.$x500
=072  \\$aJ2.$x500.$x600.$x813.$x500
=150  \\$aPork Meat
=450  \\$wnnna$aPork
=450  \\$aBacon
=450  \\$aCured Ham
=450  \\$aPig Meat
=450  \\$wnnna$aHam, Cured
=450  \\$wnnna$aMeat, Pig
=450  \\$wnnna$aMeat, Pork
=450  \\$wnnna$aMeats, Pig
=450  \\$wnnna$aMeats, Pork
=450  \\$wnnna$aPig Meats
=450  \\$wnnna$aPork Meats
=680  \\$iMEAT or flesh of a pig (Sus scrofa) used as food.
=688  \\$a2020; use RED MEAT 2016-2019
=750  \0$aPork$0(DLC) sh 85105003$5IEN-M

=LDR  00735nz  a2200181n  4500
=001  9881668299802441
=005  20210623121313.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079702
=035  \\$a(NLM)9812405787100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x859.$x833.$x500.$x625
=150  \\$aPomegranate
=450  \\$wnnna$aPunica granatum
=450  \\$wnnna$aPomegranates
=680  \\$iA deciduous shrub or small tree in the family Lythraceae, order Myrtales, superorder Rosanae. It bears edible reddish-purple fruit berries with seeds and pulp produced from the ovary of a single flower.
=688  \\$a2020; use LYTHRACEAE 2001-2019
=750  \2$aPomegranate$0(DLC) sh 85104756$5IEN-M

=LDR  00923nz  a2200289n  4500
=001  9881668414602441
=005  20210617131021.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080050
=035  \\$a(NLM)9812405735600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x72.$x500
=072  \\$aM1.$x150.$x738
=150  \\$aPara-Athletes
=450  \\$aPara Athletes
=450  \\$aPara-Athlete
=450  \\$aParalympian
=450  \\$aParalympians
=450  \\$aParalympic Athletes
=450  \\$aWheelchair Athletes
=450  \\$wnnna$aAthlete, Paralympic
=450  \\$wnnna$aPara Athlete
=450  \\$wnnna$aParalympic Athlete
=450  \\$wnnna$aWheelchair Athlete
=680  \\$iPhysically disabled individuals who have developed skills, physical stamina and strength to participate in SPORTS or other physical activities.
=688  \\$a2020
=750  \0$aAthletes with disabilities$0(DLC) sh 94008688$5IEN-M

=LDR  00938cz  a2200217n  4500
=001  9881668487602441
=005  20210628125437.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081029
=035  \\$a(NLM)9812406222500041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 343
=072  \\$aC8.$x381.$x423.$x847
=150  \\$aPulmonary Arterial Hypertension
=450  \\$wnnna$aArterial Hypertension, Pulmonary
=450  \\$wnnna$aHypertension, Pulmonary Arterial
=680  \\$iA progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aPulmonary hypertension$0(DLC)sh 85109008$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPulmonary artery$0(DLC)sh 85108996$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aPulmonary hypertension$iand$aPulmonary artery$5IEN-M

=LDR  00750cz  a2200169n  4500
=001  9881668488102441
=005  20210628115831.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080032
=035  \\$a(NLM)9812405754900041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x96.$x628.$x57
=150  \\$aPsychology, Positive
=450  \\$aPositive Psychology
=680  \\$iThe scientific study of the strengths that enable individuals and communities to thrive. It is founded on the belief that people want to lead meaningful and fulfilling lives, to cultivate what is best within themselves, and to enhance their experiences of love, work, and play. (https://ppc.sas.upenn.edu/)
=688  \\$a2020
=750  \0$aPositive paychology$0(DLC) sh2004003042$5IEN-M

=LDR  01768cz  a2200565n  4500
=001  9881668498202441
=005  20210623140806.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080542
=035  \\$a(NLM)9812405980400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x112.$x199.$x150.$x575
=150  \\$aPresbytini
=450  \\$aAsian Colobines
=450  \\$aDouc Langurs
=450  \\$aDouc Monkeys
=450  \\$aIndian Langurs
=450  \\$aLangurs
=450  \\$aLutungs
=450  \\$aNasalis
=450  \\$aPresbytis
=450  \\$aProboscis Monkey
=450  \\$aPygathrix
=450  \\$aRhinopithecus
=450  \\$aSemnopithecus
=450  \\$aSimakobu
=450  \\$aSimias
=450  \\$aSimias concolor
=450  \\$aSnub-Nosed Monkeys
=450  \\$aTrachypithecus
=450  \\$wnnna$aAsian Colobine
=450  \\$wnnna$aColobine, Asian
=450  \\$wnnna$aDouc Langur
=450  \\$wnnna$aDouc Monkey
=450  \\$wnnna$aIndian Langur
=450  \\$wnnna$aLangur
=450  \\$wnnna$aLangur, Douc
=450  \\$wnnna$aLangur, Indian
=450  \\$wnnna$aLutung
=450  \\$wnnna$aMonkey, Douc
=450  \\$wnnna$aMonkey, Proboscis
=450  \\$wnnna$aMonkey, Snub-Nosed
=450  \\$wnnna$aMonkeys, Douc
=450  \\$wnnna$aProboscis Monkeys
=450  \\$wnnna$aSnub Nosed Monkeys
=450  \\$wnnna$aSnub-Nosed Monkey
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iThe tribe of subfamily COLOBINAE, family CERCOPITHECIDAE. They are found in India, Indonesia, Malaysia, and Thailand.
=688  \\$a2020; for PRESBYTIS and PYGATHRIX use CERCOPITHECIDAE (1980-2019)
=750  \0$aPygathrix$0(DLC) sh 98008037$5IEN-M

=LDR  01692cz  a2200469n  4500
=001  9881668507802441
=005  20210621130235.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081223
=035  \\$a(NLM)9812406166400041
=035  \\$a(DLC) sh 85132845
=035  \\$a(LIBRARY_OF_CONGRESS)98171639690000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x849.$x765.$x674
=072  \\$aD4.$x663
=150  \\$aPolycyclic Sesquiterpenes
=450  \\$aCaryophyllane
=450  \\$aCaryophyllane Derivative
=450  \\$aCaryophyllane Derivatives
=450  \\$aCaryophyllanes
=450  \\$aEremophilane
=450  \\$aEremophilane Derivative
=450  \\$aEremophilane Derivatives
=450  \\$aEremophilanes
=450  \\$aPolycyclic Sesquiterpene
=450  \\$aValerane
=450  \\$aValerane Derivative
=450  \\$aValerane Derivatives
=450  \\$aValeranes
=450  \\$wnnna$aDerivative, Caryophyllane
=450  \\$wnnna$aDerivative, Eremophilane
=450  \\$wnnna$aDerivative, Valerane
=450  \\$wnnna$aDerivatives, Caryophyllane
=450  \\$wnnna$aDerivatives, Eremophilane
=450  \\$wnnna$aDerivatives, Valerane
=450  \\$wnnna$aSesquiterpene, Polycyclic
=450  \\$wnnna$aSesquiterpenes, Polycyclic
=680  \\$iSesquiterpenes that contain two or more ring structures
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aSesquiterpenes$0(DLC)sh 89006047$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPolycyclic compounds$0(DLC)sh 85104607$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record$aSesquiterpenes$iand$aPolycyclic compounds$5IEN-M

=LDR  00671nz  a2200193n  4500
=001  9881668507902441
=005  20210621123755.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080054
=035  \\$a(NLM)9812405933200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x625
=150  \\$aPinales
=450  \\$aAraucariales
=450  \\$aCupressales
=450  \\$aTaxales
=680  \\$iOrder of Conifers of the class Pinopsida, subdivision Spermatophytina, and division Tracheophyta. The distinguishing attribute of the Pinales is the reproductive structure known as a cone.
=688  \\$a2020
=750  \0$aTaxales$0(DLC) sh 85132845$5IEN-M

=LDR  00967nz  a2200217n  4500
=001  9881668569902441
=005  20210630140231.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079562
=035  \\$a(NLM)9812405812400041
=040  \\$aDNLM$cDNLM
=072  \\$aC6.$x405.$x609
=072  \\$aF3.$x400.$x968
=150  \\$aRumination Syndrome
=450  \\$aMerycism
=450  \\$aRumination Disorders
=450  \\$wnnna$aRumination Disorder
=450  \\$wnnna$aRumination Syndromes
=680  \\$iA gastrointestinal disorder characterized by repetitive and effortless regurgitation of ingested food from the stomach to the oral cavity in the early POSTPRANDIAL PERIOD. It is associated with functional gastrointestinal pathology (e.g., increased intra-gastric pressure) and psychiatric disorders (e.g., anxiety, depression). It is not limited to infants and distinct from GERD and VOMITING.
=688  \\$a2020(1998)
=750  \0$aMerycism$0(DLC)sh 85083897$5IEN-M

=LDR  00786nz  a2200229n  4500
=001  9881668570102441
=005  20210630134709.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081202
=035  \\$a(NLM)9812406185400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x694
=072  \\$aN3.$x706.$x437.$x694
=150  \\$aRight to Work
=450  \\$aRight To Employment
=450  \\$wnnna$aEmployment, Right To
=450  \\$wnnna$aEmployments, Right To
=450  \\$wnnna$aRight To Employments
=450  \\$wnnna$aRight to Works
=680  \\$iThe right of individuals to work, to free choice of employment, to just and favorable conditions of work and to protection against unemployment.
=688  \\$a2020
=750  \0$aRight to labor$0(DLC)sh 85114090$5IEN-M

=LDR  01355cz  a2200301n  4500
=001  9881668570402441
=005  20210630134156.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080564
=035  \\$a(NLM)9812405974300041
=040  \\$aDNLM$cDNLM
=060  \0$aW 68
=072  \\$aI1.$x880.$x604.$x473.$x688
=072  \\$aN3.$x706.$x437.$x688
=072  \\$aN4.$x590.$x374.$x350.$x750
=150  \\$aRight to Health
=450  \\$aHealth Rights
=450  \\$aHealthcare Rights
=450  \\$aRight to Health Care
=450  \\$aRight to Healthcare
=450  \\$wnnna$aHealthcare Right
=450  \\$wnnna$aHealthcare, Right to
=450  \\$wnnna$aHealthcares, Right to
=450  \\$wnnna$aRight, Healthcare
=450  \\$wnnna$aRights, Healthcare
=680  \\$iRight to accessible health services physically within reach for all sections of the population, including children, adolescents, older persons, persons with disabilities and other vulnerable groups as well as financially and on the basis of non-discrimination. Accessibility also implies the right to seek, receive and impart health-related information in an accessible format for all, including persons with disabilities, but does not impair the right to have personal health data treated confidentially.
=688  \\$a2020
=750  \0$aRight to health$0(DLC)sh 91000162$5IEN-M

=LDR  00755nz  a2200241n  4500
=001  9881686329302441
=005  20210708124505.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080763
=035  \\$a(NLM)9812405954200041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x625.$x770
=072  \\$aG16.$x500.$x175.$x374.$x750
=072  \\$aG16.$x500.$x971.$x500
=150  \\$aSea Level Rise
=450  \\$aRising Sea Level
=450  \\$aSea-Level Rise
=450  \\$wnnna$aRising Sea Levels
=450  \\$wnnna$aSea Level, Rising
=450  \\$wnnna$aSea Levels, Rising
=680  \\$iAn increase in the volume of the oceans and seas causing an elevation of the air-sea interface.
=688  \\$a2020
=750  \0$aSea level$0(DLC) sh 85119230$5IEN-M

=LDR  00755cz  a2200217n  4500
=001  9881686329602441
=005  20210708123542.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000079691
=035  \\$a(NLM)9812405788200041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 352
=072  \\$aN2.$x421.$x461.$x581
=072  \\$aN2.$x421.$x726.$x809.$x659
=072  \\$aN4.$x880
=150  \\$aSchool Mental Health Services
=450  \\$aSchool-Based Mental Health Services
=450  \\$wnnna$aSchool Based Mental Health Services
=680  \\$iServices which focus on the mental well-being of pre-college and pre-university students that include COUNSELING and therapy.
=688  \\$a2020
=750  \0$aSchool mental health services$0(DLC) sh2008005028$5IEN-M

=LDR  01219cz  a2200289n  4500
=001  9881686329802441
=005  20210708122901.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080522
=035  \\$a(NLM)9812405996200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x988.$x400.$x600.$x150.$x170.$x560.$x500
=150  \\$aSapajus apella
=450  \\$aCebus apella
=450  \\$aCebus apella macrocephalus
=450  \\$aGuianan Brown Capuchin
=450  \\$aTufted Capuchin Monkeys
=450  \\$wnnna$aBrown Capuchin, Guianan
=450  \\$wnnna$aCapuchin Monkey, Tufted
=450  \\$wnnna$aCapuchin, Guianan Brown
=450  \\$wnnna$aGuianan Brown Capuchins
=450  \\$wnnna$aMonkey, Tufted Capuchin
=450  \\$wnnna$aTufted Capuchin Monkey
=667  \\$aNIM when experimental animal; diseases: coordinate with MONKEY DISEASES
=680  \\$iA species of the genus SAPAJUS, subfamily CEBINAE, family CEBIDAE, consisting of tufted capuchin monkeys with characteristic black head cap and sideburn coloration with tufts of dark fur above the ears. S. apella was known as Cebus apella and C. a. apella.
=688  \\$a2020
=750  \0$aCebus apella$0(DLC) sh 85021586$5IEN-M

=LDR  00753nz  a2200229n  4500
=001  9881686330002441
=005  20210708120844.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080463
=035  \\$a(NLM)9812406006000041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x721.$x750
=072  \\$aG1.$x311.$x330.$x500
=072  \\$aG1.$x311.$x820.$x750
=072  \\$aG16.$x500.$x275.$x815.$x750
=072  \\$aG16.$x500.$x320.$x500
=072  \\$aN6.$x230.$x600.$x750
=150  \\$aSand
=450  \\$wnnna$aSands
=680  \\$iA hard granular material that is a component of soil. It is composed of very small pieces (between 0.06 and 2.0 millimeters in diameter) of disintegrating rock.
=688  \\$a2020
=750  \0$aSand$0DLC) sh 85117166$5IEN-M

=LDR  00580nz  a2200181n  4500
=001  9881686330302441
=005  20210708120152.0
=008  190709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080682
=035  \\$a(NLM)9812405963900041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x300.$x756
=072  \\$aJ2.$x500.$x756
=150  \\$aSalads
=450  \\$aSalad
=680  \\$iA prepared mixture of cooked and/or raw vegetables, FRUIT, or other foods, garnished with a dressing CONDIMENT, and eaten as a MEAL or side dish.
=688  \\$a2020
=750  \0$aSalads$0(DLC) sh 85116680$5IEN-M

=LDR  00734cz  a2200181n  4500
=001  9881689444302441
=005  20210720150843.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080442
=035  \\$a(NLM)9812406017500041
=040  \\$aDNLM$cDNLM
=060  \0$aHM 683
=072  \\$aF1.$x829.$x401.$x694
=150  \\$aSocial Integration
=450  \\$wnnna$aIntegration, Social
=680  \\$iA dynamic and principled process where all members participate in dialogue to achieve and maintain peaceful social relations. It does not include coerced assimilation or forced integration. (from https://www.un.org/esa/socdev/sib/peacedialogue/soc_integration.htm)
=688  \\$a2020
=750  \0$aSocial integration$0(DLC)sh 85123964$5IEN-M

=LDR  01748cz  a2200541n  4500
=001  9881689444502441
=005  20210720145907.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080745
=035  \\$a(NLM)9812405958000041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 37.5.S6
=072  \\$aD5.$x937
=072  \\$aD25.$x860
=072  \\$aD27.$x720.$x102.$x751
=072  \\$aJ1.$x637.$x51.$x860
=150  \\$aSmart Materials
=450  \\$aActuating Material
=450  \\$aActuating Materials
=450  \\$aAdaptive Material
=450  \\$aAdaptive Materials
=450  \\$aIntelligent Material
=450  \\$aIntelligent Materials
=450  \\$aSensing Material
=450  \\$aSensing Materials
=450  \\$aShape Memory Material
=450  \\$aShape Memory Materials
=450  \\$aShape Memory Polymer
=450  \\$aShape Memory Polymers
=450  \\$aShape-Memory Material
=450  \\$aShape-Memory Materials
=450  \\$aShape-Memory Polymer
=450  \\$aShape-Memory Polymers
=450  \\$aSmart Material
=450  \\$wnnna$aMaterial, Actuating
=450  \\$wnnna$aMaterial, Adaptive
=450  \\$wnnna$aMaterial, Intelligent
=450  \\$wnnna$aMaterial, Sensing
=450  \\$wnnna$aMaterial, Shape Memory
=450  \\$wnnna$aMaterial, Shape-Memory
=450  \\$wnnna$aMaterial, Smart
=450  \\$wnnna$aMemory Material, Shape
=450  \\$wnnna$aMemory Polymer, Shape
=450  \\$wnnna$aPolymer, Shape Memory
=450  \\$wnnna$aPolymer, Shape-Memory
=680  \\$iMaterials designed to change properties in response to changes in their environment adopting various predetermined shapes and/or functionalities.
=688  \\$a2020
=750  \0$aSmart materials$0(DLC)sh 90000355$5IEN-M

=LDR  01084nz  a2200313n  4500
=001  9881689444802441
=005  20210720144207.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081002
=035  \\$a(NLM)9812406061600041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x250.$x868
=072  \\$aK1.$x400.$x504.$x968.$x725
=150  \\$aSino-Japanese War
=450  \\$a2nd Sino-Japanese War
=450  \\$aSecond Sino-Japanese War 1937-1945
=450  \\$aSino-Japanese War 1937-1945
=450  \\$wnnna$a1937-1945, Sino-Japanese War
=450  \\$wnnna$a2nd Sino Japanese War
=450  \\$wnnna$aSecond Sino Japanese War 1937 1945
=450  \\$wnnna$aSino Japanese War
=450  \\$wnnna$aSino Japanese War 1937 1945
=450  \\$wnnna$aSino-Japanese War, 2nd
=450  \\$wnnna$aSino-Japanese Wars, 2nd
=450  \\$wnnna$aWar 1937-1945, Sino-Japanese
=450  \\$wnnna$aWar, Sino-Japanese
=680  \\$iMilitary conflict involving China and Japan 1937 - 1945.
=688  \\$a2020
=750  \0$aSino-Japanese War, 1937-1945$0(DLC) sh 85122898$5IEN-M

=LDR  00814nz  a2200229n  4500
=001  9881689765302441
=005  20210714151415.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080883
=035  \\$a(NLM)9812406115300041
=040  \\$aDNLM$cDNLM
=072  \\$aC13.$x703.$x420.$x288.$x364
=150  \\$aShoulder Dystocia
=450  \\$aFetal Shoulder Dystocia
=450  \\$wnnna$aDystocia, Fetal Shoulder
=450  \\$wnnna$aDystocia, Shoulder
=450  \\$wnnna$aFetal Shoulder Dystocias
=450  \\$wnnna$aShoulder Dystocia, Fetal
=450  \\$wnnna$aShoulder Dystocias
=680  \\$iObstetric complication during OBSTETRIC DELIVERY in which exit of the fetus is delayed due to physical obstruction involving fetal shoulder(s).
=688  \\$a2020
=750  \0$aShoulder dystocia$5IEN$0(DLC)sh 90006064

=LDR  00891nz  a2200289n  4500
=001  9881689765702441
=005  20210714145220.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080743
=035  \\$a(NLM)9812405959900041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x552.$x33.$x769
=072  \\$aD5.$x937.$x250
=072  \\$aD25.$x58.$x664
=072  \\$aD25.$x860.$x250
=072  \\$aD27.$x720.$x102.$x751.$x250
=072  \\$aJ1.$x637.$x51.$x58.$x664
=072  \\$aJ1.$x637.$x51.$x860.$x250
=150  \\$aShape Memory Alloys
=450  \\$aShape-Memory Alloys
=450  \\$wnnna$aAlloy, Shape Memory
=450  \\$wnnna$aAlloy, Shape-Memory
=450  \\$wnnna$aShape Memory Alloy
=450  \\$wnnna$aShape-Memory Alloy
=680  \\$iALLOYS designed to recover their original shape upon heating.
=688  \\$a2020
=750  \0$aShape memory alloys$0(DLC) sh 96009394$5IEN-M

=LDR  01977cz  a2200445n  4500
=001  9881692030102441
=005  20210728130058.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080311
=035  \\$a(NLM)9812405876000041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 204
=072  \\$aC10.$x597.$x606.$x762.$x850
=150  \\$aSynesthesia
=450  \\$aChromesthesia
=450  \\$aColored Hearing Synesthesia
=450  \\$aGrapheme-Color Synesthesia
=450  \\$aIdeaesthesia
=450  \\$aIdeasthesia
=450  \\$aLexical-Gustatory Synesthesia
=450  \\$wnnna$aChromesthesias
=450  \\$wnnna$aColored Hearing Synesthesias
=450  \\$wnnna$aGrapheme Color Synesthesia
=450  \\$wnnna$aGrapheme-Color Synesthesias
=450  \\$wnnna$aHearing Synesthesia, Colored
=450  \\$wnnna$aHearing Synesthesias, Colored
=450  \\$wnnna$aIdeaesthesias
=450  \\$wnnna$aIdeasthesias
=450  \\$wnnna$aLexical Gustatory Synesthesia
=450  \\$wnnna$aLexical-Gustatory Synesthesias
=450  \\$wnnna$aSynesthesia, Colored Hearing
=450  \\$wnnna$aSynesthesia, Grapheme-Color
=450  \\$wnnna$aSynesthesia, Lexical-Gustatory
=450  \\$wnnna$aSynesthesias
=450  \\$wnnna$aSynesthesias, Colored Hearing
=450  \\$wnnna$aSynesthesias, Grapheme-Color
=450  \\$wnnna$aSynesthesias, Lexical-Gustatory
=680  \\$iThe experience of involuntary sensory cross activation where the presentation of a particular stimulus elicits a secondary sensory-perceptual experience. It most commonly occurs in the association of color with linguistic stimuli such as letters, numbers, words, or music, but can also occur between other senses. Although synesthesia can be acquired or transient due to trauma or drug use, there is also a strong genetic component, with a prevalence of about 1 in 2,000 individuals and a female to male ratio of 6:1.
=688  \\$a2020(2011)
=750  \0$aSynesthesia$0(DLC) sh 85131632$5IEN-M

=LDR  01268nz  a2200313n  4500
=001  9881692049402441
=005  20210721123059.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080888
=035  \\$a(NLM)9812406104800041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x597.$x606.$x150.$x500.$x550.$x500
=072  \\$aC23.$x888.$x592.$x604.$x150.$x500.$x550.$x500
=072  \\$aC23.$x888.$x592.$x604.$x150.$x550.$x600
=150  \\$aSpecific Language Disorder
=450  \\$aSpecific Language Impairment
=450  \\$wnnna$aDisorder, Specific Language
=450  \\$wnnna$aDisorders, Specific Language
=450  \\$wnnna$aImpairment, Specific Language
=450  \\$wnnna$aImpairments, Specific Language
=450  \\$wnnna$aLanguage Disorder, Specific
=450  \\$wnnna$aLanguage Disorders, Specific
=450  \\$wnnna$aLanguage Impairment, Specific
=450  \\$wnnna$aLanguage Impairments, Specific
=450  \\$wnnna$aSpecific Language Disorders
=450  \\$wnnna$aSpecific Language Impairments
=680  \\$iLanguage disorder that delays the mastery of oral language skills or  in children who have no hearing loss or other developmental delays.
=688  \\$a2020
=750  \0$aSpecific language imparment in children$0(DLC) sh 00002036$5IEN-M

=LDR  00922cz  a2200181n  4500
=001  9881692050402441
=005  20210721121447.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080546
=035  \\$a(NLM)9812405981300041
=040  \\$aDNLM$cDNLM
=060  \0$aWD 751
=072  \\$aH1.$x770.$x644.$x966
=150  \\$aSpace Research
=450  \\$wnnna$aResearch, Space
=680  \\$iStudies of interactions between living organisms and characteristics of the extraterrestrial environment. These studies specifically address the structure and function of living organisms in an extraterrestrial environment and interdependent relationships of organisms with each other and/or the extraterrestrial environment while also touching on the origin, evolution and potential for extraterrestrial life. (From www.nasa.gov/audience/foreducators/spacelife/)
=688  \\$a2020
=750  \0$aSpace sciences$0(DLC) sh 85125953$5IEN-M

=LDR  00942nz  a2200205n  4500
=001  9881692236502441
=005  20210726124400.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080485
=035  \\$a(NLM)9812406004500041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x490.$x746
=072  \\$aC23.$x550.$x260.$x322.$x812
=150  \\$aSudden Unexpected Death in Epilepsy
=450  \\$aSUDEP
=680  \\$iSudden death in a patient with EPILEPSY associated with SEIZURES and seizure-related symptoms (e.g., APNEA; HYPOXEMIA) without other identifiable accidental causes (e.g., DROWNING; WOUNDS AND INJURIES).
=688  \\$a2020
=750  \0$81$wb$iBroader mapping$aSudden death$0(DLC)sh 85129615$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aEpilepsy$0(DLC)sh 85044401$4BM$5IEN-M
=788  \0$aSearch also under the following Library of Congress Subject Headings used together in the same record$aSudden death$iand$aEpilepsy

=LDR  00823nz  a2200205n  4500
=001  9881642373202441
=005  20210506161933.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081186
=035  \\$a(NLM)9812406171900041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x134.$x250
=072  \\$aN4.$x452.$x910.$x200.$x250
=150  \\$aBlockchain
=450  \\$aBlock Chain
=450  \\$wnnna$aBlock Chains
=450  \\$wnnna$aBlockchains
=680  \\$iDecentralized transaction and data management technology providing security, anonymity and data integrity without any third party control of transactions. Related research is focused on improving aspects  regarding privacy and security. (From PLoS One. 2016 Oct 3;11(10):e0163477)
=688  \\$a2020
=750  \0$aBlockchains (Databases)$0(DLC)sh2016002790$5IEN-M

=LDR  00599cz  a2200169n  4500
=001  9881642373402441
=005  20210506155840.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000080803
=035  \\$a(NLM)9812405952300041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x944.$x730.$x500
=150  \\$aBiosolids
=450  \\$aBiosolid
=680  \\$iWastewater SLUDGE treated by processes such as COMPOSTING, anaerobic digestion, aerobic digestion, alkaline treatment, and PASTEURIZATION to remove HAZARDOUS CHEMICALS and pathogens.
=688  \\$a2020
=750  \0$aSewage sludge$0(DLC)sh 85120516$5IEN-M

=LDR  01559nz  a2200421n  4500
=001  9881642373702441
=005  20210506152751.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000081482
=035  \\$a(NLM)9812406307700041
=040  \\$aDNLM$cDNLM
=072  \\$aG3.$x15.$x500.$x187
=072  \\$aG3.$x787.$x24.$x500.$x187
=072  \\$aG7.$x690.$x725.$x15.$x500.$x187
=150  \\$aBioaccumulation
=450  \\$aBio Accumulation
=450  \\$aBio Amplification
=450  \\$aBio Concentration
=450  \\$aBio Magnification
=450  \\$aBio-accumulation
=450  \\$aBio-amplification
=450  \\$aBio-concentration
=450  \\$aBio-magnification
=450  \\$aBioamplification
=450  \\$aBioconcentration
=450  \\$aBiomagnification
=450  \\$wnnna$aBio Amplifications
=450  \\$wnnna$aBio-accumulations
=450  \\$wnnna$aBio-amplifications
=450  \\$wnnna$aBio-concentrations
=450  \\$wnnna$aBio-magnifications
=450  \\$wnnna$aBioamplifications
=450  \\$wnnna$aBioconcentrations
=450  \\$wnnna$aBiomagnifications
=550  \\$aChemically-Induced Disorders
=680  \\$iAn increase in the concentration of an exogenous substance in the tissues of organisms higher than surrounding ENVIRONMENT. Accumulation of such XENOBIOTICS at successively higher levels up the FOOD CHAIN is called biomagnification. Bioaccumulation of toxic chemicals (e.g., Lead and DDT) may result in CHEMICALLY-INDUCED DISORDERS.
=688  \\$a2020
=750  \0$aBioaccumulation$0(DLC) sh 89001251$5IEN-M

=LDR  03009cz  a2200649n  4500
=001  9881716705902441
=005  20210818144614.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000086382
=035  \\$a(NLM)9817067906800041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x748.$x214
=072  \\$aC1.$x748.$x610.$x763.$x500
=072  \\$aC1.$x925.$x705.$x500
=072  \\$aC1.$x925.$x782.$x600.$x550.$x200.$x163
=072  \\$aC8.$x381.$x677.$x807.$x500
=072  \\$aC8.$x730.$x214
=072  \\$aC8.$x730.$x610.$x763.$x500
=150  \\$aCOVID-19
=450  \\$wnnna$aCOVID19
=450  \\$a2019 Novel Coronavirus Disease
=450  \\$a2019 Novel Coronavirus Infection
=450  \\$a2019-nCoV Disease
=450  \\$a2019-nCoV Infection
=450  \\$aCOVID-19 Pandemic
=450  \\$aCOVID-19 Pandemics
=450  \\$aCOVID-19 Virus Disease
=450  \\$aCOVID-19 Virus Infection
=450  \\$aCoronavirus Disease 2019
=450  \\$aCoronavirus Disease-19
=450  \\$aSARS Coronavirus 2 Infection
=450  \\$aSARS-CoV-2 Infection
=450  \\$wnnna$a2019 nCoV Disease
=450  \\$wnnna$a2019 nCoV Infection
=450  \\$wnnna$a2019-nCoV Diseases
=450  \\$wnnna$a2019-nCoV Infections
=450  \\$wnnna$aCOVID 19
=450  \\$wnnna$aCOVID 19 Pandemic
=450  \\$wnnna$aCOVID 19 Virus Disease
=450  \\$wnnna$aCOVID 19 Virus Infection
=450  \\$wnnna$aCOVID-19 Virus Diseases
=450  \\$wnnna$aCOVID-19 Virus Infections
=450  \\$wnnna$aCoronavirus Disease 19
=450  \\$wnnna$aDisease 2019, Coronavirus
=450  \\$wnnna$aDisease, 2019-nCoV
=450  \\$wnnna$aDisease, COVID-19 Virus
=450  \\$wnnna$aInfection, 2019-nCoV
=450  \\$wnnna$aInfection, COVID-19 Virus
=450  \\$wnnna$aInfection, SARS-CoV-2
=450  \\$wnnna$aPandemic, COVID-19
=450  \\$wnnna$aSARS CoV 2 Infection
=450  \\$wnnna$aSARS-CoV-2 Infections
=450  \\$wnnna$aVirus Disease, COVID-19
=450  \\$wnnna$aVirus Infection, COVID-19
=680  \\$iA viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
=688  \\$a2021(2020)
=750  \0$aCovid-19 (Disease)$0(DLC)sh2020000570$5IEN-M

=LDR  00655cz  a2200193n  4500
=001  9881716706102441
=005  20210818143251.0
=008  030709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D042621
=035  \\$a(NLM)98196992500000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x400.$x425.$x293
=072  \\$aB3.$x660.$x75.$x90.$x766
=150  \\$aComamonadaceae
=450  \\$aAcidovorax
=450  \\$aHydrogenophaga
=680  \\$iA family of gram-negative aerobic bacteria in the order BURKHOLDERIALES, encompassing the acidovorans rRNA complex. Some species are pathogenic to PLANTS.
=688  \\$a2004
=750  \0$aComamonadaceae$0(DLC)sh2019103544$5IEN-M

=LDR  00552cz  a2200157n  4500
=001  9881716706302441
=005  20210818142552.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000073556
=035  \\$a(NLM)9810900687300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x75.$x90
=150  \\$aBurkholderiales
=680  \\$iAn order of gram-negative bacteria of the class BETAPROTEOBACTERIA which include highly pathogenic species such as BURKHOLDERIA; BORDETELLA; and RALSTONIA.
=688  \\$a2018
=750  \0$aBurkholderiales$0(DLC)sh2020000951$IEN-M

=LDR  00632cz  a2200181n  4500
=001  9881716706602441
=005  20210818140935.0
=008  991103\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D020562
=035  \\$a(NLM)98194213530000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x75
=150  \\$aBetaproteobacteria
=450  \\$wnnna$aProteobacteria beta
=450  \\$abeta Proteobacteria
=680  \\$iA class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material.
=688  \\$a2004 (2000)
=750  \0$aBetaproteobacteria$0(DLC)sh2020000950$5IEN-M

=LDR  02164cz  a2200421n  4500
=001  9881713700402441
=005  20210810235353.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D008342
=035  \\$a(NLM)98195060630000041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 705
=072  \\$aC5.$x116.$x99.$x370.$x231.$x576
=072  \\$aC5.$x660.$x207.$x231.$x576
=072  \\$aC11.$x270.$x147.$x750
=072  \\$aC16.$x131.$x621.$x207.$x231.$x576
=150  \\$aMandibulofacial Dysostosis
=450  \\$wnnna$aFranceschetti-Zwahlen-Klein Syndrome
=450  \\$wnnna$aMandibulofacial Dysostosis (MFD1)
=450  \\$wnnna$aTreacher Collins-Franceschetti Syndrome
=450  \\$aTreacher Collins Syndrome
=450  \\$wnnna$aDysostoses, Mandibulofacial
=450  \\$wnnna$aDysostoses, Mandibulofacial (MFD1)
=450  \\$wnnna$aDysostosis, Mandibulofacial
=450  \\$wnnna$aDysostosis, Mandibulofacial (MFD1)
=450  \\$wnnna$aFranceschetti Zwahlen Klein Syndrome
=450  \\$wnnna$aFranceschetti-Zwahlen-Klein Syndromes
=450  \\$wnnna$aMandibulofacial Dysostoses
=450  \\$wnnna$aMandibulofacial Dysostoses (MFD1)
=450  \\$wnnna$aSyndrome, Franceschetti-Zwahlen-Klein
=450  \\$wnnna$aSyndrome, Treacher Collins
=450  \\$wnnna$aSyndrome, Treacher Collins-Franceschetti
=450  \\$wnnna$aSyndromes, Franceschetti-Zwahlen-Klein
=450  \\$wnnna$aSyndromes, Treacher Collins-Franceschetti
=450  \\$wnnna$aTreacher Collins Franceschetti Syndrome
=450  \\$wnnna$aTreacher Collins-Franceschetti Syndromes
=680  \\$iA hereditary disorder occurring in two forms: the complete form (Franceschetti's syndrome) is characterized by antimongoloid slant of the palpebral fissures, COLOBOMA of the lower lid, MICROGNATHIA and hypoplasia of the ZYGOMATIC ARCHES, and CONGENITAL MICROTIA. It is transmitted as an autosomal trait. The incomplete form (Treacher Collins syndrome) is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. (Dorland, 27th ed)
=750  \0$aMandibulofacial dysostosis$0(DLC)sh2019103372$5IEN-M

=LDR  01536cz  a2200361n  4500
=001  9881718390402441
=005  20210928160156.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D010144
=035  \\$a(NLM)98198506360000041
=040  \\$aDNLM$cDNLM
=072  \\$aC4.$x557.$x470.$x200.$x240.$x187.$x500
=072  \\$aC4.$x557.$x470.$x615.$x275.$x625
=150  \\$aPaget's Disease, Mammary
=450  \\$wnnna$aMammary Paget Disease
=450  \\$wnnna$aMammary Paget's Disease
=450  \\$wnnna$aPaget Disease of Breast
=450  \\$wnnna$aPaget Disease, Mammary
=450  \\$wnnna$aPaget's Disease of the Breast
=450  \\$wnnna$aPaget's Disease of the Nipple
=450  \\$wnnna$aPaget's Disease of the Nipple and Areola
=450  \\$wnnna$aPigmented Mammary Paget Disease
=450  \\$aPaget's Disease of Breast
=450  \\$wnnna$aDisease, Mammary Paget
=450  \\$wnnna$aDisease, Mammary Paget's
=450  \\$wnnna$aMammary Pagets Disease
=450  \\$wnnna$aPaget Disease, Breast
=450  \\$wnnna$aPagets Disease, Breast
=450  \\$wnnna$aPagets Disease, Mammary
=667  \\$acoordinate IM with BREAST NEOPLASMS (IM)
=680  \\$iAn intraductal in situ carcinoma of the breast, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (Paget's cells).
=688  \\$a94; was PAGET'S DISEASE OF BREAST 1975-93 (see under CARCINOMA, DUCTAL 1975-90)
=750  \0$aPaget's disease of the breast$0(DLC)sh2019103354$5IEN-M

=LDR  00572nz  a2200181n  4500
=001  9881743835902441
=005  20211019170859.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D000084783
=035  \\$a(NLM)9817067739400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x683
=150  \\$aRecreational Drug Use
=450  \\$wnnna$aDrug Use, Recreational
=450  \\$wnnna$aRecreational Drug Uses
=680  \\$iOccasional or habitual non-prescribed, not health-related use of substances.
=688  \\$a2021
=750  \0$aRecreational drug use$0(DLC)sh2020000341$5IEN-M

=LDR  01838cz  a2200541n  4500
=001  9880364061102441
=005  20211215200649.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014019
=040  \\$aDNLM$beng$cDNLM
=072  \\$aM1.$x898
=150  \\$aTissue Donors
=450  \\$wnnna$aDonor
=450  \\$wnnna$aDonor, Organ
=450  \\$wnnna$aDonor, Ovum
=450  \\$wnnna$aDonor, Semen
=450  \\$wnnna$aDonor, Tissue
=450  \\$wnnna$aDonor, Transplant
=450  \\$wnnna$aDonors
=450  \\$wnnna$aDonors, Organ
=450  \\$wnnna$aDonors, Ovum
=450  \\$wnnna$aDonors, Semen
=450  \\$wnnna$aDonors, Tissue
=450  \\$wnnna$aDonors, Transplant
=450  \\$wnnna$aOrgan Donor
=450  \\$aOrgan Donors
=450  \\$wnnna$aOvum Donor
=450  \\$wnnna$aOvum Donors
=450  \\$wnnna$aSemen Donor
=450  \\$wnnna$aSemen Donors
=450  \\$wnnna$aTissue Donor
=450  \\$wnnna$aTransplant Donor
=450  \\$wnnna$aTransplant Donors
=550  \\$wg$aPersons
=550  \\$wh$aBlood Donors
=550  \\$wh$aLiving Donors
=550  \\$wh$aUnrelated Donors
=550  \\$aDirected Tissue Donation
=550  \\$aTissue and Organ Procurement
=550  \\$aTissue Transplantation
=550  \\$aTransplant Donor Site
=550  \\$aTransplantation
=667  \\$asemen or sperm donors: coord IM with SEMEN (IM) or SPERMATOZOA (IM); consider also INSEMINATION, ARTIFICIAL, HOMOLOGOUS (husband) (IM) or INSEMINATION, ARTIFICIAL, HETEROLOGOUS (non-husband) (IM)
=680  \\$iIndividuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.
=688  \\$a1967(1964)
=688  \\$a67(64)
=750  \0$aOrgan donors$5IEN-M$0(DLC)sh 85095463
=750  \0$aEgg donors$0(DLC)sh2005007904$5IEN-M

=LDR  01213cz  a2200265n  4500
=001  9880364109402441
=005  20211215210917.0
=008  910211\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D016524
=035  \\$aCBP3639HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aN1.$x824.$x417.$x700.$x162.$x500
=072  \\$aN4.$x452.$x677.$x800.$x162.$x500
=150  \\$aParental Leave
=450  \\$wnnna$aLeave, Maternity
=450  \\$wnnna$aLeave, Parental
=450  \\$wnnna$aLeave, Paternity
=450  \\$aMaternity Leave
=450  \\$aPaternity Leave
=550  \\$wg$aFamily Leave
=667  \\$aprenatal & postnatal leave, leave for illness of a child or leave for adoption procedures; do not confuse with FAMILY LEAVE: see MeSH definition
=680  \\$iThe authorized absence from work of either parent prior to and after the birth of their child. It includes also absence because of the illness of a child or at the time of the adoption of a child. It does not include leave for care of siblings, parents, or other family members: for this FAMILY LEAVE is available.
=688  \\$a92
=750  \0$iNarrower mapping$aPaternity leave$0(DLC)sh2020000156$4NM$5IEN-M

=LDR  01285cz  a2200361n  4500
=001  9880364552902441
=005  20141212221927.0
=008  100625\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D057829
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x906
=150  \\$aSex Reassignment Procedures
=450  \\$wnnna$aGender Change Procedure
=450  \\$wnnna$aGender Change Procedures
=450  \\$wnnna$aGender Reassignment Procedure
=450  \\$wnnna$aGender Reassignment Procedures
=450  \\$wnnna$aProcedure, Gender Change
=450  \\$wnnna$aProcedure, Gender Reassignment
=450  \\$wnnna$aProcedure, Sex Change
=450  \\$wnnna$aProcedure, Sex Reassignment
=450  \\$wnnna$aProcedures, Gender Change
=450  \\$wnnna$aProcedures, Gender Reassignment
=450  \\$wnnna$aProcedures, Sex Change
=450  \\$wnnna$aProcedures, Sex Reassignment
=450  \\$wnnna$aSex Change Procedure
=450  \\$wnnna$aSex Change Procedures
=450  \\$wnnna$aSex Reassignment Procedure
=550  \\$wg$aTherapeutics
=550  \\$wh$aSex Reassignment Surgery
=550  \\$aTranssexualism
=680  \\$iClinical treatments used to change the physiological sexual characteristics of an individual.
=688  \\$a2011
=750  \0$aSex change$0(DLC) sh 85120565$5IEN-M

=LDR  01674nz  a2200397n  4500
=001  9881773204502441
=005  20211215193608.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D027724
=035  \\$a(DNLM)D027724
=035  \\$a(NLM)98195752780000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x875.$x800
=072  \\$aE5.$x820.$x800
=150  \\$aReproductive Techniques, Assisted
=450  \\$wnnna$aAssisted Reproductive Technics
=450  \\$wnnna$aAssisted Reproductive Techniques
=450  \\$aReproductive Technology, Assisted
=450  \\$wnnna$aAssisted Reproductive Technic
=450  \\$wnnna$aAssisted Reproductive Technique
=450  \\$wnnna$aAssisted Reproductive Technologies
=450  \\$wnnna$aAssisted Reproductive Technology
=450  \\$wnnna$aReproductive Technic, Assisted
=450  \\$wnnna$aReproductive Technics, Assisted
=450  \\$wnnna$aReproductive Technique, Assisted
=450  \\$wnnna$aReproductive Technologies, Assisted
=450  \\$wnnna$aTechnic, Assisted Reproductive
=450  \\$wnnna$aTechnics, Assisted Reproductive
=450  \\$wnnna$aTechnique, Assisted Reproductive
=450  \\$wnnna$aTechniques, Assisted Reproductive
=450  \\$wnnna$aTechnologies, Assisted Reproductive
=450  \\$wnnna$aTechnology, Assisted Reproductive
=667  \\$ausually for humans; may be used for animals if specified; otherwise use BREEDING or its specifics; REPRODUCTIVE TECHNIQUES is also available
=680  \\$iClinical and laboratory techniques used to enhance fertility in humans and animals.
=688  \\$a2002
=750  \0$aHuman reproductive technology$0(DLC)sh 88005587$5IEN-M

=LDR  01152nz  a2200337n  4500
=001  9881773206102441
=005  20211215143410.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D057830
=035  \\$a(DNLM)D057830
=035  \\$a(NLM)98195788120000041
=040  \\$aDNLM$cDNLM
=060  \0$aWO 620
=072  \\$aE2.$x906.$x500
=072  \\$aE4.$x680.$x750
=072  \\$aE4.$x950.$x449
=150  \\$aSex Reassignment Surgery
=450  \\$wnnna$aGender Change Surgery
=450  \\$wnnna$aGender Confirmation Surgery
=450  \\$wnnna$aGender Reassignment Surgery
=450  \\$wnnna$aSex Change Surgery
=450  \\$wnnna$aConfirmation Surgery, Gender
=450  \\$wnnna$aGender Change Surgeries
=450  \\$wnnna$aGender Confirmation Surgeries
=450  \\$wnnna$aGender Reassignment Surgeries
=450  \\$wnnna$aSex Change Surgeries
=450  \\$wnnna$aSex Reassignment Surgeries
=550  \\$aTranssexualism
=680  \\$iSurgical treatments used to change the physiological sexual characteristics of an individual.
=688  \\$a2011
=750  \0$aGender reassignment surgery$0(DLC)sh2020000651$5IEN-M

=LDR  00931nz  a2200205n  4500
=001  9881769911002441
=005  20211207124257.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005319
=035  \\$a(DNLM)D005319
=035  \\$a(NLM)98195599950000041
=040  \\$aDNLM$cDNLM
=060  \0$aWQ 210.5
=072  \\$aD12.$x776.$x124.$x400.$x303
=072  \\$aD12.$x776.$x422.$x316.$x762.$x320
=150  \\$aFetal Hemoglobin
=450  \\$aHemoglobin F
=450  \\$wnnna$aHemoglobin, Fetal
=680  \\$iThe major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.
=750  \0$aFetal hemoglobin$0(DLC)sh2020005497$5IEN

=LDR  00715nz  a2200205n  4500
=001  9881769911402441
=005  20211207121911.0
=008  930604\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017910
=035  \\$a(DNLM)D017910
=035  \\$a(NLM)98197020520000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x123.$x691.$x230
=072  \\$aB4.$x820.$x223.$x625
=150  \\$aCystoviridae
=450  \\$aCystovirus
=667  \\$acoordinate with specific bacterium /virol
=680  \\$iA family of bacteriophages containing one genus (Cystovirus) with one member (BACTERIOPHAGE PHI 6).
=688  \\$a1994; for CYSTOVIRUS use BACTERIOPHAGE PHI 6 1994-2001
=750  \0$aCystoviridae$0(DLC)sh2020001173$5IEN-M

=LDR  00545nz  a2200181n  4500
=001  9881769911502441
=005  20211207115748.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D052160
=035  \\$a(DNLM)D052160
=035  \\$a(NLM)98199294820000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x129.$x708.$x89
=072  \\$aD3.$x633.$x100.$x185
=150  \\$aBenzothiazoles
=680  \\$iCompounds with a benzene ring fused to a thiazole ring.
=688  \\$a2006
=750  \0$aBenzothiazoles$0(DLC)sh2020001192$5IEN-M

=LDR  01026nz  a2200277n  4500
=001  9881769912002441
=005  20211207115109.0
=008  920507\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017126
=035  \\$a(DNLM)D017126
=035  \\$a(NLM)98199165540000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x123.$x660.$x550
=072  \\$aB4.$x123.$x691.$x230.$x70
=072  \\$aB4.$x820.$x223.$x625.$x70
=150  \\$aBacteriophage phi 6
=450  \\$aPhage phi 6
=450  \\$aPseudomonas phage phi 6
=450  \\$aphi 6 Phage
=450  \\$wnnna$aPhage, phi 6
=450  \\$wnnna$aPhages, phi 6
=450  \\$wnnna$aphi 6 Phages
=667  \\$acoord IM with specific Pseudomonas /virol
=680  \\$iVirulent bacteriophage and sole member of the genus Cystovirus that infects Pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also a unique lipid-containing envelope.
=688  \\$a93
=750  \0$aBacteriophage phi 6$0(DLC)sh2020001171$5IEN-M

=LDR  01031nz  a2200253n  4500
=001  9881773092402441
=005  20211220124843.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D029322
=035  \\$a(DNLM)D029322
=035  \\$a(NLM)98196078770000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x820.$x578.$x298.$x550
=150  \\$aNorovirus
=450  \\$aNorwalk-like Viruses
=450  \\$aSmall Round-Structured Viruses
=450  \\$wnnna$aNoroviruses
=450  \\$wnnna$aNorwalk like Viruses
=450  \\$wnnna$aRound-Structured Viruses, Small
=450  \\$wnnna$aSmall Round Structured Viruses
=667  \\$ainfection: coord IM with CALICIVIRIDAE INFECTIONS + probably GASTROENTERITIS (IM)
=680  \\$iA genus in the family CALICIVIRIDAE, associated with epidemic GASTROENTERITIS in humans. The type species, NORWALK VIRUS, contains multiple strains.
=688  \\$a2004 (2002); for SMALL ROUND-STRUCTURED VIRUSES use NORWALK VIRUS 1992-2001
=750  \0$aNoroviruses$0(DLC)sh2020001152$5IEN-M

=LDR  01389nz  a2200325n  4500
=001  9881773092702441
=005  20211220122706.0
=008  920520\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017497
=035  \\$a(DNLM)D017497
=035  \\$a(NLM)98198937960000041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x150.$x252.$x819.$x420
=072  \\$aC1.$x800.$x720.$x420
=072  \\$aC1.$x830.$x499
=072  \\$aC17.$x800.$x838.$x765.$x420
=072  \\$aC17.$x800.$x946.$x315.$x320
=150  \\$aHidradenitis Suppurativa
=450  \\$wnnna$aHidradenitides, Suppurative
=450  \\$wnnna$aHidradenitis, Suppurative
=450  \\$wnnna$aSuppurative Hidradenitides
=450  \\$wnnna$aSuppurative Hidradenitis
=450  \\$aAcne Inversa
=450  \\$wnnna$aAcne Inversas
=450  \\$wnnna$aInversa, Acne
=450  \\$wnnna$aInversas, Acne
=550  \\$aAcne Vulgaris
=680  \\$iA chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
=688  \\$a93
=750  \0$aHidradenitis suppurativa$0(DLC)sh2020005465$5IEN-M

=LDR  00597nz  a2200181n  4500
=001  9881791995902441
=005  20211223125950.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091488
=035  \\$a(DNLM)D000091488
=035  \\$a(NLM)9819990669100041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x781.$x500
=072  \\$aI1.$x880.$x853.$x748.$x595
=150  \\$aOstracism
=680  \\$iAn extreme form of rejection in which one is excluded and ignored in the presence of others.
=688  \\$a2022
=750  \0$aOstracism (Psychology)$0(DLC)sh2020000135$5IEN-M

=LDR  02665nz  a2200517n  4500
=001  9881796231202441
=005  20220106145757.0
=008  070709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D054877
=035  \\$a(DNLM)D054877
=035  \\$a(NLM)98193826340000041
=040  \\$aDNLM$cDNLM
=072  \\$aC16.$x131.$x77.$x944
=072  \\$aC16.$x131.$x260.$x985
=072  \\$aC16.$x320.$x180.$x985
=150  \\$aWolf-Hirschhorn Syndrome
=450  \\$wnnna$a4p Deletion Syndrome
=450  \\$wnnna$a4p- Syndrome
=450  \\$wnnna$aChromosome 4p Deletion Syndrome
=450  \\$wnnna$aChromosome 4p Monosomy
=450  \\$wnnna$aChromosome 4p Syndrome
=450  \\$wnnna$aDel(4p) Syndrome
=450  \\$wnnna$aMental Retardation, Unusual Facies, And Intrauterine Growth Retardation
=450  \\$wnnna$aPartial Monosomy 4p
=450  \\$wnnna$aPitt Syndrome
=450  \\$wnnna$aPitt-Rogers-Danks Syndrome
=450  \\$wnnna$aWolf Syndrome
=450  \\$wnnna$aWolf-Hirchhorn Syndrome
=450  \\$wnnna$a4p Syndrome, Chromosome
=450  \\$wnnna$a4p Syndromes, Chromosome
=450  \\$wnnna$aChromosome 4p Syndromes
=450  \\$wnnna$aPitt Rogers Danks Syndrome
=450  \\$wnnna$aPitt Syndromes
=450  \\$wnnna$aSyndrome, Chromosome 4p
=450  \\$wnnna$aSyndrome, Pitt
=450  \\$wnnna$aSyndrome, Pitt-Rogers-Danks
=450  \\$wnnna$aSyndrome, Wolf
=450  \\$wnnna$aSyndrome, Wolf-Hirchhorn
=450  \\$wnnna$aSyndrome, Wolf-Hirschhorn
=450  \\$wnnna$aSyndromes, Chromosome 4p
=450  \\$wnnna$aSyndromes, Pitt
=450  \\$wnnna$aWolf Hirchhorn Syndrome
=450  \\$wnnna$aWolf Hirschhorn Syndrome
=680  \\$iA syndrome caused by large deletions of the telomereic end of the short arm of CHROMOSOME 4 (4p) in Wolf-Hirchhorn syndrome critial regions (WHSCRs). Several candidate genes have been identified including WHSC1 and WHSCH2 which appear to be responsible for the core phenotype and in combination with other linked and unlinked genes determine the severity and inclusion of rarer phenotypes. Most cases have a characteristic cranio-facial defect often referred to as "Greek helmet face" - a combined result of MICROCEPHALY, broad forehead, prominent glabella, HYPERTELORISM, high arched eyebrows, short philtrum and micrognathia. In addition there is mental retardation, growth delays, EPILEPSY, and frequently a wide range of midline and skeletal defects, including HYPOSPADIAS; CONGENITAL HEART DEFECTS; CLEFT LIP; CLEFT PALATE; colobomata; CLUBFOOT; clinodactyly; SCOLIOSIS; and KYPHOSIS.
=688  \\$a2008
=750  \0$aWolf-Hirschhorn syndrome$0(DLC)sh2020000548$5IEN-M

=LDR  00698nz  a2200193n  4500
=001  9881796231902441
=005  20220106133232.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D032121
=035  \\$a(DNLM)D032121
=035  \\$a(NLM)98198198160000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x882
=150  \\$aSalvadoraceae
=450  \\$aSalvadora
=450  \\$wnnna$aSalvadoras
=680  \\$iA plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida, a small family growing in the tropics. Members contain piperidine alkaloids and GLUCOSINOLATES.
=688  \\$a2003
=750  \0$aSalvadoraceae$0(DLC)sh2015002264$5IEN-M

=LDR  00424nz  a2200133n  4500
=001  9881796232102441
=005  20220106132210.0
=008  880516\n\ancnnbabn\\\\\\\\\\\n\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D015244Q000031
=035  \\$a(DNLM)D015244Q000031
=035  \\$a(NLM)98199353270000041
=040  \\$aDNLM$cDNLM
=150  \\$aThiorphan$xanalogs & derivatives
=750  \0$iNarrower mapping$aRacecadotril$0(DLC)sh2020000604$4NM$5IEN-M

=LDR  00929cz  a2200241n  4500
=001  9880363612402441
=005  20220113204729.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009024
=035  \\$aCBA2281HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aG7.$x700.$x320.$x500
=150  \\$aMorphogenesis
=550  \\$wg$aGrowth and Development
=550  \\$wh$aBody Patterning
=550  \\$wh$aEmbryonic and Fetal Development
=550  \\$wh$aMetamorphosis, Biological
=550  \\$aEpigenesis, Genetic
=667  \\$acoordinate with specific organ or organism / embryol or /growth
=680  \\$iThe development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.
=688  \\$a72(68)
=750  \0$aMorphogenesis$5IEN$0(DLC)sh 85087346
=750  \0$iNarrower mapping$aCytomorphogenesis$0(DLC)sh2020000995$4NM$5IEN-M

=LDR  01859nz  a2200433n  4500
=001  9881796326402441
=005  20220107143959.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005634
=035  \\$a(DNLM)D005634
=035  \\$a(NLM)98197007090000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x520.$x224.$x62.$x400
=150  \\$aFructose-Bisphosphate Aldolase
=450  \\$wnnna$aAldolase A
=450  \\$wnnna$aAldolase B
=450  \\$wnnna$aAldolase C
=450  \\$wnnna$aFructose 1,6-Bisphosphate Aldolase
=450  \\$wnnna$aFructose 1,6-Bisphosphate Aldolase, Class II
=450  \\$wnnna$aFructose 1-Phosphate Aldolase
=450  \\$wnnna$aFructose Biphosphate Aldolase
=450  \\$wnnna$aFructosemonophosphate Aldolase
=450  \\$aAldolase
=450  \\$aFructosediphosphate Aldolase
=450  \\$wnnna$a1,6-Bisphosphate Aldolase, Fructose
=450  \\$wnnna$aAldolase, Fructose 1,6-Bisphosphate
=450  \\$wnnna$aAldolase, Fructose 1-Phosphate
=450  \\$wnnna$aAldolase, Fructose Biphosphate
=450  \\$wnnna$aAldolase, Fructose-Bisphosphate
=450  \\$wnnna$aAldolase, Fructosediphosphate
=450  \\$wnnna$aAldolase, Fructosemonophosphate
=450  \\$wnnna$aFructose 1 Phosphate Aldolase
=450  \\$wnnna$aFructose 1,6 Bisphosphate Aldolase
=450  \\$wnnna$aFructose Bisphosphate Aldolase
=550  \\$aFructose Intolerance
=667  \\$a/defic: consider also FRUCTOSE INTOLERANCE
=680  \\$iAn enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3S,4R)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (Enzyme Nomenclature, 1992) E.C. 4.1.2.13.
=688  \\$a98(63)
=750  \0$aAldolase$0(DLC)sh2020006299$5IEN-M

=LDR  00749nz  a2200181n  4500
=001  9881796326902441
=005  20220107141254.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000067549
=035  \\$a(DNLM)D000067549
=035  \\$a(NLM)985399402600041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x867.$x826.$x150
=150  \\$aAction Spectrum
=450  \\$wnnna$aSpectrum, Action
=680  \\$iA technique used to measure the rate of physiological activity plotted against wavelength of light. An action spectrum depicts the most effective wavelength of light (also known as spectral sensitivity) that is required for each specific process.
=688  \\$a2016
=750  \0$aAction spectroscopy$0(DLC)sh2020006308$5IEN-M

=LDR  01004nz  a2200253n  4500
=001  9881803946202441
=005  20220114133513.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D002687
=035  \\$a(DNLM)D002687
=035  \\$a(NLM)98195667270000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x460.$x200
=150  \\$aChitin Synthase
=450  \\$wnnna$aChitin Synthase 1
=450  \\$wnnna$aChitin Synthetase 2
=450  \\$wnnna$atrans-N-Acetylglucosaminosylase
=450  \\$aChitin-UDP Acetylglucosaminyltransferase
=450  \\$wnnna$aAcetylglucosaminyltransferase, Chitin-UDP
=450  \\$wnnna$aChitin UDP Acetylglucosaminyltransferase
=450  \\$wnnna$atrans N Acetylglucosaminosylase
=680  \\$iAn enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16.
=688  \\$a91(75); was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78
=750  \0$aChitin synthase$0(DLC)sh2020005525$5IEN-M

=LDR  01498nz  a2200337n  4500
=001  9881811454902441
=005  20220129232500.0
=008  150709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000068698
=035  \\$a(DNLM)D000068698
=035  \\$a(NLM)985399540200041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x705.$x429.$x906
=072  \\$aD3.$x633.$x100.$x759.$x138.$x881
=150  \\$aTenofovir
=450  \\$wnnna$a(R)-9-(2-phosphonylmethoxypropyl)adenine
=450  \\$wnnna$a9-(2-Phosphonomethoxypropyl)adenine
=450  \\$wnnna$a9-(2-Phosphonylmethoxypropyl)adenine
=450  \\$wnnna$a9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer
=450  \\$wnnna$a9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098
=450  \\$wnnna$a9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer
=450  \\$wnnna$a9-PMPA (tenofovir)
=450  \\$wnnna$aTenofovir Disoproxil
=450  \\$wnnna$aTenofovir Disoproxil Fumarate
=450  \\$wnnna$aViread
=450  \\$wnnna$aDisoproxil Fumarate, Tenofovir
=450  \\$wnnna$aDisoproxil, Tenofovir
=450  \\$wnnna$aFumarate, Tenofovir Disoproxil
=680  \\$iAn adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
=688  \\$a2016 (2001)
=750  \0$aTenofovir$0(DLC)sh2020000132$5IEN-M

=LDR  00643nz  a2200169n  4500
=001  9881811455502441
=005  20220129225141.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010705
=035  \\$a(DNLM)D010705
=035  \\$a(NLM)98197901480000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 664
=072  \\$aD2.$x522.$x741
=150  \\$aPhosgene
=680  \\$iA highly toxic gas that has been used as a chemical warfare agent. It is an insidious poison as it is not irritating immediately, even when fatal concentrations are inhaled. (From The Merck Index, 11th ed, p7304)
=750  \0$aPhosgene$0(DLC)sh 96001291$5IEN-M

=LDR  01797nz  a2200409n  4500
=001  9881811455602441
=005  20220129224115.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000073396
=035  \\$a(DNLM)D000073396
=035  \\$a(NLM)9810900707800041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x691.$x638
=072  \\$aD5.$x750.$x215
=150  \\$aMetal-Organic Frameworks
=450  \\$wnnna$aCovalent Organic Framework
=450  \\$wnnna$aPorous Coordination Networks
=450  \\$wnnna$aPorous Coordination Polymers
=450  \\$aMetal Organic Framework
=450  \\$aMetal-Organic Framework
=450  \\$aPorous Coordination Polymer
=450  \\$wnnna$aCoordination Networks, Porous
=450  \\$wnnna$aCoordination Polymer, Porous
=450  \\$wnnna$aCoordination Polymers, Porous
=450  \\$wnnna$aFramework, Covalent Organic
=450  \\$wnnna$aFramework, Metal Organic
=450  \\$wnnna$aFramework, Metal-Organic
=450  \\$wnnna$aFrameworks, Metal-Organic
=450  \\$wnnna$aMetal Organic Frameworks
=450  \\$wnnna$aNetworks, Porous Coordination
=450  \\$wnnna$aOrganic Framework, Covalent
=450  \\$wnnna$aOrganic Framework, Metal
=450  \\$wnnna$aPolymer, Porous Coordination
=450  \\$wnnna$aPolymers, Porous Coordination
=680  \\$iSupramolecular networks that consist of ordered arrangements of organic electron donor linkers (usually ditopic or polytopic organic carboxylates) and metal cations. They can have an extremely high surface area and adjustable pore size that allows for the insertion of other molecules capable of various functions such as catalysis, capture of carbon dioxide, and drug delivery.
=688  \\$a2018
=750  \0$aMetal-organic frameworks$0(DLC)sh2020006026$5IEN-M

=LDR  01135nz  a2200265n  4500
=001  9881811455802441
=005  20220129222005.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000069480
=035  \\$a(DNLM)D000069480
=035  \\$a(NLM)985400008700041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x705.$x429.$x906.$x750
=072  \\$aD3.$x383.$x742.$x680.$x245.$x500.$x600.$x750
=072  \\$aD3.$x633.$x100.$x759.$x138.$x881.$x750
=072  \\$aD13.$x570.$x230.$x329.$x525.$x500
=072  \\$aD13.$x570.$x685.$x245.$x500.$x600.$x500
=072  \\$aD26.$x310.$x423
=150  \\$aEmtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
=450  \\$wnnna$aEmtricitabine Tenofovir Disoproxil Fumarate Drug Combination
=450  \\$wnnna$aEmtricitabine-Tenofovir Disoproxil Fumarate Drug Combination
=450  \\$wnnna$aTruvada
=680  \\$iA pharmaceutical preparation of emtricitabine and tenofovir that is used as an ANTI-HIV AGENT in the treatment and prevention of HIV INFECTIONS.
=688  \\$a2016 (2005)
=750  \0$aEmtricitabine/tenofovir disoproxil fumarate$0(DLC)sh2020000037$5IEN-M

=LDR  00924nz  a2200241n  4500
=001  9881811456002441
=005  20220129221528.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000068679
=035  \\$a(DNLM)D000068679
=035  \\$a(NLM)985399550400041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x742.$x680.$x245.$x500.$x600
=072  \\$aD13.$x570.$x230.$x329.$x525
=072  \\$aD13.$x570.$x685.$x245.$x500.$x600
=150  \\$aEmtricitabine
=450  \\$wnnna$aBeta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
=450  \\$wnnna$aCoviracil
=450  \\$wnnna$aEmtriva
=450  \\$wnnna$aBeta L 2',3' dideoxy 5 fluoro 3' thiacytidine
=680  \\$iA deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.
=688  \\$a2016 (1999)
=750  \0$aEmtricitabine$0(DLC)sh2020000065$5IEN-M

=LDR  02196cz   2200457n  4500
=001  9880363896402441
=005  20220225140225.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D013313
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF3.$x80.$x931.$x500
=150  \\$aStress Disorders, Post-Traumatic
=450  \\$wnnna$aAcute Post-Traumatic Stress Disorder
=450  \\$wnnna$aAcute Post Traumatic Stress Disorder
=450  \\$wnnna$aChronic Post-Traumatic Stress Disorder
=450  \\$wnnna$aChronic Post Traumatic Stress Disorder
=450  \\$wnnna$aDelayed Onset Post-Traumatic Stress Disorder
=450  \\$wnnna$aDelayed Onset Post Traumatic Stress Disorder
=450  \\$aNeuroses, Post-Traumatic
=450  \\$wnnna$aNeuroses, Post Traumatic
=450  \\$wnnna$aNeuroses, Posttraumatic
=450  \\$wnnna$aPost-Traumatic Neuroses
=450  \\$wnnna$aPost-Traumatic Stress Disorder
=450  \\$aPost-Traumatic Stress Disorders
=450  \\$wnnna$aPost Traumatic Stress Disorders
=450  \\$wnnna$aPosttraumatic Neuroses
=450  \\$wnnna$aPosttraumatic Stress Disorder
=450  \\$wnnna$aPosttraumatic Stress Disorders
=450  \\$aPTSD
=450  \\$wnnna$aStress Disorder, Post Traumatic
=450  \\$wnnna$aStress Disorder, Post-Traumatic
=450  \\$wnnna$aStress Disorder, Posttraumatic
=450  \\$wnnna$aStress Disorders, Post Traumatic
=450  \\$wnnna$aStress Disorders, Posttraumatic
=550  \\$wg$aStress Disorders, Traumatic
=550  \\$aCombat Disorders
=667  \\$aCOMBAT DISORDERS is also available
=680  \\$iA class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.
=688  \\$a81; was NEUROSES, POST-TRAUMATIC 1963-80
=750  \0$aPost-traumatic stress disorder$0(DLC) sh 85105424$5IEN-M
=750  \0$aMoral injuries$0(DLC)sh2020005472$5IEN-M

=LDR  02053nz  a2200529n  4500
=001  9881821079402441
=005  20220225140709.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082662
=035  \\$a(DNLM)D000082662
=035  \\$a(NLM)9817067593500041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x512.$x600.$x500.$x144
=150  \\$aMagnetic Iron Oxide Nanoparticles
=450  \\$aHematite Nanoparticles
=450  \\$aIONPs
=450  \\$aIron Oxide Nanoparticles
=450  \\$aMaghemite Nanoparticles
=450  \\$aMagnetic IONPs
=450  \\$aMagnetic Iron Nanoparticles
=450  \\$aSPIONs
=450  \\$aSuperparamagnetic Iron Nanoparticles
=450  \\$aSuperparamagnetic Iron Oxide Nanoparticles
=450  \\$wnnna$aHematite Nanoparticle
=450  \\$wnnna$aIONP, Magnetic
=450  \\$wnnna$aIONPs, Magnetic
=450  \\$wnnna$aIron Nanoparticle, Magnetic
=450  \\$wnnna$aIron Nanoparticle, Superparamagnetic
=450  \\$wnnna$aIron Oxide Nanoparticle
=450  \\$wnnna$aMaghemite Nanoparticle
=450  \\$wnnna$aMagnetic IONP
=450  \\$wnnna$aMagnetic Iron Nanoparticle
=450  \\$wnnna$aNanoparticle, Hematite
=450  \\$wnnna$aNanoparticle, Iron Oxide
=450  \\$wnnna$aNanoparticle, Maghemite
=450  \\$wnnna$aNanoparticle, Magnetic Iron
=450  \\$wnnna$aNanoparticle, Superparamagnetic Iron
=450  \\$wnnna$aNanoparticles, Hematite
=450  \\$wnnna$aNanoparticles, Iron Oxide
=450  \\$wnnna$aNanoparticles, Maghemite
=450  \\$wnnna$aNanoparticles, Magnetic Iron
=450  \\$wnnna$aNanoparticles, Superparamagnetic Iron
=450  \\$wnnna$aSuperparamagnetic Iron Nanoparticle
=550  \\$aDrug Carriers
=680  \\$iSynthesized nanoparticles related to iron oxide crystalline structures with magnetic properties useful for biomedical applications. Examples include hematite, magnetite and maghemite nanoparticles.
=688  \\$a2021
=750  \0$iBroader mapping$aMagnetic nanoparticles$0(DLC)sh2020006552$4BM$5IEN-M

=LDR  01412nz  a2200349n  4500
=001  9881821097802441
=005  20220221160801.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D060449
=035  \\$a(DNLM)D060449
=035  \\$a(NLM)98194149120000041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x820.$x925
=072  \\$aG4.$x835.$x925
=150  \\$aWnt Signaling Pathway
=450  \\$wnnna$aWnt Pathway
=450  \\$wnnna$aWnt Pathway, Canonical
=450  \\$wnnna$aWnt beta-Catenin Signaling Pathway
=450  \\$aWnt Signaling
=450  \\$wnnna$aCanonical Wnt Pathway
=450  \\$wnnna$aCanonical Wnt Pathways
=450  \\$wnnna$aPathway, Canonical Wnt
=450  \\$wnnna$aPathway, Wnt
=450  \\$wnnna$aPathway, Wnt Signaling
=450  \\$wnnna$aSignaling Pathway, Wnt
=450  \\$wnnna$aSignaling, Wnt
=450  \\$wnnna$aWnt Signaling Pathways
=450  \\$wnnna$aWnt Signalings
=450  \\$wnnna$aWnt beta Catenin Signaling Pathway
=680  \\$iA complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, and the vertebrate INT gene. The signaling pathway is initiated by the binding of WNT PROTEINS to cell surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN.
=688  \\$a2012
=750  \0$aWnt pathway$0(DLC)sh2020006559$5IEN-M

=LDR  00897nz  a2200253n  4500
=001  9881821097902441
=005  20220221154756.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D058207
=035  \\$a(DNLM)D058207
=035  \\$a(NLM)98198336380000041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x660.$x871.$x790.$x600.$x925.$x500
=072  \\$aG2.$x111.$x691.$x600.$x775.$x500
=072  \\$aG3.$x734.$x871.$x790.$x600.$x831.$x500
=072  \\$aG5.$x308.$x670.$x600.$x831.$x500
=150  \\$aSumoylation
=450  \\$wnnna$aSUMO-Conjugation
=450  \\$wnnna$aSUMO Conjugation
=450  \\$wnnna$aSUMO-Conjugations
=450  \\$wnnna$aSumoylations
=680  \\$iA type of POST-TRANSLATIONAL PROTEIN MODIFICATION by SMALL UBIQUITIN-RELATED MODIFIER PROTEINS (also known as SUMO proteins).
=688  \\$a2011
=750  \0$aSumoylation$0(DLC)sh2020006035$5IEN-M

=LDR  00859nz  a2200265n  4500
=001  9881821098302441
=005  20220316130417.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085762
=035  \\$a(DNLM)D000085762
=035  \\$a(NLM)9817068016500041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 110
=072  \\$aN6.$x850.$x780.$x200.$x688
=150  \\$aPhysical Distancing
=450  \\$aPhysical Distance
=450  \\$aSocial Distancing
=450  \\$wnnna$aDistance, Physical
=450  \\$wnnna$aDistances, Physical
=450  \\$wnnna$aDistancing, Physical
=450  \\$wnnna$aDistancing, Social
=450  \\$wnnna$aPhysical Distances
=680  \\$iMaintaining recommended amount of spacial separation between self and others.
=688  \\$a2021
=750  \0$aSocial distancing (Public health)$0(DLC)sh2020006604$5IEN-M

=LDR  00926nz  a2200241n  4500
=001  9881821098602441
=005  20220221153226.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D025841
=035  \\$a(DNLM)D025841
=035  \\$a(NLM)98196377300000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x947.$x249
=150  \\$aSmall Ubiquitin-Related Modifier Proteins
=450  \\$wnnna$aSentrin Proteins
=450  \\$wnnna$aSentrins
=450  \\$wnnna$aUbiquitin-Related Modifier Protein, Small
=450  \\$aSUMO Proteins
=450  \\$wnnna$aSmall Ubiquitin Related Modifier Proteins
=450  \\$wnnna$aUbiquitin Related Modifier Protein, Small
=680  \\$iA class of structurally related proteins of 12-20 kDa in size. They covalently modify specific proteins in a manner analogous to UBIQUITIN.
=688  \\$a2002
=750  \0$aSmall ubiquitin-related modifiers$0(DLC)sh2020006037$5IEN-M

=LDR  00932nz  a2200229n  4500
=001  9881821101302441
=005  20220221144253.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D023882
=035  \\$a(DNLM)D023882
=035  \\$a(NLM)98194946260000041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x561.$x225.$x425.$x500
=072  \\$aG14.$x264
=150  \\$aDominance, Ocular
=450  \\$wnnna$aEyedness
=450  \\$aEye Dominance
=450  \\$wnnna$aDominance, Eye
=450  \\$wnnna$aOcular Dominance
=680  \\$iThe functional superiority and preferential use of one eye over the other. The term is usually applied to superiority in sighting (VISUAL PERCEPTION) or motor task but not difference in VISUAL ACUITY or dysfunction of one of the eyes. Ocular dominance can be modified by visual input and NEUROTROPHIC FACTORS.
=688  \\$a2002
=750  \0$aOcular dominance$0(DLC)sh2020006564$5IEN-M

=LDR  00983nz  a2200277n  4500
=001  9881821101502441
=005  20220221143742.0
=008  781220\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009707
=035  \\$a(DNLM)D009707
=035  \\$a(NLM)98198250670000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 56
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x180.$x625
=072  \\$aD12.$x776.$x664.$x224.$x550
=072  \\$aG5.$x360.$x160.$x180.$x625
=150  \\$aNucleosomes
=450  \\$wnnna$aDinucleosomes
=450  \\$wnnna$aPolynucleosomes
=450  \\$wnnna$aDinucleosome
=450  \\$wnnna$aNucleosome
=450  \\$wnnna$aPolynucleosome
=550  \\$aHMGN Proteins
=680  \\$iThe repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4.
=688  \\$a80
=750  \0$aNucleosomes$0(DLC)sh2020006038$5IEN-M

=LDR  01619nz  a2200409n  4500
=001  9881821103102441
=005  20220225133002.0
=008  980610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D020066
=035  \\$a(DNLM)D020066
=035  \\$a(NLM)98198719200000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x820.$x500
=072  \\$aD23.$x50.$x293.$x500
=150  \\$aMerozoite Surface Protein 1
=450  \\$wnnna$aMSA-1
=450  \\$wnnna$aMSA-1 Protein
=450  \\$wnnna$aMSA1
=450  \\$wnnna$aMSA1 Protein
=450  \\$wnnna$aMSP-1
=450  \\$wnnna$aMSP1, P. vivax
=450  \\$wnnna$aMajor Merozoite Surface Protein Precursor
=450  \\$wnnna$aMerozoite Surface Antigen 1
=450  \\$wnnna$aMerozoite Surface Protein-1
=450  \\$wnnna$aPFM-PSCP
=450  \\$wnnna$aPMMSA
=450  \\$wnnna$aPlasmodium falciparum Merozoite Precursor Surface Coat Protein
=450  \\$aMSP1
=450  \\$wnnna$aMSA 1 Protein
=450  \\$wnnna$aP. vivax MSP1
=450  \\$wnnna$aProtein, MSA-1
=450  \\$wnnna$aProtein, MSA1
=450  \\$wnnna$aSurface Protein-1, Merozoite
=667  \\$acoord IM with specific PLASMODIUM species
=680  \\$iA surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.
=688  \\$a99; use PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN (NM) 1987-98
=750  \0$iBroader mapping$aMerozoite surface proteins$0(DLC)sh2020006629$4BM$5IEN-M

=LDR  00680nz  a2200205n  4500
=001  9881821103602441
=005  20220225132634.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010782
=035  \\$a(DNLM)D010782
=035  \\$a(NLM)98195009320000041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x740.$x685
=150  \\$aPhotolysis
=450  \\$wnnna$aPhotodegradation
=550  \\$aPhotochemical Processes$wg
=680  \\$iChemical bond cleavage reactions resulting from absorption of radiant energy.
=688  \\$a74(71)
=750  \0$aPhotodegradation$0(DLC)sh2007001664$5IEN-M
=750  \0$iNarrower mapping$aFlash photolysis$0(DLC)sh85049006$4NM$5IEN-M

=LDR  00793nz  a2200217n  4500
=001  9881821103902441
=005  20220221103052.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D060466
=035  \\$a(DNLM)D060466
=035  \\$a(NLM)98194148720000041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x500.$x117.$x500
=072  \\$aD12.$x776.$x476.$x81.$x500
=150  \\$aAxin Protein
=450  \\$aAxin Proteins
=450  \\$wnnna$aProteins, Axin
=550  \\$aAxin Signaling Complex$wg
=680  \\$iA scaffolding protein that is a critical component of the axin signaling complex which binds to ADENOMATOUS POLYPOSIS COLI PROTEIN; GLYCOGEN SYNTHASE KINASE 3; and CASEIN KINASE I.
=688  \\$a2012(1997)
=750  \0$aAxin (Scaffold protein)$0(DLC)sh2020006561$5IEN-M

=LDR  01001nz  a2200253n  4500
=001  9881811555502441
=005  20220131143639.0
=008  140626\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D065126
=035  \\$a(DNLM)D065126
=035  \\$a(NLM)983985288800041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 310
=072  \\$aH2.$x403.$x645
=150  \\$aPalliative Medicine
=450  \\$wnnna$aMedicine, Palliative
=450  \\$wnnna$aPalliative Care Medicine
=450  \\$wnnna$aMedicine, Palliative Care
=550  \\$aPalliative Care
=550  \\$aHospice and Palliative Care Nursing
=667  \\$aspecialty only; use PALLIATIVE CARE for care of patients
=680  \\$iA branch of medicine concerned with preventing and relieving the suffering of patients in any stage of disease. Its focus is on comprehensive care and improving the quality of all areas of the patient's life.
=688  \\$a2015; use PALLIATIVE CARE 1996-2014
=750  \2$aPain medicine$0(DLC)sh2003008504$5IEN-M

=LDR  01134nz  a2200313n  4500
=001  9881816289102441
=005  20220210140019.0
=008  890619\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D015533
=035  \\$a(DNLM)D015533
=035  \\$a(NLM)98195379740000041
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x308.$x800
=150  \\$aTranscriptional Activation
=450  \\$wnnna$aInduction, Genetic
=450  \\$wnnna$aTrans-Activation, Genetic
=450  \\$wnnna$aTranscription Activation
=450  \\$aGene Activation
=450  \\$aGenetic Induction
=450  \\$aTransactivation
=450  \\$wnnna$aActivation, Gene
=450  \\$wnnna$aActivation, Transcription
=450  \\$wnnna$aActivation, Transcriptional
=450  \\$wnnna$aGenetic Trans-Activation
=450  \\$wnnna$aTrans Activation, Genetic
=550  \\$aGenes, Regulator
=680  \\$iProcesses that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes.
=688  \\$a2009 (1990); for GENE ACTIVATION and INDUCTION, GENETIC use GENE EXPRESSION REGULATION 1988-2008
=750  \0$aTranscriptional activation$0(DLC)sh2020006694$5IEN-M

=LDR  01021nz  a2200289n  4500
=001  9881816297402441
=005  20220208123911.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090042
=035  \\$a(DNLM)D000090042
=035  \\$a(NLM)9819990309800041
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x35.$x250.$x750
=072  \\$aL1.$x224.$x50.$x375.$x815
=072  \\$aL1.$x313.$x500.$x750.$x280.$x199.$x750
=072  \\$aL1.$x470.$x625.$x750
=150  \\$aSentiment Analysis
=450  \\$aOpinion Mining
=450  \\$aSentiment Classification
=450  \\$wnnna$aAnalysis, Sentiment
=450  \\$wnnna$aClassification, Sentiment
=450  \\$wnnna$aMining, Opinion
=450  \\$wnnna$aSentiment Analyses
=450  \\$wnnna$aSentiment Classifications
=680  \\$iA data mining technique in which subjective information such as sentiments, OPINIONS, and attitudes are extracted and analyzed from data.
=688  \\$a2022
=750  \0$aSentiment analysis$0(DLC)sh2020008029$5IEN-M

=LDR  00854nz  a2200265n  4500
=001  9881820875102441
=005  20220302151241.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009636
=035  \\$a(DNLM)D009636
=035  \\$a(NLM)98197908150000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x426.$x100.$x80.$x550
=072  \\$aD4.$x75.$x80.$x500
=150  \\$aNorbornanes
=450  \\$aNorbornane Derivatives
=450  \\$aNorbornene Derivatives
=450  \\$aNorbornenes
=450  \\$aNorcamphanes
=450  \\$wnnna$aDerivatives, Norbornane
=450  \\$wnnna$aDerivatives, Norbornene
=667  \\$aincludes norbornenes
=680  \\$iCompounds that include or are derivatives of norbornane(bicyclo[2.2.1]heptane).
=688  \\$a74(72)
=750  \0$iNarrower mapping$aNorbornene$0(DLC)sh2020006730$4NM$5IEN-M

=LDR  00864nz  a2200229n  4500
=001  9818350687506676
=005  20220225104136.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000069550
=035  \\$a(DNLM)D000069550
=035  \\$a(NLM)985399981800041
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x35.$x250.$x500
=072  \\$aL1.$x224.$x50.$x375.$x530
=150  \\$aMachine Learning
=450  \\$aTransfer Learning
=450  \\$wnnna$aLearning, Machine
=450  \\$wnnna$aLearning, Transfer
=680  \\$iA type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data.
=688  \\$a2016; use ARTIFICIAL INTELLIGENCE 1997-2015
=750  \0$iNarrower mapping$aEnsemble learning (Machine learning)$0(DLC)sh2020008824$4NLM$5DNLM

=LDR  01987nz  a2200481n  4500
=001  9818350687706676
=005  20220225102833.0
=008  950526\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D019061
=035  \\$a(DNLM)D019061
=035  \\$a(NLM)98196450520000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x725.$x800
=072  \\$aD12.$x776.$x476.$x568.$x800
=150  \\$asrc-Family Kinases
=450  \\$wnnna$asrc Tyrosine Kinases
=450  \\$wnnna$asrc-Family Tyrosine Kinases
=450  \\$aProtein-Tyrosine Kinases, src
=450  \\$aSrc Family Tyrosine Kinase
=450  \\$asrc Kinase
=450  \\$asrc Kinases
=450  \\$asrc Tyrosine Kinase
=450  \\$asrc-Family Kinase
=450  \\$asrc-Family Tyrosine Kinase
=450  \\$wnnna$aKinase, src
=450  \\$wnnna$aKinase, src Tyrosine
=450  \\$wnnna$aKinase, src-Family
=450  \\$wnnna$aKinase, src-Family Tyrosine
=450  \\$wnnna$aKinases, src
=450  \\$wnnna$aKinases, src Protein-Tyrosine
=450  \\$wnnna$aKinases, src Tyrosine
=450  \\$wnnna$aTyrosine Kinase, src
=450  \\$wnnna$aTyrosine Kinase, src-Family
=450  \\$wnnna$aTyrosine Kinases, src
=450  \\$wnnna$aTyrosine Kinases, src-Family
=450  \\$wnnna$asrc Family Kinase
=450  \\$wnnna$asrc Family Kinases
=450  \\$wnnna$asrc Family Tyrosine Kinases
=450  \\$wnnna$asrc Protein-Tyrosine Kinases
=680  \\$iA PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.
=688  \\$a96
=750  \0$aSrc family kinase$0(DLC)sh2020008797$5DNLM

=LDR  00812nz  a2200229n  4500
=001  9881816284102441
=005  20220211115632.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003996
=035  \\$a(DNLM)D003996
=035  \\$a(NLM)98194524860000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x223.$x100.$x200.$x500
=072  \\$aD2.$x241.$x223.$x100.$x300.$x595.$x202
=072  \\$aD2.$x241.$x511.$x390.$x595.$x202
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x250.$x500
=072  \\$aD2.$x455.$x426.$x559.$x389.$x127.$x281.$x595.$x202
=072  \\$aD2.$x455.$x426.$x559.$x389.$x657.$x410.$x595.$x202
=150  \\$aDicamba
=680  \\$iA chlorinated organic herbicide.
=688  \\$a91(72); was see under BENZOATES 1972-90
=750  \0$aDicamba$0(DLC)sh2020005437$5IEN-M

=LDR  02441nz  a2200565n  4500
=001  9881833969002441
=005  20220310150515.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D053549
=035  \\$a(DNLM)D053549
=035  \\$a(NLM)98196800720000041
=040  \\$aDNLM$cDNLM
=072  \\$aC16.$x131.$x77.$x350.$x856
=072  \\$aC16.$x131.$x831.$x350.$x856
=072  \\$aC16.$x320.$x850.$x250.$x856
=072  \\$aC17.$x800.$x529.$x594
=072  \\$aC17.$x800.$x804.$x350.$x856
=072  \\$aC17.$x800.$x827.$x250.$x856
=150  \\$aPachyonychia Congenita
=450  \\$wnnna$aCongenital Pachyonychia
=450  \\$wnnna$aJackson-Lawler Syndrome (Pc-2)
=450  \\$wnnna$aJackson-Lawler Type Pachyonychia Congenita
=450  \\$wnnna$aJadassohn-Lewandowski Syndrome (Pc-1)
=450  \\$wnnna$aJadassohn-Lewandowsky Syndrome
=450  \\$wnnna$aPachyonychia Congenita Jackson Lawler Type
=450  \\$wnnna$aPachyonychia Congenita Syndrome
=450  \\$wnnna$aPachyonychia Congenita Tarda, Type 1
=450  \\$wnnna$aPachyonychia Congenita, Jackson-Lawler Type
=450  \\$wnnna$aPachyonychia Congenita, Jadassohn-Lewandowsky Type
=450  \\$wnnna$aType 1 Pachyonychia Congenita
=450  \\$wnnna$aType 2 Pachyonychia Congenita
=450  \\$aPachyonychia Congenita Type 1
=450  \\$aPachyonychia Congenita, Type 1
=450  \\$aPachyonychia Congenita, Type 2
=450  \\$wnnna$aJackson Lawler Syndrome (Pc 2)
=450  \\$wnnna$aJackson Lawler Type Pachyonychia Congenita
=450  \\$wnnna$aJadassohn Lewandowski Syndrome (Pc 1)
=450  \\$wnnna$aJadassohn Lewandowsky Syndrome
=450  \\$wnnna$aPachyonychia Congenita, Jackson Lawler Type
=450  \\$wnnna$aPachyonychia Congenita, Jadassohn Lewandowsky Type
=450  \\$wnnna$aPachyonychia, Congenital
=450  \\$wnnna$aSyndrome, Jackson-Lawler (Pc-2)
=450  \\$wnnna$aSyndrome, Jadassohn-Lewandowski (Pc-1)
=450  \\$aKeratin-16$xdeficiency
=450  \\$aKeratin-6$xdeficiency
=550  \\$aKeratin-17
=550  \\$aKeratin-6
=680  \\$iA group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.
=688  \\$a2007
=750  \0$aPachyonychia congenita$0(DLC)sh2020007373$5IEN-M

=LDR  01516nz  a2200289n  4500
=001  9818350888806676
=005  20220401140735.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003358
=035  \\$a(DNLM)D003358
=035  \\$a(NLM)98199544500000041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x720.$x269
=072  \\$aJ1.$x516.$x213
=150  \\$aCosmetics
=450  \\$aPersonal Care Products
=450  \\$wnnna$aCare Product, Personal
=450  \\$wnnna$aCare Products, Personal
=450  \\$wnnna$aPersonal Care Product
=450  \\$wnnna$aProduct, Personal Care
=450  \\$wnnna$aProducts, Personal Care
=667  \\$ageneral or unspecified: prefer specifics
=680  \\$iSubstances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. (U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Office of Cosmetics Fact Sheet (web page) Feb 1995)
=750  \0$aNail polish$0(DLC)sh2020008763$4NM$5DNLM
=750  \0$aCosmetics$5IEN$0(DLC)sh 85033139

=LDR  01754nz  a2200457n  4500
=001  9818350889006676
=005  20220401140439.0
=008  020702\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D038622
=035  \\$a(DNLM)D038622
=035  \\$a(NLM)98196951080000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x615
=150  \\$aInternationality
=450  \\$wnnna$aGlobalization
=450  \\$wnnna$aInternational Aspects
=450  \\$wnnna$aInternational Perspectives
=450  \\$wnnna$aInternational Relations
=450  \\$wnnna$aMultinational Aspects
=450  \\$wnnna$aMultinational Perspectives
=450  \\$wnnna$aAspect, International
=450  \\$wnnna$aAspect, Multinational
=450  \\$wnnna$aAspects, International
=450  \\$wnnna$aAspects, Multinational
=450  \\$wnnna$aInternational Aspect
=450  \\$wnnna$aInternational Perspective
=450  \\$wnnna$aMultinational Aspect
=450  \\$wnnna$aMultinational Perspective
=450  \\$wnnna$aPerspective, International
=450  \\$wnnna$aPerspective, Multinational
=450  \\$wnnna$aPerspectives, International
=450  \\$wnnna$aPerspectives, Multinational
=450  \\$wnnna$aRelations, International
=550  \\$aInternational Law
=667  \\$aspecify geographic term if pertinent
=680  \\$iThe quality or state of relating to or affecting two or more nations. (After Merriam-Webster Collegiate Dictionary, 10th ed)
=688  \\$a2003
=750  \0$iNarrower mapping$aMultipolarity (International relations)$0(DLC)sh2020007987$4NM$5DNLM
=750  \0$aInternational relations$5IEN-M$0(DLC)sh 85067435

=LDR  01447nz  a2200385n  4500
=001  9818351288706676
=005  20220429065601.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D053768
=035  \\$a(DNLM)D053768
=035  \\$a(NLM)98198774230000041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 36.5
=072  \\$aJ1.$x637.$x512.$x600.$x500
=150  \\$aMetal Nanoparticles
=450  \\$wnnna$aMetallic Nanocrystals
=450  \\$wnnna$aMetallic Nanoparticles
=450  \\$aMetal Nanocrystals
=450  \\$wnnna$aMetal Nanocrystal
=450  \\$wnnna$aMetal Nanoparticle
=450  \\$wnnna$aMetallic Nanocrystal
=450  \\$wnnna$aMetallic Nanoparticle
=450  \\$wnnna$aNanocrystal, Metal
=450  \\$wnnna$aNanocrystal, Metallic
=450  \\$wnnna$aNanocrystals, Metal
=450  \\$wnnna$aNanocrystals, Metallic
=450  \\$wnnna$aNanoparticle, Metal
=450  \\$wnnna$aNanoparticle, Metallic
=450  \\$wnnna$aNanoparticles, Metal
=450  \\$wnnna$aNanoparticles, Metallic
=680  \\$iNanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver.
=688  \\$a2007
=750  \0$aMetal nanoparticles$0(DLC)sh2020010536$5DNLM
=750  \0$iNarrower mapping$aNickel nanoparticles$0(DLC)sh2020010538$4NM$5DNLM

=LDR  00792nz  a2200229n  4500
=001  9818351288906676
=005  20220429065929.0
=008  960610\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D019281
=035  \\$a(DNLM)D019281
=035  \\$a(NLM)98197044770000041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x206
=072  \\$aG3.$x230
=150  \\$aDimerization
=450  \\$wnnna$aDimerizations
=550  \\$aProtein Multimerization
=667  \\$acoordinate with substance but note PROTEIN DIMERIZATION see PROTEIN MULTIMERIZATION is available
=680  \\$iThe process by which two molecules of the same chemical composition form a condensation product or polymer.
=688  \\$a97
=750  \0$aDimerization$0(DLC)sh2020010518$5DNLM

=LDR  00733nz  a2200205n  4500
=001  9881929112102441
=005  20220524112346.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012929
=035  \\$a(DNLM)D012929
=035  \\$a(NLM)98199806440000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x630
=072  \\$aF1.$x829.$x316.$x777
=150  \\$aPsychological Distance
=450  \\$wnnna$aDistance, Psychological
=450  \\$wnnna$aPsychological Distances
=680  \\$iThe degree of a person's detachment from emotional involvement with people or situations.(APA Thesaurus of Psychological Index Terms accessed 12/29/2020)
=688  \\$a69
=750  \1$aSocial distance$5IEN$0(DLC)sh85123938

=LDR  01531nz  a2200397n  4500
=001  9881898412802441
=005  20220505143148.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082762
=035  \\$a(DNLM)D000082762
=035  \\$a(NLM)9817067555500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x166.$x132.$x832.$x400.$x100
=150  \\$aAmblyomma
=450  \\$aAmblyomma americanum
=450  \\$aAmblyomma maculatum
=450  \\$aAmblyomma triguttatum
=450  \\$aAmblyomma variegatum
=450  \\$aAponomma
=450  \\$aGulf Coast Tick
=450  \\$aLone Star Tick
=450  \\$aLone-Star Tick
=450  \\$aOrnate Kangaroo Tick
=450  \\$aTropical Bont Tick
=450  \\$wnnna$aLone Star Ticks
=450  \\$wnnna$aLone-Star Ticks
=450  \\$wnnna$aOrnate Kangaroo Ticks
=450  \\$wnnna$aTick, Gulf Coast
=450  \\$wnnna$aTick, Lone Star
=450  \\$wnnna$aTick, Lone-Star
=450  \\$wnnna$aTick, Ornate Kangaroo
=450  \\$wnnna$aTick, Tropical Bont
=450  \\$wnnna$aTropical Bont Ticks
=680  \\$iA genus of hardbacked TICKS, in the family IXODIDAE. It includes the lone star tick, Amblyomma americanum, and the Gulf Coast tick, Amblyomma maculatum, in the Americas. Amblyomma americanum is the primary vector of EHRLICHIA CHAFFEENSIS and EHRLICHIA EWINGII which cause EHRLICHIOSIS. Other Amblyomma-associated diseases include TULAREMIA and RICKETTSIOSIS.
=688  \\$a2021
=750  \0$aAmblyomma$0(DLC) sh 85004155$IEN-M

=LDR  01369nz  a2200361n  4500
=001  9881923276002441
=005  20220517124401.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086762
=035  \\$a(DNLM)D000086762
=035  \\$a(NLM)9817068131700041
=040  \\$aDNLM$cDNLM
=060  \0$aW 786
=072  \\$aE5.$x318.$x740.$x225.$x500.$x250
=072  \\$aN4.$x452.$x910.$x99.$x250
=150  \\$aAutomated Facial Recognition
=450  \\$aAutomated Facial Identity Recognition
=450  \\$aFacial Approximation
=450  \\$aFacial Recognition Technology
=450  \\$aFacial Recognition, Automated
=450  \\$wnnna$aApproximation, Facial
=450  \\$wnnna$aApproximations, Facial
=450  \\$wnnna$aFacial Approximations
=450  \\$wnnna$aFacial Recognition Technologies
=450  \\$wnnna$aRecognition Technologies, Facial
=450  \\$wnnna$aRecognition Technology, Facial
=450  \\$wnnna$aRecognition, Automated Facial
=450  \\$wnnna$aTechnologies, Facial Recognition
=450  \\$wnnna$aTechnology, Facial Recognition
=667  \\$aFACIAL RECOGNITION is also available
=680  \\$iElectronic identification of a human based on attributes of the face.
=688  \\$a2021; use BIOMETRIC IDENTIFICATION 2009-2020
=750  \0$aHuman face recognition (Computer science)$0(DLC)sh 97003901$5IEN-M

=LDR  00639nz  a2200169n  4500
=001  9881923276302441
=005  20220517122919.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084822
=035  \\$a(DNLM)D000084822
=035  \\$a(NLM)9817067765600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x105
=150  \\$aAuricularia
=680  \\$iA genus of fungi in the family Auriculariaceae, order Auriculariales and phylum BASIDIOMYCOTA. Auricularia fungi are basidiomycetes which are gelatinous, ear-shaped mushrooms in decaying wood.
=688  \\$a2021
=750  \0$aAuricularia$0(DLC) sh 85009547$5IEN-M

=LDR  01252nz  a2200301n  4500
=001  9881923276502441
=005  20220517120330.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082862
=035  \\$a(DNLM)D000082862
=035  \\$a(NLM)9817067733100041
=040  \\$aDNLM$cDNLM
=060  \0$aWG 265
=072  \\$aC14.$x280.$x484.$x48
=150  \\$aAortic Valve Disease
=450  \\$aAortic Heart Disease
=450  \\$aAortic Valve Disorder
=450  \\$aAortic Valvular Heart Disease
=450  \\$aAortic Valvular Heart Disorder
=450  \\$wnnna$aAortic Heart Diseases
=450  \\$wnnna$aAortic Valve Diseases
=450  \\$wnnna$aAortic Valve Disorders
=450  \\$wnnna$aHeart Disease, Aortic
=450  \\$wnnna$aValve Disease, Aortic
=450  \\$wnnna$aValve Disorder, Aortic
=680  \\$iDiseases involving the AORTIC VALVE functionality. Aortic valve disease often results in a backward and/or regurgitated blood flow into the LEFT VENTRICLE or a decreased blood flow from the heart. It includes congenital (e.g., bicuspid aortic valve), syndromic, and acquired (e.g., age-related, infection-associated) conditions.
=688  \\$a2021
=750  \0$aAortic valve$xDiseases$0(DLC) sh 85005868$5IEN-M

=LDR  00829nz  a2200217n  4500
=001  9881929100602441
=005  20220527114832.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084828
=035  \\$a(DNLM)D000084828
=035  \\$a(NLM)9817067666400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x456
=150  \\$aFungal Genus Venturia
=450  \\$aFungus Venturia
=450  \\$wnnna$aGenus Venturia, Fungal
=450  \\$wnnna$aVenturia, Fungal Genus
=450  \\$wnnna$aVenturia, Fungus
=680  \\$iA genus of fungi in the family Venturiaceae, order Venturiales, and phylum ASCOMYCOTA. Venturia fungi are ascomycetes and causative agents for plant fungal diseases such as apple scab caused by Venturia inaequalis.
=688  \\$a2021
=750  \0$aVenturia$0(DLC) sh 85142764$5IEN-M

=LDR  01114nz  a2200337n  4500
=001  9881929100802441
=005  20220527112452.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081882
=035  \\$a(DNLM)D000081882
=035  \\$a(NLM)9817067576800041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x515
=150  \\$aFreedom of Religion
=450  \\$aFreedom of Worship
=450  \\$aReligious Freedom
=450  \\$aReligious Liberty
=450  \\$aReligious Library
=450  \\$wnnna$aFreedom, Religious
=450  \\$wnnna$aFreedoms, Religious
=450  \\$wnnna$aLiberties, Religious
=450  \\$wnnna$aLiberty, Religious
=450  \\$wnnna$aLibraries, Religious
=450  \\$wnnna$aLibrary, Religious
=450  \\$wnnna$aReligion Freedom
=450  \\$wnnna$aReligious Freedoms
=450  \\$wnnna$aReligious Liberties
=450  \\$wnnna$aReligious Libraries
=680  \\$iThe right to practice, worship, observe, and teach one's beliefs without external constraints.
=688  \\$a2021
=750  \0$aFreedom of religion$0(DLC)sh 85112662$5IEN-M

=LDR  00724nz  a2200181n  4500
=001  9881929101002441
=005  20220527112047.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081902
=035  \\$a(DNLM)D000081902
=035  \\$a(NLM)9817067576000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x682
=150  \\$aFreedom of Movement
=450  \\$aRight to Freedom of Movement
=680  \\$iThe right to freedom of movement and residence within the borders of each state or nation. The right to leave any country and to return as provided in the Universal Declaration of Human Rights, Section 13, 1948.
=688  \\$a2021
=750  \0$aFreedom of movement$0(DLC)sh 85051705$5IEN-M

=LDR  00691nz  a2200193n  4500
=001  9881929101202441
=005  20220527111218.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082302
=035  \\$a(DNLM)D000082302
=035  \\$a(NLM)9817067620600041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 695
=072  \\$aJ1.$x576.$x423.$x750.$x875
=150  \\$aFood Security
=450  \\$wnnna$aSecurity, Food
=680  \\$iAccess generally by all in a community to enough nutritious food for an active, healthy life. (from http://www.fns.usda.gov/fsec/ accessed 4/22/2011).
=688  \\$a2021; use FOOD SUPPLY (2012-2020)
=750  \0$aFood security$0sh2009007706$5IEN-M

=LDR  02202cz  a2200577n  4500
=001  9881929101502441
=005  20220527105048.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086522
=035  \\$a(DNLM)D000086522
=035  \\$a(NLM)9817067884700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x126.$x990.$x643
=150  \\$aFinancial Stress
=450  \\$aEconomic Burden
=450  \\$aEconomic Hardship
=450  \\$aFinancial Burden
=450  \\$aFinancial Challenges
=450  \\$aFinancial Hardship
=450  \\$aFinancial Pressures
=450  \\$aFinancial Toxicity
=450  \\$wnnna$aBurden, Economic
=450  \\$wnnna$aBurden, Financial
=450  \\$wnnna$aBurdens, Economic
=450  \\$wnnna$aBurdens, Financial
=450  \\$wnnna$aChallenge, Financial
=450  \\$wnnna$aChallenges, Financial
=450  \\$wnnna$aEconomic Burdens
=450  \\$wnnna$aEconomic Hardships
=450  \\$wnnna$aFinancial Burdens
=450  \\$wnnna$aFinancial Challenge
=450  \\$wnnna$aFinancial Hardships
=450  \\$wnnna$aFinancial Pressure
=450  \\$wnnna$aFinancial Stresses
=450  \\$wnnna$aFinancial Toxicities
=450  \\$wnnna$aHardship, Economic
=450  \\$wnnna$aHardship, Financial
=450  \\$wnnna$aHardships, Economic
=450  \\$wnnna$aHardships, Financial
=450  \\$wnnna$aPressure, Financial
=450  \\$wnnna$aPressures, Financial
=450  \\$wnnna$aStress, Financial
=450  \\$wnnna$aStresses, Financial
=450  \\$wnnna$aToxicities, Financial
=450  \\$wnnna$aToxicity, Financial
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iStress arising from personal financial concerns. (https://www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-stress).
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aFinance, Personal$0(DLC)sh85048263$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aStress (Psychology)$0(DLC)sh85128705$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aFinance, Personal$iand$aStress (Psychology)$5IEN-M

=LDR  01768nz  a2200481n  4500
=001  9881929101702441
=005  20220527103154.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084542
=035  \\$a(DNLM)D000084542
=035  \\$a(NLM)9817067775200041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x380.$x230.$x642
=072  \\$aE1.$x370.$x405.$x245.$x787.$x642
=150  \\$aEye-Tracking Technology
=450  \\$aEye Movement Data Analysis
=450  \\$aEye-Tracking
=450  \\$aEye-Tracking System
=450  \\$aEyetracking System
=450  \\$aEyetracking Technology
=450  \\$aGaze-Tracking
=450  \\$aGaze-Tracking System
=450  \\$aGaze-Tracking Technology
=450  \\$aGazetracking System
=450  \\$wnnna$aEye Tracking
=450  \\$wnnna$aEye Tracking System
=450  \\$wnnna$aEye Tracking Technology
=450  \\$wnnna$aEye-Tracking Systems
=450  \\$wnnna$aEye-Tracking Technologies
=450  \\$wnnna$aEyetracking Systems
=450  \\$wnnna$aEyetracking Technologies
=450  \\$wnnna$aGaze Tracking
=450  \\$wnnna$aGaze Tracking System
=450  \\$wnnna$aGaze Tracking Technology
=450  \\$wnnna$aGaze-Tracking Systems
=450  \\$wnnna$aGaze-Tracking Technologies
=450  \\$wnnna$aGazetracking Systems
=450  \\$wnnna$aTechnology, Eye-Tracking
=680  \\$iTechniques used for EYE MOVEMENT MEASUREMENTS, which capture and measure a person's EYE MOVEMENT and/or EYE GAZE.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aEye tracking$0(DLC)sh2014000212$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$aTechnique$0(DLC)sh2002007892$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aEye tracking--Technique

=LDR  00594nz  a2200169n  4500
=001  9881929101802441
=005  20220527101641.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084745
=035  \\$a(DNLM)D000084745
=035  \\$a(NLM)9817067645200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x280
=150  \\$aErysiphe
=680  \\$iA genus of fungi in the family Erysiphaceae, class Leotiomycetes and phylum ASCOMYCOTA. Erysiphe fungi are plant pathogens associated with powdery mildew.
=688  \\$a2021
=750  \0$aErysiphe$0(DLC)sh 87005744$5IEN-M

=LDR  01024nz  a2200253n  4500
=001  9881929111302441
=005  20220524152037.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085202
=035  \\$a(DNLM)D000085202
=035  \\$a(NLM)9817067752900041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x305
=150  \\$aEmotional Abuse
=450  \\$aPsychological Abuse
=450  \\$wnnna$aAbuse, Emotional
=450  \\$wnnna$aAbuse, Psychological
=450  \\$wnnna$aAbuses, Emotional
=450  \\$wnnna$aAbuses, Psychological
=450  \\$wnnna$aEmotional Abuses
=450  \\$wnnna$aPsychological Abuses
=680  \\$iNonphysical abuse as defined as a pattern of behavior in which one person deliberately and repeatedly subjects another to nonphysical acts that are detrimental to behavioral and affective functioning and overall mental well-being. (APA Dictionary of Psychology, accessed 4/21/2020).
=688  \\$a2021
=750  \0$aPsychological abuse$0(DLC)sh 94002308$5IEN-M

=LDR  00598nz  a2200193n  4500
=001  9881929111502441
=005  20220524151111.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083684
=035  \\$a(DNLM)D000083684
=035  \\$a(NLM)9817067695400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x134
=150  \\$aEconomic Factors
=450  \\$wnnna$aFactors, Economic
=450  \\$wnnna$aEconomic Factor
=680  \\$iMeasures of available financial and material resources.
=688  \\$a2021
=750  \2$aEconomic indicators$0(DLC)sh 85040831$5IEN-M

=LDR  01741nz  a2200469n  4500
=001  9881929098302441
=005  20220527152215.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082424
=035  \\$a(DNLM)D000082424
=035  \\$a(NLM)9817067617400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x527.$x100.$x120.$x875.$x500
=150  \\$aInternet Addiction Disorder
=450  \\$aInternet Addiction
=450  \\$aInternet Gaming Disorder
=450  \\$aSmartphone Addiction
=450  \\$aSocial Media Addiction
=450  \\$wnnna$aAddiction Disorder, Internet
=450  \\$wnnna$aAddiction Disorders, Internet
=450  \\$wnnna$aAddiction, Internet
=450  \\$wnnna$aAddiction, Smartphone
=450  \\$wnnna$aAddiction, Social Media
=450  \\$wnnna$aAddictions, Internet
=450  \\$wnnna$aAddictions, Smartphone
=450  \\$wnnna$aAddictions, Social Media
=450  \\$wnnna$aDisorder, Internet Addiction
=450  \\$wnnna$aDisorder, Internet Gaming
=450  \\$wnnna$aDisorders, Internet Addiction
=450  \\$wnnna$aDisorders, Internet Gaming
=450  \\$wnnna$aGaming Disorder, Internet
=450  \\$wnnna$aGaming Disorders, Internet
=450  \\$wnnna$aInternet Addiction Disorders
=450  \\$wnnna$aInternet Addictions
=450  \\$wnnna$aInternet Gaming Disorders
=450  \\$wnnna$aMedia Addiction, Social
=450  \\$wnnna$aMedia Addictions, Social
=450  \\$wnnna$aSmartphone Addictions
=450  \\$wnnna$aSocial Media Addictions
=680  \\$iProblematic, compulsive Internet use that results in significant impairment of person's function in daily life.
=688  \\$a2021
=750  \0$aInternet addiction$0(DLC)sh 97009080$5IEN-M

=LDR  00683nz  a2200181n  4500
=001  9881929098702441
=005  20220527151602.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081784
=035  \\$a(DNLM)D000081784
=035  \\$a(NLM)9817067474100041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x358.$x805
=150  \\$aInterprofessional Education
=450  \\$wnnna$aEducation, Interprofessional
=680  \\$iEducation which encourages health professionals to learn their teammates' roles and responsibilities, making them better able to provide patient-centered care.
=688  \\$a2021
=750  \0$aInterprofessional Education$0(DLC)sh2010013958$5IEN-M

=LDR  00782nz  a2200229n  4500
=001  9881929099102441
=005  20220527144434.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085002
=035  \\$a(DNLM)D000085002
=035  \\$a(NLM)9817067745100041
=040  \\$aDNLM$cDNLM
=060  \0$aWK 815
=072  \\$aE2.$x491
=150  \\$aGlycemic Control
=450  \\$aBlood Glucose Control
=450  \\$wnnna$aControl, Blood Glucose
=450  \\$wnnna$aControl, Glycemic
=450  \\$wnnna$aGlucose Control, Blood
=680  \\$iStrategies used for regulating BLOOD GLUCOSE levels. Such strategies include administration of INSULIN; DIETARY MODIFICATION; and EXERCISE.
=688  \\$a2021
=750  \0$aBlood glucose monitoring$0(DLC)sh 90000834$5IEN-M

=LDR  01334nz  a2200433n  4500
=001  9881929099302441
=005  20220527143318.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085402
=035  \\$a(DNLM)D000085402
=035  \\$a(NLM)9817067674300041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x446.$x250.$x625
=072  \\$aF1.$x752.$x747.$x385.$x200.$x625
=072  \\$aF1.$x829.$x750.$x500
=150  \\$aGender Role
=450  \\$wnnna$aMan's Role
=450  \\$wnnna$aMen's Role
=450  \\$wnnna$aWoman's Role
=450  \\$wnnna$aWomen's Role
=450  \\$aSex Role
=450  \\$wnnna$aGender Roles
=450  \\$wnnna$aRole, Gender
=450  \\$wnnna$aRole, Man's
=450  \\$wnnna$aRole, Men's
=450  \\$wnnna$aRole, Sex
=450  \\$wnnna$aRole, Woman's
=450  \\$wnnna$aRole, Women's
=450  \\$wnnna$aRoles, Gender
=450  \\$wnnna$aRoles, Men's
=450  \\$wnnna$aRoles, Sex
=450  \\$wnnna$aRoles, Woman's
=450  \\$wnnna$aRoles, Women's
=450  \\$wnnna$aSex Roles
=450  \\$wnnna$aWoman's Roles
=450  \\$wnnna$aWomen's Roles
=680  \\$iSocial role encompassing a range of behaviors and attitudes that are considered acceptable based on perceived sex.
=688  \\$a2021
=750  \0$aSex role$0(DLC)sh 85120663$5IEN-M

=LDR  01226nz  a2200265n  4500
=001  9881929099502441
=005  20220527141813.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084803
=035  \\$a(DNLM)D000084803
=035  \\$a(NLM)9817067765700041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x312
=072  \\$aI1.$x880.$x302
=150  \\$aGender Equity
=450  \\$aGender Equality
=450  \\$wnnna$aEquality, Gender
=450  \\$wnnna$aEquity, Gender
=450  \\$wnnna$aGender Equalities
=450  \\$wnnna$aGender Equities
=680  \\$iFairness of treatment for men and women according to their respective needs. This may include equal treatment or treatment that is different but which is considered equivalent in terms of rights, benefits, obligations, and opportunities. (United Nations Educational, Scientific and Cultural Organization)
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aGender identity$0(DLC)sh 91003756$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aEquity$0(DLC)sh85044554$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aGender identity$iand$aEquity$5IEN-M

=LDR  03593nz  a2200949n  4500
=001  9881929392702441
=005  20220601141132.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082122
=035  \\$a(DNLM)D000082122
=035  \\$a(NLM)9817067448900041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x300.$x707.$x960
=150  \\$aInternal Hernia
=450  \\$aBroad Ligament Hernia
=450  \\$aForamen of Winslow Hernia
=450  \\$aIntersigmoid Hernia
=450  \\$aIntra Abdominal Hernia
=450  \\$aIntra-abdominal Hernia
=450  \\$aIntramesenteric Hernia
=450  \\$aLesser Sac Hernia
=450  \\$aParacaecal Hernia
=450  \\$aParacecal Herniation
=450  \\$aPelvic Internal Hernia
=450  \\$aPericaecal Hernia
=450  \\$aPericaecal Herniation
=450  \\$aPericaecal Internal Herniation
=450  \\$aPericecal Hernia
=450  \\$aRetrocecal Hernia
=450  \\$aSigmoid Mesocolon Hernia
=450  \\$aSupravesical Hernia
=450  \\$aTransmesenteric Hernia
=450  \\$aTransmesosigmoid Hernia
=450  \\$aTransomental Hernia
=450  \\$wnnna$aAbdominal Hernia, Intra
=450  \\$wnnna$aBroad Ligament Hernias
=450  \\$wnnna$aHernia Foramen, Winslow
=450  \\$wnnna$aHernia, Broad Ligament
=450  \\$wnnna$aHernia, Internal
=450  \\$wnnna$aHernia, Intersigmoid
=450  \\$wnnna$aHernia, Intra Abdominal
=450  \\$wnnna$aHernia, Intramesenteric
=450  \\$wnnna$aHernia, Lesser Sac
=450  \\$wnnna$aHernia, Paracaecal
=450  \\$wnnna$aHernia, Pelvic Internal
=450  \\$wnnna$aHernia, Pericaecal
=450  \\$wnnna$aHernia, Pericecal
=450  \\$wnnna$aHernia, Retrocecal
=450  \\$wnnna$aHernia, Sigmoid Mesocolon
=450  \\$wnnna$aHernia, Supravesical
=450  \\$wnnna$aHernia, Transmesenteric
=450  \\$wnnna$aHernia, Transmesosigmoid
=450  \\$wnnna$aHernia, Transomental
=450  \\$wnnna$aHerniation, Paracecal
=450  \\$wnnna$aHerniation, Pericaecal
=450  \\$wnnna$aInternal Hernia, Pelvic
=450  \\$wnnna$aInternal Hernias
=450  \\$wnnna$aInternal Herniation, Pericaecal
=450  \\$wnnna$aIntersigmoid Hernias
=450  \\$wnnna$aIntra Abdominal Hernias
=450  \\$wnnna$aIntra-abdominal Hernias
=450  \\$wnnna$aIntramesenteric Hernias
=450  \\$wnnna$aLesser Sac Hernias
=450  \\$wnnna$aLigament Hernia, Broad
=450  \\$wnnna$aLigament Hernias, Broad
=450  \\$wnnna$aParacaecal Hernias
=450  \\$wnnna$aParacecal Herniations
=450  \\$wnnna$aPelvic Internal Hernias
=450  \\$wnnna$aPericaecal Hernias
=450  \\$wnnna$aPericaecal Herniations
=450  \\$wnnna$aPericaecal Internal Herniations
=450  \\$wnnna$aPericecal Hernias
=450  \\$wnnna$aRetrocecal Hernias
=450  \\$wnnna$aSigmoid Mesocolon Hernias
=450  \\$wnnna$aSupravesical Hernias
=450  \\$wnnna$aTransmesenteric Hernias
=450  \\$wnnna$aTransmesosigmoid Hernias
=450  \\$wnnna$aTransomental Hernias
=450  \\$wnnna$aWinslow Hernia Foramen
=680  \\$iA protrusion of an internal abdominal organ through a hole in an anatomical structure such as a muscle or a membrane. For instance, in paraduodenal hernia the SMALL INTESTINE herniates through an opening in the MESENTERIES. It includes intra-abdominal and diaphragmatic hernias. In abdominal hernia a protrusion occurs through a weak spot in the muscle of the ABDOMINAL WALL.
=688  \\$a2021
=750  \0$aInternal abdominal hernia$0(DLC)sh 94000288$5IEN-M

=LDR  00647nz  a2200169n  4500
=001  9881929393202441
=005  20220601135118.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084827
=035  \\$a(DNLM)D000084827
=035  \\$a(NLM)9817067748000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x109
=150  \\$aInonotus
=680  \\$iA genus of fungi in the family Hymenochaetaceae, order Hymenochaetales, and phylum BASIDIOMYCOTA. Inonotus fungi are basidiomycetes and include medicinal mushrooms such as chaga mushroom (Inonotus obliquus).
=688  \\$a2021
=750  \0$aInonotus$0(DLC)sh 88005499$5IEN-M

=LDR  01496nz  a2200409n  4500
=001  9881929394502441
=005  20220601121659.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086682
=035  \\$a(DNLM)D000086682
=035  \\$a(NLM)9817067888400041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x508.$x150.$x600.$x375
=150  \\$aIndigenous Canadians
=450  \\$aCanadian Natives
=450  \\$aFirst Nation Canadians
=450  \\$aMetis Canadians
=450  \\$aNative Canadians
=450  \\$wnnna$aCanadian Native
=450  \\$wnnna$aCanadian, First Nation
=450  \\$wnnna$aCanadian, Metis
=450  \\$wnnna$aCanadian, Native
=450  \\$wnnna$aCanadians, First Nation
=450  \\$wnnna$aCanadians, Indigenous
=450  \\$wnnna$aCanadians, Metis
=450  \\$wnnna$aCanadians, Native
=450  \\$wnnna$aFirst Nation Canadian
=450  \\$wnnna$aIndigenous Canadian
=450  \\$wnnna$aMetis Canadian
=450  \\$wnnna$aNation Canadian, First
=450  \\$wnnna$aNation Canadians, First
=450  \\$wnnna$aNative Canadian
=450  \\$wnnna$aNative, Canadian
=450  \\$wnnna$aNatives, Canadian
=680  \\$iThe three groups of indigenous aboriginal peoples of Canada. These include First Nations, Inuit and Métis. These are three distinct peoples with unique histories, languages, cultural practices and spiritual beliefs.
=688  \\$a2021
=750  \0$aIndigenous peoples$zCanada$0(DLC)sh2009002946$5IEN-M

=LDR  01068nz  a2200253n  4500
=001  9881929394802441
=005  20220601112454.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085843
=035  \\$a(DNLM)D000085843
=035  \\$a(NLM)9817068013400041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x350.$x850
=072  \\$aH1.$x158.$x273.$x180.$x700.$x500
=072  \\$aH2.$x403.$x740.$x663
=150  \\$aImaging Genomics
=450  \\$aRadiogenomics (Imaging)
=450  \\$wnnna$aGenomics, Imaging
=550  \\$aRadiation Genomics
=680  \\$iThe field of study investigating the relationship between imaging features, identified during various imaging procedures, and the presence of various genetic or molecular markers of particular disorders and diseases.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aGenomics$0(DLC)sh2002000809$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xImaging$0(DLC)sh00006070$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aGenomics--Imaging

=LDR  01469nz  a2200325n  4500
=001  9881929395902441
=005  20220601102753.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081862
=035  \\$a(DNLM)D000081862
=035  \\$a(NLM)9817067608300041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x867.$x381
=150  \\$aHyperspectral Imaging
=450  \\$aHyperspectral Analysis
=450  \\$aHyperspectral Chemical Imaging
=450  \\$aHyperspectral Image Analysis
=450  \\$aHyperspectral Reflectance Imaging
=450  \\$aHyperspectral Remote Sensing
=450  \\$wnnna$aChemical Imaging, Hyperspectral
=450  \\$wnnna$aHyperspectral Analyses
=450  \\$wnnna$aHyperspectral Image Analyses
=450  \\$wnnna$aImage Analyses, Hyperspectral
=450  \\$wnnna$aImage Analysis, Hyperspectral
=450  \\$wnnna$aImaging, Hyperspectral
=450  \\$wnnna$aImaging, Hyperspectral Chemical
=450  \\$wnnna$aRemote Sensing, Hyperspectral
=680  \\$iThe use of SPECTROMETRY measurements (of radiance, reflectance, optical scattering, absorption, etc.) made for each point of an image, across the whole spectrum of a selected spectral range such as infrared, visual, ultraviolet, or X-rays. Hyperspectral images are analyzed to determine the make up and location of specific chemical compounds in the objects being imaged.
=688  \\$a2021
=750  \0$aHyperspectral imaging$0(DLC)sh2017003567$5IEN-M

=LDR  01694cz  a2200397n  4500
=001  9881929396102441
=005  20220601102425.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081762
=035  \\$a(DNLM)D000081762
=035  \\$a(NLM)9817067474500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x496
=150  \\$aHuman-Animal Interaction
=450  \\$aAnimal-Human Communication
=450  \\$aHuman-Animal Communication
=450  \\$aHuman-Animal Relationship
=450  \\$wnnna$aAnimal Human Communication
=450  \\$wnnna$aAnimal-Human Communications
=450  \\$wnnna$aCommunication, Animal-Human
=450  \\$wnnna$aCommunication, Human-Animal
=450  \\$wnnna$aCommunications, Animal-Human
=450  \\$wnnna$aCommunications, Human-Animal
=450  \\$wnnna$aHuman Animal Communication
=450  \\$wnnna$aHuman Animal Interaction
=450  \\$wnnna$aHuman Animal Relationship
=450  \\$wnnna$aHuman-Animal Communications
=450  \\$wnnna$aHuman-Animal Interactions
=450  \\$wnnna$aHuman-Animal Relationships
=450  \\$wnnna$aInteraction, Human-Animal
=450  \\$wnnna$aInteractions, Human-Animal
=450  \\$wnnna$aRelationship, Human-Animal
=450  \\$wnnna$aRelationships, Human-Animal
=680  \\$iEncompasses any situation where there is interchange between human(s) and animal(s) at an individual or cultural level. These interactions are diverse and idiosyncratic, and may be fleeting or profound. (https://www.avma.org/KB/Policies/Pages/The-Human-Animal-Bond.aspx accessed 8/22/2019).
=688  \\$a2021
=750  \0$iBroader mapping$aHuman-animal relationships$0(DLC)sh85062838$4BM$5IEN-M

=LDR  01247nz  a2200325n  4500
=001  9881929396502441
=005  20220531163302.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082922
=035  \\$a(DNLM)D000082922
=035  \\$a(NLM)9817067439000041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 503.1
=072  \\$aE1.$x370.$x225.$x875.$x408
=072  \\$aE5.$x200.$x875.$x408
=150  \\$aHIV Testing
=450  \\$aAIDS Testing
=450  \\$aHIV Infection Diagnosis
=450  \\$aHIV-AIDS Testing
=450  \\$wnnna$aDiagnosis, HIV Infection
=450  \\$wnnna$aHIV AIDS Testing
=450  \\$wnnna$aTesting, AIDS
=450  \\$wnnna$aTesting, HIV
=450  \\$wnnna$aTesting, HIV-AIDS
=667  \\$acoordinate with HIV Infections/*diag or AIDS /*diag and specific test if pertinent
=680  \\$iDiagnosis of HIV INFECTIONS by assaying bodily fluids or tissues for the presence of HIV ANTIBODIES; HIV ANTIGENS; or the VIRAL RNA of HIV.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aHIV (Viruses)$0(DLC)sh86004391$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xTesting$0(DLC)sh99005648$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aHIV (Viruses)--Testing

=LDR  01224nz  a2200229n  4500
=001  9881929396702441
=005  20220531162123.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085264
=035  \\$a(DNLM)D000085264
=035  \\$a(NLM)9817067758900041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x540.$x468
=150  \\$aHigh Reliability Organizations
=450  \\$wnnna$aHigh Reliability Organization
=450  \\$wnnna$aOrganization, High Reliability
=450  \\$wnnna$aOrganizations, High Reliability
=680  \\$iOrganizations operating complex, high-hazard domains for extended periods without serious accidents or catastrophic failures. The concept of high reliability  extends beyond standardization. High reliability organizations cultivate resilience by relentlessly prioritizing safety over other performance pressures. (from https://psnet.ahrq.gov/primer/high-reliability accessed 3/25/2020).
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aAssociations, institutions, etc.$0(DLC)sh85008810$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xReliability$0(DLC)sh99005496$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aEnterotoxins--Receptors

=LDR  00674nz  a2200169n  4500
=001  9881929396802441
=005  20220531160419.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084824
=035  \\$a(DNLM)D000084824
=035  \\$a(NLM)9817067762400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x108
=150  \\$aHericium
=680  \\$iA genus of fungi in the family Hericiaceae, order Russulales, and phylum BASIDIOMYCOTA. Hericium fungi are basidiomycetes with distinctive white fruiting body that resembles icicles such as in lion's mane mushroom, Hericium erinaceus.
=688  \\$a2021
=750  \0$aHericium$0(DLC)sh 88001071$5IEN-M

=LDR  01610nz  a2200373n  4500
=001  9881929397002441
=005  20220531155824.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083302
=035  \\$a(DNLM)D000083302
=035  \\$a(NLM)9817067791300041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x228.$x140.$x300.$x775.$x300
=072  \\$aC14.$x907.$x253.$x855.$x300
=150  \\$aHemorrhagic Stroke
=450  \\$aIntracerebral Hemorrhage Stroke
=450  \\$aIntracerebral Hemorrhagic Stroke
=450  \\$aSubarachnoid Hemorrhagic Stroke
=450  \\$wnnna$aHemorrhage Stroke, Intracerebral
=450  \\$wnnna$aHemorrhagic Stroke, Intracerebral
=450  \\$wnnna$aHemorrhagic Stroke, Subarachnoid
=450  \\$wnnna$aHemorrhagic Strokes
=450  \\$wnnna$aIntracerebral Hemorrhage Strokes
=450  \\$wnnna$aIntracerebral Hemorrhagic Strokes
=450  \\$wnnna$aStroke, Hemorrhagic
=450  \\$wnnna$aStroke, Intracerebral Hemorrhage
=450  \\$wnnna$aStroke, Intracerebral Hemorrhagic
=450  \\$wnnna$aStroke, Subarachnoid Hemorrhagic
=450  \\$wnnna$aSubarachnoid Hemorrhagic Strokes
=680  \\$iStroke due to rupture of a weakened blood vessel in the brain (e.g., CEREBRAL HEMISPHERES; CEREBELLUM; SUBARACHNOID SPACE).
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aSubarachnoid hemorrhage$0(DLC)sh85129404$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aCerebrovascular disease$0(DLC)sh85022123$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$iand$5IEN-M

=LDR  00802nz  a2200205n  4500
=001  9881929397602441
=005  20220531153928.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083342
=035  \\$a(DNLM)D000083342
=035  \\$a(NLM)9817067787700041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x599.$x323
=072  \\$aE5.$x599.$x695.$x275
=150  \\$aHealth Belief Model
=450  \\$aHealth Belief Models
=450  \\$wnnna$aModel, Health Belief
=680  \\$iA model which is based on certain predictors of a person's perception of threat severity, susceptibility, interventional benefits and self-efficacy about a health threat that can be used to promote and educate health behavior.
=688  \\$a2021
=750  \0$aHealth belief model$0(DLC)sh2011002750$5IEN-M

=LDR  00687nz  a2200193n  4500
=001  9881929087802441
=005  20220602133151.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083582
=035  \\$a(DNLM)D000083582
=035  \\$a(NLM)9817067807100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x355
=072  \\$aB3.$x440.$x475.$x100.$x355
=150  \\$aLyngbya
=550  \\$aLyngbya Toxins
=680  \\$iA unicellular, photosynthetic genus of CYANOBACTERIA belonging to the family Oscillatoriaceae. It is a known cause of seaweed dermatitis and also Ciguatera poisoning when ingested.
=688  \\$a2021
=750  \0$aLyngbya$0(DLC)sh2005007307$5IEN-M

=LDR  00603nz  a2200193n  4500
=001  9881929088002441
=005  20220602132930.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081842
=035  \\$a(DNLM)D000081842
=035  \\$a(NLM)9817067610900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.L6
=072  \\$aF4.$x754.$x528
=150  \\$aLogotherapy
=450  \\$wnnna$aLogotherapies
=680  \\$iDirective existential psychotherapy that emphasizes the importance of meaning in the person's life.
=688  \\$a2021
=750  \0$aLogotherapy$0(DLC)sh 85078141$5IEN-M

=LDR  00661nz  a2200169n  4500
=001  9881929088202441
=005  20220602132646.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084744
=035  \\$a(DNLM)D000084744
=035  \\$a(NLM)9817067646800041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x538
=150  \\$aLeptosphaeria
=680  \\$iA genus of fungi in the family Leptosphaeriaceae, order Pleosporales and phylum ASCOMYCOTA. Leptosphaeria fungi are filamentous ascomycetes mostly found in soil and rarely associated with opportunistic MYCETOMA.
=688  \\$a2021
=750  \0$aLeptosphaeria$0(DLC)sh 88021974$5IEN-M

=LDR  01077nz  a2200325n  4500
=001  9881929088402441
=005  20220602132345.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085343
=035  \\$a(DNLM)D000085343
=035  \\$a(NLM)9817067758000041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x550
=150  \\$aLatent Infection
=450  \\$aInfection Reactivation
=450  \\$aReactivated Infection
=450  \\$aReactivation Infection
=450  \\$wnnna$aInfection Reactivations
=450  \\$wnnna$aInfection, Latent
=450  \\$wnnna$aInfection, Reactivated
=450  \\$wnnna$aInfection, Reactivation
=450  \\$wnnna$aLatent Infections
=450  \\$wnnna$aReactivation Infections
=450  \\$wnnna$aReactivation, Infection
=550  \\$aReinfection
=550  \\$aVirus Activation
=550  \\$aVirus Latency
=680  \\$iDelayed infection of the host by a dormant or inactive pathogen.
=688  \\$a2021; for REACTIVATED INFECTION use REINFECTION 2021
=750  \0$aLatent virus diseases$0(DLC)sh 90002264$5IEN-M

=LDR  00993nz  a2200205n  4500
=001  9881929088502441
=005  20220602132106.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081982
=035  \\$a(DNLM)D000081982
=035  \\$a(NLM)9817067574000041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x589.$x62
=072  \\$aE5.$x642.$x62
=150  \\$aLaser Speckle Contrast Imaging
=680  \\$iTwo-dimensional imaging created from the quantification of the blurring of speckle (randomly varying intensity patterns of light seen after it is scattered through a medium) that occurs spatially or temporally.  LSCI is used for measuring blood flow in tissues such as the retina, skin, and brain.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aLaser speckle$0(DLC)sh85074784$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$vImaging$0(DLC)sh00006070$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aLaser speckle--Imaging

=LDR  00939nz  a2200265n  4500
=001  9881929088602441
=005  20220602131715.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081702
=035  \\$a(DNLM)D000081702
=035  \\$a(NLM)9817067476900041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x220.$x250
=150  \\$aJails
=450  \\$aDetention Centers
=450  \\$aGaols
=450  \\$wnnna$aCenter, Detention
=450  \\$wnnna$aCenters, Detention
=450  \\$wnnna$aDetention Center
=450  \\$wnnna$aGaol
=450  \\$wnnna$aJail
=667  \\$aspecify geographic location if pertinent
=680  \\$iPlace of confinement for persons held in lawful custody in a place under the jurisdiction of a local government such as a city or county for the confinement of persons awaiting trial or those convicted of misdemeanor crimes.
=688  \\$a2021
=750  \0$aJails$0(DLC)sh 85069253$5IEN-M

=LDR  01135nz  a2200277n  4500
=001  9818351687706676
=005  20220602155717.0
=008  010803\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D027901
=035  \\$a(DNLM)D027901
=035  \\$a(NLM)98199059280000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x583.$x40
=150  \\$aAcanthaceae
=450  \\$wnnna$aHygrophila
=450  \\$aAcanthus
=450  \\$aHypoestes
=450  \\$aRuellia
=450  \\$aThunbergia
=550  \\$aPetunia
=680  \\$iA plant family of the order Lamiales. It is characterized by simple leaves in opposite pairs, cystoliths (enlarged cells containing crystals of calcium carbonate), and bilaterally symmetrical and bisexual flowers that are usually crowded together. The common name for Ruellia of wild petunia is easily confused with PETUNIA.
=688  \\$a2002
=750  \0$iNarrower mapping$aRuellia$0(DLC)sh2020008934$4NM$5DNLM
=750  \0$aAcanthaceae$5IEN-M$0(DLC)sh 85000309

=LDR  02743nz  a2200781n  4500
=001  9882685745102441
=005  20251110152626.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085682
=035  \\$a(DNLM)D000085682
=035  \\$a(NLM)9817067895200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x906
=150  \\$aWorking Dogs
=450  \\$aDetection Dogs
=450  \\$aGuard Dogs
=450  \\$aGuardian Dogs
=450  \\$aHerding Dogs
=450  \\$aHunting Dogs
=450  \\$aMilitary Dogs
=450  \\$aMilitary Working Dogs
=450  \\$aPolice Dogs
=450  \\$aScent Detection Dogs
=450  \\$aSearch and Rescue Dogs
=450  \\$aSniffer Dogs
=450  \\$wnnna$aDetection Dog
=450  \\$wnnna$aDog, Detection
=450  \\$wnnna$aDog, Guard
=450  \\$wnnna$aDog, Guardian
=450  \\$wnnna$aDog, Herding
=450  \\$wnnna$aDog, Hunting
=450  \\$wnnna$aDog, Military
=450  \\$wnnna$aDog, Military Working
=450  \\$wnnna$aDog, Police
=450  \\$wnnna$aDog, Scent Detection
=450  \\$wnnna$aDogs, Detection
=450  \\$wnnna$aDogs, Guard
=450  \\$wnnna$aDogs, Guardian
=450  \\$wnnna$aDogs, Herding
=450  \\$wnnna$aDogs, Hunting
=450  \\$wnnna$aDogs, Military
=450  \\$wnnna$aDogs, Military Working
=450  \\$wnnna$aDog, Sniffer
=450  \\$wnnna$aDogs, Police
=450  \\$wnnna$aDogs, Scent Detection
=450  \\$wnnna$aDogs, Sniffer
=450  \\$wnnna$aDogs, Working
=450  \\$wnnna$aDog, Working
=450  \\$wnnna$aGuard Dog
=450  \\$wnnna$aGuardian Dog
=450  \\$wnnna$aHerding Dog
=450  \\$wnnna$aHunting Dog
=450  \\$wnnna$aMilitary Dog
=450  \\$wnnna$aMilitary Working Dog
=450  \\$wnnna$aPolice Dog
=450  \\$wnnna$aScent Detection Dog
=450  \\$wnnna$aSniffer Dog
=450  \\$wnnna$aWorking Dog
=450  \\$wnnna$aWorking Dog, Military
=450  \\$wnnna$aWorking Dogs, Military
=680  \\$iDogs that are trained to perform practical tasks, as opposed to PETS or companion dogs.
=680  \\$iDogs trained to use their senses, generally their sense of smell, to identify explosives, illegal drugs, blood, body fluids, and other substances.  Detection dogs may also be able to detect human disease.
=680  \\$iDogs trained to work with or for humans to locate and catch game animals.
=680  \\$iDogs that are trained to locate missing people or human remains.
=680  \\$iDogs either trained to herd livestock animals, or belonging to breeds that have been developed for herding.
=688  \\$a2021
=750  \0$aWorking dogs$0(DLC)sh 85148177$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01233nz  a2200253n  4500
=001  9818351688106676
=005  20220602155952.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009010
=035  \\$a(DNLM)D009010
=035  \\$a(NLM)98198695340000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x525
=072  \\$aL1.$x906.$x394.$x422
=072  \\$aN5.$x715.$x360.$x750.$x540
=072  \\$aN6.$x850.$x520.$x830.$x525
=150  \\$aMonte Carlo Method
=450  \\$wnnna$aMethod, Monte Carlo
=680  \\$iIn statistics, a technique for numerically approximating the solution of a mathematical problem by studying the distribution of some random variable, often generated by a computer. The name alludes to the randomness characteristic of the games of chance played at the gambling casinos in Monte Carlo. (From Random House Unabridged Dictionary, 2d ed, 1993)
=688  \\$a91(75); was see under OPERATIONS RESEARCH 1975-90
=750  \0$iNarrower mapping$aDiffusion Monte Carlo method$0(DLC)sh2020010598$4NM$5DNLM
=750  \0$aMonte Carlo method$5IEN$0(DLC)sh 85087032

=LDR  01174nz  a2200205n  4500
=001  9818351688706676
=005  20220527101423.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D032521
=035  \\$a(DNLM)D032521
=035  \\$a(NLM)98199741330000041
=040  \\$aDNLM$cDNLM
=072  \\$aG12.$x450.$x400
=150  \\$aImmunity, Herd
=450  \\$aHerd Immunity
=667  \\$ahuman & animal
=680  \\$iThe non-susceptibility to infection of a large group of individuals in a population. A variety of factors can be responsible for herd immunity and this gives rise to the different definitions used in the literature. Most commonly, herd immunity refers to the case when, if most of the population is immune, infection of a single individual will not cause an epidemic. Also, in such immunized populations, susceptible individuals are not likely to become infected. Herd immunity can also refer to the case when unprotected individuals fail to contract a disease because the infecting organism has been banished from the population.
=688  \\$a2003
=750  \0$aHerd Immunity$0(DLC)sh2020012267$5DNLM

=LDR  00931nz  a2200265n  4500
=001  9881934009802441
=005  20220607164101.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083682
=035  \\$a(DNLM)D000083682
=035  \\$a(NLM)9817067678700041
=040  \\$aDNLM$cDNLM
=072  \\$aC25.$x775.$x383.$x500
=072  \\$aC25.$x775.$x643.$x500.$x700
=072  \\$aE2.$x319.$x306.$x500.$x500.$x500
=072  \\$aF3.$x900.$x647.$x500.$x700
=150  \\$aOpiate Overdose
=450  \\$aOpioid Overdose
=450  \\$wnnna$aOpiate Overdoses
=450  \\$wnnna$aOpioid Overdoses
=450  \\$wnnna$aOverdose, Opiate
=450  \\$wnnna$aOverdose, Opioid
=680  \\$iAccidental or deliberate use of an OPIOID in excess of normal dosage. It includes overdose for prescription and illicit opioids.
=688  \\$a2021
=750  \0$iBroader mapping$aNarcotics$xOverdose$0(DLC)sh85089816$4BM$5IEN-M

=LDR  00882nz  a2200217n  4500
=001  9881934009902441
=005  20220607162926.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082563
=035  \\$a(DNLM)D000082563
=035  \\$a(NLM)9817067490700041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x874.$x500.$x875
=150  \\$aOpen Field Test
=450  \\$aNovel Object Recognition Test
=450  \\$aOpen Field Maze Test
=450  \\$wnnna$aOpen Field Tests
=450  \\$wnnna$aTest, Open Field
=680  \\$iA maze test in which an animal is placed in an open chamber designed to assess anxiety and exploratory behavior by movement patterns. In novel object recognition test various objects are added to open field to assess exploration and memory.
=688  \\$a2021
=750  \0$iBroader mapping$aMaze tests$0(DLC)sh85082458$4BM$5IEN-M

=LDR  01354nz  a2200313n  4500
=001  9881934010002441
=005  20220607162300.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086103
=035  \\$a(DNLM)D000086103
=035  \\$a(NLM)9817067878700041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x820.$x480
=150  \\$aNegative-Sense RNA Viruses
=450  \\$aAntisense-Strand RNA Viruses
=450  \\$aGroup V Single-Stranded RNA Viruses
=450  \\$wnnna$aAntisense Strand RNA Viruses
=450  \\$wnnna$aAntisense-Strand RNA Virus
=450  \\$wnnna$aGroup V Single Stranded RNA Viruses
=450  \\$wnnna$aNegative Sense RNA Viruses
=450  \\$wnnna$aNegative-Sense RNA Virus
=450  \\$wnnna$aRNA Virus, Negative-Sense
=450  \\$wnnna$aRNA Viruses, Antisense-Strand
=450  \\$wnnna$aRNA Viruses, Negative-Sense
=680  \\$iRNA viruses that have their genetic material encoded in the form of single-stranded, negative-sense RNA. Unlike RETROVIRUSES they do not employ DNA intermediates in their life-cycle
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aAntisense RNA$0(DLC)sh89003559$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aRNA viruses$0(DLC)sh85143842$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Headings$aAntisense RNA$iand$aRNA viruses$5IEN-M

=LDR  01323nz  a2200349n  4500
=001  9881934010102441
=005  20220607161837.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087162
=035  \\$a(DNLM)D000087162
=035  \\$a(NLM)9817067857600041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x325.$x877.$x750
=072  \\$aE7.$x700.$x700.$x500
=072  \\$aE7.$x858.$x594.$x875
=072  \\$aJ1.$x637.$x708.$x560.$x937.$x500
=150  \\$aN95 Respirators
=450  \\$aN95 FFRs
=450  \\$aN95 Face Masks
=450  \\$aN95 Filtering Facepiece Respirators
=450  \\$aN95 Masks
=450  \\$wnnna$aFace Mask, N95
=450  \\$wnnna$aMask, N95
=450  \\$wnnna$aMask, N95 Face
=450  \\$wnnna$aN95 FFR
=450  \\$wnnna$aN95 Face Mask
=450  \\$wnnna$aN95 Mask
=450  \\$wnnna$aN95 Respirator
=450  \\$wnnna$aRespirator, N95
=680  \\$iRespiratory protective devices designed to achieve a close seal around the nose and mouth to maintain efficient filtration of aerosolized particles and droplets. They are often fitted for the prevention of the spread of infections (e.g. COVID19) or to administer inhaled anesthetics or other gases.
=688  \\$a2021
=750  \0$iBroader mapping$aRespirators (Medical equipment)$0(DLC)sh97008479$4BM$5IEN-M

=LDR  00673nz  a2200169n  4500
=001  9881934010302441
=005  20220607161626.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084724
=035  \\$a(DNLM)D000084724
=035  \\$a(NLM)9817067771600041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x613
=150  \\$aMycosphaerella
=680  \\$iA genus of fungi in the family Mycosphaerellaceae, order Dothideomycetes and phylum ASCOMYCOTA. Mycosphaerella are endophytic fungi and causative agents for plant fungal diseases such as leaf blight and root and leaf rots.
=688  \\$a2021
=750  \0$aMycosphaerella$0(DLC)sh87002690$5IEN-M

=LDR  01295nz  a2200301n  4500
=001  9881934010602441
=005  20220607155131.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084142
=035  \\$a(DNLM)D000084142
=035  \\$a(NLM)9817067821800041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x150.$x500.$x500
=072  \\$aE5.$x318.$x740.$x250.$x507
=072  \\$aN5.$x715.$x360.$x750.$x125.$x500.$x500
=072  \\$aN5.$x715.$x360.$x750.$x200.$x563
=072  \\$aN6.$x850.$x520.$x830.$x150.$x500.$x500
=072  \\$aN6.$x850.$x520.$x830.$x250.$x507
=150  \\$aMultidimensional Scaling Analysis
=450  \\$aMultidimensional Scaling
=450  \\$wnnna$aAnalysis, Multidimensional Scaling
=450  \\$wnnna$aMultidimensional Scaling Analyses
=450  \\$wnnna$aMultidimensional Scalings
=450  \\$wnnna$aScaling Analysis, Multidimensional
=450  \\$wnnna$aScaling, Multidimensional
=680  \\$iA method of providing a visual representation of similarities among a set of data by plotting a map of perceived similarities on a set of vectors in p-dimensional space such that distances among them correspond to a function of the input matrix.
=688  \\$a2021
=750  \0$aMultidimensional scaling$0(DLC)sh85088344$5IEN-M

=LDR  01086nz  a2200277n  4500
=001  9881934010802441
=005  20220607153816.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084443
=035  \\$a(DNLM)D000084443
=035  \\$a(NLM)9817067710700041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x874.$x500.$x750
=150  \\$aMorris Water Maze Test
=450  \\$wnnna$aWater Maze Test
=450  \\$wnnna$aWater-Maze Procedure
=450  \\$aMorris Water Maze
=450  \\$wnnna$aMaze Test, Water
=450  \\$wnnna$aMaze, Morris Water
=450  \\$wnnna$aProcedure, Water-Maze
=450  \\$wnnna$aWater Maze Procedure
=450  \\$wnnna$aWater Maze, Morris
=450  \\$wnnna$aWater-Maze Procedures
=680  \\$iA maze test often used to evaluate spatial learning and memory in rodent models by measuring the time it takes for a submerged platform in an open swimming arena to be found.
=688  \\$a2021; for Morris Water Maze Test was under Maze Learning 2020
=750  \0$iBroader mapping$aMaze tests$0(DLC)sh85082458$4BM$5IEN-M

=LDR  01156nz  a2200253n  4500
=001  9881934010902441
=005  20220607151929.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082582
=035  \\$a(DNLM)D000082582
=035  \\$a(NLM)9817067490200041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x218
=072  \\$aD25.$x720.$x517
=072  \\$aJ1.$x637.$x51.$x720.$x573
=150  \\$aMolecularly Imprinted Polymers
=450  \\$wnnna$aImprinted Polymer, Molecularly
=450  \\$wnnna$aMolecularly Imprinted Polymer
=450  \\$wnnna$aPolymer, Molecularly Imprinted
=680  \\$iSynthetic polymeric matrices with artificial molecular recognition sites generated by MOLECULAR IMPRINTING TECHNIQUE. It can specifically bind target molecules (e.g., antibodies, enzymes or receptors).
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aMolecular imprinting$0(DLC)sh98002021$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPolymers$0(DLC)sh85104660$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aMolecular imprinting$iand$aPolymers$5IEN-M

=LDR  00734nz  a2200193n  4500
=001  9881934011802441
=005  20220607145445.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085883
=035  \\$a(DNLM)D000085883
=035  \\$a(NLM)9817067930800041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x950.$x375
=072  \\$aI3.$x946.$x225.$x125
=150  \\$aMilitary Deployment
=450  \\$wnnna$aDeployment, Military
=680  \\$iThe movement of MILITARY PERSONNEL and support structures to designated areas for the purpose of performing of military duties in support of a mission.
=688  \\$a2021: use MILITARY PERSONNEL 2000-2020
=750  \0$aDeployment (Strategy)$0(DLC)sh85037035$5IEN-M

=LDR  00719nz  a2200181n  4500
=001  9881934012002441
=005  20220607145204.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083822
=035  \\$a(DNLM)D000083822
=035  \\$a(NLM)9817067705400041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x775
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x775
=150  \\$aMicrobacterium
=680  \\$iA genus of gram-positive, heat-resistant BACTERIA belonging to the family Microbacteriaceae and phylum ACTINOBACTERIA. Similar to CORYNEBACTERIACEAE, it is found in dairy products and the mammalian intestinal tract.
=688  \\$a2021
=750  \0$aMicrobacterium$0(DLC)sh88023280$5IEN-M

=LDR  01136nz  a2200349n  4500
=001  9881934012202441
=005  20220607144732.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085924
=035  \\$a(DNLM)D000085924
=035  \\$a(NLM)9817067929700041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 487.5.M4
=072  \\$aM1.$x526.$x590
=150  \\$aMetal Workers
=450  \\$aIron Workers
=450  \\$aIron and Steel Workers
=450  \\$aSteel Workers
=450  \\$aWelders
=450  \\$wnnna$aIron Worker
=450  \\$wnnna$aMetal Worker
=450  \\$wnnna$aSteel Worker
=450  \\$wnnna$aWelder
=450  \\$wnnna$aWorker, Iron
=450  \\$wnnna$aWorker, Metal
=450  \\$wnnna$aWorker, Steel
=450  \\$wnnna$aWorkers, Iron
=450  \\$wnnna$aWorkers, Metal
=450  \\$wnnna$aWorkers, Steel
=680  \\$iCraftspersons who take ordinary types of flat metal and make them into specialized products for various duct and ventilation systems, as well as architectural and specialized metal fabrication.
=688  \\$a2021
=750  \0$aMetal-workers$0(DLC)sh85084098$5IEN-M

=LDR  01538nz  a2200349n  4500
=001  9881934012402441
=005  20220607143858.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086002
=035  \\$a(DNLM)D000086002
=035  \\$a(NLM)9817067933400041
=040  \\$aDNLM$cDNLM
=072  \\$aC4.$x557.$x470.$x35.$x510.$x757
=072  \\$aC4.$x557.$x470.$x660.$x510.$x757
=072  \\$aC4.$x588.$x894.$x797.$x520.$x173
=072  \\$aC4.$x588.$x894.$x797.$x640.$x350
=072  \\$aC8.$x381.$x540.$x144
=072  \\$aC8.$x785.$x520.$x124
=072  \\$aC8.$x785.$x640.$x350
=150  \\$aMesothelioma, Malignant
=450  \\$aMalignant Mesothelioma
=450  \\$aMalignant Pleural Mesothelioma
=450  \\$aMesothelioma, Malignant Pleural
=450  \\$wnnna$aMalignant Mesotheliomas
=450  \\$wnnna$aMalignant Pleural Mesotheliomas
=450  \\$wnnna$aMesotheliomas, Malignant
=450  \\$wnnna$aMesotheliomas, Malignant Pleural
=450  \\$wnnna$aPleural Mesothelioma, Malignant
=450  \\$wnnna$aPleural Mesotheliomas, Malignant
=680  \\$iA type of mesothelioma with a tendency to metastasize.  Most tumors originate from either the PLEURA or PERITONEUM, tumors may also originate in the PERICARDIUM or testicular tissue. It is associated with ASBESTOS exposure. Somatic mutations identified in WT1, BCL10, CDKN2A, NF2, and BAP1 genes are associated with the malignancy. OMIM: 156240.
=688  \\$a2021
=750  \0$iBroader mapping$aMesothelioma$0(DLC)sh85083965$4BM$5IEN-M

=LDR  01665nz  a2200421n  4500
=001  9881934012702441
=005  20220607140330.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081983
=035  \\$a(DNLM)D000081983
=035  \\$a(NLM)9817067572500041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x400.$x500
=072  \\$aN5.$x715.$x360.$x750.$x350.$x500
=072  \\$aN6.$x850.$x520.$x830.$x400.$x500
=150  \\$aMediation Analysis
=450  \\$aCausal Mediation Analysis
=450  \\$aIntermediary Factors
=450  \\$aIntermediary Variables
=450  \\$aIntervening Factors
=450  \\$aIntervening Variables
=450  \\$aMediating Factors
=450  \\$aMediating Variables
=450  \\$wnnna$aCausal Mediation Analyses
=450  \\$wnnna$aIntermediary Factor
=450  \\$wnnna$aIntermediary Variable
=450  \\$wnnna$aIntervening Factor
=450  \\$wnnna$aIntervening Variable
=450  \\$wnnna$aMediating Factor
=450  \\$wnnna$aMediating Variable
=450  \\$wnnna$aMediation Analyses
=450  \\$wnnna$aMediation Analyses, Causal
=450  \\$wnnna$aMediation Analysis, Causal
=450  \\$wnnna$aVariables, Intermediary
=550  \\$aCausality
=680  \\$iA type of statistical analysis used to understand, clarify, and explain the relationship and pathway between a presumed cause (an independent variable) and effect (dependent variable) with respect to causal links (mediating variables) and/or to analyze the effect of an intervention (mediating factor/variable) on an outcome.
=688  \\$a2021
=750  \0$aMediation (Statistics)$0(DLC)sh2007002194$5IEN-M

=LDR  00694nz  a2200229n  4500
=001  9881934013102441
=005  20220607135747.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083522
=035  \\$a(DNLM)D000083522
=035  \\$a(NLM)9817067810900041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x570.$x500
=150  \\$aMechanical Tests
=450  \\$aMechanical Testing
=450  \\$wnnna$aMechanical Test
=450  \\$wnnna$aTest, Mechanical
=450  \\$wnnna$aTesting, Mechanical
=450  \\$wnnna$aTests, Mechanical
=680  \\$iEvaluation of mechanical properties of material or a device.
=688  \\$a2021
=750  \0$aTesting$0(DLC)sh85134146$5IEN-M

=LDR  00603nz  a2200181n  4500
=001  9881934013302441
=005  20220607134412.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083842
=035  \\$a(DNLM)D000083842
=035  \\$a(NLM)9817067703800041
=040  \\$aDNLM$cDNLM
=072  \\$aD23.$x946.$x587.$x559
=150  \\$aMasked Mycotoxins
=450  \\$aBound Mycotoxins
=680  \\$iFungal toxins masked by other macromolecules thereby reducing detection levels of such mycotoxins.
=688  \\$a2021
=750  \0$iBroader mapping$aMycotoxins$0(DLC)sh85089202$4BM$5IEN-M

=LDR  00914nz  a2200277n  4500
=001  9881934013502441
=005  20220607133822.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081642
=035  \\$a(DNLM)D000081642
=035  \\$a(NLM)9817067569300041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x410.$x568.$x610.$x660
=072  \\$aG11.$x427.$x410.$x698.$x277.$x750.$x660
=072  \\$aI3.$x350.$x750.$x660
=072  \\$aI3.$x450.$x642.$x845.$x610.$x660
=150  \\$aMarathon Running
=450  \\$aMarathons
=450  \\$aUltramarathon Running
=450  \\$wnnna$aMarathon
=450  \\$wnnna$aRunning, Marathon
=450  \\$wnnna$aRunning, Ultramarathon
=550  \\$aTrack and Field
=680  \\$iA sporting event in which participants run a distance of approximately 26.2 miles in a race.
=688  \\$a2021
=750  \0$aMarathon running$0(DLC)sh85080932$5IEN-M

=LDR  01106nz  a2200313n  4500
=001  9881934014402441
=005  20220607132101.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087122
=035  \\$a(DNLM)D000087122
=035  \\$a(NLM)9817067863000041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 340.1
=072  \\$aC10.$x597.$x606.$x483
=072  \\$aC23.$x888.$x592.$x604.$x487
=072  \\$aF1.$x700.$x548
=150  \\$aMania
=450  \\$wnnna$aManic State
=450  \\$aHypomania
=450  \\$aHypomanic Episode
=450  \\$aManic Episode
=450  \\$wnnna$aEpisode, Manic
=450  \\$wnnna$aHypomanias
=450  \\$wnnna$aHypomanic Episodes
=450  \\$wnnna$aManias
=450  \\$wnnna$aManic Episodes
=680  \\$iA state of elevated excitement with over-activity sometimes accompanied with psychotic symptoms (e.g., PSYCHOMOTOR AGITATION, inflated SELF ESTEEM and flight of ideas). It is often associated with mental disorders (e.g., CYCLOTHYMIC DISORDER; and BIPOLAR DISEASES).
=688  \\$a2021(1981)
=750  \0$aMania$0(DLC)sh96000104$5IEN-M

=LDR  01416nz  a2200313n  4500
=001  9881929392802441
=005  20220601141518.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082642
=035  \\$a(DNLM)D000082642
=035  \\$a(NLM)9817067482800041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x578.$x375
=072  \\$aE1.$x370.$x376.$x537.$x250
=072  \\$aE5.$x629.$x375
=150  \\$aBrain Cortical Thickness
=450  \\$aCerebral Cortex Thickness
=450  \\$aGrey Matter Thickness
=450  \\$wnnna$aCortex Thickness, Cerebral
=450  \\$wnnna$aCortical Thickness, Brain
=450  \\$wnnna$aThickness, Brain Cortical
=450  \\$wnnna$aThickness, Cerebral Cortex
=450  \\$wnnna$aThickness, Grey Matter
=550  \\$aCerebral Cortical Thinning
=680  \\$iMeasurements of the thickness of the CEREBRAL CORTEX often detected automatically from medical imaging. Abnormal changes in cortical thickness (e.g., CORTICAL THINNING) are potential biomarkers for various neuropathologies.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aCerebral cortex$0(DLC)sh 85022087$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aThickness measurement$0(DLC)sh 85134851$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aCerebral Cortex$iand$aThickness measurement$5IEN-M

=LDR  00537nz  a2200181n  4500
=001  9881929393602441
=005  20220601133458.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081722
=035  \\$a(DNLM)D000081722
=035  \\$a(NLM)9817067475800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x401.$x23
=150  \\$aBetrayal
=450  \\$wnnna$aBetrayals
=680  \\$iAct of violation of trust or confidence of a moral standard, etc.
=688  \\$a2021
=750  \0$aBetrayal$0(DLC) sh 92003917$5IEN-M

=LDR  00874nz  a2200181n  4500
=001  9881929393802441
=005  20220601132717.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084662
=035  \\$a(DNLM)D000084662
=035  \\$a(NLM)9817067654100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x283.$x500
=150  \\$aBatrachochytrium
=450  \\$wnnna$aBatrachochytrium dendrobatidis
=680  \\$iA genus of fungi in the order Rhizophydiales, class Chytridiomycetes and phylum CHYTRIDIOMYCOTA. Batrachochytrium fungi are chytrid fungi found in aquatic habitats. Many are parasitic including Batrachochytrium dendrobatidis which is causative agent for chytrid disease in aquatic invertebrates.
=688  \\$a2021; for BATRACHOCHYTRIUM DENDROBATIDIS use CHYTRIDIOMYCOTA (2013-2020)
=750  \0$aBatrachochytrium$0(DLC) sh2006004824$5IEN-M

=LDR  02666nz  a2200625n  4500
=001  9881929408302441
=005  20220526131913.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086966
=035  \\$a(DNLM)D000086966
=035  \\$a(NLM)9817067842900041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x150.$x252.$x162
=072  \\$aC1.$x973.$x250
=072  \\$aC22.$x969.$x250
=150  \\$aBacterial Zoonoses
=450  \\$aBacterial Zoonosis
=450  \\$aBacterial Zoonotic Diseases
=450  \\$aBacterial Zoonotic Infections
=450  \\$aZoonotic Bacterial Diseases
=450  \\$aZoonotic Bacterial Infections
=450  \\$aZoonotic Spillover, Bacterial
=450  \\$wnnna$aBacterial Disease, Zoonotic
=450  \\$wnnna$aBacterial Diseases, Zoonotic
=450  \\$wnnna$aBacterial Infection, Zoonotic
=450  \\$wnnna$aBacterial Infections, Zoonotic
=450  \\$wnnna$aBacterial Zoonose
=450  \\$wnnna$aBacterial Zoonotic Disease
=450  \\$wnnna$aBacterial Zoonotic Infection
=450  \\$wnnna$aBacterial Zoonotic Spillover
=450  \\$wnnna$aBacterial Zoonotic Spillovers
=450  \\$wnnna$aDisease, Bacterial Zoonotic
=450  \\$wnnna$aDisease, Zoonotic Bacterial
=450  \\$wnnna$aDiseases, Bacterial Zoonotic
=450  \\$wnnna$aDiseases, Zoonotic Bacterial
=450  \\$wnnna$aInfection, Bacterial Zoonotic
=450  \\$wnnna$aInfection, Zoonotic Bacterial
=450  \\$wnnna$aInfections, Bacterial Zoonotic
=450  \\$wnnna$aInfections, Zoonotic Bacterial
=450  \\$wnnna$aZoonose, Bacterial
=450  \\$wnnna$aZoonoses, Bacterial
=450  \\$wnnna$aZoonosis, Bacterial
=450  \\$wnnna$aZoonotic Bacterial Disease
=450  \\$wnnna$aZoonotic Bacterial Infection
=450  \\$wnnna$aZoonotic Disease, Bacterial
=450  \\$wnnna$aZoonotic Diseases, Bacterial
=450  \\$wnnna$aZoonotic Infection, Bacterial
=450  \\$wnnna$aZoonotic Infections, Bacterial
=450  \\$wnnna$aZoonotic Spillovers, Bacterial
=667  \\$anot a routine coordinate for every zoonotic bacterial infection; index only when discussed; coordinate with specific infection term and with animal disease term if pertinent
=680  \\$iBacterial infections that may be transmitted between non-human animals and HUMANS.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aBacterial diseases$0(DLC)sh 85010843$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aZoonoses$0(DLC)sh 85150001$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aBacterial diseases$iand$aZoonoses$5IEN-M

=LDR  00962nz  a2200253n  4500
=001  9881929408502441
=005  20220525141849.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083722
=035  \\$a(DNLM)D000083722
=035  \\$a(NLM)9817067695200041
=040  \\$aDNLM$cDNLM
=072  \\$aD23.$x946.$x123.$x90
=150  \\$aBacillus thuringiensis Toxins
=450  \\$aB thuringiensis Toxins
=450  \\$aB. thuringiensis Toxins
=450  \\$aBt Toxin
=450  \\$aBt Toxins
=450  \\$wnnna$aToxin, Bt
=450  \\$wnnna$aToxins, B thuringiensis
=450  \\$wnnna$aToxins, B. thuringiensis
=680  \\$iEndotoxins produced by BACILLUS THURINGIENSIS used in transgenic plants and insecticides. When eaten by a susceptible insect they are protease activated in the insect midgut resulting in death from bacterial septicemia.
=688  \\$a2021
=750  \0$aBacillus thuringiensis$xToxicology$0(DLC) sh 00003597$5IEN-M

=LDR  00853nz  a2200253n  4500
=001  9818351885806676
=005  20220701145125.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011330
=035  \\$a(DNLM)D011330
=035  \\$a(NLM)98195368270000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x787
=072  \\$aJ3.$x220.$x500
=150  \\$aPrisons
=450  \\$aPenitentiaries
=450  \\$wnnna$aPenitentiary
=450  \\$wnnna$aPrison
=667  \\$aspecify geographic location if pertinent
=680  \\$iPenal institutions, or places of long-term confinement for prisoners.
=750  \0$iNarrower mapping$aPrivate prisons$0(DLC)sh2021000077$4NM$5DNLM
=750  \0$aPrisons$0(DLC)sh 85106996$5IEN

=LDR  01125nz  a2200241n  4500
=001  9818351885906676
=005  20220701144302.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010743
=035  \\$a(DNLM)D010743
=035  \\$a(NLM)98194900290000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 93
=072  \\$aD10.$x570.$x755
=150  \\$aPhospholipids
=450  \\$aPhosphatides
=450  \\$aPhospholipid
=680  \\$iLipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system.
=688  \\$a/metabolism was PHOSPHOLIPID METABOLISM 1965
=750  \0$iNarrower mapping$aPhosphoglycerol$0(DLC)sh2021000011$4NM$5DNLM
=750  \0$aPhospholipids$0(DLC)sh 85101108$5IEN

=LDR  00871nz  a2200217n  4500
=001  9818351886006676
=005  20220701142237.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D029592
=035  \\$a(DNLM)D029592
=035  \\$a(NLM)98194919960000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x583.$x640
=150  \\$aOleaceae
=450  \\$wnnna$aMyxopyrum
=680  \\$iA plant family of the order Lamiales. The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.
=688  \\$a2002
=750  \0$iNarrower mapping$aOsmanthus$0(DLC)sh2020000290$4NM$5DNLM
=750  \0$aOleaceae$0(DLC)sh 85094585$5IEN-M

=LDR  01731nz  a2200565n  4500
=001  9818351886106676
=005  20220701134545.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D062789
=035  \\$a(DNLM)D062789
=035  \\$a(NLM)98198510390000041
=040  \\$aDNLM$cDNLM
=060  \0$aQV 137
=072  \\$aJ1.$x637.$x767.$x844
=150  \\$aTobacco Products
=450  \\$wnnna$aBidis
=450  \\$wnnna$aBidis Tobacco
=450  \\$wnnna$aCigarillos
=450  \\$wnnna$aKreteks
=450  \\$wnnna$aKreteks Tobacco
=450  \\$wnnna$aPipe Tobacco
=450  \\$wnnna$aTobacco, Bidi
=450  \\$aCigarettes
=450  \\$aCigars
=450  \\$wnnna$aBidi
=450  \\$wnnna$aBidi Tobacco
=450  \\$wnnna$aBidi Tobaccos
=450  \\$wnnna$aBidis Tobaccos
=450  \\$wnnna$aCigar
=450  \\$wnnna$aCigarette
=450  \\$wnnna$aCigarillo
=450  \\$wnnna$aKretek
=450  \\$wnnna$aKreteks Tobaccos
=450  \\$wnnna$aPipe Tobaccos
=450  \\$wnnna$aProduct, Tobacco
=450  \\$wnnna$aProducts, Tobacco
=450  \\$wnnna$aTobacco Product
=450  \\$wnnna$aTobacco, Bidis
=450  \\$wnnna$aTobacco, Kreteks
=450  \\$wnnna$aTobacco, Pipe
=450  \\$wnnna$aTobaccos, Bidi
=450  \\$wnnna$aTobaccos, Bidis
=450  \\$wnnna$aTobaccos, Kreteks
=450  \\$wnnna$aTobaccos, Pipe
=680  \\$iSubstances and products derived from NICOTIANA TABACUM.
=688  \\$a2013
=750  \0$iNarrower mapping$aMenthol cigarettes$0(DLC)sh2020012284$4NM$5DNLM
=750  \0$aTobacco products$0(DLC)sh2013000602$5IEN-M

=LDR  01155nz  a2200313n  4500
=001  9818351886206676
=005  20220701133243.0
=008  770505\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005430
=035  \\$a(DNLM)D005430
=035  \\$a(NLM)98195505580000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x86.$x339.$x140
=150  \\$aFloors and Floorcoverings
=450  \\$wnnna$aFloors
=450  \\$aCarpets
=450  \\$aFloorcoverings
=450  \\$wnnna$aCarpet
=450  \\$wnnna$aFloor
=450  \\$wnnna$aFloorcovering
=450  \\$wnnna$aFloorcoverings and Floors
=667  \\$afor houses, commercial establishments, hospitals, institutions, etc.
=680  \\$iThe surface of a structure upon which one stands or walks.
=688  \\$a91(Aug 77); was see under FACILITY DESIGN AND CONSTRUCTION 1977-90
=750  \0$iNarrower mapping$aMats (Floor coverings)$0(DLC)sh2020012285$4NM$5DNLM
=750  \0$aFlooring$0(DLC)sh 85049176$5IEN-M
=750  \0$aFloor coverings$0(DLC)sh 85049171$5IEN-HS

=LDR  00692cz  a2200241n  4500
=001  9880363689202441
=005  20250501163405.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D009781
=035  \\$aCBA3054HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aE2.$x190.$x901.$x650
=072  \\$aK1.$x672
=150  \\$aOccultism
=450  \\$wnnna$aOccultisms
=550  \\$wg$aHumanities
=550  \\$wg$aSpiritual Therapies
=550  \\$wh$aAstrology
=667  \\$aIM
=750  \0$aOccultism$5IEN-M$0(DLC)sh 85093821
=750  \0$aOccultists$5IEN-HS$0(DLC)sh 87003651
=750  \0$iNarrower mapping$aPyramidology    $0(DLC)sh2023001997$4NM$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01289nz  a2200337n  4500
=001  9818351886406676
=005  20220701124241.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D027883
=035  \\$a(DNLM)D027883
=035  \\$a(NLM)98196566940000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x401.$x87
=150  \\$aAstragalus Plant
=450  \\$wnnna$aLocoweed, Wooly
=450  \\$aMilk Vetch
=450  \\$wnnna$aAstragalus Plants
=450  \\$wnnna$aLocoweeds, Wooly
=450  \\$wnnna$aMilk Vetchs
=450  \\$wnnna$aPlant, Astragalus
=450  \\$wnnna$aPlants, Astragalus
=450  \\$wnnna$aVetch, Milk
=450  \\$wnnna$aVetchs, Milk
=450  \\$wnnna$aWooly Locoweed
=450  \\$wnnna$aWooly Locoweeds
=680  \\$iA plant genus in the family FABACEAE, subfamily Papilionaceae, order Fabales, subclass Rosidae. Many of the species are associated with poisoning of grazing animals. Some of the species are used medicinally.
=688  \\$a2002
=750  \0$aAstragalus (Plants)$0(DLC)sh 85008877$5IEN-M
=750  \0$iNarrower mapping$aLeadville milkvetch$0(DLC)sh20210012$4NM$5DNLM

=LDR  01095nz  a2200241n  4500
=001  9818351887606676
=005  20220701122223.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D002151
=035  \\$a(DNLM)D002151
=035  \\$a(NLM)98196249090000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x131
=150  \\$aCalorimetry
=550  \\$aBasal Metabolism
=550  \\$aHot Temperature
=550  \\$aTransition Temperature
=680  \\$iThe measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
=688  \\$a67(65)
=750  \0$aCalorimetry$0(DLC)sh 89005787$5IEN
=750  \0$iNarrower mapping$aAdsorption calorimetry$0(DLC)sh2021001288$4NM$5DNLM

=LDR  01002nz  a2200253n  4500
=001  9818351887806676
=005  20220701122316.0
=008  150710\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000069550
=035  \\$a(DNLM)D000069550
=035  \\$a(NLM)985399981800041
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x35.$x250.$x500
=072  \\$aL1.$x224.$x50.$x375.$x530
=150  \\$aMachine Learning
=450  \\$aTransfer Learning
=450  \\$wnnna$aLearning, Machine
=450  \\$wnnna$aLearning, Transfer
=680  \\$iA type of ARTIFICIAL INTELLIGENCE that enable COMPUTERS to independently initiate and execute LEARNING when exposed to new data.
=688  \\$a2016; use ARTIFICIAL INTELLIGENCE 1997-2015
=750  \0$aMachine learning$0(DLC)sh 85079324$5IEN-M
=750  \0$iNarrower mapping$aTransfer learning (Machine learning)$0(DLC) sh 2021001274$4NM$5DNLM

=LDR  01438nz  a2200373n  4500
=001  9818351888006676
=005  20220617123213.0
=008  060705\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D052638
=035  \\$a(DNLM)D052638
=035  \\$a(NLM)98196526050000041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x633
=150  \\$aParticulate Matter
=450  \\$wnnna$aAir Pollutants, Particulate
=450  \\$wnnna$aAirborne Particulate Matter
=450  \\$wnnna$aAmbient Particulate Matter
=450  \\$aUltrafine Fiber
=450  \\$aUltrafine Fibers
=450  \\$aUltrafine Particle
=450  \\$aUltrafine Particles
=450  \\$aUltrafine Particulate Matter
=450  \\$wnnna$aFiber, Ultrafine
=450  \\$wnnna$aParticle, Ultrafine
=450  \\$wnnna$aParticles, Ultrafine
=450  \\$wnnna$aParticulate Air Pollutants
=450  \\$wnnna$aParticulate Matter, Airborne
=450  \\$wnnna$aParticulate Matter, Ambient
=450  \\$wnnna$aParticulate Matter, Ultrafine
=550  \\$aParticle Size
=680  \\$iParticles of any solid substance, generally under 30 microns in size, often noted as PM30. There is special concern with PM1 which can get down to PULMONARY ALVEOLI and induce MACROPHAGE ACTIVATION and PHAGOCYTOSIS leading to FOREIGN BODY REACTION and LUNG DISEASES.
=688  \\$a2007
=750  \0$aParticulate matter$0(DLC)sh2020011605$5DNLM

=LDR  01797nz  a2200433n  4500
=001  9818351888206676
=005  20220617122221.0
=008  890525\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D015997
=035  \\$a(DNLM)D015997
=035  \\$a(NLM)98196547360000041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x225.$x910
=072  \\$aE1.$x370.$x500.$x580
=072  \\$aE5.$x200.$x910
=072  \\$aE5.$x318.$x308.$x980.$x438.$x580.$x580
=072  \\$aN2.$x421.$x726.$x233.$x443.$x816
=072  \\$aN5.$x715.$x360.$x300.$x800.$x438.$x500.$x575
=072  \\$aN6.$x850.$x520.$x308.$x980.$x438.$x580.$x580
=072  \\$aN6.$x850.$x780.$x500.$x580
=150  \\$aNeonatal Screening
=450  \\$wnnna$aNewborn Screening
=450  \\$aInfant, Newborn, Screening
=450  \\$aNewborn Infant Screening
=450  \\$wnnna$aNeonatal Screenings
=450  \\$wnnna$aNewborn Infant Screenings
=450  \\$wnnna$aNewborn Screenings
=450  \\$wnnna$aScreening, Neonatal
=450  \\$wnnna$aScreening, Newborn
=450  \\$wnnna$aScreening, Newborn Infant
=450  \\$wnnna$aScreenings, Neonatal
=450  \\$wnnna$aScreenings, Newborn
=450  \\$wnnna$aScreenings, Newborn Infant
=550  \\$aPrenatal Diagnosis
=667  \\$acheck tag INFANT, NEWBORN
=680  \\$iThe identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.
=688  \\$a90
=750  \0$aNewborn screening$0(DLC)sh2021001272$5DNLM

=LDR  01270nz  a2200289n  4500
=001  9818351888406676
=005  20220617122241.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012831
=035  \\$a(DNLM)D012831
=035  \\$a(NLM)98199434100000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x937.$x650.$x100
=150  \\$aBombyx
=450  \\$wnnna$aSilkmoth
=450  \\$wnnna$aSilkworm
=450  \\$aBombyx mori
=450  \\$aSilkmoths
=450  \\$aSilkworms
=450  \\$wnnna$aBombyx morus
=450  \\$wnnna$aBombyxs
=450  \\$wnnna$amori, Bombyx
=550  \\$aSilk
=680  \\$iA genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree (on which it feeds). A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p519)
=688  \\$a2005 (1963)
=750  \0$aBombyx$0(DLC)sh2021000088$5DNLM

=LDR  00890nz  a2200241n  4500
=001  9881935014402441
=005  20220609131345.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086542
=035  \\$a(DNLM)D000086542
=035  \\$a(NLM)9817067919400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x750.$x155
=150  \\$aCalliphoridae
=450  \\$aBlow-Flies
=450  \\$aBlowflies
=450  \\$wnnna$aBlow Flies
=450  \\$wnnna$aBlow-Fly
=450  \\$wnnna$aBlowfly
=667  \\$afor killing Calliphoridae with insecticides, see note at INSECTICIDES; infestation by  maggots = MYIASIS
=680  \\$iA family of the superfamily Oestroidea in the order Diptera. Several species are major livestock pests causing MYIASIS by parasitic maggots.
=688  \\$a2021
=750  \0$aBlowflies$0(DLC) sh 85015048$5IEN-M

=LDR  01262nz  a2200313n  4500
=001  9881946898002441
=005  20220614143004.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083802
=035  \\$a(DNLM)D000083802
=035  \\$a(NLM)9817067692300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x266
=150  \\$aChilopoda
=450  \\$aCentipedes
=450  \\$aGeophilids
=450  \\$aGeophilomorpha
=450  \\$aScolopendra
=450  \\$aScolopendrid Centipedes
=450  \\$aScolopendrids
=450  \\$wnnna$aCentipede
=450  \\$wnnna$aCentipede, Scolopendrid
=450  \\$wnnna$aCentipedes, Scolopendrid
=450  \\$wnnna$aGeophilid
=450  \\$wnnna$aScolopendrid
=450  \\$wnnna$aScolopendrid Centipede
=680  \\$iClass of Arthropoda in the subphylum Myriapoda which comprises centipedes and millipedes. Chilopoda or centipedes are characterized by long multi-segmented bodies with each segment with a pair of legs. Most centipedes are predatory and venomous. While centipede bites typically only cause pain, irritation and allergic reactions they sometimes cause acute HYPERTENSION and MYOCARDIAL ISCHEMIA.
=688  \\$a2021
=750  \0$aCentipedes$0(DLC) sh 85021859$5IEN-M

=LDR  00731nz  a2200169n  4500
=001  9881946899002441
=005  20220614141811.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084823
=035  \\$a(DNLM)D000084823
=035  \\$a(NLM)9817067764000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x220
=150  \\$aCercospora
=680  \\$iA genus of fungi in the family Mycosphaerellaceae, order Capnodiales and phylum ASCOMYCOTA. Cercospora fungi are ascomycete and cCercosporaausative agents for plant fungal diseases such as leaf spots. Cercospora species produce the phytotoxin cercosporin and have no known sexual stage.
=688  \\$a2021
=750  \0$aCercospora$0(DLC) sh 850220$5IEN-M

=LDR  00636nz  a2200169n  4500
=001  9881946899402441
=005  20220614141142.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084843
=035  \\$a(DNLM)D000084843
=035  \\$a(NLM)9817067663200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x210
=150  \\$aCeratocystis
=680  \\$iA genus of fungi in the family Ceratocystidaceae, order Microascales, and phylum ASCOMYCOTA. Ceratocystis fungi are ascomycetes and causative agents for plant fungal diseases such as root rot.
=688  \\$a2021
=750  \0$aCeratocystis$0 (DLC) sh 85022032 $5IEN-M

=LDR  00770nz  a2200229n  4500
=001  9881946899602441
=005  20220614134047.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086523
=035  \\$a(DNLM)D000086523
=035  \\$a(NLM)9817067921500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x650.$x80
=150  \\$aCarnivorous Plant
=450  \\$aInsectivorous Plants
=450  \\$wnnna$aCarnivorous Plants
=450  \\$wnnna$aInsectivorous Plant
=450  \\$wnnna$aPlant, Carnivorous
=450  \\$wnnna$aPlant, Insectivorous
=680  \\$iPlants adapted to trap and kill insects and other non-plant organisms, deriving nutrients from trapped organisms.
=688  \\$a2021
=750  \0$aCarnivorous plants$0(DLC) sh 85066669$5IEN-M

=LDR  01392cz  a2200349n  4500
=001  9881946899802441
=005  20220614132924.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084802
=035  \\$a(DNLM)D000084802
=035  \\$a(NLM)9817067738900041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x126.$x990.$x551
=150  \\$aCaregiver Burden
=450  \\$wnnna$aBurnout, Caregiver
=450  \\$wnnna$aCaregiver Burnout
=450  \\$wnnna$aCaregiver Exhaustion
=450  \\$aCare Burden
=450  \\$aCare Giving Burden
=450  \\$wnnna$aBurden, Care
=450  \\$wnnna$aBurden, Care Giving
=450  \\$wnnna$aBurden, Caregiver
=450  \\$wnnna$aBurdens, Caregiver
=450  \\$wnnna$aCaregiver Burdens
=450  \\$wnnna$aExhaustion, Caregiver
=450  \\$wnnna$aGiving Burden, Care
=667  \\$aSOCIAL DETERMINANTS OF HEALTH is available
=680  \\$iThe stresses or associated emotional responses experienced by CAREGIVERS when caring for the mentally or physically disabled.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aCaregivers$0(DLC)sh 88007577$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aBurn out (Psychology)$0(DLC)sh 85018150$4BM$5IEN-M
=788  \0$iSearch also under the following Library of Congress Subject Headings used together in the same record:$aCaregivers$iand$aBurn out (psychology$5IEN-M

=LDR  01505nz  a2200313n  4500
=001  9881946900102441
=005  20220614125948.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083202
=035  \\$a(DNLM)D000083202
=035  \\$a(NLM)9817067542400041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x740.$x600.$x800.$x725.$x500.$x500
=072  \\$aN5.$x715.$x350.$x200.$x700.$x500.$x500
=072  \\$aN5.$x715.$x360.$x750.$x625.$x700.$x700.$x500.$x500
=072  \\$aN6.$x850.$x490.$x625.$x750.$x500.$x500
=072  \\$aN6.$x850.$x520.$x830.$x600.$x800.$x725.$x500.$x500
=150  \\$aCardiometabolic Risk Factors
=450  \\$wnnna$aCardiometabolic Risk Factor
=450  \\$wnnna$aFactor, Cardiometabolic Risk
=450  \\$wnnna$aFactors, Cardiometabolic Risk
=450  \\$wnnna$aRisk Factor, Cardiometabolic
=450  \\$wnnna$aRisk Factors, Cardiometabolic
=550  \\$aMetabolic Syndrome
=680  \\$iA cluster of personal behavior or lifestyle, environmental exposure, inborn or inherited conditions and characteristics, which, on the basis of epidemiological evidence,  is known to be associated with CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aMetabolic syndrome$0(DLC)sh2005005763$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xRisk factors$0(DLC)sh 00002541$4BM$5IEN-M
=788  \0$iSee also under the Library of Congress Subject Heading$aMetabolic syndrome--Risk factors$5IEN-M

=LDR  01158nz  a2200313n  4500
=001  9881949263502441
=005  20220630134351.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081682
=035  \\$a(DNLM)D000081682
=035  \\$a(NLM)9817067568000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x220
=150  \\$aCorrectional Facilities
=450  \\$aCorrectional Institutions
=450  \\$aPenal Institutions
=450  \\$wnnna$aCorrectional Facility
=450  \\$wnnna$aCorrectional Institution
=450  \\$wnnna$aFacilities, Correctional
=450  \\$wnnna$aFacility, Correctional
=450  \\$wnnna$aInstitution, Correctional
=450  \\$wnnna$aInstitution, Penal
=450  \\$wnnna$aInstitutions, Correctional
=450  \\$wnnna$aInstitutions, Penal
=450  \\$wnnna$aPenal Institution
=667  \\$aspecify geographic location if pertinent
=680  \\$iPlaces for the confinement of persons in lawful detention, including both persons awaiting trial under local jurisdiction and those persons convicted of crimes.
=688  \\$a2021
=750  \0$aCorrectional institutions$0(DLC) sh 85033017$5IEN-M

=LDR  00684nz  a2200181n  4500
=001  9881949267202441
=005  20211001000000.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000082262
=035  \\$a(DNLM)D000082262
=035  \\$a(NLM)9817067478800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x527.$x100.$x120.$x250
=072  \\$aI3.$x350.$x62
=150  \\$aCompulsive Exercise
=450  \\$wnnna$aExercise, Compulsive
=680  \\$iObsessive, excessive unhealthy levels of activity performed on a regular basis that overrides social activities and basic responsibilities and leads to anxiety when circumstances prevent exercise.
=688  \\$a2021
=750  \\$aExercise addiction $0 (DLC) sh 89002320 $5 IEN-M

=LDR  00862nz  a2200241n  4500
=001  9881949267402441
=005  20220629132147.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086723
=035  \\$a(DNLM)D000086723
=035  \\$a(NLM)9817068002900041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 142.5
=072  \\$aE1.$x55.$x500
=150  \\$aClinical Reasoning
=450  \\$aClinical Judgement
=450  \\$wnnna$aClinical Judgements
=450  \\$wnnna$aJudgement, Clinical
=450  \\$wnnna$aJudgements, Clinical
=450  \\$wnnna$aReasoning, Clinical
=680  \\$iProcess by which clinicians collect signs and process information to understand the patient's medical situation or problem, and then plan and implement appropriate medical interventions.
=688  \\$a2021
=750  \0$aMedical logic$0(DLC)sh 85082973$5EN-M

=LDR  00730nz  a2200181n  4500
=001  9881949267802441
=005  20220629125155.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086162
=035  \\$a(DNLM)D000086162
=035  \\$a(NLM)9817067939300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x232
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x663
=150  \\$aClavibacter
=680  \\$iA genus of high GC content, Gram-positive aerobic bacteria in the family Microbacteriaceae and phylum ACTINOBACTERIA. This genus contains some phytopathogenic coryneform (club-shaped) bacteria causing stunting diseases in plants.
=688  \\$a2021
=750  \0$aClavibacter$0(DLC) sh2009009121$5IEN-M

=LDR  01305nz  a2200265n  4500
=001  9881950401702441
=005  20220704145351.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081962
=035  \\$a(DNLM)D000081962
=035  \\$a(NLM)9817067574600041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x158.$x937.$x350
=072  \\$aG2.$x111.$x669.$x700.$x350
=072  \\$aG2.$x740.$x921.$x500
=072  \\$aG3.$x191.$x937.$x350
=072  \\$aG3.$x493.$x700.$x500
=072  \\$aG3.$x800.$x700.$x350
=072  \\$aG15.$x568.$x500
=150  \\$aCrassulacean Acid Metabolism
=450  \\$aCAM Photosynthesis
=450  \\$aCrassulacean Acid Metabolism Photosynthesis
=680  \\$iA water-saving mode of photosynthesis whereby CARBON DIOXIDE (CO2) taken up during the nocturnal opening of stomata (STOMATA, PLANT) is fixed to produce malate, which is accumulated in VACUOLES overnight as malic acid and subsequently decarboxylated during the day with the resulting CO2 produced being re-fixed by RUBISCO and re-assimilated through the REDUCTIVE PENTOSE PHOSPHATE CYCLE. CAM photosynthesis is found mostly in plants in arid areas, but it is also found in aquatic plants and orchids.
=688  \\$a2021
=750  \0$aCrassulacean acid metabolism$0(DLC) sh 85033775$5IEN-M

=LDR  02969nz  a2200769n  4500
=001  9881950401902441
=005  20220704144555.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086742
=035  \\$a(DNLM)D000086742
=035  \\$a(NLM)9817068002800041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 506.1
=072  \\$aE1.$x370.$x225.$x312
=072  \\$aE5.$x200.$x312
=150  \\$aCOVID-19 Testing
=450  \\$a2019 Novel Coronavirus Disease Testing
=450  \\$a2019 Novel Coronavirus Testing
=450  \\$a2019-nCoV Disease Testing
=450  \\$a2019-nCoV Infection Testing
=450  \\$a2019-nCoV Testing
=450  \\$aCOVID-19 Diagnostic Testing
=450  \\$aCOVID-19 Virus Testing
=450  \\$aCOVID19 Testing
=450  \\$aCOVID19 Virus Testing
=450  \\$aCoronavirus Disease 2019 Testing
=450  \\$aCoronavirus Disease-19 Testing
=450  \\$aSARS Coronavirus 2 Testing
=450  \\$aSARS-CoV-2 Testing
=450  \\$aSevere Acute Respiratory Syndrome Coronavirus 2 Testing
=450  \\$wnnna$a2019 nCoV Disease Testing
=450  \\$wnnna$a2019 nCoV Infection Testing
=450  \\$wnnna$a2019 nCoV Testing
=450  \\$wnnna$a2019-nCoV Disease Testings
=450  \\$wnnna$a2019-nCoV Infection Testings
=450  \\$wnnna$a2019-nCoV Testings
=450  \\$wnnna$aCOVID 19 Diagnostic Testing
=450  \\$wnnna$aCOVID 19 Testing
=450  \\$wnnna$aCOVID 19 Virus Testing
=450  \\$wnnna$aCOVID-19 Diagnostic Testings
=450  \\$wnnna$aCOVID-19 Testings
=450  \\$wnnna$aCOVID-19 Virus Testings
=450  \\$wnnna$aCOVID19 Testings
=450  \\$wnnna$aCOVID19 Virus Testings
=450  \\$wnnna$aCoronavirus Disease 19 Testing
=450  \\$wnnna$aCoronavirus Disease-19 Testings
=450  \\$wnnna$aDiagnostic Testing, COVID-19
=450  \\$wnnna$aDisease Testing, 2019-nCoV
=450  \\$wnnna$aInfection Testing, 2019-nCoV
=450  \\$wnnna$aSARS CoV 2 Testing
=450  \\$wnnna$aSARS-CoV-2 Testings
=450  \\$wnnna$aTesting, 2019-nCoV
=450  \\$wnnna$aTesting, 2019-nCoV Disease
=450  \\$wnnna$aTesting, 2019-nCoV Infection
=450  \\$wnnna$aTesting, COVID-19
=450  \\$wnnna$aTesting, COVID-19 Virus
=450  \\$wnnna$aTesting, COVID19
=450  \\$wnnna$aTesting, COVID19 Virus
=450  \\$wnnna$aTesting, Coronavirus Disease-19
=450  \\$wnnna$aTesting, SARS-CoV-2
=450  \\$wnnna$aVirus Testing, COVID-19
=450  \\$wnnna$aVirus Testing, COVID19
=680  \\$iDiagnosis of COVID-19 by assaying bodily fluids or tissues for the presence of COVID-19 antibodies, SARS-COV-2 antigens or the VIRAL RNA of SARS-COV-2.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aCovid-19 (Disease)$0(DLC)sh202000570$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xTesting$0(DLC)sh 99005648$4BM$5IEN-M
=788  \0$iSee also under the Library of Congress Subject Heading$aCovid-19 (Disease)--Testing$5IEN-M

=LDR  02902nz  a2200817n  4500
=001  9881961998402441
=005  20220711113815.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086663
=035  \\$a(DNLM)D000086663
=035  \\$a(NLM)9817067891100041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 506.6
=072  \\$aD20.$x215.$x894.$x899.$x85
=150  \\$aCOVID-19 Vaccines
=450  \\$a2019 Novel Coronavirus Vaccine
=450  \\$a2019 Novel Coronavirus Vaccines
=450  \\$a2019-nCoV Vaccine
=450  \\$a2019-nCoV Vaccines
=450  \\$aCOVID 19 Vaccine
=450  \\$aCOVID-19 Vaccine
=450  \\$aCOVID-19 Virus Vaccine
=450  \\$aCOVID-19 Virus Vaccines
=450  \\$aCOVID19 Vaccine
=450  \\$aCOVID19 Vaccines
=450  \\$aCOVID19 Virus Vaccine
=450  \\$aCOVID19 Virus Vaccines
=450  \\$aCoronavirus Disease 2019 Vaccine
=450  \\$aCoronavirus Disease 2019 Vaccines
=450  \\$aCoronavirus Disease 2019 Virus Vaccine
=450  \\$aCoronavirus Disease 2019 Virus Vaccines
=450  \\$aCoronavirus Disease-19 Vaccine
=450  \\$aCoronavirus Disease-19 Vaccines
=450  \\$aSARS Coronavirus 2 Vaccines
=450  \\$aSARS-CoV-2 Vaccine
=450  \\$aSARS-CoV-2 Vaccines
=450  \\$aSARS2 Vaccine
=450  \\$aSARS2 Vaccines
=450  \\$wnnna$a2019 nCoV Vaccine
=450  \\$wnnna$a2019 nCoV Vaccines
=450  \\$wnnna$aCOVID 19 Vaccines
=450  \\$wnnna$aCOVID 19 Virus Vaccine
=450  \\$wnnna$aCOVID 19 Virus Vaccines
=450  \\$wnnna$aCoronavirus Disease 19 Vaccine
=450  \\$wnnna$aCoronavirus Disease 19 Vaccines
=450  \\$wnnna$aSARS CoV 2 Vaccine
=450  \\$wnnna$aSARS CoV 2 Vaccines
=450  \\$wnnna$aVaccine, 2019-nCoV
=450  \\$wnnna$aVaccine, COVID 19
=450  \\$wnnna$aVaccine, COVID-19
=450  \\$wnnna$aVaccine, COVID-19 Virus
=450  \\$wnnna$aVaccine, COVID19
=450  \\$wnnna$aVaccine, COVID19 Virus
=450  \\$wnnna$aVaccine, Coronavirus Disease-19
=450  \\$wnnna$aVaccine, SARS-CoV-2
=450  \\$wnnna$aVaccine, SARS2
=450  \\$wnnna$aVaccines, 2019-nCoV
=450  \\$wnnna$aVaccines, COVID-19
=450  \\$wnnna$aVaccines, COVID-19 Virus
=450  \\$wnnna$aVaccines, COVID19
=450  \\$wnnna$aVaccines, COVID19 Virus
=450  \\$wnnna$aVaccines, Coronavirus Disease-19
=450  \\$wnnna$aVaccines, SARS-CoV-2
=450  \\$wnnna$aVaccines, SARS2
=450  \\$wnnna$aVirus Vaccine, COVID-19
=450  \\$wnnna$aVirus Vaccine, COVID19
=450  \\$wnnna$aVirus Vaccines, COVID-19
=450  \\$wnnna$aVirus Vaccines, COVID19
=680  \\$iVaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19.
=688  \\$a2021
=750  \0$aCovid-19 vaccines$0(DLC)sh2022005580$5IEN-M

=LDR  00736nz  a2200181n  4500
=001  9881977388502441
=005  20220720113453.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086262
=035  \\$a(DNLM)D000086262
=035  \\$a(NLM)9817067914700041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x988
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x915
=150  \\$aNocardiopsis
=680  \\$iA genus of gram-positive bacteria in the phylum ACTINOBACTERIA and family Nocardiopsaceae. This genus occurs in saline and alkaline soils, and is known for producing antimicrobial compounds such as thiopeptides.
=688  \\$a2021
=750  \0$iBroader mapping$aActinobacteria$0(DLC)sh2007000158$4BM$5IEN-M

=LDR  00749nz  a2200181n  4500
=001  9881977388602441
=005  20220720113402.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083962
=035  \\$a(DNLM)D000083962
=035  \\$a(NLM)9817067700900041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x986
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x887
=150  \\$aNocardioides
=680  \\$iA genus of aerobic Gram-positive high G+C DNA content bacteria in the family Nocardioidaceae and the phylum ACTINOBACTERIA. Members can utilize a wide range of carbon and nitrogen sources including ethene and VINYL CHLORIDE.
=688  \\$a2021
=750  \0$iBroader mapping$aActinobacteria$0(DLC)sh2007000158$4BM$5IEN-M

=LDR  00641nz  a2200181n  4500
=001  9881977388702441
=005  20220720113101.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086202
=035  \\$a(DNLM)D000086202
=035  \\$a(NLM)9817068019500041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x50.$x662.$x347
=150  \\$aLiberibacter
=450  \\$aCandidatus Liberibacter
=680  \\$iA genus of gram-negative ALPHAPROTEOBACTERIA in the family RHIZOBIACEAE that is a known plant pathogen transmitted by PSYLLIDS.
=688  \\$a2021
=750  \0$iBroader mapping$aRhizobiaceae$0(DLC)sh 85113710$4BM$5IEN-M

=LDR  00707nz  a2200181n  4500
=001  9881977388802441
=005  20220720112836.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086222
=035  \\$a(DNLM)D000086222
=035  \\$a(NLM)9817068017900041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x80.$x94.$x389
=150  \\$aMediterranea
=450  \\$aGenus Mediterranea
=680  \\$iA genus of gram-negative, anaerobic bacteria in the phylum BACTEROIDETES and family BACTEROIDACEAE. This genus includes the type species Mediterranea massiliensis, which resides in the human colon.
=688  \\$a2021
=750  \0$iBroader mapping$aBacteroidaceae$0(DLC)sh 85010881$4BM$5IEN-M

=LDR  00641nz  a2200169n  4500
=001  9881977389002441
=005  20220720111414.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084825
=035  \\$a(DNLM)D000084825
=035  \\$a(NLM)9817067750800041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x411
=150  \\$aFonsecaea
=680  \\$iA genus of fungi in the family Herpotrichiellaceae, order Chaetothyriales, and phylum ASCOMYCOTA. Fonsecaea fungi are ascomycetes sometimes associated with CHROMOBLASTOMYCOSIS.
=688  \\$a2021
=750  \0$iBroader mapping$aAscomycetes$0(DLC)sh 85008564$4BM$5IEN-M

=LDR  00686nz  a2200169n  4500
=001  9881977389202441
=005  20220720111116.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086183
=035  \\$a(DNLM)D000086183
=035  \\$a(NLM)9817068021100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x353.$x500.$x100.$x309
=150  \\$aExiguobacterium
=680  \\$iA genus of gram-negative bacteria in the phylum FIRMICUTES and the order BACILLALES. This genus is known for its ability to survive in a wide range of temperatures and plays a role in the diet of the MEALWORM.
=688  \\$a2021
=750  \0$iBroader mapping$aBacillaceae$0(DLC)sh 85010777$4BM$5IEN-M

=LDR  01005nz  a2200253n  4500
=001  9881977389302441
=005  20220720110705.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082564
=035  \\$a(DNLM)D000082564
=035  \\$a(NLM)9817067490300041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x425.$x874.$x500.$x500
=150  \\$aElevated Plus Maze Test
=450  \\$aElevated Plus Maze
=450  \\$aElevated Plus Maze Learning
=450  \\$aElevated Plus Maze Procedure
=450  \\$aElevated Plus-Maze
=450  \\$wnnna$aElevated Plus Mazes
=450  \\$wnnna$aElevated Plus-Mazes
=450  \\$wnnna$aMaze, Elevated Plus
=680  \\$iA maze test in which an animal is placed on the center of elevated platform and is allowed to choose one of four arms configured like a plus sign. Animals are inherently wary of open elevated areas and tend to avoid the open arms.
=688  \\$a2021
=750  \0$iBroader mapping$aMaze tests$0(DLC)sh 85082458$4BM$5IEN-M

=LDR  01070cz   2200277n  4500
=001  9880364261702441
=005  20220926161950.0
=008  960610\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019513
=035  \\$aCTL9291HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aK1.$x559.$x411.$x400.$x400
=072  \\$aK1.$x752.$x566.$x479.$x120.$x400
=150  \\$aFeminism
=450  \\$wnnna$aEthic, Feminist
=450  \\$wnnna$aEthics, Feminist
=450  \\$wnnna$aFeminist Ethic
=450  \\$aFeminist Ethics
=550  \\$wg$aHumanism
=550  \\$aWomen's Rights
=667  \\$apolit, econ & social equality of women to men
=680  \\$iThe theory of the political, economic, and social equality of the sexes and organized activity on behalf of women's rights and interests. (Webster New Collegiate Dictionary, 1981)
=688  \\$a97; was see WOMEN'S RIGHTS 1994-96
=750  \0$aFeminism$5IEN-M$0(DLC)sh 85047741
=750  \0$iNarrower mapping$aFourth-wave feminism$0(DLC)sh2021008241$4NM$5IEN-M
=750  \0$iNarrower mapping$aWhite feminism$0(DLC)sh2021008248$4NM$5IEN-M

=LDR  01314nz  a2200385n  4500
=001  9882547492302441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088823
=035  \\$a(DNLM)D000088823
=035  \\$a(NLM)9819990149300041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x150.$x750.$x750.$x500.$x500
=072  \\$aF1.$x145.$x488.$x887.$x750.$x500.$x500
=072  \\$aI1.$x880.$x604.$x473.$x650.$x968.$x500.$x500
=072  \\$aN3.$x706.$x437.$x650.$x875.$x500.$x500
=072  \\$aN5.$x300.$x150.$x800.$x750.$x500.$x500
=150  \\$aVaccination Hesitancy
=450  \\$aVaccination Delay
=450  \\$aVaccine Delay
=450  \\$aVaccine Hesitancy
=450  \\$wnnna$aDelays, Vaccination
=450  \\$wnnna$aDelays, Vaccine
=450  \\$wnnna$aDelay, Vaccination
=450  \\$wnnna$aDelay, Vaccine
=450  \\$wnnna$aHesitancy, Vaccination
=450  \\$wnnna$aHesitancy, Vaccine
=450  \\$wnnna$aVaccination Delays
=450  \\$wnnna$aVaccination Hesitancies
=450  \\$wnnna$aVaccine Delays
=450  \\$wnnna$aVaccine Hesitancies
=680  \\$iDelay in acceptance of vaccination despite availability.
=688  \\$a2022
=750  \0$aVaccine hesitancy$0(DLC)sh2021005632$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00894nz  a2200265n  4500
=001  9818352188906676
=005  20220722141539.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D031061
=035  \\$a(DNLM)D031061
=035  \\$a(NLM)98197951570000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x618.$x50.$x750.$x211
=150  \\$aCyrtosperma
=450  \\$aTaro, Giant Swamp
=450  \\$wnnna$aCyrtospermas
=450  \\$wnnna$aGiant Swamp Taro
=450  \\$wnnna$aGiant Swamp Taros
=450  \\$wnnna$aSwamp Taro, Giant
=450  \\$wnnna$aSwamp Taros, Giant
=450  \\$wnnna$aTaros, Giant Swamp
=680  \\$iA plant genus of the family ARACEAE that may be confused with other ARACEAE having similar common names.
=688  \\$a2003
=750  \0$aCyrtosperma$0(DLC)sh2021005480$5DNLM

=LDR  00733nz  a2200217n  4500
=001  9818352286206676
=005  20220722141539.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D060726
=035  \\$a(DNLM)D060726
=035  \\$a(NLM)98199132010000041
=040  \\$aDNLM$cDNLM
=060  \0$aWE 710
=072  \\$aA1.$x923
=150  \\$aTorso
=450  \\$wnnna$aTorsos
=667  \\$ado not confuse with torso protein often referred to as "torso"; "trunk" in reference to the main part of the body goes here
=680  \\$iThe central part of the body to which the neck and limbs are attached.
=688  \\$a2012
=750  \0$aTorso (Anatomy)$0(DLC)sh2021004182$5DNLM

=LDR  01566nz  a2200349n  4500
=001  9818352286406676
=005  20220722141539.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000073758
=035  \\$a(DNLM)D000073758
=035  \\$a(NLM)9810900825800041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x350.$x515.$x717
=072  \\$aE5.$x595.$x717
=150  \\$aNonlinear Optical Microscopy
=450  \\$wnnna$aCoherent Anti-Stokes Raman Microscopy
=450  \\$wnnna$aSpontaneous Raman Microscopy
=450  \\$wnnna$aSpontaneous Raman Scattering Microscopy
=450  \\$wnnna$aStimulated Raman Microscopy
=450  \\$wnnna$aStimulated Raman Scattering Microscopy
=450  \\$wnnna$aVibrational Sum Frequency Generation Microscopy
=450  \\$wnnna$aCoherent Anti Stokes Raman Microscopy
=450  \\$wnnna$aMicroscopy, Nonlinear Optical
=450  \\$wnnna$aMicroscopy, Spontaneous Raman
=450  \\$wnnna$aMicroscopy, Stimulated Raman
=450  \\$wnnna$aOptical Microscopy, Nonlinear
=450  \\$wnnna$aRaman Microscopy, Spontaneous
=450  \\$wnnna$aRaman Microscopy, Stimulated
=680  \\$iMicroscopic imaging techniques that utilize nonlinear responses of light-matter interactions which occur with high-intensity illumination, such as from LASERS, and specialized light signal detection instrumentation to produce images without the need for dyes or fluorescent labels.
=688  \\$a2018
=750  \0$aNonlinear optical microscopy$0(DLC)sh2021003944$5DNLM

=LDR  00882nz  a2200265n  4500
=001  9818352287306676
=005  20220713112038.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D035846
=035  \\$a(DNLM)D035846
=035  \\$a(NLM)98199984240000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x594
=150  \\$aLaw Enforcement
=450  \\$wnnna$aEnforcement, Law
=550  \\$aCriminal Law
=550  \\$aForensic Medicine
=550  \\$aPolice
=667  \\$aspecify geog
=680  \\$iOrganized efforts to insure obedience to the laws of a community.
=688  \\$a2003
=750  \0$iNarrower mapping$aTraffic stops (Law enforcement)$0(DLC)sh2021005584$4NM$5DNLM
=750  \0$aLaw enforcement$5IEN-M$0(DLC)sh 8507530

=LDR  02610nz  a2200589n  4500
=001  9818352287506676
=005  20220722091822.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000077318
=035  \\$a(DNLM)D000077318
=035  \\$a(NLM)9811675542100041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x671.$x579.$x800.$x500
=150  \\$aDensity Functional Theory
=450  \\$wnnna$aDFT Calculations
=450  \\$wnnna$aKS-DFT
=450  \\$wnnna$aKohn-Sham Density Functional Theory
=450  \\$aDensity Functional Calculations
=450  \\$aDensity Functional Computations
=450  \\$aDensity Functional Theory Calculations
=450  \\$aDensity Functional Theory Computations
=450  \\$aTd-DFT
=450  \\$aTd-DFT Calculations
=450  \\$aTd-DFT Computations
=450  \\$aTime-Dependent Density Functional Theory
=450  \\$aTime-Dependent Density Functional Theory Calculations
=450  \\$aTime-Dependent Density Functional Theory Computations
=450  \\$wnnna$aCalculation, Density Functional
=450  \\$wnnna$aCalculation, Td-DFT
=450  \\$wnnna$aComputation, Density Functional
=450  \\$wnnna$aComputation, Td-DFT
=450  \\$wnnna$aDFT Calculation
=450  \\$wnnna$aDensity Functional Calculation
=450  \\$wnnna$aDensity Functional Computation
=450  \\$wnnna$aDensity Functional Theories
=450  \\$wnnna$aFunctional Calculation, Density
=450  \\$wnnna$aFunctional Calculations, Density
=450  \\$wnnna$aFunctional Computation, Density
=450  \\$wnnna$aKohn Sham Density Functional Theory
=450  \\$wnnna$aTd DFT Calculations
=450  \\$wnnna$aTd DFT Computations
=450  \\$wnnna$aTd-DFT Calculation
=450  \\$wnnna$aTd-DFT Computation
=450  \\$wnnna$aTime Dependent Density Functional Theory
=450  \\$wnnna$aTime Dependent Density Functional Theory Calculations
=450  \\$wnnna$aTime Dependent Density Functional Theory Computations
=680  \\$iA theory that is used to describe the electronic ground state properties of matter. It forms the basis of methods in obtaining a solution to the Schrodinger equation for a many-body system, and to investigate the structural, magnetic, and electronic properties of molecules and materials.
=688  \\$a2019
=750  \0$iNarrower mapping$aTime-dependent density functional theory$0(DLC)sh2021005651$4NM$5DNLM
=750  \0$aDensity functionals {dollar}0 DLC)sh 85036851 {dollar}5 DNLM

=LDR  03372nz  a2200937n  4500
=001  9818352288206676
=005  20220712163037.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D008393
=035  \\$a(DNLM)D008393
=035  \\$a(NLM)98194056680000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x500.$x500
=072  \\$aI1.$x240.$x361.$x500.$x500
=072  \\$aI1.$x880.$x853.$x150.$x423.$x500.$x500
=072  \\$aN1.$x224.$x361.$x500.$x500
=072  \\$aN1.$x824.$x308.$x500.$x500
=150  \\$aMarriage
=450  \\$wnnna$aArranged Marriage
=450  \\$wnnna$aCommonlaw Marriage
=450  \\$wnnna$aConsensual Union
=450  \\$wnnna$aConsummation of Marriage
=450  \\$wnnna$aDowry
=450  \\$wnnna$aHusband-Wife Comparisons
=450  \\$wnnna$aIntermarriage
=450  \\$wnnna$aMarriage Age
=450  \\$wnnna$aMarriage Duration
=450  \\$wnnna$aMarriage Patterns
=450  \\$wnnna$aMarriage Postponement
=450  \\$wnnna$aMate Selection
=450  \\$wnnna$aMultiple Marriages
=450  \\$wnnna$aNuptiality
=450  \\$wnnna$aPolygamy
=450  \\$wnnna$aPolygyny
=450  \\$wnnna$aRemarriage
=450  \\$wnnna$aSame-Sex Marriage
=450  \\$aMarital Relationship
=450  \\$wnnna$aAge, Marriage
=450  \\$wnnna$aAges, Marriage
=450  \\$wnnna$aArranged Marriages
=450  \\$wnnna$aCommonlaw Marriages
=450  \\$wnnna$aComparison, Husband-Wife
=450  \\$wnnna$aComparisons, Husband-Wife
=450  \\$wnnna$aConsensual Unions
=450  \\$wnnna$aDowries
=450  \\$wnnna$aDuration, Marriage
=450  \\$wnnna$aHusband Wife Comparisons
=450  \\$wnnna$aHusband-Wife Comparison
=450  \\$wnnna$aIntermarriages
=450  \\$wnnna$aMarital Relationships
=450  \\$wnnna$aMarriage Ages
=450  \\$wnnna$aMarriage Consummation
=450  \\$wnnna$aMarriage Consummations
=450  \\$wnnna$aMarriage Pattern
=450  \\$wnnna$aMarriage Postponements
=450  \\$wnnna$aMarriage, Arranged
=450  \\$wnnna$aMarriage, Commonlaw
=450  \\$wnnna$aMarriage, Same-Sex
=450  \\$wnnna$aMarriages
=450  \\$wnnna$aMarriages, Arranged
=450  \\$wnnna$aMarriages, Commonlaw
=450  \\$wnnna$aMarriages, Multiple
=450  \\$wnnna$aMarriages, Same-Sex
=450  \\$wnnna$aMate Selections
=450  \\$wnnna$aPostponement, Marriage
=450  \\$wnnna$aPostponements, Marriage
=450  \\$wnnna$aRelationship, Marital
=450  \\$wnnna$aRelationships, Marital
=450  \\$wnnna$aRemarriages
=450  \\$wnnna$aSame Sex Marriage
=450  \\$wnnna$aSame-Sex Marriages
=450  \\$wnnna$aSelection, Mate
=450  \\$wnnna$aSelections, Mate
=450  \\$wnnna$aUnion, Consensual
=450  \\$wnnna$aUnions, Consensual
=667  \\$aa sociological & anthropological concept: differentiate from MARITAL STATUS, a demographic & statistical concept; SPOUSES is available for the husband or wife as a person
=680  \\$iThe social institution involving legal and/or religious sanction whereby individuals are joined together.
=750  \0$iNarrower mapping$aSlave marriage$0(DLC)sh2021005572$4NM$5DNLM
=750  \0$aMarriage$5IEN$0(DLC)sh 85081416

=LDR  01570cz  a2200433n  4500
=001  9818352288706676
=005  20220711134354.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D063505
=035  \\$a(DNLM)D063505
=035  \\$a(NLM)98198347980000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x550.$x500
=072  \\$aF1.$x145.$x813.$x629.$x625
=072  \\$aF1.$x829.$x595.$x500
=072  \\$aI1.$x880.$x735.$x820.$x500.$x500
=150  \\$aRacism
=450  \\$wnnna$aCovert Racism
=450  \\$wnnna$aRacial Bias
=450  \\$wnnna$aRacial Discrimination
=450  \\$wnnna$aRacial Prejudice
=450  \\$aEveryday Racism
=450  \\$wnnna$aBias, Racial
=450  \\$wnnna$aDiscrimination, Racial
=450  \\$wnnna$aDiscriminations, Racial
=450  \\$wnnna$aPrejudice, Racial
=450  \\$wnnna$aPrejudices, Racial
=450  \\$wnnna$aRacial Discriminations
=450  \\$wnnna$aRacial Prejudices
=450  \\$wnnna$aRacism, Covert
=450  \\$wnnna$aRacism, Everyday
=550  \\$aApartheid
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iDifferential treatment or unequal access to opportunities, based on group membership such as origin or ethnicity.
=688  \\$a2013; use PREJUDICE 1994-2012
=750  \0$iNarrower mapping$aEnvironmental racism$0(DLC)sh2021004156$4NM$5DNLM
=750  \0$aRacism$0(DLC)sh 85110266$5IEN-M

=LDR  01048nz  a2200265n  4500
=001  9818352379506676
=005  20220801111841.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011329
=035  \\$a(DNLM)D011329
=035  \\$a(NLM)98195368420000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x729
=150  \\$aPrisoners
=450  \\$aHostages
=450  \\$wnnna$aHostage
=450  \\$wnnna$aPrisoner
=667  \\$adifferentiate from CRIMINAL PSYCHOLOGY; entry term HOSTAGES: coord with VIOLENCE only if particularly discussed
=680  \\$iPersons deprived of their liberty; those held is against their will, or who are kept in confinement or custody.
=688  \\$a74(73)
=750  \0$iNarrower mapping$aInternment camp inmates$0(DLC)sh2021004023$4NM$5DNLM
=750  \0$iNarrower mapping$aNazi concentration camp inmates$0(DLC)sh2021004024$4NM$5DNLM
=750  \0$aa Prisoners$0(DLC)sh 85106950$5IEN

=LDR  03398nz  a2200793n  4500
=001  9818352380006676
=005  20220729134050.0
=008  940125\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D018562
=035  \\$a(DNLM)D018562
=035  \\$a(NLM)98197548610000041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x335
=150  \\$aDisease Transmission, Infectious
=450  \\$wnnna$aAutochthonous Transmission
=450  \\$wnnna$aCommunicable Disease Transmission
=450  \\$wnnna$aHorizontal Transmission of Infection
=450  \\$wnnna$aHorizontal Transmission of Infectious Disease
=450  \\$wnnna$aInfection Transmission
=450  \\$wnnna$aInfection Transmission, Horizontal
=450  \\$wnnna$aInfectious Disease Transmission
=450  \\$wnnna$aInfectious Disease Transmission, Horizontal
=450  \\$wnnna$aPathogen Transmission
=450  \\$wnnna$aPathogen Transmission, Horizontal
=450  \\$wnnna$aTransmission of Infectious Disease
=450  \\$wnnna$aTransmission, Infectious Disease
=450  \\$aClose-Contact Infectious Disease Transmission
=450  \\$aClose-Contact Transmission
=450  \\$aCommunity Spread
=450  \\$aCommunity Transmission
=450  \\$aDisease Superspreader Event
=450  \\$aDisease Superspreading
=450  \\$aDroplet Transmission of Infectious Disease
=450  \\$aDroplet Transmission, Infectious Disease
=450  \\$aInfectious Disease Droplet Transmission
=450  \\$aPerson-to-Person Transmission
=450  \\$wnnna$aAutochthonous Transmissions
=450  \\$wnnna$aClose Contact Infectious Disease Transmission
=450  \\$wnnna$aClose Contact Transmission
=450  \\$wnnna$aClose-Contact Transmissions
=450  \\$wnnna$aCommunity Transmissions
=450  \\$wnnna$aDisease Superspreader Events
=450  \\$wnnna$aDisease Superspreadings
=450  \\$wnnna$aDisease Transmission, Communicable
=450  \\$wnnna$aEvent, Disease Superspreader
=450  \\$wnnna$aEvents, Disease Superspreader
=450  \\$wnnna$aInfection Horizontal Transmission
=450  \\$wnnna$aPerson to Person Transmission
=450  \\$wnnna$aSuperspreader Event, Disease
=450  \\$wnnna$aSuperspreader Events, Disease
=450  \\$wnnna$aSuperspreading, Disease
=450  \\$wnnna$aSuperspreadings, Disease
=450  \\$wnnna$aTransmission, Autochthonous
=450  \\$wnnna$aTransmission, Close-Contact
=450  \\$wnnna$aTransmission, Communicable Disease
=450  \\$wnnna$aTransmission, Infection
=450  \\$wnnna$aTransmission, Pathogen
=450  \\$wnnna$aTransmission, Person-to-Person
=450  \\$wnnna$aTransmissions, Autochthonous
=450  \\$wnnna$aTransmissions, Community
=450  \\$aDisease$xtransmission
=550  \\$aFomites
=667  \\$ageneral or unspecified; prefer /transm with specific diseases
=680  \\$iThe transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal or vertical (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
=688  \\$a2009 (1995)
=750  \0$iNarrower mapping$aSuperspreader events$0(DLC)sh2021003712$4NM$5DNLM
=750  \0$aCommunicable diseases$xTransmission$0(DLC) sh 85038417$5IEN-M

=LDR  01801nz  a2200505n  4500
=001  9818352380506676
=005  20220729132724.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D046048
=035  \\$a(DNLM)D046048
=035  \\$a(NLM)98199971640000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x750.$x250.$x700
=150  \\$aSeals, Earless
=450  \\$wnnna$aPhoca groenlandica
=450  \\$wnnna$aPhocidae
=450  \\$wnnna$aSeal, Gray
=450  \\$aHalichoerus grypus
=450  \\$aMirounga
=450  \\$aPagophilus groenlandicus
=450  \\$aSeal, Elephant
=450  \\$aSeal, Harp
=450  \\$aSeals, True
=450  \\$wnnna$aEarless Seal
=450  \\$wnnna$aEarless Seals
=450  \\$wnnna$aElephant Seal
=450  \\$wnnna$aElephant Seals
=450  \\$wnnna$aGray Seal
=450  \\$wnnna$aGray Seals
=450  \\$wnnna$aHarp Seal
=450  \\$wnnna$aHarp Seals
=450  \\$wnnna$aSeal, Earless
=450  \\$wnnna$aSeal, True
=450  \\$wnnna$aSeals, Elephant
=450  \\$wnnna$aSeals, Gray
=450  \\$wnnna$aSeals, Harp
=450  \\$wnnna$aTrue Seal
=450  \\$wnnna$aTrue Seals
=667  \\$aseals unspecified goes here; FUR SEALS is also available
=680  \\$iThe family Phocidae, suborder PINNIPEDIA, order CARNIVORA, comprising the true seals. They lack external ears and are unable to use their hind flippers to walk. It includes over 18 species including the harp seal, probably the best known seal species in the world.
=688  \\$a2005
=750  \0$iNarrower mapping$aPusa$0(DLC)sh2021003914$4NM$5DNLM
=750  \0$aPhocidae$0(DLC) sh 90003944$5IEN-M

=LDR  00828nz  a2200229n  4500
=001  9818352380706676
=005  20220729131927.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005241
=035  \\$a(DNLM)D005241
=035  \\$a(NLM)98196370650000041
=040  \\$aDNLM$cDNLM
=072  \\$aA13.$x370
=150  \\$aFeathers
=450  \\$wnnna$aFeather
=550  \\$aAllergens
=680  \\$iFlat keratinous structures found on the skin surface of birds. Feathers are made partly of a hollow shaft fringed with barbs. They constitute the plumage.
=688  \\$a66(63)
=750  \0$iNarrower mapping$aPeacock feathers$0(DLC)sh2021001593$4NM$5DNLM
=750  \0$aFeathers$0(DLC)sh 85047536$5IEN

=LDR  00973nz  a2200313n  4500
=001  9818352380906676
=005  20220729131307.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D014754
=035  \\$a(DNLM)D014754
=035  \\$a(NLM)98196930250000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x856
=072  \\$aI1.$x880.$x735.$x900
=150  \\$aViolence
=450  \\$aAssaultive Behavior
=450  \\$aAtrocities
=450  \\$aBehavior, Assaultive
=450  \\$aStructural Violence
=450  \\$wnnna$aViolence, Structural
=550  \\$aBiological Warfare
=550  \\$aRiots
=550  \\$aWarfare
=550  \\$aCrime Victims
=688  \\$a70(68); ATROCITIES was heading 1963-67
=750  \0$iNarrower mapping$aObstetric violence$0(DLC)sh2021003740$4NM$5DNLM
=750  \0$aViolence$0(DLC)sh 85143514$5IEN

=LDR  00951nz  a2200289n  4500
=001  9818352381206676
=005  20220729124838.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011287
=035  \\$a(DNLM)D011287
=035  \\$a(NLM)98195308990000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x550
=072  \\$aF1.$x829.$x595
=150  \\$aPrejudice
=450  \\$aAnti-Semitism
=450  \\$aIslamophobia
=450  \\$wnnna$aAnti Semitism
=450  \\$wnnna$aAnti-Semitisms
=450  \\$wnnna$aIslamophobias
=450  \\$wnnna$aPrejudices
=680  \\$iA preconceived judgment made without factual basis.
=688  \\$a1966; for SEGREGATION use PREJUDICE 1990-2012
=750  \0$iNarrower mapping$aMisogynoir$0(DLC)sh2020010021$4NM$5DNLM
=750  \0$aPrejudices$0(DLC)sh 85106310$5IEN-M

=LDR  01223nz  a2200349n  4500
=001  9818352381506676
=005  20220729123730.0
=008  741212\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009036
=035  \\$a(DNLM)D009036
=035  \\$a(NLM)98198359660000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x937.$x650
=150  \\$aMoths
=450  \\$aAntheraea
=450  \\$aGiant Silkmoths
=450  \\$aGiant Silkworms
=450  \\$aSilkmoths, Giant
=450  \\$aSilkworms, Giant
=450  \\$wnnna$aAntheraeas
=450  \\$wnnna$aGiant Silkmoth
=450  \\$wnnna$aGiant Silkworm
=450  \\$wnnna$aMoth
=450  \\$wnnna$aSilkmoth, Giant
=450  \\$wnnna$aSilkworm, Giant
=667  \\$a/microbiol /parasitol /virol permitted; don't forget BOMBYX exists; TN 111 for eff of insecticides
=680  \\$iInsects of the suborder Heterocera of the order LEPIDOPTERA.
=688  \\$a91(75); was see under LEPIDOPTERA 1975-90
=750  \0$iNarrower mapping$aErebidae$0(DLC)sh2021005551$4NM$5DNLM
=750  \0$aMoths$0(DLC)sh 85087552$5IEN

=LDR  01281nz  a2200325n  4500
=001  9818352381706676
=005  20220729123225.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012067
=035  \\$a(DNLM)D012067
=035  \\$a(NLM)98194381040000041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x844
=150  \\$aReligion
=450  \\$aPrayer
=450  \\$aReligious Beliefs
=450  \\$aReligious Ethics
=450  \\$wnnna$aBeliefs, Religious
=450  \\$wnnna$aEthic, Religious
=450  \\$wnnna$aPrayers
=450  \\$wnnna$aReligions
=450  \\$wnnna$aReligious Belief
=550  \\$aSpiritual Therapies
=550  \\$aSecularism
=680  \\$iA set of beliefs concerning the nature, cause, and purpose of the universe, especially when considered as the creation of a superhuman agency. It usually involves devotional and ritual observances and often a moral code for the conduct of human affairs. (Random House Collegiate Dictionary, rev. ed.)
=688  \\$aRELIGION AND SOCIOLOGY was heading 1963-65
=750  \0$iNarrower mapping$aBimoism$0(DLC)sh2021003928$4NM$5DNLM
=750  \0$aReligion$0(DLC)sh 85112549$5IEN-HS

=LDR  00911nz  a2200229n  4500
=001  9818352381906676
=005  20220729122416.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D063365
=035  \\$a(DNLM)D063365
=035  \\$a(NLM)98198329760000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x903.$x149
=072  \\$aI1.$x880.$x735.$x950.$x500.$x903.$x149
=150  \\$aGenocide
=680  \\$iThe deliberate annihilation of a national, ethnic, or religious group, in part or in whole.
=688  \\$a2013; use Homicide 2000-2012
=750  \0$iNarrower mapping$aAssyrian Genocide, 1842-1933$0(DLC)sh2021001404$4NM$5DNLM
=750  \0$iNarrower mapping$aRwandan Genocide, Rwanda, 1994$0(DLC)sh2021003770$4NM$5DNLM
=750  \0$aGenocide$0(DLC)sh 85053923$5IEN-M

=LDR  01580nz  a2200373n  4500
=001  9818352382506676
=005  20220729100203.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012589
=035  \\$a(DNLM)D012589
=035  \\$a(NLM)98199526150000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x992.$x750
=150  \\$aSciuridae
=450  \\$aChipmunks
=450  \\$aCitellus
=450  \\$aEutamias
=450  \\$aPrairie Dogs
=450  \\$aSpermophilus
=450  \\$aSquirrels
=450  \\$aSusliks
=450  \\$aTamias
=450  \\$wnnna$aChipmunk
=450  \\$wnnna$aDog, Prairie
=450  \\$wnnna$aDogs, Prairie
=450  \\$wnnna$aPrairie Dog
=450  \\$wnnna$aSquirrel
=450  \\$wnnna$aSuslik
=680  \\$iA family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family.
=688  \\$a82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was see under CHIPMUNKS 1975-80
=750  \0$iNarrower mapping$aTownsend's chipmunk$0(DLC)sh2021001478$4NM$5DNLM
=750  \0$aSciuridae$0(DLC sh 85118723 {dollar}5 IEN

=LDR  00978cz   2200277n  4500
=001  9880364155102441
=005  20230901101913.0
=008  741212\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D014863
=035  \\$aCBA8210HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x479.$x900
=150  \\$aWasps
=450  \\$wnnna$aHornet
=450  \\$aHornets
=450  \\$wnnna$aJacket, Yellow
=450  \\$wnnna$aJackets, Yellow
=450  \\$wnnna$aWasp
=450  \\$wnnna$aYellow Jacket
=450  \\$aYellow Jackets
=550  \\$wg$aHymenoptera
=667  \\$a/microbiol /parasitol /virol permitted; wasp stings: coord IM with INSECT BITES AND STINGS (IM)
=680  \\$iAny of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings.
=688  \\$a91(75); was see under HYMENOPTERA 1975-90
=750  \0$aWasps$5IEN$0(DLC)sh 85145403
=750  \0$iNarrower mapping$aVespa mandarinia$0(DLC)sh2022006277$4NM$5IEN-M

=LDR  01087cz  a2200265n  4500
=001  9818352383006676
=005  20220729094558.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001516
=035  \\$a(DNLM)D001516
=035  \\$a(NLM)98195169540000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x500.$x500.$x875.$x387
=150  \\$aBees
=450  \\$aApidae
=450  \\$aApis
=450  \\$wnnna$aApi
=450  \\$wnnna$aBee
=550  \\$aApitherapy
=667  \\$adoes not include WASPS; for stings, coordinate with INSECT BITES AND STINGS
=680  \\$iInsect members of the superfamily Apoidea, found almost everywhere, particularly on flowers. About 3500 species occur in North America. They differ from most WASPS in that their young are fed honey and pollen rather than animal food.
=750  \0$iNarrower mapping$aSable Island sweat bee$0(DLC))sh2021001413$4NM$5DNLM
=750  \0$aBees$0(DLC) sh 85012843$5IEN-M

=LDR  00899nz  a2200253n  4500
=001  9818352383606676
=005  20220729092359.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009791
=035  \\$a(DNLM)D009791
=035  \\$a(NLM)98194459690000041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x277.$x750
=150  \\$aOceanography
=450  \\$wnnna$aOceanographies
=550  \\$aLimnology
=667  \\$ause for the discipline (education, history, etc) only
=680  \\$iThe science that deals with the ocean and its phenomena. (Webster, 3d ed)
=688  \\$a68
=750  \0$iNarrower mapping$aPhysical oceanography$0(DLC)sh2021001476$4NM$5DNLM
=750  \0$aOceanographers$0(DLC)sh 85093928$5IEN-M
=750  \0$aOceanography$0(DLC)sh 85093937$5IEN-H

=LDR  00766nz  a2200205n  4500
=001  9818352383806676
=005  20220729091327.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D032263
=035  \\$a(DNLM)D032263
=035  \\$a(NLM)98196884810000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x583.$x700.$x680
=150  \\$aPenstemon
=680  \\$iA plant genus of the family Plantaginaceae. Members contain phenylpropanoid and iridoid glycosides.
=688  \\$a2003
=750  \0$iNarrower mapping$aPenstemon lemhiensis$0(DLC)sh2021001477$4NM$5DNLM
=750  \0$aPenstemons$0(DLC)sh 85099608$5IEN-M

=LDR  01553nz  a2200385n  4500
=001  9818352384206676
=005  20220729090152.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003209
=035  \\$a(DNLM)D003209
=035  \\$a(NLM)98193833250000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x787.$x358
=072  \\$aJ3.$x200
=150  \\$aConcentration Camps
=450  \\$aDeath Camps
=450  \\$aInternment Camps
=450  \\$wnnna$aCamp, Concentration
=450  \\$wnnna$aCamp, Death
=450  \\$wnnna$aCamp, Internment
=450  \\$wnnna$aCamps, Concentration
=450  \\$wnnna$aCamps, Death
=450  \\$wnnna$aCamps, Internment
=450  \\$wnnna$aConcentration Camp
=450  \\$wnnna$aDeath Camp
=450  \\$wnnna$aInternment Camp
=550  \\$aHolocaust
=667  \\$aspecify geographic location if pertinent
=680  \\$iA place where large numbers of people, especially political prisoners or members of persecuted minorities, are deliberately imprisoned in a relatively small area with inadequate facilities, sometimes to provide forced labor or to await mass execution.
=688  \\$a91(75); was see under PRISONS 1975-90
=750  \0$iNarrower mapping$aNazi concentration camps$0(DLC)sh2021003726$4NM$5DNLM
=750  \0$aInternment camps {dollar}0(DLC)sh2020000306$5DNLM

=LDR  01698nz  a2200505n  4500
=001  9818352384706676
=005  20220729075953.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D031180
=035  \\$a(DNLM)D031180
=035  \\$a(NLM)98195481690000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x100.$x227
=150  \\$aCirsium
=450  \\$wnnna$aCirsium arvense
=450  \\$aThistle, Canadian
=450  \\$aThistle, Common
=450  \\$aThistle, Plume
=450  \\$aThistle, White
=450  \\$aThistle, Yellowspine
=450  \\$wnnna$aCanadian Thistle
=450  \\$wnnna$aCanadian Thistles
=450  \\$wnnna$aCirsium arvenses
=450  \\$wnnna$aCirsiums
=450  \\$wnnna$aCommon Thistle
=450  \\$wnnna$aCommon Thistles
=450  \\$wnnna$aPlume Thistle
=450  \\$wnnna$aPlume Thistles
=450  \\$wnnna$aThistles, Canadian
=450  \\$wnnna$aThistles, Common
=450  \\$wnnna$aThistles, Plume
=450  \\$wnnna$aThistles, White
=450  \\$wnnna$aThistles, Yellowspine
=450  \\$wnnna$aWhite Thistle
=450  \\$wnnna$aWhite Thistles
=450  \\$wnnna$aYellowspine Thistle
=450  \\$wnnna$aYellowspine Thistles
=450  \\$wnnna$aarvenses, Cirsium
=667  \\$aother 'thistle' plants are also available
=680  \\$iA plant genus of the family ASTERACEAE. Members contain pectolinarin (a flavonoid glycoside).
=688  \\$a2003
=750  \0$iNarrower mapping$aLongstyle thistle$0(DLC)sh2021001439$4NM$5DNLM
=750  \0$aCirsium$0(DLC)sh85026103$5IEN-M

=LDR  01251nz  a2200313n  4500
=001  9818352385406676
=005  20220729072756.0
=008  930604\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017791
=035  \\$a(DNLM)D017791
=035  \\$a(NLM)98198853210000041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x280.$x350
=072  \\$aB4.$x715.$x270
=150  \\$aGeminiviridae
=450  \\$wnnna$aTopocuvirus
=450  \\$aCurtovirus
=450  \\$aGeminivirus
=450  \\$aMastrevirus
=450  \\$wnnna$aCurtoviruses
=450  \\$wnnna$aGeminiviruses
=450  \\$wnnna$aMastreviruses
=450  \\$wnnna$aTopocuviruses
=680  \\$iA family of plant viruses where the VIRION possesses an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly. Some viruses cause economically important diseases in cultivated plants. There are four genera: Mastrevirus, Curtovirus, Topocuvirus, and BEGOMOVIRUS.
=688  \\$a1997(1994)
=750  \0$iNarrower mapping$aGrabloviruses$0(DLC)sh2021003566$4NM$5DNLM
=750  \0$aGeminiviridae$0(DLC)sh2007002906$5IEN-M

=LDR  01180nz  a2200337n  4500
=001  9818352385606676
=005  20220729072000.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001007
=035  \\$a(DNLM)D001007
=035  \\$a(NLM)98197700470000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x132
=150  \\$aAnxiety
=450  \\$wnnna$aHypervigilance
=450  \\$wnnna$aNervousness
=450  \\$wnnna$aSocial Anxiety
=450  \\$aAngst
=450  \\$aAnxiousness
=450  \\$wnnna$aAnxieties, Social
=450  \\$wnnna$aAnxiety, Social
=450  \\$wnnna$aSocial Anxieties
=550  \\$aPhobia, Social
=550  \\$aAnxiety Disorders
=550  \\$aAnti-Anxiety Agents
=667  \\$ahuman & animal; differentiate from ANXIETY DISORDERS, a psychiatric diagnosis
=680  \\$iFeelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
=750  \0$iNarrower mapping$aFear of missing out$0(DLC)sh2019103385$4NM$5DNLM
=750  \0$aAnxiety$0(DLC)sh85005835$5IEN

=LDR  00842nz  a2200229n  4500
=001  9818352385806676
=005  20220729070941.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004524
=035  \\$a(DNLM)D004524
=035  \\$a(NLM)98197503790000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x493.$x338
=150  \\$aEels
=450  \\$aAnguilliformes
=450  \\$wnnna$aEel
=667  \\$aEELS, SWAMP see SMEGMAMORPHA and EEL, ELECTRIC see ELECTROPHORUS are also available
=680  \\$iCommon name for an order (Anguilliformes) of voracious, elongate, snakelike teleost fishes.
=750  \0$iNarrower mapping$aElvers$0(DLC)sh2021001465$4NM$5DNLM
=750  \0$aEels$0(DLC)sh 85041181$5IEN

=LDR  00887nz  a2200241n  4500
=001  9818352386406676
=005  20220728164213.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D057914
=035  \\$a(DNLM)D057914
=035  \\$a(NLM)98195954040000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x44
=150  \\$aAgricultural Irrigation
=450  \\$wnnna$aAgricultural Irrigations
=450  \\$wnnna$aIrrigation, Agricultural
=450  \\$wnnna$aIrrigations, Agricultural
=680  \\$iThe routing of water to open or closed areas where it is used for agricultural purposes.
=688  \\$a2011
=750  \0$iNarrower mapping$aBasin irrigation$0(DLC)sh2020008175$4NM$5DNLM
=750  \0$aIrrigation farming$0(DLC)sh85068298$5IEN-M

=LDR  01004nz  a2200289n  4500
=001  9818352386606676
=005  20220728163402.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D057225
=035  \\$a(DNLM)D057225
=035  \\$a(NLM)98195999790000041
=040  \\$aDNLM$cDNLM
=060  \0$aW 26.55.I4
=072  \\$aL1.$x313.$x500.$x750.$x280.$x199
=072  \\$aL1.$x470.$x625
=150  \\$aData Mining
=450  \\$wnnna$aText Mining
=450  \\$wnnna$aMining, Data
=450  \\$wnnna$aMining, Text
=550  \\$aData Science
=550  \\$aBig Data
=680  \\$iUse of sophisticated analysis tools to sort through, organize, examine, and combine large sets of information.
=688  \\$a2010
=750  \0$iNarrower mapping$aAudio data mining$0(DLC)sh2021001459$4NM$5DNLM
=750  \0$iNarrower mapping$aText data mining$0(DLC)sh2019000833$4NM$5IEN-M

=LDR  00873nz  a2200229n  4500
=001  9818352387106676
=005  20220728140449.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004954
=035  \\$a(DNLM)D004954
=035  \\$a(NLM)98197969800000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x785.$x477
=072  \\$aK1.$x752.$x210
=150  \\$aEsthetics
=450  \\$aAesthetics
=680  \\$iThe branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc.
=688  \\$a67; was BEAUTY 1963-66
=750  \0$iNarrower mapping$aAesthetics, East Asian$0(DLC)sh2020000343$4NM$5DNLM
=750  \0$aAesthetics$0(DLC)sh 85001441$5IEN

=LDR  01068nz  a2200289n  4500
=001  9818352387706676
=005  20220728114812.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000069516
=035  \\$a(DNLM)D000069516
=035  \\$a(NLM)985399995400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x466
=072  \\$aN3.$x706.$x535.$x533
=150  \\$aInternational Law
=450  \\$wnnna$aLaw of Nations
=450  \\$wnnna$aPublic International Law
=450  \\$wnnna$aInternational Law, Public
=450  \\$wnnna$aInternational Laws
=450  \\$wnnna$aLaw, International
=450  \\$wnnna$aLaws, International
=680  \\$iThe body of law that governs the legal relations between or among sovereign states or nations.
=688  \\$a2016
=750  \0$iNarrower mapping$aOpposability (International law)$0(DLC)sh2021002504$4NM$5DNLM
=750  \0$aInternational law$0(DLC)sh 85067417$5IEN-M

=LDR  00766cz   2200205n  4500
=001  9880363438302441
=005  20230831164049.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D003615
=035  \\$aCAZ6756HS
=040  \\$aDNLM$beng$cDNLM
=072  \\$aI3.$x450.$x642.$x287
=150  \\$aDancing
=450  \\$wnnna$aDancings
=550  \\$wg$aRecreation
=667  \\$a/inj: coord IM with specific inj (IM); /physiol permitted; Manual 30.31+; dancing as therapy = DANCE THERAPY
=680  \\$iRhythmic and patterned body movements which are usually performed to music.
=750  \0$aDance$5IEN$0(DLC)sh 85035659
=750  \0$iNarrower mapping$aGandut (Dance)$0(DLC)sh2022007538$4NM$5IEN-M
=750  \0$iNarrower mapping$aRed River jig$0(DLC)sh2022007095$4NM$5IEN-M

=LDR  00778nz  a2200217n  4500
=001  9818352388506676
=005  20220728111225.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010209
=035  \\$a(DNLM)D010209
=035  \\$a(NLM)98195212920000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x637.$x650
=150  \\$aPaper
=450  \\$wnnna$aPapers
=550  \\$aCellulose
=680  \\$iThin sheets made from wood pulp and other fibrous substances, used for writing, drawing, printing, image duplication or wrapping.
=750  \0$iNarrower mapping$aFire resistant paper$0(DLC)sh2021002515$4NM$5DNLM
=750  \0$aPaper$5IEN$0(DLC)sh 85097578

=LDR  01554nz  a2200385n  4500
=001  9818352388706676
=005  20220728110824.0
=008  860325\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D002650
=035  \\$a(DNLM)D002650
=035  \\$a(NLM)98198959510000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x748.$x300
=072  \\$aI1.$x198.$x240.$x856.$x350.$x250.$x255
=072  \\$aI1.$x880.$x735.$x900.$x350.$x250.$x255
=150  \\$aChild Abuse, Sexual
=450  \\$aChild Molestation
=450  \\$aChild Molestation, Sexual
=450  \\$aMolestation, Sexual, Child
=450  \\$aSexual Abuse of Child
=450  \\$aSexual Abuse, Child
=450  \\$wnnna$aAbuse, Child Sexual
=450  \\$wnnna$aChild Sexual Abuse
=450  \\$wnnna$aMolestation, Child
=450  \\$wnnna$aSexual Child Abuse
=450  \\$wnnna$aSexual Child Molestation
=667  \\$acheck also tag CHILD or specific; for adult survivors of child sexual abuse, check both tags CHILD or specific + relevant adult age
=680  \\$iSexual maltreatment of the child or minor.
=688  \\$a87
=750  \0$iNarrower mapping$aChild grooming (Child sexual abuse)$0(DLC)sh2021000100$4NM$5DNLM
=750  \0$aChild sexual abuse$5IEN-HS$0(DLC)sh 85023376
=750  \0$iRelated mapping$aSexually abused children$0(DLC)sh 85120743$4RM$5IEN-M
=750  \0$iRelated mapping$aChild molesters$0(DLC)sh 85023375$4RM$5IEN-M

=LDR  01101nz  a2200289n  4500
=001  9818352388906676
=005  20220801125627.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D031063
=035  \\$a(DNLM)D031063
=035  \\$a(NLM)98197951150000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x618.$x50.$x750.$x944
=150  \\$aXanthosoma
=450  \\$wnnna$aXanthosoma sagittifollium
=450  \\$wnnna$aZanthosoma sagittifolium
=450  \\$aZanthosoma
=450  \\$wnnna$aXanthosoma sagittifolliums
=450  \\$wnnna$aXanthosomas
=450  \\$wnnna$aZanthosoma sagittifoliums
=450  \\$wnnna$aZanthosomas
=450  \\$wnnna$asagittifolium, Zanthosoma
=450  \\$wnnna$asagittifollium, Xanthosoma
=680  \\$iA plant genus of the family ARACEAE. The common names of 'Coco Yam' (Cocoyam) or 'Elephant's Ear' may be confused with COLOCASIA and other ARACEAE or with common yam (DIOSCOREA). It contains LECTINS.
=688  \\$a2003
=750  \0$aXanthosoma$0(DLC)sh2020008065$5DNLM

=LDR  01286nz  a2200349n  4500
=001  9881995696902441
=005  20220801153359.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082123
=035  \\$a(DNLM)D000082123
=035  \\$a(NLM)9817067605300041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x300.$x707.$x960.$x750
=150  \\$aParaduodenal Hernia
=450  \\$aLeft Paraduodenal Hernia
=450  \\$aObstructed Paraduodenal Hernia
=450  \\$aRight Paraduodenal Hernia
=450  \\$wnnna$aHernia, Left Paraduodenal
=450  \\$wnnna$aHernia, Obstructed Paraduodenal
=450  \\$wnnna$aHernia, Paraduodenal
=450  \\$wnnna$aHernia, Right Paraduodenal
=450  \\$wnnna$aLeft Paraduodenal Hernias
=450  \\$wnnna$aObstructed Paraduodenal Hernias
=450  \\$wnnna$aParaduodenal Hernia, Left
=450  \\$wnnna$aParaduodenal Hernia, Obstructed
=450  \\$wnnna$aParaduodenal Hernia, Right
=450  \\$wnnna$aParaduodenal Hernias
=450  \\$wnnna$aParaduodenal Hernias, Left
=450  \\$wnnna$aRight Paraduodenal Hernias
=680  \\$iA protrusion of the SMALL INTESTINE through an opening in the MESENTERY.
=688  \\$a2021
=750  \0$iBroader mapping$aInternal abdominal hernia$0(DLC)sh 94000288$4BM$5IEN-M

=LDR  00718nz  a2200181n  4500
=001  9881995697002441
=005  20220801152534.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086302
=035  \\$a(DNLM)D000086302
=035  \\$a(NLM)9817068031500041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x641
=072  \\$aB3.$x440.$x475.$x100.$x641
=150  \\$aPlanktothrix
=680  \\$iA genus of CYANOBACTERIA in the order Oscillatoriales and family Microcoleaceae. Type species of this genus are found in lakes of the Northern Hemisphere and are known producers of hepatotoxins and MICROCYSTINS.
=688  \\$a2021
=750  \0$iBroader mapping$aCyanobacteria$0(DLC)sh 85015067$4BM$5IEN-M

=LDR  00680nz  a2200181n  4500
=001  9881995697102441
=005  20220801152623.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084242
=035  \\$a(DNLM)D000084242
=035  \\$a(NLM)9817067687000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x631
=072  \\$aB3.$x440.$x475.$x100.$x631
=150  \\$aPhormidium
=680  \\$iA genus of filamentous, sheathed CYANOBACTERIA in the family Oscillatoriaceae that is found mostly in aquatic environments and is similar to the genera LYNGBYA and PLECTONEMA.
=688  \\$a2021
=750  \0$iBroader mapping$aCyanobacteria$0(DLC)sh 85015067$4BM$5IEN-M

=LDR  00660nz  a2200181n  4500
=001  9881995697302441
=005  20220801152658.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086282
=035  \\$a(DNLM)D000086282
=035  \\$a(NLM)9817067913100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x622
=072  \\$aB3.$x440.$x475.$x100.$x622
=150  \\$aPannus
=680  \\$iA genus of CYANOBACTERIA in the family Synechococcaceae that is free-floating and occurs in various water environments attaching to algae and submersed plants.
=688  \\$a2021
=750  \0$iBroader mapping$aCyanobacteria$0(DLC)sh 85015067$4BM$5IEN-M

=LDR  01423nz  a2200337n  4500
=001  9881995697502441
=005  20220801154131.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000086642
=035  \\$a(DNLM)D000086642
=035  \\$a(NLM)9817068008000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x976
=150  \\$aPangolins
=450  \\$aChinese Pangolin
=450  \\$aManidae
=450  \\$aManis
=450  \\$aManis pentadactyla
=450  \\$aPhataginus
=450  \\$aPholidota
=450  \\$aScaly Anteaters
=450  \\$aSmutsia
=450  \\$wnnna$aChinese Pangolins
=450  \\$wnnna$aPangolin
=450  \\$wnnna$aPangolin, Chinese
=450  \\$wnnna$aScaly Anteater
=667  \\$ado not confuse entry term SCALY ANTEATERS with ANTEATERS see VERMILINGUA
=680  \\$iSolitary, chiefly burrowing and nocturnal mammals of the order Pholidota. They have bodies, tails and heads encased in sharp scales, which protect them when rolled up into a ball when threatened. Also called scaly anteaters, pangolins are myrmecophagous mainly eating ants and termites and are distributed in the warmer parts of the Asia and the Africa continents. Chinese pangolins are a potential intermediate DISEASE RESERVOIR of COVID-19 virus, SARS-CoV-2.
=688  \\$a2021
=750  \0$aPangolins$0(DLC)sh 88007005$5IEN-M
=930  \\$aMeSH Mapping gwn 20220729

=LDR  01108nz  a2200289n  4500
=001  9881995792602441
=005  20220802154337.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087082
=035  \\$a(DNLM)D000087082
=035  \\$a(NLM)9817067864400041
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x820.$x578.$x344.$x588
=150  \\$aPegivirus
=450  \\$aHuman Hepegiviruses
=450  \\$aHuman Pegivirus
=450  \\$wnnna$aHepegivirus, Human
=450  \\$wnnna$aHepegiviruses, Human
=450  \\$wnnna$aHuman Hepegivirus
=450  \\$wnnna$aHuman Pegiviruses
=450  \\$wnnna$aPegivirus, Human
=450  \\$wnnna$aPegiviruses
=450  \\$wnnna$aPegiviruses, Human
=667  \\$ainfection: coordinate with FLAVIVIRIDAE INFECTIONS
=680  \\$iA genus of virus in the family FLAVIVIRIDAE. While pegivirus are mostly non-pathogenic, pegivirus coinfections are sometimes associated with NON-HODGKIN LYMPHOMA in human and a viral hepatitis Theiler's disease in horses.
=688  \\$a2021
=750  \0$iBroader mapping$aFlaviviruses$0(DLC)sh 86002175$4BM$5IEN-M

=LDR  01057nz  a2200193n  4500
=001  9881998697302441
=005  20220810163503.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085982
=035  \\$a(DNLM)D000085982
=035  \\$a(NLM)9817067636200041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x78.$x738.$x500
=072  \\$aD9.$x698.$x670.$x500
=072  \\$aD20.$x215.$x784.$x500.$x618.$x500
=150  \\$aRhamnogalacturonans
=680  \\$iTypes of polysaccharides that are components of the plant cell wall pectin matrix.  Rhamnogalacturonan I is characterized by a backbone of the repeating disaccharide (4)-alpha-D-galacturonic acid-(1,2)-alpha-L-rhamnose-(1,-) with many of the rhamnose residues substituted at C-4 with side chains of various neutral sugars linked together in various ways.  Rhamnogalacturonan II type is complex, highly branched polysaccharide where the backbone consists exclusively of D-galacturonic acid units.
=688  \\$a2021
=750  \0$iBroader mapping$aPectin$0(DLC)sh 85099115$4BM$5IEN-M

=LDR  01000nz  a2200241n  4500
=001  9881998697402441
=005  20220810163329.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084102
=035  \\$a(DNLM)D000084102
=035  \\$a(NLM)9817067796300041
=040  \\$aDNLM$cDNLM
=072  \\$aG9.$x330.$x100.$x847
=150  \\$aReturn of Spontaneous Circulation
=450  \\$aAutoresuscitation
=450  \\$aLazarus Phenomenon
=450  \\$aUnassisted Return of Spontaneous Circulation
=450  \\$wnnna$aCirculation Return, Spontaneous
=450  \\$wnnna$aPhenomenon, Lazarus
=450  \\$wnnna$aSpontaneous Circulation Return
=680  \\$iRecovery of blood circulation reestablishing blood pressure and pulse after CARDIAC ARREST. Timeline and quality of care post-return of spontaneous circulation impacts cognitive RECOVERY OF FUNCTION in CARDIAC REHABILITATION.
=688  \\$a2021
=750  \0$iBroader mapping$aBlood$xCirculation$0(DLC)sh 85014931$4BM$5IEN-M

=LDR  00868nz  a2200229n  4500
=001  9881998697502441
=005  20220810163021.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084922
=035  \\$a(DNLM)D000084922
=035  \\$a(NLM)9817067648700041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x750.$x78.$x562.$x855.$x875
=072  \\$aD9.$x301.$x416.$x750
=072  \\$aD9.$x301.$x915.$x875
=072  \\$aD9.$x698.$x365.$x855.$x875
=072  \\$aG7.$x203.$x300.$x400.$x750
=072  \\$aJ2.$x500.$x400.$x750
=150  \\$aResistant Starch
=680  \\$iDietary starch and related high-molecular carbohydrate incapable of enzymatic hydrolysis in the SMALL INTESTINE and instead ferments in the COLON, producing SHORT-CHAIN FATTY ACIDS by-products.
=688  \\$a2021
=750  \0$iBroader mapping$aStarch$0(DLC)sh 85127386$4BM$5IEN-M

=LDR  01054nz  a2200349n  4500
=001  9881998697602441
=005  20220810162522.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083102
=035  \\$a(DNLM)D000083102
=035  \\$a(NLM)9817067720800041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x741
=150  \\$aReinjuries
=450  \\$aRe-injuries
=450  \\$aRepeat Injuries
=450  \\$aRepeated injuries
=450  \\$aSecond Injuries
=450  \\$aSubsequent Injuries
=450  \\$wnnna$aInjury, Repeat
=450  \\$wnnna$aInjury, Second
=450  \\$wnnna$aInjury, Subsequent
=450  \\$wnnna$aRe-injury
=450  \\$wnnna$aReinjury
=450  \\$wnnna$aRepeat Injury
=450  \\$wnnna$aRepeated injury
=450  \\$wnnna$aSecond Injury
=450  \\$wnnna$aSubsequent Injury
=450  \\$wnnna$ainjuries, Repeated
=680  \\$iDamage inflicted on the same body part as a previous injury.
=688  \\$a2021
=750  \0$iBroader mapping$aWounds and injuries$0(DLC)sh 85148589$4BM$5IEN-M

=LDR  00892nz  a2200265n  4500
=001  9881998697702441
=005  20220810162303.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084063
=035  \\$a(DNLM)D000084063
=035  \\$a(NLM)9817067690000041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x291.$x937.$x250
=150  \\$aReinfection
=450  \\$aRe-infection
=450  \\$aRecurrent Infection
=450  \\$wnnna$aInfection, Recurrent
=450  \\$wnnna$aRe infection
=450  \\$wnnna$aRe-infections
=450  \\$wnnna$aRecurrent Infections
=450  \\$wnnna$aReinfections
=550  \\$aLatent Infection
=680  \\$iInfection by the same infectious agent following a recovery. Reinfection may be by a different strain or  the same strain.
=688  \\$a2021
=750  \0$iBroader mapping$aDiseases$xRelapse$0(DLC)sh 98007420$4BM$5IEN-M

=LDR  01256nz  a2200277n  4500
=001  9881998697802441
=005  20220810162013.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085064
=035  \\$a(DNLM)D000085064
=035  \\$a(NLM)9817067742200041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x750.$x830.$x363
=150  \\$aReceptors, Coronavirus
=450  \\$aCell Surface Receptors, Coronavirus
=450  \\$aCoronavirus Binding Site
=450  \\$aCoronavirus Cell Surface Receptors
=450  \\$aCoronavirus Receptor
=450  \\$aCoronavirus Receptors
=450  \\$aCoronavirus Spike Binding Site
=450  \\$wnnna$aReceptor, Coronavirus
=680  \\$iA broad class of cell surface proteins that bind specifically to VIRAL SPIKE PROTEINS found on a CORONAVIRUS. The attachment of the virus is the first step of a process that leads to CORONAVIRUS INFECTIONS.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aViruses$xReceptors$0(DLC)sh85143839$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aCoronaviruses$0(DLC)sh85032882$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aViruses$xReceptors$iand$aCoronaviruses$5IEN-M

=LDR  01029nz  a2200253n  4500
=001  9881998698002441
=005  20220810161817.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085844
=035  \\$a(DNLM)D000085844
=035  \\$a(NLM)9817068012100041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x158.$x273.$x180.$x350.$x925
=072  \\$aH1.$x158.$x273.$x789.$x750
=072  \\$aH2.$x403.$x740.$x669
=150  \\$aRadiation Genomics
=450  \\$aRadiogenomics (Radiometry)
=450  \\$wnnna$aGenomics, Radiation
=550  \\$aImaging Genomics
=680  \\$iThe study of the association between patient genomic data and the response to IONIZING RADIATION.
=688  \\$a2021 (2013)
=750  \0$81$wb$iBroader mapping$aGenomics$0(DLC)sh2002000809$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aIonizing radiation$0(DLC)sh85067827$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aGenomics$iand$aIonizing radiation$5IEN-M

=LDR  01136nz  a2200289n  4500
=001  9881998698202441
=005  20220810161523.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082902
=035  \\$a(DNLM)D000082902
=035  \\$a(NLM)9817067551000041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x240.$x400.$x818
=072  \\$aC14.$x280.$x400.$x818
=072  \\$aC14.$x280.$x484.$x48.$x937
=072  \\$aC16.$x131.$x240.$x400.$x817
=150  \\$aQuadricuspid Aortic Valve
=450  \\$aCongenital Quadricuspid Aortic Valve
=450  \\$aQuadricuspid Aortic Valve Condition
=450  \\$aQuadricuspid Aortic Valve Disease
=450  \\$aQuadricuspid Aortic Valve Disorder
=450  \\$aQuadricuspid Aortic Valvular Disease
=450  \\$wnnna$aAortic Valve, Quadricuspid
=450  \\$wnnna$aQuadricuspid Aortic Valves
=680  \\$iCongenital malformation where the AORTIC VALVE has four instead of three cusps. It is often associated with AORTIC REGURGITATION and AORTIC VALVE STENOSIS.
=688  \\$a2021
=750  \0$iBroader mapping$aAortic valve$xAbnormalities$0(DLC)sh2007006282$4BM$5IEN-M

=LDR  00744nz  a2200181n  4500
=001  9881998698302441
=005  20220810161224.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084382
=035  \\$a(DNLM)D000084382
=035  \\$a(NLM)9817067782100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x993
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x943
=150  \\$aPseudonocardia
=680  \\$iA genus of high GC-content ACTINOBACTERIA in the family Pseudonocardiaceae. This genus is known for its antibiotic properties which aid in the protection of leafcutter ANTS from parasites in the fungus they cultivate.
=688  \\$a2021
=750  \0$iBroader mapping$aActinobacteria$0(DLC)sh2007000158$4BM$5IEN-M

=LDR  00745nz  a2200193n  4500
=001  9881998698502441
=005  20220811120518.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000084402
=035  \\$a(DNLM)D000084402
=035  \\$a(NLM)9817067715500041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x24.$x850.$x750
=072  \\$aB3.$x510.$x400.$x500.$x750
=150  \\$aRenibacterium
=680  \\$iA genus of high GC-content, Gram-positive ACTINOBACTERIA in the family MICROCOCCACEAE. The type species of this genus, Renibacterium salmoninarum, is known to cause bacterial kidney disease in SALMONIDS.
=688  \\$a2021
=750  \0$aRenibacterium$0(DLC)sh 99003222$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  00694nz  a2200181n  4500
=001  9881998698702441
=005  20220811120522.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000084643
=035  \\$a(DNLM)D000084643
=035  \\$a(NLM)9817067667300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x487
=150  \\$aPuccinia
=680  \\$iA genus of fungi in the family Pucciniaceae, order Pucciniales, and phylum BASIDIOMYCOTA. Puccinia fungi are causative agents for some plant fungal rust diseases such as cereal rust caused by Puccinia graminis.
=688  \\$a2021
=750  \0$aPuccinia$0(DLC)sh 85108878$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  00852nz  a2200241n  4500
=001  9881998698902441
=005  20220811120517.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000082383
=035  \\$a(DNLM)D000082383
=035  \\$a(NLM)9817067619700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x858
=150  \\$aPsychotherapists
=450  \\$wnnna$aClinical Psychotherapists
=450  \\$wnnna$aClinical Psychotherapist
=450  \\$wnnna$aPsychotherapist
=450  \\$wnnna$aPsychotherapist, Clinical
=450  \\$wnnna$aPsychotherapists, Clinical
=680  \\$iTrained professionals who treat mental or emotional problems using psychological rather than solely using medical methods.
=688  \\$a2021
=750  \0$aPsychotherapists$0(DLC)sh 85108511$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  00618nz  a2200193n  4500
=001  9881998699002441
=005  20220811120515.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000087222
=035  \\$a(DNLM)D000087222
=035  \\$a(NLM)9817068121200041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x735.$x646
=150  \\$aPseudoscience
=450  \\$wnnna$aPseudosciences
=680  \\$iSystem of theories, assumptions, and methods erroneously regarded as based on science.
=688  \\$a2021
=750  \0$aPseudoscience$0(DLC)sh2001002975$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  01239nz  a2200313n  4500
=001  9881998699202441
=005  20220810154736.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085102
=035  \\$a(DNLM)D000085102
=040  \\$aDNLM$cDNLM
=072  \\$aB4.$x820.$x578
=150  \\$aPositive-Strand RNA Viruses
=450  \\$a(+) Sense RNA Viruses
=450  \\$aGroup IV Single-Stranded RNA Viruses
=450  \\$aPositive Sense RNA Viruses
=450  \\$aSense-Strand RNA Viruses
=450  \\$wnnna$aGroup IV Single Stranded RNA Viruses
=450  \\$wnnna$aPositive Strand RNA Viruses
=450  \\$wnnna$aPositive-Strand RNA Virus
=450  \\$wnnna$aRNA Virus, Positive-Strand
=450  \\$wnnna$aRNA Virus, Sense-Strand
=450  \\$wnnna$aRNA Viruses, Positive-Strand
=450  \\$wnnna$aRNA Viruses, Sense-Strand
=450  \\$wnnna$aSense Strand RNA Viruses
=450  \\$wnnna$aSense-Strand RNA Virus
=680  \\$iRNA viruses that have their genetic material encoded in the form of single-stranded, positive-sense RNA. Unlike RETROVIRUSES they do not employ DNA intermediates in their life-cycle.
=688  \\$a2021
=750  \0$iBroader mapping$aRNA viruses$0(DLC)sh 85143842$4BM$5IEN-M

=LDR  01210nz  a2200301n  4500
=001  9881998699402441
=005  20220810154353.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084483
=035  \\$a(DNLM)D000084483
=035  \\$a(NLM)9817067823900041
=040  \\$aDNLM$cDNLM
=072  \\$aG15.$x610.$x525
=150  \\$aPlant Necrosis and Chlorosis
=450  \\$aPlant Chlorosis
=450  \\$aPlant Chlorosis and Necrosis
=450  \\$aPlant Epinasty
=450  \\$aPlant Necrosis
=450  \\$wnnna$aChlorosis, Plant
=450  \\$wnnna$aEpinasty, Plant
=450  \\$wnnna$aNecroses, Plant
=450  \\$wnnna$aNecrosis, Plant
=450  \\$wnnna$aPlant Necroses
=680  \\$iPlant diseases affecting mostly leaves where either plant cells or tissues are dead and/or collapsed (necrosis) or yellowed due to loss of CHLOROPHYLL (chlorosis).
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aChlorosis (Plants)$0(DLC)sh85024589$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aNecrosis$0(DLC)sh85090575$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aChlorosis (Plants)$iand$aNecrosis$5IEN-M

=LDR  01815nz  a2200409n  4500
=001  9881998699502441
=005  20220810154207.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082462
=035  \\$a(DNLM)D000082462
=035  \\$a(NLM)9817067459200041
=040  \\$aDNLM$cDNLM
=072  \\$aG15.$x579
=150  \\$aPlant Defense Against Herbivory
=450  \\$aAnti-Herbivore Defense
=450  \\$aAnti-Herbivore Defenses
=450  \\$aHost-Plant Resistance
=450  \\$aHost-Plant Tolerance
=450  \\$aPlant Anti-Xenosis
=450  \\$aPlant Antibiosis
=450  \\$aPlant Antixenosis
=450  \\$aPlant Resistance to Herbivory
=450  \\$wnnna$aAnti Herbivore Defense
=450  \\$wnnna$aAnti Herbivore Defenses
=450  \\$wnnna$aAnti-Xenosis, Plant
=450  \\$wnnna$aAntibiosis, Plant
=450  \\$wnnna$aAntixenosis, Plant
=450  \\$wnnna$aHost Plant Resistance
=450  \\$wnnna$aHost Plant Tolerance
=450  \\$wnnna$aPlant Anti Xenosis
=450  \\$wnnna$aResistance, Host-Plant
=450  \\$wnnna$aTolerance, Host-Plant
=680  \\$iTraits developed in plants that help them avoid being used as host plants or food sources; or to tolerate and recover from HERBIVORY. Traits may be mechanical or chemical such as those that affect accessibility (thorns, thick husks, etc.), attractiveness to herbivore (odor, color, texture, etc.), digestibility (toxins, lignins, etc.), and movement in response to touch.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aPlant defenses$0(DLC)sh85102731$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aHerbivores$0(DLC)sh85060349$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aPlant defenses$iand$aHerbivores$5IEN-M

=LDR  01035nz  a2200337n  4500
=001  9881998699602441
=005  20220811120522.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000084482
=035  \\$a(DNLM)D000084482
=035  \\$a(NLM)9817067825100041
=040  \\$aDNLM$cDNLM
=072  \\$aG15.$x610.$x350
=150  \\$aPhytoplasma Disease
=450  \\$aAsh Yellows
=450  \\$aAster Yellows
=450  \\$aElm Yellows
=450  \\$aPhytoplasma Infection
=450  \\$aWitches' Broom Disease
=450  \\$wnnna$aAsh Yellow
=450  \\$wnnna$aAster Yellow
=450  \\$wnnna$aElm Yellow
=450  \\$wnnna$aInfection, Phytoplasma
=450  \\$wnnna$aPhytoplasma Diseases
=450  \\$wnnna$aPhytoplasma Infections
=450  \\$wnnna$aWitches Broom Disease
=450  \\$wnnna$aWitches' Broom Diseases
=680  \\$iPlant diseases caused by PHYTOPLASMA bacteria.
=688  \\$a2021
=750  \0$aPhytoplasma diseases$0(DLC)sh 85089193$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  00817nz  a2200181n  4500
=001  9881998699902441
=005  20220811120522.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084682
=035  \\$a(DNLM)D000084682
=035  \\$a(NLM)9817067652500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x115
=150  \\$aPhellinus
=680  \\$iA genus of fungi in the family Hymenochaetaceae, class Hymenochaetales and phylum BASIDIOMYCOTA. Phellinus fungi are basidiomycetes which form large shelf-shaped mushrooms. Phellinus linteus (now Tropicoporus linteus) is a medicinal mushroom which produces compounds such as hispidin, a phenolic compound with antioxidant properties.
=688  \\$a2021
=750  \0$aPhellinus$0(DLC)sh 88005498$5IEN-M
=930  \\$aMeSH Mapping gwn 20220810

=LDR  00844nz  a2200205n  4500
=001  9881998700102441
=005  20220810153107.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083462
=035  \\$a(DNLM)D000083462
=035  \\$a(NLM)9817067828500041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x888.$x284.$x429
=150  \\$aPersistent Organic Pollutants
=450  \\$aPersistent Organic Pollutant
=450  \\$wnnna$aPollutant, Persistent Organic
=450  \\$wnnna$aPollutants, Persistent Organic
=680  \\$iToxic chemicals that persist for long periods of time in the ENVIRONMENT and that contaminate ECOSYSTEMS where they are released and where they are transported to by wind, water, and the FOOD CHAIN.
=688  \\$a2021
=750  \0$iBroader mapping$aPersistent pollutants$0(DLC)sh 91004823$4BM$5IEN-M

=LDR  01918nz  a2200445n  4500
=001  9881810960802441
=005  20220915094245.0
=008  860624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005871
=035  \\$a(DNLM)D005871
=035  \\$a(NLM)98199847830000041
=040  \\$aDNLM$cDNLM
=072  \\$aC15.$x604.$x515.$x245
=072  \\$aC20.$x683.$x515.$x250
=150  \\$aCastleman Disease
=450  \\$wnnna$aAngiofollicular Lymph Hyperplasia
=450  \\$wnnna$aAngiofollicular Lymph Node Hyperplasia
=450  \\$wnnna$aCastleman's Disease
=450  \\$wnnna$aCastlemans Disease
=450  \\$aAngiofollicular Lymphoid Hyperplasia
=450  \\$aCastleman's Tumor
=450  \\$aGiant Lymph Node Hyperplasia
=450  \\$aHyperplasia, Giant Lymph Node
=450  \\$aLymph Node Hyperplasia, Giant
=450  \\$wnnna$aAngiofollicular Lymph Hyperplasias
=450  \\$wnnna$aAngiofollicular Lymphoid Hyperplasias
=450  \\$wnnna$aCastleman Tumor
=450  \\$wnnna$aCastlemans Tumor
=450  \\$wnnna$aDisease, Castlemans
=450  \\$wnnna$aHyperplasia, Angiofollicular Lymph
=450  \\$wnnna$aHyperplasia, Angiofollicular Lymphoid
=450  \\$wnnna$aLymph Hyperplasia, Angiofollicular
=450  \\$wnnna$aLymphoid Hyperplasia, Angiofollicular
=450  \\$wnnna$aTumor, Castleman's
=550  \\$aLymphoproliferative Disorders$wg
=680  \\$iLarge benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
=688  \\$a2018(1987)
=750  \0$aCastleman disease$0(DLC)sh2021006900$5IEN-M$0(DLC)sh2021006900$5IEN-M
=750  \0$aCastleman disease        $0(DLC)sh2021006900$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  00809nz  a2200241n  4500
=001  9882042696202441
=005  20220915094246.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D062725
=035  \\$a(DNLM)D062725
=035  \\$a(NLM)98197405970000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x940
=150  \\$aTight Junction Proteins
=450  \\$aTight Junction Protein
=450  \\$wnnna$aJunction Protein, Tight
=450  \\$wnnna$aJunction Proteins, Tight
=450  \\$wnnna$aProtein, Tight Junction
=450  \\$wnnna$aProteins, Tight Junction
=680  \\$iProteins that take part in the formation or structure of TIGHT JUNCTIONS.
=688  \\$a2013
=750  \0$aTight junction proteins$0(DLC)sh2021008222$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  00710cz  a2200181n  4500
=001  9882042696502441
=005  20220915094244.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D058873
=035  \\$a(DNLM)D058873
=035  \\$a(NLM)98199213860000041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x290.$x200.$x600
=150  \\$aPandemics
=450  \\$wnnna$aPandemic
=667  \\$acoordinate with specific disease / epidemiol and specify geographic location if pertinent
=680  \\$iEpidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.
=688  \\$a2011; use DISEASE OUTBREAKS 2006-2010

=LDR  00724nz  a2200205n  4500
=001  9882042696602441
=005  20220915094246.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D057167
=035  \\$a(DNLM)D057167
=035  \\$a(NLM)98198424010000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x543.$x940.$x200
=150  \\$aClaudins
=450  \\$wnnna$aClaudin Proteins
=450  \\$aClaudin
=680  \\$iA large family of transmembrane proteins found in TIGHT JUNCTIONS. They take part in the formation of paracellular barriers and pores that regulate paracellular permeability.
=688  \\$a2010
=750  \0$aClaudins$0(DLC)sh2021008218$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  01004nz  a2200253n  4500
=001  9882042696902441
=005  20220915094246.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D000077321
=035  \\$a(DNLM)D000077321
=035  \\$a(NLM)9811675541000041
=040  \\$aDNLM$cDNLM
=072  \\$aG17.$x35.$x250.$x500.$x250
=072  \\$aG17.$x485.$x500
=072  \\$aL1.$x224.$x50.$x375.$x530.$x250
=072  \\$aL1.$x224.$x50.$x375.$x605.$x500
=150  \\$aDeep Learning
=450  \\$wnnna$aHierarchical Learning
=450  \\$wnnna$aLearning, Deep
=450  \\$wnnna$aLearning, Hierarchical
=680  \\$iSupervised or unsupervised machine learning methods that use multiple layers of data representations generated by nonlinear transformations, instead of individual task-specific ALGORITHMS, to build and train neural network models.
=688  \\$a2019
=750  \0$aDeep learning (Machine learning)$0(DLC)sh2021006947$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  01601nz  a2200337n  4500
=001  9882042697002441
=005  20220915094245.0
=008  890906\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0  https://id.nlm.nih.gov/mesh/D015675
=035  \\$a(DNLM)D015675
=035  \\$a(NLM)98196809950000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x157.$x125.$x700
=150  \\$aOsteocalcin
=450  \\$wnnna$a4-Carboxyglutamic Protein, Bone
=450  \\$wnnna$aBone gamma-Carboxyglutamic Acid Protein
=450  \\$aBone Gla Protein
=450  \\$aCalcium-Binding Protein, Vitamin K-Dependent
=450  \\$aGla Protein, Bone
=450  \\$aVitamin K-Dependent Bone Protein
=450  \\$wnnna$a4 Carboxyglutamic Protein, Bone
=450  \\$wnnna$aBone 4-Carboxyglutamic Protein
=450  \\$wnnna$aBone gamma Carboxyglutamic Acid Protein
=450  \\$wnnna$aCalcium Binding Protein, Vitamin K Dependent
=450  \\$wnnna$aProtein, Bone 4-Carboxyglutamic
=450  \\$wnnna$aProtein, Bone Gla
=450  \\$wnnna$aVitamin K Dependent Bone Protein
=680  \\$iVitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.
=688  \\$a90; GLA-PROTEIN was see OSTEOCACLIN 1990-96
=750  \0$aOsteocalcin$0(DLC)sh2021006864$5IEN-M
=930  \\$aMeSH Mapping gwn 20220914

=LDR  00768nz  a2200253n  4500
=001  9882043676102441
=005  20220922155855.0
=008  150701\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000067572
=035  \\$a(DNLM)D000067572
=035  \\$a(NLM)985399382400041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x693
=150  \\$aMiners
=450  \\$wnnna$aMine Workers
=450  \\$wnnna$aMineworkers
=450  \\$wnnna$aMine Worker
=450  \\$wnnna$aMiner
=450  \\$wnnna$aMineworker
=450  \\$wnnna$aWorker, Mine
=450  \\$wnnna$aWorkers, Mine
=680  \\$iPersons who work in a mine to extract ore or MINERALS from the earth.
=688  \\$a2016
=750  \0$iNarrower mapping$aSmall-scale miners$0(DLC)sh2021005702$4NM$5IEN-M

=LDR  01310nz  a2200325n  4500
=001  9882045384902441
=005  20220927142934.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084562
=035  \\$a(DNLM)D000084562
=035  \\$a(NLM)9817067773800041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x241.$x400.$x500
=072  \\$aD2.$x455.$x326.$x271.$x665.$x202.$x495.$x754
=072  \\$aD2.$x455.$x426.$x392.$x368.$x367.$x379.$x249.$x700.$x775
=072  \\$aD2.$x455.$x849.$x131.$x495.$x754
=072  \\$aD23.$x767.$x261.$x700.$x735
=150  \\$aRetinyl Esters
=450  \\$aAll-Trans-Retinyl Ester
=450  \\$aAll-Trans-Retinyl Esters
=450  \\$aRetinyl Ester
=450  \\$wnnna$aAll Trans Retinyl Ester
=450  \\$wnnna$aAll Trans Retinyl Esters
=450  \\$wnnna$aEster, All-Trans-Retinyl
=450  \\$wnnna$aEster, Retinyl
=680  \\$iA carboxylic ester of retinol formed by condensation of the hydroxy group of retinol with a carboxy group.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aVitamin A$0(DLC)sh 85143952$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aEsters$0(DLC)sh 85044949$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aVitamin A$iand$aEsters$5IEN-M

=LDR  01647nz  a2200409n  4500
=001  9882045385102441
=005  20220927142751.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086702
=035  \\$a(DNLM)D000086702
=035  \\$a(NLM)9817067887500041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x374.$x458
=072  \\$aN5.$x300.$x575
=150  \\$aPractice Patterns, Pharmacists'
=450  \\$aPharmacist's Practice Patterns
=450  \\$aPractice Pattern, Pharmacist
=450  \\$wnnna$aPattern, Pharmacist Practice
=450  \\$wnnna$aPattern, Pharmacist's Practice
=450  \\$wnnna$aPattern, Pharmacists' Practice
=450  \\$wnnna$aPatterns, Pharmacist Practice
=450  \\$wnnna$aPatterns, Pharmacist's Practice
=450  \\$wnnna$aPatterns, Pharmacists' Practice
=450  \\$wnnna$aPharmacist Practice Pattern
=450  \\$wnnna$aPharmacist Practice Patterns
=450  \\$wnnna$aPharmacist's Practice Pattern
=450  \\$wnnna$aPharmacists Practice Patterns
=450  \\$wnnna$aPharmacists' Practice Pattern
=450  \\$wnnna$aPharmacists' Practice Patterns
=450  \\$wnnna$aPractice Pattern, Pharmacist's
=450  \\$wnnna$aPractice Pattern, Pharmacists'
=450  \\$wnnna$aPractice Patterns, Pharmacist
=450  \\$wnnna$aPractice Patterns, Pharmacist's
=450  \\$wnnna$aPractice Patterns, Pharmacists
=680  \\$iPatterns of practice related to how PHARMACISTS prepare or compound PRESCRIPTION DRUGS as especially influenced by cost of the service requested and provided.
=688  \\$a2021
=750  \0$aPharmacy$xPractice$0(DLC)sh2010106017$5IEN-M

=LDR  00673nz  a2200169n  4500
=001  9882045385302441
=005  20220927142414.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084725
=035  \\$a(DNLM)D000084725
=035  \\$a(NLM)9817067770000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x708
=150  \\$aPhomopsis
=680  \\$iA genus of fungi in the family Valsaceae, order Diaporthales and phylum ASCOMYCOTA. Phomopsis fungi are ascomycetes found in the soil and plants and are causative agents for plant fungal diseases such as leaf blight and fruit rots.
=688  \\$a2021
=750  \0$aPhomopsis$0(DLC)sh 92000224$5IEN-M

=LDR  00874nz  a2200205n  4500
=001  9882045385702441
=005  20220927142106.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084723
=035  \\$a(DNLM)D000084723
=035  \\$a(NLM)9817067638200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x107.$x700
=150  \\$aPhoma
=450  \\$aDeuterophoma
=450  \\$aPeyronellaea
=667  \\$ainfection: coordinate with probably PHAEOHYPHOMYCOSIS, otherwise coordinate with MYCOSES
=680  \\$iA genus of fungi in the family Didymellaceae, order Pleosporales and phylum ASCOMYCOTA. Phoma fungi are ascomycetes commonly found in soil and aquatic environments including  water distribution systems. Opportunistic superficial infection with Phoma fungi is PHAEOHYPHOMYCOSIS.
=688  \\$a2021
=750  \0$aPhoma$0(DLC)sh 88022084$5IEN-M

=LDR  00790nz  a2200229n  4500
=001  9882045390802441
=005  20220926164735.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087983
=035  \\$a(DNLM)D000087983
=035  \\$a(NLM)9819990142300041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x793
=072  \\$aL1.$x178.$x820.$x90.$x793
=072  \\$aL1.$x280.$x785
=150  \\$aSound Recordings
=450  \\$aSound Recording
=450  \\$wnnna$aRecording, Sound
=450  \\$wnnna$aRecordings, Sound
=680  \\$iThe storing of sound signals on various media such as cylinders, analog discs, digital discs, tapes, and wires.[LCSH, 10/27/2020]
=688  \\$a2022
=750  \0$iNarrower mapping$aMixtapes$0(DLC)sh2021008265$4NM$5IEN-M

=LDR  00750nz  a2200205n  4500
=001  9882045393402441
=005  20220926152420.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087862
=035  \\$a(DNLM)D000087862
=035  \\$a(NLM)9819990142800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x157.$x500
=072  \\$aL1.$x143.$x790.$x500
=150  \\$aDisinformation
=450  \\$aFake News
=450  \\$wnnna$aNews, Fake
=680  \\$iFalse information deliberately and often covertly spread in order to influence public opinion or obscure the truth. (https://www.merriam-webster.com/dictionary/disinformation)
=688  \\$a2022
=750  \0$iNarrower mapping$aGreenwashing$0(DLC)sh2021008185$4NM$5IEN-M

=LDR  01761nz  a2200481n  4500
=001  9882045394302441
=005  20220926144851.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000070777
=035  \\$a(DNLM)D000070777
=035  \\$a(NLM)987390646700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x702.$x500
=150  \\$aSchool Teachers
=450  \\$wnnna$aElementary School Teachers
=450  \\$wnnna$aHigh School Teachers
=450  \\$wnnna$aMiddle School Teachers
=450  \\$wnnna$aPre-School Teachers
=450  \\$wnnna$aElementary School Teacher
=450  \\$wnnna$aHigh School Teacher
=450  \\$wnnna$aMiddle School Teacher
=450  \\$wnnna$aPre School Teachers
=450  \\$wnnna$aPre-School Teacher
=450  \\$wnnna$aSchool Teacher
=450  \\$wnnna$aSchool Teacher, Elementary
=450  \\$wnnna$aSchool Teacher, High
=450  \\$wnnna$aSchool Teacher, Middle
=450  \\$wnnna$aSchool Teachers, Elementary
=450  \\$wnnna$aSchool Teachers, High
=450  \\$wnnna$aSchool Teachers, Middle
=450  \\$wnnna$aTeacher, Elementary School
=450  \\$wnnna$aTeacher, High School
=450  \\$wnnna$aTeacher, Middle School
=450  \\$wnnna$aTeacher, Pre-School
=450  \\$wnnna$aTeacher, School
=450  \\$wnnna$aTeachers, Elementary School
=450  \\$wnnna$aTeachers, High School
=450  \\$wnnna$aTeachers, Middle School
=450  \\$wnnna$aTeachers, Pre-School
=450  \\$wnnna$aTeachers, School
=680  \\$iMembers of staff responsible for TEACHING students in a school from pre-kindergarten through twelfth grade.
=688  \\$a2017; use FACULTY 1979-2016
=750  \0$iNarrower mapping$aAfter-school teachers$0(DLC)sh2021008120$4NM$5IEN-M
=LDR  01964cz  a2200601n  4500
=001  9880363765902441
=005  20220822103611.0
=008  990101\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D007398
=040  \\$aDNLM$beng$cDNLM
=072  \\$aF1.$x829.$x401
=150  \\$aInterpersonal Relations
=450  \\$wnnna$aCommunication, Husband-Wife
=450  \\$wnnna$aCommunication, Partner
=450  \\$wnnna$aCommunications, Husband-Wife
=450  \\$wnnna$aCommunications, Partner
=450  \\$wnnna$aGender Issue
=450  \\$wnnna$aGender Issues
=450  \\$wnnna$aGender Relation
=450  \\$aGender Relations
=450  \\$wnnna$aHusband-Wife Communication
=450  \\$wnnna$aHusband Wife Communication
=450  \\$wnnna$aHusband-Wife Communications
=450  \\$wnnna$aInteraction, Social
=450  \\$wnnna$aInteractions, Social
=450  \\$wnnna$aInterpersonal Relation
=450  \\$wnnna$aIssue, Gender
=450  \\$wnnna$aIssues, Gender
=450  \\$wnnna$aPartner Communication
=450  \\$wnnna$aPartner Communications
=450  \\$wnnna$aRelation, Gender
=450  \\$wnnna$aRelation, Interpersonal
=450  \\$wnnna$aRelations, Gender
=450  \\$wnnna$aRelations, Interpersonal
=450  \\$aSocial Interaction
=450  \\$wnnna$aSocial Interactions
=550  \\$wg$aPsychology, Social
=550  \\$wh$aDisclosure
=550  \\$wh$aDissent and Disputes
=550  \\$wh$aFamily Conflict
=550  \\$wh$aForgiveness
=550  \\$wh$aIntergenerational Relations
=550  \\$wh$aInterprofessional Relations
=550  \\$wh$aNegotiating
=550  \\$wh$aProfessional-Family Relations
=550  \\$wh$aProfessional-Patient Relations
=550  \\$wh$aSocial Skills
=550  \\$wh$aTrust
=550  \\$aEmotional Intelligence
=550  \\$aFriends
=680  \\$iThe reciprocal interaction of two or more persons.
=688  \\$a64
=750  \0$aInterpersonal relations$5IEN-HS$0(DLC)sh 85067484

=LDR  00643nz  a2200181n  4500
=001  9881977375702441
=005  20220725160822.0
=008  200709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083645
=035  \\$a(DNLM)D000083645
=035  \\$a(NLM)9817067678900041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x653
=150  \\$aSocial Evolution
=450  \\$wnnna$aEvolution, Social
=680  \\$iThe process of cumulative change that arises over successive generations in social interactions, especially between individuals of the same species.
=688  \\$a2021
=750  \0$aSocial evolution$0(DLC)sh85123940$5IEN-M

=LDR  00700nz  a2200193n  4500
=001  9881977376902441
=005  20220804101304.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083642
=035  \\$a(DNLM)D000083642
=035  \\$a(NLM)D000083642
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x747.$x792.$x962
=150  \\$aSocial Comparison
=450  \\$wnnna$aComparison, Social
=450  \\$wnnna$aSocial Comparisons
=680  \\$iPerception of one's abilities and attitudes in relation to those of others in a process that plays a significant role in self-image and subjective well-being.
=688  \\$a2021
=750  \0$aSocial comparison$0(DLC) sh2005001706$5IEN-M

=LDR  00904nz  a2200265n  4500
=001  9881977377402441
=005  20220725124423.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082723
=035  \\$a(DNLM)D000082723
=035  \\$a(NLM)9817067556200041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 520
=072  \\$aG5.$x783.$x500
=150  \\$aSexual Selection
=450  \\$aIntersexual Selection
=450  \\$wnnna$aIntersexual Selections
=450  \\$wnnna$aSelection, Intersexual
=450  \\$wnnna$aSelection, Sexual
=450  \\$wnnna$aSexual Selections
=550  \\$aSex Characteristics
=550  \\$aMating Preference, Animal
=680  \\$iA type of natural selection in which members of one sex choose to mate with members of the other sex that have genetically different components.
=688  \\$a2021
=750  \0$aSexual selection$0(DLC)sh2012002899$5IEN-M

=LDR  00927nz  a2200217n  4500
=001  9881977377602441
=005  20220725123157.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083942
=035  \\$a(DNLM)D000083942
=035  \\$a(NLM)9817067701000041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x830.$x104.$x518
=072  \\$aG11.$x561.$x35.$x369
=150  \\$aSexual Arousal
=450  \\$aArousal, Sexual
=450  \\$aSexual Excitement
=450  \\$wnnna$aExcitement, Sexual
=680  \\$iPhysiological arousal elicited by sexual contact or by other erotic stimulation resulting in impulses being transmitted through the central nervous system.The impulses also trigger the release of sex hormones, dilation of the arteries supplying the genital areas, and inhibition of vasoconstrictor centers of the lumbar nerves.
=688  \\$a2021
=750  \0$aSexual excitement$0(DLC) sh 85120733$5IEN-M

=LDR  01799nz  a2200493n  4500
=001  9881977378002441
=005  20220725114053.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081822
=035  \\$a(DNLM)D000081822
=035  \\$a(NLM)9817067473000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x50.$x116.$x812
=150  \\$aService Animals
=450  \\$aAlert Dogs
=450  \\$aAssistance Animals
=450  \\$aAssistance Dogs
=450  \\$aGuide Dogs
=450  \\$aHearing Dogs
=450  \\$aSeeing Eye Dogs
=450  \\$aService Dogs
=450  \\$wnnna$aAlert Dog
=450  \\$wnnna$aAssistance Animal
=450  \\$wnnna$aAssistance Dog
=450  \\$wnnna$aDog, Alert
=450  \\$wnnna$aDog, Assistance
=450  \\$wnnna$aDog, Guide
=450  \\$wnnna$aDog, Hearing
=450  \\$wnnna$aDog, Seeing Eye
=450  \\$wnnna$aDog, Service
=450  \\$wnnna$aDogs, Alert
=450  \\$wnnna$aDogs, Assistance
=450  \\$wnnna$aDogs, Guide
=450  \\$wnnna$aDogs, Hearing
=450  \\$wnnna$aDogs, Seeing Eye
=450  \\$wnnna$aDogs, Service
=450  \\$wnnna$aGuide Dog
=450  \\$wnnna$aHearing Dog
=450  \\$wnnna$aSeeing Eye Dog
=450  \\$wnnna$aService Animal
=450  \\$wnnna$aService Dog
=680  \\$iAnimals that have been trained to do work or perform tasks for an individual with a disability.  The task(s) performed by the animal must be directly related to the person's disability.  Emotional support, therapy, comfort, or companion animals are not considered service animals under the Americans With Disabilities Act.(www.ada.gov/regs2010/service_animal_qa.html, accessed 3/31/2020)
=688  \\$a2021
=750  \0$aAnimals as aids for people with disabilities$0(DLC) sh 99000359$5IEN-M

=LDR  00784nz  a2200217n  4500
=001  9881977378402441
=005  20220725111515.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000081843
=035  \\$a(DNLM)D000081843
=035  \\$a(NLM)9817067609600041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.S3
=072  \\$aF4.$x754.$x834
=150  \\$aSchema Therapy
=450  \\$wnnna$aSchema Therapies
=450  \\$wnnna$aTherapies, Schema
=450  \\$wnnna$aTherapy, Schema
=680  \\$iTherapy that emphasizes lifelong patterns, affective change techniques, and the therapeutic relationship. (https://www.apa.org/pubs/videos/4310804).
=688  \\$a2021; use Psychotherapy (2020)
=750  \0$aSchema-focused cognitive therapy$0(DLC) sh 90005887$5IEN-M

=LDR  00662nz  a2200193n  4500
=001  9881977379402441
=005  20220804095830.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085263
=035  \\$a(DNLM)D000085263
=035  \\$a(NLM)9817067759000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x900.$x950
=072  \\$aI3.$x733
=150  \\$aSelf-Testing
=450  \\$wnnna$aSelf Testing
=680  \\$iProcess whereby a person who wants to know his or her health status collects a specimen, performs a test and interprets the test result in private.
=688  \\$a2021
=750  \0$aPatient self-monitoring$0(DLC) sh2004010488$5IEN-M

=LDR  00714nz  a2200229n  4500
=001  9881995000002441
=005  20220726122601.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085943
=035  \\$a(DNLM)D000085943
=035  \\$a(NLM)9817067929400041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x423.$x750.$x937
=150  \\$aSupermarkets
=450  \\$aGrocery Stores
=450  \\$wnnna$aGrocery Store
=450  \\$wnnna$aStore, Grocery
=450  \\$wnnna$aStores, Grocery
=450  \\$wnnna$aSupermarket
=680  \\$iSelf-service retail markets selling groceries, fresh produce, meats and other foods.
=688  \\$a2021
=750  \0$aSupermarkets$0(DLC)sh 85130623$5IEN-M

=LDR  00698nz  a2200217n  4500
=001  9881995000402441
=005  20220726121637.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085642
=035  \\$a(DNLM)D000085642
=035  \\$a(NLM)9817067895300041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x792.$x738
=072  \\$aE5.$x916.$x920
=150  \\$aSpray Drying
=450  \\$wnnna$aDrying, Spray
=450  \\$wnnna$aSpray Dryings
=667  \\$ause only for drugs, not for food
=680  \\$iMethod of drying liquids and liquid suspensions to prepare drugs in their final dehydrated powder form.
=688  \\$a2021
=750  \0$aSpray drying$0(DLC) sh 85126986$5IEN-M

=LDR  00624nz  a2200205n  4500
=001  9881995000502441
=005  20220726115732.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085902
=035  \\$a(DNLM)D000085902
=035  \\$a(NLM)9817067930200041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x865
=072  \\$aG16.$x500.$x870
=150  \\$aSoil Erosion
=450  \\$wnnna$aErosion, Soil
=550  \\$aSoil
=680  \\$iThe displacement of significant quantities of SOIL from an area by wind or rainwater runoff.
=688  \\$a2021
=750  \0$aSoil erosion$0(DLC) sh 85124341$5IEN-M

=LDR  01048nz  a2200229n  4500
=001  9881995000902441
=005  20220726113741.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083505
=035  \\$a(DNLM)D000083505
=035  \\$a(NLM)9817067811400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x401.$x716
=150  \\$aSocial Interaction
=450  \\$aSocial Functioning
=450  \\$wnnna$aFunctioning, Social
=450  \\$wnnna$aFunctionings, Social
=450  \\$wnnna$aInteraction, Social
=450  \\$wnnna$aSocial Functionings
=680  \\$iProcess involving reciprocal response between two or more individuals. This includes the development of cooperation and competition, the influence of status and social roles, and the dynamics of group behavior, leadership, and conformity. Persistent social interaction between specific individuals leads to the formation of social relationships.
=688  \\$a2021; was Interpersonal Relations 1978-2020
=750  \0$aSocial interaction$0(DLC)SH 85123965$5IEN-M

=LDR  00660cz  a2200181n  4500
=001  9881995001002441
=005  20220726112540.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083644
=035  \\$a(DNLM)D000083644
=035  \\$a(NLM)9817067679000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x745
=150  \\$aSocial Inclusion
=450  \\$wnnna$aInclusion, Social
=680  \\$iThe process of improving the basis on which individuals and groups take part in society by improving the ability, opportunity, and dignity of those disadvantaged.
=688  \\$a2021
=750  \0$aSocial integration$0(DLC)sh 85123964$5IEN-M

=LDR  01341nz  a2200265n  4500
=001  9881995489102441
=005  20220804161044.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085142
=035  \\$a(DNLM)D000085142
=035  \\$a(NLM)9817067756800041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x920.$x930.$x831
=072  \\$aC1.$x925.$x782.$x147.$x905
=150  \\$aSevere Fever with Thrombocytopenia Syndrome
=450  \\$aSFTS Virus Infection
=450  \\$aSevere Fever with Thrombocytopenia Syndrome Bunyavirus Infection
=450  \\$wnnna$aInfection, SFTS Virus
=450  \\$wnnna$aSFTS Virus Infections
=450  \\$wnnna$aVirus Infection, SFTS
=680  \\$iA tick-borne infection with SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME BUNYAVIRUS of the genus Phlebovirus. It is associated with fever, THROMBOCYTOPENIA; LEUKOCYTOPENIA, and multiorgan dysfunction. It is found in parts of Asia including China, Japan, Korea and Vietnam and can be transmitted from infected domestic animals and humans.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aFever$0(DLC)sh 85047994$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aThrombocytopenia$0(DLC)sh 85135069$4BM$5IEN-M
=788  \2$iSearch also under the following headings used together in the same record:$aFever$iand$aThrombocytopenia$5IEN-M

=LDR  00678nz  a2200181n  4500
=001  9881995490402441
=005  20220804125315.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082982
=035  \\$a(DNLM)D000082982
=035  \\$a(NLM)9817067561300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x715.$x750
=150  \\$aToona
=450  \\$wnnna$aToonas
=680  \\$iA plant genus of the family MELIACEAE. Several members were formerly classified under CEDRELA (e.g., Toona sinensis formerly Cedrela sinensis) and produces various LIMONOIDS (e.g., toonins).
=688  \\$a2021
=750  \0$aToona$0(DLC) sh 89000199$5IEN-M

=LDR  00807nz  a2200265n  4500
=001  9881995491302441
=005  20220804104852.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083563
=035  \\$a(DNLM)D000083563
=035  \\$a(NLM)9817067810300041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x470.$x132.$x650.$x500
=150  \\$aTest Anxiety
=450  \\$aExam Anxiety
=450  \\$aExam Stress
=450  \\$aPre-Exam Anxiety
=450  \\$wnnna$aAnxiety, Exam
=450  \\$wnnna$aAnxiety, Pre-Exam
=450  \\$wnnna$aAnxiety, Test
=450  \\$wnnna$aPre Exam Anxiety
=450  \\$wnnna$aStress, Exam
=680  \\$iAnxiety related to situations where abilities or knowledge are being tested.
=688  \\$a2021
=750  \0$aTest anxiety$0(DLC) sh 85134140$5IEN-M

=LDR  01228nz  a2200289n  4500
=001  9881995491702441
=005  20230901100609.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085326
=035  \\$a(DNLM)D000085326
=035  \\$a(NLM)9817067758800041
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x824.$x245.$x788
=072  \\$aN4.$x452.$x677.$x650.$x313
=150  \\$aTeleworking
=450  \\$aFlexible Workplace
=450  \\$aRemote Working
=450  \\$aTelecommuting
=450  \\$aTelework
=450  \\$wnnna$aFlexible Workplaces
=450  \\$wnnna$aWorking, Remote
=450  \\$wnnna$aWorkplace, Flexible
=450  \\$wnnna$aWorkplaces, Flexible
=680  \\$iArrangement under which an employee performs the duties and responsibilities of such employee's position, and other authorized activities, from an approved worksite other than the location from which the employee would otherwise work. (from https://www.opm.gov/FAQs/QA.aspx?fid=b48bf83b-440c-4f1e-a88c-3cdc9d802ac8&pid=75346675-3b92-4aec-831d-58cf5b0e86d2 accessed 3/26/2020).
=688  \\$a2021
=750  \0$aTelecommuting$0(DLC)sh 85133307$5IEN-M
=750  \0$iNarrower mapping$aWorkations$0(DLC)sh2022006775$4NM$5IEN-M

=LDR  00542nz  a2200181n  4500
=001  9881995491802441
=005  20220804093704.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085944
=035  \\$a(DNLM)D000085944
=035  \\$a(NLM)9817067929300041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x845.$x880
=150  \\$aTeam Sports
=450  \\$wnnna$aTeam Sport
=680  \\$iOrganized recreational activities involving individuals.
=688  \\$a2021
=750  \0$aTeam sports$0(DLC)sh2012002377$5IEN-M

=LDR  00824nz  a2200229n  4500
=001  9881995496802441
=005  20220801141455.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083482
=035  \\$a(DNLM)D000083482
=035  \\$a(NLM)9817067811500041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x866.$x500
=150  \\$aSocial Network Analysis
=450  \\$wnnna$aAnalyses, Social Network
=450  \\$wnnna$aAnalysis, Social Network
=450  \\$wnnna$aNetwork Analyses, Social
=450  \\$wnnna$aNetwork Analysis, Social
=450  \\$wnnna$aSocial Network Analyses
=680  \\$iA set of methods that identify the ties or relationships linking each member of a group to every other member.
=688  \\$a2021
=750  \0$aSocial sciences$xNetwork analysis$0(DLC)sh 85124012$5IEN-M

=LDR  00970nz  a2200229n  4500
=001  9881995497002441
=005  20220801123359.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085022
=035  \\$a(DNLM)D000085022
=035  \\$a(NLM)9817067743600041
=040  \\$aDNLM$cDNLM
=072  \\$aE7.$x858.$x724
=150  \\$aSurgical Navigation Systems
=450  \\$wnnna$aNavigation System, Surgical
=450  \\$wnnna$aNavigation Systems, Surgical
=450  \\$wnnna$aSurgical Navigation System
=450  \\$wnnna$aSystem, Surgical Navigation
=450  \\$wnnna$aSystems, Surgical Navigation
=680  \\$iHardware and software tools that coordinate the use of imaging data (IMAGE INTERPRETATION, COMPUTER ASSISTED) to provide measurements for the planning of surgery and guidance of instruments during operating procedures in COMPUTER-ASSISTED SURGERY.
=688  \\$a2021
=750  \0$aComputer-assisted surgery$0(DLC) sh2006007439$5IEN-M

=LDR  00582nz  a2200169n  4500
=001  9881999300702441
=005  20220811122426.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086323
=035  \\$a(DNLM)D000086323
=035  \\$a(NLM)9817068028300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x125.$x500.$x658
=150  \\$aSorangium
=680  \\$iA genus of gram-negative, soil-dwelling DELTAPROTEOBACTERIA in the order MYXOCOCCALES that has gliding motility.
=688  \\$a2021
=750  \0$iBroader mapping$aMyxococcus$0(DLC)sh 85089451$4BM$5IEN-M

=LDR  00790nz  a2200241n  4500
=001  9881999300902441
=005  20220811115451.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084002
=035  \\$a(DNLM)D000084002
=035  \\$a(NLM)9817067699300041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x150.$x703.$x302.$x720.$x745
=072  \\$aC1.$x800.$x200.$x720.$x745
=072  \\$aC17.$x800.$x174.$x640.$x500
=072  \\$aC17.$x800.$x815.$x650.$x500
=072  \\$aC17.$x800.$x838.$x208.$x883.$x608
=150  \\$aTinea cruris
=450  \\$aJock Itch
=450  \\$wnnna$aJock Itchs
=680  \\$iFungal infection of the groin. The main causative fungus is TRICHOPHYTON.
=688  \\$a2021
=750  \0$iBroader mapping$aRingworm$0(DLC)sh 85114145$4BM$5IEN-M

=LDR  00753nz  a2200169n  4500
=001  9881999301102441
=005  20220811114120.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084444
=035  \\$a(DNLM)D000084444
=035  \\$a(NLM)9817067710300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x425.$x410.$x748
=150  \\$aThermotoga
=680  \\$iA genus of anaerobic, gram-negative bacteria in the family Thermotogaceae and phylum Thermotogae. Species of this genus such as THERMOTOGA MARITIMA and THERMOTOGA NEAPOLITANA are known to live in high-temperature environments and also play a role in HYDROGEN production.
=688  \\$a2021
=750  \0$iBroader mapping$aGram-negative bacteria$0(DLC)sh 85056256$4BM$5IEN-M

=LDR  00619nz  a2200181n  4500
=001  9881999301202441
=005  20220811113209.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086325
=035  \\$a(DNLM)D000086325
=035  \\$a(NLM)9817068025100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x813
=072  \\$aB3.$x440.$x475.$x100.$x813
=150  \\$aThermosynechococcus
=680  \\$iA genus of thermophilic, unicellular CYANOBACTERIA in the family Synechococcaceae that is photosynthetic.
=688  \\$a2021
=750  \0$iBroader mapping$aCyanobacteria$0(DLC)sh 85015067$4BM$5IEN-M

=LDR  00732nz  a2200169n  4500
=001  9881999301302441
=005  20220811112607.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084442
=035  \\$a(DNLM)D000084442
=035  \\$a(NLM)9817067712300041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x971
=150  \\$aThermomonospora
=680  \\$iA genus of high GC content ACTINOBACTERIA in the family Thermomonosporaceae. Species of this genus, Thermomonospora fusca and Thermomonospora curvata, are known for their roles in the industrial production of enzymes including CELLULASE.
=688  \\$a2021
=750  \0$iBroader mapping$aActinobacteria$0(DLC)sh sh2007000158$4BM$5IEN-M

=LDR  00700nz  a2200169n  4500
=001  9881999301602441
=005  20220811111856.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086324
=035  \\$a(DNLM)D000086324
=035  \\$a(NLM)9817068026700041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x510.$x460.$x400.$x400.$x49.$x957
=150  \\$aThermobifida
=680  \\$iA genus of thermophilic, gram-positive ACTINOBACTERIA in the family Nocardiopsaceae that is rod-shaped and found in decaying organic matter. This genus plays a major role in the degradation of plant cell walls.
=688  \\$a2021
=750  \0$iBroader mapping$aActinobacteria$0(DLC) sh2007000158$4BM$5IEN-M

=LDR  00654nz  a2200181n  4500
=001  9882012698602441
=005  20220822102338.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083282
=035  \\$a(DNLM)D000083282
=035  \\$a(NLM)9817067791500041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x593.$x752.$x500
=150  \\$aSocial Cognition
=450  \\$wnnna$aCognition, Social
=680  \\$iPerception, interpretation, and categorizing self  judgement of one's own social behaviors and group position and those of others.
=688  \\$a2021
=750  \0$iBroader mapping$aSocial perception$0(DLC)sh 85123982$4BM$5IEN-M

=LDR  01645nz  a2200337n  4500
=001  9882012698702441
=005  20220822101030.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084322
=035  \\$a(DNLM)D000084322
=035  \\$a(NLM)9817067682300041
=040  \\$aDNLM$cDNLM
=072  \\$aC9.$x218.$x568.$x900.$x663
=150  \\$aSemicircular Canal Dehiscence
=450  \\$aDehiscence of the Lateral Semicircular Canal
=450  \\$aDehiscence of the Posterior Semicircular Canal
=450  \\$aDehiscence of the Semicircular Canal
=450  \\$aDehiscence of the Superior Semicircular Canal
=450  \\$aLateral Canal Dehiscence Syndrome
=450  \\$aLateral Semicircular Canal Dehiscence
=450  \\$aLateral Semicircular Canal Dehiscence Syndrome
=450  \\$aPosterior Canal Dehiscence Syndrome
=450  \\$aPosterior Semicircular Canal Dehiscence
=450  \\$aPosterior Semicircular Canal Dehiscence Syndrome
=450  \\$aSemicircular Canal Dehiscence Syndrome
=450  \\$aSuperior Canal Dehiscence Syndrome
=450  \\$aSuperior Semicircular Canal Dehiscence
=450  \\$aSuperior Semicircular Canal Dehiscence Syndrome
=680  \\$iA vestibular disorder caused by a pathologic third window into the BONY LABYRINTH (in contrast to the normal ROUND WINDOW OF EAR and the OVAL WINDOW OF EAR). It can present with autophony, sound- or pressure-induced VERTIGO, and chronic disequilibrium among other vestibulocochlear symptoms.(From: Semin Neurol. 2020 Jan 27; 48: 58-65.)
=688  \\$a2021
=750  \0$iBroader Mapping$aLabyrinth (Ear)$xDiseases$0(DLC)sh 85073790$4BM$5IEN-M

=LDR  00878nz  a2200217n  4500
=001  9882095281402441
=005  20230104145655.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D046869
=035  \\$a(DNLM)D046869
=035  \\$a(NLM)98198741290000041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x280.$x283
=072  \\$aB3.$x440.$x475.$x100.$x283
=150  \\$aDolichospermum flos-aquae
=450  \\$aAnabaena flos-aquae
=450  \\$aAnabaena flosaquae
=450  \\$aDolichospermum flosaquae
=680  \\$iA species in the genus Dolichospermum containing gas vacuoles that gives buoyancy to the organism. It was formerly classified under ANABAENA. It can form extensive blooms in FRESH WATER and is responsible for acute poisonings of various animals.
=688  \\$a2022(2005)
=750  \0$iBroader mapping$aCyanobacteria$0(DLC)sh 85015067$4BM$5IEN-M

=LDR  01858cz  a2200373n  4500
=001  9882095282202441
=005  20230104141432.0
=008  030709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D044467
=035  \\$a(DNLM)D044467
=035  \\$a(NLM)98198555800000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x968.$x500
=072  \\$aM1.$x686.$x477.$x250
=072  \\$aM1.$x686.$x477.$x625.$x594.$x500
=150  \\$aAmerican Indian or Alaska Native
=450  \\$aAmerican Indians
=450  \\$aAmerican Indians or Alaska Natives
=450  \\$aAmerican Native Continental Ancestry Group
=450  \\$aAmerican Natives
=450  \\$aIndians, American
=450  \\$aNative Americans
=450  \\$aNative Americans, Federally-Recognized
=450  \\$wnnna$aAmerican Indian
=450  \\$wnnna$aAmerican Native
=450  \\$wnnna$aAmerican, Native
=450  \\$wnnna$aFederally-Recognized Native American
=450  \\$wnnna$aFederally-Recognized Native Americans
=450  \\$wnnna$aNative American
=450  \\$wnnna$aNative American, Federally-Recognized
=450  \\$wnnna$aNative, American
=680  \\$iA person having origins in any of the original peoples of North, South and Central Americas, and who maintains tribal affiliation or community attachment (https://www.federalregister.gov/documents/1997/10/30/97-28653/revisions-to-the-standards-for-the-classification-of-federal-data-on-race-and-ethnicity). In the United States it is used for classification of federal government data on race and ethnicity. Race and ethnicity terms are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies.
=688  \\$a2004
=750  \0$aIndians$0(DLC)sh 85065022$5IEN-M

=LDR  01124cz  a2200313n  4500
=001  9882104696402441
=005  20230109160547.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004442
=035  \\$a(DNLM)D004442
=035  \\$a(NLM)98197805120000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x627.$x300
=150  \\$aTachyglossidae
=450  \\$aEchidna
=450  \\$aSpiny Ant-Eater
=450  \\$aSpiny Anteater
=450  \\$aTachyglossus
=450  \\$aZaglossus
=450  \\$wnnna$aAnt-Eater, Spiny
=450  \\$wnnna$aAnt-Eaters, Spiny
=450  \\$wnnna$aAnteaters, Spiny
=450  \\$wnnna$aEchidnas
=450  \\$wnnna$aSpiny Ant Eater
=450  \\$wnnna$aSpiny Ant-Eaters
=667  \\$ado not confuse entry term SPINY ANTEATER with ANTEATERS see VERMILINGUA
=680  \\$iAn oviparous burrowing mammal of the order Monotremata native to AUSTRALIA, TASMANIA, and NEW GUINEA. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants.
=688  \\$a2022(1975)
=750  \0$aTachyglossidae$0(DLC)sh85131848$5IEN-M

=LDR  03035cz  a2200745n  4500
=001  9882116470502441
=005  20230127153959.0
=008  741111\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011695
=035  \\$a(DNLM)D011695
=035  \\$a(NLM)98194259100000041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x940.$x777
=072  \\$aC15.$x378.$x100.$x802.$x375
=072  \\$aC15.$x378.$x463.$x515.$x580
=072  \\$aC17.$x800.$x862.$x329
=072  \\$aC20.$x543.$x520.$x600
=072  \\$aC23.$x550.$x414.$x950.$x375
=072  \\$aC23.$x888.$x885.$x687.$x375
=150  \\$aIgA Vasculitis
=450  \\$wnnna$aHenoch Schonlein Purpura
=450  \\$wnnna$aHenoch-Schonlein Purpura
=450  \\$wnnna$aPurpura, Nonthrombopenic
=450  \\$wnnna$aPurpura, Schonlein-Henoch
=450  \\$aAllergic Purpura
=450  \\$aAnaphylactoid Purpura
=450  \\$aHenoch Purpura
=450  \\$aHenoch-Schoenlein Purpura
=450  \\$aPurpura Hemorrhagica
=450  \\$aPurpura, Nonthrombocytopenic
=450  \\$aPurpura, Schoenlein-Henoch
=450  \\$aRheumatoid Purpura
=450  \\$aSchoenlein-Henoch Purpura
=450  \\$aVasculitis, Hemorrhagic
=450  \\$wnnna$aHemorrhagic Vasculitis
=450  \\$wnnna$aHemorrhagica, Purpura
=450  \\$wnnna$aHenoch Schoenlein Purpura
=450  \\$wnnna$aHenoch Schonlein Purpuras
=450  \\$wnnna$aHenoch-Schonlein Purpuras
=450  \\$wnnna$aNonthrombocytopenic Purpura
=450  \\$wnnna$aNonthrombopenic Purpura
=450  \\$wnnna$aNonthrombopenic Purpuras
=450  \\$wnnna$aPurpura, Allergic
=450  \\$wnnna$aPurpura, Anaphylactoid
=450  \\$wnnna$aPurpura, Henoch
=450  \\$wnnna$aPurpura, Henoch Schonlein
=450  \\$wnnna$aPurpura, Henoch-Schoenlein
=450  \\$wnnna$aPurpura, Henoch-Schonlein
=450  \\$wnnna$aPurpura, Rheumatoid
=450  \\$wnnna$aPurpura, Schoenlein Henoch
=450  \\$wnnna$aPurpura, Schonlein Henoch
=450  \\$wnnna$aPurpuras, Henoch Schonlein
=450  \\$wnnna$aPurpuras, Henoch-Schonlein
=450  \\$wnnna$aPurpuras, Nonthrombopenic
=450  \\$wnnna$aPurpuras, Schonlein-Henoch
=450  \\$wnnna$aSchoenlein Henoch Purpura
=450  \\$wnnna$aSchonlein Purpura, Henoch
=450  \\$wnnna$aSchonlein Purpuras, Henoch
=450  \\$wnnna$aSchonlein-Henoch Purpura
=450  \\$wnnna$aSchonlein-Henoch Purpuras
=450  \\$wnnna$aVasculitis, IgA
=667  \\$anonthrombopenic: thrombopenic = PURPURA, THROMBOCYTOPENIC
=680  \\$iA systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
=688  \\$a2022(1975)
=750  \0$iBroader mapping$aVasculitis$0(DLC)sh85142363$4BM$5IEN-M

=LDR  01050cz  a2200289n  4500
=001  9882116471502441
=005  20230127153511.0
=008  220712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094862
=035  \\$a(DNLM)D000094862
=035  \\$a(NLM)9825515409700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x493
=150  \\$aOceanians
=450  \\$aOceanian People
=450  \\$aOceanic Ancestry Group
=450  \\$wnnna$aAncestry Group, Oceanic
=450  \\$wnnna$aAncestry Groups, Oceanic
=450  \\$wnnna$aGroup, Oceanic Ancestry
=450  \\$wnnna$aGroups, Oceanic Ancestry
=450  \\$wnnna$aOceanian Peoples
=450  \\$wnnna$aOceanic Ancestry Groups
=450  \\$wnnna$aPeople, Oceanian
=680  \\$iPeople native to or inhabitants of OCEANIA including MICRONESIA; MELANESIA; POLYNESIA; AUSTRALIA and NEW ZEALAND.
=688  \\$a2023(2004)
=750  \0$iNarrower mapping$aPacific Islanders$0(DLC)sh85093920$4NM$5IEN-M
=750  \0$iNarrower mapping$aAboriginal Australians$0(DLC)sh85009602$4NM$5IEN-M

=LDR  00947cz  a2200265n  4500
=001  9882133183602441
=005  20230208113853.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003765
=035  \\$a(DNLM)D003765
=035  \\$a(NLM)98194714420000041
=040  \\$aDNLM$cDNLM
=060  \0$aWU 26
=072  \\$aE6.$x570
=072  \\$aJ1.$x897.$x280.$x500.$x545.$x129.$x450
=072  \\$aL1.$x462.$x500.$x820.$x90.$x545.$x129.$x450
=150  \\$aModels, Dental
=450  \\$wnnna$aDental Model
=450  \\$wnnna$aModel, Dental
=450  \\$aDental Models
=680  \\$iPresentation devices used for patient education and technique training in dentistry.
=688  \\$a2022 (1965)
=750  \0$81$wb$iBroader mapping$aMouth$0(DLC)sh85087988$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xModels$0(DLC) sh00006390$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aMouth--Models$5IEN-M

=LDR  01122nz  a2200337n  4500
=001  9818556971706676
=005  20230310071327.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012574
=035  \\$a(DNLM)D012574
=035  \\$a(NLM)98195043790000041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x783
=072  \\$aJ3.$x832
=150  \\$aSchools
=450  \\$wnnna$aPrimary Schools
=450  \\$wnnna$aSchools, Secondary
=450  \\$wnnna$aSecondary Schools
=450  \\$wnnna$aPrimary School
=450  \\$wnnna$aSchool
=450  \\$wnnna$aSchool, Primary
=450  \\$wnnna$aSchool, Secondary
=450  \\$wnnna$aSchools, Primary
=450  \\$wnnna$aSecondary School
=667  \\$aspecify geographic location if pertinent
=680  \\$iEducational institutions.
=750  \0$iNarrower mapping$aUrban community colleges$0(DLC)sh2022005690$4NM$5DNLM
=750  \0$iNarrower mapping$aBoys' schools$0(DLC)sh2020012275$4NM$5DNLM
=750  \0$aSchools$5IEN$0(DLC)sh 85118451

=LDR  04899cz   2201621n  4500
=001  9880364251702441
=005  20230831161346.0
=008  970620\n\ancnnbabn\\\\\\\\\\|b\ana\\\\\\
=035  \\$a(DNLM)D019659
=040  \\$aDNLM$beng$cDNLM
=072  \\$aB1.$x650.$x940.$x800.$x575.$x912.$x250.$x100
=150  \\$aAsteraceae
=450  \\$aAspilia
=450  \\$wnnna$aAspilias
=450  \\$wnnna$aBane, False Leopard's
=450  \\$wnnna$aBanes, False Leopard's
=450  \\$aCarpesium
=450  \\$wnnna$aCarpesiums
=450  \\$aClibadium
=450  \\$wnnna$aClibadiums
=450  \\$aCompositae
=450  \\$aDoronicum
=450  \\$wnnna$aDoronicums
=450  \\$aEmilia Plant
=450  \\$wnnna$aEmilia Plants
=450  \\$wnnna$aEnhydra fluctuan
=450  \\$wnnna$aEnhydra fluctuans
=450  \\$wnnna$aFalse Leopard's Bane
=450  \\$wnnna$aFalse Leopard's Banes
=450  \\$wnnna$afluctuan, Enhydra
=450  \\$wnnna$afluctuans, Enhydra
=450  \\$aHeterotheca
=450  \\$wnnna$aHeterothecas
=450  \\$aIostephane
=450  \\$wnnna$aIostephanes
=450  \\$wnnna$aIxeri
=450  \\$wnnna$aIxeris
=450  \\$wnnna$aLeopard Bane, False
=450  \\$aLeopard's Bane, False
=450  \\$wnnna$aLeopards Bane, False
=450  \\$wnnna$aLeopard's Banes, False
=450  \\$wnnna$aLigularia
=450  \\$wnnna$aLigularias
=450  \\$aLychnophora
=450  \\$wnnna$aLychnophoras
=450  \\$aPhagnalon
=450  \\$wnnna$aPhagnalons
=450  \\$wnnna$aPlant, Emilia
=450  \\$wnnna$aPlants, Emilia
=450  \\$aPsacalium
=450  \\$wnnna$aPsacaliums
=450  \\$wnnna$aPseudognaphalium
=450  \\$wnnna$aPseudognaphaliums
=450  \\$wnnna$aSilphium
=450  \\$wnnna$aSilphiums
=450  \\$aSphaeranthus
=450  \\$wnnna$aTithonia
=450  \\$wnnna$aTithonias
=450  \\$wnnna$aTrixi
=450  \\$aTrixis
=450  \\$aViguiera
=450  \\$wnnna$aViguieras
=550  \\$wg$aMagnoliopsida
=550  \\$wh$aAchillea
=550  \\$wh$aAchyrocline
=550  \\$wh$aAgeratina
=550  \\$wh$aAgeratum
=550  \\$wh$aAmbrosia
=550  \\$wh$aAmmi
=550  \\$wh$aArctium
=550  \\$wh$aArnica
=550  \\$wh$aArtemisia
=550  \\$wh$aAster Plant
=550  \\$wh$aAtractylis
=550  \\$wh$aAtractylodes
=550  \\$wh$aBaccharis
=550  \\$wh$aBidens
=550  \\$wh$aCalendula
=550  \\$wh$aCallilepis
=550  \\$wh$aCarduus
=550  \\$wh$aCarthamus
=550  \\$wh$aCentaurea
=550  \\$wh$aChamomile
=550  \\$wh$aChicory
=550  \\$wh$aChromolaena
=550  \\$wh$aChrysanthemum
=550  \\$wh$aCirsium
=550  \\$wh$aCnicus
=550  \\$wh$aConyza
=550  \\$wh$aCoreopsis
=550  \\$wh$aCrepis
=550  \\$wh$aCynara
=550  \\$wh$aDahlia
=550  \\$wh$aEchinacea
=550  \\$wh$aEchinops Plant
=550  \\$wh$aEclipta
=550  \\$wh$aErigeron
=550  \\$wh$aEupatorium
=550  \\$wh$aFlaveria
=550  \\$wh$aGeigeria
=550  \\$wh$aGnaphalium
=550  \\$wh$aGrindelia
=550  \\$wh$aHaplopappus
=550  \\$wh$aHelianthus
=550  \\$wh$aHelichrysum
=550  \\$wh$aInula
=550  \\$wh$aLettuce
=550  \\$wh$aLeuzea
=550  \\$wh$aMikania
=550  \\$wh$aMilk Thistle
=550  \\$wh$aMontanoa
=550  \\$wh$aOnopordum
=550  \\$wh$aPetasites
=550  \\$wh$aPsacalium
=550  \\$wh$aPulicaria
=550  \\$wh$aRatibida
=550  \\$wh$aRudbeckia
=550  \\$wh$aSaussurea
=550  \\$wh$aScolymus
=550  \\$wh$aScorzonera
=550  \\$wh$aSenecio
=550  \\$wh$aSolidago
=550  \\$wh$aSonchus
=550  \\$wh$aStevia
=550  \\$wh$aTagetes
=550  \\$wh$aTanacetum
=550  \\$wh$aTaraxacum
=550  \\$wh$aTragopogon
=550  \\$wh$aTussilago
=550  \\$wh$aVerbesina
=550  \\$wh$aVernonia
=550  \\$wh$aWedelia
=550  \\$wh$aXanthium
=667  \\$aX ref ENHYDRA FLUCTUANS: do not confuse with the sea otter ENHYDRA LUTRIS see OTTERS; prefer specific plant; coord with specific PLANT STRUCTURES term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29
=680  \\$iA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of "daisy" refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.
=688  \\$a1998; for DORONICUM use ARNICA 1996-2002
=750  \0$aCompositae$5IEN-M$0(DLC)sh 85029393
=750  \0$iNarrower mapping$aXylorhiza$0(DLC)sh2022006764$4NM$5IEN-M

=LDR  01269nz  a2200301n  4500
=001  9818556972406676
=005  20230309183256.0
=008  050630\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D049876
=035  \\$a(DNLM)D049876
=035  \\$a(NLM)98198152910000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x644.$x80.$x850
=150  \\$aUnionidae
=450  \\$wnnna$aUnionids
=450  \\$aMussels, Native
=450  \\$wnnna$aMussel, Native
=450  \\$wnnna$aNative Mussel
=450  \\$wnnna$aNative Mussels
=450  \\$wnnna$aUnionid
=667  \\$aas animal & food; general or unspecified; prefer specifics; as food, coordinate IM with SHELLFISH (IM)
=680  \\$iA family of freshwater mussels in the class BIVALVIA. They differ from ZEBRA MUSSELS in that they are larger and posses a larval stage called glochidia, which requires attachment to the GILLS or fins of particular species of FISHES.
=688  \\$a2006
=750  \0$iNarrower mapping$aCyclonaias$0(DLC)sh2022005743$4NM$5DNLM
=750  \0$iNarrower mapping$aPurple wartyback$0(DLC)sh2022005742$4NM$5DNLM
=750  \0$aUnionidae$0(DLC) sh 85139711$5IEN-M

=LDR  00993cz  a2200253n  4500
=001  9818556972606676
=005  20230309181941.0
=008  800514\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D013240
=035  \\$a(DNLM)D013240
=035  \\$a(NLM)98199911380000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x920
=072  \\$aF1.$x145.$x813.$x854
=150  \\$aStereotyping
=450  \\$wnnna$aStigmatization
=550  \\$aSocial Perception
=667  \\$aincludes both person using stereotypic thinking & person or group being stereotyped; do not confuse with STEREOTYPED BEHAVIOR
=680  \\$iAn oversimplified perception or conception especially of persons, social groups, etc.
=688  \\$a1981
=750  \0$iNarrower mapping$aPrimitive man stereotype$0(DLC)sh2022006297$4NM$5DNLM
=750  \0$aStereotypes (Social psychology)$5IEN$0(DLC)sh 85128018

=LDR  00795nz  a2200217n  4500
=001  9818556973906676
=005  20230309181341.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D014175
=035  \\$a(DNLM)D014175
=035  \\$a(NLM)98198047980000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x559.$x423.$x796
=150  \\$aTranslating
=450  \\$wnnna$aTranslatings
=680  \\$iConversion from one language to another language.
=750  \0$iNarrower mapping$aIndirect translation$0(DLC)sh2022005476$4NM$5DNLM
=750  \0$aTranslating and interpreting$0(DLC)sh 85136958$5IEN
=750  \0$iNarrower mapping$aRetranslation$0(DLC)sh2020000627$4NM$5DNLM

=LDR  01541nz  a2200373n  4500
=001  9818556974806676
=005  20230309175031.0
=008  800402\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001001
=035  \\$a(DNLM)D001001
=035  \\$a(NLM)98193898000000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x90.$x180
=150  \\$aAnura
=450  \\$aBombina
=450  \\$aFrogs and Toads
=450  \\$aSalientia
=450  \\$aToad, Fire-Bellied
=450  \\$aToads and Frogs
=450  \\$wnnna$aAnuras
=450  \\$wnnna$aFire-Bellied Toad
=450  \\$wnnna$aFire-Bellied Toads
=450  \\$wnnna$aSalientias
=450  \\$wnnna$aToad, Fire Bellied
=450  \\$wnnna$aToads, Fire-Bellied
=667  \\$aNIM with no qualifiers when experimental animal
=680  \\$iAn order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term "toad" is ambiguous and is properly applied only to the family Bufonidae.
=688  \\$a81; FROGS & TOADS were headings 1964-80
=750  \0$iNarrower mapping$aCraugastor$0(DLC)sh2022005706$4NM$5DNLM
=750  \0$aAnura$5IEN$0(DLC)sh 85005817
=750  \0$iNarrower mapping$aEleutherodactylidae$0(DLC)sh2021008673$4NM$5IEN-M
=750  \0$iNarrower mapping$aEvergreen robber frog$0(DLC)sh2021008671$4NM$5IEN-M

=LDR  01474cz  a2200409n  4500
=001  9818556975306676
=005  20230309170741.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010290
=035  \\$a(DNLM)D010290
=035  \\$a(NLM)98193941190000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x875
=072  \\$aI1.$x880.$x853.$x150.$x688
=072  \\$aM1.$x620
=150  \\$aParents
=450  \\$wnnna$aParental Age
=450  \\$wnnna$aParenthood Status
=450  \\$wnnna$aStepparent
=450  \\$aStep-Parents
=450  \\$wnnna$aAge, Parental
=450  \\$wnnna$aAges, Parental
=450  \\$wnnna$aParent
=450  \\$wnnna$aParental Ages
=450  \\$wnnna$aStatus, Parenthood
=450  \\$wnnna$aStep Parents
=450  \\$wnnna$aStep-Parent
=450  \\$wnnna$aStepparents
=550  \\$aParental Consent
=550  \\$aParental Notification
=667  \\$aHUMAN only; /psychol: consider also PARENT-CHILD RELATIONS; "unwed parent": coord IM with ILLEGITIMACY (IM)
=680  \\$iPersons functioning as natural, adoptive, or substitute parents. The heading includes the concept of parenthood as well as preparation for becoming a parent.
=688  \\$a69(67)
=750  \0$iNarrower mapping$aCollege students as parents$0(DLC)sh2022002078$4NM$5DNLM
=750  \0$aParents$5IEN$0(DLC)sh 85098016

=LDR  01073cz  a2200241n  4500
=001  9818556975506676
=005  20230309170049.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091383
=035  \\$a(DNLM)D000091383
=035  \\$a(NLM)9819990664700041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738.$x458.$x500
=072  \\$aI1.$x880.$x604.$x473.$x700.$x500
=072  \\$aK1.$x752.$x566.$x479.$x830.$x750.$x500
=072  \\$aK1.$x752.$x566.$x869.$x250
=150  \\$aEnvironmental Justice
=450  \\$wnnna$aJustice, Environmental
=667  \\$aSOCIAL DETERMINANTS OF HEALTH is available
=680  \\$iThe fair treatment and meaningful involvement of all people regardless of race, color, national origin, or income, with respect to the development, implementation, and enforcement of environmental laws, regulations, and policies. (www.epa.gov/environmentaljustice/learn-about-environmental-justice)
=688  \\$a2022
=750  \0$iNarrower mapping$aClimate justice$0(DLC)sh2022005967$4NM$5DNLM

=LDR  01596nz  a2200457n  4500
=001  9818556976806676
=005  20230308143418.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010856
=035  \\$a(DNLM)D010856
=035  \\$a(NLM)98196135440000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x165.$x150
=150  \\$aColumbidae
=450  \\$wnnna$aDomestic Pigeons
=450  \\$wnnna$aFeral Pigeons
=450  \\$wnnna$aRock Doves
=450  \\$wnnna$aRock Pigeons
=450  \\$aColumba livia
=450  \\$aDoves
=450  \\$aPigeons
=450  \\$wnnna$aDomestic Pigeon
=450  \\$wnnna$aDove
=450  \\$wnnna$aDove, Rock
=450  \\$wnnna$aDoves, Rock
=450  \\$wnnna$aFeral Pigeon
=450  \\$wnnna$aPigeon
=450  \\$wnnna$aPigeon, Domestic
=450  \\$wnnna$aPigeon, Feral
=450  \\$wnnna$aPigeon, Rock
=450  \\$wnnna$aPigeons, Domestic
=450  \\$wnnna$aPigeons, Feral
=450  \\$wnnna$aPigeons, Rock
=450  \\$wnnna$aRock Dove
=450  \\$wnnna$aRock Pigeon
=680  \\$iFamily in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.
=688  \\$a2005 (1968)
=750  \0$iNarrower mapping$aPampusana$0(DLC)sh2022005770$4NM$5DNLM
=750  \0$aPigeons$0(DLC) sh 85102085$5IEN

=LDR  01331cz  a2200397n  4500
=001  9880788758902441
=005  20230901092055.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=035  \\$a(DNLM)D009040
=035  \\$a(NLM)98197220090000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x598
=072  \\$aK1.$x93.$x545
=072  \\$aL1.$x178.$x590.$x500
=072  \\$aL1.$x178.$x820.$x90.$x598
=150  \\$aMotion Pictures
=450  \\$wnnna$aCinema
=450  \\$wnnna$aFilms
=450  \\$wnnna$aFilms as Topic
=450  \\$wnnna$aMovies
=450  \\$wnnna$aMovies as Topic
=450  \\$wnnna$aCinemas
=450  \\$wnnna$aFilms as Topics
=450  \\$wnnna$aMotion Picture
=450  \\$wnnna$aMovies as Topics
=450  \\$wnnna$aPicture, Motion
=450  \\$wnnna$aPictures, Motion
=550  \\$wg$aArt
=550  \\$wg$aAudiovisual Aids
=550  \\$wg$aMass Media
=550  \\$aPhotography
=667  \\$adocudrama, if a motion picture, goes here; do not confuse with Publication Type DOCUMENTARIES AND FACTUAL FILMS
=680  \\$iThe art, technique, or business of producing motion pictures for entertainment, propaganda, or instruction.
=688  \\$a2018(1963)
=750  \0$aMotion pictures$0(DLC) sh 85088084$5IEN
=750  \0$iNarrower mapping$aCyberpunk films$0(DLC)sh2022007179$4NM$5IEN-M

=LDR  01644cz  a2200433n  4500
=001  9818556978006676
=005  20230308141733.0
=008  940416\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D018454
=035  \\$a(DNLM)D018454
=035  \\$a(NLM)98197847260000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x968
=072  \\$aI1.$x880.$x853.$x150.$x875
=072  \\$aM1.$x816
=150  \\$aSpouses
=450  \\$wnnna$aSpousal Notification
=450  \\$wnnna$aSpouse
=450  \\$wnnna$aWife
=450  \\$aDomestic Partners
=450  \\$aHusbands
=450  \\$aMarried Persons
=450  \\$aWives
=450  \\$wnnna$aDomestic Partner
=450  \\$wnnna$aHusband
=450  \\$wnnna$aMarried Person
=450  \\$wnnna$aNotification, Spousal
=450  \\$wnnna$aPartner, Domestic
=450  \\$wnnna$aPartners, Domestic
=450  \\$wnnna$aPerson, Married
=450  \\$wnnna$aPersons, Married
=550  \\$aMarriage
=667  \\$ahusbands, wives, or partners as persons: differentiate from MARRIAGE, the sociol or anthropol concept
=680  \\$iMarried persons, i.e., husbands and wives, or partners. Domestic partners, or spousal equivalents, are two adults who have chosen to share their lives in an intimate and committed relationship, reside together, and share a mutual obligation of support for the basic necessities of life.
=688  \\$a95
=750  \0$iNarrower mapping$aCelebrities' spouses$0(DLC)sh2021015830]$4NM$5DNLM
=750  \0$aSpouses$5IEN-M$0(DLC)sh 93004932

=LDR  01367nz  a2200385n  4500
=001  9818556979306676
=005  20230308124040.0
=008  080708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D055867
=035  \\$a(DNLM)D055867
=035  \\$a(NLM)98197669390000041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x175.$x500
=072  \\$aN6.$x230.$x100.$x230.$x100
=150  \\$aCyclonic Storms
=450  \\$wnnna$aHurricane
=450  \\$wnnna$aHurricanes
=450  \\$wnnna$aTropical Storm
=450  \\$wnnna$aTyphoon
=450  \\$wnnna$aTyphoons
=450  \\$aCyclone
=450  \\$aCyclones
=450  \\$wnnna$aCyclonic Storm
=450  \\$wnnna$aStorm, Cyclonic
=450  \\$wnnna$aStorm, Tropical
=450  \\$wnnna$aStorms, Cyclonic
=450  \\$wnnna$aStorms, Tropical
=450  \\$wnnna$aTropical Storms
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iNon-frontal low-pressure systems over tropical or sub-tropical waters with organized convection and definite pattern of surface wind circulation.
=688  \\$a2010 (2009)
=750  \0$iNarrower mapping$aHurricane Ida, 2021]$0(DLC)sh2021015552$4NM$5DNLM
=750  \0$aCyclones$0(DLC) sh 85035089$5IEN-M

=LDR  00846nz  a2200241n  4500
=001  9818556979506676
=005  20230308115221.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D001272
=035  \\$a(DNLM)D001272
=035  \\$a(NLM)98196649870000041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x275.$x63
=072  \\$aN6.$x230.$x300.$x100
=150  \\$aAtmosphere
=450  \\$wnnna$aAtmospheres
=667  \\$a/anal /chem permitted
=680  \\$iThe gaseous envelope surrounding a planet or similar body. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a74(72)
=750  \0$iNarrower mapping$aHeterosphere$0(DLC)sh2022005522$4NM$5DNLM
=750  \0$aAtmosphere$5IEN$0(DLC)sh 85009271

=LDR  01588nz  a2200445n  4500
=001  9818556979906676
=005  20230308104250.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004651
=035  \\$a(DNLM)D004651
=035  \\$a(NLM)98197471100000041
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x824.$x245
=150  \\$aEmployment
=450  \\$wnnna$aEmployment Insecurity
=450  \\$wnnna$aEmployment Status
=450  \\$wnnna$aLabor Force
=450  \\$wnnna$aMarginal Employment
=450  \\$wnnna$aOccupational Status
=450  \\$wnnna$aPrecarious Employment
=450  \\$wnnna$aStatus, Occupational
=450  \\$wnnna$aUnderemployment
=450  \\$aEmployment Termination
=450  \\$wnnna$aEmployment Insecurities
=450  \\$wnnna$aEmployment, Marginal
=450  \\$wnnna$aEmployment, Precarious
=450  \\$wnnna$aInsecurity, Employment
=450  \\$wnnna$aLabor Forces
=450  \\$wnnna$aStatus, Employment
=450  \\$wnnna$aTermination, Employment
=550  \\$aRehabilitation, Vocational
=550  \\$aWork
=667  \\$afor pay: differentiate from WORK
=680  \\$iThe state of being engaged in an activity or service for wages or salary.
=688  \\$a70
=750  \0$iNarrower mapping$aNon-standard employment$0(DLC)sh2022005471$4NM$5DNLM
=750  \0$iNarrower mapping$aPrecarious employment$0(DLC)sh2009008937$4NM$5DNLM
=750  \0$aEmployment (Economic theory)$5IEN-M$0(DLC)sh 85042916

=LDR  01237nz  a2200373n  4500
=001  9818556980706676
=005  20230308082827.0
=008  950620\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D018986
=035  \\$a(DNLM)D018986
=035  \\$a(NLM)98196515620000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x937.$x500
=150  \\$aMotor Vehicles
=450  \\$wnnna$aBuses
=450  \\$wnnna$aTrucks
=450  \\$aArmored Vehicles
=450  \\$aTanks
=450  \\$wnnna$aArmored Vehicle
=450  \\$wnnna$aMotor Vehicle
=450  \\$wnnna$aTank
=450  \\$wnnna$aTruck
=450  \\$wnnna$aVehicle, Armored
=450  \\$wnnna$aVehicle, Motor
=450  \\$wnnna$aVehicles, Armored
=450  \\$wnnna$aVehicles, Motor
=550  \\$aAutomobile Driving
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iAUTOMOBILES, trucks, buses, or similar engine-driven conveyances. (From Random House Unabridged Dictionary, 2d ed)
=688  \\$a96
=750  \0$iNarrower mapping$aElectric trucks$0(DLC)sh2022005350$4NM$5DNLM
=750  \0$aMotor vehicles$5IEN-M$0(DLC)sh 85087597

=LDR  01061nz  a2200253n  4500
=001  9818556981006676
=005  20230308071657.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087503
=035  \\$a(DNLM)D000087503
=035  \\$a(NLM)9819990178000041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x828.$x868.$x228.$x500
=072  \\$aD20.$x215.$x894.$x865.$x450.$x500
=072  \\$aD23.$x50.$x865.$x450.$x500
=150  \\$amRNA Vaccines
=450  \\$aMessenger RNA Vaccines
=450  \\$aNaked RNA Vaccines
=450  \\$aRNA Vaccines
=450  \\$wnnna$aVaccines, RNA
=680  \\$iVaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigen.
=688  \\$a2022
=750  \0$amRNA vaccines$0(DLC)sh2022005581$5DNLM

=LDR  00758nz  a2200193n  4500
=001  9818556981106676
=005  20230308071109.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000968
=035  \\$a(DNLM)D000968
=035  \\$a(NLM)98199707740000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x540.$x576.$x500.$x750
=150  \\$aAntimycin A
=450  \\$wnnna$aAntimycin A1
=680  \\$iAn antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. (From Merck Index, 12th ed)
=688  \\$a66(64)
=750  \0$aAntimycin A$0(DLC)sh202000654$5DNLM

=LDR  01083nz  a2200289n  4500
=001  9818556981506676
=005  20230307180306.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D034401
=035  \\$a(DNLM)D034401
=035  \\$a(NLM)98196435220000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x859.$x937.$x844
=150  \\$aUlmaceae
=450  \\$aCeltis
=450  \\$aHackberry
=450  \\$aZelkova
=450  \\$wnnna$aCelti
=450  \\$wnnna$aHackberries
=450  \\$wnnna$aZelkovas
=667  \\$aprefer specific plant
=680  \\$iA plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. Members are trees and shrubs of temperate regions that have watery sap and alternate leaves which are lopsided at the base. The flowers lack petals.
=688  \\$a2003
=750  \0$iNarrower mapping$aUlmaceae$0(DLC)sh2022005346$4NM$5DNLM
=750  \0$aUlmaceae$5IEN-M$0(DLC)sh 85139445

=LDR  00766nz  a2200217n  4500
=001  9818556981706676
=005  20230307175004.0
=008  930621\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017968
=035  \\$a(DNLM)D017968
=035  \\$a(NLM)98195943090000041
=040  \\$aDNLM$cDNLM
=072  \\$aD1.$x960
=150  \\$aVanadium Compounds
=450  \\$wnnna$aCompounds, Vanadium
=680  \\$iInorganic compounds that contain vanadium as an integral part of the molecule.
=688  \\$a94
=750  \0$iNarrower mapping$aVanadyl porphyrins$0(DLC)sh2022005375$4NM$5DNLM
=750  \0$aVanadium compounds$0(DLC)sh2008020195$5IEN-M

=LDR  00793nz  a2200205n  4500
=001  9818556981906676
=005  20230307175624.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D029525
=035  \\$a(DNLM)D029525
=035  \\$a(NLM)98199535350000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x859.$x750.$x500
=150  \\$aJuglandaceae
=680  \\$iThe walnut plant family of the order Juglandales, subclass Hamamelidae, class Magnoliopsida. They are mainly temperate zone trees.
=688  \\$a2002
=750  \0$iNarrower mapping$aPterocarya$0(DLC)sh2022005345$4NM$5DNLM
=750  \0$aJuglandaceae$5IEN-M$0(DLC)sh 85070976

=LDR  01285nz  a2200265n  4500
=001  9818556982106676
=005  20230307171954.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011166
=035  \\$a(DNLM)D011166
=035  \\$a(NLM)98193894920000041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 110
=072  \\$aD3.$x383.$x129.$x578.$x840.$x500
=072  \\$aD3.$x633.$x400.$x909.$x500
=072  \\$aD4.$x345.$x783.$x500
=072  \\$aD23.$x767.$x727
=150  \\$aPorphyrins
=450  \\$aPorphyrin
=667  \\$apigments; iron porphyrins = HEME or HEMIN, magnesium porphyrins = CHLOROPHYLL
=680  \\$iA group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
=750  \0$iNarrower mapping$aPetroporphyrins$0(DLC)sh2022005377$4NM$5DNLM
=750  \0$aPorphyrins$5IEN{dollar}$0(DLC)sh 85105022

=LDR  00868nz  a2200265n  4500
=001  9818556983206676
=005  20230307162913.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D002369
=035  \\$a(DNLM)D002369
=035  \\$a(NLM)98199596410000041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x270.$x282
=072  \\$aE4.$x950.$x165
=150  \\$aCastration
=450  \\$wnnna$aGonadectomy
=450  \\$wnnna$aCastrations
=450  \\$wnnna$aGonadectomies
=550  \\$aGonads
=667  \\$aprefer OVARIECTOMY or ORCHIECTOMY
=680  \\$iSurgical removal or artificial destruction of gonads.
=750  \0$iNarrower mapping$aChemical castration$0(DLC)sh2022005425$4NM$5DNLM
=750  \0$aCastration$5IEN$0(DLC)sh 85020752

=LDR  01031cz  a2200277n  4500
=001  9818556983406676
=005  20230307114221.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D013358
=035  \\$a(DNLM)D013358
=035  \\$a(NLM)98194507430000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x462.$x750.$x245.$x945.$x700
=150  \\$aSubject Headings
=450  \\$aDescriptors
=450  \\$wnnna$aDescriptor
=450  \\$wnnna$aHeading, Subject
=450  \\$wnnna$aHeadings, Subject
=450  \\$wnnna$aSubject Heading
=550  \\$aUnified Medical Language System
=667  \\$aVOCABULARY, CONTROLLED is also available
=680  \\$iTerms or expressions which provide the major means of access by subject to the bibliographic unit.
=750  \0$iNarrower mapping$aRAMEAU (Subject headings)$0(DLC)sh2021012351$4NM$5DNLM
=750  \0$aSubject headings$5IEN-M$0(DLC)sh 8512942

=LDR  01250nz  a2200301n  4500
=001  9818556983606676
=005  20230309184644.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003296
=035  \\$a(DNLM)D003296
=035  \\$a(NLM)98195583450000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x576.$x423.$x200.$x200
=150  \\$aCooking
=450  \\$aCookery
=550  \\$aDiet
=667  \\$aconsider also HOT TEMPERATURE
=680  \\$iThe art or practice of preparing food. It includes the preparation of special foods for diets in various diseases.
=688  \\$a2011; use COOKERY 2000-2010
=750  \0$iNarrower mapping$aTzotzil cooking$0(DLC)sh2022002065$4NM$5DNLM
=750  \0$aCooking$0(DLC)sh2010008400$5IEN-M
=750  \0$iNarrower mapping$aCooking (Yautia)$0(DLC)sh2020008060$4NM$5DNLM
=750  \0$iNarrower mapping$aCooking (Root crops)$0(DLC)sh2021015537$4NM$5DNLM
=750  \0$iNarrower mapping$aCooking (Tuber crops)$0(DLC)sh2022005596
=750  \0$iNarrower mapping$aCooking (Fonio)$0(DLC)sh2022005866$4NM$5DNLM
=750  \0$iNarrower mapping$aTteokbokki$0(DLC)sh2021012176$4NM$5DNLM

=LDR  01047nz  a2200277n  4500
=001  9818556983906676
=005  20230307123524.0
=008  741119\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000363
=035  \\$a(DNLM)D000363
=035  \\$a(NLM)98197137010000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x300.$x179.$x100
=150  \\$aAgaricales
=450  \\$aAgaricaceae
=450  \\$aMushrooms
=450  \\$wnnna$aAgaricale
=450  \\$wnnna$aMushroom
=550  \\$aFruiting Bodies, Fungal
=667  \\$anote entry term MUSHROOMS; poisoning = MUSHROOM POISONING
=680  \\$iAn extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms.
=688  \\$a1986(1975); for MUSHROOMS use BASIDIOMYCOTA 1963-1998; for AGARICACEAE use BASIDIOMYCOTA 1966-1974
=750  \0$iNarrower mapping$aTulostoma$0(DLC)sh2022000002$4NM$5DNLM
=750  \0$aAgaricales$5IEN-M$0(DLC)sh 85002048

=LDR  00896nz  a2200277n  4500
=001  9818556984006676
=005  20230307122519.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000072506
=035  \\$a(DNLM)D000072506
=035  \\$a(NLM)987391641200041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x40.$x415
=072  \\$aJ3.$x320
=150  \\$aGardens
=450  \\$aNurseries, Plant
=450  \\$aPlant Nurseries
=450  \\$wnnna$aGarden
=450  \\$wnnna$aNursery, Plant
=450  \\$wnnna$aPlant Nursery
=680  \\$iPlaces provided for the cultivation and/or display of PLANTS.
=688  \\$a2017; use AGRICULTURE 2016
=750  \0$iNarrower mapping$aTemporary gardens$0(DLC)sh202101585$4NM$5DNLM
=750  \0$aGardens$0(DLC)sh 85053101$5IEN-M

=LDR  01030nz  a2200301n  4500
=001  9818556984506676
=005  20230307115013.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D014925
=035  \\$a(DNLM)D014925
=035  \\$a(NLM)98197065020000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x100.$x960
=072  \\$aK1.$x517.$x946
=150  \\$aWit and Humor as Topic
=450  \\$wnnna$aHumor as Topic
=450  \\$wnnna$aWit
=450  \\$wnnna$aWit as Topic
=450  \\$wnnna$aWits
=550  \\$aLaughter
=550  \\$aLaughter Therapy
=667  \\$ado not confuse with the Publication Type WIT AND HUMOR
=680  \\$iThe comical expression of connections between ideas that awaken amusement and pleasure.
=688  \\$a2008(1963)
=750  \0$iNarrower mapping$aRiddles, Kankana$0(DLC)sh2021012183$4NM$5DNLM
=750  \0$aWit and humor$0(DLC)sh 85147124$5IEN

=LDR  00853nz  a2200253n  4500
=001  9818556984906676
=005  20230307113204.0
=008  860418\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D009049
=035  \\$a(DNLM)D009049
=035  \\$a(NLM)98197218470000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x937.$x500.$x500
=150  \\$aMotorcycles
=450  \\$aMopeds
=450  \\$wnnna$aMoped
=450  \\$wnnna$aMotorcycle
=667  \\$aMOTORCYCLES are public-road vehicles: OFF-ROAD MOTOR VEHICLES is also available
=680  \\$iTwo-wheeled, engine-driven vehicles.
=688  \\$a87
=750  \0$iNarrower mapping$aMorbidelli motorcyles$0(DLC)sh2022002101$4NM$5DNLM
=750  \0$aMotorcycles$5IEN$0(DLC)sh 85087665

=LDR  01151nz  a2200241n  4500
=001  9818556985306676
=005  20230307104628.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D003309
=035  \\$a(DNLM)D003309
=035  \\$a(NLM)98195496110000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x583.$x458.$x300
=072  \\$aL1.$x737.$x360
=072  \\$aN3.$x706.$x535.$x518.$x300
=150  \\$aCopyright
=450  \\$wnnna$aCopyrights
=667  \\$aspecify geographic term if pertinent
=680  \\$iIt is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)
=750  \0$iNarrower mapping$aFirst sale doctrine (Copyright)$0(DLC)sh2021012350$4NM$5DNLM
=750  \0$aCopyright$5IEN$0(DLC)sh 85032446

=LDR  00725nz  a2200193n  4500
=001  9818556985506676
=005  20230307093640.0
=008  180709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000077626
=035  \\$a(DNLM)D000077626
=035  \\$a(NLM)9811675509800041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x143.$x320.$x400
=150  \\$aImplementation Science
=450  \\$wnnna$aImplementation Sciences
=680  \\$iThe study of methods to promote the adoption and integration of evidence-based practices, interventions and policies into routine health care and public health settings.
=688  \\$a2019
=750  \0$aImplementation science$0(DLC)sh2021016111$5DNLM

=LDR  01186nz  a2200313n  4500
=001  9818556985606676
=005  20230307093138.0
=008  950106\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D018920
=035  \\$a(DNLM)D018920
=035  \\$a(NLM)98194279630000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x481.$x500.$x374
=150  \\$aCoculture Techniques
=450  \\$wnnna$aCo-culture
=450  \\$wnnna$aCoculture
=450  \\$aCocultivation
=450  \\$wnnna$aCo culture
=450  \\$wnnna$aCo-cultures
=450  \\$wnnna$aCocultivations
=450  \\$wnnna$aCoculture Technique
=450  \\$wnnna$aCocultures
=550  \\$aCells, Cultured
=550  \\$aTumor Cells, Cultured
=667  \\$aNIM; specify cell or tissue & infecting organism if relevant, probably NIM
=680  \\$iA technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.
=688  \\$a2005 (1996)
=750  \0$aCell coculture$0(DLC)sh2021016149$5DNLM

=LDR  00894nz  a2200265n  4500
=001  9818556986106676
=005  20230307081024.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D036624
=035  \\$a(DNLM)D036624
=035  \\$a(NLM)98197965370000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x100.$x816
=150  \\$aSolidago
=450  \\$wnnna$aSolidago virgaurea
=450  \\$aGolden Rod
=450  \\$aGoldenrod
=450  \\$wnnna$aGolden Rods
=450  \\$wnnna$aGoldenrods
=680  \\$iA plant genus of the family Asteraceae known for allergenic pollen (ALLERGENS).
=688  \\$a2003
=750  \0$iNarrower mapping$aSolidago speciosa$0(DLC)sh2021012147$4NM$5DNLM
=750  \0$aGoldenrods$5IEN-M$0(DLC)sh 85055770

=LDR  01213nz  a2200373n  4500
=001  9818556986406676
=005  20230307080235.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D032108
=035  \\$a(DNLM)D032108
=035  \\$a(NLM)98198198670000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x859.$x797.$x875.$x833
=150  \\$aSalix
=450  \\$wnnna$aGoat Willow
=450  \\$wnnna$aSalix alba
=450  \\$wnnna$aSalix caprea
=450  \\$wnnna$aSalix matsudana
=450  \\$wnnna$aSalix viminalis
=450  \\$wnnna$aWhite Willow
=450  \\$aWillow
=450  \\$wnnna$aGoat Willows
=450  \\$wnnna$aWhite Willows
=450  \\$wnnna$aWillow, Goat
=450  \\$wnnna$aWillow, White
=450  \\$wnnna$aWillows
=450  \\$wnnna$aWillows, Goat
=450  \\$wnnna$aWillows, White
=680  \\$iA plant genus of the family Salicaceae. Members contain salicin, which yields SALICYLIC ACID.
=688  \\$a2003
=750  \0$iNarrower mapping$aSalix chlorolepis$0(DLC)sh2021011945$4NM$5DNLM
=750  \0$aWillows$5IEN-M

=LDR  01379nz  a2200349n  4500
=001  9818556986606676
=005  20230307073559.0
=008  120703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D063191
=035  \\$a(DNLM)D063191
=035  \\$a(NLM)98198175600000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x720.$x750.$x750
=150  \\$aOdonata
=450  \\$wnnna$aAnisoptera
=450  \\$wnnna$aAnisozygoptera
=450  \\$wnnna$aDamselflies
=450  \\$wnnna$aDragonflies
=450  \\$wnnna$aZygoptera
=450  \\$wnnna$aAnisozygopteras
=450  \\$wnnna$aDragonfly
=450  \\$wnnna$aZygopteras
=667  \\$afor killing Odonata with insecticides, see note at INSECTICIDES
=680  \\$iAn order of insects comprising three suborders: Anisoptera, Zygoptera, and Anisozygoptera. They consist of dragonflies and damselflies.
=688  \\$a2013
=750  \0$iNarrower mapping$aRiverine clubtail$0(DLC)sh2021012142$4NM$5DNLM
=750  \0$aOdonata$0(DLC)sh 85094090$5IEN-M
=750  \0$iNarrower mapping$aHine's emerald (Insect)$0(DLC)sh2021001415$4NM$5DNLM
=750  \0$iNarrower mapping$aSomatochlora$0(DLC)sh2021001416$4NM$5DNLM
=750  \0$iNarrower mapping$aSkillet clubtail$0(DLC)sh2021012148$4NM$5DNLM

=LDR  01318nz  a2200325n  4500
=001  9818556986906676
=005  20230309165119.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D033262
=035  \\$a(DNLM)D033262
=035  \\$a(NLM)98198511310000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x308.$x502
=072  \\$aF1.$x145.$x209.$x459
=072  \\$aL1.$x399.$x250.$x660
=072  \\$aN5.$x715.$x360.$x300.$x480
=072  \\$aN6.$x850.$x520.$x308.$x502
=150  \\$aNarration
=450  \\$aNarrative Ethics
=450  \\$wnnna$aEthics, Narrative
=450  \\$wnnna$aNarrations
=550  \\$aAnecdotes as Topic
=550  \\$aNarrative Therapy
=680  \\$iThe act, process, or an instance of narrating, i.e., telling a story. In the context of MEDICINE or ETHICS, narration includes relating the particular and the personal in the life story of an individual.
=688  \\$a2003; for NARRATIVE ETHICS use ETHICS 1998-2002
=750  \0$iNarrower mapping$aPacing (Narration)$0(DLC)sh202100869$4NM$5DNLM
=750  \0$iNarrower mapping$aCircular narratives (Rhetoric)$0(DLC)sh2022005926$4NM$5DNLM
=750  \0$aNarration (Rhetoric)$0(DLC) sh 85089833$5IEN-M

=LDR  00985nz  a2200217n  4500
=001  9818556987206676
=005  20230307070744.0
=008  010725\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D029791
=035  \\$a(DNLM)D029791
=035  \\$a(NLM)98199236550000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x341.$x937
=150  \\$aEricaceae
=680  \\$iThe heath plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida that are generally shrubs or small trees. Leaves are alternate, simple, and leathery; flowers are symmetrical with a 4- or 5-parted corolla of partly fused petals.
=688  \\$a2002
=750  \0$iNarrower mapping$aLyonia (Plants)$0(DLC)sh2021015529$4NM$5DNLM
=750  \0$aEricaceae$5IEN-M$0(DLC)sh 85044612
=750  \0$iNarrower mapping$aLyonia ligustrina$0(DLC)sh2021015528$4NM$5DNLM

=LDR  01355cz  a2200337n  4500
=001  9818556987806676
=005  20230307064146.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007199
=035  \\$a(DNLM)D007199
=035  \\$a(NLM)98193910770000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x968.$x500.$x625
=072  \\$aM1.$x686.$x685.$x500
=150  \\$aIndians, South American
=450  \\$aAmerinds, South American
=450  \\$wnnna$aAmerican Amerind, South
=450  \\$wnnna$aAmerican Indian, South
=450  \\$wnnna$aAmerind, South American
=450  \\$wnnna$aIndian, South American
=450  \\$wnnna$aSouth American Amerind
=450  \\$wnnna$aSouth American Amerinds
=450  \\$wnnna$aSouth American Indian
=450  \\$wnnna$aSouth American Indians
=667  \\$aspecify geog if possible; in titles capitalize both Native and American
=680  \\$iMembers of indigenous South American populations with pre-colonial contact origins.
=750  \0$iNarrower mapping$aEbitoso Indians$0(DLC)sh2021012156$4NM$5DNLM
=750  \0$iNarrower mapping$aPayayá Indians (Brazil)$0(DLC)sh2021015547$4NM$5DNLM
=750  \0$aIndians of South America$5IEN$0(DLC)sh 85065540

=LDR  01122nz  a2200265n  4500
=001  9818556988106676
=005  20230306171854.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006110
=035  \\$a(DNLM)D006110
=035  \\$a(NLM)98195086800000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x678.$x369
=150  \\$aGrasshoppers
=450  \\$aAcrididae
=450  \\$aLocusts
=450  \\$aRomaleidae
=450  \\$wnnna$aGrasshopper
=450  \\$wnnna$aLocust
=667  \\$ado not use /drug eff for insecticides: TN 111
=680  \\$iPlant-eating orthopterans having hindlegs adapted for jumping. There are two main families: Acrididae and Romaleidae. Some of the more common genera are: Melanoplus, the most common grasshopper; Conocephalus, the eastern meadow grasshopper; and Pterophylla, the true katydid.
=688  \\$a72; LOCUSTS was see under GRASSHOPPERS 1972-77
=750  \0$iNarrower mapping$aAtlanticus davisi$0(DLC)sh2021011947$4NM$5DNLM

=LDR  00974nz  a2200265n  4500
=001  9818556988506676
=005  20230306165734.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007341
=035  \\$a(DNLM)D007341
=035  \\$a(NLM)98195973650000041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x521.$x576
=150  \\$aInsurance
=450  \\$wnnna$aIndemnity
=450  \\$wnnna$aInsurance Premiums
=450  \\$wnnna$aInsurance Premium
=450  \\$wnnna$aPremium, Insurance
=450  \\$wnnna$aPremiums, Insurance
=667  \\$acoordinate with geographic term if pertinent
=680  \\$iCoverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency.
=750  \0$iNarrower mapping$aCyber insurance$0(DLC)sh2021006936$4NM$5DNLM
=750  \0$aInsurance$5IEN$0(DLC)sh 85066802

=LDR  02364nz  a2200673n  4500
=001  9818556988706676
=005  20230306162345.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D004467
=035  \\$a(DNLM)D004467
=035  \\$a(NLM)98198257680000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x261
=072  \\$aN3.$x219
=150  \\$aEconomics
=450  \\$wnnna$aCapital
=450  \\$wnnna$aConditions, Economic
=450  \\$wnnna$aConsumption
=450  \\$wnnna$aCost of Living
=450  \\$wnnna$aEasterlin Hypothesis
=450  \\$wnnna$aEconomic Conditions
=450  \\$wnnna$aEconomic Policies
=450  \\$wnnna$aEconomic Policy
=450  \\$wnnna$aEconomics, Home
=450  \\$wnnna$aHome Economics
=450  \\$wnnna$aHousehold Consumption
=450  \\$wnnna$aMacroeconomic Factors
=450  \\$wnnna$aMicroeconomic Factors
=450  \\$wnnna$aPolicies, Economic
=450  \\$wnnna$aPolicy, Economic
=450  \\$wnnna$aProduction
=450  \\$wnnna$aRemittances
=450  \\$wnnna$aUtility Theory
=450  \\$aConsumer Price Index
=450  \\$wnnna$aCondition, Economic
=450  \\$wnnna$aConsumer Price Indices
=450  \\$wnnna$aConsumption, Household
=450  \\$wnnna$aEconomic Condition
=450  \\$wnnna$aFactor, Macroeconomic
=450  \\$wnnna$aFactor, Microeconomic
=450  \\$wnnna$aFactors, Macroeconomic
=450  \\$wnnna$aFactors, Microeconomic
=450  \\$wnnna$aHousehold Consumptions
=450  \\$wnnna$aHypothesis, Easterlin
=450  \\$wnnna$aIndex, Consumer Price
=450  \\$wnnna$aIndices, Consumer Price
=450  \\$wnnna$aLiving Cost
=450  \\$wnnna$aLiving Costs
=450  \\$wnnna$aRemittance
=450  \\$wnnna$aTheories, Utility
=450  \\$wnnna$aTheory, Utility
=450  \\$wnnna$aUtility Theories
=667  \\$ageneral or unspecified only: prefer /econ; note ECONOMIC FACTORS and SOCIOECONOMIC FACTORS are available
=680  \\$iThe science of utilization, distribution, and consumption of services and materials.
=750  \0$iNarrower mapping$aCircular economy$0(DLC)sh2021015542$4NM$5DNLM
=750  \0$aEconomists$5IEN-M$0(DLC)sh 85040878
=750  \0$aEconomics$5IEN-HS$0(DLC)sh 85040850

=LDR  01003nz  a2200277n  4500
=001  9818556988906676
=005  20230306153126.0
=008  220712\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094462
=035  \\$a(DNLM)D000094462
=035  \\$a(NLM)9825515187800041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x915
=150  \\$aWildlife Trade
=450  \\$aWildlife Poaching
=450  \\$aWildlife Trafficking
=450  \\$wnnna$aPoaching, Wildlife
=450  \\$wnnna$aTrade, Wildlife
=450  \\$wnnna$aTrafficking, Wildlife
=450  \\$wnnna$aWildlife Poachings
=450  \\$wnnna$aWildlife Trades
=450  \\$wnnna$aWildlife Traffickings
=680  \\$iCommerce of non-domesticated WILD ANIMALS or plants. Wildlife trade, particularly illegal trades, threaten ECOSYSTEMS and drives up SPECIES EXTINCTION. It also increases chance of emerging ZOONOSES.
=688  \\$a2023
=750  \0$aWildlife trafficking$0(DLC)sh2021008179$5DNLM

=LDR  00732nz  a2200229n  4500
=001  9882234659502441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089083
=035  \\$a(DNLM)D000089083
=035  \\$a(NLM)9819990380600041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x104
=150  \\$aBody Odor
=450  \\$aBromhidrosis
=450  \\$wnnna$aBody Odors
=450  \\$wnnna$aBromhidroses
=450  \\$wnnna$aOdors, Body
=680  \\$iStrong or unusual odor related to the body. Occasional abnormal body odor may be a temporary effect of a metabolic change.
=688  \\$a2022
=750  \0$aBody odor$0(DLC)sh 96008470$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  00886nz  a2200229n  4500
=001  9882234659702441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089062
=035  \\$a(DNLM)D000089062
=035  \\$a(NLM)9819990381600041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x452.$x910.$x150
=150  \\$aBiosecurity
=450  \\$aBio-Security
=450  \\$wnnna$aBio Security
=550  \\$aCommunicable Disease Control
=550  \\$aContainment of Biohazards
=680  \\$iInstitutional and personal security measures designed to prevent the loss, theft, misuse, diversion or intentional release of pathogens and toxins.(from https://www.who.int/influenza/pip/BiosecurityandBiosafety_EN_20Mar2018.pdf February,24, 2021)
=688  \\$a2022
=750  \0$aBiosecurity$0(DLC)sh2010001971$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01711nz  a2200505n  4500
=001  9882234659902441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088684
=035  \\$a(DNLM)D000088684
=035  \\$a(NLM)9819990107000041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x937.$x500.$x300
=150  \\$aAutonomous Vehicles
=450  \\$aAutomated Vehicles
=450  \\$aDriverless Vehicles
=450  \\$aSelf-Controlled Vehicles
=450  \\$aSelf-Driving Cars
=450  \\$aSelf-Driving Vehicles
=450  \\$wnnna$aAutomated Vehicle
=450  \\$wnnna$aAutonomous Vehicle
=450  \\$wnnna$aCar, Self-Driving
=450  \\$wnnna$aCars, Self-Driving
=450  \\$wnnna$aDriverless Vehicle
=450  \\$wnnna$aSelf Controlled Vehicles
=450  \\$wnnna$aSelf Driving Cars
=450  \\$wnnna$aSelf Driving Vehicles
=450  \\$wnnna$aSelf-Controlled Vehicle
=450  \\$wnnna$aSelf-Driving Car
=450  \\$wnnna$aSelf-Driving Vehicle
=450  \\$wnnna$aVehicle, Automated
=450  \\$wnnna$aVehicle, Autonomous
=450  \\$wnnna$aVehicle, Driverless
=450  \\$wnnna$aVehicle, Self-Controlled
=450  \\$wnnna$aVehicle, Self-Driving
=450  \\$wnnna$aVehicles, Automated
=450  \\$wnnna$aVehicles, Autonomous
=450  \\$wnnna$aVehicles, Driverless
=450  \\$wnnna$aVehicles, Self-Controlled
=450  \\$wnnna$aVehicles, Self-Driving
=667  \\$aself-driving cars: coordinate with AUTOMOBILES
=680  \\$iVehicles controlled by automatic directions and instructions.
=688  \\$a2022
=750  \0$aAutomated vehicles$0(DLC)sh2014001434$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01188nz  a2200361n  4500
=001  9882234660102441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088543
=035  \\$a(DNLM)D000088543
=035  \\$a(NLM)9819990298600041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x779.$x492.$x250
=072  \\$aE2.$x831.$x535.$x492.$x250
=150  \\$aAquatic Therapy
=450  \\$aAi Chi Therapy
=450  \\$aAquatic Exercise Therapy
=450  \\$aPool Therapy
=450  \\$aWater Exercise Therapy
=450  \\$aWater Tai Chi Therapy
=450  \\$wnnna$aExercise Therapy, Aquatic
=450  \\$wnnna$aExercise Therapy, Water
=450  \\$wnnna$aTherapies, Ai Chi
=450  \\$wnnna$aTherapy, Ai Chi
=450  \\$wnnna$aTherapy, Aquatic
=450  \\$wnnna$aTherapy, Aquatic Exercise
=450  \\$wnnna$aTherapy, Pool
=450  \\$wnnna$aTherapy, Water Exercise
=550  \\$aBalneology
=680  \\$iPhysical therapy administered while the body is immersed in an aquatic environment.
=688  \\$a2022
=750  \0$aAquatic exercises{dollar}xTherapeutic use$0(DLC)sh2003008311$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  00787nz  a2200205n  4500
=001  9882234660302441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089882
=035  \\$a(DNLM)D000089882
=035  \\$a(NLM)9819990334300041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x66
=150  \\$aAntimicrobial Peptides
=450  \\$aAntimicrobial Peptide
=450  \\$wnnna$aPeptide, Antimicrobial
=680  \\$iSmall peptides that play an important role in early innate and induced defenses against invading microbes. Most have positive overall charges and are referred to as cationic antimicrobial peptides.
=688  \\$a2022(2021)
=750  \0$aPeptide antibiotics$0(DLC)sh 95005451$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01878nz  a2200553n  4500
=001  9882234660502441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087602
=035  \\$a(DNLM)D000087602
=035  \\$a(NLM)9819990129300041
=040  \\$aDNLM$cDNLM
=072  \\$aG16.$x500.$x75
=150  \\$aAnthropogenic Effects
=450  \\$aAnthropogenic Activities
=450  \\$aAnthropogenic Disturbance
=450  \\$aAnthropogenic Effect
=450  \\$aAnthropogenic Factors
=450  \\$aAnthropogenic Impact
=450  \\$aAnthropogenic Impacts
=450  \\$aAnthropogenic Pressure
=450  \\$aAnthropogenic Pressures
=450  \\$aAnthropogenic Stressor
=450  \\$aAnthropogenic Stressors
=450  \\$aHuman Impact
=450  \\$aHuman Impacts
=450  \\$wnnna$aActivities, Anthropogenic
=450  \\$wnnna$aActivity, Anthropogenic
=450  \\$wnnna$aAnthropogenic Activity
=450  \\$wnnna$aAnthropogenic Disturbances
=450  \\$wnnna$aAnthropogenic Factor
=450  \\$wnnna$aDisturbance, Anthropogenic
=450  \\$wnnna$aDisturbances, Anthropogenic
=450  \\$wnnna$aEffect, Anthropogenic
=450  \\$wnnna$aEffects, Anthropogenic
=450  \\$wnnna$aFactor, Anthropogenic
=450  \\$wnnna$aFactors, Anthropogenic
=450  \\$wnnna$aImpact, Anthropogenic
=450  \\$wnnna$aImpact, Human
=450  \\$wnnna$aImpacts, Anthropogenic
=450  \\$wnnna$aImpacts, Human
=450  \\$wnnna$aPressure, Anthropogenic
=450  \\$wnnna$aPressures, Anthropogenic
=450  \\$wnnna$aStressor, Anthropogenic
=450  \\$wnnna$aStressors, Anthropogenic
=680  \\$iEnvironmental alterations resulting from human activities.
=688  \\$a2022
=750  \0$aNature{dollar}xEffect of human beings on$0(DLC)sh 85080299$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01298nz  a2200325n  4500
=001  9882234660702441
=005  20230623132541.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091122
=035  \\$a(DNLM)D000091122
=035  \\$a(NLM)9819990587100041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x250
=150  \\$aAfrotheria
=450  \\$aAfrotheres
=450  \\$aAfrotherian Mammals
=450  \\$aChrysochloridae
=450  \\$aElephant Shrews
=450  \\$aGolden Moles
=450  \\$aMacroscelidea
=450  \\$wnnna$aAfrotherian Mammal
=450  \\$wnnna$aElephant Shrew
=450  \\$wnnna$aGolden Mole
=450  \\$wnnna$aMammal, Afrotherian
=450  \\$wnnna$aMole, Golden
=450  \\$wnnna$aShrew, Elephant
=680  \\$iA placental mammal superorder that contains ELEPHANTS; MANATEES; DUGONGS; SIRENIANS; HYRAXES; AARDVARKS; elephant shrews (Macroscelidea); TENRECS; Golden moles (Chrysochloridae). Largely classified based on DNA sequence afrotherian mammals are diverse in morphology but share some common anatomical features (e.g., appearance of four‐lobed ALLANTOIS and long and mobile snout).
=688  \\$a2022
=750  \0$aAfrotherians$0(DLC)sh2003004654$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01087cz  a2200349n  4500
=001  9882234662602441
=005  20230623132540.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088662
=035  \\$a(DNLM)D000088662
=035  \\$a(NLM)9819990392700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x620.$x630.$x100
=150  \\$aAdolescent Mothers
=450  \\$aAdolescent Motherhood
=450  \\$aTeen Mothers
=450  \\$aTeenage Mothers
=450  \\$wnnna$aAdolescent Mother
=450  \\$wnnna$aMother, Adolescent
=450  \\$wnnna$aMother, Teen
=450  \\$wnnna$aMother, Teenage
=450  \\$wnnna$aMotherhood, Adolescent
=450  \\$wnnna$aMothers, Adolescent
=450  \\$wnnna$aMothers, Teen
=450  \\$wnnna$aMothers, Teenage
=450  \\$wnnna$aTeen Mother
=450  \\$wnnna$aTeenage Mother
=667  \\$ahuman only
=680  \\$iMothers aged less than 19 years at the time of child's conception or birth.
=688  \\$a2022
=750  \0$aTeenage mothers$0(DLC)sh 85000964$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01382cz  a2200433n  4500
=001  9882234662802441
=005  20230623132540.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089122
=035  \\$a(DNLM)D000089122
=035  \\$a(NLM)9819990380400041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x875.$x100.$x500
=072  \\$aI1.$x880.$x853.$x150.$x688.$x210.$x500
=072  \\$aM1.$x620.$x390.$x500
=150  \\$aAdolescent Fathers
=450  \\$aAdolescent Fatherhood
=450  \\$aTeen Fathers
=450  \\$aTeenage Fathers
=450  \\$aTeenager Fathers
=450  \\$wnnna$aAdolescent Father
=450  \\$wnnna$aAdolescent Fatherhoods
=450  \\$wnnna$aFather, Adolescent
=450  \\$wnnna$aFather, Teen
=450  \\$wnnna$aFather, Teenage
=450  \\$wnnna$aFather, Teenager
=450  \\$wnnna$aFatherhood, Adolescent
=450  \\$wnnna$aFathers, Adolescent
=450  \\$wnnna$aFathers, Teen
=450  \\$wnnna$aFathers, Teenage
=450  \\$wnnna$aFathers, Teenager
=450  \\$wnnna$aTeen Father
=450  \\$wnnna$aTeenage Father
=450  \\$wnnna$aTeenager Father
=667  \\$ahuman only
=680  \\$iFathers initially aged less than 19 years at the time of child's birth.
=688  \\$a2022
=750  \0$aTeenage fathers$0(DLC)sh 86002364$5IEN-M
=930  \\$aMeSH Mapping gwn 20230621

=LDR  01301nz  a2200253n  4500
=001  9882234663002441
=005  20230622134225.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089183
=035  \\$a(DNLM)D000089183
=035  \\$a(NLM)9819990371500041
=040  \\$aDNLM$cDNLM
=072  \\$aC5.$x116.$x900.$x853.$x625.$x800.$x744
=072  \\$aC5.$x550.$x69.$x340
=072  \\$aC5.$x550.$x114.$x865.$x800.$x744
=150  \\$aAxial Spondyloarthritis
=450  \\$aAxSpA
=450  \\$wnnna$aAxial Spondyloarthritides
=450  \\$wnnna$aSpondyloarthritides, Axial
=450  \\$wnnna$aSpondyloarthritis, Axial
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iA spectrum of chronic inflammatory conditions affecting the axial joints (e.g., SPINE), characterized by pain, stiffness of joints (ANKYLOSIS), reduced mobility and inflammation. When joint inflammation and damage are visible on regular X-rays it is called ANKYLOSING SPONDYLITIS; otherwise it is referred to as NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS. HLA-B27 ANTIGEN is a biomarker and IL-23/IL-17 pathway a potential therapeutic target for axial and other related spondyloarthritis.
=688  \\$a2022
=750  \0$iBroader mapping$aSpondyloarthropathies$0(DLC)sh 85126847$4BM$5IEN-M

=LDR  00920cz  a2200217n  4500
=001  9882234663102441
=005  20230622134004.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089582
=035  \\$a(DNLM)D000089582
=035  \\$a(NLM)9819990365600041
=040  \\$aDNLM$cDNLM
=072  \\$aD26.$x650.$x64.$x500
=072  \\$aD27.$x505.$x696.$x477.$x67.$x500
=072  \\$aD27.$x720.$x744.$x64.$x500
=150  \\$aAdjuvants, Vaccine
=450  \\$aVaccine Adjuvant
=450  \\$aVaccine Adjuvants
=680  \\$iSubstances consisting of different components, e.g. aluminum salts, EMULSIONS such as MF59 and AS03, Toll-like receptor (TLR) agonist or combinations of IMMUNOPOTENTIATORS (QS-21 and MPL in AS01), that helps increase the magnitude of an ADAPTIVE IMMUNE RESPONSE to a VACCINE.
=688  \\$a2022
=750  \0$iBroader mapping$aImmunological adjuvants$0(DLC)sh 85000895$4BM$5IEN-M

=LDR  00748nz  a2200181n  4500
=001  9882234663202441
=005  20230622133657.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090043
=035  \\$a(DNLM)D000090043
=035  \\$a(NLM)9819990308800041
=040  \\$aDNLM$cDNLM
=072  \\$aA1.$x923.$x112
=150  \\$aAbdominal Core
=450  \\$wnnna$aCore, Abdominal
=680  \\$iThe torso region located deep within the abdominal area involved in attaching the TORSO to the SPINE and the PELVIC FLOOR. Muscles in the abdominal core are important in POSTURAL BALANCE, spine stability and protection against BACK INJURIES.
=688  \\$a2022
=750  \0$iBroader mapping$aTorso (Anatomy)$0(DLC)sh2021004182$4BM$5IEN-M

=LDR  01596cz  a2200505n  4500
=001  9882234663302441
=005  20230622133148.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090982
=035  \\$a(DNLM)D000090982
=035  \\$a(NLM)9819990440100041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x828.$x868.$x228.$x500.$x750
=072  \\$aD20.$x215.$x894.$x865.$x450.$x500.$x750
=072  \\$aD20.$x215.$x894.$x899.$x85.$x500
=072  \\$aD23.$x50.$x865.$x450.$x500.$x750
=150  \\$aBNT162 Vaccine
=450  \\$aAbdavomeran
=450  \\$aBNT-162A1
=450  \\$aBNT-162B1
=450  \\$aBNT-162B2
=450  \\$aBNT-162C2
=450  \\$aBNT162A1
=450  \\$aBNT162B1
=450  \\$aBNT162B2
=450  \\$aBNT162C2
=450  \\$aCOVID-19 Vaccine Pfizer-BioNTech
=450  \\$aComirnaty
=450  \\$aPfizer Covid-19 Vaccine
=450  \\$aPidacmeran
=450  \\$aTozinameran
=450  \\$wnnna$aBNT 162A1
=450  \\$wnnna$aBNT 162B1
=450  \\$wnnna$aBNT 162B2
=450  \\$wnnna$aBNT 162C2
=450  \\$wnnna$aCOVID 19 Vaccine Pfizer BioNTech
=450  \\$wnnna$aCovid-19 Vaccine, Pfizer
=450  \\$wnnna$aPfizer Covid 19 Vaccine
=450  \\$wnnna$aPfizer-BioNTech, COVID-19 Vaccine
=450  \\$wnnna$aVaccine Pfizer-BioNTech, COVID-19
=450  \\$wnnna$aVaccine, BNT162
=450  \\$wnnna$aVaccine, Pfizer Covid-19
=680  \\$imRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech.
=688  \\$a2022(2021)
=750  \0$iBroader mapping$aCOVID-19 vaccines$0(DLC)sh2022005580$4BM$5IEN-M

=LDR  00970cz  a2200265n  4500
=001  9882234663402441
=005  20230622133235.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090984
=035  \\$a(DNLM)D000090984
=035  \\$a(NLM)9819990429500041
=040  \\$aDNLM$cDNLM
=072  \\$aD20.$x215.$x894.$x899.$x85.$x125
=150  \\$aAd26COVS1
=450  \\$wnnna$aAd26.COV2.S
=450  \\$wnnna$aJNJ 78436735
=450  \\$wnnna$aJNJ-78436735
=450  \\$aCOVID-19 Vaccine Johnson & Johnson
=450  \\$aJohnson & Johnson Covid-19 Vaccine
=450  \\$wnnna$aCOVID 19 Vaccine Johnson & Johnson
=450  \\$wnnna$aJNJ78436735
=450  \\$wnnna$aJohnson & Johnson Covid 19 Vaccine
=680  \\$iA viral vector vaccine  designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
=688  \\$a2022
=750  \0$iBroader mapping$aCOVID-19 vaccines$0(DLC)sh2022005580$4BM$5IEN-M

=LDR  01667cz  a2200517n  4500
=001  9882234663502441
=005  20230622133429.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090983
=035  \\$a(DNLM)D000090983
=035  \\$a(NLM)9819990437300041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x828.$x868.$x228.$x500.$x500
=072  \\$aD20.$x215.$x894.$x865.$x450.$x500.$x500
=072  \\$aD20.$x215.$x894.$x899.$x85.$x250
=072  \\$aD23.$x50.$x865.$x450.$x500.$x500
=150  \\$a2019-nCoV Vaccine mRNA-1273
=450  \\$aCOVID-19 Vaccine Moderna
=450  \\$aCX-024414
=450  \\$aElasomeran
=450  \\$aM-1273
=450  \\$aModerna COVID-19 Vaccine
=450  \\$aModerna COVID-19 Vaccine RNA
=450  \\$aSpikevax
=450  \\$aTAK-919
=450  \\$amRNA-1273
=450  \\$amRNA-1273.211
=450  \\$wnnna$a2019 nCoV Vaccine mRNA 1273
=450  \\$wnnna$aCOVID 19 Vaccine Moderna
=450  \\$wnnna$aCOVID-19 Vaccine, Moderna
=450  \\$wnnna$aCX 024414
=450  \\$wnnna$aCX024414
=450  \\$wnnna$aM 1273
=450  \\$wnnna$aM1273
=450  \\$wnnna$aModerna COVID 19 Vaccine
=450  \\$wnnna$aModerna COVID 19 Vaccine RNA
=450  \\$wnnna$aModerna, COVID-19 Vaccine
=450  \\$wnnna$aTAK 919
=450  \\$wnnna$aTAK919
=450  \\$wnnna$aVaccine, Moderna COVID-19
=450  \\$wnnna$amRNA 1273
=450  \\$wnnna$amRNA 1273.211
=450  \\$wnnna$amRNA-1273, 2019-nCoV Vaccine
=680  \\$imRNA vaccine against SARS-CoV-2 developed by Moderna.
=688  \\$a2022(2021)
=750  \0$iBroader mapping$aCOVID-19 vaccines$0(DLC)sh2022005580$4BM$5IEN-M

=LDR  01529nz  a2200409n  4500
=001  9882256885802441
=005  20230831114157.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D057026
=035  \\$a(DNLM)D057026
=035  \\$a(NLM)98198016910000041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x872.$x40.$x500
=072  \\$aA11.$x872.$x700.$x500
=150  \\$aInduced Pluripotent Stem Cells
=450  \\$wnnna$aFibroblast-Derived IPS Cells
=450  \\$wnnna$aFibroblast-Derived Induced Pluripotent Stem Cells
=450  \\$wnnna$aHuman Induced Pluripotent Stem Cells
=450  \\$wnnna$ahiPSC
=450  \\$aHuman Induced Pluripotent Stem Cell
=450  \\$aIPS Cell
=450  \\$aIPS Cells
=450  \\$aInduced Pluripotent Stem Cell
=450  \\$wnnna$aCell, Fibroblast-Derived IPS
=450  \\$wnnna$aCell, IPS
=450  \\$wnnna$aCells, Fibroblast-Derived IPS
=450  \\$wnnna$aCells, IPS
=450  \\$wnnna$aFibroblast Derived IPS Cells
=450  \\$wnnna$aFibroblast Derived Induced Pluripotent Stem Cells
=450  \\$wnnna$aFibroblast-Derived IPS Cell
=450  \\$wnnna$aIPS Cell, Fibroblast-Derived
=450  \\$wnnna$aIPS Cells, Fibroblast-Derived
=550  \\$aCellular Reprogramming
=680  \\$iCells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.
=688  \\$a2010
=750  \0$aInduced pluripotent stem cells    $0(DLC)sh2022007604$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  01150nz  a2200277n  4500
=001  9882256886002441
=005  20230831114157.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005877
=035  \\$a(DNLM)D005877
=035  \\$a(NLM)98196896310000041
=040  \\$aDNLM$cDNLM
=060  \0$aWK 550
=072  \\$aC5.$x116.$x99.$x492
=072  \\$aC5.$x116.$x132.$x479
=072  \\$aC19.$x700.$x355.$x528
=150  \\$aGigantism
=450  \\$wnnna$aPituitary Gigantism
=450  \\$wnnna$aGigantism, Pituitary
=550  \\$aAdenoma, Acidophil
=550  \\$aBeckwith-Wiedemann Syndrome
=550  \\$aGrowth Disorders
=550  \\$aSotos Syndrome
=680  \\$iThe condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.
=750  \0$aGigantism$0(DLC)sh2022007439$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  01014nz  a2200253n  4500
=001  9882256886202441
=005  20230831114157.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D046912
=035  \\$a(DNLM)D046912
=035  \\$a(NLM)98198739900000041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x500
=150  \\$aMultiprotein Complexes
=450  \\$wnnna$aMacromolecular Protein Complexes
=450  \\$wnnna$aComplexes, Macromolecular Protein
=450  \\$wnnna$aComplexes, Multiprotein
=450  \\$wnnna$aProtein Complexes, Macromolecular
=550  \\$aProtein Structure, Quaternary
=667  \\$ageneral only; do not use as a routine coordinate with specific multiprotein complexes; MULTIENZYME COMPLEXES is also available
=680  \\$iMacromolecular complexes formed from the association of defined protein subunits.
=688  \\$a2005; use MACROMOLECULAR SUBSTANCES 1966-2004
=750  \0$aProtein complexes $0(DLC)sh2022007451$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  00839nz  a2200229n  4500
=001  9882256886402441
=005  20230831114157.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000074823
=035  \\$a(DNLM)D000074823
=035  \\$a(NLM)9810901174000041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 30.7
=072  \\$aN1.$x400.$x530
=150  \\$aOne Health
=450  \\$wnnna$aOne Health Concept
=450  \\$wnnna$aOne Health Initiative
=450  \\$wnnna$aOne Medicine Initiative
=680  \\$iAn integrative effort of multiple disciplines working collaboratively and locally, nationally, and globally in all aspects of health care for humans, animals, and the environment.
=688  \\$a2018; use GLOBAL HEALTH 2017
=750  \0$aOne health$0(DLC)sh2022007178$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  00994nz  a2200241n  4500
=001  9882256886602441
=005  20230831114157.0
=008  170711\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000074386
=035  \\$a(DNLM)D000074386
=035  \\$a(NLM)9810901125900041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x856.$x463
=150  \\$aGender-Based Violence
=450  \\$aDowry Death
=450  \\$wnnna$aDeath, Dowry
=450  \\$wnnna$aDowry Deaths
=450  \\$wnnna$aGender Based Violence
=450  \\$wnnna$aViolence, Gender-Based
=680  \\$iViolence based on gender that results in, or is likely to result in, physical, sexual or mental harm or suffering, including threats of such acts, coercion or arbitrary deprivation of liberty, whether occurring in public or in private life. (From www.who.int/topics/gender_based_violence/en/)
=688  \\$a2018
=750  \0$aGender-based violence$0(DLC)sh2022007765$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  02405nz  a2200541n  4500
=001  9882256887002441
=005  20230831114157.0
=008  100625\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D059014
=035  \\$a(DNLM)D059014
=035  \\$a(NLM)98196565240000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x393.$x760.$x319
=150  \\$aHigh-Throughput Nucleotide Sequencing
=450  \\$wnnna$aDeep Sequencing
=450  \\$wnnna$aHigh-Throughput DNA Sequencing
=450  \\$wnnna$aHigh-Throughput RNA Sequencing
=450  \\$wnnna$aMassively-Parallel Sequencing
=450  \\$wnnna$aPyrosequencing
=450  \\$aHigh-Throughput Sequencing
=450  \\$aIllumina Sequencing
=450  \\$aIon Proton Sequencing
=450  \\$aIon Torrent Sequencing
=450  \\$aNext-Generation Sequencing
=450  \\$wnnna$aDNA Sequencing, High-Throughput
=450  \\$wnnna$aHigh Throughput DNA Sequencing
=450  \\$wnnna$aHigh Throughput Nucleotide Sequencing
=450  \\$wnnna$aHigh Throughput RNA Sequencing
=450  \\$wnnna$aHigh Throughput Sequencing
=450  \\$wnnna$aMassively Parallel Sequencing
=450  \\$wnnna$aNext Generation Sequencing
=450  \\$wnnna$aNucleotide Sequencing, High-Throughput
=450  \\$wnnna$aRNA Sequencing, High-Throughput
=450  \\$wnnna$aSequencing, Deep
=450  \\$wnnna$aSequencing, High-Throughput
=450  \\$wnnna$aSequencing, High-Throughput DNA
=450  \\$wnnna$aSequencing, High-Throughput Nucleotide
=450  \\$wnnna$aSequencing, High-Throughput RNA
=450  \\$wnnna$aSequencing, Illumina
=450  \\$wnnna$aSequencing, Ion Proton
=450  \\$wnnna$aSequencing, Ion Torrent
=450  \\$wnnna$aSequencing, Massively-Parallel
=450  \\$wnnna$aSequencing, Next-Generation
=667  \\$acoordinate with SEQUENCE ANALYSIS, DNA or SEQUENCE ANALYSIS, RNA
=680  \\$iTechniques of nucleotide sequence analysis that increase the range, complexity, sensitivity, and accuracy of results by greatly increasing the scale of operations and thus the number of nucleotides, and the number of copies of each nucleotide sequenced. The sequencing may be done by analysis of the synthesis or ligation products, hybridization to preexisting sequences, etc.
=688  \\$a2011
=750  \0$aHigh-throughput nucleotide sequencing$0(DLC)sh2022006367$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  00819nz  a2200241n  4500
=001  9882256887202441
=005  20230831114154.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012768
=035  \\$a(DNLM)D012768
=035  \\$a(NLM)98196627390000041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x110.$x232.$x778.$x500
=072  \\$aG7.$x410.$x421.$x778.$x500
=072  \\$aG16.$x12.$x500.$x535.$x778.$x500
=150  \\$aShivering
=450  \\$wnnna$aShiverings
=550  \\$aCold Temperature
=550  \\$aChills
=680  \\$iInvoluntary contraction or twitching of the muscles. It is a physiologic method of heat production in man and other mammals.
=688  \\$a70(64)
=750  \0$aShivering (Physiological effect)   $0(DLC)sh2022006596$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  00571nz  a2200205n  4500
=001  9882256887402441
=005  20230831114157.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086722
=035  \\$a(DNLM)D000086722
=035  \\$a(NLM)9817068006500041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x888.$x852.$x834
=150  \\$aRhinorrhea
=450  \\$aRunny Nose
=450  \\$wnnna$aNose, Runny
=680  \\$iExcess nasal drainage.
=688  \\$a2021
=750  \0$aRunny nose$0(DLC)sh2022006211$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  01217nz  a2200325n  4500
=001  9882256887602441
=005  20230831114157.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000080037
=035  \\$a(DNLM)D000080037
=035  \\$a(NLM)9812405753500041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x830.$x900.$x500
=072  \\$aF3.$x950.$x750.$x375.$x500
=150  \\$aHistorical Trauma
=450  \\$aHistoric Trauma
=450  \\$aHistorical Psychological Trauma
=450  \\$aIntergenerational Trauma
=450  \\$aTransgenerational Trauma
=450  \\$wnnna$aHistorical Traumas
=450  \\$wnnna$aPsychological Trauma, Historical
=450  \\$wnnna$aTransgenerational Traumas
=450  \\$wnnna$aTrauma, Historical
=450  \\$wnnna$aTrauma, Intergenerational
=450  \\$wnnna$aTrauma, Transgenerational
=450  \\$wnnna$aTraumas, Transgenerational
=680  \\$iClinical distress among descendants of survivors of mass trauma, as if they had suffered through the same extreme historic circumstances. Symptoms may persist through generations.
=688  \\$a2020
=750  \0$aGenerational Trauma$0(DLC)sh2022006359$5IEN-M
=930  \\$aMeSH Mapping NLM 20230831

=LDR  03993nz  a2200985n  4500
=001  9882256872302441
=005  20230901101309.0
=008  220713\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095083
=035  \\$a(DNLM)D000095083
=035  \\$a(NLM)9825515501500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x882
=072  \\$aN2.$x360.$x858
=150  \\$aTraditional Medicine Practitioners
=450  \\$aAfrican Witch Doctor
=450  \\$aAlternative Medicine Practitioners
=450  \\$aCAM Practitioners
=450  \\$aComplementary Health Practitioners
=450  \\$aComplementary Medicine Practitioners
=450  \\$aComplementary and Alternative Medicine Practitioners
=450  \\$aEthnobotanists
=450  \\$aHerbalists
=450  \\$aIndigenous Medicine Practitioners
=450  \\$aMedicine Men
=450  \\$aPhytotherapists
=450  \\$aShaman
=450  \\$aShamans
=450  \\$aTraditional Healers
=450  \\$aTraditional Health Practitioners
=450  \\$aWitch Doctor, African
=450  \\$wnnna$aAfrican Witch Doctors
=450  \\$wnnna$aAlternative Medicine Practitioner
=450  \\$wnnna$aCAM Practitioner
=450  \\$wnnna$aComplementary Health Practitioner
=450  \\$wnnna$aComplementary Medicine Practitioner
=450  \\$wnnna$aDoctor, African Witch
=450  \\$wnnna$aDoctors, African Witch
=450  \\$wnnna$aEthnobotanist
=450  \\$wnnna$aHealer, Traditional
=450  \\$wnnna$aHealers, Traditional
=450  \\$wnnna$aHealth Practitioner, Complementary
=450  \\$wnnna$aHealth Practitioner, Traditional
=450  \\$wnnna$aHealth Practitioners, Complementary
=450  \\$wnnna$aHealth Practitioners, Traditional
=450  \\$wnnna$aHerbalist
=450  \\$wnnna$aIndigenous Medicine Practitioner
=450  \\$wnnna$aMedicine Mens
=450  \\$wnnna$aMedicine Practitioner, Alternative
=450  \\$wnnna$aMedicine Practitioner, Complementary
=450  \\$wnnna$aMedicine Practitioner, Indigenous
=450  \\$wnnna$aMedicine Practitioner, Traditional
=450  \\$wnnna$aMedicine Practitioners, Alternative
=450  \\$wnnna$aMedicine Practitioners, Complementary
=450  \\$wnnna$aMedicine Practitioners, Indigenous
=450  \\$wnnna$aMedicine Practitioners, Traditional
=450  \\$wnnna$aMen, Medicine
=450  \\$wnnna$aMens, Medicine
=450  \\$wnnna$aPhytotherapist
=450  \\$wnnna$aPractitioner, Alternative Medicine
=450  \\$wnnna$aPractitioner, CAM
=450  \\$wnnna$aPractitioner, Complementary Health
=450  \\$wnnna$aPractitioner, Complementary Medicine
=450  \\$wnnna$aPractitioner, Indigenous Medicine
=450  \\$wnnna$aPractitioner, Traditional Health
=450  \\$wnnna$aPractitioner, Traditional Medicine
=450  \\$wnnna$aPractitioners, Alternative Medicine
=450  \\$wnnna$aPractitioners, CAM
=450  \\$wnnna$aPractitioners, Complementary Health
=450  \\$wnnna$aPractitioners, Complementary Medicine
=450  \\$wnnna$aPractitioners, Indigenous Medicine
=450  \\$wnnna$aPractitioners, Traditional Health
=450  \\$wnnna$aPractitioners, Traditional Medicine
=450  \\$wnnna$aTraditional Healer
=450  \\$wnnna$aTraditional Health Practitioner
=450  \\$wnnna$aTraditional Medicine Practitioner
=450  \\$wnnna$aWitch Doctors, African
=550  \\$aPhytotherapy
=550  \\$aMedicine, Traditional
=550  \\$aMedicine, African Traditional
=550  \\$aShamanism
=550  \\$aHerbal Medicine
=680  \\$iHealth personnel using systems of medicine based on cultural beliefs and practices handed down from generation to generation, including mystical and magical rituals (SPIRITUAL THERAPIES); TRADITIONAL MEDICINE; PHYTOTHERAPY; HERBAL MEDICINE; and other treatments which may not be explained by modern medicine.
=688  \\$a2023
=750  \0$iNarrower mapping$aTraiteurs (Healers)$0(DLC)sh2022006939$4NM$5IEN-M

=LDR  00623cz  a2200181n  4500
=001  9882256879202441
=005  20230831165751.0
=008  190708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000080503
=035  \\$a(DNLM)D000080503
=035  \\$a(NLM)9812406001300041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x462.$x500.$x682.$x192.$x459
=150  \\$aFictional Works as Topic
=667  \\$ado not confuse with the Publication Type FICTIONAL WORK
=680  \\$iWorks about creative writing, not presented as factual.
=688  \\$a2020
=750  \0$iNarrower mapping$aNukna fiction$0(DLC)sh2022007110$4NM$5IEN-M

=LDR  02170nz  a2200553n  4500
=001  9882256884702441
=005  20251118144848.0
=008  220712\n\ancnnbabn\\\D000094855
\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094855
=035  \\$a(DNLM)D000094855
=035  \\$a(NLM)9825515517200041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x445.$x500
=150  \\$aEastern European People
=450  \\$aEast European People
=450  \\$aEast European Person
=450  \\$aEast Europeans
=450  \\$aEastern European Person
=450  \\$aEastern Europeans
=450  \\$aSlavic People
=450  \\$aSlavic Peoples
=450  \\$wnnna$aEast European Peoples
=450  \\$wnnna$aEast European Persons
=450  \\$wnnna$aEastern European Peoples
=450  \\$wnnna$aEastern European Persons
=450  \\$wnnna$aEuropean People, East
=450  \\$wnnna$aEuropean People, Eastern
=450  \\$wnnna$aEuropean Peoples, East
=450  \\$wnnna$aEuropean Peoples, Eastern
=450  \\$wnnna$aEuropean Person, East
=450  \\$wnnna$aEuropean Person, Eastern
=450  \\$wnnna$aEuropean Persons, East
=450  \\$wnnna$aEuropean Persons, Eastern
=450  \\$wnnna$aEuropean, East
=450  \\$wnnna$aEuropean, Eastern
=450  \\$wnnna$aEuropeans, East
=450  \\$wnnna$aEuropeans, Eastern
=450  \\$wnnna$aPeople, East European
=450  \\$wnnna$aPeople, Eastern European
=450  \\$wnnna$aPeople, Slavic
=450  \\$wnnna$aPerson, East European
=450  \\$wnnna$aPerson, Eastern European
=450  \\$wnnna$aPersons, East European
=450  \\$wnnna$aPersons, Eastern European
=680  \\$iPeople native to or inhabitants of EASTERN EUROPE including ALBANIA; BOSNIA AND HERZEGOVINA; BULGARIA; CROATIA; CZECH REPUBLIC; ESTONIA; HUNGARY; KOSOVO; LATVIA; LITHUANIA; MOLDOVA; MONTENEGRO; POLAND; REPUBLIC OF NORTH MACEDONIA; REPUBLIC OF BELARUS; ROMANIA; RUSSIA; SERBIA; SLOVAKIA; SLOVENIA; and UKRAINE.
=688  \\$a2023
=750  \0$iNarrower mapping$aAdjarians$0(DLC)sh2022006306$4NM$5IEN-M$0(DLC)sh 85040551$5IEN-M
=750  \0$aEast Europeans$0(DLC)sh 85040551$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  00982cz  a2200229n  4500
=001  9882294809302441
=005  20231031104436.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090542
=035  \\$a(DNLM)D000090542
=035  \\$a(NLM)9819990473000041
=040  \\$aDNLM$cDNLM
=072  \\$aC16.$x320.$x565.$x398.$x481.$x500
=072  \\$aC18.$x452.$x584.$x500.$x500.$x644.$x475.$x500
=072  \\$aC18.$x452.$x584.$x563.$x481.$x500
=072  \\$aC18.$x452.$x648.$x398.$x481.$x500
=150  \\$aHomozygous Familial Hypercholesterolemia
=450  \\$aHoFH
=450  \\$wnnna$aHypercholesterolemias, Homozygous Familial
=680  \\$iA rare inherited genetic disorder, one form of HYPERLIPOPROTEINEMIA TYPE II, characterized by high level of LOW-DENSITY LIPOPROTEIN (LDL) which if not treated could elevate the chance of heart attack at an early age.
=688  \\$a2022
=750  \0$iBroader mapping$aHyperlipoproteinemia$0(DLC)sh 85063707$4BM$5IEN-M

=LDR  02880nz  a2200757n  4500
=001  9882294809502441
=005  20231031104217.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088302
=035  \\$a(DNLM)D000088302
=035  \\$a(NLM)9819990110000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x860.$x375.$x500
=072  \\$aM1.$x860.$x400.$x500
=150  \\$aHIV Non-Progressors
=450  \\$wnnna$aHIV Nonprogressors
=450  \\$wnnna$aHIV-1 Non-Progressors
=450  \\$wnnna$aHIV-1 Nonprogressors
=450  \\$aHIV Controllers
=450  \\$aHIV Elite Controllers
=450  \\$aHIV Infected Long-Term Non-Progressors
=450  \\$aHIV Infected Viremic Controllers
=450  \\$aHIV Long-Term Nonprogressors
=450  \\$aHIV Viremic Controllers
=450  \\$aHIV+ Long-Term Non-Progressors
=450  \\$aHIV-1 Infected Viremic Controllers
=450  \\$aHIV-1 Long-Term Nonprogressors
=450  \\$wnnna$aController, HIV Viremic
=450  \\$wnnna$aElite Controller, HIV
=450  \\$wnnna$aElite Controllers, HIV
=450  \\$wnnna$aHIV 1 Infected Viremic Controllers
=450  \\$wnnna$aHIV 1 Long Term Nonprogressors
=450  \\$wnnna$aHIV 1 Non Progressors
=450  \\$wnnna$aHIV 1 Nonprogressors
=450  \\$wnnna$aHIV Controller
=450  \\$wnnna$aHIV Elite Controller
=450  \\$wnnna$aHIV Infected Long Term Non Progressors
=450  \\$wnnna$aHIV Long Term Nonprogressors
=450  \\$wnnna$aHIV Long-Term Nonprogressor
=450  \\$wnnna$aHIV Non Progressors
=450  \\$wnnna$aHIV Non-Progressor
=450  \\$wnnna$aHIV Nonprogressor
=450  \\$wnnna$aHIV Viremic Controller
=450  \\$wnnna$aHIV+ Long Term Non Progressors
=450  \\$wnnna$aHIV+ Long-Term Non-Progressor
=450  \\$wnnna$aHIV-1 Long-Term Nonprogressor
=450  \\$wnnna$aHIV-1 Non-Progressor
=450  \\$wnnna$aHIV-1 Nonprogressor
=450  \\$wnnna$aLong-Term Non-Progressor, HIV+
=450  \\$wnnna$aLong-Term Non-Progressors, HIV+
=450  \\$wnnna$aLong-Term Nonprogressor, HIV
=450  \\$wnnna$aLong-Term Nonprogressor, HIV-1
=450  \\$wnnna$aLong-Term Nonprogressors, HIV
=450  \\$wnnna$aLong-Term Nonprogressors, HIV-1
=450  \\$wnnna$aNon-Progressor, HIV
=450  \\$wnnna$aNon-Progressor, HIV+ Long-Term
=450  \\$wnnna$aNon-Progressor, HIV-1
=450  \\$wnnna$aNon-Progressors, HIV+ Long-Term
=450  \\$wnnna$aNonprogressor, HIV
=450  \\$wnnna$aNonprogressor, HIV-1
=450  \\$wnnna$aNonprogressors, HIV
=450  \\$wnnna$aViremic Controller, HIV
=450  \\$wnnna$aViremic Controllers, HIV
=680  \\$iHIV-positive individuals with low VIRAL LOAD of HIV who never develop AIDS even without antiviral treatment.
=688  \\$a2022(1999)
=750  \0$iBroader mapping$aHIV-positive persons$0(DLC)sh 95001199$4BM$5IEN-M

=LDR  01245cz  a2200277n  4500
=001  9882294809702441
=005  20231031103839.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091682
=035  \\$a(DNLM)D000091682
=035  \\$a(NLM)9819990653300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x240.$x425.$x513
=072  \\$aN1.$x224.$x425.$x394
=150  \\$aHealth Inequities
=450  \\$aHealth Inequalities
=450  \\$wnnna$aHealth Inequality
=450  \\$wnnna$aHealth Inequity
=450  \\$wnnna$aInequalities, Health
=450  \\$wnnna$aInequality, Health
=450  \\$wnnna$aInequities, Health
=450  \\$wnnna$aInequity, Health
=667  \\$acoordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iDifferences in health status or in the distribution of health resources between different population groups, arising from the social conditions in which people are born, grow, live, work and age.(https://www.who.int/news-room/facts-in-pictures/detail/health-inequities-and-their-causes#:~:text=Health%20inequities%20are%20differences%20in,right%20mix%20of%20government%20policies.)
=688  \\$a2022
=750  \0$iBroader mapping$aEquality$xHealth aspects$0(DLC)sh2009125083$4BM$5IEN-M

=LDR  00989cz  a2200265n  4500
=001  9882294810002441
=005  20231031102640.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089323
=035  \\$a(DNLM)D000089323
=035  \\$a(NLM)9819990293500041
=040  \\$aDNLM$cDNLM
=060  \0$aWT 20
=072  \\$aH1.$x158.$x595
=072  \\$aH2.$x403.$x355.$x500
=150  \\$aGeroscience
=450  \\$aAging Research
=450  \\$aAnti-Aging Research
=450  \\$wnnna$aAnti Aging Research
=450  \\$wnnna$aGerosciences
=450  \\$wnnna$aResearch, Aging
=450  \\$wnnna$aResearch, Anti-Aging
=680  \\$iThe study of the BIOLOGY; BIOCHEMISTRY; and PHYSIOLOGY of AGING and the AGED and age-related diseases such as CARDIOVASCULAR DISEASES; DIABETES MELLITUS; and CANCER, as well as debilitating conditions like ARTHRITIS; FATIGUE; and FRAILTY.
=688  \\$a2022
=750  \0$iBroader mapping$aOld age$xResearch$0(DLC)sh 85094507$4BM$5IEN-M

=LDR  01100nz  a2200253n  4500
=001  9882294810102441
=005  20231031102413.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091062
=035  \\$a(DNLM)D000091062
=035  \\$a(NLM)9819990419100041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x315
=150  \\$aGamma Secretase Inhibitors and Modulators
=450  \\$aGS Inhibitors
=450  \\$aGS Inhibitors and Modulators
=450  \\$aGS Modulators
=450  \\$aGamma Secretase Inhibitors
=450  \\$aGamma Secretase Modulators
=450  \\$wnnna$aSecretase Inhibitors, Gamma
=450  \\$wnnna$aSecretase Modulators, Gamma
=680  \\$iAgents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., Aβ42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types.
=688  \\$a2022
=750  \0$iBroader mapping$aEnzyme inhibitors$0(DLC)sh 85044226$4BM$5IEN-M

=LDR  02589nz  a2200577n  4500
=001  9882294810202441
=005  20231031102134.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090303
=035  \\$a(DNLM)D000090303
=035  \\$a(NLM)9819990254200041
=040  \\$aDNLM$cDNLM
=072  \\$aC16.$x131.$x77.$x350.$x568
=072  \\$aC16.$x131.$x831.$x350.$x568
=072  \\$aC16.$x320.$x850.$x250.$x568
=072  \\$aC17.$x800.$x804.$x350.$x568
=072  \\$aC17.$x800.$x827.$x250.$x568
=150  \\$aFocal Facial Dermal Dysplasias
=450  \\$wnnna$aFocal Facial Dermal Dysplasia, Type II
=450  \\$aBitemporal Aplasia Cutis Congenita
=450  \\$aBitemporal Forceps Marks Syndrome
=450  \\$aBrauer Syndrome
=450  \\$aBrauer-Setleis Syndrome
=450  \\$aFFDD, Type 1
=450  \\$aFFDD, Type 2
=450  \\$aFFDD, Type 3
=450  \\$aFFDD, Type 4
=450  \\$aFacial Ectodermal Dysplasias
=450  \\$aFocal Facial Dermal Dysplasia 1
=450  \\$aFocal Facial Dermal Dysplasia 2
=450  \\$aFocal Facial Dermal Dysplasia 3
=450  \\$aFocal Facial Dermal Dysplasia 4
=450  \\$aFocal Facial Dermal Dysplasia Type 1
=450  \\$aFocal Facial Dermal Dysplasia Type 2
=450  \\$aFocal Facial Dermal Dysplasia Type 4
=450  \\$aHereditary Symmetrical Aplastic Nevi of Temples
=450  \\$aSetleis Syndrome
=450  \\$wnnna$aBrauer Setleis Syndrome
=450  \\$wnnna$aDysplasia, Facial Ectodermal
=450  \\$wnnna$aEctodermal Dysplasia, Facial
=450  \\$wnnna$aEctodermal Dysplasias, Facial
=450  \\$wnnna$aFacial Ectodermal Dysplasia
=450  \\$wnnna$aSyndrome, Brauer
=450  \\$wnnna$aType 1 FFDD
=450  \\$wnnna$aType 2 FFDD
=450  \\$wnnna$aType 3 FFDD
=450  \\$wnnna$aType 4 FFDD
=450  \\$wnnna$aType 4 FFDDs
=680  \\$iA heterogenous group of genetic disorders characterized by scar-like atrophic lesions on the temple region of the head including preauricular area. Location of skin defects is likely related to defects in fusion of embryonic facial prominences during development of the face. Focal facial dermal dysplasia (FFDD) is generally divided into four subtypes according to the location of the lesions and inheritance pattern: FFDD1 (Brauer syndrome); FFDD2 (Brauer-Setleis syndrome); FFDD3 (Setleis syndrome); and FFDD4. Mutations in TWIST2 Protein and/or CYP26C1 (see CYP26 FAMILY) are associated with FFDD3, and 4.
=688  \\$a2022
=750  \0$iBroader mapping$aEctodermal dysplasia$0(DLC)sh 85040890$4BM$5IEN-M

=LDR  00729nz  a2200181n  4500
=001  9882294810302441
=005  20231031101815.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089703
=035  \\$a(DNLM)D000089703
=035  \\$a(NLM)9819990351900041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x276.$x624.$x600
=150  \\$aFibroblast Growth Factor-23
=450  \\$aFibroblast Growth Factor 23
=680  \\$iA specific fibrobroblast growth factor that is primarily synthesized by OSTEOCYTES and OSTEOBLASTS. It is involved in regulating phosphate homeostasis and renal phosphate excretion.
=688  \\$a2022
=750  \0$iBroader mapping$aFibroblast growth factors$0(DLC)sh 91005352$4BM$5IEN-M

=LDR  01354cz  a2200289n  4500
=001  9882294810502441
=005  20231031101517.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091762
=035  \\$a(DNLM)D000091762
=035  \\$a(NLM)9819990545300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x125
=150  \\$aEthnic and Racial Minorities
=450  \\$aEthnic Minorities
=450  \\$aRacial Minorities
=450  \\$wnnna$aEthnic Minority
=450  \\$wnnna$aMinorities, Ethnic
=450  \\$wnnna$aMinorities, Racial
=450  \\$wnnna$aMinority, Ethnic
=450  \\$wnnna$aMinority, Racial
=450  \\$wnnna$aRacial Minority
=550  \\$aMinority Groups
=667  \\$acoordinate with specific ethnic group or racial group if pertinent; for issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iSocially constructed groups of people who differ in race, color or national, religious, or cultural origin from the dominant group and is often the majority population of the country in which they live. Ethnic minority groups generally share a common sense of identity and common characteristics such as language, religion, tribe, nationality, race, or a combination thereof.
=688  \\$a2022
=750  \0$iBroader mapping$aMinorities$0(DLC)sh 85085792$4BM$5IEN-M

=LDR  00785nz  a2200217n  4500
=001  9882294810602441
=005  20231031101140.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089983
=035  \\$a(DNLM)D000089983
=035  \\$a(NLM)9819990319100041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x92.$x831.$x230
=072  \\$aD2.$x626.$x295
=072  \\$aD3.$x633.$x100.$x127.$x203
=150  \\$aEscitalopram
=450  \\$wnnna$aEscitalopram Oxalate
=450  \\$wnnna$aLexapro
=680  \\$iS-enantiomer of CITALOPRAM. Belongs to a class of drugs known as SELECTIVE SEROTONIN REUPTAKE INHIBITORS, used to treat depression and generalized anxiety disorder.
=688  \\$a2022 (2001)
=750  \0$iBroader mapping$aPropylamine$0(DLC)sh 85107557$4BM$5IEN-M

=LDR  01076cz  a2200229n  4500
=001  9882294810702441
=005  20231031100927.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088744
=035  \\$a(DNLM)D000088744
=035  \\$a(NLM)9819990398400041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 102.7
=072  \\$aE2.$x479
=072  \\$aH2.$x403.$x200.$x550
=150  \\$aGenomic Medicine
=450  \\$wnnna$aMedicine, Genomic
=680  \\$iA medical discipline using genomic information about an individual as part of their clinical care (e.g. for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use.  (From www.genome.gov/health/Genomics-and-Medicine accessed 12/28/2020)
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aGenomics$0(DLC)sh2002000809$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aMedicine$0(DLC)sh 85083064$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aGenomics$iand$aMedicine$5IEN-M

=LDR  00879nz  a2200229n  4500
=001  9882294810902441
=005  20231031100710.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091662
=035  \\$a(DNLM)D000091662
=035  \\$a(NLM)9819990656900041
=040  \\$aDNLM$cDNLM
=072  \\$aC12.$x100
=150  \\$aGenital Diseases
=450  \\$wnnna$aDisease, Genital
=450  \\$wnnna$aDiseases, Genital
=450  \\$wnnna$aGenital Disease
=667  \\$ageneral or unspecified; GENITAL DISEASES, MALE and GENITAL DISEASES, FEMALE are available
=680  \\$iPathological processes involving the reproductive tract (GENITALIA).
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aGenerative organs$xDiseases$0(DLC)sh 85053827$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aGenerative organs--Diseases$5IEN-M

=LDR  01453nz  a2200385n  4500
=001  9882294811002441
=005  20231031100136.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088544
=035  \\$a(DNLM)D000088544
=035  \\$a(NLM)9819990297100041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x410.$x698.$x277.$x140
=072  \\$aI3.$x350.$x140
=072  \\$aI3.$x450.$x642.$x693.$x930.$x500
=072  \\$aL1.$x224.$x900.$x930.$x500
=150  \\$aExergaming
=450  \\$aActive-Video Gaming
=450  \\$aExergames
=450  \\$aVirtual Reality Exercise
=450  \\$wnnna$aActive Video Gaming
=450  \\$wnnna$aActive-Video Gamings
=450  \\$wnnna$aExercise, Virtual Reality
=450  \\$wnnna$aExercises, Virtual Reality
=450  \\$wnnna$aExergame
=450  \\$wnnna$aExergamings
=450  \\$wnnna$aGaming, Active-Video
=450  \\$wnnna$aGamings, Active-Video
=450  \\$wnnna$aVirtual Reality Exercises
=550  \\$aTelerehabilitation
=680  \\$iVideogaming that involves the player's whole body in physical exercises in order to play the videogames.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aVideo games$0(DLC)sh 85143202$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aExercise$0(DLC)sh 85046328$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aVideo games$iand$aExercise$5IEN-M

=LDR  00777nz  a2200193n  4500
=001  9882294811502441
=005  20231031091433.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089965
=035  \\$a(DNLM)D000089965
=035  \\$a(NLM)9819990278800041
=040  \\$aDNLM$cDNLM
=072  \\$aC17.$x800.$x229.$x100
=072  \\$aC23.$x888.$x885.$x328.$x500
=072  \\$aC26.$x200.$x413
=150  \\$aErythema Ab Igne
=680  \\$iA cutaneous finding caused by prolonged heat exposure (e.g., space heater) and local heat injury (e.g., caused by LASER THERAPY). It is characterized by epidermal atrophy, reticular hyperpigmentation, and telangiectatic dermatosis.
=688  \\$a2022
=750  \0$iBroader mapping$aErythema$0(DLC)sh 85044740$4BM$5IEN-M

=LDR  01680nz  a2200397n  4500
=001  9882294811602441
=005  20231031085718.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090005
=035  \\$a(DNLM)D000090005
=035  \\$a(NLM)9819990323100041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x599.$x395.$x121
=150  \\$aEpidemiological Models
=450  \\$aCommunicable Disease Models
=450  \\$aCompartmental Models
=450  \\$aModels, Epidemiological
=450  \\$aSIR Models
=450  \\$aSIS Model
=450  \\$aSusceptible Infected Recovered Models
=450  \\$aSusceptible Infected Susceptible Model
=450  \\$wnnna$aCommunicable Disease Model
=450  \\$wnnna$aCompartmental Model
=450  \\$wnnna$aDisease Model, Communicable
=450  \\$wnnna$aEpidemiological Model
=450  \\$wnnna$aModel, Communicable Disease
=450  \\$wnnna$aModel, Compartmental
=450  \\$wnnna$aModel, Epidemiological
=450  \\$wnnna$aModel, SIS
=450  \\$wnnna$aSIR Model
=450  \\$wnnna$aSIS Models
=680  \\$iMathematical models of the transmission of infectious diseases. They predict spread of a disease by incorporating disease-related (e.g., infectious agent, mode of transmission, latent period, infectious period) and abiotic factors (e.g., social, cultural, demographic, and geographic factors).
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aEpidemiology$0(DLC)sh 85044373$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xMathematical models$0(DLC)h 85082124$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aEpidemiology--Mathematical models$5IEN-M

=LDR  00874cz  a2200205n  4500
=001  9882294811702441
=005  20231031085220.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087523
=035  \\$a(DNLM)D000087523
=035  \\$a(NLM)9819990157100041
=040  \\$aDNLM$cDNLM
=072  \\$aG12.$x535.$x425.$x290
=150  \\$aEndotoxin Tolerance
=450  \\$aEndotoxin Desensitization
=450  \\$wnnna$aDesensitization, Endotoxin
=450  \\$wnnna$aTolerance, Endotoxin
=680  \\$iReduced capacity to respond to subsequent ENDOTOXIN challenges after an initial exposure. It is characterized by reduced responsiveness of INNATE IMMUNE RESPONSES, a shift from pro- to anti-inflammatory cell phenotype and impaired ANTIGEN PRESENTATION.
=688  \\$a2022
=750  \0$iBroader mapping$aImmunological tolerance$0(DLC)sh 85064577$4BM$5IEN-M

=LDR  01271nz  a2200313n  4500
=001  9882294811802441
=005  20231031084823.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091342
=035  \\$a(DNLM)D000091342
=035  \\$a(NLM)9819990695300041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x580.$x216.$x375.$x100
=150  \\$aEndoplasmic Reticulum Chaperone BiP
=450  \\$aBinding-immunoglobulin Protein Molecular Chaperone
=450  \\$aGlucose Regulated Protein 78 kDa
=450  \\$aGrp78
=450  \\$aHSPA5 Protein
=450  \\$aHeat-Shock Protein 5
=450  \\$aMolecular Chaperone BiP
=450  \\$aMolecular Chaperone GRP78
=450  \\$wnnna$aBiP, Molecular Chaperone
=450  \\$wnnna$aBinding immunoglobulin Protein Molecular Chaperone
=450  \\$wnnna$aGRP78, Molecular Chaperone
=450  \\$wnnna$aHeat Shock Protein 5
=450  \\$wnnna$aProtein, HSPA5
=680  \\$iAn ENDOPLASMIC RETICULUM  specific chaperone of the HSP70 family. They are involved in  folding and oligomerization of secreted and membrane proteins and ENDOPLASMIC RETICULUM STRESS related UNFOLDED PROTEIN RESPONSE.
=688  \\$a2022(2008)
=750  \0$iBroader mapping$aHeat shock proteins$0(DLC)sh 85059812$4BM$5IEN-M

=LDR  00684cz  a2200241n  4500
=001  9882294814202441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090262
=035  \\$a(DNLM)D000090262
=035  \\$a(NLM)9819990245300041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 260.5.H9
=072  \\$aI3.$x400
=072  \\$aI3.$x450.$x642.$x637
=150  \\$aHunting
=450  \\$aFishing
=450  \\$aTrapping
=667  \\$ahuman activity only; check tag humans
=680  \\$iFinding or capturing animals for food or sport.
=688  \\$a2022
=750  \0$aHunting$0(DLC)sh 85063117$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01435nz  a2200373n  4500
=001  9882294814402441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087508
=035  \\$a(DNLM)D000087508
=035  \\$a(NLM)9819990154700041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x318.$x308.$x985.$x450.$x500
=072  \\$aN1.$x224.$x935.$x464.$x500
=072  \\$aN6.$x850.$x505.$x400.$x975.$x450.$x500
=072  \\$aN6.$x850.$x520.$x308.$x985.$x450.$x500
=150  \\$aHealthy Life Expectancy
=450  \\$aDisability-Free Life Expectancy
=450  \\$aHALYs
=450  \\$aHealth-Adjusted Life Years
=450  \\$wnnna$aDisability Free Life Expectancy
=450  \\$wnnna$aDisability-Free Life Expectancies
=450  \\$wnnna$aExpectancy, Disability-Free Life
=450  \\$wnnna$aExpectancy, Healthy Life
=450  \\$wnnna$aHealth Adjusted Life Years
=450  \\$wnnna$aHealth-Adjusted Life Year
=450  \\$wnnna$aHealthy Life Expectancies
=450  \\$wnnna$aLife Expectancy, Disability-Free
=450  \\$wnnna$aLife Expectancy, Healthy
=450  \\$wnnna$aLife Year, Health-Adjusted
=680  \\$iThe expected number of remaining years of life spent in good health from a particular age, assuming current rates of mortality and morbidity.
=688  \\$a2022
=750  \0$aHealth expectancy$0(DLC)sh2002008579$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01745nz  a2200493n  4500
=001  9882294814702441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089922
=035  \\$a(DNLM)D000089922
=035  \\$a(NLM)9819990341300041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x224.$x230.$x260.$x115.$x625
=150  \\$aHaptic Interfaces
=450  \\$aForce Feedback Gloves
=450  \\$aHaptic Actuators
=450  \\$aHaptic Computer Interfaces
=450  \\$aHaptic Devices
=450  \\$aHaptic Glove
=450  \\$wnnna$aActuator, Haptic
=450  \\$wnnna$aActuators, Haptic
=450  \\$wnnna$aComputer Interface, Haptic
=450  \\$wnnna$aComputer Interfaces, Haptic
=450  \\$wnnna$aDevice, Haptic
=450  \\$wnnna$aDevices, Haptic
=450  \\$wnnna$aFeedback Glove, Force
=450  \\$wnnna$aFeedback Gloves, Force
=450  \\$wnnna$aForce Feedback Glove
=450  \\$wnnna$aGlove, Force Feedback
=450  \\$wnnna$aGlove, Haptic
=450  \\$wnnna$aGloves, Force Feedback
=450  \\$wnnna$aGloves, Haptic
=450  \\$wnnna$aHaptic Actuator
=450  \\$wnnna$aHaptic Computer Interface
=450  \\$wnnna$aHaptic Device
=450  \\$wnnna$aHaptic Gloves
=450  \\$wnnna$aHaptic Interface
=450  \\$wnnna$aInterface, Haptic
=450  \\$wnnna$aInterfaces, Haptic
=550  \\$aHaptic Technology
=680  \\$iComputer peripherals that enable users to interact three dimensionally with objects in virtual environments, or with equipment being teleoperated, by receiving kinesthetic, tactile, and force feedback.
=688  \\$a2022
=750  \0$aHaptic devices$0(DLC)sh2009005405$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  00702nz  a2200193n  4500
=001  9882294814902441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090208
=035  \\$a(DNLM)D000090208
=035  \\$a(NLM)9819990505200041
=040  \\$aDNLM$cDNLM
=072  \\$aI2.$x487
=072  \\$aL1.$x224.$x900.$x340
=150  \\$aGamification
=680  \\$iApplication of game mechanics to non-game contexts  to engage audiences and to inject some entertainment  into mundane activities besides generating motivational and cognitive benefits.
=688  \\$a2022
=750  \0$aGamification$0(DLC)sh2015002481$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01110nz  a2200277n  4500
=001  9882294815202441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091344
=035  \\$a(DNLM)D000091344
=035  \\$a(NLM)9819990689700041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x157.$x125.$x750.$x250
=072  \\$aD12.$x776.$x631.$x655.$x250
=150  \\$aFilaggrin Proteins
=450  \\$aFilaggrin
=450  \\$aFilaggrin Protein
=450  \\$aProfilaggrin
=450  \\$aStratum Corneum Basic Protein
=450  \\$aStratum Corneum Basic Protein Precursor
=450  \\$wnnna$aProtein, Filaggrin
=450  \\$wnnna$aProteins, Filaggrin
=680  \\$iS100 proteins that aggregate KERATINS. Filaggrin precursor proteins are localized in keratohyalin granules and processed into individual functional filaggrin molecules during terminal epidermis differentiation. Mutations in fillagrins are associated with ICHTHYOSIS VULGARIS.
=688  \\$a2022(1981)
=750  \0$aProfilaggrin$0(DLC)sh2008008889$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01099nz  a2200349n  4500
=001  9882294815302441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088082
=035  \\$a(DNLM)D000088082
=035  \\$a(NLM)9819990135200041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x559
=072  \\$aG7.$x203.$x200.$x563
=072  \\$aJ2.$x200.$x559
=072  \\$aJ2.$x350.$x594
=150  \\$aFermented Beverages
=450  \\$aCauim
=450  \\$aChicha
=450  \\$aFermented Beverage
=450  \\$aMasato
=450  \\$aPulque
=450  \\$wnnna$aBeverage, Fermented
=450  \\$wnnna$aBeverages, Fermented
=450  \\$wnnna$aCauims
=450  \\$wnnna$aChichas
=450  \\$wnnna$aMasatos
=450  \\$wnnna$aPulques
=680  \\$iBeverages that are prepared by using microorganisms to convert their components into various FERMENTATION end products.
=688  \\$a2022; use FERMENTED FOODS AND BEVERAGES 2020-2021
=750  \0$aFermented beverages$0(DLC)sh2014002425$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  00912nz  a2200217n  4500
=001  9882294815502441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090142
=035  \\$a(DNLM)D000090142
=035  \\$a(NLM)9819990264600041
=040  \\$aDNLM$cDNLM
=072  \\$aZ1.$x542.$x25
=151  \\$aEuropean Alpine Region
=451  \\$wnnna$aAlpine Region
=451  \\$wnnna$aAlps Mountain Region
=667  \\$ado not confuse with ALPINE TUNDRA see TUNDRA
=680  \\$iA territory which encompasses eight European countries: Austria, France, Germany, Italy, Liechtenstein, Monaco, Slovenia and Switzerland. The height of the Alpine mountain ridges range up to Mont Blanc at 15,782 feet above sea level, and its altitude decreases from west to east.
=688  \\$a2022
=750  \0$aAlps Region$0(DLC)sh 98002363$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  00958nz  a2200265n  4500
=001  9882294815702441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088724
=035  \\$a(DNLM)D000088724
=035  \\$a(NLM)9819990400700041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738.$x458
=072  \\$aN6.$x230.$x206
=150  \\$aEnvironmentalism
=450  \\$aEnvironmental Activism
=450  \\$aEnvironmental Advocacy
=450  \\$wnnna$aActivism, Environmental
=450  \\$wnnna$aAdvocacies, Environmental
=450  \\$wnnna$aAdvocacy, Environmental
=450  \\$wnnna$aEnvironmental Advocacies
=680  \\$iAdvocacy for the preservation, restoration, or improvement of the natural environment. It aims to reduce the impact of human activities on the earth and its inhabitants.
=688  \\$a2022
=750  \0$aEnvironmentalism$0(DLC)sh 93004752$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01058cz  a2200241n  4500
=001  9882294815902441
=005  20231030145229.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091383
=035  \\$a(DNLM)D000091383
=035  \\$a(NLM)9819990664700041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738.$x458.$x500
=072  \\$aI1.$x880.$x604.$x473.$x700.$x500
=072  \\$aK1.$x752.$x566.$x479.$x830.$x750.$x500
=072  \\$aK1.$x752.$x566.$x869.$x250
=150  \\$aEnvironmental Justice
=450  \\$wnnna$aJustice, Environmental
=667  \\$aSOCIAL DETERMINANTS OF HEALTH is available
=680  \\$iThe fair treatment and meaningful involvement of all people regardless of race, color, national origin, or income, with respect to the development, implementation, and enforcement of environmental laws, regulations, and policies. (www.epa.gov/environmentaljustice/learn-about-environmental-justice)
=688  \\$a2022
=750  \0$aEnvironmental justice$0(DLC)sh 97002483$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  00877cz  a2200241n  4500
=001  9882294816202441
=005  20231030145225.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091002
=035  \\$a(DNLM)D000091002
=035  \\$a(NLM)9819990432400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x996.$x134.$x500
=150  \\$aEconomic Stability
=450  \\$aEconomic Instability
=450  \\$wnnna$aEconomic Instabilities
=450  \\$wnnna$aInstability, Economic
=450  \\$wnnna$aStability, Economic
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iAn absence of excessive economic fluctuations which allows people the ability to access resources.
=688  \\$a2022
=750  \0$aEconomic stabilization$0(DLC)sh 85040844$5IEN-M
=930  \\$aMeSH Mapping GN 2023/10/30

=LDR  01714cz  a2200385n  4500
=001  9818769680606676
=005  20240510143248.0
=008  230726\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000097962
=035  \\$a(DNLM)D000097962
=035  \\$a(NLM)9829192732700041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 395
=072  \\$aN4.$x590.$x374.$x268
=072  \\$aN5.$x300.$x361
=150  \\$aGender-Affirming Care
=450  \\$aGender-Affirmative Care
=450  \\$aGender-Affirming Healthcare
=450  \\$aGender-Confirming Care
=450  \\$wnnna$aCare, Gender-Affirmative
=450  \\$wnnna$aCare, Gender-Affirming
=450  \\$wnnna$aCare, Gender-Confirming
=450  \\$wnnna$aGender Affirmative Care
=450  \\$wnnna$aGender Affirming Care
=450  \\$wnnna$aGender Affirming Healthcare
=450  \\$wnnna$aGender Confirming Care
=450  \\$wnnna$aGender-Affirmative Cares
=450  \\$wnnna$aGender-Affirming Cares
=450  \\$wnnna$aGender-Affirming Healthcares
=450  \\$wnnna$aGender-Confirming Cares
=450  \\$wnnna$aHealthcare, Gender-Affirming
=680  \\$iA supportive healthcare, consisting of medical, surgical, mental health, and non-medical services for TRANSGENDER PERSONS and GENDER-NONCONFORMING PERSONS. Medical and psychosocial gender affirming healthcare practices may lower rates of adverse mental health outcomes, build SELF ESTEEM, and improve overall QUALITY OF LIFE for transgender and gender diverse youth (https://opa.hhs.gov/sites/default/files/2022-03/gender-affirming-care-young-people-march-2022.pdf).
=688  \\$a2024
=750  \0$aGender-affirming care$0(DLC)sh2023000451$5DNLM

=LDR  01376cz  a2200421n  4500
=001  9818769680806676
=005  20240510141325.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012742
=035  \\$a(DNLM)D012742
=035  \\$a(NLM)98194101870000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x198.$x240.$x748
=150  \\$aSex Offenses
=450  \\$wnnna$aSexual Abuse
=450  \\$wnnna$aSexual Violence
=450  \\$aSexual Assault
=450  \\$wnnna$aAbuse, Sexual
=450  \\$wnnna$aAbuses, Sexual
=450  \\$wnnna$aAssault, Sexual
=450  \\$wnnna$aAssaults, Sexual
=450  \\$wnnna$aOffense, Sex
=450  \\$wnnna$aOffenses, Sex
=450  \\$wnnna$aSex Offense
=450  \\$wnnna$aSexual Abuses
=450  \\$wnnna$aSexual Assaults
=450  \\$wnnna$aSexual Violences
=450  \\$wnnna$aViolence, Sexual
=450  \\$wnnna$aViolences, Sexual
=550  \\$aIntimate Partner Violence
=550  \\$aParaphilic Disorders
=550  \\$aDomestic Violence
=680  \\$iAny violation of established legal or moral codes in respect to sexual behavior.
=688  \\$a68
=750  \0$aSex crimes$5IEN$0(DLC)sh 85120572
=750  \0$iNarrower mapping$aSexual assault$0(DLC)sh2022007675$4NM$5DNLM

=LDR  00811cz  a2200253n  4500
=001  9818769681206676
=005  20240510114139.0
=008  090706\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D057237
=035  \\$a(DNLM)D057237
=035  \\$a(NLM)98195997830000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x142
=150  \\$aCriminals
=450  \\$wnnna$aOffenders
=450  \\$wnnna$aCriminal
=450  \\$wnnna$aOffender
=550  \\$aCriminal Behavior
=680  \\$iPersons who have committed a crime or have been convicted of a crime.
=688  \\$a2010
=750  \0$aCriminals$0(DLC) sh 85036577$5IEN-M
=750  \0$iNarrower mapping$aKidnappers$0(DLC)sh2023000740$4NM$5DNLM

=LDR  01151cz  a2200241n  4500
=001  9818769681306676
=005  20240510112650.0
=008  080708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D055866
=035  \\$a(DNLM)D055866
=035  \\$a(NLM)98197669450000041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x250
=072  \\$aN6.$x230.$x100.$x230.$x200
=150  \\$aEarthquakes
=450  \\$wnnna$aEarthquake
=667  \\$acoordinate with DISASTERS if pertinent; specify geographic location
=680  \\$iSudden slips on a geological fault, and the resulting ground shaking and radiated seismic energy caused by the slips, or by volcanic or magmatic activity, or other sudden stress changes in the earth. Faults are fractures along which the blocks of EARTH crust on either side have moved relative to one another parallel to the fracture.
=688  \\$a2009; use DISASTERS 1976-2008
=750  \0$aEarthquakes$0(DLC) sh 85040496$5IEN-M
=750  \0$iNarrower mapping$aSlow earthquakes$0(DLC)sh2023000682$4NM$5DNLM

=LDR  01458cz  a2200385n  4500
=001  9818769681406676
=005  20240510111615.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006806
=035  \\$a(DNLM)D006806
=035  \\$a(NLM)98194658900000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x473
=072  \\$aN3.$x706.$x437
=150  \\$aHuman Rights
=450  \\$wnnna$aCollective Human Rights
=450  \\$wnnna$aEqual Rights
=450  \\$aLinguistic Rights
=450  \\$aRight to Housing and Shelter
=450  \\$aRights of Indigenous Peoples
=450  \\$wnnna$aHuman Rights, Collective
=450  \\$wnnna$aIndigenous Peoples Rights
=450  \\$wnnna$aRights, Collective Human
=450  \\$wnnna$aRights, Equal
=450  \\$wnnna$aRights, Linguistic
=550  \\$aCivil Rights
=550  \\$aHuman Rights Abuses
=550  \\$aWomen's Rights
=680  \\$iThe right of the individual to cultural, social, economic, and educational opportunities as provided by society, e.g., right to work, right to education, and right to social security.
=688  \\$a73
=750  \0$aHuman rights$5IEN$0(DLC)sh 85026379
=750  \0$iNarrower mapping$aRight to bodily autonomy$0(DLC)sh2022006327$4NM$5IEN-M
=750  \0$iNarrower mapping$aCultural rights$0(DLC)sh2023000610$4NM$5DNLM

=LDR  01268cz  a2200349n  4500
=001  9818769681606676
=005  20240510103258.0
=008  830613\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D014741
=035  \\$a(DNLM)D014741
=035  \\$a(NLM)98196345200000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x280.$x960
=150  \\$aVideo Recording
=450  \\$wnnna$aAudiovisual Recording
=450  \\$wnnna$aVideorecording
=450  \\$wnnna$aAudiovisual Recordings
=450  \\$wnnna$aRecording, Audiovisual
=450  \\$wnnna$aRecording, Video
=450  \\$wnnna$aRecordings, Audiovisual
=450  \\$wnnna$aRecordings, Video
=450  \\$wnnna$aVideo Recordings
=450  \\$wnnna$aVideorecordings
=550  \\$aVideo-Assisted Surgery
=550  \\$aThoracic Surgery, Video-Assisted
=667  \\$aVIDEODISC RECORDING & VIDEOTAPE RECORDING are also available
=680  \\$iThe storing or preserving of video signals to be played back later via a transmitter or receiver.
=688  \\$a84
=750  \0$aVideo recording$5IEN$0(DLC)sh 92003035
=750  \0$iNarrower mapping$aCellphilms$0(DLC)sh2023000495$4NM$5DNLM

=LDR  01248cz  a2200277n  4500
=001  9818769681706676
=005  20240510102543.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D015013
=035  \\$a(DNLM)D015013
=035  \\$a(NLM)98197728310000041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x190.$x525.$x937
=072  \\$aE2.$x190.$x901.$x984
=072  \\$aE2.$x779.$x474.$x937
=072  \\$aK1.$x844.$x799.$x867
=150  \\$aYoga
=550  \\$aBreathing Exercises
=550  \\$aMeditation
=550  \\$aMuscle Stretching Exercises
=667  \\$aIM; specify geog if pertinent
=680  \\$iA major orthodox system of Hindu philosophy based on Sankhya (metaphysical dualism) but differing from it in being theistic and characterized by the teaching of raja-yoga as a practical method of liberating the self. It includes a system of exercises for attaining bodily or mental control and well-being with liberation of the self and union with the universal spirit. (From Webster, 3d ed)
=750  \0$aYoga$5IEN$0(DLC)sh 85149174
=750  \0$iNarrower mapping$aŚivarājayoga$0(DLC)sh2023000463$4NM$5DNLM

=LDR  00917cz  a2200277n  4500
=001  9818769681806676
=005  20240510081956.0
=008  220721\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095284
=035  \\$a(DNLM)D000095284
=035  \\$a(NLM)9825515498500041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x968.$x650
=072  \\$aM1.$x686.$x493.$x500.$x800.$x400
=150  \\$aMaori People
=450  \\$aMaori
=450  \\$aMāori People
=450  \\$wnnna$aMaori Peoples
=450  \\$wnnna$aMāori Peoples
=450  \\$wnnna$aPeople, Maori
=450  \\$wnnna$aPeople, Māori
=680  \\$iThe indigenous aboriginal people of New Zealand.
=688  \\$a2023
=750  \0$aMāori (New Zealand people)$5DNLM$0(DLC)sh 85080815
=750  \0$iNarrower mapping$aNgāti Rongo (New Zealand people : Ngāti Whātua)$0(DLC)sh2023000546$4NM$5DNLM

=LDR  00872cz  a2200277n  4500
=001  9818769681906676
=005  20240510075236.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005381
=035  \\$a(DNLM)D005381
=035  \\$a(NLM)98195057880000041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x521
=150  \\$aFinancing, Organized
=450  \\$wnnna$aCommunity Financing
=450  \\$wnnna$aGrants
=450  \\$wnnna$aOrganized Financing
=450  \\$wnnna$aFinancing, Community
=450  \\$wnnna$aGrant
=667  \\$aIM
=680  \\$iAll organized methods of funding.
=688  \\$a68
=750  \0$aFinance$5IEN$0(DLC)sh 85048256
=750  \0$iNarrower mapping$aGrantmaking$0(DLC)sh2023000501$4NM$5DNLM

=LDR  01096cz  a2200337n  4500
=001  9818769684006676
=005  20240509170549.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011057
=035  \\$a(DNLM)D011057
=035  \\$a(NLM)98199436920000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738
=150  \\$aPolitics
=450  \\$wnnna$aConservatism
=450  \\$wnnna$aDecentralization
=450  \\$wnnna$aLiberalism
=450  \\$wnnna$aPolitical Factors
=450  \\$aPolitical Activity
=450  \\$wnnna$aActivities, Political
=450  \\$wnnna$aActivity, Political
=450  \\$wnnna$aFactor, Political
=450  \\$wnnna$aFactors, Political
=450  \\$wnnna$aPolitical Activities
=450  \\$wnnna$aPolitical Factor
=550  \\$aDissent and Disputes
=667  \\$aspecify geog if pertinent
=680  \\$iActivities concerned with governmental policies, functions, etc.
=750  \0$aPolitical science$5IEN$0(DLC)sh 85104440

=LDR  00796cz  a2200229n  4500
=001  9818769684106676
=005  20240509173117.0
=008  200707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085926
=035  \\$a(DNLM)D000085926
=035  \\$a(NLM)9817067929500041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x883.$x694
=150  \\$aTourism
=680  \\$iTravel for pleasure.
=688  \\$a2021
=750  \0$aTourism$0(DLC)sh 85136255$5IEN-M
=750  \0$iNarrower mapping$aSpiritual tourism$0(DLC)sh2021007042$4NM$5IEN-M
=750  \0$iNarrower mapping$aTea tourism$0(DLC)sh2022007714$4NM$5IEN-M
=750  \0$iNarrower mapping$aTemplestay$0(DLC)sh2023000771$4NM$5DNLM

=LDR  00717nz  a2200205n  4500
=001  9818769684206676
=005  20240509172137.0
=008  230726\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000096264
=035  \\$a(DNLM)D000096264
=035  \\$a(NLM)9829192562400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x738.$x902
=150  \\$aVoting
=450  \\$aVoter
=450  \\$aVoters
=680  \\$iMethod by which an individual or a group, such as in a meeting or an electorate, can engage for the purpose of making a collective decision or expressing an opinion.
=688  \\$a2024
=750  \0$iNarrower mapping$aTelephone voting$0(DLC)sh2022007899035$4NM$5DNLM

=LDR  00971cz  a2200241n  4500
=001  9818769684306676
=005  20240513152654.0
=008  160708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000072264
=035  \\$a(DNLM)D000072264
=035  \\$a(NLM)987391555100041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x925
=150  \\$aSports and Recreational Facilities
=550  \\$aHealth Resorts
=680  \\$iPlaces designed, built, or installed for LEISURE ACTIVITIES outside of the home.
=688  \\$a2017
=750  \0$iNarrower mapping$aPickleball courts$0(DLC)sh2020008721$4NM$5DNLM
=750  \0$iNarrower mapping$aRecreation centers$0(DLC)sh 8511198$4NM$5IEN
=750  \0$iNarrower mapping$aSports facilities$0(DLC)sh 85126921$4NM$5IEN-M
=750  \0$iNarrower mapping$aSquash courts$0(DLC)sh2023000904$4NM$5DNLM

=LDR  01635cz  a2200529n  4500
=001  9818769684406676
=005  20240509161246.0
=008  110624\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D061329
=035  \\$a(DNLM)D061329
=035  \\$a(NLM)98196621820000041
=040  \\$aDNLM$cDNLM
=072  \\$aG1.$x311.$x687
=150  \\$aOil and Gas Fields
=450  \\$wnnna$aGas Fields
=450  \\$wnnna$aGas Reservoirs
=450  \\$wnnna$aGas Wells
=450  \\$wnnna$aOil Fields
=450  \\$wnnna$aOil Reservoirs
=450  \\$wnnna$aOil Wells
=450  \\$wnnna$aOil and Gas Reservoirs
=450  \\$wnnna$aOil and Gas Wells
=450  \\$wnnna$aField, Gas
=450  \\$wnnna$aField, Oil
=450  \\$wnnna$aFields, Gas
=450  \\$wnnna$aFields, Oil
=450  \\$wnnna$aGas Field
=450  \\$wnnna$aGas Reservoir
=450  \\$wnnna$aGas Well
=450  \\$wnnna$aOil Field
=450  \\$wnnna$aOil Reservoir
=450  \\$wnnna$aOil Well
=450  \\$wnnna$aReservoir, Gas
=450  \\$wnnna$aReservoir, Oil
=450  \\$wnnna$aReservoirs, Gas
=450  \\$wnnna$aReservoirs, Oil
=450  \\$wnnna$aWell, Gas
=450  \\$wnnna$aWell, Oil
=450  \\$wnnna$aWells, Gas
=450  \\$wnnna$aWells, Oil
=550  \\$aPetroleum
=550  \\$aNatural Gas
=680  \\$iAreas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.
=688  \\$a2012
=750  \0$iNarrower mapping$aOil reservoirs$0(DLC)sh2023000799$4NM$5DNLM

=LDR  00807cz  a2200229n  4500
=001  9818769684506676
=005  20240509160541.0
=008  020703\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D031297
=035  \\$a(DNLM)D031297
=035  \\$a(NLM)98199742370000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x401.$x571
=150  \\$aLupinus
=450  \\$aLupine
=450  \\$wnnna$aLupines
=680  \\$iA plant genus of the family FABACEAE that is a source of SPARTEINE, lupanine and other lupin alkaloids.
=688  \\$a2003
=750  \0$aLupines$5IEN-M$0(DLC)sh 85078933
=750  \0$iNarrower mapping$aLupinus constancei$0(DLC)sh2023000894$4NM$5DNLM

=LDR  01276cz  a2200361n  4500
=001  9818769684606676
=005  20240509155800.0
=008  910103\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D016495
=035  \\$a(DNLM)D016495
=035  \\$a(NLM)98195726200000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x373.$x750
=072  \\$aM1.$x526.$x760
=150  \\$aPolice
=450  \\$wnnna$aPolice Force
=450  \\$wnnna$aPolice Officers
=450  \\$aLaw Enforcement Officers
=450  \\$wnnna$aEnforcement Officer, Law
=450  \\$wnnna$aEnforcement Officers, Law
=450  \\$wnnna$aLaw Enforcement Officer
=450  \\$wnnna$aOfficer, Law Enforcement
=450  \\$wnnna$aOfficer, Police
=450  \\$wnnna$aOfficers, Law Enforcement
=450  \\$wnnna$aOfficers, Police
=450  \\$wnnna$aPolice Forces
=450  \\$wnnna$aPolice Officer
=550  \\$aLaw Enforcement
=680  \\$iAgents of the law charged with the responsibility of maintaining and enforcing law and order among the citizenry.
=750  \0$aPolice$5IEN-M$0(DLC)sh 85104183
=750  \0$iNarrower mapping$aJudicial police$0(DLC)sh2022007694$4NM$5DNLM

=LDR  01561cz  a2200433n  4500
=001  9818769684706676
=005  20240509153355.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010374
=035  \\$a(DNLM)D010374
=035  \\$a(NLM)98198089470000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x500.$x131.$x617.$x690.$x60.$x716
=150  \\$aPediculus
=450  \\$wnnna$aBody Louse
=450  \\$wnnna$aHead Louse
=450  \\$wnnna$aNits
=450  \\$wnnna$aPediculi
=450  \\$aBody Lice
=450  \\$aHead Lice
=450  \\$wnnna$aBody Lices
=450  \\$wnnna$aBody Louses
=450  \\$wnnna$aHead Lices
=450  \\$wnnna$aHead Louses
=450  \\$wnnna$aLice, Body
=450  \\$wnnna$aLice, Head
=450  \\$wnnna$aLices, Body
=450  \\$wnnna$aLices, Head
=450  \\$wnnna$aLouse, Body
=450  \\$wnnna$aLouse, Head
=450  \\$wnnna$aLouses, Body
=450  \\$wnnna$aLouses, Head
=667  \\$ainfestation: coordinate IM with PEDICULOSIS see LICE INFESTATIONS (IM); for killing Pediculus with insecticides, see note at INSECTICIDES
=680  \\$iLice of the genus Pediculus, family Pediculidae. Pediculus humanus corporus is the human body louse and Pediculus humanus capitis is the human head louse.
=688  \\$a75; was see under LICE 1963-74
=750  \0$aPediculus$5IEN$0(DLC)sh 85099200
=750  \0$iNarrower mapping$aHead louse$0(DLC)sh2022008020$4NM$5DNLM

=LDR  00878cz  a2200217n  4500
=001  9818769684806676
=005  20240509151900.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D046369
=035  \\$a(DNLM)D046369
=035  \\$a(NLM)98199060030000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x620.$x750.$x250
=150  \\$aFinches
=450  \\$wnnna$aFinch
=680  \\$iCommon name for small PASSERIFORMES in the family Fringillidae. They have a short stout bill (BEAK) adapted for crushing SEEDS. Some species of Old World finches are called CANARIES.
=688  \\$a2005; use SONGBIRDS 1999-2004
=750  \0$aFinches$0(DLC) sh 85048322$5IEN-M
=750  \0$iNarrower mapping$aHaemorhous$0(DLC)sh2023000751$4NM$5DNLM

=LDR  01322cz  a2200325n  4500
=001  9818769684906676
=005  20240509151228.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D014876
=035  \\$a(DNLM)D014876
=035  \\$a(NLM)98196081720000041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 689
=072  \\$aN6.$x850.$x460.$x790
=150  \\$aWater Pollution
=450  \\$aThermal Water Pollution
=450  \\$aWater Pollution, Thermal
=450  \\$wnnna$aPollution, Thermal Water
=450  \\$wnnna$aPollution, Water
=450  \\$wnnna$aPollutions, Thermal Water
=450  \\$wnnna$aPollutions, Water
=450  \\$wnnna$aThermal Water Pollutions
=450  \\$wnnna$aWater Pollutions
=450  \\$wnnna$aWater Pollutions, Thermal
=667  \\$aIM; coord with source of pollution (IM); note entry term THERMAL WATER POLLUTION: coord with HOT TEMPERATURE (IM) only if heat is particularly discussed; specify geog if pertinent
=680  \\$iContamination of bodies of water (such as LAKES; RIVERS; SEAS; and GROUNDWATER.)
=750  \0$iNarrower mapping$aDrug pollution of water$0(DLC)sh2023000980$4NM$5DNLM
=750  \0$aWater$xPollution$5IEN$0(DLC)sh 85145467

=LDR  00927cz  a2200229n  4500
=001  9818769685006676
=005  20240509114818.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010311
=035  \\$a(DNLM)D010311
=035  \\$a(NLM)98199569560000041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x248.$x710.$x672
=150  \\$aParrots
=450  \\$aPsittacidae
=450  \\$wnnna$aParrot
=680  \\$iBIRDS of the large family Psittacidae, widely distributed in tropical regions and having a distinctive stout, curved hooked bill. The family includes LOVEBIRDS; AMAZON PARROTS; conures; PARAKEETS; and many other kinds of parrots.
=688  \\$a1991(1975)
=750  \0$aParrots$5IEN$0(DLC)sh 85098302
=750  \0$iNarrower mapping$aAra (Birds)$0(DLC)sh2023000808$4NM$5DNLM

=LDR  01557cz  a2200349n  4500
=001  9818769686606676
=005  20240509094621.0
=008  941227\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D018910
=035  \\$a(DNLM)D018910
=035  \\$a(NLM)98194041240000041
=040  \\$aDNLM$cDNLM
=072  \\$aI3.$x450.$x642.$x693.$x930
=072  \\$aL1.$x224.$x900.$x930
=150  \\$aVideo Games
=450  \\$wnnna$aComputer Games
=450  \\$wnnna$aComputer Game
=450  \\$wnnna$aGame, Computer
=450  \\$wnnna$aGame, Video
=450  \\$wnnna$aGames, Computer
=450  \\$wnnna$aGames, Video
=450  \\$wnnna$aVideo Game
=680  \\$iA form of interactive entertainment in which the player controls electronically generated images that appear on a video display screen. This includes video games played in the home on special machines or home computers, and those played in arcades.
=688  \\$a96; was see PLAY AND PLAYTHINGS 1984-95
=750  \0$aVideo games$5IEN-M$0(DLC)sh 85143202
=750  \0$iNarrower mapping$aAnimal Crossing video games$0(DLC)sh2021006922$4NM$5IEN-M
=750  \0$iNarrower mapping$aWalking simulator games$0(DLC)sh2022006107$4NM$5IEN-M
=750  \0$iNarrower mapping$aFree-to-play games$0(DLC)sh2022006036$4NM$5IEN-M
=750  \0$iNarrower mapping$aHorizon video games$0(DLC)sh2022006517$4NM$5IEN-M
=750  \0$iNarrower mapping$aVisual novels$0(DLC)sh2023000244$4NM$5DNLM

=LDR  01483cz  a2200445n  4500
=001  9818769686806676
=005  20240509090508.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012725
=035  \\$a(DNLM)D012725
=035  \\$a(NLM)98197774020000041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x802
=150  \\$aSexual Behavior
=450  \\$wnnna$aPremarital Sex Behavior
=450  \\$wnnna$aSex Behavior
=450  \\$wnnna$aSex Orientation
=450  \\$wnnna$aSexual Activities
=450  \\$aAnal Sex
=450  \\$aOral Sex
=450  \\$aSexual Activity
=450  \\$aSexual Orientation
=450  \\$wnnna$aActivities, Sexual
=450  \\$wnnna$aActivity, Sexual
=450  \\$wnnna$aBehavior, Premarital Sex
=450  \\$wnnna$aBehavior, Sex
=450  \\$wnnna$aBehavior, Sexual
=450  \\$wnnna$aOrientation, Sexual
=450  \\$wnnna$aSex, Anal
=450  \\$wnnna$aSex, Oral
=550  \\$aSex
=550  \\$aReproductive Behavior
=550  \\$aSexual Partners
=667  \\$ahuman only: SEXUAL BEHAVIOR, ANIMAL is available; do not confuse entry term SEXUAL ORIENTATION with GENDER IDENTITY (see note there)
=680  \\$iSexual activities of humans.
=688  \\$a2004 (1966)
=750  \0$aSex$5IEN$0(DLC)sh 85120549
=750  \0$iNarrower mapping$aPansexuality$0(DLC)sh2021015860$4NM$5DNLM

=LDR  00758cz  a2200217n  4500
=001  9818769687006676
=005  20240509084418.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012660
=035  \\$a(DNLM)D012660
=035  \\$a(NLM)98195377910000041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x559.$x598.$x745
=150  \\$aSemantics
=450  \\$wnnna$aSemantic
=667  \\$ado not confuse with LINGUISTICS or TERMINOLOGY AS TOPIC
=680  \\$iThe relationships between symbols and their meanings.
=750  \0$iNarrower mapping$aOronyms$0(DLC)sh2023000227$4NM$5DNLM
=750  \0$aSemantics$5IEN-HS$0(DLC)sh 85119870

=LDR  01467cz  a2200373n  4500
=001  9818769687206676
=005  20240510104216.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D010684
=035  \\$a(DNLM)D010684
=035  \\$a(NLM)98193917420000041
=040  \\$aDNLM$cDNLM
=072  \\$aK1.$x752
=150  \\$aPhilosophy
=450  \\$wnnna$aPharmacy Philosophy
=450  \\$wnnna$aPhilosophical Overview
=450  \\$aHedonism
=450  \\$aStoicism
=450  \\$wnnna$aOverview, Philosophical
=450  \\$wnnna$aOverviews, Philosophical
=450  \\$wnnna$aPharmacy Philosophies
=450  \\$wnnna$aPhilosophical Overviews
=450  \\$wnnna$aPhilosophies
=450  \\$wnnna$aPhilosophies, Pharmacy
=450  \\$wnnna$aPhilosophy, Pharmacy
=680  \\$iA love or pursuit of wisdom. A search for the underlying causes and principles of reality. (Webster, 3d ed)
=688  \\$a1963; for SECULARISM use RELIGION 1998-2001
=750  \0$aPhilosophy {dollar}5 IEN {dollar}0 (DLC)sh 85100849
=750  \0$iNarrower mapping$aPhilosophy, Belgian$0(DLC)sh2023000559$4NM$5DNLM
=750  \0$iNarrower mapping$aGrounding (Philosophy)$0(DLC)sh2023000316$4NM$5DNLM
=750  \0$iNarrower mapping$aGeneric, The (Philosophy)$0(DLC)sh2022006152$4NM$5DNLM
=750  \0$iNarrower mapping$aPosthumanism$0(DLC)sh2021001435$4NM$5DNLM

=LDR  02200cz  a2200589n  4500
=001  9818769687406676
=005  20240509083232.0
=008  990101\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D007603
=035  \\$a(DNLM)D007603
=035  \\$a(NLM)98199395760000041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x583
=072  \\$aN3.$x706.$x535
=150  \\$aJurisprudence
=450  \\$wnnna$aConstitutional Law
=450  \\$wnnna$aCourt Decision
=450  \\$wnnna$aLaw
=450  \\$wnnna$aLegal Aspects
=450  \\$wnnna$aLegal Obligations
=450  \\$wnnna$aLegal Status
=450  \\$wnnna$aState Interest
=450  \\$aLitigation
=450  \\$aMedical Jurisprudence
=450  \\$wnnna$aAspect, Legal
=450  \\$wnnna$aAspects, Legal
=450  \\$wnnna$aConstitutional Laws
=450  \\$wnnna$aCourt Decisions
=450  \\$wnnna$aDecision, Court
=450  \\$wnnna$aDecisions, Court
=450  \\$wnnna$aInterest, State
=450  \\$wnnna$aInterests, State
=450  \\$wnnna$aJurisprudence, Medical
=450  \\$wnnna$aLaw, Constitutional
=450  \\$wnnna$aLaws
=450  \\$wnnna$aLaws, Constitutional
=450  \\$wnnna$aLegal Aspect
=450  \\$wnnna$aLegal Obligation
=450  \\$wnnna$aLitigations
=450  \\$wnnna$aObligation, Legal
=450  \\$wnnna$aObligations, Legal
=450  \\$wnnna$aState Interests
=450  \\$wnnna$aStatus, Legal
=550  \\$aForensic Dentistry
=550  \\$aForensic Medicine
=550  \\$aLawyers
=667  \\$ageneral or unspecified; prefer specifics or /legis with a specific MeSH term; specify geographic location if pertinent; entry term MEDICAL JURISPRUDENCE: do not coordinate with MEDICINE; for civil suits: differentiate from FORENSIC MEDICINE which is for crime and identification
=680  \\$iThe science or philosophy of law. Also, the application of the principles of law and justice to health and medicine.
=750  \0$iNarrower mapping$aDuty of loyalty$0(DLC)sh2022008048$4NM$5DNLM
=750  \0$aJurisprudence$5IEN {dollar}0 (DLC)sh 85071088

=LDR  01985cz  a2200529n  4500
=001  9818769689006676
=005  20240507073833.0
=008  220708\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094024
=035  \\$a(DNLM)D000094024
=035  \\$a(NLM)9825515200700041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 506.5
=072  \\$aC1.$x748.$x610.$x763.$x500.$x500
=072  \\$aC1.$x925.$x705.$x500.$x500
=072  \\$aC1.$x925.$x782.$x600.$x550.$x200.$x163.$x500
=072  \\$aC8.$x381.$x677.$x807.$x500.$x500
=072  \\$aC8.$x730.$x610.$x763.$x500.$x500
=072  \\$aC23.$x550.$x291.$x500.$x829.$x375
=150  \\$aPost-Acute COVID-19 Syndrome
=450  \\$aLong COVID
=450  \\$aLong Haul COVID-19
=450  \\$aLong-Haul COVID
=450  \\$aPASC Post Acute Sequelae of COVID-19
=450  \\$aPost Acute COVID-19 Syndrome
=450  \\$aPost-Acute Sequelae of COVID-19
=450  \\$aPost-Acute Sequelae of SARS-CoV-2 Infection
=450  \\$aPost-COVID Conditions
=450  \\$wnnna$aCOVID, Long-Haul
=450  \\$wnnna$aCOVID-19 Post-Acute Sequelae
=450  \\$wnnna$aCOVID-19 Syndrome, Post-Acute
=450  \\$wnnna$aCOVID-19, Long Haul
=450  \\$wnnna$aLong Haul COVID
=450  \\$wnnna$aLong Haul COVID 19
=450  \\$wnnna$aLong Haul COVID-19s
=450  \\$wnnna$aLong-Haul COVIDs
=450  \\$wnnna$aPASC Post Acute Sequelae of COVID 19
=450  \\$wnnna$aPost Acute COVID 19 Syndrome
=450  \\$wnnna$aPost Acute Sequelae of COVID 19
=450  \\$wnnna$aPost Acute Sequelae of SARS CoV 2 Infection
=450  \\$wnnna$aPost COVID Conditions
=450  \\$wnnna$aPost-Acute COVID-19 Syndromes
=450  \\$wnnna$aPost-COVID Condition
=680  \\$iPost acute stage of COVID-19 virus infection. Persistent symptoms may include FATIGUE; DYSPNEA; and MEMORY LOSS.
=688  \\$a2023(2020)
=750  \0$aPost COVID-19 condition (Disease)$0(DLC)sh2022007836$5DNLM

=LDR  01227cz  a2200325n  4500
=001  9882487556402441
=005  20241022104639.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089803
=035  \\$a(DNLM)D000089803
=035  \\$a(NLM)9819990281100041
=040  \\$aDNLM$cDNLM
=060  \0$aWB 537
=072  \\$aE2.$x190.$x599.$x750.$x750.$x750
=072  \\$aE2.$x779.$x867.$x880.$x750.$x750
=072  \\$aE2.$x831.$x535.$x867.$x880.$x750.$x750
=150  \\$aMyofascial Release Therapy
=450  \\$aMyofascial Release
=450  \\$aMyofascial Release Treatment
=450  \\$aMyofascial Treatment
=450  \\$wnnna$aMyofascial Release Therapies
=450  \\$wnnna$aMyofascial Release Treatments
=450  \\$wnnna$aMyofascial Treatments
=450  \\$wnnna$aTherapy, Myofascial Release
=450  \\$wnnna$aTreatment, Myofascial
=450  \\$wnnna$aTreatment, Myofascial Release
=680  \\$iA massage therapy which focuses on releasing MUSCLE TIGHTNESS often used to relieve muscular pain from myofascial tissues (e.g., MYOFASCIAL PAIN SYNDROME).
=688  \\$a2022
=750  \0$iBroader mapping$aMassage$0(DLC)sh 85081957 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01329cz  a2200361n  4500
=001  9882487558802441
=005  20241022105156.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090243
=035  \\$a(DNLM)D000090243
=035  \\$a(NLM)9819990504800041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x660.$x694
=150  \\$aNucleophosmin
=450  \\$aNO38 Protein
=450  \\$aNucleolar Phosphoprotein B23
=450  \\$aNucleolar Protein B23
=450  \\$aNucleophosmid
=450  \\$aNumatrin
=450  \\$aPhosphoprotein B23, Nucleolus
=450  \\$aProtein B23
=450  \\$wnnna$aB23, Nucleolar Phosphoprotein
=450  \\$wnnna$aB23, Nucleolar Protein
=450  \\$wnnna$aB23, Nucleolus Phosphoprotein
=450  \\$wnnna$aB23, Protein
=450  \\$wnnna$aNucleolus Phosphoprotein B23
=450  \\$wnnna$aPhosphoprotein B23, Nucleolar
=450  \\$wnnna$aProtein B23, Nucleolar
=450  \\$wnnna$aProtein, NO38
=680  \\$iPredominantly localized in the CELL NUCLEOLUS, involved in diverse cellular processes such as ribosome biogenesis, cytoplasmic-nuclear trafficking, centrosome duplication, and regulation of p53.
=688  \\$a2022 (1981)
=750  \0$iBroader mapping$aNuclear proteins$0(DLC)sh2008009187$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01433cz  a2200349n  4500
=001  9882487558902441
=005  20241022104310.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087504
=035  \\$a(DNLM)D000087504
=035  \\$a(NLM)9819990172700041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x828.$x868.$x228
=072  \\$aD20.$x215.$x894.$x865.$x450
=072  \\$aD23.$x50.$x865.$x450
=150  \\$aNucleic Acid-Based Vaccines
=450  \\$aNucleic Acid Vaccine
=450  \\$aNucleic Acid Vaccines
=450  \\$aPolynucleotide Vaccine
=450  \\$aPolynucleotide Vaccines
=450  \\$wnnna$aNucleic Acid Based Vaccines
=450  \\$wnnna$aVaccine, Nucleic Acid
=450  \\$wnnna$aVaccine, Polynucleotide
=450  \\$wnnna$aVaccines, Nucleic Acid
=450  \\$wnnna$aVaccines, Nucleic Acid-Based
=450  \\$wnnna$aVaccines, Polynucleotide
=680  \\$iVaccines formulated with nucleic acids specific for a target antigen. They are designed to induce antibody production against the target by host.
=688  \\$a2022(1997)
=750  \0$81$wb$iBroader mapping$aNucleic acids$0(DLC)sh 85093144$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aVaccines$0(DLC)sh 85141718$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aNucleic acids$iand$aVaccines$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00990cz  a2200253n  4500
=001  9882487559002441
=005  20241022105053.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088783
=035  \\$a(DNLM)D000088783
=035  \\$a(NLM)9819990397300041
=040  \\$aDNLM$cDNLM
=072  \\$aG11.$x427.$x410.$x568.$x900.$x813
=072  \\$aG11.$x427.$x410.$x698.$x277.$x937.$x250
=072  \\$aI3.$x350.$x937.$x250
=072  \\$aI3.$x450.$x642.$x845.$x940.$x500
=150  \\$aNordic Walking
=450  \\$aPole Walking
=450  \\$wnnna$aWalking, Nordic
=450  \\$wnnna$aWalking, Pole
=680  \\$iForm of brisk walking, utilizing walking poles, which actively engages the trunk and upper limbs during walking, maintaining the natural gait, while the hands are performing an open-close cycle in an alternating manner.
=688  \\$a2022
=750  \0$iBroader mapping$aWalking$0(DLC)sh 85144900 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01021cz  a2200301n  4500
=001  9882487559102441
=005  20241022104950.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090862
=035  \\$a(DNLM)D000090862
=035  \\$a(NLM)9819990207800041
=040  \\$aDNLM$cDNLM
=060  \0$aWL 140
=072  \\$aC10.$x586
=072  \\$aC23.$x550.$x470.$x544
=150  \\$aNeuroinflammatory Diseases
=450  \\$aNeuroinflammation
=450  \\$aNeuroinflammatory Disorders
=450  \\$wnnna$aDisease, Neuroinflammatory
=450  \\$wnnna$aDisorder, Neuroinflammatory
=450  \\$wnnna$aNeuroinflammations
=450  \\$wnnna$aNeuroinflammatory Disease
=450  \\$wnnna$aNeuroinflammatory Disorder
=667  \\$ageneral or unspecified; prefer specifics
=680  \\$iDiseases characterized by inflammation of the nervous tissue.
=688  \\$a2022
=750  \0$iBroader mapping$aNervous system$xDiseases$0(DLC)sh 85090924$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01314cz  a2200313n  4500
=001  9882487559202441
=005  20241022104840.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091484
=035  \\$a(DNLM)D000091484
=035  \\$a(NLM)9819990671600041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x290.$x563.$x500
=150  \\$aNetwork Pharmacology
=450  \\$aDrug-Target Network
=450  \\$aSystematic Pharmacology
=450  \\$aSystems Pharmacology
=450  \\$wnnna$aDrug Target Network
=450  \\$wnnna$aDrug-Target Networks
=450  \\$wnnna$aNetwork, Drug-Target
=450  \\$wnnna$aNetworks, Drug-Target
=450  \\$wnnna$aPharmacology, Network
=450  \\$wnnna$aPharmacology, Systematic
=450  \\$wnnna$aPharmacology, Systems
=550  \\$aPolypharmacology
=680  \\$iA systems-based pharmacologic discovery process used to predict the multiple targets of multiple drugs in a complex mixture such as CHINESE HERBAL DRUGS.  It involves analytical detection of chemicals plus prediction of pharmacologic activity and protein targets for each compound in the mixture and aggregating the net physiological effect.
=688  \\$a2022
=750  \0$iBroader mapping$aPharmacology$0(DLC)sh 85100599$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01817cz  a2200361n  4500
=001  9882487559302441
=005  20241022104214.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091542
=035  \\$a(DNLM)D000091542
=035  \\$a(NLM)9819990668600041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x853.$x500.$x525
=072  \\$aN1.$x224.$x791.$x775
=072  \\$aN6.$x850.$x505.$x400.$x800.$x775
=150  \\$aNeighborhood Characteristics
=450  \\$aNeighborhood Disadvantage
=450  \\$aNeighborhood Effects
=450  \\$aNeighborhood Environment
=450  \\$aNeighborhood Safety
=450  \\$wnnna$aEffect, Neighborhood
=450  \\$wnnna$aEnvironment, Neighborhood
=450  \\$wnnna$aNeighborhood Disadvantages
=450  \\$wnnna$aNeighborhood Effect
=450  \\$wnnna$aNeighborhood Environments
=450  \\$wnnna$aSafety, Neighborhood
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH; specify geographic location if pertinent
=680  \\$iCharacteristics that may describe the demographic, social, built environment, or economic characteristics of a geographic area in which people live and can affect health and well-being of neighborhood residents. Neighborhood environments include the physical environment (unsafe air/water), built environment   (sidewalks/greenspace) and the social environment (safety, sense of community).
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aNeighborhoods$0(DLC)sh 85090662$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aQuality of life$0(DLC)sh 85109445$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aNeighborhoods$iand$aQuality of life$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01389cz  a2200373n  4500
=001  9882487559402441
=005  20241022104739.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090783
=035  \\$a(DNLM)D000090783
=035  \\$a(NLM)9819990220700041
=040  \\$aDNLM$cDNLM
=072  \\$aD26.$x255.$x260.$x750
=072  \\$aE2.$x319.$x300.$x380.$x800
=150  \\$aNanoparticle Drug Delivery System
=450  \\$aNDDSs
=450  \\$aNano Delivery System
=450  \\$aNano Drug Delivery Systems
=450  \\$aNano-Drug Delivery System
=450  \\$aNanoparticle Based Drug Delivery System
=450  \\$wnnna$aDelivery System, Nano
=450  \\$wnnna$aDelivery System, Nano-Drug
=450  \\$wnnna$aDelivery Systems, Nano
=450  \\$wnnna$aDelivery Systems, Nano-Drug
=450  \\$wnnna$aNano Delivery Systems
=450  \\$wnnna$aNano Drug Delivery System
=450  \\$wnnna$aSystem, Nano Delivery
=450  \\$wnnna$aSystem, Nano-Drug Delivery
=450  \\$wnnna$aSystems, Nano Delivery
=450  \\$wnnna$aSystems, Nano-Drug Delivery
=680  \\$iEngineered NANOPARTICLES with unique physiochemical properties which improve drug BIOAVAILABILITY and site specific drug delivery.
=688  \\$a2022
=750  \0$iBroader mapping$aDrug carriers (Pharmacy)$0(DLC)sh 85039758 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00767cz  a2200229n  4500
=001  9882487559602441
=005  20241022104431.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091203
=035  \\$a(DNLM)D000091203
=035  \\$a(NLM)9819990426300041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x755.$x750
=072  \\$aD27.$x505.$x696.$x477.$x656.$x625
=072  \\$aD27.$x505.$x954.$x248.$x538
=150  \\$aMTOR Inhibitors
=450  \\$aRapalogs
=450  \\$wnnna$aInhibitors, MTOR
=680  \\$iAgents that inhibit the activity of TOR SERINE-THREONINE KINASES.
=688  \\$a2022
=750  \0$iBroader mapping$aProtein kinases$xInhibitors$0(DLC)sh2020001156$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01489cz  a2200349n  4500
=001  9882487560002441
=005  20241022104119.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090006
=035  \\$a(DNLM)D000090006
=035  \\$a(NLM)9819990323000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x211.$x532
=150  \\$aMolybdenum Cofactors
=450  \\$aMolybdenum-Containing Cofactors
=450  \\$aPterin-based Molybdenum Cofactor
=450  \\$aPterin-based Molybdenum Cofactors
=450  \\$wnnna$aCofactor, Pterin-based Molybdenum
=450  \\$wnnna$aCofactors, Molybdenum
=450  \\$wnnna$aCofactors, Molybdenum-Containing
=450  \\$wnnna$aCofactors, Pterin-based Molybdenum
=450  \\$wnnna$aMolybdenum Cofactor, Pterin-based
=450  \\$wnnna$aMolybdenum Cofactors, Pterin-based
=450  \\$wnnna$aMolybdenum Containing Cofactors
=450  \\$wnnna$aPterin based Molybdenum Cofactor
=450  \\$wnnna$aPterin based Molybdenum Cofactors
=680  \\$iEnzyme co-factors that contain MOLYBDENUM. They play an essential role in a variety of cellular REDOX reactions.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aMolybdenum$0(DLC)sh 85086637$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aCoenzymes$0(DLC)sh 85027690$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aMolybdenum$iand$aCoenzymes$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  02546cz  a2200541n  4500
=001  9882487560202441
=005  20241022104016.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090622
=035  \\$a(DNLM)D000090622
=035  \\$a(NLM)9819990227200041
=040  \\$aDNLM$cDNLM
=072  \\$aD5.$x500.$x469
=072  \\$aD5.$x500.$x890.$x563
=072  \\$aD12.$x776.$x543.$x585.$x475.$x594
=072  \\$aD12.$x776.$x575.$x750.$x594
=150  \\$aMitochondrial Precursor Protein Import Complex Proteins
=450  \\$aMIA Complex
=450  \\$aMIM Complex
=450  \\$aMitochondrial Import Complex
=450  \\$aMitochondrial Intermembrane Space Import and Assembly Complex
=450  \\$aMitochondrial Precursor Protein Import Machinery Proteins
=450  \\$aMitochondrial Preprotein Translocases
=450  \\$aMitochondrial Protein Import Machinery Proteins
=450  \\$aSAM Complex
=450  \\$aSorting and Assembly Machinery Complex
=450  \\$aTIM Complex
=450  \\$aTIM23 Complex
=450  \\$aTIMM Complex
=450  \\$aTOM Channel
=450  \\$aTOM Complex
=450  \\$aTOM Translocase
=450  \\$aTOMM Complex
=450  \\$aTOMM Machinery
=450  \\$aTranslocase Outer Mitochondrial Membrane
=450  \\$aTranslocase of the Inner Membrane Complex
=450  \\$aTranslocase of the Inner Mitochondrial Membrane Complex
=450  \\$aTranslocase of the Outer Membrane Complex
=450  \\$aTranslocases of the Inner Membrane 23 Complex
=450  \\$aTranslocases of the Inner Membrane Complex
=450  \\$wnnna$aImport Complex, Mitochondrial
=450  \\$wnnna$aPreprotein Translocases, Mitochondrial
=450  \\$wnnna$aTranslocase, TOM
=450  \\$wnnna$aTranslocases, Mitochondrial Preprotein
=680  \\$iMultiprotein complexes that mediate import and sorting of mitochondrial preproteins into one of the four mitochondrial subcompartments: the outer membrane, the intermembrane space, the inner membrane, and the matrix. Mitochondrial protein import machinery includes translocase of the outer membrane (TOM) complex, translocases of the inner membrane (TIM) complex, beta‐barrel pathway complex, the mitochondrial intermembrane space import and assembly (MIA) pathway complex, carrier proteins of the inner membrane and the TIM23 complex and sorting and assembly machinery (SAM) complex.
=688  \\$a2022(2006)
=750  \0$iBroader mapping$aProtein complexes$0(DLC)sh2022007451$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01104cz  a2200253n  4500
=001  9882487560502441
=005  20241022103851.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088762
=035  \\$a(DNLM)D000088762
=035  \\$a(NLM)9819990403400041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x831.$x535.$x680
=150  \\$aMirror Movement Therapy
=450  \\$aMirror Therapy
=450  \\$wnnna$aMirror Movement Therapies
=450  \\$wnnna$aMovement Therapies, Mirror
=450  \\$wnnna$aMovement Therapy, Mirror
=450  \\$wnnna$aTherapies, Mirror Movement
=450  \\$wnnna$aTherapy, Mirror Movement
=680  \\$iRehabilitation therapy in which a mirror is placed between the arms or legs so that the image of a moving non-affected limb gives the illusion of normal movement in the affected limb. This stimulates different brain regions for movement, sensation, and pain. (www.cochrane.org/CD008449 access 12/28/2020)
=688  \\$a2022
=750  \0$iBroader mapping$aPhysical Therapy$0(DLC)sh 85101568 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01329cz  a2200289n  4500
=001  9882487560602441
=005  20241022103741.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088442
=035  \\$a(DNLM)D000088442
=035  \\$a(NLM)9819990390700041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x280.$x647.$x500.$x328
=072  \\$aC14.$x907.$x585.$x500.$x422
=072  \\$aC23.$x550.$x513.$x355.$x750.$x328
=072  \\$aC23.$x550.$x717.$x489.$x750.$x328
=150  \\$aMINOCA
=450  \\$aMyocardial Infarction and Non-obstructed Coronary Arteries
=450  \\$aMyocardial Infarction and Nonobstructed Coronary Arteries
=450  \\$aMyocardial Infarction with Non-obstructive Coronary Arteries
=450  \\$aMyocardial Infarction with Nonobstructive Coronary Arteries
=450  \\$wnnna$aMyocardial Infarction and Non obstructed Coronary Arteries
=450  \\$wnnna$aMyocardial Infarction with Non obstructive Coronary Arteries
=680  \\$iMyocardial infarction in the absence of obstructive coronary artery disease. CORONARY CIRCULATION disruption is due to various other factors such as ATHEROSCLEROTIC PLAQUE and CORONARY VASOSPASM.
=688  \\$a2022
=750  \0$iBroader mapping$aMyocardial infarction$0(DLC)sh 85059683 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01025cz  a2200301n  4500
=001  9882487560702441
=005  20241022103607.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090023
=035  \\$a(DNLM)D000090023
=035  \\$a(NLM)9819990312900041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x556.$x670.$x500
=072  \\$aD12.$x776.$x631.$x540
=150  \\$aMetallothionein 3
=450  \\$aGrowth Inhibitory Factor
=450  \\$aMT-III
=450  \\$aMetallothionein III
=450  \\$aMetallothionein-III
=450  \\$wnnna$a3, Metallothionein
=450  \\$wnnna$aFactor, Growth Inhibitory
=450  \\$wnnna$aIII, Metallothionein
=450  \\$wnnna$aInhibitory Factor, Growth
=450  \\$wnnna$aMT III
=680  \\$iA metallothionein that exhibits neuroinhibitory activity and is involved in the repair of neuronal damage.
=688  \\$a2022 (1993)
=750  \0$iBroader mapping$aMetallothionein$0(DLC)sh 85084134 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01676cz  a2200385n  4500
=001  9882487560802441
=005  20241022103344.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091246
=035  \\$a(DNLM)D000091246
=035  \\$a(NLM)9819990407800041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x269.$x750
=072  \\$aA11.$x118.$x637.$x555.$x567.$x569.$x500.$x75
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x550.$x500.$x75
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x569.$x500.$x75
=072  \\$aA15.$x382.$x490.$x555.$x567.$x550.$x500.$x75
=072  \\$aA15.$x382.$x490.$x555.$x567.$x569.$x500.$x75
=150  \\$aMemory T Cells
=450  \\$aCentral Memory T Cells
=450  \\$aEffector Memory T Cells
=450  \\$aMemory T Lymphocytes
=450  \\$aTissue Resident Memory T Cells
=450  \\$aVirtual Memory T Cells
=450  \\$wnnna$aLymphocyte, Memory T
=450  \\$wnnna$aLymphocytes, Memory T
=450  \\$wnnna$aMemory T Cell
=450  \\$wnnna$aMemory T Lymphocyte
=450  \\$wnnna$aT Cell, Memory
=450  \\$wnnna$aT Lymphocyte, Memory
=450  \\$wnnna$aT Lymphocytes, Memory
=680  \\$iA subset of activated T cells generated in response to primary immune challenge or immunization upon re-challenge (see IMMUNOLOGIC MEMORY). Memory T cells feature many discrete properties indicative of various differentiation such as expression pattern of CCR7 RECEPTORS and can be divided into central memory and effector memory T cells.
=688  \\$a2022
=750  \0$iBroader mapping$aT cells$0(DLC)sh 85131766 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01634cz  a2200349n  4500
=001  9882487561002441
=005  20241022103211.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091245
=035  \\$a(DNLM)D000091245
=035  \\$a(NLM)9819990409300041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x63.$x438.$x450.$x650
=072  \\$aA11.$x118.$x637.$x555.$x567.$x269.$x500
=072  \\$aA11.$x118.$x637.$x555.$x567.$x550.$x450.$x650
=072  \\$aA11.$x118.$x637.$x555.$x567.$x562.$x200.$x650
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x550.$x450.$x650
=072  \\$aA15.$x145.$x229.$x637.$x555.$x567.$x562.$x200.$x650
=072  \\$aA15.$x382.$x32.$x438.$x450.$x650
=072  \\$aA15.$x382.$x490.$x555.$x567.$x562.$x450.$x650
=150  \\$aMemory B Cells
=450  \\$aMemory B-Lymphocytes
=450  \\$wnnna$aB Cell, Memory
=450  \\$wnnna$aB-Lymphocyte, Memory
=450  \\$wnnna$aB-Lymphocytes, Memory
=450  \\$wnnna$aMemory B Cell
=450  \\$wnnna$aMemory B Lymphocytes
=450  \\$wnnna$aMemory B-Lymphocyte
=680  \\$iA subset of activated B cells generated in response to primary immune challenge or immunization which are capable of giving rise to antibody-secreting cells upon re-challenge (see IMMUNOLOGIC MEMORY). Memory B cells feature many discrete properties indicative of differentiation through ISOTYPE SWITCHING and/or IMMUNOGLOBULIN SOMATIC HYPERMUTATION for rapid and robust recall of specific antibody responses.
=688  \\$a2022
=750  \0$iBroader mapping$aB cells$0(DLC)sh 85010707 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01242cz  a2200289n  4500
=001  9882487561202441
=005  20241022103104.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090267
=035  \\$a(DNLM)D000090267
=035  \\$a(NLM)9819990479500041
=040  \\$aDNLM$cDNLM
=072  \\$aC20.$x762.$x500
=150  \\$aMast Cell Activation Syndrome
=450  \\$wnnna$aMast Cell Activation Syndromes
=450  \\$aIdiopathic Mast Cell Activation Disorder
=450  \\$aNon-Clonal Mast Cell Activation Disorder
=450  \\$aNon-Clonal Mast Cell Activation Syndrome
=450  \\$aNonclonal Mast Cell Activation Syndrome
=450  \\$anc-MCAS
=450  \\$wnnna$aNon Clonal Mast Cell Activation Disorder
=450  \\$wnnna$aNon Clonal Mast Cell Activation Syndrome
=450  \\$wnnna$anc MCAS
=680  \\$iA clinically and genetically heterogeneous group of mast cell disorders in which there is aberrant release of mast cell mediators with little to no accompanying proliferation of MAST CELLS.
=688  \\$a2022; for MAST CELL ACTIVATION SYNDROME use MASTOCYTOSIS 2018-2021
=750  \0$iBroader mapping$aMast cell disease$0(DLC)sh 85081981 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01357cz  a2200337n  4500
=001  9882487561402441
=005  20241022103005.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088263
=035  \\$a(DNLM)D000088263
=035  \\$a(NLM)9819990116100041
=040  \\$aDNLM$cDNLM
=072  \\$aA2.$x835.$x232.$x781.$x324.$x502.$x632.$x365
=150  \\$aMandibular Canal
=450  \\$aBifid Mandibular Canal
=450  \\$aInferior Alveolar Canal
=450  \\$aInferior Alveolar Foramen
=450  \\$aTrifid Mandibular Canals
=450  \\$wnnna$aAlveolar Canal, Inferior
=450  \\$wnnna$aAlveolar Foramen, Inferior
=450  \\$wnnna$aBifid Mandibular Canals
=450  \\$wnnna$aCanal, Mandibular
=450  \\$wnnna$aInferior Alveolar Canals
=450  \\$wnnna$aMandibular Canal, Bifid
=450  \\$wnnna$aMandibular Canal, Trifid
=450  \\$wnnna$aMandibular Canals
=450  \\$wnnna$aTrifid Mandibular Canal
=680  \\$iInternal aspect of the mandible from the MENTAL FORAMEN to the mandibular foramen which serves as the conduit for the INFERIOR ALVEOLAR NERVE and the inferior alveolar artery and vein. Bifid and trifid mandibular canals are normal anatomical variants.
=688  \\$a2022
=750  \0$iBroader mapping$aMandible$0(DLC)sh 85080435$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00726cz  a2200193n  4500
=001  9882487593802441
=005  20241022102902.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090562
=035  \\$a(DNLM)D000090562
=035  \\$a(NLM)9819990236600041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x578
=150  \\$aLuciferins
=450  \\$aLuciferin
=680  \\$iOrganic substances found in organisms that generate BIOLUMINESCENCE such as FIREFLY LUCIFERIN that produces light when oxidized to the excited oxyluciferin by the action of the enzyme LUCIFERASE.
=688  \\$a2022
=750  \0$iBroader mapping$aOrganic compounds$0(DLC)sh 85095499 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01452cz  a2200337n  4500
=001  9882487593902441
=005  20241022102757.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090122
=035  \\$a(DNLM)D000090122
=035  \\$a(NLM)9819990501500041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x355.$x830.$x573
=072  \\$aC17.$x800.$x862.$x406
=150  \\$aLivedoid Vasculopathy
=450  \\$aIdiopathic Atrophic Blanche
=450  \\$aLivedo Reticularis with Summer Ulceration
=450  \\$aLivedo Vasculitis
=450  \\$aLivedoid Vasculitis
=450  \\$aWhite Atrophy
=450  \\$wnnna$aAtrophic Blanche, Idiopathic
=450  \\$wnnna$aBlanches, Idiopathic Atrophic
=450  \\$wnnna$aLivedo Vasculitides
=450  \\$wnnna$aLivedoid Vasculopathies
=450  \\$wnnna$aVasculitis, Livedo
=450  \\$wnnna$aVasculitis, Livedoid
=450  \\$wnnna$aVasculopathy, Livedoid
=680  \\$iA rare cutaneous thrombotic disease due to occlusion of dermal vessels. It is characterized by purpuric maculae and ulcerations especially during summer which form scars called atrophie blanche. It is more associated with other syndromes (e.g., PROTEIN C DEFICIENCY; HYPERHOMOCYSTEINEMIA). Livedo reticularis with systemic involvement and stroke is SNEDDON SYNDROME.
=688  \\$a2022
=750  \0$iBroader mapping$aThrombosis$0(DLC)sh 85135077$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00894cz  a2200229n  4500
=001  9882487594102441
=005  20241022102645.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088746
=035  \\$a(DNLM)D000088746
=035  \\$a(NLM)9819990404600041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x463.$x593.$x71.$x375
=072  \\$aG7.$x888.$x125.$x375
=150  \\$aListening Effort
=450  \\$wnnna$aEffort, Listening
=450  \\$wnnna$aEfforts, Listening
=450  \\$wnnna$aListening Efforts
=680  \\$iThe deliberate allocation of mental resources to overcome obstacles in goal pursuit when carrying out a task, with listening effort applied more when tasks involved listening. (From Pichora-Fuller et al.2016)
=688  \\$a2022
=750  \0$iBroader mapping$aAuditory perception$0(DLC)sh 85009496$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01433cz  a2200397n  4500
=001  9882487594302441
=005  20241022102547.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089823
=035  \\$a(DNLM)D000089823
=035  \\$a(NLM)9819990327700041
=040  \\$aDNLM$cDNLM
=072  \\$aF2.$x970.$x250
=150  \\$aLife Course Perspective
=450  \\$wnnna$aAnalysis, Event History
=450  \\$wnnna$aEvent History Analysis
=450  \\$aControl Balance Theory
=450  \\$aIntegrated Life Course Theories
=450  \\$aIntegrated Theories
=450  \\$aLatent Trait Theories
=450  \\$aLatent Trait Theory
=450  \\$aLife Course Theories
=450  \\$aLife Course Theory
=450  \\$wnnna$aControl Balance Theories
=450  \\$wnnna$aEvent History Analyses
=450  \\$wnnna$aIntegrated Theory
=450  \\$wnnna$aLife Course Perspectives
=450  \\$wnnna$aPerspective, Life Course
=450  \\$wnnna$aTheory, Control Balance
=450  \\$wnnna$aTheory, Integrated
=450  \\$wnnna$aTheory, Latent Trait
=450  \\$wnnna$aTheory, Life Course
=680  \\$iAn approach to analyze one's life within the framework of various circumstances experienced in a given society throughout entirety of life.
=688  \\$a2022
=750  \0$iBroader mapping$aSocial sciences$xPhilosophy$0(DLC)sh 85124013 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01102cz  a2200277n  4500
=001  9882487594502441
=005  20241022102246.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090263
=035  \\$a(DNLM)D000090263
=035  \\$a(NLM)9819990244100041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x529
=150  \\$aLeucine-Rich Repeat Proteins
=450  \\$aLRR Proteins
=450  \\$aLeucine-Rich Repeat Protein
=450  \\$wnnna$aLeucine Rich Repeat Protein
=450  \\$wnnna$aProtein, Leucine-Rich Repeat
=450  \\$wnnna$aProteins, LRR
=450  \\$wnnna$aProteins, Leucine-Rich Repeat
=450  \\$wnnna$aRepeat Protein, Leucine-Rich
=450  \\$wnnna$aRepeat Proteins, Leucine-Rich
=680  \\$iA protein with a three-dimensional structure that forms an alpha/beta horseshoe fold. It is found in a large number of proteins with diverse functions, including in INNATE IMMUNITY RESPONSE and NERVOUS SYSTEM.
=688  \\$a2022 (1997)
=750  \0$iBroader mapping$aProteins$0(DLC)sh 85107666 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01805cz  a2200385n  4500
=001  9882487594602441
=005  20241022102138.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088502
=035  \\$a(DNLM)D000088502
=035  \\$a(NLM)9819990383900041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x384
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x472
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x880.$x810.$x375
=150  \\$aLamellar Bodies
=450  \\$aLamellar Granules
=450  \\$aLamellar Lysosomes
=450  \\$aMembrane Coating Granules
=450  \\$aMembrane-Coating Granules
=450  \\$aOdland Bodies
=450  \\$wnnna$aBody, Lamellar
=450  \\$wnnna$aGranule, Lamellar
=450  \\$wnnna$aGranule, Membrane Coating
=450  \\$wnnna$aGranule, Membrane-Coating
=450  \\$wnnna$aLamellar Body
=450  \\$wnnna$aLamellar Granule
=450  \\$wnnna$aLamellar Lysosome
=450  \\$wnnna$aLysosome, Lamellar
=450  \\$wnnna$aMembrane Coating Granule
=450  \\$wnnna$aMembrane-Coating Granule
=680  \\$iEndolysosomal organelles surrounded by multi-lamellar MEMBRANE LIPIDS. They are involved in diverse functions in storage and secretion of cellular LIPIDS. Lamellar bodies in the TYPE 2 PNEUMOCYTES produce and secrete PULMONARY SURFACTANT (e.g., DIPALMITOYL PHOSPHATIDYLCHOLINE). Lamellar bodies in the skin produce and secrete neutral lipids to provide hydrophobic barrier. Pathological accumulation of lamellar bodies are also known in lipid storage diseases (e.g.,LCAT DEFICIENCY;  and HERMANSKY-PUDLAK SYNDROME).
=688  \\$a2022
=750  \0$iBroader mapping$aCytoplasmic granules$0(DLC)sh 92000011$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01565cz  a2200397n  4500
=001  9882487594702441
=005  20241022102011.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090062
=035  \\$a(DNLM)D000090062
=035  \\$a(NLM)9819990274500041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x260.$x522.$x532
=072  \\$aD12.$x776.$x930.$x375.$x532
=150  \\$aKruppel-Like Factor 4
=450  \\$aEZF Protein
=450  \\$aEndothelial Kruppel-Like Zinc Finger Protein
=450  \\$aEpithelial Zinc Finger Protein
=450  \\$aGKLF Protein
=450  \\$aGut-Enriched Kruppel-Like Factor
=450  \\$aKlf4 Protein
=450  \\$aKrueppel-Like-Factor 4
=450  \\$wnnna$a4, Krueppel-Like-Factor
=450  \\$wnnna$a4, Kruppel-Like Factor
=450  \\$wnnna$aEndothelial Kruppel Like Zinc Finger Protein
=450  \\$wnnna$aFactor 4, Kruppel-Like
=450  \\$wnnna$aFactor, Gut-Enriched Kruppel-Like
=450  \\$wnnna$aGut Enriched Kruppel Like Factor
=450  \\$wnnna$aKruppel Like Factor 4
=450  \\$wnnna$aProtein, EZF
=450  \\$wnnna$aProtein, GKLF
=450  \\$wnnna$aProtein, Klf4
=680  \\$iA member of zinc finger-containing transcription factors that belongs to the KRUPPEL-LIKE FACTOR family, involved in the regulation of diverse cellular processes such as cell growth, proliferation, differentiation, and APOPTOSIS.
=688  \\$a2022 (1997)
=750  \0$iBroader mapping$aZinc-finger proteins$0(DLC)sh 93002533 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00918cz  a2200241n  4500
=001  9882487594802441
=005  20241022101831.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090265
=035  \\$a(DNLM)D000090265
=035  \\$a(NLM)9819990258000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x277.$x450.$x426.$x500
=072  \\$aD12.$x776.$x543.$x750.$x750.$x400.$x370.$x250
=150  \\$aKlotho Proteins
=450  \\$aalpha-Klotho Proteins
=450  \\$abeta-Klotho Proteins
=450  \\$wnnna$aalpha Klotho Proteins
=450  \\$wnnna$abeta Klotho Proteins
=680  \\$iMembrane bound glucuronidase enzymes that may play a role in activation of FIBROBLAST GROWTH FACTORS, and in the regulation of a variety of cell signaling pathways.
=688  \\$a2022
=750  \0$iBroader mapping$aGlucuronidase$0(DLC)sh 85055370 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00853cz  a2200253n  4500
=001  9882487595002441
=005  20241021155534.0
=008  040707\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D047428
=035  \\$a(DNLM)D047428
=035  \\$a(NLM)98197431150000041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x519.$x389.$x755
=150  \\$aProtein Kinase Inhibitors
=450  \\$aProtein Kinase Inhibitor
=450  \\$wnnna$aInhibitor, Protein Kinase
=450  \\$wnnna$aInhibitors, Protein Kinase
=450  \\$wnnna$aKinase Inhibitor, Protein
=450  \\$wnnna$aKinase Inhibitors, Protein
=450  \\$aProtein Kinases$xantagonists & inhibitors
=680  \\$iAgents that inhibit PROTEIN KINASES.
=688  \\$a2005
=750  \0$aProtein kinases |x Inhibitors$0(DLC)sh2020001156$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00988cz  a2200181n  4500
=001  9882487595502441
=005  20241021155530.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088828
=035  \\$a(DNLM)D000088828
=035  \\$a(NLM)9819990148500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x45.$x500
=150  \\$aMicroaggression
=680  \\$iBrief verbal, behavioral, or situational indignities that communicate hostile, derogatory, or negative slights or insults. It may may be intentional or implicit. Three subtypes have been identified: microassaults, which are purposefully discriminatory actions; microinsults, which are subtle snubs that devalue a person's identity; and microinvalidations, which are unintentional exclusions or negations of an individual's thoughts. (dictionary.apa.org/microaggression 12/30/2020)
=688  \\$a2022
=750  \0$aMicroaggressions$0(DLC)sh2015001363$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01290cz  a2200337n  4500
=001  9882487595602441
=005  20241021155533.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088042
=035  \\$a(DNLM)D000088042
=035  \\$a(NLM)9819990139900041
=040  \\$aDNLM$cDNLM
=060  \0$aWM 420.5.M5
=072  \\$aF4.$x754.$x539
=150  \\$aMentalization-Based Therapy
=450  \\$aMentalization Based Therapy
=450  \\$aMentalization-Based Treatment
=450  \\$wnnna$aMentalization Based Therapies
=450  \\$wnnna$aMentalization Based Treatment
=450  \\$wnnna$aMentalization-Based Therapies
=450  \\$wnnna$aMentalization-Based Treatments
=450  \\$wnnna$aTherapies, Mentalization Based
=450  \\$wnnna$aTherapies, Mentalization-Based
=450  \\$wnnna$aTherapy, Mentalization Based
=450  \\$wnnna$aTherapy, Mentalization-Based
=450  \\$wnnna$aTreatment, Mentalization-Based
=450  \\$wnnna$aTreatments, Mentalization-Based
=680  \\$iMentalization-based therapy (MBT) is a type of long-term psychotherapy that is based on the use of MENTALIZATION.
=688  \\$aMentalization 2019-2021
=750  \0$aMentalization Based Therapy$0(DLC)sh2017000495$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01074cz  a2200253n  4500
=001  9882487595702441
=005  20241021155533.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091182
=035  \\$a(DNLM)D000091182
=035  \\$a(NLM)9819990596500041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x190.$x488.$x708
=072  \\$aI1.$x76.$x201.$x450.$x654.$x694
=150  \\$aMedicine, Persian
=450  \\$aAncient Iranian Medicine
=450  \\$aIranian Traditional Medicine
=450  \\$aMedicine, Persian Traditional
=450  \\$aPersian Traditional Medicine
=667  \\$atraditional practice only; not for modern medicine in Iran (= MEDICINE + IRAN); MEDICINE, ARABIC is also available; follow author's terminology; Avicenna (also called Ibn Sina) is indexed as Avicenna + BIOGRAPHY + HISTORY OF MEDICINE, MEDIEVAL
=680  \\$iTraditional concepts of medicine and associated methods reflected in medicine in PERSIA.
=688  \\$a2022
=750  \0$aMedicine, Persian$0(DLC)sh 85083158$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01570cz  a2200277n  4500
=001  9882487595902441
=005  20241021155533.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090362
=035  \\$a(DNLM)D000090362
=035  \\$a(NLM)9819990472000041
=040  \\$aDNLM$cDNLM
=072  \\$aC20.$x762
=150  \\$aMast Cell Activation Disorders
=450  \\$wnnna$aMast Cell Activation Disease
=450  \\$wnnna$aMast Cell Disease
=450  \\$aClonal Mast Cell Proliferation Disorders
=450  \\$aMast-Cell Disease
=450  \\$aMonoclonal Mast Cell Activation Syndrome
=450  \\$aPrimary Mast Cell Activation Disorders
=450  \\$wnnna$aMast Cell Diseases
=450  \\$wnnna$aMast-Cell Diseases
=680  \\$iA spectrum of primary, secondary, and idiopathic disorders involving MAST CELLS and characterized by an aberrant release of mast cell mediators which result in multiple and variable inflammatory and allergic symptoms. These disorders are associated with various mutations in tyrosine kinase KIT (PROTO-ONCOGENE PROTEINS C-KIT) and other genes, underlying conditions, and responses to allergic or non-allergic triggers of mast cell stimulation and degranulation such as local anesthetics, lactam antibiotics, muscle relaxants, specific foods, environmental toxins, physical conditions such as vibration, cold, pressure, and stress.
=688  \\$a2022; for MAST CELL ACTIVATION DISEASE use MASTOCYTOSIS 2018-2021
=750  \0$aMast cell disease$0(DLC)sh 85081981$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01014cz  a2200253n  4500
=001  9882487596002441
=005  20241021155533.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090522
=035  \\$a(DNLM)D000090522
=035  \\$a(NLM)9819990473100041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x542
=072  \\$aF1.$x145.$x875.$x281.$x500
=150  \\$aMass Gatherings
=450  \\$aPublic Demonstrations
=450  \\$wnnna$aDemonstration, Public
=450  \\$wnnna$aGathering, Mass
=450  \\$wnnna$aMass Gathering
=450  \\$wnnna$aPublic Demonstration
=680  \\$iOrganized or spontaneous events where the number of people attending is sufficient to strain the planning and response resources of the community hosting the event. (WHO, 2008). These events include the gathering of people as the result of natural disasters or conflict.
=688  \\$a2022
=750  \0$aCollective behavior$0(DLC)sh 85028094$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01006cz  a2200301n  4500
=001  9882487596202441
=005  20241021155533.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090465
=035  \\$a(DNLM)D000090465
=035  \\$a(NLM)9819990474600041
=040  \\$aDNLM$cDNLM
=072  \\$aN6.$x850.$x460.$x505
=150  \\$aLight Pollution
=450  \\$aArtificial Light at Night
=450  \\$aArtificial Night Lighting
=450  \\$aArtificial Night Sky Brightness
=450  \\$aSkyglow
=450  \\$wnnna$aArtificial Night Lightings
=450  \\$wnnna$aLighting, Artificial Night
=450  \\$wnnna$aLightings, Artificial Night
=450  \\$wnnna$aNight Lighting, Artificial
=450  \\$wnnna$aNight Lightings, Artificial
=450  \\$wnnna$aPollution, Light
=680  \\$iThe inappropriate or excessive use of artificial lighting at night.
=688  \\$a2022
=750  \0$aLight pollution$0(DLC)sh 00006855$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00805cz  a2200241n  4500
=001  9882487596402441
=005  20241021155534.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090464
=035  \\$a(DNLM)D000090464
=035  \\$a(NLM)9819990475700041
=040  \\$aDNLM$cDNLM
=072  \\$aN2.$x278.$x487.$x205
=150  \\$aLaboratories, Clinical
=450  \\$wnnna$aClinical Laboratories
=450  \\$wnnna$aClinical Laboratory
=450  \\$wnnna$aLaboratory, Clinical
=550  \\$aClinical Laboratory Techniques
=550  \\$aClinical Laboratory Services
=680  \\$iFacilities equipped to carry out CLINICAL LABORATORY TECHNIQUES.
=688  \\$a2022
=750  \0$aClinical chemistry laboratories$0(DLC)sh 90002366$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01278cz  a2200373n  4500
=001  9882487596502441
=005  20241021155534.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090463
=035  \\$a(DNLM)D000090463
=035  \\$a(NLM)9819990233800041
=040  \\$aDNLM$cDNLM
=060  \0$aQU 260.5.I7
=072  \\$aC18.$x452.$x565.$x400
=150  \\$aIron Deficiencies
=450  \\$aHypoferritinemia
=450  \\$aIron Deficiency
=450  \\$aLatent Iron Deficiency
=450  \\$aSideropenia
=450  \\$wnnna$aDeficiencies, Iron
=450  \\$wnnna$aDeficiencies, Latent Iron
=450  \\$wnnna$aDeficiency, Iron
=450  \\$wnnna$aDeficiency, Latent Iron
=450  \\$wnnna$aHypoferritinemias
=450  \\$wnnna$aIron Deficiencies, Latent
=450  \\$wnnna$aIron Deficiency, Latent
=450  \\$wnnna$aLatent Iron Deficiencies
=450  \\$wnnna$aSideropenias
=450  \\$aIron$xdeficiency
=667  \\$aANEMIA, IRON-DEFICIENCY is also available
=680  \\$iDeficient amounts of iron in the body as a result of blood loss, diets deficient in iron, or an iron uptake or storage disorder.
=688  \\$a2022
=750  \0$aIron deficiency diseases$0(DLC)sh 85068189$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00691cz  a2200193n  4500
=001  9882487597102441
=005  20241022101656.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090124
=035  \\$a(DNLM)D000090124
=035  \\$a(NLM)9819990494800041
=040  \\$aDNLM$cDNLM
=072  \\$aC6.$x405.$x469.$x462
=150  \\$aIntestinal Failure
=450  \\$wnnna$aFailure, Intestinal
=680  \\$iVarious intestinal diseases functionally defined as having reduced intestine function requiring PARENTERAL NUTRITION.
=688  \\$a2022
=750  \0$iBroader mapping$aIntestines $x Diseases$0(DLC)sh 85067586 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01044cz  a2200265n  4500
=001  9882487597302441
=005  20241022101523.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091702
=035  \\$a(DNLM)D000091702
=035  \\$a(NLM)9819990653200041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x339
=072  \\$aF4.$x96.$x879.$x757.$x100
=072  \\$aI1.$x880.$x453
=150  \\$aIntersectional Framework
=450  \\$aIntersectionality
=450  \\$wnnna$aFramework, Intersectional
=450  \\$wnnna$aFrameworks, Intersectional
=450  \\$wnnna$aIntersectional Frameworks
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iInterconnections of social categorizations such as race, class, and gender, creating overlapping and interdependent systems of discrimination or disadvantage.
=688  \\$a2022
=750  \0$iBroader mapping$aIntersectionality (Sociology)$0(DLC)sh2017003056$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00682cz  a2200205n  4500
=001  9882487597402441
=005  20241022101402.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088902
=035  \\$a(DNLM)D000088902
=035  \\$a(NLM)9819990147900041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x656.$x563
=150  \\$aInterleukin Inhibitors
=450  \\$aIL Inhibitor
=450  \\$aInterleukin Inhibitor
=680  \\$iIMMUNOSUPPRESSIVE AGENTS which inhibit the action of INTERLEUKINS.
=688  \\$a2022
=750  \0$iBroader mapping$aImmunosuppressive agents$0(DLC)sh 85064589 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  02700cz  a2200757n  4500
=001  9882487597502441
=005  20241022101242.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087623
=035  \\$a(DNLM)D000087623
=035  \\$a(NLM)9819990128100041
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x200.$x885.$x287.$x500.$x364
=150  \\$aInsular Cortex
=450  \\$aBrodmann Area 13
=450  \\$aBrodmann Area 14
=450  \\$aBrodmann Area 15
=450  \\$aBrodmann Area 16
=450  \\$aBrodmann Area 43
=450  \\$aBrodmann's Area 13
=450  \\$aBrodmann's Area 14
=450  \\$aBrodmann's Area 15
=450  \\$aBrodmann's Area 16
=450  \\$aBrodmann's Area 43
=450  \\$aCentral Lobe
=450  \\$aGustatory Cortex
=450  \\$aInsula of Reil
=450  \\$aInsular Gyrus
=450  \\$aInsular Region
=450  \\$aLobus Insularis
=450  \\$aOpercular Cortex
=450  \\$aPrimary Gustatory Cortex
=450  \\$aVisceral Cortex
=450  \\$wnnna$aArea 13, Brodmann
=450  \\$wnnna$aArea 13, Brodmann's
=450  \\$wnnna$aArea 14, Brodmann
=450  \\$wnnna$aArea 14, Brodmann's
=450  \\$wnnna$aArea 15, Brodmann
=450  \\$wnnna$aArea 15, Brodmann's
=450  \\$wnnna$aArea 16, Brodmann
=450  \\$wnnna$aArea 16, Brodmann's
=450  \\$wnnna$aArea 43, Brodmann
=450  \\$wnnna$aArea 43, Brodmann's
=450  \\$wnnna$aBrodmanns Area 13
=450  \\$wnnna$aBrodmanns Area 14
=450  \\$wnnna$aBrodmanns Area 15
=450  \\$wnnna$aBrodmanns Area 16
=450  \\$wnnna$aBrodmanns Area 43
=450  \\$wnnna$aCentral Lobes
=450  \\$wnnna$aCortex, Gustatory
=450  \\$wnnna$aCortex, Insular
=450  \\$wnnna$aCortex, Opercular
=450  \\$wnnna$aCortex, Primary Gustatory
=450  \\$wnnna$aCortex, Visceral
=450  \\$wnnna$aGustatory Cortex, Primary
=450  \\$wnnna$aGyrus, Insular
=450  \\$wnnna$aInsular Cortices
=450  \\$wnnna$aInsular Regions
=450  \\$wnnna$aLobe, Central
=450  \\$wnnna$aPrimary Gustatory Cortices
=450  \\$wnnna$aRegion, Insular
=450  \\$wnnna$aVisceral Cortices
=680  \\$iA pyramidal shaped region of cerebral cortex located deep below the lateral fissure in PRIMATES. It is surrounded by the SUPERIOR TEMPORAL GYRUS, the rostral PARIETAL LOBE, the INFERIOR FRONTAL GYRUS and the ORBITAL GYRI. It is the primary gustatory cortex and is involved in sensorimotor and somatosensory as well as socioemotional functions.
=688  \\$a2022(1979)
=750  \0$iBroader mapping$aCerebral cortex$0(DLC)sh 85022087 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00748cz  a2200217n  4500
=001  9882487597602441
=005  20241022101107.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087366
=035  \\$a(DNLM)D000087366
=035  \\$a(NLM)9819990170200041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x393.$x537
=150  \\$aInformation Avoidance
=450  \\$aInformation Denial
=450  \\$wnnna$aAvoidance, Information
=450  \\$wnnna$aDenial, Information
=680  \\$iChoosing to not obtain knowledge even if having the information could be to one's benefit.
=688  \\$a2022
=750  \0$iBroader mapping$aDefense mechanisms (Psychology)$0(DLC)sh 85036436 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01264cz  a2200325n  4500
=001  9882487597702441
=005  20241022100940.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091369
=035  \\$a(DNLM)D000091369
=035  \\$a(NLM)9819990667000041
=040  \\$aDNLM$cDNLM
=072  \\$aD27.$x505.$x696.$x477.$x396
=150  \\$aImmunomodulating Agents
=450  \\$aIMiDs
=450  \\$aImmunomodulating Drugs
=450  \\$aImmunomodulatory Agents
=450  \\$aImmunomodulatory Compounds
=450  \\$aImmunomodulatory Drugs
=450  \\$aImmunomodulatory IMiD Drugs
=450  \\$aImmunomodulatory IMiDE Drugs
=450  \\$wnnna$aAgents, Immunomodulating
=450  \\$wnnna$aAgents, Immunomodulatory
=450  \\$wnnna$aDrugs, Immunomodulatory
=450  \\$wnnna$aDrugs, Immunomodulatory IMiD
=450  \\$wnnna$aDrugs, Immunomodulatory IMiDE
=680  \\$iAgents that alter the response of the immune system by activating (IMMUNOSTIMULANT) or suppressing (IMMUNOSUPPRESSIVE) the immune system and may help the body fight cancer, infection, or other diseases.
=688  \\$a2022
=750  \0$iBroader mapping$aBiological response modifiers$0(DLC)sh 85014187$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  01234cz  a2200265n  4500
=001  9882487597802441
=005  20241022100650.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091244
=035  \\$a(DNLM)D000091244
=035  \\$a(NLM)9819990410900041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x118.$x637.$x555.$x567.$x269
=150  \\$aImmunological Memory Cells
=450  \\$aImmunologic Memory Cells
=450  \\$aMemory Cells, Immunologic
=450  \\$aMemory Cells, Immunological
=450  \\$wnnna$aImmunologic Memory Cell
=450  \\$wnnna$aImmunological Memory Cell
=450  \\$wnnna$aMemory Cell, Immunologic
=450  \\$wnnna$aMemory Cell, Immunological
=680  \\$iAntigen-specific immunologic cells which have a potential to form IMMUNOLOGIC MEMORY providing a rapid and robust response against a second encounter with the same antigen. Immunologic memory cells typically include B-Lymphocytes T-Lymphocytes and sometimes adaptive NK cells. Building immunologic memory cells is a basis of how a vaccine affords immunity to a specific pathogen.
=688  \\$a2022
=750  \0$iBroader mapping$aLymphocytes$0(DLC)sh 85079147$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00918nz  a2200253n  4500
=001  9882045390802441
=005  20250211111125.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087983
=035  \\$a(DNLM)D000087983
=035  \\$a(NLM)9819990142300041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x897.$x280.$x500.$x793
=072  \\$aL1.$x178.$x820.$x90.$x793
=072  \\$aL1.$x280.$x785
=150  \\$aSound Recordings
=450  \\$aSound Recording
=450  \\$wnnna$aRecording, Sound
=450  \\$wnnna$aRecordings, Sound
=680  \\$iThe storing of sound signals on various media such as cylinders, analog discs, digital discs, tapes, and wires.[LCSH, 10/27/2020]
=688  \\$a2022
=750  \0$iNarrower mapping$aMixtapes$0(DLC)sh2021008265$4NM$5IEN-M$0(DLC)sh 85125391 $5IEN-M
=750  \0$aSound recordings$0(DLC)sh 85125391 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00758nz  a2200229n  4500
=001  9882253399802441
=005  20250211111124.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091123
=035  \\$a(DNLM)D000091123
=035  \\$a(NLM)9819990595200041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x250.$x125
=150  \\$aOrycteropodidae
=450  \\$aAardvarks
=450  \\$aOrycteropus
=450  \\$aOrycteropus afer
=450  \\$wnnna$aAardvark
=450  \\$wnnna$aOrycteropus afers
=680  \\$iAn order of placental mammals in the superorder AFROTHERIA found in Africa. It has single species Orycteropus afer.
=688  \\$a2022(1998)
=750  \0$aOrycteropodidae$0(DLC) sh2003004656$5IEN-M

=LDR  01039nz  a2200313n  4500
=001  9882253400102441
=005  20250211111124.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091343
=035  \\$a(DNLM)D000091343
=035  \\$a(NLM)9819990692200041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x257.$x133
=072  \\$aD2.$x691.$x319
=150  \\$aOrganocopper Compounds
=450  \\$aCopper-Cuprous Oxide
=450  \\$aOrganic-Copper Complex
=450  \\$aOrgano-Copper Complexes
=450  \\$aOrgano-Copper Compounds
=450  \\$aOrganocopper Complexes
=450  \\$wnnna$aComplexes, Organo-Copper
=450  \\$wnnna$aComplexes, Organocopper
=450  \\$wnnna$aCompounds, Organo-Copper
=450  \\$wnnna$aOrgano Copper Complexes
=450  \\$wnnna$aOrgano Copper Compounds
=450  \\$wnnna$aOxide, Copper-Cuprous
=680  \\$iOrganic compounds that contain COPPER as an integral part on the molecule.
=688  \\$a2022
=750  \0$aOrganocopper compounds$0(DLC) sh 85095545$5IEN-M

=LDR  01223nz  a2200361n  4500
=001  9882255467602441
=005  20250211111125.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091385
=035  \\$a(DNLM)D000091385
=035  \\$a(NLM)9819990664600041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x345.$x625.$x937
=072  \\$aG15.$x589.$x500
=150  \\$aPlant Senescence
=450  \\$aFlower Senescence
=450  \\$aLeaf Senescence
=450  \\$aPlant Aging
=450  \\$aPlant Cellular Replicative Senescence
=450  \\$aPlant Cellular Senescence
=450  \\$wnnna$aAging, Plant
=450  \\$wnnna$aCellular Senescence, Plant
=450  \\$wnnna$aFlower Senescences
=450  \\$wnnna$aSenescence, Flower
=450  \\$wnnna$aSenescence, Leaf
=450  \\$wnnna$aSenescence, Plant
=450  \\$wnnna$aSenescence, Plant Cellular
=450  \\$wnnna$aSenescences, Flower
=550  \\$aAging
=550  \\$aCellular Senescence
=680  \\$iIn plants, similarly as in animals, an age-dependent irreversible process of changes leading to the arrest of CELL DIVISION and/or PROGRAMMED CELL DEATH.
=688  \\$a2022
=750  \0$aPlants$xAging$0(DLC) sh 85102842$5IEN-M

=LDR  01344nz  a2200385n  4500
=001  9882255467802441
=005  20250211111123.0
=008  210709\n\ancnnbabn\\\\\\\\\\||\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090342
=035  \\$a(DNLM)D000090342
=035  \\$a(NLM)9819990464100041
=040  \\$aDNLM$cDNLM
=072  \\$aA18.$x24.$x625
=150  \\$aPlant Cone
=450  \\$aCatkins
=450  \\$aCones, Plant
=450  \\$aMicrostrobili
=450  \\$aMicrostrobilus
=450  \\$aPine Cone
=450  \\$aPlant Cones
=450  \\$aSeed Cones
=450  \\$aSpore Cones
=450  \\$aStrobili
=450  \\$aStrobilus
=450  \\$wnnna$aCatkin
=450  \\$wnnna$aCone, Pine
=450  \\$wnnna$aCone, Plant
=450  \\$wnnna$aCone, Seed
=450  \\$wnnna$aCone, Spore
=450  \\$wnnna$aPine Cones
=450  \\$wnnna$aSeed Cone
=450  \\$wnnna$aSpore Cone
=680  \\$iAny conical shaped aerial plant structure with scales or bracts arranged spirally around axis. It includes familiar seed cones of PINE TREE and other GYMNOSPERMS, pollen cones (e.g., microstrobilus), spore capsules in HORSETAIL and CLUBMOSS and mature female catkins or seed cones of ALDER and BIRCH trees. Cone  morphology is important in gymnosperm classification.
=688  \\$a2022
=750  \0$aCones (Botany)$0(DLC) sh 85030819$5IEN-M

=LDR  00947nz  a2200277n  4500
=001  9882545191102441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087402
=035  \\$a(DNLM)D000087402
=035  \\$a(NLM)9819990170100041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 260.5.R7
=072  \\$aI3.$x450.$x642.$x845.$x608
=150  \\$aRugby
=450  \\$aRugby, League Play
=450  \\$aRugby, Union Play
=450  \\$wnnna$aLeague Play Rugby
=450  \\$wnnna$aPlay Rugby, League
=450  \\$wnnna$aPlay Rugby, Union
=450  \\$wnnna$aUnion Play Rugbies
=450  \\$wnnna$aUnion Play Rugby
=680  \\$iTeam sport game played on a rectangular field with an oval ball by two teams of 15 players (in Rugby Union Play) or 13 players (in Rugby League Play).
=688  \\$a2022(1990)
=750  \0$aRugby football$0(DLC)sh 85115741 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00911nz  a2200241n  4500
=001  9882545191502441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089962
=035  \\$a(DNLM)D000089962
=035  \\$a(NLM)9819990346400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x825.$x569
=150  \\$aReynoutria
=450  \\$aFallopia × bohemica
=450  \\$aFallopia japonica × Fallopia sachalinensis
=450  \\$aReynoutria bohemica
=450  \\$aReynoutria × bohemica
=450  \\$wnnna$aReynoutrias
=680  \\$iGenus of flowering herbaceous perennial plants and vines in the family Polygonaceae. Some sources include plants formerly classified under Fallopia here under Reynoutria.
=688  \\$a2022
=750  \0$iBroader mapping$aPolygonaceae$0(DLC)sh 85104634 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01164nz  a2200301n  4500
=001  9882545191602441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091042
=035  \\$a(DNLM)D000091042
=035  \\$a(NLM)9819990432100041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x277.$x656.$x300.$x760.$x753
=072  \\$aD8.$x811.$x277.$x656.$x959.$x350.$x753
=072  \\$aD9.$x400.$x430.$x890.$x200.$x250.$x760
=072  \\$aD12.$x776.$x395.$x550.$x200.$x250.$x760
=072  \\$aD12.$x776.$x860.$x300.$x784
=072  \\$aD23.$x50.$x301.$x350.$x663
=150  \\$aReelin Protein
=450  \\$aReeler Protein
=450  \\$aRELN Protein
=450  \\$wnnna$aProtein, Reeler
=450  \\$wnnna$aProtein, Reelin
=450  \\$wnnna$aProtein, RELN
=680  \\$iIt is an EXTRACELLULAR MATRIX serine protease that plays an important role in the development of the central nervous system. It regulates neuronal migration and microtubule function.
=688  \\$a2022 (1995)
=750  \0$iBroader mapping$aExtracellular matrix proteins$0(DLC)sh 93000875 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01069nz  a2200277n  4500
=001  9882545191702441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090044
=035  \\$a(DNLM)D000090044
=035  \\$a(NLM)9819990307100041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x874.$x500.$x750
=150  \\$aRapid On-site Evaluation
=450  \\$aROSE Techniques
=450  \\$wnnna$aEvaluation, Rapid On-site
=450  \\$wnnna$aOn-site Evaluation, Rapid
=450  \\$wnnna$aRapid On site Evaluation
=450  \\$wnnna$aRapid On-site Evaluations
=450  \\$wnnna$aROSE Technique
=450  \\$wnnna$aTechnique, ROSE
=550  \\$aEndoscopic Ultrasound-Guided Fine Needle Aspiration
=680  \\$iA rapid laboratory service provided onsite at clinical settings (e.g., DIAGNOSTIC IMAGING suites) typically for cytomorphologic features on FINE-NEEDLE ASPIRATION.
=688  \\$a2022
=750  \0$iBroader mapping$aPoint-of-care testing$0(DLC)sh2002008700$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01409nz  a2200325n  4500
=001  9882545191802441
=005  20250211112535.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087525
=035  \\$a(DNLM)D000087525
=035  \\$a(NLM)9819990155900041
=040  \\$aDNLM$cDNLM
=072  \\$aC23.$x550.$x355.$x663
=072  \\$aC26.$x733.$x685
=072  \\$aG1.$x750.$x748.$x500.$x685
=072  \\$aN6.$x850.$x460.$x350.$x850.$x500.$x222
=072  \\$aN6.$x850.$x810.$x300.$x360.$x222
=150  \\$aRadiation Fibrosis Syndrome
=450  \\$aFibrosis, Radiation
=450  \\$aRadiation Fibrosis
=450  \\$aRadiation-Induced Fibrosis
=450  \\$wnnna$aFibrosis, Radiation-Induced
=450  \\$wnnna$aFibrosis Syndrome, Radiation
=450  \\$wnnna$aRadiation Induced Fibrosis
=680  \\$iRadiation-induced fibrosis due to increased production of FIBRIN. Its symptoms include CERVICAL DYSTONIA, difficulty with speech and swallowing, swelling in the radiation field and TRISMUS.
=688  \\$a2022(1994)
=750  \0$81$wb$iBroader mapping$aRadiation injuries$0(DLC)sh 86007210$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aFribrosis$0(DLC)sh2004000531$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aRadiation injuries$iand$aFribrosis$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  01089nz  a2200217n  4500
=001  9882545191902441
=005  20250211113201.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088782
=035  \\$a(DNLM)D000088782
=035  \\$a(NLM)9819990400500041
=040  \\$aDNLM$cDNLM
=072  \\$aF4.$x408.$x525.$x500
=150  \\$aPsychological First Aid
=450  \\$wnnna$aFirst Aid, Psychological
=680  \\$iEarly psychosocial intervention approach used during or after traumatic life events as disasters, accidents, terrorist attacks causing negative effects on individual and/or society. It focuses on determining basic physical and mental needs of individuals in major events.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aFirst aid in illness and injury$0(DLC)sh 85048581$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xPsychological aspects$0(DLC)sh2002011485$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aFirst aid in illness and injury--Psychological aspects$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  01046nz  a2200289n  4500
=001  9882545192102441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091323
=035  \\$a(DNLM)D000091323
=035  \\$a(NLM)9819990698900041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x597.$x742.$x357
=072  \\$aC23.$x888.$x592.$x742.$x357
=150  \\$aPsychogenic Nonepileptic Seizures
=450  \\$aDissociative Seizures
=450  \\$aPsychogenic Pseudoseizure
=450  \\$wnnna$aDissociative Seizure
=450  \\$wnnna$aNonepileptic Seizure, Psychogenic
=450  \\$wnnna$aPsychogenic Nonepileptic Seizure
=450  \\$wnnna$aPsychogenic Pseudoseizures
=450  \\$wnnna$aSeizure, Dissociative
=450  \\$wnnna$aSeizure, Psychogenic Nonepileptic
=680  \\$iSeizures caused by psychological factors without electrophysiological epileptic changes.
=688  \\$a2022
=750  \0$aNon-epileptic attack disorder$0(DLC)sh2012003161$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01656nz  a2200409n  4500
=001  9882545192302441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091363
=035  \\$a(DNLM)D000091363
=035  \\$a(NLM)9819990551700041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x430.$x890.$x200.$x200.$x750
=072  \\$aD12.$x776.$x395.$x550.$x200.$x200.$x750
=072  \\$aD12.$x776.$x543.$x550.$x200.$x200.$x750
=072  \\$aD23.$x50.$x301.$x350.$x200.$x750
=150  \\$aProtocadherins
=450  \\$aCadherin-Related Neuronal Receptors
=450  \\$aClustered Pcdhs
=450  \\$aClustered Protocadherins
=450  \\$acPcdhs
=450  \\$ancPcdhs
=450  \\$aNon-Clustered Pcdhs
=450  \\$aNon-Clustered Protocadherins
=450  \\$wnnna$aCadherin Related Neuronal Receptors
=450  \\$wnnna$aNeuronal Receptors, Cadherin-Related
=450  \\$wnnna$aNon Clustered Pcdhs
=450  \\$wnnna$aNon Clustered Protocadherins
=450  \\$wnnna$aPcdhs, Clustered
=450  \\$wnnna$aPcdhs, Non-Clustered
=450  \\$wnnna$aProtocadherins, Clustered
=450  \\$wnnna$aProtocadherins, Non-Clustered
=450  \\$wnnna$aReceptors, Cadherin-Related Neuronal
=680  \\$iMembers of cadherin superfamily involved in cell adhesion and cell-cell interactions in neural development. They are subdivided into clustered (cPcdhs) and non-clustered protocadherin (ncPcdhs) depending whether their genes are tandemly arranged in vertebrates.
=688  \\$a2022
=750  \0$iBroader mapping$aCadherins$0(DLC)sh2004014907$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01407nz  a2200325n  4500
=001  9882545192402441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091345
=035  \\$a(DNLM)D000091345
=035  \\$a(NLM)9819990406600041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x50.$x200.$x800.$x650
=150  \\$aProtein Glutamine gamma Glutamyltransferase 2
=450  \\$wnnna$aTGase II
=450  \\$aTGM2 Proteins
=450  \\$aTissue Transglutaminase
=450  \\$aTissue-Type Transglutaminase
=450  \\$aTransglutaminase 2
=450  \\$aTransglutaminase C
=450  \\$aTransglutaminase II
=450  \\$wnnna$aProteins, TGM2
=450  \\$wnnna$aTissue Type Transglutaminase
=450  \\$wnnna$aTransglutaminase, Tissue
=450  \\$wnnna$aTransglutaminase, Tissue-Type
=667  \\$adistinguish from GAMMA-GLUTAMYLTRANSPEPTIDASE which is involved with glutathione metabolism
=680  \\$iCalcium-dependent acyltransferase that catalyzes cross-linking of proteins at a GLUTAMINE in one chain with primary amine such as in LYSINE in another chain. In addition it can also accept monoamine substrates to catalyze post-translational modifications (e.g., protein serotonylation).
=688  \\$a2022(1999)
=750  \0$iBroader mapping$aTransglutaminases$0(DLC)sh 85136921 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01330nz  a2200313n  4500
=001  9882545192502441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088142
=035  \\$a(DNLM)D000088142
=035  \\$a(NLM)9819990122300041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x780.$x500
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x384.$x500
=150  \\$aProcessing Bodies
=450  \\$aGlycine-Tryptophan Protein of 182 KDa Bodies
=450  \\$aGW-Bodies
=450  \\$aP Bodies
=450  \\$aP-Bodies
=450  \\$wnnna$aGlycine Tryptophan Protein of 182 KDa Bodies
=450  \\$wnnna$aGW Bodies
=450  \\$wnnna$aGW-Body
=450  \\$wnnna$aP Body
=450  \\$wnnna$aP-Body
=450  \\$wnnna$aProcessing Body
=680  \\$iCytoplasmic RNP granules constitutively found in eukaryotic cells. Various proteins related to RNA regulation including RNA decay are found in P-bodies. P-bodies and STRESS GRANULES both sequester inactive mRNPs via different pathways. In P-bodies mRNAs from the stalled translational machinery are deadenylated and condensed for sequestration.
=688  \\$a2022
=750  \0$iBroader mapping$aCytoplasmic granules$0(DLC)sh 92000011$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01892nz  a2200493n  4500
=001  9882545192702441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087642
=035  \\$a(DNLM)D000087642
=035  \\$a(NLM)9819990144700041
=040  \\$aDNLM$cDNLM
=072  \\$aA8.$x186.$x211.$x200.$x885.$x287.$x500.$x571.$x735.$x500
=072  \\$aA8.$x186.$x211.$x200.$x885.$x287.$x500.$x814.$x953.$x500
=150  \\$aPrimary Visual Cortex
=450  \\$wnnna$aVisual Cortex Primary
=450  \\$aArea V1
=450  \\$aBrodmann Area 17
=450  \\$aBrodmann's Area 17
=450  \\$aCalcarine Cortex
=450  \\$aCortical Area V1
=450  \\$aStriate Cortex
=450  \\$aVisual Cortex V1
=450  \\$wnnna$aArea 17, Brodmann
=450  \\$wnnna$aArea 17, Brodmann's
=450  \\$wnnna$aArea V1, Cortical
=450  \\$wnnna$aBrodmanns Area 17
=450  \\$wnnna$aCalcarine Cortices
=450  \\$wnnna$aCortex, Calcarine
=450  \\$wnnna$aCortex Primary, Visual
=450  \\$wnnna$aCortex, Primary Visual
=450  \\$wnnna$aCortex, Striate
=450  \\$wnnna$aCortex V1, Visual
=450  \\$wnnna$aPrimary, Visual Cortex
=450  \\$wnnna$aPrimary Visual Cortices
=450  \\$wnnna$aV1, Area
=450  \\$wnnna$aV1, Cortical Area
=450  \\$wnnna$aV1, Visual Cortex
=450  \\$wnnna$aVisual Cortex, Primary
=667  \\$ado not confuse entry term STRIATE CORTEX with CORPUS STRIATUM (basal ganglia)
=680  \\$iAn area comprised of parts of OCCIPITAL LOBE and the CALCARINE SULCUS of the visual cortex in humans with direct connectivity to the LATERAL GENICULATE NUCLEUS. It is the end organ where visual stimuli are received in the visual cortex.
=688  \\$a2022(1979)
=750  \0$iBroader mapping$aVisual cortex$0(DLC)sh 85143918 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00894nz  a2200229n  4500
=001  9882545192902441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090282
=035  \\$a(DNLM)D000090282
=035  \\$a(NLM)9819990254300041
=040  \\$aDNLM$cDNLM
=072  \\$aL1.$x462.$x500.$x682.$x829.$x678.$x500
=150  \\$aPredatory Journals as Topic
=450  \\$aPredatory Journals
=450  \\$wnnna$aJournal, Predatory
=450  \\$wnnna$aJournals, Predatory
=450  \\$wnnna$aPredatory Journal
=680  \\$iWorks about medical journals that publish articles online with little or no peer review, low academic standards, and little credibility. (from Can Fam Physician. 2019 Feb; 65(2):92).
=688  \\$a2022
=750  \0$iBroader mapping$aPredatory publishing$0(DLC)sh2023001605$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00797nz  a2200205n  4500
=001  9882545193102441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090643
=035  \\$a(DNLM)D000090643
=035  \\$a(NLM)9819990455100041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x440.$x619
=150  \\$aPlanctomycetes
=450  \\$aPlanctomycetaeota
=450  \\$aPlanctomycetota
=680  \\$iA phylum of gram-negative bacteria with complex cytoplasmic membrane invaginations and crateriform structures of outer membrane. Members living in anoxic waters and sediments carry out ANAEROBIC AMMONIA OXIDATION.
=688  \\$a2022
=750  \0$iBroader mapping$aGram-negative bacteria$0(DLC)sh 85056256$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01361nz  a2200313n  4500
=001  9882545193202441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088562
=035  \\$a(DNLM)D000088562
=035  \\$a(NLM)9819990295800041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x645
=072  \\$aC23.$x550.$x291.$x902
=150  \\$aPersistent Infection
=450  \\$aChronic Infection
=450  \\$aLong Term Infection
=450  \\$wnnna$aChronic Infections
=450  \\$wnnna$aInfection, Chronic
=450  \\$wnnna$aInfection, Long Term
=450  \\$wnnna$aInfection, Persistent
=450  \\$wnnna$aLong Term Infections
=450  \\$wnnna$aPersistent Infections
=550  \\$aChronic Disease
=667  \\$acoordinate with specific infection
=680  \\$iInfection which lasts for a long period with continuous display of clinical features. Persistent infection arises due to inability of host cells to clear primary infections completely. When persistent infections are cleared so that infection symptoms are under control they are often referred to as chronic infections. LATENT INFECTIONS are infections in which manifestation of clinical symptoms appear later.
=688  \\$a2022
=750  \0$iBroader mapping$aInfection$0(DLC)sh 85066076$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01182nz  a2200241n  4500
=001  9882545193302441
=005  20250211112414.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091563
=035  \\$a(DNLM)D000091563
=035  \\$a(NLM)9819990668200041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x813.$x629.$x594
=072  \\$aF2.$x463.$x593.$x752.$x250
=150  \\$aPerceived Discrimination
=450  \\$wnnna$aDiscrimination, Perceived
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OFF HEALTH
=680  \\$iPerception of being treated badly or unfairly on the basis of race, ethnicity, gender, age, religion, physical appearance, sexual orientation, or other characteristics. This includes perceived discrimination in health care settings.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aDiscrimination$0(DLC)sh 85038376$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPerception$0(DLC)sh 85099708$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aDiscrimination$iand$aPerception$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00795nz  a2200241n  4500
=001  9882545193502441
=005  20250211111022.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088102
=035  \\$a(DNLM)D000088102
=035  \\$a(NLM)9819990133600041
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x400.$x860
=150  \\$aOrthorexia Nervosa
=450  \\$aObsessive Healthy Eating
=450  \\$aOrthorexia
=450  \\$wnnna$aHealthy Eating, Obsessive
=450  \\$wnnna$aNervosa, Orthorexia
=550  \\$aDiet, Healthy
=680  \\$iAn eating disorder that is characterized by the pathological obsession with HEALTHY EATING.
=688  \\$a2022
=750  \0$iBroader mapping$aEating disorders$0(DLC)sh 86004209$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00989nz  a2200277n  4500
=001  9882545193702441
=005  20250211111022.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088362
=035  \\$a(DNLM)D000088362
=035  \\$a(NLM)9819990391900041
=040  \\$aDNLM$cDNLM
=072  \\$aG4.$x417.$x350.$x772
=072  \\$aG9.$x188.$x665.$x750
=072  \\$aG12.$x287.$x70.$x500
=072  \\$aG12.$x450.$x564.$x809.$x750
=072  \\$aG12.$x688.$x750
=150  \\$aOpsonization
=450  \\$aOpsonophagocytosis
=450  \\$wnnna$aOpsonophagocytoses
=550  \\$aOpsonin Proteins
=680  \\$iThe process of recognizing and targeting particles by binding with OPSONINS (e.g., IgM, C1 and IgG) for phagocytosis or for antibody-dependent cell cytotoxicity.
=680  \\$iPhagocytosis initiated by opsonization.
=688  \\$a2022
=750  \0$iBroader mapping$aPhagocytosis$0(DLC)sh 85100549 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01164nz  a2200325n  4500
=001  9882547491602441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090203
=035  \\$a(DNLM)D000090203
=035  \\$a(NLM)9819990262900041
=040  \\$aDNLM$cDNLM
=072  \\$aD6.$x472.$x699.$x42.$x875
=072  \\$aD9.$x400.$x430.$x998
=072  \\$aD12.$x644.$x276.$x24.$x875
=072  \\$aD12.$x644.$x548.$x11.$x875
=072  \\$aD12.$x776.$x395.$x985
=072  \\$aD12.$x776.$x467.$x24.$x875
=072  \\$aD23.$x529.$x24.$x875
=150  \\$aZn-Alpha-2-Glycoprotein
=450  \\$aAlpha2-Seminoglycoprotein
=450  \\$aGlycoprotein, Zinc-Alpha(2)
=450  \\$aZinc-Alpha(2)-Glycoprotein
=450  \\$aZn-Alpha(2)-GP
=450  \\$wnnna$aAlpha2 Seminoglycoprotein
=450  \\$wnnna$aZn Alpha 2 Glycoprotein
=680  \\$iA soluble protein that stimulates LIPOLYSIS in ADIPOCYTES and causes the extensive fat losses associated with some advanced cancers.
=688  \\$a2022 (1977)
=750  \0$iBroader mapping$aGlycoproteins$0(DLC)sh 85055403 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01078nz  a2200253n  4500
=001  9882547491702441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091102
=035  \\$a(DNLM)D000091102
=035  \\$a(NLM)9819990590200041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x24.$x750
=072  \\$aD12.$x776.$x157.$x57.$x750
=072  \\$aD12.$x776.$x476.$x24.$x750
=150  \\$aYAP-Signaling Proteins
=450  \\$aYAP Intracellular Signaling Proteins
=450  \\$aYes-Associated Proteins
=450  \\$wnnna$aYAP Signaling Proteins
=450  \\$wnnna$aYes Associated Proteins
=680  \\$iSignal transducing adaptor proteins that were initially identified by their association with YES PROTO-ONCOGENE PROTEIN. They are downstream components of the HIPPO-SIGNALING PATHWAY, and act as transcriptional co-activators for TEAD TRANSCRIPTION FACTORS.
=688  \\$a2022
=750  \0$iBroader mapping$aSignal transducing adaptor proteins$0(DLC)sh2018000011$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00764nz  a2200229n  4500
=001  9882547491902441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091142
=035  \\$a(DNLM)D000091142
=035  \\$a(NLM)9819990591400041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x999.$x475
=150  \\$aVermilingua
=450  \\$aAnteaters
=450  \\$aCyclopes
=450  \\$aMyrmecophagidae
=450  \\$aTamandua
=680  \\$iA placental mammalian suborder of anteaters. For spiny anteater see TACHYGLOSSIDAE; and for scaly anteaters, PANGOLINS.
=688  \\$a2022(1998)
=750  \0$iBroader mapping$aXenarthra$0(DLC)sh 85040951$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01237nz  a2200229n  4500
=001  9882547492002441
=005  20250211112943.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087507
=035  \\$a(DNLM)D000087507
=035  \\$a(NLM)9819990155000041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x952.$x500
=150  \\$aVaccine Efficacy
=450  \\$aVaccine Effectiveness
=450  \\$wnnna$aEfficacy, Vaccine
=680  \\$iA measurement of disease risk reduction among vaccinated compared to unvaccinated persons under ideal conditions such as in a clinical trial. Such disease reduction measured under typical field conditions is vaccine effectiveness. In contrast vaccine potency is measured in an assay to ensure proper dosing and storage of vaccines whereas vaccine immunogenicity measures its ability to induce an immune response in a vaccinated individual in observational studies.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aVaccines$0(DLC)sh 85141718$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xEffectiveness$0(DLC)sh 00005832$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aVaccines--Effectiveness$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00950nz  a2200229n  4500
=001  9882547492102441
=005  20250211112901.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087506
=035  \\$a(DNLM)D000087506
=035  \\$a(NLM)9819990157800041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 810
=072  \\$aE5.$x952
=150  \\$aVaccine Development
=450  \\$wnnna$aDevelopment, Vaccine
=680  \\$iThe entire process of introducing a new vaccine for use in VACCINATION including pre-clinical development, testing in CONTROLLED CLINICAL TRIAL, manufacturing, approval/licensing and distribution.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aVaccines$0(DLC)sh 85141718$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xDevelopment$0(DLC)sh 99005534$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aVaccines--Development$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00904nz  a2200253n  4500
=001  9882547492602441
=005  20250211112056.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091642
=035  \\$a(DNLM)D000091642
=035  \\$a(NLM)9819990684400041
=040  \\$aDNLM$cDNLM
=072  \\$aC12
=150  \\$aUrogenital Diseases
=450  \\$aGenitourinary Diseases
=450  \\$wnnna$aDisease, Genitourinary
=450  \\$wnnna$aDisease, Urogenital
=450  \\$wnnna$aGenitourinary Disease
=450  \\$wnnna$aUrogenital Disease
=667  \\$ageneral or unspecified; MALE UROGENITAL DISEASES and FEMALE UROGENITAL DISEASES are available
=680  \\$iPathological processes of the URINARY TRACT and the reproductive system (GENITALIA).
=688  \\$a2022
=750  \0$aGenitourinary organs$xDiseases$0(DLC)sh 85053898$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00909nz  a2200229n  4500
=001  9882547492702441
=005  20250211112810.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087527
=035  \\$a(DNLM)D000087527
=035  \\$a(NLM)9819990025700041
=040  \\$aDNLM$cDNLM
=072  \\$aD23.$x946.$x710
=150  \\$aUremic Toxins
=450  \\$aUremia Toxins
=450  \\$aUremic Retention Solutes
=680  \\$iBiological solutes retained and accumulated due to kidney impairment that contribute to uremia/chronic kidney disease.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aUremia$0(DLC)sh 85141368$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aToxins$0(DLC)sh 85136335$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aUremia$iand$aToxins$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  01503nz  a2200373n  4500
=001  9882547492902441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088722
=035  \\$a(DNLM)D000088722
=035  \\$a(NLM)9819990402600041
=040  \\$aDNLM$cDNLM
=072  \\$aJ1.$x937.$x285.$x100.$x550
=150  \\$aUnmanned Aerial Devices
=450  \\$aDrone Aircraft
=450  \\$aDrones
=450  \\$aUnmanned Aerial Vehicles
=450  \\$wnnna$aAerial Devices, Unmanned
=450  \\$wnnna$aAerial Device, Unmanned
=450  \\$wnnna$aAerial Vehicles, Unmanned
=450  \\$wnnna$aAerial Vehicle, Unmanned
=450  \\$wnnna$aAircraft, Drone
=450  \\$wnnna$aAircrafts, Drone
=450  \\$wnnna$aDevices, Unmanned Aerial
=450  \\$wnnna$aDevice, Unmanned Aerial
=450  \\$wnnna$aDrone
=450  \\$wnnna$aDrone Aircrafts
=450  \\$wnnna$aUnmanned Aerial Vehicle
=450  \\$wnnna$aVehicles, Unmanned Aerial
=450  \\$wnnna$aVehicle, Unmanned Aerial
=680  \\$iPowered,  aerial  vehicles  that  do  not  carry  a  human  operator,  use aerodynamic  forces  to  provide  vehicle  lift,  can  fly  autonomously  or  be  piloted remotely,  can  be  expendable  or  recoverable,  and  can  carry  a  lethal  or  nonlethal payload. (https://apps.dtic.mil/sti/pdfs/ADA467807 pdf accessed 12/27/2020)
=688  \\$a2022
=750  \0$aDrone aircraft$0(DLC)sh 85039623 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01207nz  a2200277n  4500
=001  9882547493002441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090264
=035  \\$a(DNLM)D000090264
=035  \\$a(NLM)9819990241000041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x400.$x450.$x480.$x750
=150  \\$aUDP-Glucuronosyltransferase 1A9
=450  \\$aUDP-Glucuronosyltransferase, UGT1A9
=450  \\$aUGT1A9 Protein
=450  \\$aUridine Diphosphate-Glucuronosyltransferase 1A9
=450  \\$wnnna$a1A9, UDP-Glucuronosyltransferase
=450  \\$wnnna$a1A9, Uridine Diphosphate-Glucuronosyltransferase
=450  \\$wnnna$aProtein, UGT1A9
=450  \\$wnnna$aUDP Glucuronosyltransferase, UGT1A9
=450  \\$wnnna$aUGT1A9 UDP-Glucuronosyltransferase
=680  \\$iA PPAR alpha and PPAR gamma target gene. The enzyme plays an important role in elimination and DETOXIFICATION of drugs, XENOBIOTICS, and metabolizing endogenous compounds, including CATECHOLESTROGENS and FIBRATES.
=688  \\$a2022 (2000)
=750  \0$iBroader mapping$aGlucuronosyltransferase$0(DLC)sh 94006120 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01630nz  a2200361n  4500
=001  9882547493102441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090324
=035  \\$a(DNLM)D000090324
=035  \\$a(NLM)9819990245600041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x963
=072  \\$aD12.$x776.$x476.$x941
=072  \\$aD12.$x776.$x624.$x720
=150  \\$aTumor Protein, Translationally-Controlled 1
=450  \\$aHistamine Releasing Factor
=450  \\$aHistamine-Releasing Factor (IgE-Dependent)
=450  \\$aHistamine Releasing Factor, Lymphocyte-Dependent
=450  \\$aProtein P23, Ehrlich Ascites Tumor
=450  \\$aTPT1 Protein
=450  \\$aTranslationally-Controlled Tumor Protein
=450  \\$wnnna$aFactor, Histamine Releasing
=450  \\$wnnna$aHistamine Releasing Factor, Lymphocyte Dependent
=450  \\$wnnna$aProtein, TPT1
=450  \\$wnnna$aProtein, Translationally-Controlled Tumor
=450  \\$wnnna$aTranslationally Controlled Tumor Protein
=450  \\$wnnna$aTumor Protein, Translationally-Controlled
=450  \\$wnnna$aTumor Protein, Translationally Controlled 1
=680  \\$iA highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival.  Also, Tpt1 identified as a direct target gene of P53 tumor suppression.
=688  \\$a2022 (1985)
=750  \0$iBroader mapping$aTumor proteins$0(DLC)sh 85138552 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01632nz  a2200337n  4500
=001  9882547493202441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091364
=035  \\$a(DNLM)D000091364
=035  \\$a(NLM)9819990675200041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x644.$x360.$x24.$x469
=072  \\$aD12.$x776.$x157.$x57.$x437
=072  \\$aD12.$x776.$x476.$x24.$x484
=150  \\$aTranscriptional Coactivator with PDZ-Binding Motif Proteins
=450  \\$aTAZ-Signaling Proteins
=450  \\$aTranscriptional Coactivator with PDZ-Binding Motif Protein
=450  \\$aTranscriptional Coactivator with PDZ-Binding Motif (TAZ) Proteins
=450  \\$aWW Domain Containing Transcription Regulator 1
=450  \\$aWW Domain-Containing Transcription Regulator Protein 1
=450  \\$wnnna$aTAZ Signaling Proteins
=450  \\$wnnna$aTranscriptional Coactivator with PDZ Binding Motif Protein
=450  \\$wnnna$aTranscriptional Coactivator with PDZ Binding Motif Proteins
=450  \\$wnnna$aWW Domain Containing Transcription Regulator Protein 1
=550  \\$aYAP-Signaling Proteins
=667  \\$ado not confuse with tafazzin/TAZ protein
=680  \\$iA family of signal transducing adaptor proteins that are similar in structure and function to YAP-SIGNALING PROTEINS. They are components of the HIPPO-SIGNALING PATHWAY, and may act as transcriptional co-activators for TEAD TRANSCRIPTION FACTORS.
=688  \\$a2022
=750  \0$iBroader mapping$aSignal transducing adaptor proteins$0(DLC)sh2018000011$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01090nz  a2200241n  4500
=001  9882547493302441
=005  20250211112720.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090882
=035  \\$a(DNLM)D000090882
=035  \\$a(NLM)9819990445800041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x355.$x830.$x749
=072  \\$aC15.$x378.$x100.$x876
=072  \\$aC23.$x550.$x470.$x895
=150  \\$aThromboinflammation
=450  \\$aImmunothrombosis
=680  \\$iThrombosis with associated inflammation due to crosstalk between HEMOSTASIS and INNATE IMMUNE RESPONSES modulated by PLATELETS. It is associated with many diseases such as COVID-19; SICKLE CELL ANEMIA; and THROMBOPHLEBITIS.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aThrombosis$0(DLC)sh 85135077$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aInflammation$0(DLC)sh 85066108$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aThrombosis$iand$aInflammation$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  01370nz  a2200385n  4500
=001  9882547493502441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091124
=035  \\$a(DNLM)D000091124
=035  \\$a(NLM)9819990593300041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x50.$x150.$x900.$x649.$x313.$x250.$x875
=150  \\$aTenrecidae
=450  \\$wnnna$aEchinops telfairi
=450  \\$wnnna$aLesser Hedgehog Tenrec
=450  \\$wnnna$aSmall Madagascar Hedgehog
=450  \\$aEchinops
=450  \\$aTenrec
=450  \\$aTenrecinae
=450  \\$wnnna$aHedgehog, Small Madagascar
=450  \\$wnnna$aHedgehogs, Small Madagascar
=450  \\$wnnna$aHedgehog Tenrec, Lesser
=450  \\$wnnna$aHedgehog Tenrecs, Lesser
=450  \\$wnnna$aLesser Hedgehog Tenrecs
=450  \\$wnnna$aMadagascar Hedgehog, Small
=450  \\$wnnna$aMadagascar Hedgehogs, Small
=450  \\$wnnna$aSmall Madagascar Hedgehogs
=450  \\$wnnna$aTenrec, Lesser Hedgehog
=450  \\$wnnna$aTenrecs, Lesser Hedgehog
=680  \\$iA terrestrial, nocturnal insectivore of the family Tenrecidae which is not one of the real HEDGEHOGS.
=680  \\$iA placental mammal family in superorder Afrotheria.
=688  \\$a2022(2003)
=750  \0$aTenrecs$0(DLC)sh 85133925 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01483nz  a2200373n  4500
=001  9882547493602441
=005  20250211112322.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088942
=035  \\$a(DNLM)D000088942
=035  \\$a(NLM)9819990012600041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x145.$x527.$x100.$x120.$x875
=150  \\$aTechnology Addiction
=450  \\$aCell Phone Addiction
=450  \\$aMobile Phone Addiction
=450  \\$aVideo Game Addiction
=450  \\$wnnna$aAddiction, Cell Phone
=450  \\$wnnna$aAddiction, Mobile Phone
=450  \\$wnnna$aAddictions, Mobile Phone
=450  \\$wnnna$aAddictions, Video Game
=450  \\$wnnna$aAddiction, Video Game
=450  \\$wnnna$aCell Phone Addictions
=450  \\$wnnna$aGame Addiction, Video
=450  \\$wnnna$aMobile Phone Addictions
=450  \\$wnnna$aPhone Addiction, Mobile
=450  \\$wnnna$aTechnology Addictions
=450  \\$wnnna$aVideo Game Addictions
=680  \\$iThe inability to overcome a desire to have contact with and use technology and electronic devices.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aCompulsive behavior$0(DLC)sh 85029465$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aTechnology$0(DLC)sh 85133147$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aCompulsive behavior$iand$aTechnology$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00806nz  a2200229n  4500
=001  9882547493702441
=005  20250211111126.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091262
=035  \\$a(DNLM)D000091262
=035  \\$a(NLM)9819990416200041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x260.$x733
=072  \\$aD12.$x776.$x930.$x882
=150  \\$aTEA Domain Transcription Factors
=450  \\$aTEA Domain
=450  \\$aTEAD Transcription Factors
=680  \\$iA family of transcription factors that share a conserved TEA DNA binding domain.
=680  \\$iA 77 amino acid conserved transcriptional enhancer domain.
=688  \\$a2022
=750  \0$iBroader mapping$aTranscription factors$0(DLC)sh 92005483 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01292nz  a2200325n  4500
=001  9882547495002441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090002
=035  \\$a(DNLM)D000090002
=035  \\$a(NLM)9819990267000041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x329.$x830.$x500.$x500
=072  \\$aA11.$x872.$x590.$x500.$x500
=150  \\$aStromal Vascular Fraction
=450  \\$aAdipose Stromal Vascular Fraction
=450  \\$aAdipose SVF
=450  \\$aAutologous Adipose Stromal Vascular Fraction
=450  \\$aAutologous Adipose SVF
=450  \\$wnnna$aAdipose SVF, Autologous
=450  \\$wnnna$aFraction, Stromal Vascular
=450  \\$wnnna$aStromal Vascular Fractions
=450  \\$wnnna$aSVF, Adipose
=450  \\$wnnna$aSVF, Autologous Adipose
=450  \\$wnnna$aSVFs, Adipose
=450  \\$wnnna$aVascular Fraction, Stromal
=680  \\$iA fraction of ADIPOSE TISSUE prepared to enrich in STEM CELLS with the capacity for multi-lineage differentiation. It is used in various applications for its tissue regeneration and immunomodulation activities.
=688  \\$a2022 (2019)
=750  \0$iBroader mapping$aMesenchymal stem cells$0(DLC)sh2010012753$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00972nz  a2200217n  4500
=001  9882547495102441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000088162
=035  \\$a(DNLM)D000088162
=035  \\$a(NLM)9819990009100041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x284.$x430.$x214.$x190.$x500.$x780.$x750
=072  \\$aA11.$x284.$x430.$x214.$x190.$x875.$x190.$x190.$x384.$x750
=150  \\$aStress Granules
=450  \\$wnnna$aGranule, Stress
=450  \\$wnnna$aStress Granule
=680  \\$iCytoplasmic granules composed of RIBONUCLEOPROTEINS which form only when stress-activated pathways stall translation initiation. Stress granules and processing bodies both sequester inactive mRNPs. Stress granules clear mRNPs through autophagy and may interact with P-BODIES.
=688  \\$a2022
=750  \0$iBroader mapping$aCytoplasmic granules$0(DLC)sh 92000011$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01249nz  a2200253n  4500
=001  9882547495502441
=005  20250211111125.0
=008  240809\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091485
=035  \\$a(DNLM)D000091485
=035  \\$a(NLM)9819990670300041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x761
=150  \\$aSocial Structure
=450  \\$aSocial Systems
=450  \\$wnnna$aSocial Structures
=450  \\$wnnna$aSocial System
=450  \\$wnnna$aStructure, Social
=450  \\$wnnna$aSystem, Social
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iThe complex of relationships and systems that organize and regulate interpersonal phenomena in a group or society. The social structure of a group includes its norms and roles and the status, attraction, and communication relations that link one member to another (see group structure). The social structure of a society includes the complex of relations among its constituent individuals, groups, institutions, customs, and mores. (https://dictionary.apa.org/social‐structure)
=688  \\$a2022
=750  \0$aSocial structure$0(DLC)sh 85124078 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  00943nz  a2200277n  4500
=001  9882547495702441
=005  20250211111124.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091743
=035  \\$a(DNLM)D000091743
=035  \\$a(NLM)9819990545400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x761.$x500
=150  \\$aSocial Status
=450  \\$wnnna$aSocial Acceptance
=450  \\$wnnna$aSocial Rejection
=450  \\$aSocial Stratification
=450  \\$wnnna$aAcceptance, Social
=450  \\$wnnna$aRejection, Social
=450  \\$wnnna$aSocial Rejections
=450  \\$wnnna$aStratification, Social
=667  \\$afor issues concerning health, coordinate with SOCIAL DETERMINANTS OF HEALTH
=680  \\$iThe relative prestige, authority, and privilege of an individual or group.
=688  \\$a2022
=750  \0$aSocial status$0(DLC)sh 85124077 $5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  02113nz  a2200505n  4500
=001  9882547496102441
=005  20250211111125.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089804
=035  \\$a(DNLM)D000089804
=035  \\$a(NLM)9819990330900041
=040  \\$aDNLM$cDNLM
=072  \\$aA11.$x284.$x430.$x106.$x279.$x345.$x190.$x160.$x845.$x500
=072  \\$aD5.$x500.$x918
=072  \\$aD12.$x776.$x260.$x735.$x625
=072  \\$aD12.$x776.$x660.$x235.$x700.$x625
=072  \\$aD12.$x776.$x664.$x981
=072  \\$aG5.$x360.$x160.$x845.$x500
=150  \\$aShelterin Complex
=450  \\$aCST Complex
=450  \\$aCtc1-Stn1-Ten1 Complex
=450  \\$aPOT1-TPP1 Shelterin Complex
=450  \\$aTelomere Cap Complex
=450  \\$aTelomere POT1-TPP1 Complex
=450  \\$aTelomeric Capping Complex
=450  \\$aTelomeric Stn1-Ten1 Capping Complex
=450  \\$aTelosome
=450  \\$wnnna$aCapping Complex, Telomeric
=450  \\$wnnna$aComplex, CST
=450  \\$wnnna$aComplex, Ctc1-Stn1-Ten1
=450  \\$wnnna$aComplex, POT1-TPP1 Shelterin
=450  \\$wnnna$aComplex, Shelterin
=450  \\$wnnna$aComplex, Telomere POT1-TPP1
=450  \\$wnnna$aComplex, Telomeric Capping
=450  \\$wnnna$aCtc1 Stn1 Ten1 Complex
=450  \\$wnnna$aPOT1-TPP1 Complex, Telomere
=450  \\$wnnna$aPOT1 TPP1 Shelterin Complex
=450  \\$wnnna$aShelterin Complex, POT1-TPP1
=450  \\$wnnna$aTelomere POT1 TPP1 Complex
=450  \\$wnnna$aTelomeric Stn1 Ten1 Capping Complex
=450  \\$wnnna$aTelosomes
=680  \\$iA TELOMERE cap complex consisting of telomere-specific proteins in association with telomeric DNA such as telomeric dsDNA-sDNA junction. They are involved in the protection of chromosome ends and TELOMERASE regulation and play a role in CELLULAR SENESCENCE and ageing-related pathology. In general it consists of six mostly TELOMERE-BINDING PROTEINS (POT1, RAP1, TIN2, TPP1, TRF1, and TRF2).
=688  \\$a2022
=750  \0$iBroader mapping$aTelomere$0(DLC)sh 94005630$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01155nz  a2200265n  4500
=001  9882547496602441
=005  20250211112624.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000090663
=035  \\$a(DNLM)D000090663
=035  \\$a(NLM)9819990453500041
=040  \\$aDNLM$cDNLM
=072  \\$aF3.$x700.$x750.$x650
=150  \\$aSchizophrenia, Treatment-Resistant
=450  \\$aRefractory Schizophrenia
=450  \\$aTreatment-Resistant Schizophrenia
=450  \\$wnnna$aSchizophrenia, Refractory
=450  \\$wnnna$aSchizophrenia, Treatment Resistant
=450  \\$wnnna$aTreatment Resistant Schizophrenia
=680  \\$iA subset of schizophrenia with an inadequate response in target symptoms following treatment with two or more ANTIPSYCHOTICS.
=688  \\$a2022
=750  \0$81$wb$iBroader mapping$aSchizophrenia$0(DLC)sh 85118162$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aDrug resistance$0(DLC)sh 85039708$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aSchizophrenia$iand$aDrug resistance$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/11

=LDR  00829nz  a2200229n  4500
=001  9882547496702441
=005  20250211111123.0
=008  210709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000089945
=035  \\$a(DNLM)D000089945
=035  \\$a(NLM)9819990338500041
=040  \\$aDNLM$cDNLM
=072  \\$aB1.$x875.$x800.$x575.$x912.$x250.$x583.$x520.$x922.$x375
=150  \\$aSalvia hispanica
=450  \\$aChia Plant
=450  \\$aSalvia columbariae
=450  \\$wnnna$aChia Plants
=450  \\$wnnna$aPlant, Chia
=680  \\$iA plant species of the Salvia genus known for its seeds which are used in foods and supplements. Common name chia sometimes includes Salvia columbariae.
=688  \\$a2022
=750  \0$iBroader mapping$aSalvia$0(DLC)sh 85116966 $4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/02/07

=LDR  01277nz  a2200325n  4500
=001  9882549679602441
=005  20250214143402.0
=008  990101\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D006476
=035  \\$a(DNLM)D006476
=035  \\$a(NLM)98195299330000041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 168.5.B9
=072  \\$aB4.$x820.$x480.$x750.$x440
=150  \\$aOrthohantavirus
=450  \\$wnnna$aAndes Hantavirus
=450  \\$wnnna$aAndes Virus
=450  \\$aDobrava-Belgrade Virus
=450  \\$aHantavirus
=450  \\$wnnna$aAndes Hantaviruses
=450  \\$wnnna$aDobrava Belgrade Virus
=450  \\$wnnna$aHantavirus, Andes
=450  \\$wnnna$aHantaviruses
=450  \\$wnnna$aHantaviruses, Andes
=450  \\$wnnna$aOrthohantaviruses
=667  \\$ainfection = ORTHOHANTAVIRUS INFECTIONS or specifics
=680  \\$iA genus of the family BUNYAVIRIDAE causing HANTAVIRUS INFECTIONS, first identified during the Korean war. Infection is found primarily in rodents and humans. Transmission does not appear to involve arthropods. HANTAAN VIRUS is the type species.
=688  \\$a2023(1992); use RNA VIRUSES 1978-1986; use ARBOVIRUSES 1965-1977
=750  \0$aHantaviruses$0(DLC)sh 91003493$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00774nz  a2200229n  4500
=001  9882549679902441
=005  20250214142147.0
=008  750619\n\ancnnbabd\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D005202
=035  \\$a(DNLM)D005202
=035  \\$a(NLM)98198628920000041
=040  \\$aDNLM$cDNLM
=072  \\$aZ1.$x252.$x474
=151  \\$aAsia, Eastern
=451  \\$aEastern Asia
=451  \\$wnnna$aEast Asia
=451  \\$wnnna$aFar East
=667  \\$aa geog area of east & southeast Asia; prefer specific countries
=680  \\$iA geographic area of east and southeast Asia encompassing CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.
=688  \\$a2023(1967)
=750  \0$aEast Asia$0(DLC)sh 85040525$5IEN-M
=930  \\$aMeSH Mapping GN 2024/10/08

=LDR  00960nz  a2200217n  4500
=001  9882581728002441
=005  20250501152525.0
=008  920520\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D017407
=035  \\$a(DNLM)D017407
=035  \\$a(NLM)98197291480000041
=040  \\$aDNLM$cDNLM
=072  \\$aN1.$x824.$x417.$x700.$x162
=072  \\$aN4.$x452.$x677.$x800.$x162
=150  \\$aFamily Leave
=450  \\$wnnna$aLeave, Family
=667  \\$ato care for sibs, parents or other family members: do not confuse with PARENTAL LEAVE
=680  \\$iThe authorized absence from work of a family member to attend the illness or participate in the care of a parent, a sibling, or other family member. For the care of a parent for a child or for pre- or postnatal leave of a parent, PARENTAL LEAVE is available.
=688  \\$a93; was see PARENTAL LEAVE 1992
=750  \0$aFamily leave $0(DLC)sh 87002518$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  02062nz  a2200445n  4500
=001  9882581729102441
=005  20250501152525.0
=008  130708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D064307
=035  \\$a(DNLM)D064307
=035  \\$a(NLM)983984856200041
=040  \\$aDNLM$cDNLM
=072  \\$aG6.$x591
=072  \\$aG16.$x500.$x275.$x157.$x49.$x100.$x500
=072  \\$aN6.$x230.$x124.$x49.$x100.$x500
=150  \\$aMicrobiota
=450  \\$wnnna$aMicrobial Community
=450  \\$wnnna$aMicrobial Community Composition
=450  \\$wnnna$aMicrobial Community Structure
=450  \\$aHuman Microbiome
=450  \\$aMicrobiome
=450  \\$aMicrobiome, Human
=450  \\$wnnna$aCommunity Composition, Microbial
=450  \\$wnnna$aCommunity, Microbial
=450  \\$wnnna$aCommunity Structure, Microbial
=450  \\$wnnna$aComposition, Microbial Community
=450  \\$wnnna$aHuman Microbiomes
=450  \\$wnnna$aMicrobial Communities
=450  \\$wnnna$aMicrobial Community Compositions
=450  \\$wnnna$aMicrobial Community Structures
=450  \\$wnnna$aMicrobiomes
=450  \\$wnnna$aMicrobiotas
=550  \\$aMetagenome
=667  \\$acoordinate with specific organism, organ or other site with / microbiol if pertinent
=680  \\$iThe full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche as identified by the presence of their genomic sequence regardless of whether or not they can be cultured.
=680  \\$iThe full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within the human body as identified by their genomic sequence regardless of whether or not they can be cultured.
=680  \\$iThe full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc.
=688  \\$a2014; use METAGENOME 2008-2013
=750  \0$aMicrobiomes$0(DLC)sh2023002041$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01092nz  a2200253n  4500
=001  9882581729302441
=005  20250501152525.0
=008  741119\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D012838
=035  \\$a(DNLM)D012838
=035  \\$a(NLM)98197087280000041
=040  \\$aDNLM$cDNLM
=072  \\$aD3.$x383.$x663.$x283.$x266.$x450.$x268.$x777
=072  \\$aD3.$x633.$x100.$x150.$x266.$x450.$x268.$x777
=150  \\$aSilymarin
=450  \\$wnnna$aCarsil
=450  \\$wnnna$aKarsil
=450  \\$wnnna$aLegalon
=450  \\$wnnna$aSilimarin
=550  \\$aSilybum marianum
=680  \\$iA mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.
=688  \\$a91(75); was see under FLAVONES 1975-90
=750  \0$aSilymarin$0(DLC)sh2023001618$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01143nz  a2200289n  4500
=001  9882581729502441
=005  20250501152525.0
=008  741119\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D011094
=035  \\$a(DNLM)D011094
=035  \\$a(NLM)98197438240000041
=040  \\$aDNLM$cDNLM
=072  \\$aD2.$x455.$x326.$x271.$x665.$x550.$x600
=072  \\$aD2.$x491.$x650
=072  \\$aD5.$x750.$x716.$x507.$x600
=072  \\$aD25.$x720.$x716.$x507.$x600
=072  \\$aJ1.$x637.$x51.$x720.$x716.$x507.$x600
=150  \\$aPolyethyleneimine
=450  \\$wnnna$aPolyethylenimine
=450  \\$aPolyaziridine
=450  \\$wnnna$aPolyaziridines
=450  \\$wnnna$aPolyethyleneimines
=450  \\$wnnna$aPolyethylenimines
=680  \\$iStrongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e).
=688  \\$a91(75); was see under POLYETHYLENES 1975-90
=750  \0$aPolyethylenimine$0(DLC)sh2023001332$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01127nz  a2200301n  4500
=001  9882581729702441
=005  20250501152525.0
=008  120703\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D062028
=035  \\$a(DNLM)D062028
=035  \\$a(NLM)98195020060000041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 36
=072  \\$aE5.$x111
=072  \\$aJ1.$x293.$x69.$x124
=150  \\$aBioprinting
=450  \\$a3D Bioprinting
=450  \\$aThree-Dimensional Bioprinting
=450  \\$wnnna$a3D Bioprintings
=450  \\$wnnna$aBioprinting, 3D
=450  \\$wnnna$aBioprinting, Three-Dimensional
=450  \\$wnnna$aThree Dimensional Bioprinting
=450  \\$wnnna$aThree-Dimensional Bioprintings
=550  \\$aGuided Tissue Regeneration
=680  \\$iA material transfer technique used for assembling biological material or cells into a prescribed organization to create functional structures such as MICROCHIP ANALYTICAL DEVICES, cell microarrays, or three dimensional anatomical structures.
=688  \\$a2013
=750  \0$aBioprinting$0(DLC)sh2023001192$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01490nz  a2200409n  4500
=001  9882581729902441
=005  20250501152525.0
=008  910530\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D016912
=035  \\$a(DNLM)D016912
=035  \\$a(NLM)98193842580000041
=040  \\$aDNLM$cDNLM
=072  \\$aD4.$x210.$x500.$x668.$x651.$x693.$x762.$x450
=150  \\$aLevonorgestrel
=450  \\$wnnna$aCapronor
=450  \\$wnnna$aCerazet
=450  \\$wnnna$aD-Norgestrel
=450  \\$wnnna$aduofem
=450  \\$wnnna$aMicrolut
=450  \\$wnnna$aMicroval
=450  \\$wnnna$aMirena
=450  \\$wnnna$aNorgeston
=450  \\$wnnna$aNorLevo
=450  \\$wnnna$aNorplant
=450  \\$wnnna$aNorplant-2
=450  \\$wnnna$aPlan B
=450  \\$wnnna$aVikela
=450  \\$a18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-
=450  \\$al-Norgestrel
=450  \\$wnnna$aD Norgestrel
=450  \\$wnnna$al Norgestrel
=450  \\$wnnna$aNorplant2
=450  \\$wnnna$aNorplant 2
=680  \\$iA synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
=688  \\$a1992; use LEVONORGESTREL (NM) 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001
=750  \0$aLevonorgestrel$0(DLC)sh2022007852$5IEN-M
=930  \\$aMeSH Mapping NLM 2025/05/01

=LDR  01696nz  a2200397n  4500
=001  9882594272202441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092542
=035  \\$a(DNLM)D000092542
=035  \\$a(NLM)9825515116300041
=040  \\$aDNLM$cDNLM
=072  \\$aC8.$x460.$x799.$x315.$x500.$x500
=072  \\$aC8.$x674.$x453.$x500.$x500
=072  \\$aC9.$x603.$x799.$x315.$x500.$x500
=072  \\$aC20.$x543.$x480.$x680.$x443.$x500.$x500
=150  \\$aDust Mite Allergy
=450  \\$aDermatophagoides farinae Allergy
=450  \\$aDermatophagoides pteronyssinus Allergy
=450  \\$aDust Mite Hypersensitivity
=450  \\$aHouse Dust Mite Allergy
=450  \\$aHouse Dust Mite Hypersensitivity
=450  \\$wnnna$aAllergy, Dermatophagoides farinae
=450  \\$wnnna$aAllergy, Dermatophagoides pteronyssinus
=450  \\$wnnna$aAllergy, Dust Mite
=450  \\$wnnna$aDermatophagoides farinae Allergies
=450  \\$wnnna$aDermatophagoides pteronyssinus Allergies
=450  \\$wnnna$aDust Mite Hypersensitivities
=450  \\$wnnna$aHypersensitivity, Dust Mite
=550  \\$aAntigens, Dermatophagoides
=680  \\$iAllergic rhinitis due to HOUSE DUST MITE ALLERGENS (e.g., Der p 1 of HOUSE DUST MITES) that is triggered by the immune system.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aHouse dust mites$0(DLC)sh 95001141$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aAllergy$0(DLC)sh 85003662$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aHouse dust mites$iand$aAllergy$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01216nz  a2200337n  4500
=001  9882594272302441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092582
=035  \\$a(DNLM)D000092582
=035  \\$a(NLM)9825515102300041
=040  \\$aDNLM$cDNLM
=072  \\$aC20.$x543.$x418.$x257
=072  \\$aC23.$x888.$x119.$x344.$x173
=072  \\$aC25.$x100.$x468.$x690
=150  \\$aDrug Fever
=450  \\$aDrug-Induced Fever
=450  \\$aDrug-Induced Hyperthermia
=450  \\$wnnna$aDrug Induced Fever
=450  \\$wnnna$aDrug-Induced Fevers
=450  \\$wnnna$aDrug Induced Hyperthermia
=450  \\$wnnna$aDrug-Induced Hyperthermias
=450  \\$wnnna$aFever, Drug
=450  \\$wnnna$aFever, Drug-Induced
=450  \\$wnnna$aHyperthermia, Drug-Induced
=680  \\$iDrug-induced fever.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aDrug allergy$0(DLC)sh 85039696$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aFever$0(DLC)sh 85047994$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aDrug allergy$iand$aFever$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01356nz  a2200397n  4500
=001  9882594272502441
=005  20251029114118.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091902
=035  \\$a(DNLM)D000091902
=035  \\$a(NLM)9825515033000041
=040  \\$aDNLM$cDNLM
=072  \\$aG15.$x150
=150  \\$aDrought Resistance
=450  \\$aDrought Avoidence
=450  \\$aDrought Escape
=450  \\$aDrought Injury
=450  \\$aDrought Recovery
=450  \\$aDrought Tolerance
=450  \\$wnnna$aAvoidence, Drought
=450  \\$wnnna$aDrought Avoidences
=450  \\$wnnna$aDrought Escapes
=450  \\$wnnna$aDrought Injuries
=450  \\$wnnna$aDrought Recoveries
=450  \\$wnnna$aDrought Resistances
=450  \\$wnnna$aDrought Tolerances
=450  \\$wnnna$aInjury, Drought
=450  \\$wnnna$aRecovery, Drought
=450  \\$wnnna$aResistance, Drought
=450  \\$wnnna$aTolerance, Drought
=550  \\$aDroughts
=680  \\$iThe ability of a plant to adapt in a drought environment and tolerate a reduction in available water.
=688  \\$a2023
=750  \0$iBroader mapping$aPlants$xDrought tolerance$0(DLC)sh 85102853$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aPlants--Drought tolerance$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/19

=LDR  00753nz  a2200205n  4500
=001  9882594272602441
=005  20251027151743.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092002
=035  \\$a(DNLM)D000092002
=035  \\$a(NLM)9825515179600041
=040  \\$aDNLM$cDNLM
=072  \\$aH1.$x770.$x644.$x241.$x850.$x375
=150  \\$aDocument Analysis
=450  \\$wnnna$aAnalysis, Document
=450  \\$wnnna$aDocument Analyses
=680  \\$iA form of qualitative research that uses a systematic procedure to analyze documentary evidence and answer specific research questions.
=688  \\$a2023
=750  \0$iBroader mapping$aQualitative research$0(DLC)sh 99004969$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/19

=LDR  00943nz  a2200217n  4500
=001  9882594272702441
=005  20251027151745.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094769
=035  \\$a(DNLM)D000094769
=035  \\$a(NLM)9825515442400041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x445.$x308.$x300.$x493
=150  \\$aDNA Polymerase iota
=450  \\$wnnna$aRAD30B
=450  \\$aPOLiota
=450  \\$aPOL iota
=680  \\$iA highly error-prone DNA polymerase. It is a member of the Y-family of DNA polymerases that are DNA DAMAGE tolerant and involved in TRANSLESION DNA SYNTHESIS. DNA polymerase iota is an orthologue of yeast Rad30. Its replication fidelity is template dependent and favors Hoogsteen base-pairing at its active site.
=688  \\$a2023 (2000)
=750  \0$iBroader mapping$aDNA polymerases$0(DLC)sh 85037007$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/19

=LDR  01617nz  a2200313n  4500
=001  9882594272802441
=005  20251027151744.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094665
=035  \\$a(DNLM)D000094665
=035  \\$a(NLM)9825515422300041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x448
=150  \\$aDissection, Blood Vessel
=450  \\$wnnna$aBlood Vessel Dissection
=450  \\$aArterial Dissection
=450  \\$aDissection Artery
=450  \\$wnnna$aArterial Dissections
=450  \\$wnnna$aArteries, Dissection
=450  \\$wnnna$aArtery, Dissection
=450  \\$wnnna$aDissection, Arterial
=450  \\$wnnna$aDissection Arteries
=667  \\$acoordinate with specific aneurysm term if available; otherwise coordinate with specific vessel or precoordinated vascular disease
=680  \\$iA tear or separation of the layers by a blood vessel typically involving vessels under pressure, i.e., ARTERIES, e.g., AORTA. Tearing of the TUNICA INTIMA layer of a blood vessel may lead to interstitial HEMORRHAGE. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation.
=688  \\$a2023; use ANEURYSM, DISSECTING 2017-2022
=750  \0$81$wb$iBroader mapping$aBlood-vessels$0(DLC)sh 85015021$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xDissection$0(DLC)sh 99005672$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aBlood-vessels--Dissection$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01949nz  a2200421n  4500
=001  9882594272902441
=005  20251027151743.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093362
=035  \\$a(DNLM)D000093362
=035  \\$a(NLM)9825515377100041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x205.$x250
=072  \\$aD23.$x946.$x381.$x250
=072  \\$aG7.$x203.$x300.$x356
=072  \\$aJ2.$x500.$x356
=150  \\$aDietary Advanced Glycation End Products
=450  \\$aAdvanced Glycation Endproduct, Dietary
=450  \\$aAdvanced Glycation End Product, Dietary
=450  \\$aAdvanced Glycation Endproducts, Dietary
=450  \\$aAdvanced Glycation End Products, Dietary
=450  \\$aDietary Advanced Glycation Endproduct
=450  \\$aDietary Advanced Glycation End Product
=450  \\$aDietary Advanced Glycation Endproducts
=450  \\$aDietary AGE
=450  \\$aDietary AGEs
=450  \\$aDietary Maillard Reaction Product
=450  \\$aDietary Maillard Reaction Products
=450  \\$aMaillard Reaction Product, Dietary
=450  \\$aMaillard Reaction Products, Dietary
=450  \\$wnnna$aAGE, Dietary
=450  \\$wnnna$aAGEs, Dietary
=680  \\$iAdvanced glycation end products (AGEs) present in food. They are absorbed by the GASTROINTESTINAL SYSTEM and contribute to the body's total AGEs. The food BROWNING REACTION, such as occurs during food processing or cooking with high heat (frying, broiling, grilling, roasting, etc.) accelerates the formation of AGEs in food.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAdvanced glycation end products$0(DLC)sh2020005835$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aFood$0(DLC)sh 85050184$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAdvanced glycation end products$iand$aFood$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01277nz  a2200289n  4500
=001  9882594273002441
=005  20251027151745.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094602
=035  \\$a(DNLM)D000094602
=035  \\$a(NLM)9825515297200041
=040  \\$aDNLM$cDNLM
=072  \\$aC7.$x650.$x800.$x295
=072  \\$aC7.$x793.$x700.$x295
=072  \\$aC16.$x131.$x850.$x800.$x295
=150  \\$aDevelopmental Defects of Enamel
=450  \\$aDevelopmental Defect of Enamel
=450  \\$aDevelopmental Dental Enamel Defect
=450  \\$aDevelopmental Dental Enamel Defects
=450  \\$wnnna$aEnamel Developmental Defect
=450  \\$wnnna$aEnamel Developmental Defects
=680  \\$iDefects in normal AMELOGENESIS caused by any local, systemic, environmental, or genetic factors. Enamel defects resulting from demineralization of normally developed DENTAL ENAMEL is referred to as TOOTH DEMINERALIZATION.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aDental enamel$0(DLC)sh85042959$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xAbnormalities$0(DLC)sh99001117$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aDental enamel--Abnormalities$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  00905nz  a2200241n  4500
=001  9882594273202441
=005  20251027151745.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091982
=035  \\$a(DNLM)D000091982
=035  \\$a(NLM)9825515182400041
=040  \\$aDNLM$cDNLM
=072  \\$aN4.$x590.$x715.$x275
=150  \\$aDental Care Team
=450  \\$aOral Care Team
=450  \\$wnnna$aCare Team, Oral
=450  \\$wnnna$aDental Care Teams
=450  \\$wnnna$aOral Care Teams
=450  \\$wnnna$aTeams, Dental Care
=680  \\$iCare of dental patients by a multidisciplinary team usually organized under the leadership of a dentist; each member of the team has specific responsibilities and the whole team contributes to the oral care of the patient.
=688  \\$a2023
=750  \0$aDental teams$0(DLC)sh 85036937$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01499nz  a2200445n  4500
=001  9882594273302441
=005  20251027151743.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095002
=035  \\$a(DNLM)D000095002
=035  \\$a(NLM)9825515412300041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x220.$x145.$x875
=150  \\$aDelta Catenin
=450  \\$wnnna$ap120cas
=450  \\$wnnna$ap120(cas)
=450  \\$wnnna$ap120-catenin
=450  \\$wnnna$ap120ctn
=450  \\$wnnna$ap120(ctn)
=450  \\$aCadherin-Associated Src Substrate p120
=450  \\$aCatenin, Delta
=450  \\$aCatenin Delta-1
=450  \\$aCatenin Delta-2
=450  \\$aCatenin p120(ctn) Protein
=450  \\$aCatenin p120ctn Protein
=450  \\$aCTNND1 Protein
=450  \\$aCTNND2 Protein
=450  \\$aDelta-Catenin
=450  \\$aDelta Catenins
=450  \\$aNeurojungin
=450  \\$wnnna$aCatenins, Delta
=450  \\$wnnna$aDelta-1, Catenin
=450  \\$wnnna$aProtein, Catenin p120ctn
=450  \\$wnnna$aProtein, CTNND1
=450  \\$wnnna$aProtein, CTNND2
=680  \\$iExpressed in vascular endothelium, KERATINOCYTES and MELANOCYTES.
=680  \\$iA CATENIN protein that plays a critical role in cell adhesion and tissue morphogenesis by regulating the surface stability of C-, E-, and N- CADHERINS.
=688  \\$a2023 (1994)
=750  \0$iBroader mapping$aCatenins$0(DLC)sh2012000199$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01101cz  a2200241n  4500
=001  9882594273402441
=005  20251027151743.0
=008  250128\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093222
=035  \\$a(DNLM)D000093222
=035  \\$a(NLM)9825515370900041
=040  \\$aDNLM$cDNLM
=060  \0$aQY 21
=072  \\$aH1.$x158.$x273.$x198
=072  \\$aH2.$x403.$x650.$x500.$x500
=150  \\$aCytology
=450  \\$wnnna$aCytopathology
=450  \\$wnnna$aCytopathologies
=667  \\$aIndexers: Do not use. Use CYTODIAGNOSIS instead; the discipline only (education, history, etc); for cytological structures use the qualifer /cytol with specific anatomical term or organism; for pathological structures use the qualifer /pathol with specific anatomical term
=680  \\$iThe study of single cell as a unit of living organisms. Cytopathology, a branch of this discipline, studies structural changes of cells in diseases and is used in diagnosing diseases.
=688  \\$a2023 (1984)
=750  \0$aCytology$0(DLC)sh 85035240$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01203nz  a2200289n  4500
=001  9882594273702441
=005  20251027151744.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095043
=035  \\$a(DNLM)D000095043
=035  \\$a(NLM)9825515494100041
=040  \\$aDNLM$cDNLM
=072  \\$aD8.$x811.$x913.$x696.$x620.$x682.$x700.$x646.$x500.$x992
=072  \\$aD12.$x776.$x167.$x200.$x790
=072  \\$aD12.$x776.$x476.$x563.$x646.$x500.$x992
=150  \\$aCyclin-Dependent Kinase-Activating Kinase
=450  \\$aCDK-Activating Kinase
=450  \\$aCyclin Dependent Kinase Activating Kinase
=450  \\$aP34CDC2 Activating Kinase
=450  \\$wnnna$aActivating Kinase, P34CDC2
=450  \\$wnnna$aKinase-Activating Kinase, Cyclin-Dependent
=450  \\$wnnna$aKinase, Cyclin-Dependent Kinase-Activating
=450  \\$wnnna$aKinase, P34CDC2 Activating
=680  \\$iA highly-conserved cyclin-dependent kinase that activates other CYCLIN DEPENDENT KINASES and plays a key role in regulation of the CELL CYCLE.
=688  \\$a2023 (1990)
=750  \0$iBroader mapping$aCyclin-dependent kinases$0(DLC)sh97004870$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  02807nz  a2200661n  4500
=001  9882594273802441
=005  20251027151744.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093522
=035  \\$a(DNLM)D000093522
=035  \\$a(NLM)9825515363300041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x95.$x465.$x425.$x400.$x330.$x50.$x200
=072  \\$aE5.$x478.$x550.$x520.$x50.$x200
=150  \\$aCOVID-19 Serotherapy
=450  \\$aConvalescent Plasma Treatment for Covid-19
=450  \\$aConvalescent Serum Treatment for Covid-19
=450  \\$aCoronavirus Disease-19 Serotherapy
=450  \\$aCoronavirus Disease 2019 Serotherapy
=450  \\$aCOVID-19 Convalescent Plasma Treatment
=450  \\$aCovid-19 Convalescent Sera Treatment
=450  \\$aCOVID-19 Convalescent Serum Treatment
=450  \\$aCOVID-19 Hyperimmune Globulin Therapy
=450  \\$aCOVID19 Hyperimmune Globulin Therapy
=450  \\$aCOVID19 Serotherapy
=450  \\$aCOVID-19 Serum Therapy
=450  \\$aCOVID19 Serum Therapy
=450  \\$aHyperimmune Globulin Therapy for COVID-19
=450  \\$aSARS-CoV-2 Convalescent Plasma Treatment
=450  \\$aSARS-CoV-2 Convalescent Sera Treatment
=450  \\$aSARS-CoV-2 Convalescent Serum Treatment
=450  \\$wnnna$aConvalescent Plasma Treatment for Covid 19
=450  \\$wnnna$aConvalescent Serum Treatment for Covid 19
=450  \\$wnnna$aCoronavirus Disease-19 Serotherapies
=450  \\$wnnna$aCoronavirus Disease 19 Serotherapy
=450  \\$wnnna$aCovid 19 Convalescent Sera Treatment
=450  \\$wnnna$aCOVID-19 Serum Therapies
=450  \\$wnnna$aDisease-19 Serotherapies, Coronavirus
=450  \\$wnnna$aSerotherapies, Coronavirus Disease-19
=450  \\$wnnna$aSerotherapies, COVID19
=450  \\$wnnna$aSerotherapies, COVID-19
=450  \\$wnnna$aSerotherapy, Coronavirus Disease-19
=450  \\$wnnna$aSerotherapy, COVID19
=450  \\$wnnna$aSerotherapy, COVID-19
=450  \\$wnnna$aSerum Therapies, COVID19
=450  \\$wnnna$aSerum Therapies, COVID-19
=450  \\$wnnna$aSerum Therapy, COVID19
=450  \\$wnnna$aSerum Therapy, COVID-19
=450  \\$wnnna$aTherapies, COVID-19 Serum
=450  \\$wnnna$aTherapies, COVID19 Serum
=450  \\$wnnna$aTherapy, COVID-19 Serum
=450  \\$wnnna$aTherapy, COVID19 Serum
=680  \\$iTransfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
=688  \\$a2023 (2020)
=750  \0$81$wb$iBroader mapping$aCOVID-19 (Disease)$0(DLC)sh2020000570$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xSerotherapy$0(DLC)sh 85120337$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aCOVID-19 (Disease)--Serotherapy$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01578nz  a2200421n  4500
=001  9882594273902441
=005  20251027151745.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093485
=035  \\$a(DNLM)D000093485
=035  \\$a(NLM)9825515336100041
=040  \\$aDNLM$cDNLM
=060  \0$aWC 506.2
=072  \\$aE2.$x319.$x231
=150  \\$aCOVID-19 Drug Treatment
=450  \\$aCoronavirus Disease-19 Drug Treatment
=450  \\$aCoronavirus Disease 2019 Drug Treatment
=450  \\$aCOVID-19 Drug Therapy
=450  \\$aCOVID19 Drug Therapy
=450  \\$aCOVID19 Drug Treatment
=450  \\$wnnna$aCoronavirus Disease 19 Drug Treatment
=450  \\$wnnna$aCOVID-19 Drug Therapies
=450  \\$wnnna$aCOVID19 Drug Therapies
=450  \\$wnnna$aCOVID 19 Drug Therapy
=450  \\$wnnna$aCOVID 19 Drug Treatment
=450  \\$wnnna$aCOVID19 Drug Treatments
=450  \\$wnnna$aDrug Therapy, COVID19
=450  \\$wnnna$aDrug Therapy, COVID-19
=450  \\$wnnna$aTherapy, COVID-19 Drug
=450  \\$wnnna$aTherapy, COVID19 Drug
=450  \\$wnnna$aTreatment, COVID-19 Drug
=450  \\$aCOVID-19$xdrug therapy
=680  \\$iThe use of DRUGS to treat COVID19 or its symptoms.
=688  \\$a2023 (2020)
=750  \0$81$wb$iBroader mapping$aCOVID-19 (Disease)$0(DLC)sh2020000570$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xChemotherapy$0(DLC)sh 85023041$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aCOVID-19 (Disease)--Chemotherapy$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01097nz  a2200277n  4500
=001  9882594274002441
=005  20251027151745.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094703
=035  \\$a(DNLM)D000094703
=035  \\$a(NLM)9825515432800041
=040  \\$aDNLM$cDNLM
=072  \\$aN3.$x219.$x151.$x285
=150  \\$aCost-Effectiveness Analysis
=450  \\$aCost Effectiveness
=450  \\$aCost Effectiveness Ratio
=450  \\$wnnna$aAnalysis, Cost-Effectiveness
=450  \\$wnnna$aCost Effectiveness Analysis
=450  \\$wnnna$aCost Effectiveness Ratios
=450  \\$wnnna$aEffectiveness, Cost
=450  \\$wnnna$aEffectiveness Ratio, Cost
=450  \\$wnnna$aRatio, Cost Effectiveness
=680  \\$iA method of comparing the cost of a program with its expected outcomes that are qualitative in nature. Cost effectiveness compares alternative ways to achieve a specific set of results.
=688  \\$a2023; use COST-BENEFIT ANALYSIS 2015-2022
=750  \0$aCost effectiveness$0(DLC)sh 85033197$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01361nz  a2200409n  4500
=001  9882594274202441
=005  20251027151743.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093762
=035  \\$a(DNLM)D000093762
=035  \\$a(NLM)9825515344400041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x199
=150  \\$aCorrectional Facilities Personnel
=450  \\$aCorrectional Officers
=450  \\$aCorrectional Staff
=450  \\$aCorrectional Workers
=450  \\$aCorrections Officers
=450  \\$aPrison Guards
=450  \\$wnnna$aCorrectional Officer
=450  \\$wnnna$aCorrectional Worker
=450  \\$wnnna$aCorrections Officer
=450  \\$wnnna$aGuard, Prison
=450  \\$wnnna$aGuards, Prison
=450  \\$wnnna$aOfficer, Correctional
=450  \\$wnnna$aOfficer, Corrections
=450  \\$wnnna$aOfficers, Correctional
=450  \\$wnnna$aOfficers, Corrections
=450  \\$wnnna$aPersonnel, Correctional Facilities
=450  \\$wnnna$aPrison Guard
=450  \\$wnnna$aStaff, Correctional
=450  \\$wnnna$aWorker, Correctional
=450  \\$wnnna$aWorkers, Correctional
=680  \\$iPersons who work at JAILS; PRISONS; or other CORRECTIONAL INSTITUTIONS.
=688  \\$a2023
=750  \0$aCorrectional personnel$0(DLC)sh 85033021$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  03204nz  a2200793n  4500
=001  9882594274302441
=005  20251027151745.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094504
=035  \\$a(DNLM)D000094504
=035  \\$a(NLM)9825515481300041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x186.$x500.$x500
=072  \\$aE2.$x319.$x685.$x500
=072  \\$aE2.$x774.$x722.$x218
=150  \\$aCorneal Cross-Linking
=450  \\$aCorneal Collagen Cross-Linking
=450  \\$aEpi-off Corneal Cross-Linking
=450  \\$aEpi-off CXL
=450  \\$aEpi-on CXL
=450  \\$aEpithelium-off Corneal Cross-Linking
=450  \\$aEpithelium-off CXL
=450  \\$aEpithelium-on Corneal Cross-Linking
=450  \\$aEpithelium-on CXL
=450  \\$aTransepithelial Corneal Cross-Linking
=450  \\$aTransepithelial CXL
=450  \\$wnnna$aCollagen Cross-Linking, Corneal
=450  \\$wnnna$aCollagen Cross-Linkings, Corneal
=450  \\$wnnna$aCorneal Collagen Cross Linking
=450  \\$wnnna$aCorneal Collagen Cross-Linkings
=450  \\$wnnna$aCorneal Cross Linking
=450  \\$wnnna$aCorneal Cross-Linking, Epi-off
=450  \\$wnnna$aCorneal Cross-Linking, Epithelium-off
=450  \\$wnnna$aCorneal Cross-Linking, Epithelium-on
=450  \\$wnnna$aCorneal Cross-Linkings
=450  \\$wnnna$aCorneal Cross-Linking, Transepithelial
=450  \\$wnnna$aCross-Linking, Corneal
=450  \\$wnnna$aCross-Linking, Corneal Collagen
=450  \\$wnnna$aCross-Linking, Epi-off Corneal
=450  \\$wnnna$aCross-Linking, Epithelium-off Corneal
=450  \\$wnnna$aCross-Linking, Epithelium-on Corneal
=450  \\$wnnna$aCross-Linkings, Corneal Collagen
=450  \\$wnnna$aCross-Linking, Transepithelial Corneal
=450  \\$wnnna$aCXL, Epi-off
=450  \\$wnnna$aCXL, Epi-on
=450  \\$wnnna$aCXL, Epithelium-off
=450  \\$wnnna$aCXL, Epithelium-on
=450  \\$wnnna$aCXL, Transepithelial
=450  \\$wnnna$aEpi off Corneal Cross Linking
=450  \\$wnnna$aEpi-off Corneal Cross-Linkings
=450  \\$wnnna$aEpi off CXL
=450  \\$wnnna$aEpi-off CXLs
=450  \\$wnnna$aEpi on CXL
=450  \\$wnnna$aEpi-on CXLs
=450  \\$wnnna$aEpithelium off Corneal Cross Linking
=450  \\$wnnna$aEpithelium-off Corneal Cross-Linkings
=450  \\$wnnna$aEpithelium off CXL
=450  \\$wnnna$aEpithelium-off CXLs
=450  \\$wnnna$aEpithelium on Corneal Cross Linking
=450  \\$wnnna$aEpithelium-on Corneal Cross-Linkings
=450  \\$wnnna$aEpithelium on CXL
=450  \\$wnnna$aEpithelium-on CXLs
=450  \\$wnnna$aTransepithelial Corneal Cross Linking
=450  \\$wnnna$aTransepithelial Corneal Cross-Linkings
=450  \\$wnnna$aTransepithelial CXLs
=680  \\$iAn ophthalmic treatment used to prevent weakening or bulging of the CORNEA in corneal ECTASIA, e.g., post-LASIK ectasia, KERATOCONUS and pellucid marginal corneal degeneration. It uses UV-A and RIBOFLAVIN to crosslink and strengthen COLLAGEN fibers within the cornea.
=688  \\$a2023
=750  \0$iBroader mapping$aPhotochemotherapy$0(DLC)sh 85101147$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01328nz  a2200277n  4500
=001  9882594274402441
=005  20251029113946.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093922
=035  \\$a(DNLM)D000093922
=035  \\$a(NLM)9825515200600041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x292.$x562.$x700.$x375
=072  \\$aC10.$x500.$x198
=072  \\$aC11.$x590.$x436.$x400
=072  \\$aC16.$x131.$x666.$x198
=150  \\$aCongenital Cranial Dysinnervation Disorders
=450  \\$aCongenital Cranial Dysinnervation Syndromes
=450  \\$aCongenital Fibrosis Syndromes
=450  \\$aCongenital Innervation Dysgenesis Syndrome
=450  \\$wnnna$aCongenital Fibrosis Syndrome
=680  \\$iCongenital neurodevelopmental diseases characterized by abnormal eye, eyelid, and facial movements. Congenital cranial dysinnervation disorders (CCDDs) are caused by abnormal innervation of CRANIAL NERVES (e.g., CNs III, IV and VI) resulting in aplasia or hypoplasia of the ocular and facial musculature involved in EYE MOVEMENTS.
=688  \\$a2023
=750  \0$iBroader mapping$aNervous system$xAbnormalities$0(DLC)sh 85090918$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aNervous system--Abnormalities$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01129nz  a2200301n  4500
=001  9882594274602441
=005  20251029113900.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093182
=035  \\$a(DNLM)D000093182
=035  \\$a(NLM)9825515377800041
=040  \\$aDNLM$cDNLM
=072  \\$aE1.$x370.$x225.$x124.$x100.$x174
=072  \\$aE5.$x200.$x124.$x100.$x174
=150  \\$aComprehensive Metabolic Panel
=450  \\$aCMP Testing
=450  \\$aComprehensive Metabolic Panel Testing
=450  \\$wnnna$aCMP Testings
=450  \\$wnnna$aComprehensive Metabolic Panels
=450  \\$wnnna$aPanel, Comprehensive Metabolic
=450  \\$wnnna$aPanels, Comprehensive Metabolic
=450  \\$wnnna$aTesting, CMP
=450  \\$wnnna$aTestings, CMP
=680  \\$iA series of blood tests on one panel that measure the body's chemical balance and metabolism.
=688  \\$a2023
=750  \0$iBroader mapping$aMetabolism$xTesting$0(DLC)sh 87000524$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aMetabolism--Testing$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01126nz  a2200277n  4500
=001  9882594274802441
=005  20251029113819.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094523
=035  \\$a(DNLM)D000094523
=035  \\$a(NLM)9825515285800041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x124.$x486.$x485.$x114.$x224.$x342
=072  \\$aD12.$x776.$x124.$x790.$x651.$x114.$x224.$x306
=072  \\$aD12.$x776.$x377.$x715.$x548.$x114.$x224.$x463
=072  \\$aD26.$x310.$x358
=150  \\$aCombined Antibody Therapeutics
=450  \\$aAntibody Cocktail
=450  \\$wnnna$aAntibody Therapeutics, Combined
=450  \\$wnnna$aCocktail, Antibody
=450  \\$wnnna$aTherapeutics, Combined Antibody
=680  \\$iCombinations of monoclonal antibodies used therapeutically to modulate the IMMUNE SYSTEM.
=688  \\$a2023
=750  \0$iBroader mapping$aMonoclonal antibodies$xTherapeutic use$0(DLC)sh2010102330$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aMonoclonal antibodies--Therapeutic use$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01097nz  a2200313n  4500
=001  9882594274902441
=005  20251027151744.0
=008  240809\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094767
=035  \\$a(DNLM)D000094767
=035  \\$a(NLM)9825515424700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x373.$x250.$x500
=072  \\$aM1.$x526.$x485.$x67.$x150.$x500
=072  \\$aM1.$x526.$x625.$x500
=072  \\$aN2.$x360.$x67.$x150.$x500
=150  \\$aCombat Medics
=450  \\$aCombat Medic
=450  \\$aCombat Medical Technicians
=450  \\$aField Medical Service Technicians
=450  \\$wnnna$aCombat Medical Technician
=450  \\$wnnna$aMedical Technician, Combat
=450  \\$wnnna$aMedical Technicians, Combat
=450  \\$wnnna$aMedic, Combat
=450  \\$wnnna$aMedics, Combat
=680  \\$iIndividuals trained to provide medical care in a military operational or combat environment.
=688  \\$a2023
=750  \0$iBroader mapping$aEmergency medical technicians$0(DLC)sh 85042754$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01466nz  a2200325n  4500
=001  9882594275102441
=005  20251029113738.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000091942
=035  \\$a(DNLM)D000091942
=035  \\$a(NLM)9825515032400041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x760.$x169.$x63.$x500.$x477.$x250
=072  \\$aE2.$x831.$x477.$x250
=072  \\$aH2.$x403.$x680.$x600.$x750.$x250
=072  \\$aN2.$x421.$x784.$x511.$x250
=150  \\$aCognitive Training
=450  \\$wnnna$aMemory Training
=450  \\$aBrain Training
=450  \\$aCognitive Rehabilitation
=450  \\$wnnna$aRehabilitation, Cognitive
=450  \\$wnnna$aTraining, Brain
=450  \\$wnnna$aTraining, Cognitive
=450  \\$wnnna$aTraining, Memory
=680  \\$iEnhancement strategies to improve duration and retention of information.
=680  \\$iA non-pharmacological form of treatment focusing on guided practice on tasks that target specific cognitive functions. These functions include memory, attention, and problem-solving. (from Cochrane.org/CD013069/DEMENTIA_cognitive-training-people-mild-moderate-dementia)
=688  \\$a2023
=750  \0$iBroader mapping$aNervous system$xDiseases$xPatients$xRehabilitation$0(DLC)sh2010103647$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aNervous system--Diseases--Patients--Rehabilitation$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  00951nz  a2200241n  4500
=001  9882594275202441
=005  20251027151745.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094407
=035  \\$a(DNLM)D000094407
=035  \\$a(NLM)9825515193300041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x752.$x227
=072  \\$aG7.$x180.$x562.$x190.$x500
=150  \\$aChronotype
=450  \\$aMorningness Eveningness Preferences
=450  \\$wnnna$aChronotypes
=450  \\$wnnna$aMorningness Eveningness Preference
=450  \\$wnnna$aPreference, Morningness Eveningness
=680  \\$iThe natural inclination or preference of time of day in which an individual or an organism has the most activity, particularly as it relates to sleeping pattern and circadian sleep-wake preferences.
=688  \\$a2023
=750  \0$iBroader mapping$aCircadian rhythms$0(DLC)sh 85026049$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  02102nz  a2200445n  4500
=001  9882594275302441
=005  20251029113628.0
=008  220711\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092702
=035  \\$a(DNLM)D000092702
=035  \\$a(NLM)9825515365400041
=040  \\$aDNLM$cDNLM
=072  \\$aC12.$x50.$x351.$x968.$x419.$x780.$x750.$x250
=072  \\$aC12.$x200.$x777.$x419.$x780.$x750.$x250
=072  \\$aC12.$x950.$x419.$x780.$x750.$x250
=072  \\$aC23.$x550.$x291.$x500.$x906.$x250
=072  \\$aC24.$x80.$x183
=150  \\$aChronic Kidney Diseases of Uncertain Etiology
=450  \\$aChronic Interstitial Nephritis of Agricultural Communities
=450  \\$aChronic Kidney Disease of Nontraditional Etiology
=450  \\$aChronic Kidney Disease of Uncertain Etiology
=450  \\$aChronic Kidney Disease of Unknown Etiology
=450  \\$aChronic Kidney Disease of Unknown or Uncertain Etiology
=450  \\$aCINAC
=450  \\$aCINAC Chronic Interstitial Nephritis in Agricultural Communities
=450  \\$aCKD of Uncertain Etiology
=450  \\$aCKDu Chronic Kidney Disease of Uncertain Etiology
=450  \\$aCKDu Chronic Kidney Disease of Unknown Etiology
=450  \\$aCKDu Chronic Kidney Diseases of Uncertain Etiology
=450  \\$aKDUCAL
=450  \\$aKidney Disease of Unknown Cause in Agricultural Laborers
=450  \\$aMesoamerican Nephropathy
=450  \\$wnnna$aMesoamerican Nephropathies
=450  \\$wnnna$aNephropathy, Mesoamerican
=450  \\$wnnna$aUncertain Etiology CKD
=680  \\$iChronic kidney diseases not associated with traditional RISK FACTORS, e.g., TYPE 2 DIABETES MELLITUS and HYPERTENSION, but rather with infectious diseases, exposure to environmental toxins, or other unknown factors. They are most prevalent in agricultural communities of DEVELOPING COUNTRIES.
=688  \\$a2023
=750  \0$iBroader mapping$aKidneys$xDiseases$0(DLC)sh 85072261$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aKidneys--Diseases$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01236nz  a2200313n  4500
=001  9882594275402441
=005  20251027151743.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094482
=035  \\$a(DNLM)D000094482
=035  \\$a(NLM)9825515289600041
=040  \\$aDNLM$cDNLM
=072  \\$aC17.$x800.$x862.$x945.$x533.$x500
=072  \\$aC20.$x543.$x480.$x904.$x533.$x500
=072  \\$aC23.$x550.$x291.$x500.$x360.$x500
=150  \\$aChronic Inducible Urticaria
=450  \\$wnnna$aUrticaria, Aquagenic
=450  \\$aAquagenic Urticaria
=450  \\$aCIndU
=450  \\$aUrticaria, Vibratory
=450  \\$aVibratory Urticaria
=450  \\$wnnna$aAquagenic Urticarias
=450  \\$wnnna$aChronic Inducible Urticarias
=450  \\$wnnna$aInducible Urticaria, Chronic
=450  \\$wnnna$aVibratory Urticarias
=680  \\$iChronic urticaria with identified triggering factor which is either physical, e.g., vibratory urticaria, or non-physical, e.g., aquagenic urticaria.
=688  \\$a2023; use CHRONIC URTICARIA 2020-2022, for URTICARIA, AQUAGENIC use under UTTICARIA 2013-2022
=750  \0$iBroader mapping$aUrticaria$0(DLC)sh 85141474$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  00993nz  a2200289n  4500
=001  9882594275602441
=005  20251027151743.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094850
=035  \\$a(DNLM)D000094850
=035  \\$a(NLM)9825515511800041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x330.$x375
=150  \\$aCentral Asian People
=450  \\$aCentral Asian Person
=450  \\$aCentral Asians
=450  \\$wnnna$aAsian, Central
=450  \\$wnnna$aAsian People, Central
=450  \\$wnnna$aAsian Person, Central
=450  \\$wnnna$aCentral Asian Peoples
=450  \\$wnnna$aCentral Asian Persons
=450  \\$wnnna$aPeople, Central Asian
=450  \\$wnnna$aPerson, Central Asian
=680  \\$iPeople native to or inhabitants of CENTRAL ASIA including KAZAKHSTAN; KYRGYZSTAN; TAJIKISTAN; TURKMENISTAN and UZBEKISTAN.
=688  \\$a2023
=750  \0$aCentral Asians$0(DLC)sh2019001903$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01219nz  a2200337n  4500
=001  9882594275802441
=005  20251027151745.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094866
=035  \\$a(DNLM)D000094866
=035  \\$a(NLM)9825515521700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x429
=150  \\$aCentral American People
=450  \\$aCentral American Person
=450  \\$aCentral Americans
=450  \\$wnnna$aAmerican, Central
=450  \\$wnnna$aAmerican People, Central
=450  \\$wnnna$aAmerican Person, Central
=450  \\$wnnna$aAmerican Persons, Central
=450  \\$wnnna$aAmericans, Central
=450  \\$wnnna$aCentral American Peoples
=450  \\$wnnna$aCentral American Persons
=450  \\$wnnna$aPeople, Central American
=450  \\$wnnna$aPeoples, Central American
=450  \\$wnnna$aPerson, Central American
=450  \\$wnnna$aPersons, Central American
=680  \\$iPeople native to or inhabitants of CENTRAL AMERICA including BELIZE; COSTA RICA; EL SALVADOR; GUATEMALA; HONDURAS; NICARAGUA; and PANAMA.
=688  \\$a2023
=750  \0$aCentral Americans$0(DLC)sh 89002831$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01626nz  a2200409n  4500
=001  9882594276002441
=005  20251029110904.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094629
=035  \\$a(DNLM)D000094629
=035  \\$a(NLM)9825515563600041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x448.$x250.$x128
=072  \\$aC14.$x907.$x109.$x70.$x500.$x128
=150  \\$aDissection, Thoracic Aorta
=450  \\$aAortic Arch Dissection
=450  \\$aDescending Aorta Dissection
=450  \\$aDescending Thoracic Aortic Dissection
=450  \\$aDissection, Aortic Arch
=450  \\$aDissection, Descending Aorta
=450  \\$aDissection, Descending Thoracic Aorta
=450  \\$aThoracic Aorta Dissection
=450  \\$aThoracic Aortic Dissection
=450  \\$wnnna$aAorta Dissection, Descending
=450  \\$wnnna$aAorta Dissection, Thoracic
=450  \\$wnnna$aAortic Arch Dissections
=450  \\$wnnna$aAortic Dissection, Thoracic
=450  \\$wnnna$aArch Dissection, Aortic
=450  \\$wnnna$aDescending Aorta Dissections
=450  \\$wnnna$aDissections, Aortic Arch
=450  \\$wnnna$aDissection, Thoracic Aortic
=450  \\$wnnna$aThoracic Aorta Dissections
=450  \\$wnnna$aThoracic Aortic Dissections
=680  \\$iDissection or a tear of the THORACIC AORTA. It includes aortic root dissection, ascending aortic dissection, aortic arch dissection and descending thoracic aortic dissection.
=688  \\$a2023
=750  \0$iBroader mapping$aDissecting aortic aneurysms$0(DLC)sh 85038483$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01109nz  a2200313n  4500
=001  9882594276202441
=005  20251029110910.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094630
=035  \\$a(DNLM)D000094630
=035  \\$a(NLM)9825515553400041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x448.$x250.$x128.$x500
=072  \\$aC14.$x907.$x109.$x70.$x500.$x128.$x500
=150  \\$aDissection, Ascending Aorta
=450  \\$aAortic Root Dissection
=450  \\$aAscending Aorta Dissection
=450  \\$aAscending Aortic Dissection
=450  \\$aDissection, Aortic Root
=450  \\$wnnna$aAorta Dissection, Ascending
=450  \\$wnnna$aAortic Dissection, Ascending
=450  \\$wnnna$aAortic Root Dissections
=450  \\$wnnna$aAscending Aorta Dissections
=450  \\$wnnna$aAscending Aortic Dissections
=450  \\$wnnna$aDissection, Ascending Aortic
=450  \\$wnnna$aRoot Dissection, Aortic
=688  \\$a2023
=750  \0$iBroader mapping$aDissecting aortic aneurysms$0(DLC)sh 85038483$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01506nz  a2200373n  4500
=001  9882594276302441
=005  20251027151744.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094631
=035  \\$a(DNLM)D000094631
=035  \\$a(NLM)9825515459800041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x448.$x250.$x64
=072  \\$aC14.$x907.$x109.$x70.$x500.$x64
=150  \\$aDissection, Abdominal Aorta
=450  \\$aAbdominal Aortic Dissection
=450  \\$aDissection, Thoracoabdominal Aorta
=450  \\$aThoracoabdominal Aortic Dissection
=450  \\$wnnna$aAbdominal Aorta Dissection
=450  \\$wnnna$aAbdominal Aorta Dissections
=450  \\$wnnna$aAbdominal Aortic Dissections
=450  \\$wnnna$aAorta Dissection, Abdominal
=450  \\$wnnna$aAorta Dissection, Thoracoabdominal
=450  \\$wnnna$aAortic Dissection, Abdominal
=450  \\$wnnna$aAortic Dissection, Thoracoabdominal
=450  \\$wnnna$aDissection, Abdominal Aortic
=450  \\$wnnna$aDissection, Thoracoabdominal Aortic
=450  \\$wnnna$aThoracoabdominal Aorta Dissection
=450  \\$wnnna$aThoracoabdominal Aorta Dissections
=450  \\$wnnna$aThoracoabdominal Aortic Dissections
=680  \\$iDissection or a tear of the ABDOMINAL AORTA. It includes thoracoabdominal aortic dissection at the aortic hiatus.
=688  \\$a2023
=750  \0$iBroader mapping$aDissecting aortic aneurysms$0(DLC)sh 85038483$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  02091nz  a2200517n  4500
=001  9882594276502441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094845
=035  \\$a(DNLM)D000094845
=035  \\$a(NLM)9825515521800041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x254.$x750.$x500
=150  \\$aCentral African People
=450  \\$aCentral African Person
=450  \\$aCentral Africans
=450  \\$aMiddle African People
=450  \\$aMiddle African Person
=450  \\$aMiddle Africans
=450  \\$wnnna$aAfrican, Central
=450  \\$wnnna$aAfrican, Middle
=450  \\$wnnna$aAfrican People, Central
=450  \\$wnnna$aAfrican People, Middle
=450  \\$wnnna$aAfrican Peoples, Central
=450  \\$wnnna$aAfrican Peoples, Middle
=450  \\$wnnna$aAfrican Person, Central
=450  \\$wnnna$aAfrican Person, Middle
=450  \\$wnnna$aAfrican Persons, Central
=450  \\$wnnna$aAfrican Persons, Middle
=450  \\$wnnna$aAfricans, Central
=450  \\$wnnna$aAfricans, Middle
=450  \\$wnnna$aCentral African Peoples
=450  \\$wnnna$aCentral African Persons
=450  \\$wnnna$aMiddle African
=450  \\$wnnna$aMiddle African Peoples
=450  \\$wnnna$aMiddle African Persons
=450  \\$wnnna$aPeople, Central African
=450  \\$wnnna$aPeople, Middle African
=450  \\$wnnna$aPerson, Central African
=450  \\$wnnna$aPerson, Middle African
=450  \\$wnnna$aPersons, Central African
=450  \\$wnnna$aPersons, Middle African
=680  \\$iPeople native to or inhabitants of the CENTRAL AFRICA including CAMEROON; CENTRAL AFRICAN REPUBLIC; CHAD; CONGO; DEMOCRATIC REPUBLIC OF THE CONGO; EQUATORIAL GUINEA; GABON; and SAO TOME AND PRINCIPE. It includes indigenous peoples in the Congo Basin. Sometimes people native or inhabitants of the country of Central African Republic are referred to as Central Africans.
=688  \\$a2023
=750  \0$iBroader mapping$aAfricans$0(DLC)sh 85001757$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01140nz  a2200253n  4500
=001  9882594276702441
=005  20251027151743.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094859
=035  \\$a(DNLM)D000094859
=035  \\$a(NLM)9825515415200041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x413
=150  \\$aCaribbean People
=450  \\$aCaribbeans
=450  \\$aWest Indian People
=450  \\$wnnna$aCaribbean Peoples
=450  \\$wnnna$aPeople, Caribbean
=450  \\$wnnna$aPeople, West Indian
=450  \\$wnnna$aWest Indian Peoples
=680  \\$iPeople native to or inhabitants of islands in the Caribbean Sea or CARIBBEAN including ANTIGUA AND BARBUDA; ARUBA; BAHAMAS; BARBADOS; BRITISH VIRGIN ISLANDS; CARIBBEAN NETHERLANDS; CUBA; CURACAO; DOMINICA; DOMINICAN REPUBLIC; GRENADA; GUADELOUPE; HAITI; JAMAICA; MARTINIQUE; PUERTO RICO; SAINT KITTS AND NEVIS; SAINT LUCIA; SAINT VINCENT AND THE GRENADINES; SINT MAARTEN; TRINIDAD AND TOBAGO; and UNITED STATES VIRGIN ISLANDS.
=688  \\$a2023
=750  \0$aCaribbeans$0(DLC)sh2023001699$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/14

=LDR  01319nz  a2200277n  4500
=001  9882594276902441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094542
=035  \\$a(DNLM)D000094542
=035  \\$a(NLM)9825515581800041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x196.$x401.$x663.$x500
=072  \\$aE5.$x301.$x300.$x663.$x250
=150  \\$aCapillary Isoelectric Focusing
=450  \\$aCIEF Capillary Isoelectric Focusing
=450  \\$aiCIEF
=450  \\$aImaged Capillary Isoelectric Focusing
=450  \\$wnnna$aCapillary Isoelectric Focusings
=450  \\$wnnna$aIsoelectric Focusing, Capillary
=680  \\$iIsoelectric focusing in capillary gels instead of slab gels. Capillary gel electrophoresis generally allows higher resolution, higher detection sensitivity and easier integration with other separation and detection techniques.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aCapillary electrophoresis$0(DLC)sh 90002644$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aIsoelectric focusing$0(DLC)sh 85068632$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aCapillary electrophoresis$iand$aIsoelectric focusing$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01947nz  a2200373n  4500
=001  9882594277102441
=005  20251027151744.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092182
=035  \\$a(DNLM)D000092182
=035  \\$a(NLM)9825515162500041
=040  \\$aDNLM$cDNLM
=072  \\$aC17.$x800.$x113
=072  \\$aC18.$x452.$x174.$x130.$x93
=150  \\$aCalcinosis Cutis
=450  \\$aCutaneous Calcification
=450  \\$aDystrophic Calcinosis Cutis
=450  \\$aIatrogenic Calcinosis Cutis
=450  \\$aIdiopathic Calcinosis Cutis
=450  \\$aMetastatic Calcinosis Cutis
=450  \\$wnnna$aCalcification, Cutaneous
=450  \\$wnnna$aCalcinosis Cutis, Dystrophic
=450  \\$wnnna$aCalcinosis Cutis, Iatrogenic
=450  \\$wnnna$aCalcinosis Cutis, Idiopathic
=450  \\$wnnna$aCalcinosis Cutis, Metastatic
=450  \\$wnnna$aCutaneous Calcifications
=680  \\$iPathological deposition of calcium in the skin and subcutaneous tissue. Excessive calcification of the skin may be associated with underlying diseases that cause tissue damage (e.g., EHLERS-DANLOS SYNDROME; PSEUDOXANTHOMA ELASTICUM; ROTHMUND-THOMSON SYNDROME; and WERNER SYNDROME) or that cause abnormal calcium and phosphate metabolism (e.g., CALCIPHYLAXIS; CHRONIC KIDNEY FAILURE; HYPERPARATHYROIDISM; and SARCOIDOSIS).
=680  \\$iCalcinosis cutis with normal laboratory values of calcium and phosphorus and an underlying disease causing tissue damage.
=680  \\$iCalcinosis cutis with abnormal calcium and phosphate metabolism and associated with HYPERCALCAEMIA and HYPERPHOSPHATAEMIA.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aSkin$0(DLC)sh 85123164$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xCalcification$0(DLC)sh 85018762$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aSkin--Calcification$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01201nz  a2200289n  4500
=001  9882594277302441
=005  20251029105411.0
=008  220714\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092468
=035  \\$a(DNLM)D000092468
=035  \\$a(NLM)9825515258100041
=040  \\$aDNLM$cDNLM
=072  \\$aD12.$x776.$x660.$x235.$x25
=072  \\$aD12.$x776.$x664.$x235.$x25
=072  \\$aD12.$x776.$x930.$x900.$x100
=150  \\$aBromodomain Containing Proteins
=450  \\$aBRDs Containing Protein
=450  \\$aBromodomain-Containing Proteins
=450  \\$wnnna$aContaining Protein, BRDs
=450  \\$wnnna$aContaining Proteins, Bromodomain
=450  \\$wnnna$aProtein, BRDs Containing
=450  \\$wnnna$aProteins, Bromodomain Containing
=450  \\$wnnna$aProteins, Bromodomain-Containing
=680  \\$iNon-histone chromosomal proteins that regulate GENE EXPRESSION through a variety of mechanisms including recognizing acetylated HISTONE LYSINE residues and through transcriptional machinery regulation.
=688  \\$a2023 (2001)
=750  \0$iNarrower mapping$aBromodomain-containing protein 1$0(DLC)sh2008008885$4NM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01252nz  a2200421n  4500
=001  9882594277502441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094345
=035  \\$a(DNLM)D000094345
=035  \\$a(NLM)9825515580100041
=040  \\$aDNLM$cDNLM
=060  \0$aWH 470
=072  \\$aN2.$x421.$x911.$x100
=150  \\$aBlood Donation
=450  \\$aBlood Donating
=450  \\$aPlasma Donation
=450  \\$aPlatelet Donation
=450  \\$wnnna$aBlood Donations
=450  \\$wnnna$aDonating, Blood
=450  \\$wnnna$aDonation, Blood
=450  \\$wnnna$aDonation, Plasma
=450  \\$wnnna$aDonation, Platelet
=450  \\$wnnna$aDonations, Blood
=450  \\$wnnna$aDonations, Plasma
=450  \\$wnnna$aDonations, Platelet
=450  \\$wnnna$aPlasma Donations
=450  \\$wnnna$aPlatelet Donations
=550  \\$aBlood Banks
=550  \\$aBlood Donors
=550  \\$aPlasmapheresis
=550  \\$aPlateletpheresis
=550  \\$aPhlebotomy
=550  \\$aBlood Banking
=680  \\$iVoluntary giving of BLOOD.
=688  \\$a2023; use BLOOD DONORS 1978-2022
=750  \0$aDirected blood donations$0(DLC)sh 87005306$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01075nz  a2200265n  4500
=001  9882594277802441
=005  20251029113549.0
=008  240809\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094902
=035  \\$a(DNLM)D000094902
=035  \\$a(NLM)9825515519500041
=040  \\$aDNLM$cDNLM
=060  \0$aWH 460
=072  \\$aE2.$x792.$x833.$x230.$x250
=072  \\$aE5.$x760.$x833.$x230.$x250
=072  \\$aN2.$x421.$x911.$x50
=150  \\$aBlood Banking
=450  \\$wnnna$aBanking, Blood
=450  \\$aBlood Banks$xadministration & dosage
=450  \\$aBlood Banks$xmethods
=680  \\$iThe administrative procedures and methods required for collecting, characterizing and storing blood or plasma in BLOOD BANKS.
=688  \\$a2023; use BLOOD BANKS 1966-2022
=750  \0$iBroader mapping$aInformation storage and retrieval systems$xBlood banks$0(DLC)sh2021000222$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aInformation storage and retrieval systems--Blood banks$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01521nz  a2200349n  4500
=001  9882594277902441
=005  20251029113436.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093663
=035  \\$a(DNLM)D000093663
=035  \\$a(NLM)9825515330200041
=040  \\$aDNLM$cDNLM
=072  \\$aC12.$x50.$x351.$x500.$x852.$x667.$x250
=150  \\$aBicornuate Uterus
=450  \\$aBicornuate Bicollis
=450  \\$aBicornuate Bicollis Uterus
=450  \\$aBicornuate Unicollis
=450  \\$aBicornuate Unicollis Uterus
=450  \\$aDouble Uterus and Longitudinal Vaginal Septum
=450  \\$wnnna$aBicolli, Bicornuate
=450  \\$wnnna$aBicollis, Bicornuate
=450  \\$wnnna$aBicollis Uterus, Bicornuate
=450  \\$wnnna$aBicornuate Bicolli
=450  \\$wnnna$aUnicollis, Bicornuate
=450  \\$wnnna$aUnicollis Uterus, Bicornuate
=450  \\$wnnna$aUterus, Bicornuate Bicollis
=450  \\$wnnna$aUterus, Bicornuate Unicollis
=680  \\$iA congenital uterine anomaly in which the UTERUS is divided into two uterine horns with a significant cleft at the uterine fundus due to partial fusion of the MULLERIAN DUCTS. Bicornuate uterus is sometimes associated with a longitudinal vaginal septum and abnormal development of renal tracts.
=688  \\$a2023
=788  \0$iSearch under the Library of Congress Subject Heading$aUterus--Diseases$5IEN-M
=750  \0$iBroader mapping$aUterus$xDiseases$0(DLC)sh 85141611$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00956nz  a2200241n  4500
=001  9882594278002441
=005  20251027151743.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094861
=035  \\$a(DNLM)D000094861
=035  \\$a(NLM)9825515411200041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x493.$x500
=150  \\$aAustralasian People
=450  \\$aAustralasians
=450  \\$wnnna$aAustralasian Peoples
=450  \\$wnnna$aPeople, Australasian
=680  \\$iPeople native to or inhabitants of AUSTRALASIA including AUSTRALIA and NEW ZEALAND.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAustralians$0(DLC)sh 85009651$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aNew Zealanders$0(DLC)sh 85091526$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAustralians$iand$aNew Zealanders$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  01087nz  a2200253n  4500
=001  9882594278202441
=005  20251027151742.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094202
=035  \\$a(DNLM)D000094202
=035  \\$a(NLM)9825515207600041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x270.$x906
=150  \\$aAsian American Native Hawaiian and Pacific Islander
=450  \\$aAANHPI
=450  \\$aAsian American Pacific Islander
=450  \\$aAsian Americans Pacific Islanders
=680  \\$iMembers of Asian American, Native Hawaiian, and Pacific Islander community.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAsian Americans$0(DLC)sh 85008644$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aHawaiians$0(DLC)sh 85059379$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aPacific Islanders$0(DLC)sh 85093920$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAsian Americans$iand$aHawaiians$iand$aPacific Islanders$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  00838nz  a2200229n  4500
=001  9882594278402441
=005  20251027151744.0
=008  220708\n\ancnnbabd\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095143
=035  \\$a(DNLM)D000095143
=035  \\$a(NLM)9825515499600041
=040  \\$aDNLM$cDNLM
=072  \\$aZ1.$x252.$x245.$x782
=151  \\$aAsia, Southern
=451  \\$aBritish Indian Ocean Territory
=451  \\$aSouthern Asia
=451  \\$wnnna$aAsia, South
=451  \\$wnnna$aSouth Asia
=680  \\$iThe geographical designation for the countries of AFGHANISTAN; BANGLADESH; BHUTAN; INDIA; MALDIVES; NEPAL; PAKISTAN; and SRI LANKA.
=688  \\$a2023(1983); for BRITISH INDIAN OCEAN TERRITORY use AFRICA, EASTERN 1983-2022
=750  \0$aSouth Asia$0(DLC)sh 85125541$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00840nz  a2200217n  4500
=001  9882594278702441
=005  20251027151743.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092003
=035  \\$a(DNLM)D000092003
=035  \\$a(NLM)9825515179400041
=040  \\$aDNLM$cDNLM
=060  \0$aQT 26.5
=072  \\$aH1.$x158.$x273.$x904.$x500
=072  \\$aH1.$x770.$x644.$x81
=150  \\$aArtificial Life
=450  \\$wnnna$aLife, Artificial
=680  \\$iResearch involving the synthesis of life and life-like phenomena and the application of such techniques toward the enhancement of our theoretical understanding of life and life-like phenomena, studied through the use of computer programs.
=688  \\$a2023
=750  \0$aArtificial life$0(DLC)sh 95009889$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01582nz  a2200301n  4500
=001  9882594278902441
=005  20251029113322.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092183
=035  \\$a(DNLM)D000092183
=035  \\$a(NLM)9825515150300041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x280.$x195.$x400.$x500
=072  \\$aC14.$x280.$x238.$x100.$x250
=150  \\$aApical Hypertrophic Cardiomyopathy
=450  \\$aApical-Variant HCM
=450  \\$aLeft Ventricular Apical Hypertrophic Cardiomyopathy
=450  \\$wnnna$aApical Hypertrophic Cardiomyopathies
=450  \\$wnnna$aApical Variant HCM
=450  \\$wnnna$aApical-Variant HCMs
=450  \\$wnnna$aCardiomyopathy, Apical Hypertrophic
=450  \\$wnnna$aHCM, Apical-Variant
=450  \\$wnnna$aHypertrophic Cardiomyopathy, Apical
=680  \\$iA hypertrophic cardiomyopathy characterized by apical hypertrophy, typically LEFT VENTRICULAR HYPERTROPHY (described as ace of spades sign), and deep T-wave inversions in EKG. Clinical symptoms include minor symptoms such as CHEST PAIN; DYSPNEA; and SYNCOPE to more complex symptoms such as ATRIAL FIBRILLATION; VENTRICULAR FIBRILLATION; MYOCARDIAL INFARCTION and CONGESTIVE HEART FAILURE. A transient left ventricular apical hypertrophy is sometimes associated with TAKOTSUBO CARDIOMYOPATHY.
=688  \\$a2023
=750  \0$iBroader mapping$aHeart$xHypertrophy$0(DLC)sh 85059682$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aHeart--Hypertrophy$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01296nz  a2200277n  4500
=001  9882594279002441
=005  20251027151745.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094666
=035  \\$a(DNLM)D000094666
=035  \\$a(NLM)9825515418700041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x109.$x70.$x625
=072  \\$aC23.$x550.$x414.$x838.$x175
=150  \\$aAortic Intramural Hematoma
=450  \\$aIntramural Hematoma Aorta
=450  \\$wnnna$aAortic Intramural Hematomas
=450  \\$wnnna$aHematoma, Aortic Intramural
=450  \\$wnnna$aIntramural Hematoma Aortas
=450  \\$wnnna$aIntramural Hematoma, Aortic
=680  \\$iAn atypical form of AORTIC DISSECTION in which subintimal dissection of the aortic TUNICA MEDIA without initial laceration of the aortic TUNICA INTIMA. It may begin from a rupture of the VASA VASORUM feeding aortic media.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aDissecting aortic aneurysms$0(DLC)sh 85038483$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aHematoma$0(DLC)sh 85060135$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aDissecting aortic aneurysms$iand$aHematoma$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/22

=LDR  00824nz  a2200253n  4500
=001  9882594279202441
=005  20251027151745.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095026
=035  \\$a(DNLM)D000095026
=035  \\$a(NLM)9825515401800041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x604.$x473.$x700.$x250
=072  \\$aK1.$x752.$x566.$x479.$x830.$x750.$x250
=072  \\$aN3.$x706.$x437.$x700.$x500
=072  \\$aN5.$x350.$x958.$x750.$x500
=150  \\$aAntiracism
=450  \\$aAnti-Racism
=450  \\$wnnna$aAnti Racism
=550  \\$aRacism
=680  \\$iBeliefs, actions or intentions, and policies that oppose RACISM or discrimination  based on RACE.
=688  \\$a2023
=750  \0$aAnti-racism$0(DLC)sh2007000043$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00854nz  a2200217n  4500
=001  9882594279302441
=005  20251029110245.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094627
=035  \\$a(DNLM)D000094627
=035  \\$a(NLM)9825515449500041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x125.$x750
=072  \\$aC14.$x907.$x109.$x139.$x125.$x750
=150  \\$aDescending Thoracic Aortic Aneurysm
=450  \\$aAneurysm, Descending Thoracic Aorta
=667  \\$adissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of the DESCENDING THORACIC AORTA.
=688  \\$a2023
=750  \0$iBroader mapping$aAortic aneurysms$0(DLC)sh 85005864$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01066nz  a2200253n  4500
=001  9882594279402441
=005  20251029110309.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094624
=035  \\$a(DNLM)D000094624
=035  \\$a(NLM)9825515563800041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x75.$x500
=072  \\$aC14.$x907.$x109.$x139.$x75.$x500
=150  \\$aAortic Aneurysm, Thoracoabdominal
=450  \\$wnnna$aThoracoabdominal Aortic Aneurysm
=450  \\$aTAA Thoracoabdominal Aortic Aneurysm
=450  \\$wnnna$aAneurysm, Thoracoabdominal Aortic
=450  \\$wnnna$aThoracoabdominal Aortic Aneurysms
=667  \\$adissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of ABDOMINAL AORTA at the aortic hiatus.
=688  \\$a2023; use AORTIC ANEURYSM, THORACIC 2008-2022
=750  \0$iBroader mapping$aAortic aneurysms$0(DLC)sh 85005864$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00855nz  a2200229n  4500
=001  9882594279502441
=005  20251029110302.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094628
=035  \\$a(DNLM)D000094628
=035  \\$a(NLM)9825515460300041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x125.$x375
=072  \\$aC14.$x907.$x109.$x139.$x125.$x375
=150  \\$aAortic Root Aneurysm
=450  \\$aAneurysm, Aortic Root
=450  \\$wnnna$aAortic Root Aneurysms
=667  \\$adissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of the AORTIC ROOT.
=688  \\$a2023
=750  \0$iBroader mapping$aAortic aneurysms$0(DLC)sh 85005864$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01153nz  a2200301n  4500
=001  9882594279602441
=005  20251029110257.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094625
=035  \\$a(DNLM)D000094625
=035  \\$a(NLM)9825515568500041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x125.$x500
=072  \\$aC14.$x907.$x109.$x139.$x125.$x500
=150  \\$aAneurysm, Ascending Aorta
=450  \\$aAAA Ascending Aorta Aneurysm
=450  \\$aAscending Aorta Aneurysm
=450  \\$aAscending Aortic Aneurysm
=450  \\$wnnna$aAneurysm, Ascending Aortic
=450  \\$wnnna$aAorta Aneurysm, Ascending
=450  \\$wnnna$aAortic Aneurysm, Ascending
=450  \\$wnnna$aAscending Aorta Aneurysms
=450  \\$wnnna$aAscending Aortic Aneurysms
=667  \\$adissecting aneurysm: coordinate with AORTIC DISSECTION; rupture: coordinate with AORTIC RUPTURE
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of the ASCENDING AORTA.
=688  \\$a2023
=750  \0$iBroader mapping$aAortic aneurysms$0(DLC)sh 85005864$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00787nz  a2200229n  4500
=001  9882594279702441
=005  20251027151744.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094626
=035  \\$a(DNLM)D000094626
=035  \\$a(NLM)9825515459200041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x239.$x125.$x250
=072  \\$aC14.$x907.$x109.$x139.$x125.$x250
=150  \\$aAneurysm, Aortic Arch
=450  \\$aAortic Arch Aneurysm
=450  \\$wnnna$aAortic Arch Aneurysms
=450  \\$wnnna$aArch Aneurysm, Aortic
=680  \\$iAn abnormal balloon- or sac-like dilatation in the wall of the AORTIC ARCH.
=688  \\$a2023
=750  \0$iBroader mapping$aAortic aneurysms$0(DLC)sh 85005864$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01029nz  a2200265n  4500
=001  9882594280002441
=005  20251027151745.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094343
=035  \\$a(DNLM)D000094343
=035  \\$a(NLM)9825515185900041
=040  \\$aDNLM$cDNLM
=072  \\$aD6.$x472.$x334.$x851.$x968.$x250
=150  \\$aAnabolic Androgenic Steroids
=450  \\$wnnna$aAnabolic Steroids
=450  \\$aAnabolic Androgenic Steroid
=450  \\$aAnabolic Steroid
=450  \\$wnnna$aAndrogenic Steroid, Anabolic
=450  \\$wnnna$aAndrogenic Steroids, Anabolic
=450  \\$wnnna$aSteroid, Anabolic Androgenic
=450  \\$wnnna$aSteroids, Anabolic Androgenic
=680  \\$iSynthetic, or human-made, variations of the male sex hormone testosterone often misused by athletes to enhance performance.
=688  \\$a2023; for ANABOLIC STEROID use TESTOSTERONE CONGENERS 2017-2022
=750  \0$aAnabolic steroids$0(DLC)sh 85004733$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01704nz  a2200445n  4500
=001  9882594280202441
=005  20251027151744.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092562
=035  \\$a(DNLM)D000092562
=035  \\$a(NLM)9825515104900041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x150.$x703.$x40
=072  \\$aC1.$x748.$x43
=072  \\$aC1.$x748.$x749.$x134
=072  \\$aC8.$x460.$x692.$x752.$x134
=072  \\$aC8.$x674.$x28
=072  \\$aC8.$x730.$x43
=072  \\$aC8.$x730.$x749.$x134
=072  \\$aC9.$x603.$x692.$x752.$x134
=072  \\$aC20.$x543.$x480.$x680.$x38
=150  \\$aAllergic Fungal Sinusitis
=450  \\$aAllergic Aspergillus Sinusitis
=450  \\$aAllergic Fungal Rhinosinusitis
=450  \\$aSphenoid Allergic Fungal Sinusitis
=450  \\$wnnna$aAllergic Aspergillus Sinusitides
=450  \\$wnnna$aAllergic Fungal Rhinosinusitides
=450  \\$wnnna$aAllergic Fungal Sinusitides
=450  \\$wnnna$aAspergillus Sinusitis, Allergic
=450  \\$wnnna$aFungal Rhinosinusitis, Allergic
=450  \\$wnnna$aFungal Sinusitis, Allergic
=450  \\$wnnna$aRhinosinusitis, Allergic Fungal
=450  \\$wnnna$aSinusitides, Allergic Fungal
=450  \\$wnnna$aSinusitis, Allergic Aspergillus
=450  \\$wnnna$aSinusitis, Allergic Fungal
=667  \\$acoordinate with specific fungal infection
=680  \\$iFungal infection in the PARANASAL SINUSES characterized by common allergy respiratory symptoms, recurrent NASAL POLYPS and/or ASTHMA with buildup of allergic MUCIN.
=688  \\$a2023
=750  \0$iBroader mapping$aMycoses$0(DLC)sh 85089198$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00626nz  a2200217n  4500
=001  9882594280502441
=005  20251027151745.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094842
=035  \\$a(DNLM)D000094842
=035  \\$a(NLM)9825515532200041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x254
=150  \\$aAfrican People
=450  \\$aAfricans
=450  \\$wnnna$aAfrican Peoples
=450  \\$wnnna$aPeople, African
=680  \\$iPeople native to or inhabitants of AFRICA.
=688  \\$a2023
=750  \0$aAfricans$0(DLC)sh 85001757$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00946nz  a2200229n  4500
=001  9882594280602441
=005  20251029114240.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094683
=035  \\$a(DNLM)D000094683
=035  \\$a(NLM)9825515428500041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x109.$x70
=150  \\$aAcute Aortic Syndrome
=450  \\$wnnna$aAcute Aortic Syndromes
=450  \\$wnnna$aAortic Syndrome, Acute
=450  \\$wnnna$aAortic Syndromes, Acute
=680  \\$iA group of aortic diseases presented with acute chest pain. It commonly includes AORTIC DISSECTION; AORTIC INTRAMURAL HEMATOMA; PENETRATING ATHEROSCLEROTIC ULCER and sometimes aortic aneurysms.
=688  \\$a2023
=750  \0$iBroader mapping$aAorta$xDiseases$0(DLC)sh 85005858$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aAorta--Diseases$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  01042nz  a2200289n  4500
=001  9882594280802441
=005  20251027151745.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092863
=035  \\$a(DNLM)D000092863
=035  \\$a(NLM)9825515375800041
=040  \\$aDNLM$cDNLM
=060  \0$aW 67
=072  \\$aN4.$x590.$x374.$x350.$x250
=072  \\$aN5.$x300.$x430.$x188
=150  \\$aAccess to Primary Care
=450  \\$aAccessibility of Primary Care
=450  \\$aAccessible Primary Care
=450  \\$wnnna$aAccessible Primary Cares
=450  \\$wnnna$aPrimary Care Accessibilities
=450  \\$wnnna$aPrimary Care Accessibility
=450  \\$wnnna$aPrimary Care, Accessible
=550  \\$aPrimary Health Care
=680  \\$iThe degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive PRIMARY CARE.
=688  \\$a2023
=750  \0$iBroader mapping$aHealth services accessibility$0(DLC)sh 92006496$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/05/09

=LDR  00644nz  a2200181n  4500
=001  9882685744902441
=005  20251110152944.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086326
=035  \\$a(DNLM)D000086326
=035  \\$a(NLM)9817068023500041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x660.$x75.$x90.$x941
=150  \\$aXylophilus
=680  \\$iA genus of gram-negative, aerobic BETAPROTEOBACTERIA in the order Burkholderiales that is a known cause of diseases in plants.
=688  \\$a2021
=750  \0$iBroader mapping$aBurkholderiales$0(DLC)sh2020000951$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  00976nz  a2200241n  4500
=001  9882685745302441
=005  20251110152646.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000082483
=035  \\$a(DNLM)D000082483
=035  \\$a(NLM)9817067458400041
=040  \\$aDNLM$cDNLM
=072  \\$aI1.$x880.$x787.$x190.$x500.$x500
=072  \\$aJ3.$x340.$x30.$x500
=150  \\$aWorkhouses
=450  \\$aPoorhouses
=450  \\$wnnna$aPoorhouse
=450  \\$wnnna$aWorkhouse
=550  \\$aForced Labor, Employment
=680  \\$iAn establishment offering relief for the destitute poor in an area, funded from the local poor tax, which provided some combination of communal accommodation and a requirement for inmates, particularly the able-bodies, to perform work. (from Workhouses.org.uk accessed 12/11/2019).
=688  \\$a2021; use Poorhouses (1996-2020)
=750  \0$aWorkhouses$0(DLC)sh 85148171$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01076nz  a2200277n  4500
=001  9882685745502441
=005  20251110152327.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085222
=035  \\$a(DNLM)D000085222
=035  \\$a(NLM)9817067761900041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x203.$x100.$x418.$x750
=072  \\$aJ2.$x200.$x418.$x750
=150  \\$aWater Insecurity
=450  \\$aWater Scarcity
=450  \\$wnnna$aInsecurities, Water
=450  \\$wnnna$aInsecurity, Water
=450  \\$wnnna$aScarcity, Water
=450  \\$wnnna$aWater Insecurities
=450  \\$wnnna$aWater Scarcities
=680  \\$iThe lack of reliable access to adequate quantities of acceptable quality water for sustaining livelihoods, human and well-being. (from https://www.unwater.org/publications accessed3/34/2020).
=680  \\$iLack of sufficient available water resources to meet the demands of water usage within a region.
=688  \\$a2021
=750  \0$aWater security$0(DLC)sh2011003817$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  00678nz  a2200217n  4500
=001  9882685745702441
=005  20251110152204.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000085925
=035  \\$a(DNLM)D000085925
=035  \\$a(NLM)9817067929600041
=040  \\$aDNLM$cDNLM
=072  \\$aJ3.$x985
=072  \\$aN2.$x278.$x956
=150  \\$aWaiting Rooms
=450  \\$aWaiting Room
=450  \\$wnnna$aRooms, Waiting
=680  \\$iArea for the use of persons such as clients, patients or visitors before an appointment or service.
=688  \\$a2021
=750  \0$aWaiting rooms$0(DLC)sh2003010800$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  02250nz  a2200565n  4500
=001  9882685745902441
=005  20251110153345.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086965
=035  \\$a(DNLM)D000086965
=035  \\$a(NLM)9817067846400041
=040  \\$aDNLM$cDNLM
=072  \\$aC1.$x925.$x933
=072  \\$aC1.$x973.$x500
=072  \\$aC22.$x969.$x500
=150  \\$aViral Zoonoses
=450  \\$aViral Zoonosis
=450  \\$aViral Zoonotic Disease
=450  \\$aViral Zoonotic Diseases
=450  \\$aViral Zoonotic Infections
=450  \\$aZoonotic Spillover, Viral
=450  \\$aZoonotic Viral Infections
=450  \\$wnnna$aDiseases, Viral Zoonotic
=450  \\$wnnna$aDisease, Viral Zoonotic
=450  \\$wnnna$aInfections, Viral Zoonotic
=450  \\$wnnna$aInfections, Zoonotic Viral
=450  \\$wnnna$aInfection, Viral Zoonotic
=450  \\$wnnna$aInfection, Zoonotic Viral
=450  \\$wnnna$aViral Infections, Zoonotic
=450  \\$wnnna$aViral Infection, Zoonotic
=450  \\$wnnna$aViral Zoonose
=450  \\$wnnna$aViral Zoonotic Infection
=450  \\$wnnna$aViral Zoonotic Spillover
=450  \\$wnnna$aViral Zoonotic Spillovers
=450  \\$wnnna$aZoonoses, Viral
=450  \\$wnnna$aZoonose, Viral
=450  \\$wnnna$aZoonosis, Viral
=450  \\$wnnna$aZoonotic Diseases, Viral
=450  \\$wnnna$aZoonotic Disease, Viral
=450  \\$wnnna$aZoonotic Infections, Viral
=450  \\$wnnna$aZoonotic Infection, Viral
=450  \\$wnnna$aZoonotic Spillovers, Viral
=450  \\$wnnna$aZoonotic Viral Infection
=667  \\$anot a routine coordinate for every zoonotic viral infection; index only when discussed; coordinate with specific infection term and with animal disease term if pertinent
=680  \\$iViral infections that may be transmitted between non-human animals and HUMANS.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aViruses$0(DLC)sh 85143833$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aZoonoses$0(DLC)sh 85150001$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aViruses$iand$aZoonoses$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01146nz  a2200289n  4500
=001  9882685746002441
=005  20251110153303.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000087002
=035  \\$a(DNLM)D000087002
=035  \\$a(NLM)9817067866000041
=040  \\$aDNLM$cDNLM
=072  \\$aG2.$x111.$x873.$x875
=150  \\$aViral Transcription
=450  \\$aEarly Gene Transcription, Viral
=450  \\$aEarly Gene Transcription, Virus
=450  \\$aLate Gene Transcription, Viral
=450  \\$aLate Gene Transcription, Virus
=450  \\$aTranscription, Viral
=450  \\$aVirus Transcription
=450  \\$wnnna$aTranscription, Virus
=680  \\$iThe biosynthesis of subgenomic viral RNAs, transcribed from the VIRAL GENOME.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aGenetic transcription$0(DLC)sh 85053872$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aViruses$0(DLC)sh 85143833$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aGenetic transcription$iand$aViruses$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  00993nz  a2200265n  4500
=001  9882685746202441
=005  20251110152751.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086942
=035  \\$a(DNLM)D000086942
=035  \\$a(NLM)9817067997900041
=040  \\$aDNLM$cDNLM
=072  \\$aA21.$x249.$x750
=150  \\$aViral Envelope
=450  \\$aVirus Envelope
=450  \\$wnnna$aEnvelopes, Viral
=450  \\$wnnna$aEnvelopes, Virus
=450  \\$wnnna$aEnvelope, Viral
=450  \\$wnnna$aEnvelope, Virus
=450  \\$wnnna$aViral Envelopes
=450  \\$wnnna$aVirus Envelopes
=680  \\$iBilayer lipid membrane acquired by VIRAL PARTICLES during VIRAL MORPHOGENESIS. Although the LIPIDS of the viral envelope are host derived, various virus-encoded INTEGRAL MEMBRANE PROTEINS, i.e. VIRAL ENVELOPE PROTEINS are incorporated there.
=688  \\$a2021
=750  \0$aViral envelopes$0(DLC)sh 85143729$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01206nz  a2200289n  4500
=001  9882685746302441
=005  20251110153205.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000084323
=035  \\$a(DNLM)D000084323
=035  \\$a(NLM)9817067783700041
=040  \\$aDNLM$cDNLM
=072  \\$aG7.$x888
=150  \\$aVestibulocochlear Physiological Phenomena
=450  \\$aAuditory Physiology
=450  \\$aVestibulocochlear Physiological Phenomenon
=450  \\$aVestibulocochlear Physiology
=450  \\$wnnna$aPhenomena, Vestibulocochlear Physiological
=450  \\$wnnna$aPhenomenon, Vestibulocochlear Physiological
=450  \\$wnnna$aPhysiological Phenomena, Vestibulocochlear
=450  \\$wnnna$aPhysiological Phenomenon, Vestibulocochlear
=680  \\$iProcesses and properties of the VESTIBULOCOCHLEAR SYSTEM and the CRANIAL NERVE VIII.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aAcoustic nerve$0(DLC)sh 85000584$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xPhysiology$0(DLC)sh 99005103$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aAcoustic nerve--Physiology$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01495nz  a2200469n  4500
=001  9882685746502441
=005  20251110153032.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083442
=035  \\$a(DNLM)D000083442
=035  \\$a(NLM)9817067831000041
=040  \\$aDNLM$cDNLM
=072  \\$aA2.$x835.$x232.$x834.$x946
=150  \\$aVertebral Body
=450  \\$aCancellous Centra
=450  \\$aCancellous Centrum
=450  \\$aSpinous Processes
=450  \\$aTransverse Processes
=450  \\$aVertebral Arch
=450  \\$aVertebral Arch Pedicles
=450  \\$aVertebral Centra
=450  \\$aVertebral Centrum
=450  \\$aVertebral Lamina
=450  \\$aVertebral Pedicles
=450  \\$wnnna$aArch, Vertebral
=450  \\$wnnna$aBody, Vertebral
=450  \\$wnnna$aCancellous Centras
=450  \\$wnnna$aCancellous Centrums
=450  \\$wnnna$aCentrum, Vertebral
=450  \\$wnnna$aLamina, Vertebral
=450  \\$wnnna$aPedicle, Vertebral
=450  \\$wnnna$aPedicle, Vertebral Arch
=450  \\$wnnna$aProcesses, Spinous
=450  \\$wnnna$aVertebral Arch Pedicle
=450  \\$wnnna$aVertebral Bodies
=450  \\$wnnna$aVertebral Centras
=450  \\$wnnna$aVertebral Laminas
=450  \\$wnnna$aVertebral Pedicle
=680  \\$iMain portion of the vertebra which bears majority of the weight.
=688  \\$a2021
=750  \0$iBroader mapping$aSpine$0(DLC)sh 85126694$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01967nz  a2200337n  4500
=001  9882685746602441
=005  20251110153439.0
=008  200707\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000083123
=035  \\$a(DNLM)D000083123
=035  \\$a(NLM)9817067717200041
=040  \\$aDNLM$cDNLM
=072  \\$aB3.$x300.$x390.$x400.$x800.$x750.$x100.$x750
=072  \\$aB3.$x353.$x500.$x750.$x750.$x100.$x750
=072  \\$aB3.$x510.$x100.$x750.$x750.$x100.$x750
=072  \\$aB3.$x510.$x400.$x790.$x750.$x100.$x750
=150  \\$aVancomycin-Resistant Staphylococcus aureus
=450  \\$aGlycopeptide-Intermediate S. aureus
=450  \\$aGlycopeptide-Intermediate Staphylococcus aureus
=450  \\$aGlycopeptide-Resistant S. aureus
=450  \\$aGlycopeptide-Resistant Staphylococcus aureus
=450  \\$aVancomycin-Intermediate S. aureus
=450  \\$aVancomycin-Intermediate Staphylococcus aureus
=450  \\$aVancomycin-Resistant S. aureus
=667  \\$ainfection: coordinate with STAPHYLOCOCCAL INFECTIONS or specifics
=680  \\$iIsolates of the Staphylococcus aureus that are resistant to the antibiotic VANCOMYCIN. The S. aureus becomes resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE. Vancomycin‐intermediate S. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. These S. aureus with reduced susceptibility to vancomycin and related GLYCOPEPTIDE antibiotics are often seen in HEALTHCARE ASSOCIATED INFECTIONS.
=688  \\$a2021
=750  \0$81$wb$iBroader mapping$aStaphylococcus aureus$0(DLC)sh 85127365$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aVancomycin resistance$0(DLC)sh 98004195$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aStaphylococcus aureus$iand$aVancomycin resistance$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  00912nz  a2200277n  4500
=001  9882685746802441
=005  20251110152025.0
=008  200709\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000086825
=035  \\$a(DNLM)D000086825
=035  \\$a(NLM)9817068127800041
=040  \\$aDNLM$cDNLM
=072  \\$aE5.$x320.$x775
=072  \\$aJ1.$x293.$x910.$x500
=072  \\$aL1.$x224.$x900.$x900
=150  \\$aUser-Centered Design
=450  \\$aUsability Testing
=450  \\$wnnna$aDesigns, User-Centered
=450  \\$wnnna$aDesign, User-Centered
=450  \\$wnnna$aTesting, Usability
=450  \\$wnnna$aUser Centered Design
=450  \\$wnnna$aUser-Centered Designs
=680  \\$iDesign process using input from users regarding systems, devices, or software.
=688  \\$a2021
=750  \0$aUser-centered system design$0(DLC)sh2006002024$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/10

=LDR  01753nz  a2200481n  4500
=001  9882669963502441
=005  20251118144848.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094846
=035  \\$a(DNLM)D000094846
=035  \\$a(NLM)9825515519000041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x254.$x750.$x750
=150  \\$aEast African People
=450  \\$aEast African Person
=450  \\$aEast Africans
=450  \\$aEastern African People
=450  \\$aEastern African Person
=450  \\$aEastern Africans
=450  \\$wnnna$aAfrican, East
=450  \\$wnnna$aAfrican, Eastern
=450  \\$wnnna$aAfrican People, Eastern
=450  \\$wnnna$aAfrican Person, East
=450  \\$wnnna$aAfrican Person, Eastern
=450  \\$wnnna$aAfrican Persons, East
=450  \\$wnnna$aAfrican Persons, Eastern
=450  \\$wnnna$aAfricans, East
=450  \\$wnnna$aAfricans, Eastern
=450  \\$wnnna$aEast African
=450  \\$wnnna$aEast African Peoples
=450  \\$wnnna$aEast African Persons
=450  \\$wnnna$aEastern African Peoples
=450  \\$wnnna$aEastern African Persons
=450  \\$wnnna$aPeople, East African
=450  \\$wnnna$aPeople, Eastern African
=450  \\$wnnna$aPerson, East African
=450  \\$wnnna$aPerson, Eastern African
=450  \\$wnnna$aPersons, East African
=450  \\$wnnna$aPersons, Eastern African
=680  \\$iPeople native to or inhabitants of EASTERN AFRICA including BURUNDI, DJIBOUTI, ERITREA, ETHIOPIA, KENYA, RWANDA, SOMALIA, SOUTH SUDAN, SUDAN, TANZANIA, and UGANDA and islands COMOROS; MADAGASCAR and SEYCHELLES.
=688  \\$a2023
=750  \0$aEast Africans$0(DLC)sh2015000976$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  01405nz  a2200301n  4500
=001  9882687997202441
=005  20251118142247.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094365
=035  \\$a(DNLM)D000094365
=035  \\$a(NLM)9825515190100041
=040  \\$aDNLM$cDNLM
=072  \\$aA6.$x688.$x357.$x250
=072  \\$aA8.$x186.$x211.$x180.$x497.$x352.$x435.$x125
=072  \\$aA8.$x186.$x211.$x200.$x317.$x357.$x352.$x435.$x125
=072  \\$aA8.$x713.$x357.$x250
=150  \\$aHypothalamic-Pituitary-Gonadal Axis
=450  \\$aHPG Axis
=450  \\$aHypothalamic-Pituitary-Gonadal Endocrine Axis
=450  \\$wnnna$aAxis, HPG
=450  \\$wnnna$aAxis, Hypothalamic-Pituitary-Gonadal
=450  \\$wnnna$aAxis, Hypothalamic-Pituitary-Gonadal Endocrine
=450  \\$wnnna$aHypothalamic Pituitary Gonadal Axis
=450  \\$wnnna$aHypothalamic Pituitary Gonadal Endocrine Axis
=680  \\$iA collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS, the PITUITARY GLAND and the GONADS. It plays a central role in endocrine regulation of gonadal function including release of hormones: GNRH; LUTEINIZING HORMONE; FOLLICLE-STIMULATING HORMONE and TESTOSTERONE.
=688  \\$a2023
=750  \0$iBroader mapping$aHypothalamo-hypophyseal system$0(DLC)sh 85063823$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  03800nz  a2200949n  4500
=001  9882687997302441
=005  20251118141804.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092483
=035  \\$a(DNLM)D000092483
=035  \\$a(NLM)9825515258600041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x88.$x134.$x500.$x500
=072  \\$aC26.$x88.$x390.$x500
=072  \\$aC26.$x404.$x20.$x125
=072  \\$aC26.$x404.$x500.$x500
=150  \\$aHumeral Fractures, Distal
=450  \\$aCapitellum Humeri Fracture
=450  \\$aCapitellum Humerus Fracture
=450  \\$aDistal Humeral Fractures
=450  \\$aDistal Humerus Fractures
=450  \\$aHahn-Steinthal Fracture
=450  \\$aHumeral Capitellar Fractures
=450  \\$aHumeral Trochlear Fractures
=450  \\$aIntercondylar Humeral Fractures
=450  \\$aIntercondylar Humerus Fractures
=450  \\$aKocher-Lorenz Fracture
=450  \\$aLateral Condylar Fracture of Humerus
=450  \\$aLateral Condylar Fractures of Humerus
=450  \\$aLateral Condyle Fracture of Humerus
=450  \\$aLateral Condyle Fractures of Humerus
=450  \\$aLateral Epicondylar Fracture of Humerus
=450  \\$aLateral Epicondylar Fractures of Humerus
=450  \\$aLateral Epicondyle Fracture of Humerus
=450  \\$aLateral Epicondyle Fractures of Humerus
=450  \\$aLateral Epicondyle Fractures of the Elbow
=450  \\$aLateral Humeral Condyle Fractures
=450  \\$aSupracondylar Distal Humeral Fracture
=450  \\$aSupracondylar Distal Humeral Fractures
=450  \\$aSupracondylar Distal Humerus Fracture
=450  \\$aSupracondylar Distal Humerus Fractures
=450  \\$aTrochlear Fractures, Humerus
=450  \\$wnnna$aCapitellar Fracture, Humeral
=450  \\$wnnna$aCapitellum Humeri Fractures
=450  \\$wnnna$aCapitellum Humerus Fractures
=450  \\$wnnna$aDistal Humeral Fracture
=450  \\$wnnna$aDistal Humerus Fracture
=450  \\$wnnna$aFracture, Capitellum Humeri
=450  \\$wnnna$aFracture, Capitellum Humerus
=450  \\$wnnna$aFracture, Distal Humeral
=450  \\$wnnna$aFracture, Distal Humerus
=450  \\$wnnna$aFracture, Hahn-Steinthal
=450  \\$wnnna$aFracture, Humeral Capitellar
=450  \\$wnnna$aFracture, Humeral Trochlear
=450  \\$wnnna$aFracture, Humerus Trochlear
=450  \\$wnnna$aFracture, Intercondylar Humeral
=450  \\$wnnna$aFracture, Intercondylar Humerus
=450  \\$wnnna$aFracture, Kocher-Lorenz
=450  \\$wnnna$aFractures, Humeral Capitellar
=450  \\$wnnna$aFractures, Humeral Trochlear
=450  \\$wnnna$aHahn Steinthal Fracture
=450  \\$wnnna$aHumeral Capitellar Fracture
=450  \\$wnnna$aHumeral Fracture, Distal
=450  \\$wnnna$aHumeral Fracture, Intercondylar
=450  \\$wnnna$aHumeral Trochlear Fracture
=450  \\$wnnna$aHumeri Fracture, Capitellum
=450  \\$wnnna$aHumerus Fracture, Capitellum
=450  \\$wnnna$aHumerus Fracture, Distal
=450  \\$wnnna$aHumerus Fracture, Intercondylar
=450  \\$wnnna$aHumerus Trochlear Fracture
=450  \\$wnnna$aHumerus Trochlear Fractures
=450  \\$wnnna$aIntercondylar Humeral Fracture
=450  \\$wnnna$aIntercondylar Humerus Fracture
=450  \\$wnnna$aKocher Lorenz Fracture
=450  \\$wnnna$aTrochlear Fracture, Humeral
=450  \\$wnnna$aTrochlear Fracture, Humerus
=680  \\$iFractures of the distal HUMERUS at the ELBOW JOINT.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aHumerus$0(DLC)sh 85062928$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xFractures$0(DLC)sh00005813$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aHumerus--Fractures$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01663nz  a2200385n  4500
=001  9882687997402441
=005  20251118142104.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094302
=035  \\$a(DNLM)D000094302
=035  \\$a(NLM)9825515315300041
=040  \\$aDNLM$cDNLM
=060  \0$aQW 166
=072  \\$aB4.$x280.$x210.$x655.$x450
=072  \\$aB4.$x613.$x204.$x655.$x450
=150  \\$aHuman Papillomavirus Viruses
=450  \\$wnnna$aHPV, Human Papillomavirus Viruses
=450  \\$wnnna$aHuman Papilloma Virus
=450  \\$aHPV Human Papillomavirus
=450  \\$aHuman Papillomavirus
=450  \\$wnnna$aHPV Human Papillomaviruses
=450  \\$wnnna$aHuman Papillomaviruses
=450  \\$wnnna$aHuman Papilloma Viruses
=450  \\$wnnna$aHuman Papillomaviruses, HPV
=450  \\$wnnna$aHuman Papillomavirus, HPV
=450  \\$wnnna$aHuman Papillomavirus Virus
=450  \\$wnnna$aPapilloma Virus, Human
=450  \\$wnnna$aPapillomavirus Virus, Human
=450  \\$wnnna$aVirus, Human Papilloma
=450  \\$wnnna$aVirus, Human Papillomavirus
=667  \\$ainfection = HUMAN PAPILLOMAVIRUS INFECTION see PAPILLOMAVIRUS INFECTIONS
=680  \\$iA large group of viruses that cause HUMAN PAPILLOMAVIRUS INFECTION, e.g., GENITAL WARTS and cancer of the CERVIX; VAGINA; VULVA; ANUS; or OROPHARYNX. Most common clinically important human papilloma viruses are taxonomically members of ALPHAPAPILLOMAVIRUS and GAMMAPAPILLOMAVIRUS.
=688  \\$a2023; use ALPHAPAPILLOMAVIRUS 2016-2022
=750  \0$iBroader mapping$aPapillomaviruses$0(DLC)sh 85097679$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  00855nz  a2200265n  4500
=001  9882687997502441
=005  20251118142549.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092525
=035  \\$a(DNLM)D000092525
=035  \\$a(NLM)9825515102000041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x404.$x61.$x712
=072  \\$aC26.$x404.$x525.$x250
=072  \\$aC26.$x558.$x276.$x712
=072  \\$aC26.$x558.$x554.$x625.$x250
=150  \\$aHoffa Fracture
=450  \\$aBicondylar Hoffa Fractures
=450  \\$aHoffa Fragment
=450  \\$wnnna$aFracture, Hoffa
=450  \\$wnnna$aFragment, Hoffa
=680  \\$iCoronal plane fractures of the FEMUR condyle at the KNEE.
=688  \\$a2023
=750  \2$iNarrower mapping$aFemoral Fractures, Distal$0(DNLM)D000092524$4NM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  00632nz  a2200205n  4500
=001  9882687997602441
=005  20251118144848.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094502
=035  \\$a(DNLM)D000094502
=035  \\$a(NLM)9825515293900041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x526.$x485.$x810.$x557
=072  \\$aN2.$x360.$x810.$x557
=150  \\$aGynecologists
=450  \\$wnnna$aGynecologist
=680  \\$iQualified medical professionals who specialize in GYNECOLOGY.
=688  \\$a2023
=750  \0$aGynecologists$0(DLC)sh 85058088$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  01766nz  a2200481n  4500
=001  9882687997702441
=005  20251118141730.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092923
=035  \\$a(DNLM)D000092923
=035  \\$a(NLM)9825515376800041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x316.$x223
=150  \\$aGroup Dynamics
=450  \\$aGroup Interaction
=450  \\$aGroup Pressures
=450  \\$aGroupthink
=450  \\$aOrganizational Behavior
=450  \\$aOrganizational Dynamics
=450  \\$aSocial Dynamics
=450  \\$aSocial Group Dynamics
=450  \\$aSocial Loafing
=450  \\$wnnna$aBehavior, Organizational
=450  \\$wnnna$aDynamics, Organizational
=450  \\$wnnna$aDynamics, Social
=450  \\$wnnna$aGroup Dynamic
=450  \\$wnnna$aGroup Dynamic, Social
=450  \\$wnnna$aGroup Dynamics, Social
=450  \\$wnnna$aGroup Pressure
=450  \\$wnnna$aInteraction, Group
=450  \\$wnnna$aLoafing, Social
=450  \\$wnnna$aOrganizational Behaviors
=450  \\$wnnna$aOrganizational Dynamic
=450  \\$wnnna$aPressure, Group
=450  \\$wnnna$aSocial Dynamic
=450  \\$wnnna$aSocial Group Dynamic
=450  \\$wnnna$aSocial Loafings
=680  \\$iProcesses of change in any social group from formation to functioning. It includes various forces that drive relationship among members and interaction with other groups.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aSocial groups$0(DLC)sh 85123946$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xRelations$0(DLC)sh00007590$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aSocial groups--Relations$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  02067nz  a2200493n  4500
=001  9882687997802441
=005  20251118141354.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093422
=035  \\$a(DNLM)D000093422
=035  \\$a(NLM)9825515236700041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x205.$x625.$x500
=072  \\$aD9.$x400.$x430.$x825.$x500
=072  \\$aD12.$x776.$x124.$x335
=072  \\$aD12.$x776.$x395.$x351.$x500
=072  \\$aD23.$x946.$x381.$x625.$x500
=150  \\$aGlycated Serum Proteins
=450  \\$aGlycated Blood Protein
=450  \\$aGlycated Blood Proteins
=450  \\$aGlycated Serum Protein
=450  \\$aGlycosylated Blood Protein
=450  \\$aGlycosylated Blood Proteins
=450  \\$aGlycosylated Serum Protein
=450  \\$aGlycosylated Serum Proteins
=450  \\$aSerum Protein, Glycated
=450  \\$aSerum Protein, Glycosylated
=450  \\$wnnna$aBlood Protein, Glycated
=450  \\$wnnna$aBlood Protein, Glycosylated
=450  \\$wnnna$aBlood Proteins, Glycated
=450  \\$wnnna$aBlood Proteins, Glycosylated
=450  \\$wnnna$aProtein, Glycated Blood
=450  \\$wnnna$aProtein, Glycosylated Blood
=450  \\$wnnna$aProteins, Glycated Blood
=450  \\$wnnna$aProteins, Glycosylated Blood
=450  \\$wnnna$aProteins, Glycosylated Serum
=450  \\$wnnna$aSerum Proteins, Glycated
=450  \\$wnnna$aSerum Proteins, Glycosylated
=680  \\$iProteins in serum that have undergone, in vivo, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAdvanced glycation end products$0(DLC)sh2020005835$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aBlood proteins$0(DLC)sh 85015016$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAdvanced glycation end products$iand$aBlood proteins$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01737nz  a2200409n  4500
=001  9882687997902441
=005  20251118141439.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093423
=035  \\$a(DNLM)D000093423
=035  \\$a(NLM)9825515353700041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x205.$x625.$x500.$x500
=072  \\$aD9.$x400.$x430.$x825.$x500.$x500
=072  \\$aD12.$x776.$x34.$x841.$x113
=072  \\$aD12.$x776.$x124.$x335.$x500
=072  \\$aD12.$x776.$x124.$x727.$x188
=072  \\$aD12.$x776.$x395.$x351.$x500.$x500
=072  \\$aD23.$x946.$x381.$x625.$x500.$x500
=150  \\$aGlycated Serum Albumin
=450  \\$aGlycated Albumin, Serum
=450  \\$aGlycoalbumin
=450  \\$aGlycosyl-Albumin
=450  \\$aGlycosylated Serum Albumin
=450  \\$aSerum Albumin, Glycosylated
=450  \\$wnnna$aAlbumin, Glycated Serum
=450  \\$wnnna$aAlbumin, Glycosylated Serum
=450  \\$wnnna$aAlbumin, Serum Glycated
=450  \\$wnnna$aGlycosyl Albumin
=450  \\$wnnna$aSerum Albumin, Glycated
=450  \\$wnnna$aSerum Glycated Albumin
=680  \\$iSerum albumin that has undergone, in vivo, spontaneous, non-enzymatic modification with reducing sugars via the MAILLARD REACTION. They are analyzed to measure control of HYPERGLYCEMIA.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAdvanced glycation end products$0(DLC)sh2020005835$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aSerum albumin$0(DLC)sh 85120333$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAdvanced glycation end products$iand$aSerum albumin$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01321nz  a2200265n  4500
=001  9882687998002441
=005  20251118141413.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000093844
=035  \\$a(DNLM)D000093844
=035  \\$a(NLM)9825515354400041
=040  \\$aDNLM$cDNLM
=072  \\$aD9.$x400.$x205.$x625
=072  \\$aD9.$x400.$x430.$x825
=072  \\$aD12.$x776.$x395.$x351
=072  \\$aD12.$x776.$x794.$x375
=072  \\$aD23.$x946.$x381.$x625
=150  \\$aGlycated Proteins
=450  \\$wnnna$aProteins, Glycated
=680  \\$iAdvanced glycation end products formed from the spontaneous, non-enzymatic reaction of sugars with free amino groups in proteins. In the past, a glycosylated protein sometimes referred to a glycated protein.  GLYCOSYLATED PROTEINS is now restricted to proteins glycosylated by GLYCOSYLTRANSFERASES or via specialized organic chemistry reactions.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aAdvanced glycation end products$0(DLC)sh2020005835$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aProteins$0(DLC)sh 85107666$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aAdvanced glycation end products$iand$aProteins$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01406nz  a2200325n  4500
=001  9882687998102441
=005  20251118141951.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094582
=035  \\$a(DNLM)D000094582
=035  \\$a(NLM)9825515577000041
=040  \\$aDNLM$cDNLM
=072  \\$aG9.$x330.$x380.$x375
=150  \\$aGlobal Longitudinal Strain
=450  \\$aLeft Ventricular Global Longitudinal Strain
=450  \\$aLV-GLS
=450  \\$aRight Ventricular Global Longitudinal Strain
=450  \\$aRV-GLS
=450  \\$wnnna$aGlobal Longitudinal Strains
=450  \\$wnnna$aLongitudinal Strain, Global
=450  \\$wnnna$aLongitudinal Strains, Global
=450  \\$wnnna$aLV GLS
=450  \\$wnnna$aRV GLS
=450  \\$wnnna$aRV-GLSs
=450  \\$wnnna$aStrain, Global Longitudinal
=450  \\$wnnna$aStrains, Global Longitudinal
=680  \\$iGlobal longitudinal strain (GLS) is a measure of ventricular function derived from 2-dimensional echocardiographic images by quantifying the relative length change in myocardial length between end-diastole and end-systole. GLS is used to predict cardiovascular outcomes and has been proposed to be a better measure of cardiac dysfunction than VENTRICULAR EJECTION FRACTION.
=688  \\$a2023
=750  \0$iBroader mapping$aHemodynamics$0(DLC)sh 85060196$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01972nz  a2200481n  4500
=001  9882687998202441
=005  20251118141201.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095024
=035  \\$a(DNLM)D000095024
=035  \\$a(NLM)9825515508000041
=040  \\$aDNLM$cDNLM
=060  \0$aW 750
=072  \\$aH1.$x158.$x273.$x540.$x321
=072  \\$aI1.$x198.$x780.$x945
=150  \\$aForensic Microbiology
=450  \\$aForensic Microbial Science
=450  \\$aMicrobial Forensics
=450  \\$aMicrobial Forensic Science
=450  \\$aPostmortem Microbiology
=450  \\$aPost Mortem Microbiology
=450  \\$aPost-Mortem Microbiology
=450  \\$wnnna$aForensic Microbial Sciences
=450  \\$wnnna$aForensic Science, Microbial
=450  \\$wnnna$aForensic Sciences, Microbial
=450  \\$wnnna$aForensics, Microbial
=450  \\$wnnna$aMicrobial Forensic Sciences
=450  \\$wnnna$aMicrobial Science, Forensic
=450  \\$wnnna$aMicrobial Sciences, Forensic
=450  \\$wnnna$aMicrobiology, Forensic
=450  \\$wnnna$aMicrobiology, Postmortem
=450  \\$wnnna$aMicrobiology, Post Mortem
=450  \\$wnnna$aMicrobiology, Post-Mortem
=450  \\$wnnna$aScience, Forensic Microbial
=450  \\$wnnna$aScience, Microbial Forensic
=450  \\$wnnna$aSciences, Forensic Microbial
=450  \\$wnnna$aSciences, Microbial Forensic
=680  \\$iThe scientific discipline dedicated to analyzing evidence from BIOTERRORISM, biocrime, HOAX, or inadvertent microorganism/toxin release for attribution purposes.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aMicrobiology$0(DLC)sh 85084783$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aForensic sciences$0(DLC)sh 90001487$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aMicrobiology$iand$aForensic sciences$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01264nz  a2200313n  4500
=001  9882687998502441
=005  20251118144848.0
=008  220713\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092965
=035  \\$a(DNLM)D000092965
=035  \\$a(NLM)9825515090200041
=040  \\$aDNLM$cDNLM
=060  \0$aWA 708
=072  \\$aG7.$x203.$x300.$x523
=072  \\$aJ2.$x500.$x523
=150  \\$aFood, Processed
=450  \\$aFood, Ultra-Processed
=450  \\$aProcessed Foods
=450  \\$aUltra-Processed Foods
=450  \\$wnnna$aFoods, Processed
=450  \\$wnnna$aFoods, Ultra-Processed
=450  \\$wnnna$aFood, Ultra Processed
=450  \\$wnnna$aProcessed Food
=450  \\$wnnna$aUltra-Processed Food
=450  \\$wnnna$aUltra Processed Foods
=680  \\$iAny raw agricultural commodity that has been subject to washing, cleaning, milling, cutting, chopping, heating, pasteurizing, blanching, cooking, canning, freezing, drying, dehydrating, mixing, packaging or other procedures that alter the food from its natural state. (from  A Guide to Federal Terms and Acronyms. Lanham, MD: Government Institutes.1991)
=688  \\$a2023
=750  \0$aProcessed foods$0(DLC)sh 99005861$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  01402nz  a2200337n  4500
=001  9882687998602441
=005  20251118141113.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092222
=035  \\$a(DNLM)D000092222
=035  \\$a(NLM)9825515006900041
=040  \\$aDNLM$cDNLM
=072  \\$aC10.$x500.$x507.$x400.$x125
=072  \\$aC16.$x131.$x666.$x507.$x400.$x125
=150  \\$aFocal Cortical Dysplasia
=450  \\$aTaylor Dysplasia
=450  \\$aTaylor Focal Cortical Dysplasia
=450  \\$aTaylor's FCD
=450  \\$wnnna$aCortical Dysplasia, Focal
=450  \\$wnnna$aDysplasia, Focal Cortical
=450  \\$wnnna$aDysplasia, Taylor
=450  \\$wnnna$aFCD, Taylor's
=450  \\$wnnna$aFocal Cortical Dysplasias
=450  \\$wnnna$aTaylor FCD
=450  \\$wnnna$aTaylors FCD
=680  \\$iAbnormal, non-neoplastic cell proliferation of the CEREBRAL CORTEX confined to an area in any lobe. Focal cortical dysplasia in the temporal lobe is associated with TEMPORAL LOBE EPILEPSY.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aCerebral cortex$0(DLC)sh 85022087$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aDysplasia$0(DLC)sh 87007530$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aCerebral cortex$iand$aDysplasia$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01198nz  a2200337n  4500
=001  9882687998702441
=005  20251118141647.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092504
=035  \\$a(DNLM)D000092504
=035  \\$a(NLM)9825515272200041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x404.$x23
=150  \\$aFibula Fractures
=450  \\$aFibula Shaft Fractures
=450  \\$aMaisonneuve Fracture
=450  \\$aMaisonneuve Fracture Dislocation
=450  \\$wnnna$aDislocation, Maisonneuve Fracture
=450  \\$wnnna$aFibula Fracture
=450  \\$wnnna$aFibula Shaft Fracture
=450  \\$wnnna$aFracture Dislocation, Maisonneuve
=450  \\$wnnna$aFracture, Fibula
=450  \\$wnnna$aFracture, Fibula Shaft
=450  \\$wnnna$aFracture, Maisonneuve
=450  \\$wnnna$aShaft Fracture, Fibula
=680  \\$iFractures of the FIBULA.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aFibula$0(DLC)sh 85048041$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xFractures$0(DLC)sh00005813$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aFibula--Fractures$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01350nz  a2200337n  4500
=001  9882687998802441
=005  20251118142550.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092524
=035  \\$a(DNLM)D000092524
=035  \\$a(NLM)9825515117200041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x404.$x61.$x213
=072  \\$aC26.$x558.$x276.$x213
=150  \\$aFemoral Fractures, Distal
=450  \\$aDistal Femoral Fractures
=450  \\$aDistal Femur Fractures
=450  \\$aFemur Fractures, Distal
=450  \\$aLateral Femoral Condyle Fractures
=450  \\$aMedial Femoral Condyle Fractures
=450  \\$wnnna$aDistal Femoral Fracture
=450  \\$wnnna$aDistal Femur Fracture
=450  \\$wnnna$aFemoral Fracture, Distal
=450  \\$wnnna$aFemur Fracture, Distal
=450  \\$wnnna$aFracture, Distal Femoral
=450  \\$wnnna$aFracture, Distal Femur
=680  \\$iFractures of the distal FEMUR from the articular surface in the KNEE to the condylar region of the femur. A subset with a coronal-plane fracture of the distal femur condyle(s) is Hoffa Fracture.
=688  \\$a2023
=750  \2$iNarrower mapping$aFemoral Fractures, Distal$0(DNLM)D000092524$4NM$5IEN-M
=750  \0$81$wb$iBroader mapping$aFemur$xFractures$0(DLC)sh2009124221$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01264nz  a2200325n  4500
=001  9882687998902441
=005  20251118141016.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092802
=035  \\$a(DNLM)D000092802
=035  \\$a(NLM)9825515086500041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x370.$x82
=072  \\$aI1.$x880.$x853.$x150.$x439.$x500
=072  \\$aI1.$x880.$x853.$x500.$x600.$x375
=150  \\$aFamily Support
=450  \\$aFamily Assistance
=450  \\$aFamily Encouragement
=450  \\$wnnna$aAssistance, Family
=450  \\$wnnna$aEncouragement, Family
=450  \\$wnnna$aFamily Assistances
=450  \\$wnnna$aFamily Encouragements
=450  \\$wnnna$aFamily Supports
=450  \\$wnnna$aSupport, Family
=680  \\$iSupport systems that provide assistance and encouragement between and among members of a FAMILY.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aFamilies$0(DLC)sh 85047009$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aSocial networks$0(DLC)sh 87002172$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aFamilies$iand$aSocial networks$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01310nz  a2200373n  4500
=001  9882687999102441
=005  20251118144845.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092842
=035  \\$a(DNLM)D000092842
=035  \\$a(NLM)9825515381600041
=040  \\$aDNLM$cDNLM
=072  \\$aF1.$x829.$x263.$x315.$x250.$x125
=072  \\$aI1.$x240.$x361.$x330.$x500
=072  \\$aI1.$x880.$x853.$x150.$x423.$x250.$x125
=072  \\$aN1.$x224.$x361.$x330.$x500
=072  \\$aN1.$x824.$x308.$x125.$x500
=072  \\$aN6.$x850.$x505.$x400.$x400.$x580.$x500
=150  \\$aExtended Family
=450  \\$aExtended Household
=450  \\$aMultigenerational Family
=450  \\$aMultigenerational Household
=450  \\$wnnna$aExtended Families
=450  \\$wnnna$aExtended Households
=450  \\$wnnna$aFamily, Extended
=450  \\$wnnna$aFamily, Multigenerational
=450  \\$wnnna$aHousehold, Extended
=450  \\$wnnna$aHousehold, Multigenerational
=450  \\$wnnna$aMultigenerational Families
=450  \\$wnnna$aMultigenerational Households
=680  \\$iA household with members of at least three generations.
=688  \\$a2023; use FAMILY 1979-2022
=750  \0$aExtended families$0(DLC)sh2005004783$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  02702nz  a2200541n  4500
=001  9882687999202441
=005  20251118140930.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092202
=035  \\$a(DNLM)D000092202
=035  \\$a(NLM)9825515003500041
=040  \\$aDNLM$cDNLM
=072  \\$aC20.$x543.$x480.$x363
=150  \\$aExercise-Induced Allergies
=450  \\$aExercise-Induced Anaphylaxis
=450  \\$aExercise-Induced Anaphylaxis and Urticaria
=450  \\$aExercise-Induced Urticaria
=450  \\$aFood-Dependent Exercise-Induced Allergies
=450  \\$aPost-Exertional Allergic Reactions
=450  \\$aWDEIA
=450  \\$aWheat-Dependent Exercise-Induced Anaphylaxis
=450  \\$wnnna$aAllergic Reaction, Post-Exertional
=450  \\$wnnna$aAllergic Reactions, Post-Exertional
=450  \\$wnnna$aAllergy, Exercise-Induced
=450  \\$wnnna$aAllergy, Food-Dependent Exercise-Induced
=450  \\$wnnna$aAnaphylaxis, Exercise-Induced
=450  \\$wnnna$aAnaphylaxis, Wheat-Dependent Exercise-Induced
=450  \\$wnnna$aExercise Induced Allergies
=450  \\$wnnna$aExercise-Induced Allergy
=450  \\$wnnna$aExercise-Induced Allergy, Food-Dependent
=450  \\$wnnna$aExercise Induced Anaphylaxis
=450  \\$wnnna$aExercise Induced Anaphylaxis and Urticaria
=450  \\$wnnna$aExercise-Induced Anaphylaxis, Wheat-Dependent
=450  \\$wnnna$aExercise-Induced Anaphylaxi, Wheat-Dependent
=450  \\$wnnna$aExercise Induced Urticaria
=450  \\$wnnna$aExercise-Induced Urticarias
=450  \\$wnnna$aFood Dependent Exercise Induced Allergies
=450  \\$wnnna$aFood-Dependent Exercise-Induced Allergy
=450  \\$wnnna$aPost-Exertional Allergic Reaction
=450  \\$wnnna$aPost Exertional Allergic Reactions
=450  \\$wnnna$aUrticaria, Exercise-Induced
=450  \\$wnnna$aWheat Dependent Exercise Induced Anaphylaxis
=680  \\$iAllergic reactions following a period of exercise. Elevated serum HISTAMINE and TRYPTASE levels and cutaneous MAST CELL degranulation are often associated with post-exertional allergic reactions which sometimes are triggered only in combination with prior consumption of a specific food such as wheat. Allergic symptoms produced post-exercise range from skin eruption, asthma, bronchospasm, and anaphylaxis.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aExercise$0(DLC)sh 85046328$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aAllergy$0(DLC)sh 85003662$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aExercise$iand$aAllergy$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  00781nz  a2200265n  4500
=001  9882687999402441
=005  20251118144848.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094854
=035  \\$a(DNLM)D000094854
=035  \\$a(NLM)9825515519400041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x445
=150  \\$aEuropean People
=450  \\$aEuropean Person
=450  \\$aEuropeans
=450  \\$wnnna$aEuropean Peoples
=450  \\$wnnna$aEuropean Persons
=450  \\$wnnna$aPeople, European
=450  \\$wnnna$aPerson, European
=450  \\$wnnna$aPersons, European
=680  \\$iPeople native to or inhabitants of EUROPE.
=688  \\$a2023
=750  \0$aEuropeans$0(DLC)sh 85045859$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17

=LDR  01338nz  a2200301n  4500
=001  9882687999502441
=005  20251118140835.0
=008  220712\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094363
=035  \\$a(DNLM)D000094363
=035  \\$a(NLM)9825515196200041
=040  \\$aDNLM$cDNLM
=072  \\$aG5.$x308.$x203.$x280
=150  \\$aEpigenetic Memory
=450  \\$aEpigenetic Cellular Memory
=450  \\$aEpigenetic Transcriptional Memory
=450  \\$aTransgenerational Epigenetic Memory
=450  \\$wnnna$aCellular Memory, Epigenetic
=450  \\$wnnna$aEpigenetic Cellular Memories
=450  \\$wnnna$aEpigenetic Memory, Transgenerational
=450  \\$wnnna$aMemory, Epigenetic
=450  \\$wnnna$aTranscriptional Memory, Epigenetic
=680  \\$iVarious mechanisms by which a stable propagation of changes in gene expression that is passed from egg and sperm to the embryo persists via epigenetic changes, e.g., DNA METHYLATION pattern changes.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aEpigenesis$0(DLC)sh 85044382$4BM$5IEN-M
=750  \0$81$wb$iBroader mapping$aMemory$0(DLC)sh 85083497$4BM$5IEN-M
=788  \0$iSearch also under the Library of Congress Subject Headings used together in the same record:$aEpigenesis$iand$aMemory$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01838nz  a2200481n  4500
=001  9882687999602441
=005  20251118142646.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094682
=035  \\$a(DNLM)D000094682
=035  \\$a(NLM)9825515438900041
=040  \\$aDNLM$cDNLM
=072  \\$aE4.$x100.$x814.$x529.$x953
=072  \\$aE4.$x100.$x814.$x868.$x500.$x500
=072  \\$aE4.$x502.$x382.$x953
=072  \\$aE4.$x650.$x200.$x500
=150  \\$aEndovascular Aneurysm Repair
=450  \\$aBEVAR
=450  \\$aBranched Endovascular Aneurysm Repair
=450  \\$aEndovascular Aortic Repair
=450  \\$aEndovascular Stent Grafting
=450  \\$aFenestrated Endovascular Aneurysm Repair
=450  \\$aFEVAR
=450  \\$aTEVAR
=450  \\$aThoracic Endovascular Aneurysm Repair
=450  \\$aThoracic Endovascular Aortic Repair
=450  \\$aThoracic Endovascular Repair
=450  \\$wnnna$aAneurysm Repair, Endovascular
=450  \\$wnnna$aAortic Repair, Endovascular
=450  \\$wnnna$aEndovascular Aneurysm Repairs
=450  \\$wnnna$aEndovascular Aortic Repairs
=450  \\$wnnna$aEndovascular Repair, Thoracic
=450  \\$wnnna$aEndovascular Stent Graftings
=450  \\$wnnna$aRepair, Endovascular Aneurysm
=450  \\$wnnna$aRepair, Endovascular Aortic
=450  \\$wnnna$aRepair, Thoracic Endovascular
=450  \\$wnnna$aStent Grafting, Endovascular
=450  \\$wnnna$aThoracic Endovascular Repairs
=680  \\$iA minimally invasive surgical technique to repair aneurysms through the lumen of a blood vessel.
=680  \\$iRepair of THORACIC AORTIC ANEURYSM with an endovascular stent graft.
=688  \\$a2023
=750  \0$iBroader mapping$aBlood-vessels$xEndoscopic surgery$0(DLC)sh 92000235$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01387nz  a2200337n  4500
=001  9882687999702441
=005  20251118141608.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092722
=035  \\$a(DNLM)D000092722
=035  \\$a(NLM)9825515250200041
=040  \\$aDNLM$cDNLM
=072  \\$aE2.$x348
=072  \\$aE5.$x200.$x500.$x454.$x750
=072  \\$aE5.$x242.$x448.$x750
=072  \\$aE5.$x301.$x500.$x750
=150  \\$aElectroporation Therapies
=450  \\$aElectroporation Therapeutic Uses
=450  \\$aElectroporation Therapy
=450  \\$aTherapeutic Use of Electroporation
=450  \\$wnnna$aElectroporation Therapeutic Use
=450  \\$wnnna$aTherapeutic Use, Electroporation
=450  \\$wnnna$aTherapeutic Uses, Electroporation
=450  \\$wnnna$aTherapies, Electroporation
=450  \\$wnnna$aTherapy, Electroporation
=680  \\$iTreatment modalities that use pulsed electrical currents to permeabilize cell membranes and thereby enhance uptake of substances into cells of the body.
=688  \\$a2023
=750  \0$81$wb$iBroader mapping$aElectroporation$0(DLC)sh 89001422$4BM$5IEN-M
=780  \0$81$wb$iBroader mapping$xTherapeutic use$0(DLC)sh2001008985$4BM$5IEN-M
=788  \0$iSearch under the Library of Congress Subject Heading$aElectroporation--Therapeutic use$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  00849nz  a2200277n  4500
=001  9882687999902441
=005  20251118140710.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092464
=035  \\$a(DNLM)D000092464
=035  \\$a(NLM)9825515278200041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x88.$x134
=150  \\$aElbow Injuries
=450  \\$aElbow Joint Injuries
=450  \\$wnnna$aElbow Injury
=450  \\$wnnna$aElbow Joint Injury
=450  \\$wnnna$aInjury, Elbow
=450  \\$wnnna$aInjury, Elbow Joint
=450  \\$wnnna$aJoint Injury, Elbow
=450  \\$aElbow$xinjuries
=450  \\$aElbow Joint$xinjuries
=680  \\$iInjuries involving the ELBOW and ELBOW JOINT.
=688  \\$a2023
=750  \0$aElbow$xWounds and injuries$0(DLC)sh 85041536$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01305nz  a2200361n  4500
=001  9882688000102441
=005  20251118140602.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000092482
=035  \\$a(DNLM)D000092482
=035  \\$a(NLM)9825515105600041
=040  \\$aDNLM$cDNLM
=072  \\$aC26.$x88.$x134.$x500
=072  \\$aC26.$x404.$x20
=150  \\$aElbow Fractures
=450  \\$aProximal Radial Fractures
=450  \\$aProximal Radius Fractures
=450  \\$aProximal Ulna Fractures
=450  \\$wnnna$aElbow Fracture
=450  \\$wnnna$aFracture, Elbow
=450  \\$wnnna$aFracture, Proximal Radial
=450  \\$wnnna$aFracture, Proximal Radius
=450  \\$wnnna$aFracture, Proximal Ulna
=450  \\$wnnna$aProximal Radial Fracture
=450  \\$wnnna$aProximal Radius Fracture
=450  \\$wnnna$aProximal Ulna Fracture
=450  \\$wnnna$aRadial Fracture, Proximal
=450  \\$wnnna$aRadius Fracture, Proximal
=450  \\$wnnna$aUlna Fracture, Proximal
=680  \\$iFractures of the distal HUMERUS and the proximal ULNA and the RADIUS at the ELBOW JOINT, including the head, anatomic and surgical necks, and tuberosities.
=688  \\$a2023
=750  \0$aElbow$xFracture$0(DLC)sh 85041534$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  02433nz  a2200517n  4500
=001  9882688000202441
=005  20251118141905.0
=008  220708\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000094623
=035  \\$a(DNLM)D000094623
=035  \\$a(NLM)9825515547200041
=040  \\$aDNLM$cDNLM
=072  \\$aC14.$x907.$x55.$x448.$x250.$x256
=072  \\$aC14.$x907.$x454.$x240.$x500
=072  \\$aC15.$x378.$x463.$x515.$x240.$x500
=072  \\$aC16.$x131.$x831.$x428.$x500
=072  \\$aC16.$x320.$x850.$x260.$x500
=072  \\$aC17.$x300.$x200.$x310.$x500
=072  \\$aC17.$x800.$x804.$x428.$x500
=072  \\$aC17.$x800.$x827.$x260.$x500
=150  \\$aEhlers-Danlos Syndrome, Type IV
=450  \\$wnnna$aEDS IV
=450  \\$wnnna$aEhlers Danlos Syndrome, Arterial Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Arterial Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Ecchymotic Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Ecchymotic Type
=450  \\$wnnna$aEhlers Danlos Syndrome, Sack-Barabas Type
=450  \\$wnnna$aEhlers-Danlos Syndrome, Sack-Barabas Type
=450  \\$wnnna$aEhlers Danlos Syndrome Type 4, Autosomal Dominant
=450  \\$wnnna$aEhlers-Danlos Syndrome, Type IV, Autosomal Dominant
=450  \\$wnnna$aEhlers-Danlos Syndrome, Vascular Type
=450  \\$aType IV Ehlers-Danlos Syndrome
=450  \\$aVascular Ehlers-Danlos Syndrome
=450  \\$aVascular Type Ehlers-Danlos Syndrome
=450  \\$wnnna$aEhlers Danlos Syndrome, Sack Barabas Type
=450  \\$wnnna$aEhlers-Danlos Syndromes, Vascular
=450  \\$wnnna$aEhlers-Danlos Syndrome, Vascular
=450  \\$wnnna$aSyndromes, Vascular Ehlers-Danlos
=450  \\$wnnna$aSyndrome, Vascular Ehlers-Danlos
=450  \\$wnnna$aType IV Ehlers Danlos Syndrome
=450  \\$wnnna$aVascular Ehlers Danlos Syndrome
=450  \\$wnnna$aVascular Ehlers-Danlos Syndromes
=680  \\$iA subtype of Ehlers-Danlos syndrome (EDS) characterized by vascular pathologies, e.g., AORTIC DISSECTION in addition to common EDS findings, e.g., hyperextensible skin and joints, skin fragility and reduced wound healing capability. It is associated with mutations in collagen type III alpha 1 chain gene (COLLAGEN TYPE III).
=688  \\$a2023; see EHLERS-DANLOS SYNDROME 2008-2022
=750  \0$iBroader mapping$aEhlers-Danlos syndrome$0(DLC)sh 85041368$4BM$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/18

=LDR  01337nz  a2200373n  4500
=001  9882688000502441
=005  20251118144848.0
=008  240809\n\ancnnbaba\\\\\\\\\\\|\ana\\\\\\
=024  8\$0https://id.nlm.nih.gov/mesh/D000095225
=035  \\$a(DNLM)D000095225
=035  \\$a(NLM)9825515501700041
=040  \\$aDNLM$cDNLM
=072  \\$aM1.$x686.$x330.$x500
=150  \\$aEast Asian People
=450  \\$wnnna$aEast Asians
=450  \\$wnnna$aEastern Asian People
=450  \\$wnnna$aEastern Asians
=450  \\$wnnna$aFar East Asians
=450  \\$wnnna$aAsian, East
=450  \\$wnnna$aAsian, Eastern
=450  \\$wnnna$aAsian, Far East
=450  \\$wnnna$aAsian People, East
=450  \\$wnnna$aAsian People, Eastern
=450  \\$wnnna$aEast Asian
=450  \\$wnnna$aEast Asian Peoples
=450  \\$wnnna$aEastern Asian
=450  \\$wnnna$aEastern Asian Peoples
=450  \\$wnnna$aFar East Asian
=450  \\$wnnna$aPeople, East Asian
=450  \\$wnnna$aPeople, Eastern Asian
=680  \\$iPersons native to or inhabitants of EAST ASIA including CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.
=688  \\$a2023; for CHINESE use ASIANS 1981-2022, for JAPANESE use ASIANS 2004-2022; for KOREANS use ASIANS 2004-2022
=750  \0$aEast Asians$0(DLC)sh2007004486$5IEN-M
=930  \\$aMeSH Mapping GN 2025/11/17